FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Kumarasuriyar, A
   Grondahl, L
   Nurcombe, V
   Cool, SM
AF Kumarasuriyar, Arjuna
   Grondahl, Lisbeth
   Nurcombe, Victor
   Cool, Simon M.
TI Osteoblasts up-regulate the expression of extracellular proteases
   following attachment to
   Poly(beta-hydroxybutyrate-co-beta-hydroxyvalerate)
SO GENE
LA English
DT Article
DE Extracellular matrix; Matrix metalloproteinase; Collagen; Osteopontin
ID GROWTH-FACTOR-BETA; IN-VITRO; SURFACE-ROUGHNESS; GENE-EXPRESSION;
   BONE-CELLS; COLLAGEN; FIBRONECTIN; PROTEIN; ADHESION; DIFFERENTIATION
AB MC3T3-E1 cells demonstrate a lag in osteogenic development when seeded onto Poly(beta-hydroxybutyrate-co-beta-hydroxyvalerate) (PHBV), a biomaterial with substantial potential for bone tissue repair. To determine if this was due to the priority of extracellular matrix (ECM) remodelling over other developmental processes, gene expression levels of proteins involved in the production, maintenance and turnover of the ECM were compared between cells grown on PHBV and tissue culture plastic (TCP) 24 h after seeding. When grown on PHBV, MC3T3-E1 cells up-regulated proteins such as the matrix metalloproteinases and down-regulated the expression of proteins such as collagens that are involved in cell-substrate interactions, but in later-stage processes. The results also suggest that proteins such as fibronectin and aggrecan, and particularly osteopontin, may be more suitable candidates for PHBV functionalization for optimal MC3T3-E1 cell growth than proteins like osteonectin, periostin, vitronectin or collagen. This study confirms the importance of understanding the specific response of therapeutically-relevant cells, such as human stem cells, to candidate biomaterial surfaces in order to achieve optimal regenerative therapies. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Kumarasuriyar, Arjuna; Nurcombe, Victor; Cool, Simon M.] Natl Univ Singapore, Inst Mol & Cell Biol, Singapore 138673, Singapore.
   [Kumarasuriyar, Arjuna] Univ Queensland, Sch Biomed Sci, St Lucia, Qld 4072, Australia.
   [Grondahl, Lisbeth] Univ Queensland, Sch Mol & Microbial Sci, St Lucia, Qld 4072, Australia.
RP Cool, SM (reprint author), Natl Univ Singapore, Inst Mol & Cell Biol, 61 Biopolis Dr, Singapore 138673, Singapore.
EM scool@imcb.a-star.edu.sg
RI ASTAR, IMCB/E-2320-2012
OI Grondahl, Lisbeth/0000-0001-6012-9808
FU Singapore's Agency for Science Technology and Research (A-STAR);
   Biomedical Research Council (BMRC); Institute of Molecular and Cell
   Biology (IMCB), Singapore; Wesley Research Institute, Brisbane,
   Australia [2000100294]; Australian Research Council [DP0209873,
   DP0343547]
FX This work was supported by Singapore's Agency for Science Technology and
   Research (A-STAR), the Biomedical Research Council (BMRC) of Singapore,
   the Institute of Molecular and Cell Biology (IMCB), Singapore and the
   Wesley Research Institute, Brisbane, Australia (Grant No 2000100294) and
   the Australian Research Council (DP0209873 and DP0343547).
CR ANDRIANARIVO AG, 1992, J CELL PHYSIOL, V153, P256, DOI 10.1002/jcp.1041530205
   Aubin JE, 1998, BIOCHEM CELL BIOL, V76, P899, DOI 10.1139/bcb-76-6-899
   Bhati RS, 2001, J BIOMED MATER RES, V56, P74, DOI 10.1002/1097-4636(200107)56:1<74::AID-JBM1070>3.0.CO;2-M
   BITTERMAN PB, 1983, J CELL BIOL, V97, P1925, DOI 10.1083/jcb.97.6.1925
   BOSKEY AL, 1993, BONE MINER, V22, P147, DOI 10.1016/S0169-6009(08)80225-5
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   CAPLAN AI, 1994, CLIN PLAST SURG, V21, P429
   Celic S, 1998, J ENDOCRINOL, V158, P377, DOI 10.1677/joe.0.1580377
   Claes LE, 1998, CLIN ORTHOP RELAT R, pS356
   D'Alonzo RC, 2002, J BIOL CHEM, V277, P24788, DOI 10.1074/jbc.M202604200
   DEAK F, 1986, P NATL ACAD SCI USA, V83, P3766, DOI 10.1073/pnas.83.11.3766
   FOGERTY FJ, 1990, J CELL BIOL, V111, P699, DOI 10.1083/jcb.111.2.699
   GOGOLEWSKI S, 1992, Clinical Materials, V10, P13, DOI 10.1016/0267-6605(92)90079-9
   HANKS SK, 1992, P NATL ACAD SCI USA, V89, P8487, DOI 10.1073/pnas.89.18.8487
   Holland J, 1996, BIOMATERIALS, V17, P2147, DOI 10.1016/0142-9612(96)00028-2
   Horiuchi K, 1999, J BONE MINER RES, V14, P1239, DOI 10.1359/jbmr.1999.14.7.1239
   Jackson RA, 2006, J CELL PHYSIOL, V209, P894, DOI 10.1002/jcp.20779
   JUNDT G, 1987, CELL TISSUE RES, V248, P409
   Kaartinen MT, 1999, J BIOL CHEM, V274, P1729, DOI 10.1074/jbc.274.3.1729
   Keen I, 2007, J BIOMAT SCI-POLYM E, V18, P1101, DOI 10.1163/156856207781554046
   Ku Y, 2005, BIOMATERIALS, V26, P5153, DOI 10.1016/j.biomaterials.2005.01.060
   Kumarasuriyar A, 2005, TISSUE ENG, V11, P1281, DOI 10.1089/ten.2005.11.1281
   LIAN JB, 1992, CRIT REV ORAL BIOL M, V3, P269, DOI 10.1177/10454411920030030501
   Lincks J, 1998, BIOMATERIALS, V19, P2219, DOI 10.1016/S0142-9612(98)00144-6
   Linez-Bataillon P, 2002, BIOMOL ENG, V19, P133, DOI 10.1016/S1389-0344(02)00024-2
   Mackie EJ, 1998, BONE, V22, P301, DOI 10.1016/S8756-3282(97)00297-4
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   MASI L, 1992, CALCIFIED TISSUE INT, V51, P202, DOI 10.1007/BF00334548
   Mongiat M, 2003, J BIOL CHEM, V278, P17491, DOI 10.1074/jbc.M210529200
   Norris RA, 2007, J CELL BIOCHEM, V101, P695, DOI 10.1002/jcb.21224
   SELMANI A, 1995, MICROSCOPICAL ANAL 2, P165
   Stefansson S, 2007, J BIOL CHEM, V282, P15679, DOI 10.1074/jbc.M702125200
   SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191
   TAMADA Y, 1994, J BIOMED MATER RES, V28, P783, DOI 10.1002/jbm.820280705
   Tanaka Y, 2000, J BONE MINER RES, V15, P1912, DOI 10.1359/jbmr.2000.15.10.1912
   TAYLOR MS, 1994, J APPL BIOMATER, V5, P151, DOI 10.1002/jab.770050208
   TERMINE JD, 1981, CELL, V26, P99, DOI 10.1016/0092-8674(81)90037-4
   van den Dolder J, 2003, TISSUE ENG, V9, P505, DOI 10.1089/107632703322066688
   Wang M, 2001, J MATER SCI-MATER M, V12, P855, DOI 10.1023/A:1012899318688
   Wang MS, 2004, LANGMUIR, V20, P7753, DOI 10.1021/la049849+
   Weber GF, 1996, SCIENCE, V271, P509, DOI 10.1126/science.271.5248.509
   Weston BS, 2003, J AM SOC NEPHROL, V14, P601, DOI 10.1097/01.ASN.0000051600.53134.B9
   WLODARSKI KH, 1990, CLIN ORTHOP RELAT R, P276
   Zeitler P, 2004, HISTOPATHOLOGY, V44, P360, DOI 10.1111/j.1365-2559.2004.01854.x
NR 44
TC 2
Z9 2
U1 1
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-1119
J9 GENE
JI Gene
PD JAN 1
PY 2009
VL 428
IS 1-2
BP 53
EP 58
DI 10.1016/j.gene.2008.09.020
PG 6
WC Genetics & Heredity
SC Genetics & Heredity
GA 389DN
UT WOS:000262071000010
PM 18930122
DA 2018-10-19
ER

PT S
AU Mack, D
   Davies, AP
   Harris, LG
   Knobloch, JKM
   Rohde, H
AF Mack, Dietrich
   Davies, Angharad P.
   Harris, Llinos G.
   Knobloch, Johannes K. M.
   Rohde, Holger
BE Lindhorst, TK
   Oscarson, S
TI Staphylococcus epidermidis Biofilms: Functional Molecules, Relation to
   Virulence, and Vaccine Potential
SO GLYCOSCIENCE AND MICROBIAL ADHESION
SE Topics in Current Chemistry
LA English
DT Review; Book Chapter
DE Adhesion; Biofilm; Escherichia coli; Foreign body-related infection;
   Polysaccharide intercellular adhesin; Staphylococcus epidermidis;
   Vaccines
ID POLYSACCHARIDE INTERCELLULAR ADHESIN; COAGULASE-NEGATIVE STAPHYLOCOCCI;
   POLY-N-ACETYLGLUCOSAMINE; FOREIGN-BODY INFECTION;
   ACCUMULATION-ASSOCIATED PROTEIN; CATHETER-ASSOCIATED INFECTION;
   FIBRINOGEN-BINDING-PROTEIN; DEVICE-RELATED INFECTION; SIGMA-FACTOR
   SIGMA(B); SURFACE POLYSACCHARIDE
AB Medical device-associated infections, most frequently caused by Staphylococcus epidermidis and Staphylococcus aureus, are of increasing importance in modern medicine. The formation of adherent, multilayered bacterial biofilms is crucial in the pathogenesis of these infections. Polysaccharide intercellular adhesin (PIA), a homoglycan of beta-1,6-linked 2-acetamido-2-deoxy-D-glucopyranosyl residues, of which about 15% are non-N-acetylated, is central to biofilm accumulation in staphylococci. It transpires that polysaccharides - structurally very similar to PIA - are also key to biofilm formation in a number of other organisms including the important human pathogens Escherichia coli, Aggregatibacter (Actinobacillus) actinomycetemcomitans, Yersinia pestis, and Bordetella spp.. Apparently, synthesis of PIA and related polysaccharides is a general feature important for biofilm formation in diverse bacterial genera. Current knowledge about the structure and biosynthesis of PIA and related polysaccharides is reviewed. Additionally, information on their role in pathogenesis of biomaterial-related and other type of infections and the potential use of PIA and related compounds for prevention of infection is evaluated.
C1 [Mack, Dietrich; Davies, Angharad P.; Harris, Llinos G.] Swansea Univ, Sch Med, Inst Life Sci, Swansea SA2 8PP, W Glam, Wales.
   [Knobloch, Johannes K. M.] Univ Lubeck, Inst Med Mikrobiol & Hyg, Lubeck, Germany.
   [Rohde, Holger] Univ Klinikum Hamburg Eppendorf, Zentrum Klin Pathol, Inst Med Mikrobiol Virol & Hyg, Hamburg, Germany.
RP Mack, D (reprint author), Swansea Univ, Sch Med, Inst Life Sci, Swansea SA2 8PP, W Glam, Wales.
EM D.Mack@swansea.ac.uk
RI Knobloch, Johannes/D-6456-2011
OI Knobloch, Johannes/0000-0002-2591-6387; Davies,
   Angharad/0000-0003-4190-8894; Harris, Llinos/0000-0002-0295-3038
FU Medical Research Council [G0801929]
CR Allignet J, 2001, INFECT IMMUN, V69, P712, DOI 10.1128/IAI.69.2.712-718.2001
   Arciola CR, 2004, BIOMATERIALS, V25, P4825, DOI 10.1016/j.biomaterials.2003.11.056
   Banner MA, 2007, J BACTERIOL, V189, P2793, DOI 10.1128/JB.00952-06
   Bateman A, 2005, BIOINFORMATICS, V21, P1301, DOI 10.1093/bioinformatics/bti206
   Begun J, 2007, PLOS PATHOG, V3, P526, DOI 10.1371/journal.ppat.0030057
   Bobrov AG, 2008, ENVIRON MICROBIOL, V10, P1419, DOI 10.1111/j.1462-2920.2007.01554.x
   Bobrov AG, 2007, ADV EXP MED BIOL, V603, P201
   Bowden MG, 2002, J BIOL CHEM, V277, P43017, DOI 10.1074/jbc.M207921200
   Bustanji Y, 2003, P NATL ACAD SCI USA, V100, P13292, DOI 10.1073/pnas.1735343100
   Cerca N, 2007, INFECT IMMUN, V75, P3406, DOI 10.1128/IAI.00078-07
   Cerca N, 2007, P NATL ACAD SCI USA, V104, P7528, DOI 10.1073/pnas.0700630104
   Cerca N, 2006, INFECT IMMUN, V74, P4849, DOI 10.1128/IAI.00230-06
   Chokr A, 2007, MICROB PATHOGENESIS, V42, P94, DOI 10.1016/j.micpath.2006.09.001
   Chokr A, 2006, INT J MED MICROBIOL, V296, P381, DOI 10.1016/j.ijmm.2006.02.018
   Christensen Gordon D., 1994, P45
   Conlon KM, 2004, J BACTERIOL, V186, P6208, DOI 10.1128/JB.186.18.6208-6219.2004
   Conlon KM, 2002, J BACTERIOL, V184, P4400, DOI 10.1128/JB.184.16.4400-4408.2002
   Corrigan RM, 2007, MICROBIOL-SGM, V153, P2435, DOI 10.1099/mic.0.2007/006676-0
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Cramton SE, 1999, INFECT IMMUN, V67, P5427
   Cucarella C, 2001, J BACTERIOL, V183, P2888, DOI 10.1128/JB.183.9.2888-2896.2001
   Darby C, 2002, NATURE, V417, P243, DOI 10.1038/417243a
   Darby C, 2008, TRENDS MICROBIOL, V16, P158, DOI 10.1016/j.tim.2008.01.005
   Dobinsky S, 2003, J BACTERIOL, V185, P2879, DOI 10.1128/JB.185.9.2879-2886.2003
   DREWRY DT, 1990, J CLIN MICROBIOL, V28, P1292
   Eckhart L, 2007, BRIT J DERMATOL, V156, P1342, DOI 10.1111/j.1365-2133.2007.07886.x
   ESPERSEN F, 1990, APMIS, V98, P471, DOI 10.1111/j.1699-0463.1990.tb01059.x
   Favero MS, 1996, AM J INFECT CONTROL, V24, P380
   Fey PD, 1999, J INFECT DIS, V179, P1561, DOI 10.1086/314762
   Fitzpatrick F, 2005, J CLIN MICROBIOL, V43, P1973, DOI 10.1128/JCM.43.4.1973-1976.2005
   Fluckiger U, 2005, INFECT IMMUN, V73, P1811, DOI 10.1128/IAI.73.3.1811-1819.2005
   Forman S, 2006, MICROBIOL-SGM, V152, P3399, DOI 10.1099/mic.0.29224-0
   Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289
   Francois P, 2003, FEMS IMMUNOL MED MIC, V35, P135, DOI 10.1016/S0928-8244(02)00463-7
   Frank KL, 2004, J CLIN MICROBIOL, V42, P4846, DOI 10.1128/JCM.42.10.4846-4849.2004
   Frank KL, 2008, CLIN MICROBIOL REV, V21, P111, DOI 10.1128/CMR.00036-07
   Frank KL, 2007, INFECT IMMUN, V75, P4728, DOI 10.1128/IAI.00640-07
   Gening ML, 2007, CARBOHYD RES, V342, P567, DOI 10.1016/j.carres.2006.08.010
   Gerke C, 1998, J BIOL CHEM, V273, P18586, DOI 10.1074/jbc.273.29.18586
   Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005
   Goller C, 2006, J BACTERIOL, V188, P8022, DOI 10.1128/JB.01106-06
   Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x
   Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821
   Harris LG, 2004, J MATER SCI-MATER M, V15, P311, DOI 10.1023/B:JMSM.0000021093.84680.bb
   Hartford O, 2001, MICROBIOL-SGM, V147, P2545, DOI 10.1099/00221287-147-9-2545
   Heilmann C, 2003, MICROBIOL-SGM, V149, P2769, DOI 10.1099/mic.0.26527-0
   Heilmann C, 1996, INFECT IMMUN, V64, P277
   Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x
   Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x
   Hennig S, 2007, INT J MED MICROBIOL, V297, P117, DOI 10.1016/j.ijmm.2006.12.001
   Higashi JM, 1998, J BIOMED MATER RES, V39, P341, DOI 10.1002/(SICI)1097-4636(19980305)39:3<341::AID-JBM1>3.0.CO;2-J
   HOGT AH, 1986, J BIOMED MATER RES, V20, P533, DOI 10.1002/jbm.820200409
   HOGT AH, 1985, J GEN MICROBIOL, V131, P2485
   HOGT AH, 1986, INFECT IMMUN, V51, P294
   Hussain M, 2001, MICROB PATHOGENESIS, V31, P261, DOI 10.1006/mpat.2001.0469
   Hussain M, 1997, INFECT IMMUN, V65, P519
   Itoh Y, 2005, J BACTERIOL, V187, P382, DOI 10.1128/JB.187.1.382-387.2005
   Itoh Y, 2008, J BACTERIOL, V190, P3670, DOI 10.1128/JB.01920-07
   Izano EA, 2008, MICROB PATHOGENESIS, V44, P52, DOI 10.1016/j.micpath.2007.08.004
   Izano EA, 2008, APPL ENVIRON MICROB, V74, P470, DOI 10.1128/AEM.02073-07
   Izano EA, 2007, MICROB PATHOGENESIS, V43, P1, DOI 10.1016/j.micpath.2007.02.004
   Jager S, 2005, APPL ENVIRON MICROB, V71, P5577, DOI 10.1128/AEM.71.9.5577-5581.2005
   Jefferson KK, 2004, J BACTERIOL, V186, P2449, DOI 10.1128/JB.186.8.2449-2456.2004
   Jefferson KK, 2003, MOL MICROBIOL, V48, P889, DOI 10.1046/j.1365-2958.2003.03482.x
   Joyce JG, 2003, CARBOHYD RES, V338, P903, DOI 10.1016/S0008-6215(03)00045-4
   Kaplan JB, 2004, J BACTERIOL, V186, P8213, DOI 10.1128/JB.186.24.8213-8220.2004
   Kaplan JB, 2004, ANTIMICROB AGENTS CH, V48, P2633, DOI 10.1128/AAC.48.7.2633-2636.2004
   Kaplan JB, 2003, J BACTERIOL, V185, P4693, DOI 10.1128/JB.185.16.4693-4692.2003
   Kelly-Quintos C, 2006, INFECT IMMUN, V74, P2742, DOI 10.1128/IAI.74.5.2742-2750.2006
   Kelly-Quintos C, 2005, J INFECT DIS, V192, P2012, DOI 10.1086/497604
   Knobloch JKM, 2004, INFECT IMMUN, V72, P3838, DOI 10.1128/IAI.72.7.3838-3848.2004
   Knobloch JKM, 2002, MED MICROBIOL IMMUN, V191, P101, DOI 10.1007/s00430-002-0124-3
   Knobloch JKM, 2001, J BACTERIOL, V183, P2624, DOI 10.1128/JB.183.8.2624-2633.2001
   Kogan G, 2006, FEMS MICROBIOL LETT, V255, P11, DOI 10.1111/j.1574-6968.2005.00043.x
   KOJIMA Y, 1990, J INFECT DIS, V162, P435, DOI 10.1093/infdis/162.2.435
   Kristian SA, 2004, MICROB PATHOGENESIS, V36, P237, DOI 10.1016/j.micpath.2003.12.004
   Kristian SA, 2008, J INFECT DIS, V197, P1028, DOI 10.1086/528992
   KRISTINSSON KG, 1988, J MED MICROBIOL, V27, P207, DOI 10.1099/00222615-27-3-207
   Kropec A, 2005, INFECT IMMUN, V73, P6868, DOI 10.1128/IAI.73.10.6868-6876.2005
   Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557
   Li DQ, 2001, CURR MICROBIOL, V42, P361, DOI 10.1007/s002840010230
   Li HL, 2005, INFECT IMMUN, V73, P3188, DOI 10.1128/IAI.73.5.3188-3191.2005
   Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806
   Lu TK, 2007, P NATL ACAD SCI USA, V104, P11197, DOI 10.1073/pnas.0704624104
   LUDWICKA A, 1984, ZBL BAKT-INT J MED M, V256, P479, DOI 10.1016/S0174-3031(84)80024-4
   Mack D, 1996, J INFECT DIS, V174, P881, DOI 10.1093/infdis/174.4.881
   Mack D, 2006, INT J ARTIF ORGANS, V29, P343
   MACK D, 1994, INFECT IMMUN, V62, P3244
   Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996
   Mack D, 1999, INFECT IMMUN, V67, P1004
   MACK D, 1992, INFECT IMMUN, V60, P2048
   Mack D, 2001, METHOD ENZYMOL, V336, P215, DOI 10.1016/S0076-6879(01)36592-8
   MACK D, 2006, INT J MED MICROBIOL, V296, P133
   MACK D, 2000, HDB STUDYING BACTERI, P307
   Mack D., 1999, J HOSP INFECT, V43, P113
   Mack D., 2006, BIOFILMS INFECT ANTI, P109
   Mack D, 2007, ANAL BIOANAL CHEM, V387, P399, DOI 10.1007/s00216-006-0745-2
   Maira-Litran T, 2005, INFECT IMMUN, V73, P6752, DOI 10.1128/IAI.73.10.6752-6762.2005
   Maira-Litran T, 2004, VACCINE, V22, P872, DOI 10.1016/j.vaccine.2003.11.033
   Maira-Litran T, 2002, INFECT IMMUN, V70, P4433, DOI 10.1128/IAI.70.8.4433-4440.2002
   McKenney D, 1999, SCIENCE, V284, P1523, DOI 10.1126/science.284.5419.1523
   McKenney D, 1998, INFECT IMMUN, V66, P4711
   Moretro T, 2003, APPL ENVIRON MICROB, V69, P5648, DOI 10.1128/AEM.69.9.5648-5655.2003
   MULLER E, 1993, J INFECT DIS, V168, P1211, DOI 10.1093/infdis/168.5.1211
   Nilsson M, 1998, INFECT IMMUN, V66, P2666
   O'Gara JP, 2007, FEMS MICROBIOL LETT, V270, P179, DOI 10.1111/j.1574-6968.2007.00688.x
   O'Neill E, 2008, J BACTERIOL, V190, P3835, DOI 10.1128/JB.00167-08
   Otto M, 2004, FRONT BIOSCI, V9, P841, DOI 10.2741/1295
   Parise G, 2007, J BACTERIOL, V189, P750, DOI 10.1128/JB.00953-06
   PASCUAL A, 1986, EUR J CLIN MICROBIOL, V5, P518, DOI 10.1007/BF02017694
   Patel JD, 2007, J BIOMED MATER RES A, V80A, P742, DOI 10.1002/jbm.a.31103
   PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101
   Pei L, 2001, J INFECT DIS, V184, P52, DOI 10.1086/321003
   Perry RD, 2004, J BACTERIOL, V186, P1638, DOI 10.1128/JB.186.6.1638-1647.2004
   Qin ZQ, 2007, MICROBIOL-SGM, V153, P2083, DOI 10.1099/mic.0.2007/006031-0
   Quoc PHT, 2007, INFECT IMMUN, V75, P1079, DOI 10.1128/IAI.01143-06
   Ramasubbu N, 2005, J MOL BIOL, V349, P475, DOI 10.1016/j.jmb.2005.03.082
   Rennermalm A, 2004, INFECT IMMUN, V72, P3081, DOI 10.1128/IAI.72.5.3081-3083.2004
   Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104
   Roche FM, 2003, MICROBIOL-SGM, V149, P2759, DOI 10.1099/mic.0.26412-0
   Roche FM, 2003, MICROBIOL-SGM, V149, P643, DOI 10.1099/mic.0.25996-0
   Rohde H, 2004, J CLIN MICROBIOL, V42, P5614, DOI 10.1128/JCM.42.12.5614-5619.2004
   Rohde H, 2001, MED MICROBIOL IMMUN, V190, P105, DOI 10.1007/s00430-001-0099-5
   Rohde H, 2005, MOL MICROBIOL, V55, P1883, DOI 10.1111/j.1365-2958.04515.x
   Rohde H, 2007, BIOMATERIALS, V28, P1711, DOI 10.1016/j.biomaterials.2006.11.046
   Rohde H, 2006, REV MED MICROBIOL, V17, P45
   Rupp ME, 2001, J INFECT DIS, V183, P1038, DOI 10.1086/319279
   Rupp ME, 1999, INFECT IMMUN, V67, P2656
   Rupp ME, 1999, INFECT IMMUN, V67, P2627
   Rupp ME, 2001, METHOD ENZYMOL, V336, P206, DOI 10.1016/S0076-6879(01)36591-6
   RUPP ME, 1994, CLIN INFECT DIS, V19, P231, DOI 10.1093/clinids/19.2.231
   RUPP ME, 1992, INFECT IMMUN, V60, P4322
   Sadovskaya I, 2005, INFECT IMMUN, V73, P3007, DOI 10.1128/IAI.73.5.3007-3017.2005
   Samek O, 2008, LASER PHYS LETT, V5, P465, DOI 10.1002/lapl.200810011
   Sloan GP, 2007, J BACTERIOL, V189, P8270, DOI 10.1128/JB.00785-07
   TIMMERMAN CP, 1991, INFECT IMMUN, V59, P4187
   TOJO M, 1988, J INFECT DIS, V157, P713, DOI 10.1093/infdis/157.4.713
   Tormo MA, 2005, J BACTERIOL, V187, P2348, DOI 10.1128/JB.187.7.2348-2356.2005
   Tormo MA, 2005, MICROBIOL-SGM, V151, P2465, DOI 10.1099/mic.0.27865-0
   van den Berg B, 2004, SCIENCE, V304, P1506, DOI 10.1126/science.1097524
   Vandecasteele SJ, 2003, J INFECT DIS, V188, P730, DOI 10.1086/377452
   Vandecasteele SJ, 2003, CLIN MICROBIOL INFEC, V9, P114, DOI 10.1046/j.1469-0691.2003.00544.x
   Vaudaux Pierre E., 1994, P1
   Veenstra GJC, 1996, J BACTERIOL, V178, P537, DOI 10.1128/jb.178.2.537-541.1996
   Vernachio JH, 2006, ANTIMICROB AGENTS CH, V50, P511, DOI 10.1128/AAC.50.2.511-518.2006
   Vuong C, 2004, J BIOL CHEM, V279, P54881, DOI 10.1074/jbc.M411374200
   Vuong C, 2004, CELL MICROBIOL, V6, P269, DOI 10.1111/j.1462-5822.2004.00367.x
   Wang CZ, 2007, MICROBES INFECT, V9, P1376, DOI 10.1016/j.micinf.2007.06.012
   Wang L, 2008, J INFECT DIS, V197, P1254, DOI 10.1086/586714
   Wang X, 2004, J BACTERIOL, V186, P2724, DOI 10.1128/JB.186.9.2724-2734.2004
   Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487
   Williams RJ, 2002, INFECT IMMUN, V70, P6805, DOI 10.1128/IAI.70.12.6805-6810.2002
   Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946
   Xu L, 2006, INFECT IMMUN, V74, P488, DOI 10.1128/IAI.74.1.488-496.2006
   Ziebuhr W, 1999, MOL MICROBIOL, V32, P345, DOI 10.1046/j.1365-2958.1999.01353.x
   Ziebuhr W, 1997, INFECT IMMUN, V65, P890
   ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305
   ZIMMERLI W, 1982, J INFECT DIS, V146, P487, DOI 10.1093/infdis/146.4.487
NR 158
TC 17
Z9 18
U1 1
U2 12
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0340-1022
BN 978-3-642-01304-1; 978-3-642-01303-4
J9 TOP CURR CHEM
JI Top. Curr. Chem.
PY 2009
VL 288
BP 157
EP 182
DI 10.1007/128_2008_19
D2 10.1007/978-3-642-01304-1
PG 26
WC Chemistry, Multidisciplinary
SC Chemistry
GA BQG02
UT WOS:000280911900007
PM 22328030
DA 2018-10-19
ER

PT J
AU Kadau, D
   Herrmann, HJ
   Andrade, JS
   Araujo, AD
   Bezerra, LJC
   Maia, LP
AF Kadau, Dirk
   Herrmann, Hans J.
   Andrade, Jose S., Jr.
   Araujo, Ascanio D.
   Bezerra, Luiz J. C.
   Maia, Luis P.
TI Living quicksand
SO GRANULAR MATTER
LA English
DT Article
DE Granular matter; Contact dynamics; Simulations; Distinct element method;
   Quicksand; Collapsible soil; Biomaterial
ID DUNES
AB The image of quicksand merciless swallowing a victim has inspired the fantasy of kids and helped writers and moviemakers to get rid of evil figures. Is this really possible? This is still disputed since till today it is not even clear what quicksand exactly is. In soil mechanics, the "quick-condition" is usually described as a liquefaction due to high water pressure essentially possible with any soil. However, previous studies have detected anomalous rheological properties from natural quicksand. Pushed by these contradicting points of view we set off to Len double dagger ois Maranhenses in North-East Brazil, where quicksands are common, to investigate rheology and strength in situ. We found that along very quiet drying lakes cyanobacteria cement an impermeable crust above a suspension of grains. Beyond a critical pressure, the crust fails releasing water from the collapsing colloidal structure and radically changing the depth dependence of the shear strength from a constant to a linear function. The sedimenting solid fraction and the rapid increase of shear strength can indeed trap an intruder endangering his life if the basin is sufficiently deep. As opposed to some previous studies, we find that this quicksand condition cannot be restored once it has collapsed. Finally, we also show some preliminary results from a contact dynamics model specially designed to mimic the living quicksand behavior.
C1 [Kadau, Dirk; Herrmann, Hans J.; Andrade, Jose S., Jr.] ETH Honggerberg, Inst Bldg Mat, CH-8093 Zurich, Switzerland.
   [Herrmann, Hans J.; Andrade, Jose S., Jr.; Araujo, Ascanio D.] Univ Fed Ceara, Dept Fis, BR-60451970 Fortaleza, Ceara, Brazil.
   [Bezerra, Luiz J. C.; Maia, Luis P.] Univ Fed Ceara, BR-60165081 Fortaleza, Ceara, Brazil.
RP Kadau, D (reprint author), ETH Honggerberg, Inst Bldg Mat, CH-8093 Zurich, Switzerland.
EM dkadau@ethz.ch
RI Kadau, Dirk/B-4697-2010; Andrade, Jose/C-5451-2013; Universidade Federal
   do Ceara, Physics Department/J-4630-2016; UFC, DF/E-1564-2017; Sistemas
   Complexos, Inct/J-8597-2013; Tmcocean, Inct/J-8735-2013
OI Andrade, Jose/0000-0002-5571-7610; Universidade Federal do Ceara,
   Physics Department/0000-0002-9247-6780; 
FU Max Planck Prize; CNPq; CAPES; FUNCAP; FINEP; Volkswagenstiftung
FX We thank Sarah Springman for lending us her equipment. We thank Andrea
   Cristina da Silva Ferreira for making the images of Fig. 4 and CNPq,
   CAPES, FUNCAP, FINEP, the Volkswagenstiftung and the Max Planck Prize
   for financial support.
CR Bahlmann L, 2002, RESUSCITATION, V53, P101, DOI 10.1016/S0300-9572(02)00009-6
   Caballero G, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.018001
   Clayton C.R.I., 1995, SITE INVESTIGATION
   Craig R.F., 1997, SOIL MECH
   DANIN A, 1978, FLORA, V167, P409
   DANIN A, 1991, J ARID ENVIRON, V21, P193, DOI 10.1016/S0140-1963(18)30682-7
   El Shamy U, 2005, J ENG MECH-ASCE, V131, P413, DOI 10.1061/(ASCE)0733-9399(2005)131:4(413)
   Freundlich H, 1935, T FARADAY SOC, V31, P0769, DOI 10.1039/tf9353100769
   Huerta DA, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.031307
   JEAN M, 1992, CONTACT MECHANICS : INTERNATIONAL SYMPOSIUM, PROCEEDINGS, P31
   Kadau D, 2003, PHASE TRANSIT, V76, P315, DOI 10.1080/0141159021000051460
   Khaldoun A, 2005, NATURE, V437, P635, DOI 10.1038/437635a
   Kruszelnicki K, 1996, NEW SCI, V152, P26
   Lambe T.W, 1969, SOIL MECH
   Lohse D, 2004, NATURE, V432, P689, DOI 10.1038/432689a
   MATTHES GH, 1953, QUICKSAND SCI AM, V188, P97
   MOREAU JJ, 1994, EUR J MECH A-SOLID, V13, P93
   PARKER WR, 1966, NATURE, V210, P1247, DOI 10.1038/2101247a0
   Royer JR, 2005, NAT PHYS, V1, P164, DOI 10.1038/nphys175
   Schwammle V, 2003, NATURE, V426, P619, DOI 10.1038/426619a
   Smith E. R, 1946, OHIO J SCI, V46, P327
   Yamasaki S, 2003, SCI AM, V288, P95
NR 22
TC 9
Z9 9
U1 3
U2 15
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1434-7636
J9 GRANUL MATTER
JI Granul. Matter
PD JAN
PY 2009
VL 11
IS 1
BP 67
EP 71
DI 10.1007/s10035-008-0117-z
PG 5
WC Materials Science, Multidisciplinary; Mechanics; Physics, Applied
SC Materials Science; Mechanics; Physics
GA 392CB
UT WOS:000262279400008
DA 2018-10-19
ER

PT J
AU Jiang, N
   Pu, YQ
   Samuel, R
   Ragauskas, AJ
AF Jiang, Nan
   Pu, Yunqiao
   Samuel, Reichel
   Ragauskas, Arthur J.
TI Perdeuterated pyridinium molten salt (ionic liquid) for direct
   dissolution and NMR analysis of plant cell walls
SO GREEN CHEMISTRY
LA English
DT Article
ID LIGNOCELLULOSIC MATERIALS; GREEN CHEMISTRY; CELLULOSE; LIGNIN; WOOD;
   BIOFUELS; BIOMASS; TRANSFORMATION
AB A bi-solvent system consisting of perdeuterated pyridinium molten salt and DMSO-d(6) (dimethyl sulfoxide-d(6)) has been developed for direct dissolution and nuclear magnetic resonance (NMR) analysis of plant cell walls, which will shed a new light on efficient detailed structure of the plant cell walls and benefit lignin engineering for biofuel and biomaterial research.
C1 [Jiang, Nan; Pu, Yunqiao; Samuel, Reichel; Ragauskas, Arthur J.] Georgia Inst Technol, Sch Chem & Biochem, BioEnergy Sci Ctr, Inst Paper Sci & Technol, Atlanta, GA 30332 USA.
RP Jiang, N (reprint author), Georgia Inst Technol, Sch Chem & Biochem, BioEnergy Sci Ctr, Inst Paper Sci & Technol, Atlanta, GA 30332 USA.
EM Arthur.ragauskas@chemistry.gatech.edu
RI Ragauskas, Art/J-7486-2016
OI Ragauskas, Art/0000-0002-3536-554X; Pu, Yunqiao/0000-0003-2554-1447
FU BioEnergy Science Center (BESC) [DE-AC05-00OR22725]; Office of
   Biological and Environmental Research in the DOE Office of Science
FX The funding (DE-AC05-00OR22725) from the BioEnergy Science Center
   (BESC), a U. S. Department of Energy Bioenergy Research Center supported
   by the Office of Biological and Environmental Research in the DOE Office
   of Science, is acknowledged. The authors would like to gratefully
   acknowledge the financial support from the DOE Office of Biological and
   Environmental Research through the BioEnergy Science Center.
CR Abbott AP, 2006, GREEN CHEM, V8, P784, DOI 10.1039/b605258d
   Barthel S, 2006, GREEN CHEM, V8, P301, DOI 10.1039/b513157j
   Baucher M, 2003, CRIT REV BIOCHEM MOL, V38, P305, DOI 10.1080/10409230390242443
   CHANG HM, 1975, HOLZFORSCHUNG, V29, P153, DOI 10.1515/hfsg.1975.29.5.153
   Clark JH, 2006, GREEN CHEM, V8, P853, DOI 10.1039/b604483m
   Corma A, 2007, CHEM REV, V107, P2411, DOI 10.1021/cr050989d
   Davin LB, 2005, CURR OPIN BIOTECH, V16, P407, DOI 10.1016/j.copbio.2005.06.011
   Fort DA, 2007, GREEN CHEM, V9, P63, DOI 10.1039/b607614a
   Fukaya Y, 2008, GREEN CHEM, V10, P44, DOI 10.1039/b713289a
   Gaspar AR, 2007, GREEN CHEM, V9, P717, DOI 10.1039/b607824a
   Giernoth R, 2008, EUR J ORG CHEM, P2881, DOI 10.1002/ejoc.200700784
   Hardacre C, 2001, CHEM COMMUN, P367, DOI 10.1039/b009097m
   Horvath IT, 2007, CHEM REV, V107, P2169, DOI 10.1021/cr078380v
   Huber GW, 2007, ANGEW CHEM INT EDIT, V46, P7184, DOI 10.1002/anie.200604504
   Ikeda T, 2002, J AGR FOOD CHEM, V50, P129, DOI 10.1021/jf010870f
   Jung H. G., 1993, FORAGE CELL WALL STR, P1
   Kilpelainen I, 2007, J AGR FOOD CHEM, V55, P9142, DOI 10.1021/jf071692e
   KONDO T, 1995, J SCI FOOD AGR, V68, P383, DOI 10.1002/jsfa.2740680318
   Lewis N. G., 1989, PLANT CELL WALL POLY, V399, P1
   Li CZ, 2008, GREEN CHEM, V10, P177, DOI 10.1039/b711512a
   Liu CF, 2007, J AGR FOOD CHEM, V55, P2399, DOI 10.1021/jf062876g
   Pena L, 2001, TRENDS BIOTECHNOL, V19, P500, DOI 10.1016/S0167-7799(01)01815-7
   Petrus L, 2006, GREEN CHEM, V8, P861, DOI 10.1039/b605036k
   Pu YQ, 2008, BIOFUEL BIOPROD BIOR, V2, P58, DOI 10.1002/bbb.48
   Pu YQ, 2007, J WOOD CHEM TECHNOL, V27, P23, DOI 10.1080/02773810701282330
   Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736
   Ralph J., 1999, ADV LIGNOCELLULOSICS, P55
   Ralph S. A., 2004, NMR DATABASE LIGNIN
   Rencoret J, 2008, HOLZFORSCHUNG, V62, P514, DOI 10.1515/HF.2008.096
   RIO JCD, 2008, J AGR FOOD CHEM, V56, P9525
   Sheldon R, 2001, CHEM COMMUN, P2399, DOI 10.1039/b107270f
   Sticklen M, 2006, CURR OPIN BIOTECH, V17, P315, DOI 10.1016/j.copbio.2006.05.003
   Swatloski RP, 2002, J AM CHEM SOC, V124, P4974, DOI 10.1021/ja025790m
   Tsioptsias C, 2008, GREEN CHEM, V10, P965, DOI 10.1039/b803869d
   Vitz J, 2009, GREEN CHEM, V11, P417, DOI 10.1039/b818061j
   Wasserscheid P, 2000, ANGEW CHEM INT EDIT, V39, P3772, DOI 10.1002/1521-3773(20001103)39:21<3772::AID-ANIE3772>3.0.CO;2-5
   Welton T, 1999, CHEM REV, V99, P2071, DOI 10.1021/cr980032t
   Wu J, 2004, BIOMACROMOLECULES, V5, P266, DOI 10.1021/bm034398d
   Xie H, 2007, BIOMACROMOLECULES, V8, P3740, DOI 10.1021/bm700679s
   Yelle DJ, 2008, MAGN RESON CHEM, V46, P508, DOI 10.1002/mrc.2201
   Zhao H, 2008, GREEN CHEM, V10, P696, DOI 10.1039/b801489b
   Zhu SD, 2006, GREEN CHEM, V8, P325, DOI 10.1039/b601395c
NR 42
TC 41
Z9 42
U1 1
U2 25
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1463-9262
J9 GREEN CHEM
JI Green Chem.
PY 2009
VL 11
IS 11
BP 1762
EP 1766
DI 10.1039/b913609f
PG 5
WC Chemistry, Multidisciplinary; GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY
SC Chemistry; Science & Technology - Other Topics
GA 515MS
UT WOS:000271476500010
DA 2018-10-19
ER

PT S
AU Falkner, J
   Weisbecker, A
AF Falkner, Juergen
   Weisbecker, Anette
BE Altmann, J
   Buyya, R
   Rana, OF
TI Engineering of Services and Business Models for Grid Applications
SO GRID ECONOMICS AND BUSINESS MODELS
SE Lecture Notes in Computer Science
LA English
DT Proceedings Paper
CT 6th International Workshop on Grid Economics and Business Models
CY AUG 24, 2009
CL Delft, NETHERLANDS
DE Software-as-a-Service models; Grid value chain; Business modeling and
   analysis
AB In the context of using grid applications in medicine and bioinformatics a combination of classic biomedical services like the analysis of biomaterial with grid services is quite common. Services for customers in those fields need to comprise both and offer an easy way to use these combined services. Within the German project Services@MediGRID(1), methods for the systematic development of complex customer services including the use of grid applications are developed. In coordination with this service engineering approach for grid applications, commercial business models are derived for a set of biomedical grid services.
C1 [Falkner, Juergen; Weisbecker, Anette] Fraunhofer Inst Arbeitswirtschaft & Org, D-70569 Stuttgart, Germany.
RP Falkner, J (reprint author), Fraunhofer Inst Arbeitswirtschaft & Org, Nobelstr 12, D-70569 Stuttgart, Germany.
EM Juergen.Falkner@iao.fraunhofer.de; Anette.Weisbecker@iao.fraunhofer.de
CR BAUR T, 2007, MOVING BITS BUSINESS
   BRENNER M, 2008, ACCOUNTING VERMITTEL
   Bullinger H.-J., 2003, SERVICE ENG ENTWICKL
   FALKNER J, 2007, P CRAC GRID WORKSH 2
   LAUDON KC, 2004, E COMMERCE BUSINESS
   Meiren T, 2002, SERVICE ENG UNTERNEH
   ROTHFUSS T, 2007, THESIS, P39
   SAX U, 2006, GRID COMPUTING BIOME
   SHOSTAK L, 1981, MARKETING SERVICES, P221
   WIEBELITZ J, 2008, KONZEPT ACCOUNTING D
   WIECZOREK M, 2008, FUTURE GENERATION CO
   WOLF A, D GRDL BESCHREIBEN A
NR 12
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0302-9743
BN 978-3-642-03863-1
J9 LECT NOTES COMPUT SC
PY 2009
VL 5745
BP 140
EP 149
PG 10
WC Computer Science, Information Systems; Computer Science, Theory &
   Methods
SC Computer Science
GA BLC79
UT WOS:000269932800011
DA 2018-10-19
ER

PT J
AU Ehrenfest, DMD
   de Peppo, GM
   Doglioli, P
   Sammartino, G
AF Ehrenfest, David M. Dohan
   de Peppo, Giuseppe M.
   Doglioli, Pierre
   Sammartino, Gilberto
TI Slow release of growth factors and thrombospondin-1 in Choukroun's
   platelet-rich fibrin (PRF): a gold standard to achieve for all surgical
   platelet concentrates technologies
SO GROWTH FACTORS
LA English
DT Article
DE Coagulation; drug delivery; fibrin; growth factors; platelet
   concentrate; platelet-rich fibrin; platelet-rich plasma
ID LEUKOCYTE GEL; BONE-GRAFTS; PLASMA-RICH; IN-VITRO; SYSTEM; KIT;
   ANGIOGENESIS; FIBROBLASTS; OSTEOBLASTS; MECHANISM
AB Platelet concentrates for surgical topical applications are nowadays often used, but quantification of the long-term growth factor release from these preparations in most cases is impossible. Indeed, in most protocols, platelets are massively activated and there is no significant fibrin matrix to support growth factor release and cell migration. Choukroun's platelet-rich fibrin (PRF), a second generation platelet concentrate, is a leucocyte- and platelet-rich fibrin biomaterial. Here, we show that this dense fibrin membrane releases high quantities of three main growth factors (Transforming Growth Factor b-1 (TGF beta-1), platelet derived growth factor AB, PDGF-AB; vascular endothelial growth factor, VEGF) and an important coagulation matricellular glycoprotein (thrombospondin-1, TSP-1) during 7 days. Moreover, the comparison between the final released amounts and the initial content of the membrane (after forcible extraction) allows us to consider that the leucocytes trapped in the fibrin matrix continue to produce high quantities of TGF beta-1 and VEGF during the whole experimental time.
C1 [Ehrenfest, David M. Dohan; de Peppo, Giuseppe M.] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Biomat, S-41390 Gothenburg, Sweden.
   [Doglioli, Pierre] Jules Ferry Inst, Cell Culture Lab, Cannes, France.
   [Ehrenfest, David M. Dohan; Sammartino, Gilberto] Univ Naples Federico II, Dept Odontostomatol & Maxillofacial Sci, Naples, Italy.
   [Ehrenfest, David M. Dohan] AP HP, Fdn Res LoB5, Paris, France.
RP Ehrenfest, DMD (reprint author), Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Biomat, Medicinaregatan 8B, S-41390 Gothenburg, Sweden.
EM LoB5@mac.com
RI Dohan Ehrenfest, David/C-8866-2012
FU The LoB5 Foundation; AP-HP,Paris, France
FX This work was partially supported by a grant from The LoB5 Foundation
   for Research, AP-HP,Paris, France.
CR Anitua E, 1999, INT J ORAL MAX IMPL, V14, P529
   Anitua E, 2008, J BIOMED MATER RES B, V84B, P415, DOI 10.1002/jbm.b.30886
   Anitua E, 2007, BIOMATERIALS, V28, P4551, DOI 10.1016/j.biomaterials.2007.06.037
   Appel TR, 2002, CLIN ORAL IMPLAN RES, V13, P522, DOI 10.1034/j.1600-0501.2002.130512.x
   Bonnefoy A, 2006, BLOOD, V107, P955, DOI 10.1182/blood-2004-12-4856
   Braccini F, 2007, Rev Laryngol Otol Rhinol (Bord), V128, P255
   Cenni E, 2005, J PERIODONTOL, V76, P323, DOI 10.1902/jop.2005.76.3.323
   Choukroun J, 2006, ORAL SURG ORAL MED O, V101, P299, DOI 10.1016/j.tripleo.2005.07.012
   Choukroun J., 2001, IMPLANTODONTIE, V42, P55
   Choukroun J., 2001, INDIAN J DENT RES, V42, P55
   Choukroun J I, 2007, Rev Laryngol Otol Rhinol (Bord), V128, P27
   Clark RAF, 2001, ANN NY ACAD SCI, V936, P355
   Diss A, 2008, ORAL SURG ORAL MED O, V105, P572, DOI 10.1016/j.tripleo.2007.08.021
   Dohan DM, 2007, ORAL SURG ORAL MED O, V103, P305, DOI 10.1016/j.tripleo.2006.10.009
   Dohan DM, 2007, ORAL SURG ORAL MED O, V103, P587, DOI 10.1016/j.tripleo.2007.03.016
   Dohan David M, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V101, pe37, DOI 10.1016/j.tripleo.2005.07.008
   Dohan David M, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V101, pe51, DOI 10.1016/j.tripleo.2005.07.010
   Dohan David M, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V101, pe45, DOI 10.1016/j.tripleo.2005.07.009
   El-Sharkawy H, 2007, J PERIODONTOL, V78, P661, DOI 10.1902/jop.2007.060302
   Everts PAM, 2008, J BIOMED MATER RES A, V85A, P1135, DOI 10.1002/jbm.a.31570
   Graziani F, 2006, CLIN ORAL IMPLAN RES, V17, P212, DOI 10.1111/j.1600-0501.2005.2005.01203.x
   Italiano JE, 2008, BLOOD, V111, P1227, DOI 10.1182/blood-2007-09-113837
   Jurk K, 2003, FASEB J, V17, P1490, DOI 10.1096/fj.02-0830fje
   Leitner GC, 2006, VOX SANG, V91, P135, DOI 10.1111/j.1423-0410.2006.00815.x
   Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002
   Marx RE, 1998, ORAL SURG ORAL MED O, V85, P638, DOI 10.1016/S1079-2104(98)90029-4
   Moojen DJF, 2008, J ORTHOP RES, V26, P404, DOI 10.1002/jor.20519
   Nielsen HJ, 2001, VOX SANG, V80, P170, DOI 10.1046/j.1423-0410.2001.00028.x
   SAADOUN AP, 2007, PRACT PROCED AESTHET, V19, P81
   Sanchez M, 2007, AM J SPORT MED, V35, P245, DOI 10.1177/0363546506294078
   Soadoun A.P., 2007, PRACT PROCED AESTHET, V19, P88
   Thor A, 2007, INT J ORAL MAX SURG, V36, P1164, DOI 10.1016/j.ijom2007.05.023
   van Hinsbergh VWM, 2001, ANN NY ACAD SCI, V936, P426
   Weibrich G, 2005, INT J ORAL MAX IMPL, V20, P118
   Weibrich G, 2003, CLIN ORAL IMPLAN RES, V14, P233, DOI 10.1034/j.1600-0501.2003.140215.x
   Weibrich G, 2002, J CRANIO MAXILL SURG, V30, P97, DOI 10.1054/jems.2002.0285
   Weibrich G, 2002, INT J ORAL MAX IMPL, V17, P184
   Werther K, 2002, SCAND J CLIN LAB INV, V62, P343, DOI 10.1080/00365510260296492
NR 38
TC 157
Z9 160
U1 2
U2 18
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0897-7194
EI 1029-2292
J9 GROWTH FACTORS
JI Growth Factors
PY 2009
VL 27
IS 1
BP 63
EP 69
DI 10.1080/08977190802636713
PG 7
WC Cell Biology; Endocrinology & Metabolism
SC Cell Biology; Endocrinology & Metabolism
GA 387FS
UT WOS:000261937700007
PM 19089687
DA 2018-10-19
ER

PT B
AU Kushwaha, SS
   Ghoshdastidar, PS
AF Kushwaha, Sandeep Singh
   Ghoshdastidar, P. S.
GP ASME
TI NUMERICAL PREDICTION OF THE TEMPERATURE DISTRIBUTION WITHIN A HUMAN EYE
   DURING LASER SURGERY
SO HT2008: PROCEEDING OF THE ASME SUMMER HEAT TRANSFER CONFERENCE, VOL 3
LA English
DT Proceedings Paper
CT ASME Heat Transfer Summer Conference
CY AUG 10-14, 2008
CL Jacksonville, FL
SP ASME, Heat Transfer Div
ID CORNEAL TEMPERATURE; RADIATION; MODEL; COMPUTATION
AB In this paper a computational heat transfer model for prediction of the temperature distribution within the human eye during laser surgery is presented. The heat transfer within a tissue is described by the classic Pennes bioheat transfer equation. The intraocular temperature distribution is calculated using finite-difference method. Two types of computational domain have been considered: (i) rectangular parallelepiped and (ii) cylindrical. The eye is modeled as a composite layered structure consisting of four different ocular tissues, namely, cornea, aqueous, lens and vitreous. It is assumed that the eye is symmetrical about the pupillary axis. The absorption probability of ocular tissue is modulated based on the Lambert-Beer's law to reproduce the exponential attenuation of the laser light with depth within a biomaterial. The heat flow is modeled as transient and three-dimensional for rectangular parallelepiped geometry and two-dimensional (axi-symmetric) for the cylindrical geometry. The results indicate that for the insulation condition imposed on the periphery of the eye the model based on rectangular parallelepiped geometry of the eye at no laser power and at the initial temperature of 25 degrees C predicts temperature closer to in-vitro experimental measurements reported in literature whereas the model based on cylindrical geometry predicts higher temperature. The opposite is true (that is, lower temperature is predicted by the model based on cylindrical geometry) for high laser heat flux (2000 W/m(2)) and higher initial temperature (37 degrees C). This study also presents changes in eye temperature subjected to intermittent laser source used in laser surgery techniques such as PRK and LASIK. A comparison of the results based on three different boundary conditions such as convection (h(b) = 10 W/m(2) K), constant temperature (37 degrees C) and insulation on the eye periphery reveals that the model based on insulation condition predicts results closer to that of in-vitro experiment at no laser power and initial temperature of 25 degrees C whereas at a laser power of 200 W/m(2) and at the initial temperature of 37 degrees C insulation boundary condition produces highest temperature followed by that produced by convection and constant temperature conditions. The heat transfer is one-dimensional for the insulated eye periphery whereas multi-dimensional heat flow takes place when the circumferential boundary condition is either convective or isothermal.
C1 [Kushwaha, Sandeep Singh; Ghoshdastidar, P. S.] Indian Inst Technol, Dept Mech Engn, Kanpur 208016, Uttar Pradesh, India.
RP Kushwaha, SS (reprint author), Indian Inst Technol, Dept Mech Engn, Kanpur 208016, Uttar Pradesh, India.
EM psg@iitk.ac.in
CR CHARLES MW, 1975, PHYS MED BIOL, V20, P202, DOI 10.1088/0031-9155/20/2/002
   Chua KJ, 2005, INT COMMUN HEAT MASS, V32, P1057, DOI 10.1016/j.icheatmasstransfer.2004.10.030
   EERON N, 1989, CURRENT EYE RES, V8, P901
   FIELDER AR, 1981, T OPHTHAL SOC UK, V101, P22
   GROS C, 1967, J RADIOL ELEC MED N, V48, P95
   GUY AW, 1975, IEEE T MICROW THEORY, VMT23, P492, DOI 10.1109/TMTT.1975.1128606
   HUBER A, 1960, Ophthalmologica, V139, P351
   Jain RK, 1983, HYPERTHERMIA CANC TH
   LAGENDIJK JJW, 1982, PHYS MED BIOL, V27, P1301, DOI 10.1088/0031-9155/27/11/001
   MAPSTONE R, 1968, BRIT J OPHTHALMOL, V52, P729, DOI 10.1136/bjo.52.10.729
   MAPSTONE R, 1968, EXP EYE RES, V7, P237, DOI 10.1016/S0014-4835(68)80073-9
   Morgan P B, 1999, Cont Lens Anterior Eye, V22, P11, DOI 10.1016/S1367-0484(99)80025-3
   Ng EYK, 2007, COMPUT BIOL MED, V37, P829, DOI 10.1016/j.compbiomed.2006.08.023
   Ng EYK, 2006, COMPUT METH PROG BIO, V82, P268, DOI 10.1016/j.cmpb.2006.04.001
   PENNES HH, 1948, J APPL PHYSIOL, V1, P93
   Purslow Christine, 2005, Eye Contact Lens, V31, P117, DOI 10.1097/01.ICL.0000141921.80061.17
   Purslow Christine, 2005, Cont Lens Anterior Eye, V28, P29, DOI 10.1016/j.clae.2004.10.001
   SCHWARTZ B, 1965, ARCH OPHTHALMOL-CHIC, V74, P237
   SCOTT JA, 1988, PHYS MED BIOL, V33, P227, DOI 10.1088/0031-9155/33/2/003
   SCOTT JA, 1988, PHYS MED BIOL, V33, P243, DOI 10.1088/0031-9155/33/2/004
   Sekins K. M., 1982, THERAPEUTIC HEAT COL
   TAFLOVE A, 1975, IEEE T MICROW THEORY, V23, P888, DOI 10.1109/TMTT.1975.1128708
   WADDELL DE, 1992, ADV BIOL HEAT MASS T
   ZEISS ERICH, 1930, ARCH AUGENHEILK, V102, P523
   Zhigilei LV, 2000, J APPL PHYS, V88, P1281, DOI 10.1063/1.373816
NR 25
TC 0
Z9 0
U1 0
U2 2
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-4849-4
PY 2009
BP 331
EP 340
PG 10
WC Thermodynamics; Engineering, Mechanical
SC Thermodynamics; Engineering
GA BJF84
UT WOS:000265480000037
DA 2018-10-19
ER

PT S
AU Sakiyama, Y
   Graves, DB
AF Sakiyama, Yukinori
   Graves, David B.
BE Zhu, S
   Yan, J
TI Modeling and Data Needs of Atmospheric Pressure Gas Plasma and
   Biomaterial Interaction
SO ICAMDATA-2008
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT 6th International Conference on Atomic and Molecular Data and Their
   Applications
CY OCT 27-31, 2008
CL Beijing, PEOPLES R CHINA
SP Inst Appl Phys & Computat Math, Natl Nat Sci Fdn China, Chinese Acad Engn Phys, Natl High Tech Inertial Confine Fus Comm
DE plasma-biomaterial interaction; modeling; atmospheric pressure
ID STREPTOCOCCUS-MUTANS BACTERIA; OF-THE-ART; STERILIZATION; COAGULATION;
   CELLS
AB Non-thermal atmospheric pressure plasmas have received considerable attention recently. One promising application of non-thermal plasma devices appears to be biomaterial and biomedical treatment. Various biological and medical effects of non-thermal plasmas have been observed by a variety of investigators, including bacteria sterilization, cell apoptosis, and blood coagulation, among others. The mechanisms of the plasma-biomaterial interaction are however only poorly understood. A central scientific challenge is therefore how to answer the question: "What plasma-generated agents are responsible for the observed biological effects?" Our modeling efforts are motivated by this question. In this paper, we review our modeling results of the plasma needle discharge. Then, we address data needs for further modeling and understanding of plasma-biomaterial interaction
C1 [Sakiyama, Yukinori; Graves, David B.] Univ Calif Berkeley, Dept Chem Engn, Berkeley, CA 94720 USA.
RP Sakiyama, Y (reprint author), Univ Calif Berkeley, Dept Chem Engn, Berkeley, CA 94720 USA.
EM ysaki@berkeley.edu
CR Deng XT, 2007, J APPL PHYS, V101, DOI 10.1063/1.2717576
   Fridman G, 2006, PLASMA CHEM PLASMA P, V26, P425, DOI 10.1007/s11090-006-9024-4
   Goree J, 2006, IEEE T PLASMA SCI, V34, P1317, DOI 10.1109/TPS.2006.878431
   Goree J, 2006, J PHYS D APPL PHYS, V39, P3479, DOI 10.1088/0022-3727/39/16/S05
   Laroussi M, 2005, PLASMA PROCESS POLYM, V2, P391, DOI 10.1002/ppap.200400078
   Palanker DV, 2001, INVEST OPHTH VIS SCI, V42, P2673
   Raiser J, 2006, J PHYS D APPL PHYS, V39, P3520, DOI 10.1088/0022-3727/39/16/S10
   Sakiyama Y, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/9/095204
   Sakiyama Y, 2006, J PHYS D APPL PHYS, V39, P3644, DOI 10.1088/0022-3727/39/16/018
   Sakiyama Y, 2006, J PHYS D APPL PHYS, V39, P3451, DOI 10.1088/0022-3727/39/16/S01
   Sakiyama Y, 2007, J APPL PHYS, V101, DOI 10.1063/1.2715745
   Sakiyama Y, 2007, IEEE T PLASMA SCI, V35, P1279, DOI 10.1109/TPS.2007.906129
   Sladek REJ, 2005, J PHYS D APPL PHYS, V38, P1716, DOI 10.1088/0022-3727/38/11/012
   Sladek REJ, 2004, IEEE T PLASMA SCI, V32, P1540, DOI 10.1109/TPS.2004.832636
   Stoffels E, 2003, J PHYS D APPL PHYS, V36, P2908, DOI 10.1088/0022-3727/36/23/007
   Stoffels E, 2008, IEEE T PLASMA SCI, V36, P1441, DOI 10.1109/TPS.2008.2001084
   Woloszko J, 2000, PROC SPIE, V3907, P306, DOI 10.1117/12.386267
NR 17
TC 0
Z9 0
U1 0
U2 5
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-0661-2
J9 AIP CONF PROC
PY 2009
VL 1125
BP 188
EP 193
PG 6
WC Mathematics, Applied; Physics, Atomic, Molecular & Chemical
SC Mathematics; Physics
GA BJV98
UT WOS:000267286700018
DA 2018-10-19
ER

PT S
AU Rezende, RA
   Rezende, MCAF
   Maciel, R
   Bartolo, PJS
   Mendes, A
AF Rezende, R. A.
   Rezende, M. C. A. F.
   Maciel Filho, R.
   Bartolo, P. J. S.
   Mendes, A.
BE Pierucci, S
TI Genetic Algorithms for Optimising Alginated-Scaffolds for Tissue
   Engineering
SO ICHEAP-9: 9TH INTERNATIONAL CONFERENCE ON CHEMICAL AND PROCESS
   ENGINEERING, PTS 1-3
SE Chemical Engineering Transactions
LA English
DT Proceedings Paper
CT 9th International Conference on Chemical and Process Engineering
CY MAY 10-13, 2009
CL Rome, ITALY
SP Italian Assoc Chem Engn
AB The increase of the rate of transplants due to damaged or affected tissues or organs by accidents or diseases and also by the aging of the population in many countries, alternative ways of restoring and replacing tissues have been researched and implemented and very successful. Biofabrication by means of rapid prototyping techniques can help in the fashioning and final production of scaffolds devoted to support and stimulate the growth of new tissues. For soft tissues, a biomaterial known as Alginate has been studied and used as raw-material for scaffolds fabrication. A Scaffold should own very dynamical and adaptive characteristics. In this sense, it is fundamental to know better the mechanical and chemical properties since the scaffold must guarantee good strength and stiffness at the same time the material degrades gradually. The present and future of biomedical materials development requires this degree of control prediction in the design, synthesis, and function of next-generation materials. A prediction job is possible and it has already been used so that the scaffold state can be forecasted before its fabrication and, as a good alternative, to know how and how much alginate should be used. A single mathematical model experimentally obtained describes an interesting physical behaviour, that is, in the case of this work, the degradation of alginated-scaffolds. Evolutionary algorithms, like Genetic Algorithms (GA), represent a class of stochastic optimisation procedures based on natural systems according to Darwin's observations, and the modern synthetic theory of evolution. The objective of GA is to find out the best values of alginate amount for scaffold fabrication that maximize the elastic modulus. In summary, the paper presents an optimisation process scheme using Genetic Algorithms to maximize the elastic modulus and therefore to aid the design of scaffolds in alginate. The optimization is very welcome to tissue engineering and Biofabrication.
C1 [Rezende, R. A.; Rezende, M. C. A. F.; Maciel Filho, R.; Bartolo, P. J. S.; Mendes, A.] Univ Estadual Campinas, Sch Chem Engn, BR-13083970 Campinas, SP, Brazil.
RP Rezende, RA (reprint author), Univ Estadual Campinas, Sch Chem Engn, Cidade Univ Zeferino Vaz,POB 6066, BR-13083970 Campinas, SP, Brazil.
EM rezende@.feq.unicamp.br
RI Rezende, Rodrigo/H-4893-2014; Bartolo, Paulo/F-2421-2013
OI Rezende, Rodrigo/0000-0002-6604-5880; Bartolo,
   Paulo/0000-0003-3683-726X; Mendes, Ausenda/0000-0003-3004-8972
CR CARROLL D, 2008, CARROLLS FORTRAN GEN
   Deb K, 2000, COMPUT METHOD APPL M, V186, P311, DOI 10.1016/S0045-7825(99)00389-8
   HUTMACHER DW, 2006, ADV MANUFACT TECH ME, P163
   REZENDE MCA, 2007, EVOLUTIONARY OPTIMIS
   REZENDE RA, 2007, CHEM ENG T ICHEAP 8
NR 5
TC 1
Z9 1
U1 0
U2 2
PU AIDIC SERVIZI SRL
PI MILANO
PA VIA GIUSEPPE COLOMBO 81/A, MILANO, MI 20133, ITALY
SN 1974-9791
BN 978-88-95608-01-3
J9 CHEM ENGINEER TRANS
PY 2009
VL 17
BP 1305
EP 1310
DI 10.3303/CET0917218
PG 6
WC Engineering, Environmental; Engineering, Chemical
SC Engineering
GA BLS30
UT WOS:000270930200218
DA 2018-10-19
ER

PT B
AU Arifvianto, B
   Suyitno
AF Arifvianto, B.
   Suyitno
GP IEEE
TI Surface Roughness and Wettability of AISI 316L Induced by Surface
   Mechanical Attrition Treatment with Different Milling Ball Diameter
SO ICICI-BME: 2009 INTERNATIONAL CONFERENCE ON INSTRUMENTATION,
   COMMUNICATION, INFORMATION TECHNOLOGY, AND BIOMEDICAL ENGINEERING
LA English
DT Proceedings Paper
CT International Conference on Instrumentation, Communication, Information
   Technology and Biomedical Engineering
CY NOV 23-25, 2009
CL Bandung, INDONESIA
SP IEEE
DE milling ball diameter; surface mechanical attrition treatment; surface
   roughness; wettability; AISI 316L
ID STAINLESS-STEEL; CELL-ADHESION; PROTEIN ADSORPTION; METALLIC MATERIALS;
   TITANIUM; BEHAVIOR; LAYER; TECHNOLOGY
AB Surface roughness and wettability determines the rate and quality of protein adsorption and cells adhesion on biomaterial. For this case, a rough- and hydrophilic-surface are preferable rather than a smooth- and hydrophobic-one. This paper discusses the effect of milling ball diameter used in surface mechanical attrition treatment (SMAT) on the roughness and wettability of AISI 316L. All samples were treated for 15 minutes with 250 balls whose diameter of 1/8", 3/16", and 1/4". The result shows enhanced surface roughness and reduced droplet contact angle of AISI 316L surface after SMAT. The ball's radius of curvature influences the pit geometry and the roughness of sample's surface. In addition, the performance of SMAT is still lacking to produce a hydrophilic surface.
C1 [Arifvianto, B.; Suyitno] Gadjah Mada Univ, Dept Mech & Ind Engn, Ctr Innovat Med Equipments & Devices CIMEDs, Yogyakarta 55281, Indonesia.
RP Arifvianto, B (reprint author), Gadjah Mada Univ, Dept Mech & Ind Engn, Ctr Innovat Med Equipments & Devices CIMEDs, Jl Grafika 2, Yogyakarta 55281, Indonesia.
EM budi.arif@ugm.ac.id
RI Arifvianto, Budi/D-9344-2013
CR Aparicio C, 2003, BIOMATERIALS, V24, P263, DOI 10.1016/S0142-9612(02)00314-9
   ARIFVIANTO B, 2009, P INT C MAT MET TECH, P14
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   BOMBAC D, 2007, MAT GEOENVIRONMENT, V54, P151
   CAREW OE, 2004, INTRO MAT MED, P23
   Chen XH, 2005, SCRIPTA MATER, V52, P1039, DOI 10.1016/j.scriptamat.2005.01.023
   Dao M, 2007, ACTA MATER, V55, P4041, DOI 10.1016/j.actamat.2007.01.038
   Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X
   Elias CN, 2008, J MECH BEHAV BIOMED, V1, P234, DOI 10.1016/j.jmbbm.2007.12.002
   ITO Y, 1991, J BIOMED MATER RES, V25, P1325, DOI 10.1002/jbm.820251102
   Khang D, 2008, BIOMATERIALS, V29, P970, DOI 10.1016/j.biomaterials.2007.11.009
   Liu G, 2000, MAT SCI ENG A-STRUCT, V286, P91, DOI 10.1016/S0921-5093(00)00686-9
   Lu K, 2004, MAT SCI ENG A-STRUCT, V375, P38, DOI 10.1016/j.msea.2003.10.261
   Mendonca G, 2008, BIOMATERIALS, V29, P3822, DOI 10.1016/j.biomaterials.2008.05.012
   OSHIDA Y, 1993, J MATER SCI-MATER M, V4, P443, DOI 10.1007/BF00120123
   PALSSON BO, 2004, TISSUE ENG, P20
   PIATTELLI M, 2002, J ORAL IMPLANTOLOGY, V28
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   RAMSDEN JJ, 2007, ANN CIRP, V56, P687, DOI DOI 10.1016/J.CIRP.2007.10.001
   Roland T, 2007, MAT SCI ENG A-STRUCT, V445, P281, DOI 10.1016/j.msea.2006.09.041
   Tao NR, 2003, MATER TRANS, V44, P1919, DOI 10.2320/matertrans.44.1919
   Todaka Y, 2004, MATER TRANS, V45, P376, DOI 10.2320/matertrans.45.376
   Uelzen T, 2003, THIN SOLID FILMS, V434, P311, DOI 10.1016/S0040-6090(03)00484-X
   Vogler EA, 1999, J BIOMAT SCI-POLYM E, V10, P1015, DOI 10.1163/156856299X00667
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Zhang HW, 2003, ACTA MATER, V51, P1871, DOI 10.1016/S1359-6454(02)00594-3
NR 26
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4244-4999-6
PY 2009
BP 69
EP 72
PG 4
WC Engineering, Biomedical; Instruments & Instrumentation;
   Telecommunications
SC Engineering; Instruments & Instrumentation; Telecommunications
GA BPV98
UT WOS:000280118800014
DA 2018-10-19
ER

PT B
AU Huang, H
   Guo, ZX
AF Huang, Huan
   Guo, Zhixiong
GP ASME
TI 3-D MICRO-FABRICATION AND SEPARATION OF PDMS BY ULTRA-SHORT PULSED LASER
SO IMECE 2008: HEAT TRANSFER, FLUID FLOWS, AND THERMAL SYSTEMS, VOL 10, PTS
   A-C
LA English
DT Proceedings Paper
CT ASME International Mechanical Engineering Congress and Exposition
CY OCT 31-NOV 06, 2008
CL Boston, MA
SP Amer Soc Mech Engineers
ID FEMTOSECOND LASER; BREAKDOWN; POLYMERS; MICROFABRICATION; ABLATION;
   SURFACE; GLASS
AB In this paper, micro-fabrication of bio-degradable polymer-PDMS via an ultra-short pulsed (USP) laser is reported for potential applications in biomaterial, biomedicine, and tissue engineering. Thin layer PDMS separation has been presented with a minimum of about 20 pin thickness and a 3-dimensional PDMS micro-channel network has also been shown. The surface condition and thickness of the separated PDMS layer are examined using SEM and surface profilometre. This work on using USP laser for separation of bio-degradable polymer is the first of its kind, and it shows great potential biomedical application for tissue microprocessing and separation.
C1 [Huang, Huan; Guo, Zhixiong] Rutgers State Univ, Dept Mech & Aerosp Engn, Piscataway, NJ 08854 USA.
RP Huang, H (reprint author), Rutgers State Univ, Dept Mech & Aerosp Engn, Piscataway, NJ 08854 USA.
EM zguo@rci.rutgers.edu
RI Guo, Zhixiong/B-9303-2009
OI Guo, Zhixiong/0000-0003-0481-2738
CR Becker H, 2000, ELECTROPHORESIS, V21, P12, DOI 10.1002/(SICI)1522-2683(20000101)21:1<12::AID-ELPS12>3.3.CO;2-Z
   Bityurin N, 2005, ANN RP CH C, V101, P216, DOI 10.1039/b408910n
   Bohme R, 2006, J PHYS D APPL PHYS, V39, P1398, DOI 10.1088/0022-3727/39/7/010
   Chen S, 2003, INT J MATER PROD TEC, V18, P457, DOI 10.1504/IJMPT.2003.002502
   CHEN SC, 2005, HDB BIODEGRADABLE PO, V1, P1
   Feng Q, 1997, IEEE J QUANTUM ELECT, V33, P127, DOI 10.1109/3.552252
   Hammer DX, 1996, IEEE J QUANTUM ELECT, V32, P670, DOI 10.1109/3.488842
   Kancharla VV, 2002, BIOMED MICRODEVICES, V4, P105, DOI 10.1023/A:1014679013888
   Kondo T, 2004, THIN SOLID FILMS, V453, P550, DOI 10.1016/j.tsf.2003.11.180
   Li Y, 2001, OPT LETT, V26, P1912, DOI 10.1364/OL.26.001912
   Lippert T, 2004, ADV POLYM SCI, V168, P51, DOI 10.1007/b12682
   Liu X, 1997, IEEE J QUANTUM ELECT, V33, P1706, DOI 10.1109/3.631270
   Loesel FH, 1996, IEEE J QUANTUM ELECT, V32, P1717, DOI 10.1109/3.538774
   Sakai T, 2007, J PHYS D APPL PHYS, V40, P2102, DOI 10.1088/0022-3727/40/7/036
   SALOMATINA E., 2006, J BIOMEDICAL OPTICS, V11
   Sharobaro V I, 2008, Ann Burns Fire Disasters, V21, P31
   STEFAN N, 2000, ADV ENG MATER, V2, P23
   Vestentoft K, 2005, APPL PHYS A-MATER, V80, P493, DOI 10.1007/s00339-004-3079-y
   Wolfe DB, 2003, ADV MATER, V15, P62, DOI 10.1002/adma.200390012
NR 19
TC 0
Z9 0
U1 2
U2 5
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-4871-5
PY 2009
BP 1273
EP 1278
PG 6
WC Thermodynamics; Engineering, Mechanical
SC Thermodynamics; Engineering
GA BJE16
UT WOS:000265085300149
DA 2018-10-19
ER

PT J
AU Tatara, RA
   Rosentrater, KA
   Suraparaju, S
AF Tatara, R. A.
   Rosentrater, K. A.
   Suraparaju, S.
TI Design properties for molded, corn-based DDGS-filled phenolic resin
SO INDUSTRIAL CROPS AND PRODUCTS
LA English
DT Article
DE Biofillers; Bioplastics; Mechanical properties; Physical properties;
   Biodegradability
ID MOLDING POWDER; LIGNIN; WOOD
AB With the rapid growth in the ethanol fuel industry in recent years, considerable research is being devoted to maximizing the use of processing coproducts, such as distillers dried grains with solubles (DDGS), typically for livestock diets. Because these residues contain high fiber levels, they may be amendable to incorporation into polymers as well, which is an option that could garner greater economic returns. Thus, the goal of this study was to demonstrate the viability of using corn-based DDGS as a biofiller with phenolic resin, in order to produce a novel biomaterial. DDGS was blended with phenolic resin at four levels (0%, 25%, 50%, and 75%, by weight), and then compression molded at 13.8, 34.5, or 48.3 MPa (1.0, 2.5, or 3.5 tons/in.(2)) and 157, 174, or 191 degrees C (315, 345, or 375 F). Molded specimens were then tested for a variety of mechanical and physical properties. Pressure and temperature each had little effect on the resulting properties. DDGS, on the other hand, greatly influenced all of the properties. Tensile yield strengths ranged from 14.5 MPa (2102 psi) to 4.3 MPa (621 psi), while the Young's modulus ranged from 2296 MPa (333,000 psi) to 841 MPa (122,000 psi) as the DDGS content increased. For all time periods studied, water absorption increased as DDGS level increased. Moreover, as DDGS content increased to a maximum of 75%, biodegradability increased from 0% to 38% while the surface hardness decreased 25%. These results were similar to those from other studies that have investigated biofillers, Follow-up studies should aim to optimize the strength of the DDGS-blended resins through the use of coupling agents or other additives. (C) 2008 Elsevier B.V. All rights reserved
C1 [Tatara, R. A.] No Illinois Univ, Dept Technol, De Kalb, IL 60115 USA.
   [Rosentrater, K. A.] ARS, USDA, N Cent Agr Res Lab, Brookings, SD 57006 USA.
   [Suraparaju, S.] No Illinois Univ, Dept Mech Engn, De Kalb, IL 60115 USA.
RP Tatara, RA (reprint author), No Illinois Univ, Dept Technol, De Kalb, IL 60115 USA.
EM tatara@ceet.niu.edu; krosentr@ngirl.ars.usda.gov; krishnal150@gmail.com
OI Rosentrater, Kurt/0000-0003-0131-7037
FU U.S. Department of Agriculture-Agriculture Research Service; Department
   of Technology at Northern Illinois University
FX This work was supported by the U.S. Department of
   Agriculture-Agriculture Research Service as well as the Department of
   Technology at Northern Illinois University. Additionally, the authors
   would like to thank S.J. Nichols for assistance with the physical
   property measurements.
CR Hattali S, 2005, J APPL POLYM SCI, V97, P1065, DOI [10.1002/app.21243, 10.1002/APP.21243]
   Kharade AY, 1998, EUR POLYM J, V34, P201
   Leite JL, 2004, BRAZ J CHEM ENG, V21, P253, DOI 10.1590/S0104-66322004000200015
   Maldas D, 1997, J REINF PLAST COMP, V16, P870, DOI 10.1177/073168449701601001
   Maldas D, 1996, POLYM-PLAST TECHNOL, V35, P917, DOI 10.1080/03602559608000607
   Mohanty A. K., 2000, MACROMOL MATER ENG, V277, P1
   Mohanty AK, 2001, COMPOS INTERFACE, V8, P313, DOI 10.1163/156855401753255422
   SURAPARAJU S, 2007, THESIS NO ILLINOIS U
   Tatara RA, 2007, J POLYM ENVIRON, V15, P89, DOI 10.1007/s10924-007-0052-9
   Xanthos M, 2005, FUNCTIONAL FILLERS FOR PLASTICS, P1, DOI 10.1002/3527605096
NR 10
TC 23
Z9 23
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0926-6690
J9 IND CROP PROD
JI Ind. Crop. Prod.
PD JAN
PY 2009
VL 29
IS 1
BP 9
EP 15
DI 10.1016/j.indcrop.2008.03.002
PG 7
WC Agricultural Engineering; Agronomy
SC Agriculture
GA 392JN
UT WOS:000262299100002
DA 2018-10-19
ER

PT B
AU Turak, F
   Turhan, K
   Ozgur, MU
AF Turak, Fatma
   Turhan, Kadir
   Oezguer, Mahmure Usetun
BE Sener, B
TI Sorption of Pb(II) and Zn(II) Ions from Aqueous Solution by Tannin
   Resins
SO INNOVATIONS IN CHEMICAL BIOLOGY
LA English
DT Proceedings Paper
CT 9th Eurasia Conference on Chemical Sciences
CY SEP 09-13, 2006
CL Antalya, TURKEY
SP IUPAC, Soc Biol Divers
DE Biomaterial; heavy metals; lead; resin; tannin; zinc
ID RECOVERY; URANIUM; ADSORPTION; REMOVAL; SOILS; WATER
AB Recently, the interest on biomaterials and especially in tannins was growing and some attractive results were obtained in the adsorption of some metals by tannin adsorbents. Tannins are widely distributed in nature and have multiple adjacent poly-hydroxyphenyl groups in their chemical structure which have extremely high affinity for heavy metal ions. This study will describe how tannin can be used as an effective zinc and lead sorbent by the use of tannin resins. Batch method was used in the experiments in which pH profile, adsorption time, adsorbent/liquid ratios, initial concentration of metal ions, adsorbent amount and temperature were investigated to determine binding properties of adsorbent for the Zn(II) and Pb(II) ions.
C1 [Turak, Fatma; Turhan, Kadir; Oezguer, Mahmure Usetun] Yildiz Tekn Univ, Dept Chem, TR-34220 Istanbul, Turkey.
RP Turak, F (reprint author), Yildiz Tekn Univ, Dept Chem, Davutpasa Campus, TR-34220 Istanbul, Turkey.
EM fturak2005@yahoo.com.tr; turhankadir@yahoo.com
CR APARITTUKUL R, 2004, SONGKLANAKARIN J SCI, V26, P199
   Bhattacharjee S, 2003, WATER RES, V37, P3954, DOI 10.1016/S0043-1354(03)00315-4
   Covelo EF, 2004, J COLLOID INTERF SCI, V280, P343, DOI 10.1016/j.jcis.2004.08.012
   Ho YS, 2002, PROCESS BIOCHEM, V37, P1421, DOI 10.1016/S0032-9592(02)00036-5
   KOSHIWADA Y, 1992, J NAT PRODUCTS, V55, P1003
   MASATOSHI G, 2000, APPL BIOCHEM BIOTECH, V84, P1021
   NAKAJIMA A, 1990, J CHEM TECHNOL BIOT, V47, P31
   NAKAJIMA A, 1987, J CHEM TECHNOL BIOT, V40, P223
   Nakano Y, 2000, J CHEM ENG JPN, V33, P747, DOI 10.1252/jcej.33.747
   OKUDA T, 1990, HETEROCYCLES, V30, P202
   SAKAGUCHI T, 1987, SEPAR SCI TECHNOL, V22, P1609, DOI 10.1080/01496398708058421
   Santana JL, 2002, J RADIOANAL NUCL CH, V251, P467, DOI 10.1023/A:1014846612052
   SUZIKI Y, 2004, AICHE 2003 ANN M AUS
   TACKETT SL, 1987, J CHEM EDUC, V64, P14
   *US EPA, 2300384005 US EPA
   Wang YJ, 2006, J HAZARD MATER, V137, P76, DOI 10.1016/j.jhazmat.2006.02.032
   Xuepin L, 2004, J RADIOANAL NUCL CHE, V260, P619
   YAMGUCHI H, 1992, J APPL POLYM SCI, V45, P1463
NR 18
TC 0
Z9 0
U1 0
U2 6
PU SPRINGER
PI DORDRECHT
PA PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
BN 978-1-4020-6954-3
PY 2009
BP 277
EP 283
DI 10.1007/978-1-4020-6955-0_29
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Applied
SC Biochemistry & Molecular Biology; Chemistry
GA BIT27
UT WOS:000262502000029
DA 2018-10-19
ER

PT J
AU Castillo, J
   Dimaki, M
   Svendsen, WE
AF Castillo, Jaime
   Dimaki, Maria
   Svendsen, Winnie Edith
TI Manipulation of biological samples using micro and nano techniques
SO INTEGRATIVE BIOLOGY
LA English
DT Review
ID ATOMIC-FORCE MICROSCOPY; FIELD-FLOW-FRACTIONATION; ACTUATED SILICON
   MICROGRIPPER; BLOOD-CELL-SEPARATION; SINGLE DNA-MOLECULES;
   ELECTRON-MICROSCOPY; OPTICAL TRAP; DIELECTROPHORETIC MANIPULATION;
   NANOMECHANICAL PROPERTIES; CHROMOSOMAL DISSECTION
AB The constant interest in handling, integrating and understanding biological systems of interest for the biomedical field, the pharmaceutical industry and the biomaterial researchers demand the use of techniques that allow the manipulation of biological samples causing minimal or no damage to their natural structure. Thanks to the advances in micro- and nanofabrication during the last decades several manipulation techniques offer us the possibility to image, characterize and manipulate biological material in a controlled way. Using these techniques the integration of biomaterials with remarkable properties with physical transducers has been possible, giving rise to new and highly sensitive biosensing devices. This article reviews the different techniques available to manipulate and integrate biological materials in a controlled manner either by sliding them along a surface (2-D manipulation), by grapping them and moving them to a flew position (3-D manipulation), or by manipulating and relocating them applying external forces. The advantages and drawbacks are mentioned together with examples that reflect the state of the art of manipulation techniques for biological samples (171 references).
C1 [Castillo, Jaime; Dimaki, Maria; Svendsen, Winnie Edith] Tech Univ Denmark, DTU Nanotech, Dept Micro & Nanotechnol, DK-2800 Lyngby, Denmark.
RP Castillo, J (reprint author), Tech Univ Denmark, DTU Nanotech, Dept Micro & Nanotechnol, DK-2800 Lyngby, Denmark.
EM Jaime.castillo@nanotech.dtu.dk
RI Castillo-Leon, Jaime/C-2567-2011; Dimaki, Maria/J-9985-2012; Svendsen,
   Winnie/A-2976-2012
OI Castillo-Leon, Jaime/0000-0003-0901-5244; Dimaki,
   Maria/0000-0001-5037-2388; Svendsen, Winnie/0000-0002-9197-6505
FU European Community [BeNatural/NMP4-CT-2006-033256]
FX Funding from the European Community (BeNatural/NMP4-CT-2006-033256) is
   gratefully acknowledged.
CR Abbott JJ, 2007, IEEE ROBOT AUTOM MAG, V14, P92, DOI 10.1109/MRA.2007.380641
   Abu-Lail NI, 2003, J MICROSC-OXFORD, V212, P217, DOI 10.1111/j.1365-2818.2003.01261.x
   Afrin R, 2005, PROTEIN SCI, V14, P1447, DOI 10.1110/ps.041282305
   Amato I, 2005, CELL, V123, P967, DOI 10.1016/j.cell.2005.12.001
   AN J, 2008, IEEE INF C NAN ENG M, P965
   Arata HF, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2177374
   Arata HF, 2008, ANAL BIOANAL CHEM, V391, P2385, DOI 10.1007/s00216-008-1853-y
   ASHKIN A, 1986, OPT LETT, V11, P288, DOI 10.1364/OL.11.000288
   ASHKIN A, 1987, SCIENCE, V235, P1517, DOI 10.1126/science.3547653
   Ashkin A, 2000, IEEE J SEL TOP QUANT, V6, P841, DOI 10.1109/2944.902132
   Babic B, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2834698
   Bazou D, 2008, TOXICOL IN VITRO, V22, P1321, DOI 10.1016/j.tiv.2008.03.014
   Bazou D, 2005, ULTRASOUND MED BIOL, V31, P423, DOI 10.1016/j.ultrasmedbio.2004.12.007
   BECKER FF, 1994, J PHYS D APPL PHYS, V27, P2659, DOI 10.1088/0022-3727/27/12/030
   Bergmans L, 2005, INT ENDOD J, V38, P775, DOI 10.1111/j.1365-2591.2005.00999.x
   Berry CC, 2003, J PHYS D APPL PHYS, V36, pR198, DOI 10.1088/0022-3727/36/13/203
   Beyeler F, 2007, J MICROELECTROMECH S, V16, P7, DOI 10.1109/JMEMS.2006.885853
   Birkbeck AL, 2003, BIOMED MICRODEVICES, V5, P47, DOI 10.1023/A:1024463316562
   Blideran MM, 2006, J VAC SCI TECHNOL B, V24, P3239, DOI 10.1116/1.2357961
   Blideran MM, 2006, MICROELECTRON ENG, V83, P1382, DOI 10.1016/j.mee.2006.01.054
   Boggild P, 2001, NANOTECHNOLOGY, V12, P331, DOI 10.1088/0957-4484/12/3/322
   Boncheva M, 2005, MRS BULL, V30, P736, DOI 10.1557/mrs2005.208
   Borgatti M, 2008, INT J MOL MED, V21, P3
   Brambilla G, 2007, LASER FOCUS WORLD, V43, P85
   Brown RM, 2007, BIOMACROMOLECULES, V8, P70, DOI 10.1021/bm060546z
   Bustamante C, 2003, NATURE, V421, P423, DOI 10.1038/nature01405
   Carlson K, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/34/345501
   Castelino K, 2005, ROBOTICA, V23, P435, DOI 10.1017/S0263574704000864
   Castillo J, 2008, ELECTROPHORESIS, V29, P5026, DOI 10.1002/elps.200800260
   Chen X, 2008, SENSOR ACTUAT B-CHEM, V130, P216, DOI 10.1016/j.snb.2007.07.126
   Chronis N, 2005, J MICROELECTROMECH S, V14, P857, DOI 10.1109/JMEMS.2005.845445
   CHRONIS N, 2004, IEEE INT C MICR MECH, P17
   CHUN A, 2007, NANOTECHNOLOGY BIOL
   Cugat O, 2003, IEEE T MAGN, V39, P3607, DOI 10.1109/TMAG.2003.816763
   de Vries AHB, 2005, BIOPHYS J, V88, P2137, DOI 10.1529/biophysj.104.052035
   de Vries AHB, 2007, NANO LETT, V7, P1424, DOI 10.1021/nl070603+
   Desai JP, 2007, ANNU REV BIOMED ENG, V9, P35, DOI 10.1146/annurev.bioeng.9.060906.151940
   Dhar P, 2007, J PHYS CHEM B, V111, P13097, DOI 10.1021/jp0764485
   Dimaki M, 2008, J PHYS CONF SER, V100, DOI 10.1088/1742-6596/100/5/052047
   Docoslis A, 1999, CYTOTECHNOLOGY, V30, P133, DOI 10.1023/A:1008050809217
   Dong LQ, 2007, CHEM-EUR J, V13, P822, DOI 10.1002/chem.200601320
   Dong LX, 2007, IEEE ROBOT AUTOM MAG, V14, P111, DOI 10.1109/M-RA.2007.905335
   Duwez AS, 2008, NAT NANOTECHNOL, V3, P188, DOI 10.1038/nnano.2008.80
   EIGLER DM, 1990, NATURE, V344, P524, DOI 10.1038/344524a0
   Eriksson E, 2007, J OPT A-PURE APPL OP, V9, pS113, DOI 10.1088/1464-4258/9/8/S02
   Evander M, 2007, ANAL CHEM, V79, P2984, DOI 10.1021/ac061576v
   Fahlbusch S, 2005, J MATER PROCESS TECH, V167, P371, DOI 10.1016/j.jmatprotec.2005.06.022
   Falvo MR, 1999, NATURE, V397, P236
   Fatoyinbo HO, 2008, ELECTROPHORESIS, V29, P3, DOI 10.1002/elps.200700586
   FEYNMAN RP, 1960, ENG SCI, V23, P36
   Fukuda T, 2003, P IEEE, V91, P1803, DOI 10.1109/JPROC.2003.818334
   FULLER DN, 2006, NUCLEIC ACIDS RES, V34
   Galletto R, 2006, NATURE, V443, P875, DOI 10.1038/nature05197
   GASPERIS GD, 1999, BIOMEDICAL MICRODEVI, V2, P41, DOI DOI 10.1023/A:1009955200029
   Gore J, 2006, NATURE, V442, P836, DOI 10.1038/nature04974
   GRAHAM W, 1998, CURR OP OBSTET GYN, V10, P221
   Grier DG, 2003, NATURE, V424, P810, DOI 10.1038/nature01935
   Griessl SJH, 2004, J PHYS CHEM B, V108, P11556, DOI 10.1021/jp049521p
   Gu M, 2004, APPL PHYS LETT, V84, P4236, DOI 10.1063/1.1756200
   Hashiguchi G, 2003, ANAL CHEM, V75, P4347, DOI 10.1021/ac034501p
   HATAMURA Y, 1990, IEEE P MICR SYST INV, P203
   Holzel R, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.128102
   Holzel R, 2003, IEE Proc Nanobiotechnol, V150, P47, DOI 10.1049/ip-nbt:20031006
   Hortola P, 2008, MICRON, V39, P53, DOI 10.1016/j.micron.2006.12.004
   Ino K, 2008, LAB CHIP, V8, P134, DOI 10.1039/b712330b
   Iwasaka M, 1996, J APPL PHYS, V79, P4708, DOI 10.1063/1.361647
   IWASAKA M, 2006, J APPL PHYS, V99
   Ji HM, 2008, BIOMED MICRODEVICES, V10, P251, DOI 10.1007/s10544-007-9131-x
   Jonsson H, 2005, PERFUSION-UK, V20, P39, DOI 10.1191/0267659105pf782oa
   Jonsson H, 2004, ANN THORAC SURG, V78, P1572, DOI 10.1016/j.athoracsur.2004.04.071
   Jung JY, 2007, ANAL CHEM, V79, P5087, DOI 10.1021/ac0702903
   Kaminskyj SGW, 2008, MICRON, V39, P349, DOI 10.1016/j.micron.2007.10.023
   KASAS S, 2008, PFLUEGERS ARCH, V456, P189
   Kehr J, 2003, CURR OPIN PLANT BIOL, V6, P617, DOI 10.1016/j.pbi.2003.09.002
   KIM K, 2008, J MICROMECH MICROENG, V28
   Kim P, 1999, SCIENCE, V286, P2148, DOI 10.1126/science.286.5447.2148
   Kim SM, 2008, LAB CHIP, V8, P1015, DOI 10.1039/b800835c
   Koschwanez JH, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2722400
   Krichevsky A, 2007, J APPL PHYS, V101, DOI 10.1063/1.2405730
   Kufer SK, 2008, SCIENCE, V319, P594, DOI 10.1126/science.1151424
   Kumara MT, 2006, NANO LETT, V6, P2121, DOI 10.1021/nl060598u
   Kumemura M, 2007, CHEMPHYSCHEM, V8, P1875, DOI 10.1002/cphc.200700268
   Kumetsov Y, 2008, J VIROL, V82, P7551, DOI 10.1128/JVI.00016-08
   Laakso JM, 2008, SCIENCE, V321, P133, DOI 10.1126/science.1159419
   LAL R, 1994, AM J PHYSIOL, V266, pC1
   Laney DE, 1997, BIOPHYS J, V72, P806, DOI 10.1016/S0006-3495(97)78714-9
   Lapizco-Encinas BH, 2007, ELECTROPHORESIS, V28, P4521, DOI 10.1002/elps.200700303
   Laurell T, 2007, CHEM SOC REV, V36, P492, DOI 10.1039/b601326k
   Laval JM, 2000, ANALYST, V125, P29, DOI 10.1039/a907827d
   Layton BE, 2005, MICROELECTRON J, V36, P644, DOI 10.1016/j.mejo.2005.04.051
   Lazar KL, 2005, BIOCHEMISTRY-US, V44, P12681, DOI 10.1021/bi0509705
   Lee H, 2004, IEEE T MAGN, V40, P2991, DOI 10.1109/TMAG.2004.829179
   Lee H, 2004, APPL PHYS LETT, V85, P1063, DOI 10.1063/1.1776339
   Lee H, 2006, IEEE J SOLID-ST CIRC, V41, P1471, DOI 10.1109/JSSC.2006.874331
   Li MQ, 1999, APPL PHYS A-MATER, V68, P255, DOI 10.1007/s003390050884
   Loewik DWPM, 2008, J PEPT SCI, V14, P127, DOI 10.1002/psc.969
   Lowik DWPM, 2007, ADV MATER, V19, P1191, DOI 10.1002/adma.200602295
   Manero JM, 2003, MICROSC RES TECHNIQ, V61, P469, DOI 10.1002/jemt.10358
   Marcus MS, 2007, SMALL, V3, P1610, DOI 10.1002/smll.200700130
   Menachery A, 2005, IEE P-NANOBIOTECHNOL, V152, P145, DOI 10.1049/ip-nbt:20050010
   Menger FM, 2002, P NATL ACAD SCI USA, V99, P4818, DOI 10.1073/pnas.062524299
   MESTRES P, 2003, MICROSC MICROANAL, V9, P490
   MESTRES P, 2007, MICROSC MICROANAL, V13, P244
   Michel JP, 2006, P NATL ACAD SCI USA, V103, P6184, DOI 10.1073/pnas.0601744103
   MILES M, 1990, PHYS WORLD, V3, P28, DOI 10.1088/2058-7058/3/10/19
   Minelli Caterina, 2008, Journal of Nanobiotechnology, V6, P3, DOI 10.1186/1477-3155-6-3
   Mita M, 2005, J MICROELECTROMECH S, V14, P23, DOI 10.1109/JMEMS.2004.838997
   Molhave K, 2006, NANOTECHNOLOGY, V17, P2434, DOI 10.1088/0957-4484/17/10/002
   Muscariello L, 2005, J CELL PHYSIOL, V205, P328, DOI 10.1002/jcp.20444
   NISHIOKA M, 1995, J ELECTROSTAT, V35, P83, DOI 10.1016/0304-3886(95)00013-Z
   Nozawa N, 2007, IEEJ T ELECTR ELECTR, V2, P284, DOI 10.1002/iee.20143
   Park J, 2005, LAB CHIP, V5, P91, DOI 10.1039/b404990j
   Parra A, 2007, LANGMUIR, V23, P2747, DOI 10.1021/la062864p
   Petersson F, 2005, LAB CHIP, V5, P20, DOI 10.1039/b405748c
   Petersson F, 2007, ANAL CHEM, V79, P5117, DOI 10.1021/ac070444e
   Pethig R, 2008, IET NANOBIOTECHNOL, V2, P31, DOI 10.1049/iet-nbt:20070027
   PETHIG R, 2007, IET NANOBIOTECHNOL, V2, P31
   POHL HA, 1951, J APPL PHYS, V22, P869, DOI 10.1063/1.1700065
   POHL HA, 1958, J APPL PHYS, V29, P1182, DOI 10.1063/1.1723398
   PURCELL EM, 1977, AM J PHYS, V45, P3, DOI 10.1119/1.10903
   Reches M, 2006, NAT NANOTECHNOL, V1, P195, DOI 10.1038/nnano.2006.139
   Regtmeier J, 2007, ANAL CHEM, V79, P3925, DOI 10.1021/ac062431r
   Rubio-Sierra FJ, 2005, ADV ENG MATER, V7, P193, DOI 10.1002/adem.200400174
   Sacconi L, 2006, CELL BIOCHEM BIOPHYS, V45, P289, DOI 10.1385/CBB:45:3:289
   Sardan O, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/37/375501
   Schaap IAT, 2006, BIOPHYS J, V91, P1521, DOI 10.1529/biophysj.105.077826
   Scheibel T, 2003, P NATL ACAD SCI USA, V100, P4527, DOI 10.1073/pnas.0431081100
   Schopper B, 1999, HUM REPROD, V14, P186, DOI 10.1093/humrep/14.suppl_1.186
   Sia SK, 2003, ELECTROPHORESIS, V24, P3563, DOI 10.1002/elps.200305584
   SITTI M, 2001, IEEE NAN C NOV, P75
   Sitti M, 2007, IEEE ROBOT AUTOM MAG, V14, P53, DOI 10.1109/MRA.2007.339606
   Solano B, 2007, MICROELECTRON ENG, V84, P1219, DOI 10.1016/j.mee.2007.01.153
   Stark RW, 1998, APPL PHYS A-MATER, V66, pS579, DOI 10.1007/s003390051205
   Stark RW, 2003, EUR BIOPHYS J BIOPHY, V32, P33, DOI 10.1007/s00249-002-0270-y
   STOKES D, 2008, MICROSC MICROANAL, V9, P190
   Strick T, 2000, PROG BIOPHYS MOL BIO, V74, P115, DOI 10.1016/S0079-6107(00)00018-3
   Stuhrmann B, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2214961
   Suehiro J, 1998, J PHYS D APPL PHYS, V31, P3298, DOI 10.1088/0022-3727/31/22/019
   Sun Y, 2003, IEEE T NANOBIOSCI, V2, P279, DOI 10.1109/TNB.2003.820273
   TADIR Y, 1989, FERTIL STERIL, V52, P870
   Tai CH, 2007, BIOMED MICRODEVICES, V9, P533, DOI 10.1007/s10544-007-9061-7
   Tai SSW, 2001, SCANNING, V23, P267
   TONER M, 2008, IEEE INT C MICR MECH, P54
   TRIMMER WSN, 1989, SENSOR ACTUATOR, V19, P267, DOI 10.1016/0250-6874(89)87079-9
   Tuukkanen S, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/29/295204
   Urdaneta M, 2007, ELECTROPHORESIS, V28, P3145, DOI 10.1002/elps.200600786
   Wakayama NI, 1998, J CRYST GROWTH, V191, P199, DOI 10.1016/S0022-0248(98)00117-1
   Wang BG, 2007, CELL TISSUE RES, V328, P515, DOI 10.1007/s00441-006-0367-1
   Wang XB, 2000, ANAL CHEM, V72, P832, DOI 10.1021/ac990922o
   Wautelet M, 2001, EUR J PHYS, V22, P601, DOI 10.1088/0143-0807/22/6/305
   Wilhelm C, 2007, BIOMATERIALS, V28, P3797, DOI 10.1016/j.biomaterials.2007.04.047
   Wong PK, 2004, J MICROELECTROMECH S, V13, P940, DOI 10.1109/JMEMS.2004.838382
   Wu AG, 2004, ANAL BIOCHEM, V325, P293, DOI 10.1016/j.ab.2003.11.005
   Wu J, 2008, IET NANOBIOTECHNOL, V2, P14, DOI 10.1049/iet-nbt:20070023
   Yamada M, 2004, BIOTECHNOL BIOENG, V88, P489, DOI 10.1002/bit.20276
   YAMAHATA C, 2006, INT C MICR MED BIOL, P123
   Yamahata C, 2008, J MICROELECTROMECH S, V17, P623, DOI 10.1109/JMEMS.2008.922080
   Yang J, 2000, BIOPHYS J, V78, P2680, DOI 10.1016/S0006-3495(00)76812-3
   Yang J, 1999, ANAL CHEM, V71, P911, DOI 10.1021/ac981250p
   Yang M, 2007, SENSOR ACTUAT A-PHYS, V135, P73, DOI 10.1016/j.sna.2006.06.071
   Yi CQ, 2006, ANAL CHIM ACTA, V560, P1, DOI 10.1016/j.aca.2005.12.037
NR 161
TC 87
Z9 87
U1 3
U2 59
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1757-9694
EI 1757-9708
J9 INTEGR BIOL-UK
JI Integr. Biol.
PD JAN
PY 2009
VL 1
IS 1
BP 30
EP 42
DI 10.1039/b814549k
PG 13
WC Cell Biology
SC Cell Biology
GA 457ZL
UT WOS:000266978200004
PM 20023789
DA 2018-10-19
ER

PT J
AU Guo, LM
   Zhao, JL
   Wang, XX
   Xu, XW
   Liu, HY
   Li, YX
AF Guo, Limin
   Zhao, Jianling
   Wang, Xixin
   Xu, Xuewen
   Liu, Heye
   Li, Yangxian
TI Structure and Bioactivity of Zirconia Nanotube Arrays Fabricated by
   Anodization
SO INTERNATIONAL JOURNAL OF APPLIED CERAMIC TECHNOLOGY
LA English
DT Article
ID SIMULATED BODY-FLUID; APATITE FORMATION; PHASE-TRANSFORMATION; TITANIUM;
   DEPOSITION; ZRO2; BIOMATERIAL; COATINGS; ANATASE; ABILITY
AB Zirconia nanotube arrays with a diameter of 300-350 nm and a length of 100 mu m were prepared by anodization of zirconium in an organic electrolyte containing NH(4)F. The zirconia layers were annealed at 200-800 degrees C in air. The morphologies of the specimens were observed using scanning electron microscopy. The phase structure was identified by X-ray diffraction and Fourier transform infrared spectroscopy. The bioactivity of zirconia nanotubes at different annealing temperatures was assessed by simulated body fluids immersion experiments. Results show that the nanotube arrays were stable when annealed at 600 degrees C. The tubal layers containing zirconia with a low crystallinity and amorphous structure are more bioactive compared with a well-crystallized structure.
C1 [Guo, Limin; Zhao, Jianling; Wang, Xixin; Xu, Xuewen; Liu, Heye; Li, Yangxian] Hebei Univ Technol, Sch Mat Sci & Engn, Tianjin 300130, Peoples R China.
RP Guo, LM (reprint author), Hebei Univ Technol, Sch Mat Sci & Engn, Tianjin 300130, Peoples R China.
EM hebutzhaoj@126.com
RI zhao, jianling/J-9513-2012
OI zhao, jian ling/0000-0002-7844-9137; Xu, Xuewen/0000-0002-7277-8730
FU Tianjin Natural Science Foundation [07JCYBJC03300]; Natural Science
   Foundation of Hebei Province of China [E2007000044]; Chinese Ministry of
   Education [208013]
FX This work was supported by Tianjin Natural Science Foundation
   (07JCYBJC03300) and Natural Science Foundation of Hebei Province of
   China (E2007000044) and the Key Project of Chinese Ministry of Education
   (No. 208013).
CR Benali B, 2006, APPL SURF SCI, V253, P1222, DOI 10.1016/j.apsusc.2006.01.060
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Denry I, 2008, DENT MATER, V24, P299, DOI 10.1016/j.dental.2007.05.007
   JONANSSON CB, 1994, J MATER SCI-MATER M, V5, P340
   Kawashita M, 2003, BIOMATERIALS, V24, P2477, DOI 10.1016/S0142-9612(03)00050-4
   Ko T, 2003, MATER LETT, V57, P2472, DOI 10.1016/S0167-577X(02)01296-X
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Lee WJ, 2005, ELECTROCHEM SOLID ST, V8, pB7, DOI 10.1149/1.1857115
   Lee W, 2006, NAT MATER, V5, P741, DOI 10.1038/nmat1717
   Liang H, 2007, APPL SURF SCI, V253, P3326, DOI 10.1016/j.apsusc.2006.07.038
   Liu XY, 2003, SURF COAT TECH, V172, P270, DOI 10.1016/S0257-8972(03)00344-X
   LIUA X, 2006, BIOMATERIALS, V27, P3904
   Lu YP, 2003, MATER SCI TECH-LOND, V19, P260, DOI 10.1179/026708303225009625
   Moulzolf SC, 1997, J VAC SCI TECHNOL A, V15, P1211, DOI 10.1116/1.580595
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Song KC, 2000, MATER LETT, V42, P283, DOI 10.1016/S0167-577X(99)00199-8
   Thomsen P, 1997, J MATER SCI-MATER M, V8, P653, DOI 10.1023/A:1018579605426
   Uchida M, 2002, J CERAM SOC JPN, V110, P710, DOI 10.2109/jcersj.110.710
   Uchida M, 2002, BIOMATERIALS, V23, P313, DOI 10.1016/S0142-9612(01)00110-7
   Vollath D, 2006, J NANOPART RES, V8, P1003, DOI 10.1007/s11051-006-9116-3
   Wang CM, 2004, J MATER RES, V19, P1315, DOI 10.1557/jmr.2004.0175
   Wang XX, 2000, J BIOMED MATER RES, V52, P171, DOI 10.1002/1097-4636(200010)52:1<171::AID-JBM22>3.0.CO;2-O
   Wei DQ, 2007, SURF COAT TECH, V201, P8723, DOI 10.1016/j.surfcoat.2006.12.010
   Wu JM, 2006, SURF COAT TECH, V201, P755, DOI 10.1016/j.surfcoat.2005.12.025
   Wu JM, 2004, J AM CERAM SOC, V87, P1635, DOI 10.1111/j.1551-2916.2004.01635.x
   Xiao XF, 2007, MATER CHEM PHYS, V106, P27, DOI 10.1016/j.matchemphys.2007.05.014
   Xu RQ, 2008, J APPL ELECTROCHEM, V38, P1229, DOI 10.1007/s10800-008-9543-1
   Xu RQ, 2008, KEY ENG MAT, V368-372, P1510, DOI 10.4028/www.scientific.net/KEM.368-372.1510
   Yan YY, 2007, SURF COAT TECH, V201, P5692, DOI 10.1016/j.surfcoat.2006.07.058
   Yang YZ, 2003, BIOMATERIALS, V24, P619, DOI 10.1016/S0142-9612(02)00376-9
   Yasuda K, 2007, ADV MATER, V19, P1757, DOI 10.1002/adma.200601912
   Yeh SW, 2007, MAT SCI ENG A-STRUCT, V452, P313, DOI 10.1016/j.msea.2006.10.131
   Zhao JL, 2008, CORROS SCI, V50, P1593, DOI 10.1016/j.corsci.2008.01.026
   Zhao JL, 2005, NANOTECHNOLOGY, V16, P2450, DOI 10.1088/0957-4484/16/10/077
   Zhao YB, 2007, MATER LETT, V61, P942, DOI 10.1016/j.matlet.2006.06.018
NR 35
TC 28
Z9 28
U1 1
U2 16
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1546-542X
J9 INT J APPL CERAM TEC
JI Int. J. Appl. Ceram. Technol.
PY 2009
VL 6
IS 5
BP 636
EP 641
DI 10.1111/j.1744-7402.2008.02305.x
PG 6
WC Materials Science, Ceramics
SC Materials Science
GA 490IQ
UT WOS:000269494800010
DA 2018-10-19
ER

PT J
AU Dashtban, M
   Schraft, H
   Qin, WS
AF Dashtban, Mehdi
   Schraft, Heidi
   Qin, Wensheng
TI Fungal Bioconversion of Lignocellulosic Residues; Opportunities &
   Perspectives
SO INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES
LA English
DT Review
DE Biomass; Lignocellulose; Bioconversion; Fungi; Cellulases; Cellulosome
ID BASIDIOMYCETE PHANEROCHAETE-CHRYSOSPORIUM; SOLID-STATE FERMENTATION;
   EXTRACELLULAR BETA-GLUCOSIDASE; ENHANCED CELLULASE PRODUCTION; REESEI
   RUT C30; TRICHODERMA-REESEI; SACCHAROMYCES-CEREVISIAE; MIXED CULTURE;
   BROWN-ROT; SIMULTANEOUS SACCHARIFICATION
AB The development of alternative energy technology is critically important because of the rising prices of crude oil, security issues regarding the oil supply, and environmental issues such as global warming and air pollution. Bioconversion of biomass has significant advantages over other alternative energy strategies because biomass is the most abundant and also the most renewable biomaterial on our planet. Bioconversion of lignocellulosic residues is initiated primarily by microorganisms such as fungi and bacteria which are capable of degrading lignocellulolytic materials. Fungi such as Trichoderma reesei and Aspergillus niger produce large amounts of extracellular cellulolytic enzymes, whereas bacterial and a few anaerobic fungal strains mostly produce cellulolytic enzymes in a complex called cellulosome, which is associated with the cell wall. In filamentous fungi, cellulolytic enzymes including endoglucanases, cellobiohydrolases (exoglucanases) and beta-glucosidases work efficiently on cellulolytic residues in a synergistic manner. In addition to cellulolytic/hemicellulolytic activities, higher fungi such as basidiomycetes (e. g. Phanerochaete chrysosporium) have unique oxidative systems which together with ligninolytic enzymes are responsible for lignocellulose degradation. This review gives an overview of different fungal lignocellulolytic enzymatic systems including extracellular and cellulosome-associated in aerobic and anaerobic fungi, respectively. In addition, oxidative lignocellulose-degradation mechanisms of higher fungi are discussed. Moreover, this paper reviews the current status of the technology for bioconversion of biomass by fungi, with focus on mutagenesis, co-culturing and heterologous gene expression attempts to improve fungal lignocellulolytic activities to create robust fungal strains.
C1 [Dashtban, Mehdi; Qin, Wensheng] Lakehead Univ, Biorefining Res Initiat, Thunder Bay, ON P7B 5E1, Canada.
   [Dashtban, Mehdi; Schraft, Heidi; Qin, Wensheng] Lakehead Univ, Dept Biol, Thunder Bay, ON P7B 5E1, Canada.
RP Qin, WS (reprint author), Lakehead Univ, Biorefining Res Initiat, 955 Oliver Rd, Thunder Bay, ON P7B 5E1, Canada.
EM wqin@lakeheadu.ca
CR Abbas A, 2005, CURR GENET, V47, P49, DOI 10.1007/s00294-004-0550-4
   Ahamed A, 2008, BIOCHEM ENG J, V42, P41, DOI 10.1016/j.bej.2008.05.007
   ALI BRS, 1995, FEMS MICROBIOL LETT, V125, P15, DOI 10.1016/0378-1097(94)00472-4
   Alonso A, 2008, PHYSIOL PLANTARUM, V132, P102, DOI 10.1111/j.1399-3054.2007.00997.x
   Anderson WF, 2008, J IND MICROBIOL BIOT, V35, P355, DOI 10.1007/s10295-007-0291-8
   Arora DS, 2002, INT BIODETER BIODEGR, V50, P115, DOI 10.1016/S0964-8305(02)00064-1
   Baldrian P, 2008, FEMS MICROBIOL REV, V32, P501, DOI 10.1111/j.1574-6976.2008.00106.x
   Baminger U, 2001, APPL ENVIRON MICROB, V67, P1766, DOI 10.1128/AEM.67.4.1766-1774.2001
   Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022
   Bayer EA, 1998, CURR OPIN STRUC BIOL, V8, P548, DOI 10.1016/S0959-440X(98)80143-7
   BHAT KM, 1987, APPL ENVIRON MICROB, V53, P2175
   Bourne Y, 2001, CURR OPIN STRUC BIOL, V11, P593, DOI 10.1016/S0959-440X(00)00253-0
   Bower BS, 2005, WO Patent, Patent No. [WO2005093073, 2005093073]
   BROCK BJ, 1995, APPL ENVIRON MICROB, V61, P3076
   Cai YJ, 1999, APPL ENVIRON MICROB, V65, P553
   Call HP, 1997, J BIOTECHNOL, V53, P163, DOI 10.1016/S0168-1656(97)01683-0
   Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663
   CAO WG, 1993, CAN J MICROBIOL, V39, P125, DOI 10.1139/m93-018
   CHAHAL DS, 1985, APPL ENVIRON MICROB, V49, P205
   Champagne P, 2007, RESOUR CONSERV RECY, V50, P211, DOI 10.1016/j.resconrec.2006.09.003
   Chen HZ, 1998, FEMS MICROBIOL LETT, V159, P63, DOI 10.1111/j.1574-6968.1998.tb12842.x
   Chu BCH, 2007, BIOTECHNOL ADV, V25, P425, DOI 10.1016/j.biotechadv.2007.04.001
   Dan S, 2000, J BIOL CHEM, V275, P4973, DOI 10.1074/jbc.275.7.4973
   Dijkerman R, 1997, ARCH MICROBIOL, V167, P137, DOI 10.1007/s002030050426
   Divne C, 1998, J MOL BIOL, V275, P309, DOI 10.1006/jmbi.1997.1437
   DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495
   Doi RH, 2008, ANN NY ACAD SCI, V1125, P267, DOI 10.1196/annals.1419.002
   DUENAS R, 1995, WORLD J MICROB BIOT, V11, P333, DOI 10.1007/BF00367112
   DUFF SJB, 1985, BIOTECHNOL LETT, V7, P185, DOI 10.1007/BF01027817
   ENOKI A, 1992, MATER ORGANISMEN, V27, P247
   Enoki A, 2003, ACS SYM SER, V845, P140
   EVANS CS, 1985, APPL MICROBIOL BIOT, V22, P128
   Fenel F, 2006, J BIOTECHNOL, V121, P102, DOI 10.1016/j.jbiotec.2005.07.010
   Fenel F, 2004, J BIOTECHNOL, V108, P137, DOI 10.1016/j.jbiotec.2003.11.002
   Ferraz A, 2003, ENZYME MICROB TECH, V32, P59, DOI 10.1016/S0141-0229(02)00267-3
   Foreman PK, 2003, J BIOL CHEM, V278, P31988, DOI 10.1074/jbc.M304750200
   Galbe M, 2002, APPL MICROBIOL BIOT, V59, P618, DOI 10.1007/s00253-002-1058-9
   Georgieva TI, 2008, APPL BIOCHEM BIOTECH, V148, P35, DOI 10.1007/s12010-007-8085-z
   Gerbi C, 1996, CURR MICROBIOL, V32, P256, DOI 10.1007/s002849900046
   GILBERT M, 1993, APPL MICROBIOL BIOT, V40, P508
   Gomes I, 2000, APPL MICROBIOL BIOT, V53, P461, DOI 10.1007/s002530051642
   Grassick A, 2004, EUR J BIOCHEM, V271, P4495, DOI 10.1111/j.1432-1033.2004.04409.x
   Griffith GW, 2009, FUNGAL ECOL, V2, P87, DOI 10.1016/j.funeco.2009.01.005
   GUILLEN F, 1992, EUR J BIOCHEM, V209, P603, DOI 10.1111/j.1432-1033.1992.tb17326.x
   Gupte A, 1997, BIOTECHNOL PROGR, V13, P166, DOI 10.1021/bp970004g
   Gutierrez-Correa M, 1998, BIOTECHNOL LETT, V20, P45, DOI 10.1023/A:1005379030092
   Hahn-Hagerdal B, 2006, TRENDS BIOTECHNOL, V24, P549, DOI 10.1016/j.tibtech.2006.10.004
   Hao JJ, 2007, J IND MICROBIOL BIOT, V34, P233, DOI 10.1007/s10295-006-0191-3
   Hao JJ, 2006, J EUKARYOT MICROBIOL, V53, P193, DOI 10.1111/j.1550-7408.2006.00093.x
   Henriksson G, 2000, J BIOTECHNOL, V78, P93, DOI 10.1016/S0168-1656(00)00206-6
   HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309
   Hill J, 2006, P NATL ACAD SCI USA, V103, P11206, DOI 10.1073/pnas.0604600103
   Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016
   Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509
   Howard R. L., 2003, African Journal of Biotechnology, V2, P602
   Ishikawa E, 2005, J BIOSCI BIOENG, V99, P331, DOI 10.1263/jbb.99.331
   JOHNSON KG, 1990, WORLD J MICROB BIOT, V6, P209, DOI 10.1007/BF01200943
   Juhasz T, 2003, FOOD TECHNOL BIOTECH, V41, P49
   Kalogo Y, 2007, ENVIRON SCI TECHNOL, V41, P35, DOI 10.1021/es061117b
   Karhumaa K, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-18
   Khan MMH, 2007, J ENVIRON SCI HEAL B, V42, P381, DOI 10.1080/03601230701312647
   Kim S, 2004, BIOMASS BIOENERG, V26, P361, DOI 10.1016/j.biombioe.2003.08.002
   Kovacs K, 2008, ENZYME MICROB TECH, V43, P48, DOI 10.1016/j.enzmictec.2008.02.006
   KUBICEK CP, 1981, EUR J APPL MICROBIOL, V13, P226, DOI 10.1007/BF00500103
   Kumar R, 2008, J IND MICROBIOL BIOT, V35, P377, DOI 10.1007/s10295-008-0327-8
   Kurek B, 2000, J AGR FOOD CHEM, V48, P3058, DOI 10.1021/jf000015g
   Kurzatkowski W, 1996, APPL ENVIRON MICROB, V62, P2859
   LAMED R, 1983, J BACTERIOL, V156, P828
   Larsson S, 2000, APPL BIOCHEM BIOTECH, V84-6, P617, DOI 10.1385/ABAB:84-86:1-9:617
   Lee Sung S., 2001, Canadian Journal of Microbiology, V47, P754, DOI 10.1139/cjm-47-8-754
   LEVINE JS, 1996, BIOMASS BURNING GLOB, V1, P35
   LI XL, 1991, APPL ENVIRON MICROB, V57, P3331
   Li Ya-ling, 2006, Weishengwu Xuebao, V46, P143
   LICHT FO, 2008, ANN WORLD ETHANOL PR
   Ljungdahl LG, 2008, ANN NY ACAD SCI, V1125, P308, DOI 10.1196/annals.1419.030
   Lynd LR, 2005, CURR OPIN BIOTECH, V16, P577, DOI 10.1016/j.copbio.2005.08.009
   Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002
   MAHESHWARI DK, 1994, CARBOHYD POLYM, V23, P161, DOI 10.1016/0144-8617(94)90098-1
   Maheshwari R, 2000, MICROBIOL MOL BIOL R, V64, P461, DOI 10.1128/MMBR.64.3.461-488.2000
   Makela MR, 2009, MICROBIOL-SGM, V155, P2726, DOI 10.1099/mic.0.028860-0
   MANDELS M, 1976, J FERMENT TECHNOL, V54, P267
   MANDELS M, 1971, APPL MICROBIOL, V21, P152
   Martin C, 2007, BIORESOURCE TECHNOL, V98, P1767, DOI 10.1016/j.biortech.2006.07.021
   Martinez AT, 2005, INT MICROBIOL, V8, P195
   MCMILLAN JD, 1994, APPL BIOCHEM BIOTECH, V45-6, P569, DOI 10.1007/BF02941831
   Mendels M., 1969, ADV CHEM SER, V95, P391, DOI [DOI 10.1021/BA-1969-0095.CH023, 10.1021/ba-1969-0095.ch023]
   Miettinen-Oinonen A, 2005, J BIOTECHNOL, V116, P305, DOI 10.1016/j.jbiotec.2004.10.017
   MONTENECOURT BS, 1977, APPL ENVIRON MICROB, V34, P777
   MONTENECOURT BS, 1979, ACS SYM SER, V181, P289, DOI DOI 10.1021/BA-1979-0181.CH014
   Morais H, 2002, J CHROMATOGR B, V770, P111, DOI 10.1016/S0378-4347(01)00561-8
   Moredo N, 2003, WORLD J MICROB BIOT, V19, P665, DOI 10.1023/A:1025198917474
   Mosier N, 2005, BIORESOURCE TECHNOL, V96, P673, DOI 10.1016/j.biortech.2004.06.025
   Murray P, 2004, PROTEIN EXPRES PURIF, V38, P248, DOI 10.1016/j.pep.2004.08.006
   Nagy T, 2007, J MOL BIOL, V373, P612, DOI 10.1016/i.jmb.2007.08.007
   Nilvebrant NO, 2003, APPL BIOCHEM BIOTECH, V105, P615
   Ohgren K, 2006, J BIOTECHNOL, V126, P488, DOI 10.1016/j.jbiotec.2006.05.001
   OKADA H, 2000, J MOL CATAL B-ENZYM, P249
   ORPIN CG, 1975, J GEN MICROBIOL, V91, P249, DOI 10.1099/00221287-91-2-249
   Ozkose E, 2001, CAN J BOT, V79, P666, DOI 10.1139/cjb-79-6-666
   Palacios-Orueta A, 2005, ENVIRON MONIT ASSESS, V104, P189, DOI 10.1007/s10661-005-1611-y
   Palmqvist E, 2000, BIORESOURCE TECHNOL, V74, P17, DOI 10.1016/S0960-8524(99)00160-1
   PANDA T, 1983, BIOTECHNOL LETT, V5, P767, DOI 10.1007/BF01386499
   Park YS, 2002, APPL MICROBIOL BIOT, V58, P761, DOI 10.1007/s00253-002-0965-0
   PHILIPPIDIS GP, 1993, BIOTECHNOL BIOENG, V41, P846, DOI 10.1002/bit.260410903
   Pokhrel D, 2005, WASTE MANAGE, V25, P555, DOI 10.1016/j.wasman.2005.01.020
   Qin YQ, 2008, J BIOTECHNOL, V135, P190, DOI 10.1016/j.jbiotec.2008.03.016
   Rahman Z, 2009, BIOSCI BIOTECH BIOCH, V73, P1083, DOI 10.1271/bbb.80852
   Raman B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005271
   RENGANATHAN V, 1990, APPL MICROBIOL BIOT, V32, P609
   ROGER V, 1992, REPROD NUTR DEV, V32, P321, DOI 10.1051/rnd:19920402
   Rosgaard L, 2006, BIOTECHNOL PROGR, V22, P493, DOI 10.1021/bp050361o
   ROUVINEN J, 1990, SCIENCE, V249, P380, DOI 10.1126/science.2377893
   Rubin EM, 2008, NATURE, V454, P841, DOI 10.1038/nature07190
   Saha BC, 2003, J IND MICROBIOL BIOT, V30, P279, DOI 10.1007/s10295-003-0049-x
   Saha BC, 2000, BIOTECHNOL ADV, V18, P403, DOI 10.1016/S0734-9750(00)00044-6
   Sanchez C, 2009, BIOTECHNOL ADV, V27, P185, DOI 10.1016/j.biotechadv.2008.11.001
   Sandgren M, 2005, PROG BIOPHYS MOL BIO, V89, P246, DOI 10.1016/j.pbiomolbio.2004.11.002
   Schiffer HW, 2008, ENERG POLICY, V36, P2464, DOI 10.1016/j.enpol.2008.02.045
   SCHNEIDER H, 1981, BIOTECHNOL LETT, V3, P89, DOI 10.1007/BF00145116
   Seidl V, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-327
   Shallom D, 2003, CURR OPIN MICROBIOL, V6, P219, DOI 10.1016/S1369-5274(03)00056-0
   Shi J, 2008, BIORESOURCE TECHNOL, V99, P6556, DOI 10.1016/j.biortech.2007.11.069
   SIVAN A, 1984, PHYTOPATHOLOGY, V74, P498, DOI 10.1094/Phyto-74-498
   Solov'eva I. V., 2005, Mikrobiologiya, V74, P172
   SONG BC, 2008, J MICROBIOL BIOTECHN, V18, P404
   SREBOTNIK E, 1988, APPL ENVIRON MICROB, V54, P2608
   *STAT CAN, 2005, 16201XIE STAT CAN, P8
   Stenberg K, 2000, BIOTECHNOL BIOENG, V68, P204, DOI 10.1002/(SICI)1097-0290(20000420)68:2<204::AID-BIT9>3.0.CO;2-4
   STOCKTON BC, 1991, BIOTECHNOL LETT, V13, P57, DOI 10.1007/BF01033518
   Suzuki MR, 2006, ENVIRON MICROBIOL, V8, P2214, DOI 10.1111/j.1462-2920.2006.01160.x
   Taherzadeh MJ, 2008, INT J MOL SCI, V9, P1621, DOI 10.3390/ijms9091621
   Tanaka H, 1999, HOLZFORSCHUNG, V53, P21, DOI 10.1515/HF.1999.004
   Tanaka H, 2007, J BIOTECHNOL, V128, P500, DOI 10.1016/j.jbiotec.2006.12.010
   Turner P, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-9
   United Nations Department of Economic and Social Affairs, 2007, ESAPWP202 UN DEP EC
   Viikari L, 2007, ADV BIOCHEM ENG BIOT, V108, P121, DOI 10.1007/10_2007_065
   Wang L, 2008, SCI CHINA SER C, V51, P214, DOI 10.1007/s11427-008-0033-9
   Wang Wei, 2006, Biotechnology Journal, V1, P447, DOI 10.1002/biot.200500016
   Wen ZY, 2004, BIORESOURCE TECHNOL, V91, P31, DOI 10.1016/S0960-8524(03)00166-4
   Weng JK, 2008, CURR OPIN BIOTECH, V19, P166, DOI 10.1016/j.copbio.2008.02.014
   WILSON CA, 1992, APPL MICROBIOL BIOT, V37, P125
   Yang WH, 2004, BIOTECHNOL LETT, V26, P1799, DOI 10.1007/s10529-004-4612-y
   Yoon JJ, 2007, J MICROBIOL BIOTECHN, V17, P800
   Zhang YHP, 2006, BIOTECHNOL ADV, V24, P452, DOI 10.1016/j.biotechadv.2006.03.003
   Zhang YHP, 2007, BIOTECHNOL BIOENG, V97, P214, DOI 10.1002/bit.21386
   Zhou SG, 2000, J BACTERIOL, V182, P5676, DOI 10.1128/JB.182.20.5676-5682.2000
NR 146
TC 314
Z9 334
U1 10
U2 158
PU IVYSPRING INT PUBL
PI LAKE HAVEN
PA PO BOX 4546, LAKE HAVEN, NSW 2263, AUSTRALIA
SN 1449-2288
J9 INT J BIOL SCI
JI Int. J. Biol. Sci.
PY 2009
VL 5
IS 6
BP 578
EP 595
DI 10.7150/ijbs.5.578
PG 18
WC Biochemistry & Molecular Biology; Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics
GA 526FD
UT WOS:000272272200007
PM 19774110
OA DOAJ Gold
DA 2018-10-19
ER

PT S
AU Wang, XH
   Schroder, HC
   Muller, WEG
AF Wang, Xiaohong
   Schroeder, Heinz C.
   Mueller, Werner E. G.
BE Jeon, KW
TI GIANT SILICEOUS SPICULES FROM THE DEEP-SEA GLASS SPONGE MONORHAPHIS
   CHUNI
SO INTERNATIONAL REVIEW OF CELL AND MOLECULAR BIOLOGY, VOL 273
SE International Review of Cell and Molecular Biology
LA English
DT Review; Book Chapter
DE Sponge; Porifera; Hexactinellida; Spicule; Giant basal spicule;
   Silicatein; Biomaterial science
ID DEMOSPONGE SUBERITES-DOMUNCULA; GEODIA-CYDONIUM; HEXACTINELLID
   MONORHAPHIS; EVOLUTIONARY RELATIONSHIPS; SILICATEIN FILAMENTS; DIATOM
   FRUSTULE; BIOSILICA-GLASS; SNOWBALL EARTH; AMINO-ACID; PORIFERA
AB Only 13 years after realizing, during a repair of a telegraph cable pulled out from the deep sea, that the depth of the ocean is plentifully populated with a highly diverse fauna and flora, the Challenger expedition (1873-1876) treasured up a rich collection of vitreous sponges (Hexactinellida). They had been described by Schulze and represent the phylogenetically oldest class of siliceous sponges (phylum Porifera); they are eye-catching because of their distinct body plan, which relies on a filigree skeleton. It is constructed by an array of morphologically determined elements, the spicules. Soon after, during the German Deep Sea Expedition "Valdivia" (1898-1899), Schulze could describe the largest siliceous hexactinellid sponge on Earth, the up to 3-m high Monorhaphis chuni, which develops the equally largest bio-silica structure, the giant basal spicules (3 m x 10 mm). Using these spicules as a model, basic knowledge on the morphology, formation, and development of the skeletal elements could be achieved. They are formed by a proteinaceous scaffold (composed of a 27-kDa protein), which mediates the formation of the siliceous lamellae, into which the proteins are encased. The high number of 800 of 5-10 mu m thick lamellae is concentrically arranged around the axial canal. The silica matrix is composed of almost pure silicon oxide, providing it with unusually optophysical properties, which are superior to those of man-made waveguides. Experiments might suggest that the spicules function in vivo as a nonocular photoreception system. In addition, the spicules have exceptional mechanical properties, combining mechanical stability with strength and stiffness. Like demosponges, also the hexactinellids synthesize their silica enzymatically, via the enzyme silicatein (27-kDa protein). It is suggested that these basic insights will surely contribute to a further applied utilization and exploration of silica in bio-material/biomedical science.
C1 [Wang, Xiaohong] Natl Res Ctr Geoanal, Beijing, Peoples R China.
   [Schroeder, Heinz C.; Mueller, Werner E. G.] Johannes Gutenberg Univ Mainz, Inst Physiol Chem, Angew Mol Biol Abt, D-6500 Mainz, Germany.
RP Wang, XH (reprint author), Natl Res Ctr Geoanal, 26 Baiwanzhuang Dajie, Beijing, Peoples R China.
CR Aizenberg J, 2004, P NATL ACAD SCI USA, V101, P3358, DOI 10.1073/pnas.0307843101
   Bocage J. V. Barboza Du., 1864, Proceedings of the Zoological Society of London, P265
   BRAUN CL, 1993, J CHEM EDUC, V70, P612, DOI 10.1021/ed070p612
   Butschli O, 1901, Z WISS ZOOL ABT A, V69, P235
   CAMPBELL LG, 1876, CHALLENGER
   Carrera MG, 1999, J PALEONTOL, V73, P26, DOI 10.1017/S0022336000027517
   CattaneoVietti R, 1996, NATURE, V383, P397, DOI 10.1038/383397b0
   Cha JN, 1999, P NATL ACAD SCI USA, V96, P361, DOI 10.1073/pnas.96.2.361
   Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404
   Chono K, 2002, BRAIN RES, V951, P107, DOI 10.1016/S0006-8993(02)03143-8
   Chun C, 1900, TIEFEN WELTMEERES
   DIEHLSEIFERT B, 1985, EUR J BIOCHEM, V147, P517
   Eckert C, 2006, J HISTOCHEM CYTOCHEM, V54, P1031, DOI 10.1369/jhc.5A6903.2006
   Ehrlich H., 2006, RUSS J MAR BIOL, V32, P217
   Ehrlich H, 2007, HDB BIOMINERALIZATIO, V1, P23
   GRANT RE, 1833, LANCET, V1, P153
   Hastings JW, 1996, GENE, V173, P5, DOI 10.1016/0378-1119(95)00676-1
   HECKY RE, 1973, MAR BIOL, V19, P323, DOI 10.1007/BF00348902
   Hoffman PF, 1998, SCIENCE, V281, P1342, DOI 10.1126/science.281.5381.1342
   Hoffman PF, 2002, TERRA NOVA, V14, P129, DOI 10.1046/j.1365-3121.2002.00408.x
   Hyman L.H., 1940, INVERTEBRATES PROTOZ
   Knoll AH, 2003, REV MINERAL GEOCHEM, V54, P329, DOI 10.2113/0540329
   Krasko A, 2002, DNA CELL BIOL, V21, P67, DOI 10.1089/10445490252810320
   Krasko A, 1997, P ROY SOC B-BIOL SCI, V264, P1077, DOI 10.1098/rspb.1997.0149
   Krasko A, 2000, EUR J BIOCHEM, V267, P4878, DOI 10.1046/j.1432-1327.2000.01547.x
   Kruse M, 1998, J MOL EVOL, V46, P721, DOI 10.1007/PL00006353
   Kruse M, 1997, MOL BIOL EVOL, V14, P1326, DOI 10.1093/oxfordjournals.molbev.a025742
   LEVI C, 1989, J MATER SCI LETT, V8, P337, DOI 10.1007/BF00725516
   Leys SP, 2007, ADV MAR BIOL, V52, P1, DOI 10.1016/S0065-2881(06)52001-2
   Leys SP, 2002, J COMP PHYSIOL A, V188, P199, DOI 10.1007/s00359-002-0293-y
   Leys SP, 2001, BIOL BULL-US, V201, P323, DOI 10.2307/1543611
   LI CW, 1998, SCIENCE, V279, P897
   LI J, 1987, OCEANOL LIMNOL SINIC, V18, P135
   Lobel KD, 1996, MAR BIOL, V126, P353, DOI 10.1007/BF00354617
   Lobel KD, 1996, J MATER SCI LETT, V15, P648, DOI 10.1007/BF00264101
   MACKIE GO, 1979, C INT CNRS, V291, P145
   Mayer G, 2005, SCIENCE, V310, P1144, DOI 10.1126/science.1116994
   MAYER G, 2005, EUPL ASP MAT RES SOC, V844
   Molly L, 2006, CLIN ORAL IMPLAN RES, V17, P481, DOI 10.1111/j.1600-0501.2006.01286.x
   MORT JS, 2002, HDB PROTEOLYTIC ENZY, P617
   Muller WEG, 2007, BIOGEOSCIENCES, V4, P219, DOI 10.5194/bg-4-219-2007
   Muller WEG, 2008, J EXP BIOL, V211, P300, DOI 10.1242/jeb.008193
   Muller WEG, 2008, CELL TISSUE RES, V333, P339, DOI 10.1007/s00441-008-0624-6
   Muller WEG, 2008, J STRUCT BIOL, V161, P188, DOI 10.1016/j.jsb.2007.10.009
   Muller WEG, 2008, FEBS J, V275, P362, DOI 10.1111/j.1742-4658.2007.06206.x
   Muller WEG, 2007, BIOMATERIALS, V28, P4501, DOI 10.1016/j.biomaterials.2007.06.030
   Muller WEG, 2007, CELL TISSUE RES, V329, P363, DOI 10.1007/s00441-007-0402-x
   Muller WEG, 2007, GENE, V395, P62, DOI 10.1016/j.gene.2007.02.014
   Muller W. E. G., 2005, ENCY MOL CELL BIOL M, V13, P269
   Muller WEG, 2006, MICRON, V37, P107, DOI 10.1016/j.micron.2005.09.003
   Muller WEG, 2006, BIOSENS BIOELECTRON, V21, P1149, DOI 10.1016/j.bios.2005.04.017
   Muller WEG, 2005, CELL TISSUE RES, V321, P285, DOI 10.1007/s00441-005-1141-5
   Muller WEG, 1999, MAR ECOL PROG SER, V178, P205, DOI 10.3354/meps178205
   Muller WEG, 2004, INT REV CYTOL, V235, P53, DOI 10.1016/S0074-7696(04)35002-3
   Muller WEG, 2003, PROG MOLEC, V33, P195
   Muller WEG, 2002, GENE, V295, P299, DOI 10.1016/S0378-1119(02)00690-X
   Muller WEG, 1998, NATURWISSENSCHAFTEN, V85, P11, DOI 10.1007/s001140050444
   Muller WEG, 2001, COMP BIOCHEM PHYS A, V129, P433, DOI 10.1016/S1095-6433(00)00360-3
   MULLER WEG, 1995, NATURWISSENSCHAFTEN, V82, P36
   MULLER WEG, 2007, HDB BIOMINERALIZATIO, V1, P59
   MULLER WEG, 2009, CELLULAR MO IN PRESS
   MULLER WEG, 2007, Patent No. 7229807
   MULLER WEG, 2007, Patent No. 7169589
   MULLER WEG, 2008, CHEM MATER, DOI DOI 10.1021/CRN800734Q
   Murr MM, 2005, P NATL ACAD SCI USA, V102, P11657, DOI 10.1073/pnas.0503968102
   Murray J., 1912, DEPTHS OCEAN
   Nakamura Y, 1997, DNA Res, V4, P401, DOI 10.1093/dnares/4.6.401
   Pavans de Ceccatty M., 1974, AM ZOOL, V14, P895
   Perovic S, 1999, CELL TISSUE RES, V296, P395, DOI 10.1007/s004410051299
   PFEIFER K, 1993, GLYCOBIOLOGY, V3, P179, DOI 10.1093/glycob/3.2.179
   Pilcher H, 2005, NATURE, V435, P1022, DOI 10.1038/4351022a
   Pisera A, 2003, MICROSC RES TECHNIQ, V62, P312, DOI 10.1002/jemt.10398
   RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6
   Reiswig HM, 2006, CAN J ZOOL, V84, P195, DOI 10.1139/Z05-174
   Reitner J., 2002, SYSTEMA PORIFERA GUI, P52
   ROBINSON PN, 2007, JAVA PROGRAM DRAWING
   ROUX M, 1991, B SOC GEOL FR, V162, P675
   Sandford F, 2003, MICROSC RES TECHNIQ, V62, P336, DOI 10.1002/jemt.10400
   Sarikaya M, 2001, J MATER RES, V16, P1420, DOI 10.1557/JMR.2001.0198
   Schmidt O., 1870, GRUNDZUGE SPONGIEN F
   Schroder HC, 2006, J BIOL CHEM, V281, P12001, DOI 10.1074/jbc.M512677200
   Schroder HC, 2004, BIOCHEM J, V381, P665, DOI 10.1042/BJ20040463
   Schroder HC, 2003, PROG MOLEC, V33, P249
   Schroder HC, 2004, CELL TISSUE RES, V316, P271, DOI 10.1007/s00441-004-0869-7
   Schroder HC, 2003, BBA-PROTEINS PROTEOM, V1651, P41, DOI 10.1016/S1570-9639(03)00233-4
   Schroder HC, 2008, NAT PROD REP, V25, P455, DOI 10.1039/b612515h
   Schroder HC, 2007, NATURWISSENSCHAFTEN, V94, P339, DOI 10.1007/s00114-006-0192-0
   Schulze F. E., 1904, HEXACTINELLIDA WISSE, P1898
   SCHUMACHER A, 1976, Southwestern Naturalist, V21, P1, DOI 10.2307/3670317
   Schutze J, 1999, P ROY SOC B-BIOL SCI, V266, P63, DOI 10.1098/rspb.1999.0605
   Shimizu K, 1998, P NATL ACAD SCI USA, V95, P6234, DOI 10.1073/pnas.95.11.6234
   SIMPSON TL, 1985, ZOOMORPHOLOGY, V105, P375, DOI 10.1007/BF00312281
   STEIN JG, 1994, POLIT PSYCHOL, V15, P1, DOI 10.2307/3791436
   Steiner M., 1993, Berliner Geowissenschaftliche Abhandlungen Reihe E Palaeobiologie, V9, P293
   Sumerel JL, 2003, PROG MOLEC, V33, P225
   TABACHNICK KR, 2002, SYSTEMA PORIFERA GUI, P1264
   THOMSON CW, 1874, DEPTHS SEA
   Uriz MJ, 2006, CAN J ZOOL, V84, P322, DOI 10.1139/Z06-032
   Uriz MJ, 2003, MICROSC RES TECHNIQ, V62, P279, DOI 10.1002/jemt.10395
   Walker G., 2003, SNOWBALL EARTH STORY
   WANG X, 2006, ADV EARTH SCI, V21, P37
   WANG XH, 2008, MONOGRAPHIS J STRUCT, V164, P270
   Wang Xiao-Hong, 2007, Acta Zoologica Sinica, V53, P557
   Weaver JC, 2007, J STRUCT BIOL, V158, P93, DOI 10.1016/j.jsb.2006.10.027
   Wiens M, 2006, DEV GENES EVOL, V216, P229, DOI 10.1007/s00427-005-0047-2
   YOSHIDA M, 1979, ASS HDB SENSORY PHYS, P581
   Zhang SC, 2000, ORG GEOCHEM, V31, P273, DOI 10.1016/S0146-6380(00)00003-6
NR 107
TC 38
Z9 40
U1 0
U2 19
PU ELSEVIER ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1937-6448
BN 978-0-12-374804-1
J9 INT REV CEL MOL BIO
JI Int. Rev. Cell Mol. Biol.
PY 2009
VL 273
BP 69
EP +
DI 10.1016/S1937-6448(08)01803-0
PG 50
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA BIY74
UT WOS:000263825900003
PM 19215903
DA 2018-10-19
ER

PT S
AU Dubash, AD
   Menold, MM
   Samson, T
   Boulter, E
   Garcia-Mata, R
   Doughman, R
   Burridge, K
AF Dubash, Adi D.
   Menold, Marisa M.
   Samson, Thomas
   Boulter, Etienne
   Garcia-Mata, Rafael
   Doughman, Renee
   Burridge, Keith
BE Jeon, KW
TI FOCAL ADHESIONS: NEW ANGLES ON AN OLD STRUCTURE
SO INTERNATIONAL REVIEW OF CELL AND MOLECULAR BIOLOGY, VOL 277
SE International Review of Cell and Molecular Biology
LA English
DT Review; Book Chapter
DE Focal adhesion; Extracellular matrix; Integrins; Syndecan-4; GEF; Rho
   GTPase; RhoA; Biomaterial surfaces; Mechanotransduction; Focal adhesion
   disassembly
ID PROTEIN-KINASE-C; CELL-MATRIX ADHESIONS; SMOOTH-MUSCLE-CELLS; NUCLEOTIDE
   EXCHANGE FACTOR; ACTIN STRESS FIBERS; SELF-ASSEMBLED MONOLAYERS;
   INTEGRIN-LINKED KINASE; GTP-BINDING PROTEIN; AORTIC ENDOTHELIAL-CELLS;
   INTERFERENCE REFLECTION MICROSCOPY
AB Focal adhesions have been intensely studied ever since their discovery in 1971. The last three decades have seen major advances in understanding the structure of focal adhesions and the functions they serve in cellular adhesion, migration, and other biological processes. In this chapter, we begin with a historical perspective of focal adhesions, provide an overview of focal adhesion biology, and highlight recent major advances in the field. Specifically, we review the different types of matrix adhesions and the role different Rho GTPases play in their formation. We discuss the relative contributions of integrin and syndecan adhesion receptors to the formation of focal adhesions. We also focus on new insights gained from studying focal adhesions on biomaterial surfaces and from the growing field of mechanotransduction. Throughout this chapter, we have highlighted areas of focal adhesion biology where major questions still remain to be answered.
C1 [Dubash, Adi D.; Menold, Marisa M.; Samson, Thomas; Boulter, Etienne; Garcia-Mata, Rafael; Doughman, Renee; Burridge, Keith] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA.
   [Dubash, Adi D.; Menold, Marisa M.; Samson, Thomas; Boulter, Etienne; Garcia-Mata, Rafael; Doughman, Renee; Burridge, Keith] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.
RP Dubash, AD (reprint author), Univ N Carolina, Dept Cell & Dev Biol, CB 7295, Chapel Hill, NC 27599 USA.
RI Boulter, Etienne/R-1737-2016
OI Boulter, Etienne/0000-0001-6597-9086
FU NIGMS NIH HHS [GM029860]
CR ABERCROM.M, 1971, EXP CELL RES, V67, P359, DOI 10.1016/0014-4827(71)90420-4
   ABERCROMBIE M, 1975, EXP CELL RES, V92, P57, DOI 10.1016/0014-4827(75)90636-9
   Abram CL, 2003, J BIOL CHEM, V278, P16844, DOI 10.1074/jbc.M300267200
   Albinsson S, 2004, J BIOL CHEM, V279, P34849, DOI 10.1074/jbc.M403370200
   Alexander NR, 2008, CURR BIOL, V18, P1295, DOI 10.1016/j.cub.2008.07.090
   AMATO PA, 1983, J CELL BIOL, V96, P750, DOI 10.1083/jcb.96.3.750
   Ariga K, 2006, J NANOSCI NANOTECHNO, V6, P2278, DOI 10.1166/jnn.2006.503
   Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014
   Arthur WT, 2002, BIOL RES, V35, P239, DOI 10.4067/S0716-97602002000200016
   Arthur WT, 2001, MOL BIOL CELL, V12, P2711, DOI 10.1091/mbc.12.9.2711
   Arthur WT, 2000, CURR BIOL, V10, P719, DOI 10.1016/S0960-9822(00)00537-6
   Artym VV, 2006, CANCER RES, V66, P3034, DOI 10.1158/0008-5472.CAN-05-2177
   Avalos AM, 2004, J BIOL CHEM, V279, P39139, DOI 10.1074/jbc.M403439200
   BACIU PC, 1995, MOL BIOL CELL, V6, P1503
   Baldassarre M, 2003, MOL BIOL CELL, V14, P1074, DOI 10.1091/mbc.E02-05-0308
   Bass MD, 2008, J CELL BIOL, V181, P1013, DOI 10.1083/jcb.200711129
   Bass MD, 2007, J CELL BIOL, V177, P527, DOI 10.1083/jcb.200610076
   Bass MD, 2002, BIOCHEM J, V368, P1, DOI 10.1042/BJ20021228
   BASS MD, 2007, EUR PHYS J E, V3, P372
   Beauvais DLM, 2004, J CELL BIOL, V167, P171, DOI 10.1083/jcb.200404171
   Beauvais DM, 2003, EXP CELL RES, V286, P219, DOI 10.1016/S0014-4827(03)00126-5
   BECKERLE MC, 1987, CELL, V51, P569, DOI 10.1016/0092-8674(87)90126-7
   Belkin AM, 1997, J CELL BIOL, V139, P1583, DOI 10.1083/jcb.139.6.1583
   Belkin AM, 1996, J CELL BIOL, V132, P211, DOI 10.1083/jcb.132.1.211
   Beningo KA, 2004, P NATL ACAD SCI USA, V101, P18024, DOI 10.1073/pnas.0405747102
   Berdeaux RL, 2004, J CELL BIOL, V166, P317, DOI 10.1083/jcb.200312168
   Bershadsky A, 1996, CURR BIOL, V6, P1279, DOI 10.1016/S0960-9822(02)70714-8
   Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241
   Blattler T, 2006, J NANOSCI NANOTECHNO, V6, P2237, DOI 10.1166/jnn.2006.501
   Block MR, 2008, EUR J CELL BIOL, V87, P491, DOI 10.1016/j.ejcb.2008.02.012
   Bloom L, 1999, MOL BIOL CELL, V10, P1521, DOI 10.1091/mbc.10.5.1521
   Borradori L, 1999, J INVEST DERMATOL, V112, P411, DOI 10.1046/j.1523-1747.1999.00546.x
   Bowden ET, 1999, ONCOGENE, V18, P4440, DOI 10.1038/sj.onc.1202827
   Bradley WD, 2006, MOL BIOL CELL, V17, P4827, DOI 10.1091/mbc.E06-02-0132
   Brandt D, 2002, J BIOL CHEM, V277, P20903, DOI 10.1074/jbc.M200946200
   Brock A, 2003, LANGMUIR, V19, P1611, DOI 10.1021/la026394k
   Brown MC, 2002, MOL BIOL CELL, V13, P1550, DOI 10.1091/mbc.02-02-0015
   Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436
   Burgstaller G, 2004, J CELL SCI, V117, P223, DOI 10.1242/jcs.00839
   Burns S, 2001, BLOOD, V98, P1142, DOI 10.1182/blood.V98.4.1142
   BURRIDGE K, 1980, CELL, V19, P587, DOI 10.1016/S0092-8674(80)80035-3
   BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415
   Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463
   Cai XM, 2008, MOL CELL BIOL, V28, P201, DOI 10.1128/MCB.01324-07
   Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071
   CALIGARISCAPPIO F, 1986, BLOOD, V67, P233
   Carman CV, 2007, IMMUNITY, V26, P784, DOI 10.1016/j.immuni.2007.04.015
   Castellano F, 2001, SEMIN IMMUNOL, V13, P347, DOI 10.1006/smim.2001.0331
   Cavalcanti-Adam EA, 2006, EUR J CELL BIOL, V85, P219, DOI 10.1016/j.ejcb.2005.09.011
   Cavalcanti-Adam EA, 2007, BIOPHYS J, V92, P2964, DOI 10.1529/biophysj.106.089730
   Chan EWL, 2006, J AM CHEM SOC, V128, P15542, DOI [10.1021/ja065828l, 10.1021/ja0658281]
   CHARDIN P, 1989, EMBO J, V8, P1087, DOI 10.1002/j.1460-2075.1989.tb03477.x
   Chellaiah M, 1996, MOL BIOL CELL, V7, P743
   Chellaiah MA, 2000, J BIOL CHEM, V275, P11993, DOI 10.1074/jbc.275.16.11993
   Chellaiah MA, 2001, J BIOL CHEM, V276, P47434, DOI 10.1074/jbc.M107494200
   Chen CS, 2008, J CELL SCI, V121, P3285, DOI 10.1242/jcs.023507
   CHEN WT, 1984, J CELL BIOL, V98, P1546, DOI 10.1083/jcb.98.4.1546
   CHEN WT, 1982, J CELL BIOL, V95, P205, DOI 10.1083/jcb.95.1.205
   CHEN WT, 1989, J EXP ZOOL, V251, P167, DOI 10.1002/jez.1402510206
   CHEN WT, 1985, NATURE, V316, P156, DOI 10.1038/316156a0
   CHEN WT, 1990, CELL DIFFER DEV, V32, P329, DOI 10.1016/0922-3371(90)90047-Z
   Chew TL, 1998, J MUSCLE RES CELL M, V19, P839, DOI 10.1023/A:1005417926585
   Chikumi H, 2002, J BIOL CHEM, V277, P12463, DOI 10.1074/jbc.M108504200
   Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5
   ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403
   Collin O, 2008, CURR BIOL, V18, P1288, DOI 10.1016/j.cub.2008.07.046
   Couchman JR, 1999, J CELL SCI, V112, P3415
   Couchman JR, 2003, NAT REV MOL CELL BIO, V4, P926, DOI 10.1038/nrm1257
   Couchman JR, 2001, INT REV CYTOL, V207, P113
   Cox EA, 2001, MOL BIOL CELL, V12, P265, DOI 10.1091/mbc.12.2.265
   CROWLEY E, 1995, J CELL BIOL, V131, P525, DOI 10.1083/jcb.131.2.525
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   CURTIS ASG, 1964, J CELL BIOL, V20, P199, DOI 10.1083/jcb.20.2.199
   Cutler SM, 2003, BIOMATERIALS, V24, P1759, DOI 10.1016/S0142-9612(02)00570-7
   Danen EHJ, 2005, J CELL BIOL, V169, P515, DOI 10.1083/jcb.200412081
   Danen EHJ, 2002, J CELL BIOL, V159, P1071, DOI 10.1083/jcb.200205014
   DANOWSKI BA, 1989, J CELL SCI, V93, P255
   DAVIS S, 1991, SCIENCE, V252, P712, DOI 10.1126/science.1708917
   Defilippi P, 2006, TRENDS CELL BIOL, V16, P257, DOI 10.1016/j.tcb.2006.03.003
   del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912
   Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211
   DEPASQUALE JA, 1987, J CELL BIOL, V105, P2803, DOI 10.1083/jcb.105.6.2803
   Deroanne CF, 2001, CARDIOVASC RES, V49, P647, DOI 10.1016/S0008-6363(00)00233-9
   Destaing O, 2003, MOL BIOL CELL, V14, P407, DOI 10.1091/mbc.E02-07-0389
   Digman MA, 2009, P NATL ACAD SCI USA, V106, P2170, DOI 10.1073/pnas.0806036106
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Dourdin N, 2001, J BIOL CHEM, V276, P48382, DOI 10.1074/jbc.M108893200
   Dovas A, 2006, J CELL SCI, V119, P2837, DOI 10.1242/jcs.03020
   Dubash AD, 2007, J CELL SCI, V120, P3989, DOI 10.1242/jcs.003806
   Echtermeyer F, 1999, J CELL SCI, V112, P3433
   Echtermeyer F, 2001, J CLIN INVEST, V107, pR9, DOI 10.1172/JCI10559
   Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5
   Evans E, 2001, ANNU REV BIOPH BIOM, V30, P105, DOI 10.1146/annurev.biophys.30.1.105
   Evans JG, 2003, J CELL BIOL, V161, P697, DOI 10.1083/jcb.200212037
   Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262
   Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024
   Franco S, 2004, EXP CELL RES, V299, P179, DOI 10.1016/j.yexcr.2004.05.021
   Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175
   Fukuhara S, 2001, ONCOGENE, V20, P1661, DOI 10.1038/sj.onc.1204182
   Fukuhara S, 2000, FEBS LETT, V485, P183, DOI 10.1016/S0014-5793(00)02224-9
   Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868
   GABBIANI G, 1971, EXPERIENTIA, V27, P549, DOI 10.1007/BF02147594
   Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153
   Gallant ND, 2007, J NANOSCI NANOTECHNO, V7, P803, DOI 10.1166/jnn.2007.507
   Garcia AJ, 2005, BIOMATERIALS, V26, P7525, DOI 10.1016/j.biomaterials.2005.05.029
   Gates BD, 2005, CHEM REV, V105, P1171, DOI 10.1021/cr030076o
   GAVAZZI I, 1989, J CELL SCI, V94, P85
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   GEIGER B, 1979, CELL, V18, P193, DOI 10.1016/0092-8674(79)90368-4
   Georges PC, 2005, J APPL PHYSIOL, V98, P1547, DOI 10.1152/japplphysiol.01121.2004
   Giannone G, 2006, TRENDS CELL BIOL, V16, P213, DOI 10.1016/j.tcb.2006.02.005
   Giannone G, 2003, J CELL BIOL, V163, P409, DOI 10.1083/jcb.200302001
   Gilmore AP, 1996, NATURE, V381, P531, DOI 10.1038/381531a0
   Gimona M, 2008, CURR OPIN CELL BIOL, V20, P235, DOI [10.1016/j.ceb.2008.01.005, 10.1016/j.ceb.2008.0i.005]
   Gimona M, 2006, INT J BIOCHEM CELL B, V38, P1875, DOI 10.1016/j.biocel.2006.05.003
   Glogauer M, 1998, PFLUG ARCH EUR J PHY, V435, P320
   Gringel A, 2006, J CELL PHYSIOL, V209, P568, DOI 10.1002/jcp.20777
   GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401
   Hai CM, 2002, EXP CELL RES, V280, P64, DOI 10.1006/excr.2002.5592
   HALLIDAY NL, 1995, EXP CELL RES, V217, P109, DOI 10.1006/excr.1995.1069
   Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112
   Hashimoto S, 2004, P NATL ACAD SCI USA, V101, P6647, DOI 10.1073/pnas.0401753101
   HASTON WS, 1983, EXP CELL RES, V146, P117, DOI 10.1016/0014-4827(83)90330-0
   HEATH JP, 1993, SYM SOC EXP BIOL, V47, P35
   HEATH JP, 1978, J CELL SCI, V29, P197
   HENSON MM, 1985, HEARING RES, V20, P207, DOI 10.1016/0378-5955(85)90025-5
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hill MM, 2002, CURR BIOL, V12, P1251, DOI 10.1016/S0960-9822(02)00973-9
   Hodgson L, 2007, J AM CHEM SOC, V129, P9264, DOI 10.1021/ja072900m
   Holinstat M, 2006, J BIOL CHEM, V281, P2296, DOI 10.1074/jbc.M511248200
   Hotchin NA, 1995, J CELL BIOL, V131, P1857, DOI 10.1083/jcb.131.6.1857
   Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093
   Houseman BT, 1998, J ORG CHEM, V63, P7552, DOI 10.1021/jo981113s
   Houseman BT, 2001, BIOMATERIALS, V22, P943, DOI 10.1016/S0142-9612(00)00259-3
   Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036
   Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098
   Humphries Martin J, 2005, Novartis Found Symp, V269, P178
   Humphries MJ, 2005, NOVART FDN SYMP, V269, P223
   Humphries MJ, 2005, NOVART FDN SYMP, V269, P188
   Huttenlocher A, 1997, J BIOL CHEM, V272, P32719, DOI 10.1074/jbc.272.52.32719
   Huttenlocher A, 1996, J CELL BIOL, V134, P1551, DOI 10.1083/jcb.134.6.1551
   HYNES RO, 1978, CELL, V15, P875, DOI 10.1016/0092-8674(78)90272-6
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Iba K, 2000, J CELL BIOL, V149, P1143, DOI 10.1083/jcb.149.5.1143
   Ilic Dusko, 1995, Nature (London), V377, P539
   Ingber DE, 1997, ANNU REV PHYSIOL, V59, P575, DOI 10.1146/annurev.physiol.59.1.575
   Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev
   Ishiguro K, 2000, J BIOL CHEM, V275, P5249, DOI 10.1074/jbc.275.8.5249
   Iwanicki MP, 2008, J CELL SCI, V121, P895, DOI 10.1242/jcs.020941
   IZZARD CS, 1988, CELL MOTIL CYTOSKEL, V10, P137, DOI 10.1002/cm.970100118
   IZZARD CS, 1986, EXP CELL RES, V165, P320, DOI 10.1016/0014-4827(86)90586-0
   IZZARD CS, 1976, J CELL SCI, V21, P129
   IZZARD SL, 1987, EXP CELL RES, V170, P214, DOI 10.1016/0014-4827(87)90131-5
   JAMIESON JS, 2009, J CELL BIOL IN PRESS
   Janiak A, 2006, MOL BIOL CELL, V17, P1606, DOI 10.1091/mbc.E05-06-0549
   Jiang GY, 2003, NATURE, V424, P334, DOI 10.1038/nature01805
   Jockusch BM, 1995, ANNU REV CELL DEV BI, V11, P379, DOI 10.1146/annurev.cellbio.11.1.379
   Johnson CP, 2007, BLOOD, V109, P3538, DOI 10.1182/blood-2006-07-038588
   Johnson RP, 2000, J BIOL CHEM, V275, P95, DOI 10.1074/jbc.275.1.95
   Jurdic P, 2006, EUR J CELL BIOL, V85, P195, DOI 10.1016/j.ejcb.2005.09.008
   Kato M, 2004, BIOCHEMISTRY-US, V43, P2699, DOI 10.1021/bi0352670
   Katsumi A, 2005, J BIOL CHEM, V280, P16546, DOI 10.1074/jbc.C400455200
   Katsumi A, 2004, J BIOL CHEM, V279, P12001, DOI 10.1074/jbc.R300038200
   Katsumi A, 2002, J CELL BIOL, V158, P153, DOI 10.1083/jcb.200201105
   Katz BZ, 2000, MOL BIOL CELL, V11, P1047, DOI 10.1091/mbc.11.3.1047
   Kaverina I, 1999, J CELL BIOL, V146, P1033, DOI 10.1083/jcb.146.5.1033
   Kim T, 2009, CANCER METAST REV, V28, P77, DOI 10.1007/s10555-008-9167-2
   KOZMA R, 1995, MOL CELL BIOL, V15, P1942
   Kulkarni SV, 2000, J CELL BIOL, V149, P457, DOI 10.1083/jcb.149.2.457
   KUMAGAI H, 1991, BIOCHEM BIOPH RES CO, V177, P74, DOI 10.1016/0006-291X(91)91950-H
   Kuo S C, 1992, Trends Cell Biol, V2, P116, DOI 10.1016/0962-8924(92)90016-G
   Kusano Y, 2000, EXP CELL RES, V256, P434, DOI 10.1006/excr.2000.4802
   LAZARIDES E, 1975, CELL, V6, P289, DOI 10.1016/0092-8674(75)90180-4
   Lazzari M, 2006, J NANOSCI NANOTECHNO, V6, P892, DOI 10.1166/jnn.2006.172
   Lee SE, 2007, J BIOMECH, V40, P2096, DOI 10.1016/j.jbiomech.2007.04.006
   Lehnert D, 2004, J CELL SCI, V117, P41, DOI 10.1242/jcs.00836
   LEHTO VP, 1982, LAB INVEST, V47, P391
   LEVESQUE MJ, 1985, J BIOMECH ENG-T ASME, V107, P341, DOI 10.1115/1.3138567
   Liao YC, 2007, J CELL BIOL, V176, P43, DOI 10.1083/jcb.200608015
   Lieb E, 2005, BIOMATERIALS, V26, P2333, DOI 10.1016/j.biomaterials.2004.07.010
   Lim ST, 2003, J BIOL CHEM, V278, P13795, DOI 10.1074/jbc.M208300200
   Lim Y, 2008, J CELL BIOL, V180, P187, DOI 10.1083/jcb.200708194
   Linder S, 2000, J IMMUNOL, V165, P221, DOI 10.4049/jimmunol.165.1.221
   Linder S, 1999, P NATL ACAD SCI USA, V96, P9648, DOI 10.1073/pnas.96.17.9648
   Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4
   Linder S, 2007, TRENDS CELL BIOL, V17, P107, DOI 10.1016/j.tcb.2007.01.002
   Ling K, 2003, J CELL BIOL, V163, P1339, DOI 10.1083/jcb.200310067
   Liu BP, 1998, CELL ADHES COMMUN, V5, P249, DOI 10.3109/15419069809040295
   Liu ML, 2006, MOL BIOL CELL, V17, P1880, DOI 10.1091/mbc.E06-01-0002
   Liu WF, 2007, CIRC RES, V101, pE44, DOI 10.1161/CIRCRESAHA.107.158329
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   LO SH, 1994, J CELL BIOL, V125, P1067, DOI 10.1083/jcb.125.5.1067
   Lo SH, 2002, CANCER RES, V62, P4217
   Lo SH, 1997, J CELL BIOL, V136, P1349, DOI 10.1083/jcb.136.6.1349
   Lock JG, 2008, SEMIN CANCER BIOL, V18, P65, DOI 10.1016/j.semcancer.2007.10.001
   Luxenburg C, 2006, J CELL SCI, V119, P4878, DOI 10.1242/jcs.03271
   Lynch DK, 1999, ONCOGENE, V18, P8024
   MacKenna DA, 1998, J CLIN INVEST, V101, P301, DOI 10.1172/JCI1026
   Mackinnon AC, 2002, CURR BIOL, V12, P787, DOI 10.1016/S0960-9822(02)00810-2
   Mahalingam Y, 2007, J BIOL CHEM, V282, P3221, DOI 10.1074/jbc.M604938200
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   Majumdar M, 1999, J BIOL CHEM, V274, P26815, DOI 10.1074/jbc.274.38.26815
   MARCHISIO PC, 1988, J CELL BIOCHEM, V37, P151, DOI 10.1002/jcb.240370203
   MARCHISIO PC, 1984, J CELL BIOL, V99, P1696, DOI 10.1083/jcb.99.5.1696
   Masiero L, 1999, J CELL SCI, V112, P3205
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   McClary KB, 1999, BIOMATERIALS, V20, P2435, DOI 10.1016/S0142-9612(99)00171-4
   McCleverty CJ, 2007, PROTEIN SCI, V16, P1223, DOI 10.1110/ps.072798707
   McQuade KJ, 2006, J CELL SCI, V119, P2445, DOI 10.1242/jcs.02970
   Meller N, 2005, J CELL SCI, V118, P4937, DOI 10.1242/jcs.02671
   Merkel R, 1999, NATURE, V397, P50, DOI 10.1038/16219
   Miao H, 2002, J CELL SCI, V115, P2199
   Mizutani K, 2002, CANCER RES, V62, P669
   MOCHITATE K, 1991, EXP CELL RES, V193, P198, DOI 10.1016/0014-4827(91)90556-A
   Moon SY, 2003, TRENDS CELL BIOL, V13, P13, DOI 10.1016/S0962-8924(02)00004-1
   Moreau V, 2003, MOL CELL BIOL, V23, P6809, DOI 10.1128/MCB.23.19.6809-6822.2003
   Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289
   Mostafavi-Pour Z, 2001, MATRIX BIOL, V20, P63, DOI 10.1016/S0945-053X(00)00131-1
   Mrksich M, 1996, ANNU REV BIOPH BIOM, V25, P55, DOI 10.1146/annurev.bb.25.060196.000415
   Munevar S, 2004, J CELL SCI, V117, P85, DOI 10.1242/jcs.00795
   Narumiya S, 2000, METHOD ENZYMOL, V325, P273
   Nayal A, 2004, CURR OPIN CELL BIOL, V16, P94, DOI 10.1016/j.ceb.2003.11.007
   NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4
   Oh ES, 1997, J BIOL CHEM, V272, P11805, DOI 10.1074/jbc.272.18.11805
   Oh ES, 1997, J BIOL CHEM, V272, P8133, DOI 10.1074/jbc.272.13.8133
   Oikawa T, 2008, J CELL BIOL, V182, P157, DOI 10.1083/jcb.200801042
   Olski TM, 2001, J CELL SCI, V114, P525
   Ory S, 2000, J CELL SCI, V113, P1177
   Osiak AE, 2005, EXP CELL RES, V307, P342, DOI 10.1016/j.yexcr.2005.03.035
   Palecek SP, 1998, J CELL SCI, V111, P929
   Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059
   Pankov R, 2000, J CELL BIOL, V148, P1075, DOI 10.1083/jcb.148.5.1075
   Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010
   PATERSON HF, 1990, J CELL BIOL, V111, P1001, DOI 10.1083/jcb.111.3.1001
   Pelham RJ, 1998, BIOL BULL, V194, P348, DOI 10.2307/1543109
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Pellegrin S, 2007, J CELL SCI, V120, P3491, DOI 10.1242/jcs.018473
   Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665
   Petrie TA, 2006, BIOMATERIALS, V27, P5459, DOI 10.1016/j.biomaterials.2006.06.027
   Pfaff M, 2001, J CELL SCI, V114, P2775
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Powelka AM, 2004, TRAFFIC, V5, P20, DOI 10.1046/j.1600-0854.2003.00150.x
   Puklin-Faucher E, 2006, J CELL BIOL, V175, P349, DOI 10.1083/jcb.200602071
   Puklin-Faucher E, 2009, J CELL SCI, V122, P179, DOI 10.1242/jcs.042127
   Qian XL, 2007, P NATL ACAD SCI USA, V104, P9012, DOI 10.1073/pnas.0703033104
   Ren XD, 2000, J CELL SCI, V113, P3673
   Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578
   RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7
   Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175
   Romer LH, 2006, CIRC RES, V98, P606, DOI 10.1161/01.RES.0000207408.31270.db
   Rosenberger G, 2006, EUR J CELL BIOL, V85, P265, DOI 10.1016/j.ejcb.2005.10.007
   Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587
   RUBIN EJ, 1988, MOL CELL BIOL, V8, P418, DOI 10.1128/MCB.8.1.418
   Sai XR, 1999, J CELL SCI, V112, P1365
   Sakai T, 2003, GENE DEV, V17, P926, DOI 10.1101/gad.255603
   Samson T, 2007, J BIOL CHEM, V282, P15730, DOI 10.1074/jbc.M611197200
   Saoncella S, 2004, J BIOL CHEM, V279, P47172, DOI 10.1074/jbc.C400299200
   Saoncella S, 1999, P NATL ACAD SCI USA, V96, P2805, DOI 10.1073/pnas.96.6.2805
   Sawada Y, 2001, J CELL SCI, V114, P1221
   Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044
   Schramp M, 2008, J CELL BIOL, V181, P1195, DOI 10.1083/jcb.200801078
   Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cb.11.110195.003001
   Schwartz MA, 2008, CURR OPIN CELL BIOL, V20, P551, DOI 10.1016/j.ceb.2008.05.005
   Sechi AS, 2000, J CELL SCI, V113, P3685
   Shikata Y, 2005, EXP CELL RES, V304, P40, DOI 10.1016/j.yexcr.2004.11.001
   Shin SK, 2006, CURR OPIN CHEM BIOL, V10, P423, DOI 10.1016/j.cbpa.2006.08.006
   Sieg DJ, 1999, J CELL SCI, V112, P2677
   Simons M, 2001, CELL SIGNAL, V13, P855, DOI 10.1016/S0898-6568(01)00190-5
   SINGER II, 1981, CELL, V24, P481, DOI 10.1016/0092-8674(81)90339-1
   SINGER II, 1979, CELL, V16, P675, DOI 10.1016/0092-8674(79)90040-0
   SKALLI O, 1986, J CELL BIOL, V103, P2787, DOI 10.1083/jcb.103.6.2787
   Small JV, 1998, BBA-MOL CELL RES, V1404, P271, DOI 10.1016/S0167-4889(98)00080-9
   SORANNO T, 1982, J CELL BIOL, V95, P127, DOI 10.1083/jcb.95.1.127
   Spatz JP, 2007, METHOD CELL BIOL, V83, P89, DOI 10.1016/S0091-679X(07)83005-6
   Spinardi L, 2004, EXP CELL RES, V295, P360, DOI 10.1016/j.yexcr.2004.01.007
   Stanchi F, 2005, J CELL SCI, V118, P5899, DOI 10.1242/jcs.02686
   Steimle PA, 1999, J BIOL CHEM, V274, P18414, DOI 10.1074/jbc.274.26.18414
   Stofega MR, 2004, MOL BIOL CELL, V15, P2965, DOI 10.1091/mbc.E03-08-0604
   Suzuki N, 2003, P NATL ACAD SCI USA, V100, P733, DOI 10.1073/pnas.0234057100
   Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652
   Tague SE, 2004, P NATL ACAD SCI USA, V101, P9671, DOI 10.1073/pnas.0403531101
   Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2
   Tamada M, 2004, DEV CELL, V7, P709, DOI 10.1016/j.devcel.2004.08.021
   Tamariz E, 2002, MOL BIOL CELL, V13, P3915, DOI 10.1091/mbc.E02-05-0291
   TARONE G, 1985, EXP CELL RES, V159, P141, DOI 10.1016/S0014-4827(85)80044-6
   Tatin F, 2006, J CELL SCI, V119, P769, DOI 10.1242/jcs.02787
   Tehrani S, 2006, MOL BIOL CELL, V17, P2882, DOI 10.1091/mbc.E06-03-0187
   TERUKINA S, 1985, AM J NEPHROL, V5, P248, DOI 10.1159/000166943
   Thodeti CK, 2003, J BIOL CHEM, V278, P9576, DOI 10.1074/jbc.M208937200
   Thoumine O, 2000, EUR BIOPHYS J BIOPHY, V29, P398, DOI 10.1007/s002490000087
   Tkachenko E, 2006, CIRC RES, V98, P1398, DOI 10.1161/01.RES.0000225283.71490.5a
   Tkachenko E, 2005, CIRC RES, V96, P488, DOI 10.1161/01.RES.0000159708.71142.c8
   Tkachenko E, 2004, J CELL SCI, V117, P3189, DOI 10.1242/jcs.01190
   TOMASEK JJ, 1986, J HAND SURG-AM, V11A, P365, DOI 10.1016/S0363-5023(86)80143-5
   TOMASEK JJ, 1992, ANAT REC, V232, P359, DOI 10.1002/ar.1092320305
   Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809
   Torgler CN, 2004, DEV CELL, V6, P357, DOI 10.1016/S1534-5807(04)00055-3
   Tzima E, 2001, EMBO J, V20, P4639, DOI 10.1093/emboj/20.17.4639
   Varon C, 2006, MOL CELL BIOL, V26, P3582, DOI 10.1.128/MCB.26.9.3582-3594.2006
   Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6
   Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890
   von Wichert G, 2003, J CELL BIOL, V161, P143, DOI 10.1083/jcb.200211061
   Voss AK, 2003, DEVELOPMENT, V130, P355, DOI 10.1242/dev.00217
   Vouret-Craviari V, 2004, J CELL SCI, V117, P4559, DOI 10.1242/jcs.01331
   Wang F, 1997, BIOCHEM J, V324, P481, DOI 10.1042/bj3240481
   Wang Q, 2004, J BIOL CHEM, V279, P28831, DOI 10.1074/jbc.C400105200
   Wang RX, 2005, J BIOL CHEM, V280, P28803, DOI 10.1074/jbc.M501421200
   Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044
   WAYNER EA, 1989, J CELL BIOL, V109, P1321, DOI 10.1083/jcb.109.3.1321
   Weaver AM, 2006, CLIN EXP METASTAS, V23, P97, DOI 10.1007/s10585-006-9014-1
   Webb BA, 2005, AM J PHYSIOL-CELL PH, V289, pC898, DOI 10.1152/ajpcell.00095.2005
   Webb BA, 2007, EUR J CELL BIOL, V86, P189, DOI 10.1016/j.ejcb.2007.01.003
   Webb DJ, 2003, CURR OPIN CELL BIOL, V15, P614, DOI 10.1016/S0955-0674(03)00105-4
   Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094
   Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660
   Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs/01118
   White DP, 2007, J CELL BIOL, V177, P515, DOI 10.1083/jcb.200609004
   Whiteford JR, 2007, EXP CELL RES, V313, P3902, DOI 10.1016/j.yexcr.2007.08.002
   Whiteford JR, 2006, J BIOL CHEM, V281, P32156, DOI 10.1074/jbc.M605553200
   Whitesides George M, 2005, Sci Prog, V88, P17, DOI 10.3184/003685005783238462
   Wilcox-Adelman SA, 2003, GLYCOCONJUGATE J, V19, P305, DOI 10.1023/A:1025304602057
   Wilcox-Adelman SA, 2002, J BIOL CHEM, V277, P32970, DOI 10.1074/jbc.M201283200
   WILSON E, 1993, J CELL BIOL, V123, P741, DOI 10.1083/jcb.123.3.741
   WILSON E, 1995, J CLIN INVEST, V96, P2364, DOI 10.1172/JCI118293
   WONG AJ, 1983, SCIENCE, V219, P867, DOI 10.1126/science.6681677
   WOODS A, 1986, EMBO J, V5, P665, DOI 10.1002/j.1460-2075.1986.tb04265.x
   WOODS A, 1988, COLLAGEN REL RES, V8, P155
   WOODS A, 1994, MOL BIOL CELL, V5, P183
   Woods A, 2000, ARCH BIOCHEM BIOPHYS, V374, P66, DOI 10.1006/abbi.1999.1607
   WOODS A, 1992, J CELL SCI, V101, P277
   Woods A, 2001, CURR OPIN CELL BIOL, V13, P578, DOI 10.1016/S0955-0674(00)00254-4
   Woods A, 1998, TRENDS CELL BIOL, V8, P189, DOI 10.1016/S0962-8924(98)01244-6
   Yamaguchi H, 2006, EUR J CELL BIOL, V85, P213, DOI 10.1016/j.ejcb.2005.10.004
   Yamaguchi H, 2005, J CELL BIOL, V168, P441, DOI 10.1083/jcb.200407076
   Yano Y, 1996, AM J PHYSIOL-CELL PH, V271, pC635
   Yano Y, 1996, BIOCHEM BIOPH RES CO, V224, P508, DOI 10.1006/bbrc.1996.1057
   Yoneda A, 2007, MOL BIOL CELL, V18, P66, DOI 10.1091/mbc.E06-08-0684
   Zaidel-Bar R, 2004, BIOCHEM SOC T, V32, P416, DOI 10.1042/BST0320416
   Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858
   Zaidel-Bar R, 2007, J CELL SCI, V120, P137, DOI 10.1242/jcs.03314
   Zamir E, 2000, NAT CELL BIOL, V2, P191
   Zamir E, 2001, J CELL SCI, V114, P3583
   Zamir E, 1999, J CELL SCI, V112, P1655
   Zamir E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001901
   Zervas CG, 2001, J CELL BIOL, V152, P1007, DOI 10.1083/jcb.152.5.1007
   Zhai JB, 2003, J BIOL CHEM, V278, P24865, DOI 10.1074/jbc.M302381200
   ZHANG D, 1995, J CELL SCI, V108, P2285
   Zhong CL, 1998, J CELL BIOL, V141, P539, DOI 10.1083/jcb.141.2.539
   Zhou ST, 2006, AM J PHYSIOL-CELL PH, V290, pC463, DOI 10.1152/ajpcell.00350.2005
   Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004
   Zimerman B, 2004, CELL MOTIL CYTOSKEL, V58, P143, DOI 10.1002/cm.20005
   Zrihan-Licht S, 2000, ONCOGENE, V19, P1318, DOI 10.1038/sj.onc.1203422
NR 353
TC 54
Z9 54
U1 1
U2 26
PU ELSEVIER ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1937-6448
BN 978-0-12-374808-9
J9 INT REV CEL MOL BIO
JI Int. Rev. Cell Mol. Biol.
PY 2009
VL 277
BP 1
EP 65
DI 10.1016/S1937-6448(09)77001-7
PG 65
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA BLU15
UT WOS:000271018400001
PM 19766966
DA 2018-10-19
ER

PT S
AU Olt, J
   Laur, M
AF Olt, Jueri
   Laur, Mihkel
BE Malinovska, L
   Mezote, A
   Kronbergs, E
   Nulle, I
TI BRIQUETTING DIFFERENT KINDS OF HERBACEOUS BIOMATERIAL
SO INTERNATIONAL SCIENTIFIC CONFERENCE: ENGINEERING FOR RURAL DEVELOPMENT
SE Engineering for Rural Development
LA English
DT Proceedings Paper
CT 8th International Scientific Conference on Engineering for Rural
   Development
CY MAY 28-29, 2009
CL Jelgava, LATVIA
SP Latvian Council Sci, AGRO SILJA, UNISAN Ltd, Jozi Ltd, Jelgavas Dzirnavas
DE herbaceous biomass; screw briquette press; solid biofuel; combustion
   testing parameters
AB The paper analyses the features of producing briquette from different herbaceous biomaterial and cardboard waste and describes the problems that can arise in the pressing operation. The screw press was used. The proper briquette was formed from wheat straw, rye straw and cardboard and the satisfactory one from rye straw together with meadow hay. While the rye straw briquette exhibited the highest calorific value and the lowest ash content, the leaf briquette had the highest ash content and the lowest calorific value.
C1 [Olt, Jueri; Laur, Mihkel] Estonian Univ Life Sci, EE-51014 Tartu, Estonia.
RP Olt, J (reprint author), Estonian Univ Life Sci, Kreutzwaldi 1, EE-51014 Tartu, Estonia.
EM jyri.olt@emu.ee
CR KASK U, BIOMASSI ALTERNATIIV
   OLT J, 2008, ERINEVA BIOMATERJALI, P27
   *SERWIS AKPIA, 2006, BIOM BS06 MAN
   ESTI ENERGEETIKA ARV
NR 4
TC 2
Z9 3
U1 0
U2 3
PU LATVIA UNIV AGRICULTURE, FACULTY ENGINEERING, INST MECHANICS
PI JELGAVA
PA 5 J CAKSTES BLVD, JELGAVA, LV-3001, LATVIA
SN 1691-3043
J9 ENG RUR DEVELOP
PY 2009
BP 224
EP 228
PG 5
WC Agricultural Engineering
SC Agriculture
GA BLL49
UT WOS:000270448200038
DA 2018-10-19
ER

PT J
AU Burkett, JR
   Wojtas, JL
   Cloud, JL
   Wilker, JJ
AF Burkett, Jeremy R.
   Wojtas, Jessica L.
   Cloud, Joshua L.
   Wilker, Jonathan J.
TI A Method for Measuring the Adhesion Strength of Marine Mussels
SO JOURNAL OF ADHESION
LA English
DT Article
DE Adhesion; Bioadhesion; Biological adhesion; Biological material;
   Biomaterial; Marine; Mussel
ID OXIDE SURFACE-CHARGE; MYTILUS-EDULIS-L; ZEBRA MUSSELS; CROSS-LINKING;
   L-DOPA; ATTACHMENT; PROTEINS; BYSSUS; MODULUS; RELEASE
AB Marine mussels produce a byssal adhesive assembly for attachment to surfaces in the marine environment. The byssus is characterized by an array of adhesive plaques, each attached to threads that are anchored inside the animal. Here we describe a rapid method for determining detachment force, area, and overall adhesion of mussel plaques. Adhesion forces for mussels attached to glass, aluminum, acrylic, polyvinyl chloride (PVC), and Silastic (R) T2 are reported. This method may aid in the development of new adhesive materials and antifouling surfaces.
C1 [Burkett, Jeremy R.; Wojtas, Jessica L.; Cloud, Joshua L.; Wilker, Jonathan J.] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA.
RP Wilker, JJ (reprint author), Purdue Univ, Dept Chem, 560 Oval Dr, W Lafayette, IN 47907 USA.
EM wilker@purdue.edu
FU Office of Naval Research
FX We thank John Slavin and Albena Ivanisevic for help in obtaining water
   contact angle data and Emily Carrington for helpful discussions. This
   work was supported by the Office of Naval Research.
CR Ackerman JD, 1996, J ENVIRON ENG-ASCE, V122, P141, DOI 10.1061/(ASCE)0733-9372(1996)122:2(141)
   Aldred N, 2007, J R SOC INTERFACE, V4, P1159, DOI 10.1098/rsif.2007.1026
   Aldred N, 2006, J ROY SOC INTERFACE, V3, P37, DOI 10.1098/rsif.2005.0074
   ALLEN J A, 1976, Journal of Molluscan Studies, V42, P279
   [Anonymous], 2005, D100205 ASTM
   Bell EC, 1997, MAR ECOL PROG SER, V159, P197, DOI 10.3354/meps159197
   Brady RF, 2000, BIOFOULING, V15, P73, DOI 10.1080/08927010009386299
   CRISP DJ, 1985, J COLLOID INTERF SCI, V104, P40, DOI 10.1016/0021-9797(85)90007-4
   Dobson KD, 1997, LANGMUIR, V13, P2614, DOI 10.1021/la961053q
   DOLMER P, 1994, OPHELIA, V40, P63, DOI 10.1080/00785326.1994.10429551
   Dormon JM, 1997, J ENVIRON ENG-ASCE, V123, P933, DOI 10.1061/(ASCE)0733-9372(1997)123:9(933)
   Hennebert E, 2008, J STRUCT BIOL, V164, P108, DOI 10.1016/j.jsb.2008.06.007
   Irwin EF, 2008, J BIOMAT SCI-POLYM E, V19, P1363, DOI 10.1163/156856208786052407
   JENSEN RA, 1988, J COMP PHYSIOL B, V158, P317, DOI 10.1007/BF00695330
   Kamino K, 2000, J BIOL CHEM, V275, P27360
   Lichtenegger HC, 2002, SCIENCE, V298, P389, DOI 10.1126/science.1075433
   Miserez A, 2008, SCIENCE, V319, P1816, DOI 10.1126/science.1154117
   Naldrett MJ, 1997, MAR BIOL, V127, P629, DOI 10.1007/s002270050053
   Ohkawa K, 1999, BIOFOULING, V13, P337, DOI 10.1080/08927019909378389
   Ostomel TA, 2007, LANGMUIR, V23, P11233, DOI 10.1021/la701281t
   PRICE HA, 1980, J MAR BIOL ASSOC UK, V60, P1035, DOI 10.1017/S0025315400042065
   Rzepecki L. M., 1991, Molecular Marine Biology and Biotechnology, V1, P78
   Sever MJ, 2004, ANGEW CHEM INT EDIT, V43, P448, DOI 10.1002/anie.200352759
   SMEATHERS JE, 1979, J MOLLUS STUD, V45, P219, DOI 10.1093/oxfordjournals.mollus.a065497
   Sun YJ, 2004, BIOFOULING, V20, P279, DOI 10.1080/08927010400026383
   TAYLOR SW, 1994, INORG CHEM, V33, P5819, DOI 10.1021/ic00103a032
   Taylor SW, 1996, INORG CHEM, V35, P7572, DOI 10.1021/ic960514s
   Thurston RM, 2007, J PLAST FILM SHEET, V23, P63, DOI 10.1177/8756087907078698
   WAITE JH, 1981, SCIENCE, V212, P1038, DOI 10.1126/science.212.4498.1038
   Waite JH, 2002, INTEGR COMP BIOL, V42, P1172, DOI 10.1093/icb/42.6.1172
   WANG TT, 1972, J APPL POLYM SCI, V16, P1901, DOI 10.1002/app.1972.070160804
   Yamamoto H, 1997, J MAR BIOTECHNOL, V5, P133
   Young G. A., 1982, ADHESION, V6, P19
   Zhao H, 2006, J BIOL CHEM, V281, P11090, DOI 10.1074/jbc.M510792200
NR 34
TC 34
Z9 35
U1 4
U2 46
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0021-8464
J9 J ADHESION
JI J. Adhes.
PY 2009
VL 85
IS 9
BP 601
EP 615
AR PII 914185290
DI 10.1080/00218460902996903
PG 15
WC Engineering, Chemical; Materials Science, Multidisciplinary; Mechanics
SC Engineering; Materials Science; Mechanics
GA 491UB
UT WOS:000269604000004
DA 2018-10-19
ER

PT J
AU Sawa, Y
   Tatsumi, E
   Funakubo, A
   Horiuchi, T
   Iwasaki, K
   Kishida, A
   Masuzawa, T
   Matsuda, K
   Nishimura, M
   Nishimura, T
   Tomizawa, Y
   Yamaoka, T
   Watanabe, H
AF Sawa, Y.
   Tatsumi, E.
   Funakubo, A.
   Horiuchi, T.
   Iwasaki, K.
   Kishida, A.
   Masuzawa, T.
   Matsuda, K.
   Nishimura, M.
   Nishimura, T.
   Tomizawa, Y.
   Yamaoka, T.
   Watanabe, H.
TI Journal of Artificial Organs 2008: the year in review
SO JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Review
DE Artificial heart (basic); Artificial heart (clinical); Cardiopulmonary
   bypass; Artificial lung; Blood vessel prosthesis; Pacemaker; Artificial
   valve; Biomaterial; Tissue engineering; Dialysis; Apheresis; Artificial
   liver; Artificial pancreas; Artificial skin; Artificial muscle;
   Artificial bone; Artificial neuron
ID CULTURED DERMAL SUBSTITUTE; VENTRICULAR ASSIST DEVICE; BILEAFLET
   MECHANICAL VALVE; RETINAL PROSTHESES; WAVELET ANALYSIS; CLOSING SOUND;
   FLOW-FIELD; HEART; PUMP; CAVITATION
C1 [Sawa, Y.] Osaka Univ, Div Cardiovasc Surg, Dept Surg, Grad Sch Med, Suita, Osaka 5650871, Japan.
   [Tatsumi, E.] Natl Cardiovasc Ctr, Res Inst, Adv Med Engn Ctr, Dept Artificial Organs, Suita, Osaka 565, Japan.
   [Funakubo, A.] Tokyo Denki Univ, Dept Elect & Comp Engn, Sch Sci & Engn, Tokyo 101, Japan.
   [Horiuchi, T.] Mie Univ, Fac Engn, Dept Chem Mat, Tsu, Mie 514, Japan.
   [Iwasaki, K.] Waseda Univ, Waseda Inst Adv Study, Tokyo, Japan.
   [Kishida, A.] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo, Japan.
   [Masuzawa, T.] Ibaraki Univ, Dept Mech Engn, Hitachi, Ibaraki, Japan.
   [Matsuda, K.] Univ Yamanashi Hosp, Chuo, Japan.
   [Nishimura, M.] Tottori Univ, Fac Med, Div Organ Regenerat Surg, Yonago, Tottori 683, Japan.
   [Nishimura, T.] Univ Tokyo, Dept Therapeut Strategy Heart Failure, Tokyo, Japan.
   [Tomizawa, Y.] Tokyo Womens Med Univ, Dept Cardiovasc Surg, Tokyo, Japan.
   [Yamaoka, T.] Natl Cardiovasc Ctr, Res Inst, Dept Biomed Engn, Suita, Osaka 565, Japan.
   [Watanabe, H.] Niigata Univ, Div Thorac & Cardiovasc Surg, Grad Sch Med & Dent Sci, Niigata, Japan.
RP Sawa, Y (reprint author), Osaka Univ, Div Cardiovasc Surg, Dept Surg, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.
EM sawa@surg1.med.osaka-u.ac.jp
CR Abe Y, 2008, J ARTIF ORGANS, V11, P191, DOI 10.1007/s10047-008-0434-3
   Akutsu T, 2008, J ARTIF ORGANS, V11, P75, DOI 10.1007/s10047-008-0410-y
   Akutsu T, 2008, J ARTIF ORGANS, V11, P67, DOI 10.1007/s10047-008-0411-x
   [Anonymous], 2006, J ARTIF ORGANS, V9, P1
   Bara CL, 2008, J ARTIF ORGANS, V11, P123, DOI 10.1007/s10047-008-0416-5
   Fukamachi K, 2008, J ARTIF ORGANS, V11, P12, DOI 10.1007/s10047-007-0399-7
   Hashimoto A, 2008, J ARTIF ORGANS, V11, P225, DOI 10.1007/s10047-008-0436-1
   Hexig B, 2008, J ARTIF ORGANS, V11, P204, DOI 10.1007/s10047-008-0429-0
   Homma A, 2008, J ARTIF ORGANS, V11, P182, DOI 10.1007/s10047-008-0433-4
   Kansaku R, 2008, J ARTIF ORGANS, V11, P24, DOI 10.1007/s10047-008-0401-z
   Kawakami H, 2008, J ARTIF ORGANS, V11, P177, DOI 10.1007/s10047-008-0427-2
   Kobayashi H, 2008, J ARTIF ORGANS, V11, P141, DOI 10.1007/s10047-008-0421-8
   Kurokawa N, 2008, J ARTIF ORGANS, V11, P216, DOI 10.1007/s10047-008-0426-3
   Lee HS, 2008, J ARTIF ORGANS, V11, P60, DOI 10.1007/s10047-008-0408-5
   Lee H, 2007, J ARTIF ORGANS, V10, P181, DOI 10.1007/s10047-007-0382-3
   Liborio AB, 2008, J ARTIF ORGANS, V11, P156, DOI 10.1007/s10047-008-0419-2
   Matsuda M, 2008, J ARTIF ORGANS, V11, P148, DOI 10.1007/s10047-008-0417-4
   Nakamura T, 2008, J ARTIF ORGANS, V11, P134, DOI 10.1007/s10047-008-0414-7
   Narita Y, 2008, J ARTIF ORGANS, V11, P91, DOI 10.1007/s10047-008-0407-6
   Niinomi M, 2008, J ARTIF ORGANS, V11, P105, DOI 10.1007/s10047-008-0422-7
   Nishimura K, 2008, J ARTIF ORGANS, V11, P165, DOI 10.1007/s10047-008-0423-6
   Okamoto K, 2008, J ARTIF ORGANS, V11, P45, DOI 10.1007/s10047-008-0403-x
   Saijo H, 2008, J ARTIF ORGANS, V11, P171, DOI 10.1007/s10047-008-0425-4
   Sakamoto Y, 2008, J ARTIF ORGANS, V11, P163, DOI 10.1007/s10047-008-0424-5
   Sato K, 2008, J ARTIF ORGANS, V11, P201, DOI 10.1007/s10047-008-0430-7
   Sawa Y, 2008, J ARTIF ORGANS, V11, P4, DOI 10.1007/s10047-008-0404-9
   Sawa Y, 2007, J ARTIF ORGANS, V10, P53, DOI 10.1007/s10047-007-0386-z
   Shiono M, 2008, J ARTIF ORGANS, V11, P19, DOI 10.1007/s10047-007-0402-3
   Sugiki H, 2008, J ARTIF ORGANS, V11, P29, DOI 10.1007/s10047-007-0400-5
   Sugiki H, 2007, J ARTIF ORGANS, V10, P16, DOI 10.1007/s10047-006-0364-x
   Suzuki Y, 2008, J ARTIF ORGANS, V11, P160, DOI 10.1007/s10047-008-0420-9
   Suzuki Y, 2008, J ARTIF ORGANS, V11, P111, DOI 10.1007/s10047-008-0415-6
   Takatani S, 2008, J ARTIF ORGANS, V11, P1, DOI 10.1007/s10047-008-0405-8
   Takezawa A, 2008, J ARTIF ORGANS, V11, P212, DOI 10.1007/s10047-008-0432-5
   Tamaki T, 2008, J ARTIF ORGANS, V11, P38, DOI 10.1007/s10047-007-0398-8
   Tokunaga S, 2008, J ARTIF ORGANS, V11, P53, DOI 10.1007/s10047-008-0409-4
   Tokunaga S, 2008, J ARTIF ORGANS, V11, P130, DOI 10.1007/s10047-008-0413-8
   Tomizawa Y, 2008, J ARTIF ORGANS, V11, P117, DOI 10.1007/s10047-008-0418-3
   Yamada N, 2008, J ARTIF ORGANS, V11, P100, DOI 10.1007/s10047-008-0406-7
   Yamada N, 2008, J ARTIF ORGANS, V11, P221, DOI 10.1007/s10047-008-0428-1
   Yamamoto T, 2008, J ARTIF ORGANS, V11, P238, DOI 10.1007/s10047-008-0435-2
   Yamane T, 2008, J ARTIF ORGANS, V11, P232, DOI 10.1007/s10047-008-0431-6
NR 42
TC 8
Z9 8
U1 1
U2 13
PU SPRINGER TOKYO
PI TOKYO
PA 1-11-11 KUDAN-KITA, CHIYODA-KU, TOKYO, 102-0073, JAPAN
SN 1434-7229
J9 J ARTIF ORGANS
JI J. Artif. Organs
PY 2009
VL 12
IS 1
BP 1
EP 7
DI 10.1007/s10047-009-0451-x
PG 7
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 452PI
UT WOS:000266553100001
PM 19330497
DA 2018-10-19
ER

PT J
AU Nagai, N
   Nakayama, Y
   Nishi, S
   Munekata, M
AF Nagai, Nobuhiro
   Nakayama, Yasuhide
   Nishi, Shogo
   Munekata, Masanobu
TI Development of novel covered stents using salmon collagen
SO JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE Covered stent; Salmon collagen; Balloon-expandable stent;
   Self-expandable stent
ID BIOLOGICAL-PROPERTIES; FIBRILLAR GEL; IN-VITRO; BIOMATERIAL; ANEURYSMS;
   GRAFTS
AB In this study, we newly developed self-expandable or balloon-expandable covered stents with a biodegradable salmon collagen (SC) film. The SC-covered stents were fabricated by placing a bare stent in a mixture of acidic SC solution and a fibrillogenesis-inducing buffer (pH 6.8) including a cross-linking agent (water-soluble carbodiimide), and subsequent incubation at VC for 24 It and lyophilization. The stents obtained were completely covered with an SC film having a nanofibrous structure (fibril diameter, about 70 nm). On immersion in water, the film is converted to a gel with slight swelling. There was no rupture of the SC cover after mounting on a balloon catheter or after expansion. Preliminary implantation was conducted by placing the balloon-expandable covered stents in the common carotid arteries of beagles. One month after implantation, angiography showed that all stented arteries were patent with no significant neointimal thickening. In conclusion, SC is potentially useful as a cover material of endovascular stents to enhance patency.
C1 [Nagai, Nobuhiro] Hokkaido Univ, CRIS, Kita Ku, Sapporo, Hokkaido 0010021, Japan.
   [Nakayama, Yasuhide] Natl Cardiovasc Ctr, Dept Bioengn, Adv Med Engn Ctr, Res Inst, Osaka, Japan.
   [Nakayama, Yasuhide; Munekata, Masanobu] Hokkaido Univ, Div Biotechnol & Macromol Chem, Grad Sch Engn, Sapporo, Hokkaido 0010021, Japan.
   [Nishi, Shogo] Sapporo Higashi Tokushukai Hosp, Dept Neurosurg, Sapporo, Hokkaido, Japan.
RP Nagai, N (reprint author), Hokkaido Univ, CRIS, Kita Ku, N21-W10, Sapporo, Hokkaido 0010021, Japan.
EM nagai491@yahoo.co.jp
CR Berglund JD, 2004, TISSUE ENG, V10, P1526, DOI 10.1089/ten.2004.10.1526
   Briguori C, 2002, CATHETER CARDIO INTE, V55, P326, DOI 10.1002/ccd.10063
   Gu LX, 2005, J BIOMECH, V38, P1221, DOI 10.1016/j.jbiomech.2004.06.008
   Kallinteri P, 2002, BIOMATERIALS, V23, P4819, DOI 10.1016/S0142-9612(02)00233-8
   Laaksovirta S, 2002, J ENDOUROL, V16, P311, DOI 10.1089/089277902760102811
   McKenna CJ, 1998, J AM COLL CARDIOL, V31, P1434, DOI 10.1016/S0735-1097(98)00080-1
   Nagai N, 2004, J BIOSCI BIOENG, V98, P493, DOI 10.1016/S1389-1723(05)00319-1
   Nagai N, 2008, J BIOMATER APPL, V23, P275, DOI 10.1177/0885328208092109
   Nagai N, 2008, J BIOMED MATER RES B, V87B, P432, DOI 10.1002/jbm.b.31121
   Nagai N, 2007, J BIOMED MATER RES A, V82A, P395, DOI 10.1002/jbm.a.31110
   Nagai N, 2008, J BIOSCI BIOENG, V106, P412, DOI 10.1263/jbb.106.412
   Nakayama Y, 2003, J BIOMED MATER RES A, V64A, P52, DOI 10.1002/jbm.a.10314
   Nakayama Y, 2007, J ARTIF ORGANS, V10, P171, DOI 10.1007/s10047-007-0376-1
   NIMNI ME, 1987, J BIOMED MATER RES, V21, P741, DOI 10.1002/jbm.820210606
   Nishi S, 2003, NEUROSURGERY, V53, P1397, DOI 10.1227/01.NEU.0000093427.89827.12
   NISHI S, 2003, NEUROSURGERY, V53, P1404
   Sato S, 2007, J BIOMED MATER RES B, V83B, P345, DOI 10.1002/jbm.b.30802
   Thierry B, 2005, J BIOMED MATER RES A, V75A, P556, DOI 10.1002/jbm.a.30450
   Yunoki S, 2004, J BIOSCI BIOENG, V98, P40, DOI 10.1263/jbb.98.40
NR 19
TC 9
Z9 10
U1 0
U2 9
PU SPRINGER TOKYO
PI TOKYO
PA 1-11-11 KUDAN-KITA, CHIYODA-KU, TOKYO, 102-0073, JAPAN
SN 1434-7229
J9 J ARTIF ORGANS
JI J. Artif. Organs
PY 2009
VL 12
IS 1
BP 61
EP 66
DI 10.1007/s10047-008-0446-z
PG 6
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 452PI
UT WOS:000266553100011
PM 19330508
DA 2018-10-19
ER

PT J
AU Duraiswamy, N
   Choksi, TD
   Pinchuk, L
   Schoephoerster, RT
AF Duraiswamy, Nandini
   Choksi, Tejas D.
   Pinchuk, Leonard
   Schoephoerster, Richard T.
TI A Phospholipid-modified Polystyrene-Polyisobutylene-Polystyrene (SIBS)
   Triblock Polymer for Enhanced Hemocompatibility and Potential Use in
   Artificial Heart Valves
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE SIBS; phospholipids; platelets; biomaterial; synthetic heart valve;
   hemocompatibility
ID HARD-SEGMENT CONTENT; PROTEIN ADSORPTION; POLYURETHANE; CALCIFICATION;
   MECHANISM; FAILURE; MODELS; REDUCE; BLOOD; LIFE
AB Poly(styrene-block-isobutylene-block-styrene)('SIBS') is selected for a novel trileaflet heart valve due to its high resistance to oxidation, hydrolysis, and enzyme attack. SIBS is modified using six different phospholipids and its mechanical properties characterized by tensile stress, peel strength, shear strength, contact angle, and surface energy, and then for hemocompatibility by studying the adhesion of fluorescently labeled platelets in a parallel plate chamber under physiological flow conditions. Phospholipid modification decreases SIBS tensile stress (at 45% strain) by 30% and reduces platelet adhesion by a factor of 10, thereby improving its hemocompatibility and its potential use as a synthetic heart valve.
C1 [Duraiswamy, Nandini; Choksi, Tejas D.] Florida Int Univ, Dept Biomed Engn, Miami, FL 33199 USA.
   [Pinchuk, Leonard] Innovia LLC, Miami, FL USA.
   [Schoephoerster, Richard T.] Univ Texas El Paso, Coll Engn, El Paso, TX 79968 USA.
RP Duraiswamy, N (reprint author), Florida Int Univ, Dept Biomed Engn, Miami, FL 33199 USA.
EM ndura002@fiu.edu
FU NIH [2 R44 HL070401-02]; NHLBI
FX This project was partially funded by a SBIR grant 2 R44 HL070401-02 from
   NIH and the NHLBI. We thank Bhavani Jayachandran, graduate student, for
   her help as phlebotomist in this study. We also thank Dr James Byrne,
   laboratory manager, for his help with design of chambers and microscope
   optics. Last but not the least, we especially thank those who donated
   blood.
CR BERNACCA GM, 1995, BIOMATERIALS, V16, P279, DOI 10.1016/0142-9612(95)93255-C
   Bernacca GM, 1998, INT J ARTIF ORGANS, V21, P814
   Bluestein D, 2000, J BIOMECH ENG-T ASME, V122, P125, DOI 10.1115/1.429634
   Carretero Marta, 1994, Sangre (Saragossa), V39, P337
   Chen JH, 1998, J BIOMED MATER RES, V41, P633, DOI 10.1002/(SICI)1097-4636(19980915)41:4<633::AID-JBM16>3.0.CO;2-F
   Duraiswamy N, 2005, ANN BIOMED ENG, V33, P1767, DOI 10.1007/s10439-005-7598-2
   Gallocher SL, 2006, J BIOMED MATER RES B, V79B, P325, DOI 10.1002/jbm.b.30546
   Gray RJ, 1996, TEX HEART I J, V23, P36
   GROTH T, 1994, J BIOMAT SCI-POLYM E, V6, P497, DOI 10.1163/156856294X00464
   HAYWARD JA, 1984, BIOMATERIALS, V5, P135, DOI 10.1016/0142-9612(84)90047-4
   Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C
   Jumaa M, 2000, EUR J PHARM SCI, V9, P285, DOI 10.1016/S0928-0987(99)00071-8
   LITTLE SH, 2003, COCHRANE DB SYST REV, V4
   Morimoto N, 2002, BIOMATERIALS, V23, P4881, DOI 10.1016/S0142-9612(02)00246-6
   NISTAL F, 1990, J THORAC CARDIOV SUR, V99, P1074
   Nuttelman CR, 2002, BIOMATERIALS, V23, P3617, DOI 10.1016/S0142-9612(02)00093-5
   OZAKI S, 2003, THORAC CARDIOVASC SU, V9, P245
   PARFEEV VM, 1982, MEKH KOMPOZ MATER, V1, P110
   PINCHUK L, 1999, P SOC BIOMATERIALS
   SCHOEN FJ, 1983, AM J CARDIOL, V51, P957, DOI 10.1016/S0002-9149(83)80173-8
   SEELIG A, 1977, BIOCHEMISTRY-US, V16, P45, DOI 10.1021/bi00620a008
   Sodian R, 2000, TISSUE ENG, V6, P183, DOI 10.1089/107632700320793
   Stock U A, 2001, J Long Term Eff Med Implants, V11, P249
   TOKUMURA A, 1981, BIOCHEM BIOPH RES CO, V99, P391, DOI 10.1016/0006-291X(81)91758-7
   van der Heiden AP, 1998, J BIOMED MATER RES, V40, P195, DOI 10.1002/(SICI)1097-4636(199805)40:2<195::AID-JBM4>3.0.CO;2-G
   VROMAN L, 1988, B NEW YORK ACAD MED, V64, P352
NR 26
TC 15
Z9 16
U1 1
U2 21
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD JAN
PY 2009
VL 23
IS 4
BP 367
EP 379
DI 10.1177/0885328208093854
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 391ME
UT WOS:000262236600005
PM 18697881
DA 2018-10-19
ER

PT J
AU Zeugolis, DI
   Paul, RG
   Attenburrow, G
AF Zeugolis, D. I.
   Paul, R. G.
   Attenburrow, G.
TI Extruded Collagen Fibres for Tissue-Engineering Applications: Influence
   of Collagen Concentration and NaCl Amount
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Collagen scaffold; structural characteristics; thermal properties;
   mechanical properties
ID RAT TAIL TENDON; POLYMER NANOFIBER MESH; MECHANICAL-PROPERTIES;
   CROSS-LINKING; THERMAL-STABILITY; I COLLAGEN; PROTEIN PRECIPITATION;
   TENSILE PROPERTIES; ENDOTHELIAL-CELLS; FRACTURE-BEHAVIOR
AB Extruded collagen fibres have been shown to be a competitive biomaterial for tissue-engineering applications. Since different tissues are coming in different textures, as far as it is concerned their fibre diameter and consequently their mechanical properties, herein we aim to investigate the influence of the collagen concentration and the amount of NaCl on the properties of these fibres. Scanning electron microscopy study revealed that the substructure of the collagen fibres was the same, regardless of the treatment. The thermal properties were found to be independent of the collagen concentration or the amount of NaCl utilized (P > 0.05). An inversely proportional relationship between dry fibre diameter and stress at break was observed. Increasing the collagen concentration yielded fibres with significant higher diameter (P < 0.002), strain (P < 0.009) and force (P < 0.001) values, whilst the stress (P < 0.008) and modulus (P < 0.009) values were decreased. For the fabrication of fibres with reproducible properties, 20% NaCl was found to be the optimum. Overall, reconstituted collagen fibres were produced with properties similar to native or synthetic fibres to suit a wide range of tissue-engineering applications. (C) Koninklijke Brill NV, Leiden, 2009
C1 [Zeugolis, D. I.] Natl Univ Singapore, Tissue Modulat Lab, Tissue Engn Programme, Singapore 117510, Singapore.
   [Zeugolis, D. I.] Natl Univ Singapore, Fac Engn, Div Bioengn, Singapore 117576, Singapore.
   [Zeugolis, D. I.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Immunol Programme, Singapore 117456, Singapore.
   [Paul, R. G.] Devro Plc, Glasgow G69 0JE, Lanark, Scotland.
   [Attenburrow, G.] Univ Northampton, Sch Appl Sci, Northampton NN2 7AL, England.
RP Zeugolis, DI (reprint author), Natl Univ Singapore, Tissue Modulat Lab, Tissue Engn Programme, Singapore 117510, Singapore.
EM dzeugolis@gmail.com
OI zeugolis, dimitrios/0000-0002-7599-5191
FU University of Northampton; EPSRC
FX The authors would like to thank Mrs. P. Potter, Ms. S. Lee, Mrs. T.
   Hayes and Mr. L. Stathopoulos for excellent technical assistance and Dr.
   S. Jeyapalina and Dr. P Antunes for their useful discussion. D. I.
   Zeugolis is grateful to The University of Northampton and EPSRC for
   their financial support.
CR Agrawal CM, 2000, BIOMATERIALS, V21, P2443, DOI 10.1016/S0142-9612(00)00112-5
   ARUMUGAM V, 1992, J MATER SCI, V27, P2649, DOI 10.1007/BF00540684
   ATTENBURROW GE, 1979, J MATER SCI, V14, P2679, DOI 10.1007/BF00610639
   Babin H, 2001, FOOD HYDROCOLLOID, V15, P271, DOI 10.1016/S0268-005X(01)00025-X
   BAILEY AJ, 1992, J SOC LEATH TECH CH, V76, P111
   Bailey AJ, 1989, CONNECTIVE TISSUE ME
   Bleach NC, 2002, BIOMATERIALS, V23, P1579, DOI 10.1016/S0142-9612(01)00283-6
   Bonassar LJ, 1998, J CELL BIOCHEM, P297, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<297::AID-JCB36>3.0.CO;2-6
   BROKAW JL, 1985, INT J BIOL MACROMOL, V7, P135, DOI 10.1016/0141-8130(85)90015-7
   Bunyaratavej P, 2001, J PERIODONTOL, V72, P215, DOI 10.1902/jop.2001.72.2.215
   CANDLISH JK, 1964, BIOCHIM BIOPHYS ACTA, V88, P553, DOI 10.1016/0926-6577(64)90098-1
   CAVALLARO JF, 1994, BIOTECHNOL BIOENG, V43, P781, DOI 10.1002/bit.260430813
   Chen GP, 2000, J BIOMED MATER RES, V51, P273, DOI 10.1002/(SICI)1097-4636(200008)51:2<273::AID-JBM16>3.0.CO;2-O
   CHEN W, 1993, CHEM ENG SCI, V48, P1775, DOI 10.1016/0009-2509(93)80347-S
   Chevallay B, 2000, J BIOMED MATER RES, V49, P448, DOI 10.1002/(SICI)1097-4636(20000315)49:4<448::AID-JBM3>3.0.CO;2-L
   CHRISTIANSEN DL, 1993, CELL MATER, V3, P177
   Christiansen DL, 2000, MATRIX BIOL, V19, P409, DOI 10.1016/S0945-053X(00)00089-5
   Clyne T. W., 1996, INTRO COMPOSITE MAT
   Cornwell KG, 2007, J BIOMED MATER RES A, V80A, P362, DOI 10.1002/jbm.a.30893
   Cornwell KG, 2004, J BIOMED MATER RES A, V71A, P55, DOI 10.1002/jbm.a.30132
   DANIELSEN CC, 1982, CONNECT TISSUE RES, V9, P219, DOI 10.3109/03008208209160265
   DANIELSEN CC, 1988, J BIOMECH, V21, P207, DOI 10.1016/0021-9290(88)90171-6
   DANIELSEN CC, 1981, MECH AGEING DEV, V15, P269, DOI 10.1016/0047-6374(81)90135-4
   DOMBI GW, 1993, J SURG RES, V54, P21, DOI 10.1006/jsre.1993.1004
   DUNN MG, 1992, AM J SPORT MED, V20, P507, DOI 10.1177/036354659202000504
   DUNN MG, 1993, J BIOMED MATER RES, V27, P1545, DOI 10.1002/jbm.820271211
   Field JR, 2004, INJURY, V35, P243, DOI 10.1016/S0020-1383(03)00089-5
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Friess W, 1996, BIOMATERIALS, V17, P2289, DOI 10.1016/0142-9612(96)00047-6
   Fu J, 2002, BIOMATERIALS, V23, P4425, DOI 10.1016/S0142-9612(02)00182-5
   Gentleman E, 2003, BIOMATERIALS, V24, P3805, DOI 10.1016/S0142-9612(03)00206-0
   GOLDSTEIN JD, 1989, J BONE JOINT SURG AM, V71A, P1183, DOI 10.2106/00004623-198971080-00010
   GOUPIL D, 1996, BIOMATERIALS SCI INT, P356
   GROSS J, 1955, P NATL ACAD SCI USA, V41, P1, DOI 10.1073/pnas.41.1.1
   HANTHAMRONGWIT M, 1994, J BIOMED MATER RES, V28, P213, DOI 10.1002/jbm.820280211
   He W, 2005, BIOMATERIALS, V26, P7606, DOI 10.1016/j.biomaterials.2005.05.049
   He W, 2006, TISSUE ENG, V12, P2457, DOI 10.1089/ten.2006.12.2457
   Hepworth DG, 2002, COMPOS PART A-APPL S, V33, P797, DOI 10.1016/S1359-835X(02)00025-8
   HORMANN H, 1971, BIOCHEMISTRY-US, V10, P932
   Huang YF, 2001, EXP EYE RES, V73, P521, DOI 10.1006/exer.2001.1057
   Hutmacher, 2007, HDB ENG BIOPOLYMERS, P773
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   Jancic R, 2000, MATER LETT, V42, P350, DOI 10.1016/S0167-577X(99)00210-4
   Jarvinen TAH, 2004, J ORTHOP RES, V22, P1303, DOI 10.1016/j.orthres.2004.04.003
   Jiang FZ, 2004, J STRUCT BIOL, V148, P268, DOI 10.1016/j.jsb.2004.07.001
   JIMENEZ S, 1973, BIOCHEM BIOPH RES CO, V52, P106, DOI 10.1016/0006-291X(73)90960-1
   KADLER KE, 1987, J BIOL CHEM, V262, P15696
   KATO YP, 1989, BIOMATERIALS, V10, P38, DOI 10.1016/0142-9612(89)90007-0
   KATO YP, 1991, J BONE JOINT SURG AM, V73A, P561, DOI 10.2106/00004623-199173040-00013
   Kielty CM, 2002, CONNECTIVE TISSUE IT, P159
   Kim WS, 2001, CHEM ENG SCI, V56, P6525, DOI 10.1016/S0009-2509(01)00311-6
   Knight DP, 1998, J BIOMED MATER RES, V41, P185, DOI 10.1002/(SICI)1097-4636(199808)41:2<185::AID-JBM2>3.3.CO;2-L
   KomsaPenkova R, 1996, BBA-PROTEIN STRUCT M, V1297, P171, DOI 10.1016/S0167-4838(96)00092-1
   Koob TJ, 2002, BIOMATERIALS, V23, P203, DOI 10.1016/S0142-9612(01)00096-5
   KOPP J, 1989, Matrix, V9, P443
   Kwon IK, 2005, BIOMACROMOLECULES, V6, P2096, DOI 10.1021/bm050086u
   Laude D, 2000, J BIOMECH ENG-T ASME, V122, P231, DOI 10.1115/1.429653
   LIGHT ND, 1985, METHODS SKIN RES, P559
   Loret B, 2004, MECH MATER, V36, P515, DOI 10.1016/S0167-6636(03)00074-7
   LUESCHER M, 1974, BIOPOLYMERS, V13, P2489, DOI 10.1002/bip.1974.360131208
   Lynn AK, 2004, J BIOMED MATER RES B, V71B, P343, DOI 10.1002/jbm.b.30096
   Makela P, 2002, BIOMATERIALS, V23, P2587, DOI 10.1016/S0142-9612(01)00396-9
   Miles CA, 2001, BIOPHYS J, V80, P1480, DOI 10.1016/S0006-3495(01)76120-6
   Orban JM, 2004, J BIOMED MATER RES A, V68A, P756, DOI 10.1002/jbm.a.20110
   Osborne CS, 1998, MED BIOL ENG COMPUT, V36, P129, DOI 10.1007/BF02522870
   Paul R Gordon, 2003, ScientificWorldJournal, V3, P138
   PETITE H, 1994, J BIOMED MATER RES, V28, P159, DOI 10.1002/jbm.820280204
   Pins GD, 1997, J APPL POLYM SCI, V63, P1429, DOI 10.1002/(SICI)1097-4628(19970314)63:11<1429::AID-APP5>3.3.CO;2-O
   Pins GD, 1995, MAT SCI ENG C-BIOMIM, V3, P101, DOI 10.1016/0928-4931(95)00109-3
   Pins GD, 1997, BIOPHYS J, V73, P2164, DOI 10.1016/S0006-3495(97)78247-X
   Rajini KH, 2001, J MATER SCI, V36, P5589, DOI 10.1023/A:1012509514714
   RAMSHAW JAM, 1984, ANAL BIOCHEM, V141, P361, DOI 10.1016/0003-2697(84)90056-3
   Rault I, 1996, J MATER SCI-MATER M, V7, P215, DOI 10.1007/BF00119733
   RIGBY BJ, 1959, J GEN PHYSIOL, V43, P265, DOI 10.1085/jgp.43.2.265
   Roche S, 2001, BIOMATERIALS, V22, P9, DOI 10.1016/S0142-9612(00)00084-3
   ROSENBLO.J, 1973, ARCH BIOCHEM BIOPHYS, V158, P478, DOI 10.1016/0003-9861(73)90539-0
   Saito Y, 2002, J THORAC CARDIOV SUR, V123, P161, DOI 10.1067/mtc.2002.118503
   Shao YX, 2001, CEMENT CONCRETE RES, V31, P1153, DOI 10.1016/S0008-8846(01)00535-X
   Silver FH, 2003, J BIOMECH, V36, P1529, DOI 10.1016/S0021-9290(03)00135-0
   Silver FH, 2001, SKIN RES TECHNOL, V7, P18, DOI 10.1034/j.1600-0846.2001.007001018.x
   Silver FH, 2001, J APPL POLYM SCI, V79, P134, DOI 10.1002/1097-4628(20010103)79:1<134::AID-APP160>3.0.CO;2-E
   Silver FH, 2000, CONNECT TISSUE RES, V41, P155, DOI 10.3109/03008200009067667
   Sionkowska A, 2005, INT J BIOL MACROMOL, V35, P145, DOI 10.1016/j.ijbiomac.2005.01.009
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Thomason JL, 1999, COMPOS SCI TECHNOL, V59, P2315, DOI 10.1016/S0266-3538(99)00083-4
   Tsaliki E, 2004, FOOD HYDROCOLLOID, V18, P631, DOI 10.1016/j.foodhyd.2003.11.001
   VEIS A, 1961, ARCH BIOCHEM BIOPHYS, V94, P20, DOI 10.1016/0003-9861(61)90005-4
   VERZAR F, 1965, BIOCH PHYSL TISSU CO, P381
   VOGEL HG, 1974, CONNECT TISSUE RES, V2, P177, DOI 10.3109/03008207409152242
   WANG MC, 1994, BIOMATERIALS, V15, P507
   Weadock KS, 1996, J BIOMED MATER RES, V32, P221, DOI 10.1002/(SICI)1097-4636(199610)32:2<221::AID-JBM11>3.0.CO;2-M
   WOODLEY DT, 1991, J INVEST DERMATOL, V97, P580, DOI 10.1111/1523-1747.ep12481920
   YANNAS IV, 1972, J POLYM SCI A2, V10, P577, DOI 10.1002/pol.1972.160100401
   YANNAS IV, 1972, J MACROMOL SCI R M C, VC  7, P49, DOI 10.1080/15321797208068160
   ZEUGOLIS DI, 2008, J MAT RES A IN PRESS
   ZEUGOLIS DI, 2008, J BIOMED B IN PRESS
   ZEUGOLIS DI, 2008, J APPL POLY IN PRESS
NR 97
TC 13
Z9 13
U1 1
U2 17
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2009
VL 20
IS 2
BP 219
EP 234
DI 10.1163/156856209X404505
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 410WB
UT WOS:000263607900005
PM 19154671
DA 2018-10-19
ER

PT J
AU Jus, S
   Kokol, V
   Guebitz, GM
AF Jus, Suzana
   Kokol, Vanja
   Guebitz, Georg M.
TI Tyrosinase-Catalysed Coating of Wool Fibres With Different Protein-Based
   Biomaterials
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Wool fibres; protein substrates; tyrosinase; enzymatic coupling; coating
ID RAMAN-SPECTROSCOPY; CROSS-LINKING; INFRARED-SPECTROSCOPY;
   STRUCTURAL-CHANGES; SILK FIBROIN; BOMBYX-MORI; COLLAGEN; KERATIN;
   TEXTILES; ELASTIN
AB The potential of tyrosinases to activate tyrosine residues of wool protein fibres for cross-linking with different materials like collagen, elastin and gelatine was assessed. Natural fibres like wool offer an excellent environment for the growth of micro-organisms when the conditions like moisture, oxygen and temperature are appropriate. Coating with collagen, a very useful biomaterial with bactericidal and fungicidal properties, could be used to improve the properties of wool-based materials, especially when applied in hygienically sensitive applications like in hospitals. Tyrosinases were shown to catalyse the oxidation of tyrosine residues in wool and wool hydrolysates as model substrates, as determined by UV-Vis spectroscopy. Structural differences of the surface were evident from the increase of the intensity in the NH bending and stretching regions in the spectra of NIR FT Raman analysis of the enzyme treated and grafted wool fibres. The durability of the coating was also shown by using FITC-labelled collagen that was bound to the wool fibres, even after severe washing. Additionally, antimicrobial properties were successfully imparted due to the collagen grafted on the wool fibres. The functional and mechanical properties of the treated wool fibres showed no significant changes. (C) Koninklijke Brill NV, Leiden, 2009
C1 [Jus, Suzana; Kokol, Vanja] Univ Maribor, Fac Mech Engn, Dept Textile Mat & Design, SI-2000 Maribor, Slovenia.
   [Jus, Suzana; Guebitz, Georg M.] Graz Univ Technol, Inst Environm Biotechnol, A-8010 Graz, Austria.
RP Kokol, V (reprint author), Univ Maribor, Fac Mech Engn, Dept Textile Mat & Design, Smetanova Ulica 17, SI-2000 Maribor, Slovenia.
EM vanja.kokol@uni-mb.si
FU EC's 6 FP [MTKD-CT-2005-029540, POLYSURF]
FX This research project has been supported by a Marie Curie Transfer of
   Knowledge Fellowship of the EC's 6 FP (MTKD-CT-2005-029540, POLYSURF).
CR BOWES JH, 1948, BIOCHEM J, V43, P358, DOI 10.1042/bj0430358
   Carlson GA, 2004, BIOCHEM BIOPH RES CO, V321, P472, DOI 10.1016/j.bbrc.2004.06.165
   Caspers PJ, 1998, BIOSPECTROSCOPY, V4, pS31, DOI 10.1002/(SICI)1520-6343(1998)4:5+<S31::AID-BSPY4>3.0.CO;2-M
   Cortez J, 2004, ENZYME MICROB TECH, V34, P64, DOI 10.1016/j.enzmictec.2003.08.004
   DOYLE BB, 1975, BIOPOLYMERS, V14, P937, DOI 10.1002/bip.1975.360140505
   Elliott JT, 2007, BIOMATERIALS, V28, P576, DOI 10.1016/j.biomaterials.2006.09.023
   Espin JC, 2000, EUR J BIOCHEM, V267, P1270, DOI 10.1046/j.1432-1327.2000.01013.x
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   FRUSHOUR BG, 1975, BIOPOLYMERS, V14, P379, DOI 10.1002/bip.1975.360140211
   GRAHAM CE, 1948, J BIOL CHEM, V177, P529
   Kuboe Y, 2004, BIOMACROMOLECULES, V5, P348, DOI 10.1021/bm034363d
   Lantto R, 2007, J AGR FOOD CHEM, V55, P1248, DOI 10.1021/jf0623485
   Lantto R., 2005, Journal of the Textile Institute, V96, P109, DOI 10.1533/joti.2004.0080
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Madhan B, 2005, INT J BIOL MACROMOL, V37, P47, DOI 10.1016/j.ijbiomac.2005.08.005
   MELHUISH WH, 1993, J SOC DYERS COLOUR, V109, P163
   Monti P, 2001, J RAMAN SPECTROSC, V32, P103, DOI 10.1002/jrs.675
   Monti P, 1998, J RAMAN SPECTROSC, V29, P297, DOI 10.1002/(SICI)1097-4555(199804)29:4<297::AID-JRS240>3.0.CO;2-G
   Okuyama K, 2006, BIOPOLYMERS, V84, P421, DOI 10.1002/bip.20499
   PARKER FS, 1975, APPL SPECTROSC, V29, P129, DOI 10.1366/000370275774455266
   PARKER SF, 1992, VIB SPECTROSC, V3, P87, DOI 10.1016/0924-2031(92)80002-J
   Pielesz A, 2000, J MOL STRUCT, V555, P325, DOI 10.1016/S0022-2860(00)00617-7
   Purwar R, 2004, AATCC REV, V4, P22
   RAMACHANDRAN T, 2003, TEXT ENG, V84, P42
   Schafer K, 1997, J SOC DYERS COLOUR, V113, P350
   SIEGEL RC, 1970, BIOCHEMISTRY-US, V9, P4486, DOI 10.1021/bi00825a004
   SIZER IW, 1946, J BIOL CHEM, V163, P145
   Thalmann CR, 2002, EUR FOOD RES TECHNOL, V214, P276, DOI 10.1007/s00217-001-0455-0
   Wojciechowska E, 2004, J MOL STRUCT, V704, P315, DOI 10.1016/j.molstruc.2004.03.044
   Wojciechowskaa E., 1999, J MOL STRUCT, V511-512, P307
NR 31
TC 19
Z9 20
U1 1
U2 26
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2009
VL 20
IS 2
BP 253
EP 269
DI 10.1163/156856209X404523
PG 17
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 410WB
UT WOS:000263607900007
PM 19154673
DA 2018-10-19
ER

PT J
AU Ji, GZ
   Wei, X
   Chen, GQ
AF Ji, Guang-Zhen
   Wei, Xing
   Chen, Guo-Qiang
TI Growth of Human Umbilical Cord Wharton's Jelly-Derived Mesenchymal Stem
   Cells on the Terpolyester
   Poly(3-hydroxybutyrate-co-3-hydroxyvalerateco-3-hydroxyhexanoate)
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Polyhydroxyalkanoates; PHBV; PHBHHx; PLA; mesenchymal stem cells
ID POLY-BETA-HYDROXYBUTYRATE; IN-VITRO; OSTEOBLAST ADHESION;
   SURFACE-ROUGHNESS; PROLIFERATION;
   POLY(3-HYDROXYBUTYRATE-CO-3-HYDROXYHEXANOATE); POLYHYDROXYALKANOATES;
   BIOMATERIALS; FIBROBLAST; PROTEIN
AB As a new member of the polyhydroxyalkanoate (PHA) family, the terpolyester poly(3-hydroxybutyrateco-3- hydroxyvalerate-co-3-hydroxyhexanoate) (PHBVHHx) was evaluated for its biocompatibility for human umbilical cord Wharton's jelly-derived mesenchymal stem cells (WJ-MSCs). More WJ-MSC adhesion and proliferation were observed on PHBVHHx film compared with films made of poly(L-lactic acid) (PLA), poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) and poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHx). Higher DNA synthesis by WJ-MSCs was detected on PHBVHHx film than on PLA, PHBV and PHBHHx films. PHBVHHx film had a rougher surface and more adsorption of extracellular matrix (ECM) proteins including collagen I, fibronectin and vitronectin, compared with PLA, PHBV and PHBHHx films. PHBVHHx film was also more hydrophobic than PLA and PHBV. These results demonstrated that PHBVHHx could be a promising biomaterial in medical implant applications for supporting the growth of cells, including WJ-MSCs. (c) Koninklijke Brill NV, Leiden, 2009
C1 [Ji, Guang-Zhen; Wei, Xing; Chen, Guo-Qiang] Shantou Univ, Multidisciplinary Res Ctr, Shantou 515063, Guangdong, Peoples R China.
   [Chen, Guo-Qiang] Tsinghua Univ, Dept Biol Sci & Biotechnol, Minist Educ, Prot Sci Lab, Beijing 100084, Peoples R China.
RP Wei, X (reprint author), Shantou Univ, Multidisciplinary Res Ctr, Shantou 515063, Guangdong, Peoples R China.
EM wei70@hotmail.com
FU Li Ka Shing Foundation; State High Tech Project 863 [2006AA02Z242]
FX The authors are grateful to the Li Ka Shing Foundation and State High
   Tech Project 863 (Grant No. 2006AA02Z242) for financial support of this
   work.
CR Advincula MC, 2006, BIOMATERIALS, V27, P2201, DOI 10.1016/j.biomaterials.2005.11.014
   ALTANKOV G, 1994, J MATER SCI-MATER M, V5, P732, DOI 10.1007/BF00120366
   ANDERSON AJ, 1990, MICROBIOL REV, V54, P450
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Beeka M. V., 2008, BIOMATERIALS, V29, P780, DOI [10.1016/j.biomaterials.2007.10.039, DOI 10.1016/J.BIOMATERIALS.2007.10.039]
   BYROM D, 1992, FEMS MICROBIOL LETT, V103, P247, DOI 10.1111/j.1574-6968.1992.tb05844.x
   Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   Chen GQ, 2001, APPL MICROBIOL BIOT, V57, P50
   CHEN QM, 1994, J BIOL CHEM, V269, P26602
   CROSS SJ, 1987, CYTOBIOS, V50, P41
   Dee K.C., 2002, INTRO TISSUE BIOMATE, P37
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   Deng Y, 2002, BIOMATERIALS, V23, P4049, DOI 10.1016/S0142-9612(02)00136-9
   Elloumi I, 2006, BIOMATERIALS, V27, P3451, DOI 10.1016/j.biomaterials.2006.02.003
   GROTH T, 1995, J BIOMAT SCI-POLYM E, V7, P297
   Hatano K, 1999, BONE, V25, P439, DOI 10.1016/S8756-3282(99)00192-1
   HOWARD A, 1951, EXP CELL RES, V2, P178, DOI 10.1016/0014-4827(51)90083-3
   HRABAK O, 1992, FEMS MICROBIOL LETT, V103, P251, DOI 10.1111/j.1574-6968.1992.tb05845.x
   IGURA K, 2006, INT J MOL MED, V18, P1089
   Karahuseyinoglu S, 2007, STEM CELLS, V25, P319, DOI 10.1634/stemcells.2006-0286
   Karinaga R, 2006, BIOMATERIALS, V27, P1626, DOI 10.1016/j.biomaterials.2005.08.023
   Kundu AK, 2006, BIOCHEM BIOPH RES CO, V347, P347, DOI 10.1016/j.bbrc.2006.06.110
   Lee JH, 1999, J BIOMAT SCI-POLYM E, V10, P283
   Lee YJ, 2006, BIOMATERIALS, V27, P3738, DOI 10.1016/j.biomaterials.2006.02.032
   Li J, 2005, J BIOMED MATER RES A, V75A, P985, DOI 10.1002/jbm.a.30504
   Loh XJ, 2006, BIOMATERIALS, V27, P1841, DOI 10.1016/j.biomaterials.2005.10.038
   McChalicher CWJ, 2007, J BIOTECHNOL, V132, P296, DOI 10.1016/j.jbiotec.2007.04.014
   Owen G Rh, 2005, Eur Cell Mater, V9, P85
   Qu XH, 2005, BIOMATERIALS, V26, P6991, DOI 10.1016/j.biomaterials.2005.05.034
   Qu XH, 2006, J BIOMAT SCI-POLYM E, V17, P1107, DOI 10.1163/156856206778530704
   Sarugaser R, 2005, STEM CELLS, V23, P220, DOI 10.1634/stemcells.2004-0166
   SCANDOLA M, 1989, MAKROMOL CHEM-RAPID, V10, P47
   Steinbuchel A, 2001, MACROMOL BIOSCI, V1, P1
   Tziampazis E, 2000, BIOMATERIALS, V21, P511, DOI 10.1016/S0142-9612(99)00212-4
   Wang HS, 2004, STEM CELLS, V22, P1330, DOI 10.1634/stemcells.2004-0013
   Wang YW, 2005, BIOMATERIALS, V26, P755, DOI 10.1016/j.biomaterials.2004.03.023
   Wang YW, 2004, BIOMATERIALS, V25, P669, DOI 10.1016/S0142-9612(03)00561-1
   Wang YW, 2003, BIOMATERIALS, V24, P4621, DOI 10.1016/S0142-9612(03)00356-9
   Weiss ML, 2006, STEM CELLS, V24, P781, DOI 10.1634/stemcells.2005-0330
   Williams SF, 1999, INT J BIOL MACROMOL, V25, P111, DOI 10.1016/S0141-8130(99)00022-7
   Zanchetta P, 2001, COLLOID SURFACE B, V22, P301, DOI 10.1016/S0927-7765(01)00200-4
   Zhao W, 2007, PROCESS BIOCHEM, V42, P1342, DOI 10.1016/j.procbio.2007.07.006
   ZHU XY, 1995, MOL BIOL CELL, V6, P273
NR 43
TC 13
Z9 14
U1 1
U2 7
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2009
VL 20
IS 3
BP 325
EP 339
DI 10.1163/156856209X412191
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 410WD
UT WOS:000263608100004
PM 19192359
DA 2018-10-19
ER

PT J
AU Acharya, C
   Kumary, TV
   Ghosh, SK
   Kundu, SC
AF Acharya, Chitrangada
   Kumary, T. V.
   Ghosh, Sudip K.
   Kundu, S. C.
TI Characterization of Fibroin and PEG-Blended Fibroin Matrices for In
   Vitro Adhesion and Proliferation of Osteoblasts
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Silk protein fibroin; secondary structure; thermal properties;
   osteoblast; von Kossa staining
ID SILK-BASED BIOMATERIALS; BOMBYX-MORI; POLY(ETHYLENE GLYCOL);
   PHYSICAL-PROPERTIES; CELL ATTACHMENT; STEM-CELLS; TISSUE; SURFACES;
   GROWTH; DIFFERENTIATION
AB Silk fibroin protein, isolated from cocoons of the domesticated mulberry silkworm, Bombyx mori, finds extensive application in biomaterial design. In this study, poly(ethylene glycol) (PEG) 4000 has been used for blending fibroin from both B. mori and Antheraea mylitta, the wild tropical non-mulberry silkworm. PEG-blended films have shown marked changes from the pure fibroin films with respect to thermal properties and mechanical properties. FT-IR spectroscopy confirmed incorporation of new functional groups like quinone oximes. Pure fibroin and PEG-blended fibroin films showed biocompatibility with the HOS osteosarcoma cell line. Von Kossa staining confirmed nodule formation due to mineralization and differentiation of osteoblasts on pure and blended matrices. On account of increased surface roughness, higher elongation percentage, higher thermostability and better activity of osteoblasts in terms of intracellular alkaline phosphatase production, PEG-blended A. mylitta fibroin film shows better potential than PEG-blended B. mori fibroin film for use as potential biomaterial. (C) Koninklijke Brill NV, Leiden, 2009
C1 [Acharya, Chitrangada; Ghosh, Sudip K.; Kundu, S. C.] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
   [Kumary, T. V.] Sree Chitra Tirunal Inst Med Sci, Trivandrum, Kerala, India.
RP Kundu, SC (reprint author), Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
EM kundu@hijli.iitkgp.ernet.in
RI Kundu, Subhas/P-1989-2016
OI Kundu, Subhas/0000-0002-7170-2291
FU Department of Biotechnology and Council of Scientific and Industrial
   Research, Govt of India, New Delhi
FX This work was supported by the Department of Biotechnology and Council
   of Scientific and Industrial Research, Govt of India, New Delhi. The
   authors wish to thank Ms. Charu Vepari, Dr. Dulal Panda, Dr. S. Dhara,
   Ms. Jen Kang and Ms. Xianyan Wang for their comments on the original
   manuscript.
CR Acharya C, 2008, J MATER SCI-MATER M, V19, P2827, DOI 10.1007/s10856-008-3408-3
   Ahmed N, 2000, CYTOKINE, V12, P289, DOI 10.1006/cyto.1999.0588
   Ahn SE, 2006, BIOCHEM BIOPH RES CO, V340, P403, DOI 10.1016/j.bbrc.2005.12.020
   Akai H., 1998, P 3 INT NAT C WILD S, P255
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   ASAKURA T, 1992, J APPL POLYM SCI, V46, P49, DOI 10.1002/app.1992.070460106
   Benoit DSW, 2005, BIOMATERIALS, V26, P5209, DOI 10.1016/j.biomaterials.2005.01.045
   Burdick JA, 2002, J CONTROL RELEASE, V83, P53, DOI 10.1016/S0168-3659(02)00181-5
   Cai KY, 2002, BIOMATERIALS, V23, P1153, DOI 10.1016/S0142-9612(01)00230-7
   CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1101, DOI 10.1002/jbm.820290910
   Datta A, 2001, INSECT BIOCHEM MOLEC, V31, P1013, DOI 10.1016/S0965-1748(01)00049-2
   DRUMHELLER PD, 1995, J BIOMED MATER RES, V29, P207, DOI 10.1002/jbm.820290211
   Gotoh Y, 1997, BIOMATERIALS, V18, P267, DOI 10.1016/S0142-9612(96)00137-8
   Gotoh Y, 1997, POLYMER, V38, P487, DOI 10.1016/S0032-3861(96)00665-9
   Halsted WS, 1913, J AMER MED ASSOC, V60, P1119, DOI 10.1001/jama.1913.04340150001001
   Hojo K, 2001, BIOORG MED CHEM LETT, V11, P1429, DOI 10.1016/S0960-894X(01)00225-6
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   IMAI Y, 1985, KOBUNSHI RONBUNSHU, V42, P713, DOI 10.1295/koron.42.713
   Inoue S, 2000, J BIOL CHEM, V275, P40517, DOI 10.1074/jbc.M006897200
   ITO Y, 1992, SYNTHESIS BIOCOMPOSI, P15
   Kim CH, 2006, J BIOMED MATER RES B, V78B, P283, DOI 10.1002/jbm.b.30484
   KIM MS, 2006, TISSUE ENG, V12, P2683
   Lee SJ, 2000, CARBOHYD POLYM, V41, P197, DOI 10.1016/S0144-8617(99)00088-0
   LIANG CX, 1992, POLYMER, V33, P4388, DOI 10.1016/0032-3861(92)90285-5
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Lv QA, 2005, POLYMER, V46, P12662, DOI 10.1016/j.polymer.2005.10.137
   MINOURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511, DOI 10.1006/bbrc.1995.1368
   MORI H, 2000, REV MOL BIOTECHNOL, V74, P95, DOI DOI 10.1016/S1389-0352(00)00004-0
   MOSSMANN T, 1983, J IMMUNOL METHODS, V65, P55
   Muthuvel A, 2006, CLIN CHIM ACTA, V374, P122, DOI 10.1016/j.cca.2006.06.003
   OKKEMA A Z, 1989, Journal of Biomaterials Science Polymer Edition, V1, P43, DOI 10.1163/156856289X00055
   Peter SJ, 1998, J BIOMED MATER RES, V43, P422, DOI 10.1002/(SICI)1097-4636(199824)43:4<422::AID-JBM9>3.3.CO;2-T
   Sampaio S, 2005, J BIOTECHNOL, V116, P21, DOI 10.1016/j.jbiotec.2004.10.003
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Uebersax L, 2008, J CONTROL RELEASE, V127, P12, DOI 10.1016/j.jconrel.2007.11.006
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   YAMAGUCHI K, 1989, J MOL BIOL, V210, P127, DOI 10.1016/0022-2836(89)90295-7
   Yu XJ, 2004, P NATL ACAD SCI USA, V101, P11203, DOI 10.1073/pnas.0402532101
   Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413
NR 41
TC 6
Z9 6
U1 0
U2 10
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2009
VL 20
IS 5-6
BP 543
EP 565
DI 10.1163/156856209X426385
PG 23
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 440NM
UT WOS:000265707000001
PM 19323875
DA 2018-10-19
ER

PT J
AU Nagai, N
   Kobayashi, H
   Katayama, S
   Munekata, M
AF Nagai, Nobuhiro
   Kobayashi, Hatsumi
   Katayama, Shizuka
   Munekata, Masanobu
TI Preparation and Characterization of Collagen from Soft-Shelled Turtle
   (Pelodiscus Sinensis) Skin for Biomaterial Applications
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Collagen; fibrillogenesis; biomaterial; cell culture
ID FIBRIL FORMATION; OUTER SKIN; I COLLAGEN; GEL; PROLIFERATION;
   CONTRACTION; DELIVERY; CULTURE; GROWTH
AB Collagen was isolated from the skin of soft-shelled turtle (Pelodiscus sinensis) by acid solubilization with pepsin. The yield of soft-shelled turtle collagen (STC) was 12.1% on a dry weight basis. The electrophoresis assay showed that STC consisted of a alpha(1)alpha(2) heterodimer similar to porcine collagen (PC). Amino-acid composition analysis showed that the hydroxyproline content of STC was 7.8%, which was lower than that of PC (9.5%). The denaturation temperature of STC was 36 degrees C from optical rotation analysis. An accelerated fibrillogenesis of STC was observed in phosphate-buffered saline at 25 degrees C. The resulting STC fibrillar gel had microfibrillar network with fibril diameter of ca. 124 nm, as revealed by observation with scanning electron microscopy. The compressive moduli of the STC gel and the PC gel were 3.2 +/- 0.8 kPa and 3.6 +/- 0.3 kPa, respectively. The potential of the STC gel for biomaterial applications was investigated by in vitro cell culture. Human dermal fibroblasts were three-dimensionally cultured in the STC gel and their growth was evaluated by DNA content measurement. Steady growth was observed in the STC gel for a 6-day culture period, although the growth rate was slower than in the PC gel. In conclusion, STC could be used as a novel collagen source for biomaterial applications. (C) Koninklijke Brill NV, Leiden, 2009
C1 [Nagai, Nobuhiro] Hokkaido Univ, Kita Ku, Sapporo, Hokkaido 0010021, Japan.
   [Kobayashi, Hatsumi] Ihara & Co Ltd, Otaru, Hokkaido 0470261, Japan.
   [Katayama, Shizuka; Munekata, Masanobu] Hokkaido Univ, Kita Ku, Grad Sch Engn, Div Biotechnol & Macromol Chem, Sapporo, Hokkaido 0608628, Japan.
RP Nagai, N (reprint author), Hokkaido Univ, Kita Ku, N21-W10, Sapporo, Hokkaido 0010021, Japan.
EM nagai491@yahoo.co.jp
CR Burjanadze TV, 2000, BIOPOLYMERS, V53, P523, DOI 10.1002/(SICI)1097-0282(200005)53:6<523::AID-BIP8>3.0.CO;2-7
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Galois L, 2006, BIOMATERIALS, V27, P79, DOI 10.1016/j.biomaterials.2005.05.098
   Garrone R, 1997, MICROSC RES TECHNIQ, V38, P407, DOI 10.1002/(SICI)1097-0029(19970815)38:4<407::AID-JEMT8>3.0.CO;2-F
   Kadler KE, 1996, BIOCHEM J, V316, P1
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Nagai N, 2007, J BIOMED MATER RES A, V82A, P395, DOI 10.1002/jbm.a.31110
   Nagai T, 2004, Z NATURFORSCH C, V59, P271
   Nagai T, 2002, FOOD CHEM, V76, P149, DOI 10.1016/S0308-8146(01)00255-2
   Nomura Y, 2002, BIOSCI BIOTECH BIOCH, V66, P2673, DOI 10.1271/bbb.66.2673
   Nomura Y, 2001, BIOMACROMOLECULES, V2, P105, DOI 10.1021/bm000085w
   Phillips JA, 2003, BIOCHEM BIOPH RES CO, V312, P725, DOI 10.1016/j.bbrc.2003.10.179
   Sano A, 2003, ADV DRUG DELIVER REV, V55, P1651, DOI 10.1016/j.addr.2003.08.005
   Senaratne LS, 2006, BIORESOURCE TECHNOL, V97, P191, DOI 10.1016/j.biortech.2005.02.024
   Swatschek D, 2002, EUR J PHARM BIOPHARM, V53, P107, DOI 10.1016/S0939-6411(01)00192-8
   Takahashi T, 2007, TISSUE ENG, V13, P1583, DOI 10.1089/ten.2006.0322
   Tuan TL, 1996, EXP CELL RES, V223, P127, DOI 10.1006/excr.1996.0065
   Yunoki S, 2004, J BIOSCI BIOENG, V98, P40, DOI 10.1263/jbb.98.40
   Zhang Y, 2007, FOOD CHEM, V103, P906, DOI 10.1016/j.foodchem.2006.09.053
NR 20
TC 7
Z9 12
U1 0
U2 10
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2009
VL 20
IS 5-6
BP 567
EP 576
DI 10.1163/156856209X426394
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 440NM
UT WOS:000265707000002
PM 19323876
DA 2018-10-19
ER

PT J
AU Yeh, HY
   Lin, JC
AF Yeh, Hsi-Yi
   Lin, Jui-Che
TI Bioactivity and Platelet Adhesion Study of a Human
   Thrombomodulin-Immobilized Nitinol Surface
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Nitinol; human thrombomodulin; protein immobilization;
   antithrombogenicity; platelet adhesion
ID IN-VITRO; PROTEIN IMMOBILIZATION; CORROSION-RESISTANCE; ARTIFICIAL
   SALIVA; ORTHODONTIC WIRES; NICKEL RELEASE; ION RELEASE;
   BIOCOMPATIBILITY; IMPLANTS; STENTS
AB Nitinol is a newly developed biomaterial that is gaining popularity in many biomedical applications. It has been reported that nitinol would not induce an inflammatory response and repulsion by the immunization after implantation in the human body. Besides, nitinol is a kind of shape memory alloy, which can memorize shapes at different temperatures. This can improve the convenience in surgery. However, nitinol has poor blood compatibility, so that further modification was needed to improve the antithrombogenicity. Human thrombomodulin (hTM), an endothelial-cell-associated glycoprotein, can be considered as a natural potent anticoagulant by converting thrombin from a procoagulant protease to an anticoagulant. In this study, the surface of nitinol was pre-activated by utilizing silanization with amino-terminated silane. The incorporated amino groups were available for the subsequent covalent immobilization of hTM by 2,4,6-trichloro-1,3,5-triazine (TCT), the coupling reagent. The surface density of immobilized hTM was determined by the Bradford method. The bioactivity of immobilized hTM and blood compatibility of various nitinol substrates were evaluated by the protein C activation assay and platelet adhesion test. It was observed that the immobilized hTM still had the ability to enhance protein C activation, though its activity was lower than the free hTM in solution. Furthermore, the platelet adhesion test showed that only a few platelets were adhered on the hTM-immobilized nitinol substrate. Therefore, the immobilization of thrombomodulin onto nitinol substrate could improve the blood compatibility of nitinol and might have the potential of application in antithrombogenic medical applications. (C) Koninklijke Brill NV, Leiden, 2009
C1 [Yeh, Hsi-Yi; Lin, Jui-Che] Natl Cheng Kung Univ, Dept Chem Engn, Tainan, Taiwan.
RP Lin, JC (reprint author), Natl Cheng Kung Univ, Dept Chem Engn, Tainan, Taiwan.
EM jclin@mail.ncku.edu.tw
RI Lin, Jui-Che/C-8230-2012
OI Lin, Jui-Che/0000-0003-4436-655X
CR BASS JK, 1993, AM J ORTHOD DENTOFAC, V103, P280, DOI 10.1016/0889-5406(93)70009-D
   BLOOM AL, 1994, HAEMOSTATIS THROMBOS
   BONDE M, 1992, ANAL BIOCHEM, V200, P195, DOI 10.1016/0003-2697(92)90298-L
   BUEHLER WJ, 1963, J APPL PHYS, V34, P1475, DOI 10.1063/1.1729603
   Clarke B, 2006, J BIOMED MATER RES A, V79A, P61, DOI 10.1002/jbm.a.30720
   DITTMAN WA, 1990, BLOOD, V75, P329
   Edano T, 1998, BIOL PHARM BULL, V21, P375
   EIGLER NL, 1993, J AM COLL CARDIOL, V13, P1207
   ESMON CT, 1995, FASEB J, V9, P946
   ESMON CT, 1989, J BIOL CHEM, V264, P4743
   Gotman I, 1997, J ENDOUROL, V11, P383, DOI 10.1089/end.1997.11.383
   Han HS, 2000, FIBRINOLYSIS PROTEOL, V14, P221, DOI 10.1054/fipr.2000.0059
   Han HS, 2001, J BIOMAT SCI-POLYM E, V12, P1075, DOI 10.1163/15685620152691869
   Hildebrandt P, 2001, BIOMATERIALS, V22, P503, DOI 10.1016/S0142-9612(00)00217-9
   Huang HH, 2003, BIOMATERIALS, V24, P3585, DOI 10.1016/S0142-9612(03)00188-1
   Huang HH, 2003, J BIOMED MATER RES A, V66A, P829, DOI 10.1002/jbm.a.10463
   Jia WY, 1999, J BIOMED MATER RES, V48, P488, DOI 10.1002/(SICI)1097-4636(1999)48:4<488::AID-JBM14>3.3.CO;2-4
   Kong XQ, 2002, BIOMATERIALS, V23, P1775, DOI 10.1016/S0142-9612(01)00304-0
   Lahann J, 2001, BIOMATERIALS, V22, P817, DOI 10.1016/S0142-9612(00)00244-1
   Lin JC, 1999, BIOMATERIALS, V20, P1613, DOI 10.1016/S0142-9612(99)00068-X
   Lin JC, 2000, J BIOMED MATER RES, V51, P413, DOI 10.1002/1097-4636(20000905)51:3<413::AID-JBM16>3.0.CO;2-L
   Lin JC, 2000, J BIOMAT SCI-POLYM E, V11, P701, DOI 10.1163/156856200743968
   LIU M, 2007, LANGMUIR, V28, P9378
   McPherson TB, 1997, J BIOMED MATER RES, V38, P289
   O'Brien B, 2002, BIOMATERIALS, V23, P1739, DOI 10.1016/S0142-9612(01)00299-X
   Rajan DK, 2007, CARDIOVASC INTER RAD, V30, P662, DOI 10.1007/s00270-007-9083-9
   Rechavia E, 1998, CATHETER CARDIO DIAG, V45, P202, DOI 10.1002/(SICI)1097-0304(199810)45:2<202::AID-CCD20>3.0.CO;2-L
   Ries MW, 2003, AM HEART J, V145, P737, DOI 10.1067/mhj.2003.7
   Ryhanen J, 1997, J BIOMED MATER RES, V35, P451
   Sadler JE, 1997, THROMB HAEMOSTASIS, V78, P392
   SANO S, 1993, BIOMATERIALS, V14, P817, DOI 10.1016/0142-9612(93)90003-K
   Song HY, 1999, RADIOLOGY, V213, P905, DOI 10.1148/radiology.213.3.r99dc02905
   Sperling C, 2004, BIOMATERIALS, V25, P5101, DOI 10.1016/j.biomaterials.2003.12.014
   Sun XL, 2006, BIOCONJUGATE CHEM, V17, P52, DOI 10.1021/bc0502311
   Tepe G, 2006, BIOMATERIALS, V27, P643, DOI 10.1016/j.biomaterials.2005.06.004
   UCHIDA E, 1993, LANGMUIR, V9, P1121, DOI 10.1021/la00028a040
   Wu B, 2007, BIOMATERIALS, V28, P4047, DOI 10.1016/j.biomaterials.2007.06.002
   Yeh HY, 2008, J BIOMAT SCI-POLYM E, V19, P291, DOI 10.1163/156856208783720985
NR 38
TC 13
Z9 13
U1 0
U2 10
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2009
VL 20
IS 5-6
BP 807
EP 819
DI 10.1163/156856209X426952
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 440NM
UT WOS:000265707000017
PM 19323891
DA 2018-10-19
ER

PT J
AU Huang, X
   Shen, CY
   Chen, JC
   Li, Q
AF Huang, Xia
   Shen, Chang-Yu
   Chen, Jia-Chang
   Li, Qian
TI A Library of L-Tyrosine-Derived Biodegradable Polyarylates for Potential
   Biomaterial Applications, Part I: Synthesis, Characterization and
   Accelerated Hydrolytic Degradation
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Biodegradation; L-tyrosine; cyclic dipeptide; polyarylate;
   structure-property correlations
ID PSEUDO-POLY(AMINO ACIDS); POLYCARBONATES; COPOLYMERS; RELAXATION;
   CURRENTS; DESIGN
AB A combinatorial library of biodegradable polyarylates derived from L-tyrosine was synthesized and characterized. These polyarylates are A-B-type co-polymers consisting of a cyclic dipeptide and a diacid. General structure-property correlations were established by comparing aryl diacid co-polymers and aliphatic diacid co-polymers. The synthesized polymers were characterized by FT-IR, H-1-NMR, C-13-NMR for their chemical structure, by DSC and TGA for their thermal characteristics and by GPC for their molecular weight distribution. The T-g of polymers decreased and water absorption increased with increasing number of methylene groups in the polymer backbone. Using a cyclic peptide derived from L-tyrosine as co-monomer we obtained optimum bioactivity and biocompatibility. Combinatorial approaches of designing material increased effectively the number of available degradable polymers which can be used in different biomaterials applications. General structure-property correlation makes polymers' properties varied in a predictable and systematic fashion. Accelerated hydrolytic degradation studies of polyarylates were performed at 70 degrees C in acid and alkali medium. The degradation rates of polymers were in accordance with their water absorption. The degradation rates of samples in acid medium were lower than those in alkali medium. (C) Koninklijke Brill NV, Leiden, 2009
C1 [Huang, Xia; Shen, Chang-Yu; Li, Qian] Zhenzhou Univ, Natl Engn Res Ctr Adv Polymer Proc Technol, Zhenzhou 450002, Peoples R China.
   [Chen, Jia-Chang] Xi An Jiao Tong Univ, State Key Lab Mech Behav Mat, Xian 710049, Peoples R China.
RP Huang, X (reprint author), Zhenzhou Univ, Natl Engn Res Ctr Adv Polymer Proc Technol, Zhenzhou 450002, Peoples R China.
EM happyhxia@163.com
CR Agrawal CM, 1997, J BIOMED MATER RES, V38, P105, DOI 10.1002/(SICI)1097-4636(199722)38:2<105::AID-JBM4>3.0.CO;2-U
   ARNOLD LJ, 1983, TARGETED DRUGS, P89
   Botelho EC, 2001, MACROMOLECULES, V34, P3367, DOI 10.1021/ma000902k
   Bourke SL, 2003, ADV DRUG DELIVER REV, V55, P447, DOI 10.1016/S0169-409X(03)00038-3
   Brocchini S, 1998, J BIOMED MATER RES, V42, P66, DOI 10.1002/(SICI)1097-4636(199810)42:1<66::AID-JBM9>3.0.CO;2-M
   Cabrele C, 1999, J ORG CHEM, V64, P4353, DOI 10.1021/jo982402j
   CHANDAN P, 1995, PEPTIDES, V16, P151
   COOK B, 1992, J CHEM SOC PERK T 1, P1199, DOI 10.1039/p19920001199
   ERTEL SI, 1994, J BIOMED MATER RES, V28, P919, DOI 10.1002/jbm.820280811
   GOLDBERG EP, 1964, J POLYM SCI C, V4, P707
   HE WD, 2003, POLYM CHEM EXPT, P48
   HUANG X, 2008, J APPL POLY IN PRESS
   Iijima T, 2003, POLYM INT, V52, P773, DOI 10.1002/pi.1146
   Kimura Y, 1996, PHYTOCHEMISTRY, V41, P665, DOI 10.1016/0031-9422(95)00693-1
   KOHN J, 1993, TRENDS POLYM SCI, V1, P206
   LI T, 2004, CHEM IND TIMES, V18, P37
   MAO H, 1999, Patent No. 5912225
   MERRILL SH, 1961, J POLYM SCI, V55, P343, DOI 10.1002/pol.1961.1205516133
   PULAPURA S, 1990, BIOMATERIALS, V11, P666, DOI 10.1016/0142-9612(90)90025-L
   PULAPURA S, 1992, BIOPOLYMERS, V32, P411, DOI 10.1002/bip.360320418
   Puma M, 1999, J POLYM SCI POL PHYS, V37, P3504, DOI 10.1002/(SICI)1099-0488(19991215)37:24<3504::AID-POLB11>3.0.CO;2-Y
   Sen Gupta A, 2005, POLYMER, V46, P2133, DOI 10.1016/j.polymer.2005.01.023
   Sen Gupta A, 2004, POLYMER, V45, P4653, DOI 10.1016/j.polymer.2004.04.052
   Suarez N, 2001, POLYMER, V42, P8671, DOI 10.1016/S0032-3861(01)00437-2
   Tangpasuthadol V, 1996, BIOMATERIALS, V17, P463, DOI 10.1016/0142-9612(96)89665-7
   Tangpasuthadol V, 2000, BIOMATERIALS, V21, P2371, DOI 10.1016/S0142-9612(00)00104-6
   WIPF P, 1995, CHEM REV, V95, P2115, DOI 10.1021/cr00038a013
NR 27
TC 1
Z9 2
U1 0
U2 7
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2009
VL 20
IS 7-8
BP 935
EP 955
DI 10.1163/156856209X444358
PG 21
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 454DS
UT WOS:000266662600005
PM 19454161
DA 2018-10-19
ER

PT J
AU Hu, Y
   Wu, YZ
   Cai, JY
   Ma, SY
   Wang, XP
AF Hu, Yi
   Wu, Yangzhe
   Cai, Jiye
   Ma, Shuyuan
   Wang, Xiaoping
TI The Procoagulant Properties of Hyaluronic Acid-Collagen (I)/Chitosan
   Complex Film
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Biomacromolecule complex film; platelet-derived microparticles; atomic
   force microscopy; flow cytometry; procoagulant properties
ID ATOMIC-FORCE MICROSCOPY; PLATELET PLASMA-MEMBRANE; GROOVED SUBSTRATA;
   STEM-CELLS; FACTOR-VA; IN-VITRO; MICROPARTICLES; VESICULATION;
   FIBROBLASTS; SCAFFOLDS
AB Biomaterial-induced human platelet activation remains one of the most crucial factors to determine the procoagulant properties of the biomaterial. In this experiment, a new type of biomacromolecule complex film (hyaluronic acid-collagen (I)/chitosan, HCC) was prepared using the electrostatic self-assembly method. Then the procoagulant properties of this complex film were characterized. Based on the nano-resolution of atomic force microscopy, the platelet-derived microparticles (PMPs) that present the activation of platelets were clearly visualized on the membrane surface of platelets for the first time, and the measurement indicated that the size of PMPs is around 50-110 nm. Furthermore, the results of AFM measurement were confirmed by flow cytometry analysis. The expression of CD62P (P-selectin) dramatically increased after the platelet-rich plasma interacted with the biomaterial solution. From the results, we could draw the conclusion that this biomacromolecule complex film has promising procoagulant properties, and has the potential to be practically used as procoagulant material. (C) Koninklijke Brill NV, Leiden, 2009
C1 [Hu, Yi; Wu, Yangzhe; Cai, Jiye] Jinan Univ, Dept Chem, Guangzhou 510632, Guangdong, Peoples R China.
   [Ma, Shuyuan; Wang, Xiaoping] Jinan Univ, Affiliated Hosp 1, Guangzhou 510632, Guangdong, Peoples R China.
RP Cai, JY (reprint author), Jinan Univ, Dept Chem, Guangzhou 510632, Guangdong, Peoples R China.
EM tjycai@jnu.edu.cn
RI Wu, Yangzhe/C-4435-2012
FU National Natural Science Foundation of China [60578025, 30540420311]
FX This research project is supported by the National Natural Science
   Foundation of China (Nos 60578025 and 30540420311). Y. H. and Y. W.
   contributed equally to this work.
CR Alonso JL, 2003, LIFE SCI, V72, P2553, DOI 10.1016/S0024-3205(03)00165-6
   BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   Blinc A, 2000, FIBRINOLYSIS PROTEOL, V14, P288, DOI 10.1054/fipr.2000.0085
   Cauwenberghs S, 2006, FEBS LETT, V580, P5313, DOI 10.1016/j.febslet.2006.08.082
   Chan BP, 2005, J BIOMED MATER RES A, V75A, P689, DOI 10.1002/jbm.a.30469
   DACHARYPRIGENT J, 1993, BLOOD, V81, P2554
   Damji A, 1996, EXP CELL RES, V228, P114, DOI 10.1006/excr.1996.0306
   Dang JM, 2006, BIOMATERIALS, V27, P406, DOI 10.1016/j.biomaterials.2005.07.033
   Freyssinet JM, 2003, J THROMB HAEMOST, V1, P1655, DOI 10.1046/j.1538-7836.2003.00309.x
   Fungaloi P, 2002, PHOTOCHEM PHOTOBIOL, V75, P412, DOI 10.1562/0031-8655(2002)075<0412:PATPTT>2.0.CO;2
   Graff J, 2002, J PHARMACOL EXP THER, V300, P952, DOI 10.1124/jpet.300.3.952
   Haque T, 2005, INT J ARTIF ORGANS, V28, P631
   Horber JKH, 2003, SCIENCE, V302, P1002, DOI 10.1126/science.1067410
   Hu Y, 2007, INT J MOL SCI, V8, P1, DOI 10.3390/i8010001
   Kang I, 2007, THROMB RES, V119, P731, DOI 10.1016/j.thromres.2006.06.010
   Lauer G, 2001, BIOMATERIALS, V22, P2799, DOI 10.1016/S0142-9612(01)00024-2
   Ma L, 2004, BIOMATERIALS, V25, P2997, DOI 10.1016/j.biomaterials.2003.09.092
   Martinez MC, 2005, AM J PHYSIOL-HEART C, V288, P1004
   Meinel L, 2004, J BIOMED MATER RES A, V71A, P25, DOI 10.1002/jbm.a.30117
   OAKLEY C, 1993, J CELL SCI, V106, P343
   RUF A, 1995, SEMIN THROMB HEMOST, V21, P146, DOI 10.1055/s-2007-1000389
   Siedlecki CA, 1999, BIOMATERIALS, V20, P1521, DOI 10.1016/S0142-9612(99)00065-4
   SIMS PJ, 1989, J BIOL CHEM, V264, P17049
   SIMS PJ, 1988, J BIOL CHEM, V263, P18205
   WIEDMER T, 1990, BIOCHEMISTRY-US, V29, P623, DOI 10.1021/bi00455a005
   WOJCIAKSTOTHARD B, 1995, CELL MOTIL CYTOSKEL, V31, P147, DOI 10.1002/cm.970310207
   Wu YZ, 2006, MICRON, V37, P139, DOI 10.1016/j.micron.2005.08.007
   YANO Y, 1994, BIOCHEM J, V299, P303, DOI 10.1042/bj2990303
NR 28
TC 3
Z9 3
U1 0
U2 8
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2009
VL 20
IS 7-8
BP 1111
EP 1118
DI 10.1163/156856209X444457
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 454DS
UT WOS:000266662600016
PM 19454172
DA 2018-10-19
ER

PT J
AU Sugiura, H
   Yunoki, S
   Kondo, E
   Ikoma, T
   Tanaka, J
   Yasuda, K
AF Sugiura, Hiroaki
   Yunoki, Shunji
   Kondo, Eiji
   Ikoma, Toshiyuki
   Tanaka, Junzo
   Yasuda, Kazunori
TI In Vivo Biological Responses and Bioresorption of Tilapia Scale Collagen
   as a Potential Biomaterial
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Biocompatibility; bioresorption; collagen; cross-linking; inflammation
ID CROSS-LINKING; TISSUE; BONE; BIOCOMPATIBILITY; DENATURATION; CARTILAGE;
   SCAFFOLDS; MATRICES; RHBMP-2; SPONGES
AB To date, collagen for biomedical uses has been obtained from mammalian sources. The purpose of this study was to evaluate the in vivo biological responses and bioresorption of collagen obtained from tilapia (Oreochromis niloticas) scales as compared to those of collagen from porcine dermis. Collagen sponges with micro-porous structures were fabricated from reconstituted collagen fibrils using freeze-drying and cross-linked by dehydrothermal treatment (DHT treatment) or additional treatment with a water-soluble carbodiimide (WSC treatment). The mechanical properties of the tilapia collagen sponges were similar to those of porcine collagen sponges with the same cross-linking methods, where WSC treatment remarkably improved the properties over DHT treatment alone. The pellet implantation tests into the paravertebral muscle of rabbits demonstrated that tilapia collagen caused rare inflammatory responses at 1- and 4-week implantations, statistically similar to those of porcine collagen and a high-density polyethylene as a negative control. The bioresorption rates of both the collagen implants were similar, except for the DHT-treated tilapia collagen sponges at 1-week implantation. These results suggest that tilapia collagen is a potential alternative to conventional mammalian collagens in biomedical uses. (C) Koninklijke Brill NV, Leiden, 2009
C1 [Yunoki, Shunji] Kanazawa Inst Technol, Genome Biotechnol Lab, Hakusan City, Ishikawa 9240838, Japan.
   [Sugiura, Hiroaki; Kondo, Eiji; Yasuda, Kazunori] Hokkaido Univ, Dept Sports Med & Joint Reconstruct Surg, Grad Sch Med, Sapporo, Hokkaido 0608638, Japan.
   [Kondo, Eiji; Tanaka, Junzo] Hokkaido Univ, Div Frontier Res, CRIS, Sapporo, Hokkaido 0010021, Japan.
   [Ikoma, Toshiyuki] Natl Inst Mat Sci, Ctr Biomat, Tsukuba, Ibaraki 3050044, Japan.
   [Tanaka, Junzo] Dept Met & Ceram Sci, Meguro Ku, Tokyo 1528550, Japan.
RP Yunoki, S (reprint author), Kanazawa Inst Technol, Genome Biotechnol Lab, Yatsukaho 3-1, Hakusan City, Ishikawa 9240838, Japan.
EM jonio530@yahoo.co.jp
RI Kondo, Eiji/G-2004-2012; Ikoma, Toshiyuki/E-4288-2012; Yasuda,
   Kazunori/C-9998-2009
OI Ikoma, Toshiyuki/0000-0003-3154-1777; 
FU Japan Science and Technology Agency.
FX This research was supported in part by a grant program 'Collaborative
   Development of Innovative Seeds' from the Japan Science and Technology
   Agency.
CR Aigner T, 2003, ADV DRUG DELIVER REV, V55, P1569, DOI 10.1016/j.addr.2003.08.009
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Burjanadze TV, 2000, BIOPOLYMERS, V53, P523, DOI 10.1002/(SICI)1097-0282(200005)53:6<523::AID-BIP8>3.0.CO;2-7
   Chen GP, 2001, BIOMATERIALS, V22, P2563, DOI 10.1016/S0142-9612(00)00447-6
   Damink L. H. H. O., 1994, J MATER SCI-MATER M, V6, P460
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Friess W, 1999, INT J PHARM, V187, P91, DOI 10.1016/S0378-5173(99)00174-X
   Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010
   GORHAM SD, 1992, INT J BIOL MACROMOL, V14, P129, DOI 10.1016/S0141-8130(05)80002-9
   Hiraoka Y, 2003, TISSUE ENG, V9, P1101, DOI 10.1089/10763270360728017
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Ikoma T, 2003, INT J BIOL MACROMOL, V32, P199, DOI 10.1016/S0141-8130(03)00054-0
   Kadler KE, 1996, BIOCHEM J, V316, P1
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   *MIN HLTH LAB WELF, 2003, 0213001 IYAKUSHINHAT
   Mooney DT, 1996, BIOMATERIALS, V17, P115, DOI 10.1016/0142-9612(96)85756-5
   NAGAI T, 2001, FOOD CHEM, V72, P423
   Osborne CS, 1999, BIOMATERIALS, V20, P283, DOI 10.1016/S0142-9612(98)00179-3
   Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3
   Rochdi A, 1999, BIOPOLYMERS, V50, P690, DOI 10.1002/(SICI)1097-0282(199912)50:7<690::AID-BIP2>3.0.CO;2-P
   Ruszczak Z, 2003, ADV DRUG DELIVER REV, V55, P1595, DOI 10.1016/j.addr.2003.08.003
   Song E, 2006, BIOMATERIALS, V27, P2951, DOI 10.1016/j.biomaterials.2006.01.015
   Tanabe Y, 2008, J MATER SCI-MATER M, V19, P1379, DOI 10.1007/s10856-007-3255-7
   WANG MC, 1994, BIOMATERIALS, V15, P507
   WEADOCK K, 1983, BIOMATER ARTIF CELL, V11, P293, DOI 10.3109/10731198309118815
   WOOD GC, 1960, BIOCHEM J, V75, P588, DOI 10.1042/bj0750588
   Yunoki S, 2003, J BIOSCI BIOENG, V96, P575, DOI 10.1016/S1389-1723(04)70152-8
   Yunoki S, 2007, J MATER SCI-MATER M, V18, P1369, DOI 10.1007/s10856-007-0121-6
NR 29
TC 24
Z9 25
U1 1
U2 15
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2009
VL 20
IS 10
BP 1353
EP 1368
DI 10.1163/092050609X12457418396658
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 482OV
UT WOS:000268899500002
PM 19622276
DA 2018-10-19
ER

PT J
AU Srivastava, A
   Kumar, A
AF Srivastava, Akshay
   Kumar, Ashok
TI Synthesis and Characterization of a Temperature-Responsive Biocompatible
   Poly(N-vinylcaprolactam) Cryogel: a Step Towards Designing a Novel Cell
   Scaffold
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Smart cryogels; porosity; blood compatibility; protein adsorption;
   poly(N-vinylcaprolactam)
ID N-VINYLCAPROLACTAM; HYDROGELS; REPLACEMENT; UROKINASE; BEHAVIOR; BINDING
AB A poly(N-vinylcaprolactam) (PVCl) cryogel and poly(N-vinylcaprolactam)-co-gelatin interpenetrating cryogel network were synthesized and characterized with respect to physical and biological properties. The PVCl cryogel was synthesized in 5% dimethyl sulfoxide (DMSO) containing aqueous medium and PVCl-co-gelatin interpenetrating cryogel network was synthesized in water as solvent. Both these cryogel networks have good physical morphology as confirmed by scanning electron microscopy. The porosity of these cryogels were characterized by various methods like, adsorption of water and cyclohexane and confirmed by analysis on mercury porosimeter and nitrogen adsorption studies. The porosity of PVCl and PVCl-co-gelatin cryogels was 96% and 98%, respectively, and the permeability of the two types of cryogels was 1.01 x 10(-12) m(4)/Ns and 1.66 x 10(-12) m(4)/Ns, respectively. The effective diffusion coefficients (D(eff)) of bovine serum albumin (BSA) in PVCl cryogel and PVCl-co-gelatin cryogel were 3.5 x 10(-7) cm(2)/s and 3.4 x 10(-7) cm(2)/s, respectively. These materials were further characterized to demonstrate its interaction with biological system. The blood compatibility studies showed minimal hemolysis (4-6%) caused by these materials and a very low adsorption of BSA (0.001-0.002 mg/g dry scaffold). However, the fetal bovine serum (FBS) adsorption studies demonstrate the protein binding at 37 degrees C. Furthermore, cytotoxicity test and the fibroblast cell adhesion studies showed the potential of these PVCl-based cryogels for suitable biomaterial applications. (C) Koninklijke Brill NV, Leiden, 2009
C1 [Srivastava, Akshay; Kumar, Ashok] Indian Inst Technol Kanpur, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India.
RP Kumar, A (reprint author), Indian Inst Technol Kanpur, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India.
EM ashokkum@iitk.ac.in
RI Kumar, Ashok/G-8515-2015
FU Department of Biotechnology (DBT); Department of Science and Technology
   (DST); Ministry of Science and Technology, Government of India
   Organizations.; University Grants Commission, India
FX The work was financially supported by Department of Biotechnology (DBT)
   and Department of Science and Technology (DST), Ministry of Science and
   Technology, Government of India Organizations. A. S. gratefully
   acknowledges the fellowship received from University Grants Commission,
   India. The authors would like to acknowledge Dr. Mahesh W. Kasturi, NCl
   Pune, India for experiments carried out on nitrogen adsorption and
   TG/DTA.
CR Abed MA, 2005, EUR POLYM J, V41, P2395, DOI 10.1016/j.europolymj.2005.04.027
   Adrados BP, 2001, J CHROMATOGR A, V930, P73, DOI 10.1016/S0021-9673(01)01142-6
   Bajpai AK, 2006, J MATER SCI-MATER M, V17, P49, DOI 10.1007/s10856-006-6329-z
   Bansal V, 2007, INT J BIOL SCI, V3, P64
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BURCZAK K, 1994, BIOMATERIALS, V15, P231, DOI 10.1016/0142-9612(94)90072-8
   Dainiak MB, 2006, P NATL ACAD SCI USA, V103, P849, DOI 10.1073/pnas.0508432103
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Ferreira L, 2006, J BIOMED MATER RES B, V77B, P55, DOI 10.1002/jbm.b.30394
   Hukins DWL, 1999, J MATER CHEM, V9, P629, DOI 10.1039/a807411i
   Kirsh YE, 2002, EUR POLYM J, V38, P403, DOI 10.1016/S0014-3057(00)00219-6
   Kumar A, 2006, BIOTECHNOL BIOENG, V93, P636, DOI 10.1002/bit.20719
   Kumar A, 2005, J MOL RECOGNIT, V18, P84, DOI 10.1002/jmr.693
   Kumar A, 2003, J IMMUNOL METHODS, V283, P185, DOI 10.1016/j.jim.2003.09.017
   Lau ACW, 1999, MACROMOLECULES, V32, P581, DOI 10.1021/ma980850n
   Levesque SG, 2005, BIOMATERIALS, V26, P7436, DOI 10.1016/j.biomaterials.2005.05.054
   Li JS, 2005, J BIOMATER APPL, V19, P253, DOI 10.1177/0885328205047219
   Lozinsky VI, 2003, TRENDS BIOTECHNOL, V21, P445, DOI 10.1016/j.tibtech.2003.08.002
   Lozinsky VI, 2000, POLYMER, V41, P6507, DOI 10.1016/S0032-3861(99)00844-7
   Nilsang S, 2007, BIOTECHNOL PROGR, V23, P932, DOI 10.1021/bp0700399
   Plieva FM, 2005, SOFT MATTER, V1, P303, DOI 10.1039/b510010k
   Sayil C, 2001, POLYMER, V42, P7639, DOI 10.1016/S0032-3861(01)00279-8
   SINGH DK, 1994, J APPL POLYM SCI, V53, P1115, DOI 10.1002/app.1994.070530814
   Srivastava A, 2007, MAT SCI ENG A-STRUCT, V464, P93, DOI 10.1016/j.msea.2007.03.057
   Swieszkowski W, 2006, BIOMATERIALS, V27, P1534, DOI 10.1016/j.biomaterials.2005.08.032
   Washburn EW, 1921, PHYS REV, V17, P273, DOI 10.1103/PhysRev.17.273
   WEIA G, 2004, BIOMATERIALS, V25, P4749, DOI DOI 10.1016/J.BIOMATERIALS.2003.12.005
   WOCRLY S, 1998, J BIOMAT SCI-POLYM E, V9, P681
NR 28
TC 9
Z9 9
U1 1
U2 31
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2009
VL 20
IS 10
BP 1393
EP 1415
DI 10.1163/092050609X12457418891946
PG 23
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 482OV
UT WOS:000268899500005
PM 19622279
DA 2018-10-19
ER

PT J
AU Min, SJ
   Gao, X
   Liu, L
   Tian, L
   Zhu, LJ
   Zhang, HP
   Yao, JM
AF Min, Sijia
   Gao, Xin
   Liu, Lin
   Tian, Li
   Zhu, Liangjun
   Zhang, Haiping
   Yao, Juming
TI Fabrication and Characterization of Porous Tubular Silk Fibroin
   Scaffolds
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Silk fibroin; porous scaffold; tubular scaffold; polyethylene glycol
   diglycidyl ether (PGDE); biomaterial
ID BLOOD-VESSEL; VASCULAR CELLS; BOMBYX-MORI; HOLY-GRAIL; IN-VITRO; TISSUE;
   COLLAGEN; COMPOSITE; POLYMER; SURGERY
AB Silk fibroin (SF) has been one of promising resources of biotechnology and biomedical materials due to its unique properties. Here, different sizes of porous tubular scaffolds were fabricated from a SF aqueous solution with the addition of poly(ethylene glycol diglycidyl ether) (PGDE). The scaffolds were generally flexible and transparent at the wet state with a pore size of 81-128 mu m and porosity of 90-96%, depending on the concentrations of SF and PGDE. The mechanical properties measurement showed that the tubular SF scaffolds had satisfying tensile and compression properties, especially the excellent deformation-recovery ability. FT-IR spectra indicated that the SF in the tubular scaffolds was in a beta-sheet structure, and no PGDE characteristic band was observed, suggesting that the PGDE could be removed from the scaffolds by soaking in deionized water. The cell compatibility of scaffolds was evaluated, and no obvious cytotoxicity to mouse L-929 fibroblasts was detected. (C) Koninklijke Brill NV, Leiden, 2009
C1 [Min, Sijia; Gao, Xin; Tian, Li; Zhu, Liangjun; Zhang, Haiping] Zhejiang Univ, Coll Anim Sci, Hangzhou 310029, Zhejiang, Peoples R China.
   [Liu, Lin; Yao, Juming] Zhejiang Sci Tech Univ, Coll Mat & Text, Key Lab Adv Text Mat & Mfg Technol, Minist Educ, Hangzhou 310018, Zhejiang, Peoples R China.
RP Min, SJ (reprint author), Zhejiang Univ, Coll Anim Sci, Kaixuan Rd 268, Hangzhou 310029, Zhejiang, Peoples R China.
EM minsj@zju.edu.cn
RI Yao, Juming/N-7886-2014; Tian, Li/M-7364-2016
OI Tian, Li/0000-0003-1497-7923
FU Special Funds of Cooperation between Hangzhou City and Zhejiang
   University, Key Program of Science and Technology Plan of Zhejiang
   Province [2007C2118]; Program for New Century Excellent Talents in
   University [NCET070763]; National Natural Science Foundation of China
   [30870628, 10672145]
FX This work was financially supported by Special Funds of Cooperation
   between Hangzhou City and Zhejiang University, Key Program of Science
   and Technology Plan of Zhejiang Province (2007C2118), Program for New
   Century Excellent Talents in University (NCET070763) and National
   Natural Science Foundation of China (Nos 30870628 and 10672145).
CR Berglund JD, 2003, BIOMATERIALS, V24, P1241, DOI 10.1016/S0142-9612(02)00506-9
   Conte MS, 1998, FASEB J, V12, P43
   Harris JR, 2002, J OTOLARYNGOL, V31, P89, DOI 10.2310/7070.2002.18928
   Heise M, 2006, EUR J VASC ENDOVASC, V32, P418, DOI 10.1016/j.ejvs.2006.03.002,
   Hirai J, 1996, CELL TRANSPLANT, V5, P93, DOI 10.1016/0963-6897(95)02002-0
   Hoerstrup SP, 2001, EUR J CARDIO-THORAC, V20, P164, DOI 10.1016/S1010-7940(01)00706-0
   Hosseinkhani H, 2006, J BIOACT COMPAT POL, V21, P277, DOI 10.1177/0883911506066934
   Isenberg BC, 2006, CIRC RES, V98, P25, DOI 10.1161/01.RES.0000196867.12470.84
   Kakisis JD, 2005, J VASC SURG, V41, P349, DOI 10.1016/j.jvs.2004.12.026
   Kim BS, 1999, EXP CELL RES, V251, P318, DOI 10.1006/excr.1999.4595
   Kong LJ, 2005, J BIOMED MATER RES A, V75A, P275, DOI 10.1002/jbm.a.30414
   Lee KJ, 2007, EUR POLYM J, V43, P4460, DOI 10.1016/j.eurpolymj.2007.07.020
   Li L, 2008, J MATER SCI-MATER M, V19, P577, DOI 10.1007/s10856-007-3004-y
   Lin F, 2008, MATER CHEM PHYS, V111, P92, DOI 10.1016/j.matchemphys.2008.03.019
   Liu L, 2008, J BIOMAT SCI-POLYM E, V19, P325, DOI 10.1163/156856208783721010
   Lovett M, 2007, BIOMATERIALS, V28, P5271, DOI 10.1016/j.biomterials.2007.08.008
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Shum-Tim D, 1999, ANN THORAC SURG, V68, P2298, DOI 10.1016/S0003-4975(99)01055-3
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Tamada Y, 2005, BIOMACROMOLECULES, V6, P3100, DOI 10.1021/bm050431f
   Tranquillo RT, 1996, BIOMATERIALS, V17, P349, DOI 10.1016/0142-9612(96)85573-6
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang L, 2004, J EUR CERAM SOC, V24, P2707, DOI 10.1016/j.jeurceramsoc.2003.09.006
   WEINBERG CB, 1986, SCIENCE, V231, P397, DOI 10.1126/science.2934816
   Yao J., 2004, ENCY BIOMATERIALS BI, P1363
   Yao JM, 2004, BIOMACROMOLECULES, V5, P680, DOI 10.1021/bm034285u
   Yao JM, 2002, MACROMOLECULES, V35, P6, DOI 10.1021/ma011335j
NR 27
TC 14
Z9 16
U1 1
U2 26
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2009
VL 20
IS 13
BP 1961
EP 1974
DI 10.1163/156856208X396056
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 509MF
UT WOS:000271021200010
PM 19793450
DA 2018-10-19
ER

PT J
AU Calejo, MT
   Morais, ZB
   Fernandes, AI
AF Calejo, M. T.
   Morais, Z. B.
   Fernandes, A. I.
TI Isolation and Biochemical Characterisation of a Novel Collagen from
   Catostylus tagi
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Catostylus tagi; marine collagen; collagen structure; biomaterial; drug
   delivery
ID CUCUMBER STICHOPUS-JAPONICUS; MAJOR EDIBLE COMPONENT; AMINO-ACID
   COMPOSITION; CRANIAL CARTILAGE; SOLUBLE COLLAGEN; SKIN COLLAGEN; OUTER
   SKIN; DELIVERY; TROPOCOLLAGEN; DISACCHARIDE
AB A preliminary biochemical approach to the study of collagen isolated from the medusa Catostylus tagi is reported and results are discussed in view of its use as a natural matrix for biomedical applications. Collagen from the jellyfish umbrella was isolated by pepsin digestion and purified by dialysis and salt precipitation. As expected, glycine represented almost one-third of the total amino acids. Aromatic amino-acid content was very low and imino acids were fewer than in collagens from fish and mammalian sources. Results from SDS-PAGE, ion-exchange chromatography and N-terminal amino-acid sequencing revealed an alpha 1 alpha 2 alpha 3 heterotrimer, similar to vertebrate type V/XI. The molecular mass of two of the polypeptide chains was close to 85 kDa and 100 kDa for the third. However, the two chains presenting similar molecular mass, showed differences in charge and primary structure. Further characterisation showed a glycosylated protein with the carbohydrate moiety comprising almost 7% of the total mass, a denaturation temperature of 29.9 degrees C and multiple isoelectric points. Incubation with glutamyl endopeptidase resulted in significant digestion, in agreement with the protein's high content of Asp and Glu. (C) Koninklijke Brill NV, Leiden, 2009
C1 [Calejo, M. T.; Morais, Z. B.; Fernandes, A. I.] Inst Super Ciencias Saude Egas Moniz, Ctr Polimeros Biomed, P-2829511 Caparica, Portugal.
RP Fernandes, AI (reprint author), Inst Super Ciencias Saude Egas Moniz, Ctr Polimeros Biomed, Campus Univ, P-2829511 Caparica, Portugal.
EM aifernandes@egasmoniz.edu.pt
OI Fernandes, Ana Isabel/0000-0003-2705-4845; Morais,
   Zilda/0000-0001-5285-994X
FU Fundacao para a Ciencia e a Tecnologia [PPCDT/SAU-FCF/57911/2004]
FX This work was financially supported by Fundacao para a Ciencia e a
   Tecnologia (PPCDT/SAU-FCF/57911/2004). We wish to thank ICN for the
   support in the capture of the medusa. We would also like to acknowledge
   Ana Ramos (DQ/FCT/UNL) for granting access to the equipment used in
   viscosity measurements, Rute Pinheiro (ITN) for the lyophilisation of
   the samples and Narcisa Bandarra (IPIMAR) for the amino-acid analysis.
CR [Anonymous], 2005, OFFICIAL METHODS ANA, P8
   BEAUDET R, 1974, J BIOL CHEM, V249, P6468
   Bergeon M T, 1967, J Okla State Med Assoc, V60, P330
   Bhattacharjee A, 2005, IUBMB LIFE, V57, P161, DOI 10.1080/15216540500090710
   Burjanadze TV, 2000, BIOPOLYMERS, V53, P523, DOI 10.1002/(SICI)1097-0282(200005)53:6<523::AID-BIP8>3.0.CO;2-7
   BUTLER WT, 1965, J BIOL CHEM, V240, P3449
   BUTLER WT, 1966, J BIOL CHEM, V241, P3882
   Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731
   Cui FX, 2007, FOOD CHEM, V100, P1120, DOI 10.1016/j.foodchem.2005.11.019
   Deutzmann R, 2000, DEVELOPMENT, V127, P4669
   Fowler SJ, 2000, J BIOL CHEM, V275, P39589, DOI 10.1074/jbc.M005871200
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Hiraoka Y, 2003, TISSUE ENG, V9, P1101, DOI 10.1089/10763270360728017
   Ho HO, 1997, J CONTROL RELEASE, V44, P103, DOI 10.1016/S0168-3659(96)01513-1
   JACKSON DS, 1958, BIOCHIM BIOPHYS ACTA, V27, P418, DOI 10.1016/0006-3002(58)90356-1
   Kadler KE, 1996, BIOCHEM J, V316, P1
   KIMURA S, 1981, J BIOL CHEM, V256, P3230
   KIMURA S, 1972, J BIOCHEM-TOKYO, V71, P367, DOI 10.1093/oxfordjournals.jbchem.a129777
   KIMURA S, 1983, J FOOD SCI, V48, P1758, DOI 10.1111/j.1365-2621.1983.tb05078.x
   Kittiphattanabawon P, 2005, FOOD CHEM, V89, P363, DOI 10.1016/j.foodchem.2004.02.042
   Klein AW, 2001, DERMATOL CLIN, V19, P491, DOI 10.1016/S0733-8635(05)70290-4
   Kolodziejska I, 1999, FOOD CHEM, V66, P153, DOI 10.1016/S0308-8146(98)00251-9
   KRAMP PL, 1961, J MAR BIOL ASSOC UK, V40, P7, DOI 10.1017/S0025315400007347
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   MANN K, 1992, EUR J BIOCHEM, V210, P839, DOI 10.1111/j.1432-1033.1992.tb17487.x
   MIURA S, 1985, J BIOL CHEM, V260, P5352
   Nagai T, 2000, FOOD CHEM, V70, P205, DOI 10.1016/S0308-8146(00)00081-9
   Nagai T, 2002, FOOD CHEM, V76, P149, DOI 10.1016/S0308-8146(01)00255-2
   Nagai T, 2001, FOOD CHEM, V72, P425, DOI 10.1016/S0308-8146(00)00249-1
   Nagai T, 1999, J SCI FOOD AGR, V79, P855, DOI 10.1002/(SICI)1097-0010(19990501)79:6<855::AID-JSFA299>3.3.CO;2-E
   Neklyudov AD, 2003, APPL BIOCHEM MICRO+, V39, P229, DOI 10.1023/A:1023589624514
   RIGBY BJ, 1968, NATURE, V219, P166, DOI 10.1038/219166a0
   Sadowska M, 2003, FOOD CHEM, V81, P257, DOI 10.1016/S0308-8146(02)00420-X
   Saito M, 2002, J FOOD SCI, V67, P1319, DOI 10.1111/j.1365-2621.2002.tb10281.x
   SALDANHA L, 1997, FAUNA SUBMARINA ATLN, P70
   Sivakumar P, 1998, BBA-GEN SUBJECTS, V1381, P161, DOI 10.1016/S0304-4165(98)00023-3
   Sivakumar P, 2003, COMP BIOCHEM PHYS B, V134, P171, DOI 10.1016/S1096-4959(02)00224-5
   SPIRO RG, 1980, J BIOL CHEM, V255, P5347
   TAKEMA Y, 1982, BIOCHIM BIOPHYS ACTA, V706, P123, DOI 10.1016/0167-4838(82)90382-X
   Theis ER, 1942, J BIOL CHEM, V146, P163
   Wallace DG, 2003, ADV DRUG DELIVER REV, V55, P1631, DOI 10.1016/j.addr.2003.08.004
   Young S, 2005, J CONTROL RELEASE, V109, P256, DOI 10.1016/j.jconrel.2005.09.023
   Zhang Y, 2007, FOOD CHEM, V103, P906, DOI 10.1016/j.foodchem.2006.09.053
NR 44
TC 8
Z9 9
U1 0
U2 18
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2009
VL 20
IS 14
BP 2073
EP 2087
DI 10.1163/156856208X399125
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 514XD
UT WOS:000271428700007
PM 19874678
DA 2018-10-19
ER

PT J
AU Schutte, RJ
   Parisi-Amon, A
   Reichert, WM
AF Schutte, Robert J.
   Parisi-Amon, Andreina
   Reichert, W. Monty
TI Cytokine profiling using monocytes/macrophages cultured on common
   biomaterials with a range of surface chemistries
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biomaterial; cytokine; macrophage; foreign body reaction; in vitro
ID STIMULATED HUMAN MONOCYTES; LEUKEMIA-CELL LINE; IN-VITRO; PROTEIN
   EXPRESSION; MACROPHAGES; DIFFERENTIATION; CHEMOKINES; RESPONSES; MODEL;
   THP-1
AB Cytokines, chemokines, and growth factors were assayed from the supernatants of monocytes and macrophages cultured on common biomaterials with a range Of Surface chemistries. TNF-alpha, MCP-1, MIP-1 alpha, IL-8, IL-6, IL-1 beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue Culture polystyrene (TCPS) plates. Empty TCPS wells and organo-tin polyvinyl chloride served as "blanks" and positive controls, respectively. Results showed an overall increase in cytokine, chemokine, and growth factor production as monocytes are activated or differentiated into macrophages and that proinflammatory and anti-wound healing cytokines and chemokines dominate this profile. However, cytokine production was only modestly affected by the Surface chemistry of these four stable and noncytotoxic biomaterials. (C) 2608 Wiley Periodicals, Inc. J Biomed Mater Res 88A: 128-139, 2009
C1 [Schutte, Robert J.; Parisi-Amon, Andreina; Reichert, W. Monty] Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA.
RP Reichert, WM (reprint author), Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA.
EM reichert@duke.edu
FU National Institutes of Health NIH [DK54932]; National Science Foundation
FX Contract grant sponsor: National Institutes of Health; contract grant
   number: NIH DK54932; Contract grant sponsor: National Science Foundation
CR Anderson J.M., 1994, PROB GEN SURG, V11, P147
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   AntalSzalmas P, 1997, J LEUKOCYTE BIOL, V61, P721
   AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244
   Babensee JE, 2005, J BIOMED MATER RES A, V74A, P503, DOI 10.1002/jbm.a.30429
   Brodbeck WG, 2003, J BIOMED MATER RES A, V64A, P320, DOI 10.1002/jbm.a.10425
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Dinnes DLM, 2007, J BIOMED MATER RES A, V80A, P895, DOI 10.1002/jbm.a.30967
   Foster N, 2007, J LEUKOCYTE BIOL, V81, P893, DOI 10.1189/jlb.0206086
   Godek ML, 2006, J BIOMAT SCI-POLYM E, V17, P1141, DOI 10.1163/156856206778530731
   Gretzer C, 2003, BIOMATERIALS, V24, P2843, DOI 10.1016/S0142-9612(03)00097-8
   Haeffner A, 1997, J IMMUNOL, V158, P1310
   Jones JA, 2007, J BIOMED MATER RES A, V83A, P585, DOI 10.1002/jbm.a.31221
   Kim DH, 2007, BIOMATERIALS, V28, P3369, DOI 10.1016/j.biomaterials.2007.04.010
   Lewis JB, 2005, J BIOMED MATER RES A, V74A, P474, DOI 10.1002/jmb.a.30383
   Matzelle MM, 2004, BIOMATERIALS, V25, P295, DOI 10.1016/S0142-9612(03)00531-3
   Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325
   Mukaida N, 1998, CYTOKINE GROWTH F R, V9, P9, DOI 10.1016/S1359-6101(97)00022-1
   Norton LW, 2005, BIOMATERIALS, V26, P3285, DOI 10.1016/j.biomaterials.2004.07.069
   Prichard HL, 2007, BIOMATERIALS, V28, P936, DOI 10.1016/j.biomaterials.2006.09.012
   Ramegowda B, 1996, INFECT IMMUN, V64, P1173
   ROSS GD, 1993, CLIN EXP IMMUNOL, V92, P181
   Scapini P, 2000, IMMUNOL REV, V177, P195, DOI 10.1034/j.1600-065X.2000.17706.x
   Schwende H, 1996, J LEUKOCYTE BIOL, V59, P555
   Shin BC, 2001, J BIOMAT SCI-POLYM E, V12, P467, DOI 10.1163/156856201300194216
   Song EW, 2000, CELL IMMUNOL, V204, P19, DOI 10.1006/cimm.2000.1687
   *STAND IOF, 1999, BIOL EV MED DEV
   SUNDERKOTTER C, 1994, J LEUKOCYTE BIOL, V55, P410
   Sweet MJ, 1996, J LEUKOCYTE BIOL, V60, P8
   Thomsen P, 2001, CURR OPIN SOLID ST M, V5, P163, DOI 10.1016/S1359-0286(01)00004-3
   TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208
NR 33
TC 86
Z9 87
U1 3
U2 17
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN
PY 2009
VL 88A
IS 1
BP 128
EP 139
DI 10.1002/jbm.a.31863
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 380NH
UT WOS:000261471900013
PM 18260130
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Fritsch, A
   Dormieux, L
   Hellmich, C
   Sanahuja, J
AF Fritsch, Andreas
   Dormieux, Luc
   Hellmich, Christian
   Sanahuja, Julien
TI Mechanical behavior of hydroxyapatite biomaterials: An experimentally
   validated micromechanical model for elasticity and strength
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE hydroxyapatite; biomaterials; micromechanics; elasticity; strength
ID CONTINUUM MICROMECHANICS; BONE; APATITES; POROSITY
AB Hydroxyapatite (HA) biomaterials production has been a major field in biomaterials science and biomechanical engineering. As concerns prediction of their stiffness and strength, we propose to go beyond statistical correlations with porosity or empirical structure-property relationships, as to resolve the material-immanent microstructures governing the overall mechanical behavior. The macroscopic mechanical properties are estimated from the microstructures of the materials and their composition, in a homogenization process based on Continuum micromechanics. Thereby, biomaterials are envisioned as porous polycrystals consisting of HA needles and spherical pores. Validation of respective micromechanical models relies on two independent experimental sets: biomaterial-specific macroscopic (homogenized) stiffness and uniaxial (tensile and compressive) strength predicted from biomaterial-specific porosities, on the basis of biomaterial-independent ("universal") elastic and strength properties of HA, are compared with corresponding biomaterial-specific experimentally determined (acoustic and mechanical) stiffness mid strength values. The good agreement between model predictions and the corresponding experiments underlines the potential of micromechanical modeling in improving biomaterial design, through optimization of key parameters such as porosities or geometries of microstructures, in order to reach the desired values for biomaterial stiffness or strength. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 88A: 149-161, 2009
C1 [Hellmich, Christian] Vienna Univ Technol, Inst Mech Mat & Struct, A-1040 Vienna, Austria.
   [Fritsch, Andreas; Dormieux, Luc] Ecole Natl Ponts & Chaussees, LMSGC, Lab Mat & Struct, Marne La Vallee, France.
   [Sanahuja, Julien] Lafarge Res Ctr, St Quentin Fallavier, France.
RP Hellmich, C (reprint author), Vienna Univ Technol, Inst Mech Mat & Struct, A-1040 Vienna, Austria.
EM christian.hellmich@tuwien.ac.at
CR AKAO M, 1981, J MATER SCI, V16, P809, DOI 10.1007/BF00552220
   ARITA IH, 1995, BIOMATERIALS, V16, P403, DOI 10.1016/0142-9612(95)98858-B
   ASHMAN RB, 1987, J BIOMECH, V20, P979, DOI 10.1016/0021-9290(87)90327-7
   ASHMAN RB, 1984, J BIOMECH, V17, P349, DOI 10.1016/0021-9290(84)90029-0
   BENVENISTE Y, 1987, MECH MATER, V6, P147, DOI 10.1016/0167-6636(87)90005-6
   Carcione J. M., 2001, HDB GEOPHYS EXPLORAT, V31
   Charriere E, 2001, BIOMATERIALS, V22, P2937, DOI 10.1016/S0142-9612(01)00041-2
   COWIN SC, 1992, J MECH PHYS SOLIDS, V40, P1459, DOI 10.1016/0022-5096(92)90029-2
   Cowin SC, 2003, TRANSPORT POROUS MED, V50, P35, DOI 10.1023/A:1020626717067
   DEWITH G, 1981, J MATER SCI, V16, P1592
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   DRIESSEN AA, 1982, BIOMATERIALS, V3, P113
   ESHELBY JD, 1957, P ROY SOC LOND A MAT, V241, P396
   FRAME JW, 1981, BIOMATERIALS, V2, P19, DOI 10.1016/0142-9612(81)90082-X
   Fritsch A, 2006, CR MECANIQUE, V334, P151, DOI 10.1016/j.crme.2006.01.008
   Fritsch A, 2007, J THEOR BIOL, V244, P597, DOI 10.1016/j.jtbi.2006.09.013
   GILMORE RS, 1982, J MATER SCI, V17, P1131, DOI 10.1007/BF00543533
   Hashin Z, 1962, J APPL MECH, V29, P143, DOI DOI 10.1115/1.3636446
   Hellmich C, 2004, EUR J MECH A-SOLID, V23, P783, DOI 10.1016/j.euromechsol.2004.05.004
   Hellmich C, 2002, J ENG MECH-ASCE, V128, P898, DOI 10.1061/(ASCE)0733-9399(2002)128:8(898)
   HERSHEY AV, 1954, J APPL MECH-T ASME, V21, P236
   HILL R, 1963, J MECH PHYS SOLIDS, V11, P357, DOI 10.1016/0022-5096(63)90036-X
   Hofstetter K., 2006, Computer Assisted Mechanics and Engineering Sciences, V13, P523
   Hofstetter K, 2005, EUR J MECH A-SOLID, V24, P1030, DOI 10.1016/j.euromechsol.2005.05.006
   Jones J.R., 2005, BIOMATERIALS ARTIFIC
   KATZ JL, 1971, J BIOMECH, V4, P221, DOI 10.1016/0021-9290(71)90007-8
   KATZ JL, 1990, CONCISE ENCY MED DEN, P87
   Kolsky H, 1953, STRESS WAVES SOLIDS
   KRONER E, 1958, Z PHYS, V151, P504, DOI 10.1007/BF01337948
   Liu DM, 1998, CERAM INT, V24, P441, DOI 10.1016/S0272-8842(97)00033-3
   MARTIN RI, 1995, J MATER SCI-MATER M, V6, P138, DOI 10.1007/BF00120289
   Mastrogiacomo M, 2006, BIOMATERIALS, V27, P3230, DOI 10.1016/j.biomaterials.2006.01.031
   MAYR E, 1997, THIS IS BIOL SCI LIV
   MORI T, 1973, ACTA METALL MATER, V21, P571, DOI 10.1016/0001-6160(73)90064-3
   Peelen J. G. J., 1978, Ceramurgia International, V4, P71, DOI 10.1016/0390-5519(78)90122-9
   PICHLER B, 2007, INT J NUMERICAL ANAL, V31, P11
   Pichler B, 2007, BIFURCATIONS, INSTABILITIES, DEGRADATION IN GEOMECHANICS, P245, DOI 10.1007/978-3-540-49342-6_12
   RAO WR, 1974, J DENT RES, V53, P1351, DOI 10.1177/00220345740530061001
   SALENCON J, 2001, HDB CONTINUUM MECH G
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Schreiber E., 1973, ELASTIC CONSTANTS TH
   SHAREEF MY, 1993, BIOMATERIALS, V14, P69, DOI 10.1016/0142-9612(93)90078-G
   SUQUET P, CONTINUUM MICROMECHA
   Verma D, 2006, J BIOMED MATER RES A, V78A, P772, DOI 10.1002/jbm.a.30774
   Woodard JR, 2007, BIOMATERIALS, V28, P45, DOI 10.1016/j.biomaterials.2006.08.021
   Yunoki S, 2006, MATER LETT, V60, P999, DOI 10.1016/j.matlet.2005.10.064
   Zaoui A, 2002, J ENG MECH-ASCE, V128, P808, DOI 10.1061/(ASCE)0733-9399(2002)128:8(808)
NR 47
TC 59
Z9 60
U1 1
U2 18
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN
PY 2009
VL 88A
IS 1
BP 149
EP 161
DI 10.1002/jbm.a.31727
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 380NH
UT WOS:000261471900015
PM 18286602
DA 2018-10-19
ER

PT J
AU Wilshaw, SP
   Burke, D
   Fisher, J
   Ingham, E
AF Wilshaw, Stacy-Paul
   Burke, Dermot
   Fisher, John
   Ingham, Eileen
TI Investigation of the Antiadhesive Properties of Human Mesothelial Cells
   Cultured In Vitro on Implantable Surgical Materials
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE adhesions; cell interactions; biomaterials; mesothelial cells; cell
   culture
ID SMALL-INTESTINAL SUBMUCOSA; ABDOMINAL-WALL RECONSTRUCTION; POLYPROPYLENE
   MESH; REPAIR; BIOMATERIAL; PERMACOL; MODEL; DOG
AB The aim of the study was to evaluate the interactions of Permacol, Prolene mesh, Surgisis Gold, and Alloderm with human mesothelial cells in vitro. The capacity of primary human mesothelial cells to adhere to the surface of Alloderm, Surgisis Gold, Prolene mesh, and Permacol as well as support the proliferation and viability of the seeded cells was determined. Production of antifibrinolytic, fibrinolytic, and inflammatory mediators (IL-8, TPA, MMP-1, PAI-1, and TGF-beta) was assessed over an 8-day period. The adhesive nature of the implantable materials was determined by assessment of the strength of any fibrin clots formed between two surfaces of each implant material. Surgisis Gold and Permacol were capable of supporting the attachment and proliferation of primary human mesothelial cells and maintaining viability over an 8-day culture period. Mesothelial cells were shown to have covered the surface of Permacol and Surgisis Gold in a monolayer. The viability of cells cultured on Permacol was significantly greater than the other implant materials tested. Mesothelial cells cultured on Permacol or Surgisis were shown to be producing high levels of fibrinolytic compounds and low levels of antifibrinolytic and inflammatory mediators. Alloderm was shown to produce high levels of IL-8 and antifibrinolytic mediators when compared with the other implantable materials. Permacol was shown to be an unreliable surface for clot formation in vitro and any clots formed were shown to be significantly weaker than the clots produced between two surfaces of tissue culture plastic, Prolene mesh, Alloderm, and Surgisis Gold. This in vitro study indicated that Permacol and Surgisis Gold supported the growth and fibrinolytic activity of human mesothelial cells; however, Permacol was shown to be superior in this respect. 0 2008 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 89B: 49-60, 2009
C1 [Wilshaw, Stacy-Paul; Ingham, Eileen] Univ Leeds, Inst Med & Biol Engn, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England.
   [Burke, Dermot] Gen Infirm, Dept Colorectal Surg, Leeds LS1 3EX, W Yorkshire, England.
   [Fisher, John] Univ Leeds, Inst Med & Biol Engn, Fac Engn, Leeds LS2 9JT, W Yorkshire, England.
RP Wilshaw, SP (reprint author), Univ Leeds, Inst Med & Biol Engn, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England.
EM s.wilshaw@leeds.ac.uk
OI Wilshaw, Stacy-Paul/0000-0002-7599-8165
FU Tissue Science Laboratories
FX Contract grant sponsor: Tissue Science Laboratories
CR BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   Bittinger F, 1999, J SURG RES, V82, P28, DOI 10.1006/jsre.1998.5449
   Clarke KM, 1996, J SURG RES, V60, P107, DOI 10.1006/jsre.1996.0018
   El-Ghalbzouri A, 2002, BRIT J DERMATOL, V147, P230, DOI 10.1046/j.1365-2133.2002.04871.x
   Harper C, 2001, HOSP MED, V62, P90, DOI 10.12968/hosp.2001.62.2.2379
   Herrick SE, 2004, INT J BIOCHEM CELL B, V36, P621, DOI 10.1016/j.biocel.2003.11.002
   Holl-Allen R T, 1984, J R Coll Surg Edinb, V29, P151
   Holl-Allen R T, 1984, J R Coll Surg Edinb, V29, P154
   Kaleya Ronald N, 2005, Hernia, V9, P269, DOI 10.1007/s10029-005-0003-0
   Konstantinovic ML, 2005, BJOG-INT J OBSTET GY, V112, P1554, DOI 10.1111/j.1471-0528.2005.00688.x
   Liyanage SH, 2006, J PLAST RECONSTR AES, V59, P553, DOI 10.1016/j.bjps.2005.06.008
   Mathes SJ, 2000, ANN SURG, V232, P586, DOI 10.1097/00000658-200010000-00014
   Mutsaers SE, 1997, EUR J CELL BIOL, V72, P24
   Mutsaers SE, 2002, RESPIROLOGY, V7, P171, DOI 10.1046/j.1440-1843.2002.00404.x
   Mutsaers SE, 2004, INT J BIOCHEM CELL B, V36, P9, DOI 10.1016/S1357-2725(03)00242-5
   Pachence JM, 1996, J BIOMED MATER RES, V33, P35, DOI 10.1002/(SICI)1097-4636(199621)33:1<35::AID-JBM6>3.0.CO;2-N
   PREVEL CD, 1995, ANN PLAS SURG, V35, P374, DOI 10.1097/00000637-199510000-00008
   Saray A, 2003, AESTHET PLAST SURG, V27, P368, DOI 10.1007/s00266-003-3012-3
   Sokal R. R., 2001, BIOMETRY
   Standeven KF, 2002, DIABETES, V51, P189, DOI 10.2337/diabetes.51.1.189
   STYLIANOU E, 1990, KIDNEY INT, V37, P1563, DOI 10.1038/ki.1990.150
   Sulaiman H, 2002, BIOCHEM SOC T, V30, P126, DOI 10.1042/BST0300126
   Vrijland WW, 2000, BRIT J SURG, V87, P348, DOI 10.1046/j.1365-2168.2000.01364.x
   WAINWRIGHT DJ, 1995, BURNS, V21, P243, DOI 10.1016/0305-4179(95)93866-I
   Yung S, 2006, PERITON DIALYSIS INT, V26, P162
NR 26
TC 11
Z9 13
U1 0
U2 4
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JAN
PY 2009
VL 88B
IS 1
BP 49
EP 60
DI 10.1002/jbm.b.31148
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 386PO
UT WOS:000261895300006
PM 18546180
DA 2018-10-19
ER

PT J
AU Mukherjee, DP
   Smith, DF
   Rogers, SH
   Emmanual, JE
   Jadin, KD
   Hayes, BK
AF Mukherjee, Debi P.
   Smith, Dollie F.
   Rogers, Shelia H.
   Emmanual, Janson E.
   Jadin, Kyle D.
   Hayes, Byron K.
TI Effect of 3D-Microstructure of Bioabsorbable PGA:TMC Scaffolds on the
   Growth of Chondrogenic Cells
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE bioabsorbable scaffold; chondrogenesis; tissue engineering; biochemical
   analysis; mesenchymal stroma cells; collagen typing; aggrecans
ID MARROW STROMAL CELLS; IN-VITRO; POLYMER MATRICES; CHONDROCYTES;
   CARTILAGE; POLY(L-LACTIDE); ATTACHMENT; ADHESION; COLLAGEN; PLATES
AB Various biomaterial scaffolds have been investigated for cartilage tissue engineering, although little attention has been paid to the effect of scaffold microstructure on tissue growth. Non-woven, fibrous, bioabsorbable scaffolds constructed from a copolymer of glycolide and trimethylene carbonate with varying levels of porosity and pore size were seeded with mesenchymal stroma cells with a chondrogenic lineage. Scaffolds and media were evaluated for both cell and extracellular matrix organization and content after up to 28 days of culture in a spinner flask. Analysis of DNA and glycosaminoglycan contents showed that the most porous of the three scaffold types, with a porosity of 81 % and a porometry determined mean flow pore diameter of 54 mu m, supported the most rapid proliferation of cells and accumulation of extracellular matrix. Analysis of the high porosity scaffold system, using Western Blot and immunohistochemistry confirmed the presence of collagen type It and absence of collagen type 1, and demonstrated cells with a chondrocyte morphology with aggrecan and collagen 11 accumulation attached to the scaffolds. It was concluded that the 3D-microstructural characteristics of the scaffold (interconnecting porosity and pore size) play an important role in proliferation and phenotype of chondrogenic cells and accumulation of extracellular matrix molecules. (c) 2008 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 88B: 92-102, 2009
C1 [Mukherjee, Debi P.; Smith, Dollie F.; Rogers, Shelia H.] Louisiana State Univ, Hlth Sci Ctr, Dept Orthopaed Surg, Shreveport, LA 71130 USA.
   [Emmanual, Janson E.; Jadin, Kyle D.; Hayes, Byron K.] WL Gore & Assoc Inc, Flagstaff, AZ USA.
RP Mukherjee, DP (reprint author), Louisiana State Univ, Hlth Sci Ctr, Dept Orthopaed Surg, Shreveport, LA 71130 USA.
EM dmukhe@lsuhsc.edu
FU W.L. Gore & Associates, Inc.. Flagstaff, Arizona, USA
FX Contract grant sponsor: W.L. Gore & Associates, Inc.. Flagstaff,
   Arizona, USA.
CR ATTAWIA MA, 1995, BIOCHEM BIOPH RES CO, V213, P639, DOI 10.1006/bbrc.1995.2179
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   BERGSMA JE, 1995, BIOMATERIALS, V16, P25, DOI 10.1016/0142-9612(95)91092-D
   Berry CC, 2004, BIOMATERIALS, V25, P5781, DOI 10.1016/j.biomaterials.2004.01.029
   Bhati RS, 2001, J BIOMED MATER RES, V56, P74, DOI 10.1002/1097-4636(200107)56:1<74::AID-JBM1070>3.0.CO;2-M
   BOSTMAN O, 1990, J BONE JOINT SURG BR, V72, P592
   CIMA LG, 1991, J BIOMECH ENG-T ASME, V113, P143, DOI 10.1115/1.2891228
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   DRURY RAB, 1980, CARLETONS HISTOLOGIC, P246
   Evans MDM, 1997, EXP CELL RES, V233, P88, DOI 10.1006/excr.1997.3523
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   Grad S, 2003, J BIOMED MATER RES A, V66A, P571, DOI 10.1002/jbm.a.10007
   Gugala Z, 2000, J BIOMED MATER RES, V49, P183, DOI 10.1002/(SICI)1097-4636(200002)49:2<183::AID-JBM5>3.0.CO;2-D
   HOLLANDER AP, 1994, J CLIN INVEST, V93, P1722, DOI 10.1172/JCI117156
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   Javazon EH, 2001, STEM CELLS, V19, P219, DOI 10.1634/stemcells.19-3-219
   Jones JR, 2006, J MATER SCI-MATER M, V17, P989, DOI 10.1007/s10856-006-0434-x
   KATZ AR, 1985, SURG GYNECOL OBSTET, V161, P213
   KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5
   Laurencin CT, 1996, BONE, V19, pS93, DOI 10.1016/S8756-3282(96)00132-9
   LUNA LG, 1992, HISTOPATHOLOGICAL ME, P456
   Muschler GE, 2004, J BONE JOINT SURG AM, V86A, P1541, DOI 10.2106/00004623-200407000-00029
   Prockop DJ, 2001, SCIENCE, V293, P211
   PUELACHER WC, 1994, INT J ORAL MAX SURG, V23, P49, DOI 10.1016/S0901-5027(05)80328-5
   Schreiber RE, 2000, METH MOL B, V139, P301
   Schwarz EJ, 2001, GENE THER, V8, P1214, DOI 10.1038/sj.gt.3301517
   Sekiya I, 2002, P NATL ACAD SCI USA, V99, P4397, DOI 10.1073/pnas.052716199
   Sittinger M, 1996, J BIOMED MATER RES, V33, P57, DOI 10.1002/(SICI)1097-4636(199622)33:2<57::AID-JBM1>3.0.CO;2-K
   Suuronen R, 1998, J ORAL MAXIL SURG, V56, P604, DOI 10.1016/S0278-2391(98)90461-X
   VERHEYEN CCPM, 1993, J BIOMED MATER RES, V27, P1115, DOI 10.1002/jbm.820270817
   Zeltinger J, 2001, TISSUE ENG, V7, P557, DOI 10.1089/107632701753213183
NR 31
TC 14
Z9 14
U1 1
U2 8
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JAN
PY 2009
VL 88B
IS 1
BP 92
EP 102
DI 10.1002/jbm.b.31155
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 386PO
UT WOS:000261895300011
PM 18546178
DA 2018-10-19
ER

PT J
AU Engelsman, AF
   van der Mei, HC
   Francis, KP
   Busscher, HJ
   Ploeg, RJ
   van Dam, GM
AF Engelsman, Anton F.
   van der Mei, Henny C.
   Francis, Kevin P.
   Busscher, Henk J.
   Ploeg, Rutger J.
   van Dam, Gooitzen M.
TI Real Time Noninvasive Monitoring of Contaminating Bacteria in a Soft
   Tissue Implant Infection Model
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE bioluminescent imaging; in vivo infection; animal model; implant
   infection; biofilm
ID IN-VIVO; POLYMERIC SURFACE; BIOFILM INFECTION; MOUSE MODEL; REPAIR; MICE
AB Infection is the main cause of biomaterials-related failure. A simple technique to test in-vivo new antimicrobial and/or nonadhesive implant coatings is unavailable. Current in vitro methods for studying bacterial adhesion and growth on biomaterial surfaces lack the influence of the host immune system. Most in vivo methods to study biomaterials-related infections routinely involve implant-removal, preventing comprehensive longitudinal monitoring. In vivo imaging circumvents these drawbacks and is based on the use of noninvasive optical imaging of bioluminescent bacteria. Staphylococcus aureus Xen29 is genetically modified to be stably bioluminescent, by the introduction of a modified full lux operon onto its chromosome. Surgical meshes with adhering S. aureus Xen29 were implanted in mice and bacterial growth and spread into the surrounding tissue was monitored longitudinally from bioluminescence with a highly sensitive CCD camera. Distinct spatiotemporal bioluminescence patterns, extending beyond the mesh area into surrounding tissues were observed. After 10 days, the number of living organisms isolated from explanted meshes was found to correlate with bioluminescence prior to sacrifice of the animals. Therefore, it is concluded that in vivo imaging using bioluminescent bacteria is ideally suited to study antimicrobial coatings taking into account the host immune system. In addition, longitudinal monitoring of infection in one animal will significantly reduce the number of experiments and animals. (c) 2008 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 88B: 123-129, 2009
C1 [Engelsman, Anton F.; van der Mei, Henny C.; Busscher, Henk J.] Univ Med Ctr Groningen, Dept Biomed Engn, Groningen, Netherlands.
   [Engelsman, Anton F.; van der Mei, Henny C.; Francis, Kevin P.; Busscher, Henk J.; Ploeg, Rutger J.; van Dam, Gooitzen M.] Univ Groningen, NL-9700 AB Groningen, Netherlands.
   [Francis, Kevin P.; Ploeg, Rutger J.; van Dam, Gooitzen M.] Univ Med Ctr Groningen, Dept Surg, Groningen, Netherlands.
   [Francis, Kevin P.; van Dam, Gooitzen M.] Univ Med Ctr Groningen, Bioopt Imaging Ctr Groningen, Groningen, Netherlands.
RP Busscher, HJ (reprint author), Univ Med Ctr Groningen, Dept Biomed Engn, Groningen, Netherlands.
EM h.j.busscher@med.umcg.nl
CR Broekhuizen CAN, 2007, INFECT IMMUN, V75, P1129, DOI 10.1128/IAI.01262-06
   Carbajo M A, 2000, JSLS, V4, P141
   Contag PR, 1998, NAT MED, V4, P245, DOI 10.1038/nm0298-245
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Davidson CAB, 2004, J MOL RECOGNIT, V17, P180, DOI 10.1002/jmr.662
   Engelsman AF, 2007, BIOMATERIALS, V28, P2314, DOI 10.1016/j.biomaterials.2007.01.028
   Francis KP, 2000, INFECT IMMUN, V68, P3594, DOI 10.1128/IAI.68.6.3594-3600.2000
   Gottenbos B, 2003, BIOMATERIALS, V24, P2707, DOI 10.1016/S0142-9612(03)00083-8
   Gottenbos B, 2002, J MATER SCI-MATER M, V13, P717, DOI 10.1023/A:1016175502756
   GRISTINA A G, 1988, Medical Progress Through Technology, V14, P205
   Heniford BT, 2003, ANN SURG, V238, P391, DOI 10.1097/01.sla.0000086662.49499.ab
   Jenkins DE, 2003, CLIN EXP METASTAS, V20, P733, DOI 10.1023/B:CLIN.0000006815.49932.98
   Kadurugamuwa JL, 2003, ANTIMICROB AGENTS CH, V47, P3130, DOI 10.1128/AAC.47.10.3130-3137.2003
   Kadurugamuwa JL, 2003, INFECT IMMUN, V71, P882, DOI 10.1128/IAI.71.2.882-890.2003
   Klinge U, 2002, J BIOMED MATER RES, V63, P765, DOI 10.1002/jbm.10449
   Kuklin NA, 2003, ANTIMICROB AGENTS CH, V47, P2740, DOI 10.1128/AAC.47.9.2740-2748.2003
   Monzon M, 2001, J ORTHOPAED RES, V19, P820, DOI 10.1016/S0736-0266(00)00076-0
   Moriyama Y, 2005, PHOTOCHEM PHOTOBIOL, V81, P1351, DOI 10.1562/2005-02-28-RA-450
   Mouchess ML, 2006, J COMPUT ASSIST TOMO, V30, P525, DOI 10.1097/00004728-200605000-00030
   Parveen A, 2001, FEMS MICROBIOL LETT, V199, P115, DOI 10.1016/S0378-1097(01)00169-0
   Petersen S, 2001, EUR J SURG, V167, P453
   Rice BW, 2001, J BIOMED OPT, V6, P432, DOI 10.1117/1.1413210
   Rocchetta HL, 2001, ANTIMICROB AGENTS CH, V45, P129, DOI 10.1128/AAC.45.1.129-137.2001
NR 23
TC 40
Z9 42
U1 1
U2 13
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JAN
PY 2009
VL 88B
IS 1
BP 123
EP 129
DI 10.1002/jbm.b.31158
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 386PO
UT WOS:000261895300014
PM 18618733
DA 2018-10-19
ER

PT J
AU Schopka, S
   Schmid, FX
   Hirt, S
   Birnbaum, DE
   Schmid, C
   Lehle, K
AF Schopka, Simon
   Schmid, Franz-Xaver
   Hirt, Stephan
   Birnbaum, Dietrich E.
   Schmid, Christof
   Lehle, Karla
TI Recellularization of Biological Heart Valves With Human Vascular Cells:
   In Vitro Hemocompatibility Assessment
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE endothelial cells; decellularized bovine pericardium; functional
   analysis; preseeding; fibroblasts; cardiovascular tissue engineering;
   hemocompatibility
ID ENDOTHELIAL-CELLS; PLATELET-ADHESION; AORTIC VALVES; TISSUE; EXPERIENCE;
   GLUTARALDEHYDE; BIOPROSTHESES; MODEL; CALCIFICATION; REPLACEMENT
AB Coverage of cardiovascular bioprostheses with autologous endothelium is used for the purpose of improving blood compatibility. The aim of our study was to analyze endothelialization potential of glutaraldehyde-fixed heart valves, cellular functions of seeded endothelial cells (EC), and the impact of a two-stage seeding protocol using human vascular fibroblasts (FB) and EC from saphenous veins (HSVEC) on cellular functional properties in vitro. Adherence and morphology of adhered cells were assessed by scanning electronic microscopy and immunohistochemistry. Reproducible, complete surface coverage with EC was established on decellularized and glutaraldehyde-fixed bovine pericardium. Analyzing functional properties of cells directly adhered to biomaterial revealed nonproliferative cells, which were capable of inflammatory Stimulation in terms of TNF-induced increase in interleukin-6 secretion and adhesion or inflammatory cells. Furthermore, EC showed sustained antithrombotic properties quantified by platelet adhesion onto EC and prostacyclin secretion by EC. Preseeding with vascular fibroblasts using a two-stage seeding protocol induced EC proliferation and improved inflammatory and anti-thrombotic functions. Cardiovascular biomaterials differ significantly in their potential to allow for adhesion of human EC. Successfully endothelialized biomaterial, however, revealed cellular properties which are likely to be favorable to improving performance of biomaterials. Two-stage seeding adds regenerative potential and improves cell functions of adherent EC. (c) 2008 Wiley Periodicals. Inc. J Biomed Mater Res Part B: Appl Biomater 88B: 130-138. 2009
C1 [Schopka, Simon; Schmid, Franz-Xaver; Hirt, Stephan; Birnbaum, Dietrich E.; Schmid, Christof; Lehle, Karla] Univ Regensburg Hosp, Dept Cardiothorac Surg, D-93042 Regensburg, Germany.
RP Lehle, K (reprint author), Univ Regensburg Hosp, Dept Cardiothorac Surg, D-93042 Regensburg, Germany.
EM Karla.Lehle@klinik.uni-regensburg.de
CR BENGTSSON L, 1993, J THORAC CARDIOV SUR, V106, P434
   CANNEGIETER SC, 1994, CIRCULATION, V89, P635, DOI 10.1161/01.CIR.89.2.635
   Chennazhy KP, 2005, BIOMATERIALS, V26, P5658, DOI 10.1016/j.biomaterials.2005.02.024
   DECLERCK LS, 1994, J IMMUNOL METHODS, V172, P115, DOI 10.1016/0022-1759(94)90384-0
   Dohmen PM, 2007, ANN THORAC SURG, V84, P729, DOI 10.1016/j.athoracsur.2007.04.072
   Emery RW, 2005, ANN THORAC SURG, V79, P776, DOI 10.1016/j.athoracsur.2004.08.047
   Fang NT, 2007, CHINESE MED J-PEKING, V120, P696
   Fann JI, 1996, ANN THORAC SURG, V62, P1301, DOI 10.1016/0003-4975(96)00629-7
   FISCHLEIN T, 1992, TRANSPL P, V24, P2988
   Fischlein T, 1996, J HEART VALVE DIS, V5, P58
   Grabenwoger M, 1996, ANN THORAC SURG, V62, P772
   GRENIER G, 2003, IN VITRO CELL DEV-AN, V39, P131, DOI DOI 10.1007/S11626-003-0007-Y
   Gulbins H, 2006, ANN THORAC SURG, V81, P1472, DOI 10.1016/j.athoracsur.2005.11.011
   Gulbins H, 2005, ANN THORAC SURG, V79, P2119, DOI 10.1016/j.athorascur.2004.05.085
   Gulbins H, 2005, THORAC CARDIOV SURG, V53, P96, DOI 10.1055/s-2004-830325
   Gulbins H, 2003, J THORAC CARDIOV SUR, V126, P890, DOI 10.1016/S0022-5223(03)00609-3
   Gulbins H, 2003, J THORAC CARDIOV SUR, V125, P592, DOI 10.1067/mtc.2003.48
   HOFFMAN D, 1992, CIRCULATION, V86, P75
   Human P, 2001, ANN THORAC SURG, V71, pS385, DOI 10.1016/S0003-4975(01)02492-4
   Kasimir MT, 2005, THROMB HAEMOSTASIS, V94, P562, DOI 10.1160/TH05-01-0025
   Kim SS, 2006, EXP MOL MED, V38, P273, DOI 10.1038/emm.2006.33
   Lehle K, 2007, BIOCHEM BIOPH RES CO, V357, P308, DOI 10.1016/j.bbrc.2007.03.147
   Lehner G, 1997, EUR J CARDIO-THORAC, V11, P498, DOI 10.1016/S1010-7940(96)01096-2
   Levi M, 2004, CIRCULATION, V109, P2698, DOI 10.1161/01.CIR.0000131660.51520.9A
   Leyh RG, 2006, ANN THORAC SURG, V81, P1466, DOI 10.1016/j.athoracsur.2005.08.083
   McGuigan AP, 2007, BIOMATERIALS, V28, P2547, DOI 10.1016/j.biomaterials.2007.01.039
   Mendelson K, 2006, ANN BIOMED ENG, V34, P1799, DOI 10.1007/s10439-006-9163-z
   Remy-Zolghadri M, 2004, J VASC SURG, V39, P613, DOI 10.1016/j.jvs.2003.08.007
   Schmidt D, 2007, CIRCULATION, V116, pI64, DOI 10.1161/CIRCULATIONAHA.106.6806637
   Schoen FJ, 2005, ANN THORAC SURG, V79, P1072, DOI 10.1016/j.athoracsur.2004.06.033
   Schoen FJ, 1999, J BIOMED MATER RES, V47, P439, DOI 10.1002/(SICI)1097-4636(19991215)47:4<439::AID-JBM1>3.0.CO;2-O
   Simon P, 2003, EUR J CARDIO-THORAC, V23, P1002, DOI 10.1016/S1010-7940(03)00094-0
   Sodian R, 2000, CIRCULATION, V102, P22
   Sozzani Silvano, 2004, Methods Mol Biol, V239, P1
   Stevens Joanne M, 2004, Methods Mol Biol, V272, P145
   Trantina-Yates AE, 2001, BIOMATERIALS, V22, P1837, DOI 10.1016/S0142-9612(00)00365-3
   YACOUB M, 1995, J THORAC CARDIOV SUR, V110, P186, DOI 10.1016/S0022-5223(05)80025-X
   Yacoub N, 2005, NAT CLIN PRACT CARD, V2, P60, DOI 10.1038/ncpcardio0112
NR 38
TC 17
Z9 17
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JAN
PY 2009
VL 88B
IS 1
BP 130
EP 138
DI 10.1002/jbm.b.31159
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 386PO
UT WOS:000261895300015
PM 18615474
DA 2018-10-19
ER

PT J
AU Imen, EH
   Nakamura, M
   Mie, M
   Kobatake, E
AF Imen, Elloumi Hannachi
   Nakamura, Makiko
   Mie, Masayasu
   Kobatake, Eiry
TI Construction of multifunctional proteins for tissue engineering:
   Epidermal growth factor with collagen binding and cell adhesive
   activities
SO JOURNAL OF BIOTECHNOLOGY
LA English
DT Article
DE Epidermal growth factor; Cell adhesion; Fusion protein; Hydrophobic
   structure; Collagen binding
ID FACTOR FUSION PROTEIN; BOVINE PROPOLYPEPTIDE; VONWILLEBRAND-FACTOR;
   IN-VIVO; FIBRONECTIN; REPAIR; DOMAIN; BIOMATERIALS; MIGRATION; HYDROGELS
AB The development of different techniques based oil natural and polymeric scaffolds are useful for the design of different biomimetic materials. These approaches. however. require Supplementary steps for the chemical or physical modification of the biomaterial. To avoid Such steps, in the present study, we constructed a new multifunctional protein that can he easily immobilized onto hydrophobic surfaces, and at the same time helps enhance specific cell adhesion and proliferation onto collagen Substrates. A collagen binding domain was Fused to a previously constructed protein, which had an epidermal growth factor fused to a hydrophobic peptide that allows for cell adhesion. The new fusion protein. designated fnCBD-ERE-EGF is produced in Escherichia coli. and its abilities to bind to collagen and promote cell proliferation were investigated. fnCBD-ERE-EGF was shown to keep both collagen binding and cell growth-promoting activities comparable to those of the corresponding unfused proteins. The results obtained in this study also Suggest the use of a fnCBD-ERE-EGF as an alternative for the design of multifunctional ECM-bound growth factor based materials. (c) 2008 Elsevier B.V. All rights reserved.
C1 [Imen, Elloumi Hannachi; Nakamura, Makiko; Mie, Masayasu; Kobatake, Eiry] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Informat, Midori Ku, Yokohama, Kanagawa 2268501, Japan.
RP Kobatake, E (reprint author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Informat, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268501, Japan.
EM ekobatak@bio.titech.ac.jp
RI Elloumi-Hannachi, Imen/A-9881-2010; Mie, Masayasu/C-5995-2015
OI Mie, Masayasu/0000-0003-2255-3346; Hannachi, Imen/0000-0002-8663-384X
CR Altroff H, 2001, J BIOL CHEM, V276, P38885, DOI 10.1074/jbc.M105868200
   Andrades JA, 2001, PROTOPLASMA, V218, P95, DOI 10.1007/BF01288365
   ANDREE C, 1994, P NATL ACAD SCI USA, V91, P12188, DOI 10.1073/pnas.91.25.12188
   AOTA S, 1994, J BIOL CHEM, V269, P24756
   Bello Y M, 2001, Am J Clin Dermatol, V2, P305, DOI 10.2165/00128071-200102050-00005
   Ellis DL, 1996, BIOMATERIALS, V17, P291, DOI 10.1016/0142-9612(96)85567-0
   Elloumi I, 2006, BIOMATERIALS, V27, P3451, DOI 10.1016/j.biomaterials.2006.02.003
   Gobin AS, 2002, FASEB J, V16, P751, DOI 10.1096/fj.01-0759fje
   Halstenberg S, 2002, BIOMACROMOLECULES, V3, P710, DOI 10.1021/bm015629o
   HOYER LW, 1981, BLOOD, V58, P1
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   Ishikawa T, 2001, J BIOCHEM-TOKYO, V129, P627, DOI 10.1093/oxfordjournals.jbchem.a002900
   Juncosa-Melvin N, 2006, TISSUE ENG, V12, P681, DOI 10.1089/ten.2006.12.681
   Kato K, 2007, BIOCONJUGATE CHEM, V18, P2137, DOI 10.1021/bc700259g
   Kobatake E, 2000, BIOMACROMOLECULES, V1, P382, DOI 10.1021/bm000284f
   Lutolf MP, 2003, BIOMACROMOLECULES, V4, P713, DOI 10.1021/bm025744e
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   MASSIA SP, 1992, J BIOL CHEM, V267, P14019
   Nimni ME, 1997, BIOMATERIALS, V18, P1201, DOI 10.1016/S0142-9612(97)00050-1
   Sakiyama-Elbert SE, 2001, ANN REV MATER RES, V31, P183, DOI 10.1146/annurev.matsci.31.1.183
   TAKAGI J, 1992, BIOCHEMISTRY-US, V31, P8530, DOI 10.1021/bi00151a021
   TAKAGI J, 1991, J BIOL CHEM, V266, P5575
   Tieliewuhan Y, 2004, DENT MATER J, V23, P258, DOI 10.4012/dmj.23.258
   Tirrell M, 2002, SURF SCI, V500, P61, DOI 10.1016/S0039-6028(01)01548-5
   Voigt DW, 2006, WOUNDS, V18, P1
   West JL, 1999, MACROMOLECULES, V32, P241, DOI 10.1021/ma981296k
   Wong JY, 2002, BIOMATERIALS, V23, P3865, DOI 10.1016/S0142-9612(02)00127-8
NR 28
TC 19
Z9 19
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1656
J9 J BIOTECHNOL
JI J. Biotechnol.
PD JAN 1
PY 2009
VL 139
IS 1
BP 19
EP 25
DI 10.1016/j.jbiotec.2008.09.011
PG 7
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 399JG
UT WOS:000262795600004
PM 18984018
DA 2018-10-19
ER

PT J
AU Shinya, N
   Oka, S
   Miyabashira, S
   Kaetsu, H
   Uchida, T
   Sueyoshi, M
   Takase, K
   Akuzawa, M
   Miyamoto, A
   Shigaki, T
AF Shinya, Noriko
   Oka, Shirou
   Miyabashira, Sumika
   Kaetsu, Hiroshi
   Uchida, Takanori
   Sueyoshi, Masuo
   Takase, Kozo
   Akuzawa, Masao
   Miyamoto, Atsushi
   Shigaki, Takamichi
TI Improvement of the Tissue-adhesive and Sealing Effect of Fibrin Sealant
   Using Polyglycolic Acid Felt
SO JOURNAL OF INVESTIGATIVE SURGERY
LA English
DT Article
DE fibrin sealant; polyglycolic acid felt; biocompatibility; biomaterial;
   adhesive force; sealing effect
ID CEREBROSPINAL-FLUID LEAKAGE; CLINICAL-APPLICATIONS; DEVICE; GLUE
AB Although fibrin sealant (FS) has an advantage of high biocompatibility, its adhesive force and sealing effect have been generally considered to be inadequate. In the present study, a high adhesive force and sealing effect were obtained by first rubbing fibrinogen solution into the target tissue, attaching polyglycolic acid (PGA) felt to the treated area, and finally spraying it with FS. This method was compared with three conventional FS application methods and a method using fibrin glue-coated collagen fleece. The adhesive force resulting from the present method was 12 times higher than that for the sequential application method, 4.5 times higher than the spray method, 2.5 times higher than the rubbing and spray method, and 2.2 times higher than the use of fibrin glue-coated collagen fleece. The high adhesive force of FS with PGA felt seemed to be due the high fibrin content of the fibrin gel (FG). Light and electron microscopic observations suggested that the formation of FG in closer contact with the muscle fibers was a factor contributing to this superior adhesive force. Comparison of the sealing effect of the present method with other methods using various biomaterials in combination with FS showed that the sealing effect of FS with PGA felt was 1.4 times higher that of polyglactin 910, 1.8 times that of polytetrafluoroethylene, and 6.7 times that of oxidized regenerated cellulose.
C1 [Shinya, Noriko; Oka, Shirou; Miyabashira, Sumika; Kaetsu, Hiroshi; Uchida, Takanori; Shigaki, Takamichi] Chemosero Therapeut Res Inst KAKETSUKEN, Kumamoto 8691298, Japan.
   [Sueyoshi, Masuo] Miyazaki Univ, Nishi Miyazaki 8892192, Japan.
   [Takase, Kozo; Akuzawa, Masao; Miyamoto, Atsushi] Kagoshima Univ, Kagoshima 8690065, Japan.
RP Shinya, N (reprint author), Chemosero Therapeut Res Inst KAKETSUKEN, 1314-1 Kyokushikawabe, Kumamoto 8691298, Japan.
EM shinya@kaketsuken.or.jp
CR BASU S, 1995, ANN THORAC SURG, V60, P1255, DOI 10.1016/0003-4975(95)00599-G
   Blomback B, 1956, ARK KEMI, V10, P415
   Chang Huang, 1992, Journal of the Formosan Medical Association, V91, P601
   Fukunaga N, 1998, INT J ADHES ADHES, V18, P345, DOI 10.1016/S0143-7496(98)00016-5
   Gika Masatoshi, 2007, Interact Cardiovasc Thorac Surg, V6, P12
   Jackson MR, 1996, BLOOD COAGUL FIBRIN, V7, P737, DOI 10.1097/00001721-199611000-00001
   Kaetsu H, 2000, INT J ADHES ADHES, V20, P27, DOI 10.1016/S0143-7496(99)00011-1
   Kawamura M, 2001, SURG LAPARO ENDO PER, V11, P43, DOI 10.1097/00019509-200102000-00012
   KAWAMURA M, 2005, EUR J CARDIO-THORAC, V28, P1
   KOBAYASHI T, 2002, J NEW REM CLIN, V51, P58
   Matsui Y, 1999, Kyobu Geka, V52, P211
   Minato Naoki, 2004, Jpn J Thorac Cardiovasc Surg, V52, P361
   Miyamoto Hideaki, 2003, Jpn J Thorac Cardiovasc Surg, V51, P232, DOI 10.1007/s11748-003-0019-2
   Morikawa T, 1999, EUR SURG RES, V31, P180, DOI 10.1159/000008637
   Nakajima S, 2001, NEUROSURGERY, V49, P117, DOI 10.1097/00006123-200107000-00018
   Radosevich M, 1997, VOX SANG, V72, P133, DOI 10.1046/j.1423-0410.1997.7230133.x
   Sawamura Y, 1999, NEUROSURGERY, V44, P332, DOI 10.1097/00006123-199902000-00048
   SHIMIZU Y, 1996, PHARM MED, V14, P153
   SHINYA N, 1999, SCI REP CHEMOSEROTHE, V8, P54
   Sierra D H, 1993, J Biomater Appl, V7, P309, DOI 10.1177/088532829300700402
   TAKAGI M, 1996, J NEW REMEDIES CLIN, V45, P21
   YANAGIHARA E, 1997, ADHES TECHNOL, V17, P29
   Yasuda H, 2005, NEUROPATHOLOGY, V25, P66, DOI 10.1111/j.1440-1789.2004.00590.x
NR 23
TC 10
Z9 10
U1 0
U2 2
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 0894-1939
J9 J INVEST SURG
JI J. Invest. Surg.
PY 2009
VL 22
IS 5
BP 383
EP 389
DI 10.1080/08941930903214743
PG 7
WC Surgery
SC Surgery
GA 510MG
UT WOS:000271092000010
PM 19842894
DA 2018-10-19
ER

PT J
AU Yang, KK
   Zhou, Y
   Lu, F
   Huang, FY
   Qiu, ZC
   Wang, YZ
AF Yang, Ke-Ke
   Zhou, Yan
   Lu, Fang
   Huang, Fu-Yun
   Qiu, Zhi-Cheng
   Wang, Yu-Zhong
TI A Novel Potential Ecomaterial Based on Poly(p-Dioxanone)/Montmorillonite
   Nanocomposite With Improved Crystalline, Processing, and Mechanical
   Properties
SO JOURNAL OF MACROMOLECULAR SCIENCE PART B-PHYSICS
LA English
DT Article
DE crystallization; mechanical properties; montmorillonite; nanocomposite;
   poly(p-dioxanone); rheology
ID MOLECULAR-WEIGHTS; MORPHOLOGY; MONTMORILLONITE; BEHAVIOR; SILICATE;
   POLYMERIZATION; DEGRADATION; POLYLACTIDE; COMPOSITES; NUCLEATION
AB Poly(p-dioxanone) (PPDO) is a useful biomaterial and potential ecomaterial due to its biodegradability and good mechanical properties. Like other aliphatic polyesters, however, it has a low crystallization rate and low melt strength; it is difficult to produce thin films from it by blown film processing. In this work, poly(p-dioxanone)/montmorillonite (MMT) nanocomposites have been prepared successfully by in situ ring-opening polymerization of p-dioxanone and MMTs. The novel, biodegradable nanocomposites have a remarkably increased crystallization rate and melt strength; moreover, they can be blown into thin films, which have excellent mechanical properties. A typical sample showed a tensile strength of 59.2 MPa and elongation at break 605%.
C1 [Yang, Ke-Ke; Zhou, Yan; Lu, Fang; Huang, Fu-Yun; Qiu, Zhi-Cheng; Wang, Yu-Zhong] Sichuan Univ, Coll Chem, Ctr Degradable & Flame Retardant Polymer Mat ERCE, State Key Lab Polymer Mat Engn, Chengdu 610064, Peoples R China.
   [Zhou, Yan] Mianyang Normal Coll, Dept Chem & Chem Engn, Mianyang, Peoples R China.
RP Wang, YZ (reprint author), Sichuan Univ, Coll Chem, Ctr Degradable & Flame Retardant Polymer Mat ERCE, State Key Lab Polymer Mat Engn, Chengdu 610064, Peoples R China.
EM yzwang@email.scu.edu.cn
RI Wang, Yu-Zhong/E-3633-2013; Yang, Ke-Ke/G-6131-2018
OI Wang, Yu-Zhong/0000-0001-7535-7635; Yang, Ke-Ke/0000-0002-7019-6059
FU National Science Foundation of China [20504022]; New Century Excellent
   Talents in University [NCET07-0586]; National Science Fund [50525309]
FX This work was supported financially by the National Science Foundation
   of China (20504022), the program for New Century Excellent Talents in
   University (NCET07-0586), and the National Science Fund for
   Distinguished Young Scholars (50525309).
CR Bhattarai SR, 2006, ACTA BIOMATER, V2, P207, DOI 10.1016/j.actbio.2005.10.007
   Bhattarai SR, 2004, BIOMATERIALS, V25, P2595, DOI 10.1016/j.biomaterials.2003.09.043
   Chen SC, 2007, J BIOMED MATER RES A, V80A, P453, DOI 10.1002/jbm.a.30938
   Choi WM, 2003, J APPL POLYM SCI, V90, P525, DOI 10.1002/app.12702
   Dong T, 2005, MACROMOLECULES, V38, P7736, DOI 10.1021/ma050826r
   Furuhashi Y, 2004, MACROMOL RAPID COMM, V25, P1943, DOI 10.1002/marc.200400399
   Gopakumar TG, 2002, POLYMER, V43, P5483, DOI 10.1016/S0032-3861(02)00403-2
   Gorrasi G, 2003, POLYMER, V44, P2271, DOI 10.1016/S0032-3861(03)00108-3
   Huang FY, 2005, J POLYM SCI POL CHEM, V43, P2298, DOI 10.1002/pola.20707
   Huang HX, 2006, J POLYM SCI POL CHEM, V44, P1245, DOI 10.1002/pola.21240
   Kai WH, 2004, J APPL POLYM SCI, V94, P2466, DOI 10.1002/app.21204
   Krikorian V, 2004, MACROMOLECULES, V37, P6480, DOI 10.1021/ma049283w
   Liu TB, 2003, PROG POLYM SCI, V28, P5, DOI 10.1016/S0079-6700(02)00077-1
   Liu WJ, 2002, J APPL POLYM SCI, V86, P2145, DOI 10.1002/app.11023
   Maiti P, 2002, CHEM MATER, V14, P4654, DOI 10.1021/cm020391b
   Nam JY, 2003, MACROMOLECULES, V36, P7126, DOI 10.1021/ma034623j
   Nishida H, 2000, MACROMOLECULES, V33, P6982, DOI 10.1021/ma000457t
   Pluta M, 2004, POLYMER, V45, P8239, DOI 10.1016/j.polymer.2004.09.057
   Ray SS, 2003, MACROMOL RAPID COMM, V24, P815, DOI 10.1002/marc.200300008
   Sabino MA, 2004, BIOMACROMOLECULES, V5, P358, DOI 10.1021/bm034367i
   Sabino MA, 2000, MACROMOL CHEM PHYSIC, V201, P2687, DOI 10.1002/1521-3935(20001201)201:18<2687::AID-MACP2687>3.0.CO;2-#
   Sabino MA, 2000, J MATER SCI, V35, P5071, DOI 10.1023/A:1004831731756
   Suzuki A, 2006, J ORTHOP RES, V24, P327, DOI 10.1002/jor.20049
   Thellen C, 2005, POLYMER, V46, P11716, DOI 10.1016/j.polymer.2005.09.057
   Tortora M, 2002, MACROMOL MATER ENG, V287, P243, DOI 10.1002/1439-2054(20020401)287:4<243::AID-MAME243>3.0.CO;2-R
   Toyoda H, 2005, BONE, V37, P555, DOI 10.1016/j.bone.2005.04.042
   Wang K, 2005, POLYMER, V46, P9022
   Wang XL, 2004, ACTA MATER, V52, P4899, DOI 10.1016/j.actamat.2004.06.044
   Wu ZG, 2002, POLYM TEST, V21, P479, DOI 10.1016/S0142-9418(01)00113-1
   Yang KK, 2004, MATER CHEM PHYS, V87, P218, DOI 10.1016/j.matchemphys.2004.05.038
   Yang KK, 2002, J MACROMOL SCI-POL R, VC42, P373, DOI 10.1081/MC-120006453
   Yomeda M, 2005, BIOMATERIALS, V26, P5145
   Yoon KR, 2003, ADV MATER, V15, P2063, DOI 10.1002/adma.200305562
   Zhao ZD, 2004, MATER LETT, V58, P802, DOI 10.1016/j.matlet.2003.07.016
   Zheng L, 2005, EUR POLYM J, V41, P1243, DOI 10.1016/j.eurpolymj.2004.12.018
NR 35
TC 9
Z9 11
U1 1
U2 22
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 0022-2348
J9 J MACROMOL SCI B
JI J. Macromol. Sci. Part B-Phys.
PY 2009
VL 48
IS 5
BP 1031
EP 1041
DI 10.1080/00222340903035170
PG 11
WC Polymer Science
SC Polymer Science
GA 492EE
UT WOS:000269636600014
DA 2018-10-19
ER

PT J
AU Li, L
   Meng, LJ
   Zhang, XK
   Fu, CL
   Lu, QH
AF Li, Ling
   Meng, Lingjie
   Zhang, Xiaoke
   Fu, Chuanlong
   Lu, Qinghua
TI The ionic liquid-associated synthesis of a cellulose/SWCNT complex and
   its remarkable biocompatibility
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID WALLED CARBON NANOTUBES; SOLUBILIZATION; DNA; COMPOSITES; DISPERSION;
   VIABILITY; POLYMERS; GROWTH
AB Single-walled carbon nanotubes (SWCNTs) wrapped with cellulose have been successfully prepared by the treatment of SWCNTs with a cellulose solution in the ionic liquid 1-butyl-3-methylimidazolium bromide. The obtained SWCNT complex can be dispersed in water, forming a stable solution with excellent biocompatibility. It was found that long cellulose/SWCNT scaffolds could promote the growth of HeLa cells. In suspensions, short cellulose/SWCNTs complexes tend to enter HeLa cells and show little affect on cell proliferation. Therefore, the complexes have potential applications in biomaterial scaffolds and intracellular drug delivery systems.
C1 [Li, Ling; Meng, Lingjie; Zhang, Xiaoke; Fu, Chuanlong; Lu, Qinghua] Shanghai Jiao Tong Univ, Sch Chem & Chem Technol, Shanghai 200240, Peoples R China.
RP Lu, QH (reprint author), Shanghai Jiao Tong Univ, Sch Chem & Chem Technol, Shanghai 200240, Peoples R China.
EM qhlu@sjtu.edu.cn
RI Meng, Lingjie/B-4101-2015
OI Meng, Lingjie/0000-0003-0428-9780
FU National Natural Science Foundation of China [60577049]; Shanghai
   Municipal Science and Technology Commission [034319224, 0652nm017];
   Shanghai Leading Academic Discipline Project [B202]
FX This work was supported by the National Natural Science Foundation of
   China (no. 60577049), the Shanghai Municipal Science and Technology
   Commission (no. 034319224, 0652nm017) and the Shanghai Leading Academic
   Discipline Project (no. B202).
CR Alvaro M, 2007, J AM CHEM SOC, V129, P5647, DOI 10.1021/ja0690520
   Bagheri M, 2008, BIOMACROMOLECULES, V9, P381, DOI 10.1021/bm701023w
   Bottini M, 2006, BIOMACROMOLECULES, V7, P2259, DOI 10.1021/bm0602031
   Chambers G, 2003, NANO LETT, V3, P843, DOI 10.1021/nl034181p
   Chitta R, 2007, J PHYS CHEM C, V111, P6947, DOI 10.1021/jp0704416
   COHEN JJ, 1993, IMMUNOL TODAY, V14, P126, DOI 10.1016/0167-5699(93)90214-6
   Dalton AB, 2004, ADV FUNCT MATER, V14, P1147, DOI 10.1002/adfm.200400190
   Dieckmann GR, 2003, J AM CHEM SOC, V125, P1770, DOI 10.1021/ja029084x
   Dupont J, 2002, CHEM REV, V102, P3667, DOI 10.1021/cr010338r
   Fan SS, 2008, SENSOR ACTUAT B-CHEM, V132, P34, DOI 10.1016/j.snb.2008.01.010
   Fei ZF, 2006, CHEM-EUR J, V12, P2122, DOI 10.1002/chem.200500581
   Gigliotti B, 2006, NANO LETT, V6, P159, DOI 10.1021/nl0518775
   Grossiord N, 2006, CHEM MATER, V18, P1089, DOI 10.1021/cm051881h
   Haggenmueller R, 2008, LANGMUIR, V24, P5070, DOI 10.1021/la703008r
   Hecht DS, 2006, NANO LETT, V6, P2031, DOI 10.1021/nl061231s
   Hedderman TG, 2006, J PHYS CHEM B, V110, P3895, DOI 10.1021/jp055647q
   Huddleston JG, 2001, GREEN CHEM, V3, P156, DOI 10.1039/b103275p
   HUDDLESTON JG, 1998, CHEM COMMUN, V1765, P1766
   IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0
   Jin H, 2008, NANO LETT, V8, P1577, DOI 10.1021/nl072969s
   Kam NWS, 2006, ANGEW CHEM INT EDIT, V45, P577, DOI 10.1002/anie.200503389
   Kang YJ, 2003, J AM CHEM SOC, V125, P5650, DOI 10.1021/ja034082d
   Karajanagi SS, 2006, LANGMUIR, V22, P1392, DOI 10.1021/la0528201
   Kim OK, 2003, J AM CHEM SOC, V125, P4426, DOI 10.1021/ja029233b
   Liu P, 2005, EUR POLYM J, V41, P2693, DOI 10.1016/j.eurpolymj.2005.05.017
   MINAMI N, 2006, APPL PHYS LETT, V88, P93102
   Mulder B, 2008, SCIENCE, V322, P1643, DOI 10.1126/science.1168512
   NAOFUMI A, 2006, CHEM LETT, V35, P508
   Nikolaev P, 1999, CHEM PHYS LETT, V313, P91, DOI 10.1016/S0009-2614(99)01029-5
   Numata M, 2005, J AM CHEM SOC, V127, P5875, DOI 10.1021/ja044168m
   O'Connell MJ, 2001, CHEM PHYS LETT, V342, P265, DOI 10.1016/S0009-2614(01)00490-0
   Rinaldi R, 2008, ANGEW CHEM INT EDIT, V47, P8047, DOI 10.1002/anie.200802879
   Shin HI, 2005, MACROMOL RAPID COMM, V26, P1451, DOI 10.1002/marc.200500290
   Star A, 2002, ANGEW CHEM INT EDIT, V41, P2508, DOI 10.1002/1521-3773(20020715)41:14<2508::AID-ANIE2508>3.0.CO;2-A
   Star A, 2001, ANGEW CHEM INT EDIT, V40, P1721, DOI 10.1002/1521-3773(20010504)40:9<1721::AID-ANIE17210>3.0.CO;2-F
   Sun L, 2008, CARBON, V46, P320, DOI 10.1016/j.carbon.2007.11.051
   Swatloski RP, 2002, J AM CHEM SOC, V124, P4974, DOI 10.1021/ja025790m
   Takahashi T, 2004, JPN J APPL PHYS 1, V43, P3636, DOI 10.1143/JJAP.43.3636
   Worle-Knirsch JM, 2006, NANO LETT, V6, P1261, DOI 10.1021/nl060177c
   Xie XL, 2005, MAT SCI ENG R, V49, P89, DOI 10.1016/j.mser.2005.04.002
   Zhang XK, 2008, CARBON, V46, P453, DOI 10.1016/j.carbon.2007.12.015
   Zhang YJ, 2005, LANGMUIR, V21, P4797, DOI 10.1021/la050026+
   Zheng M, 2003, SCIENCE, V302, P1545, DOI 10.1126/science.1091911
   Zorbas V, 2004, J AM CHEM SOC, V126, P7222, DOI 10.1021/ja049202b
NR 44
TC 34
Z9 35
U1 1
U2 40
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
J9 J MATER CHEM
JI J. Mater. Chem.
PY 2009
VL 19
IS 22
BP 3612
EP 3617
DI 10.1039/b823322e
PG 6
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 450OO
UT WOS:000266410900008
DA 2018-10-19
ER

PT J
AU Santos, MI
   Pashkuleva, I
   Alves, CM
   Gomes, ME
   Fuchs, S
   Unger, RE
   Reis, RL
   Kirkpatrick, CJ
AF Santos, M. I.
   Pashkuleva, I.
   Alves, C. M.
   Gomes, M. E.
   Fuchs, S.
   Unger, R. E.
   Reis, R. L.
   Kirkpatrick, C. J.
TI Surface-modified 3D starch-based scaffold for improved
   endothelialization for bone tissue engineering
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID MARROW STROMAL CELLS; FLOW PERFUSION BIOREACTOR; FIBER-MESH SCAFFOLDS;
   PROTEIN ADSORPTION; IN-VITRO; OSTEOGENIC DIFFERENTIATION; POLYMERIC
   BIOMATERIALS; INTEGRIN BINDING; PLASMA TREATMENT; GROWTH-FACTORS
AB Providing adequate vascularization is one of the main hurdles to the widespread clinical application of bone tissue engineering approaches. Due to their unique role in blood vessel formation, endothelial cells (EC) play a key role in the establishment of successful vascularization strategies. However, currently available polymeric materials do not generally support EC growth without coating with adhesive proteins. In this work we present argon plasma treatment as a suitable method to render the surface of a 3D starch-based scaffold compatible for ECs, this way obviating the need for protein pre-coating. To this end we studied the effect of plasma modification on surface properties, protein adsorption and ultimately on several aspects regarding EC behaviour. Characterization of surface properties revealed increased surface roughness and change in topography, while at the chemical level a higher oxygen content was demonstrated. The increased surface roughness of the material, together with the changed surface chemistry modulated protein adsorption as indicated by the different adsorption profile observed for vitronectin. In vitro studies showed that human umbilical vein ECs (HUVECs) seeded on plasma-modified scaffolds adhered, remained viable, proliferated, and maintained the typical cobblestone morphology, as observed for positive controls (scaffold pre-coated with adhesive proteins). Furthermore, genotypic expression of endothelial markers was maintained and neighbouring cells expressed PECAM-1 at the single-cell-level. These results indicate that Ar plasma modification is an effective methodology with potential to be incorporated in biomaterial strategies to promote the formation of vascularized engineered bone.
C1 [Santos, M. I.; Fuchs, S.; Unger, R. E.; Kirkpatrick, C. J.] Johannes Gutenberg Univ Mainz, Inst Pathol, D-55101 Mainz, Germany.
   [Santos, M. I.; Pashkuleva, I.; Alves, C. M.; Gomes, M. E.; Reis, R. L.] PT Govt Associated Lab, IBB, Braga, Portugal.
   [Santos, M. I.; Pashkuleva, I.; Alves, C. M.; Gomes, M. E.; Reis, R. L.] Univ Minho, 3Bs Res Grp, Headquarters European Inst Excellence Tissue Engn, P-4806909 Taipas, Guimaraes, Portugal.
RP Kirkpatrick, CJ (reprint author), Johannes Gutenberg Univ Mainz, Inst Pathol, Langenbeckstr 1, D-55101 Mainz, Germany.
EM kirkpatrick@ukmainz.de
RI Alves, Catarina/B-3632-2018; Gomes, Manuela/B-6282-2009; Pashkuleva,
   Iva/B-5590-2008; Reis, Rui L./A-8938-2008; Group, 3Bs/E-4374-2012
OI Alves, Catarina/0000-0001-6003-9159; Gomes, Manuela/0000-0002-2036-6291;
   Pashkuleva, Iva/0000-0001-6818-3374; Reis, Rui L./0000-0002-4295-6129;
   Group, 3Bs/0000-0002-5195-3456
CR Adriaens A, 1999, MASS SPECTROM REV, V18, P48, DOI 10.1002/(SICI)1098-2787(1999)18:1<48::AID-MAS2>3.3.CO;2-9
   Alves CM, 2007, BIOMATERIALS, V28, P307, DOI 10.1016/j.biomaterials.2006.09.010
   Alves CM, 2003, J MATER SCI-MATER M, V14, P157, DOI 10.1023/A:1022023930825
   Bhati RS, 2001, J BIOMED MATER RES, V56, P74, DOI 10.1002/1097-4636(200107)56:1<74::AID-JBM1070>3.0.CO;2-M
   Cassell OCS, 2002, BRIT J PLAST SURG, V55, P603, DOI 10.1054/bjps.2002.3950
   Cassie ABD, 1944, T FARADAY SOC, V40, P0546, DOI 10.1039/tf9444000546
   Chen RR, 2007, PHARM RES, V24, P258, DOI 10.1007/s11095-006-9173-4
   Chim H, 2003, J BIOMED MATER RES A, V65A, P327, DOI 10.1002/jbm.a.10478
   Chu CFL, 1999, BBA-GEN SUBJECTS, V1472, P479, DOI 10.1016/S0304-4165(99)00151-8
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   DAVIES PF, 1993, J CLIN INVEST, V91, P2640, DOI 10.1172/JCI116503
   Douglas T, 2007, BIOMOL ENG, V24, P455, DOI 10.1016/j.bioeng.2007.07.008
   ERTEL SI, 1990, J BIOMED MATER RES, V24, P1637, DOI 10.1002/jbm.820241207
   Faucheux N, 2006, BIOMATERIALS, V27, P234, DOI 10.1016/j.biomaterials.2005.05.076
   Fauza DO, 2003, CURR OPIN PEDIATR, V15, P267, DOI 10.1097/00008480-200306000-00007
   Gomes ME, 2008, J TISSUE ENG REGEN M, V2, P243, DOI 10.1002/term.89
   Gomes ME, 2006, TISSUE ENG, V12, P801, DOI 10.1089/ten.2006.12.801
   Gomes ME, 2006, TISSUE ENG, V12, P177, DOI 10.1089/ten.2006.12.177
   Gomes ME, 2003, J BIOMED MATER RES A, V67A, P87, DOI 10.1002/jbm.a.10075
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Inagaki N., 1996, PLASMA SURFACE MODIF
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Kneser U, 2006, J CELL MOL MED, V10, P7, DOI 10.1111/j.1582-4934.2006.tb00287.x
   Kneser U, 2006, TISSUE ENG, V12, P1721, DOI 10.1089/ten.2006.12.1721
   KottkeMarchant K, 1996, J BIOMED MATER RES, V30, P209
   LEAVESLEY DI, 1993, J CELL BIOL, V121, P163, DOI 10.1083/jcb.121.1.163
   Lee MH, 2006, BIOMATERIALS, V27, P1907, DOI 10.1016/j.biomaterials.2005.11.003
   Lin J, 2007, J TISSUE ENG REGEN M, V1, P211, DOI 10.1002/term.27
   Liu XH, 2004, ANN BIOMED ENG, V32, P477, DOI 10.1023/B:ABME.0000017544.36001.8e
   Marin V, 2001, J IMMUNOL METHODS, V254, P183, DOI 10.1016/S0022-1759(01)00408-2
   MASSIA SP, 1991, J BIOMED MATER RES, V25, P223, DOI 10.1002/jbm.820250209
   Masuda H, 2003, CARDIOVASC RES, V58, P390, DOI 10.1016/S0008-6363(02)00785-X
   McCarthy I, 2006, J BONE JOINT SURG AM, V88A, P4, DOI 10.2106/JBJS.F.00890
   Moldovan NI, 2002, ARCH PATHOL LAB MED, V126, P320
   Muschler GE, 2004, J BONE JOINT SURG AM, V86A, P1541, DOI 10.2106/00004623-200407000-00029
   Oehr C, 2003, NUCL INSTRUM METH B, V208, P40, DOI 10.1016/S0168-583X(03)00650-5
   Ogaki R, 2008, SURF INTERFACE ANAL, V40, P1202, DOI 10.1002/sia.2866
   Oliveira AL, 2004, J MATER SCI-MATER M, V15, P533, DOI 10.1023/B:JMSM.0000021134.34651.d3
   Patel ZS, 2004, J BIOMAT SCI-POLYM E, V15, P701, DOI 10.1163/156856204774196117
   Pavlov MP, 2004, MACROMOL BIOSCI, V4, P776, DOI 10.1002/mabi.200400002
   Pompe T, 2007, BIOMATERIALS, V28, P28, DOI 10.1016/j.biomaterials.2006.08.028
   Pu FR, 2002, BIOMATERIALS, V23, P2411, DOI 10.1016/S0142-9612(01)00377-5
   Punshon G, 2005, BIOMATERIALS, V26, P6271, DOI 10.1016/j.biomaterials.2005.03.034
   Roy H, 2006, FEBS LETT, V580, P2879, DOI 10.1016/j.febslet.2006.03.087
   Ruardy TG, 1997, J COLLOID INTERF SCI, V188, P209, DOI 10.1006/jcis.1997.4769
   Sanborn SL, 2002, BIOMATERIALS, V23, P1, DOI 10.1016/S0142-9612(01)00066-7
   Santos MI, 2007, BIOMATERIALS, V28, P240, DOI 10.1016/j.biomaterials.2006.08.006
   SCHWARTZ MA, 1993, J CELL BIOL, V120, P1003, DOI 10.1083/jcb.120.4.1003
   TAJIMA S, 2007, J BIOMED MATER RES A, V84, P828
   Tidwell CD, 1997, LANGMUIR, V13, P3404, DOI 10.1021/la9604341
   Tzoneva R, 2007, BBA-GEN SUBJECTS, V1770, P1538, DOI 10.1016/j.bbagen.2007.07.008
   UNDERWOOD PA, 1989, J CELL SCI, V93, P641
   Unger RE, 2004, BIOMATERIALS, V25, P5137, DOI 10.1016/j.biomaterials.2003.12.040
   Unger RE, 2007, BIOMATERIALS, V28, P3965, DOI 10.1016/j.biomaterials.2007.05.032
   VANWACHEM PB, 1987, J BIOMED MATER RES, V21, P1317, DOI 10.1002/jbm.820211104
   Wang YX, 2004, PHARM RES, V21, P1362, DOI 10.1023/B:PHAM.0000036909.41843.18
   Warnke PH, 2004, LANCET, V364, P766, DOI 10.1016/S0140-6736(04)16935-3
   Yamashita H, 1997, EXP CELL RES, V235, P218, DOI 10.1006/excr.1997.3664
NR 59
TC 23
Z9 24
U1 1
U2 16
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
J9 J MATER CHEM
JI J. Mater. Chem.
PY 2009
VL 19
IS 24
BP 4091
EP 4101
DI 10.1039/b819089e
PG 11
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 455WC
UT WOS:000266797500007
DA 2018-10-19
ER

PT J
AU Gautrot, JE
   Zhu, XX
AF Gautrot, Julien E.
   Zhu, X. X.
TI Macrocyclic bile acids: from molecular recognition to degradable
   biomaterial building blocks
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Review
ID CATION-BINDING PROPERTIES; RING-CLOSURE REACTIONS;
   THERMODYNAMICALLY-CONTROLLED CYCLIZATION; OPENING METATHESIS
   POLYMERIZATION; POTENTIAL BIOMEDICAL APPLICATIONS; STEROID-CAPPED
   PORPHYRIN; CHOLIC-ACID; LITHOCHOLIC ACID; ARCHITECTURAL COMPONENT; ESTER
   DERIVATIVES
AB Bile acids are naturally occurring compounds that are present in large amounts in the human body where they play a role in fat solubilisation. Their macrocyclic counterparts display a unique combination of controllable conformation and functionality that makes these compounds ideal building blocks for molecular recognition, asymmetric synthesis, molecular knots and synthetic biopolymers. The synthesis of these steroidal macrocycles is reviewed first with an emphasis on the conditions that allow for the control of the oligomer distribution. The different applications of these compounds in fields such as sensing, biomimetics and biomaterials are then examined in detail.
C1 [Gautrot, Julien E.; Zhu, X. X.] Univ Montreal, Dept Chim, Montreal, PQ H3C 3J7, Canada.
RP Gautrot, JE (reprint author), Univ Cambridge, Dept Chem, Melville Lab Polymer Synth, Lensfield Rd, Cambridge CB2 1EW, England.
EM julian.zhu@umontreal.ca; jeg45@cam.ac.uk
RI Zhu, X. X./C-8991-2009; Gautrot, Julien/S-7920-2016
OI Zhu, X. X./0000-0003-0828-299X; Gautrot, Julien/0000-0002-1614-2578
CR AHLHEIM M, 1988, MAKROMOL CHEM-RAPID, V9, P299
   ALBERT D, 1994, TETRAHEDRON LETT, V35, P565, DOI 10.1016/S0040-4039(00)75839-4
   Albert D, 1998, ANGEW CHEM INT EDIT, V37, P2727, DOI 10.1002/(SICI)1521-3773(19981016)37:19<2727::AID-ANIE2727>3.0.CO;2-G
   Averin AD, 2005, CHEM-EUR J, V11, P7030, DOI 10.1002/chem.200500784
   Babu P, 2003, P INDIAN AS-CHEM SCI, V115, P607
   Bhattarai KM, 1997, J ORG CHEM, V62, P8463, DOI 10.1021/jo971272w
   BHATTARAI KM, 1992, J CHEM SOC CHEM COMM, P752, DOI 10.1039/c39920000752
   Bode CA, 2007, J PEPT SCI, V13, P702, DOI 10.1002/psc.868
   BonarLaw RP, 1995, J CHEM SOC PERK T 1, P3085, DOI 10.1039/p19950003085
   BONARLAW RP, 1989, J CHEM SOC CHEM COMM, P1050, DOI 10.1039/c39890001050
   BONARLAW RP, 1993, TETRAHEDRON, V49, P9829, DOI 10.1016/S0040-4020(01)80185-X
   BONARLAW RP, 1990, ANGEW CHEM INT EDIT, V29, P1407, DOI 10.1002/anie.199014071
   BONARLAW RP, 1993, TETRAHEDRON, V49, P9855
   BONARLAW RP, 1993, TETRAHEDRON, V49, P9845, DOI 10.1016/S0040-4020(01)80186-1
   BONARLAW RP, 1994, PURE APPL CHEM, V66, P803, DOI 10.1351/pac199466040803
   BONARLAW RP, 1993, TETRAHEDRON LETT, V34, P1677, DOI 10.1016/0040-4039(93)85039-Y
   BONARLAW RP, 1992, TETRAHEDRON LETT, V33, P2071, DOI 10.1016/0040-4039(92)88145-U
   BONARLAW RP, 1995, J AM CHEM SOC, V117, P259, DOI 10.1021/ja00106a029
   BONARLAW RP, 1993, J CHEM SOC CHEM COMM, P456, DOI 10.1039/c39930000456
   BONARLAW RP, 1991, J CHEM SOC CHEM COMM, P574, DOI 10.1039/c39910000574
   BonarLaw RP, 1995, J AM CHEM SOC, V117, P12397, DOI 10.1021/ja00155a004
   Brady PA, 1996, CHEM COMMUN, P319, DOI 10.1039/cc9960000319
   Brady PA, 1997, J CHEM SOC PERK T 1, P3237, DOI 10.1039/a703390g
   BRADY PA, 1998, NEW J CHEM, P411
   Bruggemann J, 2007, ANGEW CHEM INT EDIT, V46, P254, DOI 10.1002/anie.200601938
   Chahar M, 2007, TETRAHEDRON, V63, P171, DOI 10.1016/j.tet.2006.10.037
   Chattopadhyay P, 2007, BIOORG MED CHEM LETT, V17, P1553, DOI 10.1016/j.bmcl.2006.12.115
   Chattopadhyay P, 2006, TETRAHEDRON, V62, P8620, DOI 10.1016/j.tet.2006.06.029
   Chen WH, 2005, J AM CHEM SOC, V127, P12727, DOI 10.1021/ja053527q
   Czajkowska D, 2006, POL J CHEM, V80, P663
   Czajkowska D, 2007, TETRAHEDRON LETT, V48, P2851, DOI 10.1016/j.tetlet.2007.02.099
   Davis AP, 1996, CHEM COMMUN, P453, DOI 10.1039/cc9960000453
   Davis AP, 1999, ANGEW CHEM INT EDIT, V38, P2978
   DAVIS AP, 1993, CHEM SOC REV, V22, P243, DOI 10.1039/cs9932200243
   Davis AP, 1996, ANGEW CHEM INT EDIT, V35, P1312, DOI 10.1002/anie.199613121
   DAVIS AP, 1991, J CHEM SOC CHEM COMM, P612, DOI 10.1039/c39910000612
   Davis AP, 1996, CHEM COMMUN, P449, DOI 10.1039/cc9960000449
   Dias JR, 2002, J AM CHEM SOC, V124, P4647, DOI 10.1021/ja011797c
   DIETRICHBUCHECKER CO, 1990, ANGEW CHEM INT EDIT, V29, P1154, DOI 10.1002/anie.199011541
   DIETRICHBUCHECKER CO, 1989, ANGEW CHEM INT EDIT, V28, P189, DOI 10.1002/anie.198901891
   Dukh M, 2003, ORG BIOMOL CHEM, V1, P3458, DOI 10.1039/b302947f
   ERCOLANI G, 1993, J AM CHEM SOC, V115, P3901, DOI 10.1021/ja00063a008
   EVANS SM, 1995, J MOL STRUC-THEOCHEM, V334, P193, DOI 10.1016/0166-1280(94)04026-O
   EVANS SM, 1994, J MOL STRUC-THEOCHEM, V308, P159
   Feigel M, 2006, EUR J ORG CHEM, P371, DOI 10.1002/ejoc.200500408
   Feigel M, 2006, ANGEW CHEM INT EDIT, V45, P5698, DOI 10.1002/anie.200601111
   GALLI C, 1977, J AM CHEM SOC, V99, P2591, DOI 10.1021/ja00450a031
   GALLI C, 1973, J AM CHEM SOC, V95, P8374, DOI 10.1021/ja00806a028
   GAO H, 1998, NEW J CHEM, P579
   Gao HW, 1997, SYNTHETIC COMMUN, V27, P757, DOI 10.1080/00397919708004196
   Gao HW, 1998, EUR J ORG CHEM, P719
   Gao HW, 1998, CROAT CHEM ACTA, V71, P827
   Gauthier MA, 2007, J R SOC INTERFACE, V4, P1145, DOI 10.1098/rsif.2007.1018
   Gautrot JE, 2006, J BIOMAT SCI-POLYM E, V17, P1123, DOI 10.1163/156856206778530713
   GAUTROT JE, 2006, ANAL CHIM ACTA
   GAUTROT JE, IN PRESS
   Gautrot JE, 2008, CHEM COMMUN, P1674, DOI 10.1039/b719021b
   Gautrot JE, 2006, ANGEW CHEM INT EDIT, V45, P6872, DOI 10.1002/anie.200602096
   Ghosh S, 2005, ORG LETT, V7, P1441, DOI 10.1021/ol047462s
   Gouin S, 2000, MACROMOLECULES, V33, P5379, DOI 10.1021/ma991364i
   Haapala M, 2001, MAT SCI ENG C-BIO S, V18, P21, DOI 10.1016/S0928-4931(01)00351-4
   HOFMANN AF, 1984, J LIPID RES, V25, P1477
   Irie S, 1996, SYNTHESIS-STUTTGART, P1135
   JACOBSON H, 1950, J CHEM PHYS, V18, P1600, DOI 10.1063/1.1747547
   Janout V, 1996, J AM CHEM SOC, V118, P1573, DOI 10.1021/ja953261v
   Janout V, 2005, J AM CHEM SOC, V127, P22, DOI 10.1021/ja044257z
   Janout V, 1997, J AM CHEM SOC, V119, P640, DOI 10.1021/ja962405i
   Janout V, 2000, J AM CHEM SOC, V122, P2671, DOI 10.1021/ja000007g
   Karabulut HRF, 2007, TETRAHEDRON, V63, P5030, DOI 10.1016/j.tet.2007.03.129
   Khatri VK, 2007, J ORG CHEM, V72, P10224, DOI 10.1021/jo701341r
   Khatri VK, 2006, ORG LETT, V8, P1755, DOI 10.1021/ol060168a
   Kohmoto S, 1996, CHEM COMMUN, P1869, DOI 10.1039/cc9960001869
   Kolehmainen E, 1996, SYNTHESIS-STUTTGART, P1082
   Lappalainen K, 1997, LIEBIGS ANN-RECL, P1965
   LAPPALAINEN KV, 1995, SPECTROCHIM ACTA A, V51, P1543, DOI 10.1016/0584-8539(95)01466-8
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Li YX, 1997, CHEM REV, V97, P283, DOI 10.1021/cr9600565
   Li YX, 1997, SYNTHESIS-STUTTGART, P425
   Lotowski Z, 2008, MONATSH CHEM, V139, P213, DOI 10.1007/s00706-007-0768-1
   Lukashev NV, 2006, POL J CHEM, V80, P559
   MACKAY LG, 1993, J CHEM SOC PERK T 1, P1377, DOI 10.1039/p19930001377
   MAITRA U, 1992, J ORG CHEM, V57, P6979, DOI 10.1021/jo00051a057
   MAITRA U, 1994, J ORG CHEM, V59, P6114, DOI 10.1021/jo00099a055
   Maitra U, 1996, CURR SCI INDIA, V71, P617
   MANDOLINI L, 1978, J AM CHEM SOC, V100, P550, DOI 10.1021/ja00470a032
   MILJKOVIC D, 1987, TETRAHEDRON LETT, V28, P5737, DOI 10.1016/S0040-4039(00)96828-X
   MUELLER JE, 1991, J AM CHEM SOC, V113, P6306, DOI 10.1021/ja00016a077
   Nair V, 1997, SYNTHETIC COMMUN, V27, P3095, DOI 10.1080/00397919708005015
   Nair V, 1996, SYNTHETIC COMMUN, V26, P697, DOI 10.1080/00397919608086743
   Nichifor M, 2004, REACT FUNCT POLYM, V59, P141, DOI 10.1016/j.reactfunctpolym.2004.01.003
   NOLL O, 1996, MAKROMOL CHEM-RAPID, V9, P299
   Pandey PS, 2002, J CHEM SOC PERK T 1, P918, DOI 10.1039/b200320c
   Pandey PS, 2002, TETRAHEDRON, V58, P355, DOI 10.1016/S0040-4020(01)01116-4
   Pandey PS, 1997, TETRAHEDRON LETT, V38, P5045, DOI 10.1016/S0040-4039(97)01100-3
   Ra CS, 2000, B KOREAN CHEM SOC, V21, P342
   Rasmussen BS, 2002, J CHEM SOC PERK T 1, P1723, DOI 10.1039/b110865b
   Rivera DG, 2007, MOLECULES, V12, P1890, DOI 10.3390/12081890
   Safarowsky O, 2000, ANGEW CHEM INT EDIT, V39, P1616, DOI 10.1002/(SICI)1521-3773(20000502)39:9<1616::AID-ANIE1616>3.0.CO;2-Y
   Seeman NC, 1998, ANGEW CHEM INT EDIT, V37, P3220, DOI 10.1002/(SICI)1521-3773(19981217)37:23<3220::AID-ANIE3220>3.0.CO;2-C
   Semlyen J.A., 1976, ADV POLYM SCI, V21, P41
   Tamminen J, 2000, SYNTHESIS-STUTTGART, P1464
   Tamminen J, 2001, MOLECULES, V6, P21, DOI 10.3390/60100021
   Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619
   Tian Z, 2002, SYNTHETIC COMMUN, V32, P3821, DOI 10.1081/SCC-120015401
   Valkonen A, 2007, J MOL STRUCT, V846, P65, DOI 10.1016/j.molstruc.2007.01.030
   Virtanen E, 2004, EUR J ORG CHEM, P3385, DOI 10.1002/ejoc.200300699
   Virtanen E, 2003, J ORGANOMET CHEM, V668, P43, DOI 10.1016/S0022-328X(02)02096-X
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Wess G, 1996, ANGEW CHEM INT EDIT, V35, P2222, DOI 10.1002/anie.199622221
   Wessjohann LA, 2005, ANGEW CHEM INT EDIT, V44, P4785, DOI 10.1002/anie.200500019
   Wessjohann LA, 2006, J ORG CHEM, V71, P7521, DOI 10.1021/jo0608570
   WINNIK MA, 1981, CHEM REV, V81, P491, DOI 10.1021/cr00045a004
   Yoo HS, 2005, J CONTROL RELEASE, V103, P235, DOI 10.1016/j.jconrel.2004.11.033
   Zhang JB, 2003, J AM CHEM SOC, V125, P13984, DOI 10.1021/ja036390h
   Zhu XX, 2002, ACCOUNTS CHEM RES, V35, P539, DOI 10.1021/ar0101180
   ZHU XX, 2007, Patent No. 60952702
   Zuluaga F, 1999, POLYM BULL, V42, P41, DOI 10.1007/s002890050432
NR 117
TC 22
Z9 22
U1 1
U2 22
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
J9 J MATER CHEM
JI J. Mater. Chem.
PY 2009
VL 19
IS 32
BP 5705
EP 5716
DI 10.1039/b821340b
PG 12
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 480NB
UT WOS:000268741000003
DA 2018-10-19
ER

PT J
AU Joo, MK
   Park, MH
   Choi, BG
   Jeong, B
AF Joo, Min Kyung
   Park, Min Hee
   Choi, Bo Gyu
   Jeong, Byeongmoon
TI Reverse thermogelling biodegradable polymer aqueous solutions
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Review
ID SOL-GEL TRANSITION; PLGA-PEG-PLGA; THERMOSENSITIVE
   POLY(ORGANOPHOSPHAZENE) HYDROGELS; BLOCK-COPOLYMER HYDROGELS; CONTROLLED
   DRUG-DELIVERY; CHITOSAN-BASED HYDROGELS; AMINO-ACID ESTERS; IN-SITU;
   POLY(ETHYLENE GLYCOL); TRIBLOCK COPOLYMERS
AB A reverse thermogelling polymer aqueous solution is a free-flowing sol at a low temperature and becomes a semisolid gel as the temperature increases. It is expected to be a very promising biomaterial as a minimally invasive injectable system for drug delivery and tissue engineering applications. The principles of materials design are (1) balancing the hydrophobicity and hydrophilicty of a polymer, (2) controlling the topology of a polymer, (3) matching the degradation kinetics of a polymer with a specific biomedical application, and (4) controlling the biocompatibility of the material with a drug as well as a host. This article covers recent progress of reverse theromogelling biodegradable polymers based on aliphatic polyesters, polyphosphazenes, poloxamer derivatives, polysaccharides, polypeptides, poly(propylene phosphate)s, polyorthoesters, polycarbonates, polycyanoacrylates, and poly( N-(2-hydroxyethyl) methacrylamide-lactate) s. The material characteristics, driving forces or mechanism for sol-gel transition, and their biomedical applications are summarized. In addition, the authors' perspectives on future reverse theromogelling materials design are suggested.
C1 [Joo, Min Kyung; Park, Min Hee; Choi, Bo Gyu; Jeong, Byeongmoon] Ewha Womans Univ, Dept Bioinspired Sci, Dept Chem & Nano Sci, Seoul 120750, South Korea.
RP Jeong, B (reprint author), Ewha Womans Univ, Dept Bioinspired Sci, Dept Chem & Nano Sci, Seoul 120750, South Korea.
EM bjeong@ewha.ac.kr
RI Wang, Chun-Hung/F-1722-2015
FU Korea Research Foundation [KRF-2008-C00590]; Korean government
   [R11-2005-008-00000-0, R01-2007-00020141-0]
FX This work was supported by the Korea Research Foundation (Grant:
   KRF-2008-C00590), Korea Science and Engineering Foundation grant (KOSEF)
   funded by the Korean government ( MEST) ( Grant: R11-2005-008-00000-0
   and R01-2007-00020141-0). MKJ and BGC are thankful for Seoul Science
   Fellowships.
CR Aggeli A, 1997, NATURE, V386, P259, DOI 10.1038/386259a0
   Ahn JS, 2005, POLYM INT, V54, P842, DOI 10.1002/pi.1780
   Ayres L, 2005, MACROMOLECULES, V38, P1699, DOI 10.1021/ma047923p
   Bae SJ, 2005, MACROMOLECULES, V38, P5260, DOI 10.1021/ma050489m
   Bae SJ, 2006, MACROMOLECULES, V39, P4873, DOI 10.1021/ma060153s
   Behravesh E, 2002, BIOMACROMOLECULES, V3, P153, DOI 10.1021/bm010137x
   Berrada M, 2005, BIOMATERIALS, V26, P2115, DOI 10.1016/j.biomaterials.2004.06.013
   Betre H, 2006, BIOMATERIALS, V27, P91, DOI 10.1016/j.biomaterials.2005.05.071
   Bhattarai N, 2005, J CONTROL RELEASE, V103, P609, DOI 10.1016/j.jconrel.2004.12.019
   Cappello J, 1998, J CONTROL RELEASE, V53, P105, DOI 10.1016/S0168-3659(97)00243-5
   Chapanian R, 2009, BIOMATERIALS, V30, P295, DOI 10.1016/j.biomaterials.2008.09.038
   Chen SB, 2005, INT J PHARM, V288, P207, DOI 10.1016/j.ijpharm.2004.09.026
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   Cho J, 2006, CARBOHYD POLYM, V63, P507, DOI 10.1016/j.carbpol.2005.10.013
   Cho JY, 2005, BIOMACROMOLECULES, V6, P3267, DOI 10.1021/bm050313s
   Cho JY, 2006, J DRUG DELIV SCI TEC, V16, P71, DOI 10.1016/S1773-2247(06)50011-5
   Cho KY, 2003, INT J PHARM, V260, P83, DOI 10.1016/S0378-5173(03)00259-X
   Cho YW, 2006, MACROMOL CHEM PHYSIC, V207, P412, DOI 10.1002/macp.200500483
   Choi BG, 2007, J PHYS CHEM B, V111, P7715, DOI 10.1021/jp072970f
   Choi S, 2004, PHARM RES, V21, P827, DOI 10.1023/B:PHAM.0000026435.27086.94
   Choi S, 2003, PHARM RES, V20, P2008, DOI 10.1023/B:PHAM.0000008050.99985.5c
   Choi YY, 2008, SOFT MATTER, V4, P2383, DOI 10.1039/b809116a
   Chung HJ, 2008, J CONTROL RELEASE, V127, P22, DOI 10.1016/j.jconrel.2007.12.008
   Cohn D, 2006, BIOMATERIALS, V27, P1718, DOI 10.1016/j.biomaterials.2005.10.035
   Cohn D, 2003, J MATER SCI-MATER M, V14, P175, DOI 10.1023/A:1022080115804
   Cohn D, 2003, BIOMATERIALS, V24, P3707, DOI 10.1016/S0142-9612(03)00245-X
   Duncan R, 2003, NAT REV DRUG DISCOV, V2, P347, DOI 10.1038/nrd1088
   Duvvuri S, 2005, J CONTROL RELEASE, V108, P282, DOI 10.1016/j.jconrel.2005.09.002
   Fujiwara T, 2001, MACROMOL BIOSCI, V1, P204, DOI 10.1002/1616-5195(20010701)1:5<204::AID-MABI204>3.3.CO;2-8
   Ganji F, 2008, CARBOHYD POLYM, V74, P435, DOI 10.1016/j.carbpol.2008.03.017
   Gezimati J, 1996, J AGR FOOD CHEM, V44, P804, DOI 10.1021/jf950445k
   GOA KL, 1994, DRUGS, V47, P536, DOI 10.2165/00003495-199447030-00009
   Ha DI, 2006, MACROMOL RES, V14, P87, DOI 10.1007/BF03219073
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   He CL, 2008, J CONTROL RELEASE, V127, P189, DOI 10.1016/j.jconrel.2008.01.005
   Heller J, 2002, ADV DRUG DELIVER REV, V54, P1015, DOI 10.1016/S0169-409X(02)00055-8
   Hoffmann MAM, 1997, J AGR FOOD CHEM, V45, P2942, DOI 10.1021/jf960789q
   Huang K, 2002, BIOMACROMOLECULES, V3, P397, DOI 10.1021/bm015650p
   Huh KM, 2001, MACROMOLECULES, V34, P8657, DOI 10.1021/ma0106649
   Huynh DP, 2008, BIOMATERIALS, V29, P2527, DOI 10.1016/j.biomaterials.2008.02.016
   Huynh DP, 2006, POLYMER, V47, P7918, DOI 10.1016/j.polymer.2006.09.021
   Hwang MJ, 2005, BIOMACROMOLECULES, V6, P885, DOI 10.1021/bm049347a
   Hwang MJ, 2004, MACROMOLECULES, V37, P8820, DOI 10.1021/ma0487397
   Hyun H, 2007, BIOMACROMOLECULES, V8, P1093, DOI 10.1021/bm060771u
   IWASAKI Y, 2007, MACROMOLECUES, V40, P8138
   JANG Z, 2007, POLYMER, V48, P4786
   Jeong B, 1999, J CONTROL RELEASE, V62, P109, DOI 10.1016/S0168-3659(99)00061-9
   Jeong B, 2003, J PHYS CHEM B, V107, P10032, DOI 10.1021/jp027339n
   Jeong B, 1999, MACROMOLECULES, V32, P7064, DOI 10.1021/ma9908999
   Jeong B, 2002, ADV DRUG DELIVER REV, V54, P37, DOI 10.1016/S0169-409X(01)00242-3
   Jeong B, 1999, COLLOID SURFACE B, V16, P185, DOI 10.1016/S0927-7765(99)00069-7
   Jeong B, 2000, J BIOMED MATER RES, V50, P171, DOI 10.1002/(SICI)1097-4636(200005)50:2<171::AID-JBM11>3.0.CO;2-F
   Jeong B, 2002, BIOMACROMOLECULES, V3, P865, DOI 10.1021/bm025536m
   Jeong B, 2000, J CONTROL RELEASE, V63, P155, DOI 10.1016/S0168-3659(99)00194-7
   Jiang ZQ, 2007, POLYMER, V48, P4786, DOI 10.1016/j.polymer.2007.06.003
   Jin KM, 2008, J CONTROL RELEASE, V127, P249, DOI 10.1016/j.jconrel.2008.01.015
   Jo S, 2006, MACROMOL BIOSCI, V6, P923, DOI 10.1002/mabi.200600127
   Joo MK, 2007, MACROMOLECULES, V40, P5111, DOI 10.1021/ma070008u
   Jun YJ, 2006, ANGEW CHEM INT EDIT, V45, P6173, DOI 10.1002/anie.200601108
   Kan P, 2005, J BIOMED MATER RES B, V75B, P185, DOI 10.1002/jbm.b.30286
   Kang GD, 2005, MACROMOL RAPID COMM, V26, P1615, DOI 10.1002/marc.200500472
   Kang GD, 2006, INT J PHARM, V319, P29, DOI 10.1016/j.ijpharm.2006.03.032
   Kang GD, 2006, EUR J PHARM BIOPHARM, V63, P340, DOI 10.1016/j.ejpb.2006.01.001
   Karino T, 2006, MACROMOLECULES, V39, P9435, DOI 10.1021/ma062203z
   Kataoka T, 2006, J PHYS CHEM B, V110, P24377, DOI 10.1021/jp0649246
   Kempe S, 2008, EUR J PHARM BIOPHARM, V68, P26, DOI 10.1016/j.ejpb.2007.05.020
   Kidowaki M, 2006, CHEM COMMUN, P4102, DOI 10.1039/b607373e
   Kim KT, 2005, ANGEW CHEM INT EDIT, V44, P7964, DOI 10.1002/anie.200502809
   Kim SJ, 2005, J CONTROL RELEASE, V104, P323, DOI 10.1016/j.jcornel.2005.02.012
   Kim SY, 2008, J PHYS CHEM B, V112, P7420, DOI 10.1021/jp711291x
   Kim SY, 2007, MACROMOLECULES, V40, P5519, DOI 10.1021/ma070190z
   Kitabatake N, 2001, J AGR FOOD CHEM, V49, P4011, DOI 10.1021/jf001380a
   Klok HA, 2002, ANGEW CHEM INT EDIT, V41, P1509, DOI 10.1002/1521-3773(20020503)41:9<1509::AID-ANIE1509>3.0.CO;2-K
   Kuroiwa K, 2004, J AM CHEM SOC, V126, P2016, DOI 10.1021/ja037847q
   Lao UL, 2007, BIOMACROMOLECULES, V8, P3736, DOI 10.1021/bm700662n
   Lee BH, 2004, MACROMOLECULES, V37, P4533, DOI 10.1021/ma0305838
   Lee BH, 2002, POLYM INT, V51, P658, DOI 10.1002/pi.1019
   Lee BH, 2002, MACROMOLECULES, V35, P3876, DOI 10.1021/ma012093q
   Lee J, 2006, POLYMER, V47, P3760, DOI 10.1016/j.polymer.2006.03.109
   Lee J, 2006, BIOMACROMOLECULES, V7, P1729, DOI 10.1021/bm0600062
   Lee PY, 2007, MOL THER, V15, P1189, DOI 10.1038/sj.mt.6300156
   Lee PY, 2003, PHARM RES, V20, P1995, DOI 10.1023/B:PHAM.0000008048.58777.da
   Lee SB, 2005, POLYM INT, V54, P1225, DOI 10.1002/pi.1702
   Lee SB, 1999, MACROMOLECULES, V32, P7820, DOI 10.1021/ma990645n
   Lee SJ, 2006, J POLYM SCI POL CHEM, V44, P888, DOI 10.1002/pola.21193
   Liang HF, 2004, BIOMACROMOLECULES, V5, P1917, DOI 10.1021/bm049831
   Linghu E, 2005, ENDOSCOPY, V37, P1140, DOI 10.1055/s-870224
   Liu SQ, 2008, CARBOHYD POLYM, V72, P133, DOI 10.1016/j.carbpol.2007.07.040
   Loh XJ, 2008, BIOMATERIALS, V29, P2164, DOI 10.1016/j.biomaterials.2008.01.016
   Loh XJ, 2007, EXPERT OPIN THER PAT, V17, P965, DOI 10.1517/13543776.17.8.965
   Loh XJ, 2007, BIOMATERIALS, V28, P4113, DOI 10.1016/j.biomaterials.2007.05-016
   Loh XJ, 2007, BIOMACROMOLECULES, V8, P585, DOI 10.1021/bm0607933
   Mayo L, 2008, EUR J PHARM BIOPHARM, V70, P199, DOI 10.1016/j.ejpb.2008.04.025
   Megeed Z, 2002, PHARMACEUT RES, V19, P954, DOI 10.1023/A:1016406120288
   Megeed Z, 2002, ADV DRUG DELIVER REV, V54, P1075, DOI 10.1016/S0169-409X(02)00063-7
   Molinaro G, 2002, BIOMATERIALS, V23, P2717, DOI 10.1016/S0142-9612(02)00004-2
   MULLER RH, 1990, BIOMATERIALS, V11, P590, DOI 10.1016/0142-9612(90)90084-4
   Nagahama K, 2008, ADV FUNCT MATER, V18, P1220, DOI 10.1002/adfm.200700587
   Neradovic D, 1999, MACROMOL RAPID COMM, V20, P577, DOI 10.1002/(SICI)1521-3927(19991101)20:11<577::AID-MARC577>3.0.CO;2-D
   Niu GG, 2008, BIOMACROMOLECULES, V9, P2621, DOI 10.1021/bm800573e
   Nowak AP, 2002, NATURE, V417, P424, DOI 10.1038/417424a
   Oh HJ, 2008, MACROMOLECULES, V41, P8204, DOI 10.1021/ma8014504
   Palazolo G, 2000, J AGR FOOD CHEM, V48, P3817, DOI 10.1021/jf991353o
   Park KH, 2006, J BIOSCI BIOENG, V101, P238, DOI 10.1263/jbb.101.238
   Park KH, 2005, J BIOMAT SCI-POLYM E, V16, P1421, DOI 10.1163/156856205774472272
   Park SH, 2008, MACROMOLECULES, V41, P6486, DOI 10.1021/ma800562s
   Park SY, 2007, MACROMOL RAPID COMM, V28, P1172, DOI 10.1002/marc.200600914
   Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389
   Pochan DJ, 2003, J AM CHEM SOC, V125, P11802, DOI 10.1021/ja0353154
   Qiao MX, 2005, INT J PHARM, V294, P103, DOI 10.1016/j.ijpharm.2005.01.017
   Ramesh CR, 2001, US Patent, Patent No. [6,201,072 B1, 6201072, 6,201,072]
   Rathi R., 2000, US patent, Patent No. 6117949
   Reiersen H, 1998, J MOL BIOL, V283, P255, DOI 10.1006/jmbi.1998.2067
   Samlowski WE, 2006, J IMMUNOTHER, V29, P524, DOI 10.1097/01.cji.0000211306.05869.25
   Schacht E, 2006, J CONTROL RELEASE, V116, P219, DOI 10.1016/j.jconrel.2006.07.026
   SCHILD HG, 1992, PROG POLYM SCI, V17, P163, DOI 10.1016/0079-6700(92)90023-R
   Seong JY, 2005, POLYMER, V46, P5075, DOI 10.1016/j.polymer.2005.04.024
   Shim WS, 2005, BIOMACROMOLECULES, V6, P2930, DOI 10.1021/bm050521k
   Singh S, 2007, INT J PHARM, V341, P68, DOI 10.1016/j.ijpharm.2007.03.054
   Soga O, 2004, BIOMACROMOLECULES, V5, P818, DOI 10.1021/bm049955q
   Sohn YS, 2004, POLYMER, V45, P3081, DOI 10.1016/j.polymer.2004.02.062
   Sosnik A, 2005, BIOMATERIALS, V26, P349, DOI 10.1016/j.biomaterials.2004.02.041
   Sosnik A, 2004, BIOMATERIALS, V25, P2851, DOI 10.1016/j.biomaterials.2003.09.057
   Suh JM, 2005, ADV MATER, V17, P118, DOI 10.1002/adma.200400905
   Sun KH, 2006, BIOMACROMOLECULES, V7, P2871, DOI 10.1021/bm060512r
   Takeuchi Y, 2006, J POLYM SCI POL CHEM, V44, P671, DOI 10.1002/pola.21189
   TAYLOR LD, 1975, J POLYM SCI POL CHEM, V13, P2551, DOI 10.1002/pol.1975.170131113
   Toti US, 2007, J CONTROL RELEASE, V119, P34, DOI 10.1016/j.jconrel.2007.01.003
   URRY DW, 1977, PROTEIN BASED MAT
   Vauthier C, 2003, ADV DRUG DELIVER REV, V55, P519, DOI 10.1016/S0169-409X(03)00041-3
   Vermonden T, 2008, BIOMACROMOLECULES, V9, P919, DOI 10.1021/bm7013075
   Vermonden T, 2006, LANGMUIR, V22, P10180, DOI 10.1021/la062224m
   Vukelja SJ, 2007, ANTI-CANCER DRUG, V18, P283, DOI 10.1097/CAD.0b013e328011a51d
   Wang C, 1999, NATURE, V397, P417, DOI 10.1038/17092
   Wang J, 2001, J AM CHEM SOC, V123, P9480, DOI 10.1021/ja016062m
   Wang J, 2004, MACROMOLECULES, V37, P670, DOI 10.1021/ma035453d
   Wang YC, 2009, BIOMACROMOLECULES, V10, P66, DOI 10.1021/bm800808q
   Weng L, 2008, BIOMATERIALS, V29, P3905, DOI 10.1016/j.biomaterials.2008.06.025
   Wright ER, 2002, ADV DRUG DELIVER REV, V54, P1057, DOI 10.1016/S0169-409X(02)00059-5
   Xiong XY, 2006, J APPL POLYM SCI, V100, P4163, DOI 10.1002/app.23470
   Xiong XY, 2005, POLYMER, V46, P1841, DOI 10.1016/j.polymer.2005.01.01
   Xu JZ, 2007, POLYMER, V48, P3673, DOI 10.1016/j.polymer.2007.04.061
   Yokoi H, 2005, P NATL ACAD SCI USA, V102, P8414, DOI 10.1073/pnas.0407843102
   Yu L, 2006, ANGEW CHEM INT EDIT, V45, P2232, DOI 10.1002/anie.200503575
   Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k
   Yu L, 2007, J POLYM SCI POL CHEM, V45, P1122, DOI 10.1002/pola.21876
   Zentner GM, 2001, J CONTROL RELEASE, V72, P203, DOI 10.1016/S0168-3659(01)00276-0
   Zhang H, 2008, MACROMOLECULES, V41, P6493, DOI 10.1021/ma7026484
   Zhang Z, 2006, J CONTROL RELEASE, V112, P57, DOI 10.1016/j.jconrel.2006.01.010
   Zhong ZY, 2002, MACROMOL CHEM PHYS, V203, P1797, DOI 10.1002/1521-3935(200208)203:12<1797::AID-MACP1797>3.0.CO;2-A
NR 150
TC 100
Z9 102
U1 4
U2 109
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
J9 J MATER CHEM
JI J. Mater. Chem.
PY 2009
VL 19
IS 33
BP 5891
EP 5905
DI 10.1039/b902208b
PG 15
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 482KD
UT WOS:000268885900003
DA 2018-10-19
ER

PT J
AU Murphy, AR
   Kaplan, DL
AF Murphy, Amanda R.
   Kaplan, David L.
TI Biomedical applications of chemically-modified silk fibroin
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID HUMAN BONE-MARROW; BOMBYX-MORI SILK; MESENCHYMAL STEM-CELLS; OSTEOBLAST
   IN-VITRO; CONTROLLED-RELEASE; BIOMATERIAL COATINGS; 3-D SCAFFOLDS;
   POLY(D,L-LACTIC ACID); ARGINYL RESIDUE; DRUG-DELIVERY
AB Silk proteins belong to a class of unique, high molecular weight, block copolymer-like proteins that have found widespread use in biomaterials and regenerative medicine. The useful features of these proteins, including self-assembly, robust mechanical properties, biocompatibility and biodegradability can be enhanced through a variety of chemical modifications. These modifications provide chemical handles for the attachment of growth factors, cell binding domains and other polymers to silk, expanding the range of cell and tissue engineering applications attainable. This review focuses on the chemical reactions that have been used to modify the amino acids in silk proteins, and describes their utility in biomedical applications.
C1 [Murphy, Amanda R.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
FU Tissue Engineering Resource Center [P41 EB002520]
FX A. M. would like to thank the Training in Education and Critical
   Research Skills Program at Tufts University and the Ruth L. Kirschstein
   National Research Service Award Postdoctoral Fellowship supported by
   NIH/NIAMS for funding. We also thank the NIH via the Tissue Engineering
   Resource Center (P41 EB002520) for additional support.
CR Acharya C, 2008, J MATER SCI-MATER M, V19, P2827, DOI 10.1007/s10856-008-3408-3
   Acharya C, 2008, BIOMATERIALS, V29, P4665, DOI 10.1016/j.biomaterials.2008.08.033
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Bayraktar O, 2005, EUR J PHARM BIOPHARM, V60, P373, DOI 10.1016/j.ejpb.2005.02.002
   Cai KY, 2002, BIOMATERIALS, V23, P1603, DOI 10.1016/S0142-9612(01)00287-3
   Cai KY, 2002, BIOMATERIALS, V23, P1153, DOI 10.1016/S0142-9612(01)00230-7
   Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120
   Fang HY, 2006, CHEM PHARM BULL, V54, P156
   Freddi G, 2006, J BIOTECHNOL, V125, P281, DOI 10.1016/j.jbiotec.2006.03.003
   Furuzono T, 2000, BIOMATERIALS, V21, P327, DOI 10.1016/S0142-9612(99)00177-5
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Gotoh K, 2000, BIOSCI BIOTECH BIOCH, V64, P1664, DOI 10.1271/bbb.64.1664
   Gotoh Y, 1997, BIOMATERIALS, V18, P267, DOI 10.1016/S0142-9612(96)00137-8
   Gotoh Y, 2004, BIOMATERIALS, V25, P1131, DOI 10.1016/S0142-9612(03)00633-1
   Gotoh Y, 1996, INT J BIOL MACROMOL, V19, P41, DOI 10.1016/0141-8130(96)01098-7
   GOTOH Y, 1993, BIOCONJUGATE CHEM, V4, P554, DOI 10.1021/bc00024a020
   Gotoh Y, 1996, INT J BIOL MACROMOL, V18, P19, DOI 10.1016/0141-8130(95)01039-4
   GOTOH Y, 1992, INT J BIOL MACROMOL, V14, P198, DOI 10.1016/S0141-8130(05)80027-3
   Gotoh Y, 1998, J BIOMED MATER RES, V39, P351, DOI 10.1002/(SICI)1097-4636(19980305)39:3<351::AID-JBM2>3.0.CO;2-I
   Grinnell F, 1978, Int Rev Cytol, V53, P65
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Heslot H, 1998, BIOCHIMIE, V80, P19, DOI 10.1016/S0300-9084(98)80053-9
   Hofmann S, 2006, J CONTROL RELEASE, V111, P219, DOI 10.1016/j.jconrel.205.12.009
   Hofmann S, 2007, BIOMATERIALS, V28, P1152, DOI 10.1016/j.biomaterials.2006.10.019
   Hofmann S, 2006, TISSUE ENG, V12, P2729, DOI 10.1089/ten.2006.12.2729
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Inouye K, 1998, J BIOCHEM BIOPH METH, V37, P159, DOI 10.1016/S0165-022X(98)00024-4
   JACOBSON BS, 1982, TISSUE CELL, V14, P69, DOI 10.1016/0040-8166(82)90008-8
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Karageorgiou V, 2006, J BIOMED MATER RES A, V78A, P324, DOI 10.1002/jbm.a.30728
   Kardestuncer T, 2006, CLIN ORTHOP RELAT R, P234, DOI 10.1097/01.blo.0000205879.50834.fe
   Katayama H, 2000, BIOL PHARM BULL, V23, P1229
   Keselowsky BG, 2007, J BIOMED MATER RES A, V80A, P700, DOI 10.1002/jbm.a.30898
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013
   Kim HJ, 2007, MACROMOL BIOSCI, V7, P643, DOI 10.1002/mabi.200700030
   Kim MS, 2007, TISSUE ENG, V13, P2095, DOI 10.1089/ten.2006.0062
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Kirker-Head C, 2007, BONE, V41, P247, DOI 10.1016/j.bone.2007.04.186
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Lovett M, 2007, BIOMATERIALS, V28, P5271, DOI 10.1016/j.biomterials.2007.08.008
   Ma XL, 2006, J BIOMED MATER RES B, V78B, P89, DOI 10.1002/jbm.b.30466
   Matsumoto A, 2006, J PHYS CHEM B, V110, P21630, DOI 10.1021/jp056350v
   Mauney JR, 2007, BIOMATERIALS, V28, P5280, DOI 10.1016/j.biomaterials.2007.08.017
   Meinel L, 2006, BONE, V39, P922, DOI 10.1016/j.bone.2006.04.019
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Meinel L, 2004, J BIOMED MATER RES A, V71A, P25, DOI 10.1002/jbm.a.30117
   Murphy AR, 2008, BIOMATERIALS, V29, P2829, DOI 10.1016/j.biomaterials.2008.03.039
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Rappaport C, 2003, IN VITRO CELL DEV-AN, V39, P187
   Sampaio S, 2005, J BIOTECHNOL, V116, P21, DOI 10.1016/j.jbiotec.2004.10.003
   Soffer L, 2008, J BIOMAT SCI-POLYM E, V19, P653, DOI 10.1163/156856208784089607
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Takeuchi Y, 1997, J BIOL CHEM, V272, P29309, DOI 10.1074/jbc.272.46.29309
   Tamada Y, 2004, BIOMATERIALS, V25, P377, DOI 10.1016/S0142-9612(03)00533-7
   Uebersax L, 2006, TISSUE ENG, V12, P3417, DOI 10.1089/ten.2006.12.3417
   Valluzzi R, 2002, PHILOS T ROY SOC B, V357, P165, DOI 10.1098/rstb.2001.1032
   Vepari CP, 2006, BIOTECHNOL BIOENG, V93, P1130, DOI 10.1002/bit.20833
   Wang X, 2008, BIOMATERIALS, V29, P894, DOI 10.1016/j.biomaterials.2007.10.055
   Wang XY, 2007, J CONTROL RELEASE, V121, P190, DOI 10.1016/j.jconrel.2007.06.006
   Wang X, 2007, BIOMATERIALS, V28, P4161, DOI 10.1016/j.biomaterials.2007.05.036
   Wang XQ, 2007, J CONTROL RELEASE, V117, P360, DOI 10.1016/j.jconrel.2006.11.021
   Wang XY, 2005, LANGMUIR, V21, P11335, DOI 10.1021/la051862m
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   Wang YZ, 2005, BIOMATERIALS, V26, P7082, DOI 10.1016/j.biomaterials.2005.05.022
   WEIGEL PH, 1978, J BIOL CHEM, V253, P330
   Wilz A, 2008, BIOMATERIALS, V29, P3609, DOI 10.1016/j.biomaterials.2008.05.010
   Winkler S, 2000, BIOCHEMISTRY-US, V39, P12739, DOI 10.1021/bi001335w
   Xiao GZ, 1998, J BIOL CHEM, V273, P32988, DOI 10.1074/jbc.273.49.32988
   Xu WP, 2008, TISSUE ENG PT A, V14, P549, DOI 10.1089/tea.2007.0227
   Zhang XH, 2008, BIOMATERIALS, V29, P2217, DOI 10.1016/j.biomaterials.2008.01.022
   Zhang YQ, 2006, J BIOMED MATER RES B, V79B, P275, DOI 10.1002/jbm.b.30539
   Zhao CH, 2003, BIOPOLYMERS, V69, P253, DOI 10.1002/bip.10350
   Zhou CZ, 2001, PROTEINS, V44, P119, DOI 10.1002/prot.1078
NR 80
TC 149
Z9 156
U1 7
U2 105
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
EI 1364-5501
J9 J MATER CHEM
JI J. Mater. Chem.
PY 2009
VL 19
IS 36
BP 6443
EP 6450
DI 10.1039/b905802h
PG 8
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 490IH
UT WOS:000269493600001
PM 20161439
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Chang, SH
   Hsu, YM
   Wang, YJ
   Tsao, YP
   Tung, KY
   Wang, TY
AF Chang, Shih-Hsin
   Hsu, Yuan-Ming
   Wang, Yng Jiin
   Tsao, Yeou-Ping
   Tung, Kwan-Yi
   Wang, Tao-Yuan
TI Fabrication of pre-determined shape of bone segment with
   collagen-hydroxyapatite scaffold and autogenous platelet-rich plasma
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID GUIDED BONE; IN-VIVO; TISSUE; RECONSTRUCTION; REGENERATION; GROWTH;
   ENHANCEMENT; PERIOSTEUM; CERAMICS; DEFECTS
AB Background Reconstruction of large segment of bony defects is frequently needed in hand surgery. Autogenous bone grafting is considered the standard in management of these bony defects but has limited source of graft material. Collagen and hydroxyapatite have been used as bone-filling materials and are known to serve as the osteoconductive scaffold for bone regeneration. On the other hand, platelet-rich plasma is a kind of natural source of growth factors, and has been used successfully in bone regeneration and improving wound healing. This study was designed to evaluate the effectiveness of using biohybrids of platelet-rich plasma and collagen-hydroxyapatite beads for fabricating of protrusive bone in a rabbit animal model. Methods Biomaterial beads comprised of particulate hydroxyapatite dispersed in fibrous collagen (type I) matrices were prepared and filled in the ringed polytetrafluoroethylene (PTFE) artificial vascular graft (3 cm long, 1 cm in diameter). New Zealand White rabbits were each implanted with two cylindrical PTFE artificial vascular graft over both iliac crests (n = 16). A 2 x 0.5 cm opening was created at the side of each PTFE chamber to allow the content of chamber in contact with the bone marrow of the ileum. The chambers were empty (groups A and D), filled with type I collagen/hydroxyapatite beads (groups B and C). In groups C and D, autologous platelet rich plasma (PRP) was given by transcutaneous injection method into the chambers every week. After 12 weeks, the animals were sacrificed and the chambers were harvested for radiological and histological analysis. Results In plain radiographs, the group C chambers had significantly higher bone tissue engineered (average calcified density 0.95, average calcified area 61.83%) compared with other groups (P < 0.001). In histological examination, there was a creeping substitution of the implant by the in-growth of fibrovascular tissue in group C. Abundant fibrovascular networks positioned interstitially between these biomaterial beads in all parts of chamber. Degradation of these beads and newly formed capillaries and osteoids around the degraded matrixes are shown. The continually calcification in the matrixes or degraded matrixes is evidenced by the strong green fluorescence observed under the confocal microscope. In group B, looser architecture without evidence of tissue in-growth was shown. In the scaffold absent groups (A and D), there was only fibrous tissue shown within the chamber. Conclusions In this study, we have demonstrated a feasible approach to fabricate an osseous tissue that meets clinical need. Using the type I collagen/ hydroxyapatite gel beads matrixes and intermittent injection of autologous platelet-rich-plasma, specific 3D osseous tissues with fibrovascular network structure from pre-exist bony margin were successfully created in an in vivo animal model.
C1 [Tsao, Yeou-Ping; Tung, Kwan-Yi] Mackay Mem Hosp, Dept Med Res, Taipei, Taiwan.
   [Hsu, Yuan-Ming; Wang, Yng Jiin] Natl Yang Ming Univ, Inst Biomed Engn, Taipei 112, Taiwan.
   [Wang, Tao-Yuan] Mackay Mem Hosp, Dept Pathol, Taipei, Taiwan.
RP Tung, KY (reprint author), Mackay Mem Hosp, Dept Med Res, Taipei, Taiwan.
EM prschang@ms1.mmh.org.tw
RI Hsu, Yuan-Ming/E-1370-2011
OI Hsu, Yuan-Ming/0000-0003-4135-7885
FU Ministry of Education-Aim; Mackay Memorial Hospital, Taipei, Taiwan,
   Republic of China
FX This work has been supported by grants from Ministry of Education-Aim
   for the Top University Plan, and from the Mackay Memorial Hospital,
   Taipei, Taiwan, Republic of China.
CR CIMA LG, 1991, J BIOMECH ENG-T ASME, V113, P143, DOI 10.1115/1.2891228
   CRANE GM, 1995, NAT MED, V1, P1322, DOI 10.1038/nm1295-1322
   DAHLIN C, 1988, PLAST RECONSTR SURG, V81, P672, DOI 10.1097/00006534-198805000-00004
   de Obarrio J J, 2000, Int J Periodontics Restorative Dent, V20, P486
   Dugrillon A, 2002, INT J ORAL MAX SURG, V31, P615, DOI 10.1054/ijom.2002.0322
   Gosain AF, 2002, PLAST RECONSTR SURG, V109, P619, DOI 10.1097/00006534-200202000-00032
   Hentz VR, 2001, NEW ENGL J MED, V344, P1547, DOI 10.1056/NEJM200105173442011
   Hokugo A, 2004, TISSUE ENG, V10, P978, DOI 10.1089/1076327041887646
   Hsu FY, 1999, BIOMATERIALS, V20, P1931
   HUANGLEE LLH, 1993, BIOMED ENG-APP BAS C, V5, P664
   Kale S, 2000, NAT BIOTECHNOL, V18, P954
   Kellomaki M, 2000, BIOMATERIALS, V21, P2495, DOI 10.1016/S0142-9612(00)00117-4
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee HB, 2000, PLAST RECONSTR SURG, V105, P1448, DOI 10.1097/00006534-200004040-00029
   MAROUF H A, 1990, International Journal of Oral and Maxillofacial Implants, V5, P148
   Marx RE, 1998, ORAL SURG ORAL MED O, V85, P638, DOI 10.1016/S1079-2104(98)90029-4
   Merlino G, 2007, J HAND SURG-BRIT EUR, V32E, P98, DOI 10.1016/j.jhsb.2006.08.015
   Miyamoto I, 2004, CLIN ORAL IMPLAN RES, V15, P308, DOI 10.1111/j.1600-0501.2004.01011.x
   Oyama T, 2004, J ORAL MAXIL SURG, V62, P555, DOI 10.1016/j.joms.2003.08.023
   Sachlos E., 2003, European Cells & Materials, V5, P29
   Sachlos E, 2006, TISSUE ENG, V12, P2479, DOI 10.1089/ten.2006.12.2479
   Schilephake H., 2002, INT J ORAL MAXILLOF, V31, P469, DOI DOI 10.1054/IJOM.2002.0244
   Shea LD, 2000, TISSUE ENG, V6, P605, DOI 10.1089/10763270050199550
   SONNLEITNER D, 2000, J ORAL MAXILLOFAC IM, V15, P879
   Tamai N, 2002, J BIOMED MATER RES, V59, P110, DOI 10.1002/jbm.1222
   Thomson RC, 1999, BIOMATERIALS, V20, P2007, DOI 10.1016/S0142-9612(99)00103-9
   Wahl DA, 2007, J MATER SCI-MATER M, V18, P201, DOI 10.1007/s10856-006-0682-9
   WAKE MC, 1994, CELL TRANSPLANT, V3, P339, DOI 10.1177/096368979400300411
   Weng YL, 2001, J ORAL MAXIL SURG, V59, P185, DOI 10.1053/joms.2001.20491
   Yoshikawa T, 2000, TRANSPLANTATION, V69, P128, DOI 10.1097/00007890-200001150-00022
NR 30
TC 34
Z9 41
U1 1
U2 10
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JAN
PY 2009
VL 20
IS 1
BP 23
EP 31
DI 10.1007/s10856-008-3507-1
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 395PE
UT WOS:000262535200003
PM 18651114
DA 2018-10-19
ER

PT J
AU Coelho, PG
   de Assis, SL
   Costa, I
   Thompson, VP
AF Coelho, Paulo G.
   Luiz de Assis, Sergio
   Costa, Isolda
   Thompson, Van P.
TI Corrosion resistance evaluation of a Ca- and P-based bioceramic thin
   coating in Ti-6Al-4V
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID PLASMA-SPRAYED HYDROXYAPATITE; CALCIUM-PHOSPHATE COATINGS; VIVO
   DISSOLUTION BEHAVIOR; ORAL IMPLANT SURFACES; IN-VIVO; HYDROGEN-PEROXIDE;
   BIOMATERIAL APPLICATIONS; TITANIUM IMPLANTS; CERAMIC COATINGS; PART 2
AB The objective of this study was to physico/chemically characterize and determine the corrosion resistance of a Calcium-Phosphate (Ca-P) based bioceramic thin coating processed by a sputtering process on titanium alloy (Ti-6Al-4V). The samples utilized in this study were uncoated and coated disks of 10 mm diameter by 3 mm thickness. The coating was characterized by SEM, XPS + ion beam milling (IBM), thin-film mode XRD, and atomic force microscope (AFM) (n = 3). Coated and uncoated Ti-6Al-4V disk surfaces were tested in Phosphate Buffered Saline (PBS) at 25A degrees C through an area of 0.79 cm(2). A three-electrode cell set-up was used with a saturated calomel electrode (SCE) and a platinum wire as reference and counter electrodes. After 3, 17, and 25 days of immersion, electrochemical impedance spectroscopy (EIS) experiments were performed (n = 3). The EIS tests were carried out in potentiostatic mode at the open circuit potential (OCP). The frequency range considered was from 100 kHz to 10 mHz, using 10 mV root mean square as the amplitude of the perturbation signal. A potentiodynamic polarization scan using a frequency response analyzer potentiostat, was acquired following 3 days of immersion in PBS. The potentiodynamic polarization scans (n = 3) were carried out with a scan rate of 1 mV/s ranging from -0.8V(SCE) to 3.0V(SCE). Results: The physico/chemical characterization showed an amorphous Ca- and P-based coating of 400-700 nm thickness with Ca-P nanometer size particles embedded in a Ca-P matrix. The Bode phase angle diagrams showed highly capacitive results at low and medium frequencies for both surfaces tested. The polarization curves showed low current densities at the corrosion potential (E (corr)), in the order of 10(-8)A/cm(2), typical of passive materials with protective surface films. Coated sample current densities were comparable to the uncoated samples. Conclusion: Coated and uncoated samples were stable in the test solution with a protective film maintained throughout the 25 day immersion test period.
C1 [Coelho, Paulo G.; Thompson, Van P.] NYU, Coll Dent, Dept Biomat & Biomimet, New York, NY 10100 USA.
   [Luiz de Assis, Sergio; Costa, Isolda] IPEN CNEN SP, Ctr Mat Sci & Technol, BR-05508900 Sao Paulo, Brazil.
RP Coelho, PG (reprint author), NYU, Coll Dent, Dept Biomat & Biomimet, 345 E 24th St,Room 804S, New York, NY 10100 USA.
EM pgcoelho@nyu.edu
RI Costa, Isolda/E-8506-2012
OI Costa, Isolda/0000-0002-4987-3334; Thompson, Van P/0000-0003-0033-0344
CR Advincula MC, 2007, J BIOMED MATER RES B, V80B, P107, DOI 10.1002/jbm.b.30575
   Albrektsson T, 2004, INT J PROSTHODONT, V17, P544
   Albrektsson T, 2004, INT J PROSTHODONT, V17, P536
   Bauer TW, 1999, SKELETAL RADIOL, V28, P423, DOI 10.1007/s002560050541
   COELHO PG, 2005, NANOTECHNOLOGY, V1, P316
   COELHO PG, 2008, J BIOMED MAT RES A
   Davies JE, 2007, BIOMATERIALS, V28, P5058, DOI 10.1016/j.biomaterials.2007.07.049
   de Groot KKC, 1990, HDB BIOACTIVE CERAMI, VII, P17
   Eisenbarth E, 2002, BIOMOL ENG, V19, P243, DOI 10.1016/S1389-0344(02)00032-1
   Eisenbarth E, 2004, BIOMATERIALS, V25, P5705, DOI 10.1016/j.biomaterials.2004.01.021
   FURLONG RJ, 1991, J BONE JOINT SURG BR, V73, P741
   Gonzalez JEG, 1999, J ELECTROANAL CHEM, V471, P109, DOI 10.1016/S0022-0728(99)00260-0
   HANAWA T, 1992, BIOMATERIALS, V13, P20, DOI 10.1016/0142-9612(92)90089-7
   Hsu RWW, 2004, MAT SCI ENG A-STRUCT, V380, P100, DOI 10.1016/j.msea.2004.03.069
   KAY J F, 1992, Dental Clinics of North America, V36, P1
   Lacefield W R, 1988, Ann N Y Acad Sci, V523, P72, DOI 10.1111/j.1749-6632.1988.tb38501.x
   Lacefield W R, 1998, Implant Dent, V7, P315, DOI 10.1097/00008505-199807040-00010
   Lavos-Valereto C, 2002, J BIOMED MATER RES, V63, P664, DOI 10.1002/jbm.10351
   LEGEROS JP, 1994, CHARACTERIZATION PER, V1196, P33
   Legeros RZ, 2003, J MATER SCI-MATER M, V14, P201, DOI 10.1023/A:1022872421333
   LEGEROS RZ, 2002, CLIN ORTHOP RELAT R, V395, P81, DOI DOI 10.1097/00003086-200202000-00009
   Lemons Jack E, 2004, J Oral Implantol, V30, P318, DOI 10.1563/0712.1
   LEMONS JE, 1999, BIOMATERIALS DENT IM, P271
   ONG JL, 1994, BIOMATERIALS, V15, P337, DOI 10.1016/0142-9612(94)90245-3
   Ong JL, 2004, BIOMATERIALS, V25, P4601, DOI 10.1016/j.biomaterials.2003.11.053
   Ong JL, 2002, INT J ORAL MAX IMPL, V17, P581
   ONG JL, 1995, J BIOMED MATER RES, V29, P165, DOI 10.1002/jbm.820290205
   Pan J, 1996, ELECTROCHIM ACTA, V41, P1143, DOI 10.1016/0013-4686(95)00465-3
   Pan J, 1996, J BIOMED MATER RES, V30, P393
   PAN J, 1994, J BIOMED MATER RES, V28, P113, DOI 10.1002/jbm.820280115
   Pan J, 1997, J BIOMED MATER RES, V35, P309, DOI 10.1002/(SICI)1097-4636(19970605)35:3<309::AID-JBM5>3.3.CO;2-N
   Park YS, 2005, INT J ORAL MAX IMPL, V20, P31
   Porter AE, 2002, BIOMATERIALS, V23, P725, DOI 10.1016/S0142-9612(01)00177-6
   Soballe K, 1999, J LONG-TERM EFF MED, V9, P131
   Sun LM, 2001, J BIOMED MATER RES, V58, P570, DOI 10.1002/jbm.1056.abs
   TENGVALL P, 1989, BIOMATERIALS, V10, P166, DOI 10.1016/0142-9612(89)90019-7
   TENGVALL P, 1992, BIOMATERIALS, V13, P367, DOI 10.1016/0142-9612(92)90042-M
   Tsui YC, 1998, BIOMATERIALS, V19, P2031, DOI 10.1016/S0142-9612(98)00104-5
   Wolke JGC, 2003, BIOMATERIALS, V24, P2623, DOI 10.1016/S0142-9612(03)00067-X
   Wolke JGC, 1998, J BIOMED MATER RES, V39, P524
   Yang YZ, 2005, BIOMATERIALS, V26, P327, DOI 10.1016/j.biomaterials.2004.02.029
NR 41
TC 16
Z9 17
U1 0
U2 17
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JAN
PY 2009
VL 20
IS 1
BP 215
EP 222
DI 10.1007/s10856-008-3562-7
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 395PE
UT WOS:000262535200024
PM 18726187
DA 2018-10-19
ER

PT J
AU Liu, BS
   Yao, CH
   Wang, W
   Lee, S
   Lo, CC
   Liu, CK
   Chen, YS
AF Liu, Bai-Shuan
   Yao, Chun-Hsu
   Wang, Walter
   Lee, Sanboh
   Lo, Chun-Chiang
   Liu, Chien-Kuo
   Chen, Yueh-Sheng
TI Effect of Drying Method on the Characteristics of Genipin Cross-linked
   Gelatin Films
SO JOURNAL OF MEDICAL AND BIOLOGICAL ENGINEERING
LA English
DT Article
DE Genipin; Gelatin; Drying method; Oven-drying; Room temperature-drying;
   Freeze-drying; Biomaterial
ID IN-VITRO EVALUATION; BIOLOGICAL TISSUE FIXATION; LINKING REAGENT;
   CYTOTOXICITY; COLLAGEN; VIVO; CARBODIIMIDE; PROSTHESES; COMPOSITE;
   RELEASE
AB A naturally occuring crosslinking agent, genipin, was used in this study to crosslink gelatin to develop a biodegradable film for biomedical applications. This study attempted to understand how different drying methods, oven-drying (80 degrees C), room temperature-drying (RTD, 25 degrees C) and freeze-drying (-20 degrees C) affected the characteristics of biomaterials. The physical and chemical characteristics of genipin cross-linked gelatin film, after drying using the three methods, were investigated. Both the drying rate and ratio were highest in the oven, followed by room temperature-drying and freeze-drying. Scanning electron microscope (SEM) images reveal the oven-dried films had a smooth surface morphology and their cross-sections exhibited a fusion-like appearance. The films dried at room temperature had flat and smooth surface structures and cross-sections. The cross-sections of the freeze-dried films were as porous as its surface morphology. The oven-dried film had the highest glass transition temperature (T(g)) and melting point (T(m)), followed by the freeze-dried film and the film dried at room temperature. The tensile test indicated that the tensile strength of the oven-dried film was the highest, followed by those dried at room temperature and freeze-dried film. However, the tensile elongation and toughness followed the order RTD > Oven >> Lyophilizer. In the rehydration test, the film dried at room temperature presented the highest weight-change ratio; the weight-change ratio of the oven-dried film almost equaled that of the freeze-dried film. However, the thickness-change ratio of the films dried by different methods varied significantly (P < 0.05). The attenuated total reflection Fourier-transform infrared (ATR-FTIR) spectrometric absorption peaks were similarly consistent among the films dried by the three methods. The order of absorption intensity of the peaks was Lyophilizer approximate to Oven > RTD. Energy-dispersive X-ray (EDX) analysis identified carbon, nitrogen and oxygen on the surfaces of all of the dried films. The oxygen concentration was almost the same as in the variously dried films; however, the carbon and nitrogen contents varied significantly (P < 0.05).
C1 [Yao, Chun-Hsu; Chen, Yueh-Sheng] China Med Univ, Dept Biomed Imaging & Radiol Sci, Taichung 404, Taiwan.
   [Liu, Bai-Shuan] Cent Taiwan Univ Sci & Technol, Dept Med Imaging & Radiol Sci, Taichung 406, Taiwan.
   [Wang, Walter; Chen, Yueh-Sheng] China Med Univ, Inst Chinese Med Sci, Taichung 404, Taiwan.
   [Lee, Sanboh; Liu, Chien-Kuo] Natl Tsing Hua Univ, Dept Mat Sci & Engn, Hsinchu 300, Taiwan.
   [Lo, Chun-Chiang] Herbiotech Dev Inc, Taipei 235, Taiwan.
RP Chen, YS (reprint author), China Med Univ, Dept Biomed Imaging & Radiol Sci, Taichung 404, Taiwan.
EM bsliu@ctust.edu.tw; yuehsc@mail.cmu.edu.tw
CR AKAO T, 1994, BIOL PHARM BULL, V17, P1573
   Balakrishnan B, 2006, BIOMATERIALS, V27, P1355, DOI 10.1016/j.biomaterials.2005.08.021
   Bigi A, 2002, BIOMATERIALS, V23, P4827, DOI 10.1016/S0142-9612(02)00235-1
   BOTTOMS E, 1966, NATURE, V211, P97, DOI 10.1038/211097a0
   Chang WH, 2003, J BIOMAT SCI-POLYM E, V14, P481, DOI 10.1163/156856203766652084
   Chen YS, 2005, BIOMATERIALS, V26, P3911, DOI 10.1016/j.biomaterials.2004.09.060
   Dong ZF, 2006, J MEMBRANE SCI, V280, P37, DOI 10.1016/j.memsci.2006.01.002
   FUJIMORI E, 1965, BIOPOLYMERS, V3, P115, DOI 10.1002/bip.360030202
   GAHTAN V, 1995, J SURG RES, V58, P105, DOI 10.1006/jsre.1995.1017
   Ginalska G, 2005, EUR J VASC ENDOVASC, V29, P419, DOI 10.1016/j.ejvs.2004.12.030
   Ho JC, 2001, APPL THERM ENG, V21, P1779, DOI 10.1016/S1359-4311(01)00047-3
   Huang LLH, 1998, J BIOMED MATER RES, V42, P568, DOI 10.1002/(SICI)1097-4636(19981215)42:4<568::AID-JBM13>3.0.CO;2-7
   Lewicki PP, 2006, TRENDS FOOD SCI TECH, V17, P153, DOI 10.1016/j.tifs.2005.10.012
   Liu BS, 2003, J BIOMED MATER RES A, V67A, P1163, DOI 10.1002/jbm.a.20017
   Liu TY, 2006, J MAGN MAGN MATER, V304, pE397, DOI 10.1016/j.jmmm.2006.01.203
   Lohre J M, 1993, ASAIO J, V39, P106, DOI 10.1097/00002480-199304000-00007
   LOHRE JM, 1992, ARTIF ORGANS, V16, P630
   MAROIS Y, 1995, BIOMATERIALS, V16, P1131, DOI 10.1016/0142-9612(95)93576-Y
   NISHI C, 1995, J BIOMED MATER RES, V29, P829, DOI 10.1002/jbm.820290707
   Sung HW, 1999, J BIOMED MATER RES, V46, P520
   Sung HW, 2003, J BIOMED MATER RES A, V64A, P427, DOI 10.1002/jbm.a.10346
   Sung HW, 1999, J BIOMAT SCI-POLYM E, V10, P63, DOI 10.1163/156856299X00289
   Sung HW, 1998, J BIOMED MATER RES, V42, P560, DOI 10.1002/(SICI)1097-4636(19981215)42:4<560::AID-JBM12>3.0.CO;2-I
   Sung HW, 2000, BIOMATERIALS, V21, P1353, DOI 10.1016/S0142-9612(00)00017-X
   Sung HW, 1999, BIOMATERIALS, V20, P1759, DOI 10.1016/S0142-9612(99)00069-1
   TOUYAMA R, 1994, CHEM PHARM BULL, V42, P668
   Ueda H, 2003, J CONTROL RELEASE, V88, P55, DOI 10.1016/S0168-3659(02)00481-9
   Wang J, 2006, J CONTROL RELEASE, V113, P31, DOI 10.1016/j.jconrel.2006.03.011
   Ward A. G., 1977, SCI TECHNOLOGY GELAT
   Yao CH, 2005, BIOMATERIALS, V26, P3065, DOI 10.1016/j.biomaterials.2004.09.011
   Yao CH, 2004, MATER CHEM PHYS, V83, P204, DOI 10.1016/j.mathchemphys.2003.08.027
   Zhang YZ, 2006, POLYMER, V47, P2911, DOI 10.1016/j.polymer.2006.02.046
NR 32
TC 7
Z9 7
U1 0
U2 15
PU INST BIOMEDICAL ENGINEERING
PI TAINAN CITY
PA NAT CHENG KUNG UNIV, NO 1 UNIVERSITY RD, TAINAN CITY, TAIWAN 701,
   PEOPLES R CHINA
SN 1609-0985
J9 J MED BIOL ENG
JI J. Med. Biol. Eng.
PY 2009
VL 29
IS 1
BP 29
EP 38
PG 10
WC Engineering, Biomedical
SC Engineering
GA 452NO
UT WOS:000266547700006
DA 2018-10-19
ER

PT J
AU Yeh, CC
   Li, YT
   Chiang, PH
   Huang, CH
   Wang, YW
   Chang, HI
AF Yeh, Chih-Chang
   Li, Yun-Ting
   Chiang, Pei Hsiu
   Huang, Chun-Hao
   Wang, Yiwei
   Chang, Hsin-I
TI Characterizing Microporous PCL Matrices for Application of Tissue
   Engineering
SO JOURNAL OF MEDICAL AND BIOLOGICAL ENGINEERING
LA English
DT Article
DE Polycaprolactone; Tissue engineering; Cytocompatibility; Fibroblast
ID CELL SUPPORT MEMBRANES; DRUG-DELIVERY SYSTEMS; MECHANICAL-PROPERTIES;
   SURFACE MODIFICATION; POLYCAPROLACTONE; POLY(EPSILON-CAPROLACTONE);
   BONE; SCAFFOLDS; SKIN; BIOCOMPOSITES
AB Polycaprolactone (PCL) is a semicrystalline polymer and has been fabricated into various forms such as membranes, films, matrices, fibers, micro/nano particles, capsules and reservoir devices for drug delivery and tissue engineering due to its good biocompatibility. In this study, microporous PCL matrices (MPM) with 10-20 mu m pores on the surface were produced using various PCL molecular weight from 40,000 to 80,000 by precipitation casting method. The tensile strength of MPM prepared using 12.5% w/v polymer solution tended to increase from 0.83 Mpa to 1.42 Mpa and the elongation rate was improved from 35.2% to 117.8% when increasing PCL molecular weight. In addition, there was also a significant increase in compression and bending strength. MPM exhibited high porosity up to 72.4%, and the porosity of MPM reduced with rising of PCL solution concentration and molecular weight. The crystallinity of MPM prepared using 12.5% CAPA 6400 polymer solution was measured at approximately 67%, while moelcular weight showed a minor effect on the crystallinity of MPM. In cytocompatibility studies, MPM prepared using CAPA 6500 and 6800 showed higher cell attachment than CAPA 6400. Three-point bending test also showed that MPM prepared with low molecular weight (CAPA 6400) had a higher fragility for easy breakdown of tissue scaffold. Therefore, MPM prepared using CAPA 6500 (or CAPA 6800) may be more suitable tissue scaffold for biomedical application. Herein, we report that processing parameters such as polymer solution concentrations and molecular weight could modify the porosity and stiffness of MPM and then influence cell/biomaterial interaction.
C1 [Li, Yun-Ting; Chiang, Pei Hsiu; Huang, Chun-Hao; Chang, Hsin-I] Natl Chia Yi Univ, Dept Biochem Sci & Technol, Chiayi 600, Taiwan.
   [Yeh, Chih-Chang] Chia Yi Vet Hosp, Dept Orthoped, Chiayi 600, Taiwan.
   [Wang, Yiwei] Univ Queensland, Sch Pharm, Brisbane, Qld 4072, Australia.
RP Chang, HI (reprint author), Natl Chia Yi Univ, Dept Biochem Sci & Technol, Chiayi 600, Taiwan.
EM hchang@mail.ncyu.edu.tw
FU Geriatric Medicine Research Project of the Veterans Affairs Commission,
   Executive Yuan, Taiwan [RVHCY97002]; National Science Council, Taiwan
   [NSC-97-2320-B-415-004]
FX This work was supported by a Geriatric Medicine Research Project of the
   Veterans Affairs Commission, Executive Yuan, Taiwan (grant #RVHCY97002)
   and by the National Science Council, Taiwan (grant
   NSC-97-2320-B-415-004)
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.0.CO;2-J
   ALI SAM, 1993, BIOMATERIALS, V14, P648, DOI 10.1016/0142-9612(93)90063-8
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Chang HI, 2006, J CONTROL RELEASE, V110, P414, DOI 10.1016/j.jconrel.2005.10.028
   Chang HI, 2005, J CONTROL RELEASE, V106, P263, DOI 10.1016/j.conrel.2005.05.013
   Cheng ZY, 2004, BIOMATERIALS, V25, P1991, DOI 10.1016/j.biomaterials.2003.08.038
   Chong MSK, 2007, MAT SCI ENG C-BIO S, V27, P309, DOI 10.1016/j.msec.2006.03.008
   Ciapetti G, 2003, BIOMATERIALS, V24, P3815, DOI 10.1016/S0142-9612(03)00263-1
   Coombes AGA, 2004, BIOMATERIALS, V25, P315, DOI 10.1016/S0142-9612(03)00535-0
   Coombes AGA, 2002, BIOMATERIALS, V23, P2113, DOI 10.1016/S0142-9612(01)00341-6
   Dai NT, 2005, BIOCHEM BIOPH RES CO, V329, P905, DOI 10.1016/j.bbrc.2005.02.059
   Dai NT, 2004, BIOMATERIALS, V25, P4263, DOI 10.1016/j.biomaterials.2003.11.022
   ENGELBERG I, 1991, BIOMATERIALS, V12, P292, DOI 10.1016/0142-9612(91)90037-B
   GOGOLEWSKI S, 2000, INJURY, V31
   Hashemi J, 2005, CLIN BIOMECH, V20, P645, DOI 10.1016/j.clinbiomech.2005.02.008
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Kweon H, 2003, BIOMATERIALS, V24, P801, DOI 10.1016/S0142-9612(02)00370-8
   Magnussen RA, 2005, J ORTHOP RES, V23, P576, DOI 10.1016/j.orthres.2004.12.006
   Mark C., 1990, BIODEGRADABLE POLYM, P71
   Marra KG, 1999, J BIOMED MATER RES, V47, P324, DOI 10.1002/(SICI)1097-4636(19991205)47:3<324::AID-JBM6>3.0.CO;2-Y
   PITT CG, 1979, J BIOMED MATER RES, V13, P497, DOI 10.1002/jbm.820130313
   PITT CG, 1981, J APPL POLYM SCI, V26, P3779, DOI 10.1002/app.1981.070261124
   PITT CG, 1979, J PHARM SCI, V68, P1534, DOI 10.1002/jps.2600681219
   PITT CG, 1980, CONTROLLED RELEASE B, P19
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Skoglund P, 1996, J APPL POLYM SCI, V61, P2455, DOI 10.1002/(SICI)1097-4628(19960926)61:13<2455::AID-APP25>3.0.CO;2-1
   Wang YW, 2007, BIOMATERIALS, V28, P4619, DOI 10.1016/j.biomaterials.2007.07.006
   Williams JM, 2005, BIOMATERIALS, V26, P4817, DOI 10.1016/j.biomaterials.2004.11.057
   Williamson MR, 2004, BIOMATERIALS, V25, P459, DOI 10.1016/S0142-9612(03)00536-2
   Yang J, 2002, J BIOMED MATER RES, V62, P438, DOI 10.1002/jbm.10318
NR 30
TC 9
Z9 10
U1 0
U2 12
PU INST BIOMEDICAL ENGINEERING
PI TAINAN CITY
PA NAT CHENG KUNG UNIV, NO 1 UNIVERSITY RD, TAINAN CITY, TAIWAN 701,
   PEOPLES R CHINA
SN 1609-0985
J9 J MED BIOL ENG
JI J. Med. Biol. Eng.
PY 2009
VL 29
IS 2
BP 92
EP 97
PG 6
WC Engineering, Biomedical
SC Engineering
GA 452NP
UT WOS:000266547800006
DA 2018-10-19
ER

PT J
AU Jiang, T
   Wang, GX
   Qiu, JH
   Luo, LL
   Zhang, GQ
AF Jiang, Tao
   Wang, Guixue
   Qiu, Juhui
   Luo, Lailong
   Zhang, Guoquan
TI Preparation and Biocompatibility of Polyvinyl Alcohol-Small Intestinal
   Submucosa Hydrogel/Membranes
SO JOURNAL OF MEDICAL AND BIOLOGICAL ENGINEERING
LA English
DT Article
DE Polyvinyl alcohol (PVA); Small intestinal submucosa (SIS); Crosslinking;
   Hydrogel; Biomechanical property; Biocompatibility
ID BLOOD COMPATIBILITY; HYDROGELS; GROWTH; ENDOTHELIALIZATION;
   BIOMATERIALS; IMPROVEMENT; GRAFTS
AB In this study, two kinds of hydrogel membrane were developed. One was a hydrogel membrane which contained polyvinyl alcohol (PVA), dimethyl sulfoxide (DMSO) and porcine small intestinal submucosa (SIS) powders. Another was a hydrogel membrane consisting of PVA and SIS, but not DMSO. These two kinds of material both were crosslinked by N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide hydrochloride (EDC) and N- hydroxysuccinimide (NHS). The results of mechanical and biocompatible testing showed that mechanical properties, blood and cell compatibility of the hydrogel membranes were changed when the DMSO was added in PVA-SIS system. Hemolysis rates of PVA-DMSO-SIS and PVA-SIS hydrogel membranes were calculated to be 0.8% and 0.5%, respectively. The number of adherent platelets on PVA-DMSO-SIS membrane was about 20% of the PVA-SIS, and there was no sign of accumulation, and almost no pseudopodium could be observed. The endothelial cell adhesion and growth text showed that the endothelial cells were amicable with the two kinds of hydrogel membrane and the endothelialization property of PVA-SIS membrane was better than that of PVA-DMSO-SIS membrane. These results demonstrated that PVA-DMSO-SIS and PVA-SIS hydrogel membranes had potential biomechanical and biological properties as a novel biomaterial for intravascular applications.
C1 [Jiang, Tao; Wang, Guixue; Qiu, Juhui; Luo, Lailong] Chongqing Univ, Lab Biomech & Tissue Repair, Bioengn Coll, Chongqing 400044, Peoples R China.
   [Jiang, Tao; Wang, Guixue; Qiu, Juhui; Luo, Lailong] Chongqing Univ, Lab Biomech & Tissue Repair, Project 111, Chongqing 400044, Peoples R China.
   [Jiang, Tao; Zhang, Guoquan] Med Coll China People Armed Police Forces, Dept Histol & Embryol, Tianjin 300162, Peoples R China.
RP Wang, GX (reprint author), Chongqing Univ, Lab Biomech & Tissue Repair, Bioengn Coll, Chongqing 400044, Peoples R China.
EM wanggx@cqu.edu.cn
OI Guixue, Wang/0000-0002-9192-8757
FU Chongqing University Postgraduates' Science and Innovation Fund
   [200706A1B0140234]; Chinese Ministry of Science and Technology
   [2004DFA06400]; Chongqing Municipality, China [DRC2005 1006,
   CSTC2006AA5014-3]
FX This work was financially supported by Chongqing University
   Postgraduates' Science and Innovation Fund (200706A1B0140234) and by
   grants from the Chinese Ministry of Science and Technology
   (2004DFA06400) and the Chongqing Municipality, China (DRC2005 1006,
   CSTC2006AA5014-3).
CR Abraham GA, 2000, J BIOMED MATER RES, V51, P442, DOI 10.1002/1097-4636(20000905)51:3<442::AID-JBM19>3.3.CO;2-W
   Ayyildiz A, 2008, ANZ J SURG, V78, P82, DOI 10.1111/j.1445-2197.2007.04361.x
   Chen JY, 2002, BIOMATERIALS, V23, P2545, DOI 10.1016/S0142-9612(01)00389-1
   Cho SW, 2006, J BIOMED MATER RES A, V76A, P252, DOI 10.1002/jbm.a.30535
   Cikirikcioglu M, 2006, INT J ARTIF ORGANS, V29, P990
   DAMINK LHHO, 1995, J MATER SCI-MATER M, V6, P460, DOI 10.1007/BF00123371
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Hodde J, 2002, TISSUE ENG, V8, P295, DOI 10.1089/107632702753725058
   Ishihara K, 1999, BIOMATERIALS, V20, P1553, DOI 10.1016/S0142-9612(98)00206-3
   JACOB SW, 1986, CRYOBIOLOGY, V23, P14, DOI 10.1016/0011-2240(86)90014-3
   Koyano T, 1998, J BIOMED MATER RES, V39, P486
   Lin WC, 2006, COLLOID SURFACE B, V47, P43, DOI 10.1016/j.colsurfb.2005.11.013
   Nugent MJD, 2005, J MATER SCI-MATER M, V16, P1149, DOI 10.1007/s10856-005-4722-7
   Palmaz JC, 1998, J VASC INTERV RADIOL, V9, P7, DOI 10.1016/S1051-0443(98)70476-2
   Palmer EM, 2002, TISSUE ENG, V8, P893, DOI 10.1089/10763270260424259
   Scotchford CA, 1998, BIOMATERIALS, V19, P1, DOI 10.1016/S0142-9612(97)00236-6
   TRIEU H, 1995, POLYMER, V36, P2531, DOI 10.1016/0032-3861(95)91198-G
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   Wei Dangheng, 2006, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V23, P1367
   Wissink MJB, 2001, BIOMATERIALS, V22, P2291, DOI 10.1016/S0142-9612(00)00418-X
   Zhao XB, 2007, J BIOMED MATER RES A, V80A, P539, DOI 10.1002/jbm.a.30925
   Zheng-Qiu G, 1998, BIO-MED MATER ENG, V8, P75
NR 22
TC 15
Z9 16
U1 3
U2 9
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1609-0985
EI 2199-4757
J9 J MED BIOL ENG
JI J. Med. Biol. Eng.
PY 2009
VL 29
IS 2
SI SI
BP 102
EP 107
PG 6
WC Engineering, Biomedical
SC Engineering
GA 452NP
UT WOS:000266547800008
DA 2018-10-19
ER

PT J
AU Kinnari, TJ
   Esteban, J
   Martin-De-Hijas, NZ
   Sanchez-Munoz, O
   Sanchez-Salcedo, S
   Colilla, M
   Vallet-Regi, M
   Gomez-Barrena, E
AF Kinnari, Teemu J.
   Esteban, Jaime
   Martin-de-Hijas, Nieves Z.
   Sanchez-Munoz, Orlando
   Sanchez-Salcedo, Sandra
   Colilla, Montserrat
   Vallet-Regi, Maria
   Gomez-Barrena, Enrique
TI Influence of surface porosity and pH on bacterial adherence to
   hydroxyapatite and biphasic calcium phosphate bloceramics
SO JOURNAL OF MEDICAL MICROBIOLOGY
LA English
DT Article
ID IN-VITRO EVALUATION; STAPHYLOCOCCUS-AUREUS; ADHESION; BIOMATERIAL;
   CERAMICS
AB Hydroxyapatite (HA) and biphasic calcium phosphate (BCP) ceramic materials are widely employed as bone substitutes due to their porous and osteoconductive structure, Their porosity and the lowering of surrounding pH as a result of surgical trauma may, however, predispose these materials to bacterial infections. For this reason, the influence of porosity and pH on the adherence of common Gram-positive bacteria to the surfaces of these materials requires investigation. Mercury intrusion porosimetry measurements revealed that the pore size distribution of both bioceramics had, on a logarithmic scale, a sinusoidal frequency distribution ranging from 50 to 300 nm, with a mean pore diameter of 200 nm. Moreover, total porosity was 20 % for HA and 50 % for BCP. Adherence of Staphylococcus aureus and Staphylococcus epidermidis was studied at a physiological pH of 7.4 and at a pH simulating bone infection of 6.8. Moreover, the effect of pH on the zeta- potential of HA, BCP and of both staphylococci was evaluated. Results showed that when pH decreased from 7.4 to 6.8, the adherence of both staphylococci to HA and BCP surfaces decreased significantly, although at the same time the negative C-potential values of the ceramic surfaces and both bacteria diminished. At both pH values, the number of S. aureus adhered to the HA surface appeared to be lower than that for BCP. A decrease in pH to 6.8 reduced the adherence of both bacterial species (mean 57 %). This study provides evidence that HA and BCP ceramics do not have pores sufficiently large to allow the internalization of staphylococci. Their anti-adherent properties seemed to improve when pH value decreased, suggesting that HA and BCP bioceramics are not compromised upon orthopaedic use.
C1 [Kinnari, Teemu J.; Esteban, Jaime; Martin-de-Hijas, Nieves Z.] Fdn Jimenez Diaz, UTE, Dept Clin Microbiol, E-28040 Madrid, Spain.
   [Kinnari, Teemu J.; Gomez-Barrena, Enrique] Fdn Jimenez Diaz, UTE, Dept Orthopaed Surg & Traumatol, E-28040 Madrid, Spain.
   [Kinnari, Teemu J.] Univ Helsinki, Cent Hosp, Dept Otolaryngol, FI-00029 Helsinki, Finland.
   [Sanchez-Munoz, Orlando] Univ Helsinki, Cent Hosp, Dept Med, FI-00029 Helsinki, Finland.
   [Sanchez-Munoz, Orlando] Univ Valencia, Inst Ciencias Mat, E-46071 Valencia, Spain.
   [Sanchez-Salcedo, Sandra; Colilla, Montserrat; Vallet-Regi, Maria] Compultense Univ Madrid, Fac Pharm, Dept Inorgan & Bioinorgan Chem, E-28040 Madrid, Spain.
RP Kinnari, TJ (reprint author), Fdn Jimenez Diaz, UTE, Dept Clin Microbiol, Avda Reyes Catolicos 2, E-28040 Madrid, Spain.
EM teemu.j.kinnari@helsinki.fi
RI GOMEZ-BARRENA, ENRIQUE/A-2799-2008; Colilla, Montserrat/N-4628-2014;
   Esteban, Jaime/S-6554-2018; SANCHEZ-SALCEDO, SANDRA/N-4501-2014;
   Vallet-Regi, Maria/M-3378-2014
OI GOMEZ-BARRENA, ENRIQUE/0000-0003-1065-6137; Colilla,
   Montserrat/0000-0003-1961-4160; Esteban, Jaime/0000-0002-8971-3167;
   SANCHEZ-SALCEDO, SANDRA/0000-0002-1889-2057; Vallet-Regi,
   Maria/0000-0002-6104-4889
CR An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Bannerman TL, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P390
   Becker MW, 2003, GROUND WATER, V41, P682, DOI 10.1111/j.1745-6584.2003.tb02406.x
   BESSMAN AN, 1989, DIABETES, V38, P659, DOI 10.2337/diabetes.38.5.659
   Bohner M, 2001, EUR SPINE J, V10, pS114, DOI 10.1007/s005860100276
   Borum L, 2003, BIOMATERIALS, V24, P3681, DOI 10.1016/S0142-9612(03)00240-0
   Brokke P, 1991, J Biomater Appl, V5, P204, DOI 10.1177/088532829100500305
   DUCHEYNE P, 1992, J BIOMED MATER RES, V26, P147, DOI 10.1002/jbm.820260203
   Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HOGT AH, 1985, J GEN MICROBIOL, V131, P2485
   Jones DS, 1997, BIOMATERIALS, V18, P503, DOI 10.1016/S0142-9612(96)00170-6
   Katsaros D, 2004, IEEE INTERNET COMPUT, V8, P37, DOI 10.1109/MIC.2004.1297272
   Kim HJ, 1999, COLLOID SURFACE A, V149, P561, DOI 10.1016/S0927-7757(98)00765-1
   Konttinen YT, 2001, J BONE MINER RES, V16, P1780, DOI 10.1359/jbmr.2001.16.10.1780
   LEGEROS RZ, 1996, BIOCERAMICS, V9, P7
   LOCCI R, 1981, ZBL BAKT MIK HYG B, V173, P300
   Munoz OLS, 2003, ELECTROPHORESIS, V24, P390, DOI 10.1002/elps.200390049
   Pereira MA, 2000, J IND MICROBIOL BIOT, V24, P181, DOI 10.1038/sj.jim.2900799
   PRINGLE JH, 1986, APPL ENVIRON MICROB, V51, P1321
   RAO MKY, 1993, COLLOID SURFACE A, V79, P293, DOI 10.1016/0927-7757(93)80182-E
   REYNOLDS EC, 1983, INFECT IMMUN, V39, P1285
   Sanchez-Salcedo S, 2006, TISSUE ENG, V12, P279, DOI 10.1089/ten.2006.12.279
   Sari A, 2003, J CRANIOFAC SURG, V14, P919, DOI 10.1097/00001665-200311000-00016
   Smith O, 2004, J MATER SCI-MATER M, V15, P841, DOI 10.1023/B:JMSM.0000036270.68200.97
   Truesdail SE, 1998, J COLLOID INTERF SCI, V203, P369, DOI 10.1006/jcis.1998.5541
   Valle J, 2003, MOL MICROBIOL, V48, P1075, DOI 10.1046/j.1365-2958.2003.03493.x
   Vallet-Regi M, 2004, PROG SOLID STATE CH, V32, P1, DOI 10.1016/j.progsolidstchem.2004.07.001
   Vallet-Regi M, 2001, J CHEM SOC DALTON, P97, DOI 10.1039/b007852m
   Vallet-Regi M, 2006, DALTON T, P5211, DOI 10.1039/b610219k
   Wadstrom T, 1989, J Invest Surg, V2, P353, DOI 10.3109/08941938909018261
   Wang J, 2004, BIOMATERIALS, V25, P3163, DOI 10.1016/j.biomaterials.2003.10.010
   Washburn EW, 1921, P NATL ACAD SCI USA, V7, P115, DOI 10.1073/pnas.7.4.115
   Zamora N, 2007, CLIN MICROBIOL INFEC, V13, P902, DOI 10.1111/j.1469-0691.2007.01769.x
NR 35
TC 36
Z9 37
U1 1
U2 10
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 0022-2615
EI 1473-5644
J9 J MED MICROBIOL
JI J. Med. Microbiol.
PD JAN
PY 2009
VL 58
IS 1
BP 132
EP 137
DI 10.1099/jmm.0.002758-0
PG 6
WC Microbiology
SC Microbiology
GA 392PK
UT WOS:000262314400018
PM 19074665
OA Bronze
DA 2018-10-19
ER

PT J
AU Diaz, M
   Barba, F
   Miranda, M
   Guitian, F
   Torrecillas, R
   Moya, JS
AF Diaz, Marcos
   Barba, Flora
   Miranda, Miriam
   Guitian, Francisco
   Torrecillas, Ramon
   Moya, Jose S.
TI Synthesis and Antimicrobial Activity of a Silver-Hydroxyapatite
   Nanocomposite
SO JOURNAL OF NANOMATERIALS
LA English
DT Article
ID PROSTHETIC-JOINT INFECTIONS; ANTIBACTERIAL PROPERTIES; ESCHERICHIA-COLI;
   DENTAL IMPLANTS; BONE-CEMENT; NANOPARTICLES; ANTIBIOTICS; PROPHYLAXIS;
   RELEASE; CARE
AB A silver-hydroxyapatite nanocomposite has been obtained by a colloidal chemical route and subsequent reduction process in H(2)/Ar atmosphere at 350 degrees C. This material has been characterized by TEM, XRD, and UV-Visible spectroscopy, showing the silver nanoparticles (similar to 65 nm) supported onto the HA particles (similar to 130 nm) surface without a high degree of agglomeration. The bactericidal effect against common Gram-positive and Gram-negative bacteria has been also investigated. The results indicated a high antimicrobial activity for Staphylococcus aureus, Pneumococcus and Escherichia coli, so this material can be a promising antimicrobial biomaterial for implant and reconstructive surgery applications. Copyright (C) 2009 Marcos Diaz et al.
C1 [Miranda, Miriam; Torrecillas, Ramon] CSIC, CINN, Dept Nanostruct Mat, Oviedo 33011, Spain.
   [Diaz, Marcos; Moya, Jose S.] CSIC, Inst Ciencia Mat Madrid, Dept Biomat & Bioinspired Mat, E-28049 Madrid, Spain.
   [Barba, Flora] CSIC, Inst Ceram & Vidrio, Dept Ceram, E-28049 Madrid, Spain.
   [Guitian, Francisco] Univ Santiago de Compostela, Inst Ceram Galicia, Santiago De Compostela 15706, Spain.
RP Torrecillas, R (reprint author), CSIC, CINN, Dept Nanostruct Mat, Francisco Pintado Fe 26, Oviedo 33011, Spain.
EM r.torrecillas@cinn.es
RI Torrecillas, Ramon/G-7851-2011; Diaz, Marcos/G-5925-2014; Moya,
   Jose/I-5841-2013
OI Torrecillas, Ramon/0000-0003-3856-0217; Diaz,
   Marcos/0000-0001-7751-4913; 
FU Bioker Research S. L.; Spanish Ministry of Education and Science
   [20071210]
FX This work was supported by Bioker Research S. L. and by the Spanish
   Ministry of Education and Science under Project CENIT-INTELIMPLANT
   (ref.: 20071210). M. D ' iaz has been supported by SpanishMinistry of
   Education and Science and CSIC under I3P Program financed by European
   Social Fund. The authors thank Raul Pina for the technical support in
   the TEM study.
CR *AG HEALTHC RES QU, 2007, ORTH PROC INCR DRAM
   Alt V, 2004, BIOMATERIALS, V25, P4383, DOI 10.1016/j.biomaterials.2003.10.078
   Arumugam SK, 2007, J BIOMED MATER RES A, V80A, P391, DOI 10.1002/jbm.a.30895
   Bellantone M, 2002, ANTIMICROB AGENTS CH, V46, P1940, DOI 10.1128/AAC.46.6.1940-1945.2002
   Calhoun J H, 1994, Contemp Orthop, V28, P157
   Chen S, 2003, AUST DENT J, V48, P212, DOI 10.1111/j.1834-7819.2003.tb00034.x
   Chen W, 2007, J BIOMED MATER RES A, V82A, P899, DOI 10.1002/jbm.a.31197
   Chen W, 2006, BIOMATERIALS, V27, P5512, DOI 10.1016/j.biomaterials.2006.07.003
   Cho KH, 2005, ELECTROCHIM ACTA, V51, P956, DOI 10.1016/j.electacta.2005.04.071
   Chung RJ, 2005, J SOL-GEL SCI TECHN, V33, P229, DOI 10.1007/s10971-005-5618-1
   Cushing BL, 2004, CHEM REV, V104, P3893, DOI 10.1021/cr030027b
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Dunn K, 2004, BURNS, V30, pS1, DOI 10.1016/j.burns.2004.06.000
   GERHART TN, 1993, J ORTHOPAED RES, V11, P250, DOI 10.1002/jor.1100110212
   Han IH, 2007, BIOMED MATER, V2, pS91, DOI 10.1088/1748-6041/2/3/S01
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b
   JARCHO M, 1992, Dental Clinics of North America, V36, P19
   Kumar R, 2005, BIOMATERIALS, V26, P2081, DOI 10.1016/j.biomaterials.2004.05.030
   Leach W J, 1992, J R Coll Surg Edinb, V37, P265
   Lee D, 2005, LANGMUIR, V21, P9651, DOI 10.1021/la0513306
   Machtei EE, 2008, CLIN ORAL IMPLAN RES, V19, P259, DOI 10.1111/j.1600-0501.2007.01466.x
   MALCHAU H, 2006, WELL CEMENTED TOTAL, P291
   Panacek A, 2006, J PHYS CHEM B, V110, P16248, DOI 10.1021/jp063826h
   Percival SL, 2005, J HOSP INFECT, V60, P1, DOI 10.1016/j.jhin.2004.11.014
   Pourbaix M., 1974, ATLAS ELECTROCHEMICA
   Price JS, 1996, J BIOMED MATER RES, V30, P281, DOI 10.1002/(SICI)1097-4636(199603)30:3<281::AID-JBM2>3.0.CO;2-M
   Rameshbabu N, 2007, J BIOMED MATER RES A, V80A, P581, DOI 10.1002/jbm.a.30958
   Sambhy V, 2006, J AM CHEM SOC, V128, P9798, DOI 10.1021/ja061442z
   Shahverdi AR, 2007, NANOMED-NANOTECHNOL, V3, P168, DOI 10.1016/j.nano.2007.02.001
   Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012
   Sudo A, 2008, J ARTHROPLASTY, V23, P145, DOI 10.1016/j.arth.2006.09.009
   Tirrell M, 2002, SURF SCI, V500, P61, DOI 10.1016/S0039-6028(01)01548-5
   Trampuz A, 2005, SWISS MED WKLY, V135, P243
   Wu P, 2006, BIOMATERIALS, V27, P2450, DOI 10.1016/j.biomaterials.2005.11.031
   Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181
NR 36
TC 50
Z9 53
U1 5
U2 33
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 1687-4110
J9 J NANOMATER
JI J. Nanomater.
PY 2009
AR 498505
DI 10.1155/2009/498505
PG 6
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 465BP
UT WOS:000267555900001
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Sanchez, M
   Anitua, E
   Cugat, R
   Azofra, J
   Guadilla, J
   Seijas, R
   Andia, I
AF Sanchez, Mikel
   Anitua, Eduardo
   Cugat, Ramon
   Azofra, Juan
   Guadilla, Jorge
   Seijas, Roberto
   Andia, Isabel
TI Nonunions Treated With Autologous Preparation Rich in Growth Factors
SO JOURNAL OF ORTHOPAEDIC TRAUMA
LA English
DT Article
DE bone graft; fracture fixation; growth factors; nonunion; platelets;
   percutaneous injection
ID HUMAN TENDON CELLS; PLATELET GEL; FIBRIN MATRICES; PLASMA RICH; IGF-I;
   BONE; TGF-BETA-1; FUSIONS; PROLIFERATION; FIXATION
AB Objectives: To evaluate the clinical safety and efficacy of using a biologic technology known as preparation rich in growth factors (PRGF) for the treatment of nonhypertrophic nonunion.
   Design: The design of the study was a retrospective case series.
   Setting: The private practice was in 2 centers.
   Patients: There were 15 patients with a total of 16 aseptic non-unions, 12 diaphyseal and 4 supracondylar, diagnosed as nonhypertrophic. The mean time since prior surgical treatment was 21 months (9-46 months).
   Intervention: Supracondylar and diaphyseal nonunions followed surgical fixation with condylar plating or intramedullary nailing, whereas a composite biomaterial created by mixing PRGF with bone allograft was applied. The area was then covered with autologous fibrin membranes. Stable nonunions were treated with repeated percutaneous injections of PRGF; this minimally invasive procedure was also applied if delayed healing was suspected after surgical treatment.
   Main Outcome Measurements: Radiographic union using radiographic views was taken in 2 planes. Clinical outcome evaluated pain, motion at the fracture site upon manual stress testing, and recovery of range of motion.
   Results: All nonunions treated operatively heated after a single procedure, even though additional PRGF had to be injected in 2 patients. Two of 3 stable nonunions achieved healing only after repeated percutaneous PRGF injections. The mean time from surgery and/or PRGF application to union was 4.9 months (2-8 months). Complications associated with the described procedure were not observed.
   Conclusion: This study, although uncontrolled, shows that PRGF technology is clinically safe and can enhance the healing of nonhypertrophic nonunions.
C1 [Sanchez, Mikel; Azofra, Juan; Guadilla, Jorge] Clin USP La Esperanza, UCA, Vitoria, Spain.
   [Anitua, Eduardo; Andia, Isabel] BTI IMASD, Inst Biotechnol, Minano 01510, Alava, Spain.
   [Cugat, Ramon; Seijas, Roberto] Hosp Quiron, Inst Traumatol Quiron, Barcelona, Spain.
RP Andia, I (reprint author), BTI IMASD, Inst Biotechnol, Leonardo Da Vinci 14, Minano 01510, Alava, Spain.
EM isabel.andia@bti-imasd.com
RI Andia, Isabel/D-4853-2012; Anitua, Eduardo/O-1154-2018; Seijas,
   Roberto/F-1500-2016
OI Andia, Isabel/0000-0003-0607-4767; Anitua, Eduardo/0000-0002-8386-5303;
   Seijas, Roberto/0000-0003-1854-309X
FU Basque and Spanish Governments
FX Supported by the Basque and Spanish Governments.
CR Anitua E, 2006, TRENDS BIOTECHNOL, V24, P227, DOI 10.1016/j.tibtech.2006.02.010
   Anitua E, 2006, J BIOMED MATER RES A, V77A, P285, DOI 10.1002/jbm.a.30585
   Anitua E, 2005, J ORTHOP RES, V23, P281, DOI 10.1016/j.orthres.2004.08.015
   Anitua E, 2004, THROMB HAEMOSTASIS, V91, P4, DOI 10.1160/TH03-07-0440
   Anitua E, 1999, INT J ORAL MAX IMPL, V14, P529
   ANITUA E, 1999, INT J ORAL MAXILLOF, V13, P154
   Anitua E, 2008, TRENDS PHARMACOL SCI, V29, P37, DOI 10.1016/j.tips.2007.10.010
   Anitua E, 2008, J BIOMED MATER RES B, V84B, P415, DOI 10.1002/jbm.b.30886
   Anitua E, 2007, BIOMATERIALS, V28, P4551, DOI 10.1016/j.biomaterials.2007.06.037
   Anitua E, 2007, PLAST RECONSTR SURG, V119, P950, DOI 10.1097/01.prs.0000255543.43695.1d
   Anitua E, 2007, INT J ORAL MAX IMPL, V22, P138
   Carreon LY, 2005, SPINE, V30, pE243, DOI 10.1097/01.brs.0000160846.85397.44
   Castro FP, 2004, J SPINAL DISORD TECH, V17, P380, DOI 10.1097/01.bsd.0000110342.54707.19
   Everts PAM, 2006, ACTA ANAESTH SCAND, V50, P593, DOI 10.1111/j.1399-6576.2006.01005.x
   Everts PAM, 2006, GROWTH FACTORS, V24, P165, DOI 10.1080/08977190600821327
   Gandhi A, 2006, BONE, V38, P540, DOI 10.1016/j.bone.2005.10.019
   Lieberman JR, 2002, J BONE JOINT SURG AM, V84A, P1032, DOI 10.2106/00004623-200206000-00022
   Lowery GL, 1999, BONE, V25, p47S, DOI 10.1016/S8756-3282(99)00132-5
   Luginbuehl V, 2004, EUR J PHARM BIOPHARM, V58, P197, DOI 10.1016/j.ejpb.2004.03.004
   Mariconda M, 2008, J ORTHOP TRAUMA, V22, P342, DOI 10.1097/BOT.0b013e318172cea5
   Marx RE, 2004, J ORAL MAXIL SURG, V62, P489, DOI 10.1016/j.joms.2003.12.003
   Marx RE, 1998, ORAL SURG ORAL MED O, V85, P638, DOI 10.1016/S1079-2104(98)90029-4
   Nurden AT, 2008, FRONT BIOSCI-LANDMRK, V13, DOI 10.2741/2947
   Phieffer LS, 2006, J BONE JOINT SURG AM, V88A, P206, DOI 10.2106/00004623-200601000-00026
   ROUKIS TS, 2006, ADV THER, V23, P228
   Sanchez M, 2003, MED SCI SPORT EXER, V35, P1648, DOI 10.1249/01.MSS.0000089344.44434.50
   Sanchez M., 2003, CUADER ARTROSCOPIA, V10, P12
   Sanchez M, 2007, AM J SPORT MED, V35, P245, DOI 10.1177/0363546506294078
   Simpson AHRW, 2006, J BONE JOINT SURG BR, V88B, P701, DOI 10.1302/0301-620X.88B6
   Struijs PAA, 2007, J ORTHOP TRAUMA, V21, P507, DOI 10.1097/BOT.0b013e31812e5578
   Tomic S, 2007, J ORTHOP TRAUMA, V21, P549, DOI 10.1097/BOT.0b013e31814612c8
   Tsay RC, 2005, J ORAL MAXIL SURG, V63, P521, DOI 10.1016/j.joms.2004.09.012
   Weber BG, 1976, PSEUDOARTHROSIS PATH
   Weiner Bradley K., 2003, Spine, V28, P1968, DOI 10.1097/01.BRS.0000083141.02027.48
   Wildemann B, 2004, CALCIFIED TISSUE INT, V74, P388, DOI 10.1007/s00223-003-0117-2
   Wildemann B, 2003, J BIOMED MATER RES B, V65B, P150, DOI 10.1002/jbm.b.10512
   Zimmermann G, 2005, BONE, V36, P779, DOI 10.1016/j.bone.2005.02.011
   Zlowodzki M, 2006, J ORTHOP TRAUMA, V20, P366, DOI 10.1097/00005131-200605000-00013
NR 38
TC 45
Z9 49
U1 1
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0890-5339
J9 J ORTHOP TRAUMA
JI J. Orthop. Trauma
PD JAN
PY 2009
VL 23
IS 1
BP 52
EP 59
DI 10.1097/BOT.0b013e31818faded
PG 8
WC Orthopedics; Sport Sciences
SC Orthopedics; Sport Sciences
GA 392PN
UT WOS:000262314700008
PM 19104304
DA 2018-10-19
ER

PT J
AU Ryan, E
   Donnelly, R
   Gilmore, B
   Gorman, S
AF Ryan, E.
   Donnelly, R.
   Gilmore, B.
   Gorman, S.
TI Design of a polymeric delivery system incorporating a model
   bacteriophage for wound dressings and biomaterial coatings
SO JOURNAL OF PHARMACY AND PHARMACOLOGY
LA English
DT Meeting Abstract
C1 [Ryan, E.; Donnelly, R.; Gilmore, B.; Gorman, S.] Queens Univ Belfast, Belfast, Antrim, North Ireland.
EM eryan04@qub.ac.uk
CR Adams M. D., 1959, BACTERIOPHAGES
NR 1
TC 0
Z9 0
U1 0
U2 4
PU PHARMACEUTICAL PRESS-ROYAL PHARMACEUTICAL SOC GREAT BRITIAN
PI LONDON
PA 1 LAMBETH HIGH ST, LONDON SE1 7JN, ENGLAND
SN 0022-3573
J9 J PHARM PHARMACOL
JI J. Pharm. Pharmacol.
PY 2009
VL 61
MA 55
BP A42
EP A43
PG 2
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 496ID
UT WOS:000269962900056
DA 2018-10-19
ER

PT J
AU Kipnusu, WK
   Katana, G
   Migwi, CM
   Rathore, IVS
   Sangoro, JR
   Tsuwi, J
   Serghei, A
   Kremer, F
AF Kipnusu, W. K.
   Katana, G.
   Migwi, C. M.
   Rathore, I. V. S.
   Sangoro, J. R.
   Tsuwi, J.
   Serghei, A.
   Kremer, F.
TI Molecular Dynamics Characterization of Nandi Flame Seed Cuticle
   Biomaterial
SO JOURNAL OF POLYMER MATERIALS
LA English
DT Article
DE Nandi flame; biomaterial; cuticle
ID PLANT-CELL-WALLS; CELLULOSE; SPECTROSCOPY
AB Surface Probe Microscopy and Fourier Transform Infrared (FTIR) spectroscopy have been used to characterize Nandi flame Seed Cuticles (NFSC). The FTIR has revealed that cuticles are predominantly composed of Pectin and Cellulose. The surface analysis using Atomic Force Microscopy (AFM) has shown that the cuticles are porous with average pore size of 0.5nm. The cuticles also have highly oriented topography with pores concentrated within cavities that are spaced at regular intervals. Other regions showed intertwined ridges. Molecular dynamics of the cuticles have been analyzed using Dielectric spectroscopy (DS). From isochronal and isothermal DS loss plots, two dynamical molecular processes that are strongly dependent on temperature and frequency were observed. Using differential scanning calorimetry (DSC) the cuticles have been shown to have glass transition temperature of (T(g)) 54.5 degrees C and crystallization temperature (T(c)) of 352.4 degrees C.
C1 [Kipnusu, W. K.; Katana, G.; Migwi, C. M.; Rathore, I. V. S.] Kenyatta Univ, Dept Phys, Nairobi 00100, Kenya.
   [Sangoro, J. R.; Tsuwi, J.; Serghei, A.; Kremer, F.] Univ Leipzig, Inst Expt Phys 1, D-04103 Leipzig, Germany.
   [Tsuwi, J.] Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland.
RP Katana, G (reprint author), Kenyatta Univ, Dept Phys, POB 43844, Nairobi 00100, Kenya.
EM katana_gona@yahoo.com
RI Sangoro, Joshua/A-6573-2011
OI Sangoro, Joshua/0000-0002-5483-9528
CR Baker AA, 2000, BIOPHYS J, V79, P1139, DOI 10.1016/S0006-3495(00)76367-3
   Birnie A., 1997, WHAT TREE IS BEGINNE
   Chen L, 1997, J MICROSC-OXFORD, V188, P62, DOI 10.1046/j.1365-2818.1997.2470805.x
   CHENYANG L, 2006, MACROMOLECULES, V39, P8867
   DASGUPTA DK, 1978, J PHYS D APPL PHYS, V11, P955, DOI 10.1088/0022-3727/11/6/015
   Eduardo R., 2005, J MATER CHEM, V15, P3650, DOI 10.1039/b505640n
   Ek R, 1997, J MATER SCI, V32, P4807, DOI 10.1023/A:1018643300711
   Heckman EM, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2378400
   Hedvig P., 1977, DIELECTRIC SPECTROSC
   Jansson H, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.011901
   JURGEN E, 2004, CELLULOSE, V9, P225
   KATANA G, 1994, THESIS MAINZ
   Khare PK, 2000, B MATER SCI, V23, P17, DOI 10.1007/BF02708605
   Kovacs A. J., 1963, ADV POLYM SCI, V3, P394, DOI DOI 10.1007/BFB0050366
   MCCANN MC, 1993, J CELL SCI, V106, P1347
   SENE CFB, 1994, PLANT PHYSIOL, V106, P1623, DOI 10.1104/pp.106.4.1623
   Singh B, 2006, J APPL PHYS, V100, DOI 10.1063/1.2220488
   SKOOG DA, 1998, PRINCIPLES INSTRUMEN, P905
   Wojciechowski P, 2006, MATER SCI-POLAND, V24, P507
   YOUNG KJ, 1999, J MEMBRANE SCI, V163, P159
   Yu Z, 2007, APPL OPTICS, V46, P1507, DOI 10.1364/AO.46.001507
NR 21
TC 0
Z9 0
U1 0
U2 4
PU M D PUBLICATIONS
PI NEW DELHI
PA PRINTS INDIA, 11, DARYA GANJ, NEW DELHI, 110 002, INDIA
SN 0973-8622
J9 J POLYM MATER
JI J. Polym. Mater.
PD JAN-MAR
PY 2009
VL 26
IS 1
BP 129
EP 139
PG 11
WC Polymer Science
SC Polymer Science
GA 468VB
UT WOS:000267850900012
DA 2018-10-19
ER

PT S
AU Wang, LL
   Yang, JF
   Sun, KN
   Liu, AH
   Qiu, LP
   Li, AM
AF Wang, Lanlei
   Yang, Jiafeng
   Sun, Kangning
   Liu, Aihong
   Qiu, Liping
   Li, Aimin
BE Wang, H
   Hie, JRH
   Zhang, J
TI Preparation and Biocompatibility Study of Nano-Hydroxyapatite Composite
   Materials
SO JOURNAL OF SCIENTIFIC CONFERENCE PROCEEDINGS, VOL 1, NOS. 2 AND 3
SE Journal of Scientific Conference Proceedings
LA English
DT Proceedings Paper
CT 7th International Conference on Nanoscience and Technology
CY FEB 27-29, 2008
CL Chennai, INDIA
DE Nano Biomaterial; Hydroxyapatite; Chitosan; Biocompatibility; Tissue
   Engineering; Basic Fibroblast Growth Factor (bFGF)
ID FIBROBLAST-GROWTH-FACTOR; CHITOSAN; SCAFFOLD
AB In order to prepare scaffold materials for tissue engineering formed by nano-hydroxyapatite, Chitosan and growth factors (nHA/CS/bFGF) and to detect characterization and biocompatibility, we firstly adopt chemical precipitation to obtain nano-hydroxyapatite which is then mixed with chitosan in various mass ratios and handled by mechanical milling. Secondly, we add both pore-making agent and dichlorobenzene with the same masses into the above material, treat it by ball-milling and pour citric acid solution in to obtain the test sample after the procedure of blending, pressure and ejection. Disinfect it and dip into basic fibroblast growth factor, (bFGF) solution for freeze drying. Finally, we use both rotating target XRD and SEM to represent the sample composition and fractal characteristics and detect biocompatibility in accordance with ISO 16993-2002. The experimental results indicate that the sample material meets the design requirements with pores different in size and reaches the biological indicators, which shows it is suitable for tissue engineering material.
C1 [Wang, Lanlei] Sichuan Univ, Dept Orthodont, West China Coll Stomatol, Chengdu 610041, Sichuan, Peoples R China.
   [Yang, Jiafeng; Sun, Kangning; Liu, Aihong; Li, Aimin] Shandong Univ, Key Lab Liquid Struct & Hered Mat, Minist Educ, Jinan 250061, Shandong, Peoples R China.
   [Yang, Jiafeng; Qiu, Liping] Shandong Univ, Hosp 2, Dept Plast Surg, Jinan 250033, Shandong, Peoples R China.
RP Yang, JF (reprint author), Shandong Univ, Key Lab Liquid Struct & Hered Mat, Minist Educ, Jinan 250061, Shandong, Peoples R China.
FU National Natural Science Foundation of China [30540061]; Natural Science
   Fund of Shandong Province [Q2006C08]; Science and Technology Key Project
   of Shandong Province [2006GGB0157]
FX This work was supported by National Natural Science Foundation of China
   (30540061) Natural Science Fund of Shandong Province (Q2006C08) and
   Science and Technology Key Project of Shandong Province (2006GGB0157).
CR CHAN TMY, 1995, PROCEEDINGS OF THE SIXTH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P282, DOI 10.1109/SBEC.1995.514502
   Chen F, 2002, MATER LETT, V57, P858, DOI 10.1016/S0167-577X(02)00885-6
   Ehrlich H, 2006, J MEMBRANE SCI, V273, P124, DOI 10.1016/j.memsci.2005.11.050
   Finucane D, 1999, ENDOD DENT TRAUMATOL, V15, P273
   *GBT, 14233293 GBT
   *GBT, 16886111997 GBT 11
   GOSPONDAROWICZ D, 1990, CLIN ORTHOP RELAT R, V8, P231
   Hu QL, 2004, BIOMATERIALS, V25, P779, DOI 10.1016/S0142-9612(03)00582-9
   *ISO, 1993, 112681 ISO, P1
   KAWAGUCHI H, 1994, ENDOCRINOLOGY, V135, P774, DOI 10.1210/en.135.2.774
   Kim SE, 2003, J CONTROL RELEASE, V91, P365, DOI 10.1016/S0168-3659(03)00274-8
   KUMAR G, 2000, J POLYM, V6, P2157
   LI JJ, 2005, ORTHOP J CHIN, V17, P1334
   LI LH, 2005, J FUNCTIONAL POLYM, V2, P347
   LI QL, 2006, MATER LETT, V61, P1
   LIU AH, 2007, J SYNTHETIC CRYSTALS, V2, P276
   LU CX, 2006, CHEM IND ENG PROGR J, V7, P755
   Matsuda A, 2004, MAT SCI ENG C-BIO S, V24, P723, DOI 10.1016/j.msec.2004.08.047
   Nettles DL, 2002, TISSUE ENG, V8, P1009, DOI 10.1089/107632702320934100
   PHILLIPS GD, 1991, P SOC EXP BIOL MED, V2, P197
   Rossa C, 2000, J PERIODONTOL, V71, P775, DOI 10.1902/jop.2000.71.5.775
   Yamada S, 2003, J BIOMED MATER RES A, V66A, P500, DOI 10.1002/jbm.a.10009
   YANG JF, 2001, MODERN REHABILITATIO, V11, P102
   YANG JF, 2001, MODERN REHABILITATIO, V8, P102
   YANG JF, 2005, J WUHAN UNIV TECHNOL, V20, P144
   ZHANG L, 2003, J JINAN U NATURAL SC, V3, P86
   Zhang Y, 2002, J BIOMED MATER RES, V62, P378, DOI 10.1002/jbm.10312
   ZHAO DM, 2006, CHIN J ORTHOP, V11, P769
   ZHAO DM, 2006, CHIN J PLAST, V6, P461
   Zhao DM, 2007, CHINESE MED J-PEKING, V120, P1187
NR 30
TC 1
Z9 1
U1 0
U2 4
PU AMER  SCIENTIFIC  PUBLISHERS
PI STEVENSON RANCH
PA 25650 N LEWIS WY, STEVENSON RANCH, CA 91381-1439 USA
SN 1937-6456
J9 J SCI CONF PROC
PY 2009
VL 1
IS 2-3
BP 315
EP +
DI 10.1166/jcp.2009.1063
PG 3
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied; Physics, Condensed Matter
SC Science & Technology - Other Topics; Materials Science; Physics
GA BRH77
UT WOS:000282747200052
DA 2018-10-19
ER

PT J
AU Devillers, S
   Cuvelier, N
   Delhalle, J
   Mekhalif, Z
AF Devillers, S.
   Cuvelier, N.
   Delhalle, J.
   Mekhalif, Z.
TI Grafting PEG Fragments on Phynox Substrates Modified with
   11-Phosphoundecanoic Acid
SO JOURNAL OF THE ELECTROCHEMICAL SOCIETY
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYERS; NATIVE-OXIDE SURFACE; PHOSPHONIC ACID;
   ALUMINUM-OXIDE; ALKYLPHOSPHONIC ACID; OCTADECYLPHOSPHONIC ACID;
   ALKANEPHOSPHONIC ACIDS; TITANIUM SURFACES; TI45NB ALLOY; FILMS
AB Phynox, a cobalt-chromium alloy, exhibits interesting mechanical properties, making it a valuable material for several applications. However, applications as a biomaterial often require specific surface properties that can be imparted with suitable surface functionalizations. The aim of this work is to functionalize the Phynox surfaces with 11-phosphoundecanoic acid monolayers, creating a platform for a large variety of postgrafting chemical reactions, e. g., with alcohols and amines, to modify and control the surface properties. In the first part, we assess the interaction between the two terminal moieties of the 11-phosphoundecanoic acid and the Phynox surface by studying the grafting of n-dodecylphosphonic acid and n-dodecanoic acid. To illustrate the potential of the 11-phosphoundecanoic acid monolayer, we report on our first attempts to postgraft small poly(ethylene glycol) (PEG) fragments by the Steglich esterification reaction between the carboxylic end of the grafted 11-phosphoundecanoic acid molecules and the alcohol function of PEG fragments. (C) 2009 The Electrochemical Society. [DOI: 10.1149/1.3236479] All rights reserved.
C1 [Devillers, S.; Cuvelier, N.; Delhalle, J.; Mekhalif, Z.] Univ Namur, Fac Univ Notre Dame Paix, Lab Chem & Electrochem Surfaces, B-5000 Namur, Belgium.
RP Devillers, S (reprint author), Univ Namur, Fac Univ Notre Dame Paix, Lab Chem & Electrochem Surfaces, B-5000 Namur, Belgium.
EM zineb.mekhalif@fundp.ac.be
FU FUNDP and La Region Wallonne [516114]
FX This work has been supported by the FUNDP and La Region Wallonne (VISMAT
   project/convention no. 516114).
CR Adden N, 2006, LANGMUIR, V22, P8197, DOI 10.1021/la060754c
   Arnould C, 2009, J COLLOID INTERF SCI, V336, P497, DOI 10.1016/j.jcis.2009.03.092
   Arnould C, 2008, ELECTROCHIM ACTA, V53, P5632, DOI 10.1016/j.electacta.2008.03.003
   Bhushan B, 2006, MICROSYST TECHNOL, V12, P588, DOI 10.1007/s00542-006-0111-5
   Blajiev OL, 2008, PROG ORG COAT, V63, P272, DOI 10.1016/j.porgcoat.2007.11.007
   Brodard-Severac F, 2008, CHEM MATER, V20, P5191, DOI 10.1021/cm8012683
   Brukman MJ, 2006, LANGMUIR, V22, P3988, DOI 10.1021/la052847k
   Chen YX, 2001, MATER RES BULL, V36, P2605, DOI 10.1016/S0025-5408(01)00731-0
   Ferreira JM, 2005, J COLLOID INTERF SCI, V286, P258, DOI 10.1016/j.jcis.2004.11.008
   FOLKERS JP, 1995, LANGMUIR, V11, P813, DOI 10.1021/la00003a024
   Forget L, 2003, APPL SURF SCI, V205, P44, DOI 10.1016/S0169-4332(02)00937-6
   Gadegaard N, 2008, LANGMUIR, V24, P2057, DOI 10.1021/la701733n
   Gao W, 1996, LANGMUIR, V12, P6429, DOI 10.1021/la9607621
   Gawalt ES, 2001, LANGMUIR, V17, P5736, DOI 10.1021/la010649x
   Giza M, 2008, LANGMUIR, V24, P8688, DOI 10.1021/la8000619
   Gnauck M, 2007, LANGMUIR, V23, P377, DOI 10.1021/la0606648
   Gouzman I, 2006, SURF SCI, V600, P773, DOI 10.1016/j.susc.2005.11.030
   Griep-Raming N, 2004, LANGMUIR, V20, P11811, DOI 10.1021/la0485327
   Hanson EL, 2003, J AM CHEM SOC, V125, P16074, DOI 10.1021/ja035956z
   Hauffman T, 2008, LANGMUIR, V24, P13450, DOI 10.1021/la801978a
   Helmy R, 2002, LANGMUIR, V18, P8924, DOI 10.1021/la0262506
   Hofer R, 2001, LANGMUIR, V17, P4014, DOI 10.1021/la001756e
   Hoque E, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2186311
   Hoque E, 2007, J PHYS CHEM C, V111, P3956, DOI 10.1021/jp066101m
   Hoque E, 2006, J PHYS CHEM B, V110, P10855, DOI 10.1021/jp061327a
   Hsu CW, 2008, J COLLOID INTERF SCI, V324, P236, DOI 10.1016/j.jcis.2008.04.037
   Hsu CW, 2009, J COLLOID INTERF SCI, V329, P182, DOI 10.1016/j.jcis.2008.10.008
   Kanta A, 2006, COLLOID SURFACE A, V291, P51, DOI 10.1016/j.colsurfa.2005.12.057
   Kim CS, 2001, SENSOR ACTUAT B-CHEM, V76, P442, DOI 10.1016/S0925-4005(01)00653-0
   Liakos IL, 2007, LANGMUIR, V23, P995, DOI 10.1021/la062233v
   Luschtinetz R, 2008, SURF SCI, V602, P1347, DOI 10.1016/j.susc.2008.01.035
   Maege I, 1997, PROG ORG COAT, V34, P1
   Mani G, 2008, LANGMUIR, V24, P6774, DOI 10.1021/la8003646
   Marcinko S, 2004, LANGMUIR, V20, P2270, DOI 10.1021/la034914l
   McNatt JS, 2003, LANGMUIR, V19, P1148, DOI 10.1021/la0265979
   Midwood KS, 2004, LANGMUIR, V20, P5501, DOI 10.1021/la049506b
   Minet I, 2009, J COLLOID INTERF SCI, V332, P317, DOI 10.1016/j.jcis.2008.12.066
   Mutin PH, 2003, CR CHIM, V6, P1153, DOI 10.1016/j.crci.2003.07.006
   Nie HY, 2006, J PHYS CHEM B, V110, P21101, DOI 10.1021/jp062811g
   Park H, 2006, J PHYS CHEM B, V110, P8740, DOI 10.1021/jp060397e
   Paszternak A, 2007, ELECTROCHIM ACTA, V53, P337, DOI 10.1016/j.electacta.2007.04.005
   Pellerite MJ, 2003, J PHYS CHEM B, V107, P11726, DOI 10.1021/jp0354200
   Philippin G, 2003, APPL SURF SCI, V212, P530, DOI 10.1016/S0169-4332(03)00051-5
   Pilbath A, 2009, SURF COAT TECH, V203, P1182, DOI 10.1016/j.surfcoat.2008.10.016
   Pilbath A, 2008, APPL SURF SCI, V255, P1841, DOI 10.1016/j.apsusc.2008.06.039
   Podstawka E, 2007, SURF SCI, V601, P4586, DOI 10.1016/j.susc.2007.07.013
   Quinones R, 2008, THIN SOLID FILMS, V516, P8774, DOI 10.1016/j.tsf.2008.06.055
   Quinones R, 2007, LANGMUIR, V23, P10123, DOI 10.1021/la701110p
   Quinones R, 2007, SURF INTERFACE ANAL, V39, P593, DOI 10.1002/sia.2561
   Raman A, 2006, LANGMUIR, V22, P6469, DOI 10.1021/la060636p
   Schwartz J, 2003, MAT SCI ENG C-BIO S, V23, P395, DOI 10.1016/S0928-4931(02)00310-7
   Silverman BM, 2005, LANGMUIR, V21, P225, DOI 10.1021/la0482271
   Sun SQ, 2007, NANO LETT, V7, P3753, DOI 10.1021/nl072181
   Tsud N, 2007, SURF SCI, V601, P3060, DOI 10.1016/j.susc.2007.05.007
   Van Alsten JG, 1999, LANGMUIR, V15, P7605, DOI 10.1021/la981694g
   Viornery C, 2002, LANGMUIR, V18, P2582, DOI 10.1021/la010908i
   Wapner K, 2008, INT J ADHES ADHES, V28, P59, DOI 10.1016/j.ijadhadh.2007.05.001
   Zorn G, 2007, J MATER SCI-MATER M, V18, P1309, DOI 10.1007/s10856-006-0117-7
   Zorn G, 2005, CHEM MATER, V17, P4218, DOI 10.1021/cm050477f
   Zoulalian V, 2006, J PHYS CHEM B, V110, P25603, DOI 10.1021/jp066811s
NR 60
TC 7
Z9 7
U1 0
U2 7
PU ELECTROCHEMICAL SOC INC
PI PENNINGTON
PA 65 SOUTH MAIN STREET, PENNINGTON, NJ 08534 USA
SN 0013-4651
J9 J ELECTROCHEM SOC
JI J. Electrochem. Soc.
PY 2009
VL 156
IS 12
BP P177
EP P184
DI 10.1149/1.3236479
PG 8
WC Electrochemistry; Materials Science, Coatings & Films
SC Electrochemistry; Materials Science
GA 512BZ
UT WOS:000271218900087
DA 2018-10-19
ER

PT J
AU Chen, H
   Shan, ZH
AF Chen Hui
   Shan Zhi-Hua
TI THE REACTION MECHANISM BETWEEN COLLAGEN AND PHENOL OXAZOLIDINE E TANNING
   MATRICES
SO JOURNAL OF THE SOCIETY OF LEATHER TECHNOLOGISTS AND CHEMISTS
LA English
DT Article
ID STABILIZATION; STABILITY
AB Collagen, a unique connective tissue protein finds extensive application as biomaterial in wound healing, as drug carrier, cosmetics, etc. A work has been undertaken to study the stabilization of collagen using di and trihydric phenols -oxazolidine E Tanning Matrices.
   Resorcinol-oxazolidine E Tanning Matrix treated collagen has been found to be more stable than that of sequential combination tannages with the same materials. The study has demonstrated that oxazolidine E underwent ring opening to form the N-methylol intermediate and reacted with the hydrogen bonds of resorcinol to form the Tanning Matrix. The Tanning Matrix then penetrated into the collagen fibres and by aggregation prevented the denaturation of collagen fibres with heating. The next reaction is the involvement of hydrogen bonds and hydrophobic interactions, and the aldehyde groups of oxazolidine E in reaction with basic amino acid side chains of collagen as the major force involved in the stabilization of collagen. In this way, a multiple point combination tanning occurs with the Tanning Matrix creating a high level stabilization of collagen and high hydrothermal stability.
C1 [Chen Hui; Shan Zhi-Hua] Sichuan Univ, Key Lab Leather Engn Dept, Chengdu 61006, Peoples R China.
RP Chen, H (reprint author), Sichuan Univ, Key Lab Leather Engn Dept, Chengdu 61006, Peoples R China.
FU Doctoral program of Higher Education [20050610046]; National Science
   Foundation of China [50573051]; Sichuan University Young Fund [07062];
   National Plan 973 [2007CB616909]
FX The authors would like to thank the Research Fund for the Doctoral
   program of Higher Education (No:20050610046) and National Science
   Foundation of China (No:50573051) for financial support, we would also
   like to thank Sichuan University Young Fund (No. 07062) and National
   Plan 973 (No. 2007CB616909).
CR Bigi A, 2001, BIOMATERIALS, V22, P763, DOI 10.1016/S0142-9612(00)00236-2
   BURTON D, 1953, J SOC LEATHER TRADE, V37, P219
   Choudhury SD, 2007, J AGR FOOD CHEM, V55, P6813, DOI 10.1021/jf070025i
   CHOUDHURY SD, 2007, INT J BIOL MACROMOL, P351
   COHENA NS, 2000, THERMOCHIM ACTA, P111
   Dasgupta S, 2002, J SOC LEATH TECH CH, V86, P188
   EVANS CS, 2007, J SOC LEATHER TECHNO, V91, P188
   Gustavson K. H, 1956, CHEM TANNING PROCESS
   Jia PX, 2007, J AM LEATHER CHEM AS, V102, P227
   Lu ZB, 2003, J SOC LEATH TECH CH, V87, P173
   Tang HR, 2003, J AGR FOOD CHEM, V51, P6652, DOI 10.1021/jf034380u
   TANG HR, 2003, BIOPOLYMERS IN PRESS
   THOMAS AW, 1956, J AM LEATHER CHEM AS, V51, P235
   Usha R, 2006, COLLOID SURFACE B, V48, P101, DOI 10.1016/j.colsurfb.2006.01.015
NR 14
TC 2
Z9 2
U1 0
U2 4
PU SOC LEATHER TECHNOL CHEMISTS
PI MOULTON
PA 8 COPPER LEAF CLOSE, MOULTON NN3 7HS, NORTHAMPTON, ENGLAND
SN 0144-0322
J9 J SOC LEATH TECH CH
JI J. Soc. Leather Technol. Chem.
PD JAN-FEB
PY 2009
VL 93
IS 1
BP 21
EP 25
PG 5
WC Materials Science, Textiles
SC Materials Science
GA 415LU
UT WOS:000263936100005
DA 2018-10-19
ER

PT J
AU Joska, L
   Fojt, J
   Vesely, J
AF Joska, L.
   Fojt, J.
   Vesely, J.
TI Corrosion behaviour of titanium alloyed by molybdenum
SO KOVOVE MATERIALY-METALLIC MATERIALS
LA English
DT Article
DE titanium; molybdenum; titanium beta alloys; fluorides; corrosion
ID NB-ZR-TA; FLUORIDE CONCENTRATION; STRENGTHENING MECHANISMS; PH;
   RESISTANCE; TRANSFORMATION; FE
AB Titanium is a metallic biomaterial used for a long period of time. The current interest is focused on P titanium alloys; molybdenum is one of the elements that close the alpha region effectively. The objective of this work was to prepare titanium-molybdenum experimental alloys and to describe their corrosion properties in environments interesting from application in dentistry point of view.
   The measurements were done using Ti grade 2, Ti15Mo and Ti30Mo alloys. Corrosion properties were studied in the physiological solution at three pH levels and fluoride ions content up to 5000 ppm. Measurements were done by standard electrochemical techniques.
   Corrosion properties of the studied alloys were at higher pH values comparable with the properties of titanium. Decrease of pH and presence of fluorides resulted in the case of titanium in pronounced decrease of corrosion resistance. The change was not so sharp for alloys, alloying resulted in improvement of corrosion behaviour.
C1 [Joska, L.; Fojt, J.] Inst Chem Technol, Dept Met & Corros Engn, CR-16628 Prague 6, Czech Republic.
   [Vesely, J.] UJP As, Prague 15610 5, Czech Republic.
RP Joska, L (reprint author), Inst Chem Technol, Dept Met & Corros Engn, Tech 5, CR-16628 Prague 6, Czech Republic.
EM joskal@vscht.cz
OI Fojt, Jaroslav/0000-0002-1425-5464
FU Ministry of Education, Youth and Sports of the Czech Republic [MSM
   6046137302]
FX This study was supported by the research project MSM 6046137302
   (Ministry of Education, Youth and Sports of the Czech Republic).
CR Rezende MCRA, 2007, J MATER SCI-MATER M, V18, P149, DOI 10.1007/s10856-006-0674-9
   Banerjee R, 2004, BIOMATERIALS, V25, P3413, DOI 10.1016/j.biomaterials.2003.10.041
   BOERE G, 1995, J APPL BIOMATER, V6, P283, DOI 10.1002/jab.770060409
   Dekker M., 1985, STANDARD POTENTIALS
   Elias LM, 2006, MAT SCI ENG A-STRUCT, V432, P108, DOI 10.1016/j.msea.2006.06.013
   Fovet Y, 2001, TALANTA, V53, P1053, DOI 10.1016/S0039-9140(00)00592-0
   Gonzalez JEG, 1999, J ELECTROANAL CHEM, V471, P109, DOI 10.1016/S0022-0728(99)00260-0
   Hanada S., 2005, INT C SER, V1284, P239, DOI DOI 10.1016/J.ICS.2005.06.084
   Hashimoto K, 2007, CORROS SCI, V49, P42, DOI 10.1016/j.corsci.2006.05.003
   JABLOKOV VR, 2005, J ASTM INT, V2, P8
   Lin DJ, 2002, BIOMATERIALS, V23, P1723, DOI 10.1016/S0142-9612(01)00233-2
   Murray JL, 1987, PHASE DIAGRAMS BINAR
   Nag S, 2005, MAT SCI ENG C-BIO S, V25, P357, DOI 10.1016/j.msec.2004.12.013
   Nakagawa M, 1999, J DENT RES, V78, P1568, DOI 10.1177/00220345990780091201
   Oliveira NTC, 2007, MAT SCI ENG A-STRUCT, V452, P727, DOI 10.1016/j.msea.2006.11.061
   Pourbaix M., 1974, ATLAS ELECTROCHEMICA
   Robin A, 2007, J APPL ELECTROCHEM, V37, P511, DOI 10.1007/s10800-006-9283-z
   Schiff N, 2002, BIOMATERIALS, V23, P1995, DOI 10.1016/S0142-9612(01)00328-3
   ToumelinChemla F, 1996, J DENT, V24, P109, DOI 10.1016/0300-5712(95)00033-X
   Yang GJ, 2005, J ALLOY COMPD, V392, P291, DOI 10.1016/j.jallcom.2004.08.099
   YONTCHEV E, 1986, J ORAL REHABIL, V13, P365, DOI 10.1111/j.1365-2842.1986.tb00671.x
   Yu ZT, 2006, MAT SCI ENG A-STRUCT, V438, P391, DOI 10.1016/j.msea.2005.12.079
NR 23
TC 0
Z9 0
U1 0
U2 6
PU REDAKCIA KOVOVE MATERIALY
PI BRATISLAVA 38
PA UL RACIANSKA 75, PO BOX 95, 830 08 BRATISLAVA 38, SLOVAKIA
SN 0023-432X
J9 KOVOVE MATER
JI Kov. Mater.-Met. Mater.
PY 2009
VL 47
IS 5
BP 309
EP 315
PG 7
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 538IQ
UT WOS:000273178200004
DA 2018-10-19
ER

PT J
AU Pernagallo, S
   Diaz-Mochon, JJ
   Bradley, M
AF Pernagallo, Salvatore
   Diaz-Mochon, Juan Jose
   Bradley, Mark
TI A cooperative polymer-DNA microarray approach to biomaterial
   investigation
SO LAB ON A CHIP
LA English
DT Article
ID GENE-EXPRESSION; CELL INTERACTION; STEM-CELLS; TISSUE; SCALE; LEUKEMIA;
   SURFACE; PROLIFERATION; SCIENCE; BINDING
AB In this study, polymer microarrays were used for the rapid identification of polymer substrates upon which a suspension cell line would both adhere and proliferate giving a detailed and rapid understanding of cell-biomaterial interactions. Analysis demonstrated that suspension K562 human erythroleukemic cells, which normally grow in suspension, adhered and proliferated on several different polymers. Phenotypic and transcriptomic analysis techniques allowed examination of the interaction between cells and polymers permitting the elucidation of putative links between phenotypic responses to cell-biomaterial interactions and global gene expression.
C1 [Pernagallo, Salvatore; Diaz-Mochon, Juan Jose; Bradley, Mark] Univ Edinburgh, Sch Chem, Edinburgh EH9 3JJ, Midlothian, Scotland.
RP Bradley, M (reprint author), Univ Edinburgh, Sch Chem, Joseph Black Bldg,Kings Bldg,W Main Rd, Edinburgh EH9 3JJ, Midlothian, Scotland.
EM Mark.Bradley@ed.ac.uk
RI Diaz-Mochon, Juan/A-4297-2009; Pernagallo, Salvatore/B-4739-2009
OI Diaz-Mochon, Juan/0000-0002-3599-1954; 
FU Engineering and Physical Sciences Research Council [EP/C54157X/1,
   EP/C54112X/1]
CR Allen LT, 2003, P NATL ACAD SCI USA, V100, P6331, DOI 10.1073/pnas.1031426100
   Anderson DG, 2004, SCIENCE, V305, P1923, DOI 10.1126/science.1099987
   Anderson DG, 2005, BIOMATERIALS, V26, P4892, DOI 10.1016/j.biomaterials.2004.11.052
   Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   Calcabrini A, 1999, J MATER SCI-MATER M, V10, P613, DOI 10.1023/A:1008983623840
   Carinci F, 2003, J BIOMED MATER RES B, V66B, P341, DOI 10.1002/jbm.b.10021
   Chaterji S, 2007, PROG POLYM SCI, V32, P1083, DOI 10.1016/j.progpolymsci.2007.05.018
   Chen QZ, 2008, MAT SCI ENG R, V59, P1, DOI 10.1016/j.mser.2007.08.001
   Demoulin JB, 2004, J BIOL CHEM, V279, P35392, DOI 10.1074/jbc.M405924200
   Diaz-Mochon JJ, 2007, CHEM SOC REV, V36, P449, DOI 10.1039/b511848b
   DOHERTY PJ, 1992, BIOM TISS INT 2 CONS
   Garrigues GE, 2005, BIOMATERIALS, V26, P2933, DOI 10.1016/j.biomaterials.2004.06.034
   GREIGER B, 2001, NAT REV MOL CELL BIO, V2, P793
   HARTLEY JW, 1977, P NATL ACAD SCI USA, V74, P789, DOI 10.1073/pnas.74.2.789
   Hewes JD, 2002, APPL SURF SCI, V189, P196, DOI 10.1016/S0169-4332(01)01005-4
   Hubbell JA, 2004, NAT BIOTECHNOL, V22, P828, DOI 10.1038/nbt0704-828
   Itthichaisri C, 2007, J BIOMED MATER RES A, V82A, P777, DOI 10.1002/jbm.a.31191
   KARIN M, 1984, ENVIRON HEALTH PERSP, V54, P111, DOI 10.2307/3429797
   Klapperich CM, 2004, BIOMATERIALS, V25, P5631, DOI 10.1016/j.biomaterials.2004.01.025
   KLEIN E, 1976, INT J CANCER, V18, P421, DOI 10.1002/ijc.2910180405
   Ku CH, 2002, BIOMATERIALS, V23, P4193, DOI 10.1016/S0142-9612(02)00161-8
   Lariviere L, 2006, NAT STRUCT MOL BIOL, V13, P895, DOI 10.1038/nsmb1143
   LOZZIO CB, 1975, BLOOD, V45, P321
   Ma PX, 2008, ADV DRUG DELIVER REV, V60, P184, DOI 10.1016/j.addr.2007.08.041
   Ma ZW, 2007, COLLOID SURFACE B, V60, P137, DOI 10.1016/j.colsurfb.2007.06.019
   Mant A, 2006, BIOMATERIALS, V27, P5299, DOI 10.1016/j.biomaterials.2006.04.040
   Mefti N, 2006, INT J SOLIDS STRUCT, V43, P7378, DOI 10.1016/j.ijsolstr.2006.05.006
   Mizomoto H., 2004, THESIS U SOUTHAMPTON
   Nadeau V, 2005, POLYMER, V46, P11263, DOI 10.1016/j.polymer.2005.09.079
   Pernagallo S, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034112
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Thaburet JFO, 2004, MACROMOL RAPID COMM, V25, P366, DOI 10.1002/marc.200300234
   Tourniaire G, 2006, CHEM COMMUN, P2118, DOI 10.1039/b602009g
   Unciti-Broceta A, 2008, J COMB CHEM, V10, P179, DOI 10.1021/cc7001556
   Wang JH, 2006, BIOMATERIALS, V27, P3441, DOI 10.1016/j.biomaterials.2006.02.002
   WHEELER DB, 2005, NAT GENET, V37, P25
   Zhang HQ, 2003, MACROMOL RAPID COMM, V24, P81, DOI 10.1002/marc.200390002
   Zhang R, 2008, CHEM COMMUN, P1317, DOI 10.1039/b717932d
   Ziauddin J, 2001, NATURE, V411, P107, DOI 10.1038/35075114
NR 39
TC 24
Z9 24
U1 2
U2 6
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1473-0197
J9 LAB CHIP
JI Lab Chip
PY 2009
VL 9
IS 3
BP 397
EP 403
DI 10.1039/b808363k
PG 7
WC Biochemical Research Methods; Chemistry, Multidisciplinary; Chemistry,
   Analytical; Nanoscience & Nanotechnology
SC Biochemistry & Molecular Biology; Chemistry; Science & Technology -
   Other Topics
GA 397FZ
UT WOS:000262649600004
PM 19156288
DA 2018-10-19
ER

PT J
AU Lee, SA
   Chung, SE
   Park, W
   Lee, SH
   Kwon, S
AF Lee, Seung Ah
   Chung, Su Eun
   Park, Wook
   Lee, Sung Hoon
   Kwon, Sunghoon
TI Three-dimensional fabrication of heterogeneous microstructures using
   soft membrane deformation and optofluidic maskless lithography
SO LAB ON A CHIP
LA English
DT Article
ID MICRO-STEREOLITHOGRAPHY; MICROFLUIDIC CHANNELS; FLOW LITHOGRAPHY; PHASE
   MASKS; NANOSTRUCTURES; HYDROGELS; PHOTOPOLYMERIZATION; PARTICLES;
   PLATFORM; DEVICES
AB We propose a method for high-throughput generation of 3D microstructures using a membrane-mounted microfluidic channel. Utilizing an optofluidic maskless lithography system, photopolymerized 3D microstructures are fabricated in a layer-by-layer fashion with the thickness of each layer controlled by the deformation of the membrane. The combination of low numerical aperture optical systems for photopolymerization and a soft membrane for height control allows large area projection lithography with high vertical resolution, overcoming the trade-off between vertical resolution and the field-of-view. The material composition of each layer is varied using microfluidic control of photocurable resin and composite microstructures with heterogeneity in both lateral and vertical directions are generated. Using this technique, we demonstrate three-dimensional patterning of different types of cells in a hydrogel for a microfluidic platform to study co-culture and cell-to-cell interactions. The proposed technique is fast and simple, allowing parallel synthesis of complex heterogeneous 3D microstructures and in situ biomaterial patterning for microfluidic bioassays.
C1 [Lee, Seung Ah; Chung, Su Eun; Park, Wook; Lee, Sung Hoon; Kwon, Sunghoon] Seoul Natl Univ, Sch Elect Engn & Comp Sci, Seoul 151744, South Korea.
RP Kwon, S (reprint author), Seoul Natl Univ, Sch Elect Engn & Comp Sci, San 56-1,Sillim Dong, Seoul 151744, South Korea.
EM skwon@snu.ac.kr
FU KOSEF; Korea government (MEST) [2008-05446]; Seoul RBD program
   [NT070084]; Ministry of Knowledge Economy
FX This work was partly supported by the NSI-NCRC project of KOSEF, the
   KOSEF grant funded by the Korea government (MEST) (2008-05446), the
   Seoul R&BD program(NT070084) and the SystemIC 2010 project of the
   Ministry of Knowledge Economy.
CR Beebe DJ, 2000, P NATL ACAD SCI USA, V97, P13488, DOI 10.1073/pnas.250273097
   Cheung YK, 2007, LAB CHIP, V7, P574, DOI 10.1039/b700869d
   Chung SE, 2008, NAT MATER, V7, P581, DOI 10.1038/nmat2208
   Chung SE, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2759988
   Dendukuri D, 2006, NAT MATER, V5, P365, DOI 10.1038/nmat1617
   Dendukuri D, 2008, MACROMOLECULES, V41, P8547, DOI 10.1021/ma801219w
   Du YA, 2008, P NATL ACAD SCI USA, V105, P9522, DOI 10.1073/pnas.0801866105
   Grover WH, 2003, SENSOR ACTUAT B-CHEM, V89, P315, DOI 10.1016/S0925-4005(02)00468-9
   Harmon ME, 2003, POLYMER, V44, P4547, DOI 10.1016/S0032-3861(03)00463-4
   Hsu CH, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1850593
   Jang JH, 2007, ANGEW CHEM INT EDIT, V46, P9027, DOI 10.1002/anie.200703525
   Jeon S, 2004, P NATL ACAD SCI USA, V101, P12428, DOI 10.1073/pnas.0403048101
   Kim MS, 2007, BIOMED MICRODEVICES, V9, P25, DOI 10.1007/s10544-006-9016-4
   Koh WG, 2006, ANAL BIOANAL CHEM, V385, P1389, DOI 10.1007/s00216-006-0571-6
   Liu VA, 2002, BIOMED MICRODEVICES, V4, P257, DOI 10.1023/A:1020932105236
   Maruo S, 1997, OPT LETT, V22, P132, DOI 10.1364/OL.22.000132
   Olsen KG, 2002, ANAL CHEM, V74, P1436, DOI 10.1021/ac0156969
   Panda P, 2008, LAB CHIP, V8, P1056, DOI 10.1039/b804234a
   Pregibon DC, 2007, SCIENCE, V315, P1393, DOI 10.1126/science.1134929
   Shir D, 2008, NANO LETT, V8, P2236, DOI 10.1021/nl080841k
   Sun C, 2005, SENSOR ACTUAT A-PHYS, V121, P113, DOI 10.1016/j.sna.2004.12.011
   Tan W, 2004, BIOMATERIALS, V25, P1355, DOI 10.1016/j.biomaterials.2003.08.021
   Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113
   Yeh J, 2006, BIOMATERIALS, V27, P5391, DOI 10.1016/j.biomaterials.2006.06.005
   Zaumseil J, 2003, NANO LETT, V3, P1223, DOI 10.1021/nl0344007
   Zhang X, 1999, SENSOR ACTUAT A-PHYS, V77, P149, DOI 10.1016/S0924-4247(99)00189-2
NR 26
TC 64
Z9 64
U1 5
U2 50
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1473-0197
J9 LAB CHIP
JI Lab Chip
PY 2009
VL 9
IS 12
BP 1670
EP 1675
DI 10.1039/b819999j
PG 6
WC Biochemical Research Methods; Chemistry, Multidisciplinary; Chemistry,
   Analytical; Nanoscience & Nanotechnology
SC Biochemistry & Molecular Biology; Chemistry; Science & Technology -
   Other Topics
GA 453MZ
UT WOS:000266616000004
PM 19495448
DA 2018-10-19
ER

PT J
AU Fabela-Sanchez, O
   Zarate-Trivino, DG
   Elizalde-Pena, EA
   Garcia-Carvajal, Z
   Sanchez, IC
   Parra-Cid, C
   Gomez-Garcia, R
   Ibarra, C
   Garcia-Gaitan, B
   Zavala, R
   Guevara-Olvera, L
   Villasenor-Ortega, F
   Munoz-Sanchez, CI
   Perez-Perez, C
   Herrera-Perez, S
   Velasquillo, C
   Luna-Barcenas, G
   Solis, L
AF Fabela-Sanchez, O.
   Zarate-Trivino, D. G.
   Elizalde-Pena, E. A.
   Garcia-Carvajal, Z.
   Sanchez, I. C.
   Parra-Cid, C.
   Gomez-Garcia, R.
   Ibarra, C.
   Garcia-Gaitan, B.
   Zavala, R.
   Guevara-Olvera, L.
   Villasenor-Ortega, F.
   Munoz-Sanchez, C. I.
   Perez-Perez, C.
   Herrera-Perez, S.
   Velasquillo, C.
   Luna-Barcenas, G.
   Solis, L.
TI Mammalian Cell Culture on a Novel Chitosan-Based Biomaterial Crosslinked
   with Gluteraldehyde
SO MACROMOLECULAR SYMPOSIA
LA English
DT Proceedings Paper
CT 1st US-Mexican Symposium on Advances in Polymer Science
CY DEC 07-10, 2008
CL Los Cabos, MEXICO
SP Mexican Polymer Soc, Amer Chem Soc, Polymer Chem Div, Natl Council Sci & Technol, CIQA, FUMEC, US Off Naval Res Global
DE cell culture; chitosan; crosslinking; tissues engineering; xanthan
ID XANTHAN GUM; HYDROGELS; CHITIN; DEGRADATION; RECRUITMENT; DESIGN
AB A novel (Chitosan-g-Glycidyl Methacrylate)-Xanthan, (CTS-g-GMA)-X, hydrogel was successfully synthesized at Cinvestav Queretaro. in the present work, we attempt to study the in vitro biocompatibility of (CTS-g-GMA)-X hydrogels as scaffolds for neural cells obtained from cerebral cortex of mice; skin cells from skin of mice; and chondrocytes from human cartilage. The results obtained in the live/dead assay show that the materials maintain the morphology and viability of the cells. However the high friability of the materials prevented an extended test time in this assay. Therefore, glutaraldehyde (GL) was added to the structure as crosslinking agent to enhance friability. All results point out that [(CTS-g-GMA)-X]-GL hydrogel is viable as a scaffold for chondrocytes and skin cells; and (CTS-g-GMA)-X for neural cell due to their physicochemical properties and biocompatibility with the cells for both materials.
C1 [Parra-Cid, C.; Gomez-Garcia, R.; Ibarra, C.; Velasquillo, C.; Solis, L.] Inst Nacl Rehabil, Tissue Engn Cell Therapy & Regenerat Med Unit, Mexico City, DF, Mexico.
   [Fabela-Sanchez, O.; Guevara-Olvera, L.; Villasenor-Ortega, F.; Munoz-Sanchez, C. I.; Perez-Perez, C.; Herrera-Perez, S.] Inst Tecnol Celaya, Dept Biochem Engn, Celaya 38010, Gto, Mexico.
   [Zarate-Trivino, D. G.; Elizalde-Pena, E. A.; Garcia-Carvajal, Z.; Luna-Barcenas, G.] CINVESTAV Queretaro, Polymer & Biopolymer Res Grp, Queretaro 76230, Mexico.
   [Elizalde-Pena, E. A.; Sanchez, I. C.] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA.
   [Garcia-Gaitan, B.; Zavala, R.] Inst Tecnol Toluca, Res & Grad Sch Div, Toluca, Edo Mex, Mexico.
RP Velasquillo, C (reprint author), Inst Nacl Rehabil, Tissue Engn Cell Therapy & Regenerat Med Unit, Mexico City, DF, Mexico.
EM mvelasquillo@hotmail.com; gluna@qro.cinvestav.mx
OI Fabela, Omar/0000-0001-5477-1167; Luna-Barcenas,
   Gabriel/0000-0002-1162-6928; ZARATE TRIVINO, DIANA
   GINETTE/0000-0002-0852-8948
CR Alexanian AR, 2005, EXP NEUROL, V191, P193, DOI 10.1016/j.expneurol.2004.10.006
   Basavaraju KC, 2007, CARBOHYD POLYM, V69, P462, DOI 10.1016/j.carbpol.2007.01.004
   Berger J, 2004, EUR J PHARM BIOPHARM, V57, P19, DOI 10.1016/s0939-6411(03)00161-9
   Chen Fuquan, 2006, Lin Chuang Er Bi Yan Hou Ke Za Zhi, V20, P656
   Chevrier A, 2007, OSTEOARTHR CARTILAGE, V15, P316, DOI 10.1016/j.joca.2006.08.007
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   ELIZALDEPENA EA, 2009, J BIOMATERI IN PRESS
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Flores-Ramirez N, 2005, J BIOMAT SCI-POLYM E, V16, P473, DOI 10.1163/1568562053700174
   Furth ME, 2007, BIOMATERIALS, V28, P5068, DOI 10.1016/j.biomaterials.2007.07.042
   Hirano S, 1999, POLYM INT, V48, P732, DOI 10.1002/(SICI)1097-0126(199908)48:8<732::AID-PI211>3.3.CO;2-L
   HOFMANN R, 2002, ENG LIFE SCI, V2, P304
   Jampala SN, 2005, J AGR FOOD CHEM, V53, P3618, DOI 10.1021/jf0479113
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Kopecek J, 2007, BIOMATERIALS, V28, P5185, DOI 10.1016/j.biomaterials.2007.07.044
   Krajewska B, 2001, J CHEM TECHNOL BIOT, V76, P636, DOI 10.1002/jctb.429.abs
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lii CY, 2002, EUR POLYM J, V38, P1377, DOI 10.1016/S0014-3057(02)00008-3
   Lin YL, 2008, SURG NEUROL, V70, P9, DOI 10.1016/j.surneu.2008.01.057
   Lin-Vien D., 1991, HDB INFRARED RAMAN C
   Mundargi RC, 2007, CARBOHYD POLYM, V69, P130, DOI 10.1016/j.carbpol.2006.09.007
   MUZZARELLI R, 2008, CARBOHYDRAT IN PRESS
   Neamnark A, 2008, EUR POLYM J, V44, P2060, DOI 10.1016/j.eurpolymj.2008.04.016
   Pawlak A, 2003, THERMOCHIM ACTA, V396, P153, DOI 10.1016/S0040-6031(02)00523-3
   Pretsch E., 1989, TABLES SPECTRAL DATA
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   Schlabe J, 2008, BURNS, V34, P376, DOI 10.1016/j.burns.2007.04.005
   SHU MJ, 2004, BIOMATERIALS, V25, P3273
   Soares RMD, 2005, POLYM DEGRAD STABIL, V90, P449, DOI 10.1016/j.polydegradstab.2005.04.007
   Srivastava A, 2007, J APPL POLYM SCI, V104, P470, DOI 10.1002/app.24760
   Su L, 2003, CARBOHYD POLYM, V53, P497, DOI 10.1016/S0144-8617(02)00287-4
   Suarez-Rodriguez R, 2004, STEM CELLS, V22, P1373, DOI 10.1634/stemcells.2003-0049
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Wang YC, 2008, MOL CELL PROTEOMICS, V7, P145, DOI 10.1074/mcp.M700207-MCP200
   Zong ZW, 2006, J RADIAT RES, V47, P287, DOI 10.1269/jrr.0531
NR 36
TC 1
Z9 1
U1 0
U2 5
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1022-1360
EI 1521-3900
J9 MACROMOL SYMP
JI Macromol. Symp.
PY 2009
VL 283-84
BP 181
EP +
DI 10.1002/masy.200950924
PG 11
WC Polymer Science
SC Polymer Science
GA 509HM
UT WOS:000271005700025
DA 2018-10-19
ER

PT S
AU Xin, RL
   Wang, MY
   Gao, JC
   Liu, P
   Liu, Q
AF Xin, Renlong
   Wang, Maoyin
   Gao, Jiacheng
   Liu, Pei
   Liu, Qing
BE Gu, ZW
   Han, YF
   Pan, FH
   Wang, XT
   Weng, D
   Zhou, SX
TI Effect of Microstructure and Texture on Corrosion Resistance of
   Magnesium Alloy
SO MATERIALS RESEARCH, PTS 1 AND 2
SE Materials Science Forum
LA English
DT Proceedings Paper
CT International Materials Research Conference
CY JUN 09-12, 2008
CL Chongqing, PEOPLES R CHINA
SP Mat Res Soc, Chinese Mat Res Soc
DE Magnesium Alloy; Corrosion; Microstructure; Texture; Biomaterial
AB Magnesium alloys are considered as candidate materials for biodegradable implants. However, the key issue is that they corrode too fast in physiological environment. The aim of this study is to investigate the effect of microstructure and texture of magnesium alloys on their corrosion resistance. Magnesium alloy AZ31 extruded rod, hot rolled sheet and extruded sheet with different initial microstructure and texture were prepared. Then they were immersed in conventional simulated body fluid (SBF) for several days for corrosion evaluation. The corrosion products and precipitates oil their surfaces were examined by scanning electron microscopy (SFM). The preliminary results showed that the initial microstructure and texture of AZ31 alloys has considerable effect on the weight loss rate of the alloys, suggesting that it is possible to enhance the corrosion resistance of AZ31 alloys through tailoring the microstructure and texture of the alloys.
C1 [Xin, Renlong; Wang, Maoyin; Gao, Jiacheng; Liu, Pei; Liu, Qing] Chongqing Univ, Coll Mat Sci & Engn, Chongqing 400044, Peoples R China.
RP Xin, RL (reprint author), Chongqing Univ, Coll Mat Sci & Engn, Chongqing 400044, Peoples R China.
EM rlxin@cqu.edu.cn; wang527146@163.com; gaojch@cqu.edu.cn;
   hopeliupei.1986@163.com; qingliu@cqu.edu.cn
CR Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Pardo A, 2008, CORROS SCI, V50, P823, DOI 10.1016/j.corsci.2007.11.005
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   Wang H, 2008, MATER LETT, V62, P2476, DOI 10.1016/j.matlet.2007.12.052
   Zreiqat H, 2002, J BIOMED MATER RES, V62, P175, DOI 10.1002/jbm.10270
NR 5
TC 7
Z9 8
U1 0
U2 8
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2009
VL 610-613
BP 1160
EP 1163
DI 10.4028/www.scientific.net/MSF.610-613.1160
PG 4
WC Materials Science, Multidisciplinary
SC Materials Science
GA BJH58
UT WOS:000265909700207
DA 2018-10-19
ER

PT S
AU Wang, J
   Zeng, RC
   Chen, J
   Chen, RS
AF Wang, Jun
   Zeng, Rongchang
   Chen, Jun
   Chen, Rongshi
BE Gu, ZW
   Han, YF
   Pan, FH
   Wang, XT
   Weng, D
   Zhou, SX
TI Corrosion Behavior of Magnesium Alloy AX53 in Simulated Body Fluids
SO MATERIALS RESEARCH, PTS 1 AND 2
SE Materials Science Forum
LA English
DT Proceedings Paper
CT International Materials Research Conference
CY JUN 09-12, 2008
CL Chongqing, PEOPLES R CHINA
SP Mat Res Soc, Chinese Mat Res Soc
DE Magnesium Alloys; Corrosion; Simulated Body Fluid; Biomaterial
ID IN-VIVO CORROSION; BONE; BIOMATERIALS; VITRO
AB Magnesium alloys have attracted scientists' attention as potential implant materials, due to their excellent biocompatibility and good mechanical compatibility. Potentiodynamic electrochemical technique was applied to investigate the corrosion behavior of magnesium alloy AX53 (Mg-4.76Al-3.17Ca) in Hank's solutions, 0.9 wt% NaCl+0.7 g/L NaHCO(3) solutions and 0.9 wt% NaCl solutions at room temperature. Corrosion morphologies of the alloys were observed by means of scanning electron microscope, and the chemical compositions were examined through x-ray diffraction. The results demonstrated that free corrosion potential (Ecorr) of AX53 in 0.9 wt % NaCl solution rose rapidly at initial stage, and then stabilized, whereas Ecorr of this alloy increased continuously in the other two Solutions. Corrosion rates in Hank's solutions were lower than in the other solutions. Intergranular corrosion occurred in these solutions.
C1 [Wang, Jun; Zeng, Rongchang; Chen, Jun] Chongqing Inst Technol, Sch Mat Sci & Engn, Chongqing 400050, Peoples R China.
   [Chen, Rongshi] Chinese Acad Sci, Inst Met Res, Environm Corros Ctr, Shenyang 110016, Peoples R China.
RP Wang, J (reprint author), Chongqing Inst Technol, Sch Mat Sci & Engn, Chongqing 400050, Peoples R China.
EM wangjun9129@163.com; rczeng2001@yahoo.com.cn; chenjun@cqit.edu.cn;
   rschen@imr.ac.cn
CR Bai J, 2007, J ALLOY COMPD, V437, P247, DOI 10.1016/j.jallcom.2006.07.096
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Liu CL, 2007, MAT SCI ENG A-STRUCT, V456, P350, DOI 10.1016/j.msea.2006.12.020
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Xu LP, 2008, J MATER SCI-MATER M, V19, P1017, DOI 10.1007/s10856-007-3219-y
   Zeng 2 R. C., 2006, T NONFERR METAL SOC, V16, P763
   Zeng R C, 2007, T NONFERR METAL SOC, V17, P166
   ZENG RC, 2007, MAT SCI TECHNOL, V23, P353
   ZENG RC, 2007, T NONFERR METAL SOC, V17, P193
   Zeng RC, 2008, ADV ENG MATER, V10, pB3, DOI 10.1002/adem.200800035
   Zhong Y, 2006, SCRIPTA MATER, V55, P573, DOI 10.1016/j.scriptamat.2006.03.068
NR 14
TC 1
Z9 1
U1 0
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2009
VL 610-613
BP 1174
EP 1178
DI 10.4028/www.scientific.net/MSF.610-613.1174
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA BJH58
UT WOS:000265909700210
DA 2018-10-19
ER

PT S
AU Zhu, DB
   Xu, AP
   Qu, YX
   Mi, ZM
   Li, JQ
AF Zhu, Dongbin
   Xu, Anping
   Qu, Yunxia
   Mi, Zhimei
   Li, Jianqiang
BE Gu, ZW
   Han, YF
   Pan, FH
   Wang, XT
   Weng, D
   Zhou, SX
TI Fabrication and Antibacterial Performance of Bio-graded Nano-composite
   Materials by Using Inkjet Printing Method
SO MATERIALS RESEARCH, PTS 1 AND 2
SE Materials Science Forum
LA English
DT Proceedings Paper
CT International Materials Research Conference
CY JUN 09-12, 2008
CL Chongqing, PEOPLES R CHINA
SP Mat Res Soc, Chinese Mat Res Soc
DE Fabrication; Biomaterial; Antibacterial; Graded Distribution; Inkjet
   Printing
ID HEAT-TREATMENT; TOURMALINE; GROWTH; STREPTOCOCCI; EXTRACT; MUTANS; PH
AB The graded composite materials were fabricated by direct inkjet printing of nano-electropolar mineral and nano-hydroxyapatite powders for the study of inhibiting function on streptococcus mutans, which is a primary pathogen for human dental caries. The electropolar mineral can be utilized in many fields due to its spontaneous permanent polarity and far infrared emission properties. In this study, the graded distribution of the streptococcus mutans on the surface of graded composite materials was investigated by energy dispersion spectrometry, and the mechanism of which is that the streptococcus mutans was remained in the culture of pH at about 8.5 self-adjustment induced by the electropolar mineral. This culture inhibits growth and acid production of streptococcus mutans. Therefore, this composite materials have inhibitory effects on streptococcus mutans, and can be used as a promising biomaterial for preventing human teeth from caries.
C1 [Zhu, Dongbin; Xu, Anping; Qu, Yunxia; Mi, Zhimei; Li, Jianqiang] Hebei Univ Technol, Sch Mech Engn, Tianjin 300130, Peoples R China.
RP Zhu, DB (reprint author), Hebei Univ Technol, Sch Mech Engn, Tianjin 300130, Peoples R China.
EM zhu_dongbin@163.com; xap@hebut.edu.cn; quyunxia69@163.com;
   mzm2006start@126.com; skyljq@126.com
CR Calvert P, 2007, SCIENCE, V318, P208, DOI 10.1126/science.1144212
   Castaneda C, 2006, PHYS CHEM MINER, V33, P207, DOI 10.1007/s00269-006-0067-0
   Dashper SG, 2000, J DENT RES, V79, P90, DOI 10.1177/00220345000790011601
   ESGALHADO ME, 1995, PROCESS BIOCHEM, V30, P667, DOI 10.1016/0032-9592(94)00044-I
   JESSICA WN, 2007, APPL ENVIRON MICROB, V73, P5633
   Jin ZZ, 2003, CHINESE PHYS, V12, P222, DOI 10.1088/1009-1963/12/2/319
   Matsumoto M, 1999, CARIES RES, V33, P441, DOI 10.1159/000016549
   Nakamura T, 1994, FERROELECTRICS, V155, P207, DOI 10.1080/00150199408007508
   NAMBA T, 1982, PLANTA MED, V44, P100, DOI 10.1055/s-2007-971412
   Ooshima T, 2000, ARCH ORAL BIOL, V45, P639, DOI 10.1016/S0003-9969(00)00042-X
   Shih WJ, 2004, J CRYST GROWTH, V270, P211, DOI 10.1016/j.jcrysgro.2004.06.023
   Shouji N, 2000, CARIES RES, V34, P94, DOI 10.1159/000016559
   Wang JW, 2006, J AM CERAM SOC, V89, P3285, DOI 10.1111/j.1551-2916.2006.01206.x
   Xia MS, 2006, PROCESS BIOCHEM, V41, P221, DOI 10.1016/j.procbio.2005.05.012
   Xu AP, 2005, Proceedings of the International Conference on Mechanical Engineering and Mechanics 2005, Vols 1 and 2, P1216
   Xu AP, 2005, COMPUT AIDED DESIGN, V37, P1308, DOI 10.1016/j.cad.2005.01.005
   Xu T, 2006, BIOMATERIALS, V27, P3580, DOI 10.1016/j.biomaterials.2006.01.048
   Yoshitake N, 1996, J INTEL MAT SYST STR, V7, P260, DOI [10.1177/1045389X9600700303, DOI 10.1177/1045389X9600700303]
   Zhu D, 2008, J AM CERAM SOC, V91, P2588, DOI 10.1111/j.1551-2916.2008.02487.x
NR 19
TC 0
Z9 0
U1 1
U2 9
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2009
VL 610-613
BP 1192
EP 1197
DI 10.4028/www.scientific.net/MSF.610-613.1192
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA BJH58
UT WOS:000265909700214
DA 2018-10-19
ER

PT S
AU Zhu, QX
   Wu, JQ
   Feng, Q
   Wang, HP
AF Zhu, Qingxia
   Wu, Jianqing
   Feng, Qing
   Wang, Heping
BE Gu, ZW
   Han, YF
   Pan, FH
   Wang, XT
   Weng, D
   Zhou, SX
TI Effect of the Surface Energy on the Biomineralization Behavior and Cell
   Compatibility of Carbonated Hydroxyapatite
SO MATERIALS RESEARCH, PTS 1 AND 2
SE Materials Science Forum
LA English
DT Proceedings Paper
CT International Materials Research Conference
CY JUN 09-12, 2008
CL Chongqing, PEOPLES R CHINA
SP Mat Res Soc, Chinese Mat Res Soc
DE Carbonated Hydroxyapatite; Surface Energy; Biomineralization; Cell
   Compatibility
ID IN-VITRO; APATITE; OSTEOCLAST; COMPOSITE; ADHESION; STRENGTH; KINETICS
AB Carbonated hydroxyapatite (CHA) and hydroxyapatite (HA) were prepared by the wet chemical method. The contact angle was measured to calculate the surface energy. The biomineralization process in SBF solution of HA and CHA were investigated in vitro. The cell attachment and proliferation behavior of CHA and HA were compared by the cell Culture experiments. The results show that the polar component Of surface energy of B-type CHA is higher than that of HA. Osteoblastic cells attach and proliferate very well oil the surface, which indicates the excellent cell compatibility. The CHA have high bioactivity owing to rapid formation of hydroxyl-carbonate-apatite (HCA) mineralized layer oil the biomaterial's Surface in SBF.
C1 [Zhu, Qingxia; Feng, Qing; Wang, Heping] Jingdezhen Ceram Inst, Jingdezhen 333001, Peoples R China.
   [Wu, Jianqing] S China Univ Technol, Sch Mat Sci & Engn, Guangzhou 510640, Peoples R China.
RP Zhu, QX (reprint author), Jingdezhen Ceram Inst, Jingdezhen 333001, Peoples R China.
EM qingxia-zhu@163.com; imjqwu@scut.edu.cn
CR Chou L, 1999, BIOMATERIALS, V20, P977, DOI 10.1016/S0142-9612(98)00254-3
   Elena L, 2004, BIOMATERIALS, V25, P1763
   Ito A, 1997, J BIOMED MATER RES, V36, P522, DOI 10.1002/(SICI)1097-4636(19970915)36:4<522::AID-JBM10>3.0.CO;2-C
   KOKUBO T, 2000, BONE ENG
   LI SP, 2000, BIOMEDICAL MAT INTRO
   MEYER U, 1993, CELL MATER, V3, P129
   Morgan EF, 1997, J MATER SCI-MATER M, V8, P559, DOI 10.1023/A:1018550831834
   Ni J, 2002, MAT SCI ENG C-BIO S, V20, P101, DOI 10.1016/S0928-4931(02)00019-X
   Redey SA, 1999, J BIOMED MATER RES, V45, P140, DOI 10.1002/(SICI)1097-4636(199905)45:2<140::AID-JBM9>3.3.CO;2-9
   Redey SA, 2000, J BIOMED MATER RES, V50, P353, DOI 10.1002/(SICI)1097-4636(20000605)50:3<353::AID-JBM9>3.0.CO;2-C
   REY C, 1989, CALCIFIED TISSUE INT, V45, P157, DOI 10.1007/BF02556059
   Roether JA, 2002, BIOMATERIALS, V23, P3871, DOI 10.1016/S0142-9612(02)00131-X
   Spence GM, 2006, KEY ENG MAT, V309-311, P207, DOI 10.4028/www.scientific.net/KEM.309-311.207
   TANG PF, 2005, BEIJING BIOMED ENG, V6, P401
   Tang RK, 2003, J CRYST GROWTH, V249, P614, DOI 10.1016/S0022-0248(02)02332-1
   VANKOOTEN TG, 1992, BIOMATERIALS, V13, P897, DOI 10.1016/0142-9612(92)90112-2
   WANG H, 2006, J CENT S U T, V5, P942
   WU JH, 1999, COLLOID INTERFACE CH
   ZHAO ZG, 2004, COLLOID INTERFACE CH
NR 19
TC 1
Z9 1
U1 1
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2009
VL 610-613
BP 1203
EP 1207
DI 10.4028/www.scientific.net/MSF.610-613.1203
PN 1-2
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA BJH58
UT WOS:000265909700216
DA 2018-10-19
ER

PT S
AU Li, XN
   Chen, XM
   Hu, WL
AF Li, Xiangnan
   Chen, Xiaoming
   Hu, Weilan
BE Gu, ZW
   Han, YF
   Pan, FH
   Wang, XT
   Weng, D
   Zhou, SX
TI In Situ Synthesis and Characterization of beta-tricalcium Phosphate/Na
   Doped 58S Bioglass Composite by Sol-gel Technique
SO MATERIALS RESEARCH, PTS 1 AND 2
SE Materials Science Forum
LA English
DT Proceedings Paper
CT International Materials Research Conference
CY JUN 09-12, 2008
CL Chongqing, PEOPLES R CHINA
SP Mat Res Soc, Chinese Mat Res Soc
DE In Situ Synthesis; beta-tricalcium Phosphate; Na-doped 58S Bioglass;
   Sol-gel Technique
ID BIOACTIVE GLASS; IMPROVEMENT
AB In situ synthesis technique of beta-tricalcium phosphate(beta-TCP)/Na-doped 58S bioglass composite powders were investigated. Firstly, the beta-TCP ultra-micro powders are synthesized via wet chemical method beta-TCP/Na doped 58S bioglass composite powders were synthesized in situ by sol-gel technique, using tetraethyl orthosilicate(TEOS), triethyl phosphate(TEP), calcium nitrate tetrahydrate(Ca(NO(3))(2)center dot 4H(2)O), sodium nitrate(NaNO(3)) as starting materials. The composite powders were characterized by XRD, EDX and SEM. The bioactivity of the synthesized powders was analyzed by immersion studies in Simulated body fluid (SBF). The results show that the composite powders are made up of good crystalline beta-TCP and amorphous bioglass, and it was conformed that the material had good osteoproduction and bioactivities, that is an indication of bioactive potential in vivo. It is believed that the beta-TCP/Na-doped 58S bioglass (58SN) composite by sol-gel technique in situ could be a desirable biomaterial for preparing scaffold of bone tissue engineering.
C1 [Li, Xiangnan; Chen, Xiaoming; Hu, Weilan] Wuhan Univ Technol, Biomed Mat & Engn Res Ctr, Wuhan 430070, Peoples R China.
RP Li, XN (reprint author), Wuhan Univ Technol, Biomed Mat & Engn Res Ctr, Wuhan 430070, Peoples R China.
EM xiangnanlidong@163.com; xmchenw@126.com; huweilanweilan@163.com
CR Andersson J, 2005, BIOMATERIALS, V26, P6827, DOI 10.1016/j.biomaterials.2005.05.002
   Balamurugan A, 2006, MATER LETT, V60, P3752, DOI 10.1016/j.matlet.2006.03.102
   Balamurugan A, 2007, ACTA BIOMATER, V3, P255, DOI 10.1016/j.actbio.2006.09.005
   Bow JS, 2004, BIOMATERIALS, V25, P3155, DOI 10.1016/j.biomaterials.2003.10.046
   Descamps M, 2007, J EUR CERAM SOC, V27, P2401, DOI 10.1016/j.jeurceramsoc.2006.09.005
   Fathi MH, 2008, MAT SCI ENG A-STRUCT, V474, P128, DOI 10.1016/j.msea.2007.05.041
   HENCH LL, 1978, J NON-CRYST SOLIDS, V28, P83, DOI 10.1016/0022-3093(78)90077-7
   Kannan S, 2007, CERAM INT, V33, P637, DOI 10.1016/j.ceramint.2005.11.014
   Li N, 2005, CERAM INT, V31, P641, DOI 10.1016/j.ceramint.2004.05.011
   MANITHA BN, 2008, ACTA BIOMATER, V4, P173
   PARIENTE JP, 2002, J BIOMED MATER RES, V61, P524
   REG MV, 2004, J SOLID STATE IONICS, V172, P445
   Ryu HS, 2002, BIOMATERIALS, V23, P909, DOI 10.1016/S0142-9612(01)00201-0
   ZHANG Y, 2005, J CURRENT APPL PHYS, V5, P531
   Zhao ZW, 2004, J CENT SOUTH UNIV T, V11, P147, DOI 10.1007/s11771-004-0030-5
NR 15
TC 1
Z9 1
U1 1
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2009
VL 610-613
BP 1278
EP 1283
DI 10.4028/www.scientific.net/MSF.610-613.1278
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA BJH58
UT WOS:000265909700233
DA 2018-10-19
ER

PT J
AU Jiang, LY
   Li, YB
   Zhang, L
   Wang, XJ
AF Jiang, LiuYun
   Li, YuBao
   Zhang, Li
   Wang, XueJiang
TI Preparation and characterization of a novel composite containing
   carboxymethyl cellulose used for bone repair
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article
DE Carboxymethyl cellulose; Nano-hydroxyapatite; Chitosan; Composite;
   Compressive strength
ID HYDROXYAPATITE; SCAFFOLDS; BIOCOMPATIBILITY; PARTICLES; IMPLANTS;
   SURFACE
AB The composite biomaterial made from nano-hydroxyapatite(n-HA) and chitosan(CS) cross-linked with carboxymethyl cellulose(CMC) by a co-solution method has been studied. Fourier transform infrared absorption spectra (IR), X-ray diffraction (XRD), burn-out test, chemical analysis, transmission electron microscope(TEM) and universal material testing machine were used to test the properties of the composite. The experiment of SBF soaking for 8 weeks was used to investigate their degradation and bioactivity in vitro. The results show that the formation of composite is mainly contributed to the ionic cross-linking of CMC with CS, and n-HA particles in the form of nanometer grade short crystals are uniformly distributed in the organic network structure of polyelectrolyte complexes, which endows the composite with high compressive strength and good bioactivity, The compressive strength and degradation rate are concerned with the content of n-HA. It can be stated that the n-HA/CS/CMC composite whose weight ratio is 40/30/30 may be a potential candidate as one of novel bone repair materials because of its high compressive strength and acceptable degradation rate as well as good bioactivity, displaying a promising prospect of the clinical application of CMC-contained composite in the field of bone repair. (c) 2008 Elsevier B.V. All rights reserved.
C1 [Jiang, LiuYun; Li, YuBao; Zhang, Li; Wang, XueJiang] Sichuan Univ, Analyt & Testing Ctr, Res Ctr Nanobiomat, Chengdu 610064, Peoples R China.
   [Jiang, LiuYun] Chinese Acad Sci, Chengdu Inst Organ Chem, Chengdu 610041, Peoples R China.
RP Li, YB (reprint author), Sichuan Univ, Analyt & Testing Ctr, Res Ctr Nanobiomat, Chengdu 610064, Peoples R China.
EM nic7504@scu.edu.cn
FU China-Netherlands Programme Strategic Alliances [2004CB720604]
FX This study was funded by the China-Netherlands Programme Strategic
   Alliances (China 973 found: 2004CB720604).
CR Adekogbe I, 2005, BIOMATERIALS, V26, P7241, DOI 10.1016/j.biomaterials.2005.05.043
   Argiielles-Monal W., 1988, MAKROMOL CHEM-RAPID, V9, P693
   Bakos D, 1999, BIOMATERIALS, V20, P191, DOI 10.1016/S0142-9612(98)00163-X
   Biswal DR, 2004, CARBOHYD POLYM, V57, P379, DOI 10.1016/j.carbpol.2004.04.020
   Chen F, 2002, MATER LETT, V57, P858, DOI 10.1016/S0167-577X(02)00885-6
   Gomez-Vega JM, 2000, BIOMATERIALS, V21, P105, DOI 10.1016/S0142-9612(99)00131-3
   He DL, 2000, TALANTA, V50, P1267, DOI 10.1016/S0039-9140(99)00229-5
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hong ZK, 2004, POLYMER, V45, P6699, DOI 10.1016/j.polymer.2004.07.036
   Itoh S, 2001, J BIOMED MATER RES, V54, P445, DOI 10.1002/1097-4636(20010305)54:3<445::AID-JBM190>3.3.CO;2-0
   Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7
   Kim SB, 2004, BIOMATERIALS, V25, P5715, DOI 10.1016/j.biomaterials.2004.01.022
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Kong LJ, 2005, J BIOMED MATER RES A, V75A, P275, DOI 10.1002/jbm.a.30414
   LAHIJI A, 2000, J BIOMED MATER RES, V49, P301
   Li ZS, 2005, BIOMATERIALS, V26, P3919, DOI 10.1016/j.biomaterials.2004.09.062
   LISJAN W, 2002, J BIOMED MATER RES, V63, P610
   Loke WK, 2000, J BIOMED MATER RES, V53, P8
   Mendes SC, 2001, BIOMATERIALS, V22, P2057, DOI 10.1016/S0142-9612(00)00395-1
   Murugan R, 2004, BIOMATERIALS, V25, P3829, DOI 10.1016/j.biomaterials.2003.10.016
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Sailaja GS, 2003, J MATER SCI, V38, P3653, DOI 10.1023/A:1025689701309
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Valeriani M, 2002, Acta Chir Plast, V44, P71
   Wang L, 2007, CARBOHYD POLYM, V68, P740, DOI 10.1016/j.carbpol.2006.08.010
   Yin YJ, 2004, MACROMOL BIOSCI, V4, P971, DOI 10.1002/mabi.200400063
   ZANG L, 2004, HIGH TECHNOL LETT, V10, P48
   Zhao F, 2002, BIOMATERIALS, V23, P3227, DOI 10.1016/S0142-9612(02)00077-7
NR 28
TC 38
Z9 42
U1 3
U2 40
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD JAN 1
PY 2009
VL 29
IS 1
BP 193
EP 198
DI 10.1016/j.msec.2008.06.009
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA 390AM
UT WOS:000262136700031
DA 2018-10-19
ER

PT J
AU Jiang, YJ
   Sun, QY
   Jiang, ZY
   Zhang, L
   Li, J
   Li, L
   Sun, XH
AF Jiang, Yanjun
   Sun, Qianyun
   Jiang, Zhongyi
   Zhang, Lei
   Li, Jian
   Li, Lin
   Sun, Xiaohui
TI The improved stability of enzyme encapsulated in biomimetic titania
   particles
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article
DE Titania nanoparticles; Protamine; Biomimetic synthesis; Yeast alcohol
   dehydrogenase encapsulation; Stability
ID FERRITE COMPOSITE NANOPARTICLES; SOL-GEL MATERIALS; BIOMATERIAL SYSTEM;
   PROTEIN ENCAPSULATION; BIOCOMPATIBLE METHOD; IMMOBILIZED ENZYMES;
   SILICA; EFFICIENT; DIOXIDE; CARRIER
AB This study demonstrates a novel biomimetic approach for the entrapment of yeast alcohol dehydrogenase (YADH) within titania nanoparticles to improve its stability. Protamine was as the template and catalyst for the condensation of titanium (IV) bis(ammonium lactato) dihydroxide (Ti-BALDH) into titania nanoparticles in which YADH was trapped. The as-prepared titania/protamine/YADH composites were characterized by scanning electron microscopy (SEM), transmission electron microscopy (TEM), dynamic light scattering (DLS), X-ray powder diffraction (XRD) and X-ray photoelectron spectroscopy (XPS). The mechanism of YADH encapsulation was tentatively proposed from a series of experimental results. The preliminary investigation showed that encapsulated YADH could retain most of its initial activity. Compared to free YADH. encapsulated YADH exhibited significantly improved thermal, pH and recycling stability. After 5 weeks storage, no substantial loss of catalytic activity for encapsulated YADH was observed. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Jiang, Yanjun; Sun, Qianyun; Jiang, Zhongyi; Zhang, Lei; Li, Jian; Li, Lin; Sun, Xiaohui] Tianjin Univ, Key Lab Green Chem Technol, Minist Educ, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China.
RP Jiang, ZY (reprint author), Tianjin Univ, Key Lab Green Chem Technol, Minist Educ, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China.
EM zhyjiang@tju.edu.cn
RI Dom, Rekha/B-7113-2012
FU National Natural Science Foundation of China [20576096]; Ministry of
   Education of China; Innovative Research Team in University (PCSIRT);
   Program of Introducing Talents of Discipline [B06006]
FX Financial support from the National Natural Science Foundation of China
   (Grant No. 20576096), the Cross-Century Talent Raising Program of
   Ministry of Education of China, the program for Changjiang Scholars,
   Innovative Research Team in University (PCSIRT) and financial support
   from the Program of Introducing Talents of Discipline to Universities
   (No.B06006) are greatly appreciated.
CR Avnir D, 2006, J MATER CHEM, V16, P1013, DOI 10.1039/5512706h
   Cao LQ, 2005, CURR OPIN CHEM BIOL, V9, P217, DOI 10.1016/j.cbpa.2005.02.014
   Cao LQ, 2003, CURR OPIN BIOTECH, V14, P387, DOI 10.1016/S0958-1669(03)00096-X
   Chen X, 2007, CHEM REV, V107, P2891, DOI 10.1021/cr0500535
   Chen Y, 2006, CHEM MATER, V18, P5326, DOI 10.1021/cm060948d
   Cole KE, 2006, CHEM MATER, V18, P4592, DOI 10.1021/cm060807b
   Curulli A, 2006, SURF INTERFACE ANAL, V38, P478, DOI 10.1002/sia.2217
   Eggers DK, 2001, PROTEIN SCI, V10, P250, DOI 10.1110/ps.36201
   Frenkel-Mullerad H, 2005, J AM CHEM SOC, V127, P8077, DOI 10.1021/ja0507719
   Gadre SY, 2006, J AM CERAM SOC, V89, P2987, DOI 10.1111/j.1551-2916.2006.01307.x
   Gill I, 2001, CHEM MATER, V13, P3404, DOI 10.1021/cm0102483
   Gottfried DS, 1999, J PHYS CHEM B, V103, P2803, DOI 10.1021/jp9840230
   Hartmann M, 2005, CHEM MATER, V17, P4577, DOI 10.1021/cm0485658
   IVNITSKI D, 2008, SMALL, V3, P357
   Jiang YJ, 2008, IND ENG CHEM RES, V47, P2495, DOI 10.1021/ie071315r
   Jiang ZY, 2006, J BIOMAT SCI-POLYM E, V17, P21, DOI 10.1163/156856206774879144
   Kim J, 2006, CHEM ENG SCI, V61, P1017, DOI 10.1016/j.ces.2005.05.067
   Luckarift HR, 2004, NAT BIOTECHNOL, V22, P211, DOI 10.1038/nbt931
   Luckarift HR, 2006, SMALL, V2, P640, DOI 10.1002/smll.200500376
   Mateo C, 2007, ENZYME MICROB TECH, V40, P1451, DOI 10.1016/j.enzmictec.2007.01.018
   Miller SA, 2006, MACROMOL BIOSCI, V6, P839, DOI 10.1002/mabi.200600140
   Naik RR, 2004, CHEM COMMUN, P1684, DOI 10.1039/b404586f
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   Ravindra R, 2004, J AM CHEM SOC, V126, P12224, DOI 10.1021/ja046900n
   Rawat J, 2007, MATER SCI TECH-LOND, V23, P97, DOI 10.1179/174328407X158488
   Reetz MT, 2003, ADV SYNTH CATAL, V345, P717, DOI 10.1002/adsc.200303016
   Roth KM, 2005, J AM CHEM SOC, V127, P325, DOI 10.1021/ja045308v
   Sewell SL, 2006, CHEM MATER, V18, P3108, DOI 10.1021/cm060342p
   Sheldon RA, 2007, ADV SYNTH CATAL, V349, P1289, DOI 10.1002/adsc.200700082
   Sumerel JL, 2003, CHEM MATER, V15, P4804, DOI 10.1021/cm030254u
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   Yi YY, 2006, CHEM MATER, V18, P5336, DOI 10.1021/cm0609471
   Zhang Y, 2008, CHEM MATER, V20, P1041, DOI 10.1021/cm701959e
NR 34
TC 31
Z9 33
U1 3
U2 58
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD JAN 1
PY 2009
VL 29
IS 1
BP 328
EP 334
DI 10.1016/j.msec.2008.07.006
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA 390AM
UT WOS:000262136700053
DA 2018-10-19
ER

PT J
AU Xiao, XF
   Liu, RF
   Tian, T
AF Xiao, X. -F.
   Liu, R. -F.
   Tian, T.
TI Preparation and bioactivity of embedded-style hydroxyapatite-titania
   nanotube arrays
SO MATERIALS SCIENCE-POLAND
LA English
DT Article
DE hydroxyapatite; bioactivity; composite; biomaterial; nanotube array;
   titania
ID ANODIC-OXIDATION; POROUS TITANIUM; COATINGS; ELECTROLYTES; FABRICATION
AB Embedded-style hydroxyapatite-titania nanotube arrays were successfully prepared by anodic oxidation of titanium substrate and centrifugal filling hydroxyapatite precursor sol into hollow nanotubes. The morphology, microstructure and thermal stability of the samples were characterized by X-ray diffraction, environmental scanning electron microscopy, and energy dispersive X-ray analysis. The results show that the structure of titania nanotube arrays is stable at 500 degrees C or below, and the crystallized hydroxyapatite could be formed from hydroxyapatite precursor sol after calcining at 500 degrees C for 4 h. The optimum calcining temperature for this material is 500 degrees C. An obvious apatite layer formed on the surface of the embedded-style material after soaking in simulated body fluid for 5 days, indicating that the material possesses a good in vitro apatite forming ability on its surface.
C1 [Xiao, X. -F.; Liu, R. -F.; Tian, T.] Fujian Normal Univ, Coll Chem & Mat Sci, Fuzhou 350007, Peoples R China.
RP Xiao, XF (reprint author), Fujian Normal Univ, Coll Chem & Mat Sci, Fuzhou 350007, Peoples R China.
EM rfliu@vip.sina.com
FU National Nature Science Foundation of China [30600149]; Science Research
   Foundation of the Ministry of Health and United Fujian Provincial Health
   and Education [WKJ 2005-2-008]; Fujian Development and Reform Commission
   of China [2004 ( 477)]; Fujian Provincial Department of Science and
   Technology [2006I0015]; Fujian Nature Science Foundation [2007J0144]
FX The authors thank the National Nature Science Foundation of China
   (30600149), the Science Research Foundation of the Ministry of Health
   and United Fujian Provincial Health and Education Project for Tackling
   the Key Research, PR China (WKJ 2005-2-008), Fujian Development and
   Reform Commission of China (No. 2004 ( 477)), Fujian Provincial
   Department of Science and Technology (No. 2006I0015) and Fujian Nature
   Science Foundation (2007J0144).
CR AKAO M, 1981, J MATER SCI, V16, P809, DOI 10.1007/BF00552220
   Beranek R, 2003, ELECTROCHEM SOLID ST, V6, pB12, DOI 10.1149/1.1545192
   Cai QY, 2005, J MATER RES, V20, P230, DOI 10.1557/JMR.2005.0020
   DUCHEYNE P, 1990, BIOMATERIALS, V11, P244, DOI 10.1016/0142-9612(90)90005-B
   GONG DW, 2001, J MATER RES, V12, P3331
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Mor GK, 2005, NANO LETT, V5, P191, DOI 10.1021/nl048301k
   Mor GK, 2003, J MATER RES, V18, P2588, DOI 10.1557/JMR.2003.0362
   Noort R. V, 1987, J MATER SCI, V22, P3801, DOI DOI 10.1007/BF01133326
   ONG JL, 1994, BIOMATERIALS, V15, P337, DOI 10.1016/0142-9612(94)90245-3
   OSBORN JF, 1980, BIOMATERIALS, V1, P108, DOI 10.1016/0142-9612(80)90009-5
   PILLIAR RM, 1993, BIOCERAMICS, V6, P165
   Sul YT, 2001, MED ENG PHYS, V23, P329, DOI 10.1016/S1350-4533(01)00050-9
   SUN L, 2002, J BIOMED MATER RES, V2, P228
   TENGVALL P, 1992, Clinical Materials, V9, P115, DOI 10.1016/0267-6605(92)90056-Y
   Weng WJ, 1998, J MATER SCI-MATER M, V9, P159, DOI 10.1023/A:1008819703551
   Xiao FXB, 2005, MATER LETT, V59, P1660, DOI 10.1016/j.matlet.2005.01.037
   Yang BC, 2004, BIOMATERIALS, V25, P1003, DOI 10.1016/S0142-9612(03)00626-4
NR 18
TC 3
Z9 4
U1 0
U2 4
PU OFICYNA WYDAWNICZA POLITECHNIKI WROCLAWSKIEJ
PI WROCLAW
PA WYBRZEZE WYSPIANSKIEGO 27, 50-370 WROCLAW, POLAND
SN 0137-1339
J9 MATER SCI-POLAND
JI Mater. Sci.
PY 2009
VL 27
IS 1
BP 23
EP 31
PG 9
WC Materials Science, Multidisciplinary
SC Materials Science
GA 473MA
UT WOS:000268209700002
DA 2018-10-19
ER

PT J
AU Hamilton, DW
   Jamshidi, F
   Brunette, DM
AF Hamilton, D. W.
   Jamshidi, F.
   Brunette, D. M.
TI Focal adhesion mediated intracellular signaling, Stat3 translocation and
   osteoblast differentiation: regulation by substratum topography
SO MATERIALWISSENSCHAFT UND WERKSTOFFTECHNIK
LA English
DT Article
DE substratum topography; osteoblast; JAK-STAT; FAK; ERK 1/2;
   differentiation; intracellular signaling; biomaterial
ID IN-VITRO; DIFFERENT DIMENSIONS; TITANIUM SURFACES; EPITHELIAL-CELLS;
   IMPLANT SURFACES; FIBROBLASTS; GUIDANCE; TISSUE; ACTIVATION; EXPRESSION
AB Osseointegration is a necessary process for stabilization of implants that contact bone. Implant substratum topography has been identified as an important modulator of osteoblast differentiation, although the molecular processes involved are poorly understood. The aim of this study was to assess adhesion mediated molecular events induced in rat calvarial osteoblasts by topographies produced using microfabrication techniques. Specifically, we investigated the activation of tyrosine phosphorylation, focal adhesion kinase (FAK), extracellular regulated kinase 1/2 (ERK-1/2), janus kinase-1 and 2 (JAK-1 and 2), and the transcription factor Stat3. Microfabricated topographies stimulated altered focal adhesion (FA) arrangements, which correlated with regions of increased tyrosine phosphorylation. FAK, and ERK 1/2. Inhibition of JAK-1 using piceatannol attenuated the phosphorylation of FAK and ERK 1/2 on 30/mu m deep grooves, but not smooth, but inhibited proliferation on all surfaces tested. Inhibition of microtubule nucleation, JAK-1, JAK-2 and phospholipase-C had no effect on nuclear translocation of Stat3 irrespective of topography. We conclude that nuclear translocation of Stat3 is independent of substratum topography, but JAK-1 is involved in focal adhesion mediated signal transduction. Further understanding of the molecular regulation of osteoblast differentiation by substratum topography will allow the design of more suitable biomaterials for orthopaedic and dental applications.
C1 [Jamshidi, F.; Brunette, D. M.] Univ British Columbia, Dept Oral Biol & Med Sci, Fac Dent, Vancouver, BC V6T 1Z3, Canada.
   [Hamilton, D. W.] Univ Western Ontario, CIHR Grp Skeletal Dev & Remodeling, London, ON N6A 5C1, Canada.
RP Hamilton, DW (reprint author), Univ British Columbia, Dept Oral Biol & Med Sci, Fac Dent, 2199 Wesbrook Mail, Vancouver, BC V6T 1Z3, Canada.
EM brunette@interchange.ubc.ca
RI Hamilton, Douglas/L-8932-2015
OI Hamilton, Douglas/0000-0002-9798-5197
FU Canadian Institutes of Health Research Net program (CIHR)
FX This work was funded by Canadian Institutes of Health Research Net
   program and CIHR operating grant to D. M. Brunette.
CR Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545
   Baier R E, 1988, Int J Oral Maxillofac Implants, V3, P9
   Beaman FD, 2006, RADIOL CLIN N AM, V44, P451, DOI 10.1016/j.rcl.2006.01.001
   Boyan B. D., 2003, European Cells & Materials, V6, P22
   BRUNETTE DM, 1986, EXP CELL RES, V164, P11, DOI 10.1016/0014-4827(86)90450-7
   BRUNETTE DM, 2005, INT C SER, V1284, P229
   CAMPORESE DS, 1981, ELECTRON DEVIC LETT, V2, P61, DOI 10.1109/EDL.1981.25341
   Carinci Francesco, 2003, J Oral Implantol, V29, P215, DOI 10.1563/1548-1336(2003)029<0215:AOOMCR>2.3.CO;2
   Chehroudi B, 1997, J BIOMED MATER RES, V34, P279
   CHEHROUDI B, 1992, CELL MATER, V2, P89
   CLARK P, 1991, J CELL SCI, V99, P73
   Dalby MJ, 2003, EXP CELL RES, V284, P274, DOI 10.1016/S0014-4827(02)00053-8
   Duan ZF, 2006, CLIN CANCER RES, V12, P6844, DOI 10.1158/1078-0432.CCR-06-1330
   Frenkel SR, 2002, J BIOMED MATER RES, V63, P706, DOI 10.1002/jbm.10408
   Guillemot F, 2005, EXPERT REV MED DEVIC, V2, P741, DOI 10.1586/17434440.2.6.741
   Hallab NJ, 1995, J LONG-TERM EFF MED, V5, P209
   Hamilton DW, 2006, CALCIFIED TISSUE INT, V78, P314, DOI 10.1007/s00223-005-0238-x
   Hamilton DW, 2007, BIOMATERIALS, V28, P1806, DOI 10.1016/j.biomaterials.2006.11.041
   Hamilton DW, 2007, BIOMATERIALS, V28, P2281, DOI 10.1016/j.biomaterials.2007.01.026
   Hamilton DW, 2005, EXP CELL RES, V309, P429, DOI 10.1016/j.yexcr.2005.06.015
   Itoh S, 2006, BONE, V39, P505, DOI 10.1016/j.bone.2006.02.074
   Kamimura D, 2003, Rev Physiol Biochem Pharmacol, V149, P1
   Learmonth ID, 2006, P I MECH ENG H, V220, P229, DOI 10.1243/095441105X69123
   Migliaccio S, 1998, STEROIDS, V63, P352, DOI 10.1016/S0039-128X(98)00040-3
   Morra M, 2007, EXPERT REV MED DEVIC, V4, P361, DOI 10.1586/17434440.4.3.361
   Morra M, 2006, EUR CELLS MATER, V12, P1
   Oakley C, 1997, EXP CELL RES, V234, P413, DOI 10.1006/excr.1997.3625
   Owen GR, 2005, BIOMATERIALS, V26, P7447, DOI 10.1016/j.biomaterials.2005.05.055
   Qu J, 1996, Oral Dis, V2, P102
   Qu Z, 2007, J BIOMED MATER RES A, V82A, P658, DOI 10.1002/bjm.a.31023
   Refai AK, 2004, J BIOMED MATER RES A, V70A, P194, DOI 10.1002/jbm.a.30075
   Rouahi M, 2006, BIOMATERIALS, V27, P2829, DOI 10.1016/j.biomaterials.2006.01.001
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Schuler M, 2006, BIOMATERIALS, V27, P4003, DOI 10.1016/j.biomaterials.2006.03.009
   Takebe J, 2007, J BIOMED MATER RES A, V80A, P711, DOI 10.1002/jbm.a.30988
   Walboomers XF, 1999, J BIOMED MATER RES, V47, P204, DOI 10.1002/(SICI)1097-4636(199911)47:2<204::AID-JBM10>3.0.CO;2-H
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   WOJCIAKSTOTHARD B, 1995, CELL MOTIL CYTOSKEL, V31, P147, DOI 10.1002/cm.970310207
   Zamir E, 2001, J CELL SCI, V114, P3583
NR 39
TC 2
Z9 2
U1 0
U2 9
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0933-5137
J9 MATERIALWISS WERKST
JI Materialwiss. Werkstofftech.
PD JAN
PY 2009
VL 40
IS 1-2
BP 101
EP 107
DI 10.1002/mawe.200800370
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA 413MD
UT WOS:000263796300016
DA 2018-10-19
ER

PT J
AU Meek, MF
   Den Dunnen, WFA
AF Meek, Marcel F.
   Den Dunnen, Wilfred F. A.
TI POROSITY OF THE WALL OF A NEUROLAC (R) NERVE CONDUIT HAMPERS NERVE
   REGENERATION
SO MICROSURGERY
LA English
DT Article
ID PERIPHERAL-NERVE; IN-VITRO; REPAIR; RAT;
   POLY(DL-LACTIDE-EPSILON-CAPROLACTONE); DEGRADATION; LESIONS; GRAFTS;
   GUIDES; VIVO
AB One way to improve nerve regeneration and bridge longer nerve gaps may be the use of semipermeable/porous conduits. With porosity less biomaterial is used for the nerve conduit. We evaluated the short-term effects of porous Neurolac (R) nerve conduits for in vivo peripheral nerve regeneration. In 10 male Black Hooded rats, a gap of 10 mm was bridged by a porous Neurolac (R) nerve conduit. Evaluation point ranged from 3 to 12 weeks. The sciatic nerve function was not measurable due to automutilation and flexion contractures. The gait-stance duration showed no improvement with time, indicating a disturbed walking pattern. The nerve guides showed very fast degradation with swelling, fragmentation, and collapse. Furthermore, a severe foreign body reaction occurred. Nerve regeneration was severely hampered. This study showed no beneficial effects of porous Neurolac (R) nerve conduits when compared with previous findings with nonporous copolymeric nerve guides of a slightly different composition. (C) 2009 Wiley-Liss, Inc. Microsurgery 29:473-478, 2009.
C1 [Meek, Marcel F.] Scheper Hosp, Dept Plast & Hand Surg, Emmen, Netherlands.
   [Den Dunnen, Wilfred F. A.] Univ Groningen, Dept Pathol & Lab Med, Univ Med Ctr Groningen, Groningen, Netherlands.
RP Meek, MF (reprint author), Scheper Hosp, Dept Plast & Hand Surg, Boermarkeweg 60, Emmen, Netherlands.
EM marcelfmeek@hotmail.com
RI den Dunnen, Wilfred/A-4034-2009
CR AEBISCHER P, 1988, BRAIN RES, V454, P179, DOI 10.1016/0006-8993(88)90817-7
   BAIN JR, 1989, PLAST RECONSTR SURG, V83, P129, DOI 10.1097/00006534-198901000-00024
   Chang CJ, 2007, J BIOMED MATER RES B, V83B, P206, DOI 10.1002/jbm.b.30785
   den Dunnen WFA, 2000, J BIOMED MATER RES, V51, P575, DOI 10.1002/1097-4636(20000915)51:4<575::AID-JBM5>3.3.CO;2-Q
   DENDUNNEN WFA, 1993, J MATER SCI-MATER M, V4, P521, DOI 10.1007/BF00120133
   denDunnen WFA, 1996, J BIOMED MATER RES, V31, P105, DOI 10.1002/(SICI)1097-4636(199605)31:1<105::AID-JBM13>3.0.CO;2-M
   DenDunnen WFA, 1996, MICROSURG, V17, P348, DOI 10.1002/(SICI)1098-2752(1996)17:7<348::AID-MICR2>3.0.CO;2-C
   denDunnen WFA, 1997, J BIOMED MATER RES, V36, P337, DOI 10.1002/(SICI)1097-4636(19970905)36:3<337::AID-JBM9>3.3.CO;2-8
   Doolabh VB, 1996, REV NEUROSCIENCE, V7, P47
   GRIJPMA DW, 1991, POLYM BULL, V25, P327, DOI 10.1007/BF00316902
   IJkema-Paassen J, 2005, ANN ANAT, V187, P113, DOI 10.1016/j.aanat.2004.11.001
   JENQ CB, 1987, BRAIN RES, V408, P239, DOI 10.1016/0006-8993(87)90379-9
   KNOOPS B, 1990, J NEUROPATH EXP NEUR, V49, P438, DOI 10.1097/00005072-199007000-00007
   MEEK M, 2000, ARTIFICIAL NERVE GUI
   Meek MF, 2008, ANN PLAS SURG, V60, P466, DOI 10.1097/SAP.0b013e31804d441c
   Meek M F, 2003, Ned Tijdschr Geneeskd, V147, P717
   Meek MF, 2002, J RECONSTR MICROSURG, V18, P97, DOI 10.1055/s-2002-19889
   Meek MF, 2001, MUSCLE NERVE, V24, P753, DOI 10.1002/mus.1066
   WALKER JL, 1994, J NEUROSCI METH, V52, P47, DOI 10.1016/0165-0270(94)90054-X
   Wang SG, 2003, J BIOMED MATER RES A, V66A, P522, DOI 10.1002/jbm.a.10008
NR 20
TC 42
Z9 44
U1 1
U2 9
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0738-1085
J9 MICROSURG
JI Microsurgery
PY 2009
VL 29
IS 6
BP 473
EP 478
DI 10.1002/micr.20642
PG 6
WC Surgery
SC Surgery
GA 494BA
UT WOS:000269782900008
PM 19308952
DA 2018-10-19
ER

PT B
AU Xie, O
   Chong, PLG
   Zhou, J
AF Xie, Oliver
   Chong, Parkson Lee-Gau
   Zhou, Jack
GP ASME
TI A SMART ACTUATOR DESIGN FOR MULTIPLE BIO-REAGENT MIXING IN A HIGH
   PRESSURE OPTICAL CELL FOR BIO-PHYSICAL RESEARCH APPLICATIONS
SO MSEC 2008: PROCEEDINGS OF THE ASME INTERNATIONAL MANUFACTURING SCIENCE
   AND ENGINEERING CONFERENCE 2008, VOL 1
LA English
DT Proceedings Paper
CT ASME International Manufacturing Science and Engineering Conference
CY OCT 07-10, 2008
CL Evanston, IL
SP ASME, Mfg Engn Div
ID MEMBRANES
AB During the past two decades, bio-physicists have had an increasing interest in finding out what happens when two biomaterial solutions are mixed under high pressure. Compared to temperature, pressure makes more contributions to our fundamental understanding of the structure-function relationship of biological systems, because pressure produces only volume changes under isothermal conditions, and pressure results can then be interpreted in a more straightforward manner. Window-type High Pressure Optical Cell (HPOC) such as the one designed by Paladini and Weber have provided biophysicists with a powerful tool to understanding the structure-function relationships of biological molecules. However, the conventional HPOC is only good for single solution testing and does not allow for quick mixing and stirring of additional components while the specimen is under pressure.
   This research is to thoroughly study the feasibility of Shape Memory Alloy (SMA) as an actuator to perform mixing and agitation functions; and five types of SMA actuators were designed, simulated and tested for unplugging and mixing purposes. To conduct this research, SMA helical springs were fabricated in house according to the design requirements. With different combinations of SMA tensile springs, SMA compressive spring and biasing spring, significant ranges of vibration were developed. To further improving mixing process, a unique hybrid design of SMA as an actuator to unplug the stopper and micro-motor as a stir device to agitate the solutions was developed. Rapid mixing of 95% of total solution in 10 seconds was achieved under 300 bars. A new HPOC was designed according to the new cuvette with its new unplug and mixing mechanism. Our industrial partner, ISS, further modified our design for easy manufacturing reason and fabricated the HPOC which made SMA actuator mixing test under pressure possible. A complete testing of the new HPOC system to observe bio-reagent mixing and reaction under high pressure was conducted and the results were satisfactory.
C1 [Xie, Oliver; Zhou, Jack] Drexel Univ, Dept Mech Engn & Mech, Philadelphia, PA 19104 USA.
RP Xie, O (reprint author), Drexel Univ, Dept Mech Engn & Mech, Philadelphia, PA 19104 USA.
CR CHONG PLG, 1983, BIOCHEMISTRY-US, V22, P409, DOI 10.1021/bi00271a026
   Czeslik C, 1998, CHEM PHYS LIPIDS, V91, P135, DOI 10.1016/S0009-3084(97)00104-7
   Olsher M, 2005, BIOCHEMISTRY-US, V44, P2080, DOI 10.1021/bi047710s
   PALADINI AA, 1981, BIOCHEMISTRY-US, V20, P2587, DOI 10.1021/bi00512a034
   WONG PTT, 1985, J CHEM PHYS, V83, P3268, DOI 10.1063/1.449185
   Zhou JG, 1998, REV SCI INSTRUM, V69, P3958, DOI 10.1063/1.1149206
   Zhou JG, 2000, REV SCI INSTRUM, V71, P4249, DOI 10.1063/1.1290036
NR 7
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-4851-7
PY 2009
BP 577
EP 581
PG 5
WC Engineering, Mechanical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BJK26
UT WOS:000266633200071
DA 2018-10-19
ER

PT B
AU Lu, L
   Wootton, D
   Lelkes, PI
   Zhou, J
AF Lu, Lin
   Wootton, David
   Lelkes, Peter I.
   Zhou, Jack
GP ASME
TI STUDY OF STRUCTURED POROGEN METHOD FOR BONE SCAFFOLD FABRICATION
SO MSEC 2008: PROCEEDINGS OF THE ASME INTERNATIONAL MANUFACTURING SCIENCE
   AND ENGINEERING CONFERENCE 2008, VOL 2
LA English
DT Proceedings Paper
CT ASME International Manufacturing Science and Engineering Conference
CY OCT 07-10, 2008
CL Evanston, IL
SP ASME, Mfg Engn Div
ID RESORBABLE POLYMERS; ACID)
AB The increasing demand on bone scaffolds has promoted the development of tissue engineering fabrication technique for manufacturing bone scaffold. In this study, a novel structured porogen method for bone scaffold fabrication has been explored. This method has demonstrated highly efficient and reproducible fabrication of structured bone scaffolds which mimics the bone structure. By using commercially available Drop on Demand (DDP) system and three dimensional printer (3-DP) system, at first designed structured porogens can be manufactured, and then bone scaffolds can be fabricated by injecting the biocomposite materials into the porogens. The mechanical properties of the fabricated scaffolds using DDP system have been characterized. The biocompatibility of our fabricated scaffolds using 3-DP has been examined. With incorporating of bioactive calcium phosphate into the composite materials, the mechanical strength and bioactivity of the scaffolds made by the structured porogen method can be improved significantly. This structured porogen method has a potential to be used on various Solid Freeform Fabrication systems which allows each system to use a single ubiquitous building material to fabricate multiple biomaterial scaffolds with sufficient mechanical integrity.
C1 [Lu, Lin; Zhou, Jack] Drexel Univ, Dept Mech Engn & Mech, Philadelphia, PA 19104 USA.
RP Lu, L (reprint author), Drexel Univ, Dept Mech Engn & Mech, Philadelphia, PA 19104 USA.
CR CARTER DR, 1976, SCIENCE, V194, P1174, DOI 10.1126/science.996549
   Chapekar MS, 2000, J BIOMED MATER RES, V53, P617, DOI 10.1002/1097-4636(2000)53:6<617::AID-JBM1>3.3.CO;2-3
   COOMBES AGA, 1992, BIOMATERIALS, V13, P297, DOI 10.1016/0142-9612(92)90053-Q
   COOMBES AGA, 1992, BIOMATERIALS, V13, P217, DOI 10.1016/0142-9612(92)90187-S
   Daculsi G, 1998, BIOMATERIALS, V19, P1473, DOI 10.1016/S0142-9612(98)00061-1
   Flautre B, 1999, J MATER SCI-MATER M, V10, P811, DOI 10.1023/A:1008923625599
   Gadzag A., 1995, J AM ACAD ORTHOP SUR, V3, P1
   Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
   Hong SJ, 2006, J NEUROSURG-SPINE, V4, P154, DOI 10.3171/spi.2006.4.2.154
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   LIN L, 2007, P MSEC 2007 ASME INT
   MIKOS AG, 1993, J BIOMED MATER RES, V27, P183, DOI 10.1002/jbm.820270207
   MONDRINOS MJ, 2006, BIOMATERIAL
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   Oonishi H, 1999, J BIOMED MATER RES, V44, P31, DOI 10.1002/(SICI)1097-4636(199901)44:1<31::AID-JBM4>3.0.CO;2-9
   Ruhe PQ, 2006, TISSUE ENG, V12, P789, DOI 10.1089/ten.2006.12.789
   Schnettler R, 2004, EUR J TRAUMA, V30, P219
   Singhal A R, 1996, Tissue Eng, V2, P197, DOI 10.1089/ten.1996.2.197
NR 18
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-4852-4
PY 2009
BP 491
EP 496
PG 6
WC Biotechnology & Applied Microbiology; Engineering, Mechanical;
   Nanoscience & Nanotechnology
SC Biotechnology & Applied Microbiology; Engineering; Science & Technology
   - Other Topics
GA BJK29
UT WOS:000266633800060
DA 2018-10-19
ER

PT S
AU Chen, C
   Chen, J
   Li, Q
   Chen, J
   Tu, Q
   Chen, S
   Liu, S
   Huang, N
AF Chen, Cheng
   Chen, Junying
   Li, Quanli
   Chen, Jialong
   Tu, Qiufen
   Chen, Songmei
   Liu, Shihui
   Huang, Nan
BE Yin, YS
   Wang, X
TI The biological behavior of endothelial progenitor cells on titanium
   surface immobilized by CD34 antibody
SO MULTI-FUNCTIONAL MATERIALS AND STRUCTURES II, PTS 1 AND 2
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT 2nd International Conference on Multi-Functional Materials and
   Structures
CY OCT 09-12, 2009
CL Qingdao, PEOPLES R CHINA
SP KC Wong EducN, Natl Nat Sci Fdn Comm, Dept Engn & Mat Sci, Ocean Univ China, Hong Kong Polytechn Univ, Soc High Level Experts Qingdao, Mat & Chem Engn Branch
DE Titanium; Layer-by-layer self-assembly technique; CD34; Endothelial
   progenitor cells; Endothelialization
AB The biological modification of biomaterials surface was an important means for surface endothelialization. In this work, an extracellular matrix-like (ECM-like) surface modification was developed for inducing endothelialization on titanium cardiovascular implant surface. To solve the problem of antibody denaturing caused in the randomly immobilizing, cluster of differentiation 34 (CD34) antibody was directly immobilized on titanium surface using a layer-by-layer self-assembly (LBL) technique. The biological behaviors of the endothelial progenitor cells (EPCs) on modified titanium surface were investigated by in vitro cell culture experiment. The results showed that the avidin, biotinylated protein A and the CD34 antibody were successfully assembled onto the NaOH etched titanium surface. The results of cells experiment suggested that the CD34 antibody immobilized surfaces promoted EPCs attachment and capture in vitro. It was believed that the response of adhesion, proliferation, differentiation of EPCs to titanium surface was regulated by modifying the surface chemistry which controlled the cell-biomaterial interactions. This work provided a surface biomodification means to increase the biocompatibility of titanium-based vascular implant surfaces.
C1 [Chen, Cheng; Chen, Junying; Li, Quanli; Chen, Jialong; Tu, Qiufen; Chen, Songmei; Liu, Shihui; Huang, Nan] SW Jiaotong Univ, Key Lab Adv Technol Mat, Educ Minist China, Chengdu, Peoples R China.
RP Chen, C (reprint author), SW Jiaotong Univ, Key Lab Adv Technol Mat, Educ Minist China, Chengdu, Peoples R China.
EM chenc167@163.com; chenjy@263.net
RI Chen, Jialong/E-4388-2015
OI Chen, Jialong/0000-0002-5323-1801
CR Cai KY, 2005, BIOMATERIALS, V26, P5960, DOI 10.1016/j.biomaterials.2005.03.020
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   FENG B, 2003, MATER CHARACT, V49, P129, DOI DOI 10.1016/S1044-5803(02)00341-8
   Hong J, 1999, THROMB HAEMOSTASIS, V82, P58
   Kumari TV, 2002, BIO-MED MATER ENG, V12, P329
   Li Cheng, 2004, Hemodial Int, V8, P360, DOI 10.1111/j.1492-7535.2004.80412.x
   Liu Q, 2002, BIOMATERIALS, V23, P3103, DOI 10.1016/S0142-9612(02)00050-9
   Takemoto S, 2004, BIOMATERIALS, V25, P3485, DOI 10.1016/j.biomaterials.2003.10.070
   Tirrell M, 2002, SURF SCI, V500, P61, DOI 10.1016/S0039-6028(01)01548-5
NR 9
TC 2
Z9 2
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-0-87849-304-3
J9 ADV MATER RES-SWITZ
PY 2009
VL 79-82
BP 707
EP 710
DI 10.4028/www.scientific.net/AMR.79-82.707
PN 1-2
PG 4
WC Materials Science, Multidisciplinary
SC Materials Science
GA BPW51
UT WOS:000280155900176
DA 2018-10-19
ER

PT S
AU Guan, RG
   Zhao, T
   Wang, LL
   Cui, T
AF Guan, Ren-guo
   Zhao, Tong
   Wang, Lin-lin
   Cui, Tong
BE Yin, YS
   Wang, X
TI New magnesium alloys for potential application of implantation
   biomaterial
SO MULTI-FUNCTIONAL MATERIALS AND STRUCTURES II, PTS 1 AND 2
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT 2nd International Conference on Multi-Functional Materials and
   Structures
CY OCT 09-12, 2009
CL Qingdao, PEOPLES R CHINA
SP KC Wong EducN, Natl Nat Sci Fdn Comm, Dept Engn & Mat Sci, Ocean Univ China, Hong Kong Polytechn Univ, Soc High Level Experts Qingdao, Mat & Chem Engn Branch
DE Magnesium alloy; Biomaterial; Chemical composition; Microstructure;
   Property
ID CORROSION
AB New magnesium alloys with optimized chemical compositions with good biocompatibility were designed. Experimental results show that MZ alloy mainly consists of Ca2Mg5Zn5+alpha (Mg) and MgZn+MgZn2+Mg2Ca+Zn-Zr compounds. Ca has a strong capability for grain refinement in such alloy. Zr can refine magnesium alloy. Zn addition does not refine the solidification microstructure but plays significant strengthening role during aging treatment. The main strengthening phases of Mg-Zn-Zr alloy are gamma(MgZn) and delta(Mg2Zn3). The tensile strength of MZ alloy plate aged at 170 degrees C for 12h is 320MPa, and the elongation-to-failure is 18.4%, the alloy has a potential application of implantation biomaterial.
C1 [Guan, Ren-guo] Northeastern Univ, Mat & Met Coll, Sch Met & Mat, Box317, Shenyang 110004, Peoples R China.
   [Zhao, Tong] Hosp Liaoning Univ Tradit Chinese Med, Shenyang 110032, Peoples R China.
RP Guan, RG (reprint author), Northeastern Univ, Mat & Met Coll, Sch Met & Mat, Box317, Shenyang 110004, Peoples R China.
EM guanrg@smm.neu.edu.cn; zhaotong@126.com; wangll@smm.neu.edu.cn;
   ct@smm.neu.edu.cn
FU National High-tech R & D Program of China [2007AA03Z111]; Natural
   Science Foundation of China [50604007]; Program for New Century
   Excellent Talents in University,China [NCET-08-0097]
FX Authors gratefully thank for the supports: National High-tech R & D
   Program of China (Grant No. 2007AA03Z111), Natural Science Foundation of
   China (Grant No. 50604007) and Program for New Century Excellent Talents
   in University (NCET-08-0097), China.
CR Alves H, 2001, MATER TECHNOL, V16, P110, DOI 10.1080/10667857.2001.11752920
   KONG ZG, 2004, BEIJING U AEROSPACE, V30, P972
   [刘生发 Liu Shengfa], 2003, [铸造, Foundry], V52, P246
   LUO ZP, 1993, ACTA MET SIN, V29, P23
   Mukai T, 2001, SCRIPTA MATER, V45, P89, DOI 10.1016/S1359-6462(01)00996-4
   Ren YB, 2005, ACTA METALL SIN, V41, P1228
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   WOJCIECH S, 1998, MAT RES, V9, P94
   ZHANG J, 2002, ORDNANCE MAT SCI ENG, V25, P50
NR 9
TC 3
Z9 3
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-0-87849-304-3
J9 ADV MATER RES-SWITZ
PY 2009
VL 79-82
BP 1443
EP +
DI 10.4028/www.scientific.net/AMR.79-82.1443
PN 1-2
PG 2
WC Materials Science, Multidisciplinary
SC Materials Science
GA BPW51
UT WOS:000280155900358
DA 2018-10-19
ER

PT J
AU Martinez, E
   Lagunas, A
   Mills, CA
   Rodriguez-Segui, S
   Estevez, M
   Oberhansl, S
   Comelles, J
   Samitier, J
AF Martinez, E.
   Lagunas, A.
   Mills, C. A.
   Rodriguez-Segui, S.
   Estevez, M.
   Oberhansl, S.
   Comelles, J.
   Samitier, J.
TI Stem cell differentiation by functionalized micro- and nanostructured
   surfaces
SO Nanomedicine
LA English
DT Review
DE cell pattering; differentiation; microcontact printing; micropatterning;
   microstructure; nanoimprinting; nanostructure; stem cells
ID ACTIVATED POLYMER SURFACE; SELF-ASSEMBLED MONOLAYERS; MARROW STROMAL
   CELLS; EXTRACELLULAR-MATRIX; OSTEOGENIC DIFFERENTIATION;
   BASEMENT-MEMBRANE; SOFT LITHOGRAPHY; GROWTH-FACTOR; MICROTEXTURED
   SURFACES; SUBSTRATE INTERACTIONS
AB New fabrication technologies and, in particular, new nanotechnologies have provided biomaterial and biomedical scientists with enormous possibilities when designing customized supports and scaffolds with controlled nanoscale topography and chemistry. The main issue now is how to effectively design these components and choose the appropriate combination of structure and chemistry to tailor towards applications as challenging and complex as stem cell differentiation. Occasionally, an incomplete knowledge of the fundamentals of biological differentiation process has hampered this issue. However, the recent technological advances in creating controlled cellular microenvironments can be seen as a powerful tool for furthering fundamental biology studies. This article reviews the main strategies followed to achieve solutions to this challenge, particularly emphasizing the working hypothesis followed by the authors to elucidate the mechanisms behind the observed effects of structured surfaces on cell behavior.
C1 [Martinez, E.; Lagunas, A.; Mills, C. A.; Rodriguez-Segui, S.; Estevez, M.; Oberhansl, S.; Comelles, J.; Samitier, J.] IBEC, Nanobioengn Grp, Barcelona 08028, Spain.
   [Rodriguez-Segui, S.; Estevez, M.; Samitier, J.] Univ Barcelona, Dept Elect, Barcelona 08028, Spain.
RP Martinez, E (reprint author), IBEC, Nanobioengn Grp, Baldrir Reixac 10-12, Barcelona 08028, Spain.
EM emartinez@pcb.ub.es
RI MARTINEZ, ELENA/F-7572-2014; Mills, Christopher/C-5535-2009; Martinez,
   Elena/C-6008-2009
OI Mills, Christopher/0000-0002-2906-4978; Comelles,
   Jordi/0000-0002-9297-830X; Rodriguez-Segui, Santiago/0000-0003-2952-8485
CR Abrams GA, 2000, CELL TISSUE RES, V299, P39, DOI 10.1007/s004419900074
   Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.0.CO;2-J
   Alvarez M, 1997, ENDOCRINOLOGY, V138, P482, DOI 10.1210/en.138.1.482
   Andersson AS, 2003, BIOMATERIALS, V24, P3427, DOI 10.1016/S0142-9612(03)00208-4
   Baac HW, 2004, MAT SCI ENG C-BIO S, V24, P209, DOI 10.1016/j.msec.2003.09.009
   Baharvand H, 2008, DIFFERENTIATION, V76, P465, DOI 10.1111/j.1432-0436.2007.00252.x
   Barberi T, 2003, NAT BIOTECHNOL, V21, P1200, DOI 10.1038/nbt870
   Behonick DJ, 2003, MECH DEVELOP, V120, P1327, DOI 10.1016/j.mod.2003.05.002
   Benoit DSW, 2005, BIOMATERIALS, V26, P5209, DOI 10.1016/j.biomaterials.2005.01.045
   Bhatnagar P, 2008, BIOMED MICRODEVICES, V10, P567, DOI 10.1007/s10544-008-9167-6
   Bretagnol F, 2007, SENSOR ACTUAT B-CHEM, V123, P283, DOI 10.1016/j.snb.2006.08.040
   Britland S, 1996, EXP CELL RES, V228, P313, DOI 10.1006/excr.1996.0331
   Cancedda R, 2003, MATRIX BIOL, V22, P81, DOI 10.1016/S0945-053X(03)00012-X
   Cavalcanti-Adam EA, 2007, BIOPHYS J, V92, P2964, DOI 10.1529/biophysj.106.089730
   Charest JL, 2005, J VAC SCI TECHNOL B, V23, P3011, DOI 10.1116/1.2127951
   Charest JL, 2006, BIOMATERIALS, V27, P2487, DOI 10.1016/j.biomaterials.2005.11.022
   Charest JL, 2004, BIOMATERIALS, V25, P4767, DOI 10.1016/j.biomaterials.2003.12.011
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120
   Cheng K, 2008, BIOMATERIALS, V29, P2802, DOI 10.1016/j.biomaterials.2008.03.015
   CHUNG BG, 2008, BIOMATERIAL IN PRESS
   Clarke I J, 1987, J Reprod Fertil Suppl, V34, P1
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Curtis A. S. G., 1994, BIOMECHANICS CELLS, P121
   Curtis ASG, 2006, NANOMEDICINE-UK, V1, P67, DOI 10.2217/17435889.1.1.67
   CURTIS ASG, 1964, J NATL CANCER I, V33, P15
   Curtis ASG, 2004, IEEE T NANOBIOSCI, V3, P61, DOI 10.1109/TNB.2004.824276
   Curtis ASG, 2001, BIOPHYS CHEM, V94, P275, DOI 10.1016/S0301-4622(01)00247-2
   CURTIS ASG, 1978, NATURE, V274, P52, DOI 10.1038/274052a0
   Dalby MJ, 2007, J CELL BIOCHEM, V102, P1234, DOI 10.1002/jcb.21354
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dalby MJ, 2007, J CELL BIOCHEM, V100, P326, DOI 10.1002/jcb.21058
   Dalby MJ, 2006, BIOMATERIALS, V27, P2980, DOI 10.1016/j.biomaterials.2006.01.010
   Dalby MJ, 2004, INT J BIOCHEM CELL B, V36, P2005, DOI 10.1016/j.biocel.2004.03.001
   Dalby MJ, 2004, BIOMATERIALS, V25, P5415, DOI 10.1016/j.biomaterials.2003.12.049
   Dalby MJ, 2003, EXP CELL RES, V284, P274, DOI 10.1016/S0014-4827(02)00053-8
   Dang JM, 2007, ADV MATER, V19, P2775, DOI 10.1002/adma.200602159
   Dawson E, 2008, ADV DRUG DELIVER REV, V60, P215, DOI 10.1016/j.addr.2007.08.037
   Dawson JI, 2008, ARCH BIOCHEM BIOPHYS, V473, P124, DOI 10.1016/j.abb.2008.03.024
   Dike LE, 1996, J CELL SCI, V109, P2855
   Dike LE, 1999, IN VITRO CELL DEV-AN, V35, P441
   DiMuzio P, 2007, J VASC SURG, V45, p99A, DOI 10.1016/j.jvs.2007.02.046
   Ding S, 2004, NAT BIOTECHNOL, V22, P833, DOI 10.1038/nbt987
   DRAKE CJ, 1995, J CELL SCI, V108, P2655
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   DUMONT IE, 2002, AM J PHYSIOL-CELL PH, V283, pC2
   DUNN GA, 1986, J CELL SCI, V83, P313
   Dusseiller MR, 2005, BIOMATERIALS, V26, P5917, DOI 10.1016/j.biomaterials.2005.02.032
   EMBRECHTS A, 2008, LANGMUIR IN PRESS
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Faid K, 2005, BIOMED MICRODEVICES, V7, P179, DOI 10.1007/s10544-005-3023-8
   Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024
   Fan HB, 2008, BIOMATERIALS, V29, P1017, DOI 10.1016/j.biomaterials.2007.10.048
   FELDHERR CM, 1993, EXP CELL RES, V205, P179, DOI 10.1006/excr.1993.1073
   Fixe F, 2004, LAB CHIP, V4, P191, DOI 10.1039/b316616c
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7
   Fujita S, 2008, BIOMATERIALS, V29, P4494, DOI 10.1016/j.biomaterials.2008.08.027
   Fukuda J, 2006, BIOMATERIALS, V27, P1479, DOI 10.1016/j.biomaterials.2005.09.015
   Gadegaard N, 2006, MICROELECTRON ENG, V83, P1577, DOI 10.1016/j.mee.2006.01.147
   Gallagher JO, 2002, IEEE T NANOBIOSCI, V1, P24, DOI 10.1109/TNB.2002.806918
   Gelain F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000119
   Gerecht S, 2007, BIOMATERIALS, V28, P4068, DOI 10.1016/j.biomaterials.2007.05.027
   Gomez N, 2007, BIOMATERIALS, V28, P271, DOI 10.1016/j.biomaterials.2006.07.043
   HAMMARBACK JA, 1985, J NEUROSCI RES, V13, P213, DOI 10.1002/jnr.490130115
   Hansen JC, 2007, J BIOMECH, V40, P2865, DOI 10.1016/j.jbiomech.2007.03.018
   Harris DT, 2007, EXPERT OPIN BIOL TH, V7, P1311, DOI 10.1517/14712598.7.9.1311
   Hasenbein ME, 2002, BIOMATERIALS, V23, P3937, DOI 10.1016/S0142-9612(02)00129-1
   Hasirci V, 2006, NANOMEDICINE-UK, V1, P73, DOI 10.2217/17435889.1.1.73
   Hung AM, 2007, NANO LETT, V7, P1165, DOI 10.1021/nl062835z
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Hwang NS, 2008, ADV DRUG DELIVER REV, V60, P199, DOI 10.1016/j.addr.2007.08.036
   Hyun J, 2001, LANGMUIR, V17, P6358, DOI 10.1021/la010695x
   INGBER DE, 1989, CELL, V58, P803, DOI 10.1016/0092-8674(89)90928-8
   INGBER DE, 1989, J CELL BIOL, V109, P317, DOI 10.1083/jcb.109.1.317
   INGBER DE, 1990, P NATL ACAD SCI USA, V87, P3579, DOI 10.1073/pnas.87.9.3579
   JEDLICKA S, 2007, MATER RES SOC S P, V950, pD4
   Johansson F, 2006, BIOMATERIALS, V27, P1251, DOI [10.1016/j.biomaterials.2005.07.047, 10.1016/j.niomaterials.2005.07.047]
   Johnson A., 2002, MOL BIOL CELL, P1065
   Kajstura J, 2005, CIRC RES, V96, P127, DOI 10.1161/01.RES.0000151843.79801.60
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kardestuncer T, 2006, CLIN ORTHOP RELAT R, P234, DOI 10.1097/01.blo.0000205879.50834.fe
   Karuri NW, 2004, J CELL SCI, V117, P3153, DOI 10.1242/jcs.01146
   KASTEN P, 2008, ACTA BIOMAT IN PRESS
   Keselowsky BG, 2007, J BIOMED MATER RES A, V80A, P700, DOI 10.1002/jbm.a.30898
   Khademhosseini A, 2006, BIOMATERIALS, V27, P5968, DOI 10.1016/j.biomaterials.2006.06.035
   Khor HL, 2007, BIOMACROMOLECULES, V8, P1530, DOI 10.1021/bm0611533
   KIM E, 1995, NATURE, V376, P581, DOI 10.1038/376581a0
   Kim HW, 2008, J BIOMED MATER RES A, V85A, P651, DOI 10.1002/jbm.a.31339
   Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013
   Kim SJ, 2008, J MATER SCI-MATER M, V19, P2953, DOI 10.1007/s10856-008-3413-6
   Kleinman HK, 2003, CURR OPIN BIOTECH, V14, P526, DOI 10.1016/j.copbio.2003.08.002
   Koh HS, 2008, BIOMATERIALS, V29, P3574, DOI 10.1016/j.biomaterials.2008.05.014
   Kong HJ, 2007, NAT REV DRUG DISCOV, V6, P455, DOI 10.1038/nrd2309
   KUMAR A, 1993, APPL PHYS LETT, V63, P2002, DOI 10.1063/1.110628
   Kunzler TP, 2007, BIOMATERIALS, V28, P5000, DOI 10.1016/j.biomaterials.2007.08.009
   Lim JY, 2007, TISSUE ENG, V13, P1879, DOI 10.1089/ten.2006.0154
   LIPSKI AM, 2008, BIOMATERIAL IN PRESS
   Lipski AM, 2007, ADV MATER, V19, P553, DOI 10.1002/adma.200502617
   LOPEZ GP, 1993, J AM CHEM SOC, V115, P5877, DOI 10.1021/ja00066a087
   Lu Y, 2006, J BIOMED MATER RES A, V77A, P396, DOI 10.1002/jbm.a.30601
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Magnusson AK, 2008, J NEUROSCI RES, V86, P2363, DOI 10.1002/jnr.21688
   Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849
   MARSHAK DR, 2001, STEM CELL BIOL 40, pCH10
   Martinez E, 2008, MICRON, V39, P111, DOI 10.1016/j.micron.2006.12.003
   MATSUDA T, 1993, Patent No. 5593814
   Matsuzaka K, 2003, BIOMATERIALS, V24, P2711, DOI 10.1016/S0142-9612(03)00085-1
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   MCNAMEE HP, 1993, J CELL BIOL, V121, P673, DOI 10.1083/jcb.121.3.673
   Mei Y, 2007, CURR OPIN CHEM BIOL, V11, P388, DOI 10.1016/j.cbpa.2007.07.006
   Metallo CM, 2007, BIOTECHNOL PROGR, V23, P18, DOI 10.1021/bp060350a
   Mills CA, 2006, J BIOMED MATER RES A, V76A, P781, DOI 10.1002/jbm.a.30539
   Mills CA, 2007, SMALL, V3, P871, DOI 10.1002/smll.200600683
   Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542
   Moroni L, 2008, ADV FUNCT MATER, V18, P53, DOI 10.1002/adfm.200601158
   Moviglia GA, 2006, CYTOTHERAPY, V8, P196, DOI 10.1080/14653240600735958
   Mrksich M, 1996, P NATL ACAD SCI USA, V93, P10775, DOI 10.1073/pnas.93.20.10775
   Murray P, 2004, PHILOS T ROY SOC B, V359, P1009, DOI 10.1098/rstb.2003.1460
   Murugan R, 2007, J NANOSCI NANOTECHNO, V7, P4595, DOI 10.1166/jnn2007.008
   Nakajima M, 2007, BIOMATERIALS, V28, P1048, DOI 10.1016/j.biomaterials.2006.10.004
   Nisbet DR, 2008, J BIOMAT SCI-POLYM E, V19, P623, DOI 10.1163/156856208784089652
   Nur-E-Kamal A, 2006, STEM CELLS, V24, P426, DOI 10.1634/stemcells.2005-0170
   Ooe H, 2005, J VAC SCI TECHNOL B, V23, P375, DOI 10.1116/1.1861929
   Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765
   Pattison MA, 2005, BIOMATERIALS, V26, P2491, DOI 10.1016/j.biomaterials.2004.07.011
   Pease LF, 2007, NAT NANOTECHNOL, V2, P545, DOI 10.1038/nnano.2007.264
   Pellegrini G, 2007, SEMIN CELL DEV BIOL, V18, P805, DOI 10.1016/j.semcdb.2007.09.011
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   PLOPPER GE, 1995, MOL BIOL CELL, V6, P1349
   Popat KC, 2007, J BIOMED MATER RES A, V80A, P955, DOI 10.1002/jbm.a.31028
   Provenzano PP, 2006, MATRIX BIOL, V25, P71, DOI 10.1016/j.matbio.2005.09.005
   Ramanujam PS, 2005, OPT MATER, V27, P1175, DOI 10.1016/j.optmat.2004.08.079
   Recknor JB, 2006, BIOMATERIALS, V27, P4098, DOI 10.1016/j.biomaterials.2006.03.029
   Recknor JB, 2004, BIOMATERIALS, V25, P2753, DOI 10.1016/j.biomaterials.2003.11.045
   Riesle J, 1998, J CELL BIOCHEM, V71, P313, DOI 10.1002/(SICI)1097-4644(19981201)71:3<313::AID-JCB1>3.0.CO;2-C
   Rosenthal A, 2007, BIOMATERIALS, V28, P3208, DOI 10.1016/j.biomaterials.2007.03.023
   ROSKELLEY CD, 1995, CURR OPIN CELL BIOL, V7, P736, DOI 10.1016/0955-0674(95)80117-0
   Ruiz A, 2007, MICROELECTRON ENG, V84, P1733, DOI 10.1016/j.mee.2007.01.200
   SAFINIA L, 2005, E POLYM
   Saha K, 2007, CURR OPIN CHEM BIOL, V11, P381, DOI 10.1016/j.cbpa.2007.05.030
   Saha K, 2007, J BIOMED MATER RES A, V81A, P240, DOI 10.1002/jbm.a.30986
   Salber J, 2007, SMALL, V3, P1023, DOI 10.1002/smll.200600596
   Santiago LY, 2006, BIOMATERIALS, V27, P2962, DOI 10.1016/j.biomaterials.2006.01.011
   Schmalenberg KE, 2004, BIOMATERIALS, V25, P1851, DOI 10.1016/j.biomaterials.2003.08.048
   Schuldiner M, 2000, P NATL ACAD SCI USA, V97, P11307, DOI 10.1073/pnas.97.21.11307
   SCHWARTZ MA, 1991, P NATL ACAD SCI USA, V88, P7849, DOI 10.1073/pnas.88.17.7849
   Sefcik LS, 2008, J TISSUE ENG REGEN M, V2, P210, DOI 10.1002/term.85
   Shiraki N, 2008, GENES CELLS, V13, P731, DOI 10.1111/j.1365-2443.2008.01201.x
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   Smith AM, 2006, ADV FUNCT MATER, V16, P1022, DOI 10.1002/adfm.200500568
   Sniadecki N, 2006, ANN BIOMED ENG, V34, P59, DOI 10.1007/s10439-005-9006-3
   Sobajima S, 2008, SPINE J, V8, P888, DOI 10.1016/j.spinee.2007.09.011
   Soen Y, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100076
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Srouji S, 2008, J MATER SCI-MATER M, V19, P1249, DOI 10.1007/s10856-007-3218-z
   Sun S, 2006, BIOELECTROCHEMISTRY, V69, P133, DOI 10.1016/j.bioelechem.2005.11.007
   SYMPSON CJ, 1994, J CELL BIOL, V125, P681, DOI 10.1083/jcb.125.3.681
   Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383
   TEIXEIRA AI, 2004, J BIOMED MATER RES A, V71, P3153
   Thapa A, 2003, J BIOMED MATER RES A, V67A, P1374, DOI 10.1002/jbm.a.20037
   Tsuruma A, 2008, COLLOID SURFACE A, V313, P536, DOI 10.1016/j.colsurfa.2007.05.079
   Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435
   Veiseh M, 2004, BIOMATERIALS, V25, P3315, DOI 10.1016/j.biomaterials.2003.10.014
   Vieu C, 2000, APPL SURF SCI, V164, P111, DOI 10.1016/S0169-4332(00)00352-4
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   WATT FM, 1988, P NATL ACAD SCI USA, V85, P5576, DOI 10.1073/pnas.85.15.5576
   WICHA MS, 1980, DEV BIOL, V80, P253, DOI 10.1016/0012-1606(80)90402-9
   WILLERTH SM, 2008, STEM CELL R IN PRESS
   WU J, 2008, BIOSCI HYPOTHESES, V1, P2
   Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153
   Xia YN, 1996, SCIENCE, V273, P347, DOI 10.1126/science.273.5273.347
   Yang ZP, 2000, LANGMUIR, V16, P7482, DOI 10.1021/la0000623
   Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031
   Zahor D, 2007, MAT SCI ENG C-BIO S, V27, P117, DOI 10.1016/j.msec.2006.03.005
   Zhao XM, 1996, ADV MATER, V8, P837, DOI 10.1002/adma.19960081016
   Zhou YF, 2007, BIOMATERIALS, V28, P814, DOI 10.1016/j.biomaterials.2006.09.032
NR 180
TC 58
Z9 60
U1 0
U2 57
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1743-5889
J9 NANOMEDICINE-UK
JI Nanomedicine
PD JAN
PY 2009
VL 4
IS 1
BP 65
EP 82
DI 10.2217/17435889.4.1.65
PG 18
WC Biotechnology & Applied Microbiology; Nanoscience & Nanotechnology
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics
GA 395JC
UT WOS:000262519400010
PM 19093897
DA 2018-10-19
ER

PT S
AU Azmah, MA
   Rafaie, HA
   Amizam, S
   Abdullah, S
   Rusop, M
AF Azmah, M. A.
   Rafaie, H. A.
   Amizam, S.
   Abdullah, S.
   Rusop, M.
BE Rusop, M
   Soga, T
TI Optimization of Current Density during the Preparation of Silicon
   Quantum Dots Nanoparticles by Electro-Chemical Deposition
SO NANOSCIENCE AND NANOTECHNOLOGY
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT International Conference on Nanoscience and Nanotechnology (NANO-SciTech
   2008)
CY NOV 18-21, 2008
CL Selangor, MALAYSIA
SP Univ Teknologi MARA, Nagoya Inst Technol, Inst Elect, Informat & Commun Engineers, Inst Mat Malaysia, Malaysian Assoc Solid State Sci & Technol, Minist Sci, Technol & Innovat, Minist Higher Educ
DE Silicon Quantum Dots Nanoparticles; SQDNs; Current Density;
   Electrochemical Etching
ID POROUS SILICON
AB Silicon quantum dots nanoparticles (SQDNs) have a good potential in applications for optical devices and also in biomaterial. SQDNs made from free standing nanostructured porous silicon. In this paper, we study about the effect of using different current density on the preparation of SQDNs and the distance of electrode and also etching time was constant for every samples. SQDNs have been prepared by electrochemical etching in hydrofluoric (HF) solution at ratio 1:1 of ethanol as an electrolyte. The photoluminescence (PL) spectrometer used to characterize the optical properties. The result shows that the intensity of PL increased when the current density higher. Scanning electron microscope (SEM) also used to characterize the structural morphology of sample.
C1 [Azmah, M. A.; Rafaie, H. A.; Amizam, S.; Abdullah, S.; Rusop, M.] Univ Teknol MARA, Inst Sci, NANO SciTech Ctr, Shah Alam 40450, Selangor, Malaysia.
RP Azmah, MA (reprint author), Univ Teknol MARA, Inst Sci, NANO SciTech Ctr, Shah Alam 40450, Selangor, Malaysia.
EM rusop8@gmail.com; rusop8@gmail.com
RI Mahmood, Mohamad Rusop/N-4237-2017; Ahmad Rafaie, Hartini/C-8346-2014
OI Mahmood, Mohamad Rusop/0000-0002-5842-627X; Ahmad Rafaie,
   Hartini/0000-0003-0244-7570; Ahmad Rafaie, Hartini/0000-0003-4644-7695
CR ABDULLAH S, 2007, OPTIMIZATION ELECTRO, P248
   Coffer JL, 2005, PHYS STATUS SOLIDI A, V202, P1451, DOI 10.1002/pssa.200461134
   Collins RT, 1997, PHYS TODAY, V50, P24, DOI 10.1063/1.881650
   Jakubowicz J, 2007, PHYSICA E, V38, P139, DOI 10.1016/j.physe.2006.12.017
   Sailor MJ, 2005, CHEM COMMUN, P1375, DOI 10.1039/b417554a
   STEINER P, 1993, APPL PHYS LETT, V62, P2700, DOI 10.1063/1.109236
NR 6
TC 0
Z9 0
U1 0
U2 2
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-0673-5
J9 AIP CONF PROC
PY 2009
VL 1136
BP 686
EP 689
PG 4
WC Nanoscience & Nanotechnology
SC Science & Technology - Other Topics
GA BKQ06
UT WOS:000268921300134
DA 2018-10-19
ER

PT S
AU Manocha, S
   Manocha, LM
   Yasuda, E
   Manocha, C
AF Manocha, S.
   Manocha, L. M.
   Yasuda, E.
   Manocha, Chhavi
BE Mathur, S
   Singh, M
   Ohji, T
   Wereszczak, A
TI MICROSTRUCTURE AND PROPERTIES OF CARBON NANOTUBES REINFORCED TITANIA
   MATRIX COMPOSITES PREPARED UNDER DIFFERENT SINTERING CONDITIONS
SO NANOSTRUCTURED MATERIALS AND NANOTECHNOLOGY II
SE Ceramic Engineering and Science Proceedings
LA English
DT Proceedings Paper
CT 32nd International Conference on Advanced Ceramics and Composites
CY JAN 27-FEB 01, 2008
CL Daytona Beach, FL
SP Amer Ceram Soc, ACerS Engn Ceram Div
AB The properties of titanium based ceramics can be tailored either through control of microstructure at nanoscale or through addition of nano reinforcements to have prospective material for structural applications and as biomaterial. Amongst nanoscale reinforcements, carbon nanotubes, being the most promising materials as reinforcements for ceramics, present studies were undertaken to develop Carbon nanotubes reinforced Titania matrix composites and to study its microstructure and properties.
   Multiwall carbon nanotubes (CNTs) synthesized by CCVD technique were used as reinforcements. Titania matrix was prepared using sol-gel technique. CNTs were coated with Titania sol using spray drier. CNTs Titania ratio was kept as 1:100. Composites of titania/carbon nanotubes were prepared through sintering under normal pressure as well as under hot press at 1400 degrees C under 33 KPa pressure. Sol-gel technique coupled with spray dryer resulted in uniform distribution of CNTs in Titania matrix. Titania ceramic composites prepared using carbon nanotubes as reinforcements result in change in physical properties, enhanced compressive strength. These results show that I-lot Press Sintering technique results in composites with reduced porosity and about 20% enhancement in compressive strength.
C1 [Manocha, S.; Manocha, L. M.] Sardar Patel Univ, Dept Mat Sci, Vallabh Vidyanagar 388120, Gujarat, India.
   [Yasuda, E.] Tokyo Inst Technol, Mat & Struct Lab, Yokohama, Kanagawa, Japan.
   [Manocha, Chhavi] GCET Engn Coll, Vallabh Vidyanagar, Gujarat, India.
RP Manocha, S (reprint author), Sardar Patel Univ, Dept Mat Sci, Vallabh Vidyanagar 388120, Gujarat, India.
EM manocha52@rediffmail.com
CR *BRINK, 1986, SOL GEL PROC
   BUSCHOW KHJ, 2001, ENCY MAT SCI TECHNOL, V7, P6205
   BUSCHOW KHJ, 2001, ENCY MAT SCI TECHNOL, V10, P9366
   Krenkel W., 2001, HIGH TEMPERATURE CER
   MANOCHA LM, 2004, T MAT RES SOC JPN, V29, P3569
   NIHARA K, 1998, HIGH TEMPERATURE CER, V2
NR 6
TC 0
Z9 0
U1 0
U2 0
PU AMER CERAMIC SOC
PI WESTERVILLE
PA 735 CERAMIC PLACE, WESTERVILLE, OH 43081-8720 USA
SN 0196-6219
BN 978-0-470-34498-9
J9 CERAM ENG SCI PROC
PY 2009
VL 29
IS 8
BP 139
EP +
PG 2
WC Nanoscience & Nanotechnology; Materials Science, Ceramics
SC Science & Technology - Other Topics; Materials Science
GA BJC87
UT WOS:000264857300013
DA 2018-10-19
ER

PT B
AU Yadavalli, VK
   Pidaparti, RM
AF Yadavalli, Vamsi K.
   Pidaparti, Ramana M.
BE Laudon, M
   Romanowicz, B
TI Nanocomposites based on Self-assembly of Collagen with DNA
SO NANOTECH CONFERENCE & EXPO 2009, VOL 2, TECHNICAL PROCEEDINGS:
   NANOTECHNOLOGY 2009: LIFE SCIENCES, MEDICINE, DIAGNOSTICS, BIO MATERIALS
   AND COMPOSITES
LA English
DT Proceedings Paper
CT Nanotech 2009 Conference
CY MAY 03-07, 2009
CL Houston, TX
SP Acctron AG, Adv Energy Consortium, Alliance NanoHealth, Appl Mat, Bayer Material Science, Buchanan Ingersoll & Rooney PC, Buhler PARTEC GmbH, Ctr Appl Nanotechnol GmbH, Ctr Biol & Environm Nanotechnol, Clean Technol & Sustainable Ind Org, CMP, CTC Nanotechnol GmbH, DREEBIT GmbH, ETH Zurich, ETH Transfer, ETH Zurich, MNSP, Foley & Lardner LLP, FDA, Goodwin Procter LLC, HiNanoAnalytics, Houston Technol Ctr, Inno X GmbH, Innovat Alliance Carbon Nanotubes, Italian Trade Commiss, Jackson Walker LLP, JENOPTIK, Lockheed Martin, Nano Sci & Technol Inst, nano tech 2009 Japan, NanoEurope Fair & Conf, Nanograde Llc, NanoInk, NANOSENSORS, NanoSPRINT, NanoWorld AG, NCI, NIH, Opportun Houston, OSEC, Pearland Econ Dev Corp, Res Germany Land Ideas, Richard Smalley Inst Nanoscale Sci & Technol, Taylor & Francis Grp LLC, CRC Press, TechConnect, Texas Nanotechnol Initiat, IEEE Stand Assoc, Russian Corp Nanotechnologies, TurboBeads Llc, Weidmann Plast Technol AG
DE collagen; DNA; self-assembly; nanoindentation
ID ATELOCOLLAGEN; DELIVERY; FIBRILS; PROTEIN; HELIX; AFM
AB Collagen is a major extracellular component that is a key contributor to the mechanical strength of tissue, tendons, skin, cartilage and bones. It is characterized by the assembly and arrangement of suprafibrillar architectures by the assembly of lower order components. Collagen complexes with other (bio) polymers have been used to enhance the properties of collagen as a biomaterial structural strength, biocompatibility and non-toxicity. Collagen-DNA complexes in particular, represent novel biomaterials that can also be utilized as carriers in drug and gene delivery systems. Controlling collagen/DNA to assemble hierarchical organization ex vivo remains a significant challenge and may lead to development of superior fibers for multiple applications. Here we present some initial atomic force microscopy (AFM) studies on experiments to investigate the self-assembly of collagen with DNA to observe the morphology of the structures that are formed at a single fiber level. These fibers were characterized using nanoindentation techniques to determine their mechanical stiffness.
C1 [Yadavalli, Vamsi K.] Virginia Commonwealth Univ, Dept Chem & Life Sci Engn, Med Coll Virginia Campus, Richmond, VA 23284 USA.
   [Pidaparti, Ramana M.] Virginia Commonwealth Univ, Dept Mech Engn, Richmond, VA 23284 USA.
RP Yadavalli, VK (reprint author), Virginia Commonwealth Univ, Dept Chem & Life Sci Engn, Med Coll Virginia Campus, Richmond, VA 23284 USA.
EM vyadavalli@vcu.edu; rmpidaparti@vcu.edu
OI Yadavalli, Vamsi/0000-0002-8879-1948
CR Brodsky B, 1997, MATRIX BIOL, V15, P545, DOI 10.1016/S0945-053X(97)90030-5
   Engel A, 2000, NAT STRUCT BIOL, V7, P715, DOI 10.1038/78929
   Hanai K, 2004, HUM GENE THER, V15, P263, DOI 10.1089/104303404322886110
   Heim AJ, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2367660
   Honma K, 2001, BIOCHEM BIOPH RES CO, V289, P1075, DOI 10.1006/bbrc.2001.6133
   Klug A, 2004, J MOL BIOL, V335, P3, DOI 10.1016/j.jmb.2003.11.015
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Lodish H., 2000, MOL CELL BIOL, P154
   Lorenzo AC, 2005, J BIOMECH, V38, P1527, DOI 10.1016/j.jbiomech.2004.07.011
   Mrevlishvili GM, 2005, INT J BIOL MACROMOL, V36, P324, DOI 10.1016/j.ijbiomac.2005.07.006
   Muller DJ, 2002, PROG BIOPHYS MOL BIO, V79, P1, DOI 10.1016/S0079-6107(02)00009-3
   Murata M, 2002, BRIT J ORAL MAX SURG, V40, P131, DOI 10.1054/bjom.2001.0743
   Ochiya T, 1999, NAT MED, V5, P707
   PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403
   Ramshaw JAM, 1996, BIOTECHNOL GENET ENG, V13, P335, DOI 10.1080/02648725.1996.10647934
   Salamon M, 2005, P NATL ACAD SCI USA, V102, P13783, DOI 10.1073/pnas.0503718102
   Sano A, 2003, ADV DRUG DELIVER REV, V55, P1651, DOI 10.1016/j.addr.2003.08.005
   Svintradze DV, 2008, BIOMACROMOLECULES, V9, P21, DOI 10.1021/bm7008813
   Vinckier A, 1998, FEBS LETT, V430, P12, DOI 10.1016/S0014-5793(98)00592-4
   Wenger MPE, 2007, BIOPHYS J, V93, P1255, DOI 10.1529/biophysj.106.103192
   Whitesides GM, 2002, P NATL ACAD SCI USA, V99, P4769, DOI 10.1073/pnas.082065899
   Withers JR, 2006, ADV COLLOID INTERFAC, V120, P57, DOI 10.1016/j.cis.2006.03.002
   Zhaoping L, 2005, NEURON, V47, P143, DOI 10.1016/j.neuron.2005.04.005
NR 23
TC 0
Z9 0
U1 0
U2 3
PU CRC PRESS-TAYLOR & FRANCIS GROUP
PI BOCA RATON
PA 6000 BROKEN SOUND PARKWAY NW, STE 300, BOCA RATON, FL 33487-2742 USA
BN 978-1-4398-1783-4
PY 2009
BP 266
EP +
PG 3
WC Biotechnology & Applied Microbiology; Engineering, Biomedical;
   Nanoscience & Nanotechnology
SC Biotechnology & Applied Microbiology; Engineering; Science & Technology
   - Other Topics
GA BMQ02
UT WOS:000273330500073
DA 2018-10-19
ER

PT B
AU Peramo, A
   Marcelo, CL
   Goldstein, SA
   Martin, DC
AF Peramo, A.
   Marcelo, C. L.
   Goldstein, S. A.
   Martin, D. C.
BE Laudon, M
   Romanowicz, B
TI Bioartifical mucosa: delivery of biomaterials to the skin-percutaneous
   device interface in in vitro human organotypic skin cultures
SO NANOTECH CONFERENCE & EXPO 2009, VOL 2, TECHNICAL PROCEEDINGS:
   NANOTECHNOLOGY 2009: LIFE SCIENCES, MEDICINE, DIAGNOSTICS, BIO MATERIALS
   AND COMPOSITES
LA English
DT Proceedings Paper
CT Nanotech 2009 Conference
CY MAY 03-07, 2009
CL Houston, TX
SP Acctron AG, Adv Energy Consortium, Alliance NanoHealth, Appl Mat, Bayer Material Science, Buchanan Ingersoll & Rooney PC, Buhler PARTEC GmbH, Ctr Appl Nanotechnol GmbH, Ctr Biol & Environm Nanotechnol, Clean Technol & Sustainable Ind Org, CMP, CTC Nanotechnol GmbH, DREEBIT GmbH, ETH Zurich, ETH Transfer, ETH Zurich, MNSP, Foley & Lardner LLP, FDA, Goodwin Procter LLC, HiNanoAnalytics, Houston Technol Ctr, Inno X GmbH, Innovat Alliance Carbon Nanotubes, Italian Trade Commiss, Jackson Walker LLP, JENOPTIK, Lockheed Martin, Nano Sci & Technol Inst, nano tech 2009 Japan, NanoEurope Fair & Conf, Nanograde Llc, NanoInk, NANOSENSORS, NanoSPRINT, NanoWorld AG, NCI, NIH, Opportun Houston, OSEC, Pearland Econ Dev Corp, Res Germany Land Ideas, Richard Smalley Inst Nanoscale Sci & Technol, Taylor & Francis Grp LLC, CRC Press, TechConnect, Texas Nanotechnol Initiat, IEEE Stand Assoc, Russian Corp Nanotechnologies, TurboBeads Llc, Weidmann Plast Technol AG
DE medical device; skin biomaterial; implant interface; osseointegration;
   port access devices
ID INFECTIONS
AB We have developed an in vitro Culture system composed of organotypic human skin explants interfaced with titanium rods or stainless steel fixator pins. The use of this interface provides a model to evaluate strategies for creating a stable, long-term connection with living skin and chronic percutaneous devices. Our hypothesis is that the delivery of specific biomaterials at this interface will create a dynamic, slowly flowing matrix for skin biointegration, local administration of drugs or antimicrobials. We define this concept as the generation of an artificial mucosa, because it mimics the situation of several epithelial tissues (like the periodontal junction between the tooth and the junctional epithelium [I]) where antimicrobial peptides and mucins are constantly extruded
C1 [Peramo, A.; Martin, D. C.] Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA.
   [Marcelo, C. L.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA.
   [Goldstein, S. A.] Univ Michigan, Dept Orthoped Surg, Ann Arbor, MI 48109 USA.
RP Peramo, A (reprint author), Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA.
EM aperamo@umich.edu; cmarcelo@umich.edu; stevegld@umich.edu;
   milty@umich.edu
OI Martin, David/0000-0003-1195-3838
CR Dale BA, 2002, PERIODONTOL 2000, V30, P70, DOI 10.1034/j.1600-0757.2002.03007.x
   MAHAN J, 1991, ORTHOPEDICS, V14, P305
   Peramo A, 2009, ANN BIOMED ENG, V37, P401, DOI 10.1007/s10439-008-9614-9
   Von Eiff C, 2005, INT J ARTIF ORGANS, V28, P1146
   VONRECUM AF, 1984, J BIOMED MATER RES, V18, P323, DOI 10.1002/jbm.820180403
   WINTER GD, 1974, J BIOMED MATER RES, V8, P99, DOI 10.1002/jbm.820080311
   2004, Patent No. 61063704
NR 7
TC 0
Z9 0
U1 0
U2 0
PU CRC PRESS-TAYLOR & FRANCIS GROUP
PI BOCA RATON
PA 6000 BROKEN SOUND PARKWAY NW, STE 300, BOCA RATON, FL 33487-2742 USA
BN 978-1-4398-1783-4
PY 2009
BP 298
EP +
PG 2
WC Biotechnology & Applied Microbiology; Engineering, Biomedical;
   Nanoscience & Nanotechnology
SC Biotechnology & Applied Microbiology; Engineering; Science & Technology
   - Other Topics
GA BMQ02
UT WOS:000273330500081
DA 2018-10-19
ER

PT J
AU Kardam, A
   Goyal, P
   Arora, JK
   Raj, KR
   Srivastava, S
AF Kardam, Abhishek
   Goyal, Pritee
   Arora, J. K.
   Raj, K. Rohit
   Srivastava, Shalini
TI Novel biopolymeric material: Synthesis and characterization for
   decontamination of cadmium from waste water
SO NATIONAL ACADEMY SCIENCE LETTERS-INDIA
LA English
DT Article
DE Graft co-polymerization; Zea mays Cob Powder; regeneration cycle; novel
   polymerized biomaterial
ID INDICA LEAF POWDER; BIOSORPTION; CHROMIUM; REMOVAL
AB Considering the metal-acid interaction responsible for binding of metal species, enrichment of carboxylate ion using Graft co-polymerization process has been carried out onto Zea mays Cob Powder [ZMCP] which results into the increase in % sorption efficiency [79.36 to 92.48] and stability in terms of regeneration cycles [3 to 5]. Evidences in support of novel polymerized biomaterial designed have been given on the basis of FTIR and TGA.
C1 [Kardam, Abhishek; Goyal, Pritee; Raj, K. Rohit; Srivastava, Shalini] Dayalbagh Educ Inst, Fac Sci, Dept Chem, Agra 282110, Uttar Pradesh, India.
   [Arora, J. K.] Dayalbagh Educ Inst, Tech Coll, Dept Math, Agra 282110, Uttar Pradesh, India.
RP Kardam, A (reprint author), Dayalbagh Educ Inst, Fac Sci, Dept Chem, Agra 282110, Uttar Pradesh, India.
EM smohanm@rediffmail.com
CR Goyal P, 2008, INT J ENVIRON SCI TE, V5, P27, DOI 10.1007/BF03325994
   Goyal P., 2007, J NUCL AGR BIOL, V36, P16
   Goyal P, 2008, NATL ACAD SCI LETT, V31, P347
   Goyal P, 2007, ARCH ENVIRON PROT, V33, P35
   Kratochvil D, 1998, TRENDS BIOTECHNOL, V16, P291, DOI 10.1016/S0167-7799(98)01218-9
   PAGNANELLI F, 2002, ENVIRON SCI TECHNOL, V15, P47
   Sharma P, 2007, CHEM SPEC BIOAVAILAB, V19, P175, DOI 10.3184/095422907X255938
   *SPSS MARK DEP, 1983, SPSS STAT PACK SOC S
   2003, MED PLANTS INDIA ENC
NR 9
TC 15
Z9 15
U1 0
U2 1
PU NATL ACAD SCIENCES INDIA
PI ALLAHABAD
PA 5 LAJPATRAI RD, ALLAHABAD 211002, INDIA
SN 0250-541X
J9 NATL ACAD SCI LETT
JI Natl. Acad. Sci. Lett.-India
PY 2009
VL 32
IS 5-6
BP 179
EP 181
PG 3
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 466AZ
UT WOS:000267633900008
DA 2018-10-19
ER

PT J
AU Mitragotri, S
   Lahann, J
AF Mitragotri, Samir
   Lahann, Joerg
TI Physical approaches to biomaterial design
SO NATURE MATERIALS
LA English
DT Review
ID MONOLAYER-PROTECTED NANOPARTICLES; RECEPTOR-MEDIATED ENDOCYTOSIS;
   CELLULAR TRACTION FORCES; NONVIRAL GENE DELIVERY; DRUG-DELIVERY;
   POLYMERIC NANOPARTICLES; MULTICOMPARTMENT MICELLES; NONSPHERICAL
   PARTICLES; INTRACELLULAR DELIVERY; COLLOID PARTICLES
AB The development of biomaterials for drug delivery, tissue engineering and medical diagnostics has traditionally been based on new chemistries. However, there is growing recognition that the physical as well as the chemical properties of materials can regulate biological responses. Here, we review this transition with regard to selected physical properties including size, shape, mechanical properties, surface texture and compartmentalization. In each case, we present examples demonstrating the significance of these properties in biology. We also discuss synthesis methods and biological applications for designer biomaterials, which offer unique physical properties.
C1 [Mitragotri, Samir] Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA.
   [Lahann, Joerg] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.
   [Lahann, Joerg] Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA.
   [Lahann, Joerg] Univ Michigan, Dept Macromol Sci & Engn, Ann Arbor, MI 48109 USA.
RP Mitragotri, S (reprint author), Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA.
EM samir@engineering.ucsb.edu; lahann@umich.edu
RI Lahann, Joerg/J-7663-2013
FU National Institute of Health [1VO1 HL080718]; Department of Defense; NSF
   [DMR-0449462]
FX We acknowledge support from the National Institute of Health Program of
   Excellence in Nanotechnology (1VO1 HL080718), the Department of Defense
   (Idea award) and the NSF (Career award DMR-0449462). We thank A. Arora
   and N. Doshi for help in preparing the manuscript.
CR Alexis F, 2008, MOL PHARMACEUT, V5, P505, DOI 10.1021/mp800051m
   Bao ZN, 2002, CHEM MATER, V14, P24, DOI 10.1021/cm010739n
   BASINSKA T, 1993, J BIOACT COMPAT POL, V8, P205, DOI 10.1177/088391159300800301
   Beningo KA, 2004, P NATL ACAD SCI USA, V101, P18024, DOI 10.1073/pnas.0405747102
   Beningo KA, 2002, J CELL SCI, V115, P849
   Beningo KA, 2002, TRENDS CELL BIOL, V12, P79, DOI 10.1016/S0962-8924(01)02205-X
   BENZEEV A, 1983, J CELL PHYSIOL, V114, P145, DOI 10.1002/jcp.1041140202
   Berkland C, 2001, J CONTROL RELEASE, V73, P59, DOI 10.1016/S0168-3659(01)00289-9
   Berkland C, 2007, PHARM RES, V24, P1007, DOI 10.1007/s11095-006-9197-9
   Bershadsky AD, 2006, EUR J CELL BIOL, V85, P165, DOI 10.1016/j.ejcb.2005.11.001
   Blattman JN, 2004, SCIENCE, V305, P200, DOI 10.1126/science.1100369
   Cao L, 2007, ADV DRUG DELIVER REV, V59, P1340, DOI 10.1016/j.addr.2007.08.012
   Carter SR, 2004, ADV FUNCT MATER, V14, P553, DOI 10.1002/adfm.200305069
   Caruso F, 1998, SCIENCE, V282, P1111, DOI 10.1126/science.282.5391.1111
   Cayre O, 2003, CHEM COMMUN, P2296, DOI 10.1039/b307296g
   Cayre O, 2003, J MATER CHEM, V13, P2445, DOI 10.1039/b308817k
   Champion JA, 2006, P NATL ACAD SCI USA, V103, P4930, DOI 10.1073/pnas.0600997103
   Champion JA, 2008, PHARM RES-DORDR, V25, P1815, DOI 10.1007/s11095-008-9562-y
   Champion JA, 2007, J CONTROL RELEASE, V121, P3, DOI 10.1016/j.jconrel.2007.03.022
   Champion JA, 2007, P NATL ACAD SCI USA, V104, P11901, DOI 10.1073/pnas.0705326104
   Champion JA, 2009, PHARM RES-DORD, V26, P244, DOI 10.1007/s11095-008-9626-z
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chen HY, 2007, P NATL ACAD SCI USA, V104, P11173, DOI 10.1073/pnas.0702749104
   Chhabra R, 2007, J AM CHEM SOC, V129, P10304, DOI 10.1021/ja072410u
   Chithrani BD, 2006, NANO LETT, V6, P662, DOI 10.1021/nl052396o
   Clark HA, 1999, ANAL CHEM, V71, P4831, DOI 10.1021/ac990629o
   Dalby MJ, 2004, EUR J CELL BIOL, V83, P159, DOI 10.1078/0171-9335-00369
   Dalby MJ, 2004, EXP CELL RES, V295, P387, DOI 10.1016/j.yexcr.2004.02.004
   Dalby MJ, 2003, BIOMATERIALS, V24, P927, DOI 10.1016/S0142-9612(02)00427-1
   Decuzzi P, 2008, BIOPHYS J, V94, P3790, DOI 10.1529/biophysj.107.120238
   Decuzzi P, 2006, BIOMATERIALS, V27, P5307, DOI 10.1016/j.biomaterials.2006.05.024
   Decuzzi P, 2009, PHARM RES-DORD, V26, P235, DOI 10.1007/s11095-008-9697-x
   Dendukuri D, 2006, NAT MATER, V5, P365, DOI 10.1038/nmat1617
   Dickerson EB, 2008, CANCER LETT, V269, P57, DOI 10.1016/j.canlet.2008.04.026
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   du Roure O, 2005, P NATL ACAD SCI USA, V102, P2390, DOI 10.1073/pnas.0408482102
   Edwards DA, 1997, SCIENCE, V276, P1868, DOI 10.1126/science.276.5320.1868
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Engler AJ, 2004, SURF SCI, V570, P142, DOI 10.1016/j.susc.2004.06.179
   Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004
   Euliss LE, 2006, CHEM SOC REV, V35, P1095, DOI 10.1039/b600913c
   Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566
   FROJMOVIC MM, 1982, PHYSIOL REV, V62, P185
   Gao HJ, 2005, P NATL ACAD SCI USA, V102, P9469, DOI 10.1073/pnas.0503879102
   Geng Y, 2007, NAT NANOTECHNOL, V2, P249, DOI 10.1038/nnano.2007.70
   Ghosh K, 2007, ADV DRUG DELIVER REV, V59, P1306, DOI 10.1016/j.addr.2007.08.014
   Glotzer SC, 2007, NAT MATER, V6, P557, DOI 10.1038/nmat1949
   GOLDSMITH HL, 1986, THROMB HAEMOSTASIS, V55, P415
   Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221
   Gratton SEA, 2008, P NATL ACAD SCI USA, V105, P11613, DOI 10.1073/pnas.0801763105
   Gratton SEA, 2007, J CONTROL RELEASE, V121, P10, DOI 10.1016/j.jconrel.2007.05.027
   Graziano A, 2008, J CELL PHYSIOL, V214, P166, DOI 10.1002/jcp.21175
   GREF R, 1994, SCIENCE, V263, P1600, DOI 10.1126/science.8128245
   Griffin MA, 2004, J CELL SCI, V117, P5855, DOI 10.1242/jcs.01496
   Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858
   HO CC, 1993, COLLOID POLYM SCI, V271, P469, DOI 10.1007/BF00657391
   ILLUM L, 1982, INT J PHARM, V12, P135
   Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev
   Jackson AM, 2004, NAT MATER, V3, P330, DOI 10.1038/nmat1116
   Johnson CP, 2007, SCIENCE, V317, P663, DOI 10.1126/science.1139857
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   Karp JM, 2007, CURR OPIN BIOTECH, V18, P454, DOI 10.1016/j.copbio.2007.09.008
   Kisak ET, 2004, CURR MED CHEM, V11, P199, DOI 10.2174/0929867043456197
   Kisak ET, 2002, LANGMUIR, V18, P284, DOI 10.1021/la0156053
   Kohane DS, 2007, BIOTECHNOL BIOENG, V96, P203, DOI 10.1002/bit.21301
   Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.3.CO;2-X
   Kong HJ, 2005, NAT MATER, V4, P460, DOI 10.1038/nmat1392
   Kong HJ, 2007, NANO LETT, V7, P161, DOI 10.1021/nl062485g
   Kubowicz S, 2005, ANGEW CHEM INT EDIT, V44, P5262, DOI 10.1002/anie.200500584
   Kumar MNVR, 2000, J PHARM PHARM SCI, V3, P234
   Kwiatkowska K, 1999, BIOESSAYS, V21, P422, DOI 10.1002/(SICI)1521-1878(199905)21:5<422::AID-BIES9>3.0.CO;2-#
   Lamprecht A, 2001, PHARM RES-DORDR, V18, P788, DOI 10.1023/A:1011032328064
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lee CH, 2005, BIOMATERIALS, V26, P1261, DOI 10.1016/j.biomaterials.2004.04.037
   Lehnert D, 2004, J CELL SCI, V117, P41, DOI 10.1242/jcs.00836
   Li ZB, 2004, SCIENCE, V306, P98, DOI 10.1126/science.1103350
   Liu WF, 2007, ADV DRUG DELIVER REV, V59, P1319, DOI 10.1016/j.addr.2007.08.011
   Loscertales IG, 2002, SCIENCE, V295, P1695, DOI 10.1126/science.1067595
   Luo XL, 2007, CHEM COMMUN, P3207, DOI 10.1039/b702488f
   Makino H, 2004, J BIOSCI BIOENG, V98, P374, DOI 10.1263/jbb.98.374
   Manoharan VN, 2003, SCIENCE, V301, P483, DOI 10.1126/science.1086189
   May RC, 2001, J CELL SCI, V114, P1061
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Milner KR, 2007, J BIOMED MATER RES A, V82A, P80, DOI 10.1002/jbm.a.31049
   Mitragotri S, 2009, PHARM RES-DORD, V26, P232, DOI 10.1007/s11095-008-9740-y
   Moghimi SM, 2001, PHARMACOL REV, V53, P283
   Moghimi SM, 2005, FASEB J, V19, P311, DOI 10.1096/fj.04-2747rev
   Mohraz A, 2005, LANGMUIR, V21, P5298, DOI 10.1021/la046908a
   Monsonego A, 2003, SCIENCE, V302, P834, DOI 10.1126/science.1088469
   Mooney DJ, 1999, SCI AM, V280, P60, DOI 10.1038/scientificamerican0499-60
   Muro S, 2008, MOL THER, V16, P1450, DOI 10.1038/mt.2008.127
   Nakayama K, 2004, J BIOCHEM, V136, P751, DOI 10.1093/jb/mvh183
   Nandivada H, 2006, ANGEW CHEM INT EDIT, V45, P3360, DOI 10.1002/anie.200600357
   Napier ME, 2007, POLYM REV, V47, P321, DOI 10.1080/15583720701454999
   Osaki F, 2004, J AM CHEM SOC, V126, P6520, DOI 10.1021/ja048792a
   Owens DE, 2006, INT J PHARM, V307, P93, DOI 10.1016/j.ijpharm.2005.10.010
   Patil VRS, 2001, BIOPHYS J, V80, P1733, DOI 10.1016/S0006-3495(01)76144-9
   Paunov VN, 2004, ADV MATER, V16, P788, DOI 10.1002/adma.200306476
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   Perro A, 2005, CHEM COMMUN, P5542, DOI 10.1039/b507486j
   Picart C, 2007, NATURE, V448, P879, DOI 10.1038/448879a
   Pregibon DC, 2007, SCIENCE, V315, P1393, DOI 10.1126/science.1134929
   Rehfeldt F, 2007, ADV DRUG DELIVER REV, V59, P1329, DOI 10.1016/j.addr.2007.08.007
   Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253
   Rice JM, 2003, BIOMATERIALS, V24, P4799, DOI 10.1016/S0142-9612(03)00381-8
   Roh KH, 2005, NAT MATER, V4, P759, DOI 10.1038/nmat1486
   Rolland JP, 2005, J AM CHEM SOC, V127, P10096, DOI 10.1021/ja051977c
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Salem AK, 2003, NAT MATER, V2, P668, DOI 10.1038/nmat974
   Sanders JE, 2002, J BIOMED MATER RES, V62, P222, DOI 10.1002/jbm.10285
   Senaratne W, 2005, BIOMACROMOLECULES, V6, P2427, DOI 10.1021/bm050180a
   Sengupta S, 2005, NATURE, V436, P568, DOI 10.1038/nature03794
   Shen H, 2004, NAT MATER, V3, P569, DOI 10.1038/nmat1179
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Singh M, 2007, EXPERT REV VACCINES, V6, P797, DOI 10.1586/14760584.6.5.797
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   STOLNIK S, 1995, ADV DRUG DELIVER REV, V16, P195, DOI 10.1016/0169-409X(95)00025-3
   Sung KE, 2008, J AM CHEM SOC, V130, P1335, DOI 10.1021/ja0762700
   TABATA Y, 1990, ADV POLYM SCI, V94, P107
   Tao SL, 2006, NAT PROTOC, V1, P3153, DOI 10.1038/nprot.2006.451
   Tao SL, 2005, J CONTROL RELEASE, V109, P127, DOI 10.1016/j.jconrel.2005.09.019
   Utada AS, 2005, SCIENCE, V308, P537, DOI 10.1126/science.1109164
   Verma A, 2008, NAT MATER, V7, P588, DOI 10.1038/nmat2202
   Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890
   Wang MD, 2007, EXPERT REV ANTICANC, V7, P833, DOI 10.1586/14737140.7.6.833
   Wang Y, 2006, NAT MATER, V5, P791, DOI 10.1038/nmat1737
   Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G
   Yang MT, 2007, ADV MATER, V19, P3119, DOI 10.1002/adma.200701956
   Yang SH, 2005, J BIOMED MATER RES B, V74B, P468, DOI 10.1002/jbm.b.30200
   Yin YD, 2001, ADV MATER, V13, P267, DOI 10.1002/1521-4095(200102)13:4<267::AID-ADMA267>3.0.CO;2-9
   Yoshida M, 2008, ACS NANO, V2, P1101, DOI 10.1021/nn800332g
   Yoshida M, 2007, BIOMATERIALS, V28, P2446, DOI 10.1016/j.biomaterials.2007.01.048
   Young KD, 2006, MICROBIOL MOL BIOL R, V70, P660, DOI 10.1128/MMBR.00001-06
   Zavaleta C, 2008, NANO LETT, V8, P2800, DOI 10.1021/nl801362a
   Zhang YW, 2007, POLYMER, V48, P5639, DOI 10.1016/j.polymer.2007.07.046
NR 135
TC 769
Z9 791
U1 17
U2 542
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1476-1122
EI 1476-4660
J9 NAT MATER
JI Nat. Mater.
PD JAN
PY 2009
VL 8
IS 1
BP 15
EP 23
DI 10.1038/NMAT2344
PG 9
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 386FC
UT WOS:000261866700013
PM 19096389
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Checa, AG
   Ramirez-Rico, J
   Gonzalez-Segura, A
   Sanchez-Navas, A
AF Checa, Antonio G.
   Ramirez-Rico, Joaquin
   Gonzalez-Segura, Alicia
   Sanchez-Navas, Antonio
TI Nacre and false nacre (foliated aragonite) in extant monoplacophorans
   (=Tryblidiida: Mollusca)
SO NATURWISSENSCHAFTEN
LA English
DT Article
DE Monoplacophorans; Mollusca; Biomineralization; Microstructure; Nacre;
   Foliated aragonite; Evolution
ID ATOMIC-FORCE MICROSCOPY; SHELL MICROSTRUCTURES; SELF-ORGANIZATION;
   BIVALVIA; CONSTRAINTS; ELECTRON; GROWTH; LAYER
AB Extant monoplacophorans (Tryblidiida, Mollusca) have traditionally been reported as having an internal nacreous layer, thus representing the ancestral molluscan condition. The examination of this layer in three species of Neopilinidae (Rokopella euglypta, Veleropilina zografi, and Micropilina arntzi) reveals that only V. zografi secretes an internal layer of true nacre, which occupies only part of the internal shell surface. The rest of the internal surface of V. zografi and the whole internal surfaces of the other two species examined are covered by a material consisting of lath-like, instead of brick-like, crystals, which are arranged into lamellae. In all cases examined, the crystallographic c-axis in this lamellar material is perpendicular to the surface of laths and the a-axis is parallel to their long dimension. The differences between taxa relate to the frequency of twins, which is much higher in Micropilina. In general, the material is well ordered, particularly towards the margin, where lamellae pile up at a small step size, which is most likely due to processes of crystal competition. Given its morphological resemblance to the foliated calcite of bivalves, we propose the name foliated aragonite for this previously undescribed biomaterial secreted by monoplacophorans. We conclude that the foliated aragonite probably lacks preformed interlamellar membranes and is therefore not a variant of nacre. A review of the existing literature reveals that previous reports of nacre in the group were instead of the aragonitic foliated layer and that our report of nacre in V. zografi is the first undisputed evidence of nacre in monoplacophorans. From the evolutionary viewpoint, the foliated aragonite could easily have been derived from nacre. Assuming that nacre represents the ancestral condition, as in other molluscan classes, it has been replaced by foliated aragonite along the tryblidiidan lineage, although the fossil record does not presently provide evidence as to when this replacement took place.
C1 [Checa, Antonio G.] Univ Granada, Fac Ciencias, Dept Estratig & Paleontol, E-18071 Granada, Spain.
   [Ramirez-Rico, Joaquin] Univ Seville, Fac Fis, Dept Fis Mat Condensada, E-41012 Seville, Spain.
   [Gonzalez-Segura, Alicia] Univ Granada, Ctr Instrumentac Cient, E-18071 Granada, Spain.
   [Sanchez-Navas, Antonio] Univ Granada, Fac Ciencias, Dept Mineral & Petrol, E-18071 Granada, Spain.
RP Checa, AG (reprint author), Univ Granada, Fac Ciencias, Dept Estratig & Paleontol, Ave Fuentenueva S-N, E-18071 Granada, Spain.
EM acheca@ugr.es
RI Ramirez-Rico, Joaquin/A-7006-2009; Sanchez Navas, Antonio/G-5715-2015;
   Checa, Antonio/A-6157-2008
OI Ramirez-Rico, Joaquin/0000-0002-1184-0756; Sanchez Navas,
   Antonio/0000-0003-0588-9884; Checa, Antonio/0000-0001-7873-7545
FU Ministerio de Educacion y Ciencia [CGL2004-00802, CGL2007-60549];
   Research Group [RMN190]
FX Serge Gofas ( Departamento de Biologia Animal, Universidad de Malaga),
   Anders Waren, and Karin Sindemark Kronestedt ( Swedish Museum of Natural
   History) contributed in an essential manner by providing specimens.
   X-ray diffraction data of Fig. S2 are joint unpublished results of A. C.
   with Alejandro Rodriguez-Navarro ( Departamento de Mineralog a y
   Petrologia, Universidad de Granada). TEM sections of Fig. S3 are from
   the original material of the late Hiroshi Nakahara, kindly ceded by
   Mitsuo Kakei ( School of Dentistry, Meikai University). J.R-R. is
   grateful to the Spanish Junta de Andaluc a for his research grant. The
   study has been funded by Projects CGL2004-00802 and CGL2007-60549
   (Ministerio de Educacion y Ciencia) and by Research Group RMN190 ( Junta
   de Andaluc a).
CR Addadi Lia, 2006, Chemistry, V12, P980, DOI 10.1002/chem.200500980
   BEVELANDER G, 1969, CALC TISS RES, V3, P84, DOI 10.1007/BF02058648
   Cartwright JHE, 2007, J R SOC INTERFACE, V4, P491, DOI 10.1098/rsif.2006.0188
   Chateigner D, 2000, J STRUCT GEOL, V22, P1723, DOI 10.1016/S0191-8141(00)00088-2
   Checa AG, 2005, BIOMATERIALS, V26, P1071, DOI 10.1016/j.biomaterials.2004.04.007
   Checa AG, 2001, P ROY SOC B-BIOL SCI, V268, P771, DOI 10.1098/rspb.2000.1415
   Checa AG, 2007, J STRUCT BIOL, V157, P393, DOI 10.1016/j.jsb.2006.09.005
   Cruz R, 2003, SCANNING, V25, P12, DOI 10.1002/sca.4950250104
   Erben H. K., 1972, BIOMINERALISATION, V4, P15
   ERBEN HK, 1968, ABHANDLUNGEN MATH NA, P1
   Hedegaard C, 1998, J MOLLUS STUD, V64, P133, DOI 10.1093/mollus/64.1.133
   Lemche H., 1959, Galathea Report, V3, P9
   Lindberg David R., 1996, P67
   MANNE S, 1994, P ROY SOC B-BIOL SCI, V256, P17, DOI 10.1098/rspb.1994.0043
   Meenakshi V.R., 1970, ANTON BRUUN REPORT, V2, P3
   MUTVEI H, 1978, ZOOL SCR, V7, P287, DOI 10.1111/j.1463-6409.1978.tb00612.x
   Mutvei H., 1991, P157
   Mutvei H., 1980, P49
   MUTVEI H, 1970, BIOMINERALISATION, V2, P47
   Nakahara H., 1991, P343
   NAKAHARA H, 1979, Venus the Japanese Journal of Malacology, V38, P205
   Peel J. S., 1991, B GRONLANDS GEOLOGIS, V161, P11
   Runnegar B., 1983, Memoir of the Association of Australasian Palaeontologists, V1, P121
   RUNNEGAR B, 1985, ALCHERINGA, V9, P245, DOI 10.1080/03115518508618971
   Schaffer TE, 1997, CHEM MATER, V9, P1731, DOI 10.1021/cm960429i
   Schmidt W. J., 1959, Galathea Report, V3, P73
   TAVIANI M, 1990, LETHAIA, V23, P213, DOI 10.1111/j.1502-3931.1990.tb01361.x
   TRAVIS DF, 1969, AM ZOOL, V9, P635
   UBUKATA T, 1994, PALAEONTOLOGY, V37, P241
   Urgorri V, 2005, J MOLLUS STUD, V71, P59, DOI 10.1093/mollus/eyi008
   WADA K, 1960, J ELECTRON MICROSC, V9, P21
   WADA K, 1972, BIOMINERALISATION, V4, P141
   Wada K., 1961, B NATN PEARL RES LAB, V7, P703
   WAREN A, 1992, VELIGER, V35, P165
   Waren A, 1996, ZOOL SCR, V25, P215, DOI 10.1111/j.1463-6409.1996.tb00163.x
   WATABE N, 1965, J ULTRA MOL STRUCT R, V12, P351, DOI 10.1016/S0022-5320(65)80104-6
   WEINER S, 1981, BIOL MACROMOL, P467
   WISE S JR, 1970, Eclogae Geologicae Helvetiae, V63, P775
NR 38
TC 31
Z9 31
U1 1
U2 14
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0028-1042
J9 NATURWISSENSCHAFTEN
JI Naturwissenschaften
PD JAN
PY 2009
VL 96
IS 1
BP 111
EP 122
DI 10.1007/s00114-008-0461-1
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 385CP
UT WOS:000261791000013
PM 18843476
DA 2018-10-19
ER

PT J
AU Okner, R
   Domb, AJ
   Mandler, D
AF Okner, Regina
   Domb, Abraham Jacob
   Mandler, Daniel
TI Electrochemically deposited poly(ethylene glycol)-based sol-gel thin
   films on stainless steel stents
SO NEW JOURNAL OF CHEMISTRY
LA English
DT Article
ID SURFACE MODIFICATION; PROTEIN ADSORPTION; CORROSION PROTECTION;
   PLATELET-ADHESION; POLYMERIC BIOMATERIALS; BLOOD COMPATIBILITY;
   BACTERIAL ADHESION; PITTING CORROSION; STOCHASTIC-MODELS; IN-VITRO
AB Poly(ethylene glycol) (PEG) was modified with 3-isocyanatopropyltriethoxysilane (IPTS) to obtain PEG-disilane. This monomer was electrochemically polymerized and deposited onto a stainless steel surface to form a thin PEGylated sol-gel film. The monomer was characterized by H-1-NMR and FTIR spectroscopy. The sol-gel film was characterized by absorption-reflection infrared spectroscopy (AR-FTIR), energy dispersive X-ray analysis (EDX), cyclic voltammetry (CV), profilometry, scanning electron microscopy (SEM) and potentiodynamic polarization. AR-FTIR confirmed the formation of a polymer, while the stability of the polymeric film on stainless steel in buffer phosphate was studied by scanning electron microscopy (SEM). The polymer was successfully electrodeposited onto 316L coronary stents. Its flexibility was examined by dilating the coated stents and inspecting it by SEM. The hydrophilic, smooth PEGylated sol-gel coating significantly reduced the activation and adhesion of platelets as compared with the bare stainless steel surface. This coating, which can be applied to complex geometries, such as stents, is likely to serve as an excellent biomaterial.
C1 [Okner, Regina; Mandler, Daniel] Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel.
   [Okner, Regina; Domb, Abraham Jacob] Hebrew Univ Jerusalem, Fac Med, Sch Pharm, Dept Med Chem & Nat Prod, IL-91120 Jerusalem, Israel.
RP Mandler, D (reprint author), Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel.
EM avid@ekmd.huji.ac.il; mandler@vms.huji.ac.il
RI Mandler, Daniel/M-4149-2017
OI Mandler, Daniel/0000-0003-2490-1084; Domb, Abraham
   J./0000-0002-2241-7726
FU The Harvey M. Krueger Family Center for Nanoscience and Nanotechnology
   of the Hebrew University
FX Varon et al. are warmly acknowledged for assisting in performing the
   blood platelet function test. The Harvey M. Krueger Family Center for
   Nanoscience and Nanotechnology of the Hebrew University is acknowledged.
CR AMIJI M, 1993, J BIOMAT SCI-POLYM E, V4, P217, DOI 10.1163/156856293X00537
   AMIJI M, 1994, ACS SYM SER, V540, P135
   AMIJI M, 1992, BIOMATERIALS, V13, P682, DOI 10.1016/0142-9612(92)90128-B
   ATTWOOD D, 1985, INT J PHARM, V26, P25, DOI 10.1016/0378-5173(85)90197-8
   AVNIR D, 1995, ACCOUNTS CHEM RES, V28, P328, DOI 10.1021/ar00056a002
   Balakrishnan B, 2005, BIOMATERIALS, V26, P3495, DOI 10.1016/j.biomaterials.2004.09.032
   Bayramoglu G, 2008, J APPL POLYM SCI, V109, P749, DOI 10.1002/app.28062
   BERTOCCI U, 1986, J ELECTROCHEM SOC, V133, P1782, DOI 10.1149/1.2109018
   BRINKER CJ, 1990, J NON-CRYST SOLIDS, V121, P294, DOI 10.1016/0022-3093(90)90147-E
   BRINKER CJ, 1990, SOL GEL SCI PHYS CHE, pCH3
   BURNS NL, 1995, LANGMUIR, V11, P2768, DOI 10.1021/la00007a070
   Chaterji S, 2007, PROG POLYM SCI, V32, P1083, DOI 10.1016/j.progpolymsci.2007.05.018
   DEMOZ A, 1993, LANGMUIR, V9, P1046, DOI 10.1021/la00028a028
   Ebelmen M, 1846, ANN CHIM PHYS, V16, P129
   Escobar-Chavez JJ, 2006, J PHARM PHARM SCI, V9, P339
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   GUZMAN M, 1994, DRUG DEV IND PHARM, V20, P2041
   Harrell TM, 2004, J SOL-GEL SCI TECHN, V31, P349, DOI 10.1023/B:JSST.0000048015.39441.ee
   Harris JM, 1992, POLY ETHYLENE GLYCOL
   HOFFMAN AS, 1987, ANN NY ACAD SCI, V516, P96, DOI 10.1111/j.1749-6632.1987.tb33033.x
   HOLMBERG K, 1993, J ADHES SCI TECHNOL, V7, P503, DOI 10.1163/156856193X00826
   Iguerb O, 2008, SURF INTERFACE ANAL, V40, P386, DOI 10.1002/sia.2701
   ISHIHARA K, 1995, BIOMATERIALS, V16, P873, DOI 10.1016/0142-9612(95)94150-J
   Jo S, 2000, BIOMATERIALS, V21, P605, DOI 10.1016/S0142-9612(99)00224-0
   Journeycake JM, 2003, CURR OPIN HEMATOL, V10, P369, DOI 10.1097/00062752-200309000-00008
   Kang CK, 2007, J MATER SCI-MATER M, V18, P1389, DOI 10.1007/s10856-006-0079-9
   Kim H, 2005, J SOL-GEL SCI TECHN, V36, P213, DOI 10.1007/s10971-005-3782-y
   Kumar DS, 2007, J MATER SCI-MATER M, V18, P1831, DOI 10.1007/s10856-007-3033-6
   LARM O, 1983, BIOMATER ARTIF CELL, V11, P161, DOI 10.3109/10731198309118804
   LEE JH, 1995, PROG POLYM SCI, V20, P1043, DOI 10.1016/0079-6700(95)00011-4
   LI J, 1993, LANGMUIR, V9, P591, DOI 10.1021/la00026a038
   Lu YF, 1997, NATURE, V389, P364, DOI 10.1038/38699
   Lunt TT, 1997, J ELECTROCHEM SOC, V144, P1620, DOI 10.1149/1.1837651
   Luo XL, 2004, ANAL BIOCHEM, V334, P284, DOI 10.1016/j.ab.2004.07.005
   Lutz JF, 2008, J POLYM SCI POL CHEM, V46, P3459, DOI 10.1002/pola.22706
   Park HD, 2006, MACROMOL RES, V14, P73, DOI 10.1007/BF03219071
   Park K, 2000, J BIOMAT SCI-POLYM E, V11, P1121, DOI 10.1163/156856200744228
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   Quinet M, 2007, PROG ORG COAT, V58, P46, DOI 10.1016/j.porgcoat.2006.11.007
   Roach GW, 1996, NEW ENGL J MED, V335, P1857, DOI 10.1056/NEJM199612193352501
   Roux S, 2001, J MATER CHEM, V11, P3360, DOI 10.1039/b105060p
   Savion N, 2006, PATHOPHYSIOL HAEMO T, V35, P83, DOI 10.1159/000093548
   SCHMOLKA IR, 1994, ANN NY ACAD SCI, V720, P92, DOI 10.1111/j.1749-6632.1994.tb30437.x
   SEEGER JM, 1995, J VASC SURG, V22, P327, DOI 10.1016/S0741-5214(95)70148-6
   Shacham R, 1999, ADV MATER, V11, P384, DOI 10.1002/(SICI)1521-4095(199903)11:5<384::AID-ADMA384>3.3.CO;2-D
   SHARMA CP, 1994, B MATER SCI, V17, P1317, DOI 10.1007/BF02747230
   Sheffer M, 2004, CORROS SCI, V46, P2975, DOI 10.1016/j.corsci.2004.05.001
   Sheffer M, 2003, CORROS SCI, V45, P2893, DOI 10.1016/S0010-938X(03)00106-9
   Shustak G, 2003, ELECTROANAL, V15, P398, DOI 10.1002/elan.200390046
   Sosnik A, 2004, BIOMATERIALS, V25, P2851, DOI 10.1016/j.biomaterials.2003.09.057
   TAN JS, 1993, BIOMATERIALS, V14, P823, DOI 10.1016/0142-9612(93)90004-L
   Toledano R, 2008, CHEM MATER, V20, P4276, DOI 10.1021/cm800002z
   Tsunoda N, 1999, ASAIO J, V45, P418, DOI 10.1097/00002480-199909000-00010
   UCHIDA E, 1994, LANGMUIR, V10, P481, DOI 10.1021/la00014a023
   Virmani R, 2002, CIRCULATION, V106, P2649, DOI 10.1161/01.CIR.0000041632.02514.14
   Walcarius A, 2001, CHEM MATER, V13, P3351, DOI 10.1021/cm0110167
   Wang Y, 2003, J FOOD SCI, V68, P2772, DOI 10.1111/j.1365-2621.2003.tb05803.x
   Wei J, 2003, COLLOID SURFACE B, V32, P275, DOI 10.1016/S0927-7765(03)00180-2
   WILLIAMS DE, 1985, J ELECTROCHEM SOC, V132, P1804, DOI 10.1149/1.2114221
   WILLIAMS DE, 1985, J ELECTROCHEM SOC, V132, P1796, DOI 10.1149/1.2114220
   Wu YG, 2005, J BIOMED MATER RES A, V74A, P722, DOI 10.1002/jbm.a.30381
   Zhang F, 2001, BIOMATERIALS, V22, P1541, DOI 10.1016/S0142-9612(00)00310-0
   2004, Patent No. 0236399
NR 63
TC 13
Z9 15
U1 1
U2 22
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1144-0546
EI 1369-9261
J9 NEW J CHEM
JI New J. Chem.
PY 2009
VL 33
IS 7
BP 1596
EP 1604
DI 10.1039/b901864f
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA 467HC
UT WOS:000267728200023
DA 2018-10-19
ER

PT B
AU Moiseeva, E
   Harnett, C
AF Moiseeva, Evgeniya
   Harnett, Cindy
GP SIST
TI Shear-Based Droplet Production for Biomaterial Printing
SO NIP 25: DIGITAL FABRICATION 2009, TECHNICAL PROGRAM AND PROCEEDINGS
LA English
DT Proceedings Paper
CT 25th International Conference on Digital Printing Technologies
CY SEP 20-24, 2009
CL Louisville, KY
SP Soc Imaging Sci & Technol, Imaging Soc Japan
ID MICROFLUIDIC DEVICE; GENERATION
AB The highly uniform shear forces at millimeter and smaller dimensions can produce monodisperse particles spontaneously during continuous flow of immiscible fluids. Microfluidic techniques have also recently been used to generate and organize arrays of solid monodisperse microparticles with various material properties. Combining these developments with a well-engineered "chip-to-world" interface will provide a new high-resolution 3-D printing technology for rapid prototyping and biotechnology.
   We produced hydrogel droplets at rates of 10-200 Hz in PDMS microreactors. Droplets were monodisperse, with 50-200 micron diameter dependent on flow rate, channel shape and the presence of surfactants. Droplets may be dispensed from the chip in their liquid state, or solidified by one of three mechanisms. Ultraviolet (UV) light was used to solidify photosensitized hydrogels. We also discuss other hydrogel systems that are solidified by a chemical reaction (sodium alginate and CaCl(2)) or by thermal gelation (Pluronic F-127), methods to vary the droplets' chemical composition and mechanical properties, and methods for closed-loop electrical feedback on particle position for precision fabrication. Biocompatible hydrogels are of great interest for biomaterial applications such as drug delivery and tissue engineering.
C1 [Moiseeva, Evgeniya; Harnett, Cindy] Univ Louisville, Louisville, KY 40292 USA.
RP Moiseeva, E (reprint author), Univ Louisville, Louisville, KY 40292 USA.
CR Ahn K, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2164911
   Anna SL, 2003, APPL PHYS LETT, V82, P364, DOI 10.1063/1.1537519
   Choi CH, 2007, BIOMED MICRODEVICES, V9, P855, DOI 10.1007/s10544-007-9098-7
   Dendukuri D, 2005, LANGMUIR, V21, P2113, DOI 10.1021/la047368k
   Jeong WJ, 2005, LANGMUIR, V21, P3738, DOI 10.1021/la0501051
   Link DR, 2006, ANGEW CHEM INT EDIT, V45, P2556, DOI 10.1002/anie.200503540
   Nisisako T, 2004, CHEM ENG J, V101, P23, DOI 10.1016/j.cej.2003.11.019
   Scott R, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2900010
   Seo M, 2005, LANGMUIR, V21, P4773, DOI 10.1021/la050070p
   Song H, 2003, ANGEW CHEM INT EDIT, V42, P768, DOI 10.1002/anie.200390203
   Teh SY, 2008, LAB CHIP, V8, P198, DOI 10.1039/b715524g
   Thorsen T, 2001, PHYS REV LETT, V86, P4163, DOI 10.1103/PhysRevLett.86.4163
   Umbanhowar PB, 2000, LANGMUIR, V16, P347, DOI 10.1021/la990101e
   Wang L, 2007, LAB CHIP, V7, P1114, DOI 10.1039/b705386j
   Xia Y.N., 1998, ANGEW CHEM INT EDIT, V37, P551, DOI DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G
   Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k
NR 16
TC 0
Z9 0
U1 0
U2 4
PU SOC IMAGING SCIENCE & TECHNOLOGY
PI SPRINGFIELD
PA 7003 KILWORTH LANE, SPRINGFIELD, VA 22151 USA
BN 978-0-89208-287-2
PY 2009
BP 806
EP 809
PG 4
WC Engineering, Manufacturing; Imaging Science & Photographic Technology
SC Engineering; Imaging Science & Photographic Technology
GA BPN16
UT WOS:000279358900218
DA 2018-10-19
ER

PT J
AU Dudek, A
AF Dudek, Agata
TI Surface properties in titanium with hydroxyapatite coating
SO OPTICA APPLICATA
LA English
DT Article; Proceedings Paper
CT 11th Workshop on Surface Physics and Thin-Film Structures
CY MAY 19-22, 2009
CL Szklarska Poreba, POLAND
DE hydroxyapatite; zirconia; XRD
ID RAMAN-SPECTROSCOPY; ZIRCONIA; COMPOSITE; CERAMICS
AB Due to its wide range of possible applications in current technology, hydroxyapatite, as a biomaterial, has been of great interest to scholars. Improvement in mechanical properties can be achieved by addition of zirconia, partially stabilized by yttrium, into a resistant oxide phase. The present study describes the microstructure and phases which are typical of composite coatings after plasma spraying.
C1 Czestochowa Tech Univ, Inst Mat Engn, PL-42200 Czestochowa, Poland.
RP Dudek, A (reprint author), Czestochowa Tech Univ, Inst Mat Engn, Armii Krajowej 19, PL-42200 Czestochowa, Poland.
EM dudek@mim.pez.czest.pl
CR Chevalier J, 2004, BIOMATERIALS, V25, P5539, DOI 10.1016/j.biomaterials.2004.01.002
   Fu L, 2000, SURF COAT TECH, V127, P66, DOI 10.1016/S0257-8972(00)00559-4
   Hartmann P, 2001, J SOLID STATE CHEM, V160, P460, DOI 10.1006/jssc.2001.9274
   Inuzuka M, 2004, SOLID STATE IONICS, V172, P509, DOI 10.1016/j.ssi.2004.01.054
   Khalil KA, 2007, MAT SCI ENG A-STRUCT, V456, P368, DOI 10.1016/j.msea.2006.12.005
   Pappas D, 2000, TALANTA, V51, P131, DOI 10.1016/S0039-9140(99)00254-4
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Schrader B, 1999, J MOL STRUCT, V481, P21, DOI 10.1016/S0022-2860(98)00650-4
   Silva CC, 2004, J PHYS CHEM SOLIDS, V65, P1031, DOI 10.1016/j.jpcs.2003.10.071
   Sung YM, 2003, J CRYST GROWTH, V254, P411, DOI 10.1016/S0022-0248(03)01191-6
   Wunderlich B., 1973, MACROMOLECULAR PHYS, V2
   Yoshida K, 2006, J EUR CERAM SOC, V26, P515, DOI 10.1016/j.jeurceramsoc.2005.07.047
NR 12
TC 8
Z9 8
U1 0
U2 1
PU TECHNICAL UNIV WROCLAW
PI WROCLAW
PA WYBRZEZE WYSPIANSKIEGO 27, EXPORT-IMPORT DIVISION, 50-370 WROCLAW,
   POLAND
SN 0078-5466
EI 1899-7015
J9 OPT APPL
JI Opt. Appl.
PY 2009
VL 39
IS 4
BP 825
EP 831
PG 7
WC Optics
SC Optics
GA 555QS
UT WOS:000274529200024
DA 2018-10-19
ER

PT S
AU Nomizu, M
   Yamagata, N
   Mochizuki, M
   Kikkawa, V
   Kadoya, Y
AF Nomizu, Motovoshi
   Yamagata, Natsumi
   Mochizuki, Mayumi
   Kikkawa, Vaniato
   Kadoya, Yuichi
BE DelValle, S
   Escher, E
   Lubell, WD
TI Peptide-Chitosan Matrix: a New Multifunctional Biomaterial
SO PEPTIDES FOR YOUTH
SE Advances in Experimental Medicine and Biology
LA English
DT Article; Proceedings Paper
CT 20th American-Peptide-Society Symposium
CY JUN 26-30, 2007
CL Montreal, CANADA
SP Amer Peptide Soc
ID MEMBRANE; INTEGRIN; ALPHA-1
C1 [Nomizu, Motovoshi; Yamagata, Natsumi; Mochizuki, Mayumi; Kikkawa, Vaniato] Tokyo Univ Pharm & Life Sci, Tokyo 1920392, Japan.
   [Kadoya, Yuichi] Kitasato Univ, Sch Med, Sagamihara, Kanagawa 2288555, Japan.
RP Nomizu, M (reprint author), Tokyo Univ Pharm & Life Sci, Tokyo 1920392, Japan.
RI Kikkawa, Yamato/D-1503-2010
CR Ikemoto S, 2006, J BIOMED MATER RES A, V79A, P716, DOI 10.1002/jbm.a.30804
   MILES AJ, 1995, J BIOL CHEM, V270, P29047, DOI 10.1074/jbc.270.49.29047
   MOCHIZUKI M, 2003, FASEB J, V17, P876
   Mochizuki M, 2007, BIOPOLYMERS, V88, P122, DOI 10.1002/bip.20684
   Richard BL, 1996, EXP CELL RES, V228, P98, DOI 10.1006/excr.1996.0304
   Suzuki N, 2003, J BIOL CHEM, V278, P45697, DOI 10.1074/jbc.M304667200
   Weeks BS, 1998, EXP CELL RES, V243, P375, DOI 10.1006/excr.1998.4157
NR 7
TC 0
Z9 1
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
SN 0065-2598
BN 978-0-387-73656-3
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2009
VL 611
BP 253
EP 255
DI 10.1007/978-0-387-73657-0_116
PG 3
WC Biochemistry & Molecular Biology; Medicine, Research & Experimental
SC Biochemistry & Molecular Biology; Research & Experimental Medicine
GA BJH04
UT WOS:000265773200116
PM 19400183
DA 2018-10-19
ER

PT S
AU Morozan, A
   Nastase, F
   Dumitru, A
   Nastase, C
   Vulpe, S
   Filipescu, M
AF Morozan, Adina
   Nastase, Florin
   Dumitru, Anca
   Nastase, Claudia
   Vulpe, Silviu
   Filipescu, Mihaela
BE Correia, A
   Saenz, JJ
   Ordejon, P
TI Plasma processing of polypyrrole-heparin thin films on titanium
   substrates for biomedical applications
SO PHYSICA STATUS SOLIDI C - CURRENT TOPICS IN SOLID STATE PHYSICS, VOL 6,
   NO 10
SE Physica Status Solidi C-Current Topics in Solid State Physics
LA English
DT Proceedings Paper
CT 9th International Conference on Trends in Nanotechnology (TNT2008)
CY SEP 01-05, 2008
CL Oviedo, SPAIN
ID POLYMERIZED THIOPHENE; BLOOD COMPATIBILITY; BIOCOMPATIBILITY;
   ELECTROPOLYMERIZATION
AB Conducting polymers such as polypyrrole (PPy) offer a new class of material for trial use in biological applications. The plasma polymerization is the process mostly used for the deposition of thin polymer and polymer-based composity films with a variable amunt of functionalities available for reactoin with biomolecules. Heparin (Hep) is a potent anticoagulant that can be immobilized on biomaterial surfaces to increase their hemocompatability. Efforts are to attach Hep to polymeric materials. In this context, the strategy followed in this work was based on a plasma deposition of PPy and PPy-Hep films onto Ti substrate. The PPy and PPy-Hep films were investigated using Fourier Transform Infrared Spectroscopy (FT-IR) and Atomic Force Microscopy (AFM). (C) 2009 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
C1 [Morozan, Adina; Nastase, Florin; Dumitru, Anca; Nastase, Claudia; Vulpe, Silviu] Univ Bucharest, Polymer Sci Grp, POB MG 40, Bucharest 077125, Romania.
   [Filipescu, Mihaela] Nat Inst Lasers Plasma & Radiat Phys, Bucharest 077125, Romania.
RP Morozan, A (reprint author), Univ Bucharest, Polymer Sci Grp, POB MG 40, Bucharest 077125, Romania.
EM adina.morozan@gmail.com; nastasef@psg.unibuc.ro
RI Dumitru, Anca/B-6704-2011; Nastase, Claudia/B-5674-2008; FILIPESCU,
   MIHAELA/A-7196-2017; Nastase, Florin/B-1158-2008; Vulpe,
   Silviu/D-1591-2011
OI Nastase, Claudia/0000-0001-5544-0845; FILIPESCU,
   MIHAELA/0000-0003-4073-8555; Nastase, Florin/0000-0002-6764-0403; 
FU Ministry of Education, Research and Youth; Romania [CEEX No. 194/2006]
FX This work was supported by the Ministry of Education, Research and
   Youth; Romania (Grant CEEX No. 194/2006).
CR Arbizzani C, 2007, ELECTROCHIM ACTA, V52, P3274, DOI 10.1016/j.electacta.2006.10.003
   Ateh DD, 2006, J R SOC INTERFACE, V3, P741, DOI 10.1098/rsif.2006.0141
   Bhat NV, 1998, J APPL POLYM SCI, V70, P203, DOI 10.1002/(SICI)1097-4628(19981003)70:1<203::AID-APP20>3.0.CO;2-6
   De Giglio E, 2001, BIOMATERIALS, V22, P2609, DOI 10.1016/S0142-9612(00)00449-X
   Garner B, 1999, J BIOMED MATER RES, V44, P121, DOI 10.1002/(SICI)1097-4636(199902)44:2<121::AID-JBM1>3.0.CO;2-A
   George PM, 2005, BIOMATERIALS, V26, P3511, DOI 10.1016/j.biomaterials.2004.09.037
   Grodzinski J.J., 1999, REACT FUNCT POLYM, V39, P99, DOI DOI 10.1016/S1381-5148(98)00054-6
   HAN DK, 1989, J BIOMED MATER RES-A, V23, P211
   HYNEK B, 1992, PLASMA POLYM PROCESS
   Karakisla M, 1996, J APPL POLYM SCI, V59, P1347, DOI 10.1002/(SICI)1097-4628(19960228)59:9<1347::AID-APP1>3.3.CO;2-K
   Khan W, 2007, ACTA BIOMATER, V3, P541, DOI 10.1016/j.actbio.2007.01.006
   Kumar D, 1998, EUR POLYM J, V34, P1053, DOI 10.1016/S0014-3057(97)00204-8
   Lin Y, 1996, J APPL POLYM SCI, V60, P543
   Liu XY, 2004, SURF COAT TECH, V186, P227, DOI 10.1016/j.surfcoat.2004.02.045
   Malmstrom JA, 1998, ANN BIOMED ENG, V26, P1055, DOI 10.1114/1.35
   Mao C, 2008, COLLOID SURFACE B, V67, P41, DOI 10.1016/j.colsurfb.2008.07.012
   Nader HB, 1999, BRAZ J MED BIOL RES, V32, P529, DOI 10.1590/S0100-879X1999000500005
   SEIFERT B, 1995, J BIOMAT SCI-POLYM E, V7, P277, DOI 10.1163/156856295X00319
   Serra Morenos J, 2008, ELECTROCHIM ACTA, V53, P2154, DOI DOI 10.1016/J.ELECTACTA.2007.09.045
   Silverstein MS, 2002, POLYMER, V43, P11, DOI 10.1016/S0032-3861(01)00582-1
   Wang XD, 2004, J BIOMED MATER RES A, V68A, P411, DOI 10.1002/jbm.a.20065
   WEST JL, 2004, ENCY BIOMATERIALS BI, P89
NR 22
TC 2
Z9 2
U1 0
U2 6
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PAPPELALLEE 3, W-69469 WEINHEIM, GERMANY
SN 1862-6351
J9 PHYS STATUS SOLIDI C
PY 2009
VL 6
IS 10
BP 2195
EP +
DI 10.1002/pssc.200881715
PG 2
WC Nanoscience & Nanotechnology; Physics, Applied; Physics, Condensed
   Matter
SC Science & Technology - Other Topics; Physics
GA BPO53
UT WOS:000279541800020
DA 2018-10-19
ER

PT J
AU Rimola, A
   Corno, M
   Zicovich-Wilson, CM
   Ugliengo, P
AF Rimola, Albert
   Corno, Marta
   Marcelo Zicovich-Wilson, Claudio
   Ugliengo, Piero
TI Ab initio modeling of protein/biomaterial interactions: competitive
   adsorption between glycine and water onto hydroxyapatite surfaces
SO PHYSICAL CHEMISTRY CHEMICAL PHYSICS
LA English
DT Article
ID MOLECULAR-DYNAMICS SIMULATIONS; SILICA SURFACE; STATHERIN; PROTEINS;
   B3LYP; PRINCIPLES; CRYSTALS; BIOLOGY; BINDING
AB Both glycine and water exhibit a high affinity towards the hydroxyapatite HA surfaces. What happens when they are co-adsorbed at the HA (001) surface? B3LYP periodic calculations reveal that glycine displaces the pre-adsorbed water interacting directly with the HA surface.
C1 [Rimola, Albert; Corno, Marta; Ugliengo, Piero] Univ Turin, Dipartimento Chim IFM, NIS Ctr Excellence & INSTM, I-10125 Turin, Italy.
   [Marcelo Zicovich-Wilson, Claudio] Univ Autonoma Estado Morelos, Fac Ciencias, Cuernavaca 62209, Morelos, Mexico.
RP Ugliengo, P (reprint author), Univ Turin, Dipartimento Chim IFM, NIS Ctr Excellence & INSTM, Via P Giuria 7, I-10125 Turin, Italy.
EM piero.ugliengo@unito.it
RI zicovich-wilson, claudio/B-7789-2015; Rimola, Albert/K-1813-2014;
   ugliengo, piero/H-6373-2015; Corno, Marta/I-4310-2012
OI zicovich-wilson, claudio/0000-0001-6116-9166; Rimola,
   Albert/0000-0002-9637-4554; ugliengo, piero/0000-0001-8886-9832; Corno,
   Marta/0000-0001-7248-2705
CR Capriotti LA, 2007, J AM CHEM SOC, V129, P5281, DOI 10.1021/ja070356b
   Carravetta V, 2006, J PHYS CHEM B, V110, P6160, DOI 10.1021/jp056760j
   Chen PH, 2008, J AM CHEM SOC, V130, P2862, DOI 10.1021/ja076607y
   Chen X, 2007, J PHYS CHEM C, V111, P1284, DOI 10.1021/jp0646630
   Corno M, 2007, EUR J MINERAL, V19, P757, DOI 10.1127/0935-1221/2007/0019-1764
   Corno M, 2009, LANGMUIR, V25, P2188, DOI 10.1021/la803253k
   Costa D, 2008, PHYS CHEM CHEM PHYS, V10, P6360, DOI 10.1039/b806501b
   De M, 2008, ADV MATER, V20, P4225, DOI 10.1002/adma.200703183
   Elangovan S, 2007, LANGMUIR, V23, P11200, DOI 10.1021/la7013978
   FERNANDEZ VL, 1992, J AM CHEM SOC, V114, P9634, DOI 10.1021/ja00050a051
   Gambino GL, 2004, J PHYS CHEM B, V108, P2600, DOI 10.1021/jp035991s
   Goobes G, 2007, MAGN RESON CHEM, V45, pS32, DOI 10.1002/mrc.2123
   Goobes G, 2006, P NATL ACAD SCI USA, V103, P16083, DOI 10.1073/pnas.0607193103
   Gray JJ, 2004, CURR OPIN STRUC BIOL, V14, P110, DOI 10.1016/j.sbi.2003.12.001
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hudson S, 2008, ANGEW CHEM INT EDIT, V47, P8582, DOI 10.1002/anie.200705238
   Lomenech C, 2005, CHEMPHYSCHEM, V6, P1061, DOI 10.1002/cphc.200400608
   Makrodimitris K, 2007, J AM CHEM SOC, V129, P13713, DOI 10.1021/ja074602v
   MARX D, 2000, MODERN METHODS ALGOR, V1
   Nonella M, 2008, CHEMPHYSCHEM, V9, P414, DOI 10.1002/cphc.200700546
   Pareek A, 2008, LANGMUIR, V24, P2459, DOI 10.1021/la701929p
   Patwardhan SV, 2007, J MATER CHEM, V17, P2875, DOI 10.1039/b704075j
   Rimola A, 2006, LANGMUIR, V22, P6593, DOI 10.1021/la0610203
   Rimola A, 2008, LANGMUIR, V24, P14027, DOI 10.1021/la8029352
   Rimola A, 2008, J AM CHEM SOC, V130, P16181, DOI 10.1021/ja806520d
   Sarikaya M, 2003, NAT MATER, V2, P577, DOI 10.1038/nmat964
   Tomsia AP, 2005, ADV ENG MATER, V7, P999, DOI 10.1002/adem.200500143
   Vallet-Regi M, 2006, CHEM-EUR J, V12, P5934, DOI 10.1002/chem.200600226
   VoDinh T, 2007, NANOTECHNOLOGY IN BIOLOGY AND MEDICINE: METHODS, DEVICES, AND APPLICATIONS, P1
   Wallwork ML, 2001, LANGMUIR, V17, P2508, DOI 10.1021/la001281r
   Zhang YH, 2005, ANGEW CHEM INT EDIT, V44, P615, DOI 10.1002/anie.200460741
NR 31
TC 31
Z9 31
U1 3
U2 23
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1463-9076
J9 PHYS CHEM CHEM PHYS
JI Phys. Chem. Chem. Phys.
PY 2009
VL 11
IS 40
BP 9005
EP 9007
DI 10.1039/b913311a
PG 3
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA 505MW
UT WOS:000270698900004
PM 19812818
DA 2018-10-19
ER

PT J
AU Rimola, A
   Corno, M
   Zicovich-Wilson, CM
   Ugliengo, P
AF Rimola, Albert
   Corno, Marta
   Zicovich-Wilson, Claudio Marcelo
   Ugliengo, Piero
TI Ab initio modeling of protein/biomaterial interactions: competitive
   adsorption between glycine and water onto hydroxyapatite surfaces (vol
   11, pg 9005, 2009)
SO PHYSICAL CHEMISTRY CHEMICAL PHYSICS
LA English
DT Correction
RI zicovich-wilson, claudio/B-7789-2015; ugliengo, piero/H-6373-2015;
   Rimola, Albert/K-1813-2014; Corno, Marta/I-4310-2012
OI zicovich-wilson, claudio/0000-0001-6116-9166; ugliengo,
   piero/0000-0001-8886-9832; Rimola, Albert/0000-0002-9637-4554; Corno,
   Marta/0000-0001-7248-2705
CR Pareek A, 2009, LANGMUIR, V25, P1453, DOI 10.1021/la802706y
   Rimola A, 2009, PHYS CHEM CHEM PHYS, V11, P9005, DOI 10.1039/b913311a
NR 2
TC 2
Z9 2
U1 1
U2 5
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1463-9076
J9 PHYS CHEM CHEM PHYS
JI Phys. Chem. Chem. Phys.
PY 2009
VL 11
IS 48
BP 11662
EP 11662
PG 1
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA 526EV
UT WOS:000272271400048
DA 2018-10-19
ER

PT J
AU Chlupac, J
   Filova, E
   Bacakova, L
AF Chlupac, J.
   Filova, E.
   Bacakova, L.
TI Blood Vessel Replacement: 50 years of Development and Tissue Engineering
   Paradigms in Vascular Surgery
SO PHYSIOLOGICAL RESEARCH
LA English
DT Review
DE Small-caliber vascular grafts; Synthetic polymers; Biomaterials; Tissue
   engineering; Stem cells; Dynamic bioreactor; Shear stress
ID CORONARY-ARTERY-BYPASS; BONE-MARROW-CELLS; PROSPECTIVE RANDOMIZED
   MULTICENTER; AORTIC GRAFT INFECTION; CRITICAL LIMB ISCHEMIA; LESSER
   SAPHENOUS-VEIN; EXPANDED POLYTETRAFLUOROETHYLENE; ENDOTHELIAL-CELLS;
   HEMODIALYSIS ACCESS; SHEAR-STRESS
AB The gold standard material in bypass surgery of blood vessels remains the patient's own artery or vein. However, this material may be unavailable, or may suffer vein graft disease. Currently available vascular prostheses, namely polyethylene terephthalate (PET, Dacron) and expanded polytetrafluoroethylene (ePTFE), perform well as large-caliber replacements, but their long-term patency is discouraging in small-caliber applications (<6 mm), such as in coronary, crural or microvessel surgery. This failure is mainly a result of an unfavorable healing process with surface thrombogenicity, due to lack of endothelial cells and anastomotic intimal hyperplasia caused by hemodynamic disturbances. An ideal small-diameter vascular graft has become a major focus of research. Novel biomaterials have been manufactured, and tissue-biomaterial interactions have been optimized. Tissue engineering technology has proven that the concept of partially or totally living blood vessels is feasible. The purpose of this review is to outline the vascular graft materials that are currently being implanted, taking into account cell-biomaterial physiology, tissue engineering approaches and the collective achievements of the authors.
C1 [Chlupac, J.; Filova, E.; Bacakova, L.] Acad Sci Czech Republic, Inst Physiol, Dept Growth & Differentiat Cell Populat, CZ-14220 Prague 4, Czech Republic.
   [Chlupac, J.; Filova, E.; Bacakova, L.] Cardiovasc Res Ctr, Prague, Czech Republic.
   [Chlupac, J.] Inst Clin & Expt Med, Transplant Surg Clin, Prague, Czech Republic.
RP Bacakova, L (reprint author), Acad Sci Czech Republic, Inst Physiol, Dept Growth & Differentiat Cell Populat, Videnska 1083, CZ-14220 Prague 4, Czech Republic.
EM lucy@biomed.cas.cz
RI Filova, Elena/C-2209-2012; Bacakova, Lucie/C-2664-2012
OI Bacakova, Lucie/0000-0002-1818-9484
FU Ministry of Education, Youth and Sports of the Czech Republic
   [1M6798582302]; Academy of Sciences of the Czech Republic [1QS500110564]
FX This study was supported by the Centre for Cardiovascular Research
   (grant No. 1M6798582302 provided by the Ministry of Education, Youth and
   Sports of the Czech Republic) and by the Academy of Sciences of the
   Czech Republic (grant No. 1QS500110564). Mr. Robin Healey (Czech
   Technical University, Prague) is gratefully acknowledged for his
   language revision of the manuscript. We also thank Mrs. Jana Vobornikova
   for her excellent technical assistance in preparing the manuscript.
CR Aldenhoff YBJ, 2001, J BIOMED MATER RES, V54, P224, DOI 10.1002/1097-4636(200102)54:2<224::AID-JBM9>3.0.CO;2-E
   Ali AT, 2009, J VASC SURG, V50, P30, DOI 10.1016/j.jvs.2009.01.008
   Alobaid N, 2005, CLIN HEMORHEOL MICRO, V33, P209
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Bacakova L, 2004, PHYSIOL RES, V53, pS35
   Bacakova L, 2007, J MATER SCI-MATER M, V18, P1317, DOI 10.1007/s10856-006-0074-1
   Bader A, 2000, TRANSPLANTATION, V70, P7
   Baguneid MS, 2006, BRIT J SURG, V93, P282, DOI 10.1002/bjs.5256
   Bastounis E, 1999, EUR J VASC ENDOVASC, V18, P127, DOI 10.1053/ejvs.1999.0880
   Beghi C, 2002, CHEST, V122, P2075, DOI 10.1378/chest.122.6.2075
   BERGER K, 1972, ANN SURG, V175, P118, DOI 10.1097/00000658-197201000-00018
   Bhattacharya V, 2000, BLOOD, V95, P581
   BLAKEMORE AH, 1954, ANN SURG, V140, P324, DOI 10.1097/00000658-195409000-00008
   BLUMENBERG RM, 1991, J VASC SURG, V14, P175
   Bordenave L, 2005, CLIN HEMORHEOL MICRO, V33, P227
   Bordenave L, 1999, ENDOTHELIUM-J ENDOTH, V6, P267, DOI 10.3109/10623329909078494
   Bordenave L, 2008, EXPERT REV MED DEVIC, V5, P337, DOI 10.1586/17434440-5.3-337
   BORETOS JW, 1967, SCIENCE, V158, P1481, DOI 10.1126/science.158.3807.1481
   Bosiers M, 2006, J VASC SURG, V43, P313, DOI 10.1016/j.jvs.2005.10.037
   Brewster DC, 1997, J VASC SURG, V25, P365, DOI 10.1016/S0741-5214(97)70359-8
   Brooks EE, 1997, J BIOL CHEM, V272, P29207, DOI 10.1074/jbc.272.46.29207
   Brynda E, 2005, LANGMUIR, V21, P7877, DOI 10.1021/la046846o
   BRYNDA E, 2008, Patent No. 2006821
   Calligaro KD, 1997, J VASC SURG, V26, P919, DOI 10.1016/S0741-5214(97)70003-X
   Campbell GR, 2007, CURR PHARM BIOTECHNO, V8, P43, DOI 10.2174/138920107779941426
   Campbell JH, 1999, CIRC RES, V85, P1173
   CHANG BB, 1992, J VASC SURG, V15, P152, DOI 10.1016/0741-5214(92)70023-E
   Chemla ES, 2009, BRIT J SURG, V96, P34, DOI 10.1002/bjs.6434
   CHESHIRE NJW, 1992, J VASC SURG, V15, P167, DOI 10.1016/0741-5214(92)70025-G
   Chien S, 2007, AM J PHYSIOL-HEART C, V292, pH1209, DOI 10.1152/ajpheart.01047.2006
   Chlupac J, 2006, ATHEROSCLEROSIS SUPP, V7, P159, DOI 10.1016/S1567-5688(06)80624-0
   CHLUPAC J, 2008, ENG BIOMATER, V81, P108
   CHLUPAC J, 2006, PHYSIOL RES, V55, pP24
   CHLUPAC J, 2006, ENG BIOMATER, V58, P10
   CHLUPAC J, 2008, PHYSIOL RES, V57, pP77
   CLOWES AW, 1987, AM J SURG, V153, P501, DOI 10.1016/0002-9610(87)90802-6
   Conte MS, 1998, FASEB J, V12, P43
   Cooper GJ, 1996, EUR J CARDIO-THORAC, V10, P129, DOI 10.1016/S1010-7940(96)80135-7
   Daculsi R, 2007, ENDOTHELIUM-J ENDOTH, V14, P163, DOI 10.1080/10623320701421602
   Dahl SLM, 2003, CELL TRANSPLANT, V12, P659, DOI 10.3727/000000003108747136
   Dardik H, 2002, J VASC SURG, V35, P64, DOI 10.1067/mva.2002.121053
   de Mel Achala, 2008, Expert Rev Cardiovasc Ther, V6, P1259, DOI 10.1586/14779072.6.9.1259
   Dereume J P, 1993, Cardiovasc Surg, V1, P499
   Deutsch M, 2001, EUR J VASC ENDOVASC, V21, P508, DOI 10.1053/ejvs.2001.1361
   Deutsch M, 2009, J VASC SURG, V49, P352, DOI 10.1016/j.jvs.2008.08.101
   Devine C, 2004, J VASC SURG, V40, P924, DOI 10.1016/j.jvs.2004.08.033
   Doty JR, 1999, ANN THORAC SURG, V67, P1111, DOI 10.1016/S0003-4975(99)00145-9
   Earnshaw JJ, 2000, BRIT J SURG, V87, P758, DOI 10.1046/j.1365-2168.2000.01490.x
   Ehrbar M, 2005, J CONTROL RELEASE, V101, P93, DOI 10.1016/j.jconrel.2004.07.018
   Emrecan B, 2006, NEPHROL DIAL TRANSPL, V21, P2290, DOI 10.1093/ndt/gfl164
   Fahner PJ, 2006, J VASC SURG, V44, P518, DOI 10.1016/j.jvs.2006.05.037
   Faries PL, 2000, J VASC SURG, V31, P1119, DOI 10.1016/S0741-5214(00)90101-0
   Fernandez P, 2007, TISSUE ENG, V13, P1607, DOI 10.1089/ten.2006.0399
   Fernandez-Cobo Mariana, 2006, Infect Agent Cancer, V1, P7, DOI 10.1186/1750-9378-1-7
   Filova E, 2009, J BIOMED MATER RES A, V90A, P55, DOI 10.1002/jbm.a.32065
   Fischer EIC, 2005, ARTIF ORGANS, V29, P122, DOI 10.1111/j.1525-1594.2005.29023.x
   Fisher RK, 2003, EUR J VASC ENDOVASC, V25, P235, DOI 10.1053/ejvs.2002.1840
   Glickman MH, 2001, J VASC SURG, V34, P465, DOI 10.1067/mva.2001.117330
   GOLDEN MA, 1990, J VASC SURG, V11, P838, DOI 10.1067/mva.1990.18047
   Goyanes J, 1906, SIGLO MED, V53, P446
   GRAY JL, 1994, J SURG RES, V57, P596, DOI 10.1006/jsre.1994.1189
   GROSS RE, 1948, NEW ENGL J MED, V239, P578, DOI 10.1056/NEJM194810142391604
   GUIDOIN R, 1993, BIOMATERIALS, V14, P678, DOI 10.1016/0142-9612(93)90067-C
   GUIDOIN R, 1993, BIOMATERIALS, V14, P694, DOI 10.1016/0142-9612(93)90068-D
   Guidoin R, 1996, ASAIO J, V42, P974, DOI 10.1097/00002480-199642060-00010
   Guyton RA, 2006, ANN THORAC SURG, V81, P1949, DOI 10.1016/j.athoracsur.2006.03.020
   Haruguchi Hiroaki, 2003, J Artif Organs, V6, P227, DOI 10.1007/s10047-003-0232-x
   Heise M, 2006, EUR J VASC ENDOVASC, V32, P418, DOI 10.1016/j.ejvs.2006.03.002,
   HERRING M, 1978, SURGERY, V84, P498
   HERRING M, 1984, J VASC SURG, V1, P279, DOI 10.1067/mva.1984.avs0010279
   HERRING MB, 1979, ANN SURG, V190, P84, DOI 10.1097/00000658-197907000-00019
   HURT AV, 1983, AM J SURG, V146, P844, DOI 10.1016/0002-9610(83)90356-2
   Isenberg BC, 2006, CIRC RES, V98, P25, DOI 10.1161/01.RES.0000196867.12470.84
   Ishii Y, 2008, J THORAC CARDIOV SUR, V135, P1237, DOI 10.1016/j.jtcvs.2007.09.077
   JABOULAY M, 1896, LYON MED, V81, P97
   Jeschke MG, 1999, J VASC SURG, V29, P168, DOI 10.1016/S0741-5214(99)70358-7
   Johnson WC, 2000, J VASC SURG, V32, P268, DOI 10.1067/mva.2000.106944
   Kachlik D, 2007, J VASC RES, V44, P157, DOI 10.1159/000099142
   Kakisis JD, 2005, J VASC SURG, V41, P349, DOI 10.1016/j.jvs.2004.12.026
   Kalra M, 2003, J VASC SURG, V38, P215, DOI 10.1016/S0741-5214(03)00331-8
   Kapfer X, 2006, EUR J VASC ENDOVASC, V32, P155, DOI 10.1016/j.ejvs.2005.12.015
   Katzman HE, 2005, J AM COLL SURGEONS, V201, P223, DOI 10.1016/j.jamcollsurg.2005.03.040
   Kieffer E, 2004, J VASC SURG, V39, P1009, DOI 10.1016/j.jvs.2003.12.040
   Klinkert P, 2004, EUR J VASC ENDOVASC, V27, P357, DOI 10.1016/j.ejvs.2003.12.027
   KOHLER TR, 1992, SURGERY, V112, P901
   L'Heureux N, 1998, FASEB J, V12, P47
   L'Heureux N, 2006, NAT MED, V12, P361, DOI 10.1038/nm1364
   L'Heureux N, 2007, NEW ENGL J MED, V357, P1451, DOI 10.1056/NEJMc071536
   L'Heureux N, 2007, NAT CLIN PRACT CARD, V4, P389, DOI 10.1038/ncpcardio0930
   Lantz G C, 1993, J Invest Surg, V6, P297, DOI 10.3109/08941939309141619
   LAUBE HR, J THORAC CARDIOVASC, V120, P134
   Laurila K, 2006, J VASC SURG, V44, P985, DOI 10.1016/j.jvs.2006.06.037
   Lawson JA, 1999, EUR J VASC ENDOVASC, V18, P149, DOI 10.1016/S1078-5884(99)90865-1
   Lee HJ, 2002, J BIOMAT SCI-POLYM E, V13, P939, DOI 10.1163/156856202320401979
   Lee SW, 2008, J AM COLL CARDIOL, V52, P727, DOI 10.1016/j.jacc.2008.04.056
   Lehoux S, 2006, J INTERN MED, V259, P381, DOI 10.1111/j.1365-2796.2006.01624.x
   Leon Luis R Jr, 2007, Vasc Endovascular Surg, V41, P537, DOI 10.1177/1538574407305019
   Lim HJ, 2007, BIOTECHNOL PROGR, V23, P693, DOI 10.1021/bp060338i
   LINTON RR, 1955, SURGERY, V38, P817
   LOPEZ PP, 2008, SURG BASIC SCI CLIN, P521
   MAGOMETSCHNIGG H, 1992, J VASC SURG, V15, P527, DOI 10.1016/0741-5214(92)90192-B
   Mahmood A, 2002, J VASC SURG, V36, P772, DOI 10.1067/mva.2002.127527
   Mamode N, 2000, COCHRANE DB SYST REV, V2
   Marois Y, 1996, BIOMATERIALS, V17, P3, DOI 10.1016/0142-9612(96)80749-6
   Matia I, 2008, EUR J VASC ENDOVASC, V35, P353, DOI 10.1016/j.ejvs.2007.09.022
   Matia I, 2007, EUR J VASC ENDOVASC, V34, P424, DOI 10.1016/j.ejvs.2007.04.005
   Matsumura G, 2003, CIRCULATION, V108, P1729, DOI 10.1161/01.CIR.0000092165.32213.61
   Matsuura JH, 2004, J AM COLL SURGEONS, V198, P778, DOI 10.1016/j.jamcollsurg.2004.01.020
   McAllister TN, 2009, LANCET, V373, P1440, DOI 10.1016/S0140-6736(09)60248-8
   Meinhart J, 1997, ASAIO J, V43, pM515
   Met R, 2008, CARDIOVASC INTER RAD, V31, P687, DOI 10.1007/s00270-008-9331-7
   Mirzaie M, 2007, EUR J VASC ENDOVASC, V33, P610, DOI 10.1016/j.ejvs.2006.11.042
   Moawad John, 2003, Vasc Endovascular Surg, V37, P381, DOI 10.1177/153857440303700601
   Muto A, 2007, J VASC SURG, V45, p15A, DOI 10.1016/j.jvs.2007.02.061
   Nezic DG, 2006, EUR J CARDIO-THORAC, V30, P341, DOI 10.1016/j.ejcts.2006.05.012
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Nishlbe T, 2007, VASCULAR, V15, P356, DOI 10.2310/6670.2007.00053
   Noishiki Y, 1996, NAT MED, V2, P90, DOI 10.1038/nm0196-90
   Norgren L, 2007, J VASC SURG, V45, pS5, DOI 10.1016/j.jvs.2006.12.037
   NORTON L, 1975, SURGERY, V77, P280
   O'Brien TP, 2007, ANN VASC SURG, V21, P611, DOI 10.1016/j.avsg.2007.04.006
   Pamula E, 2008, J MATER SCI-MATER M, V19, P425, DOI 10.1007/s10856-007-3001-1
   Panneton JM, 2004, ANN VASC SURG, V18, P199, DOI 10.1007/s10016-004-0012-y
   Quarmby JW, 1998, BRIT J SURG, V85, P775
   Rademacher A, 2001, INT J ARTIF ORGANS, V24, P235
   RAHLF G, 1986, THORAC CARDIOV SURG, V34, P43, DOI 10.1055/s-2007-1020371
   Remy-Zolghadri M, 2004, J VASC SURG, V39, P613, DOI 10.1016/j.jvs.2003.08.007
   Ricotta J. J, 2005, VASCULAR SURG, P688
   Riedel T, 2009, J BIOMED MATER RES A, V88A, P437, DOI 10.1002/jbm.a.31755
   Riha GM, 2005, TISSUE ENG, V11, P1535, DOI 10.1089/ten.2005.11.1535
   Roll Stephanie, 2008, BMC Surg, V8, P22, DOI 10.1186/1471-2482-8-22
   Salacinski HJ, 2001, MED BIOL ENG COMPUT, V39, P609, DOI 10.1007/BF02345431
   Sarjeant JM, 2002, CARDIOVASC PATHOL, V11, P263, DOI 10.1016/S1054-8807(02)00125-4
   Sarkar S, 2006, EUR J VASC ENDOVASC, V31, P627, DOI 10.1016/j.ejvs.2006.01.006
   Sasaki H, 2008, J CARDIAC SURG, V23, P398, DOI 10.1111/j.1540-8191.2008.00623.x
   Sato S, 2008, ANN THORAC SURG, V86, P1278, DOI 10.1016/j.athoracsur.2008.03.035
   Sauvage L., 1986, VASCULAR GRAFT UPDAT, P16
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   Schouten O, 2005, EUR J VASC ENDOVASC, V29, P457, DOI 10.1016/j.ejvs.2005.01.010
   Schwarzbach MHM, 2006, J VASC SURG, V44, P46, DOI 10.1016/j.jvs.2006.03.001
   Scott EC, 2007, SEMIN VASC SURG, V20, P158, DOI 10.1053/j.semvascsurg.2007.07.007
   Seifalian AM, 2003, BIOMATERIALS, V24, P2549, DOI 10.1016/S0142-9612(02)00608-7
   Seifalian AM, 2002, ARTIF ORGANS, V26, P307, DOI 10.1046/j.1525-1594.2002.06841.x
   Shi Q, 1997, J VASC SURG, V25, P736, DOI 10.1016/S0741-5214(97)70303-3
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Shin'oka T, 2005, J THORAC CARDIOV SUR, V129, P1330, DOI 10.1016/j.jtcvs.2004.12.047
   Shin'oka T, 2001, NEW ENGL J MED, V344, P532, DOI 10.1056/NEJM200102153440717
   SIEGMAN FA, 1979, SURG GYNECOL OBSTET, V148, P930
   SITZMANN JV, 1984, SURGERY, V95, P154
   Sriram V, 2001, CIRCULATION, V103, P2414
   Stark TD, 2003, PROCEEDINGS OF THE TWENTY-NINTH ANNUAL CONFERENCE ON EXPLOSIVES AND BLASTING TECHNIQUE, VOL 1, P47
   Stehouwer CDA, 2009, EUR J INTERN MED, V20, P132, DOI 10.1016/j.ejim.2008.09.013
   STEWART GJ, 1975, J LAB CLIN MED, V85, P208
   Swenne CL, 2006, THORAC CARDIOV SURG, V54, P300, DOI 10.1055/s-2006-924093
   Tiwari A, 2003, EUR J VASC ENDOVASC, V25, P287, DOI 10.1053/ejvs.2002.1810
   Tiwari A, 2002, CARDIOVASC SURG, V10, P191, DOI 10.1016/S0967-2109(02)00004-2
   Tiwari A, 2001, EUR J VASC ENDOVASC, V21, P193, DOI 10.1053/ejvs.2001.1316
   VANOTTERLOO JCAD, 1991, J VASC SURG, V14, P59
   Vara DS, 2005, PATHOL BIOL, V53, P599, DOI 10.1016/j.patbio.2004.12.006
   Varu VN, 2009, VASC ENDOVASC SURG, V43, P121, DOI 10.1177/1538574408322752
   VOORHEES AB, 1952, ANN SURG, V135, P332, DOI 10.1097/00000658-195203000-00006
   Vroman L, 1969, J Biomed Mater Res, V3, P43, DOI 10.1002/jbm.820030106
   Walpoth BH, 1998, CIRCULATION, V98, pII319
   Watson HR, 1999, BRIT J SURG, V86, P981, DOI 10.1046/j.1365-2168.1999.01193.x
   WEINBERG CB, 1986, SCIENCE, V231, P397, DOI 10.1126/science.2934816
   WISSELINK W, 1993, AM J SURG, V166, P200, DOI 10.1016/S0002-9610(05)81056-6
   WU MHD, 1995, J VASC SURG, V22, P382, DOI 10.1016/S0741-5214(95)70005-6
   Xue L, 2003, J VASC SURG, V37, P472, DOI 10.1067/mva.2003.88
   Yoshizumi M, 2003, J PHARMACOL SCI, V91, P172
   ZACHARIAS RK, 1987, J VASC SURG, V6, P429, DOI 10.1067/mva.1987.avs0060429
   Zarbiv G, 2007, EXPERT OPIN BIOL TH, V7, P1183, DOI 10.1517/14712598.7.8.1183
   Zdrahala RJ, 1996, J BIOMATER APPL, V11, P37, DOI 10.1177/088532829601100102
   Zhang Z, 1997, BIOMATERIALS, V18, P113, DOI 10.1016/S0142-9612(96)00054-3
   Zilla P, 2007, BIOMATERIALS, V28, P5009, DOI 10.1016/j.biomaterials.2007.07.017
NR 174
TC 154
Z9 157
U1 4
U2 86
PU ACAD SCIENCES CZECH REPUBLIC, INST PHYSIOLOGY
PI PRAGUE 4
PA VIDENSKA 1083, PRAGUE 4 142 20, CZECH REPUBLIC
SN 0862-8408
EI 1802-9973
J9 PHYSIOL RES
JI Physiol. Res.
PY 2009
VL 58
SU 2
BP S119
EP S139
PG 21
WC Physiology
SC Physiology
GA 542ZC
UT WOS:000273537200013
PM 20131930
DA 2018-10-19
ER

PT J
AU Gosain, AK
   Chim, H
   Arneja, JS
AF Gosain, Arun K.
   Chim, Harvey
   Arneja, Jugpal S.
TI Application-Specific Selection of Biomaterials for Pediatric
   Craniofacial Reconstruction: Developing a Rational Approach to Guide
   Clinical Use
SO PLASTIC AND RECONSTRUCTIVE SURGERY
LA English
DT Article
ID HYDROXYAPATITE-DERIVED BIOMATERIALS; ADULT SHEEP MODEL;
   CALCIUM-PHOSPHATE CEMENT; CRANIAL VAULT; FRONTAL CRANIOPLASTY;
   BONE-REPLACEMENT; RISK-FACTORS; DEFECTS; IMMATURE; SKELETON
AB Background: Biomaterials provide an invaluable alternative to autogenous bone graft for pediatric craniofacial reconstruction. However, there is no uniform agreement on the choice of biomaterial for different reconstructive needs.
   Methods: Patients who had reconstruction of the craniofacial skeleton with alloplastic materials from 1994 to 2006 by a single surgeon were reviewed. Biomaterials used consisted of three classes: cement pastes, biomaterials designed to be replaced by bone, and prefabricated polymers. The study included 25 patients with a mean age of 5.5 years and a mean follow-up of 3.3 years.
   Results: Cement pastes used for onlay augmentation to the cranial skeleton in eight patients consisted of hydroxyapatite (n = 5) and calcium phosphate (n = 3). One patient had a postoperative infection that resolved with partial implant removal and antibiotics. Biomaterials designed to be replaced by bone consisted of bioactive glass (n = 3) and demineralized bone (n = 8), which were used for inlay reconstruction of full-thickness calvarial defects in 11 patients. Computed tomographic scanning showed adequate bone mineralization in nine patients; two of the three patients with calvarial defects greater than 5 cm in diameter demonstrated variable mineralization. Prefabricated porous polyethylene was used in six patients for either onlay malar augmentation (n = 3) or inlay calvarial reconstruction (n = 3). One patient had a peri-implant infection that resolved with aspiration, irrigation, and intravenous antibiotics.
   Conclusions: The authors developed an algorithm to guide use of biomaterials in craniofacial reconstruction based on whether (1) growth of the underlying craniofacial skeleton is nearly complete (>90 percent); (2) onlay or inlay reconstruction is to be performed; and (3) the reconstruction is performed in a load-bearing or non-load-bearing area. (Plast. Reconstr. Surg. 123: 319, 2009.)
C1 Childrens Hosp Michigan, Case Sch Med, Dept Plast Surg, Detroit, MI 48201 USA.
   Childrens Hosp Michigan, Sect Plast Surg, Detroit, MI 48201 USA.
   Wayne State Univ, Detroit, MI 48202 USA.
RP Gosain, AK (reprint author), Univ Hosp, Case Sch Med, Dept Plast Surg, LKS MS 5044,11100 Euclid Ave, Cleveland, OH 44106 USA.
EM arun.gosain@uhhospitals.org
OI Arneja, Jugpal/0000-0002-5870-7039
CR Baker SB, 2002, PLAST RECONSTR SURG, V109, P1789, DOI 10.1097/00006534-200205000-00003
   Burstein FD, 2006, PLAST RECONSTR SURG, V118, P482, DOI 10.1097/01.prs.0000234811.48147.64
   Cenzi R, 2005, J CRANIOFAC SURG, V16, P526, DOI 10.1097/01.scs.0000168761.46700.dc
   Cho YR, 2004, CLIN PLAST SURG, V31, P377, DOI 10.1016/j.cps.2004.03.001
   Dougherty W R, 1994, J Craniofac Surg, V5, P26, DOI 10.1097/00001665-199402000-00007
   Friedman CD, 1998, J BIOMED MATER RES, V43, P428, DOI 10.1002/(SICI)1097-4636(199824)43:4<428::AID-JBM10>3.0.CO;2-0
   Gosain A. K, 2003, OPER TECH PLAST RECO, V9, P23
   Gosain AF, 2002, PLAST RECONSTR SURG, V109, P619, DOI 10.1097/00006534-200202000-00032
   Gosain AK, 2004, PLAST RECONSTR SURG, V114, P1155, DOI 10.1097/01.prs.0000135852.45465.a9
   Gosain AK, 2005, PLAST RECONSTR SURG, V116, P1044, DOI 10.1097/01.prs.0000178402.77445.44
   Gosain AK, 2005, PLAST RECONSTR SURG, V116, P663, DOI 10.1097/01.prs.0000176289.05374.5b
   Gosain AK, 2004, PLAST RECONSTR SURG, V114, P590, DOI 10.1097/01.PRS.0000128355.95900.DD
   Gosain AK, 1999, J CRANIOFAC SURG, V10, P404, DOI 10.1097/00001665-199909000-00006
   Greenberg BM, 2005, ANN PLAS SURG, V55, P43, DOI 10.1097/01.sap.0000168157.10664.9c
   Honnebier MB, 2008, PLAST RECONSTR SURG, V121, P919, DOI 10.1097/01.prs.0000299936.95276.24
   Kirschner RE, 2002, ANN PLAS SURG, V49, P33, DOI 10.1097/00000637-200207000-00005
   Kwon Brian, 2005, Spine J, V5, p224S, DOI 10.1016/j.spinee.2005.02.007
   Losee JE, 2003, J CRANIOFAC SURG, V14, P117, DOI 10.1097/00001665-200301000-00022
   MANSON PN, 1986, PLAST RECONSTR SURG, V77, P888, DOI 10.1097/00006534-198606000-00003
   Matic D, 2002, PLAST RECONSTR SURG, V110, P1, DOI 10.1097/00006534-200207000-00001
   Menderes A, 2004, J CRANIOFAC SURG, V15, P719, DOI 10.1097/00001665-200409000-00004
   MOTOKI DS, 1990, CLIN PLAST SURG, V17, P527
   REHMAN I, 1994, BIOMATERIALS, V15, P865, DOI 10.1016/0142-9612(94)90044-2
   Salyer K E, 1992, J Craniofac Surg, V3, P55, DOI 10.1097/00001665-199209000-00002
   SALYER KE, 1989, PLAST RECONSTR SURG, V84, P236, DOI 10.1097/00006534-198908000-00008
   SALYER KE, 1995, PLAST RECONSTR SURG, V96, P770, DOI 10.1097/00006534-199509001-00002
   SANDHU SH, 2003, SPINE, V28, pS64
   Smartt JM, 2005, PLAST RECONSTR SURG, V115, P1642, DOI 10.1097/01.PRS.0000161466.74294.1E
   Termaat MF, 2005, J BONE JOINT SURG AM, V87A, P1367, DOI 10.2106/JBJS.D.02585
   WOLFE SA, 1986, PLAST RECONSTR SURG, V77, P901
   Zins JE, 2007, PLAST RECONSTR SURG, V120, P1332, DOI 10.1097/01.prs.0000279557.29134.cd
NR 31
TC 18
Z9 19
U1 0
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0032-1052
EI 1529-4242
J9 PLAST RECONSTR SURG
JI Plast. Reconstr. Surg.
PD JAN
PY 2009
VL 123
IS 1
BP 319
EP 330
DI 10.1097/PRS.0b013e318193478c
PG 12
WC Surgery
SC Surgery
GA 392QQ
UT WOS:000262317700040
PM 19116568
DA 2018-10-19
ER

PT S
AU Wu, AHF
   Cho, KL
   Liaw, II
   Zhang, H
   Lamb, RN
AF Wu, Alex H. F.
   Cho, K. L.
   Liaw, Irving I.
   Zhang, Hua
   Lamb, Robert N.
BE Bauer, S
   Cheng, Z
   Wrobleski, DA
   Zhang, Q
TI Synthesis of Poly(Methylmethacrylate) Latex With Enhanced Rigidity
   Through Surfactant Control
SO POLYMER-BASED SMART MATERIALS - PROCESSES, PROPERTIES AND APPLICATION
SE Materials Research Society Symposium Proceedings
LA English
DT Proceedings Paper
CT Symposium on Polymer-Based Materials held at the 2008 MRS Fall Meeting
CY DEC 02-05, 2008
CL Boston, MA
SP Mat Res Soc
AB Water-based polymer latexes have attracted much attention since their invention in the early 1950s. Its advantages for both general health and the environment were recognized as they emit far less volatile organic compounds (VOCs) than their solvent-based counterparts.
   The performance of latex paints and coatings is directly proportional to the case of particle deformation. This is the main driving force for the paints and coatings industry to focus its research efforts towards understanding its mechanism.
   In contrast, little has been published with respect to enhancing latex's resistance against deformation despite Such needs in applications such as templating porous ceramics for catalysis and biomaterial engineering. Specifically, the latex's resistance to deformation is crucial to retain a network of uniform pores for applications relating to enzyme immobilization and materials reinforcement.
   The current study reports increased heat-resistance observed in latexes when synthesized using a rigid surfactant, dimethyl siloxane - ethylene oxide block copolymer (PDMS-PEO). The film formation process for this latex was deduced using atomic force microscopy and subsequent roughness analysis. A comparative study using a non-ionic long-chain hydrocarbon surfactant, morpholine oleate, was also conducted.
C1 [Wu, Alex H. F.] Univ New South Wales, Sch Chem, Sydney, NSW, Australia.
   [Cho, K. L.; Liaw, Irving I.; Zhang, Hua; Lamb, Robert N.] Univ Melbourne, Sch Chem, Melbourne, Vic, Australia.
   [Lamb, Robert N.] Australian Synchrotron Co Ltd, Clayton, Vic 3168, Australia.
RP Wu, AHF (reprint author), Univ New South Wales, Sch Chem, Sydney, NSW, Australia.
CR Guo TY, 2007, J NON-CRYST SOLIDS, V353, P2893, DOI 10.1016/j.jnoncrysol.2007.06.023
   Keddie JL, 1997, MAT SCI ENG R, V21, P101, DOI 10.1016/S0927-796X(97)00011-9
   MATTOON RW, 1947, J CHEM PHYS, V15, P209, DOI 10.1063/1.1746475
   *MILL, 2008, MILL PROD DET
   PADGET JC, 1994, J COATING TECHNOL, V66, P89
   Sivakumar M, 2002, J APPL POLYM SCI, V83, P3045, DOI 10.1002/app.10310
NR 6
TC 1
Z9 1
U1 0
U2 1
PU MATERIALS RESEARCH SOC
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 978-1-60511-106-3
J9 MATER RES SOC SYMP P
PY 2009
VL 1134
BP 109
EP +
PG 2
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Polymer Science
SC Science & Technology - Other Topics; Materials Science; Polymer Science
GA BMR07
UT WOS:000273375700017
DA 2018-10-19
ER

PT J
AU Raschip, IE
   Vasile, C
   Macocinschi, D
AF Raschip, Irina Elena
   Vasile, Cornelia
   Macocinschi, Doina
TI Compatibility and biocompatibility study of new HPC/PU blends
SO POLYMER INTERNATIONAL
LA English
DT Article
DE hydroxypropylcellulose; polyurethane; compatibility; biomedical
   applications
ID SEGMENTED POLYURETHANE ELASTOMERS; DYNAMIC MECHANICAL-PROPERTIES;
   CROSS-LINKED POLYURETHANE; HARD SEGMENT; CONTACT ANGLES;
   4,4'-DIPHENYLMETHANE DIISOCYANATE; HYDROXYPROPYL CELLULOSE; BLOOD
   COMPATIBILITY; PHYSICAL-PROPERTIES; CHEMICAL-STRUCTURE
AB BACKGROUND: Polymer blending is one of the most useful methods for the improvement or modification of the physicochernical properties of polymeric materials without altering the structure and function of individual polymers. The blends between biopolymers and synthetic polymers are of particular significance because they can combine biocompatibility with good processability and mechanical resistance and can be used as biomaterials. The aim of the blending of hydroxypropylcellulose (HPC) and polyurethane (PU) is to find applications for newly synthesized PUs and also to create new materials with possible medical applications and enhanced surface properties.
   RESULTS: Films containing mostly HPC or mostly PU are found to be homogeneous and transparent, while for the intermediate composition range a morphology of a fine dispersion in a continuous matrix is characteristic. The values of the blood - biomaterial interfacial tension (gamma(SL)) are in the range 1.96-3.27 mN m(-1), which allows us to conclude that these materials have a good haemocompatibility.
   CONCLUSION: The thermomechanical and morphological behaviour were explored and specific interactions were evident between the PU blocks and the HPC chains especially in the 60% HPC-20% HPC/40% PU-80% PU composition range because of the high degree of compatibility. The blends obtained are not cytotoxic and exhibit good surface properties and haemocompatibility. Therefore they could be candidates for medical and pharmaceutical applications. (C) 2008 Society of Chemical Industry
C1 [Raschip, Irina Elena; Vasile, Cornelia; Macocinschi, Doina] Petru Poni Inst Macromol Chem, Dept Phys Chem Polymers, Iasi 700487, Romania.
RP Raschip, IE (reprint author), Petru Poni Inst Macromol Chem, Dept Phys Chem Polymers, 41A Gr Ghica Voda Alley, Iasi 700487, Romania.
EM iecoj@icmpp.ro
RI Vasile, Cornelia/C-4194-2012; Macocinschi, Doina/C-2565-2012
CR Adhikari R, 2000, J APPL POLYM SCI, V78, P1071
   Adhikari R, 1999, J APPL POLYM SCI, V74, P2979, DOI 10.1002/(SICI)1097-4628(19991213)74:12<2979::AID-APP25>3.0.CO;2-F
   ASPLER JS, 1982, POLYMER, V23, P43, DOI 10.1016/0032-3861(82)90012-X
   Bajsic EG, 2000, J ELASTOM PLAST, V32, P162, DOI 10.1106/Q4CF-0J7G-0H93-C265
   Bicerano J., 1993, PREDICTION POLYM PRO
   Carpov A, 2000, CELL CHEM TECHNOL, V34, P455
   CASSU SN, 1997, POLYMER, V38, P3861
   Chattopadhyay DK, 2006, J POLYM SCI POL PHYS, V44, P102, DOI 10.1002/polb.20586
   Chattopadhyay DK, 2005, IND ENG CHEM RES, V44, P1772, DOI 10.1021/ie0492348
   Chattopadhyay DK, 2005, J APPL POLYM SCI, V95, P1509, DOI 10.1002/app.21494
   Chen KS, 2002, J POLYM RES-TAIWAN, V9, P119, DOI 10.1023/A:1021193901753
   Chen TK, 1998, MACROMOLECULES, V31, P1312, DOI 10.1021/ma970913m
   Chen W., 1992, ADV URETHANE SCI TEC, V11, P110
   Cheng LP, 2003, EUR POLYM J, V39, P601, DOI 10.1016/S0014-3057(02)00235-5
   Coelho JFJ, 2006, J VINYL ADDIT TECHN, V12, P156, DOI 10.1002/vnl.20088
   CognetGeorjon E, 1996, MACROMOL CHEM PHYSIC, V197, P3593, DOI 10.1002/macp.1996.021971109
   Coleman MM, 1991, SPECIFIC INTERACTION
   CRACIUNESCU O, 2007, ACTA MICROSC, V16, P15
   CRACIUNESCU O, 2007, P INT C NAN CHALK GR, P197
   DAVE V, 1995, MACROMOLECULES, V28, P3531, DOI 10.1021/ma00114a006
   Doelker E., 1993, ADV POLYM SCI, V107, P200
   EATON RF, 1976, POLYM PREPR AM CHEM, V17, P54
   ERBIL Y, 1997, CRC HDB SURFACE COLL, pCH9
   FEDORS RF, 1974, POLYM ENG SCI, V14, P472, DOI 10.1002/pen.760140611
   FEDORS RF, 1974, POLYM ENG SCI, V14, P147, DOI 10.1002/pen.760140211
   FOWKES FM, 1991, LANGMUIR, V7, P2464, DOI 10.1021/la00059a012
   Gomez-Carracedo A, 2003, J THERM ANAL CALORIM, V73, P587, DOI 10.1023/A:1025434314396
   Grassy F., 2000, POLYM SURFACES PHYS
   GRIGORIU A, 2001, B I POLITECH IASI, V1, P109
   Hatakeyama T, 2004, THERMOCHIM ACTA, V416, P29, DOI 10.1016/j.tca.2002.12.002
   Heijkants RGJC, 2005, BIOMATERIALS, V26, P4219, DOI 10.1016/j.biomaterials.2004.11.005
   HELSTAD K, 2007, FOOD HYDROCOLLOIDS, V21, P26
   *HERC INC, 1990, TECHN B HERC INC
   Huang YH, 2006, CARBOHYD POLYM, V66, P500, DOI 10.1016/j.carbpol.2006.04.001
   Ioan S, 2004, HIGH PERFORM POLYM, V16, P123, DOI 10.1177/0954008304038964
   Israelachvili JN, 1992, INTERMOLECULAR SURFA
   Jena KK, 2007, EUR POLYM J, V43, P1825, DOI 10.1016/j.eurpolymj.2007.02.042
   KAJIWARA K, 1974, MACROMOLECULES, V7, P121, DOI 10.1021/ma60037a023
   KAMBRIC HE, 1986, CHEM ENG NEWS   0414, P30
   KEIJI H, 1987, HDB POLYURETHANE RES, P299
   KYU T, 1985, MACROMOLECULES, V18, P2331, DOI 10.1021/ma00153a053
   Lupu M, 2007, POLYM INT, V56, P389, DOI 10.1002/pi.2163
   Martin DJ, 1997, J APPL POLYM SCI, V64, P803, DOI 10.1002/(SICI)1097-4628(19970425)64:4<803::AID-APP20>3.0.CO;2-T
   MILLER JA, 1985, MACROMOLECULES, V18, P32, DOI 10.1021/ma00143a005
   Mishra AK, 2006, J APPL POLYM SCI, V102, P3158, DOI 10.1002/app.24343
   Monteiro OAC, 1999, INT J BIOL MACROMOL, V26, P119, DOI 10.1016/S0141-8130(99)00068-9
   Nyamweya N, 2000, PHARMACEUT RES, V17, P625, DOI 10.1023/A:1007585403781
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   PAIKSUNG CS, 1980, MACROMOLECULES, V13, P117, DOI 10.1021/ma60073a023
   Park JS, 2001, POLYMER, V42, P4271, DOI 10.1016/S0032-3861(00)00768-0
   PETROVIC ZS, 1985, RUBBER CHEM TECHNOL, V58, P685, DOI 10.5254/1.3536086
   Rabel W., 1977, Physikalische Blaetter, V33, P151
   RASCHIP IE, 2006, NEW TRENDS NATURAL S, P69
   RIALS TG, 1988, J APPL POLYM SCI, V36, P749, DOI 10.1002/app.1988.070360402
   RUCKENSTEIN E, 1984, J COLLOID INTERF SCI, V101, P436, DOI 10.1016/0021-9797(84)90055-9
   SAKELLARIOU P, 1995, PROG POLYM SCI, V20, P889, DOI 10.1016/0079-6700(95)00008-4
   Seydibeyoglu MO, 2008, COMPOS SCI TECHNOL, V68, P908, DOI 10.1016/j.compscitech.2007.08.008
   Sivakumar M, 2000, J MEMBRANE SCI, V169, P215, DOI 10.1016/S0376-7388(99)00339-7
   Solis-Correa RE, 2007, J BIOMAT SCI-POLYM E, V18, P561, DOI 10.1163/156856207780852488
   STROM G, 1987, J COLLOID INTERF SCI, V119, P352, DOI 10.1016/0021-9797(87)90280-3
   SUTO S, 1986, J APPL POLYM SCI, V31, P1327, DOI 10.1002/app.1986.070310517
   SZYCHER M, 1983, ELASTOMERICS, V3, P11
   TAKAHARA A, 1985, POLYMER, V26, P978, DOI 10.1016/0032-3861(85)90217-4
   Tanaka T, 1999, POLYM INT, V48, P811, DOI 10.1002/(SICI)1097-0126(199909)48:9<811::AID-PI221>3.0.CO;2-V
   Tsai YM, 1998, POLYM INT, V47, P445, DOI 10.1002/(SICI)1097-0126(199812)47:4<445::AID-PI82>3.0.CO;2-B
   Utracki L., 1989, POLYM ALLOYS BLENDS
   Van Krevelen D.W., 1990, PROPERTIES POLYM
   VANOSS CJ, 1988, LANGMUIR, V4, P884, DOI 10.1021/la00082a018
   Vasile C., 2003, HDB POLYM BLENDS COM
   Vega-Baudrit J, 2007, INT J ADHES ADHES, V27, P469, DOI 10.1016/j.ijadhadh.2006.08.001
   WANG CB, 1983, MACROMOLECULES, V16, P775, DOI 10.1021/ma00239a014
   YAMASHITA S, 1989, RUBBER WORLD, V6, P21
NR 72
TC 13
Z9 14
U1 1
U2 25
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 0959-8103
J9 POLYM INT
JI Polym. Int.
PD JAN
PY 2009
VL 58
IS 1
BP 4
EP 16
DI 10.1002/pi.2468
PG 13
WC Polymer Science
SC Polymer Science
GA 391CZ
UT WOS:000262212200002
DA 2018-10-19
ER

PT J
AU Nasreen, Z
   Khan, RA
   Khan, MA
   Mustafa, AI
AF Nasreen, Zinia
   Khan, Ruhul A.
   Khan, Mubarak A.
   Mustafa, A. I.
TI Preparation and Characterization of Chitosan Coated Surgical Gauze Using
   Potassium Persulfate as Thermal Initiator
SO POLYMER-PLASTICS TECHNOLOGY AND ENGINEERING
LA English
DT Article
DE Biomaterial; Chitin; Chitosan; Coating; Surgical gauze
ID GRAFT-COPOLYMERIZATION; BACTERIAL CELLULOSE; ACETOBACTER-XYLINUM;
   DERIVATIVES; CHITIN; FILMS; MONOMERS; COTTON; FIBER; ACID
AB Chitosan powder was extracted from prawn shell via chitin formation by chemical treatment. Chitosan solution (2wt.%) was prepared in aqueous solution containing ethanoic acid (2wt.%) along with varying amounts of potassium persulphate as thermal initiator (10 to 50mg). Surgical gauze was immersed in the chitosan solution for 10-45min. Coating was carried out at 70-110C and heating time varied from 30-180min. Chitosan uptake and the mechanical properties of the chitosan coated surgical gauze, such as tensile strength (TS) and elongation at break (Eb), were measured. Soaking time, curing time, and curing temperature of the surgical gauze were optimized for the preparation of coated gauze over chitosan uptake and mechanical properties. Surgical gauze soaked for 20min at 90C for 120min of curing showed the highest chitosan uptake and TS (9MPa). Soil burial tests revealed that coated gauze became twisted and almost degraded within 6 weeks of ageing. Water uptake properties of the coated gauze were monitored. Scanning electron microscopic analysis of the surface of the coated gauze found that the coating of chitosan became brittle with the use of higher amounts (50mg) of thermal initiator.
C1 [Khan, Ruhul A.; Khan, Mubarak A.] Bangladesh Atom Energy Commiss, Inst Nucl Sci & Technol, Radiat & Polymer Chem Lab, Dhaka 1000, Bangladesh.
   [Nasreen, Zinia] Dhaka Univ Engn & Technol, Dept Chem, Dhaka, Bangladesh.
   [Mustafa, A. I.] Univ Dhaka, Dept Appl Chem & Chem Technol, Dhaka 1000, Bangladesh.
RP Khan, MA (reprint author), Bangladesh Atom Energy Commiss, Inst Nucl Sci & Technol, Radiat & Polymer Chem Lab, POB 3787, Dhaka 1000, Bangladesh.
EM makhan.inst@gmail.com
CR AIBA S, 1989, INT J BIOL MACROMOL, V11, P249, DOI 10.1016/0141-8130(89)90077-9
   Caner C, 2007, J SCI FOOD AGR, V87, P227, DOI 10.1002/jsfa.2698
   Don TM, 2001, J POLYM SCI POL CHEM, V39, P1646, DOI 10.1002/pola.1142
   Don TM, 2002, J APPL POLYM SCI, V86, P3057, DOI 10.1002/app.11329
   Ferdous S, 2003, J MACROMOL SCI PURE, VA40, P817, DOI 10.1081/MA-120022273
   Gurdag G, 2001, J APPL POLYM SCI, V80, P2267, DOI 10.1002/app.1331
   Haque P, 2007, CARBOHYD POLYM, V68, P109, DOI 10.1016/j.carbpol.2006.07.020
   Haque P, 2005, NUCL INSTRUM METH B, V236, P314, DOI 10.1016/j.nimb.2005.03.267
   HIRANO S, 2001, J CARBO POLYM, V41, P175
   Hirano S., 1996, BIOTECHNOLOGY ANN RE, V2, P235
   Khan F, 1997, J APPL POLYM SCI, V65, P459, DOI 10.1002/(SICI)1097-4628(19970718)65:3<459::AID-APP5>3.0.CO;2-G
   KHAN MA, 1998, INST33NRCD8
   Kittur FS, 2002, CARBOHYD POLYM, V49, P185, DOI 10.1016/S0144-8617(01)00320-4
   Li JJ, 2007, BIOMATERIALS, V28, P781, DOI 10.1016/j.biomaterials.2006.09.042
   Liu XD, 2001, CARBOHYD POLYM, V44, P233, DOI 10.1016/S0144-8617(00)00206-X
   MATHUR NK, 1990, J CHEM EDUC, V67, P938, DOI 10.1021/ed067p938
   Najjar AMK, 2000, J APPL POLYM SCI, V77, P2314, DOI 10.1002/1097-4628(20000906)77:10<2314::AID-APP25>3.0.CO;2-7
   OGAWA R, 1991, SEN-I GAKKAISHI, V47, P456
   OKEILABOU A, 2007, J APPL POLYM SCI, V103, P2021
   Omura Y, 2003, POLYM ADVAN TECHNOL, V14, P35, DOI 10.1002/pat.295
   Qin YM, 2008, J APPL POLYM SCI, V107, P993, DOI 10.1002/app.27183
   Ravi Kumar Majeti N. V., 2000, REACTIVE FUNCTIONAL, V46, P1
   Roberts G, 1992, CHITIN CHEM
   Sakairi N, 1998, CARBOHYD POLYM, V35, P233, DOI 10.1016/S0144-8617(97)00135-5
   SEO H, 1993, KINOU ZAIRYO, V13, P25
   SHIGEMASA Y, 1995, BIOTECHNOL GENET ENG, V13, P383
   Shin H, 1998, SEN-I GAKKAISHI, V54, P400, DOI 10.2115/fiber.54.8_400
   SHIN Y, 1994, HANGUK SAMYU KONGHAK, V31, P583
   Shirai A, 1997, CARBOHYD POLYM, V32, P223, DOI 10.1016/S0144-8617(97)00009-X
   Srinivasa PC, 2007, J FOOD ENG, V80, P184, DOI 10.1016/j.jfoodeng.2006.05.007
   Sugimoto M, 1998, CARBOHYD POLYM, V36, P49, DOI 10.1016/S0144-8617(97)00235-X
   Xu HT, 2007, POLYM ADVAN TECHNOL, V18, P869, DOI 10.1002/pat.906
NR 32
TC 3
Z9 3
U1 1
U2 5
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 0360-2559
J9 POLYM-PLAST TECHNOL
JI Polym.-Plast. Technol. Eng.
PY 2009
VL 48
IS 2
BP 121
EP 129
AR PII 908029761
DI 10.1080/03602550802539957
PG 9
WC Polymer Science
SC Polymer Science
GA 397EA
UT WOS:000262644000002
DA 2018-10-19
ER

PT S
AU Sane, P
   Kilpelainen, S
   Tuomisto, F
AF Sane, Petri
   Kilpelainen, Simo
   Tuomisto, Filip
BE Wang, SJ
   Chen, ZQ
   Wang, B
   Jean, YC
TI 4-channel digital positron lifetime spectrometer for studying biological
   samples
SO POSITRON AND POSITRONIUM CHEMISTRY
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 9th International Workshop on Positron and Positronium Chemistry
CY MAY 11-15, 2008
CL Wuhan Univ, Wuhan, PEOPLES R CHINA
SP Hubei Provincial Govt, Chinese Nucl Phys Soc, Natl Nat Sci Fdn China, Adv Measurement Technol Inc
HO Wuhan Univ
DE Digital positron lifetime measurement; 4-channel detector setup;
   Biomaterial
AB In this work a novel detector setup for PALS-studies on biomolecular materials is presented. When pursuing optimal detecting efficiency and lifetime component resolution one must make compromises when using only one detector pair. With smaller scintillation heads the resolution is higher, but the detecting efficiency decreases and vice versa. When measuring biological materials that do not withstand long measurement periods, sacrifices are made for gaining efficiency. The price of this optimization is low resolution of the lifetime components, namely separating the always present water's lifetime component of similar to 1.8 ns from the actual material's lifetime component, typically >2 ns. A solution to this problem is measuring the annihilation spectra with two individual detector pairs simultaneously. Using analog setup, it would require duplicate ADC-hardware that are both expensive and degrade by time. With a fully digital setup, the need for hardware is smaller and the precision of the setup is constant during its service life.
C1 [Sane, Petri; Kilpelainen, Simo; Tuomisto, Filip] Helsinki Univ Technol, Dept Engn Phys, Helsinki 02015, Finland.
RP Sane, P (reprint author), Helsinki Univ Technol, Dept Engn Phys, Otakaari 1M, Helsinki 02015, Finland.
EM petri.sane@tkk.fi
RI Tuomisto, Filip/B-8189-2008
OI Tuomisto, Filip/0000-0002-6913-5654
CR AAVIKKO R, 2006, THESIS HELSINKI U TE
   Mogensen O. E., 1995, POSITRON ANNIHILATIO
   Nissila J, 2005, NUCL INSTRUM METH A, V538, P778, DOI 10.1016/j.nima.2004.08.102
   Rytsola K, 2002, APPL SURF SCI, V194, P260, DOI 10.1016/S0169-4332(02)00128-9
   Saito H, 2002, NUCL INSTRUM METH A, V487, P612, DOI 10.1016/S0168-9002(01)02172-6
   SHUKLA A, 1993, NUCL INSTRUM METH A, V335, P310, DOI 10.1016/0168-9002(93)90286-Q
NR 6
TC 4
Z9 4
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2009
VL 607
BP 254
EP 256
DI 10.4028/www.scientific.net/MSF.607.254
PG 3
WC Materials Science, Multidisciplinary; Physics, Atomic, Molecular &
   Chemical
SC Materials Science; Physics
GA BJC57
UT WOS:000264749800071
DA 2018-10-19
ER

PT S
AU Kadau, D
   Herrmann, HJ
   Andrade, JS
AF Kadau, Dirk
   Herrmann, Hans J.
   Andrade, Jose S., Jr.
BE Nakagawa, M
   Luding, S
TI Mechanical behavior of "living quicksand": Simulation and Experiment
SO POWDERS AND GRAINS 2009
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT 6th International Conference on the Micromechanics of Granular Media
CY JUL 13-17, 2009
CL Golden, CO
SP Assoc Study Micromech Granular Media, Univ Twente, Colorado Sch Mines
DE Granular matter; Contact Dynamics Simulations; Distinct Element Method;
   Quicksand; Collapsible soil; Biomaterial
AB The nature and danger of quicksand has been disputed since a long time. Despite widespread belief that humans can be swallowed or even sucked in, engineers of soil mechanics have typically asserted that, since the density of sludge is larger than that of water, a person cannot fully submerge.
   We investigated a specific type of quicksand at the shore of drying lagoons. Cyanobacteria form an impermeable crust, giving the impression of stable ground. After breaking the crust a person rapidly sinks to the bottom of the field. We measured the shear strength of the material before and after perturbation and found a drastic change. The initial structure cannot be restored once it had collapsed, i.e. the material investigated shows a strong memory effect.
   We simulated a model for this type of quicksand in which we constructed a tenuous granular structure representing the unperturbed soil. The initial structure consists of cohesive disks put together by ballistic deposition and settled by gravity using Contact Dynamics. We study the material behavior by determining the shear strength of the model material and by penetration tests, i.e. pushing in an object, which leads to breaking of cohesive bonds. We investigate how deep the object can be pushed in and how well the intruder is captured by the material after it collapsed above the intruder. During the penetration process we measured the relation between the driving force and the resulting velocity of the intruder.
C1 [Kadau, Dirk; Herrmann, Hans J.; Andrade, Jose S., Jr.] ETH, Inst Bldg Mat, CH-8093 Zurich, Switzerland.
RP Kadau, D (reprint author), ETH, Inst Bldg Mat, CH-8093 Zurich, Switzerland.
RI Kadau, Dirk/B-4697-2010
CR [Anonymous], 1984, SCI DIGEST, V92, P20
   Bahlmann L, 2002, RESUSCITATION, V53, P101, DOI 10.1016/S0300-9572(02)00009-6
   CLAYTON CRI, 1995, SITE INVESTIGATION, P38001
   CRAIG RF, 1997, SOIL MECH, P38001
   DANIN A, 1978, FLORA, V167, P409
   DANIN A, 1991, J ARID ENV, V21, P38001
   ELSHAMY U, 2005, ENG MECH, P413
   Freundlich H, 1935, T FARADAY SOC, V31, P0769, DOI 10.1039/tf9353100769
   HUERTA DA, 2005, PHYS REV E, V729, P8001
   JEAN M, 1992, CONTACT MECHANICS : INTERNATIONAL SYMPOSIUM, PROCEEDINGS, P31
   Kadau D, 2003, PHASE TRANSIT, V76, P315, DOI 10.1080/0141159021000051460
   KADAU D, 2009, GRANULAR MA IN PRESS, P38001
   Khaldoun A, 2005, NATURE, V437, P635, DOI 10.1038/437635a
   Kruszelnicki K, 1996, NEW SCI, V152, P26
   LAMBE TW, 1969, SOIL MECH, P38001
   Lohse D, 2004, NATURE, V432, P689, DOI 10.1038/432689a
   Matthes G. H, 1953, SCI AM, V188, P97
   MOREAU JJ, 1994, EUR J MECH A-SOLID, V13, P93
   PARKER WR, 1966, NATURE, P38001
   Schwammle V, 2003, NATURE, V426, P619, DOI 10.1038/426619a
   Smith E. R, 1946, OHIO J SCI, V46, P327
   Yamasaki S, 2003, SCI AM, V288, P95
NR 22
TC 2
Z9 2
U1 0
U2 0
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-0682-7
J9 AIP CONF PROC
PY 2009
VL 1145
BP 981
EP 984
PG 4
WC Materials Science, Multidisciplinary; Mechanics
SC Materials Science; Mechanics
GA BLN80
UT WOS:000270602900223
DA 2018-10-19
ER

PT B
AU Tang, Q
   Yu, JR
   Chen, L
   Zhu, J
   Hu, ZM
AF Tang Qi
   Yu Junrong
   Chen Lei
   Zhu Jing
   Hu Zuming
GP ICAFPM
TI Preparation of hydroxyl terminated poly (dimethyl siloxane) (PDMS) open
   networks and its IPN system with poly (2-hydroxyethyl methacrylate)
   (PHEMA)
SO PROCEEDINGS OF 2009 INTERNATIONAL CONFERENCE ON ADVANCED FIBERS AND
   POLYMER MATERIALS, VOLS 1 AND 2
LA English
DT Proceedings Paper
CT International Conference on Advanced Fibers and Polymer Materials
CY OCT 21-24, 2009
CL Shanghai, PEOPLES R CHINA
SP Minist Educ China, Nat Sci Fdn China
DE poly (dimethylsiloxane); poly (2-hydroxyethyl methacrylate); IPNs;
   hydrogel content
ID SILICONE-RUBBER-HYDROGEL; POLYMERIC BIOMATERIALS; SURFACE; COMPOSITES;
   MULTIBLOCK; COPOLYMERS; HEMA
AB Poly (dimethyl siloxane) (PDMS) has been widely used as a biomaterial due to its good compatibility, high mechanical strength, excellent oxygen permeability and ease of fabrication. However, modifications with hydrophilic functional groups or polymers are necessary to improve its surface wettability and water permeability for more extensive use such as drug delivery and long-term implantation. In the current work, interpenetrating polymer networks (IPNs) of hydroxyl terminated PDMS and poly (2-hydroxyethyl methacrylate) (PHEMA) were prepared by monomer immersion method and influencing factors on hydrogel content were investigated. Improved surface wettability and swelling ability suggested the hydrogel component were present on the surface as well as in the bulk material. Hydrogel content in the IPN system can be optimized by addition of solvent during both PDMS curing procedure and subsequent hydrogel incorporation step for better water permeability.
C1 [Tang Qi; Yu Junrong; Chen Lei; Zhu Jing; Hu Zuming] Donghua Univ, Coll Mat Sci & Engn, Shanghai 201620, Peoples R China.
RP Hu, ZM (reprint author), Donghua Univ, Coll Mat Sci & Engn, Shanghai 201620, Peoples R China.
EM hzm@dhu.edu.com.cn
CR Abbasi F, 2003, J POLYM SCI POL PHYS, V41, P2145, DOI 10.1002/polb.10559
   Abbasi F, 2002, J APPL POLYM SCI, V86, P3480, DOI 10.1002/app.10774
   Abbasi F, 2002, J APPL POLYM SCI, V85, P1825, DOI 10.1002/app.10609
   CHEN X, 1993, MACROMOLECULES, V26, P3778, DOI 10.1021/ma00067a009
   Hron P, 1997, BIOMATERIALS, V18, P1069, DOI 10.1016/S0142-9612(97)00039-2
   HSIUE GH, 1994, BIOMATERIALS, V15, P163
   Khorasani MT, 1999, RADIAT PHYS CHEM, V55, P685, DOI 10.1016/S0969-806X(99)00212-1
   Liu L, 2005, BIOMATERIALS, V26, P233, DOI 10.1016/j.biomaterials.2004.02.025
   LOPOUR P, 1995, BIOMATERIALS, V16, P633, DOI 10.1016/0142-9612(95)93861-7
   Senshu K, 1997, MACROMOLECULES, V30, P4421, DOI 10.1021/ma9616219
   TEZUKA Y, 1995, MACROMOLECULES, V28, P8251, DOI 10.1021/ma00128a040
NR 11
TC 0
Z9 0
U1 0
U2 12
PU CHEMICAL INDUSTRY PRESS
PI BEIJING
PA NO. 3 HUIXINLI CHAOYANGQU, BEIJING 100029, PEOPLES R CHINA
BN 978-7-122-06787-6
PY 2009
BP 252
EP 254
PG 3
WC Materials Science, Multidisciplinary; Materials Science, Textiles;
   Polymer Science
SC Materials Science; Polymer Science
GA BUG55
UT WOS:000289224100077
DA 2018-10-19
ER

PT B
AU Yang, YQ
AF Yang Yiqi
GP ICAFPM
TI Some protein fibers from bioenergy crops
SO PROCEEDINGS OF 2009 INTERNATIONAL CONFERENCE ON ADVANCED FIBERS AND
   POLYMER MATERIALS, VOLS 1 AND 2
LA English
DT Proceedings Paper
CT International Conference on Advanced Fibers and Polymer Materials
CY OCT 21-24, 2009
CL Shanghai, PEOPLES R CHINA
SP Minist Educ China, Nat Sci Fdn China
AB We report the development of protein fibers from some energy crops and the application of these fibers as tissue engineering scaffolds. Corn, soybean and wheat are three of the major crops for bioenergy productions. After the use of carbohydrates and oils from these crops for bioenergy, large quantity of the protein rich co-products or by-products remains to be used to decrease the cost of bioenergy production and increase the value of the crops. Currently, the main application of the remaining materials after energy production is as animal feeds. Our efforts are on using the proteins from these materials to make fibers for various purposes. We will present the formation, characterization, modification and application of these protein fibers. Our results show that some protein fibers from these energy crops have mechanical properties similar to wool and cytocompatibility better than PLA fibers, a common biomaterial for tissue engineering.
C1 Univ Nebraska, Dept Text Clothing & Design, Lincoln, NE 68583 USA.
RP Yang, YQ (reprint author), Univ Nebraska, Dept Text Clothing & Design, 234 HECO Bldg, Lincoln, NE 68583 USA.
EM yyang2@unl.edu
NR 0
TC 0
Z9 0
U1 0
U2 0
PU CHEMICAL INDUSTRY PRESS
PI BEIJING
PA NO. 3 HUIXINLI CHAOYANGQU, BEIJING 100029, PEOPLES R CHINA
BN 978-7-122-06787-6
PY 2009
BP 559
EP 559
PG 1
WC Materials Science, Multidisciplinary; Materials Science, Textiles;
   Polymer Science
SC Materials Science; Polymer Science
GA BUG55
UT WOS:000289224100167
DA 2018-10-19
ER

PT B
AU Liu, XY
AF Liu Xiangyang
GP ICAFPM
TI From Structure to Mechanical Properties of Spider Silk: Surviving from
   Severe Collision
SO PROCEEDINGS OF 2009 INTERNATIONAL CONFERENCE ON ADVANCED FIBERS AND
   POLYMER MATERIALS, VOLS 1 AND 2
LA English
DT Proceedings Paper
CT International Conference on Advanced Fibers and Polymer Materials
CY OCT 21-24, 2009
CL Shanghai, PEOPLES R CHINA
SP Minist Educ China, Nat Sci Fdn China
AB Spiders and silkworms, the two major sources of silk in nature, have developed the capacity by evolution to spin silk independently, however their fibers have distinct mechanical properties. Spider dragline silk, the main structural web silk, is exceptionally strong and extensible. Its toughness is far superior to that of commercial polyaramid filaments which are used in materials for bulletproof vests and reinforced composites for aircraft panels. As a remarkable biomaterial that has been optimized by millions of years of evolution, spider dragline silk is not only extremely light and strong, but also displays the function of adsorbing the energy of a severe collision. The property of stretch-hardening of spider silk plays an important role in capturing flying insects. It is observed that the spider web can snag a bee flying at 30 km/hour without breaking. However, such a severe collision to the web could knock down the spider from the web if the silk fibers are rigid. On the other hand, the property of stretch-hardening makes spider silk can dissipate the shocking energy quickly, and effectively prevents a drastic impact to the web. Our results show that compared to silkworm silk, spider dragline can acquire extra toughness as a stretch-hardening material. In contract to spider dragline silk, the silkworm silk from a cocoon shell layer is meant to protect the moth pupa against any possible external attack. Therefore, the property of stretch-hardening is not required for the silkworm silk fiber. In this talk, I will discuss the structures leading to the different properties of spider silk and silkworm silk.
C1 Natl Univ Singapore, Fac Sci, Dept Phys, Biophys & Micro Nanostruct Lab, Singapore 117542, Singapore.
RP Liu, XY (reprint author), Natl Univ Singapore, Fac Sci, Dept Phys, Biophys & Micro Nanostruct Lab, Singapore 117542, Singapore.
EM phyliuxy@nus.edu.sg
RI Zhou, Weiqian/B-8991-2011; Liu, XY/E-5090-2010
NR 0
TC 0
Z9 0
U1 1
U2 10
PU CHEMICAL INDUSTRY PRESS
PI BEIJING
PA NO. 3 HUIXINLI CHAOYANGQU, BEIJING 100029, PEOPLES R CHINA
BN 978-7-122-06787-6
PY 2009
BP 839
EP 839
PG 1
WC Materials Science, Multidisciplinary; Materials Science, Textiles;
   Polymer Science
SC Materials Science; Polymer Science
GA BUG55
UT WOS:000289224100247
DA 2018-10-19
ER

PT B
AU Zou, M
   Hong, F
AF Zou Min
   Hong Feng
GP ICAFPM
TI Preparation of bacterial cellulose pellets as carriers for laccase
   immobilization
SO PROCEEDINGS OF 2009 INTERNATIONAL CONFERENCE ON ADVANCED FIBERS AND
   POLYMER MATERIALS, VOLS 1 AND 2
LA English
DT Proceedings Paper
CT International Conference on Advanced Fibers and Polymer Materials
CY OCT 21-24, 2009
CL Shanghai, PEOPLES R CHINA
SP Minist Educ China, Nat Sci Fdn China
DE bacterial cellulose pellets; laccase; adsorption; immobilization
AB Bacterial cellulose (BC) is pure cellulose synthesized by some bacteria. However, the application of BC pellets in enzyme immobilization was rarely reported. The form of BC is usually membrane prepared by static cultivation traditionally. In the present research, a kind of bacterial cellulose beads, the particle size of which ranges from 8 to 10 mm, were prepared. After alkali treatment and freeze-drying, the pellets were used for laccase immobilization by adsorption. The properties of immobilized enzyme were characterized. The results showed that the immobilized laccase exhibited the maximal activity at pH 3.5 and the reaction temperature was 60 degrees C. Compared with free enzyme, the pH and thermal stabilities of the enzyme were increased after the immobilization. Therefore, bacterial cellulose pellets are practical and potential biomaterial carriers in enzyme engineering.
C1 [Zou Min; Hong Feng] Donghua Univ, Inst Biol Sci & Biotechnol, Grp Microbiol Engn & Ind Biotechnol, Shanghai 201620, Peoples R China.
RP Hong, F (reprint author), Donghua Univ, Inst Biol Sci & Biotechnol, Grp Microbiol Engn & Ind Biotechnol, Shanghai 201620, Peoples R China.
EM fhong@dhu.edu.cn
RI Hong, Feng/D-3878-2017
OI Hong, Feng/0000-0001-5120-3519
CR Cheng HP, 2002, BIOTECHNOL APPL BIOC, V35, P125, DOI 10.1042/BA20010066
   COUTO SR, 2006, BIOTECHNOL MOL BIOL, V1, P117
   DING Z, 2006, CHINA BREWING, P9
   EVANS BR, 2003, J BIOS BIOE, V18, P917
   Hong F, 2002, BIOTECHNOL BIOENG, V79, P438, DOI 10.1002/bit.10297
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   Sheng C.W., 2008, J MOL CATAL B-ENZYM, V54, P103
   Valla Svein, 2009, P43
   Xu F, 2007, MODERN BIOOXIDATION, P43, DOI DOI 10.1002/9783527611522.CH2
NR 9
TC 0
Z9 0
U1 2
U2 6
PU CHEMICAL INDUSTRY PRESS
PI BEIJING
PA NO. 3 HUIXINLI CHAOYANGQU, BEIJING 100029, PEOPLES R CHINA
BN 978-7-122-06787-6
PY 2009
BP 1162
EP 1164
PG 3
WC Materials Science, Multidisciplinary; Materials Science, Textiles;
   Polymer Science
SC Materials Science; Polymer Science
GA BUG55
UT WOS:000289224100347
DA 2018-10-19
ER

PT B
AU Pezzotti, G
   Tibuzzi, A
   Lavecchia, T
   Rea, G
   Giardi, MT
AF Pezzotti, G.
   Tibuzzi, A.
   Lavecchia, T.
   Rea, G.
   Giardi, M. T.
BE DiNatale, C
   DAmico, A
   Martinelli, E
   Paolesse, R
TI PORTABLE BIO-AMPEROMETER FOR PHOTOACTIVE BIOMATERIAL MONITORING
SO PROCEEDINGS OF THE 13TH ITALIAN CONFERENCE ON SENSORS AND MICROSYSTEMS
LA English
DT Proceedings Paper
CT 13th Italian Conference on Sensors and Microsystems
CY FEB 19-21, 2008
CL Rome, ITALY
ID PHOTOSYSTEM-II; HERBICIDES; BIOSENSOR
AB A portable multifunction amperometric transducer for monitoring bioactive material has been designed, manufactured and tested. It has been specifically designed to operate with a wide range of photoactive biosamples. Each of the two sensing cells in the instrument features two different LED optical sources to detect the photosynthetical activity of plants (i.e. spinacia oleracea) and microrganisms (i.e. algae and cyanobacteria). Target applications belong to the agro-food, pharmaceutical and biomedical fields. In this work experimental determination of common water pollutants is reported by testing water samples of the river Tevere.
C1 [Pezzotti, G.; Tibuzzi, A.; Lavecchia, T.] Biosensor Srl, Vle Tivoli Km 18-642, I-00018 Rome, Italy.
   [Rea, G.; Giardi, M. T.] CNR, IC, Res Area Rome, I-00016 Monterotondo, Italy.
RP Pezzotti, G (reprint author), Biosensor Srl, Vle Tivoli Km 18-642, I-00018 Rome, Italy.
CR Koblizek M, 2002, BIOTECHNOL BIOENG, V78, P110, DOI 10.1002/bit.10190
   Malhotra BD, 2003, SENSOR ACTUAT B-CHEM, V91, P117, DOI 10.1016/S0925-4005(03)00075-3
   Touloupakis E, 2005, BIOSENS BIOELECTRON, V20, P1984, DOI 10.1016/j.bios.2004.08.035
   Vikas Anjum, 2007, SENSORS TRANSDUCERS, V76, P935
NR 4
TC 0
Z9 0
U1 1
U2 1
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA PO BOX 128 FARRER RD, SINGAPORE 9128, SINGAPORE
BN 978-981-283-597-0
PY 2009
BP 99
EP +
PG 2
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology;
   Remote Sensing
SC Engineering; Science & Technology - Other Topics; Remote Sensing
GA BIY69
UT WOS:000263783800018
DA 2018-10-19
ER

PT S
AU Jia, H
   Jia, YY
   Wang, J
   Hu, Y
   Zhang, Y
   Jia, SR
AF Jia Hui
   Jia Yuanyuan
   Wang Jiao
   Hu Yuan
   Zhang Yuan
   Jia Shiru
BE Shi, R
   Fu, WJ
   Wang, YQ
   Wang, HB
TI Potentiality of Bacterial Cellulose as the Scaffold of Tissue
   Engineering of Cornea
SO PROCEEDINGS OF THE 2009 2ND INTERNATIONAL CONFERENCE ON BIOMEDICAL
   ENGINEERING AND INFORMATICS, VOLS 1-4
SE International Conference on Biomedical Engineering and Informatics
LA English
DT Proceedings Paper
CT 2nd International Conference on Biomedical Engineering and Informatics
   (BMEI)
CY OCT 17-19, 2009
CL Tianjin Univ Technol, Tianjin, PEOPLES R CHINA
SP IEEE Engn Med & Biol Soc
HO Tianjin Univ Technol
DE Bacterial cellulose; Cornea; Tissue engineering; Scaffold; Corneal
   stromal cells
ID MECHANICAL-PROPERTIES; MICROBIAL CELLULOSE
AB The bacterial cellulose (BC) secreted by Gluconacetobacter xylinus was explored as a novel scaffold material due to its unusual biocompatibility, light transmittance and material properties. The specific surface area of the frozen-dried BC sheet based on BET isotherm was 22.886 m(2)/g, and the porosity was around 90%. It is known by SEM graphs that significant difference in porosity and pore size exists in the two sides of air-dried BC sheets. The width of cellulose ribbons was 10 nm to 100 nm known by AFM image. The examination of the growth of human corneal stromal cells on BC demonstrated that the material supported the growth and proliferation of human corneal stromal cells. The ingrowth of corneal stromal cells into the scaffold was verified by Laser Scanning Confocal Microscope. The results suggest the potentiality for this biomaterial as a scaffold for tissue engineering of artificial cornea.
C1 [Jia Hui; Wang Jiao] Jilin Univ, Affiliated Hosp 1, Changchun 130031, Jilin Province, Peoples R China.
   [Jia Yuanyuan; Jia Shiru] Tianjin Univ Sci & Technol, key Lab Ind Microbiol, Tianjin 300457, Peoples R China.
   [Hu Yuan] Southern Med Univ, Shenzhen 510515, Peoples R China.
   [Zhang Yuan] Ehime Univ, Matsuyama, Ehime 790, Japan.
RP Jia, H (reprint author), Jilin Univ, Affiliated Hosp 1, Changchun 130031, Jilin Province, Peoples R China.
EM jiahui515@yahoo.com.cn
FU Science and Technology Agency of Jilin Province for the financial
   support [20010407]; China Ministry of Science and Technology is
   appreciated for the support of Major State Basic Research Development
   [2007CB714305]; Tianjin University of Science and Technology [20070443]
FX The authors wish to acknowledge the Science and Technology Agency of
   Jilin Province for the financial support of Project No. 20010407. China
   Ministry of Science and Technology is appreciated for the support of
   Major State Basic Research Development Program (No. 2007CB714305). The
   paper is supported by Tianjin University of Science and Technology under
   Contract No. 20070443 as well.
CR Backdahl H, 2006, BIOMATERIALS, V27, P2141, DOI 10.1016/j.biomaterials.2005.10.026
   BROWN RM, 1989, Patent No. 8912107
   Choi YJ, 2004, J CHEM TECHNOL BIOT, V79, P79, DOI 10.1002/jctb.942
   Cienchanska D., 2004, FIBRES TEXT EAST EUR, V12, P69
   Czaja W, 2006, BIOMATERIALS, V27, P145, DOI 10.1016/j.biomaterials.2005.07.035
   HAMLYN PF, 1997, Patent No. 2314856
   Helenius G, 2006, J BIOMED MATER RES A, V76A, P431, DOI 10.1002/jbm.a.30570
   JIA YY, 2008, P 2 INT PAP ENV C TI, P977
   Jonas R, 1998, POLYM DEGRAD STABIL, V59, P101, DOI 10.1016/S0141-3910(97)00197-3
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   Klemm D., 1999, POLYM NEWS, V24, P377
   Legeza VI, 2004, B EXP BIOL MED+, V138, P311
   MIRANDA BT, 1965, NATL APPL SCI B U PH, V19, P67
   NISHI Y, 1990, J MATER SCI, V25, P2997, DOI 10.1007/BF00584917
   Nogi M, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2146056
   Shah J, 2005, APPL MICROBIOL BIOT, V66, P352, DOI 10.1007/s00253-004-1756-6
   Shoda M, 2005, BIOTECHNOL BIOPROC E, V10, P1, DOI 10.1007/BF02931175
   Sokolnicki AM, 2006, J MEMBRANE SCI, V272, P15, DOI 10.1016/j.memsci.2005.06.065
   Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049
   Wan WK, 2006, ACS SYM SER, V938, P221
   Wan W. K., 2005, US Patent, Patent No. [2005037082, US 2,005,037,082]
   WATANABE K, 1993, CYTOTECHNOLOGY, V13, P107, DOI 10.1007/BF00749937
   Yano H, 2005, ADV MATER, V17, P153, DOI 10.1002/adma.200400597
   2006, APPL SURF SCI, V252, P6360
NR 24
TC 0
Z9 0
U1 1
U2 3
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1948-2914
BN 978-1-4244-4133-4
J9 INT CONF BIOMED
PY 2009
BP 1138
EP +
PG 3
WC Computer Science, Artificial Intelligence; Computer Science,
   Interdisciplinary Applications; Computer Science, Theory & Methods;
   Engineering, Biomedical; Engineering, Electrical & Electronic
SC Computer Science; Engineering
GA BNP62
UT WOS:000275179901004
DA 2018-10-19
ER

PT B
AU Golan, S
   Elata, D
   Dinnar, U
AF Golan, S.
   Elata, D.
   Dinnar, U.
GP ASME
TI EXTRACTING THE ELASTIC MODULUS OF COMPLIANT MATERIALS USING A NOVEL
   PLATE BULGE TESTING TECHNIQUE
SO PROCEEDINGS OF THE 9TH BIENNIAL CONFERENCE ON ENGINEERING SYSTEMS DESIGN
   AND ANALYSIS - 2008, VOL 2
LA English
DT Proceedings Paper
CT 9th Biennial Conference on Engineering Systems Design and Analysis
CY JUL 07-09, 2008
CL Haifa, ISRAEL
SP ASME, Petroleum Div
DE Biomaterial; Elasticity; Finite element analysis; Mechanical properties
ID ATOMIC-FORCE MICROSCOPY; THIN-FILMS; MECHANICAL CHARACTERIZATION;
   PACKABLE COMPOSITES; TISSUE; INDENTATION; SCAFFOLDS; NETWORKS;
   NANOINDENTATION; ELASTOGRAPHY
AB The mechanical properties of compliant materials such as biological tissues and biocompatible soft polymers are essential in medical research and engineering applications. These properties are often determined using techniques that require costly instrumentation (e.g. pull test machines). Alternative and more accessible methods can significantly aid the characterization process. The bulge test determines a material elastic modulus by analyzing the pressure-deflection response of thin samples made of this material. The technique has been extensively employed in the characterization of metals and semiconductors (modulus similar to 100 GPa). By employing plate rather than membrane mechanics, the present study extends bulge testing to characterize materials with a modulus that is five orders of magnitude lower (similar to 1 MPa). The novel method is demonstrated analytically using plate theory, numerically using finite element modeling and experimentally by successfully applying it to polydimethylsiloxane (modulus similar to 1.33 MPa). The introduced technique does not require costly equipment, is simple to implement and presents an appealing alternative to current characterization approaches.
C1 [Golan, S.; Dinnar, U.] Technion Israel Inst Technol, Dept Biomed Engn, IL-32000 Haifa, Israel.
RP Golan, S (reprint author), Technion Israel Inst Technol, Dept Biomed Engn, IL-32000 Haifa, Israel.
EM gsaar@tx.technion.ac.il
OI Elata, David/0000-0002-3816-6669
CR Abe Y, 2005, BIOMATERIALS, V26, P3405, DOI 10.1016/j.biomaterials.2004.09.029
   Abe Y, 2001, DENT MATER, V17, P520, DOI 10.1016/S0109-5641(01)00012-4
   Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.0.CO;2-J
   Armani D, 1999, PROC IEEE MICR ELECT, P222, DOI 10.1109/MEMSYS.1999.746817
   Billiar KL, 2000, J BIOMECH ENG-T ASME, V122, P23, DOI 10.1115/1.429624
   Carrillo F, 2005, J MATER RES, V20, P2820, DOI 10.1557/JMR.2005.0354
   Chen N, 2006, J MICROSC-OXFORD, V221, P203, DOI 10.1111/j.1365-2818.2006.01553.x
   Converse GL, 2007, BIOMATERIALS, V28, P927, DOI 10.1016/j.biomaterials.2006.10.031
   Cox MAJ, 2006, J BIOMECH ENG-T ASME, V128, P428, DOI 10.1115/1.2187040
   du Roure O, 2005, P NATL ACAD SCI USA, V102, P2390, DOI 10.1073/pnas.0408482102
   Edwards RL, 2004, EXP MECH, V44, P49, DOI 10.1177/0014485104039749
   HOHLFELDER RJ, 1998, STANFORD U STANFORD
   Hosokawa K, 2002, J MICROMECH MICROENG, V12, P1, DOI 10.1088/0960-1317/12/1/301
   Kennedy MS, 2005, MICROSYST TECHNOL, V11, P298, DOI [10.1007/s00542-004-0439-7, 10.1007/S00542-004-0439-7]
   Khalil AS, 2005, ANN BIOMED ENG, V33, P1631, DOI 10.1007/s10439-005-6766-3
   Kim T., 2000, ADV STUD CONT MATH, V2, P9
   L'Heureux N, 1998, FASEB J, V12, P47
   Lee JN, 2004, LANGMUIR, V20, P11684, DOI 10.1021/la048562+
   Lin-Gibson S, 2006, BIOMATERIALS, V27, P1711, DOI 10.1016/j.biomaterials.2005.10.040
   LIORENTE MA, 1979, J CHEM PHYS, V71, P682
   Mariani M, 2006, TISSUE ENG, V12, P547, DOI 10.1089/ten.2006.12.547
   MARK JE, 1979, J CHEM PHYS, V70, P1794, DOI 10.1063/1.437652
   MARK JE, 1966, J APPL PHYS, V37, P4635, DOI 10.1063/1.1708109
   Martin I, 2000, BIORHEOLOGY, V37, P141
   Mata A, 2005, BIOMED MICRODEVICES, V7, P281, DOI 10.1007/s10544-005-6070-2
   Mitchell JS, 2003, J AEROSPACE ENG, V16, P46, DOI 10.1061/(ASCE)0893-1321(2003)16:2(46)
   Ophir J, 1999, P I MECH ENG H, V213, P203, DOI 10.1243/0954411991534933
   Peter SJ, 1998, J BIOMED MATER RES, V43, P422, DOI 10.1002/(SICI)1097-4636(199824)43:4<422::AID-JBM9>3.3.CO;2-T
   Rau K, 2002, MATER RES INNOV, V5, P151, DOI 10.1007/s10019-002-8640-8
   Roeder R, 1999, J BIOMED MATER RES, V47, P65, DOI 10.1002/(SICI)1097-4636(199910)47:1<65::AID-JBM9>3.0.CO;2-F
   Scott ON, 2004, ACTA MATER, V52, P4877, DOI 10.1016/j.actamat.2004.06.043
   Srikar VT, 2003, EXP MECH, V43, P238, DOI 10.1007/BF02410522
   Stafford CM, 2004, NAT MATER, V3, P545, DOI 10.1038/nmat1175
   Sun YJ, 2004, LANGMUIR, V20, P5837, DOI 10.1021/la036461q
   Timoshenko S. P, 1959, THEORY PLATES SHELLS
   VLASSAK JJ, 1992, J MATER RES, V7, P3242, DOI 10.1557/JMR.1992.3242
   Waldman SD, 2002, J MATER SCI-MATER M, V13, P933, DOI 10.1023/A:1019896210320
   White CC, 2005, J POLYM SCI POL PHYS, V43, P1812, DOI 10.1002/polb.20455
   Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153
   Zhang Y, 2001, J NON-CRYST SOLIDS, V282, P159, DOI 10.1016/S0022-3093(01)00345-3
NR 40
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-4836-4
PY 2009
BP 85
EP 91
PG 7
WC Automation & Control Systems; Engineering, Biomedical; Engineering,
   Mechanical
SC Automation & Control Systems; Engineering
GA BIX59
UT WOS:000263619300012
DA 2018-10-19
ER

PT B
AU Sealy, MP
   Guo, YB
   Salahshoor, M
   Caslaru, R
AF Sealy, M. P.
   Guo, Y. B.
   Salahshoor, M.
   Caslaru, R.
GP ASME
TI FABRICATION AND FINITE ELEMENT SIMULATION OF SEQUENTIAL LASER SHOCK
   PEENING OF BIODEGRADABLE Mg-Ca IMPLANTS
SO PROCEEDINGS OF THE ASME INTERNATIONAL MANUFACTURING SCIENCE AND
   ENGINEERING CONFERENCE, VOL 1
LA English
DT Proceedings Paper
CT ASME International Manufacturing Science and Engineering Conference
CY OCT 04-07, 2009
CL West Lafayette, IN
SP ASME, Manufact Engn Div
DE Metallic biomaterial; laser shock peening; surface integrity; corrosion;
   implants; finite element simulation
ID STRESS-DISTRIBUTION; CONFINED GEOMETRY; MAGNESIUM ALLOYS;
   BONE-RESORPTION; WAVE GENERATION; PLASMA; WATER; CORROSION; PROPERTY;
   ALUMINUM
AB Current biocompatible metals such as steel and titanium alloys have excellent corrosive properties and superior strengths. However, their strengths are often too high and as a result have a negative effect on the body. Therefore, Magnesium (Mg) alloys with relatively low strengths are ideal biocompatible metallic materials. The problem with Mg implants is how to control corrosion rates so that the degradation of Mg implants may match with bone growth. The high compressive residual stress induced by laser shock peening (LSP) has a great potential to slow down the corrosion rate. LSP is a known surface treatment method to impart compressive residual stress in subsurface of a metal. Therefore, LSP was initiated in this study to investigate surface topography and integrity produced by peening a Mg alloy. A 3D semi-infinite simulation has also been developed to predict the topography and residual stress fields produced by sequential peening. The dynamic mechanical behavior was modeled using a user material subroutine of the internal state variable plasticity model. The temporal and spatial peening pressure was modeled using a user load subroutine. The simulated dent agrees with the measured dent topography in terms of profile and depth. Sequential peening was found to increase the tensile pile up region which is critical to tribological applications. The predicted residual stress profiles are also presented.
C1 [Sealy, M. P.; Guo, Y. B.; Salahshoor, M.; Caslaru, R.] Univ Alabama, Dept Mech Engn, Tuscaloosa, AL 35487 USA.
RP Guo, YB (reprint author), Univ Alabama, Dept Mech Engn, Tuscaloosa, AL 35487 USA.
EM yguo@eng.ua.edu
RI Sealy, Michael/K-5248-2017
OI Sealy, Michael/0000-0002-9236-5458
CR Abaqus, 2007, AN US MAN
   Abbas G, 2005, APPL SURF SCI, V247, P347, DOI [10.1016/j.apsusc.2005.01.169, 10.1016/J.APSUSC.2005.01.169]
   Aksakal B, 2008, J MATER SCI-MATER M, V19, P2097, DOI 10.1007/s10856-007-3304-2
   Au AG, 2007, J BIOMECH, V40, P1410, DOI 10.1016/j.jbiomech.2006.05.020
   BAMMANN, 1996, THEOR APP MECH, P359
   Benli S, 2008, J BIOMECH, V41, P3229, DOI 10.1016/j.jbiomech.2008.08.003
   Berthe L, 1999, J APPL PHYS, V85, P7552, DOI 10.1063/1.370553
   Berthe L, 1997, J APPL PHYS, V82, P2826, DOI 10.1063/1.366113
   Braisted W, 1999, INT J FATIGUE, V21, P719, DOI 10.1016/S0142-1123(99)00035-3
   BROOKS V, 2008, THESIS U ALABAMA
   CASLARU R, 2008, T NAMRI SME, V37, P159
   Clauer AH, 1996, P SURF PERF TIT, P217
   Completo A, 2008, J BIOMECH, V41, P560, DOI 10.1016/j.jbiomech.2007.10.006
   Dane C. B., 1998, ADV AER MAT PROC C 9
   DEVAUX D, 1993, J APPL PHYS, V74, P2268, DOI 10.1063/1.354710
   FABBRO R, 1990, J APPL PHYS, V68, P775, DOI 10.1063/1.346783
   FAIRAND BP, 1976, OPT COMMUN, V18, P588, DOI 10.1016/0030-4018(76)90327-8
   FAIRAND BP, 1972, J APPL PHYS, V43, P3893, DOI 10.1063/1.1661837
   FAN Y, 2005, J APPL PHYS, V98
   Gefen A, 2002, MED BIOL ENG COMPUT, V40, P311, DOI 10.1007/BF02344213
   Guo YB, 2005, INT J MECH SCI, V47, P1423, DOI 10.1016/j.ijmecsci.2005.04.015
   Ilich JZ, 2000, J AM COLL NUTR, V19, P715, DOI 10.1080/07315724.2000.10718070
   Isaksson H., 2003, BIOENG C, P1041
   Manna S., 1996, U.S. Patent, Patent No. [5,569,018, 5569018]
   Masse J. E., 1995, SURFACE COATINGS TEC, V70, P179
   Mondal AK, 2008, SURF COAT TECH, V202, P3187, DOI 10.1016/j.surfcoat.2007.11.030
   Montross CS, 1999, INT J ROCK MECH MIN, V36, P849, DOI 10.1016/S0148-9062(99)00054-6
   Nagels J, 2003, J SHOULDER ELB SURG, V12, P35, DOI 10.1067/mse.2003.22
   Peyre P, 1996, MAT SCI ENG A-STRUCT, V210, P102, DOI 10.1016/0921-5093(95)10084-9
   SEALY MP, 2008, INT J COMP METHODS E, V10, P149
   SEILER HG, 1987, HDB TOXICITY INORGAN
   Shi JF, 2007, P I MECH ENG H, V221, P903, DOI 10.1243/09544119JEIM256
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   Warren AW, 2008, INT J FATIGUE, V30, P188, DOI 10.1016/j.ijfatigue.2007.01.033
   WARREN AW, 2005, P ASME INT MECH ENG
   WARREN AW, 2007, T NAMRI SME, V35, P409
   Wu B., 2005, J APPL PHYS, V97, P1
   ZHANG W, 2004, ASME, V26, P10
   Zhang WW, 2002, J MANUF SCI E-T ASME, V124, P369, DOI 10.1115/1.1445149
NR 39
TC 0
Z9 0
U1 0
U2 3
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-4361-1
PY 2009
BP 1
EP 8
PG 8
WC Engineering, Biomedical; Engineering, Manufacturing
SC Engineering
GA BRC98
UT WOS:000282383100001
DA 2018-10-19
ER

PT B
AU Yin, J
   Huang, Y
AF Yin, Jun
   Huang, Yong
GP ASME
TI INVESTIGATION OF PROCESS-INDUCED CELL MEMBRANE STABILITY USING MOLECULAR
   DYNAMICS SIMULATION
SO PROCEEDINGS OF THE ASME INTERNATIONAL MANUFACTURING SCIENCE AND
   ENGINEERING CONFERENCE, VOL 1
LA English
DT Proceedings Paper
CT ASME International Manufacturing Science and Engineering Conference
CY OCT 04-07, 2009
CL West Lafayette, IN
SP ASME, Manufact Engn Div
ID LIPID-BILAYERS; MECHANICAL-STRESS; PRESSURE; HYDRATION;
   DIPALMITOYLPHOSPHATIDYLCHOLINE; PHASE; MODEL; DPPC
AB Manufacturing process-induced damage to cells is of significant importance in biomaterial direct writing. For safe and reproducible cell direct writing, the process-induced cell damage must be understood in addition to biological property research. The objective of this study is to investigate the cell membrane stability under the external normal pressure. It is performed by studying the dipalmitoylphosphatidylcholine (DPPC) bilayer behavior under different normal pressures using molecular dynamics (MD). It is found that as the normal pressure increases, the thickness of DPPC bilayer decreases and the area of per DPPC molecule increases; and as the normal pressure increases, the rupture force to break the bilayer structure decreases, which can also be explained by the change of free energy difference before and after rupture under different normal pressures. This study serves as the first step towards understanding of the cell damage mechanism in cell direct writing.
C1 [Yin, Jun; Huang, Yong] Clemson Univ, Dept Mech Engn, Clemson, SC 29634 USA.
RP Huang, Y (reprint author), Clemson Univ, Dept Mech Engn, Clemson, SC 29634 USA.
EM juny@clemson.edu; yongh@clemson.edu
RI Yin, Jun/K-1037-2014
CR Akinlaja J, 1998, BIOPHYS J, V75, P247, DOI 10.1016/S0006-3495(98)77511-3
   Ayton GS, 2004, BIOPHYS J, V87, P3299, DOI 10.1529/biophysj.004.047811
   Barron JA, 2004, THIN SOLID FILMS, V453, P383, DOI 10.1016/j.tsf.2003.11.161
   Barron JA, 2004, BIOSENS BIOELECTRON, V20, P246, DOI [10.1016/j.bios.2004.01.011, 10.1016/j.bios..2004.01.011]
   Barron JA, 2004, BIOMED MICRODEVICES, V6, P139, DOI 10.1023/B:BMMD.0000031751.67267.9f
   Berger O, 1997, BIOPHYS J, V72, P2002, DOI 10.1016/S0006-3495(97)78845-3
   Cleary S. F., 1977, Laser applications in medicine and biology vol.3, P175
   De Vita R, 2007, J PHYS A-MATH THEOR, V40, P13179, DOI 10.1088/1751-8113/40/43/023
   Grubmuller H, 1996, SCIENCE, V271, P997, DOI 10.1126/science.271.5251.997
   Hopkinson D., 2006, P SPIE, V6170
   KNECHT V, 2005, J CHEM PHYS, V122
   Koshiyama K, 2006, BIOPHYS J, V91, P2198, DOI 10.1529/biophysj.105.077677
   LANDIN J, 1995, J PHYS CHEM-US, V99, P4471, DOI 10.1021/j100013a017
   Lechuga J, 2008, INT J NUMER METH FL, V57, P677, DOI 10.1002/fld.1588
   Leontiadou H, 2004, BIOPHYS J, V86, P2156, DOI 10.1016/S0006-3495(04)74275-7
   LITSTER JD, 1975, PHYS LETT A, VA 53, P193, DOI 10.1016/0375-9601(75)90402-8
   Marrink SJ, 2005, CHEM PHYS LIPIDS, V135, P223, DOI 10.1016/j.chemphyslip.2005.03.001
   Marrink SJ, 1998, BIOPHYS J, V74, P931, DOI 10.1016/S0006-3495(98)74016-0
   Meyer HW, 2000, CHEM PHYS LIPIDS, V105, P149, DOI 10.1016/S0009-3084(00)00124-9
   NEEDHAM D, 1990, BIOPHYS J, V58, P997, DOI 10.1016/S0006-3495(90)82444-9
   Patel RY, 2005, J PHYS CHEM B, V109, P14667, DOI 10.1021/jp052697m
   Rawicz W, 2000, BIOPHYS J, V79, P328, DOI 10.1016/S0006-3495(00)76295-3
   Ringeisen BR, 2004, TISSUE ENG, V10, P483, DOI 10.1089/107632704323061843
   Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408
   SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720
   Tieleman DP, 1996, J CHEM PHYS, V105, P4871, DOI 10.1063/1.472323
   Tieleman DP, 1997, BBA-REV BIOMEMBRANES, V1331, P235, DOI 10.1016/S0304-4157(97)00008-7
   Tieleman DP, 2003, J AM CHEM SOC, V125, P6382, DOI 10.1021/ja029504i
   van der Spoel D, 2010, GROMACS USER MANUAL
   VANGUNSTEREN WF, 1996, BIOMOLECULAR SIMULAT
   WANG W, 2008, ASME, V130, P10
   WANG W, 2009, ASME IN PRESS
   Wang W, 2007, T NAMRI SME, V35, P217
   Weiner J. H., 1983, STAT MECH ELASTICITY
   YIN J, 2009, SURF REV LETT, V14, P671
   Yin J, 2009, J COLLOID INTERF SCI, V329, P410, DOI 10.1016/j.jcis.2008.09.070
   Zhu FQ, 2002, BIOPHYS J, V83, P154, DOI 10.1016/S0006-3495(02)75157-6
NR 37
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-4361-1
PY 2009
BP 9
EP 16
PG 8
WC Engineering, Biomedical; Engineering, Manufacturing
SC Engineering
GA BRC98
UT WOS:000282383100002
DA 2018-10-19
ER

PT B
AU Wang, W
   Huang, Y
   Lin, YF
AF Wang, Wei
   Huang, Yong
   Lin, Yafu
GP ASME
TI MODELING OF THERMOELASTIC STRESS WAVE IN LASER-ASSISTED CELL DIRECT
   WRITING
SO PROCEEDINGS OF THE ASME INTERNATIONAL MANUFACTURING SCIENCE AND
   ENGINEERING CONFERENCE, VOL 2
LA English
DT Proceedings Paper
CT ASME International Manufacturing Science and Engineering Conference
CY OCT 04-07, 2009
CL West Lafayette, IN
SP ASME, Manufact Engn Div
ID LIQUIDS; ABLATION; GENERATION; ABSORPTION; MECHANISMS; WATER
AB Laser-assisted cell direct-write technique has been a promising biomaterial direct-write method. For safe and reproducible cell direct writing, the cell damage due to process-induced external stress must be understood in addition to biological property research. The objective of this study is to model the thermoelastic stress wave propagation inside the coating in laser-assisted cell direct writing when the vaporization or optical breakdown of coating materials is not available. It is found that a bipolar pressure pair has been developed within a finite thin coating medium, locations near the laser focal spot experience higher stresses, and shorter duration laser pulses lead to higher thermoelastic stresses. This study will help understand the photomechanical stress and its relevance with biomaterial damage in laser-assisted cell direct writing.
C1 [Wang, Wei; Huang, Yong; Lin, Yafu] Clemson Univ, Dept Mech Engn, Clemson, SC 29634 USA.
RP Huang, Y (reprint author), Clemson Univ, Dept Mech Engn, Clemson, SC 29634 USA.
EM wwang@clemson.edu; yongh@clemson.edu; yaful@clemson.edu
CR ANDERSON RR, 1983, SCIENCE, V220, P524, DOI 10.1126/science.6836297
   Barron JA, 2004, BIOMED MICRODEVICES, V6, P139, DOI 10.1023/B:BMMD.0000031751.67267.9f
   CAROME EF, 1964, APPL PHYS LETT, V4, P95, DOI 10.1063/1.1753985
   DINGUS RS, 1991, P SOC PHOTO-OPT INS, V1427, P45, DOI 10.1117/12.44088
   DINGUS RS, 1994, P SOC PHOTO-OPT INS, V2134, P434
   Frenz M, 1996, PHYS REV LETT, V76, P3546, DOI 10.1103/PhysRevLett.76.3546
   Georgiou S, 2003, CHEM REV, V103, P349, DOI 10.1021/cr010429o
   Gusev V. E., 1993, LASER OPTOACOUSTICS
   LANDAU L, 1981, HYDRODYNAMIK
   Noack J, 1999, IEEE J QUANTUM ELECT, V35, P1156, DOI 10.1109/3.777215
   Odde DJ, 1999, TRENDS BIOTECHNOL, V17, P385, DOI 10.1016/S0167-7799(99)01355-4
   Odde DJ, 2000, BIOTECHNOL BIOENG, V67, P312, DOI 10.1002/(SICI)1097-0290(20000205)67:3<312::AID-BIT7>3.0.CO;2-F
   Paltauf G, 1998, J ACOUST SOC AM, V104, P890, DOI 10.1121/1.423334
   Paltauf G, 1997, J APPL PHYS, V82, P1525, DOI 10.1063/1.365953
   Paltauf G, 2003, CHEM REV, V103, P487, DOI 10.1021/cr010436c
   Park HK, 1996, J APPL PHYS, V80, P4072, DOI 10.1063/1.363370
   PARK HK, 1994, THESIS U CALIFORNIA
   Ringeisen BR, 2004, TISSUE ENG, V10, P483, DOI 10.1089/107632704323061843
   SIGRIST MW, 1978, J ACOUST SOC AM, V64, P1652, DOI 10.1121/1.382132
   Vogel A, 2003, CHEM REV, V103, P577, DOI 10.1021/cr010379n
   WANG W, 2009, ASME IN PRESS
NR 21
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-4362-8
PY 2009
BP 705
EP 712
PG 8
WC Engineering, Manufacturing; Engineering, Mechanical
SC Engineering
GA BRC99
UT WOS:000282383200083
DA 2018-10-19
ER

PT B
AU Nain, AS
   Miller, E
   Sitti, M
   Campbell, P
   Amon, C
AF Nain, Amrinder S.
   Miller, Eric
   Sitti, Metin
   Campbell, Phil
   Amon, Cristina
GP ASME
TI FABRICATION OF SINGLE AND MULTI-LAYER FIBROUS BIOMATERIAL SCAFFOLDS FOR
   TISSUE ENGINEERING
SO PROCEEDINGS OF THE ASME INTERNATIONAL MECHANICAL ENGINEERING CONGRESS
   AND EXPOSITION 2008, VOL 2
LA English
DT Proceedings Paper
CT ASME International Mechanical Engineering Congress and Exposition
CY OCT 31-NOV 06, 2008
CL Boston, MA
SP Amer Soc Mech Engineers
ID PEPTIDE-AMPHIPHILE NANOFIBERS; POLYMER NANOFIBERS; CELL; ADHESION;
   SURFACE; MATRIX
AB For regenerative medicine applications, we need to expand our understanding of the mechanisms by which nature assembles and functionalizes specialized complex tissues to form a complete organism. The first step towards this goal involves understanding the underlying complex mechanisms of highly organized behavior spanning not only diverse scientific fields, but also nano, micro and macro length-scales. For example, an engineered fibrous biomaterial scaffold possessing the hierarchal spatial properties of a native extracellular matrix (ECM) can serve as a building block upon which living cells are seeded for repair or regeneration. The hierarchical nature of ECM along with the inherent topological constraints of fiber diameter, fiber spacing, multi-layer configurations provide different pathways for living cells to adapt and conform. to the surrounding environment. Our previously developed Spinneret based Tunable Engineered Parameters (STEP) technique to deposit biomaterial scaffolds in aligned configurations has been used for the first time to deposit single and multi-layer biological scaffolds of fibrinogen. Fibrinogen is a very well established tissue engineering scaffold material, as it improves cellular interactions and allows scaffold remodeling compared to synthetic polymers. Current state-of-the-art fiber deposition techniques lack the ability to fabricate scaffolds of desired fiber dimensions and orientations and in this study we present fabrication and aligned deposition of fibrinogen fiber arrays with diameters ranging from sub-200 nm to sub-microns and several millimeters in length. The fabricated scaffolds are then cultured with pluripotent mouse C2C12 cells for seven days and cells on the scaffolds are observed to elongate resembling myotube morphology along the fiber axis, spread along intersecting layers and fuse into bundles at the macroscale. Additionally, we demonstrate the ability to deposit poly (lactic-co-glycolic acid) (PLGA), Polystyrene (PS) biomaterial scaffolds of different diameters to investigate the effects of topological variations on cellular adhesion, proliferation and migration. Previous studies have indicated cells making right angle transitions upon encountering perpendicular double layer fibers and cellular motion is thwarted in the vicinity of diverging fibers. Current ongoing studies are aimed at determining the effects of fiber diameter and fiber spacing on mouse C2C12 cellular adhesion and migration, which are envisioned to aid in the design of future scaffolds for tissue engineering possessing appropriate material and geometrical properties.
C1 [Nain, Amrinder S.; Miller, Eric; Campbell, Phil] Carnegie Mellon Univ, Inst Complex Engineered Syst, Pittsburgh, PA 15213 USA.
RP Nain, AS (reprint author), Carnegie Mellon Univ, Inst Complex Engineered Syst, 1201 Hamburg Hall,5000 Forbes Ave, Pittsburgh, PA 15213 USA.
EM anain@andrew.cmu.edu; edmiller@andrew.cmu.edu; sitti@cmu.edu;
   pcampbel@cs.cmu.edu; cristina.amon@utoronto.ca
CR Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237
   Bull SR, 2005, NANO LETT, V5, P1, DOI 10.1021/nl0484898
   Feng L, 2002, ANGEW CHEM INT EDIT, V41, P1221, DOI 10.1002/1521-3773(20020402)41:7<1221::AID-ANIE1221>3.0.CO;2-G
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   GU B, 2003, POLYM PREP-ACS, V44, P142
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Ma PX, 1999, J BIOMED MATER RES, V46, P60, DOI 10.1002/(SICI)1097-4636(199907)46:1<60::AID-JBM7>3.0.CO;2-H
   Martin CR, 1996, CHEM MATER, V8, P1739, DOI 10.1021/cm960166s
   Miller DC, 2005, J BIOMED MATER RES A, V73A, P476, DOI 10.1002/jbm.a.30318
   Moissoglu K, 2006, BIOL CELL, V98, P547, DOI 10.1042/BC20060025
   Nain AS, 2006, IEEE T NANOTECHNOL, V5, P499, DOI 10.1109/TNANO.2006.880453
   NAIN AS, 2008, SMALL IN PRESS
   NAIN AS, 2007, THESIS CARNEGIE MELL
   NAIN AS, 2006, APPL PHYS LETT, V89, P7
   Norman J, 2006, ANN BIOMED ENG, V34, P89, DOI 10.1007/s10439-005-9005-4
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Reneker DH, 1996, NANOTECHNOLOGY, V7, P216, DOI 10.1088/0957-4484/7/3/009
   Silver F. H., 1999, BIOMATERIALS SCI BIO
   Thapa A, 2003, BIOMATERIALS, V24, P2915, DOI 10.1016/S0142-9612(03)00123-6
   Ward GF, 2001, FILTR SEPARAT, V38, P42, DOI 10.1016/S0015-1882(01)80540-1
   Wnek GE, 2003, NANO LETT, V3, P213, DOI 10.1021/nl025866c
   Xu CY, 2004, BIOMATERIALS, V25, P877, DOI 10.1016/S0142-9612(03)00593-3
   Xu JT, 2004, BIOMED MICRODEVICES, V6, P117, DOI 10.1023/B:BMMD.0000031748.13353.10
   Yang F, 2004, BIOMATERIALS, V25, P1891, DOI 10.1016/j.biomaterials.2003.08.062
   Zhang YZ, 2005, J MATER SCI-MATER M, V16, P933, DOI 10.1007/s10856-005-4428-x
   Zhong SP, 2006, J BIOMED MATER RES A, V79A, P456, DOI 10.1002/jbm.a.30870
   Zong XH, 2005, BIOMATERIALS, V26, P5330, DOI 10.1016/j.biomaterials.2005.01.052
NR 28
TC 0
Z9 0
U1 0
U2 4
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-4863-0
PY 2009
BP 231
EP 238
PG 8
WC Biotechnology & Applied Microbiology; Engineering, Biomedical;
   Engineering, Mechanical
SC Biotechnology & Applied Microbiology; Engineering
GA BJH60
UT WOS:000265911300039
DA 2018-10-19
ER

PT B
AU Pelegrl, A
   Shan, BX
AF Pelegrl, Assimina
   Shan, Baoxiang
GP ASME
TI DYNAMIC ANALYSIS OF SOFT TISSUES USING A STATE SPACE MODEL
SO PROCEEDINGS OF THE ASME SUMMER BIOENGINEERING CONFERENCE 2008, PTS A AND
   B
LA English
DT Proceedings Paper
CT ASME Summer Bioengineering Conference
CY JUN 25-29, 2008
CL Marco Isl, FL
SP Amer Soc Mech Engineers, Bioengn Div
AB Research on the biomechanical behavior of soft tissues has drawn a lot of recent attention due to its application in tumor pathology, rehabilitation, surgery and biomaterial implants. In this study a finite element (FE) model is applied to represent soft tissues and phantoms with complex geometry and heterogeneous material properties. A solid 3D mixed u-p element S8P0 (8-node for displacement and 1-node for internal pressure) is implemented to capture the near-incompressibility inherent in soft tissues. A dynamic analysis of soft tissues' response to excitation is explored in which, the second order differential equation representing the soft tissues in FE necessitates a time-consuming numerical solution procedure. Moreover, the second-order representation is complicated in estimating the tissue mechanical properties by inverse procedure. Thus, a state space (SS) model is used to equivalently represent soft tissues by transforming the second-order differential equation into a system of linear first-order differential equations. The linear and time-invariant SS representation of soft tissues for general dynamic analysis can reduce the computational cost and a provide framework for the "forward" simulation and "inverse" identification of soft tissues.
C1 [Pelegrl, Assimina; Shan, Baoxiang] State Univ New Jersey, Piscataway, NJ USA.
RP Pelegrl, A (reprint author), State Univ New Jersey, Piscataway, NJ USA.
CR CALMAN K, 1998, CLIN EXAMINATION BRE
   Carter FJ, 2001, MED IMAGE ANAL, V5, P231, DOI 10.1016/S1361-8415(01)00048-2
   Doyley MM, 2004, IEEE T MED IMAGING, V23, P1404, DOI 10.1109/TMI.2004.834624
   KOGIT LM, 2007, 2007 ASME INT MECH E
   Konofagou EE, 2003, ULTRASOUND MED BIOL, V29, P1405, DOI 10.1016/S0301-5629(03)00953-0
   Liu Y, 2005, IEEE T MED IMAGING, V24, P1323, DOI 10.1109/TMI.2005.857232
   Lus H, 2003, J ENG MECH-ASCE, V129, P477, DOI 10.1061/(ASCE)0733-9399(2003)129:5(477)
   MALEKE CM, 2005, EL IM C AUST TX
   Palmeri ML, 2005, IEEE T ULTRASON FERR, V52, P1699, DOI 10.1109/TUFFC.2005.1561624
NR 9
TC 0
Z9 0
U1 1
U2 2
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-4321-5
PY 2009
BP 1031
EP 1032
PG 2
WC Engineering, Biomedical
SC Engineering
GA BIW31
UT WOS:000263364700516
DA 2018-10-19
ER

PT B
AU Xu, XH
   He, CL
AF Xu Xiao-hong
   He Chuang-long
GP Donghua University
TI Crosslinking of electrospun fibrinogen nanofibers
SO PROCEEDINGS OF THE FIBER SOCIETY 2009 SPRING CONFERENCE, VOLS I AND II
LA English
DT Proceedings Paper
CT Spring Conference of the Fiber-Society
CY MAY 27-29, 2009
CL Donghua Univ, Shanghai, PEOPLES R CHINA
SP Fiber Soc, DU, Coll Textiles, Key Lab Textiles Sci & Technol, Minist Educ, Engn Res enter Ind Textiles , Minist Educ, State Key Lab Modificat Chem Fibers, Key Lab Sci & Technol Eco Textiles, Minist Educ, Natl Engn Res Ctr Dyeing & Finishing Textiles
HO Donghua Univ
DE Fibrinogen Electrospinning Genipin Crosslink
ID IN-VITRO EVALUATION
AB The aim of this study was to enhance the mechanical strength and control the biodegradability of electrospun fibrinogen nanofibers by crosslinking with different methods. The electrospun fibrinogen scaffolds were successfully fabricated as a biomimetic scaffold for tissue engineering. The morphologies of the resulting nanofibers were observed under scanning electron microscopy (SEM), and their mechanical properties were tested by uniaxial tensile test. The results indicated that the mechanical properties of electrospun fibrinogen nanofibers were significantly increased after crosslinked by genipin vapour, thus crosslinked electrospun fibrinogen nanofibers should be a very promising biomaterial for tissue engineering scaffold.
C1 [Xu Xiao-hong; He Chuang-long] Donghua Univ, Coll Chem & Chem Engn & Biolotechnol, Shanghai 201620, Peoples R China.
RP Xu, XH (reprint author), Donghua Univ, Coll Chem & Chem Engn & Biolotechnol, Shanghai 201620, Peoples R China.
EM hcl@dhu.edu.cn
RI He, Chuanglong/C-2976-2011
OI He, Chuanglong/0000-0001-8330-8542
CR Bigi A, 2001, BIOMATERIALS, V22, P763, DOI 10.1016/S0142-9612(00)00236-2
   CLARK RAF, 1982, J INVEST DERMATOL, V79, P264, DOI 10.1111/1523-1747.ep12500075
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Huang ZM, 2004, POLYMER, V45, P5361, DOI 10.1016/j.polymer.2004.04.005
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   McManus MC, 2006, ACTA BIOMATER, V2, P19, DOI 10.1016/j.actbio.2005.09.008
   Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x
   Ramakrishna S, 2006, MATER TODAY, V9, P40, DOI 10.1016/S1369-7021(06)71389-X
   Raymond Z., 1999, BIOMATERIALS, V20, P921
   SCOTT AS, 2008, BIOMED MATER, V3, P45001
   SERGIO TG, 2009, ACS APPL MAT INTERFA, V1, P218
   Tsai CC, 2000, J BIOMED MATER RES, V52, P58, DOI 10.1002/1097-4636(200010)52:1<58::AID-JBM8>3.0.CO;2-0
   Zhang XH, 2008, BIOMATERIALS, V29, P2217, DOI 10.1016/j.biomaterials.2008.01.022
NR 13
TC 0
Z9 0
U1 0
U2 3
PU DONGHUA UNIV PRESS
PI SHANGHAI
PA 1882 YAN AN WEST RD, SHANGHAI, 00000, PEOPLES R CHINA
BN 978-7-5064-5635-7
PY 2009
BP 931
EP 935
PG 5
WC Biotechnology & Applied Microbiology; Nanoscience & Nanotechnology;
   Materials Science, Textiles
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics; Materials Science
GA BLM57
UT WOS:000270540900254
DA 2018-10-19
ER

PT J
AU DiCarlo, BB
   Hu, JC
   Gross, T
   Vago, R
   Athanasiou, KA
AF DiCarlo, B. B.
   Hu, J. C.
   Gross, T.
   Vago, R.
   Athanasiou, K. A.
TI Biomaterial effects in articular cartilage tissue engineering using
   polyglycolic acid, a novel marine origin biomaterial, IGF-I, and
   TGF-beta 1
SO PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART H-JOURNAL OF
   ENGINEERING IN MEDICINE
LA English
DT Article
DE tissue engineering; chondrocytes; articular cartilage; biomaterials;
   scaffolds; growth factors; insulin-like growth factor I; transforming
   growth factor beta 1
ID GROWTH-FACTORS; NATURAL CORAL; BONE; VITRO; CELL; CHONDROCYTES;
   SUBPOPULATIONS; BIOMATRICES; COMPOSITES; CONSTRUCTS
AB Bovine articular chondrocytes were seeded on either polyglycolic acid (PGA) non-woven mesh scaffolds or a biomatrix from the species Porites lutea (POR). These constructs were cultured for 6 weeks in the presence of insulin-like growth factor (IGF)-I (10 ng/ml or 100 ng/ml) or transforming growth factor (TGF)-beta 1 (5 ng/ml or 30 ng/ml) to determine the in-vitro articular cartilage regeneration capacity of each. Histology, deoxyribonucleic acid content, collagen I and II (immunohistochemistry and enzyme-linked immunosorbent assay), and glycosaminoglycan (GAG) contents were measured at 0 weeks, 2 weeks, and 6 weeks to assess the characteristics of chondrogenesis. Both scaffolds supported the maintenance of the chondrocytic phenotype, as evidenced by the predominance of collagen II and the presence of rounded chondrocytes embedded in lacunae. Regardless of growth factor treatment, cells cultured on PGA scaffolds produced more collagen type II than those cultured on POR. Conversely, by 6 weeks, cells cultured on POR scaffolds produced more GAG than those cultured on PGA scaffolds, again regardless of the growth factor used. Across the two groups, 100 ng/ml of IGF-I had the greatest overall effect in GAG content. This work indicates that PGA and the POR scaffolds are both effective growth matrices for articular cartilage, with each scaffold exhibiting different yet desirable profiles of articular cartilage growth.
C1 [DiCarlo, B. B.; Hu, J. C.; Athanasiou, K. A.] Rice Univ, Dept Bioengn, Houston, TX 77251 USA.
   [Gross, T.; Vago, R.] Ben Gurion Univ Negev, Dept Biotechnol Engn, IL-84105 Beer Sheva, Israel.
RP Athanasiou, KA (reprint author), Rice Univ, Dept Bioengn, MS-142,POB 1892, Houston, TX 77251 USA.
EM athanasiou@rice.edu
OI Hu, Jerry/0000-0003-0651-1461
FU Binational Science Foundation (BSF) [2001045]
FX This work was partially supported by the Binational Science Foundation
   (BSF # 2001045).
CR Abramovitch-Gottlib L, 2006, TISSUE ENG, V12, P729, DOI 10.1089/ten.2006.12.729
   Agrawal C M, 1995, Tissue Eng, V1, P241, DOI 10.1089/ten.1995.1.241
   Agrawal CM, 1997, MATER SCI FORUM, V250, P115, DOI 10.4028/www.scientific.net/MSF.250.115
   Almarza AJ, 2004, TISSUE ENG, V10, P1787, DOI 10.1089/ten.2004.10.1787
   Athanasiou KA, 1998, ARTHROSCOPY, V14, P726, DOI 10.1016/S0749-8063(98)70099-4
   Birk RZ, 2006, TISSUE ENG, V12, P21, DOI 10.1089/ten.2006.12.21
   Blunk T, 2002, TISSUE ENG, V8, P73, DOI 10.1089/107632702753503072
   Brown AN, 2000, TISSUE ENG, V6, P297, DOI 10.1089/107632700418029
   Buckwalter JA, 1998, J ORTHOP SPORT PHYS, V28, P192, DOI 10.2519/jospt.1998.28.4.192
   Bueno EM, 2005, TISSUE ENG, V11, P1699, DOI 10.1089/ten.2005.11.1699
   Darling EM, 2005, CELL TISSUE RES, V322, P463, DOI 10.1007/s00441-005-0020-4
   Darling EM, 2005, J ORTHOP RES, V23, P425, DOI 10.1016/j.orthres.2004.08.008
   Darling EM, 2003, ANN BIOMED ENG, V31, P1114, DOI 10.1114/1.1603752
   Demers C, 2002, BIO-MED MATER ENG, V12, P15
   Freed LE, 1998, EXP CELL RES, V240, P58, DOI 10.1006/excr.1998.4010
   Fricain JC, 1998, J DENT RES, V77, P406, DOI 10.1177/00220345980770020901
   Gooch KJ, 2002, TISSUE ENG, V8, P591, DOI 10.1089/107632702760240517
   Green D, 2002, BONE, V30, P810, DOI 10.1016/S8756-3282(02)00727-5
   Hu J, 2000, J MATER SCI TECHNOL, V16, P591
   Hu JC, 2005, BIOMATERIALS, V26, P2001, DOI 10.1016/j.biomaterials.2004.06.008
   HU JC, 2003, TISSUE ENG MUSCULOSK, P227
   Kellner K, 2002, TISSUE ENG, V8, P561, DOI 10.1089/107632702760240481
   KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5
   Kunisaki SM, 2006, STEM CELLS DEV, V15, P245, DOI 10.1089/scd.2006.15.245
   Liu YC, 2002, TISSUE ENG, V8, P709, DOI 10.1089/107632702760240616
   Mahmoudifar N, 2005, BIOMATERIALS, V26, P7012, DOI 10.1016/j.biomaterials.2005.04.062
   Martin I, 2000, BIORHEOLOGY, V37, P141
   Moran JM, 2003, TISSUE ENG, V9, P63, DOI 10.1089/107632703762687546
   O'Connor WJ, 2000, ORTHOP CLIN N AM, V31, P399, DOI 10.1016/S0030-5898(05)70159-0
   Ohgushi H, 1999, J BIOMED MATER RES, V48, P913, DOI 10.1002/(SICI)1097-4636(1999)48:6<913::AID-JBM22>3.0.CO;2-0
   Pietila K, 1999, CELLS TISSUES ORGANS, V164, P30, DOI 10.1159/000016640
   Risbud MV, 2002, TRENDS BIOTECHNOL, V20, P351, DOI 10.1016/S0167-7799(02)02016-4
   Sandell LJ, 2001, ARTHRITIS RES, V3, P107, DOI 10.1186/ar148
   Shany B, 2006, TISSUE ENG, V12, P1763, DOI 10.1089/ten.2006.12.1763
   Shany B, 2005, TISSUE ENG, V11, P585, DOI 10.1089/ten.2005.11.585
   Sittinger M, 1996, J BIOMED MATER RES, V33, P57, DOI 10.1002/(SICI)1097-4636(199622)33:2<57::AID-JBM1>3.0.CO;2-K
   VACANTI CA, 1993, TRANSPLANT P, V25, P1019
   Vago R, 2002, J BIOCHEM BIOPH METH, V50, P253, DOI 10.1016/S0165-022X(01)00235-4
   Vuola J, 1996, BIOMATERIALS, V17, P1761, DOI 10.1016/0142-9612(95)00351-7
   Vuola J, 2000, J BIOMED MATER RES, V51, P117, DOI 10.1002/(SICI)1097-4636(200007)51:1<117::AID-JBM15>3.0.CO;2-9
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
NR 41
TC 4
Z9 5
U1 0
U2 9
PU PROFESSIONAL ENGINEERING PUBLISHING LTD
PI WESTMINISTER
PA 1 BIRDCAGE WALK, WESTMINISTER SW1H 9JJ, ENGLAND
SN 0954-4119
J9 P I MECH ENG H
JI Proc. Inst. Mech. Eng. Part H-J. Eng. Med.
PD JAN
PY 2009
VL 223
IS H1
BP 63
EP 73
DI 10.1243/09544119JEIM424
PG 11
WC Engineering, Biomedical
SC Engineering
GA 410JS
UT WOS:000263573900006
PM 19239068
DA 2018-10-19
ER

PT S
AU Bouslama, N
   Ben Ayed, F
   Bouaziz, J
AF Bouslama, N.
   Ben Ayed, F.
   Bouaziz, J.
BE Cheikhrouhou, A
TI Mechanical properties of tricalcium phosphate-fluorapatite-alumina
   composites
SO PROCEEDINGS OF THE JMSM 2008 CONFERENCE
SE Physics Procedia
LA English
DT Proceedings Paper
CT 11th Maghreb Days Conference on Materials Science/JMSM 2008
CY NOV 04-08, 2008
CL Mahdia, TUNISIA
DE Biomaterial; Alumina; Sintering; Composites; Mechanical Properties
ID SINTERED FLUORAPATITE; BIOCERAMICS; ELABORATION; ATMOSPHERE
AB This study deals to produce tricalcium phosphate - fluorapatite composites sintering at various temperatures (1300 degrees C, 1350 degrees C and 1400 degrees C) and with different alumina additives amounts (2.5 wt%, 5 wt%, 7.5 wt%, 10 wt% and 20 wt%). The characterization of samples before and after sintering was investigated, using X-ray diffraction, infrared spectroscopy, scanning electronic microscopy and by analysis using (31)P and (27)Al nuclear magnetic resonance. Mechanical properties have been measured by Brazilian test. The evolution of composite rupture strength was studied as a function of sintering temperature. The effect of sintering on the mechanical properties was measured with the change in composition and microstructure of the composite. The mechanical resistances of composites were increased with the temperatures and with concentrations of alumina. At 1350 degrees C, the mechanical resistance reaches its maximum value with 5 wt % Al(2)O(3) (13.6 MPa) whereas the optimum density is about 90 % with 2.5 wt % Al(2)O(3). (C) 2009 Elsevier B.V. All rights reserved
C1 [Bouslama, N.; Ben Ayed, F.; Bouaziz, J.] Natl Sch Engn Sfax, Lab Ind Chem, Sfax 3038, Tunisia.
RP Ben Ayed, F (reprint author), Natl Sch Engn Sfax, Lab Ind Chem, BP 1173, Sfax 3038, Tunisia.
EM benayedfoued@yahoo.fr
OI bouaziz, jamel/0000-0002-2598-7302
CR [Anonymous], 1984, ANN BOOK ASTM STAND, V0.042, P336
   Ben Ayed F, 2001, ANN CHIM-SCI MAT, V26, P75, DOI 10.1016/S0151-9107(01)80101-X
   Ben Ayed F, 2001, J ALLOY COMPD, V322, P238, DOI 10.1016/S0925-8388(01)01200-2
   Ben Ayed F, 2000, J EUR CERAM SOC, V20, P1069, DOI 10.1016/S0955-2219(99)00272-1
   Ben Ayed F, 2008, CERAM INT, V34, P1885, DOI 10.1016/j.ceramint.2007.07.017
   Ben Ayed F, 2008, J EUR CERAM SOC, V28, P1995, DOI 10.1016/j.jeurceramsoc.2008.02.004
   Ben Ayed F, 2007, CR PHYS, V8, P101, DOI 10.1016/j.crhy.2006.10.017
   Ben Ayed F, 2006, CR PHYS, V7, P825, DOI 10.1016/j.crhy.2006.07.012
   Ben Ayed F, 2006, ANN CHIM-SCI MAT, V31, P393, DOI 10.3166/acsm.31.393-406
   BIENIAWSKI ZT, 1978, INT J ROCK MECH MIN, V15, P99
   Brunauer S., 1938, J AM CHEM SOC, V60, P310
   Chaari K, 2009, MATER CHEM PHYS, V113, P219, DOI 10.1016/j.matchemphys.2008.07.079
   DESTAINVILLE A, 2003, MATER CHEM PHYS, V80, P69
   Elliott JC, 1994, STRUCTURE CHEM APATI
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Kim HW, 2003, MAT SCI ENG C-BIO S, V23, P515, DOI 10.1016/S0928-4931(02)00355-7
   Kim S, 2002, J MATER SCI-MATER M, V13, P307, DOI 10.1023/A:1014019103240
   Kong YM, 1999, J AM CERAM SOC, V82, P2963
   Landi E, 2000, J EUR CERAM SOC, V20, P2377, DOI 10.1016/S0955-2219(00)00154-0
   Legeros Racquel Z., 1993, Clinical Materials, V14, P65, DOI 10.1016/0267-6605(93)90049-D
   Uwe P, 1993, J MATER SCI-MATER M, V4, P292
   Varma HK, 2001, MATER LETT, V49, P83, DOI 10.1016/S0167-577X(00)00346-3
   Wang CX, 2004, MATER CHARACT, V52, P301, DOI 10.1016/j.matchar.2004.06.007
NR 23
TC 9
Z9 9
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1875-3892
J9 PHYSCS PROC
PY 2009
VL 2
IS 3
BP 1441
EP 1448
DI 10.1016/j.phpro.2009.11.114
PG 8
WC Physics, Condensed Matter; Spectroscopy
SC Physics; Spectroscopy
GA BQW44
UT WOS:000282008100111
OA Other Gold
DA 2018-10-19
ER

PT J
AU Rayson, GD
   Williams, PA
AF Rayson, Gary D.
   Williams, Patrick A.
TI Competitive Metal Ion Binding to a Silicate-Immobilized Datura innoxia
   Biomaterial
SO SEPARATION SCIENCE AND TECHNOLOGY
LA English
DT Article
DE biosorption; competitive binding; Datura innoxia; metal ions
AB Metal ion binding with a flowing system to a biosorbent comprised of cultured cell-wall fragment within a polysilicate matrix has been investigated. Solutions containing 0.10mM Pb2+, Cu2+, Ni2+, Cd2+, and Zn2+ were exposed to the material in combinations of two, three, and five metals while simultaneously monitoring the concentration of all metals in the effluent stream. A relative affinity order of Pb2+Cu2+Zn2+Cd2+Ni2+ was determined when all five metal ions were exposed to the material. Lower-affinity metal ions were exposed to the material sequentially. Both metal-specific and common binding sites were observed for each metal ion. The presence of both binding sites that are common to all metal ions investigated and sites that appear to be unique for each metal ion could significantly impact the utility of single-metal ion studies on the application of such biosorbents for the selective removal of metal ions from natural water.
C1 [Rayson, Gary D.; Williams, Patrick A.] New Mexico State Univ, Dept Chem & Biochem, Las Cruces, NM 88003 USA.
RP Rayson, GD (reprint author), New Mexico State Univ, Dept Chem & Biochem, Box 30001 MSC 3C, Las Cruces, NM 88003 USA.
EM garayson@nmsu.edu
FU Waste-Management Education and Research Consortium through their
   Department of Energy; Department of Defense Graduate Fellowship
FX Financial support by the Waste-Management Education and Research
   Consortium through their Department of Energy research component and
   their Department of Defense Graduate Fellowship program (PAW) is
   gratefully acknowledged.
CR BARRER RM, 1953, J CHEM SOC, P4184
   BARRRETT EP, 1952, J IND ENG CHEM, V44, P1827
   Bedell G. W., 1990, IMMOBILIZATION NONVI, P313
   DARNALL DW, 1991, Patent No. 4992207
   DARNALL DW, 1989, HAZARDOUS WASTE TREA, P113
   Drake LR, 1996, ANAL CHEM, V1, P22
   Fourest E, 1996, ENVIRON SCI TECHNOL, V30, P277, DOI 10.1021/es950315s
   Gardea-Torresdey JL, 1999, J HAZARD MATER, V69, P41, DOI 10.1016/S0304-3894(99)00057-6
   Gardea-Torresdey JL, 2001, ENVIRON TOXICOL CHEM, V20, P2572, DOI 10.1897/1551-5028(2001)020<2572:AOCIBC>2.0.CO;2
   JACKSON PJ, 1993, DEV BIOL PLANT, V4, P220
   KUSKE CR, 1994, J BIOL CHEM, V269, P6223
   Lin S, 1996, ANAL CHEM, V68, P4087, DOI 10.1021/ac960569b
   Lin S, 2002, ADV ENVIRON RES, V6, P523, DOI 10.1016/S1093-0191(01)00078-8
   Stark P. C., 1999, ADV ENVIRON RES, V3, P74
   Stark PC, 2000, ADV ENVIRON RES, V4, P113, DOI 10.1016/S1093-0191(00)00012-5
   Volesky B., 2000, BIOL ABWASSERREINIGU, V14, P17
   Williams PA, 2003, J HAZARD MATER, V99, P277, DOI 10.1016/S0304-3894(03)00005-0
   Xia HY, 2002, ADV ENVIRON RES, V7, P157, DOI 10.1016/S1093-0191(01)00121-6
   Xia HY, 1998, ENVIRON SCI TECHNOL, V32, P2688, DOI 10.1021/es980171s
NR 19
TC 0
Z9 0
U1 1
U2 2
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 0149-6395
J9 SEPAR SCI TECHNOL
JI Sep. Sci. Technol.
PY 2009
VL 44
IS 4
BP 854
EP 873
AR PII 909210042
DI 10.1080/01496390802691299
PG 20
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA 414OU
UT WOS:000263874900004
DA 2018-10-19
ER

PT S
AU Lendlein, A
   Behl, M
AF Lendlein, Andreas
   Behl, Marc
BE Vincenzini, P
   Darrigo, G
TI Shape-Memory Polymers for Biomedical Applications
SO SMART MATERIALS & MICRO/NANOSYSTEMS
SE Advances in Science and Technology
LA English
DT Proceedings Paper
CT 3rd International Conference on Smart Materials, Structures and Systems
CY JUN 08-13, 2008
CL Acireale, ITALY
DE multi-functional polymer; triple shape polymer; shape-memory polymer;
   biomaterial
ID NETWORKS; SEGMENTS; LIGHT
AB Most polymers used in clinical applications today are materials that have been developed originally for application areas other than biomedicine. On the other side, different biomedical applications are demanding different combinations of material properties and functionalities. Compared to the intrinsic material properties, a functionality is not given by nature but result from the combination of the polymer architecture and a suitable process. Examples for functionalities that play a prominent role in the development of multifunctional polymers for medical applications are biofunctionality (e.g. cell or tissue specificity), degradability, or shape-memory functionality. In this sense, an important aim for developing multifunctional polymers is tailoring of biomaterials for specific biomedical applications. Here the traditional approach, which is designing a single new homo- or copolymer, reaches its limits. The strategy, that is applied here, is the development of polymer systems whose macroscopic properties can be tailored over a wide range by variation of molecular parameters.
   The Shape-memory capability of a material is its ability to trigger a predefined shape change by exposure to an external stimulus. A change in shape initiated by heat is called thermally-induced shape-memory effect. Thermally, light-, and magnetically induced shape-memory polymers will be presented, that were developed especially for minimally invasive surgery and other biomedical applications. Furthermore triple-shape polymers will be introduced, that have the capability to perform two subsequent shape changes. Thus enabling more complex movements of a polymeric material.
C1 [Lendlein, Andreas; Behl, Marc] GKSS Res Ctr Geesthacht GmbH, Polymer Res Inst, D-14513 Teltow, Germany.
RP Lendlein, A (reprint author), GKSS Res Ctr Geesthacht GmbH, Polymer Res Inst, Kantstr 55, D-14513 Teltow, Germany.
EM andreas.lendlein@gkss.de
RI Behl, Marc/K-9429-2013; Lendlein, Andreas/K-9553-2013
OI Behl, Marc/0000-0002-1507-0277; Lendlein, Andreas/0000-0003-4126-4670
CR Alteheld A, 2005, ANGEW CHEM INT EDIT, V44, P1188, DOI 10.1002/anie.200461360
   BEHL M, 2008, INTELLIGENT MAT
   BEHL M, 2007, SHAPE MEMORY POLYM
   Behl M, 2007, SOFT MATTER, V3, P58, DOI 10.1039/b610611k
   Behl M, 2007, MATER TODAY, V10, P20, DOI 10.1016/S1369-7021(07)70047-0
   Bellin I, 2006, P NATL ACAD SCI USA, V103, P18043, DOI 10.1073/pnas.0608586103
   Bellin I, 2007, J MATER CHEM, V17, P2885, DOI 10.1039/b702524f
   Choi NY, 2006, ADV ENG MATER, V8, P439, DOI 10.1002/adem.200600020
   El Feninat F, 2002, ADV ENG MATER, V4, P91, DOI 10.1002/1527-2648(200203)4:3<91::AID-ADEM91>3.0.CO;2-B
   Jiang HY, 2006, ADV MATER, V18, P1471, DOI 10.1002/adma.200502266
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Lendlein A, 2002, ANGEW CHEM INT EDIT, V41, P2034, DOI 10.1002/1521-3773(20020617)41:12<2034::AID-ANIE2034>3.0.CO;2-M
   Lendlein A, 2005, MATER SCI FORUM, V492-493, P219, DOI 10.4028/www.scientific.net/MSF.492-493.219
   Lendlein A, 2005, J POLYM SCI POL CHEM, V43, P1369, DOI 10.1002/pola.20598
   Lendlein A, 2001, P NATL ACAD SCI USA, V98, P842, DOI 10.1073/pnas.031571398
   Lendlein A, 2005, NATURE, V434, P879, DOI 10.1038/nature03496
   Maitland DJ, 2002, LASER SURG MED, V30, P1
   Mohr R, 2006, P NATL ACAD SCI USA, V103, P3540, DOI 10.1073/pnas.0600079103
   Yu YL, 2005, MACROMOL CHEM PHYS, V206, P1705, DOI 10.1002/macp.200500318
NR 19
TC 26
Z9 26
U1 0
U2 8
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1662-0356
BN 978-3-908158-20-2
J9 ADV SCI TECH
PY 2009
VL 54
BP 96
EP 102
PG 7
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA BJD42
UT WOS:000265012100013
DA 2018-10-19
ER

PT S
AU Corney, JR
   Torres-Sanchez, C
AF Corney, J. R.
   Torres-Sanchez, C.
GP ASME
TI TOWARDS FUNCTIONALLY GRADED CELLULAR MICROSTRUCTURES
SO SMASIS2008: PROCEEDINGS OF THE ASME CONFERENCE ON SMART MATERIALS,
   ADAPTIVE STRUCTURES AND INTELLIGENT SYSTEMS - 2008, VOL 1
SE Proceedings of the ASME Conference on Smart Materials Adaptive
   Structures and Intelligent Systems
LA English
DT Proceedings Paper
CT Conference on Smart Materials, Adaptive Structures and Intelligent
   Systems
CY OCT 28-30, 2008
CL Ellicott City, MD
SP ASME, Nanotechnol Inst
DE polymeric foam; graded porosity; sonication; manufacture
ID MECHANICAL-PROPERTIES; FABRICATION; ULTRASOUND; POROSITY; FOAMS;
   BIOMATERIALS; DIFFUSION; SCAFFOLDS
AB Many materials require functionally graded cellular microstructures whose porosity (i.e. ratio of the void to solid volume of a material) is engineered to meet specific requirements. Indeed numerous applications have demonstrated the engineering potential of porous materials (e.g. polymeric foams) in areas ranging from biomaterial science through to structural engineering.
   Although a huge variety of foams can be manufactured with homogenous porosity, for heterogeneous foams there are no generic processes for controlling the distribution of porosity throughout the resulting matrix. Motivated by the desire to create a flexible process for engineering heterogeneous foams, this paper reports how ultrasound, applied during some of the foaming stages of a polyurethane (PU) melt, affects both the cellular structure and distribution of the pore size.
   The experimental results allowed an empirical understanding of how the parameters of ultrasound exposure (i.e. frequency and acoustic pressure) influenced the volume and distribution of pores within the final polyurethane matrix: the data demonstrates that porosity (i.e. volume fraction) varies in direct proportion to the acoustic pressure magnitude of the ultrasound signal. The effects of ultrasound on porosity demonstrated by this work offer the prospect of a manufacturing process that can adjust the cellular geometry of foam and hence ensure that the resulting characteristics match the functional requirements.
C1 [Corney, J. R.; Torres-Sanchez, C.] Univ Strathclyde, DMEM, Glasgow G1 1XJ, Lanark, Scotland.
RP Corney, JR (reprint author), Univ Strathclyde, DMEM, James Weir Bldg, Glasgow G1 1XJ, Lanark, Scotland.
RI Torres-Sanchez, Carmen/A-8213-2010
OI Torres-Sanchez, Carmen/0000-0002-1649-2068
CR ALBERS VM, 1965, UNDERWATER ACOUSTICS, V2
   BALASUBRAMANIAM K, 2006, REV SCI INSTRUMENTS, V77
   Boccaccini AR, 1999, J POROUS MAT, V6, P369, DOI 10.1023/A:1009673814848
   Cheeke J. D. N., 2002, FUNDAMENTALS APPL UL
   Chen PY, 2008, J MECH BEHAV BIOMED, V1, P208, DOI 10.1016/j.jmbbm.2008.02.003
   CRUM LA, 1980, J ACOUST SOC AM, V68, P203, DOI 10.1121/1.384624
   Dutta D., 2001, J COMPUT INF SCI ENG, V1, P60, DOI DOI 10.1115/1.1355029
   FLOROS JD, 1994, FOOD TECHNOL-CHICAGO, V48, P79
   Font R, 2002, J APPL POLYM SCI, V85, P1945, DOI 10.1002/app.10745
   Gallego-Juarez JA, 2000, ULTRASONICS, V38, P331, DOI 10.1016/S0041-624X(99)00183-3
   GALLEGOJUAREZ JA, P IEEE ULTR S, P571
   Gibson L. G., 1997, CELLULAR SOLIDS STRU
   Jackson TR, 1999, MATER DESIGN, V20, P63, DOI 10.1016/S0261-3069(99)00011-4
   LEIGHTON TG, 1995, ULTRASON SONOCHEM, V2, pS123, DOI 10.1016/1350-4177(95)00021-W
   Malcolm AA, 2007, J MATER PROCESS TECH, V192, P391, DOI 10.1016/j.jmatprotec.2007.04.041
   Mano JF, 2005, MAT SCI ENG C-BIO S, V25, P93, DOI 10.1016/j.msec.2005.01.001
   Mason TJ, 2004, ULTRASON SONOCHEM, V11, P205, DOI 10.1016/j.ultsonch.2004.01.025
   Montminy MD, 2004, J COLLOID INTERF SCI, V280, P202, DOI 10.1016/j.jcis.2004.07.032
   Mulet A, 2003, FOOD SCI TECHNOL INT, V9, P215, DOI 10.1177/108201303034641
   Peng HX, 2000, J EUR CERAM SOC, V20, P807, DOI 10.1016/S0955-2219(99)00229-0
   Pitt William G, 2004, Expert Opin Drug Deliv, V1, P37, DOI 10.1517/17425247.1.1.37
   Price GJ, 2002, EUR POLYM J, V38, P1531, DOI 10.1016/S0014-3057(02)00039-3
   Raum K, 2006, PHYS MED BIOL, V51, P747, DOI 10.1088/0031-9155/51/3/018
   ROJAS AJ, 1982, POLYM ENG SCI, V22, P840, DOI 10.1002/pen.760221310
   Taboas JM, 2003, BIOMATERIALS, V24, P181, DOI 10.1016/S0142-9612(02)00276-4
   Torres-Sanchez C, 2008, ULTRASON SONOCHEM, V15, P408, DOI 10.1016/j.ultsonch.2007.05.002
   TORRESSSNCHEZ C, 2008, THESIS HERIOTWATT U
   van Tienen TG, 2002, BIOMATERIALS, V23, P1731, DOI 10.1016/S0142-9612(01)00280-0
   Yan YN, 2003, MATER LETT, V57, P2623, DOI 10.1016/S0167-577X(02)01339-3
   YOSHIZAWA M, 2004, ULTR S 2004 IEEE, V1763, P1769
   Zhang XD, 1999, J COLLOID INTERF SCI, V215, P270, DOI 10.1006/jcis.1999.6233
NR 31
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
SN 2153-2001
BN 978-0-7918-4331-4
J9 PROC ASME CONF SMART
PY 2009
BP 45
EP 53
PG 9
WC Computer Science, Artificial Intelligence; Engineering, Mechanical;
   Materials Science, Multidisciplinary
SC Computer Science; Engineering; Materials Science
GA BJE63
UT WOS:000265211900006
DA 2018-10-19
ER

PT J
AU Allan, IU
   Shevchenko, RV
   Rowshanravan, B
   Kara, B
   Jahoda, CA
   James, SE
AF Allan, I. U.
   Shevchenko, R. V.
   Rowshanravan, B.
   Kara, B.
   Jahoda, C. A.
   James, S. E.
TI THE USE OF CONFOCAL LASER SCANNING MICROSCOPY TO ASSESS THE POTENTIAL
   SUITABILITY OF 3D SCAFFOLDS FOR TISSUE REGENERATION, BY MONITORING
   EXTRA-CELLULAR MATRIX DEPOSITION AND BY QUANTIFYING CELLULAR
   INFILTRATION AND PROLIFERATION
SO SOFT MATERIALS
LA English
DT Article
DE -smooth muscle actin; Alexafluor; Biocompatibility; Collagen I;
   Fibronectin; Image analysis
ID FULL-THICKNESS WOUNDS; DERMAL SUBSTITUTE; MTT ASSAY; IN-VITRO; SKIN;
   KERATINOCYTES; FIBROBLASTS; FIBRIN; BIOLUMINESCENCE; CYTOTOXICITY
AB The great many varieties of dermal regeneration materials currently being developed requires that sound in vitro assessments of their potential to be infiltrated with host cells are needed prior to any in vivo studies. The biocompatibility of scaffolds is conventionally determined by indirect biochemical assays as measures of cell number/viability within these materials. A disadvantage of these methods is the failure to provide information pertaining to the spatial distribution of cells in situ. In the case of dermal regeneration, if cells are only present in appreciable numbers on the outer portion of a scaffold, then critical aspects such as extra-cellular matrix (ECM) production and vascularization will be limited, and the likelihood of successful tissue regeneration low. Thus, direct enumeration of cells within scaffolds, with respect to spatial distribution and time, is required to adequately assess the potential biocompatibility. In this article we demonstrate a systematic approach to the quantification of infiltration and proliferation of primary human dermal fibroblasts into the dermal regeneration scaffold, Integra (R) (the most frequently used dermal regeneration template in burns patients), using confocal laser scanning microscopy (CLSM). Scaffold samples were placed on top of confluent cell layers and infiltrated by cells migrating from the culture dish against gravity. Cells were then enumerated (by nuclear staining) with respect to their location within the scaffold and over a time period of up to 28 days. Large increases in cell numbers were observed on the surface of the scaffolds, together with measurable increases in cell numbers within their interiors. We also describe the immunofluorescent staining of fibroblasts and ECM components as well as the subsequent use of CLSM to qualitatively assess the potential for scaffold re-modeling. Of particular note was the cellular deposition of a ofronto of fibronectin matching the maximum extent of cell infiltration at each time point. We suggest that this key ECM component is a useful indicator of the extent of cellular re-modeling of a biomaterial.
C1 [Allan, I. U.; Shevchenko, R. V.; Rowshanravan, B.; James, S. E.] Univ Brighton, Sch Pharm & Biomol Sci, Brighton BN2 4GJ, E Sussex, England.
   [Kara, B.] Avecia Biol, Billingham, Cleveland, England.
   [Jahoda, C. A.] Univ Durham, Dept Biol Sci, Durham, England.
RP Allan, IU (reprint author), Univ Brighton, Sch Pharm & Biomol Sci, Brighton BN2 4GJ, E Sussex, England.
EM i.u.allan@brighton.ac.uk
FU Technology Strategy Board (TSB) [TP/4/BIO/6/1/22353]; DTI [MMP4.5]
FX This work was funded by The Technology Strategy Board (TSB) (project
   number: TP/4/BIO/6/1/22353). TSB is a business-led executive
   non-departmental public body, established by the government. Its mission
   is to promote and support research into, and development and
   exploitation of, technology and innovation for the benefit of U. K.
   business, in order to increase economic growth and improve the quality
   of life. It is sponsored by the Department for Innovation, Universities
   and Skills (DIUS). Please visit www.innovateuk.org for further
   information.; The primary human fibroblast cell strain SKF371 was
   produced in-house as part of a cell bank developed during a DTI-funded
   project (MMP4.5).
CR AHMED SA, 1994, J IMMUNOL METHODS, V170, P211
   Bannasch H, 2008, BURNS, V34, P1015, DOI 10.1016/j.burns.2007.12.009
   Bopp Stephanie K., 2008, BMC Pharmacology, V8, P8, DOI 10.1186/1471-2210-8-8
   CROUCH SPM, 1993, J IMMUNOL METHODS, V160, P81, DOI 10.1016/0022-1759(93)90011-U
   Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2
   DESAI M H, 1991, Journal of Burn Care and Rehabilitation, V12, P540, DOI 10.1097/00004630-199111000-00009
   Eckes B, 2000, MATRIX BIOL, V19, P325, DOI 10.1016/S0945-053X(00)00077-9
   Funk D, 2007, BIOTECHNIQUES, V43, P178, DOI 10.2144/000112528
   Gilbert TW, 2009, J SURG RES, V152, P135, DOI 10.1016/j.jss.2008.02.013
   Greiling D, 1997, J CELL SCI, V110, P861
   Hansbrough John F., 1992, Journal of Burn Care and Rehabilitation, V13, P519, DOI 10.1097/00004630-199209000-00004
   Harrison CA, 2008, BURNS, V34, P153, DOI 10.1016/j.burns.2007.08.011
   Hinz B, 2001, MOL BIOL CELL, V12, P2730, DOI 10.1091/mbc.12.9.2730
   Jones I, 2003, WOUND REPAIR REGEN, V11, P132, DOI 10.1046/j.1524-475X.2003.11209.x
   KANGAS L, 1984, MED BIOL, V62, P338
   Lamme EN, 2000, J PATHOL, V190, P595, DOI 10.1002/(SICI)1096-9896(200004)190:5<595::AID-PATH572>3.0.CO;2-V
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Mahoney MJ, 2006, BIOMATERIALS, V27, P2265, DOI 10.1016/j.biomaterials.2005.11.007
   Mandal BB, 2008, MACROMOL BIOSCI, V8, P807, DOI 10.1002/mabi.200800113
   Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Ng KW, 2004, BIOMATERIALS, V25, P2807, DOI 10.1016/j.biomaterials.2003.09.058
   PARENTEAU NL, 1992, CYTOTECHNOLOGY, V9, P163, DOI 10.1007/BF02521744
   Rowe SL, 2006, BIOMACROMOLECULES, V7, P2942, DOI 10.1021/bm0602233
   Shevchenko RV, 2008, WOUND REPAIR REGEN, V16, P198, DOI 10.1111/j.1524-475X.2008.00360.x
   Stamenkovic I, 2003, J PATHOL, V200, P448, DOI 10.1002/path.1400
   Vellonen KS, 2004, EUR J PHARM SCI, V23, P181, DOI 10.1016/j.ejps.2004.07.006
   Wang HJ, 2004, TISSUE ENG, V10, P1054, DOI 10.1089/1076327041887709
   Wierzbicka-Patynowski I, 2003, J CELL SCI, V116, P3269, DOI 10.1242/jcs.00670
NR 29
TC 2
Z9 2
U1 0
U2 11
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1539-445X
EI 1539-4468
J9 SOFT MATER
JI Soft Mater.
PY 2009
VL 7
IS 4
BP 319
EP 341
AR PII 917253382
DI 10.1080/15394450903372679
PG 23
WC Materials Science, Multidisciplinary
SC Materials Science
GA 528XX
UT WOS:000272481400007
DA 2018-10-19
ER

PT J
AU Pepe, A
   Armenante, MR
   Bochicchio, B
   Tamburro, AM
AF Pepe, Antonietta
   Armenante, Maria Rosaria
   Bochicchio, Brigida
   Tamburro, Antonio Mario
TI Formation of nanostructures by self-assembly of an elastin peptide
SO SOFT MATTER
LA English
DT Article
ID AMYLOID FIBRIL FORMATION; RAMAN OPTICAL-ACTIVITY; POLYPROLINE-II; HUMAN
   TROPOELASTIN; SUPRAMOLECULAR ORGANIZATION; UNFOLDED PROTEINS;
   NMR-SPECTROSCOPY; COLLAGEN MODELS; IN-VITRO; CONFORMATION
AB Elastin and elastin-related peptides have great potential in the biomaterial field, because of their peculiar mechanical properties and spontaneous self-assembling behavior. Depending on their sequences and under appropriate experimental conditions, they are able to self-assemble in different fiber morphologies, including amyloid-like fibers. Temperature-triggered self-assembly of a small elastin peptide shows a novel complex aggregation mechanism as revealed by different microscopy techniques. The conformations of the peptide have been investigated in solution and in the aggregated state by different spectroscopic techniques (CD, NMR, FT-IR) and revealed that the conformations adopted by the peptides in water in the prefibrillar state correspond to those populated by other elastin peptides, mainly polyproline II helix (PPII) and random coil. Conversely, the aggregated state shows evidence for antiparallel cross-beta structures. Our molecular studies highlight the important role of PPII conformation on the prefibrillar state, putting forward the hypothesis that aggregation takes place through addition of the monomer in the PPII conformation with preformed beta-sheet aggregates and/or through direct interaction of PPII helices.
C1 [Pepe, Antonietta; Armenante, Maria Rosaria; Bochicchio, Brigida; Tamburro, Antonio Mario] Univ Basilicata, Dept Chem, I-85100 Potenza, Italy.
RP Tamburro, AM (reprint author), Univ Basilicata, Dept Chem, Via N Sauro 85, I-85100 Potenza, Italy.
EM antonio.tamburro@unibas.it
RI Pepe, Antonietta/J-2489-2012; Bochicchio, Brigida/P-2912-2015
OI Pepe, Antonietta/0000-0002-1285-2273; Bochicchio,
   Brigida/0000-0002-0700-9257
FU EU [018960]
FX We thank Dr Angelo De Stradis for TEM micrographs. Mr Alessandro Laurita
   for TEM and ESEM micrographs. Dr Roberta Flamia for AFM images. The
   financial support of EU (Elastage - Contract no. 018960) is gratefully
   acknowledged.
CR BANDEKAR J, 1992, BIOCHIM BIOPHYS ACTA, V1120, P123, DOI 10.1016/0167-4838(92)90261-B
   Bellingham CM, 2003, BIOPOLYMERS, V70, P445, DOI 10.1002/bip.10512
   Bellingham CM, 2001, BBA-PROTEIN STRUCT M, V1550, P6, DOI 10.1016/S0167-4838(01)00262-X
   Blanch EW, 2004, J MOL BIOL, V343, P467, DOI 10.1016/j.jmb.2004.08.058
   Blanch EW, 2000, J MOL BIOL, V301, P553, DOI 10.1006/jmbi.2000.3981
   Bochicchio B, 2002, CHIRALITY, V14, P782, DOI 10.1002/chir.10153
   BOCHICCHIO B, 2008, CHIRALITY
   Bochicchio B, 2007, BIOMACROMOLECULES, V8, P3478, DOI 10.1021/bm700636a
   BRESSAN GM, 1987, BIOCHEMISTRY-US, V26, P1497, DOI 10.1021/bi00380a001
   Calamai M, 2005, BIOPHYS J, V89, P4201, DOI 10.1529/biophysj.105.068726
   Channon K, 2008, SOFT MATTER, V4, P647, DOI 10.1039/b713013a
   CHERNY I, 2008, BIOMACROMOLECULES, V7, P2776
   Chilkoti A, 2006, CURR OPIN CHEM BIOL, V10, P652, DOI 10.1016/j.cbpa.2006.10.010
   Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901
   Clarke AW, 2006, BIOCHEMISTRY-US, V45, P9989, DOI 10.1021/bi0610092
   DAVIS DG, 1985, J AM CHEM SOC, V107, P2820, DOI 10.1021/ja00295a052
   del Mercato LL, 2008, BIOMACROMOLECULES, V9, P796, DOI 10.1021/bm7010104
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   DOYLE BB, 1971, BIOCHEMISTRY-US, V10, P3052
   Eker F, 2004, BIOCHEMISTRY-US, V43, P6893, DOI 10.1021/bi049542+
   Fiebig KM, 1996, J PHYS CHEM-US, V100, P2661, DOI 10.1021/jp952747v
   Flamia R, 2004, BIOMACROMOLECULES, V5, P1511, DOI 10.1021/bm049930r
   Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003
   Goddard T. D., SPARKY
   Hill EK, 2006, BIOMACROMOLECULES, V7, P10, DOI 10.1021/bm050578
   HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047
   JACKSON M, 1995, CRIT REV BIOCHEM MOL, V30, P95, DOI 10.3109/10409239509085140
   Jarvet J, 2003, FEBS LETT, V555, P371, DOI 10.1016/S0014-5793(03)01293-6
   JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208
   Knowles TP, 2007, SCIENCE, V318, P1900, DOI 10.1126/science.1150057
   Kozel BA, 2003, J BIOL CHEM, V278, P18491, DOI 10.1074/jbc.M212715200
   Krebs MRH, 2007, BIOPHYS J, V92, P1336, DOI 10.1529/biophysj.106.094342
   Krebs MRH, 2004, P NATL ACAD SCI USA, V101, P14420, DOI 10.1073/pnas.0405933101
   Krysmann MJ, 2007, SOFT MATTER, V3, P1401, DOI 10.1039/b709889h
   Monsellier E, 2007, EMBO REP, V8, P737, DOI 10.1038/sj.embor.7401034
   MOORE WH, 1975, P NATL ACAD SCI USA, V72, P4933, DOI 10.1073/pnas.72.12.4933
   Nagapudi K, 2005, BIOMATERIALS, V26, P4695, DOI 10.1016/j.biomaterials.2004.11.027
   Nilsson MR, 2004, METHODS, V34, P151, DOI 10.1016/j.ymeth.2004.03.012
   Pepe A, 2005, MATRIX BIOL, V24, P96, DOI 10.1016/j.matbio.2005.01.004
   Pepe A, 2007, NANOMEDICINE-UK, V2, P203, DOI 10.2217/17435889.2.2.203
   Rodriguez-Cabello JC, 2004, ADV EXP MED BIOL, V553, P45
   ROSE GD, 1985, ADV PROTEIN CHEM, V37, P1, DOI 10.1016/S0065-3233(08)60063-7
   SEGAL DM, 1969, J MOL BIOL, V43, P487, DOI 10.1016/0022-2836(69)90354-4
   Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317
   Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897
   Sharman GJ, 1998, J AM CHEM SOC, V120, P5291, DOI 10.1021/ja9705405
   Shi ZS, 2002, ADV PROTEIN CHEM, V62, P163
   Syme CD, 2002, EUR J BIOCHEM, V269, P148, DOI 10.1046/j.0014-2956.2001.02633.x
   Tamburro A. M., 1990, ELASTIN CHEM BIOL AS, P127
   TAMBURRO AM, 1992, J BIOMOL STRUCT DYN, V10, P441, DOI 10.1080/07391102.1992.10508661
   Tamburro AM, 2005, J BIOL CHEM, V280, P2682, DOI 10.1074/jbc.M411617200
   Tamburro AM, 2003, BIOCHEMISTRY-US, V42, P13347, DOI 10.1021/bi034837t
   TIFFANY ML, 1968, BIOPOLYMERS, V6, P1379, DOI 10.1002/bip.1968.360060911
   Trabbic-Carlson K, 2003, BIOMACROMOLECULES, V4, P572, DOI 10.1021/bm025671z
   TRAUB W, 1969, J MOL BIOL, V43, P479, DOI 10.1016/0022-2836(69)90353-2
   Uversky VN, 2007, NANOMEDICINE-UK, V2, P615, DOI 10.2217/17435889.2.5.615
   Wagenseil Jessica E., 2007, Birth Defects Research, V81, P229, DOI 10.1002/bdrc.20111
   WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010
   WOODY RW, 1992, ADV BIOPHYS CHEM, V2, P37
   Wuthrich K., 1986, NMR PROTEINS NUCL AC
   Zhang JH, 2006, NEUROL RES, V28, P687, DOI 10.1179/016164106X154438
NR 61
TC 12
Z9 12
U1 0
U2 16
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
J9 SOFT MATTER
JI Soft Matter
PY 2009
VL 5
IS 1
BP 104
EP 113
DI 10.1039/b811286j
PG 10
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA 406CH
UT WOS:000263272100014
DA 2018-10-19
ER

PT J
AU Straley, KS
   Heilshorn, SC
AF Straley, Karin S.
   Heilshorn, Sarah C.
TI Independent tuning of multiple biomaterial properties using protein
   engineering
SO SOFT MATTER
LA English
DT Article
ID SPINAL-CORD-INJURY; EXTRACELLULAR-MATRIX PROTEINS; CELL-MIGRATION; NERVE
   REGENERATION; NEURITE OUTGROWTH; NEURAL TISSUE; GUIDANCE CHANNELS;
   PERIPHERAL-NERVES; AXONAL GROWTH; HYDROGEL
AB A key attribute missing from many current biomaterials is the ability to independently tune multiple biomaterial properties without simultaneously affecting other material parameters. Because cells are well known to respond to changes in the initial elastic modulus, degradation rate, and cell adhesivity of a biomaterial, it is critical to develop synthetic design strategies that allow decoupled tailoring of each individual parameter in order to systematically optimize cell-scaffold interactions. We present the development of a biomimetic scaffold composed of chemically crosslinked, elastin-like proteins designed to support neural regeneration through a combination of cell adhesion and cell-induced degradation and remodeling. The design of these engineered proteins includes cell adhesion sequences to enable neuronal attachment as well as sequences sensitive to cleavage by urokinase plasminogen activator (uPA), a protease locally secreted from the tips of growing neurites, to enable highly localized and tunable degradation properties. These engineered proteins are produced using recombinant techniques and chemically crosslinked into highly swollen hydrogels with controllable mechanical properties. Through a modest 3% change in the chemical identity of three otherwise identical engineered proteins, we can modify the uPA substrate specificity resulting in tunable changes in protease degradation half-life over two orders of magnitude. Under high uPA exposure, the designed scaffolds exhibit systematic variation of scaffold lifetime, from being fully degraded within a single day to showing no noticeable degradation within a full week. In vitro studies using the model PC-12 neuronal-like cell line show that the crosslinked proteins support tunable cell adhesion and neuronal differentiation. Increasing the density of RGD peptides present in the protein substrates leads to increased cell adhesion and more extensive neurite outgrowth. These engineered proteins offer the ability to independently tailor the mechanics, degradation properties, and cell adhesivity of scaffolds for the study of central nervous system regeneration.
C1 [Heilshorn, Sarah C.] Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA.
   [Straley, Karin S.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.
RP Heilshorn, SC (reprint author), Stanford Univ, Dept Mat Sci & Engn, 476 Lomita Mall,McCullough Bldg,Room 246, Stanford, CA 94305 USA.
EM heilshorn@stanford.edu
FU National Academies Keck Futures Initiative; John and Ulla deLarios
   Scholar Fund; Hellman Faculty Scholar Fund
FX The authors acknowledge funding support from the National Academies Keck
   Futures Initiative, the John and Ulla deLarios Scholar Fund, and the
   Hellman Faculty Scholar Fund. We thank the Stanford Center on Polymer
   Interfaces and Macromolecular Assemblies for the use of equipment.
CR Bakshi A, 2004, J NEUROSURG-SPINE, V1, P322, DOI 10.3171/spi.2004.1.3.0322
   Balgude AP, 2001, BIOMATERIALS, V22, P1077, DOI 10.1016/S0142-9612(00)00350-1
   BANKER GA, 1998, CULTURING NERVE CELL
   Belkas JS, 2005, BIOMATERIALS, V26, P1741, DOI 10.1016/j.biomaterials.2004.05.031
   Belkas JS, 2004, NEUROL RES, V26, P151, DOI 10.1179/016164104225013798
   Dalton PD, 2002, BIOMATERIALS, V23, P3843, DOI 10.1016/S0142-9612(02)00120-5
   Davis ME, 2005, CIRC RES, V97, P8, DOI 10.1161/01.RES.0000173376.39447.01
   Di Zio K, 2003, MACROMOLECULES, V36, P1553, DOI 10.1021/ma0256587
   Fehlings MG, 2006, SPINE, V31, pS28, DOI 10.1097/01.brs.0000217973.11402.7f
   Fischer H, 2004, PROTEIN SCI, V13, P2825, DOI 10.1110/ps.04688204
   Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/01.wnr.0000048003.96487.97
   Freier T, 2005, BIOMATERIALS, V26, P5872, DOI 10.1016/j.biomaterials.2005.02.033
   Fung YC, 1993, BIOMECHANICS MECH PR
   Galtrey CM, 2007, BRAIN, V130, P926, DOI 10.1093/brain/awl372
   Gazzano-Santoro H, 1999, J PHARMACEUT BIOMED, V21, P945, DOI 10.1016/S0731-7085(99)00225-3
   Geller HM, 2002, EXP NEUROL, V174, P125, DOI 10.1006/exnr.2002.7865
   Harris JL, 2000, P NATL ACAD SCI USA, V97, P7754, DOI 10.1073/pnas.140132697
   Heilshorn SC, 2005, BIOMACROMOLECULES, V6, P318, DOI 10.1021/bm049627q
   Heilshorn SC, 2003, BIOMATERIALS, V24, P4245, DOI 10.1016/S0142-9612(03)00294-1
   Huang YC, 2006, ARTIF ORGANS, V30, P514, DOI 10.1111/j.1525-1594.2006.00253.x
   IJkema-Paassen J, 2004, BIOMATERIALS, V25, P1583, DOI 10.1016/S0142-9612(03)00504-0
   Inoue N, 2006, J BIOMAT SCI-POLYM E, V17, P837, DOI 10.1163/156856206777996835
   Ke SH, 1997, J BIOL CHEM, V272, P20456, DOI 10.1074/jbc.272.33.20456
   Kim S, 2005, J BIOMED MATER RES A, V75A, P73, DOI 10.1002/jbm.a.30375
   Leach JB, 2007, J NEURAL ENG, V4, P26, DOI 10.1088/1741-2560/4/2/003
   Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j
   Levesque SG, 2007, BIOCONJUGATE CHEM, V18, P874, DOI 10.1021/bc0602127
   Little L, 2008, CHEM REV, V108, P1787, DOI 10.1021/cr078228t
   Liu JC, 2004, BIOMACROMOLECULES, V5, P497, DOI 10.1021/bm034340z
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Mahoney MJ, 2006, BIOMATERIALS, V27, P2265, DOI 10.1016/j.biomaterials.2005.11.007
   McHale MK, 2005, TISSUE ENG, V11, P1768, DOI 10.1089/ten.2005.11.1768
   Meiners S, 2003, MOL NEUROBIOL, V27, P177, DOI 10.1385/MN:27:2:177
   Metters AT, 2000, POLYMER, V41, P3993, DOI 10.1016/S0032-3861(99)00629-1
   Meyer DE, 1999, NAT BIOTECHNOL, V17, P1112, DOI 10.1038/15100
   Musoke-Zawedde P, 2006, BIOMED MATER, V1, P162, DOI 10.1088/1748-6041/1/3/011
   NICOL A, 1992, J BIOMED MATER RES, V26, P393, DOI 10.1002/jbm.820260309
   Nomura H, 2006, J NEUROTRAUM, V23, P496, DOI 10.1089/neu.2006.23.496
   Novikova LN, 2003, CURR OPIN NEUROL, V16, P711, DOI 10.1097/01.wco.0000102620.38669.3e
   Nowatzki PJ, 2004, BIOMATERIALS, V25, P1261, DOI 10.1016/S0142-9612(03)000365-5
   Oakland RJ, 2006, P I MECH ENG H, V220, P489, DOI [10.1243/09544119JETM135, 10.1243/09544119JEIMI135]
   Oudega M, 2001, BIOMATERIALS, V22, P1125, DOI 10.1016/S0142-9612(00)00346-X
   Ozawa H, 2001, J NEUROSURG, V95, P221, DOI 10.3171/spi.2001.95.2.0221
   Peppas NA, 2000, ANNU REV BIOMED ENG, V2, P9, DOI 10.1146/annurev.bioeng.2.1.9
   Pittier R, 2005, J NEUROBIOL, V63, P1, DOI 10.1002/neu.20116
   PITTMAN RN, 1989, J NEUROSCI, V9, P4269
   RICHARDSON PM, 1980, NATURE, V284, P264, DOI 10.1038/284264a0
   Rizzi SC, 2006, BIOMACROMOLECULES, V7, P3019, DOI 10.1021/bm060504a
   SAWHNEY AS, 1993, MACROMOLECULES, V26, P581, DOI 10.1021/ma00056a005
   Schlosshauer B, 2006, NEUROSURGERY, V59, P740, DOI 10.1227/01.NEU.0000235197.36789.42
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Schwab ME, 2002, SCIENCE, V295, P1029, DOI 10.1126/science.1067840
   Seeds NW, 1997, CELL TISSUE RES, V290, P367, DOI 10.1007/s004410050942
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008
   URRY DW, 1991, J BIOACT COMPAT POL, V6, P263, DOI 10.1177/088391159100600306
   URRY DW, 1992, BIOPOLYMERS, V32, P1243, DOI 10.1002/bip.360320913
   West JL, 1999, MACROMOLECULES, V32, P241, DOI 10.1021/ma981296k
   Woerly S, 2001, BIOMATERIALS, V22, P1095, DOI 10.1016/S0142-9612(00)00354-9
   Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535
   Yamaguchi I, 2003, BIOMATERIALS, V24, P3285, DOI 10.1016/S0142-9612(03)00163-7
   Young RC, 2002, BRIT J PLAST SURG, V55, P235, DOI 10.1054/bjps.2002.3798
   Yu LMY, 2007, J BIOMED MATER RES A, V82A, P243, DOI 10.1002/jbm.a.31069
   Zaman MH, 2007, ANN BIOMED ENG, V35, P91, DOI 10.1007/s10439-006-9205-6
NR 64
TC 98
Z9 99
U1 4
U2 67
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
J9 SOFT MATTER
JI Soft Matter
PY 2009
VL 5
IS 1
BP 114
EP 124
DI 10.1039/b808504h
PG 11
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA 406CH
UT WOS:000263272100015
DA 2018-10-19
ER

PT J
AU Schultz, KM
   Baldwin, AD
   Kiick, KL
   Furst, EM
AF Schultz, Kelly M.
   Baldwin, Aaron D.
   Kiick, Kristi L.
   Furst, Eric M.
TI Rapid rheological screening to identify conditions of biomaterial
   hydrogelation
SO SOFT MATTER
LA English
DT Article
ID PEG HYDROGELS; MICRORHEOLOGY; MATRICES; GELATION
AB Hydrogels engineered for biomedical applications consist of numerous components, each of which can affect the material assembly and final mechanical properties. We present methods that rapidly generate rheological libraries to identify regimes of hydrogel assembly in a large composition parameter space. This method conserves both material and time, and leads to critical insight into assembly mechanisms and mechanics, which can then be used for further materials development and optimization.
C1 [Schultz, Kelly M.; Furst, Eric M.] Univ Delaware, Dept Chem Engn, Newark, DE 19716 USA.
   [Schultz, Kelly M.; Furst, Eric M.] Univ Delaware, Ctr Mol & Engn Thermodynam, Newark, DE 19716 USA.
   [Baldwin, Aaron D.; Kiick, Kristi L.] Univ Delaware, Dept Mat Sci & Engn, Newark, DE 19716 USA.
   [Baldwin, Aaron D.; Kiick, Kristi L.] Univ Delaware, Delaware Biotechnol Inst, Newark, DE 19716 USA.
RP Furst, EM (reprint author), Univ Delaware, Dept Chem Engn, 150 Acad St, Newark, DE 19716 USA.
EM furst@udel.edu
OI Furst, Eric/0000-0002-8849-4484
FU National Institutes of Health [1 R01 EB003172-01]; National Science
   Foundation Graduate Research Fellowship (K.M.S.); National Science
   Foundation IGERT [DGE-0221651]
FX The authors acknowledge the financial support of the National Institutes
   of Health (1 R01 EB003172-01), a National Science Foundation Graduate
   Research Fellowship (K.M.S.), and the National Science Foundation IGERT
   (DGE-0221651).
CR Benoit DSW, 2007, BIOMATERIALS, V28, P66, DOI 10.1016/j.biomaterials.2006.08.033
   Breedveld V, 2003, J MATER SCI, V38, P4461, DOI 10.1023/A:1027321232318
   Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Flory PJ, 1941, J AM CHEM SOC, V63, P3083, DOI 10.1021/ja01856a061
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Larsen T, 2008, KOREA-AUST RHEOL J, V20, P165
   Larsen TH, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.146001
   Lee KY, 2000, NATURE, V408, P998
   MASON TG, 1995, PHYS REV LETT, V74, P1250, DOI 10.1103/PhysRevLett.74.1250
   Nie T, 2007, J CONTROL RELEASE, V122, P287, DOI 10.1016/j.jconrel.2007.04.019
   Raeber GP, 2005, BIOPHYS J, V89, P1374, DOI 10.1529/biophysj.104.050682
   Savin T, 2005, BIOPHYS J, V88, P623, DOI [10.1529/biophysj.104.042457, 10.1529/biophysj.104.04245]
   Seal BL, 2006, MACROMOLECULES, V39, P2268, DOI 10.1021/ma0524528
   Veerman C, 2006, MACROMOLECULES, V39, P6608, DOI 10.1021/ma0609331
   Yamaguchi N, 2007, J AM CHEM SOC, V129, P3040, DOI 10.1021/ja0680358
NR 16
TC 23
Z9 23
U1 1
U2 14
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
J9 SOFT MATTER
JI Soft Matter
PY 2009
VL 5
IS 4
BP 740
EP 742
DI 10.1039/b818178k
PG 3
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA 406CJ
UT WOS:000263272300005
PM 20046915
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Bulwan, M
   Zapotoczny, S
   Nowakowska, M
AF Bulwan, Maria
   Zapotoczny, Szczepan
   Nowakowska, Maria
TI Robust "one-component" chitosan-based ultrathin films fabricated using
   layer-by-layer technique
SO SOFT MATTER
LA English
DT Article
ID POLYELECTROLYTE MULTILAYERS; HEPARIN; CHITIN; WATER; PH; COMPLEXATION;
   CONSTRUCTION; BIOMATERIAL; DELIVERY; BEHAVIOR
AB "One-component" chitosan-based multilayer films have been formed and characterized for the first time. Two derivatives of chitosan containing oppositely charged strong ionic groups were synthesized for that purpose. Low molecular weight chitosan was modified by glycidyltrimethylammonium chloride to obtain the cationic form (CCh) of the polymer. The anionic form of chitosan (ACh) was obtained by sulfonation of carboxymethylchitosan with trimethylamine-sulfur trioxide. The two derivatives of chitosan were used to prepare stable multilayer polyelectrolyte films through a layer-by-layer (LbL) deposition technique. The films revealed smooth surfaces and linear growth of the thickness during LbL adsorption as measured by atomic force microscope (AFM). Contact angle measurements revealed a very hydrophilic nature of the formed films. In contrast, the hybrid films, made of one of the chitosan derivatives and the synthetic oppositely charged polyelectrolyte, demonstrated non-linear growths and much higher surface roughnesses. So far, the multilayer films built of natural polymers like chitosan and alginate as well as the mentioned hybrid films have shown difficulties in regular formation related to the differences in polymer backbones and/or the charge distribution along them. The approach proposed here omits the inherent entropic barrier and leads to the controlled formation of robust "one-component" multilayer films. The entropy-driven formation of such films was also supported by the calorimetric studies on the model polyelectrolyte complexes in solution. Thanks to biocompatibility and bacteriostatic properties of chitosan and its derivatives, CCh/ACh multilayer films may be potentially useful for many biomedical and environmental protection applications.
C1 [Bulwan, Maria; Zapotoczny, Szczepan; Nowakowska, Maria] Jagiellonian Univ, Fac Chem, PL-30060 Krakow, Poland.
RP Bulwan, M (reprint author), Jagiellonian Univ, Fac Chem, Ingardena 3, PL-30060 Krakow, Poland.
RI Zapotoczny, Szczepan/A-4987-2012
OI Zapotoczny, Szczepan/0000-0001-6662-7621
FU The Polish Ministry of Science and Higher Education [N205 105435]
FX The Authors would like to acknowledge financial support of The Polish
   Ministry of Science and Higher Education in the form of grant number
   N205 105435 and thank Dr Piotr Bonarek (Jagiellonian University) for his
   help with ICT experiments.
CR Adamczyk Z, 2007, COLLOID SURFACE A, V302, P455, DOI 10.1016/j.colsurfa.2007.03.013
   Agnihotri SA, 2004, J CONTROL RELEASE, V100, P5, DOI 10.1016/j.jconrel.2004.08.010
   Bertrand P, 2000, MACROMOL RAPID COMM, V21, P319, DOI 10.1002/(SICI)1521-3927(20000401)21:7<319::AID-MARC319>3.0.CO;2-7
   Bharadwaj S, 2006, LANGMUIR, V22, P6093, DOI 10.1021/la0518391
   Bixler HJ, 1969, ENCYCLOPEDIA POLYMER, V10, P765
   Boddohi S, 2008, BIOMACROMOLECULES, V9, P2021, DOI 10.1021/bm8002573
   Bucur CB, 2006, J AM CHEM SOC, V128, P13690, DOI 10.1021/ja064532c
   Caruso F, 2000, CHEM-EUR J, V6, P413, DOI 10.1002/(SICI)1521-3765(20000204)6:3<413::AID-CHEM413>3.0.CO;2-9
   Chen LY, 2005, J POLYM SCI POL PHYS, V43, P296, DOI 10.1002/polb.20212
   Cho J, 2006, BIOMACROMOLECULES, V7, P2845, DOI 10.1021/bm060436s
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Elzbieciak M, 2009, LANGMUIR, V25, P3255, DOI 10.1021/la803988k
   Elzbieciak M, 2008, COLLOID SURFACE A, V321, P258, DOI 10.1016/j.colsurfa.2008.01.036
   Feng Q, 2005, COLLOID SURFACE A, V257-58, P85, DOI 10.1016/j.colsurfa.2004.10.099
   Feng X, 2008, COLLOID SURFACE A, V317, P535, DOI 10.1016/j.colsurfa.2007.11.053
   Fu JH, 2005, BIOMATERIALS, V26, P6684, DOI 10.1016/j.biomaterials.2005.04.034
   Hejazi R, 2003, J CONTROL RELEASE, V89, P151, DOI 10.1016/S0168-3659(03)00126-3
   Holme KR, 1997, CARBOHYD RES, V302, P7, DOI 10.1016/S0008-6215(97)00117-1
   Jiang CY, 2006, ADV MATER, V18, P829, DOI 10.1002/adma.200502444
   Kaminski K, 2008, BIOMACROMOLECULES, V9, P3127, DOI 10.1021/bm800724q
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   Liu XF, 2001, J APPL POLYM SCI, V79, P1324
   LVOV Y, 1993, LANGMUIR, V9, P481, DOI 10.1021/la00026a020
   Lvov Y, 1998, J BIOMAT SCI-POLYM E, V9, P345, DOI 10.1080/09205063.1998.9753060
   Marinsky JA, 1998, J PHYS CHEM B, V102, P6949, DOI 10.1021/jp980982i
   No HK, 2000, REV ENVIRON CONTAM T, V163, P1
   Payne GF, 2007, SOFT MATTER, V3, P521, DOI 10.1039/b613872a
   Richert L, 2004, LANGMUIR, V20, P448, DOI 10.1021/la035415n
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   Sorlier P, 2001, BIOMACROMOLECULES, V2, P765, DOI 10.1021/bm015531+
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Yuan WY, 2007, LANGMUIR, V23, P13046, DOI 10.1021/la702774a
   Zhang YJ, 2005, BIOMACROMOLECULES, V6, P2365, DOI 10.1021/bm050058b
   ZOMERSKA K, 2006, J CONTROL RELEASE, V116, pE13
NR 34
TC 28
Z9 28
U1 1
U2 28
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
J9 SOFT MATTER
JI Soft Matter
PY 2009
VL 5
IS 23
BP 4726
EP 4732
DI 10.1039/b909355a
PG 7
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA 521GH
UT WOS:000271907900017
DA 2018-10-19
ER

PT J
AU Leroy, S
   Steinberger, A
   Cottin-Bizonne, C
   Trunfio-Sfarghiu, AM
   Charlaix, E
AF Leroy, S.
   Steinberger, A.
   Cottin-Bizonne, C.
   Trunfio-Sfarghiu, A. -M.
   Charlaix, E.
TI Probing biolubrication with a nanoscale flow
SO SOFT MATTER
LA English
DT Article
ID SUPPORTED PHOSPHOLIPID-BILAYERS; SURFACE FORCES APPARATUS;
   LIPID-BILAYER; INTERMONOLAYER FRICTION; BOUNDARY LUBRICATION; MOLECULAR
   FRICTION; DIFFUSION; MEMBRANES; WATER; MONOLAYERS
AB The fluidity of lipid membranes is an essential property for their biological function. Here we use a dynamic surface forces apparatus to probe flow at the nanoscale on supported phospholipid bilayers and we present direct mechanical measurements of their fluidity. We show that gel-phase DPPC bilayers deposited on glass behave as a rigid surface for the flow, whereas fluid DOPC bilayers are mobile and slide with a very low friction coefficient. These findings provide new perspectives for the investigation of the lubricant properties of phospholipid bilayers and for the design of biomaterial and biomedical devices of low frictional properties.
C1 [Leroy, S.; Steinberger, A.; Cottin-Bizonne, C.; Trunfio-Sfarghiu, A. -M.; Charlaix, E.] Univ Lyon, F-69000 Lyon, France.
   [Leroy, S.; Steinberger, A.; Cottin-Bizonne, C.; Trunfio-Sfarghiu, A. -M.; Charlaix, E.] Univ Lyon 1, CNRS, UMR 5586, Lab PMCN, F-69622 Villeurbanne, France.
RP Leroy, S (reprint author), Univ Lyon, F-69000 Lyon, France.
EM Samuel.Leroy@lpmcn.univ-lyon1.fr; elisabeth.charlaix@lpmcn.univ-lyon1.fr
RI Trunfio-Sfarghiu, Ana-Maria/I-2293-2016; Cottin-Bizonne,
   Cecile/R-3783-2017
OI Trunfio-Sfarghiu, Ana-Maria/0000-0001-9494-6793; Cottin-Bizonne,
   Cecile/0000-0001-5807-9215
CR Baumgart T, 2002, BIOPHYS J, V83, P1489, DOI 10.1016/S0006-3495(02)73919-2
   Bocquet L, 2007, SOFT MATTER, V3, P685, DOI 10.1039/b616490k
   Briscoe WH, 2006, NATURE, V444, P191, DOI 10.1038/nature05196
   Cottin-Bizonne C, 2008, LANGMUIR, V24, P1165, DOI 10.1021/la7024044
   Cross B, 2006, EUROPHYS LETT, V73, P390, DOI 10.1209/epl/i2005-10416-4
   den Otter WK, 2007, BIOPHYS J, V93, P423, DOI 10.1529/biophysj.107.105395
   Drummond C, 2008, LANGMUIR, V24, P1560, DOI 10.1021/la702392v
   EVANS E, 1994, CHEM PHYS LIPIDS, V73, P39, DOI 10.1016/0009-3084(94)90173-2
   EVANS E, 1988, J FLUID MECH, V194, P553, DOI 10.1017/S0022112088003106
   Fournier JB, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.018102
   Grant LM, 2002, BIOPHYS J, V82, P1373, DOI 10.1016/S0006-3495(02)75492-1
   Hetzer M, 1998, LANGMUIR, V14, P982, DOI 10.1021/la9712810
   HILLS BA, 1985, ANN BIOMED ENG, V13, P573, DOI 10.1007/BF02584258
   Jonsson P, 2009, LANGMUIR, V25, P6279, DOI 10.1021/la8042268
   Klein J, 2009, SCIENCE, V323, P47, DOI 10.1126/science.1166753
   Liu YF, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.040901
   Malmstadt N, 2006, NANO LETT, V6, P1961, DOI 10.1021/nl0611034
   MERKEL R, 1989, J PHYS-PARIS, V50, P1535, DOI 10.1051/jphys:0198900500120153500
   Raphael RM, 1996, BIOPHYS J, V71, P1374, DOI 10.1016/S0006-3495(96)79340-2
   Restagno F, 2002, REV SCI INSTRUM, V73, P2292, DOI 10.1063/1.1476719
   Seu KJ, 2007, BIOPHYS J, V92, P2445, DOI 10.1529/biophysj.106.099721
   Shkulipa SA, 2005, BIOPHYS J, V89, P823, DOI 10.1529/biophysj.105.062653
   TAMM LK, 1985, BIOPHYS J, V47, P105, DOI 10.1016/S0006-3495(85)83882-0
   Tanaka M, 2005, NATURE, V437, P656, DOI 10.1038/nature04164
   Taylor JD, 2007, LAB CHIP, V7, P927, DOI 10.1039/b618940g
   Tiberg F, 2000, EUR BIOPHYS J BIOPHY, V29, P196, DOI 10.1007/PL00006646
   Trunfio-Sfarghiu AM, 2007, TRIBOL INT, V40, P1500, DOI 10.1016/j.triboint.2007.02.008
   Trunfio-Sfarghiu AM, 2008, LANGMUIR, V24, P8765, DOI 10.1021/la8005234
   VINOGRADOVA OI, 1995, LANGMUIR, V11, P2213, DOI 10.1021/la00006a059
   Wong JY, 1999, BIOPHYS J, V77, P1458, DOI 10.1016/S0006-3495(99)76993-6
NR 30
TC 7
Z9 7
U1 0
U2 17
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
J9 SOFT MATTER
JI Soft Matter
PY 2009
VL 5
IS 24
BP 4997
EP 5002
DI 10.1039/b914543e
PG 6
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA 526EX
UT WOS:000272271600018
DA 2018-10-19
ER

PT S
AU Cui, CX
   Qi, YM
   Zhang, MF
   Li, JG
   Liu, SJ
   Xue, XL
   Huang, N
AF Cui, C. X.
   Qi, Y. M.
   Zhang, M. F.
   Li, J. G.
   Liu, S. J.
   Xue, X. L.
   Huang, N.
BE Kisailus, D
   Estroff, L
   Gupta, HS
   landis, WJ
   Zavattieri, PD
TI Histological and Mechanical Evaluation of the In Vivo Bone-Bonding
   Ability of K2TinO2n+1/beta-Ti Alloy as a Novel Bioactive Material
SO STRUCTURE-PROPERTY RELATIONSHIPS IN BIOMINERALIZED AND BIOMIMETIC
   COMPOSITES
SE Materials Research Society Symposium Proceedings
LA English
DT Proceedings Paper
CT Symposium on Structure-Property Relationships in Biomineralized and
   Biomimetic Composites held at the 2009 MRS Spring Meeting
CY APR 14-17, 2009
CL San Francisco, CA
SP Mat Res Soc
DE K2TinO2n+1 biocoating; Ti-15Mo-3Nb alloy; bone-bonding; in vivo study
ID PLASMA-SPRAYED COATINGS; TITANIUM-ALLOY; HYDROXYAPATITE; IMPLANTS;
   HYDROXYLAPATITE; TISSUE; REPLACEMENT; ZIRCONIA; STRENGTH
AB The purpose of this study was to histologically and mechanically appraise the in vivo bone-bonding abilities of K2TinO2n+1 coated and uncoated Ti-15Mo-3Nb (TMN) implants. According to GB/T16886.6-1997 biological evaluation of medical devices Part 6:Tests for local effects after implantation, the two types of implants were implanted into the proximal metaphyses of Chinese white rabbits' femurs for 12, 26 and 52 weeks and investigated by pushing out test, scanning electron microscopy (SEM) attached to an energy-dispersive X-ray micro-analyzer (EDX) and light microscopy. The bone-bonding abilities of the K2TinO2n+1 biocoating/Ti-15Mo-3Nb (KBT) gradient biomaterial implants were higher than those of T implants at different periods of implantation. The K2TinO2n+1 biocoating (KB) could stimulate new bone rapid formation at the early stages of implantation. And the implants with the biocoating eventually bonded to bone directly, with no intervening soft tissue layer, that was an osseocoalescence. However, the type of bone-bonding between TMN titanium alloy implants and bone was a simple osseocoaptation. The more excellent bone-bonding ability of the KBT implants should be attributed to the superficial characteristics, the bioactivity of low potassium titanate and biostability of high potassium titanate.
C1 [Cui, C. X.; Qi, Y. M.; Liu, S. J.; Xue, X. L.; Huang, N.] Hebei Univ Technol, Sch Mat Sci & Engn, Rd 1, Tianjin 300130, Peoples R China.
   [Zhang, M. F.] Tianjin Med Univ, Dept Pathol, Tianjin 300070, Peoples R China.
   [Li, J. G.] Tianjin Hosp, Dept Spine Surg, Tianjin 300211, Peoples R China.
RP Cui, CX (reprint author), Hebei Univ Technol, Sch Mat Sci & Engn, Rd 1, Tianjin 300130, Peoples R China.
EM hutcui@hebut.edu.cn; ymqi@hebut.edu.cn
FU National Key Innovation Project of Science & Technology of China
   [02CJ-02-02-18]
FX We thank Jin Mengjue and her groups in Laboratory Animal Center of
   Tianjin Medical University for feeding the testing animals. We also
   thank Prof. Zhang Mingfang and his groups in Department of Pathology of
   Tianjin Medical University for their technical support about the
   histology analysis. This work was financially supported by a grant of
   the National Key Innovation Project of Science & Technology of China
   under Grant No. 02CJ-02-02-18.
CR BRANEMARK PI, 1985, TISSUE INTEGRATED PR, P199
   CHENG LZ, 2003, CONT HISTOLOGY, P248
   COOK SD, 1992, J BIOMED MATER RES, V26, P989, DOI 10.1002/jbm.820260803
   Cui CX, 2003, RARE METAL MAT ENG, V32, P627
   DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203
   DHERT WJA, 1991, J BIOMED MATER RES, V25, P1183, DOI 10.1002/jbm.820251002
   Dubruille JH, 1999, INT J ORAL MAX IMPL, V14, P271
   GEESINK RGT, 1995, J BONE JOINT SURG BR, V77B, P534
   HAYASHI K, 1993, J BIOMED MATER RES, V27, P557, DOI 10.1002/jbm.820270502
   Hench LL, 1998, J BIOMED MATER RES, V41, P511, DOI 10.1002/(SICI)1097-4636(19980915)41:4<511::AID-JBM1>3.0.CO;2-F
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Kaneko S, 2001, BIOMATERIALS, V22, P875, DOI 10.1016/S0142-9612(01)00036-9
   KOKUBO T, 1991, BIOMATERIALS, V12, P155, DOI 10.1016/0142-9612(91)90194-F
   Lee TM, 2004, J BIOMED MATER RES A, V71A, P652, DOI 10.1002/jbm.a.30190
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Niinomi M, 1999, MAT SCI ENG A-STRUCT, V263, P193, DOI 10.1016/S0921-5093(98)01167-8
   Niinomi M, 2003, SCI TECHNOL ADV MAT, V4, P445, DOI 10.1016/j.stam.2003.09.002
   OVERGAARD S, 1995, J BONE JT SURG BR S3, V77, P285
   [戚玉敏 Qi Yumin], 2006, [功能材料, Journal of Functional Materials], V37, P1638
   Ravaglioli A, 1989, BIOCERAMICS, V1, P13
   SOBALLE K, 1993, J BONE JOINT SURG BR, V75, P270
   SOBALLE K, 1991, CLIN ORTHOP RELAT R, P300
   UNGERSBOCK A, 1994, J MATER SCI-MATER M, V5, P788, DOI 10.1007/BF00213136
   WANG BC, 1993, J MATER SCI-MATER M, V4, P394, DOI 10.1007/BF00122198
   Wang K, 1996, MAT SCI ENG A-STRUCT, V213, P134, DOI 10.1016/0921-5093(96)10243-4
   WILLIAMS DF, 1994, J BONE JOINT SURG BR, V76B, P348
   XU YJ, 2002, ORTHOPAEDIL BIOMECHA, V21, P765
   ZHENG QX, 2000, CHIN BIOMED ENG ACTA, V19, P217
NR 28
TC 0
Z9 0
U1 0
U2 3
PU MATERIALS RESEARCH SOC
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 978-1-60511-160-5
J9 MATER RES SOC SYMP P
PY 2009
VL 1187
BP 175
EP +
PG 3
WC Materials Science, Multidisciplinary; Materials Science, Biomaterials
SC Materials Science
GA BNA18
UT WOS:000274017800024
DA 2018-10-19
ER

PT B
AU Zhou, DX
   Li, Y
AF Zhou, Dang-Xia
   Li, Yi
BE Li, Y
   Li, JS
   Chen, AZ
TI Safety Evaluation of Biomaterials
SO TEXTILE BIOENGINEERING AND INFORMATICS SYMPOSIUM PROCEEDINGS, VOLS 1 AND
   2
LA English
DT Proceedings Paper
CT International Symposium of Textile Bioengineering and Informatics (TBIS)
   held at the 4th World-Association-for-Chinese-Biomedical-Engineers
   (WACBE)
CY JUL 26-29, 2009
CL Hong Kong, PEOPLES R CHINA
DE Biomaterial; Animal model; Safety evaluation; Subchronic toxicity;
   Chronic toxicity; Biocompatibility testing
ID TESTS
AB In recent years, more and more biomaterials are developed. Whatever may be the origin of materials developed, once they are implanted into the body they interface with living tissues. The safety that we are concerned about is related to the biological and chemical interaction of biomaterials with human bodies. The aim of this paper is to review related safety evaluation tests of biomaterials.
C1 [Zhou, Dang-Xia; Li, Yi] Hong Kong Polytech Univ, Inst Text & Clothing, Hong Kong, Hong Kong, Peoples R China.
RP Li, Y (reprint author), Hong Kong Polytech Univ, Inst Text & Clothing, Hong Kong, Hong Kong, Peoples R China.
EM tcliyi@polyu.edu.hk
RI Report, TBIS/G-5407-2012; LI, YI/G-4421-2012
OI LI, YI/0000-0002-2092-4505
CR Ali AQ, 2008, TOXICOL IN VITRO, V22, P57, DOI 10.1016/j.tiv.2007.08.001
   ANDREAS F, 1999, BIOMATERIALS EVALUAT, P135
   CARFI M, 2007, TOXICOLOGY, V229, P181
   DAVID JK, 2006, TOXICOLOGICAL TESTIN, P135
   GAD SC, 2002, SAFETY EVALUATION ME, P105
   Herzyk DJ, 2007, J IMMUNOTOXICOL, V4, P143, DOI 10.1080/15476910701337308
   Muller U, 2008, Med Device Technol, V19, P32
   Robichaud CO, 2005, ENVIRON SCI TECHNOL, V39, P8985, DOI 10.1021/es0506509
   Xu XZ, 2006, BIOMATERIALS, P135
   Yudovin-Farber I, 2008, BIOMACROMOLECULES, V9, P3044, DOI 10.1021/bm8004897
   Zhang C, 2008, EUR J PHARM SCI, V33, P415, DOI 10.1016/j.ejps.2008.01.012
NR 11
TC 0
Z9 0
U1 1
U2 1
PU HONG KONG POLYTECHNIC UNIV
PI KOWLOON
PA INST TEXTILES & CLOTHING, YUK CHOI RD, HUNG HOM, KOWLOON, 00000, PEOPLES
   R CHINA
BN 977-1-94234-300-5
PY 2009
BP 47
EP 49
DI 10.3993/tbis2009010
PG 3
WC Engineering, Biomedical; Materials Science, Biomaterials; Materials
   Science, Textiles
SC Engineering; Materials Science
GA BLH51
UT WOS:000270182100010
DA 2018-10-19
ER

PT B
AU Zhao, Z
   Chen, AZ
   Han, YX
   Li, Y
   Hu, JY
AF Zhao, Zheng
   Chen, Ai-Zheng
   Han, Yan-Xia
   Li, Yi
   Hu, Jun-Yan
BE Li, Y
   Li, JS
   Chen, AZ
TI Characterization of Polypeptides from Acidic Hydrolysate of Wool
SO TEXTILE BIOENGINEERING AND INFORMATICS SYMPOSIUM PROCEEDINGS, VOLS 1 AND
   2
LA English
DT Proceedings Paper
CT International Symposium of Textile Bioengineering and Informatics (TBIS)
   held at the 4th World-Association-for-Chinese-Biomedical-Engineers
   (WACBE)
CY JUL 26-29, 2009
CL Hong Kong, PEOPLES R CHINA
DE Wool; Acidic hydrolysis; Isoelectric precipitation; Polypeptide
ID ISOELECTRIC SOLUBILIZATION/PRECIPITATION; PROTEIN
AB The polypeptides hydrolysate was obtained by acidic hydrolysis of wool. The results of ninhydrin reaction and biuret reaction indicate hydrolysis degree of wool keratin was about 33%. By isoelectric precipitation technique, acidic polypeptide and neutral polypeptide were separated from the composite hydrolysate. Then their corresponding dry powders were prepared by spray drying, and their surface morphologies were also confirmed by scanning electron microscope (SEM). The results of TG-DSC measurements revealed that the acidic and neutral polypeptides has higher glass transition temperature (100.3 degrees C, 78.2 degrees C) and lower decomposition temperature (179.3 degrees C, 187.0 degrees C) than that of wool. The Fourier transform infrared spectroscopy (FTIR) measurement also demonstrated the differences in chemistry between wool and the two kinds of polypeptides. Furthermore, X-ray powder diffraction (XRPD) analysis showed that the component of the wool possessed an amorphous form, while that of the two kinds of polypeptides possessed crystalline form. The different characteristics of these two kinds of polypeptides have different potential applications as functional biomaterial
C1 [Zhao, Zheng; Chen, Ai-Zheng; Han, Yan-Xia; Li, Yi; Hu, Jun-Yan] Hong Kong Polytech Univ, Inst Text & Clothing, Hong Kong, Hong Kong, Peoples R China.
RP Li, Y (reprint author), Hong Kong Polytech Univ, Inst Text & Clothing, Hong Kong, Hong Kong, Peoples R China.
EM tcliyi@polyu.edu.hk
RI LI, YI/G-4421-2012; Report, TBIS/G-5407-2012; HU, JUNYAN/G-8806-2012;
   HU, Junyan/J-7323-2012; Zhao, Zheng/K-7150-2012
OI LI, YI/0000-0002-2092-4505; 
CR Barba C, 2008, SKIN RES TECHNOL, V14, P243, DOI 10.1111/j.1600-0846.2007.00280.x
   Chen YC, 2009, J FOOD SCI, V74, pH31, DOI 10.1111/j.1750-3841.2008.01026.x
   DAVEN P, 1990, BIOTECHNOL LETT, V12, P71
   Davis J R, 2001, AMINO ACIDS PEPTIDES, P1
   Gigliotti JC, 2008, FOOD CHEM, V111, P209, DOI 10.1016/j.foodchem.2008.03.030
   LI JW, 1994, PRINCIPLES METHODS B, P150
   TORANDIAZ I, 1985, BIOTECHNOL LETT, V7, P527, DOI 10.1007/BF01199873
   Tung WS, 2009, ACTA BIOMATER, V5, P50, DOI 10.1016/j.actbio.2008.08.009
   [张立娟 ZHANG Lijuan], 2008, [食品工业科技, Science & Technology of Food Industry], V29, P241
NR 9
TC 3
Z9 3
U1 0
U2 5
PU HONG KONG POLYTECHNIC UNIV
PI KOWLOON
PA INST TEXTILES & CLOTHING, YUK CHOI RD, HUNG HOM, KOWLOON, 00000, PEOPLES
   R CHINA
BN 977-1-94234-300-5
PY 2009
BP 50
EP 54
DI 10.3993/tbis2009011
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials; Materials
   Science, Textiles
SC Engineering; Materials Science
GA BLH51
UT WOS:000270182100011
DA 2018-10-19
ER

PT J
AU Amrute, KV
   Badlani, GH
AF Amrute, Kaytan V.
   Badlani, Gopal H.
TI The Science behind Biomaterials in Female Stress Urinary Incontinence
   Surgery
SO THESCIENTIFICWORLDJOURNAL
LA English
DT Article
DE biomaterials; stress urinary incontinence; autologous grafts;
   allografts; xenografts; synthetic grafts
ID PELVIC ORGAN PROLAPSE; FREE VAGINAL TAPE; FASCIA LATA; SEXUAL FUNCTION;
   SYNTHETIC SLINGS; CADAVERIC FASCIA; PORCINE DERMIS; SHORT-TERM; RAT
   MODEL; WOMEN
AB Female stress urinary incontinence, while not life threatening, can present with various social and economic implications. Biomaterials, primarily synthetic, are often utilized to augment surgical correction. Repair with biomaterials involves midurethral support to function against weakened connective tissue caused by injury, abnormal collagen metabolism, or genetic predisposition. Even though efficacy rates are high, the potential for complications, such as erosion, are great without comprehension of inherent characteristics of each graft material. Low-weight, macroporous, monofilament synthetic grafts and noncross-linked biologic grafts are examples of biomaterials that implant reasonably well with host tissue. This paper reviews the justification for biomaterial use, host reaction, and the various parameters of natural and synthetic grafts.
C1 [Badlani, Gopal H.] Wake Forest Univ, Baptist Med Ctr, Dept Urol, Winston Salem, NC 27157 USA.
   [Amrute, Kaytan V.] Jacobi Med Ctr, Dept Obstet Gynecol, Bronx, NY 10461 USA.
RP Badlani, GH (reprint author), Wake Forest Univ, Baptist Med Ctr, Dept Urol, Med Ctr Blvd, Winston Salem, NC 27157 USA.
EM kvamrute@gmail.com; gbadlani@wfubmc.edu
CR Abouassaly R, 2004, BJU INT, V94, P110, DOI 10.1111/j.1464-410X.2004.04910.x
   Amid PK, 1997, HERNIA, V1, P15, DOI DOI 10.1007/BF02426382
   BECK RP, 1988, OBSTET GYNECOL, V72, P699
   Birch C, 2005, BEST PRACT RES CL OB, V19, P979, DOI 10.1016/j.bpobgyn.2005.08.013
   BOBYN JD, 1982, BIOMED MAT RES, V16, P517
   Chaikin DC, 1998, J UROLOGY, V160, P1312, DOI 10.1016/S0022-5347(01)62524-2
   Chen B, 2004, NEUROUROL URODYNAM, V23, P119, DOI 10.1002/nau.20012
   Chen BH, 2002, INT UROGYNECOL J PEL, V13, P80, DOI 10.1007/s001920200020
   Chen Y, 2004, NEUROUROL URODYNAM, V23, P367, DOI 10.1002/nau.20006
   Choe JM, 1999, UROLOGY, V54, P641, DOI 10.1016/S0090-4295(99)00190-9
   Davila GW, 2006, INT UROGYNECOL J, V17, pS51, DOI 10.1007/s00192-006-0099-5
   DELANCEY JOL, 1994, AM J OBSTET GYNECOL, V170, P1713, DOI 10.1016/S0002-9378(12)91840-2
   Deprest J, 2006, INT UROGYNECOL J, V17, pS16, DOI 10.1007/s00192-006-0101-2
   Dietz HP, 2005, BJOG-INT J OBSTET GY, V112, P334, DOI 10.1111/j.1471-0528.2004.00428.x
   Elzevier HW, 2004, INT UROGYNECOL J, V15, P313, DOI 10.1007/s00192-004-1149-5
   FitzGerald MP, 1999, AM J OBSTET GYNECOL, V181, P1339, DOI 10.1016/S0002-9378(99)70374-1
   Gandhi S, 2005, AM J OBSTET GYNECOL, V192, P1643, DOI 10.1016/j.ajog.2004.11.044
   GANDHI S, 2005, FEMALE UROLOGY UROGY, P119
   Gomelsky A, 2007, INT UROGYNECOL J, V18, P1337, DOI 10.1007/s00192-007-0333-9
   Gomelsky A, 2007, J UROLOGY, V178, P1171, DOI 10.1016/j.juro.2007.05.123
   GUERRERO K, 2008, INT C SOC ICS M OCT
   GUNER H, 1994, GYNECOL OBSTET INVES, V37, P52, DOI 10.1159/000292521
   Hannestad YS, 2000, J CLIN EPIDEMIOL, V53, P1150, DOI 10.1016/S0895-4356(00)00232-8
   Howden NS, 2006, AM J OBSTET GYNECOL, V194, P1444, DOI 10.1016/j.ajog.2006.01.058
   Huang KH, 2005, INT UROGYNECOL J, V16, P437, DOI 10.1007/s00192-004-1275-0
   Jones JS, 2005, BJU INT, V96, P103, DOI 10.1111/j.1464-410X.2005.05576.x
   Karlovsky Matthew E, 2005, Curr Urol Rep, V6, P376, DOI 10.1007/s11934-005-0057-7
   Klinge U, 2002, J SURG RES, V103, P208, DOI 10.1006/jsre.2002.6358
   Kobashi KC, 2005, NAT CLIN PRACT UROL, V2, P84, DOI 10.1038/ncpuro0094
   Kushner L, 2004, NEUROUROL URODYNAM, V23, P198, DOI 10.1002/nau.10174
   Latini JM, 2004, J UROLOGY, V171, P1180, DOI 10.1097/01.ju.0000111807.67599.8d
   Lemer ML, 1999, NEUROUROL URODYNAM, V18, P497, DOI 10.1002/(SICI)1520-6777(1999)18:5<497::AID-NAU12>3.0.CO;2-K
   Lord HE, 2006, BJU INT, V98, P367, DOI 10.1111/j.1464-410X.2006.06333.x
   McBride AW, 2005, AM J OBSTET GYNECOL, V192, P1677, DOI 10.1016/j.ajog.2005.01.078
   MCGUIRE EJ, 1980, J UROLOGY, V124, P256, DOI 10.1016/S0022-5347(17)55396-3
   MCINTOSH LJ, 1995, J SOC GYNECOL INVEST, V2, P559, DOI 10.1016/1071-5576(94)00050-B
   Moalli PA, 2006, INT UROGYNECOL J, V17, pS48, DOI 10.1007/s00192-006-0106-x
   MORGAN JE, 1995, J UROLOGY, V154, P1013, DOI 10.1016/S0022-5347(01)66961-1
   Morgan TO, 2000, J UROLOGY, V163, P1845, DOI 10.1016/S0022-5347(05)67557-X
   Olsen AL, 1997, OBSTET GYNECOL, V89, P501, DOI 10.1016/S0029-7844(97)00058-6
   Petros P E, 1990, Acta Obstet Gynecol Scand Suppl, V153, P7
   Roth CC, 2006, CURR OPIN UROL, V16, P234, DOI 10.1097/01.mou.0000232042.95427.9f
   Rovner Eric S, 2004, Rev Urol, V6 Suppl 3, pS29
   Rutner AB, 2003, UROLOGY, V62, P805, DOI 10.1016/S0090-4295(03)00664-2
   Sentilhes L, 2008, INT UROGYNECOL J, V19, P763, DOI 10.1007/s00192-007-0521-7
   SHAH DK, 2002, AUA M ORL FL
   Shah SM, 2005, UROLOGY, V65, P270, DOI 10.1016/j.urology.2004.08.058
   Silva WA, 2005, CURR OPIN OBSTET GYN, V17, P519, DOI 10.1097/01.gco.0000180156.64879.00
   Subak LL, 2008, OBSTET GYNECOL, V111, P899, DOI 10.1097/AOG.0b013e31816a1e12
   Thiel M, 2005, BJU INT, V95, P833, DOI 10.1111/j.1464-410X.2005.05411.x
   Weber AM, 2001, AM J OBSTET GYNECOL, V185, P1299, DOI 10.1067/mob.2001.119081
   Weinberger MW, 1996, OBSTET GYNECOL, V87, P50, DOI 10.1016/0029-7844(95)00347-9
   Wilson L, 2001, OBSTET GYNECOL, V98, P398, DOI 10.1016/S0029-7844(01)01464-8
   Winters JC, 2006, INT UROGYNECOL J, V17, pS34, DOI 10.1007/s00192-006-0108-8
   Yamada BS, 2006, J UROLOGY, V176, P651, DOI 10.1016/j.juro.2006.03.064
   Young SB, 2001, AM J OBSTET GYNECOL, V185, P32, DOI 10.1067/mob.2001.116370
   Zheng F, 2004, AM J OBSTET GYNECOL, V191, P1961, DOI 10.1016/j.ajog.2004.01.091
NR 57
TC 5
Z9 5
U1 0
U2 2
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1537-744X
J9 THESCIENTIFICWORLDJO
JI TheScientificWorldJOURNAL
PY 2009
VL 9
BP 23
EP 31
DI 10.1100/tsw.2009.7
PG 9
WC Environmental Sciences; Multidisciplinary Sciences
SC Environmental Sciences & Ecology; Science & Technology - Other Topics
GA 395RW
UT WOS:000262542200005
PM 19151895
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT S
AU Singh, S
   Lapin, N
   Singh, PK
   Khan, MA
   Chabal, YJ
AF Singh, Shalini
   Lapin, Norman
   Singh, P. K.
   Khan, Mukhtar A.
   Chabal, Yves J.
BE Singh, MR
   Lipson, RH
TI Attachment Of Streptavidin-Biotin On 3-Aminopropyltriethoxysilane
   (APTES) Modified Porous Silicon Surfaces
SO TRANSPORT AND OPTICAL PROPERTIES OF NANOMATERIALS
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT International Conference on Transport and Optical Properties of
   Nanomaterials (ICTOPON 2009)
CY JAN 05-08, 2009
CL Allahabad, INDIA
SP Univ Western Ontario, Western Inst Nanomat Sci, Ctr Interdisciplinary Studies Chem Phys, Allahabad Univ, Govt India, Dept Bio Technol, Govt India, Dept Sci & Technol, Govt India, Def Res Dev Org, Indian Space Res Org, Council Sci & Ind Res, Board Res Nucl Sci, Indian Natl Sci Acad, Harish Chandra Res Inst
ID BIOSENSOR; MICROCAVITIES; CRYSTALS; BINDING
AB Nanostructured porous silicon (PS) has a large surface area that can be well controlled and modified to have a high specificity for biomolecules. These properties make it a very promising biomaterial, in particular for sensing devices that need to be linked to the biological system and completely compatible with standard integrated circuit processes. We report the formation of nanostructured PS on boron doped, p-type silicon (100) wafers by electrochemical anodization, using aqueous hydrofluoric acid and isopropyl alcohol solutions and a constant current density 50 mA/cm(2). The pore diameter can be tuned by varying the etching conditions. The interaction of streptavidin with biotin was studied on 3-aminopropyltriethoxysilane (APTES) functionalized PS surfaces using infrared absorption spectroscopy to characterize the surface at each step, including subsequent reaction steps. These studies show that the streptavidin-biotin interaction on modified PS surfaces depends on the details of the APTES adsorption process.
C1 [Singh, Shalini; Singh, P. K.] Natl Phys Lab, Elect Mat Div, Dr KS Krishnan Rd, New Delhi 110012, India.
   [Lapin, Norman; Chabal, Yves J.] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08854 USA.
   [Singh, Shalini; Khan, Mukhtar A.] Aligarh Muslim Univ, Fac Life Sci, Aligarh 202001, Uttar Pradesh, India.
   [Chabal, Yves J.] Univ Texas Dallas, Dept Mat Sci & Engn, Richardson, TX 75080 USA.
RP Singh, S (reprint author), Natl Phys Lab, Elect Mat Div, Dr KS Krishnan Rd, New Delhi 110012, India.
RI Chabal, Yves/A-5998-2011
OI Chabal, Yves/0000-0002-6435-0347
FU National Science Foundation [CHE-0415652]; Council for Scientific and
   Industrial Research, India
FX This work was supported by the National Science Foundation (grant
   CHE-0415652) and Council for Scientific and Industrial Research, India
CR Bessueille F, 2005, BIOSENS BIOELECTRON, V21, P908, DOI 10.1016/j.bios.2005.02.007
   BLUMEL J, 1995, J AM CHEM SOC, V117, P2112
   CANHAM LT, 1990, APPL PHYS LETT, V57, P1046, DOI 10.1063/1.103561
   CHAIET L, 1964, ARCH BIOCHEM BIOPHYS, V106, P1, DOI 10.1016/0003-9861(64)90150-X
   Chan S, 2001, J AM CHEM SOC, V123, P11797, DOI 10.1021/ja016555r
   Cullis AG, 1997, J APPL PHYS, V82, P909, DOI 10.1063/1.366536
   Cunin F, 2002, NAT MATER, V1, P39, DOI 10.1038/nmat702
   Dancil KPS, 1999, J AM CHEM SOC, V121, P7925, DOI 10.1021/ja991421n
   De Stefano L, 2006, BIOSENS BIOELECTRON, V21, P1664, DOI 10.1016/j.bios.2005.08.012
   Green N M, 1975, Adv Protein Chem, V29, P85, DOI 10.1016/S0065-3233(08)60411-8
   HIGASHI GS, 1993, HDB SEMICONDUCTOR WA, P433
   KERN W, 1990, J ELECTROCHEM SOC, V137, P1887, DOI 10.1149/1.2086825
   Lin VSY, 1997, SCIENCE, V278, P840, DOI 10.1126/science.278.5339.840
   Liu Z, 2005, J PHYS CHEM B, V109, P16866, DOI 10.1021/jp0535240
   Mathew FP, 2005, BIOSENS BIOELECTRON, V20, P1656, DOI 10.1016/j.bios.2004.08.006
   Mirsky VM, 1997, BIOSENS BIOELECTRON, V12, P977, DOI 10.1016/S0956-5663(97)00053-5
   Ouyang H, 2005, ADV FUNCT MATER, V15, P1851, DOI 10.1002/adfm.200500218
   Pacholski C, 2005, J AM CHEM SOC, V127, P11636, DOI 10.1021/ja0511671
   PRADIER CM, 2002, SURF SCI, V193, P502
   Rendina I, 2007, PHYSICA E, V38, P188, DOI 10.1016/j.physe.2006.12.050
   Rossi AM, 2007, BIOSENS BIOELECTRON, V23, P741, DOI 10.1016/j.bios.2007.06.004
   Socrates G., 2001, INFRARED RAMAN CHARA
   UHLIR A, 1956, AT&T TECH J, V35, P333, DOI 10.1002/j.1538-7305.1956.tb02385.x
   Weiss SM, 2005, OPT EXPRESS, V13, P1090, DOI 10.1364/OPEX.13.001090
   Xia B, 2006, J MATER CHEM, V16, P570, DOI 10.1039/b511175g
NR 25
TC 3
Z9 3
U1 3
U2 10
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-0684-1
J9 AIP CONF PROC
PY 2009
VL 1147
BP 443
EP +
PG 3
WC Nanoscience & Nanotechnology; Optics; Physics, Applied
SC Science & Technology - Other Topics; Optics; Physics
GA BLE18
UT WOS:000269998300062
DA 2018-10-19
ER

PT J
AU Gomez-Guillen, MC
   Perez-Mateos, M
   Gomez-Estaca, J
   Lopez-Caballero, E
   Gimenez, B
   Montero, P
AF Gomez-Guillen, M. C.
   Perez-Mateos, M.
   Gomez-Estaca, J.
   Lopez-Caballero, E.
   Gimenez, B.
   Montero, P.
TI Fish gelatin: a renewable material for developing active biodegradable
   films
SO TRENDS IN FOOD SCIENCE & TECHNOLOGY
LA English
DT Review
ID BROWNSTRIPE RED SNAPPER; WATER-VAPOR PERMEABILITY; ACID-SOLUBLE
   COLLAGEN; PERCH LATES-NILOTICUS; POLLOCK SKIN GELATIN; SOY PROTEIN
   ISOLATE; UGNI-MOLINAE TURCZ; EDIBLE FILMS; FUNCTIONAL-PROPERTIES;
   PHYSICAL-PROPERTIES
AB Most films used to preserve foodstuffs are made from synthetic plastic materials. However, for environmental reasons, attention has recently turned to biodegradable films. Gelatin has been extensively studied for its film-forming capacity and applicability as an outer covering to protect food against drying, light, and oxygen. Moreover, it is one of the first materials proposed as a carrier of bioactive components. Gelatins from alternatives to mammalian species are gaining prominence, especially gelatins from marine fish species. Because of their good film-forming abilities, fish gelatins may be a good alternative to synthetic plastics for making films to preserve foodstuffs. The mechanical and barrier properties of these films depend largely on the physical and chemical characteristics of the gelatin, especially the amino acid composition, which is highly species specific, and the molecular weight distribution, which depends mainly on processing conditions. Different film formulations can be developed to extend the films' physical and chemical properties and to add new functional attributes. This paper reviews the most recent scientific literature dealing with films based on gelatins from different fish species and considers various strategies intended to improve the physical properties of such films by combining fish gelatins with such other biopolymers as soy protein isolate, oils and fatty acids, and certain polysaccharides. The use of plasticizers and cross-linking agents is also discussed. Specific attributes, such as antimicrobial and antioxidant activities, may be also conferred by blending the gelatin with chitosan, lysozyme, essential oils, plant extracts, or vitamin C to produce an active packaging biomaterial.
C1 [Gomez-Guillen, M. C.; Perez-Mateos, M.; Gomez-Estaca, J.; Lopez-Caballero, E.; Gimenez, B.; Montero, P.] CSIC, Inst Frio, E-28040 Madrid, Spain.
RP Gomez-Guillen, MC (reprint author), CSIC, Inst Frio, C Jose Antonio Novais 10, E-28040 Madrid, Spain.
EM cgomez@if.csic.es
RI Montero Garcia, Maria Pilar/L-2872-2014; Gomez-Guillen, M.
   Carmen/K-7796-2014; Gomez-Estaca, Joaquin/H-5766-2012; Lopez,
   Elvira/K-6478-2014; PEREZ-MATEOS, Miriam/F-2471-2010
OI Montero Garcia, Maria Pilar/0000-0003-3142-4538; Gomez-Guillen, M.
   Carmen/0000-0003-1063-9169; Gomez-Estaca, Joaquin/0000-0003-1324-5739;
   Lopez, Elvira/0000-0002-4890-3829; PEREZ-MATEOS,
   Miriam/0000-0003-3822-1389
FU Spanish "Ministerio de Educacion y Ciencia" [AGL2005-02380/ALI]
FX This work was supported by the Spanish "Ministerio de Educacion y
   Ciencia" (proyect AGL2005-02380/ALI).
CR Aewsiri T, 2008, INT J FOOD SCI TECH, V43, P685, DOI 10.1111/j.1365-2621.2006.01509.x
   AGUADO J, 1999, RSC CLEAN TECHNOLOGY, P1
   Aguilar-Mendez MA, 2008, J SCI FOOD AGR, V88, P185, DOI 10.1002/jsfa.3068
   Antoniewski M. N., 2007, J FOOD SCI, V72, P382
   Arnesen JA, 2007, BIORESOURCE TECHNOL, V98, P53, DOI 10.1016/j.biortech.2005.11.021
   Arvanitoyannis I, 1998, CARBOHYD POLYM, V36, P105, DOI 10.1016/S0144-8617(98)00017-4
   Arvanitoyannis IS, 2002, PROTEIN-BASED FILMS AND COATINGS, P275
   Arvanitoyannis IS, 1998, CARBOHYD POLYM, V37, P371, DOI 10.1016/S0144-8617(98)00083-6
   Avena-Bustillos RJ, 2006, J FOOD SCI, V71, P202
   Badii F, 2006, FOOD HYDROCOLLOID, V20, P630, DOI 10.1016/j.foodhyd.2005.06.006
   Bertan LC, 2005, FOOD HYDROCOLLOID, V19, P73, DOI 10.1016/j.foodhyd.2004.04.017
   Bigi A, 2001, BIOMATERIALS, V22, P763, DOI 10.1016/S0142-9612(00)00236-2
   Bower C. K., 2006, J FOOD SCI, V71, P141
   Cao N, 2007, FOOD HYDROCOLLOID, V21, P1153, DOI 10.1016/j.foodhyd.2006.09.001
   Cao N, 2007, FOOD HYDROCOLLOID, V21, P575, DOI 10.1016/j.foodhyd.2006.07.001
   Carvalho RA, 2008, FOOD HYDROCOLLOID, V22, P1117, DOI 10.1016/j.foodhyd.2007.06.003
   Chambi H, 2006, FOOD RES INT, V39, P458, DOI 10.1016/j.foodres.2005.09.009
   Cho SH, 2006, FOOD HYDROCOLLOID, V20, P810, DOI 10.1016/j.foodhyd.2005.08.002
   Cho SM, 2005, FOOD HYDROCOLLOID, V19, P221, DOI 10.1016/j.foodhyd.2004.05.005
   Cho SM, 2004, FOOD HYDROCOLLOID, V18, P573, DOI 10.1016/j.foodhyd.2003.10.001
   Choi SS, 2000, J FOOD SCI, V65, P194, DOI 10.1111/j.1365-2621.2000.tb15978.x
   Colla E, 2006, J AGR FOOD CHEM, V54, P6645, DOI 10.1021/jf0611217
   Coma V, 2002, J FOOD SCI, V67, P1162, DOI 10.1111/j.1365-2621.2002.tb09470.x
   Cuq B, 1997, J AGR FOOD CHEM, V45, P622, DOI 10.1021/jf960352i
   de Carvalho RA, 2004, FOOD HYDROCOLLOID, V18, P717, DOI 10.1016/j.foodhyd.2003.10.005
   DENAVI G, 2007, 11 C ARG CIENC TECN
   DJABOUROV M, 1993, BIORHEOLOGY, V30, P191
   Ferndandez-Diaz MD, 2003, FOOD HYDROCOLLOID, V17, P281, DOI 10.1016/S0268-005X(02)00078-4
   Gennadios A., 1994, EDIBLE COATINGS FILM, P210
   Gimenez B, 2009, FOOD HYDROCOLLOID, V23, P585, DOI 10.1016/j.foodhyd.2008.07.003
   Gimenez B, 2005, FOOD HYDROCOLLOID, V19, P941, DOI 10.1016/j.foodhyd.2004.09.01
   Gimenez B, 2005, FOOD HYDROCOLLOID, V19, P951, DOI 10.1016/j.foodhyd.2004.09.012
   Gimenez B, 2005, FOOD HYDROCOLLOID, V19, P958, DOI 10.1016/j.foodhyd.2004.12.012
   *GME, 2007, GME MARK DAT OFF WEB
   Gomez-Estaca J, 2009, J FOOD ENG, V90, P480, DOI 10.1016/j.jfoodeng.2008.07.022
   Gomez-Estaca J, 2009, FOOD CHEM, V112, P18, DOI 10.1016/j.foodchem.2008.05.034
   Gomez-Estaca J, 2007, FOOD CHEM, V105, P511, DOI 10.1016/j.foodchem.2007.04.006
   Gomez-Guillen MC, 2007, FOOD HYDROCOLLOID, V21, P1133, DOI 10.1016/j.foodhyd.2006.08.006
   Gomez-Guillen MC, 2005, FOOD HYDROCOLLOID, V19, P923, DOI 10.1016/j.foodhyd.2004.12.011
   Gomez-Guillen MC, 2001, J FOOD SCI, V66, P213, DOI 10.1111/j.1365-2621.2001.tb11319.x
   Gomez-Guillen MC, 2002, FOOD HYDROCOLLOID, V16, P25, DOI 10.1016/S0268-005X(01)00035-2
   GOMEZESTACA J, 2007, THESIS U COMPLUTENSE
   GOMEZESTACA J, 2006, J AQUATIC F IN PRESS
   Gudmundsson M, 1997, J FOOD SCI, V62, P37, DOI 10.1111/j.1365-2621.1997.tb04363.x
   Guilbert Stephane, 1996, Lebensmittel-Wissenschaft and Technologie, V29, P10, DOI 10.1006/fstl.1996.0002
   HABITANTE AM, 2005, 5 IB C FOOD ENG 4 6
   Haug IJ, 2004, FOOD HYDROCOLLOID, V18, P203, DOI 10.1016/S0268-005X(03)00065-1
   Hernandez-Munoz P, 2004, FOOD HYDROCOLLOID, V18, P403, DOI 10.1016/S0268-005X(03)00128-0
   HERNANDEZIZQUIE.VM, 2008, J FOOD SCI, V73, P30, DOI DOI 10.1111/J.1750-3841.2007.00636.X
   Huang RH, 2005, INT J BIOL MACROMOL, V36, P120, DOI 10.1016/j.ijbiomac.2005.05.001
   Jagannath JH, 2003, J APPL POLYM SCI, V88, P64, DOI 10.1002/app.11602
   Jamilah B, 2002, FOOD CHEM, V77, P81, DOI 10.1016/S0308-8146(01)00328-4
   Jeon YJ, 2002, J AGR FOOD CHEM, V50, P5167, DOI 10.1021/jf011693l
   Johnston-Banks F. A., 1990, FOOD GELS, P233
   Jongiareonrak A, 2006, FOOD HYDROCOLLOID, V20, P1216, DOI 10.1016/j.foodhyd.2006.01.006
   Jongjareonrak A, 2006, FOOD HYDROCOLLOID, V20, P492, DOI 10.1016/j.foodhyd.2005.04.007
   Jongjareonrak A, 2006, EUR FOOD RES TECHNOL, V222, P650, DOI 10.1007/s00217-005-0151-6
   Jongjareonrak A, 2006, EUR FOOD RES TECHNOL, V222, P229, DOI 10.1007/s00217-005-0004-3
   Jongjareonrak A, 2008, FOOD HYDROCOLLOID, V22, P449, DOI 10.1016/j.foodhyd.2007.01.002
   Kasankala LM, 2007, BIORESOURCE TECHNOL, V98, P3338, DOI 10.1016/j.biortech.2006.03.019
   Kim KM, 2006, LWT, V39, P364
   Kirwan M.J., 2003, FOOD PACKAGING TECHN, P174
   Kolodziejska I, 2007, FOOD CHEM, V103, P295, DOI 10.1016/j.foodchem.2006.07.049
   Kolodziejska I, 2006, CARBOHYD POLYM, V65, P404, DOI 10.1016/j.carbpol.2006.01.025
   Ku K, 2007, J MICROBIOL BIOTECHN, V17, P520
   Lai HM, 2006, EUR FOOD RES TECHNOL, V222, P291, DOI 10.1007/s00217-005-0035-9
   Le Tien C, 2000, J AGR FOOD CHEM, V48, P5566, DOI 10.1021/jf0002241
   Ledward D. A., 1986, FUNCTIONAL PROPERTIE, P171
   LEUENBERGER BH, 1991, FOOD HYDROCOLLOID, V5, P353, DOI 10.1016/S0268-005X(09)80047-7
   Li B, 2006, FOOD RES INT, V39, P544, DOI 10.1016/j.foodres.2005.10.015
   Lim LT, 1999, J FOOD SCI, V64, P616, DOI 10.1111/j.1365-2621.1999.tb15096.x
   Liu LS, 2007, J AGR FOOD CHEM, V55, P2349, DOI 10.1021/jf062612u
   Longares A, 2005, INT DAIRY J, V15, P1255, DOI 10.1016/j.idairyj.2004.11.017
   Lopez-Caballero ME, 2005, FOOD HYDROCOLLOID, V19, P303, DOI 10.1016/j.foodhyd.2004.06.006
   Lukasik KV, 2006, FOOD HYDROCOLLOID, V20, P96, DOI 10.1016/j.foodhyd.2005.03.007
   Lukasik KV, 2006, FOOD HYDROCOLLOID, V20, P88, DOI 10.1016/j.foodhyd.2005.03.006
   Masschalck B, 2003, CRIT REV MICROBIOL, V29, P191, DOI 10.1080/713610448
   Menegalli FC, 1999, DRY TECHNOL, V17, P1697, DOI 10.1080/07373939908917646
   Montero P, 2000, J FOOD SCI, V65, P434, DOI 10.1111/j.1365-2621.2000.tb16022.x
   MONTERO P, 1990, J AGR FOOD CHEM, V38, P604, DOI 10.1021/jf00093a004
   Morillon V, 2002, CRIT REV FOOD SCI, V42, P67, DOI 10.1080/10408690290825466
   Muyonga JH, 2004, FOOD CHEM, V86, P325, DOI 10.1016/j.foodchem.2003.09.038
   Muyonga JH, 2004, FOOD CHEM, V85, P81, DOI 10.1016/j.foodchem.2003.06.006
   Nalinanon S, 2008, FOOD HYDROCOLLOID, V22, P615, DOI 10.1016/j.foodhyd.2007.01.012
   NORLAND RE, 1990, ADVANCES IN FISHERIES TECHNOLOGY AND BIOTECHNOLOGY FOR INCREASED PROFITABILITY, P325
   Oussalah M, 2004, J AGR FOOD CHEM, V52, P5598, DOI 10.1021/jf049389q
   Park JW, 2008, LWT-FOOD SCI TECHNOL, V41, P692, DOI 10.1016/j.lwt.2007.04.015
   Perez-Mateos M., 2009, FOOD HYDROCOLLOIDS, V22, P53
   Piotrowska B., 2005, ADV CHITIN SCI, P71
   Pranoto Y, 2007, LWT-FOOD SCI TECHNOL, V40, P766, DOI 10.1016/j.lwt.2006.04.005
   Rahman MS, 2008, FOOD CHEM, V108, P472, DOI 10.1016/j.foodchem.2007.10-079
   Ray SS, 2003, PROG POLYM SCI, V28, P1539, DOI 10.1016/j.progpolymsci.2003.08.002
   Rhim JW, 2000, J AGR FOOD CHEM, V48, P4937, DOI 10.1021/jf0005418
   Rubilar M, 2006, J AGR FOOD CHEM, V54, P59, DOI 10.1021/jf051571j
   Sarabia AI, 2000, FOOD CHEM, V70, P71, DOI 10.1016/S0308-8146(00)00073-X
   Seydim AC, 2006, FOOD RES INT, V39, P639, DOI 10.1016/j.foodres.2006.01.013
   Simon-Lukasik KV, 2004, FOOD HYDROCOLLOID, V18, P621, DOI 10.1016/j.foodhyd.2003.09.006
   Sionkowska A, 2004, BIOMATERIALS, V25, P795, DOI 10.1016/S0142-9612(03)00595-7
   Sobral PJA, 2001, FOOD HYDROCOLLOID, V15, P377, DOI 10.1016/S0268-005X(01)00060-1
   SONGCHOTIKUNPAN R, 2008, INT J BIOL MACROMOL, V42, P247
   Sorrentino A, 2007, TRENDS FOOD SCI TECH, V18, P84, DOI 10.1016/j.tifs.2006.09.004
   Stainsby G, 1987, ADV MEAT RES, V4, P209
   Sztuka K, 2008, EUR FOOD RES TECHNOL, V226, P1127, DOI 10.1007/s00217-007-0641-9
   Tang CH, 2005, J BIOTECHNOL, V120, P296, DOI 10.1016/j.jbiotec.2005.06.020
   Tapia-Blacido D., 2007, J FOOD SCI, V72, P293
   TARAVEL MN, 1995, BIOMATERIALS, V16, P865, DOI 10.1016/0142-9612(95)94149-F
   Tharanathan RN, 2003, TRENDS FOOD SCI TECH, V14, P71, DOI 10.1016/S0924-2244(02)00280-7
   Thomazine M., 2005, J FOOD SCI, V70, P172, DOI DOI 10.111/J.1365-2621.2005.TB07132.X
   Vanin FM, 2005, FOOD HYDROCOLLOID, V19, P899, DOI 10.1016/j.foodhyd.2004.12.003
   WAINEWRIGHT FW, 1977, SCI TECHNOLOGY GELAT, P507
   WETZEL R, 1987, COLLOID POLYM SCI, V265, P1036, DOI 10.1007/BF01417460
   Xue CH, 1998, BIOSCI BIOTECH BIOCH, V62, P206, DOI 10.1271/bbb.62.206
   YANG H, 2007, J FOOD SCI, V72
   Yi J. B., 2006, J FOOD SCI, V71, P376
   Zhang S., 2007, J FOOD SCI, V72, P498
   Zhou P, 2004, J FOOD SCI, V69, pC393
   Zhou P, 2006, J FOOD SCI, V71, pC313, DOI 10.1111/j.1750-3841.2006.00065.x
   Ziegler G. R., 1990, Advances in Food and Nutrition Research, V34, P203, DOI 10.1016/S1043-4526(08)60008-X
   Zivanovic S., 2005, J FOOD SCI, V70, P45
NR 119
TC 185
Z9 195
U1 11
U2 183
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0924-2244
J9 TRENDS FOOD SCI TECH
JI Trends Food Sci. Technol.
PY 2009
VL 20
IS 1
BP 3
EP 16
DI 10.1016/j.tifs.2008.10.002
PG 14
WC Food Science & Technology
SC Food Science & Technology
GA 402LU
UT WOS:000263016000001
DA 2018-10-19
ER

PT J
AU Tur, K
AF Tur, Kazim
TI Biomaterials and Tissue Engineering for Regenerative Repair of Articular
   Cartilage Defects
SO TURKISH JOURNAL OF RHEUMATOLOGY-TURK ROMATOLOJI DERGISI
LA English
DT Article
DE Classification of biomaterials; tissue engineering; cartilage repair;
   tissue regeneration; biomimetic
ID MESENCHYMAL STEM-CELLS; CHONDROGENIC DIFFERENTIATION; DERMAL
   FIBROBLASTS; IN-VITRO; SCAFFOLDS; CHONDROCYTES; HYDROGELS; CULTURE; BONE
AB Articular cartilage defects heal very poorly and lead to degenerative arthritis. Existing medications cannot promote healing process; cartilage defects eventually require surgical replacements with autografts. As there is not enough source of articular cartilage that can be donated for autografting, materials that promote cartilage regeneration are important in both research and clinical applications. Tissue engineering involves cell growth on biomaterial scaffolds in vitro. These cells are then injected into cartilage defects for biological in vivo regeneration of the cartilage tissue. This review aims first to provide a brief introduction to the types of materials in medicine (biomaterials), to their roles in treatment of diseases, and to design factors and general requirements of biomaterials. Then, it attempts to sum up the recent advances in engineering articular cartilage; one of the most challenging area of study in biomaterials based tissue engineering, as an example to the research on regenerative solutions to musculoskeletal problems with an emphasis on the biomaterials that have been developed as scaffolds for cartilage tissue engineering. The definitive goal on cartilage regeneration is to develop a system using biomimetic approach to produce cartilage tissue that mimics native tissue properties, provides rapid restoration of tissue function, and is clinically translatable. This is obviously an ambitious goal; however, significant progress have been made in recent years; and further advances in materials design and technology will pave the way for creating significantly custom-made cellular environment for cartilage regeneration. (Turk J Rheumatol 2009; 24: 206-17)
C1 Atilim Univ, Dept Mat Engn, Ankara, Turkey.
RP Tur, K (reprint author), Atilim Univ, Dept Mat Engn, Ankara, Turkey.
EM tur@atilim.edu.tr
CR Agrawal CM, 1998, JOM-J MIN MET MAT S, V50, P31, DOI 10.1007/s11837-998-0064-5
   Basu B, 2009, ADV BIOMATERIALS FUN
   Ben-Nissan B., 2004, ENG MAT BIOMEDICAL A
   BENNISSAN B, 2004, MATER FORUM, P104
   Black J., 1992, BIOL PERFORMANCE MAT
   BORETOS JW, 1987, ADV CERAM MATER, V2, P15
   Bryant SJ, 2002, J BIOMED MATER RES, V59, P63, DOI 10.1002/jbm.1217
   Bryant SJ, 2003, J BIOMED MATER RES A, V64A, P70, DOI 10.1002/jbm.a.10319
   Chia SL, 2006, TISSUE ENG, V12, P1945, DOI 10.1089/ten.2006.12.1945
   Chiang HS, 2009, J FORMOS MED ASSOC, V108, P87, DOI 10.1016/S0929-6646(09)60039-5
   Chung C, 2008, ADV DRUG DELIVER REV, V60, P243, DOI 10.1016/j.addr.2007.08.027
   DEC KC, 2002, INTRO TISSUE BIOMATE
   Dumont J, 1999, CONNECT TISSUE RES, V40, P259, DOI 10.3109/03008209909000704
   Encyclop&AELIG;dia Britannica, ENC BRIT
   ENGELBERG I, 1991, BIOMATERIALS, V12, P292, DOI 10.1016/0142-9612(91)90037-B
   Fisher JP, 2004, J BIOMED MATER RES A, V71A, P268, DOI 10.1002/jbm.a.30148
   French MM, 2004, ANN BIOMED ENG, V32, P50, DOI 10.1023/B:ABME.0000007790.65773.e0
   Frenkel SR, 2004, ANN BIOMED ENG, V32, P26, DOI 10.1023/B:ABME.0000007788.41804.0d
   Genes NG, 2004, ARCH BIOCHEM BIOPHYS, V422, P161, DOI 10.1016/j.abb.2003.11.023
   Helmick CG, 2008, ARTHRITIS RHEUM, V58, P15, DOI 10.1002/art.23177
   Hench L. L., 1991, CERAMICS 21 CENTURY, P519
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Hutmacher DW, 2001, J BIOMED MATER RES, V55, P203, DOI 10.1002/1097-4636(200105)55:2<203::AID-JBM1007>3.3.CO;2-Z
   Hwang NS, 2006, TISSUE ENG, V12, P2695, DOI 10.1089/ten.2006.12.2695
   Kim SE, 2003, J CONTROL RELEASE, V91, P365, DOI 10.1016/S0168-3659(03)00274-8
   Lee CR, 2005, TISSUE ENG, V11, P1562, DOI 10.1089/ten.2005.11.1562
   Lee CR, 2000, TISSUE ENG, V6, P555, DOI 10.1089/107632700750022198
   LeGeros R Z, 1988, Adv Dent Res, V2, P164
   Li WJ, 2003, J BIOMED MATER RES A, V67A, P1105, DOI 10.1002/jbm.a.10101
   Malpeli M, 2004, TISSUE ENG, V10, P145, DOI 10.1089/107632704322791790
   Mauck RL, 2006, OSTEOARTHR CARTILAGE, V14, P179, DOI 10.1016/j.joca.2005.09.002
   Mesa JM, 2006, PLAST RECONSTR SURG, V118, P41, DOI 10.1097/01.prs.0000231929.37736.28
   Muller FA, 2006, BIOMATERIALS, V27, P3955, DOI 10.1016/j.biomaterials.2006.02.031
   Ng KW, 2005, J ORTHOP RES, V23, P134, DOI 10.1016/j.orthres.2004.05.015
   Nicoll SB, 2001, CONNECT TISSUE RES, V42, P59, DOI 10.3109/03008200109014249
   Ochi M, 2001, ARTIF ORGANS, V25, P172, DOI 10.1046/j.1525-1594.2001.025003172.x
   Park J., 2007, BIOMATERIALS
   Radice M, 2000, J BIOMED MATER RES, V50, P101, DOI 10.1002/(SICI)1097-4636(200005)50:2<101::AID-JBM2>3.0.CO;2-M
   Ratner B. D., 1996, BIOMATERIALS SCI INT
   Solchaga LA, 2005, OSTEOARTHR CARTILAGE, V13, P297, DOI 10.1016/j.joca.2004.12.016
   Spector M, 2006, SWISS MED WKLY, V136, P293
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   STOOP R, 2008, INJURY, pS77
   TABATA Y, 2008, INFLAMM REGEN, V28, P86
   Temenoff JS, 2002, J BIOMED MATER RES, V59, P429, DOI 10.1002/jbm.1259
   VanVlack LH, 1989, ELEMENTS MAT SCI ENG
   Wang YZ, 2005, BIOMATERIALS, V26, P7082, DOI 10.1016/j.biomaterials.2005.05.022
   Williams D., 1990, CONCISE ENCY MED DEN
   Woodfield TBF, 2002, CRIT REV EUKAR GENE, V12, P209, DOI 10.1615/CritRevEukaryotGeneExpr.v12.i3.40
   Zein I, 2002, BIOMATERIALS, V23, P1169, DOI 10.1016/S0142-9612(01)00232-0
NR 50
TC 4
Z9 4
U1 0
U2 9
PU AVES YAYINCILIK, IBRAHIM KARA
PI ISTANBUL
PA KIZILELMA CAD 5-3, FINDIKZADE, ISTANBUL, 34096, TURKEY
SN 1309-0291
J9 TURK J RHEUMATOL
JI Turk. J. Rheumatol.
PY 2009
VL 24
IS 4
BP 206
EP 217
PG 12
WC Rheumatology
SC Rheumatology
GA 548BE
UT WOS:000273933000008
DA 2018-10-19
ER

PT J
AU Gift, BW
   English, RV
   Nadelstein, B
   Weigt, AK
   Gilger, BC
AF Gift, Barrett W.
   English, Robert V.
   Nadelstein, Brad
   Weigt, Anne K.
   Gilger, Brian C.
TI Comparison of capsular opacification and refractive status after
   placement of three different intraocular lens implants following
   phacoemulsification and aspiration of cataracts in dogs
SO VETERINARY OPHTHALMOLOGY
LA English
DT Article
DE design; dog; intraocular lens; material; posterior capsular
   opacification; refractive error
ID COLLAGEN TYPE-IV; HUMAN AUTOPSY EYES; OPTIC EDGE DESIGN; POSTERIOR
   CAPSULE; PHOTOGRAPHIC ASSESSMENT; SURGICAL PREVENTION; PSEUDOPHAKIC
   EYES; EPITHELIAL-CELLS; HAPTIC DESIGN; IN-VITRO
AB To evaluate the effect of lens design and biomaterial on formation of posterior capsular opacification (PCO) and refractive correction.
   Sixty dogs undergoing bilateral phacoemulsification for mature or diabetic cataracts.
   One randomly selected eye received a rounded edge 41D polymethyl-methacrylate (PMMA) intraocular replacement lens (IOL) and the contralateral eye received either a squared edge 41D hydrophilic acrylic IOL (n = 35) or a squared edge 40D hydrophobic acrylic IOL (n = 25). At the (mean = 79 day) reexamination period, PCO was graded using direct slit-lamp observation and by masked observer evaluation of digital images of the IOLs. Streak retinoscopy and B-mode ultrasound were performed at this period.
   The PCO score via direct slit-lamp was significantly lower for the hydrophilic acrylic IOL when compared to the PMMA IOL. Masked observer evaluation of digital images revealed that the acrylic IOLs had lower but generally not statistically significant PCO scores than the PMMA IOLs. Streak retinoscopy showed that the PMMA IOL was significantly closer to emmetropia (+0.44 D) when compared to either the hydrophilic acrylic (+0.96 D) or the hydrophobic acrylic (+1.2 D) IOLs. B-mode ultrasonography revealed the center of the hydrophilic acrylic IOL is 0.31 mm closer to the retina and the center of the hydrophobic acrylic IOL is 0.63 mm further from the retina when compared to the center of the PMMA to retina distance.
   Square edged foldable acrylic IOLs show a predisposition towards generating slightly less PCO than round edged PMMA IOLs in the early postoperative period, however, both acrylic IOLs had greater persistent hyperopia than the PMMA IOLs.
C1 [Gift, Barrett W.; English, Robert V.] Anim Eye Care Associates, Cary, NC USA.
   [Nadelstein, Brad] Anim Eye Care Associates, Chesapeake, VA USA.
   [Weigt, Anne K.] Anim Eye Care Associates, Laurel, MD USA.
   [Gilger, Brian C.] N Carolina State Univ, Coll Vet Med, Dept Clin Sci, Raleigh, NC USA.
RP English, RV (reprint author), Anim Eye Care Associates, Cary, NC USA.
EM visionrecords@mac.com
CR Abela-Formanek C, 2002, J CATARACT REFR SURG, V28, P50, DOI 10.1016/S0886-3350(01)01122-1
   Apple D J, 2000, Trans Am Ophthalmol Soc, V98, P257
   Apple DJ, 2001, OPHTHALMOLOGY, V108, P505, DOI 10.1016/S0161-6420(00)00589-3
   Apple DJ, 2000, J CATARACT REFR SURG, V26, P180, DOI 10.1016/S0886-3350(99)00353-3
   Aslam TM, 2002, BRIT J OPHTHALMOL, V86, P1181, DOI 10.1136/bjo.86.10.1181
   Auffarth GU, 2003, OPHTHALMOLOGY, V110, P772, DOI 10.1016/S0161-6420(02)01980-2
   Awasthi N, 2006, INVEST OPHTH VIS SCI, V47, P4482, DOI 10.1167/iovs.06-0139
   Beale AB, 2006, VET OPHTHALMOL, V9, P335, DOI 10.1111/j.1463-5224.2006.00473.x
   Bender L, 2004, J CATARACT REFR SURG, V30, P2058, DOI 10.1016/j.jcrs.2004.05.010
   Bras ID, 2006, VET OPHTHALMOL, V9, P317, DOI 10.1111/j.1463-5224.2006.00458.x
   Buehl W, 2002, J CATARACT REFR SURG, V28, P265, DOI 10.1016/S0886-3350(01)01228-7
   Camparini M, 2000, INVEST OPHTH VIS SCI, V41, P3074
   Cheng JW, 2007, AM J OPHTHALMOL, V143, P428, DOI 10.1016/j.ajo.2006.11.045
   COTTRILL NB, 1989, AM J VET RES, V50, P898
   Davidson MG, 2001, VET OPHTHALMOL, V4, P1, DOI 10.1046/j.1463-5224.2001.00175.x
   Davidson MG, 2000, J CATARACT REFR SURG, V26, P1550, DOI 10.1016/S0886-3350(99)00451-4
   Davidson MG, 2007, VET OPHTHALMOLOGY, P859
   Findl O, 2003, J CATARACT REFR SURG, V29, P106, DOI 10.1016/S0886-3350(02)01509-2
   Findl O, 2003, INVEST OPHTH VIS SCI, V44, P275, DOI 10.1167/iovs.02-0619
   Findl O, 2007, COCHRANE DB SYST REV, V3
   FINE IH, 1992, J CATARACT REFR SURG, V18, P508, DOI 10.1016/S0886-3350(13)80108-3
   Friedman DS, 1999, INVEST OPHTH VIS SCI, V40, P1715
   GAIDDON J, 1991, AM J VET RES, V52, P781
   Gerardi J. G., 1999, Veterinary Ophthalmology, V2, P163
   GREEN WR, 1985, T OPHTHAL SOC UK, V104, P727
   Lane SS, 2004, J CATARACT REFR SURG, V30, P2397, DOI 10.1016/j.jcrs.2004.03.041
   Linnola RJ, 2003, J CATARACT REFR SURG, V29, P146, DOI 10.1016/S0886-3350(02)01422-0
   Linnola RJ, 2000, J CATARACT REFR SURG, V26, P1792, DOI 10.1016/S0886-3350(00)00748-3
   Linnola RJ, 2000, J CATARACT REFR SURG, V26, P1807, DOI 10.1016/S0886-3350(00)00747-1
   MCDONNELL PJ, 1983, OPHTHALMOLOGY, V90, P1548
   Meacock WR, 2001, J CATARACT REFR SURG, V27, P1366, DOI 10.1016/S0886-3350(01)01024-0
   Moreno-Montanes J, 2005, INVEST OPHTH VIS SCI, V46, P3999, DOI 10.1167/iovs.04-1531
   NASISSE MP, 1988, SEMIN VET MED SURG, V3, P52
   NASISSE MP, 1995, GRAEF ARCH CLIN EXP, V233, P63, DOI 10.1007/BF00241473
   Nishi O, 2000, J CATARACT REFR SURG, V26, P1543, DOI 10.1016/S0886-3350(00)00426-0
   Nishi O, 2004, J CATARACT REFR SURG, V30, P2170, DOI 10.1016/j.jcrs.2004.05.022
   Nishi O, 2001, J CATARACT REFR SURG, V27, P608, DOI 10.1016/S0886-3350(00)00644-1
   NISHI O, 1986, J CATARACT REFR SURG, V12, P519, DOI 10.1016/S0886-3350(86)80126-2
   Nishi O, 2007, J CATARACT REFR SURG, V33, P1065, DOI 10.1016/j.jcrs.2007.02.022
   Nishi Y, 2007, J CATARACT REFR SURG, V33, P227, DOI 10.1016/j.jcrs.2006.10.020
   Oner FH, 2000, J CATARACT REFR SURG, V26, P722, DOI 10.1016/S0886-3350(99)00456-3
   Oshika T, 1998, BRIT J OPHTHALMOL, V82, P549, DOI 10.1136/bjo.82.5.549
   Pandey Suresh K., 2004, Indian Journal of Ophthalmology, V52, P99
   Peng Q, 2000, J CATARACT REFR SURG, V26, P188, DOI 10.1016/S0886-3350(99)00354-5
   Ram J, 1999, OPHTHALMOLOGY, V106, P883, DOI 10.1016/S0161-6420(99)00505-9
   Ram J, 1999, OPHTHALMOLOGY, V106, P891, DOI 10.1016/S0161-6420(99)00506-0
   Ram J, 2001, J CATARACT REFR SURG, V27, P1039, DOI 10.1016/S0886-3350(00)00841-5
   Ravalico G, 1996, J CATARACT REFR SURG, V22, P98, DOI 10.1016/S0886-3350(96)80277-X
   Sacu S, 2005, J CATARACT REFR SURG, V31, P1888, DOI 10.1016/j.jcrs.2005.03.072
   Sacu S, 2006, AM J OPHTHALMOL, V141, P488, DOI 10.1016/j.ajo.2005.10.041
   Schaumberg DA, 1998, OPHTHALMOLOGY, V105, P1213, DOI 10.1016/S0161-6420(98)97023-3
   SELLMAN TR, 1988, J CATARACT REFR SURG, V14, P68, DOI 10.1016/S0886-3350(88)80067-1
   Sigle KJ, 2006, JAVMA-J AM VET MED A, V228, P74, DOI 10.2460/javma.228.1.74
   Tetz MR, 1997, J CATARACT REFR SURG, V23, P1515, DOI 10.1016/S0886-3350(97)80022-3
   WATSON JL, 2007, VET OPHTHALMOLOGY, V10, P398
   Yan Q, 2005, GRAEF ARCH CLIN EXP, V243, P1253, DOI 10.1007/s00417-005-1181-2
NR 56
TC 14
Z9 14
U1 0
U2 2
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1463-5216
J9 VET OPHTHALMOL
JI Vet. Ophthalmol.
PD JAN-FEB
PY 2009
VL 12
IS 1
BP 13
EP 21
DI 10.1111/j.1463-5224.2009.00667.x
PG 9
WC Veterinary Sciences
SC Veterinary Sciences
GA 390GJ
UT WOS:000262152000003
PM 19152593
DA 2018-10-19
ER

PT J
AU Modak, PR
   Singh, KS
   Connor, DA
AF Modak, Poly R.
   Singh, Kripa S.
   Connor, Dennis A.
TI Experimental Study on the Elimination of Colour and Organic Matter from
   Wastewater Using an Inexpensive Biomaterial, Chitosan
SO WATER QUALITY RESEARCH JOURNAL OF CANADA
LA English
DT Article
DE reactive azo dyes; chitosan; adsorbent; primary coagulant; colour;
   organic matter
AB Chitosan has been investigated as an inexpensive, biologically derived adsorbent and/or primary coagulant for two reactive azo dyes in textile wastewater. At natural pH, complete elimination of colour was achieved from 0.1 g/L aqueous solutions of the textile dyes Procion Orange MX-2R and Procion Red MX-5B with a dose of 6 g of chitosan per litre of dye solution. However, when pH was lowered (to 4.8 and 5.5 respectively), a dose of only 1 g of chitosan per litre was necessary to eliminate colour and drastically reduce TOC (total organic carbon) and chemical oxygen demand for the same concentration of dyes. This allowed about an 80% reduction in sludge volume production. Addition of sodium phosphate dibasic and potassium sulfate improved the dye removal at higher pH. Colour removal decreased significantly with or without added salts as pH was adjusted above 7. Equilibrium adsorption experiments showed that both dye solutions follow the Freundlich isotherm, but not the Langmuir isotherm. Kinetics measurements show a better fit to the pseudosecond-order Lagergren model than to the first-order Lagergren model. Brunauer-Emmett-Teller, or BET, surface area analysis and scanning electron microscope micrographs were included for better understanding of the nature of the chitosan surface with and without adsorbed dye. Chitosan appears to be a natural, clean and excellent product for the adsorption of Procion Orange MX-2R and Procion Red MX-5B in mildly acidic conditions.
C1 [Modak, Poly R.; Singh, Kripa S.; Connor, Dennis A.] Univ New Brunswick, Dept Civil & Chem Engn, Fredericton, NB E3B 5A3, Canada.
RP Singh, KS (reprint author), Univ New Brunswick, Dept Civil & Chem Engn, POB 4400, Fredericton, NB E3B 5A3, Canada.
EM singhk@unb.ca
FU Government of New Brunswick; NSERC; AIF
FX The authors would like to acknowledge the financial support provided to
   the first author by the Government of New Brunswick through their Work
   Ability program. The financial support for this research project was
   provided by the NSERC and AIF research grants of the second author.
CR Aksu Z, 2005, PROCESS BIOCHEM, V40, P1347, DOI 10.1016/j.procbio.2004.06.007
   Allen S J, 1987, J SEPAR P TECHNOL, V8, P18
   Anjaneyulu Y., 2005, Reviews in Environmental Science and Bio/Technology, V4, P245, DOI 10.1007/s11157-005-1246-z
   [APHA (American Public Health Association) AWWA (American Water Works Association) WEF (Water Environment Federation)], 2005, STAND METH EX WAT WA
   Armagan B, 2004, DESALINATION, V170, P33, DOI 10.1016/j.desal.2004.02.091
   BAHORSKY M, 1998, EMERGING TECHNOLOGIE
   BALASUBRAMANIAN S, 2007, INT J ENV CULTURAL E, V3, P39
   Beydilli MI, 1998, WATER SCI TECHNOL, V38, P225, DOI 10.1016/S0273-1223(98)00531-9
   Blackburn RS, 2004, ENVIRON SCI TECHNOL, V38, P4905, DOI 10.1021/es049972n
   Blackburn RS, 2003, J APPL POLYM SCI, V89, P1026, DOI 10.1002/app.12226
   BROWN MA, 1993, CRIT REV ENV SCI TEC, V23, P249, DOI 10.1080/10643380490434119
   CARLIELL CM, 1995, WATER SA, V21, P61
   Chiou MS, 2003, CHEMOSPHERE, V50, P1095, DOI 10.1016/S0045-6535(02)00636-7
   Crini G, 2006, BIORESOURCE TECHNOL, V97, P1061, DOI 10.1016/j.biortech.2005.05.001
   Crini G, 2005, PROG POLYM SCI, V30, P38, DOI 10.1016/j.progpolymsci.2004.11.002
   Forgacs E, 2004, ENVIRON INT, V30, P953, DOI 10.1016/j.envint.2004.02.001
   Freundlich H. M. F., 1907, J PHYS CHEM-US, V57, P385, DOI DOI 10.1021/JE900585T
   Golob V, 2005, DYES PIGMENTS, V67, P93, DOI 10.1016/j.dyepig.2004.11.003
   Golob V, 2005, DYES PIGMENTS, V64, P57, DOI 10.1016/j.dyepig.2004.04.006
   Gong RM, 2005, J HAZARD MATER, V121, P247, DOI 10.1016/j.jhazmat.2005.01.029
   Gottlieb A, 2003, J BIOTECHNOL, V101, P49, DOI 10.1016/S0168-1656(02)00302-4
   Guibal E, 2006, SEPAR SCI TECHNOL, V41, P2487, DOI 10.1080/01496390600742807
   GUPTA GS, 1990, WATER RES, V24, P45, DOI 10.1016/0043-1354(90)90063-C
   Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5
   Juang RS, 1997, J CHEM TECHNOL BIOT, V70, P391, DOI 10.1002/(SICI)1097-4660(199712)70:4<391::AID-JCTB792>3.0.CO;2-V
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004
   Largergren S, 1898, HANDLINGAR, V24, P1, DOI DOI 10.1007/BF01501332
   Manu B, 2002, BIORESOURCE TECHNOL, V82, P225, DOI 10.1016/S0960-8524(01)00190-0
   MCKAY G, 1983, CHEM ENG J BIOCH ENG, V27, P187, DOI 10.1016/0300-9467(83)80075-6
   PAGGA U, 1986, CHEMOSPHERE, V15, P479, DOI 10.1016/0045-6535(86)90542-4
   Robinson T, 2001, BIORESOURCE TECHNOL, V77, P247, DOI 10.1016/S0960-8524(00)00080-8
   Sakkayawong N, 2005, J COLLOID INTERF SCI, V286, P36, DOI 10.1016/j.jcis.2005.01.020
   Sethuraman V.V., 1975, ENVIRON SCI TECHNOL, V9, P1139
   STEFANCICH S, 1994, CARBOHYD POLYM, V24, P17, DOI 10.1016/0144-8617(94)90112-0
   Uzun I, 2006, DYES PIGMENTS, V70, P76, DOI 10.1016/j.dyepig.2005.04.016
   Varma AJ, 2004, CARBOHYD POLYM, V55, P77, DOI 10.1016/j.carbpol.2003.08.005
   Willmott N, 1998, J SOC DYERS COLOUR, V114, P38
   Wong CK, 2006, HUM ECOL RISK ASSESS, V12, P289, DOI 10.1080/10807030500531604
   Wong YC, 2004, PROCESS BIOCHEM, V39, P693, DOI 10.1016/S0032-9592(03)00152-3
   Yang CL, 2005, J HAZARD MATER, V127, P40, DOI 10.1016/j.jhazmat.2005.05.050
   Yang XY, 2001, CHEM ENG J, V83, P15, DOI 10.1016/S1385-8947(00)00233-3
   YOSHIDA H, 1993, CHEM ENG SCI, V48, P2267, DOI 10.1016/0009-2509(93)80242-I
NR 43
TC 3
Z9 3
U1 0
U2 5
PU CANADIAN ASSOC WATER QUALITY
PI GLOUCESTER
PA C/O DR H R EISENHAUER, ENVIRONMENTAL TECHNOL CENTRE, 3439 RIVER ROAD
   SOUTH, GLOUCESTER, ONTARIO K1A 0H3, CANADA
SN 1201-3080
J9 WATER QUAL RES J CAN
JI Water Qual. Res. J. Canada
PY 2009
VL 44
IS 3
BP 295
EP 306
PG 12
WC Water Resources
SC Water Resources
GA V16DG
UT WOS:000207849700009
DA 2018-10-19
ER

PT S
AU Fassina, L
   Saino, E
   Visai, L
   De Angelis, MGC
   Benazzo, F
   Magenes, G
AF Fassina, L.
   Saino, E.
   Visai, L.
   De Angelis, M. G. Cusella
   Benazzo, F.
   Magenes, G.
BE Dossel, O
   Schlegel, WC
TI Enhancement of a culture of human osteoblasts inside hydroxyap atite
   scaffolds via [2 mT; 75 Hz]-electromagnetic bioreactor
SO WORLD CONGRESS ON MEDICAL PHYSICS AND BIOMEDICAL ENGINEERING, VOL 25, PT
   10: BIOMATERIALS, CELLULAR AND TISSUE ENGINEERING, ARTIFICIAL ORGANS
SE IFMBE Proceedings
LA English
DT Proceedings Paper
CT 11th International Congress of the IUPESM/World Congress on Medical
   Physics and Biomedical Engineering
CY SEP 07-12, 2009
CL Munich, GERMANY
SP IUPESM, Int Org Med Phys (IOMP)
DE Hydroxyapatite; electromagnetic stimulation; osteoblast; cell
   proliferation; bone extracellular matrix; surface modification; biomime
   tics
ID POLYURETHANE POROUS SCAFFOLD; CALCIFIED MATRIX PRODUCTION;
   BONE-FORMATION; SAOS-2 CELLS; IN-VITRO; CALCIFICATION; DEGRADATION;
   REPAIR
AB Biomaterials have been widely used in reconstructive bone surgery to heal critical-size long bone defect s due to trauma, tumor resection, and tissue degeneration. In particular, porous hydroxyapatite is commonly employed owing to its biocompatibility; in addition, the in vitro modification of hydroxyapatite with osteogenic signals enhances the tissue regeneration in vivo, suggesting that the biomaterial modification could play an important role in tissue engineering. In this study we have followed a biomimetic strategy where electromagnetically stimulated SAOS -2 human osteoblasts prolif crated and built their extracellular matrix inside porous h ydroxyapatite. In comparison with control conditions, the electromagnetic stimulus (magnetic field, 2 mT; frequency, 75 Hz) increased, in vitro, the cell proliferation and the coating of hydroxyapatite with bone proteins (decorin, osteocalcin, osteopontin, t ype-I collagen, and type -III collagen). The physical stimulus aimed at obtaining a better in vitro modification of porous hydroxyapatite in terms of cell colonization and coating with osteogenic signals, like bone matrix proteins. The modified biomaterial could be used, in clinical applications, as an implant for bone repair.
C1 [Fassina, L.; Magenes, G.] Univ Pavia, Dipartimento Informat & Sistemist, Via Ferrata 1, I-27100 Pavia, Italy.
   [Saino, E.; Visai, L.] Univ Pavia, Dipartimento Biochim, I-27100 Pavia, Italy.
   [De Angelis, M. G. Cusella] Univ Pavia, Dipartimento Med Sperimentale, I-27100 Pavia, Italy.
   [Benazzo, F.] Univ Pavia, IRCCS San Matteo, Dipartimento SMEC, I-27100 Pavia, Italy.
   [Fassina, L.; Saino, E.; Visai, L.; De Angelis, M. G. Cusella; Benazzo, F.; Magenes, G.] Univ Pavia, Ctr Tissue Engn, I-27100 Pavia, Italy.
RP Fassina, L (reprint author), Univ Pavia, Dipartimento Informat & Sistemist, Via Ferrata 1, I-27100 Pavia, Italy.
EM lorenzo.fassina@unipv.it
RI Magenes, Giovanni/C-4202-2012; Fassina, Lorenzo/K-9283-2015
OI Magenes, Giovanni/0000-0002-7558-1490; Fassina,
   Lorenzo/0000-0002-5587-4632
FU Fondazione Cariplo [2004.1424/10.8485, 2006.0581/10.8485]; FIRB from
   Italian Ministry of Education [RBIP06FH7J]; University and Research to
   M.G. C. De A
FX This work was supported by Fondazione Cariplo Grants 2004.1424/10.8485
   and 2006.0581/10.8485) to F. B. and by FIRB Grant (RBIP06FH7J) from
   Italian Ministry of Education, University and Research to M.G. C. De A..
CR Akita S, 2004, TISSUE ENG, V10, P789, DOI 10.1089/1076327041348338
   Artzi Z, 2001, INT J PERIODONT REST, V21, P395
   Botchwey EA, 2001, J BIOMED MATER RES, V55, P242
   CANE V, 1993, J ORTHOPAED RES, V11, P664, DOI 10.1002/jor.1100110508
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   COHEN RE, 1994, J PERIODONTOL, V65, P1008, DOI 10.1902/jop.1994.65.11.1008
   Devin JE, 1996, J BIOMAT SCI-POLYM E, V7, P661, DOI 10.1163/156856296X00435
   Fassina L, 2007, Technol Health Care, V15, P33
   Fassina L, 2005, TISSUE ENG, V11, P685, DOI 10.1089/ten.2005.11.685
   Fassina L, 2006, TISSUE ENG, V12, P1985, DOI 10.1089/ten.2006.12.1985
   Fisher LW, 1995, ACTA ORTHOP SCAND, V66, P61
   FITZSIMMONS RJ, 1994, CALCIFIED TISSUE INT, V55, P376, DOI 10.1007/BF00299318
   Gorna K, 2003, J BIOMED MATER RES A, V67A, P813, DOI 10.1002/jbm.a.10148
   Gorna K, 2002, J BIOMED MATER RES, V60, P592, DOI 10.1002/jbm.10100
   Li JKJ, 2006, ULTRASOUND MED BIOL, V32, P769, DOI 10.1016/j.ultrasmedbio.2006.01.017
   Mauney JR, 2004, TISSUE ENG, V10, P81, DOI 10.1089/107632704322791727
   Nishikawa M, 2004, CELL TRANSPLANT, V13, P367, DOI 10.3727/000000004783983819
   Pavalko FM, 2003, J CELL BIOCHEM, V88, P104, DOI 10.1002/jcb.10284
   Ripamonti U, 2006, J ANAT, V209, P447, DOI 10.1111/j.1469-7580.2006.00635.x
   Rossi A, 1996, BIOCHEMISTRY-US, V35, P6048, DOI 10.1021/bi9518151
   Stephan EB, 1999, J PERIODONTOL, V70, P364, DOI 10.1902/jop.1999.70.4.364
   VOGEL KG, 1987, J BIOL CHEM, V262, P13607
NR 22
TC 0
Z9 0
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
SN 1680-0737
BN 978-3-642-03899-0
J9 IFMBE PROC
PY 2009
VL 25
IS 10
BP 87
EP +
PG 2
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA BQW95
UT WOS:000282043000026
DA 2018-10-19
ER

PT S
AU Frober, U
   Stubenrauch, M
   Weiss, T
   Berg, A
   Voges, D
   Schade, R
   Hildebrand, G
   Schnabelrauch, M
   Liefeith, K
   Hoffmann, M
   Witte, H
AF Froeber, U.
   Stubenrauch, M.
   Weiss, T.
   Berg, A.
   Voges, D.
   Schade, R.
   Hildebrand, G.
   Schnabelrauch, M.
   Liefeith, K.
   Hoffmann, M.
   Witte, H.
BE Dossel, O
   Schlegel, WC
TI Microsystems for the Characterization of 3D-ECM Analogous Bio-Interfaces
SO WORLD CONGRESS ON MEDICAL PHYSICS AND BIOMEDICAL ENGINEERING, VOL 25, PT
   10: BIOMATERIALS, CELLULAR AND TISSUE ENGINEERING, ARTIFICIAL ORGANS
SE IFMBE Proceedings
LA English
DT Proceedings Paper
CT 11th International Congress of the IUPESM/World Congress on Medical
   Physics and Biomedical Engineering
CY SEP 07-12, 2009
CL Munich, GERMANY
SP IUPESM, Int Org Med Phys (IOMP)
DE biomaterial; scaffold; two-photon-polymerization; microsystem
AB Characteristics of scaffold materials for tissue engineering have to be adapted to the respective cell lines. Especially cartilage cells require an artificial 3-dimensional extra cellular matrix, to behave and grow like in natural environment. To reach this goal, biomaterials have to be developed that fulfill these requirements. A novel structuring technique for degradable polymer scaffolds is 2-photon-polymerization. For defining best chemical and geometrical properties a microsystem is necessary that can be used as a test-environment in cell-cultivation-experiments. In this paper we describe both materials for and the process of 2-photon-polymerization. We introduce a silicon-glass-micro system with scaffold integration option for testing of scaffold materials and structures.
C1 [Froeber, U.; Stubenrauch, M.; Hoffmann, M.; Witte, H.] Ilmenau Univ Technol, Inst Micro & Nanotechnol, Max Planck Ring 12, D-98693 Ilmenau, Germany.
   [Weiss, T.; Schade, R.; Hildebrand, G.; Liefeith, K.] Inst Bioproc & Analyt Measurement Techn, Heilbad, Germany.
   [Berg, A.; Schnabelrauch, M.] INNOVENT Technolieentwicklung Jena, Jena, Germany.
RP Frober, U (reprint author), Ilmenau Univ Technol, Inst Micro & Nanotechnol, Max Planck Ring 12, D-98693 Ilmenau, Germany.
EM Ulrike.froeber@tu-ilmenau.de
RI Witte, Hartmut/O-4436-2014
OI Witte, Hartmut/0000-0001-6055-2921
FU Thuringer Kultusministerium [B514-06016]
FX This work has been supported by Thuringer Kultusministerium under
   contract B514-06016.
CR FROBER U, 2008, IFMBE P ANTW BELG
   Hutmacher DW, 2004, TRENDS BIOTECHNOL, V22, P354, DOI 10.1016/j.tibtech.2004.05.006
   LaFratta CN, 2007, ANGEW CHEM INT EDIT, V46, P6238, DOI 10.1002/anie.200603995
   MARTINI J, 2006, P SOC PHOTO-OPT INS, V6089, P274
   Stangegaard M, 2006, LAB CHIP, V6, P1045, DOI 10.1039/b603379b
   Stubenrauch M., 2007, BLACK SILICON EINSTE
   Stubenrauch M., 2008, BIOMEMS NEW METHODS
NR 7
TC 1
Z9 1
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
SN 1680-0737
BN 978-3-642-03899-0
J9 IFMBE PROC
PY 2009
VL 25
IS 10
BP 94
EP +
PG 2
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA BQW95
UT WOS:000282043000028
DA 2018-10-19
ER

PT S
AU Jager, M
   Herten, M
   Jelinek, EM
   Fochtmann, U
   Krauspe, R
AF Jaeger, M.
   Herten, M.
   Jelinek, E. M.
   Fochtmann, U.
   Krauspe, R.
BE Dossel, O
   Schlegel, WC
TI Bone Marrow Concentrate: a novel tool for bone repair!
SO WORLD CONGRESS ON MEDICAL PHYSICS AND BIOMEDICAL ENGINEERING, VOL 25, PT
   10: BIOMATERIALS, CELLULAR AND TISSUE ENGINEERING, ARTIFICIAL ORGANS
SE IFMBE Proceedings
LA English
DT Proceedings Paper
CT 11th International Congress of the IUPESM/World Congress on Medical
   Physics and Biomedical Engineering
CY SEP 07-12, 2009
CL Munich, GERMANY
SP IUPESM, Int Org Med Phys (IOMP)
DE Osteoblast; mesenchymal stem cell; bone regeneration; bone marrow
ID STEM-CELLS; PERICYTES
AB Background: Recently controversy has arisen regarding the role of mesenchymal stem cell (MSC) in orthopaedic surgery with their potential clinical application in cartilage and bone regeneration. Although autologous bone grafting is still the "gold standard" to heal critical size bony defects, it is associated with significant donor site morbidity. We present clinical and experimental data of autologous bone marrow aspiration concentrate (MAC) in patients with local bone defects. Materials and Methods: Clinical trial: 44 patients with pseudarthrosis or local bone defects (bone cysts, benign bone tumors, revision endoprosthetic surgery) underwent Jamshidi vacuum aspiration (posterior iliac crest) followed by bone marrow concentration via density gradient centrifugation (Smart prep2 (R), Harvest Technologies). BMAC was incubated with bovine hydroxyapatite (HA) carrier (Orthoss (R), Geistlich) or a collagen membrane (Gelaspon (R), Chauvin Ankerpharm). Bone defects were treated with cancellous bone grafting supplemented by BMAC/biomaterial-composit. Bone regeneration was determined by clinical and radiological examinations. Experimental data: Mononuclear cells were counted and colony forming units (CFU-F/-ALP) determined. In addition, cellular adherence and proliferation on scaffolds was analyzed and the osteogenic potential of BMAC evaluated. Results: All of the 44 patients showed new bone formation/healing during follow up. There was no servere perioperative complication. However, one patient showed persisting hematoma, and three other individuals had prolonged wound secretions (three required revision surgery). The average concentration factor for BMAC was 5.7 (SD: 1.01). In vitro CFU appeared earlier and were larger suggesting a higher regenerative potential in BMAC. It was shown that BMACells adhered on the scaffold, proliferated and displayed osteogenic differentiation with and without DAG supplementation. Conclusion: Our interim data showed that application of BMAC is easy to handle, a safe procedure and successful in treatment of local bone defects. However, additional supplements (growth factors e.g. BMPs) might be able to improve the clinical outcome of BMAC.
C1 [Jaeger, M.; Herten, M.; Jelinek, E. M.; Fochtmann, U.; Krauspe, R.] Univ Dusseldorf, Res Lab Regenerat Med & Biomat, Dept Orthopaed, Univ Hosp Dusseldorf, D-40225 Dusseldorf, Germany.
RP Jager, M (reprint author), Univ Dusseldorf, Res Lab Regenerat Med & Biomat, Dept Orthopaed, Univ Hosp Dusseldorf, Moorenstr 5, D-40225 Dusseldorf, Germany.
EM Jaeger@med.uni-duesseldorf.de
CR Bianco P, 2006, METHOD ENZYMOL, V419, P117, DOI 10.1016/S0076-6879(06)19006-0
   Doherty MJ, 1998, J BONE MINER RES, V13, P828, DOI 10.1359/jbmr.1998.13.5.828
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Farrington-Rock C, 2004, CIRCULATION, V110, P2226, DOI 10.1161/01.CIR.0000144457.55518.E5
   Hernigou P, 2005, J BONE JOINT SURG AM, V87A, P1430, DOI 10.2106/JBJS.D.02215
   Hernigou P, 2006, J BONE JOINT SURG AM, V88A, P2565, DOI 10.2106/JBJS.E.01455
   Jager M, 2009, CURR STEM CELL RES T, V4, P34, DOI 10.2174/157488809787169039
   Shi S, 2003, J BONE MINER RES, V18, P696, DOI 10.1359/jbmr.2003.18.4.696
   Szpalski Marek, 2005, Acta Orthop Belg, V71, P133
   Tokunaga A, 2008, J BONE MINER RES, V23, P1519, DOI 10.1359/JBMR.080409
NR 10
TC 0
Z9 0
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
SN 1680-0737
BN 978-3-642-03899-0
J9 IFMBE PROC
PY 2009
VL 25
IS 10
BP 116
EP 118
PG 3
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA BQW95
UT WOS:000282043000034
DA 2018-10-19
ER

PT S
AU Lotan, E
   Einav, S
AF Lotan, E.
   Einav, S.
BE Dossel, O
   Schlegel, WC
TI Seeding Human Mesenchymal Stem Cells into Fibrin-Based Scaffolds - A
   Potential for a Future Angiogenic Therapy?
SO WORLD CONGRESS ON MEDICAL PHYSICS AND BIOMEDICAL ENGINEERING, VOL 25, PT
   10: BIOMATERIALS, CELLULAR AND TISSUE ENGINEERING, ARTIFICIAL ORGANS
SE IFMBE Proceedings
LA English
DT Proceedings Paper
CT World Congress on Medical Physics and Biomedical Engineering
CY SEP 07-12, 2009
CL Munich, GERMANY
SP IUPESM, IOMP
DE Mesenchymal stem cells; bioreactor; Endothelial cell; Fibrin scaffold;
   Tissue Engineering
ID BONE-MARROW; ENDOTHELIAL-CELLS; ORIGIN
AB Experimental studies have demonstrated that mesenchymal stem cells (MSCs) can induce neovascularization and improve heart function in ischemic myocardium. There is evidence to suggest that these cells can promote angiogenesis, presumably on account of the "paracrine effect". A main obstacle to effective cell therapy is the lack of an optimal cell delivery technique. Furthermore, recipient ischemic tissue may be inadequate for retention of donor cells in sufficient quantity to allow for the desired effect. Cell-based angiogenesis may, therefore, benefit from tissue engineering strategies for the purpose of improving the administration of cells and optimizing their specific homing. In this study, we have generated and expanded human MSCs from bone marrow (BM), and controlled their differentiation under different conditions. Furthermore, a bioreactor system was designed and built to impart cyclic strains onto the cell-seeded fibrin-based scaffold in vitro, evaluating the possible effects on its incorporated cells. Our results showed that human MSCs can be induced to express, in vitro, markers of the endothelial lineage and function in a fibrin-based scaffold. We found that the cells, seeded in scaffolds in a bioreactor, obtained greater viability, and expressed the same level of endothelial markers compared to cells plated on conventional lab surfaces. It is therefore postulated that fibrin-based scaffold may have potential as a biomaterial scaffold and MSC-seeded fibrin scaffolds may be an alternative to cellular transplantation of BM stem cells (BMSc) as future angiogenic therapy.
C1 [Lotan, E.; Einav, S.] Tel Aviv Univ, Dept Biomed Engn, IL-69978 Tel Aviv, Israel.
RP Lotan, E (reprint author), Tel Aviv Univ, Dept Biomed Engn, 38 Beeri St, IL-69978 Tel Aviv, Israel.
EM elotan@post.tau.ac.il
CR Abdel-Latif A, 2007, ARCH INTERN MED, V167, P989, DOI 10.1001/archinte.167.10.989
   Anversa P, 2002, NATURE, V415, P240, DOI 10.1038/415240a
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Barron V, 2003, ANN BIOMED ENG, V31, P1017, DOI 10.1114/1.1603260
   Dow J, 2005, CARDIOVASC RES, V67, P301, DOI 10.1016/j.cardiores.2005.04.011
   HOFMANN, 1999, CIRCULATION, V100, P1163
   Huang CYC, 2004, STEM CELLS, V22, P313, DOI 10.1634/stemcells.22-3-313
   Markowicz M, 2005, EUR J PLAST SURG, V28, P284, DOI 10.1007/s00238-005-0768-5
   Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377
   Phinney DG, 2002, J CELL BIOCHEM, P7, DOI 10.1002/jcb.10084
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Reyes M, 2002, J CLIN INVEST, V109, P337, DOI 10.1172/JCI200214327
NR 12
TC 0
Z9 0
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
SN 1680-0737
BN 978-3-642-03899-0
J9 IFMBE PROC
PY 2009
VL 25
IS 10
BP 260
EP 263
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA BQW95
UT WOS:000282043000075
DA 2018-10-19
ER

PT J
AU Wang, PJ
   He, F
   Liao, DH
   Zhang, J
   Li, WC
   Zhang, YF
   Huang, TZ
   Li, XY
   Zeng, YJ
AF Wang, Pei-Jun
   He, Fan
   Liao, Dong-Hua
   Zhang, Jing
   Li, Wen-Chun
   Zhang, Yi-Fei
   Huang, Tie-Zhu
   Li, Xiao-Yang
   Zeng, Yan-Jun
TI The impact of age on incremental elastic modulus and incremental
   compliance of pig hepatic portal vein for liver xenotransplantation
SO XENOTRANSPLANTATION
LA English
DT Article
DE biomechanics; hepatic portal vein; incremental compliance; incremental
   modulus; pig; xenotransplantation
ID TRANSPLANTATION
AB Pigs are currently considered the most likely source of organs for human xenotransplantation because of anatomical and physiological similarities to humans, and the relative ease to be bred in large numbers. Along with the fast development of the genetic engineering and organ transplant immunity medical science, the research of liver xenotransplantation suffers the very big valuing in recent years. Whether the livers from different species after transplanting can perform the normal function, depends on the function regeneration and lucid rates of hepatic portal vein. The objective of this study was to investigate the age effect on biomechanical properties of pig hepatic portal vein to pave the way for seeking a reliable biomaterial for future pig-to-human liver xenotransplantation.
   The biomechanical remodelling of the hepatic portal vein of pigs for 1,2,3,4,5 and 6 months (n = 6 per month) were measured in this study. The blood vessel was given periodic permanent loading and unloading, and repeated force-deformation data were obtained. The incremental modulus (Einc), the longitudinal incremental modulus (Ep), the circumferential incremental modulus (Ev), incremental compliance (C) and wall thickness were calculated based on the recorded pressure-diameter curves from experimental data.
   The incremental modulus, pressure strain modulus and the volume modulus of the pig hepatic portal vein increases with the age increased (P < 0.01), while the compliance decreased with the increasing of the age (P < 0.01).
   Our present study suggests that the biomechanical properties of the pig hepatic portal vein are age dependent, the pig hepatic portal vein with biomechanical properties that match those of human hepatic portal vein should be chosen for liver xenotransplantation.
C1 [He, Fan; Zhang, Jing; Li, Xiao-Yang; Zeng, Yan-Jun] Beijing Univ Technol, Ctr Biomed Engn, Beijing 100022, Peoples R China.
   [Liao, Dong-Hua] Aalborg Hosp, Ctr Excellence Visceral Biomech & Pain, Aalborg, Denmark.
   [Wang, Pei-Jun; Li, Wen-Chun; Zhang, Yi-Fei; Huang, Tie-Zhu] Yunyang Med Coll, Lab Med Biomech, Shiyan, Peoples R China.
RP Zeng, YJ (reprint author), Beijing Univ Technol, Ctr Biomed Engn, Beijing 100022, Peoples R China.
EM yjzeng@bjut.edu.cn
CR Bravata DM, 1999, LIVER TRANSPLANT SUR, V5, P318, DOI 10.1002/lt.500050404
   CHRISTIANE JB, 1998, INT J ANGIOL, V7, P52
   Cox R. H., 1978, AM J PHYSIOL, V234, P533
   Crick SJ, 1999, J ANAT, V195, P341, DOI 10.1046/j.1469-7580.1999.19530341.x
   Fung J, 1997, WORLD J SURG, V21, P956, DOI 10.1007/s002689900333
   Groth C G, 2000, J Hepatobiliary Pancreat Surg, V7, P364, DOI 10.1007/s005340070030
   Haruguchi Hiroaki, 2003, J Artif Organs, V6, P227, DOI 10.1007/s10047-003-0232-x
   HASSON JE, 1984, ARCH SURG-CHICAGO, V119, P788
   Hayashi S, 1998, TRANSPLANT P, V30, P3225, DOI 10.1016/S0041-1345(98)01293-7
   Li WC, 2006, ANN VASC SURG, V20, P237, DOI 10.1007/s10016-006-9020-4
   Li WC, 2006, J BIOMED MATER RES B, V76B, P93, DOI 10.1002/jbm.b.30339
   MAKOWKA L, 1995, TRANSPLANTATION, V59, P1654, DOI 10.1097/00007890-199506270-00002
   Neuberger J, 1999, LANCET, V354, P1636, DOI 10.1016/S0140-6736(99)90002-8
   STARZL TE, 1968, ANN SURG, V168, P392, DOI 10.1097/00000658-196809000-00009
   SUN W, 2001, J MED BIOMECH, V16, P222
   Terajima H, 1997, TRANSPLANTATION, V63, P507, DOI 10.1097/00007890-199702270-00004
   *US FDA, 2007, ORG TRANSPL AN EX PO
   YU QL, 1993, AM J PHYSIOL, V265, pH52
NR 18
TC 7
Z9 7
U1 0
U2 9
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0908-665X
J9 XENOTRANSPLANTATION
JI Xenotransplantation
PD JAN-FEB
PY 2009
VL 16
IS 1
BP 5
EP 10
DI 10.1111/j.1399-3089.2008.00505.x
PG 6
WC Medicine, Research & Experimental; Transplantation
SC Research & Experimental Medicine; Transplantation
GA 408WZ
UT WOS:000263467600003
PM 19243555
DA 2018-10-19
ER

PT S
AU Ribeiro, MA
   Ramos, AS
   Manfredini, MI
   Alves, HA
   Honda, RY
   Kostov, KG
   Lucena, EF
   Ramos, ECT
   Mota, RP
   Algatti, MA
   Kayama, ME
AF Ribeiro, M. A.
   Ramos, A. S.
   Manfredini, M. I.
   Alves, H. A.
   Honda, R. Y.
   Kostov, K. G.
   Lucena, E. F.
   Ramos, E. C. T.
   Mota, R. P.
   Algatti, M. A.
   Kayama, M. E.
BE Serquis, A
   Balseiro, C
   Bolcatto, P
TI Polyurethane coating with thin polymer films produced by plasma
   polymerization of diglyme
SO XIX LATIN AMERICAN SYMPOSIUM ON SOLID STATE PHYSICS (SLAFES)
SE Journal of Physics Conference Series
LA English
DT Proceedings Paper
CT 19th Latin American Symposium on Solid State Physics (SLAFES)
CY OCT 05-10, 2008
CL Puerto Iguazu, ARGENTINA
SP Consejo Nacl Investigaciones Cientificas Tecnicas (CONICET), Agencia Nacl Promocion Cientifica Tecnologica (ANPCyT), Tecnologia Innovacion, Secretaria Estado Ciencia, Univ Nacl Litoral, Centro Latinoamericano Fisica, Inst Phys (IOP) Publishing, European Phys Journal (EPJ), EDP Sci, Soc Italiana Fisica, Springer
ID BIOMEDICAL APPLICATIONS; SURFACES; FUTURE
AB Aqueous-based polyurethane dispersions have been widely utilized as lubricants in textile, shoes, automotive, biomaterial and many other industries because they are less aggressive to surrounding environment. In this work thin films with different thickness were deposited on biocompatible polyurethane by plasma polymerization process using diethylene glycol dimethyl ether (Diglyme) as monomer. Molecular structure of the films was analyzed by Fourier Transform Infrared spectroscopy. The spectra exhibited absorption bands of O-H (3500-3200cm(-1)), C-H (3000-2900cm(-1)), C=O (1730-1650cm(-1)), C-O and C-O-C bonds at 1200-1600cm(-1). The samples wettability was evaluated by measurements of contact angle using different liquids such as water, glycerol, poly-ethane and CMC. The polyurethane surface showed hydrophilic behavior after diglyme plasma-deposition with contact angle dropping from 85(0) to 22(0). Scanning Electron Microscopy revealed that diglyme films covered uniformly the polyurethane surfaces ensuring to it a biocompatible characteristic.
C1 [Ribeiro, M. A.; Ramos, A. S.; Manfredini, M. I.; Alves, H. A.; Ramos, E. C. T.] UNIVAP, Sao Jose Dos Campos, SP, Brazil.
RP Mota, RP (reprint author), FEG DFQ UNESP, Av Ariberto Pereira Cunha 333, BR-12516410 Guaratingueta, SP, Brazil.
EM rmota@feg.unesp.br
RI Mota, Rogerio/C-6480-2012; Kostov, Konstantin/C-2666-2012; Algatti,
   Mauricio/C-2383-2012
OI Algatti, Mauricio/0000-0002-3225-5425; Kayama,
   Milton/0000-0003-3745-2425; Kostov, Konstantin/0000-0002-9821-8088
CR Alcantar NA, 2000, J BIOMED MATER RES, V51, P343, DOI 10.1002/1097-4636(20000905)51:3<343::AID-JBM7>3.0.CO;2-D
   Biederman H, 2000, SURF COAT TECH, V125, P371, DOI 10.1016/S0257-8972(99)00578-2
   Biederman H., 2004, PLASMA POLYM FILMS
   Bogaerts A, 2002, SPECTROCHIM ACTA B, V57, P609, DOI 10.1016/S0584-8547(01)00406-2
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Cicala G, 1999, APPL PHYS LETT, V75, P37, DOI 10.1063/1.124269
   d'Agostino R, 2005, PLASMA PROCESS POLYM, V2, P7, DOI 10.1002/ppap.200400074
   d'Agostino R., 2008, ADV PLASMA TECHNOLOG
   DAGOSTINO R, 1997, NATO ASI SERIES E, V346
   Favia P, 1998, SURF COAT TECH, V98, P1102, DOI 10.1016/S0257-8972(97)00285-5
   Hendricks SK, 2000, J BIOMED MATER RES, V50, P160, DOI 10.1002/(SICI)1097-4636(200005)50:2<160::AID-JBM10>3.0.CO;2-M
   Hippler R., 2008, LOW TEMPERATURE PLAS
   Oehr C, 1999, SURF COAT TECH, V116, P25, DOI 10.1016/S0257-8972(99)00201-7
   Ratner BD, 2004, BIOMATERIALS SCI INT
   Sardella E, 2004, PLASMA PROCESS POLYM, V1, P63, DOI 10.1002/ppap.200400013
   Sardella E, 2006, PLASMA PROCESS POLYM, V3, P456, DOI 10.1002/ppap.200600041
   Shul R. J., 2000, HDB ADV PLASMA PROCE
   Zdrahala RJ, 1999, J BIOMATER APPL, V14, P67, DOI 10.1177/088532829901400104
NR 18
TC 1
Z9 1
U1 0
U2 6
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 1742-6588
J9 J PHYS CONF SER
PY 2009
VL 167
AR 012056
DI 10.1088/1742-6596/167/1/012056
PG 5
WC Nanoscience & Nanotechnology; Physics, Condensed Matter
SC Science & Technology - Other Topics; Physics
GA BYH53
UT WOS:000298811200056
OA Bronze
DA 2018-10-19
ER

PT B
AU Kalnin, DJE
AF Kalnin, Daniel J. E.
BE Lomello, M
   Beauquis, S
   Durand, C
   Galez, PH
TI Characterization of Lipid Nanostructures using DSC coupled to SAXS and
   WAXS
SO XXXV JEEP - 35TH CONFERENCE ON PHASE EQUILIBRIA
LA English
DT Proceedings Paper
CT 35th JEEP Conference on Phase Equilibria
CY APR 01-03, 2009
CL Annecy, FRANCE
SP Univ Paul Verlaine, Ville Saint-Avold, Lorraine, NETZSCH, TA Instruments
DE Lipid structures; mesophases and biomaterial studies; polymorphism;
   small angle X-ray scattering; triacylglycerols; multiphase systems
ID X-RAY-DIFFRACTION; FAT CRYSTALLIZATION; MOLECULAR-STRUCTURE;
   POLYMORPHISM; CRYSTAL; FORMS; BEHAVIOR
AB Lipids are self-assembling molecules responsible for compartment formation in animal cells. Beside bilayer membranes, they also form all kind of aggregates and mesophases thank to their aptitude to modulate interface curvature. The characterization of the internal structure of such systems is complex and requires the use of combined techniques. Up to recently, droplet size, dilution and complexity prevented any direct identification of the crystalline varieties formed by triacylglycerols inside emulsion globules. Crystallization within this submicron droplets can now be conveniently monitored using Synchrotron X-ray diffraction coupled with DSC. Crystal forms and polymorphism can be influenced by different factors and here we focus on influence factors for crystallization kinetics of emulsified lipids.
C1 YKI Inst Surface Chem, SE-11486 Stockholm, Sweden.
RP Kalnin, DJE (reprint author), YKI Inst Surface Chem, Box 5607, SE-11486 Stockholm, Sweden.
EM Daniel.Kalnin@Yki.Se
CR Dohi K, 2002, J CRYST GROWTH, V237, P2227, DOI 10.1016/S0022-0248(01)02281-3
   GIBON V, 1984, B SOC CHIM BELG, V93, P27
   HEMQUIST L, 1982, FETT SEIFEN ANSTR, V84, P349
   HUANG TC, 1993, J APPL CRYSTALLOGR, V26, P180, DOI 10.1107/S0021889892009762
   Kalnin D, 2005, EUR J LIPID SCI TECH, V107, P594, DOI 10.1002/ejlt.200501010
   Kalnin D, 2004, CRYST GROWTH DES, V4, P1283, DOI 10.1021/cg030071k
   Kalnin D, 2002, FOOD RES INT, V35, P927, DOI 10.1016/S0963-9969(02)00155-2
   KALNIN D, 2009, FOOD BIOPHYS, V3, P163
   LARSSON K, 1972, FETTE SEIFEN ANSTR V, V74, P136, DOI 10.1002/lipi.19720740302
   LARSSON K, 1966, ACTA CHEM SCAND, V20, P2255, DOI 10.3891/acta.chem.scand.20-2255
   Larsson K., 1994, LIPIDS MOL ORG PHYS, V5
   LARSSON K, 1986, LIPID HDB, P321
   Lopez C, 2001, J COLLOID INTERF SCI, V240, P150, DOI 10.1006/jcis.2001.7664
   MADELMONT CG, 1983, J COLLOID INTERF SCI, V95, P471
   OHKURA K, 1972, B CHEM SOC JPN, V45, P2651, DOI 10.1246/bcsj.45.2651
   OLLIVON M, 1982, THERMOCHIM ACTA, V53, P183, DOI 10.1016/0040-6031(82)85007-7
   OLLIVON M, 1982, THESIS U PIERRE MARI
   OLLIVON M, 1996, OILS FATS MANUAL, V1
   SATO K, 1989, J AM OIL CHEM SOC, V66, P664, DOI 10.1007/BF02669949
   Sato K, 2001, CHEM ENG SCI, V56, P2255, DOI 10.1016/S0009-2509(00)00458-9
   Small D. M., 1986, HDB LIPID RES PHYS C
   Van Langevelde A, 2000, ACTA CRYSTALLOGR B, V56, P1103, DOI 10.1107/S0108768100009927
   1998, J Thermal Anal, V51, P783
NR 23
TC 1
Z9 1
U1 0
U2 7
PU E D P SCIENCES
PI CEDEX A
PA 17 AVE DU HOGGAR PARC D ACTIVITES COUTABOEUF BP 112, F-91944 CEDEX A,
   FRANCE
PY 2009
AR 00017
DI 10.1051/jeep/200900017
PG 5
WC Chemistry, Physical; Materials Science, Multidisciplinary; Metallurgy &
   Metallurgical Engineering
SC Chemistry; Materials Science; Metallurgy & Metallurgical Engineering
GA BUU71
UT WOS:000290391700016
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Mayer, I
   Gdalya, S
   Burghaus, O
   Reinen, D
AF Mayer, Isaac
   Gdalya, Sarit
   Burghaus, Olaf
   Reinen, Dirk
TI A Spectroscopic and Structural Study of M(3d)(2+)-Doped beta-Tricalcium
   Phosphate - the Binding Properties of Ni2+ and Cu2+ in the
   Pseudo-Octahedral Ca(5)O-6 Host-Sites
SO ZEITSCHRIFT FUR ANORGANISCHE UND ALLGEMEINE CHEMIE
LA English
DT Article
ID CRYSTAL-STRUCTURE; STABILIZING IMPURITY; EPR; BETA-CA3(PO4)2; SPECTRA;
   MG
AB The pseudo-octahedral Ca(5)(2+) position in beta-Ca-3(PO4)(2) is a highly interesting host site with unexpectedly short Ca-O bond lengths, which can be easily substituted by small 3d-cations, such as Ni2+. Also Cu2+ may fully replace Ca(5)(2+), leading to remarkably large energetic and steric distortion effects due to E-g circle times epsilon(g) Jahn-Teller coupling - with a ground-state splitting of about 1.25 cV. The Cu(Ni)-O bond is strongly ionic according to a 3d-mixing coefficient of the e(g)-electrons above 0.90, as revealed by EPR- and d-d spectroscopy. It is suggested that the flexibility of the Ca(5)O-6 host polyhedra, which lie isolated in the lattice, in respect to deformations and to substitutions by smaller cations is one reason that beta-TCP is a useful biomaterial.
C1 [Burghaus, Olaf; Reinen, Dirk] Univ Marburg, Fachbereich Chem, D-35032 Marburg, Germany.
   [Mayer, Isaac; Gdalya, Sarit] Hebrew Univ Jerusalem, Dept Inorgan & Analyt Chem, IL-91904 Jerusalem, Israel.
RP Reinen, D (reprint author), Univ Marburg, Fachbereich Chem, D-35032 Marburg, Germany.
EM reinen@chemie.uni-marburg.de
CR Abragam A., 1970, ELECT PARMAGNETIC RE
   AMMETER JH, 1969, THESIS ETH ZURICH
   COFFMAN RE, 1969, J CHEM PHYS, V48, P609
   DICKENS B, 1974, J SOLID STATE CHEM, V10, P232, DOI 10.1016/0022-4596(74)90030-9
   Figgis B. N., 2000, LIGAND FIELD THEORY
   FRIEBEL C, 1969, Z NATURFORSCH PT A, VA 24, P1518
   *INT CTR DIFFR DAT, 2005, 090169 INT CTR DIFFR
   *INT CTR DIFFR DAT, 2005, 09432 INT CTR DIFFR
   Mayer I, 2008, MATER RES BULL, V43, P447, DOI 10.1016/j.materresbull.2007.02.031
   MAYER I, ACTA CRYSTA IN PRESS
   McGarvey B.R., 1966, TRANSITION METAL CHE, V3, P90
   REINEN D, 1976, Z ANORG ALLG CHEM, V424, P31, DOI 10.1002/zaac.19764240107
   Reinen D, 1998, COORDIN CHEM REV, V175, P91, DOI 10.1016/S0010-8545(98)00181-7
   REINEN D, 1965, BERICH BUNSEN GESELL, V69, P82, DOI 10.1002/bbpc.19650690113
   Reinen D., 1979, STRUCT BOND, V37, P1
   RILEY M, COMMUNICATION
   Riley MJ, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3086038
   SAAVEDRA A, 1977, Z ANORG ALLG CHEM, V435, P91, DOI 10.1002/zaac.19774350112
   SCHMITZDUMONT O, 1968, MONATSH CHEM, V99, P1285, DOI 10.1007/BF00902672
   SCHROEDER LW, 1977, J SOLID STATE CHEM, V22, P253, DOI 10.1016/0022-4596(77)90002-0
   SHANNON RD, 1969, ACTA CRYSTALL B-STRU, VB 25, P925, DOI 10.1107/S0567740869003220
   STEFFEN G, 1990, INORG CHEM, V29, P2123, DOI 10.1021/ic00336a018
   Tregenna-Piggott PLW, 2003, ADV QUANTUM CHEM, V44, P461, DOI 10.1016/S0065-3276(03)44030-6
NR 23
TC 3
Z9 3
U1 0
U2 5
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0044-2313
J9 Z ANORG ALLG CHEM
JI Z. Anorg. Allg. Chem.
PY 2009
VL 635
IS 12
BP 2039
EP 2045
DI 10.1002/zaac.200900236
PG 7
WC Chemistry, Inorganic & Nuclear
SC Chemistry
GA 516XB
UT WOS:000271575500046
DA 2018-10-19
ER

PT J
AU Yuan, NY
   Tsai, RY
   Ho, MH
   Wang, DM
   Lai, JY
   Hsieh, HJ
AF Yuan, Nai-Yi
   Tsai, Ruei-Yi
   Ho, Ming-Hwa
   Wang, Da-Ming
   Lai, Juin-Yih
   Hsieh, Hsyue-Jen
TI Fabrication and characterization of chondroitin sulfate-modified
   chitosan membranes for biomedical applications
SO DESALINATION
LA English
DT Article; Proceedings Paper
CT 4th Conference of the Aseanian-Membrane-Society
CY AUG 16-18, 2007
CL Taipei, TAIWAN
SP Aseanian Membrane Soc
DE Biomaterial; Chitosan; Chondroitin sulfate; Freeze-gelation; Porous
   membrane
ID POROUS SCAFFOLDS; STATE CHARACTERIZATION; CROSS-LINKING; DESIGN
AB Chitosan (CH) is a biomaterial with antiseptic, bioactive, and biocompatible properties. To further enhance the performance of chitosan membranes, chondroitin Sulfate (CS) was utilized to modify the porous chitosan membranes fabricated by the freeze-gelation method. The cross-linking of CS to CH was mediated by ionic interaction and covalent cross-linking using EDC/NHS coupling reagents. The pore structures, mechanical properties, and surface hydrophilicity of the porous chondroitin sulfate-modified chitosan (CH/CS) membranes could be altered by varying the weight ratio of CS to CH. The membranes had interconnected stratiform pore structure with surface pore size ranging from 10 to 40 mu m. Among various CH/CS membranes the one with the weight ratio of 90/10 (CH to CS) possessed the highest mechanical strength (18.61 N/g), about 40% increase as compared with the unmodified CH membrane. The addition of CS improved the hydrophilicity of the membranes. Preliminary cell culture experiments revealed that the proliferation of the gingival fibroblasts on the CH/CS surface was slightly better than that on the CH surface. In summary, the CH/CS membranes (especially the 90/10 membrane), due to their higher mechanical strength, hydrophilicity, and better cell compatibility, are promising biomaterials for tissue engineering applications.
C1 [Yuan, Nai-Yi; Tsai, Ruei-Yi; Wang, Da-Ming; Hsieh, Hsyue-Jen] Natl Taiwan Univ, Dept Chem Engn, Taipei 106, Taiwan.
   [Ho, Ming-Hwa] Natl Taiwan Univ Sci & Technol, Dept Chem Engn, Taipei 106, Taiwan.
   [Lai, Juin-Yih] Chung Yuan Christian Univ, Res & Dev Ctr Membrane Technol, Chungli 320, Taiwan.
RP Hsieh, HJ (reprint author), Natl Taiwan Univ, Dept Chem Engn, Taipei 106, Taiwan.
EM hjhsieh@ntu.edu.tw
RI Lai, Juin-Yih/B-4461-2011
CR Chen YL, 2006, BIOMATERIALS, V27, P2222, DOI 10.1016/j.biomaterials.2005.10.029
   COHEN S, 1993, CLIN MATER, V13, P3, DOI 10.1016/0267-6605(93)90082-I
   Denuziere A, 1998, BIOMATERIALS, V19, P1275, DOI 10.1016/S0142-9612(98)00036-2
   FLETCHER M, 1982, APPL ENVIRON MICROB, V44, P184
   GOOZEN M, 1997, APPL CHITIN CHITOSAN
   Ho MH, 2004, BIOMATERIALS, V25, P129, DOI 10.1016/S0142-9612(03)00483-6
   Khalid MN, 2002, EUR J PHARM SCI, V15, P425, DOI 10.1016/S0928-0987(02)00029-5
   Ma L, 2004, BIOMATERIALS, V25, P2997, DOI 10.1016/j.biomaterials.2003.09.092
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   MUZZARELLI R, 1988, BIOMATERIALS, V9, P247, DOI 10.1016/0142-9612(88)90092-0
   Nam YS, 1999, J BIOMED MATER RES, V47, P8, DOI 10.1002/(SICI)1097-4636(199910)47:1<8::AID-JBM2>3.0.CO;2-L
   Pieper JS, 2000, BIOMATERIALS, V21, P581, DOI 10.1016/S0142-9612(99)00222-7
   Rhoades J, 2000, APPL ENVIRON MICROB, V66, P80, DOI 10.1128/AEM.66.1.80-86.2000
   SAMUELS RJ, 1981, J POLYM SCI POL PHYS, V19, P1081, DOI 10.1002/pol.1981.180190706
   Thomson RC, 1999, BIOMATERIALS, V20, P2007, DOI 10.1016/S0142-9612(99)00103-9
   Wang YC, 2003, BIOMACROMOLECULES, V4, P224, DOI 10.1021/bm0256294
   YUI T, 1994, MACROMOLECULES, V27, P7601, DOI 10.1021/ma00104a014
   Zaia J, 2001, ANAL CHEM, V73, P6030, DOI 10.1021/ac015577t
NR 18
TC 22
Z9 23
U1 1
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0011-9164
J9 DESALINATION
JI Desalination
PD DEC 31
PY 2008
VL 234
IS 1-3
BP 166
EP 174
DI 10.1016/j.desal.2007.09.083
PG 9
WC Engineering, Chemical; Water Resources
SC Engineering; Water Resources
GA 381WK
UT WOS:000261566400021
DA 2018-10-19
ER

PT J
AU Li, YC
   Cai, YR
   Kong, XD
   Yao, JM
AF Li, Yucheng
   Cai, Yurong
   Kong, Xiangdong
   Yao, Juming
TI Anisotropic growth of hydroxyapatite on the silk fibroin films
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Hydroxyapatite; Silk fibroin films; Biomineralization;
   Pre-calcification; Simulated body fluid (SBF)
ID MATRIX PROTEIN; NANOCRYSTALS; SCAFFOLDS; ORGANIZATION; BIOMATERIAL;
   COMPOSITES; CRYSTALS; SYSTEM; BONE
AB Bombyx mori silk fibroin is of practical interest for its excellent intrinsic properties utilizable in the biotechnological and biomedical fields. Here, the silk fibroin films were pretreated with different methods and then used as the template for the hydroxyapatite (HA) crystal growth. To study the effect of silk films' surface structure on the protein biomineralization, the films were immersed into 1.5 times simulated body fluid (1.5 x SBF) to induce the HA deposition at 37 degrees C. The results showed that an anisotropic growth of HA crystals was observed on the different films as judging from XRD, TEM and HRTEM data. This was thought that the positions and density of carboxyl groups, C = O and amino groups on the surface of SF films may be different, which play the key effect on HA crystal growth. (C) 2008 Elsevier B. V. All rights reserved.
C1 [Li, Yucheng; Cai, Yurong; Yao, Juming] Zhejiang Sci Tech Univ, Coll Mat & Text, Minist Educ, Key Lab Adv Text Mat & Mfg Technol, Hangzhou 310018, Peoples R China.
   [Kong, Xiangdong] Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou 310018, Peoples R China.
RP Yao, JM (reprint author), Zhejiang Sci Tech Univ, Coll Mat & Text, Minist Educ, Key Lab Adv Text Mat & Mfg Technol, Xiasha Higher Educ Pk, Hangzhou 310018, Peoples R China.
EM yaoj@zstu.edu.cn
RI Yao, Juming/N-7886-2014
FU Program for Changjiang Scholars and Innovative Research Team in
   University [IRT0654]; Program for New Century Excellent Talents in
   University [NCET070763]; National Natural Science Foundation of China
   [10672145]; Key Project of Chinese Ministry of Education [207042]
FX The work is financially supported by the Program for Changjiang Scholars
   and Innovative Research Team in University (IRT0654), Program for New
   Century Excellent Talents in University (NCET070763), National Natural
   Science Foundation of China (No. 10672145) and the Key Project of
   Chinese Ministry of Education (No. 207042).
CR Alivisatos AP, 2000, SCIENCE, V289, P736, DOI 10.1126/science.289.5480.736
   Bai LQ, 2008, APPL SURF SCI, V254, P2988, DOI 10.1016/j.apsusc.2007.10.049
   Cai YR, 2007, J MATER CHEM, V17, P3780, DOI 10.1039/b705129h
   Chen JD, 2007, BIOMATERIALS, V28, P2275, DOI 10.1016/j.biomaterials.2007.01.033
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   Ehrlich H, 2006, J MEMBRANE SCI, V273, P124, DOI 10.1016/j.memsci.2005.11.050
   He G, 2003, NAT MATER, V2, P552, DOI 10.1038/nmat945
   Kasuga T, 2001, BIOMATERIALS, V22, P19, DOI 10.1016/S0142-9612(00)00091-0
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kong XD, 2004, J CRYST GROWTH, V270, P197, DOI 10.1016/j.jcrysgro.2004.06.007
   Lee SM, 2003, ADV MATER, V15, P441, DOI 10.1002/adma.200390102
   LEGEROS RZ, 1994, HYDROXYAPATITE AND RELATED MATERIALS, P3
   Lin F, 2008, MATER CHEM PHYS, V111, P92, DOI 10.1016/j.matchemphys.2008.03.019
   Liu DM, 2002, BIOMATERIALS, V23, P1679, DOI 10.1016/S0142-9612(01)00295-2
   Liu L, 2008, J BIOMAT SCI-POLYM E, V19, P325, DOI 10.1163/156856208783721010
   Nemoto R, 2004, J AM CERAM SOC, V87, P1014, DOI 10.1111/j.1551-2916.2004.01014.x
   Riman RE, 2002, SOLID STATE IONICS, V151, P393, DOI 10.1016/S0167-2738(02)00545-3
   Tadic D, 2004, BIOMATERIALS, V25, P987, DOI 10.1016/S0142-9612(03)00621-5
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang L, 2004, J EUR CERAM SOC, V24, P2707, DOI 10.1016/j.jeurceramsoc.2003.09.006
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   WEINER S, 1986, FEBS LETT, V206, P262, DOI 10.1016/0014-5793(86)80993-0
   Yang M, 2008, BIOMACROMOLECULES, V9, P416, DOI 10.1021/bm700665m
   Yao J., 2004, ENCY BIOMATERIALS BI, P1363
   Zhai Y, 2006, J CRYST GROWTH, V291, P202, DOI 10.1016/j.jcrysgro.2006.03.006
   Zhang D, 2003, ORG LETT, V5, P3221, DOI 10.1021/o1035012e
   Zhou P, 2004, BIOCHEMISTRY-US, V43, P11302, DOI 10.1021/bi049344i
NR 27
TC 27
Z9 35
U1 0
U2 35
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD DEC 30
PY 2008
VL 255
IS 5
BP 1681
EP 1685
DI 10.1016/j.apsusc.2008.06.009
PN 1
PG 5
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 377TS
UT WOS:000261274100008
DA 2018-10-19
ER

PT J
AU Ao, YH
   Xu, JJ
   Shen, XW
   Fu, DG
   Yuan, CW
AF Ao, Yanhui
   Xu, Jingjing
   Shen, Xunwei
   Fu, Degang
   Yuan, Chunwei
TI Magnetically separable composite photocatalyst with enhanced
   photocatalytic activity
SO JOURNAL OF HAZARDOUS MATERIALS
LA English
DT Article
DE Magnetic activated carbon; Magnetically separable; Photocatalysis;
   Titania; Phenol
ID ACTIVATED CARBON; BIOMATERIAL SYSTEM; NANOPARTICLES; TITANIA; WATER;
   DEGRADATION; ANATASE; PHENOL; SHELL; CORE
AB A novel magnetically separable composite photocatalyst, anatase titania-coated magnetic activated carbon (TMAC), was prepared in this article. In the synthesis, magnetic activated carbon (MAC) was firstly obtained by adsorbing magnetic Fe(3)O(4) nanoparticles onto the activated carbon (AC),and then the obtained MAC was directly coated by anatase titania nanoparticles prepared at low temperature (i.e. 75 degrees C). The prepared samples were characterized by XRD, SEM and vibrating sample magnetometer (VSM). The composite photocatalyst can be easily separated from solution by a magnet, its photocatalytic activity in degradation of phenol in aqueous solution also has dramatic enhancement compared to that of the neat titania. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Ao, Yanhui; Xu, Jingjing; Fu, Degang] SE Univ, Sch Chem & Chem Engn, Nanjing 210096, Peoples R China.
   [Ao, Yanhui; Xu, Jingjing; Shen, Xunwei; Fu, Degang; Yuan, Chunwei] SE Univ, State Key Lab Bioelect, Nanjing 210096, Peoples R China.
   [Ao, Yanhui; Xu, Jingjing; Fu, Degang] SE Univ, Key Lab Environm & Biosafety Suzhou, Res Inst, Suzhou 215123, Peoples R China.
RP Fu, DG (reprint author), SE Univ, Sch Chem & Chem Engn, Nanjing 210096, Peoples R China.
EM andyao@seu.edu.cn; fudegang@seu.edu.cn
RI Fu, DG/G-4750-2012
OI Fu, DG/0000-0002-0113-5308
FU National Natural Science Foundation of China [60121101]; Hi-Tech
   Research and Development Program (863 Program) of China [2002AA302304]
FX This work was supported by the National Natural Science Foundation of
   China (No. 60121101) and Hi-Tech Research and Development Program (863
   Program) of China (No. 2002AA302304). We are also very grateful to Prof.
   Zhang Yu and Dr. Liu Ji-wei in Southeast University for their help in
   VSM experiments.
CR Beydoun D, 2000, J PHYS CHEM B, V104, P4387, DOI 10.1021/jp992088c
   Bickley RI, 1997, MATER CHEM PHYS, V51, P47, DOI 10.1016/S0254-0584(97)80265-9
   Carpio E, 2005, J MOL CATAL A-CHEM, V228, P293, DOI 10.1016/j.molcata.2004.09.066
   Chen F, 2001, CHEMOSPHERE, V44, P1159, DOI 10.1016/S0045-6535(00)00277-0
   Chung YS, 2004, MATER CHEM PHYS, V86, P375, DOI 10.1016/j.matchemphys.2004.03.027
   FOX MA, 1993, CHEM REV, V93, P341, DOI 10.1021/cr00017a016
   Fujishima A., 2000, J PHOTOCH PHOTOBIO C, V1, P1, DOI DOI 10.1016/S1389-5567(00)00002-2
   HOFFMANN MR, 1995, CHEM REV, V95, P96
   HOWE RF, 1987, J PHYS CHEM-US, V91, P3906, DOI 10.1021/j100298a035
   Huang J., 1997, ZAIRYO TO KANKYO, V469, P651
   LITTER MI, 1994, J PHOTOCH PHOTOBIO A, V84, P183, DOI 10.1016/1010-6030(94)03858-9
   MADHUSUDHAN RP, 1995, J MATER SCI, V30, P4980
   Matos J, 1998, APPL CATAL B-ENVIRON, V18, P281, DOI 10.1016/S0926-3373(98)00051-4
   MATTHEWS RW, 1990, WATER RES, V24, P653, DOI 10.1016/0043-1354(90)90199-G
   MILIS A, 1994, J MOL CATAL, V87, P67, DOI 10.1016/0304-5102(93)E0213-Z
   Mills A, 1997, J PHOTOCH PHOTOBIO A, V108, P1, DOI 10.1016/S1010-6030(97)00118-4
   NAVIO JA, 1992, J MATER SCI, V27, P3036, DOI 10.1007/BF01154116
   OLLIS DF, 1985, ENVIRON SCI TECHNOL, V19, P480, DOI 10.1021/es00136a002
   Pankhurst QA, 2003, J PHYS D APPL PHYS, V36, pR167, DOI 10.1088/0022-3727/36/13/201
   Pera-Titus M, 2004, APPL CATAL B-ENVIRON, V47, P219, DOI 10.1016/j.apcatb.2003.09.010
   Pozzo RL, 1997, CATAL TODAY, V39, P219, DOI 10.1016/S0920-5861(97)00103-X
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   Rana S, 2005, MAT SCI ENG B-SOLID, V119, P144, DOI 10.1016/j.mseb.2005.02.043
   Rawat J, 2007, MAT SCI ENG C-BIO S, V27, P540, DOI 10.1016/j.msec.2006.05.021
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   Toyoda M, 2003, DESALINATION, V159, P273, DOI 10.1016/S0011-9164(03)90079-8
   Tryba B, 2003, APPL CATAL B-ENVIRON, V41, P427, DOI 10.1016/S0926-3373(02)00173-X
   Xie YB, 2003, APPL CATAL B-ENVIRON, V46, P251, DOI 10.1016/S0926-3373(03)00211-X
   Yuan J.N., 1995, ZAIRYO TO KANKYO, V44, P534
NR 29
TC 32
Z9 36
U1 2
U2 28
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-3894
J9 J HAZARD MATER
JI J. Hazard. Mater.
PD DEC 30
PY 2008
VL 160
IS 2-3
BP 295
EP 300
DI 10.1016/j.jhazmat.2008.02.114
PG 6
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA 377ML
UT WOS:000261255200005
PM 18406055
DA 2018-10-19
ER

PT J
AU Park, D
   Ahn, CK
   Kim, YM
   Yun, YS
   Park, JM
AF Park, Donghee
   Ahn, Chi Kyu
   Kim, Young Mi
   Yun, Yeoung-Sang
   Park, Jong Moon
TI Enhanced abiotic reduction of Cr(VI) in a soil slurry system by natural
   biomaterial addition
SO JOURNAL OF HAZARDOUS MATERIALS
LA English
DT Article
DE Hexavalent chromium; Remediation; Reduction; Soil slurry system; Organic
   reductant; Pine bark
ID IN-SITU REMEDIATION; HEXAVALENT CHROMIUM; CONTAMINATED SOILS; ACTIVATED
   CARBONS; BIOMASS; KINETICS; REMOVAL
AB Among various plant-based natural biomaterials, pine bark was chosen as an efficient biomaterial capable of removing toxic Cr(VI) from aqueous solution. XPS spectra indicated that Cr(VI) was abiotically reduced to Cr(III) in both liquid and solid phases. The Cr(VI)-reducing capacity of pine bark was determined as 545 (+/- 1.3) mg-Cr(VI) g(-1) of it, which was 8.7 times higher than that of a common chemical Cr(VI)-reductant, FeSO(4)center dot 7H(2)O. Because pine bark could completely reduce toxic Cr(VI) to less toxic or nontoxic Cr(III) even at neutral pH, it was used as an organic reductant to remediate Cr(VI)-contaminated soil in this study. Soil slurry system using a bottle roller was applied to ex situ slurry-phase remediation experiments. In the soil slurry system, pine bark completely reduced Cr(VI) to Cr(III) and adsorbed the reduced-Cr(III) on its surface. Abiotic remediation rate of Cr(Vi)-contaminated soil increased with the increase of pine bark dosage and with the decreases of Cr(VI) and water contents. In conclusion, pine bark can be used to remediate Cr(VI)-contaminated soil efficiently and environmentally friendly. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Park, Donghee; Ahn, Chi Kyu; Kim, Young Mi; Park, Jong Moon] Pohang Univ Sci & Technol, Adv Environm Biotechnol Res Ctr, Dept Chem Engn, Sch Environm Sci & Engn, Pohang 790784, South Korea.
   [Yun, Yeoung-Sang] Chonbuk Natl Univ, Div Environm & Chem Engn, Ind Technol Res Inst, Jeonju 561756, South Korea.
RP Park, JM (reprint author), Pohang Univ Sci & Technol, Adv Environm Biotechnol Res Ctr, Dept Chem Engn, Sch Environm Sci & Engn, San 31, Pohang 790784, South Korea.
EM jmpark@postech.ac.kr
RI Yun, Yeoung-Sang/F-8340-2011
OI Yun, Yeoung-Sang/0000-0002-2583-8278
FU KOSEF through the AEBRC; Program for Advanced Education of Chemical
   Engineers at POSTECH; MCCIE; KOTEF through the Human Resource Training
   Project for Regional Innovation at Chonbuk National University
FX This work was financially supported by the KOSEF through the AEBRC and
   the Program for Advanced Education of Chemical Engineers at POSTECH.
   This work was also partially supported by the MCCIE and KOTEF through
   the Human Resource Training Project for Regional Innovation at Chonbuk
   National University.
CR Argun ME, 2005, ENVIRON TECHNOL, V26, P479, DOI 10.1080/09593332608618532
   Barnhart J, 1997, REGUL TOXICOL PHARM, V26, pS3, DOI 10.1006/rtph.1997.1132
   Blowes DW, 1997, ENVIRON SCI TECHNOL, V31, P3348, DOI 10.1021/es960844b
   Bras IP, 1999, ENVIRON SCI TECHNOL, V33, P631, DOI 10.1021/es980402v
   Clesceri L. S., 1998, STANDARD METHODS EXA, P366
   Costa M, 2006, CRIT REV TOXICOL, V36, P155, DOI 10.1080/10408440500534032
   Deng BL, 1996, ENVIRON SCI TECHNOL, V30, P2484, DOI 10.1021/es950780p
   Kamaludeen SPB, 2003, REV ENVIRON CONTAM T, V178, P93, DOI 10.1007/0-387-21728-2_4
   Kozuh N, 2000, ENVIRON SCI TECHNOL, V34, P112, DOI 10.1021/es981162m
   LOSI ME, 1994, ENVIRON TOXICOL CHEM, V13, P1727, DOI 10.1897/1552-8618(1994)13[1727:FACABR]2.0.CO;2
   Mohan D, 2006, J HAZARD MATER, V137, P762, DOI 10.1016/j.jhazmat.2006.06.060
   Park D, 2006, IND ENG CHEM RES, V45, P2405, DOI 10.1021/ie0509387
   Park D, 2005, CHEMOSPHERE, V60, P1356, DOI 10.1016/j.chemosphere.2005.02.020
   Park D, 2005, PROCESS BIOCHEM, V40, P2559, DOI 10.1016/j.procbio.2004.12.002
   Park D, 2004, ENVIRON SCI TECHNOL, V38, P4860, DOI 10.1021/es035329
   Park D, 2007, CHEMOSPHERE, V66, P939, DOI 10.1016/j.chemosphere.2006.05.068
   Proctor D. M., 1997, CHROMIUM SOIL PERSPE
   Seaman JC, 1999, ENVIRON SCI TECHNOL, V33, P938, DOI 10.1021/es980546+
   Szulczewski MD, 2001, ENVIRON SCI TECHNOL, V35, P1134, DOI 10.1021/es001301b
   Szulczewski MD, 1997, ENVIRON SCI TECHNOL, V31, P2954, DOI 10.1021/es9701772
   Thornton EC, 1999, ENVIRON SCI TECHNOL, V33, P4096, DOI 10.1021/es9812507
   Tokunaga TK, 2003, J ENVIRON QUAL, V32, P1641, DOI 10.2134/jeq2003.1641
NR 22
TC 22
Z9 23
U1 0
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-3894
J9 J HAZARD MATER
JI J. Hazard. Mater.
PD DEC 30
PY 2008
VL 160
IS 2-3
BP 422
EP 427
DI 10.1016/j.jhazmat.2008.03.044
PG 6
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA 377ML
UT WOS:000261255200024
PM 18434006
DA 2018-10-19
ER

PT J
AU O'Brien, CP
   Stuart, SJ
   Bruce, DA
   Latour, RA
AF O'Brien, C. P.
   Stuart, S. J.
   Bruce, D. A.
   Latour, R. A.
TI Modeling of Peptide Adsorption Interactions with a Poly(lactic acid)
   Surface
SO LANGMUIR
LA English
DT Article
ID MOLECULAR-DYNAMICS SIMULATIONS; PROTEIN ADSORPTION; FREE-ENERGY;
   CONFORMATIONAL-CHANGES; SOLID-SURFACES; DISTRIBUTIONS; POLY(L-LACTIDE);
   ENERGETICS; MECHANICS; POLYMERS
AB The biocompatibility of implanted materials and devices is governed by the conformation, orientation, and composition of the layer of proteins that adsorb to the surface of the material immediately upon implantation, so an understanding of this adsorbed protein layer is essential to the rigorous and methodical design of implant materials. In this study, novel molecular dynamics techniques were employed in order to determine the change in free energy for the adsorption of a solvated nine-residue peptide (GGGG-K-GGGG) to a crystalline polylactide surface in an effort to elucidate the fundamental mechanisms that govern protein adsorption. This system, like many others, involves two distinct types of sampling problems: a spatial sampling problem, which arises due to entropic effects creating barriers in the free energy profile, and a conformational sampling problem, which occurs due to barriers in the potential energy landscape. In a two-step process that addresses each sampling problem in turn, the technique of biased replica exchange molecular dynamics was refined and applied in order to overcome these sampling problems and, using the information available at the atomic level of detail afforded by molecular simulation, both quantify and characterize the interactions between the peptide and a relevant biomaterial surface. The results from these simulations predict a fairly strong adsorption response with an adsorption free energy of -2.5 +/- 0.6 kcal/mol (mean +/- 95% confidence interval), with adsorption primarily due to hydrophobic interactions between the nonpolar groups of the peptide and the PLA surface. As part of a larger and ongoing effort involving both simulation and experimental investigations, this work contributes to the goal of transforming the engineering of biomaterials from one dominated by trial-and-error to one which is guided by an atomic-level understanding of the interactions that occur at the tissue-biomaterial interface.
C1 [O'Brien, C. P.; Latour, R. A.] Clemson Univ, Dept Bioengn, Clemson, SC 29634 USA.
   [Stuart, S. J.] Clemson Univ, Dept Chem, Clemson, SC 29634 USA.
   [Bruce, D. A.] Clemson Univ, Dept Chem & Biomol Engn, Clemson, SC 29634 USA.
RP Latour, RA (reprint author), Clemson Univ, Dept Bioengn, Clemson, SC 29634 USA.
RI Stuart, Steven/H-1111-2012; Bruce, David/E-9572-2011
FU National Science Foundation [EEC-9731680]; Center for Advanced
   Engineering Fibers and Films (CAEFF); NIH [R01 EB006163, R01 GM074511];
   NJ Center for Biomaterials RESBIO [P41 EB001046]; Clemson University
FX This work was supported by the ERC pro,gram of the National Science
   Foundation under Award Number EEC-9731680 as part of the Center for
   Advanced Engineering Fibers and Films (CAEFF). Partial support was also
   provided by NIH R01 EB006163, R01 GM074511, and the NJ Center for
   Biomaterials RESBIO (NIH, P41 EB001046). We would like to thank the
   Department of Mathematical Sciences at Clemson University for the use of
   their computational cluster environment. The authors would also like to
   acknowledge the support of the staff from the Cyberinfrastructure
   Technology Integration group, and the use of the advanced computational
   resources deployed and maintained by Clemson Computing and Information
   Technology.
CR Agnihotri A, 2004, LANGMUIR, V20, P8846, DOI 10.1021/la049239
   ANDERSEN HC, 1983, J COMPUT PHYS, V52, P24, DOI 10.1016/0021-9991(83)90014-1
   ANDERSON JM, 1990, INT J ARTIF ORGANS, V13, P375
   [Anonymous], 2008, ENCY BIOMATERIALS BI, P270
   BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E
   Branden C.-I., 1998, INTRO PROTEIN STRUCT
   BRASH JL, 1995, PROTEINS INTERFACES, V2, P1
   BROOKS BR, 1983, J COMPUT CHEM, V4, P217
   CLAESSON PM, 1995, ADV COLLOID INTERFAC, V57, P161, DOI 10.1016/0001-8686(95)00241-H
   Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005
   GROSSFIELD A, 2006, IMPLEMENTATION WHAM
   GUNSTEREN WF, 1989, COMPUTER SIMULATION, V1
   Hlady V, 1996, CURR OPIN BIOTECH, V7, P72, DOI 10.1016/S0958-1669(96)80098-X
   HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Ishaug-Riley SL, 1999, BIOMATERIALS, V20, P2245, DOI 10.1016/S0142-9612(99)00155-6
   ISRAELACHVILI JN, 1992, INTERMOLECULAR SURFA, P246
   Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   Kasemo B, 1999, Adv Dent Res, V13, P8
   Kirkwood JG, 1935, J CHEM PHYS, V3, P300, DOI 10.1063/1.1749657
   KUMAR S, 1995, J COMPUT CHEM, V16, P1339, DOI 10.1002/jcc.540161104
   Lamoureux G, 2003, J CHEM PHYS, V119, P5185, DOI 10.1063/1.1598191
   LEACH AR, 2001, MOL MODELLING PRINCI, P179
   Lennard-Jones JE, 1931, P PHYS SOC, V43, P461, DOI 10.1088/0959-5309/43/5/301
   Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045
   Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286
   Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065
   MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f
   Martyna GJ, 1996, MOL PHYS, V87, P1117, DOI 10.1080/00268979600100761
   McAliley JH, 2008, J PHYS CHEM A, V112, P7244, DOI 10.1021/jp712114q
   Mezei M, 1989, MOL SIMULAT, V3, P301, DOI 10.1080/08927028908031382
   NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201
   OBRIEN CP, 2005, THESIS CLEMSON U
   OVERBEEK JTG, 1977, J COLLOID INTERF SCI, V58, P408, DOI 10.1016/0021-9797(77)90151-5
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6
   Rathore N, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1831273
   Ratner B. D., 1996, BIOMATERIALS SCI INT
   Raut VP, 2005, LANGMUIR, V21, P1629, DOI 10.1021/la047807f
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   ROUX B, 1995, COMPUT PHYS COMMUN, V91, P275, DOI 10.1016/0010-4655(95)00053-I
   RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5
   SADANA A, 1992, CHEM REV, V92, P1799, DOI 10.1021/cr00016a006
   Sasaki S, 2003, MACROMOLECULES, V36, P8385, DOI 10.1021/ma0348674
   Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9
   Thanki PN, 2006, APPL SURF SCI, V253, P2758, DOI DOI 10.1016/J.APSUSC.2006.05.047
   TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8
   Vernekar V. N., 2005, MATER RES INNOV, V9, P337
   Wang F, 2008, BIOINTERPHASES, V3, P9, DOI 10.1116/1.2840054
   Wei Y, 2008, LANGMUIR, V24, P6721, DOI 10.1021/la8005772
   Zhang J, 2007, POLYMER, V48, P4900, DOI 10.1016/j.polymer.2007.06.030
NR 52
TC 35
Z9 36
U1 0
U2 33
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD DEC 16
PY 2008
VL 24
IS 24
BP 14115
EP 14124
DI 10.1021/la802588n
PG 10
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 382UU
UT WOS:000261631700043
PM 19360943
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Mise, T
   Ishikawa, M
   Nishimoto, K
   Meguro, T
AF Mise, Takaya
   Ishikawa, Makishi
   Nishimoto, Kensaku
   Meguro, Takashi
TI A new approach for preventing charging up of soft material samples by
   coating with conducting polymers in SIMS analysis
SO APPLIED SURFACE SCIENCE
LA English
DT Article; Proceedings Paper
CT 16th International Conference on Secondary Ion Mass Spectrometry (SIMS )
CY OCT 29-NOV 02, 2007
CL Kanazawa, JAPAN
DE Secondary ion mass spectroscopy; Soft material; Sensitivity; Ion beam
AB Dynamic secondary ion mass spectroscopy (SIMS) analysis of soft materials such as polymer or biomaterial is one of challenging subjects due to the charge up effect brought from the irradiation of a primary ion beam, hampering the collection of secondary ions. Conventional methods against the charging up are the electron beam irradiation for charge compensation and surface coating with metal, normally gold. Those methods require a compromise analytical condition, reducing the primary ion beam current to suppress the range of the charging, which degrading the performances of the SIMS analyses. We have proposed that a thicker conductive layer, capable of delocalizing the charge onto the surface, should be put on a soft insulator sample to avoid charging up. The depth pro. le of the hair sample coated wholly with a polythiophen-based conducting polymer was successfully measured in longer time without any charging up even in the maximum current of the oxygen primary ion beam (O(2)(+): 7.5 keV, 400 nA) or using an electron beam compensation system. Thus, the proposed method coating with a conductive organic polymer against the charging issue would be expected as a breakthrough on SIMS analysis. (c) 2008 Elsevier B.V. All rights reserved.
C1 [Mise, Takaya; Meguro, Takashi] RIKEN, Wako, Saitama 3510198, Japan.
   [Ishikawa, Makishi; Nishimoto, Kensaku] CAMECA Instruments Japan, Chiyoda Ku, Tokyo 1010021, Japan.
RP Mise, T (reprint author), RIKEN, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.
EM tmise@riken.jp
CR Shibahara K, 2003, APPL SURF SCI, V203, P387, DOI 10.1016/S0169-4332(02)00682-7
NR 1
TC 0
Z9 0
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD DEC 15
PY 2008
VL 255
IS 4
BP 1113
EP 1115
DI 10.1016/j.apsusc.2008.05.040
PG 3
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 377OB
UT WOS:000261259400083
DA 2018-10-19
ER

PT J
AU Al-Ahmad, A
   Wiedmann-Al-Ahmad, M
   Carvalho, C
   Lang, M
   Follo, M
   Braun, G
   Wittmer, A
   Mulhaupt, R
   Hellwig, E
AF Al-Ahmad, A.
   Wiedmann-Al-Ahmad, M.
   Carvalho, C.
   Lang, M.
   Follo, M.
   Braun, G.
   Wittmer, A.
   Muelhaupt, R.
   Hellwig, E.
TI Bacterial and Candida albicans adhesion on rapid prototyping-produced
   3D-scaffolds manufactured as bone replacement materials
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE rapid prototyping; tissue engineering; bacterial colonization; dental
   pathogens; saliva
ID TISSUE REGENERATION MEMBRANES; IN-VIVO; STAPHYLOCOCCUS-EPIDERMIDIS;
   PSEUDOMONAS-AERUGINOSA; STREPTOCOCCUS-MUTANS; POLYMER SURFACES;
   SCAFFOLDS; CELLS; VITRO; HYDROXYAPATITE
AB Rapid prototyping (RP)-produced scaffolds are gaining increasing importance in scaffold-guided tissue engineering. Microbial adhesion on the surface of replacement materials has a strong influence on healing and long-term Outcome. Consequently, it is important to examine the adherence of microorganisms on RP-produced scaffolds. This research focussed on manufacturing of scaffolds by 3D-bioplotting and examination of their microbial adhesion characteristics. Tricalciumphosphate (TCP), calcium/sodium alginate, and poly(lactide-co-glycolic acid) (PLGA) constructs were produced and used to study the adhesion of dental pathogens. Six oral bacterial strains, one Candida strain and human saliva were used for the adhesion studies. The number of colony forming units (CFU) were determined and scanning electron microscopy (SEM) and confocal laser scanning microscopy (CLSM) were performed. Microorganisms adhered to all scaffolds. All strains, except for Streptococcus oralis, adhered best to PLGA scaffolds. Streptococcus oralis adhered to each of the biomaterials equally. Streptococcus mutans and Enterococcus faecalis adhered best to PLGA scaffolds, followed by alginate and TCP. Prevotella nigrescens, Porphyromonas gingivalis, Streptococcus sanguis, and Candida albicans showed the highest adherence to PLGA, followed by TCP and alginate. In contrast, the microorganisms of saliva adhered significantly better to TCP, followed by PLGA and alginate. SEM observations correlated with the results of the CFU determinations. CLSM detected bacteria within deeper sheets of alginate. In Conclusion, because of the high adherence rate of oral pathogens to the scaffolds, the application of these biomaterials for bone replacement in oral surgery Could result in biomaterial-related infections. Strategies to decrease microbial adherence and to prevent infections due to oral pathogens are discussed. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 87A: 933-943, 2008
C1 [Al-Ahmad, A.; Lang, M.; Braun, G.; Hellwig, E.] Univ Freiburg, Dept Operat Dent & Periodontol, Freiburg, Germany.
   [Wiedmann-Al-Ahmad, M.] Univ Freiburg, Dept Oral & Maxillofacial Surg, Freiburg, Germany.
   [Carvalho, C.; Muelhaupt, R.] Univ Freiburg, Freiburg Mat Res Ctr, Freiburg, Germany.
   [Carvalho, C.; Muelhaupt, R.] Univ Freiburg, Inst Macromol Chem, D-7800 Freiburg, Germany.
   [Follo, M.] Univ Freiburg, Dept Hematol & Oncol, Freiburg, Germany.
   [Wittmer, A.] Univ Freiburg, Inst Med Microbiol & Hyg, Freiburg, Germany.
RP Al-Ahmad, A (reprint author), Univ Freiburg, Dept Operat Dent & Periodontol, Freiburg, Germany.
EM ali.al-ahmad@uniklinik-freiburg.de
OI Follo, Marie/0000-0002-3090-7442
CR Al-Ahmad A, 2007, J MED MICROBIOL, V56, P681, DOI 10.1099/jmm.0.47094-0
   Alsberg E, 2003, J DENT RES, V82, P903, DOI 10.1177/154405910308201111
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   de Resende MA, 2006, MYCOPATHOLOGIA, V162, P39, DOI 10.1007/s11046-006-0029-6
   Balazs DJ, 2004, BIOMATERIALS, V25, P2139, DOI 10.1016/j.biomaterials.2003.08.053
   BAUMGARTNER JN, 1996, ASAIO J, V42, P476
   Beikler T, 2006, J PERIODONTOL, V77, P1323, DOI 10.1902/jop.2006.050204
   Carlen A, 2003, ORAL MICROBIOL IMMUN, V18, P203, DOI 10.1034/j.1399-302X.2003.00043.x
   Carlen A, 1998, CARIES RES, V32, P447, DOI 10.1159/000016486
   Chua CK, 2004, J MATER SCI-MATER M, V15, P1113, DOI 10.1023/B:JMSM.0000046393.81449.a5
   Ciardelli G, 2004, J MATER SCI-MATER M, V15, P305, DOI 10.1023/B:JMSM.0000021092.03087.d4
   Cohen SR, 2006, J CRANIOFAC SURG, V17, P40, DOI 10.1097/01.scs.0000200411.22583.4e
   Dexter SJ, 2001, J BIOMED MATER RES, V56, P222, DOI 10.1002/1097-4636(200108)56:2<222::AID-JBM1087>3.0.CO;2-L
   Foster JS, 2004, APPL ENVIRON MICROB, V70, P4340, DOI 10.1128/AEM.70.7.4340-4348.2004
   Garvin K, 2005, CLIN ORTHOP RELAT R, P105, DOI 10.1097/01.blo.0000175720.99118.fe
   GIBBONS RJ, 1989, J DENT RES, V68, P750, DOI 10.1177/00220345890680050101
   GIBBONS RJ, 1989, J DENT RES, V68, P1303, DOI 10.1177/00220345890680090201
   Golecka M, 2006, TRANSPLANT P, V38, P155, DOI 10.1016/j.transproceed.2005.12.078
   Gottenbos B, 2000, J BIOMED MATER RES, V50, P208, DOI 10.1002/(SICI)1097-4636(200005)50:2<208::AID-JBM16>3.0.CO;2-D
   Hung SL, 2002, J PERIODONTOL, V73, P843, DOI 10.1902/jop.2002.73.8.843
   Landers R, 2002, BIOMATERIALS, V23, P4437, DOI 10.1016/S0142-9612(02)00139-4
   Landes CA, 2006, PLAST RECONSTR SURG, V117, P2347, DOI 10.1097/01.prs.0000218787.49887.73
   Ma PX, 2001, TISSUE ENG, V7, P23, DOI 10.1089/107632701300003269
   MAEKAWA S, 1992, MICROBIOL IMMUNOL, V36, P671, DOI 10.1111/j.1348-0421.1992.tb02070.x
   Makinen TJ, 2005, BONE, V36, P292, DOI 10.1016/j.bone.2004.11.009
   Malaisrie SC, 1998, LARYNGOSCOPE, V108, P1733, DOI 10.1097/00005537-199811000-00026
   MARSH P, 1999, ORALE MIKROBIOLOGIE, P15
   Matsuno T, 2006, DENT MATER J, V25, P138, DOI 10.4012/dmj.25.138
   NYVAD B, 1990, CARIES RES, V24, P267, DOI 10.1159/000261281
   Otten JE, 2005, J BIOMED MATER RES B, V74B, P627, DOI 10.1002/jbm.b.30250
   Park KD, 1998, BIOMATERIALS, V19, P851, DOI 10.1016/S0142-9612(97)00245-7
   Rucker M, 2006, BIOMATERIALS, V27, P5027, DOI 10.1016/j.biomaterials.2006.05.033
   Sanchez-Salcedo S, 2006, TISSUE ENG, V12, P279, DOI 10.1089/ten.2006.12.279
   Schirrmeister JF, 2007, J ENDODONT, V33, P536, DOI 10.1016/j.joen.2007.01.012
   Sela MN, 2003, CLIN ORAL IMPLAN RES, V14, P263, DOI 10.1034/j.1600-0501.2003.140302.x
   Speranza G, 2004, BIOMATERIALS, V25, P2029, DOI 10.1016/j.biomaterials.2003.08.061
   STEMBERGER A, 1997, NEW ANTICOAGULANTS C, P377
   Tan KH, 2005, P I MECH ENG H, V219, P183, DOI 10.1243/095441105X9345
   Tan KH, 2003, BIOMATERIALS, V24, P3115, DOI 10.1016/S0142-9612(03)00131-5
   Teng LJ, 2002, J CLIN MICROBIOL, V40, P3172, DOI 10.1128/JCM.40.9.3172-3178.2002
   THOMSON RC, 2000, PRINCIPLES TISSUE EN, P251
   Triandafillu K, 2003, BIOMATERIALS, V24, P1507, DOI 10.1016/S0142-9612(02)00515-X
   Wagner M, 2007, J BIOMED MATER RES A, V83A, P1154, DOI 10.1002/jbm.a.31416
   Weng YL, 2006, TISSUE ENG, V12, P1503, DOI 10.1089/ten.2006.12.1503
   WILSON M, 1989, J DENT, V17, P166, DOI 10.1016/0300-5712(89)90069-9
   Wu-Yuan C D, 1995, J Oral Implantol, V21, P207
   Yenice I, 2002, INT J PHARM, V242, P271, DOI 10.1016/S0378-5173(02)00186-2
   Yuan J, 2007, BIOMATERIALS, V28, P1005, DOI 10.1016/j.biomaterials.2006.10.015
NR 48
TC 12
Z9 12
U1 0
U2 26
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 15
PY 2008
VL 87A
IS 4
BP 933
EP 943
DI 10.1002/jbm.a.31832
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 374WY
UT WOS:000261075600010
PM 18228269
DA 2018-10-19
ER

PT J
AU Serrano, MC
   Pagani, R
   Ameer, GA
   Vallet-Regi, M
   Portoles, MT
AF Serrano, M. Concepcion
   Pagani, Raffaella
   Ameer, Guillermo A.
   Vallet-Regi, Maria
   Portoles, M. Teresa
TI Endothelial cells derived from circulating progenitors as an effective
   source to functional endothelialization of NaOH-treated
   poly(epsilon-caprolactone) films
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE endothelial progenitor cell; poly(epsilon-caprolactone); nitric oxide;
   endothelial cell markers; tissue engineering
ID TISSUE PLASMINOGEN-ACTIVATOR; HUMAN UMBILICAL VEIN; NITRIC-OXIDE;
   IN-VITRO; CULTURED HUMAN; EPSILON-CAPROLACTONE; VASCULAR GRAFTS;
   RELAXING FACTOR; PROLIFERATION; ANGIOGENESIS
AB Biomaterials have been widely used to prepare synthetic vascular grafts over the past thirty years, but the inherent thrombogenicity of their Surface can lead to graft failure. Endothelial progenitor cells (EPC) are circulating premature cells able to differentiate in either myocardial or endothelial cells (EC). The therapeutic potential of these cells and its easy obtaining technique are important reasons why these cells Could be used to improve the performance of vascular grafts. In this study, two different stages of differentiation of EC derived from EPC (EC1 and EC2) were characterized and Cultured on poly(E-caprolactone) (PCL) films treated with NaOH (PCL-NaOH). We investigated by immunolabeling the expression of CD31, von Willebrand factor (vWF), and endothelial nitric oxide synthase (eNOS) in these cells during the differentiation process. The proliferation, cell cycle, and mitochondrial function of EC2 cultured on PCL-NaOH were evaluated at different times. The effect of this biomaterial on the nitric oxide (NO) content was also measured. The mature EC obtained from circulating progenitor cells (EC,) showed an appropriate growth and functionality on NaOH-treated films. They conserved their capacity to define vessel-like structures in culture and increased their basal NO production. These results underline the potential usefulness of these EC, to,et a functional endothelialization of polymers with applications in vascular tissue engineering. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 87A: 964-971,2008
C1 [Serrano, M. Concepcion; Pagani, Raffaella; Portoles, M. Teresa] Univ Complutense, Fac Chem, Dept Biochem & Mol Biol 1, E-28040 Madrid, Spain.
   [Ameer, Guillermo A.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.
   [Vallet-Regi, Maria] Univ Complutense, Fac Pharm, Dept Inorgan & Bioinorg Chem, E-28040 Madrid, Spain.
RP Portoles, MT (reprint author), Univ Complutense, Fac Chem, Dept Biochem & Mol Biol 1, E-28040 Madrid, Spain.
EM portoles@quim.ucm.es
RI Ameer, Guillermo/B-6765-2009; Portoles, Maria Teresa/U-1678-2017;
   Serrano, Maria Concepcion/D-7442-2014; Vallet-Regi, Maria/M-3378-2014
OI Portoles, Maria Teresa/0000-0002-9681-0184; Serrano, Maria
   Concepcion/0000-0002-5010-644X; Vallet-Regi, Maria/0000-0002-6104-4889
FU Fundacion MMA; Comuniclad de Madrid [0505/MAT/0324]
FX Contract grant sponsor: Fundacion MMA [(2004-033), coordinated by Dr. J.
   V. Comas (Pediatric Heart Institute, Hospital Universitario "12 de
   Octubre", Madrid, Spain)]; Contract grant sponsor: Comuniclad de Madrid;
   contract grant number: S-0505/MAT/0324
CR ALLEN J, TISSUE ENG IN PRESS, DOI DOI 10.1089/TEN.2007.0265
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221
   Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD
   Badorff C, 2003, CIRCULATION, V107, P1024, DOI 10.1161/01.CIR.0000051460.85800.BB
   CALLOW AD, 1982, SURG CLIN N AM, V62, P501
   DAVIE EW, 1995, THROMB HAEMOSTASIS, V74, P1
   DEGRAAF JC, 1992, CIRCULATION, V85, P2284, DOI 10.1161/01.CIR.85.6.2284
   DELISSER HM, 1994, IMMUNOL TODAY, V15, P490, DOI 10.1016/0167-5699(94)90195-3
   Deutsch M, 1997, J VASC SURG, V25, P757, DOI 10.1016/S0741-5214(97)70307-0
   DICHEK D, 1989, BLOOD, V74, P222
   Donnelly R, 2002, LANCET, V359, P2048, DOI 10.1016/S0140-6736(02)08946-8
   EICKHOFF JH, 1987, J VASC SURG, V6, P506, DOI 10.1067/mva.1987.avs0060506
   ESMON CT, 1987, SCIENCE, V235, P1348, DOI 10.1126/science.3029867
   Genove E, 2005, BIOMATERIALS, V26, P3341, DOI 10.1016/j.biomaterials.2004.08.012
   GIMBRONE MA, 1990, ANN NY ACAD SCI, V598, P77, DOI 10.1111/j.1749-6632.1990.tb42279.x
   HANSON SR, 1993, J CLIN INVEST, V92, P2003, DOI 10.1172/JCI116795
   HARKER LA, 1992, THROMBOSIS CARDIOVAS, P1
   HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.biochem.54.1.1015
   HERRING M, 1978, SURGERY, V84, P498
   Heyligers JMM, 2005, ANN VASC SURG, V19, P448, DOI 10.1007/s10016-005-0026-0
   Hristov M, 2003, TRENDS CARDIOVAS MED, V13, P201, DOI 10.1016/S1050-1738(03)00077-X
   IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265
   Khang G, 2002, J APPL POLYM SCI, V85, P1253, DOI 10.1002/app.10680
   Khor HL, 2002, MAT SCI ENG C-BIO S, V20, P71, DOI 10.1016/S0928-4931(02)00015-2
   LEVIN EG, 1983, P NATL ACAD SCI-BIOL, V80, P6804, DOI 10.1073/pnas.80.22.6804
   Michiels C, 2003, J CELL PHYSIOL, V196, P430, DOI 10.1002/jcp.10333
   MONCADA S, 1982, ARTERIOSCLEROSIS, V2, P193, DOI 10.1161/01.ATV.2.3.193
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Murohara T, 2000, J CLIN INVEST, V105, P1527, DOI 10.1172/JCI8296
   Nakatsubo N, 1998, FEBS LETT, V427, P263, DOI 10.1016/S0014-5793(98)00440-2
   PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0
   PENNICA D, 1983, NATURE, V301, P214, DOI 10.1038/301214a0
   Perego G, 2003, J BIOMAT SCI-POLYM E, V14, P1057, DOI 10.1163/156856203769231565
   Pusztaszeri MP, 2006, J HISTOCHEM CYTOCHEM, V54, P385, DOI 10.1369/jhc.4A6514.2005
   Riha GM, 2005, TISSUE ENG, V11, P1535, DOI 10.1089/ten.2005.11.1535
   Serrano MC, 2006, BIOMATERIALS, V27, P4706, DOI 10.1016/j.biomaterials.2006.05.007
   Serrano MC, 2005, BIOMATERIALS, V26, P5827, DOI 10.1016/j.biomaterials.2005.02.039
   Serrano MC, 2005, MACROMOL BIOSCI, V5, P415, DOI 10.1002/mabi.200400214
   Serrano MC, 2004, BIOMATERIALS, V25, P5603, DOI 10.1016/j.biomaterials.2004.01.037
   Shibuya M, 2001, CELL STRUCT FUNCT, V26, P25, DOI 10.1247/csf.26.25
   Shirota T, 2003, TISSUE ENG, V9, P127, DOI 10.1089/107632703762687609
   Solomonson LP, 2003, J EXP BIOL, V206, P2083, DOI 10.1242/jeb.00361
   STANHOPE SJ, 1994, GAIT POSTURE, V2, P54
   Walenta K, 2005, BIOCHEM BIOPH RES CO, V333, P476, DOI 10.1016/j.bbrc.2005.05.153
   WEKSLER BB, 1977, P NATL ACAD SCI USA, V74, P3922, DOI 10.1073/pnas.74.9.3922
   Wu X, 2004, AM J PHYSIOL-HEART C, V287, pH480, DOI 10.1152/ajpheart.01232.2003
   Yamamoto K, 2003, J APPL PHYSIOL, V95, P2081, DOI 10.1152/japplphysiol.00232.2003
   Zhang HP, 2002, BIOMATERIALS, V23, P1485, DOI 10.1016/S0142-9612(01)00274-5
NR 49
TC 24
Z9 24
U1 0
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 15
PY 2008
VL 87A
IS 4
BP 964
EP 971
DI 10.1002/jbm.a.31728
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 374WY
UT WOS:000261075600013
PM 18257077
DA 2018-10-19
ER

PT J
AU Jarmar, T
   Palmquist, A
   Brnemark, R
   Hermansson, L
   Engqvist, H
   Thomsen, P
AF Jarmar, Tobias
   Palmquist, Anders
   Brnemark, Rickard
   Hermansson, Leif
   Engqvist, Hakan
   Thomsen, Peter
TI Technique for preparation and characterization in cross-section of oral
   titanium implant surfaces using focused ion beam and transmission
   electron microscopy
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE SEM; FIB and TEM analysis; dental implant; titanium oxide; surface
   analysis; interface
ID SPECTROSCOPIC CHARACTERIZATION; TEETH
AB The surface properties of materials are believed to control most of the biological reactions toward implanted materials. To study the surface structure, elemental distribution, and morphology, using transmission electron microscopy (TEM) techniques, thin foils of the surface (in cross-section) are needed. These have been cumbersome to produce, in particular, from the normally irregular screw-shaped metal implants. Focused ion beam (FIB) microscopy has been developed partly for TEM sample preparation, mainly within the microelectronics industry. Our study describes a method based on FIB for producing electron transparent foils/sections from a metal implant for TEM analysis. Using a screw-shaped titanium dental implant, it wash demonstrated that thin foils can be prepared With submicron specificity and from almost any surface geometry. A comparison of different lift-out techniques showed that the in situ lift-out preparation technique allowed plasma cleaning and produced particularly good samples with excellent yield. The titanium oxide on the implant Surface was analyzed using energy-filtered TEM (EFTEM) and high-resolution TEM (HRTEM) and the TiO(2) rutile phase being determined via the lattice parameters. This study provides the first set of data for the optimization of a new route for preparation and analysis of biomaterial surfaces and interfaces. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 87A: 1003-1009, 2008
C1 [Jarmar, Tobias; Palmquist, Anders; Thomsen, Peter] Inst Biomat & Cell Therapy, Gothenburg, Sweden.
   [Jarmar, Tobias; Hermansson, Leif; Engqvist, Hakan] Doxa AB, SE-75421 Uppsala, Sweden.
   [Jarmar, Tobias; Hermansson, Leif; Engqvist, Hakan] Uppsala Univ, Dept Engn Sci, SE-75121 Uppsala, Sweden.
   [Palmquist, Anders; Brnemark, Rickard] Integrum AB, SE-41104 Gothenburg, Sweden.
   [Palmquist, Anders; Thomsen, Peter] Univ Gothenburg, Sahlgrenska Acad, Dept Biomat, SE-40530 Gothenburg, Sweden.
   [Brnemark, Rickard] Univ Gothenburg, Sahlgrenska Acad, Dept Orthopaed, SE-40530 Gothenburg, Sweden.
RP Palmquist, A (reprint author), Inst Biomat & Cell Therapy, Gothenburg, Sweden.
EM anders.palmquist@biomaterials.gu.se
RI Palmquist, Anders/D-2171-2014
OI Thomsen, Peter/0000-0003-3910-6665; Engqvist, Hakan/0000-0001-9529-650X
FU VINNOVA VinnVaxt Program Biomedical Development in Western Sweden;
   Swedish Research Council [K2006-73X-09495-16-3]; Goran Gustafsson
   Foundation; Doxa AB; Integrum AB
FX Contract grant sponsor: VINNOVA VinnVaxt Program Biomedical Development
   in Western Sweden; Contract grant sponsor: Swedish Research Council;
   contract grant number: K2006-73X-09495-16-3; Contract grant sponsor:
   Goran Gustafsson Foundation, Doxa AB, and Integrum AB
CR Beste U, 2006, INT J REFRACT MET H, V24, P168, DOI 10.1016/j.ijrmhm.2005.05.003
   Bicais-Lepinay N, 2002, MICROELECTRON RELIAB, V42, P1747, DOI 10.1016/S0026-2714(02)00224-X
   BJURSTEN LM, 1990, BIOMATERIALS, V11, P596, DOI 10.1016/0142-9612(90)90085-5
   Branemark P I, 1977, Scand J Plast Reconstr Surg Suppl, V16, P1
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   Engqvist H, 2006, J BIOMED MATER RES A, V78A, P20, DOI 10.1002/jbm.a.30696
   Engqvist H, 2004, BIOMATERIALS, V25, P2781, DOI 10.1016/j.biomaterials.2003.09.053
   ERICSON LE, 1991, BONE-BIOMATERIAL INTERFACE, P425
   *JCPDS, 2005, 0211272 PDF JCPDS IN
   *JCPDS, 2005, 0441294 PDF JCPDS IN
   *JCPDS, 2005, 0291360 PDF JCPDS IN
   *JCPDS, 2005, 0211276 PDF JCPDS IN
   KASEMO B, 1988, J BIOMED MATER RES-A, V22, P145, DOI 10.1002/jbm.820221307
   Langford RM, 2001, J VAC SCI TECHNOL A, V19, P2186, DOI 10.1116/1.1378072
   Lausmaa J, 1996, J ELECTRON SPECTROSC, V81, P343, DOI 10.1016/0368-2048(95)02530-8
   LAUSMAA J, 1990, APPL SURF SCI, V44, P133, DOI 10.1016/0169-4332(90)90100-E
   PALMQUIST A, 2008, ACTA ORTHOP IN PRESS
   RADEGRAN G, 1991, J ELECTRON MICR TECH, V19, P99, DOI 10.1002/jemt.1060190110
   THOMSEN P, 1985, BIOMATERIALS, V6, P421, DOI 10.1016/0142-9612(85)90104-8
   WIESLER DG, 1992, SURF SCI, V268, P57, DOI 10.1016/0039-6028(92)90950-B
   Williams D. B., 1996, TRANSMISSION ELECT M
NR 21
TC 42
Z9 42
U1 0
U2 14
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 15
PY 2008
VL 87A
IS 4
BP 1003
EP 1009
DI 10.1002/jbm.a.31856
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 374WY
UT WOS:000261075600018
PM 18257067
DA 2018-10-19
ER

PT J
AU Brummer, F
   Pfannkuchen, M
   Baltz, A
   Hauser, T
   Thiel, V
AF Bruemmer, Franz
   Pfannkuchen, Martin
   Baltz, Alexander
   Hauser, Thomas
   Thiel, Vera
TI Light inside sponges
SO JOURNAL OF EXPERIMENTAL MARINE BIOLOGY AND ECOLOGY
LA English
DT Article
DE Aplysina; light conduction; porifera; spicula; sponges; Tethya
ID MARINE SPONGE; SUBERITES-DOMUNCULA; SILICATEIN; PORIFERA; CYANOBACTERIA;
   EVOLUTION; SPICULES; DEMOSPONGIAE; MYOTROPHIN; PHYLOGENY
AB Sponges are the most basal metazoan organisms. As sessile filter feeders in marine or freshwater habitats, they often live in close association with phototrophic microorganisms. Active photosynthesis by the associated microorganisms has been believed to be restricted to the outer tissue portion of the sponge hosts. However, phototrophic microorganisms have also been detected in deeper tissue regions. In many cases they are found around spicules, siliceous skelettal elements of demosponges and hexactinellids. The finding of phototrophic organisms seemingly assembled around spicules led to the hypothesis of a siliceous light transmission system in sponges. The principle ability to conduct light was already shown for sponge derived, explanted spicules. However it was not shown until now, that in deed sponges have a light transmission system, and can harbour photosynthetically active microorganisms in deeper tissue regions.
   Here we show for the first time, that, as hypothesized 13 year ago, sponge spicules in living specimens transmit light into deeper tissue regions. Our results demonstrate that in opposite to the actual opinion, photosynthetically active microorganisms can also live in deeper tissue regions, and not only directly beneath the surface, when a light transmission system (spicules) is present.
   Our results show the possibility of massive or globular sponges being supplied with photosynthetic products or pathways throughout their whole body, implying not only a more important role of these endobioses. Our findings also elucidate the in-situ function of a recently more and more interesting biomaterial, which is unique not only for its mechanical, electrical and optical properties. Biosilica is of special interest for the possibility to produce it enzymatically under environmental conditions. (C) 2008 Published by Elsevier B.V.
C1 [Bruemmer, Franz; Pfannkuchen, Martin; Baltz, Alexander; Hauser, Thomas] Univ Stuttgart, Inst Biol, Abt Zool, D-70569 Stuttgart, Germany.
   [Thiel, Vera] IFM GEOMAR, Leibniz Inst Marine Sci, D-24105 Kiel, Germany.
RP Brummer, F (reprint author), Univ Stuttgart, Inst Biol, Abt Zool, Pfaffenwaldring 57, D-70569 Stuttgart, Germany.
EM franz.bruemmer@bio.uni-stuttgart.de
RI Pfannkuchen, Martin/A-9173-2012
OI Pfannkuchen, Martin/0000-0002-6253-4716
FU Federal Ministry of Education and Reseach (BMBF) [03F0414D]; Universitat
   Stuttgart, Germany
FX This work is dedicated to Elda Gaino and Michele SarA for asking the
   right questions already years ago, as well as Werner E.G. Muller for his
   continuous, stimulating work on sponges. [SS]
CR Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100
   Aizenberg J, 2004, P NATL ACAD SCI USA, V101, P3358, DOI 10.1073/pnas.0307843101
   Bergquist PR, 1978, SPONGES
   Boury-Esnault N, 2006, CAN J ZOOL, V84, P205, DOI 10.1139/Z06-003
   BRUMMER F, 2004, B MUS 1 BIOL U GENOV, V68, P219
   CattaneoVietti R, 1996, NATURE, V383, P397, DOI 10.1038/383397b0
   Cha JN, 1999, P NATL ACAD SCI USA, V96, P361, DOI 10.1073/pnas.96.2.361
   GAINO E, 1994, MAR ECOL PROG SER, V108, P147, DOI 10.3354/meps108147
   Gaino E, 2006, INVERTEBR BIOL, V125, P281, DOI 10.1111/j.1744-7410.2006.00061.x
   Gupta S, 2006, FOLIA MICROBIOL, V51, P121, DOI 10.1007/BF02932166
   Hill MS, 2005, MAR ECOL PROG SER, V291, P93, DOI 10.3354/meps291093
   Krasko A, 2000, EUR J BIOCHEM, V267, P4878, DOI 10.1046/j.1432-1327.2000.01547.x
   Muller WEG, 2003, PROG MOLEC, V33, P195
   MULLER WEG, 2005, BIOSENS BIOELECTRON, V21, P1149
   Mullineaux CW, 2005, J EXP BOT, V56, P389, DOI 10.1093/jxb/eri064
   Nickel M, 2006, ZOOMORPHOLOGY, V125, P225, DOI 10.1007/s00435-006-0022-0
   Perry CC, 2003, REV MINERAL GEOCHEM, V54, P291, DOI 10.2113/0540291
   Reiswig HM, 2006, CAN J ZOOL, V84, P195, DOI 10.1139/Z05-174
   Sara M., 2002, SYSTEMA PORIFERA GUI, V1, P245
   Sarikaya M, 2001, J MATER RES, V16, P1420, DOI 10.1557/JMR.2001.0198
   Shimizu K, 1998, P NATL ACAD SCI USA, V95, P6234, DOI 10.1073/pnas.95.11.6234
   Steindler L, 2005, APPL ENVIRON MICROB, V71, P4127, DOI 10.1128/AEM.71.7.4127-4131.2005
   TABACHNICK KR, 2002, SYSTEMA PORIFERA GUI, P1264
   Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06
   Thiel V, 2007, FEMS MICROBIOL ECOL, V59, P47, DOI 10.1111/j.1574-6941.2006.00217.x
   UNSON MD, 1994, MAR BIOL, V119, P1, DOI 10.1007/BF00350100
   VACELET J, 1995, NATURE, V377, P296, DOI 10.1038/377296a0
   WILKINSON CR, 1979, NATURE, V279, P527, DOI 10.1038/279527a0
   WILKINSON CR, 1980, ENDOCYTOBIOLOGY ENDO, P553
   Xiao SH, 2005, PALAEOGEOGR PALAEOCL, V220, P89, DOI 10.1016/j.palaeo.2002.02.001
NR 30
TC 23
Z9 25
U1 1
U2 26
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-0981
J9 J EXP MAR BIOL ECOL
JI J. Exp. Mar. Biol. Ecol.
PD DEC 15
PY 2008
VL 367
IS 2
BP 61
EP 64
DI 10.1016/j.jembe.2008.06.036
PG 4
WC Ecology; Marine & Freshwater Biology
SC Environmental Sciences & Ecology; Marine & Freshwater Biology
GA 385XM
UT WOS:000261846900001
DA 2018-10-19
ER

PT J
AU Muthutantri, A
   Huang, J
   Edirisinghe, M
AF Muthutantri, Anushini
   Huang, Jie
   Edirisinghe, Mohan
TI Novel preparation of graded porous structures for medical engineering
SO JOURNAL OF THE ROYAL SOCIETY INTERFACE
LA English
DT Article
DE bioceramic; microstructure; sintering; biomedical; electrohydrodynamic
   spraying
ID HYDROXYAPATITE CERAMICS; MECHANICAL-PROPERTIES; POLYLACTIDE FOAMS;
   POROSITY; COMPOSITE; BIOGLASS(R); FABRICATION; SCAFFOLDS; BONE
AB The gradation of porosity in a biomaterial can be very useful for a variety of medical engineering applications such as filtration, bone replacement and implant development. However, the preparation of such structures is not a technologically trivial task and replication methods do not offer an easy solution. In this work, we elucidate the preparation of structures having a graded porosity by electrohydrodynamic spraying, using zirconia (ZrO(2)), which is widely used in biomedical and other applications. The processes are generic and can be achieved using other bioactive ceramics with similar particle characteristics. The pores on the sprayed surface, the innermost surface and lengthwise cross sections have been analysed in addition to the change in depth of penetration as a function of spraying time. Control of porosity, pore size and depth of penetration has been obtained by varying parameters such as the spraying time, sintering temperature and the sacrificial template. It has been possible to obtain structures with interconnected pore networks of pore size greater than 100 mu m as well as scattered pores smaller than 10 mu m in size.
C1 [Muthutantri, Anushini; Huang, Jie; Edirisinghe, Mohan] UCL, Dept Mech Engn, London WC1E 7JE, England.
RP Edirisinghe, M (reprint author), UCL, Dept Mech Engn, Torrington Pl, London WC1E 7JE, England.
EM m.edirisinghe@ucl.ac.uk
FU EPSRC [GR/S 97880]; Royal Society, UK; Engineering and Physical Sciences
   Research Council [GR/S97880/02, GR/S97880/01]
FX EPSRC grant GR/S 97880 and the Royal Society, UK (Brian Mercer Fund) are
   gratefully acknowledged for funding the research.
CR Becker BS, 1997, J MATER SCI-MATER M, V8, P793, DOI 10.1023/A:1018525015421
   Boccaccini AR, 2003, J MATER SCI-MATER M, V14, P443, DOI 10.1023/A:1023266902662
   Castillo M, 2003, ADV SPACE RES, V32, P265, DOI 10.1016/S0273-1177(03)00392-2
   Chen QZ, 2006, J AM CERAM SOC, V89, P1534, DOI 10.1111/j.1551-2916.2006.00935.x
   Christel P, 1988, BIOCERAMICS MAT CHAR, V523, P234
   Corbin SF, 1999, MAT SCI ENG A-STRUCT, V262, P192, DOI 10.1016/S0921-5093(98)01019-3
   Dariel MP, 2001, MATER CHEM PHYS, V67, P192, DOI 10.1016/S0254-0584(00)00438-7
   GOMEZ A, 1994, PHYS FLUIDS, V6, P404, DOI 10.1063/1.868037
   Grigoriev DA, 2002, J APPL PHYS, V91, P437, DOI 10.1063/1.1420762
   Hartmann R. P. A., 1996, J AEROSOL SCI, V27, pS177, DOI DOI 10.1016/0021-8502(96)00161-9
   Helmer J. D., 1969, S US CER SURG IMPL C
   Hing KA, 1999, J MATER SCI-MATER M, V10, P135, DOI 10.1023/A:1008929305897
   Holtappels P, 2006, FUEL CELLS, V6, P113, DOI 10.1002/fuce.200500116
   Jayasinghe SN, 2004, J EUR CERAM SOC, V24, P2203, DOI 10.1016/j.jeurcernsoc.2003.07.001
   Kim HW, 2004, J BIOMED MATER RES B, V70B, P270, DOI 10.1002/jbm.b.30032
   Lu WW, 2003, J MATER SCI-MATER M, V14, P1039, DOI 10.1023/B:JMSM.0000004000.56814.9e
   Luyten J, 2005, ADV APPL CERAM, V104, P4, DOI 10.1179/174367605225010990
   MIAO X, 2003, BIOCERAMICS, V15, P595
   MIKOS AG, 1994, BIOMATERIALS, V15, P55, DOI 10.1016/0142-9612(94)90197-X
   Muthutantri A, 2008, J MATER SCI-MATER M, V19, P1485, DOI 10.1007/s10856-008-3379-4
   Okii N, 2001, NEUROL MED-CHIR, V41, P100, DOI 10.2176/nmc.41.100
   Pompe W, 2003, MAT SCI ENG A-STRUCT, V362, P40, DOI 10.1016/S0921-5093(03)00580-X
   Robinson JH, 2008, KEY ENG MATER, V361-363, P3, DOI 10.4028/www.scientific.net/KEM.361-363.3
   Roether JA, 2002, BIOMATERIALS, V23, P3871, DOI 10.1016/S0142-9612(02)00131-X
   Steffens HD, 1999, J THERM SPRAY TECHN, V8, P517, DOI 10.1361/105996399770350197
   Tampieri A, 2001, BIOMATERIALS, V22, P1365, DOI 10.1016/S0142-9612(00)00290-8
   Tulliani JM, 1999, J AM CERAM SOC, V82, P961, DOI 10.1111/j.1151-2916.1999.tb01860.x
   Vaz L, 1999, J MATER SCI-MATER M, V10, P239, DOI 10.1023/A:1008910213166
   Werner J, 2002, BIOMATERIALS, V23, P4285, DOI 10.1016/S0142-9612(02)00191-6
   Yoshida K, 2006, J EUR CERAM SOC, V26, P515, DOI 10.1016/j.jeurceramsoc.2005.07.047
   Zeschky J, 2005, ACTA MATER, V53, P927, DOI 10.1016/j.actamat.2004.10.039
NR 31
TC 20
Z9 20
U1 0
U2 14
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1742-5689
J9 J R SOC INTERFACE
JI J. R. Soc. Interface
PD DEC 6
PY 2008
VL 5
IS 29
BP 1459
EP 1467
DI 10.1098/rsif.2008.0092
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 382YY
UT WOS:000261642500007
PM 18426768
OA Bronze, Green Published
DA 2018-10-19
ER

PT J
AU Rimola, A
   Corno, M
   Zicovich-Wilson, CM
   Ugliengo, P
AF Rimola, Albert
   Corno, Marta
   Marcelo Zicovich-Wilson, Claudio
   Ugliengo, Piero
TI Ab Initio Modeling of Protein/Biomaterial Interactions: Glycine
   Adsorption at Hydroxyapatite Surfaces
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID SOLID-STATE NMR; DRUG-DELIVERY; AMINO-ACIDS; GAS-PHASE; STATHERIN;
   CRYSTALS; PROTEIN; RECOGNITION; ZWITTERION; AMELOGENIN
AB How does glycine adsorb at hydroxyapatite surfaces? Ab initio simulations based on periodic B3LYP GTO calculations reveal the detailed mechanism of binding to the (001) and (010) Surfaces by shedding light on how acid and basic amino acid residues of proteins interact with hydroxyapatite based biomaterials.
C1 [Rimola, Albert; Corno, Marta; Ugliengo, Piero] Univ Turin, IFM, Dipartimento Chim, NIS Ctr Excellence,Natl Consortium, I-10125 Turin, Italy.
   [Rimola, Albert; Corno, Marta; Ugliengo, Piero] Univ Turin, INSTM Mat Sci & Technol, I-10125 Turin, Italy.
   [Marcelo Zicovich-Wilson, Claudio] Univ Autonoma Estado Morelos, Fac Ciencias, Cuernavaca 62209, Morelos, Mexico.
RP Ugliengo, P (reprint author), Univ Turin, IFM, Dipartimento Chim, NIS Ctr Excellence,Natl Consortium, Via P Giuria 7, I-10125 Turin, Italy.
EM piero.ugliengo@unito.it
RI Rimola, Albert/K-1813-2014; ugliengo, piero/H-6373-2015;
   zicovich-wilson, claudio/B-7789-2015; Corno, Marta/I-4310-2012
OI Rimola, Albert/0000-0002-9637-4554; ugliengo, piero/0000-0001-8886-9832;
   zicovich-wilson, claudio/0000-0001-6116-9166; Corno,
   Marta/0000-0001-7248-2705
FU CONACYT [46983]; MIUR [COFIN2006, Prot. 2006032335005]
FX A.R. is indebted to the Ramon Areces Foundation for a postodoctoral
   fellowship. C.Z.W. thanks CONACYT (Project 46983) for financial support.
   Financial support from MIUR (Project COFIN2006, Prot. 2006032335005) and
   from the Regione Piemonte (Bando ricerca scientifica Piemonte 2004,
   Settore: Nanotecnologie e nanoscienze, "Materiali nanostrutturati
   biocompatibili per applicazioni biomediche") is gratefully acknowledged.
   Roberto Orlando is acknowledged for critically reading the
CR Bertozzi C. R., 2006, Publication No. WO/2006/062776, Patent No. 2006062776
   Capriotti LA, 2007, J AM CHEM SOC, V129, P5281, DOI 10.1021/ja070356b
   Chen PH, 2008, J AM CHEM SOC, V130, P2862, DOI 10.1021/ja076607y
   Chen X, 2007, J PHYS CHEM C, V111, P1284, DOI 10.1021/jp0646630
   CORNO M, LANGMUIR UNPUB
   Corno M, 2007, EUR J MINERAL, V19, P757, DOI 10.1127/0935-1221/2007/0019-1764
   Corral I, 2006, CHEM-EUR J, V12, P6787, DOI 10.1002/chem.200600127
   Gibson JM, 2006, J AM CHEM SOC, V128, P5364, DOI 10.1021/ja056731m
   Goobes R, 2007, BIOCHEMISTRY-US, V46, P4725, DOI 10.1021/bi602345a
   Gray JJ, 2004, CURR OPIN STRUC BIOL, V14, P110, DOI 10.1016/j.sbi.2003.12.001
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Hijon N, 2004, CHEM MATER, V16, P1451, DOI 10.1021/cm031164s
   JENSEN JH, 1995, J AM CHEM SOC, V117, P8159, DOI 10.1021/ja00136a013
   Kirkham J, 2002, CURR OPIN COLLOID IN, V7, P124, DOI 10.1016/S1359-0294(02)00017-1
   Kokubo T., 1990, BIOMED MAT RES, V24, P721, DOI DOI 10.1002/JBM.820240607
   Long JR, 2001, BIOCHEMISTRY-US, V40, P15451, DOI 10.1021/bi010864c
   Makrodimitris K, 2007, J AM CHEM SOC, V129, P13713, DOI 10.1021/ja074602v
   Palazzo B, 2005, MAT SCI ENG C-BIO S, V25, P207, DOI 10.1016/j.msec.2005.01.011
   Pan HH, 2007, LANGMUIR, V23, P8972, DOI 10.1021/la700567r
   Ratner B. D., 2004, BIOMATERIAL SCI INTR
   Rimola A, 2006, LANGMUIR, V22, P6593, DOI 10.1021/la0610203
   Schroder E, 2003, ANAL BIOCHEM, V313, P176, DOI 10.1016/S0003-2697(02)00567-5
   Shaw WJ, 2004, J BIOL CHEM, V279, P40263, DOI 10.1074/jbc.C400322200
   Shaw WJ, 2000, J AM CHEM SOC, V122, P1709, DOI 10.1021/ja9842823
   SIMMER JP, 1995, CRIT REV ORAL BIOL M, V6, P84, DOI 10.1177/10454411950060020701
   Song J, 2005, J AM CHEM SOC, V127, P3366, DOI 10.1021/ja043776z
   Strittmatter EF, 2000, J PHYS CHEM A, V104, P9793, DOI 10.1021/jp002970e
   Tomsia AP, 2005, ADV ENG MATER, V7, P999, DOI 10.1002/adem.200500143
   Vallet-Regi M, 2006, CHEM-EUR J, V12, P5934, DOI 10.1002/chem.200600226
   VoDinh T, 2007, NANOTECHNOLOGY IN BIOLOGY AND MEDICINE: METHODS, DEVICES, AND APPLICATIONS, P1
   Wallwork ML, 2001, LANGMUIR, V17, P2508, DOI 10.1021/la001281r
   Wierzbicki A, 2000, J MOL STRUC-THEOCHEM, V529, P73, DOI 10.1016/S0166-1280(00)00534-0
NR 33
TC 69
Z9 69
U1 6
U2 54
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD DEC 3
PY 2008
VL 130
IS 48
BP 16181
EP +
DI 10.1021/ja806520d
PG 4
WC Chemistry, Multidisciplinary
SC Chemistry
GA 406UG
UT WOS:000263319800028
PM 18989958
DA 2018-10-19
ER

PT J
AU Palestino, G
   Agarwal, V
   Aulombard, R
   Perez, E
   Gergely, C
AF Palestino, Gabriela
   Agarwal, Vivechana
   Aulombard, Roger
   Perez, Elias
   Gergely, Csilla
TI Biosensing and Protein Fluorescence Enhancement by Functionalized Porous
   Silicon Devices
SO LANGMUIR
LA English
DT Article
ID DIRECT ELECTRON-TRANSFER; HYDROGEN-PEROXIDE; MESOPOROUS SILICA; OXIDASE;
   MICROCAVITIES; STABILITY; IMMOBILIZATION
AB Porous silicon (PSi) is a promising biomaterial presenting the advantage of being biocompatible and bioresorbable. Due to the large specific surface area and unique optical features, these microporous structures are excellent candidates for biosensing applications. Investigating device functionality and developing simple Si-based transducers need to be addressed in novel biological detection. Our work demonstrates that, among the various PSi configurations for molecular detection, PSi microcavity structure demonstrates the best biosensing performance, reflected through the enhanced luminescence response and the changes in the refractive index. For successful immobilization, molecular infiltration and confinement are the two key factors that are controlled by the pore size distribution of the PSi microcavities and by the surface modification obtained by silane-glutaraldehyde chemistry. Enhancement of the fluorescence emission of confined fluorescent biomolecules in the active layer of PSi microcavities was observed for a nonlabeled protein with a natural green fluorescence, the glucose oxidase enzyme (GOX). An increase in the fluorescence emission was also observed when functionalized PSi material was used to detect specific binding between biotin and a low concentration of labeled streptavidin. Evidence for the enzymatic activity of GOX in its adsorbed form is also presented. Use of smart silicon devices, enabling enhancement of fluorescence emission of biomolecules, offers easy-to-use biosensing, based on the luminescence response of the molecules to be detected.
C1 [Palestino, Gabriela; Aulombard, Roger; Gergely, Csilla] Univ Montpellier 2, CNRS, UMR 5650, Etud Semicond Grp, F-34095 Montpellier 5, France.
   [Palestino, Gabriela] Univ Autonoma San Luis Potosi, Fac Ciencias Quim, San Luis Potosi 78000, Mexico.
   [Perez, Elias] Univ Autonoma San Luis Potosi, Inst Fis, San Luis Potosi 78000, Mexico.
   [Agarwal, Vivechana] CIICAP UAEM, Cuernavaca, Morelos, Mexico.
RP Gergely, C (reprint author), Univ Montpellier 2, CNRS, UMR 5650, Etud Semicond Grp, Pl Eugene Bataillon, F-34095 Montpellier 5, France.
EM gergely@ges.univ-montp2.fr
RI Perez, Elias/D-3281-2011
OI Perez, Elias/0000-0003-3002-7100
FU Phoremost European Network of Excellence [511616]; Nano-Photonics to
   Realise Molecular Scale Technologies; Ecos-North French-Mexican program
   [M06P01]; CONACyT [57631]
FX This work was supported by the Phoremost European Network of Excellence,
   Project Nr. 511616: "Nano-Photonics to Realise Molecular Scale
   Technologies" and the M06P01 Ecos-North French-Mexican program. Authors
   thank E. Estephan and M. Saab for help with the AFM images. Thanks are
   going to F. Cuisinier and L. Zimanyi for valuable discussions. G.P.
   thanks PROMEP support. V.A. acknowledges the financial support from the
   CONACyT (57631) project and the technical support from D. Becerra.
CR Agarwal V, 2007, J PHYS D APPL PHYS, V40, P3203, DOI 10.1088/0022-3727/40/10/026
   Agarwal V, 2003, APPL PHYS LETT, V82, P1512, DOI 10.1063/1.1559420
   Anglin EJ, 2004, LANGMUIR, V20, P11264, DOI 10.1021/la048105t
   Bengtsson M, 2000, PHYS STATUS SOLIDI A, V182, P533, DOI 10.1002/1521-396X(200011)182:1<533::AID-PSSA533>3.0.CO;2-W
   CANHAM LT, 1990, APPL PHYS LETT, V57, P1046, DOI 10.1063/1.103561
   Canham LT, 1999, ADV MATER, V11, P1505, DOI 10.1002/(SICI)1521-4095(199912)11:18<1505::AID-ADMA1505>3.3.CO;2-3
   Chan S, 2001, MAT SCI ENG C-BIO S, V15, P277, DOI 10.1016/S0928-4931(01)00219-3
   Chan S, 2001, J AM CHEM SOC, V123, P11797, DOI 10.1021/ja016555r
   Chan S, 2001, OPT MATER, V17, P31, DOI 10.1016/S0925-3467(01)00016-7
   Chin V, 2001, ADV MATER, V13, P1877, DOI 10.1002/1521-4095(200112)13:24<1877::AID-ADMA1877>3.0.CO;2-4
   Dai ZH, 2004, BIOSENS BIOELECTRON, V19, P861, DOI 10.1016/j.bios.2003.08.024
   DeLouise LA, 2004, ANAL CHEM, V76, P6915, DOI 10.1021/ac0488208
   Han KC, 2005, BIOCHEM ENG J, V22, P161, DOI 10.1016/j.bej.2004.09.011
   HAYNES CA, 1994, COLLOID SURFACE B, V2, P517
   He F, 2006, ADV FUNCT MATER, V16, P91, DOI 10.1002/adfm.200500602
   Ivnitski D, 2008, SMALL, V4, P357, DOI 10.1002/smll.200700725
   KILLIAN KA, 2007, ADV FUNCT MATER, P1
   Lees IN, 2003, LANGMUIR, V19, P9812, DOI 10.1021/la035197y
   Low SP, 2006, BIOMATERIALS, V27, P4538, DOI 10.1016/j.biomaterials.2006.04.015
   Lu YJ, 2007, ADV FUNCT MATER, V17, P2160, DOI 10.1002/adfm.200600505
   Matveeva EG, 2007, ANAL BIOCHEM, V363, P239, DOI 10.1016/j.ab.2007.01.030
   MUNOLLI V, 1999, 2 SCI TECHNOL, V14, P1052
   Orth RN, 2003, BIOMED MICRODEVICES, V5, P29, DOI 10.1023/A:1024459215654
   Ouyang H, 2005, ADV FUNCT MATER, V15, P1851, DOI 10.1002/adfm.200500218
   Ouyang H, 2005, P SPIE, V6005
   Palestino AG, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2786596
   PALESTINO G, 2008, SPIE, V6991
   Pickup JC, 2005, BIOSENS BIOELECTRON, V20, P2555, DOI 10.1016/j.bios.2004.10.002
   Sapelkin AV, 2006, BIOMATERIALS, V27, P842, DOI 10.1016/j.biomaterials.2005.06.023
   Setzu S., 1999, J LUMIN, V80, P129
   Yoshimoto M, 2006, BIOCHEM ENG J, V30, P158, DOI 10.1016/j.bej.2006.03.004
   Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391
NR 32
TC 43
Z9 43
U1 1
U2 26
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD DEC 2
PY 2008
VL 24
IS 23
BP 13765
EP 13771
DI 10.1021/la8015707
PG 7
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 376XO
UT WOS:000261216500077
PM 18959435
DA 2018-10-19
ER

PT J
AU Hook, F
   Kasemo, B
   Grunze, M
   Zauscher, S
AF Hook, Fredrik
   Kasemo, Bengt
   Grunze, Michael
   Zauscher, Stefan
TI Quantitative Biological Surface Science: Challenges and Recent Advances
SO ACS NANO
LA English
DT Article
ID QUARTZ-CRYSTAL MICROBALANCE; SELF-ASSEMBLED MONOLAYERS; SINGLE-MOLECULE
   DETECTION; LIPID-MEMBRANES; WATER; ADSORPTION; CONVERSATION;
   COADSORPTION; INTERFACE; PROTEINS
AB Biological surface science is a broad, interdisciplinary subfield of surface science, where properties and processes at biological and synthetic surfaces and interfaces are investigated, and where biofunctional surfaces are fabricated. The need to study and to understand biological surfaces and interfaces in liquid environments provides sizable challenges M, as well as fascinating opportunities. Here, we report on recent progress in biological surface E. science that was described within the program assembled by the Biomaterial Interface Division of the Science and Technology of Materials, Interfaces and Processes (www.avs.org) during their 55th International Symposium and Exhibition held in Boston, October 19-24, 2008. The selected examples show that the rapid progress in nanoscience and nanotechnology, hand-in-hand with theory and simulation, provides increasingly sophisticated methods and tools to unravel the mechanisms and details of complex processes at biological surfaces and in-depth understanding of biomolecular surface interactions.
C1 [Hook, Fredrik; Kasemo, Bengt] Chalmers, Dept Appl Phys, SE-41296 Gothenburg, Sweden.
   [Grunze, Michael] Univ Heidelberg, D-69120 Heidelberg, Germany.
   [Zauscher, Stefan] Duke Univ, Dept Mech Engn & Mat Sci, Durham, NC 27708 USA.
RP Hook, F (reprint author), Chalmers, Dept Appl Phys, SE-41296 Gothenburg, Sweden.
EM fredrik.hook@chalmers.se
RI Hook, Fredrik/F-6701-2010; Grunze, Michael/H-1600-2013
CR Armani AM, 2007, SCIENCE, V317, P783, DOI 10.1126/science.1145002
   BRUCKBAUER A, 2007, BIOPHYS J, V93, P3210
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Cho NJ, 2007, J AM CHEM SOC, V129, P10050, DOI 10.1021/ja0701412
   Dahlin AB, 2008, ACS NANO, V2, P2174, DOI 10.1021/nn800254h
   DU Q, 1994, SCIENCE, V264, P826, DOI 10.1126/science.264.5160.826
   Gunnarsson A, 2008, NANO LETT, V8, P183, DOI 10.1021/nl072401j
   HANSMA PK, 1989, SCIENCE, V243, P641, DOI 10.1126/science.2464851
   Heydt M, 2007, J ADHESION, V83, P417, DOI 10.1080/00218460701377388
   JONSSON M, 2008, ANAL CHEM, V71, P2174
   Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X
   Keller CA, 1998, BIOPHYS J, V75, P1397, DOI 10.1016/S0006-3495(98)74057-3
   Knoll W, 2008, ELECTROCHIM ACTA, V53, P6680, DOI 10.1016/j.electacta.2008.02.121
   Luthgens E, 2005, CHEMPHYSCHEM, V6, P444, DOI 10.1002/cphc.200400446
   Maccarini M, 2007, BIOINTERPHASES, V2, pMR1, DOI 10.1116/1.2768902
   Mamatkulov SI, 2004, LANGMUIR, V20, P4756, DOI 10.1021/la036036x
   Mamdouh W, 2008, J AM CHEM SOC, V130, P695, DOI 10.1021/ja076832f
   MCCLAIN WH, 1988, SCIENCE, V240, P793, DOI 10.1126/science.2452483
   Reimhult E, 2004, ANAL CHEM, V76, P7211, DOI 10.1021/ac0492970
   RODAHL M, 1995, REV SCI INSTRUM, V66, P3924, DOI 10.1063/1.1145396
   Schiller SM, 2003, ANGEW CHEM INT EDIT, V42, P208, DOI 10.1002/anie.200390080
   Schilp S, 2007, BIOINTERPHASES, V2, P143, DOI 10.1116/1.2806729
   Schmitt EK, 2008, SOFT MATTER, V4, P250, DOI 10.1039/b716723g
   Schmitt EK, 2006, BIOPHYS J, V91, P2163, DOI 10.1529/biophysj.106.083592
   Schwendel D, 2003, LANGMUIR, V19, P2284, DOI 10.1021/la026716k
   Sebba DS, 2008, APPL PHYS B-LASERS O, V93, P69, DOI 10.1007/s00340-008-3212-2
   Shevchuk AI, 2006, ANGEW CHEM INT EDIT, V45, P2212, DOI 10.1002/anie.200503915
   WANG G, 2008, REV SCI INSTRUM, V79
   Wang RLC, 2000, PHYS CHEM CHEM PHYS, V2, P1721, DOI 10.1039/a909598e
   Weiskopf D, 2007, LANGMUIR, V23, P9134, DOI 10.1021/la701080u
   Weiss PS, 2008, ACS NANO, V2, P1979, DOI 10.1021/nn800663f
   Weiss PS, 2007, ACS NANO, V1, P3, DOI 10.1021/nn7001294
   Xu SL, 2006, NANO LETT, V6, P1434, DOI 10.1021/nl060563u
   2008, BIOINTERPHASES, V3, pFA1
NR 34
TC 40
Z9 40
U1 0
U2 42
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1936-0851
J9 ACS NANO
JI ACS Nano
PD DEC
PY 2008
VL 2
IS 12
BP 2428
EP 2436
DI 10.1021/nn800800v
PG 9
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA 388MJ
UT WOS:000262023600005
PM 19206275
DA 2018-10-19
ER

PT J
AU Wollensak, G
   Iomdina, E
AF Wollensak, Gregor
   Iomdina, Elena
TI Long-term biomechanical properties after collagen crosslinking of sclera
   using glyceraldehyde
SO ACTA OPHTHALMOLOGICA
LA English
DT Article
DE collagen crosslinking; glyceraldehyde; myopia; sclera
ID MYOPIA PROGRESSION; MAILLARD REACTION; OCULAR-TISSUES; GLYCATION;
   KERATOCONUS; COMPLICATIONS; ORGANIZATION; PRODUCTS; PROTEINS; GELATIN
AB Chemical crosslinking by glyceraldehyde has been shown to increase significantly the biomechanical rigidity of sclera. It might therefore become an option for a sclera-based treatment of progressive myopia. The present pilot study was designed to test the long-term biomechanical efficiency of the new crosslinking method.
   Six Chinchilla rabbits were treated with sequential sub-Tenon's injections of 0.15 ml 0.5 m glyceraldehyde, which were given in the supero-nasal quadrant of the right eye (OD) five times over 14 days. The rabbits were killed 4 months and 8 months after crosslinking treatment, respectively. Biomechanical stress-strain measurements of scleral strips from the treatment area were performed and compared to non-treated contralateral control sclera using a microcomputer-controlled biomaterial testing device. In addition, the eyes were examined histologically by light microscopy to evaluate possible side-effects.
   Following the crosslinking treatment, the ultimate stress was 10.2 +/- 2.3 MPa after 4 months and 8.5 +/- 2.2 MPa after 8 months versus 2.4 +/- 0.3 MPa in the controls (increases of 325% and 254.17%, respectively); Young's modulus was 104.6 +/- 13.7 MPa after 4 months and 53.2 +/- 5.2 MPa after 8 months versus 9.6 +/- 1.3 MPa in the controls (increases of 989.6% and 554.17%, respectively); and ultimate strain was 15.8 +/- 1.5% after 4 months and 24.1 +/- 0.7% after 8 months versus 38.4 +/- 4.6% in the controls (decreases of 58.84% and 37.24%, respectively). Histologically, no side-effects were found.
   Our new method of scleral collagen crosslinking proved very efficient in increasing scleral biomechanical strength over a period of up to 8 months. Glyceraldehyde can be applied easily by sequential parabulbar injections. Before clinical application in myopic patients, a study in an animal myopia model is recommended.
C1 [Wollensak, Gregor] Univ Halle Wittenberg, Dept Ophthalmol, Halle, Germany.
   [Iomdina, Elena] Moscow Helmholtz Res Inst Eye Dis, Moscow, Russia.
RP Wollensak, G (reprint author), Wildentensteig 4, D-14195 Berlin, Germany.
EM gwollens@hotmail.com
CR Ambati J, 2000, INVEST OPHTH VIS SCI, V41, P1181
   Avetisov ES, 1997, ACTA OPHTHALMOL SCAN, V75, P618
   AWETISSOW ES, 1980, KLIN MONATSBL AUGENH, V176, P777, DOI 10.1055/s-2008-1057552
   BAI PM, 1992, CONNECT TISSUE RES, V28, P1, DOI 10.3109/03008209209014224
   Bailey AJ, 1998, MECH AGEING DEV, V106, P1, DOI 10.1016/S0047-6374(98)00119-5
   BAILEY AJ, 1987, EYE-T OPHTH SOC UK, V1, P175, DOI 10.1038/eye.1987.34
   Bell G R, 1993, J Am Optom Assoc, V64, P332
   BELL GR, 1978, J AM OPTOM ASSOC, V49, P1399
   Bullimore MA, 2002, INVEST OPHTH VIS SCI, V43, P2110
   Edwards MH, 1996, ACTA OPHTHALMOL SCAN, V74, P213
   FUNATA M, 1990, GRAEF ARCH CLIN EXP, V228, P174, DOI 10.1007/BF02764314
   Gerrard JA, 2002, FOOD CHEM, V79, P343, DOI 10.1016/S0308-8146(02)00174-7
   Girton TS, 1999, J BIOMED MATER RES, V46, P87, DOI 10.1002/(SICI)1097-4636(199907)46:1<87::AID-JBM10>3.0.CO;2-K
   Iomdina E.N., 1993, P 14 C BIOM PAR INT, P616
   Kosmala JD, 2000, BIOMATERIALS, V21, P2019, DOI 10.1016/S0142-9612(00)00057-0
   Kumar CM, 2003, EYE, V17, P1003, DOI 10.1038/sj.eye.6700501
   Lee KW, 1999, BBA-MOL BASIS DIS, V1453, P141, DOI 10.1016/S0925-4439(98)00097-0
   LEE RE, 1981, EXP EYE RES, V32, P737, DOI 10.1016/0014-4835(81)90023-3
   MCBRIEN NA, 1994, EXP EYE RES, V59, P475, DOI 10.1006/exer.1994.1133
   McBrien NA, 2003, PROG RETIN EYE RES, V22, P307, DOI 10.1016/S1350-9462(02)00063-0
   MECHANIC G, 1972, BIOCHEM BIOPH RES CO, V47, P267, DOI 10.1016/S0006-291X(72)80038-X
   Paul RG, 1996, INT J BIOCHEM CELL B, V28, P1297, DOI 10.1016/S1357-2725(96)00079-9
   Pierro L, 1999, RETINA-J RET VIT DIS, V19, P401, DOI 10.1097/00006982-199909000-00005
   Rada JAS, 2006, EXP EYE RES, V82, P185, DOI 10.1016/j.exer.2005.08.009
   SADY C, 1995, BIOCHEM BIOPH RES CO, V214, P793, DOI 10.1006/bbrc.1995.2356
   Saw SM, 2002, BRIT J OPHTHALMOL, V86, P1306, DOI 10.1136/bjo.86.11.1306
   Seiler T, 2000, GRAEF ARCH CLIN EXP, V238, P822, DOI 10.1007/s004179900111
   Tano Y, 2002, AM J OPHTHALMOL, V134, P645, DOI 10.1016/S0002-9394(02)01883-4
   Tessier FJ, 2003, BIOCHEM J, V369, P705, DOI 10.1042/BJ20020668
   Tezel G, 2007, INVEST OPHTH VIS SCI, V48, P1201, DOI 10.1167/iovs.06-0737
   Vandelli MA, 2001, INT J PHARM, V215, P175, DOI 10.1016/S0378-5173(00)00681-5
   Watson PG, 2004, EXP EYE RES, V78, P609, DOI 10.1016/S0014-4835(03)00212-4
   Weale RA, 2003, SURV OPHTHALMOL, V48, P515, DOI 10.1016/S0039-6257(03)00086-9
   Wildsoet CF, 1999, OPTOMETRY VISION SCI, V76, P341, DOI 10.1097/00006324-199906000-00001
   Wollensak G, 2005, ACTA OPHTHALMOL SCAN, V83, P477, DOI 10.1111/j.1600-0420.2005.00447.x
   Wollensak G, 2004, J CATARACT REFR SURG, V30, P689, DOI 10.1016/j.jcrs.2003.11.032
   Wollensak G, 2003, AM J OPHTHALMOL, V135, P620, DOI 10.1016/S0002-9394(02)02220-1
   WOLLENSAK G, 2008, J CATARACT IN PRESS
   Wollensak G, 2006, CURR OPIN OPHTHALMOL, V17, P356, DOI 10.1097/01.icu.0000233954.86723.25
   Xu L, 2007, OPHTHALMOLOGY, V114, P121, DOI 10.1016/j.ophtha.2006.05.071
   ZUCLICH JA, 1989, HEALTH PHYS, V56, P671, DOI 10.1097/00004032-198905000-00012
NR 41
TC 24
Z9 29
U1 2
U2 7
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1755-375X
J9 ACTA OPHTHALMOL
JI Acta Ophthalmol.
PD DEC
PY 2008
VL 86
IS 8
BP 887
EP 893
DI 10.1111/j.1755-3768.2007.01156.x
PG 7
WC Ophthalmology
SC Ophthalmology
GA 377IA
UT WOS:000261243700015
PM 18537936
OA Bronze
DA 2018-10-19
ER

PT J
AU Kretlow, JD
   Mikos, AG
AF Kretlow, James D.
   Mikos, Antonios G.
TI From Material to Tissue: Biomaterial Development, Scaffold Fabrication,
   and Tissue Engineering
SO AICHE JOURNAL
LA English
DT Review
DE biomaterials; tissue engineering; drug delivery; polymer scaffolds;
   hydrogels; biomimetics; bioreactors
ID MARROW STROMAL CELLS; OLIGO(POLY(ETHYLENE GLYCOL) FUMARATE); CO-ETHYLENE
   GLYCOL); IN-VITRO DEGRADATION; FLOW PERFUSION BIOREACTOR;
   POLY(DL-LACTIC-CO-GLYCOLIC ACID) FOAMS; BIODEGRADABLE POLYMER
   MICROPARTICLES; CATIONIZED GELATIN MICROSPHERES; CROSS-LINKING
   CHARACTERISTICS; BONE MORPHOGENETIC PROTEIN-2
AB The need for techniques to facilitate the regeneration of failing or destroyed tissues remains great with the aging of the worldwide population and the continued incidence of trauma and diseases such as cancer. A 16-year history in biomaterial scaffold development and tissue engineering is examined, beginning with the synthesis of novel materials and fabrication of 3D porous scaffolds. Exploring cell-scaffold interactions and subsequently cellular delivery using biomaterial carriers, we have developed a variety of techniques for bone and cartilage engineering. In addition to delivering cells, we have utilized growth factors, DNA, and peptides to improve the in vitro and in vivo regeneration of tissues. This review covers important developments and discoveries within our laboratory, and the increasing breadth in the scope of our work within the expanding field of tissue engineering is presented. (C) 2008 American Institute of Chemical Engineers AIChE J, 54: 3048-3067, 2008
C1 [Kretlow, James D.; Mikos, Antonios G.] Rice Univ, Dept Bioengn, Houston, TX 77251 USA.
   [Mikos, Antonios G.] Rice Univ, Dept Chem & Biomol Engn, Houston, TX 77251 USA.
RP Mikos, AG (reprint author), Rice Univ, Dept Bioengn, Houston, TX 77251 USA.
EM mikos@rice.edu
FU National Institutes of Health; National Science Foundation; NASA;
   Whitaker Foundation; Rice University Institute of Biosciences and
   Bioengineering through the Biotechnology Training [T32 GM008362];
   National Institute of General Medical Sciences [T32 GM007330]
FX The authors acknowledge financial support by the National Institutes of
   Health, National Science Foundation, NASA, Whitaker Foundation, and
   other agencies and companies for research towards the development of new
   biomaterials (AGM). They thank all the current and past undergraduate
   students, graduate students, and postdoctoral fellows for their hard
   work during the past 16 years. They also thank their colleagues at Rice
   University and their collaborators around the world for their
   significant contributions over the years. JDK acknowledges support by
   the National Institutes of Health and Rice University Institute of
   Biosciences and Bioengineering through the Biotechnology Training Grant
   (T32 GM008362). JDK is a student in the Baylor College of Medicine
   Medical Scientist Training Program and was also supported by the
   National Institute of General Medical Sciences (T32 GM007330).
CR Ambrose CG, 2004, CLIN ORTHOP RELAT R, P293, DOI 10.1097/01.blo.0000126303.41711.a2
   Ambrose CG, 2003, CLIN ORTHOP RELAT R, P279, DOI 10.1097/01.blo.0000093920.26658.ae
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Bancroft GN, 2003, TISSUE ENG, V9, P549, DOI 10.1089/107632703322066723
   Bancroft GN, 2002, P NATL ACAD SCI USA, V99, P12600, DOI 10.1073/pnas.202296599
   Behravesh E, 2003, BIOMATERIALS, V24, P4365, DOI 10.1016/S0142-9612(03)00338-7
   Behravesh E, 2002, BIOMACROMOLECULES, V3, P153, DOI 10.1021/bm010137x
   Behravesh E, 2003, J BIOMED MATER RES A, V65A, P260, DOI 10.1002/jbm.a.10461
   Behravesh E, 2002, BIOMACROMOLECULES, V3, P1263, DOI 10.1021/bm020067
   Behravesh E, 2002, BIOMACROMOLECULES, V3, P374, DOI 10.1021/bm010158r
   Blum JS, 2004, BIOMATERIALS, V25, P5809, DOI 10.1016/j.biomaterials.2004.01.035
   Blum JS, 2004, J ORTHOPAED RES, V22, P411, DOI 10.1016/j.orthres.2003.08.006
   Blum JS, 2003, HUM GENE THER, V14, P1689, DOI 10.1089/104303403322611719
   Blum JS, 2001, J CELL BIOCHEM, V80, P532, DOI 10.1002/1097-4644(20010315)80:4<532::AID-JCB1007>3.0.CO;2-B
   Bodde EWH, 2008, J BIOMED MATER RES A, V85A, P206, DOI 10.1002/jbm.a.31549
   BODDE EW, J BIOMED A IN PRESS
   Botchwey EA, 2003, J BIOMED MATER RES A, V67A, P357, DOI 10.1002/jbm.a.10111
   BUCK BE, 1989, CLIN ORTHOP RELAT R, P129
   Burkus JK, 2002, SPINE, V27, P2396, DOI 10.1097/01.BRS.0000030193.26290.DD
   Butler D, 1998, NATURE, V391, P320
   Cheng MH, 2006, PLAST RECONSTR SURG, V118, p1E, DOI 10.1097/01.prs.0000221120.11128.1a
   Christenson EM, 2007, BIOMACROMOLECULES, V8, P3806, DOI 10.1021/bm7007235
   Cleek RL, 1997, J BIOMED MATER RES, V35, P525, DOI 10.1002/(SICI)1097-4636(19970615)35:4<525::AID-JBM12>3.0.CO;2-A
   Cooke MN, 2003, J BIOMED MATER RES B, V64B, P65, DOI 10.1002/jbm.b.10485
   Datta N, 2006, P NATL ACAD SCI USA, V103, P2488, DOI 10.1073/pnas.0505661103
   Datta N, 2005, BIOMATERIALS, V26, P971, DOI 10.1016/j.biomaterials.2004.04.001
   Dean D, 2003, TISSUE ENG, V9, P495, DOI 10.1089/107632703322066679
   Eaglstein WH, 1997, CLIN THER, V19, P894, DOI 10.1016/S0149-2918(97)80043-4
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Evans GRD, 1999, BIOMATERIALS, V20, P1109, DOI 10.1016/S0142-9612(99)00010-1
   Evans GRD, 2002, BIOMATERIALS, V23, P841, DOI 10.1016/S0142-9612(01)00190-9
   Fisher JP, 2003, BIOMACROMOLECULES, V4, P1335, DOI 10.1021/bm0300296
   Fisher JP, 2003, BIOMACROMOLECULES, V4, P1327, DOI 10.1021/bm030028d
   Fisher JP, 2002, J BIOMED MATER RES, V59, P547, DOI 10.1002/jbm.1268
   Fisher JP, 2004, J BIOMED MATER RES A, V68A, P428, DOI 10.1002/jbm.a.20073
   Fisher JP, 2002, BIOMATERIALS, V23, P4333, DOI 10.1016/S0142-9612(02)00178-3
   Fisher JP, 2001, J BIOMAT SCI-POLYM E, V12, P673
   Friedlaender GE, 2001, J BONE JOINT SURG AM, V83A, pS151
   Godbey WT, 1999, GENE THER, V6, P1380, DOI 10.1038/sj.gt.3300976
   Godbey WT, 2000, J BIOMED MATER RES, V51, P321, DOI 10.1002/1097-4636(20000905)51:3<321::AID-JBM5>3.0.CO;2-R
   Godbey WT, 2001, BIOMATERIALS, V22, P471, DOI 10.1016/S0142-9612(00)00203-9
   Godbey WT, 1999, J BIOMED MATER RES, V45, P268, DOI 10.1002/(SICI)1097-4636(19990605)45:3<268::AID-JBM15>3.0.CO;2-Q
   Godbey WT, 1999, P NATL ACAD SCI USA, V96, P5177, DOI 10.1073/pnas.96.9.5177
   Goldstein AS, 2001, BIOMATERIALS, V22, P1279, DOI 10.1016/S0142-9612(00)00280-5
   Goldstein AS, 1999, TISSUE ENG, V5, P421, DOI 10.1089/ten.1999.5.421
   Gomes ME, 2006, TISSUE ENG, V12, P801, DOI 10.1089/ten.2006.12.801
   Gomes ME, 2006, TISSUE ENG, V12, P177, DOI 10.1089/ten.2006.12.177
   Gomes ME, 2003, J BIOMED MATER RES A, V67A, P87, DOI 10.1002/jbm.a.10075
   Goodship AE, 1998, ACTA ASTRONAUT, V43, P65, DOI 10.1016/S0094-5765(98)00144-1
   Gopferich A, 1999, J BIOMED MATER RES, V46, P390
   Habraken WJEM, 2006, J BIOMAT SCI-POLYM E, V17, P1057, DOI 10.1163/156856206778366004
   HABRAKEN WJ, J BIOMED A IN PRESS
   Habraken WJEM, 2008, BIOMATERIALS, V29, P2464, DOI 10.1016/j.biomaterials.2008.02.012
   HACKER MC, J BIOMED A IN PRESS
   Hacker M, 2007, BIOMATERIALS, V28, P3497, DOI 10.1016/j.biomaterials.2007.04.018
   Hacker MC, 2008, BIOMACROMOLECULES, V9, P1558, DOI 10.1021/bm8000414
   Hacker MC, 2006, TISSUE ENG, V12, P2049, DOI 10.1089/ten.2006.12.2049
   Haesslein A, 2008, ACTA BIOMATER, V4, P1, DOI 10.1016/j.actbio.2007.08.011
   He S, 2001, POLYMER, V42, P1251, DOI 10.1016/S0032-3861(00)00479-1
   He SL, 2000, BIOMATERIALS, V21, P2389, DOI 10.1016/S0142-9612(00)00106-X
   Healthcare Cost and Utilization Project (HCUP), HEALTHC COST UT PROJ
   Hedberg EL, 2005, TISSUE ENG, V11, P1356, DOI 10.1089/ten.2005.11.1356
   Hedberg EL, 2005, BIOMATERIALS, V26, P4616, DOI 10.1016/j.biomaterials.2004.11.039
   Hedberg EL, 2005, J BIOMED MATER RES A, V72A, P343, DOI 10.1002/jbm.a.30265
   Hedberg EL, 2005, BIOMATERIALS, V26, P3215, DOI 10.1016/j.biomaterials.2004.09.012
   Hedberg EL, 2002, J CONTROL RELEASE, V84, P137, DOI 10.1016/S0168-3659(02)00261-4
   Holland TA, 2007, OSTEOARTHR CARTILAGE, V15, P187, DOI 10.1016/j.joca.2006.07.006
   Holland TA, 2005, J BIOMED MATER RES A, V75A, P156, DOI 10.1002/jbm.a.30379
   Holland TA, 2004, J CONTROL RELEASE, V94, P101, DOI 10.1016/j.jconrel.2003.09.007
   Holland TA, 2003, J CONTROL RELEASE, V91, P299, DOI 10.1016/S0168-3659(03)00258-X
   Holland TA, 2005, J CONTROL RELEASE, V101, P111, DOI 10.1016/j.jconrel.2004.07.004
   Holtorf HL, 2005, ANN BIOMED ENG, V33, P1238, DOI 10.1007/s10439-005-5536-y
   Holtorf HL, 2005, J BIOMED MATER RES A, V72A, P326, DOI 10.1002/jbm.a.30251
   Holtorf HL, 2005, BIOMATERIALS, V26, P6208, DOI 10.1016/j.biomaterials.2005.04.006
   Holtorf HL, 2005, J BIOMED MATER RES A, V74A, P171, DOI 10.1002/jbm.a.30330
   Horch RA, 2004, BIOMACROMOLECULES, V5, P1990, DOI 10.1021/bm049768s
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   ISHAUG SL, 1994, J BIOMED MATER RES, V28, P1445, DOI 10.1002/jbm.820281210
   Ishaug-Riley SL, 1998, BIOMATERIALS, V19, P1405, DOI 10.1016/S0142-9612(98)00021-0
   IshaugRiley SL, 1997, J BIOMED MATER RES, V36, P1, DOI 10.1002/(SICI)1097-4636(199707)36:1<1::AID-JBM1>3.0.CO;2-P
   Jo S, 2001, BIOMACROMOLECULES, V2, P255, DOI 10.1021/bm000107e
   Jo S, 2001, MACROMOLECULES, V34, P2839, DOI 10.1021/ma001563y
   Kajikawa Y, 2007, J CELL PHYSIOL, V210, P684, DOI 10.1002/jcp.20876
   Kasper FK, 2006, J BIOMED MATER RES A, V78A, P823, DOI 10.1002/jbm.a.30736
   Kasper FK, 2006, J BIOMED MATER RES A, V78A, P335, DOI 10.1002/jbm.a.30698
   Kasper FK, 2005, J CONTROL RELEASE, V107, P547, DOI 10.1016/j.jconrel.2005.07.005
   Kasper FK, 2005, J CONTROL RELEASE, V104, P521, DOI 10.1016/j.jconrel.2005.03.008
   Kessler P, 2005, BRIT J ORAL MAX SURG, V43, P51, DOI 10.1016/j.bjoms.2004.08.026
   KLOUDA L, 2008, TRANSLATIONAL APPROA, P325
   Kretlow JD, 2007, ADV DRUG DELIVER REV, V59, P263, DOI 10.1016/j.addr.2007.03.013
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LEACH CS, 1990, ACTA ASTRONAUT, V21, P659, DOI 10.1016/0094-5765(90)90077-X
   Leeuwenburgh SCG, 2007, J BIOMAT SCI-POLYM E, V18, P1547
   Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137
   Link DP, 2008, BIOMATERIALS, V29, P675, DOI 10.1016/j.biomaterials.2007.10.029
   LINK DP, 2008, J BIOMED MAT RES A
   Liu GZ, 2001, J CELL BIOCHEM, V83, P129, DOI 10.1002/jcb.1208
   Liu Q, 2000, BIOMATERIALS, V21, P2163, DOI 10.1016/S0142-9612(00)00137-X
   Lu L, 2000, J BIOMED MATER RES, V50, P440, DOI 10.1002/(SICI)1097-4636(20000605)50:3<440::AID-JBM19>3.0.CO;2-G
   Lu L, 2000, BIOMATERIALS, V21, P1837, DOI 10.1016/S0142-9612(00)00047-8
   Lu LC, 2001, J BONE JOINT SURG AM, V83A, pS82
   Lu LC, 1998, J BIOMAT SCI-POLYM E, V9, P1187
   Lu LC, 1999, BIOMATERIALS, V20, P2351, DOI 10.1016/S0142-9612(99)00164-7
   Lu LC, 2001, BIOMATERIALS, V22, P291, DOI 10.1016/S0142-9612(00)00179-4
   Lu LC, 2000, BIOMATERIALS, V21, P1595, DOI 10.1016/S0142-9612(00)00048-X
   Malda J, 2007, TISSUE ENG, V13, P2153, DOI 10.1089/ten.2006.0417
   Mauney JR, 2004, CALCIFIED TISSUE INT, V74, P458, DOI 10.1007/s00223-003-0104-7
   MIKOS AG, 1993, BIOTECHNOL BIOENG, V42, P716, DOI 10.1002/bit.260420606
   MIKOS AG, 1993, BIOMATERIALS, V14, P323, DOI 10.1016/0142-9612(93)90049-8
   MIKOS AG, 1994, BIOMATERIALS, V15, P55, DOI 10.1016/0142-9612(94)90197-X
   MIKOS AG, 1993, J BIOMED MATER RES, V27, P183, DOI 10.1002/jbm.820270207
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   Miller M J, 1996, Tissue Eng, V2, P51, DOI 10.1089/ten.1996.2.51
   Mistry AS, 2007, J BIOMED MATER RES A, V83A, P940, DOI 10.1002/jbm.a.31280
   MISTRY AS, 2007, THESIS RICE U HOUSTO
   Mofid MM, 2002, PLAST RECONSTR SURG, V109, P1621, DOI 10.1097/00006534-200204150-00020
   Murphy MB, 2007, BIOMACROMOLECULES, V8, P2237, DOI 10.1021/bm070121s
   Oldham JB, 2000, J BIOMECH ENG-T ASME, V122, P289, DOI 10.1115/1.429662
   Oshima Y, 2005, J HISTOCHEM CYTOCHEM, V53, P207, DOI 10.1369/jhc.4A6280.2005
   Park H, 2005, BIOMATERIALS, V26, P7095, DOI 10.1016/j.biomaterials.2005.05.083
   PARK H, J BIOMED A IN PRESS
   Park H, 2007, BIOMATERIALS, V28, P3217, DOI 10.1016/j.biomaterials.2007.03.030
   Patel ZS, 2008, ACTA BIOMATER, V4, P1126, DOI 10.1016/j.actbio.2008.04.002
   Patel ZS, 2008, PHARM RES-DORDR, V25, P2370, DOI 10.1007/s11095-008-9685-1
   PATEL ZS, BONE IN PRESS
   Payne RG, 2002, BIOMATERIALS, V23, P4381, DOI 10.1016/S0142-9612(02)00186-2
   Payne RG, 2002, BIOMATERIALS, V23, P4359, DOI 10.1016/S0142-9612(02)00184-9
   Payne RG, 2002, BIOMATERIALS, V23, P4373, DOI 10.1016/S0142-9612(02)00185-0
   Peppas NA, 2004, AICHE J, V50, P536, DOI 10.1002/aic.10048
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   Peter SJ, 2000, J BIOMED MATER RES, V50, P452, DOI 10.1002/(SICI)1097-4636(20000605)50:3<452::AID-JBM20>3.3.CO;2-S
   Peter SJ, 1998, J BIOMED MATER RES, V43, P422, DOI 10.1002/(SICI)1097-4636(199824)43:4<422::AID-JBM9>3.3.CO;2-T
   Peter SJ, 2000, BIOMATERIALS, V21, P1207, DOI 10.1016/S0142-9612(99)00254-9
   Peter SJ, 1998, J BIOMED MATER RES, V41, P1
   Peter SJ, 1999, J BIOMED MATER RES, V44, P314
   Peter SJ, 1999, J BIOMAT SCI-POLYM E, V10, P363, DOI 10.1163/156856299X00423
   Peter SJ, 1997, J BIOMAT SCI-POLYM E, V8, P893, DOI 10.1163/156856297X00074
   Peter SJ, 1998, J CELL BIOCHEM, V71, P55, DOI 10.1002/(SICI)1097-4644(19981001)71:1<55::AID-JCB6>3.0.CO;2-0
   PHAM QP, 2008, J BIOMED A IN PRESS
   Pham QP, 2008, BIOMATERIALS, V29, P2729, DOI 10.1016/j.biomaterials.2008.02.025
   Pham QP, 2006, BIOMACROMOLECULES, V7, P2796, DOI 10.1021/bm060680j
   Purdue Gary F., 1997, Journal of Burn Care and Rehabilitation, V18, P52, DOI 10.1097/00004630-199701000-00009
   Ruhe PQ, 2006, TISSUE ENG, V12, P789, DOI 10.1089/ten.2006.12.789
   Ruhe PQ, 2005, J BIOMED MATER RES A, V74A, P533, DOI 10.1002/jbm.a.30341
   Ruhe PQ, 2003, J BONE JOINT SURG AM, V85A, P75
   Ruhe PQ, 2005, J CONTROL RELEASE, V106, P162, DOI 10.1016/j.jconrel.2005.04.018
   Saraf A, 2008, BIOMACROMOLECULES, V9, P818, DOI 10.1021/bm701146f
   Shi XF, 2005, NANOTECHNOLOGY, V16, pS531, DOI 10.1088/0927-4484/16/7/030
   Shi XF, 2008, J BIOMED MATER RES A, V86A, P813, DOI 10.1002/jbm.a.31671
   Shi XF, 2007, BIOMATERIALS, V28, P4078, DOI 10.1016/j.biomaterials.2007.05.033
   Shi XF, 2006, BIOMACROMOLECULES, V7, P2237, DOI 10.1021/bm060391v
   Shin H, 2005, BIOMATERIALS, V26, P3645, DOI 10.1016/j.biomaterials.2004.09.050
   Shin H, 2004, J BIOMED MATER RES A, V69A, P535, DOI 10.1002/jbm.a.30027
   Shin H, 2004, BIOMATERIALS, V25, P895, DOI 10.1016/S0142-9612(03)00602-1
   Shin H, 2003, BIOMACROMOLECULES, V4, P552, DOI 10.1021/bm020121m
   Shin H, 2003, BIOMATERIALS, V24, P3201, DOI 10.1016/S0142-9612(03)00168-6
   Shin H, 2002, J BIOMED MATER RES, V61, P169, DOI 10.1002/jbm.10193
   Shung AK, 2003, TISSUE ENG, V9, P243, DOI 10.1089/107632703764664710
   Shung AK, 2002, J BIOMAT SCI-POLYM E, V13, P95, DOI 10.1163/156856202753525963
   Sikavitsas VI, 2005, ANN BIOMED ENG, V33, P63, DOI 10.1007/s10439-005-8963-x
   Sikavitsas VI, 2003, P NATL ACAD SCI USA, V100, P14683, DOI 10.1073/pnas.2434367100
   Sikavitsas VI, 2003, J BIOMED MATER RES A, V67A, P944, DOI 10.1002/jbm.a.10126
   Sikavitsas VI, 2002, J BIOMED MATER RES, V62, P136, DOI 10.1002/jbm.10150
   Silber JS, 2003, SPINE, V28, P134, DOI 10.1097/00007632-200301150-00008
   Sitharaman B, 2008, BONE, V43, P362, DOI 10.1016/j.bone.2008.04.013
   Sitharaman B, 2007, J BIOMAT SCI-POLYM E, V18, P655, DOI 10.1163/156856207781034133
   Sitharaman B, 2007, CONTRAST MEDIA MOL I, V2, P139, DOI 10.1002/cmmi.140
   Suggs LJ, 1998, J BIOMAT SCI-POLYM E, V9, P653, DOI 10.1163/156856298X00073
   Suggs LJ, 1999, J BIOMED MATER RES, V46, P22, DOI 10.1002/(SICI)1097-4636(199907)46:1<22::AID-JBM3>3.0.CO;2-R
   Suggs LJ, 1998, J BIOMED MATER RES, V42, P312, DOI 10.1002/(SICI)1097-4636(199811)42:2<312::AID-JBM17>3.0.CO;2-K
   Suggs LJ, 1999, BIOMATERIALS, V20, P683, DOI 10.1016/S0142-9612(98)00226-9
   Suggs LJ, 1999, CELL TRANSPLANT, V8, P345, DOI 10.1177/096368979900800402
   Tanahashi K, 2003, J BIOMED MATER RES A, V67A, P1148, DOI 10.1002/jbm.a.10147
   Tanahashi K, 2003, J BIOMED MATER RES A, V67A, P448, DOI 10.1002/jbm.a.10077
   Tanahashi K, 2002, J BIOMED MATER RES, V62, P558, DOI 10.1002/jbm.10284
   Temenoff JS, 2004, BIOMACROMOLECULES, V5, P5, DOI 10.1021/bm030067p
   Temenoff JS, 2003, BIOMACROMOLECULES, V4, P1605, DOI 10.1021/bm030056w
   Temenoff JS, 2004, J BIOMED MATER RES A, V70A, P235, DOI 10.1002/jbm.a.30064
   Temenoff JS, 2003, J BIOMAT SCI-POLYM E, V14, P989, DOI 10.1163/156856203322381465
   Temenoff JS, 2002, J BIOMED MATER RES, V59, P429, DOI 10.1002/jbm.1259
   Thomson RC, 1999, BIOMATERIALS, V20, P2007, DOI 10.1016/S0142-9612(99)00103-9
   Thomson RC, 1998, BIOMATERIALS, V19, P1935, DOI 10.1016/S0142-9612(98)00097-0
   THOMSON RC, 1995, J BIOMAT SCI-POLYM E, V7, P23, DOI 10.1163/156856295X00805
   Thomson RC, 1996, BIOMATERIALS, V17, P321, DOI 10.1016/0142-9612(96)85570-0
   Timmer MD, 2003, BIOMACROMOLECULES, V4, P1026, DOI 10.1021/bm0300150
   Timmer MD, 2003, BIOMATERIALS, V24, P4707, DOI 10.1016/S0142-9612(03)00364-8
   Timmer MD, 2003, J BIOMED MATER RES A, V66A, P811, DOI 10.1002/jbm.a.10011
   Timmer MD, 2003, J BIOMAT SCI-POLYM E, V14, P369, DOI 10.1163/156856203321478874
   Timmer MD, 2002, MACROMOLECULES, V35, P4373, DOI 10.1021/ma020028q
   Timmer MD, 2003, BIOMATERIALS, V24, P571, DOI 10.1016/S0142-9612(02)00368-X
   Ueda H, 2007, J BIOMED MATER RES A, V83A, P656, DOI 10.1002/jbm.a.31226
   Vaccaro AR, 2004, SPINE, V29, P1885, DOI 10.1097/01.brs.0000137062.79201.98
   Vaccaro AR, 2005, SPINE, V30, P2709, DOI 10.1097/01.brs.0000190812.08447.ba
   van den Dolder J, 2003, TISSUE ENG, V9, P505, DOI 10.1089/107632703322066688
   van den Dolder J, 2003, J BIOMED MATER RES A, V64A, P235, DOI 10.1002/jbm.a.10365
   Vehof JWM, 2002, J BIOMED MATER RES, V60, P241, DOI 10.1002/jbm.10073
   VONRECUM HA, 1995, BIOMATERIALS, V16, P441, DOI 10.1016/0142-9612(95)98816-W
   Wake MC, 1996, CELL TRANSPLANT, V5, P465, DOI 10.1016/0963-6897(96)00025-5
   WAKE MC, 1994, CELL TRANSPLANT, V3, P339, DOI 10.1177/096368979400300411
   Wake MC, 1998, BIOMATERIALS, V19, P1255
   WAKE MC, 1995, CELL TRANSPLANT, V4, P275, DOI 10.1177/096368979500400305
   Widmer MS, 1998, BIOMATERIALS, V19, P1945, DOI 10.1016/S0142-9612(98)00099-4
   Wolfe MS, 2002, J BIOMED MATER RES, V61, P159, DOI 10.1002/jbm.10058
   Yaszemski M J, 1995, Tissue Eng, V1, P41, DOI 10.1089/ten.1995.1.41
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P2127, DOI 10.1016/0142-9612(96)00008-7
   Young S, 2005, J CONTROL RELEASE, V109, P256, DOI 10.1016/j.jconrel.2005.09.023
   YOUNG S, 2008, THESIS RICE U HOUSTO
   Young S, 2008, TISSUE ENG PT B-REV, V14, P295, DOI 10.1089/ten.teb.2008.0153
   Young S, 2008, J BIOMED MATER RES A, V86A, P182, DOI 10.1002/jbm.a.31639
   Zimmermann C E, 2001, Clin Oral Investig, V5, P214
NR 210
TC 72
Z9 74
U1 4
U2 86
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0001-1541
EI 1547-5905
J9 AICHE J
JI AICHE J.
PD DEC
PY 2008
VL 54
IS 12
BP 3048
EP 3067
DI 10.1002/aic.11610
PG 20
WC Engineering, Chemical
SC Engineering
GA 375ZX
UT WOS:000261153400002
PM 19756176
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Uygur, F
   Ulkur, E
   Pehlivan, O
   Celikoz, B
AF Uygur, Fatih
   Ulkur, Ersin
   Pehlivan, Oezcan
   Celikoz, Bahattin
TI Soft tissue necrosis following using calcium phosphate cement in
   calcaneal bone cyst: case report
SO ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY
LA English
DT Article
DE Calcium phosphate cements; Soft tissue necrosis; Calcenous bone cyst
ID HYDROXYAPATITE CEMENT; IN-VIVO; CERAMICS; MONOXIDE; GRAFT;
   RECONSTRUCTION; AUGMENTATION; SUBSTITUTES; DEFECTS; MARROW
AB Calcium phosphate cements have received widespread attention for their possible role as bone-grafting material and bone fillers in skeletal defects. They were evaluated as a biomaterial in many aspects. No serious harmful effects such as foreign body reaction and tissue necrosis against to calcium phosphate cements have been reported yet. They were accepted as highly biocompatible materials. In this paper, we represent a patient who had soft tissue necrosis around lateral malleolar region, following using percutaneous calcium phosphate cement as a filler bone substitute in calcenous bone cyst. The possible mechanisms were discussed.
C1 [Uygur, Fatih] Haydarpasha Training Hosp, Gulhane Mil Med Acad, Dept Plast & Reconstruct Surg, TR-34668 Istanbul, Turkey.
   Haydarpasha Training Hosp, Gulhane Mil Med Acad, Burn Unit, Istanbul, Turkey.
   Haydarpasha Training Hosp, Fac Med, Istanbul, Turkey.
   [Pehlivan, Oezcan] Haydarpasha Training Hosp, Gulhane Mil Med Acad, Dept Orthoped & Traumatol, Istanbul, Turkey.
   [Pehlivan, Oezcan] Haydarpasha Training Hosp, Fac Med, Istanbul, Turkey.
RP Uygur, F (reprint author), Haydarpasha Training Hosp, Gulhane Mil Med Acad, Dept Plast & Reconstruct Surg, Selimiye Mahallesi Tibbiye, TR-34668 Istanbul, Turkey.
EM fatihuygur@hotmail.com
CR Baker SB, 2002, PLAST RECONSTR SURG, V109, P1789, DOI 10.1097/00006534-200205000-00003
   Bloemers FW, 2003, J BIOMED MATER RES B, V66B, P526, DOI 10.1002/jbm.b.10045
   CHAIN M, 1997, THESIS U ALABAMA BIR
   CHIGIRA M, 1983, J BONE JOINT SURG BR, V65, P633
   Csizy M, 2001, FOOT ANKLE INT, V22, P507, DOI 10.1177/107110070102200610
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   DEGROOT K, 1983, BIOCERAMICS CALCIUM, P99
   dos Santos LA, 2002, BIOMATERIALS, V23, P2035, DOI 10.1016/S0142-9612(01)00333-7
   FARBER JM, 1990, ORTHOPEDICS, V13, P25
   Friedman CD, 1998, J BIOMED MATER RES, V43, P428, DOI 10.1002/(SICI)1097-4636(199824)43:4<428::AID-JBM10>3.0.CO;2-0
   FUKASE Y, 1990, J DENT RES, V69, P1852, DOI 10.1177/00220345900690121201
   Geurtsen W, 2001, Aust Endod J, V27, P12
   Ginebra MP, 1997, J DENT RES, V76, P905, DOI 10.1177/00220345970760041201
   HIRANO M, 1998, JPN PHARMACOL THER, V26, P189
   HOLLINGER JO, 1986, CLIN ORTHOP RELAT R, P290
   Hollinger JO, 1996, CLIN ORTHOP RELAT R, P55
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   Jackson IT, 2000, BRIT J PLAST SURG, V53, P24, DOI 10.1054/bjps.1999.3236
   Jaffe HL, 1942, ARCH SURG-CHICAGO, V44, P1004, DOI 10.1001/archsurg.1942.01210240043003
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   Killian JT, 1998, J PEDIATR ORTHOPED, V18, P621, DOI 10.1097/00004694-199809000-00013
   Knaack D, 1998, J BIOMED MATER RES, V43, P399, DOI 10.1002/(SICI)1097-4636(199824)43:4<399::AID-JBM7>3.3.CO;2-A
   KURASHINA K, 1995, J MATER SCI-MATER M, V6, P340, DOI 10.1007/BF00120302
   Kurashina K, 1997, BIOMATERIALS, V18, P147, DOI 10.1016/S0142-9612(96)00173-1
   Kurashina K, 1997, BIOMATERIALS, V18, P539, DOI 10.1016/S0142-9612(96)00162-7
   LEGEROS RZ, 1996, BIOCERAMICS, V9, P7
   Liu CS, 1997, J BIOMED MATER RES, V35, P75, DOI 10.1002/(SICI)1097-4636(199704)35:1<75::AID-JBM7>3.0.CO;2-J
   MIRTCHI AA, 1990, BIOMATERIALS, V11, P83, DOI 10.1016/0142-9612(90)90121-6
   MIRTCHI AA, 1989, BIOMATERIALS, V10, P634, DOI 10.1016/0142-9612(89)90120-8
   Noetzel Jorn, 2005, Schweiz Monatsschr Zahnmed, V115, P1148
   Okada E, 2004, J CRANIOFAC SURG, V15, P102, DOI 10.1097/00001665-200401000-00028
   OSBORN JF, 1991, BIOMATERIALS DEGRADA, P185
   Pioletti DP, 2000, BIOMATERIALS, V21, P1103, DOI 10.1016/S0142-9612(99)00250-1
   Rougraff BT, 2002, J BONE JOINT SURG AM, V84A, P921, DOI 10.2106/00004623-200206000-00005
   SALYER KE, 1989, PLAST RECONSTR SURG, V84, P236, DOI 10.1097/00006534-198908000-00008
   Schildhauer TA, 2000, J ORTHOP TRAUMA, V14, P309, DOI 10.1097/00005131-200006000-00001
   STJOHN KR, 1995, J APPL BIOMATER, V6, P89
   Sugawara A, 1992, Dent Mater J, V11, P11
   Turk J B, 2000, Facial Plast Surg, V16, P7, DOI 10.1055/s-2000-7321
   Verheggen R, 2001, ACTA NEUROCHIR, V143, P919, DOI 10.1007/s007010170022
   Wilkins R M, 2000, J Am Acad Orthop Surg, V8, P217
   Yandow SM, 1998, J PEDIATR ORTHOPED, V18, P616, DOI 10.1097/00004694-199809000-00012
   Yuan HP, 2000, BIOMATERIALS, V21, P1283, DOI 10.1016/S0142-9612(00)00016-8
NR 43
TC 5
Z9 6
U1 0
U2 5
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0936-8051
J9 ARCH ORTHOP TRAUM SU
JI Arch. Orthop. Trauma Surg.
PD DEC
PY 2008
VL 128
IS 12
BP 1397
EP 1401
DI 10.1007/s00402-007-0534-1
PG 5
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 367AE
UT WOS:000260524100009
PM 18058113
DA 2018-10-19
ER

PT J
AU Maus, U
   Andereya, S
   Gravius, S
   Siebert, CH
   Ohnsorge, JAK
   Niedhart, C
AF Maus, Uwe
   Andereya, Stefan
   Gravius, Sascha
   Siebert, Christian H.
   Ohnsorge, Joerg A. K.
   Niedhart, Christopher
TI Lack of effect on bone healing of injectable BMP-2 augmented hyaluronic
   acid
SO ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY
LA English
DT Article
DE Hyaluronic acid; Osteogenesis; BMP-2; Biomaterial; Bone substitute
ID MORPHOGENETIC PROTEIN-2; POLYMER SCAFFOLD; IN-VITRO; CELLS; STIMULATION;
   SUBSTITUTE; DEFECTS; MODEL; SHEEP
AB Introduction Autologous bone graft is the gold standard for the filling of large osseous defects. Because of its limited supply and complications such as pain, bleeding or infection, the development of alternative bone substitutes has been the subject of several studies. In clinical practice, the most commonly used bone substitutes are calcium phosphates like hydroxyapatite or tricalcium phosphate. With the aim to improve the osseointegration of these materials, growth factors such as bone morphogenetic protein-2 (BMP-2) have been added. Preferably, an injectable bone substitute should be made available. Hyaluronic acid is a component of the extracellular matrix of many tissues, including bone. We examined the bone regenerative effect of commercially available, injectable hyaluronic acid (Hyalart(R)) with and without addition of bone morphogenetic protein-2 (BMP-2).
   Materials and methods Trepanation defects of 9.4 mm diameter in the intercondylar groove of sheep femora were filled with pure and augmented (200 mu g BMP-2) hyaluronic acid. As controls, empty defects and defects treated with autologous bone graft harvested from the contralateral side were used. After 3 months, the defects were analysed by fluorescence microscopy after intravital fluorescence staining, contact microradiography, histology and histomorphometry.
   Results Treatment of the defects with loaded and unloaded hyaluronic acid resulted in a significant lack of bone formation inside the defects. Untreated defects showed an amount of 5.1% newly formed bone, and defects treated with autologous bone graft revealed a bone content of 20%. The difference between both groups was statistically significant (P < 0.05). Furthermore, there was neither a remarkable effect in the periphery of the defects nor ectopic bone formation.
   Conclusion The application of the used injectable hyaluronic acid (Hyalart(R)) with and without BMP-2 is not advantageous as sole bone substitute for the filling of osseous defects.
C1 [Maus, Uwe; Andereya, Stefan; Gravius, Sascha; Ohnsorge, Joerg A. K.; Niedhart, Christopher] Rhein Westfal TH Aachen, Univ Hosp, Dept Orthopaed Surg, D-52074 Aachen, Germany.
   [Siebert, Christian H.] Annastift eV, Orthopaed Clin 1, D-30625 Hannover, Germany.
RP Maus, U (reprint author), Rhein Westfal TH Aachen, Univ Hosp, Dept Orthopaed Surg, Pauwelsstr 30, D-52074 Aachen, Germany.
EM umaus@ukaachen.de
CR Aebli N, 2005, J BIOMED MATER RES A, V73A, P295, DOI 10.1002/jbm.a.30299
   Arosarena O, 2005, Orthod Craniofac Res, V8, P267, DOI 10.1111/j.1601-6343.2005.00349.x
   Aslan M, 2006, J BIOMATER APPL, V20, P209, DOI 10.1177/0885328206051047
   BALAZS EA, 1989, CIBA F SYMP, V143, P265
   Cao JJ, 2005, J BONE MINER RES, V20, P30, DOI 10.1359/JBMR.041014
   Entwistle J, 1996, J CELL BIOCHEM, V61, P569, DOI 10.1002/(SICI)1097-4644(19960616)61:4<569::AID-JCB10>3.0.CO;2-B
   FEINBERG RN, 1983, SCIENCE, V220, P1177, DOI 10.1126/science.6857242
   FRASER JRE, 1989, CHIBA FDN S, V143, P41
   Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4
   Hunt DR, 2001, J PERIODONTOL, V72, P651, DOI 10.1902/jop.2001.72.5.651
   KIKUCHI T, 1993, 18 IL C RHEUM BARC J
   Kim HD, 2002, J BIOMED MATER RES, V59, P573, DOI 10.1002/jbm.10011
   Kim J, 2007, BIOMATERIALS, V28, P1830, DOI 10.1016/j.biomaterials.2006.11.050
   LAURENT TC, 1995, ANN RHEUM DIS, V54, P429, DOI 10.1136/ard.54.5.429
   Lisignoli G, 2002, BIOMATERIALS, V23, P1043, DOI 10.1016/S0142-9612(01)00216-2
   Lisignoli G, 2001, BIOMATERIALS, V22, P2095, DOI 10.1016/S0142-9612(00)00398-7
   Niedhart C, 2004, J BIOMED MATER RES B, V71B, P123, DOI 10.1002/jbm.b.30071
   Niedhart C, 2003, J BIOMED MATER RES A, V65A, P17, DOI 10.1002/jbm.a.10362
   OAKES DA, 2003, CLIN ORTHOP RELAT R, V413, P281
   Ohyama T, 2004, NEUROL MED-CHIR, V44, P234, DOI 10.2176/nmc.44.234
   PILLONI A, 1992, Journal of Dental Research, V71, P574
   Radomsky ML, 1999, J ORTHOPAED RES, V17, P607, DOI 10.1002/jor.1100170422
   Ruppert R, 1996, EUR J BIOCHEM, V237, P295, DOI 10.1111/j.1432-1033.1996.0295n.x
   SASAKI T, 1995, BONE, V16, P9, DOI 10.1016/S8756-3282(94)00001-8
   Solchaga LA, 1999, J ORTHOPAED RES, V17, P205, DOI 10.1002/jor.1100170209
   TOOLE BP, 1971, DEV BIOL, V26, P28, DOI 10.1016/0012-1606(71)90104-7
   Wiedmann-Al-Ahmad M, 2005, J MATER SCI-MATER M, V16, P57, DOI 10.1007/s10856-005-6447-z
NR 27
TC 19
Z9 22
U1 0
U2 7
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0936-8051
EI 1434-3916
J9 ARCH ORTHOP TRAUM SU
JI Arch. Orthop. Trauma Surg.
PD DEC
PY 2008
VL 128
IS 12
BP 1461
EP 1466
DI 10.1007/s00402-008-0608-8
PG 6
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 367AE
UT WOS:000260524100020
PM 18330583
DA 2018-10-19
ER

PT J
AU Sezer, AD
   Cevher, E
   Hatipoglu, F
   Ogurtan, Z
   Bas, AL
   Akbuga, J
AF Sezer, Ali Demir
   Cevher, Erdal
   Hatipoglu, Fatih
   Ogurtan, Zeki
   Bas, Ahmet Levent
   Akbuga, Juelide
TI Preparation of Fucoidan-Chitosan Hydrogel and Its Application as Burn
   Healing Accelerator on Rabbits
SO BIOLOGICAL & PHARMACEUTICAL BULLETIN
LA English
DT Article
DE fucoidan chitosan; burn healing; hydrogel; bioadhesion; texture analyzer
ID MUCOADHESIVE PROPERTIES; FUCUS-VESICULOSUS; DRUG DELIVERY; DERMAL BURN;
   FORMULATIONS; PH; POLYSACCHARIDES; IRRADIATION; MODULATION; POLYMERS
AB Treatment of dermal wounds with macromolecular agents such as natural polymers is one of the research areas of the biomaterial science. Fucoidan is a sulphated polysaccharide which is commonly obtained from seaweeds. The great number of studies on the different pharmacological properties of fucoidan is present, but there is limited information about using of fucoidan in the treatment of dermal burns. The aim of this study was to prepare fucoidan-chitosan hydrogels and to investigate their treatment efficiency on dermal burns. Hydrogels were prepared by swelling the polymers in acidic solution and their swelling, mechanical (hardness, cohesiveness and adhesiveness) and bioadhesive properties were investigated. The viscosity and water absorption capacity of formulations increased with increase in the polymer concentration. In contrast to the cohesiveness results, the adhesiveness of hydrogels increased with the polymer concentration. The bioadhesion was changed between 0.012-0.142 mJ.cm(-2) and enhanced with addition of fucoidan into gel formulations. It was formed dermal burns on seven adult male New Zealand white rabbits and the optimum gel formulation applied on the wounds. Control and treatment group biopsy samples were taken on days 7, 14 and 21 and each burn wound site was evaluated histopathollogically. No edema was seen in tested groups except control after 3 d treatment. After 7 of treatment, fibroplasia and scar were fixed on wounds treated with fucoidan-chitosan gel and fucoidan solution. The best regeneration on dermal papillary formation and the fastest closure of the wounds were observed in fucoidan-chitosan hydrogels after 14 d treatment.
C1 [Sezer, Ali Demir; Akbuga, Juelide] Marmara Univ, Fac Pharm, Dept Pharmaceut Biotechnol, TR-34668 Istanbul, Turkey.
   [Cevher, Erdal] Istanbul Univ, Fac Pharm, Dept Pharmaceut Technol, TR-34116 Istanbul, Turkey.
   [Hatipoglu, Fatih] Selcuk Univ, Fac Vet, Dept Pathol, Konya, Turkey.
   [Ogurtan, Zeki] Selcuk Univ, Fac Vet, Dept Surg, Konya, Turkey.
   [Bas, Ahmet Levent] Selcuk Univ, Fac Vet, Dept Pharmacol, TR-42075 Konya, Turkey.
RP Sezer, AD (reprint author), Marmara Univ, Fac Pharm, Dept Pharmaceut Biotechnol, TR-34668 Istanbul, Turkey.
EM adsezer@marmara.edu.tr
RI Hatipoglu, Fatih/M-8076-2014
FU Commission of Marmara University Scientific Research Project
   [SAG-060/131102]
FX This study was supported by Commission of Marmara University Scientific
   Research Project (BAPKO, SAG-060/131102).
CR Atiyeh BS, 2005, BURNS, V31, P944, DOI 10.1016/j.burns.2005.08.023
   Berger J, 2004, EUR J PHARM BIOPHARM, V57, P35, DOI 10.1016/s0939-6411(03)00160-7
   Boucard N, 2007, BIOMATERIALS, V28, P3478, DOI 10.1016/j.biomaterials.2007.04.021
   Cevher E, 2008, DRUG DELIV, V15, P57, DOI [10.1080/10717540701829234, 10.1080/10717540701829234 ]
   DESHPANDE AA, 1992, DRUG DEV IND PHARM, V18, P1225, DOI 10.3109/03639049209046329
   El-Sherbiny IM, 2005, EUR POLYM J, V41, P2584, DOI 10.1016/j.eurpolymj.2005.05.035
   Fujimura T, 2000, BIOL PHARM BULL, V23, P1180
   Gerentes P, 2002, BIOMATERIALS, V23, P1295, DOI 10.1016/S0142-9612(01)00247-2
   Ishihara M, 2002, BIOMATERIALS, V23, P833, DOI 10.1016/S0142-9612(01)00189-2
   Jones DS, 1997, INT J PHARM, V151, P223, DOI 10.1016/S0378-5173(97)04904-1
   Jones DS, 1999, J PHARM SCI, V88, P592, DOI 10.1021/js9803095
   Jurjus A, 2007, BURNS, V33, P892, DOI 10.1016/j.burns.2006.10.406
   Kellouche S, 2007, BIOCHEM BIOPH RES CO, V363, P472, DOI 10.1016/j.bbrc.2007.08.155
   KIYOZUMI T, 2006, J BIOMED MATER RES B, V79, P126
   Kiyozumi T, 2007, BURNS, V33, P642, DOI 10.1016/j.burns.2006.09.010
   Knabl JS, 1999, BURNS, V25, P715, DOI 10.1016/S0305-4179(99)00086-8
   Kondo Toshikazu, 2007, Legal Medicine, V9, P109, DOI 10.1016/j.legalmed.2006.11.009
   Leary RO, 2004, BIOL PHARM BULL, V27, P266
   Leung MYK, 2006, IMMUNOL LETT, V105, P101, DOI 10.1016/j.imlet.2006.01.009
   Li J, 2007, CLIN DERMATOL, V25, P9, DOI 10.1016/j.clindermatol.2006.09.007
   Martineau L, 2006, BURNS, V32, P70, DOI 10.1016/j.burns.2005.08.009
   Noble L, 1999, INT J PHARM, V192, P173, DOI 10.1016/S0378-5173(99)00306-3
   PATANKAR MS, 1993, J BIOL CHEM, V268, P21770
   Peng P, 2007, BIOINTERPHASES, V2, P95, DOI 10.1116/1.2751126
   Pereira MS, 1999, J BIOL CHEM, V274, P7656, DOI 10.1074/jbc.274.12.7656
   QUINN KJ, 1985, BIOMATERIALS, V6, P369, DOI 10.1016/0142-9612(85)90095-X
   RICHARDSON JL, 1992, ADV DRUG DELIVER REV, V8, P341, DOI 10.1016/0169-409X(92)90008-E
   Risbud M, 2000, J BIOSCIENCES, V25, P25, DOI 10.1007/BF02985178
   Ruperez P, 2002, J AGR FOOD CHEM, V50, P840, DOI 10.1021/jf010908o
   Sezer AD, 2008, EUR J PHARM BIOPHARM, V69, P189, DOI 10.1016/j.ejpb.2007.09.004
   SEZER AD, 2005, 12 EUR C BIOT COP DE, P77
   Sezer AD, 2007, AAPS PHARMSCITECH, V8, DOI 10.1208/pt0802039
   Shakespeare P, 2001, BURNS, V27, P517, DOI 10.1016/S0305-4179(01)00017-1
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Tacheau C, 2007, EUR J PHARMACOL, V573, P65, DOI 10.1016/j.ejphar.2007.07.030
   TAN YTF, 2000, AAPS PHARMSCITECH, V1, P1
   Trere D, 2000, MICRON, V31, P127, DOI 10.1016/S0968-4328(99)00069-4
   Ueno H, 2001, ADV DRUG DELIVER REV, V52, P105, DOI 10.1016/S0169-409X(01)00189-2
   Varshney L, 2007, NUCL INSTRUM METH B, V255, P343, DOI 10.1016/j.nimb.2006.11.101
   Vogt PM, 2006, BURNS, V32, P698, DOI 10.1016/j.burns.2006.01.007
   Whitney JD, 2003, J WOUND OSTOMY CONT, V30, P199
   Wong CF, 1999, INT J PHARM, V180, P47, DOI 10.1016/S0378-5173(98)00402-5
   Xie YJ, 2007, CARBOHYD POLYM, V69, P142, DOI 10.1016/j.carbpol.2006.09.010
   Zhao L, 2006, CARBOHYD POLYM, V64, P473, DOI 10.1016/j.carbpol.2005.12.014
   Zhao L, 2008, J BIOACT COMPAT POL, V23, P319, DOI 10.1177/0883911508092302
NR 45
TC 61
Z9 64
U1 3
U2 44
PU PHARMACEUTICAL SOC JAPAN
PI TOKYO
PA 2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN
SN 0918-6158
J9 BIOL PHARM BULL
JI Biol. Pharm. Bull.
PD DEC
PY 2008
VL 31
IS 12
BP 2326
EP 2333
DI 10.1248/bpb.31.2326
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 376SZ
UT WOS:000261204600027
PM 19043221
OA Bronze
DA 2018-10-19
ER

PT J
AU Ghasemi-Mobarakeh, L
   Prabhakaran, MP
   Morshed, M
   Nasr-Esfahani, MH
   Ramakrishna, S
AF Ghasemi-Mobarakeh, Laleh
   Prabhakaran, Molamma P.
   Morshed, Mohammad
   Nasr-Esfahani, Mohammad-Hossein
   Ramakrishna, Seeram
TI Electrospun poly(epsilon-caprolactone)/gelatin nanofibrous scaffolds for
   nerve tissue engineering
SO BIOMATERIALS
LA English
DT Article
DE Nerve tissue engineering; Electrospinning; Nanofiber; PCL; Gelatin
ID CONTROLLED FIBER ORIENTATION; FIBROUS SCAFFOLDS; STEM-CELLS; GELATIN;
   PROLIFERATION; REGENERATION; FABRICATION; STRATEGIES; MEMBRANES;
   GUIDANCE
AB Nerve tissue engineering is one of the most promising methods to restore nerve systems in human health care. Scaffold design has pivotal role in nerve tissue engineering. Polymer blending is one of the most effective methods for providing new, desirable biocomposites for tissue-engineering applications. Random and aligned PCL/gelatin biocomposite scaffolds were fabricated by varying the ratios of PCL and gelatin concentrations. Chemical and mechanical properties of PCL/gelatin nanofibrous scaffolds were measured by FFIR, porometry, contact angle and tensile measurements, while the in vitro biodegradability of the different nanofibrous scaffolds were evaluated too. PCL/gelatin 70:30 nanofiber was found to exhibit the most balanced properties to meet all the required specifications for nerve tissue and was used for in vitro culture of nerve stem cells (C17.2 cells). MTS assay and SEM results showed that the biocomposite of PCL/gelatin 70:30 nanofibrous scaffolds enhanced the nerve differentiation and proliferation compared to PCL nanofibrous scaffolds and acted as a positive cue to support neurite outgrowth. It was found that the direction of nerve cell elongation and neurite outgrowth on aligned nanofibrous scaffolds is parallel to the direction of fibers. PCL/gelatin 70:30 nanofibrous scaffolds proved to be a promising biomaterial suitable for nerve regeneration.
C1 [Ghasemi-Mobarakeh, Laleh; Prabhakaran, Molamma P.; Ramakrishna, Seeram] Natl Univ Singapore, NUS Nanosci & Nanotechnol Initiat, Singapore 117576, Singapore.
   [Ghasemi-Mobarakeh, Laleh] Islamic Azad Univ, Najafabad Branch, Esfahan, Iran.
   [Ghasemi-Mobarakeh, Laleh; Morshed, Mohammad] Isfahan Univ Technol, Dept Text Engn, Esfahan, Iran.
   [Ghasemi-Mobarakeh, Laleh; Nasr-Esfahani, Mohammad-Hossein] ACECR, Royan Inst, Dept Cell Sci Res Ctr, Tehran, Iran.
RP Ramakrishna, S (reprint author), Natl Univ Singapore, NUS Nanosci & Nanotechnol Initiat, 9 Engn Dr 1, Singapore 117576, Singapore.
EM seeram@nus.edu.sg
RI Prabhakaran, Molamma/M-8630-2013
FU National Medical Research Council [NMRC/1015/2005, R397000625213]
FX We would like to express our thanks to National Medical Research Council
   (grant number: NMRC/1015/2005, R397000625213), Singapore for their
   financial support.
CR ASHAMMAKHI N, 2008, EUROPEAN J PLASTIC S
   BELLAMKONDA R, 1994, BIOTECHNOL BIOENG, V43, P543, DOI 10.1002/bit.260430703
   Bini TB, 2006, J MATER SCI, V41, P6453, DOI 10.1007/s10853-006-0714-3
   BORDENAVE L, 1989, BIOMATERIALS, V10, P235, DOI 10.1016/0142-9612(89)90099-9
   Catledge SA, 2007, BIOMED MATER, V2, P142, DOI 10.1088/1748-6041/2/2/013
   Cheng MY, 2003, BIOMATERIALS, V24, P2871, DOI 10.1016/S0142-9612(03)00117-0
   Chong EJ, 2007, ACTA BIOMATER, V3, P321, DOI 10.1016/j.actbio.2007.01.002
   Ciardelli G, 2005, BIOMACROMOLECULES, V6, P1961, DOI 10.1021/bm0500805
   Ciardelli G, 2006, MACROMOL BIOSCI, V6, P13, DOI 10.1002/mabi.200500151
   Huang ZM, 2004, POLYMER, V45, P5361, DOI 10.1016/j.polymer.2004.04.005
   Ki CS, 2005, POLYMER, V46, P5094, DOI 10.1016/j.polymer.2005.04.040
   Kim CH, 2006, J BIOMED MATER RES B, V78B, P283, DOI 10.1002/jbm.b.30484
   Koh HS, 2008, BIOMATERIALS, V29, P3574, DOI 10.1016/j.biomaterials.2008.05.014
   Lackie JM, 2007, DICT CELL MOL BIOL
   Lee CH, 2005, BIOMATERIALS, V26, P1261, DOI 10.1016/j.biomaterials.2004.04.037
   Li DP, 2006, J MEMBRANE SCI, V286, P104, DOI 10.1016/j.memsci.2006.09.020
   Li M, 2006, J BIOMED MATER RES A, V79A, P963, DOI 10.1002/jbm.a.30833
   Li WJ, 2006, ACTA BIOMATER, V2, P377, DOI 10.1016/j.actbio.2006.02.005
   Ma PX, 2004, MATER TODAY, V7, P30, DOI 10.1016/S1369-7021(04)00233-0
   Ma ZW, 2005, TISSUE ENG, V11, P1149, DOI 10.1089/ten.2005.11.1149
   Ma ZW, 2002, J BIOMED MATER RES, V63, P838, DOI 10.1002/jbm.10470
   Ma ZW, 2005, TISSUE ENG, V11, P101, DOI 10.1089/ten.2005.11.101
   Murugan R, 2007, TISSUE ENG, V13, P1845, DOI 10.1089/ten.2006.0078
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Schnell E, 2007, BIOMATERIALS, V28, P3012, DOI 10.1016/j.biomaterials.2007.03.009
   Smith LA, 2004, COLLOID SURFACE B, V39, P125, DOI [10.1016/j.colsurfb.2003.12.004, 10.1016/j.colsurfb.2003.l2.004]
   Takahashi Y, 2005, BIOMATERIALS, V26, P3587, DOI 10.1016/j.biomaterials.2004.09.046
   Teo WE, 2005, NANOTECHNOLOGY, V16, P918, DOI 10.1088/0957-4484/16/6/049
   WAROCQUIERCLEROUT R, 1990, CYTOTECHNOLOGY, V3, P259, DOI 10.1007/BF00365490
   Xu CY, 2004, BIOMATERIALS, V25, P877, DOI 10.1016/S0142-9612(03)00593-3
   Yang F, 2004, J BIOMAT SCI-POLYM E, V15, P1483, DOI 10.1163/1568562042459733
   Yang F, 2004, BIOMATERIALS, V25, P1891, DOI 10.1016/j.biomaterials.2003.08.062
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Yarin AL, 2001, J APPL PHYS, V90, P4836, DOI 10.1063/1.1408260
   Zeng J, 2003, J APPL POLYM SCI, V89, P1085, DOI 10.1002/app.12260
   Zhang N, 2005, BRAIN RES REV, V49, P48, DOI 10.1016/j.brainresrev.2004.11.002
   Zhang YZ, 2005, J BIOMED MATER RES B, V72B, P156, DOI 10.1002/jbm.b.30128
   Zong XH, 2002, POLYMER, V43, P4403, DOI 10.1016/S0032-3861(02)00275-6
NR 39
TC 557
Z9 577
U1 33
U2 371
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2008
VL 29
IS 34
BP 4532
EP 4539
DI 10.1016/j.biomaterials.2008.08.007
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 368KH
UT WOS:000260619500007
PM 18757094
DA 2018-10-19
ER

PT J
AU Linsmeier, CE
   Wallman, L
   Faxius, L
   Schouenborg, J
   Bjursten, LM
   Danielsen, N
AF Linsmeier, Cecilia E.
   Wallman, Lars
   Faxius, Linda
   Schouenborg, Jens
   Bjursten, Lars M.
   Danielsen, Nils
TI Soft tissue reactions evoked by implanted gallium phosphide
SO BIOMATERIALS
LA English
DT Article
DE GaP; Foreign-body response; In vivo test; Soft tissue;
   Immunohistochemistry; Nanowires
ID INTRACORTICAL ELECTRODE ARRAY; SILICON MICROELECTRODE ARRAYS;
   BRAIN-TISSUE; TITANIUM IMPLANTS; RAT; CAPABILITY; NANOWIRES; SUBSTRATE;
   ALUMINUM; NEURONS
AB Neural devices may play an important role in the diagnosis and therapy of several clinical conditions, such as stroke, trauma or neurodegenerative disorders, by facilitating motor and pain control. Such interfaces, chronically implanted in the CNS, need to be biocompatible and have the ability to stimulate and record nerve signals. However, neural devices of today are not fully optimized. Nanostructured surfaces may improve electrical properties and lower evoked tissue responses. Vertical gallium phosphide (GaP) nanowires epitaxially grown from a GaP surface is one way of creating nanostructured electrodes. Thus, we chose to study the soft tissue reactions evoked by GaP surfaces. GaP and the control material titanium (Ti) were implanted in the rat abdominal wall for evaluation of tissue reactions after 1, 6, or 12 weeks. The foreign-body response was evaluated by measuring the reactive capsule thickness and by quantification of ED1-positive macrophages and total cells in the capsule. Furthermore, the concentration of Ga was measured in blood, brain, liver and kidneys. Statistically significant differences were noticed between GaP and Ti at 12 weeks for total and ED1-positive cell densities in the capsule. The chemical analysis showed that the concentration of Ga in brain, liver and kidneys increased during 12 weeks of implantation, indicating loss of Ga from the implant. Taken together, our results show that the biocompatible properties of GaP are worse than those of the well-documented biomaterial Ti. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Linsmeier, Cecilia E.; Wallman, Lars; Schouenborg, Jens; Danielsen, Nils] Lund Univ, Neuronano Res Ctr, SE-22184 Lund, Sweden.
   [Faxius, Linda; Bjursten, Lars M.] Lund Univ, Dept Clin Sci, SE-20502 Malmo, Sweden.
   [Wallman, Lars] Lund Univ, Dept Elect Measurements, SE-22100 Lund, Sweden.
RP Linsmeier, CE (reprint author), Lund Univ, Neuronano Res Ctr, BMC F10, SE-22184 Lund, Sweden.
EM cecilia.eriksson_linsmeier@med.lu.se
RI Eriksson LInsmeier, Cecilia/N-2212-2015
OI Schouenborg, Jens/0000-0002-2815-6918
FU The Royal Physiographic Society in Lund; The Knut and Alice Wallenberg
   Foundation [KAW 2004-0119]; Swedish Research Council [600012701]
FX This project was sponsored by The Royal Physiographic Society in Lund,
   The Knut and Alice Wallenberg Foundation (project number: KAW
   2004-0119), and a Linne grant (project number: 600012701) from the
   Swedish Research Council.
CR ALLEN DD, 1992, J NEUROCHEM, V58, P903, DOI 10.1111/j.1471-4159.1992.tb09342.x
   Biran R, 2005, EXP NEUROL, V195, P115, DOI 10.1016/j.expneurol.2005.04.020
   Biran R, 2007, J BIOMED MATER RES A, V82A, P169, DOI 10.1002/jbm.a.31138
   Hallstrom W, 2007, NANO LETT, V7, P2960, DOI 10.1021/nl070728e
   Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970
   HOLGERS KM, 1995, BIOMATERIALS, V16, P83, DOI 10.1016/0142-9612(95)98267-I
   Kim JR, 2004, NANOTECHNOLOGY, V15, P1397, DOI 10.1088/0957-4484/15/11/002
   KIPKE DR, 2004, P IEEE ENG MED BIOL, V7, P5344
   Maynard EM, 1997, ELECTROEN CLIN NEURO, V102, P228, DOI 10.1016/S0013-4694(96)95176-0
   Nicolelis MAL, 2003, P NATL ACAD SCI USA, V100, P11041, DOI 10.1073/pnas.1934665100
   Otto KJ, 2005, J NEURAL ENG, V2, P42, DOI 10.1088/1741-2560/2/2/005
   Otto KJ, 2005, HEARING RES, V210, P112, DOI 10.1016/j.heares.2005.08.004
   Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015
   REMES A, 1992, BIOMATERIALS, V13, P731, DOI 10.1016/0142-9612(92)90010-L
   Rosengren A, 1997, BIOMATERIALS, V18, P979, DOI 10.1016/S0142-9612(97)00012-4
   Rosengren A, 1996, BIOMATERIALS, V17, P1779, DOI 10.1016/0142-9612(95)00358-4
   Rosengren A, 2002, IEEE T BIO-MED ENG, V49, P392, DOI 10.1109/10.991167
   Rosengren A, 1998, J MATER SCI-MATER M, V9, P415, DOI 10.1023/A:1013239731256
   Rousche PJ, 1998, J NEUROSCI METH, V82, P1, DOI 10.1016/S0165-0270(98)00031-4
   Rousche PJ, 2001, IEEE T BIO-MED ENG, V48, P361, DOI 10.1109/10.914800
   Siegel S., 1956, NONPARAMETRIC STAT B
   Silva GA, 2006, NAT REV NEUROSCI, V7, P65, DOI 10.1038/nrn1827
   SONG YK, 2007, P IEEE ENG MED BIOL, V1, P445
   Tanaka A, 2004, TOXICOL APPL PHARM, V198, P405, DOI 10.1016/j.taap.2003.10.019
   THOMSEN P, 1986, SCAND J PLAST RECONS, V20, P173, DOI 10.3109/02844318609006316
   Westby GWM, 1997, J NEUROSCI METH, V76, P123, DOI 10.1016/S0165-0270(97)00088-5
   WISE KD, 1991, SCIENCE, V254, P1335, DOI 10.1126/science.1962192
   Young TH, 2006, BIOMATERIALS, V27, P3361, DOI 10.1016/j.biomaterials.2006.02.001
NR 28
TC 25
Z9 27
U1 0
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2008
VL 29
IS 35
BP 4598
EP 4604
DI 10.1016/j.biomaterials.2008.08.028
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 386EF
UT WOS:000261864400004
PM 18801568
DA 2018-10-19
ER

PT J
AU Zhang, X
   Zheng, ZZ
   Liu, P
   Ma, Y
   Lin, L
   Lang, N
   Fu, X
   Zhang, JY
   Ma, KT
   Chen, P
   Zhou, CY
   Ao, YF
AF Zhang, Xin
   Zheng, Zhuozhao
   Liu, Ping
   Ma, Yong
   Lin, Lin
   Lang, Ning
   Fu, Xin
   Zhang, Jiying
   Ma, Kangtao
   Chen, Ping
   Zhou, Chunyan
   Ao, Yingfang
TI The synergistic effects of microfracture, perforated decalcified
   cortical bone matrix and adenovirus-bone morphogenetic protein-4 in
   cartilage defect repair
SO BIOMATERIALS
LA English
DT Article
DE Articular cartilage; Decalcified cortical bone matrix (DCBM); Bone
   morphogenetic protein-4 (BMP4)
ID FULL-THICKNESS DEFECTS; STEM-CELL NICHE; ARTICULAR-CARTILAGE;
   CHONDROGENIC DIFFERENTIATION; IN-VITRO; REGENERATION; VIVO;
   HYDROXYAPATITE; ALGINATE; ADIPOSE
AB We reported a technique for articular cartilage repair, consisting of microfracture, a biomaterial scaffold of perforated decalcified cortical bone matrix (DCBM) and adenovirus-bone morphogenetic protein-4 (Ad-BMP4) gene therapy. In the present study, we evaluated its effects on the quality and quantity for induction of articular cartilage regeneration. Full-thickness defects were created in the articular cartilage of the trochlear groove of rabbits. Four groups were assigned: Ad-BMP4/perforated DCBM composite (group I); perforated DCBM alone without Ad-BMP4 (group II); DCBM without perforated (group III) and microfracture alone (group IV). Animals were sacrificed 6, 12 and 24 weeks postoperation. The harvested tissues were analyzed by magnetic resonance image, scanning electron microscope, histological examination and immunohistochemistry. Group I showed vigorous and rapid repair leading to regeneration of hyaline articular cartilage at 6 weeks and to complete repair of articular cartilage and subchondral bone at 12 weeks. Groups II and III completely repaired the defect with hyaline cartilage at 24 weeks, but group II was more rapid than group III in the regeneration of repair tissue. In group IV the defects were concave and filled with fibrous tissue at 24 weeks. These findings demonstrated that this composite biotechnology can rapidly repair large areas of cartilage defect with regeneration of native hyaline articular cartilage. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Zhang, Xin; Liu, Ping; Ma, Yong; Lin, Lin; Fu, Xin; Zhang, Jiying; Ao, Yingfang] Peking Univ, Third Hosp, Dept Sports Med, Beijing 100083, Peoples R China.
   [Ma, Kangtao; Chen, Ping; Zhou, Chunyan] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Biochem & Mol Biol, Beijing 100083, Peoples R China.
   [Zheng, Zhuozhao; Lang, Ning] Peking Univ, Third Hosp, Dept Diagnost Radiol, Beijing 100083, Peoples R China.
RP Ao, YF (reprint author), Peking Univ, Third Hosp, Dept Sports Med, Beijing 100083, Peoples R China.
EM chunyanzhou@bjmu.edu.cn; yingfang.ao@vip.sina.com
FU Chinese National Science and Technology
FX This work was supported by the Chinese National Science and Technology
   Supporting Plan.
CR BERT JM, 1993, RHEUM DIS CLIN N AM, V19, P725
   Buma P, 2003, BIOMATERIALS, V24, P3255, DOI 10.1016/S0142-9612(03)00143-1
   Catanese J, 1999, J BIOMECH, V32, P1365, DOI 10.1016/S0021-9290(99)00128-1
   CHIROFF RT, 1977, J BIOMED MATER RES, V11, P165, DOI 10.1002/jbm.820110203
   Cohen SB, 2003, BIOMATERIALS, V24, P2653, DOI 10.1016/S0142-9612(03)00058-9
   Gelse K, 2003, ARTHRITIS RHEUM, V48, P430, DOI 10.1002/art.10759
   Glansbeek HL, 1997, ARTHRITIS RHEUM, V40, P1020, DOI 10.1002/art.1780400605
   JOHNSON L L, 1986, Arthroscopy, V2, P54, DOI 10.1016/S0749-8063(86)80012-3
   Kramer J, 2000, MECH DEVELOP, V92, P193, DOI 10.1016/S0925-4773(99)00339-1
   Kumai T, 1999, J BONE JOINT SURG AM, V81A, P1229, DOI 10.2106/00004623-199909000-00004
   Kuo AC, 2006, OSTEOARTHR CARTILAGE, V14, P1126, DOI 10.1016/j.joca.2006.04.004
   Kuroda R, 2006, ARTHRITIS RHEUM, V54, P433, DOI 10.1002/art.21632
   Lee CR, 2003, J ORTHOPAED RES, V21, P272, DOI 10.1016/S0736-0266(02)00153-5
   Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525
   Lin HF, 2002, NAT REV GENET, V3, P931, DOI 10.1038/nrg952
   Minas T, 1997, ORTHOPEDICS, V20, P525
   MORALES TI, 1988, J BIOL CHEM, V263, P12828
   MUCKLE DS, 1990, J BONE JOINT SURG BR, V72, P60
   Peng HR, 2002, J CLIN INVEST, V110, P751, DOI 10.1172/JCI200215153
   Reddi AH, 1998, NAT BIOTECHNOL, V16, P247, DOI 10.1038/nbt0398-247
   Reddi AH, 2003, ANN RHEUM DIS, V62, P73
   SCHOFIELD R, 1978, BLOOD CELLS, V4, P7
   Sellers RS, 1997, J BONE JOINT SURG AM, V79A, P1452, DOI 10.2106/00004623-199710000-00002
   Semba I, 2000, DEV DYNAM, V217, P401, DOI 10.1002/(SICI)1097-0177(200004)217:4<401::AID-DVDY7>3.0.CO;2-D
   SHAPIRO F, 1993, J BONE JOINT SURG AM, V75A, P532, DOI 10.2106/00004623-199304000-00009
   Shen HC, 2004, BONE, V34, P982, DOI 10.1016/j.bone.2004.01.028
   Sitnicka E, 1996, BLOOD, V88, P82
   Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160
   Steinert A, 2003, J ORTHOPAED RES, V21, P1090, DOI 10.1016/S0736-0266(03)00100-1
   Suominen E, 1996, J BIOMED MATER RES, V32, P543, DOI 10.1002/(SICI)1097-4636(199612)32:4<543::AID-JBM7>3.0.CO;2-R
   Tan CF, 2003, TRANSPLANT P, V35, P3105, DOI 10.1016/j.transproceed.2003.10.019
   Tan TCF, 1996, SKELETAL RADIOL, V25, P749, DOI 10.1007/s002560050173
   Ushida T, 2002, CELL TRANSPLANT, V11, P489
   van Susante JLC, 1998, BIOMATERIALS, V19, P2367, DOI 10.1016/S0142-9612(98)00158-6
   WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579, DOI 10.2106/00004623-199404000-00013
   Zhang X, 2006, CALCIFIED TISSUE INT, V79, P169, DOI 10.1007/s00223-006-0083-6
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
NR 37
TC 33
Z9 35
U1 0
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2008
VL 29
IS 35
BP 4616
EP 4629
DI 10.1016/j.biomaterials.2008.07.051
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 386EF
UT WOS:000261864400006
PM 18793797
DA 2018-10-19
ER

PT J
AU Lovett, ML
   Cannizzaro, CM
   Vunjak-Novakovic, G
   Kaplan, DL
AF Lovett, Michael L.
   Cannizzaro, Christopher M.
   Vunjak-Novakovic, Gordana
   Kaplan, David L.
TI Gel spinning of silk tubes for tissue engineering
SO BIOMATERIALS
LA English
DT Article
DE Silk; Vascular grafts; Arterial tissue engineering; Mechanical
   properties; Endothelial cells; Smooth muscle cells
ID FIBROIN AQUEOUS-SOLUTION; HUMAN SAPHENOUS-VEIN; BOMBYX-MORI;
   STRUCTURAL-CHARACTERIZATION; BIOMATERIAL COATINGS; BLOOD-VESSELS;
   SCAFFOLDS; FIBERS; GRAFTS; REGENERATION
AB Tubular vessels for tissue engineering are typically fabricated using a molding, dipping, or electrospinning technique. While these techniques provide some control over inner and outer diameters of the tube, they lack the ability to align the polymers or fibers of interest throughout the tube. This is an important aspect of biomaterial composite structure and function for mechanical and biological impact of tissue outcomes. We present a novel aqueous process system to spin tubes from biopolymers and proteins such as silk fibroin. Using silk as an example, this method of winding an aqueous solution around a reciprocating rotating mandrel offers substantial improvement in the control of the tube properties, specifically with regard to winding pattern, tube porosity, and composite features. Silk tube properties are further controlled via different post-spinning processing mechanisms such as methanol treatment, air-drying, and lyophilization. This approach to tubular scaffold manufacture offers numerous tissue engineering applications such as complex composite biomaterial matrices, blood vessel grafts and nerve guides, among others. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Lovett, Michael L.; Cannizzaro, Christopher M.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Vunjak-Novakovic, Gordana] Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
RI vunjak-novakovic, gordana/J-9279-2012
OI Vunjak-Novakovic, Gordana/0000-0002-9382-1574
FU Tissue Engineering Resource Center (TERC); NIH [EB002520]; National
   Institute of Biomedical Imaging and Bioengineering
FX We acknowledge funding from the Tissue Engineering Resource Center
   (TERC) through the NIH - grant EB002520 from the National Institute of
   Biomedical Imaging and Bioengineering. We would also like to acknowledge
   the assistance of Jonathan Kluge in the mechanical testing of the silk
   tubes and the Tufts machine shop (in particular, Larry McMaster, Scott
   MacCorkle, and Denis DuPuis) in the construction of the silk winding
   apparatus.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Asakura T, 2007, BIOMACROMOLECULES, V8, P175, DOI 10.1021/bm060874z
   Baguneid MS, 2006, BRIT J SURG, V93, P282, DOI 10.1002/bjs.5256
   DONOVAN DL, 1990, J VASC SURG, V12, P531, DOI 10.1067/mva.1990.22707
   Fidkowski C, 2005, TISSUE ENG, V11, P302, DOI 10.1089/ten.2005.11.302
   Fukae R, 2005, POLYMER, V46, P11193, DOI 10.1016/j.polymer.2005.10.001
   Girard A, 2005, POINT VET, V36, P8
   Ha SW, 2005, BIOMACROMOLECULES, V6, P1722, DOI 10.1021/bm050010y
   Han DW, 2005, TISSUE ENG, V11, P1054, DOI 10.1089/ten.2005.11.1054
   Hoenig MR, 2005, ARTERIOSCL THROM VAS, V25, P1128, DOI 10.1161/01.ATV.0000158996.03867.72
   Isenberg BC, 2006, ANN BIOMED ENG, V34, P971, DOI 10.1007/s10439-006-9101-0
   Jain RK, 2005, NAT BIOTECHNOL, V23, P821, DOI 10.1038/nbt0705-821
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Jin HJ, 2006, BIONANOTECHNOLOGY: PROTEINS TO NANODEVICES, P189, DOI 10.1007/978-1-4020-4375-8_10
   Kannan RY, 2006, BIOMATERIALS, V27, P4618, DOI 10.1016/j.biomaterials.2006.04.024
   Kim SH, 2006, J BIOMAT SCI-POLYM E, V17, P1359, DOI 10.1163/156856206778937244
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Liivak O, 1998, MACROMOLECULES, V31, P2947, DOI 10.1021/ma971626l
   Lovett M, 2007, BIOMATERIALS, V28, P5271, DOI 10.1016/j.biomterials.2007.08.008
   Moutos FT, 2007, NAT MATER, V6, P162, DOI 10.1038/nmat1822
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Niklason LE, 2001, J VASC SURG, V33, P628, DOI 10.1067/mva.2001.111747
   Notin L, 2006, ACTA BIOMATER, V2, P387, DOI 10.1016/j.actbio.2006.03.003
   Phillips DM, 2005, J MATER CHEM, V15, P4206, DOI 10.1039/b510069k
   Remuzzi A, 2004, TISSUE ENG, V10, P699, DOI 10.1089/1076327041348347
   Sanchez C, 2005, NAT MATER, V4, P277, DOI 10.1038/nmat1339
   Santana Daniel Bia, 2007, Cell and Tissue Banking, V8, P43, DOI 10.1007/s10561-006-9000-5
   Soffer L, 2008, J BIOMAT SCI-POLYM E, V19, P653, DOI 10.1163/156856208784089607
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Trabbic KA, 1998, MACROMOLECULES, V31, P462, DOI 10.1021/ma9708860
   Wang H, 2005, INT J BIOL MACROMOL, V36, P66, DOI 10.1016/j.ijbiomac.2005.03.011
   Wang XY, 2007, J CONTROL RELEASE, V121, P190, DOI 10.1016/j.jconrel.2007.06.006
   Wang XY, 2005, LANGMUIR, V21, P11335, DOI 10.1021/la051862m
   Xie F, 2006, INT J BIOL MACROMOL, V38, P284, DOI 10.1016/j.ijbiomac.2006.03.021
   Yang Y, 2007, BIOMATERIALS, V28, P5526, DOI 10.1016/j.biomaterials.2007.09.001
   Zhang XH, 2008, BIOMATERIALS, V29, P2217, DOI 10.1016/j.biomaterials.2008.01.022
NR 38
TC 73
Z9 76
U1 6
U2 64
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2008
VL 29
IS 35
BP 4650
EP 4657
DI 10.1016/j.biomaterials.2008.08.025
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 386EF
UT WOS:000261864400009
PM 18801570
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Acharya, C
   Hinz, B
   Kundu, SC
AF Acharya, Chitrangada
   Hinz, Boris
   Kundu, Subhas C.
TI The effect of lactose-conjugated silk biomaterials on the development of
   fibrogenic fibroblasts
SO BIOMATERIALS
LA English
DT Article
DE Film; Scaffold; Lactose; Silk fibroin; Myofibroblast
ID SMOOTH MUSCLE ACTIN; OSTEOBLAST IN-VITRO; POLY(D,L-LACTIC ACID);
   CHEMICAL-MODIFICATION; TGF-BETA; FIBROIN; MYOFIBROBLAST; CELLS;
   ADHESION; GROWTH
AB Surface properties of implanted biomaterials can cause fibrotic tissue reactions by stimulating differentiation of host fibroblasts into contractile myofibroblasts. Silk fibroin (SF) protein has been used as biomaterial in pure and blended form. however, its effect on myofibroblast differentiation remains elusive. We here conjugated SF with lactose using cyanuric chloride as coupling spacer. NMR spectroscopy and the conjugates ability to agglomerate Abrus precatorius agglutinin verified efficient conjugation. Two-dimensional films and three-dimensional scaffolds produced from pure and lactose-conjugated SF solutions were tested as culture substrates for subcutaneous fibroblasts and myofibroblasts. Lactose-conjugated SF substrates mediated higher adhesion, proliferation and viability of fibroblastic cells than pure SF. This SF film composition promotes better attachment of fibroblasts than myofibroblasts. Profibrotic cytokine TGF beta 1 was ineffective in inducing fibroblast-to-myofibroblast differentiation on such substrates. Pre-differentiated myofibroblasts lost their contractile phenotype within a few days of being cultured on lactose-conjugated SF. Myofibroblast differentiation was also suppressed by growth in three-dimensional lactose-conjugated SF scaffolds that, however, support population with fibroblasts, We propose that this biomaterial will promote tissue integration without causing a fibrotic host reaction. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Hinz, Boris] Ecole Polytech Fed Lausanne, LCB, CH-1015 Lausanne, Switzerland.
   [Acharya, Chitrangada; Kundu, Subhas C.] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
RP Hinz, B (reprint author), Ecole Polytech Fed Lausanne, LCB, Batiment SG-AA-B 143,Stn 15, CH-1015 Lausanne, Switzerland.
EM boris.hinz@epfl.ch; kundu@hijli.iitkgp.ernet.in
OI Hinz, Boris/0000-0002-0526-393X; Kundu, Subhas C./0000-0002-7170-2291
FU Swiss National Science Foundation [3100A0-102150/1, 3100A0-11373311];
   Gebert-Ruf Stiftung, Switzerland
FX We are grateful to J. Smith-Clerc for excellent technical assistance, to
   the staff of the Biolmaging and Optics platform of the EPFL for
   providing image facilities and training, and to J.-J. Meister for
   providing laboratory facilities. This work was financially supported by
   the Department of Biotechnology, Council of Scientific and Industrial
   Research, Government of India, New Delhi. CA and SCK are grateful for
   receiving a short-term research fellowship from the
   IIT-Kharagpur-EPFL-Lausanne exchange program which was kindly
   coordinated by Dr. P. Rastogi (EPFL). BH acknowledges support from the
   Swiss National Science Foundation (grants #3100A0-102150/1 and
   #3100A0-11373311) and the Gebert-Ruf Stiftung, Switzerland for this
   work.
CR ACHARYA C, J BIOMATER IN PRESS
   ACHARYA C, J MAT SCI P IN PRESS
   Acharya C, 2008, J MATER SCI-MATER M, V19, P2827, DOI 10.1007/s10856-008-3408-3
   Acharya Chitrangada, 2008, Biotechnol J, V3, P226, DOI 10.1002/biot.200700120
   Arora PD, 1999, AM J PATHOL, V154, P871, DOI 10.1016/S0002-9440(10)65334-5
   Cai KY, 2002, BIOMATERIALS, V23, P1603, DOI 10.1016/S0142-9612(01)00287-3
   Cai KY, 2002, BIOMATERIALS, V23, P1153, DOI 10.1016/S0142-9612(01)00230-7
   Dal Pra I, 2005, BIOMATERIALS, V26, P1987, DOI 10.1016/j.biomaterials.2004.06.036
   Dal Pra I, 2006, INT J MOL MED, V18, P241
   Darby IA, 2007, INT REV CYTOL, V257, P143, DOI 10.1016/S0074-7696(07)57004-X
   Desmouliere A, 2003, LAB INVEST, V83, P1689, DOI 10.1097/01.LAB.0000101911.53973.90
   Fini M, 2005, BIOMATERIALS, V26, P3527, DOI 10.1016/j.biomaterials.2004.09.040
   Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427
   Goffin JM, 2006, J CELL BIOL, V172, P259, DOI 10.1083/jcb.200506179
   Gotoh Y, 1997, BIOMATERIALS, V18, P267, DOI 10.1016/S0142-9612(96)00137-8
   Gotoh Y, 2004, BIOMATERIALS, V25, P1131, DOI 10.1016/S0142-9612(03)00633-1
   GOTOH Y, 1993, BIOCONJUGATE CHEM, V4, P554, DOI 10.1021/bc00024a020
   Gotoh Y, 1996, INT J BIOL MACROMOL, V18, P19, DOI 10.1016/0141-8130(95)01039-4
   Heckmann D, 2007, METHOD ENZYMOL, V426, P463, DOI 10.1016/S0076-6879(07)26020-3
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hino T, 2003, J COLLOID INTERF SCI, V266, P68, DOI 10.1016/S0021-9797(03)00584-8
   Hinz B, 2006, EUR J CELL BIOL, V85, P175, DOI 10.1016/j.ejcb.2005.09.004
   Hinz B, 2001, MOL BIOL CELL, V12, P2730, DOI 10.1091/mbc.12.9.2730
   Hinz B, 2003, MOL BIOL CELL, V14, P2508, DOI 10.1091/mbc.E02-11-0729
   Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613
   Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112
   Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev
   Kawaguchi T, 1999, J COLLOID INTERF SCI, V210, P290, DOI 10.1006/jcis.1998.5976
   KIM HJ, 2008, BONE
   KUNDU J, MAT SCI ENG IN PRESS
   Kundu J, 2008, J MATER SCI-MATER M, V19, P2679, DOI 10.1007/s10856-008-3398-1
   Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev
   Li MZ, 2003, BIOMATERIALS, V24, P357, DOI 10.1016/S0142-9612(02)00326-5
   Lovett M, 2007, BIOMATERIALS, V28, P5271, DOI 10.1016/j.biomterials.2007.08.008
   Ma XL, 2006, J BIOMED MATER RES B, V78B, P89, DOI 10.1002/jbm.b.30466
   Mauney JR, 2007, BIOMATERIALS, V28, P5280, DOI 10.1016/j.biomaterials.2007.08.017
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   MINOURA N, 1995, J BIOMED MATER RES, V29, P1215, DOI 10.1002/jbm.820291008
   MINOURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511, DOI 10.1006/bbrc.1995.1368
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   Morgan AW, 2008, BIOMATERIALS, V29, P2556, DOI 10.1016/j.biomaterials.2008.02.007
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   MURPHY AR, 2008, BIOMATERIALS
   Roche AC, 2003, CELL MOL LIFE SCI, V60, P288, DOI 10.1007/s000180300024
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Schaffner P, 2003, CELL MOL LIFE SCI, V60, P119, DOI 10.1007/s000180300008
   Schneider A, 2006, BIOMACROMOLECULES, V7, P2882, DOI 10.1021/bm0605208
   Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208
   SKALLI O, 1986, J CELL BIOL, V103, P2787, DOI 10.1083/jcb.103.6.2787
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Sugihara A, 2000, P SOC EXP BIOL MED, V225, P58, DOI 10.1046/j.1525-1373.2000.22507.x
   Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809
   Uebersax L, 2006, TISSUE ENG, V12, P3417, DOI 10.1089/ten.2006.12.3417
   Unger RE, 2004, BIOMATERIALS, V25, P5137, DOI 10.1016/j.biomaterials.2003.12.040
   VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97
   Wang JX, 2006, EXP CELL RES, V312, P205, DOI 10.1016/j.yexcr.2005.11.004
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042
   Yamamoto K, 2007, BIOMATERIALS, V28, P1838, DOI 10.1016/j.biomaterials.2006.11.045
   Yoon JJ, 2002, BIOTECHNOL BIOENG, V78, P1, DOI 10.1002/bit.10239
   Zhang YQ, 2006, J BIOMED MATER RES B, V79B, P275, DOI 10.1002/jbm.b.30539
   Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413
NR 62
TC 33
Z9 36
U1 1
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2008
VL 29
IS 35
BP 4665
EP 4675
DI 10.1016/j.biomaterials.2008.08.033
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 386EF
UT WOS:000261864400011
PM 18804860
DA 2018-10-19
ER

PT J
AU Antoci, V
   Adams, CS
   Parvizi, J
   Davidson, HM
   Composto, RJ
   Freeman, TA
   Wickstrom, E
   Ducheyne, P
   Jungkind, D
   Shapiro, IM
   Hickok, NJ
AF Antoci, Valentin, Jr.
   Adams, Christopher S.
   Parvizi, Javad
   Davidson, Helen M.
   Composto, Russell J.
   Freeman, Theresa A.
   Wickstrom, Eric
   Ducheyne, Paul
   Jungkind, Donald
   Shapiro, Irving M.
   Hickok, Noreen J.
TI The inhibition of Staphylococcus epidermidis biofilm formation by
   vancomycin-modified titanium alloy and implications for the treatment of
   periprosthetic infection
SO BIOMATERIALS
LA English
DT Article
DE Antibacterial; Bacterial adhesion; Biofilm; Metal surface treatment;
   Bacteria; Surface modification; Titanium alloy
ID BACTERIAL-COLONIZATION; AUREUS; IMPLANTS; PROVIDES
AB Peri-prosthetic infections are notoriously difficult to treat as the biomaterial implant is ideal for bacterial adhesion and biofilm formation, resulting in decreased antibiotic sensitivity. Previously, we reported that vancomycin covalently attached to a Ti alloy surface (Vanc-Ti) could prevent bacterial colonization. Herein we examine the effect of this Vanc-Ti surface on Staphylococci epidermidis, a Gram-positive organism prevalent in orthopaedic infections. By direct colony counting and fluorescent visualization of live bacteria, S. epidermidis colonization was significantly inhibited on Vanc-Ti implants. In contrast, the gram-negative organism Escherichia coli readily colonized the Vanc-Ti rod, suggesting retention of antibiotic specificity. By histochemical and SEM analysis, Vanc-Ti prevented S. epidermidis biofilm formation, even in the presence of serum. Furthermore, when challenged multiple times with S. epidermidis, Vanc-Ti rods resisted bacterial colonization. Finally, when S. epidermidis was continuously cultured in the presence of Vanc-Ti, the bacteria maintained a Vanc sensitivity equivalent to the parent strain. These findings indicate that antibiotic derivatization of implants can result in a surface that can resist bacterial colonization. This technology holds great promise for the prevention and treatment of periprosthetic infections. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Antoci, Valentin, Jr.; Adams, Christopher S.; Parvizi, Javad; Davidson, Helen M.; Freeman, Theresa A.; Shapiro, Irving M.; Hickok, Noreen J.] Thomas Jefferson Univ, Dept Orthopaed Surg, Philadelphia, PA 19107 USA.
   [Parvizi, Javad] Rothman Inst, Philadelphia, PA USA.
   [Composto, Russell J.; Ducheyne, Paul; Shapiro, Irving M.] Univ Penn, Sch Engn & Appl Sci, Ctr Bioact Mat & Tissue Engn, Philadelphia, PA 19104 USA.
   [Composto, Russell J.] Univ Penn, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA.
   [Wickstrom, Eric; Shapiro, Irving M.; Hickok, Noreen J.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA.
   [Ducheyne, Paul] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.
   [Jungkind, Donald] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA.
RP Hickok, NJ (reprint author), Thomas Jefferson Univ, Dept Orthopaed Surg, 1015 Walnut St,Suite 501, Philadelphia, PA 19107 USA.
EM noreen.hickok@jefferson.edu
OI Freeman, Theresa/0000-0002-5959-5884; Adams,
   Christopher/0000-0003-2100-4417
FU NIAMS NIH HHS [R01 AR051303-01A2, AR-051303, R01 AR051303]; NIDCR NIH
   HHS [DE-10875, R01 DE010875-13, R01 DE010875, DE-13319, R01 DE013319,
   R01 DE013319-06]
CR Antoci V, 2007, CLIN ORTHOP RELAT R, P81, DOI 10.1097/BLO.0b013e3181123a50
   Antoci V, 2007, J ORTHOP RES, V25, P858, DOI 10.1002/jor.20348
   Bahar Gul, 2002, Mikrobiyoloji Bulteni, V36, P343
   BARTH E, 1989, BIOMATERIALS, V10, P325, DOI 10.1016/0142-9612(89)90073-2
   Biemer J J, 1973, Ann Clin Lab Sci, V3, P135
   BOYLE VJ, 1973, ANTIMICROB AGENTS CH, V3, P418, DOI 10.1128/AAC.3.3.418
   Burny F, 2000, MED ENG PHYS, V22, P469, DOI 10.1016/S1350-4533(00)00062-X
   *CLIN LAB STAND I, 2008, 18 INF JAN S, V28
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Costerton JW, 2005, CLIN ORTHOP RELAT R, P7, DOI 10.1097/01.blo.0000175128.44966.d9
   COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431
   Costerton W, 2003, J CLIN INVEST, V112, P1466, DOI 10.1172/JCI200320365
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002
   Edupuganti OP, 2007, BIOORG MED CHEM LETT, V17, P2692, DOI 10.1016/j.bmcl.2007.03.005
   Fairman R, 2005, CURR OPIN STRUC BIOL, V15, P453, DOI 10.1016/j.sbi.2005.07.005
   GRISTINA AG, 1985, SCIENCE, V228, P990, DOI 10.1126/science.4001933
   Jose B, 2005, CHEM BIOL, V12, P1041, DOI 10.1016/j.chembiol.2005.06.013
   Kilgus DJ, 2002, CLIN ORTHOP RELAT R, P116, DOI 10.1097/01.blo.0000030492.43495.63
   Nelson CL, 2004, CLIN ORTHOP RELAT R, P72, DOI 10.1097/01.bio.0000143741.92384.18
   O'Toole GA, 1999, METHOD ENZYMOL, V310, P91
   Oliveira M, 2006, VET MICROBIOL, V118, P133, DOI 10.1016/j.vetmic.2006.07.008
   Peersman G, 2001, CLIN ORTHOP RELAT R, P15
   Radin S, 2001, J BIOMED MATER RES, V57, P313, DOI 10.1002/1097-4636(200111)57:2<313::AID-JBM1173>3.0.CO;2-E
   Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1
   Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705
   Toms AD, 2006, J BONE JOINT SURG BR, V88B, P149, DOI 10.1302/0301-620X.88B2.17058
   van der Laan MJ, 2006, STAT APPL GENET MOL, V5
   Vodna L, 2007, MACROMOL BIOSCI, V7, P629, DOI 10.1002/mabi.200600290
   Vuong C, 2002, MICROBES INFECT, V4, P481, DOI 10.1016/S1286-4579(02)01563-0
NR 30
TC 132
Z9 133
U1 1
U2 56
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2008
VL 29
IS 35
BP 4684
EP 4690
DI 10.1016/j.biomaterials.2008.08.016
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 386EF
UT WOS:000261864400013
PM 18814909
OA Green Accepted, Green Published
DA 2018-10-19
ER

PT J
AU Wieghaus, KA
   Nickerson, MM
   Aronin, CEP
   Sefcik, LS
   Price, RJ
   Paige, MA
   Brown, ML
   Botchwey, EA
AF Wieghaus, Kristen A.
   Nickerson, Meghan M.
   Aronin, Caren E. Petrie
   Sefcik, Lauren S.
   Price, Richard J.
   Paige, Mikell A.
   Brown, Milton L.
   Botchwey, Edward A.
TI Expansion of microvascular networks in vivo by phthalimide neovascular
   factor 1 (PNF1)
SO BIOMATERIALS
LA English
DT Article
DE Small molecule delivery; Controlled release; Microvascular remodeling;
   Monocyte recruitment
ID ENDOTHELIAL GROWTH-FACTOR; CORONARY-ARTERY DISEASE; THERAPEUTIC
   ANGIOGENESIS; 1-MATRIX METALLOPROTEINASE; ENDOMETRIOTIC LESIONS;
   ARTERIOGENESIS; TISSUE; RELEASE; REVASCULARIZATION; REGRESSION
AB Phthalimide neovascular factor (PNF1, formerly SC-3-149) is a potent stimulator of proangiogenic signaling pathways in endothelial cells. In this study, we evaluated the in vivo effects of sustained PNF1 release to promote ingrowth and expansion of microvascular networks surrounding biomaterial implants. The dorsal skinfold window chamber was used to evaluate the structural remodeling response of the local microvasculature. PNF1 was released from poly(lactic-co-glycolic acid) (PLAGA) films, and a transport model was utilized to predict PNF1 penetration into the surrounding tissue. PNF1 significantly expanded microvascular networks within a 2 mm radius from implants after 3 and 7 days by increasing microvessel length density and lumenal diameter of local arterioles and venules. Staining of histological sections with CD11b showed enhanced recruitment of circulating white blood cells, including monocytes, which are critical for the process of vessel enlargement through arteriogenesis. As PNF1 has been shown to modulate MT1-MMP, a facilitator of CCL2 dependent leukocyte transmigration, aspects of window chamber experiments were repeated in CCR2(-/-) (CCL2 receptor) mouse chimeras to more fully explore the critical nature of monocyte recruitment on the therapeutic benefits of PNF1 function in vivo. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Wieghaus, Kristen A.; Nickerson, Meghan M.; Aronin, Caren E. Petrie; Sefcik, Lauren S.; Price, Richard J.; Botchwey, Edward A.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22908 USA.
   [Price, Richard J.] Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA.
   [Paige, Mikell A.; Brown, Milton L.] Georgetown Univ, Med Ctr, Dept Oncol, Lombardi Comprehens Canc Ctr,Drug Discovery Progr, Washington, DC 20057 USA.
RP Botchwey, EA (reprint author), Univ Virginia, Dept Biomed Engn, Box 800759, Charlottesville, VA 22908 USA.
EM eab6e@virginia.edu
FU National Institute of Arthritis and Musculoskeletal Disease (NIAMS)
   [K01AR052352-01A1]; US Department of Education's Graduate Assistance in
   Areas of National Need (GAANN); University of Virginia Biotechnology
   [5T32GM008715-08]; National Science Foundation
FX Sources for support of these studies include the National Institute of
   Arthritis and Musculoskeletal Disease (NIAMS) grant K01AR052352-01A1 to
   Dr. Botchwey. Dr. Kristen Wieghaus is supported by the US Department of
   Education's Graduate Assistance in Areas of National Need (GAANN)
   funding. Dr. Caren Petrie Aronin is also supported by GAANN funding and
   by the University of Virginia Biotechnology Training Program grant
   5T32GM008715-08. Lauren Sefcik is supported by a National Science
   Foundation Graduate Research Fellowship.
CR Barnard GC, 2005, APPL ENVIRON MICROB, V71, P5735, DOI 10.1128/AEM.71.10.5735-5742.2005
   Berglund JD, 2003, BRIT J PHARMACOL, V140, P627, DOI 10.1038/sj.bjp.0705457
   Bernas Gloria Castro, 2003, Clin Hemorheol Microcirc, V29, P199
   Bezemer JM, 2000, J CONTROL RELEASE, V64, P179, DOI 10.1016/S0168-3659(99)00127-3
   Blau HM, 2001, NAT MED, V7, P532, DOI 10.1038/87850
   Botchwey EA, 2001, J BIOMED MATER RES, V55, P242
   Brey EM, 2005, TISSUE ENG, V11, P567, DOI 10.1089/ten.2005.11.567
   Chi EY, 2003, PHARM RES-DORDR, V20, P1325, DOI 10.1023/A:1025771421906
   Faisant N, 2006, INT J PHARMACEUT, V314, P189, DOI 10.1016/j.ijpharm.2005.07.030
   Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483
   Ferrara N, 1999, NAT MED, V5, P1359, DOI 10.1038/70928
   Freedman SB, 2002, ANN INTERN MED, V136, P54, DOI 10.7326/0003-4819-136-1-200201010-00011
   Freedman SB, 2001, J MOL CELL CARDIOL, V33, P379, DOI 10.1006/jmcc.2000.1329
   Friesenecker BE, 2006, CRIT CARE, V10, DOI 10.1186/cc4922
   Fung LK, 1996, PHARM RES-DORDR, V13, P671, DOI 10.1023/A:1016083113123
   Galvez BG, 2005, J BIOL CHEM, V280, P1292, DOI 10.1074/jbc.M408673200
   Gazit Y, 1997, MICROCIRCULATION-LON, V4, P395, DOI 10.3109/10739689709146803
   GAZIT Y, 1995, PHYS REV LETT, V75, P2428, DOI 10.1103/PhysRevLett.75.2428
   Heil M, 2004, CIRC RES, V94, P671, DOI 10.1161/01.RES.0000122041.73808.B5
   Henry TD, 2003, CIRCULATION, V107, P1359, DOI 10.1161/01.CIR.0000061911.47710.8A
   Hershey JC, 2001, CARDIOVASC RES, V49, P618, DOI 10.1016/S0008-6363(00)00232-7
   HIRSCHI KK, REPARATIVE MED GROWI, P223
   HOCKEL M, 1993, ARCH SURG-CHICAGO, V128, P423
   Hoefer IE, 2002, CIRCULATION, V105, P1639, DOI 10.1161/01.CIR.0000014987.32865.8E
   Hughes GC, 2004, ANN THORAC SURG, V77, P812, DOI 10.1016/j.athorasur.2003.09.060
   Jain RK, 2005, NAT BIOTECHNOL, V23, P821, DOI 10.1038/nbt0705-821
   KEIFER FN, 2003, CURR PHARM DESIGN, V9, P1733
   King TW, 2000, J BIOMED MATER RES, V51, P383, DOI 10.1002/1097-4636(20000905)51:3<383::AID-JBM12>3.0.CO;2-D
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Laschke MW, 2006, BRIT J PHARMACOL, V149, P137, DOI 10.1038/sj.bjp.0706857
   Laschke MW, 2007, FERTIL STERIL, V87, P163, DOI 10.1016/j.fertnstert.2006.05.068
   Laschke MW, 2006, HUM REPROD, V21, P262, DOI 10.1093/humrep/dei308
   Lei Y, 2004, BASIC RES CARDIOL, V99, P121, DOI 10.1007/s00395-004-0447-x
   Qian F, 2002, J CONTROL RELEASE, V83, P427, DOI 10.1016/S0168-3659(02)00217-1
   Rucker M, 2006, BIOMATERIALS, V27, P5027, DOI 10.1016/j.biomaterials.2006.05.033
   Ruel M, 2003, CIRCULATION, V108, P335, DOI 10.1161/01.cir.0000087903.75204.ad
   Sefcik LS, 2008, BIOMATERIALS, V29, P2869, DOI 10.1016/j.biomaterials.2008.03.017
   Simons M, 2005, CIRCULATION, V111, P1556, DOI 10.1161/01.CIR.0000159345.00591.8F
   Simons M, 2002, CIRCULATION, V105, P788, DOI 10.1161/hc0802.104407
   Sithu SD, 2007, J BIOL CHEM, V282, P25010, DOI 10.1074/jbc.M611273200
   Steinstraesser L, 2006, ANN PLAS SURG, V56, P93, DOI 10.1097/01.sap.0000190883.30005.91
   Strasser JF, 1995, J PHARMACOL EXP THER, V275, P1647
   Strieth S, 2006, INT J CANCER, V119, P423, DOI 10.1002/ijc.21838
   TAKESHITA S, 1994, J CLIN INVEST, V93, P662, DOI 10.1172/JCI117018
   van Royen N, 2001, CARDIOVASC RES, V49, P543, DOI 10.1016/S0008-6363(00)00206-6
   WIEGHAUS KA, 2008, BIOINFORMATICS  0821
   Wieghaus KA, 2007, TISSUE ENG, V13, P2561, DOI 10.1089/ten.2007.0023
   Wieghaus KA, 2006, TISSUE ENG, V12, P1903, DOI 10.1089/ten.2006.12.1903
   Yu J, 2005, P NATL ACAD SCI USA, V102, P10999, DOI 10.1073/pnas.0501444102
NR 49
TC 9
Z9 9
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2008
VL 29
IS 35
BP 4698
EP 4708
DI 10.1016/j.biomaterials.2008.08.029
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 386EF
UT WOS:000261864400015
PM 18804278
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Bruggeman, JP
   de Bruin, BJ
   Bettinger, CJ
   Langer, R
AF Bruggeman, Joost P.
   de Bruin, Berend-Jan
   Bettinger, Christopher J.
   Langer, Robert
TI Biodegradable poly(polyol sebacate) polymers
SO BIOMATERIALS
LA English
DT Article
DE Biomaterial; Poly(polyol sebacate); Polyol; Polymer; Biodegradable
ID POLY(GLYCEROL SEBACATE); IN-VITRO; TISSUE; ELASTOMER; NERVE;
   DEGRADATION; SEGMENTS; XYLITOL; VIVO
AB We have developed a family of synthetic biodegradable polymers that are composed of structural units endogenous to the human metabolism, designated poly(polyol sebacate) (PPS) polymers. Material properties of PPS polymers can be tuned by altering the polyol monomer and reacting stiochiometric ratio of sebacic acid. These thermoset networks exhibited tensile Young's modiali ranging from 0.37 +/- 0.08 to 378 +/- 33 MPa with maximum elongations at break from 10.90 +/- 1.37% to 205.16 +/- 55.76%, and glass transition temperatures ranging from similar to 7-46 degrees C. In vitro degradation under physiological conditions was slower than in vivo degradation rates observed for some PPS polymers. PPS polymers demonstrated similar in vitro and in vivo biocompatibility compared to poly(L-lactic-co-glycolic acid) (PLGA). (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Bruggeman, Joost P.; de Bruin, Berend-Jan; Bettinger, Christopher J.; Langer, Robert] MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
   [Bruggeman, Joost P.; de Bruin, Berend-Jan] Erasmus Univ, Erasmus Sch Ctr, Dept Plast & Reconstruct Surg, NL-3015 GE Rotterdam, Netherlands.
   [Bettinger, Christopher J.] Charles Stark Draper Lab Inc, Ctr Biomed Engn, Cambridge, MA 02139 USA.
RP Langer, R (reprint author), MIT, Dept Chem Engn, 45 Carleton St,E25-342, Cambridge, MA 02139 USA.
EM rlanger@mit.edu
RI Bettinger, Christopher/A-3895-2009
FU J.F.S. Esser Stichting; Stichting Prof. Michael-Van Vloten Fonds;
   Charles Stark Draper Laboratory Fellowship; NIH [HL060435]
FX JPB acknowledges financial support from the J.F.S. Esser Stichting and
   the Stichting Prof. Michael-Van Vloten Fonds. CJB was funded by a
   Charles Stark Draper Laboratory Fellowship. This work was funded by NIH
   grant HL060435 and through a gift from Richard and Gail Siegal.
CR Anseth KS, 1999, NAT BIOTECHNOL, V17, P156
   Bettinger CJ, 2008, BIOMATERIALS, V29, P2315, DOI 10.1016/j.biomaterials.2008.01.029
   Bettinger CJ, 2006, BIOMATERIALS, V27, P2558, DOI 10.1016/j.biomaterials.2005.11.029
   Bettinger CJ, 2006, ADV MATER, V18, P165, DOI 10.1002/adma.200500438
   Bruggeman JP, 2008, ADV MATER, V20, P1922, DOI 10.1002/adma.200702377
   BRUGGEMAN JP, THERMOSET BIOD UNPUB
   Chen QZ, 2008, BIOMATERIALS, V29, P47, DOI 10.1016/j.biomaterials.2007.09.010
   Clerin V, 2003, TISSUE ENG, V9, P461, DOI 10.1089/107632703322066642
   den Dunnen WFA, 2000, J BIOMED MATER RES, V51, P575, DOI 10.1002/1097-4636(20000915)51:4<575::AID-JBM5>3.3.CO;2-Q
   ELLWOOD KC, 1995, AM J CLIN NUTR, V62, P1169
   Firoozbakhsh K, 2002, CLIN ORTHOP RELAT R, P240, DOI 10.1097/01.blo.0000022170.66847.1c
   Flory P. J., 1953, PRINCIPALS POLYM CHE
   Ha SK, 2006, MED ENG PHYS, V28, P534, DOI 10.1016/j.medengphy.2005.09.006
   Mahdavi A, 2008, P NATL ACAD SCI USA, V105, P2307, DOI 10.1073/pnas.0712117105
   MAINILVARLET P, 1996, J BIOMED MATER RES A, V7, P6713
   Motlagh D, 2006, BIOMATERIALS, V27, P4315, DOI 10.1016/j.biomaterials.2006.04.010
   Natah SS, 1997, AM J CLIN NUTR, V65, P947
   NIJST CLE, 2007, BIOMACROMOLECULES
   RYDEVIK BL, 1990, J ORTHOPAED RES, V8, P694, DOI 10.1002/jor.1100080511
   Schmalenberg KE, 2005, BIOMATERIALS, V26, P1423, DOI 10.1016/j.biomaterials.2004.04.046
   SESTOFT L, 1985, ACTA ANAESTH SCAND, V29, P19, DOI 10.1111/j.1399-6576.1985.tb02336.x
   Sundback CA, 2005, BIOMATERIALS, V26, P5454, DOI 10.1016/j.biomaterials.2005.02.004
   THURSTON G, 1988, CYTOMETRY, V9, P411, DOI 10.1002/cyto.990090502
   Tognana E, 2005, OSTEOARTHR CARTILAGE, V13, P129, DOI 10.1016/j.joca.2004.10.015
   Wang YD, 2003, J BIOMED MATER RES A, V66A, P192, DOI 10.1002/jbm.a.10534
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Yang J, 2006, BIOMATERIALS, V27, P1889, DOI 10.1016/j.biomaterials.2005.05.106
NR 27
TC 129
Z9 130
U1 4
U2 60
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2008
VL 29
IS 36
BP 4726
EP 4735
DI 10.1016/j.biomaterials.2008.08.037
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 372YV
UT WOS:000260939100002
PM 18824260
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Zhang, F
   Zhang, ZB
   Zhu, XL
   Kang, ET
   Neoh, KG
AF Zhang, Fan
   Zhang, Zhengbiao
   Zhu, Xiulin
   Kang, En-Tang
   Neoh, Koon-Gee
TI Silk-functionalized titanium surfaces for enhancing osteoblast functions
   and reducing bacterial adhesion
SO BIOMATERIALS
LA English
DT Article
DE Titanium; Silk; Surface-initiated ATRP; Methacrylic acid sodium salt;
   Osteoblast; Bacterial adhesion
ID POLYELECTROLYTE MULTILAYERS; RADICAL POLYMERIZATION; SERICIN;
   PROLIFERATION; ANTIBACTERIAL; ATTACHMENT; COPOLYMERS; POLYMERS; GROWTH;
   BIOMATERIALS
AB It would be ideal to have implants which can simultaneously inhibit bacterial adhesion and promote osteoblast functions. In this work, titanium surfaces were modified with poly(methacrylic acid) (P(MAA)) followed by immobilization of silk sericin. Firstly a trichlorosifane coupling agent, which is an atom transfer radical polymerization (ATRP) initiator, was immobilized on the oxidized titanium surface to facilitate the surface-initiated ATRP of methacrylic acid sodium salt (MAAS). The pendant carboxyl end groups of the grafted and partially protonated MAA chains were subsequently Coupled with silk sericin via carbodiimide chemistry. The functionalized Ti surfaces were characterized by X-ray photoelectron spectroscopy, and assayed for osteoblast cell functions and bacterial adhesion. The covalently immobilized MAA brushes significantly reduce the adhesion of the two bacterial strains (Staphylococcus aureus and Staphylococcus epidermidis) tested. The silk sericin-immobilized surfaces, at the same time, promote osteoblast cells' adhesion, proliferation, and alkaline phosphatase activity. Thus, the P(MAA) and silk sericin functionalized Ti surfaces have potential applications combating biomaterial-centered infection and promoting osseointegration. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Zhang, Fan; Zhang, Zhengbiao; Kang, En-Tang; Neoh, Koon-Gee] Natl Univ Singapore, Dept Chem & Biomol Engn, Singapore 119260, Singapore.
   [Zhang, Zhengbiao; Zhu, Xiulin] Suzhou Univ, Sch Chem & Chem Engn, Suzhou 215006, Peoples R China.
RP Neoh, KG (reprint author), Natl Univ Singapore, Dept Chem & Biomol Engn, Kent Ridge, Singapore 119260, Singapore.
EM chenkg@nus.edu.sg
RI Kang, En-Tang/G-8522-2012
OI Kang, En-Tang/0000-0003-0599-7834; Neoh, Koon Gee/0000-0002-2700-1914
FU Ministry of Education under the National University of Singapore
   [R279000202112]
FX The authors gratefully acknowledge the financial support from the
   Ministry of Education under the National University of Singapore Grant
   NO.: R279000202112.
CR Anagnostou F, 2006, BIOMATERIALS, V27, P3912, DOI 10.1016/biomaterials.2006.03.004
   Aramwit P, 2007, BIOSCI BIOTECH BIOCH, V71, P2473, DOI 10.1271/bbb.70243
   Ashford EJ, 1999, CHEM COMMUN, P1285, DOI 10.1039/a903773j
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Brunette D. M., 2001, TITANIUM MED MAT SCI
   Cai K, 2007, J BIOMED MATER RES A, V82A, P927, DOI 10.1002/jbm.a.31233
   Cai KY, 2002, BIOMATERIALS, V23, P1153, DOI 10.1016/S0142-9612(01)00230-7
   Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044
   Chua PH, 2008, BIOMATERIALS, V29, P1412, DOI 10.1016/j.biomaterials.2007.12.019
   Dalsin JL, 2003, J AM CHEM SOC, V125, P4253, DOI 10.1021/ja0284963
   DAVIES JE, 2000, BONE ENG
   Dong R, 2007, BIOMACROMOLECULES, V8, P3082, DOI 10.1021/bm700493v
   Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002
   El Khadali F, 2002, BIOMACROMOLECULES, V3, P51, DOI 10.1021/bm015563x
   Gray JE, 2003, BIOMATERIALS, V24, P2759, DOI 10.1016/S0142-9612(03)00057-7
   HARKES G, 1991, BIOMATERIALS, V12, P853, DOI 10.1016/0142-9612(91)90074-K
   HOGT AH, 1986, J BIOMED MATER RES, V20, P533, DOI 10.1002/jbm.820200409
   Kingshott P, 2003, LANGMUIR, V19, P6912, DOI 10.1021/la034032m
   Maeno S, 2005, BIOMATERIALS, V26, P4847, DOI 10.1016/j.biomaterials.2005.01.006
   Matyjaszewski K, 2001, CHEM REV, V101, P2921, DOI 10.1021/cr940534g
   MINOURA N, 1995, J BIOMED MATER RES, V29, P1215, DOI 10.1002/jbm.820291008
   Montanaro L, 2007, BIOMATERIALS, V28, P5155, DOI 10.1016/j.biomaterials.2007.08.003
   Moulder J. F., 1992, HDB XRAY PHOTOELECTR
   Narayanan R, 2008, J BIOMED MATER RES B, V85B, P279, DOI 10.1002/jbm.b.30932
   Osborne VL, 2002, CHEM COMMUN, P1838, DOI 10.1039/b204737c
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Shahab F, 2006, BIOMATERIALS, V27, P3532, DOI 10.1016/j.biomaterials.2006.02.027
   Shi ZL, 2007, IND ENG CHEM RES, V46, P439, DOI 10.1021/ie0608096
   Song WH, 2004, BIOMATERIALS, V25, P3341, DOI 10.1016/j.biomaterials.2003.09.103
   Terada S, 2002, CYTOTECHNOLOGY, V40, P3, DOI 10.1023/A:1023993400608
   Tsubouchi K, 2005, BIOSCI BIOTECH BIOCH, V69, P403, DOI 10.1271/bbb.69.403
   van den Dolder J, 2003, BIOMATERIALS, V24, P1853, DOI 10.1016/S0142-9612(02)00571-9
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Yang JM, 2003, J APPL POLYM SCI, V90, P1331, DOI 10.1002/app.12787
   Yang SY, 2003, BIOMACROMOLECULES, V4, P987, DOI 10.1021/bm034035d
   Zhang F, 2007, IND ENG CHEM RES, V46, P9077, DOI 10.1021/ie070795j
   Zhang YQ, 2006, J CHEM TECHNOL BIOT, V81, P136, DOI 10.1002/jctb.1370
   Zhang YQ, 2002, BIOTECHNOL ADV, V20, P91, DOI 10.1016/S0734-9750(02)00003-4
   Zhang YQ, 2006, J CONTROL RELEASE, V115, P307, DOI 10.1016/j.jconrel.2006.08.019
NR 40
TC 110
Z9 113
U1 4
U2 67
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2008
VL 29
IS 36
BP 4751
EP 4759
DI 10.1016/j.biomaterials.2008.08.043
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 372YV
UT WOS:000260939100004
PM 18829101
DA 2018-10-19
ER

PT J
AU Ren, PG
   Lee, SW
   Biswal, S
   Goodman, SB
AF Ren, Pei-Gen
   Lee, Sheen-Woo
   Biswal, Sandip
   Goodman, Stuart B.
TI Systemic trafficking of macrophages induced by bone cement particles in
   nude mice
SO BIOMATERIALS
LA English
DT Article
DE Macrophage; Polymethylmethacrylate; Wear debris; Non-invasive imaging;
   Animal model; In vivo test
ID TOTAL HIP-ARTHROPLASTY; NECROSIS-FACTOR-ALPHA; DEBRIS IN-VITRO;
   PERIPROSTHETIC OSTEOLYSIS; WEAR DEBRIS; BIOMATERIAL PARTICLES;
   GENE-EXPRESSION; GROWTH-FACTOR; LAK CELLS; MODEL
AB Macrophages play an important role in the biological response to wear particles, which can result in periprosthetic osteolysis and implant loosening. In this study, we demonstrate that polymer particles induce systemic trafficking of macrophages by non-invasive in vivo imaging and immunohistochemistry. The distal femora of nude mice were injected with 10% (w/v) Simplex bone cement (BC) suspensions or saline (PBS). Reporter RAW264.7 macrophages which stably expressed the bioluminescent reporter gene fluc, and the fluorescence reporter gene gfp, were injected intravenously. Bioluminescence imaging was performed immediately and periodically at 2-day intervals until day 14. Compared to the non-operated contralateral femora, the bioluminescent signal of femora injected with BC Suspension increased 4.7 +/- 1.6 and 7.8 +/- 2.9-fold at day 6 and 8, respectively. The same values for PBS group were 1.2 +/- 0.2 and 1.4 +/- 0.5, respectively. The increase of bioluminescence of the BC group was significantly greater than the PBS group at day 8 (p < 0.05) and day 6 (p < 0.1). Histological Study confirmed the presence of reporter macrophages within the medullary canal of mice that received cement particles. Modulation of the signaling mechanisms that regulate systemic macrophage trafficking may provide a new strategy for mitigating the chronic inflammatory response and osteolysis associated with wear debris. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Ren, Pei-Gen; Goodman, Stuart B.] Stanford Univ, Sch Med, Dept Orthopaed Surg, Stanford, CA 94305 USA.
   [Lee, Sheen-Woo; Biswal, Sandip] Stanford Univ, Sch Med, Dept Radiol, Stanford, CA 94305 USA.
RP Goodman, SB (reprint author), Stanford Univ, Sch Med, Dept Orthopaed Surg, R153,300 Pasteur Dr, Stanford, CA 94305 USA.
EM goodbone@stanford.edu
RI Ren, Pei-Gen/A-4099-2009
FU National Institute of Health, the Ellenburg Chair in Surgery [R21
   AR053189, R01 AR055650-01]
FX We gratefully acknowledge Dr. Gobalakrishnan Sundaresan who supplied the
   fluc and gfp expressing RAW264.7 macrophage cell line. This study was
   supported in part by Grants R21 AR053189 and R01 AR055650-01 from the
   National Institute of Health, the Ellenburg Chair in Surgery.
CR Akisue T, 2002, J BIOMED MATER RES, V59, P507, DOI 10.1002/jbm.1264
   Archibeck M J, 2001, Instr Course Lect, V50, P185
   ATHANASOU NA, 1992, J BONE JOINT SURG BR, V74, P57
   Contag CH, 2002, ANNU REV BIOMED ENG, V4, P235, DOI 10.1146/annurev.bioeng.4.111901.093336
   DAVIS RG, 1993, J BIOMED MATER RES, V27, P1039, DOI 10.1002/jbm.820270809
   De A, 2003, MOL THER, V7, P681, DOI 10.1016/S1525-0016(03)00070-4
   Decaris E, 1999, ARTHRITIS RHEUM, V42, P1951, DOI 10.1002/1529-0131(199909)42:9<1951::AID-ANR22>3.3.CO;2-4
   DONALDSON LF, 1993, J NEUROSCI METH, V49, P5, DOI 10.1016/0165-0270(93)90103-X
   Drees P, 2007, NAT CLIN PRACT RHEUM, V3, P165, DOI 10.1038/ncprheum0428
   Epstein NJ, 2005, J ORTHOP RES, V23, P501, DOI 10.1016/j.orthres.2004.10.004
   FELGAR RE, 1990, CELL IMMUNOL, V129, P288, DOI 10.1016/0008-8749(90)90205-6
   Gao JZ, 2001, CELLS TISSUES ORGANS, V169, P12, DOI 10.1159/000047856
   GLANT TT, 1993, J BONE MINER RES, V8, P1071
   Goodman SB, 2005, CLIN ORTHOP RELAT R, P39, DOI 10.1097/01/blo.0000149998.88218.05
   HOROWITZ SM, 1995, J BIOMED MATER RES, V29, P477, DOI 10.1002/jbm.820290407
   JONES LC, 1987, CLIN ORTHOP RELAT R, P192
   Kelly S, 2007, EUR J NEUROSCI, V26, P935, DOI 10.1111/j.1460-9568.2007.05737.x
   KIM KJ, 1993, CLIN ORTHOP RELAT R, P142
   Kinov P, 2006, J ORTHOP RES, V24, P55, DOI 10.1002/jor.20013
   Kumagai K, 2008, J ORTHOP RES, V26, P165, DOI 10.1002/jor.20477
   KUPPEN PJK, 1992, INT J CANCER, V52, P266, DOI 10.1002/ijc.2910520219
   LINDER L, 1983, CLIN ORTHOP RELAT R, P93
   LOTZE MT, 1980, J IMMUNOL, V125, P1487
   MAGHAZACHI A A, 1988, Cellular Immunology, V115, P179
   MALONEY WJ, 1995, J BONE JOINT SURG AM, V77, P1448, DOI 10.2106/00004623-199509000-00022
   Merkel KD, 1999, AM J PATHOL, V154, P203, DOI 10.1016/S0002-9440(10)65266-2
   Miyanishi K, 2003, J BONE MINER RES, V18, P1573, DOI 10.1359/jbmr.2003.18.9.1573
   Nakashima Y, 1998, J BONE JOINT SURG BR, V80B, P694, DOI 10.1302/0301-620X.80B4.8374
   Nakashima Y, 1999, J BONE JOINT SURG AM, V81A, P603, DOI 10.2106/00004623-199905000-00002
   Purdue PE, 2007, CLIN ORTHOP RELAT R, P251, DOI 10.1097/01.blo.0000238813.95035.1b
   QUINN J, 1992, J BONE JOINT SURG BR, V74, P652
   Quinn JMW, 1998, CALCIFIED TISSUE INT, V62, P527, DOI 10.1007/s002239900473
   RICHARDSON DR, 1976, BASIC CIRCULATORY PH, P101
   Rocchetta HL, 2001, ANTIMICROB AGENTS CH, V45, P129, DOI 10.1128/AAC.45.1.129-137.2001
   Sabokbar A, 1998, ARCH ORTHOP TRAUM SU, V117, P136, DOI 10.1007/s004020050213
   SCHMALZRIED TP, 1992, J BONE JOINT SURG AM, V74A, P849, DOI 10.2106/00004623-199274060-00006
   Talmo CT, 2006, CLIN ORTHOP RELAT R, P254, DOI 10.1097/01.blo.0000246531.59876.a8
   Wang ML, 2004, J ARTHROPLASTY, V19, P1028, DOI 10.1016/j.arth.2004.03.024
   Zilber S, 2008, J BIOMED MATER RES B, V84B, P286, DOI 10.1002/jbm.b.30872
NR 39
TC 28
Z9 29
U1 1
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2008
VL 29
IS 36
BP 4760
EP 4765
DI 10.1016/j.biomaterials.2008.09.004
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 372YV
UT WOS:000260939100005
PM 18824259
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Gilbert, TW
   Wognum, S
   Joyce, EM
   Freytes, DO
   Sacks, MS
   Badylak, SF
AF Gilbert, Thomas W.
   Wognum, Silvia
   Joyce, Erinn M.
   Freytes, Donald O.
   Sacks, Michael S.
   Badylak, Stephen F.
TI Collagen fiber alignment and biaxial mechanical behavior of porcine
   urinary bladder derived extracellular matrix
SO BIOMATERIALS
LA English
DT Article
DE Extracellular matrix; Scaffold; Collagen fiber alignment; Biaxial
   mechanical behavior
ID SMALL-INTESTINAL SUBMUCOSA; INPLANE SHEAR; TENDON REPAIR; DOG-MODEL;
   SCAFFOLDS; TISSUE; CELLS; QUANTIFICATION; RECONSTRUCTION; BIOMATERIAL
AB The collagen fiber alignment and biomechanical behavior of naturally occurring extracellular matrix (ECM) scaffolds are important considerations for the design of medical devices from these materials. Both should be considered in order to produce a device to meet tissue specific mechanical requirements (e.g., tendon vs. urinary bladder), and Could ultimately affect the remodeling response in vivo. The present study evaluated the collagen fiber alignment and biaxial mechanical behavior of ECM scaffold material harvested from porcine urinary bladder tunica mucosa and basement membrane (together referred to as urinary bladder matrix (UBM)) and ECM harvested from urinary bladder submucosa (UBS). Since the preparation of UBM allows for control of the direction of delamination, the effect of the delamination method on the mechanical behavior of UBM was determined by delaminating the submucosa and other abluminal layers by scraping along the longitudinal axis of the bladder (apex to neck) (UBML) or along the circumferential direction (UBMC). The processing of UBS does not allow for similar directional control. UBML and UBS had similar collagen fiber distributions, with a preferred collagen fiber alignment along the longitudinal direction. UBMC showed a more homogenous collagen fiber orientation. All samples showed a stiffer mechanical behavior in the longitudinal direction. Despite similar collagen fiber distributions, UBML and UBS showed quite different mechanical behavior for the applied loading patterns with UBS showing a much more pronounced toe region. The mechanical behavior for UBMC in both directions was similar to the mechanical behavior of UBML. There are distinct differences in the mechanical behavior of different layers of ECM from the porcine urinary bladder, and the processing methods can substantially alter the mechanical behavior observed. (c) 2008 Elsevier Ltd. All rights Feserved.
C1 [Gilbert, Thomas W.; Freytes, Donald O.; Badylak, Stephen F.] Univ Pittsburgh, Dept Surg, McGowan Inst Regenerat Med, Pittsburgh, PA 15219 USA.
   [Wognum, Silvia; Joyce, Erinn M.; Sacks, Michael S.] Univ Pittsburgh, Dept Bioengn, Engineered Tissue Mech & Mechanobiol Lab, Pittsburgh, PA 15219 USA.
RP Badylak, SF (reprint author), Univ Pittsburgh, Dept Surg, McGowan Inst Regenerat Med, 100 Technol Dr,Suite 200, Pittsburgh, PA 15219 USA.
EM badylaks@upmc.edu
OI Badylak, Stephen/0000-0003-3555-0689
FU NIBIB NIH HHS [R01 EB000506, R01 EB000506-02]
CR Androjna C, 2007, TISSUE ENG, V13, P233, DOI 10.1089/ten.2006.0050
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Badylak S, 2000, J PEDIATR SURG, V35, P1097, DOI 10.1053/jpsu.2000.7834
   Badylak SF, 2005, J SURG RES, V128, P87, DOI 10.1016/j.jss.2005.03.002
   Badylak SF, 2001, EXP HEMATOL, V29, P1310, DOI 10.1016/S0301-472X(01)00729-9
   BEATTIE AJ, TISSUE ENG IN PRESS
   Bolland F, 2007, BIOMATERIALS, V28, P1061, DOI 10.1016/j.biomaterials.2006.10.005
   Brennan EP, 2006, TISSUE ENG, V12, P2949, DOI 10.1089/ten.2006.12.2949
   Brown AL, 2002, BIOMATERIALS, V23, P2179, DOI 10.1016/S0142-9612(01)00350-7
   Brown B, 2006, TISSUE ENG, V12, P519, DOI 10.1089/ten.2006.12.519
   Coburn JC, 2007, J BIOMED MATER RES A, V81A, P250, DOI 10.1002/jbm.a.30943
   Derwin KA, 2006, J BONE JOINT SURG AM, V88A, P2665, DOI 10.2106/JBJS.E.01307
   Freytes DO, 2004, BIOMATERIALS, V25, P2353, DOI 10.1016/j.biomaterials.2003.09.015
   FREYTES DO, 2008, J BIOMED MAT A  0128
   Freytes DO, 2008, J BIOMED MATER RES B, V84B, P408, DOI 10.1002/jbm.b.30885
   Freytes DO, 2006, J BIOMED MATER RES B, V78B, P327, DOI 10.1002/jbm.b.30491
   Gilbert TW, 2007, J BONE JOINT SURG AM, V89A, P621, DOI 10.2106/JBJS.F.00742
   Gilbert TW, 2007, TISSUE ENG, V13, P1313, DOI 10.1089/ten.2006.0318
   Gilbert TW, 2006, J BIOMECH ENG-T ASME, V128, P890, DOI 10.1115/1.2354200
   Gloeckner DC, 2000, J BIOMED MATER RES, V52, P365, DOI 10.1002/1097-4636(200011)52:2<365::AID-JBM17>3.0.CO;2-3
   Gloeckner DC, 2002, J UROLOGY, V167, P2247, DOI 10.1016/S0022-5347(05)65137-3
   KOCHUPURA PV, 2005, CIRCULATION, V112, P1144
   Li F, 2004, ENDOTHELIUM-J ENDOTH, V11, P199, DOI 10.1080/10623320490512390
   Nagatomi J, 2005, ANN BIOMED ENG, V33, P1078, DOI 10.1007/s10439-005-5776-x
   Nieponice A, 2006, ANN THORAC SURG, V82, P2050, DOI 10.1016/j.athoracsur.2006.06.036
   Raghavan D, 2005, J BIOMED MATER RES A, V73A, P90, DOI 10.1002/jbm.a.30268
   Record RD, 2001, BIOMATERIALS, V22, P2653, DOI 10.1016/S0142-9612(01)00007-2
   REING JE, 2008, TISSUE ENG A    0724
   ROBINSON KA, 2005, CIRCULATION, V112, P1135
   Sacks MS, 1999, J BIOMED MATER RES, V46, P1, DOI 10.1002/(SICI)1097-4636(199907)46:1<1::AID-JBM1>3.0.CO;2-7
   Sacks MS, 1997, ANN BIOMED ENG, V25, P678, DOI 10.1007/BF02684845
   Sacks MS, 1998, ANN BIOMED ENG, V26, P892, DOI 10.1114/1.135
   Sacks MS, 1999, J BIOMECH ENG-T ASME, V121, P551, DOI 10.1115/1.2835086
   Sacks MS, 2000, J ELASTICITY, V61, P199, DOI 10.1023/A:1010917028671
   Sacks MS, 2003, J BIOMECH ENG-T ASME, V125, P280, DOI 10.1115/1.1544508
   Sarikaya A, 2002, TISSUE ENG, V8, P63, DOI 10.1089/107632702753503063
   Sun W, 2003, J BIOMECH ENG-T ASME, V125, P372, DOI 10.1115/1.1572518
   Vande Geest JP, 2004, J BIOMECH ENG-T ASME, V126, P815, DOI 10.1115/1.1824121
   Wallis MC, 2008, TISSUE ENG PT A, V14, P339, DOI 10.1089/tea.2006.0398
   Zantop T, 2006, J ORTHOP RES, V24, P1299, DOI 10.1002/jor.20071
NR 40
TC 77
Z9 80
U1 0
U2 27
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2008
VL 29
IS 36
BP 4775
EP 4782
DI 10.1016/j.biomaterials.2008.08.022
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 372YV
UT WOS:000260939100007
PM 18801572
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Rockwood, DN
   Akins, RE
   Parrag, IC
   Woodhouse, KA
   Rabolt, JF
AF Rockwood, Danielle N.
   Akins, Robert E., Jr.
   Parrag, Ian C.
   Woodhouse, Kimberly A.
   Rabolt, John F.
TI Culture on electrospun polyurethane scaffolds decreases atrial
   natriuretic peptide expression by cardiomyocytes in vitro
SO BIOMATERIALS
LA English
DT Article
DE Cardiac tissue engineering; Electrospinning; Biodegradable polyurethane;
   Atrial natriuretic peptide (ANP); Cardiomyocyte
ID GENE-EXPRESSION; CARDIAC-MUSCLE; VENTRICULAR MYOCYTES; TISSUE
   ARCHITECTURE; MESSENGER-RNA; HEART; SKELETAL; CELLS; ARRANGEMENT;
   ALIGNMENT
AB The function of the mammalian heart depends on the functional alignment of cardiomyocytes, and controlling cell alignment is an important consideration in biomaterial design for cardiac tissue engineering and research. The physical cues that guide functional cell alignment in vitro and the impact of substrate-imposed alignment on cell phenotype, however, are only partially understood. In this report, primary cardiac ventricular cells were grown on electrospun, biodegradable polyurethane (ES-PU) with either aligned or unaligned microfibers. ES-PU scaffolds supported high-density cultures and cell subpopulations remained intact over two weeks in culture. ES-PU cultures contained electricall-coupled y cardiomyocytes with connexin-43 localized to points of cell:cell contact. Multi-cellular organization correlated with rnicrofiber orientation and aligned materials yielded highly oriented cardiomyocyte groupings. Atrial natriuretic peptide, a molecular marker that shows decreasing expression during ventricular cell maturation, was significantly lower in cultures grown on ES-PU scaffolds than in those grown on tissue culture polystyrene. Cells grown on aligned ES-PU had significantly lower steady state levels of ANP and constitutively released less ANP over time indicating that scaffold-imposed cell organization resulted in a shift in cell phenotype to a more mature state. We conclude that the physical organization of microfibers in ES-PU scaffolds impacts both multi-cellular architecture and cardiac cell phenotype in vitro. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Akins, Robert E., Jr.] Alfred I DuPont Hosp Children, Wilmington, DE 19803 USA.
   [Rockwood, Danielle N.; Rabolt, John F.] Univ Delaware, Dept Mat Sci & Engn, Newark, DE 19711 USA.
   [Parrag, Ian C.; Woodhouse, Kimberly A.] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3E5, Canada.
RP Akins, RE (reprint author), Alfred I DuPont Hosp Children, 1600 Rockland Rd, Wilmington, DE 19803 USA.
EM rakins@nemours.org
OI Akins, Robert/0000-0001-9706-0752
FU NSF [DMR - 0315461]; National Center for Research Resources at NIH [1
   P20-RR020173-01]; Nemours Foundation (REA); Canadian Institutes for
   Health Research (KAW); Natural Science and Engineering Research Council
   - Canada (KAW)
FX The authors would like to thank Therese McLaughlin for the help with
   cell culture, Frank Kriss and Dr. Chao Ni for assistance in electron
   microscopy, and Melissa Rhodes, Steve Beard, Alfred Lance and Dave
   Cowgill for the help in manufacturing the mandrel used for aligning the
   fibers during electrospinning. In addition, the authors greatly
   appreciate the help of Dr. Chuanzhao Li and Robert Long with flow
   cytometry data collection. This work was funded through NSF (NIRT and
   DMR - 0315461 to JFR), the National Center for Research Resources at NIH
   (RPG# 1 P20-RRO20173-01 to REA), the Nemours Foundation (REA), the
   Canadian Institutes for Health Research (KAW), and the Natural Science
   and Engineering Research Council - Canada (KAW).
CR Akins RE, 2007, DNA CELL BIOL, V26, P425, DOI 10.1089/dna.2006.0543
   Barber RD, 2005, PHYSIOL GENOMICS, V21, P389, DOI 10.1152/physiolgenomics.00025.2005
   Barth AS, 2005, PFLUG ARCH EUR J PHY, V450, P201, DOI 10.1007/s00424-005-1404-8
   Baudino TA, 2008, MICROSC MICROANAL, V14, P117, DOI 10.1017/S1431927608080021
   BLOCH KD, 1986, CELL, V47, P695, DOI 10.1016/0092-8674(86)90512-X
   Cameron VA, 2003, ENDOCRINOLOGY, V144, P2191, DOI 10.1210/en.2003-0127
   Carrier RL, 2002, TISSUE ENG, V8, P175, DOI 10.1089/107632702753724950
   CLAYCOMB WC, 1988, BIOCHEM J, V255, P617
   DEBOLD AJ, 1981, LIFE SCI, V28, P89, DOI 10.1016/0024-3205(81)90370-2
   Fink C, 2000, FASEB J, V14, P669
   Guenet JL, 1996, MAMM GENOME, V7, P13, DOI 10.1007/s003359900004
   HARDING SE, 1994, EUR HEART J, V15, P35, DOI 10.1093/eurheartj/15.suppl_D.35
   Hooks DA, 2007, CIRC RES, V101, pE103, DOI 10.1161/CIRCRESAHA.107.161075
   HORI K, 2000, SCAND J GASTROENTERO, V35, P24
   IRONS CE, 1993, AM J PHYSIOL, V264, pH282
   Koibuchi N, 2007, CIRC RES, V100, P850, DOI 10.1161/01.RES.000026193.13269.bf
   LEGRICE IJ, 1995, AM J PHYSIOL-HEART C, V269, pH571
   LU L, 1996, MRS BULL, V31, P28
   Matsuda T, 2005, BIOCHEM BIOPH RES CO, V326, P228, DOI 10.1016/j.bbrc.2004.11.019
   McDevitt TC, 2003, J BIOMED MATER RES A, V66A, P586, DOI 10.1002/jbm.a.10504
   McDevitt TC, 2002, J BIOMED MATER RES, V60, P472, DOI 10.1002/jbm.1292
   McGrath MF, 2005, PEPTIDES, V26, P933, DOI 10.1016/j.peptides.2004.12.022
   Nemer M, 2008, CARDIOVASC PATHOL, V17, P48, DOI 10.1016/j.carpath.2007.06.005
   Opie L. H., 2004, HEART PHYSL CELL CIR
   Pandey KN, 2005, PEPTIDES, V26, P901, DOI 10.1016/j.peptides.2004.09.024
   Reinecke H, 2000, J CELL BIOL, V149, P731, DOI 10.1083/jcb.149.3.731
   Riboldi SA, 2008, J BIOMED MATER RES A, V84A, P1094, DOI 10.1002/jbm.a.31534
   Riboldi SA, 2005, BIOMATERIALS, V26, P4606, DOI 10.1016/j.biomaterials.2004.11.035
   Rockwood DN, 2007, J BIOMAT SCI-POLYM E, V18, P743, DOI 10.1163/156856207781034115
   SCHULTE R, 2000, BIOMED TECH, V45, P97
   SIMPSON DG, 1994, J CELL PHYSIOL, V161, P89, DOI 10.1002/jcp.1041610112
   Skarja GA, 1998, J BIOMAT SCI-POLYM E, V9, P271, DOI 10.1163/156856298X00659
   SPERELAKIS N, 1978, ENVIRON HEALTH PERSP, V26, P243, DOI 10.2307/3428847
   Vandenburgh HH, 1996, AM J PHYSIOL-CELL PH, V270, pC1284
   WOLLENBERGER A, 1985, BASIC RES CARDIOL, V80, P9
   Wu CF, 1997, J BIOL CHEM, V272, P14860, DOI 10.1074/jbc.272.23.14860
   Xin M, 2007, P NATL ACAD SCI USA, V104, P7975, DOI 10.1073/pnas.0702447104
   Yamane M, 2007, BIOCHEM BIOPH RES CO, V353, P1023, DOI 10.1016/j.bbrc.2006.12.144
   Zimmermann WH, 2002, CIRC RES, V90, P223, DOI 10.1161/hh0202.103644
   Zong XH, 2005, BIOMATERIALS, V26, P5330, DOI 10.1016/j.biomaterials.2005.01.052
NR 40
TC 78
Z9 80
U1 0
U2 41
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2008
VL 29
IS 36
BP 4783
EP 4791
DI 10.1016/j.biomaterials.2008.08.034
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 372YV
UT WOS:000260939100008
PM 18823659
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Qiu, JJ
   He, ZX
   Liu, CM
   Guo, XD
   Zheng, QX
AF Qiu, Jin-Jun
   He, Zhao-Xuan
   Liu, Cheng-Mei
   Guo, Xiao-Dong
   Zheng, Qi-Xing
TI Crosslinking property of an oligomeric unsaturated phosphoester used as
   a potential injectable biomaterial
SO BIOMEDICAL MATERIALS
LA English
DT Article; Proceedings Paper
CT 5th China-Korea Symposium on Biomaterials and Nano-Biotechnology
CY OCT 14-18, 2007
CL Wuhan, PEOPLES R CHINA
ID IN-VIVO DEGRADATION; ORTHOPEDIC BIOMATERIALS; MECHANICAL-PROPERTIES;
   BONE-CEMENT; POLY(PHOSPHOESTER); SITU; POLYPHOSPHOESTER; COMPOSITE;
   POLYANHYDRIDES; DELIVERY
AB An unsaturated polyphosphoester (UPPE) that has double bonds in repeatable units could crosslink with a vinyl monomer. A study of how the crosslinking temperature, setting time and mechanical properties are affected by the UPPE molecular weight, N-vinyl pyrrolidinone (NVP)/UPPE ratio and benzoyl peroxide (BPO)/UPPE ratio was conducted. The results of the study indicated that the maximum crosslinking temperature is between 41.1 degrees C and 82.3 degrees C, which is lower than the 97 degrees C of poly(methyl methacrylate) bone cement. The BPO concentration strongly affected the maximum temperature and setting time. High concentration of BPO gives a rapid polymerization rate, causing reaction heat to be released immediately. The compressive strength and compressive modulus will be enhanced with an increase in the NVP/UPPE ratio, the UPPE molecular weight and the BPO concentration. For all formulations, the compressive strength values are between 3.3 MPa and 11.0 MPa and the compressive modulus values are between 4.9 MPa and 101.9 MPa. These initial studies suggest that UPPE is one kind of potential injectable bone tissue engineering scaffold material.
C1 [Qiu, Jin-Jun; He, Zhao-Xuan; Liu, Cheng-Mei] Huazhong Univ Sci & Technol, Dept Chem & Chem Engn, Wuhan 430074, Peoples R China.
   [Guo, Xiao-Dong; Zheng, Qi-Xing] Huazhong Univ Sci & Technol, Union Hosp, Dept Orthoped, Wuhan 430022, Peoples R China.
RP Qiu, JJ (reprint author), Huazhong Univ Sci & Technol, Dept Chem & Chem Engn, Wuhan 430074, Peoples R China.
EM liukui@hust.edu.cn
RI guo, xiaodong/K-2600-2013
CR Burdick JA, 2001, J BIOMAT SCI-POLYM E, V12, P1253, DOI 10.1163/156856201753395789
   Burdick JA, 2002, J BIOMED MATER RES, V63, P484, DOI 10.1002/jbm.10298
   Burkoth AK, 2000, BIOMATERIALS, V21, P2395, DOI 10.1016/S0142-9612(00)00107-1
   Chaubal MV, 2003, J BIOMAT SCI-POLYM E, V14, P45, DOI 10.1163/15685620360511137
   DAHIYAT BI, 1995, J CONTROL RELEASE, V33, P13, DOI 10.1016/0168-3659(94)00039-W
   Frazier DD, 1997, J BIOMED MATER RES, V35, P383, DOI 10.1002/(SICI)1097-4636(19970605)35:3<383::AID-JBM12>3.0.CO;2-G
   GOLDSTEIN SA, 1991, J BIOMECH, V24, P135, DOI 10.1016/0021-9290(91)90384-Y
   He SL, 2000, BIOMATERIALS, V21, P2389, DOI 10.1016/S0142-9612(00)00106-X
   Huang SW, 2004, BIOMACROMOLECULES, V5, P306, DOI 10.1021/bm034241l
   JEFFERISS CD, 1975, J BONE JOINT SURG BR, V57, P511
   KE TY, 1998, GAODENG XUEXIAO HUAX, V19, P1335
   Kumar N, 2002, ADV DRUG DELIVER REV, V54, P889, DOI 10.1016/S0169-409X(02)00050-9
   Leong KW, 1995, CHINESE J POLYM SCI, V13, P289
   Pascual B, 1996, BIOMATERIALS, V17, P509, DOI 10.1016/0142-9612(96)82725-6
   Peter SJ, 1998, J BIOMED MATER RES, V41, P1
   Peter SJ, 1999, J BIOMED MATER RES, V44, P314
   Qiu JJ, 2006, J APPL POLYM SCI, V102, P3095, DOI 10.1002/app.23720
   Salem AK, 2003, ADV MATER, V15, P210, DOI 10.1002/adma.200390047
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   Wan ACA, 2004, J BIOMED MATER RES B, V70B, P91, DOI 10.1002/jbm.b.30022
   Wan ACA, 2001, BIOMATERIALS, V22, P1147, DOI 10.1016/S0142-9612(00)00355-0
   Wang DA, 2003, BIOMATERIALS, V24, P3969, DOI 10.1016/S0142-9612(03)00280-1
   Wang J, 2001, J AM CHEM SOC, V123, P9480, DOI 10.1021/ja016062m
   Wang S, 2001, BIOMATERIALS, V22, P1157, DOI 10.1016/S0142-9612(00)00356-2
   Yaszemski M J, 1995, Tissue Eng, V1, P41, DOI 10.1089/ten.1995.1.41
   Zhao Z, 2003, ADV DRUG DELIVER REV, V55, P483, DOI 10.1016/S0169-409X(03)00040-1
NR 26
TC 4
Z9 8
U1 0
U2 15
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD DEC
PY 2008
VL 3
IS 4
AR 044107
DI 10.1088/1748-6041/3/4/044107
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 376TX
UT WOS:000261207000011
PM 19029608
DA 2018-10-19
ER

PT J
AU Tang, XJ
   Gui, L
   Lu, XY
AF Tang, Xiao-Jun
   Gui, Lai
   Lue, Xiao-Ying
TI Hard tissue compatibility of natural hydroxyapatite/chitosan composite
SO BIOMEDICAL MATERIALS
LA English
DT Article; Proceedings Paper
CT 5th China-Korea Symposium on Biomaterials and Nano-Biotechnology
CY OCT 14-18, 2007
CL Wuhan, PEOPLES R CHINA
ID BONE-GRAFT SUBSTITUTES; IN-VITRO; CHITOSAN; OSTEOCONDUCTION;
   REGENERATION; BIOMATERIAL; REPAIR; PASTE
AB The natural hydroxyapatite/chitosan (NHC) composite is a new synthesized material. The aim of this experiment was to assess the bone tissue compatibility of this NHC composite in vivo. Twenty-four healthy New Zealand rabbits were included in this study. Of those, 20 were used as the experimental group and four as the control group. In the experimental group, animals receive a cranium defect procedure and NHC composite repair. In the control group, animals underwent the cranium defect procedure without NHC composite repair. At 1, 4, 12, 24, and 40 weeks after surgery, the animals were sacrificed and samples were taken and assessed by gross observation, three-dimensional (3D) computerized tomographic (CT) reconstruction, histology and scanning electron microscope. Our results showed that at 1 week after repairing the bone defect with the NHC composite in the experimental group, new bone appeared around the composite and matured gradually. At 24 weeks after surgery, there were little collagenous tissues present between the material and surrounding bones. At 40 weeks after surgery, new bone had grown into the mature bone and total osseointegration had occurred. In the control group, however, no bone defect healing was observed at 40 weeks after surgery. All these results of the present in vivo work suggest that the NHC composite has a good hard tissue biocompatibility and an excellent osteoconductivity. It is suitable for artificial bone implants and frame materials of tissue engineering.
C1 [Tang, Xiao-Jun; Gui, Lai] Chinese Acad Med Sci, Plast Surg Hosp, Dept Craniomaxillofacial Sur, Beijing 100144, Peoples R China.
   [Tang, Xiao-Jun; Gui, Lai] Peking Union Med Coll, Beijing 100144, Peoples R China.
   [Lue, Xiao-Ying] Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing 210096, Peoples R China.
RP Tang, XJ (reprint author), Chinese Acad Med Sci, Plast Surg Hosp, Dept Craniomaxillofacial Sur, 33 Ba Da Chu Rd, Beijing 100144, Peoples R China.
EM laiguiplastic@tom.com; luxy@seu.edu.cn
CR Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282
   Arts JJC, 2006, BIOMATERIALS, V27, P1110, DOI 10.1016/j.biomaterials.2005.07.024
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Carvalho Alexandre L, 2007, J Oral Implantol, V33, P267, DOI 10.1563/1548-1336(2007)33[267:EOGSOT]2.0.CO;2
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   Chang MC, 2002, BIOMATERIALS, V23, P4811, DOI 10.1016/S0142-9612(02)00232-6
   DEGROOT K, 1980, BIOMATERIALS, V1, P47, DOI 10.1016/0142-9612(80)90059-9
   DING YH, 2001, CHIN J MARINE DRUGS, V20, P32
   Gardiner A, 2007, SPORTS MED ARTHROSC, V15, P158, DOI 10.1097/JSA.0b013e31805c090b
   HEIMKE G, 1987, BIOMATERIALS CLIN AP, V9, P93
   Janes KA, 2003, J APPL POLYM SCI, V88, P2769, DOI 10.1002/app.12016
   Klokkevold PR, 1996, J PERIODONTOL, V67, P1170, DOI 10.1902/jop.1996.67.11.1170
   Kofron MD, 2004, CURR OPIN BIOTECH, V15, P399, DOI 10.1016/j.copbio.2004.07.004
   Kuo SM, 2006, J BIOMED MATER RES A, V76A, P408, DOI 10.1002/jbm.a.30534
   Lahiji A, 2000, J BIOMED MATER RES, V51, P586
   Laurencin C, 2006, EXPERT REV MED DEVIC, V3, P49, DOI 10.1586/17434440.3.1.49
   LU XY, 2005, 3 INT S AP CORR BIOM
   Lue XY, 2007, KEY ENG MATER, V342-343, P213, DOI 10.4028/www.scientific.net/KEM.342-343.213
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   Manjubala I, 2000, J MATER SCI-MATER M, V11, P705, DOI 10.1023/A:1008915510976
   Mukherjee DP, 2003, J BIOMED MATER RES B, V67B, P603, DOI 10.1002/jbm.b.10050
   MUZZARELLI RAA, 1993, BIOMATERIALS, V14, P39, DOI 10.1016/0142-9612(93)90073-B
   Pang EK, 2005, J PERIODONTOL, V76, P1526, DOI 10.1902/jop.2005.76.9.1526
   PANTALEONE D, 1992, CARBOHYD RES, V237, P325, DOI 10.1016/S0008-6215(92)84256-R
   Park JB, 2007, IMPLANT DENT, V16, P246, DOI 10.1097/ID.0b013e3181237926
   Park YJ, 2000, BIOMATERIALS, V21, P153
   Seo DS, 2008, ANN BIOMED ENG, V36, P132, DOI 10.1007/s10439-007-9394-7
   Takagi S, 2003, DENT MATER, V19, P797, DOI 10.1016/S0109-5641(03)00028-9
   Varum KM, 1997, CARBOHYD RES, V299, P99, DOI 10.1016/S0008-6215(96)00332-1
   Wang XH, 2002, BIOMATERIALS, V23, P4167, DOI 10.1016/S0142-9612(02)00153-9
   Zhang L, 2005, J MATER SCI-MATER M, V16, P213, DOI 10.1007/s10856-005-6682-3
   ZHENG BZ, 2004, THESIS SE U NANJING, P39
NR 32
TC 13
Z9 17
U1 1
U2 9
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD DEC
PY 2008
VL 3
IS 4
AR 044115
DI 10.1088/1748-6041/3/4/044115
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 376TX
UT WOS:000261207000019
PM 19029618
DA 2018-10-19
ER

PT J
AU Fozdar, DY
   Wu, X
   Patrick, CW
   Chen, S
AF Fozdar, David Y.
   Wu, Xuemei
   Patrick, Charles W., Jr.
   Chen, Shaochen
TI Micro-well texture printed into PEG hydrogels using the FILM
   nanomanufacturing process affects the behavior of preadipocytes
SO BIOMEDICAL MICRODEVICES
LA English
DT Article
DE adipose tissue engineering; nanomanufacturing; polyethylene glycol;
   preadipocyte; tissue scaffold
ID FLAP; FAT; DIFFERENTIATION; TRANSPLANTATION; NANOSTRUCTURES;
   RECONSTRUCTION; ADHESION; ATROPHY; TENSION; CELLS
AB To date, biomaterial scaffolds for adipose tissue engineering have focused on macro- and upper micro-scale fabrication, biocompatibility, and biodegradation, but have failed to recapitulate the sub-micron dimensions of native extracellular matrix (ECM) and, therefore, have not optimized material-cell interactions. Here, we report the findings from a study investigating the effects of a quasi-mimetic sub-micron (< 1 mu m) surface texture on the qualitative behavior of preadipocytes (PAs). We found that PAs in contact with tread-like micro-well structures exhibit a different morphology relative to PAs seeded onto control smooth glass surfaces. Additionally, the micro-well topography induced isolated PAs to undergo adipogenesis, which usually occurs in the presence of aggregates of contact-inhibited PAs. The micro-well structures were printed into polyethylene glycol dimethacrylate (PEGDMA) using the recently reported nanomanufacturing process called Flash Imprint Lithography Using a Mask Aligner (FILM). FILM is a simple process that can be utilized to fabricate micro- and nanostructures in UV-curable materials (D.Y. Fozdar, W. Zhang, M. Palard, C.W. Patrick Jr., S.C. Chen, Flash Imprint Lithography Using A Mask Aligner (FILM): A Method for Printing Nanostructures in Photosensitive Hydrogels for Tissue Engineering. Nanotechnology 19, 2008). We demonstrate the utilization of the FILM process for a tissue engineering application for the first time. The micro-well topographical theme is characterized by contact angle and surface energy analysis and the results were compared with those for smooth glass and unpatterned PEGDMA surfaces. Based on our observations, we believe that the micro-well texture may ultimately be beneficial on implantable tissue scaffolds.
C1 [Fozdar, David Y.; Chen, Shaochen] Univ Texas Austin, Dept Mech Engn, Ctr Nano Mol Sci & Technol, Microelect Res Ctr, Austin, TX 78712 USA.
   [Wu, Xuemei; Patrick, Charles W., Jr.] Univ Texas MD Anderson Canc Ctr, Dept Biomed Engn, Houston, TX 77030 USA.
RP Chen, S (reprint author), Univ Texas Austin, Dept Mech Engn, Ctr Nano Mol Sci & Technol, Microelect Res Ctr, 1 Univ Stn,C2200, Austin, TX 78712 USA.
EM davidfozdar@mail.utexas.edu; scchen@mail.utexas.edu
FU Office of Naval Research to SCC; Susan G. Komen Foundation; NCI
   [CA16672]; M. D. Anderson Cancer Center; NSF at UT-Austin
FX We acknowledge the technical assistance of Ms. Krithi Mittakanti during
   her summer internship. This work is supported in part by a grant from
   the Office of Naval Research to SCC. CWP acknowledges the grant from the
   Susan G. Komen Foundation and a NCI grant CA16672 awarded to M. D.
   Anderson Cancer Center. Work was performed in part at the Center for
   Nano and Molecular Science and Technology (CNM) and at the
   Microelectronics Research Center (MRC), a part of the National
   Microfabrication Infrastructure Network supported by NSF at UT- Austin.
CR Abrams GA, 2000, CELL TISSUE RES, V299, P39, DOI 10.1007/s004419900074
   ADAMSON AW, 1970, J COLLOID INTERF SCI, V34, P461, DOI 10.1016/0021-9797(70)90206-7
   ADAMSON AW, 1982, PHYS CHEM SURFACES
   Andreas JM, 1938, J PHYS CHEM-US, V42, P1001, DOI 10.1021/j100903a002
   Asai S, 2006, ANN PLAS SURG, V57, P154, DOI 10.1097/01.sap.0000216243.91162.c2
   BILLINGS E, 1989, PLAST RECONSTR SURG, V83, P368, DOI 10.1097/00006534-198902000-00033
   Cassie ABD, 1944, T FARADAY SOC, V40, P0546, DOI 10.1039/tf9444000546
   Colburn M, 1999, P SOC PHOTO-OPT INS, V3676, P379, DOI 10.1117/12.351155
   ERSEK RA, 1991, PLAST RECONSTR SURG, V87, P219, DOI 10.1097/00006534-199102000-00001
   Fowkes FM, 1940, J AM CHEM SOC, V62, P3377, DOI 10.1021/ja01869a029
   FOZDAR DY, 2008, NANOTECHNOLOGY, V19, DOI DOI 10.1088/0957-4484/19/21/215303
   GIRIFALCO LA, 1957, J PHYS CHEM-US, V61, P904, DOI 10.1021/j150553a013
   Hunt JA, 2003, PLAST RECONSTR SURG, V111, P1497, DOI 10.1097/01.PRS.0000049646.25757.BE
   Kim P, 2005, NANOTECHNOLOGY, V16, P2420, DOI 10.1088/0957-4484/16/10/072
   Patel PN, 2005, TISSUE ENG, V11, P1498, DOI 10.1089/ten.2005.11.1498
   Patrick CW, 1999, TISSUE ENG, V5, P139, DOI 10.1089/ten.1999.5.139
   Patrick CW, 2000, SEMIN SURG ONCOL, V19, P302, DOI 10.1002/1098-2388(200010/11)19:3<302::AID-SSU12>3.0.CO;2-S
   Patrick CW, 2001, ANAT RECORD, V263, P361, DOI 10.1002/ar.1113
   Patrick CW, 2002, TISSUE ENG, V8, P283, DOI 10.1089/107632702753725049
   Sniadecki N, 2006, ANN BIOMED ENG, V34, P59, DOI 10.1007/s10439-005-9006-3
   Steinberg T, 2007, NANO LETT, V7, P287, DOI [10.1021/nl062271z, 10.1021/nl06227z]
   Vaienti L, 2005, PLAST RECONSTR SURG, V116, P699, DOI 10.1097/01.prs.0000177449.12366.48
   Wang XC, 2005, ANN PLAS SURG, V55, P617, DOI 10.1097/01.sap.0000189659.76694.e2
   Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058
   Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031
NR 25
TC 8
Z9 8
U1 0
U2 9
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1387-2176
J9 BIOMED MICRODEVICES
JI Biomed. Microdevices
PD DEC
PY 2008
VL 10
IS 6
BP 839
EP 849
DI 10.1007/s10544-008-9198-z
PG 11
WC Engineering, Biomedical; Nanoscience & Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA 348YQ
UT WOS:000259246400008
PM 18561027
DA 2018-10-19
ER

PT J
AU Park, D
   Lim, SR
   Yun, YS
   Park, JM
AF Park, Donghee
   Lim, Seong-Rin
   Yun, Yeoung-Sang
   Park, Jong Moon
TI Development of a new Cr(VI)-biosorbent from agricultural biowaste
SO BIORESOURCE TECHNOLOGY
LA English
DT Article
DE Biosorption; Chromium; Cr(VI)-biosorbent; Reduction; Agricultural
   biowaste
ID HEXAVALENT CHROMIUM REMOVAL; DEAD FUNGAL BIOMASS; AQUEOUS-SOLUTIONS;
   TRIVALENT CHROMIUM; ACTIVATED CARBONS; CR(VI) REMOVAL; WASTE-WATER;
   BIOSORPTION; MECHANISM; SORPTION
AB Among useless but abundant agricultural biowastes such as banana skin, green tea waste, oak leaf, walnut shell, peanut shell and rice husk, in this study, banana skin was screened as the most efficient biomaterial to remove toxic Cr(VI) from aqueous solution. X-ray photoelectron spectroscopy (XPS) study revealed that the mechanism of Cr(VI) biosorption by banana skin was its complete reduction into Cr(III) in both aqueous and solid phases and partial binding of the reduced-Cr(III), in the range of pH 1.5-4 tested. One gram of banana skin Could reduce 249.6 (+/- 4.2) mg of Cr(VI) at initial pH 1.5. Namely, Cr(VI)-reducing capacity of banana skin was four times higher than that of a common chemical Cr(VI)-reductant, FeSO4 center dot 7H(2)O. To diminish undesirable/serious organic leaching from the biomaterial and to enhance removal efficiency of total Cr, its powder was immobilized within Ca-alginate bead. The developed Cr(VI)-biosorbent Could completely reduce toxic Cr(VI) to less toxic Cr(Ill) and Could remove almost of the reduced-Cr(III) from aqueous phase. On the basis of removal mechanisms of Cr(VI) and total Cr by the Cr(VI)-biosorbent, a kinetic model was derived and could be Successfully used to predict their removal behaviors in aqueous phase. In conclusion, Our Cr(VI)-biosorbent must be a potent candidate to substitute for chemical reductants as well as adsorbents for treating Cr(VI)-bearing wastewaters. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Park, Donghee; Park, Jong Moon] Pohang Univ Sci & Technol, Adv Environm Biotechnol Res Ctr, Dept Chem Engn, Sch Environm Sci & Engn, Pohang 790784, South Korea.
   [Lim, Seong-Rin] Univ Minnesota, Dept Bioprod & Biosyst Engn, St Paul, MN 55108 USA.
   [Yun, Yeoung-Sang] Chonbuk Natl Univ, Ind Technol Res Inst, Div Environm & Chem Engn, Jeonju 561756, South Korea.
RP Park, JM (reprint author), Pohang Univ Sci & Technol, Adv Environm Biotechnol Res Ctr, Dept Chem Engn, Sch Environm Sci & Engn, San 31,Hyoja Dong, Pohang 790784, South Korea.
EM jmpark@postech.ac.kr
RI Yun, Yeoung-Sang/F-8340-2011
OI Yun, Yeoung-Sang/0000-0002-2583-8278; Lim, Seong-Rin/0000-0002-5192-0486
FU KOSEF; Program for Advanced Education of Chemical Engineers at POSTECH;
   Korea Ministry of Environment
FX This work was financially Supported by the KOSEF through the AEBRC and
   the Program for Advanced Education of Chemical Engineers at POSTECH.
   This work was also partially supported by Korea Ministry of Environment
   as "The Eco-technopia 21 project".
CR ABBAS M, 2008, WATER AIR SOIL POLL, DOI DOI 10.1007/S11270-007-9613-8
   Anderson RA, 1997, REGUL TOXICOL PHARM, V26, pS35, DOI 10.1006/rtph.1997.1136
   Araujo MM, 1997, INT BIODETER BIODEGR, V40, P63, DOI 10.1016/S0964-8305(97)00064-4
   Baral A., 2002, ENVIRON SCI POLICY, V5, P121, DOI DOI 10.1016/S1462-9011(02)00028-X
   Barnhart J, 1997, REGUL TOXICOL PHARM, V26, pS3, DOI 10.1006/rtph.1997.1132
   Clesceri L. S., 1998, STANDARD METHODS EXA, P366
   Copello GJ, 2008, BIORESOURCE TECHNOL, V99, P6538, DOI 10.1016/j.biortech.2007.11.055
   Costa LG, 2003, BIOMARKERS, V8, P1, DOI 10.1080/13547500210148315
   Dambies L, 2001, COLLOID SURFACE A, V177, P203, DOI 10.1016/S0927-7757(00)00678-6
   Deng SB, 2005, ENVIRON SCI TECHNOL, V39, P8490, DOI 10.1021/es050697u
   Dupont L, 2003, ENVIRON SCI TECHNOL, V37, P4235, DOI 10.1021/es0342345
   ELANGOVAN R, 2008, J HAZARD MATER, DOI DOI 10.1016/J.JHAZMAR.2007.06.06
   ELANGOVAN R, 2008, CHEM ENG J, DOI DOI 10.1016/J.CEJ.2007.10.102
   ERTUGAY N, 2008, J HAZARD MATER, DOI DOI 10.1016/J.JHAZMAT.2007.10.07
   Gao H, 2008, J HAZARD MATER, V150, P446, DOI 10.1016/j.jhazmat.2007.04.126
   Gode F, 2005, J HAZARD MATER, V119, P175, DOI 10.1016/j.jhazmat.2004.12.004
   Gode F, 2008, J HAZARD MATER, V152, P1201, DOI 10.1016/j.jhazmat.2007.07.104
   Gokhale SV, 2008, BIORESOURCE TECHNOL, V99, P3600, DOI 10.1016/j.biortech.2007.07.039
   GUPTA VK, 2008, J HAZARD MATER, DOI DOI 10.1016/J.JHAZMAT.2007.10.03
   HAMEED BH, 2008, J HAZARD MATER, DOI DOI 10.1016/JJHAZMAT.2008.01.19
   KUMAR PA, 2008, CEHM ENG J, DOI DOI 10.1016/J.CEJ.2007.11.004
   Li HD, 2008, BIORESOURCE TECHNOL, V99, P6271, DOI 10.1016/j.biortech.2007.12.002
   Liu CC, 2006, IND ENG CHEM RES, V45, P8891, DOI 10.1021/ie060978q
   LOW KS, 1995, BIORESOURCE TECHNOL, V51, P227, DOI 10.1016/0960-8524(94)00123-I
   Mohan D, 2006, J HAZARD MATER, V137, P762, DOI 10.1016/j.jhazmat.2006.06.060
   Nakano Y, 2001, WATER RES, V35, P496, DOI 10.1016/S0043-1354(00)00279-7
   Noeline BF, 2005, SEP PURIF TECHNOL, V45, P131, DOI 10.1016/j.seppur.2005.03.004
   Park D, 2006, IND ENG CHEM RES, V45, P2405, DOI 10.1021/ie0509387
   Park D, 2005, CHEMOSPHERE, V60, P1356, DOI 10.1016/j.chemosphere.2005.02.020
   Park D, 2005, WATER RES, V39, P533, DOI 10.1016/j.watres.2004.11.002
   Park D, 2005, PROCESS BIOCHEM, V40, P2559, DOI 10.1016/j.procbio.2004.12.002
   Park D, 2004, ENVIRON SCI TECHNOL, V38, P4860, DOI 10.1021/es035329
   PARK D, 2006, IND ENG CHEM RES, V46, P5059
   Park D, 2008, BIORESOURCE TECHNOL, V99, P1141, DOI 10.1016/j.biortech.2007.02.025
   Park D, 2007, CHEMOSPHERE, V66, P939, DOI 10.1016/j.chemosphere.2006.05.068
   Park HG, 2004, J CHEM TECHNOL BIOT, V79, P1080, DOI 10.1002/jctb.1080
   PEHLIVAN E, 2008, J HAZARD MATER, DOI DOI 10.1016/J.JHAZMAT.2007.11.07
   Qin G, 2005, ENVIRON SCI TECHNOL, V39, P6321, DOI 10.1021/es050486p
   RAWAJFIH Z, 2008, J CHEM THERMODYN, DOI DOI 10.1016/J.JCT.2008.01.00
   Shibi IG, 2006, J CHEM TECHNOL BIOT, V81, P433, DOI 10.1002/jctb.1423
   SRIVASTAVA HCP, 1986, ENVIRON TECHNOL LETT, V7, P55, DOI 10.1080/09593338609384391
   VOLESKY B, 1995, BIOTECHNOL PROGR, V11, P235, DOI 10.1021/bp00033a001
   VOLESKY B, 2007, WATER RES, P4017
   WANG XS, 2008, J ENVIRON MANAGE, DOI DOI 10.1016/J.JENVM.2008.01.01
   Yang L, 2008, BIORESOURCE TECHNOL, V99, P297, DOI 10.1016/j.biortech.2006.12.021
   Yun YS, 2001, ENVIRON SCI TECHNOL, V35, P4353, DOI 10.1021/es010866k
   ZUBAIR A, 2008, WATER AIR SOIL POLL, DOI DOI 10.1017/S11270-008-9626-Y
NR 47
TC 143
Z9 153
U1 2
U2 65
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0960-8524
J9 BIORESOURCE TECHNOL
JI Bioresour. Technol.
PD DEC
PY 2008
VL 99
IS 18
BP 8810
EP 8818
DI 10.1016/j.biortech.2008.04.042
PG 9
WC Agricultural Engineering; Biotechnology & Applied Microbiology; Energy &
   Fuels
SC Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels
GA 358AN
UT WOS:000259888700044
PM 18511265
DA 2018-10-19
ER

PT J
AU Ip, AWM
   Barford, JP
   Mckay, G
AF Ip, A. W. M.
   Barford, J. P.
   McKay, G.
TI Production and comparison of high surface area bamboo derived active
   carbons
SO BIORESOURCE TECHNOLOGY
LA English
DT Article
DE Bamboo; Activated carbon; Phosphoric acid activation; Adsorption; Acid
   dye
ID PORE-SIZE DISTRIBUTION; REACTIVE DYES; BONE CHAR; ADSORPTIVE PROPERTIES;
   CHEMICAL ACTIVATION; COMPONENT SYSTEMS; TEXTILE EFFLUENT;
   AQUEOUS-SOLUTION; PHOSPHORIC-ACID; REMOVAL
AB High surface area activated carbons have been produced from the natural biomaterial bamboo, using phosphoric acid as the activating agent. The effects of phosphoric acid impregnation ratio, activation temperature, heating rate on the carbon surface area, porosity and mass yield are presented. Three of these bamboo derived active carbons, surface areas 1337,1628 and 2123 m(2)/g were assessed for their ability to adsorb Acid Red 18 dye from aqueous solution; these results were compared with three conventional adsorbents: activated carbon F400, bone char and peat. Isotherm data were analysed using Langmuir. Freundlich, Redlich-Peterson and Langmuir-Freundlich isotherms. Different isotherms provided the best fit correlations to the adsorption experimental data but the Langmuir-Freundlich equation provided the best overall correlation of data. The adsorption capacities of two of the selected bamboo derived carbons were much greater than the capacities of the other three adsorbents. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Ip, A. W. M.; Barford, J. P.; McKay, G.] Hong Kong Univ Sci & Technol, Dept Chem Engn, Kowloon, Hong Kong, Peoples R China.
RP Mckay, G (reprint author), Hong Kong Univ Sci & Technol, Dept Chem Engn, Kowloon, Hong Kong, Peoples R China.
EM kemckayg@ust.hk
OI Barford, John/0000-0003-0494-4837
CR Abe I, 2004, J COLLOID INTERF SCI, V275, P35, DOI 10.1016/j.jcis.2003.12.031
   Adinata D, 2007, BIORESOURCE TECHNOL, V98, P145, DOI 10.1016/j.biortech.2005.11.006
   Al-Degs Y, 2000, WATER RES, V34, P927, DOI 10.1016/S0043-1354(99)00200-6
   Al-Degs YS, 2004, SEPAR SCI TECHNOL, V39, P97, DOI 10.1081/SS-120027403
   Allen SJ, 2004, J COLLOID INTERF SCI, V280, P322, DOI 10.1016/j.jcis.2004.08.078
   Asada T, 2002, J HEALTH SCI, V48, P473, DOI 10.1248/jhs.48.473
   Asada T, 2006, J HEALTH SCI, V52, P585, DOI 10.1248/jhs.52.585
   BROWN MA, 1993, CRIT REV ENV SCI TEC, V23, P249, DOI 10.1080/10643380490434119
   Cheung CW, 2000, SEP PURIF TECHNOL, V19, P55, DOI 10.1016/S1383-5866(99)00073-8
   Cheung CW, 2001, WATER RES, V35, P605, DOI 10.1016/S0043-1354(00)00306-7
   Choy KKH, 1999, RESOUR CONSERV RECY, V27, P57, DOI 10.1016/S0921-3449(98)00085-8
   Crini G, 2006, BIORESOURCE TECHNOL, V97, P1061, DOI 10.1016/j.biortech.2005.05.001
   Easton J.R., 1995, COLOUR DYEHOUSE EFFL, V89, P9
   El-Hendawy ANA, 2003, CARBON, V41, P713, DOI 10.1016/S0008-6223(03)00029-0
   Forgacs E, 2004, ENVIRON INT, V30, P953, DOI 10.1016/j.envint.2004.02.001
   Freundlich H M F, 1906, J PHYS CHEM, V57, P385
   Girgis BS, 1997, ADSORPT SCI TECHNOL, V15, P277, DOI 10.1177/026361749701500403
   Guo YP, 2007, BIORESOURCE TECHNOL, V98, P1513, DOI 10.1016/j.biortech.2006.06.027
   Ho YS, 1998, CHEM ENG J, V70, P115, DOI 10.1016/S0923-0467(98)00076-1
   Ho YS, 2002, WATER AIR SOIL POLL, V141, P1, DOI 10.1023/A:1021304828010
   Jagtoyen M, 1998, CARBON, V36, P1085, DOI 10.1016/S0008-6223(98)00082-7
   Juang RS, 2001, ADSORPTION, V7, P65, DOI 10.1023/A:1011225001324
   KANEKO K, 1994, J MEMBRANE SCI, V96, P59, DOI 10.1016/0376-7388(94)00126-X
   Kim YJ, 2006, CARBON, V44, P1592, DOI 10.1016/j.carbon.2006.02.011
   Koutcheiko S, 2007, BIORESOURCE TECHNOL, V98, P2459, DOI 10.1016/j.biortech.2006.09.038
   Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004
   Lima IM, 2005, BIORESOURCE TECHNOL, V96, P699, DOI 10.1016/j.biortech.2004.06.021
   LOWELL S, 2004, CHARACTERIZATION POR, P67
   Mizuta K, 2004, BIORESOURCE TECHNOL, V95, P255, DOI 10.1016/j.biortech.2004.02.015
   Moreno-Castilla C, 1997, CARBON, V35, P1619, DOI 10.1016/S0008-6223(97)00121-8
   Mudoga HL, 2008, BIORESOURCE TECHNOL, V99, P3528, DOI 10.1016/j.biortech.2007.07.058
   NEWCOMBE G, 1997, CARBON, V33, P15
   Pereira MFR, 2003, CARBON, V41, P811, DOI 10.1016/S0008-6223(02)00406-2
   Puziy AM, 2002, APPL SURF SCI, V200, P196, DOI 10.1016/S0169-4332(02)00883-8
   Rahman IA, 2005, BIORESOURCE TECHNOL, V96, P1578, DOI 10.1016/j.biortech.2004.12.015
   REDLICH O, 1959, J PHYS CHEM-US, V63, P1024, DOI 10.1021/j150576a611
   Reife A., 1994, ENV CHEM DYES PIGMEN, P265
   Robinson T, 2001, BIORESOURCE TECHNOL, V77, P247, DOI 10.1016/S0960-8524(00)00080-8
   Rouquerol F., 1999, ADSORPTION POWDERS P, P439
   San Miguel G, 2006, J CHEM TECHNOL BIOT, V81, P1685, DOI 10.1002/jctb.1600
   Santhy K, 2006, BIORESOURCE TECHNOL, V97, P1329, DOI 10.1016/j.biortech.2005.05.016
   SIPS R, 1948, J CHEM PHYS, V16, P490, DOI 10.1063/1.1746922
   Sudaryanto Y, 2006, BIORESOURCE TECHNOL, V97, P734, DOI 10.1016/j.biortech.2005.04.029
   Suzuki RM, 2007, BIORESOURCE TECHNOL, V98, P1985, DOI 10.1016/j.biortech.2006.08.001
   Tsang DCW, 2007, WATER AIR SOIL POLL, V184, P141, DOI 10.1007/s11270-007-9404-2
   Tseng RL, 2006, J HAZARD MATER, V136, P671, DOI 10.1016/j.jhazmat.2005.12.048
   Walker GM, 2001, CHEM ENG J, V83, P201, DOI 10.1016/S1385-8947(00)00257-6
   Wang L, 2006, STROKE, V37, P679
   Wu FC, 1999, J ENVIRON SCI HEAL A, V34, P1753, DOI 10.1080/10934529909376927
NR 49
TC 69
Z9 70
U1 1
U2 26
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0960-8524
J9 BIORESOURCE TECHNOL
JI Bioresour. Technol.
PD DEC
PY 2008
VL 99
IS 18
BP 8909
EP 8916
DI 10.1016/j.biortech.2008.04.076
PG 8
WC Agricultural Engineering; Biotechnology & Applied Microbiology; Energy &
   Fuels
SC Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels
GA 358AN
UT WOS:000259888700059
PM 18572403
DA 2018-10-19
ER

PT J
AU Speziale, P
   Visai, L
   Rindi, S
   Pietrocola, G
   Provenza, G
   Provenzano, M
AF Speziale, Pietro
   Visai, Livia
   Rindi, Simonetta
   Pietrocola, Giampiero
   Provenza, Giulio
   Provenzano, Maria
TI Prevention and Treatment of Staphylococcus Biofilms
SO CURRENT MEDICINAL CHEMISTRY
LA English
DT Review
DE Staphylococcus; biofilm; biomaterials; therapeutic strategies
ID POLYSACCHARIDE INTERCELLULAR ADHESIN; ACCUMULATION-ASSOCIATED PROTEIN;
   POLY-N-ACETYLGLUCOSAMINE; WALL TEICHOIC-ACIDS; EPIDERMIDIS BIOFILMS;
   MONOCLONAL-ANTIBODIES; AUREUS BIOFILM; ARTIFICIAL SURFACES; BINDING
   PROTEINS; MATRIX-MOLECULES
AB Staphylococcus growth on medical devices represents a common occurrence that can lead to serious illness and death. Biomaterial-associated infection, mostly caused by Staphylococcus epidermidis and Staphylococcus aureus, is fairly complicated by the organism'development of a biofilm, which provides a microenvironment that protects from attack by the host immune system and antibiotics. In this review we present recent insights regarding S. aureus and S. epidermidis structural and functional factors that are effective in biofilm development and describe the regulation of their expression. On the basis of the knowledge gained, we also present the potential and limits of current biochemical and biophysical strategies aimed at preventing biofilm formation or at the treatment of established mature biofilms.
C1 [Speziale, Pietro] Univ Pavia, Fac Med & Surg, Dept Biochem, I-27100 Pavia, Italy.
RP Speziale, P (reprint author), Univ Pavia, Fac Med & Surg, Dept Biochem, Viale Taramelli 3-B, I-27100 Pavia, Italy.
EM pspeziale@unipv.it
OI PIETROCOLA, GIAMPIERO/0000-0002-7069-8155
FU Italian Ministry of Health [RF-IOR-2006-349032]
FX This work was supported by a grant from the Italian Ministry of Health
   to P. S. (Identification code: RF-IOR-2006-349032. Opportunistic
   bacteria in orthopaedic implant infections; new strategies of molecular
   and gene therapies).
CR Allignet J, 2001, INFECT IMMUN, V69, P712, DOI 10.1128/IAI.69.2.712-718.2001
   Banner MA, 2007, J BACTERIOL, V189, P2793, DOI 10.1128/JB.00952-06
   Boelens JJ, 2000, J INFECT DIS, V181, P1167, DOI 10.1086/315344
   Boles BR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000052
   Bowden MG, 2008, J BIOL CHEM, V283, P638, DOI 10.1074/jbc.M706252200
   Bowden MG, 2005, MICROBIOL-SGM, V151, P1453, DOI 10.1099/mic.0.27534-0
   Bowden MG, 2002, J BIOL CHEM, V277, P43017, DOI 10.1074/jbc.M207921200
   Brady RA, 2006, INFECT IMMUN, V74, P3415, DOI 10.1128/IAI.00392-06
   Bryers JD, 2008, BIOTECHNOL BIOENG, V100, P1, DOI 10.1002/bit.21838
   Burton E, 2006, ANTIMICROB AGENTS CH, V50, P1835, DOI 10.1128/AAC.50.5.1835-1840.2006
   CERCA N, 2007, INFECT IMMUN, V75, P2406
   Chavakis T, 2005, THROMB HAEMOSTASIS, V94, P278, DOI 10.1160/TH05-05-0306
   Conlon KM, 2004, J BACTERIOL, V186, P6208, DOI 10.1128/JB.186.18.6208-6219.2004
   Conlon KM, 2002, J BACTERIOL, V184, P4400, DOI 10.1128/JB.184.16.4400-4408.2002
   Corrigan RM, 2007, MICROBIOL-SGM, V153, P2435, DOI 10.1099/mic.0.2007/006676-0
   Cramton SE, 1999, INFECT IMMUN, V67, P5427
   Cramton SE, 2001, INFECT IMMUN, V69, P4079, DOI 10.1128/IAI.69.6.4079-4085.2001
   Cucarella C, 2001, J BACTERIOL, V183, P2888, DOI 10.1128/JB.183.9.2888-2896.2001
   Doherty N, 2006, J BACTERIOL, V188, P2885, DOI 10.1128/JB.188.8.2885-2897.2006
   Domanski PJ, 2005, INFECT IMMUN, V73, P5229, DOI 10.1128/IAI.73.8.5229-5232.2005
   Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0
   Frank KL, 2007, INFECT IMMUN, V75, P4728, DOI 10.1128/IAI.00640-07
   Gerke C, 1998, J BIOL CHEM, V273, P18586, DOI 10.1074/jbc.273.29.18586
   Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x
   Gross M, 2001, INFECT IMMUN, V69, P3423, DOI 10.1128/IAI.69.5.3423-3426.2001
   Gu J, 2005, J HOSP INFECT, V61, P342, DOI 10.1016/j.jhin.2005.04.017
   Gyimesi E, 2004, IMMUNOL LETT, V95, P185, DOI 10.1016/j.imlet.2004.07.007
   Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x
   Hell W, 2003, FEMS MICROBIOL LETT, V227, P47, DOI 10.1016/S0378-1097(03)00647-5
   Hennig S, 2008, J BACTERIOL, V190, P1488, DOI 10.1128/JB.01290-07
   Illingworth B, 2000, J HEART VALVE DIS, V9, P135
   Izano EA, 2008, APPL ENVIRON MICROB, V74, P470, DOI 10.1128/AEM.02073-07
   Ji GY, 1997, SCIENCE, V276, P2027, DOI 10.1126/science.276.5321.2027
   Joh D, 1999, MATRIX BIOL, V18, P211, DOI 10.1016/S0945-053X(99)00025-6
   Johnson M, 2008, INFECT IMMUN, V76, P1756, DOI 10.1128/IAI.01635-07
   Josefsson E, 2001, J INFECT DIS, V184, P1572, DOI 10.1086/324430
   Josefsson E, 1998, MICROBIOL-UK, V144, P3387, DOI 10.1099/00221287-144-12-3387
   Kaplan JB, 2004, ANTIMICROB AGENTS CH, V48, P2633, DOI 10.1128/AAC.48.7.2633-2636.2004
   Karchmer Adolf W., 1994, P213
   KEOGH JR, 1994, J LAB CLIN MED, V124, P537
   Knobloch JKM, 2004, INFECT IMMUN, V72, P3838, DOI 10.1128/IAI.72.7.3838-3848.2004
   Kockro RA, 2000, J MED MICROBIOL, V49, P441, DOI 10.1099/0022-1317-49-5-441
   Kong H, 2008, LANGMUIR, V24, P2051, DOI 10.1021/la703085e
   Kreikemeyer B, 2002, INT J MED MICROBIOL, V292, P283, DOI 10.1078/1438-4221-00212
   Kristian SA, 2008, J INFECT DIS, V197, P1028, DOI 10.1086/528992
   Leid JG, 2002, INFECT IMMUN, V70, P6339, DOI 10.1128/IAI.70.11.6339-6345.2002
   Lim Y, 2004, J BACTERIOL, V186, P722, DOI 10.1128/JB.186.3.722-729.2004
   MACK D, 1994, INFECT IMMUN, V62, P3244
   Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996
   Mack D, 1999, INFECT IMMUN, V67, P1004
   Meenan NAG, 2007, J BIOL CHEM, V282, P25893, DOI 10.1074/jbc.M703063200
   Nilsson IM, 1998, J CLIN INVEST, V101, P2640, DOI 10.1172/JCI1823
   Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x
   O'Neill E, 2008, J BACTERIOL, V190, P3835, DOI 10.1128/JB.00167-08
   O'Seaghdha M, 2006, FEBS J, V273, P4831, DOI 10.1111/j.1742-4658.2006.05482.x
   Otto M, 2008, CURR TOP MICROBIOL, V322, P207
   Palmer RJ, 2007, J BACTERIOL, V189, P7948, DOI 10.1128/JB.00787-07
   Projan SJ, 2006, CURR OPIN PHARMACOL, V6, P473, DOI 10.1016/j.coph.2006.04.005
   Qin ZQ, 2007, MICROBIOL-SGM, V153, P2083, DOI 10.1099/mic.0.2007/006031-0
   Resch A, 2006, PROTEOMICS, V6, P1867, DOI 10.1002/pmic.200500531
   Rivera J, 2007, THROMB HAEMOSTASIS, V98, P503, DOI 10.1160/TH07-03-0233
   Roche FM, 2003, MICROBIOL-SGM, V149, P643, DOI 10.1099/mic.0.25996-0
   Rodrigues LR, 2006, J APPL MICROBIOL, V100, P470, DOI 10.1111/j.1365-2672.2005.02826.x
   Rohde H, 2004, J CLIN MICROBIOL, V42, P5614, DOI 10.1128/JCM.42.12.5614-5619.2004
   Rohde H, 2005, MOL MICROBIOL, V55, P1883, DOI 10.1111/j.1365-2958.04515.x
   Rohde H, 2007, BIOMATERIALS, V28, P1711, DOI 10.1016/j.biomaterials.2006.11.046
   Sadovskaya I, 2004, CARBOHYD RES, V339, P1467, DOI 10.1016/j.carres.2004.03.017
   Sass P, 2007, APPL ENVIRON MICROB, V73, P347, DOI 10.1128/AEM.01616-06
   Schlag S, 2007, J BACTERIOL, V189, P7911, DOI 10.1128/JB.00598-07
   Sharma M, 2008, ANTIMICROB AGENTS CH, V52, P299, DOI 10.1128/AAC.00988-07
   Sifri CD, 2003, INFECT IMMUN, V71, P2208, DOI 10.1128/IAI.71.4.2208-2217.2003
   Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1
   Sun DQ, 2005, CLIN DIAGN LAB IMMUN, V12, P93, DOI 10.1128/CDLI.12.1.93-100.2005
   Tormo MA, 2005, J BACTERIOL, V187, P2348, DOI 10.1128/JB.187.7.2348-2356.2005
   Tormo MA, 2005, MICROBIOL-SGM, V151, P2465, DOI 10.1099/mic.0.27865-0
   TUROS E, 2007, BIOORG MED CHEM LETT, V17, P3466
   van der Borden AJ, 2004, APPL ENVIRON MICROB, V70, P6871, DOI 10.1128/AEM.70.11.6871-6874.2004
   Vergara-Irigaray M, 2008, MICROBIOL-SGM, V154, P865, DOI 10.1099/mic.0.2007/013292-0
   Visai L, 2000, J BIOL CHEM, V275, P39837, DOI 10.1074/jbc.M005297200
   von Eiff C, 2002, LANCET INFECT DIS, V2, P677, DOI 10.1016/S1473-3099(02)00438-3
   Vuong C, 2004, J BIOL CHEM, V279, P54881, DOI 10.1074/jbc.M411374200
   Vuong C, 2004, CELL MICROBIOL, V6, P269, DOI 10.1111/j.1462-5822.2004.00367.x
   Vuong C, 2003, J INFECT DIS, V188, P706, DOI 10.1086/377239
   Vuong C, 2008, J INFECT DIS, V198, P258, DOI 10.1086/589307
   Walencka E, 2008, FOLIA MICROBIOL, V53, P61, DOI 10.1007/s12223-008-0009-y
   Walencka E, 2007, Z NATURFORSCH C, V62, P433
   Wann ER, 2000, J BIOL CHEM, V275, P13863, DOI 10.1074/jbc.275.18.13863
   Weigel LM, 2007, ANTIMICROB AGENTS CH, V51, P231, DOI 10.1128/AAC.00576-06
   Williams P, 2007, MICROBIOL-SGM, V153, P3923, DOI 10.1099/mic.0.2007/012856-0
   WITHCHURCH CB, 2002, SCIENCE, V295, P1487
   Wu JA, 2003, ANTIMICROB AGENTS CH, V47, P3407, DOI 10.1128/AAC.47.11.3407-3414.2003
   Yao YF, 2005, J INFECT DIS, V191, P289, DOI 10.1086/426945
   Zhu Y, 2007, INFECT IMMUN, V75, P4219, DOI 10.1128/IAI.00509-07
NR 93
TC 29
Z9 35
U1 0
U2 8
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 0929-8673
J9 CURR MED CHEM
JI Curr. Med. Chem.
PD DEC
PY 2008
VL 15
IS 30
BP 3185
EP 3195
DI 10.2174/092986708786848442
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Pharmacology &
   Pharmacy
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA 386OK
UT WOS:000261892300004
PM 19075662
DA 2018-10-19
ER

PT J
AU Suzuki, K
AF Suzuki, Kaoru
TI Free electron laser induced forward transfer method of biomaterial for
   marking
SO ELECTRICAL ENGINEERING IN JAPAN
LA English
DT Article
DE direct write marking; biomaterial; free electron laser induced forward
   transfer
ID FILMS
AB Biomaterial, Such its chitosan and poly lactic acid, containing a fluorescence agent was deposited onto biologic hard tissue, Such as teeth, the claws of-dogs or cats, or a sapphire Substrate by free electron laser induced forward transfer method for direct write marking. Spin-coated biomaterial with the fluorescence agent Rhodamin 613 or zinc phthalocyanine target on it sapphire plate was ablated by a free electron laser (resonance absorption wavelength of biomaterial: 3380 nm). In particular, the influence of the spin-coating film-forming temperature on hardness and adhesion strength of the biomaterial is Studied. The effect of resonance excitation of the biomaterial target by turning the free electron laser is discussed with respect to damage in terms of biomaterial, rhodamin-6G, or zinc phthalocyanine For direct write marking. (C) 2008 Wiley Periodicals, Inc.
C1 Nihon Univ, Tokyo 102, Japan.
RP Suzuki, K (reprint author), Nihon Univ, Tokyo 102, Japan.
FU Ministry of Education, Culture, Sports, Science, and Technology
FX This study has been financially supported by a grant from the Ministry
   of Education, Culture, Sports, Science, and Technology to promote the
   multi-disciplinary research project "Academic Frontier"; and "High Tech
   Research Center."
CR BOHANDY J, 1988, J APPL PHYS, V63, P1158, DOI 10.1063/1.340023
   FRABIAN J, 1992, CHEM REV, V92, P1197
   Gattin R, 2001, J POLYM ENVIRON, V9, P11, DOI 10.1023/A:1016036302871
   *HARD TISS RES GRO, 2005, HARD TISS RES HDB MA, P335
   Ishihara M, 2002, TRENDS GLYCOSCI GLYC, V14, P331, DOI 10.4052/tigg.14.331
   Stark DA, 2005, DEV DYNAM, V233, P983, DOI 10.1002/dvdy.20385
   Suzuki K, 2005, P SOC PHOTO-OPT INS, V5713, P610, DOI 10.1117/12.590972
   TABATA Y, 2003, BIOMATERIALS, P1
   TUAN VD, 2003, BIOMEDICAL PHOTONICS, P833
   WROBEL JJ, 1982, APPL PHYS LETT, V40, P928, DOI 10.1063/1.92957
NR 10
TC 3
Z9 3
U1 2
U2 8
PU SCRIPTA TECHNICA-JOHN WILEY & SONS
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158 USA
SN 0424-7760
J9 ELECTR ENG JPN
JI Electr. Eng. Jpn.
PD DEC
PY 2008
VL 165
IS 4
BP 60
EP 66
DI 10.1002/eej.20795
PG 7
WC Engineering, Electrical & Electronic
SC Engineering
GA 343MH
UT WOS:000258857400007
DA 2018-10-19
ER

PT J
AU Sunil, P
   Goel, SC
   Rastogi, A
   Aryya, NC
AF Sunil, P.
   Goel, S. C.
   Rastogi, A.
   Aryya, N. C.
TI Incorporation and biodegradation of hydroxyapatite-tricalcium phosphate
   implanted in large metaphyseal defects-An animal study
SO INDIAN JOURNAL OF EXPERIMENTAL BIOLOGY
LA English
DT Article
DE Bioactive ceramics; Bone substitutes; Hydroxyapatite; Metaphyseal
   defects; Tricalcium phosphate
ID BONE-GRAFT SUBSTITUTE; POROUS HYDROXYAPATITE; CALCIUM; CERAMICS; SURGERY
AB Incorporation and biodegradation of hydroxyapatite(HA)-tricalcium phosphate(TCP) granules implanted in 5 x 5 x 5 mm distal femoral metaphyseal defects created in 18 adult rabbits were studied. In two rabbits, the defects were left to heal spontaneously without any implant. Roentgenographic and histological study by light microscopy was done on silver nitrate stained undecalcified sections as well as haematoxylin-eosin stained decalcified sections. The synthetic HA-TCP was biocompatible and produced no adverse reactions. The implant was osteoconductive and allowed good new bone formation to occur, mainly from periphery to center, but mature trabeculae could be delineated only at 4-6 months. The HA-TCP biomaterial had very low biodegradability with marked amount of intact implant still present at final follow up. Bonding between implant and bone, though a close biological bond, was not uniformly strong. Rate of bone ingrowth was very slow and large areas of implant at center did not show new bone formation at 12 months.
C1 [Sunil, P.; Goel, S. C.; Rastogi, A.] Banaras Hindu Univ, Dept Orthopaed, Varanasi 221005, Uttar Pradesh, India.
   [Aryya, N. C.] Banaras Hindu Univ, Inst Med Sci, Dept Pathol, Varanasi 221005, Uttar Pradesh, India.
RP Sunil, P (reprint author), Flat 201,Plot G-47,Pride Dream House Apartments,P, Hyderabad 500008, Andhra Pradesh, India.
EM sunilortho@yahoo.com
CR BUCHOLZ R, 1988, CLIN ORTHOP RELAT R, V240, P53
   Bucholz R, 1989, ORTHOP CLIN N AM, V18, P323
   Daculsi G, 1998, BIOMATERIALS, V19, P1473, DOI 10.1016/S0142-9612(98)00061-1
   DACULSI G, 1990, J BIOMED MATER RES, V24, P379, DOI 10.1002/jbm.820240309
   DEGROOT K, 1980, BIOMATERIALS, V1, P47, DOI 10.1016/0142-9612(80)90059-9
   FLATLEY TJ, 1983, CLIN ORTHOP RELAT R, P246
   HOLMES R, 1984, CLIN ORTHOP RELAT R, P252
   HOLMES RE, 1986, J BONE JOINT SURG AM, V68A, P904, DOI 10.2106/00004623-198668060-00013
   Keating JF, 2001, J BONE JOINT SURG BR, V83B, P3, DOI 10.1302/0301-620X.83B1.11952
   LANE JM, 1999, CLIN ORTHOP S, V367, P107
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   LEGEROS RZ, 1995, BIOCERAMICS, V8, P81
   NICHOLAS RW, 1994, CLIN ORTHOP RELAT R, V306, P107
   Oonishi H, 1997, J BONE JOINT SURG BR, V79B, P87, DOI 10.1302/0301-620X.79B1.1290
   Takaoka T, 1996, BIOMATERIALS, V17, P1499, DOI 10.1016/0142-9612(96)89774-2
   THOMAS WB, 2002, CLIN ORTHOP RELAT R, V395, P11
   UCHIDA A, 1984, J BONE JOINT SURG BR, V66, P269
   UCHIDA A, 1990, J BONE JOINT SURG BR, V72, P298
   Yamamoto T, 2000, J BONE JOINT SURG BR, V82B, P1117, DOI 10.1302/0301-620X.82B8.11194
NR 19
TC 8
Z9 8
U1 0
U2 2
PU NATL INST SCIENCE COMMUNICATION
PI NEW DELHI
PA DR K S KRISHNAN MARG, NEW DELHI 110 012, INDIA
SN 0019-5189
J9 INDIAN J EXP BIOL
JI Indian J. Exp. Biol.
PD DEC
PY 2008
VL 46
IS 12
BP 836
EP 841
PG 6
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA 382TE
UT WOS:000261627500006
PM 19245181
DA 2018-10-19
ER

PT J
AU Nejadnik, MR
   Engelsman, AF
   Fernandez, ICS
   Busscher, HJ
   Norde, W
   van der Mei, HC
AF Nejadnik, M. Reza
   Engelsman, Anton F.
   Fernandez, Isabel C. Saldarriaga
   Busscher, Henk J.
   Norde, Willem
   van der Mei, Henny C.
TI Bacterial colonization of polymer brush-coated and pristine silicone
   rubber implanted in infected pockets in mice
SO JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
LA English
DT Article
ID STAPHYLOCOCCUS-EPIDERMIDIS; TISSUE
AB Curing biomaterial-associated infection (BAI) frequently includes antibiotic treatment, implant removal and re-implantation. However, revision implants are at a greater risk of infection as they may attract bacteria from their infected surroundings. Polymer brush-coatings attract low numbers of bacteria, but the virtue of polymer brush-coatings in vivo has seldom been investigated. Here, we determine the possible benefits of polymer brush-coated versus pristine silicone rubber in revision surgery, using a murine model.
   BAI was induced in 26 mice by subcutaneous implantation of silicone rubber discs with a biofilm of Staphylococcus aureus Xen29. During the development of BAI, half of the mice received rifampicin/vancomycin treatment. After 5 days, the infected discs were removed from all mice, and either a polymer brush-coated or pristine silicone rubber disc was re-implanted. Revision discs were explanted after 5 days, and the number of cfu cultured from the discs and the surrounding tissue was determined.
   None of the polymer brush-coated discs after antibiotic treatment appeared colonized by staphylococci, whereas 83% of the pristine silicone rubber discs were re-infected. Polymer brush-coated discs also showed reduced colonization rates in the absence of antibiotic treatment when compared with pristine silicone rubber discs. Tissue surrounding the discs was culture-positive in all cases.
   Polymer brush-coatings are less prone to re-infection than pristine silicone rubber when used in revision surgery, i.e. when implanted in a subcutaneous pocket infected by a staphylococcal BAI. Antibiotic pre-treatment during the development of BAI hardly had any effect in preventing the colonization of pristine silicone rubber.
C1 [Nejadnik, M. Reza; Engelsman, Anton F.; Fernandez, Isabel C. Saldarriaga; Busscher, Henk J.; Norde, Willem; van der Mei, Henny C.] Univ Med Ctr Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
   [Nejadnik, M. Reza; Engelsman, Anton F.; Fernandez, Isabel C. Saldarriaga; Busscher, Henk J.; Norde, Willem; van der Mei, Henny C.] Univ Groningen, NL-9713 AV Groningen, Netherlands.
   [Norde, Willem] Wageningen Univ, Lab Phys Chem & Colloid Sci, NL-6703 HB Wageningen, Netherlands.
RP van der Mei, HC (reprint author), Univ Med Ctr Groningen, Dept Biomed Engn, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
EM h.c.van.der.mei@med.umcg.nl
FU University of Groningen-University Medical Center Groningen, Groningen,
   The Netherlands
FX This research was funded by the University of Groningen-University
   Medical Center Groningen, Groningen, The Netherlands.
CR Broekhuizen CAN, 2008, J BIOMED MATER RES A, V85A, P498, DOI 10.1002/jbm.a.31528
   Broekhuizen CAN, 2007, INFECT IMMUN, V75, P1129, DOI 10.1128/IAI.01262-06
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Darouiche RO, 2001, CLIN INFECT DIS, V33, P1567, DOI 10.1086/323130
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Kadurugamuwa JL, 2003, INFECT IMMUN, V71, P882, DOI 10.1128/IAI.71.2.882-890.2003
   Liu VA, 2002, J BIOMED MATER RES, V60, P126, DOI 10.1002/jbm.10005
   Nejadnik MR, 2008, APPL ENVIRON MICROB, V74, P916, DOI 10.1128/AEM.01557-07
   QUESADA ET, 1993, J UROLOGY, V149, P46, DOI 10.1016/S0022-5347(17)35995-5
NR 10
TC 18
Z9 18
U1 5
U2 13
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-7453
J9 J ANTIMICROB CHEMOTH
JI J. Antimicrob. Chemother.
PD DEC
PY 2008
VL 62
IS 6
BP 1323
EP 1325
DI 10.1093/jac/dkn395
PG 3
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA 373MH
UT WOS:000260975500030
PM 18812426
OA Bronze
DA 2018-10-19
ER

PT J
AU Willcox, MDP
   Hume, EBH
   Aliwarga, Y
   Kumar, N
   Cole, N
AF Willcox, M. D. P.
   Hume, E. B. H.
   Aliwarga, Y.
   Kumar, N.
   Cole, N.
TI A novel cationic-peptide coating for the prevention of microbial
   colonization on contact lenses
SO JOURNAL OF APPLIED MICROBIOLOGY
LA English
DT Article
DE antimicrobial cationic peptides; biomaterial; contact lens; Pseudomonas;
   Staphylococcus
ID CENTRAL VENOUS CATHETERS; CONTROLLED-TRIAL; IN-VITRO; INFECTION;
   ANTIBACTERIAL; MELITTIN; BIOFILMS; MORPHOLOGY; VIABILITY; BACTERIA
AB To develop an antimicrobial peptide with broad spectrum activity against bacteria implicated in biomaterial infection of low toxicity to mammalian cells and retaining its antimicrobial activity when covalently bound to a biomaterial surface.
   A synthetic peptide (melimine) was produced by combining portions of the antimicrobial cationic peptides mellitin and protamine. In contrast to the parent peptide melittin which lysed sheep red blood cells at > 10 mu g ml(-1), melimine lysed sheep red blood cells only at concentrations > 2500 mu g ml(-1), well above bactericidal concentrations. Additionally, melimine was found to be stable to heat sterilization. Evaluation by electron microscopy showed that exposure of both Pseudomonas aeruginosa and Staphylococcus aureus to melimine at the minimal inhibitory concentration (MIC) produced changes in the structure of the bacterial membranes. Further, repeated passage of these bacteria in sub-MIC concentrations of melimine did not result in an increase in the MIC. Melimine was tested for its ability to reduce bacterial adhesion to contact lenses when adsorbed or covalently attached. Approximately 80% reduction in viable bacteria was seen against both P. aeruginosa and S. aureus for 500 mu g per lens adsorbed melimine. Covalently linked melimine (18 +/- 4 mu g per lens) showed > 70% reduction of these bacteria to the lens.
   We have designed and tested a synthetic peptide melimine incorporating active regions of protamine and mellitin which may represent a good candidate for development as an antimicrobial coating for biomaterials.
   Infection associated with the use of biomaterials remains a major barrier to the long-term use of medical devices. The antimicrobial peptide melimine is an excellent candidate for development as an antimicrobial coating for such devices.
C1 [Willcox, M. D. P.; Hume, E. B. H.; Aliwarga, Y.; Cole, N.] Univ New S Wales, Eye Res Inst, Sydney, NSW 2052, Australia.
   [Hume, E. B. H.; Cole, N.] Vis Cooperat Res Ctr, Sydney, NSW, Australia.
   [Willcox, M. D. P.; Hume, E. B. H.; Cole, N.] Univ New S Wales, Sch Optometry & Vis Sci, Sydney, NSW 2052, Australia.
   [Kumar, N.] Univ New S Wales, Sch Chem, Sydney, NSW 2052, Australia.
RP Willcox, MDP (reprint author), Univ New S Wales, Eye Res Inst, Level 4,North Wing,Rupert Myers Bldg,Gate 14,Bark, Sydney, NSW 2052, Australia.
EM m.willcox@ier.org.au
OI cole, nerida/0000-0002-9866-4694
FU Australian Research Council's [DP0663368]
FX This research was supported under Australian Research Council's
   Discovery Projects funding scheme (Project number DP0663368). The
   authors thank Dr Judith Flanagan for assistance with the preparation of
   this manuscript.
CR Bach A, 1996, INTENS CARE MED, V22, P1066, DOI 10.1007/BF01699229
   BANDYK DF, 1984, ARCH SURG-CHICAGO, V119, P102
   Bechinger B, 1997, J MEMBRANE BIOL, V156, P197, DOI 10.1007/s002329900201
   BOMAN HG, 1989, FEBS LETT, V259, P103, DOI 10.1016/0014-5793(89)81505-4
   Bong JJ, 2003, J CLIN PATHOL, V56, P731, DOI 10.1136/jcp.56.10.731
   Bryers JD, 2006, BIOMATERIALS, V27, P5039, DOI 10.1016/j.biomaterials.2006.05.034
   Ciresi DL, 1996, AM SURGEON, V62, P641
   COLE N, 1994, J BIOCH, V8, P971
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   COSTERTON JW, 1981, ANNU REV MICROBIOL, V35, P299, DOI 10.1146/annurev.mi.35.100181.001503
   Darouiche RO, 1999, NEW ENGL J MED, V340, P1, DOI 10.1056/NEJM199901073400101
   Donlan RM, 2001, EMERG INFECT DIS, V7, P277, DOI 10.3201/eid0702.010226
   Douglas J.L., 1992, INFECT ENDOCARDITIS, P375
   FLOWERS RH, 1989, JAMA-J AM MED ASSOC, V261, P878, DOI 10.1001/jama.261.6.878
   Friedrich CL, 2000, ANTIMICROB AGENTS CH, V44, P2086, DOI 10.1128/AAC.44.8.2086-2092.2000
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   HAYNIE SL, 1995, ANTIMICROB AGENTS CH, V39, P301, DOI 10.1128/AAC.39.2.301
   Jones JR, 2006, J MATER SCI-MATER M, V17, P989, DOI 10.1007/s10856-006-0434-x
   Juvvadi P, 1996, J AM CHEM SOC, V118, P8989, DOI 10.1021/ja9542911
   KAMAL GD, 1991, JAMA-J AM MED ASSOC, V265, P2364, DOI 10.1001/jama.265.18.2364
   Lam PK, 2004, BRIT J BIOMED SCI, V61, P125, DOI 10.1080/09674845.2004.11732656
   Leung D, 2005, BIOMATERIALS, V26, P7145, DOI 10.1016/j.biomaterials.2005.05.014
   MAKI DG, 1988, AM J MED, V85, P307, DOI 10.1016/0002-9343(88)90579-7
   Mangoni ML, 2004, BIOCHEM J, V380, P859, DOI 10.1042/BJ20031975
   MASUR H, 1980, J THORAC CARDIOV SUR, V80, P31
   MOR A, 1994, J BIOL CHEM, V269, P31635
   NEU HC, 1992, SCIENCE, V257, P1073
   Neut D, 2003, BIOMATERIALS, V24, P1829, DOI 10.1016/S0142-9612(02)00614-2
   NosBarbera S, 1997, CORNEA, V16, P101
   Ravikumar T, 2006, BIOMACROMOLECULES, V7, P2762, DOI 10.1021/bm060476w
   SHIMODA M, 1995, INFECT IMMUN, V63, P2886
   Subbalakshmi C, 1999, FEBS LETT, V448, P62, DOI 10.1016/S0014-5793(99)00328-2
   Thornton J, 1996, ANAESTHESIA, V51, P1018, DOI 10.1111/j.1365-2044.1996.tb14994.x
   van de Belt H, 2001, ACTA ORTHOP SCAND, V72, P557
   Williams TJ, 2003, CURR EYE RES, V27, P227, DOI 10.1076/ceyr.27.4.227.16602
NR 35
TC 92
Z9 94
U1 2
U2 44
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1364-5072
J9 J APPL MICROBIOL
JI J. Appl. Microbiol.
PD DEC
PY 2008
VL 105
IS 6
BP 1817
EP 1825
DI 10.1111/j.1365-2672.2008.03942.x
PG 9
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA 375PH
UT WOS:000261125300010
PM 19016975
OA Bronze
DA 2018-10-19
ER

PT J
AU Sadykov, MR
   Olson, ME
   Halouska, S
   Zhu, YF
   Fey, PD
   Powers, R
   Somerville, GA
AF Sadykov, Marat R.
   Olson, Michael E.
   Halouska, Steven
   Zhu, Yefei
   Fey, Paul D.
   Powers, Robert
   Somerville, Greg A.
TI Tricarboxylic Acid Cycle-Dependent Regulation of Staphylococcus
   epidermidis Polysaccharide Intercellular Adhesin Synthesis
SO JOURNAL OF BACTERIOLOGY
LA English
DT Article
ID CHAIN AMINO-ACIDS; COAGULASE-NEGATIVE STAPHYLOCOCCI; BACILLUS-SUBTILIS;
   BIOFILM FORMATION; STATIONARY-PHASE; GENE-EXPRESSION; ESCHERICHIA-COLI;
   LACTOCOCCUS-LACTIS; CRYSTAL-STRUCTURE; GLOBAL REGULATOR
AB Staphylococcus epidermidis is a major nosocomial pathogen primarily infecting immunocompromised individuals or those with implanted biomaterials (e. g., catheters). Biomaterial-associated infections often involve the formation of a biofilm on the surface of the medical device. In S. epidermidis, polysaccharide intercellular adhesin (PIA) is an important mediator of biofilm formation and pathogenesis. Synthesis of PIA is regulated by at least three DNA binding proteins (IcaR, SarA, and sigma(B)) and several environmental and nutritional conditions. Previously, we observed the environmental conditions that increased PIA synthesis decreased tricarboxylic acid (TCA) cycle activity. In this study, S. epidermidis TCA cycle mutants were constructed, and the function of central metabolism in PIA biosynthesis was examined. TCA cycle inactivation altered the metabolic status of S. epidermidis, resulting in a massive derepression of PIA biosynthetic genes and a redirection of carbon from growth into PIA biosynthesis. These data demonstrate that the bacterial metabolic status is a critical regulatory determinant of PIA synthesis. In addition, these data lead us to propose that the TCA cycle acts as a signal transduction pathway to translate external environmental cues into intracellular metabolic signals that modulate the activity of transcriptional regulators.
C1 [Sadykov, Marat R.; Zhu, Yefei; Somerville, Greg A.] Univ Nebraska, Dept Vet & Biomed Sci, Lincoln, NE 68583 USA.
   [Olson, Michael E.; Fey, Paul D.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA.
   [Halouska, Steven; Powers, Robert] Univ Nebraska, Dept Chem, Lincoln, NE 68522 USA.
RP Somerville, GA (reprint author), Univ Nebraska, Dept Vet & Biomed Sci, 155 VBS,Fair St & E Campus Loop, Lincoln, NE 68583 USA.
EM gsomerville3@unl.edu
RI Sadykov, Marat/H-3147-2011; Somerville, Greg/B-1326-2013; Zhu,
   Yefei/F-8940-2013
OI Somerville, Greg/0000-0002-0991-8737; 
FU Hatch Act; National Institute of General Medical Sciences [GM076585];
   American Heart Association [0760005Z, 0860033Z]
FX This article is a contribution of the University of Nebraska
   Agricultural Research Division, supported in part by funds provided
   through the Hatch Act, the National Institute of General Medical
   Sciences (GM076585), and the American Heart Association (0760005Z) to G.
   A. S. and the American Heart Association (0860033Z) to R. P.
CR Baughn AD, 2002, P NATL ACAD SCI USA, V99, P4662, DOI 10.1073/pnas.052710199
   Begun J, 2007, PLOS PATHOG, V3, P526, DOI 10.1371/journal.ppat.0030057
   Bischoff M, 2004, J BACTERIOL, V186, P4085, DOI 10.1128/JB.186.13.4085-4099.2004
   Brekasis D, 2003, EMBO J, V22, P4856, DOI 10.1093/emboj/cdg453
   Bruckner R, 1997, FEMS MICROBIOL LETT, V151, P1
   Chatterjee I, 2006, APPL ENVIRON MICROB, V72, P2627, DOI 10.1128/AEM.72.4.2627-2636.2006
   Cho SH, 2002, INT J ANTIMICROB AG, V19, P570, DOI 10.1016/S0924-8579(02)00101-2
   COLLINS FM, 1962, J GEN MICROBIOL, V29, P531, DOI 10.1099/00221287-29-3-531
   Conlon KM, 2004, J BACTERIOL, V186, P6208, DOI 10.1128/JB.186.18.6208-6219.2004
   Conlon KM, 2002, FEMS MICROBIOL LETT, V216, P171, DOI 10.1016/S0378-1097(02)01031-5
   Conlon KM, 2002, J BACTERIOL, V184, P4400, DOI 10.1128/JB.184.16.4400-4408.2002
   Craig JE, 1997, J BACTERIOL, V179, P7351, DOI 10.1128/jb.179.23.7351-7359.1997
   Cramton SE, 2001, INFECT IMMUN, V69, P4079, DOI 10.1128/IAI.69.6.4079-4085.2001
   Cui Q, 2008, NAT BIOTECHNOL, V26, P162, DOI 10.1038/nbt0208-162
   DEAN BA, 1973, J HYG-CAMBRIDGE, V71, P261, DOI 10.1017/S0022172400022737
   DEIGHTON M, 1993, INFECT IMMUN, V61, P4473
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Dobinsky S, 2003, J BACTERIOL, V185, P2879, DOI 10.1128/JB.185.9.2879-2886.2003
   Foster TJ, 1998, METHOD MICROBIOL, V27, P433
   GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P
   Gaudu P, 2003, MOL MICROBIOL, V50, P183, DOI 10.1046/j.1365-2958.2003.03700.x
   Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x
   Gracia E, 1999, LUMINESCENCE, V14, P23, DOI 10.1002/(SICI)1522-7243(199901/02)14:1<23::AID-BIO513>3.0.CO;2-M
   GREENE C, 1995, MOL MICROBIOL, V17, P1143, DOI 10.1111/j.1365-2958.1995.mmi_17061143.x
   Guedon E, 2001, MOL MICROBIOL, V40, P1227, DOI 10.1046/j.1365-2958.2001.02470.x
   Handke LD, 2007, CAN J MICROBIOL, V53, P82, DOI 10.1139/W06-108
   Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x
   HENKIN TM, 1991, MOL MICROBIOL, V5, P575, DOI 10.1111/j.1365-2958.1991.tb00728.x
   Jeng WY, 2008, NUCLEIC ACIDS RES, V36, P1567, DOI 10.1093/nar/gkm1176
   Jourlin-Castelli C, 2000, J MOL BIOL, V295, P865, DOI 10.1006/jmbi.1999.3420
   Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882
   Karp PD, 2005, NUCLEIC ACIDS RES, V33, P6083, DOI 10.1093/nar/gki892
   Kim HJ, 2002, MOL MICROBIOL, V45, P179, DOI 10.1046/j.1365-2958.2002.03003.x
   Knobloch JKM, 2004, INFECT IMMUN, V72, P3838, DOI 10.1128/IAI.72.7.3838-3848.2004
   Knobloch JKM, 2001, J BACTERIOL, V183, P2624, DOI 10.1128/JB.183.8.2624-2633.2001
   Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049
   Kornmann H, 2003, APPL MICROBIOL BIOT, V62, P168, DOI 10.1007/s00253-003-1299-2
   Kozitskaya S, 2004, INFECT IMMUN, V72, P1210, DOI 10.1128/IAI.72.2.1210-1215.2004
   Lamb HK, 2003, J BIOL CHEM, V278, P32107, DOI 10.1074/jbc.M304104200
   Lauble H, 1996, P NATL ACAD SCI USA, V93, P13699, DOI 10.1073/pnas.93.24.13699
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996
   MACK D, 1992, INFECT IMMUN, V60, P2048
   Maira-Litran T, 2002, INFECT IMMUN, V70, P4433, DOI 10.1128/IAI.70.8.4433-4440.2002
   Majerczyk CD, 2008, J BACTERIOL, V190, P2257, DOI 10.1128/JB.01545-07
   MCCOMBIE H, 1946, NATURE, V158, P382, DOI 10.1038/158382a0
   MEKALANOS JJ, 1992, J BACTERIOL, V174, P1
   NOVICK RP, 1991, METHOD ENZYMOL, V204, P587
   Olson ME, 2006, CLIN ORTHOP RELAT R, P21, DOI 10.1097/01.blo.0000229320.45416.0c
   PROJAN SJ, 1989, J BACTERIOL, V171, P1841, DOI 10.1128/jb.171.4.1841-1845.1989
   Rachid S, 2000, J BACTERIOL, V182, P6824, DOI 10.1128/JB.182.23.6824-6826.2000
   Rachid S, 2000, ANTIMICROB AGENTS CH, V44, P3357, DOI 10.1128/AAC.44.12.3357-3363.2000
   Ratnayake-Lecamwasam M, 2001, GENE DEV, V15, P1093, DOI 10.1101/gad.874201
   Rupp ME, 1999, INFECT IMMUN, V67, P2656
   Rupp ME, 1999, INFECT IMMUN, V67, P2627
   RUPP ME, 1997, STAPHYLOCOCCI HUMAN, P379
   Sambrook J., 1989, MOL CLONING LAB MANU
   SCHENK S, 1992, FEMS MICROBIOL LETT, V94, P133
   Seidl K, 2008, INFECT IMMUN, V76, P2044, DOI 10.1128/IAI.00035-08
   Shivers RP, 2004, MOL MICROBIOL, V53, P599, DOI 10.1111/j.1365-2958.2004.04135.x
   Somerville G, 1999, J BACTERIOL, V181, P1072
   Somerville GA, 2003, INFECT IMMUN, V71, P4724, DOI 10.1128/IAI.71.8.4724-4732.2003
   Somerville GA, 2002, J BACTERIOL, V184, P1430, DOI 10.1128/JB.184.5.1430-1437.2002
   Somerville GA, 2002, INFECT IMMUN, V70, P6373, DOI 10.1128/IAI.70.11.6373-6382.2002
   Sonenshein AL, 2007, NAT REV MICROBIOL, V5, P917, DOI 10.1038/nrmicro1772
   Sonenshein AL, 2005, CURR OPIN MICROBIOL, V8, P203, DOI 10.1016/j.mib.2005.01.001
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   Stephenson K, 2001, P NATL ACAD SCI USA, V98, P15251, DOI 10.1073/pnas.251408398
   STRASTERS KC, 1963, J GEN MICROBIOL, V33, P213, DOI 10.1099/00221287-33-2-213
   Throup JP, 2001, BIOCHEMISTRY-US, V40, P10392, DOI 10.1021/bi0102959
   Tojo S, 2005, MOL MICROBIOL, V56, P1560, DOI 10.1111/j.1365-2958.2005.04635.x
   TOMLINS RI, 1971, CAN J MICROBIOL, V17, P759, DOI 10.1139/m71-121
   Tormo MA, 2005, J BACTERIOL, V187, P2348, DOI 10.1128/JB.187.7.2348-2356.2005
   Tramonti A, 2006, J BACTERIOL, V188, P8118, DOI 10.1128/JB.01044-06
   Varghese S, 2003, J BACTERIOL, V185, P221, DOI 10.1128/JB.185.1.221-230.2003
   von Eiff C, 2002, LANCET INFECT DIS, V2, P677, DOI 10.1016/S1473-3099(02)00438-3
   Vuong C, 2005, J BACTERIOL, V187, P2967, DOI 10.1128/JB.187.9.2967-2973.2005
   Vuong C, 2004, J BIOL CHEM, V279, P54881, DOI 10.1074/jbc.M411374200
   Vuong C, 2004, CELL MICROBIOL, V6, P269, DOI 10.1111/j.1462-5822.2004.00367.x
   Wu SW, 1996, J BACTERIOL, V178, P6036, DOI 10.1128/jb.178.20.6036-6042.1996
   Xu L, 2006, INFECT IMMUN, V74, P488, DOI 10.1128/IAI.74.1.488-496.2006
   YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9
   Ziebuhr W, 1997, INFECT IMMUN, V65, P890
   2004, AM J INFECT CONTROL, V32, P470, DOI DOI 10.1016/S0196655304005425
NR 84
TC 34
Z9 35
U1 0
U2 4
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0021-9193
EI 1098-5530
J9 J BACTERIOL
JI J. Bacteriol.
PD DEC
PY 2008
VL 190
IS 23
BP 7621
EP 7632
DI 10.1128/JB.00806-08
PG 12
WC Microbiology
SC Microbiology
GA 371VP
UT WOS:000260860500005
PM 18820013
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Ferraz, N
   Nilsson, B
   Hong, J
   Ott, MK
AF Ferraz, Natalia
   Nilsson, Bo
   Hong, Jaan
   Ott, Marjam Karlsson
TI Nanoporesize affects complement activation
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE nanotopography; nanoporous alumina; complement; whole blood; protein
   adsorption
ID SURFACES IN-VITRO; ARTIFICIAL SURFACES; PROTEIN ADSORPTION; WHOLE-BLOOD;
   MODEL; NANOTOPOGRAPHY; OSTEOBLASTS; TOPOGRAPHY; BEHAVIOR; ALUMINA
AB In the present study, we have shown the vast importance of biomaterial nanotexture when evaluating inflammatory response. For the first time in an in vitro whole blood system, we have proven that a small increase in nanoporesize, specifically 180 nm (from 20 to 200 nm), has a huge effect on the complement system. The study was done using nanoporous aluminiumoxide, a material that previously has been evaluated for potential implant use, showing good biocompatibility. This material can easily be manufactured with different pore sizes making it an excellent candidate to govern specific protein and cellular events at the tissue-material interface. We performed whole blood studies, looking at complement activation after blood contact with two pore size alumina membranes (pore diameters, 20 and 200 nm). The fluid phase was analyzed for complement soluble components, C3a and sC5b-9. In addition, surface adsorbed proteins were eluted and dot blots were performed to detect IgG, IgM, C1q, and C3. All results point to the fact that 200 nm pore size membranes are more complement activating. Significantly, higher values of complement soluble components were found after whole blood contact with 200 nm alumina and all studied proteins adsorbed more readily to this membrane than to the 20 nm pore size membrane. We hypothesize that the difference in complement activation between our two test materials is caused by the type and the amount of adsorbed proteins, as well as their conformation and orientation. The different protein patterns created on the two alumina membranes are most likely a consequence of the material topography. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 87A: 575-581, 2008
C1 [Ferraz, Natalia; Ott, Marjam Karlsson] Uppsala Univ, Dept Phys & Analyt Chem, Div Surface Biotechnol, S-75123 Uppsala, Sweden.
   [Nilsson, Bo; Hong, Jaan] Uppsala Univ, Dept Oncol Radiol & Clin Immunol, Div Clin Immunol, S-75123 Uppsala, Sweden.
RP Ott, MK (reprint author), Uppsala Univ, Dept Phys & Analyt Chem, Div Surface Biotechnol, S-75123 Uppsala, Sweden.
EM marjam.ott@ytbioteknik.uu.se
RI Nilsson, Bo/B-3102-2012
OI Nilsson, Bo/0000-0003-0057-2730
FU National Institute of Health [GM-62134, EB-003968, AI-066343-01];
   Swedish Research Council [5647, 15244]
FX Contract grant sponsor: National Institute of Health; contract grant
   numbers: GM-62134, EB-003968, Al-066343-01; Contract grant sponsor:
   Swedish Research Council; contract grant numbers: 5647, 15244
CR Andersson AS, 2003, BIOMATERIALS, V24, P3427, DOI 10.1016/S0142-9612(03)00208-4
   Andersson J, 2005, BIOMATERIALS, V26, P1477, DOI 10.1016/j.biomaterials.2004.05.011
   ANDERSSON J, 2003, THESIS UPPSALA U UPP
   CHEUNG AK, 1990, KIDNEY INT, V37, P1055, DOI 10.1038/ki.1990.85
   COURTNEY JM, 1994, BIOMATERIALS, V15, P737, DOI 10.1016/0142-9612(94)90026-4
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Curtis A, 2001, TRENDS BIOTECHNOL, V19, P97, DOI 10.1016/S0167-7799(00)01536-5
   Curtis ASG, 2004, IEEE T NANOBIOSCI, V3, P61, DOI 10.1109/TNB.2004.824276
   Dalby MJ, 2002, BIOMATERIALS, V23, P2945, DOI 10.1016/S0142-9612(01)00424-0
   Denis FA, 2002, LANGMUIR, V18, P819, DOI 10.1021/la011011o
   EKDAHL KN, 1992, SCAND J IMMUNOL, V35, P85, DOI 10.1111/j.1365-3083.1992.tb02837.x
   Eriksson C, 2001, BIOMATERIALS, V22, P1987, DOI 10.1016/S0142-9612(00)00382-3
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Gemmell CH, 1997, J BIOMED MATER RES, V37, P474
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Hong J, 1999, BIOMATERIALS, V20, P603, DOI 10.1016/S0142-9612(98)00210-5
   Horbett Thomas A., 1996, P133
   Karlsson M, 2004, MICROSC RES TECHNIQ, V63, P259, DOI 10.1002/jemt.20040
   Karlsson M, 2003, BIOMATERIALS, V24, P3039, DOI 10.1016/S0142-9612(03)00146-7
   Kasemo B, 1999, Adv Dent Res, V13, P8
   MOLLNES TE, 1985, SCAND J IMMUNOL, V22, P197, DOI 10.1111/j.1365-3083.1985.tb01871.x
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   Nilsson UR, 2001, MOL IMMUNOL, V38, P151, DOI 10.1016/S0161-5890(01)00039-6
   Park JY, 2001, BIOMATERIALS, V22, P2671, DOI 10.1016/S0142-9612(01)00009-6
   Price RL, 2003, MED BIOL ENG COMPUT, V41, P372, DOI 10.1007/BF02348445
   Rasband W, 1997, IMAGEJ
   Rice JM, 2003, BIOMATERIALS, V24, P4799, DOI 10.1016/S0142-9612(03)00381-8
   Sutherland DS, 2001, MACROMOL BIOSCI, V1, P270, DOI 10.1002/1616-5195(20010801)1:6<270::AID-MABI270>3.3.CO;2-V
   Tengvall P, 1998, BIOMATERIALS, V19, P935, DOI 10.1016/S0142-9612(98)00005-2
   Tengvall P, 2001, COLLOID SURFACE B, V20, P51, DOI 10.1016/S0927-7765(00)00174-0
   Thompson GE, 1997, THIN SOLID FILMS, V297, P192, DOI 10.1016/S0040-6090(96)09440-0
   Webster TJ, 2004, NANOTECHNOLOGY, V15, P48, DOI 10.1088/0957-4484/15/1/009
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Wettero J, 2002, BIOMATERIALS, V23, P981, DOI 10.1016/S0142-9612(01)00203-4
   Wettero J, 2001, J BIOMED MATER RES, V57, P550, DOI 10.1002/1097-4636(20011215)57:4<550::AID-JBM1201>3.0.CO;2-T
   WETTERO J, 2002, THESIS LINKOPING U L
   Whitesides GM, 2003, NAT BIOTECHNOL, V21, P1161, DOI 10.1038/nbt872
   Wieneke H, 2003, CATHETER CARDIO INTE, V60, P399, DOI 10.1002/ccd.10664
   WojciakStothard B, 1996, EXP CELL RES, V223, P426, DOI 10.1006/excr.1996.0098
   Yim EKF, 2005, NANOMED-NANOTECHNOL, V1, P10, DOI 10.1016/j.nano.2004.11.008
NR 40
TC 20
Z9 20
U1 0
U2 4
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 1
PY 2008
VL 87A
IS 3
BP 575
EP 581
DI 10.1002/jbm.a.31818
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 373PR
UT WOS:000260984800002
PM 18186072
DA 2018-10-19
ER

PT J
AU Changotade, SIT
   Korb, G
   Bassil, J
   Barroukh, B
   Willig, C
   Colliec-Jouault, S
   Durand, P
   Godeau, G
   Senni, K
AF Changotade, S. Igondjo Tchen
   Korb, G.
   Bassil, J.
   Barroukh, B.
   Willig, C.
   Colliec-Jouault, S.
   Durand, P.
   Godeau, G.
   Senni, K.
TI Potential effects of a low-molecular-weight fucoidan extracted from
   brown algae on bone biomaterial osteoconductive properties
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE fucoidan; osteoblast; bone; biomaterial; heparan mimetics
ID IN-VITRO; CELLS; SUBSTITUTES; RELEASE; CULTURE; MODEL
AB In this work, we first tested the influence of low-molecular-weight (LMW) fucoidan extracted from pheophicae cell wall on bidimensional cultured normal human osteoblasts' behaviors. Second, by impregnation procedure with LMW fucoidan of bone biomaterial (Lubboc (R)), we explored in this bone extracellular matrix context its capabilities to support human osteoblastic behavior in 3D culture. In bidimensionnal cultures, we evidenced that LMW fucoidan promotes human osteoblast proliferation and collagen type I expression and favors precocious alkaline phosphatase activity. Furthermore, with LMW fucoidan, von Kossa's staining was positive at 30 days and positive only at 45 days in the absence of LMW fucoidan. In our three-dimensional culture models with the biomaterial pretreated with LMW fucoidan, osteoblasts promptly overgrew the pretreated biomaterial. We also evidenced that osteoblasts increased proliferation with pretreated biomaterial when compared with untreated biomaterial. Osteoblasts secreted osteocalcin and expressed BMP2 receptor on control material as well as with LMW fucoidan impregnated biomaterial. In conclusion, in our experimental conditions, LMW fucoidan stimulated expression of osteoblastic markers differentiation such as alkaline phosphatase activity, collagen type I expression, and mineral deposition; furthermore, cell proliferation was favored. These findings suggest that fucoidan could be clinically useful for bone regeneration and bone substitute design. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 87A: 666-675, 2008
C1 [Changotade, S. Igondjo Tchen; Korb, G.; Bassil, J.; Barroukh, B.; Willig, C.; Godeau, G.; Senni, K.] Univ Paris 05, Lab Physiopathol Tissus Non Mineralises, Fac Chirurg Dent Montrouge, Paris, France.
   [Colliec-Jouault, S.; Durand, P.] IFREMER, Nantes, France.
RP Godeau, G (reprint author), Univ Paris 05, Lab Physiopathol Tissus Non Mineralises, Fac Chirurg Dent Montrouge, Paris, France.
EM godeau_g@yahoo.fr
OI Colliec-Jouault, Sylvia/0000-0002-2449-5410
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   ARONOW MA, 1990, J CELL PHYSIOL, V143, P213, DOI 10.1002/jcp.1041430203
   Basle MF, 1998, J BIOMED MATER RES, V40, P350, DOI 10.1002/(SICI)1097-4636(19980605)40:3<350::AID-JBM2>3.0.CO;2-E
   BEGLEY CT, 1993, BONE, V14, P661, DOI 10.1016/8756-3282(93)90089-S
   BERESFORD JN, 1993, AM J MED GENET, V45, P163, DOI 10.1002/ajmg.1320450205
   BUCK BE, 1994, CLIN ORTHOP RELAT R, P8
   Chabut D, 2004, THROMB RES, V113, P93, DOI 10.1016/j.thromres.2004.01.013
   Feige J J, 1995, Kidney Int Suppl, V49, pS15
   GRZESIK WJ, 1994, J BONE MINER RES, V9, P487, DOI 10.1002/jbmr.5650090408
   Habibovic P, 2005, BIOMATERIALS, V26, P3565, DOI 10.1016/j.biomaterials.2004.09.056
   Hartl A, 2004, ACTA ORTHOP SCAND, V75, P217, DOI 10.1080/00016470412331294485
   HOLDEN C M, 1990, Journal of Oral Implantology, V16, P86
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   Jager M, 2006, J BIOMED MATER RES A, V76A, P310, DOI 10.1002/jbm.a.30515
   Lake AC, 2006, J BIOL CHEM, V281, P37844, DOI 10.1074/jbc.M600686200
   LEGEROS RZ, 1993, J BONE MINER RES, V8, pS583
   Logeart D, 1996, J BIOMED MATER RES, V30, P501, DOI 10.1002/(SICI)1097-4636(199604)30:4<501::AID-JBM8>3.3.CO;2-F
   Luyt CE, 2003, J PHARMACOL EXP THER, V305, P24, DOI 10.1124/jpet.102.046144
   Matou S, 2002, THROMB RES, V106, P213, DOI 10.1016/S0049-3848(02)00136-6
   MCCAFFREY TA, 1994, J CELL PHYSIOL, V159, P51, DOI 10.1002/jcp.1041590108
   Millet J, 1999, THROMB HAEMOSTASIS, V81, P391
   Nardella A, 1996, CARBOHYD RES, V289, P201, DOI 10.1016/0008-6215(96)00110-3
   Nefussi JR, 1997, J HISTOCHEM CYTOCHEM, V45, P493, DOI 10.1177/002215549704500402
   POUMARAT G, 1993, BIOMATERIALS, V14, P337, DOI 10.1016/0142-9612(93)90051-3
   PROLO DJ, 1985, CLIN ORTHOP RELAT R, P322
   SCHOETERS G, 1992, CELL PROLIFERAT, V25, P587, DOI 10.1111/j.1365-2184.1992.tb01462.x
   Senni K, 2006, ARCH BIOCHEM BIOPHYS, V445, P56, DOI 10.1016/j.abb.2005.11.001
   SENNI K, 2003, Patent No. 6559131
NR 28
TC 34
Z9 34
U1 2
U2 12
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 1
PY 2008
VL 87A
IS 3
BP 666
EP 675
DI 10.1002/jbm.a.31819
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 373PR
UT WOS:000260984800012
PM 18189302
DA 2018-10-19
ER

PT J
AU Chang, DT
   Jones, JA
   Meyerson, H
   Colton, E
   Kwon, IK
   Matsuda, T
   Anderson, JM
AF Chang, David T.
   Jones, Jacqueline A.
   Meyerson, Howard
   Colton, Erica
   Kwon, Il Keun
   Matsuda, Takehisa
   Anderson, James M.
TI Lymphocyte/macrophage interactions: Biomaterial surface-dependent
   cytokine, chemokine, and matrix protein production
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE PET biomaterials; lymphocytes; macrophages; cytokines; matrix
   metalloproteinases
ID FOREIGN-BODY RESPONSE; GIANT-CELL FORMATION; T-CELL; IN-VITRO; ADHERENT
   MACROPHAGES; ADHESION BEHAVIOR; TISSUE INHIBITORS; HUMAN MONOCYTES; B7
   FAMILY; LYMPHOCYTES
AB The role of lymphocytes in the biological response to synthetic polymers is poorly understood despite the transient appearance of lymphocytes at the biomaterial implant site. To investigate cytokines, chemokines, and extracellular matrix (ECM) proteins produced by lymphocytes and macrophages in response to biomaterial surfaces, human peripheral blood monocytes and lymphocytes were co-cultured on polyethylene terephthalate (PET)-based material surfaces displaying distinct hydrophobic, hydrophilic/neutral, hydrophilic/anionic, and hydrophilic/cationic chemistries. Antibody array screening showed the majority of detected proteins are inflammatory mediators that guide the early inflammatory phases of wound healing. Proteomic ELISA quantification and adherent cell analysis were performed after 3, 7, and 10 days of culture. IL-2 and IFN-gamma were not detected in any co-cultures suggesting lack of lymphocyte activation. The hydrophilic/neutral surfaces increased IL-8 relative to the hydrophobic PET surface (p < 0.05). The hydrophilic/anionic surfaces promoted increased TNF-alpha over hydrophobic and cationic surfaces and increased MIP-1 beta compared to hydrophobic surfaces (p < 0.05). Since enhanced macrophage fusion was observed on hydrophilic/anionic surfaces, the production of these cytokines likely plays an important role in the fusion process. The hydrophilic/cationic surface promoted IL-10 production and increased matrix metalloproteinase (MMP)-9/tissue inhibitor of MMP (TIMP) relative to hydrophilic/neutral and anionic surfaces (p < 0.05). These results suggest hydrophilic/neutral and anionic surfaces promote pro-inflammatory responses and reduced degradation of the ECM, whereas the hydrophilic/cationic surfaces induce an anti-inflammatory response and greater MMP-9/TIMP with an enhanced potential for ECM breakdown. The study also underscores the usefulness of protein arrays in assessing the role of soluble mediators in the inflammatory response to biomaterials. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 87A: 676-687, 2008
C1 [Chang, David T.; Jones, Jacqueline A.; Anderson, James M.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   [Meyerson, Howard; Colton, Erica; Anderson, James M.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.
   [Meyerson, Howard] Univ Hosp Cleveland, Dept Pathol, Cleveland, OH 44106 USA.
   [Kwon, Il Keun] Purdue Univ, Dept Ind & Phys Pharm, W Lafayette, IN 47907 USA.
   [Kwon, Il Keun] Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA.
   [Matsuda, Takehisa] Kyushu Univ, Dept Biomed Engn, Fukuoka 812, Japan.
   [Anderson, James M.] Case Western Reserve Univ, Dept Macromol Sci, Cleveland, OH 44106 USA.
RP Anderson, JM (reprint author), Wolstein Res Bldg Room W5104,2103 Cornell Rd, Cleveland, OH 44106 USA.
EM jma6@case.edu
FU National Institutes of Health (NIH); National Institute of Biomedical
   Imaging and Bioengineering (NIBIB) [EB-000275, EB-000282, T32 GM07250]
FX Contract grant sponsors: National Institutes of Health (NIH), National
   Institute of Biomedical Imaging and Bioengineering (NIBIB); contract
   grant numbers: EB-000275, EB-000282, T32 GM07250
CR Anderson J.M., 1994, PROB GEN SURG, V11, P147
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   BACON KB, 1995, SCIENCE, V269, P1727, DOI 10.1126/science.7569902
   Bergman AJ, 1999, BIOMATERIALS, V20, P2235, DOI 10.1016/S0142-9612(99)00154-4
   Brodbeck WG, 2005, J BIOMED MATER RES A, V74A, P222, DOI 10.1002/jbm.a.30313
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Brodbeck WG, 2002, J LAB CLIN MED, V139, P90, DOI 10.1067/mlc.2002.121260
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   Broughton G, 2006, PLAST RECONSTR SURG, V117, p12S, DOI 10.1097/01.prs.0000225430.42531.c2
   Burger D, 2002, ARTHRITIS RES THER, V4, pS169, DOI 10.1186/ar558
   DeFife KM, 1997, J IMMUNOL, V158, P3385
   DING L, 1993, J IMMUNOL, V151, P1224
   Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611
   GROTH T, 1994, BIOMATERIALS, V15, P423, DOI 10.1016/0142-9612(94)90220-8
   Groux H, 2003, J AUTOIMMUN, V20, P281, DOI 10.1016/S0896-8411(03)00044-1
   Groux H, 1996, J EXP MED, V184, P19, DOI 10.1084/jem.184.1.19
   HOUSSIAU FA, 1989, J IMMUNOL, V143, P2520
   Hoves S, 2006, J IMMUNOL, V177, P2691, DOI 10.4049/jimmunol.177.4.2691
   JONES JA, 2007, J BIOMED MAT RES A
   Jones JA, 2007, J BIOMED MATER RES A, V83A, P585, DOI 10.1002/jbm.a.31221
   KAO WYJ, 1995, J BIOMED MATER RES, V29, P1267, DOI 10.1002/jbm.820291014
   Kyriakides TR, 2004, AM J PATHOL, V165, P2157, DOI 10.1016/S0002-9440(10)63265-8
   LE JM, 1988, P NATL ACAD SCI USA, V85, P8643, DOI 10.1073/pnas.85.22.8643
   MacEwan MR, 2005, J BIOMED MATER RES A, V74A, P285, DOI 10.1002/jbm.a.30316
   MAEDA M, 1986, J BIOMED MATER RES, V20, P25, DOI 10.1002/jbm.820200104
   Maghazachi AA, 1996, EUR J IMMUNOL, V26, P315, DOI 10.1002/eji.1830260207
   MALEFYT RD, 1991, J EXP MED, V174, P1209
   Marques AP, 2004, J BIOMED MATER RES A, V71A, P419, DOI 10.1002/jbm.a.30155
   MCNALLY AK, 1995, AM J PATHOL, V147, P1487
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   Mott JD, 2000, J BIOL CHEM, V275, P1384, DOI 10.1074/jbc.275.2.1384
   Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002
   Nakayama Y, 2000, J BIOMED MATER RES, V53, P584, DOI 10.1002/1097-4636(200009)53:5<584::AID-JBM19>3.0.CO;2-0
   Olson MW, 1997, J BIOL CHEM, V272, P29975, DOI 10.1074/jbc.272.47.29975
   OSTHUES A, 1992, FEBS LETT, V296, P16, DOI 10.1016/0014-5793(92)80393-U
   Romagnani S, 1999, INFLAMM BOWEL DIS, V5, P285, DOI 10.1097/00054725-199911000-00009
   Roncarolo MG, 2001, IMMUNOL REV, V182, P68, DOI 10.1034/j.1600-065X.2001.1820105.x
   SCHALL TJ, 1994, CYTOKINE HDB, P419
   Schwartz RH, 1996, J EXP MED, V184, P1, DOI 10.1084/jem.184.1.1
   Sica GL, 2003, IMMUNITY, V18, P849, DOI 10.1016/S1074-7613(03)00152-3
   STETLERSTEVENSON WG, 1993, FASEB J, V7, P1434
   Trindade MCD, 2001, BIOMATERIALS, V22, P253, DOI 10.1016/S0142-9612(00)00181-2
   Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D
   WARD SG, 1998, BIOCH J 3, V333, P4577
   Xue ML, 2005, INT J BIOCHEM CELL B, V37, P2406, DOI 10.1016/j.biocel.2005.06.003
   YOKOYAMA M, 1986, J BIOMED MATER RES, V20, P867, DOI 10.1002/jbm.820200702
NR 47
TC 40
Z9 40
U1 0
U2 27
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 1
PY 2008
VL 87A
IS 3
BP 676
EP 687
DI 10.1002/jbm.a.31630
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 373PR
UT WOS:000260984800013
PM 18200554
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Fassina, L
   Saino, E
   Visai, L
   Silvani, G
   De Angelis, MGC
   Mazzini, G
   Benazzo, F
   Magenes, G
AF Fassina, Lorenzo
   Saino, Enrica
   Visai, Livia
   Silvani, Giulia
   De Angelis, Maria Gabriella Cusella
   Mazzini, Giuliano
   Benazzo, Francesco
   Magenes, Giovanni
TI Electromagnetic enhancement of a culture of human SAOS-2 osteoblasts
   seeded onto titanium fiber-mesh scaffolds
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE electromagnetic stimulation; osteoblast; cell proliferation; calcified
   extracellular matrix; decorin; osteopontin; type-I collagen; surface
   modification; biomimetics
ID MARROW STROMAL CELLS; ECTOPIC BONE-FORMATION; POLYURETHANE POROUS
   SCAFFOLD; CALCIFIED MATRIX PRODUCTION; COMBINED MAGNETIC-FIELDS;
   PERFUSION BIOREACTOR; CALCIUM-PHOSPHATE; OSTEOGENIC CELLS; FOLLOW-UP;
   IN-VITRO
AB The surface properties of a biomaterial are fundamental to determine the response of the host tissue. In the present study, we have followed a particular biomimetic strategy where electromagnetically stimulated SAOS-2 human osteoblasts proliferated and built a calcified extracellular matrix on a titanium fiber-mesh surface. In comparison with control conditions, the electromagnetic stimulation (magnetic field intensity, 2 mT; frequency, 75 Hz) caused higher cell proliferation and increased surface coating with type-l collagen, decorin, and osteopontin (9.8-fold, 11.3-fold, and 9.5-fold, respectively). Reverse transcriptase-polymerase analysis revealed the electromagnetically upregulated transcription specific for the foregoing matrix proteins and for the growth factor TGF-beta 1. The immunofluorescence of type-I collagen, decorin, and osteopontin showed their colocalization in the cell-rich areas. The use of an electromagnetic bioreactor aimed at obtaining the surface modification of the biocompatible metallic scaffold in terms of cell colonization and coating with calcified extracellular matrix. The superficially modified biomaterial could be used, in clinical applications, as an implant for bone repair. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 87A: 750-759, 2008
C1 [Fassina, Lorenzo; Magenes, Giovanni] Univ Pavia, Dipartimento Informat & Sistemist, I-27100 Pavia, Italy.
   [Fassina, Lorenzo; Saino, Enrica; Visai, Livia; Silvani, Giulia; De Angelis, Maria Gabriella Cusella; Mazzini, Giuliano; Benazzo, Francesco; Magenes, Giovanni] Univ Pavia, CIT, I-27100 Pavia, Italy.
   [Saino, Enrica; Visai, Livia] Univ Pavia, Dipartimento Biochim, I-27100 Pavia, Italy.
   [Silvani, Giulia; De Angelis, Maria Gabriella Cusella] Univ Pavia, Dipartimento Med Sperimentale, I-27100 Pavia, Italy.
   [Mazzini, Giuliano] Univ Pavia, IGM CNR Istochim & Citometria, Dipartimento Biol Anim, I-27100 Pavia, Italy.
   [Benazzo, Francesco] Univ Pavia, Dipartimento SMEC, IRCCS San Matteo, I-27100 Pavia, Italy.
RP Fassina, L (reprint author), Univ Pavia, Dipartimento Informat & Sistemist, Via Palestro 3, I-27100 Pavia, Italy.
EM lorenzo.fassina@unipv.it
RI Magenes, Giovanni/C-4202-2012; Fassina, Lorenzo/K-9283-2015
OI Magenes, Giovanni/0000-0002-7558-1490; Fassina,
   Lorenzo/0000-0002-5587-4632; Cusella De Angelis, Maria
   Gabriella/0000-0003-2642-3346
FU Fondazione Cariplo [2004.1424/10.8485]; Italian Ministry of Education,
   University and Research [FIRBRBIP06FH7J]; University of Pavia
FX Contract grant sponsor: Fondazione Cariplo; contract grant number:
   2004.1424/10.8485; Contract grant sponsor: Italian Ministry of
   Education, University and Research (PRIN 2006 to L.V.); Contract grant
   sponsor: Italian Ministry of Education, University and Research
   (FIRBRBIP06FH7J)); Contract grant sponsor: University of Pavia (FAR
   2006)
CR Aaron RK, 1996, J ORTHOPAED RES, V14, P582, DOI 10.1002/jor.1100140412
   Aaron RK, 2004, CLIN ORTHOP RELAT R, P30, DOI 10.1097/01.blo.0000118698.46535.83
   Akita S, 2004, TISSUE ENG, V10, P789, DOI 10.1089/1076327041348338
   Banerjee AG, 2003, CANCER RES, V63, P7769
   BIANCO P, 1990, J HISTOCHEM CYTOCHEM, V38, P1549, DOI 10.1177/38.11.2212616
   Bodamyali T, 1998, BIOCHEM BIOPH RES CO, V250, P458, DOI 10.1006/bbrc.1998.9243
   Callaghan JJ, 1996, CLIN ORTHOP RELAT R, P118
   CANE V, 1993, J ORTHOPAED RES, V11, P664, DOI 10.1002/jor.1100110508
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Chang WHS, 2004, BIOELECTROMAGNETICS, V25, P457, DOI 10.1002/bem.20016
   CIOMBOR DM, 1993, J CELL BIOCHEM, V52, P37, DOI 10.1002/jcb.240520106
   Clohisy JC, 1999, J BONE JOINT SURG AM, V81A, P66, DOI 10.2106/00004623-199901000-00010
   DERYNCK R, 1985, NATURE, V316, P701, DOI 10.1038/316701a0
   Duan YR, 2004, J MATER SCI-MATER M, V15, P1205, DOI 10.1007/s10856-004-5673-0
   Fassina L, 2007, Technol Health Care, V15, P33
   Fassina L, 2005, TISSUE ENG, V11, P685, DOI 10.1089/ten.2005.11.685
   Fassina L, 2006, TISSUE ENG, V12, P1985, DOI 10.1089/ten.2006.12.1985
   Fisher L W, 1995, Acta Orthop Scand Suppl, V266, P61
   FISHER LW, 1989, J BIOL CHEM, V264, P4571
   FITZSIMMONS RJ, 1994, CLIN PLAST SURG, V21, P401
   FITZSIMMONS RJ, 1994, CALCIFIED TISSUE INT, V55, P376, DOI 10.1007/BF00299318
   FITZSIMMONS RJ, 1995, J BONE MINER RES, V10, P812
   Gorna K, 2003, J BIOMED MATER RES A, V67A, P813, DOI 10.1002/jbm.a.10148
   Heermeier K, 1998, BIOELECTROMAGNETICS, V19, P222, DOI 10.1002/(SICI)1521-186X(1998)19:4<222::AID-BEM4>3.0.CO;2-3
   Holland NB, 1998, NATURE, V392, P799
   Holtorf HL, 2005, BIOMATERIALS, V26, P6208, DOI 10.1016/j.biomaterials.2005.04.006
   Holtorf HL, 2005, J BIOMED MATER RES A, V74A, P171, DOI 10.1002/jbm.a.30330
   Hunt JA, 1997, BIOMATERIALS, V18, P1449, DOI 10.1016/S0142-9612(97)00091-4
   IshaugRiley SL, 1997, J BIOMED MATER RES, V36, P1, DOI 10.1002/(SICI)1097-4636(199707)36:1<1::AID-JBM1>3.0.CO;2-P
   Iwasaki Y, 1999, BIOMATERIALS, V20, P2185, DOI 10.1016/S0142-9612(99)00123-4
   Iwata M, 2004, BLOOD, V103, P4496, DOI 10.1182/blood-2004-01-0256
   Krout A, 2005, J BIOMED MATER RES A, V73A, P377, DOI 10.1002/jbm.a.30310
   Lohmann CH, 2000, J ORTHOP RES, V18, P637, DOI 10.1002/jor.1100180417
   Lohmann CH, 2003, J ORTHOP RES, V21, P326, DOI 10.1016/S0736-0266(02)00137-7
   MAKELA JK, 1990, BIOCHIM BIOPHYS ACTA, V1049, P171, DOI 10.1016/0167-4781(90)90037-3
   Mauney JR, 2004, TISSUE ENG, V10, P81, DOI 10.1089/107632704322791727
   Nishikawa M, 2004, CELL TRANSPLANT, V13, P367, DOI 10.3727/000000004783983819
   Otter MW, 1998, CLIN ORTHOP RELAT R, pS90
   Overbergh L, 1999, CYTOKINE, V11, P305, DOI 10.1006/cyto.1998.0426
   Pavalko FM, 2003, J CELL BIOCHEM, V88, P104, DOI 10.1002/jcb.10284
   Ratner BD, 1996, J MOL RECOGNIT, V9, P617, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<617::AID-JMR310>3.0.CO;2-D
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Rossi A, 1996, BIOCHEMISTRY-US, V35, P6048, DOI 10.1021/bi9518151
   Sanchez C, 2005, NAT MATER, V4, P277, DOI 10.1038/nmat1339
   van den Dolder J, 2003, TISSUE ENG, V9, P505, DOI 10.1089/107632703322066688
   van den Dolder J, 2003, BIOMATERIALS, V24, P1853, DOI 10.1016/S0142-9612(02)00571-9
   van den Dolder J, 2003, J BIOMED MATER RES A, V64A, P235, DOI 10.1002/jbm.a.10365
   van den Dolder J, 2003, TISSUE ENG, V9, P315, DOI 10.1089/107632703764664783
   van den Dolder J, 2003, BIOMATERIALS, V24, P1745, DOI 10.1016/S0142-9612(02)00537-9
   Vehof JWM, 2003, J BIOMED MATER RES A, V64A, P417, DOI 10.1002/jbm.a.10288
   Vehof JWM, 2002, CLIN ORAL IMPLAN RES, V13, P94, DOI 10.1034/j.1600-0501.2002.130112.x
   Vehof JWM, 2001, PLAST RECONSTR SURG, V108, P434, DOI 10.1097/00006534-200108000-00024
   VOGEL KG, 1987, J BIOL CHEM, V262, P13607
   ZOU X, 2003, APMIS S, V109, P127
NR 54
TC 27
Z9 28
U1 1
U2 11
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 1
PY 2008
VL 87A
IS 3
BP 750
EP 759
DI 10.1002/jbm.a.31827
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 373PR
UT WOS:000260984800021
PM 18200542
DA 2018-10-19
ER

PT J
AU Bodde, EWH
   Boerman, OC
   Russel, FGM
   Mikos, AG
   Spauwen, PHM
   Jansen, JA
AF Bodde, Esther W. H.
   Boerman, Otto C.
   Russel, Frans G. M.
   Mikos, Antonios G.
   Spauwen, Paul H. M.
   Jansen, John A.
TI The kinetic and biological activity of different loaded rhBMP-2 calcium
   phosphate cement implants in rats
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE BMP; drug release; calcium phosphate cement; PLGA; bone regeneration
ID BONE MORPHOGENETIC PROTEIN-2; BIODEGRADABLE POLYMER MICROPARTICLES;
   GROWTH-FACTOR BETA-1; DELIVERY SYSTEMS; IN-VIVO; BIOMATERIAL CARRIERS;
   CONTROLLED-RELEASE; ECTOPIC MODEL; DEFECTS; REPAIR
AB The healing of large bone defects can be improved by osteogenic bone graft substitutes, due to growth factor inclusion. A sustained release of these growth factors provides more efficient bioactivity when compared with burst release and might reduce the dose required for bone regeneration, which is desirable for socioeconomical and safety reasons. In this study, we compared different rhBMP-2 loadings in a sustained release system of CaP cement and PLGA-microparticles and were able to couple kinetic to biological activity data. Fifty-two rats received a critical-size cranial defect, which was left open or filled with the cement composites. The implants consisted of plain, high, and five-fold lower dose rhBMP-2 groups. Implantation time was 4 and 12 weeks. Longitudinal in vivo release was monitored by scintigraphic imaging of 131 I-labeled rhBMP-2. Quantitative analysis of the scintigraphic images revealed a sustained release of I-131-rhBMP-2 for both doses, with different release profiles between the two loadings. However, around 70% of the initial dose was retained in both implant formulations. Although low amounts of rhBMP-2 were released (2.4 +/- 0.8 mu g in 5 weeks), histology showed defect bridging in the high-dose implants. Release out of the low-dose implants was not sufficient to enhance bone formation. Implant degradation was limited in all formulations, but was mainly seen in the high-dose group. Low amounts of sustained released rhBMP-2 were sufficient to bridge critically sized defects. A substantial amount of rhBMP-2 was retained in the implants because of the slow release rate and the limited degradation. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 87A: 780-791, 2008
C1 [Bodde, Esther W. H.; Jansen, John A.] Radboud Univ Nijmegen, Med Ctr, Dept Periodontol & Biomat, NL-6525 ED Nijmegen, Netherlands.
   [Boerman, Otto C.] Radboud Univ Nijmegen, Med Ctr, Dept Nucl Med, NL-6525 ED Nijmegen, Netherlands.
   [Russel, Frans G. M.] Radboud Univ Nijmegen, Med Ctr, Dept Pharmacol & Toxicol, NL-6525 ED Nijmegen, Netherlands.
   [Mikos, Antonios G.] Rice Univ, Dept Bioengn, Houston, TX USA.
   [Spauwen, Paul H. M.] Radboud Univ Nijmegen, Med Ctr, Dept Plast & Reconstruct Surg, NL-6525 ED Nijmegen, Netherlands.
RP Jansen, JA (reprint author), Radboud Univ Nijmegen, Med Ctr, Dept Periodontol & Biomat, NL-6525 ED Nijmegen, Netherlands.
EM j.jansen@dent.umcn.nl
RI Boerman, Otto/A-8112-2014; Russel, Frans/B-3184-2014; Jansen,
   John/H-8055-2014
OI Boerman, Otto/0000-0001-6832-101X; Russel, Frans/0000-0002-7959-2314; 
CR Andrade J. D., 1996, INTERFACIAL PHENOMEN, P19
   Arnaud E, 1999, BIOMATERIALS, V20, P1909, DOI 10.1016/S0142-9612(99)00090-3
   Barnes B, 2005, SPINE, V30, P1127, DOI 10.1097/01.brs.0000162623.48058.8c
   BURKINSHAW L, 1958, PHYS MED BIOL, V2, P255, DOI 10.1088/0031-9155/2/3/305
   Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890
   Chu TMG, 2007, BIOMATERIALS, V28, P459, DOI 10.1016/j.biomaterials.2006.09.004
   Cleek RL, 1997, J BIOMED MATER RES, V35, P525, DOI 10.1002/(SICI)1097-4636(19970615)35:4<525::AID-JBM12>3.0.CO;2-A
   del Real RP, 2003, J BIOMED MATER RES A, V65A, P30, DOI 10.1002/jbm.a.10432
   Ebara S, 2002, SPINE, V27, pS10, DOI 10.1097/01.BRS.0000020727.98493.20
   FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0
   Ginebra MP, 2006, J CONTROL RELEASE, V113, P102, DOI 10.1016/j.jconrel.2006.04.007
   Groeneveld EHJ, 2000, EUR J ENDOCRINOL, V142, P9, DOI 10.1530/eje.0.1420009
   Habraken WJEM, 2006, J BIOMAT SCI-POLYM E, V17, P1057, DOI 10.1163/156856206778366004
   Hoshino M, 2006, BIOMATERIALS, V27, P4934, DOI 10.1016/j.biomaterials.2006.04.044
   Itoh K, 2001, ENDOCRINOLOGY, V142, P3656, DOI 10.1210/en.142.8.3656
   Jansen J, 2005, ORTHOP CLIN N AM, V36, P89, DOI 10.1016/j.ocl.2004.06.014
   Jansen JA, 2005, J CONTROL RELEASE, V101, P127, DOI 10.1016/j.jconrel.2004.07.005
   Kamakura S, 2004, J BIOMED MATER RES A, V71A, P299, DOI 10.1002/jbm.a.30157
   Lieberman JR, 1999, J BONE JOINT SURG AM, V81A, P905, DOI 10.2106/00004623-199907000-00002
   Lu L, 2000, J BIOMED MATER RES, V50, P440, DOI 10.1002/(SICI)1097-4636(20000605)50:3<440::AID-JBM19>3.0.CO;2-G
   Niedhart C, 2003, J BIOMED MATER RES A, V65A, P17, DOI 10.1002/jbm.a.10362
   Ooms EM, 2002, J BIOMED MATER RES, V61, P9, DOI 10.1002/jbm.10029
   Peter SJ, 2000, J BIOMED MATER RES, V50, P452, DOI 10.1002/(SICI)1097-4636(20000605)50:3<452::AID-JBM20>3.3.CO;2-S
   Rodeo SA, 2003, J BONE JOINT SURG AM, V85A, P2054, DOI 10.2106/00004623-200310000-00035
   Ruhe PQ, 2006, J MATER SCI-MATER M, V17, P919, DOI 10.1007/s10856-006-0181-z
   Ruhe PQ, 2005, J BIOMED MATER RES A, V74A, P533, DOI 10.1002/jbm.a.30341
   Ruhe PQ, 2003, J BONE JOINT SURG AM, V85A, P75
   Ruhe PQ, 2005, J CONTROL RELEASE, V106, P162, DOI 10.1016/j.jconrel.2005.04.018
   Seeherman H, 2005, CYTOKINE GROWTH F R, V16, P329, DOI 10.1016/j.cytogfr.2005.05.001
   Seeherman H, 2002, SPINE, V27, pS16, DOI 10.1097/01.BRS.0000020728.34131.03
   Seeherman HJ, 2006, J BONE JOINT SURG AM, V88A, P1553, DOI 10.2106/JBJS.E.01006
   TAKAGI K, 1982, ANN SURG, V196, P100, DOI 10.1097/00000658-198207000-00020
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 2001, J BONE JOINT SURG AM, V83A, pS128
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   Wang J, 1999, CALCIFIED TISSUE INT, V65, P486, DOI 10.1007/s002239900737
   Woo BH, 2001, PHARMACEUT RES, V18, P1747, DOI 10.1023/A:1013382832091
   Wozney JM, 2002, SPINE, V27, pS2, DOI 10.1097/01.BRS0000020725.01916.7E
   Wurzler KK, 1998, J CRANIOFAC SURG, V9, P131
   Xu C, 2005, GENE, V357, P1, DOI 10.1016/j.gene.2005.06.017
   Yuan HP, 2000, BIOMATERIALS, V21, P1283, DOI 10.1016/S0142-9612(00)00016-8
NR 41
TC 68
Z9 69
U1 2
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 1
PY 2008
VL 87A
IS 3
BP 780
EP 791
DI 10.1002/jbm.a.31830
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 373PR
UT WOS:000260984800024
PM 18200544
DA 2018-10-19
ER

PT J
AU Li, XT
   Sun, J
   Chen, S
   Chen, GQ
AF Li, Xiao-Tao
   Sun, Jie
   Chen, Song
   Chen, Guo-Qiang
TI In vitro investigation of maleated poly
   (3-hydroxybutyrate-co-3-hydroxyhexanoate) for its biocompatibility to
   mouse fibroblast L929 and human microvascular endothelial cells
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE PHB; maleated PHBHHx; maleic anhydride; L929; HMEC
ID INDUCED GRAFT-POLYMERIZATION; ARTICULAR-CARTILAGE CHONDROCYTES; TISSUE
   ENGINEERING APPLICATIONS; SURFACE WETTABILITY; ACRYLIC-ACID;
   POLY(3-HYDROXYBUTYRATE); POLY(3-HYDROXYBUTYRATE-CO-3-HYDROXYHEXANOATE);
   POLYHYDROXYALKANOATES; BIODEGRADATION; COPOLYMER
AB Poly (3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHx), a polyester with strong mechanical properties and biocompatibility, is a member of microbial polyhydroxyalkanoates (PHA) family. Maleic anhydride was used to graft PHBHHx to form maleated PHBHHx (Ma-PHBHHx). Ma-PHBHHx with a graft degree of 0.59% was found to be more thermo-stable in comparison with PHBHHx. In vitro study demonstrated that the biocompatibility to mouse fibroblast L929 and human microvascular endothelial cells (HMEC) was improved in different degrees on Ma-PHBHHx films and scaffolds. Compared with their growth on PHBHHx, L929 and HMEC grown on Ma-PHBHHx films and scaffolds showed similar to 120% and 260% more in proliferation rates, respectively. Morphology study suggested that fine whorl-like surface structures with porosities on Ma-PHBHHx films attributed to MA grafting would be better for cell attachment and proliferation. Ma-PHBHHx scaffolds prepared by thermally induced phase separation (TIPS) with increased porosity, hydrophilicity, surface energy, and charges also were more favorable for cell growth. In addition, Ma-PHBHHx showed an accelerated degradation incubation in SBF at 37 degrees C, losing 21.4% of its original weight after 21 weeks while PHBHHx just lost 7.3%. Based on the improved biocompatibility, reasonable mechanical properties as well as accelerated biodegradation, Ma-PHBHHx has shown advantages over PHBHHx as a biomaterial for biomedical applications. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 87A: 832-842,2008
C1 [Li, Xiao-Tao; Sun, Jie; Chen, Guo-Qiang] Shantou Univ, Multidisciplinary Res Ctr, Shantou 515063, Guangdong, Peoples R China.
   [Chen, Song; Chen, Guo-Qiang] Tsinghua Univ, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China.
RP Chen, GQ (reprint author), Shantou Univ, Multidisciplinary Res Ctr, Shantou 515063, Guangdong, Peoples R China.
EM chengq@stu.edu.cn
RI Chen, Song/H-3174-2011
FU Li ka Sheng Foundation; National High Tech 863 [2006AA02Z242]; State
   Basic Science Foundation 973 [2007CB707804]
FX Contract grant sponsor: Li ka Sheng Foundation; Contract grant sponsor:
   National High Tech 863; contract grant number: 2006AA02Z242; Contract
   grant sponsor: State Basic Science Foundation 973; contract grant
   number: 2007CB707804
CR Bahari K, 1997, ANGEW MAKROMOL CHEM, V250, P31, DOI 10.1002/apmc.1997.052500103
   BARHAM PJ, 1986, J POLYM SCI POL PHYS, V24, P69, DOI 10.1002/polb.1986.180240108
   Campagnola PJ, 2002, BIOPHYS J, V82, P493, DOI 10.1016/S0006-3495(02)75414-3
   Chen C, 2003, J APPL POLYM SCI, V88, P659, DOI 10.1002/app11771
   Chen C, 2002, EUR POLYM J, V38, P1663, DOI 10.1016/S0014-3057(02)00046-0
   Chen C, 2002, J APPL POLYM SCI, V84, P1789, DOI 10.1002/app.10463
   Chen FZ, 2004, J AEROSOL SCI, V35, P47, DOI 10.1016/S0021-8502(03)00383-5
   Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   Deng Y, 2003, BIOMATERIALS, V24, P4273, DOI 10.1016/S0142-9612(03)00367-3
   DOI Y, 1995, MACROMOLECULES, V28, P4822, DOI 10.1021/ma00118a007
   Doi Y., 2002, BIOPOLYMERS
   Dziubla TD, 2004, J BIOMED MATER RES A, V68A, P603, DOI 10.1002/jbm.a.20023
   Evans MDM, 1998, J BIOMED MATER RES, V40, P621, DOI 10.1002/(SICI)1097-4636(19980615)40:4<621::AID-JBM14>3.0.CO;2-I
   Grondahl L, 2005, BIOMACROMOLECULES, V6, P2197, DOI 10.1021/bm050127m
   Hazer B, 2007, APPL MICROBIOL BIOT, V74, P1, DOI 10.1007/s00253-006-0732-8
   Hu SG, 2003, BIOMATERIALS, V24, P2685, DOI 10.1016/S0142-9612(03)00079-6
   KENONG GJ, 1993, POLYMER, V34, P4089
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Luciano RM, 2003, J MATER SCI-MATER M, V14, P87, DOI 10.1023/A:1021509722296
   Ma PX, 2004, MATER TODAY, V7, P30, DOI 10.1016/S1369-7021(04)00233-0
   Mei N, 2006, J MATER SCI-MATER M, V17, P749, DOI 10.1007/s10856-006-9686-8
   Misra SK, 2006, BIOMACROMOLECULES, V7, P2249, DOI 10.1021/bm060317c
   Mitomo H, 1996, SEN-I GAKKAISHI, V52, P623, DOI 10.2115/fiber.52.11_623
   MITOMO H, 1995, J MACROMOL SCI PURE, VA32, P429, DOI 10.1080/10601329508013674
   MITOMO H, 1995, RADIAT PHYS CHEM, V46, P233, DOI 10.1016/0969-806X(95)00018-S
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   Plackett D, 2004, J POLYM ENVIRON, V12, P131, DOI 10.1023/B:JOOE.0000038544.75554.0e
   Qu XH, 2006, BIOMATERIALS, V27, P3540, DOI 10.1016/j.biomaterials.2006.02.015
   Qu XH, 2005, BIOMATERIALS, V26, P6991, DOI 10.1016/j.biomaterials.2005.05.034
   Schugens C, 1996, POLYMER, V37, P1027, DOI 10.1016/0032-3861(96)87287-9
   Shangguan YY, 2006, BIOMATERIALS, V27, P2349, DOI 10.1016/j.biomaterials.2005.11.024
   Steinbuchel A, 1991, BIOMATERIALS NOVEL M, P124
   Tesema Y, 2004, J APPL POLYM SCI, V93, P2445, DOI 10.1002/app.20787
   VANWACHEM PB, 1987, BIOMATERIALS, V8, P323, DOI 10.1016/0142-9612(87)90001-9
   Wang YW, 2004, POLYM DEGRAD STABIL, V85, P815, DOI 10.1016/j.polymdegradstab.2004.02.010
   Wang YW, 2003, BIOMATERIALS, V24, P4621, DOI 10.1016/S0142-9612(03)00356-9
   Webb K, 1998, J BIOMED MATER RES, V41, P422, DOI 10.1002/(SICI)1097-4636(19980905)41:3<422::AID-JBM12>3.0.CO;2-K
   Williams SF, 1999, INT J BIOL MACROMOL, V25, P111, DOI 10.1016/S0141-8130(99)00022-7
   Xu J, 2003, J POLYM SCI POL PHYS, V41, P2128, DOI 10.1002/polb.10556
   Yang J, 2002, BIOMATERIALS, V23, P2607, DOI 10.1016/S0142-9612(01)00400-8
   Zheng Z, 2005, BIOMATERIALS, V26, P3537, DOI 10.1016/j.biomaterials.2004.09.041
   ZOU B, 2006, CHINA BIOTECHNOL, V26, P43
NR 42
TC 15
Z9 18
U1 0
U2 12
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 1
PY 2008
VL 87A
IS 3
BP 832
EP 842
DI 10.1002/jbm.a.31890
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 373PR
UT WOS:000260984800029
PM 18306313
DA 2018-10-19
ER

PT J
AU Liu, J
   Wang, FH
   Wang, LL
   Xiao, SY
   Tong, CY
   Tang, DY
   Liu, XM
AF Liu Jun
   Wang Feng-hua
   Wang Ling-ling
   Xiao Su-yao
   Tong Chun-yi
   Tang Dong-ying
   Liu Xuan-ming
TI Preparation of fluorescence starch-nanoparticle and its application as
   plant transgenic vehicle
SO JOURNAL OF CENTRAL SOUTH UNIVERSITY OF TECHNOLOGY
LA English
DT Article
DE fluorescence nanoparticle; plant; gene vehicle; ultrasound-mediation;
   transformation
ID GENE DELIVERY; MAMMALIAN-CELLS; DNA PROTECTION; ULTRASOUND;
   TRANSFORMATION; BOMBARDMENT; CARRIER; TOOL
AB Starch-nanoparticles were synthesized in water-in-oil microemusion at room temperature, and the starch-nanoparticles were coated with poly-L-lysine. The surface of the starch-nanoparticles was combined with fluorescence material Ru(bpy)(3)(2+) center dot 6H(2)O, and then the particles were characterized via transmission electron microscope. The fluorescence nanoparticles were conjugated with plasmid DNA to form complexes, and then treated with ultrasound and DNase I. pEGAD plasmid DNA-nanoparticle complexes were co-cultured with plant suspension cells of Dioscrea Zigiberensis G H Wright, and treated with ultrasound. The results show that the diameter of the fluorescence starch-nanoparticles is 50-100 nm. DNA-nanoparticle complexes can protect DNA from ultrasound damage as well as from DNase I cleavage. Mediated by ultrasound, pEGAD plasmid DNA-nanoparticle complexes can pierce into the cell wall, cell membrane and nucleus membrane of plant suspension cells. The green fluorescence protein(GFP) gene at a high frequency exceeds 5%. This nano-biomaterial can efficiently solve the problem that exterior genes cannot traverse the plant cell wall easily.
C1 [Liu Jun; Wang Feng-hua; Xiao Su-yao; Tong Chun-yi; Tang Dong-ying; Liu Xuan-ming] Hunan Univ, Coll Life Sci & Biotechnol, Changsha 410082, Hunan, Peoples R China.
   [Liu Jun] Hunan Univ, Coll Mat Sci & Engn, Changsha 410082, Hunan, Peoples R China.
   [Wang Ling-ling] Hunan Univ, Sch Phys & Microelect Sci, Changsha 410082, Hunan, Peoples R China.
RP Liu, XM (reprint author), Hunan Univ, Coll Life Sci & Biotechnol, Changsha 410082, Hunan, Peoples R China.
EM sw_xml@hnu.cn
FU "985" Program of China [200501]
FX Project(200501) supported the "985" Program of China
CR BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297
   Chai LY, 2006, J CENT SOUTH UNIV T, V13, P17, DOI 10.1007/s11771-006-0099-0
   Chowdhury EH, 2004, GENE, V341, P77, DOI 10.1016/j.gene.2004.07.015
   Deng CX, 2004, ULTRASOUND MED BIOL, V30, P519, DOI 10.1016/j.ultrasmedbio.2004.01.005
   Gelvin SB, 2003, MICROBIOL MOL BIOL R, V67, P16, DOI 10.1128/MMBR.67.1.16-37.2003
   He XX, 2003, J AM CHEM SOC, V125, P7168, DOI 10.1021/ja034450d
   Hood JD, 2002, SCIENCE, V296, P2404, DOI 10.1126/science.1070200
   Liu J, 2005, ANAL SCI, V21, P193, DOI 10.2116/analsci.21.193
   Liu J, 2005, CHEM J CHINESE U, V26, P634
   Luo D, 2000, NAT BIOTECHNOL, V18, P33
   Men S, 2003, PLANT CELL REP, V21, P592, DOI 10.1007/s00299-002-0559-4
   MILLER DL, 1993, ULTRASOUND MED BIOL, V19, P343, DOI 10.1016/0301-5629(93)90106-X
   Roy I, 2005, P NATL ACAD SCI USA, V102, P279, DOI 10.1073/pnas.0408039101
   STACHEL SE, 1985, NATURE, V318, P624, DOI 10.1038/318624a0
   Taylor NJ, 2002, DNA CELL BIOL, V21, P963, DOI 10.1089/104454902762053891
   Thomas M, 2003, P NATL ACAD SCI USA, V100, P9138, DOI 10.1073/pnas.1233634100
   Xiao SY, 2005, SCI CHINA SER B, V48, P162, DOI 10.1360/04yb0010
   Yu DM, 2007, CHINESE SCI BULL, V52, P2913, DOI 10.1007/s11434-007-0388-5
NR 18
TC 28
Z9 29
U1 0
U2 41
PU JOURNAL OF CENTRAL SOUTH UNIV TECHNOLOGY
PI HUNAN
PA EDITORIAL OFFICE, CHANGSHA, HUNAN 410083, PEOPLES R CHINA
SN 1005-9784
J9 J CENT SOUTH UNIV T
JI J. Cent. South Univ. Technol.
PD DEC
PY 2008
VL 15
IS 6
BP 768
EP 773
DI 10.1007/s11771-008-0142-4
PG 6
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 384OA
UT WOS:000261752900006
DA 2018-10-19
ER

PT J
AU Shen, XR
   Nagai, N
   Murata, M
   Nishimura, D
   Sugi, M
   Munekata, M
AF Shen, XuanRi
   Nagai, Nobuhiro
   Murata, Masaru
   Nishimura, Daisuke
   Sugi, Masahito
   Munekata, Masanobu
TI Development of salmon milt DNA/salmon collagen composite for wound
   dressing
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID UV-IRRADIATION; DNA; GEL; PROLIFERATION; ATELOCOLLAGEN; FIBROBLASTS;
   BIOMATERIAL; ADENOSINE; GROWTH; FILMS
AB This study aims to develop a novel wound dressing comprising salmon milt DNA (sDNA) and salmon collagen (SC). The sDNA/SC composites were prepared by incubating a mixture of an acidic SC solution, an sDNA solution, and a collagen fibrillogenesis inducing buffer (pH 6.8) containing a crosslinking agent (water-soluble carbodiimide) for gelation, and a subsequent ventilation-drying process to give sDNA/SC films. The conjugation between sDNA and SC were confirmed by sDNA-elution assay and fluorescence microscopy. The sDNA/SC films with various doses of sDNA (sDNA/SC weight ratios of 1:5, 1:10, and 1:20) were used for in vitro cell cultures to evaluate their growth potentials of normal human dermal fibroblasts (NHDF) and normal human epidermal keratinocytes (NHEK). It was found that NHDF proliferation was increased by sDNA conjugation, whereas NHEK proliferation was dose-dependently inhibited. In light of the in vitro results, the appropriate dose of sDNA for in vivo study was determined to be the ratio of 1:10. For the implantation in full-thickness skin defects in rat dorsal region, the sDNA/SC films were reinforced by incorporating them on a porous SC sponge, because the sDNA/SC films exhibited early contraction and inadequate morphologic stability when implanted in vivo. The regenerated tissue in the sDNA/SC sponge group showed similar morphology to native dermis, while the SC sponge group without sDNA showed epithelial overgrowth, indicating that additional sDNA could reduce epidermal overgrowth. Furthermore, blood capillary formation was significantly enhanced in the sDNA/SC sponge group when compared to the SC sponge group. In conclusion, the results suggest that the sDNA/SC composite could be a potential wound dressing for clinical applications.
C1 [Shen, XuanRi; Munekata, Masanobu] Hokkaido Univ, Grad Sch Engn, Div Biotechnol & Macromol Chem, Kita Ku, Sapporo, Hokkaido 0608628, Japan.
   [Nagai, Nobuhiro] Hokkaido Univ, Creat Res Initiat Sousei, Sapporo, Hokkaido 0010021, Japan.
   [Murata, Masaru] Hlth Sci Univ Hokkaido, Sch Dent, Div Oral & Maxillofacial Surg, Tobetsu Cho, Hokkaido 0610293, Japan.
   [Nishimura, Daisuke; Sugi, Masahito] Inst Nissei Bio Co Ltd, Eniwa, Hokkaido 0611374, Japan.
RP Shen, XR (reprint author), Hokkaido Univ, Grad Sch Engn, Div Biotechnol & Macromol Chem, Kita Ku, N13-W8, Sapporo, Hokkaido 0608628, Japan.
EM sxrcg@yahoo.co.jp
FU Japan Society for the Promotion of Science (JSPS)
FX Shen thanks the Japan Society for the Promotion of Science (JSPS) for a
   post-doctoral fellowship for foreign researchers.
CR COOK PW, 1995, J INVEST DERMATOL, V104, P976, DOI 10.1111/1523-1747.ep12606228
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   DOILLON CJ, 1986, BIOMATERIALS, V7, P3, DOI 10.1016/0142-9612(86)90080-3
   Falabella AF, 2006, DERMATOL THER, V19, P317, DOI 10.1111/j.1529-8019.2006.00090.x
   Fukushima T, 2004, BIOMATERIALS, V25, P5491, DOI 10.1016/j.biomaterials.2004.01.006
   Giraud-Guille MM, 2000, BIOMATERIALS, V21, P899, DOI 10.1016/S0142-9612(99)00244-6
   Holen E, 2006, NUTRITION, V22, P90, DOI 10.1016/j.nut.2006.01.001
   Ishihara M, 2002, BIOMATERIALS, V23, P833, DOI 10.1016/S0142-9612(01)00189-2
   KALDLER KE, 1996, BIOCH J 1, V316, P1
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Liu WG, 2005, BIOMATERIALS, V26, P2705, DOI 10.1016/j.biomaterials.2004.07.038
   MIAN M, 1992, INT J TISSUE REACT, V14, P1
   Montesinos MC, 2002, AM J PATHOL, V160, P2009, DOI 10.1016/S0002-9440(10)61151-0
   Nagai N, 2004, J BIOSCI BIOENG, V98, P493, DOI 10.1016/S1389-1723(05)00319-1
   Nagai N, 2004, J BIOSCI BIOENG, V97, P389, DOI 10.1263/jbb.97.389
   Nagai N, 2007, J BIOMED MATER RES A, V82A, P395, DOI 10.1002/jbm.a.31110
   Purna S K, 2000, Burns, V26, P54
   Queen Douglas, 2004, Int Wound J, V1, P59, DOI 10.1111/j.1742-4801.2004.0009.x
   Ramshaw JAM, 1996, BIOTECHNOL GENET ENG, V13, P335, DOI 10.1080/02648725.1996.10647934
   Song E, 2006, BIOMATERIALS, V27, P2951, DOI 10.1016/j.biomaterials.2006.01.015
   Thellung S, 1999, LIFE SCI, V64, P1661, DOI 10.1016/S0024-3205(99)00104-6
   van den Beucken JJJP, 2006, BIOMATERIALS, V27, P691, DOI 10.1016/j.biomaterials.2005.06.015
   Yamada M, 2002, CHEM-EUR J, V8, P1407, DOI 10.1002/1521-3765(20020315)8:6<1407::AID-CHEM1407>3.0.CO;2-L
   Yamada M, 2001, BIOMATERIALS, V22, P3121, DOI 10.1016/S0142-9612(01)00061-8
   Yunoki S, 2004, J BIOSCI BIOENG, V98, P40, DOI 10.1263/jbb.98.40
NR 25
TC 16
Z9 18
U1 0
U2 6
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD DEC
PY 2008
VL 19
IS 12
BP 3473
EP 3479
DI 10.1007/s10856-008-3512-4
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 353LZ
UT WOS:000259570800001
PM 18592347
DA 2018-10-19
ER

PT J
AU Vohra, S
   Hennessy, KM
   Sawyer, AA
   Zhuo, Y
   Bellis, SL
AF Vohra, Shikhar
   Hennessy, Kristin M.
   Sawyer, Amber A.
   Zhuo, Ya
   Bellis, Susan L.
TI Comparison of mesenchymal stem cell and osteosarcoma cell adhesion to
   hydroxyapatite
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID ADSORBED SERUM-PROTEINS; GROWTH-FACTOR-BETA; BONE-MARROW-CELLS;
   OSTEOBLASTIC DIFFERENTIATION; TRANSCRIPTION FACTOR; GENE-EXPRESSION;
   PRECURSOR CELLS; RGD PEPTIDES; I COLLAGEN; FIBRONECTIN
AB Immortalized cells are often used to model the behavior of osteogenic cells on orthopaedic and dental biomaterials. In the current study we compared the adhesive behavior of two osteosarcoma cell lines, MG-63 and Saos-2, with that of mesenchymal stem cells (MSCs) on hydroxyapatite (HA). It was found that osteosarcoma cells demonstrated maximal binding to fibronectin-coated HA, while MSCs alternately preferred HA coated with collagen-I. Interesting, the binding of MG-63 and Saos-2 cells to fibronectin was mediated by both alpha 5 and alpha v-containing integrin heterodimers, whereas only alpha v integrins were used by MSCs. Cell spreading was also markedly different for the three cell types. Osteosarcoma cells exhibited optimal spreading on fibronectin, but poor spreading on HA disks coated with fetal bovine serum. In contrast, MSCs spread very well on serum-coated surfaces, but less extensively on fibronectin. Finally, we evaluated integrin expression and found that MSCs have higher levels of alpha 2 integrin subunits relative to MG-63 or Saos-2 cells, which may explain the enhanced adhesion of MSCs on collagen-coated HA. Collectively our results suggest that osteosarcoma cells utilize different mechanisms than MSCs during initial attachment to protein-coated HA, thereby calling into question the suitability of these cell lines as in vitro models for cell/biomaterial interactions.
C1 [Vohra, Shikhar; Bellis, Susan L.] Univ Alabama Birmingham, Dept Biomed Engn, Birmingham, AL 35294 USA.
RP Bellis, SL (reprint author), Univ Alabama Birmingham, Dept Physiol & Biophys, MCLM 982A,1918 Univ Blvd, Birmingham, AL 35294 USA.
EM bellis@physiology.uab.edu
FU NIAMS [R01AR51539]; NIBIB
FX The authors gratefully acknowledge support from NIAMS grant R01AR51539
   (SLB) and a predoctoral NRSA from NIBIB (KMH).
CR AKIYAMA SK, 1987, J BIOL CHEM, V262, P17536
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   CLOVER J, 1994, BONE, V15, P585, DOI 10.1016/8756-3282(94)90305-0
   Conget PA, 1999, J CELL PHYSIOL, V181, P67, DOI 10.1002/(SICI)1097-4652(199910)181:1<67::AID-JCP7>3.3.CO;2-3
   DASTYCH J, 1994, J IMMUNOL, V152, P213
   Davies JE, 1996, ANAT REC, V245, P426
   Duan XP, 2004, CLIN EXP METASTAS, V21, P747, DOI 10.1007/s10585-005-0599-6
   Dumbleton J, 2004, J BONE JOINT SURG AM, V86A, P2526, DOI 10.2106/00004623-200411000-00028
   Geesink RGT, 2002, CLIN ORTHOP RELAT R, P53, DOI 10.1097/00003086-200202000-00007
   Gronthos S, 2001, BONE, V28, P174, DOI 10.1016/S8756-3282(00)00424-5
   HEINO J, 1989, J BIOL CHEM, V264, P380
   Hennessy KM, 2008, BIOMATERIALS, V29, P3075, DOI 10.1016/j.biomaterials.2008.04.014
   Karrholm J, 1997, J PEDIATR ORTHOP B, V6, P91
   Keselowsky BG, 2007, J BIOMED MATER RES A, V80A, P700, DOI 10.1002/jbm.a.30898
   Kilpadi KL, 2001, J BIOMED MATER RES, V57, P258, DOI 10.1002/1097-4636(200111)57:2<258::AID-JBM1166>3.0.CO;2-R
   Kilpadi KL, 2004, J BIOMED MATER RES A, V68A, P273, DOI 10.1002/jbm.a.20043
   Kinashi T, 1999, J IMMUNOL, V162, P2850
   LENTER M, 1994, J BIOL CHEM, V269, P12263
   LEVESQUE JP, 1995, J EXP MED, V181, P1805, DOI 10.1084/jem.181.5.1805
   Marco RAW, 2003, J CELL BIOCHEM, V88, P1038, DOI 10.1002/jcb.10465
   Mizuno M, 2001, J BIOCHEM-TOKYO, V129, P133, DOI 10.1093/oxfordjournals.jbchem.a002824
   Mizuno M, 2000, J CELL PHYSIOL, V184, P207, DOI 10.1002/1097-4652(200008)184:2<207::AID-JCP8>3.3.CO;2-L
   Moursi AM, 1997, J CELL SCI, V110, P2187
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Ringe J, 2002, NATURWISSENSCHAFTEN, V89, P338, DOI 10.1007/s00114-002-0344-9
   Sawyer AA, 2005, BIOMATERIALS, V26, P1467, DOI 10.1016/j.biomaterials.2004.05.008
   Sawyer AA, 2007, BIOMATERIALS, V28, P383, DOI 10.1016/j.biomaterials.2006.08.031
   Schneider GB, 2001, J DENT RES, V80, P1540, DOI 10.1177/00220345010800061201
   Siebers MC, 2005, BIOMATERIALS, V26, P137, DOI 10.1016/j.biomaterials.2004.02.021
   Soballe K, 2003, ACTA ORTHOP SCAND, V74, P239
   STEELE JG, 1995, BIOMATERIALS, V16, P1057, DOI 10.1016/0142-9612(95)98901-P
   Suzawa M, 2002, J BONE MINER RES, V17, P240, DOI 10.1359/jbmr.2002.17.2.240
   Tabb MM, 2003, J BIOL CHEM, V278, P43919, DOI 10.1074/jbc.M303136200
   Takeuchi Y, 1997, J BIOL CHEM, V272, P29309, DOI 10.1074/jbc.272.46.29309
   Tamura Y, 2001, J BONE MINER RES, V16, P1772, DOI 10.1359/jbmr.2001.16.10.1772
   Tang CH, 2004, TOXICON, V43, P11, DOI 10.1016/j.toxicon.2003.01.008
   Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0
   Xiao GZ, 1998, J BIOL CHEM, V273, P32988, DOI 10.1074/jbc.273.49.32988
   Xiao GZ, 2000, J BIOL CHEM, V275, P4453, DOI 10.1074/jbc.275.6.4453
NR 39
TC 27
Z9 27
U1 0
U2 8
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD DEC
PY 2008
VL 19
IS 12
BP 3567
EP 3574
DI 10.1007/s10856-008-3525-z
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 353LZ
UT WOS:000259570800012
PM 18626747
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Wu, YZ
   Hu, Y
   Cai, JY
   Ma, SY
   Wang, XP
AF Wu, Yangzhe
   Hu, Yi
   Cai, Jiye
   Ma, Shuyuan
   Wang, Xiaoping
TI Coagulation property of hyaluronic acid-collagen/chitosan complex film
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID ATOMIC-FORCE MICROSCOPY; IN-VITRO; PLATELET-ADHESION; RECEPTOR
   EXPRESSION; STEM-CELLS; CHITOSAN; COLLAGEN; SCAFFOLDS; ACTIVATION;
   BIOCOMPATIBILITY
AB Biomacromolecule has been widely used as biomedical material. Because different biomacromolecules possess different properties, how to exhibit the respective advantages of different components on one type of biomaterial becomes the hot spot in the field of biomaterial studying. This work reported a type of complex film that consisted of hyaluronic acid (HA), type I collagen (Col-I), and chitosan (CS) (HA-Col-I/CS, HCC). Then, a series of experiments were performed, such as inverted microscopic observation, atomic force microscopic (AFM) imaging, flow cytometry (FCM) measurement, MTT assay, and MIC assay. In the present work, we observed the growing condition of 3T3 fibroblasts on the surface of the HCC complex film, visualized the morphological changes of platelets during the coagulation process, and discovered microparticles on the platelet membrane. Moreover, we confirmed the microparticles are the platelet-derived microparticles (PMPs) using the FCM. In addition, the minimal inhibitory concentration (MIC) of HCC against Escherichia coli (E. coli) 8099 was 0.025 mg/ml, against Staphylococcus aureus (S. aureus) ATCC 6538 was 0.1 mg/ml. The results together indicated that the HCC film possessed promising coagulation property, cell compatibility and anti-bacteria property, and the potential in future clinical application such as wound healing and bandage.
C1 [Wu, Yangzhe; Hu, Yi; Cai, Jiye] Jinan Univ, Dept Chem, Guangzhou 510632, Guangdong, Peoples R China.
   [Ma, Shuyuan; Wang, Xiaoping] Jinan Univ, Affiliated Hosp 1, Guangzhou 510632, Guangdong, Peoples R China.
RP Cai, JY (reprint author), Jinan Univ, Dept Chem, Guangzhou 510632, Guangdong, Peoples R China.
EM tjycai@jnu.edu.cn
RI Wu, Yangzhe/C-4435-2012
FU NSFC [60578025, 30540420311]
FX We thank associate professor Meiying Zhang (Biomedicine Research &
   Development Center, Jinan University) for her warm help in cell culture
   techniques. This work is supported by the NSFC (No. 60578025,
   30540420311).
CR Abatangelo G, 1997, BIOMATERIALS, V18, P1411, DOI 10.1016/S0142-9612(97)00089-6
   Alberio Lorenzo J, 2004, Curr Hematol Rep, V3, P338
   Alonso JL, 2003, LIFE SCI, V72, P2553, DOI 10.1016/S0024-3205(03)00165-6
   Aurigemma C, 2007, THROMB RES, V120, P901, DOI 10.1016/j.thromres.2007.01.009
   BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   Blinc A, 2000, FIBRINOLYSIS PROTEOL, V14, P288, DOI 10.1054/fipr.2000.0085
   CATANI L, 2006, EXP HEMATOL, V134, P879
   Cauwenberghs S, 2006, FEBS LETT, V580, P5313, DOI 10.1016/j.febslet.2006.08.082
   Chan BP, 2005, J BIOMED MATER RES A, V75A, P689, DOI 10.1002/jbm.a.30469
   Choi W, 2008, ACTA ODONTOL SCAND, V66, P31, DOI 10.1080/00016350701884612
   Dang JM, 2006, BIOMATERIALS, V27, P406, DOI 10.1016/j.biomaterials.2005.07.033
   Feng Q, 2005, COLLOID SURFACE A, V257-58, P85, DOI 10.1016/j.colsurfa.2004.10.099
   Fernandez-Barbero JE, 2006, CLIN ORAL IMPLAN RES, V17, P687, DOI 10.1111/j.1600-0501.2006.01179.x
   Fungaloi P, 2002, PHOTOCHEM PHOTOBIOL, V75, P412, DOI 10.1562/0031-8655(2002)075<0412:PATPTT>2.0.CO;2
   Garrison MD, 1997, ANN NY ACAD SCI, V831, P101
   Haque T, 2005, INT J ARTIF ORGANS, V28, P631
   Horber JKH, 2003, SCIENCE, V302, P1002, DOI 10.1126/science.1067410
   Hu Y, 2007, INT J MOL SCI, V8, P1, DOI 10.3390/i8010001
   Ilveskero S, 2001, ARTERIOSCL THROM VAS, V21, P628, DOI 10.1161/01.ATV.21.4.628
   Jiansu C., 2005, ARTIFI ORGANS, V29, P104
   Kalsch T, 2007, THROMB RES, V120, P703, DOI 10.1016/j.thromres.2006.12.022
   Kalsch T, 2006, INT J CARDIOL, V111, P217, DOI 10.1016/j.ijcard.2005.08.001
   Kang I, 2007, THROMB RES, V119, P731, DOI 10.1016/j.thromres.2006.06.010
   Kanno M, 2002, J BIOMED MATER RES, V60, P53, DOI 10.1002/jbm.1280
   Li B, 2006, CARBOHYD POLYM, V65, P488, DOI 10.1016/j.carbpol.2006.02.006
   Linden MD, 2004, SEMIN THROMB HEMOST, V30, P501, DOI 10.1055/s-2004-835671
   Ma L, 2004, BIOMATERIALS, V25, P2997, DOI 10.1016/j.biomaterials.2003.09.092
   Mao JS, 2003, BIOMATERIALS, V24, P1621, DOI 10.1016/S0142-9612(02)00549-5
   Meinel L, 2004, J BIOMED MATER RES A, V71A, P25, DOI 10.1002/jbm.a.30117
   Nan Liu, 2006, Carbohydrate Polymers, V64, P60, DOI 10.1016/j.carbpol.2005.10.028
   Qu CX, 2006, J CLIN LAB ANAL, V20, P250, DOI 10.1002/jcla.20150
   Rammelt S, 2006, BIOMATERIALS, V27, P5561, DOI 10.1016/j.biomaterials.2006.06.034
   Rodrigues SN, 2006, BIOMATERIALS, V27, P5357, DOI 10.1016/j.biomaterials.2006.06.010
   Serebruany V, 2007, THROMB RES, V119, P175, DOI 10.1016/j.thromres.2006.02.004
   Siedlecki CA, 1998, BIOMATERIALS, V19, P441, DOI 10.1016/S0142-9612(97)00222-6
   Siedlecki CA, 1999, BIOMATERIALS, V20, P1521, DOI 10.1016/S0142-9612(99)00065-4
   Stuhlmeier KM, 2006, WIEN MED WOCHENSCHR, V156, P563, DOI 10.1007/s10354-006-0351-0
   Tanabe T, 2002, BIOMATERIALS, V23, P817, DOI 10.1016/S0142-9612(01)00187-9
   Toes GJ, 1999, BIOMATERIALS, V20, P1951, DOI 10.1016/S0142-9612(99)00100-3
   Vidovic A, 2007, PSYCHIAT RES, V150, P211, DOI 10.1016/j.psychres.2006.05.004
   Wang J, 2006, NUCL INSTRUM METH B, V242, P12, DOI 10.1016/j.nimb.2005.08.100
   Wang XY, 2008, J BIOMED MATER RES A, V84A, P384, DOI 10.1002/jbm.a.31326
   Yamada T, 2005, J BIOSCI BIOENG, V99, P521, DOI 10.1263/jbb.99.521
   YANO Y, 1994, BIOCHEM J, V299, P303, DOI 10.1042/bj2990303
NR 44
TC 19
Z9 20
U1 3
U2 20
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD DEC
PY 2008
VL 19
IS 12
BP 3621
EP 3629
DI 10.1007/s10856-008-3477-3
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 353LZ
UT WOS:000259570800018
PM 18642062
DA 2018-10-19
ER

PT J
AU Shafqat, F
   Bhatti, HN
   Hanif, MA
   Zubair, A
AF Shafqat, Faiza
   Bhatti, Haq Nawaz
   Hanif, Muhammad Asif
   Zubair, Ammara
TI KINETIC AND EQUILIBRIUM STUDIES OF CR(III) AND CR(VI) SORPTION FROM
   AQUEOUS SOLUTION USING ROSA GRUSS AN TEPLITZ (RED ROSE) WASTE BIOMASS
SO JOURNAL OF THE CHILEAN CHEMICAL SOCIETY
LA English
DT Article
DE biosorption; pretreatment; Cr(III); Cr(VI); biomass
ID HEAVY-METAL BIOSORPTION; ASPERGILLUS-NIGER; HEXAVALENT CHROMIUM; ALGAL
   BIOMASS; REMOVAL; IONS; LEAD; PB(II); COPPER; ZINC
AB The biosorption of Cr(III) and Cr(VI) from synthetic solution using dried untreated and pretreated Rosa gruss an teplitz waste biomass was evaluated in this study. The results showed that initial pH, biosorbent dose, sorbent particle size, initial metal concentration, time and temperature affected chromium uptake capacity of rose biomass. The effect of twenty different pretreatments including gaseous and Other reagents on Cr(III) and Cr(VI) uptake capacity of Rosa gruss an teplitz waste biomass was comprehensively described. Uptake capacity of Rosa grass an teplitz waste biomass was significantly affected after pretreatment. The metal uptake capacity of biomass was not only found related to nature of pretreatment but also found strongly related to oxidation state of chromium. The estimation of the correlation coefficients for Cr(VI) showed that the experimental data fit better to Freundlich model. The Langmuir isotherm provided the best correlation for Cr(III) onto the rose waste biomass. The biosorption phenomenon was dependent on the temperature with maximum adsorption at 30 degrees C. Biosorption of Cr(III) and Cr(VI) ions on to biomass followed pseudo 2(nd) order adsorption kinetic model. The results Confirmed that rose waste biomass is a potential biomaterial to remove Cr(III) and Cr(VI) ions with a high biosorption capacity 45.03 mg/g and 48.75 mg/g for Cr(III) and Cr(VI) respectively.
C1 [Shafqat, Faiza; Bhatti, Haq Nawaz; Hanif, Muhammad Asif; Zubair, Ammara] Univ Agr Faisalabad, Dept Chem & Biochem, Ind Biotechnol Lab, Faisalabad 38040, Pakistan.
   [Hanif, Muhammad Asif] Univ Agr Faisalabad, Inst Hort Sci, Rose Lab, Faisalabad 38040, Pakistan.
RP Shafqat, F (reprint author), Univ Agr Faisalabad, Dept Chem & Biochem, Ind Biotechnol Lab, Faisalabad 38040, Pakistan.
EM hnbhatti2005@yahoo.com
RI Hanif, Muhammad Asif/G-7242-2015; Bhatti, Haq Nawaz/I-2069-2015
CR Ahalya N, 2005, ELECTRON J BIOTECHN, V8, DOI 10.2225/vol8-issue3-fulltext-10
   Ahluwalia SS, 2005, ENG LIFE SCI, V5, P158, DOI 10.1002/elsc.200420066
   Ashkenazy R, 1997, BIOTECHNOL BIOENG, V5, P1
   Bai S, 2001, BIORESOURCE TECHNOL, V79, P73, DOI 10.1016/S0960-8524(00)00107-3
   BHATTACHARYYA KG, 2004, J HAZARD MAT, V97
   Bhatti HN, 2007, PROCESS BIOCHEM, V42, P547, DOI 10.1016/j.procbio.2006.11.009
   Bishnoi NR, 2007, J HAZARD MATER, V145, P142, DOI 10.1016/j.jhazmat.2006.10.093
   Bishnoi NR, 2004, J SCI IND RES INDIA, V63, P813
   Boddu VM, 2003, ENVIRON SCI TECHNOL, V37, P4449, DOI 10.1021/es021013a
   BRIERLEY JA, 1985, Patent No. 85112810
   Cabuk Ahmet, 2005, Turkish Journal of Biology, V29, P23
   CELEYA RJ, 2000, BIOPROCESS ENG, V22, P539
   Chand Shri, 1994, Indian Journal of Environmental Health, V36, P151
   Conrad K, 2007, BIORESOURCE TECHNOL, V98, P89, DOI 10.1016/j.biortech.2005.11.018
   Cordero B, 2004, ENVIRON CHEM, V1, P180, DOI 10.1071/EN04039
   Deng SB, 2005, WATER RES, V39, P2167, DOI 10.1016/j.watres.2005.03.033
   Deo N., 1992, INDIAN J ENV PROTECT, V12, P828
   DOW JM, 1997, J GEN MICROBIOL, V99, P29
   Fourest E, 1996, ENVIRON SCI TECHNOL, V30, P277, DOI 10.1021/es950315s
   GALUN M, 1987, WATER AIR SOIL POLL, V33, P359, DOI 10.1007/BF00294204
   Gupta VK, 2001, WATER RES, V35, P4079, DOI 10.1016/S0043-1354(01)00138-5
   Hanif MA, 2007, J HAZARD MATER, V139, P345, DOI 10.1016/j.jhazmat.2006.06.040
   HELLAWELL JM, 1989, NY POLLUTION MONITOR, P546
   HOLAN ZR, 1995, APPL BIOCHEM BIOTECH, V53, P133, DOI 10.1007/BF02788603
   HUANG C, 1996, WATER RES, V30, P985
   Javed MA, 2007, SEPAR SCI TECHNOL, V42, P3641, DOI 10.1080/01496390701710794
   Kapoor A, 1999, BIORESOURCE TECHNOL, V70, P95, DOI 10.1016/S0960-8524(98)00192-8
   Kapoor A, 1997, BIORESOURCE TECHNOL, V61, P221, DOI 10.1016/S0960-8524(97)00055-2
   Kapoor A, 1998, BIORESOURCE TECHNOL, V63, P109, DOI 10.1016/S0960-8524(97)00118-1
   KAUFMAN DB, 1970, AM J DIS CHILD, V119, P374, DOI 10.1001/archpedi.1970.02100050376021
   Kratochvil D, 1998, ENVIRON SCI TECHNOL, V32, P2693, DOI 10.1021/es971073u
   Lazaro N, 2003, WATER RES, V37, P2118, DOI 10.1016/S0043-1354(02)00575-4
   LEONARD A, 1980, MUTAT RES, V76, P227, DOI 10.1016/0165-1110(80)90018-4
   Loaec M, 1997, WATER RES, V31, P1171, DOI 10.1016/S0043-1354(96)00375-2
   LUEF E, 1991, APPL MICROBIOL BIOT, V34, P688, DOI 10.1007/BF00167924
   MCGAHREN WJ, 1984, PROCESS BIOCHEM, V19, P88
   MITTELMAN MW, 1985, APPL ENVIRON MICROB, V49, P846
   Mungasavalli DP, 2007, COLLOID SURFACE A, V301, P214, DOI 10.1016/j.colsurfa.2006.12.060
   MURALEEDHARAN TR, 1990, BIOTECHNOL BIOENG, V35, P320, DOI 10.1002/bit.260350314
   Niu H, 2003, HYDROMETALLURGY, V71, P209, DOI 10.1016/S0304-386X(03)00158-0
   Nomanbhay S. M., 2005, ELE J BIOTECHNOL, V8, P44
   Nriega JO, 1988, CHROMIUM NATURAL HUM, P44
   Ozer A, 2003, J HAZARD MATER, V100, P219, DOI 10.1016/S0304-3894(03)00109-2
   Park D, 2005, CHEMOSPHERE, V60, P1356, DOI 10.1016/j.chemosphere.2005.02.020
   Quek SY, 1998, WATER SA, V24, P251
   RAUF A, 2008, J HAZARD MATER, DOI DOI 10.1016/J.HAZMAT.2008.04.040
   Sag Y, 2000, PROCESS BIOCHEM, V36, P157, DOI 10.1016/S0032-9592(00)00200-4
   Saravanane R, 2002, Indian J Environ Health, V44, P78
   Schiewer S, 2000, ENVIRONMENTAL MICROBE-METAL INTERACTIONS, P329
   TAPIA J, 2002, B SOC CHIL QUIM, V4, P469
   Tewari N, 2005, BIOCHEM ENG J, V23, P185, DOI 10.1016/j.bej.2005.01.011
   TOBIN JM, 1990, ENZYME MICROB TECH, V12, P591, DOI 10.1016/0141-0229(90)90132-A
   Tsui MTK, 2006, CHEMOSPHERE, V65, P51, DOI 10.1016/j.chemosphere.2006.03.002
   Veglio F, 2003, PROCESS BIOCHEM, V38, P953, DOI 10.1016/S0032-9592(02)00235-2
   VOLESKY B, 1995, BIOTECHNOL PROGR, V11, P235, DOI 10.1021/bp00033a001
   Volesky B., 2003, SORPTION BIOSORPTION, P316
   Waranusantigul P, 2003, ENVIRON POLLUT, V125, P385, DOI 10.1016/S0269-7491(03)00107-6
   Yan GY, 2000, WATER SA, V26, P119
   Zafar MN, 2007, J HAZARD MATER, V143, P478, DOI 10.1016/j.jhazmat.2006.09.055
   ZUBAIR A, 2008, WATER AIR SOIL POLL, V191, P308
NR 60
TC 17
Z9 17
U1 0
U2 2
PU SOC CHILENA QUIMICA
PI CONCEPCION
PA CASILLA 2613, CONCEPCION, 00000, CHILE
SN 0717-9324
J9 J CHIL CHEM SOC
JI J. Chil. Chem. Soc.
PD DEC
PY 2008
VL 53
IS 4
BP 1667
EP 1672
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA 391GT
UT WOS:000262222500005
OA Other Gold, Bronze
DA 2018-10-19
ER

PT J
AU Jaworski, R
   Pierlot, C
   Pawlowski, L
   Bigan, M
   Quivrin, M
AF Jaworski, Roman
   Pierlot, Christel
   Pawlowski, Lech
   Bigan, Muriel
   Quivrin, Maxime
TI Synthesis and Preliminary Tests of Suspension Plasma Spraying of Fine
   Hydroxyapatite Powder
SO JOURNAL OF THERMAL SPRAY TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT International Thermal Spray Conference (ITSC 2008)
CY JUN 02-04, 2008
CL Maastricht, NETHERLANDS
SP ASM Thermal Spray Soc, German Welding Soc, Int Inst Welding
DE biomedical coatings; hydroxyapatite; powder manufacturing; suspension
   plasma spraying
ID COATINGS; MICROSTRUCTURE; PARAMETERS
AB The synthetic hydroxyapatite (HA, Ca(10)(PO(4))(6)(OH)(2)) is a very useful biomaterial for numerous applications in medicine, such as e. g., fine powder for suspension plasma spraying. The powder was synthesized using aqueous solution of ammonium phosphate (H(2)(PO(4))NH(4)) and calcium nitrate (Ca(NO(3))center dot 4H(2)O) in the carefully controlled experiments. The synthesized fine powder was characterized by X-ray diffraction (XRD) and scanning electron microscope (SEM). The powder was formulated into water and alcohol based suspension and used to carry out the initial tests of plasma spraying onto titanium substrate. The phase analysis of sprayed coating was made with the XRD.
C1 [Jaworski, Roman; Pawlowski, Lech] Ecole Natl Super Chim Lille, Serv Thermal Spraying, F-59650 Villeneuve Dascq, France.
   [Pierlot, Christel; Bigan, Muriel; Quivrin, Maxime] ENSCL, UMR CNRS 8009, LCOM, F-59652 Villeneuve Dascq, France.
RP Jaworski, R (reprint author), Ecole Natl Super Chim Lille, Serv Thermal Spraying, BP 90180,8 Ave Mendeleiev, F-59650 Villeneuve Dascq, France.
EM lech.pawlowski@ensc-lille.fr
RI Pawlowski, Lech/G-9383-2016
OI Pawlowski, Lech/0000-0002-9716-4700
CR *AFNOR, 1993, S94067 AFNOR
   Best SM, 2008, J EUR CERAM SOC, V28, P1319, DOI 10.1016/j.jeurceramsoc.2007.12.001
   Bouyer E, 1997, IEEE T PLASMA SCI, V25, P1066, DOI 10.1109/27.649627
   Dyshlovenko S, 2006, SURF COAT TECH, V200, P3845, DOI 10.1016/j.surfcoat.2004.11.037
   Dyshlovenko S, 2006, SURF COAT TECH, V200, P3757, DOI 10.1016/j.surfcoat.2005.04.002
   FAUCHAIS P, 2007, 1 SCI WORKSH THERM S
   Gitzhofer F., 1997, Suspension Plasma Spraying, Patent No. [US5609921, 5609921]
   Heimann RB, 2006, SURF COAT TECH, V201, P2012, DOI 10.1016/j.surfcoat.2006.04.052
   Hornez JC, 2007, BIOMOL ENG, V24, P505, DOI 10.1016/j.bioeng.2007.08.015
   Jaworski R, 2007, MATERIALWISS WERKST, V38, P125, DOI 10.1002/mawe.200600120
   JAWORSKI R, SURF COAT TECH UNPUB
   JAWORSKI R, 2008, SURF COAT TECH, V202, P2544
   Jaworski R, 2008, J THERM SPRAY TECHN, V17, P73, DOI 10.1007/s11666-007-9147-z
   Markovic M, 2004, J RES NATL INST STAN, V109, P553, DOI 10.6028/jres.109.042
   PAWLOWSKI L, 2008, SCI ENG THERMAL SPRA, P101
   Pawlowski L, 2008, SURF COAT TECH, V202, P4318, DOI 10.1016/j.surfcoat.2008.04.004
   Prevey PS, 2000, J THERM SPRAY TECHN, V9, P369, DOI 10.1361/105996300770349827
   SANTOS C, 1995, MAT CLIN APPL, P11
   Wittmann-Teneze K, 2008, SURF COAT TECH, V202, P4349, DOI 10.1016/j.surfcoat.2008.04.008
NR 19
TC 10
Z9 10
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1059-9630
J9 J THERM SPRAY TECHN
JI J. Therm. Spray Technol.
PD DEC
PY 2008
VL 17
IS 5-6
BP 679
EP 684
DI 10.1007/s11666-008-9220-2
PG 6
WC Materials Science, Coatings & Films
SC Materials Science
GA 379QQ
UT WOS:000261411700014
DA 2018-10-19
ER

PT J
AU Peretz, H
   Blinder, P
   Baranes, D
   Vago, R
AF Peretz, H.
   Blinder, P.
   Baranes, D.
   Vago, R.
TI Aragonite crystalline matrix as an instructive microenvironment for
   neural development
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE tissue engineering; aragonite skeleton; cell-material interactions;
   biomaterials; calcium uptake; neural bioengineering
ID RAT CORTICAL-NEURONS; NEURITE OUTGROWTH; EXTRACELLULAR-MATRIX; SYNAPSE
   FORMATION; SCHWANN-CELLS; COLLAGEN GEL; MARROW-CELLS; OPTIC TRACT;
   IN-VITRO; TISSUE
AB The ability to mimic cell-matrix interactions in a way that closely resembles the natural environment is of a great importance for both basic neuroscience and for fabrication of potent scaffolding materials for nervous tissue engineering. Such scaffolding materials should not only facilitate cell attachment but also create a microenvironment that provides essential developmental and survival cues. We previously found that porous aragonite crystalline matrices of marine origin are an adequate and active biomaterial that promotes neural cell growth and tissue development. Here we studied the mechanism underlying these neural cell-material interactions, focusing on the three-dimensional (31)) surface architecture and matrix activity of these scaffolds. We introduced a new cloning technique of the hydrozoan Millepora dichotoma, through which calcein or (45)Ca(2+) were incorporated into the organism's growing skeleton and neuronal cells could then be cultured on the labelled matrices. Herein, we describe the role of matrix 3D architecture on neural cell type composition and survival in culture, and report for the first time on the capacity of neurons and astrocytes to exploit calcium ions from the supporting biomatrix. We found that hippocampal cells growing on the prelabelled aragonite lattice took up aragonite-derived Ca(2+), and even enhanced this uptake when extracellular calcium ions were chelated by EGTA. When the aragonite-derived Ca2+ uptake was omitted by culturing the cells on coral skeletons coated with gold, cell survival was reduced but not arrested, suggesting a role for matrix architecture in neural survival. in addition, we found that the effects of scaffold architecture and chemistry on cell survival were more profound for neurons than for astrocytes. We submit that translocation of calcium from the biomaterial to the cells activates a variety of membrane-bound signalling molecules and leads to the subsequent cell behaviour. This kind of cell-material interaction possesses great potential for fabricating advanced biomaterials for neural tissue-engineering applications. Copyright (C) 2008 John Wiley & Sons, Ltd.
C1 [Vago, R.] Ben Gurion Univ Negev, Dept Biotechnol Engn, IL-84105 Beer Sheva, Israel.
   [Peretz, H.; Blinder, P.; Baranes, D.] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.
   [Peretz, H.; Blinder, P.; Baranes, D.] Ben Gurion Univ Negev, Nat Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel.
RP Vago, R (reprint author), Ben Gurion Univ Negev, Dept Biotechnol Engn, IL-84105 Beer Sheva, Israel.
EM rvago@bgu.ac.il
RI Blinder, Pablo/D-2472-2009
OI Blinder, Pablo/0000-0002-4042-214X
FU National Institute for Biotechnology in the Negev grant; Horowitz
   Foundation; Bionational Science Foundation (BSF) [2001045]
FX The authors wish to thank the staff of the Intertiniversity Institute
   for Marine Science, Eilat, for their field, administrative and technical
   support during this study. We thank Ms Rina Jeger and Ms Yona
   Lichtenfeld for technical assistance, and Ms Inez Murinek for her
   fruitful discussions and comments on the manuscript. This research was
   partially supported by the National Institute for Biotechnology in the
   Negev grant, by the Horowitz Foundation ('Establishment of the Israeli
   Cellome Network') and by the Bionational Science Foundation (BSF), Grant
   No. 2001045.
CR ABBOTT A, 2003, NATURE, V424, P70
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   ATALA A, 2002, METHODS TISSUE ENG
   Baranes D, 2007, TISSUE ENG, V13, P473, DOI 10.1089/ten.2006.0052
   Baranes D, 1996, P NATL ACAD SCI USA, V93, P4706, DOI 10.1073/pnas.93.10.4706
   Baum BJ, 2000, J AM DENT ASSOC, V131, P309, DOI 10.14219/jada.archive.2000.0174
   Birk RZ, 2006, TISSUE ENG, V12, P21, DOI 10.1089/ten.2006.12.21
   Bolz H, 2002, ADV EXP MED BIOL, V514, P399
   Chierzi S, 2005, EUR J NEUROSCI, V21, P2051, DOI 10.1111/j.1460-9568.2005.04066.x
   Demers C, 2002, BIO-MED MATER ENG, V12, P15
   DOHERTY MJ, 1994, BIOMATERIALS, V15, P601, DOI 10.1016/0142-9612(94)90210-0
   DOWLING JE, 1992, NEURONS NETWORKS INT
   Edelman DB, 2005, EXP NEUROL, V192, P1, DOI 10.1016/j.expneurol.2004.10
   Evans GRD, 2000, SEMIN SURG ONCOL, V19, P312, DOI 10.1002/1098-2388(200010/11)19:3<312::AID-SSU13>3.0.CO;2-M
   Gautier SE, 1998, J BIOMED MATER RES, V42, P642, DOI 10.1002/(SICI)1097-4636(19981215)42:4<642::AID-JBM22>3.0.CO;2-K
   Gil ML, 1996, INFECT IMMUN, V64, P5239
   Gomez TM, 2006, NAT REV NEUROSCI, V7, P115, DOI 10.1038/nrn1844
   Gomez TM, 2000, J NEUROBIOL, V44, P174, DOI 10.1002/1097-4695(200008)44:2<174::AID-NEU7>3.3.CO;2-I
   GOSHIMA J, 1991, CLIN ORTHOP RELAT R, P274
   GOTTLIBABRAMOWI.L, 2006, TISSUE ENG, V12, P729
   GRD E, 2000, SEMIN SURG ONCOL, V19, P312
   Hayman MW, 2005, J BIOCHEM BIOPH METH, V62, P231, DOI 10.1016/j.jbbm.2004.12.001
   Hayman MW, 2004, BIOCHEM BIOPH RES CO, V314, P483, DOI 10.1016/j.bbrc.2003.12.135
   Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   HYAFIL F, 1981, CELL, V26, P447, DOI 10.1016/0092-8674(81)90214-2
   Kale S, 2000, NAT BIOTECHNOL, V18, P954
   Kelm JM, 2006, J BIOTECHNOL, V121, P86, DOI 10.1016/j.jbiotec.2005.07.009
   LETOURNEAU PC, 1994, J NEUROSCI, V14, P915
   Lin PW, 2005, J BIOMED MATER RES B, V75B, P146, DOI 10.1002/jbm.b.30276
   O'Connor SM, 2000, BIOSENS BIOELECTRON, V14, P871
   O'Connor SM, 2000, J NEUROSCI METH, V102, P187, DOI 10.1016/S0165-0270(00)00303-4
   O'Connor SM, 2001, NEUROSCI LETT, V304, P189, DOI 10.1016/S0304-3940(01)01769-4
   O'Shaughnessy TJ, 2003, NEUROSCI LETT, V340, P169, DOI 10.1016/S0304-3940(03)00083-1
   OHGUSHI H, 1989, ACTA ORTHOP SCAND, V60, P334, DOI 10.3109/17453678909149289
   PERETZ H, 2007, TISSUE ENG, V113, P461
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Phillips JB, 2005, TISSUE ENG, V11, P1611, DOI 10.1089/ten.2005.11.1611
   Plant GW, 2000, CELL TRANSPLANT, V9, P759, DOI 10.1177/096368970000900603
   PLANT GW, 1995, BRAIN RES, V671, P119, DOI 10.1016/0006-8993(94)01312-6
   POKUTTA S, 1994, EUR J BIOCHEM, V223, P1019, DOI 10.1111/j.1432-1033.1994.tb19080.x
   RADICE GL, 2001, CELL ADHESION, P63
   ROUDIER M, 1995, J BIOMED MATER RES, V29, P909, DOI 10.1002/jbm.820290802
   SCHUGENS C, 1995, J BIOMED MATER RES, V29, P1349, DOI 10.1002/jbm.820291106
   Shany B, 2006, TISSUE ENG, V12, P1763, DOI 10.1089/ten.2006.12.1763
   Shany B, 2005, TISSUE ENG, V11, P585, DOI 10.1089/ten.2005.11.585
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Tian WM, 2005, TISSUE ENG, V11, P513, DOI 10.1089/ten.2005.11.513
   Vago R, 2002, J BIOCHEM BIOPH METH, V50, P253, DOI 10.1016/S0165-022X(01)00235-4
   Zhang N, 2005, BRAIN RES REV, V49, P48, DOI 10.1016/j.brainresrev.2004.11.002
NR 51
TC 9
Z9 9
U1 0
U2 8
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD DEC
PY 2008
VL 2
IS 8
BP 463
EP 471
DI 10.1002/term.118
PG 9
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 391ZO
UT WOS:000262272900002
PM 18924122
DA 2018-10-19
ER

PT J
AU Deng, C
   Weng, J
   Lu, X
   Zhou, SB
   Wan, JX
   Qu, SX
   Feng, B
   Li, XH
AF Deng, C.
   Weng, J.
   Lu, X.
   Zhou, S. B.
   Wan, J. X.
   Qu, S. X.
   Feng, B.
   Li, X. H.
TI Preparation and in vitro bioactivity of poly(D,L-lactide) composite
   containing hydroxyapatite nanocrystals
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article
DE Preparation; In vitro bioactivity; Composite; Thin film
ID MECHANICAL-PROPERTIES; APATITE; BIOMATERIALS; REPLACEMENT; TISSUE; BONE
AB The nano-sized hydroxyapatite (n-HA) was incorporated into poly(D,L-Lactide) (PDLLA) to form a bioactive and biodegradable composite for application in hard tissue replacement and regeneration. Thin film of PDLLA composite containing 20 mass% of n-HA fillers was successfully developed through integration of solvent co-blending and hot pressing techniques. firstly, n-HA and PDLLA were chemically synthesized, respectively, then mixed together and homogeneously dispersed in N,N-dimethyl formamide(DMF) solvent, finally, the dried blended hybrid containing PDLLA matrix and n-HA fillers was put into the mould and compacted by hot-pressing machine under 8 MPa pressure at 110 degrees C for 15 min. In vitro studies were conducted using the simulated body fluid(SBF). Composite specimens were soaked in SBF from I day to 21 days prior to surface analysis. Results obtained from scanning electron microscopy(SEM) examination, Energy dispersive X-ray detector(EDX) analysis and Xray diffraction (XRD) analysis showed that a layer of non-stoichiometric apatite formed within 7 days on HA/PDLLA composite surface after its immersion in SBF, demonstrating moderate in vitro bioactivity of n-HA/PDLLA composite, though a moderate rate of apatite formation in SBF was found on initial stage of immersion periods for n-HA/PDLLA composite, compared to the other biomaterial composite. This type of composite film exhibited certain desirable bioactive characteristics, and they are promising bone candidates to develop novel bioactive composites for biomedical application. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Deng, C.; Weng, J.; Lu, X.; Zhou, S. B.; Wan, J. X.; Qu, S. X.; Feng, B.; Li, X. H.] SW Jiaotong Univ, Sch Mat Sci & Engn, Minist Educ, Key Lab Adv Technol Mat, Chengdu 610031, Peoples R China.
RP Weng, J (reprint author), SW Jiaotong Univ, Sch Mat Sci & Engn, Minist Educ, Key Lab Adv Technol Mat, Chengdu 610031, Peoples R China.
EM jweng@home.swjtu.edu.cn
RI LU, xiong/B-3092-2010; QU, SHU XIN/H-3036-2011; Feng, Bo/B-3498-2010;
   Weng, Jie/B-3005-2010; zhou, shaobing/B-3148-2010
OI LU, xiong/0000-0001-6367-430X; 
FU Chinese Ministry of Education
FX This project is supported by Trans-Century Training Program Foundation
   for the Talents by Chinese Ministry of Education.
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   BONFIELD W, 1981, BIOMATERIALS, V2, P185, DOI 10.1016/0142-9612(81)90050-8
   Deng XM, 2001, BIOMATERIALS, V22, P2867, DOI 10.1016/S0142-9612(01)00031-X
   HENCH LL, 1993, INTRO BIOCERAMICS, P11
   Hong ZK, 2005, BIOMATERIALS, V26, P6296, DOI 10.1016/j.biomaterials.2005.04.018
   Kim HM, 2001, KEY ENG MATER, V192-195, P47, DOI DOI 10.4028/WWW.SCIENTIFIC.NET/KEM.192-195.47
   Leonor IB, 2003, BIOMATERIALS, V24, P579, DOI 10.1016/S0142-9612(02)00371-X
   Li Y. B., 1994, J MATER SCI-MATER M, V5, P252, DOI DOI 10.1007/BF00122393)
   Liu Q, 1998, BIOMATERIALS, V19, P1067, DOI 10.1016/S0142-9612(98)00033-7
   Liu Q, 1997, BIOMATERIALS, V18, P1263, DOI 10.1016/S0142-9612(97)00069-0
   NENAD I, 2004, APPL SURF SCI, V238, P314
   NEO M, 1992, J BIOMED MATER RES, V26, P1419, DOI 10.1002/jbm.820261103
   Ni J, 2002, MAT SCI ENG C-BIO S, V20, P101, DOI 10.1016/S0928-4931(02)00019-X
   Shikinami Y, 1999, BIOMATERIALS, V20, P859, DOI 10.1016/S0142-9612(98)00241-5
   Silvio L.D., 1998, J MATER SCI-MATER M, V9, P845
   Verrier S, 2004, BIOMATERIALS, V25, P3013, DOI 10.1016/j.biomaterials.2003.09.081
   Wang M, 2001, J MATER SCI-MATER M, V12, P821, DOI 10.1023/A:1017933220894
   Weng J, 1997, BIOMATERIALS, V18, P1027, DOI 10.1016/S0142-9612(97)00022-7
   Yu SC, 2005, BIOMATERIALS, V26, P2343, DOI 10.1016/j.biomaterials.2004.07.028
NR 19
TC 17
Z9 17
U1 1
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD DEC 1
PY 2008
VL 28
IS 8
BP 1304
EP 1310
DI 10.1016/j.msec.2008.01.003
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA 385YD
UT WOS:000261848600017
DA 2018-10-19
ER

PT J
AU Weng, YJ
   Ren, JR
   Huang, N
   Wang, J
   Chen, JY
   Leng, YX
   Liu, HQ
AF Weng, Y. J.
   Ren, J. R.
   Huang, N.
   Wang, J.
   Chen, J. Y.
   Leng, Y. X.
   Liu, H. Q.
TI Surface engineering of Ti-O films by photochemical immobilization of
   gelatin
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article
DE Gelatin; Ti-O film; Photochemical immobilization; Cell growth
ID VEIN ENDOTHELIAL-CELLS; IMMERSION ION-IMPLANTATION; COVALENT
   IMMOBILIZATION; IN-VITRO; PLASMA DEPOSITION; CARBON-FILMS; TITANIUM;
   BIOMATERIALS; BEHAVIOR; ADHESION
AB Crystalline Ti-O films were prepared by unbalanced magnetron sputtering and the structure was confirmed by XRD. An organic layer of 3-aminopropylphosphonic acid (APP) was first introduced on the Ti-O films by self-assembling. The stability of the APP on Ti-O films was confirmed by XPS and FTIR analysis. Simultaneously, azido group was introduced in gelatin molecule to act as photoreactive point. The derivated gelatin was spin-coated onto the self-assembled layer and immobilized by UV irradiating. Chemical patterned surface was obtained by using a photomask when irradiating and confirmed by sirius red staining and surface profile analysis. Measured by surface profilometer, the thickness of the immobilized gelatin was about 5-20 nm. The adhering of human endothelial EVC304 cells on APP modified surface was enhanced in the cell culture test. Moreover, the adherence and growth of cells were prior on gelatin-immobilized region visually seen on the patterned surface. This result indicated gelatin-immobilized Ti-O Surface can serve as a biocompatible biomaterial for endothelialization. (c) 2008 Elsevier B.V. All rights reserved.
C1 [Weng, Y. J.; Ren, J. R.; Huang, N.; Wang, J.; Chen, J. Y.; Leng, Y. X.; Liu, H. Q.] SW Jiaotong Univ, Minist Educ, Key Lab Adv Technol Mat, Chengdu 610031, Peoples R China.
   [Weng, Y. J.; Ren, J. R.; Huang, N.; Wang, J.; Chen, J. Y.; Leng, Y. X.; Liu, H. Q.] SW Jiaotong Univ, Dept Mat Engn, Chengdu 610031, Peoples R China.
RP Huang, N (reprint author), SW Jiaotong Univ, Dept Mat Engn, Chengdu 610031, Peoples R China.
EM nhuang@263.net
RI Leng, Yongxiang/G-5488-2010; Leng, Y.X./C-2278-2012
OI Leng, Y.X./0000-0001-6823-1233
FU Key Basic Research [2005CB623904]; Natural Science Foundation of China
   [30300087, 30670564]; NSFCRGC [30318006]
FX This work was financially supported by Key Basic Research Project No.
   2005CB623904, Natural Science Foundation of China No. 30300087# and
   30670564#, and NSFCRGC 30318006#.
CR Backer MV, 2006, BIOMATERIALS, V27, P5452, DOI 10.1016/j.biomaterials.2006.06.025
   Barbucci R, 2003, BIOMATERIALS, V24, P915, DOI 10.1016/S0142-9612(02)00425-8
   Chen JY, 2006, NUCL INSTRUM METH B, V242, P26, DOI 10.1016/j.nimb.2005.08.098
   Chen JY, 2004, SURF COAT TECH, V186, P270, DOI 10.1016/j.surfcoat.2004.02.050
   Chu PK, 2007, SURF COAT TECH, V201, P8076, DOI 10.1016/j.surfcoat.2005.12.053
   Gao XY, 1998, EUR J PHARM BIOPHARM, V45, P275, DOI 10.1016/S0939-6411(98)00010-1
   Gawalt ES, 2003, LANGMUIR, V19, P200, DOI 10.1021/la0203436
   GRIESSER HJ, 1994, J BIOMAT SCI-POLYM E, V5, P531, DOI 10.1163/156856294X00194
   Harsch A, 2000, J NEUROSCI METH, V98, P135, DOI 10.1016/S0165-0270(00)00196-5
   Hasebe T, 2007, DIAM RELAT MATER, V16, P1343, DOI 10.1016/j.diamond.2006.12.009
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   HUANG Y, 2005, BIOMATERIALS, V26, P761
   Ito Y, 2000, J INORG BIOCHEM, V79, P77, DOI 10.1016/S0162-0134(99)00159-2
   Jing FJ, 2007, DIAM RELAT MATER, V16, P550, DOI 10.1016/j.diamond.2006.11.051
   Kim YJ, 2000, BIOMATERIALS, V21, P121, DOI 10.1016/S0142-9612(99)00137-4
   Konno T, 2005, BIOMATERIALS, V26, P1381, DOI 10.1016/j.biomaterials.2004.04.047
   Kouvroukoglou S, 2000, BIOMATERIALS, V21, P1725, DOI 10.1016/S0142-9612(99)00205-7
   Kuijpers AJ, 2000, BIOMATERIALS, V21, P1763, DOI 10.1016/S0142-9612(00)00064-8
   Leng YX, 2006, SURF COAT TECH, V201, P157, DOI 10.1016/j.surfcoat.2005.11.074
   [刘敬肖 Liu Jingxiao], 2002, [材料研究学报, Chinese Journal of Materials Research], V16, P529
   Lu G, 2000, SURF SCI, V458, P80, DOI 10.1016/S0039-6028(00)00420-9
   Muller R, 2006, BIOMATERIALS, V27, P4059, DOI 10.1016/j.biomaterials.2006.03.019
   Nilsing M, 2005, SURF SCI, V582, P49, DOI 10.1016/j.susc.2005.02.044
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Wang AF, 2005, COLLOID SURFACE B, V43, P245, DOI 10.1016/j.colsurfb.2005.04.015
   Zhu AP, 2002, BIOMATERIALS, V23, P4657, DOI 10.1016/S0142-9612(02)00215-6
   Zhu YB, 2004, BIOMATERIALS, V25, P423, DOI 10.1016/S0142-9612(03)00549-0
   Zhu YB, 2002, BIOMATERIALS, V23, P4889, DOI 10.1016/S0142-9612(02)00247-8
NR 28
TC 9
Z9 9
U1 0
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD DEC 1
PY 2008
VL 28
IS 8
BP 1495
EP 1500
DI 10.1016/j.msec.2008.04.004
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA 385YD
UT WOS:000261848600045
DA 2018-10-19
ER

PT J
AU Kurella, AK
   Hu, MZ
   Dahotre, NB
AF Kurella, Anil K.
   Hu, Michael Z.
   Dahotre, Narendra B.
TI Effect of microstructural evolution on wettability of laser coated
   calcium phosphate on titanium alloy
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article
DE Laser; Wettability; Biocompatibility; Calcium phosphate; Titanium alloy;
   Biomaterial
ID COATINGS; HYDROXYAPATITE; BIOMATERIALS; CO2-LASER; ZIRCONIA
AB Surface engineering of synthetic implant materials provides an exciting opportunity to mimic natural biomaterials. Surface that are bioactive and textured at multi-scale have the potential for easier osseointegration. Ti alloy surfaces known for their biocompatibility are coated with bioactive calcium phosphate using a laser source at multiple processing speeds. The resulting surface has multi-scale morphology and multi-phase chemical nature. Faster processing speeds showed improved wettability to water along with higher degree of crystallinity in the phases present. Furthermore. decreased laser processing speeds induced formation of increased amount of glassy phases that are expected to provide increased biocompatibility. The combination of these opposing effects Suggested that optimum crystallinity leading to optimum wettability can be produced at intermediate speeds for improved biocompatibility. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Kurella, Anil K.; Dahotre, Narendra B.] Univ Tennessee, Dept Mat Sci & Engn, Knoxville, TN 37996 USA.
   [Hu, Michael Z.] Oak Ridge Natl Lab, Nucl Sci & Technol Div, Oak Ridge, TN 37831 USA.
   [Dahotre, Narendra B.] Oak Ridge Natl Lab, Div Mat Sci & Technol, Oak Ridge, TN 37831 USA.
RP Dahotre, NB (reprint author), Univ Tennessee, Dept Mat Sci & Engn, Knoxville, TN 37996 USA.
EM ndahotre@utk.edu
OI Hu, Michael/0000-0001-8461-9684
FU Division of Materials Science [KC 02 03 010]; Office of Science; U.S.
   Department of Energy at Oak Ridge National Laboratory
   [DE-AC05-00OR22725]
FX This work is partially supported by the Division of Materials Science
   (KC 02 03 010), Office of Science, the U.S. Department of Energy at Oak
   Ridge National Laboratory managed by UT-Battelle, LLC, for the U.S.
   Department of Energy under contract DE-AC05-00OR22725.
CR Agathopoulos S, 1996, J MATER SCI-MATER M, V7, P629, DOI 10.1007/BF00058203
   Bento AC, 1996, J APPL PHYS, V79, P6848, DOI 10.1063/1.362650
   CHIANG M, 1997, PRINCIPLES CERAMICS, P1
   Cui CX, 2005, MATER LETT, V59, P3144, DOI 10.1016/j.matlet.2005.05.037
   DIASA AG, 2005, J NONCRYST SOLIDS, P810
   EUSTATHOPOULOS MG, 1999, WETTABILITY HIGH TEM, P36
   Hao L, 2003, MAT SCI ENG C-BIO S, V23, P627, DOI 10.1016/S0928-4931(03)00056-0
   Harimkar SP, 2007, J APPL PHYS, V101, DOI 10.1063/1.2710288
   Harimkar SP, 2006, J PHYS D APPL PHYS, V39, P1642, DOI 10.1088/0022-3727/39/8/025
   Khor KA, 2004, BIOMATERIALS, V25, P4009, DOI 10.1016/j.biomaterials.2003.10.089
   Kurella A, 2006, J MATER SCI-MATER M, V17, P565, DOI 10.1007/s10856-006-8941-3
   KURELLA A, 2006, ACTABIOMATERIALIA, V2, P777
   Liao CJ, 1999, BIOMATERIALS, V20, P1807, DOI 10.1016/S0142-9612(99)00076-9
   Lusquinos F, 2003, J BIOMED MATER RES A, V64A, P630, DOI 10.1002/jbm.a.10440
   Moritz N, 2004, J MATER SCI-MATER M, V15, P787, DOI 10.1023/B:JMSM.0000032819.64994.42
   Sun LM, 2003, MAT SCI ENG A-STRUCT, V360, P70, DOI 10.1016/S0921-5093(03)00439-8
   Tan J, 2004, BIOMATERIALS, V25, P3593, DOI 10.1016/j.biomaterials.2003.10.034
   Tian YS, 2005, APPL SURF SCI, V242, P177, DOI 10.1016/j.apsusc.2004.08.011
   Vallet-Regi M, 2001, J CHEM SOC DALTON, P97, DOI 10.1039/b007852m
   Webster TJ, 2003, J BIOMED MATER RES A, V67A, P975, DOI 10.1002/jbm.a.10160
NR 20
TC 10
Z9 10
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD DEC 1
PY 2008
VL 28
IS 8
BP 1560
EP 1564
DI 10.1016/j.msec.2008.04.015
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA 385YD
UT WOS:000261848600054
DA 2018-10-19
ER

PT J
AU Popovici, A
   Fodor, O
   Moldovan, M
   Roman, A
   Borzea, D
AF Popovici, A.
   Fodor, O.
   Moldovan, M.
   Roman, A.
   Borzea, D.
TI "In vitro" study of a new composite biomaterial for indirect
   restorations
SO OPTOELECTRONICS AND ADVANCED MATERIALS-RAPID COMMUNICATIONS
LA English
DT Article
DE Advanced materials; Composite resin; Inlay; Scanning electron microscopy
ID MECHANICAL-PROPERTIES; MARGINAL ADAPTATION; AGENTS; INLAY
AB The purpose of this study was to evaluate the ability of a new Romanian composite biomaterial to be used for indirect restorations ( inlays). In this purpose, 40 standardized class II cavities were prepared on freshly extracted, sound third molars and restored with composite inlays using the Romanian composite Barodent as well as a well known trademark composite. The restored teeth were sectioned mesio-distally and then analysed. The structure of the inlays and the adhesion to the dental tissues were investigated by using scanning electron microscopy and X-ray dispersive energy analysis. The SEM micrographs showed a rather homogeneous structure of the Romanian composite, as well as its quality of adhesion to the dental hard tissues.
C1 [Popovici, A.; Roman, A.; Borzea, D.] Iuliu Hatieganu Univ Med & Pharm, Cluj Napoca, Romania.
   [Fodor, O.] Univ Oradea, Fac Med & Pharm, Oradea, Romania.
   [Moldovan, M.] Univ Babes Bolyai, Raluca Ripan Inst Res Chem, R-3400 Cluj Napoca, Romania.
RP Popovici, A (reprint author), Iuliu Hatieganu Univ Med & Pharm, Cluj Napoca, Romania.
EM andrapopovici@yahoo.com
RI Moldovan, Marioara/N-6387-2017; Soanca, Andrada/O-5008-2014
OI Roman, Alexandra/0000-0002-0649-9426
CR BOWEN RL, 1992, J AM DENT ASSOC, V123, P33
   BRYANT RW, 2002, PRESERVATION RESTAUR
   COLCERIU A, 2007, ADV MAT RAPID COMM, V1, P231
   Craig RG, 2002, RESTORATIVE DENT MAT
   de Andrade OS, 2007, DENT MATER, V23, P279, DOI 10.1016/j.dental.2006.01.028
   DOUGLAS AT, 2001, PRACT P AESTHET DENT, V13, P51
   FERRARI M, 2001, QUINTESSENCE PUBL, V1, P95
   Gerdolle DA, 2005, J PROSTHET DENT, V93, P563, DOI 10.1016/j.prosdent.2005.04.004
   Irie M, 2001, DENT MATER, V17, P347, DOI 10.1016/S0109-5641(00)00093-2
   KOUBI S, 2006, INFORM DENT, V5, P194
   Miara P, 1998, Pract Periodontics Aesthet Dent, V10, P423
   Moldovan M, 2007, J OPTOELECTRON ADV M, V9, P3415
   Popovici A., 2005, ENG BIOMATERIALS, V47-53, P15
   RASKIN A, 2005, REALITES CLIN, V16, P297
   RASKIN H, 2005, REALITES CLIN, V16, P313
   Rosin Michael, 2003, Clin Oral Investig, V7, P20
   Soares CJ, 2003, OPER DENT, V28, P689
   TASSERY H, 1998, INFORM DENT, V6, P365
   WEISROCK G, 2003, FACULTE ODONTOLOGIE, P25
NR 19
TC 5
Z9 5
U1 0
U2 6
PU NATL INST OPTOELECTRONICS
PI BUCHAREST-MAGURELE
PA 1 ATOMISTILOR ST, PO BOX MG-5, BUCHAREST-MAGURELE 76900, ROMANIA
SN 1842-6573
J9 OPTOELECTRON ADV MAT
JI Optoelectron. Adv. Mater.-Rapid Commun.
PD DEC
PY 2008
VL 2
IS 12
BP 891
EP 894
PG 4
WC Materials Science, Multidisciplinary; Optics
SC Materials Science; Optics
GA 389KG
UT WOS:000262090700033
DA 2018-10-19
ER

PT J
AU Kim, IY
   Chung, JH
   Choi, YJ
   Cho, CS
AF Kim, In-yong
   Chung, Jong-hoon
   Choi, Yun-jaie
   Cho, Chong-su
TI Protein and Gene Delivery in Tissue Engineering
SO TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE Tissue engineering; protein delivery; gene delivery; scaffold;
   biomaterial
ID PLASMA GLOW-DISCHARGE; DNA DELIVERY; CONTROLLED-RELEASE; DRUG-DELIVERY;
   GROWTH-FACTOR; IMMOBILIZED POLYURETHANES; COLLAGEN HYDROGELS; IN-VIVO;
   SCAFFOLDS; POLYMER
AB In regenerative medicine, growing demand for tissues and organs has led to the rapid development of tissue engineering as an alternative. To improve functional scaffold, many biomaterials serve dual purposes; in addition to providing cell support, cutting-edge scaffolds biologically interact with adhering and invading cells and effectively guide cellular growth and development by releasing bioactive proteins and genes. For achieving the ambitious goal of tissue regeneration and replacement, it is more important to understand the basic principles of protein and gene delivery as well as design of the system required by using proper biomaterials. This review covered the requirement in the materials choice, the strategies, the main techniques for producing proteins and genes releasing scaffolds.
C1 [Kim, In-yong; Choi, Yun-jaie; Cho, Chong-su] Seoul Natl Univ, Dept Agr Biotech, Seoul 151921, South Korea.
   [Kim, In-yong] Univ Illinois, Dept Mat Sci Eng, Urbana, IL 61801 USA.
   [Chung, Jong-hoon] Seoul Natl Univ, Dept Biosyst & Biomat Eng, Seoul 151921, South Korea.
RP Kim, IY (reprint author), Seoul Natl Univ, Dept Agr Biotech, Seoul 151921, South Korea.
EM chocs@plaza.snu.ac.kr
RI Choi, Yunjaie/B-4697-2014
FU National Research Laboratory of Korean Science and Engineering
   Foundation [ROA-2008-000-20024-0]
FX This work was supported from National Research Laboratory of Korean
   Science and Engineering Foundation(ROA-2008-000-20024-0).
CR Adekogbe I, 2005, BIOMATERIALS, V26, P7241, DOI 10.1016/j.biomaterials.2005.05.043
   Bae JS, 1999, BIOMATERIALS, V20, P529, DOI 10.1016/S0142-9612(98)00204-X
   Behravesh E, 2003, J BIOMED MATER RES A, V65A, P260, DOI 10.1002/jbm.a.10461
   Benoit DSW, 2006, BIOMATERIALS, V27, P6102, DOI 10.1016/j.biomaterials.2006.06.031
   Bhattarai N, 2005, J CONTROL RELEASE, V103, P609, DOI 10.1016/j.jconrel.2004.12.019
   BIRAN R, 2000, J BIOMED MATER RES, V55, P1
   Bleiziffer O, 2007, J CELL MOL MED, V11, P206, DOI 10.1111/j.1582-4934.2007.00027.x
   Bonadio J, 1999, NAT MED, V5, P753, DOI 10.1038/10473
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   Cadee JA, 2002, J CONTROL RELEASE, V78, P1, DOI 10.1016/S0168-3659(01)00483-7
   Chen CS, 2000, METH MOL B, V139, P209
   Chun KW, 2005, BIOMATERIALS, V26, P3319, DOI 10.1016/j.biomaterials.2004.07.055
   CHUNG E, 2006, TISSUE ENG REGEN MED, V3, P39
   Cohen-Sacks H, 2004, J CONTROL RELEASE, V95, P309, DOI 10.1016/j.jconrel.2003.11.001
   De Laporte L, 2007, ADV DRUG DELIVER REV, V59, P292, DOI 10.1016/j.addr.2007.03.017
   DeLong SA, 2005, J CONTROL RELEASE, V109, P139, DOI 10.1016/j.jconrel.2005.09.020
   DRUMHELLER PD, 1995, BIOMEDICAL ENG HDB, P1583
   FABRIZIUSHOMAN DJ, 1991, J BIOMAT SCI-POLYM E, V3, P27, DOI 10.1163/156856292X00060
   GLASS J, 1994, ANN NY ACAD SCI, V745, P177
   Hacker M, 2003, BIOMATERIALS, V24, P4459, DOI 10.1016/S0142-9612(03)00346-6
   Hirano Y, 2004, ADV MATER, V16, P17, DOI 10.1002/adma.200300383
   Huang YC, 2003, J BIOMED MATER RES A, V67A, P1384, DOI 10.1002/jbm.a.20036
   Ignatius A, 2005, BIOMATERIALS, V26, P311, DOI 10.1016/j.biomaterials.2004.02.045
   Jang JH, 2005, MOL THER, V12, P475, DOI 10.1016/j.ymrhe.2005.03.036
   JANG JW, 2005, TISSUE ENG REGEN MED, V2, P34
   Jewell CM, 2006, BIOMACROMOLECULES, V7, P2483, DOI 10.1021/bm0604808
   Ji J, 2004, BIOMATERIALS, V25, P1859, DOI 10.1016/j.biometerials.2003.08.031
   Kang IK, 1996, BIOMATERIALS, V17, P841, DOI 10.1016/0142-9612(96)81422-0
   Kasper FK, 2005, J CONTROL RELEASE, V104, P521, DOI 10.1016/j.jconrel.2005.03.008
   KHANG G, 2004, TISSUE ENG REGEN MED, V1, P9
   Khang Gilson, 2006, [Tissue Engineering and Regenerative Medicine, 조직공학과 재생의학], V3, P376
   Kim EJ, 1998, BIOMATERIALS, V19, P239, DOI 10.1016/S0142-9612(98)00203-8
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   KIM SK, 2005, TISSUE ENG REGEN MED, V2, P130
   Kim SH, 2008, TISSUE ENG REGEN MED, V5, P351
   Kuhl PR, 1997, NAT MED, V3, P93, DOI 10.1038/nm0197-93
   Laham RJ, 1999, CIRCULATION, V100, P1865, DOI 10.1161/01.CIR.100.18.1865
   Langer R, 2001, SCIENCE, V293, P58, DOI 10.1126/science.1063273
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Langer R, 1998, NATURE, V392, P5
   Leach JB, 2005, BIOMATERIALS, V26, P125, DOI 10.1016/j.biomaterials.2004.02.018
   LEE JE, 2005, TISSUE ENG REGEN MED, V2, P41
   Leonard M, 2004, J CONTROL RELEASE, V98, P395, DOI 10.1016/j.jconrel.2004.05.009
   Liang DH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gnil171
   Luo D, 2000, NAT BIOTECHNOL, V18, P33
   Luu YK, 2003, J CONTROL RELEASE, V89, P341, DOI 10.1016/S0168-3659(03)00097-X
   Mann BK, 2001, BIOMATERIALS, V22, P439, DOI 10.1016/S0142-9612(00)00196-4
   Mellott MB, 2001, BIOMATERIALS, V22, P929, DOI 10.1016/S0142-9612(00)00258-1
   Mikulec LJ, 1996, J BIOMED MATER RES, V32, P203, DOI 10.1002/(SICI)1097-4636(199610)32:2<203::AID-JBM8>3.0.CO;2-X
   Mooney DJ, 1999, SCI AM, V280, P60, DOI 10.1038/scientificamerican0499-60
   Nie Y, 2006, DRUG DELIV, V13, P441, DOI 10.1080/10717540600640302
   Nobs L, 2003, INT J PHARM, V250, P327, DOI 10.1016/S0378-5173(02)00542-2
   Oh SH, 2003, BIOMATERIALS, V24, P4011, DOI 10.1016/S0142-9612(03)00284-9
   Pannier AK, 2004, MOL THER, V10, P19, DOI 10.1016/j.ymthe.2004.03.020
   Pannier AK, 2008, ACTA BIOMATER, V4, P26, DOI 10.1016/j.actbio.2007.08.008
   PARK IK, 2004, TISSUE ENG REGEN MED, V1, P164
   Park JS, 2007, TISSUE ENG REGEN MED, V4, P347
   Quick DJ, 2003, PHARM RES, V20, P1730, DOI 10.1023/B:PHAM.0000003368.66471.6a
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Roy K, 2003, MOL THER, V7, P401, DOI 10.1016/1525-0016(03)00008-X
   Santerre JP, 2005, BIOMATERIALS, V26, P7457, DOI 10.1016/j.biomaterials.2005.05.079
   Sarasam A, 2005, BIOMATERIALS, V26, P5500, DOI 10.1016/j.biomaterials.2005.01.071
   Schek RM, 2004, MOL THER, V9, P130, DOI 10.1016/j.ymthe.2003.10.002
   Schmedlen KH, 2002, BIOMATERIALS, V23, P4325, DOI 10.1016/S0142-9612(02)00177-1
   Segura T, 2005, BIOMATERIALS, V26, P1575, DOI 10.1016/j.biomaterials.2004.05.007
   Seo SJ, 2006, BIOMATERIALS, V27, P1487, DOI 10.1016/j.biomaterials.2005.09.018
   Shakesheff KM, 1998, J BIOMAT SCI-POLYM E, V9, P507, DOI 10.1163/156856298X00596
   Shea LD, 1999, NAT BIOTECHNOL, V17, P551
   Shen H, 2004, NAT MATER, V3, P569, DOI 10.1038/nmat1179
   Sohier J, 2006, J CONTROL RELEASE, V111, P95, DOI 10.1016/j.conrel.2005.11.016
   Sohier J, 2003, J CONTROL RELEASE, V87, P57, DOI 10.1016/S0168-3659(02)00350-4
   Sokolsky-Papkov M, 2007, ADV DRUG DELIVER REV, V59, P187, DOI 10.1016/j.addr.2007.04.001
   Stachelek SJ, 2004, GENE THER, V11, P15, DOI 10.1038/sj.gt.3302129
   Tabata Y, 2000, J BIOMAT SCI-POLYM E, V11, P915, DOI 10.1163/156856200744101
   Tessmar JK, 2007, ADV DRUG DELIVER REV, V59, P274, DOI 10.1016/j.addr.2007.03.020
   Whang K, 2000, BIOMATERIALS, V21, P2545, DOI 10.1016/S0142-9612(00)00122-8
   Wieland JA, 2007, J CONTROL RELEASE, V120, P233, DOI 10.1016/j.jconrel.2007.04.015
   Wozney JM, 2004, CURR OPIN BIOTECH, V15, P392, DOI 10.1016/j.copbio.2004.08.001
   Zhang YZ, 2006, BIOMACROMOLECULES, V7, P1049, DOI 10.1021/bm050743i
   Zheng J, 2000, BIOTECHNOL PROGR, V16, P254, DOI 10.1021/bp990150h
NR 80
TC 10
Z9 10
U1 2
U2 9
PU KOREAN TISSUE ENGINEERING REGENERATIVE MEDICINE SOC
PI JEONJU
PA CHONBUK NATIONAL UNIV, DEPT POLYMER-NANO SCIENCE & TECH, 664-14,
   DUCKJIN, JEONJU, 561-756, SOUTH KOREA
SN 1738-2696
J9 TISSUE ENG REGEN MED
JI Tissue Eng. Regen. Med.
PD DEC
PY 2008
VL 5
IS 4-6
BP 671
EP 677
PG 7
WC Cell & Tissue Engineering; Engineering, Biomedical
SC Cell Biology; Engineering
GA 379EY
UT WOS:000261380700019
DA 2018-10-19
ER

PT J
AU Jin, Z
   Gong, YQ
   Qin, XC
   Zhang, J
   Zhu, YC
   Lin, GT
   Lue, TF
   Xin, ZC
AF Jin, Zhe
   Gong, Yan-Qing
   Qin, Xin-Cheng
   Zhang, Jian
   Zhu, Yi-Chen
   Lin, Gui-ting
   Lue, Tom F.
   Xin, Zhong-Cheng
TI Biodegradable Poly(lactic-co-glycolic acid) Maxpol-T/S as Novel Scaffold
   for Adipose Derived Stem Cells and Fibroblast Growth In Vitro
SO TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE Adipose-derived stem cells; fibroblasts; GFP; PLGA mesh; cell adhesion;
   tissue engineering
ID VENOUS PATCH GRAFT; PEYRONIES-DISEASE; DIFFERENTIATION; REGENERATION
AB To explore the ability of MaxPol-T/S, a novelbiodegradable poly-lactic-co-glycolic acid(PLGA) scaffold, in providing a cell-matrix interaction interface for cell growth, we generated GFP positive adipose derived stem cell(ADSC(GFP+)) and fibroblasts(FCGFP+) for investigating the cellular growth on this biomaterial. The MaxPol-T/S was produced through salt-leaching/particulate-leaching technology for tissue engineering, which provides a modified surface for the best cellular attachment sites and nutrient supply and waste exchange conditions. The morphological features of MaxPol-T/S were studied with a scanning electron microscope and the ADSC(GFP+) and FCGFP+ were confirmed by auto-fluorescence microscopy and flow cytometry assay. Being seeded onto the MaxPol-T/S in vitro, the growth and morphology of ADSC(GFP+) and FCGFP+ were further verified by auto-fluorescence microscopy and MMT test. The ADSCs and fibroblasts, expressed strong GFP signals in the cytoplasm and nucleus, adhered and proliferated on the surface of scaffold MaxPol-T/S. Both cell lines survived on the scaffold more than 21 days in vitro and formed three-dimensional colonies on the surface of the MaxPol-T. In conclusion, MaxPol-T/S is a novel PLGA scaffold for ADSC(GFP+) and FCGFP+ and implies a promising technique for tissue engineering.
C1 [Jin, Zhe; Gong, Yan-Qing; Qin, Xin-Cheng; Zhang, Jian; Xin, Zhong-Cheng] Peking Univ, Androl Ctr, Hosp 1, Beijing 100034, Peoples R China.
   [Lin, Gui-ting; Lue, Tom F.] Univ Calif San Francisco, Dept Urol, Sch Med, San Francisco, CA 94143 USA.
RP Jin, Z (reprint author), Peking Univ, Androl Ctr, Hosp 1, Beijing 100034, Peoples R China.
EM xinzc@bjmu.edu.cn
CR Bhatnagar RS, 2004, P ANN INT IEEE EMBS, V26, P5021
   BROCK G, 1993, J UROLOGY, V150, P1306, DOI 10.1016/S0022-5347(17)35766-X
   Choi YS, 2006, BIOCHEM BIOPH RES CO, V345, P631, DOI 10.1016/j.bbrc.2006.04.128
   El-Sakka AI, 1998, J UROLOGY, V160, P2050, DOI 10.1016/S0022-5347(01)62240-7
   FOURNIER GR, 1993, J UROLOGY, V149, P1321, DOI 10.1016/S0022-5347(17)36382-6
   Hirsch A, 2005, J PERIODONTOL, V76, P1323, DOI 10.1902/jop.2005.76.8.1323
   Kim M, 2006, BIOCHEM BIOPH RES CO, V348, P386, DOI 10.1016/j.bbrc.2006.07.063
   Lue TF, 1998, J UROLOGY, V160, P2047, DOI 10.1016/S0022-5347(01)62239-0
   Ning HX, 2006, DIFFERENTIATION, V74, P510, DOI 10.1111/j.1432-0436.2006.00081.x
   Rahmani M E, 2006, J Contemp Dent Pract, V7, P63
   Shen Francis H, 2006, Spine J, V6, P615, DOI 10.1016/j.spinee.2006.03.006
   Strem BM, 2005, TRENDS BIOTECHNOL, V23, P64, DOI 10.1016/j.tibtech.2004.12.003
   Yang XBB, 2004, TISSUE ENG, V10, P1148, DOI 10.1089/1076327041887871
   Yoon E, 2007, TISSUE ENG, V13, P619, DOI 10.1089/ten.2006.0102
   Zigdon H, 2006, Refuat Hapeh Vehashinayim (1993), V24, P19
NR 15
TC 1
Z9 1
U1 0
U2 4
PU KOREAN TISSUE ENGINEERING REGENERATIVE MEDICINE SOC
PI JONGRO-GU
PA 199-1, DONGSUNG-DONG,, JONGRO-GU, SEOUL 110-810, SOUTH KOREA
SN 1738-2696
J9 TISSUE ENG REGEN MED
JI Tissue Eng. Regen. Med.
PD DEC
PY 2008
VL 5
IS 4-6
BP 869
EP 876
PG 8
WC Cell & Tissue Engineering; Engineering, Biomedical
SC Cell Biology; Engineering
GA 379EY
UT WOS:000261380700045
DA 2018-10-19
ER

PT J
AU Chou, AI
   Reza, AT
   Nicoll, SB
AF Chou, Alice I.
   Reza, Anna T.
   Nicoll, Steven B.
TI Distinct Intervertebral Disc Cell Populations Adopt Similar Phenotypes
   in Three-Dimensional Culture
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID BONE MORPHOGENETIC PROTEIN-2; LONG-TERM CULTURE; HYDROSTATIC-PRESSURE;
   ANULUS FIBROSUS; IN-VITRO; EXTRACELLULAR-MATRIX; NUCLEUS PULPOSUS;
   CHONDROCYTES; EXPRESSION; CARTILAGE
AB Tissue engineering strategies have the potential to improve upon current techniques for intervertebral disc repair. However, determining a suitable biomaterial scaffold for disc regeneration is difficult due to the complex fibrocartilaginous structure of the tissue. In this study, cells isolated from three distinct regions of the intervertebral disc, the outer and inner annulus fibrosus and nucleus pulposus, were expanded and seeded on resorbable polyester fiber meshes and encapsulated in calcium crosslinked alginate hydrogels, both chosen to approximate the native tissue architecture. Three-dimensional (3D) constructs were cultured for 14 days in vitro and evaluated histologically and quantitatively for gene expression and production of types I and II collagen and proteoglycans. During monolayer expansion, the cell populations maintained their distinct phenotypic morphology and gene expression profiles. However, after 14 days in 3D culture, there were no significant differences in morphology, gene expression, or protein production between all three cell populations grown in either alginate or polyester fiber meshes. The results of this study indicate that the culture environment may have a greater impact on cellular behavior than the intrinsic origin of the cells, and suggest that only a single-cell type may be required for intervertebral disc regenerative therapies.
C1 [Chou, Alice I.; Reza, Anna T.; Nicoll, Steven B.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.
   [Nicoll, Steven B.] Univ Penn, Dept Orthopaed Surg, Philadelphia, PA 19104 USA.
RP Nicoll, SB (reprint author), Univ Penn, Dept Bioengn, 240 Skirkanich Hall,210 S 33rd St, Philadelphia, PA 19104 USA.
EM nicoll@seas.upenn.edu
FU NIH [EB002425]; National Science Foundation
FX This work was supported by NIH grant EB002425 and a National Science
   Foundation graduate fellowship (A R.). The II-II6B3 antibody developed
   by TF Linsenmayer was obtained from the Developmental Studies Hybridoma
   Bank developed under the auspices of the NICHD and maintained by the
   University of Iowa, Department of Biological Sciences, Iowa City, IA
   52242.
CR Alini M, 2003, SPINE, V28, P446, DOI 10.1097/00007632-200303010-00007
   An H, 2003, SPINE, V28, pS24, DOI 10.1097/00007632-200308011-00005
   Antoniou J, 1996, J CLIN INVEST, V98, P996, DOI 10.1172/JCI118884
   Aoki M, 2004, J BIOMED MATER RES B, V71B, P252, DOI 10.1002/jbm.b.30084
   BAYLISS MT, 1988, SPINE, V13, P972, DOI 10.1097/00007632-198809000-00003
   BENYA PD, 1978, CELL, V15, P1313, DOI 10.1016/0092-8674(78)90056-9
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   Cao DJ, 2006, TISSUE ENG, V12, P1369, DOI 10.1089/ten.2006.12.1369
   CAO Y, 1994, TRANSPLANT P, V26, P3390
   Caruso AB, 2005, J BIOMED MATER RES A, V73A, P388, DOI 10.1002/jbm.a.30233
   Chiba K, 1997, SPINE, V22, P2885, DOI 10.1097/00007632-199712150-00011
   Chou AI, 2006, SPINE, V31, P1875, DOI 10.1097/01.brs.0000229222.98051.9a
   Darling EM, 2005, J ORTHOP RES, V23, P425, DOI 10.1016/j.orthres.2004.08.008
   FARNDALE RW, 1982, CONNECT TISSUE RES, V9, P247, DOI 10.3109/03008208209160269
   GLOWACKI J, 1983, P SOC EXP BIOL MED, V172, P93
   Gruber H E, 2000, BMC Musculoskelet Disord, V1, P1, DOI 10.1186/1471-2474-1-1
   Gruber HE, 1997, MATRIX BIOL, V16, P285, DOI 10.1016/S0945-053X(97)90016-0
   Gruber HE, 1997, EXP CELL RES, V235, P13, DOI 10.1006/excr.1997.3647
   Gruber Helen E, 2004, Spine J, V4, P44, DOI 10.1016/S1529-9430(03)00425-X
   Guilak F, 1999, SPINE, V24, P2475, DOI 10.1097/00007632-199912010-00009
   GUO JF, 1989, CONNECT TISSUE RES, V19, P277, DOI 10.3109/03008208909043901
   Horner HA, 2002, SPINE, V27, P1018, DOI 10.1097/00007632-200205150-00004
   Huang Russel C, 2006, Spine J, V6, P242, DOI 10.1016/j.spinee.2005.04.013
   Hutton WC, 1999, SPINE, V24, P1507, DOI 10.1097/00007632-199908010-00002
   Hutton WC, 2001, CLIN BIOMECH, V16, P728, DOI 10.1016/S0268-0033(01)00080-8
   Kasra M, 2003, J ORTHOPAED RES, V21, P597, DOI 10.1016/S0736-0266(03)00027-5
   Kim DJ, 2003, SPINE, V28, P2679, DOI 10.1097/01.BRS.0000101445.46487.16
   Lee CH, 2005, BIOMATERIALS, V26, P1261, DOI 10.1016/j.biomaterials.2004.04.037
   Luo XM, 2004, SPINE, V29, P79, DOI 10.1097/01.BRS.0000105527.13866.0F
   MALDONADO BA, 1992, J ORTHOP RES, V10, P677, DOI 10.1002/jor.1100100510
   MARCHAND F, 1990, SPINE, V15, P402, DOI 10.1097/00007632-199005000-00011
   Melrose J, 2003, EUR SPINE J, V12, P57, DOI 10.1007/s00586-002-0434-6
   Mizuno H, 2006, BIOMATERIALS, V27, P362, DOI 10.1016/j.biomaterials.2005.06.042
   Mizuno H, 2004, SPINE, V29, P1290, DOI 10.1097/01.BRS.0000128264.46510.27
   NEIDLINGERWILKE C, 2006, EUR SPINE J S15, V15, P372
   OEGEMA TR, 1993, CLIN SPORT MED, V12, P419
   Rannou F, 2000, J LAB CLIN MED, V136, P412, DOI 10.1067/mlc.2000.109755
   Reza AT, 2008, ANN BIOMED ENG, V36, P204, DOI 10.1007/s10439-007-9407-6
   Seidel JO, 2004, BIORHEOLOGY, V41, P445
   Singer VL, 1997, ANAL BIOCHEM, V249, P228, DOI 10.1006/abio.1997.2177
   Tsai TT, 2007, SPINE, V32, P495, DOI 10.1097/01.brs.0000257341.88880.f1
   URBAN JPG, 1993, MUSCULOSKELETAL SOFT-TISSUE AGING: IMPACT ON MOBILITY, P391
   VACANTI CA, 1994, CLIN PLAST SURG, V21, P445
   VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0
   Wang JY, 2001, SPINE, V26, P1747, DOI 10.1097/00007632-200108150-00003
   Wong M, 2003, BONE, V33, P685, DOI 10.1016/S8756-3282(03)00242-4
   Yoon ST, 2003, SPINE, V28, P1773, DOI 10.1097/01.BRS.0000083204.44190.34
NR 47
TC 35
Z9 40
U1 3
U2 6
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD DEC
PY 2008
VL 14
IS 12
BP 2079
EP 2087
DI 10.1089/ten.tea.2007.0337
PG 9
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 379NN
UT WOS:000261403500015
PM 18636941
OA Green Published
DA 2018-10-19
ER

PT J
AU Georgakoudi, I
   Rice, WL
   Hronik-Tupaj, M
   Kaplan, DL
AF Georgakoudi, Irene
   Rice, William L.
   Hronik-Tupaj, Marie
   Kaplan, David L.
TI Optical Spectroscopy and Imaging for the Noninvasive Evaluation of
   Engineered Tissues
SO TISSUE ENGINEERING PART B-REVIEWS
LA English
DT Article
ID LIGHT-SCATTERING SPECTROSCOPY; MESENCHYMAL STEM-CELLS; ADHESION CONTACT
   DYNAMICS; MODE CONFOCAL MICROSCOPY; COHERENCE TOMOGRAPHY; IN-VITRO;
   MULTIPHOTON MICROSCOPY; 2ND-HARMONIC GENERATION; 2-PHOTON EXCITATION;
   OSTEOGENIC DIFFERENTIATION
AB Optical spectroscopy and imaging approaches offer the potential to noninvasively assess different aspects of the cellular, extracellular matrix, and scaffold components of engineered tissues. In addition, the combination of multiple imaging modalities within a single instrument is highly feasible, allowing acquisition of complementary information related to the structure, organization, biochemistry, and physiology of the sample. The ability to characterize and monitor the dynamic interactions that take place as engineered tissues develop promises to enhance our understanding of the interdependence of processes that ultimately leads to functional tissue outcomes. It is expected that this information will impact significantly upon our abilities to optimize the design of biomaterial scaffolds, bioreactors, and cell systems. Here, we review the principles and performance characteristics of the main methodologies that have been exploited thus far, and we present examples of corresponding tissue engineering studies.
C1 [Georgakoudi, Irene; Rice, William L.; Hronik-Tupaj, Marie; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Georgakoudi, I (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM Irene.Georgakoudi@tufts.edu
FU NSF [BES 0547292]; NIH [P41 EB002520]
FX Funding for the development of optical spectroscopic imaging approaches
   for tissue engineering applications has been provided in our
   laboratories by NSF (BES 0547292) and NIH (P41 EB002520 Tissue
   Engineering Resource Center).
CR Allen J, 2007, BIOMATERIALS, V28, P162, DOI 10.1016/j.biomaterials.2006.07.002
   Arifler D, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2398932
   Ashjian P, 2004, TISSUE ENG, V10, P411, DOI 10.1089/107632704323061771
   Azrad E, 2006, J RAMAN SPECTROSC, V37, P480, DOI 10.1002/jrs.1420
   Backman V, 2001, IEEE J SEL TOP QUANT, V7, P887, DOI 10.1109/2944.983289
   Bagnaninchi PO, 2007, TISSUE ENG, V13, P323, DOI 10.1089/ten.2006.0168
   Campagnola PJ, 2002, BIOPHYS J, V82, P493, DOI 10.1016/S0006-3495(02)75414-3
   Caspi O, 2007, CIRC RES, V100, P263, DOI 10.1161/01.RES.0000257776.05673.ff
   Chen F, 2007, MAT SCI ENG C-BIO S, V27, P325, DOI 10.1016/j.msec.2006.05.004
   CHENG PC, 2005, HDB BIOL CONFOCAL MI, P703
   CHRIS X, 1996, BIOIMAGING, V4, P198
   COGAN U, 1976, EUR J BIOCHEM, V65, P71, DOI 10.1111/j.1432-1033.1976.tb10390.x
   de Boer JF, 2003, OPT LETT, V28, P2067, DOI 10.1364/OL.28.002067
   DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027
   Dennis T, 2007, PROC SPIE, V6446, DOI 10.1117/12.699244
   Drezek RA, 2003, CANCER, V98, P2015, DOI 10.1002/cncr.11678
   Du M, 2003, J BIOL CHEM, V278, P6002, DOI 10.1074/jbc.M209606200
   Dubruel P, 2007, BIOMACROMOLECULES, V8, P338, DOI 10.1021/bm0606869
   Dumas D, 2004, BIORHEOLOGY, V41, P459
   Fang H, 2003, IEEE J SEL TOP QUANT, V9, P267, DOI 10.1109/JSTQE.2003.812515
   Fang N, 2005, MACROMOL BIOSCI, V5, P1022, DOI 10.1002/mabi.200500123
   Fawzi-Grancher S, 2006, ANN BIOMED ENG, V34, P1767, DOI 10.1007/s10439-006-9180-y
   Feng QL, 2005, MATER SCI FORUM, V475-479, P2391, DOI 10.4028/www.scientific.net/MSF.475-479.2391
   Georgakoudi I, 2002, AM J OBSTET GYNECOL, V186, P374, DOI 10.1067/mob.2002.121075
   Georgakoudi I, 2001, GASTROENTEROLOGY, V120, P1620, DOI 10.1053/gast.2001.24842
   Georgakoudi I, 2007, OPT EXPRESS, V15, P1043, DOI 10.1364/OE.15.001043
   Gomes ME, 2003, J BIOMED MATER RES A, V67A, P87, DOI 10.1002/jbm.a.10075
   Gonzalez S., 2008, International Journal of Cosmetic Science, V30, P1, DOI 10.1111/j.1468-2494.2008.00406.x
   Gupta S, 2008, BIOMATERIALS, V29, P2359, DOI 10.1016/j.biomaterials.2008.01.034
   Holzer W, 2005, CHEM PHYS, V308, P69, DOI 10.1016/j.chemphys.2004.08.006
   Huang SH, 2002, BIOPHYS J, V82, P2811, DOI 10.1016/S0006-3495(02)75621-X
   Huzaira M, 2001, J INVEST DERMATOL, V116, P846, DOI 10.1046/j.0022-202x.2001.01337.x
   INOUE S, 2005, HDB BIOL CONFOCAL MI, P1
   Jacques SL, 1998, PHOTOCHEM PHOTOBIOL, V67, P23
   Kierdaszuk B, 1996, BIOPHYS CHEM, V62, P1, DOI 10.1016/S0301-4622(96)02182-5
   Kim A, 2006, EXP CELL RES, V312, P3683, DOI 10.1016/j.yexcr.2006.08.009
   Kim YL, 2003, IEEE J SEL TOP QUANT, V9, P243, DOI 10.1109/JSTQE.2003.814183
   Ko HJ, 2006, TISSUE ENG, V12, P63, DOI 10.1089/ten.2006.12.63
   Konig K, 2005, BIOMATERIALS, V26, P495, DOI 10.1016/j.biomaterials.2004.02.059
   Kostyuk O, 2004, BIOPHYS J, V87, P648, DOI 10.1529/biophysj.103.038976
   Kostyuk O, 2004, J PHYSIOL-LONDON, V554, P791, DOI 10.1113/physiol.2004.054809
   LAKOWICZ JR, 1995, BIOPHYS CHEM, V56, P263, DOI 10.1016/0301-4622(95)00040-5
   Landis FA, 2006, BIOMACROMOLECULES, V7, P1751, DOI 10.1021/bm0600466
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Larson DR, 2003, SCIENCE, V300, P1434, DOI 10.1126/science.1083780
   Lee HS, 2006, TISSUE ENG, V12, P2835, DOI 10.1089/ten.2006.12.2835
   Leong DT, 2006, CELLS TISSUES ORGANS, V182, P1, DOI 10.1159/000091713
   Lu CW, 2008, OPT LETT, V33, P416, DOI 10.1364/OL.33.000416
   Luong LN, 2006, BIOMATERIALS, V27, P1175, DOI 10.1016/j.biomaterials.2005.07.043
   Mahoney MJ, 2006, BIOMATERIALS, V27, P2265, DOI 10.1016/j.biomaterials.2005.11.007
   Martina M, 2005, BIOMATERIALS, V26, P5609, DOI 10.1016/j.biomaterials.2005.02.011
   Mason C, 2004, PHYS MED BIOL, V49, P1097, DOI 10.1088/0031-9155/49/7/002
   Mason C, 2004, BIOSENS BIOELECTRON, V20, P414, DOI 10.1016/j.bios.2004.03.035
   Mujat C, 2008, INT J CANCER, V122, P363, DOI 10.1002/ijc.23120
   Muller M, 2007, CHEMPHYSCHEM, V8, P2156, DOI 10.1002/cphc.200700202
   Nadiarnykh O, 2007, OPT EXPRESS, V15, P3348, DOI 10.1364/OE.15.003348
   Navarro FA, 2004, PLAST RECONSTR SURG, V114, P121, DOI 10.1097/01.PRS.0000128374.20913.4B
   Notingher I, 2004, ANAL CHEM, V76, P3185, DOI 10.1021/ac0498720
   Opitz F, 2004, CARDIOVASC RES, V63, P719, DOI 10.1016/j.cardiores.2004.05.002
   Palero JA, 2007, BIOPHYS J, V93, P992, DOI 10.1529/biophysj.106.099457
   Pancrazio JJ, 2007, BIOSENS BIOELECTRON, V22, P2803, DOI 10.1016/j.bios.2006.12.023
   Patterson GH, 2000, BIOPHYS J, V78, P2159, DOI 10.1016/S0006-3495(00)76762-2
   Peretti GM, 2006, CONNECT TISSUE RES, V47, P190, DOI 10.1080/03008200600809935
   Petroll WM, 2006, SCANNING, V28, P305
   Pierce MC, 2004, J INVEST DERMATOL, V123, P458, DOI 10.1111/j.0022-202X.2004.23404.x
   Rice WL, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2823019
   Rice WL, 2008, BIOMATERIALS, V29, P2015, DOI 10.1016/j.biomaterials.2007.12.049
   RichardsKortum R, 1996, ANNU REV PHYS CHEM, V47, P555, DOI 10.1146/annurev.physchem.47.1.555
   Richardson SM, 2006, BIOMATERIALS, V27, P4069, DOI 10.1016/j.biomaterials.2006.03.017
   Schenke-Layland K, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1896966
   Schenke-Layland K, 2006, ADV DRUG DELIVER REV, V58, P878, DOI 10.1016/j.addr.2006.07.004
   SCOTT TG, 1970, J AM CHEM SOC, V92, P687, DOI 10.1021/ja00706a043
   Skala MC, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2717503
   Smith IO, 2006, J BIOMED MATER RES B, V79B, P185, DOI 10.1002/jbm.b.30529
   Spoler F, 2006, SKIN RES TECHNOL, V12, P261, DOI 10.1111/j.0909-752X.2006.00163.x
   Squirrell JM, 2003, MICROSC MICROANAL, V9, P190, DOI 10.1017/S1431927603030174
   Sun S, 2006, BIOELECTROCHEMISTRY, V69, P133, DOI 10.1016/j.bioelechem.2005.11.007
   SZUTS EZ, 1991, ARCH BIOCHEM BIOPHYS, V287, P297, DOI 10.1016/0003-9861(91)90482-X
   Tamariz E, 2002, MOL BIOL CELL, V13, P3915, DOI 10.1091/mbc.E02-05-0291
   Tan W, 2004, TISSUE ENG, V10, P1747, DOI 10.1089/ten.2004.10.1747
   Tan W, 2006, OPT EXPRESS, V14, P7159, DOI 10.1364/OE.14.007159
   Tan WJ, 2005, BIOMATERIALS, V26, P891, DOI 10.1016/j.biomaterials.2004.03.041
   Theer P, 2003, OPT LETT, V28, P1022, DOI 10.1364/OL.28.001022
   Turner NJ, 2004, BIOMATERIALS, V25, P5955, DOI 10.1016/j.biomaterials.2004.02.002
   Wang AMJ, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1989335
   Wang YZ, 2005, BIOMATERIALS, V26, P7082, DOI 10.1016/j.biomaterials.2005.05.022
   Wenger A, 2004, TISSUE ENG, V10, P1536, DOI 10.1089/1076327042500283
   Wu J, 2003, MICROSC MICROANAL, V9, P574, DOI [10.1017/S14319276030302777, 10.1017/S1431927603030277]
   Xu CY, 2006, OPT LETT, V31, P1079, DOI 10.1364/OL.31.001079
   Xu CY, 2004, TISSUE ENG, V10, P1160, DOI 10.1089/ten.2004.10.1160
   Xu XQ, 2003, EUR BIOPHYS J BIOPHY, V32, P355, DOI 10.1007/s00249-003-0285-z
   Yang Y, 2006, PHYS MED BIOL, V51, P1649, DOI 10.1088/0031-9155/51/7/001
   Yeh AT, 2004, J BIOMED OPT, V9, P248, DOI 10.1117/1-16486461
   Zhao YS, 2005, J HEART LUNG TRANSPL, V24, P1091, DOI 10.1016/j.healun.2004.07.010
   Zipfel WR, 2003, P NATL ACAD SCI USA, V100, P7075, DOI 10.1073/pnas.0832308100
   Zoumi A, 2002, P NATL ACAD SCI USA, V99, P11014, DOI 10.1073/pnas.172368799
   Zoumi A, 2004, BIOPHYS J, V87, P2778, DOI 10.1529/biophysj.104.042887
NR 97
TC 60
Z9 60
U1 0
U2 14
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3368
EI 1937-3376
J9 TISSUE ENG PART B-RE
JI Tissue Eng. Part B-Rev.
PD DEC
PY 2008
VL 14
IS 4
BP 321
EP 340
DI 10.1089/ten.teb.2008.0248
PG 20
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 382TI
UT WOS:000261627900001
PM 18844604
OA Green Published
DA 2018-10-19
ER

PT J
AU Singh, M
   Berkland, C
   Detamore, MS
AF Singh, Milind
   Berkland, Cory
   Detamore, Michael S.
TI Strategies and Applications for Incorporating Physical and Chemical
   Signal Gradients in Tissue Engineering
SO TISSUE ENGINEERING PART B-REVIEWS
LA English
DT Review
ID NERVE GROWTH-FACTOR; IMMOBILIZED CONCENTRATION GRADIENTS;
   HIGH-THROUGHPUT CHARACTERIZATION; COMBINATORIAL MATERIALS SCIENCE;
   FUNCTIONALLY GRADED MATERIAL; FREQUENCY PLASMA DISCHARGE; GUIDED NEURITE
   OUTGROWTH; PORE-SIZE GRADIENT; WETTABILITY GRADIENT; PLATELET-ADHESION
AB From embryonic development to wound repair, concentration gradients of bioactive signaling molecules guide tissue formation and regeneration. Moreover, gradients in cellular and extracellular architecture as well as in mechanical properties are readily apparent in native tissues. Perhaps tissue engineers can take a cue from nature in attempting to regenerate tissues by incorporating gradients into engineering design strategies. Indeed, gradient-based approaches are an emerging trend in tissue engineering, standing in contrast to traditional approaches of homogeneous delivery of cells and/or growth factors using isotropic scaffolds. Gradients in tissue engineering lie at the intersection of three major paradigms in the field-biomimetic, interfacial, and functional tissue engineering-by combining physical (via biomaterial design) and chemical (with growth/differentiation factors and cell adhesion molecules) signal delivery to achieve a continuous transition in both structure and function. This review consolidates several key methodologies to generate gradients, some of which have never been employed in a tissue engineering application, and discusses strategies for incorporating these methods into tissue engineering and implant design. A key finding of this review was that two-dimensional physicochemical gradient substrates, which serve as excellent high-throughput screening tools for optimizing desired biomaterial properties, can be enhanced in the future by transitioning from two dimensions to three dimensions, which would enable studies of cell-protein-biomaterial interactions in a more native tissue-like environment. In addition, biomimetic tissue regeneration via combined delivery of graded physical and chemical signals appears to be a promising strategy for the regeneration of heterogeneous tissues and tissue interfaces. In the future, in vivo applications will shed more light on the performance of gradient-based mechanical integrity and signal delivery strategies compared to traditional tissue engineering approaches.
C1 [Singh, Milind; Berkland, Cory; Detamore, Michael S.] Univ Kansas, Dept Chem & Petr Engn, Lawrence, KS 66045 USA.
   [Berkland, Cory] Univ Kansas, Dept Pharmaceut Chem, Lawrence, KS 66045 USA.
RP Detamore, MS (reprint author), Univ Kansas, Dept Chem & Petr Engn, 1530 W 15th St,Learned Hall,Room 4132, Lawrence, KS 66045 USA.
EM detamore@ku.edu
FU NIH/NIDCR [1 R21 DE017673-01A1]; Juvenile Diabetes Research Foundation;
   University of Kansas General Research Fund
FX The present work was supported by NIH/NIDCR grant 1 R21 DE017673-01A1,
   the Juvenile Diabetes Research Foundation and the University of Kansas
   General Research Fund.
CR Adams DN, 2005, J NEUROBIOL, V62, P134, DOI 10.1002/neu.20075
   Alberts B, 2002, MOL BIOL CELL
   Alexander MR, 2004, J MATER CHEM, V14, P408, DOI 10.1039/b311256j
   Beauregard G P, 1999, Biomed Sci Instrum, V35, P415
   Bhat RR, 2005, J POLYM SCI POL PHYS, V43, P3384, DOI 10.1002/polb.20640
   Bhat RR, 2004, MACROMOL RAPID COMM, V25, P270, DOI 10.1002/marc.200300163
   Bogdanski D, 2002, BIOMATERIALS, V23, P4549, DOI 10.1016/S0142-9612(02)00200-4
   Boughton P, 2001, CERAM ENG SCI PROC, V22, P593
   BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453
   Burdick JA, 2004, LANGMUIR, V20, P5153, DOI 10.1021/la049298n
   Caelen I, 2000, LANGMUIR, V16, P9125, DOI 10.1021/la000851k
   Cao X, 2003, NEUROSCIENCE, V122, P381, DOI 10.1016/j.neuroscience.2003.08.018
   Cao X, 2001, NEUROSCIENCE, V103, P831, DOI 10.1016/S0306-4522(01)00029-X
   CHAUDHURY MK, 1992, SCIENCE, V256, P1539, DOI 10.1126/science.256.5063.1539
   Chen CC, 2006, J BIOMED MATER RES B, V78B, P146, DOI 10.1002/jbm.b.30465
   Chen GP, 2001, BIOMATERIALS, V22, P2453, DOI 10.1016/S0142-9612(00)00432-4
   Chen RR, 2003, PHARMACEUT RES, V20, P1103, DOI 10.1023/A:1025034925152
   Choee JH, 2004, J APPL POLYM SCI, V92, P599, DOI 10.1002/app.20048
   Clark R. A. F., 1996, WOUND REPAIR OVERVIE
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   DeLong SA, 2005, J CONTROL RELEASE, V109, P139, DOI 10.1016/j.jconrel.2005.09.020
   DeLong SA, 2005, BIOMATERIALS, V26, P3227, DOI 10.1016/j.biomaterials.2004.09.021
   Dertinger SKW, 2001, ANAL CHEM, V73, P1240, DOI 10.1021/ac001132d
   Dertinger SKW, 2002, P NATL ACAD SCI USA, V99, P12542, DOI 10.1073/pnas.192457199
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Dodla MC, 2008, BIOMATERIALS, V29, P33, DOI 10.1016/j.biomaterials.2007.08.045
   Dodla MC, 2006, J BIOMED MATER RES A, V78A, P213, DOI 10.1002/jbm.a.30747
   Dubruel P, 2007, BIOMACROMOLECULES, V8, P338, DOI 10.1021/bm0606869
   Eichmann A, 2005, CURR OPIN NEUROBIOL, V15, P108, DOI 10.1016/j.conb.2005.01.008
   Eidelman N, 2004, J RES NATL INST STAN, V109, P219, DOI 10.6028/jres.109.014
   ELWING H, 1987, J BIOMED MATER RES, V21, P1023, DOI 10.1002/jbm.820210808
   ELWING H, 1987, J COLLOID INTERF SCI, V119, P203, DOI 10.1016/0021-9797(87)90260-8
   ELWING H, 1987, PROG COLLOID POLYM S, V74, P103
   Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5
   Engler AJ, 2004, SURF SCI, V570, P142, DOI 10.1016/j.susc.2004.06.179
   Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004
   Eufinger H, 2007, BIOMATERIALS, V28, P475, DOI 10.1016/j.biomaterials.2006.08.055
   FISHER PR, 1989, J CELL BIOL, V108, P973, DOI 10.1083/jcb.108.3.973
   Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/01.wnr.0000048003.96487.97
   FOCUS W, 2003, EMBO J, V22, P2318
   Gelain F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000119
   Genzer J, 2008, LANGMUIR, V24, P2294, DOI 10.1021/la7033164
   Georges PC, 2005, J APPL PHYSIOL, V98, P1547, DOI 10.1152/japplphysiol.01121.2004
   Gerstenfeld LC, 2002, J BONE MINER RES, V17, P221, DOI 10.1359/jbmr.2002.17.2.221
   GOLANDER CG, 1990, BIOMATERIALS, V11, P32, DOI 10.1016/0142-9612(90)90048-U
   GOLANDER CG, 1989, COLLOID SURFACE, V42, P165, DOI 10.1016/0166-6622(89)80084-8
   Gray DS, 2003, J BIOMED MATER RES A, V66A, P605, DOI 10.1002/jbm.a.10585
   GRUNER H, 1987, CHEM ABSTR, V106
   Gunawan RC, 2006, LANGMUIR, V22, P4250, DOI 10.1021/la0531493
   Guo WH, 2006, BIOPHYS J, V90, P2213, DOI 10.1529/biophysj.105.070144
   Gurdon JB, 2001, NATURE, V413, P797, DOI 10.1038/35101500
   Haga H, 2005, BIOPHYS J, V88, P2250, DOI 10.1529/biophysj.104.047654
   Halfter W, 1996, J NEUROSCI, V16, P4389
   Harley BA, 2006, BIOMATERIALS, V27, P866, DOI 10.1016/j.biomaterials.2005.07.012
   Harris BP, 2006, LANGMUIR, V22, P4467, DOI 10.1021/la053417x
   Harris BP, 2006, MACROMOLECULES, V39, P2764, DOI 10.1021/ma0512051
   Hedia HS, 2004, BIO-MED MATER ENG, V14, P133
   Herbert CB, 1997, CHEM BIOL, V4, P731, DOI 10.1016/S1074-5521(97)90311-2
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   HLADY V, 1991, APPL SPECTROSC, V45, P246, DOI 10.1366/0003702914337533
   Horb ME, 2000, BIOESSAYS, V22, P599
   Hsu YH, 2007, J MATER SCI-MATER M, V18, P2251, DOI 10.1007/s10856-007-3126-2
   Hypolite CL, 1997, BIOCONJUGATE CHEM, V8, P658, DOI 10.1021/bc9701252
   Ilkhanizadeh S, 2007, BIOMATERIALS, V28, P3936, DOI 10.1016/j.biomaterials.2007.05.018
   Ingber DE, 2006, TISSUE ENG, V12, P3265, DOI 10.1089/ten.2006.12.3265
   Iqbal P, 2007, J MATER CHEM, V17, P5097, DOI 10.1039/b712687e
   Iwasaki Y, 1999, BIOMATERIALS, V20, P2185, DOI 10.1016/S0142-9612(99)00123-4
   Iwasaki Y, 1998, J BIOMAT SCI-POLYM E, V9, P801, DOI 10.1163/156856298X00163
   Jacot JG, 2006, J BIOMED MATER RES A, V79A, P485, DOI 10.1002/jbm.a.30812
   Jaklenec A, 2008, BIOMATERIALS, V29, P1518, DOI 10.1016/j.biomaterials.2007.12.004
   Jandeleit B, 1999, ANGEW CHEM INT EDIT, V38, P2495
   Jeon NL, 2000, LANGMUIR, V16, P8311, DOI 10.1021/la000600b
   Jeong BJ, 1996, J COLLOID INTERF SCI, V178, P757, DOI 10.1006/jcis.1996.0174
   Julthongpiput D, 2005, NANO LETT, V5, P1535, DOI 10.1021/nl050612n
   Kang CE, 2004, J BIOMED MATER RES A, V71A, P403, DOI 10.1002/jbm.a.30137
   Kapur TA, 2004, J BIOMED MATER RES A, V68A, P235, DOI 10.1002/jbm.a.10168
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kennedy SB, 2006, BIOMATERIALS, V27, P3817, DOI 10.1016/j.biomaterials.2006.02.044
   Khang G, 1999, BIO-MED MATER ENG, V9, P179
   Kidoaki A, 2008, J BIOTECHNOL, V133, P225, DOI 10.1016/j.jbiotec.2007.08.015
   Kieback B, 2003, MAT SCI ENG A-STRUCT, V362, P81, DOI 10.1016/S0921-5093(03)00578-1
   Kim HM, 2000, J MATER SCI-MATER M, V11, P555, DOI 10.1023/A:1008924102096
   Kim HW, 2004, J BIOMED MATER RES B, V70B, P270, DOI 10.1002/jbm.b.30032
   Kim MS, 2008, PROG POLYM SCI, V33, P138, DOI 10.1016/j.progpolymsci.2007.06.001
   Knapp DM, 1999, EXP CELL RES, V247, P543, DOI 10.1006/excr.1998.4364
   Kramer S, 2004, J AM CHEM SOC, V126, P5388, DOI 10.1021/ja031674n
   Kunzler TP, 2007, BIOMATERIALS, V28, P5000, DOI 10.1016/j.biomaterials.2007.08.009
   Lagoa ALC, 2008, J MATER SCI-MATER M, V19, P417, DOI 10.1007/s10856-006-0022-0
   Lapizco-Encinas BH, 2007, ELECTROPHORESIS, V28, P4521, DOI 10.1002/elps.200700303
   LEE JH, 1993, J BIOMAT SCI-POLYM E, V4, P467
   Lee JH, 1998, J COLLOID INTERF SCI, V205, P323, DOI 10.1006/jcis.1998.5688
   Lee JH, 1998, J BIOMED MATER RES, V41, P304, DOI 10.1002/(SICI)1097-4636(199808)41:2<304::AID-JBM16>3.0.CO;2-K
   Lee JH, 1997, BIOMATERIALS, V18, P351, DOI 10.1016/S0142-9612(96)00128-7
   LEE JH, 1992, J COLLOID INTERF SCI, V151, P563, DOI 10.1016/0021-9797(92)90504-F
   Lee JH, 1997, J BIOMED MATER RES, V34, P105, DOI 10.1002/(SICI)1097-4636(199701)34:1<105::AID-JBM14>3.0.CO;2-J
   Lee JH, 1998, J BIOMED MATER RES, V40, P180, DOI 10.1002/(SICI)1097-4636(199805)40:2<180::AID-JBM2>3.0.CO;2-H
   Lee JH, 1999, J BIOMAT SCI-POLYM E, V10, P283
   Lee SJ, 2003, J COLLOID INTERF SCI, V259, P228, DOI 10.1016/S0021-9797(02)00163-7
   Li B, 2005, BIOMATERIALS, V26, P4956, DOI 10.1016/j.biomaterials.2005.01.018
   Li B, 2005, BIOMATERIALS, V26, P1487, DOI 10.1016/j.biomaterials.2004.05.004
   Li S, 2005, ANNU REV BIOMED ENG, V7, P105, DOI 10.1146/annurev.bioeng.7.060804.100340
   Lin-Gibson S, 2006, BIOMATERIALS, V27, P1711, DOI 10.1016/j.biomaterials.2005.10.040
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Ma PX, 2001, J BIOMED MATER RES, V56, P469, DOI 10.1002/1097-4636(20010915)56:4<469::AID-JBM1118>3.0.CO;2-H
   Malda J, 2004, BIOMATERIALS, V25, P5773, DOI 10.1016/j.biomaterials.2004.01.028
   Marshall GW, 2001, J BIOMED MATER RES, V54, P87, DOI 10.1002/1097-4636(200101)54:1<87::AID-JBM10>3.0.CO;2-Z
   Mei Y, 2006, J BIOMED MATER RES A, V79A, P974, DOI 10.1002/jbm.a.30883
   Meier MAR, 2004, J MATER CHEM, V14, P3289, DOI 10.1039/b406497f
   Meier MAR, 2004, MACROMOL RAPID COMM, V25, P21, DOI 10.1002/marc.200300147
   Meredith JC, 2000, MACROMOLECULES, V33, P5760, DOI 10.1021/ma0004662
   Meredith JC, 2003, J BIOMED MATER RES A, V66A, P483, DOI 10.1002/jbm.a.10004
   Meredith JC, 2000, MACROMOLECULES, V33, P9747, DOI 10.1021/ma001298g
   Messersmith PB, 2008, SCIENCE, V319, P1767, DOI 10.1126/science.1155122
   MOGHE PV, 1995, J IMMUNOL METHODS, V180, P193, DOI 10.1016/0022-1759(94)00314-M
   Moore K, 2006, TISSUE ENG, V12, P267, DOI 10.1089/ten.2006.12.267
   Morgenthaler S, 2003, LANGMUIR, V19, P10459, DOI 10.1021/la0347071
   Morgenthaler S, 2006, BIOINTERPHASES, V1, P156, DOI 10.1116/1.2431704
   Moritz T, 2000, J MATER SCI, V35, P2235, DOI 10.1023/A:1004774809436
   Mortensen A, 1995, INT MATER REV, V40, P239, DOI 10.1179/imr.1995.40.6.239
   Muratoglu OK, 2002, BIOMATERIALS, V23, P717, DOI 10.1016/S0142-9612(01)00176-4
   Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008
   NELSON RD, 1975, J IMMUNOL, V115, P1650
   NIINO M, 1990, ISIJ INT, V30, P699, DOI 10.2355/isijinternational.30.699
   Oh SH, 2007, BIOMATERIALS, V28, P1664, DOI 10.1016/j.biomaterials.2006.11.024
   Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765
   Parry KL, 2006, SURF INTERFACE ANAL, V38, P1497, DOI 10.1002/sia.2400
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Peyton SR, 2005, J CELL PHYSIOL, V204, P198, DOI 10.1002/jcp.20274
   PITT WG, 1989, J COLLOID INTERF SCI, V133, P223, DOI 10.1016/0021-9797(89)90295-6
   Plummer ST, 2002, LANGMUIR, V18, P4142, DOI 10.1021/la011742o
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Righetti PG, 2005, J CHROMATOGR A, V1079, P24, DOI 10.1016/j.chroma.2005.01.018
   Roberson S, 2003, APPL SURF SCI, V203, P855, DOI 10.1016/S0169-4332(02)00822-X
   RODBARD D, 1971, ANAL BIOCHEM, V40, P135, DOI 10.1016/0003-2697(71)90087-X
   Rosoff WJ, 2005, BIOTECHNOL BIOENG, V91, P754, DOI 10.1002/bit.20564
   Rosoff WJ, 2004, NAT NEUROSCI, V7, P678, DOI 10.1038/nn1259
   Roy TD, 2003, J BIOMED MATER RES A, V66A, P283, DOI 10.1002/jbm.a.10582
   Ruardy TG, 1997, SURF SCI REP, V29, P3, DOI 10.1016/S0167-5729(97)00008-3
   Schwarz K, 1998, MACROMOL RAPID COMM, V19, P613, DOI 10.1002/(SICI)1521-3927(19981201)19:12<613::AID-MARC613>3.3.CO;2-D
   Schwarz U, 2007, SOFT MATTER, V3, P263, DOI 10.1039/b606409d
   Shen FW, 2005, CLIN ORTHOP RELAT R, P80, DOI 10.1097/01.blo.0000149999.17123.e8
   Sherwood JK, 2002, BIOMATERIALS, V23, P4739, DOI 10.1016/S0142-9612(02)00223-5
   Simon CG, 2005, BIOMATERIALS, V26, P6906, DOI 10.1016/j.biomaterials.2005.04.050
   Singh M, 2008, TISSUE ENG PART C-ME, V14, P299, DOI 10.1089/ten.tec.2008.0167
   Smith AP, 2003, MACROMOL RAPID COMM, V24, P131, DOI 10.1002/marc.200390001
   Smith AP, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.015503
   Smith AP, 2001, J POLYM SCI POL PHYS, V39, P2141, DOI 10.1002/polb.1188
   Spijker HT, 2002, J ADHES SCI TECHNOL, V16, P1703, DOI 10.1163/156856102320396094
   Spijker HT, 2002, BIOMATERIALS, V23, P757, DOI 10.1016/S0142-9612(01)00181-8
   Suciati T, 2006, J MATER SCI-MATER M, V17, P1049, DOI 10.1007/s10856-006-0443-9
   Sung FJ, 2005, BIOMATERIALS, V26, P4557, DOI 10.1016/j.biomaterials.2004.11.034
   Suresh S, 2001, SCIENCE, V292, P2447, DOI 10.1126/science.1059716
   Tampieri A, 2001, BIOMATERIALS, V22, P1365, DOI 10.1016/S0142-9612(00)00290-8
   TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123
   Thieme M, 2001, J MATER SCI-MATER M, V12, P225, DOI 10.1023/A:1008958914818
   Tomkoria S, 2004, MED ENG PHYS, V26, P815, DOI 10.1016/j.medengphy.2004.07.006
   UEDAYUKOSHI T, 1995, LANGMUIR, V11, P4135, DOI 10.1021/la00010a080
   Van Vlierberghe S, 2007, BIOMACROMOLECULES, V8, P331, DOI 10.1021/bm060684o
   Vaz L, 1999, J MATER SCI-MATER M, V10, P239, DOI 10.1023/A:1008910213166
   Vepari CP, 2006, BIOTECHNOL BIOENG, V93, P1130, DOI 10.1002/bit.20833
   Vunjak-Novakovic G, 2006, TISSUE ENG, V12, P3261, DOI 10.1089/ten.2006.12.3261
   Walker GM, 2005, LAB CHIP, V5, P611, DOI 10.1039/b417245k
   Wang M, 1999, J MATER SCI-MATER M, V10, P269, DOI 10.1023/A:1008901428552
   Washburn NR, 2004, BIOMATERIALS, V25, P1215, DOI 10.1016/j.biomaterials.2003.08.043
   Watari F, 2004, COMPOS SCI TECHNOL, V64, P893, DOI 10.1016/j.compscitech.2003.09.005
   Weeber HA, 2007, GRAEF ARCH CLIN EXP, V245, P1357, DOI 10.1007/s00417-007-0537-1
   Werner J, 2002, BIOMATERIALS, V23, P4285, DOI 10.1016/S0142-9612(02)00191-6
   Whittle JD, 2003, CHEM COMMUN, P1766, DOI 10.1039/b305445b
   WIJESUNDARA MBJ, 1987, J COLLOID INTERF SCI, V119, P203
   Wong JY, 2003, LANGMUIR, V19, P1908, DOI 10.1021/la026403p
   Woodfield TBF, 2005, TISSUE ENG, V11, P1297, DOI 10.1089/ten.2005.11.1297
   Wu T, 2003, J MATER SCI, V38, P4471, DOI 10.1023/A:1027373216389
   Xu HHK, 2007, BIOMATERIALS, V28, P3786, DOI 10.1016/j.biomaterials.2007.05.015
   YAMADA KM, 1991, J BIOL CHEM, V266, P12809
   Yang J, 2007, J BIOMECH, V40, P2377, DOI 10.1016/j.jbiomech.2006.11.019
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
   Zaari N, 2004, ADV MATER, V16, P2133, DOI 10.1002/adma.200400883
   Zeltinger J, 2001, TISSUE ENG, V7, P557, DOI 10.1089/107632701753213183
   Zelzer M, 2008, BIOMATERIALS, V29, P172, DOI 10.1016/j.biomaterials.2007.09.026
   Zhao B, 2004, LANGMUIR, V20, P11748, DOI 10.1021/la047681m
   Zhu L, 2006, J BIOMED MATER RES A, V78A, P515, DOI 10.1002/jbm.e.30745
   ZICHA D, 1991, J CELL SCI, V99, P769
   ZIGMOND SH, 1973, J EXP MED, V137, P387, DOI 10.1084/jem.137.2.387
   Zmora S, 2002, BIOMATERIALS, V23, P4087, DOI 10.1016/S0142-9612(02)00146-1
NR 185
TC 107
Z9 108
U1 4
U2 62
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3368
EI 1937-3376
J9 TISSUE ENG PART B-RE
JI Tissue Eng. Part B-Rev.
PD DEC
PY 2008
VL 14
IS 4
BP 341
EP 366
DI 10.1089/ten.teb.2008.0304
PG 26
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 382TI
UT WOS:000261627900002
PM 18803499
OA Green Accepted, Green Published
DA 2018-10-19
ER

PT J
AU Zawaneh, PN
   Putnam, D
AF Zawaneh, Peter N.
   Putnam, David
TI Materials in Surgery: A Review of Biomaterials in Postsurgical Tissue
   Adhesion and Seroma Prevention
SO TISSUE ENGINEERING PART B-REVIEWS
LA English
DT Review
ID OXIDIZED-REGENERATED CELLULOSE; PROSPECTIVE RANDOMIZED-TRIAL; TEX
   SURGICAL MEMBRANE; UTERINE HORN MODEL; MODIFIED RADICAL-MASTECTOMY;
   BREAST-CANCER SURGERY; POSTOPERATIVE ABDOMINAL ADHESIONS; LINKED
   HYALURONIC-ACID; LATISSIMUS-DORSI FLAP; AXILLARY NODE DISSECTION
AB Postoperative tissue adhesion is a complex inflammatory disorder in which tissues that normally remain separated in the body grow into each other. Seroma is a common postoperative complication that arises when serous fluid collects in the space generated following surgeries that require extensive dissection and that create large empty spaces. Postsurgical tissue adhesion and seroma formation are two serious surgical complications that have received more attention recently from the biomaterials community. This paper provides a review of the pathogenesis and treatment of these surgical complications, with a thorough overview of biomaterial-based treatment and prevention methods.
C1 [Putnam, David] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA.
   [Zawaneh, Peter N.; Putnam, David] Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA.
RP Putnam, D (reprint author), Cornell Univ, Dept Biomed Engn, 270 Olin Hall, Ithaca, NY 14853 USA.
EM dap43@cornell.edu
OI Putnam, David/0000-0002-0794-4915
FU Coulter Foundation
FX The authors would like to acknowledge the Coulter Foundation for
   funding. We would also like to acknowledge Careless and Henry 195 for
   allowing us to publish Table 3.
CR Ackroyd R, 1997, BREAST, V6, P271, DOI 10.1016/S0960-9776(97)90003-5
   Acunzo G, 2003, HUM REPROD, V18, P1918, DOI 10.1093/humrep/deg368
   Adwani A, 2006, INT J CLIN PRACT, V60, P562, DOI 10.1111/j.1368-5031.2005.00689.x
   Agrawal A, 2006, ANZ J SURG, V76, P1088, DOI 10.1111/j.1445-2197.2006.03949.x
   AITKEN DR, 1983, SURG CLIN N AM, V63, P1331
   AITKEN DR, 1984, SURG GYNECOL OBSTET, V158, P327
   Akhtar S, 2005, PLAST RECONSTR SURG, V116, P347, DOI 10.1097/01.PRS.0000173545.11707.ED
   Al-Musawi D, 2001, GYNAECOL ENDOSC, V10, P123, DOI 10.1046/j.1365-2508.2001.00422.x
   Albala DM, 2003, CARDIOVASC SURG, V11, P5, DOI 10.1016/S0967-2109(03)00065-6
   Allison DD, 2006, TISSUE ENG, V12, P2131, DOI 10.1089/ten.2006.12.2131
   Almond A, 2007, CELL MOL LIFE SCI, V64, P1591, DOI 10.1007/s00018-007-7032-z
   ALVANDY LJ, 1991, AUST NZ J SURG, V9, P670
   Andrades P, 2007, AESTHET PLAST SURG, V31, P514, DOI 10.1007/s00266-007-0078-3
   ARRAJAB A, 1995, EUR J SURG, V161, P341
   ARRAJAB A, 1991, J SURG RES, V50, P212, DOI 10.1016/0022-4804(91)90180-T
   Avital S, 2005, DIS COLON RECTUM, V48, P153, DOI 10.1007/s10350-004-0748-z
   AZZIZ R, 1993, SURG GYNECOL OBSTET, V177, P135
   Bae J, 2005, ANN SURG, V241, P534, DOI 10.1097/01.sla.0000154281.79639.89
   Banerjee D, 2001, ANN ROY COLL SURG, V83, P268
   BAROUDI R, 1988, AESTHETIC SURG J, V18, P440
   Barwell J, 1997, ANN ROY COLL SURG, V79, P435
   Beck DE, 1997, EUR J SURG, V163, P49
   Beck DE, 2003, DIS COLON RECTUM, V46, P1310, DOI 10.1097/01.DCR.0000089117.62296.E4
   Becker JM, 1996, J AM COLL SURGEONS, V183, P297
   Bennett SL, 2003, J CARDIAC SURG, V18, P494, DOI 10.1046/j.0886-0440.2003.00303.x
   Berger A, 2001, BREAST CANCER RES TR, V67, P9, DOI 10.1023/A:1010671209279
   BEST CL, 1991, OBSTET GYNECOL, V78, P858
   BEST CL, 1992, FERTIL STERIL, V58, P817
   Binda MM, 2006, FERTIL STERIL, V86, P166, DOI 10.1016/j.fertnstert.2005.11.079
   Boland GM, 2006, J SURG RES, V132, P3, DOI 10.1016/j.jss.2005.12.002
   Bold EL, 1996, AM J OTOLARYNG, V17, P27, DOI 10.1016/S0196-0709(96)90039-3
   Bonnema J, 1999, EUR J SURG, V165, P9, DOI 10.1080/110241599750007441
   Bonnema J, 1997, AM J SURG, V173, P76, DOI 10.1016/S0002-9610(96)00416-3
   BONNEMA J, 1994, BRIT J SURG, V81, P1693, DOI 10.1002/bjs.1800811144
   BOURKE JB, 1976, BRIT J SURG, V63, P67, DOI 10.1002/bjs.1800630115
   BOYERS SP, 1990, PROG CLIN BIOL RES, V358, P93
   BOYERS SP, 1988, FERTIL STERIL, V49, P1066
   Bristow RE, 2007, GYNECOL ONCOL, V104, P739, DOI 10.1016/j.ygyno.2006.09.029
   Brown CB, 2007, FERTIL STERIL, V88, P1413, DOI 10.1016/j.fertnstert.2006.12.084
   Browse DJ, 1996, EUR J SURG ONCOL, V22, P569, DOI 10.1016/S0748-7983(96)92164-2
   Brunelli G, 2005, J ORTHOP RES, V23, P1377, DOI 10.1016/j.orthres.2005.05.001
   BRYANT M, 1987, BRIT J SURG, V74, P1187, DOI 10.1002/bjs.1800741239
   Buckenmaier CC, 1999, AM SURGEON, V65, P274
   BUDD DC, 1978, AM J SURG, V135, P218, DOI 10.1016/0002-9610(78)90103-4
   Burak WE, 1997, J SURG ONCOL, V64, P27, DOI 10.1002/(SICI)1096-9098(199701)64:1<27::AID-JSO6>3.3.CO;2-9
   Burkhard MJ, 1996, VET CLIN PATH, V25, P114, DOI 10.1111/j.1939-165X.1996.tb00978.x
   Burns JW, 1997, EUR J SURG, V163, P40
   CANIS M, 1992, FERTIL STERIL, V58, P617
   Carcoforo P, 2003, J AM COLL SURGEONS, V196, P365, DOI 10.1016/S1072-7515(02)01757-X
   Carless PA, 2006, BRIT J SURG, V93, P810, DOI 10.1002/bjs.5432
   Cashman J, 2004, INFLAMM RES, V53, P355, DOI 10.1007/s00011-004-1272-2
   Cheong YC, 2001, HUM REPROD UPDATE, V7, P556, DOI 10.1093/humupd/7.6.556
   CHILSON TR, 1992, AM SURGEON, V58, P750
   CHMIELEWSKI GW, 1992, AM SURGEON, V58, P590
   Chung TL, 2006, BREAST J, V12, P442, DOI 10.1111/j.1075-122X.2006.00300.x
   Coveney E C, 1993, Eur J Surg Oncol, V19, P143
   DAWSON I, 1989, BRIT J SURG, V76, P311, DOI 10.1002/bjs.1800760329
   De Iaco PA, 2001, SURGERY, V130, P60, DOI 10.1067/msy.2001.115102
   De Iaco PA, 1998, FERTIL STERIL, V69, P318
   Del Rosso G, 2000, NEPHROL DIAL TRANSPL, V15, P927
   DEVIRGILIO C, 1990, ARCH SURG-CHICAGO, V125, P1378
   DIAMOND M, 1996, J GYNECOL SURG, V7, P1
   DIAMOND M, 1984, INFERTILITY, V39, P7
   DIAMOND M P, 1987, Microsurgery, V8, P197, DOI 10.1002/micr.1920080406
   DIAMOND MP, 1991, FERTIL STERIL, V55, P700
   DIAMOND MP, 1991, FERTIL STERIL, V55, P389
   Diamond MP, 1998, FERTIL STERIL, V69, P1067, DOI 10.1016/S0015-0282(98)00057-0
   Diamond MP, 1996, FERTIL STERIL, V66, P904, DOI 10.1016/S0015-0282(16)58716-0
   DIAMOND MP, 1988, INT J FERTIL, V33, P278
   DIAMOND MP, 1988, INT J FERTIL, V33, P372
   DIAMOND MP, 1984, FERTIL STERIL, V42, P717
   DINEEN P, 1976, SURG GYNECOL OBSTET, V142, P481
   Dinsmore RC, 2000, AM SURGEON, V66, P982
   diZerega GS, 2007, FERTIL STERIL, V87, P485, DOI 10.1016/j.fertnstert.2006.07.1505
   Dizerega GS, 2007, J BIOMED MATER RES B, V81B, P239, DOI 10.1002/jbm.b.30659
   diZerega GS, 2002, HUM REPROD, V17, P1031, DOI 10.1093/humrep/17.4.1031
   DIZEREGA GS, 1994, FERTIL STERIL, V61, P219
   DLUGI AM, 1984, SEMIN REPROD ENDOCR, V2, P125, DOI 10.1055/s-2007-1023838
   Dunn R, 2001, FERTIL STERIL, V75, P411, DOI 10.1016/S0015-0282(00)01677-0
   Elbert DL, 1998, J BIOMED MATER RES, V42, P55, DOI 10.1002/(SICI)1097-4636(199810)42:1<55::AID-JBM8>3.0.CO;2-N
   ELLIS H, 1965, BRIT J SURG, V52, P471, DOI 10.1002/bjs.1800520616
   ELLIS H, 1990, SURG GYNECOL OBSTET, V171, P521
   Ellis H, 1999, LANCET, V353, P1476, DOI 10.1016/S0140-6736(98)09337-4
   Eroglu E, 1996, EUR J SURG ONCOL, V22, P137, DOI 10.1016/S0748-7983(96)90567-3
   FABRI PJ, 1983, SURGERY, V94, P336
   Fazio VW, 2006, DIS COLON RECTUM, V49, P1, DOI 10.1007/s10350-005-0268-5
   Ferland R, 2001, HUM REPROD, V16, P2718, DOI 10.1093/humrep/16.12.2718
   FILMAR S, 1989, AM J OBSTET GYNECOL, V160, P1062, DOI 10.1016/0002-9378(89)90161-0
   FILMAR S, 1989, AM J OBSTET GYNECOL, V160, P1068, DOI 10.1016/0002-9378(89)90162-2
   FLEW TJ, 1979, BRIT J SURG, V66, P302, DOI 10.1002/bjs.1800660503
   FOWLER JM, 1991, GYNECOL ONCOL, V43, P141, DOI 10.1016/0090-8258(91)90060-I
   FRANKLIN R, 1995, FERTIL STERIL, V63, P491
   Galatius H, 2003, BREAST, V12, P338, DOI 10.1016/S0960-9776(03)00110-3
   GAUWERKY JFH, 1986, BIOL RES PREG PERIN, V7, P93
   Gilly FN, 1998, EUR SURG RES, V30, P439, DOI 10.1159/000008611
   GOLDBERG JM, 1987, OBSTET GYNECOL, V70, P846
   Gomel V, 1996, J REPROD MED, V41, P35
   Gonzalez Ernest A, 2003, Breast J, V9, P385, DOI 10.1046/j.1524-4741.2003.09504.x
   Guida M, 2004, HUM REPROD, V19, P1461, DOI 10.1093/humrep/deh238
   Gupta R, 2001, EUR J SURG ONCOL, V27, P26, DOI 10.1053/ejso.2000.1054
   GURGAN T, 1991, FERTIL STERIL, V56, P1176
   HANEY AF, 1995, FERTIL STERIL, V63, P1021, DOI 10.1016/S0015-0282(16)57541-4
   HANEY AF, 1992, FERTIL STERIL, V57, P202
   HANEY AF, 1993, FERTIL STERIL, V60, P550
   HARADA RN, 1992, SURG GYNECOL OBSTET, V175, P450
   HARRIS JM, 1997, AM CHEM SOC S SERIES
   Hashemi Esmat, 2004, World J Surg Oncol, V2, P44, DOI 10.1186/1477-7819-2-44
   HAYES JA, 1984, AUST NZ J SURG, V54, P25, DOI 10.1111/j.1445-2197.1984.tb06680.x
   HILLWEST JL, 1994, FERTIL STERIL, V62, P630
   HILLWEST JL, 1994, OBSTET GYNECOL, V83, P59
   HIRAIZUMI Y, 1995, SPINE, V20, P2272, DOI 10.1097/00007632-199511000-00002
   HOLTZ G, 1982, FERTIL STERIL, V37, P494
   *INT TC7 ADH BARR, 1989, FERTIL STERIL, V51, P933
   INWANG R, 1991, ANN ROY COLL SURG, V73, P326
   Ito T, 2007, BIOMATERIALS, V28, P3418, DOI 10.1016/j.biomaterials.2007.04.017
   Ito T, 2007, BIOMATERIALS, V28, P1778, DOI 10.1016/j.biomaterials.2006.12.012
   Ito T, 2007, BIOMATERIALS, V28, P975, DOI 10.1016/j.biomaterials.2006.10.021
   Jackson JK, 2002, PHARM RES-DORDR, V19, P411, DOI 10.1023/A:1015175108183
   Jain PK, 2004, BRIT J SURG, V91, P54, DOI 10.1002/bjs.4435
   JANSEN RPS, 1985, AM J OBSTET GYNECOL, V153, P363, DOI 10.1016/0002-9378(85)90072-9
   JEFFREY SS, 1995, ARCH SURG-CHICAGO, V130, P909
   Johns DA, 2003, J AM ASSOC GYN LAP, V10, P334, DOI 10.1016/S1074-3804(05)60257-5
   Johns DB, 1997, FERTIL STERIL, V68, P37, DOI 10.1016/S0015-0282(97)81472-0
   Johnson L, 2005, AM J SURG, V189, P319, DOI 10.1016/j.amjsurg.2005.01.004
   Keogh GW, 1998, BREAST, V7, P39, DOI 10.1016/S0960-9776(98)90050-9
   Kerin MJ, 1996, EUR J SURG ONCOL, V22, P571, DOI 10.1016/S0748-7983(96)92190-3
   KEYES EL, 1953, AMA ARCH SURG, V66, P446, DOI 10.1001/archsurg.1953.01260030461012
   Komatsu K, 2007, THORAC CARDIOV SURG, V55, P385, DOI 10.1055/s-2007-965174
   Kopelman D, 1999, EUR J SURG, V165, P117
   KRINSKY AH, 1984, FERTIL STERIL, V41, P647
   Kudo FA, 2004, SURG TODAY, V34, P648, DOI 10.1007/s00595-004-2792-7
   Kulber DA, 1997, PLAST RECONSTR SURG, V99, P842, DOI 10.1097/00006534-199703000-00034
   Kumar S, 1995, J R Coll Surg Edinb, V40, P292
   Kuroi Katsumasa, 2005, Breast Cancer, V12, P288, DOI 10.2325/jbcs.12.288
   Lang RA, 2007, FERTIL STERIL, V88, P1180, DOI 10.1016/j.fertnstert.2007.01.108
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Langer S, 2003, AM SURGEON, V69, P77
   LARSEN BB, 1955, JAMA-J AM MED ASSOC, V159, P24, DOI 10.1001/jama.1955.02960180026006
   Larsson B, 1996, J REPROD MED, V41, P27
   Laverson S, 1999, PLAST RECONSTR SURG, V104, P1212, DOI 10.1097/00006534-199909040-00082
   LEACH RE, 1990, AM J OBSTET GYNECOL, V162, P1317, DOI 10.1016/0002-9378(90)90044-8
   Lee JH, 2005, J APPL POLYM SCI, V96, P1138, DOI 10.1002/app.21558
   LINDSEY WH, 1995, LARYNGOSCOPE, V105, P241, DOI 10.1288/00005537-199503000-00003
   LINDSEY WH, 1990, ARCH SURG-CHICAGO, V125, P305
   LINKSY CB, 1988, INFERTILITY, V11, P273
   LINSKY CB, 1987, J REPROD MED, V32, P17
   Liu CD, 1997, AM SURGEON, V63, P868
   Liu YC, 2007, FERTIL STERIL, V87, P940, DOI 10.1016/j.fertnstert.2006.07.1532
   LOTZE MT, 1981, ANN SURG, V193, P288, DOI 10.1097/00000658-198103000-00007
   Lumachi F, 2004, EJSO, V30, P526, DOI 10.1016/j.ejso.2004.03.003
   Lumachi F, 2004, AM SURGEON, V70, P80
   Lundorff P, 2005, HUM REPROD, V20, P514, DOI 10.1093/humrep/deh651
   Lundorff P, 2001, HUM REPROD, V16, P1982, DOI 10.1093/humrep/16.9.1982
   Mais V, 1995, HUM REPROD, V10, P3133, DOI 10.1093/oxfordjournals.humrep.a135873
   Mais V, 2006, HUM REPROD, V21, P1248, DOI 10.1093/humrep/dei488
   MAIS V, 1995, OBSTET GYNECOL, V86, P512, DOI 10.1016/S0029-7844(95)80007-7
   MARCH CM, 1992, FERTIL STERIL, V57, P921
   MARIANNE D, 2005, SOUTH MED J, V98, P1039
   Matsuda S, 2002, BIOMATERIALS, V23, P2901, DOI 10.1016/S0142-9612(01)00418-5
   MCCARTHY PM, 1986, SURG GYNECOL OBSTET, V162, P418
   McCaul JA, 2000, BREAST, V9, P144, DOI 10.1054/brst.1999.0126
   MCDONALD MN, 1988, J REPROD MED, V33, P436
   McLeod R, 2006, DIS COLON RECTUM, V49, P1234, DOI 10.1007/s10350-006-0621-3
   Menon NG, 2003, ANN PLAS SURG, V50, P639, DOI 10.1097/01.SAP.0000054182.47311.17
   Mensitieri M, 1996, J MATER SCI-MATER M, V7, P695, DOI 10.1007/BF00123409
   Menzies D, 2006, ANN ROY COLL SURG, V88, P375, DOI 10.1308/003588406X114730
   Mettler L, 2004, FERTIL STERIL, V82, P398, DOI 10.1016/j.fertnstert.2003.12.046
   Mohri Y, 2005, AM SURGEON, V71, P861
   MOLL HD, 1991, AM J VET RES, V52, P88
   MONTZ FJ, 1992, GYNECOL ONCOL, V45, P290, DOI 10.1016/0090-8258(92)90306-4
   Moore M, 2001, J AM COLL SURGEONS, V192, P591, DOI 10.1016/S1072-7515(01)00827-4
   Moore MM, 1997, AM SURGEON, V63, P97
   MORRIS AM, 1973, BRIT J SURG, V60, P357, DOI 10.1002/bjs.1800600509
   MOSS JP, 1981, SURG GYNECOL OBSTET, V152, P517
   Muller SA, 2005, EUR J OBSTET GYN R B, V120, P222, DOI 10.1016/j.ejorgb.2004.09.011
   Muller SA, 2003, ARCH SURG-CHICAGO, V138, P286, DOI 10.1001/archsurg.138.3.286
   Muller SA, 2002, FERTIL STERIL, V77, P1269, DOI 10.1016/S0015-0282(02)03094-7
   Murphy DJ, 2002, AM J VET RES, V63, P1448, DOI 10.2460/ajvr.2002.63.1448
   Nehez L, 2006, SCAND J GASTROENTERO, V41, P1110, DOI 10.1080/00365520600554550
   NICHTER LS, 1983, ANN PLAS SURG, V11, P233, DOI 10.1097/00000637-198309000-00010
   Nur I, 2005, EUR SURG RES, V37, P159, DOI 10.1159/000085963
   O'Hea BJ, 1999, AM J SURG, V177, P450, DOI 10.1016/S0002-9610(99)00089-6
   ODWYER PJ, 1991, SURG GYNECOL OBSTET, V172, P55
   OSTEEN RT, 1994, CANCER, V73, P1994, DOI 10.1002/1097-0142(19940401)73:7<1994::AID-CNCR2820730735>3.0.CO;2-O
   PAGIDAS K, 1992, FERTIL STERIL, V57, P199
   PARIKH HK, 1992, J SURG ONCOL, V51, P266, DOI 10.1002/jso.2930510413
   Peacock KE, 2006, FERTIL STERIL, V85, P1261, DOI 10.1016/j.fertnstert.2005.07.1337
   Pellicano M, 2003, FERTIL STERIL, V80, P441, DOI 10.1016/S0015-0282(03)00597-1
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   PETREK JA, 1992, SURG GYNECOL OBSTET, V175, P405
   PETREK JA, 1990, ARCH SURG-CHICAGO, V125, P378
   Pogson CJ, 2003, EUR J SURG ONCOL, V29, P711, DOI 10.1016/S0748-7983(03)00096-9
   POLISHUK WZ, 1971, J OBSTET GYN BR COMM, V78, P724
   Porter KA, 1998, AM J SURG, V176, P8, DOI 10.1016/S0002-9610(98)00093-2
   Putnam D, 2006, NAT MATER, V5, P439, DOI 10.1038/nmat1645
   Ray NF, 1998, J AM COLL SURGEONS, V186, P1, DOI 10.1016/S1072-7515(97)00127-0
   Reichel W, 2001, PERITON DIALYSIS INT, V21, P414
   Reid R L, 1993, Prog Clin Biol Res, V381, P261
   Reijnen MMPJ, 2003, BRIT J SURG, V90, P533, DOI 10.1002/bjs.4141
   Rendu F, 2001, PLATELETS, V12, P261, DOI 10.1080/09537100120068170
   Rice DC, 2000, J SURG ONCOL, V73, P224, DOI 10.1002/(SICI)1096-9098(200004)73:4<224::AID-JSO7>3.0.CO;2-0
   Ridings P, 1998, ANN ROY COLL SURG, V80, P61
   Rodgers KE, 1997, FERTIL STERIL, V67, P553, DOI 10.1016/S0015-0282(97)80085-4
   Rodgers KE, 2000, FERTIL STERIL, V73, P831, DOI 10.1016/S0015-0282(99)00642-1
   RODIER JF, 1987, INT SURG, V72, P166
   Roses DF, 1999, ANN SURG, V230, P194, DOI 10.1097/00000658-199908000-00009
   RYAN CK, 1995, AM J SURG, V169, P154, DOI 10.1016/S0002-9610(99)80125-1
   Sanders RP, 1996, J SURG RES, V61, P65, DOI 10.1006/jsre.1996.0082
   Saravelos HG, 1996, J REPROD MED, V41, P42
   SAWHNEY AS, 1994, J BIOMED MATER RES, V28, P831, DOI 10.1002/jbm.820280710
   SAY CC, 1974, SURG GYNECOL OBSTET, V138, P370
   Schafer M, 1998, DIGEST SURG, V15, P148, DOI 10.1159/000018609
   Schuijtvlot M, 2002, BREAST, V11, P94, DOI 10.1054/brst.2001.0366
   Schultz I, 1997, ANN SURG ONCOL, V4, P293, DOI 10.1007/BF02303577
   Schwabegger A, 1997, ANN PLAS SURG, V38, P594, DOI 10.1097/00000637-199706000-00005
   SCHWARTZ LB, 1991, SEMIN REPROD ENDOCR, V9, P89, DOI 10.1055/s-2007-1019398
   SEKIBA K, 1992, OBSTET GYNECOL, V79, P518
   Shamley DR, 2005, BREAST CANCER RES TR, V90, P263, DOI 10.1007/s10549-004-4727-9
   SHEPPARD BB, 1993, AM SURGEON, V59, P786
   Silverman RP, 1999, PLAST RECONSTR SURG, V103, P531, DOI 10.1097/00006534-199902000-00025
   SITZMANN JV, 1983, SURGERY, V93, P345
   SOMERS RG, 1992, ANN SURG, V215, P146, DOI 10.1097/00000658-199202000-00009
   STEINLEITER A, 1993, PROG CLIN BIOL RES, V381, P325
   STEINLEITNER A, 1991, OBSTET GYNECOL, V77, P48
   *SURG MEMBR STUD G, 1991, FERTIL STERIL, V57, P921
   Talbot ML, 2002, ANZ J SURG, V72, P488, DOI 10.1046/j.1445-2197.2002.02456.x
   Tang CL, 2006, ANN SURG, V243, P449, DOI 10.1097/01.sla.0000207837.71831.a2
   TEJLER G, 1985, BRIT J SURG, V72, P542, DOI 10.1002/bjs.1800720714
   Tekin E, 2001, EUR SURG RES, V33, P245, DOI 10.1159/000049713
   TERRELL GS, 1992, SURG GYNECOL OBSTET, V175, P437
   Thornton MH, 1998, HUM REPROD, V13, P1480, DOI 10.1093/humrep/13.6.1480
   Tingstedt B, 2007, EUR SURG RES, V39, P259, DOI 10.1159/000102591
   Titley OG, 1997, BRIT J PLAST SURG, V50, P106, DOI 10.1016/S0007-1226(97)91321-7
   Tomita K, 2007, ANN PLAS SURG, V59, P149, DOI 10.1097/SAP.0b013e31802c54ef
   Tsuji S, 2005, EUR J OBSTET GYN R B, V123, P244, DOI 10.1016/j.ejogrb.2005.04.012
   TULANDI T, 1994, FERTIL STERIL, V61, P548
   Uchida K, 2005, SURG TODAY, V35, P1054, DOI 10.1007/s00595-005-3085-5
   UDEN P, 1993, EUR J SURG, V159, P263
   ULIBARRI JI, 1990, LANCET, V336, P258, DOI 10.1016/0140-6736(90)91793-A
   Ulusoy Ali Naki, 2003, Breast J, V9, P393, DOI 10.1046/j.1524-4741.2003.09506.x
   Unalp HR, 2007, BREAST J, V13, P588, DOI 10.1111/j.1524-4741.2007.00509.x
   URMAN B, 1991, FERTIL STERIL, V56, P568
   VANHEURN LWE, 1995, BRIT J SURG, V82, P931, DOI 10.1002/bjs.1800820725
   VAXMAN F, 1995, EUR SURG RES, V27, P346, DOI 10.1159/000129419
   VEMER HM, 1982, BRIT J OBSTET GYNAEC, V89, P473, DOI 10.1111/j.1471-0528.1982.tb03639.x
   Verco S, 2002, FERTIL STERIL, V78, pS114, DOI 10.1016/S0015-0282(02)03681-6
   Verco SJS, 2000, HUM REPROD, V15, P1764, DOI 10.1093/humrep/15.8.1764
   Wang JY, 1996, ANN PLAS SURG, V37, P400, DOI 10.1097/00000637-199610000-00009
   WATTBOOLSEN S, 1989, DAN MED BULL, V36, P487
   WATTBOOLSEN S, 1988, ACTA ONCOL, V27, P663, DOI 10.3109/02841868809091765
   Wedderburn A, 2000, EUR J SURG ONCOL, V26, P142, DOI 10.1053/ejso.1999.0757
   Weinrach JC, 2004, ANN PLAS SURG, V53, P12, DOI 10.1097/01.sap.0000112286.30212.12
   Weis C, 2004, J BIOMED MATER RES B, V70B, P191, DOI 10.1002/jbm.b.30007
   WEST JL, 1995, BIOMATERIALS, V16, P1153, DOI 10.1016/0142-9612(95)93579-3
   West JL, 1996, J REPROD MED, V41, P149
   Wiener M, 2007, J PLAST RECONSTR AES, V60, P573, DOI 10.1016/j.bjps.2006.11.021
   Wilson MS, 2002, COLORECTAL DIS, V4, P355
   Wiseman DM, 1998, FERTIL STERIL, V70, P702, DOI 10.1016/S0015-0282(98)00270-2
   Wiseman DM, 1999, J INVEST SURG, V12, P141
   WISEMAN DM, 1992, J REPROD MED, V37, P766
   Wiseman DM, 1999, J REPROD MED, V44, P325
   Woodworth PA, 2000, AM SURGEON, V66, P444
   WURSTER SH, 1995, J SURG RES, V59, P97, DOI 10.1006/jsre.1995.1138
   WYMAN A, 1993, BRIT J SURG, V80, P871, DOI 10.1002/bjs.1800800722
   YAACOBI Y, 1993, J SURG RES, V55, P422, DOI 10.1006/jsre.1993.1163
   Yea Y, 2007, J CONTROL RELEASE, V120, P178, DOI 10.1016/j.jconrel.2007.04.016
   Yeo Y, 2007, BIOMATERIALS, V28, P3704, DOI 10.1016/j.biomaterials.2007.04.033
   Yeo Y, 2007, ANN SURG, V245, P819, DOI 10.1097/01.sla.0000251519.49405.55
   Yeo Y, 2006, BIOMATERIALS, V27, P4698, DOI 10.1016/j.biomaterials.2006.04.043
   Young P, 2005, FERTIL STERIL, V84, P1450, DOI 10.1016/j.fertnstert.2005.04.055
   Zeng QQ, 2007, WORLD J SURG, V31, P2125, DOI 10.1007/s00268-007-9242-9
NR 271
TC 17
Z9 17
U1 1
U2 17
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3368
EI 1937-3376
J9 TISSUE ENG PART B-RE
JI Tissue Eng. Part B-Rev.
PD DEC
PY 2008
VL 14
IS 4
BP 377
EP 391
DI 10.1089/ten.teb.2008.0226
PG 15
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 382TI
UT WOS:000261627900004
PM 18816187
DA 2018-10-19
ER

PT J
AU Jones, KS
AF Jones, Kim S.
TI Assays on the Influence of Biomaterials on Allogeneic Rejection in
   Tissue Engineering
SO TISSUE ENGINEERING PART B-REVIEWS
LA English
DT Review
ID KAPPA-B ACTIVATION; DELAYED-TYPE HYPERSENSITIVITY; MESENCHYMAL
   STEM-CELLS; REGULATORY T-CELLS; RENAL-TRANSPLANT RECIPIENTS;
   FOREIGN-BODY RESPONSE; ANTI-HLA ANTIBODIES; TOLL-LIKE RECEPTORS;
   IN-VITRO CULTURE; DENDRITIC CELLS
AB In tissue engineering, innate responses to biomaterial scaffolds will affect rejection of allogeneic cells. Biomaterials directly influence innate and adaptive immune cell adhesion, reactive oxygen intermediate production, cytokine secretion, nuclear factor-kappa B nuclear translocation, gene expression, and cell surface markers, all of which are likely to affect allogeneic rejection responses. A major goal in tissue engineering is to induce transplant tolerance, potentially by manipulating the biomaterial component. This review describes methods of measuring responses of macrophages, dendritic cells, and T cells stimulated in vitro and in vivo and addresses key factors in assay development. Such tests include mixed leukocyte reactions, enzyme-linked immunosorbent spot assays, trans-vivo delayed-type hypersensitivity assays, and measurement of dendritic cell subsets and anti-donor antibodies; we propose extending these studies to tissue engineering.
C1 McMaster Univ, Dept Chem Engn, Hamilton, ON L8S 4L7, Canada.
RP Jones, KS (reprint author), McMaster Univ, Dept Chem Engn, 1280 Main St W, Hamilton, ON L8S 4L7, Canada.
EM kjones@mcmaster.ca
CR Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593
   Afzali B, 2007, CLIN EXP IMMUNOL, V148, P32, DOI 10.1111/j.1365-2249.2007.03356.x
   Ainslie KM, 2007, LANGMUIR, V23, P747, DOI 10.1021/la060948s
   Anderson JM, 2007, BIOMATERIALS, V28, P5114, DOI [10.1016/j.biomaterials.2007.07.010, 10.1016/j.biornaterials.2007.07.010]
   ANDERSON JM, 1993, CARDIOVASC PATHOL S, V2, P33
   Ansaloni L, 2007, J INVEST SURG, V20, P237, DOI 10.1080/08941930701481296
   ARRAJAB A, 1994, CELL TRANSPLANT, V3, P493, DOI 10.1177/096368979400300606
   Arredouani M, 2004, J EXP MED, V200, P267, DOI 10.1084/jem.20040731
   Arredouani MS, 2006, AM J RESP CELL MOL, V35, P474, DOI 10.1165/rcmb.0128OC
   Badylak SF, 2001, EXP HEMATOL, V29, P1310, DOI 10.1016/S0301-472X(01)00729-9
   Banerjee A, 2007, IMMUNOL CELL BIOL, V85, P420, DOI 10.1038/sj.icb.7100098
   Bellingham CM, 2003, BIOPOLYMERS, V70, P445, DOI 10.1002/bip.10512
   Bellini A, 2007, LAB INVEST, V87, P858, DOI 10.1038/labinvest.3700654
   Bennewitz NL, 2005, BIOMATERIALS, V26, P2991, DOI 10.1016/j.biomaterials.2004.08.023
   Bickerstaff AA, 2000, TRANSPLANTATION, V69, P1517, DOI 10.1097/00007890-200004150-00055
   Borges O, 2007, INT J PHARM, V337, P254, DOI 10.1016/j.ijpharm.2007.01.021
   Brodbeck WG, 2005, J BIOMED MATER RES A, V74A, P222, DOI 10.1002/jbm.a.30313
   Burlingham WJ, 2007, AM J TRANSPLANT, V7, P466, DOI 10.1111/j.1600-6143.2006.01627.x
   Butler LM, 2007, THROMB HAEMOSTASIS, V97, P814, DOI 10.1160/TH06-08-0439
   Canton I, 2007, TISSUE ENG, V13, P1013, DOI 10.1089/ten.2006.0357
   Carrodeguas L, 1999, HUM IMMUNOL, V60, P640, DOI 10.1016/S0198-8859(99)00002-6
   Champion JA, 2006, P NATL ACAD SCI USA, V103, P4930, DOI 10.1073/pnas.0600997103
   Champion JA, 2008, PHARM RES-DORDR, V25, P1815, DOI 10.1007/s11095-008-9562-y
   Chockalingam K, 2007, PROTEIN ENG DES SEL, V20, P155, DOI 10.1093/protein/gzm008
   COLIGAN JE, 2001, CURRENT PROTOCOLS IM
   Cornelius RM, 2002, J BIOMED MATER RES, V60, P622, DOI 10.1002/jbm.10117
   Csencsits KL, 2003, AM J TRANSPLANT, V3, P107, DOI 10.1034/j.1600-6143.2003.00036.x
   DeFife KM, 1999, J BIOMED MATER RES, V45, P148, DOI 10.1002/(SICI)1097-4636(199905)45:2<148::AID-JBM10>3.0.CO;2-U
   Derks RA, 2005, CURR OPIN IMMUNOL, V17, P560, DOI 10.1016/j.coi.2005.07.011
   Ding TT, 2007, J MATER SCI-MATER M, V18, P2233, DOI 10.1007/s10856-007-3014-9
   Drukker M, 2008, SEMIN IMMUNOL, V20, P123, DOI 10.1016/j.smim.2007.11.002
   Endres S, 2008, J MATER SCI-MATER M, V19, P1209, DOI 10.1007/s10856-007-3104-8
   Garrigues GE, 2005, BIOMATERIALS, V26, P2933, DOI 10.1016/j.biomaterials.2004.06.034
   Geissler F, 2001, TRANSPLANT P, V33, P1377, DOI 10.1016/S0041-1345(00)02517-3
   Gemmell CH, 1996, J BIOMED MATER RES, V32, P29, DOI 10.1002/(SICI)1097-4636(199609)32:1<29::AID-JBM4>3.0.CO;2-R
   GEMMELL CH, 1995, J LAB CLIN MED, V125, P276
   Giavaresi G, 2006, J BIOMAT SCI-POLYM E, V17, P1405, DOI 10.1163/156856206778937226
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   GOULMY E, 1989, TRANSPLANTATION, V48, P559, DOI 10.1097/00007890-198910000-00004
   Grandjean-Laquerriere A, 2004, BIOMATERIALS, V25, P5921, DOI 10.1016/j.biomaterials.2004.02.003
   Grandjean-Laquerriere A, 2007, BIOMATERIALS, V28, P400, DOI 10.1016/j.biomaterials.2006.09.015
   Guardino AE, 2006, CYTOTHERAPY, V8, P277, DOI 10.1080/14653240600735701
   Hamdy S, 2007, J BIOMED MATER RES A, V81A, P652, DOI 10.1002/jbm.a.31019
   Ho TY, 2007, BIOMATERIALS, V28, P4370, DOI 10.1016/j.biomaterials.2007.07.005
   Holan V, 1996, TRANSPLANTATION, V62, P1050
   Ishido N, 1999, TRANSPLANT P, V31, P2880, DOI 10.1016/S0041-1345(99)00600-4
   Iwamoto M, 2005, FEBS LETT, V579, P4423, DOI 10.1016/j.febslet.2005.07.007
   Jeong HJ, 2006, CLIN EXP ALLERGY, V36, P785, DOI 10.1111/j.1365-2222.2006.02508.x
   Jiang SP, 2006, HUM IMMUNOL, V67, P765, DOI 10.1016/j.humimm.2006.07.013
   Jiang SQ, 2004, CURR OPIN IMMUNOL, V16, P550, DOI 10.1016/j.coi.2004.07.011
   Jones JA, 2004, J BIOMAT SCI-POLYM E, V15, P567, DOI 10.1163/156856204323046843
   Jones KS, 2006, TRANSPLANTATION, V82, P415, DOI 10.1097/01.tp.0000228917.57323.ec
   Kabelitz D, 2007, CURR OPIN IMMUNOL, V19, P39, DOI 10.1016/j.coi.2006.11.007
   Kang CM, 2005, AM J RESP CELL MOL, V33, P290, DOI 10.1165/rcmb.2005-0003OC
   Kao WYJ, 2001, BIOMATERIALS, V22, P2901, DOI 10.1016/S0142-9612(01)00037-0
   Keyser KA, 2007, CELL TRANSPLANT, V16, P555, DOI 10.3727/000000007783464939
   Ko IK, 2007, ANN BIOMED ENG, V35, P101, DOI 10.1007/s10439-006-9204-7
   Kobayashi T, 2003, TRANSPLANTATION, V75, P619, DOI 10.1097/01.TP.0000053749.36365.7E
   Korbutt GS, 2004, DIABETOLOGIA, V47, P1810, DOI 10.1007/s00125-004-1531-3
   KUMAR RK, 1990, IMMUNOL INVEST, V19, P363, DOI 10.3109/08820139009050776
   Lepthien S, 2006, APPL MICROBIOL BIOT, V73, P740, DOI 10.1007/s00253-006-0665-2
   Lewis JB, 2003, J BIOMED MATER RES A, V64A, P217, DOI 10.1002/jbm.a.10352
   Liu GW, 2007, IMMUNOLOGY, V122, P149, DOI 10.1111/j.1365-2567.2007.02651.x
   Longhi MP, 2006, TRENDS IMMUNOL, V27, P102, DOI 10.1016/j.it.2005.12.008
   Lucarelli M, 2004, EUR CYTOKINE NETW, V15, P339
   Luzardo-Alvarez A, 2005, J CONTROL RELEASE, V109, P62, DOI 10.1016/j.jconrel.2005.09.015
   LYNCH I, 2006, SCI STKE, pE14
   MacEwan MR, 2005, J BIOMED MATER RES A, V74A, P285, DOI 10.1002/jbm.a.30316
   Marques AP, 2005, J MATER SCI-MATER M, V16, P1029, DOI 10.1007/s10856-005-4757-9
   Maskarinec SA, 2005, CURR OPIN BIOTECH, V16, P422, DOI 10.1016/j.copbio.2005.06.009
   Matheson LA, 2007, BIOTECHNIQUES, V42, P744, DOI 10.2144/000112460
   Matheson LA, 2006, BIOCHEM CELL BIOL, V84, P763, DOI 10.1139/O06-093
   Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059
   Mazariegos GV, 2005, AM J TRANSPLANT, V5, P314, DOI 10.1111/j.1600-6143.2004.00672.x
   Mazariegos GV, 2003, AM J TRANSPLANT, V3, P689, DOI 10.1034/j.1600-6143.2003.00109.x
   McKenna RM, 2000, TRANSPLANTATION, V69, P319, DOI 10.1097/00007890-200002150-00001
   Mebouta-Nkamgueu E, 2001, J MATER SCI-MATER M, V12, P351, DOI 10.1023/A:1011255406438
   Mollnes TE, 1998, VOX SANG, V74, P303, DOI 10.1111/j.1423-0410.1998.tb05435.x
   Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132
   Niemeyer P, 2007, TISSUE ENG, V13, P111, DOI 10.1089/ten.2006.0114
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   Ochando JC, 2006, NAT IMMUNOL, V7, P652, DOI 10.1038/ni1333
   Osborne JL, 2008, ACTA BIOMATER, V4, P49, DOI 10.1016/j.actbio.2007.07.007
   Otsuka H, 2006, EUR CELLS MATER, V12, P36, DOI 10.22203/eCM.v012a04
   Pleiss J, 2006, APPL MICROBIOL BIOT, V73, P735, DOI 10.1007/s00253-006-0664-3
   Rasmusson I, 2007, J LEUKOCYTE BIOL, V82, P887, DOI 10.1189/jlb.0307140
   Robitaille R, 2005, BIOMATERIALS, V26, P4119, DOI 10.1016/j.biomaterials.2004.10.028
   Rocha PN, 2003, IMMUNOL REV, V196, P51, DOI 10.1046/j.1600-065X.2003.00090.x
   Sabokbar A, 2003, J MATER SCI-MATER M, V14, P731, DOI 10.1023/A:1025088418878
   Schmidt DR, 2007, J BIOMED MATER RES A, V83A, P617, DOI 10.1002/jbm.a.31270
   Sefton MV, 2001, J BIOMED MATER RES, V55, P447, DOI 10.1002/1097-4636(20010615)55:4<447::AID-JBM1036>3.0.CO;2-5
   Stabler CL, 2005, TISSUE ENG, V11, P404, DOI 10.1089/ten.2005.11.404
   Strober S, 2000, TRANSPLANTATION, V69, P1549
   SUCIUFOCA N, 1991, TRANSPLANTATION, V51, P593, DOI 10.1097/00007890-199103000-00011
   THOMAS J, 1977, SURGERY, V81, P125
   VanBuskirk AM, 2000, J CLIN INVEST, V106, P145, DOI 10.1172/JCI9171
   Walsh PT, 2004, J CLIN INVEST, V114, P1398, DOI 10.1172/JCI200423238
   Wu ACK, 2006, BIOMATERIALS, V27, P4715, DOI 10.1016/j.biomaterials.2006.05.010
   Wu GJ, 2007, FOOD CHEM TOXICOL, V45, P250, DOI 10.1016/j.fct.2006.07.025
   Xu QY, 2007, J IMMUNOL, V178, P3983, DOI 10.4049/jimmunol.178.6.3983
   Yamamoto Ken-ichiro, 2005, J Artif Organs, V8, P257, DOI 10.1007/s10047-005-0315-y
   Yamamoto Y, 2007, BIOSCI BIOTECH BIOCH, V71, P238, DOI 10.1271/bbb.60416
   YANG D, 2008, J BIOMED MAT A  0603
   Yates SF, 2007, J IMMUNOL, V179, P967, DOI 10.4049/jimmunol.179.2.967
   Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058
   Yoon HJ, 2007, BIOCHEM BIOPH RES CO, V358, P954, DOI 10.1016/j.bbrc.2007.05.042
   Yoshida M, 2004, J BIOMED MATER RES A, V71A, P45, DOI 10.1002/jbm.a.30131
   Yoshida M, 2007, J BIOMED MATER RES A, V80A, P7, DOI 10.1002/jbm.a.30832
   Yoshida M, 2006, J BIOMED MATER RES A, V79A, P393, DOI 10.1002/jbm.a.30798
   Yoshida M, 2006, J BIOMAT SCI-POLYM E, V17, P893, DOI 10.1163/156856206777996844
   Zhai Y, 1999, CRIT REV IMMUNOL, V19, P155
NR 111
TC 9
Z9 9
U1 0
U2 18
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3368
J9 TISSUE ENG PART B-RE
JI Tissue Eng. Part B-Rev.
PD DEC
PY 2008
VL 14
IS 4
BP 407
EP 417
DI 10.1089/ten.teb.2008.0264
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 382TI
UT WOS:000261627900006
PM 18826337
DA 2018-10-19
ER

PT J
AU Chen, J
   Zeng, RC
   Huang, WJ
   Zheng, ZQ
   Wang, ZL
   Wang, J
AF Chen Jun
   Zeng Rong-chang
   Huang Wei-jiu
   Zheng Zi-qing
   Wang Zhen-lin
   Wang Jun
TI Characterization and wear resistance of macro-arc oxidation coating on
   magnesium alloy AZ91 in simulated body fluids
SO TRANSACTIONS OF NONFERROUS METALS SOCIETY OF CHINA
LA English
DT Article
DE magnesium alloy; macro-arc oxidation; coating; erosion corrosion;
   biomaterial; simulated body fluid
ID CORROSION BEHAVIOR
AB The mechanical characteristics of the macro-arc oxidation (MAO) coating on Mg alloy AZ91 were examined by means of nano scratch tester. The corrosion and erosion corrosion behavior of AZ91 with and without MAO coating were investigated by using potentiodynamic electrochemical technique and micro-abrasion tribometer in simulated body fluids, respectively. The influence of HCO(3)(-) ions on the erosion corrosion was discussed. The results show that the coating and its substrate are in a pronounced bond. The MAO coating increases 1-2 orders of magnitude of the corrosion resistance of AZ91 alloy. HCO(3)(-) ions enhance the corrosion rates of the AZ91 alloys more significantly than the alloys with MAO coating. However, there exists an obvious passivation process of AZ91 without coating in the HCO(3)(-) solutions. Moreover, an MgCO(3) film formed in HCO(3)(-) containing solutions leads to an enhancement in micro-wear resistance. MAO coating deteriorates the erosion corrosion resistance of AZ91 alloy due to the formation of oxidation debris resulted from the broken MAO coating.
C1 [Chen Jun; Zeng Rong-chang; Huang Wei-jiu; Zheng Zi-qing; Wang Zhen-lin; Wang Jun] Chongqing Inst Technol, Sch Mat Sci & Engn, Chongqing 400050, Peoples R China.
RP Zeng, RC (reprint author), Chongqing Inst Technol, Sch Mat Sci & Engn, Chongqing 400050, Peoples R China.
EM rczeng2001@yahoo.com.cn
RI Zeng, Rong-Chang/H-4154-2011
OI Zeng, Rong-Chang/0000-0002-5945-3851
FU National Natural Science Foundation of China [50405005]; New Century
   Excellent Talents in University, China [NCET-05-0777]; Natural Science
   Foundation of Chongqing Science and Technology Commission, China
   [2008BB0063]
FX Project(50405005) supported by the National Natural Science Foundation
   of China; Project(NCET-05-0777) supported by the New Century Excellent
   Talents in University, China; Project(8655, CSTC 2008BB0063) supported
   by the Natural Science Foundation of Chongqing Science and Technology
   Commission, China
CR ABDULLAT YA, 2001, MAT T, V42, P1777
   Gao Jia-cheng, 2004, Chinese Journal of Nonferrous Metals, V14, P1508
   GULBRANDSEN E, 1992, ELECTROCHIM ACTA, V37, P1403, DOI 10.1016/0013-4686(92)87014-Q
   Hara N, 2007, CORROS SCI, V49, P166, DOI 10.1016/j.corsci.2006.05.033
   Huang WJ, 2006, T NONFERR METAL SOC, V16, pS1827
   Li LC, 2004, SURF COAT TECH, V185, P92, DOI 10.1016/j.surfcoat.2004.01.004
   Muller L, 2006, ACTA BIOMATER, V2, P181, DOI 10.1016/j.actbio.2005.11.001
   Song G, 1997, CORROS SCI, V39, P1981, DOI 10.1016/S0010-938X(97)00090-5
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Xin YC, 2007, J MATER RES, V22, P2004, DOI 10.1557/JMR.2007.0233
   Zeng RC, 2007, T NONFERR METAL SOC, V17, pS166
   Zeng RC, 2007, J MATER SCI TECHNOL, V23, P353
   Zhang XP, 2007, J MATER SCI, V42, P8523, DOI 10.1007/s10853-007-1738-z
   Zhao H, 2006, T NONFERR METAL SOC, V16, pS1814
NR 15
TC 24
Z9 24
U1 1
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1003-6326
J9 T NONFERR METAL SOC
JI Trans. Nonferrous Met. Soc. China
PD DEC
PY 2008
VL 18
BP S361
EP S364
DI 10.1016/S1003-6326(10)60232-4
PG 4
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 390HP
UT WOS:000262155200070
DA 2018-10-19
ER

PT J
AU Alfaro, MP
   Pagni, M
   Vincent, A
   Atkinson, J
   Hill, MF
   Cates, J
   Davidson, JM
   Rottman, J
   Lee, E
   Young, PP
AF Alfaro, Maria P.
   Pagni, Matthew
   Vincent, Alicia
   Atkinson, James
   Hill, Michael F.
   Cates, Justin
   Davidson, Jeffrey M.
   Rottman, Jeffrey
   Lee, Ethan
   Young, Pampee P.
TI The Wnt modulator sFRP2 enhances mesenchymal stem cell engraftment,
   granulation tissue formation and myocardial repair
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE regeneration; wound healing
ID SIGNALING PATHWAY; BONE-MARROW; STROMAL CELLS; MRL MOUSE; HEART;
   DIFFERENTIATION; FIBROSIS; MURINE; TARGET; MODEL
AB Cell-based therapies, using multipotent mesenchymal stem cells (MSCs) for organ regeneration, are being pursued for cardiac disease, orthopedic injuries and biomaterial fabrication. The molecular pathways that regulate MSC-mediated regeneration or enhance their therapeutic efficacy are, however, poorly understood. We compared MSCs isolated from MRL/MpJ mice, known to demonstrate enhanced regenerative capacity, to those from C57BL/6 (WT) mice. Compared with WT-MSCs, MRL-MSCs demonstrated increased proliferation, in vivo engraftment, experimental granulation tissue reconstitution, and tissue vascularity in a murine model of repair stimulation. The MRL-MSCs also reduced infarct size and improved function in a murine myocardial infarct model compared with WT-MSCs. Genomic and functional analysis indicated a downregulation of the canonical Writ pathway in MRL-MSCs characterized by significant up-regulation of specific secreted frizzled-related proteins (sFRPs). Specific knockdown of sFRP2 by shRNA in MRL-MSCs decreased their proliferation and their engraftment in and the vascular density of MRL-MSC-generated experimental granulation tissue. These results led us to generate WT-MSCs overexpressing sFRP2 (sFRP2-MSCs) by retroviral transduction. sFRP2-MSCs maintained their ability for multilineage differentiation in vitro and, when implanted in vivo, recapitulated the MRL phenotype. Peri-infarct intramyocardial injection of sFRP2-MSCs resulted in enhanced engraftment, vascular density, reduced infarct size, and increased cardiac function after myocardial injury in mice. These findings implicate sFRP2 as a key molecule for the biogenesis of a superior regenerative phenotype in MSCs.
C1 [Alfaro, Maria P.; Pagni, Matthew; Vincent, Alicia; Atkinson, James; Cates, Justin; Davidson, Jeffrey M.; Young, Pampee P.] Vanderbilt Univ, Dept Pathol, Sch Med, Nashville, TN 37232 USA.
   [Hill, Michael F.; Rottman, Jeffrey; Young, Pampee P.] Vanderbilt Univ, Dept Internal Med, Sch Med, Nashville, TN 37232 USA.
   [Lee, Ethan] Vanderbilt Univ, Dept Cell & Dev Biol, Sch Med, Nashville, TN 37232 USA.
   [Pagni, Matthew; Vincent, Alicia; Atkinson, James; Davidson, Jeffrey M.; Rottman, Jeffrey; Young, Pampee P.] Dept Vet Affairs Med Ctr, Nashville, TN 37232 USA.
RP Young, PP (reprint author), Vanderbilt Univ, Dept Pathol, Sch Med, Nashville, TN 37232 USA.
EM pampee.young@vanderbilt.edu
OI Cates, Justin/0000-0002-7336-5196
FU National Institutes of Health [HL088424, P40RR017447]; Veterans Affairs
   ARCD award; American Heart Association; Vanderbilt Discovery Award;
   National Institute of Diabetes and Digestive and Kidney Diseases [U24
   DK-59637]
FX This work was supported National Institutes of Health Grant HL088424,
   Veterans Affairs ARCD award, American Heart Association and Vanderbilt
   Discovery Award to PPY. All microarray experiments were performed in the
   Vanderbilt Microarray Shared Resource. Some of the materials used were
   provided by the Tulane Center for Gene Therapy through National
   Institutes of Health National Center for Research Resources Grant
   P40RR017447. Echocardiography and MI surgery were performed in the
   Cardiovascular Pathophysiology and Complications Core (CPCC) of the
   Vanderbilt Mouse Metabolic Phenotyping Center (MMPQ which is supported
   by the National Institute of Diabetes and Digestive and Kidney Diseases
   Grant U24 DK-59637.
CR Amado LC, 2005, P NATL ACAD SCI USA, V102, P11474, DOI 10.1073/pnas.0504388102
   BADOO M, 2003, J CELL BIOCHEM, V89, P1235
   Bedelbaeva K, 2004, CLONING STEM CELLS, V6, P352, DOI 10.1089/clo.2004.6.352
   Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090
   Colter DC, 2001, P NATL ACAD SCI USA, V98, P7841, DOI 10.1073/pnas.141221698
   Cooney R, 1997, J TRAUMA, V42, P415, DOI 10.1097/00005373-199703000-00008
   CSELENYI CS, 2008, SCI SIGNALI IN PRESS
   DUFOURCQ P, 2007, AM J PATHOL, V172, P37
   Falanga V, 2007, TISSUE ENG, V13, P1299, DOI 10.1089/ten.2006.0278
   Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200
   Gregory CA, 2003, J BIOL CHEM, V278, P28067, DOI 10.1074/jbc.M300373200
   GREGORY CA, 2005, J BIOL CHEM, V280, P33132
   Heber-Katz E, 2004, PHILOS T ROY SOC B, V359, P785, DOI 10.1098/rstb.2004.1468
   Heber-Katz E, 1999, SEMIN CELL DEV BIOL, V10, P415, DOI 10.1006/scdb.1999.0328
   Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002
   Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870
   Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623
   Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57
   KRUMMEL TM, 1988, J PEDIATR SURG, V23, P647, DOI 10.1016/S0022-3468(88)80638-9
   Lescher B, 1998, DEV DYNAM, V213, P440, DOI 10.1002/(SICI)1097-0177(199812)213:4<440::AID-AJA9>3.0.CO;2-6
   Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578
   Luo Q, 2004, J BIOL CHEM, V279, P55958, DOI 10.1074/jbc.M407810200
   McBrearty BA, 1998, P NATL ACAD SCI USA, V95, P11792, DOI 10.1073/pnas.95.20.11792
   Mirotsou M, 2007, P NATL ACAD SCI USA, V104, P1643, DOI 10.1073/pnas.0610024104
   Otto TC, 2005, CRIT REV BIOCHEM MOL, V40, P229, DOI 10.1080/10409230591008189
   Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637
   Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f
   Rattner A, 1997, P NATL ACAD SCI USA, V94, P2859, DOI 10.1073/pnas.94.7.2859
   Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522
   Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442
   Tropel P, 2004, EXP CELL RES, V295, P395, DOI 10.1016/j.yexcr.2003.12.030
   Van Raay TJ, 2005, NEURON, V46, P23, DOI 10.1016/j.neuron.2005.02.023
   Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9
   Wawrzak D, 2007, BIOCHEM BIOPH RES CO, V357, P1119, DOI 10.1016/j.bbrc.2007.04.069
   Yano F, 2005, BIOCHEM BIOPH RES CO, V333, P1300, DOI 10.1016/j.bbrc.2005.06.041
   Zimmet JM, 2005, BASIC RES CARDIOL, V100, P471, DOI 10.1007/s00395-005-0553-4
NR 36
TC 110
Z9 118
U1 0
U2 7
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD NOV 25
PY 2008
VL 105
IS 47
BP 18366
EP 18371
DI 10.1073/pnas.0803437105
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 380TY
UT WOS:000261489300060
PM 19017790
OA Bronze, Green Published
DA 2018-10-19
ER

PT J
AU Tsuji, H
   Yamamura, Y
   Ono, T
   Saeki, T
   Daimon, H
   Fujie, K
AF Tsuji, Hideto
   Yamamura, Yoshiko
   Ono, Tomoyuki
   Saeki, Takashi
   Daimon, Hiroyuki
   Fujie, Koichi
TI Hydrolytic Degradation and Monomer Recovery of Poly(butylene succinate)
   and Poly(butylene succinate/adipate) in the Melt
SO MACROMOLECULAR REACTION ENGINEERING
LA English
DT Article
DE biodegradable; hydrolysis; hydrolytic degradation; monomer recovery;
   recycling
ID LACTIC-ACID; HYDROTHERMAL CONDITIONS; POLY(L-LACTIC ACID); SUPERCRITICAL
   WATER; PET WASTE; POLY(ETHYLENE-TEREPHTHALATE); DEPOLYMERIZATION;
   POLY(EPSILON-CAPROLACTONE); BIOMATERIAL; COPOLYMERS
AB Aliphatic dicarboxylic acid/aliphatic diol-derived polyesters, poly(butylene succinate) and poly(butylene succinate/adipate), have been hydrolytically degraded in the melt in high-temperature and high-pressure water over a wide temperature range of 180-300 degrees C for periods of up to 30 min. The formation/decomposition of succinic acid (SA), adipic acid (AA), and butane-1,4-diol (BD), plus the molecular weight change of PBS and PBSA were then investigated. SA and AA were recovered at maximum yields of 65-80%, whereas BD was recovered at a maximum yield of only 30%, probably because of its decomposition. The obtained results were compared with those reported for aliphatic hydroxycarboxylic acid-derived polyesters and aromatic dicarboxylic acid/aliphatic diol-derived polyesters.
C1 [Tsuji, Hideto; Yamamura, Yoshiko; Ono, Tomoyuki; Saeki, Takashi; Daimon, Hiroyuki; Fujie, Koichi] Toyohashi Univ Technol, Dept Ecol Engn, Fac Engn, Aichi 4418580, Japan.
   [Fujie, Koichi] Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan.
RP Tsuji, H (reprint author), Toyohashi Univ Technol, Dept Ecol Engn, Fac Engn, Tempaku Cho, Aichi 4418580, Japan.
EM tsuji@eco.tut.ac.jp
RI Tsuji, Hideto/M-3665-2014
OI Tsuji, Hideto/0000-0001-9986-5933; Fujie, Koichi/0000-0002-8540-6469
FU Ministry of Education, Culture, Sports, Science and Technology (Japan)
FX The authors thank Yoshikazu Hosoda and Yashiro Okino at Showa High
   Polymer Co. Ltd., for supplying PBS and PBSA. This research was
   supported by The 21st Century COE Program, "Ecological Engineering for
   Homeostatic Human Activities", of the Ministry of Education, Culture,
   Sports, Science and Technology (Japan).
CR Adschiri T, 1997, KAGAKU KOGAKU RONBUN, V23, P505, DOI 10.1252/kakoronbunshu.23.505
   Ahn BD, 2001, J APPL POLYM SCI, V82, P2808
   ALBERTSSON AC, 2002, ADV POLYM SCI, V157
   Avadanei L, 2002, MATER PLAST, V39, P234
   Awaja F, 2005, EUR POLYM J, V41, P1453, DOI 10.1016/j.eurpolymj.2005.02.005
   CAMPANELLI JR, 1993, J APPL POLYM SCI, V48, P443, DOI 10.1002/app.1993.070480309
   Cho K, 2001, J APPL POLYM SCI, V79, P1025
   DOI Y, 2002, POLYESTERS 1 3 BIOPO, V2
   DOI Y, 1994, BIODEGRADABLE PLASTI
   DOMB AJ, 1997, HDB BIODEGRADABLE PO
   Du J, 2006, POLYM DEGRAD STABIL, V91, P3281, DOI 10.1016/j.polymdegradstab.2006.06.006
   FAISAL M, 2006, WASTE MANAGEMENT ENV, V3, P225
   Faisal M, 2007, ASIAN J CHEM, V19, P1714
   Han SI, 2005, ADV FUNCT MATER, V15, P367, DOI 10.1002/adfm.200400079
   Ikada Y, 2000, MACROMOL RAPID COMM, V21, P117, DOI 10.1002/(SICI)1521-3927(20000201)21:3<117::AID-MARC117>3.0.CO;2-X
   Kaplan D.L., 1998, BIOPOLYMERS RENEWABL
   Karayannidis GP, 2007, MACROMOL MATER ENG, V292, P128, DOI 10.1002/mame.200600341
   Kint DPR, 2003, POLYMER, V44, P1321, DOI 10.1016/S0032-3861(02)00938-2
   Kozlowski M, 2003, POLIMERY-W, V48, P606
   Li HY, 2005, MACROMOL BIOSCI, V5, P433, DOI 10.1002/mabi.200400183
   Li LX, 1999, IND ENG CHEM RES, V38, P2599, DOI 10.1021/ie980520r
   Lorenzetti C, 2006, J POLYM ENVIRON, V14, P89, DOI 10.1007/s10924-005-8711-1
   Lyoo WS, 2000, POLYMER, V41, P9055, DOI 10.1016/S0032-3861(00)00154-3
   Mobley D., 1994, PLASTICS MICROBES
   MOK WSL, 1989, J ORG CHEM, V54, P4596, DOI 10.1021/jo00280a027
   Nikles DE, 2005, MACROMOL MATER ENG, V290, P13, DOI 10.1002/mame.200400186
   Paszun D, 1997, IND ENG CHEM RES, V36, P1373, DOI 10.1021/ie960563c
   Saeki T, 2005, POLYMER, V46, P2157, DOI 10.1016/j.polymer.2005.01.030
   Saeki T, 2004, KOBUNSHI RONBUNSHU, V61, P561, DOI 10.1295/koron.61.561
   Scheirs J, 1998, WILEY SERIES POLYM S
   Scott G., 2002, BIODEGRADABLE POLYM
   Shinoda H, 2003, POLYM DEGRAD STABIL, V80, P241, DOI 10.1016/S0141-3910(02)00404-4
   Taniguchi I, 2002, MACROMOL BIOSCI, V2, P447, DOI 10.1002/mabi.200290002
   Tsuji H, 2000, J APPL POLYM SCI, V77, P1452, DOI 10.1002/1097-4628(20000815)77:7<1452::AID-APP7>3.0.CO;2-S
   Tsuji H, 2005, POLYM DEGRAD STABIL, V89, P336, DOI 10.1016/j.polymdegradstab.2005.01.018
   Tsuji H, 2003, BIOMACROMOLECULES, V4, P835, DOI 10.1021/bm034060j
   Uesaka T, 2002, J APPL POLYM SCI, V83, P1750, DOI 10.1002/app.10104
   Vert M., 1992, BIODEGRADABLE POLYM
   VERT M, 1995, MACROMOL SCI PURE A, V32, P787
   Yang Y, 2001, PROG CHEM, V13, P65
NR 40
TC 7
Z9 7
U1 0
U2 20
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1862-832X
J9 MACROMOL REACT ENG
JI Macromol. React. Eng.
PD NOV 21
PY 2008
VL 2
IS 6
BP 522
EP 528
DI 10.1002/mren.200800027
PG 7
WC Engineering, Chemical; Polymer Science
SC Engineering; Polymer Science
GA 380CT
UT WOS:000261444100004
DA 2018-10-19
ER

PT J
AU Huang, Y
   Lue, XY
   Ma, JW
   Huang, N
AF Huang Yan
   Lue Xiaoying
   Ma Jingwu
   Huang Nan
TI In vitro investigation of protein adsorption and platelet adhesion on
   inorganic biomaterial surfaces
SO APPLIED SURFACE SCIENCE
LA English
DT Article; Proceedings Paper
CT 1st International Symposium on Surface and Interfaces of Biomaterials
CY OCT 05-07, 2007
CL SW Jiaotong Univ, Chengdu, PEOPLES R CHINA
HO SW Jiaotong Univ
DE DLC and Ti; Surface property; Protein adsorption; Platelet adhesion;
   Blood compatibility
ID CARBON; ALBUMIN; FILMS; ASSAY; DLC
AB The aim of this paper was to study the surface properties, protein adsorption and platelet adhesion behaviors of diamond-like carbon (DLC) and titanium (Ti) films. The surface energy and microstructures of these films were characterized by contact angle measurement and atomic force microscopy (AFM). A modified Coomassie brilliant blue (CBB) protein assay was used to study the amount of adsorbed proteins. Platelet adhesion was assessed by scanning electron microscopy (SEM). The AFM results show that the DLC film is smoother than Ti. Protein adsorption results from CBB protein assay show that the ratio of adsorbed albumin (Alb) to IgG (R(A/I)) on DLC is larger than Ti, which coincide with the sequence of the ratio of interfacial tension between solid surface and Alb (gamma(S,Alb)) to interfacial tension between surface and IgG (gamma(S,IgG)) (gamma(S,Alb)/gamma(S,IgG)). The DLC film has a preferential adsorption for Alb. The results suggest that the ratio of gamma(S,Alb)/gamma(S,IgG) may indicate an Alb/IgG affinity ratio of materials. More platelets adhere on Ti film than on DLC, which may correspond to the surface roughness of materials. The conclusion is the blood compatibility of DLC seems to be better than Ti. (C) 2008 Elsevier B. V. All rights reserved.
C1 [Huang Yan; Lue Xiaoying; Ma Jingwu] Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing 210096, Peoples R China.
   [Huang Nan] SW Jiaotong Univ, Inst Biomat & Surface Engn, Chengdu 610031, Peoples R China.
RP Lue, XY (reprint author), Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing 210096, Peoples R China.
EM luxy@seu.edu.cn; nhuang@263.com
CR AGATHOPOULOS S, 1995, J BIOMED MATER RES, V29, P421, DOI 10.1002/jbm.820290402
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Chen JY, 2002, SURF COAT TECH, V156, P289, DOI 10.1016/S0257-8972(02)00089-0
   FORBES CD, 1994, THROMBOSIS ARTIFICIA, P84712
   GOODMAN SL, 1984, SEM 1984, V1, P279
   GU HQ, 1993, BIOMEDICAL MAT, P84712
   Huang Y, 2007, KEY ENG MATER, V330-332, P893
   Lu XY, 2007, SURF COAT TECH, V201, P6843, DOI 10.1016/j.surfcoat.2006.09.019
   PAUL L, 1981, J COLLOID INTERF SCI, V84, P546, DOI 10.1016/0021-9797(81)90245-9
   Wang XH, 2003, COLLOID SURFACE B, V30, P111, DOI 10.1016/S0927-7765(03)00078-X
NR 10
TC 19
Z9 19
U1 3
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD NOV 15
PY 2008
VL 255
IS 2
BP 257
EP 259
DI 10.1016/j.apsusc.2008.06.192
PG 3
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 366VD
UT WOS:000260510600002
DA 2018-10-19
ER

PT J
AU Li, X
   Yao, J
   Yang, X
   Tian, W
   Liu, L
AF Li, Xiaoyu
   Yao, Jinfeng
   Yang, Xiaojuan
   Tian, Weidong
   Liu, Lei
TI Surface modification with fibronectin or collagen to improve the cell
   adhesion
SO APPLIED SURFACE SCIENCE
LA English
DT Article; Proceedings Paper
CT 1st International Symposium on Surface and Interfaces of Biomaterials
CY OCT 05-07, 2007
CL SW Jiaotong Univ, Chengdu, PEOPLES R CHINA
HO SW Jiaotong Univ
DE Surface modification; Cellular attachment; Proliferation
ID ACRYLIC-ACID; FILMS; POLYHYDROXYALKANOATES; PLASMA; PHBHHX
AB Objective: The surface of biomaterials plays a critical role in determining bioactivity. The aim of this study was to evaluate the cell adhesion and proliferation of ADSCs on the surface of biomaterial which is modified with fibronectin or collagen.
   Materials and methods: Adipose-derived stromal cells (ADSCs) were obtained from SD rats, expanded in culture, and seeded onto scaffold surface-modified with fibronectin or collagen. To characterize cellular attachment, cells were incubated on scaffold for 1 and 2 h and then counted the cells attached onto the scaffold. The MTT assay was chosen to evaluate the proliferation at days 1, 4, 7 and 14. After 7 d of culture, scanning electron microscope was chosen to observe cell morphology and attachment of ADSCs on the scaffolds.
   Results: Attachment at 1 and 2 h of cells on scaffold modified with fibronectin was significantly greater than in control, but not with collagen. The MTT assay revealed that ADSCs proliferation tendency was nearly parallel to that in control. The scanning electron microscope (SEM) showed that ADSCs in experiment expanded thoroughly and excreted much extracellular materials. Conclusions: Surface modification with fibronectin or collagen can enhance the attachment of cultured ADSCs on the scaffold, but it had not evident effect to proliferation. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Liu, Lei] Sichuan Univ, W China Hosp Stomatol, Dept Oral & Maxillofacial Surg, Chengdu 610041, Peoples R China.
   [Yao, Jinfeng; Tian, Weidong] State Key Lab Oral Dis, Chengdu 610044, Peoples R China.
RP Liu, L (reprint author), Sichuan Univ, W China Hosp Stomatol, Dept Oral & Maxillofacial Surg, Chengdu 610041, Peoples R China.
EM drtwd@sina.com; drliulei@163.com
RI liu, lei/B-2263-2012; Yu, Mei/G-4994-2015
OI Yu, Mei/0000-0003-0306-6817
CR Cheng ZY, 2004, BIOMATERIALS, V25, P1991, DOI 10.1016/j.biomaterials.2003.08.038
   Dennis J E, 1993, J Oral Implantol, V19, P106
   Faucheux N, 1999, BIOMATERIALS, V20, P159, DOI 10.1016/S0142-9612(98)00156-2
   GRINNELL F, 1983, J CELL PHYSIOL, V116, P289, DOI 10.1002/jcp.1041160305
   Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9
   Gupta B, 2002, BIOMATERIALS, V23, P863, DOI 10.1016/S0142-9612(01)00195-8
   Kang ET, 1997, J PHYS CHEM B, V101, P10744, DOI 10.1021/jp9727052
   Kose GT, 2003, BIOMATERIALS, V24, P1949, DOI 10.1016/S0142-9612(02)00613-0
   Li J, 2005, J BIOMED MATER RES A, V75A, P985, DOI 10.1002/jbm.a.30504
   Qu XH, 2005, BIOMATERIALS, V26, P6991, DOI 10.1016/j.biomaterials.2005.05.034
   Rahaman MN, 2005, BIOTECHNOL BIOENG, V91, P261, DOI 10.1002/bit.20292
   Ruoslahti E, 1996, TUMOR BIOL, V17, P117, DOI 10.1159/000217975
   Yang XS, 2002, BIOMATERIALS, V23, P1391, DOI 10.1016/S0142-9612(01)00260-5
   Zhang DM, 2000, SURF COAT TECH, V131, P350, DOI 10.1016/S0257-8972(00)00810-0
NR 14
TC 8
Z9 9
U1 1
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD NOV 15
PY 2008
VL 255
IS 2
BP 459
EP 461
DI 10.1016/j.apsusc.2008.06.105
PG 3
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 366VD
UT WOS:000260510600057
DA 2018-10-19
ER

PT J
AU Poole-Warren, LA
   Farrugia, B
   Fong, N
   Hume, E
   Simmons, A
AF Poole-Warren, L. A.
   Farrugia, B.
   Fong, N.
   Hume, E.
   Simmons, A.
TI Controlling cell-material interactions with polymer nanocomposites by
   use of surface modifying additives
SO APPLIED SURFACE SCIENCE
LA English
DT Article; Proceedings Paper
CT 1st International Symposium on Surface and Interfaces of Biomaterials
CY OCT 05-07, 2007
CL SW Jiaotong Univ, Chengdu, PEOPLES R CHINA
HO SW Jiaotong Univ
DE Polyurethane; Organosilicate; Biomaterial; Antibacterial; Platelet
   adhesion; Fibroblast adhesion
AB Polymer nanocomposites (NC) are fabricated by incorporating well dispersed nanoscale particles within a polymer matrix. This study focuses on elastomeric polyurethane (PU) based nanocomposites, containing organically modified silicates (OMS), as bioactive materials. Nanocomposites incorporating chlorhexidine diacetate as an organic modifier (OM) were demonstrated to be antibacterial with a dose dependence related to both the silicate loading and the loading of OM. When the non-antibacterial OM dodecylamine was used, both cell and platelet adhesion were decreased on the nanocomposite surface. These results suggest that OM is released from the polymer and can impact on cell behaviour at the interface. Nanocomposites have potential use as bioactive materials in a range of biomedical applications. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Poole-Warren, L. A.; Farrugia, B.; Fong, N.; Hume, E.; Simmons, A.] Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW 2052, Australia.
RP Poole-Warren, LA (reprint author), Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW 2052, Australia.
EM l.poolewarren@unsw.edu.au
OI Simmons, Anne/0000-0002-3758-7306; Farrugia, Brooke/0000-0003-1303-4165;
   Poole-Warren, Laura/0000-0002-4414-022X
CR Cormio L, 2001, EUR UROL, V40, P354, DOI 10.1159/000049799
   FARRUGIA B, 2007, ESB              SEP, P84712
   GOLOMB G, 1991, J BIOMED MATER RES, V25, P937, DOI 10.1002/jbm.820250803
   PITT WG, 1988, BIOMATERIALS, V9, P36, DOI 10.1016/0142-9612(88)90067-1
   Styan KE, 2008, J BIOMED MATER RES A, V86A, P571, DOI 10.1002/jbm.a.31667
   Wang XP, 2007, ACTA BIOMATER, V3, P757, DOI 10.1016/j.actbio.2007.01.004
NR 6
TC 11
Z9 11
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD NOV 15
PY 2008
VL 255
IS 2
BP 519
EP 522
DI 10.1016/j.apsusc.2008.06.062
PG 4
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 366VD
UT WOS:000260510600074
DA 2018-10-19
ER

PT J
AU Oudadesse, H
   Derrien, AC
   Martin, S
   Chaair, H
   Cathelineau, G
AF Oudadesse, H.
   Derrien, A. C.
   Martin, S.
   Chaair, H.
   Cathelineau, G.
TI Surface and interface investigation of aluminosilicate biomaterial by
   the "in vivo'' experiments
SO APPLIED SURFACE SCIENCE
LA English
DT Article; Proceedings Paper
CT 1st International Symposium on Surface and Interfaces of Biomaterials
CY OCT 05-07, 2007
CL SW Jiaotong Univ, Chengdu, PEOPLES R CHINA
HO SW Jiaotong Univ
DE Composite; In vivo; Bone-graft interface; Surface; Interface
AB Porous mixtures of aluminosilicate/calcium phosphate have been studied for biomaterials applications. Aluminosilicates formed with an inorganic polymeric constitution present amorphous zeolites because of their 3D network structure and present the ability to link to bone matrix. Amorphous geopolymers of the potassium-poly(sialate)-nanopolymer type were synthesised at low temperature and studied for their use as potential biomaterials. They were mixed with 13% weight of calcium phosphate like biphasic hydroxyapatite and beta-tricalcium phosphate. In this study, "in vivo'' experiments were monitored to evaluate the biocompatibility, the surface and the interface behaviour of these composites when used as bone implants. Moreover, it has been demonstrated using histological and physicochemical studies that the developed materials exhibited a remarkable bone bonding when implanted in a rabbit's thighbone for a period of 1 month. The easy synthesis conditions (low temperature) of this composite and the fast intimate links with bone constitute an improvement of synthetic bone graft biomaterial. (c) 2008 Elsevier B.V. All rights reserved.
C1 [Oudadesse, H.; Derrien, A. C.; Martin, S.; Cathelineau, G.] Univ Rennes 1, CNRS, SCR, UMR 6226, F-35042 Rennes, France.
   [Chaair, H.] Univ Hassan 2, Fac Sci & Tech, FSTM LGP, Mohammadia, Morocco.
RP Oudadesse, H (reprint author), Univ Rennes 1, CNRS, SCR, UMR 6226, 263 Gen Leclerc, F-35042 Rennes, France.
EM hassane.oudadesse@univ-rennes1.fr
CR Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   Irigaray JL, 2001, BIOMATERIALS, V22, P629, DOI 10.1016/S0142-9612(00)00172-1
   KIM HW, 2005, J BIOMED MATER RES B, V77, P323
   NI GX, 2005, J BIOMED RES B, V77, P409
   Oudadesse H, 2007, J MATER SCI, V42, P3092, DOI 10.1007/s10853-006-0524-7
   Oudadesse H, 2005, EUR PHYS J-APPL PHYS, V31, P217, DOI 10.1051/epjap:2005062
   OUDADESSE H, 2006, JTAC, V82, P323
   OUDADESSE H, 2007, BIOMED MATER, V2, P59
   OUDADESSE H, 2007, J RADIOANAL NUCL CHE, V274, P431
   YAMAGUCHI M, 1988, BIOCHEM PHARMACOL, V37, P4075, DOI 10.1016/0006-2952(88)90098-6
NR 10
TC 7
Z9 7
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD NOV 15
PY 2008
VL 255
IS 2
BP 593
EP 596
DI 10.1016/j.apsusc.2008.06.086
PG 4
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 366VD
UT WOS:000260510600094
DA 2018-10-19
ER

PT J
AU Xia, H
   Suo, ZY
   Qiang, GJ
   Chang, CJ
AF Xia, Huang
   Suo, Zheng Yuan
   Qiang, Gao Ji
   Chang, Cheng Jia
TI Synthesis, characterization, and degradation of a novel
   L-tyrosine-derived polycarbonate for potential biomaterial applications
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE biodegradable; degradation; polycarbonate
ID PSEUDO-POLY(AMINO ACIDS); POLYARYLATES; COPOLYMERS; RELAXATION;
   CURRENTS; DESIGN
AB A novel class of pseudo-poly(amino acid)s was synthesized with a cyclic dipeptide as new diphenole. Nonpeptide bonds alternating with a peptide bond structure were introduced into the backbone of the pseudopoly(amino acid)s. The cyclic dipeptide in this study was obtained from natural L-tyrosine. L-tyrosine is a major nutrient amino acid with a phenolic hydroxyl group, so a polycarbonate derived from the cyclic dipeptide should possess more optimum mechanical properties, bioactivity, and biocompatibility. The hydrolytic specimen of the resulting polycarbonate was prepared by a modified solvent evaporation process. Under strongly alkaline conditions, degradation testing was performed. The tyrosine-derived polycarbonate possessed a low glass-transition temperature value and a high thermal decomposition temperature value, which formed a broad mean thermal processing range. The most important results of our study were the effects of the polycarbonate degradation on the local pH values, which were smaller than those of other biodegradable polymers [e.g., poly(lactic acid), poly(glycolic acid), and poly(lactic glycolic acid)]. The synthesized polymer and cyclic dipeptide were characterized with Fourier transform infrared, C-13-NMR, and H-1-NMR spectroscopy to determine their chemical structures; by differential scanning calorimetry and thermoogravimetric analysis to determine the thermal properties of the polymer; by gel permeation chromatography to determine the polymer's molecular weight; and by X-ray diffraction to determine the polymer's morphology. (C) 2008 Wiley Periodicals, Inc.
C1 [Xia, Huang; Qiang, Gao Ji; Chang, Cheng Jia] Xi An Jiao Tong Univ, State Key Lab Mech Behav Mat, Xian 710049, Peoples R China.
   [Suo, Zheng Yuan] Xi An Jiao Tong Univ, Sch Sci, Xian 710049, Peoples R China.
RP Xia, H (reprint author), Xi An Jiao Tong Univ, State Key Lab Mech Behav Mat, Xian 710049, Peoples R China.
EM happyhxia@163.com
CR Bourke SL, 2003, ADV DRUG DELIVER REV, V55, P447, DOI 10.1016/S0169-409X(03)00038-3
   Cabrele C, 1999, J ORG CHEM, V64, P4353, DOI 10.1021/jo982402j
   COOK B, 1992, J CHEM SOC PERK T 1, P1199, DOI 10.1039/p19920001199
   ERTEL SI, 1994, J BIOMED MATER RES, V28, P919, DOI 10.1002/jbm.820280811
   GOLDBERG EP, 1964, J POLYM SCI C, V4, P707
   Kimura Y, 1996, PHYTOCHEMISTRY, V41, P665, DOI 10.1016/0031-9422(95)00693-1
   KOHN J, 1987, J AM CHEM SOC, V109, P817, DOI 10.1021/ja00237a030
   KOHN J, 1993, TRENDS POLYM SCI, V1, P206
   KOHN J, 1984, POLYM MAT SCI ENG, V51, P119
   LI T, 2004, J CHEM IND TIMES, V18, P37
   MAO H, 1999, Patent No. 5912225
   MERRILL SH, 1961, J POLYM SCI, V55, P343, DOI 10.1002/pol.1961.1205516133
   ODonnell PB, 1997, ADV DRUG DELIVER REV, V28, P25, DOI 10.1016/S0169-409X(97)00049-5
   PULAPURA S, 1990, BIOMATERIALS, V11, P666, DOI 10.1016/0142-9612(90)90025-L
   PULAPURA S, 1992, BIOPOLYMERS, V32, P411, DOI 10.1002/bip.360320418
   Puma M, 1999, J POLYM SCI POL PHYS, V37, P3504, DOI 10.1002/(SICI)1099-0488(19991215)37:24<3504::AID-POLB11>3.0.CO;2-Y
   Sen Gupta A, 2005, POLYMER, V46, P2133, DOI 10.1016/j.polymer.2005.01.023
   Sen Gupta A, 2004, POLYMER, V45, P4653, DOI 10.1016/j.polymer.2004.04.052
   Suarez N, 2001, POLYMER, V42, P8671, DOI 10.1016/S0032-3861(01)00437-2
   Tangpasuthadol V, 1996, BIOMATERIALS, V17, P463, DOI 10.1016/0142-9612(96)89665-7
   Tangpasuthadol V, 2000, BIOMATERIALS, V21, P2371, DOI 10.1016/S0142-9612(00)00104-6
   WIPF P, 1995, CHEM REV, V95, P2115, DOI 10.1021/cr00038a013
NR 22
TC 5
Z9 5
U1 0
U2 12
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-8995
EI 1097-4628
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD NOV 15
PY 2008
VL 110
IS 4
BP 2168
EP 2178
DI 10.1002/app.28755
PG 11
WC Polymer Science
SC Polymer Science
GA 356CC
UT WOS:000259755300035
DA 2018-10-19
ER

PT J
AU Dos Santos, I
   Mazeres, S
   Freche, M
   Lacout, JL
   Sautereau, AM
AF Dos Santos, Isabelle
   Mazeres, Serge
   Freche, Michele
   Lacout, Jean-Louis
   Sautereau, Anne-Marie
TI FRET: A tool to study the interaction between apatite and collagen?
SO MATERIALS LETTERS
LA English
DT Article
DE FRET; luminescence; composite materials; apatite; collagen; molecular
   interaction
ID SELF-ORGANIZATION MECHANISM; HYDROXYAPATITE; COMPOSITE; NANOCOMPOSITES;
   NANOCRYSTALS
AB Fluorescence Resonance Energy Transfer, FRET, is largely used in biology to demonstrate the occurrence of molecular interactions. In order to investigate the vicinity between collagen and calcium phosphate in bone substitute biomaterial, composites constituted of autofluorescent collagen and apatite doped by europium were synthesized by a precipitation method. The first results show a fluorescence energy transfer between the two fluorescent components and are very promising. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Dos Santos, Isabelle; Sautereau, Anne-Marie] Univ Toulouse 3, Fac Pharm, Serv Pharm Galen, Inst Carnot,CIRIMAT,PPB,UMR 5085, F-31062 Toulouse 4, France.
   [Mazeres, Serge] CNRS, IPBS, F-31077 Toulouse, France.
   [Freche, Michele; Lacout, Jean-Louis] ENSIACET INPT, UMR 5085, CIRIMAT, Inst Carnot,PPB, F-31077 Toulouse, France.
RP Sautereau, AM (reprint author), Univ Toulouse 3, Fac Pharm, Serv Pharm Galen, Inst Carnot,CIRIMAT,PPB,UMR 5085, 118 Route Narbonne, F-31062 Toulouse 4, France.
EM serge.mazeres@ipbs.fr; Michele.Freche@ensiacet.fr;
   jeanLouis.Lacout@ensiacet.fr; asautere@cict.fr
CR Bazin H, 2001, SPECTROCHIM ACTA A, V57, P2197, DOI 10.1016/S1386-1425(01)00493-0
   Doat A, 2004, J SOLID STATE CHEM, V177, P1179, DOI 10.1016/j.jssc.2003.10.023
   FUJIMOTO D, 1978, J BIOCHEM-TOKYO, V83, P863, DOI 10.1093/oxfordjournals.jbchem.a131983
   Hallworth R, 2006, BRAIN RES, V1091, P122, DOI 10.1016/j.brainres.2006.02.076
   Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7
   Kikuchi M, 2004, COMPOS SCI TECHNOL, V64, P819, DOI 10.1016/j.compscitech.2003.09.002
   Lin XY, 2004, MATER LETT, V58, P3569, DOI 10.1016/j.matlet.2004.06.044
   Murugan R, 2005, COMPOS SCI TECHNOL, V65, P2385, DOI 10.1016/j.compscitech.2005.07.022
   Rhee SH, 2000, J AM CERAM SOC, V83, P2890
   Roveri N, 2003, MAT SCI ENG C-BIO S, V23, P441, DOI 10.1016/S0928-4931(02)00318-1
   Tampieri A, 2003, J BIOMED MATER RES A, V67A, P618, DOI 10.1002/jbm.a.10039
   Wang YJ, 2006, ADV ENG MATER, V8, P97, DOI 10.1002/adem.200500220
   Zhang W, 2003, CHEM MATER, V15, P3221, DOI 10.1021/cm030080g
NR 13
TC 3
Z9 3
U1 0
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD NOV 15
PY 2008
VL 62
IS 28
BP 4377
EP 4379
DI 10.1016/j.matlet.2008.07.035
PG 3
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 351JJ
UT WOS:000259420300022
DA 2018-10-19
ER

PT J
AU Zhang, H
   Wei, YT
   Tsang, KS
   Sun, CR
   Li, J
   Huang, H
   Cui, FZ
   An, YH
AF Zhang, Han
   Wei, Yue Teng
   Tsang, Kam Sze
   Sun, Chong Ran
   Li, Jin
   Huang, Hua
   Cui, Fu Zhai
   An, Yi Hua
TI Implantation of neural stem cells embedded in hyaluronic acid and
   collagen composite conduit promotes regeneration in a rabbit facial
   nerve injury model
SO JOURNAL OF TRANSLATIONAL MEDICINE
LA English
DT Article
ID CULTURED SCHWANN-CELLS; EXTRACELLULAR-MATRIX; PERIPHERAL-NERVES;
   PROGENITOR CELLS; SPINAL-CORD; TRANSPLANTATION; GRAFTS; DIFFERENTIATION;
   ENHANCEMENT; ALLOGRAFT
AB The implantation of neural stem cells (NSCs) in artificial scaffolds for peripheral nerve injuries draws much attention. NSCs were ex-vivo expanded in hyaluronic acid (HA)-collagen composite with neurotrophin-3, and BrdU-labeled NSCs conduit was implanted onto the ends of the transected facial nerve of rabbits. Electromyography demonstrated a progressive decrease of current threshold and increase of voltage amplitude in de-innervated rabbits after implantation for one, four, eight and 12 weeks compared to readouts derived from animals prior to nerve transection. The most remarkable improvement, observed using Electrophysiology, was of de-innervated rabbits implanted with NSCs conduit as opposed to de-innervated counterparts with and without the implantation of HA-collagen, NSCs and HA-collagen, and HA-collagen and neurotrophin-3. Histological examination displayed no nerve fiber in tissue sections of de-innervated rabbits. The arrangement and S-100 immunoreactivity of nerve fibers in the tissue sections of normal rabbits and injured rabbits after implantation of NSCs scaffold for 12 weeks were similar, whereas disorderly arranged minifascicles of various sizes were noted in the other three arms. BrdU(+) cells were detected at 12 weeks post-implantation. Data suggested that NSCs embedded in HA-collagen biomaterial could facilitate re-innervations of damaged facial nerve and the artificial conduit of NSCs might offer a potential treatment modality to peripheral nerve injuries.
C1 [Zhang, Han; Sun, Chong Ran; Li, Jin; Huang, Hua; An, Yi Hua] Capital Med Univ, Beijing Neurosurg Inst, Beijing, Peoples R China.
   [Wei, Yue Teng; Cui, Fu Zhai] Tsinghua Univ, Dept Mat Sci & Engn, Beijing 100084, Peoples R China.
   [Tsang, Kam Sze; Li, Jin] Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China.
   [Tsang, Kam Sze; Li, Jin] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China.
   [Sun, Chong Ran] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurosurg, Hangzhou 310003, Zhejiang, Peoples R China.
RP An, YH (reprint author), Capital Med Univ, Beijing Neurosurg Inst, Beijing, Peoples R China.
EM meishazhang@yahoo.com.cn; yeting_smth@hotmail.com; tsangks@cuhk.edu.hk;
   sunfootprint@yahoo.com.cn; flintli@yahoo.com.cn; ama_225@sina.com;
   cuifz@tsinghua.edu.cn; riveran@163.com
RI Wei, Yueteng/B-4653-2012
FU National Science Foundation of Beijing, China [7042014]; National
   Natural Science Foundation of China [50573044]; National Basic Research
   Program of China [2005CB623905]
FX Research support: This study is supported in part by the grants from the
   7042014 of the National Science Foundation of Beijing, China, the
   50573044 of the National Natural Science Foundation of China and the
   2005CB623905 of the National Basic Research Program of China.
CR BAIN JR, 1992, PLAST RECONSTR SURG, V90, P1036, DOI 10.1097/00006534-199212000-00015
   Brannvall K, 2007, J NEUROSCI RES, V85, P2138, DOI 10.1002/jnr.21358
   Chu K, 2003, NEUROSCI LETT, V343, P129, DOI 10.1016/S0304-3940(03)00174-5
   Evans GRD, 2002, BIOMATERIALS, V23, P841, DOI 10.1016/S0142-9612(01)00190-9
   Fansa H, 2001, PLAST RECONSTR SURG, V107, P485, DOI 10.1097/00006534-200102000-00026
   Fansa H, 2004, NEUROL RES, V26, P167, DOI 10.1179/016164104225013842
   Fong SP, 2007, J NEUROSCI RES, V85, P1851, DOI 10.1002/jnr.21319
   Francel PC, 1997, J NEUROSURG, V87, P887, DOI 10.3171/jns.1997.87.6.0887
   Frerichs O, 2002, MICROSURG, V22, P311, DOI 10.1002/micr.10056
   Heath CA, 2000, TRENDS BIOTECHNOL, V18, P17, DOI 10.1016/S0167-7799(99)01396-7
   Hori J, 2007, OCUL IMMUNOL INFLAMM, V15, P261, DOI 10.1080/09273940701382242
   Hou S, 2006, NEUROSCIENCE, V137, P519, DOI 10.1016/j.neuroscience.2005.09.029
   Hudson TW, 2000, ORTHOP CLIN N AM, V31, P485, DOI 10.1016/S0030-5898(05)70166-8
   Jeong SW, 2003, STROKE, V34, P2258, DOI 10.1161/01.STR.0000083698.20199.1F
   Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101
   Le Belle JE, 2004, J NEUROSCI RES, V76, P174, DOI 10.1002/jnr.20035
   Lin WL, 2005, J NEUROCYTOL, V34, P397, DOI 10.1007/s11068-006-8726-0
   Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2
   Ma W, 2004, EXP NEUROL, V190, P276, DOI 10.1016/j.expneurol.2003.10.016
   Mackinnon SE, 2001, PLAST RECONSTR SURG, V107, P1419, DOI 10.1097/00006534-200105000-00016
   Midha R, 2003, J NEUROSURG, V99, P555, DOI 10.3171/jns.2003.99.3.0555
   Millesi H, 2000, HAND CLIN, V16, P73
   Mligiliche N, 2002, J BIOMED MATER RES, V63, P591, DOI 10.1002/jbm.10349
   Rauch U, 2004, CELL MOL LIFE SCI, V61, P2031, DOI 10.1007/s00018-004-4043-x
   Routsellis-Theotokis Andreas, 2008, V438, P31, DOI 10.1007/978-1-59745-133-8_4
   Tang SQ, 2007, J BIOMED MATER RES A, V82A, P323, DOI 10.1002/jbm.a.30974
   Tian WM, 2005, TISSUE ENG, V11, P513, DOI 10.1089/ten.2005.11.513
NR 27
TC 32
Z9 37
U1 0
U2 21
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1479-5876
J9 J TRANSL MED
JI J. Transl. Med.
PD NOV 5
PY 2008
VL 6
AR 67
DI 10.1186/1479-5876-6-67
PG 11
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 393KU
UT WOS:000262373000002
PM 18986538
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Chaa, L
   Joly, N
   Lequart, V
   Faugeron, C
   Mollet, JC
   Martin, P
   Morvan, H
AF Chaa, Lahouari
   Joly, Nicolas
   Lequart, Vincent
   Faugeron, Celine
   Mollet, Jean-Claude
   Martin, Patrick
   Morvan, Henri
TI Isolation, characterization and valorization of hemicelluloses from
   Aristida pungens leaves as biomaterial
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE arabinoxylan; Aristida pungens; hemicelluloses; plastic films
ID WHEAT-STRAW HEMICELLULOSES; STRUCTURAL-CHARACTERIZATION;
   QUANTITATIVE-DETERMINATION; PLASTIC FILMS; RICE STRAW; CELLULOSE;
   POLYSACCHARIDES; DERIVATIVES; ALKALI; XYLAN
AB Aristida pungens, a perennial grass widely distributed on the Algerian and regions, may potentially be the source of raw cell wall material to promote a local development in North Africa. Hemicelluloses the main, matrix cell wall polymers of this species were isolated from leaves with 14% KOH aqueous solution characterized and converted as plastic material. The extraction procedure yielded two hemicellulose fractions (A and B) accounting for 3.5 and 10.1% of the starting leaf material, respectively. GC and C-13 NMR showed the presence of xylose as the main component with arabinosyl residues. Both analyses indicate that hemicelluloses from A. pungens leaves are arabinoxylans. Arabinoxylans were transformed into hydrophobic plastics by grafting of lauroyl chloride. The resulting materials were characterized by FT-IR and H-1 NMR spectroscopies, with both mechanical and thermogravimetric analysis. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Joly, Nicolas; Lequart, Vincent; Martin, Patrick] IUT Bethune, Dept Chim, Unite Catalyse & Chim Solide, UMR CNRS 8181, F-62408 Bethune, France.
   [Chaa, Lahouari] Univ Sci & Tech Lille Flandres Artois, EA 2465, Lab Physiopathol Barriere Hematho Encephal, Fac Jean Perrin, F-62307 Lens, France.
   Univ Sci & Tech Lille Flandres Artois, Lab Glycobiol & Physiol Vegetale, Fac Jean Perrin, F-62307 Lens, France.
   [Faugeron, Celine] Fac Sci & Tech, EA 1069, Lab Chim Substances Nat, F-87060 Limoges, France.
   [Mollet, Jean-Claude] Univ Rouen, IFRMP23, FRE CNRS 3090, Lab Glycobiol & Transports Chez Vegetaux, F-76821 Mont St Aignan, France.
RP Joly, N (reprint author), IUT Bethune, Dept Chim, Unite Catalyse & Chim Solide, UMR CNRS 8181, 1230 Rue Univ,BP 819, F-62408 Bethune, France.
EM nicolas.joly@univ-artois.fr
RI Joly, Nicolas/O-5749-2016
OI Joly, Nicolas/0000-0003-0516-2466; Patrick, Martin/0000-0001-7507-5910
FU "Institut Universitaire de Technologie" of Bethune
FX We thank the "Institut Universitaire de Technologie" of Bethune for
   financial support. The authors are also grateful to Dr. Emmanuel Maes
   (UMR CNRS 8576, Unite de Glycobiologie Structurale et Fonctionnelle,
   Lille, France) for <SUP>13</SUP>C NMR analysis.
CR Bechet G., 1982, BIOCENOSES B ECOLOGI, V1, P79
   Bendahou A, 2007, CARBOHYD POLYM, V68, P601, DOI 10.1016/j.carbpol.2006.10.016
   BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1
   BUCHALA AJ, 1972, PHYTOCHEMISTRY, V11, P1249, DOI 10.1016/S0031-9422(00)90071-2
   Buckeridge MS, 2004, CEREAL CHEM, V81, P115, DOI 10.1094/CCHEM.2004.81.1.115
   Chaikumpollert O, 2004, CARBOHYD POLYM, V57, P191, DOI 10.1016/j.carbpol.2004.04.011
   DUBOIS M, 1956, ANAL CHEM, V28, P356, DOI DOI 10.1021/AC60111A017
   DUSTERHOFT EM, 1992, J SCI FOOD AGR, V59, P151, DOI 10.1002/jsfa.2740590204
   Ebringerova A, 2000, MACROMOL RAPID COMM, V21, P542
   FONTANILLE M, 2002, CHIM PHYSICO CHIM PO, P586
   FORD CW, 1986, CARBOHYD RES, V147, P101, DOI 10.1016/0008-6215(86)85010-8
   Gabrielii I, 1998, J APPL POLYM SCI, V69, P1661, DOI 10.1002/(SICI)1097-4628(19980822)69:8<1661::AID-APP19>3.3.CO;2-K
   Gabrielii I, 2000, CARBOHYD POLYM, V43, P367, DOI 10.1016/S0144-8617(00)00181-8
   Gontard N, 1994, FOOD PACKAGING PRESE, P159
   GRANDTNER G, 2005, POLYM B, V4, P235
   HATFIELD RD, 1989, AGRON J, V81, P39, DOI 10.2134/agronj1989.00021962008100010007x
   Hoije A, 2005, CARBOHYD POLYM, V61, P266, DOI 10.1016/j.carbpol.2005.02.009
   Joly N, 2005, J APPL POLYM SCI, V97, P1266, DOI 10.1002/app.21783
   JOLY N, 2006, E-POLYMERS, V70, P1
   Kacurakova M, 2000, CARBOHYD POLYM, V43, P195, DOI 10.1016/S0144-8617(00)00151-X
   Kayserilioglu BS, 2003, BIORESOURCE TECHNOL, V87, P239, DOI 10.1016/S0960-8524(02)00258-4
   MOINE C, 2004, J ENV SCI HLTH B, V39, P4627
   Rantanen H, 2007, CARBOHYD POLYM, V68, P350, DOI 10.1016/j.carbpol.2006.11.022
   Satge C, 2002, CARBOHYD POLYM, V49, P373, DOI 10.1016/S0144-8617(02)00004-8
   Satge C, 2004, CR CHIM, V7, P135, DOI 10.1016/j.crci.2003.11.003
   Sun RC, 1996, CARBOHYD POLYM, V29, P325, DOI 10.1016/S0144-8617(96)00018-5
   Sun RC, 2000, CARBOHYD POLYM, V42, P111, DOI 10.1016/S0144-8617(99)00136-8
   Sun RC, 2002, CARBOHYD POLYM, V50, P263, DOI 10.1016/S0144-8617(02)00037-1
   Sun RC, 2002, CARBOHYD POLYM, V49, P415, DOI 10.1016/S0144-8617(01)00349-6
   Sun RC, 1999, IND CROP PROD, V10, P209, DOI 10.1016/S0926-6690(99)00025-4
   Verbruggen MA, 1998, CARBOHYD RES, V306, P275, DOI 10.1016/S0008-6215(97)10065-9
   VICKEN JP, 2003, PLANT PHYSIOL, V132, P1781
   WHISTLER RL, 1993, IND GUMS, P295
   Xiao B, 2001, POLYM DEGRAD STABIL, V74, P307, DOI 10.1016/S0141-3910(01)00163-X
   Zanetta JP, 1999, GLYCOBIOLOGY, V9, P255, DOI 10.1093/glycob/9.3.255
NR 35
TC 24
Z9 26
U1 0
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD NOV 4
PY 2008
VL 74
IS 3
BP 597
EP 602
DI 10.1016/j.carbpol.2008.04.017
PG 6
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 355KQ
UT WOS:000259708200038
DA 2018-10-19
ER

PT J
AU Shim, J
   Hagerman, E
   Wu, B
   Gupta, V
AF Shim, Jaewoo
   Hagerman, Elizabeth
   Wu, Ben
   Gupta, Vijay
TI Measurement of the tensile strength of cell-biomaterial interface using
   the laser spallation technique
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Cell adhesion; Laser spallation experiment; Tensile strength; Osteoblast
   adhesion; Fibroblasts
ID NB SAPPHIRE INTERFACES; ADHESION STRENGTH; SURFACE-ROUGHNESS;
   SHEAR-STRESS; SHOCK-WAVES; FIBRONECTIN; DETACHMENT; PULSES; ENERGY;
   FORCE
AB A previously developed laser spallation technique to determine the tensile strength of thin film interfaces was successfully adopted to determine the tensile strength of interfaces between three different live mammalian cells (osteoblast, chondrocyte and fibroblast) and polystyrene (untreated and fibronectin coated) and titanium surfaces. No noticeable differences in the interfacial tensile strength values were found across the three cell types on the same substrate although osteoblasts showed slightly lower adhesion strength when cultured on untreated polystyrene surfaces. Significant differences were, however, measured for cells treated on different surfaces. Use of fibronectin increased the interfacial tensile strength for all cell types, kind cells bonded much better to titanium than to untreated polystyrene surfaces. Cell interfacial strength was higher when cultured with serum than in a serum-free environment. The results demonstrate the remarkable sensitivity of the laser spallation experiment in determining the effects of local interfacial microstructure and chemistry on cell adhesion. (C) 2008 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Shim, Jaewoo; Hagerman, Elizabeth; Wu, Ben; Gupta, Vijay] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA.
   [Wu, Ben; Gupta, Vijay] Univ Calif Los Angeles, Dept Mat Sci & Engn, Los Angeles, CA 90095 USA.
   [Gupta, Vijay] Univ Calif Los Angeles, Dept Mech Engn, Los Angeles, CA 90095 USA.
RP Gupta, V (reprint author), Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA.
EM vgupta@seas.ucla.edu
CR ANDERHOL.NC, 1970, APPL PHYS LETT, V16, P113, DOI 10.1063/1.1653116
   ANDRES J, 1998, J BIOL CHEM, V273, P10988
   Antoun T., 2003, SPALL FRACTURE
   BARKER LM, 1970, J APPL PHYS, V41, P4208, DOI 10.1063/1.1658439
   BARKER LM, 1972, EXP MECH, V12, P209, DOI 10.1007/BF02318100
   Berthe L, 1997, J APPL PHYS, V82, P2826, DOI 10.1063/1.366113
   Bolis C, 2007, J PHYS D APPL PHYS, V40, P3155, DOI 10.1088/0022-3727/40/10/019
   Bundy KJ, 2001, CELL BIOL INT, V25, P289, DOI 10.1006/cbir.2000.0648
   Cargill RS, 1999, BIOMATERIALS, V20, P2417, DOI 10.1016/S0142-9612(99)00169-6
   CHEN PC, 1993, MULTIDIMENSIONAL MIC
   COGSWELL CJ, 1994, 3 DIMENSIONAL MICROS
   FABBRO R, 1990, J APPL PHYS, V68, P775, DOI 10.1063/1.346783
   FISHER JC, 1948, J APPL PHYS, V19, P1062, DOI 10.1063/1.1698012
   Garcia AJ, 2003, CELL BIOCHEM BIOPHYS, V39, P61, DOI 10.1385/CBB:39:1:61
   Goldstein AS, 2002, J BIOMED MATER RES, V59, P665, DOI 10.1002/jbm.1276
   GUPTA V, 1992, J MECH PHYS SOLIDS, V40, P141, DOI 10.1016/0022-5096(92)90296-E
   GUPTA V, 1994, J ADHES SCI TECHNOL, V8, P713, DOI 10.1163/156856194X00447
   Gupta V, 1997, J AM CERAM SOC, V80, P3172
   GUPTA V, 1993, REV SCI INSTRUM, V64, P1611, DOI 10.1063/1.1144034
   Hagerman E, 2007, J BIOMED MATER RES A, V82A, P852, DOI 10.1002/jbm.a.31011
   Hallab NJ, 1995, J LONG-TERM EFF MED, V5, P209
   Hallab NJ, 2001, TISSUE ENG, V7, P55, DOI 10.1089/107632700300003297
   Hochmuth RM, 2000, J BIOMECH, V33, P15, DOI 10.1016/S0021-9290(99)00175-X
   KUO SC, 1993, BIOPHYS J, V65, P2191, DOI 10.1016/S0006-3495(93)81277-3
   Lev LC, 1996, J APPL PHYS, V80, P529, DOI 10.1063/1.362757
   Mal A, 2002, P SOC PHOTO-OPT INS, V4702, P339, DOI 10.1117/12.469894
   MAL AK, 2005, P 2 INT S MECH SCI B
   Matsumoto B, 1993, CELL BIOL APPL CONFO
   Merkel R, 1999, NATURE, V397, P50, DOI 10.1038/16219
   MONCHALIN JP, 1986, MATER EVAL, V44, P1231
   PRONIN A, 1993, REV SCI INSTRUM, V64, P2233, DOI 10.1063/1.1144452
   Reyes CD, 2003, J BIOMED MATER RES A, V67A, P328, DOI 10.1002/jbm.a.10122
   Richards RG, 1995, CELL BIOL INT, V19, P1015, DOI 10.1006/cbir.1995.1044
   Scheffer L, 2001, EUR BIOPHYS J BIOPHY, V30, P83, DOI 10.1007/s002490000122
   TRUSKEY GA, 1990, J BIOMED MATER RES, V24, P1333, DOI 10.1002/jbm.820241006
   VANKOOTEN TG, 1994, MED ENG PHYS, V16, P506, DOI 10.1016/1350-4533(94)90077-9
   Vossen J. L., 1978, Adhesion Measurement of Thin Films, Thick Films and Bulk Coatings, P122, DOI 10.1520/STP38629S
   Williams PR, 1998, PHYS MED BIOL, V43, P3101, DOI 10.1088/0031-9155/43/10/028
   Yamamoto A, 2000, J BIOMED MATER RES, V50, P114, DOI 10.1002/(SICI)1097-4636(200005)50:2<114::AID-JBM4>3.3.CO;2-Y
   YUAN J, 1993, J APPL PHYS, V74, P2388, DOI 10.1063/1.354698
   YUAN J, 1993, J APPL PHYS, V74, P2405, DOI 10.1063/1.354700
   YUAN J, 1995, ACTA METALL MATER, V43, P781, DOI 10.1016/0956-7151(94)00258-J
   YUAN J, 1995, ACTA METALL MATER, V43, P769, DOI 10.1016/0956-7151(94)00257-I
   YUAN J, 1994, THESIS DARTMOUTH COL
NR 44
TC 9
Z9 9
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD NOV
PY 2008
VL 4
IS 6
BP 1657
EP 1668
DI 10.1016/j.actbio.2008.06.001
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 377LT
UT WOS:000261253400009
PM 18640086
DA 2018-10-19
ER

PT J
AU Zalfen, AM
   Nizet, D
   Jerome, C
   Frankenne, F
   Foidart, JM
   Maquet, V
   Lecomte, F
   Hubert, P
   Evrard, B
AF Zalfen, A. M.
   Nizet, D.
   Jerome, C.
   Frankenne, F.
   Foidart, J. M.
   Maquet, V.
   Lecomte, F.
   Hubert, P.
   Evrard, B.
TI Controlled release of drugs from multi-component biomaterials
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Drug delivery; Controlled release; Hydrogel; Poly(2-hydroxyethyl
   methacrylate); Microspheres
ID POLY(2-HYDROXYETHYL METHACRYLATE) HYDROGELS; DELIVERY SYSTEMS;
   INJECTABLE MICROSPHERES; EPSILON-CAPROLACTONE; SWELLING BEHAVIORS;
   POLY(EPSILON-CAPROLACTONE); PERMEABILITY; FORMULATIONS; MECHANISMS;
   COPOLYMERS
AB In order to control their release, drugs are encapsulated into systems which are expected to provide a certain site with a predetermined amount of drug over a well-defined period of time. Here we report on a multi-component drug delivery biomaterial that consists of a hydrogel matrix in which drug-loaded biodegradable microcarriers are dispersed, and whose potential applications could be found in the design of implantable devices with long-term activity, as required by contraceptive and hormone replacement treatments. The release profile of the drug can actually be tuned by the complex interplay of several release mechanisms, including the permeability and eventually the degradation rate of the microcarriers and the diffusion through the hydrogel. The hydrogel consisted of 2-hydroxyethyl methacrylate cross-linked by ethylene glycol dimethacrylate. The microcarriers were biodegradable poly-epsilon-caprolactone (PCL) microspheres in which active molecules, such as levonorgestrel (LNG), were encapsulated. The hydrogels were characterized by water swelling, thermal properties, LNG diffusion through drug-free and drug-depleted hydrogel membranes and LNG release from devices with drug dispersed in the hydrogel. The PCL microspheres were observed by scanning electron microscopy; their size distribution, LNG loading and release were also investigated. The hydrogel-microsphere assemblies were characterized in terms of the distribution of the microspheres within the hydrogel, water swelling and the release of the encapsulated molecules. The developed device, due to its composite structure, has the ability to combine several release mechanisms, leading to drug release obeying zero-order kinetics for most of the time. (C) 2008 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Zalfen, A. M.; Jerome, C.; Frankenne, F.] Univ Liege, Ctr Educ & Res Macromol, B-4000 Liege, Belgium.
   [Nizet, D.; Evrard, B.] Univ Liege, Inst Pharm, Pharmaceut Technol Lab, B-4000 Liege, Belgium.
   [Frankenne, F.; Foidart, J. M.] Univ Liege, Lab Biol Tumeurs & Dev, B-4000 Liege, Belgium.
   [Maquet, V.] KitoZyme, B-4040 Herstal, Belgium.
   [Lecomte, F.; Hubert, P.] Univ Liege, Analyt Chem Lab, B-4000 Liege, Belgium.
RP Zalfen, AM (reprint author), Univ Liege, Ctr Educ & Res Macromol, B-4000 Liege, Belgium.
EM Alina.Zalfen@ulg.ac.be
FU Walloon Region Ministry; IAP program
FX The authors wish to thank to the Walloon Region Ministry for the
   financial support accorded in the framework of the IMPUT project through
   the DGTRE. C.J. thanks the IAP program "Functional Supramolecular
   Systems" for financial support.
CR Amsden B, 1998, MACROMOLECULES, V31, P8382, DOI 10.1021/ma980765f
   BENOIT JP, 1986, INT J PHARM, V29, P95, DOI 10.1016/0378-5173(86)90106-7
   Bhattachar SN, 2002, INT J PHARM, V236, P135, DOI 10.1016/S0378-5173(02)00027-3
   Brazel CS, 1999, POLYMER, V40, P3383, DOI 10.1016/S0032-3861(98)00546-1
   Buntner B, 1998, J CONTROL RELEASE, V56, P159, DOI 10.1016/S0168-3659(98)00085-6
   Chen DR, 2000, POLYM DEGRAD STABIL, V67, P455, DOI 10.1016/S0141-3910(99)00145-7
   Dalton PD, 2001, BIOMATERIALS, V22, P2661, DOI 10.1016/S0142-9612(01)00008-4
   Dash AK, 1997, J MICROENCAPSUL, V14, P101, DOI 10.3109/02652049709056471
   Dhanaraju MD, 2006, J BIOMED MATER RES A, V76A, P63, DOI 10.1002/jbm.a.30458
   Dhanaraju MD, 2004, CHEM PHARM BULL, V52, P976, DOI 10.1248/cpb.52.976
   Dhanaraju MD, 2003, INT J PHARM, V268, P23, DOI 10.1016/j.ijpharm.2003.08.011
   Dziubla TD, 2001, BIOMATERIALS, V22, P2893, DOI 10.1016/S0142-9612(01)00035-7
   Freitas S, 2005, J CONTROL RELEASE, V102, P313, DOI 10.1016/j.jconrel.2004.10.015
   Garcia O, 2000, EUR POLYM J, V36, P111, DOI 10.1016/S0014-3057(99)00037-3
   Gehrke SH, 1997, ANN NY ACAD SCI, V831, P179
   Gupta P, 2002, DRUG DISCOV TODAY, V7, P569, DOI 10.1016/S1359-6446(02)02255-9
   He HY, 2004, J CONTROL RELEASE, V95, P391, DOI 10.1016/j.jconrel.2003.12.004
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Huang X, 2001, J CONTROL RELEASE, V73, P121, DOI 10.1016/S0168-3659(01)00248-6
   Jeong JC, 2003, J CONTROL RELEASE, V92, P249, DOI 10.1016/S0168-3659(03)00367-5
   Kishida A., 2002, POLYM BIOMATERIALS, P133
   Lee WF, 1998, POLYM GELS NETW, V6, P493, DOI 10.1016/S0966-7822(99)00002-7
   Liu Q, 2000, BIOMATERIALS, V21, P2163, DOI 10.1016/S0142-9612(00)00137-X
   Lu SX, 1999, J CONTROL RELEASE, V57, P291, DOI 10.1016/S0168-3659(98)00125-4
   OKADA H, 1995, CRIT REV THER DRUG, V12, P1
   Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4
   PINCHUK L, 1984, J BIOMED MATER RES, V18, P671, DOI 10.1002/jbm.820180608
   Pitt C. G., 1980, BIODEGRADABLE DELIVE, P17
   PITT CG, 1979, J BIOMED MATER RES, V13, P497, DOI 10.1002/jbm.820130313
   PITT CG, 1981, J APPL POLYM SCI, V26, P3779, DOI 10.1002/app.1981.070261124
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   REFOJO MF, 1967, J POLYM SCI A1, V5, P3103, DOI 10.1002/pol.1967.150051211
   Rosca ID, 2004, J CONTROL RELEASE, V99, P271, DOI 10.1016/j.jconrel.2004.07.007
   Siewert M., 2003, AAPS PHARMSCITECH, V4, P1
   SINCLAIR GW, 1984, J MEMBRANE SCI, V17, P329, DOI 10.1016/S0376-7388(00)83223-8
   Sinha VR, 2004, INT J PHARMACEUT, V278, P1, DOI 10.1016/j.ijpharm.2004.01.044
   SONG SZ, 1981, J PHARM SCI, V70, P216, DOI 10.1002/jps.2600700226
   Venter JP, 2001, EUR J PHARM SCI, V13, P169, DOI 10.1016/S0928-0987(01)00110-5
   Wang JQ, 2005, EUR POLYM J, V41, P1143, DOI 10.1016/j.europolymj.2004.11.034
   WASHINGTON C, 1990, INT J PHARM, V58, P1, DOI 10.1016/0378-5173(90)90280-H
   Weldemeersch D, 2003, ANN NY ACAD SCI, V997, P174, DOI 10.1196/annals.1290.020
   Yoo JW, 2006, J CONTROL RELEASE, V112, P1, DOI 10.1016/j.jconrel.2006.01.021
   Zahedi P, 2007, EUR J PHARM BIOPHARM, V65, P320, DOI 10.1016/j.ejpb.2006.10.025
NR 43
TC 27
Z9 29
U1 3
U2 25
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD NOV
PY 2008
VL 4
IS 6
BP 1788
EP 1796
DI 10.1016/j.actbio.2008.05.021
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 377LT
UT WOS:000261253400023
PM 18583206
DA 2018-10-19
ER

PT J
AU Wu, F
   Wei, J
   Guo, H
   Chen, FP
   Hong, H
   Liu, CS
AF Wu, Fan
   Wei, Jie
   Guo, Han
   Chen, Fangping
   Hong, Hua
   Liu, Changsheng
TI Self-setting bioactive calcium-magnesium phosphate cement with high
   strength and degradability for bone regeneration
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Magnesium phosphate; Calcium phosphate; Calcium-magnesium phosphate
   cement; Biodegradability; Biocompatibility
ID BETA-TRICALCIUM PHOSPHATE; IN-VITRO BIOACTIVITY; MECHANICAL-PROPERTIES;
   GRAFT SUBSTITUTES; TISSUE-RESPONSE; REPAIR; VIVO; RESORPTION; DIHYDRATE;
   CONCRETE
AB Calcium phosphate cement (CPC) has been successfully used in clinics as bone repair biomaterial for many years. However, poor mechanical properties and a low biodegradation rate limit any further applications. Magnesium phosphate cement (MPC) is characterized by fast setting, high initial strength and relatively rapid degradation in vivo. In this study, MPC was combined with CPC to develop novel calcium-magnesium phosphate cement (CMPC). The setting time, compressive strength, phase composition of hardened cement, degradation in vitro, cells responses in vitro by MG-63 cell culture and tissue responses in vivo by implantation of CMPC in bone defect of rabbits were investigated. The results show that CMPC has a shorter setting time and markedly better mechanical properties than either CPC or MPC. Moreover, CMPC showed significantly improved degradability compared to CPC in simulated body fluid. Cell culture results indicate that CMPC is biocompatible and could support cell attachment and proliferation. To investigate the in vivo biocompatibility and osteogenesis, the CMPC samples were implanted into bone defects in rabbits. Histological evaluation showed that the introduction of MPC into CPC enhanced the efficiency of new bone formation. CMPC also exhibited good biocompatibility, biodegradability and osteoconductivity with host bone in vivo. The results obtained suggest that CMPC, having met the basic requirements of bone tissue engineering, might have a significant clinical advantage over CPC, and may have the potential to be applied in orthopedic, reconstructive and maxillofacial surgery. (C) 2008 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Wu, Fan; Wei, Jie; Guo, Han; Chen, Fangping; Hong, Hua; Liu, Changsheng] E China Univ Sci & Technol, Engn Res Ctr Biomed Mat, Key Lab Ultrafine Mat, Minist Educ, Shanghai 200237, Peoples R China.
RP Liu, CS (reprint author), E China Univ Sci & Technol, Engn Res Ctr Biomed Mat, Key Lab Ultrafine Mat, Minist Educ, 130 Meilong Rd, Shanghai 200237, Peoples R China.
EM csliu@sh163.net
FU National Science Fund for Distinguished Young Scholars of China
   [20425621]; Major State Basic Research Program of China [2005CCA01000];
   Basic Research Foundation of the Shanghai Science and Technology
   Committee [05DJ14005]; Nano special program of Science and Technology
   Development of Shanghai [0652nm021]
FX The authors appreciate financial support from the National Science Fund
   for Distinguished Young Scholars of China (Grant No. 20425621), the
   Major State Basic Research Program of China (No. 2005CCA01000) and the
   Basic Research Foundation of the Shanghai Science and Technology
   Committee (05DJ14005), and Nano special program of Science and
   Technology Development of Shanghai (No. 0652nm021).
CR Abdelrazig B, 1984, P BR CERAM SOC, V35, P141
   ABDELRAZIG BEI, 1989, CEMENT CONCRETE RES, V19, P247, DOI 10.1016/0008-8846(89)90089-6
   Apelt D, 2004, BIOMATERIALS, V25, P1439, DOI 10.1016/j.biomaterials.2003.08.073
   Bodde EWH, 2007, J BIOMED MATER RES B, V83B, P161, DOI 10.1002/jbm.b.30780
   Bohner M, 2004, BIOMATERIALS, V25, P741, DOI 10.1016/S0142-9612(03)00573-8
   Brown P.W., 1986, CEMENTS RES PROGR, V99, P352
   BURGUERA E, 2004, J BIOMED MATER RES A, V71, P272
   Burguera EF, 2006, J BIOMED MATER RES B, V77B, P126, DOI 10.1002/jbm.b.30403
   Burguera EF, 2005, J BIOMED MATER RES A, V75A, P966, DOI 10.1002/jbm.a.30497
   Carey LE, 2005, BIOMATERIALS, V26, P5002, DOI 10.1016/j.biomaterials.2005.01.015
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   del Real RP, 2003, J BIOMED MATER RES A, V65A, P30, DOI 10.1002/jbm.a.10432
   Fernandez E, 1998, J BIOMED MATER RES, V41, P560, DOI 10.1002/(SICI)1097-4636(19980915)41:4<560::AID-JBM7>3.0.CO;2-A
   Guo DG, 2006, J BIOMED MATER RES A, V77A, P313, DOI 10.1002/jbm.a.30629
   Hall DA, 1998, J AM CERAM SOC, V81, P1550
   Hipedinger NE, 2004, CEMENT CONCRETE RES, V34, P157, DOI 10.1016/S0008-8846(03)00256-4
   Hollinger JO, 1996, CLIN ORTHOP RELAT R, P55
   Huan Z, 2007, ACTA BIOMATER, V3, P952, DOI 10.1016/j.actbio.2007.05.003
   JAZAIRI BEI, 1987, CONCRETE, V21, P25
   Julien M, 2007, BIOMATERIALS, V28, P956, DOI 10.1016/j.biomaterials.2006.10.018
   KENT JN, 1986, J ORAL MAXIL SURG, V44, P597, DOI 10.1016/S0278-2391(86)80069-6
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Komaki H, 2006, BIOMATERIALS, V27, P5118, DOI 10.1016/j.biomaterials.2006.05.031
   Kondo N, 2005, BIOMATERIALS, V26, P5600, DOI 10.1016/j.biomaterials.2005.02.026
   Le Nihouannen D, 2005, BONE, V36, P1086, DOI 10.1016/j.bone.2005.02.017
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Liu CS, 2006, BIOMATERIALS, V27, P5003, DOI 10.1016/j.biomaterials.2006.05.043
   Liu CS, 2003, BIOMATERIALS, V24, P2995, DOI 10.1016/S0142-9612(03)00125-X
   LIU CS, Patent No. 7094286
   LIU CS, 1996, THESIS E CHINA U SCI
   Niedhart C, 2001, J BIOMED MATER RES, V55, P530, DOI 10.1002/1097-4636(20010615)55:4<530::AID-JBM1046>3.0.CO;2-D
   Ogose A, 2002, J BIOMED MATER RES, V63, P601, DOI 10.1002/jbm.10380
   Ohura K, 1996, J BIOMED MATER RES, V30, P193, DOI 10.1002/(SICI)1097-4636(199602)30:2<193::AID-JBM9>3.0.CO;2-M
   Ooms EM, 2003, BIOMATERIALS, V24, P749, DOI 10.1016/S0142-9612(02)00408-8
   POPOVICS S, 1987, ACI MATER J, V84, P64
   Ruhe PQ, 2004, BIOMATERIALS, V25, P2123, DOI 10.1016/j.biomaterials.2003.09.007
   Saravanapavan P, 2001, J BIOMED MATER RES, V54, P608, DOI 10.1002/1097-4636(20010315)54:4<608::AID-JBM180>3.0.CO;2-U
   SARKAR AK, 1990, AM CERAM SOC BULL, V69, P234
   SEEHRA SS, 1993, CEMENT CONCRETE RES, V23, P254, DOI 10.1016/0008-8846(93)90090-V
   Soudee E, 2002, CEMENT CONCRETE RES, V32, P153, DOI 10.1016/S0008-8846(01)00647-0
   Soudee E, 2000, CEMENT CONCRETE RES, V30, P315, DOI 10.1016/S0008-8846(99)00254-9
   Stevenson S, 1996, CLIN ORTHOP RELAT R, P66
   Theiss F, 2005, BIOMATERIALS, V26, P4383, DOI 10.1016/j.biomaterials.2004.11.056
   Ueyama Y, 2001, J BIOMED MATER RES, V55, P652, DOI 10.1002/1097-4636(20010615)55:4<652::AID-JBM1060>3.0.CO;2-K
   WU JG, 2006, SHANGHAI MED J, V29, P230
   Wu Jian-guo, 2005, Fudan Xuebao (Yixuekexueban), V32, P707
   Wu Z. Z., 2005, CLIN MED J CHINA, V12, P261
   Wu Zizheng, 2006, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V20, P912
   Xu HHK, 2004, J BIOMED MATER RES A, V68A, P725, DOI 10.1002/jbm.a.20093
   Xu HHK, 2002, J DENT RES, V81, P219, DOI 10.1177/154405910208100315
   Xu HHK, 2007, DENT MATER, V23, P433, DOI 10.1016/j.dental.2006.02.014
   Yang QB, 1999, CEMENT CONCRETE RES, V29, P389, DOI 10.1016/S0008-8846(98)00230-0
   Zhao WY, 2005, BIOMATERIALS, V26, P6113, DOI 10.1016/j.biomaterials.2005.04.025
NR 53
TC 105
Z9 120
U1 6
U2 111
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD NOV
PY 2008
VL 4
IS 6
BP 1873
EP 1884
DI 10.1016/j.actbio.2008.06.020
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 377LT
UT WOS:000261253400032
PM 18662897
DA 2018-10-19
ER

PT J
AU Xin, YC
   Huo, KF
   Tao, H
   Tang, GY
   Chu, PK
AF Xin, Yunchang
   Huo, Kaifu
   Tao, Hu
   Tang, Guoyi
   Chu, Paul K.
TI Influence of aggressive ions on the degradation behavior of biomedical
   magnesium alloy in physiological environment
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Magnesium alloys; Biomaterial; Degradation; Aggressive ions
ID SULFATE-SOLUTIONS; CORROSION; MECHANISMS; IMPLANTS; CHLORIDE
AB Various electrochemical approaches, including potentiodynamic polarization, open circuit potential evolution and electrochemical impedance spectroscopy (EIS), are employed to investigate the degradation behavior of biomedical magnesium alloy under the influence of aggressive ions, such as chloride, phosphate, carbonate and sulfate, in a physiological environment. The synergetic effects and mutual influence of these ions on the degradation behavior of Mg are revealed. Our results demonstrate that chloride ions can induce porous pitting corrosion. In the presence of phosphates, the corrosion rate decreases and the formation of pitting corrosion is significantly delayed due to precipitation of magnesium phosphate. Hydrogen carbonate ions are observed to stimulate the corrosion of magnesium alloy during the early immersion stage but they can also induce rapid passivation on the surface. This surface passivation behavior mainly results from the fast precipitation of magnesium carbonate in the corrosion product layer that can subsequently inhibit pitting corrosion completely. Sulfate ions are also found to stimulate magnesium dissolution. These results improve our understanding on the degradation mechanism of surgical magnesium in the physiological environment. (C) 2008 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Xin, Yunchang; Huo, Kaifu; Tao, Hu; Chu, Paul K.] City Univ Hong Kong, Dept Phys & Mat Sci, Kowloon, Hong Kong, Peoples R China.
   [Xin, Yunchang; Tang, Guoyi] Tsinghua Univ, Shenzhen Grad Sch, Adv Mat Inst, Shenzhen 518055, Peoples R China.
   [Huo, Kaifu] Wuhan Univ Sci & Technol, Coll Mat & Met, Hubei Prov Key Lab Refractories & Ceram, Wuhan 430081, Peoples R China.
RP Chu, PK (reprint author), City Univ Hong Kong, Dept Phys & Mat Sci, Tat Chee Ave, Kowloon, Hong Kong, Peoples R China.
EM paul.chu@cityu.edu.hk
RI Xin, Yunchang/M-3976-2016; Xin, Yunchang/C-7315-2008; Hu,
   Tao/H-5137-2011; Chu, Paul/B-5923-2013; HUO, Kaifu/C-3246-2016
OI Hu, Tao/0000-0001-6937-4017; Chu, Paul/0000-0002-5581-4883; HUO,
   Kaifu/0000-0001-5670-8233
FU City University of Hong Kong Applied Research Grant [9667002]; Key Grant
   Project of Educational Commission of Hubei Province [Z200711001]; Key
   Project of Chinese Ministry of Education [208087]
FX The Project was supported by a City University of Hong Kong Applied
   Research Grant (ARG, No. 9667002), the Key Grant Project of Educational
   Commission of Hubei Province (Z200711001) and the Key Project of Chinese
   Ministry of Education (No. 208087).
CR Baril G, 2007, J ELECTROCHEM SOC, V154, pC108, DOI 10.1149/1.2401056
   CHO SB, 1995, J AM CERAM SOC, V78, P1769, DOI 10.1111/j.1151-2916.1995.tb08887.x
   Gao Jia-cheng, 2004, Chinese Journal of Nonferrous Metals, V14, P1508
   Lindstrom R, 2004, CORROS SCI, V46, P1141, DOI 10.1016/j.corsci.2003.09.010
   Mathieu S, 2003, CORROS SCI, V45, P2741, DOI 10.1016/S0010-938X(03)00109-4
   McBride ED, 1938, J AMER MED ASSOC, V111, P2464, DOI 10.1001/jama.1938.02790530018007
   Morks MF, 2004, MATER LETT, V58, P3316, DOI 10.1016/j.matlet.2004.06.027
   Revell PA, 2004, KEY ENG MAT, V254-2, P447, DOI 10.4028/www.scientific.net/KEM.254-256.447
   Shao CL, 2006, J MATER SCI, V41, P3821, DOI 10.1007/s10853-005-5623-3
   Song G, 1997, CORROS SCI, V39, P1981, DOI 10.1016/S0010-938X(97)00090-5
   Song GL, 1999, ADV ENG MATER, V1, P11, DOI 10.1002/(SICI)1527-2648(199909)1:1<11::AID-ADEM11>3.0.CO;2-N
   Song GL, 2003, ADV ENG MATER, V5, P837, DOI 10.1002/adem.200310405
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Tongamp W, 2007, J MATER SCI, V42, P9210, DOI 10.1007/s10853-007-1866-5
   Vormann Juergen, 2003, Molecular Aspects of Medicine, V24, P27, DOI 10.1016/S0098-2997(02)00089-4
   Weng J, 1997, BIOMATERIALS, V18, P1027, DOI 10.1016/S0142-9612(97)00022-7
   WILTE F, 2006, BIOMATERIALS, V27, P1013
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Yamasaki Y, 2003, BIOMATERIALS, V24, P4913, DOI 10.1016/S0142-9612(03)00414-9
   Zhang YJ, 2005, CORROS SCI, V47, P2816, DOI 10.1016/j.corsci.2005.01.010
   Zreiqat H, 2002, J BIOMED MATER RES, V62, P175, DOI 10.1002/jbm.10270
NR 21
TC 178
Z9 184
U1 2
U2 79
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD NOV
PY 2008
VL 4
IS 6
BP 2008
EP 2015
DI 10.1016/j.actbio.2008.05.014
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 377LT
UT WOS:000261253400045
PM 18571486
DA 2018-10-19
ER

PT J
AU Liu, YY
   Liu, DM
   Chen, SY
   Tung, TH
   Liu, TY
AF Liu, Yen-Yu
   Liu, Dean-Mo
   Chen, San-Yuan
   Tung, Tsan-Hua
   Liu, Tse-Ying
TI In situ synthesis of hybrid nanocomposite with highly order arranged
   amorphous metallic copper nanoparticle in poly(2-hydroxyethyl
   methacrylate) and its potential for blood-contact uses
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Copper nanoparticles; Cupric oxide; pHEMA; Hybrid; Surface charge
ID NITRIC-OXIDE; HEMOCOMPATIBILITY; COMPATIBILITY; PLASMA; BIOMATERIALS;
   REDUCTION; PLATELETS; MEMBRANE; COATINGS; COMPLEX
AB A hybrid consisting of a highly ordered nanostructure of metallic Cu(0) nanoparticles embedded in a poly(2-hydroxyethyl methacrylate) (pHEMA) matrix was successfully synthesized by in situ photopolymerization, followed by in situ chemical reduction. The evolution of an ordered nanostructure of Cu(0) showing a nearly amorphous nature is discussed, and it is proposed that it is due to a coupling interaction between the Cu precursor and the unpaired O of the COOR group, associated with water molecules, among pHEMA molecules. The hybrids showed a negative surface charge and considerable improvement in blood compatibility compared to neat pHEMA and the widely used biomaterial polysulfonate. (C) 2008 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Liu, Yen-Yu; Liu, Dean-Mo; Chen, San-Yuan; Tung, Tsan-Hua] Natl Chiao Tung Univ, Dept Mat Sci & Engn, Hsinchu, Taiwan.
   [Liu, Tse-Ying] Natl Yang Ming Univ, Inst Biomed Engn, Taipei 112, Taiwan.
RP Liu, DM (reprint author), Natl Chiao Tung Univ, Dept Mat Sci & Engn, 1001 Ta Hsueh Rd, Hsinchu, Taiwan.
EM deanmo_liu@yahoo.ca; sanyuanchen@mail.nctu.edu.tw
FU National Science Council of the Republic of China, Taiwan
   [NSC96-2113-M-009-027-MY2]
FX This work was financially supported by the National Science Council of
   the Republic of China, Taiwan under Contract of No.
   NSC96-2113-M-009-027-MY2.
CR BAURSCHMIDT P, 1977, J BIOENG, V1, P261
   Bolz A, 1996, TEX HEART I J, V23, P162
   Dey RK, 2005, J MACROMOL SCI PURE, VA42, P351, DOI 10.1081/MA-200050470
   Goda T, 2006, EXPERT REV MED DEVIC, V3, P167, DOI 10.1586/17434440.3.2.167
   Grunkemeier JM, 1998, J BIOMED MATER RES, V41, P657, DOI 10.1002/(SICI)1097-4636(19980915)41:4<657::AID-JBM18>3.0.CO;2-B
   Hirota E, 2006, J BIOMED MATER RES A, V76A, P540, DOI 10.1002/jbm.a.30563
   Hu CC, 2006, J CHEM ENG JPN, V39, P1283, DOI 10.1252/jcej.39.1283
   Huang C, 1999, APPL PHYS LETT, V74, P1692, DOI 10.1063/1.123657
   Kong DY, 1999, BIOORG MED CHEM LETT, V9, P1087
   Kung FC, 2007, POLYM ADVAN TECHNOL, V18, P286, DOI 10.1002/pat.863
   Liu Y, 2007, SURF COAT TECH, V201, P6851, DOI 10.1016/j.surfcoat.2006.09.021
   Merga G, 2007, J PHYS CHEM C, V111, P12220, DOI 10.1021/jp074257w
   Oh BK, 2004, BIOMATERIALS, V25, P283, DOI 10.1016/S0142-9612(03)00530-1
   Ratner BD, 2007, BIOMATERIALS, V28, P5144, DOI 10.1016/j.biomaterials.2007.07.035
   Shih CC, 2005, J BIOMED MATER RES A, V74A, P325, DOI 10.1002/ibm.a.30255
   Skarja GA, 1997, J BIOMED MATER RES, V34, P439, DOI 10.1002/(SICI)1097-4636(19970315)34:4<439::AID-JBM5>3.0.CO;2-L
   Topala I, 2007, PLASMA CHEM PLASMA P, V27, P95, DOI 10.1007/s11090-006-9046-y
   Tsyganov IA, 2007, NUCL INSTRUM METH B, V257, P122, DOI 10.1016/j.nimb.2006.12.169
   Wang J, 2007, COLLOID SURFACE A, V302, P494, DOI 10.1016/j.colsurfa.2007.03.021
   Wu YD, 2007, SENSOR ACTUAT B-CHEM, V121, P36, DOI 10.1016/j.snb.2006.09.025
   Zhang HP, 2003, J AM CHEM SOC, V125, P5015, DOI 10.1021/ja0291538
NR 21
TC 16
Z9 17
U1 1
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD NOV
PY 2008
VL 4
IS 6
BP 2052
EP 2058
DI 10.1016/j.actbio.2008.05.022
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 377LT
UT WOS:000261253400050
PM 18585991
DA 2018-10-19
ER

PT J
AU Duran, N
   Alvarenga, MA
   Da Silva, EC
   Melo, PS
   Marcato, PD
AF Duran, N.
   Alvarenga, M. A.
   Da Silva, E. C.
   Melo, P. S.
   Marcato, P. D.
TI Microencapsulation of Antibiotic Rifampicin in
   Poly(3-hydroxybutyrate-co-3-hydroxyvalerate)
SO ARCHIVES OF PHARMACAL RESEARCH
LA English
DT Article
DE Controlled release/delivery; Emulsion/microemulsion; Biomaterial;
   Microparticles; Biodegradable polymers;
   Poly(3-hydroxybutyrate-co-3-hydroxyvalerate); Rifampicin; Antibacterial
   Activity; Cytotoxicity
ID ANTIBACTERIAL ACTIVITY EVALUATION; LOADED PLGA MICROSPHERES;
   EXPERIMENTAL TUBERCULOSIS; V79 FIBROBLASTS; DRUG-DELIVERY; RELEASE;
   NANOPARTICLES; POLY(EPSILON-CAPROLACTONE); MICROPARTICLES; CYTOTOXICITY
AB The aim of this study was the preparation of microparticles containing rifampicin using a biodegradable polymer poly(3-hydroxybutyrate-co-3-hydroxyvalerate) for oral administration produced by a bacteria. The poly(3-hydroxybutyrate-co-3-hydroxyvalerate) microparticles with and without rifampicin were prepared by the emulsification and solvent evaporation method, in which chloroform and polyvinyl alcohol are used as the solvent and emulsifier, respectively. Microparticles were obtained within a size range of 20-60 mu m by changing the initial poly(3-hydroxybutyrate-co-3-hydroxyvalerate), polyvinyl alcohol and rifampicin concentrations. An encapsulation efficiency value of 14% was obtained. The optimized total yield of 60% of the poly(3-hydroxybutyrate-co-3-hydroxyvalerate)/rifampicin was obtained. A load of 0.035 mg/l mg of PHBV was reached. Almost 90% of the drug loaded in the microparticles was released after 24 h. The size, encapsulation efficiency and ribampicin release of the microparticles varied as a function of the initial poly(3-hydroxybutyrate-co-3-hydroxyvalerate), polyvinyl alcohol and rifampicin concentrations. It was demonstrated that the microencapsulated rifampicin, although was not totally available in the medium, exhibited a similar inhibition value as free rifampicin at 24 h of incubation with S. aureus. Cytotoxicity assays demonstrated a reduction of the toxicity when rifampicin was microencapsulated in poly(3-hydroxybutyrate-co-3-hydroxyvalerate) while maintaining its antibacterial activity.
C1 [Duran, N.; Marcato, P. D.] Univ Estadual Campinas, Inst Quim, Biol Chem Lab, BR-13083970 Campinas, SP, Brazil.
   [Alvarenga, M. A.; Da Silva, E. C.] Univ Mogi das Cruzes, Biol Chem & Biotechnol Lab, Nucleo Ciencias Ambientais, Mogi Das Cruzes, SP, Brazil.
   [Melo, P. S.] Univ Estadual Campinas, Inst Biol, Dept Bioquim, BR-13083970 Campinas, SP, Brazil.
   [Melo, P. S.] Metropolitam Integrated Fac Campinas METROCAMP, Campinas, SP, Brazil.
RP Duran, N (reprint author), Univ Estadual Campinas, Inst Quim, Biol Chem Lab, CP 6154, BR-13083970 Campinas, SP, Brazil.
EM duran@iqm.unicamp.br
RI Marcato, Priscyla/D-4371-2012
OI Duran, Nelson/0000-0001-8372-5143
FU CNPq; FAPESP; Brazilian Network in Nanobiotechnology and Brazilian
   Network in Nanocosmetics (MCT/CNPq)
FX We acknowledge the financial support from CNPq, FAPESP, Brazilian
   Network in Nanobiotechnology and Brazilian Network in Nanocosmetics
   (MCT/CNPq).
CR Anisimova YV, 2000, J NANOPART RES, V2, P165, DOI 10.1023/A:1010061013365
   BIANCHI V, 1990, TOXICOL IN VITRO, V4, P9, DOI 10.1016/0887-2333(90)90003-C
   Borenfreund E., 1984, J TISSUE CULTURE MET, V9, P7
   Borin A, 2007, ANAL BIOANAL CHEM, V387, P1105, DOI 10.1007/s00216-006-0971-7
   Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0
   Celikkaya E, 1996, ARTIF ORGANS, V20, P743
   Chen J, 2002, J MICROENCAPSUL, V19, P191, DOI 10.1080/02652040110065431
   CINGI MR, 1991, TOXICOL IN VITRO, V5, P119, DOI 10.1016/0887-2333(91)90031-8
   Coccoli V, 2008, J MATER SCI-MATER M, V19, P1703, DOI 10.1007/s10856-007-3253-9
   Coimbra PA, 2008, J MICROENCAPSUL, V25, P170, DOI [10.1080/02652040701814140, 10.1080/02652040701814140 ]
   Correa DHA, 2005, EUR J PHARMACOL, V510, P17, DOI 10.1016/j.ejphar.2005.01.016
   Dang MH, 1997, J ENVIRON POLYM DEGR, V5, P49
   DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6
   Duran N, 2007, PHARMAZIE, V62, P287, DOI 10.1691/ph.2007.4.6058
   Duran N, 2006, J CHEMOTHERAPY, V18, P473, DOI 10.1179/joc.2006.18.5.473
   Esmaeili F, 2007, NANOMED-NANOTECHNOL, V3, P161, DOI 10.1016/j.nano.2007.03.003
   FUMORI I, 2004, COLLOID SURFACE B, V39, P17
   GOGOLEWSKI S, 1993, J BIOMED MATER RES, V27, P1135, DOI 10.1002/jbm.820270904
   Govender T, 1999, J CONTROL RELEASE, V57, P171, DOI 10.1016/S0168-3659(98)00116-3
   HARMA R, 2001, PHARM RES, V18, P1405
   Kamath M. P., 2000, Indian Journal of Experimental Biology, V38, P113
   Kassab AC, 1997, J BIOMAT SCI-POLYM E, V8, P947, DOI 10.1163/156856297X00119
   Labana S, 2002, INT J ANTIMICROB AG, V20, P301, DOI 10.1016/S0924-8579(02)00175-9
   Marcato PD, 2008, J NANOSCI NANOTECHNO, V8, P2216, DOI 10.1166/jnn.2008.274
   Pandey R, 2006, DRUG DELIV, V13, P287, DOI 10.1080/10717540500398076
   Pandey R, 2005, TUBERCULOSIS, V85, P415, DOI 10.1016/j.tube.2005.08.009
   Pandey R, 2003, J ANTIMICROB CHEMOTH, V52, P981, DOI 10.1093/jac/dkg477
   Pandey Rajesh, 2006, Indian Journal of Experimental Biology, V44, P459
   Petrelli D, 2008, J MED MICROBIOL, V57, P364, DOI 10.1099/jmm.0.47621-0
   Pich A, 2006, POLYMER, V47, P1912, DOI 10.1016/j.polymer.2006.01.038
   Schaffazick SR, 2003, QUIM NOVA, V26, P726, DOI 10.1590/S0100-40422003000500017
   Sendil D, 1999, J CONTROL RELEASE, V59, P207, DOI 10.1016/S0168-3659(98)00195-3
   Sharma R, 2007, J ANTIMICROB CHEMOTH, V59, P499, DOI 10.1093/jac/dkl533
   Takenaga M, 2008, DRUG DELIV, V15, P169, DOI 10.1080/10717540801952530 
   Tomoda K, 2005, COLLOID SURFACE B, V45, P1, DOI 10.1016/j.colsurfb.2005.06.014
   Tomoda K, 2007, COLLOID SURFACE B, V55, P115, DOI 10.1016/j.colsurfb.2006.11.030
   ULAIN Q, 2003, J ANTIMICROB CHEMOTH, V51, P931
   Zahoor A, 2005, INT J ANTIMICROB AG, V26, P298, DOI 10.1016/j.ijantimicag.2005.07.012
   ZAHOOR A, 2007, NANOMEDICINE NBM, V3, P239
NR 39
TC 25
Z9 27
U1 1
U2 19
PU PHARMACEUTICAL SOC KOREA
PI SEOUL
PA 1489-3 SUHCHO-DONG, SUHCHO-KU, SEOUL 137-071, SOUTH KOREA
SN 0253-6269
J9 ARCH PHARM RES
JI Arch. Pharm. Res.
PD NOV
PY 2008
VL 31
IS 11
BP 1509
EP 1516
DI 10.1007/s12272-001-2137-7
PG 8
WC Chemistry, Medicinal; Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 387GC
UT WOS:000261938700018
PM 19023549
DA 2018-10-19
ER

PT J
AU de Mel, A
   Jell, G
   Stevens, MM
   Seifalian, AM
AF de Mel, Achala
   Jell, Gavin
   Stevens, Molly M.
   Seifalian, Alexander M.
TI Biofunctionalization of Biomaterials for Accelerated in Situ
   Endothelialization: A Review
SO BIOMACROMOLECULES
LA English
DT Review
ID COLONY-STIMULATING FACTOR; STEM-CELL FACTOR; EXTRACELLULAR-MATRIX
   PROTEINS; RANDOMIZED CONTROLLED-TRIAL; SYNTHETIC VASCULAR GRAFTS;
   PACLITAXEL-ELUTING STENT; CORONARY-ARTERY-DISEASE; PROGENITOR CELLS;
   NITRIC-OXIDE; NEOINTIMAL HYPERPLASIA
AB The higher patency rates of cardiovascular implants, including vascular bypass grafts, stents, and heart valves are related to their ability to inhibit thrombosis, intimal hyperplasia, and calcification. In native tissue, the endothelium plays a major role in inhibiting these processes. Various bioengineering research strategies thereby aspire to induce endothelialization of graft surfaces either prior to implantation or by accelerating in situ graft endothelialization. This article reviews potential bioresponsive molecular components that can be incorporated into (and/or released from) biomaterial surfaces to obtain accelerated in situ endothelialization of vascular grafts. These molecules could promote in situ endothelialization by the mobilization of endothelial progenitor cells (EPC) from the bone marrow, encouraging cell-specific adhesion (endothelial cells (EC) and/or EPC) to the graft and, once attached, by controlling the proliferation and differentiation of these cells. EC and EPC interactions with the extracellular matrix continue to be a principal source of inspiration for material biofunctionalization, and therefore, the latest developments in understanding these interactions will be discussed.
C1 [de Mel, Achala; Seifalian, Alexander M.] UCL, Ctr Nanotechnol Biomat & Tissue Engn, UCL Div Surg & Intervent Sci, London, England.
   [Jell, Gavin; Stevens, Molly M.] Univ London Imperial Coll Sci Technol & Med, Dept Mat, London, England.
   [Jell, Gavin; Stevens, Molly M.] Univ London Imperial Coll Sci Technol & Med, Inst Biomed Engn, London, England.
   [Seifalian, Alexander M.] Royal Free Hampstead NHS Trust Hosp, Univ Dept Surg, London, England.
RP Seifalian, AM (reprint author), UCL, Ctr Nanotechnol Biomat & Tissue Engn, UCL Div Surg & Intervent Sci, London, England.
EM a.seifalian@ucl.ac.uk
RI Seifalian, Alexander/I-6028-2013; Jell, Gavin/B-7855-2010; Jell,
   Gavin/C-4893-2009
OI Seifalian, Alexander/0000-0002-1180-3322; 
FU Engineering and Physical Sciences Research Council [EP/D064872/1]
CR Aicher A, 2005, HYPERTENSION, V45, P321, DOI 10.1161/01.HYP.0000154789.28695.ea
   ALLENDER S, 2007, BRIT EART FDN ANN RE
   Alobaid N, 2006, EUR J VASC ENDOVASC, V32, P76, DOI 10.1016/j.ejvs.2005.11.034
   Alobaid N, 2005, CLIN HEMORHEOL MICRO, V33, P209
   Amarnath LP, 2006, BIOMATERIALS, V27, P1416, DOI 10.1016/j.biomaterials.2005.08.008
   Aoki J, 2005, J AM COLL CARDIOL, V45, P1574, DOI 10.1016/j.jacc.2005.01.048
   Ashman LK, 1999, INT J BIOCHEM CELL B, V31, P1037, DOI 10.1016/S1357-2725(99)00076-X
   Baguneid M, 2004, BIOTECHNOL APPL BIOC, V39, P151, DOI 10.1042/BA20030148
   Bahlmann FH, 2003, KIDNEY INT, V64, P1648, DOI 10.1046/j.1523-1755.2003.00279.x
   Bhat VD, 1998, J BIOMED MATER RES, V40, P57, DOI 10.1002/(SICI)1097-4636(199804)40:1<57::AID-JBM7>3.3.CO;2-6
   Blindt R, 2006, J AM COLL CARDIOL, V47, P1786, DOI 10.1016/j.jacc.2005.11.081
   Bonzani IC, 2006, CURR OPIN CHEM BIOL, V10, P568, DOI 10.1016/j.cbpa.2006.09.009
   Brewster LP, 2007, BIOMATERIALS, V28, P5028, DOI 10.1016/j.biomaterials.2007.07.048
   BUNTING S, 1977, LANCET, V2, P1075
   Cagiannos C, 2005, J VASC SURG, V42, P980, DOI 10.1016/j.jvs.2005.06.018
   Cavallaro G, 2007, J SURG RES, V137, P122, DOI 10.1016/j.jss.2006.07.038
   Chavakis E, 2005, J EXP MED, V201, P63, DOI 10.1084/jem.20041402
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   CHENG S, 1994, J MED CHEM, V37, P1, DOI 10.1021/jm00027a001
   Cho CS, 2006, BIOMATERIALS, V27, P576, DOI 10.1016/j.biomaterials.2005.06.008
   Choi CH, 2007, BIOMATERIALS, V28, P1672, DOI 10.1016/j.biomaterials.2006.11.031
   COYLE CH, 2006, J BIOMATER APPL
   Dalby MJ, 2005, MED ENG PHYS, V27, P730, DOI 10.1016/j.medengphy.2005.04.005
   Daub K, 2007, SEMIN THROMB HEMOST, V33, P173, DOI 10.1055/s-2007-969031
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Dentelli P, 2007, BLOOD, V109, P4264, DOI 10.1182/blood-2006-06-029603
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Doyle B, 2005, TRENDS BIOTECHNOL, V23, P444, DOI 10.1016/j.tibtech.2005.05.013
   Duan XD, 2007, BIOMATERIALS, V28, P78, DOI 10.1016/j.biomaterials.2006.08.034
   Ehrbar M, 2005, J CONTROL RELEASE, V101, P93, DOI 10.1016/j.jconrel.2004.07.018
   FERNANDEZ P, 2007, TISSUE ENG
   Frost MC, 2005, J BIOMED MATER RES A, V72A, P409, DOI 10.1002/jbm.a.30275
   Frost MC, 2004, J AM CHEM SOC, V126, P1348, DOI 10.1021/ja039466i
   Fujiyama S, 2003, CIRC RES, V93, P980, DOI 10.1161/01.RES.0000099245.08637.CE
   Gasteier P, 2007, MACROMOL BIOSCI, V7, P1010, DOI 10.1002/mabi.200700064
   Gauvreau V, 2005, BIOCONJUGATE CHEM, V16, P1088, DOI 10.1021/bc049717s
   Gelain F, 2007, MACROMOL BIOSCI, V7, P544, DOI 10.1002/mabi.200700033
   George J, 2005, CARDIOVASC RES, V68, P299, DOI 10.1016/j.cardiores.2005.06.022
   GREISLER HP, 1987, J VASC SURG, V5, P393, DOI 10.1067/mva.1987.avs0050393
   Groll J, 2005, J BIOMED MATER RES A, V74A, P607, DOI 10.1002/jbm.a.30335
   GROTE K, 2007, BLOOD
   GROVES JT, 2005, SCI STKE, pE45
   Han DK, 2006, ARTIF ORGANS, V30, P955, DOI 10.1111/j.1525-1594.2006.00327.x
   Hasegawa T, 2007, J THORAC CARDIOV SUR, V133, P1268, DOI 10.1016/j.jtcvs.2006.12.049
   Hattori K, 2001, BLOOD, V97, P3354, DOI 10.1182/blood.V97.11.3354
   Heilshorn SC, 2005, BIOMACROMOLECULES, V6, P318, DOI 10.1021/bm049627q
   Heilshorn SC, 2003, BIOMATERIALS, V24, P4245, DOI 10.1016/S0142-9612(03)00294-1
   Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hirano Y, 2004, ADV MATER, V16, P17, DOI 10.1002/adma.200300383
   Hoffmann J, 2006, J BIOMAT SCI-POLYM E, V17, P985, DOI 10.1163/156856206778366059
   Hollenbeck ST, 2004, J SURG RES, V120, P288, DOI 10.1016/j.jss.2004.01.008
   Hristov M, 2007, CIRC RES, V100, P590, DOI 10.1161/01.RES.0000259043.42571.68
   Hsu SH, 2004, J BIOTECHNOL, V111, P143, DOI 10.1016/j.jbiotec.2004.03.014
   Hsu SH, 2003, ARTIF ORGANS, V27, P1068, DOI 10.1111/j.1525-1594.2003.07141.x
   HUBBELL JA, 1991, BIO-TECHNOL, V9, P568, DOI 10.1038/nbt0691-568
   Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098
   Hunter WL, 2006, ADV DRUG DELIVER REV, V58, P347, DOI 10.1016/j.addr.2006.01.013
   Hynd MR, 2007, J NEUROSCI METH, V162, P255, DOI 10.1016/j.jneumeth.2007.01.024
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Inoguchi H, 2007, BIOMATERIALS, V28, P486, DOI 10.1016/j.biomaterials.2006.09.020
   Ishizawa K, 2004, BIOCHEM BIOPH RES CO, V324, P276, DOI 10.1016/j.bbrc.2004.09.049
   Jevon M, 2008, CELL PROLIFERAT, V41, P146, DOI 10.1111/j.1365-2184.2008.00488.x
   Jiang XS, 2006, BIOMATERIALS, V27, P2723, DOI 10.1016/j.biomaterials.2005.12.001
   Jun HW, 2005, TISSUE ENG, V11, P1133, DOI 10.1089/ten.2005.11.1133
   Jun HW, 2005, BIOMACROMOLECULES, V6, P838, DOI 10.1021/bm049419y
   Kang HJ, 2004, LANCET, V363, P751, DOI 10.1016/S0140-6736(04)15689-4
   Kannan RY, 2006, BIOMATERIALS, V27, P4618, DOI 10.1016/j.biomaterials.2006.04.024
   Kannan RY, 2006, BIOMACROMOLECULES, V7, P215, DOI 10.1021/bm050590z
   Kannan RY, 2005, J BIOMED MATER RES B, V74B, P570, DOI 10.1002/jbm.b.30247
   Kannan RY, 2005, ACCOUNTS CHEM RES, V38, P879, DOI 10.1021/ar050055b
   Karrer L, 2005, INT J ARTIF ORGANS, V28, P993
   Kaul S, 2000, J AM COLL CARDIOL, V35, P493, DOI 10.1016/S0735-1097(99)00543-4
   KHADEMHOSSEINI A, 2007, NANOBIOTECHNOL DRUG
   Kidane AG, 2004, BIOMACROMOLECULES, V5, P798, DOI 10.1021/bm0344553
   Kidane AG, 2006, J BIOMED MATER RES A, V79A, P606, DOI 10.1002/jbm.a.30817
   Kleinman HK, 2003, CURR OPIN BIOTECH, V14, P526, DOI 10.1016/j.copbio.2003.08.002
   Klenkler BJ, 2005, BIOMATERIALS, V26, P7286, DOI 10.1016/j.biomaterials.2005.05.045
   KOIVUNEN E, 1995, BIO-TECHNOL, V13, P265, DOI 10.1038/nbt0395-265
   Kojima N, 2006, BIOMATERIALS, V27, P4904, DOI 10.1016/j.biomaterials.2006.05.026
   Koo LY, 2002, J CELL SCI, V115, P1423
   Kotch FW, 2006, P NATL ACAD SCI USA, V103, P3028, DOI 10.1073/pnas.0508783103
   Kown MH, 2001, J THORAC CARDIOV SUR, V121, P971, DOI 10.1067/mtc.2001.112532
   Krenning G, 2007, BIOMATERIALS, V28, P1470, DOI 10.1016/j.biomaterials.2006.11.017
   Krijgsman B, 2002, TISSUE ENG, V8, P673, DOI 10.1089/107632702760240580
   Kumar TRS, 2001, BIOMATERIALS, V22, P2769
   Lahtinen M, 2007, EUR J CARDIO-THORAC, V31, P383, DOI 10.1016/j.ejcts.2006.11.048
   Langer H, 2006, CIRC RES, V98, pE2, DOI 10.1161/01.RES.0000201285.87524.9e
   Langer HF, 2007, SEMIN THROMB HEMOST, V33, P136, DOI 10.1055/s-2007-969026
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Larsen CC, 2007, BIOMATERIALS, V28, P3537, DOI 10.1016/j.biomaterials.2007.04.026
   Letourneur D, 2002, J BIOMED MATER RES, V60, P94, DOI 10.1002/jbm.10072
   Lev EI, 2006, THROMB HAEMOSTASIS, V96, P498, DOI 10.1160/TH06-05-0250
   Li C, 2005, J BIOMAT SCI-POLYM E, V16, P875, DOI 10.1163/1568562054255754
   Lin X, 2006, BBA-GEN SUBJECTS, V1760, P1403, DOI 10.1016/j.bbagen.2006.05.010
   Liu JC, 2004, BIOMACROMOLECULES, V5, P497, DOI 10.1021/bm034340z
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   Mart RJ, 2006, SOFT MATTER, V2, P822, DOI 10.1039/b607706d
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   Massia SP, 2001, J BIOMED MATER RES, V56, P390, DOI 10.1002/1097-4636(20010905)56:3<390::AID-JBM1108>3.0.CO;2-L
   McMillan R, 2001, J BIOMED MATER RES, V54, P272, DOI 10.1002/1097-4636(200102)54:2<272::AID-JBM15>3.0.CO;2-3
   Meinhart JG, 2005, TISSUE ENG, V11, P887, DOI 10.1089/ten.2005.11.887
   Meinhart JG, 2001, ANN THORAC SURG, V71, pS327, DOI 10.1016/S0003-4975(01)02555-3
   Melero-Martin JM, 2007, BLOOD, V109, P4761, DOI 10.1182/blood-2006-12-062471
   Miller DC, 2004, BIOMATERIALS, V25, P53, DOI 10.1016/S0142-9612(03)00471-X
   Mochizuki M, 2003, FASEB J, V17, P875, DOI 10.1096/fj.02-0564fje
   Mochizuki M, 2007, ARCH BIOCHEM BIOPHYS, V459, P249, DOI 10.1016/j.abb.2006.12.026
   Moore MAS, 2001, ANN NY ACAD SCI, V938, P36
   Mougin K, 2005, LANGMUIR, V21, P4809, DOI 10.1021/la050613v
   Ochsenhirt SE, 2006, BIOMATERIALS, V27, P3863, DOI 10.1016/j.biomaterials.2005.12.012
   Olbrich M, 2007, J BIOMAT SCI-POLYM E, V18, P453, DOI 10.1163/156856207780425059
   Park K, 2000, J BIOMAT SCI-POLYM E, V11, P1121, DOI 10.1163/156856200744228
   PATEL S, 2007, J BIOMED MAT RES A
   PIERSCHBACHER M, 1983, P NATL ACAD SCI-BIOL, V80, P1224, DOI 10.1073/pnas.80.5.1224
   PIERSCHBACHER MD, 1987, J BIOL CHEM, V262, P17294
   Plouffe BD, 2007, LANGMUIR, V23, P5050, DOI 10.1021/la0700220
   Putnam AJ, 1996, NAT MED, V2, P824, DOI 10.1038/nm0796-824
   Qin GJ, 2006, J EXP MED, V203, P153, DOI 10.1084/jem.20050459
   RADOMSKI MW, 1987, LANCET, V2, P1057
   Randone B, 2005, J SURG RES, V127, P70, DOI 10.1016/j.jss.2004.09.005
   Reyes CD, 2007, BIOMATERIALS, V28, P3228, DOI 10.1016/j.biomaterials.2007.04.003
   Reyes CD, 2003, J BIOMED MATER RES A, V65A, P511, DOI 10.1002/jbm.a.10550
   Reynolds MM, 2006, BIOMACROMOLECULES, V7, P987, DOI 10.1021/bm060028o
   Rodenberg EJ, 2007, TISSUE ENG, V13, P2653, DOI 10.1089/ten.2007.0037
   Rosso F, 2004, J CELL PHYSIOL, V199, P174, DOI 10.1002/jcp.10471
   Ruegg C, 2004, BBA-REV CANCER, V1654, P51, DOI 10.1016/j.bbcan.2003.09.003
   Salacinski HJ, 2003, J BIOMED MATER RES A, V66A, P688, DOI 10.1002/jbm.a.10020
   Salacinski HJ, 2000, EUR J VASC ENDOVASC, V20, P342, DOI 10.1053/ejvs.2000.1185
   Santiago LY, 2006, BIOMATERIALS, V27, P2962, DOI 10.1016/j.biomaterials.2006.01.011
   Sarkar S, 2007, MED BIOL ENG COMPUT, V45, P327, DOI 10.1007/s11517-007-0176-z
   Sarkar S, 2007, J BIOMED MATER RES B, V82B, P100, DOI 10.1002/jbm.b.30710
   Schachner M, 2000, NATURE, V405, P747, DOI 10.1038/35015648
   Schense JC, 2000, J BIOL CHEM, V275, P6813, DOI 10.1074/jbc.275.10.6813
   Schofer J, 2003, LANCET, V362, P1093, DOI 10.1016/S0140-6736(03)14462-5
   Seifalian AM, 2002, ARTIF ORGANS, V26, P209, DOI 10.1046/j.1525-1594.2002.00878.x
   Shin JH, 2007, J AM CHEM SOC, V129, P4612, DOI 10.1021/ja0674338
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Smadja DM, 2007, CELL BIOL TOXICOL, V23, P223, DOI 10.1007/s10565-007-0177-6
   SMITH JW, 1990, J BIOL CHEM, V265, P2168
   SMITH JW, 1990, J BIOL CHEM, V265, P12267
   Stegemann JP, 2007, TISSUE ENG, V13, P2601, DOI 10.1089/ten.2007.0196
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Stone GW, 2005, JAMA-J AM MED ASSOC, V294, P1215, DOI 10.1001/jama.294.10.1215
   Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441
   TAITE LJ, 2007, J BIOMED MAT RES B
   Takamiya M, 2006, ARTERIOSCL THROM VAS, V26, P751, DOI 10.1161/01.ATV.0000205607.98538.9a
   Tan YH, 2007, CARDIOVASC RES, V73, P823, DOI 10.1016/j.cardiores.2006.12.015
   TASHIRO K, 1989, J BIOL CHEM, V264, P16174
   Thebaud NB, 2007, J MATER SCI-MATER M, V18, P339, DOI 10.1007/s10856-006-0698-1
   Thomas AC, 2003, CARDIOVASC PATHOL, V12, P271, DOI 10.1016/S1054-8807(03)00086-3
   Tigue CC, 2007, BONE MARROW TRANSPL, V40, P185, DOI 10.1038/sj.bmt.1705722
   Tiwari A, 2003, EUR J VASC ENDOVASC, V25, P325, DOI 10.1053/ejvs.2002.1854
   Urao N, 2006, CIRC RES, V98, P1405, DOI 10.1161/01.RES.0000224117.59417.f3
   Urban P, 2007, LANCET, V369, P619, DOI 10.1016/S0140-6736(07)60289-X
   Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78
   VANE JR, 1991, WIEN KLIN WOCHENSCHR, V103, P403
   Vats A, 2005, LANCET, V366, P592, DOI 10.1016/S0140-6736(05)66879-1
   Veiseh M, 2007, LANGMUIR, V23, P4472, DOI 10.1021/la062849k
   Verma S, 2005, NEW ENGL J MED, V353, P730, DOI 10.1056/NEJMcibr052030
   Walpoth BH, 2007, J THORAC CARDIOV SUR, V133, P1163, DOI 10.1016/j.jtcvs.2007.01.029
   Walter DH, 2002, CIRCULATION, V105, P3017, DOI 10.1161/01.CIR.0000018166.84319.55
   Wang CH, 2006, CIRC RES, V99, P617, DOI 10.1161/01.RES.0000243210.79654.fd
   Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427
   Weber LM, 2007, BIOMATERIALS, V28, P3004, DOI 10.1016/j.biomaterials.2007.03.005
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Wojakowski W, 2006, EUR HEART J, V27, P1013, DOI 10.1093/eurheartj/ehi889
   Woolfson DN, 2006, CURR OPIN CHEM BIOL, V10, P559, DOI 10.1016/j.cbpa.2006.09.019
   Xiao Y, 1996, BIOPHYS J, V71, P2869, DOI 10.1016/S0006-3495(96)79484-5
   Yim EKF, 2005, NANOMED-NANOTECHNOL, V1, P10, DOI 10.1016/j.nano.2004.11.008
   Yin ZL, 1997, CLIN EXP PHARMACOL P, V24, P436, DOI 10.1111/j.1440-1681.1997.tb01218.x
   Yoshioka T, 2006, CARDIOVASC RES, V70, P61, DOI 10.1016/j.cardiores.2005.12.013
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
NR 173
TC 202
Z9 203
U1 8
U2 116
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD NOV
PY 2008
VL 9
IS 11
BP 2969
EP 2979
DI 10.1021/bm800681k
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 371UM
UT WOS:000260856900001
PM 18831592
DA 2018-10-19
ER

PT J
AU Strand, SP
   Issa, MM
   Christensen, BE
   Varum, KM
   Artursson, P
AF Strand, Sabina P.
   Issa, Mohamed M.
   Christensen, Bjorn E.
   Varum, Kjell M.
   Artursson, Per
TI Tailoring of Chitosans for Gene Delivery: Novel Self-Branched
   Glycosylated Chitosan Oligomers with Improved Functional Properties
SO BIOMACROMOLECULES
LA English
DT Article
ID ADMINISTRATION IN-VIVO; TRANSFECTION EFFICIENCY; PHYSICOCHEMICAL
   PROPERTIES; INTRACELLULAR TRAFFICKING; CHEMICAL-MODIFICATION;
   LIGHT-SCATTERING; MOLECULAR-WEIGHT; VITRO; DNA; CYTOTOXICITY
AB Chitosan is a promising biomaterial with an attractive safety profile; however, its application potential for gene delivery is hampered by poor compatibility at physiological pH values. Here we have tailored the molecular architecture of chitosan to improve the functional properties and gene transfer efficacy of chitosan oligomers and have developed self-branched glycosylated chitosan oligomer (SB-TCO) substituted with a trisaccharide containing N-acetylglucosamine, AAM. SB-TCO was prepared by controlled depolymerization of chitosan, followed by simultaneous branching and AAM substitution. The product was fully soluble at physiological pH and complexed plasmid DNA into polyplexes of high colloidal and physical stability. SB-TCO displayed high transfection efficacy in HEK293 cells, reaching transfection efficiencies of up to 70%, and large amounts of transgene were produced. Gene transfer efficacy was confirmed in HepG2 cells, where gene expression levels mediated by SB-TCO were up to 10 and 4 times higher than those obtained with unsubstituted and substituted linear oligomers, respectively. The rapid onset of transgene expression in both cell lines indicates efficient DNA release and transcription from SB-TCO polyplexes. In comparison with 22 kDa linear PEI-based transfection reagent used as the control, SB-TCO possessed higher gene transfer efficacy, significantly lower cytotoxicity, and improved serum compatibility.
C1 [Strand, Sabina P.; Christensen, Bjorn E.; Varum, Kjell M.] Norwegian Univ Sci & Technol NTNU, Norwegian Biopolymer Lab NOBIPOL, Dept Biotechnol, N-7491 Trondheim, Norway.
   [Strand, Sabina P.; Issa, Mohamed M.; Artursson, Per] Uppsala Univ, Dept Pharm, S-75123 Uppsala, Sweden.
RP Strand, SP (reprint author), Norwegian Univ Sci & Technol NTNU, Norwegian Biopolymer Lab NOBIPOL, Dept Biotechnol, N-7491 Trondheim, Norway.
EM sabina.strand@biotech.ntnu.no
RI Christensen, Bjorn E./G-6033-2015
OI Christensen, Bjorn E./0000-0002-1135-9815
FU Norwegian University of Science and Technology; Novamatrix/FMC
   Biopolymer AS (Oslo, Norway)
FX This work was supported by a post doc fellowship from Norwegian
   University of Science and Technology to S.P.S. and a grant from
   Novamatrix/FMC Biopolymer AS (Oslo, Norway).
CR Akinc A, 2003, BIOCONJUGATE CHEM, V14, P979, DOI 10.1021/bc034067y
   Arote R, 2007, BIOMATERIALS, V28, P735, DOI 10.1016/j.biomaterials.2006.09.028
   Bowman K, 2006, INT J NANOMED, V1, P117, DOI 10.2147/nano.2006.1.2.117
   Breunig M, 2004, J NANOSCI NANOTECHNO, V4, P512, DOI 10.1166/jnn.2004.080
   Breunig M, 2007, P NATL ACAD SCI USA, V104, P14454, DOI 10.1073/pnas.0703882104
   Christensen BE, 2008, CARBOHYD POLYM, V74, P559, DOI 10.1016/j.carbpol.2008.04.012
   Corsi K, 2003, BIOMATERIALS, V24, P1255, DOI 10.1016/S0142-9612(02)00507-0
   Dang JM, 2006, ADV DRUG DELIVER REV, V58, P487, DOI 10.1016/j.addr.2006.03.001
   Danielsen S, 2005, BBA-GEN SUBJECTS, V1721, P44, DOI 10.1016/j.bbagen.2004.10.011
   Danielsen S, 2004, BIOMACROMOLECULES, V5, P928, DOI 10.1021/bm034502r
   Dash PR, 2000, J BIOL CHEM, V275, P3793, DOI 10.1074/jbc.275.6.3793
   Fischer D, 2003, BIOMATERIALS, V24, P1121, DOI 10.1016/S0142-9612(02)00445-3
   Forrest ML, 2003, BIOCONJUGATE CHEM, V14, P934, DOI 10.1021/bc034014g
   Germershaus O, 2008, J CONTROL RELEASE, V125, P145, DOI 10.1016/j.jconrel.2007.10.013
   Hashimoto M, 2006, BIOCONJUGATE CHEM, V17, P309, DOI 10.1021/bc050228h
   Huang M, 2005, J CONTROL RELEASE, V106, P391, DOI 10.1016/j.cornel.2005.05.004
   Hunter AC, 2006, ADV DRUG DELIVER REV, V58, P1523, DOI 10.1016/j.addr.2006.09.008
   Issa MM, 2006, J CONTROL RELEASE, V115, P103, DOI 10.1016/j.jconrel.2006.06.029
   Issa Mohamed M, 2005, Drug Discov Today Technol, V2, P1, DOI 10.1016/j.ddtec.2005.05.008
   Jiang X, 2006, J GENE MED, V8, P477, DOI 10.1002/jgm.868
   Jon S, 2003, BIOMACROMOLECULES, V4, P1759, DOI 10.1021/bm034176f
   Kean T, 2005, J CONTROL RELEASE, V103, P643, DOI 10.1016/j.jconrel.2004.01.001
   Kim TH, 2007, PROG POLYM SCI, V32, P726, DOI 10.1016/j.progpolymsci.2007.05.001
   Koping-Hoggard M, 2004, GENE THER, V11, P1441, DOI 10.1038/sj.gt.3302312
   Koping-Hoggard M, 2003, J GENE MED, V5, P130, DOI 10.1002/jgm.327
   Koping-Hoggard M, 2001, GENE THER, V8, P1108, DOI 10.1038/sj.gt.3301492
   Lavertu M, 2006, BIOMATERIALS, V27, P4815, DOI 10.1016/j.biomaterials.2006.04.029
   Lee D, 2007, PHARM RES, V24, P157, DOI 10.1007/s11095-006-9136-9
   Lee KY, 2007, MACROMOL RES, V15, P195, DOI 10.1007/BF03218774
   Lv HT, 2006, J CONTROL RELEASE, V114, P100, DOI 10.1016/j.jconrel.2006.04.014
   Mao SR, 2004, INT J PHARM, V281, P45, DOI 10.1016/j.ijpharm.2004.05.019
   Merdan T, 2005, BIOCONJUGATE CHEM, V16, P785, DOI 10.1021/bc049743q
   Mishra S, 2004, EUR J CELL BIOL, V83, P97, DOI 10.1078/0171-9335-00363
   Moghimi SM, 2005, MOL THER, V11, P990, DOI 10.1016/j.mythe.2005.02.010
   Nagasaki T, 2004, BIOCONJUGATE CHEM, V15, P249, DOI 10.1021/bc034178x
   Park IK, 2003, J DISPER SCI TECHNOL, V24, P489, DOI 10.1081/DIS-120021804
   Romoren K, 2003, INT J PHARM, V261, P115, DOI 10.1016/S0378-5173(03)00301-6
   Srinivasachari S, 2007, BIOMATERIALS, V28, P2885, DOI 10.1016/j.biomaterials.2007.01.037
   Srinivasachari S, 2006, J AM CHEM SOC, V128, P8176, DOI 10.1021/ja0585580
   Strand SP, 2005, BIOMACROMOLECULES, V6, P3357, DOI 10.1021/bm0503726
   Strand SP, 2001, BIOMACROMOLECULES, V2, P1310, DOI 10.1021/bm015598x
   Thanou M, 2002, BIOMATERIALS, V23, P153, DOI 10.1016/S0142-9612(01)00090-4
   Thomas Philip, 2005, Journal of Pharmacological and Toxicological Methods, V51, P187, DOI 10.1016/j.vascn.2004.08.014
   Tommeraas K, 2001, CARBOHYD RES, V333, P137, DOI 10.1016/S0008-6215(01)00130-6
   Tommeraas K, 2002, CARBOHYD RES, V337, P2455, DOI 10.1016/S0008-6215(02)00334-8
   Varum K. M., 2004, POLYSACCHARIDES STRU, P625
   VARUM KM, 1994, CARBOHYD POLYM, V25, P65, DOI 10.1016/0144-8617(94)90140-6
   Zhang YQ, 2007, BIOTECHNOL APPL BIOC, V46, P197, DOI 10.1042/BA2060163
NR 48
TC 65
Z9 69
U1 0
U2 25
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD NOV
PY 2008
VL 9
IS 11
BP 3268
EP 3276
DI 10.1021/bm800832u
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 371UM
UT WOS:000260856900040
PM 18834173
DA 2018-10-19
ER

PT J
AU Liu, Y
   Strauss, J
   Camesano, TA
AF Liu, Yatao
   Strauss, Joshua
   Camesano, Terri A.
TI Adhesion forces between Staphylococcus epidermidis and surfaces bearing
   self-assembled monolayers in the presence of model proteins
SO BIOMATERIALS
LA English
DT Article
DE Bacterial adhesion; Atomic force microscopy; Adhesion; Biofouling
ID FIBRONECTIN-BINDING PROTEIN; BIOFILM FORMATION; BACTERIAL ADHESION;
   MICROBIAL BIOFILMS; OPTICAL TWEEZERS; POLYMER BRUSHES; AUREUS; SILVER;
   INFECTIONS; INHIBITION
AB Self-assembled monolayers (SAMs) are being developed into coatings to reduce microbial biofilm formation on biomaterials. To test anti-adhesion properties, SAMs can be easily constructed on gold, and used to represent a coated biomaterial. However, coatings that prevent bacterial adhesion must also resist protein adsorption. We explored the competitive effects of bacteria and protein for adsorption to SAMs, choosing fetal bovine serum (FBS) to represent protein non-specific binding, and fibronectin (FN) to evaluate ligand/receptor binding. Staphylococcus epidermidis were immobilized on an atomic force microscope (AFM) tip and used as a force probe to detect the interaction forces between bacteria and gold-coated SAMs. The SAMs tested were alkanethiol molecules terminating in isophthalic acid (IPA) or isophthalic acid with silver (IAG). While S. epidermidis showed weak interactions with FBS, the bacteria showed strong adhesion with FN, due to ligand/receptor binding. Bacterial retention and viability experiments were correlated with the force measurements. S. epidermidis interacting with IAG SAMs showed a loss of viability, due to the mobility of silver ions. For most substrata, there was a link between high adhesion forces with bacteria and a high percentage of dead cells being retained on that substratum (even in the absence of a specific biocidal effect, such as silver). This may suggest that high adhesion forces can cause stress to the bacteria which contributed to their death. The relationship between highly adhesive SAMs and bacterial inactivation may be useful in future biomaterial design. When evaluating coatings for biomaterials, it is important to consider the interplay between bacteria, proteins, and the coating material. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Liu, Yatao; Strauss, Joshua; Camesano, Terri A.] Worcester Polytech Inst, Dept Chem Engn, Life Sci & Bioengn Ctr, Worcester, MA 01609 USA.
RP Camesano, TA (reprint author), Worcester Polytech Inst, Dept Chem Engn, Life Sci & Bioengn Ctr, Gateway Pk,100 Inst Rd, Worcester, MA 01609 USA.
EM terric@wpi.edu
RI Liu, Yatao/D-1702-2010
OI Liu, Yatao/0000-0003-3623-1030
FU National Science Foundation [BES 0238627]
FX This work was supported in part by the National Science Foundation
   through grant BES 0238627. We are grateful to Prof. W. Grant McGimpsey
   and Mr. Eftim Milkani for their assistance with SAMs preparation, and to
   Ms. Xiaoshu Dai and Prof. Satya Shivkumar for their assistance with SEM
   measurements. We also thank Dr. Stephen Heard, Dr. Ray Emerson, and Mr.
   Pete Driscoll for helpful discussions throughout the course of these
   studies.
CR Arciola CR, 2003, BIOMATERIALS, V24, P3013, DOI 10.1016/S0142-9612(03)00133-9
   Bahna P, 2007, INT J ANTIMICROB AG, V29, P593, DOI 10.1016/j.ijantimicag.2006.12.013
   Balazs DJ, 2004, BIOMATERIALS, V25, P2139, DOI 10.1016/j.biomaterials.2003.08.053
   Barthelson R, 1998, INFECT IMMUN, V66, P1439
   Bechert T, 1999, INFECTION, V27, pS24, DOI 10.1007/BF02561613
   Bologna RA, 1999, UROLOGY, V54, P982, DOI 10.1016/S0090-4295(99)00318-0
   Boulmedais F, 2004, BIOMATERIALS, V25, P2003, DOI 10.1016/j.biomaterials.2003.08.039
   Bruinsma GM, 2001, J MICROBIOL METH, V45, P95, DOI 10.1016/S0167-7012(01)00238-X
   Bruinsma GM, 2001, BIOMATERIALS, V22, P3217, DOI 10.1016/S0142-9612(01)00159-4
   Burnham NA, 2003, NANOTECHNOLOGY, V14, P1, DOI 10.1088/0957-4484/14/1/301
   Busscher HJ, 2008, APPL ENVIRON MICROB, V74, P2559, DOI 10.1128/AEM.02839-07
   BUSSCHER HJ, 1987, FEMS MICROBIOL LETT, V46, P165, DOI 10.1016/0378-1097(87)90062-0
   Bustanji Y, 2003, P NATL ACAD SCI USA, V100, P13292, DOI 10.1073/pnas.1735343100
   CAMESANO TA, 2007, Patent No. 2007109689
   Chapman RG, 2001, LANGMUIR, V17, P1225, DOI 10.1021/la001222d
   Chen W, 2006, BIOMATERIALS, V27, P5512, DOI 10.1016/j.biomaterials.2006.07.003
   Cheng G, 2007, BIOMATERIALS, V28, P4192, DOI 10.1016/j.biomaterials.2007.05.041
   Dufrene YF, 2001, ULTRAMICROSCOPY, V86, P113, DOI 10.1016/S0304-3991(00)00079-6
   Emerson RJ, 2006, LANGMUIR, V22, P11311, DOI 10.1021/la061984u
   Ewald A, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-22
   GAO XP, 1992, J PHYS CHEM-US, V96, P4156, DOI 10.1021/j100190a011
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Hall-Stoodley L, 2002, CURR OPIN BIOTECH, V13, P228, DOI 10.1016/S0958-1669(02)00318-X
   HEILMANN C, 2003, MED IMPLICATIONS BIO, P110
   Hendricks SK, 2000, J BIOMED MATER RES, V50, P160, DOI 10.1002/(SICI)1097-4636(200005)50:2<160::AID-JBM10>3.0.CO;2-M
   Hou SY, 2007, APPL ENVIRON MICROB, V73, P4300, DOI 10.1128/AEM.02633-06
   Huesca M, 2000, INFECT IMMUN, V68, P1156, DOI 10.1128/IAI.68.3.1156-1163.2000
   Ista LK, 1996, FEMS MICROBIOL LETT, V142, P59
   Jarvis RA, 2005, J BIOMED MATER RES A, V75A, P41, DOI 10.1002/jbm.a.30404
   Joh D, 1998, EUR J BIOCHEM, V258, P897, DOI 10.1046/j.1432-1327.1998.2580897.x
   Keane FM, 2007, BIOCHEMISTRY-US, V46, P7226, DOI 10.1021/bi700454x
   Kinnari TJ, 2004, LARYNGOSCOPE, V114, P2038, DOI 10.1097/01.mlg.0000147944.20676.17
   Lee S, 2005, LANGMUIR, V21, P11957, DOI 10.1021/la051932p
   Liu Y, 2008, COLLOID SURFACE B, V65, P35, DOI 10.1016/j.colsurfb.2008.02.012
   Liu YT, 2007, LANGMUIR, V23, P7134, DOI 10.1021/la700575u
   Lu TK, 2007, P NATL ACAD SCI USA, V104, P11197, DOI 10.1073/pnas.0704624104
   Mack D, 2006, INT J ARTIF ORGANS, V29, P343
   Mack D, 1999, J HOSP INFECT, V43, pS113, DOI 10.1016/S0195-6701(99)90074-9
   Melaiye A, 2005, EXPERT OPIN THER PAT, V15, P125, DOI 10.1517/13543776
   Melchior MB, 2006, VET J, V171, P398, DOI 10.1016/j.tvjl.2005.01.006
   MENDEZVILAS M, 2008, COLLOID SURFACE B, V63, P101
   Montanaro L, 1999, MICROBIOLOGICA, V22, P331
   MOSHER DF, 1980, SCIENCE, V209, P927, DOI 10.1126/science.7403857
   Nienow AW, 2005, INZ CHEM PROCESOWA, V26, P395
   Oliveira M, 2006, VET MICROBIOL, V118, P133, DOI 10.1016/j.vetmic.2006.07.008
   Ostaci RV, 2008, LANGMUIR, V24, P2732, DOI 10.1021/la703086x
   Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m
   Patel JD, 2007, J BIOMED MATER RES A, V80A, P742, DOI 10.1002/jbm.a.31103
   Percival SL, 2005, J HOSP INFECT, V60, P1, DOI 10.1016/j.jhin.2004.11.014
   Popat KC, 2007, BIOMATERIALS, V28, P4880, DOI 10.1016/j.biomaterials.2007.07.037
   Qiu Y, 2007, INT J ARTIF ORGANS, V30, P828
   Rodriguez JA, 2003, J AM CHEM SOC, V125, P276, DOI 10.1021/ja021007e
   Rudino-Pinera E, 2007, J MOL BIOL, V368, P833, DOI 10.1016/j.jmb.2007.02.061
   Sahoo S, 2006, BIOTECHNOL BIOENG, V94, P118, DOI 10.1002/bit.20835
   Schwarz-Linek U, 2003, NATURE, V423, P177, DOI 10.1038/nature0189
   Shi JX, 2004, ANAL CHEM, V76, P632, DOI 10.1021/ac020796f
   SIGNAS C, 1989, P NATL ACAD SCI USA, V86, P699, DOI 10.1073/pnas.86.2.699
   Simpson KH, 2004, BIOMOL ENG, V21, P105, DOI 10.1016/j.bioeng.2004.08.00l
   Simpson KH, 2003, J BACTERIOL, V185, P2031, DOI 10.1128/JB.185.6.2031-2035.2003
   Sone H, 2004, JPN J APPL PHYS 1, V43, P4663, DOI 10.1143/JJAP.43.4663
   Steenackers M, 2007, SMALL, V3, P1764, DOI 10.1002/smll.200700187
   Stewart PS, 1996, ANTIMICROB AGENTS CH, V40, P2517, DOI 10.1128/AAC.40.11.2517
   Stobie N, 2008, BIOMATERIALS, V29, P963, DOI 10.1016/j.biomaterials.2007.10.057
   STRAUSS J, 2008, ACS SYM SER, V984, P79
   Vadillo-Rodrigues V, 2004, APPL ENVIRON MICROB, V70, P5441, DOI 10.1128/AEM.70.9.5441-5446.2004
   VANOSS CJ, 1994, INTERFACIAL FORCES A
   Vericat C, 2006, J PHYS-CONDENS MAT, V18, pR867, DOI 10.1088/0953-8984/18/48/R01
   Vericat C, 2000, J PHYS CHEM B, V104, P302, DOI 10.1021/jp9927451
   Wang MS, 2004, LANGMUIR, V20, P7753, DOI 10.1021/la049849+
   WIENCEK KM, 1995, J BACTERIOL, V177, P1959, DOI 10.1128/jb.177.8.1959-1966.1995
   Williams RJ, 2002, INFECT IMMUN, V70, P6805, DOI 10.1128/IAI.70.12.6805-6810.2002
   Woodyard LL, 1996, J CONTROL RELEASE, V40, P23, DOI 10.1016/0168-3659(95)00135-2
   Wu P, 2006, BIOMATERIALS, V27, P2450, DOI 10.1016/j.biomaterials.2005.11.031
   Xu LC, 2007, BIOMATERIALS, V28, P3273, DOI 10.1016/j.biomaterials.2007.03.032
   Yongsunthon R, 2006, J ELECTRON SPECTROSC, V150, P228, DOI 10.1016/j.elspec.2005.06.012
   Yongsunthon R, 2007, LANGMUIR, V23, P2289, DOI 10.1021/la063117v
NR 76
TC 59
Z9 59
U1 1
U2 48
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2008
VL 29
IS 33
BP 4374
EP 4382
DI 10.1016/j.biomaterials.2008.07.044
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 361WL
UT WOS:000260158100002
PM 18760835
DA 2018-10-19
ER

PT J
AU Ju, DJ
   Byun, IG
   Park, JJ
   Lee, CH
   Ahn, GH
   Park, TJ
AF Ju, D. J.
   Byun, I. G.
   Park, J. J.
   Lee, C. H.
   Ahn, G. H.
   Park, T. J.
TI Biosorption of a reactive dye (Rhodamine-B) from an aqueous solution
   using dried biomass of activated sludge
SO BIORESOURCE TECHNOLOGY
LA English
DT Article
DE biosorption; dried activated sludge; Rhodamine-B; swelling; pretreatment
ID EFFLUENT; REMOVAL
AB Low cost, locally available biomaterial was tested for its ability to remove reactive dyes from aqueous solution. Granules prepared from dried activated Sludge (DAS) were utilized as a sorbent for the uptake of Rhodamine-B (Rh-B) dye. The effects of various experimental parameters (dye concentration, sludge concentrations, swelling, pretreatment and other factors) were investigated and optimal experimental conditions were ascertained. Nearly 15 min was required for the equilibrium adsorption, and Rh-B dyes could be removed effectively. Dye removal performance of Rh-B and DAS increased with increasing concentrations. The acid pretreated biomass exhibited a slightly better biosorption capacity that, alkali pretreated or non-pretreated biomass. The optimum swelling time for dye adsorption of the DAS within the swelling time range studied was 12 h. Both the Freundlich and Langmuir isotherm models Could describe the adsorption equilibrium of the reactive dye onto the activated sludge with the Langmuir isotherm showing the better agreement of the two. Second-order kinetic models confirmed the agreement. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Ju, D. J.; Byun, I. G.; Park, J. J.; Park, T. J.] Pusan Natl Univ, Dept Environm Engn, Pusan 609735, South Korea.
   [Lee, C. H.; Ahn, G. H.] Catholic Univ, Dept Environm Engn, Pusan 609323, South Korea.
RP Ju, DJ (reprint author), Pusan Natl Univ, Dept Environm Engn, Pusan 609735, South Korea.
EM ju123c@pusan.ac.kr
CR Aksu Z, 2001, BIOCHEM ENG J, V7, P79, DOI 10.1016/S1369-703X(00)00098-X
   Annadurai G, 2003, ADV ENVIRON RES, V7, P739, DOI 10.1016/S1093-0191(02)00044-8
   Bai RS, 2002, WATER RES, V36, P1224, DOI 10.1016/S0043-1354(01)00330-X
   Carliell CM, 1996, WATER SA, V22, P225
   Choy KKH, 1999, RESOUR CONSERV RECY, V27, P57, DOI 10.1016/S0921-3449(98)00085-8
   Gong RM, 2007, BIORESOURCE TECHNOL, V98, P1319, DOI 10.1016/j.biortech.2006.04.034
   Hu TL, 1996, WATER RES, V30, P2522, DOI 10.1016/0043-1354(96)00123-6
   Huang BR, 1999, MATER CHEM PHYS, V59, P143, DOI 10.1016/S0254-0584(99)00036-X
   Ju D. J., 2006, WATER PRACTICE TECHN, V1
   Largergren S, 1898, HANDLINGAR, V24, P1, DOI DOI 10.1007/BF01501332
   Liversidge RM, 1997, PROCESS BIOCHEM, V32, P473, DOI 10.1016/S0032-9592(96)00107-0
   Morais LC, 1999, WATER RES, V33, P979, DOI 10.1016/S0043-1354(98)00294-2
   Moran C, 1997, J SOC DYERS COLOUR, V113, P272
   Mukhopadhyay M, 2007, BIORESOURCE TECHNOL, V98, P1781, DOI 10.1016/j.biortech.2006.06.025
   PONNUSAMI V, 2006, J HAZARD MATER, P7
   Robinson T, 2002, ENVIRON INT, V28, P29, DOI 10.1016/S0160-4120(01)00131-3
   Tunali S, 2005, MINER ENG, V18, P681, DOI 10.1016/j.mineng.2004.11.002
   Waranusantigul P, 2003, ENVIRON POLLUT, V125, P385, DOI 10.1016/S0269-7491(03)00107-6
   YEH CF, 1993, J CHROMATOGR A, V630, P2
   ZHOU WC, 1993, FEMS MICROBIOL LETT, V107, P157, DOI 10.1111/j.1574-6968.1993.tb06023.x
NR 20
TC 54
Z9 60
U1 0
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0960-8524
J9 BIORESOURCE TECHNOL
JI Bioresour. Technol.
PD NOV
PY 2008
VL 99
IS 17
BP 7971
EP 7975
DI 10.1016/j.biortech.2008.03.061
PG 5
WC Agricultural Engineering; Biotechnology & Applied Microbiology; Energy &
   Fuels
SC Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels
GA 341TT
UT WOS:000258738700008
PM 18511271
DA 2018-10-19
ER

PT J
AU Yu, H
   Tyo, K
   Alper, H
   Klein-Marcuschamer, D
   Stephanopoulos, G
AF Yu, Huimin
   Tyo, Keith
   Alper, Hal
   Klein-Marcuschamer, Daniel
   Stephanopoulos, Gregory
TI A High-Throughput Screen for Hyaluronic Acid Accumulation in Recombinant
   Escherichia coli Transformed by Libraries of Engineered Sigma Factors
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE Hyaluronic acid; high throughput screening; translucent colony
   identification; alcian blue staining; global transcriptional machinery
   engineering; sigma factor engineering
ID TRANSCRIPTION MACHINERY; STREPTOCOCCUS; CULTURE; BIOSYNTHESIS; GROWTH;
   MUTANT; RPOS; CELL
AB Hyaluronic acid (HA) is an important biomaterial with functional medical and cosmetic applications. As its synthesis has been recently reported in recombinant bacteria, it is of interest to develop a high throughput screening method for the rapid isolation of HA accumulating strains transformed by combinatorial libraries. Here we report a novel two-step screening strategy to select for better HA-producing recombinant Escherichia coli strains transformed by mutation libraries of rpoD and rpoS, coding for the sigma(D) and sigma(s) factors of the RNA polymerase, respectively. The first screen, based on translucent colony morphology identification, was used to qualitatively distinguish HA-producing strains on agar plates from non-HA producing strains that exhibit dense colony morphology. The second screen was based on the photometric measurement of an alcian blue staining solution that precipitates with HA, creating an inverse relationship between HA concentration and alcian blue absorbance. The color attenuation fitted a second-order polynomial between HA concentration and OD540 absorbance. Using the alcian blue absorbance quantification, 74 translucent colonies from the HA-rpoD library and 78 translucent colonies from the HA-rpoS library were isolated and cultured for optimal strain selection. Three representative superior recombinants with high, medium and low increase of HA accumulation, respectively, were identified by the screen from the HA-rpoD and HA-rpoS mutant library. Further flask culture confirmed that results of the library screen were reliable and the superior recombinant D72 highly accumulated HA of 561.4 mg/L with a productivity of similar to 265 mg HA/g dry cell. Sequencing results showed that the mutant rpoD gene in D72 is in a truncated D protein that lacks the conserved regions 3 and 4 of the a Generally, this two-step high throughput screen presents a promising strategy for selecting superior HA-producing strains from large scale mutation libraries.
C1 [Yu, Huimin; Tyo, Keith; Alper, Hal; Klein-Marcuschamer, Daniel; Stephanopoulos, Gregory] MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
   [Yu, Huimin] Tsinghua Univ, Dept Chem Engn, Beijing 100084, Peoples R China.
RP Stephanopoulos, G (reprint author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
EM gregstep@mit.edu
RI Tyo, Keith/H-6227-2012; Tyo, Keith/D-1817-2009
FU Singapore-MIT Alliance [SMA-2]; National Key Basic Research Project 973
   of China [2007CB714304]
FX Contract grant sponsor Singapore-MIT Alliance Contract grant number:
   SMA-2 Contract grant sponsor: National Key Basic Research Project 973 of
   China Contract grant number: 2007CB714304
CR Alper H, 2007, METAB ENG, V9, P258, DOI 10.1016/j.ymben.2006.12.002
   Alper H, 2006, SCIENCE, V314, P1565, DOI 10.1126/science.1131969
   BELLEMANN P, 1994, INT J BIOL MACROMOL, V16, P290, DOI 10.1016/0141-8130(94)90058-2
   Chong BF, 2003, J BIOTECHNOL, V100, P33, DOI 10.1016/S0168-1656(02)00239-0
   DEANGELIS PL, 1993, J BIOL CHEM, V268, P14568
   Farewell A, 1998, MOL MICROBIOL, V29, P1039, DOI 10.1046/j.1365-2958.1998.00990.x
   FERRANTE ND, 1956, J BIOL CHEM, V220, P303
   Follstad BD, 1999, BIOTECHNOL BIOENG, V63, P675, DOI 10.1002/(SICI)1097-0290(19990620)63:6<675::AID-BIT5>3.0.CO;2-R
   GOA KL, 1994, DRUGS, V47, P536, DOI 10.2165/00003495-199447030-00009
   Gregory BD, 2005, MOL MICROBIOL, V56, P1208, DOI 10.1111/j.1365-2958.2005.04624.x
   HELMANN JD, 1988, ANNU REV BIOCHEM, V57, P839, DOI 10.1146/annurev.bi.57.070188.004203
   Hoover DM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e43
   Jin YS, 2007, METAB ENG, V9, P337, DOI 10.1016/j.ymben.2007.03.003
   Jin YS, 2005, APPL ENVIRON MICROB, V71, P8249, DOI 10.1128/AEM.71.12.8249-8256.2005
   Kakizaki I, 2002, EUR J BIOCHEM, V269, P5066, DOI 10.1046/j.1432-1033.2002.03217.x
   Kim JH, 1996, ENZYME MICROB TECH, V19, P440, DOI 10.1016/S0141-0229(96)00019-1
   KISS RD, 1991, BIOTECHNOL PROGR, V7, P501, DOI 10.1021/bp00012a004
   Kumari K, 1997, J BIOL CHEM, V272, P32539, DOI 10.1074/jbc.272.51.32539
   LAUREN TC, 1998, CHEM BIOL MED APPL H
   LONETTO M, 1992, J BACTERIOL, V174, P3843, DOI 10.1128/jb.174.12.3843-3849.1992
   NEIDHARDT FC, 1974, J BACTERIOL, V119, P736
   Ogrodowski CS, 2005, APPL BIOCHEM BIOTECH, V121, P753
   Penney DP, 2002, BIOTECH HISTOCHEM, V77, P237, DOI 10.1080/714028210
   Sambrook J, 1988, MOL CLONING LAB MANU
   SAN KY, 1984, BIOTECHNOL BIOENG, V26, P1209, DOI 10.1002/bit.260261009
   Stephanopoulos G, 1997, CHEM ENG SCI, V52, P2607, DOI 10.1016/S0009-2509(97)00077-8
   STEPHANOPOULOS G, 1993, TRENDS BIOTECHNOL, V11, P392, DOI 10.1016/0167-7799(93)90099-U
   STEPHANOPOULOS G, 1979, AICHE J, V25, P863, DOI 10.1002/aic.690250515
   Stephanopoulos G, 2001, SCIENCE, V292, P2024, DOI 10.1126/science.1062556
   VALLINO JJ, 1994, BIOTECHNOL PROGR, V10, P320, DOI 10.1021/bp00027a013
   Venturi V, 2003, MOL MICROBIOL, V49, P1, DOI 10.1046/j.1365-2958.2003.03547.x
   Wang FL, 1998, BIOTECHNOL BIOENG, V58, P325, DOI 10.1002/(SICI)1097-0290(19980420)58:2/3<325::AID-BIT33>3.0.CO;2-8
   Widner B, 2005, APPL ENVIRON MICROB, V71, P3747, DOI 10.1128/AEM.71.7.3747-3752.2005
   Wosten MMSM, 1998, FEMS MICROBIOL REV, V22, P127, DOI 10.1016/S0168-6445(98)00011-4
   Yu HM, 2008, METAB ENG, V10, P24, DOI 10.1016/j.ymben.2007.09.001
NR 35
TC 39
Z9 41
U1 1
U2 30
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0006-3592
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD NOV 1
PY 2008
VL 101
IS 4
BP 788
EP 796
DI 10.1002/bit.21947
PG 9
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 360AY
UT WOS:000260030600014
PM 18500764
DA 2018-10-19
ER

PT J
AU Tyndall, A
   Ladner, UM
   Matucci-Cerinic, M
AF Tyndall, Alan
   Ladner, Ulf M.
   Matucci-Cerinic, Marco
TI The EULAR Scleroderma Trials And Research group (EUSTAR): an
   international framework for accelerating scleroderma research
SO CURRENT OPINION IN RHEUMATOLOGY
LA English
DT Review
DE EUSTAR; minimal essential data set; scleroderma; systemic sclerosis;
   teaching
ID DISEASE-ACTIVITY CRITERIA; PULMONARY ARTERIAL-HYPERTENSION; ENDOTHELIAL
   GROWTH-FACTOR; SYSTEMIC-SCLEROSIS; EUROPEAN MULTICENTER; DOUBLE-BLIND;
   FIBROSIS; BOSENTAN; SURVIVAL; REGISTRY
AB Purpose of review Systemic sclerosis has a complex pathogenesis and a multifaceted clinical spectrum without a specific treatment. Under the auspices of the European League Against Rheumatism, the European League Against Rheumatism Scleroderma Trials And Research group (EUSTAR) has been founded in Europe to foster the study of systemic sclerosis with the aim of achieving equality of assessment and care of systemic sclerosis patients throughout the world according to evidence-based principles.
   Recent findings EUSTAR created the minimal essential data set, a simple two-page form with basic demographics and mostly yes/no answers to clinical and laboratory parameters, to track patients throughout Europe. Currently, over 7000 patients are registered from 150 centres in four continents, and several articles have been published with the data generated by the minimal essential data set. A commitment of EUSTAR is also to teaching and educating, and for this reason there are two teaching courses and a third is planned for early in 2009. These courses have built international networks among young investigators improving the quality of multicentre clinical trials. EUSTAR has organized several rounds of 'teach the teachers' to further standardize the skin scoring.
   Summary EUSTAR activities have extended beyond European borders, and EUSTAR now includes expert,,, from several nations. The growth of data and biomaterial might ensure many further fruitful multicentre studies, but the financial sustainability of EUSTAR remains an issue that may jeopardize the existence of this group as well as that of other organizations in the world.
C1 [Tyndall, Alan] Univ Basel, Dept Rheumatol, Basel, Switzerland.
   [Ladner, Ulf M.] Univ Giessen, Dept Internal Med & Rheumatol, Giessen, Germany.
   [Matucci-Cerinic, Marco] Univ Florence, Div Rheumatol AOUC, Dept Biomed, Denothe Ctr, I-50139 Florence, Italy.
RP Matucci-Cerinic, M (reprint author), Univ Florence, Div Rheumatol AOUC, Dept Biomed, Denothe Ctr, Villa Monna Tessa,Viale Pieraccini 18, I-50139 Florence, Italy.
EM cerinic@unifi.it
FU EULAR
FX A.T. is the Secretary and founding member of EUSTAR, U.M.L. is the
   Treasurer and founding member of EUSTAR and M.M.-C. is the Chairman and
   founding member of EUSTAR. The authors are indebted to EULAR for
   continuous support and funding.
CR Abraham DJ, 2005, TRENDS IMMUNOL, V26, P587, DOI 10.1016/j.it.2005.09.004
   Allanore Y, 2007, ANN RHEUM DIS, V66, P257, DOI 10.1136/ard.2006.054346
   Bryan C, 1999, ARTHRITIS RHEUM, V42, P2660, DOI 10.1002/1529-0131(199912)42:12<2660::AID-ANR23>3.0.CO;2-N
   Channick RN, 2001, LANCET, V358, P1119, DOI 10.1016/S0140-6736(01)06250-X
   Clements PJ, 1999, ARTHRITIS RHEUM, V42, P1194, DOI 10.1002/1529-0131(199906)42:6<1194::AID-ANR16>3.0.CO;2-7
   Czirjak L, 2007, ANN RHEUM DIS, V66, P966, DOI 10.1136/ard.2006.066530
   Della Rossa A, 2001, ANN RHEUM DIS, V60, P585, DOI 10.1136/ard.60.6.585
   Distler JHW, 2007, ARTHRITIS RHEUM, V56, P311, DOI 10.1002/art.22314
   Distler O, 2002, ARTHRITIS RES, V4, DOI 10.1186/ar596
   Farge D, 2004, ANN RHEUM DIS, V63, P974, DOI 10.1136/ard.2003.011205
   Hoyles RK, 2006, ARTHRITIS RHEUM, V54, P3962, DOI 10.1002/art.22204
   Manetti M, 2007, ARTHRITIS RHEUM, V56, P3442, DOI 10.1002/art.22940
   Mukerjee D, 2003, ANN RHEUM DIS, V62, P1088, DOI 10.1136/ard.62.11.1088
   ROZMAN B, 2007, ANN RHEUM DIS
   Rubin LJ, 2002, NEW ENGL J MED, V346, P896, DOI 10.1056/NEJMoa012212
   Steen VD, 2000, ARTHRITIS RHEUM, V43, P2437, DOI 10.1002/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U
   Tashkin DP, 2007, AM J RESP CRIT CARE, V176, P1026, DOI 10.1164/rccm.200702-3260C
   Tyndall A, 2005, Ann Rheum Dis, V64, P1107, DOI 10.1136/ard.2005.036038
   TYNDALL A, 2008, NAT CLIN PR IN PRESS
   Valentini G, 2003, ANN RHEUM DIS, V62, P901, DOI 10.1136/ard.62.9.901
   Valentini G, 2001, ANN RHEUM DIS, V60, P592, DOI 10.1136/ard.60.6.592
   Walker UA, 2007, ANN RHEUM DIS, V66, P754, DOI 10.1136/ard.2006.062901
   Williams MH, 2006, HEART, V92, P926, DOI 10.1136/hrt.2005.069484
NR 23
TC 3
Z9 3
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1040-8711
J9 CURR OPIN RHEUMATOL
JI Curr. Opin. Rheumatol.
PD NOV
PY 2008
VL 20
IS 6
BP 703
EP 706
DI 10.1097/BOR.0b013e328311f841
PG 4
WC Rheumatology
SC Rheumatology
GA 374LW
UT WOS:000261045900011
PM 18946332
DA 2018-10-19
ER

PT J
AU Griffiths, LG
   Choe, L
   Lee, KH
   Reardon, KF
   Orton, EC
AF Griffiths, Leigh G.
   Choe, Leila
   Lee, Kelvin H.
   Reardon, Kenneth F.
   Orton, E. Christopher
TI Protein extraction and 2-DE of water- and lipid-soluble proteins from
   bovine pericardium, a low-cellularity tissue
SO ELECTROPHORESIS
LA English
DT Article
DE Biological scaffold; Bovine pericardium; 2-DE; Protein extraction
ID 2-DIMENSIONAL GEL-ELECTROPHORESIS; PORCINE HEART-VALVES;
   MASS-SPECTROMETRIC IDENTIFICATION; IMMOBILIZED PH GRADIENTS; PROTEOMIC
   ANALYSIS; SUBCELLULAR-LOCALIZATION; MEMBRANE-PROTEINS; XENOGENEIC
   TISSUE; ESCHERICHIA-COLI; DECELLULARIZATION
AB Bovine pericardium. (BP) is an important biomaterial used in the production of glutaraldehyde-fixed heart valves and tissue-engineering applications. The ability to perform proteomic analysis on BP is useful for a range of studies, including investigation of immune rejection after implantation. However, proteomic analysis of fibrous tissues such as BP is challenging due to their relative low-cellularity and abundance of extracellular matrix. A variety of methods for tissue treatment, protein extraction, and;fractionation were investigated with the aim of producing high-quality 2-DE gels for both water- and lipid-soluble BP proteins. Extraction of water-soluble proteins with 3-(benzyldimethylammonio)-propanesulfonate followed by n-dodecyl beta-D-maltoside extraction and ethanol precipitation for lipid-soluble proteins provided the best combination of yield, spot number, and resolution on 2-DE gels (Protocol E2). ESI-quadrupole/ion trap or MALDI-TOF/TOF MS protein identifications were performed to confirm bovine origin and appropriate subcellular prefractionation of resolved proteins. Twenty-five unique, predominantly cytoplasmic bovine proteins were identified from the water-soluble fraction. Thirty-two unique, predominantly membrane bovine proteins were identified from the lipid-soluble fraction. These results demonstrated that the final protocol produced high-quality proteomic data from this important tissue for both cytoplasmic and membrane proteins.
C1 [Reardon, Kenneth F.] Colorado State Univ, Dept Chem & Biol Engn, Ft Collins, CO 80523 USA.
   [Griffiths, Leigh G.; Orton, E. Christopher] Colorado State Univ, Dept Clin Sci, Ft Collins, CO 80523 USA.
   [Choe, Leila; Lee, Kelvin H.] Univ Delaware, Dept Chem Engn, Newark, DE USA.
   [Choe, Leila; Lee, Kelvin H.] Univ Delaware, Delaware Biotechnol Inst, Newark, DE USA.
RP Reardon, KF (reprint author), Colorado State Univ, Dept Chem & Biol Engn, Ft Collins, CO 80523 USA.
EM kenneth.reardon@colostate.edu
RI Crozier, Laura/C-2170-2011; Reardon, Kenneth/A-1952-2016
OI Reardon, Kenneth/0000-0002-7753-4049
FU National Heart Lung and Blood Institute (NHLBI) at the National
   Institutes of Health [HL081107]
FX The authors thank Carla Lacerda for her technical advice. This research
   was supported by grant number HL081107 from the National Heart Lung and
   Blood Institute (NHLBI) at the National Institutes of Health. Contents
   are solely the responsibility of the authors and do not necessarily
   represent the official views of NIH.
CR Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016
   Bierczynska-Krzysik A, 2006, NEUROCHEM INT, V49, P245, DOI 10.1016/j.neuint.2006.01.013
   Bunai K, 2005, J CHROMATOGR B, V815, P227, DOI 10.1016/j.chromb.2004.08.030
   Bunai K, 2003, PROTEOMICS, V3, P1738, DOI 10.1002/pmic.200300529
   Butt RH, 2006, J PROTEOME RES, V5, P437, DOI 10.1021/pr0503634
   Catterall JB, 2006, RHEUMATOLOGY, V45, P1101, DOI 10.1093/rheumatology/kel060
   Cebotari S, 2002, CIRCULATION S1, V106, P163
   Choe LH, 2005, ELECTROPHORESIS, V26, P2437, DOI 10.1002/elps.200410336
   Churchward Matthew A, 2005, Proteome Sci, V3, P5, DOI 10.1186/1477-5956-3-5
   ELSHOURBAGY NA, 1987, J BIOL CHEM, V262, P7973
   Erdbrugger W, 2006, TISSUE ENG, V12, P2059, DOI 10.1089/ten.2006.12.2059
   Finehout EJ, 2004, ELECTROPHORESIS, V25, P2564, DOI 10.1002/elps.200406012
   Frayne J, 1999, CELL TISSUE RES, V298, P415, DOI 10.1007/s004410050064
   Gan CS, 2005, PROTEOMICS, V5, P2468, DOI 10.1002/pmic.200401266
   Gaus K, 2004, FASEB J, V18, P574, DOI 10.1096/fj.03-0486fje
   Gharahdaghi F, 1999, ELECTROPHORESIS, V20, P601, DOI 10.1002/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.0.CO;2-6
   Goncalves A, 2003, CIRCULATION, V108, P436
   Goncalves AC, 2005, J HEART VALVE DIS, V14, P212
   Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V
   Gorg A, 2004, PROTEOMICS, V4, P3665, DOI 10.1002/pmic.200401031
   Gorg A., 2000, PROTEOME RES 2 DIMEN
   HANSSON SF, 2004, PROTEOME SCI, V2
   Heeger PS, 2003, AM J TRANSPLANT, V3, P525, DOI 10.1034/j.1600-6143.2003.00123.x
   Helling S, 2006, PROTEOMICS, V6, P4506, DOI 10.1002/pmic.200600169
   Hermansson M, 2004, J BIOL CHEM, V279, P43514, DOI 10.1074/jbc.M407041200
   Hess JL, 2005, J CHROMATOGR B, V815, P65, DOI 10.1016/j.jchromb.2004.07.047
   Hopkinson A, 2005, PROTEOMICS, V5, P1967, DOI 10.1002/pmic.200401073
   Human P, 2001, J Long Term Eff Med Implants, V11, P199
   ISHIHARA T, 1981, J THORAC CARDIOV SUR, V81, P747
   Jarrold B, 2005, ELECTROPHORESIS, V26, P2269, DOI 10.1002/gel.200410367
   Kasimir MT, 2006, J HEART VALVE DIS, V15, P278
   Kasimir MT, 2003, INT J ARTIF ORGANS, V26, P421
   KOVACIC RT, 1991, BIOCHEMISTRY-US, V30, P9015, DOI 10.1021/bi00101a015
   Krah Alexander, 2004, Methods Mol Med, V94, P19
   Lacerda CMR, 2007, J PROTEOME RES, V6, P1145, DOI 10.1021/pr060477v
   Lammi MJ, 2006, ELECTROPHORESIS, V27, P2687, DOI 10.1002/elps.200600004
   Lechler RI, 2005, NAT MED, V11, P605, DOI 10.1038/nm1251
   Maestro MM, 2006, ACTA BIOMATER, V2, P213, DOI 10.1016/j.actbio.2005.11.004
   MANCHESTER KL, 1995, BIOTECHNIQUES, V19, P208
   Manji RA, 2006, CIRCULATION, V114, P318, DOI 10.1161/CIRCULATIONAHA.105.549311
   Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4
   Mitra SK, 2007, J PROTEOME RES, V6, P1933, DOI 10.1021/pr060525b
   Mol A, 2004, J HEART VALVE DIS, V13, P272
   MONTECUCCO C, 1983, EUR J BIOCHEM, V132, P189, DOI 10.1111/j.1432-1033.1983.tb07346.x
   Nair RR, 2006, J BIOL CHEM, V281, P26424, DOI 10.1074/jbc.M602703200
   O'Brien M F, 1999, Semin Thorac Cardiovasc Surg, V11, P194
   Oh-Ishi M, 2007, J CHROMATOGR B, V849, P211, DOI 10.1016/j.jchromb.2006.10.064
   Pedersen SK, 2003, J PROTEOME RES, V2, P303, DOI 10.1021/pr025588i
   Puvimanasinghe JPA, 2006, EUR J CARDIO-THORAC, V29, P374, DOI 10.1016/j.ejcts.2005.11.037
   Rabilloud T, 1997, ELECTROPHORESIS, V18, P307, DOI 10.1002/elps.1150180303
   RABILLOUD T, 2000, PROTEOME RES 2 DIMEN
   Ruiz-Romero C, 2005, PROTEOMICS, V5, P3048, DOI 10.1002/pmic.200402106
   Satyal SH, 1998, GENE DEV, V12, P1962, DOI 10.1101/gad.12.13.1962
   Schwarzenbacher R, 1999, EMBO J, V18, P6228, DOI 10.1093/emboj/18.22.6228
   Shaw MM, 2003, PROTEOMICS, V3, P1408, DOI 10.1002/pmic.200300471
   Simon P, 2003, EUR J CARDIO-THORAC, V23, P1002, DOI 10.1016/S1010-7940(03)00094-0
   Song J, 2006, ELECTROPHORESIS, V27, P3144, DOI 10.1002/elps.200500921
   Sprenger J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S3
   Stanley BA, 2003, PROTEOMICS, V3, P815, DOI 10.1002/pmic.200300388
   Stock UA, 2006, BIOMATERIALS, V27, P1, DOI 10.1016/j.biomaterials.2005.05.100
   Terasaki PI, 2005, CURR OPIN IMMUNOL, V17, P541, DOI 10.1016/j.coi.2005.07.018
   Terrier B, 2007, AUTOIMMUN REV, V6, P176, DOI 10.1016/j.autrev.2006.10.004
   Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107
   Ueda Y, 2006, INT J ARTIF ORGANS, V29, P781
   Vincent D, 2006, ELECTROPHORESIS, V27, P1853, DOI 10.1002/elps.200500698
   von Oppell U O, 2001, J Long Term Eff Med Implants, V11, P105
   Vuillard L, 1998, EUR J BIOCHEM, V256, P128, DOI 10.1046/j.1432-1327.1998.2560128.x
   Wilcox HE, 2005, J HEART VALVE DIS, V14, P228
   WILCOX HE, 2005, J HEART VALVE DIS, V14, P236
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
   Yan JX, 2000, ELECTROPHORESIS, V21, P3666, DOI 10.1002/1522-2683(200011)21:17<3666::AID-ELPS3666>3.0.CO;2-6
   YU WH, 1995, J BIOL CHEM, V270, P13998, DOI 10.1074/jbc.270.23.13998
   Zilla P, 2004, BIOTECHNOL APPL BIOC, V40, P57, DOI 10.1042/BA20030211
NR 73
TC 10
Z9 11
U1 0
U2 7
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0173-0835
J9 ELECTROPHORESIS
JI Electrophoresis
PD NOV
PY 2008
VL 29
IS 22
BP 4508
EP 4515
DI 10.1002/elps.200800108
PG 8
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 384JM
UT WOS:000261741100009
PM 18985661
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Li, Z
   Peng, J
   Wang, GJ
   Yang, Q
   Yu, HL
   Guo, QY
   Wang, AY
   Zhao, B
   Lu, SB
AF Li, Zhi
   Peng, Jiang
   Wang, Guanjun
   Yang, Qiang
   Yu, Hailong
   Guo, Quanyi
   Wang, Aiyuan
   Zhao, Bin
   Lu, Shibi
TI Effects of local release of hepatocyte growth factor on peripheral nerve
   regeneration in acellular nerve grafts
SO EXPERIMENTAL NEUROLOGY
LA English
DT Article
DE Hepatocyte growth factor; Acellular nerve; Peripheral nerve; Nerve
   regeneration
ID FACTOR-SCATTER FACTOR; RAT SCIATIC-NERVE; NEUROTROPHIC FACTOR;
   SCHWANN-CELLS; GENE-THERAPY; PURIFICATION; NEURONS; REPAIR; EXPRESSION;
   ALLOGRAFTS
AB Options for reconstructing peripheral nerve gaps after trauma are limited. The acellular nerve is a new kind of biomaterial used to reconstruct the Peripheral nerve defect, but its use Could be improved upon. We aimed to investigate the effect of adenoviral transfection with hepatocyte growth factor (HGF) on the functional recovery of transected sciatic nerves repaired by acellular nerve grafting. 30 Rats were divided into three groups (10/group) for autografting and acellular grafting, as well as acellular grafting with adenovirus transfection of HGF (1 x 10(8) pfu) injected in muscles around the proximal and distal allograft coapation, Sciatic functional index (SFI) was evaluated every 4 weeks to week 16 by measuring rat footprints on walking-track testing. The three groups presented initial complete functional loss, followed by slow but steady recovery, with final similar SFIs. Weight of the gastrocnemius and soleus muscles, histologic and morphometric study and neovascularization in the nerve grafts were evaluated at week 16. Autografting gave the best functional recovery, but HGF-treated acellular grafting gave better recovery than acellular grafting alone. Neovascularization was greater with HGF-treated acellular grafting than with autografting and acellular grafting alone. Axonal regeneration distance of autografting on the 20th postoperative day was the longest in the three groups,while that of acellular grafting alone was the smallest. Acellular nerve grafting may be useful for functional peripheral nerve regeneration, and with human HGF gene transfection may improve on acellular grafting alone in functional recovery. (C) 2008 Elsevier Inc. All rights reserved.
C1 [Li, Zhi; Peng, Jiang; Wang, Guanjun; Yang, Qiang; Yu, Hailong; Guo, Quanyi; Wang, Aiyuan; Zhao, Bin; Lu, Shibi] Chinese Peoples Liberat Army Gen Hosp, Key Lab Peoples Liberat Army, Inst Orthoped, Beijing 100853, Peoples R China.
RP Lu, SB (reprint author), Chinese Peoples Liberat Army Gen Hosp, Key Lab Peoples Liberat Army, Inst Orthoped, Beijing 100853, Peoples R China.
EM shibilu301@gmail.com
FU Nature Science Foundation of China [30571875]
FX This study was funded by Nature Science Foundation of China (30571875).
   The authors thank technicians Yoe Tian, Li Zhang, Xiang Sui and
   Jingxiang Huang for help with histology examination and animal
   operation. The recombinant replication-defective adenovirus carrying HGF
   (Ad-HGF) or GFP (Ad-GFP) IS Courtesy of the Department of Experimental
   Hematology, Beijing Institute of Radiation Medicine.
CR ANDERSON WF, 1992, SCIENCE, V256, P808, DOI 10.1126/science.1589762
   BRUNELLI GA, 1994, MICROSURG, V15, P176, DOI 10.1002/micr.1920150307
   CARLTON J M, 1986, Surgical Forum (Chicago), V37, P611
   Chattopadhyay M, 2002, ANN NEUROL, V51, P19, DOI 10.1002/ana.10061
   Davey F, 2000, MOL CELL NEUROSCI, V15, P79, DOI 10.1006/mcne.1999.0803
   DEMEDINACELI L, 1982, EXP NEUROL, V77, P634, DOI 10.1016/0014-4886(82)90234-5
   Dumont CE, 1997, TRANSPLANTATION, V63, P1210, DOI 10.1097/00007890-199705150-00004
   Ebens A, 1996, NEURON, V17, P1157, DOI 10.1016/S0896-6273(00)80247-0
   EVANS PJ, 1994, PROG NEUROBIOL, V43, P187, DOI 10.1016/0301-0082(94)90001-9
   FAWCETT JW, 1986, J NEUROSURG, V65, P354, DOI 10.3171/jns.1986.65.3.0354
   FoidartDessalle M, 1997, EXP NEUROL, V148, P236, DOI 10.1006/exnr.1997.6542
   GOHDA E, 1988, J CLIN INVEST, V81, P414, DOI 10.1172/JCI113334
   HAASE G, 1998, J NEUROL SCI, V160, P97
   HAASE SC, 2000, SURG FORUM, V51, P607
   Hashimoto N, 2001, NEUROREPORT, V12, P1403, DOI 10.1097/00001756-200105250-00022
   Hudson TW, 2004, TISSUE ENG, V10, P1641, DOI 10.1089/ten.2004.10.1641
   JUNG W, 1994, J CELL BIOL, V126, P485, DOI 10.1083/jcb.126.2.485
   KIM DH, 1993, J RECONSTR MICROSURG, V9, P415, DOI 10.1055/s-2007-1006750
   KRAMER H, 1955, J HISTOCHEM CYTOCHEM, V3, P227, DOI 10.1177/3.3.227
   KRASNOSELSKY A, 1994, J NEUROSCI, V14, P7284
   Lee AC, 2003, EXP NEUROL, V184, P295, DOI 10.1016/S0014-4886(03)00258-9
   LUNDBORG G, 1982, EXP NEUROL, V76, P361, DOI 10.1016/0014-4886(82)90215-1
   MACKINNON S E, 1990, Journal of Reconstructive Microsurgery, V6, P117, DOI 10.1055/s-2007-1006810
   Maina F, 1999, NAT NEUROSCI, V2, P213, DOI 10.1038/6310
   Matsumoto K, 1996, J BIOCHEM-TOKYO, V119, P591
   NAKAMURA T, 1986, P NATL ACAD SCI USA, V83, P6489, DOI 10.1073/pnas.83.17.6489
   NAKAMURA T, 1984, BIOCHEM BIOPH RES CO, V122, P1450, DOI 10.1016/0006-291X(84)91253-1
   Navarro X, 1996, J Peripher Nerv Syst, V1, P53
   Newman JP, 1996, ARCH OTOLARYNGOL, V122, P399
   Okura Y, 1999, EUR J NEUROSCI, V11, P4139, DOI 10.1046/j.1460-9568.1999.00832.x
   Oppenheim RW, 1996, NEURON, V17, P195, DOI 10.1016/S0896-6273(00)80151-8
   RESTREPO Y, 1983, Microsurgery, V4, P105, DOI 10.1002/micr.1920040207
   Rubin A, 2003, LARYNGOSCOPE, V113, P985, DOI 10.1097/00005537-200306000-00013
   Sondell M, 1998, BRAIN RES, V795, P44, DOI 10.1016/S0006-8993(98)00251-0
   Terzis JK, 1997, J RECONSTR MICROSURG, V13, P215, DOI 10.1055/s-2007-1006407
   WEBER RA, 1993, MICROSURG, V14, P323, DOI 10.1002/micr.1920140507
   Yang XM, 1998, J NEUROSCI, V18, P8369
   ZALEWSKI AA, 1995, EXP NEUROL, V133, P189, DOI 10.1006/exnr.1995.1021
NR 38
TC 32
Z9 41
U1 1
U2 9
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4886
J9 EXP NEUROL
JI Exp. Neurol.
PD NOV
PY 2008
VL 214
IS 1
BP 47
EP 54
DI 10.1016/j.expneurol.2008.07.007
PG 8
WC Neurosciences
SC Neurosciences & Neurology
GA 368JM
UT WOS:000260617400006
PM 18680744
DA 2018-10-19
ER

PT J
AU Rosa, AL
   de Oliveira, PT
   Beloti, MM
AF Rosa, Adalberto Luiz
   de Oliveira, Paulo Tambasco
   Beloti, Marcio Mateus
TI Macroporous scaffolds associated with cells to construct a hybrid
   biomaterial for bone tissue engineering
SO EXPERT REVIEW OF MEDICAL DEVICES
LA English
DT Review
DE biomaterial; bone; osteoblastic cell; scaffold; tissue engineering
ID EMBRYONIC STEM-CELLS; IN-VITRO OSTEOGENESIS; MARROW STROMAL CELLS;
   OF-THE-ART; OSTEOBLAST PHENOTYPE; BIOACTIVE GLASS; CULTURE PERIOD;
   GROWTH-FACTORS; DIFFERENTIATION; REPAIR
AB Bone tissue has the ability to heal without a scar and to remodel, which promotes three basic functions: locomotion, protection of internal organs and mineral homeostasis. Although bone regeneration is highly efficient, some clinical situations - such as large bone defects - require specific treatments in order to promote bone healing. Allogenic or autologous bone grafts have been used in these procedures with limited success and, based on this, bone tissue-engineering approaches have been investigated extensively. Tissue engineering has been defined as the application of principles and techniques of the life sciences and engineering to the design, modification and growth of living tissues using biomaterials, cells and growth factors, alone or in combination. The association of cells with porous scaffolds to produce 3D hybrid osteogenic constructs is a common subject in bone tissue-engineering research and will be the focus of this review. We will present some aspects of bone biology, the cells and scaffolds used to engineer bone, and techniques to fabricate the hybrid biomaterial.
C1 [Rosa, Adalberto Luiz; de Oliveira, Paulo Tambasco; Beloti, Marcio Mateus] Univ Sao Paulo, Cell Culture Lab, Sch Dent, BR-14040904 Ribeirao Preto, SP, Brazil.
RP Beloti, MM (reprint author), Univ Sao Paulo, Cell Culture Lab, Sch Dent, Av Cafe S-N, BR-14040904 Ribeirao Preto, SP, Brazil.
EM adalrosa@forp.usp.br; tambasco@usp.br; mmbeloti@usp.br
RI Beloti, Marcio/E-7473-2012; Rosa, Adalberto/A-6314-2008; Tambasco de
   Oliveira, Paulo/F-9749-2010
OI Beloti, Marcio/0000-0003-0149-7189; Rosa, Adalberto/0000-0002-6495-2778;
   Tambasco de Oliveira, Paulo/0000-0002-6662-0486
CR Andrews PW, 2005, BIOCHEM SOC T, V33, P1526, DOI 10.1042/BST0331526
   Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285
   Becker W, 1996, J PERIODONTOL, V67, P1025, DOI 10.1902/jop.1996.67.10.1025
   Beloti MM, 2006, J BIOMED MATER RES A, V79A, P282, DOI 10.1002/jbm.a.30801
   Beloti MM, 2008, CLIN ORAL IMPLAN RES, V19, P48, DOI 10.1111/j.1600-0501.2007.01420.x
   Beloti Márcio Mateus, 2005, Braz. Dent. J., V16, P156, DOI 10.1590/S0103-64402005000200013
   Beloti MM, 2009, J BIOMATER APPL, V23, P481, DOI 10.1177/0885328208094082
   Beloti Marcio Mateus, 2008, J Biomed Mater Res A, V84, P435, DOI 10.1002/jbm.a.31344
   Beloti MM, 2005, BIOMATERIALS, V26, P4245, DOI 10.1016/j.biomaterials.2004.10.039
   Bielby RC, 2004, TISSUE ENG, V10, P1518, DOI 10.1089/ten.2004.10.1518
   BOSKEY AL, 1985, CALCIFIED TISSUE INT, V37, P57, DOI 10.1007/BF02557680
   Buckwalter J A, 1996, Instr Course Lect, V45, P387
   Buckwalter J A, 1996, Instr Course Lect, V45, P371
   Castano-Izquierdo H, 2007, J BIOMED MATER RES A, V82A, P129, DOI 10.1002/jbm.a.31082
   Charles-Harris M, 2007, BIOMATERIALS, V28, P4429, DOI 10.1016/j.biomaterials.2007.06.029
   Chen QZZ, 2006, BIOMATERIALS, V27, P2414, DOI 10.1016/j.biomaterials.2005.11.025
   CITARDI MJ, 1994, OTOLARYNG CLIN N AM, V27, P891
   Costantino PD, 2001, ARCH OTOLARYNGOL, V127, P588, DOI 10.1001/archotol.127.5.588
   de la Piedra C, 2008, J ORTHOP RES, V26, P200, DOI 10.1002/jor.20466
   de Oliveira PT, 2008, J HISTOCHEM CYTOCHEM, V56, P629, DOI 10.1369/jhc.2008.950758
   de Oliveira PT, 2007, J BIOMED MATER RES A, V80A, P554, DOI 10.1002/jbm.a.30955
   Downey PA, 2006, PHYS THER, V86, P77, DOI 10.1093/ptj/86.1.77
   Drukker M, 2002, P NATL ACAD SCI USA, V99, P9864, DOI 10.1073/pnas.142298299
   Duplomb L, 2007, STEM CELLS, V25, P544, DOI 10.1634/stemcells.2006-0395
   Eberli D, 2006, METHOD ENZYMOL, V420, P287, DOI 10.1016/S0076-6879(06)20013-2
   EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0
   Fandrich F, 2002, NAT MED, V8, P171, DOI 10.1038/nm0202-171
   FRIEDENS.AJ, 1966, J EMBRYOL EXP MORPH, V16, P381
   FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009
   Gao YB, 2006, J BIOMED MATER RES A, V79A, P193, DOI 10.1002/jbm.a.30761
   Gericke A, 2005, CALCIFIED TISSUE INT, V77, P45, DOI 10.1007/s00223-004-1288-1
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Goldstein AS, 2001, BIOMATERIALS, V22, P1279, DOI 10.1016/S0142-9612(00)00280-5
   HABAL MB, 1994, CLIN PLAST SURG, V21, P349
   Habraken WJEM, 2007, ADV DRUG DELIVER REV, V59, P234, DOI 10.1016/j.addr.2007.03.011
   Handschel J, 2006, INT J ORAL MAX IMPL, V21, P890
   Holtorf HL, 2005, ANN BIOMED ENG, V33, P1238, DOI 10.1007/s10439-005-5536-y
   Holy CE, 2000, J BIOMED MATER RES, V51, P376, DOI 10.1002/1097-4636(20000905)51:3<376::AID-JBM11>3.0.CO;2-G
   Ishaug-Riley SL, 1998, BIOMATERIALS, V19, P1405, DOI 10.1016/S0142-9612(98)00021-0
   Jain KK, 2005, EXPERT OPIN BIOL TH, V5, P153, DOI 10.1517/14712598.5.2.153
   Jonsson KB, 1999, ACTA ORTHOP SCAND, V70, P365, DOI 10.3109/17453679908997826
   Karner E, 2007, STEM CELLS DEV, V16, P39, DOI 10.1089/scd.2006.0010
   Karsenty G, 2001, Novartis Found Symp, V232, P6
   Kaushal S, 2001, NAT MED, V7, P1035, DOI 10.1038/nm0901-1035
   Kneser U, 2006, J CELL MOL MED, V10, P7, DOI 10.1111/j.1582-4934.2006.tb00287.x
   Lane JM, 1999, CLIN ORTHOP RELAT R, P216
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lian J B, 1995, Iowa Orthop J, V15, P118
   Lickorish D, 2007, BIOMATERIALS, V28, P1495, DOI 10.1016/j.biomaterials.2006.11.025
   Liu HF, 2008, BIOMATERIALS, V29, P662, DOI 10.1016/j.biomaterials.2007.10.035
   LOVERIDGE N, 1999, J ANIM SCI S, V77, pS190
   Liporaci JL, 2008, J MATER SCI-MATER M, V19, P833, DOI 10.1007/s10856-007-3081-y
   Mao X, 2005, TISSUE CELL, V37, P349, DOI 10.1016/j.tice.2005.05.003
   Navarro M, 2004, J MATER SCI-MATER M, V15, P419, DOI 10.1023/B:JMSM.0000021113.88702.9d
   Ng AMH, 2008, J BIOMED MATER RES A, V85A, P301, DOI 10.1002/jbm.a.31324
   Oreffo ROC, 2005, STEM CELL REV, V1, P169, DOI 10.1385/SCR:1:2:169
   Polak JM, 2006, ANN NY ACAD SCI, V1068, P352, DOI 10.1196/annals.1346.001
   Ranly DM, 2007, J BONE JOINT SURG AM, V89A, P139, DOI 10.2106/JBJS.F.00388
   Ren J, 2007, J BIOMAT SCI-POLYM E, V18, P505, DOI 10.1163/156856207780852578
   ROBEY PG, 1993, J BONE MINER RES, V2, pS483
   Roussy Y, 2007, CLIN ORAL IMPLAN RES, V18, P639, DOI 10.1111/j.1600-0501.2007.01385.x
   Ruhe PQ, 2005, J BIOMED MATER RES A, V74A, P533, DOI 10.1002/jbm.a.30341
   Sabolinski ML, 1996, BIOMATERIALS, V17, P311, DOI 10.1016/0142-9612(96)85569-4
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Schantz JT, 2002, CELL TRANSPLANT, V11, P125
   Schek RM, 2004, TISSUE ENG, V10, P1376, DOI 10.1089/ten.2004.10.1376
   Fo HOS, 2007, CLIN ORAL IMPLAN RES, V18, P333, DOI 10.1111/j.1600-0501.2006.01313.x
   Schwarz R P, 1992, J Tissue Cult Methods, V14, P51, DOI 10.1007/BF01404744
   Shapiro F, 2008, EUR CELLS MATER, V15, P53, DOI 10.22203/eCM.v015a05
   Shieh SJ, 2005, SURGERY, V137, P1, DOI 10.1016/j.surg.2004.04.002
   Siggelkow H, 1999, J CELL BIOCHEM, V75, P22, DOI 10.1002/(SICI)1097-4644(19991001)75:1<22::AID-JCB3>3.3.CO;2-Y
   Sikavitsas VI, 2002, J BIOMED MATER RES, V62, P136, DOI 10.1002/jbm.10150
   SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0
   Sommerfeldt DW, 2001, EUR SPINE J, V10, pS86, DOI 10.1007/s005860100283
   Sreerekha PR, 2006, CELL PROLIFERAT, V39, P301, DOI 10.1111/j.1365-2184.2006.00389.x
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899
   VACANTI JP, 1999, LANCET S1, V354, pS132
   Wiesmann HP, 2004, INT J ORAL MAX SURG, V33, P523, DOI 10.1016/j.ijom.2004.04.005
   Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761
   Yang TH, 2001, J BIOMED MATER RES, V55, P379, DOI 10.1002/1097-4636(20010605)55:3<379::AID-JBM1026>3.0.CO;2-Z
   Yao J, 2005, J BIOMED MATER RES A, V75A, P794, DOI 10.1002/jbm.a.30494
   Yao J, 2005, BIOMATERIALS, V26, P1935, DOI 10.1016/j.biomaterials.2004.06.027
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
   Zaidi N, 2007, ANN NY ACAD SCI, V1117, P62, DOI 10.1196/annals.1402.074
   Zandstra PW, 2000, BIOTECHNOL BIOENG, V69, P607, DOI 10.1002/1097-0290(20000920)69:6<607::AID-BIT4>3.3.CO;2-6
   Zhang Y, 2004, J MATER SCI-MATER M, V15, P255, DOI 10.1023/B:JMSM.0000015485.94665.25
   zur Nieden NI, 2003, DIFFERENTIATION, V71, P18, DOI 10.1046/j.1432-0436.2003.700602.x
NR 87
TC 20
Z9 21
U1 1
U2 20
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1743-4440
EI 1745-2422
J9 EXPERT REV MED DEVIC
JI Expert Rev. Med. Devices
PD NOV
PY 2008
VL 5
IS 6
BP 719
EP 728
DI 10.1586/17434440.5.6.719
PG 10
WC Engineering, Biomedical
SC Engineering
GA 380HR
UT WOS:000261457300015
PM 19025348
DA 2018-10-19
ER

PT J
AU Pulkkinen, HJ
   Tiitu, V
   Valonen, P
   Hamalainen, ER
   Lammi, MJ
   Kiviranta, I
AF Pulkkinen, H. J.
   Tiitu, V.
   Valonen, P.
   Hamalainen, E-R
   Lammi, M. J.
   Kiviranta, I.
TI Recombinant human type II collagen as a material for cartilage tissue
   engineering
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE Bovine chondrocyte; Cartilage tissue engineering; Collagen gel; Human
   type II collagen
ID BOVINE ARTICULAR-CARTILAGE; IN-VITRO; PROTEOGLYCAN SYNTHESIS;
   EXTRACELLULAR-MATRIX; DEDIFFERENTIATED CHONDROCYTES; BIODEGRADABLE
   HYDROGELS; ALLOGRAFT CHONDROCYTES; MECHANICAL COMPRESSION; BIOSYNTHETIC
   RESPONSE; DYNAMIC COMPRESSION
AB Purpose: Collagen type II is the major component of cartilage and would be an optimal scaffold material for reconstruction of injured cartilage tissue. In this study, the feasibility of recombinant human type II collagen gel as a 3-dimensional culture system for bovine chondrocytes was evaluated in vitro.
   Methods: Bovine chondrocytes (4x10(6) cells) were seeded within collagen gels and cultivated for up to 4 weeks. The gels were investigated with confocal microscopy, histology, and biochemical assays.
   Results: Confocal microscopy revealed that the cells maintained their viability during the entire cultivation period. The chondrocytes were evenly distributed inside the gels, and the number of cells and the amount of the extracellular matrix increased during cultivation. The chondrocytes maintained their round phenotype during the 4-week cultivation period. The glycosaminoglycan levels of the tissue increased during the experiment. The relative levels of aggrecan and type II collagen mRNA measured with real-time polymerase chain reaction (PCR) showed an increase at 1 week.
   Conclusion: Our results imply that recombinant human type II collagen is a promising biomaterial for cartilage tissue engineering, allowing homogeneous distribution in the gel and biosynthesis of extracellular matrix components. (Int J Artif Organs 2008; 31: 960-9)
C1 [Pulkkinen, H. J.; Tiitu, V.; Valonen, P.; Lammi, M. J.] Univ Kuopio, Dept Anat, Inst Biomed, FIN-70211 Kuopio, Finland.
   [Pulkkinen, H. J.; Tiitu, V.; Valonen, P.; Kiviranta, I.] Jyvaskyla Cent Hosp, Dept Orthopaed & Traumatol, Jyvaskyla, Finland.
   [Hamalainen, E-R] Univ Oulu, Bioproc Engn Lab, Oulu, Finland.
   [Lammi, M. J.] Univ Kuopio, Dept Biosci, FIN-70211 Kuopio, Finland.
   [Kiviranta, I.] Helsinki Univ Hosp, Dept Orthopaed & Traumatol, Helsinki, Finland.
RP Pulkkinen, HJ (reprint author), Univ Kuopio, Dept Anat, Inst Biomed, POB 1627, FIN-70211 Kuopio, Finland.
EM hertta.pulkkinen@uku.fi
RI Lammi, Mikko/B-9291-2008; Kuopio, Dept Biosci/A-4529-2010
OI Lammi, Mikko/0000-0002-6181-9904; 
FU TEKES COMBIO project, Sigrid Juselius Foundation, and by the Academy of
   Finland [107605]
FX The recombinant human type II collagen was donated by Fibrogen Europe,
   Helsinki, Finland. This work was funded by the TEKES COMBIO project,
   Sigrid Juselius Foundation, and by the Academy of Finland (project no.
   107605).
CR BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1
   Bosnakovski D, 2006, BIOTECHNOL BIOENG, V93, P1152, DOI 10.1002/bit.20828
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Buckwalter JA, 1998, J ORTHOP SPORT PHYS, V28, P192, DOI 10.2519/jospt.1998.28.4.192
   Bulpitt P, 1999, J BIOMED MATER RES, V47, P152
   Buma P, 2003, BIOMATERIALS, V24, P3255, DOI 10.1016/S0142-9612(03)00143-1
   CHARRIERE G, 1989, J AM ACAD DERMATOL, V21, P1203, DOI 10.1016/S0190-9622(89)70330-3
   Chen MY, 2006, BIORHEOLOGY, V43, P337
   Dausse Y, 2003, OSTEOARTHR CARTILAGE, V11, P16, DOI 10.1053/joca.2002.0859
   DeFail AJ, 2006, BIOMATERIALS, V27, P1579, DOI 10.1016/j.biomaterials.2005.08.013
   Fisher JP, 2004, J BIOMED MATER RES A, V71A, P268, DOI 10.1002/jbm.a.30148
   FREED LE, 1994, J BIOMED MATER RES, V28, P891, DOI 10.1002/jbm.820280808
   Freyria AM, 2005, TISSUE ENG, V11, P674, DOI 10.1089/ten.2005.11.674
   Galois L, 2006, BIOMATERIALS, V27, P79, DOI 10.1016/j.biomaterials.2005.05.098
   Grigolo B, 2001, BIOMATERIALS, V22, P2417, DOI 10.1016/S0142-9612(00)00429-4
   Grinnell F, 2000, TRENDS CELL BIOL, V10, P362, DOI 10.1016/S0962-8924(00)01802-X
   Hoemann CD, 2005, J BONE JOINT SURG AM, V87A, P2671, DOI 10.2106/JBJS.D.02536
   Hoemann CD, 2005, OSTEOARTHR CARTILAGE, V13, P318, DOI 10.1016/j.joca.2004.12.001
   Holland TA, 2007, OSTEOARTHR CARTILAGE, V15, P187, DOI 10.1016/j.joca.2006.07.006
   HOLMDAHL R, 1986, ARTHRITIS RHEUM, V29, P400, DOI 10.1002/art.1780290314
   Hsu SH, 2004, ARTIF ORGANS, V28, P693, DOI 10.1111/j.1525-1594.2004.00046.x
   Hunter CJ, 2002, BIOMATERIALS, V23, P1249, DOI 10.1016/S0142-9612(01)00245-9
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Kapyla J, 2004, J BIOL CHEM, V279, P51677, DOI 10.1074/jbc.M409412200
   Kiraly K, 1996, HISTOCHEM J, V28, P99, DOI 10.1007/BF02331414
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   Kopakkala-Tani M, 2006, BIORHEOLOGY, V43, P271
   Lammi MJ, 2004, J RHEUMATOL, V31, P2449
   Lee CR, 2003, J BIOMED MATER RES A, V64A, P560, DOI 10.1002/jbm.a.10443
   Lemare F, 1998, J CELL PHYSIOL, V176, P303, DOI 10.1002/(SICI)1097-4652(199808)176:2<303::AID-JCP8>3.0.CO;2-S
   Malemud C J, 1994, Osteoarthritis Cartilage, V2, P29, DOI 10.1016/S1063-4584(05)80004-4
   MANKIN HJ, 1982, J BONE JOINT SURG AM, V64, P460, DOI 10.2106/00004623-198264030-00022
   MOW VC, 1992, BIOMATERIALS, V13, P67, DOI 10.1016/0142-9612(92)90001-5
   Mukaida T, 2005, J ORTHOP SCI, V10, P521, DOI 10.1007/s00776-005-0930-8
   Nehrer S, 1998, BIOMATERIALS, V19, P2313, DOI 10.1016/S0142-9612(98)00143-4
   Nehrer S, 1997, BIOMATERIALS, V18, P769, DOI 10.1016/S0142-9612(97)00001-X
   Ochi M, 2002, J BONE JOINT SURG BR, V84B, P571, DOI 10.1302/0301-620X.84B4.11947
   Ochi M, 2001, ARTIF ORGANS, V25, P172, DOI 10.1046/j.1525-1594.2001.025003172.x
   ODRISCOLL SW, 1988, J BONE JOINT SURG AM, V70A, P595, DOI 10.2106/00004623-198870040-00017
   Olsen D, 2003, ADV DRUG DELIVER REV, V55, P1547, DOI 10.1016/j.addr.2003.08.008
   Park H, 2005, BIOMATERIALS, V26, P7095, DOI 10.1016/j.biomaterials.2005.05.083
   PARKKINEN JJ, 1993, ARCH BIOCHEM BIOPHYS, V300, P458, DOI 10.1006/abbi.1993.1062
   PARKKINEN JJ, 1992, J ORTHOPAED RES, V10, P610, DOI 10.1002/jor.1100100503
   Pulkkinen H, 2006, BIO-MED MATER ENG, V16, pS29
   Pulliainen O, 2007, TISSUE ENG, V13, P1347, DOI 10.1089/ten.2006.0347
   Qu CJ, 2007, CONNECT TISSUE RES, V48, P27, DOI 10.1080/03008200601044128
   SAH RLY, 1989, J ORTHOPAED RES, V7, P619, DOI 10.1002/jor.1100070502
   SALTER DM, 1992, BRIT J RHEUMATOL, V31, P231
   SCHUMAN L, 1995, BIOMATERIALS, V16, P809, DOI 10.1016/0142-9612(95)99644-2
   Sharma B, 2004, ANN BIOMED ENG, V32, P148, DOI 10.1023/B:ABME.0000007799.60142.78
   Shields KJ, 2004, TISSUE ENG, V10, P1510, DOI 10.1089/1076327042500373
   Solchaga LA, 1999, J ORTHOPAED RES, V17, P205, DOI 10.1002/jor.1100170209
   SPEER DP, 1979, CLIN ORTHOP RELAT R, P326
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Toyras J, 2003, ULTRASOUND MED BIOL, V29, P447, DOI 10.1016/S0301-5629(02)00708-1
   Vasara AI, 2004, CALCIFIED TISSUE INT, V74, P107, DOI 10.1007/s00223-002-2153-8
   Veilleux NH, 2004, TISSUE ENG, V10, P119, DOI 10.1089/107632704322791763
   Vickers SM, 2006, TISSUE ENG, V12, P1345, DOI 10.1089/ten.2006.12.1345
   WAKITANI S, 1989, J BONE JOINT SURG BR, V71, P74
   Weiser L, 1999, TISSUE ENG, V5, P533, DOI 10.1089/ten.1999.5.533
   Woods A, 2007, J CELL PHYSIOL, V213, P1, DOI 10.1002/jcp.21110
   Yang CL, 2004, BIODRUGS, V18, P103, DOI 10.2165/00063030-200418020-00004
NR 62
TC 18
Z9 19
U1 0
U2 7
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD NOV
PY 2008
VL 31
IS 11
BP 960
EP 969
PG 10
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 405SU
UT WOS:000263245300006
PM 19089798
DA 2018-10-19
ER

PT J
AU Liang, YS
   Zhao, W
   Chen, GQ
AF Liang, Yan-Sheng
   Zhao, Wei
   Chen, Guo-Qiang
TI Study on the biocompatibility of novel terpolyester
   poly(3-hydroxybutyrate-co-3-hydroxyvalerate-co-3-hydroxyhexanoate)
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE PHB; terpolyester; polyhydroxyalkanoates; PHA; 3-hydroxyvalerate;
   3-hydroxyhexanoate; fibroblast L929; osteoblast MC3T3
ID IN-VITRO; CELL-ADHESION; DIFFERENT ROUGHNESS; SURFACE-ROUGHNESS;
   TISSUE-REACTIONS; PROLIFERATION; ATTACHMENT;
   POLY(3-HYDROXYBUTYRATE-CO-3-HYDROXYHEXANOATE); POLYHYDROXYALKANOATES;
   BIODEGRADATION
AB Terpolyester poly(3-hydroxybutyrate-co-3-hydroxyvalerate-co-3-hydroxyhexanoate) (PHBVHHx) containing 5.3 mol% 3-hydroxyvalerate (3-HV) and 10.2 mol % 3-hydroxyhexanoate was obtained via microbial synthesis using recombinant Aeromonas hydrophila. For the first time in vitro biocompatibility of the terpolyester was evaluated in comparison with poly(L-lactic acid), poly (3-hydroxybutyrate), poly(3-hydroxybutyrate-co-3-hydroxyvalerate), and poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHx). Scanning electron microscopy showed whorls-like morphology only on PHBVHHx film Surface. Methylthiazol tetrazolium assay demonstrated that PHBVHHx was better than the above four materials in promoting cell attachment and proliferation of fibroblast cell line L929 and osteciblast cell line MC3T3, respectively. Histological study using rabbits proved that PHBVHHx was a fairly harmless implantable biomaterial. Thus, PHBVHHx with an adjustable mechanical properties, combined with its biocompatibility, are in the process of developing into a new generation of bioimplant material. (c) 2008 Wiley Periodicals, Inc.
C1 [Liang, Yan-Sheng; Zhao, Wei; Chen, Guo-Qiang] Shantou Univ, Multidisciplinary Res Ctr, Shantou 515063, Guangdong, Peoples R China.
RP Chen, GQ (reprint author), Shantou Univ, Multidisciplinary Res Ctr, Shantou 515063, Guangdong, Peoples R China.
EM chengq@stu.edu.cn
FU Li Ka Shing Foundation; State High Tech Project (863) [2006AA02Z242]
FX Contract grant sponsor: Li Ka Shing Foundation; Contract grant sponsor:
   State High Tech Project (863), contract grant number: 2006AA02Z242
CR Akhtar S., 1990, THESIS U BATH
   Andrade J D, 1973, Med Instrum, V7, P110
   BARBARA DB, 1996, BIOMATERIALS, V17, P137
   Cai KY, 2002, BIOMATERIALS, V23, P1603, DOI 10.1016/S0142-9612(01)00287-3
   Campoccia D, 2003, BIOMATERIALS, V24, P587, DOI 10.1016/S0142-9612(02)00373-3
   Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   Chou L, 1999, BIOMATERIALS, V20, P977, DOI 10.1016/S0142-9612(98)00254-3
   Davis DH, 2002, BIOMATERIALS, V23, P4019, DOI 10.1016/S0142-9612(02)00152-7
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   GREENBERG JH, 1981, DEV BIOL, V87, P259, DOI 10.1016/0012-1606(81)90149-4
   Kose GT, 2003, BIOMATERIALS, V24, P4999, DOI 10.1016/S0142-9612(03)00417-4
   Lee SY, 1996, BIOTECHNOL BIOENG, V49, P1
   Linez-Bataillon P, 2002, BIOMOL ENG, V19, P133, DOI 10.1016/S1389-0344(02)00024-2
   Lu XY, 2005, FEMS MICROBIOL LETT, V243, P149, DOI 10.1016/j.femsle.2004.11.051
   MENG V, 2007, J BIOMAT SCI-POLYM E, V18, P81
   MILLER ND, 1987, BIOMATERIALS, V8, P129, DOI 10.1016/0142-9612(87)90102-5
   Misra SK, 2006, BIOMACROMOLECULES, V7, P2249, DOI 10.1021/bm060317c
   Parkins W M, 1943, Ann Surg, V118, P193, DOI 10.1097/00000658-194308000-00004
   PIGLOWSKI J, 1994, BIOMATERIALS, V15, P909, DOI 10.1016/0142-9612(94)90116-3
   Pol BJM, 1996, J BIOMED MATER RES, V32, P307
   Qu XH, 2006, BIOMATERIALS, V27, P3540, DOI 10.1016/j.biomaterials.2006.02.015
   Qu XH, 2006, J BIOMAT SCI-POLYM E, V17, P1107, DOI 10.1163/156856206778530704
   Shum-Tim D, 1999, ANN THORAC SURG, V68, P2298, DOI 10.1016/S0003-4975(99)01055-3
   STEELE JG, 1993, J BIOMAT SCI-POLYM E, V5, P245
   Tsai CC, 2001, BIOMATERIALS, V22, P523, DOI 10.1016/S0142-9612(00)00206-4
   van den Dolder J, 2003, BIOMATERIALS, V24, P1853, DOI 10.1016/S0142-9612(02)00571-9
   Wang YW, 2004, BIOMATERIALS, V25, P669, DOI 10.1016/S0142-9612(03)00561-1
   Webb K, 1998, J BIOMED MATER RES, V41, P422, DOI 10.1002/(SICI)1097-4636(19980905)41:3<422::AID-JBM12>3.0.CO;2-K
   WILLIAMS SF, 2001, BIOPOLYMERS POLYESTE, V3, P91
   Yang M, 2004, BIOMATERIALS, V25, P1365, DOI 10.1016/j.biomaterials.2003.08.018
   Yang XS, 2002, BIOMATERIALS, V23, P1391, DOI 10.1016/S0142-9612(01)00260-5
   Zheng Z, 2005, BIOMATERIALS, V26, P3537, DOI 10.1016/j.biomaterials.2004.09.041
NR 32
TC 9
Z9 10
U1 0
U2 2
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD NOV
PY 2008
VL 87A
IS 2
BP 441
EP 449
DI 10.1002/jbm.a.31801
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 360PF
UT WOS:000260068900017
PM 18186048
DA 2018-10-19
ER

PT J
AU Sieminski, AL
   Semino, CE
   Gong, H
   Kamm, RD
AF Sieminski, A. L.
   Semino, C. E.
   Gong, H.
   Kamm, R. D.
TI Primary sequence of ionic self-assembling peptide gels affects
   endothelial cell adhesion and capillary morphogenesis
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE capillary morphogenesis; endothelial cell; biomaterial; self-assembling;
   adhesion
ID COMPLEMENTARY OLIGOPEPTIDE; IN-VITRO; MECHANICAL-PROPERTIES; MATRICES;
   SCAFFOLDS; MICROENVIRONMENTS; ANGIOGENESIS; MICROVESSELS; GENERATION;
   OUTGROWTH
AB Appropriate choice of biomaterial Supports is critical for the study of capillary morphogenesis in vitro as well as to support vascularization of engineered tissues in vivo. Self-assembling peptides are a class of synthetic, ionic, oligopeptides that spontaneously assemble into gets with an ECM-like microarchitecture when exposed to salt. In this paper, the ability of four different self-assembling peptide gels to promote endothelial cell adhesion and capillary morphogenesis is explored. Human umbilical vein endothelial cells (HUVECs) were cultured within ionic self-assembling peptide family members, RAD16-I ((RADA)(4), RAD16-II ((RARADADA)(2)), KFE-8 ((FKFE)(2)), or KLD-12 ((KLDL)(3)). HUVECs SLIspended in RAD16-I or RAD16-II gels elongated and formed interconnected capillary-like networks resembling in vivo capillaries, while they remained round and formed clusters within KFE-8 Or KLD-12 gels. As HUVECs attach to RAD16-I and RAD16-II significantly better than the other peptides, these differences appear to be explained by differences in cell adhesion. Although adhesion likely occurs via bound adhesion proteins, there appears to be no difference in protein binding to the peptides investigated. Results indicate that, although these oligopeptides have similar mechanisms of self-assembly, their primary sequence can greatly affect cell adhesion. Additionally, a Subset of these biomimetic ECM-like materials Support capillary morphogenesis and thus may be useful for supporting vascularization. (C) 2008 Wiley Periodicals, Inc.
C1 [Sieminski, A. L.; Semino, C. E.; Kamm, R. D.] MIT, Biol Engn Div, Cambridge, MA 02139 USA.
   [Semino, C. E.] MIT, Ctr Biomed Engn, Cambridge, MA 02139 USA.
   [Gong, H.] Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA.
RP Kamm, RD (reprint author), MIT, Biol Engn Div, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
EM rdkamm@mit.edu
OI Gong, Haiyan/0000-0002-7204-5019; /0000-0002-7232-304X
FU National Institutes of Health [R01-EB003805]; Draper Laboratory
   University IRD [DL-H-550151]; National Institutes of Health
FX The authors thank 3DM for the generous gift of RAD16-I (BD PuraMatrix);
   Keith Gooch, Mike DiMicco, John Kisiday, Wonmuk Hwang, and Lisa Spirio
   for insightful discussions; and Yamilee Toussaint and Estevan Martinez
   for their technical assistance. The authors also gratefully acknowledge
   funding from the National Institutes of Health grant R01-EB003805
   (R.D.K.), Draper Laboratory University IR&D grant DL-H-550151, and the
   National Institutes of Health Ruth L. Kirschstein National Research
   Service Award (A.L.S).
CR Baugh L, 2004, J BIOMED MATER RES A, V69A, P525, DOI 10.1002/jbm.a.30026
   DAVIS GE, 1995, EXP CELL RES, V216, P113, DOI 10.1006/excr.1995.1015
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   DVORAK HF, 1987, LAB INVEST, V57, P673
   Genove E, 2005, BIOMATERIALS, V26, P3341, DOI 10.1016/j.biomaterials.2004.08.012
   Gobin AS, 2002, FASEB J, V16, P751, DOI 10.1096/fj.01-0759fje
   Gong HY, 2002, EXP EYE RES, V75, P347, DOI 10.1006/exer.2002.2010
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Hall Heike, 2004, Angiogenesis, V7, P213, DOI 10.1007/s10456-004-1328-5
   Holder WD, 1997, TISSUE ENG, V3, P149, DOI 10.1089/ten.1997.3.149
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   Koike N, 2004, NATURE, V428, P138, DOI 10.1038/428138a
   Korff T, 1999, J CELL SCI, V112, P3249
   Leon EJ, 1998, J BIOMAT SCI-POLYM E, V9, P297, DOI 10.1163/156856298X00668
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Marini DM, 2002, NANO LETT, V2, P295, DOI 10.1021/nl015697g
   Narmoneva DA, 2004, CIRCULATION, V110, P962, DOI 10.1161/01.CIR.0000140667.37070.07
   Narmoneva DA, 2005, BIOMATERIALS, V26, P4837, DOI 10.1016/j.biomaterials.2005.01.005
   Nor JE, 2001, LAB INVEST, V81, P453
   Peters MC, 2002, J BIOMED MATER RES, V60, P668, DOI 10.1002/jbm.10134
   Schechner JS, 2000, P NATL ACAD SCI USA, V97, P9191, DOI 10.1073/pnas.150242297
   Semino CE, 2004, TISSUE ENG, V10, P643, DOI 10.1089/107632704323061997
   Semino CE, 2003, DIFFERENTIATION, V71, P262, DOI 10.1046/j.1432-0436.2003.7104503.x
   Sieminski AL, 2007, CELL BIOCHEM BIOPHYS, V49, P73, DOI 10.1007/s12013-007-0046-1
   Sieminski AL, 2005, TISSUE ENG, V11, P1332, DOI 10.1089/ten.2005.11.1332
   Sieminski AL, 2004, EXP CELL RES, V297, P574, DOI 10.1016/j.yexcr.2004.03.035
   Sieminski AL, 2002, TISSUE ENG, V8, P1057, DOI 10.1089/107632702320934155
   Urech L, 2005, BIOMATERIALS, V26, P1369, DOI 10.1016/j.biomaterials.2004.04.045
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Yang JW, 2001, NAT BIOTECHNOL, V19, P219, DOI 10.1038/85655
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
   ZHANG SG, 1994, BIOPOLYMERS, V34, P663, DOI 10.1002/bip.360340508
   ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334
   Zhang SG, 1999, BIOMATERIALS, V20, P1213, DOI 10.1016/S0142-9612(99)00014-9
   ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y
NR 36
TC 82
Z9 82
U1 0
U2 25
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD NOV
PY 2008
VL 87A
IS 2
BP 494
EP 504
DI 10.1002/jbm.a.31785
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 360PF
UT WOS:000260068900023
PM 18186067
DA 2018-10-19
ER

PT J
AU Yildirim, ED
   Yin, X
   Nair, K
   Sun, W
AF Yildirim, Eda D.
   Yin, Xi
   Nair, Kalyani
   Sun, Wei
TI Fabrication, Characterization, and Biocompatibility of Single-Walled
   Carbon Nanotube-Reinforced Alginate Composite Scaffolds Manufactured
   Using Freeform Fabrication Technique
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE tissue scaffold; tissue engineering; alginate; single-walled carbon
   nanotube (SWCNT); freeform fabrication
ID TISSUE ENGINEERED CONSTRUCTS; ENHANCED OSTEOBLAST ADHESION;
   PERIPHERAL-NERVE REPAIR; NANOPHASE CERAMICS; PULMONARY TOXICITY;
   HEALTH-RISKS; NEURONAL GROWTH; HIPCO PROCESS; DEPOSITION; POLYMER
AB Composite polymeric scaffolds from alginate and single-walled carbon nanotube (SWCNT) were produced using a freeform fabrication technique. The scaffolds were characterized for their structural, mechanical, and biological properties by scanning electron microscopy, Raman spectroscopy, tensile testing, and cell-scaffold interaction study. Three-dimensional hybrid alginate/SWCNT tissue scaffolds were fabricated in a multinozzle biopolymer deposition system, which makes possible to disperse and align SWCNTs in the alginate matrix. The structure of the resultant scaffolds was significantly altered due to SWCNT reinforcement, which was confirmed by Raman spectroscopy. Microtensile testing presented a reinforcement effect of SWCNT to the mechanical strength of the alginate struts. Ogden constitutive modeling was utilized to predict the stress-strain relationship of the alginate scaffold, which compared well with the experimental data. Cellular study by rat heart endothelial cell showed that the SWCNT incorporated in the alginate structure improved cell adhesion and proliferation. Our study suggests that hybrid alginate/SWCNT scaffolds are a promising biomaterial for tissue engineering applications. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 87B: 406-414, 2008
C1 [Yildirim, Eda D.; Yin, Xi; Nair, Kalyani; Sun, Wei] Drexel Univ, Dept Mech Engn & Mech, Lab Comp Aided Tissue Engn, Philadelphia, PA 19104 USA.
RP Sun, W (reprint author), Drexel Univ, Dept Mech Engn & Mech, Lab Comp Aided Tissue Engn, Philadelphia, PA 19104 USA.
EM sunwei@drexel.edu
FU NSF [0427216, 0219176]
FX Contract grant sponsor: NSF; contract grant numbers: 0427216, 0219176
CR *ABAQUS, ABAQUS AN VERS 6 5 U
   ADAMS D, 1978, J BIOMED MATER RES, V12, P35, DOI 10.1002/jbm.820120104
   Ajayan PM, 1999, CHEM REV, V99, P1787, DOI 10.1021/cr970102g
   Andrews R, 2004, CURR OPIN SOLID ST M, V8, P31, DOI 10.1016/j.cossms.2003.10.006
   AYAD L, 1994, EXTRACELLULAR MATRIX
   Biercuk MJ, 2002, APPL PHYS LETT, V80, P2767, DOI 10.1063/1.1469696
   Bronikowski MJ, 2001, J VAC SCI TECHNOL A, V19, P1800, DOI 10.1116/1.1380721
   Carter FJ, 2001, MED IMAGE ANAL, V5, P231, DOI 10.1016/S1361-8415(01)00048-2
   Chiang IW, 2001, J PHYS CHEM B, V105, P8297, DOI 10.1021/jp0114891
   Cooper CA, 2002, COMPOS SCI TECHNOL, V62, P1105, DOI 10.1016/S0266-3538(02)00056-8
   Correa-Duarte MA, 2004, NANO LETT, V4, P2233, DOI 10.1021/nl048574f
   Craighead HG, 2001, CURR OPIN SOLID ST M, V5, P177, DOI 10.1016/S1359-0286(01)00005-5
   Dai HJ, 2002, ACCOUNTS CHEM RES, V35, P1035, DOI 10.1021/ar0101640
   Dee KC, 1996, BIOMATERIALS, V17, P209, DOI 10.1016/0142-9612(96)85765-6
   DRESSELHAUS MS, 1996, SCI FULLERENES CARBO, P756
   Elias KL, 2002, BIOMATERIALS, V23, P3279, DOI 10.1016/S0142-9612(02)00087-X
   Evans GRD, 2001, ANAT RECORD, V263, P396, DOI 10.1002/ar.1120
   Harrison BS, 2007, BIOMATERIALS, V28, P344, DOI 10.1016/j.biomaterials.2006.07.044
   Hu H, 2004, NANO LETT, V4, P507, DOI 10.1021/nl035193d
   Hudson TW, 2000, ORTHOP CLIN N AM, V31, P485, DOI 10.1016/S0030-5898(05)70166-8
   Jia G, 2005, ENVIRON SCI TECHNOL, V39, P1378, DOI 10.1021/es048729l
   Kay S, 2002, TISSUE ENG, V8, P753, DOI 10.1089/10763270260424114
   KHALIL SA, 1986, INT J FRACTURE, V31, P37, DOI 10.1007/BF00033928
   Khalil S, 2007, MAT SCI ENG C-BIO S, V27, P469, DOI 10.1016/j.msec.2006.05.023
   KHAN S, 2002, CARBON NANOTUBE BASE
   Lam CW, 2006, CRIT REV TOXICOL, V36, P189, DOI 10.1080/10408440600570233
   Lam CW, 2004, TOXICOL SCI, V77, P126, DOI 10.1093/toxsci/kfg243
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LANGONE F, 1995, BIOMATERIALS, V16, P347, DOI 10.1016/0142-9612(95)93851-4
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Li RH, 1996, BIOTECHNOL BIOENG, V50, P365, DOI 10.1002/(SICI)1097-0290(19960520)50:4<365::AID-BIT3>3.0.CO;2-J
   MacDonald RA, 2005, J BIOMED MATER RES A, V74A, P489, DOI 10.1002/jbm.a.30386
   Mattson MP, 2000, J MOL NEUROSCI, V14, P175, DOI 10.1385/JMN:14:3:175
   Ounaies Z, 2003, COMPOS SCI TECHNOL, V63, P1637, DOI 10.1016/S0266-3538(03)00067-8
   Price RL, 2003, BIOMATERIALS, V24, P1877, DOI 10.1016/S0142-9612(02)00609-9
   Savaiano JK, 2004, BIOMATERIALS, V25, P1205, DOI 10.1016/j.biomaterials.2003.08.012
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   Siegel RW, 1996, SCI AM, V275, P74, DOI 10.1038/scientificamerican1296-74
   Stichel CC, 1999, EUR J NEUROSCI, V11, P632, DOI 10.1046/j.1460-9568.1999.00466.x
   Thostenson ET, 2001, COMPOS SCI TECHNOL, V61, P1899, DOI 10.1016/S0266-3538(01)00094-X
   Vacanti JP, 1999, LANCET, V354, pSI32
   Warheit D, 2003, ABSTR PAP AM CHEM S, V225, pU955
   Warheit DB, 2006, CARBON, V44, P1064, DOI 10.1016/j.carbon.2005.10.013
   Warheit DB, 2004, ABSTR PAP AM CHEM S, V227, pU1232
   Warheit DB, 2004, TOXICOL SCI, V77, P117, DOI 10.1093/toxsci/kfg228
   Weber W. H., 2000, RAMAN SCATTERING MAT
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Webster TJ, 1999, NANOSTRUCT MATER, V12, P983, DOI 10.1016/S0965-9773(99)00283-4
   Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0
   Webster TJ, 2001, TISSUE ENG, V7, P291, DOI 10.1089/10763270152044152
   Webster TJ, 2001, BIOMATERIALS, V22, P1327, DOI 10.1016/S0142-9612(00)00285-4
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Wilson CE, 2002, J MATER SCI-MATER M, V13, P1265, DOI 10.1023/A:1021139415528
   Woodfield TBF, 2004, BIOMATERIALS, V25, P4149, DOI 10.1016/j.biomaterials.2003.10.056
   Yakobson BI, 1997, AM SCI, V85, P324
   Zanello LP, 2006, NANO LETT, V6, P562, DOI 10.1021/nl051861e
NR 56
TC 44
Z9 45
U1 3
U2 39
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD NOV
PY 2008
VL 87B
IS 2
BP 406
EP 414
DI 10.1002/jbm.b.31118
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 364SG
UT WOS:000260355000013
PM 18506813
DA 2018-10-19
ER

PT J
AU Nagai, N
   Nakayama, Y
   Zhou, YM
   Takamizawa, K
   Mori, K
   Munekata, M
AF Nagai, Nobuhiro
   Nakayama, Yasuhide
   Zhou, Yue-Min
   Takamizawa, Keiichi
   Mori, Kazuo
   Munekata, Masanobu
TI Development of Salmon Collagen Vascular Graft: Mechanical and Biological
   Properties and Preliminary Implantation Study
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE vascular graft; salmon collagen; biodegradable scaffold; implantation;
   regenerative medicine
ID HUMAN BLOOD-VESSEL; BIODEGRADABLE POLYMER; FIBRIL FORMATION;
   CROSS-LINKING; IN-VITRO; CELLS; BIOMATERIAL; ARTERIES; SCAFFOLD; MODEL
AB Elastic salmon collagen (SC) vascular grafts were prepared by incubating a mixture of acidic SC solution and a fibrillogenesis-inducing buffer containing a crosslinking agent [water-soluble carbodiiimide (WSC)] in a tubular mold at 4 degrees C for 24 h and then at 60 degrees C for 5 min. Subsequently, re-crosslinking in ethanol solution containing WSC was performed. The dimension of the SC grafts was easily controlled by changing the size of the mold used. The compliance (stiffness parameter: beta) and burst strength of the SC grafts (internal diameter, 2 mm; length, 20 mm; and wall thickness, 0.75 mm) that were prepared for implantation were 18.2 and 1434 mmHg, respectively; both these values were comparable with those of native vessels. Upon placement in rat subcutaneous pouches, the SC grafts were gradually biodegraded with little inflammatory reaction. The SC grafts were preliminarily implanted in rat abdominal aortas by using specially designed vascular connecting system. This system was used because the graft exhibited easy tearing and thus inadequate suturability. There was neither aneurysm formation nor graft rupture, but mild thrombus formation was seen within the 4-week observation period. These grafts may be ideal for use in regenerative medicine because we believe that SC would be completely replaced with native vascular tissues after implantation, although further improvement in the mechanical properties of the graft is needed for anastomosis. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res Part 13: Appl Biomater 87B: 432-439, 2008
C1 [Nagai, Nobuhiro] Hokkaido Univ, CRIS, Sapporo, Hokkaido 0010021, Japan.
   [Nakayama, Yasuhide; Zhou, Yue-Min; Takamizawa, Keiichi] Natl Cardiovasc Ctr, Res Inst, Adv Med Engn Ctr, Dept Bioengn, Osaka 5658565, Japan.
   [Nakayama, Yasuhide; Munekata, Masanobu] Hokkaido Univ, Grad Sch Engn, Div Biotechnol & Macromol Chem, Sapporo, Hokkaido 0608628, Japan.
   [Mori, Kazuo] Ihara & Co Ltd, Otaru, Hokkaido 0470261, Japan.
RP Nagai, N (reprint author), Hokkaido Univ, CRIS, Sapporo, Hokkaido 0010021, Japan.
EM nagai491@yahoo.co.jp; nakayama@ri.ncvc.go.jp
CR BASSIOUNY HS, 1992, J VASC SURG, V15, P708, DOI 10.1016/0741-5214(92)90019-5
   Bassiouny HS, 1992, J VASC SURG, V15, P716
   Damink LHHO, 1996, BIOMATERIALS, V17, P679, DOI 10.1016/0142-9612(96)86737-8
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   HAYASHI K, 1985, Journal of Biomedical Materials Research, V19, P133, DOI 10.1002/jbm.820190204
   HAYASHI K, 1980, J BIOMECH, V13, P175, DOI 10.1016/0021-9290(80)90191-8
   HAYASHI K, 1986, NEW APPROACHES CARDI, P258
   Isenberg BC, 2006, CIRC RES, V98, P25, DOI 10.1161/01.RES.0000196867.12470.84
   Iwai S, 2005, ANN THORAC SURG, V80, P1821, DOI 10.1016/j.athoracsur.2005.03.139
   Iwai S, 2004, J THORAC CARDIOV SUR, V128, P472, DOI 10.1016/j.jtcvs.2004.04.013
   Kadler KE, 1996, BIOCHEM J, V316, P1
   Kakisis JD, 2005, J VASC SURG, V41, P349, DOI 10.1016/j.jvs.2004.12.026
   L'Heureux N, 1998, FASEB J, V12, P47
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Lepidi S, 2006, EUR J VASC ENDOVASC, V32, P411, DOI 10.1016/j.ejvs.2006.02.012
   LHEUREUX N, 1993, J VASC SURG, V17, P499, DOI 10.1016/0741-5214(93)90150-K
   Nagai N, 2004, J BIOSCI BIOENG, V97, P389, DOI 10.1263/jbb.97.389
   Nakayama Y, 2004, CELL TRANSPLANT, V13, P439, DOI 10.3727/000000004783983828
   Polanowska-Grabowska R, 1999, THROMB HAEMOSTASIS, V81, P118
   Sakai Osamu, 2005, J Artif Organs, V8, P119, DOI 10.1007/s10047-005-0294-z
   Shum-Tim D, 1999, ANN THORAC SURG, V68, P2298, DOI 10.1016/S0003-4975(99)01055-3
   TAKAMIZAWA K, 1987, J BIOMECH, V20, P7, DOI 10.1016/0021-9290(87)90262-4
   WEINBERG CB, 1986, SCIENCE, V231, P397, DOI 10.1126/science.2934816
   WILDEVUUR CRH, 1987, BIOMATERIALS, V8, P418, DOI 10.1016/0142-9612(87)90076-7
   Yunoki S, 2004, J BIOSCI BIOENG, V98, P40, DOI 10.1263/jbb.98.40
   Yunoki S, 2003, J BIOSCI BIOENG, V96, P575, DOI 10.1016/S1389-1723(04)70152-8
   Yunoki S, 2007, J MATER SCI-MATER M, V18, P1369, DOI 10.1007/s10856-007-0121-6
NR 27
TC 14
Z9 14
U1 0
U2 6
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD NOV
PY 2008
VL 87B
IS 2
BP 432
EP 439
DI 10.1002/jbm.b.31121
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 364SG
UT WOS:000260355000016
PM 18478534
DA 2018-10-19
ER

PT J
AU Ban, S
   Sato, H
   Suehiro, Y
   Nakanishi, H
   Nawa, M
AF Ban, Seiji
   Sato, Hideo
   Suehiro, Yasuhiko
   Nakanishi, Hideo
   Nawa, Masahiro
TI Biaxial Flexure Strength and Low Temperature Degradation of Ce-TZP/Al2O3
   Nanocomposite and Y-TZP as Dental Restoratives
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE zirconia; dental/craniofacial material; degradation; surface
   characteristics
ID TRANSFORMATION-TOUGHENED ZIRCONIA; TETRAGONAL ZRO2 POLYCRYSTALS;
   YTTRIA-STABILIZED ZIRCONIA; MECHANICAL-PROPERTIES; HEAT-TREATMENT;
   GRAIN-SIZE; CERAMICS; WATER; BIOMATERIAL; STRESS
AB The purpose of the present study was to evaluate the mechanical durability of a zirconia/alumina nanocomposite stabilized with cerium oxide (Ce-TZP/Al2O3 nanocomposite) in comparison to yttria-stabilized tetragonal zirconia polycrystals (Y-TZP) and discuss its application on ceramic dental restorations. The disk-shaped specimens of both materials were stored in physiological saline solution at 80 degrees C for 30 days, in 4% acetic acid at 80 degrees C for 30 days, and in an autoclave at 121 degrees C for 10 days. Before and after storage, specimens were subjected to the biaxial flexure test and to the determination of the monoclinic zirconia content. After autoclaving, Y-TZP showed remarkable increasing of the content of monoclinic zirconia: 0.3 vol% before and 49.9 vol% after, and slight decreasing of biaxial flexure strength: 1046 MPa before and 892 MPa after; whereas Ce-TZP/Al2O3 nanocomposite showed no significant difference in the monoclinic content (4.8-5.5 vol%) and the biaxial flexure strength (1371-1422 MPa) after storage in any conditions. It is concluded that, compared to Y-TZP, the Ce-TZP/Al2O3 nanocomposite has a high biaxial flexure strength along with a satisfactory durability in terms of low-temperature aging degradation in above conditions. This study indicates that the Ce-TZP/Al2O3 nanocomposite demonstrates excellent mechanical durability for dental restorations such as all-ceramic bridges. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 87B: 492-498, 2008
C1 [Ban, Seiji; Sato, Hideo] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Biomat Sci, Kagoshima 8900145, Japan.
   [Suehiro, Yasuhiko; Nakanishi, Hideo; Nawa, Masahiro] Matsushita Elect Works, Adv Technol Fus Lab, Kadoma, Osaka 5718686, Japan.
RP Ban, S (reprint author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Biomat Sci, Kagoshima 8900145, Japan.
EM sban@denta.hal.kagoshima-u.ac.jp
FU Japan Society for the Promotion of Science [18390521]
FX Contract grant sponsor: Japan Society for the Promotion of Science
   (Grant-in-Aid for General Scientific Research): contract grant number:
   18390521
CR Anusavice KJ, 2003, PHILLIPS SCI DENT MA, P655
   Ardlin BI, 2002, DENT MATER, V18, P590, DOI 10.1016/S0109-5641(01)00095-1
   Ban S, 2007, KEY ENG MATER, V330-332, P353, DOI 10.4028/www.scientific.net/KEM.330-332.353
   Ban S, 2006, KEY ENG MAT, V309-311, P1219, DOI 10.4028/www.scientific.net/KEM.309-311.1219
   BAN S, 1990, J DENT RES, V69, P1791, DOI 10.1177/00220345900690120201
   BAN S, 2005, DENT MATER J, V24, P70
   BASU D, 1995, CERAM INT, V21, P277, DOI 10.1016/0272-8842(95)99794-C
   Blaine L., 2001, KEY ENG MATER, V192, P553
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Chevalier J, 1999, J AM CERAM SOC, V82, P2150
   Chevalier J, 2007, ANNU REV MATER RES, V37, P1, DOI 10.1146/annurev.matsci.37.052506.084250
   Deville S, 2005, J BIOMED MATER RES B, V72B, P239, DOI 10.1002/jbm.b.30123
   DRUMMOND JL, 1989, J AM CERAM SOC, V72, P675, DOI 10.1111/j.1151-2916.1989.tb06194.x
   FRANGINI S, 2001, KEY ENG MATER, V192, P557
   GARVIE RC, 1975, NATURE, V258, P703, DOI 10.1038/258703a0
   GUPTA TK, 1978, J MATER SCI, V13, P1464, DOI 10.1007/BF00553200
   Kosmac T, 2004, KEY ENG MAT, V254-2, P683, DOI 10.4028/www.scientific.net/KEM.254-256.683
   LAWSON S, 1995, J EUR CERAM SOC, V15, P485, DOI 10.1016/0955-2219(95)00035-S
   Lin J-D, 2002, MATER CHEM PHYS, V77, P808
   LU HY, 1987, J AM CERAM SOC, V70, P537, DOI 10.1111/j.1151-2916.1987.tb05701.x
   MENDELSON MI, 1969, J AM CERAM SOC, V52, P443, DOI 10.1111/j.1151-2916.1969.tb11975.x
   Nawa M, 1998, CERAM INT, V24, P497, DOI 10.1016/S0272-8842(97)00048-5
   Nawa M, 1998, J EUR CERAM SOC, V18, P209, DOI 10.1016/S0955-2219(97)00116-7
   Niihara K., 1991, J CERAM SOC JPN, V99, P974, DOI DOI 10.2109/JCERSJ.99.974
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Sato H, 2008, DENT MATER J, V27, P408, DOI 10.4012/dmj.27.408
   SATO T, 1985, AM CERAM SOC BULL, V64, P1382
   SATO T, 1985, J AM CERAM SOC, V68, P356, DOI 10.1111/j.1151-2916.1985.tb15239.x
   SHIMIZU K, 1993, J BIOMED MATER RES, V27, P729, DOI 10.1002/jbm.820270605
   SWAIN MV, 1986, J AM CERAM SOC, V69, P511, DOI 10.1111/j.1151-2916.1986.tb04785.x
   Tanaka K, 2003, J BIOMED MATER RES A, V67A, P200, DOI 10.1002/jbm.a.10006
   Tanaka K, 2002, J BIOMED MATER RES, V63, P262, DOI 10.1002/jbm.10182
   TORAYA H, 1984, J AM CERAM SOC, V67, pC119
   TSUKUMA K, 1985, J MATER SCI, V20, P1178, DOI 10.1007/BF01026311
   WURST JC, 1972, J AM CERAM SOC, V55, P109, DOI 10.1111/j.1151-2916.1972.tb11224.x
NR 35
TC 75
Z9 76
U1 2
U2 10
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD NOV
PY 2008
VL 87B
IS 2
BP 492
EP 498
DI 10.1002/jbm.b.31131
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 364SG
UT WOS:000260355000024
PM 18491411
DA 2018-10-19
ER

PT J
AU Martineau, L
   Davis, SC
   Peng, HT
   Hung, A
AF Martineau, Lucie
   Davis, Stephen C.
   Peng, Henry T.
   Hung, Andy
TI Controlling Methicillin Resistant Staphyloccocus aureus and Pseudomonas
   aeruginosa Wound Infections with a Novel Biomaterial (vol 20, pg 217,
   2007)
SO JOURNAL OF INVESTIGATIVE SURGERY
LA English
DT Correction
C1 [Martineau, Lucie] DRDC, Valcartier, PQ, Canada.
   [Davis, Stephen C.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA.
   [Peng, Henry T.; Hung, Andy] DRDC, Toronto, ON, Canada.
RP Martineau, L (reprint author), DRDC, Valcartier, PQ, Canada.
CR Martineau L, 2007, J INVEST SURG, V20, P217, DOI 10.1080/10717540701481275
NR 1
TC 0
Z9 0
U1 0
U2 0
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 0894-1939
J9 J INVEST SURG
JI J. Invest. Surg.
PD NOV-DEC
PY 2008
VL 21
IS 6
BP 375
EP 375
DI 10.1080/08941930802584576
PG 1
WC Surgery
SC Surgery
GA 400DL
UT WOS:000262848100012
OA Bronze
DA 2018-10-19
ER

PT J
AU Lawrence, BD
   Omenetto, F
   Chui, K
   Kaplan, DL
AF Lawrence, Brian D.
   Omenetto, Fiorenzo
   Chui, Katherine
   Kaplan, David L.
TI Processing methods to control silk fibroin film biomaterial features
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Article
ID CORNEAL EPITHELIAL-CELLS; CONFORMATION TRANSITION KINETICS; TRANSFORM
   INFRARED-SPECTROSCOPY; POLY(ETHYLENE OXIDE); CYTOSKELETAL ORGANIZATION;
   NANOSCALE TOPOGRAPHY; THERMAL-PROPERTIES; HIGH-PRESSURE; BETA-SHEET;
   IN-VITRO
AB Control of silk structural and morphological features is reported for fibroin protein films via all aqueous processing, with and without polyethylene oxide (PEO). Silk films with thicknesses from 500 nm to 50 mu m were generated with controllable surface morphologies by employing soft-lithography surface patterning or by adjusting PEO concentrations. FTIR analysis indicated that water-annealing, used to cure or set the films, resulted in increased beta-sheet and alpha-helix content within the films. Steam sterilization provided an additional control point by increasing beta-sheet content, while reducing random coil and turn structures, yet retaining film transparency and material integrity. Increased PEO concentration used during processing resulted in decreased sizes of surface globule structures, while simultaneously increasing uniformity of these features. The above results indicate that both surface and bulk morphologies and structures can be controlled by adjusting PEO concentration. The combined tool set for controlling silk film geometry and structure provides a foundation for further study of novel silk film biomaterial systems. These silk film biomaterials have potential applicability for a variety of optical and regenerative medicine applications due to their optical clarity, impressive mechanical properties, slow degradability, and biocompatibility.
C1 [Lawrence, Brian D.; Omenetto, Fiorenzo; Chui, Katherine; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA USA.
EM David.Kaplan@tufts.edu
FU NIH P41 Tissue Engineering Resource Center; U. S. Army Research
   Laboratory; U. S. Army Research Office [W911NF-07-1-0618]; DARPA-DSO
FX The authors thank the NIH P41 Tissue Engineering Resource Center for
   support for this work. Additionally, the authors would like to thank
   Mark Cronin-Golomb for technical assistance with AFM imaging, Xiao Hu
   for technical assistance with FTIR, and Katherine Chui for providing
   technical assistance in material processing. This material is based upon
   work supported in part by the U. S. Army Research Laboratory and the U.
   S. Army Research Office under contract number W911NF-07-1-0618 and by
   the DARPA-DSO.
CR Abrams GA, 2000, CORNEA, V19, P57, DOI 10.1097/00003226-200001000-00012
   Agarwal N, 1997, J APPL POLYM SCI, V63, P401
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Arai T, 2004, J APPL POLYM SCI, V91, P2383, DOI 10.1002/app.13393
   ARRONDO JLR, 1993, PROG BIOPHYS MOL BIO, V59, P23, DOI 10.1016/0079-6107(93)90006-6
   ASAKURA T, 1985, MACROMOLECULES, V18, P1841, DOI 10.1021/ma00152a009
   Chen X, 2001, BIOPHYS CHEM, V89, P25, DOI 10.1016/S0301-4622(00)00213-1
   Chen X, 2007, PROTEINS, V68, P223, DOI 10.1002/prot.21414
   Crabb RAB, 2006, TISSUE ENG, V12, P1565, DOI 10.1089/ten.2006.12.1565
   CUNIBERTI C, 1972, POLYMER, V13, P379, DOI 10.1016/0032-3861(72)90058-4
   Diehl KA, 2005, J BIOMED MATER RES A, V75A, P603, DOI 10.1002/jbm.a.30467
   DONG A, 1990, BIOCHEMISTRY-US, V29, P3303, DOI 10.1021/bi00465a022
   DUNN GA, 1986, J CELL SCI, V83, P313
   FINK AL, 1998, FOLD DES, V3, DOI DOI 10.1016/S1359-0278(98)00005-4
   Fitton JH, 1998, J BIOMED MATER RES, V42, P245
   Gupta MK, 2007, LANGMUIR, V23, P1315, DOI 10.1021/la062047p
   Hammouda B, 2004, MACROMOLECULES, V37, P6932, DOI 10.1021/ma049623d
   Hofmann S, 2006, J CONTROL RELEASE, V111, P219, DOI 10.1016/j.jconrel.205.12.009
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Hu X, 2007, THERMOCHIM ACTA, V461, P137, DOI 10.1016/j.tca.2006.12.011
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Jin HJ, 2004, BIOMACROMOLECULES, V5, P711, DOI 10.1021/bm0343287
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Jung C, 2000, J MOL RECOGNIT, V13, P325, DOI 10.1002/1099-1352(200011/12)13:6<325::AID-JMR507>3.0.CO;2-C
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   Kardestuncer T, 2006, CLIN ORTHOP RELAT R, P234, DOI 10.1097/01.blo.0000205879.50834.fe
   Karlon WJ, 1999, ANN BIOMED ENG, V27, P712, DOI 10.1114/1.226
   Karuri NW, 2006, IEEE T NANOBIOSCI, V5, P273, DOI 10.1109/TNB.2006.886570
   Karuri NW, 2004, J CELL SCI, V117, P3153, DOI 10.1242/jcs.01146
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Lawrence BD, 2008, BIOMACROMOLECULES, V9, P1214, DOI 10.1021/bm701235f
   Liliensiek SJ, 2006, J BIOMED MATER RES A, V79A, P185, DOI 10.1002/jbm.a.30744
   Loesberg WA, 2007, BIOMATERIALS, V28, P3944, DOI 10.1016/j.biomaterials.2007.05.030
   Matsumoto A, 2006, J PHYS CHEM B, V110, P21630, DOI 10.1021/jp056350v
   MEARS DR, 1969, J APPL PHYS, V40, P4229, DOI 10.1063/1.1657180
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   MINOURA N, 1995, J BIOMED MATER RES, V29, P1215, DOI 10.1002/jbm.820291008
   Motta A, 2002, MACROMOL CHEM PHYSIC, V203, P1658, DOI 10.1002/1521-3935(200207)203:10/11<1658::AID-MACP1658>3.0.CO;2-3
   Nakafuku C, 2003, J APPL POLYM SCI, V87, P1962, DOI 10.1002/app.11601
   NAKAFUKU C, 1993, POLYMER, V34, P4166, DOI 10.1016/0032-3861(93)90684-3
   *NIH, IM J
   *NIH, 1 37C
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   PARK J, 2004, THESIS TUFTS U MEDFO, P56
   Smith CK, 1997, ACCOUNTS CHEM RES, V30, P153, DOI 10.1021/ar9601048
   Speare JO, 2003, BIOPOLYMERS, V72, P193, DOI 10.1002/bip.10337
   Suh KY, 2004, ADV MATER, V16, P584, DOI 10.1002/adma.200306180
   Teixeira AI, 2004, J BIOMED MATER RES A, V71A, P369, DOI 10.1002/jbm.a.30089
   Tretinnikov ON, 2001, LANGMUIR, V17, P7406, DOI 10.1021/la010791y
   TSUKADA M, 1994, J POLYM SCI POL PHYS, V32, P961, DOI 10.1002/polb.1994.090320519
   Valluzzi R, 2004, BIOMACROMOLECULES, V5, P696, DOI 10.1021/bm0343085
   Valluzzi R, 1999, J PHYS CHEM B, V103, P11382, DOI 10.1021/jp991363s
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   Vunjak-Novakovic G, 2004, ANNU REV BIOMED ENG, V6, P131, DOI 10.1146/annurev.bioeng.6.040803.140037
   Wang XQ, 2008, BIOMATERIALS, V29, P1054, DOI 10.1016/j.biomaterials.2007.11.003
   Wang XY, 2005, LANGMUIR, V21, P11335, DOI 10.1021/la051862m
   Wilson D, 2000, BIOPHYS J, V78, P2690, DOI 10.1016/S0006-3495(00)76813-5
   Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153
   Zhao DB, 2007, CLEAN-SOIL AIR WATER, V35, P42, DOI 10.1002/clen.200600015
NR 63
TC 82
Z9 85
U1 5
U2 73
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0022-2461
J9 J MATER SCI
JI J. Mater. Sci.
PD NOV
PY 2008
VL 43
IS 21
BP 6967
EP 6985
DI 10.1007/s10853-008-2961-y
PG 19
WC Materials Science, Multidisciplinary
SC Materials Science
GA 367AU
UT WOS:000260525700020
DA 2018-10-19
ER

PT J
AU Zhang, HP
   Lu, X
   Fang, LM
   Weng, J
   Huang, N
   Leng, Y
AF Zhang, Hong-Ping
   Lu, Xiong
   Fang, Li-Ming
   Weng, Jie
   Huang, Nan
   Leng, Yang
TI Molecular dynamics simulation of RGD peptide adsorption on titanium
   oxide surfaces
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID FORCE-FIELD; AB-INITIO; IN-VIVO; IMPLANTS; ADHESION; COMPASS; BLOOD
AB Peptide Arg-Gly-Asp (RGD) sequence is a ubiquitous adhesive motif found in various bone extracellular matrix proteins and is crucial in the biomaterial surface/interface reaction. This study analyzed the adsorption of RGD on different titanium oxide surfaces with molecular dynamics simulation. The simulation results indicate that the RGD peptide binds strongly with anatase (001) and rutile (010). RGD conformation changes due to the variation of the backbone torsion angle in the middle of the RGD chain. Pair correlation function analysis indicates that the interaction of the RGD peptide and the titanium oxide results from hydrogen bonding and the groups in RGD play different roles during the adsorption process. This study provides useful information on how to design titanium surfaces in order to modulate peptide or protein adsorption.
C1 [Zhang, Hong-Ping; Lu, Xiong; Weng, Jie; Huang, Nan] SW Jiaotong Univ, Sch Mat Sci & Engn, Minist Educ, Key Lab Adv Technol Mat, Chengdu 610031, Sichuan, Peoples R China.
   [Fang, Li-Ming] S China Univ Technol, Dept Polymer Sci & Engn, Sch Mat Sci & Engn, Guangzhou 510641, Peoples R China.
   [Fang, Li-Ming; Leng, Yang] Hong Kong Univ Sci & Technol, Dept Engn Mech, Kowloon, Hong Kong, Peoples R China.
RP Lu, X (reprint author), SW Jiaotong Univ, Sch Mat Sci & Engn, Minist Educ, Key Lab Adv Technol Mat, Chengdu 610031, Sichuan, Peoples R China.
EM luxiong_2004@163.com
RI Leng, Yang/B-3187-2010; Weng, Jie/B-3005-2010; LU, xiong/B-3092-2010
OI LU, xiong/0000-0001-6367-430X; Fang, Liming/0000-0003-4263-8478
FU National Natural Science Foundation of China [30700172]; Specialized
   Research [20070613019]; MSTC [2006BAI16B01]
FX This project was financially supported by the National Natural Science
   Foundation of China (No. 30700172), Specialized Research Fund for the
   Doctoral Program of Higher Education for Young Teacher (20070613019) and
   National Key Project of Scientific and Technical Supporting Programs
   Fund from MSTC (2006BAI16B01).
CR Bhowmik R, 2007, POLYMER, V48, P664, DOI 10.1016/j.polymer.2006.11.015
   Diebold U, 2003, SURF SCI REP, V48, P53, DOI 10.1016/S0167-5729(02)00100-0
   Elmengaard B, 2005, BIOMATERIALS, V26, P3521, DOI 10.1016/j.biomaterials.2004.09.039
   Ferris DM, 1999, BIOMATERIALS, V20, P2323, DOI 10.1016/S0142-9612(99)00161-1
   Iucci G, 2007, MAT SCI ENG C-BIO S, V27, P1201, DOI 10.1016/j.msec.2006.09.038
   Kantarci N, 2005, POLYMER, V46, P4307, DOI 10.1016/j.polymer.2005.03.016
   Monti S, 2007, J PHYS CHEM C, V111, P7765, DOI 10.1021/jp071095v
   Rammelt S, 2006, BIOMATERIALS, V27, P5561, DOI 10.1016/j.biomaterials.2006.06.034
   Rybolt TR, 2007, J COLLOID INTERF SCI, V314, P434, DOI 10.1016/j.jcis.2007.05.083
   Schuler M, 2006, BIOMATERIALS, V27, P4003, DOI 10.1016/j.biomaterials.2006.03.009
   Sun H, 2005, J COMPUT CHEM, V26, P169, DOI 10.1002/jcc.20153
   Sun H, 1998, COMPUT THEOR POLYM S, V8, P229, DOI 10.1016/S1089-3156(98)00042-7
   Sun H, 1998, J PHYS CHEM B, V102, P7338, DOI 10.1021/jp980939v
   Thor A, 2007, BIOMATERIALS, V28, P966, DOI 10.1016/j.biomaterials.2006.10.020
   Tosatti S, 2003, BIOMATERIALS, V24, P4949, DOI 10.1016/S0142-9612(03)00420-4
   Toth R, 2006, BIOMACROMOLECULES, V7, P1714, DOI 10.1021/bm050937y
   Wang YM, 2007, SURF SCI, V601, P63, DOI 10.1016/j.susc.2006.09.005
   WILFRED HJC, 1990, ANGEW CHEM INT EDIT, V29, P992, DOI DOI 10.1002/ANIE.199009921
   Yang ZY, 2007, ENG ANAL BOUND ELEM, V31, P402, DOI 10.1016/j.enganabound.2006.07.012
   Zhao BH, 2005, CURR APPL PHYS, V5, P407, DOI 10.1016/j.cap.2005.01.002
NR 20
TC 11
Z9 11
U1 3
U2 29
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD NOV
PY 2008
VL 19
IS 11
BP 3437
EP 3441
DI 10.1007/s10856-008-3498-y
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 347FY
UT WOS:000259127200014
PM 18584123
DA 2018-10-19
ER

PT J
AU He, J
   Zhou, W
   Zhou, XJ
   Zhong, XX
   Zhang, XL
   Wan, PB
   Zhu, BS
   Chen, WT
AF He, Jie
   Zhou, Wei
   Zhou, Xiaojian
   Zhong, Xiaoxia
   Zhang, Xiuli
   Wan, Pengbo
   Zhu, Bangshang
   Chen, Wantao
TI The anatase phase of nanotopography titania plays an important role on
   osteoblast cell morphology and proliferation
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID ORTHOPEDIC APPLICATIONS; BIOLOGICAL RESPONSES; PROTEIN ADSORPTION;
   IN-VITRO; ADHESION; WETTABILITY; TOPOGRAPHY; COATINGS; TIO2;
   BIOMATERIALS
AB The surface properties of biomaterials play a vital role in cell morphology and behaviors such as cell adhesion, migration, proliferation and differentiation. Three different crystal phases of titania film (rutile, anatase and amorphous titania) with similar roughness were successfully synthesized by DC reactive magnetron sputtering. The surface roughness of each film was about 8-10 nm. Primary rat osteoblasts were used to observe changes in morphology and to evaluate cell behavior at the film surface. The number of the osteoblasts on anatase film was significantly higher than rutile and amorphous films after 36 and 72 h incubation. More importantly, synthesis of alkaline phosphatase was significantly greater by osteoblasts cultured on anatase film than on rutile and amorphous films after 7 and 14 days. In addition, the cells grown on the anatase phase film had the largest spreading area; the actin filaments in cells with regular directions were well defined and fully spreaded. The results indicate that the anatase phase of titania with nanoscale topography yield the best biological effects for cell adhesion, spreading, proliferation and differentiation. There are strong therapeutic prospects for this biomaterial film for osteoblast proliferation, with possible applications for orthopedic and dental implant.
C1 [He, Jie; Zhou, Wei; Wan, Pengbo; Chen, Wantao] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Oral & Maxillofacial Surg, Shanghai 200011, Peoples R China.
   [Zhou, Wei; Zhang, Xiuli] Shanghai Jiao Tong Univ, Dept Phys, Shanghai 200030, Peoples R China.
   [Zhou, Xiaojian; Zhong, Xiaoxia; Chen, Wantao] Shanghai Key Lab Stomatol, Shanghai 200011, Peoples R China.
   [Zhu, Bangshang] Shanghai Jiao Tong Univ, Instrumental Anal Ctr, Shanghai 200030, Peoples R China.
RP Chen, WT (reprint author), Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Oral & Maxillofacial Surg, Shanghai 200011, Peoples R China.
EM chenwantao2002@hotmail.com
RI zhong, xiaoxia/O-1081-2015; zhou, wei/D-2312-2017
OI zhong, xiaoxia/0000-0002-5371-7932; zhou, wei/0000-0002-5257-3885
FU National Natural Science Foundation of China [30572053]; Shanghai
   Science and Technology Committee [0452nm063, 0652nm018]
FX The authors would like to thank Mrs. QH Lu (Analysis and Measurement
   Center of Shanghai JiaoTong University) for AFM measurement and
   modification of the manuscript. The project was financially supported by
   the National Natural Science Foundation of China (30572053) and Shanghai
   Science and Technology Committee (0452nm063 and 0652nm018).
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Anselme K, 2006, BIOMATERIALS, V27, P1187, DOI 10.1016/j.biomaterials.2005.10.009
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Black J, 1998, HDB BIOMATERIAL PROP, P179
   Bordji K, 1996, BIOMATERIALS, V17, P929, DOI 10.1016/0142-9612(96)83289-3
   BOYD DA, 2006, NANO LETT, V11, P2592, DOI DOI 10.1021/N1062061M
   Brunette DM, 1999, J BIOMECH ENG-T ASME, V121, P49, DOI 10.1115/1.2798042
   Cai KY, 2006, COLLOID SURFACE B, V49, P136, DOI 10.1016/j.colsurfb.2006.02.016
   Cai KY, 2005, BIOMATERIALS, V26, P5960, DOI 10.1016/j.biomaterials.2005.03.020
   Chen XB, 2006, J NANOSCI NANOTECHNO, V6, P906, DOI 10.1166/jnn.2006.160
   Eisenbarth E, 2007, BIOMOL ENG, V24, P27, DOI 10.1016/j.bioeng.2006.05.016
   Karlsson M, 2003, BIOMATERIALS, V24, P3039, DOI 10.1016/S0142-9612(03)00146-7
   Kriparamanan R, 2006, J NANOSCI NANOTECHNO, V6, P1905, DOI 10.1166/jnn.2006.330
   Lee TM, 2002, J MATER SCI-MATER M, V13, P281, DOI 10.1023/A:1014010901423
   Leeuwenburgh S, 2005, J BIOMED MATER RES A, V74A, P275, DOI 10.1002/jbm.a.30420
   Oh SH, 2005, BIOMATERIALS, V26, P4938, DOI 10.1016/j.biomaterials.2005.01.048
   Perla V, 2005, J BIOMED MATER RES A, V75A, P356, DOI 10.1002/jbm.a.30423
   Rabady R, 2005, APPL OPTICS, V44, P378, DOI 10.1364/AO.44.000378
   Sato M, 2004, EXPERT REV MED DEVIC, V1, P105, DOI 10.1586/17434440.1.1.105
   Sato M, 2005, BIOMATERIALS, V26, P1349, DOI 10.1016/j.biomaterials.2004.04.044
   Suzuki O, 2006, J BIOMED MATER RES B, V77B, P201, DOI 10.1002/jbm.b.30407
   VONRECUM AF, 1995, J BIOMAT SCI-POLYM E, V7, P181, DOI 10.1163/156856295X00698
   Webster TJ, 2007, ADV BIOCHEM ENG BIOT, V103, P275, DOI 10.1007/10_021
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Webster TJ, 2004, BIOMATERIALS, V25, P4731, DOI 10.1016/j.biomaterials.2003.12.002
   Wei JH, 2007, J BIOMED MATER RES B, V81B, P66, DOI 10.1002/jbm.b.30638
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Yao C, 2006, J NANOSCI NANOTECHNO, V6, P2682, DOI 10.1166/jnn.2006.447
   Yim EKF, 2005, NANOMED-NANOTECHNOL, V1, P10, DOI 10.1016/j.nano.2004.11.008
   Zhou W, 2006, SURF COAT TECH, V200, P6155, DOI 10.1016/j.surfcoat.2005.09.029
   Zhou W, 2007, J BIOMED MATER RES A, V81A, P453, DOI 10.1002/jbm.a.30987
   Zhu BS, 2005, TISSUE ENG, V11, P825, DOI 10.1089/ten.2005.11.825
   Zhu BS, 2004, BIOMATERIALS, V25, P4215, DOI 10.1016/j.biomaterials.2003.11.020
NR 33
TC 99
Z9 102
U1 1
U2 38
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD NOV
PY 2008
VL 19
IS 11
BP 3465
EP 3472
DI 10.1007/s10856-008-3505-3
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 347FY
UT WOS:000259127200017
PM 18592349
DA 2018-10-19
ER

PT J
AU Garmendia, N
   Bilbao, L
   Munoz, R
   Imbuluqueta, G
   Garcia, A
   Bustero, I
   Calvo-Barrio, L
   Arbiol, J
   Obieta, I
AF Garmendia, N.
   Bilbao, L.
   Munoz, R.
   Imbuluqueta, G.
   Garcia, A.
   Bustero, I.
   Calvo-Barrio, L.
   Arbiol, J.
   Obieta, I.
TI Zirconia Coating of Carbon Nanotubes by a Hydrothermal Method
SO JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
LA English
DT Article
DE Nanozirconia; Carbon Nanotubes; Nanocomposites; Hydrothermal; Coating
ID STABILIZED ZIRCONIA; IN-SITU; COMPOSITES; TEMPERATURE; NANOCOMPOSITES;
   SIMULATION
AB Carbon nanotubes have unique mechanical properties that open attractive possibilities in many fields, such as the biomedical one. Currently, zirconia ceramics are widely used as femoral heads, but case studies show that delayed failure can occur in vivo due to crack propagation. Nanotubes could avoid the slow crack propagation and enhance the toughness of the ceramic material used for prostheses fabrication. In this work, single-wall carbon nanotubes and multi-wall carbon nanotubes have been partially coated with nanozirconia via hydrothermal synthesis and characterized by several techniques: X-ray diffraction, infrared spectroscopy, scanning electron microscope, transmission electron microscope, electron energy loss spectra, X-ray photoelectronic spectroscopy and atomic force microscopy. By means of these techniques, the existence of bonds between zirconium and the carbon nanotube has been proved. The as covered nanotubes should offer a better wettability in the ceramic matrix and improve the dispersion of the carbon nanotubes, to obtain the desired new ceramic biomaterial with a longer lifetime and better reliability.
C1 [Garmendia, N.; Bilbao, L.; Munoz, R.; Imbuluqueta, G.; Garcia, A.; Bustero, I.; Obieta, I.] INASMET TECNALIA, E-20009 San Sebastian, Spain.
   [Calvo-Barrio, L.; Arbiol, J.] Univ Barcelona, TEM MAT, Serv Cient Tecnis, E-08028 Barcelona, Spain.
   [Calvo-Barrio, L.; Arbiol, J.] Univ Barcelona, EME CeRMAE IN2 UB, Dept Elect, E-08028 Barcelona, Spain.
RP Garmendia, N (reprint author), INASMET TECNALIA, Mikeletegi Pasealekua 2,Parque Tecnol, E-20009 San Sebastian, Spain.
RI Calvo-Barrio, Lorenzo/F-3123-2016; Obieta, Isabel/A-7137-2011; Arbiol,
   Jordi/B-6048-2008; Munoz Gomez, Roberto/Q-5768-2017
OI Calvo-Barrio, Lorenzo/0000-0002-6993-1482; Arbiol,
   Jordi/0000-0002-0695-1726; Munoz Gomez, Roberto/0000-0002-7668-6681
FU Basque Government [PI-2004-2, BF105.R2.555]
FX The authors thank the Basque Government (PI-2004-2, BF105.R2.555 and
   Etortek: Nanornaterials) for its financial support.
CR An JW, 2002, J CERAM PROCESS RES, V3, P174
   [Anonymous], 1997, 13356 ISO
   Arbiol J, 2002, MAT SCI ENG B-SOLID, V91, P534, DOI 10.1016/S0921-5107(01)01067-4
   CHEN F, 2005, J AM CERAM SOC, V88, P2469
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   COCKE DL, 1988, APPL SURF SCI, V31, P471, DOI 10.1016/0169-4332(88)90009-8
   Curtin WA, 2004, MATER TODAY, V7, P44, DOI 10.1016/S1369-7021(04)00508-5
   DAUSKARDT RH, 1989, J AM CERAM SOC, V72, P1124, DOI 10.1111/j.1151-2916.1989.tb09694.x
   Deville S, 2005, J AM CERAM SOC, V88, P1273, DOI 10.1111/j.1551-2916.2005.00221.x
   Deville S, 2005, J BIOMED MATER RES B, V72B, P239, DOI 10.1002/jbm.b.30123
   Garcia A, 2006, PHYS STATUS SOLIDI A, V203, P1117, DOI 10.1002/pssa.200566149
   GARVIE RC, 1972, J AM CERAM SOC, V55, P303, DOI 10.1111/j.1151-2916.1972.tb11290.x
   Gremillard L, 2002, J AM CERAM SOC, V85, P401
   Hernadi K, 2003, ACTA MATER, V51, P1447, DOI 10.1016/S1359-6454(02)00539-6
   Huang YL, 2004, J UNIV SCI TECHNOL B, V11, P13
   Lupo F, 2004, CARBON, V42, P1995, DOI 10.1016/j.carbon.2004.03.037
   Matsui K, 2003, J AM CERAM SOC, V86, P1401, DOI 10.1111/j.1151-2916.2003.tb03483.x
   Peigney A, 2002, CHEM PHYS LETT, V352, P20, DOI 10.1016/S0009-2614(01)01441-5
   Rul S, 2003, J EUR CERAM SOC, V23, P1233, DOI 10.1016/S0955-2219(02)00286-8
   Seeger T, 2001, CHEM PHYS LETT, V339, P41, DOI 10.1016/S0009-2614(01)00256-1
   Seeger T, 2002, CHEM COMMUN, P34, DOI 10.1039/b109441f
   Shan Y, 2005, NANOTECHNOLOGY, V16, P625, DOI 10.1088/0957-4484/16/6/001
   Xia B, 2000, J AM CERAM SOC, V83, P1077
   Zhao LP, 2004, CARBON, V42, P423, DOI 10.1016/j.carbon.2003.10.024
NR 24
TC 5
Z9 6
U1 3
U2 18
PU AMER SCIENTIFIC PUBLISHERS
PI STEVENSON RANCH
PA 25650 NORTH LEWIS WAY, STEVENSON RANCH, CA 91381-1439 USA
SN 1533-4880
J9 J NANOSCI NANOTECHNO
JI J. Nanosci. Nanotechnol.
PD NOV
PY 2008
VL 8
IS 11
BP 5678
EP 5683
DI 10.1166/jnn.2008.211
PG 6
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 379IV
UT WOS:000261390800010
PM 19198288
DA 2018-10-19
ER

PT J
AU Zietek, M
   Gedrange, T
   Mikulewicz, M
AF Zietek, M.
   Gedrange, T.
   Mikulewicz, M.
TI LONG TERM EVALUATION OF BIOMATERIAL APPLICATION IN SURGICAL TREATMENT OF
   PERIODONTITIS
SO JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
LA English
DT Article; Proceedings Paper
CT 2nd Dental Continuing Education Meeting on Regenerative Medicine
CY MAR 10-14, 2008
CL South Tyrol, ITALY
DE periodontitis; biomaterials; bone graft material
ID BONE; DEFECTS; HYDROXYAPATITE; SUBSTITUTES; DISEASES
AB Regenerative treatment of periodontally damaged teeth is a demanding task. Advantages which comes With use of biomaterials are mainly connected with fact that traditional, surgical treatment protocols often do not lead to bone regeneration. The aim of this research was to evaluate clinical and radiological effectiveness of Surgical periodontal treatment (with application of HA-Biocer, Biogramu, Bio-Oss) after eight years prior to surgical protocol. Clinical evaluation consisted of measuring depths with perio probe, than evaluation of API (approximal plaque-index) hygiene index (%). Calculation Of Modified sulcus bleeding index - SBI (%) by Muhlemann and Son was done. Engelberger, Marthaler and Rateitschak index on x-rays was calculated. Routine check up eight years after Surgical treatment of periodontitis with use of biomaterials was conducted on 32 patients (20 woman, 12 men). The group of patients was divided into: 28 patients with chronic periodontitis (CP), and 4 patients with general aggressive periodontitis (GAP). Eight years after surgical treatment increase of bleeding areas were observed - in all applied biomaterials. For Bio-Oss average percent of SBI 45.2% (+/- 24.3), for Biogran 62% (+/- 36.2) and respectively for HA-Bioccr 51% (+/- 33.2) API index (%) oil teeth proximal surfaces was estimated for Biogran 47%, BioOss - 46.5% and for HA-Biocer 45.6%. Mean pocket depth (mm) has decreased - in case of all applied biomaterials. Radiological index was also calculated. Decrease of index value was stated. Outcomes of 8 years study indicate, decrease of oral hygiene, increase bleeding, decrease of Engelberger, Marthaler, Rateitchak index. It is necessary to perform routine check up of and control on oral hygiene. It seems to be important to mobilize patients to preserve high oral hygiene.
C1 [Zietek, M.] Wroclaw Med Univ, Dept Periodontol, PL-50425 Wroclaw, Poland.
   [Gedrange, T.] Ernst Moritz Arndt Univ Greifswald, Dept Orthodont Prevent & Pediat Dent, Greifswald, Germany.
   [Mikulewicz, M.] Wroclaw Med Univ, Individual Lab Facial Growth Defects, Dept Dentofacial Orthoped & Orthodont, Wroclaw, Poland.
RP Zietek, M (reprint author), Wroclaw Med Univ, Dept Periodontol, Krakowska 26, PL-50425 Wroclaw, Poland.
EM paradont@stom.am.wroc.pl
CR Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1
   CALLAN DP, 1993, J PERIODONTOL, V64, P575, DOI 10.1902/jop.1993.64.6.575
   Czesnikiewicz-Guzik M, 2007, J PHYSIOL PHARMACOL, V58, P5
   Gonciarz M, 2006, J PHYSIOL PHARMACOL, V57, P155
   Greenwald AS, 2001, J BONE JOINT SURG AM, V83A, P98, DOI 10.2106/00004623-200100022-00007
   HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253
   HENKEL KO, 2005, KEY ENG MATER, P885
   Mai R, 2007, ANN ANAT, V189, P350, DOI 10.1016/j.aanat.2007.02.023
   Mai R, 2006, J CRANIO MAXILL SURG, V34, P101, DOI 10.1016/S1010-5182(06)60022-X
   MELHER AH, 1962, ORAL SURG ORAL MED O, V15, P996
   Nasr HF, 1999, PERIODONTOL 2000, V19, P74, DOI 10.1111/j.1600-0757.1999.tb00148.x
   OHAZAMA A, 1999, J JAPAN SOC PERIODON, V41, P153
   OONISHI H, 1997, CLIN ORTHOP RELAT R, V334, P316
   Persson GR, 2000, J CLIN PERIODONTOL, V27, P104, DOI 10.1034/j.1600-051x.2000.027002104.x
   Proff P, 2006, ANN ANAT, V188, P353, DOI 10.1016/j.aanat.2006.02.003
   Richardson CR, 1999, J CLIN PERIODONTOL, V26, P421, DOI 10.1034/j.1600-051X.1999.260702.x
NR 16
TC 20
Z9 20
U1 2
U2 3
PU POLISH PHYSIOLOGICAL SOC
PI GRZEGORZECKA
PA JAGIELLONIAN UNIV SCHOOL MED, INST PHYSIOLOGY, 31-531 KRAKOW, 16
   GRZEGORZECKA, POLAND
SN 0867-5910
J9 J PHYSIOL PHARMACOL
JI J. Physiol. Pharmacol.
PD NOV
PY 2008
VL 59
SU 5
BP 81
EP 86
PG 6
WC Physiology
SC Physiology
GA 388CG
UT WOS:000261997300010
PM 19075328
DA 2018-10-19
ER

PT J
AU Chuo, CB
   Thomas, SS
AF Chuo, C. B.
   Thomas, S. S.
TI Absorbable mesh and topical negative pressure therapy for closure of
   abdominal dehiscence with exposed bowel
SO JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY
LA English
DT Article
DE Abdominal wall reconstruction; Abdominal dehiscence; Porcine dermis
   mesh; Permacol; Topical negative pressure therapy
ID WALL RECONSTRUCTION; RAT MODEL; PERMACOL(TM); REPAIR; DEFECTS; IMPLANT
AB Permacol (TM) mesh is a porcine dermis-derived biomaterial used for the repair of abdominal incisional and inguinal hernia. It has been found to be a safe and effective alternative to non-absorbable mesh for application over exposed bowel. This mesh has also been successfully applied over contaminated abdominal, wound beds and around stomas. Topical. negative pressure therapy has been used for the management of wound complications after surgical implantation of Permacol (TM) mesh. We describe our experience with the combined use of Permacol (TM) mesh and simultaneous application of topical negative pressure therapy to aid wound contraction and granulation in a patient with abdominal dehiscence and exposed bowel. (C) 2007 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.
C1 [Chuo, C. B.; Thomas, S. S.] Univ Hosp Birmingham Fdn Trust, Dept Burns & Plast Surg, Selly Oak Hosp, Birmingham, W Midlands, England.
RP Chuo, CB (reprint author), Univ Hosp Birmingham Fdn Trust, Dept Burns & Plast Surg, Selly Oak Hosp, Birmingham, W Midlands, England.
EM chuocb@rcsed.ac.uk
CR Adedeji OA, 2002, BRIT J PLAST SURG, V55, P85, DOI 10.1054/bjps.2001.3711
   DAYTON MT, 1986, ARCH SURG-CHICAGO, V121, P954
   Hammond TM, 2006, BRIT J SURG, V93, P39
   Harper C, 2001, HOSP MED, V62, P90, DOI 10.12968/hosp.2001.62.2.2379
   Holl-Allen R T, 1984, J R Coll Surg Edinb, V29, P151
   Holl-Allen R T, 1984, J R Coll Surg Edinb, V29, P154
   Liyanage SH, 2006, J PLAST RECONSTR AES, V59, P553, DOI 10.1016/j.bjps.2005.06.008
   Macleod TM, 2005, BRIT J PLAST SURG, V58, P518, DOI 10.1016/j.bjps.2004.12.012
   MacLeod TM, 2003, BRIT J PLAST SURG, V56, P775, DOI 10.1016/S0007-1226(03)00383-7
   Mathes SJ, 2000, ANN SURG, V232, P586, DOI 10.1097/00000658-200010000-00014
   SARMAH BD, 1984, BRIT J SURG, V71, P524, DOI 10.1002/bjs.1800710717
   VANDERLEI B, 1989, BRIT J SURG, V76, P803, DOI 10.1002/bjs.1800760813
   VOYLES CR, 1981, ANN SURG, V194, P219, DOI 10.1097/00000658-198108000-00017
NR 13
TC 11
Z9 13
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1748-6815
J9 J PLAST RECONSTR AES
JI J. Plast. Reconstr. Aesthet. Surg.
PD NOV
PY 2008
VL 61
IS 11
BP 1378
EP 1381
DI 10.1016/j.bjps.2007.04.012
PG 4
WC Surgery
SC Surgery
GA 374AC
UT WOS:000261013600018
PM 17544349
DA 2018-10-19
ER

PT J
AU Schneider, J
   Begand, S
   Kriegel, R
   Kaps, C
   Glien, W
   Oberbach, T
AF Schneider, Jens
   Begand, Sabine
   Kriegel, Ralf
   Kaps, Christian
   Glien, Wilfried
   Oberbach, Thomas
TI Low-Temperature Aging Behavior of Alumina-Toughened Zirconia
SO JOURNAL OF THE AMERICAN CERAMIC SOCIETY
LA English
DT Article
ID MONOCLINIC PHASE-TRANSFORMATION; CERAMIC FEMORAL-HEAD; JOINT PROSTHESES;
   Y-TZP; DIFFRACTION DATA; DEGRADATION; YTTRIA; HIP; POLYCRYSTALS;
   BIOMATERIAL
AB The corrosion of alumina-toughened zirconia (ATZ) as a consequence of hydrothermal treatment was investigated, especially the transformation kinetics from tetragonal zirconia to the monoclinic phase. For this purpose, polished ATZ specimens (R(a)< 5 nm) were aged in water vapor at different temperatures ranging from 70 degrees to 134 degrees C. The fraction of the monoclinic phase was determined using X-ray diffraction and Rietveld refinement. The isothermal transformation curves obtained were fitted to the Mehl-Johnson-Avrami equation by least squares. An Arrhenius plot of the fitted transformation rates was used to determine the activation energy and the pre-exponential factor. Following this procedure, the kinetic parameters of the phase transformation were extrapolated down to body temperature and the formation of the monoclinic phase was simulated. In addition, optical interferometry on well-polished specimens (R(a)< 2 nm) was alternatively used to calculate the monoclinic fraction from the histogram dataset. The results agree very well with those of the X-ray measurements. Additionally, the development of surface roughness with increasing aging time is discussed.
C1 [Schneider, Jens; Kaps, Christian] Bauhaus Univ Weimar, D-99423 Weimar, Germany.
   [Glien, Wilfried; Oberbach, Thomas] Mathys Orthopad GmbH, D-07646 Morsdorf, Germany.
   [Kriegel, Ralf] Hermsdorfer Inst Tech Keram, D-07629 Hermsdorf Thuringia, Germany.
RP Schneider, J (reprint author), Bauhaus Univ Weimar, D-99423 Weimar, Germany.
EM jens.schneider@bauing.uni-weimar.de
OI Kriegel, Ralf/0000-0001-8326-6004; Begand, Sabine/0000-0001-5877-8227
CR Begand S, 2006, KEY ENG MAT, V309-311, P1261, DOI 10.4028/www.scientific.net/KEM.309-311.1261
   Begand S, 2005, KEY ENG MAT, V284-286, P1019, DOI 10.4028/www.scientific.net/KEM.284-286.1019
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Chevalier J, 1999, J AM CERAM SOC, V82, P2150
   Chevalier J, 1997, BIOCERAMICS, P10
   Chevalier J, 2007, ANNU REV MATER RES, V37, P1, DOI 10.1146/annurev.matsci.37.052506.084250
   CHRISTIAN JW, 2002, THEORY PHASE TRANSFO, V1, P529
   De Aza AH, 2002, BIOMATERIALS, V23, P937, DOI 10.1016/S0142-9612(01)00206-X
   DEVILLE S, 1999, BIOMED MAT RES B, V72, P139
   DEVILLE S, 2005, BIOMATERIALS, V27, P2186
   Gremillard L, 2004, J EUR CERAM SOC, V24, P3483, DOI 10.1016/j.jeurceramsoc.2003.11.025
   HARAGUCHI K, 2003, J BONE JOINT SURG BR, V85, P996
   Heinicke G., 1984, TRIBOCHEMISTRY, P111
   Hernigou P, 2003, J BONE JOINT SURG BR, V85B, P504, DOI 10.1302/0301-620X.85B4.13397
   HOWARD CJ, 1991, J MATER SCI, V26, P127, DOI 10.1007/BF00576042
   Hummer CD, 1995, J ARTHROPLASTY, V10, P848, DOI 10.1016/S0883-5403(05)80085-3
   JANSEN E, 1994, J APPL CRYSTALLOGR, V27, P492, DOI 10.1107/S0021889893012348
   LANGE FF, 1986, J AM CERAM SOC, V69, P237, DOI 10.1111/j.1151-2916.1986.tb07415.x
   LANGE FF, 1982, J MATER SCI, V17, P225, DOI 10.1007/BF00809057
   Maccauro G, 2004, J BONE JOINT SURG BR, V86B, P1192, DOI 10.1302/0301-620X.86B8.15012
   Masonis JL, 2004, J ARTHROPLASTY, V19, P898, DOI 10.1016/j.arth.2004.02.045
   Panagiotopoulos EC, 2007, CLIN BIOMECH, V22, P856, DOI 10.1016/j.clinbiomech.2007.04.007
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Rahaman MN, 2007, J AM CERAM SOC, V90, P1965, DOI 10.1111/j.1551-2916.2007.01725.x
   RUHLE M, 1988, PHYSICA B & C, V150, P86, DOI 10.1016/0378-4363(88)90110-6
   Santos EM, 2004, J ARTHROPLASTY, V19, P30, DOI 10.1016/j.arth.2004.06.017
   SATO T, 1985, J AM CERAM SOC, V68, P356, DOI 10.1111/j.1151-2916.1985.tb15239.x
   SCHMAUDER S, 1986, J AM CERAM SOC, V69, P534, DOI 10.1111/j.1151-2916.1986.tb04789.x
   THIESSEN PA, 1967, GRUNDLAGEN TRIBOCHEM, P25
   TSUBAKINO H, 1991, J AM CERAM SOC, V74, P440, DOI 10.1111/j.1151-2916.1991.tb06905.x
   TSUBAKINO H, 1994, SOLID SOLID PHASE TR, P749
   WINTER M, 1992, CLIN ORTHOP RELAT R, P73
   Yasuda K, 1999, J MATER SCI, V34, P3597, DOI 10.1023/A:1004630800871
   YOSHIMURA M, 1987, J MATER SCI LETT, V6, P465, DOI 10.1007/BF01756800
NR 34
TC 40
Z9 40
U1 0
U2 24
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0002-7820
J9 J AM CERAM SOC
JI J. Am. Ceram. Soc.
PD NOV
PY 2008
VL 91
IS 11
BP 3613
EP 3618
DI 10.1111/j.1551-2916.2008.02700.x
PG 6
WC Materials Science, Ceramics
SC Materials Science
GA 374SI
UT WOS:000261063600022
DA 2018-10-19
ER

PT J
AU Long, LH
   Zhang, FM
   Chen, L
   Chen, LD
   Chang, J
AF Long, Lihua
   Zhang, Faming
   Chen, Lei
   Chen, Lidong
   Chang, Jiang
TI Preparation and properties of beta-CaSiO3/ZrO2 (3Y) nanocomposites
SO JOURNAL OF THE EUROPEAN CERAMIC SOCIETY
LA English
DT Article
DE nanocomposites; mechanical properties; ZrO2
ID CERAMICS; ZIRCONIA; BIOMATERIAL; BIOACTIVITY
AB beta-CaSiO3/ZrO2 (3Y) nanocomposites were successfully fabricated by spark plasma sintering (SPS) technique. The addition of nanocrystalline ZrO2 could inhibit the phase transition of micrometer sized CaSiO3 and increase its phase transitional temperature. The relative densities of the dense beta-CaSiO3/ZrO2 nanocomposites were above 98%. Nanocrystalline ZrO2 has formed a network structure in the nanocomposites, which could improve the mechanical properties of nanocomposites. The fracture strength and fracture toughness of the nanocomposites were as high as 395 MPa and 4.08 MPa m(1/2) respectively. The nanocomposites showed good in vitro bioactivity with hydroxyapatite (HA) layer formation on the ZrO2 network of the nanocomposites in simulated body fluid. The spark plasma sintered beta-CaSiO3/ZrO2 (3Y) nanocomposite may provide a new bone graft for load bearing applications. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Zhang, Faming; Chen, Lei; Chang, Jiang] Chinese Acad Sci, Shanghai Inst Ceram, Biomat & Tissue Engn Res Ctr, Shanghai 200050, Peoples R China.
   [Long, Lihua; Chen, Lidong] Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
   [Long, Lihua] Chinese Acad Sci, Grad Sch, Shanghai 200050, Peoples R China.
RP Chang, J (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, Biomat & Tissue Engn Res Ctr, Shanghai 200050, Peoples R China.
EM jchang@mail.sic.ac.cn
RI Chen, Lidong/F-2705-2010; Zhang, Faming/G-2804-2013
OI Zhang, Faming/0000-0001-7653-8163; Chen, Lidong/0000-0002-9683-037X
FU National Basic Science Research Program of China (973 Program)
   [2005CB522704]; Funds of the Chinese Academy of Sciences [KGCX2-YW-207];
   Funds of the Shanghai Institute of Ceramics Chinese Academy of Sciences
   for Innovation of Science and Technology [SCX0606]
FX This work is supported by the National Basic Science Research Program of
   China (973 Program) (Grant No.: 2005CB522704), the Funds of the Chinese
   Academy of Sciences for Key Topics in Innovation Engineering (Grant No.:
   KGCX2-YW-207) and the Funds of the Shanghai Institute of Ceramics
   Chinese Academy of Sciences for Innovation of Science and Technology
   (Grant No.: SCX0606).
CR Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   DEAZA PN, 1994, SCRIPTA METALL MATER, V31, P1001, DOI 10.1016/0956-716X(94)90517-7
   Hazar ABY, 2007, CERAM INT, V33, P687, DOI 10.1016/j.ceramint.2006.12.013
   Kutty MG, 2001, CERAM ENG SCI PROC, V22, P601
   LI LK, 2005, J INORG MATER, V20, P692
   Lin KL, 2005, CERAM INT, V31, P323, DOI 10.1016/j.ceramint.2004.05.023
   Long LH, 2006, J EUR CERAM SOC, V26, P1701, DOI 10.1016/j.eurceramsoc.2005.03.247
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Rice RW, 1996, J MATER SCI, V31, P1969, DOI 10.1007/BF00356616
   Shi JL, 1999, J MATER RES, V14, P1398, DOI 10.1557/JMR.1999.0190
   Silva VV, 2001, COMPOS SCI TECHNOL, V61, P301, DOI 10.1016/S0266-3538(00)00222-0
   SIYU N, 2006, J BIOMED MATER RES A, V76, P196
   Tadashi Kokubo, 2006, BIOMATERIALS, V27, P2907
NR 13
TC 13
Z9 14
U1 1
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0955-2219
J9 J EUR CERAM SOC
JI J. Eur. Ceram. Soc.
PD NOV
PY 2008
VL 28
IS 15
BP 2883
EP 2887
DI 10.1016/j.jeurceramsoc.2008.05.006
PG 5
WC Materials Science, Ceramics
SC Materials Science
GA 356DL
UT WOS:000259758800009
DA 2018-10-19
ER

PT J
AU Carvalho, V
   Domingues, L
   Gama, M
AF Carvalho, Vera
   Domingues, Lucilia
   Gama, Miguel
TI The Inhibitory Effect of an RGD-Human Chitin-Binding Domain Fusion
   Protein on the Adhesion of Fibroblasts to Reacetylated Chitosan Films
SO MOLECULAR BIOTECHNOLOGY
LA English
DT Article
DE Human chitin-binding module (ChBM); RGD; Fibroblasts; Cell adhesion;
   Reacetylated chitosan (RC) films
ID CELL-ADHESION; BIOMATERIALS; PURIFICATION; POLYMERS; CHITOTRIOSIDASE;
   BIOTECHNOLOGY; FIBRONECTIN; ACETYLATION; ATTACHMENT; SCAFFOLDS
AB Biomaterials used for tissue engineering applications must provide a structural support for the tissue development and also actively interact with cells, promoting adhesion, proliferation, and differentiation. To achieve this goal, adhesion molecules may be used, such as the tripeptide Arg-Gly-Asp (RGD). A method based on the use of a carbohydrate-binding module, with affinity for chitin, was tested as an alternative approach to the chemical grafting of bioactive peptides. This approach would simultaneously allow the production of recombinant peptides (alternatively to peptide synthesis) and provide a simple way for the specific and strong adsorption of the peptides to the biomaterial.
   A fusion recombinant protein, containing the RGD sequence fused to a human chitin-binding module (ChBM), was expressed in E. coli. The adhesion of fibroblasts to reacetylated chitosan (RC) films was the model system selected to analyze the properties of the obtained proteins. Thus, the evaluation of cell attachment and proliferation on polystyrene surfaces and reacetylated chitosan films, coated with the recombinant proteins, was performed using mouse embryo fibroblasts 3T3. The results show that the recombinant proteins affect negatively fibroblasts anchorage to the materials surface, inhibiting its adhesion and proliferation. We also conclude that this negative effect is fundamentally due to the human chitin-binding domain.
C1 [Carvalho, Vera; Domingues, Lucilia; Gama, Miguel] Univ Minho, Ctr Biol Engn, Inst Biotechnol & Bioengn, IBB, P-4710057 Braga, Portugal.
RP Gama, M (reprint author), Univ Minho, Ctr Biol Engn, Inst Biotechnol & Bioengn, IBB, Campus Gualtar, P-4710057 Braga, Portugal.
EM fmgama@deb.uminho.pt
RI Domingues, Lucilia/B-2191-2010; Gama, Miguel/I-3140-2015
OI Domingues, Lucilia/0000-0003-1089-7627; Gama,
   Miguel/0000-0002-5655-0015; Carvalho, Vera/0000-0003-1468-0433
FU Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BD/27359/2006]; 
   [POCTI/BIO/45356/2002]
FX Vera Carvalho was supported by the grant SFRH/BD/27359/2006 from
   Fundacao para a Ciencia e Tecnologia, Portugal. This study was supported
   by the Portuguese grant POCTI/BIO/45356/2002: "FUNCARB-FUNcionalizacao
   de materiais biome medicos usando um dominio de ligacao a
   CARBohidratos''.
CR ANDRADE FK, 2008, J BIOMEDICAL MAT R A
   Babu KS, 2008, PROTEIN EXPRES PURIF, V57, P201, DOI 10.1016/j.pep.2007.10.004
   BOOT RG, 1995, J BIOL CHEM, V270, P26252, DOI 10.1074/jbc.270.44.26252
   CARVALHO V, 2007, AUSTR J BIOTECHNOL S, V131, pS254
   Chatelet C, 2001, BIOMATERIALS, V22, P261, DOI 10.1016/S0142-9612(00)00183-6
   Chiba M, 1996, J IMMUNOL METHODS, V191, P55, DOI 10.1016/0022-1759(96)00021-X
   Chong SR, 1997, GENE, V192, P271, DOI 10.1016/S0378-1119(97)00105-4
   Dodane V, 1998, PHARM SCI TECHNOL TO, V1, P246, DOI 10.1016/S1461-5347(98)00059-5
   Elbert DL, 1996, ANNU REV MATER SCI, V26, P365, DOI 10.1146/annurev.ms.26.080196.002053
   Felt O, 1998, DRUG DEV IND PHARM, V24, P979, DOI 10.3109/03639049809089942
   Freier T, 2005, BIOMATERIALS, V26, P5872, DOI 10.1016/j.biomaterials.2005.02.033
   Hamilton V, 2006, J MATER SCI-MATER M, V17, P1373, DOI 10.1007/s10856-006-0613-9
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hirano S, 1996, Biotechnol Annu Rev, V2, P237, DOI 10.1016/S1387-2656(08)70012-7
   Hsu SH, 2004, J BIOTECHNOL, V111, P143, DOI 10.1016/j.jbiotec.2004.03.014
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   IKADA Y, 1994, BIOMATERIALS, V15, P725, DOI 10.1016/0142-9612(94)90025-6
   ILUM L, 1994, PHARM RES, V11, P1186
   Khatuntseva SA, 2008, J BIOTECHNOL, V133, P123, DOI 10.1016/j.jbiotec.2007.08.044
   Koide SS, 1998, NUTR RES, V18, P1091, DOI 10.1016/S0271-5317(98)00091-8
   Levesque SG, 2006, BIOMATERIALS, V27, P5277, DOI 10.1016/j.biomaterials.2006.06.004
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   MOREIRA S, 2008, DEV STRATEGY F UNPUB
   PELUSO G, 1994, BIOMATERIALS, V15, P1215, DOI 10.1016/0142-9612(94)90272-0
   Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200
   RENKEMA GH, 1995, J BIOL CHEM, V270, P2198, DOI 10.1074/jbc.270.5.2198
   RUIZHERRERA J, 1978, P 1 INT C CHIT CHIT, P11
   Sakiyama-Elbert SE, 2001, ANN REV MATER RES, V31, P183, DOI 10.1146/annurev.matsci.31.1.183
   Shahidi F, 1999, TRENDS FOOD SCI TECH, V10, P37, DOI 10.1016/S0924-2244(99)00017-5
   SHIGEMASA Y, 1995, BIOTECHNOL GENET ENG, V13, P383
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Tjoelker LW, 2000, J BIOL CHEM, V275, P514, DOI 10.1074/jbc.275.1.514
   Tsigos I, 2000, TRENDS BIOTECHNOL, V18, P305, DOI 10.1016/S0167-7799(00)01462-1
   UGAROVA TP, 1995, BIOCHEMISTRY-US, V34, P4457, DOI 10.1021/bi00013a039
   van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417
   Wang TW, 2006, J BIOMED MATER RES B, V79B, P379, DOI 10.1002/jbm.b.30552
   WIERZBA A, 1995, BIOTECHNOL BIOENG, V46, P185, DOI 10.1002/bit.260460302
   Yang F, 2005, BIOMATERIALS, V26, P5991, DOI 10.1016/j.biomaterials.2005.03.018
NR 40
TC 7
Z9 10
U1 1
U2 5
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 1073-6085
J9 MOL BIOTECHNOL
JI Mol. Biotechnol.
PD NOV
PY 2008
VL 40
IS 3
BP 269
EP 279
DI 10.1007/s12033-008-9089-9
PG 11
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA 360OZ
UT WOS:000260068300007
PM 18677572
DA 2018-10-19
ER

PT J
AU Wessels, QB
   Pretorius, E
AF Wessels, Q. B.
   Pretorius, E.
TI Enhanced stabilization of collagen-based dermal regeneration scaffolds
   through the combination of physical and chemical crosslinking
SO SOUTH AFRICAN JOURNAL OF SCIENCE
LA English
DT Article
ID PORE-SIZE; POROUS SCAFFOLDS; MAMMALIAN SKIN; TISSUE; MATRIX;
   GLUTARALDEHYDE; BIOMATERIALS; DEPOSITION; MORPHOLOGY; GROWTH
AB The use of collagen in the biomedical device Industry has led to major advances In soft tissue repair. This Is attributed largely to the favourable biological and physiochemical properties of collagen. Regenerative medicine and tissue engineering favoured the use of this biomaterial and various commercial products have become available In the past few decades. This study alms to develop a collagen and chondroitin-6-sulphate dermal regeneration scaffold with enhanced resistance against enzymatic degradation. Frozen slurries (0.5% collagen) were dried under vacuum, coated with silicone, crosslinked and then thoroughly rinsed. The scaffolds were subjected to a range of quantitative and qualitative tests that Included: scanning electron microscopy analysis, collagenase enzymatic degradation, and cytotoxicity assessment. Scaffold resistance to enzymatic degradation was manipulated after dehydrothermal treatment by employing combinations of crosslinking agents, such as glutaraldehyde and/or carbodiimide, with or without the presence of L-lysine. Results indicate that highly porous (mean pore diameter of 87.3 mu m), bioactive, non-cytotoxic tissue engineering matrices were obtained. Enhanced stability of these scaffolds was achieved through extensive crosslinking and suggests the potential to prevent in vivo wound contraction sufficiently.
C1 [Wessels, Q. B.; Pretorius, E.] Univ Pretoria, Fac Hlth Sci, Dept Anat, ZA-0001 Pretoria, South Africa.
RP Wessels, QB (reprint author), So Biotech Pty Ltd, POB 17198, ZA-0410 Lyttolton, South Africa.
EM quenton.w@southmod.co.za
CR Bansky R, 2005, Bratisl Lek Listy, V106, P221
   BILLIGHARM L, 1951, J EXP BIOL, V28, P385
   BILLINGHAM RE, 1955, J ANAT, V89, P114
   Borden M, 2003, BIOMATERIALS, V24, P597, DOI 10.1016/S0142-9612(02)00374-5
   BURKE JF, 1981, ANN SURG, V194, P413, DOI 10.1097/00000658-198110000-00005
   Claase MB, 2003, J BIOMED MATER RES A, V64A, P291, DOI 10.1002/jbm.a.10418
   DAMINK LHHO, 1995, J MATER SCI-MATER M, V6, P460, DOI 10.1007/BF00123371
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   DOILLON CJ, 1986, J BIOMED MATER RES, V20, P1219, DOI 10.1002/jbm.820200811
   Hara M, 2006, J ORAL TISSUE ENG, V3, P118
   HEIMBACH D, 1988, ANN SURG, V208, P313, DOI 10.1097/00000658-198809000-00008
   Kuberka M, 2002, INT J ARTIF ORGANS, V25, P67
   LIVECCHI AB, 1994, J BIOMED MATER RES, V28, P839, DOI 10.1002/jbm.820280802
   Ma L, 2004, BIOMATERIALS, V25, P2997, DOI 10.1016/j.biomaterials.2003.09.092
   Ma L, 2003, J BIOMAT SCI-POLYM E, V14, P861
   MANDL I, 1953, J CLIN INVEST, V32, P1323, DOI 10.1172/JCI102861
   MOORE S, 1948, J BIOL CHEM, V176, P367
   Nehrer S, 1997, BIOMATERIALS, V18, P769, DOI 10.1016/S0142-9612(97)00001-X
   O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6
   Orban JM, 2004, J BIOMED MATER RES A, V68A, P756, DOI 10.1002/jbm.a.20110
   Pachence JM, 1996, J BIOMED MATER RES, V33, P35, DOI 10.1002/(SICI)1097-4636(199621)33:1<35::AID-JBM6>3.0.CO;2-N
   Paddle-Ledinek JE, 2006, PLAST RECONSTR SURG, V117, P110
   PAGGIARO AO, 2003, MICROSC ACTA, V21, P205
   Pek YS, 2004, BIOMATERIALS, V25, P473, DOI 10.1016/S0142-9612(03)00541-6
   PIEZ KA, 1967, TREATISE COLLAGEN, V1, P207
   Salem AK, 2002, J BIOMED MATER RES, V61, P212, DOI 10.1002/jbm.10195
   Sipe JD, 2002, ANN NY ACAD SCI, V961, P1, DOI 10.1111/j.1749-6632.2002.tb03040.x
   SPEER DP, 1980, J BIOMED MATER RES, V14, P753, DOI 10.1002/jbm.820140607
   STEFFEN C, 1968, IMMUNOLOGY, V15, P135
   Vacanti CA, 2006, TISSUE ENG, V12, P1137, DOI 10.1089/ten.2006.12.1137
   WAKE MC, 1994, CELL TRANSPLANT, V3, P339, DOI 10.1177/096368979400300411
   WILLIAMS W, 2002, TOTAL, P783
   Yannas Ioannis V., 1998, Wound Repair and Regeneration, V6, P518, DOI 10.1046/j.1524-475X.1998.60604.x
   YANNAS IV, 1982, SCIENCE, V215, P174, DOI 10.1126/science.7031899
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
   Yannas IV, 2005, J R SOC INTERFACE, V2, P403, DOI 10.1098/rsif.2005.0062
   YANNAS IV, 2002, ANN NY ACAD SCI, V961, P280
   Zeltinger J, 2001, TISSUE ENG, V7, P557, DOI 10.1089/107632701753213183
NR 38
TC 7
Z9 7
U1 0
U2 1
PU ACAD SCIENCE SOUTH AFRICA A S S AF
PI LYNWOOD RIDGE
PA PO BOX 72135, LYNWOOD RIDGE 0040, SOUTH AFRICA
SN 0038-2353
EI 1996-7489
J9 S AFR J SCI
JI S. Afr. J. Sci.
PD NOV-DEC
PY 2008
VL 104
IS 11-12
BP 513
EP 516
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 417QE
UT WOS:000264090400026
DA 2018-10-19
ER

PT J
AU Krenning, G
   Moonen, JRAJ
   van Luyn, MJA
   Harmsen, MC
AF Krenning, Guido
   Moonen, Jan-Renier A. J.
   van Luyn, Marja J. A.
   Harmsen, Martin C.
TI Generating New Blood Flow: Integrating Developmental Biology and Tissue
   Engineering
SO TRENDS IN CARDIOVASCULAR MEDICINE
LA English
DT Review
ID ENDOTHELIAL PROGENITOR CELLS; SMOOTH-MUSCLE-CELLS;
   EPITHELIAL-MESENCHYMAL TRANSFORMATION; EMBRYONIC STEM-CELLS; GROWTH
   FACTOR-BB; IN-VITRO; MATRIX METALLOPROTEINASES; EXTRACELLULAR-MATRIX;
   PHENOTYPIC MODULATION; PARACRINE MECHANISMS
AB Vascular tissue engineering aims to restore blood flow by seeding artificial tubular scaffolds with endothelial and smooth muscle cells, thus creating bioartificial blood vessels. Herein, the progenitors of smooth muscle and endothelial cells hold great promise because they efficiently differentiate and harbor longevity. In this review, we describe a novel tissue engineering approach that uses current insights from developmental biology, that is, progenitor cell plasticity, and the latest advances in biomaterial design. We focus specifically on developmental processes that regulate progenitor cell (trans)differentiation and offer a platform for the integration of these molecular clues into biomaterial design. We propose a novel engineering paradigm for the creation of a small-diameter blood vessel wherein progenitor cell differentiation and tissue organization are instructed by the biomaterial solely. With this review, we emphasize the power of integrating developmental biology and material science for vascular tissue engineering. (Trends Cardiovasc Med 2008;18:312-323) (C) 2008, Elsevier Inc.
C1 [Krenning, Guido; Moonen, Jan-Renier A. J.; van Luyn, Marja J. A.; Harmsen, Martin C.] Univ Groningen, Stem Cell & Tissue Engn Res Grp, Div Med Biol, Univ Med Ctr Groningen,Dept Pathol & Med Biol, NL-9713 GZ Groningen, Netherlands.
RP Harmsen, MC (reprint author), Univ Groningen, Stem Cell & Tissue Engn Res Grp, Div Med Biol, Univ Med Ctr Groningen,Dept Pathol & Med Biol, Hanzepl 1,EA11, NL-9713 GZ Groningen, Netherlands.
EM m.c.harm-sen@med.umcg.nl
RI Krenning, Guido/B-2704-2008
CR Alobaid N, 2006, EUR J VASC ENDOVASC, V32, P76, DOI 10.1016/j.ejvs.2005.11.034
   Arciniegas E, 2006, DIFFERENTIATION, V74, P277, DOI 10.1111/j.1432-0436.2006.00079.x
   Arciniegas E, 2000, ANAT RECORD, V258, P47, DOI 10.1002/(SICI)1097-0185(20000101)258:1<47::AID-AR6>3.0.CO;2-W
   Arciniegas E, 2007, AM J PHYSIOL-LUNG C, V293, pL1, DOI 10.1152/ajplung.00378.2006
   Armstrong EJ, 2004, CIRC RES, V95, P459, DOI 10.1161/01.RES.0000141146.95728.da
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Benchabane H, 2003, MOL CELL BIOL, V23, P6646, DOI 10.1128/MCB.23.18.6646-6661.2003
   Botta R, 2004, FASEB J, V18, P1392, DOI 10.1096/fj.03-0879fje
   Brody S, 2006, TISSUE ENG, V12, P413, DOI 10.1089/ten.2006.12.413
   Calera MR, 2004, EXP CELL RES, V300, P248, DOI 10.1016/j.yexcr.2004.07.007
   Camoretti-Mercado B, 2006, J BIOL CHEM, V281, P20383, DOI 10.1074/jbc.M602748200
   Chen CN, 2006, P NATL ACAD SCI USA, V103, P2665, DOI 10.1073/pnas.0510913103
   Choi JS, 2008, BIOMATERIALS, V29, P2899, DOI 10.1016/j.biomaterials.2008.03.031
   Couet F, 2007, MACROMOL BIOSCI, V7, P701, DOI 10.1002/mabi.200700002
   Deguchi J, 1999, GENE THER, V6, P956, DOI 10.1038/sj.gt.3300918
   Deissler H, 2006, INT J MOL MED, V18, P577
   Duong TD, 2004, DEV DYNAM, V229, P42, DOI 10.1002/dvdy.10465
   Feng YZ, 2004, BIOCHEMISTRY-US, V43, P15811, DOI 10.1021/bi049174+
   Ferrari G, 2006, P NATL ACAD SCI USA, V103, P17260, DOI 10.1073/pnas.0605556103
   Ferreira LS, 2007, BIOMATERIALS, V28, P2706, DOI 10.1016/j.biomaterials.2007.01.021
   Frank R, 1996, J INVEST DERMATOL, V106, P36, DOI 10.1111/1523-1747.ep12327182
   Fujiyama S, 2003, CIRC RES, V93, P980, DOI 10.1161/01.RES.0000099245.08637.CE
   Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826
   Gong YH, 2007, J BIOMED MATER RES B, V82B, P192, DOI 10.1002/jbm.b.30721
   GRANT DS, 1989, CELL, V58, P933, DOI 10.1016/0092-8674(89)90945-8
   Ha CH, 2008, J BIOL CHEM, V283, P7261, DOI 10.1074/jbc.M702881200
   Hall SM, 2002, AM J RESP CELL MOL, V26, P333, DOI 10.1165/ajrcmb.26.3.4698
   Hao H, 2002, ARTERIOSCL THROM VAS, V22, P1093, DOI 10.1161/01.ATV.0000022407.91111.E4
   Hautmann MB, 1997, J BIOL CHEM, V272, P10948
   Herbrig K, 2004, AM J KIDNEY DIS, V44, P840, DOI 10.1053/j.ajkd.2004.08.001
   Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287
   Hocking DC, 1998, J CELL BIOL, V141, P241, DOI 10.1083/jcb.141.1.241
   Hyman KM, 2002, SURGERY, V132, P173, DOI 10.1067/msy.2002.125304
   Igreja C, 2008, EXP HEMATOL, V36, P193, DOI 10.1016/j.exphem.2007.09.001
   Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396
   Isenberg BC, 2008, BIOMATERIALS, V29, P2565, DOI 10.1016/j.biomaterials.2008.02.023
   Ishihara H, 2008, J NEUROPATH EXP NEUR, V67, P435, DOI 10.1097/NEN.0b013e31816fd622
   Ishisaki A, 2003, J BIOL CHEM, V278, P1303, DOI 10.1074/jbc.M207329200
   Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397
   Kannan RY, 2005, J BIOMED MATER RES B, V74B, P570, DOI 10.1002/jbm.b.30247
   Kawamoto A, 2008, TRENDS CARDIOVAS MED, V18, P33, DOI 10.1016/j.tcm.2007.11.004
   Kawamoto A, 2007, CATHETER CARDIO INTE, V70, P477, DOI 10.1002/ccd.21292
   Kilian O, 2004, EUR J MED RES, V9, P337
   Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC
   Koshida R, 2005, ARTERIOSCL THROM VAS, V25, P2548, DOI 10.1161/01.ATV.0000188511.84138.9b
   KRENNING G, 2008, J CELL MOL IN PRESS
   Krenning G, 2008, BIOMATERIALS, V29, P3703, DOI 10.1016/j.biomaterials.2008.05.034
   Krenning G, 2007, BIOMATERIALS, V28, P1470, DOI 10.1016/j.biomaterials.2006.11.017
   KRUG EL, 1987, DEV BIOL, V120, P348, DOI 10.1016/0012-1606(87)90237-5
   Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080
   Young HL, 2007, AM J RESP CELL MOL, V37, P485, DOI 10.1165/rcmb.2006-0439OC
   Li L, 1996, J CELL BIOL, V132, P849, DOI 10.1083/jcb.132.5.849
   Li XM, 1997, BIOCHEM J, V327, P709, DOI 10.1042/bj3270709
   Liebner S, 2004, J CELL BIOL, V166, P359, DOI 10.1083/jcb.200403050
   Lin YK, 2007, J BIOMATER APPL, V21, P265, DOI 10.1177/0885328206063502
   Malmstrom J, 2004, MOL CELL PROTEOMICS, V3, P466, DOI 10.1074/mcp.M300108-MCP200
   Mercado-Pimentel ME, 2007, DEV BIOL, V304, P420, DOI 10.1016/j.ydbio.2006.12.038
   Miyata T, 2005, J CELL PHYSIOL, V204, P948, DOI 10.1002/jcp.20362
   Moonen JRAJ, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2283
   Nagai R, 2001, ANN NY ACAD SCI, V947, P56
   Nillesen STM, 2007, BIOMATERIALS, V28, P1123, DOI 10.1016/j.biomaterials.2006.10.029
   Noseda M, 2004, CIRC RES, V94, P910, DOI 10.1161/01.RES.0000124300.76171.C9
   O'Riordan E, 2007, AM J PHYSIOL-HEART C, V292, pH285, DOI 10.1152/ajpheart.00560.2006
   OLSON EN, 1995, DEV BIOL, V172, P2, DOI 10.1006/dbio.1995.0002
   Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911
   Paranya G, 2001, AM J PATHOL, V159, P1335, DOI 10.1016/S0002-9440(10)62520-5
   Pike DB, 2006, BIOMATERIALS, V27, P5242, DOI 10.1016/j.biomaterials.2006.05.018
   Pollman MJ, 1999, CIRCULATION, V99, P2019, DOI 10.1161/01.CIR.99.15.2019
   Reddy K, 2003, TISSUE CELL, V35, P260, DOI 10.1016/S0040-8166(03)00039-9
   Rensen SSM, 2007, NETH HEART J, V15, P100, DOI 10.1007/BF03085963
   Rohde E, 2006, STEM CELLS, V24, P357, DOI 10.1634/stemcells.2005-0072
   Sakao S, 2007, FASEB J, V21, P3640, DOI 10.1096/fj.07-8432com
   Sarkar S, 2006, BIOMATERIALS, V27, P4775, DOI 10.1016/j.biomaterials.2006.04.038
   Seliktar D, 2004, J BIOMED MATER RES A, V68A, P704, DOI 10.1002/jbm.a.20091
   Shadwick RE, 1999, J EXP BIOL, V202, P3305
   Sinha S, 2004, AM J PHYSIOL-CELL PH, V287, pC1560, DOI 10.1152/ajpcell.00221.2004
   Smadja DM, 2008, J CELL MOL MED, V12, P975, DOI 10.1111/j.1582-4934.2007.00161.x
   Song WM, 2000, DEV BIOL, V227, P606, DOI 10.1006/dbio.2000.9919
   Taipale J, 1997, FASEB J, V11, P51
   Takahashi M, 2006, AM J PHYSIOL-HEART C, V291, pH886, DOI 10.1152/ajpheart.00142.2006
   Tanaka T, 2004, MOL VIS, V10, P462
   TEI K, 2008, STEM CELLS, P2007
   Thomas V, 2006, J BIOMAT SCI-POLYM E, V17, P969, DOI 10.1163/156856206778366022
   TSILIBARY EC, 1990, J CELL BIOL, V111, P1583, DOI 10.1083/jcb.111.4.1583
   Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953
   Vasita R, 2008, CURR TOP MED CHEM, V8, P341
   YAMAMOTO M, 1993, EXP CELL RES, V204, P121, DOI 10.1006/excr.1993.1016
   Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471
   Yoon CH, 2005, CIRCULATION, V112, P1618, DOI 10.1161/CIRCULATIONAHA.104.503433
   ZAMORA PO, 1993, BIOCHIM BIOPHYS ACTA, V1182, P197, DOI 10.1016/0925-4439(93)90141-M
   Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613
   Zentilin L, 2006, BLOOD, V107, P3546, DOI 10.1182/blood-2005-08-3215
   Zhang SJ, 2006, CELL RES, V16, P577, DOI 10.1038/sj.cr.7310075
   Zhang XF, 2005, J CELL PHYSIOL, V202, P205, DOI 10.1002/jcp.20106
   Zilberman A, 1998, CIRC RES, V82, P566, DOI 10.1161/01.RES.82.5.566
   Zisch AH, 2003, CARDIOVASC PATHOL, V12, P295, DOI 10.1016/S1054-8807(03)00089-9
   Zisch AH, 2003, FASEB J, V17, P2260, DOI 10.1096/fj.02-1041fje
NR 97
TC 15
Z9 16
U1 1
U2 15
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1050-1738
J9 TRENDS CARDIOVAS MED
JI Trends Cardiovasc. Med.
PD NOV
PY 2008
VL 18
IS 8
BP 312
EP 323
AR PII S1050-1738(09)00026-7
DI 10.1016/j.tcm.2009.01.004
PG 12
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 434HA
UT WOS:000265264600006
PM 19345319
DA 2018-10-19
ER

PT J
AU McCann, L
   Udofia, I
   Graindorge, S
   Ingham, E
   Jin, Z
   Fisher, J
AF McCann, L.
   Udofia, I.
   Graindorge, S.
   Ingham, E.
   Jin, Z.
   Fisher, J.
TI Tribological testing of articular cartilage of the medial compartment of
   the knee using a friction simulator
SO TRIBOLOGY INTERNATIONAL
LA English
DT Article; Proceedings Paper
CT 34th Leeds-Lyon Symposium on Tribology
CY SEP 04-07, 2007
CL Inst Natl Sci Appliquees, Lyon, FRANCE
HO Inst Natl Sci Appliquees
DE articular cartilage; friction; wear; contact stress; hemiarthroplasty;
   knee
ID INNOVATIVE CHONDROPLASTY MATERIALS; HEMIARTHROPLASTY; REGENERATION;
   THICKNESS; LOADS; TIME; WEAR
AB The aim of this study was to develop a tribological simulation of a unicondylar natural knee, to measure the friction and wear of articular cartilage (AC) against itself (AC-vs-AC) and against stainless steel (SS) simulating a hemiarthroplasty (AC-vs-SS). AC-vs-AC produced low levels of friction and no wear was found. AC-vs-SS showed higher levels of friction and significant AC wear. Using AC-vs-SS with elevated loading, the wear of AC was accelerated and through to bone. This study demonstrated the importance of contact stress in the design of a spacer hemiarthroplasty for the medial compartmental knee. Initial results showed the importance of contact mechanics, stress and biomaterial type in determining short-term tribological function and long-term clinical outcome of hemiarthroplasty. Crown Copyright (C) 2008 Published by Elsevier Ltd. All rights reserved.
C1 [McCann, L.; Udofia, I.; Graindorge, S.; Ingham, E.; Jin, Z.; Fisher, J.] Univ Leeds, Inst Med & Biol Engn, Sch Mech Engn, Leeds LS2 9JT, W Yorkshire, England.
RP McCann, L (reprint author), Univ Leeds, Inst Med & Biol Engn, Sch Mech Engn, Leeds LS2 9JT, W Yorkshire, England.
EM menimc@leeds.ac.uk
CR AMSTUTZ HC, 1994, J BONE JOINT SURG BR, V76B, P423
   Ateshian GA, 1998, J TRIBOL-T ASME, V120, P241, DOI 10.1115/1.2834416
   Baliunas AJ, 2002, OSTEOARTHR CARTILAGE, V10, P573, DOI 10.1053/joca.2002.0797
   Bell CJ, 2006, P I MECH ENG H, V220, P23, DOI 10.1243/095441105X69060
   DARCY J, 1976, J BONE JOINT SURG BR, V58, P279
   FINLAY JB, 1986, J BIOMECH, V19, P703, DOI 10.1016/0021-9290(86)90194-6
   Forster H, 1996, Proc Inst Mech Eng H, V210, P109, DOI 10.1243/PIME_PROC_1996_210_399_02
   FORSTER H, 1995, P LUBR LUBR S
   Freeman ME, 2000, WEAR, V241, P129, DOI 10.1016/S0043-1648(00)00387-2
   Hallock RH, 2003, CLIN ORTHOP RELAT R, P154, DOI 10.1097/01.blo.0000093031.56370.90
   Katta J, 2007, P I MECH ENG J-J ENG, V221, P175, DOI 10.1243/13506501JET240
   Kawalec JS, 1998, J BIOMED MATER RES, V41, P534, DOI 10.1002/(SICI)1097-4636(19980915)41:4<534::AID-JBM4>3.0.CO;2-D
   KIM Y-H, 1989, Yonsei Medical Journal, V30, P280
   Koo S, 2007, J BIOMECH, V40, P2961, DOI 10.1016/j.jbiomech.2007.02.005
   KOSASHVILI, 2008, INJURY, V39, P232
   MacIntosh D L, 1972, J Bone Joint Surg Br, V54, P244
   Mow V., 1997, BASIC ORTHOPAEDIC BI
   MOW VC, 1980, J BIOMECH ENG-T ASME, V102, P73, DOI 10.1115/1.3138202
   Northwood E, 2007, P I MECH ENG H, V221, P263, DOI 10.1243/09544119JEIM178
   NORTHWOOD E, 2006, P ORTH RES SOC ORS
   Northwood E, 2007, CLIN BIOMECH, V22, P834, DOI 10.1016/j.clinbiomech.2007.03.008
   O'Driscoll SW, 1998, J BONE JOINT SURG AM, V80A, P1795, DOI 10.2106/00004623-199812000-00011
   Schwartz CJ, 2007, WEAR, V262, P1315, DOI 10.1016/j.wear.2007.01.007
   SCOTT RD, 1985, J BONE JOINT SURG AM, V67A, P203, DOI 10.2106/00004623-198567020-00004
   Sisto DJ, 2005, J BONE JOINT SURG AM, V87A, P1706, DOI 10.2106/JBJS.D.02339
   van der Meulen MCH, 2002, J ORTHOPAED RES, V20, P669, DOI 10.1016/S0736-0266(01)00182-6
NR 26
TC 19
Z9 19
U1 1
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0301-679X
J9 TRIBOL INT
JI Tribol. Int.
PD NOV
PY 2008
VL 41
IS 11
BP 1126
EP 1133
DI 10.1016/j.triboint.2008.03.012
PG 8
WC Engineering, Mechanical
SC Engineering
GA 337JX
UT WOS:000258433500021
DA 2018-10-19
ER

PT J
AU Zini, E
   Gazzano, M
   Scandola, M
   Wallner, SR
   Gross, RA
AF Zini, Elisa
   Gazzano, Massimo
   Scandola, Mariastella
   Wallner, Sabine R.
   Gross, Richard A.
TI Glycolipid Biomaterials: Solid-State Properties of a Poly(sophorolipid)
SO MACROMOLECULES
LA English
DT Article
ID TEMPERATURE MODULATED DSC; MELTING BEHAVIOR; OLEIC-ACID; SOPHOROLIPIDS;
   SOPHOROSE; PHASE
AB Structural complexity inherited from a microbial synthesis of glycolipids was translated into unique poly(sophorolipid) biomaterials. ROMP polymerization of natural diacetylated lactonic sophorolipids gave a high molecular weight polymer with asymmetric bola-amphiphilic repeating units. The poly(sophorolipid) chain alternates C18 oleic-like aliphatic segments (90% cis-configured double bonds) with bulky diacetylated disaccharide moieties. The solid-state properties were investigated by means of TGA, DSC, TMDSC, and variable-temperature X-ray diffraction. The poly(sophorolipid) is a solid at room temperature that undergoes the glass transition at 61 degrees C and melts at 123 degrees C. The crystal phase is associated with ordered packing of the aliphatic chain segments. The semicrystalline poly(sophorolipid) also displays a long-range order (d = 2.44 nm) involving sophorose groups that is found to persist after crystal phase melting (in high-T diffractograms) with a slightly shortened distance (2.27 nm). Upon annealing at 80 degrees C the poly(sophorolipid) recrystallizes and concomitantly the disaccharide units space out again at 2.44nm. An exothermal phenomenon that immediately follows melting and is revealed by TMDSC might be associated with the observed adjustment of sophorose units spacing in the melt. The peculiar structural organization of this novel biomaterial is discussed.
C1 [Zini, Elisa; Scandola, Mariastella] Univ Bologna, Dept Chem G Ciamician, I-40126 Bologna, Italy.
   [Zini, Elisa; Scandola, Mariastella] UdR Bologna, INSTM, Natl Consoritum Mat Sci & Technol, I-40126 Bologna, Italy.
   [Gazzano, Massimo] ISOF CNR, Dept Chem G Ciamician, I-40126 Bologna, Italy.
   [Wallner, Sabine R.; Gross, Richard A.] Polytech Univ, Six Metrotech Ctr, Dept Chem & Biol Sci, NSF 1,UCRC Ctr Biocatalysis & Bioproc Macromol, Brooklyn, NY 11201 USA.
RP Scandola, M (reprint author), Univ Bologna, Dept Chem G Ciamician, Via Selmi 2, I-40126 Bologna, Italy.
RI Gazzano, Massimo/D-9880-2012
OI Gazzano, Massimo/0000-0003-1352-9547
FU Italian Ministry for University and Research (MUR); National Science
   Foundation Industrial/University Cooperative Research Center for
   Biocatalysis; Polytechnic University
FX We thank the Italian Ministry for University and Research (MUR) and the
   National Science Foundation Industrial/University Cooperative Research
   Center for Biocatalysis and Bioprocessing of Macromolecules at
   Polytechnic University for their financial support to this work.
CR Bluth MH, 2006, CRIT CARE MED, V34, P188, DOI 10.1097/01.CCM.0000196212.56885.50
   Focarete ML, 2002, MACROMOLECULES, V35, P8066, DOI 10.1021/ma0205966
   Fuhrhop AH, 2004, CHEM REV, V104, P2901, DOI 10.1021/cr030602b
   Gao W, 2007, MACROMOLECULES, V40, P145, DOI 10.1021/ma0620159
   Guilmanov V, 2002, BIOTECHNOL BIOENG, V77, P489, DOI 10.1002/bit.10177
   Kaneko F, 1997, J PHYS CHEM B, V101, P1803, DOI 10.1021/jp963400a
   Klemm D., 1998, COMPREHENSIVE CELLUL, V1
   Liu T, 2001, POLYMER, V42, P6453, DOI 10.1016/S0032-3861(01)00173-2
   OHANESSIAN J, 1978, ACTA CRYSTALLOGR B, V34, P3666, DOI 10.1107/S0567740878014788
   Okazaki I, 1997, MACROMOLECULES, V30, P1758, DOI 10.1021/ma961539d
   Qiu ZB, 2003, POLYMER, V44, P7781, DOI 10.1016/j.polymer.2003.10.045
   RAFF RA, 1965, HIGH POLYM 1, V20
   Ribeiro M, 1999, J THERM ANAL CALORIM, V57, P253, DOI 10.1023/A:1010112801307
   Sahoo B, 2006, BIOMACROMOLECULES, V7, P1042, DOI 10.1021/bm050703e
   Sauer BB, 2000, POLYMER, V41, P1099, DOI 10.1016/S0032-3861(99)00258-X
   Shah V, 2005, ANTIMICROB AGENTS CH, V49, P4093, DOI 10.1128/AAC.49.10.4093-4100.2005
   Singh SK, 2003, J ORG CHEM, V68, P5466, DOI 10.1021/jo0204395
   Tandon P, 2000, J MOL STRUCT, V524, P201, DOI 10.1016/S0022-2860(00)00378-1
   Van Bogaert INA, 2007, APPL MICROBIOL BIOT, V76, P23, DOI 10.1007/s00253-007-0988-7
   Wunderlich B., 1980, MACROMOLECULAR PHYS, V3
   Zhou SQ, 2004, LANGMUIR, V20, P7926, DOI 10.1021/la048590s
   Zini E, 2003, BIOMACROMOLECULES, V4, P821, DOI 10.1021/bm034040h
NR 22
TC 17
Z9 17
U1 0
U2 13
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0024-9297
EI 1520-5835
J9 MACROMOLECULES
JI Macromolecules
PD OCT 28
PY 2008
VL 41
IS 20
BP 7463
EP 7468
DI 10.1021/ma800496f
PG 6
WC Polymer Science
SC Polymer Science
GA 363GM
UT WOS:000260255800032
DA 2018-10-19
ER

PT J
AU Kang, C
   Weiss, SM
AF Kang, Christopher
   Weiss, Sharon M.
TI Photonic crystal with multiple-hole defect for sensor applications
SO OPTICS EXPRESS
LA English
DT Article
ID SILICON WAVE-GUIDE; SLOW-LIGHT; BENDS; LASER; TRANSMISSION; NANOCAVITY;
   DOMAIN; SLABS
AB A photonic crystal defect consisting of several subwavelength holes was investigated as a means to increase the surface area of the defect region without compromising the quality factor of the structure. Finite-difference time-domain calculations were performed to determine the relationships between the size of the multi-hole defect (MHD) region, resonance frequency, quality factor, and refractive index of the defect holes. The advantage of using the MHD for sensing applications is demonstrated through a comparison with a single hole defect (SHD) photonic crystal structure. Assuming the same monolayer thickness of biomaterial coats the defect hole walls of the MHD and SHD, the MHD has a three times larger change in resonance frequency and two times larger quality factor. (C) 2008 Optical Society of America
C1 [Kang, Christopher; Weiss, Sharon M.] Vanderbilt Univ, Interdisciplinary Grad Program Mat Sci, Nashville, TN 37235 USA.
   [Weiss, Sharon M.] Vanderbilt Univ, Dept Elect Engn & Comp Sci, Nashville, TN 37235 USA.
RP Kang, C (reprint author), Vanderbilt Univ, Interdisciplinary Grad Program Mat Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.
EM chris.kang@vanderbilt.edu
RI Weiss, Sharon/B-4806-2012
CR Akahane Y, 2003, NATURE, V425, P944, DOI 10.1038/nature02063
   Asano T, 2006, IEEE J SEL TOP QUANT, V12, P1123, DOI 10.1109/JSTQE.2006.881639
   Assefa S, 2006, OPT LETT, V31, P745, DOI 10.1364/OL.31.000745
   Baba T, 1999, ELECTRON LETT, V35, P654, DOI 10.1049/el:19990438
   BERENGER JP, 1994, J COMPUT PHYS, V114, P185, DOI 10.1006/jcph.1994.1159
   Chutinan A, 2000, PHYS REV B, V62, P4488, DOI 10.1103/PhysRevB.62.4488
   Farjadpour A, 2006, OPT LETT, V31, P2972, DOI 10.1364/OL.31.002972
   Garnett JCM, 1904, PHILOS T R SOC LOND, V203, P385, DOI 10.1098/rsta.1904.0024
   Imada M, 1999, APPL PHYS LETT, V75, P316, DOI 10.1063/1.124361
   Jiang YQ, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2138367
   Johnson SG, 2001, OPT EXPRESS, V8, P173, DOI 10.1364/OE.8.000173
   Kang C, 2008, PROC SPIE, V7031, DOI 10.1117/12.798277
   Lee M, 2007, OPT EXPRESS, V15, P4530, DOI 10.1364/OE.15.004530
   Levy O, 1997, PHYS REV B, V56, P8035, DOI 10.1103/PhysRevB.56.8035
   Loncar M, 2003, APPL PHYS LETT, V82, P4648, DOI 10.1063/1.1586781
   Mandelshtam VA, 1998, J CHEM PHYS, V109, P4128, DOI 10.1063/1.477013
   Mekis A, 1996, PHYS REV LETT, V77, P3787, DOI 10.1103/PhysRevLett.77.3787
   Morton KJ, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/34/345301
   Painter O, 1999, SCIENCE, V284, P1819, DOI 10.1126/science.284.5421.1819
   Rong G, 2008, BIOSENS BIOELECTRON, V23, P1572, DOI 10.1016/j.bios.2008.01.017
   Schmidt B, 2004, APPL PHYS LETT, V85, P4854, DOI 10.1063/1.1819997
   Soljacic M, 2002, J OPT SOC AM B, V19, P2052, DOI 10.1364/JOSAB.19.002052
   Taflove A., 2000, COMPUTATIONAL ELECTR
NR 23
TC 28
Z9 28
U1 0
U2 7
PU OPTICAL SOC AMER
PI WASHINGTON
PA 2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA
SN 1094-4087
J9 OPT EXPRESS
JI Opt. Express
PD OCT 27
PY 2008
VL 16
IS 22
BP 18188
EP 18193
DI 10.1364/OE.16.018188
PG 6
WC Optics
SC Optics
GA 371XL
UT WOS:000260865900102
PM 18958096
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Cheung, CY
   McCartney, SJ
   Anseth, KS
AF Cheung, Charles Y.
   McCartney, Suzanne J.
   Anseth, Kristi S.
TI Synthesis of Polymerizable Superoxide Dismutase Mimetics to Reduce
   Reactive Oxygen Species Damage in Transplanted Biomedical Devices
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
ID BETA-CELL DESTRUCTION; HYDROGEN-PEROXIDE; IN-VITRO; MANGANESE PORPHYRIN;
   DIABETES-MELLITUS; ISLET GRAFTS; T-CELLS; RADICALS; ANION;
   METALLOPORPHYRINS
AB A new polymerizable superoxide dismutase (SOD) mimetic metalloporphyrin macromer was synthesized to minimize inflammatory damage associated with tissue transplantation and biomaterial implantation, such as the use of encapsulated pancreatic islets for the treatment of type I diabetes mellitus (TIDM). This functional SOD mimetic, Mn(III) Tetrakis[1-(3-acryloxy-propyl)-4-pyridyl] porphyrin (MnTPPyP-Acryl), was copolymerized and crosslinked with poly(ethylene glycol) diacrylate (PEGDA) to form hydrogel networks that may actively reduce reactive oxygen species (ROS) damage associated with biomaterial implantation. Solution phase activity assays with MnTPPyP-Acryl macromers showed comparable SOD activity to MnTMPyP, a non-polymerizable commercially available SOD mimetic. This work also describes the development of a new, simple, and inexpensive solid phase assay system that was developed to assess the activity of MnTPPyP-Acryl macromers polymerized within PEGDA hydrogels, which has the potential to fulfill an existing void with the biochemical tools available for testing other immobilized ROS antagonists. With this new assay system, hydrogels containing up to 0.25 mol% MnTPPyP-Acryl showed significantly higher levels of SOD activity, whereas control hydrogels polymerized with inactive MnTPPyP-Acryl macromers showed only background levels of activity. The potential for repeated use of such hydrogel devices to consistently reduce superoxide anion concentrations was demonstrated upon retention of 100% SOD activity for at least 72 h post-polymerization. These results demonstrate the potential that polymerizable SOD mimetics may have for integration into medical devices for the minimization of inflammatory damage upon transplantation, such as during the delivery of encapsulated pancreatic islets.
C1 [Cheung, Charles Y.; McCartney, Suzanne J.; Anseth, Kristi S.] Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA.
   Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA.
RP Cheung, CY (reprint author), Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA.
EM kristi.anseth@colorado.edu
FU NSF [EEC0444771]
FX This work was partially supported by the NSF (EEC0444771).
CR Ali SS, 2004, FREE RADICAL BIO MED, V37, P1191, DOI 10.1016/j.freeradbiomed.2004.07.002
   ASAYAMA K, 1986, J LAB CLIN MED, V107, P459
   Asayama S, 2004, BIOCONJUGATE CHEM, V15, P1360, DOI 10.1021/bc049865i
   Batinic-Haberle I, 1999, INORG CHEM, V38, P4011, DOI 10.1021/ic990118k
   Batinic-Haberle I, 1998, J BIOL CHEM, V273, P24521, DOI 10.1074/jbc.273.38.24521
   Benaglia M, 2002, ORG LETT, V4, P4229, DOI 10.1021/ol0267230
   Benov L, 2005, FREE RADICAL RES, V39, P81, DOI 10.1080/10715760400022368
   BUTLER J, 1975, Biochimica et Biophysica Acta, V408, P215
   Cheung CY, 2006, BIOCONJUGATE CHEM, V17, P1036, DOI 10.1021/bc060023o
   Day BJ, 1997, ARCH BIOCHEM BIOPHYS, V347, P256, DOI 10.1006/abbi.1997.0341
   Emregul E, 2005, ANAL BIOANAL CHEM, V383, P947, DOI 10.1007/s00216-005-0102-x
   Ewing JF, 1995, ANAL BIOCHEM, V232, P243, DOI 10.1006/abio.1995.0014
   FAULKNER KM, 1994, J BIOL CHEM, V269, P23471
   GRANKVIST K, 1986, INT J BIOCHEM, V18, P109, DOI 10.1016/0020-711X(86)90141-2
   GRANKVIST K, 1981, NATURE, V294, P158, DOI 10.1038/294158a0
   HASEGAWA E, 1978, EUR POLYM J, V14, P123, DOI 10.1016/0014-3057(78)90076-9
   Ho E, 1999, P SOC EXP BIOL MED, V222, P205, DOI 10.1046/j.1525-1373.1999.d01-137.x
   HORIO F, 1994, DIABETOLOGIA, V37, P22
   KAJIWARA A, 1994, POLYM J, V26, P215, DOI 10.1295/polymj.26.215
   KAMACHI M, 1987, MACROMOLECULES, V20, P2665, DOI 10.1021/ma00177a005
   Kawakami H, 1999, POLYM ADVAN TECHNOL, V10, P270, DOI 10.1002/(SICI)1099-1581(199905)10:5<270::AID-PAT873>3.0.CO;2-C
   MCCORD JM, 1969, J BIOL CHEM, V244, P6049
   Muscoli C, 2003, BRIT J PHARMACOL, V140, P445, DOI 10.1038/sj.bjp.0705430
   NISHIKIMI M, 1972, BIOCHEM BIOPH RES CO, V46, P849, DOI 10.1016/S0006-291X(72)80218-3
   NOMIKOS IN, 1989, IMMUNOL CELL BIOL, V67, P85, DOI 10.1038/icb.1989.12
   Nuttelman CR, 2004, J BIOMED MATER RES A, V68A, P773, DOI 10.1002/jbm.a.20112
   Ohse T, 1999, J BIOMAT SCI-POLYM E, V10, P917, DOI 10.1163/156856299X00531
   PACKER E, 1997, HDB SYNTHETIC ANTIOX
   PAPACCIO G, 1993, HISTOL HISTOPATHOL, V8, P751
   PASTERNACK RF, 1981, J INORG BIOCHEM, V15, P261, DOI 10.1016/S0162-0134(00)80161-0
   Pastor I, 2004, ANAL BIOCHEM, V334, P335, DOI 10.1016/j.ab.2004.08.012
   Piganelli JD, 2002, DIABETES, V51, P347, DOI 10.2337/diabetes.51.2.347
   Rabinovitch A, 1998, BIOCHEM PHARMACOL, V55, P1139, DOI 10.1016/S0006-2952(97)00492-9
   RAO UM, 1989, FREE RADICAL BIO MED, V7, P513
   Rogers CJ, 2005, TETRAHEDRON, V61, P12140, DOI 10.1016/j.tet.2005.07.115
   SALINAS CN, 2008, UNPUB
   Salvemini D, 2002, NAT REV DRUG DISCOV, V1, P367, DOI 10.1038/nrd796
   Tarpey MM, 2001, CIRC RES, V89, P224, DOI 10.1161/hh1501.094365
   Tay T, 2007, REACT FUNCT POLYM, V67, P999, DOI 10.1016/j.reactfunctpolym.2007.06.003
   TSUCHIDA E, 1978, MACROMOLECULES, V11, P947, DOI 10.1021/ma60065a021
   Tyrberg B, 1999, PHARMACOL TOXICOL, V85, P269, DOI 10.1111/j.1600-0773.1999.tb02021.x
   Votyakova TV, 2004, ARCH BIOCHEM BIOPHYS, V431, P138, DOI 10.1016/j.abb.2004.07.025
   Weber LM, 2007, CELL TRANSPLANT, V16, P1049, DOI 10.3727/000000007783472336
   WERINGER EJ, 1986, AM J PATHOL, V125, P107
   Yoon JW, 1998, AUTOIMMUNITY, V27, P109, DOI 10.3109/08916939809008041
   Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391
NR 46
TC 32
Z9 32
U1 4
U2 19
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-301X
EI 1616-3028
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD OCT 23
PY 2008
VL 18
IS 20
BP 3119
EP 3126
DI 10.1002/adfm.200800566
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 369PV
UT WOS:000260707300003
DA 2018-10-19
ER

PT J
AU Velzenberger, E
   Pezron, I
   Legeay, G
   Nagel, MD
   El Kirat, K
AF Velzenberger, Elodie
   Pezron, Isabelle
   Legeay, Gilbert
   Nagel, Marie-Danielle
   El Kirat, Karim
TI Probing Fibronectin-Surface Interactions: A Multitechnique Approach
SO LANGMUIR
LA English
DT Article
ID HUMAN PLASMA FIBRONECTIN; MARROW STROMAL CELLS; PROTEIN ADSORPTION;
   POLYMER SURFACES; DRUG-DELIVERY; ENDOTHELIAL-CELLS; EPITHELIAL-CELLS;
   MELANOMA-CELLS; ADHESION; SUBSTRATUM
AB The development of adhesive as well as antiadhesive surfaces is essential in various biomaterial applications. In this study, we have used a multidisciplinary approach that combines biological and physicochemical methods to progress in our understanding of cell-surface interactions. Four model surfaces have been used to investigate fibronectin (Fn) adsorption and the subsequent morphology and adhesion of preosteoblasts. Such experimental conditions lead us to distinguish between anti- and proadhesive substrata. Our results indicate that Fn is not able to induce cell adhesion on antiadhesive materials. On adhesive substrata, Fn did not increase the number of adherent cells but favored their spreading. This work also examined Fn-surface interactions using ELISA immunoassays, fluorescent labeling of Fn, and force spectroscopy with Fn-modified tips. The results provided clear evidence of the advantages and limitations of each technique. All of the techniques confirmed the important adsorption of Fn on proadhesive surfaces for cells. By contrast, antiadhesive substrata for cells avoided Fn adsorption. Furthermore, ELISA experiments enabled us to verify the accessibility of cell binding sites to adsorbed Fn molecules.
C1 [Velzenberger, Elodie; Nagel, Marie-Danielle; El Kirat, Karim] Univ Technol Compiegne, CNRS, UMR Biomecan & Bioingn 6600, F-60205 Compiegne, France.
   [Pezron, Isabelle] Univ Technol Compiegne, EA Transformat Integrees Mat Renouvelable, F-60205 Compiegne, France.
RP Velzenberger, E (reprint author), Univ Technol Compiegne, CNRS, UMR Biomecan & Bioingn 6600, BP 20529, F-60205 Compiegne, France.
EM elodie.velzenberger@utc.fr
RI EL KIRAT, Karim/A-4590-2017; EL KIRAT, Karim/C-5136-2009
OI EL KIRAT, Karim/0000-0003-4884-7270; pezron,
   isabelle/0000-0002-1083-3343
FU Universite de Technologie de Compiegne
FX The support of the Universite de Technologie de Compiegne [UTC, Plan de
   Pluriformation (PPF Nanobiotechnologies)] is gratefully acknowledged. We
   thank the Service d'Analyses Physico-Chimiques of UTC for the use of the
   atomic force microscope and Statice Santd Company for the culture device
   packaging and sterilization.
CR AKIYAMA SK, 1994, COLLOID SURFACE B, V2, P241, DOI 10.1016/0927-7765(94)80038-3
   Alsteens D, 2007, LANGMUIR, V23, P11977, DOI 10.1021/la702765c
   Barbucci R, 2004, J BIOMAT SCI-POLYM E, V15, P607, DOI 10.1163/156856204323046870
   Baujard-Lamotte L, 2008, COLLOID SURFACE B, V63, P129, DOI [10.1016/j.colsurfb.2007.11.015, 10.1016/j.coisurfb.2007.11.015]
   Beck D E, 1997, Eur J Surg Suppl, P49
   BENTLEY KL, 1985, J BIOMED MATER RES, V19, P757, DOI 10.1002/jbm.820190704
   Bergkvist M, 2003, J BIOMED MATER RES A, V64A, P349, DOI 10.1002/jbm.a.10423
   Blanco EM, 2008, LANGMUIR, V24, P2284, DOI 10.1021/la702957f
   Buckenmaier CC, 2000, AM SURGEON, V66, P1041
   Caruso DM, 2006, J BURN CARE RES, V27, P298, DOI 10.1097/01.BCR.0000216741.21433.66
   Cha P, 2008, LANGMUIR, V24, P2553, DOI 10.1021/la703310k
   Chiumiento A, 2006, J MATER SCI-MATER M, V17, P427, DOI 10.1007/s10856-006-8470-0
   Datta N, 2005, BIOMATERIALS, V26, P971, DOI 10.1016/j.biomaterials.2004.04.001
   Dewez JL, 1999, BIOMATERIALS, V20, P547, DOI 10.1016/S0142-9612(98)00207-5
   El Kirat K, 2005, J BIOMED NANOTECHNOL, V1, P39, DOI 10.1166/jbn.2005.011
   ERICKSON HP, 1983, J BIOL CHEM, V258, P4539
   ERTEL SI, 1991, J BIOMAT SCI-POLYM E, V3, P163, DOI 10.1163/156856291X00269
   Faucheux N, 2006, BIOMATERIALS, V27, P234, DOI 10.1016/j.biomaterials.2005.05.076
   Fuse Y, 2007, DENT MATER J, V26, P814, DOI 10.4012/dmj.26.814
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Guest JF, 2005, CURR MED RES OPIN, V21, P281, DOI 10.1185/030079905X25532
   Guest JF, 2005, CURR MED RES OPIN, V21, P81, DOI 10.1185/030079904X15219
   Hindie A, 2005, BIOMOL ENG, V22, P205, DOI 10.1016/j.bioeng.2005.07.002
   Hindie M, 2006, J CELL BIOCHEM, V99, P96, DOI 10.1002/jcb.20833
   Hoffmann C, 2008, ANAL BIOCHEM, V372, P62, DOI 10.1016/j.ab.2007.07.027
   Karp JM, 2007, CURR OPIN BIOTECH, V18, P454, DOI 10.1016/j.copbio.2007.09.008
   Khang D, 2008, BIOMATERIALS, V29, P970, DOI 10.1016/j.biomaterials.2007.11.009
   Kim MS, 2007, TISSUE ENG, V13, P2095, DOI 10.1089/ten.2006.0062
   Kohane DS, 2008, PEDIATR RES, V63, P487, DOI 10.1203/01.pdr.0000305937.26105.e7
   KOWALCZYNSKA HM, 1994, COLLOID SURFACE B, V2, P291, DOI 10.1016/0927-7765(94)80043-X
   Langer R, 2001, SCIENCE, V293, P58, DOI 10.1126/science.1063273
   LEE JH, 1991, BIOMATERIALS, V12, P443
   Lipson MJ, 2007, OPTOMETRY VISION SCI, V84, P593, DOI 10.1097/OPX.0b013e31811ece4a
   Liu LS, 2007, CELLULOSE, V14, P15, DOI 10.1007/s10570-006-9095-7
   MacDonald DE, 1998, J BIOMED MATER RES, V41, P120
   Meyer EE, 2005, P NATL ACAD SCI USA, V102, P6839, DOI 10.1073/pnas.0502110102
   MIKLAVIC SJ, 1994, J PHYS CHEM-US, V98, P9022, DOI 10.1021/j100087a034
   Nonckreman CJ, 2007, J BIOMED MATER RES A, V81A, P791, DOI 10.1002/jbm.a.31111
   Ravenscroft MJ, 2006, ANN ROY COLL SURG, V88, P18, DOI 10.1308/003588406X82989
   Rosso F, 2005, J CELL PHYSIOL, V203, P465, DOI 10.1002/jcp.20270
   Rothenfluh DA, 2008, NAT MATER, V7, P248, DOI 10.1038/nmat2116
   RUOSLAHTI E, 1986, CELL, V44, P517, DOI 10.1016/0092-8674(86)90259-X
   Saika S, 2003, J CATARACT REFR SURG, V29, P1198, DOI 10.1016/S0886-3350(02)01988-0
   Shen MC, 2004, J BIOMED MATER RES A, V70A, P533, DOI 10.1002/jbm.a.30069
   Sousa SR, 2008, J BIOMED MATER RES A, V84A, P281, DOI 10.1002/jbm.a.31201
   Sousa SR, 2007, LANGMUIR, V23, P7046, DOI 10.1021/la062956e
   STEELE JG, 1995, BIOMATERIALS, V16, P1057, DOI 10.1016/0142-9612(95)98901-P
   Stephansson SN, 2002, BIOMATERIALS, V23, P2527, DOI 10.1016/S0142-9612(01)00387-8
   Szabo A, 2000, EUR SURG RES, V32, P125, DOI 10.1159/000008751
   TAMADA Y, 1993, POLYMER, V34, P2208, DOI 10.1016/0032-3861(93)90752-V
   Thorsen T, 2002, SCIENCE, V298, P580, DOI 10.1126/science.1076996
   Vallieres K, 2007, LANGMUIR, V23, P9745, DOI 10.1021/la701323q
   van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417
   van der Zijpp YJT, 2003, J BIOMED MATER RES A, V65A, P51, DOI 10.1002/jbm.a.10327
   van't Riet M, 2003, ANN SURG, V237, P123, DOI 10.1097/00000658-200301000-00017
   VELZENBERGER E, 2008, CELLULOSE, P347
   Versura P, 1999, J CATARACT REFR SURG, V25, P527
   Williams D, 2008, MED DEVICE TECHNOL, V19, P10
   Wu PC, 1998, DRUG DEV IND PHARM, V24, P179, DOI 10.3109/03639049809085604
NR 59
TC 15
Z9 15
U1 0
U2 10
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD OCT 21
PY 2008
VL 24
IS 20
BP 11734
EP 11742
DI 10.1021/la801727p
PG 9
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 360HT
UT WOS:000260049300057
PM 18816077
DA 2018-10-19
ER

PT J
AU Tiong, WHC
   Damodaran, G
   Naik, H
   Kelly, JL
   Pandit, A
AF Tiong, William H. C.
   Damodaran, Gopinath
   Naik, Hemantkumar
   Kelly, John L.
   Pandit, Abhay
TI Enhancing Amine Terminals in an Amine-Deprived Collagen Matrix
SO LANGMUIR
LA English
DT Article
ID CROSS-LINKED COLLAGEN; NMR RELAXATION PARAMETERS; DERMAL SHEEP COLLAGEN;
   IN-VITRO; PAMAM DENDRIMERS; POLYAMIDOAMINE DENDRIMERS; MICROBIAL
   TRANSGLUTAMINASE; BIOLOGICAL EVALUATION; CHAIN DYNAMICS; CELL VIABILITY
AB Collagen, though widely used as a core biomaterial in many clinical applications, is often limited by its rapid degradability which prevents full exploitation of its potential in vivo. Polyamidoamine (PAMAM) dendrimer, a highly branched macromolecule, possesses versatile multiterminal amine surface groups that enable them to be tethered to collagen molecules and enhance their potential. In this study, we hypothesized that incorporation of PAMAM dendrimer in a collagen matrix through cross-linking will result in a durable, cross-linked collagen biomaterial with free -NH2 groups available for further multi-biomolecular tethering. The aim of this study was to assess the physicochemical properties of a G1 PAMAM cross-linked collagen matrix and its cellular sustainability in vitro. Different amounts of G I PAMAM dendrimer (5 or 10 mg) were integrated into bovine-derived collagen matrices through a cross-linking process, mediated by 5 or 25 mM 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) in 5 mM N-hydroxysuccinimide (NHS) and 50 mM 2-morpholinoethane sulfonic acid buffer at pH 5.5. The physicochemical properties of resultant matrices were investigated with scanning electron microscopy (SEM), collagenase degradation assay, differential scanning calorimetry (DSC), Fourier transform infrared (FTIR) spectra, and ninhydrin assay. Cellular sustainability of the matrices was assessed with Alamar Blue assay and SEM. There was no significant difference in cellular behavior between the treated and nontreated groups. However, the benefit of incorporating PAMAM in the cross-linking reaction was limited when higher concentrations of either agent were used. These results confirm the hypothesis that PAMAM dendrimer can be incorporated in the collagen cross-linking process in order to modulate the properties of the resulting cross-linked collagen biomaterial with free -NH2 groups available for multi-biomolecular tethering.
C1 [Tiong, William H. C.; Damodaran, Gopinath; Naik, Hemantkumar; Pandit, Abhay] Natl Univ Ireland, Natl Ctr Biomed Engn Sci, Galway, Ireland.
   [Kelly, John L.] Univ Hosp Galway, Dept Plast Reconstruct & Hand Surg, Galway, Ireland.
RP Pandit, A (reprint author), Natl Univ Ireland, Natl Ctr Biomed Engn Sci, Galway, Ireland.
EM abhay.pandit@nuigalway.ie
RI Pandit, Abhay/B-6187-2008; Tiong, William/G-6010-2018; Naik,
   Hemantkumar/G-1101-2011
OI Pandit, Abhay/0000-0002-6292-4933; Tiong, William/0000-0002-1254-8490;
   Damodaran, Gopinath/0000-0002-1697-0357
FU Enterprise Ireland
FX The authors gratefully acknowledge the financial support from Enterprise
   Ireland (Technology Development Grant).
CR Baek MG, 2002, BIOORGAN MED CHEM, V10, P11, DOI 10.1016/S0968-0896(01)00248-6
   BARTH A, 2002, C Q REV BIOPHYS, V35, P369
   Bielinska AU, 2000, BIOMATERIALS, V21, P877, DOI 10.1016/S0142-9612(99)00229-X
   Boas U, 2001, J ORG CHEM, V66, P2136, DOI 10.1021/jo001573x
   Buehler MJ, 2008, J MECH BEHAV BIOMED, V1, P59, DOI 10.1016/j.jmbbm.2007.04.001
   BURKE JF, 1981, ANN SURG, V194, P413, DOI 10.1097/00000658-198110000-00005
   Chan JCY, 2008, BIOMACROMOLECULES, V9, P528, DOI 10.1021/bm701055k
   Chen P, 2005, TISSUE ENG, V11, P1436, DOI 10.1089/ten.2005.11.1436
   Chen RN, 2005, BIOMATERIALS, V26, P4229, DOI 10.1016/j.biomaterials.2004.11.012
   Chevallay B, 2000, MED BIOL ENG COMPUT, V38, P211, DOI 10.1007/BF02344779
   DAMINK LHHO, 1995, J MATER SCI-MATER M, V6, P460, DOI 10.1007/BF00123371
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   DAMODARAN G, J BIOMED MAT RES A
   Domanski DM, 2004, BIOELECTROCHEMISTRY, V63, P193, DOI 10.1016/j.bioelechem.2003.09.024
   Duan X, 2007, J BIOMAT SCI-POLYM E, V18, P701, DOI 10.1163/156856207781034151
   Duan X, 2006, BIOMATERIALS, V27, P4608, DOI 10.1016/j.biomaterials.2006.04.022
   Duan X, 2005, J BIOMED MATER RES A, V75A, P510, DOI 10.1002/jbm.a.30475
   Duan XD, 2007, BIOMATERIALS, V28, P78, DOI 10.1016/j.biomaterials.2006.08.034
   Duncan R, 2005, ADV DRUG DELIVER REV, V57, P2215, DOI 10.1016/j.addr.2005.09.019
   Everaerts F, 2008, J BIOMED MATER RES A, V85A, P547, DOI 10.1002/jbm.a.31524
   Fail CA, 2002, LANGMUIR, V18, P264, DOI 10.1021/la0111598
   Fini M, 2007, J ORTHOP RES, V25, P98, DOI 10.1002/jor.20295
   Fischer D, 2003, BIOMATERIALS, V24, P1121, DOI 10.1016/S0142-9612(02)00445-3
   FISHER J, 1987, LIFE SUPPORT SYST, V5, P189
   Frenkel SR, 1997, J BONE JOINT SURG BR, V79B, P831, DOI 10.1302/0301-620X.79B5.7278
   Garcia Y, 2007, J MATER SCI-MATER M, V18, P1991, DOI 10.1007/s10856-007-3091-9
   Gingras M, 2008, GLIA, V56, P354, DOI 10.1002/glia.20617
   Gopinath D, 2005, J BIOMED MATER RES A, V73A, P320, DOI 10.1002/jbm.a.30303
   Hanthamrongwit M, 1996, BIOMATERIALS, V17, P775, DOI 10.1016/0142-9612(96)81414-1
   Hong MY, 2003, LANGMUIR, V19, P416, DOI 10.1021/a1020431q
   Jevprasesphant R, 2003, PHARM RES-DORDR, V20, P1543, DOI 10.1023/A:1026166729873
   Jevprasesphant R, 2003, INT J PHARM, V252, P263, DOI 10.1016/S0378-5173(02)00623-3
   Kobayashi H, 2001, MAGNET RESON MED, V46, P781, DOI 10.1002/mrm.1257.abs
   Ma L, 2004, BIOMATERIALS, V25, P2997, DOI 10.1016/j.biomaterials.2003.09.092
   Malik N, 2000, J CONTROL RELEASE, V65, P133, DOI 10.1016/S0168-3659(99)00246-1
   Malik N, 1999, ANTI-CANCER DRUG, V10, P767, DOI 10.1097/00001813-199909000-00010
   Maraval V, 2003, J ORG CHEM, V68, P6043, DOI 10.1021/jo0344438
   MELTZER AD, 1992, MACROMOLECULES, V25, P4549, DOI 10.1021/ma00044a014
   MELTZER AD, 1992, MACROMOLECULES, V25, P4541, DOI 10.1021/ma00044a013
   Murray MM, 2007, J ORTHOP RES, V25, P1007, DOI 10.1002/jor.20367
   NAKAJIMA N, 1995, BIOCONJUGATE CHEM, V6, P123, DOI 10.1021/bc00031a015
   Nourse A, 2000, BIOPOLYMERS, V53, P316, DOI 10.1002/(SICI)1097-0282(20000405)53:4<316::AID-BIP4>3.3.CO;2-A
   O Halloran DM, 2006, TISSUE ENG, V12, P1467, DOI 10.1089/ten.2006.12.1467
   OBRIEN TK, 1984, T AM SOC ART INT ORG, V30, P440
   Ohan MP, 2003, J BIOMED MATER RES A, V67A, P1188, DOI 10.1002/jbm.a.20018
   Orban JM, 2004, J BIOMED MATER RES A, V68A, P756, DOI 10.1002/jbm.a.20110
   Osborne CS, 1998, MED BIOL ENG COMPUT, V36, P129, DOI 10.1007/BF02522870
   PETITE H, 1994, J BIOMED MATER RES, V28, P159, DOI 10.1002/jbm.820280204
   PETITE H, 1990, J BIOMED MATER RES, V24, P179, DOI 10.1002/jbm.820240205
   Powell HM, 2006, BIOMATERIALS, V27, P5821, DOI 10.1016/j.biomaterials.2006.07.030
   Rault I, 1996, J MATER SCI-MATER M, V7, P215, DOI 10.1007/BF00119733
   Roberts JC, 1996, J BIOMED MATER RES, V30, P53, DOI 10.1002/(SICI)1097-4636(199601)30:1<53::AID-JBM8>3.0.CO;2-Q
   Roberts JC, 1990, BIOCONJUGATE CHEM, V1, P305, DOI 10.1021/bc00005a001
   Rodkey WG, 1999, CLIN ORTHOP RELAT R, pS281
   Sanchez-Sancho F, 2002, BIOCONJUGATE CHEM, V13, P647, DOI 10.1021/bc0155824
   Schlegel AK, 1997, BIOMATERIALS, V18, P535, DOI 10.1016/S0142-9612(96)00175-5
   Schoof H, 2001, J BIOMED MATER RES, V58, P352, DOI 10.1002/jbm.1028
   Shanmugasundaram N, 2004, J BIOMATER APPL, V18, P247, DOI 10.1177/0885328204040945
   Shaunak S, 2004, NAT BIOTECHNOL, V22, P977, DOI 10.1038/nbt995
   Shukla S, 2003, BIOCONJUGATE CHEM, V14, P158, DOI 10.1021/bc025586o
   STAROS JV, 1986, ANAL BIOCHEM, V156, P220, DOI 10.1016/0003-2697(86)90176-4
   Svenson S, 2005, ADV DRUG DELIVER REV, V57, P2106, DOI 10.1016/j.addr.2005.09.018
   VANLUYN MJA, 1992, J BIOMED MATER RES, V26, P1091, DOI 10.1002/jbm.820260810
   VANWACHEM PB, 1994, J BIOMED MATER RES, V28, P353, DOI 10.1002/jbm.820280310
   Wang XH, 2003, BIOMATERIALS, V24, P3213, DOI 10.1016/S0142-9612(03)00170-4
   WEADOCK KS, 1995, J BIOMED MATER RES, V29, P1373, DOI 10.1002/jbm.820291108
   Wu P, 2004, ANGEW CHEM INT EDIT, V43, P3928, DOI 10.1002/anie.200454078
   Wu XY, 2004, MACROMOL BIOSCI, V4, P71, DOI 10.1002/mabi.200300041
   Zeeman R, 1999, BIOMATERIALS, V20, P921, DOI 10.1016/S0142-9612(98)00242-7
NR 69
TC 14
Z9 15
U1 1
U2 14
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD OCT 21
PY 2008
VL 24
IS 20
BP 11752
EP 11761
DI 10.1021/la801913c
PG 10
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 360HT
UT WOS:000260049300059
PM 18774827
DA 2018-10-19
ER

PT J
AU Yang, T
   Zaman, MH
AF Yang, Tianyi
   Zaman, Muhammad H.
TI Cell Adhesion to Nanoligands: Effects of Ligand Size and Concentration
   in Solution
SO LANGMUIR
LA English
DT Article
ID MUTATIONS; DISEASE; SURFACES; KINETICS; FAMILY; LAYERS; MODEL; FLOW
AB Cells interact with both tethered and motile ligands in their extracellular environment to initiate and regulate signaling, adhesion, and migration. A quantitative and fundamental understanding of these receptor-ligand interactions is necessary for drug discovery, tissue engineering, and biomaterial fabrication. In this paper, we present a mean field approach to quantify the fundamental thermodynamics of interaction between the cell surface receptors and motile ligands in solvent. Our studies show that the free energy of interaction between the receptors and the nanosized ligands depends strongly on the ligand size and the effects at lower and higher concentrations show completely opposite trends that cannot be explained by simple scaling laws. In addition, we also observe various regimes of strong and weak adhesion as a function of ligand size and concentration. Our calculations provide insights into understanding cell-matrix interactions at a fundamental level as well as to identify potential avenues for fabrication of nanoligands for therapeutic and biotechnological purposes.
C1 [Zaman, Muhammad H.] Univ Texas Austin, Dept Biomed Engn, Inst Theoret Chem, Austin, TX 78712 USA.
   [Yang, Tianyi] Univ Texas Austin, Dept Phys, Austin, TX 78712 USA.
RP Zaman, MH (reprint author), Univ Texas Austin, Dept Biomed Engn, Inst Theoret Chem, Austin, TX 78712 USA.
EM mhzaman@mail.utexas.edu
FU Robert A. Welch Foundation [F-1677]; Cockrell School of Engineering
FX M.H.Z. gratefully acknowledges the support of a Robert A. Welch
   Foundation Grant (F-1677) and faculty startup funds from the Cockrell
   School of Engineering at UT Austin. The authors would like to thank
   Prof. Igal Szleifer (Northwestern) for his support and guidance during
   early stages of model development. We are also deeply grateful to the
   reviewers of our manuscript for their detailed and insightful comments
   and suggestions.
CR Alberts B, 2002, MOL BIOL CELL
   Bodian DL, 2008, BIOCHEMISTRY-US, V47, P5424, DOI 10.1021/bi800026k
   CARIGNANO MA, 1993, J CHEM PHYS, V98, P5006, DOI 10.1063/1.464954
   DESIMONE DW, 1987, BIOCHEM SOC T, V15, P789
   Gao M, 2002, J MUSCLE RES CELL M, V23, P513, DOI 10.1023/A:1023466608163
   Gensure RC, 2005, J CLIN INVEST, V115, P1250, DOI 10.1172/JCI200522760
   HAMMER DA, 1993, BLOOD CELLS, V19, P261
   HAMMER DA, 1989, CELL BIOPHYS, V14, P139, DOI 10.1007/BF02797131
   HAMMER DA, 1987, BIOPHYS J, V52, P475, DOI 10.1016/S0006-3495(87)83236-8
   Huang YB, 2002, MACROMOLECULES, V35, P1373, DOI 10.1021/ma011294r
   Huang YB, 2001, J CHEM PHYS, V114, P3809, DOI 10.1063/1.1345723
   Hynes RO, 2000, J CELL BIOL, V150, pF89, DOI 10.1083/jcb.150.2.F89
   Hynes RO, 2004, MATRIX BIOL, V23, P333, DOI 10.1016/j.matbio.2004.08.001
   Krammer A, 1999, P NATL ACAD SCI USA, V96, P1351, DOI 10.1073/pnas.96.4.1351
   Longo G, 2005, LANGMUIR, V21, P11342, DOI 10.1021/la051685p
   Lupo I, 2005, BRIT J DERMATOL, V153, P1019, DOI 10.1111/j.1365-2133.2005.06842.x
   Miyamoto Y, 2007, HUM GENET, V121, P625, DOI 10.1007/s00439-007-0354-y
   Press W. H., 2007, NUMERICAL RECIPES C
   Segev F, 2006, INVEST OPHTH VIS SCI, V47, P565, DOI 10.1167/iovs.05-0771
   VIKKULA M, 1994, ANN MED, V26, P107
   WARD MD, 1993, BIOPHYS J, V64, P936, DOI 10.1016/S0006-3495(93)81456-5
   WARD MD, 1995, ANN BIOMED ENG, V23, P322, DOI 10.1007/BF02584432
   WILLIAMS CJ, 1995, J RHEUMATOL, V22, P28
   Yang TY, 2008, CHEM PHYS LETT, V454, P362, DOI 10.1016/j.cplett.2008.01.088
   Yang TY, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2424985
   Zaman MH, 2007, BIOPHYS J, V92, pL17, DOI 10.1529/biophysj.106.097519
   Zhu C, 2000, J BIOMECH, V33, P23, DOI 10.1016/S0021-9290(99)00163-3
NR 27
TC 2
Z9 2
U1 0
U2 3
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD OCT 21
PY 2008
VL 24
IS 20
BP 11819
EP 11827
DI 10.1021/la801885c
PG 9
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 360HT
UT WOS:000260049300067
PM 18816080
DA 2018-10-19
ER

PT J
AU Zisch, AH
   Zimmermann, R
AF Zisch, Andreas H.
   Zimmermann, Roland
TI Bioengineering of foetal membrane repair
SO SWISS MEDICAL WEEKLY
LA English
DT Article
DE spontaneous PPROM; iatrogenic PPROM; tissue sealants; foetoscopy;
   injectable hydrogel; scaffolds
ID PRETERM PREMATURE RUPTURE; FETOSCOPIC ACCESS SITES; RABBIT MODEL;
   STRUCTURAL CHARACTERISTICS; GENETIC AMNIOCENTESIS; CLOSURE TECHNIQUES;
   MESENCHYMAL CELLS; GELATIN SPONGE; EXPERIENCE; DELIVERY
AB Preterm premature rupture of the foetal membranes (fruber vorzeitiger Blasensprung) has remained a devastating complication of pregnancy with very high risk of pregnancy loss. Several methods of sealing spontaneously ruptured membranes to stop amniotic fluid leakage and prolong pregnancy have been tested, but no one of them has achieved a clinical breakthrough. Also, needle and foetoscopic puncture of membranes for diagnostic or surgical interventions in the amniotic cavity carry a significant risk of persistent membrane leakage and subsequent rupture - thus limiting the developing field of intrauterine foetal surgery. Efforts are concentrated on taking action before rupture rather than reacting after rupture: one avenue of research concerns prophylactic plugging of foetoscopic access sites in foetal membranes at the time of intervention, thus inhibiting leakage and rupture. Foetal membrane injuries, spontaneous or iatrogenic, constitute extreme challenges to repair: thinness of foetal membrane tissue, difficult localisation and accessibility of the rupture site, the need for injectable sealants, vet gluing conditions and poor wound healing in this tissue all complicate repair. The goal is to achieve immediate and at the same time long-lasting closure of the membrane leak. Here we review approaches to closure of foetal membrane defects with liquid sealants or solid biomaterial scaffolds, with the focus on prophylactic plugging of foetoscopic access sites.
C1 [Zisch, Andreas H.; Zimmermann, Roland] Univ Zurich Hosp, Dept Obstet, CH-8091 Zurich, Switzerland.
   [Zisch, Andreas H.] Swiss Fed Inst Technol, Dept Mat, CH-1015 Lausanne, Switzerland.
   [Zisch, Andreas H.] Zurich Ctr Integrat Human Physiol, Zurich, Switzerland.
RP Zisch, AH (reprint author), Univ Zurich Hosp, Dept Obstet, Frauenklinikstr 10, CH-8091 Zurich, Switzerland.
EM andreas.zisch@usz.ch
CR Bilic G, 2005, AM J OBSTET GYNECOL, V193, P1724, DOI 10.1016/j.ajog.2005.04.005
   Bilic G, 2004, AM J OBSTET GYNECOL, V190, P87, DOI 10.1016/j.ajog.2003.07.011
   Deprest JA, 1997, PRENATAL DIAG, V17, P1247, DOI 10.1002/(SICI)1097-0223(199712)17:13<1247::AID-PD329>3.3.CO;2-N
   Deprest JA, 1999, HUM REPROD, V14, P1730, DOI 10.1093/humrep/14.7.1730
   Deprest J, 2006, SEMIN FETAL NEONAT M, V11, P398, DOI 10.1016/j.siny.2006.09.003
   Devlieger R, 2003, AM J OBSTET GYNECOL, V188, P844, DOI 10.1067/mob.2003.213
   DEVLIEGER R, 2006, AM J OBSTET GVNECOL
   Ghezzi F, 2002, AM J OBSTET GYNECOL, V186, P268, DOI 10.1067/mob.2002.119628
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Gratacos E, 2000, AM J OBSTET GYNECOL, V182, P142, DOI 10.1016/S0002-9378(00)70503-5
   Gratacos E, 2006, PLACENTA, V27, P452, DOI 10.1016/j.placenta.2005.03.008
   Lee BP, 2002, BIOMACROMOLECULES, V3, P1038, DOI 10.1021/bm025546n
   Luks FI, 1999, AM J OBSTET GYNECOL, V181, P995, DOI 10.1016/S0002-9378(99)70338-8
   MALAK TM, 1994, BRIT J OBSTET GYNAEC, V101, P375, DOI 10.1111/j.1471-0528.1994.tb11908.x
   Mallik AS, 2007, OBSTET GYNECOL, V110, P1121, DOI 10.1097/01.AOG.0000284624.23598.7c
   McLaren J, 1999, HUM REPROD, V14, P237, DOI 10.1093/humrep/14.1.237
   Mercer BM, 2003, OBSTET GYNECOL, V101, P178, DOI 10.1016/S0029-7844(02)02366-9
   O'Brien JM, 2002, AM J OBSTET GYNECOL, V187, P1143, DOI 10.1067/mob.2002.127124
   Ochsenbein-Kolble N, 2007, AM J OBSTET GYNECOL, V196, P263, DOI 10.1016/j.ajog.2006.10.904
   Ochsenbein-Kolble N, 2003, J PERINAT MED, V31, P287, DOI 10.1515/JPM.2003.040
   Papadopulos NA, 1998, AM J OBSTET GYNECOL, V178, P938, DOI 10.1016/S0002-9378(98)70527-7
   Papadopulos NA, 2006, FETAL DIAGN THER, V21, P494, DOI 10.1159/000095660
   Parry S, 1998, NEW ENGL J MED, V338, P663, DOI 10.1056/NEJM199803053381006
   Portmann-Lanz CB, 2007, PLACENTA, V28, P6, DOI 10.1016/j.placenta.2006.01.004
   Quintero RA, 1998, AM J OBSTET GYNECOL, V179, P71, DOI 10.1016/S0002-9378(98)70252-2
   Quintero RA, 2001, CLIN PERINATOL, V28, P861, DOI 10.1016/S0095-5108(03)00083-6
   Quintero RA, 1999, AM J OBSTET GYNECOL, V181, P744, DOI 10.1016/S0002-9378(99)70522-3
   Quintero RA, 2002, AM J OBSTET GYNECOL, V186, P155, DOI 10.1067/mob.2002.119185
   Romero R, 1998, AM J OBSTET GYNECOL, V179, P186, DOI 10.1016/S0002-9378(98)70271-6
   Sciscione AC, 2001, AM J OBSTET GYNECOL, V184, P368, DOI 10.1067/mob.2001.111796
   Sener T, 1997, AM J OBSTET GYNECOL, V177, P1535, DOI 10.1016/S0002-9378(97)70104-2
   Wenstrom KD, 1998, AM J OBSTET GYNECOL, V178, P546, DOI 10.1016/S0002-9378(98)70436-3
   West JL, 1996, P NATL ACAD SCI USA, V93, P13188, DOI 10.1073/pnas.93.23.13188
   Yoon BH, 2001, AM J OBSTET GYNECOL, V185, P1162, DOI 10.1067/mob.2001.117678
   Young B K, 2004, J Matern Fetal Neonatal Med, V16, P235
   Young BK, 2004, FETAL DIAGN THER, V19, P296, DOI 10.1159/000076715
NR 36
TC 5
Z9 5
U1 0
U2 7
PU E M H SWISS MEDICAL PUBLISHERS LTD
PI MUTTENZ
PA FARNSBURGERSTR 8, CH-4132 MUTTENZ, SWITZERLAND
SN 1424-7860
J9 SWISS MED WKLY
JI Swiss Med. Wkly.
PD OCT 18
PY 2008
VL 138
IS 41-42
BP 596
EP 601
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA 362YM
UT WOS:000260233100001
PM 18941945
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Yang, H
   Zhang, L
   Xu, KW
AF Yang, Hui
   Zhang, Lin
   Xu, Ke-Wei
TI Effect of fabrication processes on orientation growth of La/HAP crystal
SO JOURNAL OF MATERIALS PROCESSING TECHNOLOGY
LA English
DT Article
DE crystal orientation; lanthanum; hydroxyapatite; biomaterial;
   nanomaterial
ID HYDROXYAPATITE CRYSTALS; COLLAGEN; BONE
AB Hydroxyapatite doped with lanthanum (La/HAP) was prepared using co-precipitation method in this study. The effects of the concentration of La3+, stirring, aging time, hydrothermal treatment and calcination temperature on orient growth of the La/HAP were investigated. The phase composition of the La/HAP was analyzed by means of X-ray diffraction (XRD). The parameter (c/a) values of the orient growth of the La/HAP were calculated based on XRD data. The results show that the orient growth of La/HAP crystal is slightly affected by the concentration of La3+ in reaction solution whereas the growth of the crystal is closely related to the aging time and the calcination temperature. As the calcination temperature changes from 100 degrees C to 750 degrees C, the La/HAP crystal tends to grow along a-axis. The tendency of the crystal growth in the direction of c-axis becomes obvious at 70 degrees C as aging time extends. However, stirring appears to restrain the growth of crystal in c-axis. The hydrothermal treatment at 125 degrees C seems helpful for getting a low c/a value crystal and changes the La/HAP from needle shape to rod one. The direction of the c-axis of the La/HAP lattice seems to be the same as that of the long-axis of the La/HAP nanoparticles. The assynthesized La/HAP powder mainly consists of HAP phase with slight La2O3 phase and has good thermostability. (C) 2008 Published by Elsevier B.V.
C1 [Yang, Hui; Xu, Ke-Wei] Xi An Jiao Tong Univ, State Key Lab Mech Behav Mat, Xian 710049, Peoples R China.
   [Yang, Hui; Zhang, Lin] Shaanxi Univ Sci & Technol, Life Coll Sci & Engn, Xianyang 712081, Peoples R China.
RP Xu, KW (reprint author), Xi An Jiao Tong Univ, State Key Lab Mech Behav Mat, Xian 710049, Peoples R China.
EM kwxu@xjtu.edu.cn
FU Bureau of Science Technology [GG 200354]; Natural Science Foundation
   [2004B24]; Shaanxi University of Science Technology [sust-B104]
FX This work was financially supported by the Key Research item of
   Technology of Bureau of Science & Technology of Xi'an city, Shaanxi
   Province of China (Grant no. GG 200354) and partially supported by the
   Natural Science Foundation of Shaanxi Province of China (Grant no.
   2004B24) and the Research Team Foundation of Shaanxi University of
   Science & Technology (sust-B104).
CR Aizawa M, 2005, BIOMATERIALS, V26, P3427, DOI 10.1016/j.biomaterials.2004.09.044
   Bouyer E, 2000, J MATER SCI-MATER M, V11, P523, DOI 10.1023/A:1008918110156
   CAO XZ, 1984, INORG CHEM, P173
   Feng QL, 1999, J MATER SCI LETT, V18, P559, DOI 10.1023/A:1006686713882
   Fraser AC, 1999, BRIT POULTRY SCI, V40, P626, DOI 10.1080/00071669987016
   Kaneko T, 2004, CHEM MATER, V16, P5596, DOI 10.1021/cm0490975
   Kikuchi M, 2004, COMPOS SCI TECHNOL, V64, P819, DOI 10.1016/j.compscitech.2003.09.002
   Lee BT, 2006, MAT SCI ENG A-STRUCT, V429, P348, DOI 10.1016/j.msea.2006.05.090
   Liu Rong fang, 2003, Journal of the Chinese Ceramic Society, V31, P615
   Massa EA, 2002, MATER RES SOC SYMP P, V711, P257
   Matsuda A, 2004, MAT SCI ENG C-BIO S, V24, P717, DOI 10.1016/j.msec.2004.08.048
   Oktar F.N., 2006, KEY ENG MATER, V18, P101
   Park SS, 2005, KEY ENG MAT, V277-279, P113, DOI 10.4028/www.scientific.net/KEM.277-279.113
   Rodriguez-Lorenzo LM, 2000, CHEM MATER, V12, P2460, DOI 10.1021/cm001033g
   Rokita E, 2005, NUCL INSTRUM METH B, V240, P69, DOI 10.1016/j.nimb.2005.06.089
   SHAW WJ, 2004, J BIOL CHEM, V279, P40236
   TIAN CX, 1999, J PANZHIHUA U, V16, P77
   Ueshima M, 2002, SOLID STATE IONICS, V151, P29, DOI 10.1016/S0167-2738(02)00600-8
   Webster TJ, 2004, BIOMATERIALS, V25, P2111, DOI 10.1016/j.biomaterials.2003.09.001
   Zhai Y, 2005, CURR APPL PHYS, V5, P429, DOI 10.1016/j.cap.2005.01.004
   ZHANG LJ, 2004, THIN SOLID FILMS, V458, P287, DOI DOI 10.1016/J.TSF.2003.11.296
NR 21
TC 5
Z9 6
U1 0
U2 7
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0924-0136
J9 J MATER PROCESS TECH
JI J. Mater. Process. Technol.
PD OCT 16
PY 2008
VL 207
IS 1-3
BP 276
EP 282
DI 10.1016/j.jmatprotec.2007.12.079
PG 7
WC Engineering, Industrial; Engineering, Manufacturing; Materials Science,
   Multidisciplinary
SC Engineering; Materials Science
GA 356NZ
UT WOS:000259786200034
DA 2018-10-19
ER

PT J
AU Wheeldon, IR
   Gallaway, JW
   Barton, SC
   Banta, S
AF Wheeldon, Ian R.
   Gallaway, Joshua W.
   Barton, Scott Calabrese
   Banta, Scott
TI Bioelectrocatalytic hydrogels from electron-conducting
   metallopolypeptides coassembled with bifunctional enzymatic building
   blocks
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE biocatalysis; biofuel cell; biomaterial; laccase; protein
ID BIOFUEL CELLS; STREPTOMYCES-COELICOLOR; CIRCULAR-DICHROISM; SMALL
   LACCASE; PROTEIN; DESIGN; BIOSENSORS; SECONDARY; KINETICS; MODEL
AB Here, we present two bifunctional protein building blocks that coassemble to form a bioelectrocatalytic hydrogel that catalyzes the reduction of dioxygen to water. One building block, a metallopolypeptide based on a previously designed triblock polypeptide, is electron-conducting. A second building block is a chimera of artificial alpha-helical leucine zipper and random coil domains fused to a polyphenol oxidase, small laccase (SLAC). The metallopolypeptide has a helix-random-helix secondary structure and forms a hydrogel via tetrameric coiled coils. The helical and random domains are identical to those fused to the polyphenol oxidase. Electron-conducting functionality is derived from the divalent attachment of an osmium bis-bipyrdine complex to histidine residues within the peptide. Attachment of the osmium moiety is demonstrated by mass spectroscopy (MS-MALDI-TOF) and cyclic voltammetry. The structure and function of the alpha-helical domains are confirmed by circular dichroism spectroscopy and by rheological measurements. The metallopolypeptide shows the ability to make electrical contact to a solid-state electrode and to the redox centers of modified SLAC. Neat samples of the modified SLAC form hydrogels, indicating that the fused alpha-helical domain functions as a physical cross-linker. The fusion does not disrupt dimer formation, a necessity for catalytic activity. Mixtures of the two building blocks coassemble to form a continuous supramolecular hydrogel that, when polarized, generates a catalytic current in the presence of oxygen. The specific application of the system is a biofuel cell cathode, but this protein-engineering approach to advanced functional hydrogel design is general and broadly applicable to biocatalytic, biosensing, and tissue-engineering applications.
C1 [Wheeldon, Ian R.; Gallaway, Joshua W.; Banta, Scott] Columbia Univ, Dept Chem Engn, New York, NY 10027 USA.
   [Barton, Scott Calabrese] Michigan State Univ, Dept Chem Engn & Mat Sci, E Lansing, MI 48824 USA.
RP Banta, S (reprint author), Columbia Univ, Dept Chem Engn, 500 W 120th St, New York, NY 10027 USA.
EM sbanta@cheme.columbia.edu
OI Gallaway, Joshua/0000-0002-6798-7781
FU Air Force Office of Scientific Research Multidisciplinary University
   Research Initiative [FA9550-06-1-0264]
FX We thank D. Tirrell (Caffech) for the kind gift of the expression
   plasmid pQE9AC10Atrp, G. Canters (Leiden University, The Netherlands)
   for his gift of pSLAC, and Y. Itagaki for his help with the MS-MALDI
   experiments. This work was supported by Air Force Office of Scientific
   Research Multidisciplinary University Research Initiative
   (FA9550-06-1-0264).
CR BARTLETT PN, 1993, J ELECTROANAL CHEM, V362, P1
   Barton SC, 2004, CHEM REV, V104, P4867, DOI 10.1021/cr020719k
   Bullen RA, 2006, BIOSENS BIOELECTRON, V21, P2015, DOI 10.1016/j.bios.2006.01.030
   Chau Y, 2008, BIOMATERIALS, V29, P1713, DOI 10.1016/j.biomaterials.2007.11.046
   Chockalingam K, 2007, PROTEIN ENG DES SEL, V20, P155, DOI 10.1093/protein/gzm008
   Ehrick JD, 2005, NAT MATER, V4, P298, DOI 10.1038/nmat1352
   Gallaway J, 2008, BIOSENS BIOELECTRON, V23, P1229, DOI 10.1016/j.bios.2007.11.004
   Gallaway JW, 2008, J AM CHEM SOC, V130, P8527, DOI 10.1021/ja0781543
   Haines-Butterick L, 2007, P NATL ACAD SCI USA, V104, P7791, DOI 10.1073/pnas.0701980104
   Heller A, 2006, CURR OPIN CHEM BIOL, V10, P664, DOI 10.1016/j.cbpa.2006.09.018
   HENNESSEY JP, 1981, BIOCHEMISTRY-US, V20, P1085, DOI 10.1021/bi00508a007
   Ikeda T, 2003, BBA-PROTEINS PROTEOM, V1647, P121, DOI 10.1016/S1570-9639(03)00075-X
   Iwasaki Y, 2002, BIOSENS BIOELECTRON, V17, P783, DOI 10.1016/S0956-5663(02)00054-4
   JOHNSON WC, 1990, PROTEIN-STRUCT FUNCT, V7, P214
   Kavanagh GM, 1998, PROG POLYM SCI, V23, P533, DOI 10.1016/S0079-6700(97)00047-6
   Kopecek J, 2007, BIOMATERIALS, V28, P5185, DOI 10.1016/j.biomaterials.2007.07.044
   LAU SYM, 1984, J BIOL CHEM, V259, P3253
   Machczynski MC, 2004, PROTEIN SCI, V13, P2388, DOI 10.1110/ps.04759104
   Maciejewska M, 2006, ELECTROCHEM COMMUN, V8, P1119, DOI 10.1016/j.elecom.2006.04.021
   Mano N, 2002, J PHYS CHEM B, V106, P8842, DOI 10.1021/jp025955d
   Mano N, 2006, J PHYS CHEM B, V110, P11180, DOI 10.1021/jp055654e
   Murphy WL, 2007, ANGEW CHEM INT EDIT, V46, P3066, DOI 10.1002/anie.200604808
   Newman JD, 2006, MOL BIOTECHNOL, V32, P249, DOI 10.1385/MB:32:3:249
   Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389
   Shen W, 2006, NAT MATER, V5, P153, DOI 10.1038/nmat1573
   Shen W, 2005, MACROMOLECULES, V38, P3909, DOI 10.1021/ma048348s
   Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880
   Ulijn RV, 2007, MATER TODAY, V10, P40, DOI 10.1016/S1369-7021(07)70049-4
   van Hest JCM, 2001, CHEM COMMUN, P1897, DOI 10.1039/b105185g
   Wang C, 1999, NATURE, V397, P417, DOI 10.1038/17092
   Wheeldon IR, 2007, BIOMACROMOLECULES, V8, P2990, DOI 10.1021/bm700858p
NR 31
TC 46
Z9 46
U1 1
U2 27
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD OCT 7
PY 2008
VL 105
IS 40
BP 15275
EP 15280
DI 10.1073/pnas.0805249105
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 364UI
UT WOS:000260360500014
PM 18824691
OA Bronze, Green Published
DA 2018-10-19
ER

PT J
AU Yamada, M
   Aono, H
AF Yamada, Masanori
   Aono, Hirofumi
TI DNA-inorganic hybrid material as selective absorbent for harmful
   compounds
SO POLYMER
LA English
DT Article
DE Biopolymers; Organic-inorganic hybrid materials; DNA
ID DOUBLE-STRANDED DNA; CALF THYMUS DNA; NUCLEIC-ACIDS; METAL-IONS;
   DEOXYRIBONUCLEIC-ACID; POLYMER ELECTROLYTES; FUNCTIONAL MATERIALS;
   CIRCULAR-DICHROISM; GEL; COMPOSITE
AB Double-stranded DNA is one of functional polymers, but the large amounts of DNA sources, such as salmon milt and shellfish gonads, have been discarded as industrial wastes. Therefore, conversion of this discarded DNA to be a useful material would be beneficial to utilize the unique property of DNA. These materials including DNA have been prepared by mixing with the organic polymers, such as alginic acid, collagen, and chitosan. However, since these materials have consisted from entirely organic components, these do not have the mechanical strength for a material. So, we prepared the organic-inorganic hybrid materials by mixing DNA with silane coupling reagents bis(trimethoxysilylpropyl)amine or bis[(3-trimethoxysilyl)propyl]ethylenediamine. These hybrid materials with the flexibility were water-insoluble and resistant to hydrolysis by nuclease. In addition, the mechanical strength of this hybrid material was approximately twice as high as that of DNA without mixing with silane coupling reagents. Furthermore, the double-stranded DNA in the hybrid materials has been maintained in a B-form structure in aqueous solution. Thus, we demonstrated the utilization of DNA as a functional material. As a result, this material could selectively accumulate harmful DNA-intercalating compounds with the planar structure, such as dibenzo-p-dioxin, dibenzofuran, and ethidium bromide. Organic-inorganic hybrid material including double-stranded DNA has potential to serve as a useful biomaterial for medical, engineering, and environmental applications. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Yamada, Masanori; Aono, Hirofumi] Okayama Univ Sci, Fac Sci, Dept Chem, Okayama 7000005, Japan.
RP Yamada, M (reprint author), Okayama Univ Sci, Fac Sci, Dept Chem, Okayama 7000005, Japan.
EM myamada@chem.ous.ac.jp
FU Ministry of Education, Culture, Sports, Science and Technology of Japan
   [19750187]
FX This work was supported by the Grants-in-Aid for Scientific Research
   from the Ministry of Education, Culture, Sports, Science and Technology
   of Japan (No. 19750187).
CR ALLEN FS, 1972, BIOPOLYMERS, V11, P853, DOI 10.1002/bip.1972.360110410
   Arakawa H, 2000, J BIOL CHEM, V275, P10150, DOI 10.1074/jbc.275.14.10150
   ARMSTRONG RW, 1970, J AM CHEM SOC, V92, P3174, DOI 10.1021/ja00713a041
   Banyay M, 2003, BIOPHYS CHEM, V104, P477, DOI 10.1016/S0301-4622(03)00035-8
   Coradin T, 2007, ACCOUNTS CHEM RES, V40, P819, DOI 10.1021/ar068129m
   GEACINTOV NE, 1976, J AM CHEM SOC, V98, P6444, DOI 10.1021/ja00437a002
   Gill I, 2000, TRENDS BIOTECHNOL, V18, P469, DOI 10.1016/S0167-7799(00)01493-1
   Hackl EV, 2005, INT J BIOL MACROMOL, V35, P175, DOI 10.1016/j.ijbiomac.2005.01.011
   Honma I, 2003, SOLID STATE IONICS, V162, P237, DOI 10.1016/S0167-2738(03)00260-1
   Honma I, 2003, J ELECTROCHEM SOC, V150, pA616, DOI 10.1149/1.1566018
   Honma I, 2002, ELECTROCHEMISTRY, V70, P920
   Iwata K, 1996, INT J BIOL MACROMOL, V18, P149, DOI 10.1016/0141-8130(95)01073-4
   Kandimalla VB, 2006, CHEM-EUR J, V12, P1074, DOI 10.1002/chem.200500178
   Lee SL, 2004, J PHYS CHEM B, V108, P3098, DOI 10.1021/jp0311409
   LEPECQ JB, 1967, J MOL BIOL, V27, P87, DOI 10.1016/0022-2836(67)90353-1
   Liu XD, 2003, INT J BIOL MACROMOL, V32, P121, DOI 10.1016/S0141-8130(03)00045-X
   Liu XD, 2007, ADV POLYM SCI, V209, P149, DOI 10.1007/12_2006_106
   McManus JJ, 2004, J AM CHEM SOC, V126, P15966, DOI 10.1021/ja046105+
   MOORE DS, 1974, BIOPOLYMERS, V13, P977, DOI 10.1002/bip.1974.360130512
   NAGATA C, 1967, B CHEM SOC JPN, V40, P2564, DOI 10.1246/bcsj.40.2564
   Nishikawa O, 2004, ELECTROCHIM ACTA, V50, P667, DOI 10.1016/j.electacta.2003.12.069
   Pereira APV, 2000, J NON-CRYST SOLIDS, V273, P180, DOI 10.1016/S0022-3093(00)00166-6
   Saenger W., 1987, PRINCIPLES NUCL ACID
   Satoh S, 2005, POLYM J, V37, P94, DOI 10.1295/polymj.37.94
   Shinkai S, 2005, SUPRAMOL CHEM, V17, P181, DOI 10.1080/10610270412331328925
   TAJMIRRIAHI HA, 1993, BIOPOLYMERS, V33, P1819, DOI 10.1002/bip.360331208
   TSO POP, 1964, P NATL ACAD SCI USA, V51, P17, DOI 10.1073/pnas.51.1.17
   Umeno D, 1998, BIOCONJUGATE CHEM, V9, P719, DOI 10.1021/bc980019f
   Uragami T., 2005, BIOMACROMOLECULES, V6, P368
   Vince J, 2006, LANGMUIR, V22, P6489, DOI 10.1021/la060694a
   Wang LL, 2001, CHEM MATER, V13, P1273, DOI 10.1021/cm000869g
   Wang ZJ, 2006, TALANTA, V69, P686, DOI 10.1016/j.talanta.2005.11.004
   WARING MJ, 1981, ANNU REV BIOCHEM, V50, P159, DOI 10.1146/annurev.bi.50.070181.001111
   Yamada M, 2002, CHEM-EUR J, V8, P1407, DOI 10.1002/1521-3765(20020315)8:6<1407::AID-CHEM1407>3.0.CO;2-L
   Yamada M, 2005, POLYMER, V46, P10102, DOI 10.1016/j.polymer.2005.07.086
   Yamada M, 2002, ENVIRON SCI TECHNOL, V36, P949, DOI 10.1021/es011008r
   Yamada M, 2008, INT J BIOL MACROMOL, V42, P478, DOI 10.1016/j.ijbiomac.2008.03.005
   Yamada M, 2008, POLYM J, V40, P327, DOI 10.1295/polymj.PJ2007215
   Yang KG, 2005, DESALINATION, V175, P297, DOI 10.1016/j.desal.2004.08.046
   Yoshinaga I, 1996, J SOL-GEL SCI TECHN, V6, P151, DOI 10.1007/BF00425972
NR 40
TC 20
Z9 20
U1 2
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0032-3861
J9 POLYMER
JI Polymer
PD OCT 6
PY 2008
VL 49
IS 21
BP 4658
EP 4665
DI 10.1016/j.polymer.2008.08.027
PG 8
WC Polymer Science
SC Polymer Science
GA 360MZ
UT WOS:000260062900024
DA 2018-10-19
ER

PT J
AU Xiao, YM
   Li, DX
   Chen, XN
   Lu, J
   Fan, HS
   Zhang, XD
AF Xiao, Yumei
   Li, Dongxiao
   Chen, Xuening
   Lu, Jian
   Fan, Hongsong
   Zhang, Xingdong
TI Preparation and cytocompatibility of chitosan-modified polylactide
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE polylactide; chitosan; microspheres; surface modification;
   cytocompatibility
ID LACTIC ACID MEMBRANE; POLY(L-LACTIC ACID); COLLAGEN; SURFACE;
   IMMOBILIZATION; SCAFFOLD; GROWTH
AB Chitosan-modified PLA (CMPLA) was fabricated to improve cytocompatibility of polylactide (PLA). PMAA-grafted PLA (PMAA-PLA) was obtained through alpha-methacrylic acid (MAA) grafted polymerization on PLA surface with photooxidization and UV irradiation. Steady PMAA-PLA microparticle Suspension with an average size as 172.8 +/- 3.6 nm and zeta potential as -95.0 +/- 0.6 mV was prepared through solvent volatilization. By static electricity interaction and other interactions between PMAA-PLA microsparticles and chitosan molecules, CMPLA was obtained. FTIR, XPS, SEM, and zeta potential analyses indicated that CMPLA was modified with chitosan molecules uniformly. Compared with the PLA control, CMPLA adapted to supporting the attachment and proliferation of L929 cells better. The obtained CMPLA was expected to be used as perfect biomaterial for tissue regeneration. (C) 2008 Wiley Periodicals, Inc.
C1 [Xiao, Yumei; Li, Dongxiao; Chen, Xuening; Lu, Jian; Fan, Hongsong; Zhang, Xingdong] Sichuan Univ, Engn Res Ctr Biomat, Chengdu 610041, Peoples R China.
   [Li, Dongxiao] Sichuan Inst Chinese Mat Med, Chengdu 610041, Peoples R China.
RP Xiao, YM (reprint author), Sichuan Univ, Engn Res Ctr Biomat, Chengdu 610041, Peoples R China.
EM xymzl2000@126.com
RI Lu, Jian/G-5407-2010
CR Cui YL, 2003, BIOMATERIALS, V24, P3859, DOI 10.1016/S0142-9612(03)00209-6
   Hong Y, 2005, BIOMATERIALS, V26, P6305, DOI 10.1016/j.biomaterials.2005.03.038
   Ide A, 2001, MAT SCI ENG C-BIO S, V17, P95, DOI 10.1016/S0928-4931(01)00315-0
   Ma ZW, 2005, BIOMATERIALS, V26, P1253, DOI 10.1016/j.biomaterials.2004.04.031
   Ma ZW, 2002, J BIOMED MATER RES, V63, P838, DOI 10.1002/jbm.10470
   Ma ZW, 2002, EUR POLYM J, V38, P2279, DOI 10.1016/S0014-3057(02)00119-2
   Malvern Instruments Ltd, 2004, ZET NAN US MAN
   MAO YM, 2007, MATER LETT, V61, P59
   MIKOS AG, 1994, BIOMATERIALS, V15, P55, DOI 10.1016/0142-9612(94)90197-X
   Sato T, 2004, MAT SCI ENG C-BIO S, V24, P365, DOI 10.1016/j.msec.2003.12.010
   Suh H, 2001, BIOMATERIALS, V22, P219, DOI 10.1016/S0142-9612(00)00177-0
   Xiao YM, 2007, MATER LETT, V61, P2601, DOI 10.1016/j.matlet.2006.10.006
   Yang Y, 2003, NUCL INSTRUM METH B, V207, P165, DOI 10.1016/S0168-583X(03)00456-7
   Zhu YB, 2003, BIOMACROMOLECULES, V4, P446, DOI 10.1021/bm025723k
NR 14
TC 11
Z9 14
U1 4
U2 26
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD OCT 5
PY 2008
VL 110
IS 1
BP 408
EP 412
DI 10.1002/app.28493
PG 5
WC Polymer Science
SC Polymer Science
GA 340GJ
UT WOS:000258633800050
DA 2018-10-19
ER

PT J
AU Yliperttula, M
   Chung, BG
   Navaladi, A
   Manbachi, A
   Urtti, A
AF Yliperttula, Marjo
   Chung, Bong Geun
   Navaladi, Akshay
   Manbachi, Amir
   Urtti, Arto
TI High-throughput screening of cell responses to biomaterials
SO EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
LA English
DT Review
DE high-throughput screening; biomaterial; tissue engineering;
   biocompatibility; cell culture; microarray; microfluidics; drug
   discovery
ID EMBRYONIC STEM-CELLS; MICROSCALE TECHNOLOGIES; DIFFERENTIATION;
   MICROARRAYS; ARRAYS; FABRICATION; ADHESION; SURFACE; PROLIFERATION;
   MICROWELLS
AB Biomaterials have emerged as powerful regulators of the cellular microenvironment for drug discovery, tissue engineering research and chemical testing. Although biomaterial-based matrices control the cellular behavior, these matrices are still far from being optimal. In principle, efficacy of biomaterial development for the cell cultures can be improved by using high-throughput techniques that allow screening of a large number of materials and manipulate microenvironments in a controlled manner. Several cell responses such as toxicity, proliferation, and differentiation have been used to evaluate the biomaterials thus providing basis for further selection of the lead biomimetic materials or microenvironments. Although high-throughput techniques provide an initial screening of the desired properties, more detailed follow-up studies of the selected materials are required to understand the true value of a 'positive hit'. High-throughput methods may become important tools in the future development of biomaterials-based cell cultures that will enable more realistic pre-clinical prediction of pharmacokinetics, pharmacodynamics, and toxicity. This is highly important, because predictive pre-clinical methods are needed to improve the high attrition rate of drug candidates during clinical testing. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Yliperttula, Marjo] Univ Helsinki, Div Biopharm & Pharmacokinet, FIN-00014 Helsinki, Finland.
   [Yliperttula, Marjo; Chung, Bong Geun; Navaladi, Akshay; Manbachi, Amir] MIT, Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
   [Chung, Bong Geun] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Biomed Engn,Dept Med, Boston, MA 02115 USA.
   [Navaladi, Akshay] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
   [Manbachi, Amir] Univ Toronto, Inst Biomat & Biomed Engn IBBME, Toronto, ON, Canada.
   [Urtti, Arto] Univ Helsinki, Drug Discovery & Dev Technol Ctr, FIN-00014 Helsinki, Finland.
RP Yliperttula, M (reprint author), Univ Helsinki, Div Biopharm & Pharmacokinet, Viikinkaari 5E, FIN-00014 Helsinki, Finland.
EM marjo.yliperttula@helsinki.fi
OI Manbachi, Amir/0000-0003-0206-5230
CR Albrecht DR, 2005, LAB CHIP, V5, P111, DOI 10.1039/b406953f
   ALLEN LT, 2003, INTERACTION SOFT CON
   Anderson DG, 2004, P NATL ACAD SCI USA, V101, P16028, DOI 10.1073/pnas.0407218101
   Anderson DG, 2004, SCIENCE, V305, P1923, DOI 10.1126/science.1099987
   Anderson DG, 2005, BIOMATERIALS, V26, P4892, DOI 10.1016/j.biomaterials.2004.11.052
   Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   Bailey SN, 2004, P NATL ACAD SCI USA, V101, P16144, DOI 10.1073/pnas.0404425101
   Brummelkamp TR, 2006, NAT CHEM BIOL, V2, P202, DOI 10.1038/nchembio774
   Burdick JA, 2004, LANGMUIR, V20, P5153, DOI 10.1021/la049298n
   Cabodi M, 2005, J AM CHEM SOC, V127, P13788, DOI 10.1021/ja054820t
   CALDWELL JS, 2006, ADV CANCER RES, V96, P145
   Castel D, 2006, DRUG DISCOV TODAY, V11, P616, DOI 10.1016/j.drudis.2006.05.015
   Chai C, 2007, MOL THER, V15, P467, DOI 10.1038/sj.mt.6300084
   Chung BG, 2005, LAB CHIP, V5, P401, DOI 10.1039/b417651k
   DeMali KA, 2003, CURR OPIN CELL BIOL, V15, P572, DOI 10.1016/S0955-0674(03)00109-1
   Diaz-Mochon JJ, 2007, CHEM SOC REV, V36, P449, DOI 10.1039/b511848b
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Erfle H, 2004, BIOTECHNIQUES, V37, P454, DOI 10.2144/04373RT01
   Falsey JR, 2001, BIOCONJUGATE CHEM, V12, P346, DOI 10.1021/bc000141q
   Fittkau MH, 2005, BIOMATERIALS, V26, P167, DOI 10.1016/j.biomaterials.2004.02.012
   Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736
   Garcia AJ, 2005, BIOMATERIALS, V26, P7525, DOI 10.1016/j.biomaterials.2005.05.029
   Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618
   Goodman SL, 1996, BIOMATERIALS, V17, P2087, DOI 10.1016/0142-9612(96)00016-6
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Haney SA, 2006, DRUG DISCOV TODAY, V11, P889, DOI 10.1016/j.jdrudis.2006.08.015
   Hirsch LR, 2006, ANN BIOMED ENG, V34, P15, DOI 10.1007/s10439-005-9001-8
   Hubbell JA, 2004, NAT BIOTECHNOL, V22, P828, DOI 10.1038/nbt0704-828
   Ito Y, 2005, BIOMATERIALS, V26, P211, DOI 10.1016/j.biomaterials.2004.02.019
   James K, 1996, MRS BULL, V21, P22, DOI 10.1557/S0883769400031808
   Karp JM, 2007, LAB CHIP, V7, P786, DOI 10.1039/b705085m
   Kennedy SB, 2006, BIOMATERIALS, V27, P3817, DOI 10.1016/j.biomaterials.2006.02.044
   Khademhosseini A, 2005, LAB CHIP, V5, P1380, DOI 10.1039/b508096g
   Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102
   Khademhosseini A, 2006, J BIOMAT SCI-POLYM E, V17, P1221, DOI 10.1163/156856206778667488
   Khademhosseini A, 2006, BIOMATERIALS, V27, P5968, DOI 10.1016/j.biomaterials.2006.06.035
   Kudelska-Mazur Dorota, 2005, Cell and Tissue Banking, V6, P55, DOI 10.1007/s10561-005-1911-z
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lavik EB, 2005, BIOMATERIALS, V26, P3187, DOI 10.1016/j.biomaterials.2004.08.022
   Lysaght MJ, 2000, ASAIO J, V46, P515, DOI 10.1097/00002480-200009000-00001
   Massia SP, 2001, J BIOMED MATER RES, V56, P390, DOI 10.1002/1097-4636(20010905)56:3<390::AID-JBM1108>3.0.CO;2-L
   Mei Y, 2007, CURR OPIN CHEM BIOL, V11, P388, DOI 10.1016/j.cbpa.2007.07.006
   Meredith JC, 2003, J BIOMED MATER RES A, V66A, P483, DOI 10.1002/jbm.a.10004
   Moeller HC, 2008, BIOMATERIALS, V29, P752, DOI 10.1016/j.biomaterials.2007.10.030
   Paasonen L, 2007, J CONTROL RELEASE, V122, P86, DOI 10.1016/j.jconrel.2007.06.009
   Pihl J, 2005, ANAL CHEM, V77, P3897, DOI 10.1021/ac050218+
   Pinaud F, 2006, BIOMATERIALS, V27, P1679, DOI 10.1016/j.biomaterials.2005.11.018
   Ratner Buddy D., 1996, P1, DOI 10.1016/B978-012582460-6/50002-5
   Shin H, 2007, BIOMATERIALS, V28, P126, DOI 10.1016/j.biomaterials.2006.08.007
   Simon CG, 2005, BIOMATERIALS, V26, P6906, DOI 10.1016/j.biomaterials.2005.04.050
   Stevens MM, 2005, BIOMATERIALS, V26, P7636, DOI 10.1016/j.biomaterials.2005.05.001
   Tan WJ, 2005, BIOMATERIALS, V26, P891, DOI 10.1016/j.biomaterials.2004.03.041
   Tanase M, 2005, LAB CHIP, V5, P598, DOI 10.1039/b500243e
   Wang ZH, 2007, LAB CHIP, V7, P740, DOI 10.1039/b618734j
   Weng JF, 2006, CURR MED CHEM, V13, P897, DOI 10.2174/092986706776361076
   Yamada Yoshihiko, 1992, Current Opinion in Cell Biology, V4, P819, DOI 10.1016/0955-0674(92)90105-L
   Yang X, 2006, COMB CHEM HIGH T SCR, V9, P123, DOI 10.2174/138620706775541891
NR 58
TC 47
Z9 47
U1 2
U2 33
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-0987
J9 EUR J PHARM SCI
JI Eur. J. Pharm. Sci.
PD OCT 2
PY 2008
VL 35
IS 3
BP 151
EP 160
DI 10.1016/j.ejps.2008.04.012
PG 10
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 358VC
UT WOS:000259944600001
PM 18586092
DA 2018-10-19
ER

PT J
AU Moisel, M
   de Mele, MAFL
   Muller, WD
AF Moisel, Marion
   Fernandez Lorenzo de Mele, Monica Alicia
   Mueller, Wolf-Dieter
TI Biomaterial Interface Investigated by Electrochemical Impedance
   Spectroscopy
SO ADVANCED ENGINEERING MATERIALS
LA English
DT Article
ID IN-VITRO CORROSION; SELF-ASSEMBLED MONOLAYERS; OSTEOBLAST-LIKE CELLS;
   BOVINE SERUM-ALBUMIN; BY-LAYER ADSORPTION; STAINLESS-STEEL; TITANIUM
   SURFACES; TI-6AL-4V ALLOY; ALTERNATING POLYCATION; CELLULAR BEHAVIOR
AB Application of a biomaterial requires profound knowledge about the features and structure of the biomaterial - tissue interface. Electrochemical techniques, especially electrochemical impedance spectroscopy (EIS) enable a fast non-destructive characterization of the interface. This review summarizes the application of EIS in different biological environments.
C1 [Moisel, Marion; Mueller, Wolf-Dieter] Univ Sch Dent Med, Charite, D-14197 Berlin, Germany.
   [Fernandez Lorenzo de Mele, Monica Alicia] Univ Nacl La Plata, INIFTA, La Plata, Buenos Aires, Argentina.
RP Moisel, M (reprint author), Univ Sch Dent Med, Charite, Assinannshauserstr 4-6, D-14197 Berlin, Germany.
RI Fernandez Lorenzo de Mele, Monica/I-1388-2015
OI Fernandez Lorenzo de Mele, Monica/0000-0002-8093-7551
CR Aas V, 2002, ANN NY ACAD SCI, V967, P506
   Aguey-Zinsou KF, 2003, J AM CHEM SOC, V125, P530, DOI 10.1021/ja028293e
   Arndt S, 2004, BIOSENS BIOELECTRON, V19, P583, DOI 10.1016/S0956-5663(03)00269-0
   Assis SL, 2005, J BIOMED MATER RES B, V73B, P109, DOI 10.1002/jbm.b.30205
   Atanasov V, 2006, BIOCONJUGATE CHEM, V17, P631, DOI 10.1021/bc050328n
   Bjorefors F, 2007, ANAL CHEM, V79, P8391, DOI 10.1021/ac071399d
   Bouafsoun A, 2007, MACROMOL BIOSCI, V7, P599, DOI 10.1002/mabi.200600263
   Bouafsoun A, 2007, BIOELECTROCHEMISTRY, V70, P401, DOI 10.1016/j.bioelechem.2006.05.012
   Busalmen JP, 2003, BIOTECHNOL BIOENG, V82, P619, DOI 10.1002/bit.10600
   Busalmen JP, 2001, APPL ENVIRON MICROB, V67, P3188, DOI 10.1128/AEM.67.7.3188-3194.2001
   Cabilio NR, 2000, LANGMUIR, V16, P8480, DOI 10.1021/la0003948
   Chen HJ, 2007, BIOSENS BIOELECTRON, V22, P1811, DOI 10.1016/j.bios.2006.08.013
   Cho S, 2008, SENSORS-BASEL, V8, P1198, DOI 10.3390/s8021198
   Choi H. J., 2005, NANOTECHNOLOGY, V16, P143
   Contu F, 2003, J BIOMED MATER RES A, V67A, P246, DOI 10.1002/jbm.a.10113
   Crespo GA, 2008, ANAL CHEM, V80, P1316, DOI 10.1021/ac071156l
   Ehret R, 1997, BIOSENS BIOELECTRON, V12, P29, DOI 10.1016/0956-5663(96)89087-7
   Friedrich MG, 2008, J PHYS CHEM B, V112, P3193, DOI 10.1021/jp709717k
   Garcia-Alonso MC, 2003, BIOMATERIALS, V24, P19, DOI 10.1016/S0142-9612(02)00237-5
   Gawad S, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2737751
   GIAEVER I, 1993, NATURE, V366, P591, DOI 10.1038/366591a0
   GIAEVER I, 1991, P NATL ACAD SCI USA, V88, P7896, DOI 10.1073/pnas.88.17.7896
   Gimsa J, 2005, J NEUROSCI METH, V142, P251, DOI 10.1016/j.jneumeth.2004.09.001
   Gonzalez JEG, 1999, J ELECTROANAL CHEM, V471, P109, DOI 10.1016/S0022-0728(99)00260-0
   Guan JG, 2004, J BIOSCI BIOENG, V97, P219
   Handrea M, 2003, BIOELECTROCHEMISTRY, V61, P1, DOI 10.1016/S1567-5394(03)00047-1
   Hang TC, 2004, BIOSENS BIOELECTRON, V19, P1537, DOI 10.1016/j.bios.2003.12.014
   Herzog G, 2007, ANALYST, V132, P615, DOI 10.1039/b701472d
   Hiromoto S, 2002, CORROS SCI, V44, P955, DOI 10.1016/S0010-938X(01)00110-X
   Huang HH, 2005, DENT MATER, V21, P749, DOI 10.1016/j.dental.2005.01.009
   Huang HH, 2004, BIOCHEM BIOPH RES CO, V314, P787, DOI 10.1016/j.bbrc.2003.12.173
   HUIQI H, 2008, BIOELECTROCHEMISTRY, V72, P161
   Jacquot BC, 2008, BIOSENS BIOELECTRON, V23, P1503, DOI 10.1016/j.bios.2008.01.006
   JEYKUMARI D, 2008, BIOSENS BIOELECTRON
   Ji JA, 2004, COLLOID SURFACE B, V34, P185, DOI 10.1016/j.colsurfb.2003.12.015
   Jia NQ, 2005, ELECTROCHIM ACTA, V51, P611, DOI 10.1016/j.electacta.2005.05.032
   Jie M, 1999, ELECTROCHEM COMMUN, V1, P425, DOI 10.1016/S1388-2481(99)00071-5
   K'Owino IO, 2005, ELECTROANAL, V17, P2101, DOI 10.1002/elan.200503371
   Kai M, 2008, J PEPT SCI, V14, P192, DOI 10.1002/psc.974
   Karpagavalli R, 2007, J BIOMED MATER RES A, V83A, P1087, DOI 10.1002/jbm.a.31447
   Lange R, 2002, BIOMOL ENG, V19, P255, DOI 10.1016/S1389-0344(02)00047-3
   LEWIS G, 1993, J APPL BIOMATER, V4, P47, DOI 10.1002/jab.770040106
   Lewis G, 2007, BIO-MED MATER ENG, V17, P97
   Li XM, 2003, NANOTECHNOLOGY, V14, P1064, DOI 10.1088/0957-4484/14/10/302
   Lu HY, 2006, ELECTROANAL, V18, P1511, DOI 10.1002/elan.200603557
   Luong JHT, 2001, ANAL CHEM, V73, P1844, DOI 10.1021/ac0011585
   Mantzila AG, 2008, ANAL CHEM, V80, P1169, DOI [10.1021/ac071570l, 10.1021/ac071570I]
   MITRA P, 1991, BIOTECHNIQUES, V11, P504
   Moulton SE, 2005, LANGMUIR, V21, P316, DOI 10.1021/la0487242
   Mustafa K, 2002, J BIOMED MATER RES, V59, P655, DOI 10.1002/jbm.1275
   Naumowicz M, 2003, BIOELECTROCHEMISTRY, V61, P21, DOI 10.1016/S1567-5394(03)00056-2
   Omanovic S, 1999, LANGMUIR, V15, P8315, DOI 10.1021/la990474f
   Pan J, 1998, J BIOMED MATER RES, V40, P244, DOI 10.1002/(SICI)1097-4636(199805)40:2<244::AID-JBM9>3.0.CO;2-L
   Pan J, 1996, J BIOMED MATER RES, V30, P393
   Pei RJ, 2001, BIOMACROMOLECULES, V2, P463, DOI 10.1021/bm0001289
   Pei RJ, 2001, BIOSENS BIOELECTRON, V16, P355, DOI 10.1016/S0956-5663(01)00150-6
   Phillips RKR, 2001, LANGMUIR, V17, P2471, DOI 10.1021/la0007729
   Qiu YL, 2008, ANAL CHEM, V80, P990, DOI 10.1021/ac701745c
   Rondelli G, 2006, J BIOMED MATER RES B, V79B, P320, DOI 10.1002/jbm.b.30545
   Sapper A, 2006, ANAL CHEM, V78, P5184, DOI 10.1021/ac060094g
   Scharnweber D, 2002, J MATER SCI-MATER M, V13, P1215, DOI 10.1023/A:1021118811893
   Serro AP, 1997, BIOMATERIALS, V18, P963, DOI 10.1016/S0142-9612(97)00031-8
   Shih CC, 2005, J BIOMED MATER RES A, V74A, P325, DOI 10.1002/ibm.a.30255
   SILVA MPD, 2003, J MATER SCI-MATER M, V14, P511
   Smiechowski MF, 2006, BIOSENS BIOELECTRON, V22, P670, DOI 10.1016/j.bios.2006.02.008
   Sun YY, 2006, BIOMATERIALS, V27, P4042, DOI 10.1016/j.biomaterials.2006.03.014
   Takhistov P, 2004, BIOSENS BIOELECTRON, V19, P1445, DOI 10.1016/j.bios.2003.08.015
   Tang DP, 2005, BIOSENS BIOELECTRON, V21, P539, DOI 10.1016/j.bios.2004.11.024
   TAYLOR GT, 1993, APPL SPECTROSC, V47, P1140, DOI 10.1366/0003702934068053
   TIRUPPATHI C, 1992, P NATL ACAD SCI USA, V89, P7919, DOI 10.1073/pnas.89.17.7919
   Wang CX, 2003, BIOMATERIALS, V24, P3069, DOI 10.1016/S0142-9612(03)00154-6
   Wang Y, 2008, ANAL CHEM, V80, P2255, DOI 10.1021/ac7024688
   Wegener J, 1999, PFLUG ARCH EUR J PHY, V437, P925, DOI 10.1007/s004240050864
   Wegener J, 2000, BRAIN RES, V853, P115, DOI 10.1016/S0006-8993(99)02317-3
   Weikart CM, 2001, J BIOMED MATER RES, V54, P597, DOI 10.1002/1097-4636(20010315)54:4<597::AID-JBM170>3.3.CO;2-J
   WILLIAMS R, 1988, BIOMATERIALS, V40, P181
   Xiao CD, 2002, ANAL CHEM, V74, P5748, DOI 10.1021/ac025848f
   Xie QJ, 2003, J COLLOID INTERF SCI, V262, P107, DOI 10.1016/S0021-9797(03)00196-6
   Yun YH, 2007, NANOTECHNOLOGY, V18, P1
   Zhang H, 2006, J PHYS CHEM B, V110, P2171, DOI 10.1021/jp055301f
NR 80
TC 26
Z9 26
U1 0
U2 14
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1438-1656
J9 ADV ENG MATER
JI Adv. Eng. Mater.
PD OCT
PY 2008
VL 10
IS 10
BP B33
EP B46
DI 10.1002/adem.200800184
PG 14
WC Materials Science, Multidisciplinary
SC Materials Science
GA 374GK
UT WOS:000261031600014
DA 2018-10-19
ER

PT J
AU Malasoma, A
   Fritsch, A
   Kohlhauser, C
   Brynk, T
   Vitale-Brovarone, C
   Pakiela, Z
   Eberhardsteiner, J
   Hellmich, C
AF Malasoma, A.
   Fritsch, A.
   Kohlhauser, C.
   Brynk, T.
   Vitale-Brovarone, C.
   Pakiela, Z.
   Eberhardsteiner, J.
   Hellmich, C.
TI Micromechanics of bioresorbable porous CEL2 glass ceramic scaffolds for
   bone tissue engineering
SO ADVANCES IN APPLIED CERAMICS
LA English
DT Article; Proceedings Paper
CT EUROMAT 2007 Conference
CY SEP, 2007
CL Nurnberg, GERMANY
SP Federat European Mat Soc
DE Continuum micromechanics; Bioactive glass ceramic scaffolds; Elasticity;
   Strength; Porosity
ID STRENGTH CRITERION; ELASTIC PROPERTIES; HYDROXYAPATITE; INCLUSIONS;
   HOMOGENIZATION; COMPOSITES
AB Owing to their stimulating effects on bone cells, ceramics are identified as expressly promising materials for fabrication of tissue engineering (TE) scaffolds. To ensure the mechanical competence of TE scaffolds, it is of central importance to understand the impact of pore shape and volume on the mechanical behaviour of the scaffolds, also under complex loading states. Therefore, the theory of continuum micromechanics is used as basis for a material model predicting relationships between porosity and elastic/strength properties. The model, which mathematically expresses the mechanical behaviour of a ceramic matrix (based on a glass system of the type SiO(2)-P(2)O(5)-CaO-MgO-Na(2)O-K(2)O; called CEL2) in which interconnected pores are embedded, is carefully validated through a wealth of independent experimental data. The remarkably good agreement between porosity based model predictions for the elastic and strength properties of CEL2-based porous scaffolds and corresponding experimentally determined mechanical properties underlines the great potential of micromechanical modelling for speeding up the biomaterial and tissue engineering scaffold development process-by delivering reasonable estimates for the material behaviour, also beyond experimentally observed situations.
C1 [Fritsch, A.; Kohlhauser, C.; Eberhardsteiner, J.; Hellmich, C.] Vienna Univ Technol, Inst Mech Mat & Struct, A-1040 Vienna, Austria.
   [Malasoma, A.; Vitale-Brovarone, C.] Politecn Torino, Dept Mat Sci & Chem Engn, Turin, Italy.
   [Brynk, T.; Pakiela, Z.] Warsaw Univ Technol, Fac Mat Sci & Engn, Warsaw, Poland.
RP Hellmich, C (reprint author), Vienna Univ Technol, Inst Mech Mat & Struct, A-1040 Vienna, Austria.
EM christian.hellmich@tuwien.ac.at
RI Vitale Brovarone, Chiara/G-9630-2012
OI Vitale Brovarone, Chiara/0000-0003-2413-5594; Brynk,
   Tomasz/0000-0002-5825-4789; Eberhardsteiner, Josef/0000-0001-9030-6107
CR AKAO M, 1981, J MATER SCI, V16, P809, DOI 10.1007/BF00552220
   ASHMAN RB, 1984, J BIOMECH, V17, P349, DOI 10.1016/0021-9290(84)90029-0
   Barthelemy JF, 2004, INT J NUMER ANAL MET, V28, P565, DOI 10.1002/nag.368
   Barthelemy JF, 2003, CR MECANIQUE, V331, P271, DOI 10.1016/S1631-0721(03)00063-9
   Boccaccini AR, 2005, MAT SCI ENG C-BIO S, V25, P23, DOI 10.1016/j.msec.2004.03.002
   BOUCHER S, 1976, REV M, V22, P31
   Cancedda R, 2007, BIOMATERIALS, V28, P2505, DOI 10.1016/j.biomaterials.2007.01.022
   Charriere E, 2001, BIOMATERIALS, V22, P2937, DOI 10.1016/S0142-9612(01)00041-2
   Dormieux L, 2002, J MECH PHYS SOLIDS, V50, P2203, DOI 10.1016/S0022-5096(02)00008-X
   Dormieux L, 2001, J ENG MECH-ASCE, V127, P1267, DOI 10.1061/(ASCE)0733-9399(2001)127:12(1267)
   Dormieux L, 2006, MICROPOROMECHANICS
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   ESHELBY JD, 1957, P ROY SOC LOND A MAT, V241, P396
   Fedorov F. I, 1968, THEORY ELASTIC WAVES
   Fritsch A, 2007, WOODHEAD PUBL MATER, P529, DOI 10.1533/9781845693817.2.529
   Fritsch A, 2007, J MATER SCI, V42, P8824, DOI 10.1007/s10853-007-1859-4
   Fritsch A, 2009, J BIOMED MATER RES A, V88A, P149, DOI 10.1002/jbm.a.31727
   Hashin Z, 1962, J APPL MECH, V29, P143, DOI DOI 10.1115/1.3636446
   HILL R, 1963, J MECH PHYS SOLIDS, V11, P357, DOI 10.1016/0022-5096(63)90036-X
   Jones J.R., 2005, BIOMATERIALS ARTIFIC
   KOHLHAUSER C, 2008, STRAIN
   KREHER W, 1990, J MECH PHYS SOLIDS, V38, P115, DOI 10.1016/0022-5096(90)90023-W
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   MCLAUGHLIN R, 1977, INT J ENG SCI, V15, P237, DOI 10.1016/0020-7225(77)90058-1
   Molinari A, 1996, INT J SOLIDS STRUCT, V33, P3131, DOI 10.1016/0020-7683(95)00275-8
   SUQUET P, 1997, CONTINUUM MICROMECHA
   Verma D, 2006, J BIOMED MATER RES A, V78A, P772, DOI 10.1002/jbm.a.30774
   Vitale-Brovarone C, 2007, ACTA BIOMATER, V3, P199, DOI 10.1016/j.actbio.2006.07.012
   WALSH JB, 1965, J AM CERAM SOC, V48, P605, DOI 10.1111/j.1151-2916.1965.tb14687.x
   Zaoui A, 2002, J ENG MECH-ASCE, V128, P808, DOI 10.1061/(ASCE)0733-9399(2002)128:8(808)
   ZIMMERMAN RW, 1991, MECH MATER, V12, P17, DOI 10.1016/0167-6636(91)90049-6
NR 31
TC 9
Z9 9
U1 1
U2 5
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 1743-6753
J9 ADV APPL CERAM
JI Adv. Appl. Ceram.
PD OCT
PY 2008
VL 107
IS 5
BP 277
EP 286
DI 10.1179/174367508X306488
PG 10
WC Materials Science, Ceramics
SC Materials Science
GA 370RH
UT WOS:000260779900008
DA 2018-10-19
ER

PT J
AU Rowlands, AS
   George, PA
   Cooper-White, JJ
AF Rowlands, Andrew S.
   George, Peter A.
   Cooper-White, Justin J.
TI Directing osteogenic and myogenic differentiation of MSCs: interplay of
   stiffness and adhesive ligand presentation
SO AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
LA English
DT Article
DE mesenchymal stem cells; extracellular matrix proteins; substrate
   elasticity
ID MESENCHYMAL STEM-CELLS; CYTOSKELETAL TENSION; SUBSTRATE; INTEGRINS;
   MATRIX; MECHANISMS; CROSSTALK; MOLECULES; SHAPE; RHOA
AB The mechanical properties of the extracellular matrix (ECM) can exert significant influence in determining cell fate. Human mesenchymal stem cells (MSCs) grown on substrates with varying stiffness have been shown to express various cell lineage markers, without the use of toxic DNA demethylation agents or complex cocktails of expensive growth factors. Here we investigated the myogenic and osteogenic potential of various polyacrylamide gel substrates that were coated with covalently bound tissue-specific ECM proteins (collagen I, collagen IV, laminin, or fibronectin). The gel-protein substrates were shown to support the growth and proliferation of MSCs in a stiffness-dependent manner. Higher stiffness substrates encouraged up to a 10-fold increase in cell number over lower stiffness gels. There appears to be definitive interplay between substrate stiffness and ECM protein with regard to the expression of both osteogenic and myogenic transcription factors by MSCs. Of the 16 gel-protein combinations investigated, osteogenic differentiation was found to occur significantly only on collagen I-coated gels with the highest modulus gel tested (80 kPa). Myogenic differentiation occurred on all gel-protein combinations that had stiffnesses >9 kPa but to varying extents as ascertained by MyoD1 expression. Peak MyoD1 expression was seen on gels with a modulus of 25 kPa coated in fibronectin, with similar levels of expression observed on 80-kPa collagen I-coated gels. The modulation of myogenic and osteogenic transcription factors by various ECM proteins demonstrates that substrate stiffness alone does not direct stem cell lineage specification. This has important implications in the development of tailored biomaterial systems that more closely mimic the microenvironment found in native tissues.
C1 [Rowlands, Andrew S.; George, Peter A.; Cooper-White, Justin J.] Univ Queensland, Tissue Engn & Microfluid Lab, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld 4072, Australia.
RP Cooper-White, JJ (reprint author), Univ Queensland, Tissue Engn & Microfluid Lab, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld 4072, Australia.
EM j.cooperwhite@uq.edu.au
RI Cooper-White, Justin/B-2567-2010
OI Cooper-White, Justin/0000-0002-1920-8229
FU Australian Research Council Discovery Grants Scheme; The University of
   Queensland; Australian Institute for Bioengineering and Nanotechnology
FX This study was supported by the Australian Research Council Discovery
   Grants Scheme, The University of Queensland and the Australian Institute
   for Bioengineering and Nanotechnology.
CR ARNOLD IC, 2007, J CELL PHYSL, V213, P341
   Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011
   Bhadriraju K, 2007, EXP CELL RES, V313, P3616, DOI 10.1016/j.yexcr.2007.07.002
   Brooke G, 2007, SEMIN CELL DEV BIOL, V18, P846, DOI 10.1016/j.semcdb.2007.09.012
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/01.wnr.0000048003.96487.97
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   GUMBINER BM, 1993, NEURON, V11, P551, DOI 10.1016/0896-6273(93)90068-3
   Guo WH, 2006, BIOPHYS J, V90, P2213, DOI 10.1529/biophysj.105.070144
   HANTAI D, 1983, COLLAGEN REL RES, V3, P381
   Humphries MJ, 2004, BIOCHEM SOC T, V32, P822, DOI 10.1042/BST0320822
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Jones JL, 1999, J CLIN PATHOL-MOL PA, V52, P208
   LIGHT N, 1984, BIOCHEM J, V219, P1017, DOI 10.1042/bj2191017
   Magne D, 2005, TRENDS MOL MED, V11, P519, DOI 10.1016/j.molmed.2005.09.002
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Palsson B.O., 2004, TISSUE ENG
   Peyton SR, 2005, J CELL PHYSIOL, V204, P198, DOI 10.1002/jcp.20274
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cb.11.110195.003001
   Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65
   Segers VFM, 2006, AM J PHYSIOL-HEART C, V290, pH1370, DOI 10.1152/ajpheart.00523.2005
   Semler EJ, 2005, BIOTECHNOL BIOENG, V89, P296, DOI 10.1002/bit.20328
   Tao H, 2005, DEV GROWTH DIFFER, V47, P423
   Viguet-Carrin S, 2006, OSTEOPOROSIS INT, V17, P319, DOI 10.1007/s00198-005-2035-9
   Wong JY, 2004, SURF SCI, V570, P119, DOI 10.1016/j.susc.2004.06.186
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
NR 30
TC 281
Z9 286
U1 2
U2 67
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0363-6143
J9 AM J PHYSIOL-CELL PH
JI Am. J. Physiol.-Cell Physiol.
PD OCT
PY 2008
VL 295
IS 4
BP C1037
EP C1044
DI 10.1152/ajpcell.67.2008
PG 8
WC Cell Biology; Physiology
SC Cell Biology; Physiology
GA 358NW
UT WOS:000259925800019
PM 18753317
OA Bronze
DA 2018-10-19
ER

PT J
AU Marcal, H
   Wanandy, NS
   Sanguanchaipaiwong, V
   Woolnough, CE
   Lauto, A
   Mahler, SM
   Foster, LJR
AF Marcal, Helder
   Wanandy, Nico S.
   Sanguanchaipaiwong, Vorapat
   Woolnough, Catherine E.
   Lauto, Antonio
   Mahler, Stephen M.
   Foster, L. John R.
TI BioPEGylation of Polyhydroxyalkanoates: Influence on Properties and
   Satellite-Stem Cell Cycle
SO BIOMACROMOLECULES
LA English
DT Article
ID POLYHYDROXYOCTANOATE-DIETHYLENE GLYCOL; IN-VIVO; BIOSYNTHESIS;
   BIOCOMPATIBILITY; REGENERATION; DEGRADATION; MORPHOLOGY; APOPTOSIS;
   PRODUCTS; HYBRIDS
AB The addition of poly(ethylene glycol), PEG, to bioprocessing systems producing polyhydroxyalkanoates (PHAs), has been reported as a means of their molecular weight control and can also support bioPEGylation, resulting in hybrids with amphiphillic properties. However, the study of such natural-synthetic hybrids of PHA-b-PEG is still in its infancy. In this study, we report the influence of bioPEGylation of polyhydroxyoctanoate (PHO) on its physiochemical, material, and biological properties. Consistent with previous studies, bioPEGylation with diethylene glycol (DEG) showed a significant reduction in PHA molecular weight (57%). In comparison to solvent cast films of PHO, PHO-b-DEG films possessed a noticeable X-ray diffraction peak at 9.82 degrees and increased Young's modulus of 11 Gpa (83%). Potential biocompatibility was investigated by measuring the early phase of apoptosis in myoblastic satellite-stem cells (C2C12). Comparative analysis of cell proliferation and progression in the presence of the mcl-PHA and its hybrid showed that the latter induced significant cell cycle progression: the first time a biomaterial has been shown to do so. Microtopographies of the film surfaces demonstrated that these differences were not due to changes in surface morphology; both polymers possessed average surface rugosities of 1.4 +/- 0.2 mu m. However, a slight decrease in surface hydrophobicity (3.5 +/- 0.9 degrees) due to the hydrophilic DEG may have exerted an influence. The results support the further study of bioPEGylated PHAs as potential biomaterials in the field of tissue engineering.
C1 [Marcal, Helder; Wanandy, Nico S.; Sanguanchaipaiwong, Vorapat; Woolnough, Catherine E.; Lauto, Antonio; Foster, L. John R.] Univ New S Wales, BioPolymer Res Grp, Sydney, NSW 2052, Australia.
   [Marcal, Helder; Wanandy, Nico S.; Sanguanchaipaiwong, Vorapat; Woolnough, Catherine E.; Lauto, Antonio; Foster, L. John R.] Univ New S Wales, Ctr Adv Macromol Design, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.
   [Mahler, Stephen M.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld 4072, Australia.
RP Foster, LJR (reprint author), Univ New S Wales, BioPolymer Res Grp, Sydney, NSW 2052, Australia.
EM J.Foster@unsw.edu.au
RI Mahler, Stephen/B-4824-2009; Marcal, Helder/A-7690-2008
CR Ausubel R. M., 1995, CURRENT PROTOCOLS MO
   BENNET AM, 1999, SCIENCE, V278, P1288
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Bucci DZ, 2005, POLYM TEST, V24, P564, DOI 10.1016/j.polymertesting.2005.02.008
   Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   Cheng S, 2006, BIOMATERIALS, V27, P3758, DOI 10.1016/j.biomaterials.2006.02.046
   Chinga G, 2004, J PULP PAP SCI, V30, P222
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Foster LJR, 2008, BIOMACROMOLECULES, V9, P314, DOI 10.1021/bm7006289
   Foster LJR, 2007, APPL MICROBIOL BIOT, V75, P1241, DOI 10.1007/s00253-007-0976-y
   Foster LJR, 2005, POLYMER, V46, P6587, DOI 10.1016/j.polymer.2005.05.012
   Foster LJR, 2001, J BIOMAT SCI-POLYM E, V12, P317, DOI 10.1163/156856201750180843
   Foster LJR, 1995, BIOMATERIALS, V16, P314
   GROSS RA, 1989, MACROMOLECULES, V22, P1106, DOI 10.1021/ma00193a018
   Grounds MD, 1998, ANN NY ACAD SCI, V854, P78, DOI 10.1111/j.1749-6632.1998.tb09894.x
   Kim S S, 1999, Semin Pediatr Surg, V8, P119
   Lee SY, 1999, APPL ENVIRON MICROB, V65, P2762
   Marois Y, 1999, TISSUE ENG, V5, P369, DOI 10.1089/ten.1999.5.369
   MARTIN SJ, 1996, ANNEXIN, V5
   Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150
   Saad B, 1996, J BIOMED MATER RES, V32, P355
   Saad B, 1999, INT J BIOL MACROMOL, V25, P293, DOI 10.1016/S0141-8130(99)00044-6
   Sanguanchaipaiwong V, 2004, BIOMACROMOLECULES, V5, P643, DOI 10.1021/bm0344708
   SCHLEGEL HG, 1961, NATURE, V19, P15
   STEINBUCHEL A, 1996, BIOTECHNOLOGY
   VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I
   Wang YW, 2003, BIOMATERIALS, V24, P4621, DOI 10.1016/S0142-9612(03)00356-9
   WILLIAMS SF, 2001, Patent No. 819447
   Xiao XQ, 2007, BIOMATERIALS, V28, P3608, DOI 10.1016/j.biomaterials.2007.04.046
   Young RC, 2002, BRIT J PLAST SURG, V55, P235, DOI 10.1054/bjps.2002.3798
   Zanzig J, 2003, J BIOACT COMPAT POL, V18, P339, DOI 10.1177/088391103038229
   Zhao K, 2003, BIOCHEM ENG J, V16, P115, DOI 10.1016/S1369-703X(03)00029-9
   Zhao K, 2003, BIOMATERIALS, V24, P1041, DOI 10.1016/S0142-9612(02)00426-X
NR 33
TC 13
Z9 13
U1 0
U2 3
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD OCT
PY 2008
VL 9
IS 10
BP 2719
EP 2726
DI 10.1021/bm800418e
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 360HV
UT WOS:000260049500023
PM 18754686
DA 2018-10-19
ER

PT J
AU Lipski, AM
   Pino, CJ
   Haselton, FR
   Chen, IW
   Shastri, VP
AF Lipski, Anna M.
   Pino, Christopher J.
   Haselton, Frederick R.
   Chen, I-Wei
   Shastri, V. Prasad
TI The effect of silica nanoparticle-modified surfaces on cell morphology,
   cytoskeletal organization and function
SO BIOMATERIALS
LA English
DT Article
DE focal adhesions; F-actin fibers; nanoroughness; endothelial cells;
   preosteoblasts; nano-mechanotransduction
ID ENHANCED OSTEOBLAST ADHESION; SERUM VITRONECTIN; ENDOTHELIAL-CELLS;
   FIBRONECTIN; TISSUE; DIFFERENTIATION; PROLIFERATION; FIBROBLASTS;
   ATTACHMENT; ELASTICITY
AB Chemical and morphological characteristics of a biomaterial surface are thought to play an important role in determining cellular differentiation and apoptosis. In this report, we investigate the effect of nanoparticle (NP) assemblies arranged on a flat substrate on cytoskeletal organization, proliferation and metabolic activity on two cell types, Bovine aortic endothelial cells (BAECs) and mouse calvarial pre-osteoblasts (MC3T3-E1). To vary roughness without altering chemistry, glass substrates were coated with monodispersed silica nanoparticles of 50, 100 and 300 nm in diameter. The impact of surface roughness at the nanoscale on cell morphology was studied by quantifying cell spreading, shape, cytoskeletal F-actin alignment, and recruitment of focal adhesion complexes (FAC) using image analysis. Metabolic activity was followed using a thiazolyl blue tetrazolium bromide assay. In the two cell types tested, surface roughness introduced by nanoparticles had cell type specific effects on cell morphology and metabolism. While BAEC on NP-modified substrates exhibited smaller cell areas and fewer focal adhesion complexes compared to BAEC grown on glass, MC3T3-E1 cells in contrast exhibited larger cell areas on NP-modified surfaces and an increased number of FACs, in comparison to unmodified glass. However, both cell types on 50 nm NP had the highest proliferation rates (comparable to glass control) whereas cells grown on 300 nm NP exhibited inhibited proliferation. Interestingly, for both cell types surface roughness promoted the formation of long, thick F-actin fibers, which aligned with the long axis of each cell. These findings are consistent with our earlier result that osteogenic differentiation of human mesenchymal progenitor cells is enhanced on NP-modified surfaces. Our finding that nanoroughness, as imparted by nanoparticle assemblies, effects cellular processes in a cell specific manner, can have far reaching consequences on the development of "smart" biomaterials especially for directing stem cell differentiation. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Shastri, V. Prasad] Vanderbilt Univ, Dept Biomed Engn, Stevenson Ctr 5824, Nashville, TN 37235 USA.
   [Lipski, Anna M.; Chen, I-Wei; Shastri, V. Prasad] Univ Penn, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA.
RP Shastri, VP (reprint author), Vanderbilt Univ, Dept Biomed Engn, Stevenson Ctr 5824, Stn B 351631, Nashville, TN 37235 USA.
EM prasad.shastri@vanderbilt.edu
RI Zhou, Feng/E-9510-2011
OI Chen, I-Wei/0000-0002-4045-4467; Pino, Christopher/0000-0003-4063-9215
FU National Institutes of Health [R24 AI-47739-03]; NSF IGERT Fellowship;
   Ada I. Pressman Memorial Scholarship; Society of Women Engineers; The
   Nanotechnology Institute; Ben-Franklin Technology Partners of
   Northeastern Pennsylvania; National Institute of Health Vascular
   Training Grant [NIH HL 0775]
FX This work was supported in part by National Institutes of Health (R24
   AI-47739-03) sub-award to VPS, an NSF IGERT Fellowship and an Ada I.
   Pressman Memorial Scholarship given by the Society of Women Engineers to
   AML, The Nanotechnology Institute, through the Ben-Franklin Technology
   Partners of Northeastern Pennsylvania, and graduate fellowship to CJP
   through National Institute of Health Vascular Training Grant (NIH HL
   0775).
CR Anselme K, 2000, BIOMATERIALS, V21, P1567, DOI 10.1016/S0142-9612(00)00042-9
   AUGUSTINVOSS HG, 1993, J CELL PHYSIOL, V157, P279, DOI 10.1002/jcp.1041570210
   BASSELL GJ, 1994, J CELL BIOL, V126, P863, DOI 10.1083/jcb.126.4.863
   Boudreau N, 1998, CURR OPIN CELL BIOL, V10, P640, DOI 10.1016/S0955-0674(98)80040-9
   BOURKE BM, 1986, J VASC SURG, V4, P257, DOI 10.1067/mva.1986.avs0040257
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463
   Curtis ASG, 2004, IEEE T NANOBIOSCI, V3, P61, DOI 10.1109/TNB.2004.824276
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Eisenbarth E, 2002, BIOMOL ENG, V19, P233, DOI 10.1016/S1389-0344(02)00028-X
   Engler A. J., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P335
   Engler AJ, 2007, METHOD CELL BIOL, V83, P521, DOI 10.1016/S0091-679X(07)83022-6
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0
   Ingber DE, 2003, J CELL SCI, V116, P1397, DOI 10.1242/jcs.00360
   Itala A, 2002, J BIOMED MATER RES, V62, P404, DOI 10.1002/jbm.10273
   JAYAGOPAL A, 2008, NANOTECHNOLOGIES LIF, P461
   Kennedy SB, 2006, BIOMATERIALS, V27, P3817, DOI 10.1016/j.biomaterials.2006.02.044
   Kieswetter K, 1996, J BIOMED MATER RES, V32, P55, DOI 10.1002/(SICI)1097-4636(199609)32:1<55::AID-JBM7>3.0.CO;2-O
   Kurpinski K, 2006, P NATL ACAD SCI USA, V103, P16095, DOI 10.1073/pnas.0604182103
   Lincks J, 1998, BIOMATERIALS, V19, P2219, DOI 10.1016/S0142-9612(98)00144-6
   Lipski AM, 2007, ADV MATER, V19, P553, DOI 10.1002/adma.200502617
   Ludbrook J, 1998, CLIN EXP PHARMACOL P, V25, P1032, DOI 10.1111/j.1440-1681.1998.tb02179.x
   Mandrekar SJ, 2003, STAT METHODS MED RES, V12, P505, DOI 10.1191/0962280203sm346oa
   Maniotis AJ, 1997, J CELL BIOCHEM, V65, P114
   Martin I, 1999, EXP CELL RES, V253, P681, DOI 10.1006/excr.1999.4708
   Martin I, 2001, J CELL BIOCHEM, V83, P121, DOI 10.1002/jcb.1203
   MARTIN JY, 1995, J BIOMED MAT RES MAR, P29
   MOSSMANN T, 1983, J IMMUNOL METHODS, V65, P55
   Nitschke M, 2002, J BIOMED MATER RES, V59, P632, DOI 10.1002/jbm.1274.abs
   NORRIS WD, 1990, J CELL SCI, V95, P255
   OHARA PT, 1979, EXP CELL RES, V121, P235, DOI 10.1016/0014-4827(79)90002-8
   SCHWING C, 2002, KLINIKMANAG AKTUELL, V4, P8
   Small JV, 1998, BBA-MOL CELL RES, V1404, P271, DOI 10.1016/S0167-4889(98)00080-9
   STEELE JG, 1992, J BIOMED MATER RES, V26, P861, DOI 10.1002/jbm.820260704
   STEELE JG, 1994, J BIOMAT SCI-POLYM E, V6, P511, DOI 10.1163/156856294X00473
   van Kooten TG, 1998, J BIOMED MATER RES, V43, P1
   Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0
   Webster TJ, 2001, TISSUE ENG, V7, P291, DOI 10.1089/10763270152044152
   Wu MH, 2003, J COLLOID INTERF SCI, V265, P304, DOI 10.1016/S0021-9797(03)00311-4
NR 40
TC 120
Z9 121
U1 2
U2 63
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2008
VL 29
IS 28
BP 3836
EP 3846
DI 10.1016/j.biomaterials.2008.06.002
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 345SN
UT WOS:000259017000010
PM 18606447
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Paula, NE
   Skazik, C
   Harwardt, M
   Bartneck, M
   Denecke, B
   Klee, D
   Salber, J
   Zwadlo-Klarwasser, G
AF Paula, Nora E.
   Skazik, Claudia
   Harwardt, Marc
   Bartneck, Matthias
   Denecke, Bernd
   Klee, Doris
   Salber, Jochen
   Zwadlo-Klarwasser, Gabriele
TI Topographical control of human macrophages by a regularly micro
   structured polyvinylidene fluoride surface
SO BIOMATERIALS
LA English
DT Article
DE Microstructure; Nanotopography; Macrophage; Inflammation; Cytokine; Gene
   expression
ID FOREIGN-BODY REACTION; HUMAN-MONOCYTES; MONOCLONAL-ANTIBODY; EXPRESSION;
   CYTOKINES; CELLS; DIFFERENTIATION; ACTIVATION; POLARIZATION; CHEMOKINES
AB In this study we investigated the influence of surface topography on the inflammatory response of human macrophages. We generated different polyvinylidene fluoride (PVDF) surfaces including (i) a smooth surface of PVDF spherulites as a control, (ii) a randomly nanotextured surface with alumina particles, and (iii) a microstructure using laser ablation. The identical chemistry of all PVDF surfaces was demonstrated by X-ray photoelectron spectroscopy. The topography was evaluated by white light interferometry and X-profile analysis. Macrophages were cultured on the different surfaces including lipopolysaccharide (LPS) treatment as an inflammatory activator. Our results demonstrate that the microstructured surface but not the nanotexured significantly affects the activation of primary human macrophages by inducing a specific cytokine and gene expression pattern. This activation resulted in a subtype of macrophages with pro- but also anti-inflammatory properties. Interestingly, the response on the topography differed from that triggered by LPS, pointing to a different activation state of the cells. Our data clearly show that a particular topography induces an inflammatory response. This suggests that the modification of topography could influence the inflammatory potency of a biomaterial and hence could affect the biocompatibility of implants. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Paula, Nora E.; Bartneck, Matthias; Denecke, Bernd; Zwadlo-Klarwasser, Gabriele] Rhein Westfal TH Aachen, Univ Hosp, IZKF Biomat, D-52074 Aachen, Germany.
   [Skazik, Claudia] Rhein Westfal TH Aachen, Univ Hosp, Dept Dermatol, D-52074 Aachen, Germany.
   [Harwardt, Marc; Klee, Doris; Salber, Jochen] Rhein Westfal TH Aachen, Inst Tech & Macromol Chem, D-52074 Aachen, Germany.
   [Harwardt, Marc; Klee, Doris; Salber, Jochen] Rhein Westfal TH Aachen, DWI, D-52074 Aachen, Germany.
RP Paula, NE (reprint author), Rhein Westfal TH Aachen, Univ Hosp, IZKF Biomat, Pauwelsstr 30, D-52074 Aachen, Germany.
EM npaul@ukaachen.de
FU Interdisciplinary Centre for Clinical Research (IZKF-BIOMAT) [TVB105];
   "Biointerface" [GRK1035]
FX Supported by a grant from the Interdisciplinary Centre for Clinical
   Research (IZKF-BIOMAT) within the faculty of Medicine at the RWTH Aachen
   (TVB105) and a grant from the DFG research training group "Biointerface"
   (GRK1035).
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2007, BIOMATERIALS, V28, P5114, DOI [10.1016/j.biomaterials.2007.07.010, 10.1016/j.biornaterials.2007.07.010]
   Andrew DP, 1998, J IMMUNOL, V161, P5027
   BHARDWAJ RS, 1992, EUR J IMMUNOL, V22, P1891, DOI 10.1002/eji.1830220732
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Curtis ASG, 1998, J BIOMAT SCI-POLYM E, V9, P1313, DOI 10.1163/156856298X00415
   DIEGELMANN RF, 1981, PLAST RECONSTR SURG, V68, P107, DOI 10.1097/00006534-198107000-00025
   Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80
   Graziano A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000496
   Hogger P, 1998, J IMMUNOL, V161, P1883
   HUANG R, 1993, SCAND J IMMUNOL, V38, P359, DOI 10.1111/j.1365-3083.1993.tb01738.x
   Jones JA, 2007, J BIOMED MATER RES A, V83A, P585, DOI 10.1002/jbm.a.31221
   JUNGNICKEL BJ, 1996, POLY VINYLIDENE FLUO
   Kenis G, 2002, CYTOKINE, V19, P228, DOI 10.1016/S1043-4666(02)91961-7
   Klee D, 2003, BIOMATERIALS, V24, P3663, DOI 10.1016/S0142-9612(03)00235-7
   Klinge U, 2002, BIOMATERIALS, V23, P3487, DOI 10.1016/S0142-9612(02)00070-4
   Malle E, 2007, BRIT J PHARMACOL, V152, P838, DOI 10.1038/sj.bjp.0707358
   Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015
   Mantovani A, 2007, EUR J IMMUNOL, V37, P14, DOI 10.1002/eji.200636910
   Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303
   MEYLE J, 1995, J BIOMED MATER RES, V29, P81, DOI 10.1002/jbm.820290112
   Neuss S, 2008, BIOMATERIALS, V29, P302, DOI 10.1016/j.biomaterials.2007.09.022
   Polentarutti N, 1997, EUR CYTOKINE NETW, V8, P271
   Refai AK, 2004, J BIOMED MATER RES A, V70A, P194, DOI 10.1002/jbm.a.30075
   Rinaldo Jr G., 1994, J POLYM SCI B, V32, P859
   SALTHOUSE TN, 1984, J BIOMED MATER RES, V18, P395, DOI 10.1002/jbm.820180407
   SKAZIK C, EXP DERMATO IN PRESS
   SRIKANTH S, 1994, J BIOL CHEM, V269, P32626
   Stout RD, 2004, J LEUKOCYTE BIOL, V76, P509, DOI 10.1189/jlb.0504272
   Tan KS, 2006, BIOMATERIALS, V27, P5170, DOI 10.1016/j.biomaterials.2006.05.002
   ZWADLO G, 1987, EXP CELL BIOL, V55, P295
   ZWADLO G, 1986, J IMMUNOL, V137, P512
NR 32
TC 62
Z9 62
U1 3
U2 27
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2008
VL 29
IS 30
BP 4056
EP 4064
DI 10.1016/j.biomaterials.2008.07.010
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 359YV
UT WOS:000260025100004
PM 18667233
DA 2018-10-19
ER

PT J
AU Wittmer, CR
   Phelps, JA
   Lepus, CM
   Saltzman, WM
   Harding, MJ
   Van Tassel, PR
AF Wittmer, Corinne R.
   Phelps, Jennifer A.
   Lepus, Christin M.
   Saltzman, William M.
   Harding, Martha J.
   Van Tassel, Paul R.
TI Multilayer nanofilms as substrates for hepatocellular applications
SO BIOMATERIALS
LA English
DT Article
DE Layer-by-layer; Multilayer film; Nanofilm biomaterial; Hepatocyte; Liver
ID POLYELECTROLYTE MULTILAYER; CELL-ADHESION; ONCOSTATIN-M;
   EXTRACELLULAR-MATRIX; SURFACE-MODIFICATION; GRATING COUPLERS; PROTEIN
   ADSORPTION; FETAL HEPATOCYTES; IN-VITRO; FILMS
AB Multilayer nanofilms, formed by the layer-by-layer (LbL) adsorption of positively and negatively charged polyelectrolytes, are promising substrates for tissue engineering. We investigate here the attachment and function of hepatic cells on multilayer films in terms of film composition, terminal layer, rigidity, charge, and presence of biofunctional species. Human hepatocellular carcinoma (HepG2) cells, adult rat hepatocytes (ARH), and human fetal hepatoblasts (HFHb) are studied on films composed of the polysaccharides chitosan (CHI) and alginate (ALG), the polypeptides poly(L-lySine) (PLL) and poly(L-glutamic acid) (PGA), and the synthetic polymers poly(allylamine hydrochloride) (PAH) and poly(styrene sulfonate) (PSS). The influence of chemical cross-linking following LbL assembly is also investigated. We find HepG2 to reach confluence after 7 days of culture on only 2 of 18 candidate multilayer systems: (PAH-PSS)(n) (i.e. nPAH-PSS bilayers) and cross-linked (PLL-ALG)(n)-PLL. Cross-linked PLL-ALG and PLL-PGA films support attachment and function of ARH, independently of the terminal layer, Provided collagen is adsorbed to the top of the film. (PAH-PSS),, cross-linked (PLL-ALG),, and cross-linked (PLL-PCA)(n)-PLL films all support attachment, layer confluence, and function of HFHb, with the latter film promoting the greatest level of function at 8 days. Overall, film composition, terminal layer, and rigidity are key variables in promoting attachment and function of hepatic cells, while film charge and biofunctionality are somewhat less important. These studies reveal optimal candidate multilayer biomaterials for human liver tissue engineering applications. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Wittmer, Corinne R.; Phelps, Jennifer A.; Van Tassel, Paul R.] Yale Univ, Dept Chem Engn, New Haven, CT 06520 USA.
   [Lepus, Christin M.; Harding, Martha J.] Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06520 USA.
   [Saltzman, William M.] Yale Univ, Dept Biomed Engn, New Haven, CT 06520 USA.
RP Van Tassel, PR (reprint author), Yale Univ, Dept Chem Engn, 9 Hillhouse Ave, New Haven, CT 06520 USA.
EM paul.vantassel@yale.edu
RI Van Tassel, Paul/D-1087-2017
FU National Institutes of Health [R01-EB00258]
FX We are grateful to jean Wilson for assistance with the albumin ELISA
   analysis, Kathy Harry and the Yale Liver Center (#DK-P30-34989) for
   providing adult rat hepatocytes, and the National Institutes of Health
   for financial support (through grant R01-EB00258).
CR Allen JW, 2002, TISSUE ENG, V8, P725, DOI 10.1089/10763270260424097
   Benkirane-Jessel N, 2005, ADV FUNCT MATER, V15, P648, DOI 10.1002/adfm.200400129
   Berg MC, 2004, LANGMUIR, V20, P1362, DOI 10.1021/la0355489
   Berthiaume F, 1996, FASEB J, V10, P1471
   Boura C, 2003, BIOMATERIALS, V24, P3521, DOI 10.1016/S0142-9612(03)00214-X
   BOYER JL, 1990, METHOD ENZYMOL, V192, P501
   Chan C, 2004, LIVER TRANSPLANT, V10, P1331, DOI 10.1002/lt.20229
   Chung TW, 2002, BIOMATERIALS, V23, P2827, DOI 10.1016/S0142-9612(01)00399-4
   CIMA LG, 1991, BIOTECHNOL BIOENG, V38, P145, DOI 10.1002/bit.260380207
   CIMA LG, 1991, T ASME, V113, P143
   Dan YY, 2006, P NATL ACAD SCI USA, V103, P9912, DOI 10.1073/pnas.0603824103
   Davis MW, 1996, BIOMATERIALS, V17, P365, DOI 10.1016/0142-9612(96)85575-X
   Deurholt T, 2006, CELL TRANSPLANT, V15, P811, DOI 10.3727/000000006783464417
   Hammond JS, 2006, EXPERT REV MED DEVIC, V3, P21, DOI 10.1586/17434440.3.1.21
   HORBETT TA, 1993, CARDIOVASC PATHOL, V2, pS137
   Jessel N, 2006, P NATL ACAD SCI USA, V103, P8618, DOI 10.1073/pnas.0508246103
   Jessel N, 2003, ADV MATER, V15, P692, DOI 10.1002/adma.200304634
   Kamiya A, 2002, HEPATOLOGY, V35, P1351, DOI 10.1053/jhep.2002.33331
   Kamiya A, 2001, FEBS LETT, V492, P90, DOI 10.1016/S0014-5793(01)02140-8
   Kamiya A, 1999, EMBO J, V18, P2127, DOI 10.1093/emboj/18.8.2127
   Khopade AJ, 2003, LANGMUIR, V19, P6219, DOI 10.1021/la030016d
   Kidambi S, 2004, J AM CHEM SOC, V126, P16286, DOI 10.1021/ja046188u
   Kidambi S, 2007, MACROMOL BIOSCI, V7, P344, DOI 10.1002/mabi.200600205
   Kinoshita T, 1999, P NATL ACAD SCI USA, V96, P7265, DOI 10.1073/pnas.96.13.7265
   Kreke MR, 2005, BIOMATERIALS, V26, P2975, DOI 10.1016/j.biomaterials.2004.08.013
   Kulig KM, 2004, TRANSPL IMMUNOL, V12, P303, DOI 10.1016/j.trim.2003.12.005
   Lazaro CA, 2003, HEPATOLOGY, V38, P1095, DOI 10.1053/jhep.2003.50448
   LUKOSZ W, 1991, BIOSENS BIOELECTRON, V6, P227, DOI 10.1016/0956-5663(91)80007-K
   Ma ZW, 2007, COLLOID SURFACE B, V60, P137, DOI 10.1016/j.colsurfb.2007.06.019
   Mendelsohn JD, 2003, BIOMACROMOLECULES, V4, P96, DOI 10.1021/bm0256101
   MOONEY D, 1992, J CELL PHYSIOL, V151, P497, DOI 10.1002/jcp.1041510308
   NELLEN PM, 1988, SENSOR ACTUATOR, V15, P285, DOI 10.1016/0250-6874(88)87017-3
   Park IK, 2003, BIOMATERIALS, V24, P2331, DOI 10.1016/S0142-9612(03)00108-X
   Picart C, 2005, ADV FUNCT MATER, V15, P83, DOI 10.1002/adfm.200400106
   RAMSDEN JJ, 1993, J STAT PHYS, V73, P853, DOI 10.1007/BF01052813
   Richert L, 2004, BIOMACROMOLECULES, V5, P284, DOI 10.1021/bm0342281
   Richert L, 2002, BIOMACROMOLECULES, V3, P1170, DOI 10.1021/bm.0255490
   Richert L, 2004, BIOMACROMOLECULES, V5, P1908, DOI 10.1021/bm0498023
   Rodahl M, 1996, SENSOR ACTUAT B-CHEM, V37, P111, DOI 10.1016/S0925-4005(97)80077-9
   Rodahl M, 1996, ANAL CHEM, V68, P2219, DOI 10.1021/ac951203m
   RODAHL M, 1995, REV SCI INSTRUM, V66, P3924, DOI 10.1063/1.1145396
   Rodahl M, 1997, FARADAY DISCUSS, V107, P229, DOI 10.1039/a703137h
   Salloum DS, 2005, BIOMACROMOLECULES, V6, P161, DOI 10.1021/bm0497015
   Semler EJ, 2000, BIOTECHNOL BIOENG, V69, P359, DOI 10.1002/1097-0290(20000820)69:4<359::AID-BIT2>3.0.CO;2-Q
   Semler EJ, 2005, BIOTECHNOL BIOENG, V89, P296, DOI 10.1002/bit.20328
   Semler EJ, 2001, BIOTECHNOL BIOENG, V75, P510, DOI 10.1002/bit.10113
   Tan W, 2005, J BIOMED MATER RES A, V72A, P146, DOI 10.1002/jbm.a.30182
   TIEFENTHALER K, 1989, J OPT SOC AM B, V6, P209, DOI 10.1364/JOSAB.6.000209
   Tryoen-Toth P, 2002, J BIOMED MATER RES, V60, P657, DOI 10.1002/jbm.10110
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Voros J, 2002, BIOMATERIALS, V23, P3699, DOI 10.1016/S0142-9612(02)00103-5
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Wittmer CR, 2007, BIOMATERIALS, V28, P851, DOI 10.1016/j.biomaterials.2006.09.037
NR 53
TC 76
Z9 76
U1 2
U2 52
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2008
VL 29
IS 30
BP 4082
EP 4090
DI 10.1016/j.biomaterials.2008.06.027
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 359YV
UT WOS:000260025100007
PM 18653230
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Osathanon, T
   Linnes, ML
   Rajachar, RM
   Ratner, BD
   Somerman, MJ
   Giachelli, CM
AF Osathanon, Thanaphum
   Linnes, Michael L.
   Rajachar, Rupak M.
   Ratner, Buddy D.
   Somerman, Martha J.
   Giachelli, Cecilia M.
TI Microporous nanofibrous fibrin-based scaffolds for bone tissue
   engineering
SO BIOMATERIALS
LA English
DT Article
DE Fibrin; Calcium phosphate; Hydroxyapatite; Bone tissue engineering
ID CALCIUM-PHOSPHATE GRANULES; MESENCHYMAL STEM-CELLS; OF-THE-ART;
   IN-VITRO; OCTACALCIUM PHOSPHATE; INORGANIC-PHOSPHATE; MINERALIZED
   COLLAGEN; TRICALCIUM PHOSPHATE; CALVARIAL DEFECTS; GENE-EXPRESSION
AB The fibrotic response of the body to synthetic polymers limits their success in tissue engineering and other applications. Though porous polymers have demonstrated improved healing, difficulty in controlling their pore sizes and pore interconnections has clouded the understanding of this phenomenon. In this study, a novel method to fabricate natural polymer/calcium phosphate composite scaffolds with tightly controllable pore size, Pore interconnection, and calcium phosphate deposition was developed. Microporous, nanofibrous fibrin scaffolds were fabricated using sphere-templating methods. Composite scaffolds were created by solution deposition of calcium phosphate on fibrin Surfaces OF by direct incorporation of nanocrystalline hydroxyapatite (nHA). The SEM results showed that fibrin scaffolds exhibited a highly porous and interconnected structure. Osteoblast-like cells, obtained from murine calvaria, attached, Spread and showed a polygonal morphology on the Surface of the biomaterial. Multiple cell layers and fibrillar Matrix deposition were observed. Moreover, cells seeded on mineralized fibrin scaffolds exhibited significantly higher alkaline phosphatase activity as well as osteoblast marker gene expression compared to fibrin scaffolds and nHA incorporated fibrin scaffolds (0.25 and 0.5 g). All types of scaffolds were degraded both in vitro and in vivo. Furthermore, these scaffolds promoted bone formation in a mouse calvarial defect model and the bone formation was enhanced by addition of FhBMP-2. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Osathanon, Thanaphum; Somerman, Martha J.; Giachelli, Cecilia M.] Univ Washington, Sch Dent, Dept Oral Biol, Seattle, WA 98195 USA.
   [Osathanon, Thanaphum; Linnes, Michael L.; Rajachar, Rupak M.; Ratner, Buddy D.; Giachelli, Cecilia M.] Univ Washington, Coll Engn, Dept Bioengn, Seattle, WA 98195 USA.
   [Somerman, Martha J.] Univ Washington, Sch Dent, Dept Periodont, Seattle, WA 98195 USA.
RP Giachelli, CM (reprint author), Univ Washington, Dept Bioengn, POB 355061,Foege Hall,Room N330L, Seattle, WA 98192 USA.
EM ceci@u.washington.edu
OI Linnes, Michael/0000-0003-0504-7177
FU NSF [EEC-9872882, EEC-9529161]; School of Dentistry Research Funding;
   University of Washington [NIH/NIDCR DE15109]; Anandamahidol Foundation
FX The authors gratefully acknowledge the UWEB Optical Microscopy and Image
   Analysis Shared Resource (NSF Grants EEC-9872882 and EEC-9529161), the
   UW center of Nanotechnology. This study was funded in part by the School
   of Dentistry Research Funding, University of Washington, NIH/NIDCR
   DE15109 (MS), and unrestricted funds to CG. TO is supported by a
   scholarship from the Anandamahidol Foundation, under the Royal Patronage
   of His Majesty the King of Thailand.
CR Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   Beck GR, 2003, J CELL BIOCHEM, V90, P234, DOI 10.1002/jcb.10266
   Beck GR, 2003, J BIOL CHEM, V278, P41921, DOI 10.1074/jbc.M304470200
   Bootle-Wilbraham C. A., 2001, Angiogenesis, V4, P269
   CHENG PT, 1987, CALCIFIED TISSUE INT, V40, P339, DOI 10.1007/BF02556696
   Cowan CM, 2004, NAT BIOTECHNOL, V22, P560, DOI 10.1038/nbt958
   Crane NJ, 2006, BONE, V39, P434, DOI 10.1016/j.bone.2006.02.059
   Cronin KJ, 2007, J BIOMED MATER RES B, V82B, P122, DOI 10.1002/jbm.b.30713
   Datta NS, 2005, J BONE MINER RES, V20, P1051, DOI 10.1359/JBMR.050106
   Foster BL, 2006, CALCIFIED TISSUE INT, V78, P103, DOI 10.1007/s00223-005-0184-7
   FOWLER BO, 1993, CHEM MATER, V5, P1417, DOI 10.1021/cm00034a009
   Herrick S, 1999, INT J BIOCHEM CELL B, V31, P741, DOI 10.1016/S1357-2725(99)00032-1
   Hirata K, 2003, BONE, V32, P502, DOI 10.1016/S8756-3282(03)00054-1
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   Itaka K, 2007, MOL THER, V15, P1655, DOI 10.1038/sj.mt.6300218
   Jegoux F, 2005, ARCH ORTHOP TRAUM SU, V125, P153, DOI 10.1007/s00402-004-0748-4
   Jono S, 2000, CIRC RES, V87, pE10, DOI 10.1161/01.RES.87.7.e10
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Karp JM, 2004, J BIOMED MATER RES A, V71A, P162, DOI 10.1002/jbm.a.30147
   Kim SS, 2006, BIOMATERIALS, V27, P1399, DOI 10.1016/j.biomaterials.2005.08.016
   KIM SS, 2008, J BIOMED MAT RES A
   Le Guehennec L, 2005, J MATER SCI-MATER M, V16, P29, DOI 10.1007/s10856-005-6443-3
   Lee YJ, 2006, BIOMATERIALS, V27, P3738, DOI 10.1016/j.biomaterials.2006.02.032
   Lincks J, 1998, BIOMATERIALS, V19, P2219, DOI 10.1016/S0142-9612(98)00144-6
   Linnes MP, 2007, BIOMATERIALS, V28, P5298, DOI 10.1016/j.biomaterials.2007.08.020
   Liu XH, 2004, ANN BIOMED ENG, V32, P477, DOI 10.1023/B:ABME.0000017544.36001.8e
   Lynch MP, 1998, J CELL BIOCHEM, V68, P31
   Mankani MH, 2004, RADIOLOGY, V230, P369, DOI 10.1148/radiol.2302011529
   Nakade O, 2001, J BONE MINER METAB, V19, P13, DOI 10.1007/s007740170055
   NANCOLLAS GH, 1992, PURE APPL CHEM, V64, P1673, DOI 10.1351/pac199264111673
   Niemeyer P, 2004, CELLS TISSUES ORGANS, V177, P68, DOI 10.1159/000079182
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Schliephake H, 2004, CLIN ORAL IMPLAN RES, V15, P112, DOI 10.1111/j.1600-0501.2004.00992.x
   Schmoekel HG, 2005, BIOTECHNOL BIOENG, V89, P253, DOI 10.1002/bit.20168
   Siebers MC, 2006, J BIOMED MATER RES A, V78A, P258, DOI 10.1002/jbm.a.30700
   TADDEI P, 2000, BIOPOLYMERS, P57
   TAKEI A, 1995, IN VITRO CELL DEV-AN, V31, P467
   Tarasevich BJ, 2003, J PHYS CHEM B, V107, P10367, DOI 10.1021/jp027445p
   Uebersax L, 2006, TISSUE ENG, V12, P3417, DOI 10.1089/ten.2006.12.3417
   WAKE MC, 1994, CELL TRANSPLANT, V3, P339, DOI 10.1177/096368979400300411
   Yamada Y, 2003, J CRANIO MAXILL SURG, V31, P27, DOI 10.1016/S1010-5182
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
   Yuan HP, 1998, J MATER SCI-MATER M, V9, P723, DOI 10.1023/A:1008950902047
   ZHOU H, 2007, J BIOL CHEM
NR 44
TC 94
Z9 101
U1 2
U2 51
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2008
VL 29
IS 30
BP 4091
EP 4099
DI 10.1016/j.biomaterials.2008.06.030
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 359YV
UT WOS:000260025100008
PM 18640716
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Crawford, A
   Hatton, PV
AF Crawford, A.
   Hatton, P. V.
TI Cell-Biomaterial Interactions in Skeletal Tissue Engineering.
SO BIOMEDICINE & PHARMACOTHERAPY
LA English
DT Meeting Abstract
CT 7th International Congress on Progress in Bioengineering
CY OCT 27-30, 2008
CL Pisa, ITALY
C1 [Crawford, A.; Hatton, P. V.] Univ Sheffield, Ctr Biomat & Tissue Engn, Sheffield, S Yorkshire, England.
EM a.crawford@sheffield.ac.uk
NR 0
TC 0
Z9 0
U1 1
U2 5
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75724 PARIS, FRANCE
SN 0753-3322
J9 BIOMED PHARMACOTHER
JI Biomed. Pharmacother.
PD OCT
PY 2008
VL 62
IS 8
BP 493
EP 494
DI 10.1016/j.biopha.2008.07.014
PG 2
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA 370CA
UT WOS:000260739100014
DA 2018-10-19
ER

PT J
AU Vozzi, G
   Chiono, V
   Vozzi, F
   Salvadori, C
   Dini, F
   Carlucci, F
   Arispici, M
   Burchielli, S
   Ciardelli, G
   Giusti, P
AF Vozzi, G.
   Chiono, V.
   Vozzi, F.
   Salvadori, C.
   Dini, F.
   Carlucci, F.
   Arispici, M.
   Burchielli, S.
   Ciardelli, G.
   Giusti, P.
TI Nerve regeneration using novel biomaterial supports
SO BIOMEDICINE & PHARMACOTHERAPY
LA English
DT Meeting Abstract
CT 7th International Congress on Progress in Bioengineering/7th
   International Congress on Vascular Endothelium/9the International
   Congress on Advances in Management of Malignancies
CY OCT 27-30, 2008
CL Pisa, ITALY
C1 [Vozzi, G.; Giusti, P.] Univ Pisa, Dept Chem Engn Ind Chem & Mat Sci, I-56126 Pisa, Italy.
   [Vozzi, G.; Vozzi, F.] Univ Pisa, Interdepartmental Res Ctr E Piaggio, I-56126 Pisa, Italy.
   [Chiono, V.; Ciardelli, G.] Politecn Torino, Dept Mech, I-10129 Turin, Italy.
   [Vozzi, F.; Burchielli, S.] CNR, Inst Clin Physiol, I-56126 Pisa, Italy.
   [Salvadori, C.; Arispici, M.] Univ Pisa, Dept Anim Pathol Prophylaxis & Hyg Aliments, I-56126 Pisa, Italy.
   [Dini, F.; Carlucci, F.] Univ Pisa, Fac Vet, Dept Vet Clin, I-56126 Pisa, Italy.
EM g.vozzi@ing.unipi.it
RI Vozzi, Giovanni/F-9787-2014; Chiono, Valeria/G-3631-2014
OI Vozzi, Giovanni/0000-0002-9414-9994; 
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75724 PARIS, FRANCE
SN 0753-3322
J9 BIOMED PHARMACOTHER
JI Biomed. Pharmacother.
PD OCT
PY 2008
VL 62
IS 8
BP 495
EP 496
DI 10.1016/j.biopha.2008.07.018
PG 2
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA 370CA
UT WOS:000260739100018
DA 2018-10-19
ER

PT J
AU Hui, FFC
   Chan, CW
   Qin, L
   Li, G
   Lee, KM
   Hu, YY
   Leung, KS
   Cheng, CYJ
AF Hui, Fan Fong Celine
   Chan, Chun Wai
   Qin, Ling
   Li, Gang
   Lee, Kwong Man
   Hu, Yun Yu
   Leung, Kwok Sui
   Cheng, Chun Yiu Jack
TI Low intensity pulsed ultrasound enhances spinal fusion supplemented with
   tissue engineered biomaterial composite
SO BONE
LA English
DT Meeting Abstract
CT International Conference on Osteoporosis and Bone Research
CY OCT 22-25, 2008
CL Beijing, PEOPLES R CHINA
SP Chinese Med Assoc, Int Bone & Mineral Soc, Int Chinese Hard Tissue Soc
C1 [Hui, Fan Fong Celine; Chan, Chun Wai; Qin, Ling; Leung, Kwok Sui; Cheng, Chun Yiu Jack] Chinese Univ Hong Kong, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China.
   [Li, Gang] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China.
   [Lee, Kwong Man] Chinese Univ Hong Kong, Lee Hysan Clin Res Labs, Hong Kong, Hong Kong, Peoples R China.
   [Hu, Yun Yu] Inst Orthopaed & Traumatol, Xian, Peoples R China.
RI Qin, Ling/J-9047-2018; Chan, Chun Wai/B-5889-2015; Li, Gang/J-7830-2018
OI Qin, Ling/0000-0001-6173-6167; Li, Gang/0000-0002-3981-2239
NR 0
TC 0
Z9 0
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 8756-3282
J9 BONE
JI Bone
PD OCT
PY 2008
VL 43
SU 1
BP S44
EP S44
DI 10.1016/j.bone.2008.08.020
PG 1
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 360TT
UT WOS:000260081500084
DA 2018-10-19
ER

PT J
AU Finotelli, PV
   Sampaio, DA
   Morales, MA
   Rossi, AM
   Rocha-Leao, MH
AF Finotelli, P. V.
   Sampaio, D. A.
   Morales, M. A.
   Rossi, A. M.
   Rocha-Leao, M. H.
TI Ca ALGINATE AS SCAFFOLD FOR IRON OXIDE NANOPARTICLES SYNTHESIS
SO BRAZILIAN JOURNAL OF CHEMICAL ENGINEERING
LA English
DT Article
DE Alginate; Nanotechnology and Magnetite
ID CONTRAST AGENTS; PARTICLES; FE3O4; HYPERTHERMIA; DEXTRAN
AB Recently, nanotechnology has developed to a stage that makes it possible to process magnetic nanoparticles for the site-specific delivery of drugs. To this end, it has been proposed as biomaterial for drug delivery system in which the drug release rates would be activated by a magnetic external stimuli. Alginate has been used extensively in the food, pharmaceutical and biomedical industries for their gel forming properties in the presence of multivalent cations. In this study, we produced iron oxide nanoparticles by coprecipitation of Fe(III) and Fe(II). The nanoparticles were entrapped in Ca alginate beads before and after alginate gelation. XRD analysis showed that particles should be associated to magnetite or maghemite with crystal size of 9.5 and 4.3 nm, respectively. Studies using Mossbauer spectroscopy corroborate the superparamagnetic behavior. The combination of magnetic properties and the biocompatibility of alginate suggest that this biomaterial may be used as biomimetic system.
C1 [Finotelli, P. V.; Morales, M. A.; Rocha-Leao, M. H.] Univ Fed Rio de Janeiro, Inst Quim, Ctr Technol, BR-21949900 Rio De Janeiro, Brazil.
   [Rossi, A. M.] Ctr Brasileiro Pesquisas Fis, Rio De Janeiro, Brazil.
RP Rocha-Leao, MH (reprint author), Univ Fed Rio de Janeiro, Inst Quim, Ctr Technol, BR-21949900 Rio De Janeiro, Brazil.
EM mhrl@eq.ufrj.br
RI Morales, Marco/G-1229-2012
OI Morales, Marco/0000-0002-3098-5731
FU Brazilian Council for Scientific and Technological Development
   (CNPq/Pronex); CAPES
FX This study was supported by the Brazilian Council for Scientific and
   Technological Development (CNPq/Pronex). The first author is grateful to
   CAPES for the financial support. The alginate was kindly supplied by ISP
   Alginates Inc.
CR BAHADUR D, 2003, BIOMATER MAGNET, V28, P639
   Bergemann C, 1999, J MAGN MAGN MATER, V194, P45, DOI 10.1016/S0304-8853(98)00554-X
   CHAN DCF, 1993, J MAGN MAGN MATER, V122, P374
   Cheng FY, 2005, BIOMATERIALS, V26, P729, DOI 10.1016/j.biomaterials.2004.03.016
   Cullity B.D., 1978, ELEMENTS XRAY DIFFRA
   DIONNE GF, 1975, P IEEE, V63, P77
   Dyal A, 2003, J AM CHEM SOC, V125, P1684, DOI 10.1021/ja021223n
   Fried T, 2001, ADV MATER, V13, P1158, DOI 10.1002/1521-4095(200108)13:15<1158::AID-ADMA1158>3.0.CO;2-6
   Hafeli UO, 2004, INT J PHARM, V277, P19, DOI 10.1016/j.ijpharm.2003.03.002
   Hong CY, 1997, J APPL PHYS, V81, P4275, DOI 10.1063/1.364800
   Jordan A, 1999, J MAGN MAGN MATER, V194, P185, DOI 10.1016/S0304-8853(98)00558-7
   Kang YS, 1996, CHEM MATER, V8, P2209, DOI 10.1021/cm960157j
   Kim DK, 2001, J MAGN MAGN MATER, V225, P256, DOI 10.1016/S0304-8853(00)01255-5
   Lubbe AS, 1996, CANCER RES, V56, P4686
   MARTINSEN A, 1989, BIOTECHNOL BIOENG, V33, P79, DOI 10.1002/bit.260330111
   Matsumoto M., 1991, IEEE Translation Journal on Magnetics in Japan, V6, P648, DOI 10.1109/TJMJ.1991.4565229
   MORISAKO A, 1987, IEEE T MAGN, V23, P56, DOI 10.1109/TMAG.1987.1064821
   Pardoe H, 2001, J MAGN MAGN MATER, V225, P41, DOI 10.1016/S0304-8853(00)01226-9
   Reynolds CH, 2000, J AM CHEM SOC, V122, P8940, DOI 10.1021/ja001426g
   Saiyed Z., 2003, BIOMAGN RES TECHNOL, V1, P2, DOI DOI 10.1186/1477-044X-1-2
   SAPIESZKO RS, 1980, J COLLOID INTERF SCI, V74, P405, DOI 10.1016/0021-9797(80)90210-6
   Thode K, 1997, J DRUG TARGET, V5, P35, DOI 10.3109/10611869708995856
   Vandenberghe RE, 2000, HYPERFINE INTERACT, V126, P247, DOI 10.1023/A:1012603603203
   Vijayakumar R, 2000, MAT SCI ENG A-STRUCT, V286, P101, DOI 10.1016/S0921-5093(00)00647-X
   WEISSLEDER R, 1990, RADIOLOGY, V175, P489, DOI 10.1148/radiology.175.2.2326474
NR 25
TC 13
Z9 13
U1 0
U2 10
PU BRAZILIAN SOC CHEMICAL ENG
PI SAO PAULO
PA RUA LIBERO BADARO 152-11 ANDAR, CEP 01008-90 SAO PAULO, BRAZIL
SN 0104-6632
J9 BRAZ J CHEM ENG
JI Braz. J. Chem. Eng.
PD OCT-DEC
PY 2008
VL 25
IS 4
BP 759
EP 764
DI 10.1590/S0104-66322008000400013
PG 6
WC Engineering, Chemical
SC Engineering
GA 376UE
UT WOS:000261207700013
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Vucurovic, V
   Razmovski, R
   Rebic, M
AF Vucurovic, Vesna
   Razmovski, Radojka
   Rebic, Mario
TI A CORN STEM AS BIOMATERIAL FOR SACCHAROMYCES CEREVISIAE CELLS
   IMMOBILIZATION FOR THE ETHANOL PRODUCTION
SO CHEMICAL INDUSTRY & CHEMICAL ENGINEERING QUARTERLY
LA English
DT Article
DE corn stem; yeast immobilization; fermentation; ethanol yield
ID FERMENTATION; BAGASSE
AB This study provides a preliminary contribution to the development of a bioprocess for the production of ethanol using Saccharomyces cerevisiae cells immobilized onto a corn stem. For this purpose, the yeast cells were submitted to the batch tests in situ adsorption onto 0.5 cm long corn stem. Cells immobilization was analyzed by optical microscopy The number of the yeast cells, fermentation kinetics, the ethanol yield in the presence or the absence of the support in the fermentation medium was investigated. It was determined that the addition of the corn stem led to the abrupt increase of the yeast cells number in substrate, ethanol yield pH value, a total dissolved salts content and substrate conductivity. The addition of 5 and 10g of the corn stem pith per liter of the medium decreased the amount of residual sugar. The results indicate that a corn stem might be a good carder for the yeast cell immobilization, and also a cheap alternative recourse of mineral components with the possibility of application for improving ethanol productivites.
C1 [Vucurovic, Vesna; Razmovski, Radojka; Rebic, Mario] Univ Novi Sad, Fac Technol, Novi Sad 21000, Serbia.
RP Vucurovic, V (reprint author), Univ Novi Sad, Fac Technol, Bul Cara Lazara 1, Novi Sad 21000, Serbia.
FU Ministry of Science and Technological Development of Serbia [BTN 20009]
FX The final support from the Ministry of Science and Technological
   Development of Serbia is highly acknowledged (BTN 20009).
CR Anderson WF, 2008, J IND MICROBIOL BIOT, V35, P355, DOI 10.1007/s10295-007-0291-8
   Bai FW, 2008, BIOTECHNOL ADV, V26, P89, DOI 10.1016/j.biotechadv.2007.09.002
   BATTACHARYA AK, 2006, J MATER SCI, V41, P2443
   Beltran-Garcia M. J., 2001, J MEX CHEM SOC, V45, P77
   BRANYIK T, 2005, P 2 MERC C CHEM ENG
   CAPUTI A, 1968, AM J ENOL VITICULT, V19, P160
   de Vasconcelos JN, 2004, BRAZ J CHEM ENG, V21, P357, DOI 10.1590/S0104-66322004000300002
   Fujii N, 1999, PROCESS BIOCHEM, V34, P147, DOI 10.1016/S0032-9592(98)00085-5
   Jung HG, 2006, CROP SCI, V46, P1793, DOI 10.2135/cropsci2005.02-0085
   PARMANIK K, 2004, J CH, V85, P31
   Plessas S, 2007, BIORESOURCE TECHNOL, V98, P860, DOI 10.1016/j.biortech.2006.03.014
   Reddy N, 2005, POLYMER, V46, P5494, DOI 10.1016/j.polymer.2005.04.073
   Santos DT, 2008, J FOOD ENG, V86, P542, DOI 10.1016/j.jfoodeng.2007.11.004
   Thamae T, 2008, J MATER SCI, V43, P4057, DOI 10.1007/s10853-008-2495-3
   Verbelen PJ, 2006, BIOTECHNOL LETT, V28, P1515, DOI 10.1007/s10529-006-9132-5
   Yu JL, 2007, J BIOTECHNOL, V129, P415, DOI 10.1016/j.jbiotec.2007.01.039
NR 16
TC 7
Z9 7
U1 0
U2 9
PU ASSOC CHEMICAL ENG
PI BELGRADE
PA KNEZA MILOSO 9-I, BELGRADE, 11000, SERBIA
SN 1451-9372
J9 CHEM IND CHEM ENG Q
JI Chem. Ind. Chem. Eng. Q.
PD OCT-DEC
PY 2008
VL 14
IS 4
BP 235
EP 238
DI 10.2298/CICEQ0804235V
PG 4
WC Chemistry, Applied; Engineering, Chemical
SC Chemistry; Engineering
GA 392BO
UT WOS:000262278100007
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Choi, JH
   Bischof, JC
AF Choi, Jeung Hwan
   Bischof, John C.
TI A quantitative analysis of the thermal properties of porcine liver with
   glycerol at subzero and cryogenic temperatures
SO CRYOBIOLOGY
LA English
DT Article
DE Thermal property; Subzero; Liver; Glycerol
ID DIFFERENTIAL SCANNING CALORIMETRY; CONDUCTIVITY; H2O-NACL-GLYCEROL;
   CRYSTALLIZATION; BIOMATERIALS; SULFOXIDE; KINETICS; SOLIDS; MELTS; ICE
AB There is a lack of information on the effect of cryoprotective agents (CPAs) on the thermal properties of biomaterials at cryobiologically relevant temperatures (i.e. <233.15 K, -40 degrees C). Thermal properties that are of most interest include: thermal conductivity, density, specific heat, and latent heat resulting from phase change in tissue systems. Availability of such information would be beneficial for accurate mathematical modeling of cryobiological applications. Recently, we reported these thermal properties in phosphate buffered saline (PBS) with varying concentrations of glycerol, a widely used cryoprotective agent. In this study we extend these results by assessing the effects of glycerol on the thermal properties of porcine liver at subzero temperatures. Differential scanning calorimeter (DSC) was used to measure the specific heat and the latent heat release of porcine liver immersed in PBS and varying concentrations of glycerol. The specific heat data obtained from the DSC experiments were also used to predict the bulk thermal conductivity. This was done using a transient heat transfer model with a thermistor probe technique. Results show that the introduction of glycerol significantly alters thermal properties from known values for H2O and non-treated liver. Therefore, inaccuracies in thermal predictions can be expected due to the application of measured vs. predicted thermal properties such as from weight averaging. This supports the need for these and other measurements of biomaterial thermal properties, with and without CPA addition, in the cryogenic regime. (C) 2008 Elsevier Inc. All rights reserved.
C1 [Choi, Jeung Hwan; Bischof, John C.] Univ Minnesota, Dept Mech Engn, Minneapolis, MN 55455 USA.
   [Bischof, John C.] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA.
   [Bischof, John C.] Univ Minnesota, Dept Urol Surg, Minneapolis, MN 55455 USA.
RP Bischof, JC (reprint author), Univ Minnesota, Dept Mech Engn, 111 Church St SE, Minneapolis, MN 55455 USA.
EM bischof@umn.edu
FU United States National Science Foundation (NSF) [CTS 0313934]
FX Statement of funding: This work was supported by the United States
   National Science Foundation (NSF) under Grant No. CTS 0313934.
CR ASHWORTH T, 1972, P 4 INT CRYOG ENG C, P24
   BAI XM, 1991, J BIOMECH ENG-T ASME, V113, P423, DOI 10.1115/1.2895422
   Balasubramaniam TA, 1997, J BIOMECH ENG-T ASME, V99, P148
   BALD WB, 1982, REP PROG PHYS, V45, P1381, DOI 10.1088/0034-4885/45/12/001
   BIRGE NO, 1986, PHYS REV B, V34, P1631, DOI 10.1103/PhysRevB.34.1631
   Bischof JC, 2007, ANN BIOMED ENG, V35, P292, DOI 10.1007/s10439-006-9176-7
   BOUTRON P, 1979, CRYOBIOLOGY, V16, P372, DOI 10.1016/0011-2240(79)90050-6
   BOUTRON P, 1986, CRYOBIOLOGY, V23, P88, DOI 10.1016/0011-2240(86)90022-2
   BOWMAN HF, 1975, ANNU REV BIOPHYS BIO, V4, P43, DOI 10.1146/annurev.bb.04.060175.000355
   CAHILL DG, 1987, PHYS REV B, V35, P4067, DOI 10.1103/PhysRevB.35.4067
   Carslaw H. S., 1959, CONDUCTION HEAT SOLI
   Chato JC, 1985, HEAT TRANSFER MED BI, P167
   CHEN MM, 1981, J BIOMECH ENG-T ASME, V103, P253
   CHIU J, 1979, THERMOCHIM ACTA, V34, P267, DOI 10.1016/0040-6031(79)87116-6
   CHOI JH, 2007, INT J HEAT IN PRESS
   COCKS FH, 1975, J APPL PHYS, V46, P3444, DOI 10.1063/1.322066
   COOPER TE, 1972, J HEAT TRANSFER, P133
   Fennema O. R., 1973, LOW TEMPERATURE PRES
   Hey JM, 1998, CRYOBIOLOGY, V37, P119, DOI 10.1006/cryo.1998.2108
   Hobbs P. V., 1974, ICE PHYS
   Hohne GWH, 1996, DIFFERENTIAL SCANNIN
   JOCHEM M, 1987, CRYOBIOLOGY, V24, P513, DOI 10.1016/0011-2240(87)90055-1
   KEATING MY, 1990, THERMOCHIM ACTA, V166, P69, DOI 10.1016/0040-6031(90)80170-4
   KHANNA YP, 1988, POLYM ENG SCI, V28, P1034, DOI 10.1002/pen.760281604
   Klinger J., 1973, PHYS CHEM ICE, P114
   LIDE DR, 2006, HDB CHEM PHYS, P6
   Luyet B, 1968, Biodynamica, V10, P167
   NEWMAN AA, 1968, PHYS PROPERTIES GLYC, P21
   OWEN MS, 2002, ASHRAE HDB REFRIGERA, P81
   OZISIK MN, 1993, HEAT CONDUCTION, P214
   Poppendiek H. F., 1966, CRYOBIOLOGY, V3, P318
   RUBINSKY B, 1984, CRYOBIOLOGY, V21, P303, DOI 10.1016/0011-2240(84)90326-2
   SHEPARD ML, 1976, CRYOBIOLOGY, V13, P9, DOI 10.1016/0011-2240(76)90154-1
   VALVANO JW, 1988, LOW TEMPERATURE BIOT, P331
   Zhang A, 2004, CELL PRESERV TECHNOL, V2, P157, DOI 10.1089/153834404774101990
   Zhang H., 2002, CELL PRESERV TECHNOL, V1, P141
NR 36
TC 14
Z9 15
U1 0
U2 11
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0011-2240
J9 CRYOBIOLOGY
JI Cryobiology
PD OCT
PY 2008
VL 57
IS 2
BP 79
EP 83
DI 10.1016/j.cryobio1.2008.05.004
PG 5
WC Biology; Physiology
SC Life Sciences & Biomedicine - Other Topics; Physiology
GA 365LD
UT WOS:000260407000001
PM 18656857
DA 2018-10-19
ER

PT J
AU Witte, F
   Hort, N
   Vogt, C
   Cohen, S
   Kainer, KU
   Willumeit, R
   Feyerabend, F
AF Witte, Frank
   Hort, Norbert
   Vogt, Carla
   Cohen, Smadar
   Kainer, Karl Ulrich
   Willumeit, Regine
   Feyerabend, Frank
TI Degradable biomaterials based on magnesium corrosion
SO CURRENT OPINION IN SOLID STATE & MATERIALS SCIENCE
LA English
DT Review
DE Magnesium alloy; Biodegradable; Corrosion; In vivo; In vitro; Animal
   model; Implant
ID PLASMA-MASS SPECTROMETRY; IN-VIVO CORROSION; ATOMIC-ABSORPTION
   SPECTROMETRY; OPTICAL-EMISSION-SPECTROMETRY; PORCINE CORONARY-ARTERIES;
   BONE IMPLANT APPLICATION; BLOOD-FLOW DISTRIBUTION; BROWN ADIPOSE-TISSUE;
   MECHANICAL-PROPERTIES; ALLOY STENTS
AB Biodegradable metals are breaking the current paradigm in biomaterial science to develop only corrosion resistant metals. In particular, metals which consist of trace elements existing in the human body are promising candidates for temporary implant materials. These implants would be temporarily needed to provide mechanical support during the healing process of the injured or pathological tissue. Magnesium and its alloys have been investigated recently by many authors as a suitable biodegradable biomaterial. In this investigative review we would like to summarize the latest achievements and comment on the selection and use, test methods and the approaches to develop and produce magnesium alloys that are intended to perform clinically with an appropriate host response. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Witte, Frank] Hannover Med Sch, Lab Biomech & Biomat, D-30625 Hannover, Germany.
   [Witte, Frank; Cohen, Smadar] Ben Gurion Univ Negev, Dept Biotechnol Engn, IL-84105 Beer Sheva, Israel.
   [Hort, Norbert; Kainer, Karl Ulrich; Willumeit, Regine; Feyerabend, Frank] GKSS Forschungszentrum Geesthacht GmbH, Inst Mat Res, D-21502 Geesthacht, Germany.
   [Vogt, Carla] Leibniz Univ Hannover, Inst Inorgan Chem, D-30167 Hannover, Germany.
RP Witte, F (reprint author), Hannover Med Sch, Lab Biomech & Biomat, Anna von Borries Str 1-7, D-30625 Hannover, Germany.
EM fwitte@web.de; norbert.hort@gkss.de; vogt@acc.uni-hannover.de;
   s.cohen@bgu.il.co; karl.kai-ner@gkss.de; regine.willumeit@gkss.de;
   frank.feyer-abend@gkss.de
RI Feyerabend, Frank/A-1124-2010; Kainer, Karl/D-6417-2011; Hort,
   Norbert/G-1913-2011; Willumeit, Regine/I-8029-2013; COHEN,
   SMADAR/F-1901-2012
OI Feyerabend, Frank/0000-0001-9532-0207; Kainer, Karl/0000-0002-9630-0985;
   Hort, Norbert/0000-0002-6636-1568; Willumeit,
   Regine/0000-0002-6004-6946; Witte, Frank/0000-0001-9154-6217
CR ABOUSHAKRA FR, 1989, TRACE ELEM MED, V6, P142
   Ambard Alberto J, 2006, J Prosthodont, V15, P321, DOI 10.1111/j.1532-849X.2006.00129.x
   Ambat R, 2000, CORROS SCI, V42, P1433, DOI 10.1016/S0010-938X(99)00143-2
   An YH, 1999, ANIMAL MODELS ORTHOP
   Anetzberger H, 2004, J APPL PHYSIOL, V96, P1928, DOI 10.1152/japplphysiol.00904.2003
   Aral H, 2008, ECOTOX ENVIRON SAFE, V70, P349, DOI 10.1016/j.ecoenv.2008.02.026
   ARMSTRONG RB, 1984, AM J PHYSIOL, V246, pH59
   Aschner M, 2007, TOXICOL APPL PHARM, V221, P131, DOI 10.1016/j.taap.2007.03.001
   *ASM INT, 1988, MAGN BIN PHAS DIAGR
   *ASTM B, STAND PRACT TEMP DES
   *ASTM B, STAND PRACT COD UN M
   Avedesian M. M., 1999, MAGNESIUM MAGNESIUM
   Bach FW, 2003, MATER SCI FORUM, V419-4, P1037, DOI 10.4028/www.scientific.net/MSF.419-422.1037
   BANKS RA, 1981, CLIN EXP PHARMACOL P, V8, P543, DOI 10.1111/j.1440-1681.1981.tb00764.x
   BARUTHIO F, 1988, CLIN CHEM, V34, P227
   BAUCCIO ML, 2001, ASM METALS REFERENCE
   Becker JS, 2005, ANAL CHEM, V77, P3208, DOI 10.1021/ac040184q
   Begerow J, 2000, J ANAL ATOM SPECTROM, V15, P347, DOI 10.1039/a909056h
   Bell G, 1968, TXB PHYSL BIOCH
   Benes B, 2000, BIOL TRACE ELEM RES, V75, P195, DOI 10.1385/BTER:75:1-3:195
   Beyersmann D, 2008, ARCH TOXICOL, V82, P493, DOI 10.1007/s00204-008-0313-y
   Bichet DG, 2006, J AM SOC NEPHROL, V17, P920, DOI 10.1681/ASN.2006020135
   Bock NA, 2008, BRAIN RES, V1198, P160, DOI 10.1016/j.brainres.2007.12.065
   BOYER HE, 1985, METALLS HDB
   Brewer GJ, 2007, EXP BIOL MED, V232, P323
   Browse DJ, 1997, EUR J PHARMACOL, V320, P139, DOI 10.1016/S0014-2999(96)00887-4
   CROSBY WH, 1974, JAMA-J AM MED ASSOC, V227, P310, DOI 10.1001/jama.227.3.310
   Di Mario Carlo, 2004, J Interv Cardiol, V17, P391, DOI 10.1111/j.1540-8183.2004.04081.x
   Emley E. F., 1966, PRINCIPLES MAGNESIUM
   Erbel R, 2007, LANCET, V369, P1869, DOI 10.1016/S0140-6736(07)60853-8
   EVANS FG, 1976, ANAT REC, V185, P1, DOI 10.1002/ar.1091850102
   Ferreira PC, 2008, REV LAT-AM ENFERM, V16, P151, DOI 10.1590/S0104-11692008000100023
   FEYERABEND F, 2008, BIOMED MAT RES A, DOI DOI 10.1002/JBM.A.32151
   Feyerabend F, 2006, TISSUE ENG, V12, P3545, DOI 10.1089/ten.2006.12.3545
   FOERSTER GS, 1975, GT75112
   FRIEDRICH HE, 2006, MORDIKE BL MAGNESIUM
   Garcia EE, 2001, J ANAL ATOM SPECTROM, V16, P825, DOI 10.1039/b100779n
   Gelinas Y, 1997, BIOL TRACE ELEM RES, V59, P63, DOI 10.1007/BF02783231
   Ghazi AM, 2000, J ANAL ATOM SPECTROM, V15, P1335, DOI 10.1039/b001888k
   Gilca M, 2007, J POSTGRAD MED, V53, P207, DOI 10.4103/0022-3859.33869
   Giles JJ, 2006, CURR PHARM DESIGN, V12, P1531, DOI 10.2174/138161206776389804
   Gopferich A, 1996, BIOMATERIALS, V17, P103, DOI 10.1016/0142-9612(96)85755-3
   Gordon T, 2003, MUTAT RES-FUND MOL M, V533, P99, DOI 10.1016/j.mrfmmm.2003.08.022
   Gruhl S, 2009, J ANAL ATOM SPECTROM, V24, P181, DOI 10.1039/b813734j
   GRZESIAK JJ, 1995, J CLIN INVEST, V95, P227, DOI 10.1172/JCI117644
   Grzesiak JJ, 2008, INT J CANCER, V122, P2199, DOI 10.1002/ijc.23368
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   HAFSTROM L, 1980, CANCER RES, V40, P481
   HAMILTON E I, 1976, Science of the Total Environment, V5, P1, DOI 10.1016/0048-9697(76)90023-1
   Hartwig A, 2001, MUTAT RES-FUND MOL M, V475, P113, DOI 10.1016/S0027-5107(01)00074-4
   HASSEL T, 2007, MAGNESIUM TECHNOLOGY, P359
   HEIM T, 1966, J PHYSIOL-LONDON, V186, P42, DOI 10.1113/jphysiol.1966.sp008019
   Hongchun X., 2000, J ANAL SPECTROM, V15, P759
   Hyder F, 2000, J CEREBR BLOOD F MET, V20, P485, DOI 10.1097/00004647-200003000-00007
   Iwase M, 2000, HYPERTENS RES, V23, P503, DOI 10.1291/hypres.23.503
   JACKSON BP, 2006, PLASM WINT C 2006 TU
   Janssens K, 1999, FRESEN J ANAL CHEM, V363, P413, DOI 10.1007/s002160051212
   Ji YJ, 2000, BIOMED ENVIRON SCI, V13, P287
   JOHNSON JRK, 1968, CLIN CHEM, V14, P1218
   KAESE V, 2002, BEITRAG KORROSIONSSC
   Kammer C., 2000, MAGNESIUM TASCHENBUC
   Kannan MB, 2008, BIOMATERIALS, V29, P2306, DOI 10.1016/j.biomaterials.2008.02.003
   Kaya RA, 2007, J NEUROSURG-SPINE, V6, P141, DOI 10.3171/spi.2007.6.2.141
   KIILERICH S, 1980, CLIN CHIM ACTA, V105, P231, DOI 10.1016/0009-8981(80)90465-9
   KIRKPATRICK CJ, 1990, J MATER SCI-MATER M, V1, P9, DOI 10.1007/BF00705347
   KNOOP FM, 1994, ERZEUGUNG KONSOLIDIE
   Koganezawa T, 2006, BRIT J PHARMACOL, V148, P579, DOI 10.1038/sj.bjp.0706765
   Kostova Irena, 2007, Metal-Based Drugs, P15925, DOI 10.1155/2007/15925
   Kraft R, 2005, PFLUG ARCH EUR J PHY, V451, P204, DOI 10.1007/s00424-005-1428-0
   KRAUSE C, 2007, MAGNESIUM TECHNOLOGY, P329
   Krejcova A, 2001, J ANAL ATOM SPECTROM, V16, P1002, DOI 10.1039/b101941o
   Kuper C, 2007, CURR GENOMICS, V8, P209
   KURIHARA T, 1992, LIFE SCI, V51, P6
   Kuwahara H, 2001, MATER TRANS, V42, P1317, DOI 10.2320/matertrans.42.1317
   Lango T, 1996, UNDERSEA HYPERBAR M, V23, P247
   Larsen M, 2008, J ORTHOP RES, V26, P746, DOI 10.1002/jor.20561
   Lastra MD, 2001, J TRACE ELEM MED BIO, V15, P5, DOI 10.1016/S0946-672X(01)80019-5
   Levesque J, 2008, ACTA BIOMATER, V4, P284, DOI 10.1016/j.actbio.2007.09.012
   Liddington RC, 2002, J CELL BIOL, V158, P833, DOI 10.1083/jcb.200206011
   Liu CL, 2007, J MATER RES, V22, P1806, DOI 10.1557/JMR.2007.0241
   Loghin Felicia, 1999, Metal-Based Drugs, V6, P87, DOI 10.1155/MBD.1999.87
   Magda D, 2006, SEMIN CANCER BIOL, V16, P466, DOI 10.1016/j.semcancer.2006.09.002
   MAKAR GL, 1993, INT MATER REV, V38, P138, DOI 10.1179/imr.1993.38.3.138
   MAKINO T, 1981, CLIN CHEM, V27, P1445
   MARTIN B, 1998, SKELETAL TISSUE MECH
   Martinez R, 2001, J ANAL ATOM SPECTROM, V16, P250, DOI 10.1039/b009469m
   Matheson PJ, 2008, AM J SURG, V196, P293, DOI 10.1016/j.amjsurg.2007.11.013
   *MEL, 2005, MAGN EL DAT
   *MEL, 2005, MAGN DAT 497
   Milavec-Puretic V, 1998, ARCH ORTHOP TRAUM SU, V117, P383, DOI 10.1007/s004020050272
   Morant C, 2003, APPL SURF SCI, V220, P79, DOI 10.1016/S0169-4332(03)00746-3
   MOUREN S, 1994, ANESTHESIOLOGY, V80, P634, DOI 10.1097/00000542-199403000-00021
   Müller Wolf Dieter, 2007, Mat. Res., V10, P5, DOI 10.1590/S1516-14392007000100003
   NEITE G, 1996, MAT SCI TECHNOLOGY
   NIXON DE, 1989, ANALYST, V114, P1671, DOI 10.1039/an9891401671
   Okazaki Y, 1998, BIOMATERIALS, V19, P1197, DOI 10.1016/S0142-9612(97)00235-4
   Perna L, 2002, J ANAL ATOM SPECTROM, V17, P1166, DOI 10.1039/b202451a
   PIIPER J, 1962, J APPL PHYSIOL, V17, P268
   Post JI, 2008, AMYOTROPH LATERAL SC, V9, P149, DOI 10.1080/17482960801934015
   Reinoso RF, 1997, J PHARMACOL TOXICOL, V38, P87, DOI 10.1016/S1056-8719(97)00053-1
   Ren YB, 2005, ACTA METALL SIN, V41, P1228
   Renkema KY, 2008, ANN MED, V40, P82, DOI 10.1080/07853890701689645
   RENNER F, 2004, EINLFUSSGROSSEN SCHW
   Rettig R, 2008, J BIOMED MATER RES A, V85A, P167, DOI 10.1002/jbm.a.31550
   Revie R. Winston, 2000, UHLIGS CORROSION HDB
   RINK TJ, 1982, J CELL BIOL, V95, P189, DOI 10.1083/jcb.95.1.189
   Rokhlin L.L., 2003, MAGNESIUM ALLOYS CON
   ROMANI A, 1992, ARCH BIOCHEM BIOPHYS, V298, P1, DOI 10.1016/0003-9861(92)90086-C
   Rosenberg K, 1998, J BIOL CHEM, V273, P20397, DOI 10.1074/jbc.273.32.20397
   Rousselle AV, 2002, HISTOL HISTOPATHOL, V17, P1025, DOI 10.14670/HH-17.1025
   Rubin H, 2005, P NATL ACAD SCI USA, V102, P9276, DOI 10.1073/pnas.0503688102
   Rubin H, 2005, BIOESSAYS, V27, P311, DOI 10.1002/bies.20183
   Sahin O, 2006, PATHOLOGY, V38, P58, DOI 10.1080/00313020500464904
   SALTMAN PD, 1993, J AM COLL NUTR, V12, P384, DOI 10.1080/07315724.1993.10718327
   Schlingmann KP, 2005, J PHYSIOL-LONDON, V566, P301, DOI 10.1113/jphysiol.2004.080200
   Seifert EL, 2006, BIOL NEONATE, V90, P104, DOI 10.1159/000092069
   SHAW BA, 2003, ASM HDB A, V13
   Shingde M, 2005, MED J AUSTRALIA, V183, P145
   Song GL, 1999, ADV ENG MATER, V1, P11, DOI 10.1002/(SICI)1527-2648(199909)1:1<11::AID-ADEM11>3.0.CO;2-N
   Song GL, 2007, ADV ENG MATER, V9, P298, DOI 10.1002/adem.200600252
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   Song YW, 2008, MATER LETT, V62, P3276, DOI 10.1016/j.matlet.2008.02.048
   SPEICH M, 1981, CLIN CHEM, V27, P246
   STATLAND BE, 1976, CLIN BIOCHEM, V9, P26, DOI 10.1016/S0009-9120(76)80008-2
   TAHAN JE, 1994, ANAL CHIM ACTA, V295, P187, DOI 10.1016/0003-2670(94)80350-1
   VAUPEL P, 1976, PFLUG ARCH EUR J PHY, V361, P201, DOI 10.1007/BF00583467
   Villaneuva M, 2000, J ANAL ATOM SPECTROM, V15, P877, DOI 10.1039/a907603d
   Von der Hoeh N, 2006, DEUT TIERARZTL WOCH, V113, P439
   Waksman R, 2005, EUR HEART J, V26, P417
   Waksman R, 2006, J AM COLL CARDIOL, V47, p23B
   Waksman R, 2005, CIRCULATION, V112, pU539
   Waksman R, 2006, CATHETER CARDIO INTE, V68, P607, DOI 10.1002/ccd.20727
   Waksman R, 2009, JACC-CARDIOVASC INTE, V2, P312, DOI 10.1016/j.jcin.2008.09.015
   Wambach PF, 2008, J CHEM HEALTH SAF, V15, P5, DOI 10.1016/j.jchas.2008.01.012
   Wang H, 2008, MATER LETT, V62, P2476, DOI 10.1016/j.matlet.2007.12.052
   Wang QD, 2001, J MATER SCI, V36, P3035
   Wen CE, 2004, MATER LETT, V58, P357, DOI [10.1016/S0167-577X(03)00500-7, 10.1016/S0167-577X(03)004500-7]
   WILLIAMS LR, 1989, CLIN PHYS PHYSIOL M, V10, P187, DOI 10.1088/0143-0815/10/3/001
   Wintermantel E, 2002, MEDIZINTECHNIK BIOKO
   Witte F, 2007, J BIOMED MATER RES A, V81A, P757, DOI 10.1002/jbm.a.31293
   Witte F, 2007, J BIOMED MATER RES A, V81A, P748, DOI 10.1002/jbm.a.31170
   Witte F, 2006, MATERIALWISS WERKST, V37, P504, DOI 10.1002/mawe.200600027
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   WITTE F, 2006, PROGR BIOMEDICAL OPT
   Witte F, 2008, J BIOMED MATER RES A, V86A, P1041, DOI 10.1002/jbm.a.31713
   Witte F, 2007, BIOMATERIALS, V28, P2163, DOI 10.1016/j.biomaterials.2006.12.027
   Xu LP, 2008, J MATER SCI-MATER M, V19, P1017, DOI 10.1007/s10856-007-3219-y
   Xu LP, 2007, J BIOMED MATER RES A, V83A, P703, DOI 10.1002/jbm.a.31273
   Zhang GD, 2007, ACTA METALL SIN, V43, P1186
NR 150
TC 823
Z9 859
U1 28
U2 399
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1359-0286
EI 1879-0348
J9 CURR OPIN SOLID ST M
JI Curr. Opin. Solid State Mat. Sci.
PD OCT-DEC
PY 2008
VL 12
IS 5-6
BP 63
EP 72
DI 10.1016/j.cossms.2009.04.001
PG 10
WC Materials Science, Multidisciplinary; Physics, Applied; Physics,
   Condensed Matter
SC Materials Science; Physics
GA 462YD
UT WOS:000267394000001
DA 2018-10-19
ER

PT J
AU Smith, CD
   Masouros, S
   Hill, AM
   Wallace, AL
   Amis, AA
   Bull, AMJ
AF Smith, Christopher D.
   Masouros, Spyros
   Hill, Adam M.
   Wallace, Andrew L.
   Amis, Andrew A.
   Bull, Anthony M. J.
TI Mechanical testing of intra-articular tissues. Relating experiments to
   physiological function
SO CURRENT ORTHOPAEDICS
LA English
DT Article
DE Cartilage; Labrum; Meniscus; Ligament; Biomechanical properties; Testing
ID ANTERIOR CRUCIATE LIGAMENT; HUMAN ARTICULAR-CARTILAGE; INFERIOR
   GLENOHUMERAL LIGAMENT; IMPLANTABLE FORCE TRANSDUCER; MEDIAL COLLATERAL
   LIGAMENT; CROSS-SECTIONAL AREA; ROTATOR CUFF MUSCLES; IN-VIVO;
   KNEE-JOINT; HIP-JOINT
AB There is a wealth of data published on the biomechanical properties of intra-articular tissues. However, much of this information is not intuitively applicable to clinical practice due to both methodological disparity between studies and the relevance of the methodology used to test the biomaterial. This inevitably results in comparison difficulties with other experimental data produced for the same tissue, or indeed different tissues.
   Therefore, this review highlights the salient issues that need to be considered when trying to interpret biomechanical testing scenarios and how they influence clinical practice. As such, different testing protocols and their clinical relevance are scrutinised. The importance of recreating the physiological loading conditions and the interpretation of the functional anatomy are highlighted. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Smith, Christopher D.; Masouros, Spyros; Hill, Adam M.; Bull, Anthony M. J.] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England.
   [Smith, Christopher D.; Masouros, Spyros; Amis, Andrew A.] Univ London Imperial Coll Sci Technol & Med, Dept Mech Engn, London, England.
   [Wallace, Andrew L.; Amis, Andrew A.] Univ London Imperial Coll Sci Technol & Med, Dept Musculoskeletal Surg, London, England.
RP Bull, AMJ (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England.
EM a.bull@imperial.ac.uk
RI Masouros, Spyros/S-7151-2017; Bull, Anthony/C-2317-2008
OI Masouros, Spyros/0000-0003-1700-5548; Bull, Anthony/0000-0002-4473-8264
CR AMIS AA, 1980, J BIOMECH, V13, P765, DOI 10.1016/0021-9290(80)90238-9
   AMIS AA, 1979, J ENG MED H, P41
   ARMSTRONG CG, 1982, J BONE JOINT SURG AM, V64, P88, DOI 10.2106/00004623-198264010-00013
   ASPDEN RM, 1985, J ANAT, V140, P371
   Ballard RE, 1998, J APPL PHYSIOL, V84, P1976
   Bergmann G, 2001, J BIOMECH, V34, P859, DOI 10.1016/S0021-9290(01)00040-9
   BERGMANN G, 1984, J BIOMECH, V17, P907, DOI 10.1016/0021-9290(84)90004-6
   BERGMANN G, 2006, J BIOMECH S1, V39, pS134
   BEYNNON B, 1992, INT ORTHOP, V16, P1
   Beynnon BD, 1998, J BIOMECH, V31, P519, DOI 10.1016/S0021-9290(98)00044-X
   Bull AMJ, 2005, KNEE SURG SPORT TR A, V13, P145, DOI 10.1007/s00167-004-0556-y
   BUTLER DL, 1992, J BIOMECH, V25, P511, DOI 10.1016/0021-9290(92)90091-E
   Cerulli G, 2003, KNEE SURG SPORT TR A, V11, P307, DOI 10.1007/s00167-003-0403-6
   Chae Y, 2003, LASER SURG MED, V32, P271, DOI 10.1002/lsm.10167
   CHAI BF, 1990, CHINESE MED J-PEKING, V103, P290
   Chang YW, 2000, J SHOULDER ELB SURG, V9, P188, DOI 10.1067/mse.2000.105135
   CHIMICH D, 1992, J BIOMECH, V25, P831, DOI 10.1016/0021-9290(92)90223-N
   COOPER DE, 1992, J BONE JOINT SURG AM, V74A, P46, DOI 10.2106/00004623-199274010-00007
   Daniel M, 2001, MED ENG PHYS, V23, P347, DOI 10.1016/S1350-4533(01)00051-0
   DAVY DT, 1988, J BONE JOINT SURG AM, V70A, P45, DOI 10.2106/00004623-198870010-00008
   Dennerlein JT, 1998, J BIOMECH, V31, P295, DOI 10.1016/S0021-9290(98)00006-2
   Duda GN, 1997, J BIOMECH, V30, P933, DOI 10.1016/S0021-9290(97)00057-2
   Edwards A, 2007, ARTHROSCOPY, V23, P284, DOI 10.1016/j.arthro.2006.11.005
   Elisa JJ, 2006, J BIOMECH, V39, P865, DOI 10.1016/j.jbiomech.2005.01.030
   ENGLISH TA, 1979, J BIOMED ENG     APR, P111
   Ferguson SJ, 2001, J ORTHOPAED RES, V19, P887, DOI 10.1016/S0736-0266(01)00007-9
   FISHER IA, 2000, MATH INVESTIGATION I
   FITHIAN DC, 1990, CLIN ORTHOP RELAT R, P19
   FUKASHIRO S, 1995, EUR J APPL PHYSIOL O, V71, P453, DOI 10.1007/BF00635880
   Gabrion A, 2005, SURG RADIOL ANAT, V27, P507, DOI 10.1007/s00276-005-0031-6
   GLOS DL, 1993, J BIOMECH ENG-T ASME, V115, P335, DOI 10.1115/1.2895495
   Gupte CM, 2002, J BIOMECH, V35, P1623, DOI 10.1016/S0021-9290(02)00238-5
   Hara H, 1996, J Shoulder Elbow Surg, V5, P263, DOI 10.1016/S1058-2746(96)80052-8
   Haut TL, 1997, J BIOMECH, V30, P79, DOI 10.1016/S0021-9290(96)00108-X
   Heller MO, 2001, J BIOMECH, V34, P883, DOI 10.1016/S0021-9290(01)00039-2
   HIROTANI H, 1975, Anatomischer Anzeiger, V138, P29
   HODGE WA, 1989, J BONE JOINT SURG AM, V71A, P1378, DOI 10.2106/00004623-198971090-00015
   HOERNING EK, 2005, J BONE JOINT SURG S1, V87, pC162
   HOLDEN JP, 1994, J BIOMECH, V27, P517, DOI 10.1016/0021-9290(94)90063-9
   Huang CY, 2005, J BIOMECH, V38, P799, DOI 10.1016/j.jbiomech.2004.05.006
   Hughes HE, 1996, BEHAV BRAIN RES, V75, P83, DOI 10.1016/0166-4328(96)00175-1
   Iglic Ales, 2002, Comput Methods Biomech Biomed Engin, V5, P185, DOI 10.1080/10255840290010300
   Jurvelin J S, 2003, Proc Inst Mech Eng H, V217, P215, DOI 10.1243/095441103765212712
   Juul-Kristensen B, 2000, CELLS TISSUES ORGANS, V167, P214, DOI 10.1159/000016784
   KAPITONOVA MY, 2003, J PATHOL, V25, P15
   KEATING JF, 1993, J BONE JOINT SURG BR, V75, P137
   KEMPSON GE, 1968, NATURE, V220, P1127, DOI 10.1038/2201127b0
   KENNEDY JC, 1976, J BONE JOINT SURG AM, V58, P350, DOI 10.2106/00004623-197658030-00009
   KIM YT, 1995, CLIN ORTHOP RELAT R, P176
   Lechner K, 2000, J ORTHOPAED RES, V18, P945, DOI 10.1002/jor.1100180614
   Lee TQ, 1999, CLIN BIOMECH, V14, P471, DOI 10.1016/S0268-0033(99)00007-8
   Leslie BW, 2000, P I MECH ENG H, V214, P631, DOI 10.1243/0954411001535651
   Lisi AJ, 2006, J APPL BIOMECH, V22, P234, DOI 10.1123/jab.22.3.234
   McGibbon CA, 1997, ARTHRIT CARE RES, V10, P300, DOI 10.1002/art.1790100504
   McMahon PJ, 1999, J BONE JOINT SURG BR, V81B, P406, DOI 10.1302/0301-620X.81B3.9153
   McMahon PJ, 2001, J SHOULDER ELB SURG, V10, P482, DOI 10.1067/mse.2001.116870
   MERKEL KHH, 1980, ARCH ORTHOP TRAUM SU, V97, P185, DOI 10.1007/BF00389725
   Mine T, 2000, ARCH ORTHOP TRAUM SU, V120, P201, DOI 10.1007/s004020050044
   Montella Andrea, 1992, Archivio Italiano di Anatomia e di Embriologia, V97, P1
   Muehleman C, 2004, OSTEOARTHR CARTILAGE, V12, P97, DOI 10.1016/j.joca.2003.10.001
   NEURATH M, 1992, UNFALLCHIRURG, V95, P17
   Nishida K, 1996, J Shoulder Elbow Surg, V5, P132, DOI 10.1016/S1058-2746(96)80008-5
   NOYES FR, 1984, J BONE JOINT SURG AM, V66A, P344, DOI 10.2106/00004623-198466030-00005
   OZKAYA N, 1999, FUNDAMENTALS BIOMECH, P125
   Park S, 1999, GAIT POSTURE, V10, P211, DOI 10.1016/S0966-6362(99)00033-8
   Park S, 2004, OSTEOARTHR CARTILAGE, V12, P65, DOI 10.1016/j.joca.2003.08.005
   Petersen W, 2003, ARCH ORTHOP TRAUM SU, V123, P283, DOI 10.1007/s00402-003-0527-7
   Petersen W, 1998, ANAT EMBRYOL, V197, P317, DOI 10.1007/s004290050141
   Pioletti DP, 1999, MED ENG PHYS, V21, P95, DOI 10.1016/S1350-4533(99)00028-4
   Provenzano PP, 2002, J APPL PHYSIOL, V92, P362
   Putz R, 1998, ORTHOPADE, V27, P675, DOI 10.1007/PL00003452
   Race A, 2000, SPINE, V25, P662, DOI 10.1097/00007632-200003150-00003
   REEVES B, 1968, Journal of Bone and Joint Surgery British Volume, V50-B, P858
   Robinson JR, 2005, J BIOMECH, V38, P1067, DOI 10.1016/j.jbiomech.2004.05.034
   Schatzmann L, 1998, Knee Surg Sports Traumatol Arthrosc, V6 Suppl 1, pS56, DOI 10.1007/s001670050224
   Seldes RM, 2001, CLIN ORTHOP RELAT R, P232
   Shepherd DET, 1999, RHEUMATOLOGY, V38, P124, DOI 10.1093/rheumatology/38.2.124
   Shepherd DET, 1997, P I MECH ENG H, V211, P155, DOI 10.1243/0954411971534278
   TISSAKHT M, 1995, J BIOMECH, V28, P411, DOI 10.1016/0021-9290(94)00081-E
   Toshiaki A, 2005, ACTA ORTHOP, V76, P509, DOI 10.1080/17453670510041493
   VANGSNESS CT, 1995, ARTHROSCOPY, V11, P180, DOI 10.1016/0749-8063(95)90064-0
   VIIDIK A, 1972, Z ANAT ENTWICKLUNGS, V136, P204, DOI 10.1007/BF00519178
   Wilke HJ, 2001, CLIN BIOMECH, V16, pS111, DOI 10.1016/S0268-0033(00)00103-0
   Wren TAL, 2003, ANN BIOMED ENG, V31, P710, DOI 10.1114/1.1569267
   XU WS, 1992, J BIOMECH ENG-T ASME, V114, P170, DOI 10.1115/1.2891368
   Zhao D, 2007, J ORTHOP RES, V25, P593, DOI 10.1002/jor.20362
NR 86
TC 5
Z9 6
U1 0
U2 8
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0268-0890
J9 CURR ORTHOPAED
JI Curr. Orthop.
PD OCT
PY 2008
VL 22
IS 5
BP 341
EP 348
DI 10.1016/j.cuor.2008.07.010
PG 8
WC Orthopedics
SC Orthopedics
GA 386JP
UT WOS:000261879800005
DA 2018-10-19
ER

PT J
AU Balamurugan, A
   Balossier, G
   Laurent-Maquin, D
   Pina, S
   Rebelo, AHS
   Faure, J
   Ferreira, JMF
AF Balamurugan, A.
   Balossier, G.
   Laurent-Maquin, D.
   Pina, S.
   Rebelo, A. H. S.
   Faure, J.
   Ferreira, J. M. F.
TI An in vitro biological and anti-bacterial study on a sol-gel derived
   silver-incorporated bioglass system
SO DENTAL MATERIALS
LA English
DT Article
DE sol-gel; bacteriostatic; silver; biomaterial
ID BIOACTIVE GLASS; SURFACE; TISSUE; COMPOSITES; BACTERIA; IONS; CELL
AB Objectives. The purpose of this study was to evaluate the in vitro antibacterial and biological activity of silver-incorporated bioactive glass system SiO2-CaO-P2O5-Ag2O (AgBG). The bacteriostatic and bactericidal proper-ties of this new quaternary glass system along with the ternary sol-gel glass system SiO2-CaO-P2O5 (BG) have been studied using Escherichia coli as a test micro-organism. The AGBG system thus appears to be a promising material for dental applications, since similar effects might be produced on a film of bacteria and mucous that grows on the teeth.
   Methods. The SiO2-CaO-P2O5-Ag2O and SiO2-CaO-P2O5 glass systems were synthesized by the sol-gel technique and characterized for their physicho-chemical properties. The antibacterial activity and biological properties were evaluated by determining the minimum inhibitory concentrations (MICs). Release of Ag+ into the culture medium was measured by inductively coupled plasma (ICP) analysis.
   Results. The in vitro antibacterial action of the SiO2-CaO-P2O5-Ag2O was compared with that of its ternary counterpart glass system. The concentrations of Ag-bioglass, in the range of 0.02-0.20 mg of Ag-bioglass per millilitre of culture medium, were found to inhibit the growth of these bacteria. The Ag-bioglass not only acts bacteriostatically but it also elicited a rapid bactericidal action. A complete bactericidal effect was elicited in the early stages of the incubation at Ag-bioglass concentration of 20mg/ml and the ternary glass system had no effect on bacterial growth or viability. The antibacterial action of Ag-bioglass was exclusively attributed to the leaching of Ag+ ions from the glass matrix.
   Significance. One of the major advantages of incorporating silver ions into a gel glass system is that the porous glass matrix can allow for controlled sustained delivery of the antibacterial agent to dental material, used even under anaerobic conditions such as deep in the periodontal pocket. This glass system also provides long-term action required for systems which are constantly at risk of microbial contamination. (C) 2008 Academy of Dental Materials. Published by Elsevier Ltd. All rights reserved.
C1 [Balamurugan, A.; Pina, S.; Rebelo, A. H. S.; Ferreira, J. M. F.] Univ Aveiro, Dept Ceram & Glass Engn, CICECO, P-3810193 Aveiro, Portugal.
   [Balossier, G.; Faure, J.] Univ Reims, INSERM, Lab Microscopie Elect Analyt, ERM 0203, F-51685 Reims 2, France.
   [Laurent-Maquin, D.] Univ Reims, INSERM, ERM 0203, F-51096 Reims 2, France.
RP Ferreira, JMF (reprint author), Univ Aveiro, Dept Ceram & Glass Engn, CICECO, P-3810193 Aveiro, Portugal.
EM jmf@cv.ua.pt
RI Pina, Sandra/H-8133-2013
OI Pina, Sandra/0000-0002-4361-1253; Ferreira, Jose/0000-0002-7520-2809
FU CICECO; INSERM ERM0203; University of Reims, France
FX The work was supported by CICECO, University of Aveiro, Portugal. The
   authors would like to acknowledge the support and technical assistance
   of L. Wortham and S. Bouthors INSERM ERM0203, Centre for Bioactive
   Materials and Tissue Engineering, University of Reims, France.
CR Adams AP, 1999, VET SURG, V28, P219, DOI 10.1053/jvet.1999.0219
   *AM SOC MICR, 1981, MAN METH GEN BACT
   [Anonymous], 92771995E ISO
   Balabas MV, 2007, NAT PHYS, V3, P2, DOI 10.1038/nphys496
   Blaker JJ, 2004, BIOMATERIALS, V25, P1319, DOI 10.1016/j.biomaterials.2003.08.007
   Bosetti M, 2002, BIOMATERIALS, V23, P887, DOI 10.1016/S0142-9612(01)00198-3
   Cao WP, 1996, CERAM INT, V22, P493, DOI 10.1016/0272-8842(95)00126-3
   CARLISLE EM, 1996, SILICON BIOCH, P123
   CHU CS, 1988, J TRAUMA, V28, P1488, DOI 10.1097/00005373-198810000-00016
   DEITCH EA, 1987, J TRAUMA, V27, P301
   Efrima S, 1998, J PHYS CHEM B, V102, P5947, DOI 10.1021/jp9813903
   FILGUEIRAS MR, 1993, J BIOMED MATER RES, V27, P445, DOI 10.1002/jbm.820270405
   George N, 1997, BURNS, V23, P493, DOI 10.1016/S0305-4179(97)00047-8
   Gillam DG, 2002, J ORAL REHABIL, V29, P305, DOI 10.1046/j.1365-2842.2002.00824.x
   Grier N., 1983, DISINFECTION STERILI
   Hattar S, 2005, BIOMATERIALS, V26, P839, DOI 10.1016/j.biomaterials.2004.03.026
   Hench LL, 1998, J BIOMED MATER RES, V41, P511, DOI 10.1002/(SICI)1097-4636(19980915)41:4<511::AID-JBM1>3.0.CO;2-F
   Hench LL, 1998, J SOL-GEL SCI TECHN, V13, P245, DOI 10.1023/A:1008643303888
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Kawashita M, 2000, BIOMATERIALS, V21, P393, DOI 10.1016/S0142-9612(99)00201-X
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Lee BS, 2005, DENT MATER J, V24, P562, DOI 10.4012/dmj.24.562
   Liau SY, 1997, LETT APPL MICROBIOL, V25, P279, DOI 10.1046/j.1472-765X.1997.00219.x
   Marcolongo M, 1998, J BIOMED MATER RES, V39, P161, DOI 10.1002/(SICI)1097-4636(199801)39:1<161::AID-JBM18>3.0.CO;2-I
   PEREIRA MM, 1994, J BIOMED MATER RES, V28, P693, DOI 10.1002/jbm.820280606
   PEREIRA MM, 1995, J AM CERAM SOC, V78, P2463, DOI 10.1111/j.1151-2916.1995.tb08686.x
   Perez-Pariente J, 1999, J BIOMED MATER RES, V47, P170, DOI 10.1002/(SICI)1097-4636(199911)47:2<170::AID-JBM6>3.0.CO;2-J
   Saravanapavan P, 2004, KEY ENG MATER, V254-2, P1087, DOI 10.4028/www.scientific.net/KEM.254-256.1087
   Saravanapavan P, 2001, J BIOMED MATER RES, V54, P608, DOI 10.1002/1097-4636(20010315)54:4<608::AID-JBM180>3.0.CO;2-U
   Sepulveda P, 2001, J BIOMED MATER RES, V58, P734, DOI 10.1002/jbm.10026
   SILHAVY TJ, 1984, EXPT GENE FUSION
   Slawson R M, 1990, Biol Met, V3, P151, DOI 10.1007/BF01140573
   SOLIOZ M, 1995, J BIOL CHEM, V270, P9217, DOI 10.1074/jbc.270.16.9217
   Stamboulis AG, 2002, ADV ENG MATER, V4, P105, DOI 10.1002/1527-2648(200203)4:3<105::AID-ADEM105>3.3.CO;2-C
   THOMPSON M, 1989, HDB INDUCTIVELY COUP
   Tiller JC, 2001, P NATL ACAD SCI USA, V98, P5981, DOI 10.1073/pnas.111143098
   WELLS TNC, 1995, BIOCHEMISTRY-US, V34, P7896, DOI 10.1021/bi00024a014
   Zamet JS, 1997, J CLIN PERIODONTOL, V24, P410, DOI 10.1111/j.1600-051X.1997.tb00205.x
NR 38
TC 141
Z9 148
U1 2
U2 57
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0109-5641
J9 DENT MATER
JI Dent. Mater.
PD OCT
PY 2008
VL 24
IS 10
BP 1343
EP 1351
DI 10.1016/j.dental.2008.02.015
PG 9
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA 350NQ
UT WOS:000259359800008
PM 18405962
DA 2018-10-19
ER

PT J
AU Lattanzi, W
   Parrilla, C
   Fetoni, A
   Logroscino, G
   Straface, G
   Pecorini, G
   Stigliano, E
   Tampieri, A
   Bedini, R
   Pecci, R
   Michetti, F
   Gambotto, A
   Robbins, PD
   Pola, E
AF Lattanzi, W.
   Parrilla, C.
   Fetoni, A.
   Logroscino, G.
   Straface, G.
   Pecorini, G.
   Stigliano, E.
   Tampieri, A.
   Bedini, R.
   Pecci, R.
   Michetti, F.
   Gambotto, A.
   Robbins, P. D.
   Pola, E.
TI Ex vivo-transduced autologous skin fibroblasts expressing human Lim
   mineralization protein-3 efficiently form new bone in animal models
SO GENE THERAPY
LA English
DT Article
DE LMP; autologous transplantation; skin fibroblasts; bone formation;
   animal models
ID MARROW STROMAL CELLS; REGIONAL GENE-THERAPY; MUSCLE-DERIVED CELLS;
   IN-VIVO; STEM-CELLS; OSTEOBLAST DIFFERENTIATION; COMPUTED-TOMOGRAPHY;
   VITRO; REGENERATION; LMP-1
AB Local gene transfer of the human Lim mineralization protein (LMP), a novel intracellular positive regulator of the osteoblast differentiation program, can induce efficient bone formation in rodents. To develop a clinically relevant gene therapy approach to facilitate bone healing, we have used primary dermal fibroblasts transduced ex vivo with Ad. LMP-3 and seeded on a hydroxyapatite/collagen matrix prior to autologous implantation. Here, we demonstrate that genetically modified autologous dermal fibroblasts expressing Ad. LMP-3 are able to induce ectopic bone formation following implantation of the matrix into mouse triceps and paravertebral muscles. Moreover, implantation of the Ad. LMP-3-modified dermal fibroblasts into a rat mandibular bone critical size defect model results in efficient healing, as determined by X-rays, histology and three-dimensional microcomputed tomography (3DmCT). These results demonstrate the effectiveness of the non-secreted intracellular osteogenic factor LMP-3 in inducing bone formation in vivo. Moreover, the utilization of autologous dermal fibroblasts implanted on a biomaterial represents a promising approach for possible future clinical applications aimed at inducing new bone formation.
C1 [Lattanzi, W.; Michetti, F.] Univ Cattolica Sacro Cuore, Dept Anat & Cell Biol, I-168 Rome, Italy.
   [Parrilla, C.; Fetoni, A.] Univ Cattolica Sacro Cuore, Dept Otolaryngol, I-168 Rome, Italy.
   [Logroscino, G.; Pola, E.] Univ Cattolica Sacro Cuore, Dept Orthopaed, Sch Med, I-168 Rome, Italy.
   [Straface, G.; Pecorini, G.] Univ Cattolica Sacro Cuore, Dept Internal Med, Sch Med, I-168 Rome, Italy.
   [Stigliano, E.] Univ Cattolica Sacro Cuore, Dept Pathol, Sch Med, I-168 Rome, Italy.
   [Tampieri, A.] CNR Natl Res Council, Dept Sci & Technol Ceram ISTEC, Faenza, Italy.
   [Bedini, R.; Pecci, R.] Ist Super Sanita, Technol & Hlth Dept, I-00161 Rome, Italy.
   [Michetti, F.] Latium Musculoskeletal Tissue Bank, Rome, Italy.
   [Gambotto, A.; Robbins, P. D.] Univ Pittsburgh, Sch Med, Dept Mol Genet & Biochem, Pittsburgh, PA USA.
RP Pola, E (reprint author), Univ Cattolica Sacro Cuore, Dept Orthopaed & Traumatol, Sch Med, Lgo Gemelli 8, I-168 Rome, Italy.
EM enrico.pola@rm.unicatt.it
RI Bedini, Rossella/B-2465-2013; Pecci, Raffaella/B-2508-2013
OI FETONI, ANNA RITA/0000-0001-5405-4301; LOGROSCINO,
   GIANDOMENICO/0000-0003-1301-5343; Bedini, Rossella/0000-0002-0830-6632
FU Italian Society of Orthopaedics and Traumatology
FX Enrico Pola was supported by a grant of the Italian Society of
   Orthopaedics and Traumatology. We thank Kaori Okada and Sun Huijie
   (Department of Surgery, University of Pittsburgh School of Medicine,
   Pittsburgh, PA, USA), and Alessandro Sbriccoli (Institute of Anatomy and
   Cell Biology, Universita` Cattolica del Sacro Cuore, Rome, Italy), for
   their invaluable technical assistance.
CR Baltzer AWA, 2000, CLIN ORTHOP RELAT R, pS120
   Blum JS, 2003, HUM GENE THER, V14, P1689, DOI 10.1089/104303403322611719
   Boden SD, 1998, SPINE, V23, P2486, DOI 10.1097/00007632-199812010-00003
   Boden SD, 1998, ENDOCRINOLOGY, V139, P5125, DOI 10.1210/en.139.12.5125
   Chang SCN, 2003, GENE THER, V10, P2013, DOI 10.1038/sj.gt.3302106
   FELDKAMP LA, 1989, J BONE MINER RES, V4, P3, DOI 10.1002/jbmr.5650040103
   Gugala Z, 2003, GENE THER, V10, P1289, DOI 10.1038/sj.gt.3302006
   Hirata K, 2003, BONE, V32, P502, DOI 10.1016/S8756-3282(03)00054-1
   Krebsbach PH, 2000, HUM GENE THER, V11, P1201, DOI 10.1089/10430340050015248
   Landi E, 2008, J MATER SCI-MATER M, V19, P239, DOI 10.1007/s10856-006-0032-y
   Lattanzi W, 2005, Eur Rev Med Pharmacol Sci, V9, P167
   Lee JY, 2002, HUM GENE THER, V13, P1201, DOI 10.1089/104303402320138989
   Lieberman JR, 1999, J BONE JOINT SURG AM, V81A, P905, DOI 10.2106/00004623-199907000-00002
   Liu YS, 2002, J BONE MINER RES, V17, P406, DOI 10.1359/jbmr.2002.17.3.406
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Mauney JR, 2005, BIOMATERIALS, V26, P3173, DOI 10.1016/j.biomaterials.2004.08.020
   Mauney JR, 2004, BIOMATERIALS, V25, P3233, DOI 10.1016/j.biomaterials.2003.10.005
   Minamide A, 2003, J BONE JOINT SURG AM, V85A, P1030, DOI 10.2106/00004623-200306000-00007
   Moutsatsos IK, 2001, MOL THER, V3, P449, DOI 10.1006/mthe.2001.0291
   Muller R, 1998, BONE, V23, P59, DOI 10.1016/S8756-3282(98)00068-4
   Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5
   Nussenbaum B, 2003, HUM GENE THER, V14, P1107, DOI 10.1089/104303403322124819
   Peng HR, 2002, J CLIN INVEST, V110, P751, DOI 10.1172/JCI200215153
   Pola E, 2004, GENE THER, V11, P683, DOI 10.1038/sj.gt.3302207
   Rutherford RB, 2002, TISSUE ENG, V8, P441, DOI 10.1089/107632702760184709
   Sangadala S, 2006, J BIOL CHEM, V281, P17212, DOI 10.1074/jbc.M511013200
   SASOV AY, 1987, J MICROSC-OXFORD, V147, P169, DOI 10.1111/j.1365-2818.1987.tb02829.x
   Shen HC, 2004, BONE, V34, P982, DOI 10.1016/j.bone.2004.01.028
   Sugiyama O, 2005, MOL THER, V11, P390, DOI 10.1016/j.ymthe.2004.10.019
   Tampieri A, 2003, J BIOMED MATER RES A, V67A, P618, DOI 10.1002/jbm.a.10039
   Tsuda H, 2005, J GENE MED, V7, P1322, DOI 10.1002/jgm.777
   Viggeswarapu M, 2001, J BONE JOINT SURG AM, V83A, P364, DOI 10.2106/00004623-200103000-00008
   Wang JC, 2003, J BONE JOINT SURG AM, V85A, P905, DOI 10.2106/00004623-200305000-00020
   Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944
   Yang M, 2005, CYTOTHERAPY, V7, P273, DOI 10.1080/14653240510027244
   Yoon ST, 2004, SPINE, V29, P2603, DOI 10.1097/01.brs.0000146103.94600.85
   Young DW, 2005, J CELL BIOCHEM, V94, P720, DOI 10.1002/jcb.20332
   Zhang XS, 2004, J GENE MED, V6, P4, DOI 10.1002/jgm.477
NR 38
TC 42
Z9 46
U1 0
U2 7
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0969-7128
J9 GENE THER
JI Gene Ther.
PD OCT
PY 2008
VL 15
IS 19
BP 1330
EP 1343
DI 10.1038/gt.2008.116
PG 14
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity; Medicine, Research & Experimental
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity; Research & Experimental Medicine
GA 348PN
UT WOS:000259222500005
PM 18633445
OA Green Accepted, Bronze
DA 2018-10-19
ER

PT J
AU Weir, C
   Morel-Kopp, MC
   Gill, A
   Tinworth, K
   Ladd, L
   Hunyor, SN
   Ward, C
AF Weir, Christopher
   Morel-Kopp, Marie-Christine
   Gill, Anthony
   Tinworth, Kellie
   Ladd, Leigh
   Hunyor, Stephen N.
   Ward, Christopher
TI Mesenchymal stem cells: Isolation, characterisation and in vivo
   fluorescent dye tracking
SO HEART LUNG AND CIRCULATION
LA English
DT Article
DE mesenchymal stem cells (MSC); CM-DiI; cell division and differentiation;
   sheep; biomaterials; scaffold
ID BONE-MARROW; MULTILINEAGE DIFFERENTIATION; TRANSPLANTATION;
   CARDIOMYOCYTES; MYOCARDIUM; DISEASE; REPAIR; HEART
AB Cell therapies have been used to regenerate the heart by direct myocardial delivery, by coronary infusion and by surface attached scaffolds. Multipotent mesenchymal stem cells (MSC) with capacity to differentiate into cardiomyocytes and other cell lines have been predominantly trialled in rodents. However, large animal models are increasingly needed to translate basic research into new, safe regenerative therapies. Understanding the mode of action of cell therapies in the mammalian heart has been limited by cell tracking capability. This study examined the ability to track the fate of allogeneic MSC in sheep using various fluorescent dyes.
   MSC isolated from sheep bone marrow were grown in culture following extraction and flow cytometric characterisation. After labelling with fluorescent tracking dyes (e.g. CFSE and DiI) cells were tested for in vitro and in vivo signal up to six weeks. Labelling effect on cell division and differentiation was studied.
   Several dyes lost fluorescence and slowed cell division. However, the thiol reactive dye CM-DiI showed detectable in vivo fluorescence in labelled MSC six weeks after injection into sheep skeletal muscle and two weeks after implantation of an MSC coated biomaterial scaffold. CM-DiI labelled MSC differentiated in vitro showed label retention over four weeks.
   The fluorescent membrane dye CM-DiI tracks implanted sheep MSC and provides an alternative to traditional cell markers such as gene modified GFP.
C1 [Hunyor, Stephen N.] Univ Sydney, Royal N Shore Hosp, Cardiac Technol Ctr, Dept Cardiol, Sydney, NSW 2065, Australia.
   [Weir, Christopher; Tinworth, Kellie; Ladd, Leigh; Hunyor, Stephen N.] Kolling Inst, Sydney, NSW, Australia.
   [Weir, Christopher; Morel-Kopp, Marie-Christine; Ward, Christopher] Northern Blood Res Ctr, Sydney, NSW, Australia.
   [Weir, Christopher; Morel-Kopp, Marie-Christine; Ward, Christopher] St Vincents Hosp, Dept Haematol, Sydney, NSW 2010, Australia.
   [Gill, Anthony] Dept Anat Pathol, Sydney, NSW, Australia.
RP Hunyor, SN (reprint author), Univ Sydney, Royal N Shore Hosp, Cardiac Technol Ctr, Dept Cardiol, Sydney, NSW 2065, Australia.
EM stephenh@med.usyd.edu.au
RI Gill, Anthony/D-4215-2015; Morel-Kopp, Marie-Christine/A-7470-2015
OI Gill, Anthony/0000-0002-9447-1967; Morel-Kopp,
   Marie-Christine/0000-0003-4795-1746; Ladd, Leigh/0000-0001-5997-9637
FU North Shore Heart Research Foundation [13-04/05]
FX This project was supported by North Shore Heart Research Foundation
   Grant # 13-04/05.
CR Bosnakovski D, 2005, CELL TISSUE RES, V319, P243, DOI 10.1007/s00441-004-1012-5
   Choi D, 2002, J NEUROSCI METH, V117, P167, DOI 10.1016/S0165-0270(02)00098-5
   Dai WD, 2005, CIRCULATION, V112, P214, DOI 10.1161/CIRCULATIONAHA.104.527937
   Fukuda K, 2001, ARTIF ORGANS, V25, P187, DOI 10.1046/j.1525-1594.2001.025003187.x
   Gronthos S, 2003, J CELL SCI, V116, P1827, DOI 10.1242/jcs.00369
   Hassink RJ, 2003, J AM COLL CARDIOL, V41, P711, DOI 10.1016/S0735-1097(02)02933-9
   HAUGLAND R, 2005, MOL PROBES INVITROGE, P670
   Kawada H, 2004, BLOOD, V104, P3581, DOI 10.1182/blood-2004-04-1488
   Kovacic JC, 2005, INTERN MED J, V35, P348, DOI 10.1111/j.1445-5994.2005.00840.x
   Li WJ, 2005, BIOMATERIALS, V26, P5158, DOI 10.1016/j.biomaterials.2005.01.002
   Liu JB, 2004, AM J PHYSIOL-HEART C, V287, pH501, DOI 10.1152/ajpheart.00019.2004
   LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4
   Makino S, 1999, J CLIN INVEST, V103, P697, DOI 10.1172/JCI5298
   Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587
   Piao H, 2005, EUR J HEART FAIL, V7, P730, DOI 10.1016/j.ejheart.2004.09.019
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Povysil C, 2005, Cesk Patol, V41, P133
   Rhodes NP, 2004, J MATER SCI-MATER M, V15, P391, DOI 10.1023/B:JMSM.0000021108.74004.7e
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Teng CJ, 2006, J THORAC CARDIOV SUR, V132, P628, DOI 10.1016/j.jtcvs.2006.05.034
   Weber A, 2004, EUR J CARDIO-THORAC, V26, P137, DOI 10.1016/j.ejcts.2004.03.024
   Zeng LP, 2007, CIRCULATION, V115, P1866, DOI 10.1161/CIRCULATIONAHA.106.659730
NR 22
TC 67
Z9 76
U1 0
U2 17
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1443-9506
J9 HEART LUNG CIRC
JI Heart Lung Circ.
PD OCT
PY 2008
VL 17
IS 5
BP 395
EP 403
DI 10.1016/j.hlc.2008.01.006
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 350MK
UT WOS:000259356400008
PM 18396458
DA 2018-10-19
ER

PT J
AU Hoover-Plow, JL
   Gong, Y
   Shchurin, A
   Busuttil, SJ
   Schneeman, TA
   Hart, E
AF Hoover-Plow, J. L.
   Gong, Y.
   Shchurin, A.
   Busuttil, S. J.
   Schneeman, T. A.
   Hart, E.
TI Strain and model dependent differences in inflammatory cell recruitment
   in mice
SO INFLAMMATION RESEARCH
LA English
DT Article
DE Leukocyte recruitment; Peritoneal inflammation; Inbred mouse strains;
   Metalloproteinase-9; Cytokines
ID INDUCED AIRWAY INFLAMMATION; MATRIX METALLOPROTEINASES; MURINE MODEL;
   MATRIX-METALLOPROTEINASE-9; PLASMINOGEN; RESPONSES; BIOMATERIALS;
   POLYMORPHISMS; INFILTRATION; PATHOGENESIS
AB Objective and design: The objective of this study was to determine genetic differences in inflammation in these distinct inbred mouse strains.
   Methods: Peritoneal leukocyte recruitment, matrix metalloproteinases and cytokines were quantified in A/J, 129/svJ, C57BL/6J. using thioglycollate or biomaterial implants as inflammatory stimuli.
   Results: In response to thioglycollate, A/J had significant decreases compared to C57BL/6J in both neutrophil (86%) and macrophage (62%) recruitment, and 129/svJ had a significant (43%) decrease compared to C57BL/6J in macrophage recruitment. The reduced leukocyte recruitment corresponded to reduced matrix metalloproteinase-9. In the bioimplant model, 129/svJ had a 2-fold increase in neutrophil and macrophage recruitment compared to C57BL/6J, and the increased leukocyte recruitment corresponded to elevated cytok-ines, monocyte inhibitory protein-2 and monocyte chemoattractant protein-1, in the lavage compared to the values for C57BL/6J.
   Conclusion: Not only was leukocyte recruitment strain dependent, but the three strains had marked differences in metalloproteinases and cytokine response. In addition, there were model specific differences in the metalloproteinase and cytokine response to the two inflammatory stimuli. Thus, inflammatory cell recruitment is genetically determined and stimulus specific and may determine the susceptibility to complex diseases.
C1 [Hoover-Plow, J. L.; Gong, Y.; Hart, E.] Cleveland Clin, Lerner Res Inst, Dept Cardiovasc Med, Joseph J Jacobs Ctr Thrombosis & Vasc Biol, Cleveland, OH 44195 USA.
   [Hoover-Plow, J. L.; Gong, Y.; Hart, E.] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA.
   [Busuttil, S. J.] Div Vasc Surg, Baltimore, MD 21201 USA.
   [Schneeman, T. A.] Cleveland Publ Sch, Cleveland, OH 44114 USA.
   [Shchurin, A.] Oakwood Hlth Care Syst, Med Educ Int Med, Dearborn, MI 48133 USA.
RP Hoover-Plow, JL (reprint author), Cleveland Clin, Lerner Res Inst, Dept Cardiovasc Med, Joseph J Jacobs Ctr Thrombosis & Vasc Biol, NB50,9500 Euclid Ave, Cleveland, OH 44195 USA.
EM hooveri@ccf.org
FU NIH [T32 HL07914, H1.17964, HL65205, HL078701]
FX The authors thank Dr. Edward Plow for his helpful discussion and review
   of the manuscript and Dr. Yelena Shchurina for assistance with the
   thioglycollate model, and R. Lewis and N. Klimczak for assistance with
   manuscript preparation. This study was supported by Prants from NIH. T32
   HL07914 (AS). H1.17964, HL65205, HL078701 Julp).
CR Abou-Raya A, 2006, AUTOIMMUN REV, V5, P331, DOI 10.1016/j.autrev.2005.12.006
   Atkinson JJ, 2003, AM J RESP CELL MOL, V28, P12, DOI 10.1165/rcmb.2002-0166TR
   Betsuyaku T, 1999, AM J RESP CELL MOL, V20, P1303, DOI 10.1165/ajrcmb.20.6.3558
   Bhatt DL, 2003, AM J CARDIOL, V92, P136, DOI 10.1016/S0002-9149(03)00527-7
   Bjarnadottir K, 2006, ATHEROSCLEROSIS, V188, P341, DOI 10.1016/j.atherosclerosis.2005.11.014
   Busuttil SJ, 2004, J THROMB HAEMOST, V2, P1798, DOI 10.1111/j.1538-7836.2004.00916.x
   CARMELIET P, 1994, NATURE, V368, P419, DOI 10.1038/368419a0
   Cataldo DD, 2002, AM J PATHOL, V161, P491, DOI 10.1016/S0002-9440(10)64205-8
   Delano DL, 2005, INFLAMMATION, V29, P1, DOI 10.1007/s10753-006-8962-6
   Garg P, 2006, J IMMUNOL, V177, P4103, DOI 10.4049/jimmunol.177.6.4103
   GREENBERGER MJ, 1995, J IMMUNOL, V155, P722
   HIMMELHOCH SR, 1969, BIOCHEMISTRY-US, V8, P914, DOI 10.1021/bi00831a022
   Hoover-Plow Jane, 2006, BMC Blood Disord, V6, P6, DOI 10.1186/1471-2326-6-6
   Imahara Scott D, 2004, Curr Opin Crit Care, V10, P318, DOI 10.1097/01.ccx.0000140942.42247.7e
   Kolaczkowska E, 2006, IMMUNOBIOLOGY, V211, P137, DOI 10.1016/j.imbio.2005.08.004
   Kurzawski M, 2005, INT J IMMUNOGENET, V32, P285, DOI 10.1111/j.1744-313X.2005.00524.x
   Liu Z, 2005, J CLIN INVEST, V115, P879, DOI 10.1172/JCI200523977
   Lu B, 1998, J EXP MED, V187, P601, DOI 10.1084/jem.187.4.601
   McMillan SJ, 2004, J IMMUNOL, V172, P2586, DOI 10.4049/jimmunol.172.4.2586
   NADEAU JH, 1995, J INFLAMM, V45, P27
   Nakashima K, 2006, BIOCHEM BIOPH RES CO, V344, P300, DOI 10.1016/j.bbrc.2006.03.102
   Natividad A, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-40
   Olson TS, 2002, AM J PHYSIOL-REG I, V283, pR7, DOI 10.1152/ajpregu.00738.2001
   Ploplis VA, 1998, BLOOD, V91, P2005
   Ramos CDL, 2006, EUR J IMMUNOL, V36, P2025, DOI 10.1002/eji.200636057
   Renckens R, 2006, J IMMUNOL, V176, P3735, DOI 10.4049/jimmunol.176.6.3735
   Roche JK, 2007, AM J PATHOL, V170, P526, DOI 10.2353/ajpath.2007.060366
   Stamenkovic I, 2003, J PATHOL, V200, P448, DOI 10.1002/path.1400
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Tang LP, 1996, J CLIN INVEST, V97, P1329, DOI 10.1172/JCI118549
   Tang LP, 2002, J BIOMED MATER RES, V62, P471, DOI 10.1002/jbm.10271
   Tarlton JF, 2000, AM J PATHOL, V157, P1927, DOI 10.1016/S0002-9440(10)64831-6
   TORRES JL, 1988, ARCH BIOCHEM BIOPHYS, V267, P271, DOI 10.1016/0003-9861(88)90032-X
   Van den Steen PE, 2001, BBA-GEN SUBJECTS, V1528, P61, DOI 10.1016/S0304-4165(01)00190-8
   Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D
   White P, 2002, J IMMUNOL, V168, P869, DOI 10.4049/jimmunol.168.2.869
NR 36
TC 19
Z9 19
U1 0
U2 1
PU BIRKHAUSER VERLAG AG
PI BASEL
PA VIADUKSTRASSE 40-44, PO BOX 133, CH-4010 BASEL, SWITZERLAND
SN 1023-3830
J9 INFLAMM RES
JI Inflamm. Res.
PD OCT
PY 2008
VL 57
IS 10
BP 457
EP 463
DI 10.1007/s00011-008-7062-5
PG 7
WC Cell Biology; Immunology
SC Cell Biology; Immunology
GA 387XL
UT WOS:000261984800003
PM 18827970
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Dubois, G
   Segers, VFM
   Bellamy, V
   Sabbah, L
   Peyrard, S
   Bruneval, P
   Hagege, AA
   Lee, RT
   Menasche, P
AF Dubois, Gilbert
   Segers, Vincent F. M.
   Bellamy, Valerie
   Sabbah, Laurent
   Peyrard, Severine
   Bruneval, Patrick
   Hagege, Albert A.
   Lee, Richard T.
   Menasche, Philippe
TI Self-assembling peptide nanofibers and skeletal myoblast transplantation
   in infarcted myocardium
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE allogeneic cell; cardiac tissue engineering; cell proliferation; muscle;
   peptide; scaffold
ID DELIVERY; SCAFFOLDS; HEART
AB Cell transplantation is currently limited by poor graft retention and survival in the postinfarction scar. Because this issue could potentially be addressed by embedding cells in bioinjectable scaffolds and boosting cell survival pathways, we induced a myocardial infarction in 72 rats to assess the effects of different self-assembling peptides with or without platelet-derived growth factor (PDGF-BB) on survival of transplanted skeletal myoblasts. Two weeks after coronary artery ligation, rats were randomized to receive in-scar injections of culture medium (controls, n = 11), self-assembling peptide (RAD16-I) nanofibers (NF, n = 9), skeletal myoblasts (it = 12), or skeletal myoblasts in combination with NF (n = 8). In separate experiments with different self-assembling peptides (RAD16-II), rats received in-scar injections of culture medium (controls, n = 6), skeletal myoblasts (n = 10), PDGF-loaded peptides (n = 7), or skeletal myoblasts (5 X 106) in combination with PDGF-loaded peptides (n = 9). After I month, left ventricullar function, as assessed by echocardiography, was not improved in either of the experimental groups compared with controls. This correlated with the failure of RAD16-I peptides or PDGF-loaded RAD16-II peptides to improve myoblast survival despite a greater angiogenesis. In vitro experiments confirmed that the number of myoblasts decreased over time when seeded on nanofiber gels. These data suggest that the optimal use of biomaterial scaffolds for survival of transplanted cells will require specific tailoring of the biomaterial to the cell type. (C) 2008 Wiley Periodicals, Inc.
C1 [Sabbah, Laurent; Hagege, Albert A.; Menasche, Philippe] INSERM, Lab Biosurg Res, U633, F-75015 Paris, France.
   [Dubois, Gilbert] AP HP, Ecole Chirurg, F-75005 Paris, France.
   [Segers, Vincent F. M.; Lee, Richard T.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Cardiovasc Div,Dept Med, Boston, MA 02115 USA.
   [Bellamy, Valerie] INSERM, Lab Biosurg Res, U633, F-75014 Paris, France.
   [Sabbah, Laurent; Hagege, Albert A.] Hop Europeen Georges Pompidou, AP HP, Dept Cardiol, F-75015 Paris, France.
   [Sabbah, Laurent; Bruneval, Patrick; Hagege, Albert A.; Menasche, Philippe] Univ Paris 05, Fac Med, Paris, France.
   [Peyrard, Severine] Hop Europeen Georges Pompidou, AP HP, Epidemiol & Clin Res Unit, F-75015 Paris, France.
   [Peyrard, Severine] INSERM, CIE4, F-75015 Paris, France.
   [Bruneval, Patrick] Hopital Europeen Georges Pompiclou, AP HP, Dept Pathol, F-75015 Paris, France.
   [Bruneval, Patrick] INSERM, U430, F-75015 Paris, France.
   [Menasche, Philippe] Hop Europeen Georges Pompidou, AP HP, Dept Cardiovasc Surg, F-75015 Paris, France.
RP Menasche, P (reprint author), INSERM, Lab Biosurg Res, U633, F-75015 Paris, France.
EM philippe.menasche@egp.aphp.fr
OI HAGEGE, Albert/0000-0003-4685-6077; Segers, Vincent/0000-0001-7796-2222
FU Research Foundation - Flanders (FWO); Belgian American Educational
   Foundation; National Heart, Lung, and Blood Institute; LeDucq Foundation
   (CaPTAA network)
FX Research Foundation - Flanders (FWO); Belgian American Educational
   Foundation; National Heart, Lung, and Blood Institute; LeDucq Foundation
   (CaPTAA network)
CR Azarnoush K, 2005, J THORAC CARDIOV SUR, V130, P173, DOI 10.1016/j.jtcvs.2004.11.044
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Edelberg JM, 2002, CIRCULATION, V105, P608, DOI 10.1161/hc0502.103672
   Gelain F, 2007, J NANOSCI NANOTECHNO, V7, P424, DOI 10.1166/jnn.2007.154
   Genove E, 2005, BIOMATERIALS, V26, P3341, DOI 10.1016/j.biomaterials.2004.08.012
   Holmes TC, 2002, TRENDS BIOTECHNOL, V20, P16, DOI 10.1016/S0167-7799(01)01840-6
   Hsieh PCH, 2006, CIRCULATION, V114, P637, DOI 10.1161/CIRCULATIONHA.106.639831
   Hsieh PCH, 2006, J CLIN INVEST, V116, P237, DOI 10.1172/JCI25878
   Maurel A, 2005, TRANSPLANTATION, V80, P660, DOI 10.1097/01.tp.0000172178.35488.31
   Narmoneva DA, 2005, BIOMATERIALS, V26, P4837, DOI 10.1016/j.biomaterials.2005.01.005
   Segers VFM, 2007, DRUG DISCOV TODAY, V12, P561, DOI 10.1016/j.drudis.2007.05.003
   Teng CJ, 2006, J THORAC CARDIOV SUR, V132, P628, DOI 10.1016/j.jtcvs.2006.05.034
   Zhang M, 2001, J MOL CELL CARDIOL, V33, P907, DOI 10.1006/jmcc.2001.1367
NR 15
TC 42
Z9 42
U1 0
U2 4
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD OCT
PY 2008
VL 87B
IS 1
BP 222
EP 228
DI 10.1002/jbm.b.31099
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 350CA
UT WOS:000259328900029
PM 18386833
DA 2018-10-19
ER

PT J
AU Abraham, LC
   Zuena, E
   Perez-Ramirez, B
   Kaplan, DL
AF Abraham, Leah C.
   Zuena, Erin
   Perez-Ramirez, Bernardo
   Kaplan, David L.
TI Guide to collagen characterization for biomaterial studies
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Review
DE collagen; characterization; denatured; structure; biomaterials
ID DIFFERENTIAL SCANNING CALORIMETRY; ATOMIC-FORCE MICROSCOPY; IN-VITRO
   CHARACTERIZATION; HUMAN-DIPLOID FIBROBLASTS; MARROW STROMAL CELLS;
   CIRCULAR-DICHROISM; AMINO-ACIDS; THERMAL-STABILITY; TRIPLE-HELIX;
   QUANTITATIVE-ANALYSIS
AB The structure and remodeling of collagen in vivo is critical to the pathology and healing of many human diseases, as well as to normal tissue development and regeneration. In addition, collagen matrices in the form of fibers, coatings, and films are used extensively in biomaterial and biomedical applications. The specific properties of these matrices, both in terms of physical and chemical characteristics, have a direct impact on cellular adhesion, spreading, and proliferation rates, and ultimately on the rate and extent of new extracellular matrix formation in vitro or in vivo. In recent studies, it has also been shown that collagen matrix structure has a major impact on cell and tissue outcomes related to cellular aging and differentiation potential. Collagen structure is complex because of both diversity of source materials, chemistry, and structural hierarchy. With such significant impact of collagen features on biological outcomes, it becomes essential to consider an appropriate set of analytical tools, or guide, so that collagens attained from commercial vendors are characterized in a comparative manner as an integral part of studies focused on biological parameters. The analysis should include as a starting point: (a) structural detail-mainly focused on molecular mass, purity, helical content, and bulk thermal properties, (b) chemical features-mainly focused on surface elemental analysis and hydrophobicity, and (c) morphological features at different length scales. The application of these analytical techniques to the characterization of collagen biomaterial matrices is critical in order to appropriately correlate biological responses from different studies with experimental outcomes in vitro or in vivo. As a case study, the analytical tools employed for collagen biomaterial studies are reviewed in the context of collagen remodeling by fibroblasts. The goal is to highlight the necessity of understanding collagen biophysical and chemical features as a prerequisite to (a) studies with cells and tissue formation, and (b) suggest modes to establish comparative outcomes for studies conducted in different laboratories. (C) 2008 Wiley Periodicals, Inc.
C1 [Abraham, Leah C.; Zuena, Erin; Kaplan, David L.] Tufts Univ, Dept Chem, Medford, MA 02155 USA.
   [Abraham, Leah C.; Zuena, Erin; Kaplan, David L.] Tufts Univ, Dept Biol Engn, Medford, MA 02155 USA.
   [Abraham, Leah C.; Zuena, Erin; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Bioengn & Biotechnol Ctr, Medford, MA 02155 USA.
   [Perez-Ramirez, Bernardo] Genzyme Corp, BioFormulat Dev, Framingham, MA 01701 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Chem, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
CR Abraham LC, 2004, J BIOMED MATER RES A, V70A, P39, DOI 10.1002/jbm.a.30057
   Abraham LC, 2007, EXP CELL RES, V313, P1045, DOI 10.1016/j.yexcr.2006.12.019
   Abraham LC, 2007, BIOMATERIALS, V28, P151, DOI 10.1016/j.biomaterials.2006.07.001
   Alberts B, 2002, MOL BIOL CELL
   Altankov G, 1996, J BIOMED MATER RES, V30, P385, DOI 10.1002/(SICI)1097-4636(199603)30:3<385::AID-JBM13>3.0.CO;2-J
   Angele P, 1999, TISSUE ENG, V5, P545, DOI 10.1089/ten.1999.5.545
   Awad HA, 2000, J BIOMED MATER RES, V51, P233, DOI 10.1002/(SICI)1097-4636(200008)51:2<233::AID-JBM12>3.0.CO;2-B
   Babu IR, 2001, J AM CHEM SOC, V123, P2079, DOI 10.1021/ja002165d
   Badii F, 2003, J AGR FOOD CHEM, V51, P1440, DOI 10.1021/jf020492u
   Baguneid M, 2004, BIOTECHNOL APPL BIOC, V39, P151, DOI 10.1042/BA20030148
   Basle MF, 1998, J BIOMED MATER RES, V40, P350, DOI 10.1002/(SICI)1097-4636(19980605)40:3<350::AID-JBM2>3.0.CO;2-E
   Ber S, 2005, BIOMATERIALS, V26, P1977, DOI 10.1016/j.biomaterials.2004.07.007
   Blair HC, 2002, BIOCHEM J, V364, P329, DOI 10.1042/BJ20020165
   BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191
   BONNER WM, 1974, EUR J BIOCHEM, V46, P83, DOI 10.1111/j.1432-1033.1974.tb03599.x
   BORNSTEIN MB, 1958, LAB INVEST, V7, P134
   BORNSTEIN P, 1979, CHEM BIOL COLLAGEN
   Brandt J, 1999, CLIN CHEM, V45, P47
   Brekken RA, 2000, MATRIX BIOL, V19, P569, DOI 10.1016/S0945-053X(00)00105-0
   Briggs D., 1998, SURFACE ANAL POLYM X
   Brocchini S, 1998, J BIOMED MATER RES, V42, P66, DOI 10.1002/(SICI)1097-4636(199810)42:1<66::AID-JBM9>3.0.CO;2-M
   Brown EM, 1997, J AM LEATHER CHEM AS, V92, P225
   Buijtenhuijs P, 2004, BIOTECHNOL APPL BIOC, V39, P141, DOI 10.1042/BA20030105
   BURGESON RE, 1992, CLIN ORTHOP RELAT R, V282, P250
   BURKE JF, 1981, ANN SURG, V194, P413, DOI 10.1097/00000658-198110000-00005
   CHAKRABARTTY A, 1994, PROTEIN SCI, V3, P843
   Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120
   CHEN KY, 1986, J CELL PHYSIOL, V128, P27, DOI 10.1002/jcp.1041280106
   Cheng ZY, 2004, BIOMATERIALS, V25, P1991, DOI 10.1016/j.biomaterials.2003.08.038
   Cherubino P, 2003, J Orthop Surg (Hong Kong), V11, P10
   Cochran DAE, 2001, PROTEIN SCI, V10, P1305, DOI 10.1110/ps.50701
   Consonni R, 2000, BIOPOLYMERS, V53, P99, DOI 10.1002/(SICI)1097-0282(200001)53:1<99::AID-BIP9>3.3.CO;2-4
   CRISTOFALO VJ, 1988, EXP GERONTOL, V23, P297, DOI 10.1016/0531-5565(88)90032-0
   CRISTOFALO VJ, 1993, PHYSIOL REV, V73, P617
   Day JS, 2004, BIORHEOLOGY, V41, P359
   Demers Laurence M., 2000, Cancer, V88, P2919, DOI 10.1002/1097-0142(20000615)88:12+<2919::AID-CNCR7>3.0.CO;2-Z
   Detamore MS, 2005, MATRIX BIOL, V24, P45, DOI 10.1016/j.matbio.2004.11.006
   Dewez JL, 1996, J BIOMED MATER RES, V30, P373
   Dewez JL, 1999, BIOMATERIALS, V20, P547, DOI 10.1016/S0142-9612(98)00207-5
   Diener A, 2005, BIOMATERIALS, V26, P383, DOI [10.1016/j.biomaterials.2004.02.038, 10.1016/j.biomaterials.2004.02.019]
   Dreisewerd K, 2004, ANAL CHEM, V76, P3482, DOI 10.1021/ac049928q
   Dunn CA, 2005, MOL THER, V11, P294, DOI 10.1016/j.ymthe.2004.10.005
   Eaglstein W H, 1998, Cutis, V62, P1
   Ehlers EM, 1999, ANN ANAT, V181, P513, DOI 10.1016/S0940-9602(99)80055-7
   EINBINDER J, 1951, J BIOL CHEM, V188, P335
   Ellerbroek SM, 2001, J BIOL CHEM, V276, P24833, DOI 10.1074/jbc.M005631200
   Ellerbroek SM, 2001, ARCH BIOCHEM BIOPHYS, V390, P51, DOI 10.1006/abbi.2001.2345
   Eriksen HA, 2004, BONE, V34, P720, DOI 10.1012/j.bone.2003.12.009
   Ferrando JM, 2001, WORLD J SURG, V25, P840, DOI 10.1007/s00268-001-0038-z
   FLANDIN F, 1984, BIOCHIM BIOPHYS ACTA, V791, P205, DOI 10.1016/0167-4838(84)90010-4
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Friess W, 2003, ADV DRUG DELIVER REV, V55, P1529, DOI 10.1016/j.addr.2003.08.001
   GALLOP PM, 1963, METHOD ENZYMOL, V6, P635, DOI 10.1016/0076-6879(63)06233-9
   Garfinkel S, 1996, BBA-MOL CELL RES, V1314, P109, DOI 10.1016/S0167-4889(96)00105-X
   Greenfield NJ, 1996, ANAL BIOCHEM, V235, P1, DOI 10.1006/abio.1996.0084
   GUSEV AI, 1995, ANAL CHEM, V67, P1034, DOI 10.1021/ac00102a003
   Habelitz S, 2002, J STRUCT BIOL, V138, P227, DOI 10.1016/S1047-8477(02)00029-1
   Hanley L, 1999, J MASS SPECTROM, V34, P705, DOI 10.1002/(SICI)1096-9888(199907)34:7<705::AID-JMS845>3.0.CO;2-B
   Hassenkam T, 2004, BONE, V35, P4, DOI 10.1016/j.bone.2004.02.024
   HAY ED, 1991, CELL BIOL EXTRACELLU, pR17
   HAYASHI T, 1979, BIOCHEMISTRY-US, V18, P4182, DOI 10.1021/bi00586a022
   HEALY KE, 1992, BIOMATERIALS, V13, P553, DOI 10.1016/0142-9612(92)90108-Z
   Hickman D, 2000, J BIOTECHNOL, V79, P245, DOI 10.1016/S0168-1656(00)00241-8
   Higuchi A, 2000, J BIOMAT SCI-POLYM E, V11, P149, DOI 10.1163/156856200743625
   HILDEBRAN JN, 1981, BIOCHEM J, V198, P249, DOI 10.1042/bj1980249
   Hsu SH, 2002, ARTIF ORGANS, V26, P647, DOI 10.1046/j.1525-1594.2002.06889.x
   Jelesarov I, 1999, J MOL RECOGNIT, V12, P3, DOI 10.1002/(SICI)1099-1352(199901/02)12:1<3::AID-JMR441>3.0.CO;2-6
   JENNESS DD, 1976, BIOPOLYMERS, V15, P513, DOI 10.1002/bip.1976.360150308
   Jiang FZ, 2004, MICROSC RES TECHNIQ, V64, P435, DOI 10.1002/jemt.20101
   KLEINMAN HK, 1982, BIOCHEMISTRY-US, V21, P6188, DOI 10.1021/bi00267a025
   Knott L, 1999, BRIT POULTRY SCI, V40, P371, DOI 10.1080/00071669987476
   KNOWLES GC, 1991, J CELL SCI, V98, P551
   Kordula T, 2002, INFECT IMMUN, V70, P419, DOI 10.1128/IAI.70.1.419-421.2002
   Kubisz L, 2003, INT J BIOL MACROMOL, V33, P89, DOI 10.1016/S0141-8130(03)00071-0
   KULJU KS, 1995, EXP CELL RES, V217, P336, DOI 10.1006/excr.1995.1095
   Kumar TR, 2003, J BIOMAT SCI-POLYM E, V14, P689, DOI 10.1163/156856203322274941
   Kwok DY, 1997, LANGMUIR, V13, P2880, DOI 10.1021/la9608021
   Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099
   LOW RB, 1986, CONNECT TISSUE RES, V14, P179, DOI 10.3109/03008208609014258
   Ma L, 2004, BIOMATERIALS, V25, P2997, DOI 10.1016/j.biomaterials.2003.09.092
   Mauney JR, 2004, BIOMATERIALS, V25, P3233, DOI 10.1016/j.biomaterials.2003.10.005
   Merrett K, 2002, J BIOMAT SCI-POLYM E, V13, P593, DOI 10.1163/156856202320269111
   MICHALOPOULOS G, 1975, EXP CELL RES, V94, P70, DOI 10.1016/0014-4827(75)90532-7
   Miles CA, 1999, BIOPHYS J, V76, P3243, DOI 10.1016/S0006-3495(99)77476-X
   MILLER EJ, 1971, BIOCHEMISTRY-US, V10, P1652, DOI 10.1021/bi00785a024
   Mizuno K, 2004, J BIOL CHEM, V279, P38072, DOI 10.1074/jbc.M402953200
   Morra M, 2003, BIOMATERIALS, V24, P4639, DOI 10.1016/S0142-9612(03)00360-0
   MU XC, 1995, J CELL PHYSIOL, V165, P647, DOI 10.1002/jcp.1041650324
   Murray MM, 2003, J ORTHOPAED RES, V21, P238, DOI 10.1016/S0736-0266(02)00142-0
   Ng KW, 2004, BIOMATERIALS, V25, P2807, DOI 10.1016/j.biomaterials.2003.09.058
   NIYIBIZI C, 1984, J BIOL CHEM, V259, P4170
   Paige MF, 2001, MICRON, V32, P341, DOI 10.1016/S0968-4328(00)00037-8
   Pamula E, 2004, J COLLOID INTERF SCI, V271, P80, DOI 10.1016/j.jcis.2003.11.012
   Patankar NA, 2004, LANGMUIR, V20, P8209, DOI 10.1021/la048629t
   Patino Maria G, 2002, Implant Dent, V11, P280, DOI 10.1097/00008505-200207000-00014
   PELTONEN L, 1980, P NATL ACAD SCI-BIOL, V77, P162, DOI 10.1073/pnas.77.1.162
   Qiu Q, 1998, J BIOMED MATER RES, V42, P117, DOI 10.1002/(SICI)1097-4636(199810)42:1<117::AID-JBM15>3.3.CO;2-0
   Ricard-Blum S., 2000, UNCONVENTIONAL COLLA
   Rochdi A, 1999, BIOPOLYMERS, V50, P690, DOI 10.1002/(SICI)1097-0282(199912)50:7<690::AID-BIP2>3.0.CO;2-P
   Rossi A, 1996, BIOCHEMISTRY-US, V35, P6048, DOI 10.1021/bi9518151
   SCHONHERR E, 1995, J BIOL CHEM, V270, P2776, DOI 10.1074/jbc.270.6.2776
   Shimizu T, 2003, BIOMATERIALS, V24, P2309, DOI 10.1016/S0142-9612(03)00110-8
   Sionkowska A, 1999, INT J BIOL MACROMOL, V24, P337, DOI 10.1016/S0141-8130(99)00047-1
   Stankus JJ, 2004, J BIOMED MATER RES A, V70A, P603, DOI 10.1002/jbm.a.30122
   SYKES B, 1976, BIOCHEM BIOPH RES CO, V72, P1472, DOI 10.1016/S0006-291X(76)80180-5
   Tam EM, 2004, J BIOL CHEM, V279, P43336, DOI 10.1074/jbc.M407186200
   TAMADA Y, 1994, J BIOMED MATER RES, V28, P783, DOI 10.1002/jbm.820280705
   Tampieri A, 2003, J BIOMED MATER RES A, V67A, P618, DOI 10.1002/jbm.a.10039
   Tan W, 2001, TISSUE ENG, V7, P203, DOI 10.1089/107632701300062831
   Torkian Behrooz A, 2004, Arch Facial Plast Surg, V6, P180, DOI 10.1001/archfaci.6.3.180
   TRENTHAM DE, 1977, J EXP MED, V146, P857, DOI 10.1084/jem.146.3.857
   Van Den Steen PE, 2002, FASEB J, V16, DOI 10.1096/fj.01-0688com
   Viravaidya K, 2002, BIOTECHNOL BIOENG, V78, P454, DOI 10.1002/bit.10219
   Volloch V, 2002, MATRIX BIOL, V21, P533, DOI 10.1016/S0945-053X(02)00038-0
   Vomund AN, 2004, MOL GENET METAB, V82, P144, DOI 10.1016/j.ymgme.2004.03.004
   VORM O, 1994, ANAL CHEM, V66, P3281, DOI 10.1021/ac00091a044
   Wang X, 2002, CALCIFIED TISSUE INT, V71, P186, DOI 10.1007/s00223-001-1082-2
   Wei L, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1891
   Wilson DL, 2001, P NATL ACAD SCI USA, V98, P13660, DOI 10.1073/pnas.241323198
   Xu Y, 2002, J BIOL CHEM, V277, P27312, DOI 10.1074/jbc.M201163200
   Yamauchi K, 2001, BIOMATERIALS, V22, P855, DOI 10.1016/S0142-9612(00)00249-0
   Zambonin G, 2000, J BIOMED MATER RES, V49, P120, DOI 10.1002/(SICI)1097-4636(200001)49:1<120::AID-JBM15>3.0.CO;2-Q
   Zhang J, 2005, BIOMATERIALS, V26, P3353, DOI 10.1016/j.biomaterials.2004.08.019
   Zhang LH, 2002, ARTIF CELL BLOOD SUB, V30, P319, DOI 10.1081/BIO-120006122
   Zimmermann WH, 2004, BIOMATERIALS, V25, P1639, DOI 10.1016/S0142-9612(03)00521-0
NR 125
TC 55
Z9 58
U1 2
U2 42
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD OCT
PY 2008
VL 87B
IS 1
BP 264
EP 285
DI 10.1002/jbm.b.31078
PG 22
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 350CA
UT WOS:000259328900034
PM 18386843
DA 2018-10-19
ER

PT J
AU Agarwal, V
   Lal, P
   Pruthi, P
   Pruthi, V
AF Agarwal, Vishnu
   Lal, Priyanka
   Pruthi, Parul
   Pruthi, Vikas
TI Studies of Candida albicans biofilm formed on biomaterial surfaces
SO JOURNAL OF BIOTECHNOLOGY
LA English
DT Meeting Abstract
C1 [Agarwal, Vishnu; Lal, Priyanka; Pruthi, Vikas] IIT Roorkee, Dept Biotechnol, Mol Microbiol Lab, Roorkee 247667, Uttar Pradesh, India.
   [Pruthi, Parul] HNB Garhwal Univ, HAPPRC, Garhwal, UA, India.
EM Vishnu_agarwal02@rediffmail.com
CR Kojic EM, 2004, CLIN MICROBIOL REV, V17, P255, DOI 10.1128/CMR.17.2.255-267.2004
   Ramage G, 2006, FEMS YEAST RES, V6, P979, DOI 10.1111/j.1567-1364.2006.00117.x
NR 2
TC 1
Z9 1
U1 1
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1656
EI 1873-4863
J9 J BIOTECHNOL
JI J. Biotechnol.
PD OCT
PY 2008
VL 136
SU S
MA V4-P-132
BP S451
EP S451
DI 10.1016/j.jbiotec.2008.07.1048
PG 1
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA V32VT
UT WOS:000208979402019
DA 2018-10-19
ER

PT J
AU Agnarsson, I
   Boutry, C
   Blackledge, TA
AF Agnarsson, Ingi
   Boutry, Cecilia
   Blackledge, Todd A.
TI Spider silk aging: Initial improvement in a high performance material
   followed by slow degradation
SO JOURNAL OF EXPERIMENTAL ZOOLOGY PART A-ECOLOGICAL GENETICS AND
   PHYSIOLOGY
LA English
DT Article
ID MECHANICAL-PROPERTIES; CAPTURE-SILK; FLAGELLIFORM SILK; FIBERS SPUN;
   DESIGN; BIOMATERIAL; DIFFRACTION; POLYMERS; BEHAVIOR; THREADS
AB Spider silk possesses a unique combination of high tensile strength and elasticity resulting in extraordinarily tough fibers, compared with the best synthetic materials. However, the potential application of spider silk and biomimetic fibers depends upon retention of their high performance under a variety of conditions. Here, we report on changes in the mechanical properties of dragline and capture silk fibers from several spider species over periods tip to 4 years of benign aging. We find an improvement in mechanical performance of silk fibers during the first year of aging. Fibers rapidly decrease in diameter, suggesting an increase in structural alignment and organization of molecules. One-year old silk also is stiffer and has higher stress at yield than fresh silk, whereas breaking force, elasticity, and toughness either improve or are unaffected by early aging. However, 4-year old silk shows signs of degradation as the breaking load, elasticity, and toughness are all lower than in fresh silk. Aging, however, does not reduce the tensile strength of silk. These data suggest initially rapid reorganization and tighter packaging of molecules within the fiber, followed by longer-term decomposition. We hypothesize that possibly the breakdown of amino acids via emission of ammonia gas, as is seen in long-term aging of museum silkworm fabrics, may contribute. Degradation of spider silk under benign conditions may be a concern for efforts to construct and utilize biomimetic silk analogs. However, our findings suggest an initial improvement in mechanical performance and that even old spider silk still retains impressive mechanical performance. J. Exp. Zool. 309A:494-504, 2008. (C) 2008 Wiley-Liss, Inc.
C1 [Agnarsson, Ingi; Boutry, Cecilia; Blackledge, Todd A.] Univ Akron, Dept Biol, Akron, OH 44325 USA.
   [Agnarsson, Ingi; Boutry, Cecilia; Blackledge, Todd A.] Univ Akron, Integrated Biolsci Program, Akron, OH 44325 USA.
   [Agnarsson, Ingi] Smithsonian Inst, Dept Entomol, Washington, DC 20560 USA.
RP Agnarsson, I (reprint author), Univ Akron, Dept Biol, Akron, OH 44325 USA.
EM iagnarsson@gmail.com
FU National Science Foundation [DEB-0516038, DBI-0521261]; Integrated
   Bioscience Program at University of Akron
FX This research was funded by DEB-0516038 and DBI-0521261 from the
   National Science Foundation and by the Integrated Bioscience Program at
   University of Akron. Taylor Gondek assisted with silk diameter
   measurements.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   BECKER MA, 1995, J AM INST CONSERV, V34, P141, DOI 10.2307/3179736
   Becker N, 2003, NAT MATER, V2, P278, DOI 10.1038/nmat858
   Blackledge TA, 2006, J EXP BIOL, V209, P2452, DOI 10.1242/jeb.02275
   Blackledge TA, 2005, J EXP BIOL, V208, P1937, DOI 10.1242/jeb.01597
   Blackledge TA, 2005, INVERTEBR BIOL, V124, P165, DOI 10.1111/j.1744-7410.2005.00016.x
   Blackledge TA, 2005, ZOOLOGY, V108, P41, DOI 10.1016/j.zool.2004.11.001
   Booth C., 1989, COMPREHENSIVE POLYM
   Boukezzi L, 2006, ANN CHIM-SCI MAT, V31, P561, DOI 10.3166/acsm.31.561-569
   CLOUGH RL, 1996, POLYM DURABILIT DEGR
   Davis CR, 1996, J APPL POLYM SCI, V62, P2237
   DENNY M, 1976, J EXP BIOL, V65, P483
   El Shafee E, 2003, POLYMER, V44, P3727, DOI 10.1016/S0032-3861(03)00282-9
   Elices M, 2005, JOM-US, V57, P60, DOI 10.1007/s11837-005-0218-7
   GELLYNCK K, 2006, THESIS U GENT GENT
   Gillen KT, 1996, ADV CHEM SER, V249, P557
   GOSLINE JM, 1984, NATURE, V309, P551, DOI 10.1038/309551a0
   GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   GRIFFITHS JR, 1980, J MATER SCI, V15, P491, DOI 10.1007/BF00551703
   Guan ZB, 2007, POLYM INT, V56, P467, DOI 10.1002/pi.2245
   Guinea GV, 2006, BIOMACROMOLECULES, V7, P2173, DOI 10.1021/bm060138v
   GUMARGALIEVA KZ, 1996, KINETIC THERMODYNAMI, P145
   Hayashi CY, 2001, BIOESSAYS, V23, P750, DOI 10.1002/bies.1105
   Hayashi CY, 1998, J MOL BIOL, V275, P773, DOI 10.1006/jmbi.1997.1478
   Hermes AC, 2006, BIOMACROMOLECULES, V7, P777, DOI 10.1021/bm0508313
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   Opell BD, 2008, J EXP ZOOL PART A, V309A, P11, DOI 10.1002/jez.426
   Osaki S, 2004, POLYM J, V36, P623, DOI 10.1295/polymj.36.623
   Perez-Rigueiro J, 2007, J POLYM SCI POL PHYS, V45, P786, DOI 10.1002/polb.21118
   Riekel C, 1999, INT J BIOL MACROMOL, V24, P179, DOI 10.1016/S0141-8130(98)00084-1
   RIGBY BJ, 1974, J MACROMOL SCI PHYS, VB 10, P255, DOI 10.1080/00222347408260829
   ROBINSON MS, 1981, TEXT RES J, V51, P637, DOI 10.1177/004051758105101004
   Swanson BO, 2007, J EXP ZOOL PART A, V307A, P654, DOI 10.1002/jez.420
   TOWNLEY MA, 1991, J EXP ZOOL, V259, P154, DOI 10.1002/jez.1402590203
   VADLAMUDI S, 1995, THESIS U WYOMING LAR
   Van Nimmen E, 2003, INT J MATER PROD TEC, V18, P344
   Vlasveld DPN, 2005, POLYMER, V46, P12539, DOI 10.1016/j.polymer.2005.10.120
   Vollrath F, 2006, APPL PHYS A-MATER, V82, P205, DOI 10.1007/s00339-005-3437-4
   VOLLRATH F, 1990, NATURE, V345, P526, DOI 10.1038/345526a0
   VOLLRATH F, 1992, SCI AM, V266, P70, DOI 10.1038/scientificamerican0392-70
   Vollrath F, 2002, IN VIVO, V16, P229
   VOLLRATH F, 1989, NATURE, V340, P305, DOI 10.1038/340305a0
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   Vollrath F, 2001, P ROY SOC B-BIOL SCI, V268, P2339, DOI 10.1098/rspb.2001.1590
   Vollrath F., 2000, REV MOL BIOTECHNOL, V74, P67, DOI DOI 10.1016/S1389-0352(00)00006-4)
   Yanagi Y, 2000, TEXT RES J, V70, P871, DOI 10.1177/004051750007001005
NR 47
TC 21
Z9 21
U1 0
U2 16
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1932-5223
J9 J EXP ZOOL PART A
JI J. Exp. Zool. Part A
PD OCT 1
PY 2008
VL 309A
IS 8
BP 494
EP 504
DI 10.1002/jez.480
PG 11
WC Zoology
SC Zoology
GA 355PB
UT WOS:000259719700007
PM 18626974
DA 2018-10-19
ER

PT J
AU Hu, WW
   Lang, MW
   Krebsbach, PH
AF Hu, Wei-Wen
   Lang, Michael W.
   Krebsbach, Paul H.
TI Development of adenovirus immobilization strategies for in situ gene
   therapy
SO JOURNAL OF GENE MEDICINE
LA English
DT Article
DE adenovirus; avidin/biotin; chitosan; gene delivery; surface
   modification; tissue engineering
ID BONE MORPHOGENETIC PROTEIN-2; ANTIBODY IMMOBILIZATION; TARGET-CELLS;
   CHITOSAN; DELIVERY; VECTOR; SURFACES; VIVO; SCAFFOLDS; TRANSDUCTION
AB Background Regenerative gene therapy using viral vectors enables transduced cells to express bioactive factors in vivo. Viral delivery with spatial control can enhance transduction efficiency and may limit systemic infection. Consequently, we tethered biotinylated adenovirus via interactions with avidin on chitosan surfaces to gain robust control for in situ transduction.
   Methods Avidin was either directly conjugated to chitosan (virus-biotin-avidin-material; VBAM) or indirectly clocked on biotinylated chitosan surfaces (virus-biotin-avidin-biotin-material; VBABM) to tether biotinylated adenovirus. Enzyme-linked immunosorbent assay (ELISA) and spectroscopic analysis were performed to demonstrate the binding profiles. Biotin-alkaline phosphatase and biotinylated adenovirus were used as different sized particles to evaluate binding efficiencies and were compared by the Sips isotherm adsorption method. Scanning electron microscopy (SEM) examination illustrated virus distribution, and the transduction efficiency was determined by in vitro cell transduction.
   Results ELISA and spectroscopic analysis both demonstrated that the VBAM system led to multilayer avidin formation on biomaterial surfaces, whereas VBABM formed a monolayer of avidin. Sips isotherm adsorption indicated that the VBAM method increased heterogeneity and steric hindrance of binding sites. By contrast, the VBABM method docked avidin on chitosan surfaces and orientated the binding sites to facilitate ligand binding. In addition, SFM images illustrated that the VBABM method led to more even viral distribution. In vitro cell infection experiments also demonstrated that the VBABM system enhanced virus immobilization and thus improved cell transduction efficiency over the VBAM system.
   Conclusions The VBABM strategy is a superior method for in situ transduction from biomaterials. This strategy could be adapted for use with a variety of biomaterials as well as vital vectors, and thus may be an alternative method for in vivo regenerative gene therapy. Copyright (C) 2008 John Wiley & Sons, Ltd.
C1 [Hu, Wei-Wen; Lang, Michael W.; Krebsbach, Paul H.] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA.
   [Hu, Wei-Wen; Krebsbach, Paul H.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
RP Krebsbach, PH (reprint author), Univ Michigan, Sch Dent, Dept Biol & Mat Sci, K1030,1011 N Univ Ave, Ann Arbor, MI 48109 USA.
EM paulk@umich.edu
FU AO Foundation [16-2004]
FX The research was supported by a grant from the AO Foundation (16-2004).
CR Ahmed SR, 2006, J MEMBRANE SCI, V280, P553, DOI 10.1016/j.memsci.2006.02.009
   Alden TD, 1999, HUM GENE THER, V10, P2245, DOI 10.1089/10430349950017220
   Anderson GP, 1997, BIOSENS BIOELECTRON, V12, P329, DOI 10.1016/S0956-5663(96)00074-7
   Aspden TJ, 1997, J PHARM SCI, V86, P509, DOI 10.1021/js960182o
   Bajaj B, 2001, BIOTECHNOL PROGR, V17, P587, DOI 10.1021/bp010039n
   Beer SJ, 1998, GENE THER, V5, P740, DOI 10.1038/sj.gt.3300647
   Bengali Z, 2007, J GENE MED, V9, P668, DOI 10.1002/jgm.1058
   DIMMOCK NJ, 1994, INTRO MODERN VIROLOG, P345
   Firestone MA, 1996, J AM CHEM SOC, V118, P9033, DOI 10.1021/ja961046o
   GREEN NM, 1963, BIOCHEM J, V89, P585, DOI 10.1042/bj0890585
   Hanenberg H, 1996, NAT MED, V2, P876, DOI 10.1038/nm0896-876
   Hobson DA, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-4
   Hu WW, 2007, GENE THER, V14, P891, DOI 10.1038/sj.gt.3302940
   Jang JH, 2004, EXPERT REV MED DEVIC, V1, P127, DOI 10.1586/17434440.1.1.127
   KASSEISLER A, 1994, GENE THER, V1, P395
   Klugherz BD, 2002, HUM GENE THER, V13, P443, DOI 10.1089/10430340252792576
   Levy RJ, 2001, GENE THER, V8, P659, DOI 10.1038/sj.gt.3301452
   Li ZS, 2005, BIOMATERIALS, V26, P3919, DOI 10.1016/j.biomaterials.2004.09.062
   Lu B, 1996, ANALYST, V121, pR29, DOI 10.1039/an996210029r
   Lu B, 1996, ANAL CHIM ACTA, V331, P97, DOI 10.1016/0003-2670(96)00191-2
   Mei L, 2006, J GENE MED, V8, P690, DOI 10.1002/jgm.912
   Musgrave DS, 1999, BONE, V24, P541, DOI 10.1016/S8756-3282(99)00086-1
   Nanci A, 1998, J BIOMED MATER RES, V40, P324
   Ochiya Takahiro, 2001, Current Gene Therapy, V1, P31, DOI 10.2174/1566523013348887
   Okubo Y, 2000, BIOCHEM BIOPH RES CO, V267, P382, DOI 10.1006/bbrc.1999.1975
   Onishi H, 1999, BIOMATERIALS, V20, P175, DOI 10.1016/S0142-9612(98)00159-8
   Parrott MB, 2003, MOL THER, V8, P688, DOI 10.1016/S1525-0016(03)00213-2
   Pickles RJ, 1998, J VIROL, V72, P6014
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   Shriver-Lake LC, 1997, BIOSENS BIOELECTRON, V12, P1101, DOI 10.1016/S0956-5663(97)00070-5
   SIPS R, 1948, J CHEM PHYS, V16, P490, DOI 10.1063/1.1746922
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Vijayendran RA, 2001, ANAL CHEM, V73, P471, DOI 10.1021/ac000523p
   Yao DC, 2003, ANAL CHIM ACTA, V478, P23, DOI 10.1016/S0003-2670(02)01484-8
   Yeung C, 1997, LANGMUIR, V13, P6746, DOI 10.1021/la970830z
   Yeung C, 1999, LANGMUIR, V15, P6829, DOI 10.1021/la990019j
   Zhang Y, 2002, J BIOMED MATER RES, V62, P378, DOI 10.1002/jbm.10312
NR 37
TC 17
Z9 17
U1 1
U2 12
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1099-498X
J9 J GENE MED
JI J. Gene. Med.
PD OCT
PY 2008
VL 10
IS 10
BP 1102
EP 1112
DI 10.1002/jgm.1233
PG 11
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine,
   Research & Experimental
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Research &
   Experimental Medicine
GA 367YD
UT WOS:000260587600005
PM 18618417
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Nielsen, VG
   Kirklin, JK
   Holman, WL
   George, JF
   Ellis, TC
   Steenwyk, BL
AF Nielsen, Vance G.
   Kirklin, James K.
   Holman, William L.
   George, James F.
   Ellis, Truitt C.
   Steenwyk, Brad L.
TI Patient with hypofibrinolysis-mediated thromboembolism converted to a
   hypercoagulable/hyperfibrinolytic state via ventricular assist device
   placement
SO JOURNAL OF HEART AND LUNG TRANSPLANTATION
LA English
DT Article
ID ACTIVATABLE FIBRINOLYSIS INHIBITOR; HEART-FAILURE; HUMAN PLASMA;
   HYPERCOAGULABILITY; THROMBOSIS
AB Mechanical circulatory support with ventricular assist devices (VADs) for end-stage heart failure has been a focus of intense interest for nearly four decades. Despite improvements in VAD design and biomaterial composition, it is common to administer anti-coagulation (e.g., warfarin, anti-platelet agents) to prevent both device thrombosis and thromboembolism. We present a patient with pre-operative thrombophilia (pulmonary embolism, intracardiac thrombus) and hypofibrinolysis, who subsequently developed hypercoagulability with hyperfibrinolysis with normalization of clot lifespan after left VAD placement. Such complex patient-VAD-hemostatic-state interactions serve as the rationale for continuing investigation of the effects of mechanical circulation on the fibrinolytic system and thrombophilia.
C1 [Nielsen, Vance G.; Ellis, Truitt C.; Steenwyk, Brad L.] Univ Alabama, Dept Anesthesiol, Birmingham, AL 35249 USA.
   [Nielsen, Vance G.; Kirklin, James K.; Holman, William L.; George, James F.] Univ Alabama, Dept Surg, Birmingham, AL 35249 USA.
RP Nielsen, VG (reprint author), Univ Alabama, Dept Anesthesiol, Basic Med Res 2,Room 206901,S 19th St, Birmingham, AL 35249 USA.
EM vnielsen@uab.edu
FU Departments of Anesthesiology and Surgery, University of Alabama at
   Birmingham
FX Supported by the Departments of Anesthesiology and Surgery, University
   of Alabama at Birmingham.
CR De Lorenzo F, 2003, DRUGS, V63, P565, DOI 10.2165/00003495-200363060-00004
   Jafri SM, 1997, SEMIN THROMB HEMOST, V23, P543, DOI 10.1055/s-2007-996133
   Marcucci R, 2006, J THROMB HAEMOST, V4, P1017, DOI 10.1111/j.1538-7836.2006.01916.x
   Nielsen VG, 2008, ASAIO J, V54, P351, DOI 10.1097/MAT.0b013e31817f3e03
   Nielsen VG, 2008, BLOOD COAGUL FIBRIN, V19, P283, DOI 10.1097/MBC.0b013e3282ff76c3
   Nielsen VG, 2007, BLOOD COAGUL FIBRIN, V18, P29, DOI 10.1097/MBC.0b013e3280129afe
   Nielsen VG, 2006, J HEART LUNG TRANSPL, V25, P1247, DOI 10.1016/j.healun.2006.06.009
   Schafer Andreas, 2004, Clin Lab, V50, P559
   Steenwyk BL, 2007, ANESTH ANALG, V104, P538, DOI 10.1213/01.ane.0000255155.87860.94
   Tschirkov A, 2007, J HEART LUNG TRANSPL, V26, P553, DOI 10.1016/j.healun.2007.01.030
NR 10
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1053-2498
J9 J HEART LUNG TRANSPL
JI J. Heart Lung Transplant.
PD OCT
PY 2008
VL 27
IS 10
BP 1169
EP 1171
DI 10.1016/j.healun.2008.06.009
PG 3
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery;
   Transplantation
SC Cardiovascular System & Cardiology; Respiratory System; Surgery;
   Transplantation
GA 358WI
UT WOS:000259947800018
PM 18926412
DA 2018-10-19
ER

PT J
AU Das, I
   Agrawal, NR
   Verma, S
   Ansari, SA
AF Das, Ishwar
   Agrawal, Namita R.
   Verma, Smriti
   Ansari, Shoeb A.
TI Non-equilibrium growth patterns in a reaction between thiamine and
   glucose
SO JOURNAL OF THE INDIAN CHEMICAL SOCIETY
LA English
DT Article
DE Growth pattern; fractal; biomaterial; Schiff base
ID MAILLARD REACTION; SCHIFF-BASE; COMPLEXES; COPPER; METAL
AB Reaction between glucose and thiamine has been studied in aqueous solution containing gel matrix. Growth patterns of the reactants and the product have been studied. Glucose crystallizes in the form of fractal with fractal dimension 1.74 and thiamine as spherulitic when observed under polarized light microscope. Glucose-thiamine reaction product crystallized in different morphologies. Following transitions were observed on increasing the concentration.
   Spherulite -> Ringed spherulite -> Revert spaced concentric rings
   Besides change in the morphology of the reaction product, XRD, IR and DSC studies also revealed the formation of a new product. During the reaction glucose was continuously consumed on addition of thiamine, obeying the relation [G](-1) = m log V + c, where m and c are slope and intercept respectively. Heat of fusion Delta H of the product was calculated using the expression Delta H.m = KA, where m is the mass of the substance, K and A are the calibration constant and area under the curve respectively. The value was found to be 1.36 kcal/mol, which was lower than those of the individual reactants.
C1 [Das, Ishwar; Verma, Smriti; Ansari, Shoeb A.] DDU Gorakhpur Univ, Dept Chem, Gorakhpur 273009, Uttar Pradesh, India.
   [Agrawal, Namita R.] St Andreas Coll, Dept Chem, Gorakhpur 273009, Uttar Pradesh, India.
RP Das, I (reprint author), DDU Gorakhpur Univ, Dept Chem, Gorakhpur 273009, Uttar Pradesh, India.
EM ishwar_das@rediffmail.com
FU Department of Science and Technology, New Delhi
FX Authors wish to thank Prof. K. D. S. Yadav, Head, Chemistry Department,
   DDU Gorakhpur University, Gorakhpur, for providing necessary laboratory
   facilities. We are grateful to Department of Science and Technology, New
   Delhi for providing financial support.
CR Achary G, 2007, INDIAN J CHEM TECHN, V14, P16
   Ajandouz EH, 1999, J AGR FOOD CHEM, V47, P1786, DOI 10.1021/jf980928z
   Ben-Jacob E, 1994, FRACTALS, V2, P15, DOI 10.1142/S0218348X9400003X
   BENJACOB E, 1990, NATURE, V343, P523, DOI 10.1038/343523a0
   BENJACOB E, 1994, NATURE, V368, P46, DOI 10.1038/368046a0
   Chandra D, 2007, CHEM MATER, V19, P5347, DOI 10.1021/cm701918t
   Chandra D, 2007, MICROPOR MESOPOR MAT, V101, P348, DOI 10.1016/j.micromeso.2006.11.027
   DACCORD G, 1986, PHYS REV LETT, V56, P336, DOI 10.1103/PhysRevLett.56.336
   DAS I, 1991, Indian Journal of Experimental Biology, V29, P1109
   Das I, 1997, INDIAN J CHEM A, V36, P197
   Das I, 1997, INDIAN J CHEM A, V36, P1018
   DELANGE P, 1954, NATURE, V29, P1040
   FAMILY F, 1989, PHYSICA D, V38, P98, DOI 10.1016/0167-2789(89)90178-4
   FIELDEN J, 2007, EUR J INORG CHEM, P3930
   Karaoglan GK, 2007, INDIAN J CHEM A, V46, P1273
   Komatsu H, 2007, J MOL CATAL A-CHEM, V273, P289, DOI 10.1016/j.molcata.2007.04.016
   Mandelbrot BB, 1982, FRACTAL GEOMETRY NAT
   Nagaraj RH, 1996, J BIOL CHEM, V271, P19338, DOI 10.1074/jbc.271.32.19338
   Nawale RB, 2006, INDIAN J BIOCHEM BIO, V43, P337
   Purakayastha A, 1999, NEW J CHEM, V23, P1141, DOI 10.1039/a907123g
   RASTOGI RP, 1993, J PHYS CHEM-US, V97, P4871, DOI 10.1021/j100120a046
   RASTOGI RP, 1993, INDIAN J CHEM A, V32, P749
   RASTOGI RP, 1993, J CHEM EDUC, V71, P694
   RASTOGI RP, 1991, CHEM PHYS LETT, V1, P186
   RASTOGI RP, 1992, J CHEM ED A, V69, P48
   RIEPPEL O, 1993, NATURE, V362, P216, DOI 10.1038/362216b0
   SANDER LM, 1986, NATURE, V322, P789, DOI 10.1038/322789a0
   Saracovan I, 1999, MACROMOLECULES, V32, P8918, DOI 10.1021/ma9911602
   SCHAEFFER DW, 1989, SCIENCE, V243, P1043
   SHAKLAI N, 1984, J BIOL CHEM, V259, P3812
   STANLEY HE, 1989, PHYSICA D, V38, P330, DOI 10.1016/0167-2789(89)90215-7
   VISHNOI NK, 1982, ADV PRACTICAL ORGANI, P438
NR 32
TC 0
Z9 0
U1 0
U2 2
PU SCIENTIFIC PUBL-INDIA
PI JODHPUR
PA 5-A, NEW PALI RD, PO BOX 91, NEAR HOTEL TAJ HARI MAHAL, JODHPUR, 342
   003, INDIA
SN 0019-4522
J9 J INDIAN CHEM SOC
JI J. Indian Chem. Soc.
PD OCT
PY 2008
VL 85
IS 10
BP 1004
EP 1009
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA 376TW
UT WOS:000261206900006
DA 2018-10-19
ER

PT J
AU Stylianopoulos, T
   Bashur, CA
   Goldstein, AS
   Guelcher, SA
   Barocas, VH
AF Stylianopoulos, Triantafyllos
   Bashur, Chris A.
   Goldstein, Aaron S.
   Guelcher, Scott A.
   Barocas, Victor H.
TI Computational predictions of the tensile properties of electrospun fibre
   meshes: Effect of fibre diameter and fibre orientation
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Fibrous mesh; Network architecture; Multiscale modelling; Tissue
   microstructure
ID STRUCTURAL CONSTITUTIVE MODEL; BIAXIAL MECHANICAL-PROPERTIES; STOCHASTIC
   FIBROUS NETWORKS; AORTIC-VALVE CUSP; BIOMEDICAL APPLICATIONS; COLLAGEN
   NETWORKS; ARTIFICIAL GRAFT; MEDIA EQUIVALENT; AVERAGING THEORY; VASCULAR
   GRAFT
AB The mechanical properties of biomaterial scaffolds are crucial for their efficacy in tissue engineering and regenerative medicine. At the microscopic scale, the scaffold must be sufficiently rigid to support cell adhesion, spreading, and normal extracellular matrix deposition. Concurrently, at the macroscopic scale the scaffold must have mechanical properties that closely match those of the target tissue. The achievement of both goals may be possible by careful control of the scaffold architecture. Recently, electrospinning has emerged as an attractive means to form fused fibre scaffolds for tissue engineering. The diameter and relative orientation of fibres affect cell behaviour, but their impact on the tensile properties of the scaffolds has not been rigorously characterized. To examine the structure-property relationship, electrospun meshes were made from a polyurethane elastomer with different fibre diameters and orientations and mechanically tested to determine the dependence of the elastic modulus on the mesh architecture. Concurrently, a multiscale modelling strategy developed for type I collagen networks was employed to predict the mechanical behaviour of the polyurethane meshes. Experimentally, the measured elastic modulus of the meshes varied from 0.56 to 3.0 MPa depending on fibre diameter and the degree of fibre alignment. Model predictions for tensile loading parallel to fibre orientation agreed well with experimental measurements for a wide range of conditions when a fitted fibre modulus of 18 MPa was used. Although the model predictions were less accurate in transverse loading of anisotropic samples, these results indicate that computational modelling can assist in design of electrospun artificial tissue scaffolds. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Barocas, Victor H.] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA.
   [Stylianopoulos, Triantafyllos] Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN 55455 USA.
   [Bashur, Chris A.; Goldstein, Aaron S.] Virginia Polytech Inst & State Univ, Dept Chem Engn, Blacksburg, VA 24061 USA.
   [Guelcher, Scott A.] Vanderbilt Univ, Dept Chem Engn, Nashville, TN 37235 USA.
RP Barocas, VH (reprint author), Univ Minnesota, Dept Biomed Engn, 7-105 Hasselmo Hall,312 Church St SE, Minneapolis, MN 55455 USA.
EM baroc001@umn.edu
OI Bashur, Chris/0000-0002-2637-9149; Stylianopoulos,
   Triantafyllos/0000-0002-3093-1696
FU NIH [1 R01 EB005813-01]; Charles E. Culpeper Foundation [03130];
   Institute for Critical Technologies and Sciences at Virginia Tech;
   Doctoral Dissertation Fellowship from the University of Minnesota;
   University of Minnesota Supercomputing institute
FX This work was supported by NIH grant 1 R01 EB005813-01 to VHB, and
   grants from the Charles E. Culpeper Foundation (03130) and the Institute
   for Critical Technologies and Sciences at Virginia Tech to ASG. TS was
   also supported by a Doctoral Dissertation Fellowship from the University
   of Minnesota. Simulations were made possible by resources grants from
   the University of Minnesota Supercomputing institute.
CR Agoram B, 2001, J BIOMECH ENG-T ASME, V123, P362, DOI 10.1115/1.1385843
   Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.0.CO;2-J
   Bashur CA, 2006, BIOMATERIALS, V27, P5681, DOI 10.1016/j.biomaterials.2006.07.005
   Berhan L, 2003, J COMPOS MATER, V37, P715, DOI 10.1177/002199803029725
   Billiar KL, 2000, J BIOMECH ENG-T ASME, V122, P327, DOI 10.1115/1.1287158
   Billiar KL, 2000, J BIOMECH ENG-T ASME, V122, P23, DOI 10.1115/1.429624
   Boland ED, 2006, ACS SYM SER, V918, P188
   Boland ED, 2005, ACTA BIOMATER, V1, P115, DOI 10.1016/j.actbio.2004.09.003
   Boland ED, 2001, J MACROMOL SCI PURE, V38, P1231, DOI 10.1081/MA-100108380
   Butler DL, 2000, J BIOMECH ENG-T ASME, V122, P570, DOI 10.1115/1.1318906
   Chandran PL, 2006, J BIOMECH ENG-T ASME, V128, P259, DOI 10.1115/1.2165699
   Chandran PL, 2007, J BIOMECH ENG-T ASME, V129, P137, DOI 10.1115/1.2472369
   DREW DA, 1971, STUD APPL MATH, V50, P133
   Driessen NJB, 2005, J BIOMECH ENG-T ASME, V127, P494, DOI 10.1115/1.1894373
   Enever PAJ, 2002, J SURG RES, V105, P160, DOI 10.1006/jsre.2002.6372
   Goldstein AS, 2001, BIOMATERIALS, V22, P1279, DOI 10.1016/S0142-9612(00)00280-5
   Grassl ED, 2003, J BIOMED MATER RES A, V66A, P550, DOI 10.1002/jbm.a.10589
   Grassl ED, 2002, J BIOMED MATER RES, V60, P607, DOI 10.1002/jbm.10107
   Gu SY, 2005, MACROMOL RAPID COMM, V26, P716, DOI 10.1002/marc.200400667
   Guelcher SA, 2005, ACTA BIOMATER, V1, P471, DOI 10.1016/j.actbio.2005.02.007
   Gupta P, 2005, POLYMER, V46, P4799, DOI 10.1016/j.polymer.2005.04.021
   HAYASHI K, 1980, J BIOMECH, V13, P175, DOI 10.1016/0021-9290(80)90191-8
   HAYASHI K, 1989, J BIOMED MATER RES-A, V23, P229
   Head DA, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.061907
   Huang ZM, 2004, POLYMER, V45, P5361, DOI 10.1016/j.polymer.2004.04.005
   Humphrey JD, 2003, P ROY SOC A-MATH PHY, V459, P3, DOI 10.1098/rspa.2002.1060
   Inoguchi H, 2006, BIOMATERIALS, V27, P1470, DOI 10.1016/j.biomaterials.2005.08.029
   Kwon IK, 2005, BIOMATERIALS, V26, P3929, DOI 10.1016/j.biomaterials.2004.10.007
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Macosko CW, 1994, RHEOLOGY PRINCIPLES
   Matsuda T, 2005, J BIOMED MATER RES A, V73A, P125, DOI 10.1002/jbm.a.30260
   Moran JM, 2003, TISSUE ENG, V9, P63, DOI 10.1089/107632703762687546
   Nair LS, 2004, BIOMACROMOLECULES, V5, P2212, DOI 10.1021/bm049759j
   Nemat-Nasser S, 1999, MICROMECHANICS OVERA
   Oda M, 1999, MECH GRANULAR MAT
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   ROACH MR, 1957, CAN J BIOCHEM PHYS, V35, P681
   Sonoda H, 2002, J BIOMED MATER RES, V60, P191, DOI 10.1002/jbm.10055
   Stylianopoulos T, 2007, J BIOMECH ENG-T ASME, V129, P611, DOI 10.1115/1.2746387
   Stylianopoulos T, 2007, COMPUT METHOD APPL M, V196, P2981, DOI 10.1016/j.cma.2006.06.019
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   Vaz CM, 2005, ACTA BIOMATER, V1, P575, DOI 10.1016/j.actbio.2005.06.006
   Wang CW, 2000, J ENG MATER-T ASME, V122, P460, DOI 10.1115/1.1288768
   Wang CW, 2000, J ENG MATER-T ASME, V122, P450, DOI 10.1115/1.1288769
   WHITAKER S, 1986, TRANSPORT POROUS MED, V1, P3, DOI 10.1007/BF01036523
   White JA, 2002, BIOPHYS J, V82, P2081, DOI 10.1016/S0006-3495(02)75555-0
   Wilhelm J, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.108103
   WILKES GL, 2003, COMPREHENSIVE DESK R, P624
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Zong XH, 2005, BIOMATERIALS, V26, P5330, DOI 10.1016/j.biomaterials.2005.01.052
   Zulliger MA, 2004, J BIOMECH, V37, P989, DOI 10.1016/j.jbiomech.2003.11.026
NR 51
TC 76
Z9 76
U1 1
U2 54
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD OCT
PY 2008
VL 1
IS 4
BP 326
EP 335
DI 10.1016/j.jmbbm.2008.01.003
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 359PT
UT WOS:000260001300006
PM 19627797
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Shingel, KI
   Faure, MP
   Azoulay, L
   Roberge, C
   Deckelbaum, RJ
AF Shingel, Kirill I.
   Faure, Marie-Pierre
   Azoulay, Laurent
   Roberge, Christophe
   Deckelbaum, Richard J.
TI Solid emulsion get as a vehicle for delivery of polyunsaturated fatty
   acids: implications for tissue repair, dermal angiogenesis and wound
   heating
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE solid emulsion gel; omega-3 (n-3) polyunsaturated fatty acids;
   angiogenesis; wound healing; gene expression; vascular endothelial
   growth factor
ID ENDOTHELIAL GROWTH-FACTOR; DIFFERENTIATION-RELATED PROTEIN;
   DOCOSAHEXAENOIC ACID; NITRIC-OXIDE; IN-VITRO; HEME OXYGENASE-1;
   CUTANEOUS WOUNDS; ADRP EXPRESSION; CELL-GROWTH; SKIN
AB The paper describes preparation and biological characterization of the solid hybrid biomaterial that was designed for cell-targeted lipid delivery in healing tissues. The material referred to as 'solid emulsion gel' combines a protein-stabilized lipid emulsion and a hydrogel structure in a single compartment. The potential of the omega-3 (n-3)-fatty acids rich solid emulsion gel for tissue repair applications was investigated at the macro-, micro-, molecular and gene expression levels, using human fibroblasts and endothelial cells and a porcine model of full-thickness wounds. Being non-cytotoxic in vitro and in vivo, the biomaterial was found to affect cell metabolism, modulate expression of certain genes, stimulate early angiogenesis and promote wound repair in vivo. The neovascular response in vivo was correlated with upregulated expression of the genes involved in lipid transport (e.g. adipophilin), anti-apoptosis (e.g. heat shock proteins, haem oxygenase 1) and angiogenesis (vascular endothelial growth factor, placental growth factor). Collectively, the results of this study provide first evidence that the angiogenic response provided by solid emulsion gel-mediated delivery of n-3 fatty acids is an alternative to the topical administration of exogenous growth factors or gene therapy, and can be advantageously used for the stimulation of tissue repair in complex wounds. Copyright (C) 2008 John Wiley & Sons, Ltd.
C1 [Shingel, Kirill I.; Faure, Marie-Pierre; Roberge, Christophe] BioArtificial Gel Technol BAGTECH Inc, Montreal, PQ H3A 1L4, Canada.
   [Azoulay, Laurent] McGill Univ, Ctr Hlth, Div Clin Epidemiol, Montreal, PQ, Canada.
   [Deckelbaum, Richard J.] Columbia Univ, Dept Pediat, Inst Human Nutr, New York, NY 10027 USA.
RP Shingel, KI (reprint author), BioArtificial Gel Technol BAGTECH Inc, 400 Moisonneuve Ouest,Suite 1156, Montreal, PQ H3A 1L4, Canada.
EM kirill.shingel@bagtech.com
FU NIH [HL 40404]
FX The authors are grateful to Dr Zabeida from the Department of
   Engineering Physics, Ecole Polytechnique, for help in materials
   characterization. The technical assistance of Ludmila Anohina and
   Jessica Elkouby (both from Bioartificial Gel Technologies Inc.) is also
   gratefully acknowledged. Dr Deckelbaum's laboratory is supported in part
   by NIH Grant No. HL 40404.
CR Akay G, 2004, BIOMATERIALS, V25, P3991, DOI 10.1016/j.biomaterials.2003.10.086
   Arend A, 2000, ANN NUTR METAB, V44, P217, DOI 10.1159/000046687
   Brasaemle DL, 1997, J LIPID RES, V38, P2249
   Braund Rhiannon, 2007, Current Drug Delivery, V4, P195
   BROWN LF, 1992, J EXP MED, V176, P1375, DOI 10.1084/jem.176.5.1375
   Bussolati B, 2006, ANTIOXID REDOX SIGN, V8, P1153, DOI 10.1089/ars.2006.8.1153
   Cardoso CRB, 2004, WOUND REPAIR REGEN, V12, P235
   Clark RAF, 2007, J INVEST DERMATOL, V127, P1018, DOI 10.1038/sj.jid.5700715
   Danesch U, 1996, J CELL PHYSIOL, V168, P618, DOI 10.1002/(SICI)1097-4652(199609)168:3<618::AID-JCP14>3.0.CO;2-V
   DIJKE P, 1989, BIOTECHNOLOGY, V7, P793
   DYSON M, 1992, J INVEST DERMATOL, V99, P729, DOI 10.1111/1523-1747.ep12614460
   FRANK S, 1995, J BIOL CHEM, V270, P12607, DOI 10.1074/jbc.270.21.12607
   Gao J, 1999, J BIOL CHEM, V274, P16825, DOI 10.1074/jbc.274.24.16825
   Gao J, 2000, J CELL PHYSIOL, V182, P297
   Gercek A, 2007, JPEN-PARENTER ENTER, V31, P161, DOI 10.1177/0148607107031003161
   Hankenson KD, 2000, P SOC EXP BIOL MED, V223, P88, DOI 10.1046/j.1525-1373.2000.22312.x
   Hentze H. P., 2002, REV MOL BIOTECHNOL, V90, P27, DOI [DOI 10.1016/S1389-0352(01)00046-0, 10.1016/S1389-0352(01)00046-0]
   HINMAN CD, 1963, NATURE, V200, P377, DOI 10.1038/200377a0
   Hoffman A. S., 2002, ADV DRUG DELIVERY RE, V43, P3, DOI DOI 10.1016/S0169-409X(01)00239-3
   Horch RE, 2005, J CELL MOL MED, V9, P592, DOI 10.1111/j.1582-4934.2005.tb00491.x
   Jazwa A, 2006, FREE RADICAL BIO MED, V40, P1250, DOI 10.1016/j.freeradbiomed.2005.11.016
   Jia Yi, 2005, Lipids Health Dis, V4, P14, DOI 10.1186/1476-511X-4-14
   Kashyap N, 2005, CRIT REV THER DRUG, V22, P107, DOI 10.1615/CritRevTherDrugCarrierSyst.v22.i2.10
   Kim HJ, 2005, J CELL PHYSIOL, V204, P881, DOI 10.1002/jcp.20351
   Liu J, 1999, J BIOL CHEM, V274, P15781, DOI 10.1074/jbc.274.22.15781
   MARGOLIS DJ, 1995, DERMATOL SURG, V21, P145, DOI 10.1111/j.1524-4725.1995.tb00128.x
   NISHIGAKI I, 1980, BIOCHEM MED METAB B, V24, P185, DOI 10.1016/0006-2944(80)90010-1
   Nissen NN, 1998, AM J PATHOL, V152, P1445
   O'Donnell VB, 2001, CIRC RES, V88, P12, DOI 10.1161/01.RES.88.1.12
   Oliveira FLC, 1997, JPEN-PARENTER ENTER, V21, P224, DOI 10.1177/0148607197021004224
   Pae HO, 2005, ENDOCRINOLOGY, V146, P2229, DOI 10.1210/en.2004-1431
   Petersen EW, 2005, AM J PHYSIOL-ENDOC M, V288, pE155, DOI 10.1152/ajpendo.00257.2004
   Pratt VC, 2001, LIPIDS, V36, P675, DOI 10.1007/s11745-001-0772-y
   Robson M. C., 1998, AM J SURG, V176, P80
   Rose DP, 1999, INT J ONCOL, V15, P1011
   Ruthig DJ, 1999, J NUTR, V129, P1791
   Scardino MS, 1999, VET DERMATOL, V10, P283, DOI 10.1046/j.1365-3164.1999.00148.x
   Seo T, 2005, CURR OPIN LIPIDOL, V16, P11, DOI 10.1097/00041433-200502000-00004
   Shingel KI, 2005, BIOMACROMOLECULES, V6, P1635, DOI 10.1021/bm0492475
   Shingel Kirill I, 2006, Int Wound J, V3, P332, DOI 10.1111/j.1742-481X.2006.00262.x
   Silverstein MS, 2005, POLYMER, V46, P6682, DOI 10.1016/j.polymer.2005.05.022
   Snyders R, 2007, J BIOMED MATER RES A, V83A, P88, DOI 10.1002/jbm.a.31217
   Sullivan TP, 2001, WOUND REPAIR REGEN, V9, P66, DOI 10.1046/j.1524-475x.2001.00066.x
   TILL GO, 1985, AM J PATHOL, V119, P376
   Tobin KAR, 2006, J LIPID RES, V47, P815, DOI 10.1194/jlr.M500527-JLR200
   Tsuzuki T, 2007, BIOSCI BIOTECH BIOCH, V71, P1902, DOI 10.1271/bbb.70114
   Vogt PM, 1998, CHIRURG, V69, P1197, DOI 10.1007/s001040050557
   WINTER GD, 1962, NATURE, V193, P293, DOI 10.1038/193293a0
   Wright MM, 2006, P NATL ACAD SCI USA, V103, P4299, DOI 10.1073/pnas.0506541103
   Zhang SM, 2007, POLYMER, V48, P3021, DOI 10.1016/j.polymer.2007.04.009
NR 50
TC 17
Z9 18
U1 3
U2 10
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD OCT
PY 2008
VL 2
IS 7
BP 383
EP 393
DI 10.1002/term.101
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 360ZB
UT WOS:000260096200001
PM 18642392
DA 2018-10-19
ER

PT J
AU Sen, MY
   Puskas, JE
   Ummadisetty, S
   Kennedy, JP
AF Sen, Mustafa Y.
   Puskas, Judit E.
   Ummadisetty, Subramanyam
   Kennedy, Joseph P.
TI Green Polymer Chemistry: II Enzymatic Synthesis of
   Methacrylate-Terminated Polyisobutylenes
SO MACROMOLECULAR RAPID COMMUNICATIONS
LA English
DT Article
DE enzymes; esterification; functionalization of polymers; green chemistry;
   polyisobutylene
ID TRANSFER AGENTS INIFERS; SEQUENTIAL CO-POLYMERS; ANTARCTICA-LIPASE-B;
   TELECHELIC POLYMERS; NETWORKS
AB Methacrylate-terminated polyisobutylenes (PIB-MAs) were synthesized by trans esterification of vinyl methacrylate by hydroxyl-terminated polyisobutylenes (PIB-OH) using Candida antarctica lipase B (Novozyme 435) catalyst in hexane at 50 degrees C. PIB-CH2-CH2-CH2-OH and Glissopal-OH, synthesized by anti-Markovnikov hydrobromination of allyl-terminated PIB and Glissopal (R) 2300 followed by hydrolysis, were quantitatively converted into the corresponding PIB-MAs. H-1 and C-13 NMR spectroscopy verified the formation of the expected structures. This "green" chemistry is a very promising methodology for polymer functionalization in general, and biomaterial synthesis in particular.
C1 [Sen, Mustafa Y.; Puskas, Judit E.; Ummadisetty, Subramanyam; Kennedy, Joseph P.] Univ Akron, Dept Polymer Sci, Akron, OH 44325 USA.
RP Puskas, JE (reprint author), Univ Akron, Dept Polymer Sci, Akron, OH 44325 USA.
EM jpuskas@uakron.edu
FU National Science Foundation [DMR-0509687]
FX This material is based upon work supported by the National Science
   Foundation under DMR-0509687.
CR FABER K, 1992, SYNTHESIS-STUTTGART, P895
   Georgiou TK, 2007, MACROMOLECULES, V40, P2335, DOI 10.1021/ma062307+
   Gotor-Fernandez V, 2006, ADV SYNTH CATAL, V348, P797, DOI 10.1002/adsc.200606057
   Kasper J. R., 2008, POLYM PREP-ACS, V49, P1161
   KENNEDY JP, 1983, J POLYM SCI POL CHEM, V21, P1033, DOI 10.1002/pol.1983.170210411
   KENNEDY JP, 1993, J BIOMAT SCI-POLYM E, V4, P445
   KENNEDY JP, 1983, POLYM BULL, V10, P146
   Keszler B, 2000, POLYM BULL, V43, P511, DOI 10.1007/s002890050009
   Lee GS, 2006, BIOTECHNOL LETT, V28, P581, DOI 10.1007/s10529-006-0019-2
   Leonard V, 2007, CHEMBIOCHEM, V8, P662, DOI 10.1002/cbic.200600479
   OTERA J, 2003, ESTERIFICATION METHO, P55
   Puskas JE, 2008, J POLYM SCI POL CHEM, V46, P3024, DOI 10.1002/pola.22640
   SEN MY, 2008, POLYM PREP-ACS, V49, P487
   Ummadisetty S, 2008, J POLYM SCI POL CHEM, V46, P4236, DOI 10.1002/pola.22716
   Yadav GD, 2003, ENZYME MICROB TECH, V32, P783, DOI 10.1016/S0141-0229(03)00064-4
NR 15
TC 12
Z9 12
U1 1
U2 9
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1022-1336
J9 MACROMOL RAPID COMM
JI Macromol. Rapid Commun.
PD OCT 1
PY 2008
VL 29
IS 19
BP 1598
EP 1602
DI 10.1002/marc.200800359
PG 5
WC Polymer Science
SC Polymer Science
GA 369SN
UT WOS:000260714300006
DA 2018-10-19
ER

PT J
AU Zhou, B
   Liu, Y
   Wei, W
   Mao, J
AF Zhou, Bin
   Liu, Yan
   Wei, Wei
   Mao, Jing
TI GEPIs-HA hybrid: A novel biomaterial for tooth repair
SO MEDICAL HYPOTHESES
LA English
DT Article
ID MOLECULAR BIOMIMETICS; HYDROXYAPATITE; NUCLEATION; AMELOGENIN; PEPTIDE;
   ENAMEL; GROWTH
AB Dental caries are slowly progressive and infectious disease, which result in localized dissolution and destruction of the calcified tissues. In routine clinical treatments, microleakage following with secondary caries usually occurs due to the discrepancy in physico-chemical property between fitted materials and tooth. Idea( filling materials for tooth defect should be similar to the structure and chemical composition of natural tooth. Recently, molecular biomimetics developed a novel nanotechnology through biology, which fabricate materials based on molecular recognition between genetically engineered peptides for inorganics (GEPIs) and inorganic crystal. Since GEPIs can be used in the assembly of functional nanostructures, we hypothesis that an analogue of dental hard tissue, hybrid of GEPIs and HA crystal, might be engineered using the recognition properties between GEPIs and HA crystal. (c) 2008 Published by Elsevier Ltd.
C1 [Zhou, Bin; Liu, Yan; Wei, Wei; Mao, Jing] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Stomatol, Wuhan 430030, Hubei, Peoples R China.
RP Mao, J (reprint author), Huazhong Univ Sci & Technol, Tongji Hosp, Dept Stomatol, 1095 Jiefang Rd, Wuhan 430030, Hubei, Peoples R China.
EM bzhou@tjh.tjmu.edu.cn; mao-jing1999@yahoo.com
FU National Science Foundation of China [30700957]
FX Funded by National Science Foundation of China which is conferred to Dr.
   B. Zhou (NSFC No.30700957).
CR Andersson Anita, 2007, Oral Health Prev Dent, V5, P229
   Bader J D, 2001, J Dent Educ, V65, P960
   Chen HF, 2005, J COLLOID INTERF SCI, V288, P97, DOI 10.1016/j.jcis.2005.02.064
   Gajjeraman S, 2007, J BIOL CHEM, V282, P1193, DOI 10.1074/jbc.M604732200
   Habelitz S, 2006, EUR J ORAL SCI, V114, P315, DOI 10.1111/j.1600-0722.2006.00312.x
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   KENNETH RS, 2007, DENT CLIN N AM, V51, P747
   Moradian-Oldak J, 2007, J DENT RES, V86, P487, DOI 10.1177/154405910708600603
   MUSTAFA G, 2008, BIOMACROMOLECULES, DOI DOI 10.1021/BM701037X
   Onuma K, 2005, J CRYST GROWTH, V282, P199, DOI 10.1016/j.jcrysgro.2005.04.085
   Sarikaya M, 2003, NAT MATER, V2, P577, DOI 10.1038/nmat964
   Tamerler C, 2007, ACTA BIOMATER, V3, P289, DOI 10.1016/j.actbio.2006.10.009
   Tay FR, 2008, BIOMATERIALS, V29, P1127, DOI 10.1016/j.biomaterials.2007.11.001
   Vollenweider M, 2007, ACTA BIOMATER, V3, P936, DOI 10.1016/j.actbio.2007.04.003
   Yamagishi K, 2005, NATURE, V433, P819, DOI 10.1038/433819a
NR 15
TC 4
Z9 6
U1 1
U2 13
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0306-9877
EI 1532-2777
J9 MED HYPOTHESES
JI Med. Hypotheses
PD OCT
PY 2008
VL 71
IS 4
BP 591
EP 593
DI 10.1016/j.mehy.2008.04.024
PG 3
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 361RW
UT WOS:000260145800020
PM 18657914
DA 2018-10-19
ER

PT J
AU Soman, P
   Rice, Z
   Siedlecki, CA
AF Soman, Pranav
   Rice, Zachary
   Siedlecki, Christopher A.
TI Immunological identification of fibrinogen in dual-component protein
   films by AFM imaging
SO MICRON
LA English
DT Review
DE AFW; fibrinogen; protein adsorption immunochemistry; biomaterials; gold
   labeling; biocompatibility; polymers
ID ATOMIC-FORCE MICROSCOPY; SUPPORTED PHOSPHOLIPID-BILAYERS;
   SURFACE-PLASMON RESONANCE; ION MASS-SPECTROMETRY; VOLUMETRIC
   INTERPRETATION; PLATELET-ADHESION; BINDING-SITES; ADSORPTION;
   LOCALIZATION; BIOMATERIALS
AB The success of long-term blood-contacting implanted devices is largely dependent upon the interaction of the blood components with the device biomaterial surface. The ability to study these interactions has been hindered by a lack of methods to measure single-molecule interactions in complex multi-protein environments similar to the environment found in vivo. In this paper, we demonstrate the use of atomic force microscopy (AFM) in conjunction with gold nanolabels to detect the protein fibrinogen under aqueous conditions without the topographical clues usually necessary for high resolution visualization. BSA was patterned onto both muscovite mica and plasma-treated polydimethylsiloxane (PDMS) substrates and these test substrates were subsequently backfilled with fibrinogen to yield a featureless protein layer. The fibrinogen in this dual-protein layer was detected using high resolution AFM imaging following infusion of anti-fibrinogen conjugated with nanogold particles. This AFM immuno-detection technique will potentially be applicable to complex multi-component protein films adsorbed on clinically relevant polymers used in medical devices. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Rice, Zachary; Siedlecki, Christopher A.] Penn State Univ, Coll Med, Dept Surg, Inst Biomed Engn, Hershey, PA 17033 USA.
   [Soman, Pranav; Siedlecki, Christopher A.] Penn State Univ, Coll Med, Dept Bioengn, Inst Biomed Engn, Hershey, PA 17033 USA.
RP Siedlecki, CA (reprint author), Penn State Univ, Coll Med, Dept Surg, Inst Biomed Engn, Mail Code H151,500 Univ Dr, Hershey, PA 17033 USA.
EM csiedlecki@psu.edu
FU National Heart, Lung, and Blood Institute [N01HV48191]; National
   Institute of Health; National Science Foundation [NSF EEC-0234026];
   Pennsylvania Department of Health
FX Financial support for this work was provided by National Heart, Lung,
   and Blood Institute Contract N01HV48191, the Penn State University BBSI
   program through a grant from the National Institute of Health and the
   National Science Foundation (Funding #: NSF EEC-0234026), the Dorothy
   Foehr Huck and J. Lloyd Huck Institutes of the Life Sciences, and by a
   grant from the Pennsylvania Department of Health. The Pennsylvania
   Department of Health specifically disclaims responsibility for any
   analyses, interpretations or conclusions. The authors thank Dr. Keith
   Milner for preparing the silicone stamps for micro-contact printing and
   Dr. John Flanagan for assistance with HPLC purification. The authors
   would also like to thank Dr. Li-Chong Xu and Dr. Aashiish Agnihotri for
   valuable technical discussions.
CR Agnihotri A, 2006, J BIOMAT SCI-POLYM E, V17, P227, DOI 10.1163/156856206774879036
   Agnihotri A, 2005, ULTRAMICROSCOPY, V102, P257, DOI 10.1016/j.ultramic.2004.10.006
   Agnihotri A, 2004, LANGMUIR, V20, P8846, DOI 10.1021/la049239
   Argaman M, 1997, NUCLEIC ACIDS RES, V25, P4379, DOI 10.1093/nar/25.21.4379
   Balasubramanian V, 1999, J BIOMED MATER RES, V44, P253, DOI 10.1002/(SICI)1097-4636(19990305)44:3<253::AID-JBM3>3.0.CO;2-K
   Bar G, 1997, LANGMUIR, V13, P3807, DOI 10.1021/la970091m
   BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   CALVETE JJ, 1994, THROMB HAEMOSTASIS, V72, P1
   Calvete JJ, 1999, P SOC EXP BIOL MED, V222, P29, DOI 10.1111/j.1525-1373.1999.09993.x
   Chittur KK, 1998, BIOMATERIALS, V19, P357, DOI 10.1016/S0142-9612(97)00223-8
   EPPELL SJ, 1995, BIOPHYS J, V68, P671, DOI 10.1016/S0006-3495(95)80228-6
   FARRELL DH, 1992, P NATL ACAD SCI USA, V89, P10729, DOI 10.1073/pnas.89.22.10729
   Glasmastar K, 2002, J COLLOID INTERF SCI, V246, P40, DOI 10.1006/jcis.2001.8060
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Green RJ, 1999, BIOMATERIALS, V20, P385, DOI 10.1016/S0142-9612(98)00201-4
   Green RJ, 1997, BIOMATERIALS, V18, P405, DOI 10.1016/S0142-9612(96)00141-X
   HAINFELD JF, 1997, CELL VISION, V4, P408
   Hantgan R. R., 2001, HEMOSTASIS THROMBOSI, P203
   Hinterdorfer P, 1996, P NATL ACAD SCI USA, V93, P3477, DOI 10.1073/pnas.93.8.3477
   Holland NB, 2000, J BIOMED MATER RES, V51, P307, DOI 10.1002/1097-4636(20000905)51:3<307::AID-JBM3>3.0.CO;2-H
   Horbett TA, 1993, CARDIOVASC PATHOL, V2, P137, DOI DOI 10.1016/1054-8807(93)90054-6)
   Hussain MA, 2005, LANGMUIR, V21, P6979, DOI 10.1021/la046943h
   Krishnan A, 2006, BIOMATERIALS, V27, P3187, DOI 10.1016/j.biomaterials.2005.12.032
   Lassen B, 1996, J COLLOID INTERF SCI, V179, P470, DOI 10.1006/jcis.1996.0239
   Lin H, 2000, BIOCHEMISTRY-US, V39, P3192, DOI 10.1021/bi991624o
   Marchant RE, 2002, CURR PROTEIN PEPT SC, V3, P249, DOI 10.2174/1389203023380611
   Milner KR, 2006, J BIOMED MATER RES A, V76A, P561, DOI 10.1002/jbm.a.30554
   Montesano-Roditis L, 2001, J BIOL CHEM, V276, P14117, DOI 10.1074/jbc.M008430200
   Noh H, 2006, BIOMATERIALS, V27, P5801, DOI 10.1016/j.biomaterials.2006.08.005
   Noh H, 2007, BIOMATERIALS, V28, P405, DOI 10.1016/j.biomaterials.2006.09.006
   Osada T, 2003, ULTRAMICROSCOPY, V97, P353, DOI 10.1016/S0304-3991(03)00060-3
   Pickering JP, 1998, POLYM BULL, V40, P549, DOI 10.1007/s002890050289
   Plow E. F., 2001, HEMOSTASIS THROMBOSI, P479
   PUTNAM CAJ, 1993, ULTRAMICROSCOPY, V48, P177
   Radmacher M, 1997, IEEE ENG MED BIOL, V16, P47, DOI 10.1109/51.582176
   Raghavachari M, 2000, THROMB RES, V98, P351, DOI 10.1016/S0049-3848(00)00185-7
   Reviakine I, 2000, LANGMUIR, V16, P1806, DOI 10.1021/la9903043
   Reviakine I, 2000, LANGMUIR, V16, P1473, DOI 10.1021/la990806g
   Thibault C, 2005, J Nanobiotechnology, V3, P7, DOI 10.1186/1477-3155-3-7
   Toscano A, 2006, LANGMUIR, V22, P2588, DOI 10.1021/la051641g
   Touhami A, 2003, LANGMUIR, V19, P4539, DOI 10.1021/la034136x
   Truong C. Ta., 1998, LANGMUIR, V14, P2435
   Tsai WB, 1999, J BIOMED MATER RES, V44, P130, DOI 10.1002/(SICI)1097-4636(199902)44:2<130::AID-JBM2>3.0.CO;2-9
   VOGLER EA, 1995, J BIOMED MATER RES, V29, P1017, DOI 10.1002/jbm.820290814
   Wagner MS, 2003, BIOMATERIALS, V24, P1897, DOI 10.1016/S0142-9612(02)00612-9
   Wagner MS, 2003, J BIOMED MATER RES A, V64A, P1, DOI 10.1002/jbm.a.10263
   WAKAKO S, 2006, NEUROSCI LETT, V391, P102
   Wertz CF, 2001, LANGMUIR, V17, P3006, DOI 10.1021/la0017781
   Yang RB, 2000, J COMP NEUROL, V425, P139, DOI 10.1002/1096-9861(20000911)425:1<139::AID-CNE12>3.0.CO;2-#
NR 49
TC 18
Z9 18
U1 0
U2 14
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0968-4328
J9 MICRON
JI Micron
PD OCT
PY 2008
VL 39
IS 7
BP 832
EP 842
DI 10.1016/j.micron.2007.12.013
PG 11
WC Microscopy
SC Microscopy
GA 351KI
UT WOS:000259422800011
PM 18294855
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Engberg, A
   Rosengren-Holmberg, J
   Nicholls, I
   Ekdahl, KN
AF Engberg, Anna
   Rosengren-Holmberg, Jenny
   Nicholls, Ian
   Ekdahl, Kristina Nilsson
TI Development of novel biomaterial surfaces and evaluation of their
   hemocompatibility
SO MOLECULAR IMMUNOLOGY
LA English
DT Meeting Abstract
CT 22nd International Complement Workshop
CY SEP 28-OCT 02, 2008
CL Basel, SWITZERLAND
C1 [Engberg, Anna; Rosengren-Holmberg, Jenny; Nicholls, Ian; Ekdahl, Kristina Nilsson] Univ Kalmar, Sch Pure & Appl Nat Sci, Kalmar, Sweden.
RI Nicholls, Ian/A-1976-2009
OI Nicholls, Ian/0000-0002-0407-6542; Rosengren Holmberg,
   Jenny/0000-0003-2417-9175
NR 0
TC 1
Z9 1
U1 1
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0161-5890
J9 MOL IMMUNOL
JI Mol. Immunol.
PD OCT
PY 2008
VL 45
IS 16
SI SI
MA P262
BP 4182
EP 4182
DI 10.1016/j.molimm.2008.08.261
PG 1
WC Biochemistry & Molecular Biology; Immunology
SC Biochemistry & Molecular Biology; Immunology
GA 363DB
UT WOS:000260245000268
DA 2018-10-19
ER

PT J
AU He, QH
   Zhang, ZX
   Xiong, JW
   Xiong, YY
   Xiao, H
AF He, Qinghang
   Zhang, Zhenxi
   Xiong, Jianwen
   Xiong, Yuying
   Xiao, Hua
TI A novel biomaterial - Fe3O4:TiO2 core-shell nano particle with magnetic
   performance and high visible light photocatalytic activity
SO OPTICAL MATERIALS
LA English
DT Article
DE Fe3O4:TiO2 core-shell NP; Malignant tumor therapy; Photocatalytic
   activity; Homogeneous precipitation method
ID TIO2; DISINFECTION; DEGRADATION; FILMS; DYE
AB Aiming at some disadvantages of TiO2 nano particle (TiO2 NP), this paper successfully prepared Fe3O4: TiO2 core-shell nano particle (Fe3O4:TiO2 core-shell NP) using homogeneous precipitation method. The prepared Fe3O4:TiO2 core-shell NP was characterized using XRD, TEM. UV-vis DRS, FT-IR, and VSM, respectively: the results show that Fe3O4:TiO2 core-shell NP is single dispersed with the diameter of 20 nm on average. In contrast to the traditional TiO2 NP, Fe3O4:TiO2 core-shell NP generates red shift, and has higher absorption in visible region and greater photocatalytic activity, plus additional superpara-magetism. In order to demonstrate the benefits of Fe3O4:TiO2 core-shell NP, we adopted Hela cells as a model to investigate the killing efficiency. The results show that Fe3O4:TiO2 core-shell NP is non-toxic, and much more efficient than traditional TiO2 NP combined with extra magnetic field. This shows that Fe3O4:TiO2 core-shell NP is a novel biomaterial with magnetic performance and high visible light photocatalytic activity. It would be a promising candidate in the field of malignant tumor therapy in future. (C) 2008 Elsevier B.V. All rights reserved.
C1 [He, Qinghang; Zhang, Zhenxi] Xi An Jiao Tong Univ, Key Lab Biomed Informat Engn, Minist Educ, Xian 710049, Peoples R China.
   [He, Qinghang; Zhang, Zhenxi] Xi An Jiao Tong Univ, Inst Biomed Analyt Technol & Instrumentat, Sch Life Sci & Technol, Xian 710049, Peoples R China.
   [He, Qinghang] Xiamen Food & Drug Adm, Xiamen 361004, Peoples R China.
   [Xiong, Jianwen; Xiong, Yuying; Xiao, Hua] S China Normal Univ, Dept Phys, Guangzhou 510631, Guangdong, Peoples R China.
RP Zhang, ZX (reprint author), Xi An Jiao Tong Univ, Key Lab Biomed Informat Engn, Minist Educ, Xian 710049, Peoples R China.
EM zxzhang@mail.xjtu.edu.cn
FU National Natural Science Foundation of China [60578026]
FX The authors are grateful for the financial support provided by the
   National Natural Science Foundation of China (Grant Number: 60578026).
CR Behnajady MA, 2007, CHEM ENG J, V127, P167, DOI 10.1016/j.cej.2006.09.013
   Choi H., 2007, DESALINATION, V202, P200
   Christensen PA, 2003, APPL CATAL B-ENVIRON, V41, P371, DOI 10.1016/S0926-3373(02)00172-8
   Dadjour MF, 2006, WATER RES, V40, P1137, DOI 10.1016/j.watres.2005.12.047
   FUJISHIMA A, 2000, J PHOTOCHEM PHOTOBIO, V1, P12
   GUAN B, 2007, J AM SOC SPECTROM, V81, P519
   Kleiman A, 2007, SURF COAT TECH, V201, P6358, DOI 10.1016/j.surfcoat.2006.12.002
   Li JY, 2007, J MOL CATAL A-CHEM, V261, P131, DOI 10.1016/j.molcata.2006.08.018
   Murphy AB, 2007, SOL ENERG MAT SOL C, V91, P1326, DOI 10.1016/j.solmat.2007.05.005
   OH ST, 2007, J MOL CATAL A-CHEM, V267, P118
   OKADA K, 2007, MAT RES B, V42, P1922
   SANG LX, 2003, CHEM J CHIN U CHIN, V246, P165
   Sichel C, 2007, APPL CATAL B-ENVIRON, V74, P152, DOI 10.1016/j.apcatb.2007.02.005
   Tachibana Y, 2007, SOL ENERG MAT SOL C, V91, P201, DOI 10.1016/j.solmat.2006.09.001
   XIE YB, 2006, ELECTROCHIM ACTA, V51, P3406
   Yamazaki S, 2007, J PHOTOCH PHOTOBIO A, V185, P150, DOI 10.1016/j.jphotochem.2006.05.024
   Zallen R, 2006, SOLID STATE COMMUN, V137, P154, DOI 10.1016/j.ssc.2005.10.024
   ZHAO Y, 2007, MATER LETT, V61, P83
NR 18
TC 96
Z9 104
U1 3
U2 126
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0925-3467
J9 OPT MATER
JI Opt. Mater.
PD OCT-DEC
PY 2008
VL 31
IS 2
BP 380
EP 384
DI 10.1016/j.optmat.2008.05.011
PG 5
WC Materials Science, Multidisciplinary; Optics
SC Materials Science; Optics
GA 385NZ
UT WOS:000261822200051
DA 2018-10-19
ER

PT J
AU Falco, EE
   Patel, M
   Fisher, JP
AF Falco, Erin E.
   Patel, Minal
   Fisher, John P.
TI Recent developments in cyclic acetal biomaterials for tissue engineering
   applications
SO PHARMACEUTICAL RESEARCH
LA English
DT Review
DE biomaterial; cyclic acetal; polyacetal; polyketal; tissue engineering
ID POLY(PROPYLENE FUMARATE)-BASED NETWORKS; SYNTHETIC BIODEGRADABLE
   POLYMERS; PH-DEPENDENT DEGRADATION; DRUG-DELIVERY SYSTEMS; IN-VITRO;
   MECHANICAL-PROPERTIES; POLY(L-LACTIC ACID); SURFACE-MORPHOLOGY;
   POLYACETAL; HYDROGELS
AB At an ever increasing pace, synthetic biomaterials are being developed with specific functionalities for tissue engineering applications. These biomaterials possess properties including biocompatibility, mechanical strength, and degradation as well as functionalities such as specific cell adhesion and directed cell migration. However, synthetic polymers are often not completely biologically inert and may non-specifically react with the surrounding in vivo environment. An example of this reactivity is the release of acidic degradation products from hydrolytically degradable polymers based upon an ester moiety. In order to address this concern, a novel class of biomaterials based upon a cyclic acetal unit has been developed. Scaffolds suitable for the replacement of both hard and soft tissues have been successfully fabricated from cyclic acetals and a detailed characterization of scaffold properties has been performed. Cyclic acetal based biomaterials have also been used to repair bone defects and promote bone growth, displaying a minimal inflammatory response. This review will discuss the most recent research of current biomaterials and cyclic acetals, and particularly focus on the tissue engineering applications of these materials. Finally, this review will also briefly discuss polyacetals and polyketals for drug delivery applications.
C1 [Patel, Minal; Fisher, John P.] Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
   [Falco, Erin E.] Univ Maryland, Dept Chem & Biomol Engn, College Pk, MD 20742 USA.
RP Fisher, JP (reprint author), Univ Maryland, Fischell Dept Bioengn, 3238 Jeong H Kim Engn Bldg 225, College Pk, MD 20742 USA.
EM jpfisher@umd.edu
RI Fisher, John/F-8078-2012
FU Arthritis Foundation; National Science Foundation [0448684]; State of
   Maryland Department of Business and Economic Development
FX This work was supported by the Arthritis Foundation through an Arthritis
   Investigator Award to JPF, the National Science Foundation through a
   CAREER Award to JPF (#0448684), and the State of Maryland Department of
   Business and Economic Development.
CR Al Malyan M, 2006, J CRANIOFAC SURG, V17, P302, DOI 10.1097/00001665-200603000-00018
   Allen C, 2002, BIOSCIENCE REP, V22, P225, DOI 10.1023/A:1020186505848
   An YH, 2000, BIOMATERIALS, V21, P2635, DOI 10.1016/S0142-9612(00)00132-0
   Behravesh E, 1999, CLIN ORTHOP RELAT R, pS118
   BETZ MW, 2007, J BIOMED MAT A  1116
   BETZ MW, 2008, J BIOMED A IN PRESS
   Bohner M, 2001, EUR SPINE J, V10, pS114, DOI 10.1007/s005860100276
   Bramfeldt H, 2007, J BIOMED MATER RES A, V83A, P503, DOI 10.1002/jbm.a.31300
   Brandl F, 2007, BIOMATERIALS, V28, P134, DOI 10.1016/j.biomaterials.2006.09.017
   Brem H, 1995, J NEURO-ONCOL, V26, P111, DOI 10.1007/BF01060217
   Burkoth AK, 2000, BIOMATERIALS, V21, P2395, DOI 10.1016/S0142-9612(00)00107-1
   CASCONE MG, 1995, BIOMATERIALS, V16, P569, DOI 10.1016/0142-9612(95)91131-H
   Cohen SR, 2006, J CRANIOFAC SURG, V17, P40, DOI 10.1097/01.scs.0000200411.22583.4e
   Daniels A. U., 1992, T ORTHOP RES SOC, V17, P88
   De Laporte L, 2007, ADV DRUG DELIVER REV, V59, P292, DOI 10.1016/j.addr.2007.03.017
   Delie F, 2005, MOLECULES, V10, P65, DOI 10.3390/10010065
   FALCO EE, 2007, J SURG RES      0918
   Galaev IY, 1999, TRENDS BIOTECHNOL, V17, P335, DOI 10.1016/S0167-7799(99)01345-1
   Gilbert TW, 2007, BIOMATERIALS, V28, P147, DOI 10.1016/j.biomaterials.2006.08.022
   Gillies ER, 2004, J AM CHEM SOC, V126, P11936, DOI 10.1021/ja0463738
   Gunatillake P, 2006, BIOTECHNOL ANN REV, V12, P301, DOI 10.1016/S1387-2656(06)12009-8
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   Haag R, 2006, ANGEW CHEM INT EDIT, V45, P1198, DOI 10.1002/anie.200502113
   Harrison BS, 2007, BIOMATERIALS, V28, P4628, DOI 10.1016/j.biomaterials.2007.07.003
   Heffernan MJ, 2005, BIOCONJUGATE CHEM, V16, P1340, DOI 10.1021/bc050176w
   Heller J, 2004, BIOMACROMOLECULES, V5, P1625, DOI 10.1021/bm040049n
   HOFFMAN AS, 1995, ARTIF ORGANS, V19, P458, DOI 10.1111/j.1525-1594.1995.tb02359.x
   Huang YC, 2006, ARTIF ORGANS, V30, P514, DOI 10.1111/j.1525-1594.2006.00253.x
   Il Lee K, 2007, J ACOUST SOC AM, V121, pEL263, DOI 10.1121/1.2719046
   Kaihara S, 2008, EUR J PHARM BIOPHARM, V68, P67, DOI 10.1016/j.ejpb.2007.05.019
   Kaihara S, 2007, NAT PROTOC, V2, P2767, DOI 10.1038/nprot.2007.391
   Kaihara S, 2007, MACROMOLECULES, V40, P7625, DOI 10.1021/ma071297p
   Katti DS, 2002, ADV DRUG DELIVER REV, V54, P933, DOI 10.1016/S0169-409X(02)00052-2
   Khaja SD, 2007, BIOMACROMOLECULES, V8, P1391, DOI 10.1021/bm061234z
   Kim TG, 2007, INT J PHARM, V338, P276, DOI 10.1016/j.ijpharm.2007.01.040
   Kumar N, 2002, ADV DRUG DELIVER REV, V54, P889, DOI 10.1016/S0169-409X(02)00050-9
   Kurtz SM, 2000, J BIOMED MATER RES, V52, P447
   LAM KH, 1995, J BIOMED MATER RES, V29, P929, DOI 10.1002/jbm.820290804
   LAM KH, 1993, J BIOMED MATER RES, V27, P1569, DOI 10.1002/jbm.820271214
   Lee S, 2007, BIOCONJUGATE CHEM, V18, P4, DOI 10.1021/bc060259s
   Lemcoff NG, 2002, ORG LETT, V4, P731, DOI 10.1021/ol017230i
   Lendlein A, 2005, Med Device Technol, V16, P12
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Mistry AS, 2007, J BIOMED MATER RES A, V83A, P940, DOI 10.1002/jbm.a.31280
   Moreau JL, 2007, J BIOMED MATER RES A, V81A, P594, DOI 10.1002/jbm.a.31104
   Mundargi RC, 2007, J CONTROL RELEASE, V119, P59, DOI 10.1016/j.jconrel.2007.01.008
   Nakabayashi N, 2003, BIOMATERIALS, V24, P2437, DOI 10.1016/S0142-9612(03)00112-1
   Nomura M, 2003, BIOORGAN MED CHEM, V11, P2453, DOI 10.1016/S0968-0896(03)00104-4
   Papisov MI, 2005, BIOMACROMOLECULES, V6, P2659, DOI 10.1021/bm0502157
   Patel M, 2008, PEDIATR RES, V63, P497, DOI 10.1203/01.PDR.0b013e318165eb3e
   Periti P, 2002, CLIN PHARMACOKINET, V41, P485, DOI 10.2165/00003088-200241070-00003
   Poletto FS, 2007, INT J PHARMACEUT, V345, P70, DOI 10.1016/j.ijpharm.2007.05.040
   Raghunath J, 2007, BIOTECHNOL APPL BIOC, V46, P73, DOI 10.1042/BA20060134
   Sachlos E., 2003, European Cells & Materials, V5, P29
   Sachlos E, 2003, EUR CELLS MATER, V5, P39
   Sartor O, 2003, UROLOGY, V62, P319, DOI 10.1016/S0090-4295(03)00330-3
   Schacht E, 2006, J CONTROL RELEASE, V116, P219, DOI 10.1016/j.jconrel.2006.07.026
   Schlosser M, 2005, J BIOMED MATER RES A, V72A, P317, DOI 10.1002/jbm.a.30240
   Shi XF, 2006, BIOMACROMOLECULES, V7, P2237, DOI 10.1021/bm060391v
   Sinha VR, 2004, INT J PHARMACEUT, V278, P1, DOI 10.1016/j.ijpharm.2004.01.044
   Sitharaman B, 2007, J BIOMAT SCI-POLYM E, V18, P655, DOI 10.1163/156856207781034133
   STAYTON PS, 1995, NATURE, V378, P472, DOI 10.1038/378472a0
   STENZL A, 2007, INT BRAZ J UROL, V33, P871
   Strazar K, 2006, BIOMACROMOLECULES, V7, P2507, DOI 10.1021/bm060239t
   Suggs LJ, 1999, J BIOMED MATER RES, V46, P22, DOI 10.1002/(SICI)1097-4636(199907)46:1<22::AID-JBM3>3.0.CO;2-R
   Takada S, 1998, Nihon Rinsho, V56, P675
   TAMADA Y, 1994, J BIOMED MATER RES, V28, P783, DOI 10.1002/jbm.820280705
   TAYLOR MS, 1994, J APPL BIOMATER, V5, P151, DOI 10.1002/jab.770050208
   Thompson MS, 2001, J MATER SCI-MATER M, V12, P883, DOI 10.1023/A:1012815822323
   Timmer MD, 2003, J BIOMED MATER RES A, V66A, P811, DOI 10.1002/jbm.a.10011
   Timmer MD, 2003, J BIOMAT SCI-POLYM E, V14, P369, DOI 10.1163/156856203321478874
   Timmer MD, 2003, BIOMATERIALS, V24, P571, DOI 10.1016/S0142-9612(02)00368-X
   Tomlinson R, 2003, BIOCONJUGATE CHEM, V14, P1096, DOI 10.1021/bc030028a
   Tomlinson R, 2002, MACROMOLECULES, V35, P473, DOI 10.1021/ma0108867
   UPPAL P, 1994, J OCUL PHARMACOL, V10, P471, DOI 10.1089/jop.1994.10.471
   VANWACHEM PB, 1987, BIOMATERIALS, V8, P323, DOI 10.1016/0142-9612(87)90001-9
   Vicent MJ, 2004, J DRUG TARGET, V12, P491, DOI 10.1080/10611860400011885
NR 77
TC 34
Z9 35
U1 0
U2 40
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0724-8741
EI 1573-904X
J9 PHARM RES-DORDR
JI Pharm. Res.
PD OCT
PY 2008
VL 25
IS 10
BP 2348
EP 2356
DI 10.1007/s11095-008-9620-5
PG 9
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 348CE
UT WOS:000259187800018
PM 18536870
OA Bronze
DA 2018-10-19
ER

PT J
AU Romer, L
   Scheibel, T
AF Roemer, Lin
   Scheibel, Thomas
TI The elaborate structure of spider silk Structure and function of a
   natural high performance fiber
SO PRION
LA English
DT Reprint
DE biomimetics; biotechnology; protein folding; protein assembly; spinning
ID CONSERVED C-TERMINI; DRAGLINE SILK; MECHANICAL-PROPERTIES; FLAGELLIFORM
   SILK; ESCHERICHIA-COLI; PROTEINS; SUPERCONTRACTION; DESIGN; ORIENTATION;
   SEQUENCE
AB Biomaterials, having evolved over millions of years, often exceed man-made materials in their properties. Spider silk is one outstanding fibrous biomaterial which consists almost entirely of large proteins. Silk fibers have tensile strengths comparable to steel and some silks are nearly as elastic as rubber on a weight to weight basis. In combining these two properties, silks reveal a toughness that is two to three times that of synthetic fibers like Nylon or Kevlar. Spider silk is also antimicrobial, hypoallergenic and completely biodegradable.
   This article focuses on the structure-function relationship of the characterized highly repetitive spider silk spidroins and their conformational conversion from solution into fibers. Such knowedge is of crucial importance to understanding the intrinsic properties of spider silk and to get insight into the sophisticated assembly processes of silk proteins. This review further outlines recent progress in recombinant production of spider silk proteins and their assembly into distinct polymer materials as a basis for novel products.
C1 [Roemer, Lin; Scheibel, Thomas] Univ Bayreuth, Fak Angew Nat Wissensch, Lehrstuhl Biomat, D-95447 Bayreuth, Germany.
RP Scheibel, T (reprint author), Univ Bayreuth, Fak Angew Nat Wissensch, Lehrstuhl Biomat, Univ Str 30, D-95447 Bayreuth, Germany.
EM thomas.scheibel@uni-bayreuth.de
RI Scheibel, Thomas/I-1170-2014
OI Scheibel, Thomas/0000-0002-0457-2423
CR Arcidiacono S, 2002, MACROMOLECULES, V35, P1262, DOI 10.1021/ma011471o
   Arcidiacono S, 1998, APPL MICROBIOL BIOT, V49, P31, DOI 10.1007/s002530051133
   Arzt E, 2003, P NATL ACAD SCI USA, V100, P10603, DOI 10.1073/pnas.1534701100
   Ayoub N. A., 2007, PLOS ONE, V2, P514
   Becker N, 2003, NAT MATER, V2, P278, DOI 10.1038/nmat858
   Castillo-Davis CI, 2002, NAT GENET, V31, P415, DOI 10.1038/ng1011
   Dicko C, 2004, BIOCHEMISTRY-US, V43, P14080, DOI 10.1021/bi0483413
   Emile O, 2006, NATURE, V440, P621, DOI 10.1038/440621a
   Emile O, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.167402
   Exler JH, 2007, ANGEW CHEM INT EDIT, V46, P3559, DOI 10.1002/anie.200604718
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P33, DOI 10.1007/s002530050884
   Fraser R., 1973, CONFORMATION FIBROUS
   Gao HJ, 2004, P NATL ACAD SCI USA, V101, P7851, DOI 10.1073/pnas.0400757101
   GERRITSEN V. B., 2000, PROTEIN SPOTLIGHT, V24, P1
   GOSLINE JM, 1984, NATURE, V309, P551, DOI 10.1038/309551a0
   GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0
   Hayashi CY, 2001, BIOESSAYS, V23, P750, DOI 10.1002/bies.1105
   Hayashi CY, 1998, J MOL BIOL, V275, P773, DOI 10.1006/jmbi.1997.1478
   Hermanson KD, 2007, ADV MATER, V19, P1810, DOI 10.1002/adma.200602709
   Hijirida DH, 1996, BIOPHYS J, V71, P3442, DOI 10.1016/S0006-3495(96)79539-5
   Hu X, 2006, CELL MOL LIFE SCI, V63, P1986, DOI 10.1007/s00018-006-6090-y
   Hu XY, 2007, BIOCHEMISTRY-US, V46, P3294, DOI 10.1021/bi602507e
   Huemmerich D, 2006, APPL PHYS A-MATER, V82, P219, DOI 10.1007/s00339-005-3428-5
   Huemmerich D, 2004, CURR BIOL, V14, P2070, DOI 10.1016/j.cub.2004.11.005
   Huemmerich D, 2004, BIOCHEMISTRY-US, V43, P13604, DOI 10.1021/bi048983q
   Ittah S, 2007, BIOMACROMOLECULES, V8, P2768, DOI 10.1021/bm7004559
   Jelinski LW, 1999, INT J BIOL MACROMOL, V24, P197, DOI 10.1016/S0141-8130(98)00085-3
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   KAPLAN D, 1993, ACS S SERIES
   Kenney JM, 2002, EUR J BIOCHEM, V269, P4159, DOI 10.1046/j.1432-1033.2002.03112.x
   Ko FK, 2004, BIOMACROMOLECULES, V5, P780, DOI 10.1021/bm0345099
   Kubik S, 2002, ANGEW CHEM INT EDIT, V41, P2721, DOI 10.1002/1521-3773(20020802)41:15<2721::AID-ANIE2721>3.0.CO;2-3
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   Lewis RV, 2006, CHEM REV, V106, P3762, DOI 10.1021/cr010194g
   Liu Y, 2005, NAT MATER, V4, P901, DOI 10.1038/nmet1534
   Metwalli E, 2007, APPL PHYS A-MATER, V89, P655, DOI 10.1007/s00339-007-4265-5
   Miao YG, 2006, APPL MICROBIOL BIOT, V71, P192, DOI 10.1007/s00253-005-0127-2
   Motriuk-Smith D, 2005, BIOMACROMOLECULES, V6, P3152, DOI 10.1021/bm050472b
   NENTWIG W, 1982, OECOLOGIA, V53, P412, DOI 10.1007/BF00389023
   Padgett KA, 1996, GENE, V168, P31, DOI 10.1016/0378-1119(95)00731-8
   Perez-Rigueiro J, 2003, POLYMER, V44, P3733, DOI 10.1016/S0032-3861(03)00245-3
   Rammensee S, 2006, APPL PHYS A-MATER, V82, P261, DOI 10.1007/s00339-005-3431-x
   Riekel C, 1999, INT J BIOL MACROMOL, V24, P179, DOI 10.1016/S0141-8130(98)00084-1
   Rising A, 2006, BIOMACROMOLECULES, V7, P3120, DOI 10.1021/bm060693x
   Rising A, 2005, ZOOL SCI, V22, P273, DOI 10.2108/zsj.22.273
   Scheibel T, 2005, CURR OPIN BIOTECH, V16, P427, DOI 10.1016/j.copbio.2005.05.005
   Scheibel T, 2004, MICROB CELL FACT, V3, DOI 10.1186/1475-2859-3-14
   Scheller J, 2001, NAT BIOTECHNOL, V19, P573, DOI 10.1038/89335
   Schmidt M, 2007, BIOTECHNOL LETT, V29, P1741, DOI 10.1007/s10529-007-9461-z
   Seidel A, 1998, MACROMOLECULES, V31, P6733, DOI 10.1021/ma9808880
   Sengupta S., 2007, PROTEIN FOLDING MISF, P1
   Shao Z, 1999, POLYMER, V40, P2493, DOI 10.1016/S0032-3861(98)00475-3
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   Simmons AH, 1996, SCIENCE, V271, P84, DOI 10.1126/science.271.5245.84
   Slotta U, 2007, MACROMOL BIOSCI, V7, P183, DOI 10.1002/mabi.200600201
   Slotta U, 2006, SUPRAMOL CHEM, V18, P465, DOI 10.1080/10610270600832042
   Sponner A, 2005, BIOCHEM BIOPH RES CO, V338, P897, DOI 10.1016/j.bbrc.2005.10.048
   Sponner A, 2004, BIOMACROMOLECULES, V5, P840, DOI 10.1021/bm034378b
   TERMONIA Y, 1994, PHYS REV LETT, V72, P3678, DOI 10.1103/PhysRevLett.72.3678
   Townley MA, 2006, J EXP BIOL, V209, P1463, DOI 10.1242/jeb.02147
   TRIVEDI BP, LAB SPINS ARTIFICIAL
   van Beek JD, 2002, P NATL ACAD SCI USA, V99, P10266, DOI 10.1073/pnas.152162299
   Vendrely C, 2007, MACROMOL BIOSCI, V7, P401, DOI 10.1002/mabi.200600255
   Vendrely Charlotte, 2008, V474, P3, DOI 10.1007/978-1-59745-480-3_1
   VOLLRATH F, 1991, NATURWISSENSCHAFTEN, V78, P557, DOI 10.1007/BF01134447
   Vollrath F, 2000, J Biotechnol, V74, P67
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   Vollrath F, 2001, P ROY SOC B-BIOL SCI, V268, P2339, DOI 10.1098/rspb.2001.1590
   Wilding M. A., 1996, POLYM MAT ENCY, V11, P8307
   XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120
   Yang ZT, 2000, J AM CHEM SOC, V122, P9019, DOI 10.1021/ja0017099
   ZSCHOKKE S, 1993, B BR ARACHNOL SOC, V9, P167
NR 74
TC 100
Z9 104
U1 2
U2 59
PU LANDES BIOSCIENCE
PI AUSTIN
PA 1002 WEST AVENUE, 2ND FLOOR, AUSTIN, TX 78701 USA
SN 1933-6896
J9 PRION
JI Prion
PD OCT-DEC
PY 2008
VL 2
IS 4
BP 154
EP 161
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 415DB
UT WOS:000263913400005
PM 19221522
DA 2018-10-19
ER

PT J
AU Kundu, SC
   Dash, BC
   Dash, R
   Kaplan, DL
AF Kundu, Subhas C.
   Dash, Biraja C.
   Dash, Rupesh
   Kaplan, David L.
TI Natural protective glue protein, sericin bioengineered by silkworms:
   Potential for biomedical and biotechnological applications
SO PROGRESS IN POLYMER SCIENCE
LA English
DT Review
DE Silk proteins; Sericin; Fibroin; Cosmetics; Anticancer drugs;
   Biomaterial
ID TROPICAL TASAR SILKWORM; SECRETES RECOMBINANT PROTEINS; REDUCING
   OXIDATIVE STRESS; ACUTE SERUM DEPRIVATION; BOMBYX-MORI SILKGLAND;
   LIGHT-CHAIN GENE; ANTHERAEA-MYLITTA; MOLECULAR PHYLOGENY; FIBROBLAST
   CELLS; L-ASPARAGINASE
AB Silk proteins consist of a fibrous core protein, fibroin, and glue proteins called sericins, which envelop the fibroin fiber with successive sticky layers that help in the formation of a cocoon by cementing together the silk fibers. This system is essentially a protein-fiber composite system, with fibers of the high-molecular-weight fibroin proteins surrounded by the gluelike continuous phase of the sericin. In mulberry silk produced by Bombyx man, Ser1 and Ser2 are the two major genes encoding for sericin. Ser1 is the most abundant silk sericin of B. moli and consists of repeats of a 38-amino acid motif that contributes towards the hydrophilicity of sericin. The protein has partially been characterized from non-mulberry silkworms like the tropical tasar Antheraea mylitta, and studied for various potential applications because of its unique biochemical and biophysical properties. These applications include the skincare and food industries, as coating material for biomedical applications like anticoagulants, in anticancer drugs, for drug delivery, and in tissue engineering. Sericin promotes proliferation of cells when used as a constituent of cell culture in serum-free media. Sericin also supports cell adhesion and proliferation when used in pure form and/or blended in matrices. Sericin films, 3D scaffolds, nanoparticles, composites, conjugated drugs, and recombinant sericins offer potential future options for these needs. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Kundu, Subhas C.; Dash, Biraja C.; Dash, Rupesh] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
   [Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Kundu, SC (reprint author), Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
EM kundu@hijli.iitkgp.ernet.in
RI DASH, BIRAJA/B-3966-2018
OI DASH, BIRAJA/0000-0002-1795-3284; dash, rupesh/0000-0001-5740-7053;
   Kundu, Subhas C./0000-0002-7170-2291
FU Department of Science and Technology, Department of Biotechnology [BR/PR
   6035/MED/14/733/05, BT/PR 9552/ICD/16/755/06]; Council of Scientific and
   Industrial Research, Govt. of India; Indo-US Scientific and Technology
   Foundation, New Delhi; Department of Biotechnology, Indian Institute of
   Technology, Kharagpur; the Department of Biomedical Engineering, Tufts
   University; NIH Tissue Engineering Resource Center [P41 EB002520]
FX The Department of Science and Technology, Department of Biotechnology
   (BR/PR 6035/MED/14/733/05; BT/PR 9552/ICD/16/755/06), and Council of
   Scientific and Industrial Research, Govt. of India, Indo-US Scientific
   and Technology Foundation, New Delhi supported this work at the
   Department of Biotechnology, Indian Institute of Technology, Kharagpur.
   S.C.K. wishes to thank to the Department of Biomedical Engineering,
   Tufts University for hospitality during his short visit. Support from
   the NIH Tissue Engineering Resource Center (P41 EB002520) is
   acknowledged. We appreciate the assistance of Sakya Sarkar and Ishan
   Chaturvedi during video clipping.
CR Ahmad R, 2004, DNA CELL BIOL, V23, P149, DOI 10.1089/104454904322964742
   Ahn JS, 2001, J APPL POLYM SCI, V80, P274, DOI 10.1002/1097-4628(20010411)80:2<274::AID-APP1096>3.0.CO;2-G
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Anghileri A, 2007, J BIOTECHNOL, V127, P508, DOI 10.1016/j.jbiotec.2006.07.021
   Bindu PC, 2006, BIOCHEM SYST ECOL, V34, P698, DOI 10.1016/j.bse.2006.05.003
   Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120
   Cheng TC, 2004, INSECT BIOCHEM MOLEC, V34, P523, DOI 10.1016/j.ibmb.2004.02.004
   CHEVILLARD M, 1986, NUCLEIC ACIDS RES, V14, P6341, DOI 10.1093/nar/14.15.6341
   Chevillard M, 1986, SERICOLOGIA, V26, P435
   Cho KY, 2003, INT J BIOL MACROMOL, V32, P36, DOI 10.1016/S0141-8130(03)00023-0
   CORTEZ J, 2006, ENZYME MICROB TECHNO, V40, P1698
   COUBLE P, 1985, NUCLEIC ACIDS RES, V13, P1801, DOI 10.1093/nar/13.5.1801
   COUBLE P, 1983, DEV BIOL, V97, P398, DOI 10.1016/0012-1606(83)90096-9
   COUBLE P, 1987, DEV BIOL, V124, P431, DOI 10.1016/0012-1606(87)90496-9
   Dash R, 2006, INT J BIOL MACROMOL, V38, P255, DOI 10.1016/j.ijbiomac.2006.03.001
   Dash R, 2008, BMB REP, V41, P236, DOI 10.5483/BMBRep.2008.41.3.236
   Dash R, 2008, MOL CELL BIOCHEM, V311, P111, DOI 10.1007/s11010-008-9702-z
   Dash R, 2007, COMP BIOCHEM PHYS B, V147, P129, DOI 10.1016/j.cbpb.2007.01.009
   Datta A, 2001, INSECT BIOCHEM MOLEC, V31, P1013, DOI 10.1016/S0965-1748(01)00049-2
   DEWAIR M, 1985, J ALLERGY CLIN IMMUN, V76, P537, DOI 10.1016/0091-6749(85)90772-9
   ENGEL W, 1987, Patent No. 3603595
   Evans W.C, 1996, TREASE EVANS PHARMAC
   Fabiani C, 1996, DESALINATION, V105, P1, DOI 10.1016/0011-9164(96)00050-1
   Fraga DW, 1998, TRANSPLANTATION, V65, P1060, DOI 10.1097/00007890-199804270-00009
   FUKUTA M, 1993, J BIOL CHEM, V268, P19471
   GAMO T, 1977, INSECT BIOCHEM, V7, P285, DOI 10.1016/0020-1790(77)90026-9
   Garel A, 1997, INSECT BIOCHEM MOLEC, V27, P469, DOI 10.1016/S0965-1748(97)00022-2
   GAREL A, 1994, GENETICA, V93, P125, DOI 10.1007/BF01435245
   GEIER P. W., 1963, AUSTRALIAN JOUR ZOOL, V11, P323, DOI 10.1071/ZO9630323
   Gotoh Y, 1998, J BIOMED MATER RES, V39, P351, DOI 10.1002/(SICI)1097-4636(19980305)39:3<351::AID-JBM2>3.0.CO;2-I
   GRZELAK K, 1995, COMP BIOCH PHYSL B, V110, P61
   HAMADA Y, 1987, CELL DIFFER DEV, V20, P65, DOI 10.1016/0045-6039(87)90466-0
   HENNE W, 1985, Patent No. 3408406
   Hino R, 2006, BIOMATERIALS, V27, P5715, DOI 10.1016/j.biomaterials.2006.07.028
   HIRABAYASHI K, 1989, NIPPON SANSHIGAKU ZA, V58, P81
   HOPPE U, 1984, Patent No. 3233388
   HU G, 1997, GONGXUEYUAN XUEBAO, V14, P154
   Huang J, 2003, J BIOL CHEM, V278, P46117, DOI 10.1074/jbc.M307792200
   HUI CC, 1990, J MOL BIOL, V213, P395, DOI 10.1016/S0022-2836(05)80201-3
   Inouye K, 1998, J BIOCHEM BIOPH METH, V37, P159, DOI 10.1016/S0165-022X(98)00024-4
   ISHIKAWA E, 1985, DEV GROWTH DIFFER, V27, P73
   JAFFE N, 1973, CANCER RES, V33, P1
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Johnson CD, 2001, COLEOPTS BULL, V55, P37, DOI 10.1649/0010-065X(2001)055[0037:EOACRC]2.0.CO;2
   Jolly M. S., 1969, Bulletin of Entomology Entomological Society of India, V10, P32
   Jolly M. S, 1970, Entomologist, V103, P18
   Jolly M. S., 1974, TASAR CULTURE
   JOLLY MS, 1987, FAO AGR SERVICES  29, V4, P1
   JONES D, 1985, J COMP PHYSIOL B, V155, P235, DOI 10.1007/BF00685218
   JUN L, 1997, CANYE KEXE, V23, P47
   Kaplan D, 1994, SILK POLYM MAT SCI B
   KAPLAN DL, 1992, MATER RES SOC S P, V255, P19
   KAPLAN DL, 1998, PROTEIN BASED MAT, P103
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Kato N., 1998, BIOSCI BIOTECH BIOCH, V62, P45
   KAUFFMAN WC, 1989, J CHEM ECOL, V15, P2051, DOI 10.1007/BF01207437
   KIKUCHI Y, 1992, GENE, V110, P151, DOI 10.1016/0378-1119(92)90642-3
   Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013
   KIMURA K, 1985, EXPERIENTIA, V41, P1167, DOI 10.1007/BF01951711
   KIRIKAWA M, 2000, Patent No. 2000044598
   Kweon HY, 2000, MACROMOL RAPID COMM, V21, P1302, DOI 10.1002/1521-3927(20001201)21:18<1302::AID-MARC1302>3.3.CO;2-Y
   Li AL, 2005, J GENET, V84, P137, DOI 10.1007/BF02715839
   LOTZ B, 1979, BIOCHIMIE, V61, P205, DOI 10.1016/S0300-9084(79)80067-X
   Lucas F., 1968, Comprehensive Biochem, V26, P475
   MACH V, 1995, J BIOL CHEM, V270, P9340, DOI 10.1074/jbc.270.16.9340
   MAEKAWA H, 1980, DEV BIOL, V78, P394, DOI 10.1016/0012-1606(80)90343-7
   Mahendran B, 2006, J GENET, V85, P31, DOI 10.1007/BF02728967
   Mahendran B, 2006, GENE, V370, P51, DOI 10.1016/j.gene.2005.11.010
   Mahendran B., 2005, CURR SCI, V90, P100
   Mahendran B, 2006, J BIOCHEM MOL BIOL, V39, P522
   Mandal BB, 2008, BIOTECHNOL BIOENG, V100, P1237, DOI 10.1002/bit.21835
   Mandal BB, 2008, BIOTECHNOL BIOENG, V99, P1482, DOI 10.1002/bit.21699
   Mathe G, 1970, Recent Results Cancer Res, V33, P278
   MATSUNO K, 1990, NUCLEIC ACIDS RES, V18, P1853, DOI 10.1093/nar/18.7.1853
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   MICHAILLE JJ, 1989, INSECT BIOCHEM, V19, P19, DOI 10.1016/0020-1790(89)90005-X
   MICHAILLE JJ, 1986, BIOCHIMIE, V68, P1165, DOI 10.1016/S0300-9084(86)80060-8
   MINOURA N, 1995, J BIOMED MATER RES, V29, P1215, DOI 10.1002/jbm.820291008
   MINOURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511, DOI 10.1006/bbrc.1995.1368
   MIYASHITA T, 1999, Patent No. 11152206
   Monti P, 2007, J MOL STRUCT, V834, P202, DOI 10.1016/j.molstruc.2006.11.009
   MOROOKA H, 2006, SEN-I GAKKAISHI, V62, P48
   Nagaraju J, 2002, MOL CELL PROBE, V16, P67, DOI 10.1006/mcpr.2001.0404
   NAGURA M, 2004, T 7 WORLD BIOM C, P1207
   Nagura Masanobu, 2001, Journal of Insect Biotechnology and Sericology, V70, P149
   Nakamura K, 1984, SEN-I GAKKAISHI, V40, P327
   Nakamura K., 2001, Japan Patent, Patent No. [2001106794, 2001-106794A]
   Ogawa A, 2004, J BIOSCI BIOENG, V98, P217
   Ogawa A, 1999, Japan Patent Publication Number, Patent No. [11193210 A2, 11193210]
   Ogawa S, 2007, J BIOTECHNOL, V128, P531, DOI 10.1016/j.jbiotec.2006.10.019
   OKAMOTO H, 1982, J BIOL CHEM, V257, P5192
   Osamu H., 1987, Japan Patent, Patent No. [JP62036308, 62036308]
   Padamwar M. N., 2003, INDIAN DRUGS, V40, P526
   Padamwar MN, 2004, J SCI IND RES INDIA, V63, P323
   PADAMWAR MN, 2002, 62 WORLD C FIP NIC
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Prasad MD, 2005, GENETICS, V169, P197, DOI 10.1534/gentics.104.031005
   PRUDHOMME JC, 1985, COMPREHENSIVE INSECT, V17, P571
   Reddy KD, 1999, GENOME, V42, P1057, DOI 10.1139/gen-42-6-1057
   Saha M, 2006, BIOCHEM GENET, V44, P72, DOI 10.1007/s10528-006-9007-4
   SAKAMOTO K, 2000, Patent No. 2000073090
   Sasaki M, 2000, NUTR RES, V20, P1505, DOI 10.1016/S0271-5317(00)80031-7
   Sasaki M, 2005, BIOTECHNOL APPL BIOC, V42, P183, DOI 10.1042/BA20050019
   Sasaki M, 2000, ONCOL REP, V7, P1049
   Sasaki M., 2000, FOOD SCI TECHNOL RES, V6, P280
   SEHNAL F, 1990, INT J INSECT MORPHOL, V19, P79, DOI 10.1016/0020-7322(90)90022-H
   SHIMADA T, 1995, MOL PHYLOGENET EVOL, V4, P223, DOI 10.1006/mpev.1995.1021
   SHIMURA K, 1976, J BIOCHEM-TOKYO, V80, P693, DOI 10.1093/oxfordjournals.jbchem.a131328
   SHIMURA K, 1982, Journal of Sericultural Science of Japan, V51, P20
   SINHA AK, 1994, P C CYTOL GENET, V4, P7
   SINOHARA H, 1979, COMP BIOCHEM PHYS B, V63, P87, DOI 10.1016/0305-0491(79)90239-6
   SINOHARA H, 1971, BIOCHIM BIOPHYS ACTA, V237, P273, DOI 10.1016/0304-4165(71)90317-5
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Song Y, 2006, POLYM POLYM COMPOS, V14, P169, DOI 10.1177/096739110601400206
   Song Y, 2006, POLYM INT, V55, P1350, DOI 10.1002/pi.2093
   SOONG HK, 1984, OPHTHALMOLOGY, V91, P479
   SOUCHE YS, 2000, J BIOSCIENCE, V25, P361
   SPRAGUE KU, 1975, BIOCHEMISTRY-US, V14, P925, DOI 10.1021/bi00676a008
   Suzuki N, 2004, BIOFACTORS, V21, P329, DOI 10.1002/biof.552210164
   Takahashi M, 2005, BIOTECHNOL LETT, V27, P893, DOI 10.1007/s10529-005-7177-5
   Takahashi M, 2003, BIOTECHNOL LETT, V25, P1805, DOI 10.1023/A:1026284620236
   Takasu Y, 2002, BIOSCI BIOTECH BIOCH, V66, P2715, DOI 10.1271/bbb.66.2715
   Takasu Y, 2007, INSECT BIOCHEM MOLEC, V37, P1234, DOI 10.1016/j.ibmb.2007.07.009
   Takeuchi A, 2005, J ROY SOC INTERFACE, V2, P373, DOI 10.1098/rsif.2005.0052
   Takeuchi A, 2004, KEY ENG MAT, V254-2, P403, DOI 10.4028/www.scientific.net/KEM.254-256.403
   Tamada Y, 2004, J BIOMAT SCI-POLYM E, V15, P971, DOI 10.1163/1568562041526469
   TAN YD, 2001, GENETICS, V157, P1227
   Tanaka K, 1999, BBA-PROTEIN STRUCT M, V1432, P92, DOI 10.1016/S0167-4838(99)00088-6
   Tao W, 2005, MACROMOL MATER ENG, V290, P188, DOI 10.1002/mame.200400306
   Terada S, 2002, CYTOTECHNOLOGY, V40, P3, DOI 10.1023/A:1023993400608
   Teramoto H, 2006, MACROMOLECULES, V39, P6, DOI 10.1021/ma0521147
   Teramoto H, 2005, BIOMACROMOLECULES, V6, P2049, DOI 10.1021/bm0500547
   Teramoto H, 2005, BIOSCI BIOTECH BIOCH, V69, P845, DOI 10.1271/bbb.69.845
   Teramoto H, 2007, MACROMOLECULES, V40, P1562, DOI 10.1021/ma062604e
   TOKUTAKE S, 1980, BIOCHEM J, V187, P413, DOI 10.1042/bj1870413
   Tomita M, 2003, NAT BIOTECHNOL, V21, P52, DOI 10.1038/nbt771
   Tomita M, 2007, TRANSGENIC RES, V16, P449, DOI 10.1007/s11248-007-9087-x
   Tsubouchi K, 2005, BIOSCI BIOTECH BIOCH, V69, P403, DOI 10.1271/bbb.69.403
   Tsubouchi K, 1999, Japan patent, Patent No. [11-070160A, 11070160]
   Tsukada M., 1981, B SCI I TEXT FR, V10, P141
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Veronese FM, 1999, FARMACO, V54, P497, DOI 10.1016/S0014-827X(99)00066-X
   Vicent MJ, 2006, TRENDS BIOTECHNOL, V24, P39, DOI 10.1016/j.tibtech.2005.11.006
   Voegeli R., 1993, COSMET TOILETRIES, V108, P101
   Vollrath F, 1999, INT J BIOL MACROMOL, V24, P81, DOI 10.1016/S0141-8130(98)00076-2
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   Wang Su, 1998, Journal of Sericultural Science of Japan, V67, P295
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   Wei DQ, 1989, ACTA POLYM SIN, V6, P740
   Wu JH, 2007, FOOD CHEM, V103, P1255, DOI 10.1016/j.foodchem.2006.10.042
   Wu W, 2006, POLYM INT, V55, P513, DOI 10.1002/pi.1993
   Xie RJ, 2007, KEY ENG MATER, V342-343, P241, DOI 10.4028/www.scientific.net/KEM.342-343.241
   YAMADA H, 2001, Patent No. 2001015660
   Yamada H, 1998, Japan Patent Publication Number, Patent No. [10226653 A2, 10226653]
   YAMADA H, 2001, Patent No. 2001064148
   Yamada H., 2001, INT J WILD SILKMOTH, V6, P17
   YAMADA H, 1998, Patent No. 10226626
   Yang JB, 2007, SURF INTERFACE ANAL, V39, P375, DOI 10.1002/sia.2549
   Yao YQ, 2003, CHEM J CHINESE U, V24, P2327
   YASUDA N, 1998, Patent No. 10245345
   Yoshii F, 2000, Japan Patent Publication Number, Patent No. [2000-169736, 2000169736]
   Zaoming Wen, 1996, Journal of Investigational Allergology and Clinical Immunology, V6, P237
   Zhang YQ, 2006, J CHEM TECHNOL BIOT, V81, P136, DOI 10.1002/jctb.1370
   Zhang YQ, 2004, BIOMATERIALS, V25, P3751, DOI 10.1016/j.biomaterials.2003.10.019
   Zhang YQ, 2002, BIOTECHNOL ADV, V20, P91, DOI 10.1016/S0734-9750(02)00003-4
   Zhang YQ, 2006, J CONTROL RELEASE, V115, P307, DOI 10.1016/j.jconrel.2006.08.019
   Zhao HP, 2007, ENG FRACT MECH, V74, P1953, DOI 10.1016/j.engfracmech.2006.06.010
   Zhaorigetu S, 2003, J PHOTOCH PHOTOBIO B, V71, P11, DOI 10.1016/S1011-1344(03)00092-7
   Zhaorigetu S, 2001, BIOSCI BIOTECH BIOCH, V65, P2181, DOI 10.1271/bbb.65.2181
   Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413
   Zhu Liang Jun, 1995, Journal of Sericultural Science of Japan, V64, P415
   ZHU LJ, 1991, CANYE KEXUE, V17, P33
   Zurovec M, 1998, J BIOL CHEM, V273, P15423, DOI 10.1074/jbc.273.25.15423
NR 173
TC 146
Z9 154
U1 6
U2 92
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0079-6700
J9 PROG POLYM SCI
JI Prog. Polym. Sci.
PD OCT
PY 2008
VL 33
IS 10
BP 998
EP 1012
DI 10.1016/j.progpolymsci.2008.08.002
PG 15
WC Polymer Science
SC Polymer Science
GA 384BR
UT WOS:000261719100003
DA 2018-10-19
ER

PT J
AU Ni, M
   Ratner, BD
AF Ni, Ming
   Ratner, Buddy D.
TI Differentiating calcium carbonate polymorphs by surface analysis
   techniques - an XPS and TOF-SIMS study
SO SURFACE AND INTERFACE ANALYSIS
LA English
DT Article
DE calcium carbonate; calcite; aragonite; vaterite; X-ray photoelectron
   spectroscopy; time-of-flight secondary ion mass spectroscopy; principal
   component analysis
ID ION MASS-SPECTROMETRY; HYDROXYAPATITE; MORPHOLOGY; CACO3; WATER
AB Calcium carbonate has evoked interest owing to its use as a biomaterial, and for its potential in biomineralization. Three polymorphs of calcium carbonate, i.e. calcite, aragonite, and vaterite were synthesized. Three conventional bulk analysis techniques, Fourier transform infrared (FTIR), X-ray diffraction (XRD), and SEM, were used to confirm the crystal phase of each polymorphic calcium carbonate. Two surface analysis techniques, X-ray photoelectron spectroscopy (XPS) and time-of-flight secondary ion mass spectroscopy (TOF-SIMS), were used to differentiate the surfaces of these three polymorphs of calcium carbonate. XPS results clearly demonstrate that the surfaces of these three polymorphs are different as seen in the Ca(2p) and O(1s) core-level spectra. The different atomic arrangement in the crystal lattice, which provides for a different chemical environment, can explain this surface difference. Principal component analysis (PCA) was used to analyze the TOF-SIMS data. Three polymorphs of calcium carbonate cluster into three different groups by PCA scores. This suggests that surface analysis techniques are as powerful as conventional bulk analysis to discriminate calcium carbonate polymorphs. Copyright (c) 2008 John Wiley & Sons, Ltd.
C1 [Ratner, Buddy D.] Univ Washington, UWEB, Dept Bioengn, Seattle, WA 98195 USA.
   [Ni, Ming; Ratner, Buddy D.] Univ Washington, UWEB, Dept Chem Engn, Seattle, WA 98195 USA.
RP Ratner, BD (reprint author), Univ Washington, UWEB, Dept Bioengn, Seattle, WA 98195 USA.
EM ratner@uweb.engr.washington.edu
FU NSF [EEC-9529161]; NIH [RR01296]
FX We thank Deborah Leach-Scampavia for her help with XPS and TOF-SIMS.
   This work was supported by NSF EEC-9529161 (LIWEB) and NIH RR01296
   (NESAC/BIO).
CR BAER DR, 1991, SURF INTERFACE ANAL, V17, P25, DOI 10.1002/sia.740170108
   Belu AM, 2003, BIOMATERIALS, V24, P3635, DOI 10.1016/S0142-9612(03)00159-5
   Castner DG, 1996, LANGMUIR, V12, P5083, DOI 10.1021/la960465w
   Chakrabarty D, 1999, J MATER CHEM, V9, P2953
   Chusuei CC, 1999, ANAL CHEM, V71, P149, DOI 10.1021/ac9806963
   DAMIEN CJ, 1994, CALCIFIED TISSUE INT, V55, P151, DOI 10.1007/BF00297191
   Feng QL, 2000, J CRYST GROWTH, V216, P459, DOI 10.1016/S0022-0248(00)00396-1
   Gopinath CS, 2002, MATER RES BULL, V37, P1323, DOI 10.1016/S0025-5408(02)00763-8
   Grasby SE, 2003, GEOCHIM COSMOCHIM AC, V67, P1659, DOI 10.1016/S0016-7037(00)01304-2
   Long JR, 1998, P NATL ACAD SCI USA, V95, P12083, DOI 10.1073/pnas.95.21.12083
   Lu HB, 2000, ANAL CHEM, V72, P2886, DOI 10.1021/ac990812h
   Lucas A, 2001, INT J INORG MATER, V3, P87, DOI 10.1016/S1466-6049(00)00058-1
   MANN S, 1983, STRUCT BONDING BERLI, V54, P127
   MCELHANEY RD, 1990, METALLIZATION POLYM
   Ni M, 2003, BIOMATERIALS, V24, P4323, DOI 10.1016/S0142-9612(03)00236-9
   Pang P, 2001, IND ENG CHEM RES, V40, P2445, DOI 10.1021/ie000846b
   SIMKISS K, 1964, NATURE, V201, P492, DOI 10.1038/201492a0
   Stipp SLS, 1997, SURF INTERFACE ANAL, V25, P959, DOI 10.1002/(SICI)1096-9918(199712)25:13<959::AID-SIA321>3.0.CO;2-W
   Vickerman J. C., 1997, SURFACE ANAL PRINCIP
   VUOLA J, 2000, NATURAL CORAL HYDROX
   Wagner MS, 2001, LANGMUIR, V17, P4649, DOI 10.1021/la001209t
NR 21
TC 95
Z9 96
U1 8
U2 70
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 0142-2421
J9 SURF INTERFACE ANAL
JI Surf. Interface Anal.
PD OCT
PY 2008
VL 40
IS 10
BP 1356
EP 1361
DI 10.1002/sia.2904
PG 6
WC Chemistry, Physical
SC Chemistry
GA 367ZW
UT WOS:000260592100007
PM 25031482
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Oliveira, JT
   Correlo, VM
   Sol, PC
   Costa-Pinto, AR
   Malafaya, PB
   Salgado, AJ
   Bhattacharya, M
   Charbord, P
   Neves, NM
   Reis, RL
AF Oliveira, Joao T.
   Correlo, Vitor M.
   Sol, Paula C.
   Costa-Pinto, Ana R.
   Malafaya, Patricia B.
   Salgado, Antonio J.
   Bhattacharya, Mrinal
   Charbord, Pierre
   Neves, Nuno M.
   Reis, Rui L.
TI Assessment of the Suitability of Chitosan/PolyButylene Succinate
   Scaffolds Seeded with Mouse Mesenchymal Progenitor Cells for a Cartilage
   Tissue Engineering Approach
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID CHONDROCYTE DIFFERENTIATION; CHITOSAN; BONE; REGENERATION; REPAIR;
   FIBROBLASTS; DEGRADATION; OSTEOBLASTS; FABRICATION; COMPOSITES
AB In this work, scaffolds derived from a new biomaterial originated from the combination of a natural material and a synthetic material were tested for assessing their suitability for cartilage tissue engineering applications. In order to obtain a better outcome result in terms of scaffolds' overall properties, different blends of natural and synthetic materials were created. Chitosan and polybutylene succinate (C-PBS) 50/50 (wt%) were melt blended using a twin-screw extruder and processed into 5 x 5 x 5 mm scaffolds by compression moulding with salt leaching. Micro-computed tomography analysis calculated an average of 66.29% porosity and 92.78% interconnectivity degree for the presented scaffolds. The salt particles used ranged in size between 63 and 125 mu m, retrieving an average pore size of 251.28 mu m. Regarding the mechanical properties, the compressive modulus was of 1.73 +/- 0.4 MPa (E-sec 1%). Cytotoxicity evaluation revealed that the leachables released by the developed porous structures were not harmful to the cells and hence were noncytotoxic. Direct contact assays were carried out using a mouse bone marrow-derived mesenchymal progenitor cell line (BMC9). Cells were seeded at a density of 5 x 10(5) cells/scaffold and allowed to grow for periods up to 3 weeks under chondrogenic differentiating conditions. Scanning electron microscopy analysis revealed that the cells were able to proliferate and colonize the scaffold structure, and MTS test demonstrated cell viability during the time of the experiment. Finally, Western blot performed for collagen type II, a natural cartilage extracellular matrix component, showed that this protein was being expressed by the end of 3 weeks, which seems to indicate that the BMC9 cells were being differentiated toward the chondrogenic pathway. These results indicate the adequacy of these newly developed C-PBS scaffolds for supporting cell growth and differentiation toward the chondrogenic pathway, suggesting that they should be considered for further studies in the cartilage tissue engineering field.
C1 [Oliveira, Joao T.; Correlo, Vitor M.; Sol, Paula C.; Costa-Pinto, Ana R.; Malafaya, Patricia B.; Neves, Nuno M.; Reis, Rui L.] Univ Minho, Dept Polymer Engn, 3Bs Res Grp Biomat Biodegradables & Biomimet, P-4710057 Braga, Portugal.
   [Oliveira, Joao T.; Correlo, Vitor M.; Sol, Paula C.; Costa-Pinto, Ana R.; Malafaya, Patricia B.; Neves, Nuno M.; Reis, Rui L.] Inst Biotechnol & Bioengn, PT Associated Lab, Braga, Portugal.
   [Salgado, Antonio J.] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst, P-4710057 Braga, Portugal.
   [Bhattacharya, Mrinal] Univ Minnesota, Dept Biosyst Engn, St Paul, MN 55108 USA.
   [Charbord, Pierre] Univ Tours, Fac Med, Equipe ESPRI EA 3855, INSERM, Tours, France.
RP Oliveira, JT (reprint author), Univ Minho, Dept Polymer Engn, 3Bs Res Grp Biomat Biodegradables & Biomimet, Campus Gualtar, P-4710057 Braga, Portugal.
EM Joao.oliveira@dep.uminho.pt
RI Salgado, Antonio/J-4129-2013; Group, 3Bs/E-4374-2012; Malafaya,
   Patricia/M-3994-2013; Reis, Rui L./A-8938-2008; Neves, Nuno/B-4685-2008;
   Correlo, Vitor/O-4227-2015; Pinto, Ana Rita/I-7483-2013
OI Salgado, Antonio/0000-0003-3806-9823; Group, 3Bs/0000-0002-5195-3456;
   Malafaya, Patricia/0000-0002-7916-5910; Reis, Rui
   L./0000-0002-4295-6129; Neves, Nuno/0000-0003-3041-0687; Correlo,
   Vitor/0000-0002-5516-7583; Pinto, Ana Rita/0000-0002-4764-8539; Sol,
   Paula/0000-0003-0512-0928
FU Portuguese Foundation for Science and Technology (FCT) [SFRH/
   BD17135/2004]; European NoE EXPERTISSUES [NMP3-CT-2004-500283]; European
   Project GENOSTEM [LSHB-CT-2003-503161]; FCT Project CartiScaff
   [POCTI/SAU-BMA/58991/2004]
FX J. T. Oliveira would like to acknowledge the grant (SFRH/ BD17135/2004)
   from Portuguese Foundation for Science and Technology (FCT). The authors
   would like to thank Fernanda Marques, at the Institute for Health and
   Life Sciences (ICVS), University of Minho, Braga, Portugal, for her help
   with the Western blot analysis, as well as the staff at ICVS for
   allowing to use their facilities. The monoclonal antibody for collagen
   type II was obtained from the Developmental Studies Hybridoma Bank
   developed under the auspices of the NICHD and maintained by the
   Department of Biological Sciences, University of Iowa (Iowa City, IA).
   This work was carried out under the scope of the European NoE
   EXPERTISSUES (NMP3-CT-2004-500283), and partially supported by the
   European Project GENOSTEM (LSHB-CT-2003-503161) and the FCT Project
   CartiScaff (POCTI/SAU-BMA/58991/2004).
CR Boccafoschi F, 2005, BIOMATERIALS, V26, P7410, DOI 10.1016/j.biomaterials.2005.05.052
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   CANCEDDA R, 1995, INT REV CYTOL, V159, P265, DOI 10.1016/S0074-7696(08)62109-9
   Cancedda R, 2003, MATRIX BIOL, V22, P81, DOI 10.1016/S0945-053X(03)00012-X
   Chen GP, 2005, BIOMATERIALS, V26, P2559, DOI 10.1016/j.biomaterials.2004.07.034
   Chen GP, 2004, BIOCHEM BIOPH RES CO, V322, P50, DOI 10.1016/j.bbrc.2004.07.071
   Correlo VM, 2005, MAT SCI ENG A-STRUCT, V403, P57, DOI 10.1016/j.msea.2005.04.055
   Dennis JE, 1999, J BONE MINER RES, V14, P700, DOI 10.1359/jbmr.1999.14.5.700
   Devlieghere F, 2004, FOOD MICROBIOL, V21, P703, DOI 10.1016/j.fm.2004.02.008
   Duda GN, 2005, J BIOMECH, V38, P843, DOI 10.1016/j.jbiomech.2004.04.034
   Estrada LE, 2001, OSTEOARTHR CARTILAGE, V9, P169, DOI 10.1053/joca.2000.0373
   Freier T, 2005, BIOMATERIALS, V26, P5872, DOI 10.1016/j.biomaterials.2005.02.033
   Fuss M, 2000, ANN ANAT, V182, P303
   Gartland A, 2005, BONE, V37, P530, DOI 10.1016/j.bone.2005.04.034
   Gomes ME, 2001, BIOMATERIALS, V22, P883, DOI 10.1016/S0142-9612(00)00211-8
   Gross AE, 2003, J ARTHROPLASTY, V18, P14, DOI 10.1054/arth.2003.50084
   HENRY EW, 1985, EXP NEUROL, V90, P652, DOI 10.1016/0014-4886(85)90162-1
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   *ISO, 1099312003 ISO
   Jung Y, 2005, BIOMATERIALS, V26, P6314, DOI 10.1016/j.biomaterials.2005.04.007
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   Koegler WS, 2004, BIOMATERIALS, V25, P2819, DOI 10.1016/j.biomaterials.2003.09.064
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lyoo WS, 2000, POLYMER, V41, P9055, DOI 10.1016/S0032-3861(00)00154-3
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Mahmoudifar N, 2005, BIOMATERIALS, V26, P7012, DOI 10.1016/j.biomaterials.2005.04.062
   Malafaya PB, 2003, KEY ENG MAT, V240-2, P39, DOI 10.4028/www.scientific.net/KEM.240-242.39
   Reis RL, 1996, POLYM ADVAN TECHNOL, V7, P784, DOI 10.1002/(SICI)1099-1581(199610)7:10<784::AID-PAT585>3.0.CO;2-1
   Richardson JB, 1999, J BONE JOINT SURG BR, V81B, P1064, DOI 10.1302/0301-620X.81B6.9343
   Salgado AJ, 2002, MAT SCI ENG C-BIO S, V20, P27, DOI 10.1016/S0928-4931(02)00009-7
   Silva RM, 2003, KEY ENG MAT, V240-2, P423
   Solchaga LA, 1999, J ORTHOPAED RES, V17, P205, DOI 10.1002/jor.1100170209
   Solchaga LA, 2005, OSTEOARTHR CARTILAGE, V13, P297, DOI 10.1016/j.joca.2004.12.016
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Wang YC, 2003, BIOMATERIALS, V24, P1047, DOI 10.1016/S0142-9612(02)00434-9
   Woodfield TBF, 2004, BIOMATERIALS, V25, P4149, DOI 10.1016/j.biomaterials.2003.10.056
   Yang Y, 2005, BIOMATERIALS, V26, P2585, DOI 10.1016/j.biomaterials.2004.07.046
   Zammaretti P, 2004, CURR OPIN BIOTECH, V15, P430, DOI 10.1016/j.copbio.2004.08.007
NR 39
TC 34
Z9 36
U1 0
U2 19
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD OCT
PY 2008
VL 14
IS 10
BP 1651
EP 1661
DI 10.1089/ten.tea.2007.0307
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 359OS
UT WOS:000259998000007
PM 18611147
DA 2018-10-19
ER

PT J
AU Sun, H
   Ye, F
   Wang, J
   Shi, Y
   Tu, Z
   Bao, J
   Qin, M
   Bu, H
   Li, Y
AF Sun, H.
   Ye, F.
   Wang, J.
   Shi, Y.
   Tu, Z.
   Bao, J.
   Qin, M.
   Bu, H.
   Li, Y.
TI The Upregulation of Osteoblast Marker Genes in Mesenchymal Stem Cells
   Prove the Osteoinductivity of Hydroxyapatite/Tricalcium Phosphate
   Biomaterial
SO TRANSPLANTATION PROCEEDINGS
LA English
DT Article
ID DIFFERENTIATION IN-VITRO; EXPRESSION; PROLIFERATION; SUBSTITUTES
AB Background. Calcium phosphate (Ca-P), mainly concerning hydroxyapatite (HA), is the main inorganic component of the body's hard tissue. It is acknowledged that Ca-P biomaterial not only has osteoconduction but also can form bone bonding to host bone, making an ideal tissue-engineering scaffold. However, whether Ca-P biomaterial possesses osteoinductivity is still debated. The present study was performed to explore the expression level of osteoblast maker genes in human mesenchymal stem cells (hMSCs) grown on a Ca-P biomaterial.
   Materials and methods. hMSCs were cultured on the HA/tricalcium phosphate-(TCP) double-phase ceramic. After coculture for 5, 10, 15, or 20 days, the cells were digested for isolation of total RNA. Fluorescence quantitative polymerase chain reaction was used to detect the relative mRNA levels of Runx2, collagen type 1, osteopontin, and osteocalcin, all of which are the marker genes for osteoblasts. The mg63 cell was recruited as the reference and un-cocultured hMSCs as the negative controls. Alkaline phosphatase (ALP) activity in the cells was also examined after culture for 10 or 20 days.
   Results. Our results showed that the expression levels of all four genes continued to rise during the first 10 days. Then, both collagen type I and Runx2 decreased. In contrast, osteocalcin mRNA reached its maximum at day 15 and osteopontin mRNA kept increasing throughout the whole experimental period. Additionally, ALP activity increased in a time-dependent manner.
   Conclusion. The up-regulation of all four osteoblast marker genes in hMSCs grown on Ca-P biomaterial suggested that HA/TCP biomaterials possess osteoinductivity on hMSCs, cells a mechanism that requires further investigation.
C1 [Sun, H.; Ye, F.; Wang, J.; Shi, Y.; Tu, Z.; Bao, J.; Qin, M.; Bu, H.; Li, Y.] Sichuan Univ, W China Hosp, Minist Hlth, Key Lab Transplant Engn & Immunol, Chengdu 610041, Peoples R China.
RP Shi, Y (reprint author), Sichuan Univ, W China Hosp, Minist Hlth, Key Lab Transplant Engn & Immunol, Chengdu 610041, Peoples R China.
EM shiyujun1128@hotmail.com
FU Key Basic Research Project of China [2005CB623901]
FX This work was supported by the Key Basic Research Project of China
   (2005CB623901).
CR Bao Chongyun, 2006, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V23, P442
   BURSTONE MS, 1960, ANN NY ACAD SCI, V85, P431, DOI 10.1111/j.1749-6632.1960.tb49972.x
   BUTLER WT, 1989, CONNECT TISSUE RES, V23, P123, DOI 10.3109/03008208909002412
   Catelas I, 2006, TISSUE ENG, V12, P2385, DOI 10.1089/ten.2006.12.2385
   Curran JM, 2006, BIOMATERIALS, V27, P4783, DOI 10.1016/j.biomaterials.2006.05.001
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   Duan Yourong, 2003, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V20, P22
   Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0
   DUEY P, 1997, CELL, V89, P747
   Fan HS, 2007, J NANOSCI NANOTECHNO, V7, P808, DOI 10.1166/jnn.2007.501
   Goessler UR, 2005, CELL MOL BIOL LETT, V10, P345
   Hollinger JO, 1996, CLIN ORTHOP RELAT R, P55
   Kern B, 2001, J BIOL CHEM, V276, P7101, DOI 10.1074/jbc.M006215200
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Moscoso I, 2005, TRANSPL P, V37, P481, DOI 10.1016/j.transproceed.2004.12.247
   Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3
   Shahdadfar A, 2005, STEM CELLS, V23, P1357, DOI 10.1634/stemcells.2005-0094
   Wei Xiang-yang, 2005, Zhonghua Wai Ke Za Zhi, V43, P1198
NR 18
TC 34
Z9 40
U1 1
U2 16
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0041-1345
EI 1873-2623
J9 TRANSPL P
JI Transplant. Proc.
PD OCT
PY 2008
VL 40
IS 8
BP 2645
EP 2648
DI 10.1016/j.transproceed.2008.07.096
PG 4
WC Immunology; Surgery; Transplantation
SC Immunology; Surgery; Transplantation
GA 361NL
UT WOS:000260134300061
PM 18929827
DA 2018-10-19
ER

PT J
AU Leterrier, M
   Holappa, LD
   Broglie, KE
   Beckles, DM
AF Leterrier, Marina
   Holappa, Lynn D.
   Broglie, Karen E.
   Beckles, Diane M.
TI Cloning, characterisation and comparative analysis of a starch synthase
   IV gene in wheat: functional and evolutionary implications
SO BMC PLANT BIOLOGY
LA English
DT Article
ID COLI GLYCOGEN-SYNTHASE; GLUCOSE-BINDING-SITE; GLY-GLY SEQUENCE;
   ESCHERICHIA-COLI; ACTIVE-SITE; ARABIDOPSIS-THALIANA; ADP-GLUCOSE;
   OLIGOSACCHARIDE SUBSTRATE; STRUCTURE PREDICTION; EXPRESSION ANALYSIS
AB Background: Starch is of great importance to humans as a food and biomaterial, and the amount and structure of starch made in plants is determined in part by starch synthase (SS) activity. Five SS isoforms, SSI, II, III, IV and Granule Bound SSI, have been identified, each with a unique catalytic role in starch synthesis. The basic mode of action of SSs is known; however our knowledge of several aspects of SS enzymology at the structural and mechanistic level is incomplete. To gain a better understanding of the differences in SS sequences that underscore their specificity, the previously uncharacterised SSIVb from wheat was cloned and extensive bioinformatics analyses of this and other SSs sequences were done.
   Results: The wheat SSIV cDNA is most similar to rice SSIVb with which it shows synteny and shares a similar exon-intron arrangement. The wheat SSIVb gene was preferentially expressed in leaf and was not regulated by a circadian clock. Phylogenetic analysis showed that in plants, SSIV is closely related to SSIII, while SSI, SSII and Granule Bound SSI clustered together and distinctions between the two groups can be made at the genetic level and included chromosomal location and intron conservation. Further, identified differences at the amino acid level in their glycosyltransferase domains, predicted secondary structures, global conformations and conserved residues might be indicative of intragroup functional associations.
   Conclusion: Based on bioinformatics analysis of the catalytic region of 36 SSs and 3 glycogen synthases (GSs), it is suggested that the valine residue in the highly conserved K-X-G-G-L motif in SSIII and SSIV may be a determining feature of primer specificity of these SSs as compared to GBSSI, SSI and SSII. In GBSSI, the Ile485 residue may partially explain that enzyme's unique catalytic features. The flexible 380s Loop in the starch catalytic domain may be important in defining the specificity of action for each different SS and the G-X-G in motif VI could define SSIV and SSIII action particularly.
C1 [Leterrier, Marina; Holappa, Lynn D.; Beckles, Diane M.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.
   [Broglie, Karen E.] Dupont Pioneer, Crop Genet Res, Expt Stn, Wilmington, DE 19808 USA.
   [Holappa, Lynn D.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.
RP Beckles, DM (reprint author), Univ Calif Davis, Dept Plant Sci, 1 Peter Shield Ave, Davis, CA 95616 USA.
EM msleterrier@ucdavis.edu; lholappa@oeb.harvard.edu;
   Karen.E.Broglie@cgr.dupont.com; dmbeckles@ucdavis.edu
OI Beckles, Diane/0000-0001-6336-1186
CR Ball SG, 2003, ANNU REV PLANT BIOL, V54, P207, DOI 10.1146/annurev.arplant.54.031902.134927
   BARFORD D, 1992, PROTEIN SCI, V1, P472
   Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263
   Buleon A, 1998, INT J BIOL MACROMOL, V23, P85, DOI 10.1016/S0141-8130(98)00040-3
   Buschiazzo A, 2004, EMBO J, V23, P3196, DOI 10.1038/sj.emboj.7600324
   Busi MV, 2008, PROTEINS, V70, P31, DOI 10.1002/prot.21469
   BUSI MV, 2007, PROTEINS STRUCTURE F, V9999
   CLUSTAL W, MULTIPLE SEQUENCE AL
   Cuff JA, 1999, PROTEINS, V34, P508, DOI 10.1002/(SICI)1097-0134(19990301)34:4<508::AID-PROT10>3.0.CO;2-4
   de Souza SJ, 1997, GENE, V205, P141, DOI 10.1016/S0378-1119(97)00401-0
   Denyer K, 1997, PLANT CELL ENVIRON, V20, P1566, DOI 10.1046/j.1365-3040.1997.d01-48.x
   Denyer K, 1999, BIOCHEM J, V342, P647, DOI 10.1042/0264-6021:3420647
   Denyer K, 1999, BIOCHEM J, V340, P183, DOI 10.1042/0264-6021:3400183
   Denyer K, 2001, J PLANT PHYSIOL, V158, P479, DOI 10.1078/0176-1617-00360
   deSouza SJ, 1996, P NATL ACAD SCI USA, V93, P14632, DOI 10.1073/pnas.93.25.14632
   Dian WM, 2005, J EXP BOT, V56, P623, DOI 10.1093/jxb/eri065
   Dian WM, 2003, PLANTA, V218, P261, DOI 10.1007/s00425-003-1101-9
   Edwards A, 1999, PLANT J, V17, P251, DOI 10.1046/j.1365-313X.1999.00371.x
   Edwards A, 1999, EUR J BIOCHEM, V266, P724, DOI 10.1046/j.1432-1327.1999.00861.x
   Ellis RP, 1998, J SCI FOOD AGR, V77, P289, DOI 10.1002/(SICI)1097-0010(199807)77:3<289::AID-JSFA38>3.3.CO;2-4
   Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978
   Fujita N, 2006, PLANT PHYSIOL, V140, P1070, DOI 10.1104/pp.105.071845
   FURUKAWA K, 1993, J BIOL CHEM, V268, P23837
   FURUKAWA K, 1990, J BIOL CHEM, V265, P2086
   FURUKAWA K, 1994, J BIOL CHEM, V269, P868
   Gao M, 1998, PLANT CELL, V10, P399, DOI 10.1105/tpc.10.3.399
   Gao Z, 2004, ARCH BIOCHEM BIOPHYS, V427, P1, DOI 10.1016/j.abb.2004.01.010
   Guan HP, 1998, TRENDS GLYCOSCI GLYC, V10, P307, DOI 10.4052/tigg.10.307
   Hare MP, 2003, MOL BIOL EVOL, V20, P969, DOI 10.1093/molbev/msg111
   HENNENBIERWAGEN T, 2008, PLANT PHYSIOL, P146
   Henrissat B, 2001, PLANT MOL BIOL, V47, P55, DOI 10.1023/A:1010667012056
   Hirose T, 2004, PLANTA, V220, P9, DOI 10.1007/s00425-004-1314-6
   Hitz WD, 2002, PLANT PHYSIOL, V128, P650, DOI 10.1104/pp.128.2.650
   Imparl-Radosevich JM, 1999, FEBS LETT, V457, P357, DOI 10.1016/S0014-5793(99)01066-2
   Imparl-Radosevich JM, 1998, ARCH BIOCHEM BIOPHYS, V353, P64, DOI 10.1006/abbi.1998.0613
   JENKINS JPJ, 1993, STARCH-STARKE, V45, P417
   Karplus K, 2003, PROTEINS, V53, P491, DOI 10.1002/prot.10540
   Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150
   Labesse G, 1998, BIOINFORMATICS, V14, P206, DOI 10.1093/bioinformatics/14.2.206
   Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079
   Li Zhongyi, 2003, Functional & Integrative Genomics, V3, P76
   Li ZY, 2000, PLANT PHYSIOL, V123, P613, DOI 10.1104/pp.123.2.613
   Lloyd JR, 1999, BIOCHEM J, V338, P515, DOI 10.1042/0264-6021:3380515
   MacGregor EA, 2002, J PROTEIN CHEM, V21, P297, DOI 10.1023/A:1019701621256
   MARTIN C, 1995, PLANT CELL, V7, P971
   Martin W, 2002, P NATL ACAD SCI USA, V99, P12246, DOI 10.1073/pnas.182432999
   Morell MK, 2005, CURR OPIN PLANT BIOL, V8, P204, DOI 10.1016/j.pbi.2005.01.009
   *NCBI, NCBI BAS LOC AL SEAR
   Nichols DJ, 2000, BIOCHEMISTRY-US, V39, P7820, DOI 10.1021/bi000407g
   Ohdan T, 2005, J EXP BOT, V56, P3229, DOI 10.1093/jxb/eri292
   OReilly M, 1997, NAT STRUCT BIOL, V4, P405, DOI 10.1038/nsb0597-405
   Patron NJ, 2005, J PHYCOL, V41, P1131, DOI 10.1111/j.1529-8817.2005.00135.x
   *PFAM, PFAM DAT PROT FAM HM
   Ral JP, 2004, PLANT PHYSIOL, V136, P3333, DOI 10.1104/pp.104.044131
   Rogozin IB, 2005, BRIEF BIOINFORM, V6, P118, DOI 10.1093/bib/6.2.118
   Rogozin IB, 2003, CURR BIOL, V13, P1512, DOI 10.1016/S0960-9822(03)00558-X
   Roldan I, 2007, PLANT J, V49, P492, DOI 10.1111/j.1365-313X.2006.02968.x
   Rujan T, 2001, TRENDS GENET, V17, P113, DOI 10.1016/S0168-9525(00)02209-5
   Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857
   SEARS ER, 1953, AM NAT, V87, P245, DOI 10.1086/281780
   TETLOW I, 2008, PLANT PHYSIOL, P146
   Tetlow IJ, 2006, CAN J BOT, V84, P1167, DOI 10.1139/B06-089
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Tomasik P, 2004, ADV CARBOHYD CHEM BI, V59, P175, DOI 10.1016/S0065-2318(04)59005-4
   Vrinten PL, 2000, PLANT PHYSIOL, V122, P255, DOI 10.1104/pp.122.1.255
   Wang SJ, 2001, PLANT SCI, V161, P635, DOI 10.1016/S0168-9452(01)00449-6
   Watson KA, 1999, EMBO J, V18, P4619, DOI 10.1093/emboj/18.17.4619
   Yep A, 2004, BIOCHEM BIOPH RES CO, V316, P960, DOI 10.1016/j.bbrc.2004.02.136
   Yep A, 2004, J BIOL CHEM, V279, P8359, DOI 10.1074/jbc.M312686200
   Yep A, 2006, ARCH BIOCHEM BIOPHYS, V453, P188, DOI 10.1016/j.abb.2006.07.003
   TITO TOOLS INCREMENT
   SPIDEY MRNA TO GENOM
   SAM T02 HMM BASED PR
   JNET NEURAL NETWORK
NR 74
TC 49
Z9 52
U1 5
U2 24
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2229
J9 BMC PLANT BIOL
JI BMC Plant Biol.
PD SEP 30
PY 2008
VL 8
AR 98
DI 10.1186/1471-2229-8-98
PG 21
WC Plant Sciences
SC Plant Sciences
GA 371JR
UT WOS:000260828100001
PM 18826586
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Hung, J
   Solis, J
   Guerrero, JL
   Braithwaite, GJC
   Muratoglu, OK
   Chaput, M
   Fernandez-Friera, L
   Handschumacher, MD
   Wedeen, VJ
   Houser, S
   Vlahakes, GJ
   Levine, RA
AF Hung, Judy
   Solis, Jorge
   Guerrero, J. Luis
   Braithwaite, Gavin J. C.
   Muratoglu, Orhun K.
   Chaput, Miguel
   Fernandez-Friera, Leticia
   Handschumacher, Mark D.
   Wedeen, Van J.
   Houser, Stuart
   Vlahakes, Gus J.
   Levine, Robert A.
TI A novel approach for reducing ischemic mitral regurgitation by injection
   of a polymer to reverse remodel and reposition displaced papillary
   muscles
SO CIRCULATION
LA English
DT Article; Proceedings Paper
CT 80th Annual Scientific Session of the American-Heart-Association
CY NOV 04-07, 2007
CL Orlando, FL
SP Amer Heart Assoc
DE coronary artery disease; left ventricular remodeling; mitral
   regurgitation
ID 3-DIMENSIONAL ECHOCARDIOGRAPHY; VALVULAR REGURGITATION;
   MYOCARDIAL-INFARCTION; CELL TRANSPLANTATION; COLLAGEN INJECTION;
   IN-VIVO; REPAIR; RECONSTRUCTION; ANNULOPLASTY; REPLACEMENT
AB Background-Ischemic mitral regurgitation (MR) relates to displacement of the papillary muscles from ischemic ventricular distortion. We tested the hypothesis that repositioning of the papillary muscles can be achieved by injection of polyvinyl-alcohol (PVA) polymer, a biologically inert biomaterial that has been specially formulated to produce an encapsulated, stable, resilient gel once injected into the myocardium. The purpose is to materially support the infarcted myocardium while at the same time repositioning the papillary muscles that become apically tethered in MR.
   Methods and Results-Nine sheep underwent ligation of circumflex branches to produce acute ischemic MR. PVA polymer was then injected by echo guidance into the myocardium underlying the infarcted papillary muscle. Hemodynamic data, left ventricular ejection fraction, elastance, tau (relaxation constant), left ventricular stiffness coefficient, and 2-dimensional and 3-dimensional echocardiograms were obtained post-MR and post-PVA injection. One animal died after coronary ligation and 2 did not develop MR. In the remaining 6, moderate MR developed. With PVA injection, the MR decreased significantly from moderate to trace-mild (vena contracta: 5 +/- 0.4 mm versus 2 +/- 0.7 mm, post-MR versus post-PVA injection; P < 0.0001). This was associated with a decrease in infarcted papillary muscle-to-mitral annulus tethering distance (27 +/- 4 to 24 +/- 4 mm, post-MR versus post-PVA, P < 0.001). Importantly, PVA injection was not associated with significant decreases in left ventricular ejection fraction (43 +/- 6% versus 37 +/- 4%, post-MR versus post-PVA, P=nonsignificant), elastance (3.5 +/- 1.4 versus 2.9 +/- 1.3; post-MR versus post-PVA injection, P=nonsignificant). Measures of left ventricular diastolic function, tau (100 +/- 51 ms to 84 +/- 37 ms, post-MR versus post-PVA; P=nonsignificant), and left ventricular stiffness coefficient (0.18 +/- 0.12 versus 0.14 +/- 0.08, post-MR versus post-PVA; P=nonsignificant) did not increase post-PVA.
   Conclusions-PVA polymer injection resulted in acute reverse remodeling of the ventricle with papillary muscle repositioning to decrease MR. This was not associated with an adverse effect on left ventricular systolic and diastolic function. This new approach to alter pathological anatomy after infarction may offer an alternative strategy for relieving ischemic MR by correcting the position of the affected papillary muscle, thus relieving apical tethering.
C1 [Hung, Judy] Massachusetts Gen Hosp, Cardiac Ultrasound Lab, Boston, MA 02114 USA.
   [Braithwaite, Gavin J. C.] Cambridge Polymer Inc, Boston, MA USA.
RP Hung, J (reprint author), Massachusetts Gen Hosp, Cardiac Ultrasound Lab, Blake 256,55 Fruit St, Boston, MA 02114 USA.
EM jhung@partners.org
RI Fernandez Friera, Leticia/E-9931-2015; Solis, Jorge/E-2709-2018
OI Fernandez Friera, Leticia/0000-0002-4237-2166; Solis,
   Jorge/0000-0002-4227-7062; Braithwaite, Gavin/0000-0002-6239-0046
FU NIBIB NIH HHS [R21 EB005294, R21 EB005294-02]; NHLBI NIH HHS [R01
   HL038176-14, K24 HL67434, K24 HL067434-07, R01 HL038176, K24 HL067434];
   PHS HHS [R01 038176]
CR Allen MJ, 2004, SPINE, V29, P515, DOI 10.1097/01.BRS.0000113871.67305.38
   Calafiore AM, 2001, ANN THORAC SURG, V71, P1146, DOI 10.1016/S0003-4975(00)02650-3
   Dai WD, 2005, J AM COLL CARDIOL, V46, P714, DOI 10.1016/j.jacc.2005.04.056
   Grayburn PA, 1996, CIRCULATION, V94, P119, DOI 10.1161/01.CIR.94.2.119
   Grigioni F, 2001, CIRCULATION, V103, P1759, DOI 10.1161/01.CIR.103.13.1759
   Guy TS, 2004, J AM COLL CARDIOL, V43, P377, DOI 10.1016/j.jacc.2003.07.045
   Hadlock T A, 1998, Facial Plast Surg, V14, P197, DOI 10.1055/s-2008-1064345
   Hamraoui K, 2002, J AM COLL CARDIOL, V39, P1297, DOI 10.1016/S0735-1097(02)01752-7
   HANDSCHUMACHER MD, 1993, J AM COLL CARDIOL, V21, P743, DOI 10.1016/0735-1097(93)90108-D
   He SQ, 1997, CIRCULATION, V96, P1826, DOI 10.1161/01.CIR.96.6.1826
   Hung J, 2002, CIRCULATION, V106, P2594, DOI 10.1161/01.CIR.0000038363.83133.6D
   HUNG J, 2007, CIRCULATION, V116, P259
   HUNG J, 2004, CIRCULATION S2, V110, P85
   Kershen RT, 1999, UROL CLIN N AM, V26, P81, DOI 10.1016/S0094-0143(99)80008-1
   Komeda M, 1997, J THORAC CARDIOV SUR, V113, P292, DOI 10.1016/S0022-5223(97)70326-X
   KU DB, 1999, REINFORCED UNCROSSLI
   Lamas GA, 1997, CIRCULATION, V96, P827
   Leor J, 2000, CIRCULATION, V102, P56
   Leor J, 2007, HEART, V93, P1278, DOI 10.1136/hrt.2006.093161
   Liel-Cohen N, 2000, CIRCULATION, V101, P2756, DOI 10.1161/01.CIR.101.23.2756
   LLANERAS MR, 1994, ANN THORAC SURG, V57, P432, DOI 10.1016/0003-4975(94)91012-X
   Maselli D, 2006, CIRCULATION, V114, P377, DOI 10.1161/CIRCULATIONAHA.105.609883
   McGee EC, 2004, J THORAC CARDIOV SUR, V128, P916, DOI 10.1016/j.jtcvs.2004.07.037
   MELE D, 1995, CIRCULATION, V91, P746, DOI 10.1161/01.CIR.91.3.746
   Messas E, 2006, J AM COLL CARDIOL, V47, P2086, DOI 10.1016/j.jacc.2005.12.063
   Mishra YK, 2006, ANN THORAC SURG, V81, P42, DOI 10.1016/j.athoracsur.2005.06.023
   Nasseri BA, 2001, SURGERY, V130, P781, DOI 10.1067/msy.2001.112960
   Niimi Y, 1997, NEUROSURGERY, V40, P675, DOI 10.1097/00006123-199704000-00004
   Niimi Y, 1997, NEUROSURGERY, V40, P682
   Orr TE, 1999, J BIOMED MATER RES, V44, P308, DOI 10.1002/(SICI)1097-4636(19990305)44:3<308::AID-JBM9>3.3.CO;2-H
   Otsuji Y, 1997, CIRCULATION, V96, P1999, DOI 10.1161/01.CIR.96.6.1999
   PAGEL PS, 1991, ANESTHESIOLOGY, V74, P1103, DOI 10.1097/00000542-199106000-00019
   PEPPAS N, 1973, REINFORCED UNCROSSLI
   Peppas NA, 2000, ANNU REV BIOMED ENG, V2, P9, DOI 10.1146/annurev.bioeng.2.1.9
   RADOVAN C, 1984, PLAST RECONSTR SURG, V74, P482, DOI 10.1097/00006534-198410000-00005
   Sodian R, 2000, ASAIO J, V46, P107, DOI 10.1097/00002480-200001000-00025
   Stock UA, 2001, ANNU REV MED, V52, P443, DOI 10.1146/annurev.med.52.1.443
   SUGA H, 1973, CIRC RES, V32, P314, DOI 10.1161/01.RES.32.3.314
   Tahta SA, 2002, J HEART VALVE DIS, V11, P11
   Thompson CA, 2003, J AM COLL CARDIOL, V41, P1964, DOI 10.1016/S0735-1097(03)00397-8
   Tseng WI, 1999, MAGNET RESON MED, V42, P393, DOI 10.1002/(SICI)1522-2594(199908)42:2<393::AID-MRM22>3.0.CO;2-F
   URUSHIZAKI F, 1990, INT J PHARM, V58, P135
   Wall ST, 2006, CIRCULATION, V114, P2627, DOI 10.1161/CIRCULATIONAHA.106.657270
   Wedeen VJ, 2005, MAGNET RESON MED, V54, P1377, DOI 10.1002/mrm.20642
   Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3
NR 45
TC 21
Z9 21
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0009-7322
J9 CIRCULATION
JI Circulation
PD SEP 30
PY 2008
VL 118
IS 14
SU 1
BP S263
EP S269
DI 10.1161/CIRCULATIONAHA.107.756502
PG 7
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 354OJ
UT WOS:000259648600038
PM 18824765
OA Green Accepted, Bronze
DA 2018-10-19
ER

PT J
AU Kim, WC
   Kim, JG
   Lee, JY
   Seok, HK
AF Kim, Woo-Cheol
   Kim, Jung-Gu
   Lee, Ji-Young
   Seok, Hyun-Kwang
TI Influence of Ca on the corrosion properties of magnesium for
   biomaterials
SO MATERIALS LETTERS
LA English
DT Article
DE magnesium; calcium galvanic corrosion; Hank's solution; biomaterial
   hydrogen evolution
ID IN-VIVO CORROSION; ALUMINUM ALLOYS; BONE; BEHAVIOR; MATRIX
AB The corrosion properties of a Mg alloy with Ca in Hank's solution were investigated by the hydrogen evolution test. In the test results, the hydrogen evolution rate increased with increasing Ca content. This phenomenon was caused by the precipitation of Mg(2)Ca phase in large amounts on the Mg matrix. In the case of Mg-Ca alloy, the formation of a micro-galvanic cell between the Mg(2)Ca phase and Mg matrix accelerated the preferred dissolution of the matrix. These results demonstrated that the corrosion resistance and hydrogen evolution rate are controlled by the Mg(2)Ca phase distribution in the Mg-Ca alloy system. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Kim, Woo-Cheol; Kim, Jung-Gu] Sungkyunkwan Univ, Dept Adv Mat Engn, Suwon 440746, South Korea.
   [Lee, Ji-Young; Seok, Hyun-Kwang] Korea Inst Sci & Technol, Seoul 136791, South Korea.
RP Kim, JG (reprint author), Sungkyunkwan Univ, Dept Adv Mat Engn, 300 Chunchun Dong, Suwon 440746, South Korea.
EM kimjg@skku.ac.kr
FU U&I corporation and the research program of the Short-Term Core
   Technology Development Program [10029643]
FX This work was supported by a grant from the U&I corporation and the
   research program of the Short-Term Core Technology Development Program
   (No. 10029643) of the Ministry of Commerce, Industry and Energy,
   Republic of Korea.
CR CLAES L E, 1992, Clinical Materials, V10, P41, DOI 10.1016/0267-6605(92)90083-6
   Hartwig A, 2001, MUTAT RES-FUND MOL M, V475, P113, DOI 10.1016/S0027-5107(01)00074-4
   Jones D., 1996, PRINCIPLES PREVENTIO
   Kim JG, 2003, CORROSION, V59, P228, DOI 10.5006/1.3277555
   Lee CD, 2000, MET MATER-KOREA, V6, P441, DOI 10.1007/BF03028133
   Lee CD, 2000, MET MATER-KOREA, V6, P351, DOI 10.1007/BF03028082
   LEE CD, 2000, J KOREAN INST MET MA, V38, P10
   LEE SH, 2004, J KOR SOC TREAT, V17, P173
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   MAKAR GL, 1990, J ELECTROCHEM SOC, V137, P414, DOI 10.1149/1.2086455
   Mark P. S., 2006, BIOMATERIALS, V27, P1728
   McBride ED, 1938, J AMER MED ASSOC, V111, P2464, DOI 10.1001/jama.1938.02790530018007
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   Okuma T, 2001, NUTRITION, V17, P679, DOI 10.1016/S0899-9007(01)00551-2
   Saris NEL, 2000, CLIN CHIM ACTA, V294, P1, DOI 10.1016/S0009-8981(99)00258-2
   Song GL, 2005, ADV ENG MATER, V7, P563, DOI 10.1002/adem.200500013
   Uhlig H.H., 1985, CORROSION CORROSION
   Vormann Juergen, 2003, Molecular Aspects of Medicine, V24, P27, DOI 10.1016/S0098-2997(02)00089-4
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Wolf Federica I., 2003, Molecular Aspects of Medicine, V24, P3, DOI 10.1016/S0098-2997(02)00087-0
NR 21
TC 104
Z9 115
U1 0
U2 25
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD SEP 30
PY 2008
VL 62
IS 25
BP 4146
EP 4148
DI 10.1016/j.matlet.2008.06.028
PG 3
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 344ZR
UT WOS:000258966300028
DA 2018-10-19
ER

PT J
AU Silva, EA
   Kim, ES
   Kong, HJ
   Mooney, DJ
AF Silva, Eduardo A.
   Kim, Eun-Suk
   Kong, Hyun Joon
   Mooney, David J.
TI Material-based deployment enhances efficacy of endothelial progenitor
   cells
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE biomaterial; cell therapy; ischemic diseases; neovascularization;
   regenerative medicine
ID GROWTH-FACTOR; MYOCARDIAL-INFARCTION; STEM-CELLS; ANGIOGENESIS; THERAPY;
   TRANSPLANTATION; DISEASE; SCAFFOLDS; ALGINATE; LEPTIN
AB Cell-based therapies are attractive for revascularizing and regenerating tissues and organs, but clinical trials of endothelial progenitor cell transplantation have not resulted in consistent benefit. We propose a different approach in which a material delivery system is used to create a depot of vascular progenitor cells in vivo that exit over time to repopulate the damaged tissue and participate in regeneration of a vascular network. Microenvironmental conditions sufficient to maintain the viability and outward migration of outgrowth endothelial cells (OECs) have been delineated, and a material incorporating these signals improved engraftment of transplanted cells in ischemic murine hindlimb musculature, and increased blood vessel densities from 260 to 670 vessels per mm(2), compared with direct cell injection. Further, material deployment dramatically improved the efficacy of these cells in salvaging ischemic murine limbs, whereas bolus OEC delivery was ineffective in preventing toe necrosis and foot loss. Finally, material deployment of a combination of OECs with another cell population commonly isolated from peripheral or cord blood, endothelial progenitor cells (EPCs) returned perfusion to normal levels in 40 days, and prevented toe and foot necrosis. Direct injection of an EPC/OEC combination was minimally effective in improving limb perfusion, and untreated limbs underwent autoamputation in 3 days. These results demonstrate that vascular progenitor cell utility is highly dependent on the mode of delivery, and suggest that one can create new vascular beds for a variety of applications with this material-controlled deployment of cells.
C1 [Silva, Eduardo A.; Mooney, David J.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02139 USA.
   [Silva, Eduardo A.] Univ Porto, Fac Engn, P-4099002 Oporto, Portugal.
   [Kim, Eun-Suk] Chungnam Natl Univ, Coll Med, Dept Dent, Taejon 301747, South Korea.
   [Kong, Hyun Joon] Univ Illinois, Inst Genom Biol, Dept Chem & Biomol Engn, Urbana, IL 61801 USA.
RP Mooney, DJ (reprint author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02139 USA.
EM mooneyd@seas.harvard.edu
RI Silva, Eduardo/M-2711-2015
OI Silva, Eduardo/0000-0003-3173-7622
FU National Institutes of Health [R01 HL069957]; Fundacao para Ciencia e
   Tecnologia Predoctoral Fellowship [SFRH/BD/9613/2002]
FX We thank the Biological Resources Branch of National Cancer Institute
   for generously providing VEGF<INF>165</INF> used in our studies. This
   work was supported by National Institutes of Health Grant R01 HL069957.
   E.A.S. is a student of the Gulbenkian PhD Program in Biomedicine,
   Portugal, and was supported by Fundacao para Ciencia e Tecnologia
   Predoctoral Fellowship SFRH/BD/9613/2002.
CR Akar AR, 2006, ARTIF ORGANS, V30, P213, DOI 10.1111/j.1525-1594.2006.00209.x
   Alsberg E, 2002, P NATL ACAD SCI USA, V99, P12025, DOI 10.1073/pnas.192291499
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Assmus B, 2006, NEW ENGL J MED, V355, P1222, DOI 10.1056/NEJMoa051779
   Bouhadir KH, 2001, BIOTECHNOL PROGR, V17, P945, DOI 10.1021/bp010070p
   Cao RH, 2001, P NATL ACAD SCI USA, V98, P6390, DOI 10.1073/pnas.101564798
   Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651
   Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904
   Copelan EA, 2006, NEW ENGL J MED, V354, P1813, DOI 10.1056/NEJMra052638
   Couzin J, 2004, SCIENCE, V304, P192, DOI 10.1126/science.304.5668.192
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669
   Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4
   Fuchs JR, 2003, J PEDIATR SURG, V38, P984, DOI 10.1016/S0022-3468(03)00139-8
   Gerecht-Nir S, 2004, BIOTECHNOL BIOENG, V88, P313, DOI 10.1002/bit.20248
   Hiatt WR, 2001, NEW ENGL J MED, V344, P1608, DOI 10.1056/NEJM200105243442108
   Hill E, 2006, P NATL ACAD SCI USA, V103, P2494, DOI 10.1073/pnas.0506004103
   Hofmann M, 2005, CIRCULATION, V111, P2198, DOI 10.1161/01.CIR.0000163546.27639.AA
   Hou D, 2005, CIRCULATION, V112, P1150
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06
   Ingram DA, 2005, BLOOD, V106, P1525, DOI 10.1182/blood-2005-04-1509
   Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396
   Johnson PC, 2007, TISSUE ENG, V13, P2827, DOI 10.1089/ten.2007.0335
   Kanczler JA, 2008, BIOMATERIALS, V29, P1892, DOI [10.1016/j.biomaterials.2007.12.031, 10.1016/j.biomaterials.2007.12-031]
   Koch R James, 2002, Facial Plast Surg, V18, P59, DOI 10.1055/s-2002-19828
   Kong HJ, 2005, P NATL ACAD SCI USA, V102, P4300, DOI 10.1073/pnas.0405873102
   Kong HJ, 2006, P NATL ACAD SCI USA, V103, P18534, DOI 10.1073/pnas.0605960103
   Krenning G, 2007, BIOMATERIALS, V28, P1470, DOI 10.1016/j.biomaterials.2006.11.017
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lunde ME, 2006, EPILEPSY BEHAV, V9, P355, DOI 10.1016/j.yebeh.2006.06.013
   March KL, 2004, AM J PHYSIOL-HEART C, V287, pH458, DOI 10.1152/ajpheart.00343.2004
   Murohara T, 1998, J CLIN INVEST, V101, P2567, DOI 10.1172/JCI1560
   Petrie TA, 2006, BIOMATERIALS, V27, P5459, DOI 10.1016/j.biomaterials.2006.06.027
   Prater DN, 2007, LEUKEMIA, V21, P1141, DOI 10.1038/sj.leu.2404676
   Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702
   Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313
   Rosenzweig A, 2006, NEW ENGL J MED, V355, P1274, DOI 10.1056/NEJMe068172
   Rowley JA, 2002, J BIOMED MATER RES, V60, P217, DOI 10.1002/jbm.1287
   Sales VL, 2007, CIRCULATION, V116, P155
   Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800
   Shi Q, 1998, BLOOD, V92, P362
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Sierra-Honigmann MR, 1998, SCIENCE, V281, P1683, DOI 10.1126/science.281.5383.1683
   Sieveking DP, 2008, J AM COLL CARDIOL, V51, P660, DOI 10.1016/j.jacc.2007.09.059
   Simons M, 2005, CIRCULATION, V111, P1556, DOI 10.1161/01.CIR.0000159345.00591.8F
   Srivastava D, 2006, NATURE, V441, P1097, DOI 10.1038/nature04961
   Suh W, 2005, STEM CELLS, V23, P1571, DOI 10.1634/stemcells.2004-0340
   Thebaud NB, 2007, J MATER SCI-MATER M, V18, P339, DOI 10.1007/s10856-006-0698-1
   Thornton AJ, 2004, TRANSPLANTATION, V77, P1798, DOI 10.1097/01.tp.0000131152.71117.0e
   Welt FGP, 2006, CIRCULATION, V113, P1272, DOI 10.1161/CIRCULATIONAHA.105.613034
   Wolk R, 2005, ATHEROSCLEROSIS, V183, P131, DOI 10.1016/j.athersclerosis.2005.03.048
   Woywodt A, 2006, J THROMB HAEMOST, V4, P671, DOI 10.1111/j.1538-7836.2006.01794.x
   Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471
NR 54
TC 130
Z9 133
U1 3
U2 21
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD SEP 23
PY 2008
VL 105
IS 38
BP 14347
EP 14352
DI 10.1073/pnas.0803873105
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 353TY
UT WOS:000259592400024
PM 18794520
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Eydelnant, IA
   Tufenkji, N
AF Eydelnant, Irwin Adam
   Tufenkji, Nathalie
TI Cranberry derived proanthocyanidins reduce bacterial adhesion to
   selected biomaterials
SO LANGMUIR
LA English
DT Article
ID FIMBRIATED ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA STRAINS; SECONDARY
   ENERGY MINIMUM; SURFACE-PROPERTIES; INHIBIT ADHERENCE; CELL SURFACES;
   GROWTH-MEDIUM; POROUS-MEDIA; JUICE; INFECTIONS
AB Catheter associated urinary tract infections (CAUTI) linked with the uropathogens Escherichia coli (E. coli) and Enterococcus faecalis(E. faecalis) account for the majority of nosocomial infections acquired in the clinical environment. Because these infections develop following initial adhesion of the bacteria] pathogens to the catheter surface, there is increased interest in developing effective methods to inhibit attachment of cells to biomaterials used in the manufacture of indwelling devices. High molecular weight proanthocyanidins (PAC) extracted from the North American cranberry (Vaccinium macrocarpon) were examined for their potential to reduce the initial adhesion of uropathogenic bacteria (E. coli CFF073 and E. faecalis 29212) to two model biomaterials, poly(vinyl chloride) (PVC) and polytetrafluoroethylene (PTFE). Well-controlled experiments conducted in a parallel-plate flow chamber (PPFC) demonstrated decreased attachment of both bacteria to PVC and PTFE when either the bacteria, biomaterial or both surfaces were treated with PAC. Most significant inhibition of bacterial adhesion was observed for the condition where both the bacteria and biomaterial surfaces were coated with PAC. Additional experiments conducted with nonbiological model particles demonstrate comparable extents of adhesion inhibition, supporting a nonbiospecific mechanism of PAC action. The results of this study are promising for the implementation of PAC in the clinical milieu for prevention of device associated infection as the proposed functional modification is independent of antibacterial mechanisms that may give rise to resistant strains.
C1 [Eydelnant, Irwin Adam; Tufenkji, Nathalie] McGill Univ, Dept Chem Engn, Montreal, PQ H3A 2B2, Canada.
RP Tufenkji, N (reprint author), McGill Univ, Dept Chem Engn, Montreal, PQ H3A 2B2, Canada.
EM nathalie.tufenkji@mcgill.ca
RI Eydelnant, Irwin Adam/A-9548-2008
FU NSERC; Cranberry institute; Wisconsin Cranberry Board; CRC; CFI Programs
FX This research was supported by NSERC (Discovery Grant), the Cranberry
   institute, the Wisconsin Cranberry Board and the CRC and CFI Programs.
   The authors acknowledge A. B. Howell (Rutgers) for providing cranberry
   derived proanthocyanidins, A. Manges (McGill) for providing E. coli
   CFT073, K. Harmidy for assistance with bacteria characterization, and S.
   Khan for assistance with material characterization. We thank two
   anonymous reviewers for comments that improved the manuscript.
CR Abu-Lail NI, 2003, ENVIRON SCI TECHNOL, V37, P2173, DOI 10.1021/es026159o
   Ahuja S, 1998, J UROLOGY, V159, P559, DOI 10.1016/S0022-5347(01)63983-1
   Allison DG, 2000, J BASIC MICROB, V40, P3, DOI 10.1002/(SICI)1521-4028(200002)40:1<3::AID-JOBM3>3.3.CO;2-C
   Azeredo J, 1999, COLLOID SURFACE B, V14, P141, DOI 10.1016/S0927-7765(99)00031-4
   Bos R, 1999, FEMS MICROBIOL REV, V23, P179, DOI 10.1016/S0168-6445(99)00004-2
   Burger O, 2000, FEMS IMMUNOL MED MIC, V29, P295, DOI 10.1016/S0928-8244(00)00220-0
   Burks GA, 2003, LANGMUIR, V19, P2366, DOI 10.1021/la026375a
   BUSSCHER HJ, 1984, APPL ENVIRON MICROB, V48, P980
   Castro FD, 2007, ENVIRON SCI TECHNOL, V41, P4332, DOI 10.1021/es0701558
   Considine RF, 2001, LANGMUIR, V17, P6325, DOI 10.1021/la001459+
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Darouiche RO, 2001, CLIN INFECT DIS, V33, P1567, DOI 10.1086/323130
   de Kerchove AJ, 2007, LANGMUIR, V23, P12301, DOI 10.1021/la701936x
   DERJAGUIN BV, 1941, ACTA PHYSICOCHIM URS, V14, P733, DOI DOI 10.1016/0079-6816(93)90013-1
   Di Martino P, 2006, WORLD J UROL, V24, P21, DOI 10.1007/s00345-005-0045-z
   Duguid J. L., 1980, BACTERIAL ADHERENCE, V6, P185
   Elimelech M., 1995, PARTICLE DEPOSITION, P441
   Emerson RJ, 2004, APPL ENVIRON MICROB, V70, P6012, DOI 10.1128/AEM.70.10.6012-6022.2004
   Finlay BB, 1997, SCIENCE, V276, P718, DOI 10.1126/science.276.5313.718
   Foo LY, 2000, PHYTOCHEMISTRY, V54, P173, DOI 10.1016/S0031-9422(99)00573-7
   Gallardo-Moreno AM, 2003, J ADHES SCI TECHNOL, V17, P1877, DOI 10.1163/156856103770572034
   Gupta K, 2007, J UROLOGY, V177, P2357, DOI 10.1016/j.juro.2007.01.114
   Habash MB, 1999, CAN J MICROBIOL, V45, P691, DOI 10.1139/cjm-45-8-691
   Hahn MW, 2004, ENVIRON SCI TECHNOL, V38, P5915, DOI 10.1021/es049746d
   Hook F, 1998, LANGMUIR, V14, P729, DOI 10.1021/la970815u
   Howell AB, 2005, PHYTOCHEMISTRY, V66, P2281, DOI 10.1016/j.phytochem.2005.05.022
   Howell AB, 2002, JAMA-J AM MED ASSOC, V287, P3082, DOI 10.1001/jama.287.23.3082
   Howell AB, 1998, NEW ENGL J MED, V339, P1085, DOI 10.1056/NEJM199810083391516
   Howell AB, 2007, MOL NUTR FOOD RES, V51, P732, DOI 10.1002/mnfr.200700038
   Hunter R. J., 2001, FDN COLLOID SCI, P806
   Jacobs A, 2007, COLLOID SURFACE B, V59, P35, DOI 10.1016/j.colsurfb.2007.04.008
   Johnson-White B, 2006, ANAL CHEM, V78, P853, DOI 10.1021/ac051700v
   Jucker BA, 1998, ENVIRON SCI TECHNOL, V32, P2909, DOI 10.1021/es980211s
   Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205
   Kuznar ZA, 2007, COLLOID SURFACE A, V294, P156, DOI 10.1016/j.colsurfa.2006.08.007
   Litton GM, 1996, COLLOID SURFACE A, V107, P273, DOI 10.1016/0927-7757(95)03343-2
   Liu YT, 2006, BIOTECHNOL BIOENG, V93, P297, DOI 10.1002/bit.20675
   Maki DG, 2001, EMERG INFECT DIS, V7, P342, DOI 10.3201/eid0702.010240
   NAPPER DH, 1977, J COLLOID INTERF SCI, V58, P390, DOI 10.1016/0021-9797(77)90150-3
   Redman JA, 2004, ENVIRON SCI TECHNOL, V38, P1777, DOI 10.1021/es0348871
   Rijnaarts HHM, 1999, COLLOID SURFACE B, V14, P179, DOI 10.1016/S0927-7765(99)00035-1
   RIJNAARTS HHM, 1995, COLLOID SURFACE B, V4, P191, DOI 10.1016/0927-7765(94)01164-Z
   Roosjen A, 2006, MICROBIOL-SGM, V152, P2673, DOI 10.1099/mic.0.29005-0
   Salerno MB, 2004, LANGMUIR, V20, P10625, DOI 10.1021/la048372z
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937
   Simoni SF, 2000, ENVIRON SCI TECHNOL, V34, P1011, DOI 10.1021/es990476m
   Trautner BW, 2004, AM J INFECT CONTROL, V32, P177, DOI 10.1016/j.ajilc.2003.08.005
   Triandafillu K, 2003, BIOMATERIALS, V24, P1507, DOI 10.1016/S0142-9612(02)00515-X
   Tufenkji N, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004851
   Tufenkji N, 2006, WATER RES, V40, P3315, DOI 10.1016/j.watres.2006.07.036
   VANLOOSDRECHT MCM, 1987, APPL ENVIRON MICROB, V53, P1893
   VANLOOSDRECHT MCM, 1987, APPL ENVIRON MICROB, V53, P1898
   VANOSS CJ, 2006, INTERFACIAL FORCES A
   VERWEY EJW, 1948, THEORY STABILITY LYO
   Walker SL, 2002, LANGMUIR, V18, P2193, DOI 10.1021/la011284j
   Walker SL, 2004, LANGMUIR, V20, P7736, DOI 10.1021/la049511f
   Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799
   WOODLE MC, 1992, BIOCHIM BIOPHYS ACTA, V1113, P171, DOI 10.1016/0304-4157(92)90038-C
   ZAFRIRI D, 1989, ANTIMICROB AGENTS CH, V33, P92, DOI 10.1128/AAC.33.1.92
NR 59
TC 41
Z9 41
U1 0
U2 17
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD SEP 16
PY 2008
VL 24
IS 18
BP 10273
EP 10281
DI 10.1021/la801525d
PG 9
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 347DJ
UT WOS:000259120500054
PM 18698853
DA 2018-10-19
ER

PT J
AU Califano, V
   Bloisi, F
   Vicari, LRM
   Colombi, P
   Bontempi, E
   Depero, LE
AF Califano, Valeria
   Bloisi, Francesco
   Vicari, Luciano R. M.
   Colombi, Paolo
   Bontempi, Elza
   Depero, Laura E.
TI MAPLE deposition of biomaterial multilayers
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE MAPLE; surface morphology; thin films; polyethylene glycol
ID PULSED-LASER EVAPORATION; GRAFTED POLY(ETHYLENE GLYCOL);
   POLYETHYLENE-GLYCOL; FORCE MICROSCOPY; THIN-FILMS; ABLATION; POLYMER;
   MATRIX; WATER; MORPHOLOGY
AB Double layers of polyethylene glycol (PEG) and 3-(3,4-dihydroxyphenyl)-2-methyl-L-alanine (m-DOPA) thin films were obtained by matrix assisted pulsed laser evaporation (MAPLE) technique, by depositing a first layer of m-DOPA on Si substrate and a second layer of PEG on top of it. The films were characterized by low angle X-ray diffraction (LAXRD), X-ray reflectivity (XRR), atomic force microscopy (AFM), and micro-Raman spectroscopy. From these analyses it resulted that PEG was deposited without any relevant damage both in terms of chemical structure and molecular weight. Furthermore, PEG chains were mostly in the extended conformation, although PEG micelles appeared. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Califano, Valeria; Bloisi, Francesco; Vicari, Luciano R. M.] Univ Naples Federico 2, CNR, INFM Coherentia, I-80125 Naples, Italy.
   [Bloisi, Francesco; Vicari, Luciano R. M.] Univ Naples Federico 2, Dipartimento Sci Fisiche, Fac Ingn, I-80125 Naples, Italy.
   [Colombi, Paolo; Bontempi, Elza; Depero, Laura E.] Univ Brescia, Lab Chim Tecnol, I-25123 Brescia, Italy.
RP Califano, V (reprint author), Univ Naples Federico 2, CNR, INFM Coherentia, Piazzale Tecchio 80, I-80125 Naples, Italy.
EM valeriacalifano@hotmail.com
RI Bloisi, Francesco/A-4296-2008; Depero, Laura/A-3176-2009; Colombi,
   Paolo/G-3588-2013; VICARI, Luciano Rosario Mari/L-6131-2015; Bontempi,
   Elza/F-3216-2010
OI Bloisi, Francesco/0000-0002-9714-9244; Depero,
   Laura/0000-0001-7818-3212; VICARI, Luciano Rosario
   Mari/0000-0003-1835-6411; Bontempi, Elza/0000-0003-1656-7506; COLOMBI,
   Paolo/0000-0002-0136-4442
CR Adya AK, 2005, J INDIAN CHEM SOC, V82, P1133
   Alessandri I, 2005, MAT SCI ENG C-BIO S, V25, P560, DOI 10.1016/j.msec.2005.07.006
   Alessi ML, 2005, MACROMOLECULES, V38, P9333, DOI 10.1021/ma051339e
   BLANCHET GB, 1993, APPL PHYS LETT, V62, P1026, DOI 10.1063/1.108514
   BLANDAMER MJ, 1967, MAKROMOL CHEM, V49, P124
   Bloisi F, 2007, MAT SCI ENG C-BIO S, V27, P1185, DOI 10.1016/j.msec.2006.12.005
   BONTEMPI E, 2004, RECENT RES DEV CHEM, P461
   Bozzini B, 2006, J MATER SCI-MATER EL, V17, P915, DOI 10.1007/s10854-006-0044-x
   Bubb DM, 2006, APPL PHYS A-MATER, V83, P147, DOI 10.1007/s00339-005-3478-8
   Bubb DM, 2001, APPL PHYS A-MATER, V73, P121, DOI 10.1007/s003390100884
   Bubb DM, 2002, J APPL PHYS, V91, P9809, DOI 10.1063/1.1478136
   Bubb DM, 2002, J APPL PHYS, V91, P2055, DOI 10.1063/1.1427138
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   CHRISEY DB, 1991, THIN SOLID FILMS, V206, P111, DOI 10.1016/0040-6090(91)90402-J
   Chrisey DB, 2003, CHEM REV, V103, P553, DOI 10.1021/cr010428w
   Dalsin JL, 2005, MATER TODAY, V8, P38, DOI 10.1016/S1369-7021(05)71079-8
   Dalsin JL, 2003, J AM CHEM SOC, V125, P4253, DOI 10.1021/ja0284963
   DEGENNES PG, 1993, CR HEBD ACAD SCI, V313, P1117
   Deming TJ, 1999, CURR OPIN CHEM BIOL, V3, P100, DOI 10.1016/S1367-5931(99)80018-0
   Doraiswamy A, 2007, MAT SCI ENG C-BIO S, V27, P409, DOI 10.1016/j.msec.2006.05.026
   Ebner A, 2004, MICROSC RES TECHNIQ, V65, P246, DOI 10.1002/jemt.20124
   Golander C. G., 1992, POLYETHYLENE GLYCOL, P221, DOI DOI 10.1007/978-1-4899-0703-5_15.
   Hoffmann MM, 2005, J COLLOID INTERF SCI, V287, P712, DOI 10.1016/j.jcis.2005.02.044
   Itina TE, 2001, NUCL INSTRUM METH B, V180, P238, DOI 10.1016/S0168-583X(01)00423-2
   Kaewpirom S, 2006, EUR POLYM J, V42, P1609, DOI 10.1016/j.eurpolymj.2006.01.010
   Leveugle E, 2007, J APPL PHYS, V102, DOI 10.1063/1.2783898
   Lippert T, 2003, CHEM REV, V103, P453, DOI 10.1021/cr010460q
   Lowndes DH, 1996, SCIENCE, V273, P898, DOI 10.1126/science.273.5277.898
   Mahlin D, 2005, POLYMER, V46, P12210, DOI 10.1016/j.polymer.2005.10.091
   Papra A, 2001, LANGMUIR, V17, P1457, DOI 10.1021/la000609d
   Qiu YJ, 2007, J APPL POLYM SCI, V103, P2464, DOI 10.1002/app.25362
   Rodrigo K, 2006, APPL SURF SCI, V252, P4824, DOI 10.1016/j.apsusc.2005.07.143
   Rundqvist J, 2005, LANGMUIR, V21, P2981, DOI 10.1021/la0471792
   Sanderson LAW, 1998, J COLLOID INTERF SCI, V207, P180, DOI 10.1006/jcis.1998.5727
   Sasahara K, 1998, COLLOID POLYM SCI, V276, P643, DOI 10.1007/s003960050292
   Toftmann B, 2005, APPL SURF SCI, V247, P211, DOI 10.1016/j.apsusc.2005.01.175
   Turner K, 1996, COLLOID POLYM SCI, V274, P622, DOI 10.1007/BF00653058
   Vansteenkiste SO, 2000, LANGMUIR, V16, P3330, DOI 10.1021/la981740c
   Zhigilei LV, 2003, CHEM REV, V103, P321, DOI 10.1021/cr010459r
NR 39
TC 24
Z9 24
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD SEP 15
PY 2008
VL 254
IS 22
BP 7143
EP 7148
DI 10.1016/j.apsusc.2008.05.295
PG 6
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 345LQ
UT WOS:000258998700005
DA 2018-10-19
ER

PT J
AU Mami, M
   Lucas-Girot, A
   Oudadesse, H
   Dorbez-Sridi, R
   Mezahi, F
   Dietrich, E
AF Mami, Mohamed
   Lucas-Girot, Anita
   Oudadesse, Hassane
   Dorbez-Sridi, Rachida
   Mezahi, Fatima
   Dietrich, Elodie
TI Investigation of the surface reactivity of a sol-gel derived glass in
   the ternary system SiO(2)-CaO-P(2)O(5)
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE sol-gel processing; exchange; surface; body fluid
ID IN-VITRO SYNTHESIS; BIOACTIVE GLASS; COMPOSITIONAL DEPENDENCE; MEDICAL
   APPLICATIONS; POROSITY; LAYER; CERAMICS; GROWTH; BONE; BIOMATERIALS
AB A new glass formulation, with themolar composition 60% SiO(2)-35% CaO-5% P(2)O(5), was synthesized using the sol-gel process, for applications as biomaterial in orthopaedic or maxillo facial surgery. Pellets, made of glass powder, were uniaxially compacted and soaked in simulated body fluid (SBF) for up to 7 days at 37 degrees C to evaluate glass bioactivity. Ionic exchanges at the interface glass-SBF were evaluated by studying evolutions of calcium, phosphorus and silicon concentrations in SBF using ICP-OES. Changes in glass surface, and the formation of crystalline phases were analyzed using XRD, SEM, EDS and FTIR methods. Results form ICP-OES showed a high reactivity of the glass surface with a very high and continuous release of calcium, a limited glass dissolution and an uptake of phosphorous from SBF. Results from both FTIR and XRD analysis indicated that the glass surface was progressively covered by two different phases: CaCO(3) as calcite and a carbonated apatite layer. The formation of these phases, following two different schemas, was observed after 2 h of immersion and confirmed after 7 days. SEM micrographs and EDS analysis demonstrated that the main phase, a carbonated apatite, was present as micro-spheroids and the secondary phase, calcite, was materialized by agglomerates which have diameters up to 10-15 mm. These results are in accordance with a bioactive feature of the glass studied. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Mami, Mohamed; Lucas-Girot, Anita; Oudadesse, Hassane; Mezahi, Fatima; Dietrich, Elodie] Equipe Chim Solide & Mat, UMR Sci Chim Rennes 6226, F-35042 Rennes, France.
   [Mami, Mohamed; Dorbez-Sridi, Rachida] Fac Sci Monastir, Dept Phys, Lab Physicochim Mat, Monastir 5019, Tunisia.
RP Mami, M (reprint author), Equipe Chim Solide & Mat, UMR Sci Chim Rennes 6226, Campus Beaulieu,Bat 10B,Ave Gen Leclerc, F-35042 Rennes, France.
EM mohamed_fsm@yahoo.fr
CR ANDERSSON OH, 1994, BIOCERAMICS, V7, P3
   Brink M, 1997, J BIOMED MATER RES, V37, P114, DOI 10.1002/(SICI)1097-4636(199710)37:1<114::AID-JBM14>3.0.CO;2-G
   Chang MC, 2002, BIOMATERIALS, V23, P4811, DOI 10.1016/S0142-9612(02)00232-6
   DAVIDOVITS J, 1996, Patent No. 0815064
   Derrien AC, 2004, NUCL INSTRUM METH B, V226, P281, DOI 10.1016/j.nimb.2004.06.014
   DUCHEYNE P, 1994, J CELL BIOCHEM, V56, P162, DOI 10.1002/jcb.240560207
   ELGHANNAM A, 1995, J BIOMED MATER RES, V29, P359, DOI 10.1002/jbm.820290311
   FARMER VC, 1974, SW75HR MIN SOC
   FILGUEIRAS MR, 1993, J BIOMED MATER RES, V27, P445, DOI 10.1002/jbm.820270405
   GROSS U, 1988, CRC CRITICAL REV BIO, V4, P2
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253
   HEUGHEBAERT M, 1988, J BIOMED MATER RES, V23, P258
   *JCPDS INT CTR DIF, 2002, 5586 JCPDS INT CTR D
   *JCPDS INT CTR DIF, 2002, 090432 JCPDS INT CTR
   KIM CY, 1992, J BIOMED MATER RES, V26, P1147, DOI 10.1002/jbm.820260905
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P331, DOI 10.1002/jbm.820240306
   Kokubo T., 1999, ADV SERIES CERAMICS, V1, P75
   LEGEROS RZ, 1991, BONE-BIOMATERIAL INTERFACE, P76
   LEGEROS RZ, 1990, HDB BIOACTIVE CERAMI, V2, P17
   LI R, 1991, J APPL BIOMATER, V2, P231, DOI 10.1002/jab.770020403
   Lucas A, 2001, INT J INORG MATER, V3, P87, DOI 10.1016/S1466-6049(00)00058-1
   Lucas-Girot A, 2005, J BIOMED MATER RES B, V73B, P164, DOI 10.1002/jbm.b.30210
   Lucas-Girot A, 2002, BIOMATERIALS, V23, P503, DOI 10.1016/S0142-9612(01)00132-6
   Martinez A, 2000, CHEM MATER, V12, P3080, DOI 10.1021/cm001107o
   Oudadesse H, 2007, J MATER SCI, V42, P3092, DOI 10.1007/s10853-006-0524-7
   Oudadesse H, 2004, INSTRUM SCI TECHNOL, V32, P545, DOI 10.1081/CI-200029803
   OUDADESSE H, 2007, BIOMED MATER, V2, P65
   Padilla S, 2005, BIOMATERIALS, V26, P475, DOI 10.1016/j.biomaterials.2004.02.054
   PEREIRA MM, 1994, J BIOMED MATER RES, V28, P693, DOI 10.1002/jbm.820280606
   Ramila A, 2002, CHEM MATER, V14, P542, DOI 10.1021/cm0110876
   Rehman I, 1998, J BIOMED MATER RES, V41, P162, DOI 10.1002/(SICI)1097-4636(199807)41:1<162::AID-JBM19>3.0.CO;2-P
   Roman J, 2003, CHEM MATER, V15, P798, DOI 10.1021/cm021325c
   SEPULVEDA P, 2001, J BIOMED MATER RES, V2, P301
   SING KSW, 1985, PURE APPL CHEM, V57, P603, DOI 10.1351/pac198557040603
   Smith B, 1999, INFRARED SPECTRA INT
   Vallet-Regi M, 2000, CHEM MATER, V12, P961, DOI 10.1021/cm991110b
   Vallet-Regi M, 1999, J BIOMED MATER RES, V44, P416, DOI 10.1002/(SICI)1097-4636(19990315)44:4<416::AID-JBM7>3.0.CO;2-S
   Vallet-Regi M, 2000, J BIOMED MATER RES, V51, P23, DOI 10.1002/(SICI)1097-4636(200007)51:1<23::AID-JBM4>3.0.CO;2-B
   Vallet-Regi M, 2003, EUR J INORG CHEM, P1029
   Vallet-Regi M, 2001, J CHEM SOC DALTON, P97, DOI 10.1039/b007852m
   Wanpeng C., 1996, CERAM INT, V22, P493
   ZARZYCKI J, 1982, ETAT VITREUX
   Zoulgami M, 2002, EUR PHYS J-APPL PHYS, V19, P173, DOI 10.1051/epjap:2002063
   Zoulgami M, 2001, BIOMATERIALS, V22, P1933, DOI 10.1016/S0142-9612(00)00384-7
NR 46
TC 63
Z9 63
U1 1
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD SEP 15
PY 2008
VL 254
IS 22
BP 7386
EP 7393
DI 10.1016/j.apsusc.2008.05.340
PG 8
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 345LQ
UT WOS:000258998700047
DA 2018-10-19
ER

PT J
AU Yu, SH
   Wu, YB
   Mi, FL
   Shyu, SS
AF Yu, Shu-Huei
   Wu, Yu-Bey
   Mi, Fwu-Long
   Shyu, Shin-Shing
TI Polysaccharide-based artificial extracellular matrix: Preparation and
   characterization of three-dimensional macroporous chitosan, and heparin
   composite scaffold
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE chitosan; heparin; artificial extracellular matrix; glutaraldehyde;
   scaffold
ID TISSUE; FABRICATION; HYDROGELS; COMPLEX; SPONGE; GROWTH
AB Scaffold-guided tissue engineering based on synthetic and natural occurring polymers has gained many interests in recent year. In this study, the development of a chitosan-heparin artificial extracellular matrix (AECM) is reported. Three-dimensional, macroporous composite AECMs composed of heparin (Hep) and chitosan (Chito) were prepared by an interpolyelectrolyte complex/lyophilization method. The Chito-Hep composite AECMs were respectively, crosslinked with glutaraldehyde, as well as cocrosslinked with N,N-(3-dimethylaminopropyl)-N'-ethyl carbodiimide (EDC/NHS) and N-hydroxysuccinimide (NHS). The crosslinking reactions were examined by FT-IR analysis. In physiological buffer solution (PBS), the EDC/NHS-crosslinked Chito-Hep composite AECM showed a relative lower water retention ratio than its glutaraldehyde-crosslinked counterparts. The EDC/NHS-crosslinked Chito-Hep composite AECMs showed excellent biocompatibility, according to the results of the in vitro cytotoxic test. This result suggested that the EDC/NHS-crosslinked Chito-Hep composite AECMs might be a potential biomaterial for scaffold-guided tissue engineering applications. (c) 2008 Wiley Periodicals, Inc. J Appl Polym Sci 109: 3639-3644, 2008.
C1 [Shyu, Shin-Shing] Vanung Univ, Ctr Polymer Mat Res, Chungli, Taiwan.
   [Shyu, Shin-Shing] Vanung Univ, Dept Cosmet Sci, Chungli, Taiwan.
   [Yu, Shu-Huei] Vanung Univ, Dept Polymer Mat, Chungli, Taiwan.
   [Wu, Yu-Bey] Natl Cent Univ, Dept Chem & Mat Engn, Chungli 32054, Taiwan.
   [Mi, Fwu-Long] Dept Biotechnol, Tao Yuan 320, Taiwan.
RP Shyu, SS (reprint author), Vanung Univ, Ctr Polymer Mat Res, Chungli, Taiwan.
EM ssshyu@msa.vnu.edu.tw
CR FLINT N, 1994, J CELL SCI, V107, P401
   Gilbert TW, 2005, BIOMATERIALS, V26, P1431, DOI 10.1016/j.biomaterials.2004.04.042
   Gong YH, 2006, J APPL POLYM SCI, V101, P3336, DOI 10.1002/app.23931
   Kweon DK, 2003, BIOMATERIALS, V24, P1595, DOI 10.1016/S0142-9612(02)00566-5
   Kweon DK, 2003, J APPL POLYM SCI, V87, P1784, DOI 10.1002/app.11592
   LANGER R, 1993, TISSUE ENG SCI, V260, P920
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Mann BK, 2001, BIOMATERIALS, V22, P3045, DOI 10.1016/S0142-9612(01)00051-5
   MCPHERSON JM, 1988, COLLAGEN REL RES, V8, P83
   Mi FL, 2006, J BIOMED MATER RES A, V76A, P1, DOI 10.1002/jbm.a.30298
   Mi FL, 2005, J POLYM SCI POL CHEM, V43, P1985, DOI 10.1002/pla.20669
   Mi FL, 2005, BIOMACROMOLECULES, V6, P975, DOI 10.1021/bm049335p
   Mi FL, 2001, BIOMATERIALS, V22, P165, DOI 10.1016/S0142-9612(00)00167-8
   Mi FL, 2003, BIOMATERIALS, V24, P5023, DOI 10.1016/S0142-9612(03)00413-7
   MUZZARELLI RAA, 1993, CARBOHYD POLYM, V20, P7, DOI 10.1016/0144-8617(93)90027-2
   MUZZARELLI RAA, 1994, BIOMATERIALS, V15, P1075, DOI 10.1016/0142-9612(94)90093-0
   Ozturk E, 2006, J APPL POLYM SCI, V101, P1602, DOI 10.1002/app.23563
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   VACANTI JP, 1999, TISSUE ENG, V354, P32
   Zhou QL, 2005, J APPL POLYM SCI, V98, P1373, DOI 10.1002/app.22289
NR 21
TC 9
Z9 11
U1 0
U2 16
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD SEP 15
PY 2008
VL 109
IS 6
BP 3639
EP 3644
DI 10.1002/app.28494
PG 6
WC Polymer Science
SC Polymer Science
GA 327JH
UT WOS:000257724900027
DA 2018-10-19
ER

PT J
AU Shi, ZL
   Neoh, KG
   Kang, ET
   Poh, C
   Wang, W
AF Shi, Zhilong
   Neoh, K. G.
   Kang, E. T.
   Poh, Chyekhoon
   Wang, W.
TI Bacterial adhesion and osteoblast function on titanium with
   surface-grafted chitosan and immobilized RGD peptide
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE titanium alloy; chitosan; bacterial adhesion; osteoblast; peptide
ID STAPHYLOCOCCUS-EPIDERMIDIS; ANTIBACTERIAL ACTIVITY; CELL-ADHESION;
   IN-VITRO; CHEMICAL-MODIFICATION; IMPLANT INFECTIONS; OXIDE SURFACES;
   MINERALIZATION; ATTACHMENT; BIOMATERIALS
AB Biomaterials-associated infections remain a source of serious complications in modern medicine. Mien a biomaterial is implanted in the body, the result of successful tissue integration or implant infection depends on the race for the surface between bacteria and tissue cells. One promising strategy to reduce the incidence of infection is the functionalization of the biomaterial surface to inhibit bacterial adhesion and encourage the growth of cells. In this in vitro study, the surface of titanium alloy substrates was first functionalized by covatently grafted chitosan (CS). The cell-adhesive Arg-Gly-Asp (RGD) peptide was then immobilized oil the CS-grafted surface through covalent binding of peptide to the free NH2 groups of CS. Both these functionalized surfaces showed a decrease in adhesion of Staphylococcus aureus (S. aureus) and Staphylococcus epidermis (S. epidermidis) compared with the pristine substrate. A Significant increase in osteoblast cell attachment, proliferation, and alkaline phosphatase activity x-vas observed on the surface with the immobilized Arg-Gly-Asp peptide. Thus, utilizing surface-grafted chitosan in conjunction with the cell-adhesive peptide to modify the metal surface provides a promising means for enhancing tissue integration of implants by reducing bacterial adhesion rend promoting osteoblast functions. (C) 2007 Wiley Periodicals, Inc.
C1 [Shi, Zhilong; Neoh, K. G.; Kang, E. T.] Natl Univ Singapore, Dept Chem & Biomol Engn, Kent Ridge 119260, Singapore.
   [Poh, Chyekhoon; Wang, W.] Natl Univ Singapore, Dept Orthopaed Surg, Kent Ridge 119260, Singapore.
RP Neoh, KG (reprint author), Natl Univ Singapore, Dept Chem & Biomol Engn, Kent Ridge 119260, Singapore.
EM chenkg@nus.edu.sg
RI Kang, En-Tang/G-8522-2012
OI Kang, En-Tang/0000-0003-0599-7834; Neoh, Koon Gee/0000-0002-2700-1914
CR An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Barber TA, 2003, J BIOMED MATER RES A, V64A, P38, DOI 10.1002/jbm.a.10321
   Brunette D. M., 2001, TITANIUM MED MAT SCI
   Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044
   Colon G, 2006, J BIOMED MATER RES A, V78A, P595, DOI 10.1002/jbm.a.30789
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Dee KC, 1996, BIOMATERIALS, V17, P209, DOI 10.1016/0142-9612(96)85765-6
   Dee KC, 1998, J BIOMED MATER RES, V40, P371, DOI 10.1002/(SICI)1097-4636(19980605)40:3<371::AID-JBM5>3.0.CO;2-C
   Fan XW, 2005, J AM CHEM SOC, V127, P15843, DOI 10.1021/ja0532638
   Fu JH, 2005, BIOMATERIALS, V26, P6684, DOI 10.1016/j.biomaterials.2005.04.034
   Gottenbos B, 2000, J BIOMED MATER RES, V50, P208, DOI 10.1002/(SICI)1097-4636(200005)50:2<208::AID-JBM16>3.0.CO;2-D
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Harris LG, 2004, BIOMATERIALS, V25, P4135, DOI 10.1016/j.biomaterials.2003.11.033
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b
   Ho MH, 2005, BIOMATERIALS, V26, P3197, DOI 10.1016/j.biomaterials.2004.08.032
   Holgers KM, 1999, BIOMATERIALS, V20, P1319, DOI 10.1016/S0142-9612(99)00033-2
   Hu SG, 2003, BIOMATERIALS, V24, P2685, DOI 10.1016/S0142-9612(03)00079-6
   Huh MW, 2001, J APPL POLYM SCI, V81, P2769, DOI 10.1002/app.1723
   Keselowsky BG, 2007, J BIOMED MATER RES A, V80A, P700, DOI 10.1002/jbm.a.30898
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   MacKintosh EE, 2006, J BIOMED MATER RES A, V78A, P836, DOI 10.1002/jbm.a.30905
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   MASSIA SP, 1990, ANN NY ACAD SCI, V589, P261, DOI 10.1111/j.1749-6632.1990.tb24251.x
   MASSIA SP, 1993, J BIOL CHEM, V268, P8053
   Matsunaga T, 2006, J BIOMED MATER RES A, V76A, P711, DOI 10.1002/jbm.a.30588
   Nanci A, 1998, J BIOMED MATER RES, V40, P324
   No HK, 2002, INT J FOOD MICROBIOL, V74, P65, DOI 10.1016/S0168-1605(01)00717-6
   Patel S, 2006, BIOMATERIALS, V27, P2890, DOI 10.1016/j.biomaterials.2005.12.009
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Poelstra KA, 2002, J BIOMED MATER RES, V60, P206, DOI 10.1002/jbm.10069
   Rabea EI, 2003, BIOMACROMOLECULES, V4, P1457, DOI 10.1021/bm034130m
   Rezania A, 1999, BIOTECHNOL PROGR, V15, P19, DOI 10.1021/bp980083b
   Rezania A, 1999, LANGMUIR, V15, P6931, DOI 10.1021/la990024n
   Schierholz JM, 2001, J HOSP INFECT, V49, P87, DOI 10.1053/jhin.2001.1052
   Shahab F, 2006, BIOMATERIALS, V27, P3532, DOI 10.1016/j.biomaterials.2006.02.027
   Shi ZL, 2005, BIOMATERIALS, V26, P501, DOI 10.1016/j.biomaterials.2004.02.060
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   TURKSEN K, 1992, J HISTOCHEM CYTOCHEM, V40, P1339, DOI 10.1177/40.9.1506671
   Wagner VE, 2004, BIOMATERIALS, V25, P2247, DOI 10.1016/j.biomaterials.2003.09.020
   Xiao SJ, 1997, J MATER SCI-MATER M, V8, P867, DOI 10.1023/A:1018501804943
   Yamada S, 2003, J BIOMED MATER RES A, V66A, P500, DOI 10.1002/jbm.a.10009
   Zhang H, 2004, BIOMACROMOLECULES, V5, P2461, DOI 10.1021/bm0496211
NR 43
TC 82
Z9 83
U1 2
U2 55
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 15
PY 2008
VL 86A
IS 4
BP 865
EP 872
DI 10.1002/jbm.a.31648
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 340HQ
UT WOS:000258637100002
PM 18041731
DA 2018-10-19
ER

PT J
AU Raffaelli, L
   Iommetti, PR
   Piccioni, E
   Toesca, A
   Serini, S
   Resci, F
   Missori, M
   De Spirito, M
   Manicone, PF
   Calviello, G
AF Raffaelli, Luca
   Iommetti, Pierfrancesco Rossi
   Piccioni, Elisabetta
   Toesca, Amelia
   Serini, Simona
   Resci, Federica
   Missori, Mauro
   De Spirito, Marco
   Manicone, Paolo F.
   Calviello, Gabriella
TI Growth, viability, adhesion potential, and fibronectin expression in
   fibroblasts cultured on zirconia or feldspatic ceramics in vitro
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE zirconia; fixed partial dentures; cellular adhesion; cellular growth
   rate; fibronectin
ID PARTIALLY-STABILIZED ZIRCONIA; HUMAN GINGIVAL FIBROBLASTS; DENTAL
   ALLOYS; MECHANICAL-PROPERTIES; CYTOTOXICITY; CELLS; PROLIFERATION;
   APOPTOSIS; INVITRO; ALUMINA
AB Zirconia, a biomaterial wideley used ill dentistry, has recently attracted much attention for its mechanical strength and toughness. Previously, its lack of mutagenic and carcinogenic power was reported. We describe here other essential aspects to be taken into account to define in vitro the biocompatibility of a material: the growth rate, viability, and adhesion capacity of normal stabilized cells grooving on it. To this aim, immortalized RAT-1 fibroblasts, growing either oil zirconia and on feldspatic (FE) ceramics were compared. In particular, the level of expression and the intra- and extra-cellular organization of fibronectill, a glycoprotein involved in Cellular adhesion and migration during tissue repair, was analyzed. Fibroblasts cultured on zirconia showed a higher growth rate, and underwent necrosis at lower levels than cells on FE ceramic, whereas either Materials did not stimulate apoptosis. Adhesion capacity of fibroblasts was evaluated measuring adherent cell nucleic acids with the flurometric CyQuant (R) assay, and it was found significantly higher in cells cultured on zirconia than on FE ceramic. This finding may be explained by the higher and more precocious expression of the adhesion protein fibronectin observed by indirect immunofluorescence in fibroblasts oil zirconia. Overall, the results suggest that zirconia, exerting low cytotoxicity and strongly inducing adhesion capacity, increases cellular growth rate of fibroblasts. All these features suggest that zirconia could represent a more suitable biomaterial than FE ceramic for prosthesis in dentistry. (C) 2007 Wiley Periodicals, Inc.
C1 [Piccioni, Elisabetta; Serini, Simona; Resci, Federica; Calviello, Gabriella] Catholic Univ, Inst Gen Pathol, I-00168 Rome, Italy.
   [Raffaelli, Luca; Iommetti, Pierfrancesco Rossi; Manicone, Paolo F.] Catholic Univ, Inst Clin Dent, I-00168 Rome, Italy.
   [Toesca, Amelia] Catholic Univ, Inst Human Anat, I-00168 Rome, Italy.
   [Missori, Mauro; De Spirito, Marco] Catholic Univ, Inst Phys, I-00168 Rome, Italy.
RP Calviello, G (reprint author), Catholic Univ, Inst Gen Pathol, Lgo F Vito 1, I-00168 Rome, Italy.
EM g.calviello@rm.unicatt.it
RI Missori, Mauro/H-4355-2012; De Spirito, Marco/C-5386-2008
OI De Spirito, Marco/0000-0003-4260-5107; SERINI,
   Simona/0000-0002-6894-1443; Manicone, Paolo
   Francesco/0000-0003-0283-2903; CALVIELLO, Gabriella/0000-0002-2117-5534
CR Ahmad M, 1999, BIOMATERIALS, V20, P211, DOI 10.1016/S0142-9612(98)00152-5
   BARBER S, 1984, J ORAL PATHOL MED, V13, P221, DOI 10.1111/j.1600-0714.1984.tb01420.x
   Briggs S L, 2005, J Wound Care, V14, P284
   CALES B, 1994, J MATER SCI-MATER M, V5, P376, DOI 10.1007/BF00058967
   Calviello G, 2003, CARCINOGENESIS, V24, P427, DOI 10.1093/carcin/24.3.427
   CAPUTO AA, 1980, DENT CLIN N AM, V24, P331
   CHRISTEL P, 1989, J BIOMED MATER RES, V23, P45, DOI 10.1002/jbm.820230105
   Coli P, 2004, INT J PROSTHODONT, V17, P59
   COUCHMAN JR, 1982, J CELL BIOL, V93, P402, DOI 10.1083/jcb.93.2.402
   Covacci V, 1999, BIOMATERIALS, V20, P371, DOI 10.1016/S0142-9612(98)00182-3
   CRAIG RG, 1990, J DENT RES, V69, P1539, DOI 10.1177/00220345900690081801
   DION I, 1994, J MATER SCI-MATER M, V5, P18, DOI 10.1007/BF00121148
   FARDAL O, 1986, J CLIN PERIODONTOL, V13, P735, DOI 10.1111/j.1600-051X.1986.tb00874.x
   GARVIE RC, 1975, NATURE, V258, P703, DOI 10.1038/258703a0
   GARVIE RC, 1984, J MATER SCI, V19, P3224, DOI 10.1007/BF00549808
   Griggs JA, 2003, DENT MATER, V19, P353, DOI 10.1016/S0109-5641(02)00066-0
   Grill V, 1997, ARCH ORAL BIOL, V42, P641, DOI 10.1016/S0003-9969(97)00055-1
   Grill V, 2000, QUINTESSENCE INT, V31, P741
   GRILL V, 1996, J BIOL RES, V72, P87
   GUPTA TK, 1978, J MATER SCI, V13, P1464, DOI 10.1007/BF00553200
   Helmer J, 1969, S US CER SURG IMPL S
   Hickman JA, 1997, BRIT MED BULL, V53, P632
   Josset Y, 1999, J BIOMED MATER RES, V47, P481, DOI 10.1002/(SICI)1097-4636(19991215)47:4<481::AID-JBM4>3.0.CO;2-Y
   KONONEN M, 1992, J BIOMED MATER RES, V26, P1325
   Kuru L, 1998, J DENT RES, V77, P555, DOI 10.1177/00220345980770040801
   Lohaman C.H., 2002, BIOMATERIALS, V23, P1855
   Luthardt RG, 2002, J DENT RES, V81, P487, DOI 10.1177/154405910208100711
   MACCAURO G, 1992, P 8 ESB M ROM IT JUN, P110
   Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008
   McLaren E A, 1999, Pract Periodontics Aesthet Dent, V11, P985
   Milleding P, 2001, BIOMATERIALS, V22, P2545, DOI 10.1016/S0142-9612(00)00445-2
   Neff T, 2002, J ENDODONT, V28, P811, DOI 10.1097/00004770-200212000-00005
   PAPI M, 2006, APPL PHYS LETT, V88, DOI UNSP 194102-194104
   Persson BNJ, 2005, J PHYS-CONDENS MAT, V17, pR1, DOI 10.1088/0953-8984/17/1/R01
   Phipps RP, 1997, J PERIODONTAL RES, V32, P159, DOI 10.1111/j.1600-0765.1997.tb01398.x
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Potiket N, 2004, J PROSTHET DENT, V92, P491, DOI 10.1016/j.prosdent.2004.09.001
   RIETH PH, 1976, AM CERAM SOC BULL, V55, P717
   Sadi AY, 2006, J MATER SCI-MATER M, V17, P407, DOI 10.1007/s10856-006-8467-8
   Scarano Antonio, 2003, J Oral Implantol, V29, P8, DOI 10.1563/1548-1336(2003)029<0008:BRTZCI>2.3.CO;2
   SIMION M, 1991, International Journal of Prosthodontics, V4, P543
   Sjogren G, 2000, J PROSTHET DENT, V84, P229, DOI 10.1067/mpr.2000.107227
   Solary E, 2001, THERAPIE, V56, P511
   SORENSEN JA, 2003, QUINTESSENCE DENT TE, V26, P57
   SYRJANEN S, 1985, BIOMATERIALS, V6, P169, DOI 10.1016/0142-9612(85)90005-5
   TERRANOVA VP, 1986, J PERIODONTAL RES, V21, P330, DOI 10.1111/j.1600-0765.1986.tb01467.x
   Tinschert J, 2001, INT J PROSTHODONT, V14, P231
   Warashina H, 2003, BIOMATERIALS, V24, P3655, DOI 10.1016/S0142-9612(03)00120-0
   Weinrauch Y, 1999, ANNU REV MICROBIOL, V53, P155, DOI 10.1146/annurev.micro.53.1.155
NR 49
TC 17
Z9 17
U1 0
U2 8
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 15
PY 2008
VL 86A
IS 4
BP 959
EP 968
DI 10.1002/jbm.a.31693
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 340HQ
UT WOS:000258637100012
PM 18067158
DA 2018-10-19
ER

PT J
AU Arshad, M
   Zafar, MN
   Younis, S
   Nadeem, R
AF Arshad, Mamoona
   Zafar, Muhammad Nadeem
   Younis, Sadaf
   Nadeem, Raziya
TI The use of Neem biomass for the biosorption of zinc from aqueous
   solutions
SO JOURNAL OF HAZARDOUS MATERIALS
LA English
DT Article
DE biosorption; Neem; zinc; waste water; kinetics; Gibbs free energy
ID HEAVY-METALS; AZADIRACHTA-INDICA; ADSORPTION; REMOVAL; IONS; WASTE;
   KINETICS; COPPER; EQUILIBRIUM; PESTICIDES
AB An adsorbent was developed from mature leaves and stem bark of the Neem (Azadirachta indica) tree for removing zinc from water. Adsorption was carried out in a batch process with several different concentrations of zinc by varying pH. The uptake of metal was very fast initially, but gradually slowed down indicating penetration into the interior of the adsorbent particles. The data showed that optimum pH for efficient biosorption of zinc by Neem leaves and stem bark was 4 and 5, respectively. The maximum adsorption capacity showed that the Neem biomass had a mass capacity for zinc (147.08 mg Zn/g for Neem leaves and 137.67 mg Zn/g Neem bark). The experimental results were analyzed in terms of Langmuir and Freundlich isotherms. The adsorption followed pseudo-second-order kinetic model. The thermodynamic assessment of the metal ion-Neem tree biomass system indicated the feasibility and spontaneous nature of the process and Delta G degrees values were evaluated as ranging from -26.84 to -32.75 (Neem leaves) kJ/mol and -26.04 to -29.50 (Neem bark) kJ/mol for zinc biosorption. Due to its outstanding zinc uptake capacity, the Neem tree was proved to be an excellent biomaterial for accumulating zinc from aqueous solutions. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Arshad, Mamoona; Zafar, Muhammad Nadeem; Younis, Sadaf; Nadeem, Raziya] Univ Agr Faisalabad, Dept Chem, Faisalabad 38040, Pakistan.
   [Zafar, Muhammad Nadeem] Lund Univ, Dept Analyt Chem, SE-22100 Lund, Sweden.
   [Arshad, Mamoona] Natl Inst Biotechnol & Genet Engn, Bioproc Technol Div, Faisalabad, Pakistan.
RP Zafar, MN (reprint author), Univ Agr Faisalabad, Dept Chem, Faisalabad 38040, Pakistan.
EM MNadeem.Zafar@analykem.lu.se
RI Zafar, Muhammad/B-9827-2008; Zafar, Muhammad/E-8849-2010
OI Zafar, Muhammad/0000-0002-2109-7601
FU University of Agriculture, Faisalabad, Pakistan
FX Authors are thankful to Prof. Dr. Munir Ahmad Sheikh (Chairman,
   Department of Chemistry, University of Agriculture, Faisalabad,
   Pakistan) for financial support.
CR Agrawal A, 2004, COLLOID SURFACE A, V237, P133, DOI 10.1016/j.colsurfa.2004.01.034
   ASCHER KRS, 1993, ARCH INSECT BIOCHEM, V22, P433, DOI 10.1002/arch.940220311
   Bailey SE, 1999, WATER RES, V33, P2469, DOI 10.1016/S0043-1354(98)00475-8
   Chen JP, 1997, SEPAR SCI TECHNOL, V32, P51, DOI 10.1080/01496399708003186
   Chu KH, 2002, J HAZARD MATER, V90, P77, DOI 10.1016/S0304-3894(01)00332-6
   Cordero B, 2004, ENVIRON CHEM, V1, P180, DOI 10.1071/EN04039
   CRIST RH, 1981, ENVIRON SCI TECHNOL, V15, P1212, DOI 10.1021/es00092a010
   Davis TA, 2000, WATER RES, V34, P4270, DOI 10.1016/S0043-1354(00)00177-9
   Fourest E, 1996, ENVIRON SCI TECHNOL, V30, P277, DOI 10.1021/es950315s
   Freundlich H, 1906, Z PHYS CHEM-STOCH VE, V57, P385
   GOMES NCM, 1996, REV MICROBIOLOGIA, V27, P67
   GOSSET T, 1986, WATER RES, V20, P21, DOI 10.1016/0043-1354(86)90209-5
   GROSSE DW, 1986, JAPCA J AIR WASTE MA, V36, P603, DOI 10.1080/00022470.1986.10466099
   Ho Y. S., 1995, ADSORPTION HEAVY MET
   Janson C.E., 1982, ENVIRON PROG, V1, P212
   Jnr M. H., 2004, EUR J BIOTECHNOL, V7, P313
   Kargi F, 2007, J ENVIRON MANAGE, V85, P883, DOI 10.1016/j.jenvman.2006.10.017
   Lagergren S., 1898, VETENSKAPSAKAD HANDL, V24, P1
   Langmuir I, 1916, J AM CHEM SOC, V38, P2221, DOI 10.1021/ja02268a002
   Matheickal JT, 1999, BIORESOURCE TECHNOL, V69, P223, DOI 10.1016/S0960-8524(98)00196-5
   MCKAY G, 1980, WATER RES, V14, P15, DOI 10.1016/0043-1354(80)90037-8
   Mellah A, 1997, WATER RES, V31, P621, DOI 10.1016/S0043-1354(96)00294-1
   Mohan D, 2002, WATER RES, V36, P2304, DOI 10.1016/S0043-1354(01)00447-X
   *NAT RES COUNC, 1992, NEEM TREE SOLV GLOB
   Norton L, 2004, ADV ENVIRON RES, V8, P629, DOI 10.1016/S1093-0191(03)00035-2
   Padmavathy V, 2003, PROCESS BIOCHEM, V38, P1389, DOI 10.1016/S0032-9592(02)00168-1
   Quek SY, 1998, WATER SA, V24, P251
   Reddad Z, 2002, ENVIRON SCI TECHNOL, V36, P2067, DOI 10.1021/es0102989
   Rudresh H. B., 1977, J ENV SCI TECHNOL, V122, P251
   Sag Y, 1998, HYDROMETALLURGY, V50, P297, DOI 10.1016/S0304-386X(98)00065-6
   SAG Y, 1995, PROCESS BIOCHEM, V30, P169, DOI 10.1016/0032-9592(95)95716-V
   Sanchez-Polo M., 2002, Environmental Science and Technology, V36, P3850, DOI 10.1021/es0255610
   SCHMUTTERER H, 1990, ANNU REV ENTOMOL, V35, P271, DOI 10.1146/annurev.en.35.010190.001415
   SHARMA DC, 1994, BIORESOURCE TECHNOL, V49, P31, DOI 10.1016/0960-8524(94)90170-8
   Sing C, 1998, WATER RES, V32, P2746, DOI 10.1016/S0043-1354(98)00024-4
   TIEN CT, 1991, TRACE METALS ENV, V1, P295
   Tran HH, 1999, WATER RES, V33, P2992, DOI 10.1016/S0043-1354(99)00017-2
   USDHHS Toxicological Profile for Zinc, 1993, TOX PROF ZINC
   VOLESKY B, 1995, BIOTECHNOL PROGR, V11, P235, DOI 10.1021/bp00033a001
   Volesky B., 2003, SORPTION BIOSORPTION
   Volesky B., 1990, BIOSORPTION HEAVY ME, P3
   Weber W, 1963, J SANITARY ENGINEERI, V89, P31, DOI DOI 10.1016/J.DESAL.2010.08.036
   Weber W. J., 1962, P INT C WAT POLL S, V2, P231
NR 43
TC 42
Z9 43
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-3894
J9 J HAZARD MATER
JI J. Hazard. Mater.
PD SEP 15
PY 2008
VL 157
IS 2-3
BP 534
EP 540
DI 10.1016/j.jhazmat.2008.01.017
PG 7
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA 337HK
UT WOS:000258425900041
PM 18289783
DA 2018-10-19
ER

PT J
AU Lin, F
   Li, YC
   Jin, J
   Cai, YR
   Wei, KM
   Yao, JM
AF Lin, Feng
   Li, Yucheng
   Jin, Jun
   Cai, Yurong
   Wei, Kemin
   Yao, Juming
TI Deposition behavior and properties of silk fibroin scaffolds soaked in
   simulated body fluid
SO MATERIALS CHEMISTRY AND PHYSICS
LA English
DT Article
DE microporous materials; polymers; crystal growth; mechanical properties
ID SOLID-STATE NMR; BOMBYX-MORI; BONE-FORMATION; MICROSTRUCTURE;
   NANOCOMPOSITES; BIOMATERIAL; COMPOSITE; CARTILAGE; FIBERS
AB Porous 3D silk fibroin (SF) scaffolds were prepared directly from the SF solution with the addition of methanol and glutaralclehyde by a freeze-drying method. The scaffolds were then soaked in the simulated body fluid (SBF) for the deposition of hydroxyapatite (HA) crystals. The XRD and MR results showed that the SF were in P-sheet structure, resulting in the high thermal stability and mechanical properties of scaffolds. The XRD and AAS data revealed that the SF scaffolds could induce the continuous growth and enrichment ofHA crystals onto the scaffolds with the extension ofsoaking time. The mechanical properties of scaffolds increased first with the HA-deposition within 3 d of soaking, then it declined. During the full soaking period, no significant change was observed on the porosity and water-binding ability, which were kept at about 84% and 800%, respectively. The cell cultivation results showed that the scaffolds have the satisfied cell biocompatibility, which was promoted after the HA-deposition. This work suggests that the porous 3D SF scaffolds may be a potential candidate in the bone engineering. (c) 2008 Elsevier BY. All rights reserved.
C1 [Lin, Feng; Li, Yucheng; Jin, Jun; Cai, Yurong; Yao, Juming] Zhejiang Sci Tech Univ, Coll Mat & Text, Minist Educ, Key Lab Adv Text Mat & Mfg Technol, Hangzhou 310018, Peoples R China.
   [Wei, Kemin] Zhejiang Acad Tradit Chinese Med, Hangzhou 310007, Zhejiang, Peoples R China.
RP Yao, JM (reprint author), Zhejiang Sci Tech Univ, Coll Mat & Text, Minist Educ, Key Lab Adv Text Mat & Mfg Technol, Xiasha Higher Educ Pk, Hangzhou 310018, Peoples R China.
EM yaoj@zstu.edu.cn
RI Yao, Juming/N-7886-2014
CR Akari T., 2003, J BIOMED MATER RES A, V65, P283
   Asakura T, 2001, J MOL BIOL, V306, P291, DOI 10.1006/jmbi.2000.4394
   Bouyer E, 2000, J MATER SCI-MATER M, V11, P523, DOI 10.1023/A:1008918110156
   Chang MC, 2003, BIOMATERIALS, V24, P2853, DOI 10.1016/S0142-9612(03)00115-7
   Chang MC, 2001, J MATER SCI LETT, V20, P1199, DOI 10.1023/A:1010914621089
   Choi DW, 2004, MATER RES BULL, V39, P417, DOI 10.1016/j.materresbull.2003.10.013
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   Furuzono T, 2000, J BIOMED MATER RES, V50, P344, DOI 10.1002/(SICI)1097-4636(20000605)50:3<344::AID-JBM8>3.0.CO;2-D
   Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010
   Gentleman E, 2003, BIOMATERIALS, V24, P3805, DOI 10.1016/S0142-9612(03)00206-0
   Jalota S, 2006, J MATER SCI-MATER M, V17, P697, DOI 10.1007/s10856-006-9680-1
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kong XD, 2004, J CRYST GROWTH, V270, P197, DOI 10.1016/j.jcrysgro.2004.06.007
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Li L, 2008, J MATER SCI-MATER M, V19, P577, DOI 10.1007/s10856-007-3004-y
   Liu YC, 2002, TISSUE ENG, V8, P709, DOI 10.1089/107632702760240616
   Nam J, 2001, J APPL POLYM SCI, V81, P3008, DOI 10.1002/app.1751
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Perez-Rigueiro J, 1998, J APPL POLYM SCI, V70, P2439, DOI 10.1002/(SICI)1097-4628(19981219)70:12<2439::AID-APP16>3.0.CO;2-J
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Tamada Y, 2005, BIOMACROMOLECULES, V6, P3100, DOI 10.1021/bm050431f
   Tsukada M, 1996, J APPL POLYM SCI, V60, P1619, DOI 10.1002/(SICI)1097-4628(19960606)60:10<1619::AID-APP14>3.0.CO;2-#
   Uchida M, 2004, ADV MATER, V16, P1071, DOI 10.1002/adma.200400152
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang L, 2002, J NANOPART RES, V4, P535, DOI 10.1023/A:1022841507932
   Xia WY, 2004, J BIOMED MATER RES B, V71B, P373, DOI 10.1002/jbm.b.30087
   Yamaguchi I, 2001, J BIOMED MATER RES, V55, P20, DOI 10.1002/1097-4636(200104)55:1<20::AID-JBM30>3.3.CO;2-6
   Yao J., 2004, ENCY BIOMATERIALS BI, P1363
   Yao JM, 2004, BIOMACROMOLECULES, V5, P680, DOI 10.1021/bm034285u
   Yao JM, 2002, MACROMOLECULES, V35, P6, DOI 10.1021/ma011335j
   Yao JM, 2007, ACTA CHIM SINICA, V65, P635
   ZHAO M, 2006, INT J BIOMED ENG, V29, P1
   Zhou P, 2004, BIOCHEMISTRY-US, V43, P11302, DOI 10.1021/bi049344i
NR 33
TC 33
Z9 37
U1 1
U2 21
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0254-0584
J9 MATER CHEM PHYS
JI Mater. Chem. Phys.
PD SEP 15
PY 2008
VL 111
IS 1
BP 92
EP 97
DI 10.1016/j.matchemphys.2008.03.019
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA 323MN
UT WOS:000257450300020
DA 2018-10-19
ER

PT J
AU Corno, M
   Pedone, A
   Dovesi, R
   Ugliengo, P
AF Corno, Marta
   Pedone, Alfonso
   Dovesi, Roberto
   Ugliengo, Piero
TI B3LYP simulation of the full vibrational spectrum of 45S5 bioactive
   silicate glass compared to nu-silica
SO CHEMISTRY OF MATERIALS
LA English
DT Article
ID MOLECULAR-DYNAMICS SIMULATIONS; LOCALIZED WANNIER FUNCTIONS; EFFECTIVE
   CORE POTENTIALS; HARTREE-FOCK GRADIENTS; AB-INITIO; VITREOUS-SILICA;
   ELASTIC PROPERTIES; PERIODIC-SYSTEMS; CRYSTAL CODE;
   ELECTRONIC-PROPERTIES
AB The IR spectrum of the Bioglass 45S5 (of composition 46.1 SiO2, 24.4 Na2O, 26.9 CaO. and 2.6 P2O5 mol %) has been simulated by means of periodic ab initio B3LYP calculations. The initial glass structure unit cell envisaging 78 atoms was generated through a melt quench process by means of classical molecular dynamics simulations. The molecular mechanics optimized unit cell has then been fully reoptimized (both unit-cell parameters and internal coordinates) at B3LYP level in a periodic approach using Gaussian basis sets of double-xi quality by means of the CRYSTAL06 code. Although long-range structural properties cannot be modeled by using this ab initio approach because of the intrinsic amorphous nature of the glass, the quantum mechanical simulation proved to be extremely effective in predicting and analyzing the vibrational features of this biomaterial. The effect of modifiers Na and Ca cations on the network dynamics has been assessed by comparing the 45S5 vibrational spectrum with that of amorphous nu-SiO2, both simulated at the B3LYP level. A detailed assignment of each spectral peak to the corresponding vibrational mode of the two glasses has been addressed and the role of cation modifiers on the vibrational features has been analyzed in greater details. This may be useful to support further IR and Raman investigations of the bulk structure of these materials.
C1 [Corno, Marta; Dovesi, Roberto; Ugliengo, Piero] Univ Turin, NIS Ctr Excellence, Dept IFM Chem, Turin, Italy.
   [Corno, Marta; Dovesi, Roberto; Ugliengo, Piero] Univ Turin, INSTM Mat Sci & Technol, Natl Consortium, Turin, Italy.
   [Pedone, Alfonso] Univ Modena & Reggio Emilia, Dept Chem, I-41100 Modena, Italy.
RP Ugliengo, P (reprint author), Univ Turin, NIS Ctr Excellence, Dept IFM Chem, Via P Giuria 7, Turin, Italy.
EM piero.ugliengo@unito.it
RI Corno, Marta/I-4310-2012; ugliengo, piero/H-6373-2015; Pedone,
   Alfonso/C-6286-2014
OI Corno, Marta/0000-0001-7248-2705; ugliengo, piero/0000-0001-8886-9832;
   Pedone, Alfonso/0000-0003-3772-7222
FU Italian Ministry MIUR [2006032335_005]; Regione Piemonte (Bando ricerca
   scientifica Piemonte 2004, Settore: Nanotecriologie e nanoscienze,
   "Materiali nanostrutturati biocompatibili per applicazioni biomediche")
FX Financial support from the Italian Ministry MIUR (Project COFIN2006,
   Prot. 2006032335_005 led by Prof. C. Morterra) and from the Regione
   Piemonte (Bando ricerca scientifica Piemonte 2004, Settore:
   Nanotecriologie e nanoscienze, "Materiali nanostrutturati biocompatibili
   per applicazioni biomediche", led by Prof. C. Morterra) is gratefully
   acknowledged. We thank Prof. S. Pantelides for kindly providing the
   coordinates of the starting structure of the nu-SiO<INF>2</INF> glass.
CR AHMAD N, 1988, PHILOS MAG B, V57, P677, DOI 10.1080/13642818808211238
   APRA E, 1993, J PHYS-CONDENS MAT, V5, P2969, DOI 10.1088/0953-8984/5/18/019
   Arai M., 1991, T AM CRYSTALLOGR ASS, V27, P113
   Bakos T, 2002, IEEE T NUCL SCI, V49, P2713, DOI 10.1109/TNS.2002.805342
   Bakos T, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.055508
   Baranek P, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.125102
   BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913
   Bell R., 1970, DISCUSS FARADAY SOC, V50, P55, DOI DOI 10.1039/DF9705000055
   BELL RJ, 1972, PHILOS MAG, V25, P1381, DOI 10.1080/14786437208223861
   CARPENTER JM, 1985, PHYS REV LETT, V54, P441, DOI 10.1103/PhysRevLett.54.441
   Civalleri B, 2001, CHEM PHYS LETT, V348, P131, DOI 10.1016/S0009-2614(01)01081-8
   Clark TM, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.064202
   Clayden NJ, 2005, J NON-CRYST SOLIDS, V351, P195, DOI 10.1016/j.jnoncrysol.2004.11.009
   Cora F, 2004, STRUCT BOND, V113, P171, DOI 10.1007/b97944
   Corno M, 2006, PHYS CHEM CHEM PHYS, V8, P2464, DOI 10.1039/b602419j
   Doll K, 2001, COMPUT PHYS COMMUN, V137, P74, DOI 10.1016/S0010-4655(01)00172-2
   Doll K, 2001, INT J QUANTUM CHEM, V82, P1, DOI 10.1002/1097-461X(2001)82:1<1::AID-QUA1017>3.0.CO;2-W
   Donadio D, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.214205
   Dovesi R, 2005, REV COMP CH, V21, P1, DOI 10.1002/0471720895.ch1
   Dovesi R, 2005, Z KRISTALLOGR, V220, P571, DOI 10.1524/zkri.220.5.571.65065
   DOVESI R, 1992, PHILOS T ROY SOC A, V341, P203, DOI 10.1098/rsta.1992.0094
   DOVESI R, 1991, CHEM PHYS, V156, P11, DOI 10.1016/0301-0104(91)87032-Q
   DOVESI R, 2006, CRYSTAL2006 USERS MA
   Du JC, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2345060
   ElBatal HA, 2003, MATER CHEM PHYS, V80, P599, DOI 10.1016/S0254-0584(03)00082-8
   Elgayar I, 2005, J NON-CRYST SOLIDS, V351, P173, DOI 10.1016/j.jnoncrysol.2004.07.067
   EXARHOS GJ, 1972, SOLID STATE COMMUN, V11, P755, DOI 10.1016/0038-1098(72)90502-9
   FEUSTON BP, 1988, J CHEM PHYS, V89, P5818, DOI 10.1063/1.455531
   FEUSTON BP, 1989, J CHEM PHYS, V91, P564, DOI 10.1063/1.457440
   Gale JD, 2003, MOL SIMULAT, V29, P291, DOI 10.1080/0892702031000104887
   GALEENER FL, 1983, PHYS REV B, V27, P1052, DOI 10.1103/PhysRevB.27.1052
   GALEENER FL, 1984, PHYS REV LETT, V53, P2429, DOI 10.1103/PhysRevLett.53.2429
   GERVAIS F, 1990, J NON-CRYST SOLIDS, V119, P79, DOI 10.1016/0022-3093(90)90243-F
   GRIMLEY DI, 1990, J NON-CRYST SOLIDS, V119, P49, DOI 10.1016/0022-3093(90)90240-M
   GUTTMAN L, 1986, PHYS REV B, V33, P1506, DOI 10.1103/PhysRevB.33.1506
   Habas MP, 1998, J PHYS-CONDENS MAT, V10, P6897, DOI 10.1088/0953-8984/10/31/008
   HANDKE M, 1994, J MOL STRUCT, V325, P129, DOI 10.1016/0022-2860(94)80028-6
   HAURET G, 1995, J NON-CRYST SOLIDS, V191, P85, DOI 10.1016/0022-3093(95)00322-3
   HAY PJ, 1985, J CHEM PHYS, V82, P299, DOI 10.1063/1.448975
   Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253
   HENCH LL, 1980, SCIENCE, V208, P826, DOI 10.1126/science.6246576
   HENCH LL, 1993, INTRO BIOCERAMICS
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695
   Ispas S, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevLett.87.214206
   JIN W, 1993, PHYS REV B, V48, P9359, DOI 10.1103/PhysRevB.48.9359
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   LAUGHLIN RB, 1977, PHYS REV B, V16, P2942, DOI 10.1103/PhysRevB.16.2942
   LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785
   LI D, 1995, J NON-CRYST SOLIDS, V188, P181, DOI 10.1016/0022-3093(95)00100-X
   LICHANOT A, 1993, PHYS STATUS SOLIDI B, V177, P157, DOI 10.1002/pssb.2221770111
   Lin CC, 2005, J NON-CRYST SOLIDS, V351, P3195, DOI 10.1016/j.jnoncrysol.2005.08.020
   Linati L, 2005, J PHYS CHEM B, V109, P4989, DOI 10.1021/jp046631n
   Linati L, 2008, J NON-CRYST SOLIDS, V354, P84, DOI 10.1016/j.jnoncrysol.2007.06.076
   LOCKYER MWG, 1995, J NON-CRYST SOLIDS, V188, P207, DOI 10.1016/0022-3093(95)00188-3
   Lusvardi G, 2005, J PHYS CHEM B, V109, P21586, DOI 10.1021/jp0546857
   LUSVARDI G, 2008, J BIOMATER IN PRESS
   Malavasi G, 2007, THEOR CHEM ACC, V117, P933, DOI 10.1007/s00214-006-0214-1
   MASATOSHI A, 1991, T AM CRYSTALLOGR ASS, V27, P113
   Monkhrost H. J., 1976, PHYS REV B, V8, P5188
   Noel Y, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.014111
   Oliveira JM, 2002, BIOMATERIALS, V23, P371, DOI 10.1016/S0142-9612(01)00115-6
   Pascale F, 2005, J PHYS CHEM B, V109, P18522, DOI 10.1021/jp052991e
   Pascale F, 2004, J COMPUT CHEM, V25, P888, DOI 10.1002/jcc.20019
   Pascale F, 2002, J CHEM PHYS, V117, P5337, DOI 10.1063/1.1499477
   PEDONE A, CHEM MAT UNPUB
   PEDONE A, J PHYS CHEM UNPUB
   PEDONE A, 2008, THESIS U MODENA R EM
   Pedone A, 2008, THEOR CHEM ACC, V120, P557, DOI 10.1007/s00214-008-0434-7
   Pedone A, 2007, CHEM MATER, V19, P3144, DOI 10.1021/cm062619r
   Pedone A, 2006, J PHYS CHEM B, V110, P11780, DOI 10.1021/jp0611018
   Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865
   Prencipe M., 2004, PHYS CHEM MINER, V31, P1
   Rahmani A, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.184202
   SANDERS MJ, 1984, J CHEM SOC CHEM COMM, V1271, P1984
   Sarnthein J, 1997, SCIENCE, V275, P1925, DOI 10.1126/science.275.5308.1925
   SEN PN, 1977, PHYS REV B, V15, P4030, DOI 10.1103/PhysRevB.15.4030
   Taraskin SN, 1997, PHYS REV B, V56, P8605, DOI 10.1103/PhysRevB.56.8605
   Tilocca A, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.224202
   Tilocca A, 2007, J PHYS CHEM B, V111, P14256, DOI 10.1021/jp075677o
   Tilocca A, 2006, J PHYS CHEM B, V110, P25810, DOI 10.1021/jp065146k
   Tilocca A, 2007, FARADAY DISCUSS, V136, P45, DOI 10.1039/b617540f
   Tilocca A, 2007, CHEM MATER, V19, P95, DOI 10.1021/cm061631g
   Tilocca A, 2006, J MATER CHEM, V16, P1950, DOI [10.1039/b517362k, 10.1039/B517362K]
   UGLIENGO P, 2005, MOLDRAW MOL GRAPHICS
   van Santen R. A., 1989, ADV SOLID STATE CHEM, V1, P151
   VANGINHOVEN RM, 2005, PHYS REV B, V71
   WADT WR, 1985, J CHEM PHYS, V82, P284, DOI 10.1063/1.448800
   WILLSON M, 1996, PHYS REV LETT, V77, P4023
   Zicovich-Wilson CM, 2007, J AM CHEM SOC, V129, P11512, DOI 10.1021/ja0730361
   Zicovich-Wilson CM, 2004, J COMPUT CHEM, V25, P1873, DOI 10.1002/jcc.20120
   Zicovich-Wilson CM, 2002, J CHEM PHYS, V116, P1120, DOI 10.1063/1.1425406
   Zicovich-Wilson CM, 2001, J CHEM PHYS, V115, P9708, DOI 10.1063/1.1415745
NR 94
TC 32
Z9 32
U1 2
U2 27
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0897-4756
J9 CHEM MATER
JI Chem. Mat.
PD SEP 9
PY 2008
VL 20
IS 17
BP 5610
EP 5621
DI 10.1021/cm801164u
PG 12
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 344QC
UT WOS:000258941400020
DA 2018-10-19
ER

PT J
AU Yi, F
   Lavan, DA
AF Yi, Feng
   LaVan, David A.
TI Poly(glycerol sebacate) nanofiber scaffolds by core/shell
   electrospinning
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE biomaterials; coaxial electrospinning; nanofibers; poly(glycerol
   sebacate); scaffold; tissue engineering
ID POLYMER BLENDS
AB The novel biomaterial poly(glycerol sebacate) (PGS) holds great promise for tissue engineering and regenerative medicine. PGS is a rubbery, degradable polymer much like elastin; however, it has been limited to cast structures. This work reports on the formation of PGS nanofibers in random non-woven mats for use as tissue engineering scaffolds by coaxial core/shell electrospinning. PGS nanofibers are an inexpensive and synthetic material that mimics the chemical and mechanical environment provided by elastin fibers. Poly(lactide) was used as the shell material to constrain the PGS during the curing process and was removed before cell seeding. Human microvascular endothelial cells from skin (HDMEC) were used to evaluate the in-vitro cellular compatibility of the PGS nanofiber scaffolds.
C1 [Yi, Feng; LaVan, David A.] Yale Univ, New Haven, CT 06511 USA.
RP Lavan, DA (reprint author), Yale Univ, 9Hillhouse Ave,Mason Labs Room M3, New Haven, CT 06511 USA.
EM david.lavan@yale.edu
RI LaVan, David/C-3943-2012
OI LaVan, David/0000-0002-1952-0028
CR Bhattarai N, 2006, ADV MATER, V18, P1463, DOI 10.1002/adma.200502537
   Gao J, 2006, TISSUE ENG, V12, P917, DOI 10.1089/ten.2006.12.917
   Gao J, 2007, J BIOMED MATER RES A, V83A, P1070, DOI 10.1002/jbm.a.31434
   Lee SJ, 2007, J BIOMED MATER RES A, V83A, P999, DOI 10.1002/jbm.a.31287
   Liao S, 2006, BIOMED MATER, V1, pR45, DOI 10.1088/1748-6041/1/3/R01
   Sun ZC, 2003, ADV MATER, V15, P1929, DOI 10.1002/adma.200305136
   Sundback CA, 2005, BIOMATERIALS, V26, P5454, DOI 10.1016/j.biomaterials.2005.02.004
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Wei M, 2005, MACROMOL RAPID COMM, V26, P1127, DOI 10.1002/marc.200500212
   Wei M, 2006, MACROMOL MATER ENG, V291, P1307, DOI 10.1002/mame.200600284
   Yi F, 2004, MACROMOL RAPID COMM, V25, P1038, DOI 10.1002/marc.200400021
NR 11
TC 65
Z9 65
U1 4
U2 57
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD SEP 9
PY 2008
VL 8
IS 9
BP 803
EP 806
DI 10.1002/mabi.200800041
PG 4
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 352YQ
UT WOS:000259533700001
PM 18504802
DA 2018-10-19
ER

PT J
AU Mandal, BB
   Kundu, SC
AF Mandal, Biman B.
   Kundu, Subhas C.
TI Non-bioengineered silk fibroin protein 3D scaffolds for potential
   biotechnological and tissue engineering applications
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE biomaterials; fibroin; nonmulberry silk; scaffolds; tissue engineering
ID TROPICAL TASAR SILKWORM; SODIUM DODECYL-SULFATE; MESENCHYMAL STEM-CELLS;
   ANTHERAEA-MYLITTA; IN-VITRO; MOLECULAR PHYLOGENY; 3-D SCAFFOLDS;
   BIOMATERIALS; MATRICES; INSECTS
AB This paper describes a new source for fabricating high-strength, non-bioengineered silk gland fibroin 3D scaffolds from Indian tropical tasar silkworm, Antheraea mylitta using SDS for dissolution. The scaffolds were fabricated by freeze drying at different prefreezing temperatures for pore size and porosity optimization. Superior mechanical properties with compressive strength in the range of 972 kPa were observed. The matrices were degraded by proteases within 28 d of incubation. Biocompatibility was assessed by feline fibroblast culture in vitro and confocal microscopy further confirmed adherence, spreading, and proliferation of primary dermal fibroblasts. Results indicate nonmulberry 3D silk gland fibroin protein as an inexpensive, high-strength, slow biodegradable, biocompatible, and alternative natural biomaterial.
C1 [Mandal, Biman B.; Kundu, Subhas C.] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
RP Kundu, SC (reprint author), Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
EM kundu@hijli.iitkgp.ernet.in
OI Kundu, Subhas C./0000-0002-7170-2291
FU Department of Biotechnology [BT/PR6035/MED/14/733/2005,
   BT/PR9552/ICD/16/755/2006]; Council of Scientoc Industrial Research
FX Department of Biotechnology (BT/PR6035/ MED/14/733/2005 and
   BT/PR9552/ICD/16/755/2006) and Council of Scientoc Industrial Research
   (for fellowship to B. B. M.), Government of India, New Delhi financially
   supported this work. Financial support through the IIT-Kharagpur and
   EPFL-Lausanne program, which was coordinated by Professor Promod Rastogi
   (EPFL), is gratefully acknowledged. We are indebted to Professor Jeffrey
   Alan Hubbell (EPFL), Switzerland for permitting us to use his
   laboratory, primary human dermal fibroblasts, confocal laser microscopy
   facilities, and for his kind and excellent hospitality during our short
   stay.
CR Adeloew C, 2008, BIOMATERIALS, V29, P314, DOI 10.1016/j.biomaterials.2007.09.036
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   ARAND M, 1992, ANAL BIOCHEM, V207, P73, DOI 10.1016/0003-2697(92)90502-X
   ASAKURA T, 1985, MACROMOLECULES, V18, P1841, DOI 10.1021/ma00152a009
   Dash R, 2006, INT J BIOL MACROMOL, V38, P255, DOI 10.1016/j.ijbiomac.2006.03.001
   DASH R, 2008, BMB REP, V31, P236
   Dash R, 2007, COMP BIOCHEM PHYS B, V147, P129, DOI 10.1016/j.cbpb.2007.01.009
   Domb A, 2007, ADV DRUG DELIVER REV, V59, P185, DOI 10.1016/j.addr.2007.05.001
   DUTTA A, 2001, COMP BIOCH PHYSL B, V129, P197
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   *ICH, Q3C R3 GUID RES SOLV
   IIZUKA E, 1985, J APPL POLYM SCI APP, V41, P173
   Ishaug-Riley SL, 1998, BIOMATERIALS, V19, P1405, DOI 10.1016/S0142-9612(98)00021-0
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013
   Kim HJ, 2007, MACROMOL BIOSCI, V7, P643, DOI 10.1002/mabi.200700030
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kundu S.C., 2001, INSECT BIOCHEM MOLEC, V31, P1013, DOI DOI 10.1016/S0965-1748(01)00049-2
   Kweon HY, 2000, POLYMER, V41, P7361, DOI 10.1016/S0032-3861(00)00100-2
   Lee SB, 2004, BIOMATERIALS, V25, P2309, DOI 10.1016/j.biomaterials.2003.09.016
   Li MZ, 2003, POLYM ADVAN TECHNOL, V14, P694, DOI 10.1002/pat.409
   Li MZ, 2003, INT J BIOL MACROMOL, V32, P159, DOI 10.1016/S0141-8130(03)00049-7
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Liao CJ, 2002, J BIOMED MATER RES, V59, P676, DOI 10.1002/jbm.10030
   Lutolf MP, 2003, BIOMACROMOLECULES, V4, P713, DOI 10.1021/bm025744e
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   MAGOSHI J, 1981, J POLYM SCI POL PHYS, V19, P185, DOI 10.1002/pol.1981.180190117
   MAGOSHI J, 1985, J APPL POLYM SCI APP, V41, P187
   Magoshi J., 1996, POLYM MAT ENCY, V1, P667
   Mahendran B, 2006, J GENET, V85, P31, DOI 10.1007/BF02728967
   Mahendran B, 2006, GENE, V370, P51, DOI 10.1016/j.gene.2005.11.010
   Mahendran B, 2006, J BIOCHEM MOL BIOL, V39, P522
   Mandal BB, 2008, BIOTECHNOL BIOENG, V100, P1237, DOI 10.1002/bit.21835
   Mandal BB, 2008, BIOTECHNOL BIOENG, V99, P1482, DOI 10.1002/bit.21699
   Mauney JR, 2004, TISSUE ENG, V10, P81, DOI 10.1089/107632704322791727
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Meinel L, 2004, BIOTECHNOL BIOENG, V88, P379, DOI 10.1002/bit.20252
   MIKOS AG, 2000, EJB ELECT J BIOTECHN, V3, P114
   MINGZHONG L, 1999, J APPL POLYM SCI, V79, P2185
   MINOURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511, DOI 10.1006/bbrc.1995.1368
   MIYAZAWA T, 1961, J AM CHEM SOC, V83, P712, DOI 10.1021/ja01464a042
   MOY RL, 1991, AM FAM PHYSICIAN, V44, P2123
   MUGA A, 1993, ARCH BIOCHEM BIOPHYS, V300, P451, DOI 10.1006/abbi.1993.1061
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Saha M, 2006, BIOCHEM GENET, V44, P72, DOI 10.1007/s10528-006-9007-4
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   TANFORD C, 1976, BIOCHIM BIOPHYS ACTA, V457, P133, DOI 10.1016/0304-4157(76)90009-5
   Tao W, 2007, INT J BIOL MACROMOL, V40, P472, DOI 10.1016/j.ijbiomac.2006.11.006
   TSUKADA M, 1994, J POLYM SCI POL PHYS, V32, P1407, DOI 10.1002/polb.1994.090320812
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   Wang YZ, 2005, BIOMATERIALS, V26, P7082, DOI 10.1016/j.biomaterials.2005.05.022
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
NR 55
TC 96
Z9 100
U1 0
U2 19
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD SEP 9
PY 2008
VL 8
IS 9
BP 807
EP 818
DI 10.1002/mabi.200800113
PG 12
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 352YQ
UT WOS:000259533700002
PM 18702171
DA 2018-10-19
ER

PT J
AU Barrett, DG
   Yousaf, MN
AF Barrett, Devin G.
   Yousaf, Muhammad N.
TI Poly(triol alpha-ketoglutarate) as biodegradable, chemoselective, and
   mechanically tunable elastomers
SO MACROMOLECULES
LA English
DT Article
ID RING-OPENING POLYMERIZATION; ALIPHATIC POLYESTERS; SURFACES; LIGANDS;
   BIOSYNTHESIS; COPOLYMERS; SCAFFOLDS; CHEMISTRY; STRATEGY; DELIVERY
AB We report the design of several elastomers based on the thermal polycondensation of alpha-ketoglutaric acid and one of three triols: glycerol, 1,2,4-butanetriol, or 1,2,6-hexanetriol. By varying the curing temperature and the duration of the curing process, a wide range of mechanical properties was achieved. The values of the Young's modulus (0.1 - 657.4 MPa), ultimate stress (0.2 - 30.8 MPa), and ultimate strain (22 - 583%) encompass the mechanical properties of many biological materials, increasing the probability of success for the use of poly(triol alpha-ketoglutarate) as a biomaterial. Furthermore, the poly(triol alpha-ketoglutarate) series hydrolytically degraded in as fast as 2 days and as long as 28 days in phosphate-buffered saline solutions. For postpolymerization modifications, the repeat units contain ketones, which are capable of reacting with a variety of oxyamine--terminated molecules to generate stable oxime linkages. Finally, the versatility and utility of these elastomers were demonstrated by creating micropatterned structures and films for biospecific cell scaffold supports.
C1 [Yousaf, Muhammad N.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA.
   Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA.
RP Yousaf, MN (reprint author), Univ N Carolina, Dept Chem, CB 3290, Chapel Hill, NC 27599 USA.
EM mnyousaf@email.unc.edu
FU Carolina Center for Cancer Nanotechnology Excellence; NIH; Burroughs
   Wellcome Foundation
FX The authors thank the Ashby and DeSimone research groups for insightful
   discussions. This work was supported by the Carolina Center for Cancer
   Nanotechnology Excellence, grants from the NIH to M.N.Y., and the
   Burroughs Wellcome Foundation (Interface Career Award).
CR Barrett DG, 2008, BIOMACROMOLECULES, V9, P2029, DOI 10.1021/bm800271f
   Barrett DG, 2008, CHEMBIOCHEM, V9, P62, DOI 10.1002/cbic.200700550
   Brown AH, 2007, MACROMOLECULES, V40, P4848, DOI 10.1021/ma070185v
   Chan EWL, 2006, J AM CHEM SOC, V128, P15542, DOI [10.1021/ja065828l, 10.1021/ja0658281]
   Chung IS, 2003, MACROMOLECULES, V36, P2995, DOI 10.1021/ma034029+
   Fratzl P, 1998, J STRUCT BIOL, V122, P119, DOI 10.1006/jsbi.1998.3966
   Gosline J, 2002, PHILOS T ROY SOC B, V357, P121, DOI 10.1098/rstb.2001.1022
   He WH, 2004, NATURE, V429, P188, DOI 10.1038/nature02488
   Jagur-Grodzinski J, 2006, POLYM ADVAN TECHNOL, V17, P395, DOI 10.1002/pat.729
   Kim YB, 2004, MACROMOL MATER ENG, V289, P923, DOI 10.1002/mame.200400163
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   Lazny R, 2005, J COMB CHEM, V7, P109, DOI 10.1021/cc049874y
   Lee DP, 2001, J LIPID RES, V42, P1979
   LEE MC, 1992, J BIOMECH, V25, P925, DOI 10.1016/0021-9290(92)90232-P
   Liu H, 2007, BIOMATERIALS, V28, P354, DOI 10.1016/j.biomaterials.2006.08.049
   Mahal LK, 1997, SCIENCE, V276, P1125, DOI 10.1126/science.276.5315.1125
   Nijst CLE, 2007, BIOMACROMOLECULES, V8, P3067, DOI 10.1021/bm070423u
   Odelius K, 2005, BIOMACROMOLECULES, V6, P2718, DOI 10.1021/bm050190b
   Olson DA, 2006, J AM CHEM SOC, V128, P13625, DOI 10.1021/ja063092m
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   RISSE W, 1990, MACROMOLECULES, V23, P4029, DOI 10.1021/ma00220a001
   Riva R, 2007, MACROMOLECULES, V40, P796, DOI 10.1021/ma0624090
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Sanda F, 2001, J POLYM SCI POL CHEM, V39, P265, DOI 10.1002/1099-0518(20010115)39:2<265::AID-POLA20>3.0.CO;2-D
   Shastri V. Prasad, 2003, Current Pharmaceutical Biotechnology, V4, P331, DOI 10.2174/1389201033489694
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Taniguchi I, 2005, MACROMOLECULES, V38, P216, DOI 10.1021/ma0487554
   Van Horn BA, 2008, MACROMOLECULES, V41, P1618, DOI 10.1021/ma7026963
   Wang F, 1998, MACROMOL RAPID COMM, V19, P135, DOI 10.1002/(SICI)1521-3927(19980201)19:2<135::AID-MARC135>3.0.CO;2-7
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Westcott NP, 2008, LANGMUIR, V24, P2261, DOI 10.1021/la703744v
   Yang J, 2004, ADV MATER, V16, P511, DOI 10.1002/adma.200306264
   Yang SK, 2008, MACROMOLECULES, V41, P346, DOI 10.1021/ma702052k
   Younes HM, 2004, BIOMATERIALS, V25, P5261, DOI 10.1016/j.biomaterials.2003.12.024
   Zugates GT, 2006, J AM CHEM SOC, V128, P12726, DOI 10.1021/ja061570n
NR 35
TC 35
Z9 39
U1 1
U2 10
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD SEP 9
PY 2008
VL 41
IS 17
BP 6347
EP 6352
DI 10.1021/ma8009728
PG 6
WC Polymer Science
SC Polymer Science
GA 344EL
UT WOS:000258909000015
DA 2018-10-19
ER

PT J
AU Park, SH
   Choi, BG
   Joo, MK
   Han, DK
   Sohn, YS
   Jeong, B
AF Park, So Hyun
   Choi, Bo Gyu
   Joo, Min Kyung
   Han, Dong Kenn
   Sohn, Youn Soo
   Jeong, Byeongmoon
TI Temperature-sensitive poly (caprolactone-co-trimethylene
   carbonate)-poly(ethylene glycol)-poly(caprolactone-co-trimethylene
   carbonate) as in situ gel-forming biomaterial
SO MACROMOLECULES
LA English
DT Article
ID COPOLYMER AQUEOUS-SOLUTIONS; HUMAN ARTICULAR CHONDROCYTES; POLY(ETHYLENE
   GLYCOL); TRIBLOCK COPOLYMERS; POLY(1,3-TRIMETHYLENE CARBONATE);
   MULTIBLOCK COPOLYMERS; GELATION; DEGRADATION; OXIDE); ARCHITECTURE
AB We are reporting a new thermogelling poly(caprolactone-co-trimethylene carbonate)-poly(ethylene glycol) -poly(caprolactone-co-trimethylene carbonate) (PCTC-PEG-PCTC) triblock copolymer. By incorporating the comonomer (trimethylene carbonate) up to 25-40 wt % in the polycaprolactone block, the resulting PCTC-PEG-PCTC triblock copolymer achieved so] stability while keeping the thermogelling property in a physiologically important temperature range of 10-50 degrees C. The precipitation of the polymer in water at 20 degrees C was a concern for a poly(caprolactone)-poly(ethylene glycol) -poly(caprolactone) (PCL-PEG-PCL) system for practical applications (Macromolecules 2006, 39, 4873). The PCTC-PEG-PCTC triblock copolymer thermogel did not show the characteristic peaks of the polycaprolactone crystalline domain at 2 theta = 21.5 degrees and 23.5 degrees in the X-ray diffraction spectra. The sol-to-gel transition temperature of PCTC-PEG-PCTC aqueous solution could be controlled in a range of 15-30 degrees C by varying the composition and molecular weight of PCTC. The PCTC-PEG-PCTC was not degraded in a phosphate buffer saline for 50 days, whereas significant changes in molecular weight and composition of the polymer were observed for the polymer implanted in the subcutaneous layer of rats over the same period of time. The in situ formed hydrogel of PCTC-PEG-PCTC was investigated as a three-dimensional cell culture medium. Compared with the traditional culture on a plate (two-dimensional culture), the chondrocytes cultured in the in situ formed PCTC-PEG-PCTC hydrogel (three-dimensional culture) showed a higher expression of collagen type 11 and aggrecan and suppression of collagen type I (fibroblastic gene), suggesting the excellent differentiation of the cell in the PCTC-PEG-PCTC hydrogel.
C1 [Park, So Hyun; Choi, Bo Gyu; Joo, Min Kyung; Sohn, Youn Soo; Jeong, Byeongmoon] Ewha Womans Univ, Dept Chem, Div Nano Sci, Seoul 120750, South Korea.
   [Han, Dong Kenn] Korea Adv Inst Sci & Technol, Biomat Res Ctr, Seoul 130650, South Korea.
RP Jeong, B (reprint author), Ewha Womans Univ, Dept Chem, Div Nano Sci, Seoul 120750, South Korea.
EM bjeong@ewha.ac.kr
OI Han, Dong Keun/0000-0003-4641-7883
CR ALEXANDRIDIS P, 1994, MACROMOLECULES, V27, P2414, DOI 10.1021/ma00087a009
   ALI SAM, 1993, BIOMATERIALS, V14, P648, DOI 10.1016/0142-9612(93)90063-8
   ASHWELL MS, 2008, OSTEOARTHRITIS CARTI
   Bae SJ, 2005, MACROMOLECULES, V38, P5260, DOI 10.1021/ma050489m
   Bae SJ, 2006, MACROMOLECULES, V39, P4873, DOI 10.1021/ma060153s
   Behravesh E, 2002, BIOMACROMOLECULES, V3, P153, DOI 10.1021/bm010137x
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   Booth C, 2000, MACROMOL RAPID COMM, V21, P501, DOI 10.1002/1521-3927(20000601)21:9<501::AID-MARC501>3.0.CO;2-R
   CHASIN M, 1990, BIODEGRADABLE POLYM, P3
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   CHUNG YM, 2002, BIOMACROMOLECULES, V3, P512
   Huang K, 2002, BIOMACROMOLECULES, V3, P397, DOI 10.1021/bm015650p
   Jeong B, 2003, J PHYS CHEM B, V107, P10032, DOI 10.1021/jp027339n
   Jeong B, 2002, ADV DRUG DELIVER REV, V54, P37, DOI 10.1016/S0169-409X(01)00242-3
   Jeong B, 2002, TRENDS BIOTECHNOL, V20, P305, DOI 10.1016/S0167-7799(02)01962-5
   Kim SY, 2007, MACROMOLECULES, V40, P5519, DOI 10.1021/ma070190z
   Kulkarni A, 2007, LANGMUIR, V23, P12202, DOI 10.1021/la701523e
   Lee BH, 2002, MACROMOLECULES, V35, P3876, DOI 10.1021/ma012093q
   Lee J, 2006, POLYMER, V47, P3760, DOI 10.1016/j.polymer.2006.03.109
   Lee J, 2006, BIOMACROMOLECULES, V7, P1729, DOI 10.1021/bm0600062
   Loh XJ, 2007, BIOMACROMOLECULES, V8, P585, DOI 10.1021/bm0607933
   Martin I, 1999, EXP CELL RES, V253, P681, DOI 10.1006/excr.1999.4708
   Odian G., 2004, PRINCIPLES POLYM, P40
   OHKURA M, 1992, POLYMER, V33, P5044, DOI 10.1016/0032-3861(92)90056-3
   Packhaeuser CB, 2004, EUR J PHARM BIOPHARM, V58, P445, DOI 10.1016/uj.ejpb.2004.03.003
   Park JS, 2007, J CONTROL RELEASE, V124, P51, DOI 10.1016/j.jconrel.2007,08.030
   Pego AP, 2003, J BIOMED MATER RES A, V67A, P1044, DOI 10.1002/jbm.a.10121
   Pego AP, 2002, MACROMOL BIOSCI, V2, P411, DOI 10.1002/mabi.200290000
   Sosnik A, 2005, BIOMATERIALS, V26, P349, DOI 10.1016/j.biomaterials.2004.02.041
   Sun KH, 2006, BIOMACROMOLECULES, V7, P2871, DOI 10.1021/bm060512r
   SYFTESTAD GT, 1985, DEV BIOL, V110, P275, DOI 10.1016/0012-1606(85)90087-9
   Yu L, 2006, ANGEW CHEM INT EDIT, V45, P2232, DOI 10.1002/anie.200503575
   Yu L, 2007, J POLYM SCI POL CHEM, V45, P1122, DOI 10.1002/pola.21876
   Zhang Z, 2005, BIOMACROMOLECULES, V6, P3404, DOI 10.1021/bm050460q
   ZHU KJ, 1991, MACROMOLECULES, V24, P1736, DOI 10.1021/ma00008a008
   Zwicky R, 2000, HISTOCHEM CELL BIOL, V114, P363
   Zwingmann J, 2007, TISSUE ENG, V13, P2335, DOI 10.1089/ten.2006.0393
NR 37
TC 51
Z9 51
U1 3
U2 58
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD SEP 9
PY 2008
VL 41
IS 17
BP 6486
EP 6492
DI 10.1021/ma800562s
PG 7
WC Polymer Science
SC Polymer Science
GA 344EL
UT WOS:000258909000032
DA 2018-10-19
ER

PT J
AU Zhang, H
   Yu, L
   Ding, JD
AF Zhang, Huan
   Yu, Lin
   Ding, Jiandong
TI Roles of hydrophilic homopolymers on the hydrophobic-association-induced
   physical gelling of amphiphilic block copolymers in water
SO MACROMOLECULES
LA English
DT Article
ID PEO TRIBLOCK COPOLYMERS; DRUG-DELIVERY SYSTEMS; AQUEOUS-SOLUTIONS;
   POLY(ETHYLENE GLYCOL); PHASE-BEHAVIOR; PLA HYDROGELS; GELATION; GEL;
   PLGA; RELEASE
AB Recently, the addition of poly(ethylene glycol) (PEG) homopolymers was found to significantly lower the sol-gel transition temperature T-gel of the aqueous system of a block copolymer composed of poly(lactic acid-co-glycolic acid) (PLGA) and PEG, different from the "normal" phenomenon of a T-gel increase for Pluronic hydrogels of block copolymers of PEG and poly(propylene glycol) (PPG). While such an effect is useful for applications of PLGA-PEG-PLGA physical hydrogels as an injectable biomaterial, it is puzzling why the addition of a hydrophilic homopolymer probably enhances the hydrophobic-association-induced physical gelation of ail amphiphilic block copolymer. A series of PEG homopolymers with different molecular weights and concentrations were examined in the aqueous systems of PEG/PLGA block copolymers with three compositions in the present paper. An immiscibility mechanism was put forward by us to account for the earlier spontaneous thermogelling under the assumption of the structure of a randomly percolated micelle network. Meanwhile, the late physical gelling of Pluronics in the presence of PEG homopolymers was interpreted by an order-interfering mechanism. We further found that the immiscibility mechanism might also work for Pluronics upon addition of ethylene glycol and oligo(ethylene glycol).
C1 [Zhang, Huan; Yu, Lin; Ding, Jiandong] Fudan Univ, Minist Educ, Dept Macromol Sci, Adv Mat Lab,Key Lab Mol Engn Polymers, Shanghai 200433, Peoples R China.
RP Ding, JD (reprint author), Fudan Univ, Minist Educ, Dept Macromol Sci, Adv Mat Lab,Key Lab Mol Engn Polymers, Shanghai 200433, Peoples R China.
EM jdding1@fudan.edu.cn
RI Zhang, Huan/O-7352-2014
OI Zhang, Huan/0000-0001-8625-8050
FU NSF of China [50533010, 20574013, 20774020]; Chinese Ministry of Science
   and Technology [973 Project 2005CB522700]; Chinese Ministry of Education
   [305004]; Science and Technology Developing Foundation of Shanghai
   [07JC14005, 074319117]; Shanghai Education Committee [Project B 112]
FX This work was supported by NSF of China (Grants 50533010, 20574013, and
   20774020), Chinese Ministry of Science and Technology (973 Project
   2005CB522700), Chinese Ministry of Education (Key Grant 305004), Science
   and Technology Developing Foundation of Shanghai (Grants 07JC14005 and
   074319117), and Shanghai Education Committee (Project B 112).
CR Agrawal SK, 2007, LANGMUIR, V23, P5039, DOI 10.1021/la063390x
   ALEXANDRIDIS P, 1995, COLLOID SURFACE A, V96, P1, DOI 10.1016/0927-7757(94)03028-X
   Bae SJ, 2005, MACROMOLECULES, V38, P5260, DOI 10.1021/ma050489m
   Cao YL, 1998, J BIOMAT SCI-POLYM E, V9, P475
   He YY, 2007, CHEM COMMUN, P2732, DOI 10.1039/b704490a
   Hwang MJ, 2005, BIOMACROMOLECULES, V6, P885, DOI 10.1021/bm049347a
   Hyun H, 2007, BIOMACROMOLECULES, V8, P1093, DOI 10.1021/bm060771u
   Jeong B, 1999, MACROMOLECULES, V32, P7064, DOI 10.1021/ma9908999
   Jeong B, 2002, ADV DRUG DELIVER REV, V54, P37, DOI 10.1016/S0169-409X(01)00242-3
   Jeong B, 2002, BIOMACROMOLECULES, V3, P865, DOI 10.1021/bm025536m
   Jeong B, 2000, J CONTROL RELEASE, V63, P155, DOI 10.1016/S0168-3659(99)00194-7
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   Jeong B, 2000, MACROMOLECULES, V33, P8317, DOI 10.1021/ma000638v
   Kwon KW, 2002, POLYMER, V43, P3353, DOI 10.1016/S0032-3861(02)00155-6
   Li F, 2005, MACROMOL BIOSCI, V5, P1125, DOI 10.1002/mabi.200500143
   Li SM, 2003, MACROMOLECULES, V36, P8008, DOI 10.1021/ma034734i
   LI YQ, 2005, J CHEM PHYS, V122
   MALMSTEN M, 1993, MACROMOLECULES, V26, P2905, DOI 10.1021/ma00063a040
   MALMSTEN M, 1993, MACROMOLECULES, V26, P1282, DOI 10.1021/ma00058a014
   Malmsten M, 2006, SOFT MATTER, V2, P760, DOI 10.1039/b608348j
   Mortensen K, 1995, MACROMOLECULES, V28, P8829, DOI 10.1021/ma00130a016
   Nie T, 2003, MACROMOLECULES, V36, P8825, DOI 10.1021/ma035131+
   Pandit N, 2000, J COLLOID INTERF SCI, V222, P213, DOI 10.1006/jcis.1999.6628
   Pandit N K, 1997, Pharm Dev Technol, V2, P181, DOI 10.3109/10837459709022623
   Park MJ, 2004, LANGMUIR, V20, P2456, DOI 10.1021/la035573e
   Prudhomme RK, 1996, LANGMUIR, V12, P4651, DOI 10.1021/la951506b
   Ruel-Gariepy E, 2004, EUR J PHARM BIOPHARM, V58, P409, DOI 10.1016/j.ejpb.2004.03.019
   Shim WS, 2005, BIOMACROMOLECULES, V6, P2930, DOI 10.1021/bm050521k
   Singh P, 2007, GREEN CHEM, V9, P254, DOI 10.1039/b603210a
   Tew GN, 2005, SOFT MATTER, V1, P253, DOI 10.1039/b509800a
   TUNG CYM, 1982, J APPL POLYM SCI, V27, P569, DOI 10.1002/app.1982.070270220
   WANKA G, 1994, MACROMOLECULES, V27, P4145, DOI 10.1021/ma00093a016
   YANG Z, 2008, MACROMOL RAPID COMM, V66, P509
   Yu L, 2006, ANGEW CHEM INT EDIT, V45, P2232, DOI 10.1002/anie.200503575
   Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k
   Yu L, 2008, INT J PHARM, V348, P95, DOI 10.1016/j.ijpharm.2007.07.026
   Yu L, 2007, J POLYM SCI POL CHEM, V45, P1122, DOI 10.1002/pola.21876
   Zhang J, 2007, MACROMOLECULES, V40, P5537, DOI 10.1021/ma070554n
   ZHOU Z, 1994, MACROMOLECULES, V27, P2025, DOI 10.1021/ma00086a008
NR 39
TC 84
Z9 86
U1 3
U2 100
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD SEP 9
PY 2008
VL 41
IS 17
BP 6493
EP 6499
DI 10.1021/ma7026484
PG 7
WC Polymer Science
SC Polymer Science
GA 344EL
UT WOS:000258909000033
DA 2018-10-19
ER

PT J
AU Jian, PCJ
   Liu, TF
   Tsai, CM
   Tsai, MS
   Chang, CC
AF Jian, Peng-Chung Jang
   Liu, Tzeng-Feng
   Tsai, Chuan-Mei
   Tsai, Ming-Shih
   Chang, Chia-Ching
TI Ni2+ doping DNA: a semiconducting biopolymer
SO NANOTECHNOLOGY
LA English
DT Article
ID AC-IMPEDANCE SPECTROSCOPY; SELF-ASSEMBLED MONOLAYERS; SINGLE-BASE
   MISMATCH; DIVALENT METAL-IONS; GOLD ELECTRODES; MOLECULAR WIRE;
   HYBRIDIZATION; DUPLEX
AB DNA is a one-dimensional nanowire in nature, and it may not be used in nanodevices due to its low conductivity. In order to improve the conducting property of DNA, divalent Ni2+ are incorporated into the base pairs of DNA at pH >= 8.5 and nickel DNA (Ni-DNA) is formed. Conducting scanning probe microscopy (SPM) analysis reveals that the Ni-DNA is a semiconducting biopolymer and the Schottky barrier of Ni-DNA reduces to 2 eV. Meanwhile, electrochemical analysis by cyclic voltammetry and AC impedance shows that the conductance of Ni-DNA is better than that of native DNA by a factor of approximately 20-fold. UV spectroscopy and DNA base pair mismatch analyses show that the conducting mechanism of Ni-DNA is due to electrons hopping through the pi-pi stacking of DNA base pairs. This biomaterial is a designable one-dimensional semiconducting polymer for usage in nanodevices.
C1 [Jian, Peng-Chung Jang; Liu, Tzeng-Feng] Natl Chiao Tung Univ, Dept Mat Sci & Engn, Hsinchu 30050, Taiwan.
   [Tsai, Chuan-Mei] Natl Nano Device Labs, Hsinchu 30071, Taiwan.
   [Tsai, Ming-Shih] Chupei, Cabot Microelect, Hsinchu Hsien 302, Taiwan.
   [Chang, Chia-Ching] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu 30050, Taiwan.
   [Chang, Chia-Ching] Acad Sinica, Inst Phys, Taipei 11529, Taiwan.
RP Chang, CC (reprint author), Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu 30050, Taiwan.
EM ccchang01@faculty.nctu.edu.tw
OI Chang, Chia-Ching/0000-0002-3444-0894
CR Aich P, 1999, J MOL BIOL, V294, P477, DOI 10.1006/jmbi.1999.3234
   Chi QJ, 2006, J PHYS CHEM B, V110, P1102, DOI 10.1021/jp056356k
   CHIDSEY CED, 1991, SCIENCE, V251, P919, DOI 10.1126/science.251.4996.919
   de Pablo PJ, 2000, PHYS REV LETT, V85, P4992, DOI 10.1103/PhysRevLett.85.4992
   Drummond TG, 2003, NAT BIOTECHNOL, V21, P1192, DOI 10.1038/nbt873
   ELEY DD, 1962, T FARADAY SOC, V58, P411, DOI 10.1039/tf9625800411
   FINKLEA HO, 1993, LANGMUIR, V9, P3660, DOI 10.1021/la00036a050
   Hall DB, 1996, NATURE, V382, P731, DOI 10.1038/382731a0
   Ito T, 2007, BIOSENS BIOELECTRON, V22, P1816, DOI 10.1016/j.bios.2006.08.008
   Janek RP, 1998, LANGMUIR, V14, P3011, DOI 10.1021/la970980+
   Kelley SO, 1999, NUCLEIC ACIDS RES, V27, P4830, DOI 10.1093/nar/27.24.4830
   LEE JS, 1993, BIOCHEM CELL BIOL, V71, P162, DOI 10.1139/o93-026
   Lee TY, 2001, ANAL CHEM, V73, P5629, DOI 10.1021/ac015572w
   Li CZ, 2003, J PHYS CHEM B, V107, P2291, DOI 10.1021/jp026792w
   Long YT, 2003, BIOPHYS J, V84, P3218, DOI 10.1016/S0006-3495(03)70046-0
   MILLER C, 1991, J PHYS CHEM-US, V95, P877, DOI 10.1021/j100155a072
   Moreno-Herrero F, 2003, NANOTECHNOLOGY, V14, P128, DOI 10.1088/0957-4484/14/2/305
   Peterson AW, 2001, NUCLEIC ACIDS RES, V29, P5163, DOI 10.1093/nar/29.24.5163
   Porath D, 2000, NATURE, V403, P635, DOI 10.1038/35001029
   RANDLES JEB, 1947, DISCUSS FARADAY SOC, V1, P11, DOI 10.1039/df9470100011
   Irit N, 2007, J AM CHEM SOC, V129, P84, DOI 10.1021/ja064919f
   SIMONE SA, 2006, PHYS REV B, V73
   Steichen M, 2007, BIOSENS BIOELECTRON, V22, P2237, DOI 10.1016/j.bios.2006.10.041
   WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0
   Wettig SD, 2003, ANAL SCI, V19, P23, DOI 10.2116/analsci.19.23
   Wilson E.K., 1997, CHEM ENG NEWS, V24, P33
   Wood DO, 2002, NUCLEIC ACIDS RES, V30, P2244, DOI 10.1093/nar/30.10.2244
NR 27
TC 8
Z9 8
U1 2
U2 9
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0957-4484
J9 NANOTECHNOLOGY
JI Nanotechnology
PD SEP 3
PY 2008
VL 19
IS 35
AR 355703
DI 10.1088/0957-4484/19/35/355703
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA 329CG
UT WOS:000257843900024
PM 21828857
DA 2018-10-19
ER

PT J
AU Waldeck, H
   Kao, WJ
AF Waldeck, Heather
   Kao, Weiyuan John
TI Extended interaction of beta 1 integrin subunit-deficient cells (GD25)
   with surfaces modified with fibronectin-derived peptides: Culture
   optimization, adhesion and cytokine panel studies
SO ACTA BIOMATERIALIA
LA English
DT Article
DE biological response; polymeric biomaterial; tissue engineering; cellular
   growth; surface structure
ID POLY(ETHYLENE GLYCOL) DIACRYLATE; GELATIN-BASED HYDROGELS;
   INTERPENETRATING NETWORKS; PHYSICOCHEMICAL ANALYSIS; INTEGRIN
   ACTIVATION; PEGYLATED RGD; CROSS-LINKING; GROWTH-FACTOR; BETA-1;
   EXPRESSION
AB The modification of biomaterials with extracellular matrix-mimicking factors is a common technique used to influence the cellular response through integrin-mediated signaling. The inherent limitations of antibody-inhibition studies necessitate the use of complementary methods to block integrin function to confirm cell-surface interaction. In this study, we employed a beta 1 integrin-deficient cell line, GD25, to investigate the role of beta 1 subunit in cell adhesion and subsequent cytokine (granulocyte macrophage colony stimulating factor; interleukin (IL)-1 alpha; IL-1 beta; IL-6; monocyte chemoattractant protein-l regulated upon activation, normal T-cell expressed, and secreted; tumor necrosis factor-alpha) release kinetics in the presence of tissue culture polystyrene (TCPS) and semi-interpenetrating polymer networks (sIPN) modified with fibronectin (FN)-mimic peptides (RGD, PHSRN). Culture conditions (i.e. seeding density, medium, serum supplementation) were optimized for long-term observation. Differences in cell adhesion, cell viability and cytokine release behavior were dependent on the presence of the beta 1 integrin subunit, FN, sIPN cast method and peptide identity. By comparing two complementary techniques for assaying integrin function, we observed both similarities (i.e. decreased adhesion to FN-absorbed TCPS and increased IL-1 beta release at 96 h) and differences (i.e. no difference in adhesion or IL-1 beta release in the presence of different sIPN surfaces) when the function of the beta 1 subunit was blocked in cell adhesion and signaling in the presence of biomaterials. (C) 2008 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Kao, Weiyuan John] Univ Wisconsin, Sch Pharm, Madison, WI 53705 USA.
   [Waldeck, Heather; Kao, Weiyuan John] Univ Wisconsin, Coll Engn, Dept Biomed Engn, Madison, WI 53705 USA.
RP Kao, WJ (reprint author), Univ Wisconsin, Sch Pharm, 777 Highland Ave, Madison, WI 53705 USA.
EM wjkao@pharmacy.wisc.edu
FU NIH [HL077825]
FX This work was supported by the NIH grant HL077825. The authors thank the
   laboratories of Dean Mosher, Ph.D. (University of Wisconsin-Madison) and
   Reinhard Fassler, Ph.D. (Max-Planck Institute of Biochemistry) for their
   generous donation of the GD25 and GD25 beta 1A cell lines, Amy Chung,
   Sean Zuckerman, Dave Schmidt and Becky Bader, Ph.D.
CR Alimenti E, 2004, BBA-MOL CELL RES, V1693, P73, DOI 10.1016/j.bbamrc.2004.05.007
   AOTA S, 1994, J BIOL CHEM, V269, P24756
   Armulik A, 2004, MOL BIOL CELL, V15, P2558, DOI 10.1091/mbc.E03-09-0700
   BALZAC F, 1993, J CELL BIOL, V121, P171, DOI 10.1083/jcb.121.1.171
   BALZAC F, 1994, J CELL BIOL, V127, P557, DOI 10.1083/jcb.127.2.557
   Burmania JA, 2003, J BIOMED MATER RES A, V67A, P224, DOI 10.1002/jbm.a.10106
   Burmania JA, 2003, BIOMATERIALS, V24, P3921, DOI 10.1016/S0142-9612(03)00270-9
   Chen YM, 2005, BIOMATERIALS, V26, P4588, DOI [10.1016/j.biomaterials.2004.11.025, 10.1016/j.bomaterials.2004.11.025]
   Chung AS, 2007, J BIOMAT SCI-POLYM E, V18, P713, DOI 10.1163/156856207781034179
   COELHO AL, 2005, CYTOKINE GROWTH F R, V16, P552
   Cordes N, 2006, ONCOGENE, V25, P1378, DOI 10.1038/sj.onc.1209164
   Einerson NJ, 2003, BIOMATERIALS, V24, P509, DOI 10.1016/S0142-9612(02)00369-1
   *EMD BIOSC, 2007, FMOC RES CLEAV DEPR
   FASSLER R, 1995, J CELL BIOL, V128, P979, DOI 10.1083/jcb.128.5.979
   Gattas-Asfura KM, 2005, BIOMACROMOLECULES, V6, P1503, DOI 10.1021/bm049238w
   Grundstrom G, 2003, EXP CELL RES, V291, P463, DOI 10.1016/j.yexcr.2003.07.010
   Hamilton JA, 2002, TRENDS IMMUNOL, V23, P403, DOI 10.1016/S1471-4906(02)02260-3
   Haringman JJ, 2004, ANN RHEUM DIS, V63, P1186, DOI 10.1136/ard.2004.020529
   Huebsch N, 2005, J BIOMED MATER RES B, V74B, P440, DOI 10.1002/jbm.b.30155
   Kikkawa Y, 2004, EXP CELL RES, V300, P94, DOI 10.1016/j.yexcr.2004.06.031
   LANGUINO LR, 1992, J BIOL CHEM, V267, P23439
   Li J, 2003, BIOMACROMOLECULES, V4, P1055, DOI 10.1021/bm034069l
   Lin-Gibson S, 2004, BIOMACROMOLECULES, V5, P1280, DOI 10.1021/bm0498777
   Nilsson S, 2006, EXP CELL RES, V312, P844, DOI 10.1016/j.yexcr.2005.12.001
   Ofner CM, 1996, PHARM RES-DORDR, V13, P1821
   Peng Q, 2005, J IMMUNOL, V174, P2258, DOI 10.4049/jimmunol.174.4.2258
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Phillips JM, 2005, TISSUE ENG, V11, P964, DOI 10.1089/ten.2005.11.964
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Retta SF, 2001, MOL BIOL CELL, V12, P3126, DOI 10.1091/mbc.12.10.3126
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Sakai T, 1999, J BIOL CHEM, V274, P15480, DOI 10.1074/jbc.274.22.15480
   Schneider GB, 2004, BIOMATERIALS, V25, P3023, DOI 10.1016/j.biomaterials.2003.09.084
   Sechler JL, 1997, MOL BIOL CELL, V8, P2563, DOI 10.1091/mbc.8.12.2563
   SIMS JE, 1993, P NATL ACAD SCI USA, V90, P6155, DOI 10.1073/pnas.90.13.6155
   SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0
   Stevens KR, 2002, J BIOMAT SCI-POLYM E, V13, P1353, DOI 10.1163/15685620260449741
   Tessmar JK, 2007, MACROMOL BIOSCI, V7, P23, DOI 10.1002/mabi.200600096
   Tillet E, 2002, J CELL BIOCHEM, V86, P726, DOI 10.1002/jcb.10268
   VANDERFLIER A, 1995, FEBS LETT, V369, P340, DOI 10.1016/0014-5793(95)00814-P
   Waldeck H, 2007, J BIOMED MATER RES A, V82A, P861, DOI 10.1002/jbm.a.31054
   Wennerberg K, 1996, J CELL BIOL, V132, P227, DOI 10.1083/jcb.132.1.227
   Wennerberg K, 2000, MOL CELL BIOL, V20, P5758, DOI 10.1128/MCB.20.15.5758-5765.2000
   Witte RP, 2004, J BIOMED MATER RES A, V71A, P508, DOI 10.1002/jbm.a.30179
   Zhang QH, 1999, J BIOL CHEM, V274, P368, DOI 10.1074/jbc.274.1.368
   ZHIDKOVA NI, 1995, BIOCHEM BIOPH RES CO, V214, P279, DOI 10.1006/bbrc.1995.2285
   Zilinski JL, 2004, J BIOMED MATER RES A, V68A, P392, DOI 10.1002/jbm.a.20079
NR 47
TC 4
Z9 4
U1 1
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD SEP
PY 2008
VL 4
IS 5
BP 1172
EP 1186
DI 10.1016/j.actbio.2008.03.020
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 355WQ
UT WOS:000259740400005
PM 18514047
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Tamimi, F
   Kumarasami, B
   Doillon, C
   Gbureck, U
   Le Nihouannen, D
   Cabarcos, EL
   Barralet, JE
AF Tamimi, Faleh
   Kumarasami, Balamurugan
   Doillon, Charles
   Gbureck, Uwe
   Le Nihouannen, Damien
   Lopez Cabarcos, Enrique
   Barralet, Jake E.
TI Brushite-collagen composites for bone regeneration
SO ACTA BIOMATERIALIA
LA English
DT Article
DE cell adhesion; cohesion; calcium phosphate cement; XRD; brushite
ID BETA-TRICALCIUM PHOSPHATE; I COLLAGEN; CEMENTS; DIFFERENTIATION;
   OSTEOBLASTS; OSTEOCALCIN; FRACTURES; CALLUS; ACID
AB Brushite-based biomaterials are of special interest in bone regeneration due to their biocompatibility and biodegradability oil the other hand, collagen is a well-known osteoconductive biomaterial. In the present Study a new brushite-collagen composite biomaterial is reported. This new biomaterial was prepared by combining citric acid/collagen type I solutions with it brushite cement powder. The obtained biomaterial was a cement paste, with improved handling properties. The effect of collagen oil the setting reaction of brushite cement was studied, and was found to speed up the cement setting reaction. The cement paste set into a hard ceramic material within 18.5 +/- 2.1 min and had compressive strength similar to that of spongeous bone (48.9 +/- 5.9 MPa in dry conditions and 12.7 +/- 1.5 MPa in humid conditions). The combination of collagen with citric acid revealed an interesting synergistic effect oil the compressive strength of the composite material. Moreover, this new biomaterial had excellent cohesion properties (ninefold better than brushite cement), and high cellular adhesion capacity (threefold higher than brushite cement). The composite biomaterial described in this study combines good handling properties. compressive strength, cohesion and cell adhesion capacity, along with the osteoconductive and biodegradable properties inherent in brushite and in collagen-based biomaterials. (C) 2008 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Tamimi, Faleh; Kumarasami, Balamurugan; Le Nihouannen, Damien; Barralet, Jake E.] McGill Univ, Fac Dent, Montreal, PQ, Canada.
   [Doillon, Charles] CHUL Res Ctr CHUQ, Oncol & Mol Endocrinol Res Ctr T2 32, Quebec City, PQ, Canada.
   [Gbureck, Uwe] Univ Wurzburg, Dept Funct Mat Med & Dent, D-97070 Wurzburg, Germany.
   [Lopez Cabarcos, Enrique] Univ Complutense, Fac Pharm, Dept Phys Chem, E-28040 Madrid, Spain.
RP Tamimi, F (reprint author), McGill Univ, Fac Dent, Montreal, PQ, Canada.
EM faleh.taminimarino@mail.mcgill.ca
RI barralet, jake/A-5820-2008; Lopez Cabarcos, Enrique/L-5802-2014;
   Gbureck, Uwe/G-1430-2012
OI barralet, jake/0000-0003-3543-6042; Lopez Cabarcos,
   Enrique/0000-0003-2939-4130; 
FU Ministere du Developpement economique, de l'innovation et de
   l'exportation (MDEIE); Bayerische Staatskanzlei [9.035]; DGI-Spanish
   Science and Education Ministry [MAT2006-13646-C03-01]; Canada Research
   Chair; NSERC; Alfonso Martin Escudero Foundation
FX The authors gratefully acknowledge the financial support of Ministere du
   Developpement economique, de l'innovation et de l'exportation (MDEIE),
   (Bavaria Quebec Exchange), Bayerische Staatskanzlei (Bavaria-Quebec
   project Nr. 9.035 "Knochemimplantate"), DGI-Spanish Science and
   Education Ministry project Nr. MAT2006-13646-C03-01 (F.T.), "Canada
   Research Chair" (J.B.), the NSERC Discovery grant (B.K., F.T.) and the
   "Alfonso Martin Escudero Foundation" (F.T.).
CR ALKHRAISAT MH, 2008, J BIOMED MATER RES A, V85, P710
   Barralet JE, 2004, BIOMATERIALS, V25, P2197, DOI 10.1016/j.biomaterials.2003.09.085
   Bohner M, 2005, BIOMATERIALS, V26, P6423, DOI 10.1016/j.biomaterials.2005.03.049
   Brodie JC, 2005, J BIOMED MATER RES A, V73A, P409, DOI 10.1002/jbm.a.30279
   Brown P.W., 1986, CEMENTS RES PROGR, V99, P352
   Cui FZ, 1996, J STRUCT BIOL, V117, P204, DOI 10.1006/jsbi.1996.0084
   Gbureck U, 2003, BIOMATERIALS, V24, P4123, DOI 10.1016/S0142-9612(03)00283-7
   Geissler U, 2000, J BIOMED MATER RES, V51, P752, DOI 10.1002/1097-4636(20000915)51:4<752::AID-JBM25>3.0.CO;2-7
   HAUSCHKA PV, 1989, PHYSIOL REV, V69, P990
   Hempel U, 2004, J BIOMED MATER RES B, V71B, P130, DOI 10.1002/jbm.b.30082
   Hoang QQ, 2003, NATURE, V425, P977, DOI 10.1038/nature02079
   Jayaraman Mythili, 2002, Med Sci Monit, V8, pBR481
   KUNTZE RA, 1966, NATURE, V211, P406, DOI 10.1038/211406a0
   Kurdy NMG, 1998, J ORTHOP TRAUMA, V12, P122, DOI 10.1097/00005131-199802000-00010
   LENART G, 1972, CLIN ORTHOP RELAT R, P263
   Marino FT, 2007, J BIOMED MATER RES B, V83B, P571, DOI 10.1002/jbm.b.30830
   MAROUF H A, 1990, International Journal of Oral and Maxillofacial Implants, V5, P148
   Mehlisch D R, 1989, Oral Surg Oral Med Oral Pathol, V68, P505, DOI 10.1016/0030-4220(89)90230-2
   MIRTCHI AA, 1989, BIOMATERIALS, V10, P475, DOI 10.1016/0142-9612(89)90089-6
   Ohura K, 1996, J BIOMED MATER RES, V30, P193, DOI 10.1002/(SICI)1097-4636(199602)30:2<193::AID-JBM9>3.0.CO;2-M
   Rajan N, 2006, NAT PROTOC, V1, P2753, DOI 10.1038/nprot.2006.430
   Rodrigues CVM, 2003, BIOMATERIALS, V24, P4987, DOI 10.1016/S0142-9612(03)00410-1
   Schneiders W, 2007, BONE, V40, P1048, DOI 10.1016/j.bone.2006.11.019
   SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191
   Tamimi-Marino F, 2007, J MATER SCI-MATER M, V18, P1195, DOI 10.1007/s10856-007-0139-9
   WEN HB, 1995, J STRUCT BIOL, V114, P115, DOI 10.1006/jsbi.1995.1011
   Zou C, 2005, BIOMATERIALS, V26, P5276, DOI 10.1016/j.biomaterials.2005.01.064
NR 27
TC 50
Z9 53
U1 3
U2 23
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD SEP
PY 2008
VL 4
IS 5
BP 1315
EP 1321
DI 10.1016/j.actbio.2008.04.003
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 355WQ
UT WOS:000259740400019
PM 18486574
DA 2018-10-19
ER

PT J
AU Leonor, IB
   Baran, ET
   Kawashita, M
   Reis, RL
   Kokubo, T
   Nakamura, T
AF Leonor, I. B.
   Baran, E. T.
   Kawashita, M.
   Reis, R. L.
   Kokubo, T.
   Nakamura, T.
TI Growth of a bonelike apatite on chitosan microparticles after a calcium
   silicate treatment
SO ACTA BIOMATERIALIA
LA English
DT Article
DE apatite; biomimetic process; calcium silicate; chitosan; microparticles
ID SIMULATED BODY-FLUID; FIBER MESH SCAFFOLDS; TRANSMISSION
   ELECTRON-MICROSCOPY; TISSUE-ENGINEERING APPLICATIONS; MARROW STROMAL
   CELLS; GEL-PREPARED SILICA; IN-VITRO RELEASE; OF-THE-ART; COMPOSITE
   MICROSPHERES; MECHANICAL-PROPERTIES
AB Bioactive chitosan microparticles can be prepared Successfully by treating them with a calcium silicate solution and then subsequently soaking them in simulated body fluid (SBF). Such a combination enables the development of bioactive microparticles that can be used for several applications in the medical field, including injectable biomaterial systems and tissue engineering carrier systems. Chitosan microparticles. 0.6 mu m in average size, were soaked either for 12 h in fresh calcium silicate solution (condition I) or for 1 h in calcium silicate solution that had been aged for 24 h before use (condition II). Afterwards, they were dried in air at 60 degrees C for 24 h. The samples were then soaked in SBF for 1, 3 and 7 days. After the condition I calcium silicate treatment and the Subsequent soaking in SBF, the microparticles formed a dense apatite layer after only 7 days of immersion, which is believed to be due to the formation of silanol (Si-OH) groups effective for apatite formation. For condition II, the microparticles successfully formed an apatite layer oil their Surfaces in SBF within only 1 day of immersion. (C) 2008 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Leonor, I. B.; Baran, E. T.; Reis, R. L.] Univ Minho, Dept Polymer Engn, Res Grp 3Bs, P-4710057 Braga, Portugal.
   [Leonor, I. B.; Baran, E. T.; Reis, R. L.] IBB, PT Govt Associated Lab, Braga, Portugal.
   [Kawashita, M.] Tohoku Univ, Ctr Res & Strategy Support, Aoba Ku, Sendai, Miyagi 9808579, Japan.
   [Kokubo, T.] Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Aichi 4878501, Japan.
   [Nakamura, T.] Kyoto Univ, Fac Med, Dept Orthopaed Surg, Sakyo Ku, Kyoto 6068506, Japan.
RP Leonor, IB (reprint author), Univ Minho, Dept Polymer Engn, Res Grp 3Bs, Campus Gualtar, P-4710057 Braga, Portugal.
EM belinha@dep.uminho.pt
RI Reis, Rui L./A-8938-2008; Kawashita, Masakazu/E-6632-2016; Group,
   3Bs/E-4374-2012; Baran, Erkan/Q-8482-2017; Baran, Erkan/B-1055-2016;
   Leonor, Isabel/B-5260-2011
OI Reis, Rui L./0000-0002-4295-6129; Kawashita,
   Masakazu/0000-0002-4329-9001; Group, 3Bs/0000-0002-5195-3456; Baran,
   Erkan/0000-0002-0563-6943; Baran, Erkan/0000-0002-0563-6943; Leonor,
   Isabel/0000-0002-4319-4883
FU Portuguese Foundation for Science and Technology (FCT)
   [SFRH/BD/9031/2002]; European Union [NMP3-CT-2003-505758]; European NoE
   EXPERTISSUES [NMP3-CT-2004-500283]
FX I.B.L. thanks the Portuguese Foundation for Science and Technology
   (FCT), for providing her a PhD scholarship (SFRH/BD/9031/2002), the
   European Union funded STREP Project HIPPOCRATES (NMP3-CT-2003-505758)
   and the European NoE EXPERTISSUES (NMP3-CT-2004-500283).
CR AOKI H, 1991, SCI MED APPL HYDROXY
   Berthold A, 1996, J CONTROL RELEASE, V39, P17, DOI 10.1016/0168-3659(95)00129-8
   BERTOLUZZA A, 1982, J NON-CRYST SOLIDS, V48, P117, DOI 10.1016/0022-3093(82)90250-2
   Calvert P, 1996, CHEM MATER, V8, P1715, DOI 10.1021/cm960126o
   Cho SB, 1996, J BIOMED MATER RES, V33, P145, DOI 10.1002/(SICI)1097-4636(199623)33:3<145::AID-JBM4>3.0.CO;2-Q
   CHO SB, 1995, J AM CERAM SOC, V78, P1769, DOI 10.1111/j.1151-2916.1995.tb08887.x
   Daculsi G, 1998, BIOMATERIALS, V19, P1473, DOI 10.1016/S0142-9612(98)00061-1
   Davies JE, 1997, J BIOMED MATER RES, V36, P429, DOI 10.1002/(SICI)1097-4636(19970915)36:4<429::AID-JBM1>3.0.CO;2-G
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Falini G, 2004, TISSUE ENG, V10, P1, DOI 10.1089/107632704322791646
   Gomes Manuela E, 2004, Methods Mol Biol, V238, P65
   Gomes ME, 2006, TISSUE ENG, V12, P801, DOI 10.1089/ten.2006.12.801
   Gomes ME, 2004, MACROMOL BIOSCI, V4, P737, DOI 10.1002/mabi.200400094
   Gomes ME, 2002, MAT SCI ENG C-BIO S, V20, P19, DOI 10.1016/S0928-4931(02)00008-5
   Gross KA, 1998, J BIOMED MATER RES, V39, P580, DOI 10.1002/(SICI)1097-4636(19980315)39:4<580::AID-JBM12>3.3.CO;2-Y
   Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Iooss P, 2001, BIOMATERIALS, V22, P2785, DOI 10.1016/S0142-9612(01)00022-9
   Kim HM, 2003, CURR OPIN SOLID ST M, V7, P289, DOI 10.1016/j.cossms.2003.09.014
   Kim HM, 2001, J CERAM SOC JPN, V109, pS49, DOI 10.2109/jcersj.109.1268_S49
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Koutsopoulos S, 2002, J BIOMED MATER RES, V62, P600, DOI 10.1002/jbm.10280
   Kumar G, 2000, POLYMER, V41, P2157, DOI 10.1016/S0032-3861(99)00360-2
   Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b
   LI P, 1993, J MATER SCI-MATER M, V4, P127, DOI 10.1007/BF00120381
   LI PJ, 1993, BIOMATERIALS, V14, P963, DOI 10.1016/0142-9612(93)90186-6
   LI PJ, 1995, J BIOMED MATER RES, V29, P325, DOI 10.1002/jbm.820290307
   LI PJ, 1992, J AM CERAM SOC, V75, P2094, DOI 10.1111/j.1151-2916.1992.tb04470.x
   Malafaya PB, 2006, J MATER SCI-MATER M, V17, P371, DOI 10.1007/s10856-006-8240-z
   Mano JF, 2004, COMPOS SCI TECHNOL, V64, P789, DOI 10.1016/j.compscitech.2003.09.001
   Mano JF, 2003, J MATER SCI-MATER M, V14, P127, DOI 10.1023/A:1022015712170
   Morita T, 2001, INT J PHARM, V219, P127, DOI 10.1016/S0378-5173(01)00642-1
   MUZZARELLI R, 1988, BIOMATERIALS, V9, P247, DOI 10.1016/0142-9612(88)90092-0
   NEO M, 1992, J BIOMED MATER RES, V26, P1419, DOI 10.1002/jbm.820261103
   NEO M, 1993, J BIOMED MATER RES, V27, P999, DOI 10.1002/jbm.820270805
   NEO M, 1992, J BIOMED MATER RES, V26, P255, DOI 10.1002/jbm.820260210
   Ohgushi H, 1999, J BIOMED MATER RES, V48, P913, DOI 10.1002/(SICI)1097-4636(1999)48:6<913::AID-JBM22>3.0.CO;2-0
   Oliveira JM, 2006, BIOMATERIALS, V27, P6123, DOI 10.1016/j.biomaterials.2006.07.034
   Pawlak A, 2003, THERMOCHIM ACTA, V396, P153, DOI 10.1016/S0040-6031(02)00523-3
   PERREN SM, 1994, BIODEGRADABLE IMPLAN, P35
   POSNER AS, 1985, CLIN ORTHOP RELAT R, P87
   Ragel CV, 2000, J BIOMED MATER RES, V51, P424, DOI 10.1002/1097-4636(20000905)51:3<424::AID-JBM17>3.0.CO;2-E
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Salgado AJ, 2004, TISSUE ENG, V10, P465, DOI 10.1089/107632704323061825
   Schaffazick SR, 2003, EUR J PHARM BIOPHARM, V56, P501, DOI 10.1016/S0939-6411(03)00139-5
   Silva GA, 2004, ADV EXP MED BIOL, V553, P283
   Silva GA, 2004, J BIOMED MATER RES A, V70A, P442, DOI 10.1002/jbm.a.30099
   Sivakumar M, 2002, CARBOHYD POLYM, V49, P281, DOI 10.1016/S0144-8617(01)00331-9
   Sivakumar M, 2002, BIOMATERIALS, V23, P3175, DOI 10.1016/S0142-9612(02)00066-2
   Suh H, 1998, YONSEI MED J, V39, P87, DOI 10.3349/ymj.1998.39.2.87
   Takadama H, 2002, J AM CERAM SOC, V85, P1933, DOI 10.1111/j.1151-2916.2002.tb00383.x
   Tanahashi M, 1997, J BIOMED MATER RES, V34, P305
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   Tuzlakoglu K, 2005, J MATER SCI-MATER M, V16, P1099, DOI 10.1007/s10856-005-4713-8
   Tuzlakoglu K, 2007, J MATER SCI-MATER M, V18, P1279, DOI 10.1007/s10856-006-0063-4
   Tuzlakoglu K, 2004, MACROMOL BIOSCI, V4, P811, DOI 10.1002/mabi.200300100
   Yamaguchi I, 2001, J BIOMED MATER RES, V55, P20, DOI 10.1002/1097-4636(200104)55:1<20::AID-JBM30>3.3.CO;2-6
   Zhao F, 2006, BIOMATERIALS, V27, P1859, DOI 10.1016/j.biomaterials.2005.09.031
NR 59
TC 44
Z9 49
U1 0
U2 23
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD SEP
PY 2008
VL 4
IS 5
BP 1349
EP 1359
DI 10.1016/j.actbio.2008.03.003
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 355WQ
UT WOS:000259740400023
PM 18400572
DA 2018-10-19
ER

PT J
AU Qu, ZH
   Wang, HJ
   Tang, TT
   Zhang, XL
   Wang, JY
   Dai, KR
AF Qu, Zhi-Hu
   Wang, Hua-Jie
   Tang, Ting-Ting
   Zhang, Xiao-Ling
   Wang, Jin-Ye
   Dai, Ke-Rong
TI Evaluation of the zein/inorganics composite on biocompatibility and
   osteoblastic differentiation
SO ACTA BIOMATERIALIA
LA English
DT Article
DE scaffold; zein; hydroxyapatite; mechanical properties; osteogenic
ID POROUS ZEIN SCAFFOLDS; MARROW STROMAL CELLS; MECHANICAL-PROPERTIES;
   IN-VITRO; OSTEOGENIC DIFFERENTIATION; CORN PROTEIN; BONE; PHOSPHATE;
   ADHESION; BIOMATERIAL
AB We have previously Studied the biocompatibility and mechanical properties of porous zein scaffolds. We based the study oil the concept that composite scaffold materials, especially when combined with inorganic materials, are more Suited to the mechanical and physiological demands of the host tissue than individual scaffold materials. We investigated the effect of zein/inorganic composite on the physical and biological properties of porous zein scaffolds, which were fabricated by salt-leaching. The composite was prepared by immersion in simulated body fluid. The hydroxyapatite (HA)-coated zein scaffold had the same porosity as the zein scaffold (over 75%). Using scanning electron microscopy, it was established that the morphology of pores located on the surface and within the porous scaffolds showed equally good pore interconnectivity with zein. However, the compressive Young's modulus decreased from 240.1 +/- 96.8 to 34.4 +/- 12.6 MPa, and compressive strength decreased from 7.8 +/- 1.2 to 4.2 +/- 0.8 MPa. From the in vitro test with human bone marrow stroma. cells, the osteoblastic differentiation on the surface of the HA-coated zein scaffold was increased. Lis expressed by the alkaline phosphatase activity and reverse trail scription-polymerase chain reaction analysis for marker genes. From both the mechanical and biological evaluations, the HA-coated zein scaffold was found to be the optimal biomaterial for bone tissue engineering. (C) 2008 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Wang, Jin-Ye] Chinese Acad Sci, Shanghai Inst Organ Chem, Shanghai 200032, Peoples R China.
   [Qu, Zhi-Hu; Zhang, Xiao-Ling; Dai, Ke-Rong] Shanghai Jiao Tong Univ, Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci,Sch Med,Orthopaed Cellular & Mol Bi, Shanghai 200025, Peoples R China.
   [Wang, Hua-Jie; Wang, Jin-Ye] Shanghai Jiao Tong Univ, Coll Life Sci & Biotechnol, Shanghai 200030, Peoples R China.
   [Tang, Ting-Ting; Dai, Ke-Rong] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Orthopaed, Shanghai 200011, Peoples R China.
RP Wang, JY (reprint author), Chinese Acad Sci, Shanghai Inst Organ Chem, 354 Fenglin Rd, Shanghai 200032, Peoples R China.
EM jywang@mail.sioc.ac.cn; krdai@sibs.ac.cn
RI Tang, Tingting/B-1361-2013; Wang, Jin-Ye/H-1450-2011
OI Tang, Tingting/0000-0002-1670-7452; yan, wei/0000-0001-5575-7017
FU National Program on Key Basic Research Projects of China [2005CB522700,
   2005CB724306]; National Natural Science Foundation of China [30700402];
   Science and Technology Commission of Shanghai Municipailty [05JC14034,
   07QA14062]
FX The authors gratefully acknowledge the financial support provided by the
   National Program on Key Basic Research Projects of China (973 Program)
   (Grant Nos. 2005CB522700 and 2005CB724306), National Natural Science
   Foundation of China (Grant No. 30700402), and the Science and Technology
   Commission of Shanghai Municipailty (Grant Nos. 05JC14034 and
   07QA14062).
CR Coelho MD, 2005, J BIOMED MATER RES B, V75B, P451, DOI 10.1002/jbm.b.30354
   Dong J, 2004, BIOMATERIALS, V25, P4691, DOI 10.1016/j.biomaterials.2003.10.084
   Elangovan S, 2007, LANGMUIR, V23, P11200, DOI 10.1021/la7013978
   Franceschi RT, 1999, CRIT REV ORAL BIOL M, V10, P40, DOI 10.1177/10454411990100010201
   Frank O, 2002, J CELL BIOCHEM, V85, P737, DOI 10.1002/jcb.10174
   Gong SJ, 2006, BIOMATERIALS, V27, P3793, DOI 10.1016/j.biomaterials.2006.02.019
   HARADA Y, 1989, Shikwa Gakuho, V89, P263
   Hwang DS, 2007, BIOMATERIALS, V28, P4039, DOI 10.1016/j.biomaterials.2007.05.028
   Jiang T, 2006, BIOMATERIALS, V27, P4894, DOI 10.1016/j.biomaterials.2006.05.025
   Kong LJ, 2006, EUR POLYM J, V42, P3171, DOI 10.1016/j.eurpolymj.2006.08.009
   Liu XM, 2005, BIOMATERIALS, V26, P109, DOI 10.1016/j.biomaterials.2004.02.013
   Lucas-Girot A, 2002, BIOMATERIALS, V23, P503, DOI 10.1016/S0142-9612(01)00132-6
   Marom R, 2005, J CELL PHYSIOL, V202, P41, DOI 10.1002/jcp.20109
   Morinobu M, 2003, J BONE MINER RES, V18, P1706, DOI 10.1359/jbmr.2003.18.9.1706
   Qin C, 2004, CRIT REV ORAL BIOL M, V15, P126, DOI 10.1177/154411130401500302
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Shukla R, 2001, IND CROP PROD, V13, P171, DOI 10.1016/S0926-6690(00)00064-9
   Stucki U, 2001, CLIN ORAL IMPLAN RES, V12, P121, DOI 10.1034/j.1600-0501.2001.012002121.x
   Sun HL, 2006, BIOMATERIALS, V27, P5651, DOI 10.1016/j.biomaterials.2006.07.027
   Takahashi Y, 2005, BIOMATERIALS, V26, P3587, DOI 10.1016/j.biomaterials.2004.09.046
   Wang HJ, 2005, J CONTROL RELEASE, V105, P120, DOI 10.1016/j.jconrel.2005.03.014
   Wang HJ, 2007, BIOMATERIALS, V28, P3952, DOI 10.1016/j.biomaterials.2007.05.017
   Webster TJ, 2002, J BIOMED MATER RES, V59, P312, DOI 10.1002/jbm.1247
   Xu HHK, 2005, BIOMATERIALS, V26, P1337, DOI 10.1016/j.biomaterials.2004.04.043
NR 24
TC 36
Z9 39
U1 2
U2 34
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD SEP
PY 2008
VL 4
IS 5
BP 1360
EP 1368
DI 10.1016/j.actbio.2008.03.006
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 355WQ
UT WOS:000259740400024
PM 18439886
DA 2018-10-19
ER

PT J
AU Levine, B
AF Levine, Brett
TI A New Era in Porous Metals: Applications in Orthopaedics
SO ADVANCED ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 5th Biennial International Conference on Porous Metals and Metallic
   Foams
CY SEP, 2007
CL Montreal, CANADA
ID BONE LOSS; TANTALUM IMPLANT; FIXATION; INGROWTH; OSTEONECROSIS;
   ARTHROPLASTY; ATTACHMENT; CONES; HIP
AB The development of porous metals and coatings has revolutionized the field of orthopaedics. However, most implants are fabricated utilizing traditional materials (i.e, sintered beads, fiber metal, plasma spray), which have several inherent limitations. Several new porous metals have been recently introduced to improve upon the biomaterial properties of these traditional metals. Tritanium (Stryker, Mahwah, NJ), Regenerex (Biomet, Warsaw, IN), Stiktite (Smith and Nephew, Memphis, TN), and Trabecular Metal (Zimmer, Warsaw, IN) are currently available for use in orthopaedic surgery, all with a characteristic appearance similar to cancellous bone. The open-cell structure of these materials affords several intriguing properties, including; high volumetric porosity (60-80%), low modulus of elasticity, and high frictional characteristics. The following represents a review of the biomaterial properties and applications in orthopaedic surgery for this new class of highly porous metals.
C1 Midwest Orthopaed Rush, Chicago, IL 60612 USA.
RP Levine, B (reprint author), Midwest Orthopaed Rush, 1725 W Harrison St,Suite 1063, Chicago, IL 60612 USA.
EM brettlevinemd@gmail.com
CR BOBYN JD, 1980, CLIN ORTHOP RELAT R, P263
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   CAMERON HU, 1973, J BIOMED MATER RES, V7, P301, DOI 10.1002/jbm.820070404
   Frenkel SR, 2004, J BIOMED MATER RES B, V71B, P387, DOI 10.1002/jbm.b.30104
   GALANTE J, 1971, J BONE JOINT SURG AM, VA 53, P101, DOI 10.2106/00004623-197153010-00009
   Hacking SA, 2000, J BIOMED MATER RES, V52, P631
   Kienapfel H, 1999, J ARTHROPLASTY, V14, P355, DOI 10.1016/S0883-5403(99)90063-3
   Levine B, 2006, J AM ACAD ORTHOP SUR, V14, P646, DOI 10.5435/00124635-200611000-00008
   Levine BR, 2006, BIOMATERIALS, V27, P4671, DOI 10.1016/j.biomaterials.2006.04.041
   Lombardi AV, 2007, J ARTHROPLASTY, V22, P25, DOI 10.1016/j.arth.2007.02.006
   Meneghini RM, 2008, J BONE JOINT SURG AM, V90A, P78, DOI 10.2106/JBJS.F.01495
   *NC, S03001 NC
   Radnay CS, 2006, CLIN ORTHOP RELAT R, P83, DOI 10.1097/01.blo.0000214437.57151.41
   SCHOETTLE T, 2005, P ANN M CSRS DEC 1 3
   Shuler MS, 2007, J ARTHROPLASTY, V22, P26, DOI 10.1016/j.arth.2006.03.007
   Sporer SM, 2006, J ARTHROPLASTY, V21, P87, DOI 10.1016/j.arth.2006.05.015
   Tsao AK, 2005, J BONE JOINT SURG AM, V87A, P22, DOI 10.2106/JBJS.E.00490
   Weeden SH, 2007, J ARTHROPLASTY, V22, P151, DOI 10.1016/j.arth.2007.04.024
   Wigfield C, 2003, BRIT J NEUROSURG, V17, P418, DOI 10.1080/02688690310001611206
   Zardiackas LD, 2001, J BIOMED MATER RES, V58, P180, DOI 10.1002/1097-4636(2001)58:2<180::AID-JBM1005>3.0.CO;2-5
   Zou XN, 2005, SPINE, V30, pE392, DOI 10.1097/01.brs.0000170588.80377.3f
   Zou Xuenong, 2004, Spine J, V4, P99, DOI 10.1016/S1529-9430(03)00407-8
NR 22
TC 59
Z9 61
U1 1
U2 34
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1438-1656
J9 ADV ENG MATER
JI Adv. Eng. Mater.
PD SEP
PY 2008
VL 10
IS 9
BP 788
EP 792
DI 10.1002/adem.200800215
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA 358RH
UT WOS:000259934700004
DA 2018-10-19
ER

PT J
AU Yavuz, O
   Aldissi, M
AF Yavuz, O.
   Aldissi, M.
TI Biomaterial-based infrared detection
SO BIOINSPIRATION & BIOMIMETICS
LA English
DT Article; Proceedings Paper
CT Conference on Toward Autonomous Robotic Systems 2007
CY SEP, 2007
CL Aberystwyth Univ, Aberystwyth, WALES
HO Aberystwyth Univ
ID LOBSTER SHELL; CRUSTACYANIN; BOLOMETER; ARRAY; ASTAXANTHIN
AB This effort is focused on the use of crustacyanin protein extracted from the lobster shell in IR detection and imaging applications. In addition to the protein's excellent reversible thermo-active response in the IR region of interest, electrical characteristics versus temperature showed that the protein can be used as an electro-optic thermal sensing device as well. The high sensitivity and fast response of the protein layer were further enhanced by the deposition process we used. The thin coatings were prepared by Langmuir -Blodgett and self-assembly techniques. Furthermore, the protein exhibited temperature variation under Ti: sapphire laser excitation at different wavelengths in ambient environment. We have also shown that the protein exhibits fluorescence properties after exposure to IR heat. Stability of the protein, which is important in this type of application, was also demonstrated using the different characterization tech(n)iques after repeated heating/ cooling cycles. We can conclude that this protein represents a formidable candidate for the fabrication of IR sensors and microbolometers for uncooled IR imaging applications.
C1 [Yavuz, O.; Aldissi, M.] Fractal Syst Inc, Safety Harbor, FL 34695 USA.
RP Yavuz, O (reprint author), Fractal Syst Inc, 200 9th Ave N,Suite 100, Safety Harbor, FL 34695 USA.
EM maldissi@fractalsystemsinc.com
CR BERATAN H, 1994, P SOC PHOTO-OPT INS, V2274, P147, DOI 10.1117/12.189240
   BRITTON G, 1982, CAROTENOID CHEM BIOC, P237
   BUCHWALD M, 1968, BIOCHEMISTRY-US, V7, P844, DOI 10.1021/bi00842a043
   BUCHWALD M, 1968, BIOCHEMISTRY-US, V7, P834, DOI 10.1021/bi00842a042
   CHOI IH, 1986, IEEE T ELECTRON DEV, V33, P72
   Cianci M, 2002, P NATL ACAD SCI USA, V99, P9795, DOI 10.1073/pnas.152088999
   Durbeej B, 2003, CHEM PHYS LETT, V375, P30, DOI 10.1016/S0009-2614(03)00800-5
   LIDDIARD KC, 1986, INFRARED PHYS, V26, P43, DOI 10.1016/0020-0891(86)90046-1
   Oliver AD, 1999, SENSOR ACTUAT A-PHYS, V73, P222, DOI 10.1016/S0924-4247(98)00276-3
   QUARMBY R, 1977, COMP BIOCHEM PHYS B, V56, P55, DOI 10.1016/0305-0491(77)90222-X
   Tanaka A, 1997, P SOC PHOTO-OPT INS, V3061, P198, DOI 10.1117/12.280339
   Tanaka A, 1996, IEEE T ELECTRON DEV, V43, P1844, DOI 10.1109/16.543017
   WALD G, 1948, BIOL BULL, V95, P249
   Weesie RJ, 1999, BIOSPECTROSCOPY, V5, P19, DOI 10.1002/(SICI)1520-6343(1999)5:1<19::AID-BSPY4>3.0.CO;2-E
   ZAGALSKY PF, 1976, PURE APPL CHEM, V47, P103, DOI 10.1351/pac197647020103
   ZAGALSKY PF, 1990, COMP BIOCHEM PHYS B, V97, P1, DOI 10.1016/0305-0491(90)90171-O
   Zagalsky PF, 1995, CAROTENOIDS, V1A, P287
NR 17
TC 2
Z9 2
U1 0
U2 8
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-3182
J9 BIOINSPIR BIOMIM
JI Bioinspir. Biomim.
PD SEP
PY 2008
VL 3
IS 3
AR 035007
DI 10.1088/1748-3182/3/3/035007
PG 10
WC Engineering, Multidisciplinary; Materials Science, Biomaterials;
   Robotics
SC Engineering; Materials Science; Robotics
GA 344HM
UT WOS:000258917500012
PM 18667761
DA 2018-10-19
ER

PT J
AU Jing, P
   Rudra, JS
   Herr, AB
   Collier, JH
AF Jing, Peng
   Rudra, Jai S.
   Herr, Andrew B.
   Collier, Joel H.
TI Self-assembling peptide-polymer hydrogels designed from the coiled coil
   region of fibrin
SO BIOMACROMOLECULES
LA English
DT Article
ID ARTIFICIAL PROTEIN HYDROGELS; BURIED POLAR INTERACTION; HYBRID
   BLOCK-COPOLYMERS; GCN4 LEUCINE-ZIPPER; MECHANICAL-PROPERTIES; FIBROUS
   BIOMATERIALS; POLYETHYLENE GLYCOLS; GRAFT-COPOLYMERS; DRUG-DELIVERY;
   TISSUE-REPAIR
AB Biomaterials constructed front self-assembling peptides, peptide derivatives, and peptide-polymer conjugates are receiving increasing attention as defined matrices for tissue engineering, controlled therapeutic release, and in vitro cell expansion, but many are constructed from peptide structures not typically found in the human extracellular matrix. Here we report a self-assembling biomaterial constructed from a designed peptide inspired by the coiled coil domain of human fibrin. the major protein constituent of blood clots and the provisional scaffold of wound healing. Targeted substitutions were made in the residues forming the interface between coiled coil strands for a 37-amino acid peptide front human fibrinogen to stabilize the coiled coil peptide bundle. while the solvent-exposed residues were left unchanged to provide a surface similar to that of the native protein. This peptide, which self-assembled into coiled coil dimers and tetramers, was then used to produce triblock peptide-PEG-peptide bioconjugates that self-assembled into viscoelastic hydrogel biomaterials.
C1 [Rudra, Jai S.; Collier, Joel H.] Univ Chicago, Dept Surg, Chicago, IL 60637 USA.
   [Collier, Joel H.] Univ Chicago, Comm Mol Med, Chicago, IL 60637 USA.
   [Herr, Andrew B.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA.
   [Jing, Peng] Univ Cincinnati, Dept Biomed Engn, Cincinnati, OH 45221 USA.
RP Collier, JH (reprint author), Univ Chicago, Dept Surg, Chicago, IL 60637 USA.
EM collier@uchicago.edu
RI Jing, Peng/A-8054-2011
OI Herr, Andrew/0000-0002-3598-3399
FU National Institute of Dental and Craniofacial Research [R21DE017703]
FX The authors thank Dale Schaeffer for access to the rheometer, Deb
   Conrady for help with analytical ultracentrifugation, Stephen Macha for
   assistance with mass spectrometry, and Paul Rosevear and Jack Howarth
   for access to the circular dichroism instrument. The project described
   was supported by Grant Number R21DE017703 from the National Institute of
   Dental and Craniofacial Research. The content is solely the
   responsibility of the authors and does not necessarily represent the
   official views of the National Institute of Dental and Craniofacial
   Research or the National Institutes of Health.
CR Alexandridis P, 1997, CURR OPIN COLLOID IN, V2, P478, DOI 10.1016/S1359-0294(97)80095-7
   BACHMANN MF, 1993, SCIENCE, V262, P1448, DOI 10.1126/science.8248784
   Beniash E, 2005, ACTA BIOMATER, V1, P387, DOI 10.1016/j.actbio.2005.04.002
   Benkherourou M, 2000, IEEE T BIO-MED ENG, V47, P1465, DOI 10.1109/10.880098
   Boato F, 2007, ANGEW CHEM INT EDIT, V46, P9015, DOI 10.1002/anie.200702805
   Channon K, 2008, SOFT MATTER, V4, P647, DOI 10.1039/b713013a
   Collier JH, 2003, BIOCONJUGATE CHEM, V14, P748, DOI 10.1021/bc034017t
   Collier JH, 2001, J AM CHEM SOC, V123, P9463, DOI 10.1021/ja011535a
   Dankers PYW, 2007, B CHEM SOC JPN, V80, P2047, DOI 10.1246/bcsj.80.2047
   Doolittle RF, 2003, J THROMB HAEMOST, V1, P1559, DOI 10.1046/j.1538-7836.2003.00278.x
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fehr T, 1997, J EXP MED, V185, P1785, DOI 10.1084/jem.185.10.1785
   Gelain F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000119
   Genove E, 2005, BIOMATERIALS, V26, P3341, DOI 10.1016/j.biomaterials.2004.08.012
   Gonzalez L, 1996, NAT STRUCT BIOL, V3, P1011, DOI 10.1038/nsb1296-1011
   GRADDIS TJ, 1993, BIOCHEMISTRY-US, V32, P12664, DOI 10.1021/bi00210a015
   Guler MO, 2006, BIOMACROMOLECULES, V7, P1855, DOI 10.1021/bm060161g
   Haines-Butterick L, 2007, P NATL ACAD SCI USA, V104, P7791, DOI 10.1073/pnas.0701980104
   HARBURY PB, 1994, NATURE, V371, P80, DOI 10.1038/371080a0
   HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779
   Herr AB, 2003, J MOL BIOL, V327, P645, DOI 10.1016/S0022-2836(03)00149-9
   Herr AB, 1997, J BIOL CHEM, V272, P16382, DOI 10.1074/jbc.272.26.16382
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Jung JP, 2008, BIOMATERIALS, V29, P2143, DOI 10.1016/j.biomaterials.2008.01.008
   Kennedy SB, 2005, MACROMOLECULES, V38, P7470, DOI 10.1021/ma0507261
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   Kretsinger JK, 2005, BIOMATERIALS, V26, P5177, DOI 10.1016/j.biomaterials.2005.01.029
   Law B, 2006, BIOMACROMOLECULES, V7, P1261, DOI 10.1021/bm050920f
   Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j
   Lim YB, 2008, J MATER CHEM, V18, P723, DOI 10.1039/b711188f
   LUMB KJ, 1995, BIOCHEMISTRY-US, V34, P8642, DOI 10.1021/bi00027a013
   Maas C, 2007, J BIOL CHEM, V282, P2229, DOI 10.1074/jbc.M605984200
   MacPhee CE, 2004, CURR OPIN SOLID ST M, V8, P141, DOI 10.1016/j.cossms.2004.01.010
   Mart RJ, 2006, SOFT MATTER, V2, P822, DOI 10.1039/b607706d
   Mi LX, 2006, BIOMACROMOLECULES, V7, P38, DOI 10.1021/bm050157p
   Mortensen K, 1998, CURR OPIN COLLOID IN, V3, P12, DOI 10.1016/S1359-0294(98)80036-8
   Mortensen K, 1997, MACROMOLECULES, V30, P503, DOI 10.1021/ma960457m
   NAUTIYAL S, 1995, BIOCHEMISTRY-US, V34, P11645, DOI 10.1021/bi00037a001
   Oakley MG, 1998, BIOCHEMISTRY-US, V37, P12603, DOI 10.1021/bi981269m
   Papapostolou D, 2007, P NATL ACAD SCI USA, V104, P10853, DOI 10.1073/pnas.0700801104
   Pechar M, 2002, MACROMOL BIOSCI, V2, P199, DOI 10.1002/1616-5195(200206)2:5<199::AID-MABI199>3.0.CO;2-2
   Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389
   Rajagopal K, 2004, CURR OPIN STRUC BIOL, V14, P480, DOI 10.1016/j.sbi.2004.06.006
   Ramachandran S, 2006, BIODRUGS, V20, P263, DOI 10.2165/00063030-200620050-00001
   Rosenberg AS, 2006, AAPS J, V8, pE501
   Ryadnov MG, 2003, NAT MATER, V2, P329, DOI 10.1038/nmat885
   Ryadnov MG, 2004, J AM CHEM SOC, V126, P7454, DOI 10.1021/ja048144r
   Schneider JP, 2002, J AM CHEM SOC, V124, P15030, DOI 10.1021/ja027993g
   Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0
   Shen W, 2006, NAT MATER, V5, P153, DOI 10.1038/nmat1573
   Shen W, 2005, MACROMOLECULES, V38, P3909, DOI 10.1021/ma048348s
   Shen W, 2007, SOFT MATTER, V3, P99, DOI 10.1039/b610986a
   Shen W, 2007, MACROMOLECULES, V40, P689, DOI 10.1021/ma0615194
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Smith AM, 2006, ADV FUNCT MATER, V16, P1022, DOI 10.1002/adfm.200500568
   SU JY, 1994, BIOCHEMISTRY-US, V33, P15501, DOI 10.1021/bi00255a032
   Vandermeulen GWM, 2005, MACROMOLECULES, V38, P761, DOI 10.1021/ma0485538
   Vandermeulen GWM, 2003, MACROMOLECULES, V36, P4107, DOI 10.1021/ma034124i
   Wang C, 1999, NATURE, V397, P417, DOI 10.1038/17092
   Wang C, 2001, BIOMACROMOLECULES, V2, P912, DOI 10.1021/bm0155322
   Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606
   Woolfson DN, 2006, CURR OPIN CHEM BIOL, V10, P559, DOI 10.1016/j.cbpa.2006.09.019
   Xu B, 1997, LANGMUIR, V13, P2447, DOI 10.1021/la960799l
   Yang J, 2008, BIOMACROMOLECULES, V9, P510, DOI 10.1021/brn701001f
   Yang JY, 2006, BIOMACROMOLECULES, V7, P1187, DOI 10.1021/bm051002k
   Yang JY, 2006, MACROMOL BIOSCI, V6, P201, DOI 10.1002/mabi.200500208
   Zimmerman SB, 1996, ANAL BIOCHEM, V234, P190, DOI 10.1006/abio.1996.0071
NR 67
TC 63
Z9 64
U1 1
U2 50
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD SEP
PY 2008
VL 9
IS 9
BP 2438
EP 2446
DI 10.1021/bm800459v
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 345YH
UT WOS:000259033700021
PM 18712921
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Rojo, L
   Barcenilla, JM
   Vazquez, B
   Gonzalez, R
   Roman, JS
AF Rojo, Luis
   Barcenilla, Jose. M.
   Vazquez, Blanca
   Gonzalez, Ramon
   Roman, Julio San
TI Intrinsically antibacterial materials based on polymeric derivatives of
   eugenol for biomedical applications
SO BIOMACROMOLECULES
LA English
DT Article
ID ANTIMICROBIAL ACTIVITY; IN-VITRO; CELL-ADHESION; HYDROPHOBICITY;
   METHACRYLATE; COMPOSITES; MECHANISMS; COPOLYMERS; CARVACROL; SYSTEMS
AB Infections are the most common cause of biomaterial implant failure representing a constant challenge to the more widespread application of medical implants. This study reports on the preparation and characterization of novel hydrophilic copolymeric systems provided with antibacterial properties coming from eugenol residues anchored to the macromolecular chains. Thus, high conversion copolymers were prepared from the hydrophilic monomer 2-hydroxyethyl methacrylate (HEMA) and different eugenol monomeric derivatives, eugenyl methacrylate (EgMA) and ethoxyeugenyl methacrylate (EEgMA), by bulk polymerization reaction. Thermal evaluation revealed glass transition temperature values in the range 95-58 degrees C following the order HEMA-co-EgMA > PHEMA > HEMA-co-EEgMA and a clear increase in thermal stability with the presence of any eugenyl monomer in the system. In vitro wettability studies showed a reduction of water sorption capacity and Surface free energy values with increasing the content of eugenol residues in the copolymer. The antimicrobial activity of copolymeric discs was evaluated by determining their capacity to reduce or inhibit colony formation by different bacterial species. All eugenyl containing materials showed bacteria growth inhibition, this one being higher for the EEgMA derivative copolymers.
C1 [Rojo, Luis; Vazquez, Blanca; Roman, Julio San] CSIC, Inst Polymer Sci & Technol, E-28006 Madrid, Spain.
   [Rojo, Luis; Vazquez, Blanca; Roman, Julio San] CIBER BBN, Madrid 28006, Spain.
   [Barcenilla, Jose. M.; Gonzalez, Ramon] CSIC, Inst Ind Fermentat, E-28006 Madrid, Spain.
RP Rojo, L (reprint author), CSIC, Inst Polymer Sci & Technol, C Juan Cierva 3, E-28006 Madrid, Spain.
EM rojodelolmo@ictp.csic.es
RI Gonzalez, Ramon/G-9281-2011; Rojo, Luis/B-3073-2009
OI Gonzalez, Ramon/0000-0001-7388-1660; Rojo, Luis/0000-0001-6334-6736;
   Vazquez, Blanca/0000-0001-5539-8026
FU Comision Interministerial de Ciencia y Tecnologia; CICYT
   [MAT2007-63355]; NoE EXPERTISSUES [5002832]
FX This research was supported by Comision Interministerial de Ciencia y
   Tecnologia, CICYT, (MAT2007-63355) and NoE EXPERTISSUES (UE Contract No.
   5002832).
CR ABSOLOM DR, 1983, APPL ENVIRON MICROB, V46, P90
   BAUER AW, 1966, AM J CLIN PATHOL, V45, P496
   Ben Arfa A, 2006, LETT APPL MICROBIOL, V43, P149, DOI 10.1111/j.1472-765X.2006.01938.x
   Benencia F, 2000, PHYTOTHER RES, V14, P495, DOI 10.1002/1099-1573(200011)14:7<495::AID-PTR650>3.0.CO;2-8
   Blaszyk M, 1998, INT J FOOD MICROBIOL, V39, P175, DOI 10.1016/S0168-1605(97)00134-7
   Everall N. J., 2007, VIBRATIONAL SPECTROS
   FOWKES FM, 1964, IND ENG CHEM, V56, P40, DOI 10.1021/ie50660a008
   Good RJ, 1998, J DISPER SCI TECHNOL, V19, P1163, DOI 10.1080/01932699808913235
   Gottenbos B, 2002, BIOMATERIALS, V23, P1417, DOI 10.1016/S0142-9612(01)00263-0
   HARKES G, 1991, BIOMATERIALS, V12, P853, DOI 10.1016/0142-9612(91)90074-K
   HOGT AH, 1986, J BIOMED MATER RES, V20, P533, DOI 10.1002/jbm.820200409
   Imazato S, 2003, DENT MATER, V19, P449, DOI 10.1016/S0109-5641(02)00102-1
   ISQUITH AJ, 1972, APPL MICROBIOL, V24, P859
   Kaplan AE, 1999, ENDOD DENT TRAUMATOL, V15, P42
   Kenawy ER, 2005, J BIOACT COMPAT POL, V20, P95, DOI 10.1177/0883911505049655
   Neut D, 2003, BIOMATERIALS, V24, P1829, DOI 10.1016/S0142-9612(02)00614-2
   Ortiz C, 1999, J BIOMED MATER RES, V45, P184, DOI 10.1002/(SICI)1097-4636(19990605)45:3<184::AID-JBM4>3.0.CO;2-8
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Rahim EA, 2004, J MACROMOL SCI PURE, VA41, P133, DOI 10.1081/MA-120027299
   ROJO L, 2008, DENT MAT
   Rojo L, 2008, J MATER SCI-MATER M, V19, P1467, DOI 10.1007/s10856-007-3317-x
   Rojo L, 2006, BIOMACROMOLECULES, V7, P2751, DOI 10.1021/bm0603241
   Schiraldi C, 2004, BIOMATERIALS, V25, P3645, DOI 10.1016/j.biomaterials.2003.10.059
   SIKKEMA J, 1995, MICROBIOL REV, V59, P201
   TAMM C, 1974, FEBS LETT, V48, P7, DOI 10.1016/0014-5793(74)81052-5
   Tashiro T, 2001, MACROMOL MATER ENG, V286, P63
   TYAGI AK, 1992, EUR POLYM J, V28, P419, DOI 10.1016/0014-3057(92)90265-4
   Ultee A, 2002, APPL ENVIRON MICROB, V68, P1561, DOI 10.1128/AEM.68.4.1561-1568.2002
   Vazquez BI, 2001, INT J FOOD MICROBIOL, V67, P157, DOI 10.1016/S0168-1605(01)00429-9
   VOGL O, 1979, J MACROMOL SCI CHEM, VA13, P415, DOI 10.1080/00222337908068110
   Weber FJ, 1996, BBA-REV BIOMEMBRANES, V1286, P225, DOI 10.1016/S0304-4157(96)00010-X
   Woo GLY, 2002, J BIOMED MATER RES, V59, P35, DOI 10.1002/jbm.1214
NR 32
TC 29
Z9 29
U1 4
U2 18
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD SEP
PY 2008
VL 9
IS 9
BP 2530
EP 2535
DI 10.1021/bm800570u
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 345YH
UT WOS:000259033700032
PM 18702543
DA 2018-10-19
ER

PT J
AU Griffiths, LG
   Choe, LH
   Reardon, KF
   Dow, SW
   Orton, EC
AF Griffiths, Leigh G.
   Choe, Leila H.
   Reardon, Kenneth F.
   Dow, Steven W.
   Orton, E. Christopher
TI Immunoproteomic identification of bovine pericardium xenoantigens
SO BIOMATERIALS
LA English
DT Article
DE immunoproteomics; scaffold; tissue engineering; xenoantigens; heart
   valve
ID BIOPROSTHETIC HEART-VALVE; IMMUNE-RESPONSE; PEROXIREDOXIN-I;
   LUNG-CANCER; AUTOIMMUNE-DISEASES; MEMBRANE-PROTEINS; TISSUE FAILURE; CD1
   MOLECULES; TUMOR-ANTIGEN; ALPHA-ENOLASE
AB Bovine pericardium is an important biomaterial with current application in glutaraldehyde-fixed bio-prosthetic heart valves and possible future application as an unfixed biological scaffold for tissue engineering. The importance of both humoral and cell-mediated rejection responses toward fixed and unfixed xenogeneic tissues has become increasingly apparent. However, the full scope and specific identities of bovine pericardium proteins that can elicit an immune response remain largely unknown. in this study, an immunoproteomic approach was used to survey bovine pericardium proteins for their ability to elicit a humoral immune response in rabbits. A two-stage protein extraction protocol was used to separate bovine pericardium proteins into water- and lipid-soluble fractions. Two-dimensional (2-D) gel electrophoresis was performed to separate the proteins from each fraction. Western blots were generated from 2-D gels of both bovine pericardium protein fractions. These blots were probed with serum from rabbits immunized with bovine pericardium and a secondary antibody was used to assess for IgG positivity. Western blots were compared to duplicate 2-D gels and proteins in matched spots were identified by tandem mass spectrometry. Thirty-one putative protein antigens were identified, eight of which are known to be antigenic from previous studies. All of the putative antigens demonstrated progressive staining intensity with increasing days of post-exposure serum. identified antigenic proteins represented a variety of functional and structural protein types, and included both cellular and matrix proteins. The results of this study have implications for the use of bovine pericardium as a biomaterial in bioprostheses and tissue engineering applications, as well as xenotransplantation in general. Published by Elsevier Ltd.
C1 [Griffiths, Leigh G.; Orton, E. Christopher] Colorado State Univ, Dept Clin Sci, Ft Collins, CO 80523 USA.
   [Reardon, Kenneth F.] Colorado State Univ, Dept Chem & Biol Engn, Ft Collins, CO 80523 USA.
   [Dow, Steven W.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
   [Choe, Leila H.] Univ Delaware, Dept Chem Engn, Delaware Biotechnol Inst, Newark, DE 19716 USA.
RP Griffiths, LG (reprint author), Univ Calif Davis, Dept Med & Epidemiol, 2103 Tupper Hall,1 Shields Ave, Davis, CA 95616 USA.
EM lggriffiths@ucdavis.edu
RI Reardon, Kenneth/A-1952-2016
OI Reardon, Kenneth/0000-0002-7753-4049
FU NHLBI NIH HHS [R21 HL081107, R21 HL081107-02]
CR Aslan H, 2004, RHEUMATOL INT, V24, P77, DOI 10.1007/s00296-002-0274-z
   Bader A, 1998, EUR J CARDIO-THORAC, V14, P279, DOI 10.1016/S1010-7940(98)00171-7
   Beretta B, 2001, INT ARCH ALLERGY IMM, V126, P188, DOI 10.1159/000049513
   Bertipaglia B, 2003, ANN THORAC SURG, V75, P1274, DOI 10.1016/S0003-4975(02)04706-9
   Bierczynska-Krzysik A, 2006, NEUROCHEM INT, V49, P245, DOI 10.1016/j.neuint.2006.01.013
   Bogdanos DP, 2004, J AUTOIMMUNE DIS, V1, P4
   Booth C, 2002, J HEART VALVE DIS, V11, P457
   Bricard G, 2007, CELL MOL LIFE SCI, V64, P1824, DOI 10.1007/s00018-007-7007-0
   Brichory FM, 2001, P NATL ACAD SCI USA, V98, P9824, DOI 10.1073/pnas.171320598
   Cebotari S, 2002, CIRCULATION, V106, pI63, DOI 10.1161/01.cir.0000032900.55215.85
   Chang JW, 2005, FEBS LETT, V579, P2873, DOI 10.1016/j.febslet.2005.04.028
   Choe LH, 2005, ELECTROPHORESIS, V26, P2437, DOI 10.1002/elps.200410336
   DAHM M, 1995, ANN THORAC SURG, V60, pS348, DOI 10.1016/0003-4975(95)00291-R
   DAHM M, 1990, J THORAC CARDIOV SUR, V99, P1082
   Elkins RC, 2001, ANN THORAC SURG, V71, pS428, DOI 10.1016/S0003-4975(01)02503-6
   Ezzelarab M, 2005, IMMUNOL CELL BIOL, V83, P396, DOI 10.1111/j.1440-1711.2005.01344.x
   Fang NT, 2007, CHINESE MED J-PEKING, V120, P696
   Fernandez B, 2003, MOL CELL BIOCHEM, V246, P3, DOI 10.1023/A:1023487424751
   Fujita Y, 2006, CLIN CANCER RES, V12, P6415, DOI 10.1158/1078-0432.CCR-06-1315
   Ge GX, 2004, J BIOL CHEM, V279, P41626, DOI 10.1074/jbc.M406630200
   Goldstein S, 2000, ANN THORAC SURG, V70, P1962, DOI 10.1016/S0003-4975(00)01812-9
   Goncalves AC, 2005, J HEART VALVE DIS, V14, P212
   Gumperz JE, 2006, TRAFFIC, V7, P2, DOI 10.1111/j.1600-0854.2006.00364.x
   HANSSON SF, 2004, PROTEOME SCI, V2
   He P, 2007, CANCER SCI, V98, P1234, DOI 10.1111/j.1349-7006.2007.00509.x
   Hess JL, 2005, J CHROMATOGR B, V815, P65, DOI 10.1016/j.jchromb.2004.07.047
   Hopfer U, 2006, J BIOL CHEM, V281, P8645, DOI 10.1074/jbc.M513751200
   Human P, 2001, J Long Term Eff Med Implants, V11, P199
   Human P, 2001, ANN THORAC SURG, V71, pS385, DOI 10.1016/S0003-4975(01)02492-4
   *I LAB AN RES COMM, 1996, GUID CAR US LAB AN
   Iwata Y, 2007, RHEUMATOLOGY, V46, P790, DOI 10.1093/rheumatology/kem010
   Karasawa R, 2005, MICROBIOL IMMUNOL, V49, P57, DOI 10.1111/j.1348-0421.2005.tb03640.x
   Kasimir MT, 2006, J HEART VALVE DIS, V15, P278
   Kasimir MT, 2005, TISSUE ENG, V11, P1274, DOI 10.1089/ten.2005.11.1274
   Kearns-Jonker M, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-3
   Korossis SA, 2002, J HEART VALVE DIS, V11, P463
   Krah Alexander, 2004, Methods Mol Med, V94, P19
   Lacerda CMR, 2007, J PROTEOME RES, V6, P1145, DOI 10.1021/pr060477v
   Lee SH, 2007, NAT MED, V13, P567, DOI 10.1038/nm1583
   Manji RA, 2006, CIRCULATION, V114, P318, DOI 10.1161/CIRCULATIONAHA.105.549311
   McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732
   Mendelson K, 2006, ANN BIOMED ENG, V34, P1799, DOI 10.1007/s10439-006-9163-z
   Mini R, 2006, J CHROMATOGR B, V833, P63, DOI 10.1016/j.jchromb.2005.12.052
   Mirzaie M, 2000, SCAND CARDIOVASC J, V34, P589
   Mitchison NA, 2004, NAT REV IMMUNOL, V4, P308, DOI 10.1038/nri1334
   Neuenschwander S, 2004, TRANSPL IMMUNOL, V12, P359, DOI 10.1016/S0966-3274(03)00116-3
   O'Brien M F, 1999, Semin Thorac Cardiovasc Surg, V11, P194
   Oh-Ishi M, 2007, J CHROMATOGR B, V849, P211, DOI 10.1016/j.jchromb.2006.10.064
   Oshima M, 1982, Igaku Kenkyu, V52, P313
   Pedersen SK, 2003, J PROTEOME RES, V2, P303, DOI 10.1021/pr025588i
   RABILLOUD T, 2000, PROTEOME RES 2 DIMEN
   RodriguezGarcia MI, 1996, ANN RHEUM DIS, V55, P895, DOI 10.1136/ard.55.12.895
   SALGALLER ML, 1985, J BIOMED MATER RES, V19, P1, DOI 10.1002/jbm.820190103
   Schenke-Layland K, 2003, CARDIOVASC RES, V60, P497, DOI 10.1016/j.cardiores.2003.09.002
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   Schmidt D, 2007, PHILOS T R SOC B, V362, P1505, DOI 10.1098/rstb.2007.2131
   Simon P, 2003, EUR J CARDIO-THORAC, V23, P1002, DOI 10.1016/S1010-7940(03)00094-0
   Sprenger J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S3
   Steinhoff G, 2000, CIRCULATION, V102, P50
   Taylor PM, 2007, PHILOS T R SOC B, V362, P1313, DOI 10.1098/rstb.2007.2117
   Terrier B, 2007, AUTOIMMUN REV, V6, P176, DOI 10.1016/j.autrev.2006.10.004
   Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107
   Ueda Y, 2006, INT J ARTIF ORGANS, V29, P781
   van Duivenvoorde LM, 2004, ARTHRITIS RHEUM, V50, P3354, DOI 10.1002/art.20513
   VESELY I, 1995, ANN THORAC SURG, V60, pS359, DOI 10.1016/0003-4975(95)00206-Z
   Xiang Y, 2004, ARTHRITIS RHEUM, V50, P1511, DOI 10.1002/art.20189
   Xiao Zongwei, 2005, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V22, P1203
   Yan JX, 2000, ELECTROPHORESIS, V21, P3666, DOI 10.1002/1522-2683(200011)21:17<3666::AID-ELPS3666>3.0.CO;2-6
   Zeng Xi, 2007, Ai Zheng, V26, P1080
   Zhao Dong-e, 2003, Asian Cardiovasc Thorac Ann, V11, P153
NR 70
TC 22
Z9 23
U1 0
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2008
VL 29
IS 26
BP 3514
EP 3520
DI 10.1016/j.biomaterials.2008.05.006
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 336IH
UT WOS:000258357000003
PM 18514307
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Young, TH
   Lee, CY
   Chiu, HC
   Hsu, CJ
   Lin, SJ
AF Young, Tai-Horng
   Lee, Chiao-Yun
   Chiu, Hsien-Ching
   Hsu, Chih-Jung
   Lin, Sung-Jan
TI Self-assembly of dermal papilla cells into inductive spheroidal
   microtissues on poly(ethylene-co-vinyl alcohol) membranes for hair
   follicle regeneration
SO BIOMATERIALS
LA English
DT Article
DE aggregation; dermal papilla; spheroid; tissue engineering; adhesivity;
   biomaterial
ID ADULT-RAT HEPATOCYTES; STEM-CELLS; IN-VITRO; MULTICELLULAR SPHEROIDS;
   MELANOCYTE SPHEROIDS; HOODED RAT; GROWTH; INVITRO; SKIN; SURFACE
AB Self-aggregation is key to hair follicle (HF) induction ability of dermal papilla (DP) cells and neogenesis of HF can be achieved by transplanting DP microtissues. However, there is currently lack of a suitable system that allows efficient production of DP microtissues and analysis of DP self-aggregation in vitro. We demonstrate that, at a higher seeding cell density, poly(ethylene-co-vinyl alcohol) (EVAL) membranes facilitate DP self-assembly into many compact spheroidal microtissues that are able to induce new HFs. This self-assembling process is associated with an enhanced cell movement and a declined cell-substrate adhesivity on EVAL. A compromised cell growth is also revealed on EVAL. On the contrary, a more adherent surface allows faster cell expansion but maintains DP cells in a flat morphology. Dynamically, cell migration, intercellular collision and intercellular adhesion contribute to DP microtissue formation on EVAL. Our results suggest that, for large-scale production of DP microtissues for HF regeneration, an adhesive surface is needed for quick cell expansion and a biomaterial with a lower adhesivity is required for self-aggregation. In addition, this system can be a model for investigation of DP self-aggregation in vitro. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Young, Tai-Horng; Lee, Chiao-Yun; Lin, Sung-Jan] Natl Taiwan Univ, Coll Med, Inst Biomed Engn, Taipei 100, Taiwan.
   [Young, Tai-Horng; Lee, Chiao-Yun; Lin, Sung-Jan] Natl Taiwan Univ, Coll Engn, Taipei 100, Taiwan.
   [Chiu, Hsien-Ching; Hsu, Chih-Jung; Lin, Sung-Jan] Natl Taiwan Univ Hosp, Dept Dermatol, Taipei, Taiwan.
RP Lin, SJ (reprint author), Natl Taiwan Univ, Coll Med, Inst Biomed Engn, 1,Sec 1,Jen Ai Rd, Taipei 100, Taiwan.
EM drsjlin@ntu.edu.tw
OI JEE, SHIOU-HWA/0000-0001-6737-6297; Lin, Sung-Jan/0000-0003-1325-3464;
   CHIU, HSIEN-CHING/0000-0002-1409-8470
CR Allen LT, 2006, BIOMATERIALS, V27, P3096, DOI 10.1016/j.biomaterials.2006.01.019
   Blanpain C, 2006, ANNU REV CELL DEV BI, V22, P339, DOI 10.1146/annurev.cellbio.22.010305.104357
   Botchkarev VA, 2002, J INVEST DERMATOL, V118, P3, DOI 10.1046/j.1523-1747.2002.01645.x
   BUHL AE, 1989, J INVEST DERMATOL, V92, P315, DOI 10.1111/1523-1747.ep12277095
   BURSTONE MS, 1958, J NATL CANCER I, V20, P601
   CHIN HC, 1996, J FORMOS MED ASSOC, V95, P667
   COHEN J, 1961, J EMBRYOL EXP MORPH, V9, P117
   Cotsarelis G, 2006, J INVEST DERMATOL, V126, P1459, DOI 10.1038/sj.jid.5700376
   Dubessy C, 2000, CRIT REV ONCOL HEMAT, V36, P179, DOI 10.1016/S1040-8428(00)00085-8
   Faucheux N, 2006, BIOMATERIALS, V27, P234, DOI 10.1016/j.biomaterials.2005.05.076
   Hamano T, 1998, J BIOMED MATER RES, V41, P257, DOI 10.1002/(SICI)1097-4636(199808)41:2<257::AID-JBM11>3.0.CO;2-I
   Hasskarl J, 2005, J INVEST DERMATOL, V124, P475, DOI 10.1111/j.0022-202X.2004.23574.x
   Hasskarl J, 2006, J INVEST DERMATOL, V126, P1179, DOI 10.1038/sj.jid.5700205
   IHARA S, 1991, CELL TISSUE RES, V266, P65, DOI 10.1007/BF00678712
   Inamatsu M, 1998, J INVEST DERMATOL, V111, P767, DOI 10.1046/j.1523-1747.1998.00382.x
   Ito Y, 2007, J INVEST DERMATOL, V127, P1052, DOI 10.1038/sj.jid.5700665
   JAHODA C, 1981, BRIT J DERMATOL, V105, P623, DOI 10.1111/j.1365-2133.1981.tb00971.x
   JAHODA CAB, 1991, J CELL SCI, V99, P627
   JAHODA CAB, 1993, J INVEST DERMATOL, V101, P584, DOI 10.1111/1523-1747.ep12366039
   JAHODA CAB, 1984, NATURE, V311, P560, DOI 10.1038/311560a0
   JAHODA CAB, 1984, J EMBRYOL EXP MORPH, V79, P211
   Kale S, 2000, NAT BIOTECHNOL, V18, P954
   Kelm JM, 2004, TISSUE ENG, V10, P201, DOI 10.1089/107632704322791853
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Khalil M, 2001, J HEPATOL, V34, P68, DOI 10.1016/S0168-8278(00)00080-5
   KOIDE N, 1989, BIOCHEM BIOPH RES CO, V161, P385, DOI 10.1016/0006-291X(89)91609-4
   KOIDE N, 1990, EXP CELL RES, V186, P227, DOI 10.1016/0014-4827(90)90300-Y
   Li Yu, 2005, J Dermatol Sci, V37, P58, DOI 10.1016/j.jdermsci.2004.10.001
   LICHTI U, 1993, J INVEST DERMATOL, V101, pS124, DOI 10.1111/1523-1747.ep12363165
   Lin SJ, 2006, BIOMATERIALS, V27, P1462, DOI 10.1016/j.biomaterials.2005.08.031
   Lin SJ, 2005, BIOMATERIALS, V26, P1413, DOI 10.1016/j.biomaterials.2004.05.002
   Lin SJ, 2006, BIOMATERIALS, V27, P5079, DOI 10.1016/j.biomaterials.2006.05.035
   McElwee KJ, 2003, J INVEST DERMATOL, V121, P1267, DOI 10.1111/j.1523-1747.2003.12568.x
   Millar SE, 2002, J INVEST DERMATOL, V118, P216, DOI 10.1046/j.0022-202x.2001.01670.x
   Muller-Rover S, 1998, J HISTOCHEM CYTOCHEM, V46, P1401
   OLIVER R F, 1970, Journal of Embryology and Experimental Morphology, V23, P219
   OLIVER RF, 1967, J EMBRYOL EXP MORPH, V17, P27
   OLIVER RF, 1967, J EMBRYOL EXP MORPH, V18, P43
   ORENTREICH N, 1959, ANN NY ACAD SCI, V83, P463
   Osada A, 2007, TISSUE ENG, V13, P975, DOI 10.1089/ten.2006.0304
   Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2
   PHILPOTT MP, 1992, BRIT J DERMATOL, V127, P600, DOI 10.1111/j.1365-2133.1992.tb14873.x
   PHILPOTT MP, 1990, J CELL SCI, V97, P463
   Philpott MP, 1998, MOL BASIS EPITHELIAL, P75
   REYNOLDS AJ, 1992, DEVELOPMENT, V115, P587
   Ryan PL, 2001, P NATL ACAD SCI USA, V98, P4323, DOI 10.1073/pnas.071615398
   Santini MT, 1999, PATHOBIOLOGY, V67, P148, DOI 10.1159/000028065
   Stenn KS, 2005, CURR OPIN BIOTECH, V16, P493, DOI 10.1016/j.copbio.2005.08.002
   Takeda A, 1998, SCAND J PLAST RECONS, V32, P359, DOI 10.1080/02844319850158435
   Young TH, 1998, BIOMATERIALS, V19, P717, DOI 10.1016/S0142-9612(98)00187-2
   Young TH, 2005, BIOMATERIALS, V26, P4291, DOI 10.1016/j.biomaterials.2004.10.043
   Zheng Y, 2005, J INVEST DERMATOL, V124, P867, DOI 10.1111/j.0022-202X.2005.23716.x
NR 52
TC 50
Z9 57
U1 1
U2 18
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2008
VL 29
IS 26
BP 3521
EP 3530
DI 10.1016/j.biomaterials.2008.05.013
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 336IH
UT WOS:000258357000004
PM 18533254
DA 2018-10-19
ER

PT J
AU Benzaid, R
   Chevalier, J
   Saddaoui, M
   Fantozzi, G
   Nawa, M
   Diaz, LA
   Torrecillas, R
AF Benzaid, Rajaa
   Chevalier, Jerome
   Saddaoui, Malika
   Fantozzi, Gilbert
   Nawa, Masahiro
   Diaz, Luis Antonio
   Torrecillas, Ramon
TI Fracture toughness, strength and slow crack growth in a ceria stabilized
   zirconia-alumina nanocomposite for medical applications
SO BIOMATERIALS
LA English
DT Article
DE mechanical properties; crack; alumina; zirconia; nanocomposite; fatigue
ID CE-TZP/AL2O3 NANOCOMPOSITE; JOINT PROSTHESES; CERAMICS; 3Y-TZP;
   TRANSFORMATION; PROPAGATION; INDENTATION; RESISTANCE; OXIDES; WEAR
AB Mechanical properties and slow crack growth (SCG) behavior of a 10Ce-TZP/Al2O3 nanocomposite currently developed as a biomaterial are considered. Fracture toughness is determined for sharp, long (double torsion) and short (indentation) cracks and a good agreement is found between the two types of Cracks. The main toughening mechanism in the nanocomposite is the tetragonal to monoclinic phase transformation of the ceria-stabilized zirconia (Ce-TZP) phase. Transformation at the surface of ground specimens leads to surface Compressive induced stresses and an increase in strength. Crack velocity curves (V-K-I curves) are obtained under static and cyclic fatigue using the double torsion method. The static V-K-I Curve in air reveals the three stages characteristic Of Stress corrosion with a threshold K-10 similar to 4.5 MPa m(1/2) and a fracture toughness of 8.8 MPa m(1/2) significantly higher than those of currently used inert bioceramics (i.e. alumina and Y-TZP). A Crack growth accelerating effect is shown under cyclic loading, correlated with a decrease in the threshold. However, the cyclic fatigue threshold (4 MPa m(1/2)) still stands above that of current biomedical grade alumina and zirconia. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Benzaid, Rajaa; Chevalier, Jerome; Fantozzi, Gilbert] Univ Lyon 1, Inst Natl Sci Appl Lyon, CNRS, MATEIS,UMR 5510, F-69621 Villeurbanne, France.
   [Benzaid, Rajaa; Saddaoui, Malika] Ecole Mohammadia Ingn, LERSIM, Rabat, Morocco.
   [Nawa, Masahiro] Matsushita Elect Works Ltd, Adv Technol Dev Lab, Kadoma, Osaka 571, Japan.
   [Diaz, Luis Antonio; Torrecillas, Ramon] CINN CSIC, Nanomat & Nanotechnol Res Ctr, Oviedo 33011, Spain.
RP Chevalier, J (reprint author), Univ Lyon 1, Inst Natl Sci Appl Lyon, CNRS, MATEIS,UMR 5510, 20 Ave Albert Einstein,Batiment Blaise Pascal, F-69621 Villeurbanne, France.
EM jerome.chevalier@insa-lyon.fr
RI Torrecillas, Ramon/G-7851-2011
OI Torrecillas, Ramon/0000-0003-3856-0217
CR Affatato S, 2001, BIOMATERIALS, V22, P717, DOI 10.1016/S0142-9612(00)00235-0
   BRAUN LM, 1992, J AM CERAM SOC, V75, P3049, DOI 10.1111/j.1151-2916.1992.tb04385.x
   Burger W., 2001, KEY ENG MATER, p[192, 545], DOI DOI 10.4028/WWW.SCIENTIFIC.NET/KEM.192-195.545
   Chevalier J, 1999, J AM CERAM SOC, V82, P3129
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Chevalier J, 2005, NANO LETT, V5, P1297, DOI 10.1021/nl050492j
   Chevalier J, 1997, CERAM INT, V23, P263, DOI 10.1016/S0272-8842(96)00037-5
   Chevalier J, 1996, CERAM INT, V22, P171, DOI 10.1016/0272-8842(95)00076-3
   Chevalier J, 1996, J MATER SCI, V31, P2711, DOI 10.1007/BF00687305
   De Aza AH, 2002, BIOMATERIALS, V23, P937, DOI 10.1016/S0142-9612(01)00206-X
   DRANSMANN GW, 1994, J AM CERAM SOC, V77, P1194, DOI 10.1111/j.1151-2916.1994.tb05392.x
   El Attaoui H, 2007, J EUR CERAM SOC, V27, P483, DOI 10.1016/j.jeurceramsoc.2006.04.108
   ELATTAOUI H, 2003, THESIS INSA DE LYON, P138
   Hannink RHJ, 2000, J AM CERAM SOC, V83, P461
   HEROS RJ, 1998, SEMIN ARTHROPLASTY, V9, P114
   Kelly PM, 2002, PROG MATER SCI, V47, P463, DOI 10.1016/S0079-6425(00)00005-0
   LAWSON S, 1995, J EUR CERAM SOC, V15, P485, DOI 10.1016/0955-2219(95)00035-S
   Nawa M, 1998, CERAM INT, V24, P497, DOI 10.1016/S0272-8842(97)00048-5
   Niihara K., 1991, J CERAM SOC JPN, V99, P974, DOI DOI 10.2109/JCERSJ.99.974
   Tanaka K, 2003, J BIOMED MATER RES A, V67A, P200, DOI 10.1002/jbm.a.10006
   Tanaka K, 2002, J BIOMED MATER RES, V63, P262, DOI 10.1002/jbm.10182
   Toraya H., 1984, J AM CERAM SOC, V67, P119
   Uchida M, 2002, J BIOMED MATER RES, V60, P277, DOI 10.1002/jbm.10071
   WEIBULL W, 1951, J APPL MECH-T ASME, V18, P293
   Willmann G, 2000, CLIN ORTHOP RELAT R, P22
NR 25
TC 104
Z9 105
U1 3
U2 62
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2008
VL 29
IS 27
BP 3636
EP 3641
DI 10.1016/j.biomaterials.2008.05.021
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 337MD
UT WOS:000258439300002
PM 18571716
DA 2018-10-19
ER

PT J
AU Li, XT
   Zhang, Y
   Chen, GQ
AF Li, Xiao-Tao
   Zhang, Yan
   Chen, Guo-Qiang
TI Nanofibrous polyhydroxyalkanoate matrices as cell growth supporting
   materials
SO BIOMATERIALS
LA English
DT Article
DE PHB; polyhydroxybutyrate; nanofiber; matrix; HaCat cells;
   biocompatibility; tissue engineering
ID ASSEMBLING PEPTIDE SCAFFOLDS; POLY(L-LACTIC ACID) FOAMS; IN-VITRO;
   TISSUE; REGENERATION; CRYSTALLIZATION; POLY(3-HYDROXYBUTYRATE);
   DIFFERENTIATION; DEGRADATION; BEHAVIOR
AB Polyhydroxyalkanoates (PHAs) have been demonstrated to be a family of biopolymers with good biodegradability and biocompatibility. To mimic the real microenvironment of extracellular matrix (ECM) for cell growth, novel nanofiber matrices based on PHA polymers were prepared via a phase separation process. Three-dimensional interconnected fibrous networks were observed in these matrices with average fiber diameters of 50-500 nm, which are very similar to the major ECM component collagen. Compared with nanofiber matrix made of poly(L-lactide), the mechanical properties of PHA nanofiber matrices were significantly improved, especially those matrices of PHA blends PHB/PHBHHx containing polyhydroxybutyrate (PHB) and copolyesters PHBHHx consisting of 3-hydroxybutyrate and 3-hydroxy-hexanoate, and PHB/P3HB4HB that are PHB blended with copolyesters of 3-hydroxybutyrate and 4-hydroxybutyrate, respectively. More importantly, cell attachment and growth of human keratinocyte cell line HaCat on the nanofiber PHA matrices showed a notable improvement over those on PHA matrices prepared via an Ordinary solution casting method. It was therefore Proposed that PHA nanofiber matrices combined the advantages of biodegradation, improved mechanical Strengths and the nanostructure of a natural extracellular matrix, leading to a better cell compatibility, thus they can be used for future implant biomaterial development. (C) 2008 Published by Elsevier Ltd.
C1 [Li, Xiao-Tao; Zhang, Yan; Chen, Guo-Qiang] Shantou Univ, Multidisciplinary Res Ctr, Shantou 515063, Guangdong, Peoples R China.
   [Chen, Guo-Qiang] Tsinghua Univ, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China.
RP Chen, GQ (reprint author), Shantou Univ, Multidisciplinary Res Ctr, Shantou 515063, Guangdong, Peoples R China.
EM chengq@stu.edu.cn
CR BARHAM PJ, 1986, J POLYM SCI POL PHYS, V24, P69, DOI 10.1002/polb.1986.180240108
   BARHAM PJ, 1984, J MATER SCI, V19, P2781, DOI 10.1007/BF01026954
   Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   Chen GQ, 2000, CHINESE J POLYM SCI, V18, P389
   Chen VJ, 2006, BIOMATERIALS, V27, P3973, DOI 10.1016/j.biomaterials.2006.02.043
   Chiu JB, 2007, J BIOMED MATER RES A, V83A, P1117, DOI 10.1002/jbm.a.31279
   Ellis-Behnke RG, 2006, P NATL ACAD SCI USA, V103, P5054, DOI 10.1073/pnas.0600559103
   ELSDALE T, 1972, J CELL BIOL, V54, P626, DOI 10.1083/jcb.54.3.626
   Freier T, 2002, BIOMATERIALS, V23, P2649, DOI 10.1016/S0142-9612(01)00405-7
   Gelain F, 2007, MACROMOL BIOSCI, V7, P544, DOI 10.1002/mabi.200700033
   Gelain F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000119
   GRINNELL F, 1982, METHOD ENZYMOL, V82, P535
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   HAY ED, 1991, CELL BIOL EXTRACELLU, P56
   Hazer B, 2007, APPL MICROBIOL BIOT, V74, P1, DOI 10.1007/s00253-006-0732-8
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Horii A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000190
   KENONG GJ, 1993, POLYMER, V34, P4089
   Laurencin CT, 1999, ANNU REV BIOMED ENG, V1, P19, DOI 10.1146/annurev.bioeng.1.1.19
   Lu LC, 2000, BIOMATERIALS, V21, P1595, DOI 10.1016/S0142-9612(00)00048-X
   Luo RC, 2007, J APPL POLYM SCI, V105, P3402, DOI 10.1002/app.26369
   Ma PX, 2008, ADV DRUG DELIVER REV, V60, P184, DOI 10.1016/j.addr.2007.08.041
   Ma PX, 2004, MATER TODAY, V7, P30, DOI 10.1016/S1369-7021(04)00233-0
   Ma PX, 2001, J BIOMED MATER RES, V56, P469, DOI 10.1002/1097-4636(20010915)56:4<469::AID-JBM1118>3.0.CO;2-H
   Ma PX, 1999, J BIOMED MATER RES, V46, P60, DOI 10.1002/(SICI)1097-4636(199907)46:1<60::AID-JBM7>3.0.CO;2-H
   Ma ZW, 2005, TISSUE ENG, V11, P101, DOI 10.1089/ten.2005.11.101
   MacNeil S, 2007, NATURE, V445, P874, DOI 10.1038/nature05664
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   MILLER ND, 1987, BIOMATERIALS, V8, P129, DOI 10.1016/0142-9612(87)90102-5
   Misra SK, 2006, BIOMACROMOLECULES, V7, P2249, DOI 10.1021/bm060317c
   Mosahebi A, 2002, EXP NEUROL, V173, P213, DOI 10.1006/exnr.2001.7846
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Qu XH, 2006, BIOMATERIALS, V27, P2944, DOI 10.1016/j.biomaterials.2006.01.013
   ROSENBERG MD, 1963, SCIENCE, V139, P411, DOI 10.1126/science.139.3553.411
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Shin M, 2008, J BIOMED MATER RES A, V84A, P702, DOI 10.1002/jbm.a.31392
   Shishatskaya EI, 2004, J MATER SCI-MATER M, V15, P719, DOI 10.1023/B:JMSM.0000030215.49991.0d
   Tian F, 2008, J BIOMED MATER RES A, V84A, P291, DOI 10.1002/jbm.a.31304
   Tian G, 2001, APPL SPECTROSC, V55, P888, DOI 10.1366/0003702011952686
   Valappil SP, 2006, EXPERT REV MED DEVIC, V3, P853, DOI 10.1586/17434440.3.6.853
   VONK CG, 1973, J APPL CRYSTALLOGR, V6, P148, DOI 10.1107/S0021889873008332
   WILLIAMS SF, 2002, BIOPOLYMERS, V10, P91
   Woo KM, 2003, J BIOMED MATER RES A, V67A, P531, DOI 10.1002/jbm.a.10098
   Woo KM, 2007, BIOMATERIALS, V28, P335, DOI 10.1016/j.biomaterials.2006.06.013
   Xu J, 2003, J POLYM SCI POL PHYS, V41, P2128, DOI 10.1002/polb.10556
   Zhang SG, 2004, NAT BIOTECHNOL, V22, P151, DOI 10.1038/nbt0204-151
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
   Zheng Z, 2005, BIOMATERIALS, V26, P3537, DOI 10.1016/j.biomaterials.2004.09.041
NR 48
TC 85
Z9 99
U1 1
U2 44
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2008
VL 29
IS 27
BP 3720
EP 3728
DI 10.1016/j.biomaterials.2008.06.004
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 337MD
UT WOS:000258439300012
PM 18585779
DA 2018-10-19
ER

PT J
AU Nakamura, T
   Sekiyama, E
   Takaoka, M
   Bentley, AJ
   Yokoi, N
   Fullwood, NJ
   Kinoshita, S
AF Nakamura, Takahiro
   Sekiyama, Eiichi
   Takaoka, Maho
   Bentley, Adam J.
   Yokoi, Norihiko
   Fullwood, Nigel J.
   Kinoshita, Shigeru
TI The use of trehalose-treated freeze-dried amniotic membrane for ocular
   surface reconstruction
SO BIOMATERIALS
LA English
DT Article
DE trehalose; amniotic membrane; freeze-dry; ocular surface reconstruction;
   biocompatibility
ID LIMBAL EPITHELIAL-CELLS; STEM/PROGENITOR CELLS; TRANSPLANTATION;
   CORNEAL; IDENTIFICATION; SUPPRESSION; MATRIX
AB The aim of this study was to evaluate the efficacy and safety of trehalose-treated freeze-dried amniotic membrane (TT-FDAM) for ocular surface reconstruction. Human AM deprived of amniotic epithelial cells was first incubated with 10% trehalose solution, and then freeze-dried, vacuum-packed, and sterilized with gamma-irradiation. The resultant newly developed TT-FDAM was characterized for its physical, biological, and morphological properties by comprehensive physical assays, immunohistochemistry, electron microscopy, cell adhesion assay, 3D cell culture, and an in vivo biocompatibility test. The adaptability of TT-FDAM was markedly improved as compared to FDAM. Immunohistochemistry for several extracellular matrix molecules revealed that the process of freeze-drying and irradiation apparently did not affect its biological properties, however, electron microscopy revealed that the detailed morphological appearance of TT-FDAM is more similar to that of native AM than to FDAM, Intracorneal and scleral-surface transplantation of TT-FDAM showed excellent biocompatibility with ocular surface tissues. Thus, TT-FDAM retained most of the physical, biological, and morphological characteristics of native AM, consequently it is a useful biomaterial for ocular surface reconstruction. (C) 2008 Published by Elsevier Ltd.
C1 [Nakamura, Takahiro; Sekiyama, Eiichi; Takaoka, Maho; Yokoi, Norihiko; Kinoshita, Shigeru] Kyoto Prefectural Univ Med, Grad Sch Med, Dept Ophthalmol, Kamigyo Ku, Kyoto 6020841, Japan.
   [Nakamura, Takahiro] Doshisha Univ, Res Ctr Regenerat Med, Kamigyo Ku, Kyoto 6028580, Japan.
   [Bentley, Adam J.; Fullwood, Nigel J.] Univ Lancaster, Lancaster LA1 4YQ, England.
RP Nakamura, T (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med, Dept Ophthalmol, Kamigyo Ku, 465 Kawaramachi Hirokoji, Kyoto 6020841, Japan.
EM tnakamur@ophth.kpu-m.ac.jp
OI Fullwood, Nigel James/0000-0002-9405-8515
CR AKLE CA, 1981, LANCET, V2, P1003
   Chen F, 2004, TRANSPLANT P, V36, P2812, DOI 10.1016/j.transproceed.2004.10.005
   Crowe JH, 2001, CRYOBIOLOGY, V43, P89, DOI 10.1006/cryo.2001.2353
   Dua HS, 2004, SURV OPHTHALMOL, V49, P51, DOI 10.1016/j.survophthal.2003.10.004
   Guo N, 2000, NAT BIOTECHNOL, V18, P168, DOI 10.1038/72616
   Hao YX, 2000, CORNEA, V19, P348, DOI 10.1097/00003226-200005000-00018
   Kim JS, 2000, EXP EYE RES, V70, P329, DOI 10.1006/exer.1999.0794
   Koizumi N, 2001, OPHTHALMOLOGY, V108, P1569, DOI 10.1016/S0161-6420(01)00694-7
   Matsuo T, 2002, OPHTHALMOLOGY, V109, P2024, DOI 10.1016/S0161-6420(02)01219-8
   Nakamura T, 2006, ACTA OPHTHALMOL SCAN, V84, P401, DOI 10.1111/j.1600-0420.2006.00667.x
   Nakamura T, 2003, INVEST OPHTH VIS SCI, V44, P106, DOI 10.1167/iovs.02-0195
   Nakamura T, 2004, INVEST OPHTH VIS SCI, V45, P93, DOI 10.1167/iovs.03-0752
   Nakamura T, 2008, STEM CELLS, V26, P1265, DOI 10.1634/stemcells.2007-1067
   Nakamura T, 2007, STEM CELLS, V25, P628, DOI 10.1634/stemcells.2006-0494
   Sekiyama E, 2007, INVEST OPHTH VIS SCI, V48, P1528, DOI 10.1167/iovs.06-1104
   Solomon A, 2001, BRIT J OPHTHALMOL, V85, P444, DOI 10.1136/bjo.85.4.444
   TALMI YP, 1991, PLACENTA, V12, P285, DOI 10.1016/0143-4004(91)90010-D
   TRELFORD JD, 1979, AM J OBSTET GYNECOL, V134, P833, DOI 10.1016/0002-9378(79)90957-8
   Tsai RJ, 2000, NEW ENGL J MED, V343, P86, DOI 10.1056/NEJM200007133430202
   Tseng SCG, 1999, J CELL PHYSIOL, V179, P325, DOI 10.1002/(SICI)1097-4652(199906)179:3<325::AID-JCP10>3.3.CO;2-O
NR 20
TC 28
Z9 30
U1 1
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2008
VL 29
IS 27
BP 3729
EP 3737
DI 10.1016/j.biomaterials.2008.05.023
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 337MD
UT WOS:000258439300013
PM 18547637
DA 2018-10-19
ER

PT J
AU Lee, JY
   Kang, BS
   Hicks, B
   Chancellor, TF
   Chu, BH
   Wang, HT
   Keselowsky, BG
   Ren, F
   Lele, TP
AF Lee, Jiyeon
   Kang, B. S.
   Hicks, Barrett
   Chancellor, Thomas F., Jr.
   Chu, Byung Hwan
   Wang, Hung-Ta
   Keselowsky, Benjamin G.
   Ren, F.
   Lele, Tanmay P.
TI The control of cell adhesion and viability by zinc oxide nanorods
SO BIOMATERIALS
LA English
DT Article
DE nanorods; cell adhesion; cell viability; anti-adhesion
ID CORNEAL EPITHELIAL-CELLS; ENDOTHELIAL-CELLS; FLUORESCENCE DETECTION;
   LIVING CELLS; MUSCLE-CELLS; SCALE; ZNO; NANOTOPOGRAPHY; PROLIFERATION;
   TOPOGRAPHY
AB The ability to control the behavior of cells that interact with implanted biomaterials is desirable for the success of implanted devices such as biosensors or drug delivery devices. There is a need to develop materials that can limit the adhesion and viability of cells on implanted biomaterials. In this study, we investigated the use of zinc oxide (ZnO) nanorods for modulating the adhesion and viability of NIH 3T3 fibroblasts, umbilical vein endothelial cells, and capillary endothelial cells. Cells adhered far less to ZnO nanorods than the corresponding ZnO flat substrate. The few cells that adhered to ZnO nanorods were rounded and not viable compared to the flat ZnO substrate. Cells were unable to assemble focal adhesions and stress fibers on nanorods. Scanning electron microscopy indicated that cells were not able to assemble lamellipodia on nanorods. Time-lapse imaging revealed that cells that initially adhered to nanorods were not able to spread. This suggests that it is the lack of initial spreading, rather than long-term exposure to ZnO that causes cell death. We conclude that ZnO nanorods are potentially useful as an adhesion-resistant biomaterial capable of reducing viability in anchorage-dependent cells. Published by Elsevier Ltd.
C1 [Lee, Jiyeon; Kang, B. S.; Hicks, Barrett; Chancellor, Thomas F., Jr.; Chu, Byung Hwan; Wang, Hung-Ta; Ren, F.; Lele, Tanmay P.] Univ Florida, Dept Chem Engn, Gainesville, FL 32611 USA.
   [Keselowsky, Benjamin G.] Univ Florida, Pruitt Family Dept Biomed Engn, Gainesville, FL 32611 USA.
RP Lele, TP (reprint author), Univ Florida, Dept Chem Engn, Gainesville, FL 32611 USA.
EM tlele@che.ufl.edu
RI Keselowsky, Benjamin/A-8000-2009
CR Al-Hilli SM, 2007, J APPL PHYS, V102, DOI 10.1063/1.2798582
   Andersson AS, 2003, BIOMATERIALS, V24, P3427, DOI 10.1016/S0142-9612(03)00208-4
   Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014
   Bershadsky A, 2006, CURR OPIN CELL BIOL, V18, P472, DOI 10.1016/j.ceb.2006.08.012
   Cavalcanti-Adam EA, 2007, BIOPHYS J, V92, P2964, DOI 10.1529/biophysj.106.089730
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Choi CH, 2007, BIOMATERIALS, V28, P1672, DOI 10.1016/j.biomaterials.2006.11.031
   Dalby M J, 2005, Eur Cell Mater, V9, P1
   Dalby MJ, 2008, J BIOMED MATER RES A, V84A, P973, DOI 10.1002/jbm.a.31409
   Dalby MJ, 2002, BIOMATERIALS, V23, P2945, DOI 10.1016/S0142-9612(01)00424-0
   Diehl KA, 2005, J BIOMED MATER RES A, V75A, P603, DOI 10.1002/jbm.a.30467
   Dorfman A, 2006, LANGMUIR, V22, P4890, DOI 10.1021/la053270+
   Dorfman A, 2006, ADV MATER, V18, P2685, DOI 10.1002/adma.200502616
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Garibaldi S, 2006, NANOTECHNOLOGY, V17, P391, DOI 10.1088/0957-4484/17/2/008
   Genove E, 2005, BIOMATERIALS, V26, P3341, DOI 10.1016/j.biomaterials.2004.08.012
   Girard PP, 2007, SOFT MATTER, V3, P307, DOI 10.1039/b614008d
   Gojova A, 2007, ENVIRON HEALTH PERSP, V115, P403, DOI 10.1289/ehp.8497
   Graeter SV, 2007, NANO LETT, V7, P1413, DOI 10.1021/nl070098g
   Greene LE, 2003, ANGEW CHEM INT EDIT, V42, P3031, DOI 10.1002/anie.200351461
   He W, 2008, BIOMEDICAL NANOSTRUCTURES, P25
   Kang BS, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1883330
   KANG BS, 2007, APPL PHYS LETT, V90
   Karuri NW, 2004, J CELL SCI, V117, P3153, DOI 10.1242/jcs.01146
   Khang D, 2008, BIOMATERIALS, V29, P970, DOI 10.1016/j.biomaterials.2007.11.009
   Kim W, 2007, J AM CHEM SOC, V129, P7228, DOI 10.1021/ja071456k
   Lele TP, 2006, J CELL PHYSIOL, V207, P187, DOI 10.1002/jcp.20550
   Lenhert S, 2005, BIOMATERIALS, V26, P563, DOI 10.1016/j.biomaterials.2004.02.068
   Liliensiek SJ, 2006, J BIOMED MATER RES A, V79A, P185, DOI 10.1002/jbm.a.30744
   Ma ZW, 2005, TISSUE ENG, V11, P1149, DOI 10.1089/ten.2005.11.1149
   Michikawa M, 1998, J NEUROSCI RES, V54, P58, DOI 10.1002/(SICI)1097-4547(19981001)54:1<58::AID-JNR7>3.0.CO;2-G
   Pacholski C, 2002, ANGEW CHEM INT EDIT, V41, P1188, DOI 10.1002/1521-3773(20020402)41:7<1188::AID-ANIE1188>3.0.CO;2-5
   Parker KK, 2002, FASEB J, V16, DOI 10.1096/fj.02-0038com
   Pearton SJ, 2007, TRENDS BIOTECHNOL, V25, P481, DOI 10.1016/j.tibtech.2007.07.011
   RE F, 1994, J CELL BIOL, V127, P537, DOI 10.1083/jcb.127.2.537
   Spatz JP, 2007, METHOD CELL BIOL, V83, P89, DOI 10.1016/S0091-679X(07)83005-6
   Sun XW, 1999, J APPL PHYS, V86, P408, DOI 10.1063/1.370744
   Teixeira AI, 2006, BIOMATERIALS, V27, P3945, DOI 10.1016/j.biomaterials.2006.01.044
   Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383
   Washburn NR, 2004, BIOMATERIALS, V25, P1215, DOI 10.1016/j.biomaterials.2003.08.043
   XIA N, 2008, FASEB J
   Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058
   Zhu XY, 2005, NAT MATER, V4, P403, DOI 10.1038/nmat1365
NR 43
TC 124
Z9 125
U1 2
U2 58
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2008
VL 29
IS 27
BP 3743
EP 3749
DI 10.1016/j.biomaterials.2008.05.029
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 337MD
UT WOS:000258439300015
PM 18550161
DA 2018-10-19
ER

PT J
AU Dreesmann, L
   Hajosch, R
   Ahlers, M
   Nuernberger, JV
   Schlosshauer, B
AF Dreesmann, L.
   Hajosch, R.
   Ahlers, M.
   Nuernberger, J. Vaz
   Schlosshauer, B.
TI Permeability testing of biomaterial membranes
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID ENCAPSULATED XENOGENEIC MYOBLASTS; ENDOTHELIAL GROWTH-FACTOR; IN-VITRO
   CHARACTERIZATION; BLOOD-RETINA BARRIER; EPITHELIAL-CELLS; CHROMAFFIN
   CELLS; MODEL; COLLAGEN; REGENERATION; DELIVERY
AB The permeability characteristics of biomaterials are critical parameters for a variety of implants. To analyse the permeability of membranes made from crosslinked ultrathin gelatin membranes and the transmigration of cells across the membranes, we combined three technical approaches: (1) a two-chamber-based permeability assay, (2) cell culturing with cytochemical analysis and (3) biochemical enzyme electrophoresis (zymography). Based on the diffusion of a coloured marker molecule in conjunction with photometric quantification, permeability data for a gelatin membrane were determined in the presence or absence of gelatin degrading fibroblasts. Cytochemical evaluation after cryosectioning of the membranes was used to ascertain whether fibroblasts had infiltrated the membrane inside. Zymography was used to investigate the potential release of proteases from fibroblasts, which are known to degrade collagen derivatives such as gelatin. Our data show that the diffusion equilibrium of a low molecular weight dye across the selected gelatin membrane is approached after about 6-8 h. Fibroblasts increase the permeability due to cavity formation in the membrane inside without penetrating the membrane for an extended time period (> 21 days in vitro). Zymography indicates that cavity formation is most likely due to the secretion of matrix metalloproteinases. In summary, the combination of the depicted methods promises to facilitate a more rational development of biomaterials, because it provides a rapid means of determining permeability characteristics and bridges the gap between descriptive methodology and the mechanistic understanding of permeability alterations due to biological degradation.
C1 [Dreesmann, L.; Hajosch, R.; Nuernberger, J. Vaz; Schlosshauer, B.] Univ Tubingen, NMI Nat & Med Sci Inst, D-72770 Reutlingen, Germany.
   [Ahlers, M.] GELITA AG, D-69412 Eberbach, Germany.
RP Schlosshauer, B (reprint author), Univ Tubingen, NMI Nat & Med Sci Inst, Markwiesenstr 55, D-72770 Reutlingen, Germany.
EM schlosshauer@nmi.de
CR Atkins S, 2006, NEUROREPORT, V17, P1245, DOI 10.1097/01.wnr.0000230519.39456.ea
   Bernhardt A, 2008, J MATER SCI-MATER M, V19, P269, DOI 10.1007/s10856-006-0059-0
   Bitterle E, 2006, CHEMOSPHERE, V65, P1784, DOI 10.1016/j.chemosphere.2006.04.035
   Buss A, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-17
   Duan X, 2006, BIOMATERIALS, V27, P4608, DOI 10.1016/j.biomaterials.2006.04.022
   Gabriel D, 2007, BIOCONJUGATE CHEM, V18, P1070, DOI 10.1021/bc060321l
   Giraudier S, 2004, BIOMACROMOLECULES, V5, P1662, DOI 10.1021/bm049670d
   Hillaireau H, 2007, INT J PHARM, V331, P148, DOI 10.1016/j.ijpharm.2006.10.031
   JOSEPH JM, 1994, CELL TRANSPLANT, V3, P355, DOI 10.1177/096368979400300502
   Kim IY, 2007, J BIOCHEM MOL BIOL, V40, P825
   Krzeski P, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2315
   Lalonde RL, 2007, CLIN PHARMACOL THER, V82, P21, DOI 10.1038/sj.clpt.6100235
   Li Yaqing, 2006, J Huazhong Univ Sci Technolog Med Sci, V26, P647, DOI 10.1007/s11596-006-0604-6
   LIETZ M, 2006, J BIOTECH BIOENG, V5, P99
   Lindvall O, 2008, EXP NEUROL, V209, P82, DOI 10.1016/j.expneurol.2007.08.019
   Liu YC, 2005, BIOMATERIALS, V26, P4737, DOI 10.1016/j.biomaterials.2005.01.003
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Minuth WW, 2007, BIOMED MATER, V2, pR1, DOI [10.1088/1748-6041/2/2/R01, 10.1088/1748-6041/2/R01]
   Minuth WW, 2005, BIO-MED MATER ENG, V15, P51
   Murua A, 2007, BIOMACROMOLECULES, V8, P3302, DOI 10.1021/bm070194b
   Norton LW, 2005, BIOMATERIALS, V26, P3285, DOI 10.1016/j.biomaterials.2004.07.069
   Ozgenel GY, 2003, MICROSURG, V23, P575, DOI 10.1002/micr.10209
   Peduto G, 2000, TRANSPLANTATION, V70, P78
   Rinsch C, 2002, KIDNEY INT, V62, P1395, DOI 10.1111/j.1523-1755.2002.kid574.x
   Rinsch C, 2001, GENE THER, V8, P523, DOI 10.1038/sj.gt.3301436
   Rinsch C, 2001, TRANSPLANTATION, V71, P345, DOI 10.1097/00007890-200102150-00002
   Rutkowski GE, 2002, BIOTECHNOL PROGR, V18, P362, DOI 10.1021/bp020300f
   SAGEN J, 1993, J NEUROSCI, V13, P2415
   SCHLOSSHAUER B, 2004, ENCY BIOMATERIALS BI, P1043
   Schlosshauer B, 2006, NEUROSURGERY, V59, P740, DOI 10.1227/01.NEU.0000235197.36789.42
   Schmidt PG, 2007, EXPERT OPIN BIOL TH, V7, P1427, DOI 10.1517/14712598.7.9.1427
   Steuer H, 2005, INVEST OPHTH VIS SCI, V46, P1047, DOI 10.1167/iovs.04-0925
   Steuer H, 2004, BRAIN RES PROTOC, V13, P26, DOI 10.1016/j.brainresprot.2003.12.002
   STIER H, 1995, DEVELOPMENT, V121, P1443
   Tan Q, 2007, EUR J CARDIO-THORAC, V31, P806, DOI 10.1016/j.ejcts.2007.01.045
   Tchetina EV, 2007, MATRIX BIOL, V26, P247, DOI 10.1016/j.matbio.2007.01.006
   Vessillier S, 2004, PROTEIN ENG DES SEL, V17, P829, DOI 10.1093/protein/gzh097
   Ye SH, 2004, J BIOMAT SCI-POLYM E, V15, P981, DOI 10.1163/1568562041526450
   Zurn AD, 2000, CELL TRANSPLANT, V9, P471, DOI 10.1177/096368970000900404
NR 39
TC 10
Z9 10
U1 0
U2 3
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD SEP
PY 2008
VL 3
IS 3
AR 034119
DI 10.1088/1748-6041/3/3/034119
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 344HC
UT WOS:000258916500032
PM 18708701
DA 2018-10-19
ER

PT J
AU Fleckman, P
   Olerud, JE
AF Fleckman, P.
   Olerud, J. E.
TI Models for the histologic study of the skin interface with percutaneous
   biomaterials
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID BLOOD-STREAM INFECTION; SURFACE-TOPOGRAPHY; CONNECTIVE-TISSUE; KNOCKOUT
   MICE; TERM DEVICES; IMPLANTS; PREVENTION; ATTACHMENT; TECHNOLOGY;
   PROMISE
AB Percutaneous devices are critical for health care. Access to tissue, vessels and internal organs afforded by these devices provides the means to treat and monitor many diseases. Unfortunately, such access is not restricted, and infection may compromise the usefulness of the device and even the life of the patient. New biomaterials offer the possibility of maintaining internal access while limiting microbial access, but understanding of the cutaneous/biomaterial interface and models to study this area are limited. This paper focuses on models useful for studying the morphology and biology of the intersection of skin and percutaneous biomaterials. An organ culture and a mouse model are described that offer promising possibilities for improved understanding of this critical interface.
C1 [Fleckman, P.; Olerud, J. E.] Univ Washington, Div Dermatol, Sch Med, Seattle, WA 98195 USA.
RP Fleckman, P (reprint author), Univ Washington, Div Dermatol, Sch Med, HSB BB1353,Box 356524, Seattle, WA 98195 USA.
EM fleck@u.washington.edu
FU NSF [EEC 9529161]; NIH [DK 59221]; USPHS NIBIB [1R01 EB004422-03];
   Warren G Magnuson Research Grant; George F Odland Endowed Research Fund;
   Marvin and Judy Young Research Fund
FX This work was supported by NSF EEC 9529161, NIH DK 59221, USPHS NIBIB
   1R01 EB004422-03, the Warren G Magnuson Research Grant, the George F
   Odland Endowed Research Fund and the Marvin and Judy Young Research
   Fund. Special thanks to Marcia Usui for figures.
CR Bockamp E, 2002, PHYSIOL GENOMICS, V11, P115, DOI 10.1152/physiolgenomics.00067.2002
   CHEHROUDI B, 1991, J BIOMED MATER RES, V25, P387, DOI 10.1002/jbm.820250310
   Crnich CJ, 2002, CLIN INFECT DIS, V34, P1232, DOI 10.1086/339863
   Crnich CJ, 2002, CLIN INFECT DIS, V34, P1362, DOI 10.1086/340105
   Fukano Y, 2006, WOUND REPAIR REGEN, V14, P484, DOI 10.1111/j.1743-6109.2006.00138.x
   GANGJEE T, 1985, ANN BIOMED ENG, V13, P451, DOI 10.1007/BF02407772
   Gerritsen M., 2000, Journal of Biomedical Materials Research, V52, P135, DOI 10.1002/1097-4636(200010)52:1<135::AID-JBM17>3.0.CO;2-I
   Grose R, 2004, MOL BIOTECHNOL, V28, P147, DOI 10.1385/MB:28:2:147
   Heaney TG, 1996, J BIOMED MATER RES, V32, P593, DOI 10.1002/(SICI)1097-4636(199612)32:4<593::AID-JBM12>3.0.CO;2-F
   Isenhath SN, 2007, J BIOMED MATER RES A, V83A, P915, DOI 10.1002/jbm.a.31391
   Jansen J A, 1989, J Invest Surg, V2, P29, DOI 10.3109/08941938909016502
   Jansen J A, 1994, J Invest Surg, V7, P123, DOI 10.3109/08941939409015356
   JANSEN JA, 1988, BIOMATERIALS, V9, P268, DOI 10.1016/0142-9612(88)90096-8
   JANSEN JA, 1991, J BIOMED MATER RES, V25, P1535, DOI 10.1002/jbm.820251210
   Kim H, 2006, INT J ORAL MAX IMPL, V21, P354
   Knabe C, 1999, BIOMATERIALS, V20, P503, DOI 10.1016/S0142-9612(98)00195-1
   Knowles NG, 2005, J BIOMED MATER RES A, V74A, P482, DOI 10.1002/jbm.a.30384
   Lundgren D, 1989, J Invest Surg, V2, P17, DOI 10.3109/08941938909016501
   MARSHALL AJ, 2004, POLYM PREPRINTS, V45, P100
   Mermel LA, 2000, ANN INTERN MED, V133, P395
   Mermel LA, 2000, ANN INTERN MED, V132, P391, DOI 10.7326/0003-4819-132-5-200003070-00009
   MERMEL LA, 1991, AM J MED S3B, V91, P197
   O'Grady Naomi P, 2002, MMWR Recomm Rep, V51, P1
   OKADA T, 1995, J BIOMAT SCI-POLYM E, V7, P171, DOI 10.1163/156856295X00689
   Raad Issam, 1993, Journal of Infectious Diseases, V168, P400
   Reid RR, 2004, J AM COLL SURGEONS, V199, P578, DOI 10.1016/j.jamcollsurg.2004.05.262
   Shin Y, 1997, ARTIF ORGANS, V21, P995
   SQUIER CA, 1981, J PERIODONTAL RES, V16, P434, DOI 10.1111/j.1600-0765.1981.tb00994.x
   TOKUYASU KT, 1989, HISTOCHEM J, V21, P163, DOI 10.1007/BF01007491
   VONRECUM AF, 1984, J BIOMED MATER RES, V18, P323, DOI 10.1002/jbm.820180403
   VONRECUM AF, 1981, CRC CR REV BIOM ENG, V5, P37
   Walboomers XF, 2005, J BIOMED MATER RES A, V74A, P381, DOI 10.1002/jbm.a.30337
   Weber H P, 1992, Alpha Omegan, V85, P61
   WINTER GD, 1974, J BIOMED MATER RES, V8, P99, DOI 10.1002/jbm.820080311
NR 34
TC 15
Z9 15
U1 0
U2 6
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
J9 BIOMED MATER
JI Biomed. Mater.
PD SEP
PY 2008
VL 3
IS 3
AR 034006
DI 10.1088/1748-6041/3/3/034006
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 344HC
UT WOS:000258916500008
PM 18708704
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Fonner, JM
   Forciniti, L
   Nguyen, H
   Byrne, JD
   Kou, YF
   Syeda-Nawaz, J
   Schmidt, CE
AF Fonner, John M.
   Forciniti, Leandro
   Nguyen, Hieu
   Byrne, James D.
   Kou, Yann-Fuu
   Syeda-Nawaz, Jeja
   Schmidt, Christine E.
TI Biocompatibility implications of polypyrrole synthesis techniques
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID PROTEIN ADSORPTION; IN-SITU; MECHANICAL-PROPERTIES; CONDUCTING POLYMERS;
   AQUEOUS-SOLUTIONS; FILMS; MORPHOLOGY; GUIDANCE; ELECTROPOLYMERIZATION;
   FIBRONECTIN
AB Polypyrrole (PPy) is an inherently conducting polymer that has shown great promise for biomedical applications within the nervous system. However, to effectively use PPy as a biomaterial implant, it is important to understand and reproducibly control the electrical properties, physical topography and surface chemistry of the polymer. Although there is much research published on the use of PPy in various applications, there is no systematic study linking the methodologies used for PPy synthesis to PPy's basic polymeric properties ( e. g., hydrophilicity, surface roughness), and to the biological effects these properties have on cells. Electrochemically synthesized PPy films differ greatly in their characteristics depending on synthesis parameters such as dopant, substrate and thickness, among other parameters. In these studies, we have used three dopants (chloride (Cl), tosylate (ToS), polystyrene sulfonate (PSS)), two substrates ( gold and indium tin oxide-coated glass), and a range of thicknesses, to measure and compare the biomedically important characteristics of surface roughness, contact angle, conductivity, dopant stability and cell adhesion (using PC-12 cells and Schwann cells). As predicted, we discovered large differences in roughness depending on the dopant used and the thickness of the film, while substrate choice had little effect. From contact angle measurements, PSS was found to yield the most hydrophilic material, most likely because of free charges from the long PSS chains exposed on the surface of the PPy. ToS-doped PPy films were tenfold more conductive than Cl-or PSS-doped films. X-ray photoelectron spectroscopy studies were used to evaluate dopant concentrations of PPy films stored in water and phosphate buffered saline over 14 days, and conductance studies over the same timeframe measured electrical stability. PSS proved to be the most stable dopant, though all films experienced significant decay in conductivity and dopant concentration. Cell adhesion studies demonstrated the dependence of cell outcome on film thickness and dopant choice. The strengths and weaknesses of different synthesis parameters, as demonstrated by these experiments, are critical design factors that must be leveraged when designing biomedical implants. The results of these studies should provide practical insight to researchers working with conducting polymers, and particularly PPy, on the relationships between synthesis parameters, polymeric properties and biological compatibility.
C1 [Fonner, John M.; Nguyen, Hieu; Byrne, James D.; Kou, Yann-Fuu; Syeda-Nawaz, Jeja; Schmidt, Christine E.] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA.
   [Forciniti, Leandro; Schmidt, Christine E.] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA.
RP Schmidt, CE (reprint author), Univ Texas Austin, Dept Biomed Engn, 1 Univ Stn,MC C0800, Austin, TX 78712 USA.
EM schmidt@che.utexas.edu
RI Schmidt, Christine/P-1613-2016
OI Nguyen, Hieu/0000-0002-0680-2720
FU National Institutes of Health [R01 EB004529]
FX The authors would like to thank Dr Yangming Sun and Nathalie Guimard for
   their assistance with XPS, and the Center for Nano & Molecular Science &
   Technology for the use of their facilities. This study was financially
   supported by the National Institutes of Health (R01 EB004529).
CR BAILEY SB, 1993, J NEUROCYTOL, V22, P176, DOI 10.1007/BF01246356
   Bentley David, 1994, Current Opinion in Neurobiology, V4, P43, DOI 10.1016/0959-4388(94)90030-2
   BOLTO BA, 1963, AUST J CHEM, V16, P1090, DOI 10.1071/CH9631090
   BRAY D, 1988, ANNU REV CELL BIOL, V4, P43, DOI 10.1146/annurev.cellbio.4.1.43
   Bufon CCB, 2005, J PHYS CHEM B, V109, P19191, DOI 10.1021/jp053516j
   Cai KY, 2006, COLLOID SURFACE B, V50, P1, DOI 10.1016/j.colsurfb.2006.03.016
   Carquigny S, 2008, SYNTHETIC MET, V158, P453, DOI 10.1016/j.synthmet.2008.03.010
   Chainet E, 1998, J ELECTROANAL CHEM, V451, P273
   Chehimi MM, 2004, SYNTHETIC MET, V145, P15, DOI 10.1016/j.synthmet.2004.03.015
   CLARK P, 1990, DEVELOPMENT, V108, P635
   Cui XY, 2003, BIOMATERIALS, V24, P777, DOI 10.1016/S0142-9612(02)00415-5
   DIAZ A, 1981, CHEM SCRIPTA, V17, P145
   Diaz A. F., 1982, EXTENDED LINEAR CHAI, V3, P417
   DIAZ AF, 1983, IBM J RES DEV, V27, P342, DOI 10.1147/rd.274.0342
   Dowell-Mesfin NM, 2004, J NEURAL ENG, V1, P78, DOI 10.1088/1741-2560/1/2/003
   EINHEBER S, 1993, J CELL BIOL, V123, P1223, DOI 10.1083/jcb.123.5.1223
   George PM, 2006, ADV MATER, V18, P577, DOI 10.1002/adma.200501242
   George PM, 2005, BIOMATERIALS, V26, P3511, DOI 10.1016/j.biomaterials.2004.09.037
   Guimard NK, 2007, PROG POLYM SCI, V32, P876, DOI 10.1016/j.progpolymsci.2007.05.012
   Hallab NJ, 2001, TISSUE ENG, V7, P55, DOI 10.1089/107632700300003297
   Hodgson AJ, 1996, PROC SPIE, V2716, P164, DOI 10.1117/12.232137
   Kang E. T., 1997, HDB ORGANIC CONDUCTI, P121
   Kaynak A, 1997, MATER RES BULL, V32, P271, DOI 10.1016/S0025-5408(96)00200-0
   Khorasani MT, 2006, COLLOID SURFACE B, V51, P112, DOI 10.1016/j.colsurfb.2006.06.002
   Kotwal A, 2001, BIOMATERIALS, V22, P1055, DOI 10.1016/S0142-9612(00)00344-6
   KUHN HH, 1995, SYNTHETIC MET, V71, P2139, DOI 10.1016/0379-6779(94)03198-F
   Mabrouk PA, 2005, SYNTHETIC MET, V150, P101, DOI 10.1016/j.synthmet.2005.01.011
   MADDISON DS, 1989, SYNTHETIC MET, V30, P47, DOI 10.1016/0379-6779(89)90640-1
   Miller C, 2002, TISSUE ENG, V8, P367, DOI 10.1089/107632702760184646
   Ming GL, 2001, NEURON, V29, P441, DOI 10.1016/S0896-6273(01)00217-3
   MORENO JS, 2007, BIOELECTROCHEMISTRY, V72, P3
   PINI A, 1994, CURR BIOL, V4, P131, DOI 10.1016/S0960-9822(94)00029-1
   Sadki S, 2000, CHEM SOC REV, V29, P283
   SCHMEISSER D, 1993, SYNTHETIC MET, V59, P211, DOI 10.1016/0379-6779(93)91028-Z
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   SKOTHEIM TA, 1986, HDB CONDUCTING POLYM, V2, P3510
   STANKOVIC R, 1994, EUR POLYM J, V30, P385, DOI 10.1016/0014-3057(94)90303-4
   Suarez MF, 1999, J ELECTROANAL CHEM, V462, P211, DOI 10.1016/S0022-0728(98)00414-8
   Vernitskaya TV, 1997, RUSS CHEM REV, V66, P443, DOI DOI 10.1070/RC1997V066N05ABEH000261
   Wang XD, 2004, J BIOMED MATER RES A, V68A, P411, DOI 10.1002/jbm.a.20065
   Wittmer CR, 2007, BIOMATERIALS, V28, P851, DOI 10.1016/j.biomaterials.2006.09.037
   WYNNE KJ, 1985, MACROMOLECULES, V18, P2361, DOI 10.1021/ma00154a005
   YEKTAFARD M, 1992, J ADHES SCI TECHNOL, V6, P253, DOI 10.1163/156856192X00322
   Yuan YJ, 1999, EUR POLYM J, V35, P1761, DOI 10.1016/S0014-3057(98)00268-7
NR 44
TC 86
Z9 88
U1 0
U2 34
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
J9 BIOMED MATER
JI Biomed. Mater.
PD SEP
PY 2008
VL 3
IS 3
AR 034124
DI 10.1088/1748-6041/3/3/034124
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 344HC
UT WOS:000258916500037
PM 18765899
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Pavithra, D
   Doble, M
AF Pavithra, D.
   Doble, Mukesh
TI Biofilm formation, bacterial adhesion and host response on polymeric
   implants - issues and prevention
SO BIOMEDICAL MATERIALS
LA English
DT Review
ID POLYSACCHARIDE INTERCELLULAR ADHESIN; COAGULASE-NEGATIVE STAPHYLOCOCCI;
   MEDICAL DEVICES; IN-VITRO; STREPTOCOCCUS-PNEUMONIAE; SURFACE
   MODIFICATION; BIOMATERIAL RESEARCH; BLOOD COMPATIBILITY; PROTEIN
   ADSORPTION; CELL-ADHESION
AB Several polymeric materials find application in biomedical implants and devices due to their superior physicochemical properties. The main requirement for these polymers is that they should be biocompatible, which means they prevent bacterial adhesion and are blood compatible. Many parameters contribute to the degree of biocompatibility. This paper discusses the mechanism of the formation of biofilms and lists the factors that influence the bacterial adhesion and haemocompatibility. Polymer surfaces are also modified to enhance adsorption of host cells. The physical, chemical and biological techniques are meant to modify the surface of the biomaterial but at the same time retain the key properties. The various polymer treatment processes have advantages and disadvantages and a few techniques have been proved to be both highly effective at treatment and found suitable for various in vivo environments. The current research focus pertaining to smart materials, biodegradable polymers, combinatorial chemistry, computational modelling and newer analytical techniques to understand polymer-cell interaction holds promise in designing better, cost effective and biocompatible polymers.
C1 [Pavithra, D.; Doble, Mukesh] Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India.
RP Pavithra, D (reprint author), Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India.
EM mukeshd@iitm.ac.in
OI Doble, Mukeshd/0000-0002-4335-0698
CR Allegrucci M, 2006, J BACTERIOL, V188, P2325, DOI 10.1128/JB.188.7.2325-2335.2006
   ANDERSON JM, 1935, CARDIOVASC PATHOL, V2, P335
   ANDERSON JM, 1993, CARDIOVASC PATHOL, V3, P335
   BAMFORD C H, 1992, Clinical Materials, V10, P243, DOI 10.1016/0267-6605(92)90018-O
   Baquey C, 1999, NUCL INSTRUM METH B, V151, P255, DOI 10.1016/S0168-583X(99)00106-8
   Barraud N, 2006, J BACTERIOL, V188, P7344, DOI 10.1128/JB.00779-06
   Baumgartner JN, 1997, BIOMATERIALS, V18, P831, DOI 10.1016/S0142-9612(96)00197-4
   Bernacca GM, 1998, BIOMATERIALS, V19, P1151, DOI 10.1016/S0142-9612(98)00016-7
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P837, DOI 10.1002/jbm.820260702
   BORCIA G, 2005, ROM J BIOPHYS, V15, P147
   BORRIELLO G, 2006, ANTIMICROB AGENTS CH, V3, P82
   Burmeister JS, 1998, BIOMATERIALS, V19, P307, DOI 10.1016/S0142-9612(97)00109-9
   BUSSCHER HJ, 1991, CELLS MAT, V1, P234
   Cerca N, 2005, RES MICROBIOL, V156, P506, DOI 10.1016/j.resmic.2005.01.007
   CERCA N, 2005, APPL ENVIRON MICROB, V86, P77
   Chavant P, 2007, J MICROBIOL METH, V68, P605, DOI 10.1016/j.mimet.2006.11.010
   Cho SH, 2002, INT J ANTIMICROB AG, V19, P570, DOI 10.1016/S0924-8579(02)00101-2
   Chokr A, 2006, INT J MED MICROBIOL, V296, P381, DOI 10.1016/j.ijmm.2006.02.018
   Chu CFL, 1999, BBA-GEN SUBJECTS, V1472, P479, DOI 10.1016/S0304-4165(99)00151-8
   Compan V, 2004, BIOMATERIALS, V25, P359, DOI 10.1016/S0142-9612(03)00527-1
   Cui FZ, 1999, SURF COAT TECH, V112, P278, DOI 10.1016/S0257-8972(98)00763-4
   Dewez JL, 1998, BIOMATERIALS, V19, P1441, DOI 10.1016/S0142-9612(98)00055-6
   Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002
   Duan XB, 2002, BIOMATERIALS, V23, P1197, DOI 10.1016/S0142-9612(01)00234-4
   Elwing H, 1998, BIOMATERIALS, V19, P397, DOI 10.1016/S0142-9612(97)00112-9
   Francois P, 1996, BIOMATERIALS, V17, P667, DOI 10.1016/0142-9612(96)86736-6
   FREITAS RA, 2003, NANOMEDICINE A, V2, P3510
   Gan BS, 2002, J INFECT DIS, V185, P1369, DOI 10.1086/340126
   Giacometti A, 2003, ANTIMICROB AGENTS CH, V47, P1979, DOI 10.1128/AAC.47.6.1979-1983.2003
   Gollwitzer H, 2003, J ANTIMICROB CHEMOTH, V51, P585, DOI 10.1093/jac/dkg105
   Harris LG, 2004, BIOMATERIALS, V25, P4135, DOI 10.1016/j.biomaterials.2003.11.033
   Hauert R, 2003, DIAM RELAT MATER, V12, P583, DOI 10.1016/S0925-9635(03)00081-5
   Heath DJ, 2002, BIOMATERIALS, V23, P1519, DOI 10.1016/S0142-9612(01)00282-4
   HOFFMAN A S, 1991, Clinical Materials, V8, P3, DOI 10.1016/0267-6605(91)90003-X
   HOGT AH, 1986, INFECT IMMUN, V51, P294
   HOWARD J, 2004, Patent No. 6727223
   HUISKES R, 1992, CLIN ORTHOP RELAT R, P124
   Hunt JA, 1997, BIOMATERIALS, V18, P1449, DOI 10.1016/S0142-9612(97)00091-4
   Hunt SM, 2004, APPL ENVIRON MICROB, V70, P7418, DOI 10.1128/AEM.70.12.7418-7425.2004
   Jagielski J, 2006, SURF COAT TECH, V200, P6355, DOI 10.1016/j.surfcoat.2005.11.005
   Jarry C, 2001, J BIOMED MATER RES, V58, P127, DOI 10.1002/1097-4636(2001)58:1<127::AID-JBM190>3.0.CO;2-G
   Jefferson KK, 2004, FEMS MICROBIOL LETT, V236, P163, DOI 10.1016/j.femsle.2004.06.005
   Johnston EE, 1996, J ELECTRON SPECTROSC, V81, P303, DOI 10.1016/0368-2048(95)02666-5
   Kanamaru S, 2006, INT J ANTIMICROB AG, V28, pS21, DOI 10.1016/j.ijantimicag.2006.05.006
   Kato S, 2000, BIOMATERIALS, V21, P521, DOI 10.1016/S0142-9612(99)00214-8
   Katsaros D, 2004, IEEE INTERNET COMPUT, V8, P37, DOI 10.1109/MIC.2004.1297272
   Kayirhan N, 2001, J APPL POLYM SCI, V81, P1322, DOI 10.1002/app.1557
   Kesler DJ, 1999, J VET MED B, V46, P25, DOI 10.1046/j.1439-0450.1999.00194.x
   Keuren JFW, 2003, BIOMATERIALS, V24, P1917, DOI 10.1016/S0142-9612(02)00620-8
   Khoury A E, 1992, ASAIO J, V38, pM174, DOI 10.1097/00002480-199207000-00013
   Kong KF, 2006, INT J MED MICROBIOL, V296, P133, DOI 10.1016/j.ijmm.2006.01.042
   Koromila G, 2006, BIOMATERIALS, V27, P2525, DOI 10.1016/j.biomaterials.2005.11.017
   Kruft MAB, 1997, BIOMATERIALS, V18, P31, DOI 10.1016/S0142-9612(96)00085-3
   LAMBA NMK, 1998, POLYURETHANES BIOMED, P3510
   LEE KY, 1995, BIOMATERIALS, V16, P1211, DOI 10.1016/0142-9612(95)98126-Y
   Lembke C, 2006, APPL ENVIRON MICROB, V72, P2864, DOI 10.1128/AEM.72.4.2864-2875.2006
   Locatelli CI, 2003, BRAZ J MICROBIOL, V34, P203, DOI 10.1590/S1517-83822003000300004
   Mao C, 2004, ADV COLLOID INTERFAC, V110, P5, DOI 10.1016/j.cis.2004.02.001
   Mendes SC, 2001, BIOMATERIALS, V22, P2057, DOI 10.1016/S0142-9612(00)00395-1
   MIRZADEH H, 1995, BIOMATERIALS, V16, P641, DOI 10.1016/0142-9612(95)93862-8
   Moscoso M, 2006, J BACTERIOL, V188, P7785, DOI 10.1128/JB.00673-06
   Nakano K, 2005, MICROBES INFECT, V7, P1246, DOI 10.1016/j.micinf.2005.04.012
   NGUYEN NT, 2006, NANOTECHNOLOGY, V4, P93
   Noh JH, 2007, SURF COAT TECH, V201, P5097, DOI 10.1016/j.surfcoat.2006.07.223
   OJENIJI B, 1991, CHEMOTHERAPY, V44, P13
   Oleschuk RD, 2000, BIOMATERIALS, V21, P1701, DOI 10.1016/S0142-9612(00)00054-5
   Padera RF, 2006, CARDIOVASC PATHOL, V15, P264, DOI 10.1016/j.carpath.2006.04.008
   Park K, 1998, BIOMATERIALS, V19, P387, DOI 10.1016/S0142-9612(97)00111-7
   Plowman TE, 1998, BIOMATERIALS, V19, P341, DOI 10.1016/S0142-9612(97)00113-0
   Poussard L, 2004, BIOMATERIALS, V25, P3473, DOI 10.1016/j.biomaterials.2003.10.069
   Rana N. S. S., 2001, J ELECT SPECTROSC RE, V121, P249
   Rather B.D., 1992, CLIN MAT, V11, P25
   REMICK DG, 1997, CYTOKINES HLTH DIS, P299
   Rohde H, 2007, BIOMATERIALS, V28, P1711, DOI 10.1016/j.biomaterials.2006.11.046
   Ruzicka F, 2007, J MICROBIOL METH, V68, P530, DOI 10.1016/j.mimet.2006.10.008
   SCHAKENRAAD JM, 1986, J BIOMED MATER RES, V20, P773, DOI 10.1002/jbm.820200609
   SCHAKENRAAD JM, 1989, COLLOID SURFACE, V42, P331
   SCHMIDMAIER G, 2007, INJURY, V37, pS105
   Seifert B, 1997, BIOMATERIALS, V18, P1495, DOI 10.1016/S0142-9612(97)00079-3
   SHALABY WS, 1995, BIOMATERIALS, V16, P1117
   Shangguan YY, 2006, BIOMATERIALS, V27, P2349, DOI 10.1016/j.biomaterials.2005.11.024
   Siedlecki CA, 1998, BIOMATERIALS, V19, P441, DOI 10.1016/S0142-9612(97)00222-6
   Simmons WL, 2007, J BACTERIOL, V189, P1905, DOI 10.1128/JB.01512-06
   Singhal JP, 2002, BIOMATERIALS, V23, P1139, DOI 10.1016/S0142-9612(01)00228-9
   Sodhi RNS, 1996, J ELECTRON SPECTROSC, V81, P269, DOI 10.1016/0368-2048(95)02665-7
   Song B, 2006, MICROBIOL RES, V161, P355, DOI 10.1016/j.micres.2006.01.004
   Sun YC, 2004, ADV DRUG DELIVER REV, V56, P1481, DOI 10.1016/j.addr.2004.02.009
   SUNIKET VF, 2007, J PHARM SCI, V96, P132
   Suzuki Y, 2003, NUCL INSTRUM METH B, V206, P501, DOI 10.1016/S0168-583X(03)00808-5
   SZYCHER M, 2004, BIOMATERIALS PROSTHE, V3, P707
   TANG L, 1995, BIOMATERIALS, V16, P483, DOI 10.1016/0142-9612(95)98822-V
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   Tengvall P, 1998, BIOMATERIALS, V19, P407, DOI 10.1016/S0142-9612(97)00110-5
   Tenke P, 2004, EUA UPDATE SERIES, P106
   TOOMEY R, 2003, EUR CELLS MATER, V6, P24
   Tsibouklis J, 1999, BIOMATERIALS, V20, P1229, DOI 10.1016/S0142-9612(99)00023-X
   Uyama H, 2003, BIOMACROMOLECULES, V4, P211, DOI 10.1021/bm0256092
   Van Houdt R, 2005, RES MICROBIOL, V156, P626, DOI 10.1016/j.resmic.2005.02.005
   van Merode AEJ, 2006, J BACTERIOL, V188, P2421, DOI 10.1128/JB.188.7.2421-2426.2006
   VOGLER EA, 1989, COLLOID SURFACE, V42, P233
   Zhang S, 2006, THIN SOLID FILMS, V515, P66, DOI 10.1016/j.tsf.2005.12.037
   Ziats N. P, 1998, BIOMATERIALS, V9, P5
   Zlatanic A, 2004, J POLYM SCI POL PHYS, V42, P809, DOI 10.1002/polb.10737
NR 103
TC 126
Z9 129
U1 3
U2 85
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
J9 BIOMED MATER
JI Biomed. Mater.
PD SEP
PY 2008
VL 3
IS 3
AR 034003
DI 10.1088/1748-6041/3/3/034003
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 344HC
UT WOS:000258916500005
PM 18689922
DA 2018-10-19
ER

PT J
AU Yamamichi, N
   Pugdee, K
   Chang, WJ
   Lee, SY
   Yoshinari, M
   Hayakawa, T
   Abiko, Y
AF Yamamichi, Nobuyuki
   Pugdee, Kamolparn
   Chang, Wei-Jen
   Lee, Sheng-Yang
   Yoshinari, Masao
   Hayakawa, Tohru
   Abiko, Yoshimitsu
TI Gene expression monitoring in osteoblasts on titanium coated with
   fibronectin-derived peptide
SO DENTAL MATERIALS JOURNAL
LA English
DT Article
DE Osteoblast; RGD peptide; GeneChip
ID BONE-FORMATION; CELLS; DIFFERENTIATION; ACTIVATION; IMPLANTS; SURFACES
AB Enhanced adhesion and migration of osteoblastic cells on titanium (Ti) surface is believed to increase the success rate of implant therapy. A GRGDSP peptide derived from fibronectin was coated on Ti surfaces using a tresyl chloride activation technique, and then MC3T3-E1 osteoblastic cells were cultured on the Ti surfaces. After 15 days, total RNA was isolated from the cells and gene expression level were analyzed by Affymetrix GeneChip system. The expression levels of many genes in MC3T3-E1 cells cultured on GRGDSP-coated Ti surface were altered when compared to uncoated Ti. In particular, the elevated mRNA levels of bone sialoprotein (BSP) and osteocalcin (OC) were successfully confirmed by reverse transcription-polymerase chain reaction (RT-PCR) and real-time PCR. In light of the results obtained, GRGDSP-coated Ti presented the potential of evolving into a useful biomaterial for successful implant therapy.
C1 [Hayakawa, Tohru] Nihon Univ, Sch Dent Matsuda, Dept Dent Biomat, Chiba, Japan.
   [Yamamichi, Nobuyuki; Pugdee, Kamolparn; Abiko, Yoshimitsu] Nihon Univ, Sch Dent Matsuda, Dept Biochem & Mol Biol, Chiba, Japan.
   [Chang, Wei-Jen; Lee, Sheng-Yang] Taipei Med Univ, Sch Dent, Taipei, Taiwan.
   [Yoshinari, Masao] Tokyo Dent Coll, Oral Hlth Sci Ctr, Div Oral Implants Res, Mihama Ku, Chiba 2618502, Japan.
   [Hayakawa, Tohru; Abiko, Yoshimitsu] Nihon Univ, Sch Dent Matsuda, Res Inst Oral Sci, Chiba, Japan.
RP Hayakawa, T (reprint author), Nihon Univ, Sch Dent Matsuda, Dept Dent Biomat, 2-870-1 Sakaecho Nishi, Chiba, Japan.
EM hayakawa.tohru@nihon-u.ac.jp; abiko.yoshimitsu@nihon-u.ac.jp
FU Japan Society for the Promotion of Science [A1-16209063, C-19592260];
   Ministry of Education, Culture, Sports, Science and Technology
FX This work was supported by a Grant-in-aid for Scientific Research
   (A1-16209063 and C-19592260) from the Japan Society for the Promotion of
   Science and by the "Academic Frontier" Project for Private Universities:
   matching fund subsidy from the Ministry of Education, Culture, Sports,
   Science and Technology, 2007-2011.
CR Abiko Y, 2007, INT J ORAL MED SCI, V6, P97
   Bugel S, 2003, P NUTR SOC, V62, P839, DOI 10.1079/PNS2003305
   DEAN JW, 1995, J ORAL MAXILLOFAC IM, V10, P721
   Ferris DM, 1999, BIOMATERIALS, V20, P2323, DOI 10.1016/S0142-9612(99)00161-1
   Garcia AJ, 2005, J DENT RES, V84, P407, DOI 10.1177/154405910508400502
   Gauss B, 1999, CRIT REV ORAL BIOL M, V10, P79
   Hayakawa T, 2003, J BIOMED MATER RES A, V67A, P684, DOI 10.1002/jbm.a.10143
   Hilbig H, 2007, EUR J MED RES, V12, P6
   MacDonald DE, 1998, J BIOMED MATER RES, V41, P120
   Pugdee K, 2007, DENT MATER J, V26, P647, DOI 10.4012/dmj.26.647
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Schliephake H, 2002, CLIN ORAL IMPLAN RES, V13, P312, DOI 10.1034/j.1600-0501.2002.130312.x
   WALIVAARA B, 1994, BIOMATERIALS, V15, P827, DOI 10.1016/0142-9612(94)90038-8
   Zreiqat H, 2003, J BIOMED MATER RES A, V64A, P105, DOI 10.1002/jbm.a.10376
NR 14
TC 30
Z9 30
U1 2
U2 4
PU JAPANESE SOC DENTAL MATERIALS DEVICES
PI TOKYO
PA C/O KOKU HOKEN KYOKAI, 1-43-9 KOMAGOME TS BDG, KOMAGOME, TOSHIMA-KU,
   TOKYO, 170-0003, JAPAN
SN 0287-4547
J9 DENT MATER J
JI Dent. Mater. J.
PD SEP
PY 2008
VL 27
IS 5
BP 744
EP 750
DI 10.4012/dmj.27.744
PG 7
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA 375US
UT WOS:000261139700015
PM 18972793
OA Bronze
DA 2018-10-19
ER

PT J
AU Kang, SB
   Lee, HN
   Lee, JY
   Park, JS
   Lee, HS
   Lee, JY
AF Kang, Sung-Bum
   Lee, Haet Nim
   Lee, Ji Young
   Park, Jun-Seok
   Lee, Hye Seung
   Lee, Ji Youl
TI Sphincter contractility after muscle-derived stem cells autograft into
   the cryoinjured anal sphincters of rats
SO DISEASES OF THE COLON & RECTUM
LA English
DT Article; Proceedings Paper
CT Conference of the
   Tissue-Engineering-and-Regenerative-Medicine-International-Society
   (TERMIS-EU)
CY SEP 04-07, 2007
CL London, ENGLAND
SP Tissue Engn & Regenerat Med Int Soc, European Chapter, UK Tissue & Cell Engn Soc
DE fecal incontinence; muscle-derived stem cell; anal sphincter; rat;
   cryoinjury; contractility
ID STRESS URINARY-INCONTINENCE; INJECTABLE SILICONE BIOMATERIAL; LEAK POINT
   PRESSURE; FECAL INCONTINENCE; GENE-THERAPY; INJECTION; MODEL;
   DYSFUNCTION; DIFFERENTIATION; TRANSPLANTATION
AB PURPOSE: This study was designed to determine whether the injection of muscle-derived stem cells into the anal sphincter can improve functional properties in a fecal incontinence rat model.
   METHODS: Cryoinjured rats were utilized as a fecal incontinence model. The gastrocnemius muscles of normal three-week-old female Sprague-Dawley rats were used for the purification of the muscle-derived stem cells. The experimental group was divided into three subgroups: normal control; cryoinjured; and muscle-derived stem cells (3x10(6) cells) injection group of cryoinjured rats. All groups were subsequently employed in contractility experiments using muscle strips from the anal sphincter, one week after preparation.
   RESULTS: Contractility in the cryoinjured group was significantly lower than in the control after treatment with acetylcholine and KCl. In the muscle-derived stem cells injection group, contraction amplitude was higher than in the cryoinjured group but not significantly (20.5 +/- 21.3 vs. 17.3 +/- 3.4 g per gram tissue, with acetylcholine (10(-4) mol/l); 31 +/- 14.2 vs. 18.4 +/- 7.9 g per gram tissue, with KCl (10(-4) mol/l)). PKH-26-labeled transplanted cells were detected in all of the grafted sphincters. Differentiated muscle masses stained positively for alpha smooth muscle actin and myosin heavy chain at the muscle-derived stem cells injection sites.
   CONCLUSIONS: This is the first study reporting that autologous muscle-derived stem cell grafts may be a tool for improving anal sphincter function.
C1 [Lee, Haet Nim; Lee, Ji Young; Lee, Ji Youl] Catholic Univ Korea, Dept Urol, Coll Med, Holy Family Hosp, Bucheon Si 420717, Gyonggi Do, South Korea.
   [Kang, Sung-Bum; Park, Jun-Seok] Seoul Natl Univ, Bundang Hosp, Dept Surg, Songnam, Gyonggi Do, South Korea.
   [Lee, Hye Seung] Seoul Natl Univ, Bundang Hosp, Dept Pathol, Songnam, Gyonggi Do, South Korea.
RP Lee, JY (reprint author), Catholic Univ Korea, Dept Urol, Coll Med, Holy Family Hosp, 2 Sosa Dong, Bucheon Si 420717, Gyonggi Do, South Korea.
EM uroljy@catholic.ac.kr
RI Kang, Sung-Bum/J-5361-2012; Seoul National University,
   Pathology/B-6702-2012; Lee, Hye Seung/G-6419-2011
OI Lee, Hye Seung/0000-0002-1667-7986
CR ALAMEDDINE HS, 1994, CELL TRANSPLANT, V3, P3
   Alessandri G, 2004, LANCET, V364, P1872, DOI 10.1016/S0140-6736(04)17443-6
   Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221
   Cannon TW, 2003, UROLOGY, V62, P958, DOI 10.1016/S0090-4295(03)00679-4
   Chan MKY, 2006, DIS COLON RECTUM, V49, P433, DOI 10.1007/s10350-005-0307-2
   Chermansky CJ, 2004, UROLOGY, V63, P780, DOI 10.1016/j.urology.2003.10.035
   Davis K, 2003, ALIMENT PHARM THERAP, V18, P237, DOI 10.1046/j.0269-2813.2003.01668.x
   Emans PJ, 2005, J BIOMED MATER RES A, V73A, P430, DOI 10.1002/jbm.a.30293
   Garcia-Olmo D, 2005, DIS COLON RECTUM, V48, P1416, DOI 10.1007/s10350-0052-6
   Garcia-Olmo D, 2003, INT J COLORECTAL DIS, V18, P451, DOI 10.1007/s00384-003-0490-3
   Guettier-Sigrist S, 2000, EXP CELL RES, V259, P204, DOI 10.1006/excr.2000.4968
   Gulbins H, 2003, THORAC CARDIOV SURG, V51, P295
   Hagege AA, 2003, LANCET, V361, P491, DOI 10.1016/S0140-6736(03)12458-0
   Huard J, 2002, GENE THER, V9, P1617, DOI 10.1038/sj.gt.3301816
   Hwang JH, 2004, MOL CELLS, V17, P57
   Kenefick NJ, 2002, GUT, V51, P225, DOI 10.1136/gut.51.2.225
   Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044
   Kumar D, 1998, BRIT J SURG, V85, P978
   Kwon D, 2006, UROLOGY, V68, P449, DOI 10.1016/j.urology.2006.03.040
   Lee JY, 2003, INT UROGYNECOL J, V14, P31, DOI 10.1007/s00192-002-1004-5
   Lee JY, 2004, MOL CELLS, V18, P309
   Macmillan AK, 2004, DIS COLON RECTUM, V47, P1341, DOI 10.1007/s10350-004-0593-0
   Malouf AJ, 2001, DIS COLON RECTUM, V44, P595, DOI 10.1007/BF02234337
   Pannek J, 2001, J UROLOGY, V166, P1350, DOI 10.1016/S0022-5347(05)65767-9
   Qu ZQ, 1998, J CELL BIOL, V142, P1257, DOI 10.1083/jcb.142.5.1257
   Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150
   RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275
   SHAFIK A, 1993, INT SURG, V78, P159
   SHAFIK A, 1995, DIS COLON RECTUM, V38, P583, DOI 10.1007/BF02054115
   Strasser H, 2007, LANCET, V369, P2179, DOI 10.1016/S0140-6736(07)61014-9
   Tjandra JJ, 2004, DIS COLON RECTUM, V47, P2138, DOI 10.1007/s10350-004-0760-3
   Yiou R, 2003, TRANSPLANTATION, V76, P1053, DOI 10.1097/01.TP.0000090396.71097.C2
   Yiou R, 2002, BJU INT, V89, P298, DOI 10.1046/j.1464-4096.2001.01618.x
   Yokoyama T, 2000, WORLD J UROL, V18, P56, DOI 10.1007/s003450050010
NR 34
TC 46
Z9 49
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0012-3706
J9 DIS COLON RECTUM
JI Dis. Colon Rectum
PD SEP
PY 2008
VL 51
IS 9
BP 1367
EP 1373
DI 10.1007/s10350-008-9360-y
PG 7
WC Gastroenterology & Hepatology; Surgery
SC Gastroenterology & Hepatology; Surgery
GA 339DC
UT WOS:000258557300011
PM 18536965
OA Green Published
DA 2018-10-19
ER

PT J
AU Sommer, F
   Pollinger, K
   Brandl, F
   Weiser, B
   Tessmar, J
   Blunk, T
   Gopferich, A
AF Sommer, Florian
   Pollinger, Klaus
   Brandl, Ferdinand
   Weiser, Barbara
   Tessmar, Joerg
   Blunk, Torsten
   Goepferich, Achim
TI Hyalocyte proliferation and ECM accumulation modulated by bFGF and
   TGF-beta 1
SO GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
LA English
DT Article
DE hyalocyte; transforming growth factor beta (TGF-beta); basic fibroblast
   growth factor (bFGF); cell-based vitreous substitute; tissue engineering
ID FIBROBLAST-GROWTH-FACTOR; FACTOR-BETA; TGF-BETA; CELL MIGRATION;
   VITREOUS GEL; FACTOR FGF; TISSUE; ACID; DIFFERENTIATION; EXPRESSION
AB Purpose In cases of severe retinal diseases, the vitreous body has to be removed and replaced by a suitable biomaterial. Currently, however, no satisfying long-term vitreous substitute is in clinical use. A novel therapeutic concept represents the combination of hyalocytes with suitable biomaterials. The goal of the present study was to evaluate the potential of bFGF and TGF-beta 1 as tools to control hyalocyte proliferation and the accumulation of extracellular matrix (ECM).
   Methods In vitro investigation on the influence of different concentrations of bFGF and TGF-beta 1 on hyalocyte morphology, proliferation and ECM production.
   Results Both growth factors affected hyalocyte morphology; small, round cells could be observed after bFGF supplementation, whereas the cells appeared more completely spread when cultured with TGF-beta 1. Hyalocyte proliferation was increased 3-fold by 10 ng/ml bFGF; 1 ng/ml TGF-beta 1 in contrast reduced cell proliferation to about 40% of the control. Converse effects of the growth factors could also be observed on the ECM accumulation of hyalocytes; whereas bFGF halved ECM accumulation, TGF-beta 1 enhanced the ECM production up to 3-fold. Precultivation of hyalocytes with bFGF for two passages had no influence on their subsequent accumulation of glycosaminoglycans (GAG). However, cells precultivated with bFGF exhibited a doubled accumulation of collagen compared to controls.
   Conclusions The observed opposite effects of bFGF and TGF-beta 1 on hyalocyte proliferation and ECM accumulation may allow for the control of hyaloycte properties. Therefore, these two growth factors seem to be valuable tools towards the development of a cell-based vitreous substitute.
C1 [Sommer, Florian; Pollinger, Klaus; Brandl, Ferdinand; Weiser, Barbara; Tessmar, Joerg; Blunk, Torsten; Goepferich, Achim] Univ Regensburg, Inst Pharm, Dept Pharmaceut Technol, D-93040 Regensburg, Germany.
RP Gopferich, A (reprint author), Univ Regensburg, Inst Pharm, Dept Pharmaceut Technol, Univ Str 31, D-93040 Regensburg, Germany.
EM achim.goepferich@chemie.uni-regensburg.de
RI Goepferich, Achim/G-1151-2016; Tessmar, Joerg/H-3606-2012
OI Goepferich, Achim/0000-0002-7646-0252; Tessmar,
   Joerg/0000-0001-7057-5369
CR ASSOIAN RK, 1987, P NATL ACAD SCI USA, V84, P6020, DOI 10.1073/pnas.84.17.6020
   ATTISANO L, 1994, BBA-MOL CELL RES, V1222, P71, DOI 10.1016/0167-4889(94)90026-4
   Badrinath SS, 1999, RETINA-J RET VIT DIS, V19, P51, DOI 10.1097/00006982-199901000-00008
   Benavente CA, 2003, GROWTH FACTORS, V21, P87, DOI 10.1080/08977190310001613789
   BERRADA S, 1995, IN VITRO CELL DEV-AN, V31, P698
   Bishop PN, 2002, EYE, V16, P454, DOI 10.1038/sj.eye.6700199
   Bishop PN, 2000, PROG RETIN EYE RES, V19, P323, DOI 10.1016/S1350-9462(99)00016-6
   BLOOM GUNNAR D., 1965, EXP EYE RES, V4, P249, DOI 10.1016/S0014-4835(65)80038-0
   Boltz-Nitulescu G, 1979, Adv Exp Med Biol, V121B, P223
   Borge L, 1997, IN VITRO CELL DEV-AN, V33, P703
   BROWN PD, 1988, J CELL BIOL, V106, P171, DOI 10.1083/jcb.106.1.171
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   CROSS M, 1991, CELL, V64, P271, DOI 10.1016/0092-8674(91)90638-F
   CUEVAS P, 1988, BIOCHEM BIOPH RES CO, V156, P611, DOI 10.1016/S0006-291X(88)80887-8
   DAMICO DJ, 1994, NEW ENGL J MED, V331, P95, DOI 10.1056/NEJM199407143310207
   Dickson C, 2002, MOL CELL ENDOCRINOL, V195, P65, DOI 10.1016/S0303-7207(02)00216-2
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   Frank RN, 2004, NEW ENGL J MED, V350, P48, DOI 10.1056/NEJMra021678
   FREEMAN MI, 1978, EXP EYE RES, V29, P479
   Gloor B P, 1978, Adv Ophthalmol, V36, P63
   GLOOR BP, 1973, GRAEFES ARCH CLIN EX, V187, P21
   HAUNER H, 1995, EUR J CLIN INVEST, V25, P90, DOI 10.1111/j.1365-2362.1995.tb01532.x
   Heidenkummer H.-P., 1996, Ophthalmologe, V93, P675, DOI 10.1007/s003470050057
   HENLE J, 1841, LEHRE MISCHUNGS FORM
   INOUE H, 1989, J CELL PHYSIOL, V138, P329, DOI 10.1002/jcp.1041380216
   Kay EP, 1998, CURR EYE RES, V17, P286, DOI 10.1076/ceyr.17.3.286.5212
   KEE NW, 2002, TISSUE ENG, V11, P182
   KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5
   KOBUCH K, 2002, INVEST OPHTHALMOL VI, V43
   LANGER R, 1993, TISSUE ENG SCI, V260, P920
   LAZARUS HS, 1994, ARCH OPHTHALMOL-CHIC, V112, P1356, DOI 10.1001/archopht.1994.01090220106031
   Lieb E, 2004, TISSUE ENG, V10, P1399, DOI 10.1089/1076327042500184
   LUTTY GA, 1993, INVEST OPHTH VIS SCI, V34, P477
   Martin I, 1997, ENDOCRINOLOGY, V138, P4456, DOI 10.1210/en.138.10.4456
   Martin I, 1999, EXP CELL RES, V253, P681, DOI 10.1006/excr.1999.4708
   Martin I, 2001, J CELL BIOCHEM, V83, P121, DOI 10.1002/jcb.1203
   MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121
   McGowan KB, 2002, OSTEOARTHR CARTILAGE, V10, P580, DOI 10.1053/joca.2002.0794
   Neubauer M, 2005, TISSUE ENG, V11, P1840, DOI 10.1089/ten.2005.11.1840
   NEWSOME DA, 1976, J CELL BIOL, V71, P59, DOI 10.1083/jcb.71.1.59
   Noda Y, 2004, INVEST OPHTH VIS SCI, V45, P2107, DOI 10.1167/iovs.03-1092
   OSTERLIN SE, 1968, EXP EYE RES, V7, P511, DOI 10.1016/S0014-4835(68)80004-1
   Pangborn CA, 2005, TISSUE ENG, V11, P1141, DOI 10.1089/ten.2005.11.1141
   Pei M, 2002, BIOCHEM BIOPH RES CO, V294, P149, DOI 10.1016/S0006-291X(02)00439-4
   Pickering JG, 1997, CIRC RES, V80, P627, DOI 10.1161/01.RES.80.5.627
   Qiao H, 2005, BRIT J OPHTHALMOL, V89, P513, DOI 10.1136/bjo.2004.050658
   Sakamoto Taiji, 2003, Nippon Ganka Gakkai Zasshi, V107, P866
   SALU P, 1985, OPHTHALMIC RES, V17, P125, DOI 10.1159/000265363
   Sebag J., 1989, VITREOUS
   Soman N, 2003, BIO-MED MATER ENG, V13, P59
   Sommer F, 2007, TISSUE ENG, V13, P1281, DOI 10.1089/ten.2006.0274
   Sommer F, 2006, ADV EXP MED BIOL, V585, P413
   Song QH, 2002, J CLIN PATHOL-MOL PA, V55, P164
   Spraul CW, 2004, OPHTHAL RES, V36, P166, DOI 10.1159/000077330
   Stevens MM, 2004, J ORTHOPAED RES, V22, P1114, DOI 10.1016/j.orthres.2003.12.021
   TAYLOR K B, 1969, Histochemical Journal, V1, P199, DOI 10.1007/BF01081408
   Tsutsumi S, 2001, BIOCHEM BIOPH RES CO, V288, P413, DOI 10.1006/bbrc.2001.5777
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
   WROBLEWSKI J, 1995, J BONE MINER RES, V10, P735
   ZANETTI NC, 1984, J CELL BIOL, V99, P115, DOI 10.1083/jcb.99.1.115
   Zhu M, 1997, AUST NZ J OPHTHALMOL, V25, P57
NR 61
TC 5
Z9 6
U1 0
U2 5
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0721-832X
J9 GRAEF ARCH CLIN EXP
JI Graefes Arch. Clin. Exp. Ophthalmol.
PD SEP
PY 2008
VL 246
IS 9
BP 1275
EP 1284
DI 10.1007/s00417-008-0846-z
PG 10
WC Ophthalmology
SC Ophthalmology
GA 330HV
UT WOS:000257932500009
PM 18461346
DA 2018-10-19
ER

PT J
AU Covani, U
   Cornelini, R
   Barone, A
AF Covani, Ugo
   Cornelini, Roberto
   Barone, Antonio
TI Buccal Bone Augmentation Around Immediate Implants With and Without Flap
   Elevation: A Modified Approach
SO INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS
LA English
DT Article
DE biomaterial; bone defect; dental implants; extraction sockets;
   mucoperiosteal flap
ID FRESH EXTRACTION SOCKETS; RETROSPECTIVE ANALYSIS; TOOTH EXTRACTION;
   CLINICAL REPORT; PLACEMENT; SURGERY; SITES; DOG
AB Purpose: The aim of this study was to compare the clinical success and bone healing of implants placed in fresh extraction sockets using a flapless procedure compared to those placed with flap elevation. Materials and Methods: Twenty teeth in 20 patients were selected for this study and were scheduled for tooth extraction and immediate implant placement. Ten implants were placed with flap elevation (control group), and 10 implants were placed without flap elevation (test group), All the sites selected showed a complete bone defect at the facial wall. All the implants included in this study were 2-stage implants placed at the level of palatal/lingual bone in augmented bone. Each surgical site was protected with a collagen membrane and, subsequently, a standardized radiograph was taken to evaluate the distance between the implant shoulder and the first bone-implant contact (DIB). Six months after placement, both control and test implants underwent a second-stage surgery and a clinical examination to determine the implant stability quotient, DIB, and the distance between implant shoulder and the crestal bone at the midbuccal aspect (DIC). Results: One implant failed in the test group. Only 1 implant (test group) showed bone growth over the implant neck at the re-entry procedure. Implant stability quotient (ISQ) and DIB did not show any significant differences between the control and test group; however, a higher DIC was found in the test sites compared to the control sites. Conclusion: Data from this study showed that immediate implants with and without a mucoperiosteal flap elevation can be successfully used even in the presence of bone defects requiring augmentation procedures. It was also noted that the bone regenerated reached a higher coronal level in the group with flap elevation than in the group without flap elevation. INT J ORAL MAXILLOFAC IMPLANTS 2008;23: 841-846
C1 [Covani, Ugo; Cornelini, Roberto; Barone, Antonio] Univ Genoa, Sch Dent, Dept Biophys Med & Dent Sci & Technol, Genoa, Italy.
RP Barone, A (reprint author), Piazza Diaz 10, I-55041 Camaiore, Lu, Italy.
EM barosurg@libero.it
RI Barone, Antonio/O-2738-2013
OI Barone, Antonio/0000-0003-1226-7565
CR Al-Ansari BH, 1998, INT J ORAL MAX IMPL, V13, P861
   Araujo MG, 2005, J CLIN PERIODONTOL, V32, P645, DOI 10.1111/j.1600-051X.2005.00726.x
   Botticelli D, 2004, J CLIN PERIODONTOL, V31, P820, DOI 10.1111/j.1600-051X.2004.00565.x
   Buser D, 1990, CLIN ORAL IMPLAN RES, V1, P33, DOI 10.1034/j.1600-0501.1990.010105.x
   Campelo LD, 2002, INT J ORAL MAX IMPL, V17, P271
   Covani U, 2004, INT J ORAL MAX IMPL, V19, P549
   Covani U, 2004, J PERIODONTOL, V75, P982, DOI 10.1902/jop.2004.75.7.982
   Covani U, 2003, J PERIODONTOL, V74, P268, DOI 10.1902/jop.2003.74.2.268
   Dahlin C, 1989, Int J Oral Maxillofac Implants, V4, P19
   Evian CI, 2004, INT J ORAL MAX IMPL, V19, P393
   Fortin T, 2006, INT J ORAL MAX IMPL, V21, P298
   Nemcovsky CE, 1999, J PERIODONTOL, V70, P926, DOI 10.1902/jop.1999.70.8.926
   NOBUTO T, 1989, J PERIODONTOL, V60, P709, DOI 10.1902/jop.1989.60.12.709
   Nobuto T, 2003, J PERIODONTOL, V74, P521, DOI 10.1902/jop.2003.74.4.521
   Paolantonio M, 2001, J PERIODONTOL, V72, P1560, DOI 10.1902/jop.2001.72.11.1560
   Schropp L, 2003, INT J PERIODONT REST, V23, P313
   Schwartz-Arad D, 1998, J PERIODONTOL, V69, P743, DOI 10.1902/jop.1998.69.7.743
   Schwartz-Arad D, 2000, J PERIODONTOL, V71, P923, DOI 10.1902/jop.2000.71.6.923
   Weber H P, 1992, Clin Oral Implants Res, V3, P181, DOI 10.1034/j.1600-0501.1992.030405.x
   Wilson TG, 2003, J PERIODONTOL, V74, P402, DOI 10.1902/jop.2003.74.3.402
NR 20
TC 32
Z9 35
U1 1
U2 3
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0882-2786
J9 INT J ORAL MAX IMPL
JI Int. J. Oral Maxillofac. Implants
PD SEP-OCT
PY 2008
VL 23
IS 5
BP 841
EP 846
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 364JN
UT WOS:000260332100006
PM 19014153
DA 2018-10-19
ER

PT J
AU Guhathakurta, S
   Balasubramanian, V
   Ananthakrishnan, B
   Veerappan, S
   Balasundari, R
   Tata, BVR
   Cherian, KM
AF Guhathakurta, S.
   Balasubramanian, V.
   Ananthakrishnan, B.
   Veerappan, S.
   Balasundari, R.
   Tata, B. V. R.
   Cherian, K. M.
TI Thrombogenicity studies of three different variants of processed bovine
   pericardium
SO IRBM
LA English
DT Article
DE bovine pericardium; confocal microscopy; decellurization; thrombogenic;
   transmission electron microscopypericarde bovin; microscopie confocale;
   acellurisation; thromboembolie; microscopie electronique
ID PLATELET-COLLAGEN INTERACTIONS; HEPARIN; CELLS
AB Versatile use of bovine pericardium in clinical cardiovascular surgery requires processing, especially cross-linking, to make the tissue non antigenic and mechanically strong. Forty-nine bovine pericardia were made acellular and then cross-linked by two different methods, group A (20) with formalin and group B (29) with heparin and subsequently, as a final measure, five of group B pericardia were gamma-ray sterilized with stipulated dose of 25 kGy and classified as group C. The surface property of thrombogenesis and haemolysis were compared in these three groups to identify a suitable method of processing so that it could be used in the vascular system without any thromboembolic complication. Extensive microscopical examination, mechanical testing and other physical property for biocompatibility studies were conducted on these three different groups with key focus On in Vitro thrombogenicity studies. Heparin treated group B bovine pericardium appeared to be the best method of processing among these three by the above studies and was confirmed by laser confocal microscopy. Heparin cross-linked and heparin sodium treated processing had gained the higher tensile strength, and appeared to be nonthrombogenic, noncalcifiable (by animal experiments), biocompatible biomaterial, which can be used clinically. (c) 2007 Elsevier Masson SAS. All rights reserved.
C1 [Guhathakurta, S.; Balasubramanian, V.; Ananthakrishnan, B.] Indian Inst Technol, Dept Biotechnol, Rehabil Bioengn Grp, Chennai 600036, Tamil Nadu, India.
   [Guhathakurta, S.; Ananthakrishnan, B.; Veerappan, S.; Balasundari, R.; Cherian, K. M.] Frontier Life Line Private Ltd, Int Ctr Cardiothorac & Vasc Dis, Madras 600101, Tamil Nadu, India.
   [Tata, B. V. R.] Indira Gandhi Ctr Atom Res, Kalpakkam 603102, Tamil Nadu, India.
RP Balasubramanian, V (reprint author), Indian Inst Technol, Dept Biotechnol, Rehabil Bioengn Grp, Chennai 600036, Tamil Nadu, India.
EM chanakya@iitm.ac.in
OI Ramesh, Balasundari/0000-0002-0090-2827
CR CHVAPIL M, 1970, INT REV CONNECTIVE T, V6, P1
   CORTELLARO M, 1993, ARTERIOSCLER THROMB, V13, P1412, DOI 10.1161/01.ATV.13.10.1412
   ELIEZER MA, 2005, APPL ENG MECH MED, pA1
   Falk E, 2006, J AM COLL CARDIOL, V47, pC7, DOI 10.1016/j.jacc.2005.09.068
   FRANSSON LA, 1979, FEBS LETT, V97, P119, DOI 10.1016/0014-5793(79)80065-4
   Gao YG, 2005, MOL CELLS, V19, P350
   GRABENWOGER M, 1992, J BIOMED MATER RES, V26, P1231, DOI 10.1002/jbm.820260912
   Grauss RW, 2005, EUR J CARDIO-THORAC, V27, P566, DOI 10.1016/j.ejcts.2004.12.052
   Griffin MJ, 2001, ANESTH ANALG, V93, P20
   Guhathakurta S, 2006, CURR SCI INDIA, V91, P1068
   HUANG LLL, 1990, J BIOMED MATER RES, V124, P1185
   ISHIHARA T, 1981, J THORAC CARDIOV SUR, V81, P747
   Kauhanen P, 2000, ARTERIOSCL THROM VAS, V20, pE113, DOI 10.1161/01.ATV.20.11.e113
   Keuren JFW, 2004, ARTERIOSCL THROM VAS, V24, P613, DOI 10.1161/01.ATV.0000116026.18945.66
   Laemmel E, 1998, J BIOMED MATER RES, V39, P446, DOI 10.1002/(SICI)1097-4636(19980305)39:3<446::AID-JBM14>3.0.CO;2-8
   Lassila R, 1997, ARTERIOSCL THROM VAS, V17, P3578, DOI 10.1161/01.ATV.17.12.3578
   Love JW, 1997, PRINCIPLES TISSUE EN, P365
   MENASCHE P, 1984, Life Support Systems, V2, P233
   MENASCHE P, 1986, P 3 INT S BIOL BIOPR
   Poletti LF, 1997, ARTERIOSCL THROM VAS, V17, P925, DOI 10.1161/01.ATV.17.5.925
   REIDY MA, 1992, ARCH PATHOL LAB MED, V116, P1276
   RYGG IH, 1986, P 3 INT S BIOL BIOPR, pCH49
   Vasudev SC, 2000, ARTIF ORGANS, V24, P129, DOI 10.1046/j.1525-1594.2000.06348.x
   WEINBERGER DR, 1986, HDB SCHIZOPHRENIA, V1, P397
   WON LK, 2000, BIOMATERIALS, V21, P2323
   ZACHARIAS RK, 1987, J VASC SURG, V6, P429, DOI 10.1067/mva.1987.avs0060429
NR 26
TC 5
Z9 5
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1959-0318
EI 1876-0988
J9 IRBM
JI IRBM
PD SEP
PY 2008
VL 29
IS 4
BP 223
EP 230
DI 10.1016/j.rbmret.2007.07.003
PG 8
WC Engineering, Biomedical
SC Engineering
GA 350MF
UT WOS:000259355900001
DA 2018-10-19
ER

PT J
AU Dash, BN
   Nakamura, M
   Sahoo, S
   Kotaki, M
   Nakai, A
   Hamada, H
AF Dash, B. N.
   Nakamura, M.
   Sahoo, S.
   Kotaki, M.
   Nakai, A.
   Hamada, H.
TI Mechanical Properties of Hemp Reinforced Poly(butylene succinate)
   Biocomposites
SO JOURNAL OF BIOBASED MATERIALS AND BIOENERGY
LA English
DT Article
DE Hemp; Shellac; Biopolymer; Biofiber; Surface Modification; Moisture
   Absorption
ID BIODEGRADABLE POLYESTERS; ALIPHATIC POLYESTERS; THERMAL-PROPERTIES;
   COMPOSITES; FIBER; SHELLAC
AB Hemp and poly(butylene succinate) (PBS) composites with 10, 15 and 20 wt% fiber loading were prepared by a film stacking compression molding method, followed by extrusion and injection molding. Inadequate wetting and heterogeneous distribution of fiber was observed in the crushed materials of 20 wt% of fiber loading. Therefore, this composite was reprocessed to investigate whether the fiber-by-matrix impregnation can be improved by repeated compression molding. Composites were prepared using untreated as well as shellac coated hemp and the resulting properties were compared. The main focus of the work is to optimize the fiber loading and to study the effectiveness of shellac, a nontoxic biomaterial as a coating agent for hemp fibers, in order to develop environment friendly low cost composite materials. From the evaluated properties, it is observed that, tensile and flexural properties increased while impact strength decreased with increase in fiber loading in comparison to PBS. Moisture absorption of fibers and the composite specimens (20 wt% fibers loading) were studied. Effect of moisture absorption on the tensile properties of the composites was evaluated. Surface modification of fiber had no significant contribution towards the mechanical behavior of the composites probably due to high processing temperature; however the fiber-matrix adhesion and resistance to moisture absorption improved to some extent. SEM analysis has corroborated the findings.
C1 [Dash, B. N.; Nakamura, M.; Sahoo, S.; Kotaki, M.; Nakai, A.; Hamada, H.] Kyoto Inst Technol, Dept Adv FibroSci, Sakyo Ku, Kyoto 6068585, Japan.
   [Dash, B. N.] G Sc Coll, Dept Chem, Cuttack 754029, Orissa, India.
RP Hamada, H (reprint author), Kyoto Inst Technol, Dept Adv FibroSci, Sakyo Ku, Kyoto 6068585, Japan.
EM hhamada@kit.ac.jp
CR Bismarck A, 2005, NATURAL FIBERS, BIOPOLYMERS, AND BIOCOMPOSITES, P37
   Fujimaki T, 1998, POLYM DEGRAD STABIL, V59, P209, DOI 10.1016/S0141-3910(97)00220-6
   Ikada Y, 2000, MACROMOL RAPID COMM, V21, P117, DOI 10.1002/(SICI)1521-3927(20000201)21:3<117::AID-MARC117>3.0.CO;2-X
   Kim HS, 2005, J APPL POLYM SCI, V97, P1513, DOI 10.1002/app.21905
   KROSCHWITZ JI, 1989, ENCY POLYM SCI ENG S, pP579
   Lee SM, 2005, COMPOS SCI TECHNOL, V65, P647, DOI 10.1016/j.compscitech.2004.09.023
   Lee SM, 2005, POLYM POLYM COMPOS, V13, P479, DOI 10.1177/096739110501300505
   Mcculloch L, 1943, IND ENG CHEM, V35, P825, DOI 10.1021/ie50403a022
   Mochizuki M, 1997, POLYM ADVAN TECHNOL, V8, P203
   Mohanty AK, 2005, NATURAL FIBERS, BIOPOLYMERS, AND BIOCOMPOSITES, P1
   Mohanty AK, 2001, COMPOS INTERFACE, V8, P313, DOI 10.1163/156855401753255422
   NAKAMURA M, 2006, P 4 INT WORKSH GREEN
   OHKITA T, 2005, J APPL POLYM SCI, V97, P3
   Ray D, 2006, IND ENG CHEM RES, V45, P2722, DOI 10.1021/ie0512800
   Saheb DN, 1999, ADV POLYM TECH, V18, P351, DOI 10.1002/(SICI)1098-2329(199924)18:4<351::AID-ADV6>3.3.CO;2-O
   SAHOO S, 2007, P JCOM 36 JAP SOC CO, P21
   SHARMA N, 2000, INT J POLYM MATER, V47, P351
   SHARMA S, 1983, DEFENCE SCI J, V33, P3
   Shibata M, 2004, J APPL POLYM SCI, V92, P3857, DOI 10.1002/app.20405
   Shibata M, 2003, MACROMOL MATER ENG, V288, P35, DOI 10.1002/mame.200290031
   Siriwardena S, 2003, J REINF PLAST COMP, V22, P1645, DOI 10.1177/073168403027619
   THOMSEN AB, 2000, BIORESOURCE HEMP
   WIENER V, 2003, AUTEX RES J, V3, P20
   XIA W, 2006, FOR STUD CHINA, V8, P1
NR 24
TC 13
Z9 13
U1 1
U2 12
PU AMER SCIENTIFIC PUBLISHERS
PI STEVENSON RANCH
PA 25650 NORTH LEWIS WAY, STEVENSON RANCH, CA 91381-1439 USA
SN 1556-6560
J9 J BIOBASED MATER BIO
JI J. Biobased Mater. Bioenergy
PD SEP
PY 2008
VL 2
IS 3
BP 273
EP 281
DI 10.1166/jbmb.2008.403
PG 9
WC Chemistry, Applied; Energy & Fuels; Materials Science, Biomaterials
SC Chemistry; Energy & Fuels; Materials Science
GA 373HZ
UT WOS:000260964000011
DA 2018-10-19
ER

PT J
AU Kamath, S
   Bhattacharyya, D
   Padukudru, C
   Timmons, RB
   Tang, LP
AF Kamath, Shwetha
   Bhattacharyya, Dhiman
   Padukudru, Chandana
   Timmons, Richard B.
   Tang, Liping
TI Surface chemistry influences implant-mediated host tissue responses
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE surface modification; inflammation; fibrosis; microsphere; plasma
   polymerization
ID SELF-ASSEMBLED MONOLAYERS; FUNCTIONAL-GROUPS; CELL-ADHESION; FIBROUS
   CAPSULE; PLASMA POLYMERIZATION; PROTEIN ADSORPTION; RELEASE SYSTEMS;
   HYDROXYL-GROUPS; IN-VITRO; BIOMATERIALS
AB Implant-mediated fibrotic reactions are detrimental to the performance of encapsulated cells, implanted drug release devices, and sensors. To improve the implant function and longevity, recent research has emphasized the need for inducing alterations in cellular responses. Although material surface functional groups have been shown to be potent in affecting cellular activity in vitro and short-term in vivo responses, these groups appear to have little influence on long-term in vivo fibrotic reactions, possibly as a result of insufficient interactions between recruited host cells and functional groups on the implants. To maximize the influence of functionality on cells, and to mimic drug release microspheres, functionalized micron-sized particles were created and tested for their ability in modulating tissue responses to biomaterial implants. In this work, the surfaces of polypropylene particles were controllably coated with four different functional groups, specifically -OH, -NH(2), -CF(x), and -COOH, using a radio frequency glow discharge plasma polymerization technique. The effect of these surface functionalities on host tissue responses were then evaluated using a mice subcutaneous implantation model. Major differences were observed in contrasting tissue response to the different chemistries. Surfaces with -OH and -NH(2) surface groups induced the thickest fibrous capsule accompanied with the greatest cellular infiltration into the implants. In contrast, surfaces with -CF(x) and -COOH exhibited the least inflammatory/fibrotic responses and cellular infiltrations. The present results clearly demonstrate that, by increasing the available functionalized surface area and spatial distribution, the effect of surface chemistry on tissue reactivity can be substantially enhanced. (c) 2007 Wiley Periodicals, Inc.
C1 [Tang, Liping] Univ Texas Arlington, Dept Bioengn, Biomed Engn Program, Arlington, TX 76019 USA.
   [Bhattacharyya, Dhiman; Timmons, Richard B.] Univ Texas Arlington, Dept Chem & Biochem, Arlington, TX 76019 USA.
RP Tang, LP (reprint author), Univ Texas Arlington, Dept Bioengn, Biomed Engn Program, POB 19138, Arlington, TX 76019 USA.
EM ltang@uta.edu
FU NIBIB NIH HHS [R01 EB007271, R01 EB007271-01A2, R01 EB007271-01A2S1];
   NIGMS NIH HHS [R01 GM074021]
CR AMON M, 1994, INT OPHTHALMOL, V18, P9, DOI 10.1007/BF00919407
   AMON M, 1993, J CATARACT REFR SURG, V19, P258, DOI 10.1016/S0886-3350(13)80953-4
   ANDERSON JM, 1981, J BIOMED MATER RES, V15, P889, DOI 10.1002/jbm.820150613
   ANDERSON JM, 1990, INT J ARTIF ORGANS, V13, P375
   Barbosa JN, 2006, J BIOMED MATER RES A, V76A, P737, DOI 10.1002/jbm.a.30602
   Barbosa JN, 2005, BIOMATERIALS, V26, P3021, DOI 10.1016/j.biomaterials.2004.09.002
   Barbosa JN, 2004, BIOMATERIALS, V25, P2557, DOI [10.1016/j.biomaterials.2003.09.047, 10.1016/j .biomaterials.2003.09.047]
   BARBOSA JN, 2006, J BIOMED MATER RES, V26, P737
   Beamson G., 1992, HIGH RESOLUTION XPS
   BOHNERT JL, 1986, J COLLOID INTERF SCI, V111, P363, DOI 10.1016/0021-9797(86)90040-8
   Butler K, 1997, Biomed Sci Instrum, V34, P18
   Cho J, 2006, CHEM MATER, V18, P2989, DOI 10.1021/cm060212g
   CHRISTENSON L, 1989, J BIOMED MATER RES, V23, P705, DOI 10.1002/jbm.820230704
   COLTON CK, 1995, CELL TRANSPLANT, V4, P415, DOI 10.1016/0963-6897(95)00025-S
   DESAI NP, 1992, BIOMATERIALS, V13, P505, DOI 10.1016/0142-9612(92)90101-S
   Evans-Nguyen KM, 2005, BIOCHEMISTRY-US, V44, P15561, DOI 10.1021/bi0514358
   Fournier E, 2003, BIOMATERIALS, V24, P3311, DOI 10.1016/S0142-9612(03)00161-3
   Gorbet MB, 2003, J BIOMED MATER RES A, V67A, P792, DOI 10.1002/jbm.a.10155
   Gorbet MB, 2001, J LAB CLIN MED, V137, P345, DOI 10.1067/mlc.2001.114677
   Harsch A, 2000, J NEUROSCI METH, V98, P135, DOI 10.1016/S0165-0270(00)00196-5
   Horbett TA, 1993, CARDIOVASC PATHOL, V2, P137, DOI DOI 10.1016/1054-8807(93)90054-6)
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   KUWAHARA T, 1989, CONTRIB NEPHROL, V74, P52
   LEE JH, 1991, BIOMATERIALS, V12, P443
   LEE JH, 1994, BIOMATERIALS, V15, P705, DOI 10.1016/0142-9612(94)90169-4
   LENINGER RI, 1978, ANN NY ACAD SCI, V516, P173
   Li ML, 2005, ANAL CHEM, V77, P350, DOI 10.1021/ac0488107
   LINDSAY RM, 1980, T AM SOC ART INT ORG, V26, P603
   NISHI O, 1991, J CATARACT REFR SURG, V17, P471, DOI 10.1016/S0886-3350(13)80854-1
   PANCHALINGAM V, 1993, J BIOMAT SCI-POLYM E, V5, P131
   Panchalingam V, 1993, ASAIO J, V39, pM305
   Pompe T, 2007, BIOMATERIALS, V28, P28, DOI 10.1016/j.biomaterials.2006.08.028
   Ratner BD, 2002, J CONTROL RELEASE, V78, P211, DOI 10.1016/S0168-3659(01)00502-8
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Rihova B, 2000, ADV DRUG DELIVER REV, V42, P65
   Rinsch CL, 1996, LANGMUIR, V12, P2995, DOI 10.1021/la950685u
   SANO S, 1993, BIOMATERIALS, V14, P817, DOI 10.1016/0142-9612(93)90003-K
   SAVAGE CR, 1991, CHEM MATER, V3, P575, DOI 10.1021/cm00016a005
   SEVASTIANOV VI, 1988, CRIT REV BIOCOMPAT, V4, P109
   Sharkawy AA, 1997, J BIOMED MATER RES, V37, P401
   Shen MC, 2002, J BIOMAT SCI-POLYM E, V13, P367, DOI 10.1163/156856202320253910
   SHEU MS, 1992, J ADHES SCI TECHNOL, V6, P995, DOI 10.1163/156856192X00890
   SHINODA BA, 1978, BIOMATER ARTIF CELL, V6, P305, DOI 10.3109/10731197809119791
   Socrates G., 1994, INFRARED CHARACTERIS
   SOONSHIONG P, 1991, TRANSPLANT P, V23, P758
   Sperling C, 2005, BIOMATERIALS, V26, P6547, DOI 10.1016/j.biomaterials.2005.04.042
   Susut C, 2005, INT J PHARM, V288, P253, DOI 10.1016/j.ijpharm.2004.10.004
   Tang LP, 1998, J BIOMED MATER RES, V42, P156, DOI 10.1002/(SICI)1097-4636(199810)42:1<156::AID-JBM19>3.3.CO;2-E
   Thomsen P, 2001, CURR OPIN SOLID ST M, V5, P163, DOI 10.1016/S1359-0286(01)00004-3
   WOOD RC, 1995, BIOMATERIALS, V16, P957, DOI 10.1016/0142-9612(95)93122-T
   WU Y, 1999, MATER RES SOC S P, V77, P544
   Wu YLJ, 2000, COLLOID SURFACE B, V18, P235, DOI 10.1016/S0927-7765(99)00150-2
   Zhang Z, 2003, LANGMUIR, V19, P4765, DOI 10.1021/la026980d
   ZHAO Q, 1990, J BIOMED MATER RES, V24, P621, DOI 10.1002/jbm.820240508
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
NR 56
TC 57
Z9 57
U1 0
U2 20
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 1
PY 2008
VL 86A
IS 3
BP 617
EP 626
DI 10.1002/jbm.a.31649
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 334RD
UT WOS:000258238000006
PM 18022841
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Ball, M
   Grant, DM
   Lo, WJ
   Scotchford, CA
AF Ball, Michael
   Grant, David M.
   Lo, Wei-Jen
   Scotchford, Colin A.
TI The effect of different surface morphology and roughness on
   osteoblast-like cells
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE surface morphology; surface roughness; osteoblast-like cell; cell
   adhesion; cell differentiation
ID IN-VITRO; MICROMACHINED SURFACES; BONE-CELLS; TITANIUM; HYDROXYAPATITE;
   GROWTH; MG63; 1-ALPHA,25-(OH)(2)D-3; RESPONSIVENESS; PROLIFERATION
AB Increased magnitude of biomaterial surface roughness and micromachined-grooved surfaces has both been shown to stimulate osteoblast activity, but have not been compared in the same study quantitatively. A series of titanium alloy (Ti6Al4V) samples were prepared using simple machining techniques to undertake such a comparison. Samples were either grit blasted (Gb) or shot peened (Sp) to give random discontinuities, or silicon carbide ground (SiC) to produce ordered grooves. These were compared with micropolished samples (Mp). The samples were coated with a 1 mu m continuous coating of hydroxyapatite to remove differences in surface chemistry. Human osteoblast-like cells were seeded onto the materials and metabolic activity, proliferation, alkaline phosphatase activity, and osteocalcin production assessed. Cell responses were highly dependent on the substrate that they were cultured on. Cells cultured on the smooth and ordered (Mp and SiC, respectively) samples had higher metabolic activity and a more elongated morphology than those cultured on the randomly structured Gb or Sp samples. Over 21 days, cell metabolic activity peaked relative to the control between 7 and 14 days on the Mp sample, and between 14 and 21 days on the Gb, Sp, and SiC samples. In common with other researchers, we note that micron scale topography may have potential for influencing osseointegration. More importantly, as the magnitude of the discontinuities on SiC, Gb, and Sp were similar, the differences in cell responses does not appear to lie with the size of the features, but whether the features showed an ordered or disordered structure. (c) 2007 Wiley Periodicals, Inc.
C1 [Ball, Michael] Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2AZ, England.
   [Grant, David M.; Lo, Wei-Jen; Scotchford, Colin A.] Univ Nottingham, Sch Mech Mat Mfg Engn & Management, Nottingham NG7 2RD, England.
RP Ball, M (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2AZ, England.
EM m.ball@imperial.ac.uk
OI Scotchford, Colin/0000-0003-1937-6692; Ball,
   Michael/0000-0003-4139-0802; Grant, David/0000-0002-6786-7720
CR AHMED SA, 1994, J IMMUNOL METHODS, V170, P211
   Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   Anselme K, 2002, J BIOMED MATER RES, V60, P529, DOI 10.1002/jbm.10101
   Anselme K, 2000, BIOMATERIALS, V21, P1567, DOI 10.1016/S0142-9612(00)00042-9
   Assoian RK, 1997, J CELL BIOL, V136, P1, DOI 10.1083/jcb.136.1.1
   Aubin Jane E., 1993, P1
   Ball MD, 2001, BIOMATERIALS, V22, P337, DOI 10.1016/S0142-9612(00)00189-7
   BASLE MF, 1993, J MATER SCI-MATER M, V4, P273, DOI 10.1007/BF00122280
   Batzer R, 1998, J BIOMED MATER RES, V41, P489
   Bigerelle M, 2002, BIOMATERIALS, V23, P1563, DOI 10.1016/S0142-9612(01)00271-X
   Boyan BD, 1998, J BIOMED MATER RES, V39, P77, DOI 10.1002/(SICI)1097-4636(199801)39:1<77::AID-JBM10>3.0.CO;2-L
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Boyan BD, 2001, J BIOMED MATER RES, V55, P350, DOI 10.1002/1097-4636(20010605)55:3<350::AID-JBM1023>3.0.CO;2-M
   Chehroudi B, 1997, J BIOMED MATER RES, V34, P279
   CHEHROUDI B, 1992, CELL MATER, V2, P89
   CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1101, DOI 10.1002/jbm.820290910
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X
   DeSantis D, 1996, J MATER SCI-MATER M, V7, P21, DOI 10.1007/BF00121185
   Grant DM, 1996, J MATER SCI-MATER M, V7, P579, DOI 10.1007/BF00122181
   Gray C, 1996, BONE, V18, P115, DOI 10.1016/8756-3282(95)00456-4
   Hatano K, 1999, BONE, V25, P439, DOI 10.1016/S8756-3282(99)00192-1
   Kieswetter K, 1996, CRIT REV ORAL BIOL M, V7, P329, DOI 10.1177/10454411960070040301
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   Lauer G, 2001, BIOMATERIALS, V22, P2799, DOI 10.1016/S0142-9612(01)00024-2
   Lo WJ, 1999, J BIOMED MATER RES, V46, P408, DOI 10.1002/(SICI)1097-4636(19990905)46:3<408::AID-JBM14>3.0.CO;2-Z
   Lodish H., 2000, MOL CELL BIOL, P154
   Lohmann CH, 1999, J BIOMED MATER RES, V47, P139, DOI 10.1002/(SICI)1097-4636(199911)47:2<139::AID-JBM4>3.0.CO;2-2
   Lopes MA, 2000, BIOMATERIALS, V21, P1165, DOI 10.1016/S0142-9612(00)00007-7
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   Perizzolo D, 2001, J BIOMED MATER RES, V56, P494, DOI 10.1002/1097-4636(20010915)56:4<494::AID-JBM1121>3.0.CO;2-X
   Pypen CMJM, 1997, J MATER SCI-MATER M, V8, P781, DOI 10.1023/A:1018568830442
   RAGO R, 1990, ANAL BIOCHEM, V191, P31
   Ranucci CS, 2001, J BIOMED MATER RES, V54, P149, DOI 10.1002/1097-4636(200102)54:2<149::AID-JBM1>3.0.CO;2-O
   Riehle MO, 2003, MAT SCI ENG C-BIO S, V23, P337, DOI 10.1016/S0928-4931(02)00282-5
   Schwartz Z, 2001, J BIOMED MATER RES, V56, P417, DOI 10.1002/1097-4636(20010905)56:3<417::AID-JBM1111>3.0.CO;2-K
   UNGERSBOCK A, 1995, J MATER SCI-MATER M, V5, P434
   VanKooten TG, 1997, J MATER SCI-MATER M, V8, P835
   Zreiqat H, 1999, J BIOMED MATER RES, V44, P389, DOI 10.1002/(SICI)1097-4636(19990315)44:4<389::AID-JBM4>3.0.CO;2-O
   Zreiqat H, 1999, J BIOMED MATER RES, V47, P360, DOI 10.1002/(SICI)1097-4636(19991205)47:3<360::AID-JBM10>3.0.CO;2-K
NR 40
TC 53
Z9 53
U1 0
U2 16
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 1
PY 2008
VL 86A
IS 3
BP 637
EP 647
DI 10.1002/jbm.a.31652
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 334RD
UT WOS:000258238000008
PM 18022800
DA 2018-10-19
ER

PT J
AU Betz, MW
   Modi, PC
   Caccamese, JF
   Coletti, DP
   Sauk, JJ
   Fisher, JP
AF Betz, Martha W.
   Modi, Parth C.
   Caccamese, John F.
   Coletti, Domenick P.
   Sauk, John J.
   Fisher, John P.
TI Cyclic acetal hydrogel system for bone marrow stromal cell encapsulation
   and osteodifferentiation
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biomaterials; bone marrow stromal cells; osteodifferentiation; hydrogel;
   encapsulation
ID MESENCHYMAL STEM-CELLS; POLY(PROPYLENE FUMARATE) SCAFFOLDS; IN-VITRO;
   OSTEOGENIC DIFFERENTIATION; BIOMATERIALS; GROWTH; COLLAGEN; GLYCOL);
   AGAROSE; MODEL
AB Many systems have been proposed for the encapsulation of bone marrow stromal cells (BMSCs) within degradable hydrogels. Here, we use a novel cyclic acetal-based biomaterial formed from 5-ethyl-5-(hydroxymethyl)-beta,beta-dimethyl-1,3-dioxane-2-ethanol diacrylate (EHD) and poly(ethylene glycol) diacrylate (PEGDA). A cyclic acetal-based hydrogel may be preferred as cyclic acetals hydrolytically degraded into diols and carbonyls as primary degradation products, which may not affect local acidity, unlike other widely investigated polymers. The EHD monomer and PEGDA polymer may be fabricated into a EH-PEG hydrogel by radical polymerization initiated by the ammonium persulfate (APS) and N,N,N',N'-tetramethylethylenediamine (TEMED) system. The objective of this work is to determine whether the components utilized in the fabrication of EH-PEG hydrogels as well as the EH-PEG hydrogels permit BMSC viability, metabolic activity, and osteodifferentiation. Cell viability and metabolic activity were assessed after 30 min, 1 h, and 3 h of exposure to pertinent concentrations of the initiator system (10-20 mM). Osteodifferentiation was assessed by alkaline phosphatase and osteocalcin expression after a short exposure to the initiator system to simulate the encapsulation process. Lastly, cell viability was assessed immediately after encapsulation and after 7 days of culture within the EH-PEG hydrogels. results indicate that the metabolic activity and viability of BMSCs are minimally affected, and that osteodifferentiation is not significantly affected by the APS-TEMED initiator system. Also, encapsulated BMSCs maintained viability within EH-PEG hydrogels for 7 days. This work demonstrates, that the EH-PEG hydrogel is a viable option for the encapsulation and osteodifferentiation of BMSCs. (c) 2007 Wiley Periodicals, Inc.
C1 [Betz, Martha W.; Fisher, John P.] Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
   [Modi, Parth C.] Univ Maryland, Dept Biol Resources Engn, College Pk, MD 20742 USA.
   [Caccamese, John F.; Coletti, Domenick P.; Fisher, John P.] Univ Maryland, Sch Dent, Dept Oral & Maxillofacial Surg, Baltimore, MD 21201 USA.
   [Sauk, John J.] Univ Maryland, Sch Dent, Dept Pathol, Baltimore, MD 21201 USA.
RP Fisher, JP (reprint author), Univ Maryland, Fischell Dept Bioengn, 3238 Jeong H Kim,Engn Bldg 225, College Pk, MD 20742 USA.
EM jpfisher@umd.edu
RI Fisher, John/F-8078-2012
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Barralet JE, 2005, J MATER SCI-MATER M, V16, P515, DOI 10.1007/s10856-005-0526-z
   Baskaran S, 2002, BIOCONJUGATE CHEM, V13, P1309, DOI 10.1021/bc0255485
   Batorsky A, 2005, BIOTECHNOL BIOENG, V92, P492, DOI 10.1002/bit.20614
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   Ciapetti G, 2003, BIOMATERIALS, V24, P3815, DOI 10.1016/S0142-9612(03)00263-1
   Cui FZ, 2006, J MATER SCI-MATER M, V17, P1393, DOI 10.1007/s10856-006-0615-7
   Dodla MC, 2006, J BIOMED MATER RES A, V78A, P213, DOI 10.1002/jbm.a.30747
   El-Amin SF, 2003, BIOMATERIALS, V24, P1213, DOI 10.1016/S0142-9612(02)00451-9
   Fisher JP, 2002, J BIOMED MATER RES, V59, P547, DOI 10.1002/jbm.1268
   Hong Y, 2006, J BIOMED MATER RES A, V79A, P913, DOI 10.1002/jbm.a.30837
   Ishaug-Riley SL, 1999, BIOMATERIALS, V20, P2245, DOI 10.1016/S0142-9612(99)00155-6
   Jabbari E, 2004, J MICROENCAPSUL, V21, P525, DOI 10.1080/02652040410001729296
   KAIHARA S, EUR J PHARM IN PRESS
   KONG L, 2007, J BIOMATER APPL
   Leach JB, 2003, BIOTECHNOL BIOENG, V82, P578, DOI 10.1002/bit.10605
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Ma L, 2004, BIOMATERIALS, V25, P2997, DOI 10.1016/j.biomaterials.2003.09.092
   Martens PJ, 2003, BIOMACROMOLECULES, V4, P283, DOI 10.1021/bm025666v
   Meinel L, 2006, BIOMATERIALS, V27, P4993, DOI 10.1016/j.biomaterials.2006.05.021
   Moreau JL, 2007, J BIOMED MATER RES A, V81A, P594, DOI 10.1002/jbm.a.31104
   Nuttelman CR, 2005, MATRIX BIOL, V24, P208, DOI 10.1016/j.matbio.2005.03.004
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Temenoff JS, 2004, BIOMACROMOLECULES, V5, P5, DOI 10.1021/bm030067p
   Temenoff JS, 2004, J BIOMED MATER RES A, V70A, P235, DOI 10.1002/jbm.a.30064
   VandeVord PJ, 2002, J BIOMED MATER RES, V59, P585, DOI 10.1002/jbm.1270
   VANDIJKWOLTHUIS WNE, 1995, MACROMOLECULES, V28, P6317, DOI 10.1021/ma00122a044
   Vehof JWM, 2002, J BIOMED MATER RES, V60, P241, DOI 10.1002/jbm.10073
   Vervoort L, 1999, J PHARM SCI, V88, P209, DOI 10.1021/js9802796
   Yoon DM, 2007, BIOMATERIALS, V28, P299, DOI 10.1016/j.biomaterials.2006.08.039
   Yoshida M, 2006, J BIOMED MATER RES A, V79A, P393, DOI 10.1002/jbm.a.30798
NR 31
TC 43
Z9 46
U1 2
U2 13
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 1
PY 2008
VL 86A
IS 3
BP 662
EP 670
DI 10.1002/jbm.a.31640
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 334RD
UT WOS:000258238000010
PM 18022839
DA 2018-10-19
ER

PT J
AU Nikkola, L
   Vapalahti, K
   Huolman, R
   Seppala, J
   Harlin, A
   Ashammakhi, N
AF Nikkola, L.
   Vapalahti, K.
   Huolman, R.
   Seppala, J.
   Harlin, A.
   Ashammakhi, N.
TI Multilayer Implant with Triple Drug Releasing Properties
SO JOURNAL OF BIOMEDICAL NANOTECHNOLOGY
LA English
DT Article
DE Electrospinning; Nanofibers; Composite; Multicomponent; Intelligent
   Biomaterial; Implant
ID IN-VITRO; DICLOFENAC SODIUM; STAPHYLOCOCCUS-EPIDERMIDIS; BIOABSORBABLE
   FIXATION; BIOFILM FORMATION; ELECTROSPUN; CIPROFLOXACIN; NANOFIBER;
   POLYMER; BISPHOSPHONATE
AB Tissue repair and regeneration is a multistep process. Several drug releasing materials have been developed to help the healing process of tissues after damage. Most of these are loaded with a single agent. In the current study, we developed a composite loaded with three drugs to enhance the control of the healing process of bone. The biodegradable composite comprised two anti-inflammatory agents in a nanofibrous and macrofibrous matrix and bisphosphonates in a solid membrane. Three different multilayers were studied and the release of the agents was compared. Statistical analysis revealed a close correlation of releases between the multilayer implants except the release from the solid membrane. The first phase of release was from the nanofibrous component, followed by a more steady release from the macrofibers and a later release of the agent from the solid membrane. On the basis of these results a developed multilayer composite, releasing different agents, could be adapted for bone repair and regeneration applications.
C1 [Nikkola, L.; Vapalahti, K.; Huolman, R.; Ashammakhi, N.] Tampere Univ Technol, Dept Biomed Engn, FIN-33101 Tampere, Finland.
   [Seppala, J.] Helsinki Univ Technol, Dept Chem Technol, FIN-02150 Espoo, Finland.
   [Harlin, A.] Tampere Univ Technol, Dept Fibre Mat Sci, FIN-33101 Tampere, Finland.
RP Ashammakhi, N (reprint author), Tampere Univ Technol, Dept Biomed Engn, POB 692, FIN-33101 Tampere, Finland.
RI Seppala, Jukka/G-7698-2012
FU European Commission [NMP3-CT2004-500283]
FX This study was carried out within the scope of the European Commission
   network of Excellence on bone and cartilage tissue engineering
   "EXPER-TISSUES" (Project NMP3-CT2004-500283). The authors wish to thank
   Ms. Pirjo Heikkila for her technical support.
CR Ahola N, 2003, J APPL POLYM SCI, V88, P1279, DOI 10.1002/app.11806
   Ashammakhi N, 2007, J NANOSCI NANOTECHNO, V7, P862, DOI 10.1166/jnn.2007.485
   Aspenberg P, 2002, ACTA ORTHOP SCAND, V73, P20, DOI 10.1080/000164702317281350
   Bostman O, 2000, BIOMATERIALS, V21, P2615, DOI 10.1016/S0142-9612(00)00129-0
   Bostman OM, 2000, CLIN ORTHOP RELAT R, P216
   Cryer B, 1998, AM J MED, V104, P413, DOI 10.1016/S0002-9343(98)00091-6
   Dicko A, 2008, PHARM RES-DORDR, V25, P1702, DOI 10.1007/s11095-008-9561-z
   HALTTUNEN T, 2006, MULT FUNCT GRAD MAT
   Huang ZM, 2006, J BIOMED MATER RES A, V77A, P169, DOI 10.1002/jbm.a.30564
   Jiang HL, 2004, J BIOMAT SCI-POLYM E, V15, P279, DOI 10.1163/156856204322977184
   Katti DS, 2004, J BIOMED MATER RES B, V70B, P286, DOI 10.1002/jbm.b.30041
   Kenawy ER, 2002, J CONTROL RELEASE, V81, P57, DOI 10.1016/S0168-3659(02)00041-X
   Kim K, 2004, J CONTROL RELEASE, V98, P47, DOI 10.1016/j.jconrel.2004.04.009
   Kim K, 2003, BIOMATERIALS, V24, P4977, DOI 10.1016/S0142-9612(03)00407-1
   Luong-Van E, 2006, BIOMATERIALS, V27, P2042, DOI 10.1016/j.biomaterials.2005.10.028
   Luu YK, 2003, J CONTROL RELEASE, V89, P341, DOI 10.1016/S0168-3659(03)00097-X
   Makinen TJ, 2005, J ANTIMICROB CHEMOTH, V56, P1063, DOI 10.1093/jac/dki366
   Miyajima M, 1998, J CONTROL RELEASE, V56, P85, DOI 10.1016/S0168-3659(98)00076-5
   Mo XM, 2004, BIOMATERIALS, V25, P1883, DOI 10.1016/j.biomaterials.2003.08.042
   Niemela SM, 2006, J CRANIOFAC SURG, V17, P950, DOI 10.1097/01.scs.0000231621.02888.46
   Niemela SM, 2006, J BIOMED MATER RES B, V76B, P8, DOI 10.1002/jbm.b.30414
   Nikkola L, 2006, J NANOSCI NANOTECHNO, V6, P3290, DOI 10.1166/jnn.2006.467
   Nikkola L, 2008, AIP CONF PROC, V973, P766, DOI 10.1063/1.2896878
   OSTOVIC D, 1993, PHARMACEUT RES, V10, P470, DOI 10.1023/A:1018969112754
   PETER B, 2005, J BIOMED MATER RES A, V76, P133
   Rokkanen PU, 2000, BIOMATERIALS, V21, P2607, DOI 10.1016/S0142-9612(00)00128-9
   Sendil D, 2003, BIOMATERIALS, V24, P1969, DOI 10.1016/S0142-9612(02)00567-7
   Tengvall P, 2004, BIOMATERIALS, V25, P2133, DOI 10.1016/j.biomaterials.2003.08.049
   VAPALAHTI K, 2005, THESIS TAMPERE U TEC
   Veiranto M, 2004, ADV EXP MED BIOL, V553, P197
   Veiranto M, 2002, J MATER SCI-MATER M, V13, P1259, DOI 10.1023/A:1021187331458
   VIITANEN P, 2004, THESIS TAMPERE U TEC
   Viitanen P, 2006, J MATER SCI-MATER M, V17, P1267, DOI 10.1007/s10856-006-0601-0
   Wan YQ, 2005, BIOMATERIALS, V26, P4453, DOI 10.1016/j.biomaterials.2004.11.016
   Wedemeyer C, 2005, BIOMATERIALS, V26, P3719, DOI 10.1016/j.biomaterials.2004.09.026
   Weiler A, 1996, J BONE JOINT SURG BR, V78B, P369
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Zeng J, 2005, J CONTROL RELEASE, V105, P43, DOI 10.1016/j.j.conrel.2005.02.024
   Zeng Jing, 2003, Journal of Controlled Release, V92, P227, DOI 10.1016/S0168-3659(03)00372-9
NR 39
TC 5
Z9 5
U1 2
U2 13
PU AMER SCIENTIFIC PUBLISHERS
PI STEVENSON RANCH
PA 25650 NORTH LEWIS WAY, STEVENSON RANCH, CA 91381-1439 USA
SN 1550-7033
J9 J BIOMED NANOTECHNOL
JI J. Biomed. Nanotechnol.
PD SEP
PY 2008
VL 4
IS 3
SI SI
BP 331
EP 338
DI 10.1166/jbn.2008.337
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Biomaterials
SC Science & Technology - Other Topics; Materials Science
GA 370QB
UT WOS:000260776500012
DA 2018-10-19
ER

PT J
AU Chen, B
   Peng, XH
   Sun, ST
   Fan, JH
AF Chen, Bin
   Peng, Xiang-he
   Sun, Shi-tao
   Fan, Jing-hong
TI Hydroxyapatite-Sheet Parallel Microstructure of Shinbone
SO JOURNAL OF BIONIC ENGINEERING
LA English
DT Article; Proceedings Paper
CT International Conference on Bionic Engineering (ICBE 2008)
CY OCT 10-12, 2008
CL Changchun, PEOPLES R CHINA
SP Natl Nat Sci Fdn, Minist Educ, Jilin Univ
DE shinbone; hydroxyapatite sheets; parallel microstructure; maximum
   pullout energy; fracture toughness
ID BONE; CRYSTALS
AB Bone is a natural biomaterial. It behaves favorable strength, stiffness and fracture toughness, which arc closely related to its eximious microstructure. Scanning Electron Microscope (SEM) observation on a shinbone showed that the bone is a bioceramic composite consisting of laminated hydroxyapatite and collagen matrix. The hydroxyapatite layers are parallel with the surface of the bone and consist of long and thin hydroxyapatite sheets. The observation also showed that the hydroxyapatite sheets in different hydroxyapatite layers also parallel with each other, which composes a hydroxyapatite-sheet parallel microstructure. The maximum pullout energy of the parallel microstructure was investigated based on its representative model. It was shown that the long and thin shape of the hydroxyapatite sheets in the parallel microstructure is profitable to increase the maximum pullout energy and enhance the fracture toughness of the bone.
C1 [Chen, Bin; Peng, Xiang-he; Sun, Shi-tao; Fan, Jing-hong] Chongqing Univ, Coll Resource & Environm Sci, Dept Engn Mech, Chongqing 400044, Peoples R China.
RP Chen, B (reprint author), Chongqing Univ, Coll Resource & Environm Sci, Dept Engn Mech, Chongqing 400044, Peoples R China.
EM bchen@cqu.cdu.cn
CR Currey JD, 2003, J BIOMECH, V36, P1487, DOI 10.1016/S0021-9290(03)00124-6
   FRATZL P, 1992, J BONE MINER RES, V7, P329
   Fratzl P, 2004, J MATER CHEM, V14, P2115, DOI 10.1039/b402005g
   Glimcher M.J., 1992, DISORDERS BONE MINER, P265
   LEES S, 1988, CONNECT TISSUE RES, V18, P41, DOI 10.3109/03008208809019071
   Su X, 2003, BONE, V32, P150, DOI 10.1016/S8756-3282(02)00945-6
   VINCENT JFV, 2000, HDB ELASTIC PROPERTI, V3
   WEBER M, 2005, MRS P STRUCTURE MECH, V847, P79
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   Woesz A, 2005, MAT SCI ENG C-BIO S, V25, P181, DOI 10.1016/j.msec.2005.01.014
NR 10
TC 0
Z9 0
U1 0
U2 3
PU SCIENCE CHINA PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1672-6529
J9 J BIONIC ENG
JI J. Bionic Eng.
PD SEP
PY 2008
VL 5
SU S
BP 9
EP 13
DI 10.1016/S1672-6529(08)60065-7
PG 5
WC Engineering, Multidisciplinary; Materials Science, Biomaterials;
   Robotics
SC Engineering; Materials Science; Robotics
GA 361GJ
UT WOS:000260115200003
DA 2018-10-19
ER

PT J
AU Sheu, T
   Sun, W
   Liu, X
   Chen, M
   Fauchet, PM
   Puzas, EJ
AF Sheu, T.
   Sun, W.
   Liu, X.
   Chen, M.
   Fauchet, P. M.
   Puzas, E. J.
TI Towards Development of a Porous Silicon-Based Hybrid Biomaterial with
   Osteoconductivity and Osteoinductivity.
SO JOURNAL OF BONE AND MINERAL RESEARCH
LA English
DT Meeting Abstract
CT 30th Annual Meeting of the
   American-Society-for-Bone-and-Mineral-Research
CY SEP 12-16, 2008
CL Montreal, CANADA
SP Amer Soc Bone & Mineral Res
C1 [Sheu, T.; Sun, W.; Liu, X.; Chen, M.; Fauchet, P. M.; Puzas, E. J.] Univ Rochester, Rochester, NY USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC BONE & MINERAL RES
PI WASHINGTON
PA 2025 M ST, N W, STE 800, WASHINGTON, DC 20036-3309 USA
SN 0884-0431
J9 J BONE MINER RES
JI J. Bone Miner. Res.
PD SEP
PY 2008
VL 23
BP S381
EP S381
PG 1
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 351FX
UT WOS:000259411002165
DA 2018-10-19
ER

PT J
AU Trombelli, L
   Farina, R
AF Trombelli, Leonardo
   Farina, Roberto
TI Clinical outcomes with bioactive agents alone or in combination with
   grafting or guided tissue regeneration
SO JOURNAL OF CLINICAL PERIODONTOLOGY
LA English
DT Article; Proceedings Paper
CT 6th European Workshop on Periodontology
CY FEB 02-06, 2008
CL Ittingen, SWITZERLAND
SP European Acad Periodontol, Straumann AG, Swiss Soc Periodontol
DE bioactive agents; furcation defects; growth factors; intra-osseous
   defects; morphogens; periodontal disease; periodontitis; regenerative
   therapy
ID ENAMEL-MATRIX-PROTEINS; PLATELET-RICH PLASMA; INTRABONY PERIODONTAL
   DEFECTS; BOVINE-DERIVED XENOGRAFT; BONE MORPHOGENETIC PROTEIN-2; II
   FURCATION INVOLVEMENT; GROWTH FACTOR-BB; BINDING PEPTIDE P-15; INVASIVE
   SURGICAL TECHNIQUE; UP SPLIT-MOUTH
AB Aim: The purpose of the present review was to determine the clinical effect of the use of bioactive agents (BAs) for the treatment of intra-osseous and furcation defects.
   Material and Methods: The effectiveness of the BAs was evaluated when used in addition to open flap debridement either alone or in association with grafts and/or guided tissue regeneration (GTR). Among the included agents, recombinant human platelet-derived growth factor-BB (rhPDGF-BB), platelet-rich plasma (PRP), commercially available enamel matrix derivative (cEMD) and peptide P-15 (P-15) have been clinically tested for treating periodontal defects.
   Results and Conclusions: The results of the present review indicate that: (1) cEMD either alone or in combination with grafts can be effectively used to treat intra-osseous defects and the clinical results appear to be stable long term; (2) the additional use of a graft seems to enhance the clinical outcome of cEMD; (3) the combined use of rhPDGF-BB and P-15 with a graft biomaterial has shown beneficial effects in intra-osseous defects; (4) contrasting results were reported for PRP and graft combinations; and (5) limited evidence supports the use of BAs either alone or in association with graft/GTR for the treatment of furcation defects.
C1 [Trombelli, Leonardo; Farina, Roberto] Univ Ferrara, Res Ctr Study Periodontal Dis, I-44100 Ferrara, Italy.
RP Trombelli, L (reprint author), Univ Ferrara, Res Ctr Study Periodontal Dis, Corso Giovecca 203, I-44100 Ferrara, Italy.
EM leonardo.trombelli@unife.it
RI Trombelli, Leonardo/I-4671-2015; Farina, Roberto/D-6561-2015
OI Trombelli, Leonardo/0000-0002-1147-2199; Farina,
   Roberto/0000-0002-4621-7809
CR Aghaloo TL, 2006, INT J ORAL MAX IMPL, V21, P535
   Araujo MG, 1998, J CLIN PERIODONTOL, V25, P524, DOI 10.1111/j.1600-051X.1998.tb02482.x
   Barros RRM, 2006, J PERIODONTOL, V77, P1280, DOI 10.1902/jop.2006.050161
   Bateman J, 2005, J PERIODONTOL, V76, P1833, DOI 10.1902/jop.2005.76.11.1833
   Bhatnagar RS, 1997, J BIOMOL STRUCT DYN, V14, P547, DOI 10.1080/07391102.1997.10508155
   Bhatnagar RS, 1999, TISSUE ENG, V5, P53, DOI 10.1089/ten.1999.5.53
   Bhongade Manohar L, 2007, J Contemp Dent Pract, V8, P25
   Bokan I, 2006, J CLIN PERIODONTOL, V33, P885, DOI 10.1111/j.1600-051X.2006.01010.x
   Bonta H, 2003, QUINTESSENCE INT, V34, P247
   BOSSHARDT DD, 2006, EUROPEAN J ORAL S S1, V114, P222
   BOSSHARDT DD, 2006, EUROPEAN J ORAL S S1, V114, P226
   Bosshardt DD, 2008, J CLIN PERIODONTOL, V35, P87, DOI 10.1111/j.1600-051X.2008.01264.x
   Bosshardt DD, 2006, EUR J ORAL SCI, V114, P225, DOI 10.1111/j.1600-0722.2006.00300.x
   BOWERS G, 1991, J PERIODONTOL, V62, P690, DOI 10.1902/jop.1991.62.11.690
   BOWERS GM, 1989, J PERIODONTOL, V60, P683, DOI 10.1902/jop.1989.60.12.683
   Boyne PJ, 2005, J ORAL MAXIL SURG, V63, P1693, DOI 10.1016/j.joms.2005.08.018
   Boyne PJ, 1997, INT J PERIODONT REST, V17, P10
   Bratthall G, 2001, J CLIN PERIODONTOL, V28, P923, DOI 10.1034/j.1600-051x.2001.028010923.x
   Camargo PM, 2005, INT J PERIODONT REST, V25, P49
   Camargo PM, 2002, J PERIODONTAL RES, V37, P300, DOI 10.1034/j.1600-0765.2002.01001.x
   Camargo PM, 2001, J CLIN PERIODONTOL, V28, P1016, DOI 10.1034/j.1600-051X.2001.281105.x
   Camelo M, 2003, INT J PERIODONT REST, V23, P213
   Cardaropoli G, 2002, J PERIODONTOL, V73, P501, DOI 10.1902/jop.2002.73.5.501
   CHO MI, 1995, J PERIODONTOL, V66, P522, DOI 10.1902/jop.1995.66.6.522
   Christgau M, 2006, J CLIN PERIODONTOL, V33, P908, DOI 10.1111/j.1600-051X.2006.00999.x
   Cochran DI, 2000, J PERIODONTOL, V71, P1241, DOI 10.1902/jop.2000.71.8.1241
   Cortellini P, 2005, J PERIODONTOL, V76, P341, DOI 10.1902/jop.2005.76.3.341
   Cortellini P, 2007, J CLIN PERIODONTOL, V34, P1082, DOI 10.1111/j.1600-051X.2007.01144.x
   Cortellini P, 2007, J CLIN PERIODONTOL, V34, P87, DOI 10.1111/j.1600-051X.2006.01020.x
   Czuryszkiewicz-Cyrana J, 2006, Adv Med Sci, V51 Suppl 1, P26
   Demir B, 2007, J CLIN PERIODONTOL, V34, P709, DOI 10.1111/j.1600-051X.2007.01108.x
   Dori F, 2007, J CLIN PERIODONTOL, V34, P254, DOI 10.1111/j.1600-051X.2006.01044.x
   Dori F, 2008, J CLIN PERIODONTOL, V35, P44, DOI 10.1111/j.1600-051X.2007.01161.x
   Donos N, 2004, INT J PERIODONT REST, V24, P363
   Donos N, 2003, J CLIN PERIODONTOL, V30, P1061, DOI 10.1046/j.0303-6979.2003.00429.x
   Donos N, 2003, INT J PERIODONT REST, V23, P507
   Dori F, 2005, J PERIODONTOL, V76, P2236, DOI 10.1902/jop.2005.76.12.2236
   Dori F, 2007, J PERIODONTOL, V78, P983, DOI 10.1902/jop.2007.060349
   DRAGOO MR, 1973, J PERIODONTOL, V44, P599, DOI 10.1902/jop.1973.44.10.599
   Esposito M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003875.pub2
   Farina Roberto, 2007, Oral Health Prev Dent, V5, P307
   Forabosco A, 2003, Minerva Stomatol, V52, P105
   Froum S, 2004, J PERIODONTOL, V75, P1001, DOI 10.1902/jop.2004.75.7.1001
   Froum S, 2001, INT J PERIODONT REST, V21, P437
   Gestrelius S, 1997, J CLIN PERIODONTOL, V24, P685, DOI 10.1111/j.1600-051X.1997.tb00250.x
   Giannobile William V, 2003, Ann Periodontol, V8, P193, DOI 10.1902/annals.2003.8.1.193
   Guida L, 2007, J PERIODONTOL, V78, P231, DOI 10.1902/jop.2007.060142
   Gurinsky BS, 2004, J PERIODONTOL, V75, P1309, DOI 10.1902/jop.2004.75.10.1309
   Hanna R, 2004, J PERIODONTOL, V75, P1668, DOI 10.1902/jop.2004.75.12.1668
   Harrel SK, 2005, J PERIODONTOL, V76, P380, DOI 10.1902/jop.2005.76.3.380
   Harris R J, 2000, Int J Periodontics Restorative Dent, V20, P510
   Harris RJ, 2007, INT J PERIODONT REST, V27, P171
   HATAKEYAMA M, 2008, ORAL SURG ORAL MED O, V105, P13
   Heard RH, 2000, J PERIODONTOL, V71, P1715, DOI 10.1902/jop.2000.71.11.1715
   Heden G, 2000, INT J PERIODONT REST, V20, P127
   Heden G, 1999, J CLIN PERIODONTOL, V26, P855
   Heden G, 2006, J PERIODONTOL, V77, P295, DOI 10.1902/jop.2006.050071
   Herford Alan S, 2007, J Calif Dent Assoc, V35, P335
   HIATT WH, 1978, J PERIODONTOL, V49, P495, DOI 10.1902/jop.1978.49.10.495
   Hoang AM, 2002, J DENT RES, V81, P497, DOI 10.1177/154405910208100713
   Hoffmann T, 2006, J CLIN PERIODONTOL, V33, P575, DOI 10.1111/j.1600-051X.2006.00947.x
   Howell TH, 1997, INT J PERIODONT REST, V17, P125
   Howell TH, 1997, J PERIODONTOL, V68, P1186, DOI 10.1902/jop.1997.68.12.1186
   Jepsen S, 2008, J CLIN PERIODONTOL, V35, P420, DOI 10.1111/j.1600-051X.2008.01217.x
   Jepsen S, 2004, J PERIODONTOL, V75, P1150, DOI 10.1902/jop.2004.75.8.1150
   Jepsen S, 2002, J CLIN PERIODONTOL, V29, P103, DOI 10.1034/j.1600-051X.29.s3.6.x
   Kassolis JD, 2000, J PERIODONTOL, V71, P1654, DOI 10.1902/jop.2000.71.10.1654
   Keles GC, 2006, ACTA ODONTOL SCAND, V64, P327, DOI 10.1080/00016350600758651
   Kessler E, 1996, SCIENCE, V271, P360, DOI 10.1126/science.271.5247.360
   King GN, 1998, J PERIODONTOL, V69, P561, DOI 10.1902/jop.1998.69.5.561
   King GN, 1999, J PERIODONTOL, V70, P1125, DOI 10.1902/jop.1999.70.10.1125
   Kuru B, 2006, CLIN ORAL INVEST, V10, P227, DOI 10.1007/s00784-006-0052-5
   Lallier TE, 2003, J PERIODONTOL, V74, P458, DOI 10.1902/jop.2003.74.4.458
   Lallier TE, 2001, J PERIODONTOL, V72, P990, DOI 10.1902/jop.2001.72.8.990
   Lekovic V, 2003, J CLIN PERIODONTOL, V30, P746, DOI 10.1034/j.1600-051X.2003.00368.x
   Lekovic V, 2002, J PERIODONTOL, V73, P198, DOI 10.1902/jop.2002.73.2.198
   Lekovic V, 2001, J PERIODONTOL, V72, P1157, DOI 10.1902/jop.2000.72.9.1157
   Lekovic V, 2001, J PERIODONTOL, V72, P583, DOI 10.1902/jop.2001.72.5.583
   Lekovic V, 2000, J PERIODONTOL, V71, P1110, DOI 10.1902/jop.2000.71.7.1110
   Leung George, 2003, Prim Dent Care, V10, P41, DOI 10.1308/135576103322500700
   Majzoub Z, 2005, INT J PERIODONT REST, V25, P283
   Manor A, 2000, J Int Acad Periodontol, V2, P44
   Martu S, 2000, Rev Med Chir Soc Med Nat Iasi, V104, P147
   Marx R E, 2001, Implant Dent, V10, P225
   Marx RE, 1998, ORAL SURG ORAL MED O, V85, P638, DOI 10.1016/S1079-2104(98)90029-4
   Matos SM, 2007, J PERIODONTOL, V78, P1855, DOI 10.1902/jop.2007.060474
   Mauro S, 2003, Minerva Stomatol, V52, P401
   Maycock J, 2002, CONNECT TISSUE RES, V43, P472, DOI 10.1080/03008200290000880
   McGuire MK, 2006, INT J PERIODONT REST, V26, P223
   MELCHER AH, 1976, J PERIODONTOL, V47, P256, DOI 10.1902/jop.1976.47.5.256
   Mellonig JT, 1999, INT J PERIODONT REST, V19, P9
   Meyle J, 2004, J PERIODONTOL, V75, P1188, DOI 10.1902/jop.2004.75.9.1188
   Miliauskaite A, 2007, J PERIODONTOL, V78, P2043, DOI 10.1902/jop.2007.060492
   Minabe M, 2002, INT J PERIODONT REST, V22, P595
   Mott David A, 2002, J Oral Implantol, V28, P57, DOI 10.1563/1548-1336(2002)028<0057:EOOPIV>2.3.CO;2
   Murakami Shinya, 2007, Clin Calcium, V17, P249
   Nevins M, 2005, J PERIODONTOL, V76, P2205, DOI 10.1902/jop.2005.76.12.2205
   Nevins M, 2003, J PERIODONTOL, V74, P1282, DOI 10.1902/jop.2003.74.9.1282
   Nevins M, 2007, INT J PERIODONT REST, V27, P421
   Nikolopoulos S, 2002, INT J PERIODONT REST, V22, P269
   Okuda K, 2005, J PERIODONTOL, V76, P890, DOI 10.1902/jop.2005.76.6.890
   Okuda K, 2003, J PERIODONTOL, V74, P849, DOI 10.1902/jop.2003.74.6.849
   Onodera H, 2005, BIOMED RES-TOKYO, V26, P69, DOI 10.2220/biomedres.26.69
   Ouyang XY, 2006, CHINESE MED J-PEKING, V119, P1511
   Ozcelik O, 2008, J CLIN PERIODONTOL, V35, P147, DOI 10.1111/j.1600-051X.2007.01176.x
   Ozcelik O, 2007, J CLIN PERIODONTOL, V34, P788, DOI 10.1111/j.1600-051X.2007.01120.x
   Papadopoulos CE, 2003, J PERIODONTOL, V74, P451, DOI 10.1902/jop.2003.74.4.451
   Papli R, 2007, J PERIODONTOL, V78, P185, DOI 10.1902/jop.2007.060052
   Parashis A, 2000, J CLIN PERIODONTOL, V27, P705, DOI 10.1034/j.1600-051x.2000.027009705.x
   Parashis A, 2004, INT J PERIODONT REST, V24, P81
   Parashis AO, 2006, J PERIODONTOL, V77, P103, DOI 10.1902/jop.2006.77.1.103
   PARK JB, 1995, J PERIODONTOL, V66, P462, DOI 10.1902/jop.1995.66.6.462
   Parodi R, 2004, INT J PERIODONT REST, V24, P57
   Parodi R, 2000, INT J PERIODONT REST, V20, P585
   Pietruska M D, 2001, Rocz Akad Med Bialymst, V46, P198
   Pietruska MD, 2001, EUR J ORAL SCI, V109, P178, DOI 10.1034/j.1600-0722.2001.00007.x
   Radhakrishnan Sujatha, 2004, J Int Acad Periodontol, V6, P101
   Rasperini G, 2005, INT J PERIODONT REST, V25, P121
   Rasperini G, 1999, INT J PERIODONT REST, V19, P579
   Ripamonti U, 2006, PERIODONTOL 2000, V41, P73, DOI 10.1111/j.1600-0757.2006.00155.x
   Rosen PS, 2002, J PERIODONTOL, V73, P942, DOI 10.1902/jop.2002.73.8.942
   Saito E, 2003, J PERIODONTOL, V74, P1808, DOI 10.1902/jop.2003.74.12.1808
   Sallum EA, 2004, J PERIODONTOL, V75, P1357, DOI 10.1902/jop.2004.75.10.1357
   Sammartino G, 2005, J ORAL MAXIL SURG, V63, P766, DOI 10.1016/j.jams.2005.02.010
   Sanz M, 2004, J PERIODONTOL, V75, P726, DOI 10.1902/jop.2004.75.5.726
   Scheyer ET, 2002, J PERIODONTOL, V73, P423, DOI 10.1902/jop.2002.73.4.423
   Schwarz F, 2003, J CLIN PERIODONTOL, V30, P975, DOI 10.1034/j.1600-051X.2003.00412.x
   Sculean A, 1999, J PERIODONTOL, V70, P255, DOI 10.1902/jop.1999.70.3.255
   Sculean A, 2000, INT J PERIODONT REST, V20, P375
   Sculean A, 1999, INT J PERIODONT REST, V19, P157
   Sculean A, 2005, INT J PERIODONT REST, V25, P139
   Sculean A, 2005, J CLIN PERIODONTOL, V32, P111, DOI 10.1111/j.1600-051X.2004.00635.x
   Sculean A, 2004, INT J PERIODONT REST, V24, P327
   Sculean A, 2004, J CLIN PERIODONTOL, V31, P545, DOI 10.1111/j.1600-051X.2004.00518.x
   Sculean A, 2003, Clin Oral Investig, V7, P167, DOI 10.1007/s00784-003-0212-9
   Sculean A, 2003, INT J PERIODONT REST, V23, P345
   Sculean A, 2002, INT J PERIODONT REST, V22, P259
   Sculean A, 2002, J PERIODONTOL, V73, P401, DOI 10.1902/jop.2002.73.4.401
   Sculean A, 2001, J PERIODONTOL, V72, P1695, DOI 10.1902/jop.2001.72.12.1695
   Sculean A, 2001, J CLIN PERIODONTOL, V28, P397, DOI 10.1034/j.1600-051x.2001.028005397.x
   Sculean A, 2003, INT J PERIODONT REST, V23, P47
   Sculean A, 1998, J PERIODONTAL RES, V33, P453
   Sculean A, 1999, J PERIODONTAL RES, V34, P310, DOI 10.1111/j.1600-0765.1999.tb02259.x
   Sculean A, 2000, J CLIN PERIODONTOL, V27, P466, DOI 10.1034/j.1600-051x.2000.027007466.x
   Sculean A, 2007, INT J PERIODONT REST, V27, P221
   Sculean A, 2006, J PERIODONTOL, V77, P1879, DOI 10.1902/jop.2006.060002
   Sculean A, 2007, J CLIN PERIODONTOL, V34, P507, DOI 10.1111/j.1600-051X.2007.01084.x
   Sculean A, 2006, J PERIODONTOL, V77, P1167, DOI 10.1902/jop.2006.050300
   Selvig KA, 2002, J PERIODONTOL, V73, P1020, DOI 10.1902/jop.2002.73.9.1020
   Sigurdsson TJ, 1996, INT J PERIODONT REST, V16, P525
   SIGURDSSON TJ, 1995, J PERIODONTOL, V66, P131, DOI 10.1902/jop.1995.66.2.131
   Silvestri M, 2003, J CLIN PERIODONTOL, V30, P386, DOI 10.1034/j.1600-051X.2003.10146.x
   Sipos PM, 2005, J CLIN PERIODONTOL, V32, P765, DOI 10.1111/j.1600-051X.2005.00754.x
   Sorensen RG, 2004, J CLIN PERIODONTOL, V31, P796, DOI 10.1111/j.1600-051X.2004.00544.x
   St George G, 2006, J CLIN PERIODONTOL, V33, P449, DOI 10.1111/j.1600-051X.2006.00926.x
   STAHL SS, 1983, J PERIODONTOL, V54, P325, DOI 10.1902/jop.1983.54.6.325
   Taba M Jr, 2005, Orthod Craniofac Res, V8, P292
   Tamimi FM, 2007, J ORAL MAXIL SURG, V65, P1084, DOI 10.1016/j.joms.2006.09.012
   Tonetti MS, 2004, J CLIN PERIODONTOL, V31, P1092, DOI 10.1111/j.1600-051X.2004.00615.x
   Trejo PM, 2004, J PERIODONTOL, V75, P1532, DOI 10.1902/jop.2004.75.11.1532
   Trombelli L, 2006, J CLIN PERIODONTOL, V33, P69, DOI 10.1111/j.1600-051X.2005.00865.x
   Trombelli L, 2005, PERIODONTOL 2000, V37, P88, DOI 10.1111/j.1600-0757.2004.03798.x
   Trombelli L, 2002, J CLIN PERIODONTOL, V29, P117, DOI 10.1034/j.1600-051X.29.s3.7.x
   Trombelli L, 2002, J CLIN PERIODONTOL, V29, P433, DOI 10.1034/j.1600-051X.2002.290508.x
   Tsitoura E, 2004, J CLIN PERIODONTOL, V31, P643, DOI 10.1111/j.1600-051X.2004.00555.x
   Vandana KL, 2004, INT J PERIODONT REST, V24, P185
   Vavouraki H. N., 2003, Cell and Tissue Banking, V4, P17, DOI 10.1023/A:1026383604279
   Velasquez-Plata D, 2002, J PERIODONTOL, V73, P433, DOI 10.1902/jop.2002.73.4.433
   Venezia E, 2004, CRIT REV ORAL BIOL M, V15, P382, DOI 10.1177/154411130401500605
   Walters SP, 2003, J PERIODONTOL, V74, P1161, DOI 10.1902/jop.2003.74.8.1161
   Wang HL, 2005, J PERIODONTOL, V76, P1601
   WANG HL, 1994, J PERIODONTOL, V65, P429, DOI 10.1902/jop.1994.65.5.429
   Weibrich G, 2003, CLIN ORAL IMPLAN RES, V14, P357, DOI 10.1034/j.1600-0501.2003.00810.x
   Wikesjo UME, 2005, CLIN IMPLANT DENT R, V7, P112, DOI 10.1111/j.1708-8208.2005.tb00054.x
   Wikesjo UME, 2003, J CLIN PERIODONTOL, V30, P715, DOI 10.1034/j.1600-051X.2003.00364.x
   Wikesjo UME, 2003, J CLIN PERIODONTOL, V30, P705, DOI 10.1034/j.1600-051X.2003.00363.x
   Wikesjo UME, 1999, J CLIN PERIODONTOL, V26, P392, DOI 10.1034/j.1600-051X.1999.260610.x
   Windisch P, 2002, J PERIODONTOL, V73, P409, DOI 10.1902/jop.2002.73.4.409
   Yamada Y, 2006, INT J PERIODONT REST, V26, P363
   Yassibag-Berkman Z, 2007, J PERIODONTOL, V78, P801, DOI 10.1902/jop.2007.060318
   Yilmaz S, 2007, PLATELETS, V18, P535, DOI 10.1080/09537100701481393
   Yukna RA, 1998, J PERIODONTOL, V69, P655, DOI 10.1902/jop.1998.69.6.655
   Yukna RA, 2002, INT J PERIODONT REST, V22, P147
   Yukna RA, 2002, J PERIODONTOL, V73, P123, DOI 10.1902/jop.2002.73.1.123
   Yukna RA, 2000, J PERIODONTOL, V71, P752, DOI 10.1902/jop.2000.71.5.752
   Yukna RA, 2000, J PERIODONTOL, V71, P1671, DOI 10.1902/jop.2000.71.11.1671
   Zetterstrom O, 1997, J CLIN PERIODONTOL, V24, P697, DOI 10.1111/j.1600-051X.1997.tb00252.x
   Zucchelli G, 2003, J PERIODONTOL, V74, P1725, DOI 10.1902/jop.2003.74.12.1725
   Zucchelli G, 2006, J PERIODONTOL, V77, P1788, DOI 10.1902/jop.2006.050333
NR 189
TC 114
Z9 117
U1 0
U2 20
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0303-6979
EI 1600-051X
J9 J CLIN PERIODONTOL
JI J. Clin. Periodontol.
PD SEP
PY 2008
VL 35
SU 8
BP 117
EP 135
DI 10.1111/j.1600-051X.2008.01265.x
PG 19
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 341SA
UT WOS:000258734000011
PM 18724846
DA 2018-10-19
ER

PT J
AU Ferraz, N
   Carlsson, J
   Hong, J
   Ott, MK
AF Ferraz, Natalia
   Carlsson, Jan
   Hong, Jaan
   Ott, Marjam Karlsson
TI Influence of nanoporesize on platelet adhesion and activation
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID VON-WILLEBRAND-FACTOR; PROCOAGULANT ACTIVITY; WHOLE-BLOOD; P-SELECTIN;
   SURFACES; COMPLEMENT; MICROPARTICLES; BIOMATERIALS; FIBRONECTIN;
   VITRONECTIN
AB In this study we have evaluated the influence of biomaterial nano-topography on platelet adhesion and activation. Nano-porous alumina membranes with pore diameters of 20 and 200 nm were incubated with whole blood and platelet rich plasma. Platelet number, adhesion and activation were determined by using a coulter hematology analyzer, scanning electron microscopy, immunocytochemical staining in combination with light microscopy and by enzyme immunoassay. Special attention was paid to cell morphology, microparticle generation, P-selectin expression and beta-TG production. Very few platelets were found on the 200 nm alumina as compared to the 20 nm membrane. The platelets found on the 20 nm membrane showed signs of activation such as spread morphology and protruding filipodia as well as P-selectin expression. However no microparticles were detected on this surface. Despite the fact that very few platelets were found on the 200 nm alumina in contrast to the 20 nm membrane many microparticles were detected on this surface. Interestingly, all microparticles were found inside circular shaped areas of approximately 3 mu m in diameter. Since this is the approximate size of a platelet we speculate that this is evidence of transient, non-adherent platelet contact with the surface, which has triggered platelet microparticle generation. To the authors knowledge, this is the first study that demonstrates how nanotexture can influence platelet microparticle generation. The study highlights the importance of understanding molecular and cellular events on nano-level when designing new biomaterials.
C1 [Ferraz, Natalia; Carlsson, Jan; Ott, Marjam Karlsson] Uppsala Univ, Dept Phys & Analyt Chem, Div Surface Biotechnol, BMC, S-75123 Uppsala, Sweden.
   [Hong, Jaan] Uppsala Univ, Univ Hosp, Dept Oncol Radiol & Clin Immunol, Div Clin Immunol,Rudbeck Lab, S-75185 Uppsala, Sweden.
RP Ott, MK (reprint author), Uppsala Univ, Dept Phys & Analyt Chem, Div Surface Biotechnol, BMC, Husarg 3,Box 577, S-75123 Uppsala, Sweden.
EM Marjam.Ott@ytbioteknik.uu.se
CR ALKHAMIS TM, 1988, T AM SOC ART INT ORG, V34, P868
   BOUCHARD BA, 2002, PLATELETS, P229
   Broberg M, 2002, J LAB CLIN MED, V139, P163, DOI 10.1067/mlc.2002.121604
   Broberg M, 1998, COLLOID SURFACE B, V11, P67, DOI 10.1016/S0927-7765(98)00026-5
   Curtis A, 2001, TRENDS BIOTECHNOL, V19, P97, DOI 10.1016/S0167-7799(00)01536-5
   CURTIS A, 1997, BIOMATERIALS, V18, P573
   Dalby MJ, 2002, IEEE T NANOBIOSCI, V1, P18, DOI 10.1109/TNB.2002.806933
   ERIKSSON C, 1987, BIOMATERIALS, V22, P2001
   FERRAZ N, 2008, J BIOMED MAT RES
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Gemmell CH, 2001, J BIOMAT SCI-POLYM E, V12, P933, DOI 10.1163/156856201753113114
   Godo MN, 1999, BIOMATERIALS, V20, P1117, DOI 10.1016/S0142-9612(99)00012-5
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Grunkemeier JM, 2000, BIOMATERIALS, V21, P2243, DOI 10.1016/S0142-9612(00)00150-2
   Hong J, 1999, BIOMATERIALS, V20, P603, DOI 10.1016/S0142-9612(98)00210-5
   Horstman LL, 1999, CRIT REV ONCOL HEMAT, V30, P111, DOI 10.1016/S1040-8428(98)00044-4
   Hsu SH, 2004, BIOMATERIALS, V25, P5593, DOI 10.1016/j.biomaterials.2004.01.061
   Karlsson M, 2004, MICROSC RES TECHNIQ, V63, P259, DOI 10.1002/jemt.20040
   Karlsson M, 2003, BIOMATERIALS, V24, P3039, DOI 10.1016/S0142-9612(03)00146-7
   KARLSSONPARRA A, 1983, J IMMUNOL METHODS, V64, P85, DOI 10.1016/0022-1759(83)90386-1
   Kikuchi L, 2005, BIOMATERIALS, V26, P5285, DOI 10.1016/j.biomaterials.2005.01.009
   Marcus AJ, 1999, INFLAMMATION BASIC P, P77
   Milner KR, 2006, J BIOMED MATER RES A, V76A, P561, DOI 10.1002/jbm.a.30554
   NOMURA S, 2004, PLATELETS MEGAKARYOC, P260
   Park JY, 2001, BIOMATERIALS, V22, P2671, DOI 10.1016/S0142-9612(01)00009-6
   PEERSCHKE EIB, 1993, J EXP MED, V178, P579, DOI 10.1084/jem.178.2.579
   Siedlecki CA, 1999, BIOMATERIALS, V20, P1521, DOI 10.1016/S0142-9612(99)00065-4
   SIMS PJ, 1991, IMMUNOL TODAY, V12, P338, DOI 10.1016/0167-5699(91)90012-I
   SIMS PJ, 1995, SEMIN CELL BIOL, V6, P275, DOI 10.1006/scel.1995.0037
   Thompson GE, 1997, THIN SOLID FILMS, V297, P192, DOI 10.1016/S0040-6090(96)09440-0
   Tsai WB, 2002, J BIOMED MATER RES, V60, P348, DOI 10.1002/jbm.10048
   VALLES J, 1991, BLOOD, V78, P154
   Wieneke H, 2003, CATHETER CARDIO INTE, V60, P399, DOI 10.1002/ccd.10664
   Yim EKF, 2005, NANOMED-NANOTECHNOL, V1, P10, DOI 10.1016/j.nano.2004.11.008
NR 34
TC 40
Z9 41
U1 0
U2 10
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD SEP
PY 2008
VL 19
IS 9
BP 3115
EP 3121
DI 10.1007/s10856-008-3449-7
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 316QH
UT WOS:000256964300016
PM 18414999
DA 2018-10-19
ER

PT J
AU Ramtani, S
   Geiger, D
AF Ramtani, S.
   Geiger, D.
TI ANTICYTOSKELETAL DRUGS AND TIME CULTURE EFFECTS UPON THE MECHANICAL
   BEHAVIOR OF DERMAL EQUIVALENT TISSUE SUBMITTED TO UNCONFINED COMPRESSION
   LOADING
SO JOURNAL OF MECHANICS IN MEDICINE AND BIOLOGY
LA English
DT Article
DE Biomaterial; dermal equivalent; finite strain viscoelasticity;
   unconfined compression; cytoskeletal disrupting agents
ID POPULATED COLLAGEN MICROSPHERE; CONTRACTION; FIBROBLASTS; CELLS;
   TRACTION; ACTIN; MORPHOGENESIS; DEFORMATIONS; MEMBRANE; INVITRO
AB The dermal equivalent ( DE), a dermis substitute consisting of human skin fibroblasts growing into a three-dimensional collagen matrix, is extensively used in many applications: wound-healing response, pharmacological studies, skin grafting, fibroblast proliferation and migration, extracellular matrix remodeling, and efficacy of cosmetic products. The widespread growth of numerical modeling in biomechanical research has placed a heightened emphasis on accurate material property data for soft biological tissues, in particular for equivalent dermis which has not been so thoroughly investigated. Under unconfined compression loading, the effects of the strain rate, time culture, and cytoskeleton-disrupting agents are experimentally investigated. In order to model the observed mechanical behavior of the DE under the above conditions, the internal state variable approach is adopted for finite deformation viscoelasticity and the optimized material parameters are identified with respect to the stated thermodynamic restriction (i.e. positive viscous dissipation).
C1 [Ramtani, S.] Univ Paris 13, Lab Proprietes Mecan & Thermodynam Mat, Inst Galilee, CNRS UPR 9001, F-93430 Villetaneuse, France.
   [Geiger, D.] Univ Paris 12, Fac Sci & Technol, Lab Biomecan Biomat Osteoarticulaires, CNRS SPI UMR 7052, F-94010 Creteil, France.
RP Ramtani, S (reprint author), Univ Paris 13, Lab Proprietes Mecan & Thermodynam Mat, Inst Galilee, CNRS UPR 9001, 99 Ave J-B Clement, F-93430 Villetaneuse, France.
EM ramtani@galilee.univ-paris13.fr
FU CNRS (Centre National de la Recherche Scientifique); DGA; INSERM
   (Institut National de la sante et de la Recherche Medicale)
FX The financial support of CNRS (Centre National de la Recherche
   Scientifique), DGA (Delegation Generale de l'Armement), and INSERM
   (Institut National de la sante et de la Recherche Medicale) are
   gratefully acknowledged.
CR BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274
   BELL E, 1983, J INVEST DERMATOL, V81, P2
   Boehler J. P., 1987, APPL TENSOR FUNCTION
   COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473
   Fung YC, 1993, BIOMECHANICS MECH PR
   GABBIANI G, 1971, EXPERIENTIA, V27, P549, DOI 10.1007/BF02147594
   Galbraith CG, 1998, CURR OPIN CELL BIOL, V10, P566, DOI 10.1016/S0955-0674(98)80030-6
   Germain P., 1986, MECANIQUE, VI
   GERMAIN P, 1986, MECANIQUE, V2
   GRINNEL F, 1984, J CELL SCI, V66, P31
   Grinnell F, 2000, TRENDS CELL BIOL, V10, P362, DOI 10.1016/S0962-8924(00)01802-X
   GUIDRY C, 1985, J CELL SCI, V79, P67
   HARRIS AK, 1981, NATURE, V290, P249, DOI 10.1038/290249a0
   HERLICH HP, 1990, TISSUE CELL, V22, P407
   HERLICH HP, 1988, EYE, V2, P149
   Holzapfel GA, 2000, NONLINEAR SOLID MECH
   Ingber DE, 1995, J BIOMECH, V28, P1471, DOI 10.1016/0021-9290(95)00095-X
   JANMEY PA, 1990, NATURE, V345, P89, DOI 10.1038/345089a0
   KOLODNEY MS, 1992, J CELL BIOL, V117, P73, DOI 10.1083/jcb.117.1.73
   Martin-Green M, 2000, PRINCIPLES TISSUE EN, P33
   MATSUSHITA T, 2001, RIKEN REV, V41, P67
   MOON AG, 1993, AICHE J, V39, P163, DOI 10.1002/aic.690390116
   Moulin V, 1996, BURNS, V22, P359, DOI 10.1016/0305-4179(95)00167-0
   MURRAY JD, 1984, J MATH BIOL, V19, P265, DOI 10.1007/BF00277099
   NUSGENS B, 1984, COLLAGEN REL RES, V4, P351
   OSBORN M, 1976, P NATL ACAD SCI USA, V73, P867, DOI 10.1073/pnas.73.3.867
   Pioletti DP, 2000, EUR J MECH A-SOLID, V19, P749, DOI 10.1016/S0997-7538(00)00202-3
   Pioletti DP, 1998, J BIOMECH, V31, P753, DOI 10.1016/S0021-9290(98)00077-3
   Ramtani S, 2004, J BIOMECH, V37, P1709, DOI 10.1016/j.jbiomech.2004.01.028
   SAVENJEE R, 1982, J BIOMECH, V15, P107
   STOSSEL TP, 1989, J BIOL CHEM, V264, P18261
   VERONDA DR, 1970, J BIOMECH, V3, P111, DOI 10.1016/0021-9290(70)90055-2
   WAGENSEIL JE, 2001, P ASME BIOENG C, V50, P551
   Wu HW, 1998, SCANNING, V20, P389
NR 34
TC 2
Z9 2
U1 0
U2 4
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 0219-5194
J9 J MECH MED BIOL
JI J. Mech. Med. Biol.
PD SEP
PY 2008
VL 8
IS 3
BP 339
EP 352
DI 10.1142/S0219519408002735
PG 14
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA 389LM
UT WOS:000262094100003
DA 2018-10-19
ER

PT J
AU Yang, JM
   Wang, HZ
   Yang, CC
AF Yang, Jen Ming
   Wang, Hung Zen
   Yang, Chun Chen
TI Modification and characterization of semi-crystalline poly(vinyl
   alcohol) with interpenetrating poly(acrylic acid) by UV radiation method
   for alkaline solid polymer electrolytes membrane
SO JOURNAL OF MEMBRANE SCIENCE
LA English
DT Article
DE poly(vinyl alcohol); poly(acrylic acid); ionic conductivity; alkaline
   solid polymer electrolyte membrane
ID SBS-G-VP; DMAEMA COPOLYMER MEMBRANE; POLYVINYL-ALCOHOL; POLYURETHANE
   MEMBRANE; SECONDARY BATTERIES; BIOMATERIAL USAGE; FUEL-CELLS;
   CONDUCTIVITY; PERMEATION; CHITOSAN
AB Semi-crystalline poly(vinyl alcohol) was modified by UV radiation with acrylic acid monomer to get interpenetrating poly(acrylic acid) modified poly(vinyl alcohol), PVAAA, membrane. The stability of various PVAAA membranes in water, 2 M CH(3)OH, 2 M H(2)SO(4), and 40wt% KOH aqueous media were evaluated. It was found that the stability of PVAAA membrane is stable in 40 wt% KOH solution. The PVAAA membranes were characterized by differential scanning calorimetry, X-ray diffraction, and thermogravimetry analysis. These results show that (1) the crystallinity in PVAAA decreased with increasing the content of poly(acrylic acid) in the PVAAA membranes. (2) The melting point of the PVAAA membrane is reduced with increasing the content of poly(acrylic acid) in the membrane. (3)Three stages of thermal degradation were found for pure PVA. Compared to pure PVA, the temperature of thermal degradation increased for the PVAAA membrane. The various PVAAA membranes were immersed in KOH solution to form polymer electrolyte membranes, PVAAA-KOH, and their performances for alkaline solid polymer electrolyte were conducted. At room temperature, the ionic conductivity increased from 0.044 to 0.312 S/cm. The result was due to the formation of interpenetrating polymer chain of poly(acrylic acid) in the PVAAA membrane and resulting in the increase of charge carriers in the PVA polymer matrix. Compared to the data reported for different membranes by other studies, our PVAAA membrane are highly ionic conducting alkaline solid polymer electrolytes membranes.
C1 [Yang, Jen Ming; Wang, Hung Zen] Chang Gung Univ, Dept Chem & Mat Engn, Tao Yuan 333, Taiwan.
   [Yang, Chun Chen] Ming Chi Univ Technol, Dept Chem Engn, Taipei 243, Taiwan.
RP Yang, JM (reprint author), Chang Gung Univ, Dept Chem & Mat Engn, Tao Yuan 333, Taiwan.
EM jmyang@mail.cgu.edu.tw
FU National Science Council of the Republic of China; Chang Gung Memorial
   Hospital
FX This work was supported by National Science Council of the Republic of
   China and partial financial support of Chang Gung Memorial Hospital.
CR ANDRIEU X, 1995, ELECTROCHIM ACTA, V40, P2295, DOI 10.1016/0013-4686(95)00181-D
   Asensio JA, 2004, ELECTROCHIM ACTA, V49, P4461, DOI 10.1016/j.electacta.2004.05.002
   Bae B, 2003, J MEMBRANE SCI, V220, P75, DOI 10.1016/S0376-7388(03)00216-3
   Carretta N, 2000, J MEMBRANE SCI, V166, P189, DOI 10.1016/S0376-7388(99)00258-6
   FAUVARQUE JF, 1995, ELECTROCHIM ACTA, V40, P2449, DOI 10.1016/0013-4686(95)00212-W
   Guinot S, 1998, ELECTROCHIM ACTA, V43, P1163, DOI 10.1016/S0013-4686(97)10015-9
   Holland BJ, 2001, POLYMER, V42, P6775, DOI 10.1016/S0032-3861(01)00166-5
   HSIUE GH, 1988, J BIOMED MATER RES, V22, P405, DOI 10.1002/jbm.820220504
   Iwakura C, 2002, SOLID STATE IONICS, V148, P487, DOI 10.1016/S0167-2738(02)00092-9
   Kobayashi T, 1998, SOLID STATE IONICS, V106, P219, DOI 10.1016/S0167-2738(97)00512-2
   Lee HC, 2004, ELECTROCHIM ACTA, V49, P2315, DOI 10.1016/j.electacta.2004.01.012
   Lewandowski A, 2000, SOLID STATE IONICS, V133, P265, DOI 10.1016/S0167-2738(00)00733-5
   Lewandowski A, 2001, ELECTROCHIM ACTA, V46, P2777, DOI 10.1016/S0013-4686(01)00496-0
   MILLER RL, 1989, POLYMER HDB
   Mohamad AA, 2003, SOLID STATE IONICS, V156, P171, DOI 10.1016/S0167-2738(02)00617-3
   PEYSER P, 1989, POLYMER HDB
   Rajendran S, 2004, MATER LETT, V58, P641, DOI 10.1016/S0167-577X(03)00585-8
   Subramania A, 2005, J POWER SOURCES, V141, P188, DOI 10.1016/j.powsour.2004.09.001
   Vassal N, 2000, ELECTROCHIM ACTA, V45, P1527, DOI 10.1016/S0013-4686(99)00369-2
   Wu GM, 2006, J MEMBRANE SCI, V284, P120, DOI 10.1016/j.memsci.2006.07.025
   Yang CC, 2006, J APPL ELECTROCHEM, V36, P655, DOI 10.1007/s10800-006-9117-z
   Yang CC, 2005, J POWER SOURCES, V152, P303, DOI 10.1016/j.jpowsour.2005.03.004
   Yang CC, 2004, MATER LETT, V58, P33, DOI 10.1016/S0167-577X(03)00409-9
   Yang CC, 2003, J POWER SOURCES, V122, P210, DOI 10.1016/S0378-7753(03)00429-4
   Yang CC, 2002, MATER LETT, V57, P873, DOI 10.1016/S0167-577X(02)00888-1
   Yang CC, 2002, J POWER SOURCES, V109, P22, DOI 10.1016/S0378-7753(02)00038-1
   Yang CC, 2002, J POWER SOURCES, V112, P497, DOI 10.1016/S0378-7753(02)00438-X
   Yang CC, 2006, MAT SCI ENG B-SOLID, V131, P256, DOI 10.1016/j.mseb.2006.04.036
   Yang JM, 2003, J APPL POLYM SCI, V90, P1331, DOI 10.1002/app.12787
   Yang JM, 1997, J APPL POLYM SCI, V65, P365, DOI 10.1002/(SICI)1097-4628(19970711)65:2<365::AID-APP17>3.0.CO;2-Z
   Yang JM, 1996, J BIOMED MATER RES, V31, P281
   Yang JM, 1998, J MEMBRANE SCI, V138, P19
   Yang JM, 1997, J BIOMED MATER RES, V35, P175, DOI 10.1002/(SICI)1097-4636(199705)35:2<175::AID-JBM5>3.0.CO;2-K
   Yang JM, 1997, J APPL POLYM SCI, V65, P109
   YANG JM, 1990, J APPL POLYM SCI, V39, P1475, DOI 10.1002/app.1990.070390706
   Yang JM, 1997, J MEMBRANE SCI, V128, P133, DOI 10.1016/S0376-7388(96)00312-2
   Yang JM, 1998, J BIOMED MATER RES, V39, P86, DOI 10.1002/(SICI)1097-4636(199801)39:1<86::AID-JBM11>3.0.CO;2-M
   Yang JM, 2005, J MEMBRANE SCI, V258, P97, DOI 10.1016/j.memsci.2005.02.033
   Yang JM, 1999, J BIOMED MATER RES, V45, P133, DOI 10.1002/(SICI)1097-4636(199905)45:2<133::AID-JBM8>3.3.CO;2-4
   YANG JM, 1990, J APPL POLYM SCI, V41, P1141, DOI 10.1002/app.1990.070410523
   Yang JM, 2004, J MEMBRANE SCI, V243, P1, DOI 10.1016/j.memsci.2004.03.019
NR 41
TC 38
Z9 40
U1 4
U2 25
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0376-7388
J9 J MEMBRANE SCI
JI J. Membr. Sci.
PD SEP 1
PY 2008
VL 322
IS 1
BP 74
EP 80
DI 10.1016/j.memsci.2008.05.035
PG 7
WC Engineering, Chemical; Polymer Science
SC Engineering; Polymer Science
GA 345RP
UT WOS:000259014400010
DA 2018-10-19
ER

PT J
AU Sahni, JK
   Chopra, S
   Ahmad, FJ
   Khar, RK
AF Sahni, Jasjeet K.
   Chopra, Shruti
   Ahmad, Farhan J.
   Khar, Roop K.
TI Potential prospects of chitosan derivative trimethyl chitosan chloride
   (TMC) as a polymeric absorption enhancer: synthesis, characterization
   and applications
SO JOURNAL OF PHARMACY AND PHARMACOLOGY
LA English
DT Review
ID EPITHELIAL-CELLS CACO-2; IN-VITRO EVALUATION; NASAL DELIVERY-SYSTEM;
   POORLY ABSORBABLE DRUGS; INTESTINAL-ABSORPTION; MOLECULAR-WEIGHT;
   QUATERNIZED CHITOSAN; N-TRIMETHYLCHITOSAN; VIVO; NANOPARTICLES
AB In recent years, researchers have been working extensively on various novel properties of polymers to develop increased efficiency of drug delivery and improve bioavailability of various drug molecules, especially macromolecules. Chitosan, a naturally occurring polysaccharide, because of its protonated/polymeric nature, provides effective and safe absorption of peptide and protein drugs. Its transmucosal absorption is, however, limited to acidic media because of its strong intermolecular hydrogen bonds, A new partially quaternized chitosan derivative, N-trimethyl chitosan chloride (TMC), has been synthesized with improved solubility, safety and effectiveness as an absorption enhancer at neutral pH and in aqueous environment. It enhances the absorption, especially of peptide drugs, by reversible opening of tight junctions in between epithelial cells, thereby facilitating the paracellular diffusion of peptide drugs. This derivative thus opens new perspectives as a biomaterial for various pharmaceutical applications/drug delivery systems. This review deals with the potential use of the quaternized chitosan derivative as a permeation enhancer for the mucosal delivery of macromolecular drugs along with its other biomedical applications.
C1 [Sahni, Jasjeet K.; Chopra, Shruti; Ahmad, Farhan J.; Khar, Roop K.] Hamdard Univ, Fac Pharm, Dept Pharmaceut, New Delhi, India.
RP Sahni, JK (reprint author), Hamdard Univ, Fac Pharm, Dept Pharmaceut, New Delhi, India.
EM jasjeet2975@yahoo.com
OI Ahmad, Farhan/0000-0002-0740-8573
CR Amidi M, 2006, J CONTROL RELEASE, V111, P107, DOI 10.1016/j.conrel.2005.11.014
   Amidi M, 2007, VACCINE, V25, P6818, DOI 10.1016/j.vaceine.2007.05.064
   Amidi M, 2007, VACCINE, V25, P144, DOI 10.1016/j.vaccine.2006.06.086
   ARTURSSON P, 1994, PHARMACEUT RES, V11, P1358, DOI 10.1023/A:1018967116988
   Atyabi F, 2005, CARBOHYD POLYM, V61, P39, DOI 10.1016/j.carbpol.2005.02.005
   Avadi MR, 2004, EUR POLYM J, V40, P1355, DOI 10.1016/j.europolymj.2004.02.015
   Bernkop-Schnurch A, 2001, ADV DRUG DELIVER REV, V52, P127, DOI 10.1016/S0169-409X(01)00196-X
   Boonyo W, 2007, J CONTROL RELEASE, V121, P168, DOI 10.1016/j.jconrel.2007.05.025
   Borchard G, 1996, J CONTROL RELEASE, V39, P131, DOI 10.1016/0168-3659(95)00146-8
   CHANDY T, 1991, BIOMAT ARTIF CELL IM, V19, P745, DOI 10.3109/10731199109117852
   Chen F, 2008, INT J PHARM, V349, P226, DOI 10.1016/j.ijpharm.2007.07.035
   Chen F, 2007, INT J PHARM, V336, P166, DOI 10.1016/j.ijpharm.2006.11.027
   COLO DG, 2004, J PHARM SCI, V44, P2851
   DOMARD A, 1986, INT J BIOL MACROMOL, V8, P105, DOI 10.1016/0141-8130(86)90007-3
   Dorkoosh FA, 2002, PHARMACEUT RES, V19, P1532, DOI 10.1023/A:1020416918624
   Fini A., 2003, AM J DRUG DELIV, V1, P43
   FIX J A, 1987, Journal of Controlled Release, V6, P151, DOI 10.1016/0168-3659(87)90072-1
   Florea BI, 2006, J CONTROL RELEASE, V110, P353, DOI 10.1016/j.jconrel.2005.10.001
   GUMBINER B, 1987, AM J PHYSIOL, V25, P3749
   Hamman JH, 2002, INT J PHARM, V232, P235, DOI 10.1016/S0378-5173(01)00914-0
   Hamman JH, 2003, DRUG DEV IND PHARM, V29, P161, DOI 10.1081/DDC-120016724
   Heras A, 2001, CARBOHYD POLYM, V44, P1, DOI 10.1016/S0144-8617(00)00195-8
   HOCHMAN J, 1994, J CONTROL RELEASE, V29, P253, DOI 10.1016/0168-3659(94)90072-8
   Hoppe-Seiler F., 1994, BER DTSCH CHEM GES, V27, P3329
   Illum L, 1998, PHARMACEUT RES, V15, P1326
   ILLUM L, 1994, PHARMACEUT RES, V11, P1186, DOI 10.1023/A:1018901302450
   Illum L, 2001, ADV DRUG DELIVER REV, V51, P81, DOI 10.1016/S0169-409X(01)00171-5
   Jonker C, 2002, INT J PHARM, V238, P205, DOI 10.1016/S0378-5173(02)00068-6
   Junginger HE, 1998, PHARM SCI TECHNOL TO, V1, P370, DOI 10.1016/S1461-5347(98)00100-X
   Kas HS, 1997, J MICROENCAPSUL, V14, P689, DOI 10.3109/02652049709006820
   Kato Yoshinori, 2003, Current Pharmaceutical Biotechnology, V4, P303, DOI 10.2174/1389201033489748
   Kean T, 2005, J CONTROL RELEASE, V103, P643, DOI 10.1016/j.jconrel.2004.01.001
   Kotze AF, 1999, EUR J PHARM SCI, V7, P145, DOI 10.1016/S0928-0987(98)00016-5
   Kotze AF, 1999, J PHARM SCI, V88, P253, DOI 10.1021/js980233c
   Kotze AF, 1999, EUR J PHARM BIOPHARM, V47, P269, DOI 10.1016/S0939-6411(99)00006-5
   Kotze AF, 1997, PHARMACEUT RES, V14, P1197, DOI 10.1023/A:1012106907708
   Murata J, 1997, CARBOHYD POLYM, V32, P105, DOI 10.1016/S0144-8617(96)00154-3
   MUZZARELLI RAA, 1992, CARBOHYD POLYM, V19, P231, DOI 10.1016/0144-8617(92)90074-Z
   Polnok A, 2004, EUR J PHARM BIOPHARM, V57, P77, DOI 10.1016/S0939-6411(03)00151-6
   Sandri G, 2006, J PHARM PHARMACOL, V58, P1327, DOI 10.1211/jpp.58.10.0005
   Sandri G, 2005, INT J PHARM, V297, P146, DOI 10.1016/j.ijpharm.2005.03.017
   Sandri G, 2007, EUR J PHARM BIOPHARM, V65, P68, DOI 10.1016/j.ejpb.2006.07.016
   Schipper NGM, 1999, EUR J PHARM SCI, V8, P335, DOI 10.1016/S0928-0987(99)00032-9
   Schipper NGM, 1996, PHARMACEUT RES, V13, P1686, DOI 10.1023/A:1016444808000
   Sieval AB, 1998, CARBOHYD POLYM, V36, P157, DOI 10.1016/S0144-8617(98)00009-5
   Singla AK, 2001, J PHARM PHARMACOL, V53, P1047, DOI 10.1211/0022357011776441
   Sinha VR, 2004, INT J PHARM, V274, P1, DOI 10.1016/j.ijpharm.2003.12.026
   Sinha VR, 2001, INT J PHARM, V224, P19, DOI 10.1016/S0378-5173(01)00720-7
   Snyman D, 2002, CARBOHYD POLYM, V50, P145, DOI 10.1016/S0144-8617(02)00008-5
   Snyman D, 2003, DRUG DEV IND PHARM, V29, P61, DOI 10.1081/DDC-120016684
   Thanou M, 2001, ADV DRUG DELIVER REV, V50, pS91, DOI 10.1016/S0169-409X(01)00180-6
   Thanou M, 2002, BIOMATERIALS, V23, P153, DOI 10.1016/S0142-9612(01)00090-4
   Thanou M, 2001, ADV DRUG DELIVER REV, V52, P117, DOI 10.1016/S0169-409X(01)00231-9
   Thanou M, 2001, PHARM RES-DORDR, V18, P823, DOI 10.1023/A:1011092613951
   Thanou M, 2000, PHARMACEUT RES, V17, P27, DOI 10.1023/A:1007558206506
   Thanou M, 2000, J PHARM SCI, V89, P951
   Thanou MM, 2000, J CONTROL RELEASE, V64, P15, DOI 10.1016/S0168-3659(99)00131-5
   Thanou MM, 1999, INT J PHARM, V185, P73, DOI 10.1016/S0378-5173(99)00126-X
   van der Lubben IM, 2001, EUR J PHARM SCI, V14, P201, DOI 10.1016/S0928-0987(01)00172-5
   van der Merwe SM, 2004, EUR J PHARM BIOPHARM, V57, P85, DOI 10.1016/S0939-6411(03)00152-8
   Zambito Y, 2006, EUR J PHARM BIOPHARM, V64, P16, DOI 10.1016/j.ejpb.2006.01.004
NR 61
TC 25
Z9 25
U1 2
U2 19
PU PHARMACEUTICAL PRESS-ROYAL PHARMACEUTICAL SOC GREAT BRITIAN
PI LONDON
PA 1 LAMBETH HIGH ST, LONDON SE1 7JN, ENGLAND
SN 0022-3573
J9 J PHARM PHARMACOL
JI J. Pharm. Pharmacol.
PD SEP
PY 2008
VL 60
IS 9
BP 1111
EP 1119
DI 10.1211/jpp.60.9.0001
PG 9
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 344PD
UT WOS:000258938900001
PM 18718113
DA 2018-10-19
ER

PT J
AU Falco, EE
   Roth, JS
   Fisher, JP
AF Falco, Erin E.
   Roth, J. Scott
   Fisher, John P.
TI EH networks as a scaffold for skeletal muscle regeneration in abdominal
   wall hernia repair
SO JOURNAL OF SURGICAL RESEARCH
LA English
DT Article
DE skeletal muscle; abdominal wall hernia; cyclic acetal; prosthetic
   meshes; insulin-like growth factor-1
ID SMALL-INTESTINAL SUBMUCOSA; GROWTH-FACTOR-I; POLY(PROPYLENE FUMARATE)
   SCAFFOLDS; PHOTOINITIATED CROSS-LINKING; SATELLITE CELL; POLYPROPYLENE
   MESH; INSULIN; DIFFERENTIATION; HYPERTROPHY; EXPRESSION
AB Incisional hernias are a common clinical problem occurring in up to 10% of all patients undergoing abdominal procedures. Primary closure, synthetic biomaterials, as well as xenografts and allografts have been used in hernia defect repair. Despite these approaches, the incidence of hernia recurrence ranges from 32% to 63%. To address this high recurrence rate, we propose an incisional hernia treatment that utilizes a functional biomaterial developed for skeletal muscle regeneration. In particular, we have developed a cyclic acetal biomaterial (EH network) based on 5-ethyl-5-(hydroxymethyl)-beta,beta-dimethyl-1,3-dioxane-2- ethanol diacrylate. Initial tests of the scaffold's mechanical properties indicate that the complex modulus of the EH network decreased after a significant increase in initiator concentration. Subsequent studies indicate that EH networks promote myoblastic cell attachment and proliferation as well as delivers functional insulin-like growth factor-1 to an in vitro population of skeletal myoblasts. This work establishes that an EH network, a degradable cyclic acetal biomaterial, can function as a scaffold for skeletal muscle engineering. (c) 2008 Elsevier Inc. All rights reserved.
C1 [Fisher, John P.] Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
   [Falco, Erin E.] Univ Maryland, Dept Chem & Biomol Engn, College Pk, MD 20742 USA.
   [Roth, J. Scott] Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA.
RP Fisher, JP (reprint author), Univ Maryland, Fischell Dept Bioengn, 3238 Jeong H Kim Bldg, College Pk, MD 20742 USA.
EM jpfisher@umd.edu
RI Fisher, John/F-8078-2012
FU National Science Foundation [0448684]
FX This work was supported by the National Science Foundation through a
   Career Award to JPF (no. 0448684). The authors acknowledge the editorial
   contributions provided by Rosemary Klein of the Division of General
   Surgery at the University of Maryland Medical Center.
CR Adams GR, 1998, J APPL PHYSIOL, V84, P1716
   ALLEN RE, 1989, J CELL PHYSIOL, V138, P311, DOI 10.1002/jcp.1041380213
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Badylak S, 2002, J SURG RES, V103, P190, DOI 10.1006/jsre.2001.6349
   Badylak S, 2001, J SURG RES, V99, P282, DOI 10.1006/jsre.2001.6176
   Barton-Davis ER, 1999, ACTA PHYSIOL SCAND, V167, P301
   Barton-Davis ER, 1998, P NATL ACAD SCI USA, V95, P15603, DOI 10.1073/pnas.95.26.15603
   BEGUINOT F, 1985, J BIOL CHEM, V260, P5892
   Borrazzo E C, 2004, Hernia, V8, P108, DOI 10.1007/s10029-003-0181-6
   Burger JWA, 2004, ANN SURG, V240, P578
   CAMPION DR, 1984, INT REV CYTOL, V87, P225, DOI 10.1016/S0074-7696(08)62444-4
   Clarke KM, 1996, J SURG RES, V60, P107, DOI 10.1006/jsre.1996.0018
   Danino AM, 2005, BRIT J PLAST SURG, V58, P384, DOI 10.1016/j.bjps.2004.06.004
   DEVOL DL, 1990, AM J PHYSIOL, V259, pE89
   Fisher JP, 2003, BIOMACROMOLECULES, V4, P1335, DOI 10.1021/bm0300296
   Fisher JP, 2003, BIOMACROMOLECULES, V4, P1327, DOI 10.1021/bm030028d
   Fisher JP, 2002, J BIOMED MATER RES, V59, P547, DOI 10.1002/jbm.1268
   Fisher JP, 2001, J BIOMAT SCI-POLYM E, V12, P673
   Gonzalez R, 2004, Hernia, V8, P213
   Hashimoto N, 2004, DEVELOPMENT, V131, P5481, DOI 10.1242/dev.01395
   Holterman CE, 2005, SEMIN CELL DEV BIOL, V16, P575, DOI 10.1016/j.semcdb.2005.07.004
   Jones NC, 2005, J CELL BIOL, V169, P105, DOI 10.1083/jcb.200408066
   KAIHARA S, EUR J PHARM IN PRESS
   KAIHARA S, MACROMOLECU IN PRESS
   Kayaoglu HA, 2005, J INVEST SURG, V18, P89, DOI 10.1080/08941930590926357
   Ko R, 2006, J SURG RES, V135, P9, DOI 10.1016/j.jss.2006.02.007
   Machida S, 2004, EXP GERONTOL, V39, P1521, DOI 10.1016/j.exger.2004.08.009
   Marzaro M, 2002, INT J MOL MED, V10, P177
   Matthews BD, 2003, J SURG RES, V114, P126, DOI 10.1016/S0022-4804(03)00158-6
   Moreau JL, 2007, J BIOMED MATER RES A, V81A, P594, DOI 10.1002/jbm.a.31104
   Patton JH, 2007, AM J SURG, V193, P360, DOI 10.1016/j.amjsurg.2006.09.021
   Pu LLQ, 2005, PLAST RECONSTR SURG, V115, P2127, DOI 10.1097/01.PRS.0000168883.65715.2F
   Santa Maria L, 2004, EXP CELL RES, V300, P418, DOI 10.1016/j.yexcr.2004.07.017
   Song C, 2006, SURG ENDOSC, V20, P987, DOI 10.1007/s00464-005-0676-6
NR 34
TC 12
Z9 13
U1 0
U2 2
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0022-4804
J9 J SURG RES
JI J. Surg. Res.
PD SEP
PY 2008
VL 149
IS 1
BP 76
EP 83
DI 10.1016/j.jss.2007.08.016
PG 8
WC Surgery
SC Surgery
GA 340GD
UT WOS:000258633200012
PM 18395749
DA 2018-10-19
ER

PT J
AU Larsen, T
   Schultz, K
   Furst, EM
AF Larsen, Travis
   Schultz, Kelly
   Furst, Eric M.
TI Hydrogel microrheology near the liquid-solid transition
SO KOREA-AUSTRALIA RHEOLOGY JOURNAL
LA English
DT Article; Proceedings Paper
CT 9th International Symposium on Applied Rheology
CY MAY   15, 2008
CL Korea Univ, Seoul, SOUTH KOREA
HO Korea Univ
DE hydrogel; peptide; microrheology; particle tracking; superposition;
   critical gel
ID ACTIN-FILAMENT NETWORKS; CROSS-LINKING; GEL POINT; LINEAR
   VISCOELASTICITY; REVERSIBLE HYDROGELS; PARTICLE TRACKING; DESIGNED
   PEPTIDE; DELIVERY; GELATION; CELLS
AB Multiple particle tracking microrheology is used to characterize the viscoelastic properties of biomaterial and synthetic polymer gels near the liquid-solid transition. Probe particles are dispersed in the get precursors, and their dynamics are measured as a function of the extent of reaction during gel formation. We interpret the dynamics using the generalized Stokes-Einstein relationship (GSER), using a form of the GSER that emphasizes the relationship between the probe particle mean-squared displacement and the material creep compliance. We show that long-standing concepts in gel bulk rheology are applicable to microrheological data, including time-cure Superposition to identify the gel point and critical scaling exponents, and the power-law behavior of incipient network's viscoelastic response. These experiments provide valuable insight into the rheology, structure, and kinetics of gelling materials, and are especially powerful for studying the weak incipient networks of dilute gelators, as well as scarce materials, due to the small sample size requirements and rapid data acquisition.
C1 [Furst, Eric M.] Univ Delaware, Dept Chem Engn, Newark, DE 19716 USA.
   Univ Delaware, Ctr Mol & Engn Thermodynam, Newark, DE 19716 USA.
RP Furst, EM (reprint author), Univ Delaware, Dept Chem Engn, Newark, DE 19716 USA.
EM furst@udel.edu
OI Furst, Eric/0000-0002-8849-4484
CR ADOLF D, 1990, MACROMOLECULES, V23, P3700, DOI 10.1021/ma00217a026
   BOBROFF N, 1986, REV SCI INSTRUM, V57, P1152, DOI 10.1063/1.1138619
   CHAMBON F, 1987, J RHEOL, V31, P683, DOI 10.1122/1.549955
   Chin K, 2008, BIOTECHNOL PROGR, V24, P358, DOI 10.1021/bp070160f
   Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Davis MW, 1996, BIOMATERIALS, V17, P365, DOI 10.1016/0142-9612(96)85575-X
   DERRIDA B, 1983, J PHYS LETT-PARIS, V44, pL701
   Ellis-Behnke RG, 2006, P NATL ACAD SCI USA, V103, P5054, DOI 10.1073/pnas.0600559103
   Ferry J. D., 1980, VISCOELASTIC PROPERT
   Gardel ML, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.158302
   Grinstaff MW, 2007, BIOMATERIALS, V28, P5205, DOI 10.1016/j.biomaterials.2007.08.041
   Haines-Butterick L, 2007, P NATL ACAD SCI USA, V104, P7791, DOI 10.1073/pnas.0701980104
   Hoffman A. S., 2002, ADV DRUG DELIVERY RE, V43, P3, DOI DOI 10.1016/S0169-409X(01)00239-3
   JOANNY JF, 1982, J PHYS-PARIS, V43, P467, DOI 10.1051/jphys:01982004303046700
   Langer R, 2003, AICHE J, V49, P2990, DOI 10.1002/aic.690491202
   Larsen TH, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.146001
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   MARTIN JE, 1988, PHYS REV LETT, V61, P2620, DOI 10.1103/PhysRevLett.61.2620
   MARTIN JE, 1989, PHYS REV A, V39, P1325, DOI 10.1103/PhysRevA.39.1325
   Mason TG, 2000, RHEOL ACTA, V39, P371, DOI 10.1007/s003970000094
   Mikos AG, 2006, TISSUE ENG, V12, P3307, DOI 10.1089/ten.2006.12.3307
   Nie T, 2007, J CONTROL RELEASE, V122, P287, DOI 10.1016/j.jconrel.2007.04.019
   Ozbas B, 2004, MACROMOLECULES, V37, P7331, DOI 10.1021/ma0491762
   Palmer A, 1998, RHEOL ACTA, V37, P97, DOI 10.1007/s003970050095
   Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4
   Pochan DJ, 2003, J AM CHEM SOC, V125, P11802, DOI 10.1021/ja0353154
   Rajagopal K, 2004, CURR OPIN STRUC BIOL, V14, P480, DOI 10.1016/j.sbi.2004.06.006
   Savin T, 2005, BIOPHYS J, V88, P623, DOI [10.1529/biophysj.104.042457, 10.1529/biophysj.104.04245]
   Savin T, 2007, SOFT MATTER, V3, P1194, DOI 10.1039/b700434f
   SCANLAN JC, 1991, MACROMOLECULES, V24, P47, DOI 10.1021/ma00001a008
   Schneider JP, 2002, J AM CHEM SOC, V124, P15030, DOI 10.1021/ja027993g
   STAUFFER D, 1982, ADV POLYM SCI, V44, P103
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Tseng Y, 2002, J BIOL CHEM, V277, P18143, DOI 10.1074/jbc.M110868200
   Veerman C, 2006, MACROMOLECULES, V39, P6608, DOI 10.1021/ma0609331
   WINTER HH, 1986, J RHEOL, V30, P367, DOI 10.1122/1.549853
   Winter HH, 1997, ADV POLYM SCI, V134, P165
   Wu DQ, 2008, BIOMACROMOLECULES, V9, P1155, DOI 10.1021/bm7010328
   Xu CY, 2005, BIOMACROMOLECULES, V6, P1739, DOI 10.1021/bm0500171f
   Zimenkov Y, 2006, J AM CHEM SOC, V128, P6770, DOI 10.1021/ja0605974
NR 42
TC 25
Z9 25
U1 0
U2 12
PU KOREAN SOC RHEOLOGY
PI SEOUL
PA KOREA SCI TECHNOLOGY CENTER, 635-4 YUKSAM-DONG, STE 806, KANGNAM-GOO,
   SEOUL 135-703, SOUTH KOREA
SN 1226-119X
J9 KOREA-AUST RHEOL J
JI Korea-Aust. Rheol. J.
PD SEP
PY 2008
VL 20
IS 3
BP 165
EP 173
PG 9
WC Mechanics; Polymer Science
SC Mechanics; Polymer Science
GA 354XR
UT WOS:000259673700007
DA 2018-10-19
ER

PT J
AU Arata, HF
   Gillot, F
   Nojima, T
   Fujii, T
   Fujita, H
AF Arata, Hideyuki F.
   Gillot, Frederic
   Nojima, Takahiko
   Fujii, Teruo
   Fujita, Hiroyuki
TI Millisecond denaturation dynamics of fluorescent proteins revealed by
   femtoliter container on micro-thermodevice
SO LAB ON A CHIP
LA English
DT Article
ID TOTAL ANALYSIS SYSTEMS; CHROMOPHORE FORMATION; THERMAL-ACTIVATION;
   MOLECULES
AB Real-time observation of biomolecular behavior focusing on high speed temperature response is an essential endeavor for further biological study at the molecular level. This is because most of the important biological functions at the molecular level happen at the sub-second time scale. We used our own on-chip microheaters and microcontainers to observe the denaturation dynamics of fluorescent proteins at the millisecond time scale. The microheater controls the temperature in 1 ms under the microscope. Fluorescent proteins were contained in 28 fL PDMS microcontainers to prevent them from diffusing into the solution. The proteins were denatured by high temperatures and observed by a high speed CCD camera with 5 ms per frame. Hence, denaturation speeds of red fluorescent proteins (rDsRed and rHcRed) were measured to be 5-10 ms. Green fluorescent proteins (rAcGFP and rGFPuv) denatured with bi-exponential decay. rAcGFP denatured with time constants of 5 ms and 75 ms while rGFPuv denatured with 10 ms and 130 ms. This may be the reverse process of a two step renaturation of GFP observed in a previous report. This micro-thermodevice is applicable to other biomaterials such as nucleic acids or other proteins. It does not require any chemical treatment nor mutation to the biomaterial itself. Therefore, the methodology using this general purpose device gives access to biomolecular studies in short time scales and acts as a powerful tool in molecular biology.
C1 [Arata, Hideyuki F.; Gillot, Frederic; Nojima, Takahiko; Fujii, Teruo; Fujita, Hiroyuki] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan.
   [Gillot, Frederic] CNRS, LIMMS, F-75700 Paris, France.
RP Arata, HF (reprint author), Univ Tokyo, Inst Ind Sci, Meguro Ku, 4-6-1 Komaba, Tokyo 1538505, Japan.
EM Hideyuk.Arata@curie.fr
OI NOJIMA, Takahiko/0000-0001-9873-2856
FU Japan Society of Promotion of Science (JSPS)
FX This work was supported by the Japan Society of Promotion of Science
   (JSPS). We thank Dr C. Yamahata for his help in data analysis. This
   paper was reviewed and revised while HA was working in J-L. Viovy's
   group at the Curie Institute, Paris.
CR Arata HF, 2005, ANAL CHEM, V77, P4810, DOI 10.1021/ac050385+
   ARATA HF, 2006, APPL PHYS LETT, V88, P8392
   Arata HF, 2006, SENSOR ACTUAT B-CHEM, V117, P339, DOI 10.1016/j.snb.2005.11.017
   Auroux PA, 2002, ANAL CHEM, V74, P2637, DOI 10.1021/ac020239t
   BOKMAN SH, 1981, BIOCHEM BIOPH RES CO, V101, P1372, DOI 10.1016/0006-291X(81)91599-0
   Craighead H, 2006, NATURE, V442, P387, DOI 10.1038/nature05061
   Crameri A, 1996, NAT BIOTECHNOL, V14, P315, DOI 10.1038/nbt0396-315
   GILLOT F, 2007, LAB CHIP, V7, P1
   Gurskaya NG, 2003, BIOCHEM J, V373, P403, DOI 10.1042/BJ20021966
   Gurskaya NG, 2001, FEBS LETT, V507, P16, DOI 10.1016/S0014-5793(01)02930-1
   Kato H, 1999, P NATL ACAD SCI USA, V96, P9602, DOI 10.1073/pnas.96.17.9602
   Kawaguchi K, 2001, CELL MOTIL CYTOSKEL, V49, P41, DOI 10.1002/cm.1019
   Leiderman P, 2006, BIOPHYS J, V90, P1009, DOI 10.1529/biophysj.105.069393
   Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657
   MCDONALD JC, 2002, ACC CHEM RES, V35
   Penna TCV, 2004, LETT APPL MICROBIOL, V38, P135, DOI 10.1111/j.1472-765X.2003.01460.x
   Reid BG, 1997, BIOCHEMISTRY-US, V36, P6786, DOI 10.1021/bi970281w
   Reyes DR, 2002, ANAL CHEM, V74, P2623, DOI 10.1021/ac0202435
   Rondelez Y, 2005, NAT BIOTECHNOL, V23, P361, DOI 10.1038/nbt1072
   Rondelez Y, 2005, NATURE, V433, P773, DOI 10.1038/nature03277
   Sniegowski JA, 2005, J BIOL CHEM, V280, P26248, DOI 10.1074/jbc.M412327200
   Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509
   Ueno T, 2004, MOL CELL, V14, P423, DOI 10.1016/S1097-2765(04)00261-8
   WARD WW, 1982, BIOCHEMISTRY-US, V21, P4535, DOI 10.1021/bi00262a003
NR 24
TC 16
Z9 16
U1 4
U2 9
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1473-0197
J9 LAB CHIP
JI Lab Chip
PD SEP
PY 2008
VL 8
IS 9
BP 1436
EP 1440
DI 10.1039/b806749j
PG 5
WC Biochemical Research Methods; Chemistry, Multidisciplinary; Chemistry,
   Analytical; Nanoscience & Nanotechnology
SC Biochemistry & Molecular Biology; Chemistry; Science & Technology -
   Other Topics
GA 354YO
UT WOS:000259676000003
PM 18818796
OA Bronze
DA 2018-10-19
ER

PT J
AU Silva, CCGE
   Konig, B
   Carbonari, MJ
   Yoshimoto, M
   Allegrini, S
   Bressiani, JC
AF Guedes e Silva, C. C.
   Konig, B., Jr.
   Carbonari, M. J.
   Yoshimoto, M.
   Allegrini, S., Jr.
   Bressiani, J. C.
TI Bone growth around silicon nitride implants - An evaluation by scanning
   electron microscopy
SO MATERIALS CHARACTERIZATION
LA English
DT Article
DE silicon nitride; biomaterial; bone; scanning electron microscopy
ID CERAMICS; CELLS; FIXATION
AB Silicon nitride has demonstrated to be a potential candidate for clinical applications because it is a non-cytotoxic material and has satisfactory fracture toughness, high wear resistance and low friction coefficient. In this paper, samples of silicon nitride, which were kept into rabbits' tibias for 8 weeks, and the adjacentbone tissue were analysed by scanning electron microscopy in order to verify the bone growth around the implants and the interaction between the implant and the bone. Bone growth occurred mainly in the cortical areas, although it has been observed that the newly bone tends to grow toward the marrow cavity. Differences were observed between the implants installed into distal and proximal regions. In the first region, where the distance between the implant and the cortical bone is greater than in the proximal region, the osteoconduction process was evidenced by the presence of a bridge bone formation toward the implant surface. The results showed that silicon nitride can be used as biomaterial since the newly bone grew around the implants. (c) 2007 Elsevier Inc. All rights reserved.
C1 [Guedes e Silva, C. C.] CTMSP, BR-05508000 Sao Paulo, Brazil.
   [Konig, B., Jr.; Yoshimoto, M.; Allegrini, S., Jr.] Univ Sao Paulo, ICB, BR-05508900 Sao Paulo, Brazil.
   [Carbonari, M. J.; Bressiani, J. C.] IPEN, CNEN, SP, BR-05508000 Sao Paulo, Brazil.
RP Silva, CCGE (reprint author), CTMSP, Av Prof Lineu Prestes 2468, BR-05508000 Sao Paulo, Brazil.
EM ceciliacguedes@gmail.com
RI Biofabris, Inct/I-2418-2013; Bressiani, Jose/I-1426-2012; Guedes e
   Silva, Cecilia/A-9658-2014
CR Berroth K, 2005, KEY ENG MAT, V287, P3, DOI 10.4028/www.scientific.net/KEM.287.3
   CARLSSON L, 1988, ACTA ORTHOP SCAND, V59, P272, DOI 10.3109/17453678809149361
   Caudill R F, 1991, Int J Periodontics Restorative Dent, V11, P207
   Chang YS, 1996, J BIOMED MATER RES, V30, P117, DOI 10.1002/(SICI)1097-4636(199601)30:1<117::AID-JBM15>3.0.CO;2-L
   GRISS P, 1980, MECH PROPERTIES BIOM, P217
   HARRIS WH, 1983, CLIN ORTHOP RELAT R, P7
   HOWLETT CR, 1989, CLIN ORTHOP RELAT R, P293
   Kue R, 1999, BIOMATERIALS, V20, P1195, DOI 10.1016/S0142-9612(99)00007-1
   Silva CCG, 2004, MAT SCI ENG C-BIO S, V24, P643, DOI 10.1016/j.msec.2004.08.007
   Sohrabi A, 2000, J BIOMED MATER RES, V50, P43, DOI 10.1002/(SICI)1097-4636(200004)50:1<43::AID-JBM7>3.0.CO;2-A
   SORRELL C, 2004, P 7 WORD BIOM C SYDN
NR 11
TC 15
Z9 15
U1 0
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1044-5803
J9 MATER CHARACT
JI Mater. Charact.
PD SEP
PY 2008
VL 59
IS 9
BP 1339
EP 1341
DI 10.1016/j.matchar.2007.11.007
PG 3
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Materials Science, Characterization & Testing
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 344ZF
UT WOS:000258965100029
DA 2018-10-19
ER

PT J
AU Misra, RDK
AF Misra, R. D. K.
TI Magnetic nanoparticle carrier for targeted drug delivery: perspective,
   outlook and design
SO MATERIALS SCIENCE AND TECHNOLOGY
LA English
DT Article
DE magnetic nanocarrier; nanoparticles; targeter drug delivery; stimuli
   response
ID REVERSE MICELLE TECHNIQUE; NANOCRYSTALLINE NICKEL FERRITE; COMPOSITE
   NANOPARTICLES; BIOMATERIAL SYSTEM; CONTROLLED-RELEASE; FOLATE RECEPTORS;
   SHELL; CORE; DOXORUBICIN; BEHAVIOR
AB The primary challenge in the delivery of a drug to a tumour site is to target the anticancer drug specifically into and around tumours at concentrations that will decrease their growth and/or viability. Excellent vehicles to achieve targeted drug delivery are magnetic nanocarriers. A approach to accomplish this objective is to fabricate a novel temperature and pH-responsive magnetic nanocarrier that combines tumour targeting and controlled release. In addition to controlled release, these carriers simultaneously offer the possibility of imaging the delivery process by magnetic resonance imaging. The novel aspect of this approach is the combination of thermal and pH sensitivity of the drug containing shell with magnetic properties of the core in a single unit. Furthermore, application of an external magnetic field will heat the nanoparticles and thus nanoparticle containing cells. The targeted heat will aid in the killing of tumour cells.
C1 Univ Louisiana Lafayette, Ctr Struct & Funct Mat, Lafayette, LA 70504 USA.
RP Misra, RDK (reprint author), Univ Louisiana Lafayette, Ctr Struct & Funct Mat, POB 44130, Lafayette, LA 70504 USA.
EM dmisra@louisiana.edu
CR Alarcon CDH, 2005, CHEM SOC REV, V34, P276, DOI 10.1039/b406727d
   Antony AC, 1996, ANNU REV NUTR, V16, P501, DOI 10.1146/annurev.nu.16.070196.002441
   Christie RJ, 2003, ADV DRUG DELIVER REV, V55, P421, DOI 10.1016/S0169-409X(02)00229-6
   Detty MR, 2004, J MED CHEM, V47, P3897, DOI 10.1021/jm040074b
   Etrych T, 2001, J CONTROL RELEASE, V73, P89, DOI 10.1016/S0168-3659(01)00281-4
   Firestone RA, 1996, J CONTROL RELEASE, V39, P251, DOI 10.1016/0168-3659(95)00160-3
   Giri S, 2005, ANGEW CHEM INT EDIT, V44, P5038, DOI 10.1002/anie.200501819
   Grief AD, 2005, J MAGN MAGN MATER, V293, P455, DOI 10.1016/j.jmmm.2005.02.040
   GRINBERG VY, BIOMACROMOLECULES, V2, P871
   Gu HW, 2005, CHEM COMMUN, P4270, DOI 10.1039/b507779f
   Gubbala S, 2004, PHYSICA B, V348, P317, DOI 10.1016/j.physb.2003.12.017
   Gupta A.K, 2004, IEEE T NANOBIOSCI, V41, P4137
   Hafeli UO, 2004, INT J PHARM, V277, P19, DOI 10.1016/j.ijpharm.2003.03.002
   Huh KM, 2001, POLYM J, V33, P108, DOI 10.1295/polymj.33.108
   Jordan A, 1999, J MAGN MAGN MATER, V201, P413, DOI 10.1016/S0304-8853(99)00088-8
   Kale A, 2004, J MAGN MAGN MATER, V277, P350, DOI 10.1016/j.jmmm.2003.11.015
   King HD, 1999, BIOCONJUGATE CHEM, V10, P279, DOI 10.1021/bc980100i
   Kono K, 2001, ADV DRUG DELIVER REV, V53, P307, DOI 10.1016/S0169-409X(01)00204-6
   Lemarchand C, 2004, EUR J PHARM BIOPHARM, V58, P327, DOI 10.1016/j.ejpb.2004.02.016
   Liu TY, 2006, LANGMUIR, V22, P5974, DOI 10.1021/la060371e
   Lu YJ, 2002, ADV DRUG DELIVER REV, V54, P675, DOI 10.1016/S0169-409X(02)00042-X
   Maziarz KM, 1999, J BIOL CHEM, V274, P11086, DOI 10.1074/jbc.274.16.11086
   Misra RDK, 2004, MAT SCI ENG B-SOLID, V111, P164, DOI 10.1016/j.mseb.2004.04.014
   Nathani H, 2005, MAT SCI ENG B-SOLID, V121, P126, DOI 10.1016/j.mseb.2005.03.016
   Needham D, 2001, ADV DRUG DELIVER REV, V53, P285, DOI 10.1016/S0169-409X(01)00233-2
   Orive G, 2003, CURR OPIN BIOTECH, V14, P659, DOI 10.1016/j.copbio.2003.10.007
   Qiu Y, 2001, ADV DRUG DELIVER REV, V53, P321, DOI 10.1016/S0169-409X(01)00203-4
   Rana S, 2007, ACTA BIOMATER, V3, P233, DOI 10.1016/j.actbio.2006.10.006
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   Roux E, 2003, BIOMACROMOLECULES, V4, P240, DOI 10.1021/bm025651x
   Soppimath KS, 2002, DRUG DEV IND PHARM, V28, P957, DOI 10.1081/DDC-120006428
   Trail PA, 1997, CANCER RES, V57, P100
   WEITMAN SD, 1992, CANCER RES, V52, P3396
   WILLNER D, 1993, BIOCONJUGATE CHEM, V4, P521, DOI 10.1021/bc00024a015
   Wu J, 2006, INT J PHARM, V315, P1, DOI 10.1016/j.ijpharm.2006.01.045
   You YZ, 2004, ADV MATER, V16, P1953, DOI 10.1002/adma.200400362
   Zhang J, 2008, ACTA BIOMATER, V4, P40, DOI 10.1016/j.actbio.2007.06.006
   Zhang J, 2007, ACTA BIOMATER, V3, P838, DOI 10.1016/j.actbio.2007.05.011
   Zhang JL, 2007, LANGMUIR, V23, P6342, DOI 10.1021/la0636199
NR 40
TC 33
Z9 34
U1 3
U2 20
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 0267-0836
J9 MATER SCI TECH-LOND
JI Mater. Sci. Technol.
PD SEP
PY 2008
VL 24
IS 9
BP 1011
EP 1019
DI 10.1179/174328408X341690
PG 9
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 356RT
UT WOS:000259796000002
DA 2018-10-19
ER

PT J
AU Chau, DYS
   Agashi, K
   Shakesheff, KM
AF Chau, D. Y. S.
   Agashi, K.
   Shakesheff, K. M.
TI Microparticles as tissue engineering scaffolds: manufacture,
   modification and manipulation
SO MATERIALS SCIENCE AND TECHNOLOGY
LA English
DT Review
DE biomaterial; drug delivery; microparticles; microspheres; polymers;
   tissue engineering
ID SINTERED MICROSPHERE SCAFFOLDS; SUPERCRITICAL CARBON-DIOXIDE; CONTROLLED
   DRUG-RELEASE; LACTIDE-CO-GLYCOLIDE; IN-VITRO EVALUATION; CELL-ADHESION;
   BIODEGRADABLE MICROSPHERES; MECHANICAL-PROPERTIES; SURFACE MODIFICATION;
   SOLVENT EVAPORATION
AB Tissue engineering, a field which focusses on the replacement, repair and regeneration of damaged or diseased tissue by the application of biomaterials, cells and associated biological molecules, has advanced rapidly due to the intense demand for tissue substitutes. A key principle in tissue engineering involves growing the appropriate cells in vitro for the desired application before delivery into the body of a patient. The implantable devices, biological constructs or scaffolds, developed in tissue engineering aim to provide the initial architecture required for supporting the cells as well as define the micro and macrostructure of the final engineered product. Furthermore, these scaffolds may be exploited to release drugs and/or growth factors in a controlled manner, thus facilitating the repair and regeneration of the target tissue. Microparticles, spherical carrier scaffolds, have recently received extensive interest for their potential therapeutic applications in a diverse range of clinical and regenerative medical settings. Not only can these versatile subunits be used as cell culture scaffolds, their innate structure reduces the degradation of encapsulated biologically active molecules and also allows their exploitation as a localised injectable delivery system. The purpose of the present article is to review the tissue engineering applications of these microparticles and to provide a brief overview of the critical factors considered during their formulation and use - including the range of materials used and the different modification protocols and technologies exploited to improve and enhance their mechanical properties and biocompatibility for regenerative medicine.
C1 [Chau, D. Y. S.; Agashi, K.; Shakesheff, K. M.] Univ Nottingham, Sch Pharm, Div Drug Delivery & Tissue Engn, Ctr Biomol Sci, Nottingham NG7 2RD, England.
RP Shakesheff, KM (reprint author), Univ Nottingham, Sch Pharm, Div Drug Delivery & Tissue Engn, Ctr Biomol Sci, Univ Pk, Nottingham NG7 2RD, England.
EM Kevin.Shakesheff@nottingham.ac.uk
RI Shakesheff, Kevin/O-6371-2018
OI Shakesheff, Kevin/0000-0003-3236-2439; Chau, David/0000-0001-9200-6749
CR Abdel-Fattah WI, 2007, ACTA BIOMATER, V3, P503, DOI 10.1016/j.actbio.2006.12.004
   Adamopoulos O, 2007, J MATER SCI-MATER M, V18, P1587, DOI 10.1007/s10856-007-3041-6
   Ai H, 2003, CELL BIOCHEM BIOPHYS, V39, P23, DOI 10.1385/CBB:39:1:23
   Ando S, 1999, J PHARM SCI, V88, P126, DOI 10.1021/js9801687
   ARAR HH, 1992, BIOMED SCI INSTRUM, V28, P173
   BABANSEE JE, 1998, ADV DRUG DELIV RES, V33, P111
   BAJPAI PK, 1988, J BIOMED MATER RES, V22, P1245, DOI 10.1002/jbm.820221212
   Barry JJA, 2005, ADV FUNCT MATER, V15, P1134, DOI 10.1005/adfm.200400562
   BARSOUM MW, 1997, MCGRAW HILL SERIES M, P2
   Berkland C, 2001, J CONTROL RELEASE, V73, P59, DOI 10.1016/S0168-3659(01)00289-9
   Billotte WG, 2003, BIOMATERIALS PRINCIP, P21
   Blomley MJK, 2001, BRIT MED J, V322, P1222, DOI 10.1136/bmj.322.7296.1222
   BODMEIER R, 1988, J PHARM PHARMACOL, V40, P754, DOI 10.1111/j.2042-7158.1988.tb05166.x
   BODMEIER R, 1988, J MICROENCAPSUL, V5, P325, DOI 10.3109/02652048809036729
   Botchwey EA, 2001, J BIOMED MATER RES, V55, P242
   Brigham RC, 2000, ARS COMBINATORIA, V54, P3
   Brouwers JRBJ, 1996, PHARM WORLD SCI, V18, P153, DOI 10.1007/BF00820726
   Byrne RS, 2002, INT J PHARM, V246, P61, DOI 10.1016/S0378-5173(02)00357-5
   CANDAU F, 1985, Patent No. 4521317
   CAPLAN AI, 1990, BIOMATERIALS, V11, P44
   Chang SJ, 2006, IEE PROC-NANOBIOTECH, V153, P1, DOI 10.1049/ip-nbt:20050037
   CHANG TMS, 1964, SCIENCE, V146, P524, DOI 10.1126/science.146.3643.524
   Chau DYS, 2005, BIOMATERIALS, V26, P6518, DOI 10.1016/j.biomaterials.2005.04.017
   Chau DYS, 2007, TRENDS BIOMATERIALS, P143
   Chen R, 2006, BIOMATERIALS, V27, P4453, DOI 10.1016/j.biomaterials.2006.04.011
   Cheung HY, 2007, COMPOS PART B-ENG, V38, P291, DOI 10.1016/j.compositesb.2006.06.014
   Chickering D, 1996, BIOTECHNOL BIOENG, V52, P96, DOI 10.1002/(SICI)1097-0290(19961005)52:1<96::AID-BIT9>3.0.CO;2-U
   Chung HJ, 2006, PHARM RES, V23, P1835, DOI 10.1007/s11095-006-9039-9
   Coester CJ, 2000, J MICROENCAPSUL, V17, P187
   Cool SM, 2007, J BIOMED MATER RES A, V82A, P599, DOI 10.1002/jbm.a.31174
   Coulembier O, 2006, PROG POLYM SCI, V31, P723, DOI 10.1016/j.progpolymsci.2006.08.004
   DESAI SJ, 1965, J PHARM SCI, V54, P1459, DOI 10.1002/jps.2600541012
   DROBECK HP, 1984, J ORAL MAXIL SURG, V42, P143, DOI 10.1016/S0278-2391(84)80024-5
   EDELMAN R, 1993, VACCINE, V11, P155, DOI 10.1016/0264-410X(93)90012-M
   Eldor J, 1997, ACTA ANAESTH SCAND, V41, P326, DOI 10.1111/j.1399-6576.1997.tb04689.x
   Elisseeff J, 2000, J BIOMED MATER RES, V51, P164, DOI 10.1002/(SICI)1097-4636(200008)51:2<164::AID-JBM4>3.0.CO;2-W
   Elisseeff J, 1999, P NATL ACAD SCI USA, V96, P3104, DOI 10.1073/pnas.96.6.3104
   Engwicht A, 2000, BIOMATERIALS, V21, P1587, DOI 10.1016/S0142-9612(00)00045-4
   Engwicht A, 1999, INT J PHARM, V185, P61, DOI 10.1016/S0378-5173(99)00127-1
   Fang LM, 2006, BIOMATERIALS, V27, P3701, DOI 10.1016/j.biomaterials.2006.02.023
   FOLKMAN J, 1964, J Surg Res, V4, P139, DOI 10.1016/S0022-4804(64)80040-8
   Freiberg S, 2004, INT J PHARM, V282, P1, DOI 10.1016/j.ijpharm.2004.04.013
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Gao JM, 1998, J PHARM SCI, V87, P246, DOI 10.1021/js970284u
   Goessler UR, 2004, INT J MOL MED, V13, P505
   Green D, 2003, TISSUE ENG, V9, P1159, DOI 10.1089/10763270360728062
   GREEN H, 1979, P NATL ACAD SCI USA, V76, P5665, DOI 10.1073/pnas.76.11.5665
   Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9
   GUO JF, 1989, CONNECT TISSUE RES, V19, P277, DOI 10.3109/03008208909043901
   Gutowska A, 2001, ANAT RECORD, V263, P342, DOI 10.1002/ar.1115
   Habraken WJEM, 2007, ADV DRUG DELIVER REV, V59, P234, DOI 10.1016/j.addr.2007.03.011
   Hao JY, 2004, J PHARM SCI-US, V93, P1083, DOI 10.1002/jps.20002
   Hashimoto M, 2007, J MATER SCI-MATER M, V18, P661, DOI 10.1007/s10856-007-2317-1
   Hem DL, 1998, J BIOMED MATER RES, V39, P266
   Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z
   HERBERGER JD, 1996, P INT S CONTR REL BI, V23, P835
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Homaeigohar SSH, 2006, J BIOMED MATER RES A, V78A, P129, DOI 10.1002/jbm.a.30691
   Hou QP, 2004, J MATER CHEM, V14, P1915, DOI 10.1039/b401791a
   Howe A, 1998, CURR OPIN CELL BIOL, V10, P220, DOI 10.1016/S0955-0674(98)80144-0
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Ibim SM, 1998, BIOMATERIALS, V19, P941, DOI 10.1016/S0142-9612(98)00019-2
   Ingham E, 2000, P I MECH ENG H, V214, P21, DOI 10.1243/0954411001535219
   Jabbarzadeh E, 2007, BIOTECHNOL BIOENG, V98, P1094, DOI 10.1002/bit.21495
   Jain RA, 2000, BIOMATERIALS, V21, P2475, DOI 10.1016/S0142-9612(00)00115-0
   JALIL R, 1990, J MICROENCAPSUL, V7, P297, DOI 10.3109/02652049009021842
   Jiang J, 2007, CHIM OGGI, V25, P8
   Jiang T, 2006, BIOMATERIALS, V27, P4894, DOI 10.1016/j.biomaterials.2006.05.025
   Johnson OL, 1997, PHARM RES-DORDR, V14, P730, DOI 10.1023/A:1012142204132
   Kantlehner M, 2000, CHEMBIOCHEM, V1, P107, DOI 10.1002/1439-7633(20000818)1:2<107::AID-CBIC107>3.3.CO;2-W
   Kenny SM, 2003, J MATER SCI-MATER M, V14, P923, DOI 10.1023/A:1026394530192
   KHAN MA, 1992, P INT S CONTROL REL, V23, P333
   KHAN Y, 2006, P 28 IEEE EMBS ANN I, P529
   Khan YM, 2004, J BIOMED MATER RES A, V69A, P728, DOI 10.1002/jbm.a.30051
   Khan YM, 2007, J MATER SCI, V42, P4183, DOI 10.1007/s10853-006-0636-0
   Kidoaki S, 2005, BIOMATERIALS, V26, P37, DOI 10.1016/j.biomaterials.2004.01.063
   KIM WS, 1994, PLAST RECONSTR SURG, V94, P233, DOI 10.1097/00006534-199408000-00001
   KRAJWSKI A, 2000, J MATER SCI-MATER M, V12, P763
   Kretlow JD, 2007, TISSUE ENG, V13, P927, DOI 10.1089/ten.2006.0394
   Kreuter J, 1996, J ANAT, V189, P503
   Kuhn K, 1994, Trends Cell Biol, V4, P256, DOI 10.1016/0962-8924(94)90124-4
   Kumbar SG, 2007, J BIOMED MATER RES B, V81B, P91, DOI 10.1002/jbm.b.30641
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Langer R, 1998, NATURE, V392, P5
   Li M, 2006, J BIOMED MATER RES A, V79A, P963, DOI 10.1002/jbm.a.30833
   LIM F, 1981, J PHARM SCI, V70, P351, DOI 10.1002/jps.2600700402
   Lu HH, 2003, J BIOMED MATER RES A, V64A, P465, DOI 10.1002/jbm.a.10399
   LU HH, 2005, KEY ENG MATER, V17, P607
   Martin KH, 2002, SCIENCE, V296, P1652, DOI 10.1126/science.296.5573.1652
   Masters K, 1985, SPRAY DRYING HDB
   MATHIOWITZ E, 1987, Journal of Controlled Release, V5, P13, DOI 10.1016/0168-3659(87)90033-2
   Misra SK, 2006, BIOMACROMOLECULES, V7, P2249, DOI 10.1021/bm060317c
   Mo XM, 2004, BIOMATERIALS, V25, P1883, DOI 10.1016/j.biomaterials.2003.08.042
   Morita T, 2001, INT J PHARM, V219, P127, DOI 10.1016/S0378-5173(01)00642-1
   Muller R, 2006, BIOMATERIALS, V27, P4059, DOI 10.1016/j.biomaterials.2006.03.019
   MULLER BW, 1991, Patent No. 5043280
   Muller M, 2003, J BIOMED MATER RES A, V66A, P55, DOI 10.1002/jbm.a.10502
   Nam YS, 1999, J BIOMAT SCI-POLYM E, V10, P1145
   Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8
   Niemela T, 2005, ACTA BIOMATER, V1, P235, DOI [10.1016/j.actbio.2004.11.002, 10.1016/j.actbio.2004.11002]
   NIHANT N, 1995, J CONTROL RELEASE, V35, P117, DOI 10.1016/0168-3659(95)00026-5
   OGAWA Y, 1988, CHEM PHARM BULL, V36, P1502
   Pachence JM, 1997, PRINCIPLES TISSUE EN, P273
   Park GE, 2005, BIOMATERIALS, V26, P3075, DOI 10.1016/j.biomaterials.2004.08.005
   Park J. B., 2003, BIOMATERIALS PRINCIP
   PAVANETTO F, 1993, J MICROENCAPSUL, V10, P487, DOI 10.3109/02652049309015325
   Peterson KP, 1998, P SOC EXP BIOL MED, V218, P365
   Qiu QQ, 1999, BIOMATERIALS, V20, P989, DOI 10.1016/S0142-9612(98)00183-5
   Queiroz AC, 2001, BIOMATERIALS, V22, P1393, DOI 10.1016/S0142-9612(00)00296-9
   Rantakyla M, 2002, J SUPERCRIT FLUID, V24, P251, DOI 10.1016/S0896-8446(02)00034-7
   Reis CP, 2006, J MICROENCAPSUL, V23, P245, DOI 10.1080/02652040500286086
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Rosca ID, 2004, J CONTROL RELEASE, V99, P271, DOI 10.1016/j.jconrel.2004.07.007
   RUIZ JM, 1989, INT J PHARMACEUT, V49, P69, DOI 10.1016/0378-5173(89)90154-3
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Sachlos E, 2003, BIOMATERIALS, V24, P1487, DOI 10.1016/S0142-9612(02)00528-8
   Salem AK, 2003, ADV MATER, V15, P210, DOI 10.1002/adma.200390047
   Sarkari M, 2003, BIOTECHNOL PROGR, V19, P448, DOI 10.1021/bp0255513
   Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65
   Serp D, 2000, BIOTECHNOL BIOENG, V70, P41, DOI 10.1002/1097-0290(20001005)70:1<41::AID-BIT6>3.0.CO;2-U
   Shakesheff KM, 1998, J BIOMAT SCI-POLYM E, V9, P507, DOI 10.1163/156856298X00596
   Shen Francis H, 2006, Spine J, V6, P615, DOI 10.1016/j.spinee.2006.03.006
   Shi SL, 2007, J AM CERAM SOC, V90, P3331, DOI 10.1111/j.1551-2916.2007.01882.x
   Siebers MC, 2005, BIOMATERIALS, V26, P137, DOI 10.1016/j.biomaterials.2004.02.021
   Simonoska Crcarevska M., 2008, EUR J PHARM BIOPHARM, V68, P565
   Smith TW, 1997, PSYCHOPHYSIOLOGY, V34, P65, DOI 10.1111/j.1469-8986.1997.tb02417.x
   Sokolsky-Papkov M, 2007, ADV DRUG DELIVER REV, V59, P187, DOI 10.1016/j.addr.2007.04.001
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Taylor NJ, 2002, DNA CELL BIOL, V21, P963, DOI 10.1089/104454902762053891
   Thomasin C, 1997, INT J PHARM, V147, P173, DOI 10.1016/S0378-5173(96)04810-7
   Tjia JS, 1999, BIOMATERIALS, V20, P2223, DOI 10.1016/S0142-9612(99)00153-2
   TOM JW, 1991, BIOTECHNOL PROGR, V7, P403, DOI 10.1021/bp00011a004
   Tse G, 1999, J CONTROL RELEASE, V60, P77, DOI 10.1016/S0168-3659(99)00056-5
   Tsigkou O, 2007, J BIOMED MATER RES A, V80A, P837, DOI 10.1002/jbm.a.30910
   Tsung M J, 2001, AAPS PharmSci, V3, pE11
   Turhani D, 2007, J ORAL MAXIL SURG, V65, P485, DOI 10.1016/j.joms.2005.12.065
   UCHIDA A, 1992, J ORTHOPAED RES, V10, P440, DOI 10.1002/jor.1100100317
   Uhrich KE, 1999, CHEM REV, V99, P3181, DOI 10.1021/cr940351u
   Vallet-Regi M, 2006, DALTON T, P5211, DOI 10.1039/b610219k
   van de Weert M, 2000, PHARMACEUT RES, V17, P1159, DOI 10.1023/A:1026498209874
   Vasir JK, 2003, INT J PHARM, V255, P13, DOI 10.1016/S0378-5173(03)00087-5
   Vehring R, 2008, PHARM RES-DORDR, V25, P999, DOI 10.1007/s11095-007-9475-1
   WAGENAAR BW, 1994, BIOMATERIALS, V15, P49, DOI 10.1016/0142-9612(94)90196-1
   Wahl DA, 2006, EUR CELLS MATER, V11, P43, DOI 10.22203/eCM.v011a06
   Wan YQ, 2003, BIOMATERIALS, V24, P3757, DOI [10.1016/S0142-9612(03)00251-5, 10.1016/S0142-9612(03)00251-2]
   Wang SB, 2004, MACROMOL BIOSCI, V4, P27, DOI 10.1002/mabi.200300043
   Watabe M., 2005, WO, Patent No. [2005/023468 Al, 2005023468]
   Watson MS, 2002, ADV MATER, V14, P1802, DOI 10.1002/adma.200290003
   WATTS PJ, 1990, CRIT REV THER DRUG, V7, P235
   Whitaker MJ, 2005, J CONTROL RELEASE, V101, P85, DOI 10.1016/j.jconrel.2004.07.017
   Whittlesey KJ, 2004, EXP NEUROL, V190, P1, DOI 10.1016/j.expneurol.2004.06.020
   Wickline SA, 2006, ARTERIOSCL THROM VAS, V26, P435, DOI 10.1161/01.ATV.0000201069.47550.8b
   WISE DL, 1976, LIFE SCI, V19, P867, DOI 10.1016/0024-3205(76)90314-3
   WITCHI C, 1998, J CONTROL RELEASE, V51, P327
   Wu TJ, 2007, BIOTECHNOL BIOENG, V98, P578, DOI 10.1002/bit.21452
   Wu Xue Shen, 1995, P1151
   Wu Xue Shen, 1995, P1015
   Yang F, 2004, BIOMATERIALS, V25, P1891, DOI 10.1016/j.biomaterials.2003.08.062
   Yang J, 2002, J BIOMED MATER RES, V62, P438, DOI 10.1002/jbm.10318
   Yasuji T, 2006, J PHARM SCI-US, V95, P581, DOI 10.1002/jps.20565
   Yehia Hadi N., 2007, Journal of Nanobiotechnology, V5, P8, DOI 10.1186/1477-3155-5-8
   Zimmermann Heiko, 2007, Curr Diab Rep, V7, P314, DOI 10.1007/s11892-007-0051-1
   SPHERAMINE
   INJECTABONE
NR 166
TC 8
Z9 9
U1 1
U2 35
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 0267-0836
J9 MATER SCI TECH-LOND
JI Mater. Sci. Technol.
PD SEP
PY 2008
VL 24
IS 9
BP 1031
EP 1044
DI 10.1179/174328408X341726
PG 14
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 356RT
UT WOS:000259796000005
DA 2018-10-19
ER

PT J
AU Wang, HJ
   Gong, SJ
   Wang, JY
AF Wang, H. -J.
   Gong, S. -J.
   Wang, J. -Y.
TI Mechanical improvement of zein protein as scaffold for bone tissue
   engineering
SO MATERIALS SCIENCE AND TECHNOLOGY
LA English
DT Article
DE zein; mechanical properties; fatty acids; brittleness; porosity
ID WATER-VAPOR PERMEABILITY; IN-VITRO; SECONDARY STRUCTURE; TENSILE
   PROPERTIES; LINOLEIC ACIDS; CORN PROTEIN; FILMS; BIOCOMPATIBILITY;
   CONFORMATION; POLYMERS
AB Although extensive efforts have been put into the development of porous scaffolds from natural materials for bone regeneration with encouraging results, they still have a common limitation: the inherent lack of strength associated with porosity. That is to say, they are not strong enough to meet the specific requirements of load bearing applications. The authors have reported a series studies on possible application of a natural material, zein protein from maize, as a new kind of biomaterial for tissue engineering. The result showed a good cell compatibility and biodegradability in tissue within eight months. To improve its mechanical property (especially the brittleness), stearic acid or oleic acid was added. The mechanical properties, especially the tensile and flexible properties were improved significantly. The possible mechanism is discussed.
C1 [Wang, J. -Y.] Chinese Acad Sci, Shanghai Inst Organ Chem, Shanghai 200032, Peoples R China.
   [Wang, H. -J.; Gong, S. -J.] Shanghai Jiao Tong Univ, Coll Life Sci & Biotechnol, Shanghai 200030, Peoples R China.
RP Wang, JY (reprint author), Chinese Acad Sci, Shanghai Inst Organ Chem, 354 Fenglin Lu, Shanghai 200032, Peoples R China.
EM jywang@mail.sioc.ac.cn
RI Wang, Jin-Ye/H-1450-2011
FU National Programme on Key Basic Research Projects of China
   [2005CB724306]; National Hi-Tech Research and Development Plan (863
   Project) of China [2002AA327100]
FX The present study was supported by the National Programme on Key Basic
   Research Projects of China (973 Programme, grant no. 2005CB724306), and
   the National Hi-Tech Research and Development Plan ( 863 Project) of
   China (project no. 2002AA327100). It is also grateful that Elsevier
   Limited admits us reproducing the figures in this paper.
CR Belton PS, 2005, J CEREAL SCI, V41, P203, DOI 10.1016/j.jcs.2004.06.003
   Bensaid W, 2003, BIOMATERIALS, V24, P2497, DOI 10.1016/S0142-9612(02)00618-X
   Brekke J H, 1996, Tissue Eng, V2, P97, DOI 10.1089/ten.1996.2.97
   Chen GP, 2001, MAT SCI ENG C-BIO S, V17, P63, DOI 10.1016/S0928-4931(01)00338-1
   CRANE GM, 1995, NAT MED, V1, P1322, DOI 10.1038/nm1295-1322
   Cury-Boaventura MF, 2006, CLIN NUTR, V25, P1004, DOI 10.1016/j.clnu.2006.05.008
   Daamen WF, 2003, BIOMATERIALS, V24, P4001, DOI 10.1016/S0142-9612(03)00273-4
   Deville S, 2006, BIOMATERIALS, V27, P5480, DOI 10.1016/j.biomaterials.2006.06.028
   di Gioia L, 1999, J AGR FOOD CHEM, V47, P1254, DOI 10.1021/jf980976j
   Dong J, 2004, BIOMATERIALS, V25, P4691, DOI 10.1016/j.biomaterials.2003.10.084
   Forato LA, 2004, J AGR FOOD CHEM, V52, P2382, DOI 10.1021/jf035020+
   Forato LA, 2003, BIOPOLYMERS, V72, P421, DOI 10.1002/bip.10481
   Gao CL, 2006, J AGR FOOD CHEM, V54, P4611, DOI 10.1021/jf060611w
   Gao CL, 2005, J AGR FOOD CHEM, V53, P306, DOI 10.1021/jf0492666
   Gelinsky M, 2008, CHEM ENG J, V137, P84, DOI 10.1016/j.cej.2007.09.029
   Ghanbarzadeh B, 2006, FOOD RES INT, V39, P882, DOI 10.1016/j.foodres.2006.05.011
   Gong SJ, 2006, BIOMATERIALS, V27, P3793, DOI 10.1016/j.biomaterials.2006.02.019
   Guilbert S, 1986, FOOD PACKAGING PRESE, P371
   Guo YC, 2005, J CEREAL SCI, V41, P277, DOI 10.1016/j.jcs.2004.12.005
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hsu BL, 2005, J AGR FOOD CHEM, V53, P5089, DOI 10.1021/jf0501490
   Huang Y, 2005, BIOMATERIALS, V26, P7616, DOI 10.1016/j.biomaterials.2005.05.036
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Jiang T, 2006, BIOMATERIALS, V27, P4894, DOI 10.1016/j.biomaterials.2006.05.025
   Jones JR, 2007, BIOMATERIALS, V28, P1404, DOI 10.1016/j.biomaterials.2006.11.014
   Kim S, 2008, J CEREAL SCI, V47, P1, DOI 10.1016/j.jcs.2007.08.004
   Kim S, 2004, IND CROP PROD, V20, P291, DOI 10.1016/j.indcrop.2003.10.013
   Krochta J. M., 1997, FOOD PROTEINS THEIR, P529
   Lai HM, 1997, CEREAL CHEM, V74, P83, DOI 10.1094/CCHEM.1997.74.1.83
   LAWTON JW, 1992, CEREAL CHEM, V69, P351
   Lee JH, 2003, BIOMATERIALS, V24, P2773, DOI 10.1016/S0142-9612(03)00080-2
   Mauney JR, 2005, BIOMATERIALS, V26, P3173, DOI 10.1016/j.biomaterials.2004.08.020
   Mejia CD, 2007, J CEREAL SCI, V45, P353, DOI 10.1016/j.jcs.2006.09.009
   Meyers MA, 2008, PROG MATER SCI, V53, P1, DOI 10.1016/j.pmatsci.2007.05.002
   Murphy WL, 2002, TISSUE ENG, V8, P43, DOI 10.1089/107632702753503045
   Murugan R, 2005, COMPOS SCI TECHNOL, V65, P2385, DOI 10.1016/j.compscitech.2005.07.022
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Paramawati R., 2001, Food Science and Technology Research, V7, P191, DOI 10.3136/fstr.7.191
   PARK JW, 1994, J FOOD SCI, V59, P916, DOI 10.1111/j.1365-2621.1994.tb08157.x
   Parris N, 1997, J AGR FOOD CHEM, V45, P1596, DOI 10.1021/jf960809o
   Parris N, 2000, J AGR FOOD CHEM, V48, P890, DOI 10.1021/jf991079y
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Santosa FXB, 1999, J AGR FOOD CHEM, V47, P2070, DOI 10.1021/jf981154p
   Selling GW, 2004, POLYMER, V45, P4249, DOI 10.1016/j.polymer.2004.03.097
   Shukla R, 2001, IND CROP PROD, V13, P171, DOI 10.1016/S0926-6690(00)00064-9
   Tillekeratne M, 2000, POLYM INT, V49, P127, DOI 10.1002/(SICI)1097-0126(200001)49:1<127::AID-PI320>3.3.CO;2-2
   Wang HJ, 2005, J CONTROL RELEASE, V105, P120, DOI 10.1016/j.jconrel.2005.03.014
   Wang HJ, 2007, BIOMATERIALS, V28, P3952, DOI 10.1016/j.biomaterials.2007.05.017
   Wang Y, 2005, MACROMOL BIOSCI, V5, P1200, DOI 10.1002/mabi.200500140
   Wang Y, 2003, STARCH-STARKE, V55, P25, DOI 10.1002/star.200390002
   Yu XJ, 2004, P NATL ACAD SCI USA, V101, P11203, DOI 10.1073/pnas.0402532101
NR 52
TC 6
Z9 6
U1 1
U2 22
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 0267-0836
J9 MATER SCI TECH-LOND
JI Mater. Sci. Technol.
PD SEP
PY 2008
VL 24
IS 9
BP 1045
EP 1052
DI 10.1179/174328408X341735
PG 8
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 356RT
UT WOS:000259796000006
DA 2018-10-19
ER

PT J
AU Xu, D
   Hein, S
   Wang, K
AF Xu, D.
   Hein, S.
   Wang, K.
TI Chitosan membrane in separation applications
SO MATERIALS SCIENCE AND TECHNOLOGY
LA English
DT Review
DE chitosan; membrane; separation; azeotropic; protein
ID ETHANOL-WATER MIXTURES; MOLECULARLY IMPRINTED POLYMERS; COMPLEX
   COMPOSITE MEMBRANES; CHITIN AFFINITY MEMBRANES; HOLLOW-FIBER MEMBRANES;
   DIMETHYL CARBONATE/METHANOL/WATER MIXTURES; BUTYL ETHER/METHANOL
   MIXTURES; GLYCOL AQUEOUS-SOLUTION; SOLID-PHASE EXTRACTION; DRUG-DELIVERY
   SYSTEMS
AB Membrane separation technology, owing to its low energy consumption, operational simplicity, ease of control and scale-up, has gained increasing interest. The rapid development requires highly selective membranes with high through rates and chemical/mechanical stability. Chitosan, a relatively inert biomaterial with film forming ability, has been rapidly recognised for its potential in separation and purification technology in recent decades. Because of its hydrophilicity, cationicity, biocompatibility, ease of modification, remarkable affinity to dyes, metals and proteins, chitosan membranes have become a promising candidate for several applications. In the present review, the pervaporation of azeotropic mixtures and protein purification and separation of gaseous mixtures using chitosan membranes are discussed. The general overview of the preparation of different chitosan membranes, its capabilities in the separation of various solvents, gases and biomacromolecules are presented. Finally, the opportunities, challenges and perspectives in these areas are discussed.
C1 [Xu, D.; Wang, K.] Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore 637459, Singapore.
   [Hein, S.] Univ Aarhus, Dept Mol Biol, DK-8000 Aarhus C, Denmark.
   [Hein, S.] Univ Aarhus, Interdisciplinary Nanosci Ctr, DK-8000 Aarhus C, Denmark.
RP Wang, K (reprint author), Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore 637459, Singapore.
EM mkwang@ntu.edu.sg
CR Aburto J, 2004, MACROMOLECULES, V37, P2938, DOI 10.1021/ma049961e
   Ageev EP, 2007, COLLOID J+, V69, P272, DOI 10.1134/S1061933X07030027
   Ahmad AL, 2006, J APPL POLYM SCI, V99, P1740, DOI 10.1002/app.22703
   Ahmad AL, 2005, SEPAR SCI TECHNOL, V40, P3071, DOI 10.1080/01496390500385111
   Ahmed SR, 2006, J MEMBRANE SCI, V280, P553, DOI 10.1016/j.memsci.2006.02.009
   Al Marzouqi MH, 2005, IND ENG CHEM RES, V44, P9273, DOI 10.1021/ie050526y
   Alexander C, 2003, TETRAHEDRON, V59, P2025, DOI 10.1016/S0040-4020(03)00152-2
   Alvarez-Lorenzo C, 2004, J CHROMATOGR B, V804, P231, DOI 10.1016/j.jchromb.2003.12.032
   Ansumali S, 2006, PHYSICA A, V359, P289, DOI 10.1016/j.physa.2005.04.039
   Aravind UK, 2007, J MEMBRANE SCI, V299, P146, DOI 10.1016/j.memsci.2007.04.036
   Arica MY, 2005, PROCESS BIOCHEM, V40, P1433, DOI 10.1016/j.procbio.2004.06.028
   Arica MY, 2004, J MEMBRANE SCI, V240, P167, DOI 10.1016/j.memsci.2004.05.005
   Babel S, 2003, J HAZARD MATER, V97, P219, DOI 10.1016/S0304-3894(02)00263-7
   Baker RW, 2002, IND ENG CHEM RES, V41, P1393, DOI 10.1021/ie0108088
   BAKER RW, 2004, MEMBRANE TECHNOLOGY, P365
   Bayramoglu G, 2003, J APPL POLYM SCI, V88, P1843, DOI 10.1002/app.11844
   Bayramoglu G, 2003, BIOCHEM ENG J, V13, P35, DOI 10.1016/S1369-703X(02)00098-0
   Bayramoglu G, 2002, COLLOID SURFACE A, V202, P41, DOI 10.1016/S0927-7757(01)01055-X
   Beppu MM, 2004, CHEM ENG COMMUN, V191, P1147, DOI 10.1080/00986440490463968
   Budd PM, 2004, IND ENG CHEM RES, V43, P1863, DOI 10.1021/ie034142o
   Caner C, 2007, J SCI FOOD AGR, V87, P227, DOI 10.1002/jsfa.2698
   Cao SG, 1999, J APPL POLYM SCI, V74, P1452, DOI 10.1002/(SICI)1097-4628(19991107)74:6<1452::AID-APP18>3.0.CO;2-N
   Chanachai A, 2000, J MEMBRANE SCI, V166, P271, DOI 10.1016/S0376-7388(99)00269-0
   Chen JH, 2007, J COLLOID INTERF SCI, V316, P580, DOI 10.1016/j.jcis.2007.09.022
   Chen JH, 2007, J MEMBRANE SCI, V292, P125, DOI 10.1016/j.memsci.2007.01.026
   Chen X, 2001, J APPL POLYM SCI, V79, P1144
   Chen X, 2005, J APPL POLYM SCI, V96, P1267, DOI 10.1002/app.21552
   Chen X, 1999, J APPL POLYM SCI, V73, P975, DOI 10.1002/(SICI)1097-4628(19990808)73:6<975::AID-APP15>3.0.CO;2-#
   Choudhari SK, 2007, J MEMBRANE SCI, V302, P197, DOI 10.1016/j.memsci.2007.06.045
   Chung TS, 2007, PROG POLYM SCI, V32, P483, DOI 10.1016/j.progpolymsci.2007.01.008
   Cong HL, 2007, J MEMBRANE SCI, V294, P178, DOI 10.1016/j.memsci.2007.02.035
   Cunliffe D, 2005, ADV DRUG DELIVER REV, V57, P1836, DOI 10.1016/j.addr.2005.07.015
   Dang JM, 2006, ADV DRUG DELIVER REV, V58, P487, DOI 10.1016/j.addr.2006.03.001
   Despond S, 2001, J POLYM SCI POL PHYS, V39, P3114, DOI 10.1002/polb.10064
   Devi DA, 2006, J MEMBRANE SCI, V280, P45, DOI 10.1016/j.memsci.2006.01.003
   Devi DA, 2006, J MEMBRANE SCI, V280, P138, DOI 10.1016/j.memsci.2006.01.006
   Devi DA, 2005, J MEMBRANE SCI, V262, P91, DOI 10.1016/j.memsci.2005.03.051
   Dhanuja G, 2005, SEP PURIF TECHNOL, V44, P130, DOI 10.1016/j.seppur.2005.01.001
   Duan SH, 2006, J MEMBRANE SCI, V283, P2, DOI 10.1016/j.memsci.2006.06.026
   Dubey V, 2005, J MEMBRANE SCI, V251, P131, DOI 10.1016/j.memsci.2004.11.009
   Dubois P, 2006, ADV ENG MATER, V8, P147, DOI 10.1002/adem.200500256
   Dutta PK, 2002, J MACROMOL SCI-POL R, VC42, P307, DOI 10.1081/MC-120006451
   El-Azzami LA, 2007, J POLYM SCI POL PHYS, V45, P2620, DOI 10.1002/polb.21236
   Feng XS, 1997, IND ENG CHEM RES, V36, P1048, DOI 10.1021/ie960189g
   Feng XS, 1996, J MEMBRANE SCI, V116, P67, DOI 10.1016/0376-7388(96)00022-1
   Francisco GJ, 2007, J MEMBRANE SCI, V303, P54, DOI 10.1016/j.memsci.2007.06.065
   Fu GQ, 2007, REACT FUNCT POLYM, V67, P442, DOI 10.1016/j.reactfunctpolym.2007.02.006
   Fu YJ, 2006, DESALINATION, V193, P119, DOI 10.1016/j.desa1.2005.07.049
   Gallstedt M, 2001, J POLYM SCI POL PHYS, V39, P985
   Ge JJ, 2000, J MEMBRANE SCI, V165, P75, DOI 10.1016/S0376-7388(99)00228-8
   Gerente C, 2007, CRIT REV ENV SCI TEC, V37, P41, DOI 10.1080/10643380600729089
   Ghosh R, 2002, J CHROMATOGR A, V952, P13, DOI 10.1016/S0021-9673(02)00057-2
   GOTO M, 1994, SEPAR SCI TECHNOL, V29, P1915, DOI 10.1080/01496399408002180
   Guibal E, 2004, SEP PURIF TECHNOL, V38, P43, DOI 10.1016/j.seppur.2003.10.004
   Guibal E, 2006, SEPAR SCI TECHNOL, V41, P2487, DOI 10.1080/01496390600742807
   Gumusderelioglu M, 2004, REACT FUNCT POLYM, V61, P211, DOI 10.1016/j.reactfunctpolym.2004.06.002
   Guo Q. H., 1995, J MEMBRANE SCI, V98, P223
   Guo TY, 2005, CARBOHYD POLYM, V62, P214, DOI 10.1016/j.carbpol.2005.03.012
   Guo TY, 2005, BIOMATERIALS, V26, P5737, DOI 10.1016/j.biomaterials.2005.02.017
   HADWIGER LA, 1994, MOL PLANT MICROBE IN, V7, P531, DOI 10.1094/MPMI-7-0531
   Hein S, 2008, J BIOMED MATER RES B, V86B, P558, DOI 10.1002/jbm.b.31056
   Hillberg AL, 2005, ADV DRUG DELIVER REV, V57, P1875, DOI 10.1016/j.addr.2005.07.016
   Hirano S, 1999, POLYM INT, V48, P732, DOI 10.1002/(SICI)1097-0126(199908)48:8<732::AID-PI211>3.3.CO;2-L
   Hirano S, 1996, Biotechnol Annu Rev, V2, P237, DOI 10.1016/S1387-2656(08)70012-7
   Holthoff EL, 2007, ANAL CHIM ACTA, V594, P147, DOI 10.1016/j.aca.2007.05.044
   Hoven VP, 2007, CARBOHYD POLYM, V68, P44, DOI 10.1016/j.carbpol.2006.07.008
   Hu CL, 2007, SEP PURIF TECHNOL, V55, P327, DOI 10.1016/j.seppur.2007.01.005
   Hu CL, 2007, J MEMBRANE SCI, V293, P142, DOI 10.1016/j.memsci.2007.02.009
   Huang RYM, 2000, J MEMBRANE SCI, V167, P275, DOI 10.1016/S0376-7388(99)00293-8
   Huang RYM, 2000, J MEMBRANE SCI, V176, P223, DOI 10.1016/S0376-7388(00)00443-9
   Huang RYM, 1999, J MEMBRANE SCI, V160, P17, DOI 10.1016/S0376-7388(99)00074-5
   Ito A, 1997, ANGEW MAKROMOL CHEM, V248, P85, DOI 10.1002/apmc.1997.052480105
   Iwatsubo T, 2002, J APPL POLYM SCI, V86, P265, DOI 10.1002/app.10949
   Jayakumar R, 2007, INT J BIOL MACROMOL, V40, P175, DOI 10.1016/j.ijbiomac.2006.06.021
   Jayakumar R, 2005, CARBOHYD POLYM, V62, P142, DOI 10.1016/j.carbpol.2005.07.017
   Jegal J, 1999, J APPL POLYM SCI, V71, P671, DOI 10.1002/(SICI)1097-4628(19990124)71:4<671::AID-APP19>3.0.CO;2-T
   Jiang XM, 2007, ANAL BIOANAL CHEM, V389, P355, DOI 10.1007/s00216-007-1336-6
   Jiang ZY, 2006, J MEMBRANE SCI, V280, P876, DOI 10.1016/j.memsci.2006.03.006
   Jiraratananon R, 2002, J MEMBRANE SCI, V195, P143, DOI 10.1016/S0376-7388(01)00563-4
   Jiraratananon R, 2002, J MEMBRANE SCI, V199, P211, DOI 10.1016/S0376-7388(01)00699-8
   Jonquieres A, 2002, J MEMBRANE SCI, V206, P87, DOI 10.1016/S0376-7388(01)00768-2
   Kanti P, 2004, SEP PURIF TECHNOL, V40, P259, DOI 10.1016/j.seppur.2004.03.003
   Khor E, 2002, CURR OPIN SOLID ST M, V6, P313, DOI 10.1016/S1359-0286(02)00002-5
   Kim JH, 2003, J MEMBRANE SCI, V213, P273, DOI 10.1016/S0376-7388(02)00534-3
   Kim SG, 2007, J APPL POLYM SCI, V103, P2634, DOI 10.1002/app.25386
   Kim SG, 2002, J APPL POLYM SCI, V85, P714, DOI 10.1002/app.10619
   Kim SG, 2000, J MEMBRANE SCI, V174, P1, DOI 10.1016/S0376-7388(00)00339-2
   Kim SG, 2002, J APPL POLYM SCI, V85, P1832, DOI 10.1002/app.10708
   Kim SK, 2006, FOOD RES INT, V39, P383, DOI 10.1016/j.foodres.2005.10.010
   Kittur AA, 2005, J MEMBRANE SCI, V247, P75, DOI 10.1016/j.memsci.2004.09.010
   KLEIN E, 1994, J MEMBRANE SCI, V95, P199, DOI 10.1016/0376-7388(94)00171-5
   Koczka K, 2007, CHEM ENG PROCESS, V46, P239, DOI 10.1016/j.cep.2006.05.016
   Koide SS, 1998, NUTR RES, V18, P1091, DOI 10.1016/S0271-5317(98)00091-8
   Kouketsu T, 2007, J MEMBRANE SCI, V287, P51, DOI 10.1016/j.memsci.2006.10.014
   Krajewska B, 2005, SEP PURIF TECHNOL, V41, P305, DOI 10.1016/j.seppur.2004.03.019
   Krajewska B, 2004, ENZYME MICROB TECH, V35, P126, DOI 10.1016/j.enzmictec.2003.12.013
   Kulkarni SS, 2006, J MEMBRANE SCI, V285, P420, DOI 10.1016/j.memsci.2006.09.021
   Kulkarni SS, 2006, J APPL POLYM SCI, V99, P1380, DOI 10.1002/app.22514
   Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   Kurita K, 2006, MAR BIOTECHNOL, V8, P203, DOI 10.1007/s10126-005-0097-5
   LEE YM, 1991, J MEMBRANE SCI, V64, P145, DOI 10.1016/0376-7388(91)80085-K
   Lee YM, 1997, J MEMBRANE SCI, V133, P103, DOI 10.1016/S0376-7388(97)00089-6
   LEE YM, 1993, DESALINATION, V90, P277, DOI 10.1016/0011-9164(93)80181-L
   Li BB, 2006, DESALINATION, V193, P171, DOI 10.1016/j.desa1.2005.08.021
   Li F, 2007, TALANTA, V71, P1487, DOI 10.1016/j.talanta.2006.07.023
   Li JH, 2003, J CHROMATOGR B, V791, P55, DOI 10.1016/S1570-0232(03)00203-4
   Liu BB, 2007, J APPL POLYM SCI, V106, P2117, DOI 10.1002/app.26876
   Liu CX, 2005, J MEMBRANE SCI, V267, P68, DOI 10.1016/j.memsci.2005.06.001
   Liu JH, 2003, J APPL POLYM SCI, V90, P1108, DOI 10.1002/app.12841
   Liu YL, 2007, J MEMBRANE SCI, V287, P230, DOI 10.1016/j.memsci.2006.10.040
   Liu YL, 2005, J MEMBRANE SCI, V251, P233, DOI 10.1016/j.memsci.2004.12.003
   Liu YL, 2005, BIOMACROMOLECULES, V6, P368, DOI 10.1021/bm049531w
   Lu LY, 2006, J MEMBRANE SCI, V281, P245, DOI 10.1016/j.memsci.2006.03.041
   Lu LY, 2006, J APPL POLYM SCI, V101, P167, DOI 10.1002/app.23158
   Lucia A, 2006, IND ENG CHEM RES, V45, P8319, DOI 10.1021/ie060035t
   Machado RL, 2006, PROCESS BIOCHEM, V41, P2252, DOI 10.1016/j.procbio.2006.05.015
   Mello RS, 2006, POLYM BULL, V56, P447, DOI 10.1007/s00289-006-0513-7
   Merkel TC, 2002, SCIENCE, V296, P519, DOI 10.1126/science.1069580
   Miller MD, 2004, LANGMUIR, V20, P11545, DOI 10.1021/la0479859
   MOCHIZUKI A, 1989, J APPL POLYM SCI, V37, P3375, DOI 10.1002/app.1989.070371209
   Moon GY, 1999, J MEMBRANE SCI, V156, P17
   Nam SY, 1999, J MEMBRANE SCI, V157, P63
   Nam SY, 1999, J MEMBRANE SCI, V153, P155
   Nam SY, 1997, J MEMBRANE SCI, V135, P161, DOI 10.1016/S0376-7388(97)00144-0
   Nawawi MGM, 1997, J MEMBRANE SCI, V124, P53
   Nicholas JB, 1997, TOP CATAL, V4, P157, DOI 10.1023/A:1019179903977
   Nie HL, 2007, INT J BIOL MACROMOL, V40, P261, DOI 10.1016/j.ijbiomac.2006.08.005
   Pan FS, 2007, CHEM ENG SCI, V62, P703, DOI 10.1016/j.ces.2006.07.046
   Peng FB, 2007, J MEMBRANE SCI, V300, P13, DOI [10.1016/j.memsci.2007.06.008, 10.1016/j.memwasci.2007.06.008]
   Prabaharan M, 2006, CARBOHYD POLYM, V63, P153, DOI 10.1016/j.carbpol.2005.08.051
   Prabaharan M, 2005, DRUG DELIV, V12, P41, DOI 10.1080/10717540590889781
   Prashanth KVH, 2007, TRENDS FOOD SCI TECH, V18, P117, DOI 10.1016/j.tifs.2006.10.022
   Prathab B, 2007, J POLYM SCI POL PHYS, V45, P1260, DOI 10.1002/polb.21109
   Qiao FX, 2006, CHROMATOGRAPHIA, V64, P625, DOI 10.1365/s10337-006-0097-2
   Rao KSVK, 2007, J APPL POLYM SCI, V103, P1918, DOI 10.1002/app.25078
   Rao PS, 2007, IND ENG CHEM RES, V46, P2155, DOI 10.1021/ie061268n
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   ROBESON LM, 1991, J MEMBRANE SCI, V62, P165, DOI 10.1016/0376-7388(91)80060-J
   Ruckenstein E, 1998, J MEMBRANE SCI, V142, P13, DOI 10.1016/S0376-7388(98)00025-8
   Ruckenstein E, 1997, BIOTECHNOL BIOENG, V56, P610, DOI 10.1002/(SICI)1097-0290(19971220)56:6<610::AID-BIT3>3.0.CO;2-Q
   Sashiwa H, 2004, PROG POLYM SCI, V29, P887, DOI 10.1016/j.progpolymsci.2004.04.001
   Sebti I, 2007, J AGR FOOD CHEM, V55, P693, DOI 10.1021/jf062013n
   Shahidi F, 1999, TRENDS FOOD SCI TECH, V10, P37, DOI 10.1016/S0924-2244(99)00017-5
   Shen JN, 2007, J APPL POLYM SCI, V103, P1959, DOI 10.1002/app.24910
   Shi W, 2005, J CHROMATOGR B, V819, P301, DOI 10.1016/j.jchromb.2005.02.018
   Shieh JJ, 1997, J MEMBRANE SCI, V127, P185, DOI 10.1016/S0376-7388(96)00279-7
   Shieh JJ, 1998, J MEMBRANE SCI, V148, P243, DOI 10.1016/S0376-7388(98)00165-3
   Singh DK, 2000, J MACROMOL SCI R M C, VC40, P69, DOI 10.1081/MC-100100579
   Smitha B, 2006, CARBOHYD POLYM, V66, P463, DOI 10.1016/j.carbpol.2006.04.006
   Smitha B, 2004, J MEMBRANE SCI, V241, P1, DOI 10.1016/j.memsci.2004.03.042
   SMITHA B, 2005, J CHEM TECHNOL BIOT, V80, P1416
   Sommer S, 2005, CHEM ENG PROCESS, V44, P1138, DOI 10.1016/j.cep.2005.02.006
   Sridhar S, 2005, SEPAR SCI TECHNOL, V40, P2889, DOI 10.1080/01496390500333186
   Sridhar S, 2005, SEP PURIF REV, V34, P1, DOI 10.1081/SPM-200054949
   Sridhar S, 2001, POLYM INT, V50, P1156, DOI 10.1002/pi.761
   Srinivasa PC, 2007, FOOD REV INT, V23, P53, DOI 10.1080/87559120600998163
   Su HJ, 2006, PROCESS BIOCHEM, V41, P1422, DOI 10.1016/j.procbio.2005.12.024
   Su HJ, 2005, J CHEM TECHNOL BIOT, V80, P439, DOI 10.1002/jctb.1206
   Sun HL, 2008, SEP PURIF TECHNOL, V58, P429, DOI 10.1016/j.seppur.2007.09.012
   Svang-Ariyaskul A, 2006, J MEMBRANE SCI, V280, P815, DOI 10.1016/j.memsci.2006.03.001
   Tada M, 2003, J MOL CATAL A-CHEM, V199, P115, DOI 10.1016/S1381-1169(03)00029-3
   Tamayo FG, 2007, J CHROMATOGR A, V1152, P32, DOI 10.1016/j.chroma.2006.08.095
   Tangpasuthadol V, 2003, CARBOHYD RES, V338, P937, DOI 10.1016/S0008-6215(03)00038-7
   Tarley César Ricardo Teixeira, 2005, Quím. Nova, V28, P1087, DOI 10.1590/S0100-40422005000600025
   Tharanathan RN, 2003, CRIT REV FOOD SCI, V43, P61, DOI 10.1080/10408690390826455
   Tsai HA, 2006, DESALINATION, V193, P129, DOI 10.1016/j.desa1.2005.04.140
   Tsai HA, 2004, J APPL POLYM SCI, V94, P1562, DOI 10.1002/app.20828
   Tsai HA, 2008, J MEMBRANE SCI, V309, P146, DOI 10.1016/j.memsci.2007.10.018
   Tual C, 2000, J POLYM SCI POL PHYS, V38, P1521, DOI 10.1002/(SICI)1099-0488(20000601)38:11<1521::AID-POLB120>3.0.CO;2-#
   Ulbricht M, 2006, POLYMER, V47, P2217, DOI 10.1016/j.polymer.2006.01.084
   URAGAMI T, 1990, POLYMER, V31, P668, DOI 10.1016/0032-3861(90)90287-9
   Uragami T, 2004, BIOMACROMOLECULES, V5, P1567, DOI 10.1021/bm0498880
   URAGAMI T, 1992, J MEMBRANE SCI, V74, P183, DOI 10.1016/0376-7388(92)87082-9
   Uragami T, 2002, DESALINATION, V147, P449, DOI 10.1016/S0011-9164(02)00642-2
   Uragami T, 1998, MACROMOL CHEM PHYSIC, V199, P49
   Uragami T, 1997, J MEMBRANE SCI, V124, P203, DOI 10.1016/S0376-7388(96)00238-4
   Varma AJ, 2004, CARBOHYD POLYM, V55, P77, DOI 10.1016/j.carbpol.2003.08.005
   Veerapur RS, 2007, J MEMBRANE SCI, V304, P102, DOI 10.1016/j.memsci.2007.07.006
   Volkov VI, 1998, J MEMBRANE SCI, V138, P221, DOI 10.1016/S0376-7388(97)00232-9
   Wallace DW, 2006, POLYMER, V47, P1207, DOI 10.1016/j.polymer.2005.12.079
   Wang HD, 2007, J MEMBRANE SCI, V297, P262, DOI 10.1016/j.memsci.2007.03.055
   Wang XP, 1999, J APPL POLYM SCI, V73, P1145, DOI 10.1002/(SICI)1097-4628(19990815)73:7<1145::AID-APP6>3.0.CO;2-B
   Wang XP, 2000, POLYM INT, V49, P1426, DOI 10.1002/1097-0126(200011)49:11<1426::AID-PI524>3.0.CO;2-J
   Wang XP, 1996, J MEMBRANE SCI, V119, P191, DOI 10.1016/0376-7388(96)00157-3
   Wang XP, 2000, J APPL POLYM SCI, V75, P740, DOI 10.1002/(SICI)1097-4628(20000207)75:6<740::AID-APP2>3.0.CO;2-3
   Wang XP, 1998, J APPL POLYM SCI, V69, P2035, DOI 10.1002/(SICI)1097-4628(19980906)69:10<2035::AID-APP15>3.0.CO;2-0
   Wang XW, 1998, J APPL POLYM SCI, V67, P513
   Wang YC, 2004, J MEMBRANE SCI, V239, P219, DOI 10.1016/j.memsci.2004.03.037
   Won W, 2002, J MEMBRANE SCI, V209, P493, DOI 10.1016/S0376-7388(02)00367-8
   Won WY, 2003, SEP PURIF TECHNOL, V31, P129, DOI 10.1016/S1383-5866(02)00176-4
   WU LG, 1994, J MEMBRANE SCI, V90, P199, DOI 10.1016/0376-7388(94)80071-5
   Xi FN, 2006, J CHROMATOGR A, V1125, P38, DOI 10.1016/j.chroma.2006.05.016
   Xi FN, 2004, J CHROMATOGR A, V1057, P41, DOI 10.1016/j.chroma.2004.09.059
   Xia BL, 2003, J MEMBRANE SCI, V226, P9, DOI 10.1016/j.memsci.2003.08.007
   Xia YM, 2004, J MOL CATAL B-ENZYM, V31, P111, DOI 10.1016/j.molcatb.2004.08.003
   Xia YQ, 2006, REACT FUNCT POLYM, V66, P1734, DOI 10.1016/j.reactfunctpolym.2006.08.001
   Xia YQ, 2005, BIOMACROMOLECULES, V6, P2601, DOI 10.1021/bm050324l
   Xiao JB, 2007, J APPL POLYM SCI, V103, P3050, DOI 10.1002/app.25465
   Xiao SD, 2007, J MEMBRANE SCI, V306, P36, DOI 10.1016/j.memsci.2007.08.021
   Yang L, 2002, J MEMBRANE SCI, V197, P185, DOI 10.1016/S0376-7388(01)00632-9
   Yang L, 2002, J MEMBRANE SCI, V205, P141, DOI 10.1016/S0376-7388(02)00073-X
   Zeng XF, 1996, J MEMBRANE SCI, V117, P271
   Zeng XF, 1998, J MEMBRANE SCI, V148, P195, DOI 10.1016/S0376-7388(98)00183-5
   Zeng XF, 1998, IND ENG CHEM RES, V37, P159
   Zeng XF, 1996, IND ENG CHEM RES, V35, P4169, DOI 10.1021/ie960270j
   Zeng XF, 1999, J MEMBRANE SCI, V156, P97, DOI 10.1016/S0376-7388(98)00338-X
   Zeng XF, 1999, BIOTECHNOL PROGR, V15, P1003, DOI 10.1021/bp990120e
   Zhang LN, 2000, J APPL POLYM SCI, V77, P610, DOI 10.1002/(SICI)1097-4628(20000718)77:3<610::AID-APP16>3.0.CO;2-B
   Zhang W, 2007, J MEMBRANE SCI, V295, P130, DOI 10.1016/j.memsci.2007.03.001
   Zhao ZP, 2003, J MEMBRANE SCI, V217, P151, DOI 10.1016/S0376-7388(03)00105-4
   Zou HF, 2001, J BIOCHEM BIOPH METH, V49, P199, DOI 10.1016/S0165-022X(01)00200-7
   Zulfikar MA, 2006, J APPL POLYM SCI, V99, P3163, DOI 10.1002/app.22862
NR 213
TC 28
Z9 29
U1 4
U2 96
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 0267-0836
J9 MATER SCI TECH-LOND
JI Mater. Sci. Technol.
PD SEP
PY 2008
VL 24
IS 9
BP 1076
EP 1087
DI 10.1179/174328408X341762
PG 12
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 356RT
UT WOS:000259796000009
DA 2018-10-19
ER

PT J
AU Odahara, T
   Matsumoto, H
   Chiba, A
AF Odahara, Tadayoshi
   Matsumoto, Hiroaki
   Chiba, Akihiko
TI Mechanical Properties of Biomedical Co-33Cr-5Mo-0.3N Alloy at Elevated
   Temperatures
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE cobalt chromium molybdenum alloy; biomaterial; tensile test; mechanical
   properties; ductility; elongation; fracture; dislocation; dissociated
   dislocation; shockley partials; strain rate sensitivity; dynamic strain
   aging; Portevin-LeChatelier effect
ID STAINLESS-STEEL; STRAIN-RATE; DUCTILITY; BEHAVIOR; COBALT;
   MICROSTRUCTURE; CHROMIUM; FRACTURE
AB In order to examine the mechanical properties of a biomedical Co-33Cr-5Mo-0.3N alloy at elevated temperatures. tensile tests have been conducted in the temperature range from room temperature to 1373 K at initial strain rates of 1.0 x 10(-1) s(-1) and 1.4 x 10(-4) s(-1). The 0.2% proof stress and the tensile strength as a function of temperature have the plateau and the hump, respectively, at intermediate temperatures. The elongation to fracture increases at intermediate temperatures and abruptly decreases at higher temperatures. The decrease of the elongation at higher temperatures arises from the intergranular fracture, possibly caused by the equilibrium segregation of harmful elements such as sulfur. The serrations on the stress-strain curves are observed at intermediate temperatures. The temperature range where the elongation is enhanced and the serrations appear is shifted to lower temperatures at a low strain rate. The 0.2% proof stress does not increase with increasing strain rate and the strain rate sensitivity exhibits negative values at intermediate temperatures. It is considered that a serration leading to large elongation results from the dynamic strain aging. [doi: 10.2320/matertrans.MAW200816]
C1 [Odahara, Tadayoshi; Matsumoto, Hiroaki; Chiba, Akihiko] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
RP Odahara, T (reprint author), Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
RI Chiba, Akihiko/D-1326-2011
FU Ministry of Education, Culture, Sports, Science and Technology of Japan
FX The authors would like to thank to Mr. Yuji Maekawa and Mr. Toshiyuki
   Okubo of Kamaishi Otsuchi Industrial Research Development and Training
   Center for the sample preparations. Thanks are due to Dr. Sang-Hak Lee
   of NHK spring co., ltd., Japan, for the technical supports. This
   research was supported by a Cooperation of Innovative Technology and
   Advanced Research in Evolutional Area from the Ministry of Education,
   Culture, Sports, Science and Technology of Japan.
CR BASKETTER DA, 1993, CONTACT DERMATITIS, V28, P15, DOI 10.1111/j.1600-0536.1993.tb03318.x
   BRINDLEY BJ, 1968, ACTA METALL MATER, V16, P587, DOI 10.1016/0001-6160(68)90133-8
   Chiba A, 1999, PHILOS MAG A, V79, P1533, DOI 10.1080/01418619908210378
   *EM MED SERV, 1996, ANN BOOK ASTM STAND, P4
   Granchi D, 1999, BIOMATERIALS, V20, P1079, DOI 10.1016/S0142-9612(99)00004-6
   Halim H, 2007, ACTA MATER, V55, P4151, DOI 10.1016/j.actamat.2007.03.007
   Haynes DR, 2000, J BIOMED MATER RES, V49, P167, DOI 10.1002/(SICI)1097-4636(200002)49:2<167::AID-JBM3>3.0.CO;2-9
   Huang P, 1999, MATER SCI TECH SER, V15, P1324, DOI 10.1179/026708399101505284
   KANNO M, 1987, MAT T JIM, V28, P742
   KANNO M, 1987, MAT T JIM, V28, P73
   Kim YS, 2007, J MATER PROCESS TECH, V187, P575, DOI 10.1016/j.jmatprotec.2006.11.094
   KLAWITTER JJ, 1977, J DENT RES, V56, P474, DOI 10.1177/00220345770560050501
   KOCKS UF, 1985, METALL TRANS A, V16, P2109, DOI 10.1007/BF02670415
   Lee MH, 2007, J ALLOY COMPD, V428, P99, DOI 10.1016/j.jallcom.2006.03.076
   Lee SH, 2008, MATER TRANS, V49, P260, DOI 10.2320/matertrans.MRA2007220
   Lee SH, 2006, MATER TRANS, V47, P287, DOI 10.2320/matertrans.47.287
   McLean D., 1957, GRAIN BOUNDARIES MET
   Nowosielski R, 2005, J MATER PROCESS TECH, V162, P379, DOI 10.1016/j.jmatprotec.2005.02.119
   Ozgowicz W, 2005, J MATER PROCESS TECH, V162, P392, DOI 10.1016/j.jmatprotec.2005.02.008
   PENG K, 2007, MAT SCI ENG A-STRUCT, V415, P53
   Peng KP, 2004, MAT SCI ENG A-STRUCT, V379, P372, DOI 10.1016/j.msea.2004.03.004
   SHI LQ, 1993, J MATER SCI, V28, P1312, DOI 10.1007/BF01191970
   UEMATSU Y, 1983, TETSU TO HAGANE, V69, P686
   Zhu FL, 2007, MICROELECTRON ENG, V84, P144, DOI 10.1016/j.mee.2006.09.031
NR 24
TC 9
Z9 9
U1 0
U2 2
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD SEP
PY 2008
VL 49
IS 9
BP 1963
EP 1969
DI 10.2320/matertrans.MAW200816
PG 7
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 365HH
UT WOS:000260396000008
OA Bronze
DA 2018-10-19
ER

PT J
AU Levine, DH
   Ghoroghchian, PP
   Freudenberg, J
   Zhang, G
   Therien, MJ
   Greene, MI
   Hammer, DA
   Murali, R
AF Levine, Dalia Hope
   Ghoroghchian, P. Peter
   Freudenberg, Jaclyn
   Zhang, Geng
   Therien, Michael J.
   Greene, Mark I.
   Hammer, Daniel A.
   Murali, Ramachandran
TI Polymersomes: A new multi-functional tool for cancer diagnosis and
   therapy
SO METHODS
LA English
DT Article
DE Polymersome; Diblock copolymer; Vesicle; Drug delivery; Cancer
   diagnosis; Cancer therapy; Nanoparticle; Targeting; Optical imaging;
   Near-infrared
ID INFRARED-EMISSIVE POLYMERSOMES; BLOCK-COPOLYMER VESICLES; IN-VIVO;
   FUNCTIONALIZED POLYMERSOMES; BIODEGRADABLE POLYMERSOMES; DIBLOCK
   COPOLYMERS; MOLECULAR-WEIGHT; NANOPARTICLES; PACLITAXEL; RELEASE
AB Nanoparticles are being developed as delivery vehicles for therapeutic pharmaceuticals and contrast imaging agents. Polymersomes (mesoscopic polymer vesicles) possess a number of attractive biomaterial properties that make them ideal for these applications. Synthetic control over block copolymer chemistry enables tunable design of polymersome material properties. The polymersome architecture, with its large hydrophilic reservoir and its thick hydrophobic lamellar membrane, provides significant storage capacity for both water soluble and insoluble substances (such as drugs and imaging probes). Further, the brush-like architecture of the polymersome outer shell can potentially increase biocompatibility and blood circulation times. A further recent advance is the development of multi-functional polymersomes that carry pharmaceuticals and imaging agents simultaneously. The ability to conjugate biologically active ligands to the brush surface provides a further means for targeted therapy and imaging. Hence, polymersomes hold enormous potential as nanostructured biomaterials for future in vivo drug delivery and diagnostic imaging applications. (c) 2008 Elsevier Inc. All rights reserved.
C1 [Freudenberg, Jaclyn; Zhang, Geng; Greene, Mark I.; Murali, Ramachandran] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.
   [Therien, Michael J.] Duke Univ, Dept Chem, Durham, NC 27706 USA.
   [Levine, Dalia Hope; Hammer, Daniel A.] Univ Penn, Dept Chem & Biomol Engn, Philadelphia, PA 19104 USA.
   [Ghoroghchian, P. Peter; Hammer, Daniel A.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.
RP Murali, R (reprint author), Univ Penn, Dept Pathol & Lab Med, 243 John Morgan Bldg,36th Hamilton Walk, Philadelphia, PA 19104 USA.
EM murali@mail.med.upenn.edu
FU Health Research Formula Funds; National Institutes of Health
   [EB003457-01, CA115229-01A1]
FX This work is funded, in part, under a grant through the Health Research
   Formula Funds, Commonwealth of Pennsylvania to R.M., M.J.T. and D.A.H.
   The Department specifically disclaims responsibility for any analyses,
   interpretations, or conclusions. This work is also supported, in part,
   under grants from the National Institutes of Health (EB003457-01 and
   CA115229-01A1) to D.A.H. and MJ.T. The authors thank N.A. Christian, and
   G. Robbins for sharing unpublished results and/or recently submitted
   data.
CR Ahmed F, 2004, J CONTROL RELEASE, V96, P37, DOI 10.1016/j.jconrel.2003.12.021
   Ahmed F, 2006, J CONTROL RELEASE, V116, P150, DOI 10.1016/j.jconrel.2006.07.012
   Ahmed F, 2006, MOL PHARMACEUT, V3, P340, DOI 10.1021/mp050103u
   Antonietti M, 2003, ADV MATER, V15, P1323, DOI 10.1002/adma.200300010
   Arifin DR, 2005, BIOMACROMOLECULES, V6, P2172, DOI 10.1021/bm0501454
   Bei JZ, 1997, POLYM ADVAN TECHNOL, V8, P693, DOI 10.1002/(SICI)1099-1581(199711)8:11<693::AID-PAT702>3.0.CO;2-B
   Berezov A, 2001, J MED CHEM, V44, P2565, DOI 10.1021/jm000527m
   Bermudez H, 2002, MACROMOLECULES, V35, P8203, DOI 10.1021/ma020669l
   Bolotin Elijah M., 1994, Journal of Liposome Research, V4, P455, DOI 10.3109/08982109409037057
   Borchert U, 2006, LANGMUIR, V22, P5843, DOI 10.1021/la060227t
   Brooks H, 2005, ADV DRUG DELIVER REV, V57, P559, DOI 10.1016/j.addr.2004.12.001
   Cegnar M, 2005, EXPERT OPIN BIOL TH, V5, P1557, DOI 10.1517/14712598.5.12.1557
   Cerritelli S, 2007, BIOMACROMOLECULES, V8, P1966, DOI 10.1021/bm070085x
   Choucair A, 2005, LANGMUIR, V21, P9308, DOI 10.1021/la050710o
   CHRISTIAN NA, 2007, DEV APPL TAT NEAR IN
   Christian NA, 2007, BIOCONJUGATE CHEM, V18, P31, DOI 10.1021/bc0601267
   de Menezes DEL, 1998, CANCER RES, V58, P3320
   Discher BM, 1999, SCIENCE, V284, P1143, DOI 10.1126/science.284.5417.1143
   Discher DE, 2002, SCIENCE, V297, P967, DOI 10.1126/science.1074972
   Discher DE, 2006, ANNU REV BIOMED ENG, V8, P323, DOI 10.1146/annurev.bioeng.8.061505.095838
   DUNCAN R, 2002, POLYM DRUG CONJUGATE, P197
   Figdor CG, 2004, NAT MED, V10, P475, DOI 10.1038/nm1039
   Ghoroghchian PP, 2007, CHEM MATER, V19, P1309, DOI 10.1021/cm062427w
   Ghoroghchian PP, 2006, MACROMOLECULES, V39, P1673, DOI 10.1021/ma0519009
   Ghoroghchian PP, 2005, J AM CHEM SOC, V127, P15388, DOI 10.1021/ja055571b
   Ghoroghchian PP, 2005, P NATL ACAD SCI USA, V102, P2922, DOI 10.1073/pnas.0409394102
   GHOROGHCHIAN PP, 2006, THESIS U PENNSYLVANI
   Gustafson DL, 2005, CANCER LETT, V220, P161, DOI 10.1016/j.canlet.2004.09.007
   HARAN G, 1993, BIOCHIM BIOPHYS ACTA, V1151, P201, DOI 10.1016/0005-2736(93)90105-9
   Hillmyer MA, 1996, SCIENCE, V271, P976, DOI 10.1126/science.271.5251.976
   Hillmyer MA, 1996, MACROMOLECULES, V29, P6994, DOI 10.1021/ma960774t
   Iyer AK, 2006, DRUG DISCOV TODAY, V11, P812, DOI 10.1016/j.drudis.2006.07.005
   Kelly KA, 2005, CIRC RES, V96, P327, DOI 10.1161/01.RES.0000155722.17881.dd
   Lee JCM, 2001, BIOTECHNOL BIOENG, V73, P135, DOI 10.1002/bit.1045
   Lee KY, 2007, PROG POLYM SCI, V32, P669, DOI 10.1016/j.progpolymsci.2007.04.001
   Li SL, 2007, BIOTECHNOL PROGR, V23, P278, DOI 10.1021/bp060208+
   Lin JJ, 2006, LANGMUIR, V22, P3975, DOI 10.1021/la052445c
   Lin JJ, 2004, LANGMUIR, V20, P5493, DOI 10.1021/la036417a
   LIN JJ, 2005, PHYS REV LETT, V23
   MATSUMURA Y, 1986, CANCER RES, V46, P6387
   Meng FH, 2005, J CONTROL RELEASE, V101, P187, DOI 10.1016/j.jconrel.2004.09.026
   Napoli A, 2004, NAT MATER, V3, P183, DOI 10.1038/nmat1081
   Napoli A, 2002, LANGMUIR, V18, P8324, DOI 10.1021/la025897n
   Napoli A, 2001, MACROMOLECULES, V34, P8913, DOI 10.1021/ma0108057
   Nobs L, 2004, J PHARM SCI-US, V93, P1980, DOI 10.1002/jps.20098
   O'Reilly RK, 2006, J POLYM SCI POL CHEM, V44, P5203, DOI 10.1002/pola.21602
   O'Reilly RK, 2006, CHEM SOC REV, V35, P1068, DOI 10.1039/b514858h
   Park BW, 2000, NAT BIOTECHNOL, V18, P194, DOI 10.1038/72651
   Perez JM, 2004, NANO LETT, V4, P119, DOI 10.1021/nl034983k
   Photos PJ, 2003, J CONTROL RELEASE, V90, P323, DOI 10.1016/S0168-3659(03)00201-3
   Pressly ED, 2007, BIOMACROMOLECULES, V8, P3126, DOI 10.1021/bm700541e
   Savic R, 2003, SCIENCE, V300, P615, DOI 10.1126/science.1078192
   SHARMA US, 1995, J PHARM SCI, V84, P1223, DOI 10.1002/jps.2600841015
   Sun G, 2007, ADV MATER, V19, P3157, DOI 10.1002/adma.200701973
   Sun J, 2007, LANGMUIR, V23, P8308, DOI 10.1021/la701038f
   Sun XK, 2005, BIOMACROMOLECULES, V6, P2541, DOI 10.1021/bm050260e
   Tsourkas A, 2005, BIOCONJUGATE CHEM, V16, P576, DOI 10.1021/bc050002e
   Valentini M, 2003, LANGMUIR, V19, P4852, DOI 10.1021/la026896y
   Waterhouse Dawn N., 2001, Drug Safety, V24, P903, DOI 10.2165/00002018-200124120-00004
   WEISS RB, 1990, J CLIN ONCOL, V8, P1263, DOI 10.1200/JCO.1990.8.7.1263
   Zhou W, 2006, J CONTROL RELEASE, V116, pE62, DOI 10.1016/j.jconrel.2006.09.051
   Zupancich JA, 2006, MACROMOLECULES, V39, P4286, DOI 10.1021/ma060642s
NR 62
TC 140
Z9 145
U1 0
U2 85
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1046-2023
J9 METHODS
JI Methods
PD SEP
PY 2008
VL 46
IS 1
BP 25
EP 32
DI 10.1016/j.ymeth.2008.05.006
PG 8
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 368FP
UT WOS:000260607300005
PM 18572025
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Karnik, R
   Gu, F
   Basto, P
   Cannizzaro, C
   Dean, L
   Kyei-Manu, W
   Langer, R
   Farokhzad, OC
AF Karnik, Rohit
   Gu, Frank
   Basto, Pamela
   Cannizzaro, Christopher
   Dean, Lindsey
   Kyei-Manu, William
   Langer, Robert
   Farokhzad, Omid C.
TI Microfluidic platform for controlled synthesis of polymeric
   nanoparticles
SO NANO LETTERS
LA English
DT Article
ID CDSE NANOCRYSTALS; DRUG-DELIVERY; IN-VIVO; SIZE; PARTICLES; MICROGELS;
   REACTORS; ROUTES
AB A central challenge in the development of drug-encapsulated polymeric nanoparticles is the inability to control the mixing processes required for their synthesis resulting in variable nanoparticle physicochemical properties. Nanoparticles may be developed by mixing and nanoprecipitation of polymers and drugs dissolved in organic solvents with nonsolvents. We used rapid and tunable mixing through hydrodynamic flow focusing in microfluidic channels to control nanoprecipitation of poly(lactic-co-glycolic acid)-b-poly(ethylene glycol) diblock copolymers as a model polymeric biomaterial for drug delivery. We demonstrate that by varying (1) flow rates, (2) polymer composition, and (3) polymer concentration we can optimize the size, improve polydispersity, and control drug loading and release of the resulting nanoparticles. This work suggests that microfluidics may find applications for the development and optimization of polymeric nanoparticles in the newly emerging field of nanomedicine.
C1 [Farokhzad, Omid C.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Lab Nanomed & Biomat, Boston, MA 02115 USA.
   [Farokhzad, Omid C.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Anesthesiol, Boston, MA 02115 USA.
   [Karnik, Rohit] MIT, Dept Mech Engn, Cambridge, MA 02139 USA.
   [Gu, Frank; Basto, Pamela; Cannizzaro, Christopher; Dean, Lindsey; Kyei-Manu, William; Langer, Robert] MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
   [Basto, Pamela; Langer, Robert] Harvard MIT Div Hlth Sci & Technol, MIT, Cambridge, MA 02139 USA.
   [Langer, Robert; Farokhzad, Omid C.] MIT Harvard Ctr Canc Nanotechnol Excellence, MIT, Cambridge, MA 02139 USA.
RP Farokhzad, OC (reprint author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Lab Nanomed & Biomat, Boston, MA 02115 USA.
EM ofarokhzad@zeus.bwh.harvard.edu
OI Basto, Pamela/0000-0002-5446-7963; Gu, Frank/0000-0001-8749-9075;
   Farokhzad, Omid/0000-0003-2009-270X
FU Koch-Prostate Cancer Foundation; Dana Farber Cancer Institute Prostate
   SPORE; NIH [CA119349, EB003647]; Canadian Natural Sciences and
   Engineering Research Council
FX We thank MIT's Microsystems Technology Laboratory and staff for their
   help with device fabrication. We also thank Sangeeta Bhatia (MIT) for
   graciously allowing the use of particle sizing equipment in her
   laboratory. Negative staining sample preparation and electron microscopy
   image acquisition were performed by Eliza Vasile, from the Center for
   Cancer Research, Microscopy and Imaging Core Facility, MIT. This
   research was supported by the Koch-Prostate Cancer Foundation Award in
   Nanotherapeutics (R.L. and O.C.F.), by a Concept Development Grant from
   the Dana Farber Cancer Institute Prostate SPORE (O.C.F.), and by NIH
   Grants CA119349 (R.L. and O.C.F.) and EB003647 (O.C.F.). F.G. was
   supported by a Postdoctoral Fellowship from the Canadian Natural
   Sciences and Engineering Research Council.
CR Anna SL, 2003, APPL PHYS LETT, V82, P364, DOI 10.1063/1.1537519
   Avgoustakis Konstantinos, 2004, Current Drug Delivery, V1, P321, DOI 10.2174/1567201043334605
   Chan EM, 2005, J AM CHEM SOC, V127, P13854, DOI 10.1021/ja051381p
   Cheng J, 2007, BIOMATERIALS, V28, P869, DOI 10.1016/j.biomaterials.2006.09.047
   Davaran S, 2006, INT J NANOMED, V1, P535, DOI 10.2147/nano.2006.1.4.535
   De Geest BG, 2005, LANGMUIR, V21, P10275, DOI 10.1021/la051527y
   DEMELLO A, 2006, Patent No. 7252814
   deMello AJ, 2006, NATURE, V442, P394, DOI 10.1038/nature05062
   DeMello J, 2004, LAB CHIP, V4, p11N, DOI 10.1039/b403638g
   Farokhzad OC, 2006, P NATL ACAD SCI USA, V103, P6315, DOI 10.1073/pnas.0601755103
   GREF R, 1994, SCIENCE, V263, P1600, DOI 10.1126/science.8128245
   Johnson BK, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.118302
   Knight JB, 1998, PHYS REV LETT, V80, P3863, DOI 10.1103/PhysRevLett.80.3863
   Krishnadasan S, 2007, LAB CHIP, V7, P1434, DOI 10.1039/b711412e
   Martin-Banderas L, 2005, SMALL, V1, P688, DOI 10.1002/smll.200500087
   Matteucci ME, 2006, LANGMUIR, V22, P8951, DOI 10.1021/1a061122t
   Nguyen NT, 2005, J MICROMECH MICROENG, V15, pR1, DOI 10.1088/0960-1317/15/2/R01
   Nisisako T, 2004, CHEM ENG J, V101, P23, DOI 10.1016/j.cej.2003.11.019
   Owens DE, 2006, INT J PHARM, V307, P93, DOI 10.1016/j.ijpharm.2005.10.010
   Quintanar-Guerrero D, 1998, DRUG DEV IND PHARM, V24, P1113, DOI 10.3109/03639049809108571
   Riley T, 2001, LANGMUIR, V17, P3168, DOI 10.1021/la001226i
   Seo M, 2005, LANGMUIR, V21, P11614, DOI 10.1021/la050519e
   Shestopalov I, 2004, LAB CHIP, V4, P316, DOI 10.1039/b403378g
   Wagner J, 2005, NANO LETT, V5, P685, DOI 10.1021/nl050097t
   Xu S, 2005, ANGEW CHEM INT EDIT, V44, P3799, DOI 10.1002/anie.200590085
   Xu SQ, 2005, ANGEW CHEM INT EDIT, V44, P724, DOI 10.1002/anie.200462226
   Yen BKH, 2003, ADV MATER, V15, P1858, DOI 10.1002/adma.200305162
   Zhang H, 2007, MACROMOL RAPID COMM, V28, P527, DOI 10.1002/marc.200600776
NR 28
TC 332
Z9 342
U1 17
U2 296
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1530-6984
J9 NANO LETT
JI Nano Lett.
PD SEP
PY 2008
VL 8
IS 9
BP 2906
EP 2912
DI 10.1021/nl801736q
PG 7
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 347KQ
UT WOS:000259140200053
PM 18656990
DA 2018-10-19
ER

PT J
AU Thakar, RG
   Chown, MG
   Patel, A
   Peng, L
   Kumar, S
   Desai, TA
AF Thakar, Rahul G.
   Chown, Matthew G.
   Patel, Anqj
   Peng, Lily
   Kumar, Sanjay
   Desai, Tejal A.
TI Contractility-dependent modulation of cell proliferation and adhesion by
   microscale topographical cues
SO SMALL
LA English
DT Article
DE biomaterials; cell adhesion; microfabrication; tissue engineering;
   topographical structures
ID HEPATIC STELLATE CELL; SMOOTH-MUSCLE-CELLS; STRESS FIBERS; RHO-KINASE;
   SOFT LITHOGRAPHY; FOCAL ADHESIONS; EXTRACELLULAR-MATRIX;
   SKELETAL-MUSCLE; GENE-EXPRESSION; DISTINCT ROLES
AB Engineering of cellular assembly on biomaterial scaffolds by utilizing microscale topographical cues has emerged as a powerful strategy in cardiovascular tissue engineering and regenerative medicine. However, the mechanisms through which these cues are processed to yield changes in canonical cell behaviors remain unclear. Previously, we showed that when mixtures of cardiomyocytes and fibroblasts were cultured on polydimethylsiloxane surfaces studded with microscale pillars (micropegs), fibroblast proliferation was dramatically suppressed, which suggests that the micropegs could be exploited to minimize fibrosis and scar formation. Here, we demonstrate that this effect relies on altered adhesive and micro-mechanical interactions between individual cells and micropegs. First, we show that the proliferation of a cell physically attached to a micropeg is significantly lower than that of a cell cultured on a featureless region of the substrate. Micropeg adhesion is accompanied by a marked elongation in cell and nuclear shape. When fibroblast contractility is pharmacologically attenuated through low-dose inhibition of either Rho-associated kinase or myosin light chain kinase, the potency with which micropeg adhesion suppresses cell proliferation is significantly reduced. Together, our results support a model in which cell fate decisions may be directly manipulated within tissue engineering scaffolds by the inclusion of microtopographical structures that alter cellular mechanics.
C1 [Chown, Matthew G.; Patel, Anqj; Kumar, Sanjay] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.
   [Thakar, Rahul G.; Desai, Tejal A.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA.
   [Thakar, Rahul G.; Desai, Tejal A.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA.
   [Patel, Anqj; Peng, Lily; Kumar, Sanjay; Desai, Tejal A.] UCSF UC Berkeley Joint Grad Grp Bioengn, Berkeley, CA USA.
RP Kumar, S (reprint author), Univ Calif Berkeley, Dept Bioengn, 274A Stanley Hall 1762, Berkeley, CA 94720 USA.
EM skumar@berkeley.edu; tejal.desai@ucsf.edu
FU NSF NSEC; American Heart Association [0765128Y]; Arnold and Mabel
   Beckman Young Investigator Award; UCSF Dean's Health Science Fellowship
FX We appreciate Dr. Kurt Thorn's invaluable training and assistance at the
   Nikon Imaging Center at UCSF-Mission Bay. In addition, we would like to
   express our thanks to Dr. Daniel A. Bernards for his help with SEM image
   collection. We also thank the UCSF Biomedical Micro- and Nanofabrication
   Core for allowing us to fabricate our SU-8 molds, and Dr. James J.
   Norman and Mark Steedman for guidance with the fabrication. This
   research was supported by an NSF NSEC grant to T.A.D., an American Heart
   Association Beginning Grant-in-Aid (0765128Y) and Arnold and Mabel
   Beckman Young Investigator Award to S.K., and a UCSF Dean's Health
   Science Fellowship to L.P. All SEM was performed at the Stanford
   Nanocharacterization Laboratory through the Stanford CIS grant program.
CR Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532
   BELMONT AS, 1980, CELL BIOPHYS, V2, P165, DOI 10.1007/BF02795842
   Birla RK, 2005, ARTIF ORGANS, V29, P866, DOI 10.1111/j.1525-1594.2005.00148.x
   Biswas G, 2005, CELL DEATH DIFFER, V12, P266, DOI 10.1038/sj.cdd.4401553
   Boateng SY, 2003, AM J PHYSIOL-CELL PH, V285, pC171, DOI 10.1152/ajpcell.00013.2003
   Chaubey A, 2008, J BIOMED MATER RES B, V84B, P70, DOI 10.1002/jbm.b.30846
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Clark K, 2007, TRENDS CELL BIOL, V17, P178, DOI 10.1016/j.tcb.2007.02.002
   Dalby MJ, 2004, EUR J CELL BIOL, V83, P159, DOI 10.1078/0171-9335-00369
   Dennis RG, 2001, AM J PHYSIOL-CELL PH, V280, pC288
   Deutsch J, 2000, J BIOMED MATER RES, V53, P267, DOI 10.1002/(SICI)1097-4636(2000)53:3<267::AID-JBM12>3.0.CO;2-J
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   FELDHERR CM, 1990, J CELL BIOL, V111, P1, DOI 10.1083/jcb.111.1.1
   Goffin JM, 2006, J CELL BIOL, V172, P259, DOI 10.1083/jcb.200506179
   Hu SH, 2004, FRONT BIOSCI, V9, P2177, DOI 10.2741/1352
   Huang Jing, 2004, Human Genomics, V1, P287
   Ingber DE, 1995, J BIOMECH, V28, P1471, DOI 10.1016/0021-9290(95)00095-X
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   Katoh K, 2001, J CELL BIOL, V153, P569, DOI 10.1083/jcb.153.3.569
   Katoh K, 2007, GENES CELLS, V12, P623, DOI 10.1111/j.1365-2443.2007.01073.x
   Kosnik PE, 2001, TISSUE ENG, V7, P573, DOI 10.1089/107632701753213192
   Kumar S, 2006, BIOPHYS J, V90, P3762, DOI 10.1529/biophysj.105.071506
   Kurpinski K, 2006, P NATL ACAD SCI USA, V103, P16095, DOI 10.1073/pnas.0604182103
   Lang A, 1999, ITAL J GASTROENTEROL, V31, P173
   Lee CJ, 2004, LANGMUIR, V20, P4155, DOI 10.1021/la035467c
   Lele TP, 2006, J CELL PHYSIOL, V207, P187, DOI 10.1002/jcp.20550
   Lelievre SA, 2000, CRIT REV EUKAR GENE, V10, P13
   Leor J, 2000, CIRCULATION, V102, P56
   Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849
   Matsumura F, 2005, TRENDS CELL BIOL, V15, P371, DOI 10.1016/j.tcb.2005.05.004
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Mckenzie JAG, 2007, J CELL PHYSIOL, V213, P221, DOI 10.1002/jcp.21114
   MCMAHON DK, 1994, AM J PHYSIOL, V266, pC1795
   Milner KR, 2007, J BIOMED MATER RES A, V82A, P80, DOI 10.1002/jbm.a.31049
   Motlagh D, 2003, BIOMATERIALS, V24, P2463, DOI 10.1016/S0142-9612(02)00644-0
   Pedersen JA, 2005, ANN BIOMED ENG, V33, P1469, DOI 10.1007/s10439-005-8159-4
   Peerani R, 2007, EMBO J, V26, P4744, DOI 10.1038/sj.emboj.7601896
   Pelletier S, 2005, J CELL PHYSIOL, V204, P412, DOI 10.1002/jcp.20308
   Puddu GM, 2005, J BIOMED SCI, V12, P839, DOI 10.1007/s11373-005-9024-z
   Reiss AB, 2006, J INVEST MED, V54, P123, DOI 10.2310/6550.2006.05051
   Ren Guofeng, 2003, Current Drug Targets - Inflammation and Allergy, V2, P242, DOI 10.2174/1568010033484098
   Saez A, 2007, P NATL ACAD SCI USA, V104, P8281, DOI 10.1073/pnas.0702259104
   Salber J, 2007, SMALL, V3, P1023, DOI 10.1002/smll.200600596
   Sniadecki NJ, 2007, P NATL ACAD SCI USA, V104, P14553, DOI 10.1073/pnas.0611613104
   Sun Y, 2002, BASIC RES CARDIOL, V97, P343, DOI 10.1007/s00395-002-0365-8
   Takahashi H, 2007, BIOMACROMOLECULES, V8, P3281, DOI 10.1021/bm700540p
   Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100
   Thakar RG, 2003, BIOCHEM BIOPH RES CO, V307, P883, DOI 10.1016/S0006-291X(03)01285-3
   Thomas CH, 2002, P NATL ACAD SCI USA, V99, P1972, DOI 10.1073/pnas.032668799
   Totsukawa G, 2004, J CELL BIOL, V164, P427, DOI 10.1083/jcb.200306172
   Totsukawa G, 2000, J CELL BIOL, V150, P797, DOI 10.1083/jcb.150.4.797
   WALLACE CS, 2007, AM J PHYSIOL-HEART C, V3, P1978
   Wang YC, 2004, FASEB J, V18, P525, DOI 10.1096/fj.03-0490fje
   Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335
   Yanase M, 2003, BIOCHEM BIOPH RES CO, V305, P223, DOI 10.1016/S0006-291X(03)00726-5
NR 55
TC 34
Z9 34
U1 1
U2 6
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1613-6810
J9 SMALL
JI Small
PD SEP
PY 2008
VL 4
IS 9
BP 1416
EP 1424
DI 10.1002/smll.200701302
PG 9
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 352ZV
UT WOS:000259536800024
PM 18711756
DA 2018-10-19
ER

PT J
AU Willerth, SM
   Rader, A
   Sakiyama-Elbert, SE
AF Willerth, Stephanie M.
   Rader, Allison
   Sakiyama-Elbert, Shelly E.
TI The effect of controlled growth factor delivery on embryonic stem cell
   differentiation inside fibrin scaffolds
SO STEM CELL RESEARCH
LA English
DT Article
AB The goal of this project was to develop 3-D biomaterial scaffolds that present cues to direct the differentiation of embryonic stem (ES) cell-derived neural progenitor cells, seeded inside the scaffolds, into mature neural phenotypes, specifically neurons and oligodendrocytes. Release studies were performed to determine the appropriate conditions for retention of neurotrophin-3 (NT-3), sonic hedgehog, and platelet-derived growth factor (PDGF) by an affinity-based delivery system incorporated into fibrin scaffolds. Embryoid bodies containing neural progenitors were formed from mouse ES cells, using a 4-/4+ retinoic acid treatment protocol, and then seeded inside fibrin scaffolds containing the drug delivery system. This delivery system was used to deliver various growth factor doses and combinations to the cells seeded inside the scaffolds. Controlled delivery of NT-3 and PDGF simultaneously increased the fraction of neural progenitors, neurons, and oligodendrocytes while decreasing the fraction of astrocytes obtained compared to control cultures seeded inside unmodified fibrin scaffolds with no growth factors present in the medium. These results demonstrate that such a strategy can be used to generate an engineered tissue for the potential treatment of spinal cord injury and could be extended to the study of differentiation in other tissues. (c) 2008 Elsevier B.V. All rights reserved.
C1 [Willerth, Stephanie M.; Rader, Allison; Sakiyama-Elbert, Shelly E.] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA.
   [Sakiyama-Elbert, Shelly E.] Washington Univ, Ctr Mat Innovat, St Louis, MO 63130 USA.
RP Sakiyama-Elbert, SE (reprint author), Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA.
EM sakiyama@wustl.edu
RI Sakiyama-Elbert, Shelly/A-6753-2008
OI Sakiyama-Elbert, Shelly/0000-0003-4832-5851; Willerth,
   Stephanie/0000-0002-1665-7723
FU NIH [R01 NS051454]; NIH Neuroscience Blueprint Interdisciplinary Center
   [P30 NS057105]
FX This work was supported by NIH R01 NS051454. The authors thank Amy
   Boyet, Angela Guzman, Nicole Moore, and Matthew Wood for technical
   support. The authors thank Shengzhou Wu and the Hope Center for
   Neurological Disorders, which is supported by an NIH Neuroscience
   Blueprint Interdisciplinary Center Core grant (P30 NS057105), for use of
   the real-time PCR machine.
CR BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085
   Bambakidis NC, 2003, J NEUROSURG, V99, P70, DOI 10.3171/spi.2003.99.1.0070
   Bambakidis Nicholas C, 2004, Spine J, V4, P16, DOI 10.1016/j.spinee.2003.07.004
   Beckstead BL, 2006, J BIOMED MATER RES A, V79A, P94, DOI 10.1002/jbm.a.30760
   Benoit DSW, 2007, BIOMATERIALS, V28, P66, DOI 10.1016/j.biomaterials.2006.08.033
   Benoit DSW, 2005, ACTA BIOMATER, V1, P461, DOI 10.1016/j.actbio.2005.03.002
   Calver AR, 1998, NEURON, V20, P869, DOI 10.1016/S0896-6273(00)80469-9
   Cao QL, 2001, EXP NEUROL, V167, P48, DOI 10.1006/exnr.2000.7536
   Cao QL, 2002, EXP NEUROL, V177, P349, DOI 10.1006/exner.2002.7981
   Danesin C, 2006, J NEUROSCI, V26, P5037, DOI 10.1523/JNEUROSCI.0715-06.2006
   Dutton R, 1999, J NEUROSCI, V19, P2601
   EDELMAN ER, 1991, BIOMATERIALS, V12, P619, DOI 10.1016/0142-9612(91)90107-L
   Fan VH, 2007, STEM CELLS, V25, P1241, DOI 10.1634/stemcells.2006-0320
   Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6
   Ferreira LS, 2007, BIOMATERIALS, V28, P2706, DOI 10.1016/j.biomaterials.2007.01.021
   Fressinaud C, 2005, GLIA, V49, P555, DOI 10.1002/glia.20136
   Gomez N, 2007, J BIOMED MATER RES A, V81A, P135, DOI 10.1002/jbm.a.31047
   Gomez N, 2007, BIOMATERIALS, V28, P271, DOI 10.1016/j.biomaterials.2006.07.043
   Hiraizumi Y, 1996, SPINAL CORD, V34, P394, DOI 10.1038/sc.1996.71
   HIRAIZUMI Y, 1993, BRAIN RES BULL, V30, P353, DOI 10.1016/0361-9230(93)90264-C
   Hiraizumi Y, 1992, J Am Paraplegia Soc, V15, P7
   Ho JE, 2007, J BIOMED MATER RES A, V83A, P1200, DOI 10.1002/jbm.a.31355
   ICHINOSE A, 1983, FEBS LETT, V153, P369, DOI 10.1016/0014-5793(83)80645-0
   Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005
   Kuhl PR, 1996, NAT MED, V2, P1022, DOI 10.1038/nm0996-1022
   Kumar S, 1998, J NEUROSCI RES, V54, P754, DOI 10.1002/(SICI)1097-4547(19981215)54:6<754::AID-JNR3>3.0.CO;2-K
   Lee H, 2007, STEM CELLS, V25, P1931, DOI 10.1634/stemcells.2007-0097
   Levenberg S, 2005, TISSUE ENG, V11, P506, DOI 10.1089/ten.2005.11.506
   Levenberg S, 2003, P NATL ACAD SCI USA, V100, P12741, DOI 10.1073/pnas.1735463100
   Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063
   Liu S, 2000, P NATL ACAD SCI USA, V97, P6126, DOI 10.1073/pnas.97.11.6126
   Lobsiger CS, 2000, GLIA, V30, P290, DOI 10.1002/(SICI)1098-1136(200005)30:3<290::AID-GLIA8>3.0.CO;2-6
   McDonald JW, 1999, NAT MED, V5, P1410, DOI 10.1038/70986
   Miles GB, 2004, J NEUROSCI, V24, P7848, DOI 10.1523/JNEUROSCI.1972-04.2004
   Nistor GI, 2005, GLIA, V49, P385, DOI 10.1002/glia.20127
   Oh S, 2005, DEV DYNAM, V234, P489, DOI 10.1002/dvdy.20422
   Rubin JB, 2002, DEVELOPMENT, V129, P2223
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V69, P149, DOI 10.1016/S0168-3659(00)00296-0
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V65, P389, DOI 10.1016/S0168-3659(99)00221-7
   SCHNELL L, 1994, NATURE, V367, P170, DOI 10.1038/367170a0
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Soundararajan P, 2006, J NEUROSCI, V26, P3256, DOI 10.1523/JNEUROSCI.5537-05.2006
   Soundararajan P, 2007, STEM CELLS, V25, P1697, DOI 10.1634/stemcells.2006-0654
   Taqvi S, 2006, J BIOMED MATER RES A, V79A, P689, DOI 10.1002/jbm.a.30916
   Taylor SJ, 2006, J CONTROL RELEASE, V116, P204, DOI 10.1016/j.jconrel.2006.07.005
   Taylor SJ, 2006, J CONTROL RELEASE, V113, P226, DOI 10.1016/j.jconrel.2006.05.005
   Taylor SJ, 2004, J CONTROL RELEASE, V98, P281, DOI 10.1016/j.jconrel.2004.05.003
   Thomopoulos S, 2007, J ORTHOP RES, V25, P1358, DOI 10.1002/jor.20444
   Tuszynski MH, 2003, EXP NEUROL, V181, P47, DOI 10.1016/S0014-4886(02)00055-9
   TYLERCROSS R, 1994, PROTEIN SCI, V3, P620
   Willerth SM, 2007, STEM CELLS, V25, P2235, DOI 10.1634/stemcells.2007-0111
   Willerth SM, 2007, J BIOMED MATER RES A, V80A, P13, DOI 10.1002/jbm.a.30844
   Willerth SM, 2006, BIOMATERIALS, V27, P5990, DOI 10.1016/j.biomaterials.2006.07.036
   Wissink MJB, 2001, BIOMATERIALS, V22, P2291, DOI 10.1016/S0142-9612(00)00418-X
   Wood MD, 2008, J BIOMED MATER RES A, V84A, P300, DOI 10.1002/jbm.a.31269
   Yim EKF, 2005, J BIOMAT SCI-POLYM E, V16, P1193, DOI 10.1163/156856205774269485
   Zhang FM, 2007, BIOCHEMISTRY-US, V46, P3933, DOI 10.1021/bi6025424
NR 57
TC 68
Z9 72
U1 0
U2 19
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1873-5061
J9 STEM CELL RES
JI Stem Cell Res.
PD SEP
PY 2008
VL 1
IS 3
BP 205
EP 218
DI 10.1016/j.scr.2008.05.006
PG 14
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA V12AC
UT WOS:000207571100006
PM 19383401
OA Green Accepted, Bronze
DA 2018-10-19
ER

PT J
AU Nesti, LJ
   Li, WJ
   Shanti, RM
   Jiang, YJ
   Jackson, W
   Freedman, BA
   Kuklo, TR
   Giuliani, JR
   Tuan, RS
AF Nesti, Leon J.
   Li, Wan-Ju
   Shanti, Rabie M.
   Jiang, Yi Jen
   Jackson, Wesley
   Freedman, Brett A.
   Kuklo, Timothy R.
   Giuliani, Jeffrey R.
   Tuan, Rocky S.
TI Intervertebral disc tissue engineering using a novel hyaluronic
   acid-nanofibrous scaffold (HANFS) amalgam
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; INVESTIGATIONAL DEVICE EXEMPTION; NUCLEUS
   PULPOSUS; IN-VITRO; TRANSPLANTATION THERAPY; SOLUTE TRANSPORT; LUMBAR
   FUSION; BACK-PAIN; FOLLOW-UP; DIFFERENTIATION
AB Degeneration of the intervertebral disc (IVD) represents a significant musculoskeletal disease burden. Although spinal fusion has some efficacy in pain management, spine biomechanics is ultimately compromised. In addition, there is inherent limitation of hardware-based IVD replacement prostheses, which underscores the importance of biological approaches to disc repair. In this study, we have seeded multipotent, adult human mesenchymal stem cells (MSCs) into a novel biomaterial amalgam to develop a biphasic construct that consisted of electrospun, biodegradable nanofibrous scaffold (NFS) enveloping a hyaluronic acid (HA) hydrogel center. The seeded MSCs were induced to undergo chondrogenesis in vitro in the presence of transforming growth factor-beta for up to 28 days. The cartilaginous hyaluronic acid nanofibrous scaffold (HANFS) construct architecturally resembled a native IVD, with an outer annulus fibrosus-like region and inner nucleus pulposus-like region. Histological and biochemical analyses, immunohistochemistry, and gene expression profiling revealed the time-dependent development of chondrocytic phenotype of the seeded cells. The cells also maintain the microarchitecture of a native IVD. Taken together, these findings suggest the prototypic potential of MSC-seeded HANFS constructs for the tissue engineering of biological replacements of degenerated IVD.
C1 [Nesti, Leon J.; Li, Wan-Ju; Shanti, Rabie M.; Jiang, Yi Jen; Jackson, Wesley; Tuan, Rocky S.] NIAMSD, NIH, Dept Hlth & Human Serv, Cartilage Biol & Orthopaed Branch, Bethesda, MD 20892 USA.
   [Nesti, Leon J.; Freedman, Brett A.; Kuklo, Timothy R.; Giuliani, Jeffrey R.] Walter Reed Army Med Ctr, Dept Orthopaed & Rehabil, Washington, DC 20307 USA.
   [Shanti, Rabie M.] NIH, Howard Hughes Med Inst, Res Scholars Program, Bethesda, MD 20892 USA.
RP Tuan, RS (reprint author), NIAMSD, NIH, Dept Hlth & Human Serv, Cartilage Biol & Orthopaed Branch, Bldg 50,Room 1503,MSC 8022, Bethesda, MD 20892 USA.
EM tuanr@mail.nih.gov
OI Li, Wan-Ju/0000-0002-6579-8063
FU NIAMS; NIH [ZO1 AR41131]
FX This work was supported by the Intramural Research Program of the NIAMS,
   NIH (ZO1 AR41131).
CR Abukawa H, 2003, J ORAL MAXIL SURG, V61, P94, DOI 10.1053/joms.2003.50015
   Alini M, 2003, SPINE, V28, P446, DOI 10.1097/00007632-200303010-00007
   Caterson E, 2002, MOL BIOTECHNOL, V20, P245, DOI 10.1385/MB:20:3:245
   Caterson EJ, 2001, J BIOMED MATER RES, V57, P394, DOI 10.1002/1097-4636(20011205)57:3<394::AID-JBM1182>3.0.CO;2-9
   Chen WH, 2006, J CELL PHYSIOL, V209, P744, DOI 10.1002/jcp.20765
   Cowan JA, 2006, NEUROSURGERY, V59, P15, DOI 10.1227/01.NEU.0000219836.54861.CD
   Deyo RA, 2006, SPINE, V31, P2724, DOI 10.1097/01.brs.0000244618.06877.cd
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   Fritzell P, 2001, SPINE, V26, P2521, DOI 10.1097/00007632-200112010-00002
   Ganey T, 2003, SPINE, V28, P2609, DOI 10.1097/01.BRS.0000097891.63063.78
   Hallab NJ, 2003, SPINE, V28, pS125, DOI 10.1097/00007632-200310151-00006
   Huang KY, 2007, SPINE, V32, P1174, DOI 10.1097/01.brs.0000263369.95182.19
   Huang RC, 2005, SPINE, V30, P1407, DOI 10.1097/01.brs.0000166528.67425.0e
   Imai Y, 2007, SPINE, V32, P1197, DOI 10.1097/BRS.0b013e3180574d26
   Inkinen RI, 1999, HISTOCHEM J, V31, P579, DOI 10.1023/A:1003898923823
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Le Huec JC, 2005, ORTHOP CLIN N AM, V36, P315, DOI 10.1016/j.ocl.2005.02.001
   Le Visage C, 2006, SPINE, V31, P2423, DOI 10.1097/01.brs.0000238684.04792.eb
   Lee CH, 2005, BIOMATERIALS, V26, P1261, DOI 10.1016/j.biomaterials.2004.04.037
   Leung VYL, 2006, EUR SPINE J, V15, pS406, DOI 10.1007/s00586-006-0183-z
   Li WJ, 2007, J BIOMECH, V40, P1686, DOI 10.1016/j.jbiomech.2006.09.004
   Li WJ, 2006, TISSUE ENG, V12, P1775, DOI 10.1089/ten.2006.12.1775
   Li WJ, 2006, ACTA BIOMATER, V2, P377, DOI 10.1016/j.actbio.2006.02.005
   Li WJ, 2005, BIOMATERIALS, V26, P5158, DOI 10.1016/j.biomaterials.2005.01.002
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005
   Li WJ, 2003, J BIOMED MATER RES A, V67A, P1105, DOI 10.1002/jbm.a.10101
   Li YC, 2007, DEV BIOL, V305, P411, DOI 10.1016/j.ydbio.2007.02.023
   MALDONADO BA, 1992, J ORTHOP RES, V10, P677, DOI 10.1002/jor.1100100510
   Manchikanti L, 2000, Pain Physician, V3, P167
   Masuda K, 2006, EUR SPINE J, V15, pS422, DOI 10.1007/s00586-006-0149-1
   McAfee PC, 2005, SPINE, V30, P1576, DOI 10.1097/01.brs.0000170561.25636.1c
   Meisel HJ, 2006, EUR SPINE J, V15, pS397, DOI 10.1007/s00586-006-0169-x
   Nerurkar NL, 2007, J ORTHOP RES, V25, P1018, DOI 10.1002/jor.20384
   Nesti LJ, 2002, J ORTHOPAED RES, V20, P1042, DOI 10.1016/S0736-0266(02)00020-7
   Nishida K, 2006, SPINE, V31, P1415, DOI 10.1097/01.brs.0000219945.70675.dd
   Paesold G, 2007, EUR SPINE J, V16, P447, DOI 10.1007/s00586-006-0220-y
   Panjabi M, 2007, SPINE, V32, P1311, DOI 10.1097/BRS.0b013e318059af6f
   Pfeiffer M, 2003, EUR SPINE J, V12, P76, DOI 10.1007/s00586-002-0478-7
   Riboldi SA, 2005, BIOMATERIALS, V26, P4606, DOI 10.1016/j.biomaterials.2004.11.035
   Risbud Makarand V, 2004, Spine J, V4, p348S, DOI 10.1016/j.spinee.2004.07.031
   Risbud MV, 2004, SPINE, V29, P2627, DOI 10.1097/01.brs.0000146462.92171.7f
   Rong Y, 2002, TISSUE ENG, V8, P1037, DOI 10.1089/107632702320934137
   Sakai D, 2005, SPINE, V30, P2379, DOI 10.1097/01.brs.0000184365.28481.e3
   Sakai D, 2003, BIOMATERIALS, V24, P3531, DOI 10.1016/S0142-9612(03)00222-9
   Sato M, 2003, SPINE, V28, P548, DOI 10.1097/00007632-200303150-00007
   Shuff Charles, 2005, Am J Orthop (Belle Mead NJ), V34, P8
   Steck E, 2005, STEM CELLS, V23, P403, DOI 10.1634/stemcells.2004-0107
   Stern S, 2000, ACTA ORTHOP SCAND, V71, P496, DOI 10.1080/000164700317381207
   Tsai TT, 2007, SPINE, V32, P495, DOI 10.1097/01.brs.0000257341.88880.f1
   URBAN JPG, 1977, CLIN ORTHOP RELAT R, P101
   URBAN JPG, 1982, CLIN ORTHOP RELAT R, P296
   Valdevit Antonio, 2004, Spine J, V4, p276S, DOI 10.1016/j.spinee.2004.07.016
   Venugopal J, 2005, TISSUE ENG, V11, P847, DOI 10.1089/ten.2005.11.847
   von Knoch M, 2004, J ORTHOPAED RES, V22, P237, DOI 10.1016/j.orthres.2003.08.013
   Wallach CJ, 2003, SPINE, V28, P2331, DOI 10.1097/01.BRS.0000085303.67942.94
   Wallach Corey J, 2006, Spine J, V6, P107, DOI 10.1016/j.spinee.2005.05.002
   Wilda H, 2006, BIOMATERIALS, V27, P5220, DOI 10.1016/j.biomaterials.2006.06.008
   Wilke HJ, 2006, EUR SPINE J, V15, pS433, DOI 10.1007/s00586-006-0177-x
   Williams KD, 2003, CAMPBELLS OPERATIVE, P1955
   Zigler J, 2007, SPINE, V32, P1155, DOI 10.1097/BRS.0b013e318054e377
NR 61
TC 112
Z9 122
U1 4
U2 28
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD SEP
PY 2008
VL 14
IS 9
SI SI
BP 1527
EP 1537
DI 10.1089/ten.tea.2008.0215
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 350UG
UT WOS:000259378000010
PM 18707229
OA Green Accepted, Green Published
DA 2018-10-19
ER

PT J
AU Bakker, AD
   Schrooten, J
   Van Cleynenbreugel, T
   Vanlauwe, J
   Luyten, J
   Schepers, E
   Dubruel, P
   Schacht, E
   Lammens, J
   Luyten, FP
AF Bakker, Astrid D.
   Schrooten, Jan
   Van Cleynenbreugel, Tim
   Vanlauwe, Johan
   Luyten, Jan
   Schepers, Evert
   Dubruel, Peter
   Schacht, Etienne
   Lammens, Johan
   Luyten, Frank P.
TI Quantitative screening of engineered implants in a long bone defect
   model in rabbits
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID PERIOSTEAL CELLS; STEM-CELL; IN-VIVO; LOCALIZATION; VITRO
AB We have standardized a long bone defect model in rabbits to quantitatively compare the bone healing performance of engineered biological implants and have tested the bone healing efficiency of porous cylindrical scaffolds (o-h, 6-20 mm [diameter 6 mm, height 20 mm] porosity, 70%) that were produced from hydroxyapatite (HA), titanium (Ti), and a novel biodegradable polymer-bioceramic composite (PH70 alpha TCP). Scaffolds were perfused with or without 20 x 10(6) rabbit periosteal cells (RPCs) in a bioreactor and implanted in a standardized 2 cm defect in rabbit tibiae. X-rays revealed that new bone had formed at 3 weeks after creation of the defects. At sacrifice after 10 weeks, bone corticalization was observed in the majority of animals. Although PH70 alpha TCP scaffolds did not inhibit callus formation, histomorphometric analysis revealed that there was no bone within the biomaterial, in contrast to HA and Ti scaffolds (bone volume ranging from 10% to 25%). We found that Ti and HA scaffold had good osteoconductive properties, but only HA scaffolds seeded with RPCs contributed to long bone mechanical functionality, with the maximum energy and angle being 308% and 155% greater than in control defects without scaffold.
C1 [Bakker, Astrid D.; Luyten, Frank P.] Katholieke Univ Leuven, Lab Skeletal Dev & Joint Disorders, Leuven, Belgium.
   [Schrooten, Jan] Katholieke Univ Leuven, Dept Met & Mat Engn, Leuven, Belgium.
   [Schrooten, Jan; Schepers, Evert; Lammens, Johan; Luyten, Frank P.] Katholieke Univ Leuven, Div Skeletal Tissue Engn, Leuven, Belgium.
   [Van Cleynenbreugel, Tim] Katholieke Univ Leuven, Dept Mech Engn, Leuven, Belgium.
   [Vanlauwe, Johan; Lammens, Johan] Univ Hosp Pellenberg, Dept Orthopead, Pellenberg, Belgium.
   [Luyten, Jan] Flemish Inst Technol Res, Mol, Belgium.
   [Schepers, Evert] Katholieke Univ Leuven, Dept Prosthet Dent, Leuven, Belgium.
   [Dubruel, Peter; Schacht, Etienne] Univ Ghent, Polymer Mat Res Grp, B-9000 Ghent, Belgium.
RP Luyten, FP (reprint author), UZ Leuven, Dept Rheumatol, Lab Skeletal Dev & Joint Disorders, O&N1,8th Floor,Bus 813, B-3000 Louvain, Belgium.
EM frank.luyten@uzleuven.be
RI Dubruel, Peter/A-3440-2009
OI Vanlauwe, Johan/0000-0003-0593-5414
FU The Institute for the Promotion of Innovation by Science and Technology
   in Flanders (IWT-Flanders) [GBOU-020181]
FX This work is part of the Guided Bone Engineering (GBE) project, an
   interdisciplinary research project funded by The Institute for the
   Promotion of Innovation by Science and Technology in Flanders
   (IWT-Flanders) under the program for strategic basic research
   (GBOU-020181). The scientific GBE-partners are the Department of
   Metallurgy and Materials Engineering, the Division of Biomechanics and
   Engineering Design, and the Department of Rheumatology of the Katholieke
   Universiteit Leuven, the Polymer Materials Research Group of the Ghent
   University; and VITO, the Flemish institute for technology. We thank
   Marina Marechal, Jenny Peeters, Jos Nijs, Erik-Jan Ververs, and Nele
   Bijnens for their technical assistance. We thank Thomasz Gorski for
   preparing the polymer-based scaffolds.
CR De Bari C, 2001, ARTHRITIS RHEUM, V44, P85, DOI 10.1002/1529-0131(200101)44:1<85::AID-ANR12>3.0.CO;2-6
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   EYCKMANS J, 2006, P TERMIS EU M
   Eyckmans J, 2006, TISSUE ENG, V12, P2203, DOI 10.1089/ten.2006.12.2203
   GORSKI T, 2003, 18 EUR C BIOM OCT 1
   HAMADA K, 2007, J BIOMED MATER RES A, P1552
   Hutmacher DW, 2003, TISSUE ENG, V9, pS45, DOI 10.1089/10763270360696978
   Ito Y, 2001, OSTEOARTHR CARTILAGE, V9, P215, DOI 10.1053/joca.2000.0378
   Kim MS, 2006, TISSUE ENG, V12, P2863, DOI 10.1089/ten.2006.12.2863
   KOJIMOTO H, 1988, J BONE JOINT SURG BR, V70, P543
   KOSHIHARA Y, 1991, J GERONTOL, V46, pB201, DOI 10.1093/geronj/46.5.B201
   Luyten J, 2003, ADV ENG MATER, V5, P715, DOI 10.1002/adem.200300381
   Mauney JR, 2005, TISSUE ENG, V11, P787, DOI 10.1089/ten.2005.11.787
   NAKAHARA H, 1990, CLIN ORTHOP RELAT R, P223
   Ozaki A, 2000, J Orthop Sci, V5, P64, DOI 10.1007/s007760050010
   Park H, 2007, BIOMATERIALS, V28, P3217, DOI 10.1016/j.biomaterials.2007.03.030
   SCHANTZ JT, 2002, CELL TRANSPLANT, V11, P25
   STAFFORD HJ, 1994, J ORTHOP RES, V12, P29, DOI 10.1002/jor.1100120105
   Stevens MM, 2005, P NATL ACAD SCI USA, V102, P11450, DOI 10.1073/pnas.0504705102
   Takushima A, 1998, J SURG RES, V78, P68, DOI 10.1006/jsre.1998.5378
   Teixeira AI, 2007, CELL RES, V17, P56, DOI 10.1038/sj.cr.7310414
   Uebersax L, 2006, TISSUE ENG, V12, P3417, DOI 10.1089/ten.2006.12.3417
   Van Cleynenbreugel T, 2006, MED BIOL ENG COMPUT, V44, P517, DOI 10.1007/s11517-006-0071-z
   Walkley CR, 2007, CELL, V129, P1097, DOI 10.1016/j.cell.2007.05.014
NR 24
TC 15
Z9 16
U1 3
U2 7
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
J9 TISSUE ENG PT C-METH
JI Tissue Eng. Part C-Methods
PD SEP
PY 2008
VL 14
IS 3
BP 251
EP 260
DI 10.1089/ten.tec.2008.0022
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 354AT
UT WOS:000259612000009
PM 18781837
DA 2018-10-19
ER

PT J
AU Sreenivas, SA
   Pai, KV
AF Sreenivas, S. A.
   Pai, K. V.
TI Thiolated Chitosans: Novel Polymers for Mucoadhesive Drug Delivery - A
   Review
SO TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH
LA English
DT Review
DE Thiolated chitosan; Thiomers; Mucoadhesion; Permeation enhancement; In
   situ gelation
ID IN-VITRO EVALUATION; POORLY ABSORBABLE DRUGS; SALMON-CALCITONIN;
   ABSORPTION ENHANCEMENT; RHEOLOGICAL EVALUATION; INTESTINAL-ABSORPTION;
   VIVO EVALUATION; ORAL DELIVERY; PERMEABILITY; SYSTEM
AB Chitosan is a natural polycationic copolymer consisting of glucosamine and N-acetylglucosamine units. The polymer has valuable properties as a biomaterial because it is considered to be biocompatible, biodegradable and non-toxic. The purpose of this review article is to provide detailed information about thiolated chitosans which are gaining popularity because of their high mucoadhsiveness and extended drug release properties. The derivatization of the primary amino groups of chitosan with coupling reagents bearing thiol functions leads to the formation of thiolated chitosans. Various properties of chitosan are improved by the immobilization of thiol groups. Due to the formation of disulfide bonds with mucus glycoproteins, mucoadhesiveness is augmented. The permeation of paracellular markers through mucosa can be enhanced by utilizing thiolated instead of unmodified chitosan. Moreover, thiolated chitosans display in situ gelling features due to the pH-dependent formation of inter-as well as intra-molecular disulfide bonds. This latter process provides, strong cohesion and stability of carrier matrices, being based on thiolated chitosans. The in situ gel formation within the pH range of 5 to 6.8 makes the application of thiolated chitosans on vaginal, nasal and ocular mucosa also possible. Thiolated chitosans can guarantee prolonged controlled release of embedded therapeutic ingredients.
C1 [Sreenivas, S. A.] KLESs Coll Pharm, Dept Pharmaceut, Hubli, Karnataka, India.
   [Pai, K. V.] Dept Ind Chem, Shimoga, Karnataka, India.
RP Sreenivas, SA (reprint author), KLESs Coll Pharm, Dept Pharmaceut, Hubli, Karnataka, India.
EM saiseenu7@rediffmail.com
CR Andreas B, 2000, J HIGH ENERGY PHYS
   Andreas B.S., 1998, PHARM RES, V15, P263
   Andreas B. S., 1999, SCI PHARM, V67, P196
   Andreas B.S., 2003, J CONTROL RELEASE, V93, P95
   ANDREAS BS, 2001, SCI PHARM, V69, P109
   Andreas BS, 2003, INT J PHARMACEUT, V260, P229
   ANDRES BS, 1998, J CONTROL RELEASE, V50, P215
   ARTURSSON P, 1994, PHARMACEUT RES, V11, P1358, DOI 10.1023/A:1018967116988
   Barrett WC, 1999, BIOCHEMISTRY-US, V38, P6699, DOI 10.1021/bi990240v
   Baumann H, 2001, CARBOHYD RES, V331, P43, DOI 10.1016/S0008-6215(01)00009-X
   Borchard G, 1996, J CONTROL RELEASE, V39, P131, DOI 10.1016/0168-3659(95)00146-8
   Borchard G, 2001, ADV DRUG DELIVER REV, V52, P145, DOI 10.1016/S0169-409X(01)00198-3
   Bromberg LE, 2001, J PHARM PHARMACOL, V53, P109, DOI 10.1211/0022357011775082
   Clausen AE, 2002, PHARMACEUT RES, V19, P602, DOI 10.1023/A:1015345827091
   Coppi G, 2001, DRUG DEV IND PHARM, V27, P393, DOI 10.1081/DDC-100104314
   DEASY PB, 1991, INT J PHARM, V73, P117, DOI 10.1016/0378-5173(91)90034-L
   Dodane V, 1999, INT J PHARM, V182, P21, DOI 10.1016/S0378-5173(99)00030-7
   Edsman K, 1998, EUR J PHARM SCI, V6, P105, DOI 10.1016/S0928-0987(97)00075-4
   Felt O, 1999, INT J PHARM, V180, P185, DOI 10.1016/S0378-5173(99)00003-4
   Felt O, 1998, DRUG DEV IND PHARM, V24, P979, DOI 10.3109/03639049809089942
   Fini A., 2003, AM J DRUG DELIV, V1, P43
   GRAFSTROM R, 1980, EUR J BIOCHEM, V106, P571, DOI 10.1111/j.1432-1033.1980.tb04605.x
   Guggi D, 2003, PHARM RES-DORDR, V20, P1989, DOI 10.1023/B:PHAM.0000008047.82334.7d
   Guggi D, 2003, J CONTROL RELEASE, V92, P125, DOI 10.1016/S0168-3659(03)00299-2
   Guggi D, 2003, INT J PHARM, V252, P187, DOI 10.1016/S0378-5173(02)00631-2
   Hornof MD, 2003, EUR J PHARM BIOPHARM, V55, P185, DOI 10.1016/S0939-6411(02)00162-5
   ILLUM L, 1994, PHARMACEUT RES, V11, P1186, DOI 10.1023/A:1018901302450
   Kast CE, 2003, INT J PHARM, V256, P183, DOI 10.1016/S0378-5173(03)00076-0
   Kast CE, 2002, J CONTROL RELEASE, V81, P347, DOI 10.1016/S0168-3659(02)00077-9
   Kast CE, 2001, BIOMATERIALS, V22, P2345, DOI 10.1016/S0142-9612(00)00421-X
   LANGOTH N, 2004, J CONTROL RELEASE, V177, P86
   Lee YH, 2000, ADV DRUG DELIVER REV, V42, P225, DOI 10.1016/S0169-409X(00)00063-6
   Lehr CM, 1996, EUR J DRUG METAB PH, V21, P139, DOI 10.1007/BF03190262
   Leitner VM, 2003, EUR J PHARM BIOPHARM, V56, P207, DOI 10.1016/S0939-6411(03)00061-4
   Leitner VM, 2003, EUR J PHARM SCI, V18, P89, DOI 10.1016/S0928-0987(02)00245-2
   Liu WG, 2002, J CONTROL RELEASE, V83, P1
   Lubben I. M., 2001, BIOMATERIALS, V22, P687
   Luessen HL, 1996, PHARMACEUT RES, V13, P1668, DOI 10.1023/A:1016488623022
   Ma PX, 2001, TISSUE ENG, V7, P23, DOI 10.1089/107632701300003269
   Paulsson M, 1999, EUR J PHARM SCI, V9, P99, DOI 10.1016/S0928-0987(99)00051-2
   Roldo M, 2004, EUR J PHARM BIOPHARM, V57, P115, DOI 10.1016/S0939-6411(03)00157-7
   Schipper NGM, 1999, EUR J PHARM SCI, V8, P335, DOI 10.1016/S0928-0987(99)00032-9
   Schipper NGM, 1997, PHARMACEUT RES, V14, P923, DOI 10.1023/A:1012160102740
   Senel S, 2000, BIOMATERIALS, V21, P2067, DOI 10.1016/S0142-9612(00)00134-4
   Shah RB, 2002, CRIT REV THER DRUG, V19, P135, DOI 10.1615/CritRevTherDrugCarrierSyst.v19.i2.20
   SNYDER GH, 1983, BIOCHIM BIOPHYS ACTA, V749, P219, DOI 10.1016/0167-4838(83)90228-5
   STADDON JM, 1995, J CELL SCI, V108, P609
   Takeuchi H, 2001, ADV DRUG DELIVER REV, V47, P39, DOI 10.1016/S0169-409X(00)00120-4
   Thanou M, 2001, J PHARM SCI, V90, P38, DOI 10.1002/1520-6017(200101)90:1<38::AID-JPS5>3.3.CO;2-V
   Thanou M, 2000, PHARMACEUT RES, V17, P27, DOI 10.1023/A:1007558206506
   Torres-Lugo M, 2000, BIOMATERIALS, V21, P1191, DOI 10.1016/S0142-9612(00)00011-9
NR 51
TC 31
Z9 31
U1 0
U2 13
PU PHARMACOTHERAPY GROUP
PI BENIN CITY
PA UNIV BENIN, FACULTY PHARMACY, BENIN CITY, 00000, NIGERIA
SN 1596-5996
J9 TROP J PHARM RES
JI Trop. J. Pharm. Res.
PD SEP
PY 2008
VL 7
IS 3
BP 1077
EP 1088
PG 12
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 385MO
UT WOS:000261818500010
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Phillips, JE
   Burns, KL
   Le Doux, JM
   Guldberg, RE
   Garcia, AJ
AF Phillips, Jennifer E.
   Burns, Kellie L.
   Le Doux, Joseph M.
   Guldberg, Robert E.
   Garcia, Andres J.
TI Engineering graded tissue interfaces
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE fibroblasts; gene therapy; heterogeneous tissue engineering; Runx2;
   transcription factor gradients
ID IN-VITRO; OSTEOBLAST DIFFERENTIATION; DNA DELIVERY; BONE; RUNX2/CBFA1;
   OSTEOGENESIS; FIBROBLASTS; CONSTRUCTS; MATURATION; RETROVIRUS
AB Interfacial zones between tissues provide specialized, transitional junctions central to normal tissue function. Regenerative medicine strategies focused on multiple cell types and/or bi/tri-layered scaffolds do not provide continuously graded interfaces, severely limiting the integration and biological performance of engineered tissue substitutes. Inspired by the bone-soft tissue interface, we describe a biomaterial-mediated gene transfer strategy for spatially regulated genetic modification and differentiation of primary dermal fibroblasts within tissue-engineered constructs. We demonstrate that zonal organization of osteolblastic and fibroblastic cellular phenotypes can be engineered by a simple, one-step seeding of fibroblasts onto scaffolds containing a spatial distribution of retrovirus encoding the osteogenic transcription factor Runx2/Cbfa1. Gradients of immobilized retrovirus, achieved via deposition of controlled poly(L-lysine) densities, resulted in spatial patterns of transcription factor expression, osteolblastic differentiation, and mineralized matrix deposition. Notably, this graded distribution of mineral deposition and mechanical properties was maintained when implanted in vivo in an ectopic site. Development of this facile and robust strategy is significant toward the regeneration of continuous interfacial zones that mimic the cellular and microstructural characteristics of native tissue.
C1 [Phillips, Jennifer E.; Le Doux, Joseph M.] Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   [Burns, Kellie L.; Guldberg, Robert E.; Garcia, Andres J.] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
   [Phillips, Jennifer E.; Le Doux, Joseph M.; Guldberg, Robert E.; Garcia, Andres J.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
   [Phillips, Jennifer E.; Le Doux, Joseph M.; Guldberg, Robert E.; Garcia, Andres J.] Georgia Tech Emory Ctr Engn Living Tissues, Atlanta, GA 30332 USA.
RP Garcia, AJ (reprint author), 315 Ferst Dr,Room 2314, Atlanta, GA 30332 USA.
EM andres.garcia@me.gatech.edu
RI Le Doux, Joseph/D-4876-2018
OI Le Doux, Joseph/0000-0002-6506-3905; Phillips-Cremins,
   Jennifer/0000-0002-4702-0450
FU National Institutes of Health [R01-EB003364]; National Science
   Foundation [EEC-9731643]; National Science Foundation Graduate Research
FX We thank C. Gersbach for helpful discussions and A. Lin for technical
   assistance with microCT image analysis and mechanical testing. This work
   was supported by the National Institutes of Health Grant R01-EB003364,
   the Georgia Tech/Emory Engineering Research Center on the Engineering of
   Living Tissues (National Science Foundation Grant EEC-9731643), and a
   National Science Foundation Graduate Research Fellowship (to J.E.P.).
CR Bonadio J, 1999, NAT MED, V5, P753, DOI 10.1038/10473
   Byers BA, 2006, J BIOMED MATER RES A, V76A, P646, DOI 10.1002/jbm.a.30549
   Cartmell SH, 2003, TISSUE ENG, V9, P1197, DOI 10.1089/10763270360728107
   Chen RR, 2003, PHARMACEUT RES, V20, P1103, DOI 10.1023/A:1025034925152
   Chen RR, 2007, PHARM RES, V24, P258, DOI 10.1007/s11095-006-9173-4
   Davis HE, 2004, BIOPHYS J, V86, P1234, DOI 10.1016/S0006-3495(04)74197-1
   DeLong SA, 2005, BIOMATERIALS, V26, P3227, DOI 10.1016/j.biomaterials.2004.09.021
   Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3
   Gersbach CA, 2006, GENE THER, V13, P873
   Ito H, 2005, NAT MED, V11, P291, DOI 10.1038/nm1190
   Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5
   KUROSAKA M, 1987, AM J SPORT MED, V15, P225, DOI 10.1177/036354658701500306
   Langer R, 1998, NATURE, V392, P5
   Le Doux JM, 2001, HUM GENE THER, V12, P1611, DOI 10.1089/10430340152528110
   Maleki M, 2007, LANGMUIR, V23, P10116, DOI 10.1021/la700822y
   Mikos AG, 2006, TISSUE ENG, V12, P3307, DOI 10.1089/ten.2006.12.3307
   Montcouquiol M, 2003, J NEUROSCI, V23, P9469
   Pannier AK, 2004, MOL THER, V10, P19, DOI 10.1016/j.ymthe.2004.03.020
   Phillips JE, 2006, J CELL SCI, V119, P581, DOI 10.1242/jcs.02758
   Phillips JE, 2007, TISSUE ENG, V13, P2029, DOI 10.1089/ten.2006.0041
   Phillips JE, 2006, BIOMATERIALS, V27, P5535, DOI 10.1016/j.biomaterials.2006.06.019
   Sharma B, 2004, ANN BIOMED ENG, V32, P148, DOI 10.1023/B:ABME.0000007799.60142.78
   Shea LD, 1999, NAT BIOTECHNOL, V17, P551
   Spalazzi JP, 2006, TISSUE ENG, V12, P3497, DOI 10.1089/ten.2006.12.3497
   Thomopoulos S, 2003, J ORTHOPAED RES, V21, P413, DOI 10.1016/S0736-0266(03)00057-3
   Ulloa F, 2007, CELL CYCLE, V6, P2640, DOI 10.4161/cc.6.21.4822
   Wang INE, 2007, J ORTHOP RES, V25, P1609, DOI 10.1002/jor.20475
   Woo SLY, 2006, J BIOMECH, V39, P1, DOI 10.1016/j.jbiomech.2004.10.025
   Yang SY, 2003, J BONE MINER RES, V18, P705, DOI 10.1359/jbmr.2003.18.4.705
NR 29
TC 135
Z9 134
U1 4
U2 28
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD AUG 26
PY 2008
VL 105
IS 34
BP 12170
EP 12175
DI 10.1073/pnas.0801988105
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 344DJ
UT WOS:000258905700016
PM 18719120
OA Bronze, Green Published
DA 2018-10-19
ER

PT J
AU Kempen, DHR
   Lu, L
   Classic, KL
   Hefferan, TE
   Creemers, LB
   Maran, A
   Dhert, WJA
   Yaszemski, MJ
AF Kempen, Diederik H. R.
   Lu, Lichun
   Classic, Kelly L.
   Hefferan, Theresa E.
   Creemers, Laura B.
   Maran, Avudaiappan
   Dhert, Wouter J. A.
   Yaszemski, Michael J.
TI Non-invasive screening method for simultaneous evaluation of in vivo
   growth factor release profiles from multiple ectopic bone tissue
   engineering implants
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article
DE controlled drug delivery; non-invasive screening; scintillation
   detector; radiolabelled growth factor; method validation
ID MORPHOGENETIC PROTEIN-2; CALCIUM-PHOSPHATE; DELIVERY-SYSTEMS;
   POLY(PROPYLENE FUMARATE); BIOMATERIAL CARRIERS; SUSTAINED DELIVERY;
   GELATIN HYDROGEL; COLLAGEN SPONGES; MOLECULAR-WEIGHT; RHBMP-2
AB The purpose of this study was to develop and validate a screening method based on scintillation probes for the simultaneous evaluation of in vivo growth factor release profiles of multiple implants in the same animal. First, we characterized the scintillation probes in a series of in vitro experiments to optimize the accuracy of the measurement setup. The scintillation probes were found to have a strong geometric dependence and experience saturation effects at high activities. In vitro simulation of 4 subcutaneous limb implants in a rat showed minimal interference of surrounding implants on local measurements at close to parallel positioning of the probes. These characteristics were taken into consideration for the design of the probe setup and in vivo experiment. The measurement setup was then validated in a rat subcutaneous implantation model using 4 different sustained release carriers loaded with (125)I-BMP-2 per animal. The implants were removed after 42 or 84 days of implantation, for comparison of the non-invasive method to ex vivo radioisotope counting. The non-invasive method demonstrated a good correlation with the ex vivo counting method at both time-points of all 4 carriers. Overall, this study showed that scintillation probes could be successfully used for paired measurement of 4 release profiles with minimal interference of the surrounding implants, and may find use as non-invasive screening tools for various drug delivery applications. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Kempen, Diederik H. R.; Lu, Lichun; Hefferan, Theresa E.; Maran, Avudaiappan; Yaszemski, Michael J.] Mayo Clin, Dept Orthoped Surg, Tissue Engn & Biomat Lab, Rochester, MN 55905 USA.
   [Kempen, Diederik H. R.; Lu, Lichun; Hefferan, Theresa E.; Maran, Avudaiappan; Yaszemski, Michael J.] Mayo Clin, Dept Biomed Engn, Rochester, MN 55905 USA.
   [Kempen, Diederik H. R.; Creemers, Laura B.] Univ Med Ctr Utrecht, Dept Orthopaed, NL-3508 GA Utrecht, Netherlands.
RP Yaszemski, MJ (reprint author), Mayo Clin, Dept Orthoped Surg, Tissue Engn & Biomat Lab, 200 1st St SW, Rochester, MN 55905 USA.
EM yaszemski.michael@mayo.edu
OI Creemers, Laura/0000-0002-1585-3052; Kempen,
   Diederik/0000-0002-4504-7756
FU National Institutes of Health [R01 AR45871, R01 EB03060]; Netherlands
   Organization for Health Research and Development ZonMW [920-03-325];
   Stichting Anna Fonds
FX The authors gratefully acknowledge the National Institutes of Health
   (R01 AR45871 and R01 EB03060) and The Netherlands Organization for
   Health Research and Development ZonMW (Agiko 920-03-325) and Stichting
   Anna Fonds for the financial support. The authors thank Dr. Shanfeng
   Wang and Mr. James Greutzmacher from the Tissue Engineering and
   Biomaterials laboratory and Mr. Rodney Landsworth and Mr. Al Amundson
   from Radiation Safety at Mayo Clinic for their contributions to this
   work.
CR Abdiu A, 1998, LIFE SCI, V62, P1911, DOI 10.1016/S0024-3205(98)00159-3
   Boyan BD, 1999, J BIOMED MATER RES, V46, P51, DOI 10.1002/(SICI)1097-4636(199907)46:1<51::AID-JBM6>3.0.CO;2-I
   Delgado JJ, 2006, J CONTROL RELEASE, V114, P223, DOI 10.1016/j.jconrel.2006.05.026
   Duggirala S S, 1996, Pharm Dev Technol, V1, P11, DOI 10.3109/10837459609031413
   Friess W, 1999, INT J PHARM, V187, P91, DOI 10.1016/S0378-5173(99)00174-X
   Gao TJ, 2001, J BIOMED MATER RES, V57, P92, DOI 10.1002/1097-4636(200110)57:1<92::AID-JBM1146>3.0.CO;2-1
   Hori K, 2007, J CONTROL RELEASE, V118, P169, DOI 10.1016/j.jconrel.2006.12.011
   Hosseinkhani H, 2007, J CONTROL RELEASE, V117, P380, DOI 10.1016/j.jconrel.2006.11.018
   Kempen DHR, 2006, J BIOMED MATER RES A, V77A, P103, DOI 10.1002/jbm.a.30336
   Kempen DHR, 2003, MATER SCI FORUM, V426-4, P3151, DOI 10.4028/www.scientific.net/MSF.426-432.3151
   Kempen DHR, 2008, BIOMATERIALS, V29, P3245, DOI 10.1016/j.biomaterials.2008.04.031
   Li RH, 2003, J ORTHOP RES, V21, P997, DOI 10.1016/S0736-0266(03)00082-2
   Louis-Ugbo J, 2002, J ORTHOPAED RES, V20, P1050, DOI 10.1016/S0736-0266(02)00011-6
   Oldham JB, 2000, J BIOMECH ENG-T ASME, V122, P289, DOI 10.1115/1.429662
   Rai B, 2005, BIOMATERIALS, V26, P3739, DOI 10.1016/j.biomaterials.2004.09.052
   Ranger NT, 1999, RADIOGRAPHICS, V19, P481, DOI 10.1148/radiographics.19.2.g99mr30481
   Ruhe PQ, 2006, J MATER SCI-MATER M, V17, P919, DOI 10.1007/s10856-006-0181-z
   Ruhe PQ, 2005, J CONTROL RELEASE, V106, P162, DOI 10.1016/j.jconrel.2005.04.018
   Schrier JA, 1999, PHARM DEV TECHNOL, V4, P611, DOI 10.1081/PDT-100101400
   Seeherman H, 2003, J BONE JOINT SURG AM, V85A, P96, DOI 10.2106/00004623-200300003-00016
   Takahashi Y, 2005, BIOMATERIALS, V26, P4856, DOI 10.1016/j.biomaterials.2005.01.012
   Uludag H, 2000, BIOTECHNOL PROGR, V16, P1115, DOI 10.1021/bp000066y
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 2001, J BONE JOINT SURG AM, V83A, pS128
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   Uludag H, 1999, ANN NY ACAD SCI, V875, P369, DOI 10.1111/j.1749-6632.1999.tb08519.x
   Wang SF, 2006, BIOMACROMOLECULES, V7, P1976, DOI 10.1021/bm060096a
   Woo BH, 2001, PHARMACEUT RES, V18, P1747, DOI 10.1023/A:1013382832091
   Yamamoto M, 2003, BIOMATERIALS, V24, P4375, DOI 10.1016/S0142-9612(03)00337-5
   Yamamoto M, 2000, J CONTROL RELEASE, V64, P133, DOI 10.1016/S0168-3659(99)00129-7
   Yamamoto M, 2001, J BIOMAT SCI-POLYM E, V12, P77, DOI 10.1163/156856201744461
   Yokota S, 2003, INT J PHARM, V251, P57, DOI 10.1016/S0378-5173(02)00581-1
NR 32
TC 16
Z9 16
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
J9 J CONTROL RELEASE
JI J. Control. Release
PD AUG 25
PY 2008
VL 130
IS 1
BP 15
EP 21
DI 10.1016/j.jconrel.2008.05.004
PG 7
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 352SM
UT WOS:000259517700004
PM 18554743
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Yakacki, CM
   Shandas, R
   Safranski, D
   Ortega, AM
   Sassaman, K
   Gall, K
AF Yakacki, Christopher M.
   Shandas, Robin
   Safranski, David
   Ortega, Alicia M.
   Sassaman, Katie
   Gall, Ken
TI Strong, tailored, biocompatible shape-memory polymer networks
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
ID BIOMEDICAL APPLICATIONS; HYBRID COMPOSITES; DRUG-DELIVERY; POLYURETHANE;
   RECOVERY; THERMOMECHANICS; NANOCOMPOSITES; BEHAVIOR
AB Shape-memory polymers are a class of smart materials that have recently been used in intelligent biomedical devices and industrial applications for their ability to change shape under a predetermined stimulus. In this study, photopolymerized thermoset shape-memory networks with tailored thermomechanics are evaluated to link polymer structure to recovery behavior. Methyl methacrylate (MMA) and poly(ethylene glycol) dimethacrylate (PEGDMA) are copolymerized to create networks with independently adjusted glass transition temperatures (T-g) and rubbery modulus values ranging from 56 to 92 degrees C and 9.3 to 23.0 MPa, respectively. Free-strain recovery under isothermal and transient temperature conditions is highly influenced by the Tg of the networks, while the rubbery moduli of the networks has a negligible effect on this response. The magnitude of stress generation of fixed-strain recovery correlates with network rubbery moduli, while fixed-strain recovery under isothermal conditions shows a complex evolution for varying T, The results are intended to help aid in future shape-memory device design and the MMA-co-PEGDMA network is presented as a possible high strength shape-memory biomaterial.
C1 [Yakacki, Christopher M.; Sassaman, Katie; Gall, Ken] MedShape Solut Inc, Res & Dev, Atlanta, GA 30318 USA.
   [Yakacki, Christopher M.; Safranski, David; Sassaman, Katie; Gall, Ken] Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA.
   [Shandas, Robin; Ortega, Alicia M.] Univ Colorado, Dept Mech Engn, Boulder, CO 80309 USA.
   [Gall, Ken] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
RP Yakacki, CM (reprint author), MedShape Solut Inc, Res & Dev, Atlanta, GA 30318 USA.
EM chris@medshapesolutions.com
OI Shandas, Robin/0000-0002-9473-7542
FU NIH [HL 067393, EB 004481]; NIAMS/NIH [F31AR053466]
FX This work was supported by NIH grants HL 067393 and EB 004481 The
   authors would like to thank Michael Lyons for his help and contributions
   to this work. A. M. Ortega is thankful for the financial support by the
   NIAMS/NIH F31AR053466.
CR Alteheld A, 2005, ANGEW CHEM INT EDIT, V44, P1188, DOI 10.1002/anie.200461360
   Baer G, 2007, J APPL POLYM SCI, V103, P3882, DOI 10.1002/app.25567
   Baer G, 2006, J INVEST MED, V54, pS162
   Baroli B, 2006, J CHEM TECHNOL BIOT, V81, P491, DOI 10.1002/jctb.1468
   Behl M, 2007, SOFT MATTER, V3, P58, DOI 10.1039/b610611k
   Behl M, 2007, MATER TODAY, V10, P20, DOI 10.1016/S1369-7021(07)70047-0
   Buckley PR, 2006, IEEE T BIO-MED ENG, V53, P2075, DOI 10.1109/TBME.2006.877113
   El Feninat F, 2002, ADV ENG MATER, V4, P91, DOI 10.1002/1527-2648(200203)4:3<91::AID-ADEM91>3.0.CO;2-B
   Frimpong RA, 2007, J BIOMED MATER RES A, V80A, P1, DOI 10.1002/jbm.a.30962
   Gall K, 2005, J BIOMED MATER RES A, V73A, P339, DOI 10.1002/jbm.a.30296
   HAYASHI S, 1995, PLAST ENG, V51, P29
   Kim BK, 1996, POLYMER, V37, P5781, DOI 10.1016/S0032-3861(96)00442-9
   Koerner H, 2004, NAT MATER, V3, P115, DOI 10.1038/nmat1059
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Lendlein A, 2002, ANGEW CHEM INT EDIT, V41, P2034, DOI 10.1002/1521-3773(20020617)41:12<2034::AID-ANIE2034>3.0.CO;2-M
   Lendlein A, 2005, CLIN HEMORHEOL MICRO, V32, P105
   Lendlein A, 2005, NATURE, V434, P879, DOI 10.1038/nature03496
   Liang C, 1997, J INTEL MAT SYST STR, V8, P380, DOI 10.1177/1045389X9700800411
   Liu C, 2007, J MATER CHEM, V17, P1543, DOI 10.1039/b615954k
   Liu C, 2002, J APPL MED POLYM, V6, P47
   Liu YP, 2006, INT J PLASTICITY, V22, P279, DOI 10.1016/j.ijplas.2005.03.004
   Liu YP, 2003, SMART MATER STRUCT, V12, P947, DOI 10.1088/0964-1726/12/6/012
   Maitland DJ, 2002, LASER SURG MED, V30, P1
   Metcalfe A, 2003, BIOMATERIALS, V24, P491, DOI 10.1016/S0142-9612(02)00362-9
   Metzger MF, 2002, BIOMED MICRODEVICES, V4, P89, DOI 10.1023/A:1014674912979
   Mohr R, 2006, P NATL ACAD SCI USA, V103, P3540, DOI 10.1073/pnas.0600079103
   Passy S., 2003, INT J COSMETIC SURG, V5, P193
   Ping P, 2007, J POLYM SCI POL PHYS, V45, P557, DOI 10.1002/polb.20974
   Shmulewitz A, 2006, NAT BIOTECHNOL, V24, P277, DOI 10.1038/nbt0306-277a
   Small W, 2005, OPT EXPRESS, V13, P8204, DOI 10.1364/OPEX.13.008204
   Tobushi H, 1996, SMART MATER STRUCT, V5, P483, DOI 10.1088/0964-1726/5/4/012
   Vallo CI, 2000, POLYM INT, V49, P831, DOI 10.1002/1097-0126(200008)49:8<831::AID-PI462>3.0.CO;2-3
   Wache HM, 2003, J MATER SCI-MATER M, V14, P109, DOI 10.1023/A:1022007510352
   Wang WS, 2006, EUR POLYM J, V42, P1240, DOI 10.1016/j.eurpolymj.2005.11.029
   Wei ZG, 1998, J MATER SCI, V33, P3743, DOI 10.1023/A:1004692329247
   Yakacki CM, 2007, BIOMATERIALS, V28, P2255, DOI 10.1016/j.biomaterials.2007.01.030
NR 36
TC 193
Z9 195
U1 7
U2 141
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-301X
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD AUG 22
PY 2008
VL 18
IS 16
BP 2428
EP 2435
DI 10.1002/adfm.200701049
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 343ED
UT WOS:000258834600018
PM 19633727
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Moroni, L
   Hamann, D
   Paoluzzi, L
   Pieper, J
   de Wijn, JR
   van Blitterswijk, CA
AF Moroni, Lorenzo
   Hamann, Doreen
   Paoluzzi, Luca
   Pieper, Jeroen
   de Wijn, Joost R.
   van Blitterswijk, Clemens A.
TI Regenerating Articular Tissue by Converging Technologies
SO PLOS ONE
LA English
DT Article
AB Scaffolds for osteochondral tissue engineering should provide mechanical stability, while offering specific signals for chondral and bone regeneration with a completely interconnected porous network for cell migration, attachment, and proliferation. Composites of polymers and ceramics are often considered to satisfy these requirements. As such methods largely rely on interfacial bonding between the ceramic and polymer phase, they may often compromise the use of the interface as an instrument to direct cell fate. Alternatively, here, we have designed hybrid 3D scaffolds using a novel concept based on biomaterial assembly, thereby omitting the drawbacks of interfacial bonding. Rapid prototyped ceramic particles were integrated into the pores of polymeric 3D fiber-deposited (3DF) matrices and infused with demineralized bone matrix (DBM) to obtain constructs that display the mechanical robustness of ceramics and the flexibility of polymers, mimicking bone tissue properties. Ostechondral scaffolds were then fabricated by directly depositing a 3DF structure optimized for cartilage regeneration adjacent to the bone scaffold. Stem cell seeded scaffolds regenerated both cartilage and bone in vivo.
C1 [Moroni, Lorenzo; Hamann, Doreen; de Wijn, Joost R.; van Blitterswijk, Clemens A.] Univ Twente, BMTI, NL-7500 AE Enschede, Netherlands.
   [Paoluzzi, Luca] Univ Politecn Marche, Mech Engn Inst, Ancona, Italy.
   [Pieper, Jeroen] Isotis OrthoBiologics SA, Irvine, CA USA.
   [Moroni, Lorenzo] MuscoloSkeletal Cell & Tissue Bank, Rizzoli Orthopaed Inst, Bologna, Italy.
RP Moroni, L (reprint author), Univ Twente, BMTI, POB 217, NL-7500 AE Enschede, Netherlands.
EM lmoroni@gmail.com
RI Moroni, Lorenzo/D-2826-2014
OI Moroni, Lorenzo/0000-0003-1298-6025; Paoluzzi, Luca/0000-0002-2656-5224;
   van Blitterswijk, Clemens/0000-0003-2371-4615
FU European Community project Intelliscaf [GSRD_2002_00697]
FX This project was funded by the European Community project Intelliscaf
   GSRD_2002_00697.
CR Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802
   Athanasiou KA, 2000, TISSUE ENG, V6, P361, DOI 10.1089/107632700418083
   BAKKER D, 1988, BIOMATERIALS, V9, P14, DOI 10.1016/0142-9612(88)90064-6
   Barry JJA, 2004, BIOMATERIALS, V25, P3559, DOI 10.1016/j.biomaterials.2003.10.023
   BEUMER GJ, 1994, BIOMATERIALS, V15, P551, DOI 10.1016/0142-9612(94)90022-1
   BEUMER GJ, 1994, J BIOMED MATER RES, V28, P545, DOI 10.1002/jbm.820280504
   Bezemer JM, 1999, J CONTROL RELEASE, V62, P393, DOI 10.1016/S0168-3659(99)00170-4
   Bulstra SK, 1996, J BONE JOINT SURG BR, V78B, P892, DOI 10.1302/0301-620X78B6.6806
   Chakkalakal DA, 2001, TISSUE ENG, V7, P161, DOI 10.1089/107632701300062778
   Daculsi G, 2003, J MATER SCI-MATER M, V14, P195, DOI 10.1023/A:1022842404495
   Demarteau O, 2003, BIOCHEM BIOPH RES CO, V310, P580, DOI 10.1016/j.bbrc.2003.09.099
   Deschamps AA, 2002, J CONTROL RELEASE, V78, P175, DOI 10.1016/S0168-3659(01)00497-7
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   Guldberg V. M., 1992, BONE IMPLANT GRAFTIN, P9
   Habibovic P, 2006, J BIOMED MATER RES A, V77A, P747, DOI 10.1002/jbm.a.30712
   Habibovic P, 2005, BIOMATERIALS, V26, P3565, DOI 10.1016/j.biomaterials.2004.09.056
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Huang Q, 2002, TISSUE ENG, V8, P469, DOI 10.1089/107632702760184727
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Kaito T, 2005, BIOMATERIALS, V26, P73, DOI 10.1016/j.biomaterials.2004.02.010
   Kay S, 2002, TISSUE ENG, V8, P753, DOI 10.1089/10763270260424114
   Kramer J, 2000, MECH DEVELOP, V92, P193, DOI 10.1016/S0925-4773(99)00339-1
   Kruyt MC, 2003, TISSUE ENG, V9, P327, DOI 10.1089/107632703764664792
   Laurencin CT, 1999, ANNU REV BIOMED ENG, V1, P19, DOI 10.1146/annurev.bioeng.1.1.19
   Malda J, 2005, BIOMATERIALS, V26, P63, DOI 10.1016/j.biomaterials.2004.02.046
   MARTIN I, 2006, J BIOMECH
   Mastrogiacomo M, 2006, BIOMATERIALS, V27, P3230, DOI 10.1016/j.biomaterials.2006.01.031
   Mauney JR, 2005, BIOMATERIALS, V26, P3173, DOI 10.1016/j.biomaterials.2004.08.020
   Mensik I., 2002, Cell and Tissue Banking, V3, P245, DOI 10.1023/A:1024674325253
   Moroni L, 2007, TISSUE ENG, V13, P361, DOI 10.1089/ten.2006.0127
   Moroni L, 2006, BIOMATERIALS, V27, P974, DOI 10.1016/j.biomaterials.2005.07.023
   Moroni L, 2006, J BIOMED MATER RES A, V78A, P605, DOI 10.1002/jbm.a.30716
   Moroni L, 2005, J BIOMED MATER RES A, V75A, P957, DOI 10.1002/jbm.a.30499
   Murphy CL, 2001, CONNECT TISSUE RES, V42, P87, DOI 10.3109/03008200109014251
   Peterson B, 2004, J BONE JOINT SURG AM, V86A, P2243, DOI 10.2106/00004623-200410000-00016
   REDDI AH, 1981, COLLAGEN REL RES, V1, P209
   Reuss A, 1929, Z ANGEW MATH MECH, V9, P49, DOI 10.1002/zamm.19290090104
   Rice JM, 2003, CALCIFIED TISSUE INT, V72, P726, DOI 10.1007/s00223-002-2045-y
   Schek R M, 2005, Orthod Craniofac Res, V8, P313, DOI 10.1111/j.1601-6343.2005.00354.x
   Shao XX, 2006, TISSUE ENG, V12, P1539, DOI 10.1089/ten.2006.12.1539
   Shao XX, 2006, BIOMATERIALS, V27, P1071, DOI 10.1016/j.biomaterials.2005.07.040
   Sherwood JK, 2002, BIOMATERIALS, V23, P4739, DOI 10.1016/S0142-9612(02)00223-5
   URIST MR, 1983, SCIENCE, V220, P680, DOI 10.1126/science.6403986
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   VONDERMARK K, 1979, CLIN ORTHOP RELAT R, P185
   Wang DW, 2005, J CELL PHYSIOL, V204, P184, DOI 10.1002/jcp.20324
   Wilson CE, 2006, BIOMATERIALS, V27, P302, DOI 10.1016/j.biomaterials.2005.06.041
   Woodfield TBF, 2006, BIOMATERIALS, V27, P1043, DOI 10.1016/j.biomaterials.2005.07.032
   Woodfield TBF, 2004, BIOMATERIALS, V25, P4149, DOI 10.1016/j.biomaterials.2003.10.056
   Yuan HP, 1998, J MATER SCI-MATER M, V9, P723, DOI 10.1023/A:1008950902047
   Zein I, 2002, BIOMATERIALS, V23, P1169, DOI 10.1016/S0142-9612(01)00232-0
NR 51
TC 16
Z9 16
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 21
PY 2008
VL 3
IS 8
AR e3032
DI 10.1371/journal.pone.0003032
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 422KO
UT WOS:000264426800009
PM 18716660
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Deng, M
   Chen, G
   Cichocki, F
   Burkley, D
   Zhou, J
   Vetrecin, R
AF Deng, Meng
   Chen, Gavin
   Cichocki, Frank
   Burkley, Daniel
   Zhou, Jack
   Vetrecin, Robert
TI POLY 279-Effects of physical form on in vitro degradation of an
   absorbable biomaterial made from poly(glycolide-co-lactide)
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 236th National Meeting of the American-Chemical-Society
CY AUG 17-21, 2008
CL Philadelphia, PA
SP Amer Chem Soc
C1 [Deng, Meng; Chen, Gavin; Cichocki, Frank; Burkley, Daniel; Zhou, Jack; Vetrecin, Robert] Ethicon, Somerville, NJ 08876 USA.
EM mdeng@ethus.jnj.com
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 17
PY 2008
VL 236
MA 279-POLY
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA 499WD
UT WOS:000270256308060
DA 2018-10-19
ER

PT J
AU Raines, RT
AF Raines, Ronald T.
TI FLUO 18-Fluorinated collagen as a biomaterial and in nanotechnology
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 236th National Meeting of the American-Chemical-Society
CY AUG 17-21, 2008
CL Philadelphia, PA
SP Amer Chem Soc
C1 [Raines, Ronald T.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.
   [Raines, Ronald T.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA.
EM rtraines@wisc.edu
RI Raines, Ronald/A-5009-2013
OI Raines, Ronald/0000-0001-7164-1719
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 17
PY 2008
VL 236
MA 18-FLUO
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA 499WD
UT WOS:000270256304588
DA 2018-10-19
ER

PT J
AU Mandal, BB
   Kundu, SC
AF Mandal, Biman B.
   Kundu, Subhas C.
TI Non-bioengineered silk gland fibroin protein: Characterization and
   evaluation of matrices for potential tissue engineering applications
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE non-mulberry silk; gland fibroin; sodium dodecyl sulfate; cell culture
ID TROPICAL TASAR SILKWORM; SODIUM DODECYL-SULFATE; MESENCHYMAL STEM-CELLS;
   ANTHERAEA-MYLITTA; IN-VITRO; MOLECULAR PHYLOGENY; CIRCULAR-DICHROISM;
   BETA-GALACTOSIDASE; MEMBRANE-PROTEINS; BONE-MARROW
AB The possibility of using wild non-mulberry silk protein as a biopolymer remains unexplored compared to domesticated mulberry silk protein. One of the main reasons for this was for not having any suitable method of extraction of silk protein fibroin from cocoons and silk glands. In this study non-bioengineered non-mulberry silk gland fibroin protein from tropical tasar silkworm Antheraca mylitta, is regenerated and characterized using 1% (w/v) sodium dodecyl sulfate (SDS). The new technique is important and unique because it uses a mild surfactant for fibroin dissolution and is advantageous over other previous reported techniques using chaotropic salts. Fabricated fibroin films are smooth as confirmed by atomic force microscopy. Circular dichroism spectrometry along with Fourier transformed infrared spectroscopy and X-ray diffraction reveal random coil/alpha-helix conformations in regenerated fibroin which transform to P-sheets, resulting in crystalline structure and protein insolubility through ethanol treatment. Differential scanning calorimetry shows an increase in glass transition (Tg) temperature and enhanced degradation temperature on alcohol treatment. Enhanced cell attachment and viability of AH927 feline fibroblasts were observed on fibroin matrices. Higher mechanical strength along with controllable water stability of regenerated gland fibroin films make non-mulberry Indian tropical tasar silk gland fibroin protein a promising biomaterial for tissue engineering applications.
C1 [Mandal, Biman B.; Kundu, Subhas C.] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
RP Kundu, SC (reprint author), Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
EM kundu@hijli.iitkgp.ernet.in
OI Kundu, Subhas C./0000-0002-7170-2291
CR ACHARYA C, 2007, BIOTECHNOL J, V3, P226
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   ARAND M, 1992, ANAL BIOCHEM, V207, P73, DOI 10.1016/0003-2697(92)90502-X
   ASAKURA T, 1985, MACROMOLECULES, V18, P1841, DOI 10.1021/ma00152a009
   Bondar B, 2008, BIOMATERIALS, V29, P561, DOI 10.1016/j.biomaterials.2007.10.002
   BUNNING TJ, 1994, ACS S SERIES, V544
   Cooper LF, 1998, INT J ORAL MAX IMPL, V13, P163
   D'Auria S, 2001, J BIOCHEM-TOKYO, V130, P13, DOI 10.1093/oxfordjournals.jbchem.a002951
   Dash R, 2006, INT J BIOL MACROMOL, V38, P255, DOI 10.1016/j.ijbiomac.2006.03.001
   DASH R, BIOCH MOL B IN PRESS
   Dash R, 2007, COMP BIOCHEM PHYS B, V147, P129, DOI 10.1016/j.cbpb.2007.01.009
   DUTTA A, 2001, COMP BIOCH PHYSL B, V129, P197
   Gil ES, 2006, BIOMACROMOLECULES, V7, P728, DOI 10.1021/bm050622i
   Ha SW, 2003, BIOMACROMOLECULES, V4, P488, DOI 10.1021/bm0255948
   IIZUKA E, 1985, J APPL POLYM SCI APP, V41, P173
   KAPLAN DL, 1998, PROTEIN BASED MAT, P103
   Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013
   Kim HJ, 2007, MACROMOL BIOSCI, V7, P643, DOI 10.1002/mabi.200700030
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kundu S.C., 2001, INSECT BIOCHEM MOLEC, V31, P1013, DOI DOI 10.1016/S0965-1748(01)00049-2
   Kweon HY, 2000, POLYMER, V41, P7361, DOI 10.1016/S0032-3861(00)00100-2
   Lange F, 1907, MONCH MED WOCHENSCHR, V52, P834
   Lange F, 1903, VERH DTSCH ORTHOP GE, V2, P10
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   Li MZ, 2003, POLYM ADVAN TECHNOL, V14, P694, DOI 10.1002/pat.409
   Li MZ, 2003, INT J BIOL MACROMOL, V32, P159, DOI 10.1016/S0141-8130(03)00049-7
   Ludloff K., 1927, ZENTRALBL CHIR, V54, P3162
   MAGOSHI J, 1981, J POLYM SCI POL PHYS, V19, P185, DOI 10.1002/pol.1981.180190117
   MAGOSHI J, 1985, J APPL POLYM SCI APP, V41, P187
   Magoshi J., 1996, POLYM MAT ENCY, V1, P667
   Mahendran B, 2006, J GENET, V85, P31, DOI 10.1007/BF02728967
   Mahendran B, 2006, GENE, V370, P51, DOI 10.1016/j.gene.2005.11.010
   Mahendran B, 2006, J BIOCHEM MOL BIOL, V39, P522
   Mandal BB, 2008, BIOTECHNOL BIOENG, V99, P1482, DOI 10.1002/bit.21699
   Mathur AB, 1997, BIOPOLYMERS, V42, P61, DOI 10.1002/(SICI)1097-0282(199707)42:1<61::AID-BIP6>3.0.CO;2-#
   Mauney JR, 2007, BIOMATERIALS, V28, P5280, DOI 10.1016/j.biomaterials.2007.08.017
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Meinel L, 2004, BIOTECHNOL BIOENG, V88, P379, DOI 10.1002/bit.20252
   MINGZHONG L, 1999, J APPL POLYM SCI, V79, P2185
   MINOURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511, DOI 10.1006/bbrc.1995.1368
   MIYAZAWA T, 1961, J AM CHEM SOC, V83, P712, DOI 10.1021/ja01464a042
   MOY RL, 1991, AM FAM PHYSICIAN, V44, P2123
   MUGA A, 1993, ARCH BIOCHEM BIOPHYS, V300, P451, DOI 10.1006/abbi.1993.1061
   Qiang L, 2004, J MATER SCI-MATER M, V15, P1193, DOI 10.1007/s10856-004-5918-y
   Saha M, 2006, BIOCHEM GENET, V44, P72, DOI 10.1007/s10528-006-9007-4
   Sikavitsas VI, 2001, BIOMATERIALS, V22, P2581, DOI 10.1016/S0142-9612(01)00002-3
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Tamada Y, 2005, BIOMACROMOLECULES, V6, P3100, DOI 10.1021/bm050431f
   TANFORD C, 1976, BIOCHIM BIOPHYS ACTA, V457, P133, DOI 10.1016/0304-4157(76)90009-5
   Tao W, 2007, INT J BIOL MACROMOL, V40, P472, DOI 10.1016/j.ijbiomac.2006.11.006
   Trabbic KA, 1998, MACROMOLECULES, V31, P462, DOI 10.1021/ma9708860
   TSUKADA M, 1994, J POLYM SCI POL PHYS, V32, P1407, DOI 10.1002/polb.1994.090320812
   TSUKADA M, 1994, J APPL POLYM SCI, V54, P507, DOI 10.1002/app.1994.070540411
   Unger RE, 2004, BIOMATERIALS, V25, P1069, DOI [10.1016/S0142-9612(03)00619-7, 10.1016/S0142-9612(03)00630-6]
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Vepari CP, 2006, BIOTECHNOL BIOENG, V93, P1130, DOI 10.1002/bit.20833
   Wallace BA, 2003, PROTEIN SCI, V12, P875, DOI 10.1110/ps.0229603
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   Wang YZ, 2005, BIOMATERIALS, V26, P7082, DOI 10.1016/j.biomaterials.2005.05.022
   YANG JT, 1986, METHOD ENZYMOL, V130, P208
NR 61
TC 72
Z9 72
U1 3
U2 31
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0006-3592
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD AUG 15
PY 2008
VL 100
IS 6
BP 1237
EP 1250
DI 10.1002/bit.21835
PG 14
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 330UL
UT WOS:000257968200019
PM 18383269
DA 2018-10-19
ER

PT J
AU Idibie, AC
   Iyuke, ES
AF Idibie, A. Christopher
   Iyuke, E. Sunny
TI Thermodynamics study of linamarin sorption during its isolation from
   cassava
SO COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS
LA English
DT Article
DE cassava; linamarin; adsorption isotherm; activated carbon; thermodynamic
ID CYANIDE
AB Linamarin is an important biomaterial. The removal of linamarin from aqueous solutions at different contact times, temperatures and initial concentration of crude cassava extract during its isolation using activated carbon was investigated. The extent of linamarin removal increases with increase in initial concentration of extract, contact time and temperature of the solution. The adsorption isotherm is described by means of composite isotherm where U-shaped isotherm was observed. The mole of linamarin adsorbed per pore volume of activated carbon (n(1)(s)) at different temperatures (298, 303, 318, 328, and 338 K) was almost equal (0.99, 1.00, 1.01, 1.00 and 1.00 g mol/cm(3)). The activation energy of the system (E.) was calculated as 22.61 kJ/mol. The free energy of the adsorption (Delta G degrees), enthalpy (Delta H degrees), and entropy (AS,) changes were calculated to predict the nature of adsorption. The estimated values of Delta G degrees at 298, 303, 318, 328, and 338 K were -2.45, 1.69, 1.80, 1.70, and 1.73 kJ/mol, respectively, which are relatively high except at 298 K, indicating endothermic and non-spontaneous process. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Idibie, A. Christopher; Iyuke, E. Sunny] Univ Witwatersrand, Sch Chem & Met Engn, Fac Engn, ZA-2050 Wits, Johannesburg, South Africa.
RP Idibie, AC (reprint author), Univ Witwatersrand, Sch Chem & Met Engn, Fac Engn, P Bag 3, ZA-2050 Wits, Johannesburg, South Africa.
EM krisid2007@yahoo.com
FU H.E. Griffin Cancer Trust Foundation
FX The authors wish to acknowledge the H.E. Griffin Cancer Trust Foundation
   for funding this project. We also wish to attest to the immerse support
   extended to us by Prof. Neuse in the School of polymer chemistry, Wits
   University and Dr. Hajierah Davids of the medical school of Wits
   University.
CR ATSDR, 1997, TOX PROF CYAN
   ATSDR, 2006, TOX PROF CYAN
   BRADBURY JH, 1991, J SCI FOOD AGR, V55, P277, DOI 10.1002/jsfa.2740550213
   COOKE RD, 1978, J SCI FOOD AGR, V29, P345, DOI 10.1002/jsfa.2740290408
   Idibie CA, 2007, BIOPROC BIOSYST ENG, V30, P261, DOI 10.1007/s00449-007-0122-3
   ILZA AF, 2000, BRAZ ARCH BIOL TECHN, V43, P2
   Iyuke SE, 2007, IND ENG CHEM RES, V46, P4974, DOI 10.1021/ie061512a
   Kipling J.J., 1965, ADSORPTION SOLUTION
   MANTEL CL, 1951, ADSORPTION
   MICHEAL H, 2005, ELECTRON J BIOTECHN, V8, P1
   SEIGLER DS, 1975, PHYTOCHEMISTRY, V14, P9, DOI 10.1016/0031-9422(75)85001-1
   TREBAL RE, 1981, MASS TRANSFER OPERAT
   YASEMIN B, 2006, DESALINATION, V194, P257
   Yeoh HH, 1998, TRAC-TREND ANAL CHEM, V17, P234, DOI 10.1016/S0165-9936(98)00009-0
NR 14
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7757
J9 COLLOID SURFACE A
JI Colloid Surf. A-Physicochem. Eng. Asp.
PD AUG 15
PY 2008
VL 326
IS 1-2
BP 18
EP 22
DI 10.1016/j.colsurfa.2008.05.005
PG 5
WC Chemistry, Physical
SC Chemistry
GA 352UO
UT WOS:000259523100003
DA 2018-10-19
ER

PT J
AU Cui, W
   Hu, QL
   Wu, J
   Li, BQ
   Shen, JC
AF Cui, Wei
   Hu, Qiaoling
   Wu, Jia
   Li, Baoqiang
   Shen, Jiacong
TI Preparation and characterization of magnetite/hydroxyapatite/chitosan
   nanocomposite by in situ compositing method
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE chitosan; magnetism; hydroxyapatite; nanocomposite; in situ compositing;
   magnetic polymers; nanotechnology
ID CHITOSAN; BONE; HYDROXYAPATITE; NANOCRYSTALS; PARTICLES; GELATIN; GROWTH
AB Chitosan is an important kind of biomaterial that is widely used in medical applications. One of the key concerns about its use is the preparation of composites used for bone engineering. Aim of this study concerns the preparation of three-dimensional nanocomposites having potential use in bone repair and regeneration. The magnetite/hydroxyapatite/chitosan nanocomposites were prepared via in situ compositing method by preparing precursor solutions and molds with chitosan membrane. These nanocomposites were characterized by chemical, spectroscopic, magnetic, and morphological methods. X-ray diffraction analysis results demonstrate the formation of magnetite and hydroxyapatite in the chitosan matrix. FTIR analysis indicates that inorganic nanoparticles were chemically bound to the amino and hydroxyl groups in CS molecules. From TG/DTA data, it can be concluded that during preparation raw materials were almost perfectly incorporated into the nanocomposites, and the decrease in decomposition temperatures indicates the formation of chemical bonds between inorganic nanoparticles and chitosan molecules. TEM results show that the maximum size of inorganic particles in the magnetite /hydroxyapatite/chitosan nanocomposites was under 50 nm, and these particles were dispersed homogeneously in the chitosan matrix. From the magnetic measurement, it could be concluded that the nanocomposites were superparamagnetic, which is also the peculiarity of nanomagnetites. (c) 2008 Wiley Periodicals, Inc.
C1 [Cui, Wei; Hu, Qiaoling; Wu, Jia; Li, Baoqiang; Shen, Jiacong] Zhejiang Univ, Inst Polymer Composites, Hangzhou 310027, Peoples R China.
RP Hu, QL (reprint author), Zhejiang Univ, Inst Polymer Composites, Hangzhou 310027, Peoples R China.
EM huql@zju.edu.cn
RI Li, Baoqiang/J-4526-2012
OI Li, Baoqiang/0000-0003-0278-4542
CR AJAY KG, 2005, BIOMATERIALS, V26, P3995
   ANDREW CA, 1997, J BIOMED MATER RES, V38, P235
   Baibekov IM, 2001, B EXP BIOL MED+, V131, P399, DOI 10.1023/A:1017933026086
   Bhatia SC, 2000, BIOMACROMOLECULES, V1, P413, DOI 10.1021/bm0002959
   Bigi A, 2002, J BIOMED MATER RES, V59, P709, DOI 10.1002/jbm.10045
   Hu QL, 2004, BIOMATERIALS, V25, P779, DOI 10.1016/S0142-9612(03)00582-9
   INOUE K, 1997, J ION EXCHANGE, V8, P115
   Ito M, 1999, J BIOMED MATER RES, V45, P204, DOI 10.1002/(SICI)1097-4636(19990605)45:3<204::AID-JBM7>3.0.CO;2-4
   Lee DK, 2002, J PHYS CHEM B, V106, P7267, DOI 10.1021/jp014446t
   Lee J, 1996, J COLLOID INTERF SCI, V177, P490, DOI 10.1006/jcis.1996.0062
   Markaki AE, 2004, BIOMATERIALS, V25, P4805, DOI 10.1016/j.biomaterials.2003.11.041
   Murugan R, 2004, BIOMATERIALS, V25, P3829, DOI 10.1016/j.biomaterials.2003.10.016
   Muzzarelli C, 2002, J INORG BIOCHEM, V92, P89, DOI 10.1016/S0162-0134(02)00486-5
   Oswald P, 1997, MAGN RESON IMAGING, V15, P1025, DOI 10.1016/S0730-725X(97)00004-0
   Pawlak A, 2003, THERMOCHIM ACTA, V396, P153, DOI 10.1016/S0040-6031(02)00523-3
   Prashanth KVH, 2002, CARBOHYD POLYM, V50, P27
   RAMAZAN A, 2005, J MAGNETISM MAGNETIC, V292, P108
   RAMESH S, 2001, MALAYS J CHEM, V3, P35
   Rhee SH, 2001, BIOMATERIALS, V22, P2843, DOI 10.1016/S0142-9612(01)00028-X
   Saraswathy G, 2001, B MATER SCI, V24, P415, DOI 10.1007/BF02708641
   Saravanan P, 2003, J MATER SCI LETT, V22, P1283, DOI 10.1023/A:1025470405000
   SUBHASH C, 2003, BIOMACROMOLECULES, V4, P723
   Takegami K, 1998, J BIOMED MATER RES, V43, P210, DOI 10.1002/(SICI)1097-4636(199822)43:2<210::AID-JBM16>3.0.CO;2-L
   Wang M, 1998, BIOMATERIALS, V19, P2357, DOI 10.1016/S0142-9612(98)00154-9
   WHITE LR, 1982, J COLLOID INTERF SCI, V90, P536, DOI 10.1016/0021-9797(82)90319-8
   Yamaguchi I, 2001, J BIOMED MATER RES, V55, P20, DOI 10.1002/1097-4636(200104)55:1<20::AID-JBM30>3.3.CO;2-6
NR 26
TC 13
Z9 14
U1 3
U2 43
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-8995
EI 1097-4628
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD AUG 15
PY 2008
VL 109
IS 4
BP 2081
EP 2088
DI 10.1002/app.28013
PG 8
WC Polymer Science
SC Polymer Science
GA 314ZK
UT WOS:000256847500004
DA 2018-10-19
ER

PT J
AU Rodrigues, AP
   Sanchez, EMS
   da Costa, AC
   Moraes, AM
AF Rodrigues, Ana Paula
   Saraiva Sanchez, Elisabete Maria
   da Costa, Aline Carvalho
   Moraes, Angela Maria
TI The influence of preparation conditions on the characteristics of
   chitosan-alginate dressings for skin lesions
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE membranes; biomaterials; polyelectrolytes; hydrogels; mechanical
   properties; chitosan; alginate; wound dressing; coacervates
ID MECHANICAL-PROPERTIES; WOUND DRESSINGS; MEMBRANES; FABRICATION; FILMS
AB In this work, the preparation and characterization of membranes obtained through chitosan and alginate coacervation and designed for use as wound dressings were evaluated. The influence of different stirring rates and rates of addition of chitosan solution to alginate solution on the final characteristics of the biomaterial was analyzed in detail, aiming at a simple and easily scalable membrane production protocol. The results show that membranes with dry thickness from 66 to 80 pm, wet thickness from 106 to 633 mu m, tensile strength varying from 6.86 to 31.14 MPa, elongation at break from 3.97 to 8.42%, and maximum water uptake up to 19 g of water per gram of membrane and that are able to prevent the permeation of bacteria can be obtained in a fairly reproducible way by the procedure established. The membranes prepared at flow ratio of 40 mL/h and stirring equal to 100 rpm showed a high potential for use on highly exuding wounds. (c) 2008 Wiley Periodicals, Inc.
C1 [Rodrigues, Ana Paula; Moraes, Angela Maria] Univ Estadual Campinas, Dept Biotechnol Proc, Sch Chem Engn, BR-13083970 Campinas, SP, Brazil.
   [Saraiva Sanchez, Elisabete Maria] Univ Estadual Campinas, Dept Mat Engn, Sch Mech Engn, BR-13083970 Campinas, SP, Brazil.
   [da Costa, Aline Carvalho] Univ Estadual Campinas, Dept Chem Proc, Sch Chem Engn, BR-13083970 Campinas, SP, Brazil.
RP Moraes, AM (reprint author), Univ Estadual Campinas, Dept Biotechnol Proc, Sch Chem Engn, BR-13083970 Campinas, SP, Brazil.
EM ammoraes@feq.unicamp.br
RI Costa, Aline/E-5931-2011; Moraes, Angela/K-5181-2012
OI Costa, Aline/0000-0002-4586-6882; Moraes, Angela/0000-0002-5813-332X
CR Balasubramani M, 2001, BURNS, V27, P534, DOI 10.1016/S0305-4179(01)00018-3
   BEHAR D, 1986, J BIOMED MATER RES, V20, P731, DOI 10.1002/jbm.820200607
   Hansen B, 2002, ARCH DERMATOL, V138, P909, DOI 10.1001/archderm.138.7.909
   Hoffman A. S., 2002, ADV DRUG DELIVERY RE, V43, P3, DOI DOI 10.1016/S0169-409X(01)00239-3
   Khan TA, 2000, J PHARM PHARM SCI, V3, P303
   Knill CJ, 2004, CARBOHYD POLYM, V55, P65, DOI 10.1016/j.carbpol.2003.08.004
   Lai HL, 2003, INT J PHARM, V251, P175, DOI 10.1016/S0378-5173(02)00590-2
   Loke WK, 2000, J BIOMED MATER RES, V53, P8
   Ma JB, 2001, BIOMATERIALS, V22, P331, DOI 10.1016/S0142-9612(00)00188-5
   Mao JS, 2003, BIOMATERIALS, V24, P1621, DOI 10.1016/S0142-9612(02)00549-5
   Marreco PR, 2004, J BIOMED MATER RES B, V71B, P268, DOI 10.1002/jbm.b.30081
   Mi FL, 2001, BIOMATERIALS, V22, P165, DOI 10.1016/S0142-9612(00)00167-8
   Mi FL, 2003, J MEMBRANE SCI, V212, P237, DOI 10.1016/S0376-7388(02)00505-7
   MUZZARELLI R, 1988, BIOMATERIALS, V9, P247, DOI 10.1016/0142-9612(88)90092-0
   PAUL W, 2004, BIOMATER ARTIF ORGAN, V18, P18
   Wang LH, 2001, J PHARM SCI-US, V90, P1134, DOI 10.1002/jps.1067
   Wang LH, 2002, J BIOMED MATER RES, V63, P610, DOI 10.1002/jbm.10382
   Yan XL, 2000, CHEM PHARM BULL, V48, P941
NR 18
TC 37
Z9 37
U1 0
U2 21
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD AUG 15
PY 2008
VL 109
IS 4
BP 2703
EP 2710
DI 10.1002/app.28203
PG 8
WC Polymer Science
SC Polymer Science
GA 314ZK
UT WOS:000256847500078
DA 2018-10-19
ER

PT J
AU Wang, GC
   Liu, XY
   Ding, CX
AF Wang, Guocheng
   Liu, Xuanyong
   Ding, Chuanxian
TI Phase composition and in-vitro bioactivity of plasma sprayed calcia
   stabilized zirconia coatings
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE Phase composition; Plasma spraying; Zirconia coating; Bioactivity; SBF
ID SIMULATED BODY-FLUID; APATITE-FORMING ABILITY; Y-TZP; TRANSFORMATION;
   DEPOSITION; HYDROXYAPATITE; SPECTROSCOPY; POLYCRYSTALS; BIOMATERIAL;
   DEGRADATION
AB Zirconia coatings stabilized with different calcia content (12.8 mol%, 16 mol% and 30 mol%) were fabricated on titanium alloy substrates using atmospheric plasma spraying technology. The in-vitro bioactivity of coatings was evaluated by simulated body fluid (SBF) soaking test. The morphology and phase composition of the coatings were characterized by X-ray diffraction (XRD), scanning electron microscopy (SEM), micro Raman spectroscopy, energy dispersive spectrometry (EDS) and infrared spectroscopy (IR). The results showed that the apatite was formed on the surface of the calcia stabilized zirconia coatings soaked in SBF for 28 days and the formation ability of apatite decreased with the increase in calcia content of the coating. The bioactivity of zirconia coatings was thought to be related to the Zr-OH formed on their surfaces during the phase transformation in the presence of water. Osteoblast-like MG63 cells were Cultured on the surfaces of the coatings to evaluate their cytocompatibility. Results showed that MG63 Cell grew and proliferated well on all coating surfaces, indicating that plasma sprayed calcia stabilized ZrO2 coatings were cytocompatible. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Wang, Guocheng; Liu, Xuanyong; Ding, Chuanxian] Chinese Acad Sci, Shanghai Inst Ceram, Shanghai 200050, Peoples R China.
   [Wang, Guocheng] Chinese Acad Sci, Grad Sch, Beijing 100049, Peoples R China.
RP Liu, XY (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, Shanghai 200050, Peoples R China.
EM xyliu@mail.sic.ac.cn
RI Wang, Guocheng/P-7551-2014; Liu, Xuanyong/J-2609-2018
OI Wang, Guocheng/0000-0002-8235-4472; 
FU National Basic Research Fund [2005CB623901]; National Natural Science
   Foundation of China [30700170]; Shanghai Science and Technology RD Fund
   [07QH14016, 07JC14057]; Innovation Fund of SICCAS [SCX0606]
FX This work was jointly supported by National Basic Research Fund under
   grant 2005CB623901, National Natural Science Foundation of China
   30700170, Shanghai Science and Technology R&D Fund under grant 07QH14016
   and 07JC14057, Innovation Fund of SICCAS under grant SCX0606.
CR Ashok M, 2003, MATER LETT, V57, P2066, DOI 10.1016/S0167-577X(02)01140-0
   Castkova K, 2004, CERAM-SILIKATY, V48, P85
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Christel P, 1988, Ann N Y Acad Sci, V523, P234, DOI 10.1111/j.1749-6632.1988.tb38516.x
   Clarke IC, 2003, J BONE JOINT SURG AM, V85A, P73, DOI 10.2106/00004623-200300004-00009
   DUWEZ P, 1952, J AM CERAM SOC, V35, P107, DOI 10.1111/j.1151-2916.1952.tb13081.x
   GARVIE RC, 1972, J AM CERAM SOC, V55, P303, DOI 10.1111/j.1151-2916.1972.tb11290.x
   Helmer J. D., 1969, S US CER SURG IMPL C
   Hirst RA, 2002, INFECT IMMUN, V70, P1017, DOI 10.1128/IAI.70.2.1017-1022.2002
   Kim HM, 1997, J MATER SCI-MATER M, V8, P341, DOI 10.1023/A:1018524731409
   Kingery WD, 1976, INTRO CERAMICS
   KOBAYASHI K, 1981, SOLID STATE IONICS, V3-4, P489, DOI 10.1016/0167-2738(81)90138-7
   Kosmac T, 2007, INT J APPL CERAM TEC, V4, P164, DOI 10.1111/j.1744-7402.2007.02124.x
   LANGE FF, 1986, J AM CERAM SOC, V69, P237, DOI 10.1111/j.1151-2916.1986.tb07415.x
   LI PJ, 1992, J AM CERAM SOC, V75, P2094, DOI 10.1111/j.1151-2916.1992.tb04470.x
   Liu XY, 2006, BIOMATERIALS, V27, P3904, DOI 10.1016/j.biomaterials.2006.03.007
   Orera VM, 1998, J PHYS-CONDENS MAT, V10, P7501, DOI 10.1088/0953-8984/10/33/019
   PERRY CH, 1985, J AM CERAM SOC, V68, pC184
   PHILLIPPI CM, 1971, J AM CERAM SOC, V54, P254, DOI 10.1111/j.1151-2916.1971.tb12283.x
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   SATO T, 1985, AM CERAM SOC BULL, V64, P1382
   SATO T, 1985, J AM CERAM SOC, V68, P356, DOI 10.1111/j.1151-2916.1985.tb15239.x
   Scrivani A, 2002, KEY ENG MAT, V218-2, P515, DOI 10.4028/www.scientific.net/KEM.218-220.515
   TAMARI N, 1987, NIPPON SERAM KYO GAK, V95, P806
   Uchida M, 2002, J CERAM SOC JPN, V110, P710, DOI 10.2109/jcersj.110.710
   Uchida M, 2002, J BIOMED MATER RES, V60, P277, DOI 10.1002/jbm.10071
   Wang XX, 2001, J BIOMED MATER RES, V54, P172, DOI 10.1002/1097-4636(200102)54:2<172::AID-JBM3>3.0.CO;2-#
   Weng J, 1997, BIOMATERIALS, V18, P1027, DOI 10.1016/S0142-9612(97)00022-7
   Willmann G, 1996, BIOMATERIALS, V17, P2157, DOI 10.1016/0142-9612(96)00042-7
   WU JM, 1988, J MATER SCI, V23, P3771, DOI 10.1007/BF00540526
   Yan YY, 2007, SURF COAT TECH, V201, P5692, DOI 10.1016/j.surfcoat.2006.07.058
   Yang YZ, 2003, BIOMATERIALS, V24, P619, DOI 10.1016/S0142-9612(02)00376-9
   Yasuda K, 1997, J MATER SCI, V32, P6291, DOI 10.1023/A:1018649530154
   YOSHIMURA M, 1987, J MATER SCI LETT, V6, P465, DOI 10.1007/BF01756800
   YOSHIMURA M, 1987, J MATER SCI LETT, V6, P165
NR 35
TC 27
Z9 29
U1 1
U2 10
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD AUG 15
PY 2008
VL 202
IS 24
BP 5824
EP 5831
DI 10.1016/j.surfcoat.2008.06.109
PG 8
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 363KV
UT WOS:000260267100005
DA 2018-10-19
ER

PT J
AU Lao, J
   Jallot, E
   Nedelec, JM
AF Lao, Jonathan
   Jallot, Edouard
   Nedelec, Jean-Marie
TI Strontium-delivering glasses with enhanced bioactivity: A new
   biomaterial for antiosteoporotic applications?
SO CHEMISTRY OF MATERIALS
LA English
DT Article
ID SOL-GEL GLASSES; BONE; OSTEOPOROSIS; MAGNESIUM; SCAFFOLDS; RANELATE;
   45S5
AB Bioactive glasses exhibit great performances for bone tissue regeneration. In biological conditions, they spontaneously bond to bone tissues while actively stimulating bone growth. Crucial parameters for the material's bioactivity are the kinetics of formation of the interfacial calcium phosphate layer at the glass surface, as well as the release of critical concentrations of ionic dissolution products capable of stimulating cellular responses. In this paper we report the remarkable bioactivity properties of strontium-delivering sol-gel-derived glasses in the SiO(2)-CaO-SrO system. The glasses were tested in vitro and the interface between the glass and the biological medium was chemically mapped using highly sensitive nuclear microprobes. We prove the ability of our materials to form a phosphocalcic layer at their periphery with increased kinetics of reaction. Our key result is the demonstration that Sr-doped glasses can deliver controlled doses of strontium toward the biological medium. That is the determinant for bone tissue regeneration, as far as strontium is known to positively act on bone remodeling. Sr-delivering glasses could further represent an alternative to the constraining oral administration of strontium in treatment of osteoporosis.
C1 [Nedelec, Jean-Marie] Univ Clermont Ferrand, CNRS, Lab Mat Inorgan, UMR 6002, F-63177 Clermont Ferrand, France.
   [Lao, Jonathan; Jallot, Edouard] Univ Clermont Ferrand, Phys Corpusculaire Lab, CNRS IN2P3, UMR 6533, F-63177 Aubiere, France.
   [Nedelec, Jean-Marie] Ecole Natl Super Chim Clermont Fd, F-63177 Clermont Ferrand, France.
RP Nedelec, JM (reprint author), Univ Clermont Ferrand, CNRS, Lab Mat Inorgan, UMR 6002, F-63177 Clermont Ferrand, France.
EM j-marie.nedelec@univ-bpclermont.fr
RI NEDELEC, jean-marie/A-6920-2008
OI NEDELEC, jean-marie/0000-0002-8243-6849
CR Almoznino-Sarafian D, 2007, EUR J NUTR, V46, P230, DOI 10.1007/s00394-007-0655-x
   Dahl SG, 2001, BONE, V28, P446, DOI 10.1016/S8756-3282(01)00419-7
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   HENCH LL, 1990, CHEM REV, V90, P33, DOI 10.1021/cr00099a003
   HENCH LL, 1998, J AM CERAM SOC, V81, P511
   Jones JR, 2006, BIOMATERIALS, V27, P964, DOI 10.1016/j.biomaterials.2005.07.017
   Lao J, 2006, NUCL INSTRUM METH B, V245, P511, DOI 10.1016/j.nimb.2005.12.049
   Livingston T, 2002, J BIOMED MATER RES, V62, P1, DOI 10.1002/jbm.10157
   Marie PJ, 2005, CURR OPIN PHARMACOL, V5, P633, DOI 10.1016/j.coph.2005.05.005
   Meunier PJ, 2004, NEW ENGL J MED, V350, P459, DOI 10.1056/NEJMoa022436
   OHTSUKI C, 1992, J NON-CRYST SOLIDS, V143, P84, DOI 10.1016/S0022-3093(05)80556-3
   Ortolani S, 2006, BONE, V38, P19, DOI 10.1016/j.bone.2005.10.030
   Padilla S, 2007, J BIOMED MATER RES A, V81A, P224, DOI 10.1002/jbm.a.30934
   Radin S, 2005, J BIOMED MATER RES A, V73A, P21, DOI 10.1002/jbm.a.30241
   Rijkers Ger T., 1993, Magnesium Research, V6, P205
   Sepulveda P, 2002, J BIOMED MATER RES, V61, P301, DOI 10.1002/jbm.10207
   Vallet-Regi M, 2005, CHEM MATER, V17, P1874, DOI 10.1021/cm047956j
   WEGLICKI WB, 1992, MOL CELL BIOCHEM, V110, P169, DOI 10.1007/BF02454195
   Xue WC, 2006, J BIOMED MATER RES A, V79A, P804, DOI 10.1002/jbm.a.30815
   Yan HW, 2001, CHEM MATER, V13, P1374, DOI 10.1021/cm000895e
   Yli-Urpo H, 2005, DENT MATER, V21, P201, DOI 10.1016/j.dental.2004.03.006
   Yuan HP, 2001, J BIOMED MATER RES, V58, P270, DOI 10.1002/1097-4636(2001)58:3<270::AID-JBM1016>3.0.CO;2-2
NR 22
TC 67
Z9 68
U1 1
U2 28
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0897-4756
J9 CHEM MATER
JI Chem. Mat.
PD AUG 12
PY 2008
VL 20
IS 15
BP 4969
EP 4973
DI 10.1021/cm800993s
PG 5
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 334MI
UT WOS:000258225500024
DA 2018-10-19
ER

PT J
AU Silva, SS
   Maniglio, D
   Motta, A
   Mano, JF
   Reis, RL
   Migliaresi, C
AF Silva, Simone S.
   Maniglio, Devid
   Motta, Antonella
   Mano, Joao F.
   Reis, Rui L.
   Migliaresi, Claudio
TI Genipin-modified silk-fibroin nanometric nets
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE biofibers; electrospinning; genipin; modification; silk fibroin
ID BOMBYX-MORI SILK; TISSUE ENGINEERING APPLICATIONS; ELECTROSPINNING
   METHOD; POLY(ETHYLENE OXIDE); NANOFIBERS; CHITOSAN; BIOMATERIAL;
   STABILITY; CELLS
AB Nanometric silk-fibroin nets were fabricated by electrospinning from regenerated Bombyx mori silk-fibroin (SF)/formic acid solutions with the addition of genipin (GE), 2, 15 and 24 h after the solution preparation. After spinning, the pure fibroin nanofibers were water soluble and needed a further stabilization process, whereas the reaction of fibroin with genipin resulted in water-insoluble fibroin nets due to conformational changes induced in the fibroin by the genipin. SFGE nanofibers presented diameters ranging from 140 to 590 nm and were generally thinner than pure SF nanofibers. The secondary structure of SF into SFGE nanofibers showed the presence of beta-sheet conformation together with beta-turn intermediates (turns and bends). The approach described in this paper provides an alternative method of designing SF nanofibers that are already water insoluble, without any stability post-treatment needed.
C1 [Silva, Simone S.; Mano, Joao F.; Reis, Rui L.] Dept Polymer Engn, Res Grp Biomat Biodegradables & Biomimet 3Bs, P-4710057 Braga, Portugal.
   [Silva, Simone S.; Mano, Joao F.; Reis, Rui L.] PT Govt Associated Lab, IBB, Braga, Portugal.
   [Maniglio, Devid; Motta, Antonella; Migliaresi, Claudio] Univ Trent, Dept Mat Engn & Ind Technol, I-38050 Trento, Italy.
   [Maniglio, Devid; Motta, Antonella; Migliaresi, Claudio] Univ Trent, INSTM Res Unit, I-38050 Trento, Italy.
RP Silva, SS (reprint author), Dept Polymer Engn, Res Grp Biomat Biodegradables & Biomimet 3Bs, Campus Gualtar, P-4710057 Braga, Portugal.
EM simonesilva@dep.uminho.pt
RI Group, 3Bs/E-4374-2012; Reis, Rui L./A-8938-2008; Maniglio,
   Devid/C-4187-2014; Silva, Simone/F-9757-2011; Mano, Joao/A-4418-2009
OI Group, 3Bs/0000-0002-5195-3456; Reis, Rui L./0000-0002-4295-6129;
   Maniglio, Devid/0000-0002-1653-861X; Silva, Simone/0000-0003-4268-9419;
   Mano, Joao/0000-0002-2342-3765; Motta, Antonella/0000-0003-4893-6863
FU Portuguese Foundation for Science and Technology (FCT), Portugal
   [SFRH/BD/8658/2002]; EU [NMP3-CT-2003-505758]; European NoE EXPERTISSUES
   [NMP3-CT-2004-500283]
FX We gratefully acknowledge Prof. Rolando Barbucci (Department of Chemical
   and Biosystem Sciences and Technologies, University of Siena, Italy) for
   assistance with the FTIR-spectroscopy studies. The authors acknowledge
   funding from the Portuguese Foundation for Science and Technology (FCT),
   Portugal for SFRH/BD/8658/2002 and the EU-funded Project HIPPOCRATES
   (NMP3-CT-2003-505758). This work was carried out under the scope of the
   European NoE EXPERTISSUES (NMP3-CT-2004-500283).
CR Ayutsede J, 2005, POLYMER, V46, P1625, DOI 10.1016/j.poplymer.2004.11.029
   Bhattarai N, 2005, BIOMATERIALS, V26, P6176, DOI 10.1016/j.biomaterials.2005.03.027
   Butler MF, 2003, J POLYM SCI POL CHEM, V41, P3941, DOI 10.1002/pola.10960
   Buttafoco L, 2006, BIOMATERIALS, V27, P724, DOI 10.1016/j.biomaterials.2005.06.024
   Chen C, 2006, POLYMER, V47, P6322, DOI 10.1016/j.polymer.2006.07.009
   Chen HM, 2005, J BIOMED MATER RES A, V75A, P917, DOI 10.1002/jbm.a.30492
   Chittur KK, 1998, BIOMATERIALS, V19, P357, DOI 10.1016/S0142-9612(97)00223-8
   Huang ZM, 2004, POLYMER, V45, P5361, DOI 10.1016/j.polymer.2004.04.005
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Li MY, 2005, BIOMATERIALS, V26, P5999, DOI 10.1016/j.biomaterials.2005.03.030
   Lu JW, 2006, POLYMER, V47, P8026, DOI 10.1016/j.polymer.2006.09.027
   Mi FL, 2005, J POLYM SCI POL CHEM, V43, P1985, DOI 10.1002/pla.20669
   Min BM, 2006, MACROMOL BIOSCI, V6, P285, DOI 10.1002/mabi.200500246
   Murugan R, 2006, TISSUE ENG, V12, P435, DOI 10.1089/ten.2006.12.435
   Ohgo K, 2003, POLYMER, V44, P841, DOI 10.1016/S0032-3861(02)00819-4
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Ramakrishna S, 2005, INTRODUCTION TO ELECTROSPINNING AND NANOFIBERS, P1, DOI 10.1142/9789812567611
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Servoli E, 2005, MACROMOL BIOSCI, V5, P1175, DOI 10.1002/mabi.200500137
   Sung HW, 1998, J BIOMED MATER RES, V42, P560, DOI 10.1002/(SICI)1097-4636(19981215)42:4<560::AID-JBM12>3.0.CO;2-I
   Sung HW, 2001, J BIOMED MATER RES, V55, P538, DOI 10.1002/1097-4636(20010615)55:4<538::AID-JBM1047>3.3.CO;2-U
   Um IC, 2003, INT J BIOL MACROMOL, V33, P203, DOI 10.1016/j.ijbiomac.2003.08.004
   Unger RE, 2004, BIOMATERIALS, V25, P5137, DOI 10.1016/j.biomaterials.2003.12.040
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wilson D, 2000, BIOPHYS J, V78, P2690, DOI 10.1016/S0006-3495(00)76813-5
NR 25
TC 45
Z9 45
U1 1
U2 36
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD AUG 11
PY 2008
VL 8
IS 8
BP 766
EP 774
DI 10.1002/mabi.200700300
PG 9
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 340WI
UT WOS:000258675300006
PM 18432596
DA 2018-10-19
ER

PT J
AU Shieh, MJ
   Peng, CL
   Lou, PJ
   Chiu, CH
   Tsai, TY
   Hsu, CY
   Yeh, CY
   Lai, PS
AF Shieh, Ming-Jium
   Peng, Cheng-Liang
   Lou, Pei-Jen
   Chiu, Chieh-Hua
   Tsai, Tsiao-Yu
   Hsu, Chia-Yen
   Yeh, Chen-Yu
   Lai, Ping-Shan
TI Non-toxic phototriggered gene transfection by PAMAM-porphyrin conjugates
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article
DE polyamidoamine dendrimer; photochemical internalization; cytotoxicity;
   transfection
ID PHOTOCHEMICAL INTERNALIZATION; POLYAMIDOAMINE DENDRIMERS; DRUG-DELIVERY;
   PHOTODYNAMIC THERAPY; CANCER-THERAPY; DNA COMPLEXES; CELLS; VECTORS;
   PHOTOSENSITIZER; DISRUPTION
AB Development of controllable and non-toxic gene transfection systems is a core issue in gene therapy. Photochemical internalization, an innovative strategy in cytosolic release, provides us with an opportunity to develop a light-inducible gene delivery system. In this study, a novel photochemical internalization (PCI)-mediated gene delivery system was synthesized by surface modification of polyamidoamine (PAMAM) dendrimers via 5,10,15-tri(4-acetamidophenyl)-20-mono(4-carboxyl-phenyl)porphyrin (TAMCPP) conjugated to the generation 4 PAMAM dendrimer (G4). This water-soluble PAMAM-TAMCPP conjugate was characterized for cell viability, phototoxicity, DNA complexation, and in vitro transfection activity. The results show that TAMCPP conjugation did not increase the cytotoxicity of the PAMAM dendrimer below 20 mu M, but significantly induced cell death after suitable irradiation. Under almost non-toxic G4-TAMCPP-mediated PO treatment, the expression of green fluorescent protein determined by flow cytometry could be markedly enhanced in HeLa cells. Therefore, the G4-TAMCPP conjugate had an inducible and effective gene transfection activity, and showed considerable potential as a bimodal biomaterial for PCI-mediated gene therapy. Crown Copyright (C) 2008 Published by Elsevier B.V. All rights reserved.
C1 [Tsai, Tsiao-Yu; Hsu, Chia-Yen; Yeh, Chen-Yu; Lai, Ping-Shan] Natl Chung Hsing Univ, Dept Chem, Taichung 402, Taiwan.
   [Shieh, Ming-Jium; Peng, Cheng-Liang; Chiu, Chieh-Hua] Natl Taiwan Univ, Inst Biomed Engn, Coll Med, Taipei 100, Taiwan.
   [Shieh, Ming-Jium; Peng, Cheng-Liang; Chiu, Chieh-Hua] Natl Taiwan Univ, Coll Engn, Taipei 100, Taiwan.
   [Shieh, Ming-Jium] Natl Taiwan Univ Hosp, Dept Oncol, Taipei 100, Taiwan.
   [Shieh, Ming-Jium; Lou, Pei-Jen] Coll Med, Taipei 100, Taiwan.
   [Lou, Pei-Jen] Natl Taiwan Univ Hosp, Dept Otolaryngol, Taipei 100, Taiwan.
RP Lai, PS (reprint author), Natl Chung Hsing Univ, Dept Chem, 250 Kuo Kuang Rd, Taichung 402, Taiwan.
EM f89548003@gmail.com
RI Lai, Ping-Shan/F-1500-2010
OI LOU, PEI-JEN/0000-0002-3383-8593
FU National Science Council of the Republic of China [NSC
   95-2221-E-002-025, NSC 962113-M-005-015]
FX This research was supported by grants from National Science Council of
   the Republic of China (NSC 95-2221-E-002-025 and NSC 962113-M-005-015).
CR ADLER AD, 1967, J ORG CHEM, V32, P476, DOI 10.1021/jo01288a053
   Berg K, 1999, CANCER RES, V59, P1180
   Berg K, 2005, CLIN CANCER RES, V11, P8476, DOI 10.1158/1078-0432.CCR-05.1245
   Caruso JA, 2005, BIOCHEM J, V392, P325, DOI 10.1042/BJ20050313
   De Laporte L, 2006, BIOMATERIALS, V27, P947, DOI 10.1016/j.biomaterials.2005.09.036
   Dougherty TJ, 1998, JNCI-J NATL CANCER I, V90, P889, DOI 10.1093/jnci/90.12.889
   Esfand R, 2001, DRUG DISCOV TODAY, V6, P427, DOI 10.1016/S1359-6446(01)01757-3
   Feril LB, 2006, CANCER SCI, V97, P1111, DOI 10.1111/j.1349-7006.2006.00286.x
   Folini M, 2003, CANCER RES, V63, P3490
   Han S, 2000, MOL THER, V2, P302, DOI 10.1006/mthe.2000.0142
   Jeong JH, 2007, BIOMATERIALS, V28, P1912, DOI 10.1016/j.biomaterials.2006.12.019
   Kamau SW, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl035
   Katayose S, 1997, BIOCONJUGATE CHEM, V8, P702, DOI 10.1021/bc9701306
   Kim TI, 2007, BIOMATERIALS, V28, P2061, DOI 10.1016/j.biomaterials.2006.12.013
   Kommareddy S, 2005, BIOCONJUGATE CHEM, V16, P1423, DOI 10.1021/bc050146t
   Kono K, 2005, BIOCONJUGATE CHEM, V16, P208, DOI 10.1021/bc049785e
   Kovacs JR, 2005, BIOMATERIALS, V26, P6754, DOI 10.1016/j.biomaterials.2005.04.022
   KukowskaLatallo JF, 1996, P NATL ACAD SCI USA, V93, P4897, DOI 10.1073/pnas.93.10.4897
   Kurz T, 2006, FEBS J, V273, P3106, DOI 10.1111/j.1742-4658.2006.05321.x
   Lai PS, 2007, J CONTROL RELEASE, V122, P39, DOI 10.1016/j.jconrel.2007.06.012
   LAI PS, J BIOMED A IN PRESS
   Lee CC, 2005, NAT BIOTECHNOL, V23, P1517, DOI 10.1038/nbt1171
   LEO A, 1971, CHEM REV, V71, P525, DOI 10.1021/cr60274a001
   Liu Q, 2003, GENE THER, V10, P935, DOI 10.1038/sj.gt.3302036
   Lou PJ, 2006, INT J CANCER, V119, P2692, DOI 10.1002/ijc.22098
   MacDonald L., 2001, J PORPHYR PHTHALOCYA, V5, P105
   MOAN J, 1994, INT J CANCER, V58, P865, DOI 10.1002/ijc.2910580620
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Ndoye A, 2004, J GENE MED, V6, P884, DOI 10.1002/jgm.573
   Nishiyama N, 2005, NAT MATER, V4, P934, DOI 10.1038/nmat1524
   Pandey RK, 1996, PHOTOCHEM PHOTOBIOL, V64, P194, DOI 10.1111/j.1751-1097.1996.tb02442.x
   Plank C, 1996, HUM GENE THER, V7, P1437, DOI 10.1089/hum.1996.7.12-1437
   Prasmickaite L, 2002, BRIT J CANCER, V86, P652, DOI 10.1038/sj/bjc/6600138
   Prasmickaite L, 2006, FEBS LETT, V580, P5739, DOI 10.1016/j.febslet.2006.09.028
   Roberts JC, 1996, J BIOMED MATER RES, V30, P53, DOI 10.1002/(SICI)1097-4636(199601)30:1<53::AID-JBM8>3.0.CO;2-Q
   Rodal GH, 1998, J PHOTOCH PHOTOBIO B, V45, P150, DOI 10.1016/S1011-1344(98)00175-4
   Sonawane ND, 2003, J BIOL CHEM, V278, P44826, DOI 10.1074/jbc.M308643200
   Sun JY, 2003, GENE THER, V10, P964, DOI 10.1038/sj.gt.3302039
   Tang MX, 1996, BIOCONJUGATE CHEM, V7, P703, DOI 10.1021/bc9600630
   Turk M, 2004, J CONTROL RELEASE, V96, P325, DOI 10.1016/j.jconrel.2004.01.013
   Weyergang A, 2006, J CONTROL RELEASE, V111, P165, DOI 10.1016/j.jconrel.2005.12.002
   Yoo H, 2000, NUCLEIC ACIDS RES, V28, P4225, DOI 10.1093/nar/28.21.4225
   Zhou LZ, 2007, J PHARMACEUT BIOMED, V43, P330, DOI 10.1016/j.jpba.2006.06.021
NR 43
TC 69
Z9 72
U1 5
U2 33
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
J9 J CONTROL RELEASE
JI J. Control. Release
PD AUG 7
PY 2008
VL 129
IS 3
BP 200
EP 206
DI 10.1016/j.jconrel.2008.03.024
PG 7
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 345HH
UT WOS:000258986500008
PM 18541326
DA 2018-10-19
ER

PT J
AU Shi, Q
   Ye, SJ
   Kristalyn, C
   Su, YL
   Jiang, ZY
   Chen, Z
AF Shi, Qing
   Ye, Shuji
   Kristalyn, Cornelius
   Su, Yanlei
   Jiang, Zhongyi
   Chen, Zhan
TI Probing molecular-level surface structures of polyethersulfone/Pluronic
   F127 blends using sum-frequency generation vibrational spectroscopy
SO LANGMUIR
LA English
DT Article
ID PEO-PPO-PEO; POLYSTYRENE/POLY(METHYL METHACRYLATE) BLENDS; SULFONE)
   ULTRAFILTRATION MEMBRANES; ASSISTED GRAFT-POLYMERIZATION; SCANNING FORCE
   MICROSCOPY; CONTACT-ANGLE GONIOMETRY; TRIBLOCK COPOLYMERS;
   POLY(LACTIC/GLYCOLIC ACID); PROTEIN ADSORPTION; CHEMICAL-STRUCTURE
AB We blended Pluronic F127 into polyethersulfone (PES) to improve surface propel-ties of PES, which has been extensively used in biomaterial and other applications. The molecular surface structures of PES/Pluronic F127 blends have been investigated by sum-frequency generation (SFG) vibrational spectroscopy. The molecular orientation of surface functional groups of PES changed significantly when blended with a small amount of Pluornic F127. Pluronic F127 on the blend surface also exhibited different features upon contacting with water. The entanglement of PES chains with Pluronic F127 molecules rendered the blends with long-term Surface stability in water in contrast to the situation where a layer of Pluronic F127 adsorbed on the PES surface. Atomic force microscopy (AFM) and quartz crystal microbalance (QCM) measurements were included to determine the relative amount of protein that adsorbed to the blend Surfaces. The results showed a decreased protein adsorption amount with increasing Pluronic F127 bulk concentration. The correlations between polymer surface properties and detailed molecular structures obtained by SFG would provide insight into the designing and developing of biomedical polymers and functional membranes with improved fouling-resistant properties.
C1 [Shi, Qing; Su, Yanlei; Jiang, Zhongyi] Tianjin Univ, Sch Chem Engn & Technol, Key Lab Green Chem Technol, Tianjin 300072, Peoples R China.
   [Shi, Qing; Ye, Shuji; Kristalyn, Cornelius; Chen, Zhan] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.
   [Shi, Qing; Ye, Shuji; Kristalyn, Cornelius; Chen, Zhan] Univ Michigan, Dept Macromol Sci & Engn, Ann Arbor, MI 48109 USA.
RP Chen, Z (reprint author), Tianjin Univ, Sch Chem Engn & Technol, Key Lab Green Chem Technol, Tianjin 300072, Peoples R China.
EM zhyjiang@tju.edu.cn; zhanc@umich.edu
RI Chen, Zhan/G-8312-2016; Ye, Shuji/B-4479-2010
OI Chen, Zhan/0000-0001-8687-8348; 
CR AMIJI M, 1992, BIOMATERIALS, V13, P682, DOI 10.1016/0142-9612(92)90128-B
   [Anonymous], 2001, HYPERCHEM 7 0
   Briggman KA, 2001, J PHYS CHEM B, V105, P2785, DOI 10.1021/jp0037495
   Casford MTL, 2003, LANGMUIR, V19, P7386, DOI 10.1021/la030106i
   Chen CY, 2003, MACROMOLECULES, V36, P4478, DOI 10.1021/ma025985e
   Chen CY, 2002, MACROMOLECULES, V35, P8093, DOI 10.1021/ma0205717
   Chen CY, 2005, PHYS CHEM CHEM PHYS, V7, P2357, DOI 10.1039/b501910a
   Chen CY, 2004, LANGMUIR, V20, P10186, DOI 10.1021/la049327u
   Chen CY, 2002, MACROMOLECULES, V35, P9130, DOI 10.1021/ma020614j
   Chen Q, 1999, J AM CHEM SOC, V121, P446, DOI 10.1021/ja9831453
   Chen XY, 2007, ANAL BIOANAL CHEM, V388, P65, DOI 10.1007/s00216-006-0999-8
   Chen XY, 2006, J AM CHEM SOC, V128, P2711, DOI 10.1021/ja057029t
   Chen Z, 2000, J AM CHEM SOC, V122, P10615, DOI 10.1021/ja000808j
   Chen Z, 1999, J PHYS CHEM B, V103, P2935, DOI 10.1021/jp984502z
   Chen Z, 2007, POLYM INT, V56, P577, DOI 10.1002/pi.2201
   Clarke ML, 2005, J PHYS CHEM B, V109, P22027, DOI 10.1021/jp054456k
   Dreesen L, 2001, CHEM PHYS LETT, V333, P327, DOI 10.1016/S0009-2614(00)01383-X
   Even MA, 2006, MACROMOLECULES, V39, P9396, DOI 10.1021/ma061785h
   FreijLarsson C, 1996, BIOMATERIALS, V17, P2199, DOI 10.1016/0142-9612(96)00050-6
   Gautam KS, 2000, PHYS REV LETT, V85, P3854, DOI 10.1103/PhysRevLett.85.3854
   Gautam KS, 2001, MACROMOLECULES, V34, P1137, DOI 10.1021/ma0015976
   Gracias DH, 1999, ACCOUNTS CHEM RES, V32, P930, DOI 10.1021/ar990034f
   Green RJ, 1998, J BIOMED MATER RES, V42, P165, DOI 10.1002/(SICI)1097-4636(199811)42:2<165::AID-JBM1>3.0.CO;2-N
   Harp GP, 2003, J AM CHEM SOC, V125, P11283, DOI 10.1021/ja035513v
   HIROSE C, 1992, J CHEM PHYS, V96, P997, DOI 10.1063/1.462120
   JAMES SG, 1993, J POLYM SCI POL PHYS, V31, P221, DOI 10.1002/polb.1993.090310211
   Johnson WC, 2005, J PHYS CHEM B, V109, P6280, DOI 10.1021/jp045647a
   Kim J, 2004, LANGMUIR, V20, P4640, DOI 10.1021/la0498511
   Kim J, 2003, LANGMUIR, V19, P9551, DOI 10.1021/la035496n
   Kim J. T., 2007, J FOOD SCI, V72, P214
   Kiss E, 2003, POLYM ADVAN TECHNOL, V14, P839, DOI 10.1002/pat.404
   Kiss E, 2002, J COLLOID INTERF SCI, V245, P91, DOI 10.1006/jcis.2001.7954
   Lee JH, 2000, BIOMATERIALS, V21, P683, DOI 10.1016/S0142-9612(99)00197-0
   Liu Y, 2003, J PHYS CHEM B, V107, P9774, DOI 10.1021/jp0277513
   Marsh LH, 2002, J BIOMED MATER RES, V61, P641, DOI 10.1002/jbm.10174
   Moro T, 2004, NAT MATER, V3, P829, DOI 10.1038/nmat1233
   NORMAN ME, 1992, BIOMATERIALS, V13, P841, DOI 10.1016/0142-9612(92)90177-P
   Opdahl A, 2002, LANGMUIR, V18, P9409, DOI 10.1021/la020537l
   Pieracci J, 2002, CHEM MATER, V14, P256, DOI 10.1021/cm010565+
   Ratner B. D., 1996, SURFACE MODIFICATION
   RESTOS H, 2001, MACROMOLECULES, V34, P5295
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937
   SHEN YR, 1989, NATURE, V337, P519, DOI 10.1038/337519a0
   Shi Q, 2007, J MEMBRANE SCI, V303, P204, DOI 10.1016/j.memsci.2007.07.009
   Silver F., 1989, BIOCOMPATIBILITY INT
   Sprung M, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.051809
   Susanto H, 2007, LANGMUIR, V23, P7818, DOI 10.1021/la700579x
   Taniguchi M, 2003, CHEM MATER, V15, P3805, DOI 10.1021/cm020283p
   Walton DG, 1996, PHYS REV E, V54, P2811, DOI 10.1103/PhysRevE.54.2811
   Wang J, 2002, J AM CHEM SOC, V124, P7016, DOI 10.1021/ja012387r
   Wang J, 2001, J PHYS CHEM B, V105, P12118, DOI 10.1021/jp013161d
   Wang J, 2003, ANALYST, V128, P773, DOI 10.1039/b212551j
   Wang J, 2001, J AM CHEM SOC, V123, P9470, DOI 10.1021/ja0164071
   Wang J, 2008, J PHYS CHEM B, V112, P2281, DOI 10.1021/jp077556u
   Wang YQ, 2006, J MEMBRANE SCI, V283, P440, DOI 10.1016/j.memsci.2006.07.021
   Wang YQ, 2005, LANGMUIR, V21, P11856, DOI 10.1021/la052052d
   Yang ZH, 2001, LANGMUIR, V17, P6254, DOI 10.1021/la010468v
   Zhang D, 1998, J PHYS CHEM B, V102, P6225, DOI 10.1021/jp981550a
   Zolk M, 2000, LANGMUIR, V16, P5849, DOI 10.1021/la0003239
NR 59
TC 32
Z9 35
U1 6
U2 50
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD AUG 5
PY 2008
VL 24
IS 15
BP 7939
EP 7946
DI 10.1021/la800570a
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 331TC
UT WOS:000258034500044
PM 18616306
DA 2018-10-19
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Layer-by-layer biomaterial assemblies
SO ADVANCED MATERIALS
LA English
DT News Item
CR ARIGA K, MACROMOL BIOSCI
NR 1
TC 0
Z9 0
U1 1
U2 3
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0935-9648
J9 ADV MATER
JI Adv. Mater.
PD AUG 4
PY 2008
VL 20
IS 15
BP A1
EP A1
PG 1
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 342MW
UT WOS:000258789200001
DA 2018-10-19
ER

PT J
AU Bao, WW
   Zhang, YZ
   Yin, GB
   Wu, JL
AF Bao Weiwei
   Zhang Youzhu
   Yin Guibo
   Wu Jialin
TI The structure and property of the electrospinning silk fibroin/gelatin
   blend nanofibers
SO E-POLYMERS
LA English
DT Article
ID NORMAL HUMAN KERATINOCYTES; IN-VITRO; FIBROIN; FIBROBLASTS; SCAFFOLDS;
   POLYMER; DESIGN
AB Nanofibers could provide benefits due to high surface area for biomaterial scaffolds. In order to improve both silk fibroin and gelatin performance for potential biomedical applications, in this article the electrospinning of silk fibroin ( SF)/ gelatin ( GT) blends with different composition ratio and concentration was performed with formic acid as a spinning solvent. The nanofibers morphologies and diameters were observed by Scanning electron microscopy ( SEM). Blending with GT could improve the viscosity and spinnability of spinning solution. As- spun SF/ GT blend nanofibers were more homogeneous and non- beaded than pure SF nanofibers. The diameter decreased with higher voltage at same electric field intensity. On increasing the concentrations of spinning solution, the pore diameter of nanofibers decreased, and the porosity increased. In addition, FTIR and DTA analyses showed SF/ GT nanofibers had more alpha- sheets than pure SF nanofibers, which may be caused by an intermolecular interaction between SF and GT. Blending with GT also led to substantial enhancement in mechanical properties of SF nanofibers.
C1 [Bao Weiwei; Zhang Youzhu; Yin Guibo; Wu Jialin] Soochow Univ, Sch Mat Engn, Suzhou 215021, Peoples R China.
   [Bao Weiwei] China Text Informat Ctr, Dept Ind Dev, Beijing 100742, Peoples R China.
RP Zhang, YZ (reprint author), Soochow Univ, Sch Mat Engn, Ganjiang E Rd 178, Suzhou 215021, Peoples R China.
EM baoweiwei@ctic.org.cn; zhangyouzhu@suda.edu.cn
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Courtney T, 2006, BIOMATERIALS, V27, P3631, DOI 10.1016/j.biomaterials.2006.02.024
   Deitzel JM, 2001, POLYMER, V42, P261, DOI 10.1016/S0032-3861(00)00250-0
   HANA SO, 2005, MATER LETT, V59, P2998
   He W, 2005, BIOMATERIALS, V26, P7606, DOI 10.1016/j.biomaterials.2005.05.049
   Huang L, 2000, MACROMOLECULES, V33, P2989, DOI 10.1021/ma991858f
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   KAPLAN DL, 1994, MAT SCI BIOTECHNOLOG
   Kim SH, 2003, POLYM J, V35, P185, DOI 10.1295/polymj.35.185
   KOBAYASHI T, 1996, FOODS FOOD INGREDIEN, V170, P82
   Lee KH, 2002, J POLYM SCI POL PHYS, V40, P2259, DOI 10.1002/polb.10293
   MAGOSHI J, 1977, J POLYM SCI POL PHYS, V15, P1675, DOI 10.1002/pol.1977.180150915
   Min BM, 2004, CARBOHYD POLYM, V57, P285, DOI 10.1016/j.carbpol.2004.05.007
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   PARK WH, 2001, FIBER POLYM, V2, P58, DOI DOI 10.1007/BF02875259
   Rho KS, 2006, BIOMATERIALS, V27, P1452, DOI 10.1016/j.biomaterials.2005.08.004
   Sakabe H., 1989, SEN-I GAKKAISHI, V45, P487
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Um IC, 2003, INT J BIOL MACROMOL, V33, P203, DOI 10.1016/j.ijbiomac.2003.08.004
   Vaz CM, 2005, ACTA BIOMATER, V1, P575, DOI 10.1016/j.actbio.2005.06.006
   Zhang YZ, 2006, POLYMER, V47, P2911, DOI 10.1016/j.polymer.2006.02.046
   ZHENG M, 2004, POLYMER, V45, P5361
NR 22
TC 2
Z9 2
U1 0
U2 5
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 1618-7229
J9 E-POLYMERS
JI e-Polymers
PD AUG 4
PY 2008
AR 098
PG 9
WC Polymer Science
SC Polymer Science
GA 334HZ
UT WOS:000258214200001
DA 2018-10-19
ER

PT J
AU Stynes, G
   Kiroff, GK
   Morrison, WAJ
   Kirkland, MA
AF Stynes, Gil
   Kiroff, George K.
   Morrison, Wayne A. J.
   Kirkland, Mark A.
TI Tissue compatibility of biomaterials: Benefits and problems of skin
   biointegration
SO ANZ JOURNAL OF SURGERY
LA English
DT Review
DE biocompatible materials; prostheses and implants; reconstructive
   surgical procedure; tantalum; titanium
ID VACUUM-ASSISTED CLOSURE; HUMAN LYMPHOBLASTOID-CELLS; SELF-ASSEMBLED
   MONOLAYERS; OXIDE SURFACES; IN-VITRO; INFLAMMATORY RESPONSE; SOLUBLE
   LAMININ-5; TITANIUM SURFACES; EPITHELIAL-CELLS; IMPLANTS
AB The integration of biomaterials with skin is necessary to enable infection-free access to vasculature and body cavities. Also, integrating plastics and metals with skin increases options for the reconstruction of surgical and traumatic defects and enables the permanent implantation of robotic and electronic devices. Until now, attempts to integrate biomaterials with skin permanently have failed because of epidermal marsupialization and infection. This article reviews the general properties required of biomaterials to optimize integration with body tissues, the modifications that increase biocompatibility, focusing particularly on surface functionalization and the specific requirements for biomaterial integration into skin. Critical pathophysiological processes relating to biocompatibility are discussed with particular emphasis on the skin-biomaterial interface. Future directions are speculated on, in particular, the specific utility of subatmospheric pressure dressings in facilitating tissue integration into biomaterials.
C1 [Stynes, Gil] Geelong Hosp, Dept Clin & Biomed Sci, Geelong, Vic 3220, Australia.
   [Stynes, Gil; Kirkland, Mark A.] Univ Melbourne, Dept Clin & Biomed Sci, Melbourne, Vic, Australia.
   [Stynes, Gil; Kirkland, Mark A.] Deakin Univ, Inst Biotechnol BioDeakin, Geelong, Vic 3217, Australia.
   [Morrison, Wayne A. J.] Bernard OBrien Inst Microsurg, Fitzroy, Vic, Australia.
RP Stynes, G (reprint author), Geelong Hosp, Dept Clin & Biomed Sci, Ryrie St, Geelong, Vic 3220, Australia.
EM gstynes@gmail.com
OI Stynes, Gil/0000-0003-3263-7754
CR ABDALLAH HI, 1994, ANN THORAC SURG, V57, P1017, DOI 10.1016/0003-4975(94)90228-3
   Alton E, 2007, GENE THER, V14, P1555, DOI 10.1038/sj.gt.3303033
   Argenta LC, 2006, PLAST RECONSTR SURG, V117, p127S, DOI 10.1097/01.prs.0000222551.10793.51
   Atagi TA, 2006, PLASTIC SURG, P745
   BADLEY RA, 1978, EXP CELL RES, V117, P231, DOI 10.1016/0014-4827(78)90136-2
   Baker SE, 1996, EXP CELL RES, V228, P262, DOI 10.1006/excr.1996.0325
   BISCHOFF F, 1964, PROG EXP TUMOR RES, V5, P85
   BRAND KG, 1980, PLAST RECONSTR SURG, V66, P591, DOI 10.1097/00006534-198010000-00015
   Brovelli D, 1999, LANGMUIR, V15, P4324, DOI 10.1021/la981758n
   Bruni S, 2005, ACTA BIOMATER, V1, P223, DOI 10.1016/j.actbio.2004.11.001
   BRUNK U, 1971, EXP CELL RES, V67, P407, DOI 10.1016/0014-4827(71)90426-5
   BUCHANAN RA, 1987, J BIOMED MATER RES, V21, P355, DOI 10.1002/jbm.820210308
   Chen Shao-Zong, 2005, Asian J Surg, V28, P211, DOI 10.1016/S1015-9584(09)60346-8
   CHEN WT, 1982, J CELL BIOL, V95, P205, DOI 10.1083/jcb.95.1.205
   Contreras R, 2007, J BIOMED MATER RES A, V80A, P480, DOI 10.1002/jbm.a.30961
   de Guzman RC, 2008, J BIOMED MATER RES A, V85A, P14, DOI 10.1002/jbm.a.31516
   du Preez L A, 2007, SADJ, V62, P24
   ECONOMIST T, 2007, ECONOMISTCOM
   Fukano Y, 2006, WOUND REPAIR REGEN, V14, P484, DOI 10.1111/j.1743-6109.2006.00138.x
   Hofer R, 2001, LANGMUIR, V17, P4014, DOI 10.1021/la001756e
   Hoiby N, 1994, Ugeskr Laeger, V156, P5998
   HUNT JA, 1994, ANAL CELL PATHOL, V7, P43
   Jansen J A, 1989, J Invest Surg, V2, P29, DOI 10.3109/08941938909016502
   Jeschke MG, 2004, PLAST RECONSTR SURG, V113, P525, DOI 10.1097/01.PRS.0000100813.39746.5A
   Jotterand F, 2007, NANOMEDICINE-UK, V2, P401, DOI 10.2217/17435889.2.4.401
   Kirkland MA, 2004, EXP HEMATOL, V32, P511, DOI 10.1016/j.exphem.2004.02.013
   Knetsch MLW, 2007, J BIOMED MATER RES A, V82A, P947, DOI 10.1002/ibm.a.31212
   KONONEN M, 1992, J BIOMED MATER RES, V26, P1325
   Lai JCK, 2007, P I MECH ENG H, V221, P173, DOI 10.1243/09544119JEIM210
   Lai J. C. K., 2005, ENCY BIOMATERIALS BI, P1
   LALOR PA, 1991, J BONE JOINT SURG BR, V73, P25
   Lemons J E, 1986, J Arthroplasty, V1, P143, DOI 10.1016/S0883-5403(86)80053-5
   LEW DP, 1989, EUR J CANCER CLIN ON, V25, P1379, DOI 10.1016/0277-5379(89)90091-6
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Molnar JA, 2004, PLAST RECONSTR SURG, V113, P1339, DOI 10.1097/01.PRS.0000112746.67050.68
   MORGAN RW, 1995, J CLIN EPIDEMIOL, V48, P545, DOI 10.1016/0895-4356(94)00211-8
   Morritt AN, 2007, CIRCULATION, V115, P353, DOI 10.1161/CIRCULATIONAHA.106.657379
   Morykwas MJ, 2006, PLAST RECONSTR SURG, V117, p121S, DOI 10.1097/01.prs.0000225450.12593.12
   Muller R, 2005, BIOMATERIALS, V26, P6962, DOI 10.1016/j.biomaterials.2005.05.013
   MURRAY JC, 1979, J CELL BIOL, V80, P197, DOI 10.1083/jcb.80.1.197
   Nanci A, 1998, J BIOMED MATER RES, V40, P324
   Pendegrass CJ, 2006, BIOMATERIALS, V27, P4183, DOI 10.1016/j.biomaterials.2006.03.041
   Penington DG, 2007, MED J AUSTRALIA, V187, P139
   Pennekamp PH, 2006, J ORTHOP RES, V24, P531, DOI 10.1002/jor.20066
   Pitkin M, 2006, J REHABIL RES DEV, V43, P573, DOI 10.1682/JRRD.2005.05.0160
   Puleo DA, 1997, J BIOMED MATER RES, V37, P222, DOI 10.1002/(SICI)1097-4636(199711)37:2<222::AID-JBM11>3.0.CO;2-G
   REVEL JP, 1973, EXP CELL RES, V78, P1, DOI 10.1016/0014-4827(73)90031-1
   Rushing GD, 2007, J PEDIATR SURG, V42, P93, DOI 10.1016/j.jpedsurg.2006.09.056
   Scheideler L, 2007, DENT MATER, V23, P469, DOI 10.1016/j.dental.2006.03.005
   Sclafani AP, 1997, PLAST RECONSTR SURG, V99, P41, DOI 10.1097/00006534-199701000-00007
   Siow KS, 2006, PLASMA PROCESS POLYM, V3, P392, DOI 10.1002/ppap.200600021
   SLIPMAN CW, 2004, ARCH PHYS MED REHAB, V85, pE33
   Suzuki R, 2003, J BIOMED MATER RES A, V66A, P396, DOI 10.1002/jbm.a.10001
   SUZUKI R, 2000, CLIN ORTOP REL RES, V372, P280
   Tamai  K, 2001, Breast Cancer, V8, P90, DOI 10.1007/BF02967485
   Tamura RN, 1997, J PERIODONTAL RES, V32, P287, DOI 10.1111/j.1600-0765.1997.tb00536.x
   TENGVALL P, 1989, BIOMATERIALS, V10, P166, DOI 10.1016/0142-9612(89)90019-7
   Tosatti S, 2002, LANGMUIR, V18, P3537, DOI 10.1021/la011459p
   Udipi K, 2000, J BIOMED MATER RES, V51, P549, DOI 10.1002/1097-4636(20000915)51:4<549::AID-JBM2>3.0.CO;2-Z
   VONRECUM AF, 1984, J BIOMED MATER RES, V18, P323, DOI 10.1002/jbm.820180403
   Wackenfors A, 2004, WOUND REPAIR REGEN, V12, P600, DOI 10.1111/j.1067-1927.2004.12602.x
   Wang JJ, 2007, MUTAT RES-GEN TOX EN, V628, P99, DOI 10.1016/j.mrgentox.2006.12.003
   Wang JJ, 2007, ENVIRON MOL MUTAGEN, V48, P151, DOI 10.1002/em.20287
   Whitesides George M, 2005, Sci Prog, V88, P17, DOI 10.3184/003685005783238462
   Yamauchi R, 2000, CONTACT DERMATITIS, V42, P52
   ZIMMERLI W, 1982, J INFECT DIS, V146, P487, DOI 10.1093/infdis/146.4.487
   Zuo L, 2007, MED CLIN N AM, V91, P845, DOI 10.1016/j.mcna.2007.05.004
NR 67
TC 7
Z9 7
U1 0
U2 13
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1445-1433
J9 ANZ J SURG
JI ANZ J. Surg.
PD AUG
PY 2008
VL 78
IS 8
BP 654
EP 659
DI 10.1111/j.1445-2197.2008.04609.x
PG 6
WC Surgery
SC Surgery
GA 336GZ
UT WOS:000258353600012
PM 18796021
OA Bronze
DA 2018-10-19
ER

PT J
AU Le Nihouannen, D
   Hacking, SA
   Gbureck, U
   Komarova, SV
   Barralet, JE
AF Le Nihouannen, Damien
   Hacking, S. Adam
   Gbureck, Uwe
   Komarova, Svedana V.
   Barralet, Jake E.
TI The use of RANKL-coated brushite cement to stimulate bone remodelling
SO BIOMATERIALS
LA English
DT Article
DE calcium phosphate cement; brushite; RANKL; osteoclast; controlled drug
   release
ID CALCIUM-PHOSPHATE CEMENT; STRENGTH IMPROVEMENT; HYPODERMIC INJECTION;
   IONIC MODIFICATION; GRAFT; VISCOSITY; DELIVERY; RECEPTOR
AB Calcium phosphate cements were first proposed as synthetic bone substitutes over two decades ago, however, they are characterised by slow chemical or cellular resorption and a slow osteointegration. In contrast, bone autograft has been shown to stimulate osteoclastogenesis and angiogenesis resulting in active bone remodelling and rapid graft incorporation. Therefore, we aimed to develop a biomaterial able to release a key stimulator of the bone remodelling process, cytokine RANKL. Cylinders of brushite cement, hydroxyapatite cement and sodium alginate were loaded with RANKL either by incorporation into the cement or by coating the material with Soluble RANKL. To test the biological activity of these formulations, we assessed their effectiveness in inducing osteoclast formation from RAW 264.7 monocytic cell line. Only brushite and hydroxyapatite cements coated with RANKL allowed for retaining sufficient biological activity to induce osteoclast formation. Most efficient was coating 40 mg cylinder of brushite cement with 800 ng RANKL. We have found that RANKL-coated brushite cement exhibits osteoclastogenic activity for at least 1 month at 37 degrees C. Thus, we developed a formulation of brushite cement with RANKL - a synthetic bone graft that is similar to autografts in its ability to actively induce osteoclastogenesis. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Le Nihouannen, Damien; Komarova, Svedana V.; Barralet, Jake E.] McGill Univ, Fac Dent, Montreal, PQ H3A 2B2, Canada.
   [Hacking, S. Adam] McGill Univ, Montreal Gen Hosp, Dept Orthoped, Montreal, PQ H3G 1A4, Canada.
   [Gbureck, Uwe] Univ Wurzburg, Dept Funct Mat Med & Dent, D-97070 Wurzburg, Germany.
RP Barralet, JE (reprint author), McGill Univ, Fac Dent, 3640 Univ St, Montreal, PQ H3A 2B2, Canada.
EM jake.barralet@mcgill.ca
RI barralet, jake/A-5820-2008; Gbureck, Uwe/G-1430-2012; Hacking,
   Adam/F-3645-2010
OI barralet, jake/0000-0003-3543-6042; 
CR Bandyopadhyay S, 2006, BIOCHEM PHARMACOL, V72, P184, DOI 10.1016/j.bcp.2006.04.018
   BANWART JC, 1995, SPINE, V20, P1055, DOI 10.1097/00007632-199505000-00012
   Barralet JE, 2004, J MATER SCI-MATER M, V15, P407, DOI 10.1023/B:JMSM.0000021111.48592.ab
   Barralet JE, 2004, BIOMATERIALS, V25, P2197, DOI 10.1016/j.biomaterials.2003.09.085
   Boyce T, 1999, ORTHOP CLIN N AM, V30, P571, DOI 10.1016/S0030-5898(05)70110-3
   BROWN WE, 1983, J DENT RES, V62, P672
   BURCHARDT H, 1987, ORTHOP CLIN N AM, V18, P187
   Cuckler JM, 2004, J ARTHROPLASTY, V19, P56, DOI 10.1016/j.arth.2004.03.002
   Daculsi G, 2003, J MATER SCI-MATER M, V14, P195, DOI 10.1023/A:1022842404495
   FEI Z, J MAT SCI M IN PRESS
   Gbureck U, 2004, BIOMATERIALS, V25, P2187, DOI 10.1016/j.biomaterials.2003.08.066
   Gbureck U, 2007, ADV MATER, V19, P795, DOI 10.1002/adma.200601370
   Ginebra MP, 2006, J CONTROL RELEASE, V113, P102, DOI 10.1016/j.jconrel.2006.04.007
   Grover LM, 2006, BIOMATERIALS, V27, P2178, DOI 10.1016/j.biomaterials.2005.11.012
   Habibovic P, 2005, BIOMATERIALS, V26, P3565, DOI 10.1016/j.biomaterials.2004.09.056
   Ito H, 2005, NAT MED, V11, P291, DOI 10.1038/nm1190
   Komarova SV, 2005, ENDOCRINOLOGY, V146, P3589, DOI 10.1210/en.2004-1642
   Lam J, 2001, J CLIN INVEST, V108, P971, DOI 10.1172/JCI13890
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LEGEROS R Z, 1982, Journal of Dental Research, V61, P343
   Mentaverri R, 2006, FASEB J, V20, P2562, DOI 10.1096/fj.06-6304fje
   Monaco Anthony P, 2004, Exp Clin Transplant, V2, P153
   TAMIMI F, J BIOMED A IN PRESS
   Tessmar JK, 2007, ADV DRUG DELIVER REV, V59, P274, DOI 10.1016/j.addr.2007.03.020
   Urban RM, 2007, CLIN ORTHOP RELAT R, P110, DOI 10.1097/BLO.0b013e318059b902
   Vaccaro AR, 2002, ORTHOPEDICS, V25, pS571
   Vallet-Regi M, 2006, DALTON T, P5211, DOI 10.1039/b610219k
NR 27
TC 36
Z9 36
U1 3
U2 18
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2008
VL 29
IS 22
BP 3253
EP 3259
DI 10.1016/j.biomaterials.2008.03.035
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 317IG
UT WOS:000257012700011
PM 18455230
DA 2018-10-19
ER

PT J
AU Fan, HB
   Liu, HF
   Wong, EJW
   Toh, SL
   Goh, JCH
AF Fan, Hongbin
   Liu, Haifeng
   Wong, Eugene J. W.
   Toh, Siew L.
   Goh, James C. H.
TI In vivo study of anterior cruciate ligament regeneration using
   mesenchymal stem cells and silk scaffold
SO BIOMATERIALS
LA English
DT Article
DE tissue engineering; ligament; silk; regeneration; mesenchyrnal stem
   cells
ID MARROW STROMAL CELLS; HYBRID SCAFFOLD; MECHANICAL STIMULATION; TENDON
   GRAFT; BONE TUNNEL; RECONSTRUCTION; RABBIT; FIBROBLASTS; REPAIR;
   DIFFERENTIATION
AB Although most in vitro studies indicate that silk is a suitable biomaterial for ligament tissue engineering, in vivo studies of implanted silk scaffolds for ligament reconstruction are still lacking. The objective of this study is to investigate anterior cruciate ligament (ACL) regeneration using mesenchymal stem cells (MSCs) and silk scaffold. The scaffold was fabricated by incorporating microporous silk sponges into knitted silk mesh, which mimicked the structures of ligament extracellular matrix (ECM). In vitro culture demonstrated that MSCs on scaffolds proliferated vigorously and produced abundant collagen. The transcription levels of ligament-specific genes also increased with time. Then MSCs/scaffold was implanted to regenerate ACL in vivo. After 24 weeks, histology observation showed that MSCs were distributed throughout the regenerated ligament and exhibited fibroblast morphology. The key ligament ECM components including collagen I, collagen 111, and tenascin-C were produced prominently. Furthermore, direct ligament-bone insertion with typical four zones (bone, mineralized fibrocartilage, fibrocartilage, ligament) was reconstructed, which resembled the native structure of ACL-bone insertion. The tensile strength of regenerated ligament also met the mechanical requirements. Moreover, its histological grading score was significantly higher than that of control. In conclusion, the results imply that silk scaffold has great potentials in future clinical applications. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Fan, Hongbin; Liu, Haifeng; Wong, Eugene J. W.; Toh, Siew L.; Goh, James C. H.] Natl Univ Singapore, Dept Orthopaed Surg, Div Bioengn, Singapore 117548, Singapore.
   [Toh, Siew L.] Natl Univ Singapore, Dept Mech Engn, Singapore 117548, Singapore.
RP Goh, JCH (reprint author), Natl Univ Singapore, Dept Orthopaed Surg, Div Bioengn, 10 Kent Ridge Crescent, Singapore 117548, Singapore.
EM dosgohj@nus.edu.sg
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Altman Greg, 2002, FASEB Journal, V16, P270
   AMIEL D, 1984, Journal of Orthopaedic Research, V1, P257
   BALLOCK RT, 1989, J ORTHOP RES, V7, P474, DOI 10.1002/jor.1100070404
   Butler DL, 2008, J ORTHOP RES, V26, P1, DOI 10.1002/jor.20456
   Butler DL, 2000, J BIOMECH ENG-T ASME, V122, P570, DOI 10.1115/1.1318906
   Chen JS, 2006, TISSUE ENG, V12, P3085, DOI 10.1089/ten.2006.12.3085
   Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120
   Cooper JA, 2005, BIOMATERIALS, V26, P1523, DOI 10.1016/j.biomaterials.2004.05.014
   Cooper JA, 2007, P NATL ACAD SCI USA, V104, P3049, DOI 10.1073/pnas.0608837104
   Doroski DM, 2007, BIOMATERIALS, V28, P187, DOI 10.1016/j.biomaterials.2006.08.040
   Fan HB, 2006, J BIOMED MATER RES A, V77A, P785, DOI 10.1002/jbm.a.30647
   Fan HB, 2008, BIOMATERIALS, V29, P1017, DOI 10.1016/j.biomaterials.2007.10.048
   Fan HB, 2006, BIOMATERIALS, V27, P4573, DOI 10.1016/j.biomaterials.2006.04.013
   GOOD L, 1989, ACTA ORTHOP SCAND, V60, P8, DOI 10.3109/17453678909150080
   GREENWALD D, 1994, J SURG RES, V56, P372, DOI 10.1006/jsre.1994.1058
   Gushue DL, 2005, J ORTHOP RES, V23, P735, DOI 10.1016/j.orthres.2005.01.005
   Harner C D, 2001, Instr Course Lect, V50, P463
   Hokugo A, 2006, BIOMATERIALS, V27, P61, DOI 10.1016/j.biomaterials.2005.05.030
   Lim JK, 2004, ARTHROSCOPY, V20, P899, DOI 10.1016/j.arthro.2004.06.035
   Liu HF, 2008, BIOMATERIALS, V29, P1443, DOI 10.1016/j.biomaterials.2007.11.023
   Liu HF, 2008, BIOMATERIALS, V29, P662, DOI 10.1016/j.biomaterials.2007.10.035
   Mackie EJ, 1996, J ANAT, V188, P157
   Maletius W, 1997, AM J SPORT MED, V25, P288, DOI 10.1177/036354659702500303
   Miller SL, 2002, ORTHOP CLIN N AM, V33, P675, DOI 10.1016/S0030-5898(02)00027-5
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   Moreau JE, 2005, TISSUE ENG, V11, P1887, DOI 10.1089/ten.2005.11.1887
   Ouyang HW, 2003, TISSUE ENG, V9, P431, DOI 10.1089/107632703322066615
   Petrigliano FA, 2006, ARTHROSCOPY, V22, P441, DOI 10.1016/j.arthro.2006.01.017
   Rahaman MN, 2005, BIOTECHNOL BIOENG, V91, P261, DOI 10.1002/bit.20292
   Rising A, 2005, ZOOL SCI, V22, P273, DOI 10.2108/zsj.22.273
   Sahoo S, 2006, TISSUE ENG, V12, P91, DOI 10.1089/ten.2006.12.91
   Shelburne KB, 2004, J BIOMECH, V37, P797, DOI [10.1016/j.jbiomech.2003.10.010, 10.1016/j.biomech.2003.10.010]
   Strickland SM, 2003, ORTHOP CLIN N AM, V34, P41, DOI 10.1016/S0030-5898(02)00060-3
   Van Eijk F, 2004, TISSUE ENG, V10, P893, DOI 10.1089/1076327041348428
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Weiler A, 2002, ARTHROSCOPY, V18, P124, DOI 10.1053/jars.2002.30657
   Woo SLY, 1999, CLIN ORTHOP RELAT R, pS312
   Yeh WL, 2007, J ORTHOP RES, V25, P636, DOI 10.1002/jor.20360
NR 40
TC 122
Z9 137
U1 7
U2 49
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2008
VL 29
IS 23
BP 3324
EP 3337
DI 10.1016/j.biomaterials.2008.04.012
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 321ZI
UT WOS:000257344600005
PM 18462787
DA 2018-10-19
ER

PT J
AU Kilian, O
   Wenisch, S
   Karnati, S
   Baumgart-Vogt, E
   Hild, A
   Fuhrmann, R
   Jonuleit, T
   Dingeldein, E
   Schnettler, R
   Franke, RP
AF Kilian, Olaf
   Wenisch, Sabine
   Karnati, Srikanth
   Baumgart-Vogt, Eveline
   Hild, Anne
   Fuhrmann, Rosemarie
   Jonuleit, Tarja
   Dingeldein, Elvira
   Schnettler, Reinhard
   Franke, Ralf-Peter
TI Observations on the microvasculature of bone defects filled with
   biodegradable nanoparticulate hydroxyapatite
SO BIOMATERIALS
LA English
DT Article
DE angiogenesis; endothelial cell; lymphatic vessel; hydroxyapatite
   composite; platelet; animal model
ID ENDOTHELIAL GROWTH-FACTOR; BLOOD-VESSEL FORMATION; MOLECULAR-MECHANISMS;
   VASCULAR DEVELOPMENT; POROUS IMPLANTS; ANGIOGENESIS; LYMPHANGIOGENESIS;
   VASCULOGENESIS; VEGF; NEOVASCULARIZATION
AB The microvascularization of metaphyseal bone defects filled with nanoparticulate, biodegradable hydroxyapatite biomaterial with and without platelet factors enrichment was investigated in a minipig model. Results from morphological analysis and PECAM-1 immunohistochemistry showed the formation of new blood vessels into the bone defects by sprouting and intussusception of pre-existing ones. However, no significant differences were observed in the microvascularization of the different biomaterials applied (pure versus platelet factors-enriched hydroxyapatite), concerning the number of vessels and their morphological structure at day 20 after operation. The appearance of VEGFR-2 positive endothelial progenitor cells in the connective tissue between hydroxyapatite particles was also found to be independent from platelet factors enrichment of the hydroxyapatite bone substitute. In both groups formation of lymphatic vessels was detected with a podoplanin antibody. No differences were noted between HA/PLF- and HA/PLF+ implants with respect to the podoplanin expression level, the staining pattern or number of lymphatic vessels. In conclusion, the present study demonstrates different mechanisms of blood and lymphatic vessel formation in hydroxyapatite implants in minipigs. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Kilian, Olaf; Schnettler, Reinhard] Univ Giessen, Dept Trauma Surg, D-35392 Giessen, Germany.
   [Fuhrmann, Rosemarie; Franke, Ralf-Peter] Univ Ulm, Dept Biomat, D-89069 Ulm, Germany.
   [Wenisch, Sabine; Karnati, Srikanth; Baumgart-Vogt, Eveline; Hild, Anne] Univ Giessen, Lab Expt Trauma Surg, Inst Anat & Cell Biol 2, Div Med Cell Biol, D-35390 Giessen, Germany.
   [Jonuleit, Tarja] CellMed AG, Alzenau, Germany.
   [Dingeldein, Elvira] Osartis GmbH, Obernburg, Germany.
   [Franke, Ralf-Peter] Univ Berlin, Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany.
RP Kilian, O (reprint author), Univ Giessen, Dept Trauma Surg, Rudolf Buchheim Str 7, D-35392 Giessen, Germany.
EM olaf.kilian@chiru.med.uni-giessen.de
RI Baumgart-Vogt, Eveline/I-5945-2013
OI Baumgart-Vogt, Eveline/0000-0002-8265-3763; Karnati,
   Srikanth/0000-0001-9083-2916
CR Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183
   Al-Rawi MAA, 2005, EJSO, V31, P117, DOI 10.1016/j.ejso.2004.08.015
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Auguste P, 2003, CELL TISSUE RES, V314, P157, DOI 10.1007/s00441-003-0750-0
   Augustin HG, 2001, CIRC RES, V89, P645, DOI 10.1161/res.89.8.645
   Beck L, 1997, FASEB J, V11, P365
   Betsholtz C, 2001, BIOESSAYS, V23, P494, DOI 10.1002/bies.1069
   BREITENDERGELEF.S, 1999, AM J PATHOL, V154, P386
   BURRI PH, 1990, ANAT REC, V228, P35, DOI 10.1002/ar.1092280107
   Bussolino F, 1997, TRENDS BIOCHEM SCI, V22, P251, DOI 10.1016/S0968-0004(97)01074-8
   Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220
   Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653
   Cimpean Anca Maria, 2007, Rom J Morphol Embryol, V48, P139
   Crosby JR, 2000, CIRC RES, V87, P728, DOI 10.1161/01.RES.87.9.728
   Djonov V, 2003, CELL TISSUE RES, V314, P107, DOI 10.1007/s00441-003-0784-3
   DONATH K, 1982, J ORAL PATHOL, V4, P316
   Edwards JR, 2008, HUM PATHOL, V39, P49, DOI 10.1016/j.humpath.2007.04.022
   Esser S, 1998, J CELL BIOL, V140, P947, DOI 10.1083/jcb.140.4.947
   Flamme I, 1997, J CELL PHYSIOL, V173, P206, DOI 10.1002/(SICI)1097-4652(199711)173:2<206::AID-JCP22>3.0.CO;2-C
   Gerber HP, 1999, NAT MED, V5, P623
   Gerhardt H, 2003, CELL TISSUE RES, V314, P15, DOI 10.1007/s00441-003-0745-x
   Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7
   Jeltsch M, 2003, CELL TISSUE RES, V314, P69, DOI 10.1007/s00441-003-0777-2
   Kidd KR, 2002, J BIOMED MATER RES, V59, P366, DOI 10.1002/jbm.1253
   Kilian O, 2007, GROWTH FACTORS, V25, P191, DOI 10.1080/08977190701687585
   Laschke MW, 2007, J BIOMED MATER RES B, V82B, P494, DOI 10.1002/jbm.b.30755
   Maruyama K, 2007, AM J PATHOL, V170, P1178, DOI 10.2353/ajpath.2007.060018
   Ni HY, 2003, P NATL ACAD SCI USA, V100, P2415, DOI 10.1073/pnas.2628067100
   Oh SJ, 1997, DEV BIOL, V188, P96, DOI 10.1006/dbio.1997.8639
   Oliver G, 2002, GENE DEV, V16, P773, DOI 10.1101/gad.975002
   Parsons-Wingerter P, 2006, ANAT REC PART A, V288A, P233, DOI 10.1002/ar.a.20309
   Patan S, 2000, J NEURO-ONCOL, V50, P1, DOI 10.1023/A:1006493130855
   Ramirez MI, 2002, J HISTOCHEM CYTOCHEM, V50, P33, DOI 10.1177/002215540205000104
   Risau W, 1995, ANNU REV CELL DEV BI, V11, P73, DOI 10.1146/annurev.cb.11.110195.000445
   Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0
   Steinbrech D. S., 2000, AM J PHYSIOL-CELL PH, V278, P853
   Sung HJ, 2004, BIOMATERIALS, V25, P5735, DOI 10.1016/j.biomaterials.2004.01.066
   Tadic D, 2004, BIOMATERIALS, V25, P987, DOI 10.1016/S0142-9612(03)00621-5
   Tadic D, 2002, BIOMATERIALS, V23, P2553, DOI 10.1016/S0142-9612(01)00390-8
   Uchida S, 2003, BONE, V32, P491, DOI 10.1016/S8756-3282(03)00053-X
   Vincenti V, 1996, CIRCULATION, V93, P1493, DOI 10.1161/01.CIR.93.8.1493
   Welter H, 2003, EXP CLIN ENDOCR DIAB, V111, P33, DOI 10.1055/s-2003-37498
   Williams SK, 2006, J BIOMED MATER RES A, V78A, P59, DOI 10.1002/jbm.a.30659
   Zhou AL, 1998, CELL TISSUE RES, V293, P293, DOI 10.1007/s004410051121
NR 44
TC 17
Z9 18
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG-SEP
PY 2008
VL 29
IS 24-25
BP 3429
EP 3437
DI 10.1016/j.biomaterials.2008.05.003
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 325RS
UT WOS:000257606600005
PM 18501961
DA 2018-10-19
ER

PT J
AU Clem, WC
   Chowdhury, S
   Catledge, SA
   Weimer, JJ
   Shaikh, FM
   Hennessy, KM
   Konovalov, VV
   Hill, MR
   Waterfeld, A
   Bellis, SL
   Vohra, YK
AF Clem, William C.
   Chowdhury, Shaflul
   Catledge, Shane A.
   Weimer, Jeffrey J.
   Shaikh, Faheem M.
   Hennessy, Kristin M.
   Konovalov, Valery V.
   Hill, Michael R.
   Waterfeld, Alfred
   Bellis, Susan L.
   Vohra, Yogesh K.
TI Mesenchymal stem cell interaction with ultra-smooth nanostructured
   diamond for wear-resistant orthopaedic implants
SO BIOMATERIALS
LA English
DT Article
DE diamond; mesenchymal stem cell; biocompatibility; surface treatment;
   protein adsorption; osseointegration
ID VAPOR-DEPOSITED DIAMOND; CARBON COMPOSITE FILMS; BIOMEDICAL
   APPLICATIONS; IN-VITRO; COATINGS; SURFACE; PROTEINS; ADHESION; ALLOY;
   BIOCOMPATIBILITY
AB Ultra-smooth nanostructured diamond (USND) can be applied to greatly increase the wear resistance of orthopaedic implants over conventional designs. Herein we describe surface modification techniques and cytocompatibility studies performed on this new material. We report that hydrogen (H)-terminated USND surfaces supported robust mesenchymal stem cell (MSC) adhesion and survival, while oxygen-(O) and fluorine (F)-terminated surfaces resisted cell adhesion, indicating that USND can be modified to either promote or prevent cell/biomaterial interactions. Given the favorable cell response to H-terminated USND, this material was further compared with two commonly used biocompatible metals, titanium alloy (Ti-6Al-4V) and cobalt chrome (CoCrMo). MSC adhesion and proliferation were significantly improved on USND compared with CoCrMo, although cell adhesion was greatest on Ti-6Al-4V. Comparable amounts of the pro-adhesive protein, fibronectin, were deposited from serum on the three substrates. Finally, MSCs were induced to undergo osteoblastic differentiation on the three materials, and deposition of a mineralized matrix was quantified. Similar amounts of mineral were deposited onto USND and CoCrMo, whereas mineral deposition was slightly higher on Ti-6Al-4V. When coupled with recently published wear studies, these in vitro results suggest that USND has the potential to reduce debris particle release from orthopaedic implants without compromising osseointegration.(c) 2008 Elsevier Ltd. All rights reserved.
C1 [Shaikh, Faheem M.; Hennessy, Kristin M.; Bellis, Susan L.] Univ Alabama, Dept Physiol & Biophys, Birmingham, AL 35294 USA.
   [Clem, William C.; Chowdhury, Shaflul; Catledge, Shane A.; Konovalov, Valery V.; Hill, Michael R.; Bellis, Susan L.; Vohra, Yogesh K.] Ctr Nanoscale Mat & Biointegrat, Birmingham, AL 35294 USA.
   [Clem, William C.; Hill, Michael R.; Bellis, Susan L.] Univ Alabama, Dept Biomed Engn, Birmingham, AL 35294 USA.
   [Chowdhury, Shaflul; Catledge, Shane A.; Konovalov, Valery V.; Vohra, Yogesh K.] Univ Alabama, Dept Phys, Birmingham, AL 35294 USA.
   [Weimer, Jeffrey J.] Univ Alabama, Dept Chem, Huntsville, AL 35899 USA.
   [Weimer, Jeffrey J.] Univ Alabama, Dept Chem & Mat Engn, Huntsville, AL 35899 USA.
   [Waterfeld, Alfred] Univ Alabama, Dept Chem, Tuscaloosa, AL 35487 USA.
RP Bellis, SL (reprint author), Univ Alabama, Dept Physiol & Biophys, MCLM 982A, Birmingham, AL 35294 USA.
EM bellis@uab.edu; ykvohra@uab.edu
RI Hill, Michael/N-9461-2017
OI Hill, Michael/0000-0002-7607-9064; Hill, Michael/0000-0002-2379-4240;
   Weimer, Jeffrey/0000-0002-3460-4000
FU NIBIB NIH HHS [T32EB004312, T32 EB004312]; NIAMS NIH HHS [R01AR51539,
   R01 AR051539-03, R01 AR051539]; NIDCR NIH HHS [R01 DE013952, R01
   DE013952-03]
CR Ariano P, 2005, DIAM RELAT MATER, V14, P669, DOI 10.1016/j.diamond.2004.11.021
   Catledge SA, 1999, J APPL PHYS, V86, P698, DOI 10.1063/1.370787
   Catledge SA, 1998, J APPL PHYS, V84, P6469, DOI 10.1063/1.368975
   CATLEDGE SA, 2001, MECH PROPERTIES STRU
   Chakrapani V, 2007, SCIENCE, V318, P1424, DOI 10.1126/science.1148841
   Chowdhury S, 2006, J MATER RES, V21, P2675, DOI 10.1557/JMR.2006.0334
   CHOWDHURY S, 2007, DIAMOND RELATED MAT
   Cui FZ, 2000, SURF COAT TECH, V131, P481, DOI 10.1016/S0257-8972(00)00809-4
   Dearnaley G, 2005, SURF COAT TECH, V200, P2518, DOI 10.1016/j.surfcoat.2005.07.077
   Docheva D, 2007, J CELL MOL MED, V11, P21, DOI 10.1111/j.1582-4934.2007.00001.x
   Faleiro C, 1996, BIOMETALS, V9, P321, DOI 10.1007/BF00140600
   Garcia AJ, 2005, BIOMATERIALS, V26, P7525, DOI 10.1016/j.biomaterials.2005.05.029
   Garguilo JM, 2004, DIAM RELAT MATER, V13, P595, DOI 10.1016/j.diamond.2003.10.008
   Grill A, 2003, DIAM RELAT MATER, V12, P166, DOI 10.1016/S0925-9635(03)00018-9
   Haynes DR, 1998, CLIN ORTHOP RELAT R, P223
   HAYNES DR, 1993, J BONE JOINT SURG AM, V75A, P825, DOI 10.2106/00004623-199306000-00004
   HILL MR, 2007, J BIOMEDICAL MAT R B
   Jakubowski W, 2004, DIAM RELAT MATER, V13, P1761, DOI 10.1016/j.diamond.2004.03.003
   Kawarada H, 1996, SURF SCI REP, V26, P205, DOI 10.1016/S0167-5729(97)80002-7
   Kilpadi KL, 2004, J BIOMED MATER RES A, V68A, P273, DOI 10.1002/jbm.a.20043
   Konovalov VV, 2006, J NANOSCI NANOTECHNO, V6, P258, DOI 10.1166/jnn.2006.045
   KONOVALOV VV, 2007, PCTUS2006038222
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   Maier F, 2000, PHYS REV LETT, V85, P3472, DOI 10.1103/PhysRevLett.85.3472
   Mitura K, 2006, SURF COAT TECH, V201, P2117, DOI 10.1016/j.surfcoat.2005.10.023
   Narayan RJ, 2006, DIAM RELAT MATER, V15, P1935, DOI 10.1016/j.diamond.2006.08.024
   Okroj W, 2006, DIAM RELAT MATER, V15, P1535, DOI 10.1016/j.diamond.2005.12.033
   Popov C, 2007, DIAM RELAT MATER, V16, P735, DOI 10.1016/j.diamond.2006.12.001
   Popov C, 2006, THIN SOLID FILMS, V494, P92, DOI 10.1016/j.tsf.2005.07.163
   Pypen CMJM, 1998, J MATER SCI-MATER M, V9, P761, DOI 10.1023/A:1008919422520
   Raffaini G, 2007, J MATER SCI-MATER M, V18, P309, DOI 10.1007/s10856-006-0694-5
   Roy RK, 2007, J BIOMED MATER RES B, V83B, P72, DOI 10.1002/jbm.b.30768
   Sawyer AA, 2007, BIOMATERIALS, V28, P383, DOI 10.1016/j.biomaterials.2006.08.031
   SHANBHAG AS, 1995, J ORTHOPAED RES, V13, P792, DOI 10.1002/jor.1100130520
   SHANBHAG AS, 1994, J BIOMED MATER RES, V28, P81, DOI 10.1002/jbm.820280111
   Siebers MC, 2005, BIOMATERIALS, V26, P137, DOI 10.1016/j.biomaterials.2004.02.021
   TANG L, 1995, BIOMATERIALS, V16, P483, DOI 10.1016/0142-9612(95)98822-V
NR 37
TC 49
Z9 49
U1 1
U2 28
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG-SEP
PY 2008
VL 29
IS 24-25
BP 3461
EP 3468
DI 10.1016/j.biomaterials.2008.04.045
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 325RS
UT WOS:000257606600009
PM 18490051
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Li, XM
   Cui, YD
AF Li Xinming
   Cui Yingde
TI Study on synthesis and chloramphenicol release of
   poly(2-hydroxyethylmethacrylate-co-acrylamide) hydrogels
SO CHINESE JOURNAL OF CHEMICAL ENGINEERING
LA English
DT Article
DE hydrogels; drug delivery; chloramphenicol; pH-sensible
ID OPHTHALMIC DRUG-DELIVERY; SOFT CONTACT-LENSES; HEMA HYDROGEL; TIMOLOL;
   TEAR; FORMULATIONS; MONOMERS; SYSTEMS; EYE
AB In this article, poly(2-hydroxyethylmethacrylate-co-acrylamide) hydrogels were synthesized by bulk free-radical copolymerization of 2-hydroxyethylmethacrylate (HEMA) and acrylamide (AAm) for soft contact lens(SCL)-based ophthalmic drug delivery system. The copolymer was characterized with FT-IR and SEM, the swelling property of the hydrogels were Studied by gravimetrical method, and chloramphenicol was used as a model drug to investigate drug release profile of the hydrogels. The results showed that poly(2-hydroxyethylmethacrylate-co-acrylamide) hydrogels were transparent and useful SCL biomaterial, the water content increased as AAm content increase and pH decrease, and in the same way, hydrogel composition affected chloramphenicol release process too. Migration rate of chloramphenicol increased as the AAm content in the hydrogels increased in the first stage of diffusion process, whereas there was no significant difference thereafter.
C1 [Li Xinming; Cui Yingde] Zhongkai Univ Agr & Engn, Sch Chem & Chem Engn, Guangzhou 510225, Guangdong, Peoples R China.
RP Li, XM (reprint author), Zhongkai Univ Agr & Engn, Sch Chem & Chem Engn, Guangzhou 510225, Guangdong, Peoples R China.
EM lixinming@sina.com
FU Natural Science Foundation of Guangdong Province [5300978]; Zhongkai
   University of Agriculture and Engineering [G2360221]
FX Supported by the Natural Science Foundation of Guangdong Province
   (5300978) and Zhongkai University of Agriculture and Engineering
   (G2360221).
CR Alvarez-Lorenzo C, 2002, J PHARM SCI, V91, P2182, DOI 10.1002/jps.10209
   Alvarez-Lorenzo C., 2006, AM J DRUG DELIV, V4, P131, DOI DOI 10.2165/00137696-200604030-00002
   Alvarez-Lorenzo C, 2006, J CONTROL RELEASE, V113, P236, DOI 10.1016/j.jconrel.2006.05.003
   Andrade-Vivero P, 2007, J PHARM SCI-US, V96, P802, DOI 10.1002/jps.20761
   Bourlais C L, 1998, Prog Retin Eye Res, V17, P33
   Creech JL, 2001, IND ENG CHEM RES, V40, P3015, DOI 10.1021/ie000596z
   DESHPANDE SG, 1989, J PHARM PHARMACOL, V41, P197, DOI 10.1111/j.2042-7158.1989.tb06430.x
   Ding SL, 1998, PHARM SCI TECHNOL TO, V1, P328, DOI 10.1016/S1461-5347(98)00087-X
   Garcia DM, 2004, EUR POLYM J, V40, P1683, DOI 10.1016/j.eurpolymj.2004.03.012
   Gulsen D, 2005, INT J PHARMACEUT, V292, P95, DOI 10.1016/j.ijpharm.2004.11.033
   Gulsen D, 2004, INVEST OPHTH VIS SCI, V45, P2342, DOI 10.1167/iovs.03-0959
   GULSEN D, 2000, CURRENT EYE RES, V30, P1071
   HAROLDO CBP, 2006, J APPL POLYM SCI, V102, P395
   Hiratani H, 2005, MACROMOL BIOSCI, V5, P728, DOI 10.1002/mabi.200500065
   Hiratani H, 2005, BIOMATERIALS, V26, P1293, DOI 10.1016/j.biomaterials.2004.04.030
   Hiratani H, 2004, BIOMATERIALS, V25, P1105, DOI 10.1016/S0142-9612(03)00622-7
   Hiratani H, 2002, J CONTROL RELEASE, V83, P223, DOI 10.1016/S0168-3659(02)00213-4
   Hughes PM, 2005, ADV DRUG DELIVER REV, V57, P2010, DOI 10.1016/j.addr.2005.09.004
   Karlgard CCS, 2003, INT J PHARM, V257, P141, DOI 10.1016/S0378-5173(03)00124-8
   LANG JC, 1995, ADV DRUG DELIVER REV, V16, P39, DOI 10.1016/0169-409X(95)00012-V
   Li CC, 2006, IND ENG CHEM RES, V45, P3718, DOI 10.1021/ie0507934
   Lin HR, 2000, J CONTROL RELEASE, V69, P379, DOI 10.1016/S0168-3659(00)00329-1
   McNamara NA, 1999, AM J OPHTHALMOL, V127, P659, DOI 10.1016/S0002-9394(99)00051-3
   Sano K, 1996, ACTA OPHTHALMOL SCAN, V74, P243
   Sato T, 2005, J APPL POLYM SCI, V98, P731, DOI 10.1002/app.22080
   THYGESEN JEM, 1987, ACTA OPHTHALMOL, V65, P134
   Uchida R, 2003, J CONTROL RELEASE, V92, P259, DOI 10.1016/S0168-3659(03)00368-7
   Venkatesh S, 2007, BIOMATERIALS, V28, P717, DOI 10.1016/j.biomaterials.2006.09.007
   WARLEN M, 1992, INVEST OPHTH VIS SCI, V33, P938
   Wilson CG, 2004, EXP EYE RES, V78, P737, DOI 10.1016/j.exer.2003.10.004
   Winterton LC, 2007, J BIOMED MATER RES B, V80B, P424, DOI 10.1002/jbm.b.30613
NR 31
TC 11
Z9 14
U1 1
U2 11
PU CHEMICAL INDUSTRY PRESS
PI BEIJING
PA NO. 3 HUIXINLI CHAOYANGQU, BEIJING 100029, PEOPLES R CHINA
SN 1004-9541
J9 CHINESE J CHEM ENG
JI Chin. J. Chem. Eng.
PD AUG
PY 2008
VL 16
IS 4
BP 640
EP 645
DI 10.1016/S1004-9541(08)60134-2
PG 6
WC Engineering, Chemical
SC Engineering
GA 346WN
UT WOS:000259100400022
DA 2018-10-19
ER

PT J
AU de Oliveira, RC
   de Oliveira, FHG
   Cestari, TM
   Taga, R
   Granjeiro, JM
AF de Oliveira, Rodrigo Cardoso
   Gelonese de Oliveira, Fabio Henrique
   Cestari, Tania Mary
   Taga, Rumio
   Granjeiro, Jose Mauro
TI Morphometric evaluation of the repair of critical-size defects using
   demineralized bovine bone and autogenous bone grafts in rat calvaria
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE bone repair; bovine bone; critical-size defect
ID MORPHOGENETIC PROTEIN; EXTRACELLULAR-MATRIX; REGULATORS; MORBIDITY;
   IMPLANTS; GROWTH
AB Objective: To evaluate the repair of critical-size bone defects in rats treated with demineralized bovine bone (DBB) compared with autogenous bone (AB).
   Material and method: A bone defect of 8 mm in diameter was created in the calvaria of 50 Rattus norvegicus, treated either with DBB or AB. Sub-groups of five rats of each group were killed at 7, 14, 21, 30 and 90 days post-operatively, and the skulls were removed and processed histologically. Histological sections were stained with hematoxylin and eosin.
   Result: Histological analysis showed complete closure of the defects with new bone at 90 days in group AB, and substitution of the biomaterial by fibrotic connective tissue in the DBB group at 21 days. Morphometric analysis showed that DBB was rapidly absorbed at 14 days, with its volume density decreasing from 47%+/- 0.8% at 7 days to 1.2%+/- 0.41% at 14 days. Subsequently, volume densities of the connective tissue and neoformed bone increased from 51.1%+/- 11.17% to 86.8%+/- 7.92% and from 1.9%+/- 1.13% to 12%+/- 8.02%, respectively, for the same time interval. The volume density of AB particles did not change throughout the experimental periods, but the amount of new bone increased markedly between 7 and 90 days, from 4.5%+/- 1.57% to 53.5%+/- 6.42% (P < 0.05).
   Conclusion: DBB did not provide complete repair of the defects, with significantly less new bone formation than in the AB group.
C1 [Granjeiro, Jose Mauro] Univ Fed Fluminense, Inst Biol, Dept Cellular & Mol Biol, BR-24020150 Niteroi, RJ, Brazil.
   [de Oliveira, Rodrigo Cardoso] Univ Sao Paulo, Bauru Dent Sch, UNICAMP, Inst Biol, BR-05508 Sao Paulo, Brazil.
   [Taga, Rumio] Univ Sao Paulo, Bauru Dent Sch, Dept Biol Sci, BR-05508 Sao Paulo, Brazil.
   [Granjeiro, Jose Mauro] Univ Sao Paulo, Cell & Mol Therapy Ctr, BR-05508 Sao Paulo, Brazil.
RP Granjeiro, JM (reprint author), Univ Fed Fluminense, Inst Biol, Dept Cellular & Mol Biol, Outeiro Sao Joao Baptista S-N,Campus Valonguinho, BR-24020150 Niteroi, RJ, Brazil.
EM jmgranjeiro@vm.uff.br
RI Granjeiro, Jose/D-8289-2012; Oliveira, Rodrigo/E-2551-2012; Cestari,
   Tania/E-7060-2012; Taga, Rumio/E-5794-2012
OI Granjeiro, Jose/0000-0002-8027-8293; Oliveira,
   Rodrigo/0000-0003-3070-5960; 
CR Aichelmann-Reidy M E, 1998, Dent Clin North Am, V42, P491
   BECKER W, 1995, J PERIODONTOL, V66, P822, DOI 10.1902/jop.1995.66.9.822
   Damien C J, 1995, J Biomater Appl, V9, P275
   Davies John E, 2003, J Dent Educ, V67, P932
   Gosain AK, 1997, J CRANIOFAC SURG, V8, P506, DOI 10.1097/00001665-199711000-00017
   HAGEN JW, 1992, J BIOMED MATER RES, V26, P897, DOI 10.1002/jbm.820260706
   HAMMONDS RG, 1991, MOL ENDOCRINOL, V5, P149, DOI 10.1210/mend-5-1-149
   Hartl A, 2004, ACTA ORTHOP SCAND, V75, P217, DOI 10.1080/00016470412331294485
   HERCULIANI PP, 2000, REV BRAS IMPLANT, V7, P7
   ISAKSSON S, 1992, J CRANIO MAXILL SURG, V20, P73, DOI 10.1016/S1010-5182(05)80471-8
   Joshi A, 2004, BRIT DENT J, V196, P215, DOI 10.1038/sj.bdj.4810987
   KENLEY RA, 1993, PHARMACEUT RES, V10, P1393, DOI 10.1023/A:1018902720816
   Marins Lucele Vieira, 2004, J. Appl. Oral Sci., V12, P62, DOI 10.1590/S1678-77572004000100012
   PETTIS GY, 1990, J ORAL MAXIL SURG, V48, P1068, DOI 10.1016/0278-2391(90)90291-9
   Pruss A, 2003, BIOLOGICALS, V31, P287, DOI 10.1016/j.biologicals.2003.08.002
   Raghoebar GM, 2001, CLIN ORAL IMPLAN RES, V12, P503, DOI 10.1034/j.1600-0501.2001.120511.x
   REDDI AH, 1972, P NATL ACAD SCI USA, V69, P1601, DOI 10.1073/pnas.69.6.1601
   REDDI AH, 1984, EXTRACELLULAR MATRIX, P375
   SAMPATH TK, 1984, J CELL BIOL, V98, P2192, DOI 10.1083/jcb.98.6.2192
   SAMPATH TK, 1983, P NATL ACAD SCI-BIOL, V80, P6591, DOI 10.1073/pnas.80.21.6591
   URIST MR, 1970, CLIN ORTHOP RELAT R, P271
   URIST MR, 1984, P NATL ACAD SCI-BIOL, V81, P371, DOI 10.1073/pnas.81.2.371
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   URIST MR, 1982, CLIN ORTHOP RELAT R, P219
   Weibel E R, 1969, Int Rev Cytol, V26, P235, DOI 10.1016/S0074-7696(08)61637-X
   WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241
   Wozney JM, 1998, EUR J ORAL SCI, V106, P160, DOI 10.1111/j.1600-0722.1998.tb02170.x
   Zhao YF, 1999, INT J ORAL MAX IMPL, V14, P889
NR 28
TC 12
Z9 15
U1 0
U2 1
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0905-7161
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD AUG
PY 2008
VL 19
IS 8
BP 749
EP 754
DI 10.1111/j.1600-0501.2008.01521.x
PG 6
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 324JD
UT WOS:000257514000003
PM 18720554
DA 2018-10-19
ER

PT J
AU Slater, N
   Dasmah, A
   Sennerby, L
   Hallman, M
   Piattelli, A
   Sammons, R
AF Slater, Nicola
   Dasmah, Amir
   Sennerby, Lars
   Hallman, Mats
   Piattelli, Adriano
   Sammons, Rachel
TI Back-scattered electron imaging and elemental microanalysis of retrieved
   bone tissue following maxillary sinus floor augmentation with calcium
   sulphate
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE back-scattered electron imaging; calcium sulphate; energy dispersive
   X-ray analysis; maxillary sinus augmentation; resorption
ID CLINICAL REPORT; GRAFT; DEFECT; REGENERATION; HEMIHYDRATE; SUBSTITUTES;
   PARTICLES; MEMBRANES
AB Objectives: To investigate the presence and composition of residual bone graft substitute material in bone biopsies from the maxillary sinus of human subjects, following augmentation with calcium sulphate (CaS).
   Material and methods: Bone cores were harvested from the maxillary sinus of patients who had undergone a sinus lift procedure using CaS G170 granules 4 months after the initial surgery. Samples from seven patients, which contained residual biomaterial particles, were examined by field emission scanning electron microscopy and energy dispersive X-ray spectroscopy was used to determine the composition of the remaining bone graft substitute material.
   Results: Residual graft material occurred in isolated areas surrounded by bone and consisted of individual particles up to 1 mm in length and smaller spherical granules. On the basis of 187 separate point analyses, the residual material was divided into three categories (A, B and C) consisting of: A, mainly CaS (S/P atomic% ratio >= 2.41); B, a heterogeneous mixture of CaS and calcium phosphate (S/P=0.11-2.4) and C, mainly calcium phosphate (S/P <= 0.11; C), which had a mean Ca : P ratio of 1.63 +/- 0.2, consistent with Ca-deficient hydroxyapatite. Linescans and elemental maps showed that type C material was present in areas which appeared dense and surrounded, or were adjacent to, more granular CaS-containing material, and also occurred as spherical particles. The latter could be disintegrating calcium phosphate in the final stages of the resorption process.
   Conclusions: CaS resorption in the human maxillary sinus is accompanied by CaP precipitation which may contribute to its biocompatibility and rapid replacement by bone.
C1 [Slater, Nicola; Sammons, Rachel] Univ Birmingham, Sch Dent, Birmingham B4 6NN, W Midlands, England.
   [Dasmah, Amir; Sennerby, Lars] Univ Gothenburg, Inst Clin Sci, Dept Biomat, Gothenburg, Sweden.
   [Hallman, Mats] Gavle Cent Hosp, Dept Oral & Maxillofacial Surg, S-80187 Gavle, Sweden.
   [Piattelli, Adriano] Univ G dAnnunzio, Sch Dent, Pescara, Italy.
RP Sammons, R (reprint author), Univ Birmingham, Sch Dent, St Chads Queensway, Birmingham B4 6NN, W Midlands, England.
EM r.l.sammons@bham.ac.uk
OI Sammons, Rachel/0000-0002-4787-048X
CR Atilgan S, 2007, BIOTECHNOL BIOTEC EQ, V21, P205, DOI 10.1080/13102818.2007.10817446
   Bier S J, 1999, Compend Contin Educ Dent, V20, P655
   DAMIEN CJ, 1994, CALCIFIED TISSUE INT, V55, P151, DOI 10.1007/BF00297191
   De Leonardis D, 1999, INT J ORAL MAX IMPL, V14, P869
   De Leonardis D, 2000, J PERIODONTOL, V71, P940
   DIBATTISTA P, 1995, J PERIODONTOL, V66, P673, DOI 10.1902/jop.1995.66.8.673
   DUCHEYNE P, 1992, BONE BONDING BIOMATE, P1
   Guarnieri R, 2006, INT J PERIODONT REST, V26, P79
   Guarnieri R, 2004, J PERIODONTOL, V75, P902, DOI 10.1902/jop.2004.75.6.902
   Guarnieri R, 2002, INT J PERIODONT REST, V22, P503
   KOKUBO T, 1992, BONE BONDING BIOMATE, P31
   Lazary A, 2007, BIOMATERIALS, V28, P393, DOI 10.1016/j.biomaterials.2006.09.002
   MacNeill SR, 1999, J CLIN PERIODONTOL, V26, P239, DOI 10.1034/j.1600-051X.1999.260407.x
   Mamidwar SS, 2007, J BIOMED MATER RES B, V81B, P57, DOI 10.1002/jbm.30636
   Maragos P, 2002, INT J PERIODONT REST, V22, P493
   Orsini G, 2004, J BIOMED MATER RES B, V68B, P199, DOI 10.1002/jbm.b.20012
   Orsini M, 2001, J PERIODONTOL, V72, P296, DOI 10.1902/jop.2001.72.3.296
   Pecora G, 2001, INT ENDOD J, V34, P189, DOI 10.1046/j.1365-2591.2001.00369.x
   Pecora G, 1997, Dent Clin North Am, V41, P585
   Pecora G, 1997, ORAL SURG ORAL MED O, V84, P424, DOI 10.1016/S1079-2104(97)90043-3
   Pecora GE, 1998, INT J ORAL MAX IMPL, V13, P866
   Pietrzak WS, 2000, J CRANIOFAC SURG, V11, P327, DOI 10.1097/00001665-200011040-00009
   Ricci JL, 2000, BONE ENG, P332
   Scarano A, 2007, IMPLANT DENT, V16, P195, DOI 10.1097/ID.0b013e3180587ad8
   SIDQUI M, 1995, BIOMATERIALS, V16, P1327, DOI 10.1016/0142-9612(95)91048-4
   Strocchi Rita, 2002, J Oral Implantol, V28, P273, DOI 10.1563/1548-1336(2002)028<0273:BRWCSE>2.3.CO;2
   Tay BKB, 1999, ORTHOP CLIN N AM, V30, P615, DOI 10.1016/S0030-5898(05)70114-0
   TRAINI T, 2008, CLIN IMPLANT DENTIST
   Turner TM, 2003, ORTHOPEDICS, V26, pS577
   Walsh WR, 2003, CLIN ORTHOP RELAT R, P228, DOI 10.1097/01.blo.0000030062.92399.6a
   Yoshikawa G, 2002, INT ENDOD J, V35, P255, DOI 10.1046/j.1365-2591.2002.00473.x
NR 31
TC 17
Z9 17
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
EI 1600-0501
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD AUG
PY 2008
VL 19
IS 8
BP 814
EP 822
DI 10.1111/j.1600-0501.2008.01550.x
PG 9
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 324JD
UT WOS:000257514000012
PM 18705813
DA 2018-10-19
ER

PT J
AU Hryniewicz, T
   Rokicki, R
   Rokosz, K
AF Hryniewicz, T.
   Rokicki, R.
   Rokosz, K.
TI Corrosion characteristics of medical-grade AISI Type 316L stainless
   steel surface after electropolishing in a magnetic field
SO CORROSION
LA English
DT Article
DE corrosion resistance; magnetoelectropolishing; stainless steel
AB Stainless steel materials are widely used for multiple applications because of their good mechanical properties and very good corrosion resistance in a number of environments. They are also used as biomaterials to manufacture conventional and novel medical devices. The stability of the surface oxide layer is one of the most important features of a biomaterial. Electrochemical polishing (EP) is the most extensively used surface technology for stainless steel. We have improved this surface technology by introducing a magnetic field. With a new process called magnetoelectropolishing (MEP) we can improve metal surface properties by making the stainless steel more resistant to halides encountered in a variety of body fluids, such as blood, saliva, urine, etc. Corrosion research results are presented on the behavior of the most commonly used material-medical-grade AISI Type 316L (UNS S31603) stainless steel-applied for human body implants, stents, and devices. Three basic environments have been adopted for the studies: pure distilled water, the Ringer's body fluid, and 3% sodium chloride (NaCl) aqueous solution (the most aggressive environment). The study results cover open-circuit potential and polarization curve characteristics of austenitic stainless steels (Types 304 [UNS S30400], 304L [UNS S30403], 316 [UNS S31600], and 316L), and a ferritic stainless steel (Type 430 [UNS S43000]). The comparison of the corrosion behavior of the stainless steels' surface after two electropolishing processes carried out in the absence (EP) and presence of the magnetic field (MEP) is reported. The experiments were carried out at room temperature (25 degrees C). It has been found that the proposed MEP process shifts the corrosion potentials into the direction of greater corrosion resistance.
C1 [Hryniewicz, T.; Rokosz, K.] Koszalin Univ Technol, PL-75620 Koszalin, Poland.
   [Rokicki, R.] Electrobright, Macungie, PA 18062 USA.
RP Hryniewicz, T (reprint author), Koszalin Univ Technol, Raclawicka 15-17, PL-75620 Koszalin, Poland.
EM tadeusz.hryniewicz@tu.koszalin.pl
CR Hryniewicz T, 2007, Metal Finishing, V104, P26, DOI 10.1016/S0026-0576(06)80361-2
   Hryniewicz T, 2008, SURF COAT TECH, V202, P1668, DOI 10.1016/j.surfcoat.2007.07.067
   HRYNIEWICZ T, 1989, MONOGRAPH KOSZALIN U, V26, P50
   HRYNIEWICZ T, 2007, P 16 INT MET MAT C M, P1
   HRYNIEWICZ T, 2006, COMP AUGER STUDIES 3
   HRYNIEWICZ T, 2005, ELECTROCHEMISTRY SUR, P127
   Hryniewicz T., 2007, P 15 ANN INT C COMP, P345
   HRYNIEWICZ T, 2007, P 10 SLUPSK AUT FOR, P141
   ROKICKI R, 2006, MED DEVICE DIAGN IND, V3, P1
   ROKICKI R, 2006, Patent No. 2006124472
   Sedriks A.J., 1996, CORROSION STAINLESS, P13
   SELVADURAY G, 2005, P C MAT ALS PROC MED
NR 12
TC 35
Z9 35
U1 2
U2 9
PU NATL ASSOC CORROSION ENG
PI HOUSTON
PA 1440 SOUTH CREEK DRIVE, HOUSTON, TX 77084-4906 USA
SN 0010-9312
J9 CORROSION
JI Corrosion
PD AUG
PY 2008
VL 64
IS 8
BP 660
EP 665
DI 10.5006/1.3279927
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 333UT
UT WOS:000258178800005
DA 2018-10-19
ER

PT J
AU Broekhuizen, CAN
   Schultz, MJ
   van der Wal, AC
   Boszhard, L
   de Boer, L
   Vandenbroucke-Grauls, CMJE
   Zaat, SAJ
AF Broekhuizen, Corine A. N.
   Schultz, Marcus J.
   van der Wal, Allard C.
   Boszhard, Laura
   de Boer, Leonie
   Vandenbroucke-Grauls, Christina M. J. E.
   Zaat, Sebastian A. J.
TI Tissue around catheters is a niche for bacteria associated with medical
   device infection
SO CRITICAL CARE MEDICINE
LA English
DT Article
DE biomaterial-associated infection; pathogenesis; Staphylococcus
   epidermidis; catheter; Enterococcus faecalis; tissue
ID CENTRAL VENOUS CATHETERS; RANDOMIZED CONTROLLED-TRIAL; TRANSMISSION
   ELECTRON-MICROSCOPY; ANTISEPTIC-IMPREGNATED CATHETERS; SUBCUTANEOUS
   ABSCESS FORMATION; CRITICALLY-ILL PATIENTS; FOREIGN-BODY INFECTION;
   INTENSIVE-CARE-UNIT; STAPHYLOCOCCUS-EPIDERMIDIS; SILVER SULFADIAZINE
AB Objective. To investigate whether pericatheter tissue is an additional niche for bacteria potentially causing catheter-associated infections in humans.
   Design: Postmortem patient study.
   Setting: Intensive care unit, autopsy room, and microbiological laboratory in a university hospital.
   Patients: Eighteen deceased patients from whom 35 catheters plus surrounding tissues were collected.
   Interventions: Under axenic conditions catheters and surrounding tissue were excised from deceased intensive care unit patients. The excised parts of the catheters and samples of surrounding tissue were quantitatively cultured and bacteria identified, and tissue histology/immunohistochemistry was performed.
   Measurements and main results. Nine of the 35 (26%) pericatheter tissue samples tested were highly culture positive. The corresponding catheter segments were culture negative or yielded only low numbers of bacteria. Bacteria cultured from different sites of the catheter and surrounding tissues almost all were coagulase-negative staphylococci (predominantly Staphylococcus epidermidis) and Enterococcus faecalis. In histology, bacteria were seen in tissue, intercellularly and associated with host phagocytes.
   Conclusions. Tissue surrounding biomedical devices forms a niche for bacteria. This is an as yet nonrecognized element in the pathogenesis of catheter-associated infections, with possible consequences for strategies of prevention and treatment of these infections.
C1 [Broekhuizen, Corine A. N.; Boszhard, Laura; de Boer, Leonie; Vandenbroucke-Grauls, Christina M. J. E.; Zaat, Sebastian A. J.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands.
   [Schultz, Marcus J.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Dept Intens Care Med, NL-1105 AZ Amsterdam, Netherlands.
   [Schultz, Marcus J.] Univ Amsterdam, Acad Med Ctr, Lab Expt Intens Care & Anesthesiol, NL-1105 AZ Amsterdam, Netherlands.
   [van der Wal, Allard C.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands.
   [Vandenbroucke-Grauls, Christina M. J. E.] VU Med Ctr, Dept Med Microbiol & Infect Dis, Amsterdam, Netherlands.
RP Broekhuizen, CAN (reprint author), Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.
EM s.a.zaat@amc.uva.nl
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Anderson JM, 2000, INFECT ASS INDWELLIN, P89, DOI 10.1128/9781555818067.ch5
   ARCHER GL, 2005, MANDELL DOUGLAS BENN, P2352
   Beekmann SE, 2005, MANDELL DOUGLAS BENN, P3347
   Boelens JJ, 2000, INFECT IMMUN, V68, P1692, DOI 10.1128/IAI.68.3.1692-1695.2000
   Boelens JJ, 2000, J BIOMED MATER RES, V50, P546, DOI 10.1002/(SICI)1097-4636(20000615)50:4<546::AID-JBM10>3.0.CO;2-Y
   Boelens JJ, 2000, J INFECT DIS, V181, P1337, DOI 10.1086/315369
   Bouza E, 2005, CRIT CARE MED, V33, P1953, DOI 10.1097/01.CCM.0000171842.63887.C1
   Broekhuizen CAN, 2007, INFECT IMMUN, V75, P1129, DOI 10.1128/IAI.01262-06
   Brun-Buisson C, 2004, INTENS CARE MED, V30, P837, DOI 10.1007/s00134-004-2221-9
   Caplan MJ, 2001, CUMITECH 35 POSTMORT
   COBB DK, 1992, NEW ENGL J MED, V327, P1062, DOI 10.1056/NEJM199210083271505
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Darouiche RO, 2005, ANN SURG, V242, P193, DOI 10.1097/01.sla.0000171874.29934.61
   DEJONGH DS, 1968, AM J CLIN PATHOL, V49, P424
   Dunser MW, 2005, ANESTH ANALG, V101, P1778, DOI 10.1213/01.ANE.0000184200.40689.EB
   El-Azizi Mohamed, 2005, Ann Clin Microbiol Antimicrob, V4, P2, DOI 10.1186/1476-0711-4-2
   Garland JS, 2002, PEDIATRICS, V110, P1009, DOI 10.1542/peds.110.5.1009
   Goetz AM, 1998, INFECT CONT HOSP EP, V19, P842
   Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x
   Gotz F, 2000, INFECT ASS INDWELLIN, P55
   Hannan M, 1999, ANAESTHESIA, V54, P868
   HASLETT TM, 1988, J CLIN MICROBIOL, V26, P696
   Heard SO, 1998, ARCH INTERN MED, V158, P81, DOI 10.1001/archinte.158.1.81
   KURTIN JJ, 1958, AM J CLIN PATHOL, V30, P239, DOI 10.1093/ajcp/30.3.239
   MAKI DG, 1977, NEW ENGL J MED, V296, P1305, DOI 10.1056/NEJM197706092962301
   MARRIE TJ, 1983, J CLIN MICROBIOL, V18, P1388
   MARRIE TJ, 1984, J CLIN MICROBIOL, V19, P687
   Merrer J, 2001, JAMA-J AM MED ASSOC, V286, P700, DOI 10.1001/jama.286.6.700
   Morris JA, 2006, J CLIN PATHOL, V59, P1, DOI 10.1136/jcp.2005.028183
   O'Gara JP, 2001, J MED MICROBIOL, V50, P582, DOI 10.1099/0022-1317-50-7-582
   Osma S, 2006, J HOSP INFECT, V62, P156, DOI 10.1016/j.jhin.2005.06.030
   OSTERHOLM MT, 2005, MANDELL DOUGLAS BENN, P161
   PASSERINI L, 1992, CRIT CARE MED, V20, P665, DOI 10.1097/00003246-199205000-00020
   Patel R, 2005, CLIN ORTHOP RELAT R, P41, DOI 10.1097/01.blo.0000175714.68624.74
   RAAD I, 1995, ANTIMICROB AGENTS CH, V39, P2397, DOI 10.1128/AAC.39.11.2397
   RELMAN DA, 1992, NEW ENGL J MED, V327, P293, DOI 10.1056/NEJM199207303270501
   REZNICEK MJ, 1994, CLIN LAB MED, P1349
   Safdar N, 2002, MEDICINE, V81, P466, DOI 10.1097/00005792-200211000-00007
   Schmitt SK, 1996, J CLIN MICROBIOL, V34, P508
   SHERERTZ RJ, 1990, J CLIN MICROBIOL, V28, P76
   VIRDEN CP, 1992, AESTHET PLAST SURG, V16, P173, DOI 10.1007/BF00450610
   von Eiff C, 1999, INFECTION, V27, pS7, DOI 10.1007/BF02561610
   Vuong C, 2004, J INFECT DIS, V190, P1498, DOI 10.1086/424487
   ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305
   ZIMMERLI W, 1982, J INFECT DIS, V146, P487, DOI 10.1093/infdis/146.4.487
NR 46
TC 24
Z9 25
U1 0
U2 10
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0090-3493
J9 CRIT CARE MED
JI Crit. Care Med.
PD AUG
PY 2008
VL 36
IS 8
BP 2395
EP 2402
DI 10.1097/CCM.0b013e3181818268
PG 8
WC Critical Care Medicine
SC General & Internal Medicine
GA 335DN
UT WOS:000258271100025
PM 18664789
DA 2018-10-19
ER

PT J
AU Brunot, C
   Grosgogeat, B
   Picart, C
   Lagneau, C
   Jaffrezic-Renault, N
   Ponsonnet, L
AF Brunot, C.
   Grosgogeat, B.
   Picart, C.
   Lagneau, C.
   Jaffrezic-Renault, N.
   Ponsonnet, L.
TI Response of fibroblast activity and polyelectrolyte multilayer films
   coating titanium
SO DENTAL MATERIALS
LA English
DT Article
DE titanium; polyelectrolyte multilayer films; surface roughness; dynamic
   contact angle (DCA); wettability; hysteresis (H); atomic force
   microscopy (AFM); human fibroblasts; cell response
ID QUARTZ-CRYSTAL MICROBALANCE; OSSEOINTEGRATED ORAL IMPLANTS;
   CONTACT-ANGLE HYSTERESIS; CELL-ADHESION PROPERTIES; THIN-FILMS;
   BIOMEDICAL APPLICATIONS; IMPEDANCE MEASUREMENTS; SURFACE MODIFICATION;
   EXPONENTIAL-GROWTH; ENDOTHELIAL-CELLS
AB Objectives. The study of surface properties is a recent and crucial issue in the biomaterial fields applied to Odontology. The reference biomaterial in dental implantology is titanium. The principal objective is a perfect bio-integration in the oral ecosystem, both in terms of mucosal and bone tissues. The aim of this work was to optimize the tissue-titanium interface by applying polyelectrolyte multilayer films on the surface of titanium.
   Methods. The experimental study was undertaken on pure titanium samples. Two types of film ending with polycations or polyanions were selected. Both film types were built with a first poly(ethyleneimine) (PEI) base layer and composed either of poly(styrene sulfonate) (PSS) and poly(allylamine hydrochloride) (PAH) or of hyaluronic acid (HA) and poly(L-lysine) (PLL) layers. Final architectures were as follows: PEI-(PSS/PAH)(10), or PEI-(PSS/PAH)(10)-PSS, or chemically cross-linked PEI-(HA/PLL)(10) or PEI-(HA/PLL)(10)-HA. An analysis of the physicochemical characteristics of the surfaces was carried out by tensiometry measurements (dynamic contact angle, wettability, contact angle hysteresis) and atomic force microscopy. A biological study with human fibroblasts was followed over a 7-day culture period at days 0, 2, 4 and 7 to observe the cellular response in terms of morphology (scanning electron microscopy) and viability (Mosmann's test).
   Results. The results showed that polyelectrolyte multilayer films could be successfully deposited onto titanium as previously described for glass or composite. Fibroblast adhesion and proliferation was strongly dependent on film type. SEM observations of cells on the different films agreed with the viability cell test. Furthermore, films containing PSS/PAH generated a better cellular response than films containing cross-linked HA/PLL.
   Conclusion. PSS/PAH polyelectrolyte films coating titanium could represent a new approach for oral bio-integration with great potential for clinical application in the fields of dental implantology. More particularly, the specific biofunctionalization of PSS/PAH films coating titanium could be envisioned by introducing layers of molecules that encourage the bio-integration process between the films. (c) 2007 Academy of Dental Materials. Published by Elsevier Ltd. All rights reserved.
C1 [Brunot, C.; Grosgogeat, B.; Lagneau, C.] Univ Lyon 1, Fac Odontol, Lab Multimat & Interfaces, UMR CNRS 5615, F-69372 Lyon 08, France.
   [Brunot, C.; Grosgogeat, B.] Hosp Civils Lyon, Serv Consultat & Traitements Dentaires, F-69365 Lyon, France.
   [Picart, C.] Univ Montpellier 2, Lab Dynam Mol Interact Membranaires, CNRS UMR 5235, F-34095 Montpellier 05, France.
   [Jaffrezic-Renault, N.] Univ Lyon 1, Sci Analyt Lab, UMR CNRS 5180, F-69622 Villeurbanne, France.
   [Ponsonnet, L.] Univ Rouen, Lab Polymeres Biopolymeres Membranes, CNRS UMR 6522, F-76821 Mont St Aignan, France.
RP Brunot, C (reprint author), Univ Lyon 1, Fac Odontol, Lab Multimat & Interfaces, UMR CNRS 5615, Rue Guillaume Paradin, F-69372 Lyon 08, France.
EM cbrunot.gohin@orange.fr; grosgogeat@sante.univ-lyon1.fr
OI PICART, Catherine/0000-0002-4854-6366; PICART,
   Catherine/0000-0003-0130-1000
CR Abrahamsson I, 2002, J CLIN PERIODONTOL, V29, P448, DOI 10.1034/j.1600-051X.2002.290510.x
   Ai H, 2003, CELL BIOCHEM BIOPHYS, V39, P23, DOI 10.1385/CBB:39:1:23
   Ai H, 2003, J NEUROSCI METH, V128, P1, DOI 10.1016/S0165-0270(03)00191-2
   ANDRADE J, 1983, CONTACT ANGLE INTERF, P249
   Antunes FE, 2004, LANGMUIR, V20, P4647, DOI 10.1021/la049783i
   Bearinger JP, 2003, BIOMATERIALS, V24, P1837, DOI 10.1016/S0142-9612(02)00547-1
   Boulmedais F, 2004, BIOMATERIALS, V25, P2003, DOI 10.1016/j.biomaterials.2003.08.039
   Boura C, 2003, BIOMATERIALS, V24, P3521, DOI 10.1016/S0142-9612(03)00214-X
   Brunot C, 2007, BIOMATERIALS, V28, P632, DOI 10.1016/j.biomaterials.2006.09.026
   Burke SE, 2003, BIOMACROMOLECULES, V4, P1773, DOI 10.1021/bm034184w
   Buron CC, 2006, J COLLOID INTERF SCI, V296, P409, DOI 10.1016/j.jcis.2005.09.034
   Cai KY, 2005, BIOMATERIALS, V26, P5960, DOI 10.1016/j.biomaterials.2005.03.020
   Chen JY, 2001, J COLLOID INTERF SCI, V238, P62, DOI 10.1006/jcis.2001.7460
   Chluba J, 2001, BIOMACROMOLECULES, V2, P800, DOI 10.1021/bm015529i
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Duran A, 2004, J MATER CHEM, V14, P2282, DOI 10.1039/b401370k
   Eisenbarth E, 2002, BIOMOL ENG, V19, P243, DOI 10.1016/S1389-0344(02)00032-1
   Elbert DL, 1999, LANGMUIR, V15, P5355, DOI 10.1021/la9815749
   Esposito M, 1998, EUR J ORAL SCI, V106, P721, DOI 10.1046/j.0909-8836..t01-6-.x
   Esposito M, 1998, EUR J ORAL SCI, V106, P527, DOI 10.1046/j.0909-8836..t01-2-.x
   Etienne O, 2006, J DENT RES, V85, P44, DOI 10.1177/154405910608500107
   Feng B, 2003, BIOMATERIALS, V24, P4663, DOI 10.1016/S0142-9612(03)00366-1
   Fu JH, 2005, BIOMATERIALS, V26, P6684, DOI 10.1016/j.biomaterials.2005.04.034
   Fussell GW, 2004, BIOMATERIALS, V25, P2971, DOI 10.1016/j.biomaterials.2003.09.062
   Garza JM, 2005, LANGMUIR, V21, P12372, DOI 10.1021/la051465b
   Gergely C, 2004, LANGMUIR, V20, P5575, DOI 10.1021/la049932x
   Halthur TJ, 2004, LANGMUIR, V20, P1739, DOI 10.1021/la035475t
   Hermanson G. T., 1996, BIOCONJUGATE TECHNIQ, P169
   Hermitte L, 2004, J COLLOID INTERF SCI, V272, P82, DOI 10.1016/j.jcis.2003.08.055
   Jain R, 2003, J INVEST SURG, V16, P263, DOI 10.1080/08941930390230388
   JAIN R, 2004, J BIOMED MATER RES, V1, P296
   Keller John C, 2003, Implant Dent, V12, P175
   Kim HJ, 2005, LANGMUIR, V21, P8532, DOI 10.1021/la0511182
   Kolasinska M, 2005, BIOELECTROCHEMISTRY, V66, P65, DOI 10.1016/j.bioelechem.2004.03.009
   Ladam G, 2000, LANGMUIR, V16, P1249, DOI 10.1021/la990650k
   Lavalle P, 2002, MACROMOLECULES, V35, P4458, DOI 10.1021/ma0119833
   Mhamdi L, 2006, MAT SCI ENG C-BIO S, V26, P273, DOI 10.1016/j.msec.2005.10.049
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Pavoor PV, 2006, BIOMATERIALS, V27, P1527, DOI 10.1016/j.biomaterials.2005.08.022
   Picart C, 2001, J CHEM PHYS, V115, P1086, DOI 10.1063/1.1375156
   Picart C, 2001, LANGMUIR, V17, P7414, DOI 10.1021/la010848g
   Picart C, 2002, P NATL ACAD SCI USA, V99, P12531, DOI 10.1073/pnas.202486099
   Picart C, 2005, ADV FUNCT MATER, V15, P83, DOI 10.1002/adfm.200400106
   Picart C, 2004, J PHYS CHEM B, V108, P7196, DOI 10.1021/jp037971w
   Ponsonnet L, 2003, MAT SCI ENG C-BIO S, V23, P551, DOI 10.1016/S0928-4931(03)00033-X
   Ren KF, 2005, COLLOID SURFACE B, V46, P63, DOI 10.1016/j.colsurfb.2005.09.004
   Richards R. G., 1996, Injury, V27, pSC38
   Richert L, 2004, LANGMUIR, V20, P448, DOI 10.1021/la035415n
   Richert L, 2004, BIOMACROMOLECULES, V5, P284, DOI 10.1021/bm0342281
   Richert L, 2006, CELL BIOCHEM BIOPHYS, V44, P273, DOI 10.1385/CBB:44:2:273
   Richert L, 2004, SURF SCI, V570, P13, DOI 10.1016/j.susc.2004.06.178
   RUGGE CD, 1993, J PHYS CHEM-US, V97, P8776, DOI 10.1021/j100136a021
   Rupp F, 2002, CHEM ENG TECHNOL, V25, P877, DOI 10.1002/1521-4125(20020910)25:9<877::AID-CEAT877>3.0.CO;2-D
   Sabot A, 2002, ANAL CHEM, V74, P3304, DOI 10.1021/ac0200724
   Schneider A, 2006, LANGMUIR, V22, P1193, DOI 10.1021/la0521802
   Schultz P, 2005, BIOMATERIALS, V26, P2621, DOI 10.1016/j.biomaterials.2004.06.049
   Tryoen-Toth P, 2002, J BIOMED MATER RES, V60, P657, DOI 10.1002/jbm.10110
   TSUTSUI T, 1973, JPN J MED SCI BIOL, V26, P169, DOI 10.7883/yoken1952.26.169
   van den Beucken JJJP, 2006, J BIOMED MATER RES A, V77A, P202, DOI 10.1002/jbm.a.30583
   VANOSS CJ, 1988, CHEM REV, V88, P927, DOI 10.1021/cr00088a006
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Yang SY, 2002, J AM CHEM SOC, V124, P2100, DOI 10.1021/ja017681y
   Zhu YB, 2003, BIOMACROMOLECULES, V4, P446, DOI 10.1021/bm025723k
NR 63
TC 39
Z9 39
U1 0
U2 35
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0109-5641
J9 DENT MATER
JI Dent. Mater.
PD AUG
PY 2008
VL 24
IS 8
BP 1025
EP 1035
DI 10.1016/j.dental.2007.11.022
PG 11
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA 330YN
UT WOS:000257978800003
PM 18237774
DA 2018-10-19
ER

PT J
AU Zavan, B
   Vindigni, V
   Lepidi, S
   Iacopetti, I
   Avruscio, G
   Abatangelo, G
   Cortivo, R
AF Zavan, Barbara
   Vindigni, Vincenzo
   Lepidi, Sandro
   Iacopetti, Ilaria
   Avruscio, Giampiero
   Abatangelo, Giovanni
   Cortivo, Roberta
TI Neoarteries grown in vivo using a tissue-engineered hyaluronan-based
   scaffold
SO FASEB JOURNAL
LA English
DT Article
DE elastin; vascular prosthesis; remodeling; surgery
ID SMOOTH-MUSCLE-CELLS; ADULT ARTERIAL REVASCULARIZATION; CULTURED VASCULAR
   CELLS; BLOOD-VESSEL; ENDOTHELIAL-CELLS; ELASTIN; GRAFTS; MORPHOGENESIS;
   AUTOGRAFTS; MODEL
AB Vascular tissue engineering has emerged as a promising technology for the design of an ideal, responsive, living conduit with properties similar to that of native tissue. The missing link in tissue-engineered blood vessels is elastin biosynthesis. Several biomaterials are currently used but few support elastin biosynthesis in a 3-D array. In previous studies, we demonstrated that a hyaluronan-based scaffold (HYAFF-11 (TM)) grafted in the infrarenal rat aorta successfully guided the complete regeneration of a well-functioning small-diameter (2 mm) neoartery. The aim of the present study was to test the ability of HYAFF-11 biodegradable grafts to develop into neovessels of larger size (4 mm) in a porcine model, focusing on extracellular matrix (ECM) remodeling and elastin biosynthesis. HYAFF-11 tubes (diameter 4 mm, length 5 cm) were implanted in an end-to-end fashion in the common carotid artery. Grafts were analyzed for patency with a Duplex scan every 15 days. ECM components were evaluated by histological and molecular biological methods. All the animals survived the observation period without complications. Intimal hyperplasia (initiating at the anastomotic site) and graft thrombosis led to 3 cases of partial or complete occlusion, as demonstrated by histological examination. There were no signs of stenoses or aneurysms in the remaining grafts. After 5 months, the biomaterial was almost completely degraded and replaced by a neoartery segment composed of mature smooth muscle cells, collagen, and elastin fibers organized in layers and was completely covered on the luminal surface by endothelial cells (vWF(+)). Whereas in previous small animal studies, patency rates were not optimal, those obtained in the present study using hyaluronan-based grafts of larger size confirmed the ability of these constructs to guide the development of a well-functioning neoartery, with the remarkable additional attribute of facilitating the formation of organized layers of elastin fibers.
C1 [Vindigni, Vincenzo] Univ Padua, Clin Plast Surg, I-35100 Padua, Italy.
   [Zavan, Barbara; Abatangelo, Giovanni; Cortivo, Roberta] Univ Padua, Dept Histol Microbiol & Med Biotechnol, I-35100 Padua, Italy.
   [Lepidi, Sandro] Univ Padua, Clin Vasc Surg, I-35100 Padua, Italy.
   [Avruscio, Giampiero] Univ Padua, Unit Angiol, I-35100 Padua, Italy.
   [Iacopetti, Ilaria] Univ Padua, Dept Vet Sci, I-35100 Padua, Italy.
RP Vindigni, V (reprint author), Univ Padua, Clin Plast Surg, Via Giustiniani 2, I-35100 Padua, Italy.
EM vincenzo.vindigni@unipd.it
OI Vindigni, Vincenzo/0000-0001-6638-9010
CR Alsberg E, 2002, P NATL ACAD SCI USA, V99, P12025, DOI 10.1073/pnas.192291499
   Joddar B, 2007, BIOMATERIALS, V28, P3918, DOI 10.1016/j.biomaterials.2007.05.019
   Joddar B, 2006, BIOMATERIALS, V27, P5698, DOI 10.1016/j.biomaterials.2006.07.020
   Karnik SK, 2003, DEVELOPMENT, V130, P411, DOI 10.1242/dev.00223
   Kerdjoudj H, 2007, CLIN HEMORHEOL MICRO, V37, P89
   Kielty CM, 2002, J CELL SCI, V115, P2817
   L'Heureux N, 2006, NAT MED, V12, P361, DOI 10.1038/nm1364
   L'Heureux N, 2007, NEW ENGL J MED, V357, P1451, DOI 10.1056/NEJMc071536
   L'Heureux N, 2007, NAT CLIN PRACT CARD, V4, P389, DOI 10.1038/ncpcardio0930
   Lepidi S, 2006, EUR J VASC ENDOVASC, V32, P411, DOI 10.1016/j.ejvs.2006.02.012
   LEPIDI S, 2006, FASEB J, V20, P103, DOI DOI 10.1096/FJ.05-4802FJE
   LHEUREUX N, 1993, J VASC SURG, V17, P499, DOI 10.1016/0741-5214(93)90150-K
   Li DY, 1998, NATURE, V393, P276, DOI 10.1038/30522
   Long JL, 2003, MATRIX BIOL, V22, P339, DOI 10.1016/S0945-053X(03)00052-0
   Mann BK, 2001, ANAT REC, V263, P367, DOI 10.1002/ar.1116
   Matsumura G, 2003, BIOMATERIALS, V24, P2303, DOI 10.1016/S0142-9612(03)00043-7
   *NAT RES COUNC, 1996, GUID CAR US LAB
   Patel A, 2006, CARDIOVASC RES, V71, P40, DOI 10.1016/j.cardiores.2006.02.021
   Ratcliffe A, 2000, MATRIX BIOL, V19, P353, DOI 10.1016/S0945-053X(00)00080-9
   Remuzzi A, 2004, TISSUE ENG, V10, P699, DOI 10.1089/1076327041348347
   Ross JJ, 2003, MATRIX BIOL, V22, P477, DOI 10.1016/S0945-053X(03)00078-7
   Shin'oka T, 2005, J THORAC CARDIOV SUR, V129, P1330, DOI 10.1016/j.jtcvs.2004.12.047
   Tonello C, 2003, BIOMATERIALS, V24, P1205, DOI 10.1016/S0142-9612(02)00450-7
   Turner NJ, 2004, BIOMATERIALS, V25, P5955, DOI 10.1016/j.biomaterials.2004.02.002
   VESCOVO G, 1996, BASIC APPL MYOL, V6, P183
   WEINBERG CB, 1986, SCIENCE, V231, P397, DOI 10.1126/science.2934816
   Ye Q, 2000, EUR J CARDIO-THORAC, V17, P449, DOI 10.1016/S1010-7940(00)00371-7
   Zhang WJ, 2007, J CELL MOL MED, V11, P945, DOI 10.1111/j.1582-4934.2007.00099.x
NR 28
TC 38
Z9 38
U1 0
U2 15
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
J9 FASEB J
JI Faseb J.
PD AUG
PY 2008
VL 22
IS 8
BP 2853
EP 2861
DI 10.1096/fj.08-107284
PG 9
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 332NI
UT WOS:000258089300025
PM 18385214
DA 2018-10-19
ER

PT J
AU Kim, MS
   Kwon, B
   Park, MS
   Ji, GE
AF Kim, Mi Soon
   Kwon, Bin
   Park, Myeong Soo
   Ji, Geun Eog
TI Isolation of ginsenoside Rh1 and compound K from fermented ginseng and
   efficacy assessment on systemic anaphylactic shock
SO FOOD SCIENCE AND BIOTECHNOLOGY
LA English
DT Article
DE anaphylactic shock model; compound K; ginsenoside Rh1
ID INTESTINAL BACTERIAL METABOLITE; B-16 MELANOMA-CELLS; PANAX-GINSENG;
   DRACOCEPHALUM-ARGUNENSE; ALLERGIC REACTIONS; METASTASIS; SAPONINS; ACID;
   RB-1; RB1
AB Ginsenosides are responsible for the pharmacological and biological activities of ginseng. In this study, ginsenoside Rh1 and compound K were isolated and purified from fermented ginseng substrate and their anti-allergic effects were assessed in compound 48/80-induced anaphylactic shock model. The fermented ginseng substrate was extracted by methanol and ginsenoside Rh1 and compound K were efficiently purified by preparative high performance liquid chromatography (prep HPLC). Their quality and quantity were analyzed by liquid chromatography-mass spectrometer (LC-MS) and HPLC. Ginsenoside Rh1 showed better anti-allergic effects than compound K in compound 48/80-induced anaphylactic shock model, This study suggested that fermented ginseng extracts with enriched Rh1 may be utilized as a potential biomaterial of functional food for the alleviation of allergic symptoms.
C1 [Kim, Mi Soon; Ji, Geun Eog] Seoul Natl Univ, Dept Food & Nutr, Res Inst Human Ecol, Seoul 151742, South Korea.
   [Kwon, Bin; Park, Myeong Soo; Ji, Geun Eog] Bifido Inc, Res Ctr, Hongcheon 250804, Gangwon, South Korea.
   [Park, Myeong Soo] Anyang Tech Coll, Dept Hotel Culinary Art, Anyang 430749, Gyeonggi, South Korea.
RP Ji, GE (reprint author), Seoul Natl Univ, Dept Food & Nutr, Res Inst Human Ecol, Seoul 151742, South Korea.
EM geji@snu.ac.kr
FU Small & Medium Business Administration; Ministry of Science and
   Technology, Korea [MI-0302-00-0098]
FX This work was supported by the Small & Medium Business Administration
   and the Ministry of Science and Technology (MI-0302-00-0098), Korea.
CR Akao T, 1998, J PHARM PHARMACOL, V50, P1155, DOI 10.1111/j.2042-7158.1998.tb03327.x
   Attele AS, 2002, DIABETES, V51, P1851, DOI 10.2337/diabetes.51.6.1851
   Cheng Y, 2005, ACTA PHARMACOL SIN, V26, P143, DOI 10.1111/j.1745-7254.2005.00034.x
   Chi H, 2006, J MICROBIOL BIOTECHN, V16, P1629
   Hasegawa H, 2004, J PHARMACOL SCI, V95, P153, DOI 10.1254/jphs.FMJ04001X4
   Hasegawa H, 1998, PLANTA MED, V64, P696, DOI 10.1055/s-2006-957560
   Huong NTT, 1998, BIOL PHARM BULL, V21, P978
   Jeong HJ, 2001, IMMUNOPHARM IMMUNOT, V23, P107, DOI 10.1081/IPH-100102572
   Jiang S, 2007, BIOL PHARM BULL, V30, P1707, DOI 10.1248/bpb.30.1707
   Kim SH, 2006, BIOL PHARM BULL, V29, P494, DOI 10.1248/bpb.29.494
   Kim SH, 2006, INT ARCH ALLERGY IMM, V139, P87, DOI 10.1159/000090383
   Kim XY, 2008, FOOD SCI BIOTECHNOL, V17, P184
   Lee JY, 2005, CARCINOGENESIS, V26, P359, DOI 10.1093/carcin/bgh313
   MOCHIZUKI M, 1995, BIOL PHARM BULL, V18, P1197
   ODASHIMA S, 1985, CANCER RES, V45, P2781
   OTA T, 1987, CANCER RES, V47, P3863
   Park EK, 2005, BIOL PHARM BULL, V28, P652, DOI 10.1248/bpb.28.652
   Park EK, 2004, INT ARCH ALLERGY IMM, V133, P113, DOI 10.1159/000076383
   Park M. T., 1998, J GINSENG RES, V22, P216
   SATO K, 1994, BIOL PHARM BULL, V17, P635
   SHIN JE, 2003, J GINSENG RES, V27, P129
   Tawab MA, 2003, DRUG METAB DISPOS, V31, P1065, DOI 10.1124/dmd.31.8.1065
   Wakabayashi C, 1998, BIOCHEM BIOPH RES CO, V246, P725, DOI 10.1006/bbrc.1998.8690
   Yang SO, 2006, FOOD SCI BIOTECHNOL, V15, P363
   Zhang Xin-mu, 2004, Zhongguo Zhongyao Zazhi, V29, P1085
NR 25
TC 6
Z9 6
U1 0
U2 3
PU KOREAN SOCIETY FOOD SCIENCE & TECHNOLOGY-KOSFOST
PI SEOUL
PA #605, KOREA SCI TECHNOL CENT, 635-4 YEOKSAM-DONG, KANGNAM-GU, SEOUL,
   135-703, SOUTH KOREA
SN 1226-7708
EI 2092-6456
J9 FOOD SCI BIOTECHNOL
JI Food Sci. Biotechnol.
PD AUG
PY 2008
VL 17
IS 4
BP 805
EP 808
PG 4
WC Food Science & Technology
SC Food Science & Technology
GA 343QZ
UT WOS:000258870200021
DA 2018-10-19
ER

PT J
AU Koh, LB
   Rodriguez, I
   Zhou, JJ
AF Koh, Li Buay
   Rodriguez, Isabel
   Zhou, Jijie
TI Platelet adhesion studies on nanostructured
   poly(lactic-co-glycolic-acid)-carbon nanotube composite
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE carbon nanotubes; PLGA; platelets; plasma proteins; fibrinogen
ID DIAMOND-LIKE CARBON; MECHANICAL-PROPERTIES; BLOOD COMPATIBILITY;
   POLYELECTROLYTES; BIOCOMPATIBILITY; ASSEMBLIES; SURFACES; COATINGS;
   FILMS; CELL
AB Design of blood-compatible surfaces is required to minimize platelet-surface interactions and increase the thromboresistance of foreign surfaces. Poly(lactic-co-glycolic-acid)-carbon nanotube (PLGA-CNT) composite is studied as a building material to fabricate artificial blood prostheses. This nanocomposite-based biomaterial is prepared by an electrostatic Layer-by-Layer (LbL) deposition technique, in which layers of CNTs are adsorbed onto a PLGA film. Before incubation in nonstimulated platelet-rich plasma (PRP) for platelet studies, fibrinogen is immobilized on PLGA-CNT composite. Interactions between the plasma proteins, e.g. fibrinogen and PRP, are investigated on the prepared PLGA-CNT composite. Contact angle measurements on the PLGA-CNT composite displayed a good resistance of platelets adhesion on a hydrophilic surface with an angle of 64.94 degrees as compared to pristine PLGA control with an angle of 93.43 degrees. A significant reduction of adhesion is observed on the PLGA-CNT composite, as well as the absence of platelet activation. On the contrary, both platelet adhesion and activation are observed on control samples. We inferred this suppression in secretion of granule contents in the platelet by the presence of the CNTs that resulted in the absence of platelet activation and its subsequent inhibition in the release of adhesive membrane receptors on the PLGA-CNT composite. (C) 2007 Wiley Periodicals, Inc.
C1 [Koh, Li Buay; Zhou, Jijie] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore, Singapore.
   [Rodriguez, Isabel] Inst Mat Res & Engn, Micro & Nano Syst Cluster, Singapore, Singapore.
RP Zhou, JJ (reprint author), 50 Nanyang Ave,N4-1-01, Singapore 639798, Singapore.
EM JjZhou@ntu.edu.sg
RI Zhou, Jijie/A-1962-2012; Rodriguez, Isabel/G-3178-2016; KOH, Li
   Buay/R-8919-2016; Koh, Li Buay/D-7130-2011
OI Rodriguez, Isabel/0000-0002-7178-8275; 
CR Bertrand P, 2000, MACROMOL RAPID COMM, V21, P319, DOI 10.1002/(SICI)1521-3927(20000401)21:7<319::AID-MARC319>3.0.CO;2-7
   Calvert P, 1999, NATURE, V399, P210, DOI 10.1038/20326
   Chen JY, 2001, J COLLOID INTERF SCI, V238, P62, DOI 10.1006/jcis.2001.7460
   Cochin D, 1999, MACROMOL CHEM PHYSIC, V200, P609, DOI 10.1002/(SICI)1521-3935(19990301)200:3<609::AID-MACP609>3.0.CO;2-X
   Coleman JN, 2006, CARBON, V44, P1624, DOI 10.1016/j.carbon.2006.02.038
   Cui FZ, 2000, SURF COAT TECH, V131, P481, DOI 10.1016/S0257-8972(00)00809-4
   Endo M, 2005, NANO LETT, V5, P101, DOI [10.1021/nl0482635, 10.1012/nl0482635]
   FENG L, 1995, STRUCTURE ADSORPTION, P66
   Grill A, 2003, DIAM RELAT MATER, V12, P166, DOI 10.1016/S0925-9635(03)00018-9
   Khang G, 1997, BIO-MED MATER ENG, V7, P357
   KIEFFER N, 1990, ANNU REV CELL BIOL, V6, P329
   Kolarik L, 1999, LANGMUIR, V15, P8265, DOI 10.1021/la990413h
   Kong H, 2005, POLYMER, V46, P2472, DOI 10.1016/j.polymer.2005.01.037
   LEE JH, 1994, BIOMATERIALS, V15, P705, DOI 10.1016/0142-9612(94)90169-4
   Mamalis AG, 2007, J MATER PROCESS TECH, V181, P52, DOI 10.1016/j.jmatprotec.2006.03.052
   Mamedov AA, 2002, NAT MATER, V1, P190, DOI 10.1038/nmat747
   MEHRISHI JN, 1970, NATURE, V226, P452, DOI 10.1038/226452a0
   Meng J, 2005, J BIOMED MATER RES A, V74A, P208, DOI 10.1002/jbm.a.30315
   Meng J, 2005, NANOMED-NANOTECHNOL, V1, P136, DOI 10.1016/j.nano.2005.03.003
   Mickelson ET, 1999, J PHYS CHEM B, V103, P4318, DOI 10.1021/jp9845524
   Milthorpe B., 2005, SURFACES INTERFACES, P763
   Sick PB, 2004, AM J CARDIOL, V93, P1351, DOI 10.1016/j.amjcard.2004.02.029
   Smart SK, 2006, CARBON, V44, P1034, DOI 10.1016/j.carbon.2005.10.011
   Sun TL, 2005, SMALL, V1, P959, DOI 10.1002/smll.200500095
   Tjong SC, 2006, MAT SCI ENG R, V53, P73, DOI 10.1016/j.mser.2006.06.001
   von Klitzing R, 2006, PHYS CHEM CHEM PHYS, V8, P5012, DOI 10.1039/b607760a
   Wootton DM, 1999, ANNU REV BIOMED ENG, V1, P299, DOI 10.1146/annurev.bioeng.1.1.299
   Zhu J, 2003, NANO LETT, V3, P1107, DOI 10.1021/nl0342489
NR 28
TC 22
Z9 22
U1 1
U2 20
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG
PY 2008
VL 86A
IS 2
BP 394
EP 401
DI 10.1002/jbm.a.31605
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 323MM
UT WOS:000257450200011
PM 17969028
DA 2018-10-19
ER

PT J
AU Zhu, AP
   Zhao, F
   Fang, N
AF Zhu, Ai-Ping
   Zhao, Feng
   Fang, Ning
TI Regulation of vascular smooth muscle cells on poly(ethylene
   terephthalate) film by O-carboxymethylchitosan surface immobilization
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE PET; surface modification; O-carboxymethylchitosan; regulation; vascular
   smooth muscle cells
ID ADHESION CONTACT DYNAMICS; BEHAVIOR IN-VITRO; PROTEIN ADSORPTION;
   CHITOSAN FILMS; BIOMATERIALS; HYDROPHOBICITY; FIBROBLASTS; APOPTOSIS;
   CULTURE; GROWTH
AB Specifying the chemical environment of cells is a well-established method of controlling cellular behaviors. In this study, poly(ethylene terephthalate) (PET) film was selected as a typical biomaterial to detect the effects of chemical modifications on material surface in controlling cell behaviors. Natural biopolymer chitosan and its biocompatible derivative, O-carboxymethylchitosan (OCMCS) were surface immobilized on PET, respectively, via argon plasma followed by graft copolymerization with acrylic acid (AAc), which was exploited to covalently couple PET with chitosan (CS) and OCMCS molecules. Smooth muscle cells (SMCs) displayed a surface-dependent cell spreading and cytoskeletal organization. The cells spread with a more pronounced elongated spindle shape, smaller cell area, and lower cell shape index (CSI) on OCMCS-modified PET surface than on PET, or the PAA and chitosan-immobilized PET surfaces after 24 h of culture. Cell-culture viability after 5 days showed that all the modified materials possessed good cell proliferation. Our results suggest that cell adhesion, morphology, and growth can be mediated not only by varying the functional groups, electric charge, and wettability of PET surface but also by the specific biological recognition elicited from the biomaterials. These findings strongly support the concept that the microenvironment significantly influences cell behavior, highlighting the importance of environmental material biochemistry in cell-based tissue engineering schemes. (C) 2007 Wiley Periodicals, Inc.
C1 [Zhu, Ai-Ping] Yangzhou Univ, Coll Chem & Chem Engn, Yangzhou 225002, Peoples R China.
   [Zhao, Feng] Florida State Univ, Dept Chem & Biomed Engn, Tallahassee, FL 32310 USA.
   [Fang, Ning] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.
RP Zhu, AP (reprint author), Yangzhou Univ, Coll Chem & Chem Engn, Yangzhou 225002, Peoples R China.
EM apzhu@yzu.edu.cn
CR Alves CM, 2007, BIOMATERIALS, V28, P307, DOI 10.1016/j.biomaterials.2006.09.010
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Barber TA, 2003, J BIOMED MATER RES A, V64A, P38, DOI 10.1002/jbm.a.10321
   BERGSTROM K, 1994, J BIOMAT SCI-POLYM E, V6, P123
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Brunette DM, 1999, J BIOMECH ENG-T ASME, V121, P49, DOI 10.1115/1.2798042
   Cai KY, 2001, J BIOMAT SCI-POLYM E, V12, P1303, DOI 10.1163/156856202753419240
   Chatelet C, 2001, BIOMATERIALS, V22, P261, DOI 10.1016/S0142-9612(00)00183-6
   Chen CS, 1998, BIOTECHNOL PROGR, V14, P356, DOI 10.1021/bp980031m
   CHIOU SH, 2001, J MICROENCAPSUL, V18, P603
   COLEMAN DL, 1982, J BIOMED MATER RES, V16, P381, DOI 10.1002/jbm.820160407
   Deutsch J, 2000, J BIOMED MATER RES, V53, P267, DOI 10.1002/(SICI)1097-4636(2000)53:3<267::AID-JBM12>3.0.CO;2-J
   Dike LE, 1999, IN VITRO CELL DEV-AN, V35, P441
   Fang N, 2005, MACROMOL BIOSCI, V5, P1022, DOI 10.1002/mabi.200500123
   Fischer D, 2003, BIOMATERIALS, V24, P1121, DOI 10.1016/S0142-9612(02)00445-3
   FOSTER A, 1998, P NOBCCHE, V25, P127
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Halayko AJ, 2001, J APPL PHYSIOL, V90, P358
   HORBETT TA, 1993, CARDIOVASC PATHOL, V2, pS137
   Illum L, 1998, PHARMACEUT RES, V15, P1326
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X
   Kratz G, 1997, SCAND J PLAST RECONS, V31, P119, DOI 10.3109/02844319709085478
   Lahiji A, 2000, J BIOMED MATER RES, V51, P586
   Li Song, 2003, FASEB Journal, V17, P97
   Mao JS, 2004, BIOMATERIALS, V25, P3973, DOI 10.1016/j.biomaterials.2003.10.080
   NYGREN H, 1994, BIOPHYS CHEM, V49, P263, DOI 10.1016/0301-4622(93)E0090-R
   Onishi H, 1999, BIOMATERIALS, V20, P175, DOI 10.1016/S0142-9612(98)00159-8
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   Salloum DS, 2005, BIOMACROMOLECULES, V6, P161, DOI 10.1021/bm0497015
   SCHAKENRAAD JM, 1989, COLLOID SURFACE, V42, P331
   Sechriest VF, 2000, J BIOMED MATER RES, V49, P534, DOI 10.1002/(SICI)1097-4636(20000315)49:4<534::AID-JBM12>3.0.CO;2-#
   Shigemasa Y, 1996, BIOTECHNOL GENET ENG, V13, P383, DOI 10.1080/02648725.1996.10647935
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   Stegemann JP, 2003, EXP CELL RES, V283, P146, DOI 10.1016/S0014-4827(02)00041-1
   Takagi R, 2000, J MEMBRANE SCI, V170, P19, DOI 10.1016/S0376-7388(99)00358-0
   Tangpasuthadol V, 2003, CARBOHYD RES, V338, P937, DOI 10.1016/S0008-6215(03)00038-7
   Thakar RG, 2003, BIOCHEM BIOPH RES CO, V307, P883, DOI 10.1016/S0006-291X(03)01285-3
   Thompson DM, 2001, TISSUE ENG, V7, P247, DOI 10.1089/10763270152044125
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Wang YC, 2004, FASEB J, V18, P525, DOI 10.1096/fj.03-0490fje
   Worth NF, 2001, CELL MOTIL CYTOSKEL, V49, P130, DOI 10.1002/cm.1027
   Xu CY, 2004, BIOMATERIALS, V25, P877, DOI 10.1016/S0142-9612(03)00593-3
   Zhu AP, 2006, BIOMATERIALS, V27, P2566, DOI 10.1016/j.biomaterials.2005.11.039
   Zhu AP, 2005, BIOMACROMOLECULES, V6, P2607, DOI 10.1021/bm050328q
   Zhu AP, 2005, BIOMATERIALS, V26, P6873, DOI 10.1016/j.biomaterials.2005.05.021
   Zhu AP, 2005, COLLOID SURFACE B, V43, P143, DOI 10.1016/j.colsurfb.2005.04.009
   Zhu AP, 2004, POLYM INT, V53, P15, DOI 10.1002/pi.1275
NR 48
TC 10
Z9 11
U1 1
U2 10
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG
PY 2008
VL 86A
IS 2
BP 467
EP 476
DI 10.1002/jbm.a.31567
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 323MM
UT WOS:000257450200019
PM 17975820
DA 2018-10-19
ER

PT J
AU McNally, AK
   Jones, JA
   MacEwan, SR
   Colton, E
   Anderson, JM
AF McNally, Amy K.
   Jones, Jacqueline A.
   MacEwan, Sarah R.
   Colton, Erica
   Anderson, James M.
TI Vitronectin is a critical protein adhesion substrate for IL-4-induced
   foreign body giant cell formation
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE adhesion; integrins; monocyte; macrophage; fusion; biomedical polymers
ID BIOMATERIAL SURFACE-CHEMISTRY; HUMAN MACROPHAGE ADHESION; IN-VITRO;
   SERUM-PROTEINS; INTEGRINS; APOPTOSIS; MONOCYTE; FUSION; FIBRONECTIN;
   NEUTROPHILS
AB An in vitro system of interleukin (IL)-4-induced foreign body giant cell (FBGC) formation was utilized to define the adhesion protein substrate(s) that promotes this aspect of the foreign body reaction on biomedical polymers. Human monocytes were cultured on cell culture polystyrene surfaces that had been pre-adsorbed with a synthetic arginine-glycine-aspartate peptide previously found to support optimal FBGC formation, or with various concentrations of potential physiological protein substrates, i.e. complement C3bi, collagen types I or IV, fibrinogen, plasma fibronectin, fibroblast fibronectin, laminin, thrombospondin, vitronectin, or von Willebrand factor. Cultures were evaluated on days 0 (1.5 h), 3, and 7 by May-Griinwald/Giemsa staining. Initial monocyte adhesion occurred on all adsorbed proteins. However, by day 7 of culture, only vitronectin was striking in its ability to support significant macrophage adhesion, development, and fusion leading to FBGC formation. Vitronectin supported high degrees of FBGC formation at an absorption concentration between 5 and 25 mu g/mL. These findings suggest that adsorbed vitronectin is critical in the cotlective events that support and promote FBGC formation on biomedical polymers, and that the propensity for vitronectin adsorption may underlie the material surface chemistry dependency of FBGC formation. (C) 2007 Wiley Periodicals, Inc.
C1 [McNally, Amy K.; Colton, Erica; Anderson, James M.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.
   [Jones, Jacqueline A.; MacEwan, Sarah R.; Anderson, James M.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
RP McNally, AK (reprint author), Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.
EM amy.mcnally@case.edu
OI MacEwan, Sarah/0000-0002-4365-6232
FU NIBIB NIH HHS [EB 000275, R01 EB000275, R37 EB000275]
CR Anderson J.M., 1999, TISSUE ENG VASCULAR, P197
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Anderson JM, 1999, J MATER SCI-MATER M, V10, P579, DOI 10.1023/A:1008976531592
   ANDERSON JM, 1988, ASAIO, V11, P101
   Anderson JM, 2004, BIOMATERIALS SCI INT, P296
   ANDERSSON T, 1991, Drug Investigation, V3, P45
   BAMFORD CH, 1992, VROMAN EFFECT
   Berton G, 1999, CELL SIGNAL, V11, P621, DOI 10.1016/S0898-6568(99)00003-0
   Brodbeck WG, 2003, J MATER SCI-MATER M, V14, P671, DOI 10.1023/A:1024951330265
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   Calle Y, 2006, EUR J CELL BIOL, V85, P151, DOI 10.1016/j.ejcb.2005.09.003
   CHERNY RC, 1993, J BIOL CHEM, V268, P9725
   Collier TO, 2004, J BIOMED MATER RES A, V69A, P644, DOI 10.1002/jbm.a.30030
   DeFife KM, 1999, J HISTOCHEM CYTOCHEM, V47, P65, DOI 10.1177/002215549904700107
   Duong LT, 2000, CELL MOTIL CYTOSKEL, V47, P174, DOI 10.1002/1097-0169(200011)47:3<174::AID-CM2>3.0.CO;2-N
   FABRIZIUSHOMAN DJ, 1991, J BIOMED MATER RES, V25, P953, DOI 10.1002/jbm.820250804
   Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Gonzalez-Amaro R, 1999, CRIT REV IMMUNOL, V19, P389
   HARBERS GM, 2006, INTRO BIOMATERIALS, P15
   Jenney CR, 1999, J BIOMED MATER RES, V46, P11, DOI 10.1002/(SICI)1097-4636(199907)46:1<11::AID-JBM2>3.3.CO;2-P
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Jenney CR, 1999, J BIOMED MATER RES, V44, P206, DOI 10.1002/(SICI)1097-4636(199902)44:2<206::AID-JBM11>3.0.CO;2-D
   Jenney CR, 1998, J BIOMED MATER RES, V41, P171, DOI 10.1002/(SICI)1097-4636(199808)41:2<171::AID-JBM1>3.0.CO;2-F
   Jenney CR, 2000, J BIOMED MATER RES, V50, P281, DOI 10.1002/(SICI)1097-4636(20000605)50:3<281::AID-JBM1>3.0.CO;2-5
   JONES JA, 2004, J BIOMAT SCI-POLYM E, V15, P576
   Kanse SM, 2004, ARTERIOSCL THROM VAS, V24, P2251, DOI 10.1161/01.ATV.0000146529.68729.8b
   LUSCINSKAS FW, 1994, J CELL BIOL, V125, P1417, DOI 10.1083/jcb.125.6.1417
   McNally AK, 2003, AM J PATHOL, V163, P1147, DOI 10.1016/S0002-9440(10)63474-8
   McNally AK, 2002, AM J PATHOL, V160, P621, DOI 10.1016/S0002-9440(10)64882-1
   MCNALLY AK, 1995, AM J PATHOL, V147, P1487
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   MCNALLY AK, 1996, 5 WORLD C TOR CAN MA
   McNally AK, 2007, J BIOMED MATER RES A, V82A, P568, DOI 10.1002/bjm.a.31161
   Reddig PJ, 2005, CANCER METAST REV, V24, P425, DOI 10.1007/s10555-005-5134-3
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Schvartz I, 1999, INT J BIOCHEM CELL B, V31, P539, DOI 10.1016/S1357-2725(99)00005-9
   Teitelbaum SL, 2007, AM J PATHOL, V170, P427, DOI 10.2353/ajpath.2007.060834
   Tsuji T, 2004, J MEMBRANE BIOL, V200, P115, DOI 10.1007/s00232-004-0696-5
   UNDERWOOD PA, 1989, J CELL SCI, V93, P641
   Werr J, 2000, J LEUKOCYTE BIOL, V68, P553
   Wiggins MJ, 2001, J BIOMED MATER RES, V58, P302
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
NR 45
TC 56
Z9 58
U1 1
U2 10
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG
PY 2008
VL 86A
IS 2
BP 535
EP 543
DI 10.1002/jbm.a.31658
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 323MM
UT WOS:000257450200026
PM 17994558
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Zhou, G
   Li, YB
   Lee, SW
AF Zhou, Gang
   Li, Yu-Bao
   Lee, Soo-Wohn
TI Preparation of a nano-hydroxyapatite/chitosan/konjac glucomannan
   composite as a novel degradable drug delivery system
SO JOURNAL OF CERAMIC PROCESSING RESEARCH
LA English
DT Article
DE n-HA/CS/KGM composite; in vitro test; degradability; drug delivery
ID BONE
AB A Nano-hydroxyapatite (n-HA)/chitosan (CS)/konjac glucomannan (KGM) composite was prepared by integrating composition and molding. Then, X-ray diffraction (XRD), scanning electron microscopy (SEM) and energy dispersive spectroscopy (EDS) were used to analyze the physical, chemical and degradable properties of the composite before and after immersion in simulated body flu id (SBF). Moreover, an in vitro test for drug delivery revealed that the amount of released pentoxifylline (1-[5-oxohexyl]-3, 7-dimethylxanthine)(PTX) reached a plateau and equaled 80% of the drug loaded in an implant. The newly developed n-HAJCS/KGM composite may serve as a good degradable biomaterial for an implantable drug delivery system (IDDS) in bone tissue engineering.
C1 [Zhou, Gang; Lee, Soo-Wohn] Sun Moon Univ, Dept Mat Engn, Asan 336708, Chungnam, South Korea.
   [Zhou, Gang] Sichuan Univ, Coll Chem, Chengdu 610064, Peoples R China.
   [Zhou, Gang; Li, Yu-Bao] Sichuan Univ, Res Ctr Nanobiomat, Analyt & Testing Ctr, Chengdu 610064, Peoples R China.
RP Lee, SW (reprint author), Sun Moon Univ, Dept Mat Engn, Asan 336708, Chungnam, South Korea.
EM swlee@sunmoon.ac.kr
FU China 973 fund [2007CB936102]
FX The research is supported by China 973 fund (NO. 2007CB936102).
CR ALEKHA KD, 1998, J PHARM TOX METHODS, V41, P1
   Bigi A, 1997, J INORG BIOCHEM, V68, P45, DOI 10.1016/S0162-0134(97)00007-X
   Cho YW, 1999, BIOMATERIALS, V20, P2139, DOI 10.1016/S0142-9612(99)00116-7
   DASH AK, 1992, PHARMACEUT RES, V9, P993, DOI 10.1023/A:1015842108772
   Durucan C, 2002, J MATER SCI, V37, P963, DOI 10.1023/A:1014347814241
   HENCH LL, 1993, INTRO BIOCERAMICS, P57
   Jaakkola T, 2004, BIOMATERIALS, V25, P575, DOI 10.1016/S0142-9612(03)00558-1
   JODY R, 2003, J BIOMED MATER RES A, V66, P411
   KEVOR S, 1998, BIOMATERIALS, V19, P2209
   Kim HM, 1999, J BIOMED MATER RES, V46, P228, DOI 10.1002/(SICI)1097-4636(199908)46:2<228::AID-JBM12>3.0.CO;2-J
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   OLEKSIAK JS, 2001, INTERNATIONAL, V27, P767
   SERRO AP, 2000, J BIOMED MATER RES, V49, P345
   SHENG T, 1991, BIOCHEMISTRY-US, P22
   SHINTO Y, 1992, J BONE JOINT SURG BR, V74, P600
   SZYMURAOLEKSIAK J, 2001, CERAM INT, V7, P767
   WAHLIG H, 1978, J BONE JOINT SURG BR, V60, P270
NR 17
TC 3
Z9 3
U1 0
U2 6
PU KOREAN ASSOC CRYSTAL GROWTH, INC
PI SEOUL
PA SUNGDONG POST OFFICE, P O BOX 27, SEOUL 133-600, SOUTH KOREA
SN 1229-9162
J9 J CERAM PROCESS RES
JI J. Ceram. Process. Res.
PD AUG
PY 2008
VL 9
IS 4
BP 353
EP 357
PG 5
WC Materials Science, Ceramics
SC Materials Science
GA 350WE
UT WOS:000259383500005
DA 2018-10-19
ER

PT J
AU Mathur, T
   Singhal, S
   Khan, S
   Bhateja, P
   Pandya, M
   Rattan, A
   Bhatnagar, PK
   Upadhyay, DJ
   Fatma, T
AF Mathur, T.
   Singhal, S.
   Khan, S.
   Bhateja, P.
   Pandya, M.
   Rattan, A.
   Bhatnagar, P. K.
   Upadhyay, D. J.
   Fatma, T.
TI Effect of oxazolidinone, RBx 7644 (ranbezolid), on inhibition of
   staphylococcal adherence to plastic surfaces
SO JOURNAL OF CHEMOTHERAPY
LA English
DT Article
DE RBx 7644; oxazolidinone; Staphylococcus epidermidis; Staphylococcus
   aureus; adherence; biofilms
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; DEVICE-ASSOCIATED INFECTIONS;
   IN-VITRO; BIOFILMS; AUREUS; VANCOMYCIN; RESISTANT; EPIDERMIDIS; AGENTS
AB Adhesion to biomaterial is assumed to be a crucial step in the pathogenesis of foreign body infection. Slime producing Staphylococcus epidermidis and Staphylococcus aureus have emerged as a preeminent cause of nosocomial bacteremia and infections of prosthetic medical devices. We evaluated the time-dependent anti-adhesive effect of RBx 7644 (ranbezolid), vancomycin, linezolid and quinupristin/dalfopristin on two isolates each of S. epidermidis and S. aureus. Linezolid and quinupristin/dalfopristin showed inhibition only at supra-inhibitory concentrations (2 and 4X MIC) following 2 and 4 h delayed treatment, whereas RBx 7644 demonstrated significant activity against adhesion of staphylococcal cells that had been treated with 2 to 6 h delay. When vancomycin treatment was delayed by 4 to 6 h, even concentrations above the MIC were unable to prevent adherence. This study indicates that RBx 7644 has anti-adhesion potential and may emerge as an important antibiotic for prevention and treatment of device-related infections caused by staphylococci.
C1 [Mathur, T.] Ranbaxy Res Labs, New Drug Discovery Res, Dept Infect Dis, Udyog Vihar Ind Area, Gurgaon 122001, Haryana, India.
   [Rattan, A.] SRL, Gurgaon 122001, Haryana, India.
   [Fatma, T.] Jamia Millia Islamia, Dept Biosci, New Delhi 110025, India.
RP Mathur, T (reprint author), Ranbaxy Res Labs, New Drug Discovery Res, Dept Infect Dis, Udyog Vihar Ind Area, R & D 3,Plot 20,Sector 18, Gurgaon 122001, Haryana, India.
EM tarun.mathur@ranbaxy.com
CR Amorena B, 1999, J ANTIMICROB CHEMOTH, V44, P43, DOI 10.1093/jac/44.1.43
   Bana E Costa CA, 1999, MATH MODEL-THEOR APP, V4, P131
   CARSENTIETESSE H, 1993, ANTIMICROB AGENTS CH, V37, P921, DOI 10.1128/AAC.37.4.921
   *CLIN LAB STAND I, 2006, M7A7 CSLI CLIN LAB S, V26
   COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251
   CRISTHENSEN GD, 1985, J CLIN MICROBIOL, V22, P996
   Darouiche RO, 2001, CLIN INFECT DIS, V33, P1567, DOI 10.1086/323130
   Deighton MA, 2001, METHOD ENZYMOL, V336, P177, DOI 10.1016/S0076-6879(01)36589-8
   Donlan RM, 2001, EMERG INFECT DIS, V7, P277, DOI 10.3201/eid0702.010226
   Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002
   Drago L, 2002, ANTIMICROB AGENTS CH, V46, P598, DOI 10.1128/AAC.46.2.598-599.2002
   Drees M, 2006, CURR OPIN INFECT DIS, V19, P544, DOI 10.1097/QCO.0b013e328010683e
   Drew RH, 2007, PHARMACOTHERAPY, V27, P227, DOI 10.1592/phco.27.2.227
   Giacometti A, 2005, ANTIMICROB AGENTS CH, V49, P4042, DOI 10.1128/AAC.49.10.4042-4045.2005
   Hoellman DB, 2003, ANTIMICROB AGENTS CH, V47, P1148, DOI 10.1128/AAC.47.3.1148-1150.2003
   Jones SM, 2001, LANCET, V357, P40, DOI 10.1016/S0140-6736(00)03572-8
   KLOOS WE, 1994, CLIN MICROBIOL REV, V7, P117
   Mathur T, 2004, INT J ANTIMICROB AG, V24, P369, DOI 10.1016/j.ijantimicag.2004.04.012
   MINUTH JN, 1974, ANTIMICROB AGENTS CH, V6, P411, DOI 10.1128/AAC.6.4.411
   O'Gara JP, 2001, J MED MICROBIOL, V50, P582, DOI 10.1099/0022-1317-50-7-582
   Pagano PJ, 2004, INT J ANTIMICROB AG, V23, P226, DOI 10.1016/j.ijantimicag.2003.07.012
   Raad I, 1998, LANCET, V351, P893, DOI 10.1016/S0140-6736(97)10006-X
   RAAD I, 1995, ANTIMICROB AGENTS CH, V39, P741
   RUPP ME, 1994, CLIN INFECT DIS, V19, P231, DOI 10.1093/clinids/19.2.231
   Schmitz FJ, 1999, J ANTIMICROB CHEMOTH, V44, P847, DOI 10.1093/jac/44.6.847
   Schwank S, 1998, ANTIMICROB AGENTS CH, V42, P895, DOI 10.1128/AAC.42.4.895
NR 26
TC 0
Z9 0
U1 0
U2 1
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 1120-009X
EI 1973-9478
J9 J CHEMOTHERAPY
JI J. Chemother.
PD AUG
PY 2008
VL 20
IS 4
BP 420
EP 427
DI 10.1179/joc.2008.20.4.420
PG 8
WC Oncology; Infectious Diseases; Pathology; Pharmacology & Pharmacy
SC Oncology; Infectious Diseases; Pathology; Pharmacology & Pharmacy
GA 346ZZ
UT WOS:000259109500002
PM 18676219
DA 2018-10-19
ER

PT J
AU Dekeyser, CM
   Buron, CC
   Mc Evoy, K
   Dupont-Gillain, CC
   Marchand-Brynaert, J
   Jonas, AM
   Rouxhet, PG
AF Dekeyser, C. M.
   Buron, C. C.
   Mc Evoy, K.
   Dupont-Gillain, C. C.
   Marchand-Brynaert, J.
   Jonas, A. M.
   Rouxhet, P. G.
TI Oligo(ethylene glycol) monolayers by silanization of silicon wafers:
   Real nature and stability
SO JOURNAL OF COLLOID AND INTERFACE SCIENCE
LA English
DT Article
DE silane; PEO; XPS; PCA; PBS; stability; OEG
ID SELF-ASSEMBLED MONOLAYERS; RAY PHOTOELECTRON-SPECTROSCOPY; POLY(ETHYLENE
   GLYCOL); PROTEIN ADSORPTION; RESISTANT SURFACES; SILANE MONOLAYERS;
   OXIDE); ALKYLTRICHLOROSILANES; ADHESION; GOLD
AB Grafting silicon wafers with CH3O-(CH2-CH2-O)(n)-C3H6-trimethoxysilane and -trichlorosilane (n = 6 to 9) was performed in different conditions (solvent, reaction time, washing) in order to select procedures compatible with the design of nanostructured surfaces for biomaterial applications, using electron-beam lithography. After a first screening by principal component analysis (PCA), the X-ray photoelectron spectroscopy (XPS) data were analyzed by plotting the carbon to oxygen molar ratio vs the molar ratio of carbon singly bound to oxygen [C-O] over carbon bound only to carbon and hydrogen [C-(C,H)]. This was found to be a convenient method for discarding samples containing free polymerized silane. Such excess occurred as a result of insufficient washing or unsuitable solvent for the reaction (ether), as confirmed by AFM and thickness measured by X-ray reflectometry. Angle resolved XPS analysis indicated that the grafted silane layer had a 1-2 nm thickness and was covered by a thin layer of adventitious contaminant. As a result, the surface chemical composition obtained covered a broad range (O/C of 0.4 to 1.1; C-O/C-(C,H) of 2.5 to 6.5); variations could not be related to the nature of the silane reagent and no significant difference was found between hexane and toluene as solvent for the reaction. The grafted silane layer was not stable upon incubation during 24 h in phosphate buffered saline (PBS) at 37 degrees C, which mimics biological environments. As a consequence, the grafted wafers did not show protein repellent properties. This alteration was not observed at room temperature. XPS analysis demonstrated that silane layer detachment was due to a hydrolysis within the SiO2 layer initially present at the wafer surface.
C1 [Dekeyser, C. M.; Mc Evoy, K.; Dupont-Gillain, C. C.; Rouxhet, P. G.] Univ Catholique Louvain, Unite Chim Interfaces, B-1348 Louvain, Belgium.
   [Dekeyser, C. M.; Marchand-Brynaert, J.] Univ Catholique Louvain, Unite Chim Organ & Med, B-1348 Louvain, Belgium.
   [Buron, C. C.; Jonas, A. M.] Univ Catholique Louvain, Unite Chim & Phys Hauts Polymeres, B-1348 Louvain, Belgium.
RP Rouxhet, PG (reprint author), Univ Catholique Louvain, Unite Chim Interfaces, Croix Sud 2-18, B-1348 Louvain, Belgium.
EM paul.rouxhet@uclouvain.be
RI Jonas, Alain/J-5232-2012
OI Jonas, Alain/0000-0002-4083-0688; Buron, Cedric/0000-0001-9067-7856
CR Alcantar NA, 2000, J BIOMED MATER RES, V51, P343, DOI 10.1002/1097-4636(20000905)51:3<343::AID-JBM7>3.0.CO;2-D
   AMIJI M, 1992, BIOMATERIALS, V13, P682, DOI 10.1016/0142-9612(92)90128-B
   Andrade JD, 1996, ADV CHEM SER, V248, P51
   Arys X, 2001, MACROMOLECULES, V34, P3318, DOI 10.1021/ma010092s
   Branch DW, 2001, BIOMATERIALS, V22, P1035, DOI 10.1016/S0142-9612(00)00343-4
   BRERETON RG, 2003, CHEMOMETRICS DATA AN
   BRZOSKA JB, 1994, LANGMUIR, V10, P4367, DOI 10.1021/la00023a072
   Cecchet F, 2006, LANGMUIR, V22, P1173, DOI 10.1021/la052507z
   Cheng HL, 1999, J POLYM RES-TAIWAN, V6, P123, DOI 10.1007/s10965-006-0079-y
   Denis FA, 2005, SMALL, V1, P984, DOI 10.1002/smll.200500116
   Denis FA, 2004, LANGMUIR, V20, P9335, DOI 10.1021/la049188g
   Dewez JL, 1998, BIOMATERIALS, V19, P1441, DOI 10.1016/S0142-9612(98)00055-6
   Dewez JL, 1997, J COLLOID INTERF SCI, V191, P1, DOI 10.1006/jcis.1997.4908
   Fadeev AY, 2000, LANGMUIR, V16, P7268, DOI 10.1021/la000471z
   GENET MJ, 2008, MED APPL CO IN PRESS, pCH5
   GERIN PA, 1995, J CHIM PHYS PCB, V92, P1043, DOI 10.1051/jcp/1995921043
   Herrwerth S, 2003, J AM CHEM SOC, V125, P9359, DOI 10.1021/ja034820y
   LEE JH, 1989, J BIOMED MATER RES, V23, P351, DOI 10.1002/jbm.820230306
   Lee SW, 1998, BIOMATERIALS, V19, P1669, DOI 10.1016/S0142-9612(98)00044-1
   Li LY, 2005, J PHYS CHEM B, V109, P2934, DOI 10.1021/jp0473321
   MARSDEN C, 1954, SOLVENTS MANUAL
   Michel R, 2005, LANGMUIR, V21, P12327, DOI 10.1021/la051726h
   Mougin K, 2004, LANGMUIR, V20, P4302, DOI 10.1021/la049824n
   Onclin S, 2005, ANGEW CHEM INT EDIT, V44, P6282, DOI 10.1002/anie.200500633
   Ostuni E, 1999, COLLOID SURFACE B, V15, P3, DOI 10.1016/S0927-7765(99)00004-1
   Pallandre A, 2004, NANO LETT, V4, P365, DOI 10.1021/nl035045n
   Papra A, 2001, LANGMUIR, V17, P1457, DOI 10.1021/la000609d
   Roosjen A, 2005, J BIOMED MATER RES B, V73B, P347, DOI 10.1002/jbm.b.30227
   Rye RR, 1997, LANGMUIR, V13, P2965, DOI 10.1021/la960919p
   Saq'an SA, 2004, OPT MATER, V24, P629, DOI 10.1016/S0925-3467(03)00166-6
   Sharma S, 2004, LANGMUIR, V20, P348, DOI 10.1021/la0347531
   Tanuma S, 1997, SURF INTERFACE ANAL, V25, P25, DOI 10.1002/(SICI)1096-9918(199701)25:1<25::AID-SIA207>3.3.CO;2-U
   Ulman A., 1991, INTRO ULTRATHIN ORGA
   Veiseh M, 2004, BIOMATERIALS, V25, P3315, DOI 10.1016/j.biomaterials.2003.10.014
   Vereecke G, 1998, SURF INTERFACE ANAL, V26, P490, DOI 10.1002/(SICI)1096-9918(199806)26:7<490::AID-SIA392>3.0.CO;2-U
   Vitchev RG, 2004, APPL SURF SCI, V235, P21, DOI 10.1016/j.apsusc.2004.05.135
   Wang AF, 2005, J COLLOID INTERF SCI, V291, P438, DOI 10.1016/j.jcis.2005.05.008
   Wang MJ, 2005, LANGMUIR, V21, P1848, DOI 10.1021/la048483y
   WASSERMAN SR, 1989, LANGMUIR, V5, P1074, DOI 10.1021/la00088a035
   Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G
NR 40
TC 28
Z9 29
U1 2
U2 27
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0021-9797
J9 J COLLOID INTERF SCI
JI J. Colloid Interface Sci.
PD AUG
PY 2008
VL 324
IS 1-2
BP 118
EP 126
DI 10.1016/j.jcis.2008.05.002
PG 9
WC Chemistry, Physical
SC Chemistry
GA 320KJ
UT WOS:000257232100017
PM 18533173
DA 2018-10-19
ER

PT J
AU Mouzakis, DE
   Bouropoulos, N
   Kallidonis, P
   Karnabatidis, D
   Katsanos, K
   Constantinidis, C
   Perimenis, P
   Siamblis, D
   Liatsikos, EN
AF Mouzakis, Dionysios E.
   Bouropoulos, Nikolaos
   Kallidonis, Panagiotis
   Karnabatidis, Dimitrios
   Katsanos, Konstantinos
   Constantinidis, Constantinos
   Perimenis, Petros
   Siamblis, Dimitrios
   Liatsikos, Evangelos N.
TI Viscoelastic property mapping along encrusted polymeric urinary
   catheters
SO JOURNAL OF ENDOUROLOGY
LA English
DT Article
ID URETERAL STENT; DEPOSITION; BACTERIAL
AB Purpose: Mapping of the material viscoelastic property variation along the length axis of polymeric stents.
   Materials and Methods: Five pigtail ureteral stents and five percutaneous stents placed in vivo for different periods were studied. Viscoelastic property changes along the length of polymeric stents were measured using the dynamic mechanical analysis technique. The type of encrustations was identified using FT-IR spectroscopy and their morphology by scanning electron microscopy (SEM).
   Results: Variations in viscoelastic stiffness were confirmed for both types of stents. In a few cases, the variation was quite large (400%). Various encrustation types and/or organic sheathing of the salt were found to be responsible for this effect. In detail, calcium oxalate monohydrate (COM) plaques for percutaneous and COM/organic layer for pigtail stents were recognized by FT-IR spectroscopy and SEM observation to invoke reinforcing effects along the stent axes.
   Conclusions: The phenomenon of stiffness variation along the stent axes requires further study to understand the mechanism behind it and consequently to improve the biomaterial and design of specific areas of stents as well as to avoid encrustations. This further research might lead in the near future to the development of new types of polymer stents for drug-eluting specialized areas.
C1 [Kallidonis, Panagiotis; Perimenis, Petros; Liatsikos, Evangelos N.] Univ Patras, Sch Med, Dept Urol, Patras 26500, Greece.
   [Mouzakis, Dionysios E.; Bouropoulos, Nikolaos] Univ Patras, Dept Mat Sci, Patras 26500, Greece.
   [Karnabatidis, Dimitrios; Katsanos, Konstantinos; Siamblis, Dimitrios] Univ Patras, Sch Med, Dept Radiol, Patras 26500, Greece.
   [Constantinidis, Constantinos] Univ Athens, Sch Med, Laikon Gen Hosp, Dept Urol, GR-11527 Athens, Greece.
RP Liatsikos, EN (reprint author), Univ Patras, Sch Med, Dept Urol, Patras 26500, Greece.
EM liatsikos@yahoo.com
OI Mouzakis, Dionysios E./0000-0001-5842-5202
CR Beiko DT, 2004, J UROLOGY, V171, P2438, DOI 10.1097/01.ju.0000125001.56045.6c
   Beiko DT, 2003, J ENDOUROL, V17, P195, DOI 10.1089/089277903765444294
   Bithelis G, 2004, J ENDOUROL, V18, P550, DOI 10.1089/end.2004.18.550
   Christensen R., 1982, THEORY VISCOELASTICI
   Damiano R, 2002, UROL INT, V69, P136, DOI 10.1159/000065563
   ELSHERIF A, 1995, BRIT J UROL, V76, P108, DOI 10.1111/j.1464-410X.1995.tb07842.x
   GANDERTON L, 1992, EUR J CLIN MICROBIOL, V11, P789, DOI 10.1007/BF01960877
   Kehinde EO, 2002, J UROLOGY, V167, P1334, DOI 10.1016/S0022-5347(05)65294-9
   Lawrentschuk N, 2004, ANZ J SURG, V74, P243, DOI 10.1111/j.1445-2197.2004.02947.x
   Mouzakis DE, 2006, J ENDOUROL, V20, P64, DOI 10.1089/end.2006.20.64
   MOUZAKIS DE, 1999, THESIS BERLIN
   MOUZAKIS DE, 2002, J MATER SCI, V35, P1
   OSWALT GC, 1979, J UROLOGY, V122, P249, DOI 10.1016/S0022-5347(17)56350-8
   REID G, 1995, COLLOID SURFACE B, V5, P171, DOI 10.1016/0927-7765(95)01208-Z
   Richter S, 2000, BJU INT, V85, P408, DOI 10.1046/j.1464-410x.2000.00478.x
   Robert M, 1997, UROL INT, V58, P100, DOI 10.1159/000282959
   Tieszer C, 1998, J UROLOGY, V160, P876, DOI 10.1016/S0022-5347(01)62825-8
NR 17
TC 0
Z9 0
U1 0
U2 5
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0892-7790
J9 J ENDOUROL
JI J. Endourol.
PD AUG
PY 2008
VL 22
IS 8
BP 1761
EP 1769
DI 10.1089/end.2007.0423
PG 9
WC Urology & Nephrology
SC Urology & Nephrology
GA 345YP
UT WOS:000259034700036
PM 18721048
DA 2018-10-19
ER

PT J
AU Nagai, N
   Okauchi, M
   Rodriguez, A
   Gunduz, M
   Hu, HL
   Kubota, M
   Nagaoka, N
   Inoue, M
   Nagatsuka, H
   Takagi, T
   Akao, M
AF Nagai, Noriyuki
   Okauchi, Mika
   Rodriguez, Andrea
   Gunduz, Mehmet
   Hu, Hailong
   Kubota, Midori
   Nagaoka, Noriyuki
   Inoue, Miho
   Nagatsuka, Hitoshi
   Takagi, Tohru
   Akao, Masaru
TI Development of New Titanium Coating Material (CaTiO3-aC) with Modified
   Thermal Decomposition Method
SO JOURNAL OF HARD TISSUE BIOLOGY
LA English
DT Article
DE Biomaterial; Titanium; Carbon; HA; Coating material; CaTiO3-aC
AB We developed a novel method for titanium coating material using modified thermal decomposition technique, specifically focusing on presence of CaTiO3 and carbon C. Two layers of thin film coating composed of CaTiO3-amorphous carbon compound (CaTiO3-aC) and hydroxyapatite (HA) were generated on titanium surface. In this method, ratios of Ca/P as well as Ca/Ti, sintering temperature and sintering velocity were carefully planned. Within crystal structure of CaTiO3 granules, 4 atomic % of carbon in amorphous state was included. By our method, inclusion of carbon in HA suggested formation of carbonate apatite. Regarding with attachment-detachment experiment at titanium surface, adhesion strength was 2.5 times stronger in CaTiO(3)aC/FIA coating substrate as compared to HA only coating material. Results of the novel developed modified thermal decomposition method suggested that the 2 layers biomaterial composed of CaTiO3-aC (0.6 mu m) and carbonate apatite-included HA (2.4 mu m) can be used as a coating material on titanium surface.
C1 [Nagai, Noriyuki; Okauchi, Mika; Rodriguez, Andrea; Gunduz, Mehmet; Hu, Hailong; Kubota, Midori; Nagaoka, Noriyuki; Inoue, Miho; Nagatsuka, Hitoshi; Takagi, Tohru] Okayama Univ, Dept Oral Pathol & Med, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008525, Japan.
   [Nagai, Noriyuki; Takagi, Tohru; Akao, Masaru] Int Dent Hygienist Coll Okayama, Ctr Oral Hlth Sci, Okayama, Japan.
RP Nagai, N (reprint author), Okayama Univ, Dept Oral Pathol & Med, Grad Sch Med Dent & Pharmaceut Sci, 2-5-1 Shikatacho, Okayama 7008525, Japan.
EM nori@md.okayama-u.ac.jp
FU Japan Society for the Promotion of Science [17406027, 19592236]
FX This work was supported by Grant-in-Aid for Scientific Research(B)
   (17406027) and (C) (19592236) from the Japan Society for the Promotion
   of Science.
CR Brossa F., 1993, Bio-Medical Materials and Engineering, V3, P127
   DACULSI G, 1990, SCANNING MICROSCOPY, V4, P309
   DEBRUIJIN JD, 1992, J BIOMED MATER RES, V26, P1356
   DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203
   ELLIES LG, 1992, BIOMATERIALS, V13, P313, DOI 10.1016/0142-9612(92)90055-S
   Fujishiro Y, 1998, J MATER SCI-MATER M, V9, P363, DOI 10.1023/A:1013201627622
   Hasegawa Seiichiro, 1996, Bulletin of Tokyo Medical and Dental University, V43, P25
   Kilpadi DV, 2000, INT J ORAL MAX IMPL, V15, P219
   Kweh SWK, 2002, BIOMATERIALS, V23, P381, DOI 10.1016/S0142-9612(01)00116-8
   LIN JHC, 1994, J BIOMED MATER RES, V28, P723, DOI 10.1002/jbm.820280609
   Lynn AK, 2002, BIOMATERIALS, V23, P1937, DOI 10.1016/S0142-9612(01)00321-0
   OHTSU N, 2007, J MAT SCI MAT MED, V18
   Ohtsu N, 2007, J BIOMED MATER RES A, V82A, P304, DOI 10.1002/jbm.a.31136
   OHTSUKA Y, 1994, SURF COAT TECH, V65, P224, DOI 10.1016/S0257-8972(94)80037-5
   ORLY I, 1989, CALCIFIED TISSUE INT, V45, P20, DOI 10.1007/BF02556656
   RADIN SR, 1992, J MATER SCI-MATER M, V3, P33, DOI 10.1007/BF00702942
   UKEGAWA Y, 1992, J JPN ORTHOP ASSOC, V66, P688
   Wang CK, 1997, BIOMATERIALS, V18, P1331, DOI 10.1016/S0142-9612(97)00024-0
   Webster TJ, 2003, J BIOMED MATER RES A, V67A, P975, DOI 10.1002/jbm.a.10160
   Zhou P, 1997, BIO-MED MATER ENG, V7, P67
NR 20
TC 4
Z9 4
U1 2
U2 3
PU JOURNAL HARD TISSUE BIOLOGY
PI MINATO KU
PA NIHON GAKUKUTSU KYORYOKU ZAIDAN, 3- 24- 20, NISHIAZABU, MINATO KU, TOKYO
   106-0031, JAPAN
SN 1341-7649
J9 J HARD TISSUE BIOL
JI J. Hard Tissue Biol.
PD AUG
PY 2008
VL 17
IS 2
BP 47
EP 54
DI 10.2485/jhtb.17.47
PG 8
WC Engineering, Biomedical
SC Engineering
GA V11RY
UT WOS:000207549900002
OA Bronze
DA 2018-10-19
ER

PT J
AU Acharya, C
   Ghosh, SK
   Kundu, SC
AF Acharya, Chitrangada
   Ghosh, Sudip K.
   Kundu, S. C.
TI Silk fibroin protein from mulberry and non-mulberry silkworms:
   cytotoxicity, biocompatibility and kinetics of L929 murine fibroblast
   adhesion
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID TROPICAL TASAR SILKWORM; IN-VITRO; ANTHERAEA-MYLITTA; INFLAMMATORY
   RESPONSES; RAW-264.7 MACROPHAGES; CELL-ADHESION; BOMBYX-MORI;
   ATTACHMENT; SERICIN; GROWTH
AB Silks fibers and films fabricated from fibroin protein of domesticated mulberry silkworm cocoon have been traditionally utilized as sutures in surgery and recently as biomaterial films respectively. Here, we explore the possibility of application of silk fibroin protein from non-mulberry silkworm cocoon as a potential biomaterial aid. In terms of direct inflammatory potential, fibroin proteins from Antheraea mylitta and Bombyx mori are immunologically inert and invoke minimal immune response. Stimulation of murine peritoneal macrophages and RAW 264.7 murine macrophages by these fibroin proteins both in solution and in the form of films assayed in terms of nitric oxide and TNF alpha production showed comparable stimulation as in collagen. Kinetics of adhesion of L929 murine fibroblasts, for biocompatibility evaluation, monitored every 4 h from seeding and studied over a period of 24 h, reveal A. mylitta fibroin film to be a better substrate in terms of rapid and easier cellularization. Cell viability studies by MTT assay and flow cytometric analyses indicate the ability of fibroin matrices to support cell growth and proliferation comparable to collagen for long-term culture. This matrix may have potential to serve in those injuries where rapid cellularization is essential.
C1 [Acharya, Chitrangada; Ghosh, Sudip K.; Kundu, S. C.] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
RP Kundu, SC (reprint author), Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
EM kundu@hijli.iitkgp.ernet.in
RI Kundu, Subhas/P-1989-2016
OI Kundu, Subhas/0000-0002-7170-2291
CR ACHARYA C, 2008, BIOTECHNOLOGY J, V3, P2
   Akai H, 2000, INT J WILD SILKMOTHS, V5, P255
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Bruns S, 2007, J BIOTECHNOL, V131, P335, DOI 10.1016/j.jbiotec.2007.06.024
   Cai KY, 2002, BIOMATERIALS, V23, P1153, DOI 10.1016/S0142-9612(01)00230-7
   Chiarini A, 2003, BIOMATERIALS, V24, P789, DOI 10.1016/S0142-9612(02)00417-9
   Crellin NK, 2007, J IMMUNOL METHODS, V324, P92, DOI 10.1016/j.jim.2007.05.008
   Dash R, 2007, COMP BIOCHEM PHYS B, V147, P129, DOI 10.1016/j.cbpb.2007.01.009
   Datta A, 2001, COMP BIOCHEM PHYS B, V129, P197, DOI 10.1016/S1096-4959(01)00377-3
   Datta A, 2001, INSECT BIOCHEM MOLEC, V31, P1013, DOI 10.1016/S0965-1748(01)00049-2
   EGCZKAOSYCZKA A, 1997, BIOMATERIALS, V18, P1243
   GAMO T, 1977, INSECT BIOCHEM, V7, P285, DOI 10.1016/0020-1790(77)90026-9
   Gotoh Y, 2004, BIOMATERIALS, V25, P1131, DOI 10.1016/S0142-9612(03)00633-1
   Guillou-Buffello D., 2005, BIOMATERIALS, V26, P4197
   Hofer M, 2007, INT IMMUNOPHARMACOL, V7, P1369, DOI 10.1016/j.intimp.2007.06.003
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   HOROWITZ SM, 1995, J BIOMED MATER RES, V29, P477, DOI 10.1002/jbm.820290407
   HUG TS, 2003, ASSAY DRUG DEV TECHN, V1, P1
   LEE Y, 1999, FAO AGR SERICES B, V136, pCH2
   Mahendran B, 2006, GENE, V370, P51, DOI 10.1016/j.gene.2005.11.010
   MAHENDRAN B, 2006, J GENET, V85, P1
   Mahendran B, 2006, J BIOCHEM MOL BIOL, V39, P522
   Mao JS, 2004, BIOMATERIALS, V25, P3973, DOI 10.1016/j.biomaterials.2003.10.080
   Mauney JR, 2007, BIOMATERIALS, V28, P5280, DOI 10.1016/j.biomaterials.2007.08.017
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   MINOURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511, DOI 10.1006/bbrc.1995.1368
   Miyatake K, 2007, BIOCHEM BIOPH RES CO, V360, P115, DOI 10.1016/j.bbrc.2007.06.009
   MORI H, 2000, REV MOL BIOTECHNOL, V74, P95, DOI DOI 10.1016/S1389-0352(00)00004-0
   MOSSMANN T, 1983, J IMMUNOL METHODS, V65, P55
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   PIERSCHBACHER MD, 1984, P NATL ACAD SCI-BIOL, V81, P5985, DOI 10.1073/pnas.81.19.5985
   POSTE G, 1980, NATURE, V309, P30
   Radhika M, 1999, COMP BIOCHEM PHYS C, V124, P131, DOI 10.1016/S0742-8413(99)00042-0
   RAE T, 1986, CRIT REV BIOCOMPAT, V2, P97
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   SHAMITHA G, 2000, INT J WILD SILKMOTHS, V5, P274
   SHANBHAG AS, 1995, J ORTHOPAED RES, V13, P792, DOI 10.1002/jor.1100130520
   SHANBHAG AS, 1994, J BIOMED MATER RES, V28, P81, DOI 10.1002/jbm.820280111
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Takasu Y, 2002, BIOSCI BIOTECH BIOCH, V66, P2715, DOI 10.1271/bbb.66.2715
   TAMURA T, 1988, INSECT BIOCHEM, V18, P169, DOI 10.1016/0020-1790(88)90021-2
   Unger RE, 2004, BIOMATERIALS, V25, P1069, DOI [10.1016/S0142-9612(03)00619-7, 10.1016/S0142-9612(03)00630-6]
   VOGLER EA, 1988, BIOPHYS J, V53, P759, DOI 10.1016/S0006-3495(88)83156-4
NR 45
TC 71
Z9 73
U1 1
U2 25
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD AUG
PY 2008
VL 19
IS 8
BP 2827
EP 2836
DI 10.1007/s10856-008-3408-3
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 309QZ
UT WOS:000256476600007
PM 18322779
DA 2018-10-19
ER

PT J
AU Mazzocchi, M
   Gardini, D
   Traverso, PL
   Faga, MG
   Bellosi, A
AF Mazzocchi, Mauro
   Gardini, Davide
   Traverso, Pier Luigi
   Faga, Maria Giulia
   Bellosi, Alida
TI On the possibility of silicon nitride as a ceramic for structural
   orthopaedic implants. Part II: chemical stability and wear resistance in
   body environment
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID PROCESSING ROUTES; IN-VITRO; WETTABILITY; FRICTION; JOINT;
   BIOCOMPATIBILITY; COMPOSITES; PROTEINS; ADHESION; CONTACT
AB In Part I, the processing, microstructure and mechanical properties of three silicon nitride-based ceramics were examined and their non-toxicity was demonstrated. In this Part II, some features critical to biomedical applications were investigated: (i) the wetting behaviour against aqueous media, including physiological solutions; (ii) the chemical stability in water and in physiological solutions; and (iii) the wear resistance, measured under experimental procedures that simulate the conditions typical of the hip joint prosthesis. The results confirmed that silicon nitride may serve as a biomaterial for bone substitution in load bearing prosthesis.
C1 [Mazzocchi, Mauro; Gardini, Davide; Bellosi, Alida] CNR, Inst Sci & Technol Ceram, I-48018 Faenza, Ravenna, Italy.
   [Traverso, Pier Luigi] CNR, Harine Sci Inst Unit Genova, I-16149 Genoa, Italy.
   [Faga, Maria Giulia] CNR, Inst Sci & Technol Ceram Unit, I-10135 Turin, Italy.
RP Mazzocchi, M (reprint author), CNR, Inst Sci & Technol Ceram, Via Granarolo 64, I-48018 Faenza, Ravenna, Italy.
EM mauro.mazzocchi@istec.cnr.it
RI Mazzocchi, Mauro/D-9631-2016; Gardini, Davide/A-8708-2012; Bellosi,
   Alida/B-6167-2014
OI Mazzocchi, Mauro/0000-0002-0243-6890; Gardini,
   Davide/0000-0002-8879-6044; Faga, Maria Giulia/0000-0003-1290-3314;
   Traverso, Pierluigi/0000-0003-0111-5531
CR ABREAU CS, 2002, KEY ENG MATER, V230, P919
   AGATHOPOULOS S, 1995, J BIOMED MATER RES, V29, P421, DOI 10.1002/jbm.820290402
   AGATHOPOULOS S, 1995, EUROCERAMICS 4, V8, P319
   AKAZAWA M, 1988, WEAR, V124, P123, DOI 10.1016/0043-1648(88)90239-6
   Aldini NN, 2002, J BIOMED MATER RES, V61, P282, DOI 10.1002/jbm.10162
   Amaral M, 2002, BIOMATERIALS, V23, P4123, DOI 10.1016/S0142-9612(02)00155-2
   Amaral M, 2002, BIOMATERIALS, V23, P857, DOI 10.1016/S0142-9612(01)00194-6
   Annarelli CC, 1999, J COLLOID INTERF SCI, V213, P386, DOI 10.1006/jcis.1999.6153
   BELLOSI A, 1992, J EUROP CERAM SOC, P983
   BELLOSI A, 1999, NATO ARW SERIES, P285
   Bondanini A, 2001, J MATER SCI, V36, P4851, DOI 10.1023/A:1011890926908
   Galassi C, 2000, J MATER RES, V15, P155, DOI 10.1557/JMR.2000.0026
   Giannoulis CS, 2002, J MATER SCI-MATER M, V13, P75, DOI 10.1023/A:1013646805593
   HAYNES CA, 1994, COLLOID SURFACE B, V2, P517
   HEIMKE G, 2000, BIOMATERIALS ENG DEV, V2, P253
   Howlett C., 1989, CLIN ORTHOP RELAT R, V244, P296
   IKEUCHI K, 2000, J CERAMIC PROCESSING, V1, P53
   JAHANMIR S, 1988, TRIBOL T, V31, P32, DOI 10.1080/10402008808981795
   Krajewski A, 1998, BIOMATERIALS, V19, P637, DOI 10.1016/S0142-9612(97)00153-1
   Kue R, 1999, BIOMATERIALS, V20, P1195, DOI 10.1016/S0142-9612(99)00007-1
   Kusaka J, 1999, WEAR, V225, P734, DOI 10.1016/S0043-1648(98)00386-X
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   Lopes MA, 1999, J BIOMED MATER RES, V45, P370, DOI 10.1002/(SICI)1097-4636(19990615)45:4<370::AID-JBM12>3.0.CO;2-0
   MAIER HR, 2004, CFI-CERAM FORUM INT, V81, P33
   MAZZOCCHI M, J MAT SCI MAT MED
   Murakami T, 2002, KEY ENG MAT, V218-2, P521, DOI 10.4028/www.scientific.net/KEM.218-220.521
   Neumann A, 2004, J MATER SCI-MATER M, V15, P1135, DOI 10.1023/B:JMSM.0000046396.14073.92
   NEUMANN A, 2004, WERKSTOFFTECH, V35, P569
   Rosengren A, 2003, BIOMATERIALS, V24, P147, DOI 10.1016/S0142-9612(02)00272-7
   Silva CCG, 2004, MAT SCI ENG C-BIO S, V24, P643, DOI 10.1016/j.msec.2004.08.007
   SOHRABI A, 2000, J BIOMED MATER RES, V50, P49
   SORRELL CC, 1999, P 5 M SEM IMPL SPIN, P47
   Spriano S, 2005, WEAR, V259, P919, DOI 10.1016/j.wear.2005.02.011
   Willmann G, 2001, ADV ENG MATER, V3, P135, DOI 10.1002/1527-2648(200103)3:3<135::AID-ADEM135>3.3.CO;2-2
   WILLMANN G, 2002, CFI-CERAM FORUM INT, V79, P27
   Zhou YS, 1997, WEAR, V210, P171, DOI 10.1016/S0043-1648(97)00066-5
   ZHOU YS, 1977, MAT SCI ENG C, V5, P125
NR 37
TC 46
Z9 47
U1 0
U2 19
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD AUG
PY 2008
VL 19
IS 8
BP 2889
EP 2901
DI 10.1007/s10856-008-3437-y
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 309QZ
UT WOS:000256476600015
PM 18415002
DA 2018-10-19
ER

PT J
AU Gellynck, K
   Verdonk, P
   Forsyth, R
   Almqvist, KF
   Van Nimmen, E
   Gheysens, T
   Mertens, J
   Van Langenhove, L
   Kiekens, P
   Verbruggen, G
AF Gellynck, Kris
   Verdonk, Peter
   Forsyth, Ramses
   Almqvist, Karl Fredrik
   Van Nimmen, Els
   Gheysens, Tom
   Mertens, Johan
   Van Langenhove, Lieva
   Kiekens, Paul
   Verbruggen, Gust
TI Biocompatibility and biodegradability of spider egg sac silk
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID FIBERS; PROTEINS; FIBROIN; BIOMATERIALS; CARTILAGE; SCAFFOLDS; SEQUENCE;
   BONE
AB Spider egg sac silk (SpESS) were enzymatically cleaned and their biodegradation in vivo and in vitro, as well as their biocompatibility were studied. Proteinase K treatment diminished the tenacity and the strain of the SpESS fibers in proportion to the enzyme concentration. Fibers treated with trypsin were not significantly affected. Tensile properties of Vicryl (R) , SpESS and of silkworm (Bombyx mori) silk fibers (SWS) were measured after incubation in phosphate buffered saline (PBS) at 37 degrees C up to 12 weeks. Biodegradation of SpESS and SWS was insignificant compared to Vicryl (R). Five milligram SpESS fibers from laboratory grown spiders (Araneus diadematus) were treated with proteinases before sterilization and subcutaneously implanted in Wistar rats. After 1, 4 and 7 weeks the immunological reaction was compared to untreated SpESS and polyglactin Vicryl (R) control samples. SpESS samples treated with trypsin only or in combination with a Proteinase K treatment induced less inflammatory reactions than untreated silk fibers. The enzymatical cleaning could diminish the tensile properties, but enhanced the biocompatibility of the SpESS fibers rendering them appropriate for use in biomaterial application where the slow biodegradability is an advantage.
C1 [Gellynck, Kris; Van Nimmen, Els; Van Langenhove, Lieva; Kiekens, Paul] Univ Ghent, Dept Text, Fac Sci Appl, B-9052 Ghent, Belgium.
   [Verdonk, Peter; Almqvist, Karl Fredrik] Ghent Univ Hosp, Dept Orthoped Surg, B-9000 Ghent, Belgium.
   [Forsyth, Ramses] Ghent Univ Hosp, N Goormaghtigh Inst Pathol, B-9000 Ghent, Belgium.
   [Gheysens, Tom; Mertens, Johan] Univ Ghent, Unit Anim Ecol Zoogeog & Nat Conservat, Dept Biol, Fac Sci, B-9000 Ghent, Belgium.
   [Verbruggen, Gust] Ghent Univ Hosp, Dept Rheumatol, B-9000 Ghent, Belgium.
RP Gellynck, K (reprint author), Univ Ghent, Dept Text, Fac Sci Appl, Technol PK 9, B-9052 Ghent, Belgium.
EM k.gellynck@ucl.ac.uk; Johan.mertens@ugent.be
RI gheysens, tom/J-5001-2012
OI gheysens, tom/0000-0002-8185-8986
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   [Anonymous], 1994, 109936 ISO
   Arai T, 2004, J APPL POLYM SCI, V91, P2383, DOI 10.1002/app.13393
   CASTELLI WA, 1978, ORAL SURG ORAL MED O, V45, P179, DOI 10.1016/0030-4220(78)90083-X
   DEBAKKER D, 2002, EUROPEAN ARACHNOLOGY, P356
   Fahnestock S R, 2000, J Biotechnol, V74, P105, DOI 10.1016/S1389-0352(00)00008-8
   Freddi G, 2003, J BIOTECHNOL, V106, P101, DOI 10.1016/j.jbiotec.2003.09.006
   Gheysens T, 2005, J ARACHNOL, V33, P549, DOI 10.1636/CS05-12.1
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0
   Huemmerich D, 2004, CURR BIOL, V14, P2070, DOI 10.1016/j.cub.2004.11.005
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Kubik S, 2002, ANGEW CHEM INT EDIT, V41, P2721, DOI 10.1002/1521-3773(20020802)41:15<2721::AID-ANIE2721>3.0.CO;2-3
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   LU L, 2001, CLIN ORTHOP S, V391, pS251
   Madsen B, 2000, NATURWISSENSCHAFTEN, V87, P148, DOI 10.1007/s001140050694
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   POSTLETHWAIT RW, 1975, ANN SURG, V181, P144
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Scheller J, 2001, NAT BIOTECHNOL, V19, P573, DOI 10.1038/89335
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   UFF CR, 1995, BIOMATERIALS, V16, P355, DOI 10.1016/0142-9612(95)93852-5
   VANNIMMEN E, 2003, J MAT PROD TECHNOL, V18, P345
   Viney C, 2000, J TEXT I, V91, P2, DOI 10.1080/00405000008659539
   Vollrath F, 2000, J Biotechnol, V74, P67
   Vollrath F, 1999, INT J BIOL MACROMOL, V24, P81, DOI 10.1016/S0141-8130(98)00076-2
   Vollrath F, 2002, IN VIVO, V16, P229
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
NR 29
TC 29
Z9 31
U1 1
U2 13
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD AUG
PY 2008
VL 19
IS 8
BP 2963
EP 2970
DI 10.1007/s10856-007-3330-0
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 309QZ
UT WOS:000256476600024
PM 18360800
DA 2018-10-19
ER

PT J
AU Wong, DY
   Leveque, JC
   Brumblay, H
   Krebsbach, PH
   Hollister, SJ
   LaMarca, F
AF Wong, Darice Y.
   Leveque, Jean-Christophe
   Brumblay, Hunter
   Krebsbach, Paul H.
   Hollister, Scott J.
   LaMarca, Frank
TI Macro-architectures in spinal cord scaffold implants influence
   regeneration
SO JOURNAL OF NEUROTRAUMA
LA English
DT Article
DE immunohistochemistry; in vivo studies; neural injury; polycaprolactone;
   regeneration; scaffold architecture; traumatic spinal cord injury
ID PERIPHERAL-NERVE GRAFTS; NEURAL STEM-CELLS; AXONAL REGENERATION;
   GUIDANCE CHANNELS; POLY(2-HYDROXYETHYL METHACRYLATE); FUNCTIONAL
   RECOVERY; BRAIN-STEM; INJURY; TRANSECTION; REPAIR
AB Biomaterial scaffold architecture has not been investigated as a tunable source of influence on spinal cord regeneration. This study compared regeneration in a transected spinal cord within various designed-macro-architecture scaffolds to determine if these architectures alone could enhance regeneration. Three-dimensional (3D) designs were created and molds were built on a 3-D printer. Salt-leached porous poly(epsilon-caprolactone) was cast in five different macro-architectures: cylinder, tube, channel, open-path with core, and open-path without core. The two open-path designs were created in this experiment to compare different supportive aspects of architecture provided by scaffolds and their influence on regeneration. Rats received T8 transections and implanted scaffolds for 1 and 3 months. Overall morphology and orientation of sections were characterized by H&E, luxol fast blue, and cresyl violet staining. Borders between intact gray matter and non-regenerated defect were observed from GFAP immunolabeling. Nerve fibers and regenerating axons were identified with Tuj-1 immunolabeling. The open-path designs allowed extension of myelinated fibers along the length of the defect both exterior to and inside the scaffolds and maintained their original defect length up to 3 months. In contrast, the cylinder, tube, and channel implants had a doubling of defect length from secondary damage and large scar and cyst formation with no neural tissue bridging. The open-path scaffold architectures enhanced spinal cord regeneration compared to the three other designs without the use of biological factors.
C1 [Leveque, Jean-Christophe; Brumblay, Hunter; Hollister, Scott J.; LaMarca, Frank] Univ Michigan, Dept Neurosurg, Ann Arbor, MI 48109 USA.
   [Wong, Darice Y.; Krebsbach, Paul H.; Hollister, Scott J.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
RP Hollister, SJ (reprint author), Univ Michigan, Dept Neurosurg, 1101 Beal Ave,2149 LBME, Ann Arbor, MI 48109 USA.
EM scottho@umich.edu
RI Leveque, Jean-Christophe/L-6367-2017
OI Leveque, Jean-Christophe/0000-0003-2465-444X
FU NIH [T32 DE-007057-31]
FX Thanks go to Alex Garnepudi for all his assistance. Funding was provided
   by NIH (training grant T32 DE-007057-31 to D.Y.W.).
CR Bakshi A, 2004, J NEUROSURG-SPINE, V1, P322, DOI 10.3171/spi.2004.1.3.0322
   Barnett SC, 2007, NAT CLIN PRACT NEURO, V3, P152, DOI 10.1038/ncpneuro0447
   Barritt AW, 2006, J NEUROSCI, V26, P10856, DOI 10.1523/JNEUROSCI.2980-06.2006
   Busch SA, 2007, CURR OPIN NEUROBIOL, V17, P120, DOI 10.1016/j.conb.2006.09.004
   Carone TW, 2006, J BIOMED MATER RES B, V78B, P274, DOI 10.1002/jbm.b.30483
   CLARK P, 1990, DEVELOPMENT, V108, P635
   CLARK P, 1991, J CELL SCI, V99, P73
   Dinh P, 2007, SPINE, V32, P943, DOI 10.1097/01.brs.0000261408.61303.77
   El Maarouf A, 2006, P NATL ACAD SCI USA, V103, P16989, DOI 10.1073/pnas.0608036103
   Flynn L, 2003, BIOMATERIALS, V24, P4265, DOI 10.1016/S0142-9612(03)00334-X
   Friedman JA, 2002, NEUROSURGERY, V51, P742, DOI 10.1097/00006123-200209000-00024
   Fukunaga S, 2004, J ORTHOP SCI, V9, P605, DOI 10.1007/s00776-004-0833-0
   Gelain F, 2007, J NANOSCI NANOTECHNO, V7, P424, DOI 10.1166/jnn.2007.154
   Goldner JS, 2006, BIOMATERIALS, V27, P460, DOI 10.1016/j.biomaterials.2005.06.035
   Hadlock T, 2006, EXPERT OPIN BIOL TH, V6, P1105, DOI 10.1517/14712598.6.11.1105
   Horn EM, 2007, J NEUROSURG-SPINE, V6, P133, DOI 10.3171/spi.2007.6.2.133
   HOULE JD, 1994, J NEURAL TRANSP PLAS, V5, P115, DOI 10.1155/NP.1994.115
   Houle JD, 2006, J NEUROSCI, V26, P7405, DOI 10.1523/JNEUROSCI.1166-06.2006
   Huang YC, 2005, J BIOMED MATER RES B, V74B, P659, DOI 10.1002/jbm.b.30267
   Hurtado A, 2006, BIOMATERIALS, V27, P430, DOI 10.1016/j.biomaterials.2005.07.014
   Ito Y, 1999, BIOMATERIALS, V20, P2333, DOI 10.1016/S0142-9612(99)00162-3
   Jones LL, 2003, J NEUROSCI, V23, P9276
   Kaegi S, 2002, EUR J NEUROSCI, V16, P249, DOI 10.1046/j.1460-9568.2002.02076.x
   Kuo HS, 2007, BIOCHEM BIOPH RES CO, V357, P1, DOI 10.1016/j.bbrc.2007.02.167
   Levi ADO, 2002, J NEUROSURG, V96, P197, DOI 10.3171/spi.2002.96.2.0197
   Li XG, 2006, PROG NAT SCI, V16, P1051
   Maier IC, 2006, PHILOS T R SOC B, V361, P1611, DOI 10.1098/rstb.2006.1890
   Miller C, 2002, TISSUE ENG, V8, P367, DOI 10.1089/107632702760184646
   MORI S, 1992, BRAIN DEV-JPN, V14, pS109
   NOGA BR, 1991, J NEUROSCI, V11, P1691
   Nomura H, 2006, J NEUROTRAUM, V23, P496, DOI 10.1089/neu.2006.23.496
   Nomura H, 2006, NEUROSURGERY, V59, P183, DOI 10.1227/NEU.0000219859.35349.EF
   Novikova LN, 2003, CURR OPIN NEUROL, V16, P711, DOI 10.1097/01.wco.0000102620.38669.3e
   Oudega M, 2001, BIOMATERIALS, V22, P1125, DOI 10.1016/S0142-9612(00)00346-X
   Oudega M, 1999, EUR J NEUROSCI, V11, P2453, DOI 10.1046/j.1460-9568.1999.00666.x
   Patist CM, 2004, BIOMATERIALS, V25, P1569, DOI 10.1016/S0142-9612(03)00503-9
   Schucht P, 2002, EXP NEUROL, V176, P143, DOI 10.1006/exnr.2002.7909
   Schwab JM, 2006, PROG NEUROBIOL, V78, P91, DOI 10.1016/j.pneurobio.2005.12.004
   Schwab ME, 2002, SCIENCE, V295, P1029, DOI 10.1126/science.1067840
   Stokols S, 2006, TISSUE ENG, V12, P2777, DOI 10.1089/ten.2006.12.2777
   Tate MC, 2002, CELL TRANSPLANT, V11, P283
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899
   THOENEN H, 1991, TRENDS NEUROSCI, V14, P165, DOI 10.1016/0166-2236(91)90097-E
   Tsai EC, 2006, BIOMATERIALS, V27, P519, DOI 10.1016/j.biomaterials.2005.07.025
   Tsai EC, 2004, J NEUROTRAUM, V21, P789, DOI 10.1089/0897715041269687
   Wong DY, 2007, TISSUE ENG, V13, P2515, DOI 10.1089/ten.2006.0440
   Yoshii S, 2004, J BIOMED MATER RES A, V70A, P569, DOI 10.1002/jbm.a.30120
   Yoshii S, 2003, SPINE, V28, P2346, DOI 10.1097/01.BRS.0000085302.95413.16
   Zhang N, 2005, BRAIN RES REV, V49, P48, DOI 10.1016/j.brainresrev.2004.11.002
NR 49
TC 36
Z9 38
U1 0
U2 22
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0897-7151
J9 J NEUROTRAUM
JI J. Neurotrauma
PD AUG
PY 2008
VL 25
IS 8
BP 1027
EP 1037
DI 10.1089/neu.2007.0473
PG 11
WC Critical Care Medicine; Clinical Neurology; Neurosciences
SC General & Internal Medicine; Neurosciences & Neurology
GA 343ZT
UT WOS:000258895700009
PM 18721107
OA Green Published
DA 2018-10-19
ER

PT J
AU Jeon, JH
   Piepgrass, WT
   Lin, YL
   Thornas, MV
   Puleo, DA
AF Jeon, Ju Hyeong
   Piepgrass, Ward T.
   Lin, Yi-Ling
   Thornas, Mark V.
   Puleo, David A.
TI Localized intermittent delivery of simvastatin hydroxyacid stimulates
   bone formation in rats
SO JOURNAL OF PERIODONTOLOGY
LA English
DT Article
DE controlled release; osteogenesis; simvastatin; simvastatin hydroxyacid;
   sustained release
ID BIOMATERIAL OG-PLG; IN-VITRO; MORPHOGENETIC PROTEINS; STATINS; RELEASE;
   CELLS; DIFFERENTIATION; REGENERATION; INDUCTION; MC3T3-E1
AB Background: The cholesterol-lowering drug simvastatin promotes bone formation in cell cultures and animal models. In previous studies, devices for the controlled, localized delivery of simvastatin hydroxyacid enhanced osteoblastic activity in vitro. The objective of this investigation was to determine bioactivity,of the delivery system in vivo.
   Methods: Devices for sustained or intermittent release of simvastatin hydroxyacid were formed using a blend of cellulose acetate phthalate and a poly(ethylene oxide) and poly(propylene oxide) block copolymer, and they were implanted directly over the calvarium of young male rats. Drug-free devices were used as controls. After 9, 18, or 28 days, specimens were histologically evaluated for new bone formation.
   Results: All three groups showed some level of new bone formation, but the extent of osteogenesis depended on the type of implant. Devices delivering simvastatin hydroxyacid were associated witha 77.5% to 133% increase in new woven bone thickness compared to control devices without a drug (P < 0.05). Furthermore, intermittent release stimulated a 32.3% greater response in bone thickness and a 74.1% greater bone area than did sustained delivery (P < 0.05). Although a minimal thickness of woven bone was formed directly under the device (up to 36 mu m), a significantly thicker layer was observed at the periphery (up to 205 mu m), implying mechanical and/or chemical effects directly under the implant. The percentage of lamellar bone area for intermittent and sustained release was higher than that for the control group (P < 0.05).
   Conclusion: Based on the present results of enhanced bone formation, these devices for the intermittent delivery of simvastatin hydroxyacid merit further attention for localized osteogenesis.
C1 [Puleo, David A.] Univ Kentucky, Ctr Biomed Engn, Wenner Gren Lab, Lexington, KY 40506 USA.
   [Piepgrass, Ward T.; Thornas, Mark V.] Univ Kentucky, Coll Dent, Div Periodontol, Lexington, KY 40506 USA.
   [Lin, Yi-Ling] Univ Kentucky, Coll Dent, Div Oral Pathol, Lexington, KY 40506 USA.
RP Puleo, DA (reprint author), Univ Kentucky, Ctr Biomed Engn, Wenner Gren Lab, Lexington, KY 40506 USA.
EM puleo@uky.edu
FU NIAMS NIH HHS [AR048700]
CR ADAMI S, 1987, CALCIFIED TISSUE INT, V41, P326, DOI 10.1007/BF02556671
   Andriano KP, 2000, J BIOMED MATER RES, V53, P36, DOI 10.1002/(SICI)1097-4636(2000)53:1<36::AID-JBM5>3.0.CO;2-H
   Carson JS, 2007, INJURY, V38, pS33, DOI 10.1016/j.injury.2007.02.008
   Cochran DL, 1999, J PERIODONTOL, V70, P139, DOI 10.1902/jop.1999.70.2.139
   Garrett IR, 2007, J ORTHOP RES, V25, P1351, DOI 10.1002/jor.20391
   Garrett IR, 2001, CURR PHARM DESIGN, V7, P715, DOI 10.2174/1381612013397762
   GOLDRING MB, 1990, CLIN ORTHOP RELAT R, P245
   Grasser W. A., 2003, Journal of Musculoskeletal & Neuronal Interactions, V3, P53
   Greenwald AS, 2001, J BONE JOINT SURG AM, V83A, P98, DOI 10.2106/00004623-200100022-00007
   Hughes A, 2007, CALCIFIED TISSUE INT, V81, P403, DOI 10.1007/s00223-007-9078-1
   Ikada Y, 2000, MACROMOL RAPID COMM, V21, P117, DOI 10.1002/(SICI)1521-3927(20000201)21:3<117::AID-MARC117>3.0.CO;2-X
   Ismail FA, 2006, DRUG DEV IND PHARM, V32, P1199, DOI 10.1080/03639040600751886
   Jeon JH, 2007, INT J PHARM, V340, P6, DOI 10.1016/j.ijpharm.2007.03.007
   Kirker-Head CA, 2007, JAVMA-J AM VET MED A, V231, P1039, DOI 10.2460/javma.231.7.1039
   Kureishi Y, 2000, NAT MED, V6, P1004
   Maeda T, 2004, J CELL BIOCHEM, V92, P458, DOI 10.1002/jcb.20072
   Mistry AS, 2005, ADV BIOCHEM ENG BIOT, V94, P1, DOI 10.1007/b99997
   Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946
   Nkenke E, 2001, CLIN ORAL IMPLAN RES, V12, P495, DOI 10.1034/j.1600-0501.2001.120510.x
   Nyan M, 2007, J PHARMACOL SCI, V104, P384, DOI 10.1254/jphs.SC0070184
   OHMORI Y, 1988, BIOCHIM BIOPHYS ACTA, V970, P22, DOI 10.1016/0167-4889(88)90218-2
   Oxlund H, 2001, CALCIFIED TISSUE INT, V69, P299, DOI 10.1007/s00223-001-2027-5
   Parhami F, 2002, J BONE MINER RES, V17, P1997, DOI 10.1359/jbmr.2002.17.11.1997
   Raiche AT, 2003, IEEE ENG MED BIOL, V22, P35, DOI 10.1109/MEMB.2003.1256270
   Skoglund B, 2002, J BONE MINER RES, V17, P2004, DOI 10.1359/jbmr.2002.17.11.2004
   Staal A, 2003, J BONE MINER RES, V18, P88, DOI 10.1359/jbmr.2003.18.1.88
   Stein D, 2005, J PERIODONTOL, V76, P1861, DOI 10.1902/jop.2005.76.11.1861
   Sugiyama M, 2000, BIOCHEM BIOPH RES CO, V271, P688, DOI 10.1006/bbrc.2000.2697
   Thylin MR, 2002, J PERIODONTOL, V73, P1141, DOI 10.1902/jop.2002.73.10.1141
   TODD PA, 1990, DRUGS, V40, P583, DOI 10.2165/00003495-199040040-00007
   Toh S, 2007, PHARMACOEPIDEM DR S, V16, P627, DOI 10.1002/pds.1363
   Veillard N. R., 2002, CMLS Cellular and Molecular Life Sciences, V59, P1771, DOI 10.1007/PL00012505
   Whang KM, 2005, J BIOMED MATER RES A, V74A, P237, DOI 10.1002/jbm.a.30309
   Whang KM, 2005, J BIOMED MATER RES A, V74A, P247, DOI 10.1002/jbm.a.30370
   Wong RWK, 2003, BRIT J ORAL MAX SURG, V41, P244, DOI 10.1016/S0266-4356(03)00081-0
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
NR 36
TC 26
Z9 27
U1 0
U2 5
PU AMER ACAD PERIODONTOLOGY
PI CHICAGO
PA 737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA
SN 0022-3492
J9 J PERIODONTOL
JI J. Periodont.
PD AUG
PY 2008
VL 79
IS 8
BP 1457
EP 1464
DI 10.1902/jop.2008.080004
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 336DY
UT WOS:000258345700019
PM 18672996
DA 2018-10-19
ER

PT J
AU Park, SJ
AF Park, Su-Jung
TI Chemical observation of anodic TiO2 for biomaterial application
SO METALS AND MATERIALS INTERNATIONAL
LA English
DT Article
DE anodic TiO2; chemical states; electrolyte; XPS; osteoblast-like cells
ID TITANIUM; FILMS; NANOTUBES
AB Anodic TiO2 film on Ti a substrate was fabricated at 170 V in sulfuric acid solutions containing phosphoric acid and hydrogen peroxide. The pores in the oxide layer were not uniform in size, shape, or direction of growth, particularly near the interface between the substrate and the oxide layer, compared with those of the surface layer. The formation of an irregular type of pores seemed to be caused by the spark discharge phenomena, which occurred extensively when the anodic voltage was increased. The pore diameter and the cell size increased and the number of cells per unit area decreased over time. From the analysis of chemical states in the XPS spectrum, the incorporated phosphate species were found mostly in the forms of HPO4-, PO4-, and PO3-. In addition, Ti, O, and P were well dispersed in TiO2 oxide film, as shown in the results of element mapping analyses by an energy dispersive X-ray spectrometer. An SGM observation of osteoblast-likes cells grown on treated TiO2 oxide film samples for 24 h showed clear differences in cell density and spreading pattern. MC3T3 osteoblast-like cells were flat with a polygonal configuration and were attached to the substrate by cellular extensions.
C1 Chosun Univ, Dept Dent Mat, Coll Dent, Kwangju 501759, South Korea.
RP Park, SJ (reprint author), Chosun Univ, Dept Dent Mat, Coll Dent, BK21,375 Seosuk Dong, Kwangju 501759, South Korea.
EM iamred@chosun.ac.kr
CR Afshar A, 2004, SURF COAT TECH, V186, P398, DOI 10.1016/j.surfcoat.2004.01.003
   Allred DB, 2007, ELECTROCHIM ACTA, V53, P193, DOI 10.1016/j.electacta.2007.06.019
   ASOH H, 2006, ELECTROCHEM COMMUN, V12, P1817
   BAN S, 2006, DENT MATER, V12, P1115
   Bestetti M, 2007, THIN SOLID FILMS, V515, P5253, DOI 10.1016/j.tsf.2006.12.180
   Chen JJ, 2006, J ELECTROANAL CHEM, V590, P26, DOI 10.1016/j.jelechem.2006.02.016
   Dewidar MM, 2006, MET MATER INT, V12, P193, DOI 10.1007/BF03027531
   Kohn J, 2007, BIOMATERIALS, V28, P4171, DOI 10.1016/j.biomaterials.2007.06.022
   Macak JM, 2005, ELECTROCHEM COMMUN, V7, P1133, DOI 10.1016/j.elecom.2005.08.013
   MASUMOTO K, 2006, MAT SCI ENG A-STRUCT, V25, P835
   Matykina E, 2006, ELECTROCHIM ACTA, V51, P4709, DOI 10.1016/j.electacta.2006.01.021
   MOSSMANN T, 1983, J IMMUNOL METHODS, V65, P55
   Oliveira NTC, 2006, ELECTROCHIM ACTA, V51, P3506, DOI 10.1016/j.electacta.2005.10.007
   SENTHIL EK, 2007, BONE, V41, P733
   Tanvir MT, 2007, ELECTROCHIM ACTA, V52, P6834, DOI 10.1016/j.electacta.2007.04.113
   Xu JW, 2007, ELECTROCHIM ACTA, V52, P8044, DOI 10.1016/j.electacta.2007.06.077
   ZENG P, 2007, CHINA PART, V15, P169
NR 17
TC 12
Z9 12
U1 1
U2 12
PU KOREAN INST METALS MATERIALS
PI SEOUL
PA POSCO CENTER, 4TH FL (EAST WING), 892 DAECHI-4-DONG, KANGNAM-KU, SEOUL
   135-777, SOUTH KOREA
SN 1598-9623
J9 MET MATER-INT
JI Met. Mater.-Int.
PD AUG
PY 2008
VL 14
IS 4
BP 449
EP 455
DI 10.3365/met.mat.2008.08.449
PG 7
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 344YE
UT WOS:000258962400010
DA 2018-10-19
ER

PT J
AU Andreaus, U
   Colloca, M
   Toscano, A
AF Andreaus, U.
   Colloca, M.
   Toscano, A.
TI Mechanical behaviour of physiological and prosthesized human femurs
   during stair climbing: a comparative analysis via 3D numerical
   simulation
SO MINERVA ORTOPEDICA E TRAUMATOLOGICA
LA English
DT Article
DE finite element analysis; arthroplasty, replacement, hip; femur
ID PRIMARY STABILITY; BONE; RESORPTION; STEMS
AB Aim The aim of this study was to perform finite element investigation of the mechanical behaviour of a prosthesized human femur during stair climbing. in order to numerically analyze the stress shielding phenomenon in a femoral bone with an artificial hip replacement, the strain and stress distributions both in the femur and in the stem were evaluated by using the finite element method.
   Methods. From a set of computed tomography (CT) images the geometry of the femur was recovered and me-shed. An operation of virtual surgery allowed to insert the metal stem (constructed by a CAD code) in the medullary canal.
   Results. Numerical simulation showed evidence that stresses and strain energy density increase in the distal zone of the stem-bone interface of the prosthesized femur; and hence a load transfer is determined from proximal zones to distal ones. As expected, lateral and medial zones are subjected to, respectively, tensile and compressive normal stresses in z-direction, absolute maxima being attained at the distal part of the diaphysis.
   Conclusion. The development of a computational model allowed to deal with the complexity of the biomechanical problem and to describe quantitatively the mechanical behaviour of bone tissue in contact with the metal stem. The calculated results motivate the performed analyses because they are sufficient to activate the mechanisms of deposition and resorption in the bone tissue at contact with the artificial biomaterial. Thus, stair climbing confirms to be a critical task for primary stability of the prosthesized femur.
C1 [Andreaus, U.] Univ Roma La Sapienza, Dept Struct & Geotecn Engn, I-00184 Rome, Italy.
RP Andreaus, U (reprint author), Univ Roma La Sapienza, Dept Struct & Geotecn Engn, Via Eudossiana 18, I-00184 Rome, Italy.
EM ugo.andreaus@uniroma1.it
RI Andreaus, Ugo/A-8780-2010
CR ANDREAUS U, 2005, SCI COSTRUZIONI MECC
   ANDREAUS U, 2006, G I O T, V32, P198
   ANDRIACCHI TP, 1980, J BONE JOINT SURG AM, V62, P749, DOI 10.2106/00004623-198062050-00008
   Carter DR, 2001, SKELETAL FUNCTION FO
   Chae SW, 2006, JSME INT J A-SOLID M, V49, P147, DOI 10.1299/jsmea.49.147
   *COMSON AB, 2006, COMSOL MULT 3 3 COMP
   Cowin SC., 2000, BONE MECH HDB
   DIBELLO C, 2004, BIOMATERIALI INTRODU
   Doblare M, 2004, ENG FRACT MECH, V71, P1809, DOI 10.1016/j.engfracmech.2003.08.003
   Fung YC, 1990, BIOMECHANICS MECH PR
   GUO XE, 2001, BONE MECH HDB
   HART R, 2001, BONE MECH HDB
   HUISKES R, 1992, CLIN ORTHOP RELAT R, P124
   JEBSEN KJ, 2001, BONE MECH HDB
   Kassi JP, 2005, J BIOMECH, V38, P1143, DOI 10.1016/j.jbiomech.2004.05.023
   KAUFMAN KR, 2000, BIOMEDICAL ENG HDB
   Nordin M., 2001, BASIC BIOMECHANICS M
   Ozkaya N., 1999, FUNDAMENTALS BIOMECH
   Pancanti A, 2003, J BIOMECH, V36, P777, DOI 10.1016/S0021-9290(03)00011-3
   PIETRABISSA R, 2000, BIOMATERIALI PROTESI
   RUBIN PJ, 1993, J BIOMECH, V26, P725, DOI 10.1016/0021-9290(93)90035-D
   Spears IR, 2000, J BIOMECH, V33, P1471, DOI 10.1016/S0021-9290(00)00096-8
   VANRIETBERGEN B, 1993, J BIOMECH, V26, P369, DOI 10.1016/0021-9290(93)90001-U
   Wirtz DC, 1998, Z ORTHOP GRENZGEB, V136, P310, DOI 10.1055/s-2008-1053743
   Zannoni C, 1998, MED ENG PHYS, V20, P653, DOI 10.1016/S1350-4533(98)00076-9
   ZIENKIEWICZ OC, 2000, FINTE ELEMENT METHOD, V1
   STEM MODEL
   CT DATA SET FEMUR
NR 28
TC 2
Z9 2
U1 0
U2 1
PU EDIZIONI MINERVA MEDICA
PI TURIN
PA CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY
SN 0026-4911
J9 MINERVA ORTOP TRAUMA
JI Minerva Ortop. Traumatol.
PD AUG
PY 2008
VL 59
IS 4
BP 213
EP 220
PG 8
WC Orthopedics
SC Orthopedics
GA 333JI
UT WOS:000258148400002
DA 2018-10-19
ER

PT J
AU Jayabalan, P
   Bal, BS
AF Jayabalan, P.
   Bal, B. Sonny
TI Review of biomaterials in total knee arthroplasty
SO MINERVA ORTOPEDICA E TRAUMATOLOGICA
LA English
DT Review
DE arthroplasty, replacement, knee; biocompatible materials; polyethylene;
   ceramics
ID MOLECULAR-WEIGHT POLYETHYLENE; TOTAL HIP-ARTHROPLASTY; CROSS-LINKED
   POLYETHYLENE; POROUS TANTALUM BIOMATERIAL; CERAMIC BEARING SURFACES;
   TOTAL JOINT ARTHROPLASTY; UHMWPE WEAR DEBRIS; TERM FOLLOW-UP; FEMORAL
   COMPONENTS; IN-VITRO
AB Important advancements have come over the past 15 years in our knowledge of the fabrication of total knee implants, resulting in optimistic projections of the long-term results from total knee arthroplasty. At present, one of the principal reasons for failure of total knee arthroplasty (TKA) is wear the ultra-high molecular weight polyethylene (PE) insert. Attempts to alleviate this problem have focused on highly on improved biomaterials such as highly crosslinked PE, ceramic materials, and alternative metals such as tantalum. The authors review recent developments in the field of biomaterials as applied to total TKA.
C1 [Bal, B. Sonny] Univ Missouri, Dept Orthoped Surg, Columbia, MO 65212 USA.
   [Jayabalan, P.] Univ Missouri, Comparat Orthoped Lab, Columbia, MO 65212 USA.
RP Bal, BS (reprint author), Univ Missouri, Dept Orthoped Surg, MC213,DC053-00,1 Hosp Dr, Columbia, MO 65212 USA.
EM balb@health.missouri.edu
OI Bal, B. Sonny/0000-0002-9615-8632
CR Affatato S, 2005, BIOMATERIALS, V26, P3259, DOI 10.1016/j.biomaterials.2004.07.070
   Ahn NU, 2001, J ARTHROPLASTY, V16, P136, DOI 10.1054/arth.2001.9052
   Archibeck MJ, 2000, CLIN ORTHOP RELAT R, P12
   Atsui Kaoru, 1997, Bulletin Hospital for Joint Diseases, V56, P233
   Bal B Sonny, 2006, J Knee Surg, V19, P89
   Barrere F, 2003, J BIOMED MATER RES B, V67B, P655, DOI 10.1002/jbm.b.10057
   BARTEL DL, 1986, J BONE JOINT SURG AM, V68A, P1041, DOI 10.2106/00004623-198668070-00010
   Bell CJ, 1998, J ARTHROPLASTY, V13, P280, DOI 10.1016/S0883-5403(98)90173-5
   Bizot P, 2004, J BONE JOINT SURG BR, V86B, P190, DOI 10.1302/0301-620X.86B2.14026
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   Boehler M, 2000, CLIN ORTHOP RELAT R, P85
   BOS I, 1995, ACTA ORTHOP SCAND, V66, P1, DOI 10.3109/17453679508994628
   Boutin P, 2000, CLIN ORTHOP RELAT R, V379, P3
   Buechel FF, 2002, CLIN ORTHOP RELAT R, P40, DOI 10.1097/01.blo.0000036529.46246.88
   Cales B, 2000, CLIN ORTHOP RELAT R, P94
   Chiu R, 2008, J INVEST MED, V56, P243
   CHRISTEL PS, 1992, CLIN ORTHOP RELAT R, P10
   CLARKE C, 1992, ASTM STP, V1144, P7
   Conditt MA, 2004, J BONE JOINT SURG AM, V86A, P1031, DOI 10.2106/00004623-200405000-00022
   Conditt MA, 2005, J BONE JOINT SURG AM, V87A, P326, DOI 10.2106/JBJS.C.01308
   CONNELLY G M, 1984, Journal of Orthopaedic Research, V2, P119, DOI 10.1002/jor.1100020202
   COOPER JR, 1991, J MED ENG TECHNOL, V15, P63, DOI 10.3109/03091909109009970
   D'Antonio J, 2005, CLIN ORTHOP RELAT R, P164, DOI 10.1097/01.blo.0000162995.50971.39
   DAVIDSON JA, 1994, BIO-MED MATER ENG, V4, P231
   DAVIDSON JA, 1994, BIO-MED MATER ENG, V4, P213
   DOBBS HS, 1980, BIOMATERIALS, V1, P193, DOI 10.1016/0142-9612(80)90016-2
   DORRE E, 1983, CERAMICS SURG, P61
   Ezzet KA, 2004, CLIN ORTHOP RELAT R, P120, DOI 10.1097/01.blo.000048576.70780.13
   Findlay DM, 2004, BIOMATERIALS, V25, P2215, DOI 10.1016/j.biomaterials.2003.09.005
   Fisher J, 2004, CLIN ORTHOP RELAT R, P114, DOI 10.1097/01.blo.0000148783.20469.4c
   Fisher J, 1995, Proc Inst Mech Eng H, V209, P263, DOI 10.1243/PIME_PROC_1995_209_353_02
   Font-Rodriguez DE, 1997, CLIN ORTHOP RELAT R, P79
   Germain MA, 2003, BIOMATERIALS, V24, P469, DOI 10.1016/S0142-9612(02)00360-5
   Glyn-Jones S, 2008, J ARTHROPLASTY, V23, P337, DOI 10.1016/j.arth.2006.12.117
   Goodman SB, 2007, BIOMATERIALS, V28, P5044, DOI 10.1016/j.biomaterials.2007.06.035
   Hacking SA, 2000, J BIOMED MATER RES, V52, P631
   Hallab N, 2001, J BONE JOINT SURG AM, V83A, P428, DOI 10.2106/00004623-200103000-00017
   Hallab NJ, 2005, J ORTHOP RES, V23, P384, DOI 10.1016/j.orthres.2004.09.001
   Hamada Y, 1999, J BIOMED MATER RES, V48, P301, DOI 10.1002/(SICI)1097-4636(1999)48:3<301::AID-JBM14>3.0.CO;2-9
   Hamadouche M, 2000, REV CHIR ORTHOP, V86, P474
   HARMS J, 1979, J BIOMED MATER RES, V13, P67, DOI 10.1002/jbm.820130109
   HARRIS WH, 1994, ACTA ORTHOP SCAND, V65, P113, DOI 10.3109/17453679408993734
   Harris WH, 2001, CLIN ORTHOP RELAT R, P66
   Hashiguchi T, 1999, ARCH ORTHOP TRAUM SU, V119, P30, DOI 10.1007/s004020050350
   Hatton A, 2003, BIOMATERIALS, V24, P1193, DOI 10.1016/S0142-9612(02)00510-0
   Huang CH, 2002, J ORTHOPAED RES, V20, P1038, DOI 10.1016/S0736-0266(02)00015-3
   Jacobs JJ, 1999, CLIN ORTHOP RELAT R, P173
   JACOBS JJ, 1995, CLIN ORTHOP RELAT R, P94
   Jacobs JJ, 2003, CLIN ORTHOP RELAT R, P139, DOI 10.1097/01.blo.0000096810.78689.62
   JACOBS JJ, 1991, J BONE JOINT SURG AM, V73A, P1475, DOI 10.2106/00004623-199173100-00005
   JAYABALAN PFB, 2006, HOSP SPECIAL SURG J, V3, P30
   JOHANSSON CB, 1990, BIOMATERIALS, V11, P277, DOI 10.1016/0142-9612(90)90010-N
   Kato H, 2000, J BIOMED MATER RES, V53, P28, DOI 10.1002/(SICI)1097-4636(2000)53:1<28::AID-JBM4>3.3.CO;2-6
   Keating EM, 2002, CLIN ORTHOP RELAT R, P34, DOI 10.1097/01.blo.0000030485.77561.57
   Kim HM, 1996, J BIOMED MATER RES, V32, P409, DOI 10.1002/(SICI)1097-4636(199611)32:3<409::AID-JBM14>3.0.CO;2-B
   Knight JL, 1995, J ARTHROPLASTY, V10, P748, DOI 10.1016/S0883-5403(05)80070-1
   Kokubo T, 2004, J MATER SCI-MATER M, V15, P99, DOI 10.1023/B:JMSM.0000011809.36275.0c
   Koshino T, 2002, J ARTHROPLASTY, V17, P1009, DOI 10.1054/arth.2002.35826
   Kovacik MW, 2000, CLIN ORTHOP RELAT R, P186
   Lakdawala A, 2005, J BONE JOINT SURG BR, V87B, P796, DOI 10.1302/0301-620X.87B6.15776
   LASKIN, 2007, TECH KNEE SURG, V6, P220
   Lerouge S, 1997, J BONE JOINT SURG BR, V79B, P135, DOI 10.1302/0301-620X.79B1.6621
   Li S, 2002, CLIN ORTHOP RELAT R, P75, DOI 10.1097/01.blo.0000036538.462646.74
   MALKANI AL, 1995, J BONE JOINT SURG AM, V77A, P423, DOI 10.2106/00004623-199503000-00012
   Martell JM, 2003, J ARTHROPLASTY, V18, P55, DOI 10.1054/S0883-5403(03)00341-3
   Matsuno H, 2001, BIOMATERIALS, V22, P1253, DOI 10.1016/S0142-9612(00)00275-1
   McEwen HMJ, 2005, J BIOMECH, V38, P357, DOI 10.1016/j.jbiomech.2004.02.015
   McKellop H, 2000, J BONE JOINT SURG AM, V82A, P1708, DOI 10.2106/00004623-200012000-00004
   Meneghini R Michael, 2005, Instr Course Lect, V54, P481
   Meneghini RM, 2008, J BONE JOINT SURG AM, V90A, P78, DOI 10.2106/JBJS.F.01495
   MICHEL R, 1991, ARCH ORTHOP TRAUM SU, V110, P61, DOI 10.1007/BF00393876
   Miyazaki T, 2000, J BIOMED MATER RES, V50, P35, DOI 10.1002/(SICI)1097-4636(200004)50:1<35::AID-JBM6>3.0.CO;2-8
   Mochida Y, 2002, J ARTHROPLASTY, V17, P121, DOI 10.1054/arth.2002.29330
   Muratoglu OK, 2004, CLIN ORTHOP RELAT R, P108, DOI 10.1097/01.blo.0000143801.41885.8b
   NASSER S, 1990, CLIN ORTHOP RELAT R, P171
   Nasser S, 2004, J ARTHROPLASTY, V19, P562, DOI 10.1016/j.arth.2004.02.025
   Naudie Douglas D, 2004, Instr Course Lect, V53, P251
   Nelson CL, 2003, J ARTHROPLASTY, V18, P37, DOI 10.1054/S0883-5403(03)00290-0
   Nevelos J, 2004, KNEE, V11, P163, DOI 10.1016/j.knee.2004.01.004
   OONISHI H, 1992, J LONG-TERM EFF MED, V2, P37
   Oonishi H, 2002, KEY ENG MAT, V218-2, P499, DOI 10.4028/www.scientific.net/KEM.218-220.499
   Oonishi H., 1981, ORTHOPAEDIC CERAMIC, VI
   PARIKH AMM, 2007, T ORTHOPAEDIC RES SO, V33
   Piconi C, 1998, BIOMATERIALS, V19, P1489, DOI 10.1016/S0142-9612(98)00064-7
   POGGIE RA, 1992, AM SOC TEST MATER, V1145, P65, DOI 10.1520/STP15333S
   Que L, 2000, J BIOMED MATER RES, V53, P111, DOI 10.1002/(SICI)1097-4636(2000)53:1<111::AID-JBM15>3.0.CO;2-Y
   Rader CP, 1999, J ARTHROPLASTY, V14, P840, DOI 10.1016/S0883-5403(99)90035-9
   Radnay CS, 2006, CLIN ORTHOP RELAT R, P83, DOI 10.1097/01.blo.0000214437.57151.41
   Rahbek O, 2005, INT ORTHOP, V29, P368, DOI 10.1007/s00264-005-0008-4
   RANAWAT CS, 1993, CLIN ORTHOP RELAT R, P94
   RANAWAT CS, 1988, CLIN ORTHOP RELAT R, P6
   Ries MD, 1996, J ARTHROPLASTY, V11, P974, DOI 10.1016/S0883-5403(96)80143-4
   RIES MD, 1999, EFFECT FEMORAL COMPO, V3
   RIMNAC CM, 1994, J BONE JOINT SURG AM, V76A, P1052, DOI 10.2106/00004623-199407000-00014
   Ritter MA, 2001, CLIN ORTHOP RELAT R, P94
   RUSSELL AL, 2001, T ORTHOP RES SOC, V26, P1101
   Shanbhag AS, 2000, J BIOMED MATER RES, V53, P100, DOI 10.1002/(SICI)1097-4636(2000)53:1<100::AID-JBM14>3.0.CO;2-4
   Sharkey PF, 2002, CLIN ORTHOP RELAT R, P7, DOI 10.1097/01.blo.0000036002.13841.32
   Shimko DA, 2005, J BIOMED MATER RES B, V73B, P315, DOI 10.1002/jbm.b.30229
   SHIRAZIADL A, 1993, J BIOMED MATER RES, V27, P167, DOI 10.1002/jbm.820270205
   Skinner HB, 1999, CLIN ORTHOP RELAT R, P83
   STULBERG BN, 1994, J APPL BIOMATER, V5, P9, DOI 10.1002/jab.770050103
   Subbarao E.C., 1981, ADV CERAM, V3, P1
   Thomas P, 2003, BIOMATERIALS, V24, P959, DOI 10.1016/S0142-9612(02)00432-5
   TSAO A, 1993, J BONE JOINT SURG AM, V75A, P19, DOI 10.2106/00004623-199301000-00004
   VINCE KG, 1988, ORTHOP CLIN N AM, V19, P575
   Wang A, 1998, J ARTHROPLASTY, V13, P615, DOI 10.1016/S0883-5403(98)80002-8
   WHITE SE, 1994, CLIN ORTHOP RELAT R, P176
   WRIGHT TM, 1992, CLIN ORTHOP RELAT R, P126
   Yasuda K, 2007, TECH KNEE SURG, V6, P213
   Yasuda Kazunori, 1993, Bulletin Hospital for Joint Diseases, V53, P15
   Zardiackas LD, 2001, J BIOMED MATER RES, V58, P180, DOI 10.1002/1097-4636(2001)58:2<180::AID-JBM1005>3.0.CO;2-5
   ZHANG Y, 1999, J MUSCULOSKELET RES, V27, P167
   Zou XN, 2003, APMIS, V111, P127
NR 115
TC 0
Z9 0
U1 1
U2 10
PU EDIZIONI MINERVA MEDICA
PI TURIN
PA CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY
SN 0026-4911
J9 MINERVA ORTOP TRAUMA
JI Minerva Ortop. Traumatol.
PD AUG
PY 2008
VL 59
IS 4
BP 241
EP 252
PG 12
WC Orthopedics
SC Orthopedics
GA 333JI
UT WOS:000258148400006
DA 2018-10-19
ER

PT J
AU Zhang, X
   Sharma, KK
   Boeglin, M
   Ogier, J
   Mainard, D
   Voegel, JC
   Mely, Y
   Benkirane-Jessel, N
AF Zhang, Xin
   Sharma, Kamal Kant
   Boeglin, Marcel
   Ogier, Joelle
   Mainard, Didier
   Voegel, Jean-Claude
   Mely, Yves
   Benkirane-Jessel, Nadia
TI Transfection ability and intracellular DNA pathway of nanostructured
   gene-delivery systems
SO NANO LETTERS
LA English
DT Article
ID POLYELECTROLYTE MULTILAYERS; BETA-CYCLODEXTRIN; THIN-FILMS;
   THERAPEUTICS; FLUORESCENCE; ARCHITECTURE; TRAFFICKING; DEPOSITION;
   COMPLEXES; POLYMERS
AB Considerable efforts have been devoted to the design of structured materials with functional properties. Polyelectrolyte multilayer films are now a well-established nanostructured concept with numerous potential applications, in particular as biomaterial coatings. This technique allows the preparation of nanostructured architectures exhibiting specific properties for cell-activation control and local drug delivery. In this study, we used a multilayered system made of poly-(L-lysine)/hyaluronic acid (PLL/HA) as a reservoir for active DNA complexes with nonviral gene-delivery vectors, PLL, beta-cyclodextrin (CD), and PLL-CD. When embedded into the multilayered films, the transfection efficiencies of the DNA complexes and the cell viability were improved. The highest transfection efficiency was obtained with the PLL-CD/plasmid DNA (pDNA) complexes. We found that this high transfection efficiency was related to an efficient internalization of the complexes in the cell cytoplasm and selected nuclei domains through a nonendocytotic pathway. For the first time, we report the intracellular pathway of the pDNA in complexes incorporated into the multilayered system.
C1 [Zhang, Xin; Sharma, Kamal Kant; Mely, Yves] Univ Strasbourg 1, Dept Pharmacol & Physicochim, Equipe Photophys Interact Biomol, Inst Gilbert Laustriat,UMR 7175,Fac Pharm, F-67401 Illkirch Graffenstaden, France.
   [Zhang, Xin; Ogier, Joelle; Voegel, Jean-Claude; Benkirane-Jessel, Nadia] Fac Med, INSERM, U595, F-67085 Strasbourg, France.
   [Zhang, Xin; Ogier, Joelle; Voegel, Jean-Claude; Benkirane-Jessel, Nadia] Univ Strasbourg 1, Fac Chirurg Dent, F-67000 Strasbourg, France.
   [Boeglin, Marcel] ULP, CNRS, INSERM, IGBMC,Coll France, F-67404 Strasbourg, France.
   [Mainard, Didier] CHU Nancy, Hop Cent, F-54000 Nancy, France.
   [Mainard, Didier] Univ Nancy 1, CNRS, UMR 7561, Fac Med, Vandoeuvre Les Nancy, France.
RP Mely, Y (reprint author), Univ Strasbourg 1, Dept Pharmacol & Physicochim, Equipe Photophys Interact Biomol, Inst Gilbert Laustriat,UMR 7175,Fac Pharm, BP 60024, F-67401 Illkirch Graffenstaden, France.
EM mely@pharma.u-strasbg.fr; nnadia.jessel@medecine.u-strasbg.fr
RI Benkirane-Jessel, Nadia/H-6438-2016
OI Benkirane-Jessel, Nadia/0000-0003-3059-3559
FU Agence Nationale de la Recherche [ANR06-BLAN-0197-01/CartilSpray];
   Fondation Avenir; Ligue contre le Cancer, du haut Rhin, Region Alsace;
   Canceropole du Grand Est; Faculte de Chirurgie Dentaire of Strasbourg
FX This work was supported by the project ANR06-BLAN-0197-01/CartilSpray,
   from the "Agence Nationale de la Recherche", the "Fondation Avenir", the
   "Ligue contre le Cancer, du haut Rhin, Region Alsace" and "Canceropole
   du Grand Est". X.Z thanks the Faculte de Chirurgie Dentaire of
   Strasbourg for financial support. N.J is indebted to CHU de Nancy
   (Contrat d'interface vers l'hopital).
CR Akinc A, 2002, BIOTECHNOL BIOENG, V78, P503, DOI 10.1002/bit.20215.abs
   Arima H, 2001, BIOCONJUGATE CHEM, V12, P476, DOI 10.1021/bc000111n
   Berth G, 2002, BIOMACROMOLECULES, V3, P579, DOI 10.1021/bm0200130
   Boon EM, 2000, NAT BIOTECHNOL, V18, P1096, DOI 10.1038/80301
   Clamme JP, 2003, BBA-BIOMEMBRANES, V1617, P52, DOI 10.1016/j.bbamem.2003.09.002
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Garza JM, 2005, LANGMUIR, V21, P12372, DOI 10.1021/la051465b
   Gonzalez H, 1999, BIOCONJUGATE CHEM, V10, P1068, DOI 10.1021/bc990072j
   Hartwich G, 1999, J AM CHEM SOC, V121, P10803, DOI 10.1021/ja9920664
   Hiller J, 2002, NAT MATER, V1, P59, DOI 10.1038/nmat719
   Jessel N, 2006, P NATL ACAD SCI USA, V103, P8618, DOI 10.1073/pnas.0508246103
   Jessel N, 2003, ADV MATER, V15, P692, DOI 10.1002/adma.200304634
   JESSEL N, 2004, ADV MATER, V16, P1507
   Jessel N., 2004, ADV FUNCT MATER, V14, P174
   Jessel N., 2005, ADV FUNCT MATER, V15, P648
   Jessel NB, 2004, ADV FUNCT MATER, V14, P963, DOI 10.1002/adfm.200305089
   Jewell CM, 2008, ADV DRUG DELIVER REV, V60, P979, DOI 10.1016/j.addr.2008.02.010
   Jewell CM, 2005, J CONTROL RELEASE, V106, P214, DOI 10.1016/j.jconrel.2005.04.014
   Kempf M, 2003, J DRUG TARGET, V11, P11, DOI 10.1080/1061186031000072978
   Khalil IA, 2006, PHARMACOL REV, V58, P32, DOI 10.1124/pr.58.1.8
   Krishnamoorthy G, 2002, BIOCHEMISTRY-US, V41, P15277, DOI 10.1021/bi020440y
   LVOV Y, 1993, MACROMOLECULES, V26, P5396, DOI 10.1021/ma00072a016
   Mannisto M, 2007, J GENE MED, V9, P479, DOI 10.1002/jgm.1035
   Merdan T, 2002, ADV DRUG DELIVER REV, V54, P715, DOI 10.1016/S0169-409X(02)00046-7
   Meyer F, 2006, BBA-BIOMEMBRANES, V1758, P419, DOI 10.1016/j.bbamem.2005.11.015
   Remy-Kristensen A, 2001, BBA-BIOMEMBRANES, V1514, P21, DOI 10.1016/S0005-2736(01)00359-5
   Ren KF, 2005, COLLOID SURFACE B, V46, P63, DOI 10.1016/j.colsurfb.2005.09.004
   Rimann M, 2008, BIOCONJUGATE CHEM, V19, P548, DOI 10.1021/bc7003439
   Schouten S, 1999, LANGMUIR, V15, P8133, DOI 10.1021/la990162c
   Strand SP, 2005, BIOMACROMOLECULES, V6, P3357, DOI 10.1021/bm0503726
   Wang DY, 2002, NANO LETT, V2, P857, DOI 10.1021/nl025624c
   Zhang JT, 2004, LANGMUIR, V20, P8015, DOI 10.1021/la048888i
   ZHANG X, 2008, J GENE MED
NR 33
TC 37
Z9 38
U1 2
U2 23
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1530-6984
J9 NANO LETT
JI Nano Lett.
PD AUG
PY 2008
VL 8
IS 8
BP 2432
EP 2436
DI 10.1021/nl801379y
PG 5
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 337MR
UT WOS:000258440700055
PM 18611056
DA 2018-10-19
ER

PT J
AU Cao, Y
   Li, HB
AF Cao, Yi
   Li, Hongbin
TI Engineered elastomeric proteins with dual elasticity can be controlled
   by a molecular regulator
SO NATURE NANOTECHNOLOGY
LA English
DT Article
ID FORCE-SPECTROSCOPY; MECHANICAL-PROPERTIES; BIOLOGICAL ROLES; BINDING;
   DOMAINS; STABILITY; TOPOLOGY; DESIGN; TITINS
AB Elastomeric proteins are molecular springs that confer excellent mechanical properties(1-5) to many biological tissues and biomaterials. Depending on the role performed by the tissue or biomaterial, elastomeric proteins can behave as molecular springs(1,2,6,7) or shock absorbers(3-5,8-10). Here we combine single-molecule atomic force microscopy and protein engineering techniques to create elastomeric proteins that can switch between two distinct types of mechanical behaviour in response to the binding of a molecular regulator. The proteins are mechanically labile by design and behave as entropic springs with an elasticity that is governed by their configurational entropy. However, when a molecular regulator binds to the protein, it switches into a mechanically stable state and can act as a shock absorber. These engineered proteins effectively mimic and combine the two extreme forms of elastic behaviour found in natural elastomeric proteins, and thus represent a new type of smart nanomaterial that will find potential applications in nanomechanics and material sciences.
C1 [Cao, Yi; Li, Hongbin] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada.
RP Cao, Y (reprint author), Univ British Columbia, Dept Chem, 2036 Main Mall, Vancouver, BC V6T 1Z1, Canada.
EM Hongbin@chem.ubc.ca
RI Cao, Yi/A-4200-2011; Li, Hongbin/G-2949-2012
OI Li, Hongbin/0000-0001-7813-1332; Cao, Yi/0000-0003-1493-7868
CR Ainavarapu RK, 2005, BIOPHYS J, V89, P3337, DOI 10.1529/biophysj.105.062034
   Brockwell DJ, 2005, BIOPHYS J, V89, P506, DOI 10.1529/biophysj.105.061465
   Bullard B, 2006, P NATL ACAD SCI USA, V103, P4451, DOI 10.1073/pnas.0509016103
   Bustanji Y, 2002, ANGEW CHEM INT EDIT, V41, P1546, DOI 10.1002/1521-3773(20020503)41:9<1546::AID-ANIE1546>3.0.CO;2-U
   Cao Y, 2008, J MOL BIOL, V378, P1132, DOI 10.1016/j.jmb.2008.03.046
   Cao Y, 2007, P NATL ACAD SCI USA, V104, P15677, DOI 10.1073/pnas.0705367104
   Cao Y, 2007, NAT MATER, V6, P109, DOI 10.1038/nmat1825
   Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694
   Carrion-Vazquez M, 2000, PROG BIOPHYS MOL BIO, V74, P63, DOI 10.1016/S0079-6107(00)00017-1
   Dietz H, 2004, P NATL ACAD SCI USA, V101, P16192, DOI 10.1073/pnas.0404549101
   Elvin CM, 2005, NATURE, V437, P999, DOI 10.1038/nature04085
   Gosline J, 2002, PHILOS T ROY SOC B, V357, P121, DOI 10.1098/rstb.2001.1022
   GRONENBORN AM, 1991, SCIENCE, V253, P657, DOI 10.1126/science.1871600
   Klimov DK, 2000, P NATL ACAD SCI USA, V97, P7254, DOI 10.1073/pnas.97.13.7254
   LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293
   Lee G, 2006, NATURE, V440, P246, DOI 10.1038/nature04437
   Li HB, 2000, P NATL ACAD SCI USA, V97, P6527, DOI 10.1073/pnas.120048697
   Li HB, 2002, NATURE, V418, P998, DOI 10.1038/nature00398
   Li HB, 2001, P NATL ACAD SCI USA, V98, P10682, DOI 10.1073/pnas.191189098
   Li PC, 2004, J PHYS CHEM B, V108, P745, DOI 10.1021/jp0363895
   Lu H, 2000, BIOPHYS J, V79, P51, DOI 10.1016/S0006-3495(00)76273-4
   Oberhauser AF, 1998, NATURE, V393, P181
   Paci E, 2000, P NATL ACAD SCI USA, V97, P6521, DOI 10.1073/pnas.100124597
   Sagawa T, 2005, MOL IMMUNOL, V42, P9, DOI 10.1016/j.molimm.2004.07.004
   SAUERERIKSSON AE, 1995, STRUCTURE, V3, P265, DOI 10.1016/S0969-2126(01)00157-5
   Smith BL, 1999, NATURE, V399, P761, DOI 10.1038/21607
   Tatham AS, 2000, TRENDS BIOCHEM SCI, V25, P567, DOI 10.1016/S0968-0004(00)01670-4
   Urry DW, 2002, PHILOS T R SOC B, V357, P169, DOI 10.1098/rstb.2001.1023
   WOOD SJ, 1995, BIOCHEMISTRY-US, V34, P724, DOI 10.1021/bi00003a003
NR 29
TC 46
Z9 49
U1 3
U2 31
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1748-3387
J9 NAT NANOTECHNOL
JI Nat. Nanotechnol.
PD AUG
PY 2008
VL 3
IS 8
BP 512
EP 516
DI 10.1038/nnano.2008.168
PG 5
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 335WZ
UT WOS:000258325800018
PM 18685641
DA 2018-10-19
ER

PT J
AU Ni, Y
   Zhao, X
   Zhou, L
   Shao, ZZ
   Yan, WH
   Chen, X
   Cao, ZB
   Xue, Z
   Jiang, JJ
AF Ni, Yusu
   Zhao, Xia
   Zhou, Liang
   Shao, Zhengzhong
   Yan, Wenhong
   Chen, Xin
   Cao, Zhengbing
   Xue, Zhen
   Jiang, Jack J.
TI Radiologic and histologic characterization of silk fibroin as scaffold
   coating for rabbit tracheal defect repair
SO OTOLARYNGOLOGY-HEAD AND NECK SURGERY
LA English
DT Article
ID CARTILAGE; MORI; RECONSTRUCTION; PROSTHESIS; EXPERIENCE; HEAVY
AB OBJECTIVES: To explore the feasibility of silk fibroin as a biomaterial coating used in tracheal defect reconstruction.
   METHODS: Silk fibroin was subcutaneously embedded in three rabbits and as an artificial implant material coating to reconstruct 12 rabbits' tracheal defects. The postoperative radiologic and histologic characterization was summarized.
   RESULTS: The thickness of the fibroblasts layer covering the porus and nonporus silk fibroin film was 240.4 +/- 9.9 and 302.3 +/- 10.5 mu m, respectively, and there was no statistical difference (P > 0.05) within each group. There was no foreign-body granuloma or macrophagocyte infiltration around the silk film. The tracheal reconstruction study showed a normal mucous membrane with normal cilial growth on the artificial implant and no visible granulation tissue in the reconstructed tracheal cavity.
   CONCLUSIONS: Silk fibroin is a potential new biomaterial coating for tracheal defect reconstruction. The mechanism of silk fibroin appears to promote tracheal mucous membrane, which may be related to its molecular structure and biology. (C) 2008 American Academy of Otolaryngology-Head and Neck Surgery Foundation. All rights reserved.
C1 [Zhao, Xia; Yan, Wenhong; Xue, Zhen] Fudan Univ, Huashan Hosp, Dept Otorhinolaryngol Head & Neck Surg, Shanghai 200040, Peoples R China.
   [Ni, Yusu; Zhou, Liang; Jiang, Jack J.] Fudan Univ, Shanghai Med Sch, Eye & ENT Hosp, Dept Otolaryngol, Shanghai 200040, Peoples R China.
   [Shao, Zhengzhong; Chen, Xin; Cao, Zhengbing] Fudan Univ, Key Lab Mol Engn Polymer MOE, Shanghai 200040, Peoples R China.
   [Shao, Zhengzhong; Chen, Xin; Cao, Zhengbing] Fudan Univ, Dept Macromol Sci, Shanghai 200040, Peoples R China.
   [Jiang, Jack J.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Surg, Div Otolaryngol Head & Neck Surg, Madison, WI USA.
RP Zhao, X (reprint author), Fudan Univ, Huashan Hosp, Dept Otorhinolaryngol Head & Neck Surg, 12 Wulumuqi Middle Rd, Shanghai 200040, Peoples R China.
EM zhaoxiaabc@126.com
RI cao, zhengbing/F-4544-2010; Chen, Xin/F-6802-2015
OI Chen, Xin/0000-0001-7706-4166
CR CHEN X, Patent No. 1483866
   CHEN X, Patent No. 031422012
   COTTON RT, 1989, LARYNGOSCOPE, V99, P1111
   Fuchs JR, 2001, ANN THORAC SURG, V72, P577, DOI 10.1016/S0003-4975(01)02820-X
   Inouye K, 1998, J BIOCHEM BIOPH METH, V37, P159, DOI 10.1016/S0165-022X(98)00024-4
   JINGSONG C, 2003, BIOMATERIALS, V24, P401
   KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583
   Kushibe K, 2001, ANN THORAC SURG, V71, P1666, DOI 10.1016/S0003-4975(01)02530-9
   Li MZ, 2003, BIOMATERIALS, V24, P357, DOI 10.1016/S0142-9612(02)00326-5
   LIU XY, 2002, CHIN J HEMORHEOL, V12, P266
   Motta A, 2004, J BIOMAT SCI-POLYM E, V15, P851, DOI 10.1163/1568562041271075
   Murai K, 1999, ANN THORAC SURG, V67, P776, DOI 10.1016/S0003-4975(98)01142-4
   NEVILLE WE, 1990, J THORAC CARDIOV SUR, V99, P604
   Ni Yu-su, 2005, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V40, P887
   Ning L, 2000, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V14, P44
   NING L, 1998, SPECIAL FUNCTIONAL M, V8, P217
   PIHUAN J, 2000, MED STAT, P413
   Tanaka K, 1999, BBA-PROTEIN STRUCT M, V1432, P92, DOI 10.1016/S0167-4838(99)00088-6
   Wu F, 1999, ANN NY ACAD SCI, V875, P405, DOI 10.1111/j.1749-6632.1999.tb08523.x
   [谢宇锋 Xie Yufeng], 2004, [苏州大学学报. 医学版, Suzhou University Journal of Medical Science], V24, P1
   Yildirim G, 2000, ANN OTO RHINOL LARYN, V109, P981
   Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413
NR 22
TC 19
Z9 21
U1 2
U2 19
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0194-5998
EI 1097-6817
J9 OTOLARYNG HEAD NECK
JI Otolaryngol. Head Neck Surg.
PD AUG
PY 2008
VL 139
IS 2
BP 256
EP 261
DI 10.1016/j.otohns.2008.03.028
PG 6
WC Otorhinolaryngology; Surgery
SC Otorhinolaryngology; Surgery
GA 332WM
UT WOS:000258113800015
PM 18656725
DA 2018-10-19
ER

PT J
AU Zou, J
   Asukas, J
   Inha, T
   Toppila, E
   Kellomaki, M
   Pyykko, I
AF Zou, Jing
   Asukas, Jonna
   Inha, Taija
   Toppila, Esko
   Kellomaki, Minna
   Pyykko, Ilmari
TI Biocompatibility of different biopolymers after being implanted into the
   rat cochlea
SO OTOLOGY & NEUROTOLOGY
LA English
DT Article
DE biomaterial; biocompatibility; cochlea; implant
ID DRUG-DELIVERY SYSTEMS; LONG-TERM EVALUATION; IN-VITRO; NEUROTROPHIC
   FACTOR; PHOTOCROSSLINKABLE CHITOSAN; CONTROLLED-RELEASE; ACID
   MICROSPHERES; MOLECULAR-WEIGHT; POLY(EPSILON-CAPROLACTONE);
   NANOPARTICLES
AB Objective: To assess the biocompatibility of different biopolymers with cochlea implant.
   Materials and Methods: Six bioabsorbable polymers and biostable silicone were used for testing histologic reactions in the cochlea of the rat. The samples were prepared from three 50/50 poly(DL-lactide-co-glycolide) PDLLGA having different inherent viscosity (IV) values and 75/25 poly(DL-lactide-co-epsilon-caprolactone) P(DLLA/CL), poly-epsilon-caprolactone PCL, silicone, and chitosan by extruding the biomaterial as a rod using melt molding (for 50/50 PDLLGAs and 75/25 P(DLLA/CL) and PCL), blending (for silicone), and solving (for chitosan). The rods were cut into samples of diameter of 0.5 mm and length of 2 mm. All the samples were packed and sterilized by gamma irradiation (18 kGy, less than 42 degrees C). Twenty-two male and female Sprague-Dawley rats were used in the study. Four months after the implantation, the animals were killed for histologic observation.
   Results: Chitosan does not degrade in the cochlea 4 months after implantation and, therefore, stimulates very weak inflammatory reaction. The 50/50 PDLLGA (IV, 0.83 dL/g) degrades in the cochlea 4 months after implantation and does not stimulate inflammatory reaction. The 50/50 PDLLGA (IV, 0.41 dL/g; IV, 0.37 dL/g), 75/25 P(DLLA/CL), PCL, and silicone might induce strong inflammatory reaction in the cochlea.
   Conclusion: Different degradation property of biomaterials in the cochlea indicates diverse drug releasing time in a controlled way. Chitosan is suitable for long-lasting drug delivery, whereas 50/50 PDLLGA (IV, 0.83 dL/g) favors quicker releasing. Both chitosan and 50/50 PDLLGA (IV, 0.83 dL/g) are ideal materials for cochlear drug delivery.
C1 [Zou, Jing; Toppila, Esko; Pyykko, Ilmari] Univ Tampere, Sch Med, Dept Otolaryngol, Tampere 33520, Finland.
   [Asukas, Jonna; Inha, Taija; Kellomaki, Minna] Tampere Univ Technol, Inst Biomat, FIN-33101 Tampere, Finland.
RP Zou, J (reprint author), Univ Tampere, Sch Med, Dept Otolaryngol, Biokatu 6, Tampere 33520, Finland.
EM Jing.Zou@uta.fi
RI Kellomaki, Minna/G-6190-2010
OI Kellomaki, Minna/0000-0003-4321-1820
CR Aarnisalo AA, 2000, ORL-J OTO-RHIN-LARYN, V62, P330, DOI 10.1159/000027764
   Aspden TJ, 1997, J PHARM SCI, V86, P509, DOI 10.1021/js960182o
   Batycky RP, 1997, J PHARM SCI, V86, P1464, DOI 10.1021/js9604117
   Bessho K, 2002, J BIOMED MATER RES, V61, P61, DOI 10.1002/jbm.10169
   Carrasquillo KG, 2003, INVEST OPHTH VIS SCI, V44, P290, DOI 10.1167/iovs.01-1156
   Ciapetti G, 2003, BIOMATERIALS, V24, P3815, DOI 10.1016/S0142-9612(03)00263-1
   Cui ZR, 2001, J CONTROL RELEASE, V75, P409, DOI 10.1016/S0168-3659(01)00407-2
   DenDunnen WFA, 1996, MICROSURG, V17, P348, DOI 10.1002/(SICI)1098-2752(1996)17:7<348::AID-MICR2>3.0.CO;2-C
   denDunnen WFA, 1997, J BIOMED MATER RES, V36, P337, DOI 10.1002/(SICI)1097-4636(19970905)36:3<337::AID-JBM9>3.3.CO;2-8
   Denkbas EB, 2004, J BIOMATER APPL, V18, P291, DOI 10.1177/0885328204041510
   Felt O, 1999, INT J PHARM, V180, P185, DOI 10.1016/S0378-5173(99)00003-4
   GIORDANO GG, 1995, CURR EYE RES, V14, P761, DOI 10.3109/02713689508995797
   Guerra GD, 1999, J MATER SCI-MATER M, V10, P659, DOI 10.1023/A:1008948010636
   Hinojosa R, 2001, LARYNGOSCOPE, V111, P1797, DOI 10.1097/00005537-200110000-00025
   Illum L, 2001, ADV DRUG DELIVER REV, V51, P81, DOI 10.1016/S0169-409X(01)00171-5
   Ishihara M, 2002, BIOMATERIALS, V23, P833, DOI 10.1016/S0142-9612(01)00189-2
   Jiao YY, 2002, CIRCULATION, V105, P230, DOI 10.1161/hc0202.101988
   Kanzaki S, 2002, J COMP NEUROL, V454, P350, DOI 10.1002/cne.10480
   Kim SE, 2003, J CONTROL RELEASE, V91, P365, DOI 10.1016/S0168-3659(03)00274-8
   Lalwani AK, 2002, LARYNGOSCOPE, V112, P1325, DOI 10.1097/00005537-200208000-00001
   Li S, 1999, ENCY CONTROLLED DRUG, P71
   Luong-Van E, 2006, BIOMATERIALS, V27, P2042, DOI 10.1016/j.biomaterials.2005.10.028
   Mark C., 1990, BIODEGRADABLE POLYM, P71
   Meek MF, 1999, MICROSURG, V19, P247, DOI 10.1002/(SICI)1098-2752(1999)19:5<247::AID-MICR7>3.0.CO;2-E
   Mi FL, 2002, J BIOMED MATER RES, V59, P438, DOI 10.1002/jbm.1260
   Miura M, 2002, ANN OTO RHINOL LARYN, V111, P1059, DOI 10.1177/000348940211101201
   MORITERA T, 1991, INVEST OPHTH VIS SCI, V32, P1785
   Obara K, 2003, BIOMATERIALS, V24, P3437, DOI 10.1016/S0142-9612(03)00220-5
   Onishi H, 1999, BIOMATERIALS, V20, P175, DOI 10.1016/S0142-9612(98)00159-8
   Panyam J, 2002, FASEB J, V16, DOI 10.1096/fj.02-0088com
   Perets A, 2003, J BIOMED MATER RES A, V65A, P489, DOI 10.1002/jbm.a.10542
   PITT CG, 1979, J BIOMED MATER RES, V13, P497, DOI 10.1002/jbm.820130313
   PITT CG, 1979, J PHARM SCI, V68, P1534, DOI 10.1002/jps.2600681219
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   Shinohara T, 2002, P NATL ACAD SCI USA, V99, P1657, DOI 10.1073/pnas.032677999
   SPELMAN FA, 1980, ANN OTO RHINOL LARYN, V89, P8
   Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6
   Valente M, 2002, INT J ARTIF ORGANS, V25, P777
   Zhang H, 2001, BIOMATERIALS, V22, P1653, DOI 10.1016/S0142-9612(00)00326-4
NR 39
TC 1
Z9 1
U1 1
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1531-7129
J9 OTOL NEUROTOL
JI Otol. Neurotol.
PD AUG
PY 2008
VL 29
IS 5
BP 714
EP 719
DI 10.1097/MAO.0b013e31817d874b
PG 6
WC Clinical Neurology; Otorhinolaryngology
SC Neurosciences & Neurology; Otorhinolaryngology
GA 333ZZ
UT WOS:000258193400025
PM 18580700
DA 2018-10-19
ER

PT J
AU Astala, R
   Stottt, MJ
AF Astala, R.
   Stottt, M. J.
TI First-principles study of hydroxyapatite surfaces and water adsorption
SO PHYSICAL REVIEW B
LA English
DT Article
ID STABILIZED TRICALCIUM PHOSPHATE; SYNTHETIC HYDROXYAPATITE; POTENTIAL
   MODEL; BONE; FLUORAPATITE; DISSOLUTION; CHARGE; SPECTROSCOPY; IONS
AB Hydroxyapatite (HA) is the main mineral component of natural bone and an important synthetic biomaterial. The surfaces of this material are critical as the biological action takes place at the interface between the HA and the biological medium. Ab initio total energy methods are used to study the atomic structure and surface chemistry of HA. Low index HA surfaces in vacuum, the adsorption of water on these surfaces, and the loss of Ca from them are considered. All surfaces are found to react strongly with water, and after adsorption of water (001) and Ca-rich (010), surfaces are found to be energetically favored. The loss of Ca from the surface in exchange for two H is also very favorable. The calculated energies of the various surfaces shed light on the morphologies of HA crystallites found in dissolution studies.
C1 [Astala, R.; Stottt, M. J.] Queens Univ, Dept Phys, Kingston, ON K7L 3N6, Canada.
EM astala@physics.queensu.ca; stott@mjs.phy.queensu.ca
FU NSERC; Millenium Biologix Corp.
FX The support of the NSERC and Millenium Biologix Corp. is gratefully
   acknowledged. R.A. also acknowledges the hospitality of E. Kaxiras of
   Department of Physics, Harvard University.
CR Arsic J, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.245406
   Artacho E, 1999, PHYS STATUS SOLIDI B, V215, P809, DOI 10.1002/(SICI)1521-3951(199909)215:1<809::AID-PSSB809>3.0.CO;2-0
   Astala R, 2006, CHEM MATER, V18, P413, DOI 10.1021/cm051989x
   Astala R, 2005, CHEM MATER, V17, P4125, DOI 10.1021/cm050523b
   Bazaraa MS, 1993, NONLINEAR PROGRAMMIN
   BELL LC, 1973, J COLLOID INTERF SCI, V42, P250, DOI 10.1016/0021-9797(73)90288-9
   Brown PW, 1999, J PHYS CHEM B, V103, P1671, DOI 10.1021/jp982554i
   Calderin L, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.134106
   CHANDER S, 1979, J COLLOID INTERF SCI, V70, P506, DOI 10.1016/0021-9797(79)90058-4
   de Leeuw NH, 2004, PHYS CHEM CHEM PHYS, V6, P1860, DOI 10.1039/b313242k
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   Dorozhkin SV, 1997, J COLLOID INTERF SCI, V191, P489, DOI 10.1006/jcis.1997.4942
   DRY ME, 1960, J PHYS CHEM-US, V64, P1300, DOI 10.1021/j100838a042
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   Elliott JC, 1994, STRUCTURE CHEM APATI
   Garcia AJ, 2005, BIOMATERIALS, V26, P7525, DOI 10.1016/j.biomaterials.2005.05.029
   Harding IS, 2005, BIOMATERIALS, V26, P6818, DOI 10.1016/j.biomaterials.2005.04.060
   HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRev.136.B864
   ISHIKAWA T, 1989, LANGMUIR, V5, P140, DOI 10.1021/la00085a025
   KAXIRAS E, 1987, PHYS REV B, V35, P9625, DOI 10.1103/PhysRevB.35.9625
   KAXIRAS E, 1986, PHYS REV LETT, V56, P2819, DOI 10.1103/PhysRevLett.56.2819
   KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671
   KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133
   LAKS DB, 1991, PHYS REV LETT, V66, P648, DOI 10.1103/PhysRevLett.66.648
   Markovic M, 2004, J RES NATL INST STAN, V109, P553, DOI 10.6028/jres.109.042
   Matsunaga K, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.014102
   Mkhonto D, 2002, J MATER CHEM, V12, P2633, DOI 10.1039/b204111a
   MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI 10.1103/PhysRevB.13.5188
   Ordejon P, 1996, PHYS REV B, V53, P10441, DOI 10.1103/PhysRevB.53.R10441
   Park CY, 2004, AM MINERAL, V89, P1647, DOI 10.2138/am-2004-11-1209
   Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865
   Pietak AM, 2006, BIOMATERIALS, V27, P3, DOI 10.1016/j.biomaterials.2005.05.093
   POSNER AS, 1985, J BIOMED MATER RES, V19, P241, DOI 10.1002/jbm.820190307
   ROOTARE HM, 1977, J DENT RES, V56, P1437, DOI 10.1177/00220345770560120101
   Rulis P, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.245410
   SMITH AN, 1974, J COLLOID INTERF SCI, V48, P442, DOI 10.1016/0021-9797(74)90188-X
   Troullier N., 1991, PHYS REV B, V43
   Tuck L, 2008, J MATER SCI-MATER M, V19, P917, DOI 10.1007/s10856-007-0172-8
   Vandiver J, 2005, BIOMATERIALS, V26, P271, DOI 10.1016/j.biomaterials.2004.02.053
   WEINER S, 1992, FASEB J, V6, P879
   WHALLEY E, 1957, T FARADAY SOC, V53, P1578, DOI 10.1039/tf9575301578
   Yin XL, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2178800
   Yin XL, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.205205
   Zahn D, 2003, PHYS CHEM CHEM PHYS, V5, P4004, DOI 10.1039/b306358e
NR 44
TC 54
Z9 54
U1 3
U2 46
PU AMER PHYSICAL SOC
PI COLLEGE PK
PA ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA
SN 1098-0121
EI 1550-235X
J9 PHYS REV B
JI Phys. Rev. B
PD AUG
PY 2008
VL 78
IS 7
AR 075427
DI 10.1103/PhysRevB.78.075427
PG 11
WC Physics, Condensed Matter
SC Physics
GA 351EG
UT WOS:000259406700108
DA 2018-10-19
ER

PT J
AU Lawal, OS
   Lechner, MD
   Kulicke, WM
AF Lawal, O. S.
   Lechner, M. D.
   Kulicke, W. M.
TI The synthesis conditions, characterizations and thermal degradation
   studies of an etherified starch from an unconventional source
SO POLYMER DEGRADATION AND STABILITY
LA English
DT Article
DE pigeon pea; carboxymethyl starch; characterization; thermal stability
ID CARBOXYMETHYL CASSAVA STARCH; PHYSICOCHEMICAL CHARACTERISTICS; REACTION
   PARAMETERS; POTATO STARCH; HYBRID MAIZE; DERIVATIVES; HEMICELLULOSES;
   ORIGIN; AGENT
AB Starch isolated from an under-utilized legume plant (pigeon pea) was carboxymethylated. influences of reaction parameters were investigated on the degree of substitution (DS) and the reaction efficiency (RE). Studies showed that optimal DS of 1.12 could be reached at reaction efficiency of 80.6% in isopropanolwater reaction medium (40 degrees C, 3 h). Scanning electron microscopy showed that after carboxymethylation, the granular appearance of the native starch was distorted. Wide-angle X-ray diffractometry revealed that crystallinity was reduced significantly after carboxymethylation. The infrared spectra revealed new bands in the carboxymethyl starch at nu = 1600, 1426 and 1324 cm(-1) which were attributed to carbonyl functional groups vibration, -CH2 scissoring and OH bending vibration, respectively. Broad-band C-13 NMR of carboxymethyl starch showed an intense peak at delta = 180.3 ppm which was assigned to carbonyl carbon on the carboxymethyl substituent on the AGU (Anhydroglucose Unit). DEPT (Distortionless Enhancement by Polarization Transfer) 135 NMR showed negative signals which correspond to methylene carbons on the AGU. Differential Scanning Calorimetry (DSC) suggests loss of crystallinity after carboxymethylation. Thermogravimetry (TG), Derivative Thermogravimetry (DTG) and Differential Thermal Analysis (DTA) show that thermal stability improved after carboxymethylation. The study provides information on the preparation and characterization of a biomaterial from a new source which could be used alone or in the preparation of other functional polymers for diverse polymer applications. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Lawal, O. S.] Olabisi Onabanjo Univ, Dept Chem Sci, Ago Iwoye, Ogun, Nigeria.
   [Lawal, O. S.; Kulicke, W. M.] Univ Hamburg, Inst Tech & Macromol Chem, D-20146 Hamburg, Germany.
   [Lechner, M. D.] Univ Osnabruck, Inst Phys Chem, D-49069 Osnabruck, Germany.
RP Lawal, OS (reprint author), Olabisi Onabanjo Univ, Dept Chem Sci, PMB 2002, Ago Iwoye, Ogun, Nigeria.
EM laidelawal2@yahoo.com
FU Alexander von Humboldt foundation of Germany; Abdus Salaam International
   Centre for Theoretical Physics, Trieste, Italy
FX OSL is grateful to the Alexander von Humboldt foundation of Germany for
   the award of postdoctoral fellowship with Professor Dr. W.-M. Kulicke
   and the Abdus Salaam International Centre for Theoretical Physics,
   Trieste, Italy for the award of associate of biophysics of the living
   state.
CR Adebowale KO, 2003, FOOD HYDROCOLLOID, V17, P265, DOI 10.1016/S0268-005X(02)00076-0
   Adebowale KO, 2002, NAHRUNG, V46, P311, DOI 10.1002/1521-3803(20020901)46:5<311::AID-FOOD311>3.0.CO;2-Z
   *AOAC, 1996, OFF METH AN
   Bhattacharyya D, 1995, CARBOHYD POLYM, V27, P247, DOI 10.1016/0144-8617(95)00083-6
   De Graaf RA, 2003, ADV POLYM TECH, V22, P56, DOI 10.1002/adv.10034
   Filho G. R., 2007, POLYM DEGRAD STABIL, V92, P205
   GERNAT C, 1990, STARCH-STARKE, V42, P175, DOI 10.1002/star.19900420504
   Guo MY, 2005, J APPL POLYM SCI, V96, P2132, DOI 10.1002/app.21140
   HEBEISH A, 1988, STARCH-STARKE, V40, P104, DOI 10.1002/star.19880400306
   Hebeish A., 2006, STARCH, V42, P185
   Heinze T, 2004, CELLULOSE, V11, P239, DOI 10.1023/B:CELL.0000025386.68486.a4
   Heinze T, 1999, STARCH-STARKE, V51, P11, DOI 10.1002/(SICI)1521-379X(199901)51:1<11::AID-STAR11>3.0.CO;2-2
   HIZUKURI S, 1983, BIOCHIM BIOPHYS ACTA, V760, P188, DOI 10.1016/0304-4165(83)90142-3
   HIZUKURI S, 1986, CARBOHYD RES, V141, P299
   KHALIL MI, 1990, STARCH-STARKE, V42, P60, DOI 10.1002/star.19900420209
   Kittipongpatana OS, 2006, STARCH-STARKE, V58, P587, DOI 10.1002/star.200600528
   KITTIPONGPATANA OS, 2006, STARCH, V63, P105
   Lawal OS, 2008, INT J BIOL MACROMOL, V42, P429, DOI 10.1016/j.ijbiomac.2008.02.006
   Lawal OS, 2007, STARCH-STARKE, V59, P224, DOI 10.1002/star.200600594
   Lawal OS, 2004, CARBOHYD RES, V339, P2673, DOI 10.1016/j.carres.2004.08.015
   Lawal OS, 2005, CARBOHYD POLYM, V60, P331, DOI 10.1016/j.carbpol.2005.01.011
   Lawal OS, 2004, FOOD CHEM, V87, P205, DOI 10.1016/j.foodchem.2003.11.013
   Lawal OS, 2005, INT J BIOL MACROMOL, V35, P71, DOI 10.1016/j.ijbiomac.2004.12.004
   Menard K. P., 2000, PERFORMANCE PLASTICS
   Mostafa KM, 2004, STARCH-STARKE, V56, P254, DOI 10.1002/star.200300203
   Pal S, 2005, CARBOHYD POLYM, V59, P417, DOI 10.1016/j.carbpol.2004.06.047
   PURSEGLOVE JW, 1968, TROPICAL CROPS DICOT
   Qiu HY, 1999, POLYM ADVAN TECHNOL, V10, P468, DOI 10.1002/(SICI)1099-1581(199907)10:7<468::AID-PAT898>3.3.CO;2-N
   Ren JL, 2008, POLYM DEGRAD STABIL, V93, P786, DOI 10.1016/j.polymdegradstab.2008.01.011
   Sangseethonga K, 2005, STARCH-STARKE, V57, P84, DOI 10.1002/star.200400302
   Seidel C, 2004, STARCH-STARKE, V56, P157, DOI 10.1002/star.200200165
   Shirzad-Semsar M, 2007, J PHYS CHEM B, V111, P8641, DOI 10.1021/jp0702705
   Silva GA, 2005, MAT SCI ENG C-BIO S, V25, P237, DOI 10.1016/j.msec.2005.01.012
   Singh RP, 2003, CARBOHYD RES, V338, P1759, DOI 10.1016/S0008-6215(03)00236-2
   Tijsen CJ, 2001, CARBOHYD POLYM, V45, P219, DOI 10.1016/S0144-8617(00)00243-5
   Wu ZW, 2006, J APPL POLYM SCI, V101, P2210, DOI 10.1002/app.23479
   Xiao B, 2001, POLYM DEGRAD STABIL, V74, P307, DOI 10.1016/S0141-3910(01)00163-X
   Zohuriaan MJ, 2004, POLYM TEST, V23, P575, DOI 10.1016/j.polymertesting.2003.11.001
NR 38
TC 53
Z9 57
U1 0
U2 22
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0141-3910
J9 POLYM DEGRAD STABIL
JI Polym. Degrad. Stabil.
PD AUG
PY 2008
VL 93
IS 8
BP 1520
EP 1528
DI 10.1016/j.polymdegradstab.2008.05.010
PG 9
WC Polymer Science
SC Polymer Science
GA 350YD
UT WOS:000259388900016
DA 2018-10-19
ER

PT J
AU Lee, SJ
   Van Dyke, M
   Atala, A
   Yoo, JJ
AF Lee, Sang Jin
   Van Dyke, Mark
   Atala, Anthony
   Yoo, James J.
TI Host cell mobilization for in situ tissue regeneration
SO REJUVENATION RESEARCH
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; INFLAMMATORY RESPONSES; CLINICAL-APPLICATIONS;
   DIFFERENTIATION; BIOMATERIALS; EXPANSION; THERAPY
AB Although small, localized injuries can be healed through the body's normal reparative process, large traumatic injury overwhelms this system and may result in a deficit of functional recovery, despite the use of conventional reconstructive modalities. Cell-based approaches using tissue engineering and regenerative medicine techniques have offered new opportunities for treatment. Although the fundamental principles of cell-based therapies have been demonstrated clinically on multiple tissue systems, usually a donor tissue biopsy and ex vivo cell manipulation prior to implantation in vivo are necessary. The goal of the present study was to investigate whether host biologic resources and environmental conditions could be used for in situ tissue regeneration, which may eliminate the need for donor cell procurement and subsequent in vitro cell manipulation. To address this aim, we implanted a common biomaterial into mice and characterized the infiltrating cells to determine their regenerative potential. We showed that host cell infiltrates are not entirely comprised of inflammatory and fibroblast-like cells and the normal inflammatory process can be altered by incorporating anti-inflammatory agents that influence the formation of scar tissue. In addition, the infiltrating cells are capable of differentiating into multiple cell lineages, including osteogenic, myogenic, adipogenic, and endothelial lineages, if appropriate conditions are provided. These results suggest that it is possible to recruit a predominance of cells with multilineage potential into a biomaterial scaffold. Therefore, it may be possible to enrich the infiltrate with such cell types and control their fate, provided the proper substrate-mediated signaling can be imparted into the scaffold for in situ tissue regeneration.
C1 [Lee, Sang Jin; Van Dyke, Mark; Atala, Anthony; Yoo, James J.] Wake Forest Univ Hlth Sci, Wake Forest Inst Regenerat Med, Winston Salem, NC 27157 USA.
RP Yoo, JJ (reprint author), Wake Forest Univ Hlth Sci, Wake Forest Inst Regenerat Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.
EM jyoo@wfubmc.edu
RI Yoo, James/L-4850-2017
OI Atala, Anthony/0000-0001-8186-2160; Lee, Sang Jin/0000-0002-3899-1909
CR Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Atala A, 2006, CURR OPIN PEDIATR, V18, P167, DOI 10.1097/01.mop.0000193294.94646.be
   Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   Bartsch G, 2005, STEM CELLS DEV, V14, P337, DOI 10.1089/scd.2005.14.337
   Broughton George 2nd, 2006, Plast Reconstr Surg, V117, p1e, DOI 10.1097/01.prs.0000222562.60260.f9
   Chai C, 2007, MOL THER, V15, P467, DOI 10.1038/sj.mt.6300084
   Cotran RS, 1999, ROBBINS PATHOLOGIC B
   De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274
   De Ugarte DA, 2003, ANN PLAS SURG, V50, P215, DOI 10.1097/01.SAP.0000029661.38066.15
   Deasy BM, 2002, CURR OPIN MOL THER, V4, P382
   El-Kassaby AW, 2003, J UROLOGY, V169, P170, DOI 10.1016/S0022-5347(05)64060-8
   Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433
   Guillot PV, 2007, J CELL MOL MED, V11, P935, DOI 10.1111/j.1582-4934.2007.00106.x
   Harty M, 2003, DEV DYNAM, V226, P268, DOI 10.1002/dvdy.10239
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Liu JW, 2007, J THROMB HAEMOST, V5, P826, DOI 10.1111/j.1538-7836.2007.02381.x
   Mikos AG, 1998, ADV DRUG DELIV REV, V33, P111
   MOREHEAD JM, 1994, OTOLARYNG CLIN N AM, V27, P195
   Ossendorf C, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2180
   Pfister O, 2005, CIRC RES, V97, P52, DOI 10.1161/01.RES.0000173297.53793.fa
   Shin'oka T, 2005, J THORAC CARDIOV SUR, V129, P1330, DOI 10.1016/j.jtcvs.2004.12.047
   Tang LP, 1996, J CLIN INVEST, V97, P1329, DOI 10.1172/JCI118549
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   Williams D. J., 2005, IEE Proceedings Nanobiotechnology, V152, P207, DOI 10.1049/ip-nbt:20050001
   Zhang Y, 2003, WORLD J GASTROENTERO, V9, P201, DOI 10.3748/wjg.v9.i2.201
NR 28
TC 30
Z9 30
U1 0
U2 5
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1549-1684
J9 REJUV RES
JI Rejuv. Res.
PD AUG
PY 2008
VL 11
IS 4
BP 747
EP 756
DI 10.1089/rej.2008.0691
PG 10
WC Geriatrics & Gerontology
SC Geriatrics & Gerontology
GA 351XT
UT WOS:000259459900005
PM 18729807
DA 2018-10-19
ER

PT J
AU Nain, AS
   Phillippi, JA
   Sitti, M
   MacKrell, J
   Campbell, PG
   Amon, C
AF Nain, Amritider S.
   Phillippi, Julie A.
   Sitti, Metin
   MacKrell, James
   Campbell, Phil G.
   Amon, Cristina
TI Control of cell behavior by aligned micro/nanofibrous biomaterial
   scaffolds fabricated by spinneret-based tunable engineered parameters
   (STEP) technique
SO SMALL
LA English
DT Article
DE biomaterials; dry spinning; polymer nanofibers; tissue engineering;
   tissue scaffolds
ID GENE-EXPRESSION; FIBER FORMATION; BETA-RECEPTORS; TISSUE; MUSCLE;
   INTEGRINS; PHOSPHORYLATION; DIFFERENTIATION; MORPHOGENESIS; TRANSDUCTION
C1 [Nain, Amritider S.] Carnegie Mellon Univ, ICES, Pittsburgh, PA 15213 USA.
   [Phillippi, Julie A.; MacKrell, James; Campbell, Phil G.] Carnegie Mellon Univ, MBIC, Pittsburgh, PA 15213 USA.
   [Nain, Amritider S.; Sitti, Metin] Carnegie Mellon Univ, Dept Mech Engn, Pittsburgh, PA 15213 USA.
   [Amon, Cristina] Univ Toronto, Dept Mech & Ind Engn, Fac Appl Sci & Engn, Toronto, ON M5S 1A4, Canada.
RP Nain, AS (reprint author), Carnegie Mellon Univ, ICES, 5000 Forbes Ave, Pittsburgh, PA 15213 USA.
EM anain@andrew.cmu.edu
RI Nain, Amrinder/F-2789-2014
FU Pennsylvania Infrastructure Technology Alliance (PITA: ASN, PGC, and
   MS); Pittsburgh Tissue Engineering Initiative; NSF CAREER [NSF
   IIS-0448042]
FX A. S. Nain and J. A. Phillippi contributed equally to this work. The
   authors gratefully acknowledge Eric Miller, Bahareh Behkam, Franklin
   Chung, Jason Smith, James Fitzpatrick, Greg Fisher, and Joseph Suhan for
   scaffold preparation and imaging assistance, Alan Waggoner, director of
   the Molecular Biosensor and Imaging Center (CMU) for use of the
   facilities, and Jonathan Jarvik for providing the GFP-alpha-tubulin
   vector. The authors are thankful to Purac Biochem, The Netherlands for
   supplying experimental polymeric samples. This work was supported in
   part by the Pennsylvania Infrastructure Technology Alliance (PITA: ASN,
   PGC, and MS), the Pittsburgh Tissue Engineering Initiative (JAP), and
   the NSF CAREER program (MS, NSF IIS-0448042).
CR Damsky CH, 1997, KIDNEY INT, V51, P1427, DOI 10.1038/ki.1997.195
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Gupta P, 2005, POLYMER, V46, P4799, DOI 10.1016/j.polymer.2005.04.021
   Gustafson T, 1999, EXP CELL RES, V253, P288, DOI 10.1006/excr.1999.4744
   Jarvik JW, 1996, BIOTECHNIQUES, V20, P896
   Jarvik JW, 1998, ANNU REV GENET, V32, P601, DOI 10.1146/annurev.genet.32.1.601
   KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755
   Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102
   Langer R, 2007, TISSUE ENG, V13, P1, DOI 10.1089/ten.2006.0219
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   McKee MG, 2004, MACROMOLECULES, V37, P1760, DOI 10.1021/ma035689h
   Milasincic DJ, 1996, IN VITRO CELL DEV-AN, V32, P90
   Miller DC, 2005, J BIOMED MATER RES A, V73A, P476, DOI 10.1002/jbm.a.30318
   Miyamoto S, 1996, J CELL BIOL, V135, P1633, DOI 10.1083/jcb.135.6.1633
   Moutos FT, 2007, NAT MATER, V6, P162, DOI 10.1038/nmat1822
   Nain AS, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2372694
   Nain AS, 2007, IEEE INT CONF ROBOT, P1918, DOI 10.1109/ROBOT.2007.363602
   Nain AS, 2006, IEEE T NANOTECHNOL, V5, P499, DOI 10.1109/TNANO.2006.880453
   NAIN AS, 2007, THESIS CARNEGIE MELL
   Norman J, 2006, ANN BIOMED ENG, V34, P89, DOI 10.1007/s10439-005-9005-4
   Papenburg BJ, 2007, BIOMATERIALS, V28, P1998, DOI 10.1016/j.biomaterials.2006.12.023
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Radisic M, 2003, BIOTECHNOL BIOENG, V82, P403, DOI 10.1002/bit.10594
   Riboldi SA, 2005, BIOMATERIALS, V26, P4606, DOI 10.1016/j.biomaterials.2004.11.035
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Schneller M, 1997, EMBO J, V16, P5600, DOI 10.1093/emboj/16.18.5600
   Silver F. H., 1999, BIOMATERIALS SCI BIO
   Sundberg C, 1996, J CELL BIOL, V132, P741, DOI 10.1083/jcb.132.4.741
   Thapa A, 2003, BIOMATERIALS, V24, P2915, DOI 10.1016/S0142-9612(03)00123-6
   WERB Z, 1989, J CELL BIOL, V109, P877, DOI 10.1083/jcb.109.2.877
   Xu JT, 2004, BIOMED MICRODEVICES, V6, P117, DOI 10.1023/B:BMMD.0000031748.13353.10
   YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0
   Zhong SP, 2006, J BIOMED MATER RES A, V79A, P456, DOI 10.1002/jbm.a.30870
   Ziabicki A, 1976, FUNDAMENTALS FIBER F
NR 35
TC 37
Z9 37
U1 0
U2 24
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1613-6810
J9 SMALL
JI Small
PD AUG
PY 2008
VL 4
IS 8
BP 1153
EP 1159
DI 10.1002/smll.200800101
PG 7
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 339GP
UT WOS:000258566400024
PM 18651720
DA 2018-10-19
ER

PT J
AU Kim, BS
   Atala, A
   Yoo, JJ
AF Kim, Byung-Soo
   Atala, Anthony
   Yoo, James J.
TI A collagen matrix derived from bladder can be used to engineer smooth
   muscle tissue
SO WORLD JOURNAL OF UROLOGY
LA English
DT Article
DE collagen matrix; bladder submucosa; smooth muscle
ID SMALL-INTESTINAL SUBMUCOSA; REPAIR; BIOMATERIAL; ALLODERM; CELLS
AB We have previously demonstrated that a collagen matrix derived from lamina propria, commonly known as bladder submucosa (BSM matrix), is a suitable biomaterial for several urologic applications, including reconstruction of the bladder and urethra in experimental models and clinical trials. In the present study, we evaluated the physical properties of BSM as well as its biocompatibility, cellular interactions, and ability to support the formation of functional tissue in order to determine whether this biomaterial could serve as a matrix for urinary smooth muscle tissue engineering. BSM matrix resembles the extracellular matrix of bladder submucosa in its native structure, composition, and mechanical properties. BSM matrix supported normal mitochondrial metabolic and proliferative functions of human urinary smooth muscle cells and did not induce cytotoxic effects in vitro. When implanted in vivo, BSM matrix promoted the regeneration of urinary smooth muscle tissues with contractility, which is a smooth muscle-specific tissue function. These results suggest that BSM matrix would be a useful biomaterial for urinary smooth muscle reconstruction.
C1 [Atala, Anthony; Yoo, James J.] Wake Forest Univ Hlth Sci, Wake Forest Inst Regenerat Med, Winston Salem, NC 27157 USA.
   [Kim, Byung-Soo] Hanyang Univ, Dept Bioengn, Seoul 133791, South Korea.
RP Yoo, JJ (reprint author), Wake Forest Univ Hlth Sci, Wake Forest Inst Regenerat Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.
EM jyoo@wfubmc.edu
RI Yoo, James/L-4850-2017; Kim, Byung-Soo/O-2352-2013
OI Atala, Anthony/0000-0001-8186-2160
CR Abenavoli FM, 2001, ANN PLAS SURG, V46, P354, DOI 10.1097/00000637-200103000-00039
   Atala A, 1999, J UROLOGY, V162, P1148, DOI 10.1016/S0022-5347(01)68105-9
   Atala A, 2001, Curr Urol Rep, V2, P83, DOI 10.1007/s11934-001-0030-z
   Bader A, 1998, EUR J CARDIO-THORAC, V14, P279, DOI 10.1016/S1010-7940(98)00171-7
   BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809
   BADYLAK SF, 1993, TISSUE ENGINEERING, P179
   Chen F, 1999, UROLOGY, V54, P407, DOI 10.1016/S0090-4295(99)00179-X
   Chun SY, 2007, BIOMATERIALS, V28, P4251, DOI 10.1016/j.biomaterials.2007.05.020
   Desgrandchamps F, 2000, Curr Opin Urol, V10, P201, DOI 10.1097/00042307-200005000-00003
   El-Kassaby AW, 2003, J UROLOGY, V169, P170, DOI 10.1016/S0022-5347(05)64060-8
   El-Kassaby AW, 2003, J UROLOGY, V169, P31
   Huynh T, 1999, NAT BIOTECHNOL, V17, P1083
   Kropp BP, 1996, J UROLOGY, V156, P599, DOI 10.1016/S0022-5347(01)65761-6
   OZTURK SS, 1990, BIOTECHNOL PROGR, V6, P121, DOI 10.1021/bp00002a005
   Pariente JL, 2002, J UROLOGY, V167, P1867, DOI 10.1016/S0022-5347(05)65251-2
   Sacks MS, 1999, J BIOMED MATER RES, V46, P1, DOI 10.1002/(SICI)1097-4636(199907)46:1<1::AID-JBM1>3.0.CO;2-7
   UPHILL PF, 1990, MED DEVICE TECHN NOV, P24
   WAINWRIGHT DJ, 1995, BURNS, V21, P243, DOI 10.1016/0305-4179(95)93866-I
   Wilson G J, 1990, ASAIO Trans, V36, pM340
   WILSON GJ, 1995, ANN THORAC SURG, V60, pS353, DOI 10.1016/0003-4975(95)98967-Y
   Yoo JJ, 1998, UROLOGY, V51, P221, DOI 10.1016/S0090-4295(97)00644-4
NR 21
TC 14
Z9 25
U1 0
U2 5
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0724-4983
J9 WORLD J UROL
JI World J. Urol.
PD AUG
PY 2008
VL 26
IS 4
BP 307
EP 314
DI 10.1007/s00345-008-0300-1
PG 8
WC Urology & Nephrology
SC Urology & Nephrology
GA 339LB
UT WOS:000258578000004
PM 18594823
DA 2018-10-19
ER

PT J
AU Harrington, DA
   Sharma, AK
   Erickson, BA
   Cheng, EY
AF Harrington, Daniel A.
   Sharma, Arun K.
   Erickson, Bradley A.
   Cheng, Earl Y.
TI Bladder tissue engineering through nanotechnology
SO WORLD JOURNAL OF UROLOGY
LA English
DT Article
DE bladder; tissue engineering; regenerative medicine; nanotechnology;
   self-assembly; supramolecular; scaffold; biomaterial; top-down;
   bottom-up; stem cell
ID SMALL-INTESTINAL SUBMUCOSA; FIBROBLAST-GROWTH-FACTOR;
   SMOOTH-MUSCLE-CELLS; URINARY-BLADDER; EXTRACELLULAR-MATRIX; STEM-CELLS;
   IN-VITRO; NANOFIBERS; DIFFERENTIATION; RECONSTRUCTION
AB The field of tissue engineering has developed in phases: initially researchers searched for "inert" biomaterials to act solely as replacement structures in the body. Then, they explored biodegradable scaffolds-both naturally derived and synthetic-for the temporary support of growing tissues. Now, a third phase of tissue engineering has developed, through the subcategory of "regenerative medicine." This renewed focus toward control over tissue morphology and cell phenotype requires proportional advances in scaffold design. Discoveries in nanotechnology have driven both our understanding of cell-substrate interactions, and our ability to influence them. By operating at the size regime of proteins themselves, nanotechnology gives us the opportunity to directly speak the language of cells, through reliable, repeatable creation of nanoscale features. Understanding the synthesis of nanoscale materials, via "top-down" and "bottom-up" strategies, allows researchers to assess the capabilities and limits inherent in both techniques. Urology research as a whole, and bladder regeneration in particular, are well-positioned to benefit from such advances, since our present technology has yet to reach the end goal of functional bladder restoration. In this article, we discuss the current applications of nanoscale materials to bladder tissue engineering, and encourage researchers to explore these interdisciplinary technologies now, or risk playing catch-up in the future.
C1 [Harrington, Daniel A.; Sharma, Arun K.; Cheng, Earl Y.] Childrens Mem Hosp, Div Pediat Urol, Chicago, IL 60614 USA.
   [Harrington, Daniel A.; Sharma, Arun K.; Erickson, Bradley A.; Cheng, Earl Y.] Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA.
   [Harrington, Daniel A.; Sharma, Arun K.; Cheng, Earl Y.] Northwestern Univ, Inst BioNanotechnol Med IBNAM, Chicago, IL 60611 USA.
RP Cheng, EY (reprint author), Childrens Mem Hosp, Div Pediat Urol, Chicago, IL 60614 USA.
EM echeng@childrensmemorial.org
OI Harrington, Daniel/0000-0003-2505-0349
FU NIH [DK072450, T32DK62716]; DAH
FX We would like to acknowledge our ongoing collaboration with the
   laboratory of S. Stupp in the PA work, and the laboratory of K. Shull in
   the triblock copolymer work, especially the contributions of M.
   Guvendiren toward synthesis and imaging. We would like to thank K.
   Haberstroh and J. Southgate for providing high-resolution images for
   Fig. 2. This work was partially funded under NIH Award DK072450 and
   T32DK62716. DAH was supported by the Baxter-Northwestern Early Career
   Development Award in Bioengineering, and by the Dr. Ralph and Marian C.
   Falk Medical Research Trust.
CR Baker SC, 2006, BIOMATERIALS, V27, P3136, DOI 10.1016/j.biomaterials.2006.01.026
   Behanna HA, 2005, J AM CHEM SOC, V127, P1193, DOI 10.1021/ja044863u
   Beqaj SH, 2005, J UROLOGY, V174, P1699, DOI 10.1097/01.ju.0000176633.92150.4e
   Cao Zheng-Guo, 2004, Ai Zheng, V23, P1105
   Chung SY, 2005, J UROLOGY, V174, P353, DOI 10.1097/01.ju.0000161592.00434.c1
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dankers PYW, 2007, B CHEM SOC JPN, V80, P2047, DOI 10.1246/bcsj.80.2047
   Estrada CR, 2006, CANCER RES, V66, P3078, DOI 10.1158/0008-5472CAN-05-3391
   FUJIYAMA C, 1995, J UROLOGY, V153, P2060, DOI 10.1016/S0022-5347(01)67402-0
   Gelain F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000119
   Gurocak S., 2007, Indian Journal of Urology, V23, P452
   Guvendiren M, 2007, SOFT MATTER, V3, P619, DOI 10.1039/b615412c
   Han D, 2006, NANOMED-NANOTECHNOL, V2, P37, DOI 10.1016/j.nano.2006.01.002
   Harrington DA, 2006, J BIOMED MATER RES A, V78A, P157, DOI 10.1002/jbm.a.30718
   Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999
   Hasirci V, 2006, J BIOMAT SCI-POLYM E, V17, P1241, DOI 10.1163/156856206778667442
   Hirsch LR, 2003, P NATL ACAD SCI USA, V100, P13549, DOI 10.1073/pnas.2232479100
   Hurst SJ, 2006, ANGEW CHEM INT EDIT, V45, P2672, DOI 10.1002/anie.200504025
   Hwang JJ, 2002, P NATL ACAD SCI USA, V99, P9662, DOI 10.1073/pnas.152667399
   HWANG JJ, 2001, METHODS TISSUE ENG, P741
   Imamura M, 2007, AM J PHYSIOL-RENAL, V293, pF1007, DOI 10.1152/ajprenal.00107.2007
   Jack GS, 2005, J UROLOGY, V174, P2041, DOI 10.1097/01.ju.0000176489.96993.84
   Kanematsu A, 2005, AM J PATHOL, V166, P565, DOI 10.1016/S0002-9440(10)62278-X
   Kanematsu A, 2007, INT J UROL, V14, P673, DOI 10.1111/j.1442-2042.2007.01768.x
   Kreunin P, 2007, J PROTEOME RES, V6, P2631, DOI 10.1021/pr0700807
   Kropp BP, 1996, J UROLOGY, V155, P2098, DOI 10.1016/S0022-5347(01)66117-2
   Lee H, 2007, NATURE, V448, P338, DOI 10.1038/nature05968
   Lewis JM, 2007, THESCIENTIFICWORLDJO, V7, P1230, DOI 10.1100/tsw.2007.178
   Lu Z, 2004, CLIN CANCER RES, V10, P7677, DOI 10.1158/1078-0432.CCR-04-1443
   McManus M, 2007, BIOMED MATER, V2, P257, DOI 10.1088/1748-6041/2/4/008
   Miller DC, 2005, J BIOMED MATER RES A, V73A, P476, DOI 10.1002/jbm.a.30318
   Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149
   Oehr P, 2003, ANTICANCER RES, V23, P805
   Pattison MA, 2005, BIOMATERIALS, V26, P2491, DOI 10.1016/j.biomaterials.2004.07.011
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Sheng J., 1995, Yaoxue Xuebao, V30, P706
   Shergill IS, 2006, BJU INT, V97, P219, DOI 10.1111/j.1464-410X.2006.06020.06021.05879.05881.x
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Song YS, 2007, NEUROUROL URODYNAM, V26, P584, DOI 10.1002/nau.20351
   Thapa A, 2003, J BIOMED MATER RES A, V67A, P1374, DOI 10.1002/jbm.a.20037
   Tyagi P, 2006, MOL PHARMACEUT, V3, P369, DOI 10.1021/mp060001j
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
   Zhou J, 2005, CHINESE MED J-PEKING, V118, P50
NR 43
TC 35
Z9 37
U1 0
U2 13
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0724-4983
EI 1433-8726
J9 WORLD J UROL
JI World J. Urol.
PD AUG
PY 2008
VL 26
IS 4
BP 315
EP 322
DI 10.1007/s00345-008-0273-0
PG 8
WC Urology & Nephrology
SC Urology & Nephrology
GA 339LB
UT WOS:000258578000005
PM 18536880
DA 2018-10-19
ER

PT J
AU Niinomi, M
AF Niinomi, M.
TI Improvement in mechanical performance of low-modulus beta-Ti-Nb-Ta-Zr
   system alloys by microstructural control via thermomechanical processing
SO INTERNATIONAL JOURNAL OF MODERN PHYSICS B
LA English
DT Article
DE TNTZ; fatigue strength; tensile properties; Young's modulus; cytotoxiciy
ID BIOMEDICAL APPLICATIONS; TI-29NB-13TA-4.6ZR
AB Mechanical performance parameters such as the fatigue strength, tensile strength, ductility and Young's modulus of newly developed Ti-29Nb-13Ta-4.6Zr, referred to as TNTZ, can be improved considerably by microstructural control via thermomechanical processing. Thermomechanical processing including severe cold wire drawing can generate functionalities such as super elasticity in TNTZ. The abovementioned improvement in the mechanical performance and functionality of TNTZ is associated with its nanosize structure. The cytotoxicity of TNTZ is very low and equivalent to that of pure titanium. It is expected that TNTZ will be used as a structural biomaterial.
C1 Tohoku Univ, Inst Mat Res, Dept Biomat Sci, Aoba Ku, Sendai, Miyagi 9808577, Japan.
RP Niinomi, M (reprint author), Tohoku Univ, Inst Mat Res, Dept Biomat Sci, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.
EM niinomi@imr.tohoku.ac.jp
RI Niinomi, Mitsuo/B-5965-2011
CR Akahori T, 2003, J JPN I MET, V67, P652, DOI 10.2320/jinstmet1952.67.11_652
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3
   Niinomi M, 2007, MAT SCI ENG C-BIO S, V27, P154, DOI 10.1016/j.msec.2006.04.008
NR 4
TC 2
Z9 2
U1 0
U2 8
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 0217-9792
J9 INT J MOD PHYS B
JI Int. J. Mod. Phys. B
PD JUL 30
PY 2008
VL 22
IS 18-19
BP 2787
EP 2795
DI 10.1142/S0217979208047602
PG 9
WC Physics, Applied; Physics, Condensed Matter; Physics, Mathematical
SC Physics
GA 343SZ
UT WOS:000258876700002
DA 2018-10-19
ER

PT J
AU Ohtsu, N
   Abe, C
   Ashino, T
   Semboshi, S
   Wagatsuma, K
AF Ohtsu, Naofumi
   Abe, Chikage
   Ashino, Tetsuya
   Semboshi, Satoshi
   Wagatsuma, Kazuaki
TI Calcium-hydroxide slurry processing for bioactive calcium-titanate
   coating on titanium
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE calcium titanate coating; surface modification; calcium hydroxide
   slurry; biomaterial application
ID PHOSPHATE COATINGS; THIN-FILMS; BONE; SURFACE
AB The present study investigates the relationships between the treatment conditions and characteristics of the surface layer in a surface treatment process using calcium-hydroxide slurry. Furthermore, the appropriate treatment conditions for preparing the bioactive coating are also investigated by soaking the specimens in a simulated body fluid. The treatment process using calcium-hydroxide slurry is as follows: a titanium substrate is buried in calcium hydroxide slurry, and the slurry is then heated at 873 K in air. The calcium hydroxide slurry was prepared by mixing 1 g of calcium hydroxide powder per 1, 1.2,1.5, or 2 mL of water. The slurry was heated to 873 K with various heating rates from 100 to 600 K h(-1) and held at 873 K for 1 and 2 h. As the ratio of water in the slurry increased or the heating rate decreased, the atomic ratio of calcium to titanium in the surface layer decreased. A surface treatment using slurry containing a mixture of 1.0-mL water per 1.0-g calcium hydroxide powder, a heating rate of 600 K h(-1), and a holding time of 2 h produces a crystallized stoichionnetric calcium titanate layer on the titanium substrate. Treatment using slurry of a higher water ratio or a slower heating ratio results in the formation of a dioxide layer containing locally formed calcium titanate. On the crystallized calcium titanate layer, calcium phosphate is formed faster in a simulated body fluid than in the TiO(2) layer containing calcium titanate; therefore, the treatment conditions forming the crystallized calcium titanate layer are appropriate for the bioactive coating. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Ohtsu, Naofumi] Kitami Inst Technol, Instrumental Anal Ctr, Kitami, Hokkaido 0908507, Japan.
   [Abe, Chikage; Ashino, Tetsuya; Wagatsuma, Kazuaki] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
   [Semboshi, Satoshi] Osaka Prefecture Univ, Dept Mat Sci, Sakai, Osaka 5998531, Japan.
RP Ohtsu, N (reprint author), Kitami Inst Technol, Instrumental Anal Ctr, Kitami, Hokkaido 0908507, Japan.
EM nohtsu@mail.kitami-it.ac.jp
RI Semboshi, Satoshi/A-8291-2011; Wagatsuma, Kazuaki/B-3079-2012; Ashino,
   Tetsuya/B-9979-2011; Ohtsu, Naofumi/L-6021-2018
OI Ohtsu, Naofumi/0000-0001-7935-3949
CR Asami K, 2003, SURF INTERFACE ANAL, V35, P483, DOI 10.1002/sia.1554
   DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203
   Frauchiger VM, 2004, BIOMATERIALS, V25, P593, DOI 10.1016/S0142-9612(03)00560-X
   GEESINK RGT, 1987, CLIN ORTHOP RELAT R, P147
   GEESINK RGT, 1988, J BONE JOINT SURG BR, V70, P17
   Hamada K, 2002, BIOMATERIALS, V23, P2265, DOI 10.1016/S0142-9612(01)00361-1
   Hanawa T, 1997, J BIOMED MATER RES, V36, P131, DOI 10.1002/(SICI)1097-4636(199707)36:1<131::AID-JBM16>3.0.CO;2-L
   Hanawa T, 1997, J BIOMED MATER RES, V34, P273
   Kokubo T, 1996, J AM CERAM SOC, V79, P1127, DOI 10.1111/j.1151-2916.1996.tb08561.x
   Metikos-Hukovic M, 2003, SURF COAT TECH, V165, P40, DOI 10.1016/S0257-8972(02)00732-6
   Narushima T, 2005, MATER TRANS, V46, P2246, DOI 10.2320/matertrans.46.2246
   Ohba Y, 1999, J CERAM SOC JPN, V107, P907, DOI 10.2109/jcersj.107.907
   Ohtsu N, 2006, SURF COAT TECH, V200, P5455, DOI 10.1016/j.surfcoat.2005.07.003
   Ohtsu N, 2004, MATER TRANS, V45, P1778, DOI 10.2320/matertrans.45.1778
   Ohtsu N., 2007, MAT T, V45, P105
   Ohtsu N, 2007, J BIOMED MATER RES A, V82A, P304, DOI 10.1002/jbm.a.31136
   Ohtsu N, 2007, SURF COAT TECH, V201, P7686, DOI 10.1016/j.surfcoat.2007.02.043
   Ohtsu N, 2007, J MATER SCI-MATER M, V18, P1009, DOI 10.1007/s10856-006-0114-x
   ONG JL, 1994, BIOMATERIALS, V15, P337, DOI 10.1016/0142-9612(94)90245-3
   RADIN SR, 1992, J MATER SCI-MATER M, V3, P33, DOI 10.1007/BF00702942
   Takadama H, 2001, J BIOMED MATER RES, V55, P185, DOI 10.1002/1097-4636(200105)55:2<185::AID-JBM1005>3.3.CO;2-G
   vanDijk K, 1996, BIOMATERIALS, V17, P405, DOI 10.1016/0142-9612(96)89656-6
   Wei M, 2002, BIOMATERIALS, V23, P167, DOI 10.1016/S0142-9612(01)00092-8
   YOSHINARI M, 1994, BIOMATERIALS, V15, P529, DOI 10.1016/0142-9612(94)90019-1
NR 24
TC 19
Z9 21
U1 0
U2 5
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD JUL 30
PY 2008
VL 202
IS 21
BP 5110
EP 5115
DI 10.1016/j.surfcoat.2008.05.035
PG 6
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 339PB
UT WOS:000258588400006
DA 2018-10-19
ER

PT J
AU Aliofkhazraee, M
   Rouhaghdam, AS
   Shahrabi, T
AF Aliofkhazraee, M.
   Rouhaghdam, A. Sabour
   Shahrabi, T.
TI Pulsed nanocrystalline plasma electrolytic carburising for corrosion
   protection of a gamma-TiAl alloy - Part 1. Effect of frequency and duty
   cycle
SO JOURNAL OF ALLOYS AND COMPOUNDS
LA English
DT Article
DE gamma-TiAl alloy; corrosion; pulsed nanocrystallme plasma electrolytic
   carburising; scanning electron microscopy; Ringer's solution
ID STAINLESS-STEEL; ION-IMPLANTATION; PARAMETERS
AB Tafel polarization and electrochemical impedance spectroscopy were employed in Ringer's solution to test carburised Ti-48Al-2Cr-2Nb, treated by a novel method called pulsed nanocrystalline plasma electrolytic carburising. The results show excellent corrosion resistance for modified Ti-48Al-2Cr-2Nb. The effect of frequency and duty cycle of pulsed current was investigated. It was found that frequency and duty cycle of pulsed current affect the size and porosity of nanocrystalline carbides. This surface modification with controlled effective parameters can render the Ti-48Al-2Cr-2Nb material extremely corrosion resistant as a biomaterial. (c) 2007 Elsevier B.V. All rights reserved.
C1 [Aliofkhazraee, M.; Rouhaghdam, A. Sabour; Shahrabi, T.] Tarbiat Modares Univ, Dept Mat Engn, Fac Engn, Tehran, Iran.
RP Rouhaghdam, AS (reprint author), Tarbiat Modares Univ, Dept Mat Engn, Fac Engn, POB 14115-143, Tehran, Iran.
EM sabour01@gmail.com
CR Ahangarani S, 2006, VACUUM, V80, P1032, DOI 10.1016/j.vacuum.2006.01.013
   ALIOFKHAZRAEI M, MAT SCI IN PRESS
   ALIOFKHAZRAEI M, J MAT SCI T IN PRESS, V23
   Baldwin MJ, 1998, SURF COAT TECH, V98, P1187, DOI 10.1016/S0257-8972(97)00150-3
   Baldwin MJ, 1999, THIN SOLID FILMS, V345, P108, DOI 10.1016/S0040-6090(99)00066-8
   Camps E, 1998, VACUUM, V51, P385, DOI 10.1016/S0042-207X(98)00119-5
   COLLINS GA, 1991, MAT SCI ENG A-STRUCT, V139, P171, DOI 10.1016/0921-5093(91)90613-R
   HANNULA SP, 1989, THIN SOLID FILMS, V181, P343, DOI 10.1016/0040-6090(89)90502-6
   MELETIS EI, 1993, J VAC SCI TECHNOL A, V11, P25, DOI 10.1116/1.578712
   SMITH PP, 1994, J VAC SCI TECHNOL B, V12, P940, DOI 10.1116/1.587332
   Tarakci M, 2005, SURF COAT TECH, V199, P205, DOI 10.1016/j.surfcoat.2005.02.117
   Williamson DL, 1997, NUCL INSTRUM METH B, V127, P930, DOI 10.1016/S0168-583X(97)00033-5
   Yerokhin AL, 1999, SURF COAT TECH, V122, P73, DOI 10.1016/S0257-8972(99)00441-7
NR 13
TC 19
Z9 20
U1 1
U2 6
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-8388
J9 J ALLOY COMPD
JI J. Alloy. Compd.
PD JUL 28
PY 2008
VL 460
IS 1-2
BP 614
EP 618
DI 10.1016/j.jallcom.2007.06.007
PG 5
WC Chemistry, Physical; Materials Science, Multidisciplinary; Metallurgy &
   Metallurgical Engineering
SC Chemistry; Materials Science; Metallurgy & Metallurgical Engineering
GA 320DA
UT WOS:000257212700110
DA 2018-10-19
ER

PT J
AU Muller, WEG
   Jochum, KP
   Stoll, B
   Wang, XH
AF Mueller, Werner E. G.
   Jochum, Klaus Peter
   Stoll, Brigitte
   Wang, Xiaohong
TI Formation of giant spicule from quartz glass by the deep sea sponge
   Monorhaphis
SO CHEMISTRY OF MATERIALS
LA English
DT Article
ID DEMOSPONGE SUBERITES-DOMUNCULA; SILICEOUS SPICULES; HEXACTINELLID
   MONORHAPHIS; DIATOM FRUSTULE; SILICATEIN; PROTEIN; MATRIX; BIOSILICA;
   PORIFERA; BIOMINERALIZATION
AB The skeleton of the oldest multicellular animals, the spicules from siliceous sponges (the classes of Hexactinellida and Demospongiae), is composed of amorphous hydrated silica. The most outstanding feature of these spicules is that they are synthesized by the enzyme silicatein. After having studied the largest biosilica structures on earth, the up to 3 in long (diameter of 8.5 mm) spicules from the deep-sea hexactinellid Monorhaphis chuni, we describe that this silica material has the quality of glass. Although such silica can be produced chemically only at high temperature and with aggressive chemicals, the animals fabricate this biomaterial physiologically and at low temperature (around 4 degrees C). These giant spicules are composed of almost pure silica. Likewise surprising is the fact that this biosilica contains a proteinaceous, matrix, which is silicatein. Because these composite structured spicules also function as excellent light waveguides, out- results may open new perspectives for the production of nanostructured materials and devices in the opto- and microelectronics industry.
C1 [Mueller, Werner E. G.] Johannes Gutenberg Univ Mainz, Inst Physiol Chem, Angew Mol Biol Abt, D-55099 Mainz, Germany.
   [Jochum, Klaus Peter; Stoll, Brigitte] Max Planck Inst Chem, D-55128 Mainz, Germany.
   [Wang, Xiaohong] Natl Res Ctr Geoanal, Beijing 100037, Peoples R China.
RP Muller, WEG (reprint author), Johannes Gutenberg Univ Mainz, Inst Physiol Chem, Angew Mol Biol Abt, Duesbergweg 6, D-55099 Mainz, Germany.
EM wmueller@uni-mainz.de; kpj@mpch-mainz.mpg.de
CR Aizenberg J, 2004, P NATL ACAD SCI USA, V101, P3358, DOI 10.1073/pnas.0307843101
   Brasier M, 1997, GEOLOGY, V25, P303, DOI 10.1130/0091-7613(1997)025<0303:ESSCFS>2.3.CO;2
   Cha JN, 1999, P NATL ACAD SCI USA, V96, P361, DOI 10.1073/pnas.96.2.361
   COMPTON SJ, 1985, ANAL BIOCHEM, V151, P369, DOI 10.1016/0003-2697(85)90190-3
   Dayhoff M., 1978, ATLAS PROTEIN SEQ S3, V5, P345
   Deane CM, 2001, PROTEIN SCI, V10, P599, DOI 10.1110/ps.37601
   EHRLICH H, 2008, NANOMATERIA IN PRESS
   Ehrlich H, 2007, J EXP ZOOL PART B, V308B, P347, DOI 10.1002/jez.b.21156
   FELSENSTEIN J, 1993, PHYLIP VERSION 3 5
   Foissy A, 1998, SURFACE PROPERTIES OF SILICAS, P365
   HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0
   HECKY RE, 1973, MAR BIOL, V19, P323, DOI 10.1007/BF00348902
   Hyman L.H., 1940, INVERTEBRATES PROTOZ
   Jochum KP, 2007, J ANAL ATOM SPECTROM, V22, P112, DOI 10.1039/b609547j
   Kennish M. J., 1994, PRACTICAL HDB MARINE
   Krasko A, 2000, EUR J BIOCHEM, V267, P4878, DOI 10.1046/j.1432-1327.2000.01547.x
   Lee LP, 2005, SCIENCE, V310, P1148, DOI 10.1126/science.1115248
   LEVI C, 1989, J MATER SCI LETT, V8, P337, DOI 10.1007/BF00725516
   Lobel KD, 1996, MAR BIOL, V126, P353, DOI 10.1007/BF00354617
   Lobel KD, 1996, J MATER SCI LETT, V15, P648, DOI 10.1007/BF00264101
   Maldonado M, 1999, NATURE, V401, P785, DOI 10.1038/44560
   Maldonado M, 2005, LIMNOL OCEANOGR, V50, P799, DOI 10.4319/lo.2005.50.3.0799
   MICHIN EA, 1909, ERG FORTSCHR ZOOL, V2, P171
   Miserez A, 2008, ADV FUNCT MATER, V18, P1241, DOI 10.1002/adfm.200701135
   Muller WEG, 2007, BIOGEOSCIENCES, V4, P219, DOI 10.5194/bg-4-219-2007
   Muller WEG, 2008, J STRUCT BIOL, V161, P188, DOI 10.1016/j.jsb.2007.10.009
   Muller WEG, 2008, FEBS J, V275, P362, DOI 10.1111/j.1742-4658.2007.06206.x
   Muller WEG, 2007, BIOMATERIALS, V28, P4501, DOI 10.1016/j.biomaterials.2007.06.030
   Muller WEG, 2007, CELL TISSUE RES, V329, P363, DOI 10.1007/s00441-007-0402-x
   Muller WEG, 2007, GENE, V395, P62, DOI 10.1016/j.gene.2007.02.014
   Muller W. E. G., 2005, ENCY MOL CELL BIOL M, V13, P269
   Muller WEG, 1999, TRANSPLANTATION, V68, P1215
   Muller WEG, 2006, BIOSENS BIOELECTRON, V21, P1149, DOI 10.1016/j.bios.2005.04.017
   Muller WEG, 2005, CELL TISSUE RES, V321, P285, DOI 10.1007/s00441-005-1141-5
   Muller WEG, 2004, INT REV CYTOL, V235, P53, DOI 10.1016/S0074-7696(04)35002-3
   Muller WEG, 2003, PROG MOLEC, V33, P195
   Pancer Z, 1996, CELL ADHES COMMUN, V4, P327, DOI 10.3109/15419069609010776
   Pilcher H, 2005, NATURE, V435, P1022, DOI 10.1038/4351022a
   Pisera A, 2003, MICROSC RES TECHNIQ, V62, P312, DOI 10.1002/jemt.10398
   RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6
   ROBINSON PN, 2007, JAVA PROGRAM DRAWING
   SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626
   Sandford F, 2003, MICROSC RES TECHNIQ, V62, P336, DOI 10.1002/jemt.10400
   Schacke H, 1994, USE OF AQUATIC INVERTEBRATES AS TOOLS FOR MONITORING OF ENVIRONMENTAL HAZARDS, P201
   Schroder HC, 2006, J BIOL CHEM, V281, P12001, DOI 10.1074/jbc.M512677200
   Schroder HC, 2004, BIOCHEM J, V381, P665, DOI 10.1042/BJ20040463
   SCHULZE FE, 1904, HEXACTINELLIDA WISSE, P1
   Shimizu K, 1998, P NATL ACAD SCI USA, V95, P6234, DOI 10.1073/pnas.95.11.6234
   SIMPSON TL, 1984, CELL BIOL SPONGES
   Tahir MN, 2005, CHEM COMMUN, P5533, DOI 10.1039/b510113a
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V
   Weaver JC, 2007, J STRUCT BIOL, V158, P93, DOI 10.1016/j.jsb.2006.10.027
   Woesz A, 2006, J MATER RES, V21, P2068, DOI 10.1557/JMR.2006.0251
   Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153
NR 55
TC 31
Z9 34
U1 0
U2 15
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0897-4756
J9 CHEM MATER
JI Chem. Mat.
PD JUL 22
PY 2008
VL 20
IS 14
BP 4703
EP 4711
DI 10.1021/cm800734q
PG 9
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 326NN
UT WOS:000257666300026
DA 2018-10-19
ER

PT J
AU Ponader, S
   Brandt, H
   Vairaktaris, E
   von Wilmowsky, C
   Nkenke, E
   Schlegel, KA
   Neukam, FW
   Holst, S
   Muller, FA
   Greil, P
AF Ponader, Sabine
   Brandt, Heike
   Vairaktaris, Eleftherios
   von Wilmowsky, Cornelius
   Nkenke, Emeka
   Schlegel, Karl A.
   Neukam, Friedrich W.
   Holst, Stefan
   Mueller, Frank A.
   Greil, Peter
TI In vitro response of hFOB cells to pamidronate modified sodium silicate
   coated cellulose scaffolds
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE bisphosphonates; cellulose sodium silicate; human osteoblasts; in vitro
   cell response; sol-gel coating
ID ENHANCE SCREW FIXATION; SIMULATED BODY-FLUID; BIOACTIVE GLASS;
   CALCIUM-PHOSPHATE; OSTEOBLAST DIFFERENTIATION; GENERAL-PROPERTIES;
   APATITE FORMATION; BONE; BISPHOSPHONATES; PROLIFERATION
AB The aim of the present study was to evaluate the suitability of cellulose-based scaffolds coated with pure sodium silicate gel and sodium silicate gels accumulated with different concentrations of the bisphosphonate pamidronate as scaffolds for attachment, proliferation and differentiation of' human fetal osteoblasts (hFOB 1.19).
   Human osteoblasts were cultured in vitro for a period up to 14 days on different cellulose scaffolds. Unmodified and sodium silicate coated cellulose scaffolds were used as control. Two surface-coated modifications of cellulose were applied. The scaffolds were coated in a modified two-step dip coating process with pure sodium silicate gel and pamidronate enriched sodium silicate gel, respectively. In order to investigate the influence of the pamidronate, concentrations of 0.667 mg Na-pamidronate/ml sodium silicate solution, 0.333 mg Na-pamidronate/ml sodium silicate solution and 3.33 x 10(-3) mg Na-pamidronate/ml sodium silicate solution were used for the coating process. Cell proliferation, vitality and attachment were examined by means of cell counting, WST-1 test, fluorescence and scanning electron microscopy. The relative grade of' differentiation of hFOB cells was examined by using quantitative real-time polymerase chain reaction (qRT-PCR) analysis for the gene expression of alkaline phosphatase and osteocalcin.
   Proliferation and differentiation of human osteoblasts was enhanced by the sodium silicate coatings accumulated with pamidronate compared to pure sodium silicate coatings. There was a reciprocal correlation of vitality with the concentration of pamidronate. The highest vitality was found on surfaces with the lowest pamidronate accumulation. Alkaline phosphatase, an early differentiation marker, was overexpressed after 7 days in cells on all pamidronate-containing surfaces (up to 350% compared to untreated cellulose). Osteocalcin, a late differentiation marker, was overexpressed after 14 days in cells on all coated surfaces (up to 300,000% compared to untreated cellulose).
   The results indicate that due to the modified coating procedure a homogeneous coating and thus, an enhancement of cell attachment and subsequent cellular functions can be achieved. Low concentrations of pamidronate seem to have a relevant effect on cell proliferation and vitality and, therefore, can be recommended for the improvement of the properties of a biomaterial. (c) 2008 Elsevier B.V. All rights reserved.
C1 [Ponader, Sabine; von Wilmowsky, Cornelius; Nkenke, Emeka; Schlegel, Karl A.; Neukam, Friedrich W.] Univ Erlangen Nurnberg, Dept Oral & Maxillofacial Surg, Erlangen, Germany.
   [Brandt, Heike; Mueller, Frank A.; Greil, Peter] Univ Erlangen Nurnberg, Dept Mat Sci Glass & Ceram Biomat, Erlangen, Germany.
   [Vairaktaris, Eleftherios] Univ Athens, Dept Oral & Maxillofacial Surg, Athens, Greece.
   [Holst, Stefan] Univ Erlangen Nurnberg, Dept Prosthodont, Erlangen, Germany.
RP Ponader, S (reprint author), Univ Erlangen Nurnberg, Dept Oral & Maxillofacial Surg, Erlangen, Germany.
EM sabine.ponader@uk-erlangen.de
RI Schlegel, Karl Andreas/D-1015-2010; Nkenke, Emeka/A-1064-2014
OI Nkenke, Emeka/0000-0001-9591-9359; Brandt, Heike/0000-0002-3724-5568
CR Boss JH, 1999, J LONG-TERM EFF MED, V9, P1
   Bourges X, 2002, BIOPOLYMERS, V63, P232, DOI 10.1002/bip.10053
   Bourges X, 2002, ADV COLLOID INTERFAC, V99, P215, DOI 10.1016/S0001-8686(02)00035-0
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Chapekar MS, 2000, J BIOMED MATER RES, V53, P617, DOI 10.1002/1097-4636(2000)53:6<617::AID-JBM1>3.3.CO;2-3
   DAMEN JJM, 1989, J DENT RES, V68, P1355, DOI 10.1177/00220345890680091301
   DAMEN JJM, 1992, J DENT RES, V71, P453, DOI 10.1177/00220345920710030601
   Day RM, 2005, J BIOMED MATER RES A, V75A, P778, DOI 10.1002/jbm.a.30433
   DECORREIA VF, 2006, DENT TRAUMATOL, V22, P312
   DUCHEYNE P, 1994, J BONE JOINT SURG BR, V76B, P861
   Fellah BH, 2006, J ORTHOP RES, V24, P628, DOI 10.1002/jor.20125
   Fromigue O, 2002, J ENDOCRINOL INVEST, V25, P539, DOI 10.1007/BF03345497
   Giuliani N, 1998, BONE, V22, P455, DOI 10.1016/S8756-3282(98)00033-7
   Granja PL, 2001, J MATER SCI-MATER M, V12, P785, DOI 10.1023/A:1013960601330
   Hattar S, 2005, BIOMATERIALS, V26, P839, DOI 10.1016/j.biomaterials.2004.03.026
   Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   Im GI, 2004, BIOMATERIALS, V25, P4105, DOI 10.1016/j.biomaterials.2003.11.024
   Ito Y, 1999, BIOMATERIALS, V20, P2333, DOI 10.1016/S0142-9612(99)00162-3
   Jonasova L, 2004, KEY ENG MAT, V254-2, P1013, DOI 10.4028/www.scientific.net/KEM.254-256.1013
   KARLSSON KH, 1989, J NON-CRYST SOLIDS, V112, P69, DOI 10.1016/0022-3093(89)90495-X
   Kaufmann EABE, 2000, J BIOMED MATER RES, V52, P783
   Knoblich B, 2001, J NON-CRYST SOLIDS, V283, P109, DOI 10.1016/S0022-3093(01)00356-8
   Laurence S, 2005, J BIOMED MATER RES A, V73A, P422, DOI 10.1002/jbm.a.30280
   LI PJ, 1992, J AM CERAM SOC, V75, P2094, DOI 10.1111/j.1151-2916.1992.tb04470.x
   Li XW, 2006, J MATER SCI-MATER M, V17, P573, DOI 10.1007/s10856-006-8942-2
   Loty C, 2001, J BONE MINER RES, V16, P231, DOI 10.1359/jbmr.2001.16.2.231
   Luckman SP, 1998, J BONE MINER RES, V13, P581, DOI 10.1359/jbmr.1998.13.4.581
   Mann BK, 1999, BIOMATERIALS, V20, P2281, DOI 10.1016/S0142-9612(99)00158-1
   Meraw SJ, 1999, J PERIODONTOL, V70, P1228, DOI 10.1902/jop.1999.70.10.1228
   Meraw SJ, 1999, J PERIODONTOL, V70, P151, DOI 10.1902/jop.1999.70.2.151
   MIYAMOTO T, 1989, J BIOMED MATER RES, V23, P125, DOI 10.1002/jbm.820230110
   Muller FA, 2006, KEY ENG MAT, V309-311, P1173
   Muller FA, 2006, BIOMATERIALS, V27, P3955, DOI 10.1016/j.biomaterials.2006.02.031
   Muller L, 2006, ACTA BIOMATER, V2, P181, DOI 10.1016/j.actbio.2005.11.001
   OHTSUKI C, 1992, J NON-CRYST SOLIDS, V143, P84, DOI 10.1016/S0022-3093(05)80556-3
   Oliveira AL, 2003, BIOMATERIALS, V24, P2575, DOI 10.1016/S0142-9612(03)00060-7
   Plotkin LI, 1999, J CLIN INVEST, V104, P1363, DOI 10.1172/JCI6800
   Poustis J., 1994, Clinical Materials, V16, P119, DOI 10.1016/0267-6605(94)90106-6
   Reinholz GG, 2000, CANCER RES, V60, P6001
   Rodan GA, 1996, J CLIN INVEST, V97, P2692, DOI 10.1172/JCI118722
   Rodan GA, 1998, ANNU REV PHARMACOL, V38, P375, DOI 10.1146/annurev.pharmtox.38.1.375
   Roether JA, 2002, J MATER SCI-MATER M, V13, P1207, DOI 10.1023/A:1021166726914
   Rogers MJ, 1997, CANCER, V80, P1652, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1652::AID-CNCR15>3.0.CO;2-Z
   SAHNI M, 1993, J CLIN INVEST, V91, P2004, DOI 10.1172/JCI116422
   Scriba G K, 2000, Pharm Unserer Zeit, V29, P50, DOI 10.1002/(SICI)1615-1003(200001)29:1<50::AID-PAUZ50>3.3.CO;2-F
   Shi HQ, 2000, J BIOMED MATER RES, V49, P1
   Skoglund B, 2004, J ORTHOPAED RES, V22, P1108, DOI 10.1016/j.orthres.2003.12.015
   Sparidans RW, 1998, PHARM WORLD SCI, V20, P206, DOI 10.1023/A:1008626026484
   Stangl R., 2001, European Cells & Materials, V2, P1
   Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049
   Valilmaki VV, 2006, BONE, V38, P432, DOI 10.1016/j.bone.2005.09.016
   Viitala R, 2005, J NON-CRYST SOLIDS, V351, P3225, DOI 10.1016/j.jnoncrysol.2005.08.023
   von Knoch F, 2005, BIOMATERIALS, V26, P6941, DOI 10.1016/j.biomaterials.2005.04.059
   WERMELIN K, 2007, J BIOMED MATER RES A, V86, P220
   WERMELIN K, 2007, BONE, V42, P365
   Wermelin K, 2007, ACTA ORTHOP, V78, P385, DOI 10.1080/17453670710013979
   Xynos ID, 2000, CALCIFIED TISSUE INT, V67, P321, DOI 10.1007/s002230001134
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
   Yang XBB, 2006, BIOCHEM BIOPH RES CO, V342, P1098, DOI 10.1016/j.bbrc.2006.02.021
   Yoshinari M, 2002, BIOMATERIALS, V23, P2879, DOI 10.1016/S0142-9612(01)00415-X
NR 63
TC 14
Z9 14
U1 1
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD JUL 15
PY 2008
VL 64
IS 2
BP 275
EP 283
DI 10.1016/j.colsurfb.2008.02.002
PG 9
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 326JV
UT WOS:000257655700017
PM 18346882
DA 2018-10-19
ER

PT J
AU Fundeanu, I
   van der Mei, HC
   Schouten, AJ
   Busscher, HJ
AF Fundeanu, Irina
   van der Mei, Henny C.
   Schouten, Arend J.
   Busscher, Henk J.
TI Polyacrylamide brush coatings preventing microbial adhesion to silicone
   rubber
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE biomaterial; biocompatibility; polyacrylamide brush; coating stability;
   microbial adhesion
ID IN-VIVO; POLYMER; STABILITY; SURFACES
AB Silicone rubber is a frequently used biomaterial in biomedical devices and implants, yet highly prone to microbial adhesion and the development of a biomaterial-centered infection. Effective coating of silicone rubber to discourage microbial adhesion has thus far been impossible due to the hydrophobic character of its surface, surface deterioration upon treatment and instability of coatings Linder physiological conditions. Here we present a method to successfully grow polyacrylamide (PAAm) brushes from silicone rubber surfaces after removal of low molecular weight organic molecules (LMWOM), such as silane oligomers. PAAm brush coating did not cause any surface deterioration and discouraged microbial adhesion, even after 1-month exposure to physiological fluids. The method presented opens many new avenues for the use of silicone rubber as a biomaterial, without the risk of developing a biomaterial-centered infection. (c) 2008 Elsevier B.V. All rights reserved.
C1 [van der Mei, Henny C.; Busscher, Henk J.] Univ Groningen, NL-9713 AV Groningen, Netherlands.
   [Fundeanu, Irina; Schouten, Arend J.] Univ Groningen, Dept Polymer Chem, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands.
   [van der Mei, Henny C.; Busscher, Henk J.] Univ Med Ctr Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
RP van der Mei, HC (reprint author), Univ Med Ctr Groningen, Dept Biomed Engn, POB 196, NL-9700 AD Groningen, Netherlands.
EM h.c.van.der.mei@med.umcg.nl
CR BOHDANECKY M, 1983, MAKROMOL CHEM, V184, P2061
   Branch DW, 2001, BIOMATERIALS, V22, P1035, DOI 10.1016/S0142-9612(00)00343-4
   Briseno AL, 2006, J AM CHEM SOC, V128, P3880, DOI 10.1021/ja058226v
   Cringus-Fundeanu I, 2007, LANGMUIR, V23, P5120, DOI 10.1021/la063531v
   CRINGUSFUNDEANU I, UNPUB
   Currie EPK, 2003, ADV COLLOID INTERFAC, V100, P205, DOI 10.1016/S0001-8686(02)00061-1
   CURRIE EPK, 2000, THESIS U WAGENINGEN, pCH8
   Efimenko K, 2005, POLYMER, V46, P9329, DOI 10.1016/j.polymer.2005.07.046
   Efimenko K, 2002, J COLLOID INTERF SCI, V254, P306, DOI 10.1006/jcis.202.8594
   EVERAERT EP, 1995, J ADHES SCI TECHNOL, V9, P1263, DOI 10.1163/156856195X01030
   Everaert EPJM, 1999, ARCH OTOLARYNGOL, V125, P1329, DOI 10.1001/archotol.125.12.1329
   Glasmastar K, 2003, LANGMUIR, V19, P5475, DOI 10.1021/1a026558x
   Gottenbos B, 2002, BIOMATERIALS, V23, P1417, DOI 10.1016/S0142-9612(01)00263-0
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Halperin A, 1999, LANGMUIR, V15, P2525, DOI 10.1021/la981356f
   Keefer LK, 2003, NAT MATER, V2, P357, DOI 10.1038/nmat913
   Lykissa ED, 1997, ANAL CHEM, V69, P4912, DOI 10.1021/ac970710w
   Matyjaszewski K, 2001, CHEM REV, V101, P2921, DOI 10.1021/cr940534g
   MCMILLIN CR, 1994, RUBBER CHEM TECHNOL, V67, P417, DOI 10.5254/1.3538684
   Moro T, 2004, NAT MATER, V3, P829, DOI 10.1038/nmat1233
   Morra M, 2000, J BIOMAT SCI-POLYM E, V11, P547, DOI 10.1163/156856200743869
   Roosjen A, 2005, J BIOMED MATER RES B, V73B, P347, DOI 10.1002/jbm.b.30227
   Roosjen A, 2004, LANGMUIR, V20, P10949, DOI 10.1021/la0484691
   SPERLING LH, 1992, CONFORMATION POLYM C, P175
   ZAFONTE L, 1984, P SOC PHOTO-OPT INST, V470, P164
NR 25
TC 35
Z9 37
U1 3
U2 21
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD JUL 15
PY 2008
VL 64
IS 2
BP 297
EP 301
DI 10.1016/j.colsurfb.2008.02.005
PG 5
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 326JV
UT WOS:000257655700019
PM 18356029
DA 2018-10-19
ER

PT J
AU Vondran, JL
   Sun, W
   Schauer, CL
AF Vondran, Jennifer L.
   Sun, Wei
   Schauer, Caroline L.
TI Crosslinked, electrospun chitosan-poly(ethylene oxide) nanofiber mats
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE biopolymers; crosslinking; fibers; mechanical properties
ID TISSUE-ENGINEERING SCAFFOLDS; HYALURONATE POLYELECTROLYTE COMPLEXES;
   CHITOSAN-CHONDROITIN SULFATE; POLY(ETHYLENE OXIDE); ACETIC-ACID;
   LINKING; MEMBRANES; FIBERS; MATRIX; CHITIN
AB Mechanical characterization of nanofiber mats is an underexplored area in biomaterial engineering. In this study, a chitosan-poly(ethylene oxide) copolymer blend was electrospun and crosslinked with glutaraldehyde (GA) for various time periods. The tensile and compressive mechanical integrity of the nanofibers was analyzed with increasing exposure to vapor crosslinking. Solubility, scanning electron microscopy characterization, Fourier transform infrared, uniaxial tensile tests, and nanoindentation analyses were used to identify these trends. The mechanical studies confirmed that the GA vapor crosslinking increased the stiffness and decreased the ductility of the electrospun mats. Increased exposure time to crosslinking led to changes in the mat surface color and resistance to dissolution. Scanning electron microscopy fiber counts verified that exposure to GA vapor crosslinking increased the average fiber diameter. By the use of vapor phase deposition, mechanical properties continued to change throughout the study. The crosslinking exposure time could be chosen to accommodate in vivo mechanical loading. (C) 2008 Wiley Periodicals, Inc.
C1 [Vondran, Jennifer L.; Schauer, Caroline L.] Drexel Univ, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA.
   [Sun, Wei] Drexel Univ, Dept Mech Engn & Mech, Philadelphia, PA 19104 USA.
RP Schauer, CL (reprint author), Drexel Univ, Dept Mat Sci & Engn, 3141 Chestnut St, Philadelphia, PA 19104 USA.
EM cschauer@coe.drexel.edu
RI Schauer, Caroline/D-5350-2013
CR Adekogbe I, 2005, BIOMATERIALS, V26, P7241, DOI 10.1016/j.biomaterials.2005.05.043
   Arguelles-Monal W, 1998, POLYM GELS NETW, V6, P429, DOI 10.1016/S0966-7822(98)00032-X
   Bhattarai N, 2005, BIOMATERIALS, V26, P6176, DOI 10.1016/j.biomaterials.2005.03.027
   Bigi A, 2001, BIOMATERIALS, V22, P763, DOI 10.1016/S0142-9612(00)00236-2
   Brandrup J., 2005, POLYM HDB
   Butler MF, 2003, J POLYM SCI POL CHEM, V41, P3941, DOI 10.1002/pola.10960
   Denuziere A, 1998, BIOMATERIALS, V19, P1275, DOI 10.1016/S0142-9612(98)00036-2
   Denuziere A, 1996, CARBOHYD POLYM, V29, P317, DOI 10.1016/S0144-8617(96)00035-5
   Duan B, 2004, J BIOMAT SCI-POLYM E, V15, P797, DOI 10.1163/156856204774196171
   Feng Q, 2005, COLLOID SURFACE A, V257-58, P85, DOI 10.1016/j.colsurfa.2004.10.099
   Frenot A, 2003, CURR OPIN COLLOID IN, V8, P64, DOI 10.1016/S1359-0294(03)00004-9
   Ge JJ, 2000, J MEMBRANE SCI, V165, P75, DOI 10.1016/S0376-7388(99)00228-8
   Geng XY, 2005, BIOMATERIALS, V26, P5427, DOI 10.1016/j.biomaterials.2005.01.066
   Han D, 2006, NANOMED-NANOTECHNOL, V2, P37, DOI 10.1016/j.nano.2006.01.002
   Knaul JZ, 1999, J POLYM SCI POL PHYS, V37, P1079, DOI 10.1002/(SICI)1099-0488(19990601)37:11<1079::AID-POLB4>3.0.CO;2-O
   Koide SS, 1998, NUTR RES, V18, P1091, DOI 10.1016/S0271-5317(98)00091-8
   KOYAMA Y, 1986, J APPL POLYM SCI, V31, P1951, DOI 10.1002/app.1986.070310636
   Krajewska B, 2005, SEP PURIF TECHNOL, V41, P305, DOI 10.1016/j.seppur.2004.03.019
   Krajewska B, 2001, J CHEM TECHNOL BIOT, V76, P636, DOI 10.1002/jctb.429.abs
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   Kweon DK, 2003, BIOMATERIALS, V24, P1595, DOI 10.1016/S0142-9612(02)00566-5
   Lannutti J, 2007, MAT SCI ENG C-BIO S, V27, P504, DOI 10.1016/j.msec.2006.05.019
   Li F, 2002, BIOMATERIALS, V23, P343, DOI 10.1016/S0142-9612(01)00111-9
   Li L, 2006, CARBOHYD RES, V341, P374, DOI 10.1016/j.carres.2005.11.028
   Li MY, 2005, BIOMATERIALS, V26, P5999, DOI 10.1016/j.biomaterials.2005.03.030
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005
   Li ZS, 2005, J BIOMED MATER RES A, V75A, P485, DOI 10.1002/jbm.a.30449
   Ma ZW, 2005, TISSUE ENG, V11, P101, DOI 10.1089/ten.2005.11.101
   Marguerite R., 2006, PROG POLYM SCI, V31, P603, DOI DOI 10.1016/J.PROGPOLYMSCI.2006.06.001
   Mi FL, 2005, J POLYM SCI POL CHEM, V43, P1985, DOI 10.1002/pla.20669
   Mi FL, 2002, CARBOHYD POLYM, V48, P61, DOI 10.1016/S0144-8617(01)00212-0
   Mi FL, 2002, BIOMATERIALS, V23, P181, DOI 10.1016/S0142-9612(01)00094-1
   Monteiro OAC, 1999, INT J BIOL MACROMOL, V26, P119, DOI 10.1016/S0141-8130(99)00068-9
   Musale DA, 2000, SEP PURIF TECHNOL, V21, P27, DOI 10.1016/S1383-5866(00)00188-X
   Nair LS, 2004, EXPERT OPIN BIOL TH, V4, P659, DOI 10.1517/14712598.4.5.659
   Neto CGT, 2005, CARBOHYD RES, V340, P2630, DOI 10.1016/j.carres.2005.09.011
   Ohkawa K, 2004, MACROMOL RAPID COMM, V25, P1600, DOI 10.1002/marc.200400253
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   QIN Y, 2004, MED DEVICE TECHN JAN, P34
   Rabea EI, 2003, BIOMACROMOLECULES, V4, P1457, DOI 10.1021/bm034130m
   Saltzman W. M., 2004, TISSUE ENG ENG PRINC
   Schauer CL, 2003, THIN SOLID FILMS, V434, P250, DOI 10.1016/S0040-6090(03)00055-5
   Schiffman JD, 2007, BIOMACROMOLECULES, V8, P594, DOI 10.1021/bm060804s
   Silva RM, 2004, J MATER SCI-MATER M, V15, P1105, DOI 10.1023/B:JMSM.0000046392.44911.46
   Smith LA, 2004, COLLOID SURFACE B, V39, P125, DOI [10.1016/j.colsurfb.2003.12.004, 10.1016/j.colsurfb.2003.l2.004]
   SPASOVA M, 2004, E-POLYMERS, V56, P1
   Sridhar S, 2001, POLYM INT, V50, P1156, DOI 10.1002/pi.761
   Subramanian A, 2005, J BIOMED MATER RES A, V75A, P742, DOI 10.1002/jbm.a.30489
   Subramanian A, 2005, J BIOMAT SCI-POLYM E, V16, P861, DOI 10.1163/1568562054255682
   Tual C, 2000, J POLYM SCI POL PHYS, V38, P1521, DOI 10.1002/(SICI)1099-0488(20000601)38:11<1521::AID-POLB120>3.0.CO;2-#
   Wang XH, 2003, INT J BIOL MACROMOL, V33, P95, DOI 10.1016/S0141-8130(03)00072-2
   Wang XP, 2000, J APPL POLYM SCI, V75, P740, DOI 10.1002/(SICI)1097-4628(20000207)75:6<740::AID-APP2>3.0.CO;2-3
   Welsh ER, 2002, BIOMACROMOLECULES, V3, P1370, DOI 10.1021/bm025625z
   Yamane S, 2005, BIOMATERIALS, V26, P611, DOI 10.1016/j.biomaterials.2004.03.013
NR 55
TC 38
Z9 39
U1 3
U2 47
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD JUL 15
PY 2008
VL 109
IS 2
BP 968
EP 975
DI 10.1002/app.28107
PG 8
WC Polymer Science
SC Polymer Science
GA 306SD
UT WOS:000256267200037
DA 2018-10-19
ER

PT J
AU Tarasova, A
   Griesser, HJ
   Meagher, L
AF Tarasova, Anna
   Griesser, Hans J.
   Meagher, Laurence
TI AFM study of the stability of a dense affinity-bound liposome layer
SO LANGMUIR
LA English
DT Article
ID ATOMIC-FORCE MICROSCOPY; QUARTZ-CRYSTAL MICROBALANCE; PHOTON-CORRELATION
   SPECTROSCOPY; SURFACE-IMMOBILIZED LAYERS; FRICTIONAL-PROPERTIES; INTACT
   LIPOSOMES; CHAIN-LENGTH; ADSORPTION; VESICLES; MONOLAYERS
AB Liposomes that are surface-bound to a biomaterial such as a contact lens are of interest for localized delivery of therapeutic agents, but it is not known whether such liposome layers are sufficiently robust. The stability of a dense, PEG-functionalized layer of liposomes, affinity-bound onto a multilayer coated surface, was tested under various stress conditions using colloid-probe atomic force miscroscopy (AFM). The different stress effects were generated by varying the applied normal load of the probe and the impinging fluid shear through different approach velocities and by varying the applied lateral forces by scanning under increasing force loads. The effect of applied forces (normal and lateral) was further investigated by coating the probe with a layer of albumin. The liposomes remained intact following the ramping of both protein-coated and uncoated probes under the normal and lateral loads. The low-fouling nature of these liposomes, with respect to nonspecific protein adsorption, was also demonstrated from the interaction force measurements which showed only weak adhesion from the protein layer during the contact period of the albumin-coated probe. The observed adhesive interactions were concluded to be a direct result of the applied load from the probe, during the force measurements, rather than from attraction of the protein molecules for the surface-bound liposomes. The low frictional response of the liposome layer indicated the viscoelastic nature of these molecules, which enabled liposome structure retention during the continuous load application. The demonstrated stability of the liposomes presents a system of viable and localized drug delivery in, for example, ophthalmic applications.
C1 [Tarasova, Anna; Meagher, Laurence] CSIRO Mol & Hlth Technol, Clayton, Vic 3168, Australia.
   [Tarasova, Anna; Meagher, Laurence] Univ New S Wales, Vis CRC, Kensington, NSW 2052, Australia.
   [Griesser, Hans J.] Univ S Australia, Ian Wark Res Inst, Mawson Lakes, SA 5095, Australia.
RP Tarasova, A (reprint author), CSIRO Mol & Hlth Technol, Bag 10,Bayview Ave, Clayton, Vic 3168, Australia.
EM anna.tarasova@csiro.au
RI Griesser, Hans/E-5628-2011; Meagher, Laurence/G-1412-2012
OI Griesser, Hans/0000-0003-1072-7863; Meagher,
   Laurence/0000-0002-2055-6159
CR ALLEN TM, 1991, BIOCHIM BIOPHYS ACTA, V1066, P29, DOI 10.1016/0005-2736(91)90246-5
   Bremmell KE, 2006, LANGMUIR, V22, P313, DOI 10.1021/la052143a
   Brewer NJ, 2001, LANGMUIR, V17, P1970, DOI 10.1021/la001568o
   Brochu H, 2008, LANGMUIR, V24, P2009, DOI 10.1021/la702382d
   Brochu H, 2007, LANGMUIR, V23, P7679, DOI 10.1021/la7003547
   Bushell GR, 1999, CYTOMETRY, V36, P254, DOI 10.1002/(SICI)1097-0320(19990701)36:3<254::AID-CYTO16>3.0.CO;2-4
   CHAN DYC, 1994, AFM ANAL, V2
   CLEVELAND JP, 1993, REV SCI INSTRUM, V64, P403, DOI 10.1063/1.1144209
   Danion A, 2007, J BIOMED MATER RES A, V82A, P41, DOI 10.1002/jbm.a.31147
   DESOUZA EF, 2003, REV ADV MATER SCI, V5, P41
   DUCKER WA, 1991, NATURE, V353, P239, DOI 10.1038/353239a0
   Grant LM, 2002, BIOPHYS J, V82, P1373, DOI 10.1016/S0006-3495(02)75492-1
   GRIESSER HJ, 1989, VACUUM, V39, P485, DOI 10.1016/0042-207X(89)90272-8
   Hahner G, 1997, TRIBOL LETT, V3, P359, DOI 10.1023/A:1019153726944
   HOH JH, 1994, J CELL SCI, V107, P1105
   Ji JA, 2004, COLLOID SURFACE B, V34, P185, DOI 10.1016/j.colsurfb.2003.12.015
   Kalyankar ND, 2006, LANGMUIR, V22, P5403, DOI 10.1021/la0602719
   Kanno T, 2002, ANAL BIOCHEM, V309, P196, DOI 10.1016/S0003-2697(02)00291-9
   Keller CA, 1998, BIOPHYS J, V75, P1397, DOI 10.1016/S0006-3495(98)74057-3
   Kim HI, 1999, LANGMUIR, V15, P3179, DOI 10.1021/la981497h
   Kingshott P, 2002, BIOMATERIALS, V23, P2043, DOI 10.1016/S0142-9612(01)00334-9
   Kirby AR, 1996, BIOPOLYMERS, V38, P355, DOI 10.1002/(SICI)1097-0282(199603)38:3<355::AID-BIP8>3.0.CO;2-T
   KLEIN J, 1994, NATURE, V370, P634, DOI 10.1038/370634a0
   KLIBANOV AL, 1990, FEBS LETT, V268, P235, DOI 10.1016/0014-5793(90)81016-H
   Kohli N, 2006, J COLLOID INTERF SCI, V301, P461, DOI 10.1016/j.jcis.2006.05.048
   Liang XM, 2004, COLLOID SURFACE B, V34, P41, DOI 10.1016/j.colsurfb.2003.10.017
   Liu YH, 1996, LANGMUIR, V12, P1235, DOI 10.1021/la950504o
   Muller MT, 2005, MACROMOLECULES, V38, P3861, DOI 10.1021/ma047468x
   Oncins G, 2005, LANGMUIR, V21, P7373, DOI 10.1021/la050644q
   Park JS, 2006, CHEM MATER, V18, P6147, DOI 10.1021/cm0606732
   Patel AR, 2006, LANGMUIR, V22, P7587, DOI 10.1021/la0610452
   Pignataro B, 2000, BIOPHYS J, V78, P487, DOI 10.1016/S0006-3495(00)76611-2
   Rixman MA, 2003, LANGMUIR, V19, P9357, DOI 10.1021/la0340571
   Rossi C, 2007, J PHYS CHEM B, V111, P7567, DOI 10.1021/jp0686792
   Ruozi B, 2005, EUR J PHARM SCI, V25, P81, DOI 10.1016/j.ejps.2005.01.020
   Sheth SR, 1997, P NATL ACAD SCI USA, V94, P8399, DOI 10.1073/pnas.94.16.8399
   Sittig C, 1999, J MATER SCI-MATER M, V10, P191, DOI 10.1023/A:1008997726370
   Teschke O, 2002, LANGMUIR, V18, P6513, DOI 10.1021/la025689v
   Thomson NH, 2000, LANGMUIR, V16, P4813, DOI 10.1021/la991256p
   Vermette P, 2004, BIOMACROMOLECULES, V5, P1496, DOI 10.1021/bm049941k
   Vermette P, 2002, LANGMUIR, V18, P505, DOI 10.1021/la0109967
   Vermette P, 2002, J CONTROL RELEASE, V80, P179, DOI 10.1016/S0168-3659(02)00023-8
   Viitala T, 2007, LANGMUIR, V23, P609, DOI 10.1021/la060923t
   Wei ZQ, 2001, LANGMUIR, V17, P3945, DOI 10.1021/la001185q
   Willemsen OH, 1998, BIOPHYS J, V75, P2220, DOI 10.1016/S0006-3495(98)77666-0
   Xiao XD, 1996, LANGMUIR, V12, P235, DOI 10.1021/la950771u
   Yan XP, 2004, LANGMUIR, V20, P423, DOI 10.1021/la035785b
NR 47
TC 12
Z9 12
U1 0
U2 25
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD JUL 15
PY 2008
VL 24
IS 14
BP 7371
EP 7377
DI 10.1021/la8002959
PG 7
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 323SI
UT WOS:000257468300047
PM 18547080
DA 2018-10-19
ER

PT J
AU Szili, EJ
   Kumar, S
   Smart, RSC
   Lowe, R
   Saiz, E
   Voelcker, NH
AF Szili, Endre J.
   Kumar, Sunil
   Smart, Roger St. C.
   Lowe, Rachel
   Saiz, Eduardo
   Voelcker, Nicolas H.
TI Plasma enhanced chemical vapour deposition of silica onto titanium:
   Analysis of surface chemistry, morphology and hydroxylation
SO SURFACE SCIENCE
LA English
DT Article
DE biomaterial; hydroxyl groups; plasma enhanced chemical vapour;
   deposition; silica films; titanium
ID SIMULATED BODY-FLUID; GLASS; IMMOBILIZATION; SILANE; GROWTH
AB We have been developing and characterising a procedure for the deposition of thin silica films by a plasma enhanced chemical vapour deposition (PECVD) procedure using tetraethoxysilane (TEOS) as the main precursor. The silica coatings were used for improving the corrosion resistance of metals and as bioactive coatings on biomedical metallic implants. We have improved the PECVD method for producing high quality and reproducible PECVD-silica (PECVD-SiO2) coatings on metals, primarily for biomaterial applications. In order to understand the interaction of the PECVD-SiO2 coatings with biological species (such as proteins and cells), it is important to first analyse the properties of the silica films deposited using the optimised parameters. Therefore, the work presented and discussed in this paper was carried out to analyse the characteristic features of PECVD-SiO2 deposited on titanium (Ti) substrates (PECVDSiO2-Ti). We determined that the PECVD-SiO2 Coatings on Ti were conformal to the substrate surface, strongly adhered to the underlying substrate and were resistant to delamination. The PECVD-SiO2 surface was composed of stoichiometric SiO2, showed a low carbon content (below 10 at.%) and was very hydrophilic (contact angle <10 degrees). Finally, we also showed that the PECVD-Si coatings contain surface hydroxyl groups. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Kumar, Sunil] Univ S Australia, Ian Wark Res Inst, Mawson Lakes, SA 5095, Australia.
   [Szili, Endre J.; Lowe, Rachel; Voelcker, Nicolas H.] Flinders Univ S Australia, Sch Chem Phys & Earth Sci, Bedford Pk, SA 5042, Australia.
   [Smart, Roger St. C.] Univ S Australia, Appl Ctr Struct & Synchrotron Studies, Mawson Lakes, SA 5095, Australia.
   [Saiz, Eduardo] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA.
RP Kumar, S (reprint author), Univ S Australia, Ian Wark Res Inst, Mawson Lakes, SA 5095, Australia.
EM sunil.kumar@unisa.edu.au; nico.voelcker@flinders.edu.au
RI Voelcker, Nicolas/D-6199-2012; Smart, Roger/D-1786-2009
OI Voelcker, Nicolas/0000-0002-1536-7804; 
FU NIH/NIDCR [1R01 DE11289]; TGR BioSciences Pty Ltd; Australian Research
   Council
FX This work was supported by TGR BioSciences Pty Ltd and the Australian
   Research Council. Eduardo Saiz acknowledges the support from NIH/NIDCR
   Grant No. 1R01 DE11289.
CR ABBOTT JR, 2001, J CRANIOFAC SURG, V8, P17
   Arora PS, 1996, SURF INTERFACE ANAL, V24, P539, DOI 10.1002/(SICI)1096-9918(19960916)24:9<539::AID-SIA162>3.0.CO;2-5
   BIERBAUM K, 1995, LANGMUIR, V11, P2143, DOI 10.1021/la00006a049
   Coreno J, 2001, J BIOMED MATER RES, V57, P119, DOI 10.1002/1097-4636(200110)57:1<119::AID-JBM1150>3.0.CO;2-P
   DANG TA, 1990, SURF INTERFACE ANAL, V15, P113, DOI 10.1002/sia.740150209
   DAVIES JE, 2000, BONE ENG
   Halliwell CM, 2001, ANAL CHEM, V73, P2476, DOI 10.1021/ac0010633
   Heiney PA, 2000, LANGMUIR, V16, P2651, DOI 10.1021/1a990557w
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253
   Hou PY, 2005, OXID MET, V63, P113, DOI 10.1007/s11085-005-1954-3
   HU SM, 1980, J APPL PHYS, V51, P5945, DOI 10.1063/1.327512
   Iler R.K., 1995, COLLOID CHEM SILICA
   Jesionowski T, 2001, APPL SURF SCI, V172, P18, DOI 10.1016/S0169-4332(00)00828-X
   Kim T, 2002, J VAC SCI TECHNOL A, V20, P413, DOI 10.1116/1.1448506
   Kumar S, 2007, SURF COAT TECH, V202, P1242, DOI 10.1016/j.surfcoat.2007.07.075
   LI PJ, 1992, J AM CERAM SOC, V75, P2094, DOI 10.1111/j.1151-2916.1992.tb04470.x
   Moon JH, 1996, LANGMUIR, V12, P4621, DOI 10.1021/la9604339
   Oonishi H, 1997, CLIN ORTHOP RELAT R, P316
   Sakai N, 2003, J PHYS CHEM B, V107, P1028, DOI 10.1021/jp022105p
   Shlyakhtenko LS, 2003, ULTRAMICROSCOPY, V97, P279, DOI 10.1016/S0304-3991(03)00053-6
   Soballe K, 1993, Acta Orthop Scand Suppl, V255, P1
   Stevens N, 2003, LANGMUIR, V19, P3272, DOI 10.1021/la020660c
   Teghil R, 2002, J MATER SCI LETT, V21, P379, DOI 10.1023/A:1014903117057
   Zhang HL, 2006, COLLOID SURFACE A, V291, P128, DOI 10.1016/j.colsurfa.2006.07.057
NR 25
TC 12
Z9 12
U1 4
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0039-6028
J9 SURF SCI
JI Surf. Sci.
PD JUL 15
PY 2008
VL 602
IS 14
BP 2402
EP 2411
DI 10.1016/j.susc.2008.05.027
PG 10
WC Chemistry, Physical; Physics, Condensed Matter
SC Chemistry; Physics
GA 346IN
UT WOS:000259062200018
PM 19809536
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Pyda, M
   Hu, X
   Cebe, P
AF Pyda, M.
   Hu, Xiao
   Cebe, Peggy
TI Heat capacity of silk fibroin based on the vibrational motion of
   poly(amino acid)s in the presence and absence of water
SO MACROMOLECULES
LA English
DT Article
ID THERMAL-PROPERTIES; CRYSTAL-STRUCTURE; STATE; PROTEINS; COLLAGEN; FILMS;
   SPECTROSCOPY; TRANSITION; BIOMATERIALS; CONFORMATION
AB The heat capacities in the solid state, below the glass transition, of Bombyx mori silk fibroin with and without water have been determined based on the contribution of vibrational motions of the components: poly(amino acid)s and water. These vibrational heat capacities were constructed using the Advanced Thermal Analysis System (ATHAS) Data Bank. The heat capacities, C-p, of dry silk and silk-water were linked to their vibrational spectra based on the group and skeletal vibration contributions. For dry silk, the experimental and calculated C-p agree to better than +/- 3% between 200 and 435 K. The heat capacity of the solid silk-water system, below the glass transition, was estimated from a sum of linear combinations of the molar fractions of the vibrational heat capacities of dry silk and glassy water. The approach presented allows one to predict the low-temperature vibrational heat capacity for dry silk and for the silk-water system down to 0 K and, together with an extension to higher temperatures, above the glass transition. This can be used as a reference baseline for quantitative thermal analysis of this biomaterial.
C1 [Pyda, M.] Univ Technol Rzeszow, Dept Chem, PL-35959 Rzeszow, Poland.
   [Pyda, M.] ATHAS MP, Knoxville, TN 37922 USA.
   [Hu, Xiao; Cebe, Peggy] Tufts Univ, Dept Phys & Astron, Medford, MA 02155 USA.
RP Pyda, M (reprint author), Univ Technol Rzeszow, Dept Chem, PL-35959 Rzeszow, Poland.
EM mpyda@utk.edu; peggy.cebe@tufts.edu
RI Hu, Xiao/F-2403-2012
OI Hu, Xiao/0000-0002-2579-2820; Cebe, Peggy/0000-0002-8721-644X
CR Agarwal N, 1997, J APPL POLYM SCI, V63, P401
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Chen X, 2001, POLYMER, V42, P9969, DOI 10.1016/S0032-3861(01)00541-9
   Debye P, 1912, ANN PHYS-BERLIN, V39, P789
   Di Lorenzo ML, 1999, J POLYM SCI POL PHYS, V37, P2093, DOI 10.1002/(SICI)1099-0488(19990815)37:16<2093::AID-POLB12>3.0.CO;2-2
   Drummy LF, 2005, BIOMACROMOLECULES, V6, P3328, DOI 10.1021/bm0503524
   Foo CWP, 2002, ADV DRUG DELIVER REV, V54, P1131
   FUNG BM, 1979, BIOPOLYMERS, V18, P489, DOI 10.1002/bip.1979.360180222
   HU X, 2005, AM CHEM SOC DIV POLY, V93, P652
   HU X, 2008, MACROMOLECULES, P41
   Hu X, 2007, THERMOCHIM ACTA, V461, P137, DOI 10.1016/j.tca.2006.12.011
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Huang J, 2007, POLYM REV, V47, P29, DOI 10.1080/15583720601109560
   ISHIDA M, 1990, MACROMOLECULES, V23, P88, DOI 10.1021/ma00203a017
   KAPLAN D, 1994, ACS S SERIES, V544
   Kim YS, 2003, MACROMOLECULES, V36, P6281, DOI 10.1021/ma0301451
   Lee KY, 1999, POLYMER, V40, P4131, DOI 10.1016/S0032-3861(98)00611-9
   MAGOSHI J, 1977, J POLYM SCI POL PHYS, V15, P1675, DOI 10.1002/pol.1977.180150915
   Matsumoto A, 2006, J PHYS CHEM B, V110, P21630, DOI 10.1021/jp056350v
   MCGRATH K, 1996, PROTEIN BASED MAT
   Mijovic J, 2005, MACROMOLECULES, V38, P10812, DOI 10.1021/ma051854c
   MINIAKOV AA, 2007, REV SCI INSTRUM, V78, P111
   Motta A, 2002, MACROMOL CHEM PHYSIC, V203, P1658, DOI 10.1002/1521-3935(200207)203:10/11<1658::AID-MACP1658>3.0.CO;2-3
   Pyda M, 2005, MACROMOLECULES, V38, P10472, DOI 10.1021/ma051611k
   Pyda M., 2004, The nature of biological systems as revealed by thermal methods, P307
   Pyda M, 2002, MACROMOLECULES, V35, P4009, DOI 10.1021/ma0118466
   Pyda M, 2001, J POLYM SCI POL PHYS, V39, P3038, DOI 10.1002/polb.10060
   Pyda M, 1998, J THERM ANAL CALORIM, V52, P631, DOI 10.1023/A:1010188110516
   PYDA M, 2007, ATHAS DATA BANK
   Ray VV, 2007, POLYMER, V48, P2404, DOI 10.1016/j.polymer.2007.02.055
   ROLES KA, 1991, BIOPOLYMERS, V31, P477, DOI 10.1002/bip.360310503
   ROLES KA, 1993, BIOPOLYMERS, V33, P753, DOI 10.1002/bip.360330505
   SUGISAKI M, 1968, B CHEM SOC JPN, V41, P2591, DOI 10.1246/bcsj.41.2591
   Tarasov VV, 1950, ZH FIZ KHIM+, V24, P111
   Tretinnikov ON, 2001, LANGMUIR, V17, P7406, DOI 10.1021/la010791y
   Ur'yash VF, 2006, RUSS J GEN CHEM+, V76, P1363, DOI 10.1134/S1070363206090039
   Valluzzi R, 1997, BIOPOLYMERS, V42, P705, DOI 10.1002/(SICI)1097-0282(199711)42:6<705::AID-BIP8>3.0.CO;2-Y
   Valluzzi R, 1996, MACROMOLECULES, V29, P8606, DOI 10.1021/ma9517759
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   WUNDERLICH B, 1995, PURE APPL CHEM, V67, P1019, DOI 10.1351/pac199567061019
   Wunderlich B, 2003, PROG POLYM SCI, V28, P383, DOI 10.1016/S0079-6700(02)00085-0
   Wunderlich B, 2005, THERMAL ANAL POLYM M
   Yamane T, 2003, MACROMOLECULES, V36, P6766, DOI 10.1021/ma034466o
NR 43
TC 27
Z9 27
U1 0
U2 17
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD JUL 8
PY 2008
VL 41
IS 13
BP 4786
EP 4793
DI 10.1021/ma8003357
PG 8
WC Polymer Science
SC Polymer Science
GA 322HQ
UT WOS:000257366200036
DA 2018-10-19
ER

PT J
AU Philibert, RA
   Sandhu, H
   Hollenbeck, N
   Gunter, T
   Adams, W
   Madan, A
AF Philibert, Robert A.
   Sandhu, Harinder
   Hollenbeck, Nancy
   Gunter, Tracy
   Adams, William
   Madan, Anup
TI The relationship of 5HTT (SLC6A4) methylation and genotype on mRNA
   expression and liability to major depression and alcohol dependence in
   subjects from the Iowa Adoption Studies
SO AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
LA English
DT Article
DE serotonin transporter; serotonin; mRNA; methylation; epigenetics; major
   depression; alcohol dependence
ID SEROTONIN TRANSPORTER GENE; PROMOTER POLYMORPHISM; AFFECTIVE-DISORDERS;
   ASSOCIATION; VARIANTS; DNA; METAANALYSIS; LINES
AB Serotonin Transporter (5HTT or SLC6A4) mRNA transcription is regulated by both genetic and epigenetic mechanisms. Unfortunately, despite intense scrutiny, the exact identity and contribution of each of these regulatory mechanisms, and their relationship to behavioral illness remain unknown. This lack of knowledge is critical because alterations in SLC6A4 function are posited to be central to a wide variety of CNS disorders. In order to address this shortcoming, we quantified 5HTTLPR genotype, SLC6A4 mRNA production and CpG methylation using biomaterial from 192 lymphoblast cell lines derived from subjects who participated in the latest wave of the Iowa Adoption Studies. We then analyzed the resulting data with respect to clinical characteristics. We confirmed prior findings that the short (s) 5HTTLPR allele is associated with lower amounts of mRNA transcription, but there was no significant effect of the "Long G" allele on mRNA transcription. We also found that CpG methylation was higher (P < 0.0008) and mRNA production (P < 0.0001) was lower in females as compared to males. Those subjects with a lifetime history of Alcohol Dependence had higher levels of SLC6A4 mRNA. There was a trend for an association of increased overall methylation with lifetime history of major depression. Finally, we confirm our prior findings that the exact levels of 5HTT mRNA expression are dependent on how it is measured. We conclude that both genetic variation and epigenetic modifications contribute to the regulation of SLC6A4 function and that more in-depth studies of the molecular mechanisms controlling gene activity and the relationship of these mechanisms to behavioral illness are indicated. (C) 2007 Wiley-Liss, Inc.
C1 [Philibert, Robert A.; Sandhu, Harinder; Hollenbeck, Nancy; Gunter, Tracy; Adams, William] Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA.
   [Philibert, Robert A.] Univ Iowa, Neurosci & Genet Program, Iowa City, IA 52242 USA.
   [Madan, Anup] Inst Syst Biol, Seattle, WA USA.
RP Philibert, RA (reprint author), MEB Psychiat Res, Rm 2-126, Iowa City, IA 52242 USA.
EM robert-philibert@uiowa.edu
FU NIDA NIH HHS [R01 DA015789, DA 015789]
CR Arenas M, 2007, BBA-MOL BASIS DIS, V1772, P96, DOI 10.1016/j.bbadis.2006.10.006
   *ASS AP, 1994, DIAGN STAT MAN MENT
   Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874
   Bradley SL, 2005, AM J MED GENET B, V136B, P58, DOI 10.1002/ajmg.b.30185
   BUCHOLZ KK, 1994, J STUD ALCOHOL, V55, P149, DOI 10.15288/jsa.1994.55.149
   Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968
   Collier DA, 1996, MOL PSYCHIATR, V1, P453
   Conroy J, 2004, MOL PSYCHIATR, V9, P587, DOI 10.1038/sj.mp.4001459
   Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102
   Ehrich M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1134
   Enoch Mary-Anne, 2003, Am J Pharmacogenomics, V3, P217, DOI 10.2165/00129785-200303040-00001
   Feinn R, 2005, AM J MED GENET B, V133B, P79, DOI 10.1002/ajmg.b.30132
   Fleiss JL, 1981, STAT METHODS RATES P
   GLOVER V, 1993, J PSYCHIATR RES, V27, P223, DOI 10.1016/0022-3956(93)90010-Y
   Heils A, 1996, J NEUROCHEM, V66, P2621
   Hranilovic D, 2004, BIOL PSYCHIAT, V55, P1090, DOI 10.1016/j.biopsych.2004.01.029
   Hu XZ, 2007, ARCH GEN PSYCHIAT, V64, P783, DOI 10.1001/archpsyc.64.7.783
   Hu XZ, 2006, AM J HUM GENET, V78, P815, DOI 10.1086/503850
   Hu XZ, 2005, ALCOHOL CLIN EXP RES, V29, P8, DOI 10.1097/01.ALC.0000150008.68473.62
   Kaufman J, 2007, BIOL PSYCHIAT, V61, P1228, DOI 10.1016/j.biopsych.2006.06.039
   Kendler KS, 2005, ARCH GEN PSYCHIAT, V62, P529, DOI 10.1001/archpsyc.62.5.529
   KLAUS GGB, 1987, LYMPHOCYTES PRACTICA
   LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444
   LESCH KP, 1994, J NEURAL TRANSM-GEN, V95, P157, DOI 10.1007/BF01276434
   Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527
   Lotrich FE, 2004, PSYCHIAT GENET, V14, P121, DOI 10.1097/00041444-200409000-00001
   Martin J, 2007, MOL PSYCHIATR, V12, P421, DOI 10.1038/sj.mp.4001952
   Moffitt TE, 2005, ARCH GEN PSYCHIAT, V62, P473, DOI 10.1001/archpsyc.62.5.473
   PHILIBERT RA, 2007, U IOWA ASSIGNEE COMP
   Philibert Robert, 2006, Ann Clin Psychiatry, V18, P219, DOI 10.1080/10401230600948399
   Philibert R, 2007, AM J MED GENET B, V144B, P101, DOI 10.1002/ajmg.b.30414
   Philibert RA, 2007, AM J MED GENET B, V144B, P674, DOI 10.1002/ajmg.b.30502
   Philibert RA, 2007, AM J MED GENET B, V144B, P683, DOI 10.1102/ajmg.b.30512
   Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918
   Shukla SJ, 2005, PHARMACOGENOMICS, V6, P303, DOI 10.1517/14622416.6.3.303
   Sipos L, 2005, FEBS J, V272, P3253, DOI 10.1111/j.1742-4658.2005.04757.x
   Stein MB, 2006, PSYCHOPHARMACOLOGY, V187, P68, DOI 10.1007/s00213-006-0349-8
   Stoltenberg SF, 2002, AM J MED GENET, V114, P230, DOI 10.1002/ajmg.10187
   Surtees PG, 2006, BIOL PSYCHIAT, V59, P224, DOI 10.1016/j.biopsych.2005.07.014
   Vawter MP, 2004, SCHIZOPHR RES, V67, P41, DOI 10.1016/S0920-9964(03)00151-8
   Yates W., 1998, WAY INDIVIDUALITY ME, P95
NR 41
TC 157
Z9 164
U1 1
U2 23
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4841
J9 AM J MED GENET B
JI Am. J. Med. Genet. B
PD JUL 5
PY 2008
VL 147B
IS 5
BP 543
EP 549
DI 10.1002/ajmg.b.30657
PG 7
WC Genetics & Heredity; Psychiatry
SC Genetics & Heredity; Psychiatry
GA 323LG
UT WOS:000257447000001
PM 17987668
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Wang, Q
   Xian, WJ
   Li, SF
   Liu, C
   Padua, GW
AF Wang, Qin
   Xian, Wujing
   Li, Shifeng
   Liu, Chang
   Padua, Graciela W.
TI Topography and biocompatibility of patterned hydrophobic/hydrophilic
   zein layers
SO ACTA BIOMATERIALIA
LA English
DT Article
DE biocompatibility; biomolecules structure and function; cell adhesion;
   surface modification
ID SURFACE-PLASMON RESONANCE; SELF-ASSEMBLED MONOLAYERS; CELL-SHAPE; SOFT
   LITHOGRAPHY; PROTEINS; ADSORPTION; MAIZE; BIOMATERIAL; FILMS; GOLD
AB The topography and biocompatibility of zein layers adsorbed on patterned templates containing hydrophilic and hydrophobic regions were investigated. Nanopatterned templates consisting of hydrophilic lines on a hydrophobic background were drawn by dip-pen nanolithography (DPN) on gold-coated surfaces. 16-Mercaptohexadecanoic acid (COOH(CH(2))(15)SH, MHA) was used as primary ink to generate hydrophilic lines. Unpattemed surfaces were backfilled with 18-octadecanethiol (CH(3)(CH(2))(17)SH, ODT), which generated hydrophobic regions. Zein was allowed to adsorb on patterned surfaces from alcohol-water solutions. The topography of zein deposits was observed by atomic force microscopy (AFM). Height profiles from AFM measurements revealed that zein deposits followed closely the nanopattemed templates. The biocompatibility of zein layers assembled over hydrophilic/hydrophobic micropatterned templates was investigated. Templates containing MHA lines and ODT regions were generated by micro-contact printing (mu CP). Mouse fibroblasts seeded on patterned zein layers proliferated on zein deposited over MHA lines, but not on zein over ODT. The experiment indicated that fibroblast cells were able to respond to variations in the underlying surface chemistry, transmitted by the different orientation adopted by zein on the different substrates. This property may be useful in controlling the spatial distribution of cells on patterned protein layers. (c) 2008 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Wang, Qin; Padua, Graciela W.] Univ Illinois, Dept Food Sci & Human Nutr, Urbana, IL 61801 USA.
   [Xian, Wujing] Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61801 USA.
   [Li, Shifeng; Liu, Chang] Northwestern Univ, Dept Mech Engn, Evanston, IL 60208 USA.
RP Wang, Q (reprint author), Univ Illinois, Dept Food Sci & Human Nutr, 382-D AESB,1304 W Penn Ave, Urbana, IL 61801 USA.
EM qinwang@uiuc.edu
RI Liu, Chang/B-7249-2009
OI Xian, Wujing/0000-0001-5074-0304
CR ABSOLOM DR, 1987, J BIOMED MATER RES, V21, P161, DOI 10.1002/jbm.820210202
   ARGOS P, 1982, J BIOL CHEM, V257, P9984
   Chen CS, 1998, BIOTECHNOL PROGR, V14, P356, DOI 10.1021/bp980031m
   Djalali R, 2002, J AM CHEM SOC, V124, P13660, DOI 10.1021/ja028261r
   Dong J, 2004, BIOMATERIALS, V25, P4691, DOI 10.1016/j.biomaterials.2003.10.084
   Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024
   Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514
   GEISSLER M, 2003, LANGMUIR, V19, P6111
   GENNADIOS A, 1990, FOOD TECHNOL-CHICAGO, V44, P63
   Gong SJ, 2006, BIOMATERIALS, V27, P3793, DOI 10.1016/j.biomaterials.2006.02.019
   HEIDECKER G, 1991, GENOMICS, V10, P719, DOI 10.1016/0888-7543(91)90456-O
   Jiang FZ, 2004, J STRUCT BIOL, V148, P268, DOI 10.1016/j.jsb.2004.07.001
   JONSSON U, 1982, J COLLOID INTERF SCI, V90, P148, DOI 10.1016/0021-9797(82)90408-8
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   LEE KB, 2004, NANO LETT, V4, P1872
   Libioulle L, 1999, LANGMUIR, V15, P300, DOI 10.1021/la980978y
   Lin CC, 2005, BIOMATERIALS, V26, P3655, DOI 10.1016/j.biomaterials.2004.09.051
   MacDonald DE, 2002, BIOMATERIALS, V23, P1269, DOI 10.1016/S0142-9612(01)00317-9
   Matsushima N, 1997, BBA-PROTEIN STRUCT M, V1339, P14, DOI 10.1016/S0167-4838(96)00212-9
   Nam Y, 2004, IEEE T BIO-MED ENG, V51, P158, DOI 10.1109/TBME.2003.820336
   Parker KK, 2002, FASEB J, V16, DOI 10.1096/fj.02-0038com
   Pomes A. F., 1971, ENCY POLYM SCI TECHN, V15, P125
   Rozhok S, 2003, J PHYS CHEM B, V107, P751, DOI 10.1021/jp021550h
   Scotchford CA, 1998, J BIOMED MATER RES, V41, P431, DOI 10.1002/(SICI)1097-4636(19980905)41:3<431::AID-JBM13>3.0.CO;2-L
   Shotwell M.A., 1989, BIOCH PLANTS COMPREH, V15, P297
   SINGH A, 1986, ABSTR PAP ACS, V27
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   Smith JC, 2003, NANO LETT, V3, P883, DOI 10.1021/nl025956h
   TATHAM AS, 1993, J BIOL CHEM, V268, P26253
   THOMPSON GA, 1992, PLANT MOL BIOL, V18, P827, DOI 10.1007/BF00020030
   VandeVord PJ, 2002, J BIOMED MATER RES, V59, P585, DOI 10.1002/jbm.1270
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Wang Q, 2004, BIOMACROMOLECULES, V5, P1356, DOI 10.1021/bm049965r
   Wang Q, 2003, J AGR FOOD CHEM, V51, P7439, DOI 10.1021/jf0340658
   Wang Y, 2003, MACROMOL MATER ENG, V288, P886, DOI 10.1002/mame.200300069
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   WORCH H, 1998, METALS BIOMATERIALS
   Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
   Zhang SG, 2002, CURR OPIN CHEM BIOL, V6, P865, DOI 10.1016/S1367-5931(02)00391-5
   Zhu FY, 2007, J AGR FOOD CHEM, V55, P3843, DOI 10.1021/jf063622y
NR 41
TC 27
Z9 29
U1 2
U2 50
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL
PY 2008
VL 4
IS 4
BP 844
EP 851
DI 10.1016/j.actbio.2008.01.017
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 320WQ
UT WOS:000257266300009
PM 18325861
DA 2018-10-19
ER

PT J
AU Sundaram, J
   Durance, TD
   Wang, RZ
AF Sundaram, Jaya
   Durance, Timothy D.
   Wang, Rizhi
TI Porous scaffold of gelatin-starch with nanohydroxyapatite composite
   processed via novel microwave vacuum drying
SO ACTA BIOMATERIALIA
LA English
DT Article
DE nanohydroxyapatite; gelatin; starch; microwave vacuum drying; porous
   scaffold composite
ID HYDROXYAPATITE NANOCRYSTALS; IN-VITRO; MORPHOLOGY; FOAMS; BIOCERAMICS;
   DEGRADATION; RECOMBINANT; POLYMERS; DELIVERY; BEHAVIOR
AB Hydroxyapatite (HA) is a fundamental mineral-based biomaterial, used for preparing composites for bone repair and regeneration. Gelatin blended with starch results in scaffold composites with enhanced mechanical properties. A gelatin-starch blend reinforced with HA nanocrystals (nHA) gave biocompatible composites with enhanced mechanical properties. In this study, a porous scaffold of gelatin-starch-nHA composites was fabricated through microwave vacuum drying and crosslinking using trisodium citrate. Three different composite scaffolds were prepared at three different percentages of nHA: 20%, 30% and 40%. The microstructures and compositions of the composites were analyzed. Within the porous structure, the nHA crystals were observed to precipitate. The interaction between the gelatin-starch network film and nHA crystalline material was studied using Fourier transform infrared (FTIR) spectroscopy and X-ray diffraction analysis (XRD). XRD reflections showed that there are two different minerals present in the scaffold composite. There were strong reflection peaks close to the 26 degrees and 32 degrees 2 theta angles of HA, and close to the 8 degrees and 49 degrees 2 theta angles for sodium citrate minerals. The FTIR result suggested that carboxyl groups, C=O and amino groups play crucial roles in HA formation on the surface of a gelatin network. (c) 2008 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Sundaram, Jaya; Durance, Timothy D.; Wang, Rizhi] Univ British Columbia, Vancouver, BC V6T 1Z4, Canada.
RP Sundaram, J (reprint author), Univ British Columbia, 2205 E Mall, Vancouver, BC V6T 1Z4, Canada.
EM jayas@interchange.ubc.ca
CR Brown PW, 1994, HYDROXYAPATITE RELAT
   Chang MC, 2003, BIOMATERIALS, V24, P2853, DOI 10.1016/S0142-9612(03)00115-7
   Cui ZW, 2004, J FOOD ENG, V65, P157, DOI 10.1016/j.jfoodeng.2004.01.008
   Curtil A, 1997, CRYOBIOLOGY, V34, P13, DOI 10.1006/cryo.1996.1982
   Di Silvio L, 1999, J MATER SCI-MATER M, V10, P653
   DOILLON CJ, 1986, J BIOMED MATER RES, V20, P1219, DOI 10.1002/jbm.820200811
   Durance TD, 2002, J FOOD SCI, V67, P2212, DOI 10.1111/j.1365-2621.2002.tb09529.x
   DURANCE TD, 2005, PCTCA2005001192
   Espigares I, 2002, BIOMATERIALS, V23, P1883, DOI 10.1016/S0142-9612(01)00315-5
   FRANKS F, 1994, BIO-TECHNOL, V12, P253, DOI 10.1038/nbt0394-253
   Gomes ME, 2001, BIOMATERIALS, V22, P883, DOI 10.1016/S0142-9612(00)00211-8
   JAYA S, 2007, FOOD BIOPROD PRO E C, V85, P1
   Kendrick BS, 1996, J PHARM SCI, V85, P155, DOI 10.1021/js950332f
   Kim HW, 2005, J BIOMED MATER RES A, V72A, P136, DOI 10.1002/jbm.a.30168
   KOREY DJ, 1989, J PARENT SCI TECHN, V43, P80
   Li JJ, 2007, BIOMATERIALS, V28, P781, DOI 10.1016/j.biomaterials.2006.09.042
   Lu JX, 1999, J MATER SCI-MATER M, V10, P111, DOI 10.1023/A:1008973120918
   MALAFAYA PB, 1999, P 15 EUR C BIOM BORD, P325
   MIKOS AG, 1993, BIOMATERIALS, V14, P323, DOI 10.1016/0142-9612(93)90049-8
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   Murugan R, 2005, CRYST GROWTH DES, V5, P111, DOI 10.1021/cg034227s
   Nindo CI, 2003, LEBENSM-WISS TECHNOL, V36, P507, DOI 10.1016/S0023-6438(03)00046-X
   Patel VR, 1996, PHARMACEUT RES, V13, P588, DOI 10.1023/A:1016054306763
   Reis RL, 1995, J MATER SCI-MATER M, V6, P786, DOI 10.1007/BF00134318
   Reis RL, 1996, POLYM ADVAN TECHNOL, V7, P784, DOI 10.1002/(SICI)1099-1581(199610)7:10<784::AID-PAT585>3.0.CO;2-1
   Reis RL, 1997, POLYM INT, V43, P347
   REIS RL, PLASTICS MED SURG PI, P195
   REY LR, 1992, DEV BIOLOGICALS, V74, P3
   SCAMAN CH, 2005, COMBINED MICROWAVE V, P507
   Schugens C, 1996, J BIOMED MATER RES, V30, P449, DOI 10.1002/(SICI)1097-4636(199604)30:4<449::AID-JBM3>3.0.CO;2-P
   Tanaka S, 2006, SCI TECHNOL ADV MAT, V7, P226, DOI 10.1016/j.stam.2005.11.022
   Wang YJ, 2006, ADV ENG MATER, V8, P97, DOI 10.1002/adem.200500220
   Webster TJ, 2001, BIOMATERIALS, V22, P1327, DOI 10.1016/S0142-9612(00)00285-4
   Wintermantel E, 1996, BIOMATERIALS, V17, P83, DOI 10.1016/0142-9612(96)85753-X
   WORD A. G., 1977, SCI TECHNOLOGY GELAT
   Wu C., 2004, CHIN J CLIN REHABIL, V8, P929
   Xu JL, 2004, MAT SCI ENG A-STRUCT, V374, P101, DOI 10.1016/j.msea.2003.12.040
   Yaylaoglu MB, 1999, BIOMATERIALS, V20, P711, DOI 10.1016/S0142-9612(98)00199-9
   Zhai Y, 2006, J CRYST GROWTH, V291, P202, DOI 10.1016/j.jcrysgro.2006.03.006
   Zhao F, 2002, BIOMATERIALS, V23, P3227, DOI 10.1016/S0142-9612(02)00077-7
NR 40
TC 54
Z9 56
U1 6
U2 44
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL
PY 2008
VL 4
IS 4
BP 932
EP 942
DI 10.1016/j.actbio.2008.01.019
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 320WQ
UT WOS:000257266300017
PM 18325862
DA 2018-10-19
ER

PT J
AU Piedade, AP
   Nunes, J
   Vieira, MT
AF Piedade, A. P.
   Nunes, J.
   Vieira, M. T.
TI Thin films with chemically graded functionality based on fluorine
   polymers and stainless steel
SO ACTA BIOMATERIALIA
LA English
DT Article
DE functionally graded coatings; PTFE; 316L; Stents
ID CORONARY-ARTERY-DISEASE; COATED STENTS; MICROHARDNESS; IMPLANTATION;
   CHROMIUM; SURFACES; HEPARIN; SYSTEM
AB Thin films of stainless steel and poly(tetrafluoroethylene) were co-deposited, by radiofrequency magnetron sputtering, in an inert atmosphere in order to produce a functionally graded material as a coating on a traditional biomaterial, where non-ferromagnetic characteristics and improved wettability must be ensured. These thin films are intended to modify the surface of SS316L used in stents, where the bulk/thin film couple should be regarded as a single material. This requires excellent adhesion of the coating to the substrate. All coatings were deposited with an average thickness of 500 nm. The chemical and phase characterization of the surface revealed that, with the increase in F content, the thin film evolves from a ferritic phase (alpha) to an amorphous phase with dispersion of a new crystalline ceramic phase (FeF2). For intermediate F content values, an austenitic (111) phase (gamma) was present. Bearing in mind the envisaged application, the best results were attained for thin films with a fluorine content between 10 and 20 at.%. (C) 2008 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Piedade, A. P.; Nunes, J.; Vieira, M. T.] Univ Coimbra, ICEMS, Dept Engn Mecan, Fac Ciencias & Tecnol, P-3030788 Coimbra, Portugal.
RP Piedade, AP (reprint author), Univ Coimbra, ICEMS, Dept Engn Mecan, Fac Ciencias & Tecnol, Rua Luis Reis Santos, P-3030788 Coimbra, Portugal.
EM ana.piedade@dem.uc.pt
RI Piedade, Ana/K-8637-2012
OI Piedade, Ana/0000-0002-1588-0640; Vieira, Teresa/0000-0001-9981-3826
CR Airoldi F, 2004, AM J CARDIOL, V93, P474, DOI 10.1016/j.amjcard.2003.10.048
   Antunes JM, 2002, SURF COAT TECH, V149, P27, DOI 10.1016/S0257-8972(01)01413-X
   Baker H., 1992, ASM HDB, V3
   Bakhai A, 2005, INT J CARDIOL, V102, P95, DOI 10.1016/j.ijcard.2004.04.001
   Beier F, 2006, CLIN RES CARDIOL, V95, P455, DOI 10.1007/s00392-006-0406-7
   BILLARD A, 1991, MAT SCI ENG A-STRUCT, V140, P802, DOI 10.1016/0921-5093(91)90517-Q
   Duda SH, 2002, MINIM INVASIV THER, V11, P193, DOI 10.1080/136457002760273412
   Elezi S, 2006, Minerva Cardioangiol, V54, P5
   *EN, 2005, 107132005 EN B
   *EN ISO, 2007, 1457742007 EN ISO 4
   Favia P, 1998, SURF COAT TECH, V98, P1102, DOI 10.1016/S0257-8972(97)00285-5
   GODBOLE MJ, 1993, SCRIPTA METALL MATER, V28, P1201, DOI 10.1016/0956-716X(93)90454-Z
   GOLDSCHMIDT HJ, 1967, INTERSTITIAL ALLOYS, P92
   Hanamoto K, 1997, NUCL INSTRUM METH B, V129, P228, DOI 10.1016/S0168-583X(97)00227-9
   Hassel T, 2005, MAGNESIUM TECHNOLOGY 2005, P485
   Inoue S, 2002, VACUUM, V66, P257, DOI 10.1016/S0042-207X(02)00151-3
   JEROME C, 2005, J BIOMED MATER RES A, V76, P521
   Kastrati A, 2000, CIRCULATION, V101, P2478, DOI 10.1161/01.CIR.101.21.2478
   Keykamp H., 2001, J ALLOY COMPD, V321, P138
   Koromila G, 2006, BIOMATERIALS, V27, P2525, DOI 10.1016/j.biomaterials.2005.11.017
   Latha G, 1997, J MATER ENG PERFORM, V6, P743, DOI 10.1007/s11665-997-0076-2
   Lau KW, 2004, AM HEART J, V147, P764, DOI 10.1016/j.ahj.2003.12.007
   Lide DR, 2004, HDB CHEM PHYS
   Makimura Y, 2006, APPL SURF SCI, V252, P4587, DOI 10.1016/j.apsusc.2005.06.043
   Morrison ML, 2006, DIAM RELAT MATER, V15, P138, DOI 10.1016/j.diamond.2005.08.031
   Park SJ, 2002, AM J CARDIOL, V89, P872, DOI 10.1016/S0002-9149(02)02206-3
   PIEDADE AP, 2000, THESIS U COIMBRA COI, P78
   Rodgers Campbell D K, 2002, Rev Cardiovasc Med, V3 Suppl 5, pS10
   Serruys PW, 1998, LANCET, V352, P673, DOI 10.1016/S0140-6736(97)11128-X
   Sketch MH, 2005, AM J CARDIOL, V95, P8, DOI 10.1016/j.amjcard.2004.08.055
   Sprague EA, 2000, J LONG-TERM EFF MED, V10, P97
   Tepe G, 2002, J VASC INTERV RADIOL, V13, P1029, DOI 10.1016/S1051-0443(07)61868-5
   Venkatraman S, 2003, BIOMATERIALS, V24, P2105, DOI 10.1016/S0142-9612(02)00640-3
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Zhang X, 2004, J MATER RES, V19, P1696, DOI 10.1557/JMR.2004.0215
NR 35
TC 12
Z9 12
U1 1
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL
PY 2008
VL 4
IS 4
BP 1073
EP 1080
DI 10.1016/j.actbio.2008.02.023
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 320WQ
UT WOS:000257266300032
PM 18406221
OA Green Published
DA 2018-10-19
ER

PT J
AU Henry, S
AF Henry, Sebastien
TI Medpor porous biomaterial
SO ADVANCED MATERIALS & PROCESSES
LA English
DT Article
C1 Porex Surg Inc, Newnan, GA 30265 USA.
RP Henry, S (reprint author), Porex Surg Inc, 15 Dart Rd, Newnan, GA 30265 USA.
EM sebastien.henry@porex.com
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ASM INT
PI MATERIALS PARK
PA SUBSCRIPTIONS SPECIALIST CUSTOMER SERVICE, MATERIALS PARK, OH 44073-0002
   USA
SN 0882-7958
J9 ADV MATER PROCESS
JI Adv. Mater. Process.
PD JUL
PY 2008
VL 166
IS 7
BP 65
EP 65
PG 1
WC Materials Science, Multidisciplinary
SC Materials Science
GA 327MN
UT WOS:000257733300054
DA 2018-10-19
ER

PT J
AU Stukel, JM
   Heys, JJ
   Caplan, MR
AF Stukel, Jill M.
   Heys, Jeffrey J.
   Caplan, Michael R.
TI Optimizing delivery of multivalent targeting constructs for detection of
   secondary tumors
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE mathematical model; multivalent; biomaterial; drug delivery
ID CONVECTION-ENHANCED DELIVERY; PHASE-I TRIAL; DRUG-DELIVERY;
   GLIOBLASTOMA-MULTIFORME; CELL-ADHESION; RAT-BRAIN; MULTIMERIC LIGANDS;
   CHOROID-PLEXUS; BREAST-CANCER; TRANSPORT
AB Targeting drugs or imaging molecules to specific cells by conjugating them to antibodies or ligands for cell surface receptors may allow earlier detection of pathology, better localization for intervention, and fewer side effects. Delivery of these molecules to the target is complicated by construct size, which cannot cross typical endothelial barriers such as the vascular wall, and lack of a priori knowledge of the location of secondary tumor sites to which the construct is targeted. Here we develop mathematical models for diffusive and convection-enhanced delivery of a trivalent construct. Results show that delivery of the construct to the tissue does not yield acceptable contrast or specificity; therefore, unbound construct must be removed from the area of interest by allowing diffusion out of the area or a follow-up injection of fluid containing no construct (e.g., saline). The need for this additional step requires weeks to months for diffusive delivery to yield acceptable contrast, but convection-enhanced delivery may be able to achieve acceptable contrast within several days. Thus, convection-enhanced delivery of multivalent constructs may provide a mechanism to locate secondary tumor sites without prior knowledge of their location which would greatly enhance the ability to detect and treat cancer.
C1 [Stukel, Jill M.; Caplan, Michael R.] Arizona State Univ, Harrington Dept Bioengn, Tempe, AZ 85287 USA.
   [Heys, Jeffrey J.] Arizona State Univ, Dept Chem Engn, Tempe, AZ USA.
RP Caplan, MR (reprint author), Arizona State Univ, Harrington Dept Bioengn, POB 879709, Tempe, AZ 85287 USA.
EM Michael.Caplan@asu.edu
FU NIDCR NIH HHS [K22-DE014846]; NINDS NIH HHS [R21-NS051310]
CR Ashby Lynn S, 2006, Neurosurg Focus, V20, pE3, DOI 10.3171/foc.2006.20.4.3
   BAXTER LT, 1989, MICROVASC RES, V37, P77, DOI 10.1016/0026-2862(89)90074-5
   Bellail AC, 2004, INT J BIOCHEM CELL B, V36, P1046, DOI 10.1016/j.biocel.2004.01.013
   Berens ME, 1996, J NEURO-ONCOL, V27, P11, DOI 10.1007/BF00146079
   Berens Michael E., 1999, Neoplasia (New York), V1, P208, DOI 10.1038/sj.neo.7900034
   BOBO RH, 1994, P NATL ACAD SCI USA, V91, P2076, DOI 10.1073/pnas.91.6.2076
   Bradbury M., 1979, CONCEPT BLOOD BRAIN
   Brem H, 2001, J CONTROL RELEASE, V74, P63, DOI 10.1016/S0168-3659(01)00311-X
   Caplan MR, 2005, ANN BIOMED ENG, V33, P1113, DOI 10.1007/s10439-005-5779-1
   Chen MY, 1999, J NEUROSURG, V90, P315, DOI 10.3171/jns.1999.90.2.0315
   Dreher MR, 2006, J NATL CANCER I, V98, P335, DOI 10.1093/jnci/djj070
   DVORAK HF, 1990, PROG CLIN BIOL RES, V354, P317
   DVORAK HF, 1991, CANCER CELL-MON REV, V3, P77
   FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182
   Fung LK, 1996, PHARM RES-DORDR, V13, P671, DOI 10.1023/A:1016083113123
   Ghersi-Egea JF, 2001, MICROSC RES TECHNIQ, V52, P83, DOI 10.1002/1097-0029(20010101)52:1<83::AID-JEMT10>3.0.CO;2-N
   GINGRAS MC, 1995, J NEUROIMMUNOL, V57, P143, DOI 10.1016/0165-5728(94)00178-Q
   Gonzalez AL, 2004, TISSUE ENG, V10, P1775, DOI 10.1089/ten.2004.10.1775
   Groothuis DR, 2000, BRAIN RES, V856, P281, DOI 10.1016/S0006-8993(99)02089-2
   Guerin C, 2004, INVEST NEW DRUG, V22, P27, DOI 10.1023/B:DRUG.0000006172.65135.3e
   Hall Walter A, 2003, Neurosurg Focus, V14, pe2
   Haller MF, 1998, PHARM RES-DORDR, V15, P377, DOI 10.1023/A:1011911912174
   Handl HL, 2004, EXPERT OPIN THER TAR, V8, P565, DOI 10.1517/14728222.8.6.565
   JAIN RK, 1995, MOL MED TODAY, V1, P4, DOI 10.1016/1357-4310(95)80005-0
   Johanson CE, 2005, PHARM RES-DORDR, V22, P1011, DOI 10.1007/s11095-005-6039-0
   Khan A, 2005, J NEUROSURG, V102, P53, DOI 10.3171/ped.2005.102.1.0053
   Kioi M, 2006, CANCER, V107, P1407, DOI 10.1002/cncr.22134
   Limentani SA, 2005, J NEURO-ONCOL, V72, P241, DOI 10.1007/s11060-004-2339-1
   Mak M, 1995, J NEURO-ONCOL, V26, P91, DOI 10.1007/BF01060215
   Mammen Mathai, 1998, Angew Chem Int Ed Engl, V37, P2754, DOI 10.1002/(SICI)1521-3773(19981102)37:20<2754::AID-ANIE2754>3.0.CO;2-3
   Mann BK, 2002, J BIOMED MATER RES, V60, P86, DOI 10.1002/jbm.10042
   MORRISON PF, 1986, J PHARM SCI, V75, P120, DOI 10.1002/jps.2600750204
   Morrison PF, 1999, AM J PHYSIOL-REG I, V277, pR1218, DOI 10.1152/ajpregu.1999.277.4.R1218
   MORRISON PF, 1994, AM J PHYSIOL, V266, pR292
   Nakada M, 2005, AM J PATHOL, V167, P565, DOI 10.1016/S0002-9440(10)62998-7
   Nakahara H, 1996, J BIOL CHEM, V271, P27221, DOI 10.1074/jbc.271.44.27221
   NORTHRUP SH, 1992, P NATL ACAD SCI USA, V89, P3338, DOI 10.1073/pnas.89.8.3338
   Pardridge William M, 2003, Mol Interv, V3, P90, DOI 10.1124/mi.3.2.90
   Patchell RA, 2002, J NEURO-ONCOL, V60, P37, DOI 10.1023/A:1020291229317
   Proescholdt MG, 2000, NEUROSCIENCE, V95, P577
   Raghavan Raghu, 2006, Neurosurg Focus, V20, pE12, DOI 10.3171/foc.2006.20.4.7
   SALTZMAN WM, 1991, CHEM ENG SCI, V46, P2429, DOI 10.1016/0009-2509(91)80036-X
   Saltzman WM, 1997, ADV DRUG DELIV REV, V26, P209
   Sarntinoranont M, 2003, ANN BIOMED ENG, V31, P327, DOI 10.1114/1.1554923
   Sarntinoranont M, 2003, ANN BIOMED ENG, V31, P448, DOI 10.1114/1.1558032
   Shadidi M, 2003, DRUG RESIST UPDATE, V6, P363, DOI 10.1016/j.drup.2003.11.002
   Shadidi Mohsen, 2003, FASEB Journal, V17, P256
   Sharma G, 2006, J DRUG TARGET, V14, P301, DOI 10.1080/10611860600809112
   Shimamura Takeshi, 2006, Neurosurg Focus, V20, pE11, DOI 10.3171/foc.2006.20.4.6
   Sinha R, 2006, MOL CANCER THER, V5, P1909, DOI 10.1158/1535-7163.MCT-06-0141
   Vagner J, 2004, BIOORG MED CHEM LETT, V14, P211, DOI 10.1016/j.bmcl.2003.09.079
   Walker WL, 1996, B MATH BIOL, V58, P1047
   Wang Y, 2006, ANN BIOMED ENG, V34, P114, DOI 10.1007/s10439-005-9007-2
   Wein LM, 2002, CELL PROLIFERAT, V35, P343, DOI 10.1046/j.1365-2184.2002.00246.x
   Westphal M, 2006, ACTA NEUROCHIR, V148, P269, DOI 10.1007/s00701-005-0707-z
   Woiciechowsky C, 2004, MED SCI MONITOR, V10, pBR325
   WOOLSEY TA, 2003, BRAIN ATLAS VISUAL G, P124
   Yezhelyev MV, 2006, LANCET ONCOL, V7, P657, DOI 10.1016/S1470-2045(06)70793-8
NR 58
TC 5
Z9 5
U1 0
U2 8
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD JUL
PY 2008
VL 36
IS 7
BP 1291
EP 1304
DI 10.1007/s10439-008-9498-8
PG 14
WC Engineering, Biomedical
SC Engineering
GA 307KQ
UT WOS:000256318200018
PM 18425582
DA 2018-10-19
ER

PT J
AU Nagel, MD
   Verhoef, R
   Schols, H
   Morra, M
   Knox, JP
   Ceccone, G
   Della Volpe, C
   Vigneron, P
   Bussy, C
   Gallet, M
   Velzenberger, E
   Vayssade, M
   Cascardo, G
   Cassinelli, C
   Haeger, A
   Gilliland, D
   Liakos, I
   Rodriguez-Valverde, MA
   Siboni, S
AF Nagel, Marie-Danielle
   Verhoef, Rene
   Schols, Henk
   Morra, Marco
   Knox, J. Paul
   Ceccone, Giacomo
   Della Volpe, Claudio
   Vigneron, Pascale
   Bussy, Cyrill
   Gallet, Marlene
   Velzenberger, Elodie
   Vayssade, Muriel
   Cascardo, Giovanna
   Cassinelli, Clara
   Haeger, Ash
   Gilliland, Douglas
   Liakos, Ioannis
   Rodriguez-Valverde, Miguel Angel
   Siboni, Stefano
TI Enzymatically-tailored pectins differentially influence the morphology,
   adhesion, cell cycle progression and survival of fibroblasts
SO BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
LA English
DT Article
DE pectin modified hairy region bioactivity; pectin/fibronectin
   interaction; pectin grafted-biomaterial
ID HAIRY RAMIFIED REGIONS; GROWTH-FACTOR RECEPTORS; SURFACE-CHEMISTRY;
   FIBRONECTIN CONFORMATION; ARABINOGALACTAN-PROTEINS;
   MONOCLONAL-ANTIBODIES; HUMAN KERATINOCYTES; INTEGRIN BINDING; ADSORBED
   FIBRONECTIN; RHAMNOGALACTURONAN-I
AB Improved biocompatibility and performance of biomedical devices can be achieved through the incorporation of bioactive molecules on device surfaces. Five structurally distinct pectic polysaccharides (modified hairy regions (MHRs)) were obtained by enzymatic liquefaction of apple (MHR-B, MHR-A and MHR-alpha), carrot (MHR-C) and potato (MHR-P) cells. Polystyrene (PS) Petri dishes, aminated by a plasma deposition process, were surface modified by the covalent linking of the MHRs. Results clearly demonstrate that MHR-B induces cell adhesion, proliferation and survival, in contrast to the other MHRs. Moreover, MHR-alpha causes cells to aggregate, decrease proliferation and enter into apoptosis. Cells cultured in standard conditions with 1% soluble MHR-B or MHR-alpha show the opposite behaviour to the one observed on MHR-B and -alpha-grafted PS. Fibronectin was similarly adsorbed onto MHR-B and tissue culture polystyrene (TCPS) control, but poorly on MHR-alpha. The Fn cell binding site (RGD sequence) was more accessible on MHR-B than on TCPS control, but poorly on MHR-alpha. The disintegrin echistatin inhibited fibroblast adhesion and spreading on MHR-B-grafted PS, which suggests that MHRs control fibroblast behaviour via serum-adhesive proteins. This study provides a basis for the design of intelligently-tailored biomaterial coatings able to induce specific cell functions. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Nagel, Marie-Danielle; Vigneron, Pascale; Bussy, Cyrill; Gallet, Marlene; Velzenberger, Elodie; Vayssade, Muriel] Univ Technol Compiegne, CNRS, UMR 6600, BP 20529, F-60205 Compiegne, France.
   [Verhoef, Rene; Schols, Henk] Univ Wageningen & Res Ctr, Dept Agrotechnol & Food Sci, Food Chem Lab, NL-6700 EV Wageningen, Netherlands.
   [Morra, Marco; Cascardo, Giovanna; Cassinelli, Clara] Nobil Bio Ric Srl, I-14018 Villafranca Dasti, AT, Italy.
   [Knox, J. Paul; Haeger, Ash] Univ Leeds, Ctr Plant Sci, Leeds LS2 9JT, W Yorkshire, England.
   [Ceccone, Giacomo; Gilliland, Douglas; Liakos, Ioannis] BMS, Commiss European Communities, Inst Hlth & Consumer Protect, I-21020 Ispra, VA, Italy.
   [Della Volpe, Claudio; Rodriguez-Valverde, Miguel Angel; Siboni, Stefano] Univ Trent, Dept Mat Engn & Ind Technol, I-38100 Povo, TN, Italy.
RP Nagel, MD (reprint author), Univ Technol Compiegne, CNRS, UMR 6600, BP 20529, F-60205 Compiegne, France.
EM marie-danielle.nagel@utc.fr
RI bussy, cyrill/C-7190-2008; Schols, Henk/A-1742-2009; Rodriguez-Valverde,
   Miguel Angel/B-7938-2009; della volpe, claudio/D-6733-2014; Liakos,
   Ioannis/C-5847-2014; Knox, Paul/H-4577-2012
OI bussy, cyrill/0000-0001-8870-443X; Rodriguez-Valverde, Miguel
   Angel/0000-0003-4361-6721; della volpe, claudio/0000-0002-3473-8092;
   Liakos, Ioannis/0000-0001-6403-1058; Knox, Paul/0000-0002-9231-6891
CR Briggs D., 1990, AUGER XRAY PHOTOELEC
   Brunold C, 2004, PLANTA MED, V70, P370, DOI 10.1055/s-2004-818952
   Bussy C, 2008, J BIOMED MATER RES A, V86A, P597, DOI 10.1002/jbm.a.31729
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   CLARKE AE, 1979, PHYTOCHEMISTRY, V18, P521, DOI 10.1016/S0031-9422(00)84255-7
   Clausen MH, 2003, CARBOHYD RES, V338, P1797, DOI 10.1016/S0008-6215(03)00272-6
   Coviello T, 2007, J CONTROL RELEASE, V119, P5, DOI 10.1016/j.jconrel.2007.01.004
   Deters AM, 2005, J ETHNOPHARMACOL, V102, P391, DOI 10.1016/j.jep.2005.06.038
   Deters AM, 2005, PLANTA MED, V71, P33, DOI 10.1055/s-2005-837748
   Deters AM, 2005, J CELL PHYSIOL, V202, P717, DOI 10.1002/jcp.20161
   Ding K, 2003, J NAT PROD, V66, P7, DOI 10.1021/np020118o
   Furth ME, 2007, BIOMATERIALS, V28, P5068, DOI 10.1016/j.biomaterials.2007.07.042
   Garcia AJ, 2002, CRIT REV EUKAR GENE, V12, P151, DOI 10.1615/CritRevEukaryotGeneExpr.v12.i2.50
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   GRINNELL F, 1981, J BIOMED MATER RES, V15, P363, DOI 10.1002/jbm.820150308
   Hsieh Tze-chen, 2006, BMC Complement Altern Med, V6, P30, DOI 10.1186/1472-6882-6-30
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Immerzeel P, 2004, PHYSIOL PLANTARUM, V122, P181, DOI 10.1111/j.1399-3054.2004.00395.x
   Immerzeel P, 2006, PHYSIOL PLANTARUM, V128, P18, DOI 10.1111/j.1399-3054.2006.00712.x
   IULIANO DJ, 1993, J BIOMED MATER RES, V27, P1103, DOI 10.1002/jbm.820270816
   Jackson CL, 2007, GLYCOBIOLOGY, V17, P805, DOI 10.1093/glycob/cwm054
   Jones L, 1997, PLANT PHYSIOL, V113, P1405, DOI 10.1104/pp.113.4.1405
   Kaur M, 2006, MOL CANCER THER, V5, P1265, DOI 10.1158/1535-7163.MCT-06-0014
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Kniep B, 2006, INT J CANCER, V119, P67, DOI 10.1002/ijc.21788
   Kokkonen HE, 2007, BIOMACROMOLECULES, V8, P509, DOI 10.1021/bm060614h
   Lan MA, 2005, BIOMATERIALS, V26, P4523, DOI 10.1016/j.biomaterials.2004.11.028
   LAU JM, 1987, CARBOHYD RES, V168, P245, DOI 10.1016/0008-6215(87)80029-0
   Malisan F, 2002, J EXP MED, V196, P1535, DOI 10.1084/jem.20020960
   Manton KJ, 2007, STEM CELLS, V25, P2845, DOI 10.1634/stemcells.2007-0065
   Manton KJ, 2007, J MOL HISTOL, V38, P415, DOI 10.1007/s10735-007-9121-6
   Manton KJ, 2006, J CELL PHYSIOL, V209, P219, DOI 10.1002/jcp.20727
   McCann MC, 2001, PHYTOCHEMISTRY, V57, P811, DOI 10.1016/S0031-9422(01)00144-3
   McLane MA, 1996, FEBS LETT, V391, P139, DOI 10.1016/0014-5793(96)00716-8
   MCNEIL M, 1982, PLANT PHYSIOL, V70, P1586, DOI 10.1104/pp.70.6.1586
   Morra M, 2004, BIOMACROMOLECULES, V5, P2094, DOI 10.1021/bm049834q
   Morra M, 2003, J COLLOID INTERF SCI, V259, P236, DOI 10.1016/S0021-9797(02)00204-7
   Morra M, 2007, EXPERT REV MED DEVIC, V4, P361, DOI 10.1586/17434440.4.3.361
   Morra M, 2006, EUR CELLS MATER, V12, P1
   Nergard CS, 2006, BIOMACROMOLECULES, V7, P71, DOI 10.1021/bm050355g
   Olano-Martin E, 2003, ANTICANCER RES, V23, P341
   Oomen R. J. F. J., 2003, ADV PECTIN PECTINASE, P15
   PETTIT DK, 1994, J BIOMED MATER RES, V28, P685, DOI 10.1002/jbm.820280605
   PLATT D, 1992, J NATL CANCER I, V84, P438, DOI 10.1093/jnci/84.6.438
   Popov SV, 2005, BIOCHEMISTRY-MOSCOW+, V70, P108
   Ridley BL, 2001, PHYTOCHEMISTRY, V57, P929, DOI 10.1016/S0031-9422(01)00113-3
   Sakurai MH, 1999, IMMUNOLOGY, V97, P540, DOI 10.1046/j.1365-2567.1999.00774.x
   Schols H. A, 2002, PECTINS THEIR MANIPU, P1
   SCHOLS HA, 1994, CARBOHYD RES, V256, P97, DOI 10.1016/0008-6215(94)84230-2
   SCHOLS HA, 1994, CARBOHYD RES, V256, P83, DOI 10.1016/0008-6215(94)84229-9
   Schols HA, 1995, CARBOHYD RES, V279, P265, DOI 10.1016/0008-6215(95)00287-1
   SCHOLS HA, 1990, CARBOHYD RES, V206, P117, DOI 10.1016/0008-6215(90)84011-I
   Stephansson SN, 2002, BIOMATERIALS, V23, P2527, DOI 10.1016/S0142-9612(01)00387-8
   UNDERWOOD PA, 1993, J CELL SCI, V104, P793
   VORAGEN AG, 2006, FOOD POLYSACCHARRIDE, P287
   Willats WGT, 1998, CARBOHYD RES, V308, P149, DOI 10.1016/S0008-6215(98)00070-6
   Wu SC, 2006, J BIOMED MATER RES A, V79A, P557, DOI 10.1002/jbm.a.30845
   Yates EA, 1996, GLYCOBIOLOGY, V6, P131, DOI 10.1093/glycob/6.2.131
NR 60
TC 23
Z9 25
U1 0
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-4165
EI 1872-8006
J9 BBA-GEN SUBJECTS
JI Biochim. Biophys. Acta-Gen. Subj.
PD JUL-AUG
PY 2008
VL 1780
IS 7-8
BP 995
EP 1003
DI 10.1016/j.bbagen.2008.04.002
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 321MJ
UT WOS:000257309000008
PM 18485917
DA 2018-10-19
ER

PT J
AU Wang, AY
   Foss, CA
   Leong, S
   Mo, X
   Pomper, MG
   Yu, SM
AF Wang, Allen Y.
   Foss, Catherine A.
   Leong, Shirley
   Mo, Xiao
   Pomper, Martin G.
   Yu, Seungju M.
TI Spatio-temporal modification of collagen scaffolds mediated by triple
   helical propensity
SO BIOMACROMOLECULES
LA English
DT Article
ID I COLLAGEN; EXTRACELLULAR-MATRIX; MIMETIC PEPTIDE; BINDING-SITES;
   STABILITY; PROTEIN; ATHEROSCLEROSIS; LOCALIZATION; BIOMATERIAL;
   FIBRONECTIN
AB Functionalized collagen that incorporates exogenous compounds may offer new and improved biomaterials applications, especially in drug-delivery, multifunctional implants, and tissue engineering. To that end, we developed a specific and reversible collagen modification technique utilizing associative chain interactions between synthetic collagen mimetic peptide (CMP) [(ProHypGly)(x); Hyp = hydroxyproline] and type I collagen. Here we show temperature-dependent collagen binding and subsequent release of a series of CMPs with varying chain lengths indicating a triple helical propensity driven binding mechanism. The binding took place when melted, single-strand CMPs were allowed to fold while in contact with reconstituted type I collagens. The binding affinity is highly specific to collagen as labeled CMP bound to nanometer scale periodic positions on type I collagen fibers and could be used to selectively image collagens in ex vivo human liver tissue. When heated to physiological temperature, bound CMPs discharged from the collagen at a sustained rate that correlated with CMP's triple helical propensity, suggesting that sustainability is mediated by dynamic collagen-CMP interactions. We also report on the spatially defined modification of collagen film with linear and multi-arm poly(ethylene glycol)CMP conjugates; at 37 degrees C, these PEG-CMP conjugates exhibited temporary cell repelling activity lasting up to 9 days. These results demonstrate new opportunities for targeting pathologic collagens for diagnostic or therapeutic applications and for fabricating multifunctional collagen coatings and scaffolds that can temporally and spatially control the behavior of cells associated with the collagen matrices.
C1 [Wang, Allen Y.; Mo, Xiao; Yu, Seungju M.] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA.
   [Leong, Shirley; Yu, Seungju M.] Johns Hopkins Univ, Dept Biomol & Chem Engn, Baltimore, MD 21218 USA.
   [Pomper, Martin G.; Yu, Seungju M.] Johns Hopkins Univ, Inst NanoBiotechnol, Baltimore, MD 21218 USA.
   [Foss, Catherine A.; Pomper, Martin G.] Johns Hopkins Med Inst, Dept Radiol, Baltimore, MD 21231 USA.
RP Yu, SM (reprint author), Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA.
EM yu@jhu.edu
RI Yu, Michael/A-3332-2010
FU NIGMS NIH HHS [R21 GM074812, R21 GM074812-02, R21GM-74812]
CR Ackerman MS, 1999, J BIOL CHEM, V274, P7668, DOI 10.1074/jbc.274.12.7668
   AMENTA PS, 1986, COLLAGEN REL RES, V6, P125
   Berisio R, 2004, BIOPOLYMERS, V73, P682, DOI 10.1002/bip.20017
   Bretscher LE, 2001, J AM CHEM SOC, V123, P777, DOI 10.1021/ja005542v
   CHAPMAN JA, 1974, CONNECT TISSUE RES, V2, P137, DOI 10.3109/03008207409152099
   CHRISTINA LA, 2006, FUTURE ONCOL, V2, P417
   Davies JR, 2006, J AM COLL CARDIOL, V47, pC57, DOI 10.1016/j.jacc.2005.11.049
   DeRider ML, 2002, J AM CHEM SOC, V124, P2497, DOI 10.1021/ja0166904
   Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200
   Dorweiler B, 2006, THROMB HAEMOSTASIS, V95, P182, DOI 10.1160/TH05-05-0357
   Engel J, 2005, TOP CURR CHEM, V247, P7, DOI 10.1007/b103818
   Fischbach C, 2007, BIOMATERIALS, V28, P2069, DOI 10.1016/j.biomaterials.2006.12.029
   Frank S, 2001, J MOL BIOL, V308, P1081, DOI 10.1006/jmbi.2001.4644
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Gauba V, 2007, J AM CHEM SOC, V129, P2683, DOI 10.1021/ja0683640
   Han RL, 2006, MOL MICROBIOL, V61, P351, DOI 10.1111/j.1365-2958.2006.05237.x
   Holmgren SK, 1999, CHEM BIOL, V6, P63, DOI 10.1016/S1074-5521(99)80003-9
   Huang L, 2001, J BIOMAT SCI-POLYM E, V12, P979, DOI 10.1163/156856201753252516
   Huynh T, 1999, NAT BIOTECHNOL, V17, P1083
   Jaffer FA, 2006, J AM COLL CARDIOL, V47, P1328, DOI 10.1016/j.jacc.2006.01.029
   JAKEMAN LB, 1992, J CLIN INVEST, V89, P244, DOI 10.1172/JCI115568
   Khoshnoodi J, 2006, J BIOL CHEM, V281, P38117, DOI 10.1074/jbc.R600025200
   Koch S, 2006, J MATER SCI-MATER M, V17, P735, DOI 10.1007/s10856-006-9684-x
   Koide T, 2005, CONNECT TISSUE RES, V46, P131, DOI 10.1080/03008200591008518
   Kotch FW, 2006, P NATL ACAD SCI USA, V103, P3028, DOI 10.1073/pnas.0508783103
   Kwak J, 2002, J AM CHEM SOC, V124, P14085, DOI 10.1021/ja0209621
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Lee HJ, 2006, BIOMATERIALS, V27, P5268, DOI 10.1016/j.biomaterials.2006.06.001
   Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099
   Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241
   Melacini G, 1996, J AM CHEM SOC, V118, P10725, DOI 10.1021/ja9617193
   Melacini G, 2000, J MOL BIOL, V300, P1041, DOI 10.1006/jmbi.2000.3919
   Miles CA, 2001, MICRON, V32, P325, DOI 10.1016/S0968-4328(00)00034-2
   Mo X, 2006, ANGEW CHEM INT EDIT, V45, P2267, DOI 10.1002/anie.200504529
   Myles JL, 2000, J BIOMAT SCI-POLYM E, V11, P69, DOI 10.1163/156856200743508
   Myllyharju J, 2001, ANN MED, V33, P7, DOI 10.3109/07853890109002055
   Nishi N, 1998, P NATL ACAD SCI USA, V95, P7018, DOI 10.1073/pnas.95.12.7018
   Nishi Y, 2005, BIOCHEMISTRY-US, V44, P6034, DOI 10.1021/bi047887m
   O'Connor SM, 2000, J NEUROSCI METH, V102, P187, DOI 10.1016/S0165-0270(00)00303-4
   Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103
   PEFFER NJ, 1993, P NATL ACAD SCI USA, V90, P10648, DOI 10.1073/pnas.90.22.10648
   Persikov AV, 2005, J BIOL CHEM, V280, P19343, DOI 10.1074/jbc.M501657200
   Reddi AH, 2000, TISSUE ENG, V6, P351, DOI 10.1089/107632700418074
   Sasano Y, 2000, HISTOCHEM J, V32, P591, DOI 10.1023/A:1026720003564
   Sipe JD, 2002, ANN NY ACAD SCI, V961, P1, DOI 10.1111/j.1749-6632.2002.tb03040.x
   Teshima R, 2004, J ORTHOP SCI, V9, P270, DOI 10.1007/s00776-004-0769-4
   Tiller JC, 2001, BIOTECHNOL BIOENG, V73, P246, DOI 10.1002/bit.1057
   VAPORCIYAN AA, 1993, SCIENCE, V262, P1580, DOI 10.1126/science.8248808
   Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262
   Wang AY, 2005, J AM CHEM SOC, V127, P4130, DOI 10.1021/ja0431915
   WILLIAMS BR, 1978, J BIOL CHEM, V253, P6578
   YANNAS IV, 1990, ANGEW CHEM INT EDIT, V29, P20, DOI 10.1002/anie.199000201
NR 52
TC 46
Z9 47
U1 1
U2 28
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JUL
PY 2008
VL 9
IS 7
BP 1755
EP 1763
DI 10.1021/bm701378k
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 326DX
UT WOS:000257639500007
PM 18547103
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Shin, YM
   Kim, KS
   Lim, YM
   Nho, YC
   Shin, H
AF Shin, Young Min
   Kim, Kyung-Soo
   Lim, Youn Mook
   Nho, Young Chang
   Shin, Heungsoo
TI Modulation of spreading, proliferation, and differentiation of human
   mesenchymal stem cells on gelatin-immobilized
   poly(L-lactide-co-epsilon-caprolactone) substrates
SO BIOMACROMOLECULES
LA English
DT Article
ID SURFACE MODIFICATION; ACRYLIC-ACID; PLCL SCAFFOLDS; COLLAGEN; ADHESION;
   MATRIX; GROWTH; BONE; BIOMATERIAL; OSTEOBLASTS
AB Controlled adhesion and continuous growth of human mesenchymal stem cells (hMSCs) are essential for scaffold-based delivery of hMSCs in tissue engineering applications. The main goal of this study is to develop biofunctionalized synthetic substrates to actively control adhesion, spreading, and proliferation of hMSCs. gamma-Ray irradiation was employed to graft acrylic acid (AAc) to biodegeradable poly(L-lactide-co-epsilon-caprolactone) (PLCL) films. Gelatin, a natural polymer, was then immobilized on the AAc grafted PLCL film (AAc-PLCL) to induce biomimetic interactions with the cells. The graft yield of AAc increased as the irradiation dose and AAc concentration increased, and the presence of gelatin (gelatin-AAc-PLCL) following immobilization was confirmed using ESCA. To investigate cell responses, hMSCs isolated from a human mandible were cultured on the various substrates and their adhesion, spreading, and proliferation were examined. After three days of culture, the DNA concentration from the cells cultured on gelatin-AAc-PLCL film was 2.9-fold greater than that on the PLCL film. Immunofluorescent staining of hMSCs cultured on the gelatin-AAc-PLCL films demonstrated homogeneous localization of F-Actin and vinculin in their cytoplasm, while mature adhesive structure was not observed from the cells cultured on other substrates. Furthermore, the ratio of projected area of adherent single cells on gelatin-AAc-PLCL films was significantly larger (116.80 +/- 12.78%) than that on the PLCL films (30.11 +/- 5.07%). Our results suggest that gelatin-immobilized PLCL substrates may be potentially used in tissue engineering, particularly as a stem cell delivery carrier for the regeneration of target tissue.
C1 [Shin, Young Min; Shin, Heungsoo] Hanyang Univ, Dept Bioengn, Seoul 133791, South Korea.
   [Kim, Kyung-Soo] Hanyang Univ, Dept Internal Med, Div Cardiol, Seoul 133791, South Korea.
   [Lim, Youn Mook; Nho, Young Chang] Korea Atom Energy Res Inst, Adv Radiat Technol Inst, Radiat Res Ctr Ind & Environm, Jeongeup Si 580185, Jeollabuk Do, South Korea.
RP Shin, H (reprint author), Hanyang Univ, Dept Bioengn, 17 Haengdang Dong, Seoul 133791, South Korea.
EM hshin@hanyang.ac.kr
OI Shin, Young Min/0000-0002-8818-454X
CR Aframian DJ, 2000, TISSUE ENG, V6, P209, DOI 10.1089/10763270050044380
   Amato I, 2007, BIOMATERIALS, V28, P3668, DOI 10.1016/j.biomaterials.2007.04.038
   Betz VM, 2008, FRONT BIOSCI-LANDMRK, V13, DOI 10.2741/2724
   Carlisle ES, 2000, TISSUE ENG, V6, P45, DOI 10.1089/107632700320883
   Cheng ZY, 2004, BIOMATERIALS, V25, P1991, DOI 10.1016/j.biomaterials.2003.08.038
   Choi JS, 2007, J BIOACT COMPAT POL, V22, P508, DOI 10.1177/0883911507081101
   Cui YL, 2003, J BIOMED MATER RES A, V66A, P770, DOI 10.1002/jbm.a.10071
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fan HB, 2008, BIOMATERIALS, V29, P1017, DOI 10.1016/j.biomaterials.2007.10.048
   Garkhal K, 2007, J BIOMED MATER RES A, V82A, P747, DOI 10.1002/bjm.a.31150
   Grondahl L, 2005, BIOMACROMOLECULES, V6, P2197, DOI 10.1021/bm050127m
   Guillot PV, 2007, J CELL MOL MED, V11, P935, DOI 10.1111/j.1582-4934.2007.00106.x
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hinrichs WLJ, 1997, J CONTROL RELEASE, V45, P163, DOI 10.1016/S0168-3659(96)01571-4
   Ho MH, 2007, MACROMOL BIOSCI, V7, P467, DOI 10.1002/mabi.200600241
   Hwang NS, 2008, ADV DRUG DELIVER REV, V60, P199, DOI 10.1016/j.addr.2007.08.036
   Jeong SI, 2004, J BIOMAT SCI-POLYM E, V15, P645, DOI 10.1163/156856204323046906
   Jeong SI, 2005, BIOMATERIALS, V26, P1405, DOI 10.1016/j.biomaterials.2004.04.036
   Jones E, 2008, RHEUMATOLOGY, V47, P126, DOI 10.1093/rheumatology/kem206
   Kenar H, 2008, J BIOMED MATER RES A, V85A, P1001, DOI 10.1002/jbm.a.31638
   Kim TG, 2006, TISSUE ENG, V12, P221, DOI 10.1089/ten.2006.12.221
   Klee D, 2003, BIOMATERIALS, V24, P3663, DOI 10.1016/S0142-9612(03)00235-7
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lee SD, 1996, BIOMATERIALS, V17, P1599, DOI 10.1016/0142-9612(95)00316-9
   Lee SH, 2007, ADV DRUG DELIVER REV, V59, P339, DOI 10.1016/j.addr.2007.03.016
   Li WJ, 2005, BIOMATERIALS, V26, P5158, DOI 10.1016/j.biomaterials.2005.01.002
   Ma ZW, 2005, BIOMATERIALS, V26, P1253, DOI 10.1016/j.biomaterials.2004.04.031
   Ng KW, 2005, TISSUE ENG, V11, P182, DOI 10.1089/ten.2005.11.182
   NHO Y, 2004, RADIAT PHYS CHEM, P237
   Park K, 2007, J BIOMAT SCI-POLYM E, V18, P369, DOI 10.1163/156856207780424997
   Pompe T, 2007, BIOMATERIALS, V28, P28, DOI 10.1016/j.biomaterials.2006.08.028
   Rutnakornpituk M, 2006, POLYMER, V47, P7909, DOI 10.1016/j.polymer.2006.09.028
   Santiago LY, 2006, BIOMATERIALS, V27, P2962, DOI 10.1016/j.biomaterials.2006.01.011
   Shih YRV, 2006, STEM CELLS, V24, P2391, DOI 10.1634/stemcells.2006-0253
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Shin H, 2007, BIOMATERIALS, V28, P126, DOI 10.1016/j.biomaterials.2006.08.007
   Suh H, 2001, BIOMATERIALS, V22, P219, DOI 10.1016/S0142-9612(00)00177-0
   Teraoka F, 2006, DENT MATER J, V25, P560, DOI 10.4012/dmj.25.560
   Vashi AV, 2008, BIOMATERIALS, V29, P573, DOI 10.1016/j.biomaterials.2007.10.017
   Weigel T, 2006, EXPERT REV MED DEVIC, V3, P835, DOI 10.1586/17434440.3.6.835
   YAMAGUCHI M, 2004, J ARTIF ORGANS, V7, P187
   Yang J, 2003, J BIOMED MATER RES A, V67A, P1139, DOI 10.1002/jbm.a.10034
   Yang JM, 1999, J BIOMED MATER RES, V45, P133, DOI 10.1002/(SICI)1097-4636(199905)45:2<133::AID-JBM8>3.3.CO;2-4
   Yen AHH, 2008, CELL TISSUE RES, V331, P359, DOI 10.1007/s00441-007-0467-6
   Ying L, 2003, BIOMACROMOLECULES, V4, P157, DOI 10.1021/bm025676w
   Zhu YB, 2004, TISSUE ENG, V10, P53, DOI 10.1089/107632704322791691
NR 47
TC 73
Z9 73
U1 0
U2 24
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JUL
PY 2008
VL 9
IS 7
BP 1772
EP 1781
DI 10.1021/bm701410g
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 326DX
UT WOS:000257639500009
PM 18558737
DA 2018-10-19
ER

PT J
AU Hsiong, SX
   Huebsch, N
   Fischbach, C
   Kong, HJ
   Mooney, DJ
AF Hsiong, Susan X.
   Huebsch, Nathaniel
   Fischbach, Claudia
   Kong, Hyun Joon
   Mooney, David J.
TI Integrin-adhesion ligand bond formation of preosteoblasts and stem cells
   in three-dimensional RGD presenting matrices
SO BIOMACROMOLECULES
LA English
DT Article
ID RESONANCE ENERGY-TRANSFER; MARROW STROMAL CELLS; OSTEOBLAST
   DIFFERENTIATION; OSTEOGENIC DIFFERENTIATION; EXTRACELLULAR-MATRIX;
   SIGNALING PATHWAYS; ALGINATE HYDROGELS; COLLAGEN-SYNTHESIS;
   GENE-EXPRESSION; MC3T3-E1 CELLS
AB Cell-interactive polymers have been widely used as synthetic extracellular matrices to regulate cell function and promote tissue regeneration. However, there is a lack of quantitative understanding of the cell-material interface. In this study, integrin-adhesion ligand bond formation of preosteoblasts and D1 stem cells with RGD presenting alginate matrices were examined using FRET and flow cytometry. Bond number increased with adhesion ligand density but did not change with RGD island spacing for both cell types. Integrin expression varied with cell type and substrate in 2D culture, but the integrin expression profiles of both cell types were similar when cultured in 3D RGD presenting substrates and distinct from 2D culture. In summary, combining a FRET technique to quantify bond formation with flow cytometry to elucidate integrin expression can define specific cell-material interactions for a given material system and may be useful for informing biomaterial design strategies for cell-based therapies.
C1 [Mooney, David J.] Harvard Univ, Engn Sci Lab, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.
   [Hsiong, Susan X.] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.
   [Huebsch, Nathaniel] Harvard Univ, MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
   [Fischbach, Claudia] Cornell Univ, Dept Biomed Engn, Ithaca, NY USA.
   [Kong, Hyun Joon] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA.
RP Mooney, DJ (reprint author), Harvard Univ, Engn Sci Lab, Sch Engn & Appl Sci, SEAS 325 Pierce Hall Cambridge, Cambridge, MA 02138 USA.
EM mooneyd@seas.harvard.edu
RI Fischbach, Claudia/C-8550-2009
OI Fischbach, Claudia/0000-0002-9368-0150; Huebsch,
   Nathaniel/0000-0002-3329-0214
FU NIDCR NIH HHS [R37 DE13033, R37 DE013033, R37 DE013033-12]
CR Alsberg E, 2001, J DENT RES, V80, P2025, DOI 10.1177/00220345010800111501
   Bennett JH, 2001, ARCH ORAL BIOL, V46, P229, DOI 10.1016/S0003-9969(00)00114-X
   Berney C, 2003, BIOPHYS J, V84, P3992, DOI 10.1016/S0006-3495(03)75126-1
   Chen HF, 2007, BIOPHYS J, V92, P1399, DOI 10.1529/biophysj.106.094896
   Cheng SL, 2001, J BONE MINER RES, V16, P277, DOI 10.1359/jbmr.2001.16.2.277
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Dai JW, 1999, BIOPHYS J, V77, P3363, DOI 10.1016/S0006-3495(99)77168-7
   Devine MJ, 2002, J ORTHOP RES, V20, P1232, DOI 10.1016/S0736-0266(02)00051-7
   DIDUCH DR, 1993, J BONE JOINT SURG AM, V75A, P92, DOI 10.2106/00004623-199301000-00012
   FRANCESCHI RT, 1992, J BONE MINER RES, V7, P235
   Fromigue O, 1997, CYTOKINE, V9, P613, DOI 10.1006/cyto.1997.0209
   Gilbert M, 2003, J BIOMED MATER RES A, V67A, P69, DOI 10.1002/jbm.a.10053
   Goennenwein S, 2003, BIOPHYS J, V85, P646, DOI 10.1016/S0006-3495(03)74508-1
   Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264
   HSIONG SX, 2007, J BIOMED MATER RES A, V4, P1501
   Kong HJ, 2006, P NATL ACAD SCI USA, V103, P18534, DOI 10.1073/pnas.0605960103
   KUBITSCHECK U, 1991, BIOPHYS J, V60, P307, DOI 10.1016/S0006-3495(91)82055-0
   Kundu AK, 2006, BIOCHEM BIOPH RES CO, V347, P347, DOI 10.1016/j.bbrc.2006.06.110
   Lai CF, 2005, J BONE MINER RES, V20, P330, DOI 10.1359/JBMR.041013
   Lee KY, 2004, NANO LETT, V4, P1501, DOI 10.1021/nl0493592
   Li XD, 2005, OSTEOPOROSIS INT, V16, P101, DOI 10.1007/s00198-004-1649-7
   Li XD, 2003, BONE, V33, P652, DOI 10.1016/S8756-3282(03)00239-4
   Moursi AM, 1997, J CELL SCI, V110, P2187
   NAKATANI Y, 1984, BIOCHEM BIOPH RES CO, V123, P894, DOI 10.1016/S0006-291X(84)80219-3
   Oyajobi BO, 1999, J BONE MINER RES, V14, P351, DOI 10.1359/jbmr.1999.14.3.351
   Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236
   Petrie TA, 2006, BIOMATERIALS, V27, P5459, DOI 10.1016/j.biomaterials.2006.06.027
   Pistone M, 1996, CELL BIOL INT, V20, P471, DOI 10.1006/cbir.1996.0062
   PYTELA R, 1985, P NATL ACAD SCI USA, V82, P5766, DOI 10.1073/pnas.82.17.5766
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Simmons CA, 2004, BONE, V35, P562, DOI 10.1016/j.bone.2004.02.027
   Smalley KSM, 2006, IN VITRO CELL DEV-AN, V42, P242
   SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191
   Sun S, 2006, BIOELECTROCHEMISTRY, V69, P133, DOI 10.1016/j.bioelechem.2005.11.007
   Takeuchi Y, 1997, J BIOL CHEM, V272, P29309, DOI 10.1074/jbc.272.46.29309
   Titushkin I, 2006, BIOPHYS J, V90, P2582, DOI 10.1529/biophysj.105.073775
   Xiao GZ, 2002, J BONE MINER RES, V17, P101, DOI 10.1359/jbmr.2002.17.1.101
   Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006
NR 39
TC 46
Z9 46
U1 2
U2 17
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JUL
PY 2008
VL 9
IS 7
BP 1843
EP 1851
DI 10.1021/bm8000606
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 326DX
UT WOS:000257639500018
PM 18540674
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Petrie, TA
   Raynor, JE
   Reyes, CD
   Burns, KL
   Collard, DM
   Garcia, AJ
AF Petrie, Timothy A.
   Raynor, Jenny E.
   Reyes, Catherine D.
   Burns, Kellie L.
   Collard, David M.
   Garcia, Andres J.
TI The effect of integrin-specific bioactive coatings on tissue healing and
   implant osseointegration
SO BIOMATERIALS
LA English
DT Article
DE bone; fibronectin; cell adhesion; RGD; FAK; integrins
ID TOTAL JOINT ARTHROPLASTY; IN-VIVO EVALUATION; BONE-FORMATION;
   CELL-ADHESION; OSTEOBLAST DIFFERENTIATION; BIOMATERIAL SURFACES;
   TITANIUM IMPLANTS; BINDING; ALPHA-V-BETA-3; HYDROXYAPATITE
AB Implant osseointegration, defined as bone apposition and functional fixation, is a requisite for clinical success in orthopaedic and dental applications, many of which are restricted by implant loosening. Modification of implants to present bioactive motifs such as the RGD cell-adhesive sequence from fibronectin (FN) represents a promising approach in regenerative medicine. However, these biomimetic strategies have yielded only marginal enhancements in tissue healing in vivo. In this study, clinical-grade titanium implants were grafted with a non-fouling oligo(ethylene glycol)-substituted polymer coating functionalized with controlled densities of ligands of varying specificity for target integrin receptors. Biomaterials presenting the alpha(5)beta(1)-integrin-specific FN fragment FNIII7-10 enhanced osteoblastic differentiation in bone marrow stromal cells compared to unmodified titanium and RGD-presenting surfaces. Importantly, FNIII7-10-functionalized titanium significantly improved functional implant osseointegration compared to RGD-functionalized and unmodified titanium in vivo. This study demonstrates that bioactive coatings that promote integrin binding specificity regulate marrow-derived progenitor osteoblastic differentiation and enhance healing responses and functional integration of biomedical implants. This work identifies an innovative strategy for the rational design of biomaterials for regenerative medicine. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Petrie, Timothy A.; Reyes, Catherine D.; Burns, Kellie L.; Garcia, Andres J.] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
   [Petrie, Timothy A.; Reyes, Catherine D.; Burns, Kellie L.; Garcia, Andres J.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
   [Raynor, Jenny E.; Collard, David M.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.
RP Garcia, AJ (reprint author), Georgia Inst Technol, George W Woodruff Sch Mech Engn, 315 Ferst Dr,Room 2314 IBB, Atlanta, GA 30332 USA.
EM andres.garcia@me.gatech.edu
FU NIBIB NIH HHS [R01 EB004496, R01 EB004496-04, R01 EB-004496]
CR *AM AC ORTH SURG, 2003, ARTHR TOT JOINT REPL
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Arthritis Foundation Association of State and Territorial Health Officials Centers for Disease Control and Prevention, 1999, NAT ARTHR ACT PLAN P
   Barber TA, 2007, J BIOMED MATER RES A, V80A, P306, DOI 10.1002/jbm.a.30927
   Bauer TW, 1999, SKELETAL RADIOL, V28, P483, DOI 10.1007/s002560050552
   Bauer TW, 1999, SKELETAL RADIOL, V28, P423, DOI 10.1007/s002560050541
   Carron CP, 2000, J ENDOCRINOL, V165, P587, DOI 10.1677/joe.0.1650587
   Cheng SL, 2000, J CELL BIOCHEM, V77, P265, DOI 10.1002/(SICI)1097-4644(20000501)77:2<265::AID-JCB9>3.0.CO;2-6
   Cheng SL, 2001, CALCIFIED TISSUE INT, V68, P87, DOI 10.1007/BF02678146
   Cheng SL, 2001, J BONE MINER RES, V16, P277, DOI 10.1359/jbmr.2001.16.2.277
   Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3
   Elmengaard B, 2005, BIOMATERIALS, V26, P3521, DOI 10.1016/j.biomaterials.2004.09.039
   Engleman V. Wayne, 1997, Journal of Clinical Investigation, V99, P2284, DOI 10.1172/JCI119404
   Gallant ND, 2005, MOL BIOL CELL, V16, P4329, DOI 10.1091/mbc.E05-02-0170
   Garcia AJ, 2005, BIOMATERIALS, V26, P7525, DOI 10.1016/j.biomaterials.2005.05.029
   Hanks SK, 2003, FRONT BIOSCI-LANDMRK, V8, pD982, DOI 10.2741/1114
   Hubbell JA, 2004, NAT BIOTECHNOL, V22, P828, DOI 10.1038/nbt0704-828
   Hutchinson JH, 2003, J MED CHEM, V46, P4790, DOI 10.1021/jm030306r
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Kanagaraja S, 1996, BIOMATERIALS, V17, P2225, DOI 10.1016/0142-9612(95)00311-8
   Keselowsky BG, 2005, BIOMATERIALS, V26, P413, DOI 10.1016/j.biomaterials.2004.02.050
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Nakamura I, 1999, J CELL SCI, V112, P3985
   Petrie TA, 2006, BIOMATERIALS, V27, P5459, DOI 10.1016/j.biomaterials.2006.06.027
   Pilliar RM, 2005, ORTHOP CLIN N AM, V36, P113, DOI 10.1016/j.ocl.2004.08.001
   Rammelt S, 2007, J ORTHOP RES, V25, P1052, DOI 10.1002/jor.20403
   Raynor JE, 2007, ADV MATER, V19, P1724, DOI 10.1002/adma.200602129
   Reyes CD, 2007, BIOMATERIALS, V28, P3228, DOI 10.1016/j.biomaterials.2007.04.003
   Reyes CD, 2003, J BIOMED MATER RES A, V67A, P328, DOI 10.1002/jbm.a.10122
   Schliephake H, 2002, CLIN ORAL IMPLAN RES, V13, P312, DOI 10.1034/j.1600-0501.2002.130312.x
   Siebers MC, 2007, CLIN ORAL IMPLAN RES, V18, P354, DOI 10.1111/j.1600-0501.2006.01314.x
   Tamura Y, 2001, J BONE MINER RES, V16, P1772, DOI 10.1359/jbmr.2001.16.10.1772
   Wang H, 2006, BIOMATERIALS, V27, P4192, DOI 10.1016/j.biomaterials.2006.03.034
NR 35
TC 149
Z9 153
U1 2
U2 55
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2008
VL 29
IS 19
BP 2849
EP 2857
DI 10.1016/j.biomaterials.2008.03.036
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 304YL
UT WOS:000256144900003
PM 18406458
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Williams, DF
AF Williams, David F.
TI On the mechanisms of biocompatibility
SO BIOMATERIALS
LA English
DT Article; Proceedings Paper
CT Ratner Symposium 2006
CY 2006
CL Maui, HI
DE foreign body response; inflammation; implant; scaffold; biodegradation
ID SILICONE BREAST IMPLANTS; CENTRAL VENOUS CATHETERS; TOTAL
   HIP-ARTHROPLASTY; VASCULAR GRAFTS; IN-VIVO; ALKYLENE
   BIS(DILACTOYL)-METHACRYLATE; POLYTETRAFLUOROETHYLENE GRAFTS;
   FEMOROPOPLITEAL BYPASS; SCREW AUGMENTATION; TISSUE-RESPONSE
AB The manner in which a mutually acceptable co-existence of biomaterials and tissues is developed and sustained has been the focus of attention in biomaterials science for many years, and forms the foundation of the subject of biocompatibility. There are many ways in which materials and tissues can be brought into contact such that this co-existence may be compromised, and the search for biomaterials that are able to provide for the best performance in devices has been based upon the understanding of all the interactions within biocompatibility phenomena. Our understanding of the mechanisms of biocompatibility has been restricted whilst the focus of attention has been long-term implantable devices. In this paper, over 50 years of experience with such devices is analysed and it is shown that, in the vast majority of circumstances, the sole requirement for biocompatibility in a medical device intended for long-term contact with the tissues of the human body is that the material shall do no harm to those tissues, achieved through chemical and biological inertness. Rarely has an attempt to introduce biological activity into a biomaterial been clinically successful in these applications. This essay then turns its attention to the use of biomaterials in tissue engineering, sophisticated cell, drug and gene delivery systems and applications in biotechnology, and shows that here the need for specific and direct interactions between biomaterials and tissue components has become necessary, and with this a new paradigm for biocompatibility has emerged. It is believed that once the need for this change is recognised, so our understanding of the mechanisms of biocompatibility will markedly improve. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Williams, David F.] Univ Liverpool, Liverpool L69 3BX, Merseyside, England.
   [Williams, David F.] Tsinghua Univ, Beijing 100084, Peoples R China.
RP Williams, DF (reprint author), Univ Liverpool, Liverpool L69 3BX, Merseyside, England.
EM dfw@liv.ac.uk
FU Medical Research Council; Biotechnology and Biological Sciences Research
   Council
CR Adams TST, 2007, J PLAST RECONSTR AES, V60, P210, DOI 10.1016/j.bjps.2006.01.012
   ALI SAM, 1993, J BIOMED MATER RES, V27, P1409, DOI 10.1002/jbm.820271108
   Anderson JM, 1997, ADV DRUG DELIVER REV, V28, P5, DOI 10.1016/S0169-409X(97)00048-3
   Ando W, 2007, BIOMATERIALS, V28, P5462, DOI 10.1016/j.biomaterials.2007.08.030
   Astion DJ, 1996, J BONE JOINT SURG AM, V78A, P755, DOI 10.2106/00004623-199605000-00016
   Badylak S, 2002, J SURG RES, V103, P190, DOI 10.1006/jsre.2001.6349
   Bauer TW, 1999, SKELETAL RADIOL, V28, P423, DOI 10.1007/s002560050541
   BERGSMA JE, 1995, BIOMATERIALS, V16, P25, DOI 10.1016/0142-9612(95)91092-D
   Bhattarai SR, 2006, J BIOMED MATER RES A, V78A, P247, DOI 10.1002/jbm.a.30695
   Bonzani IC, 2007, BIOMATERIALS, V28, P423, DOI 10.1016/j.biomaterials.2006.08.026
   Bostman O, 2000, BIOMATERIALS, V21, P2615, DOI 10.1016/S0142-9612(00)00129-0
   Bottio T, 2007, CARDIOVASC PATHOL, V16, P1, DOI 10.1016/j.carpath.2006.09.008
   Brash JL, 2000, J BIOMAT SCI-POLYM E, V11, P1135, DOI 10.1163/156856200744237
   Butany J, 2006, J CARDIAC SURG, V21, P530, DOI 10.1111/j.1540-8191.2006.00323.x
   Buttafoco L, 2006, BIOMATERIALS, V27, P724, DOI 10.1016/j.biomaterials.2005.06.024
   Chen R, 2006, BIOMATERIALS, V27, P4453, DOI 10.1016/j.biomaterials.2006.04.011
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   CRAGG A, 1983, RADIOLOGY, V147, P261, DOI 10.1148/radiology.147.1.6828742
   Crossley George H., 2000, Cardiology Clinics, V18, P95, DOI 10.1016/S0733-8651(05)70130-2
   Cunningham KS, 2005, LAB INVEST, V85, P9, DOI 10.1038/labinvest.3700215
   D'Antonio J, 2005, CLIN ORTHOP RELAT R, P164, DOI 10.1097/01.blo.0000162995.50971.39
   de Voogt WG, 1999, AM J CARDIOL, V83, p187D
   DELBUFALO AGA, 1993, PACE, V16, P1240
   Devine C, 2004, J VASC SURG, V40, P924, DOI 10.1016/j.jvs.2004.08.033
   DI MA, 2005, BIOMATERIALS, V26, P5983
   Di Mario Carlo, 2004, J Interv Cardiol, V17, P391, DOI 10.1111/j.1540-8183.2004.04081.x
   Donaldson K, 2006, NANOMEDICINE-UK, V1, P229, DOI 10.2217/17435889.1.2.229
   DOTTER CT, 1964, CIRCULATION, V30, P654, DOI 10.1161/01.CIR.30.5.654
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   Dumbleton J, 2004, J BONE JOINT SURG AM, V86A, P2526, DOI 10.2106/00004623-200411000-00028
   Dush DM, 2001, ANN RHEUM DIS, V60, P653, DOI 10.1136/ard.60.7.653
   Edworthy SM, 1998, J RHEUMATOL, V25, P254
   EFSING HO, 1983, WORLD J SURG, V7, P419, DOI 10.1007/BF01658094
   Eicken A, 2006, INT J CARDIOL, V107, P30, DOI 10.1016/j.ijcard.2005.02.048
   Elgohary MA, 2006, J CATARACT REFR SURG, V32, P1188, DOI 10.1016/j.jcrs.2006.01.106
   FILLINGER MF, 1990, J VASC SURG, V11, P556, DOI 10.1067/mva.1990.18322
   Fournier E, 2006, BIOMATERIALS, V27, P4963, DOI 10.1016/j.biomaterials.2006.04.045
   Frost MC, 2005, BIOMATERIALS, V26, P1685, DOI 10.1016/j.biomaterials.2004.06.006
   GEESINK RGT, 1995, J BONE JOINT SURG BR, V77B, P534
   Gerecht-Nir S, 2004, BIOTECHNOL BIOENG, V88, P313, DOI 10.1002/bit.20248
   Gong G, 1993, J Heart Valve Dis, V2, P684
   Goodman S, 2005, ORTHOP CLIN N AM, V36, P41, DOI 10.1016/j.ocl.2004.06.015
   Gorbet MB, 2005, BIOMATERIALS, V26, P6811, DOI 10.1016/j.biomaterials.2005.04.063
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   GREISLER HP, 1982, ARCH SURG-CHICAGO, V117, P1425
   Grossterlinden L, 2006, BIOMATERIALS, V27, P3379, DOI 10.1016/j.biomaterials.2006.01.051
   Hallab NJ, 2005, J ORTHOP RES, V23, P384, DOI 10.1016/j.orthres.2004.09.001
   Hemmrich K, 2005, BIOMATERIALS, V26, P7025, DOI 10.1016/j.biomaterials.2005.04.065
   Hering D, 2005, NAT CLIN PRACT CARD, V2, P415, DOI 10.1038/ncpcardio0271
   Heyligers JMM, 2006, J VASC SURG, V43, P587, DOI 10.1016/j.jvs.2005.10.038
   Hicks CR, 2003, EYE, V17, P385, DOI 10.1038/sj.eye.6700333
   Hua W, 1997, PACE, V20, P17, DOI 10.1111/j.1540-8159.1997.tb04807.x
   Human P, 2001, J Long Term Eff Med Implants, V11, P199
   Hurst SJ, 2006, ANAL CHEM, V78, P8313, DOI 10.1021/ac0613582
   Ignatius AA, 2005, J BIOMED MATER RES B, V75B, P128, DOI 10.1002/jbm.b.30274
   Ingham E, 2005, BIOMATERIALS, V26, P1271, DOI 10.1016/j.biomaterials.2004.04.035
   Janowsky EC, 2000, NEW ENGL J MED, V342, P781, DOI 10.1056/NEJM200003163421105
   Jinno T, 1998, J BIOMED MATER RES, V42, P20, DOI 10.1002/(SICI)1097-4636(199810)42:1<20::AID-JBM4>3.0.CO;2-Q
   Jones CA, 2005, CLIN GERIATR MED, V21, P527, DOI 10.1016/j.cger.2005.02.005
   Kirkpatrick WNA, 2002, BRIT J PLAST SURG, V55, P479, DOI 10.1054/bjps.2002.3903
   Klement P, 2006, BIOMATERIALS, V27, P5107, DOI 10.1016/j.biomaterials.2006.05.005
   KLEPETKO W, 1989, J THORAC CARDIOV SUR, V97, P90
   Klinkert P, 2004, EUR J VASC ENDOVASC, V27, P357, DOI 10.1016/j.ejvs.2003.12.027
   Lau H, 2001, ANN VASC SURG, V15, P383, DOI 10.1007/s100160010085
   Le Visage C, 2001, BIOMATERIALS, V22, P2229, DOI 10.1016/S0142-9612(00)00411-7
   Lemson MS, 2000, EUR J VASC ENDOVASC, V19, P336, DOI 10.1053/ejvs.1999.1040
   Long DA, 2006, ANAESTH INTENS CARE, V34, P481
   Lossdorfer S, 2004, J BIOMED MATER RES A, V70A, P361, DOI 10.1002/jbm.a.30025
   Luscher TF, 2007, CIRCULATION, V115, P1051, DOI 10.1161/CIRCULATIONAHA.106.675934
   Mamode N, 2000, COCHRANE DB SYST REV
   Mani G, 2007, BIOMATERIALS, V28, P1689, DOI 10.1016/j.biomaterials.2006.11.042
   Marotta JS, 2002, ANN PLAS SURG, V49, P227, DOI 10.1097/00000637-200209000-00001
   Marrey RV, 2006, BIOMATERIALS, V27, P1988, DOI 10.1016/j.biomaterials.2005.10.012
   Mastrogiacomo M, 2006, BIOMATERIALS, V27, P3230, DOI 10.1016/j.biomaterials.2006.01.031
   McKellop H, 2000, J BONE JOINT SURG AM, V82A, P1708, DOI 10.2106/00004623-200012000-00004
   Meinhart JG, 2001, ANN THORAC SURG, V71, pS327, DOI 10.1016/S0003-4975(01)02555-3
   MONREAL M, 1994, THROMB HAEMOSTASIS, V72, P548
   Montanaro L, 2007, BIOMATERIALS, V28, P5155, DOI 10.1016/j.biomaterials.2007.08.003
   Moutos FT, 2007, NAT MATER, V6, P162, DOI 10.1038/nmat1822
   Muller K M, 1994, Curr Top Pathol, V86, P273
   Nilsen AR, 1996, ACTA ORTHOP SCAND, V67, P57, DOI 10.3109/17453679608995610
   Norlin A, 2002, BIOMOL ENG, V19, P67, DOI 10.1016/S1389-0344(02)00013-8
   OHLIN A, 1990, ACTA ORTHOP SCAND, V61, P7, DOI 10.3109/17453679008993055
   Olson RJ, 2003, AM J OPHTHALMOL, V136, P146, DOI 10.1016/S0002-9394(03)00226-5
   Peeters P, 2006, J CARDIOVASC SURG, V47, P407
   PINCHUK L, 1994, J BIOMAT SCI-POLYM E, V6, P225, DOI 10.1163/156856294X00347
   Pinchuk L, 2008, BIOMATERIALS, V29, P448, DOI 10.1016/j.biomaterials.2007.09.041
   Poeppl N, 2007, AESTHET PLAST SURG, V31, P133, DOI 10.1007/s00266-006-0091-y
   Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015
   Porter Judith A, 2005, Gen Dent, V53, P423
   Puleo David A, 2006, Dent Clin North Am, V50, P323, DOI 10.1016/j.cden.2006.03.001
   Purdue PE, 2007, CLIN ORTHOP RELAT R, P251, DOI 10.1097/01.blo.0000238813.95035.1b
   Qu XH, 2006, BIOMATERIALS, V27, P3540, DOI 10.1016/j.biomaterials.2006.02.015
   Ren WP, 2003, BIOMATERIALS, V24, P4819, DOI 10.1016/S0142-9612(03)00384-3
   Rieder E, 2004, J THORAC CARDIOV SUR, V127, P399, DOI 10.1016/j.jtcvs.2003.06.017
   Rizkalla M, 2001, BRIT J PLAST SURG, V54, P125, DOI 10.1054/bjps.2000.3490
   Rokkanen PU, 2000, BIOMATERIALS, V21, P2607, DOI 10.1016/S0142-9612(00)00128-9
   Rosenberg NL, 1996, NEUROLOGY, V46, P308, DOI 10.1212/WNL.46.2.308
   Salzmann DL, 1999, CARDIOVASC PATHOL, V8, P63, DOI 10.1016/S1054-8807(98)00003-9
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   Schoen FJ, 2005, ANN THORAC SURG, V79, P1072, DOI 10.1016/j.athoracsur.2004.06.033
   SCHUBERT MA, 1995, J BIOMED MATER RES, V29, P337, DOI 10.1002/jbm.820290309
   Serruys PW, 2006, NEW ENGL J MED, V354, P483, DOI 10.1056/NEJMra051091
   Shanbhag AS, 2006, J AM ACAD ORTHOP SUR, V14, P215, DOI 10.5435/00124635-200604000-00003
   Shiiya N, 2006, EUR J CARDIO-THORAC, V30, P402, DOI 10.1016/j.ejcts.2006.05.014
   SIGWART U, 1987, NEW ENGL J MED, V316, P701, DOI 10.1056/NEJM198703193161201
   Simionescua DT, 2006, BIOMATERIALS, V27, P702, DOI 10.1016/j.biomaterials.2005.06.013
   Simon P, 2003, EUR J CARDIO-THORAC, V23, P1002, DOI 10.1016/S1010-7940(03)00094-0
   SMITH R, 1987, J BIOMED MATER RES, V21, P991, DOI 10.1002/jbm.820210805
   STEINERT R, 2003, CATARACT SURG
   Stone GW, 2006, MAYO CLIN PROC, V81, P641, DOI 10.4065/81.5.641
   Tanzer M, 2004, CLIN ORTHOP RELAT R, P153, DOI 10.1097/01.blo.0000128282.05708.9a
   Taylor PM, 2007, PHILOS T R SOC B, V362, P1313, DOI 10.1098/rstb.2007.2117
   Tornos P, 2005, HEART, V91, P571, DOI 10.1136/hrt.2003.032128
   Van Damme H, 2005, ACTA CHIR BELG, V105, P249
   Van Rooden CJ, 2005, J THROMB HAEMOST, V3, P2409, DOI 10.1111/j.1538-7836.2005.01398.x
   VAN ZD, 2004, ACTA CHIR BELG, V104, P158
   Venkatraman SS, 2006, BIOMATERIALS, V27, P1573, DOI 10.1016/j.biomaterials.2005.09.002
   VERT M, 1994, BIOMATERIALS, V15, P1209, DOI 10.1016/0142-9612(94)90271-2
   Wahlgren CM, 2006, CARDIOVASC INTER RAD, V29, P530, DOI 10.1007/s00270-005-0159-0
   Walluscheck KP, 2006, ITAL J VASC ENDOVASC, V13, P137
   Wang K, 1996, J INVASIVE CARDIOL, V8, P357
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Washizuka T, 2005, INT HEART J, V46, P909, DOI 10.1536/ihj.46.909
   Wejde G, 2003, J CATARACT REFR SURG, V29, P1556, DOI 10.1016/S0886-3350(03)00342-0
   WILLERT HG, 1976, BIOCOMPATIBILITY IMP, P40
   Williams D. F., 1987, DEFINITIONS BIOMATER
   Williams D, 2008, BIOMATERIALS, V29, P1737, DOI 10.1016/j.biomaterials.2008.01.003
   Williams DF, 2006, TRENDS BIOTECHNOL, V24, P4, DOI 10.1016/j.tibtech.2005.10.006
   WILLIAMS DF, NAT MAT IN PRESS
   WILLIAMS DF, 2003, IMPLANT TISSUE INTER, P407
   WILLIAMS DF, 1999, WILLIAMS DICT BIOMAT
   Wolfram Dolores, 2004, J Autoimmun, V23, P81
   Wu LB, 2005, J BIOMED MATER RES A, V75A, P767, DOI 10.1002/jbm.a.30487
   Zilla P, 2007, BIOMATERIALS, V28, P5009, DOI 10.1016/j.biomaterials.2007.07.017
NR 135
TC 965
Z9 1005
U1 34
U2 474
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2008
VL 29
IS 20
BP 2941
EP 2953
DI 10.1016/j.biomaterials.2008.04.023
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 312FS
UT WOS:000256655100001
PM 18440630
DA 2018-10-19
ER

PT J
AU Hennessy, KM
   Clem, WC
   Phipps, MC
   Sawyer, AA
   Shaikh, FM
   Bellis, SL
AF Hennessy, Kristin M.
   Clem, Will C.
   Phipps, Matthew C.
   Sawyer, Amber A.
   Shaikh, Faheem M.
   Bellis, Susan L.
TI The effect of RGD peptides on osseointegration of hydroxyapatite
   biomaterials
SO BIOMATERIALS
LA English
DT Article
DE bioadsorption; bone tissue engineering; cell adhesion; hydroxyapatite;
   osseointegration; RGD peptide
ID COATED TITANIUM IMPLANTS; MESENCHYMAL STEM-CELLS; FORMATION IN-VIVO;
   BONE-FORMATION; SIGNALING PATHWAYS; OSTEOGENIC DIFFERENTIATION;
   OSTEOBLAST ADHESION; PROTEIN ADSORPTION; SYNTHETIC PEPTIDE;
   SERUM-PROTEINS
AB Given that hydroxyrapatite (HA) biomaterials are highly efficient at adsorbing proadhesive proteins, we questioned whether functionalizing HA with RGD peptides would have any benefit. In this study, we implanted uncoated or RGD-coated HA disks into rat tibiae for 30 min to allow endogenous protein adsorption, and then evaluated mesenchymal stem cell (MSC) interactions with the retrieved disks. These experiments revealed that RGD, when presented in combination with adsorbed tibial proteins (including fibronectin, vitronectin and fibrinogen), has a markedly detrimental effect on MSC adhesion and survival. Moreover, analyses of HA disks implanted for 5 days showed that RGD significantly inhibits total bone formation as well as the amount of new bone directly contacting the implant perimeter. Thus, RGD, which is widely believed to promote cell/biomaterial interactions, has a negative effect on HA implant performance. Collectively these results suggest that, for biomaterials that are highly interactive with the tissue microenvironment, the ultimate effects of RGD will depend upon how signaling from this peptide integrates with endogenous processes such as protein adsorption. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Hennessy, Kristin M.; Shaikh, Faheem M.; Bellis, Susan L.] Univ Alabama, Dept Physiol & Biophys, Birmingham, AL 35294 USA.
   [Clem, Will C.; Bellis, Susan L.] Univ Alabama, Dept Biomed Engn, Birmingham, AL 35294 USA.
   [Phipps, Matthew C.] Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA.
   [Sawyer, Amber A.] ASTAR, Inst Mol & Cell Biol, Stem Cells & Tissue Repair Grp, Singapore 138673, Singapore.
RP Bellis, SL (reprint author), Room 982A,MCLM,1918 Univ Bldg, Birmingham, AL 35294 USA.
EM bellis@physiology.uab.edu
FU NIAMS NIH HHS [R01 AR051539-03, R01 AR051539, R01AR51539]; NCI NIH HHS
   [P30 CA13148, P30 CA013148]
CR Akiyama S K, 1996, Hum Cell, V9, P181
   Alves CM, 2007, BIOMATERIALS, V28, P307, DOI 10.1016/j.biomaterials.2006.09.010
   BAGAMBISA FB, 1994, J CRANIO MAXILL SURG, V22, P12, DOI 10.1016/S1010-5182(05)80290-2
   Balasundaram G, 2006, BIOMATERIALS, V27, P2798, DOI 10.1016/j.biomaterials.2005.12.008
   Barber TA, 2007, J BIOMED MATER RES A, V80A, P306, DOI 10.1002/jbm.a.30927
   Carvalho RS, 1998, J CELL BIOCHEM, V70, P376, DOI 10.1002/(SICI)1097-4644(19980901)70:3<376::AID-JCB11>3.0.CO;2-J
   Dahlback B, 2000, LANCET, V355, P1627, DOI 10.1016/S0140-6736(00)02225-X
   Deligianni D, 2005, J SPINAL DISORD TECH, V18, P257
   Elmengaard B, 2005, BIOMATERIALS, V26, P3521, DOI 10.1016/j.biomaterials.2004.09.039
   Elmengaard B, 2005, J BIOMED MATER RES A, V75A, P249, DOI 10.1002/jbm.a.30301
   Ferris DM, 1999, BIOMATERIALS, V20, P2323, DOI 10.1016/S0142-9612(99)00161-1
   FUJISAWA R, 1997, MATRIX BIOL, V16, P28
   Garcia AJ, 2002, CRIT REV EUKAR GENE, V12, P151, DOI 10.1615/CritRevEukaryotGeneExpr.v12.i2.50
   Garcia AJ, 2005, BIOMATERIALS, V26, P7525, DOI 10.1016/j.biomaterials.2005.05.029
   Germanier Y, 2006, CLIN ORAL IMPLAN RES, V17, P251, DOI 10.1111/j.1600-0501.2005.01222.x
   Gilbert M, 2003, J BIOMED MATER RES A, V67A, P69, DOI 10.1002/jbm.a.10053
   Gilbert M, 2000, J BIOL CHEM, V275, P16213, DOI 10.1074/jbc.M001773200
   HAUTANEN A, 1989, J BIOL CHEM, V264, P1437
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Ho JE, 2007, J BIOMED MATER RES A, V81A, P720, DOI 10.1002/jbm.a.31008
   Itoh D, 2002, J BIOMED MATER RES, V62, P292, DOI 10.1002/jbm.10338
   Johansson Staffan, 1997, Frontiers in Bioscience (online), V2, pD126
   Kamarajan P, 2007, APOPTOSIS, V12, P2221, DOI 10.1007/s10495-007-0138-9
   Kantlehner M, 2000, CHEMBIOCHEM, V1, P107, DOI 10.1002/1439-7633(20000818)1:2<107::AID-CBIC107>3.3.CO;2-W
   Kilpadi KL, 2001, J BIOMED MATER RES, V57, P258, DOI 10.1002/1097-4636(200111)57:2<258::AID-JBM1166>3.0.CO;2-R
   Kilpadi KL, 2004, J BIOMED MATER RES A, V68A, P273, DOI 10.1002/jbm.a.20043
   Kroese-Deutman HC, 2005, TISSUE ENG, V11, P1867, DOI 10.1089/ten.2005.11.1867
   Lebaron RG, 2000, TISSUE ENG, V6, P85, DOI 10.1089/107632700320720
   Matsuura T, 2000, BIOMATERIALS, V21, P1121, DOI 10.1016/S0142-9612(99)00264-1
   MOSHER DF, 1984, ANNU REV MED, V35, P561, DOI 10.1146/annurev.me.35.020184.003021
   Okamoto K, 1998, J DENT RES, V77, P481, DOI 10.1177/00220345980770030701
   PIERSCHBACHER M, 1983, P NATL ACAD SCI-BIOL, V80, P1224, DOI 10.1073/pnas.80.5.1224
   PREISSNER KT, 1991, ANNU REV CELL BIOL, V7, P275, DOI 10.1146/annurev.cb.07.110191.001423
   Roessler S, 2001, J MATER SCI-MATER M, V12, P871, DOI 10.1023/A:1012807621414
   Ruoslahti E, 2003, MATRIX BIOL, V22, P459, DOI 10.1016/S0945-053X(03)00083-0
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Salasznyk RM, 2004, CELL COMMUN ADHES, V11, P137, DOI 10.1080/15419060500242836
   Salasznyk RM, 2007, EXP CELL RES, V313, P22, DOI 10.1016/j.yexcr.2006.09.013
   Sawyer AA, 2005, BIOMATERIALS, V26, P1467, DOI 10.1016/j.biomaterials.2004.05.008
   Sawyer AA, 2005, BIOMATERIALS, V26, P7046, DOI 10.1016/j.biomaterials.2005.05.006
   Schaffner P, 1999, J MATER SCI-MATER M, V10, P837, DOI 10.1023/A:1008904513304
   Stupack DG, 2001, J CELL BIOL, V155, P459, DOI 10.1083/jcb.200106070
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Woo KM, 2007, BIOMATERIALS, V28, P2622, DOI 10.1016/j.biomaterials.2007.02.004
NR 44
TC 76
Z9 78
U1 4
U2 23
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2008
VL 29
IS 21
BP 3075
EP 3083
DI 10.1016/j.biomaterials.2008.04.014
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 312FT
UT WOS:000256655200004
PM 18440064
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Jones, KS
AF Jones, Kim S.
TI Biomaterials as vaccine adjuvants
SO BIOTECHNOLOGY PROGRESS
LA English
DT Article; Proceedings Paper
CT 57th Annual Meeting of the Canadian-Society-for-Chemical-Engineering
CY OCT 28-31, 2007
CL Edmonton, CANADA
SP Canadian Soc Chem Engn
DE vaccine; adjuvant; biomaterials; innate immunity
ID TOLL-LIKE RECEPTORS; TARGETING DENDRITIC CELLS; PATTERN-RECOGNITION
   RECEPTORS; ANTIGEN-CONTAINING LIPOSOMES; MEDIATED GENE DELIVERY;
   REGULATORY T-CELLS; IMMUNE-RESPONSE; POLY(LACTIC-CO-GLYCOLIC ACID);
   ANTITUMOR IMMUNITY; INNATE IMMUNITY
AB Biomaterials are promising candidate adjuvants to enhance vaccine efficacy. Through adjuvant design, we can broaden the use of vaccines to diseases such as AIDS, malaria, and cancer. This review addresses the fundamentals of vaccine and adjuvant function in order to determine guidelines for adjuvant design, including aspects of the vaccine such as disease target, antigen formulation, and delivery route. An ideal biomaterial adjuvant will perform three functions. (1) It will deliver the antigen selectively to dendritic cells. This has been accomplished through release of chemokines or cytokines, use of antidendritic cell antibodies, and even through particle size selection. (2) It will activate the dendritic cells, improving antigen presentation. Biomaterials themselves have been shown to activate innate immunity, but specific innate-activating ligands have also been included in adjuvant formulations. Finally, (3) it will release the antigen appropriately into the dendritic cell. Tuning release to be pH sensitive and engineering endosomal release are strategies that have been used. There is a real opportunity to rationally design better biomaterial adjuvants that will significantly expand and improve vaccine function.
C1 McMaster Univ, Dept Chem Engn, Hamilton, ON L8S 4L7, Canada.
RP Jones, KS (reprint author), McMaster Univ, Dept Chem Engn, Hamilton, ON L8S 4L7, Canada.
EM kjones@mcmaster.ca
CR Ajdary S, 2007, VACCINE, V25, P4595, DOI 10.1016/j.vaccine.2007.03.039
   Albiger B, 2007, J INTERN MED, V261, P511, DOI 10.1111/j.1365-2796.2007.01821.x
   Altin JG, 2004, EXPERT OPIN BIOL TH, V4, P1735, DOI 10.1517/14712598.4.11.1735
   Arnold R, 2006, EUR J IMMUNOL, V36, P1654, DOI 10.1002/eji.200636197
   Ataman-Onal Y, 2006, J CONTROL RELEASE, V112, P175, DOI 10.1016/j.jconrel.2006.02.006
   Babensee JE, 2005, J BIOMED MATER RES A, V74A, P503, DOI 10.1002/jbm.a.30429
   Banerjee A, 2007, IMMUNOL CELL BIOL, V85, P420, DOI 10.1038/sj.icb.7100098
   Bennewitz NL, 2005, BIOMATERIALS, V26, P2991, DOI 10.1016/j.biomaterials.2004.08.023
   Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164
   Bijker MS, 2007, EXPERT REV VACCINES, V6, P591, DOI 10.1586/14760584.6.4.591
   Blander JM, 2007, TRENDS IMMUNOL, V28, P19, DOI 10.1016/j.it.2006.11.001
   Blanks Deidra A, 2007, Curr Opin Otolaryngol Head Neck Surg, V15, P281, DOI 10.1097/MOO.0b013e32825a67a2
   Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598
   Boonyo W, 2007, J CONTROL RELEASE, V121, P168, DOI 10.1016/j.jconrel.2007.05.025
   Bosshart H, 2007, ANN NY ACAD SCI, V1096, P1, DOI 10.1196/annals.1397.064
   Bramwell VW, 2006, J PHARM PHARMACOL, V58, P717, DOI 10.1211/jpp.56.6.0002
   Burgdorf S, 2008, CURR OPIN IMMUNOL, V20, P89, DOI 10.1016/j.coi.2007.12.002
   Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971
   Cao W, 2007, CURR OPIN IMMUNOL, V19, P24, DOI 10.1016/j.coi.2006.11.004
   Carcaboso AM, 2004, VACCINE, V22, P1423, DOI 10.1016/j.vaccine.2003.10.020
   Chabalgoity JA, 2007, CYTOKINE GROWTH F R, V18, P195, DOI 10.1016/j.cytogfr.2007.01.016
   Chatchawalsaisin J, 2004, INT J PHARM, V275, P41, DOI 10.1016/j.ijpharm.2004.01.025
   Chen KQ, 2007, INT IMMUNOPHARMACOL, V7, P1271, DOI 10.1016/j.intimp.2007.05.016
   Chen WR, 2005, PHOTOCHEM PHOTOBIOL, V81, P190, DOI 10.1562/2004-07-20-RA-236.1
   Chiarella P, 2007, EXPERT OPIN BIOL TH, V7, P1551, DOI 10.1517/14712598.7.10.1551
   Christensen D, 2007, EXPERT REV VACCINES, V6, P785, DOI 10.1586/14760584.6.5-785
   COMBADIERE M, 2008, COMP IMMUNOL MICROB, V31, P293
   Copland MJ, 2003, VACCINE, V21, P883, DOI 10.1016/S0264-410X(02)00536-4
   CRITCHFIELD JM, 1995, CELL IMMUNOL, V160, P71, DOI 10.1016/0008-8749(95)80011-7
   Cui CJ, 2007, VACCINE, V25, P500, DOI 10.1016/j.vaccine.2006.07.055
   Daubenberger CA, 2007, CURR OPIN MOL THER, V9, P45
   Diebold Sandra S., 2002, Somatic Cell and Molecular Genetics, V27, P65, DOI 10.1023/A:1022975705406
   Diwan Manish, 2003, J Drug Target, V11, P495
   Ehlers M, 2007, TRENDS IMMUNOL, V28, P74, DOI 10.1016/j.it.2006.12.006
   Elamanchili P, 2007, J IMMUNOTHER, V30, P378, DOI 10.1097/CJI.0b013e31802cf3e3
   ELDRIDGE JH, 1991, INFECT IMMUN, V59, P2978
   Ertl HCJ, 1996, VACCINE, V14, P879, DOI 10.1016/0264-410X(96)00005-9
   Espuelas S, 2005, MOL IMMUNOL, V42, P721, DOI 10.1016/j.molimm.2004.09.022
   Feng L, 2006, J CONTROL RELEASE, V112, P35, DOI 10.1016/j.jconrel.2006.01.012
   Firpo EJ, 2002, IMMUNOLOGY, V107, P480, DOI 10.1046/j.1365-2567.2002.01540.x
   Flo TH, 2002, J BIOL CHEM, V277, P35489, DOI 10.1074/jbc.M201366200
   Fritz JH, 2005, J ENDOTOXIN RES, V11, P390, DOI 10.1179/096805105X76850
   Gallucci S, 2001, CURR OPIN IMMUNOL, V13, P114, DOI 10.1016/S0952-7915(00)00191-6
   Gatza E, 2002, J IMMUNOL, V169, P5227, DOI 10.4049/jimmunol.169.9.5227
   Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318
   Gogev S, 2004, VACCINE, V22, P1946, DOI 10.1016/j.vaccine.2003.11.011
   Grandjean-Laquerriere A, 2007, BIOMATERIALS, V28, P400, DOI 10.1016/j.biomaterials.2006.09.015
   Greenland JR, 2007, VACCINE, V25, P3731, DOI 10.1016/j.vaccine.2007.01.120
   GUPTA RK, 1995, VACCINE, V13, P1276
   Gutierro I, 2002, VACCINE, V21, P67, DOI 10.1016/S0264-410X(02)00435-8
   Gutierro I, 2002, VACCINE, V20, P2181, DOI 10.1016/S0264-410X(02)00146-9
   Hamdy S, 2007, J BIOMED MATER RES A, V81A, P652, DOI 10.1002/jbm.a.31019
   Hauser H, 2004, GENE THER, V11, P924, DOI 10.1038/sj.gt.3302160
   Heit A, 2007, EUR J IMMUNOL, V37, P2063, DOI 10.1002/eji.200737169
   Hem SL, 2007, EXPERT REV VACCINES, V6, P685, DOI 10.1586/14760584.6.5.685
   Iwamoto M, 2005, FEBS LETT, V579, P4423, DOI 10.1016/j.febslet.2005.07.007
   Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359
   Jechlinger W, 2006, EXPERT REV VACCINES, V5, P803, DOI 10.1586/14760584.5.6.803
   Jiang WW, 2007, J BIOMED MATER RES A, V82A, P492, DOI 10.1002/jbm.a.31175
   Jones KS, 2006, TRANSPLANTATION, V82, P415, DOI 10.1097/01.tp.0000228917.57323.ec
   Kabelitz D, 2007, CURR OPIN IMMUNOL, V19, P1, DOI 10.1016/j.coi.2006.11.018
   Kaiser-Schulz G, 2007, J IMMUNOL, V179, P2797, DOI 10.4049/jimmunol.179.5.2797
   Kaparakis M, 2007, IMMUNOL CELL BIOL, V85, P495, DOI 10.1038/sj.icb.7100105
   Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246
   Kerkmann M, 2006, OLIGONUCLEOTIDES, V16, P313, DOI 10.1089/oli.2006.16.313
   Khaja SD, 2007, BIOMACROMOLECULES, V8, P1391, DOI 10.1021/bm061234z
   Kim TH, 2006, J NANOSCI NANOTECHNO, V6, P2796, DOI 10.1166/jnn.2006.434
   Kurts C, 1999, P NATL ACAD SCI USA, V96, P12703, DOI 10.1073/pnas.96.22.12703
   Kwissa M, 2007, EXPERT REV VACCINES, V6, P673, DOI 10.1586/14760584.6.5.673
   Kwon YJ, 2005, P NATL ACAD SCI USA, V102, P18264, DOI 10.1073/pnas.0509541102
   Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758
   Leaver SK, 2007, CRIT CARE MED, V35, P1404, DOI 10.1097/01.CCM.0000261883.16943.4B
   Lee HK, 2007, SEMIN IMMUNOL, V19, P48, DOI 10.1016/j.smim.2006.12.001
   Lee JW, 2008, BIOMATERIALS, V29, P2113, DOI 10.1016/j.biomaterials.2007.12.048
   Lee MS, 2007, MOL CELLS, V23, P1
   Lee S, 2007, BIOCONJUGATE CHEM, V18, P4, DOI 10.1021/bc060259s
   Lim DG, 2002, CELL IMMUNOL, V217, P36, DOI 10.1016/S0008-8749(02)00511-7
   Little SR, 2005, ADV BIOCHEM ENG BIOT, V99, P93, DOI 10.1007/10_004
   Little SR, 2005, J CONTROL RELEASE, V107, P449, DOI 10.1016/j.jconrel.2005.04.022
   Little SR, 2004, P NATL ACAD SCI USA, V101, P9534, DOI 10.1079/pnas.0403549101
   Lu DM, 2007, EXPERT REV VACCINES, V6, P213, DOI 10.1586/14760584.6.2.213
   Macagno A, 2007, TRENDS IMMUNOL, V28, P227, DOI 10.1016/j.it.2007.03.008
   Mahnke K, 2005, CANCER RES, V65, P7007, DOI 10.1158/0008-5472.CAN-05-0938
   Mandal B, 2004, INT J PHARM, V269, P259, DOI 10.1016/j.ijpharm.2003.09.023
   Matzinger P, 1998, SEMIN IMMUNOL, V10, P399, DOI 10.1006/smim.1998.0143
   Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059
   McDevitt H, 2004, P NATL ACAD SCI USA, V101, P14627, DOI 10.1073/pnas.0405235101
   McNeela EA, 2000, VACCINE, V19, P1188, DOI 10.1016/S0264-410X(00)00309-1
   Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246
   Meng WS, 2005, EXPERT OPIN BIOL TH, V5, P1019, DOI 10.1517/14712598.5.8.1019
   Miller LH, 2005, TRENDS PARASITOL, V21, P412, DOI 10.1016/j.pt.2005.07.005
   Miyake K, 2007, SEMIN IMMUNOL, V19, P3, DOI 10.1016/j.smim.2006.12.002
   Mutwiri G, 2007, REV SCI TECH OIE, V26, P147, DOI 10.20506/rst.26.1.1731
   Ochando JC, 2006, NAT IMMUNOL, V7, P652, DOI 10.1038/ni1333
   OHAGAN DT, 1991, IMMUNOLOGY, V73, P239
   OHAGAN DT, 1991, VACCINE, V9, P768, DOI 10.1016/0264-410X(91)90295-H
   Oussoren C, 1997, BBA-BIOMEMBRANES, V1328, P261, DOI 10.1016/S0005-2736(97)00122-3
   Padovan E, 2007, TRENDS IMMUNOL, V28, P308, DOI 10.1016/j.it.2007.05.002
   Palmer K, 2001, GENE THER, V8, P282, DOI 10.1038/sj.gt.3301386
   Park JH, 2006, PHARM RES, V23, P1008, DOI 10.1007/s11095-006-0028-9
   Parker LC, 2007, CLIN EXP IMMUNOL, V147, P199, DOI 10.1111/j.1365-2249.2006.03203.x
   Partidos CD, 1996, MOL IMMUNOL, V33, P485, DOI 10.1016/0161-5890(96)00032-6
   Raimondi Giorgio, 2007, Methods Mol Biol, V380, P1
   Reddy ST, 2007, NAT BIOTECHNOL, V25, P1159, DOI 10.1038/nbtl332
   Reddy ST, 2006, TRENDS IMMUNOL, V27, P573, DOI 10.1016/j.it.2006.10.005
   Reddy ST, 2006, J APPL PHYSIOL, V101, P1162, DOI 10.1152/japplphysiol.00389.2006
   Reddy ST, 2006, J CONTROL RELEASE, V112, P26, DOI 10.1016/j.jconrel.2006.01.006
   Reiner SL, 2007, CELL, V129, P33, DOI 10.1016/j.cell.2007.03.019
   Rezaei N, 2006, INT IMMUNOPHARMACOL, V6, P863, DOI 10.1016/j.intimp.2006.02.005
   Romagne F, 2007, DRUG DISCOV TODAY, V12, P80, DOI 10.1016/j.drudis.2006.11.007
   Rouse BT, 2007, EXPERT OPIN BIOL TH, V7, P1301, DOI 10.1517/14712598.7.9.1301
   Rubartelli A, 2007, TRENDS IMMUNOL, V28, P429, DOI 10.1016/j.it.2007.08.004
   Sapin A, 2006, INT J PHARM, V309, P1, DOI 10.1016/j.ijpharm.2005.10.046
   Schiller M, 2006, EXP DERMATOL, V15, P331, DOI 10.1111/j.0906-6705.2006.00414.x
   Schmidt CS, 2007, EXPERT REV VACCINES, V6, P391, DOI 10.1586/14760584.6.3.391
   Seya T, 2006, EVID-BASED COMPL ALT, V3, P31, DOI 10.1093/ecam/nek010
   Shakweh M, 2006, J NANOSCI NANOTECHNO, V6, P2811, DOI 10.1166/jnn.2006.438
   Shen H, 2006, IMMUNOLOGY, V117, P78, DOI 10.1111/j.1365-2567.2005.02268.x
   Singh M, 2001, PHARM RES-DORDR, V18, P1476, DOI 10.1023/A:1012269226066
   Standley SM, 2004, BIOCONJUGATE CHEM, V15, P1281, DOI 10.1021/bc049956f
   Sutterwala FS, 2007, J LEUKOCYTE BIOL, V82, P259, DOI 10.1189/jlb.1206755
   Tafaghodi M, 2006, INT J PHARM, V319, P37, DOI 10.1016/j.ijpharm.2006.03.047
   Timmerman JM, 2002, BLOOD, V99, P1517, DOI 10.1182/blood.V99.5.1517
   Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038
   UCHIDA T, 1995, J PHARM PHARMACOL, V47, P556, DOI 10.1111/j.2042-7158.1995.tb06713.x
   UCHIDA T, 1994, BIOL PHARM BULL, V17, P1272
   van Broekhoven CL, 2004, CANCER RES, V64, P4357, DOI 10.1158/0008-5472.CAN-04-0138
   van Duin D, 2006, TRENDS IMMUNOL, V27, P49, DOI 10.1016/j.it.2005.11.005
   Villadangos JA, 2007, TRENDS IMMUNOL, V28, P45, DOI 10.1016/j.it.2006.12.008
   Waeckerle-Men Y, 2005, ADV DRUG DELIVER REV, V57, P475, DOI 10.1016/j.addr.2004.09.007
   Wagstaff KM, 2007, BIOCHEM J, V406, P185, DOI 10.1042/BJ20070505
   Walter E, 2001, J CONTROL RELEASE, V76, P149, DOI 10.1016/S0168-3659(01)00413-8
   Wang C, 2004, NAT MATER, V3, P190, DOI 10.1038/nmat1075
   Wang RF, 2002, NAT BIOTECHNOL, V20, P149, DOI 10.1038/nbt0202-149
   Wu KY, 2006, BIOMED ENVIRON SCI, V19, P87
   Xie Y, 2007, WORLD J GASTROENTERO, V13, P1547, DOI 10.3748/wjg.v13.i10.1547
   Xing Z, 2005, CURR GENE THER, V5, P485, DOI 10.2174/156652305774329230
   YANG D, 2008, J BIOMED MAT RES A
   Yang TC, 2006, J IMMUNOL, V176, P200, DOI 10.4049/jimmunol.176.1.200
   Yates SF, 2007, J IMMUNOL, V179, P967, DOI 10.4049/jimmunol.179.2.967
   Yoshida M, 2004, J BIOMED MATER RES A, V71A, P45, DOI 10.1002/jbm.a.30131
   Yoshida M, 2007, J BIOMED MATER RES A, V80A, P7, DOI 10.1002/jbm.a.30832
   Yoshida M, 2006, J BIOMED MATER RES A, V79A, P393, DOI 10.1002/jbm.a.30798
   Zaharoff DA, 2007, VACCINE, V25, P2085, DOI 10.1016/j.vaccine.2006.11.034
   Zhu BD, 2007, EUR J PHARM BIOPHARM, V66, P318, DOI 10.1016/j.ejpb.2006.11.028
NR 145
TC 27
Z9 28
U1 0
U2 13
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 8756-7938
J9 BIOTECHNOL PROGR
JI Biotechnol. Prog.
PD JUL-AUG
PY 2008
VL 24
IS 4
BP 807
EP 814
DI 10.1002/btpr.10
PG 8
WC Biotechnology & Applied Microbiology; Food Science & Technology
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA 348KA
UT WOS:000259208200003
PM 19194892
OA Bronze
DA 2018-10-19
ER

PT J
AU Depprich, R
   Handschel, J
   Wiesmann, HP
   Jasche-Meyer, J
   Meyer, U
AF Depprich, Rita
   Handschel, Joerg
   Wiesmann, Hans-Peter
   Jaesche-Meyer, Janine
   Meyer, Ulrich
TI Use of bioreactors in maxillofacial tissue engineering
SO BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY
LA English
DT Review
DE bioreactor; tissue engineering; reconstruction
ID OSTEOBLAST-LIKE CELLS; IN-VITRO; ARTICULAR-CARTILAGE; MECHANICAL
   STIMULI; BONE-FORMATION; FLUID-FLOW; SYSTEM; GROWTH; PRINCIPLES; CULTURE
AB Engineering of various oral tissues is a challenging issue in contemporary maxillofacial reconstructive research. In contrast to the classic biomaterial approach, tissue engineering is based on the understanding of cell driven tissue formation, and aims to generate new functional tissues, rather than just to implant non-living space holders. Researchers hope to reach this goal by combining knowledge from biology. physics, materials science, engineering, and medicine in an integrated manner. Several major technical advances have been made in this field during the last decade, and clinical application is at the stage of first clinical trials. A recent limitation of extracorporally engineered cellular substitutes is the problem of growing enlarged tissues ex vivo. One of the main research topics is therefore to scale up artificial tissue constructs for use in extended defect Situations. To overcome the monolayer inherent two-dimensional cell assembly, efforts have been made to grow cells in a three-dimensional space. Bioreactors have therefore been in focus for a considerable time to build tip enlarged tissues. The shift from the ex vivo approach of cell multiplication to the generation of a real tissue growth is mirrored by the development of bioreactors, enabling scientists to grow more complex tissue constructs. This present review intends to provide an overview of the current state of art in maxillofacial tissue engineering by the use of bioreactors, its limitations and hopes, as well as the future research trends. (C) 2008 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.
C1 [Depprich, Rita; Handschel, Joerg; Meyer, Ulrich] Westdeutsch Kieferklin, Clin Maxillofacial & Facial Plast Surg, D-40225 Dusseldorf, Germany.
   [Wiesmann, Hans-Peter] Univ Munster, Clin Cranio Maxillofacial Surg, D-18149 Munster, Germany.
   [Jaesche-Meyer, Janine] Univ Munster, Clin Orthodont, D-18149 Munster, Germany.
RP Meyer, U (reprint author), Westdeutsch Kieferklin, Clin Maxillofacial & Facial Plast Surg, Moorenstr 5, D-40225 Dusseldorf, Germany.
EM ulrich.meyer@med.uni-duesseldorf.de
CR Abukawa H, 2004, J ORAL MAXIL SURG, V62, P601, DOI 10.1016/j.joms.2003.11.010
   Botchwey EA, 2001, J BIOMED MATER RES, V55, P242
   Bottlang M, 1997, BIOMED TECH, V42, P305, DOI 10.1515/bmte.1997.42.11.305
   Brown TD, 2000, J BIOMECH, V33, P3, DOI 10.1016/S0021-9290(99)00177-3
   BUSCHMANN MD, 1995, J CELL SCI, V108, P1497
   Butler DL, 2000, J BIOMECH ENG-T ASME, V122, P570, DOI 10.1115/1.1318906
   CASSERBETTE M, 1990, CALCIFIED TISSUE INT, V46, P46, DOI 10.1007/BF02555824
   Cheng GC, 1997, CIRC RES, V80, P28, DOI 10.1161/01.RES.80.1.28
   Cheng MZ, 1996, J BONE MINER RES, V11, P502
   Curtis A, 2001, PHYS MED BIOL, V46, pR47, DOI 10.1088/0031-9155/46/4/201
   Darling EM, 2003, TISSUE ENG, V9, P9, DOI 10.1089/107632703762687492
   Domen J, 2000, IMMUNOL RES, V22, P83, DOI 10.1385/IR:22:2-3:83
   DUNCAN RL, 1995, CALCIFIED TISSUE INT, V57, P344, DOI 10.1007/BF00302070
   Freed LE, 1997, IN VITRO CELL DEV-AN, V33, P381
   Frost H. M., 2000, Journal of Musculoskeletal & Neuronal Interactions, V1, P5
   Granet C, 1998, MED BIOL ENG COMPUT, V36, P513, DOI 10.1007/BF02523224
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Hartig M, 2000, EUR BIOPHYS J BIOPHY, V29, P499, DOI 10.1007/s002490000100
   HILLSLEY MV, 1994, BIOTECHNOL BIOENG, V43, P573, DOI 10.1002/bit.260430706
   Hung CT, 2004, ANN BIOMED ENG, V32, P35, DOI 10.1023/B:ABME.0000007789.99565.42
   Jones D, 1995, BIOCHEM CELL BIOL, V73, P525, DOI 10.1139/o95-058
   Jones D. B., 2003, European Cells & Materials, V5, P48
   Jones D. B., 2003, EUR CELLS MATER, V5, P59
   Krishnan L, 2004, TISSUE ENG, V10, P241, DOI 10.1089/107632704322791880
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee JB, 1996, ENG OPTIMIZ, V27, P1, DOI 10.1080/03052159608941397
   Malda J, 2003, CRIT REV BIOTECHNOL, V23, P175, DOI 10.1080/714037688
   Martin I, 2000, BIORHEOLOGY, V37, P141
   MASI L, 1992, CALCIFIED TISSUE INT, V51, P202, DOI 10.1007/BF00334548
   Meyer U, 2006, BRIT J ORAL MAX SURG, V44, P289, DOI 10.1016/j.bjoms.2005.06.026
   Meyer U, 2004, INT J ORAL MAX SURG, V33, P635, DOI 10.1016/j.ijom.2004.04.006
   Meyer U, 2006, BRIT J ORAL MAX SURG, V44, P134, DOI 10.1016/j.bjoms.2005.05.001
   MEYER U, 1993, CELL MATER, V3, P129
   Meyer Ulrich, 2005, Head Face Med, V1, P2, DOI 10.1186/1746-160X-1-2
   Muschler GE, 2004, J BONE JOINT SURG AM, V86A, P1541, DOI 10.2106/00004623-200407000-00029
   Ogata T, 2000, J CELL BIOCHEM, V76, P529, DOI 10.1002/(SICI)1097-4644(20000315)76:4<529::AID-JCB1>3.0.CO;2-5
   Pavalko F. M., 1998, AM J PHYSIOL, V275, P1591
   Plate Ulrich, 2006, Head Face Med, V2, P6, DOI 10.1186/1746-160X-2-6
   Ratcliffe A, 2002, ANN NY ACAD SCI, V961, P210, DOI 10.1111/j.1749-6632.2002.tb03087.x
   Risbud MV, 2002, TRENDS BIOTECHNOL, V20, P351, DOI 10.1016/S0167-7799(02)02016-4
   RUBIN CT, 1987, J ORTHOPAED RES, V5, P300, DOI 10.1002/jor.1100050217
   Schmelzeisen R, 2003, J CRANIO MAXILL SURG, V31, P34, DOI 10.1016/S1010-5182
   Schwarz R P, 1992, J Tissue Cult Methods, V14, P51, DOI 10.1007/BF01404744
   STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424
   Toma CD, 1997, J BONE MINER RES, V12, P1626, DOI 10.1359/jbmr.1997.12.10.1626
   Vunjak-Novakovic Gordana, 2003, Novartis Found Symp, V249, P34
   Vunjak-Novakovics G, 2003, NOVART FDN SYMP, V249, P170
   VUNJAKNOVAKOVIC G, 2003, NOVART FDN SYMP, V249, P46
   VUNJAKNOVAKOVIC G, 2003, NOVART FDN SYMP, V249, P239
   Warnke PH, 2004, LANCET, V364, P766, DOI 10.1016/S0140-6736(04)16935-3
   Wiesmann HP, 2001, BBA-MOL CELL RES, V1538, P28, DOI 10.1016/S0167-4889(00)00135-X
   WINSTON FK, 1989, J APPL PHYSIOL, V67, P397
   Wu W, 2007, BRIT J ORAL MAX SURG, V45, P272, DOI 10.1016/j.bjoms.2006.09.004
NR 53
TC 13
Z9 13
U1 0
U2 7
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0266-4356
J9 BRIT J ORAL MAX SURG
JI Br. J. Oral Maxillofac. Surg.
PD JUL
PY 2008
VL 46
IS 5
BP 349
EP 354
DI 10.1016/j.bjoms.2008.01.012
PG 6
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA 326EB
UT WOS:000257639900001
PM 18343545
DA 2018-10-19
ER

PT J
AU Artzi, Z
   Weinreb, M
   Carmeli, G
   Lev-Dor, R
   Dard, M
   Nemcovsky, CE
AF Artzi, Zvi
   Weinreb, Miron
   Carmeli, Guy
   Lev-Dor, Rony
   Dard, Michel
   Nemcovsky, Carlos E.
TI Histomorphometric assessment of bone formation in sinus augmentation
   utilizing a combination of autogenous and hydroxyapatite/biphasic
   tricalcium phosphate graft materials: at 6 and 9 months in humans
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE alloplasts; bone regeneration; hydroxyapatite; tricalcium phosphate;
   osteoconduction; sinus augmentation
ID MARROW STROMAL CELLS; BIPHASIC CALCIUM-PHOSPHATE; NEWLY FORMED BONE;
   INJECTABLE BONE; GUIDED BONE; FLOOR AUGMENTATION; GRINDING TECHNIQUE;
   IN-VIVO; UNDECALCIFIED BONES; IMPLANT PLACEMENT
AB Objective: The aim of this study was to examine the efficacy of a new biphasic hydroxyapatite/tricalcium phosphate (HA/TCP) bone substitute in combination with particulate autogenous bone in sinus floor augmentation procedures.
   Material and methods: A simultaneous or a two-stage sinus augmentation and implant placement were conducted in 28 patients. A mixture of HA/TCP and autogenous bone chips in a 1 : 1 ratio was used as the grafting biomaterial. Cylindrical specimen bone retrieval was performed in all patients except one. Specimens were harvested either at 6 (n=14) or 9 (n=13) months post-augmentation. For histologic and histomorphometric evaluations, the non-decalcified tissue processing (Donath's technique) was performed.
   Results: Newly formed bone around the grafted particles was found in all samples. The encircling, highly cellular bone followed the outline of the grafted particles in direct contact. Both woven and lamellar types of bone were observed.
   Morphometrically, the total mean bone area fraction of all sections was 34.8 +/- 10.3%, increasing from 28.6 +/- 7.8% at 6 months to 41.6 +/- 8.3% at 9 months (P < 0.001). Mean particle area fraction average was 25.5 +/- 11.6% and 23.5 +/- 9.3% at 6 and 9 months, respectively, with a total mean of 24.5 +/- 10.4%. The increase in bone area fraction was not significantly correlated to the decrease of the grafted particles area fraction.
   Conclusions: The biphasic HA/TCP showed biocompatible and osteoconductive properties. This alloplast as a composite with autogenous bone chips promotes newly formed bone, which increases in its fraction along an extended healing period.
C1 [Artzi, Zvi; Carmeli, Guy; Lev-Dor, Rony; Nemcovsky, Carlos E.] Tel Aviv Univ, Sch Dent Med, Dept Periodontol, IL-69978 Tel Aviv, Israel.
   [Weinreb, Miron] Tel Aviv Univ, Maurice & Gabriela Goldschleger Sch Dent Med, Dept Oral Biol, IL-69978 Tel Aviv, Israel.
   [Dard, Michel] Inst Straumann AG, Basel, Switzerland.
RP Artzi, Z (reprint author), Tel Aviv Univ, Sch Dent Med, Dept Periodontol, IL-69978 Tel Aviv, Israel.
EM zviartzi@post.tau.ac.il
CR Artzi Z, 2005, J CLIN PERIODONTOL, V32, P193, DOI 10.1111/j.1600-051X.2005.00656.x
   Artzi Z, 2004, INT J ORAL MAX IMPL, V19, P357
   Artzi Z, 2003, INT J PERIODONT REST, V23, P381
   Artzi Z, 2001, J PERIODONTOL, V72, P911, DOI 10.1902/jop.2001.72.7.911
   Blouin S, 2006, J BIOMED MATER RES A, V78A, P570, DOI 10.1002/jbm.a.30721
   Boeck-Neto R, 2002, J PERIODONTOL, V73, P266, DOI 10.1902/jop.2002.73.3.266
   Boix D, 2006, J MATER SCI-MATER M, V17, P1145, DOI 10.1007/s10856-006-0542-7
   Boix D, 2004, J PERIODONTOL, V75, P663, DOI 10.1902/jop.2004.75.5.663
   BOYNE PJ, 1980, J ORAL SURG, V38, P613
   BROOK IM, 1991, BIOMATERIALS, V12, P179, DOI 10.1016/0142-9612(91)90197-I
   BURCHARDT H, 1983, CLIN ORTHOP RELAT R, P28
   BURR DB, 1993, J BIOMED MATER RES, V27, P645, DOI 10.1002/jbm.820270512
   Daculsi G, 2003, J MATER SCI-MATER M, V14, P195, DOI 10.1023/A:1022842404495
   DAVIS WH, 1984, J ORAL MAXIL SURG, V42, P606, DOI 10.1016/0278-2391(84)90092-2
   De Kok IJ, 2005, INT J ORAL MAX IMPL, V20, P511
   De Kok IJ, 2003, CLIN ORAL IMPLAN RES, V14, P481, DOI 10.1034/j.1600-0501.2003.110770.x
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   DONATH K, 1985, PATHOL RES PRACT, V179, P631, DOI 10.1016/S0344-0338(85)80209-0
   Emery SE, 1996, SPINE, V21, P2713, DOI 10.1097/00007632-199612010-00003
   Fellah BH, 2006, J ORTHOP RES, V24, P628, DOI 10.1002/jor.20125
   Fleckenstein KB, 2006, J PERIODONTOL, V77, P39, DOI 10.1902/jop.2006.77.1.39
   Garg AK, 1999, TISSUE ENGINEERING, P83
   Gauthier O, 2001, J MATER SCI-MATER M, V12, P385, DOI 10.1023/A:1011284517429
   Hallman M, 2001, Clin Implant Dent Relat Res, V3, P87, DOI 10.1111/j.1708-8208.2001.tb00236.x
   Hallman Mats, 2004, Clin Implant Dent Relat Res, V6, P82, DOI 10.1111/j.1708-8208.2004.tb00030.x
   HASHIMOTOUOSHIMA M, 1995, INT J PERIODONT REST, V15, P205
   Hellem Solve, 2003, Clin Implant Dent Relat Res, V5, P233, DOI 10.1111/j.1708-8208.2003.tb00206.x
   Hurzeler MB, 1997, CLIN ORAL IMPLAN RES, V8, P401, DOI 10.1034/j.1600-0501.1997.080507.x
   Jensen OT, 1999, SINUS BONE GRAFT, P49
   Jensen OT, 1998, INT J ORAL MAX IMPL, V13, P11
   Jung RE, 2006, CLIN ORAL IMPLAN RES, V17, P426, DOI 10.1111/j.1600-0501.2005.01228.x
   Kirsch A, 1999, SINUS BONE GRAFT, P79
   LAURENCIN CT, 1999, BONE ENG, P462
   Le Nihouannen D, 2005, BONE, V36, P1086, DOI 10.1016/j.bone.2005.02.017
   Lee TM, 2001, J BIOMED MATER RES, V55, P360, DOI 10.1002/1097-4636(20010605)55:3<360::AID-JBM1040>3.0.CO;2-Q
   Lynch SE, 1999, TISSUE ENGINEERING, pXI
   Mankani MH, 2006, STEM CELLS, V24, P2140, DOI 10.1634/stemcells.2005-0567
   Mankani MH, 2006, AM J PATHOL, V168, P542, DOI 10.2353/ajpath.2006.050407
   Mankani MH, 2001, BIOTECHNOL BIOENG, V72, P96, DOI 10.1002/1097-0290(20010105)72:1<96::AID-BIT13>3.0.CO;2-A
   Merkx MAW, 2000, CLIN ORAL IMPLAN RES, V11, P422, DOI 10.1034/j.1600-0501.2000.011005422.x
   Misch C E, 1994, J Oral Implantol, V20, P100
   Misch CE, 1999, CONT IMPLANT DENT, P469
   Ohnishi H, 2000, J PERIODONTOL, V71, P341, DOI 10.1902/jop.2000.71.3.341
   Peleg M, 2006, INT J ORAL MAX IMPL, V21, P551
   ROHRER MD, 1992, ORAL SURG ORAL MED O, V74, P73, DOI 10.1016/0030-4220(92)90218-F
   RUSSOTTI GM, 1987, HIP, V15, P120
   Schopper C, 2005, J BIOMED MATER RES B, V74B, P458, DOI 10.1002/jbm.b.30199
   St John Kenneth R., 1993, Clinical Materials, V12, P49, DOI 10.1016/0267-6605(93)90027-5
   Stewart M, 2004, J BIOMED MATER RES A, V69A, P1, DOI 10.1002/jbm.a.20071
   Tal H, 2008, CLIN ORAL IMPLAN RES, V19, P295, DOI 10.1111/j.1600-0501.2007.01424.x
   Tan YF, 2007, J BIOMED MATER RES A, V82A, P152, DOI 10.1002/jbm.a.31125
   TATUM H, 1986, DENT CLIN N AM, V30, P207
   Temenoff J.S., 1999, BONE ENG, P454
   Tong DC, 1998, INT J ORAL MAX IMPL, V13, P175
   Trojani C, 2006, BIOMATERIALS, V27, P3256, DOI 10.1016/j.biomaterials.2006.01.057
   Tulasne JF, 1999, SINUS BONE GRAFT, P107
   Watzek G, 1998, INT J ORAL MAX SURG, V27, P428, DOI 10.1016/S0901-5027(98)80031-3
   Zubery Y, 2007, J PERIODONTOL, V78, P112, DOI 10.1902/jop.2007.060055
NR 58
TC 52
Z9 55
U1 0
U2 4
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0905-7161
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD JUL
PY 2008
VL 19
IS 7
BP 686
EP 692
DI 10.1111/j.1600-0501.2008.01539.x
PG 7
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 309YM
UT WOS:000256496100008
PM 18492077
DA 2018-10-19
ER

PT J
AU Wang, X
   Lennartz, MR
   Loegering, DJ
   Stenken, JA
AF Wang, Xiangdan
   Lennartz, Michelle R.
   Loegering, Daniel J.
   Stenken, Julie A.
TI Multiplexed cytokine detection of interstitial fluid collected from
   polymeric hollow tube implants - A feasibility study
SO CYTOKINE
LA English
DT Article
DE cytokine; polyurethane; foreign body response; rat
ID IN-VIVO; BIOMATERIALS; MACROPHAGE; RESPONSES; EXPRESSION;
   BIOCOMPATIBILITY; CHEMOKINE; PRESSURE; INFLAMMATION; GENERATION
AB Cytokines are important cellular signaling proteins involved in inflammation, wound heating and are thought to direct the foreign body response to implanted materials. In this work, polyurethane tubes (25 mm length, 1.02 mm i.d., and 1.65 mm o.d.) were implanted into subcutaneous tissue of male Sprague-Dawley rats. The tubes served as the biontaterial and a means to collect the interstitial fluid that would be exchanged within the tube lumen and the surrounding tissue. After 3 and 7 days, the tubes were explanted and cytokines in the fluid were quantified with a multiplexed cytokine immunoassay. Six cytokines, interleukin-1 beta (IL-1 beta), IL-4, IL-6, IL-10, macrophage chemoattractant protein-1 (MCP-1), and tumor necrosis factor-alpha (TNF-alpha), were simultaneously quantified. All cytokine concentrations with the exception of IL-4 and TNF-a ranged between low pg/mL to mid ng/mL levels. Neither TNF-alpha nor IL-4 was detected from any sample. These results illustrate the potential of using the tube materials combined with bead-based immunoassays as a direct method for in vivo collection of multiple cytokines in low microliter sample volumes for fixed day biomaterial implant studies. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Wang, Xiangdan; Stenken, Julie A.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Chem & Chem Biol, Troy, NY 12180 USA.
   [Lennartz, Michelle R.] Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA.
   [Loegering, Daniel J.] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA.
RP Stenken, JA (reprint author), Univ Arkansas, Dept Chem & Biochem, Fayetteville, AR 72701 USA.
EM jstenken@uark.edu
FU NIBIB NIH HHS [R01 EB001441, R01 EB001441-04, EB001441]
CR Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   Ao XP, 2006, J PHARMACEUT BIOMED, V40, P915, DOI 10.1016/j.jpba.2005.07.044
   Ao XP, 2005, J MICROBIOL METH, V62, P327, DOI 10.1016/j.mimet.2005.04.016
   Baldwin L, 2008, CYTOKINE, V41, P217, DOI 10.1016/j.cyto.2007.11.015
   BREIT SN, 2001, TGF BETA RELATED CYT
   Brodbeck WG, 2003, J BIOMED MATER RES A, V64A, P320, DOI 10.1002/jbm.a.10425
   CAVAILLON JM, 1994, BIOMED PHARMACOTHER, V48, P445, DOI 10.1016/0753-3322(94)90005-1
   Clough GF, 2007, J INVEST DERMATOL, V127, P2799, DOI 10.1038/sj.jid.5700930
   COETZEE JH, 1982, COMP BIOCHEM PHYS A, V72, P173, DOI 10.1016/0300-9629(82)90028-7
   DiPietro LA, 1998, J CLIN INVEST, V101, P1693, DOI 10.1172/JCI1020
   Ferreira AM, 2005, CYTOKINE, V30, P64, DOI 10.1016/j.cyto.2004.12.00
   Gouwy M, 2005, CYTOKINE GROWTH F R, V16, P561, DOI 10.1016/j.cytogfr.2005.03.005
   Grant V, 2005, BIOCHEM BIOPH RES CO, V331, P187, DOI 10.1016/j.bbrc.2005.03.137
   Griffiths Marie M., 1996, Methods (Orlando), V9, P295, DOI 10.1006/meth.1996.0034
   Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456
   Hunt JA, 1997, J BIOMED MATER RES, V36, P542
   Hunt JA, 1997, BIOMATERIALS, V18, P1449, DOI 10.1016/S0142-9612(97)00091-4
   KOSSOVSKY N, 1993, IMMUNOMETHODS, V3, P43
   Kyriakides TR, 2004, AM J PATHOL, V165, P2157, DOI 10.1016/S0002-9440(10)63265-8
   Lefkowitz DL, 2001, IMMUNOL CELL BIOL, V79, P502, DOI 10.1046/j.1440-1711.2001.01020.x
   Li YW, 2005, BIOMATERIALS, V26, P1081, DOI 10.1016/j.biomaterials.2004.04.018
   Lord R, 2001, CYTOKINE, V13, P155, DOI 10.1006/cyto.2000.0815
   MAHIOUT A, 1989, ARTIF ORGANS, V13, P251, DOI 10.1111/j.1525-1594.1989.tb02872.x
   Marois Y, 1996, BIOMATERIALS, V17, P1835, DOI 10.1016/0142-9612(95)00245-6
   MILLER KM, 1989, J BIOMED MATER RES, V23, P1007, DOI 10.1002/jbm.820230904
   RAYMOND TL, 1983, J LIPID RES, V24, P113
   Rhodes NP, 1997, J BIOMED MATER RES, V37, P481, DOI 10.1002/(SICI)1097-4636(19971215)37:4<481::AID-JBM6>3.0.CO;2-H
   RUTILI G, 1977, ACTA PHYSIOL SCAND, V99, P1, DOI 10.1111/j.1748-1716.1977.tb10345.x
   SCHOLANDER PF, 1968, SCIENCE, V161, P321, DOI 10.1126/science.161.3839.321
   Vignali DAA, 2000, J IMMUNOL METHODS, V243, P243, DOI 10.1016/S0022-1759(00)00238-6
   Wang XD, 2007, ANAL CHEM, V79, P1816, DOI 10.1021/ac061503b
   Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.00031.2002
   Wiig H, 2000, AM J PHYSIOL-HEART C, V278, pH1627
   Wooley PH, 2002, BIOMATERIALS, V23, P517, DOI 10.1016/S0142-9612(01)00134-X
NR 35
TC 16
Z9 16
U1 3
U2 9
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1043-4666
J9 CYTOKINE
JI Cytokine
PD JUL
PY 2008
VL 43
IS 1
BP 15
EP 19
DI 10.1016/j.cyto.2008.04.009
PG 5
WC Biochemistry & Molecular Biology; Cell Biology; Immunology
SC Biochemistry & Molecular Biology; Cell Biology; Immunology
GA 328UI
UT WOS:000257823300002
PM 18519165
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Orecchio, S
   Gianguzza, A
   Culotta, L
AF Orecchio, Santino
   Gianguzza, Antonio
   Culotta, Loredana
TI Absorption of polycyclic aromatic hydrocarbons by Pinus bark: Analytical
   method and use for environmental pollution monitoring in the Palermo
   area (Sicily, Italy)
SO ENVIRONMENTAL RESEARCH
LA English
DT Article
DE PAH; bark; Pinus; bioaccumulator; GC/MS; air quality; Palermo
ID AIR; QUALITY; BIOMONITORS; LEAVES; PAHS; CITY; EXTRACTION; SAMPLERS;
   PLANTS; SOILS
AB In the light of using biomaterial as pollutants sorbents for the environmental biomonitoring, we report here the results of the absorption of polycyclic aromatic hydrocarbons (PAHs) by pine bark. Quantitative analysis of 19 different polycyclic aromatic compounds was performed, after Soxhlet extraction in dichloromethane, by means GC-MS technique. Pinus was chosen due to its wide distribution in the Mediterranean area. The passive absorption of PAH by pine bark in the metropolitan areas allowed us to evaluate the air quality of Palermo. The obtained results showed a very high range of PAHs concentrations, from 33 mu g/kg (bark dry weight), as Sigma PAHs, at the control site to 1015 mu g/kg along a road with high traffic flow. (C) 2008 Elsevier Inc. All rights reserved.
C1 [Orecchio, Santino; Gianguzza, Antonio; Culotta, Loredana] Univ Palermo, Dipartimento Chim Inorgan & Analit, I-90128 Palermo, Italy.
RP Orecchio, S (reprint author), Univ Palermo, Dipartimento Chim Inorgan & Analit, Parco Orleans 2, I-90128 Palermo, Italy.
EM orecchio@unipa.it
OI Gianguzza, Antonio/0000-0003-3993-6167; Orecchio,
   Santino/0000-0002-5429-5188
CR Alaimo MG, 2000, AEROBIOLOGIA, V16, P47
   Baumard P, 1998, MAR POLLUT BULL, V36, P577, DOI 10.1016/S0025-326X(98)00014-9
   BIDLEMAN TF, 1988, ATMOS PROCESSES ENV, V21, P361
   Bohm P, 1998, ENVIRON POLLUT, V102, P243, DOI 10.1016/S0269-7491(98)00082-7
   Caricchia AM, 1999, ATMOS ENVIRON, V33, P3731, DOI 10.1016/S1352-2310(99)00199-5
   CATSKY J, 2001, PHOTOSYNTHETICA, V39, P196
   Cortes E, 2004, J RADIOANAL NUCL CH, V262, P269
   Culotta L, 2005, POLYCYCL AROMAT COMP, V25, P327, DOI 10.1080/10406630500227262
   Culotta L, 2002, ANN CHIM-ROME, V92, P837
   DUMBAR JC, 2001, SCI TOTAL ENVIRON, V279, P1
   Gao YZ, 2004, CHEMOSPHERE, V55, P1169, DOI 10.1016/j.chemosphere.2004.01.037
   Giacalone A, 2004, POLYCYCL AROMAT COMP, V24, P135, DOI 10.1080/10406630490433223
   GIOVENCO A, 1996, INQUINAMENTO, V3, P48
   Howsam M., 1998, HDB ENV CHEM 1, P137
   IARC-International Agency for Research on Cancer, 1991, MON EV CARC RISKS HU, P43
   Kim EJ, 2003, SCI TOTAL ENVIRON, V311, P177, DOI 10.1016/S0048-9697(03)00095-0
   LANE DA, 1988, ANAL POLYCYCLIC AROM, V101, P31
   Larsen J. C., 1998, AIR POLLUTION HLTH, P33, DOI DOI 10.1039/9781847550095-00033
   LAW RJ, 1994, MAR POLLUT BULL, V29, P235, DOI 10.1016/0025-326X(94)90415-4
   Lombardo M, 2001, ATMOS ENVIRON, V35, P6435, DOI 10.1016/S1352-2310(01)00348-X
   Macaluso A, 2000, ANN CHIM-ROME, V90, P83
   Madejon P, 2006, ENVIRON POLLUT, V143, P1, DOI 10.1016/j.envpol.2005.11.008
   Malcom H. M., 1994, CALCULATION ENV ASSE
   MCVEETY B, 1967, ATMOS ENVIRON, V22, P511
   Neff J.M, 1979, POLYCYCL AROMAT COMP, P1
   Neilson A. H., 1998, HDB ENV CHEM PAHS RE, V3-J, P265
   Nielsen T, 1996, ATMOS ENVIRON, V30, P3481, DOI 10.1016/1352-2310(96)00096-9
   NISBET ICT, 1992, REGUL TOXICOL PHARM, V16, P290, DOI 10.1016/0273-2300(92)90009-X
   RAFFAELLI D, 1996, J EXP MAR BIOL ECOL, V198, P151
   RUHLING A, 1968, Botaniska Notiser, V121, P321
   Schneider K, 2002, J APPL TOXICOL, V22, P73, DOI 10.1002/jat.828
   Schulz H, 2001, ENVIRON MONIT ASSESS, V69, P283, DOI 10.1023/A:1010705907525
   Schulz H, 1999, SCI TOTAL ENVIRON, V232, P49, DOI 10.1016/S0048-9697(99)00109-6
   Simonich S.L., 1995, ENVIRON SCI TECHNOL, V29, P2095, DOI DOI 10.1021/ES00012A004
   TURKAN I, 1995, SCI TOTAL ENVIRON, V166, P61, DOI 10.1016/0048-9697(95)04518-6
   Walkenhorst A., 1993, Plants as biomonitors: indicators for heavy metals in the terrestrial environment., P523
   WILD SR, 1992, SCI TOTAL ENVIRON, V119, P85, DOI 10.1016/0048-9697(92)90258-T
NR 37
TC 28
Z9 32
U1 2
U2 18
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0013-9351
J9 ENVIRON RES
JI Environ. Res.
PD JUL
PY 2008
VL 107
IS 3
BP 371
EP 379
DI 10.1016/j.envres.2008.02.010
PG 9
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA 316PA
UT WOS:000256961000011
PM 18417111
DA 2018-10-19
ER

PT J
AU Khan, IM
   Gilbert, SJ
   Singhrao, SK
   Duance, VC
   Archer, CW
AF Khan, I. M.
   Gilbert, S. J.
   Singhrao, S. K.
   Duance, V. C.
   Archer, C. W.
TI CARTILAGE INTEGRATION: EVALUATION OF THE REASONS FOR FAILURE OF
   INTEGRATION DURING CARTILAGE REPAIR. A REVIEW
SO EUROPEAN CELLS & MATERIALS
LA English
DT Review
DE cartilage; integration; repair; autologous chondrocyte implantation
ID AUTOLOGOUS CHONDROCYTE IMPLANTATION; TISSUE-ENGINEERED CARTILAGE;
   FULL-THICKNESS DEFECTS; CONTINUOUS PASSIVE MOTION; HUMAN
   ARTICULAR-CARTILAGE; MESENCHYMAL STEM-CELLS; IN-VITRO; OSTEOCHONDRAL
   DEFECTS; CHONDRAL DEFECTS; ENZYMATIC TREATMENT
AB Articular cartilage is a challenging tissue to reconstruct or replace principally because of its avascular nature; large chondral lesions in the tissue do not spontaneously heal. Where lesions do penetrate the bony subchondral plate, formation of hematomas and the migration of mesenchymal stem cells provide an inferior and transient fibrocartilagenous replacement for hyaline cartilage. To circumvent the poor intrinsic reparative response of articular cartilage several surgical techniques based on tissue transplantation have emerged. One characteristic shared by intrinsic reparative processes and the new surgical therapies is an apparent lack of lateral integration of repair or graft tissue with the host cartilage that can lead to poor prognosis. Many factors have been cited as impeding cartilage: cartilage integration including; chondrocyte cell death, chondrocyte dedifferentiation, the nature of the collagenous and proteoglycan networks that constitute the extracellular matrix, the type of biomaterial scaffold employed in repair and the origin of the cells used to repopulate the defect or lesion. This review addresses the principal intrinsic and extrinsic factors that impede integration and describe how manipulation of these factors using a host of strategies can positively influence cartilage integration.
C1 [Khan, I. M.; Gilbert, S. J.; Singhrao, S. K.; Duance, V. C.; Archer, C. W.] Cardiff Univ, Connect Tissue Biol Labs, Sch Biosci, Cardiff CF10 3US, S Glam, Wales.
RP Archer, CW (reprint author), Cardiff Univ, Connect Tissue Biol Labs, Sch Biosci, Museum Ave, Cardiff CF10 3US, S Glam, Wales.
EM archer@cardiff.ac.uk
OI Khan, Ilyas/0000-0002-3886-1987
FU Department for Business Enterprise & Regulatory Reform
FX Funding: Department for Business Enterprise & Regulatory Reform.
CR Allen RG, 1999, J ORTHOPAED RES, V17, P430, DOI 10.1002/jor.1100170320
   AMIEL D, 1985, J BONE JOINT SURG AM, V67A, P911, DOI 10.2106/00004623-198567060-00013
   Archer CW, 2006, J ANAT, V209, P481, DOI 10.1111/j.1469-7580.2006.00624.x
   Balint L, 2005, CLIN ORTHOP RELAT R, P208, DOI 10.1097/01.blo.0000145888.86652.e9
   Barbero A, 2004, OSTEOARTHR CARTILAGE, V12, P476, DOI 10.1016/j.joca.2004.02.010
   Barnes CP, 2007, ADV DRUG DELIVER REV, V59, P1413, DOI 10.1016/j.addr.2007.04.022
   Behrens P, 2006, KNEE, V13, P194, DOI 10.1016/j.knee.2006.02.012
   Bentley G, 2003, J BONE JOINT SURG BR, V85B, P223, DOI 10.1302/0301-620X.85B2.13543
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   Blaney DE, 2005, ARTHRITIS RES THER, V7, pR1338, DOI DOI 10.1186/AR1833
   Blunk T, 2002, TISSUE ENG, V8, P73, DOI 10.1089/107632702753503072
   Bos PK, 2002, ARTHRITIS RHEUM, V46, P976, DOI 10.1002/art.10208
   Bravenboer JV, 2004, ARTHRITIS RES THER, V6, pR469, DOI 10.1186/ar1216
   Caplan AI, 2001, TRENDS MOL MED, V7, P259, DOI 10.1016/S1471-4914(01)02016-0
   COHEN I, 2006, ARCH ORTHOP TRAUMA S, V127, P763
   Cohen Ilan, 2005, Iowa Orthop J, V25, P102
   Coleman S H, 2001, Ortop Traumatol Rehabil, V3, P224
   COOK SD, 2001, CLIN ORTHOP S, V391, pS231
   Costouros JG, 2007, KNEE, V14, P107, DOI 10.1016/j.knee.2006.10.013
   D'Lima DD, 2001, J BONE JOINT SURG AM, V83A, P25, DOI 10.2106/00004623-200100021-00006
   DARABI R, 2008, CELL CYCLE, V7
   Dell'Accio F, 2003, J ORTHOPAED RES, V21, P123, DOI 10.1016/S0736-0266(02)00090-6
   DiMicco MA, 2002, OSTEOARTHR CARTILAGE, V10, P218, DOI 10.1053/joca.2001.0502
   DiMicco MA, 2001, J ORTHOPAED RES, V19, P1105, DOI 10.1016/S0736-0266(01)00037-7
   Dowthwaite GP, 2004, J CELL SCI, V117, P889, DOI 10.1242/jcs.00912
   Dowthwaite GP, 2003, MATRIX BIOL, V22, P311, DOI 10.1016/S0945-053X(03)00037-4
   Emans PJ, 2005, TISSUE ENG, V11, P1789, DOI 10.1089/ten.2005.11.1789
   Englert C, 2005, ARTHRITIS RHEUM-US, V52, P1091, DOI 10.1002/art.20986
   Englert C, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2202
   Englert C, 2006, ARTHRITIS RHEUM, V54, P3890, DOI 10.1002/art.22250
   Frenkel SR, 2004, ANN BIOMED ENG, V32, P26, DOI 10.1023/B:ABME.0000007788.41804.0d
   Garciadiego-Cazares D, 2004, DEVELOPMENT, V131, P4735, DOI 10.1242/dev.01345
   Gebauer D, 2005, ULTRASOUND MED BIOL, V31, P1391, DOI 10.1016/j.ultrasmedbio.2005.06.002
   Geutjes PJ, 2006, ADV EXP MED BIOL, V585, P279
   Giurea A, 2002, J ORTHOPAED RES, V20, P1274, DOI 10.1016/S0736-0266(02)00084-0
   Gobbi A, 2006, AM J SPORT MED, V34, P1763, DOI 10.1177/0363546506288853
   Gooch KJ, 2002, TISSUE ENG, V8, P591, DOI 10.1089/107632702760240517
   GRANDE DA, 1989, J ORTHOP RES, V7, P208, DOI 10.1002/jor.1100070208
   Gratz KR, 2006, J BIOMECH, V39, P138, DOI 10.1016/j.jbiomech.2004.10.016
   Haisch A, 2000, MED BIOL ENG COMPUT, V38, P686, DOI 10.1007/BF02344876
   Hayes AJ, 2001, ANAT EMBRYOL, V203, P469, DOI 10.1007/s004290100178
   Heyde M, 2007, J PHARM PHARMACOL, V59, P329, DOI 10.1211/jpp.59.3.0002
   Hjelle K, 2002, ARTHROSCOPY, V18, P730, DOI 10.1053/jars.2002.32839
   Horas U, 2003, J BONE JOINT SURG AM, V85A, P185, DOI 10.2106/00004623-200302000-00001
   Huntley JS, 2005, J BONE JOINT SURG AM, V87A, P351, DOI 10.2106/JBJS.D.02086
   Hunziker EB, 2007, OSTEOARTHR CARTILAGE, V15, P403, DOI 10.1016/j.joca.2006.09.010
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Hunziker EB, 1998, J BONE JOINT SURG BR, V80B, P144, DOI 10.1302/0301-620X.80B1.7531
   Hunziker EB, 2003, J BONE JOINT SURG AM, V85A, P85, DOI 10.2106/00004623-200300002-00011
   Isogai N, 2006, TISSUE ENG, V12, P691, DOI 10.1089/ten.2006.12.691
   Jackson DW, 2001, J BONE JOINT SURG AM, V83A, P53, DOI 10.2106/00004623-200101000-00008
   Jia Xiao-lin, 2005, Chin J Traumatol, V8, P175
   Johnson TS, 2004, TISSUE ENG, V10, P1308, DOI 10.1089/1076327042500445
   Jurgensen K, 1997, J BONE JOINT SURG AM, V79A, P185, DOI 10.2106/00004623-199702000-00004
   Kafienah W, 2007, ARTHRITIS RHEUM, V56, P177, DOI 10.1002/art.22285
   Kiviranta P, 2008, OSTEOARTHR CARTILAGE, V16, P796, DOI 10.1016/j.joca.2007.10.016
   Kleemann RU, 2005, OSTEOARTHR CARTILAGE, V13, P958, DOI 10.1016/j.joca.2005.06.008
   Knudson W, 2000, ARTHRITIS RHEUM, V43, P1165, DOI 10.1002/1529-0131(200005)43:5<1165::AID-ANR27>3.0.CO;2-H
   Knutsen G, 2004, J BONE JOINT SURG AM, V86A, P455, DOI 10.2106/00004623-200403000-00001
   Kuettner KE, 2005, OSTEOARTHR CARTILAGE, V13, P93, DOI 10.1016/j.joca.2004.11.006
   Kuo CK, 2006, CURR OPIN RHEUMATOL, V18, P64, DOI 10.1097/01.bor.0000198005.88568.df
   Lee D A, 1994, Osteoarthritis Cartilage, V2, P175, DOI 10.1016/S1063-4584(05)80067-6
   Lee D A, 1993, Osteoarthritis Cartilage, V1, P137, DOI 10.1016/S1063-4584(05)80029-9
   Lee MC, 2000, CLIN ORTHOP RELAT R, P286
   Lee SH, 2007, ADV DRUG DELIVER REV, V59, P339, DOI 10.1016/j.addr.2007.03.016
   Liao CJ, 2007, J BIOMED MATER RES A, V81A, P567, DOI 10.1002/jbm.a.31035
   LINSKENS MHK, 1995, NUCLEIC ACIDS RES, V23, P3244, DOI 10.1093/nar/23.16.3244
   Marcacci M, 2005, CLIN ORTHOP RELAT R, P96, DOI 10.1097/01.blo.0000165737.87628.5b
   Martin I, 2007, J BIOMECH, V40, P750, DOI 10.1016/j.jbiomech.2006.03.008
   Martin JA, 2002, BIORHEOLOGY, V39, P145
   Martin JA, 2002, J GERONTOL A-BIOL, V57, pB48, DOI 10.1093/gerona/57.2.B48
   MATSUSUE Y, 1993, ARTHROSCOPY, V9, P318, DOI 10.1016/S0749-8063(05)80428-1
   McGowan KB, 2005, J ORTHOP RES, V23, P594, DOI 10.1016/j.orthres.2004.02.015
   MUIR H, 1995, BIOESSAYS, V17, P1039, DOI 10.1002/bies.950171208
   Munirah S, 2007, J BONE JOINT SURG BR, V89B, P1099, DOI 10.1302/0301-620X.89B8
   Namba RS, 1998, J BONE JOINT SURG AM, V80A, P4, DOI 10.2106/00004623-199801000-00003
   Nixon AJ, 2007, ANN NY ACAD SCI, V1117, P310, DOI 10.1196/annals.1402.065
   Obradovic B, 2001, J ORTHOPAED RES, V19, P1089, DOI 10.1016/S0736-0266(01)00030-4
   ODRISCOLL SW, 1986, CLIN ORTHOP RELAT R, P131
   Parsch D, 2002, ARTHRITIS RHEUM, V46, P2911, DOI 10.1002/art.10626
   Pearce R H, 1991, J Rheumatol Suppl, V27, P42
   Pei M, 2002, BIOCHEM BIOPH RES CO, V294, P149, DOI 10.1016/S0006-291X(02)00439-4
   Peretti GM, 2006, CONNECT TISSUE RES, V47, P190, DOI 10.1080/03008200600809935
   Peretti GM, 1998, J ORTHOPAED RES, V16, P89, DOI 10.1002/jor.1100160115
   Perka C, 2000, CLIN EXP RHEUMATOL, V18, P13
   PETERFY CG, 1994, RADIOLOGY, V191, P413, DOI 10.1148/radiology.191.2.8153315
   Qiu W, 2000, WOUND REPAIR REGEN, V8, P383
   Ravn P, 2004, BONE, V35, P1216, DOI 10.1016/j.bone.2004.07.017
   Redman S N, 2005, Eur Cell Mater, V9, P23
   Redman SN, 2004, OSTEOARTHR CARTILAGE, V12, P106, DOI 10.1016/j.joca.2002.12.001
   Roberts S, 2003, ARTHRITIS RES THER, V5, pR60, DOI 10.1186/ar613
   Russlies M, 2002, ANN ANAT, V184, P317, DOI 10.1016/S0940-9602(02)80045-0
   Schaefer DB, 2004, BIORHEOLOGY, V41, P503
   Schulze-Tanzil G, 2002, CELL TISSUE RES, V308, P371, DOI 10.1007/s00441-002-0562-7
   Schumann D, 2006, BIO-MED MATER ENG, V16, pS37
   SHAPIRO F, 1993, J BONE JOINT SURG AM, V75A, P532, DOI 10.2106/00004623-199304000-00009
   Silverman RP, 2000, PLAST RECONSTR SURG, V105, P1393, DOI 10.1097/00006534-200004040-00019
   Singh NK, 2007, J VET MED A, V54, P210, DOI 10.1111/j.1439-0442.2007.00941.x
   Srbely John Z, 2008, J Can Chiropr Assoc, V52, P30
   Steadman JR, 2001, CLIN ORTHOP RELAT R, pS362, DOI 10.1097/00003086-200110001-00033
   Szeparowicz P, 2006, FOLIA HISTOCHEM CYTO, V44, P201
   Tatebe M, 2005, CYTOTHERAPY, V7, P520, DOI 10.1080/14653240500361350
   Tew S, 2001, CLIN ORTHOP RELAT R, pS142
   Tew SR, 2000, ARTHRITIS RHEUM-US, V43, P215, DOI 10.1002/1529-0131(200001)43:1<215::AID-ANR26>3.0.CO;2-X
   Tognana E, 2005, OSTEOARTHR CARTILAGE, V13, P129, DOI 10.1016/j.joca.2004.10.015
   Tognana E, 2007, CELLS TISSUES ORGANS, V186, P97, DOI 10.1159/000102539
   Trattnig S, 2006, EUR J RADIOL, V57, P9, DOI 10.1016/j.ejrad.2005.08.006
   Trattnig S, 2005, MAGN RESON IMAGING, V23, P779, DOI 10.1016/j.mri.2005.04.010
   Uhl M, 2005, ACTA RADIOL, V46, P875, DOI 10.1080/02841850500335127
   WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579, DOI 10.2106/00004623-199404000-00013
   Walker EA, 2000, J ORTHOPAED RES, V18, P25, DOI 10.1002/jor.1100180105
   Wang DA, 2007, NAT MATER, V6, P385, DOI 10.1038/nmat1890
   Wilke MM, 2007, J ORTHOP RES, V25, P913, DOI 10.1002/jor.20382
   Yan H, 2007, ARTHROSCOPY, V23, P178, DOI 10.1016/j.arthro.2006.09.005
   ZARNETT R, 1987, CLIN ORTHOP RELAT R, P267
   Zhang ZJ, 2005, J ORTHOP RES, V23, P433, DOI 10.1016/j.orthres.2004.08.028
   ZWILLING E, 1968, DEV BIOL, V2, pS184
NR 117
TC 99
Z9 107
U1 1
U2 22
PU SWISS SOC BIOMATERIALS, AO RESEARCH INST
PI DAVOS
PA BIO-PERFORMANCE MATERIALS & DEVICES, AO RESEARCH INST, CLAVADELERSTRASSE
   8, DAVOS, CH 7270, SWITZERLAND
SN 1473-2262
J9 EUR CELLS MATER
JI Eur. Cells Mater.
PD JUL-DEC
PY 2008
VL 16
BP 26
EP 39
DI 10.22203/eCM.v016a04
PG 14
WC Cell & Tissue Engineering; Engineering, Biomedical; Materials Science,
   Biomaterials; Orthopedics
SC Cell Biology; Engineering; Materials Science; Orthopedics
GA 442UX
UT WOS:000265867200006
PM 18770504
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Saxena, AK
   Willital, GH
AF Saxena, Amulya K.
   Willital, Guenter H.
TI Infrared thermography: Experience from a decade of pediatric imaging
SO EUROPEAN JOURNAL OF PEDIATRICS
LA English
DT Article
DE thermography; children; infrared; newborns; surgery
ID PULSED DYE-LASER; PORT-WINE STAINS; DIGITAL REPLANTATION; HEMANGIOMAS;
   CHILDHOOD; ARGON
AB The aim of this study was to evaluate the feasibility of clinical application of infrared thermography (IRT) in the pediatric population and to identify pathological states that can be diagnosed as well as followed up using this non-invasive technique. In real time computer-assisted IRT, 483 examinations were performed over a period of 10 years from 1990-2000 on 285 patients in the pediatric age group (range 1 week-16 years) presenting with a wide range of pathologies. The temperature was measured in centigrade (degrees C), and color images obtained were computer analyzed and stored on floppy discs. IRT was found to be an excellent noninvasive tool in the follow-up of hemangiomas, vascular malformations and digit amputations related to reimplantation, burns as well as skin and vascular growth after biomaterial implants in newborns with gastroschisis and giant omphaloceles. In the emergency room, it was a valuable tool for rapid diagnosis of extremity thrombosis, varicoceles, inflammation, abscesses, gangrene and wound infections. In conclusion, IRT can be performed in the pediatric age group, is non-invasive, without any biological side effects, requires no sedation or anesthesia and can be repeated as desired for follow-ups, with objective results that can demonstrated as colored images. Periodic thermographic studies to follow progression of lesions seem to be a useful and reproducible method for repeated and long-term examination.
C1 [Saxena, Amulya K.] Med Univ Graz, Dept Pediat Surg, A-8036 Graz, Austria.
   [Willital, Guenter H.] Univ Munster, Dept Pediat Surg, Munster, Germany.
RP Saxena, AK (reprint author), Med Univ Graz, Dept Pediat Surg, Auenbruggerpl 34, A-8036 Graz, Austria.
EM amulya.saxena@meduni-graz.at
CR ASHINOFF R, 1991, J AM ACAD DERMATOL, V24, P467, DOI 10.1016/0190-9622(91)70075-D
   ASHINOFF R, 1993, PEDIATR DERMATOL, V10, P77, DOI 10.1111/j.1525-1470.1993.tb00021.x
   Astner Susanne, 2005, Dermatol Ther, V18, P267, DOI 10.1111/j.1529-8019.2005.05025.x
   Batta K, 2002, LANCET, V360, P521, DOI 10.1016/S0140-6736(02)09741-6
   Chang CJ, 2001, ANN PLAS SURG, V46, P577, DOI 10.1097/00000637-200106000-00001
   COOKE E D, 1982, British Journal of Sexual Medicine, V9, P16
   ENGELS JM, 1985, APPL THERMOLOGY, P269
   GERSHONCOHEN J, 1964, ANN NY ACAD SCI, V121, P4, DOI 10.1111/j.1749-6632.1964.tb13679.x
   HACKETT MEJ, 1974, BRIT J PLAST SURG, V27, P311, DOI 10.1016/0007-1226(74)90028-9
   IKEDA K, 1990, MICROSURG, V11, P261, DOI 10.1002/micr.1920110402
   ISOGAI N, 1995, MICROSURG, V16, P556, DOI 10.1002/micr.1920160810
   IWATA G, 1992, EUR J PEDIATR SURG, V2, P308, DOI 10.1055/s-2008-1063468
   JIMENEZM.M, 1970, SURGERY, V67, P929
   Liddington MI, 1996, BURNS, V22, P26, DOI 10.1016/0305-4179(95)00076-3
   MORDON S, 1993, LASER SURG MED, V13, P124, DOI 10.1002/lsm.1900130119
   ROBICSEK F, 1984, THORAC CARDIOV SURG, V32, P260, DOI 10.1055/s-2007-1023400
   Samaras C A, 1983, Contemp Surg, V22, P31
   Saxena A, 2002, Hernia, V6, P73
   Saxena AK, 1999, PEDIATR SURG INT, V15, P75, DOI 10.1007/s003830050519
   Saxena AK, 2002, PEDIATR SURG INT, V18, P420, DOI 10.1007/s00383-002-0799-y
   Saxena AK, 1999, LANGENBECK ARCH SURG, V384, P187, DOI 10.1007/s004230050190
   Saxena AK, 1999, INT SURG, V84, P326
   SAXENA AK, 2001, ACTA CHIR AUSTRIACA, V33, P16
   SAXENA AK, 1995, 3 INT C NEW TECHN AD
   SAXENA AK, 1999, INT J SURG SCI, V6, P156
   SCHAARSCHMIDT K, 1995, LANGENBECKS ARCH CHI, P138
   STUTTGEN G, 1985, APPL THERMOLOGY, P13
   TROILIUS A, 1992, ACTA DERM-VENEREOL, V72, P6
   Tucker AT, 2000, FERTIL STERIL, V74, P802, DOI 10.1016/S0015-0282(00)01532-6
   Watanabe Yuji, 2002, Curr Opin Urol, V12, P149, DOI 10.1097/00042307-200203000-00012
   YANG W-J, 1992, Bio-Medical Materials and Engineering, V2, P7
NR 31
TC 47
Z9 48
U1 1
U2 21
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0340-6199
J9 EUR J PEDIATR
JI Eur. J. Pediatr.
PD JUL
PY 2008
VL 167
IS 7
BP 757
EP 764
DI 10.1007/s00431-007-0583-z
PG 8
WC Pediatrics
SC Pediatrics
GA 304BL
UT WOS:000256084900008
PM 17762940
DA 2018-10-19
ER

PT J
AU Marchiori-Silva, V
   Han, SW
   Novikoff, S
   Semedo, P
   Reis, RL
   Correlo, V
   Lisboa, BCG
   Camara, NOS
AF Marchiori-Silva, V.
   Han, S. W.
   Novikoff, S.
   Semedo, P.
   Reis, R. L.
   Correlo, V.
   Lisboa, B. C. G.
   Camara, N. O. S.
TI POLYHYDROXYBUTYRATE (PHB) FROM SUGAR CANE AS BIOMATERIAL FOR BONE TISSUE
   ENGINEERING USING MESENCHYMAL STEM CELLS DERIVED FROM HUMAN DENTAL PULP
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Meeting Abstract
C1 [Marchiori-Silva, V.; Han, S. W.; Novikoff, S.; Lisboa, B. C. G.] Univ Fed Sao Paulo, Ctr Interdisciplinar Terapia Gen, CINTERGEN, Sao Paulo, Brazil.
   [Reis, R. L.; Correlo, V.] 3Bs UMINHO, Braga, Portugal.
RI Reis, Rui L./A-8938-2008; Group, 3Bs/E-4374-2012; Camara,
   Niels/G-8336-2011; Correlo, Vitor/O-4227-2015; Lisboa,
   Bianca/N-6649-2013
OI Reis, Rui L./0000-0002-4295-6129; Group, 3Bs/0000-0002-5195-3456;
   Camara, Niels/0000-0001-5436-1248; Correlo, Vitor/0000-0002-5516-7583;
   Lisboa, Bianca/0000-0002-2687-5011
NR 0
TC 0
Z9 0
U1 0
U2 5
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD JUL
PY 2008
VL 31
IS 7
BP 600
EP 601
PG 2
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 351TV
UT WOS:000259449700073
DA 2018-10-19
ER

PT J
AU Nakayama, Y
   Takamizawa, K
   Ishibashi-Ueda, H
   Kanda, K
AF Nakayama, Y.
   Takamizawa, K.
   Ishibashi-Ueda, H.
   Kanda, K.
TI BIOMATERIAL SURFACE CHEMISTRY CONTROL OF FABRICATION OF BIOTUBE VASCULAR
   GRAFTS IN VIVO
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Meeting Abstract
C1 [Ishibashi-Ueda, H.] Natl Cardiovasc Ctr Hosp & Res Inst, Osaka, Japan.
   [Kanda, K.] Kyoto Prefectural Univ Med, Kyoto, Japan.
NR 0
TC 1
Z9 1
U1 0
U2 0
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD JUL
PY 2008
VL 31
IS 7
BP 631
EP 631
PG 1
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 351TV
UT WOS:000259449700192
DA 2018-10-19
ER

PT J
AU Martuscelli, R
   Maltarello, MC
   Maraldi, NM
   Sbordone, C
   Sbordone, L
AF Martuscelli, R.
   Maltarello, M. C.
   Maraldi, N. M.
   Sbordone, C.
   Sbordone, L.
TI HISTOLOGICAL AND CLINICAL SURVEY OF POLYLACTIC-POLYGLYCOLIC ACID AND
   DEXTRANE COPOLYMER IN MAXILLARY SINUS LIFT: A PILOT IN VIVO STUDY
SO INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
LA English
DT Article
DE sinus lift; PLA-GLA-dextrane copolymer; histomorphometric analysis;
   microhardness; X-ray microanalysis
ID BONE; AUGMENTATION; IMPLANTS; FLOOR
AB Of various proposed alternatives to autogenous bone, a synthetic, degradable copolymer of PLA-GLA and dextrane seems to be a promising biomaterial for maxillary sinus lift. Consecutive partially edentulous patients showing severe monolateral posterior maxillary atrophy were treated via sinus lift using PLA-GLA-dextrane copolymer as the sole filler. Delayed implant positioning was performed and cores of regenerated tissues and native bone controls were retrieved and evaluated by light and electron microscopy, histomorphometry, microhardness and qualitative X-ray analysis. Seven sinuses in 7 patients were augmented with PLA-GLA-dextrane copolymer. Six to nine months after the copolymer 'graft', 47 bone cores were retrieved: all histological sections contained newly synthesized, mineralized material and new bone in various stages of development. Histomorphometry revealed average Trabecular Bone Volume (TBV) values ranging from 51% (6 months) to 77% (9 months). Backscattered scanning electron microscopy (BSE) in experimental and control samples confirmed histology findings. Microhardness values suggested newly formed bone at nine months was not as hard as native bone. Ca and P content was similar in 9-month regenerated and native bone. Seventeen implants were inserted in the second stage of surgery: resulting Implant Success (SR) and Cumulative Success (CSR) up to 3 years were 100% following Albrektsson's criteria. Sinus lift augmentation using PLA-GLA-dextrane copolymer as the sole filler resulted in uneventful surgeries. New bone formation was evident histologically and its maturation was still in progress after 9 months. Successful, staged implant positioning was achieved in regenerated tissue.
C1 [Sbordone, L.] Univ Pisa, Dept Surg, I-56100 Pisa, Italy.
   [Martuscelli, R.] Univ Naples Federico 2, Dept Oral Sci & Maxillofacial Surg, Naples, Italy.
   [Maltarello, M. C.; Maraldi, N. M.] IOR, Lab Cell Biol & Electron Microscopy, Bologna, Italy.
   [Maraldi, N. M.] Univ Bologna, Dept Anat Sci, Bologna, Italy.
   [Sbordone, C.] Univ Naples Federico 2, Dept Maxillofacial Surg, Naples, Italy.
RP Sbordone, L (reprint author), Univ Pisa, Dept Surg, Via Roma 67, I-56100 Pisa, Italy.
EM lsbordon@med.unipi.it
CR Aghaloo TL, 2007, INT J ORAL MAX IMPL, V22, P49
   Albrektsson T, 1986, Int J Oral Maxillofac Implants, V1, P11
   Banse X, 2005, MICRON, V36, P710, DOI 10.1016/j.micron.2005.07.012
   BOYNE PJ, 1980, J ORAL SURG, V38, P613
   CHANAVAZ M, 1990, Journal of Oral Implantology, V16, P199
   Chiapasco M, 2006, CLIN ORAL IMPLAN RES, V17, P136, DOI 10.1111/j.1600-0501.2006.01357.x
   Dickson GR, 1984, METHODS CALCIFIED TI, P79
   Fini M, 2003, BIOMATERIALS, V24, P4929, DOI 10.1016/S0142-9612(03)00416-2
   Giavaresi G, 2004, BIOMATERIALS, V25, P5583, DOI 10.1016/j.biomaterials.2004.01.017
   GROWER MF, 1989, BIOMATER ARTIF CELL, V17, P291, DOI 10.3109/10731198909118286
   Huja SS, 2000, MECH TESTING BONE BO, P247
   Johansson B, 1999, INT J ORAL MAX IMPL, V14, P811
   Mangano C, 2003, INT J ORAL MAX IMPL, V18, P23
   NAKAMURA T, 1989, J BIOMED MATER RES, V23, P1115, DOI 10.1002/jbm.820231003
   PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617
   Raghoebar GM, 2001, CLIN ORAL IMPLAN RES, V12, P503, DOI 10.1034/j.1600-0501.2001.120511.x
   ROOMANS GM, 1988, J ELECTRON MICR TECH, V9, P19, DOI 10.1002/jemt.1060090104
   Tadjoedin ES, 2002, CLIN ORAL IMPLAN RES, V13, P428, DOI 10.1034/j.1600-0501.2002.130412.x
   TATUM H, 1986, DENT CLIN N AM, V30, P207
   THEUNS HM, 1993, BONE, V14, P545, DOI 10.1016/8756-3282(93)90193-E
   Tong DC, 1998, INT J ORAL MAX IMPL, V13, P175
   VISSCHER GE, 1985, J BIOMED MATER RES, V19, P349, DOI 10.1002/jbm.820190315
   von Arx T, 2005, CLIN ORAL IMPLAN RES, V16, P432, DOI 10.1111/j.1600-0501.2005.01138.x
   Wallace Stephen S, 2003, Ann Periodontol, V8, P328, DOI 10.1902/annals.2003.8.1.328
   WIPPOLD FJ, 1995, ALLERGY PROC, V16, P165, DOI 10.2500/108854195778666801
   Zaffe D, 2005, J MATER SCI-MATER M, V16, P789, DOI 10.1007/s10856-005-3574-5
NR 26
TC 3
Z9 3
U1 0
U2 3
PU BIOLIFE SAS
PI SILVA MARINA (TE)
PA VIA S STEFANO 39 BIS, 64029 SILVA MARINA (TE), ITALY
SN 0394-6320
J9 INT J IMMUNOPATH PH
JI Int. J. Immunopathol. Pharmacol.
PD JUL-SEP
PY 2008
VL 21
IS 3
BP 687
EP 695
DI 10.1177/039463200802100323
PG 9
WC Immunology; Pathology; Pharmacology & Pharmacy
SC Immunology; Pathology; Pharmacology & Pharmacy
GA 359KR
UT WOS:000259986100023
PM 18831937
OA Bronze
DA 2018-10-19
ER

PT J
AU Spear, RL
   Cameron, RE
AF Spear, Rose L.
   Cameron, Ruth E.
TI Carbon nanotubes for orthopaedic implants
SO INTERNATIONAL JOURNAL OF MATERIAL FORMING
LA English
DT Review
DE Nanotechnology; Carbon nanotubes; Bioengineering; Biomaterial;
   Nanocomposite
AB The physical and biological limitations of current orthopaedic implant materials are a major challenge for bone tissue engineering. Nanotechnology has introduced new materials and methods for meeting this challenge. The application of nanotechnology to engineering new bone substitutes finds a model in the nanoscale components of natural bone tissue. Carbon nanotubes are a macromolecular form of carbon with exceptional properties and similar morphology and dimensions to the nanoscale collagen fibers of natural bone tissue. Carbon nanotubes have been used in two main areas of bone tissue engineering: for structural and electrical enhancement of polymer and ceramic composites and for nanostructured coatings to improve the bioactivity of implant surfaces. By incorporating carbon nanotubes into the design and engineering of bone tissue substitutes, researchers have attempted to overcome limitations in the structural and biological compatibility of traditional orthopaedic implant materials.
C1 [Spear, Rose L.; Cameron, Ruth E.] Univ Cambridge, Dept Mat Sci & Met, Cambridge CB2 3QZ, England.
RP Spear, RL (reprint author), Univ Cambridge, Dept Mat Sci & Met, Pembroke St, Cambridge CB2 3QZ, England.
EM rs489@cam.ac.uk
RI Spear, Rose/H-1921-2011
OI Cameron, Ruth/0000-0003-1573-4923; Wedgbury, Rose/0000-0002-7192-5401
FU Gates Trust
FX Rose L. Spear is grateful to the Gates Trust for financial support for a
   PhD studentship.
CR Akasaka T, 2006, MAT SCI ENG C-BIO S, V26, P675, DOI 10.1016/j.msec.2005.03.009
   An JW, 2003, WEAR, V255, P677, DOI 10.1016/S0043-1648(03)00216-3
   Ayutsede J, 2006, BIOMACROMOLECULES, V7, P208, DOI 10.1021/bm0505888
   Bacakova L, 2007, DIAM RELAT MATER, V16, P2133, DOI 10.1016/j.diamond.2007.07.015
   Balani K, 2007, BIOMATERIALS, V28, P618, DOI 10.1016/j.biomaterials.2006.09.013
   Boccaccini AR, 2007, ADV FUNCT MATER, V17, P2815, DOI 10.1002/adfm.200600887
   Bottini M, 2006, TOXICOL LETT, V160, P121, DOI 10.1016/j.toxlet.2005.06.020
   Chen RJ, 2003, P NATL ACAD SCI USA, V100, P4984, DOI 10.1073/pnas.0837064100
   Chen Y, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1951054
   Chen Y, 2006, CARBON, V44, P37, DOI 10.1016/j.carbon.2005.07.011
   Daniel S, 2007, SENSOR ACTUAT B-CHEM, V122, P672, DOI 10.1016/j.snb.2006.06.014
   Davis JJ, 1998, INORG CHIM ACTA, V272, P261, DOI 10.1016/S0020-1693(97)05926-4
   De Nicola M, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/39/395013
   Dumortier H, 2006, NANO LETT, V6, P1522, DOI 10.1021/nl061160x
   Falvo MR, 1997, NATURE, V389, P582
   Gabay T, 2005, PHYSICA A, V350, P611, DOI 10.1016/j.physa.2004.11.007
   Gilmore KJ, 2007, CARBON, V45, P402, DOI 10.1016/j.carbon.2006.09.015
   Gutwein LG, 2004, 26 ANN AM CER SOC M
   Harrison BS, 2007, BIOMATERIALS, V28, P344, DOI 10.1016/j.biomaterials.2006.07.044
   Hirsch A, 2002, ANGEW CHEM INT EDIT, V41, P1853, DOI 10.1002/1521-3773(20020603)41:11<1853::AID-ANIE1853>3.0.CO;2-N
   Hirsch A, 2006, PHYS STATUS SOLIDI B, V243, P3209, DOI 10.1002/pssb.200669191
   Hutchison JL, 2001, CARBON, V39, P761, DOI 10.1016/S0008-6223(00)00187-1
   Jia G, 2005, ENVIRON SCI TECHNOL, V39, P1378, DOI 10.1021/es048729l
   Kealley C, 2006, PHYSICA B, V385, P496, DOI 10.1016/j.physb.2006.05.254
   Klumpp C, 2006, BBA-BIOMEMBRANES, V1758, P404, DOI 10.1016/j.bbamem.2005.10.008
   Li GY, 2005, CARBON, V43, P1239, DOI 10.1016/j.carbon.2004.12.017
   Liu Y, 2007, CHEM MATER, V19, P2721, DOI 10.1021/cm070002j
   Ma RZ, 1998, J MATER SCI, V33, P5243, DOI 10.1023/A:1004492106337
   MacDonald RA, 2005, J BIOMED MATER RES A, V74A, P489, DOI 10.1002/jbm.a.30386
   Pantarotto D, 2004, ANGEW CHEM INT EDIT, V43, P5242, DOI 10.1002/anie.200460437
   Peigney A, 2000, CERAM INT, V26, P677, DOI 10.1016/S0272-8842(00)00004-3
   Polizu S, 2006, J NANOSCI NANOTECHNO, V6, P1883, DOI 10.1166/jnn.2006.197
   Prato M, 2008, ACCOUNTS CHEM RES, V41, P60, DOI 10.1021/ar700089b
   RUOFF RS, 1995, CARBON, V33, P925, DOI 10.1016/0008-6223(95)00021-5
   Salvetat JP, 1999, ADV MATER, V11, P161, DOI 10.1002/(SICI)1521-4095(199902)11:2<161::AID-ADMA161>3.0.CO;2-J
   Shi XF, 2007, BIOMATERIALS, V28, P4078, DOI 10.1016/j.biomaterials.2007.05.033
   Singh R, 2006, P NATL ACAD SCI USA, V103, P3357, DOI 10.1073/pnas.0509009103
   Smart SK, 2006, CARBON, V44, P1034, DOI 10.1016/j.carbon.2005.10.011
   Spear RL, 2008, WORLD BIOMATERIAL C
   Supronowicz PR, 2002, J BIOMED MATER RES, V59, P499, DOI 10.1002/jbm.10015
   Tencer AF, 1994, BIOMECHANICS ORTHOPE, P18
   Treacy MMJ, 1996, NATURE, V381, P678, DOI 10.1038/381678a0
   Vance RJ, 2004, BIOMATERIALS, V25, P2095, DOI 10.1016/j.biomaterials.2003.08.064
   Wang SF, 2005, BIOMACROMOLECULES, V6, P3067, DOI 10.1021/bm050378v
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Webster TJ, 2004, BIOMATERIALS, V25, P4731, DOI 10.1016/j.biomaterials.2003.12.002
   Webster TJ, 2001, BIOMATERIALS, V22, P1327, DOI 10.1016/S0142-9612(00)00285-4
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Wenrong Y, 2007, NANOTECHNOL IN PRESS
   White AA, 2007, INT J APPL CERAM TEC, V4, P1, DOI 10.1111/j.1744-7402.2007.02113.x
   Wong EW, 1997, SCIENCE, V277, P1971, DOI 10.1126/science.277.5334.1971
   Yu MF, 2000, SCIENCE, V287, P637, DOI 10.1126/science.287.5453.637
   Zanello LP, 2006, NANO LETT, V6, P562, DOI 10.1021/nl051861e
   Zhao B, 2005, CHEM MATER, V17, P3235, DOI 10.1021/cm0500399
NR 54
TC 15
Z9 15
U1 0
U2 11
PU SPRINGER FRANCE
PI PARIS
PA 22 RUE DE PALESTRO, PARIS, 75002, FRANCE
SN 1960-6206
EI 1960-6214
J9 INT J MATER FORM
JI Int. J. Mater. Form.
PD JUL
PY 2008
VL 1
IS 2
BP 127
EP 133
DI 10.1007/s12289-008-0374-8
PG 7
WC Engineering, Manufacturing; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Engineering; Materials Science; Metallurgy & Metallurgical Engineering
GA V27IZ
UT WOS:000208608200011
DA 2018-10-19
ER

PT J
AU Kokubo, S
   Nozaki, K
   Fukushima, S
   Takahashi, K
   Miyata, K
   Fujimoto, R
   Yokota, S
AF Kokubo, Satoshi
   Nozaki, Kazutoshi
   Fukushima, Shinji
   Takahashi, Koichiro
   Miyata, Keiji
   Fujimoto, Ryuhei
   Yokota, Shoji
TI Recombinant human bone morphogenetic protein-2 as an osteoinductive
   biomaterial and a biodegradable carrier in a rabbit ulnar defect model
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
DE rhBMP-2; PLGA; gelatin sponge; rabbit; segmental bone defect;
   biodegradable carrier; recombinant human bone; morphogenetic protein-2;
   osteoinductive biomaterial; rabbit ulnar; defect model
ID ENDOTHELIAL GROWTH-FACTOR; STIMULATES CHEMOTACTIC MIGRATION;
   OSTEOBLASTIC DIFFERENTIATION; FRACTURE REPAIR; SKELETAL-MUSCLE;
   ANGIOGENESIS; CELLS; REGENERATION; PATHWAY; MACROPHAGES
AB We investigated early local changes induced by recombinant human bone morphogenetic protein (rhBMP)-2 and a novel carrier, poly[L-lactide-co-glycolide] copolymer-coated gelatin sponge (PGS). A 1.5 cm segmental bone defect was created in the diaphysis of the right ulna of male Japanese white rabbit. Defects received PGS with or without rhBMP-2 (0, 0.4, or 1 mg/cm(3)) and were harvested at 3, 7, 14, 21, or 28 days post implantation for histological examination. Immuno-staining for vascular endothelial growth factor (VEGF) was also performed. Spindle-shaped cells were observed in the rhBMP-2-treated groups 3 and 7 days after implantation. Bone regeneration was detected after 14 days in the rhBMP-2-treated groups and the bone area increased with time and dose. Expression of VEGF was observed in all groups at 3 days and was maintained by 14 days only in the defects treated with rhBMP-2 at a dose of 1 mg. These results indicate that rhBMP-2 exert its osteo-inductive activities via the promotion of osteogenic cell mobilization, and possibly via angiogenesis based on VEGF induction. Foreign-body reactions to the implanted PGS were similar to those observed when either poly[L-lactide-co-glycolide] copolymer or gelatin was individually implanted. These results indicate that the PGS is a useful and safe carrier for rhBMP-2.
C1 [Kokubo, Satoshi; Nozaki, Kazutoshi; Fukushima, Shinji; Takahashi, Koichiro; Miyata, Keiji] Yamanouchi Pharmaceut Co Ltd, Inst Drug Discovery Res, Tsukuba, Ibaraki 3058585, Japan.
   [Fujimoto, Ryuhei] Yamanouchi Pharmaceut Co Ltd, Inst Drug Dev Res, Itabashi Ku, Tokyo 1748511, Japan.
   [Yokota, Shoji] Yamanouchi Pharmaceut Co Ltd, Inst Drug Dev Res, Shizuoka 4250072, Japan.
RP Kokubo, S (reprint author), Yamanouchi Pharmaceut Co Ltd, Inst Drug Discovery Res, 21 Miyukigaoka, Tsukuba, Ibaraki 3058585, Japan.
EM satoshi.kokubo@jp.astellas.com
CR Bax BE, 1999, CALCIFIED TISSUE INT, V65, P83, DOI 10.1007/s002239900662
   Bosch P, 2000, J ORTHOP RES, V18, P933, DOI 10.1002/jor.1100180613
   Bostrom M, 1996, CLIN ORTHOP RELAT R, P272
   Bouxsein ML, 2001, J BONE JOINT SURG AM, V83A, P1219, DOI 10.2106/00004623-200108000-00012
   COOK SD, 1994, J BONE JOINT SURG AM, V76A, P827, DOI 10.2106/00004623-199406000-00006
   CUNNINGHAM NS, 1992, P NATL ACAD SCI USA, V89, P11740, DOI 10.1073/pnas.89.24.11740
   Deckers MML, 2002, ENDOCRINOLOGY, V143, P1545, DOI 10.1210/en.143.4.1545
   ERLEBACHER A, 1995, CELL, V80, P371, DOI 10.1016/0092-8674(95)90487-5
   Fujii T, 2006, ARTERIOSCL THROM VAS, V26, P2483, DOI 10.1161/01.ATV.0000244684.23499.bf
   Gerber HP, 1999, NAT MED, V5, P623
   Gerber HP, 2000, TRENDS CARDIOVAS MED, V10, P223, DOI 10.1016/S1050-1738(00)00074-8
   Glowacki J, 1998, CLIN ORTHOP RELAT R, pS82, DOI 10.1097/00003086-199810001-00010
   GOSPODAROWICZ D, 1989, P NATL ACAD SCI USA, V86, P7311, DOI 10.1073/pnas.86.19.7311
   Hausman MR, 2001, BONE, V29, P560, DOI 10.1016/S8756-3282(01)00608-1
   Hay E, 1999, J CELL BIOCHEM, V72, P81, DOI 10.1002/(SICI)1097-4644(19990101)72:1<81::AID-JCB9>3.0.CO;2-N
   Itoh T, 1998, J VET MED SCI, V60, P451, DOI 10.1292/jvms.60.451
   Iwaki A, 1997, J BONE MINER RES, V12, P96, DOI 10.1359/jbmr.1997.12.1.96
   Kakudo N, 2006, LIFE SCI, V79, P1847, DOI 10.1016/j.lfs.2006.06.033
   KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755
   KECK PJ, 1989, SCIENCE, V246, P1309, DOI 10.1126/science.2479987
   Kokubo S, 2003, BIOMATERIALS, V24, P1643, DOI 10.1016/S0142-9612(02)00551-3
   Lind M, 1996, BONE, V18, P53, DOI 10.1016/8756-3282(95)00423-8
   Luppen CA, 2002, J BONE MINER RES, V17, P301, DOI 10.1359/jbmr.2002.17.2.301
   Mayr-Wohlfart U, 2002, BONE, V30, P472, DOI 10.1016/S8756-3282(01)00690-1
   MEIKLE MC, 1994, BIOMATERIALS, V15, P513, DOI 10.1016/0142-9612(94)90017-5
   MIYAMOTO S, 1993, CLIN ORTHOP RELAT R, P333
   MIYAMOTO S, 1992, CLIN ORTHOP RELAT R, P274
   Nagao H, 2002, INT J ORAL MAX SURG, V31, P66, DOI 10.1054/ijom.2001.0133
   Peng HR, 2005, J BONE MINER RES, V20, P2017, DOI 10.1359/JBMR.050708
   Ranne T, 2007, J BIOACT COMPAT POL, V22, P249, DOI 10.1177/0883911507078270
   Rissanen TT, 2002, AM J PATHOL, V160, P1393, DOI 10.1016/S0002-9440(10)62566-7
   Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099
   TAKUWA Y, 1991, BIOCHEM BIOPH RES CO, V174, P96, DOI 10.1016/0006-291X(91)90490-X
   THIES RS, 1992, ENDOCRINOLOGY, V130, P1318, DOI 10.1210/en.130.3.1318
   Verhoeckx KCM, 2006, INT IMMUNOPHARMACOL, V6, P1, DOI 10.1016/j.intimp.2005.05.013
   Welch RD, 1998, J BONE MINER RES, V13, P1483, DOI 10.1359/jbmr.1998.13.9.1483
   Wozney JM, 1998, CLIN ORTHOP RELAT R, P26
   Xiong M, 1998, AM J PATHOL, V153, P587, DOI 10.1016/S0002-9440(10)65601-5
   YAMAGUCHI A, 1991, J CELL BIOL, V113, P681, DOI 10.1083/jcb.113.3.681
   Yamaguchi A, 1996, BIOCHEM BIOPH RES CO, V220, P366, DOI 10.1006/bbrc.1996.0411
   Yokota S, 2001, INT J PHARMACEUT, V223, P69, DOI 10.1016/S0378-5173(01)00728-1
   Zegzula HD, 1997, J BONE JOINT SURG AM, V79A, P1778, DOI 10.2106/00004623-199712000-00003
   Zhou DS, 2006, J BIOACT COMPAT POL, V21, P373, DOI 10.1177/0883911506068554
NR 43
TC 13
Z9 13
U1 1
U2 5
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0883-9115
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD JUL
PY 2008
VL 23
IS 4
BP 348
EP 366
DI 10.1177/0883911508092791
PG 19
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA 318BA
UT WOS:000257064500004
DA 2018-10-19
ER

PT J
AU Pappalardo, S
   Mastrangelo, F
   Marroccia, DR
   Cappello, V
   Ciampoli, C
   Carlino, V
   Tanteri, L
   Costanzo, M
   Sinatra, F
   Tete, S
AF Pappalardo, S.
   Mastrangelo, F.
   Marroccia, D. Reale
   Cappello, V.
   Ciampoli, C.
   Carlino, V.
   Tanteri, L.
   Costanzo, M.
   Sinatra, F.
   Tete, S.
TI BONE REGENERATION: IN VITRO EVALUATION OF THE BEHAVIOUR OF
   OSTEOBLAST-LIKE MG63 CELLS PLACED IN CONTACT WITH POLYLACTIC-CO-GLYCOLIC
   ACID, DEPROTEINIZED BOVINE BONE AND DEMINERALIZED FREEZE-DRIED BONE
   ALLOGRAFT
SO JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS
LA English
DT Article
DE bone; osteoblast-like cells; mg63 cells; polylactic-co-glycolic acid;
   deproteinized bovine bone; demineralized freeze-dried bone; allograft
ID AUTOGENOUS BONE; OXIDATIVE STRESS; STEM-CELLS; MATRIX; HYDROXYAPATITE;
   GRAFTS; DIFFERENTIATION; INFLAMMATION; AUGMENTATION; SUBSTITUTES
AB Insufficient bone density of the alveolar crests, caused by loss of the dental elements, sometimes impedes the primary stability of an integrated bone implant. The techniques of bone regeneration allow to obtain a sufficient quantity of alveolar bone to permit the implant rehabilitation of the edentulous crests. Today several grafting materials are available and they have different characteristics, according to their structure, which influence the different behaviour of the grafting materials to the bone and the implant surface. The aim of this study is to evaluate the interaction between a human osteosarcoma MG63 cell line and three different biomaterials: polylactic-co-glycolic acid (PLAGA), deproteinized bovine bone and demineralised freeze-dried bone allograft (DFDBA). From this study a different behaviour emerges of the osteoblast-like MG63 cells in relation to the sublayer on which these cells were placed in culture. The results of the study, in fact, demonstrate that the most osteoconductive material of the three analysed is the DFDBA, followed by DPBB. On the contrary, the PLGA, because of its roughness, does not seem to represent a valid support for cell growth, and does not encourage any morphologic modification in tumoral cells. Furthermore, deproteinized bovine bone shows a differentiating effect which could lead to hypothesise an osteoconductive capacity of this biomaterial. Further studies should be carried out with the aim of explaining the results obtained.
C1 [Mastrangelo, F.; Ciampoli, C.; Tanteri, L.; Tete, S.] Univ G dAnnunzio, Dept Oral Sci, I-66100 Chieti, Italy.
   Catania Univ, Oral Sci Sect 2, Dept Specialised Med Surg, Catania, Italy.
   [Costanzo, M.] Catania Univ, Dept Microbiol Sci & Gynaecol Sci, Catania, Italy.
   [Sinatra, F.] Catania Univ, Dept Biomed Sci, Gen Cellular & Genet Mol Biol Sect, Catania, Italy.
RP Tete, S (reprint author), Univ G dAnnunzio, Dept Oral Sci, Via Vestini 31, I-66100 Chieti, Italy.
EM tete@unich.it
OI MASTRANGELO, Filiberto/0000-0002-3746-5675
CR Acil Y, 2000, J BIOMED MATER RES, V51, P703, DOI 10.1002/1097-4636(20000915)51:4<703::AID-JBM19>3.0.CO;2-A
   Banche G, 2007, INT J IMMUNOPATH PH, V20, P129, DOI 10.1177/039463200702000115
   Barbaro MPF, 2007, INT J IMMUNOPATH PH, V20, P753, DOI 10.1177/039463200702000411
   Boyan Barbara D, 2006, Dent Clin North Am, V50, P217, DOI 10.1016/j.cden.2005.11.007
   Boyan BD, 2006, J PERIODONTOL, V77, P1555, DOI 10.1902/jop.2006.060019
   Bruzzese V, 2008, EUR J INFLAMM, V6, P93, DOI 10.1177/1721727X0800600207
   Capodiferro S, 2007, EUR J INFLAMM, V5, P51, DOI 10.1177/1721727X0700500109
   Carinci F, 2006, ARCH ORAL BIOL, V51, P154, DOI 10.1016/j.archoralbio.2005.06.006
   Chen TM, 2002, ANN PLAS SURG, V49, P272, DOI 10.1097/01.SAP.0000015488.91165.B8
   Constantino PD, 1994, OTOLARYNGOL CLIN N A, V27, P1037
   Cypher T J, 1996, J Foot Ankle Surg, V35, P413
   Eppley BL, 2005, J CRANIOFAC SURG, V16, P981, DOI 10.1097/01.scs.0000179662.38172.dd
   *EUR AG EV MED PRO, 2002, DIB ALF SCI DISC EUR
   EWERS R, 2004, CLIN ORAL IMPLAN RES, V96, P100
   Ferdinande L, 2008, INT J IMMUNOPATH PH, V21, P289, DOI 10.1177/039463200802100205
   GAMRADT SC, 2003, CLIN ORTHOP RELAT R, V183, P94
   GAO Y, 2001, MAT SCI MAT MED, V7, P815
   Gigante A, 2008, J BIOL REG HOMEOS AG, V22, P35
   Hallman M, 2002, INT J ORAL MAX IMPL, V17, P635
   Hammerle CHF, 2003, PERIODONTOL 2000, V33, P36, DOI 10.1046/j.0906-6713.2003.03304.x
   Hu ZM, 2005, J CRANIOFAC SURG, V16, P1006, DOI 10.1097/01.scs.0000170449.72040.ee
   Ingber A, 2007, INT J IMMUNOPATH PH, V20, P191, DOI 10.1177/039463200702000123
   Inoue K, 2008, INT J IMMUNOPATH PH, V21, P197, DOI 10.1177/039463200802100122
   KARABUDA C, 2001, J PERIODONTOL, V39, P89
   Katsanos GS, 2008, EUR J INFLAMM, V6, P59, DOI 10.1177/1721727X0800600202
   Lavagno L, 2007, J BIOL REG HOMEOS AG, V21, P5
   Marins Lucele Vieira, 2004, J. Appl. Oral Sci., V12, P62, DOI 10.1590/S1678-77572004000100012
   Minenna L, 2005, J CLIN PERIODONTOL, V32, P456, DOI 10.1111/j.1600-051X.2005.00696.x
   Moore WR, 2001, AUST NZ J SURG, V71, P354, DOI 10.1046/j.1440-1622.2001.2128.x
   Mott David A, 2002, J Oral Implantol, V28, P57, DOI 10.1563/1548-1336(2002)028<0057:EOOPIV>2.3.CO;2
   Mushipe MT, 2002, BIOMATERIALS, V23, P365, DOI 10.1016/S0142-9612(01)00114-4
   Nishimura Y, 2007, INT J IMMUNOPATH PH, V20, P661, DOI 10.1177/039463200702000402
   Nkenke E, 2002, CLIN ORAL IMPLAN RES, V13, P514, DOI 10.1034/j.1600-0501.2002.130511.x
   Nkenke E, 2001, CLIN ORAL IMPLAN RES, V12, P495, DOI 10.1034/j.1600-0501.2001.120510.x
   OLIVEIRA RC, 2004, BRAZ DENT J, V15, P3
   Pannone G, 2007, INT J IMMUNOPATH PH, V20, P317, DOI 10.1177/039463200702000211
   Pautke C, 2004, ANTICANCER RES, V24, P3743
   Peters K, 2007, INT J IMMUNOPATH PH, V20, P685, DOI 10.1177/039463200702000404
   Piancatelli D, 2008, INT J IMMUNOPATH PH, V21, P359, DOI 10.1177/039463200802100213
   PIATTELLI A, 2003, IMPLANTOLOGIA ORALE, V4, P77
   Rosen VB, 2002, BIOMATERIALS, V23, P921
   Sailer H F, 2000, Mund Kiefer Gesichtschir, V4 Suppl 1, pS384, DOI 10.1007/PL00014562
   SAMPATH T, 2003, BONE GRAFT SUBSTITUT, P194
   Schwartz Z, 2000, J PERIODONTOL, V71, P1258, DOI 10.1902/jop.2000.71.8.1258
   Schwartz-Arad D, 2002, Refuat Hapeh Vehashinayim (1993), V19, P35
   Serino G, 2003, CLIN ORAL IMPLAN RES, V14, P651, DOI 10.1034/j.1600-0501.2003.00970.x
   Suzuki T, 2000, J BIOSCI BIOENG, V89, P18, DOI 10.1016/S1389-1723(00)88045-7
   Tete S, 2007, INT J IMMUNOPATH PH, V20, P819, DOI 10.1177/039463200702000418
   Thorwarth M, 2005, ORAL SURG ORAL MED O, V100, P278, DOI 10.1016/j.tripleo.2004.12.017
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Vallejo LF, 2002, J BIOTECHNOL, V94, P185, DOI 10.1016/S0168-1656(01)00425-4
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
   Yukna RA, 1998, J PERIODONTOL, V69, P655, DOI 10.1902/jop.1998.69.6.655
   Zimmermann R, 2001, TRANSFUSION, V41, P1217, DOI 10.1046/j.1537-2995.2001.41101217.x
NR 54
TC 4
Z9 4
U1 0
U2 2
PU BIOLIFE SAS
PI SILVA MARINA (TE)
PA VIA S STEFANO 39 BIS, 64029 SILVA MARINA (TE), ITALY
SN 0393-974X
J9 J BIOL REG HOMEOS AG
JI J. Biol. Regul. Homeost. Agents
PD JUL-SEP
PY 2008
VL 22
IS 3
BP 175
EP 183
PG 9
WC Endocrinology & Metabolism; Immunology; Medicine, Research &
   Experimental; Physiology
SC Endocrinology & Metabolism; Immunology; Research & Experimental
   Medicine; Physiology
GA 363LS
UT WOS:000260269400005
PM 18842171
DA 2018-10-19
ER

PT J
AU Fu, Q
   Rahaman, MN
   Zhou, N
   Huang, WH
   Wang, DP
   Zhang, LY
   Li, HF
AF Fu, Qiang
   Rahaman, Mohamed N.
   Zhou, Nai
   Huang, Wenhai
   Wang, Deping
   Zhang, Liying
   Li, Haifeng
TI In vitro study on different cell response to spherical hydroxyapatite
   nanoparticles
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE nanocrystalline hydroxyapatite; cell proliferation; cell responses;
   biomaterials; L929 cell line
ID HUMAN MONOCYTES; COLORIMETRIC ASSAY; PARTICLE-SIZE; BONE-CEMENT;
   PHOSPHATE; GROWTH; CYTOKINES; TOXICITY; PROLIFERATION; CYTOTOXICITY
AB Hydroxyapatite (HA) is widely used in filling of bone defects and coating on metal parts of prosthetic implants due to its excellent biocompatibility, bioactivity, and bone-bonding properties. It has been demonstrated that micro-sized HA particles cause inflammatory reaction, especially for the needle shaped particles. However, little effort has been concentrated on the cell responses of the spherical HA nanoparticles. The aim of the present work is to chemically and physically characterize the synthesized HA nanoparticles and to investigate the in vitro cell responses. X-ray diffraction, electron microscopy, nitrogen adsorption, and Fourier transform infrared spectroscopy revealed that the particles consisted of nearly spherical crystallites of carbonate-substituted HA with size of 20-40nm and specific surface area of 75 m(2)/g. L929 cell proliferation experiments demonstrate that the spherical HA nanoparticles is more biocompatible than commercially available HA. On the other hand, U2-OS cell test results show that the inhibition rate of the spherical HA nanoparticles increases with time and concentration. The half effective inhibitory concentration (IC50) of the nanoparticles was determined to be 50.8 mu g/mL at 72 h. All these data indicated that the synthesized spherical nanocrystalline HA particles can function as an effective biomaterial for bone tumorectomy repair, while having little adverse effect.
C1 [Fu, Qiang; Rahaman, Mohamed N.] Univ Missouri, Dept Mat Sci & Engn, Rolla, MO 65409 USA.
   [Fu, Qiang; Zhou, Nai; Huang, Wenhai; Wang, Deping; Zhang, Liying] Tongji Univ, Sch Mat Sci & Engn, Shanghai 200092, Peoples R China.
   [Huang, Wenhai] Univ Missouri, Mat Res Ctr, Rolla, MO 65409 USA.
   [Li, Haifeng] Tongji Univ, Tongji Hosp, Shanghai 200065, Peoples R China.
RP Fu, Q (reprint author), Univ Missouri, Dept Mat Sci & Engn, 223 McNutt Hall, Rolla, MO 65409 USA.
EM qf7r9@umr.edu; whhuang@mail.tongji.edu.cn
RI Fu, Qiang/B-1972-2013
CR AKAO M, 1993, J MATER SCI-MATER M, V4, P569, DOI 10.1007/BF00125595
   BASLE MF, 1993, J MATER SCI-MATER M, V4, P273, DOI 10.1007/BF00122280
   Ben-Nissan B, 2004, BIOMATERIALS, V25, P4971, DOI 10.1016/j.biomaterials.2004.02.006
   Blake T, 1998, J TOXICOL ENV HEAL A, V54, P243
   Cao LY, 2005, CERAM INT, V31, P1041, DOI 10.1016/j.ceramint.2004.11.002
   EVANS EJ, 1991, BIOMATERIALS, V12, P574, DOI 10.1016/0142-9612(91)90054-E
   Filho OP, 1996, J BIOMED MATER RES, V30, P509
   Fu Q, 2005, J BIOMED MATER RES A, V74A, P156, DOI 10.1002/jbm.a.30322
   Fu QN, 2004, J MATER SCI-MATER M, V15, P1333, DOI 10.1007/s10856-004-5742-4
   GARVEY BT, 1994, J APPL BIOMATER, V5, P39, DOI 10.1002/jab.770050106
   GEESINK RGT, 1988, J BONE JOINT SURG BR, V70, P17
   Grandjean-Laquerriere A, 2004, BIOMATERIALS, V25, P5921, DOI 10.1016/j.biomaterials.2004.02.003
   Guthrie GD, 1997, ENVIRON HEALTH PERSP, V105, P1003, DOI 10.2307/3433501
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   HEO DS, 1990, CANCER RES, V50, P3681
   Huang J, 2004, J MATER SCI-MATER M, V15, P441, DOI 10.1023/B:JMSM.0000021117.67205.cf
   Huang WH, 2006, J MATER SCI-MATER M, V17, P583, DOI 10.1007/s10856-006-9220-z
   JANSEN JA, 1993, J MATER SCI-MATER M, V4, P466, DOI 10.1007/BF00120126
   KIM CY, 1989, J NON-CRYST SOLIDS, V113, P195, DOI 10.1016/0022-3093(89)90011-2
   KLEIN CPAT, 1994, BIOMATERIALS, V15, P146, DOI 10.1016/0142-9612(94)90264-X
   Laquerriere P, 2003, BIOMATERIALS, V24, P2739, DOI 10.1016/S0142-9612(03)00089-9
   Laquerriere P, 2003, COLLOID SURFACE B, V30, P207, DOI 10.1016/S0927-7765(03)00083-3
   LEGEROS RZ, 1984, PHOSPHATE MINERALS, P352
   Li S., 1996, BIOCERAMICS, V9, P225
   Liu ZS, 2003, WORLD J GASTROENTERO, V9, P1968, DOI 10.3748/wjg.v9.i9.1968
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Murugan R, 2004, BIOMATERIALS, V25, P3829, DOI 10.1016/j.biomaterials.2003.10.016
   Ninomiya JT, 2001, J ORTHOPAED RES, V19, P621, DOI 10.1016/S0736-0266(00)00061-9
   Oh SH, 2005, BIOMATERIALS, V26, P4938, DOI 10.1016/j.biomaterials.2005.01.048
   Phillips MJ, 2003, J MATER SCI-MATER M, V14, P875, DOI 10.1023/A:1025682626383
   Posner A. S., 1984, Phosphate Minerals, P330
   PULEO DA, 1991, J BIOMED MATER RES, V25, P711, DOI 10.1002/jbm.820250603
   Savic R, 2003, SCIENCE, V300, P615, DOI 10.1126/science.1078192
   SCHULLER HM, 1990, CANCER RES, V50, P1645
   STROBL JS, 1992, J PHARMACOL EXP THER, V263, P186
   Suchanek W, 1998, J MATER RES, V13, P84
   Sun JS, 1997, BIOMATERIALS, V18, P683, DOI 10.1016/S0142-9612(96)00183-4
   Tadic D, 2002, BIOMATERIALS, V23, P2553, DOI 10.1016/S0142-9612(01)00390-8
   WEHANCED TJ, 2000, BIOMATERIALS, V21, P1803
   WEI JW, 1982, CANCER RES, V42, P2571
   WILKE A, 1993, J MATER SCI-MATER M, V4, P260, DOI 10.1007/BF00122278
NR 42
TC 20
Z9 20
U1 0
U2 8
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD JUL
PY 2008
VL 23
IS 1
BP 37
EP 50
DI 10.1177/0885328207081350
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 321SK
UT WOS:000257326600002
PM 18194997
DA 2018-10-19
ER

PT J
AU Jell, G
   Notingher, I
   Tsigkou, O
   Notingher, P
   Polak, JM
   Hench, LL
   Stevens, MM
AF Jell, G.
   Notingher, I.
   Tsigkou, O.
   Notingher, P.
   Polak, J. M.
   Hench, L. L.
   Stevens, M. M.
TI Bioactive glass-induced osteoblast differentiation: A noninvasive
   spectroscopic study
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE osteoblasts; Raman spectroscopy; differentiation; bioactive glass; gene
   expression
ID CONFOCAL RAMAN MICROSPECTROSCOPY; IN-VITRO; GENE-EXPRESSION; BIOGLASS(R)
   45S5; IONIC PRODUCTS; CELL-CULTURES; LIVING CELLS; STEM-CELLS; SITU;
   DISSOLUTION
AB Here, we report on a rapid, noninvasive biophotonics system using Raman spectroscopy to detect realtime biochemical changes in foetal osteoblasts (17013s) following exposure to 45S5 Bioglass (R) (BG)-conditioned media. Bio-Raman spectroscopy, combined with multivariate statistical analysis techniques (principal component analysis and least squares analysis), was able to noninvasively identify biochemical differences in FOBs cultured for different time periods and between FOBs exposed/or not to BG-conditioned media. Gene and protein expression studies were also performed for known markers of osteoblastic differentiation, namely, alkaline phosphatase, bone sialoprotein, and collagen type I. Quantitative RT-PCR confirmed upregulation of genes associated with osteoblast differentiation after exposure to BG-conditioned media. These results suggest that Raman spectroscopy can noninvasively detect biochemical changes in FOBs associated with differentiation. This technique could have important applications in the field of regenerative medicine by enabling rapid characterization of cell or organoid behavior on novel bioactive scaffolds without damage to either cell or biomaterial. (C) 2007 Wiley Periodicals, Inc.
C1 [Jell, G.; Tsigkou, O.; Notingher, P.; Hench, L. L.; Stevens, M. M.] Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2AZ, England.
   [Notingher, I.] Univ Nottingham, Sch Phys & Astron, Nottingham NG7 2RD, England.
   [Tsigkou, O.; Polak, J. M.; Hench, L. L.] Univ London Imperial Coll Sci Technol & Med, London SW10 9NH, England.
   [Stevens, M. M.] Univ London Imperial Coll Sci Technol & Med, Inst Biomed Engn, London SW7 2AZ, England.
RP Stevens, MM (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2AZ, England.
EM m.stevens@imperial.ac.uk
RI Jell, Gavin/C-4893-2009; Jell, Gavin/B-7855-2010
OI Notingher, Ioan/0000-0002-5360-230X; Tsigkou, Olga/0000-0002-5250-8610
FU Medical Research Council
CR Bhattacharya N, 2004, Clin Exp Obstet Gynecol, V31, P167
   Buschman HP, 2001, CARDIOVASC PATHOL, V10, P69, DOI 10.1016/S1054-8807(01)00064-3
   Caspers PJ, 2001, J INVEST DERMATOL, V116, P434, DOI 10.1046/j.1523-1747.2001.01258.x
   Christodoulou I, 2005, J BIOMED MATER RES B, V74B, P529, DOI 10.1002/jbm.b.30249
   Coelho MJ, 2000, BIOMATERIALS, V21, P1087, DOI 10.1016/S0142-9612(99)00284-7
   Crow P, 2005, BRIT J CANCER, V92, P2166, DOI 10.1038/sj.bjc.6602638
   Day RM, 2005, TISSUE ENG, V11, P768, DOI 10.1089/ten.2005.11.768
   Fuchs JR, 2003, J PEDIATR SURG, V38, P1188, DOI 10.1016/S0022-3468(03)00265-3
   Golan-Mashiach M, 2004, FASEB J, V18, P147, DOI 10.1096/fj.04-2417fje
   Gough JE, 2004, J BIOMED MATER RES A, V68A, P640, DOI 10.1002/jbm.a.20075
   Haka AS, 2002, CANCER RES, V62, P5375
   Jell G, 2006, J MATER SCI-MATER M, V17, P997, DOI 10.1007/s10856-006-0435-9
   Jones JR, 2005, KEY ENG MAT, V284-286, P623, DOI 10.4028/www.scientific.net/KEM.284-286.623
   Jugdaohsingh R, 2004, J BONE MINER RES, V19, P297, DOI 10.1359/JBMR.0301225
   Krafft C, 2003, VIB SPECTROSC, V32, P75, DOI 10.1016/S0924-2031(03)00049-3
   Krupnick AS, 2004, TISSUE ENG, V10, P723, DOI 10.1089/1076327041348419
   Livingston T, 2002, J BIOMED MATER RES, V62, P1, DOI 10.1002/jbm.10157
   Maquelin K, 2003, J CLIN MICROBIOL, V41, P324, DOI 10.1128/JCM.41.1.324-329.2003
   Maquelin K, 2000, ANAL CHEM, V72, P12, DOI 10.1021/ac991011h
   Montjovent MO, 2004, BONE, V35, P1323, DOI 10.1016/j.bone.2004.07.001
   Notingher I, 2004, J R SOC INTERFACE, V1, P79, DOI 10.1098/rsif.2004.0008
   Notingher I, 2004, J CELL BIOCHEM, V92, P1180, DOI 10.1002/jcb.20136
   Notingher I, 2004, ANAL CHEM, V76, P3185, DOI 10.1021/ac0498720
   NOTINGHER J, 2003, BIOPOLYMERS, V72, P230
   Notingher L, 2005, J MOL STRUCT, V744, P179, DOI 10.1016/j.molstruc.2004.12.046
   Oonishi H, 2000, J BIOMED MATER RES, V51, P37, DOI 10.1002/(SICI)1097-4636(200007)51:1<37::AID-JBM6>3.0.CO;2-T
   Owen CA, 2006, J CELL BIOCHEM, V99, P178, DOI 10.1002/jcb.20884
   PUPPELS GJ, 1990, NATURE, V347, P301, DOI 10.1038/347301a0
   Shafer-Peltier KE, 2002, J CELL BIOCHEM, P125, DOI 10.1002/jcb.10418
   Short KW, 2005, BIOPHYS J, V88, P4274, DOI 10.1529/biophysj.103.038604
   Stone N, 2000, LARYNGOSCOPE, V110, P1756, DOI 10.1097/00005537-200010000-00037
   Thian ES, 2006, J BIOMED MATER RES B, V76B, P326, DOI 10.1002/jbm.b.30368
   Tsigkou O, 2007, J BIOMED MATER RES A, V80A, P837, DOI 10.1002/jbm.a.30910
   Uzunbajakava N, 2003, BIOPHYS J, V84, P3968, DOI 10.1016/S0006-3495(03)75124-8
   Verrier S, 2004, BIOPOLYMERS, V74, P157, DOI 10.1002/bip.20063
   WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9
   Xynos ID, 2000, CALCIFIED TISSUE INT, V67, P321, DOI 10.1007/s002230001134
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
   Yuan HP, 2001, J BIOMED MATER RES, V58, P270, DOI 10.1002/1097-4636(2001)58:3<270::AID-JBM1016>3.0.CO;2-2
NR 40
TC 56
Z9 55
U1 2
U2 32
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2008
VL 86A
IS 1
BP 31
EP 40
DI 10.1002/jbm.a.31542
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 309KO
UT WOS:000256459500004
PM 17941016
DA 2018-10-19
ER

PT J
AU Kim, JG
   Lee, KR
   Yang, SJ
AF Kim, Jung-Gu
   Lee, Kwang-Ryeol
   Yang, Seok-Jo
TI Wear-corrosion performance of Si-DLC coatings on Ti-6Al4V substrate
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE wear; corrosion; DLC; biomaterial; Ti
ID TIN COATINGS; CARBON-FILMS; BEHAVIOR; DEPOSITION; RESISTANCE; TI-6A1-4V;
   EROSION; STEEL; ALLOY
AB Si-incorporated diamond-like carbon (Si-DLC) coatings ranging from 0 to 2 at % Si were deposited on Ti-alloy substrate by means of radio frequency plasma-assisted chemical vapor deposition (r.f. PACVD) technique, using a mixture of benzene (C6H6) and silane (SiH4) as the reaction gas. The synergy in wear and corrosion of Si-DLC coatings was investigated by tribological and electrochemical techniques. The electrolyte used in this test to simulate the corrosive environment of body fluid was a 0.89 wt % NaCl solution of pH 7.4 at 37 degrees C. This study provides quantitative data for the assessment of the effect of Si incorporation on the synergistic effect between wear and corrosion in the simulated body fluid environment. In conclusion, tribological and electrochemical measurements showed that the Si-DLC films could improve wear-corrosion resistance in the simulated body fluid environment owing to the lower friction coefficient, corrosion rate, delamination area, and water uptake. (C) 2007 Wiley Periodicals, Inc.
C1 [Kim, Jung-Gu] Sungkyunkwan Univ, Dept Adv Mat Engn, Suwon 440746, South Korea.
   [Lee, Kwang-Ryeol] Korea Inst Sci & Technol, Future Technol Res Div, Seoul 130650, South Korea.
   [Yang, Seok-Jo] Chungnam Natl Univ, Dept Mechatron Engn, Taejon 305764, South Korea.
RP Kim, JG (reprint author), Sungkyunkwan Univ, Dept Adv Mat Engn, 300 Chunchun Dong, Suwon 440746, South Korea.
EM kimjg@skku.ac.kr
RI Lee, Kwang-Ryeol/E-1242-2011
OI Lee, Kwang-Ryeol/0000-0002-8211-3257
CR *ASTM, 1994, G10290 ASTM
   Barril S, 2001, TRIBOL INT, V34, P599, DOI 10.1016/S0301-679X(01)00052-4
   Choi J, 2007, DIAM RELAT MATER, V16, P1361, DOI 10.1016/j.diamond.2006.11.088
   Choi YS, 2000, CORROSION, V56, P1202, DOI 10.5006/1.3280508
   Damasceno JC, 2000, SURF COAT TECH, V133, P247, DOI 10.1016/S0257-8972(00)00932-4
   Eisenbarth E, 2002, BIOMOL ENG, V19, P243, DOI 10.1016/S1389-0344(02)00032-1
   Guleryuz H, 2004, BIOMATERIALS, V25, P3325, DOI 10.1016/j.biomaterials.2003.10.009
   Kim HG, 2005, THIN SOLID FILMS, V482, P299, DOI 10.1016/j.tsf.2004.11.164
   Lee KR, 1997, THIN SOLID FILMS, V308, P263, DOI 10.1016/S0040-6090(97)00411-2
   Liang H, 2004, VACUUM, V73, P317, DOI 10.1016/j.vacuum.2003.12.160
   LIU H, 1995, DIAMOND CHEM VAPOR D, P44
   MADSEN BW, 1988, WEAR, V123, P127, DOI 10.1016/0043-1648(88)90095-6
   Rudenja S, 1999, SURF COAT TECH, V114, P129, DOI 10.1016/S0257-8972(99)00033-X
   TSAI CH, 1993, CORROSION, V49, P726, DOI 10.5006/1.3316106
   Wan GJ, 2004, SURF COAT TECH, V186, P136, DOI 10.1016/j.surfcoat.2004.04.037
   Zhou S, 1996, CORROSION, V52, P934, DOI 10.5006/1.3292087
NR 16
TC 15
Z9 16
U1 0
U2 16
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2008
VL 86A
IS 1
BP 41
EP 47
DI 10.1002/jbm.a.31632
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 309KO
UT WOS:000256459500005
PM 17941020
DA 2018-10-19
ER

PT J
AU Lu, PL
   Lai, JY
   Tabata, Y
   Hsiue, GH
AF Lu, Pei-Lin
   Lai, Jui-Yang
   Tabata, Yasuhiko
   Hsiue, Ging-Ho
TI A methodology based on the "anterior chamber of rabbit eyes" model for
   noninvasively determining the biocompatibility of biomaterials in an
   immune privileged site
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE methodology; biocompatibility; biomaterials; immune privileged site;
   animal model
ID OLIGO(POLY(ETHYLENE GLYCOL) FUMARATE); AMNIOTIC MEMBRANE; IN-VITRO;
   INTRAOCULAR-PRESSURE; DIBLOCK COPOLYMERS; CONTROLLED-RELEASE;
   MOLECULAR-WEIGHT; DRUG-DELIVERY; CANINE MODEL; GELATIN
AB In this study, a novel methodology based on the anterior chamber of rabbit eyes model was developed to evaluate the in vivo biocompatibility of biomaterials in an immune privileged site. The 7-mm-diameter membrane implants made from either a biological tissue material (amniotic membrane, AM group) or a biomedical polymeric material (gelatin, GM group) were inserted in rabbit anterior chamber for 36 months and characterized by biomicroscopic examinations, intraocular pressure measurements, and corneal thickness measurements. The noninvasive ophthalmic parameters were scored to provide a quantitative grading system. In this animal model, both AM and GM implants were visible in an ocular immune privileged site during clinical observations. The implants of the AM group appeared as soft tissue patches and have undergone a slow dissolution process resulting in a partial reduction of their size. Additionally, the AM implants did not induce any foreign body reaction or change in ocular tissue response for the studied period. By contrast, in the GM groups, significant corneal edema, elevated intraocular pressure, and increased corneal thickness were noted in the early postoperative phase (within 3 days), but resolved rapidly with in vivo dissolution of the gelatin. The results from the ocular grading system showed that both implants had good long-term biocompatibility in an ocular immune privileged site for up to 3 years. It is concluded that the anterior chamber of rabbit eyes model is an efficient method for noninvasively determining the immune privileged fissue/biomaterial interactions. (C) 2007 Wiley Periodicals, Inc.
C1 [Lu, Pei-Lin; Lai, Jui-Yang; Hsiue, Ging-Ho] Natl Tsing Hua Univ, Dept Chem Engn, Hsinchu 30013, Taiwan.
   [Lai, Jui-Yang] Chang Gung Univ, Inst Biochem & Biomed Engn, Tao Yuan 33302, Taiwan.
   [Lai, Jui-Yang] Chang Gung Univ, Mol Med Res Ctr, Tao Yuan 33302, Taiwan.
   [Tabata, Yasuhiko] Kyoto Univ, Dept Biomat Field Tissue Engn, Inst Frontier Med Sci, Sakyo Ku, Kyoto 6068507, Japan.
RP Lai, JY (reprint author), Natl Tsing Hua Univ, Dept Chem Engn, Hsinchu 30013, Taiwan.
EM jylai@mail.cgu.edu.tw; ghhsiue@che.nthu.edu.tw
OI Lai, Jui-Yang/0000-0002-9227-8549
CR Choi TH, 2001, CORNEA, V20, P197, DOI 10.1097/00003226-200103000-00019
   Connon CJ, 2006, AM J OPHTHALMOL, V141, P190, DOI 10.1016/j.ajo.2005.08.027
   Ehlers N, 2004, EXP EYE RES, V78, P543, DOI 10.1016/j.exer.2003.09.017
   Fernandes M, 2005, CORNEA, V24, P643, DOI 10.1097/01.ico.0000151501.80952.c5
   Foster PJ, 2000, OPHTHALMOLOGY, V107, P1816, DOI 10.1016/S0161-6420(00)00343-2
   Fournier E, 2003, BIOMATERIALS, V24, P3311, DOI 10.1016/S0142-9612(03)00161-3
   Fournier E, 2006, BIOMATERIALS, V27, P4963, DOI 10.1016/j.biomaterials.2006.04.045
   Fukunaka Y, 2002, J CONTROL RELEASE, V80, P333, DOI 10.1016/S0168-3659(02)00026-3
   Hashizoe M, 1997, CURR EYE RES, V16, P633, DOI 10.1076/ceyr.16.7.633.5063
   Holland TA, 2005, J BIOMED MATER RES A, V75A, P156, DOI 10.1002/jbm.a.30379
   Hsiue GH, 2006, TRANSPLANTATION, V81, P473, DOI 10.1097/01.tp.0000194864.13539.2c
   Hsiue GH, 2006, BIOCONJUGATE CHEM, V17, P781, DOI 10.1021/bi050317u
   Hsiue GH, 2002, J BIOMED MATER RES, V61, P19, DOI 10.1002/jbm.2000
   Hsiue GH, 2002, BIOMATERIALS, V23, P457, DOI 10.1016/S0142-9612(01)00127-2
   Kasper FK, 2006, J BIOMED MATER RES A, V78A, P823, DOI 10.1002/jbm.a.30736
   Lai JY, 2006, ARCH OPHTHALMOL-CHIC, V124, P1441, DOI 10.1001/archopht.124.10.1441
   Lai JY, 2006, BIOMACROMOLECULES, V7, P1836, DOI 10.1021/bm0601575
   Li M, 2006, J BIOMED MATER RES A, V79A, P963, DOI 10.1002/jbm.a.30833
   Liu Y, 2006, BIOMACROMOLECULES, V7, P1819, DOI 10.1021/bm060160o
   Lo CL, 2006, ADV FUNCT MATER, V16, P2309, DOI 10.1002/adfm.200500627
   MELAMED S, 1980, BRIT J OPHTHALMOL, V64, P164, DOI 10.1136/bjo.64.3.164
   Miyagawa S, 2005, TRANSPLANTATION, V80, P1586, DOI 10.1097/01.tp.0000181163.69108.dd
   Nicita G, 2005, UROL INT, V75, P314, DOI 10.1159/000089165
   Okamoto T, 2004, J THORAC CARDIOV SUR, V127, P329, DOI 10.1016/j.jtcvs.2003.08.017
   Rucker M, 2006, BIOMATERIALS, V27, P5027, DOI 10.1016/j.biomaterials.2006.05.033
   Sakai S, 2006, J BIOMED MATER RES A, V78A, P394, DOI 10.1002/jbm.a.30676
   SETALA K, 1979, ACTA OPHTHALMOL, V57, P1004
   Sethuraman S, 2006, J BIOMED MATER RES A, V77A, P679, DOI 10.1002/jbm.a.30620
   Shim WS, 2006, BIOMACROMOLECULES, V7, P1935, DOI 10.1021/bm0600567
   Shimazaki J, 2002, OPHTHALMOLOGY, V109, P1285, DOI 10.1016/S0161-6420(02)01089-8
   Tabata Y, 1998, ADV DRUG DELIVER REV, V31, P287, DOI 10.1016/S0169-409X(97)00125-7
   Tsapanos VS, 2002, J BIOMED MATER RES, V63, P10, DOI 10.1002/jbm.10040
   Uzzo RG, 1999, J UROLOGY, V161, P1344, DOI 10.1016/S0022-5347(01)61681-1
   Ventura L, 2006, PHYS MED BIOL, V51, P3085, DOI 10.1088/0031-9155/51/12/006
   Wang DY, 2003, INVEST OPHTH VIS SCI, V44, P4698, DOI 10.1167/iovs.03-0272
   Watanabe J, 2005, BIOMACROMOLECULES, V6, P1797, DOI 10.1021/bm050138f
   Williams CG, 2005, BIOMATERIALS, V26, P1211, DOI 10.1016/j.biomaterials.2004.04.024
   WILLIAMS D. F., 1987, P BIOCH, P49
   Yasukawa T, 2005, ADV DRUG DELIVER REV, V57, P2033, DOI 10.1016/j.addr.2005.09.005
   YOSHIDA M, 1987, BIOMATERIALS, V8, P124, DOI 10.1016/0142-9612(87)90101-3
   Zhong ZY, 2005, BIOMACROMOLECULES, V6, P3440, DOI 10.1021/bm050505n
NR 41
TC 34
Z9 34
U1 0
U2 5
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2008
VL 86A
IS 1
BP 108
EP 116
DI 10.1002/jbm.a.31619
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 309KO
UT WOS:000256459500011
PM 17941023
DA 2018-10-19
ER

PT J
AU Kasahara, Y
   Iwasaki, N
   Yamane, S
   Igarashi, T
   Majima, T
   Nonaka, S
   Harada, K
   Nishimura, SI
   Minami, A
AF Kasahara, Yasuhiko
   Iwasaki, Norimasa
   Yamane, Shintaro
   Igarashi, Tatsuya
   Majima, Tokifumi
   Nonaka, Sachiko
   Harada, Kazuo
   Nishimura, Shin-Ichiro
   Minami, Akio
TI Development of mature cartilage constructs using novel three-dimensional
   porous scaffolds for enhanced repair of osteochondral defects
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE chitosan; cartilage; tissue engineering; hyaluronic acid/hyaluronan;
   animal model
ID AUTOLOGOUS CHONDROCYTE IMPLANTATION; FIBROBLAST-GROWTH-FACTOR;
   ARTICULAR-CARTILAGE; II COLLAGEN; TISSUE; TRANSPLANTATION; KNEE;
   REGENERATION; BIOMATERIAL; CULTURE
AB In this study, we successfully developed two types of volume-reduced three-dimensional scaffolds, including cushion- and cylinder-shape scaffolds, fabricated from chitosan-based hyaluronic acid hybrid polymer fibers. Using these scaffolds combined with a bioreactor system, we regenerated histologically and mechanically mature cartilage constructs. The final goal of this study was to clarify the ability of this engineered cartilage construct to induce cartilage repair in osteochondral defects. The mature cartilage constructs regenerated with two types of scaffolds were implanted into 5-mm diameter osteochondral defects in the patellar groove of rabbits. At 12 weeks after implantation, the reparative tissues consisted of hyaline-like cartilage with evidence of stable fusion to adjacent native cartilage and normal reconstitution of subchondral bone. The histological score of these tissues significantly outranked the value of untreated tissue. Biomechanically, compression modulus of reparative tissue at 12 weeks postoperatively was comparative to that of normal articular cartilage. Our results indicate that the implantation of constructs with mature cartilage have potential as a better approach for joint resurfacing. (C) 2007 Wiley Periodicals, Inc.
C1 [Kasahara, Yasuhiko; Iwasaki, Norimasa; Yamane, Shintaro; Igarashi, Tatsuya; Majima, Tokifumi; Minami, Akio] Hokkaido Univ, Sch Med, Dept Orthopaed Surg, Kita Ku, Sapporo, Hokkaido 0608638, Japan.
   [Kasahara, Yasuhiko; Iwasaki, Norimasa; Igarashi, Tatsuya; Majima, Tokifumi; Nishimura, Shin-Ichiro] Hokkaido Univ, Frontier Res Ctr Post Genom Sci & Technol, Sapporo, Hokkaido, Japan.
   [Nonaka, Sachiko; Harada, Kazuo] Inst Biol Chem, Sapporo, Hokkaido, Japan.
   [Nishimura, Shin-Ichiro] Hokkaido Univ, Grad Sch Sci, Div Biol Sci, Lab Biomacromol Chem, Sapporo, Hokkaido, Japan.
RP Iwasaki, N (reprint author), Hokkaido Univ, Sch Med, Dept Orthopaed Surg, Kita Ku, Kita 15,Nishi 7, Sapporo, Hokkaido 0608638, Japan.
EM niwasaki@med.hokudai.ac.jp
RI Iwasaki, Norimasa/D-6448-2012; Majima, Tokifumi/E-2412-2012; Nishimura,
   Shinichiro/F-5277-2011
CR Aigner J, 1998, J BIOMED MATER RES, V42, P172, DOI 10.1002/(SICI)1097-4636(199811)42:2<172::AID-JBM2>3.0.CO;2-M
   BELL E, 2000, PRINCIPLES TISSUE EN, P35
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Brittberg M, 2003, J BONE JOINT SURG AM, V85A, P109, DOI 10.2106/00004623-200300003-00017
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   FREED LE, 1999, CLIN ORTHOP S, V367, P46
   Frenkel SR, 1997, J BONE JOINT SURG BR, V79B, P831, DOI 10.1302/0301-620X.79B5.7278
   Fu FH, 2005, AM J SPORT MED, V33, P1658, DOI 10.1177/0363546505275148
   Fukuda A, 2005, BIOMATERIALS, V26, P4301, DOI 10.1016/j.biomaterials.2004.11.007
   Funakoshi T, 2005, J BIOMED MATER RES A, V74A, P338, DOI 10.1002/jbm.a.30237
   HANKEMEIER S, 2003, J ORTHOP RES, V21, P132
   Horas U, 2003, J BONE JOINT SURG AM, V85A, P185, DOI 10.2106/00004623-200302000-00001
   Hsu SH, 2006, ARTIF ORGANS, V30, P42, DOI 10.1111/j.1525-1594.2006.00179.x
   Ishaug-Riley SL, 1999, BIOMATERIALS, V20, P2245, DOI 10.1016/S0142-9612(99)00155-6
   Kandel RA, 2006, BIOMATERIALS, V27, P4120, DOI 10.1016/j.biomaterials.2006.03.005
   KASAHARA Y, 2007, J BIOMED MATER RES, V81, P586
   KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5
   Knutsen G, 2004, J BONE JOINT SURG AM, V86A, P455, DOI 10.2106/00004623-200403000-00001
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Minas T, 2005, CLIN ORTHOP RELAT R, P30, DOI 10.1097/01.blo.0000171916.40245.5d
   Ochi M, 2002, J BONE JOINT SURG BR, V84B, P571, DOI 10.1302/0301-620X.84B4.11947
   Otsuka Y, 1997, DEV GROWTH DIFFER, V39, P143
   Peterson L, 2003, J BONE JOINT SURG AM, V85A, P17, DOI 10.2106/00004623-200300002-00003
   Pieper JS, 2002, BIOMATERIALS, V23, P3183, DOI 10.1016/S0142-9612(02)00067-4
   Shapiro L, 1997, BIOMATERIALS, V18, P583, DOI 10.1016/S0142-9612(96)00181-0
   SHARPIO F, 1993, J BONE JOINT SURG AM, V75, P532
   Toolan BC, 1996, J BIOMED MATER RES, V31, P273, DOI 10.1002/(SICI)1097-4636(199606)31:2<273::AID-JBM15>3.0.CO;2-M
   Wayne JS, 2005, TISSUE ENG, V11, P953, DOI 10.1089/ten.2005.11.953
   Yamane S, 2005, BIOMATERIALS, V26, P611, DOI 10.1016/j.biomaterials.2004.03.013
   YAMANE S, J BIOMED MA IN PRESS
NR 31
TC 23
Z9 24
U1 0
U2 3
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2008
VL 86A
IS 1
BP 127
EP 136
DI 10.1002/jbm.a.31259
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 309KO
UT WOS:000256459500013
PM 17957716
DA 2018-10-19
ER

PT J
AU Lindholm-Sethson, B
   Ardlin, BI
AF Lindholm-Sethson, B.
   Ardlin, B. I.
TI Effects of pH and fluoride concentration on the corrosion of titanium
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE titanium; dental materials; fluoride; electrochemical techniques; pH;
   brushing
ID ELECTROCHEMICAL-BEHAVIOR; IMPEDANCE SPECTROSCOPY; PURE TITANIUM; AC
   IMPEDANCE; RESISTANCE; ALLOYS; MEDIA
AB The aim of this investigation was to confirm and summarize the corrosion behavior of titanium in saline solution at different pH and fluoride concentration, and to characterize the surface films and the stability of a passive and aged titanium surface using open circuit potential measurements, electrochemical impedance spectroscopy, and anodic polarization curves. The results from the electrochemical measurements were related to titanium released after 2-min brushing with saline solutions with different pH and fluoride concentration, that is, simulating tooth brushing with fluoride containing prophylactic substances. Titanium was analyzed using atomic adsorption spectrophotometry. The pH in the saline solution was varied between 4 and 7 with additions of sodium fluoride up to 1.0 wt %. The presence of fluoride in solution was unfavorable for the stability of titanium and led to corrosion and the release of titanium especially at low pH. The combination of low pH and presence of fluoride ions in solution destroyed a passive film on the titanium surface even after aging for 170 h in neutral saline solution. The results do not necessarily imply the occurrence of biological soft tissue related effects even if a physical contact between titanium and the surrounding milieu is prevalent. To provide a general understanding of electrochemical techniques in biomaterial research, much effort was put in the qualitative description of the results, with the intention to provide a broader understanding of especially the impedance method to other researchers. (C) 2007 Wiley Periodicals, Inc.
C1 [Lindholm-Sethson, B.] Umea Univ, Dept Chem Biophys Chem, SE-90187 Umea, Sweden.
   [Lindholm-Sethson, B.] Umea Univ, Ctr Biomed Engn & Phys, SE-90187 Umea, Sweden.
   [Ardlin, B. I.] Umea Univ, Dept Odontol, Dent Mat Sci & Dent Technician Program, SE-90187 Umea, Sweden.
RP Lindholm-Sethson, B (reprint author), Umea Univ, Dept Chem Biophys Chem, SE-90187 Umea, Sweden.
EM britta.sethson@chem.umu.se
CR ARCHER WI, 1980, ELECTROCHEMISTRY, V7, P157
   Armstrong R. D., 1978, ELECTROCHEM-SPR, V6, P98
   Blackwood DJ, 2003, CORROS REV, V21, P97
   BOERE G, 1995, J APPL BIOMATER, V6, P283, DOI 10.1002/jab.770060409
   de Mele MFL, 2000, J APPL ELECTROCHEM, V30, P95
   DONACHIE MJ, 1988, TITANIUM TECHNICAL G, pCH12
   Ellingsen JE, 2004, INT J ORAL MAX IMPL, V19, P659
   Fovet Y, 2001, TALANTA, V53, P1053, DOI 10.1016/S0039-9140(00)00592-0
   Fraker A. C., 1983, ASTM STP, V786, P206
   Huang HH, 2002, ELECTROCHIM ACTA, V47, P2311, DOI 10.1016/S0013-4686(02)00079-8
   Huang HH, 2002, BIOMATERIALS, V23, P59, DOI 10.1016/S0142-9612(01)00079-5
   Ibris N, 2002, J ELECTROANAL CHEM, V526, P53, DOI 10.1016/S0022-0728(02)00814-8
   KEDDAM M, 1984, J ELECTROCHEM SOC, V131, P2016, DOI 10.1149/1.2116010
   Lemons J E, 1992, Implant Dent, V1, P107, DOI 10.1097/00008505-199205000-00002
   LUNDE L, 1985, IFEKRE85004, P4
   Mabilleau G, 2006, ACTA BIOMATER, V2, P121, DOI 10.1016/j.actbio.2005.09.004
   MACDONALD JR, 1992, ANN BIOMED ENG, V20, P289, DOI 10.1007/BF02368532
   Nakagawa M, 2002, DENT MATER J, V21, P83, DOI 10.4012/dmj.21.83
   Nakagawa M, 1999, J DENT RES, V78, P1568, DOI 10.1177/00220345990780091201
   Pourbaix M., 1974, ATLAS ELECTROCHEMICA
   Probster L, 1992, INT J ORAL MAXILLOF, V7, P390
   Reclaru L, 1998, BIOMATERIALS, V19, P85, DOI 10.1016/S0142-9612(97)00179-8
   Schiff N, 2002, BIOMATERIALS, V23, P1995, DOI 10.1016/S0142-9612(01)00328-3
   SHARP M, 1989, J ELECTROANAL CHEM, V274, P35, DOI 10.1016/0022-0728(89)87028-7
   Siirila H S, 1991, Int J Oral Maxillofac Implants, V6, P50
   Strub JR, 2006, J AM DENT ASSOC, V137, P1289, DOI 10.14219/jada.archive.2006.0389
   ToumelinChemla F, 1996, J DENT, V24, P109, DOI 10.1016/0300-5712(95)00033-X
   Tschernitschek H, 2005, QUINTESSENCE INT, V36, P523
NR 28
TC 24
Z9 25
U1 3
U2 14
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2008
VL 86A
IS 1
BP 149
EP 159
DI 10.1002/jbm.a.31415
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 309KO
UT WOS:000256459500015
PM 17957718
DA 2018-10-19
ER

PT J
AU Wang, Y
   Zhang, LH
   Hu, M
   Liu, HC
   Wen, WS
   Xiao, HX
   Niu, Y
AF Wang, Yan
   Zhang, Lihai
   Hu, Min
   Liu, Hongchen
   Wen, Weisheng
   Xiao, Hongxi
   Niu, Yu
TI Synthesis and characterization of collagen-chitosan-hydroxyapatite
   artificial bone matrix
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE collagen; hydroxyapatite; chitosan; artificial bone matrix
ID CHONDROITIN SULFATE; TISSUE; COMPOSITE; BIOMATERIAL; SCAFFOLDS
AB In this study, anew artificial bone matrix was constructed with collagen and Ca(5)(PO(4))(3)OH (hydroxyapatite/HA) which are the main components of natural bone. To improve the property of the artificial bone matrix, chitosan (CS), a kind of positive charged polysaccharide, was crosslinked into the scaffolds. Solid-liquid phase separation method was used to shape 3D porous structure benefited for cells growing into. The artificial bone matrix was investigated by transmission electron microscopy, scanning electron microscopy, and electron spectroscopy for chemical analysis, etc. for structures and characteristics. And its ability of bone repair was investigated by orthotope bone defect reparation in vivo. The results showed that the artificial bone matrix was a porous scaffold with three-dimension interconnected fiber microstructure. HA particles were dispersed evenly among collagen fiber and CS was modified on the surface of collagen fiber. It was indicated that this artificial bone matrix could be used as a bone substitute with outstanding properties. (C) 2007 Wiley Periodicals, Inc.
C1 [Hu, Min; Liu, Hongchen; Wen, Weisheng; Xiao, Hongxi; Niu, Yu] Chinese Peoples Liberat Army Gen Hosp, Dept Stomatol, Beijing 100853, Peoples R China.
   [Wang, Yan; Zhang, Lihai] Chinese Peoples Liberat Army Gen Hosp, Dept Orthopaed, Beijing 100853, Peoples R China.
RP Hu, M (reprint author), Chinese Peoples Liberat Army Gen Hosp, Dept Stomatol, Beijing 100853, Peoples R China.
EM zhanglihai@gmail.com
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.0.CO;2-J
   [Anonymous], 2003, MAT SCI
   Barbani N, 1999, J APPL POLYM SCI, V72, P971, DOI 10.1002/(SICI)1097-4628(19990516)72:7<971::AID-APP13>3.0.CO;2-N
   Bonassar LJ, 1998, J CELL BIOCHEM, P297, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<297::AID-JCB36>3.0.CO;2-6
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   DAGALAKIS N, 1980, J BIOMED MATER RES, V14, P511, DOI 10.1002/jbm.820140417
   Du C, 1999, J BIOMED MATER RES, V44, P407, DOI 10.1002/(SICI)1097-4636(19990315)44:4<407::AID-JBM6>3.0.CO;2-T
   Friedman CD, 1998, J BIOMED MATER RES, V43, P428, DOI 10.1002/(SICI)1097-4636(199824)43:4<428::AID-JBM10>3.0.CO;2-0
   Kersteen EA, 2001, BIOPOLYMERS, V59, P24, DOI 10.1002/1097-0282(200107)59:1<24::AID-BIP1002>3.0.CO;2-N
   Knott L, 1997, BIOCHEM J, V322, P535, DOI 10.1042/bj3220535
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lauer-Fields JL, 2000, J BIOL CHEM, V275, P13282, DOI 10.1074/jbc.275.18.13282
   Liu LR, 2003, ARTIF CELL BLOOD SUB, V31, P435, DOI 10.1081/BIO-120025414
   Mao JS, 2003, BIOMATERIALS, V24, P1621, DOI 10.1016/S0142-9612(02)00549-5
   Ohta M, 2001, RADIAT PROT DOSIM, V94, P385, DOI 10.1093/oxfordjournals.rpd.a006515
   Park JC, 2000, J BIOMED MATER RES, V52, P669, DOI 10.1002/1097-4636(20001215)52:4<669::AID-JBM11>3.3.CO;2-L
   Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3
   SENA LA, 2003, ACTA MICROSC, V12, P45
   WEADOCK K, 1983, BIOMATER ARTIF CELL, V11, P293, DOI 10.3109/10731198309118815
   Yang HY, 2001, J MATER SCI TECHNOL, V17, P495
   Zhang LH, 2005, ARTIF CELL BLOOD SUB, V33, P215, DOI 10.1081/BIO-200055912
   Zhang LH, 2002, ARTIF CELL BLOOD SUB, V30, P319, DOI 10.1081/BIO-120006122
   Zhang QQ, 1997, J MATER SCI TECHNOL, V13, P179
NR 23
TC 25
Z9 27
U1 2
U2 25
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2008
VL 86A
IS 1
BP 244
EP 252
DI 10.1002/jbm.a.31758
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 309KO
UT WOS:000256459500024
PM 18080313
DA 2018-10-19
ER

PT J
AU Jones, JA
   Qin, LA
   Meyerson, H
   Kwon, IK
   Matsuda, T
   Anderson, JM
AF Jones, Jacqueline A.
   Qin, L. Abby
   Meyerson, Howard
   Kwon, Il Keun
   Matsuda, Takehisa
   Anderson, James M.
TI Instability of self-assembled monolayers as a model material system for
   macrophage/FBGC cellular behavior
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE self-assembled monolayers; instability; macrophage; foreign body giant
   cell; contact angles
ID BIOMATERIAL SURFACE-CHEMISTRY; IN-VIVO; MICROPATTERNED SURFACES;
   ALKANETHIOL MONOLAYERS; ADHERENT MACROPHAGES; ALBUMIN ADSORPTION;
   PROTEIN ADSORPTION; SOFT LITHOGRAPHY; INTEGRIN BINDING; GOLD SURFACES
AB Novel self-assembled monolayers (SAMs) designed to present homogenous surface chemistries were utilized to further investigate the material surface chemistry dependent macrophage and foreign-body giant cell (FBGC) behaviors, including macrophage adhesion, fusion, and apoptosis. Contact angle analysis revealed instabilities in the -CH3 and -COOH terminated SAM surfaces upon incubation in serum-free media (SFM) at 37 degrees C or under dry, room temperature conditions. Further analysis indicated that the -CH3 terminated SAM surface degraded rapidly within 2 h and loss of sufficient SAM units to be comparable to the gold (Au) control surface, within 24 h of incubation in SFM at 37 degrees C. After 5 days of incubation in SFM at 37 degrees C, the contact angles for the -COOH terminated SAM surfaces increased markedly. AFM analysis confirmed the desorption of -CH3 terminated SAM molecules from the surface with increased roughness and marked appearance of peaks and valleys within 2 h. A decrease in the thickness of the -COOH terminated SAM surface also suggests molecular desorption over time. No significant changes in contact angle or AFM analyses were observed on the -OH terminated SAM surfaces. Cellular adhesion decreased more rapidly on the Au control and -CH3 terminated SAM surfaces in comparison to the other surfaces. However by day 10, cellular adhesion, fusion, and apoptosis were comparable on all SAM surfaces and the Au control. These studies suggest that SAM surfaces may not be suitable for long-term studies where material dependent properties are investigated. (c) 2008 Wiley Periodicals, Inc.
C1 [Jones, Jacqueline A.; Qin, L. Abby; Anderson, James M.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   [Meyerson, Howard; Anderson, James M.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.
   [Meyerson, Howard] Univ Hosp Cleveland, Dept Pathol, Cleveland, OH 44106 USA.
   [Kwon, Il Keun] Purdue Univ, Dept Ind & Phys Pharm, W Lafayette, IN 47907 USA.
   [Kwon, Il Keun] Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA.
   [Matsuda, Takehisa] Kyushu Univ, Dept Biomed Engn, Fukuoka 812, Japan.
   [Anderson, James M.] Case Western Reserve Univ, Dept Macromol Sci, Cleveland, OH 44106 USA.
RP Anderson, JM (reprint author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
EM jma6@case.edu
FU NIBIB NIH HHS [EB-000275, R01 EB000275, R37 EB000275]
CR Brodbeck WG, 2003, J BIOMED MATER RES A, V64A, P320, DOI 10.1002/jbm.a.10425
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   Chen CS, 1998, BIOTECHNOL PROGR, V14, P356, DOI 10.1021/bp980031m
   Datwani SS, 2004, LANGMUIR, V20, P4970, DOI 10.1021/la030140x
   Flynn NT, 2003, LANGMUIR, V19, P10909, DOI 10.1021/la035331e
   Garg N, 2002, LANGMUIR, V18, P2717, DOI 10.1021/la0115278
   Ito Y, 1999, BIOMATERIALS, V20, P2333, DOI 10.1016/S0142-9612(99)00162-3
   Jiang XY, 2005, P NATL ACAD SCI USA, V102, P975, DOI 10.1073/pnas.0408954102
   Jiang XY, 2004, ANAL CHEM, V76, P6116, DOI 10.1021/ac049152t
   Jones JA, 2004, J BIOMAT SCI-POLYM E, V15, P567, DOI 10.1163/156856204323046843
   Jones JA, 2008, J BIOMED MATER RES A, V84A, P158, DOI 10.1002/jbm.a.31220
   Jones JA, 2007, J BIOMED MATER RES A, V83A, P585, DOI 10.1002/jbm.a.31221
   Kalltorp M, 1999, BIOMATERIALS, V20, P2123, DOI 10.1016/S0142-9612(99)00115-5
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Kondoh H, 1999, J CHEM PHYS, V111, P1175, DOI 10.1063/1.479302
   Lahiri J, 1999, ANAL CHEM, V71, P777, DOI 10.1021/ac980959t
   Latour RA, 2002, J BIOMED MATER RES, V60, P564, DOI 10.1002/jbm.10052
   Li LY, 2003, LANGMUIR, V19, P3266, DOI 10.1021/la026323l
   Li LY, 2003, LANGMUIR, V19, P2974, DOI 10.1021/la0262957
   Lindblad M, 1997, BIOMATERIALS, V18, P1059, DOI 10.1016/S0142-9612(97)00029-X
   Love JC, 2005, CHEM REV, V105, P1103, DOI 10.1021/cr0300789
   Martin MCL, 2003, J MATER SCI-MATER M, V14, P945, DOI 10.1023/A:1026394431100
   Martins MCL, 2003, BIOMATERIALS, V24, P3697, DOI 10.1016/S0142-9612(03)00244-8
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   Michael KE, 2003, LANGMUIR, V19, P8033, DOI 10.1021/la034810a
   Mrksich M, 1996, P NATL ACAD SCI USA, V93, P10775, DOI 10.1073/pnas.93.20.10775
   Mrksich M, 1997, EXP CELL RES, V235, P305, DOI 10.1006/excr.1997.3668
   Nelson CM, 2003, LANGMUIR, V19, P1493, DOI 10.1021/la026178b
   Noh J, 2001, LANGMUIR, V17, P7280, DOI 10.1021/la0100441
   Prathima N, 2005, LANGMUIR, V21, P2364, DOI 10.1021/la048654z
   Sayre CN, 1997, LANGMUIR, V13, P714, DOI 10.1021/la960420v
   Schoenfisch MH, 1998, J AM CHEM SOC, V120, P4502, DOI 10.1021/ja974301t
   Scotchford CA, 1998, J BIOMED MATER RES, V41, P431, DOI 10.1002/(SICI)1097-4636(19980905)41:3<431::AID-JBM13>3.0.CO;2-L
   Shyue JJ, 2004, LANGMUIR, V20, P8693, DOI 10.1021/la049247q
   SILVER IA, 1988, EXP CELL RES, V175, P266, DOI 10.1016/0014-4827(88)90191-7
   Slaughter GE, 2004, LANGMUIR, V20, P7189, DOI 10.1021/la049492s
   TANAHASKI M, 1997, J BIOMED MATER RES, V34, P314
   Wang AF, 2007, J BIOMED MATER RES A, V81A, P363, DOI 10.1002/jbm.a.31034
   Wang H., 2005, LANGMUIR, V21, P2634
   Wang MS, 2004, LANGMUIR, V20, P7753, DOI 10.1021/la049849+
   Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335
   Yang GH, 2004, LANGMUIR, V20, P3995, DOI 10.1021/la0499160
   Zhang F, 2001, J BIOMAT SCI-POLYM E, V12, P515, DOI 10.1163/156856201300194252
   Zhang YM, 1998, J AM CHEM SOC, V120, P2654, DOI 10.1021/ja9714853
NR 48
TC 11
Z9 11
U1 1
U2 10
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2008
VL 86A
IS 1
BP 261
EP 268
DI 10.1002/jbm.a.31660
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 309KO
UT WOS:000256459500026
PM 18412136
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Ma, W
   Wei, JH
   Li, YZ
   Wang, XM
   Shi, HY
   Tsutsumi, S
   Li, DH
AF Ma, Wei
   Wei, Jian-Hua
   Li, Ying-Zhe
   Wang, Xin-Mu
   Shi, Hui-Ying
   Tsutsumi, Sadami
   Li, De-Hua
TI Histological evaluation and surface componential analysis of modified
   micro-arc oxidation-treated titanium implants
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE titanium (alloys); surface modification; biocompatibility/hard tissue;
   osteogenesis
ID ANODIC OXIDE-FILMS; BONE RESPONSE; IN-VITRO; CA; COATINGS; BIOMATERIAL;
   BIOACTIVITY; INTERFACE; METAL
AB The objective of this study is to investigate soft tissue and bone tissue reaction to titanium implants treated by a modified micro arc oxidation (MAO) technique, and analyze the surface components and implant-bone contact ratio by animal experiments to evaluate the osseointegration condition of implants with this modified MAO surface. MAO titanium plates were installed subcutaneously in rabbits. Tissue reaction was evaluated by HE sections. MAO titanium implants designed for endosseous examination were installed in Beagles' femurs. Bone tissue surrounding implants was analyzed histologically. Surfaces of retrieved implants were observed and examined by SEM and EDX. All procedures were performed under the control of untreated pure titanium implants. Thin homogeneous fibrous envelope could be found without apparent inflammation cells infiltration around the subcutaneously imbedded MAO titanium plates, which was almost same as control group. Fast osteoid deposition comprising high content of calcium, phosphor, carbon, and nitrogen elements was found on the retrieved MAO implant surfaces, while comparatively less amount of carbon and nitrogen elements were found on the retrieved implants of control group. Matured bone tissue comprising bone trabeculae and Haversian canals appeared in 8 weeks, while it took 12 weeks needed to form matured bone tissue in control group. In conclusion, MAO titanium materials shows good biocompatibility and calcium phosphate inducement capability in vivo and could accelerate bone tissue growth and shorten the osseointegration time. (C) 2007 Wiley Periodicals, Inc.
C1 [Wei, Jian-Hua; Wang, Xin-Mu] Fourth Mil Med Univ, Sch Stomatol, Dept Oral & Maxillofacial Surg, Xian 710032, Peoples R China.
   [Ma, Wei; Li, De-Hua] Fourth Mil Med Univ, Sch Stomatol, Dept Dent Implant, Xian 710032, Peoples R China.
   [Li, Ying-Zhe; Tsutsumi, Sadami] Kyoto Univ, Inst Frontier Med Sci, Dept Med Simulat Engn, Kyoto 6068507, Japan.
   [Shi, Hui-Ying] Xian Univ Technol, Sch Mat Sci & Engn, Xian 710048, Peoples R China.
RP Wei, JH (reprint author), Fourth Mil Med Univ, Sch Stomatol, Dept Oral & Maxillofacial Surg, Xian 710032, Peoples R China.
EM weiyoyo@fmmu.edu.cn
CR Albrektsson T, 1998, J ORAL MAXIL SURG, V56, P1312, DOI 10.1016/S0278-2391(98)90616-4
   ALBREKTSSON T, 1987, J PROSTHET DENT, V57, P597, DOI 10.1016/0022-3913(87)90344-1
   CHAE JC, 1992, J BIOMED MATER RES, V26, P93, DOI 10.1002/jbm.820260109
   DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203
   Fini M, 1999, BIOMATERIALS, V20, P1587, DOI 10.1016/S0142-9612(99)00060-5
   Frauchiger VM, 2004, BIOMATERIALS, V25, P593, DOI 10.1016/S0142-9612(03)00560-X
   Hamadouche M, 2001, J BIOMED MATER RES, V54, P560, DOI 10.1002/1097-4636(20010315)54:4<560::AID-JBM130>3.3.CO;2-A
   Han Y, 2003, SURF COAT TECH, V168, P249, DOI 10.1016/S0257-8972(03)00016-1
   IKARASHI Y, 1992, J BIOMED MATER RES, V26, P339, DOI 10.1002/jbm.820260306
   ISHIZAWA H, 1995, J BIOMED MATER RES, V29, P65, DOI 10.1002/jbm.820290110
   ISHIZAWA H, 1995, J BIOMED MATER RES, V29, P1459, DOI 10.1002/jbm.820291118
   Kasemo B, 1999, Adv Dent Res, V13, P8
   Li LH, 2004, BIOMATERIALS, V25, P2867, DOI 10.1016/j.biomaterials.2003.09.048
   Nie X, 2000, SURF COAT TECH, V125, P407, DOI 10.1016/S0257-8972(99)00612-X
   Ong J L, 2000, Crit Rev Biomed Eng, V28, P667
   ONISHI H, 2000, J BIOMED MATER RES, V51, P37
   SCHWARTZ Z, 1994, J CELL BIOCHEM, V56, P340, DOI 10.1002/jcb.240560310
   Song WH, 2004, BIOMATERIALS, V25, P3341, DOI 10.1016/j.biomaterials.2003.09.103
   STEFLIK DE, 1994, J ORAL IMPLANTOL, V20, P198
   Suh JY, 2003, BIOMATERIALS, V24, P347, DOI 10.1016/S0142-9612(02)00325-3
   Sul YT, 2003, BIOMATERIALS, V24, P3893, DOI 10.1016/S0142-9612(03)00261-8
   Sul YT, 2001, J MATER SCI-MATER M, V12, P1025, DOI 10.1023/A:1012837905910
   TISEL CL, 1994, J BONE JOINT SURG AM, V76, P139
   Yang BC, 2004, BIOMATERIALS, V25, P1003, DOI 10.1016/S0142-9612(03)00626-4
   Zhu XL, 2001, BIOMATERIALS, V22, P2199, DOI 10.1016/S0142-9612(00)00394-X
NR 25
TC 24
Z9 32
U1 1
U2 21
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JUL
PY 2008
VL 86B
IS 1
BP 162
EP 169
DI 10.1002/jbm.b.31002
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 315PJ
UT WOS:000256891600020
PM 18098194
DA 2018-10-19
ER

PT J
AU Sicca, CM
   Corotti, MV
   Sgarbosa, SHPV
   Cestari, TM
   Cavalcanti, MGP
   Ferreira, PM
   Taga, R
   Granjeiro, JM
AF Sicca, Cristina Miguel
   Corotti, Mauro Vinicius
   Pereira Vergili Sgarbosa, Silvia Helena
   Cestari, Tania Mary
   Paraiso Cavalcanti, Marcelo Gusmao
   Ferreira, Paulo Martins
   Taga, Rumio
   Granjeiro, Jose Mauro
TI Comparative histomorphometric and tomographic analysis of maxillary
   sinus floor augmentation in rabbits using autografts and xenografts
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE sinus augmentation; xenograft; autogenous bone; maxillary sinus; rabbits
ID DEPROTEINIZED BONE PARTICLES; ANORGANIC BOVINE BONE; AUTOGENOUS BONE;
   ENDOSSEOUS IMPLANTS; ATROPHIC MAXILLA; BIO-OSS; GRAFTS; HUMANS;
   HYDROXYAPATITE; SUBSTITUTE
AB Our goal was to evaluate bone neoformation promoted by a bovine xenograft composite (XC) compared with autogenous graft for maxillary sinus augmentation in a rabbit model. The left maxillary sinus of 18 male rabbits was filled with 200 mg of cortical and cancellous autogenous bone and the right sinus was filled with 200 mg of a composite comprised organic and inorganic bovine matrices, pool of bBMPs and collagen. Postoperative implant intervals of 2, 4, and 8 weeks were analyzed. Differences in the bone optical density among the groups and experimental periods were evaluated by computed tomography analysis. The tissue response was evaluated by histomorphometric analysis of the newly formed bone, connective tissue and/or granulation tissue, residual material, and bone marrow. The tomographic analyses showed a maximum optical density in the 4-week period for both groups. Histologically, an inflammatory infiltrate was observed at 2 weeks in the XC group but exclusively around the organic particles of the biomaterial. Regarding to the amount of newly formed bone, no statistical differences (p > 0.05) were observed among the two treatments throughout the implant intervals. However, by the end of the 8 weeks, the quantity of bone marrow was two times greater (p < 0.05) in the control group than in the XC group. In conclusion, the xenograft composite promotes formation of new bone in a similar fashion to autogenous bone and could therefore be considered a biomaterial with potential applications as a bone substitute in maxillary sinus floor augmentation. (C) 2007 Wiley Periodicals, Inc.
C1 [Granjeiro, Jose Mauro] Univ Fed Fluminense, Inst Biol, Dept Cell & Mol Biol, Niteroi, RJ, Brazil.
   [Ferreira, Paulo Martins] Univ Sao Paulo, Bauru Dent Sch, Dept Prosthet Rehabil, BR-05508 Sao Paulo, Brazil.
   [Paraiso Cavalcanti, Marcelo Gusmao] Univ Iowa, Coll Med, Dept Radiol, Iowa City, IA 52242 USA.
   [Paraiso Cavalcanti, Marcelo Gusmao] Univ Sao Paulo, Sao Paulo Dent Sch, Dept Stomatol, FOUSP, BR-05508 Sao Paulo, Brazil.
   [Sicca, Cristina Miguel; Corotti, Mauro Vinicius; Pereira Vergili Sgarbosa, Silvia Helena; Cestari, Tania Mary; Taga, Rumio] Univ Sao Paulo, Bauru Dent Sch, Dept Biol Sci, BR-05508 Sao Paulo, Brazil.
RP Granjeiro, JM (reprint author), Univ Fed Fluminense, Inst Biol, Dept Cell & Mol Biol, Niteroi, RJ, Brazil.
EM jmgranjeiro@vm.uff.br
RI Granjeiro, Jose/D-8289-2012; Cestari, Tania/E-7060-2012; Taga,
   Rumio/E-5794-2012
OI Granjeiro, Jose/0000-0002-8027-8293; 
CR ASAI S, 2002, CLIN ORAL IMPLAN RES, V13, P420
   BECKER J, 1992, INT J ORAL MAX SURG, V21, P243, DOI 10.1016/S0901-5027(05)80229-2
   Berglundh T, 1997, CLIN ORAL IMPLAN RES, V8, P117, DOI 10.1034/j.1600-0501.1997.080206.x
   Boeck-Neto R, 2002, J PERIODONTOL, V73, P266, DOI 10.1902/jop.2002.73.3.266
   Cochran DI, 2000, J PERIODONTOL, V71, P1241, DOI 10.1902/jop.2000.71.8.1241
   FREDERIKSEN NL, 2003, ORAL RADIOLOGY PRINC, P250
   Froum S J, 1998, Int J Periodontics Restorative Dent, V18, P528
   Granjeiro JM, 2005, BRAZ J MED BIOL RES, V38, P1463, DOI 10.1590/S0100-879X2005001000003
   Hallman M, 2004, INT J ORAL MAX IMPL, V19, P222
   Hallman M, 2002, INT J ORAL MAX IMPL, V17, P635
   Hanisch O, 1999, INT J ORAL MAX IMPL, V14, P329
   HASS R, 2002, CLIN ORAL IMPLAN RES, V13, P396
   Hurzeler MB, 1997, CLIN ORAL IMPLAN RES, V8, P476, DOI 10.1034/j.1600-0501.1997.080606.x
   Indovina A, 2002, J ORAL MAXIL SURG, V60, P53, DOI 10.1053/joms.2002.0000
   Johansson B, 2001, DENTOMAXILLOFAC RAD, V30, P157, DOI 10.1038/sj.dmfr.4600601
   John HD, 2004, INT J ORAL MAX IMPL, V19, P199
   Joshi A, 2004, BRIT DENT J, V196, P215, DOI 10.1038/sj.bdj.4810987
   KirkerHead CA, 1997, INT J ORAL MAX IMPL, V12, P403
   LeGeros R. Z., 1995, ENCY HDB BIOMATERI A, V2, P1429
   Luna L. G., 1968, MANUAL HISTOLOGIC ST, P36
   MORSE A, 1945, J DENT RES, V24, P143, DOI 10.1177/00220345450240030501
   Nkenke E, 2002, CLIN ORAL IMPLAN RES, V13, P514, DOI 10.1034/j.1600-0501.2002.130511.x
   OLIVARES J, 1999, PSICOL CONDUCT, V7, P85
   OLIVEIRA RC, 2003, REV BRAS ORTOP, V38, P551
   Orsini G, 2005, J BIOMED MATER RES B, V74B, P448, DOI 10.1002/jbm.b.30196
   PEETZ M, 1997, OSSEOUS RECONSTRUCTI, P87
   Piattelli M, 1999, INT J ORAL MAX IMPL, V14, P835
   Raghoebar GM, 2001, CLIN ORAL IMPLAN RES, V12, P503, DOI 10.1034/j.1600-0501.2001.120511.x
   Salata Luiz A, 2002, Clin Implant Dent Relat Res, V4, P27, DOI 10.1111/j.1708-8208.2002.tb00148.x
   Schlegel AK, 1998, J LONG-TERM EFF MED, V8, P201
   Schlegel KA, 2003, INT J ORAL MAX IMPL, V18, P53
   Schultze-Mosgau S, 2001, BRIT J ORAL MAX SURG, V39, P439, DOI 10.1054/bjom.2001.0617
   Sicca Cm, 2000, REV FAC ODONTOL BAUR, V8, P1
   TAGA R, 1997, REV BRAS IMPLANT, V3, P13
   Tong DC, 1998, INT J ORAL MAX IMPL, V13, P175
   Ueda M, 2001, ARTIF ORGANS, V25, P164, DOI 10.1046/j.1525-1594.2001.025003164.x
   URIST MR, 1984, CLIN ORTHOP RELAT R, P277
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Valentini P, 2003, INT J ORAL MAX IMPL, V18, P556
   van den Bergh JPA, 2000, J CLIN PERIODONTOL, V27, P627, DOI 10.1034/j.1600-051x.2000.027009627.x
   Wada K, 2001, Int J Periodontics Restorative Dent, V21, P252
   Watanabe K, 1999, ORAL SURG ORAL MED O, V88, P26, DOI 10.1016/S1079-2104(99)70189-7
   Weibel E R, 1969, Int Rev Cytol, V26, P235, DOI 10.1016/S0074-7696(08)61637-X
   Xu H, 2005, BRIT J ORAL MAX SURG, V43, P40, DOI 10.1016/j.bjoms.2004.10.004
   Xu H, 2004, CLIN ORAL IMPLAN RES, V15, P126, DOI 10.1111/j.1600-0501.2004.01003.x
   Xu H, 2003, CLIN ORAL IMPLAN RES, V14, P548, DOI 10.1034/j.1600-0501.2003.00933.x
   Yildirim M, 2001, INT J ORAL MAX IMPL, V16, P23
   Yildirim M, 2000, CLIN ORAL IMPLAN RES, V11, P217, DOI 10.1034/j.1600-0501.2000.011003217.x
NR 48
TC 7
Z9 8
U1 0
U2 2
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JUL
PY 2008
VL 86B
IS 1
BP 188
EP 196
DI 10.1002/jbm.b.31005
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 315PJ
UT WOS:000256891600023
PM 18161780
DA 2018-10-19
ER

PT J
AU Ghosh, SK
   Nandi, SK
   Kundu, B
   Datta, S
   De, DK
   Roy, SK
   Basu, D
AF Ghosh, Samir K.
   Nandi, Samit K.
   Kundu, Biswanath
   Datta, Someswar
   De, Dipak K.
   Roy, Sujit K.
   Basu, Debabrata
TI In vivo response of porous hydroxyapatite and beta-tricalcium phosphate
   prepared by aqueous solution combustion method and comparison with
   bioglass scaffolds
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE solution combustion; calcium phosphate; bioglass; push-out test;
   vascularization
ID SCANNING-ELECTRON-MICROSCOPY; SEGMENTAL DEFECTS; BONE TISSUE; CERAMICS;
   MECHANISM; GLASS; OSTEOINDUCTION; RECONSTRUCTION; SUBSTITUTES; POROSITY
AB Pure hydroxyapatite (HAp) and a biphasic calcium phosphate [containing 90% of beta-tri-calcium phosphate (beta-TCP) and 10% HAp] were tailored through an aqueous solution combustion synthesis. Porous struts were prepared using all the powders along with bioglass, a known bioactive material, and subsequently characterized. Sterilized struts were implanted to the lateral side of radius bone of 24 black Bengal goats of either sex, in which a blank hole was left unfilled in a group of six specimens to act as control. The bone formation response of the three implanting materials in vivo has been studied using scanning electron microscope and histological analysis in contrast with positive controls. Push-out tests were used to assess the mechanical strength at the bone-biomaterial interface. It was observed that interfacial response was strongly dependent on combinations of different physical and chemical parameters. The surface of beta-TCP exhibited similar characteristics of bone and was distinct from those of intervening apatite layer of bioglass. Lower bone ingrowth and reduced strength was observed with HAp compared to beta-TCP/bioglass-based implants. Bone formation response of the Ca-P material varied according to the composition of the implanting material, which could be tailored through this novel synthesis. (C) 2007 Wiley Periodicals, Inc.
C1 [Ghosh, Samir K.; Kundu, Biswanath; Datta, Someswar; Roy, Sujit K.; Basu, Debabrata] Cent Glass & Ceram Res Inst, Kolkata, India.
   [Nandi, Samit K.; De, Dipak K.] W Bengal Univ Anim & Fishery Sci, Kolkata, India.
RP Kundu, B (reprint author), Cent Glass & Ceram Res Inst, Kolkata, India.
EM biswa_kundu@rediffmail.com
CR ALEXANDER H, 1987, CRIT REV BIOCOMPAT, V4, P43
   Annaz B, 2004, J MICROSC-OXFORD, V215, P100, DOI 10.1111/j.0022-2720.2004.01354.x
   Asada M., 1987, Yogyo-Kyokai-Shi, V95, P703
   BASSETT CAL, 1962, J BONE JOINT SURG AM, V44, P842, DOI 10.2106/00004623-196244050-00002
   Bignon A, 2003, J MATER SCI-MATER M, V14, P1089, DOI 10.1023/B:JMSM.0000004006.90399.b4
   BOLANDER ME, 1986, J BONE JOINT SURG AM, V68A, P1264, DOI 10.2106/00004623-198668080-00018
   Boyde A, 1999, BONE, V24, P579, DOI 10.1016/S8756-3282(99)00083-6
   BRANEMARK PI, 1983, BIOMATERIALS, V4, P25, DOI 10.1016/0142-9612(83)90065-0
   Chang CS, 1999, J BIOMED MATER RES, V48, P411, DOI 10.1002/(SICI)1097-4636(1999)48:4<411::AID-JBM3>3.0.CO;2-H
   Cutright D E, 1972, Oral Surg Oral Med Oral Pathol, V33, P850, DOI 10.1016/0030-4220(72)90457-4
   CZITROM AA, 1992, ALLOGRAFTS ORTHOPAED, P147
   De Aza PN, 2003, BIOMATERIALS, V24, P1437, DOI 10.1016/S0142-9612(02)00530-6
   ELLINGER RF, 1986, INT J PERIODONT REST, V3, P223
   FERREIRA VM, 1992, FERROELECTRICS, V133, P127, DOI 10.1080/00150199208217987
   Fujibayashi S, 2003, BIOMATERIALS, V24, P1349, DOI 10.1016/S0142-9612(02)00511-2
   FUJITA Y, 1991, J BIOMED MATER RES, V25, P991, DOI 10.1002/jbm.820250806
   Ghosh SK, 2004, T INDIAN CERAM SOC, V63, P27, DOI 10.1080/0371750X.2004.11012125
   Gil-Albarova J, 2004, BIOMATERIALS, V25, P4639, DOI 10.1016/j.biomaterials.2003.12.009
   GROSS U, 1988, CRC CRIT R BIOCOMP, V4, P25
   HATTORI T, 1988, ADV CERAM MATER, V3, P426
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HENCH LL, 1974, J BIOMED MATER RES, V8, P49, DOI 10.1002/jbm.820080307
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Hing KA, 2005, J MATER SCI-MATER M, V16, P467, DOI 10.1007/s10856-005-6988-1
   HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309
   JAIN SR, 1981, COMBUST FLAME, V40, P71, DOI 10.1016/0010-2180(81)90111-5
   JARCHO M, 1976, J MATER SCI, V11, P2027, DOI 10.1007/BF02403350
   KINGSLEY JJ, 1990, J MATER SCI, V25, P1305
   KLAWITTER JJ, 1971, J BIOMED MATER RES S, V2, P161, DOI DOI 10.1002/JBM.820050613
   KLUG HP, 1974, XRAY DIFFRACTION PRO, P364
   KOTANI S, 1991, J BIOMED MATER RES, V25, P1303, DOI 10.1002/jbm.820251010
   LEGEROS RZ, 1990, CRC HDB BIOACTIVE CE, P17
   Lin TC, 1997, J BIOMED MATER RES, V36, P91, DOI 10.1002/(SICI)1097-4636(199707)36:1<91::AID-JBM11>3.0.CO;2-M
   Meeder P J, 1994, Injury, V25 Suppl 1, pA2
   NAKAMURA T, 1985, J BIOMED MATER RES, V19, P685, DOI 10.1002/jbm.820190608
   NEO M, 1992, J BIOMED MATER RES, V26, P255, DOI 10.1002/jbm.820260210
   OSAKA A, 1991, J MATER SCI-MATER M, V2, P51, DOI 10.1007/BF00701687
   Ripamonti U, 1996, BIOMATERIALS, V17, P31, DOI 10.1016/0142-9612(96)80752-6
   SHIMAZAKI K, 1985, J ORTHOPAED RES, V3, P301, DOI 10.1002/jor.1100030306
   Singh S, 2000, INDIAN J ANIM SCI, V70, P276
   Vogel M, 2001, BIOMATERIALS, V22, P357, DOI 10.1016/S0142-9612(00)00191-5
   Yuan HP, 1999, BIOMATERIALS, V20, P1799, DOI 10.1016/S0142-9612(99)00075-7
NR 42
TC 78
Z9 80
U1 0
U2 23
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JUL
PY 2008
VL 86B
IS 1
BP 217
EP 227
DI 10.1002/jbm.b.31009
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 315PJ
UT WOS:000256891600026
PM 18161811
DA 2018-10-19
ER

PT J
AU Macario, DK
   Entersz, I
   Bolikal, D
   Kohn, J
   Nackman, GB
AF Macario, Danielle K.
   Entersz, Ildiko
   Bolikal, Durgadas
   Kohn, Joachim
   Nackman, Gary B.
TI Iodine inhibits antiadhesive effect of PEG: Implications for tissue
   engineering
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE cell-material interactions; in vitro; polymer; vascular; protein
   adsorption
ID CORONARY-ARTERY DISEASE; IN-STENT RESTENOSIS; PROTEIN ADSORPTION;
   DEGRADABLE BIOMATERIALS; BALLOON ANGIOPLASTY; MULTICENTER TRIAL;
   CELL-ADHESION; SURFACES; POLYETHYLENE; IMPLANTATION
AB Background: The success of a biomaterial implant may be affected by the surface chemistry's impact on protein adsorption. We have developed a series of poly(ethylene glycol) (PEG) containing, tyrosine-derived polycarbonates, which have been rendered radio-opaque by the iodination of tyrosine units in the copolymer backbone for use in resorbable biomedical implants including vascular stents and grafts. We tested the hypothesis that protein adsorption along with seeding, growth, and migration of human aortic smooth muscle cells (SMC) and human aortic endothelial cells (EC) will be modified by the presence of iodine and PEG within the polymer composition. Methods: Thin films of these polymers were prepared for the protein-material and cell-material interaction studies. Dot blot, SDS-PAGE, and XPS were used to evaluate relative protein adsorption. Cell adhesion and growth studies were performed using an NITS assay. Cell migration was evaluated using an injury model. Results: The presence of PEG attenuated protein adsorption, cell adhesion, and growth. With the subsequent incorporation of iodine, protein adsorption markedly increased while the antiadhesive effect of PEG was counteracted by iodine for EC and SMC adhesion and SMC growth. Conclusion: Iodine incorporation into the polymer resulted in increased protein adsorption thus counteracting the effect of PEG. (C) 2007 Wiley Periodicals, Inc.
C1 [Macario, Danielle K.; Entersz, Ildiko; Nackman, Gary B.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Div Vasc Surg, New Brunswick, NJ 08901 USA.
   [Bolikal, Durgadas; Kohn, Joachim] Rutgers State Univ, Dept Chem, Piscataway, NJ 08854 USA.
   [Bolikal, Durgadas; Kohn, Joachim] Rutgers State Univ, New Jersey Ctr Biomat, Piscataway, NJ 08854 USA.
RP Nackman, GB (reprint author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Div Vasc Surg, New Brunswick, NJ 08901 USA.
EM gary.nackman@umdnj.edu
FU NIBIB NIH HHS [EB003057]
CR Benzina A, 1996, J BIOMED MATER RES, V32, P459, DOI 10.1002/(SICI)1097-4636(199611)32:3<459::AID-JBM20>3.0.CO;2-A
   Brocchini S, 1998, J BIOMED MATER RES, V42, P66, DOI 10.1002/(SICI)1097-4636(199810)42:1<66::AID-JBM9>3.0.CO;2-M
   Du H, 1997, BBA-BIOMEMBRANES, V1326, P236, DOI 10.1016/S0005-2736(97)00027-8
   ERTEL SI, 1994, J BIOMED MATER RES, V28, P919, DOI 10.1002/jbm.820280811
   FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802
   Garza L, 2002, CURR OPIN CARDIOL, V17, P518, DOI 10.1097/01.HCO.0000024183.40973.4E
   Grewe PH, 2000, J AM COLL CARDIOL, V35, P157, DOI 10.1016/S0735-1097(99)00486-6
   HOPER KA, 1995, J BIOACT COMPAT POLY, V10, P327
   JAKOBSEN RJ, 1978, ARTIF ORGANS, V2, P183, DOI 10.1111/j.1525-1594.1978.tb03449.x
   LARSEN AA, 1956, J AM CHEM SOC, V78, P3210, DOI 10.1021/ja01594a066
   Lazos D, 2005, LANGMUIR, V21, P8774, DOI 10.1021/la051049r
   Lowe HC, 2002, J AM COLL CARDIOL, V39, P183, DOI 10.1016/S0735-1097(01)01742-9
   Martin EC, 1995, J VASC INTERV RADIOL, V6, P843, DOI 10.1016/S1051-0443(95)71198-8
   Muathen H.A., 1994, J CHEM RES SYNOP, V11, P405
   PALMAZ JC, 1992, CARDIOVASC INTER RAD, V15, P291, DOI 10.1007/BF02733953
   Popat KC, 2004, LANGMUIR, V20, P8035, DOI 10.1021/la049075x
   RAPOZA R J, 1989, Journal of Biomaterials Science Polymer Edition, V1, P99, DOI 10.1163/156856289X00091
   SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801
   SILVER JH, 1994, BIOMATERIALS, V15, P695, DOI 10.1016/0142-9612(94)90168-6
   Tziampazis E, 2000, BIOMATERIALS, V21, P511, DOI 10.1016/S0142-9612(99)00212-4
   Wagner MS, 2003, BIOMATERIALS, V24, P1897, DOI 10.1016/S0142-9612(02)00612-9
   Wagner VE, 2004, BIOMATERIALS, V25, P2247, DOI 10.1016/j.biomaterials.2003.09.020
   Wu YG, 2005, J BIOMED MATER RES A, V74A, P722, DOI 10.1002/jbm.a.30381
   Yu C, 1999, BIOMATERIALS, V20, P253, DOI 10.1016/S0142-9612(98)00169-0
NR 24
TC 6
Z9 6
U1 1
U2 13
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JUL
PY 2008
VL 86B
IS 1
BP 237
EP 244
DI 10.1002/jbm.b.31011
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 315PJ
UT WOS:000256891600028
PM 18161808
DA 2018-10-19
ER

PT J
AU Huang, TH
   Chang, FL
   Lin, SC
   Liu, SH
   Hsieh, SS
   Yang, RS
AF Huang, Tsang-Hai
   Chang, Feng-Ling
   Lin, Shang-Chih
   Liu, Shing-Hwa
   Hsieh, Sandy S.
   Yang, Rong-Sen
TI Endurance treadmill running training benefits the biomaterial quality of
   bone in growing male Wistar rats
SO JOURNAL OF BONE AND MINERAL METABOLISM
LA English
DT Article
DE treadmill running; biomechanics; intermittent endurance; continuous
   endurance; bone mineral density
ID MINERAL DENSITY; GROWTH-HORMONE; MECHANICAL-PROPERTIES; VOLUNTARY
   EXERCISE; CORTICAL BONE; F344 RATS; STRENGTH; MASS; COLLAGEN; TURNOVER
AB This study investigated the effects of endurance running training on the bones of growing rats. Thirty-two male Wistar rats (7 weeks old) were assigned to a sedentary control group (CON, n = 10), a continuous endurance running group (CEN, n = 10), or an intermittent endurance running group (IEN, n = 12). After an 8-week training period, both exercise groups had significantly less body weight (BW) gain but higher aerobic capacity, shown by increased muscle citrate synthase (CS) activity. Bone area (BA), areal bone mineral density (aBMD), and bone mineral content (BMC) were measured by dual-energy Xray absorptiometry (DXA) in the total femur and sections of femora. Except for showing a significantly higher aBMD in total femora, the CON group was only slightly and nonsignificantly higher in other DXA measurements. In tissue weight measurements, the CON group showed a nonsignificantly higher tissue dry weight (P = 0.146), but a significantly lower tissue water content ratio (WCR, %) as compared to the exercise group. Despite having nonsignificantly lower long bone cross-sectional parameters, both exercise groups showed significantly better biomaterial properties, as measured by a three-point bending test. In extrinsic analysis, femora of the two exercise groups showed no difference in bending load and stiffness, but were significantly higher in post-yield bending energy and total ultimate bending energy (P < 0.05). Similar phenomena were revealed in tissue-level measurements; the CEN and IEN groups were significantly higher in ultimate toughness and post-yield toughness (P < 0.05). Higher post-yield energy shown by two exercise groups implied a change in bone matrix organization. In conclusion, this study demonstrated that two endurance treadmill training modes benefit bone, with subjects showing better tissue biomaterial properties without significantly increasing aBMD, BMC, or bone dimension. Further study would be valuable to investigate the effects of endurance running on other components of bone, such as organization of bone matrix and its relationship with bone biomaterial properties.
C1 [Yang, Rong-Sen] Natl Taiwan Univ & Hosp, Dept Orthopaed, Taipei 100, Taiwan.
   [Huang, Tsang-Hai] Natl Cheng King Univ, Inst Phys Educ Hlth & Leisure Studies, Tainan, Taiwan.
   [Huang, Tsang-Hai; Chang, Feng-Ling] Natl Taiwan Normal Univ, Dept Phys Educ, Taipei, Taiwan.
   [Lin, Shang-Chih] Natl Cent Univ, Dept Mech Engn, Tao Yuan, Taiwan.
   [Liu, Shing-Hwa] Natl Taiwan Univ, Inst Toxicol, Taipei 10764, Taiwan.
   [Hsieh, Sandy S.] Natl Taiwan Normal Univ, Grad Inst Exercise & Sport Sci, Taipei, Taiwan.
RP Yang, RS (reprint author), Natl Taiwan Univ & Hosp, Dept Orthopaed, 7 Chung Shan S Rd, Taipei 100, Taiwan.
EM rsyang@ntuh.gov.tw
OI Yang, Rong-Sen/0000-0002-0553-4779; LIU, SHING-HWA/0000-0002-9976-1197
CR Banu MJ, 1999, BONE, V25, P469, DOI 10.1016/S8756-3282(99)00195-7
   Boskey AL, 1999, J BONE MINER RES, V14, P330, DOI 10.1359/jbmr.1999.14.3.330
   BOURRIN S, 1995, J BONE MINER RES, V10, P1745
   Burr DB, 2002, BONE, V31, P8, DOI 10.1016/S8756-3282(02)00815-3
   Cummings SR, 2002, JAMA-J AM MED ASSOC, V288, P1889, DOI 10.1001/jama.288.15.1889
   CURREY JD, 1979, J BIOMECH, V12, P459, DOI 10.1016/0021-9290(79)90031-9
   CURREY JD, 1988, J BIOMECH, V21, P131, DOI 10.1016/0021-9290(88)90006-1
   Davicco MJ, 1999, MECH AGEING DEV, V109, P83, DOI 10.1016/S0047-6374(99)00026-3
   Fahey TD, 2005, EXERCISE PHYSL HUMAN
   FELSON DT, 1993, J BONE MINER RES, V8, P567, DOI 10.1002/jbmr.5650080507
   FROST HM, 1987, ANAT RECORD, V219, P1, DOI 10.1002/ar.1092190104
   Hagihara Y, 2005, J BONE MINER METAB, V23, P289, DOI 10.1007/s00774-005-0601-z
   Honda A, 2001, J BONE MINER RES, V16, P1688, DOI 10.1359/jbmr.2001.16.9.1688
   Huang TH, 2003, J APPL PHYSIOL, V95, P300, DOI 10.1152/japplphysiol.01076.2002
   Huang TH, 2002, BONE, V30, P293, DOI 10.1016/S8756-3282(01)00659-7
   Iwamoto J, 2005, EXP ANIM TOKYO, V54, P1, DOI 10.1538/expanim.54.1
   Iwamoto J, 2004, J BONE MINER METAB, V22, P26, DOI 10.1007/s00774-003-0443-5
   Joo YI, 2003, BONE, V33, P485, DOI 10.1016/S8756-3285(03)00212-6
   Jurimae Toivo, 2005, Journal of Physiological Anthropology and Applied Human Science, V24, P579, DOI 10.2114/jpa.24.579
   Kiuchi A, 1998, INT J SPORTS MED, V19, P245, DOI 10.1055/s-2007-971912
   KOPP J, 1989, Matrix, V9, P443
   LIN YS, 1995, MED SCI SPORT EXER, V27, P73
   MAROTTI G, 1994, CLIN RHEUMATOL, V13, P63
   Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254
   Mazess R B, 1998, Arch Intern Med, V158, P300, DOI 10.1001/archinte.158.3.298-a
   Mosekilde L, 1999, BONE, V24, P71, DOI 10.1016/S8756-3282(98)00169-0
   NORDSLETTEN L, 1993, J BONE MINER RES, V8, P1089
   Notomi T, 2000, EUR J APPL PHYSIOL, V83, P469, DOI 10.1007/s004210000316
   Nyman JS, 2006, J BIOMECH, V39, P931, DOI 10.1016/j.jbiomech.2005.01.012
   Puustjarvi K, 1999, J BONE MINER RES, V14, P321, DOI 10.1359/jbmr.1999.14.3.321
   RICO H, 1991, MINER ELECTROL METAB, V17, P321
   SAKAMOTO K, 1987, J NUTR, V117, P390
   SHEPHERD D, 1969, METHOD ENZYMOL, V13, P11, DOI DOI 10.1016/0076-6879(69)13006-2
   SIEMON NJ, 1973, NATURE, V243, P541, DOI 10.1038/243541a0
   Skedros JG, 2006, J EXP BIOL, V209, P3025, DOI 10.1242/jeb.02304
   Soot T, 2005, J BONE MINER METAB, V23, P401, DOI 10.1007/s00774-005-0620-9
   TURNER CH, 1993, BONE, V14, P595, DOI 10.1016/8756-3282(93)90081-K
   Umemura Y, 1997, J BONE MINER RES, V12, P1480, DOI 10.1359/jbmr.1997.12.9.1480
   Viguet-Carrin S, 2006, OSTEOPOROSIS INT, V17, P319, DOI 10.1007/s00198-005-2035-9
   Wallace JD, 2000, J CLIN ENDOCR METAB, V85, P124, DOI 10.1210/jc.85.1.124
   Wang X, 2002, BONE, V31, P1, DOI 10.1016/S8756-3282(01)00697-4
   Wang XD, 2001, J ORTHOPAED RES, V19, P1021, DOI 10.1016/S0736-0266(01)00047-X
   Webb AA, 2003, BEHAV BRAIN RES, V144, P143, DOI 10.1016/S0166-4328(03)00076-7
   Welch JM, 2004, J APPL PHYSIOL, V97, P1859, DOI 10.1152/japplphysiol.00438.2004
   Welsh L, 1997, INT J SPORTS MED, V18, P247, DOI 10.1055/s-2007-972628
   WHEELER DL, 1995, MED SCI SPORT EXER, V27, P520
   YEH JK, 1993, AM J PHYSIOL, V264, pE182
   Zittermann A, 2002, EUR J NUTR, V41, P189, DOI 10.1007/s00394-002-0375-1
   Zonderland ML, 1999, EUR J APPL PHYSIOL O, V79, P391, DOI 10.1007/s004210050527
NR 49
TC 19
Z9 24
U1 0
U2 1
PU SPRINGER TOKYO
PI TOKYO
PA 1-11-11 KUDAN-KITA, CHIYODA-KU, TOKYO, 102-0073, JAPAN
SN 0914-8779
J9 J BONE MINER METAB
JI J. Bone Miner. Metab.
PD JUL
PY 2008
VL 26
IS 4
BP 350
EP 357
DI 10.1007/s00774-007-0831-3
PG 8
WC Endocrinology & Metabolism; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Research & Experimental Medicine
GA 322RG
UT WOS:000257392400007
PM 18600401
DA 2018-10-19
ER

PT J
AU Li, D
   Yang, W
   Li, GY
AF Li, Dong
   Yang, Wei
   Li, Guo-Ying
TI Extraction of native collagen from limed bovine split wastes through
   improved pretreatment methods
SO JOURNAL OF CHEMICAL TECHNOLOGY AND BIOTECHNOLOGY
LA English
DT Article
DE native collagen; pretreatment; limed bovine split wastes;
   physicochemical properties; collagen yield
ID DECALCIFICATION; BIOMATERIAL; PRODUCTS
AB BACKGROUND: The large amount of limed bovine split wastes discharged by the leather industry has raised concerns regarding their environmental effect. The objective of this work was to perform pilot plant trials to extract high-value native collagen from these wastes through improved pretreatment methods.
   RESULTS: EDTA- and HCl-pretreatment gave similar removal percentages of inorganic substances. Owing to the open structure of fibers, the collagen yield of HCl-pretreated splits (HPS) (41.31%) was higher than that of EDTA-pretreated splits (EPS) (10.42%). Furthermore, HCl-pretreated split collagen (HPC) had a more acidic isoelectric point, lower content of primary amino groups, larger Z-average particle size and higher relative viscosity than EDTA-pretreated split collagen (EPC). Electrophoretic analysis and circular dichroism spectra revealed the maintenance of polypeptide and triple helix conformation, respectively. In addition, the transition temperatures of EPC (34.7 degrees C) and HPC (34.6 degrees C) detected by differential scanning calorimetry (DSC) were close to that of commercial collagen from calfskin (CCC) (35.7 degrees C).
   CONCLUSION: A process of native collagen extraction from limed bovine split wastes was proposed. While both EPC and HPC represented similar physicochemical properties to those of CCC, the collagen yield of HPS was much higher than that of EPS. (C) 2008 Society of Chemical Industry.
C1 [Li, Dong; Yang, Wei; Li, Guo-Ying] Sichuan Univ, Key Lab Leather Chem & Engn, Minist Educ, Chengdu 610065, Peoples R China.
RP Li, GY (reprint author), Sichuan Univ, Key Lab Leather Chem & Engn, Minist Educ, Chengdu 610065, Peoples R China.
EM liguoyings@163.com
CR Alexander KTW, 1991, J SOC LEATHER TECHNO, V76, P17
   *ASS OFF AGR CHEM, 1990, OFF TENT METH AN
   BALATON AJ, 1989, ANN PATHOL, V9, P140
   BERGMAN I, 1963, ANAL CHEM, V35, P1961, DOI 10.1021/ac60205a053
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   Cabeza LF, 1998, WASTE MANAGE, V18, P211, DOI 10.1016/S0956-053X(98)00032-4
   CASSEL JM, 1966, BIOPOLYMERS, V4, P989, DOI 10.1002/bip.1966.360040904
   Dias JCCA, 2002, ARQ BRAS MED VET ZOO, V54, P618, DOI 10.1590/S0102-09352002000600010
   FAN GT, 1993, PRODUCTS RAW HIDES
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   GAYATRI R, 2001, BIOCHEM BIOPH RES CO, V283, P299
   Hattori S, 1999, J BIOCHEM-TOKYO, V125, P676, DOI 10.1093/oxfordjournals.jbchem.a022336
   KOIDE M, 1993, J BIOMED MATER RES, V27, P79, DOI 10.1002/jbm.820270111
   Leammli U. K., 1970, NATURE, V277, P680, DOI DOI 10.1038/227680A0
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   LI G. Y., 2003, J SOC LEATHER TECHNO, V88, P66
   Li GY, 2003, J AM LEATHER CHEM AS, V98, P224
   MAIRE MS, 1980, J AM LEATHER CHEM AS, V75, P16
   Morimura S, 2002, PROCESS BIOCHEM, V37, P1403, DOI 10.1016/S0032-9592(02)00024-9
   *NEW ENGL TANN CLU, 1973, LEATH FACTS
   NG KH, 1992, EUR J MORPHOL, V30, P150
   Pachence JM, 1996, J BIOMED MATER RES, V33, P35, DOI 10.1002/(SICI)1097-4636(199621)33:1<35::AID-JBM6>3.0.CO;2-N
   Peng Y, 2004, J COSMET SCI, V55, P327
   ROBERT F, 1971, BIOCHEM J, V124, P581
   RONCAROLI F, 1991, Pathologica (Genoa), V83, P307
   SAMLOFF IM, 2004, AM J MED, V79, P15
   Santos LM, 2007, J CLEAN PROD, V15, P12, DOI 10.1016/j.jclepro.2006.01.025
   Taylor MM, 2004, J AM LEATHER CHEM AS, V99, P133
   WIRSIGWIECHMANN CR, 1994, J NEUROSCI METH, V51, P213, DOI 10.1016/0165-0270(94)90013-2
   Yang L, 2003, J INORG BIOCHEM, V93, P197, DOI 10.1016/S0162-0134(02)00573-1
NR 30
TC 9
Z9 9
U1 1
U2 21
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 0268-2575
J9 J CHEM TECHNOL BIOT
JI J. Chem. Technol. Biotechnol.
PD JUL
PY 2008
VL 83
IS 7
BP 1041
EP 1048
DI 10.1002/jctb.1912
PG 8
WC Biotechnology & Applied Microbiology; Chemistry, Multidisciplinary;
   Engineering, Environmental; Engineering, Chemical
SC Biotechnology & Applied Microbiology; Chemistry; Engineering
GA 320RO
UT WOS:000257252900012
DA 2018-10-19
ER

PT J
AU Indrizzi, E
   Moricca, LM
   Pellacchia, V
   Leonardi, A
   Buonaccorsi, S
   Fini, G
AF Indrizzi, Elena
   Moricca, Luca Maria
   Pellacchia, Valentina
   Leonardi, Alessandra
   Buonaccorsi, Sara
   Fini, Giuseppina
TI Biomaterial implantation in facial esthetic diseases: Ultrasonography
   monitor follow-up
SO JOURNAL OF CRANIOFACIAL SURGERY
LA English
DT Article
DE biomaterial; reconstruction; ultrasonography
ID SURGERY
AB Facial deficit diseases are corrected by biomaterial implantation. The ideal biomaterial should be easy to implant and remove and simple to be identified by a low-dose radiation and low-cost radiologic technique. The purpose of this work was to evaluate ultrasonography (US) as a technique in monitoring biomaterial status after operation.
   In the last 3 years, for this study we used polyethylene porosus and polyacrylamide. Our study included 300 patients grouped accordingly as follows: malformative syndromes, degenerative syndromes, and esthetic problems, results of skull-facial traumas, and whether they are treated in the early phase and or the late phase. In this paper, we describe the better 15 clinical cases for their excellent result and for their variety of US images.
   Ultrasonography has been shown as an excellent way to visualize clinical features and a possible pathologic process of an implanted biomaterial; it is a noninvasive, low-radiation and low-cost dose radiologic technique.
   Reconstruction in facial deficit diseases needs adequate biomaterial to implant and a careful patients observation, that is, both clinical and radiologic. Ultrasonography is a fundamental component of the follow up of implanted biomaterial patients.
C1 [Indrizzi, Elena; Moricca, Luca Maria; Pellacchia, Valentina; Leonardi, Alessandra; Buonaccorsi, Sara; Fini, Giuseppina] Univ Roma La Sapienza, Sch Med & Surg, Cattedra Chirurg Maxillo, Rome, Italy.
RP Moricca, LM (reprint author), Via Rose,6-C, I-01036 Viterbo, Italy.
EM luca_maria@infinito.it
CR ANDREWS JM, 1966, PLAST RECONSTR SURG, V38, P581, DOI 10.1097/00006534-196638060-00017
   BEN-HUR N, 1963, Isr Med J, V22, P15
   BRALY S, 1967, PLAST RECONSTR SURG, V51, P3
   BROWN JB, 1954, AMA ARCH SURG, V68, P744, DOI 10.1001/archsurg.1954.01260050746003
   Cenzi R, 1995, Minerva Stomatol, V44, P559
   Chin E, 1968, Keisei Geka, V11, P177
   CONLEY J, 1985, ARCH OTOLARYNGOL, V111, P241
   GRUSS JS, 1985, PLAST RECONSTR SURG, V75, P303
   GUTIERREZ C, 1982, ARCH OTOLARYNGOL, V108, P243
   HELL B, 1989, J CRANIO MAXILL SURG, V17, P39, DOI 10.1016/S1010-5182(89)80126-X
   HELL B, 1993, INT J ORAL MAX SURG, V22, P173, DOI 10.1016/S0901-5027(05)80247-4
   MAAS CS, 1990, ARCH OTOLARYNGOL, V116, P551
   Meyer R, 1997, AESTHET PLAST SURG, V21, P159, DOI 10.1007/s002669900103
   Pacini S, 2003, PLAST RECONSTR SURG, V111, P489, DOI 10.1097/00006534-200301000-00092
   Pacini Stefania, 2002, Italian Journal of Anatomy and Embryology, V107, P209
   Rocher P., 1995, Revue de Stomatologie et de Chirurgie Maxillo-Faciale, V96, P281
   Sengezer M, 1992, J Craniofac Surg, V3, P125, DOI 10.1097/00001665-199211000-00003
   STOSIC S, 1991, Deutsche Stomatologie, V41, P166
   Wellisz T, 1992, J Craniofac Surg, V3, P101, DOI 10.1097/00001665-199209000-00009
   WELLISZ T, 1993, AESTHET PLAST SURG, V17, P339, DOI 10.1007/BF00437109
NR 20
TC 4
Z9 4
U1 1
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1049-2275
J9 J CRANIOFAC SURG
JI J. Craniofac. Surg.
PD JUL
PY 2008
VL 19
IS 4
BP 1098
EP 1103
DI 10.1097/SCS.0b013e3181763633
PG 6
WC Surgery
SC Surgery
GA 330EC
UT WOS:000257921300041
PM 18650740
DA 2018-10-19
ER

PT J
AU Neethling, WML
   Yadav, S
   Hodge, AJ
   Glancy, R
AF Neethling, William M. L.
   Yadav, Sumit
   Hodge, Andrew J.
   Glancy, Ross
TI Enhanced biostability and biocompatibility of decellularized bovine
   pericardium, crosslinked with an ultra-low concentration monomeric
   aldehyde and treated with ADAPT (R)
SO JOURNAL OF HEART VALVE DISEASE
LA English
DT Article; Proceedings Paper
CT 4th Biennial Meeting of the Society-for-Heart-Valve-Disease
CY JUN 15-18, 2007
CL New York, NY
SP Soc Heart Valve Dis
ID PORCINE HEART-VALVES; IN-VITRO; TISSUE; GLUTARALDEHYDE; CALCIFICATION;
   LINKING; MATRIX; BIOPROSTHESES; MODEL; RECELLULARIZATION
AB Background and aim of the study: Matrix preparation remains controversial due to incomplete cell removal, inflammatory responses, reabsorption and thrombocyte activation. Previously, crosslinked matrices have been considered unsatisfactory due to cytotoxicity. In the present study, the biostability, biocompatibility and calcification potential of a decellularized matrix crosslinked with a low concentration of monomeric glutaraldehyde (GA) and treated with the ADAPT (R) anti-calcification process were examined.
   Methods: Bovine pericardium was decellularized with Triton X-100, deoxycholate, IgePal CA-630 (R) and ribonuclease. The resulting matrices were allocated to either group I (control, n = 5), crosslinked in 0.2% polymeric GA + ADAPT (R), or to group 11 (treatment, n = 5), crosslinked in 0.05% monomeric GA + ADAPT (R). The physical properties, enzymatic degradation, histology and immunohistochemical staining of the tissues were monitored. The matrices were also implanted in the jugular vein of juvenile sheep for 200 days.
   Results: Complete acellularity was achieved. Biostability was significantly (p < 0.01) enhanced in group II, but inflammatory responses were limited in both groups. Host fibroblasts infiltrated the periphery in group I and the entire matrix in group II. The luminal surfaces were free from thrombotic depositions and covered with endothelial cells. Both groups tested positive for Factor VIII, smooth muscle alpha-actin and vimentin. Tissue extractable calcium levels were low (group I = 1.02 +/- 0.39, group II = 0.86 +/- 0.22 mu g Ca/mg tissue).
   Conclusion: Low-concentration GA-crosslinked matrices proved to be stable. The immunoreactivity of both groups was low, with host cell infiltration, migration and trans-differentiation being optimized in those grafts crosslinked with an ultra-low monomeric GA concentration. Calcification levels were close to zero in both groups. Enhanced crosslinking and effective anti-calcification produce a biomaterial with advanced in-vivo tissue-engineering properties.
C1 [Neethling, William M. L.] Univ Western Australia, Fremantle Heart Inst, Nedlands, WA 6009, Australia.
   [Neethling, William M. L.] Univ Western Australia, Sch Surg & Pathol, Nedlands, WA 6009, Australia.
   [Yadav, Sumit; Hodge, Andrew J.] Fremantle Hosp, Dept Cardiothorac Surg, Fremantle, WA 6160, Australia.
   [Glancy, Ross] Fremantle Hosp, Dept Histopathol, Fremantle, WA 6160, Australia.
RP Neethling, WML (reprint author), Fremantle Hosp, Fremantle Heart Inst, Cell Biol Res Unit, Z Block,Alma St, Fremantle, WA 6160, Australia.
EM Leon.Neethling@health.wa.gov.au
CR Chang Y, 2004, J BIOMED MATER RES A, V69A, P323, DOI 10.1002/jbm.a.30003
   COURTMAN DW, 1994, J BIOMED MATER RES, V28, P655, DOI 10.1002/jbm.820280602
   Courtman DW, 2001, J BIOMED MATER RES, V55, P576, DOI 10.1002/1097-4636(20010615)55:4<576::AID-JBM1051>3.0.CO;2-9
   Deiwick M, 1998, ANN THORAC SURG, V66, pS206, DOI 10.1016/S0003-4975(98)01125-4
   Freyman TM, 2001, PROG MATER SCI, V46, P273, DOI 10.1016/S0079-6425(00)00018-9
   Girardot JMD, 1996, J HEART VALVE DIS, V5, P518
   Goissis G, 1998, ARTIF ORGANS, V22, P210, DOI 10.1046/j.1525-1594.1998.06006.x
   Goncalves AC, 2005, J HEART VALVE DIS, V14, P212
   Hoerstrup S P, 1998, Swiss Surg, VSuppl 2, P23
   HUANGLEE LLH, 1990, J BIOMED MATER RES, V24, P1185, DOI 10.1002/jbm.820240905
   Hughes H, 1994, J Heart Valve Dis, V3, P111
   Jayakrishnan A, 1996, BIOMATERIALS, V17, P471, DOI 10.1016/0142-9612(96)82721-9
   Kasimir MT, 2006, J HEART VALVE DIS, V15, P278
   Ketchedjian A, 2005, ANN THORAC SURG, V79, P888, DOI 10.1016/j.athorascur.2004.09.033
   Kim KM, 2002, J BIOMED MATER RES, V59, P639, DOI 10.1002/jbm.10038
   KOK LP, 1990, J MICROSC-OXFORD, V158, P291, DOI 10.1111/j.1365-2818.1990.tb03003.x
   MESSIER RH, 1994, J SURG RES, V57, P1, DOI 10.1006/jsre.1994.1102
   NEETHLIN WML, 1992, J CARDIOVASC SURG, V3, P285
   Neethling WML, 2006, J CARDIOVASC SURG, V47, P711
   Neethling WML, 2004, J HEART VALVE DIS, V13, P689
   Neethling WML, 2003, J BIOMED MATER RES B, V66B, P356, DOI 10.1002/jbm.b.10015
   RASMUSSEN KE, 1974, HISTOCHEMISTRY, V38, P19, DOI 10.1007/BF00490216
   RICHARDS FM, 1968, J MOL BIOL, V37, P231, DOI 10.1016/0022-2836(68)90086-7
   Rieder E, 2004, J THORAC CARDIOV SUR, V127, P399, DOI 10.1016/j.jtcvs.2003.06.017
   ROSSI MA, 1990, J EXP PATHOL, V71, P187
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   Schoen FJ, 2005, ANN THORAC SURG, V79, P1072, DOI 10.1016/j.athoracsur.2004.06.033
   SHIN M, 1995, J CLIN LAB ANAL, V9, P424, DOI 10.1002/jcla.1860090615
   Shinoka T, 1996, CIRCULATION, V94, P164
   Singla A, 2002, J BIOMED MATER RES, V60, P368, DOI 10.1002/jbm.10077
   Torres DS, 2000, BIOMATERIALS, V21, P1607
   Valente M, 1998, J HEART VALVE DIS, V7, P180
   WOODROOF EA, 1978, J BIOENG, V2, P1
NR 33
TC 13
Z9 13
U1 0
U2 6
PU I C R PUBLISHERS
PI NORTHWOOD
PA CRISPIN HOUSE, 12/A SOUTH APPROACH, MOOR PARK, NORTHWOOD HA6 2ET,
   ENGLAND
SN 0966-8519
J9 J HEART VALVE DIS
JI J. Heart Valve Dis.
PD JUL
PY 2008
VL 17
IS 4
BP 456
EP 463
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 331LX
UT WOS:000258014800019
PM 18751476
DA 2018-10-19
ER

PT J
AU Ramanath, HS
   Chua, CK
   Leong, KF
   Shah, KD
AF Ramanath, H. S.
   Chua, C. K.
   Leong, K. F.
   Shah, K. D.
TI Melt flow behaviour of poly-epsilon-caprolactone in fused deposition
   modelling
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 5th Asian-Australian Conference on Composite Materials (ACCM-5_
CY NOV 27-30, 2006
CL Hong Kong, PEOPLES R CHINA
ID POROUS STRUCTURES; SCAFFOLDS; FABRICATION; COMPOSITES; BIOPOLYMER;
   EXTRUSION; DESIGN
AB Fused deposition modelling (FDM) is an extrusion based Rapid prototyping (RP) technique which can be used to fabricate tissue engineering scaffolds. The present work focuses on the study of the melt flow behaviour (MFB) of Poly-epsilon-caprolactone (PCL) as a representative biomaterial, on the FDM. The MFB significantly affects the quality of the scaffold which depends not only on the pressure gradient, its velocity, and the temperature gradients but also physical properties like the melt temperature and rheology. The MFB is studied using two methods: mathematical modelling and finite element analysis (FEA) using Ansys (R). The MFB is studied using accurate channel geometry by varying filament velocity at the entry and by varying nozzle diameters and angles at the exit. The comparative results of both mathematical modelling and FEA suggest that the pressure drop and the velocities of the melt flow depend on the flow channel parameters. One inference of particular interest is the temperature gradient of the PCL melt, which shows that it liquefies within 35% of the channel length. These results are invaluable to better understand the MFB of biomaterials that affects the quality of the scaffold built via FDM and can also be used to predict the MFB of other biomaterials.
C1 [Ramanath, H. S.] Singapore Inst Mfg Technol, Singapore 638075, Singapore.
   [Chua, C. K.; Leong, K. F.] Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore 639798, Singapore.
   [Shah, K. D.] Vellore Inst Technol, Sch Mech & Bldg Engn, Vellore, Tamil Nadu, India.
RP Ramanath, HS (reprint author), Singapore Inst Mfg Technol, Singapore 638075, Singapore.
EM ramanath@simtech.a-star.edu.sg
RI Leong, Kah-Fai/B-6183-2009; Chua, Chee Kai/B-6171-2009
CR Ang KC, 2007, J BIOMED MATER RES A, V80A, P655, DOI 10.1002/jbm.a.30996
   Ang KC, 2006, RAPID PROTOTYPING J, V12, P100, DOI 10.1108/135525406106524471
   *ANS INC, 2004, ANSYS EL REF MAN
   *ASM INT, 1991, ASM HDB, V2
   BELLINI A, 2002, THESIS DREXEL U US
   Chua C K, 2003, RAPID PROTOTYPING PR
   Ciardelli G, 2004, J MATER SCI-MATER M, V15, P305, DOI 10.1023/B:JMSM.0000021092.03087.d4
   Darling AL, 2004, J BIOMED MATER RES B, V70B, P311, DOI 10.1002/jbm.b.30050
   Grosvenor MP, 1996, INT J PHARM, V135, P103, DOI 10.1016/0378-5173(95)04404-3
   Ikada Y, 2000, MACROMOL RAPID COMM, V21, P117, DOI 10.1002/(SICI)1521-3927(20000201)21:3<117::AID-MARC117>3.0.CO;2-X
   Jiang KY, 2004, KEY ENG MAT, V259-2, P667, DOI 10.4028/www.scientific.net/KEM.259-260.667
   Khalil S, 2005, RAPID PROTOTYPING J, V11, P9, DOI 10.1108/13552540510573347
   Leong KF, 2003, BIOMATERIALS, V24, P2363, DOI 10.1016/S0142-9612(03)00030-9
   MICHAELI W, 1984, EXTRUSION DIES DESIG, P10
   Pingping Z, 1998, EUR POLYM J, V34, P91
   Ramanath HS, 2007, KEY ENG MATER, V334-335, P1241, DOI 10.4028/www.scientific.net/KEM.334-335.1241
   RAUWENDAAL C, 1994, POLYM EXTRUSION, P182
   *START INC, 2001, FDM 3000 SYST DOC
   THOMSON RC, 1995, J BIOMAT SCI-POLYM E, V7, P23, DOI 10.1163/156856295X00805
   Too MH, 2002, INT J ADV MANUF TECH, V19, P217, DOI 10.1007/s001700200016
   Wang CG, 2001, CHINESE J ELECTRON, V10, P42
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yang SF, 2002, TISSUE ENG, V8, P1, DOI 10.1089/107632702753503009
   Yeong WY, 2004, TRENDS BIOTECHNOL, V22, P643, DOI 10.1016/j.tibtech.2004.10.004
   Zein I, 2002, BIOMATERIALS, V23, P1169, DOI 10.1016/S0142-9612(01)00232-0
NR 25
TC 76
Z9 76
U1 5
U2 91
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUL
PY 2008
VL 19
IS 7
BP 2541
EP 2550
DI 10.1007/s10856-007-3203-6
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 301EL
UT WOS:000255879100003
PM 17619957
DA 2018-10-19
ER

PT J
AU Couet, F
   Mantovani, D
AF Couet, Frederic
   Mantovani, Diego
TI Experimental validation of a new approach for the development of
   mechano-compatible composite scaffolds for vascular tissue engineering
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 5th Asian-Australian Conference on Composite Materials (ACCM-5_
CY NOV 27-30, 2006
CL Hong Kong, PEOPLES R CHINA
AB The clinical need for the design of small-diameter vascular substitutes with high patency rates has never been so urgent as nowadays. Mechano-compatibility is widely known as one of the main key parameter for the design and the development of highly-patent vascular substitutes independently of their nature, i.e., arterial prostheses, arterial grafts or tissue-engineered blood-vessel. In this work, we attempt to target mechano-compatibility of cylindrical scaffolds for vascular tissue engineering by a computational model based on the composite theory associated with finite element and genetic algorithm. Then, cylindrical composite scaffolds were fabricated from gelatine (matrix) and silk (reinforcement) to experimentally validate theoretical results obtained by the implemented computational model. Finally, the compliance of the scaffolds was measured by an in-house developed specific device. Results show that the computational predictions from numerical simulation are in good agreement with the measurements obtained form the experimental tests. Therefore, the proposed computational model represents a valid tool to assist biomaterial scientists during the design of composite scaffolds, and especially in targeting their mechanical properties.
C1 [Mantovani, Diego] Univ Laval, Quebec Univ Hosp, Dept Mat Engn, Lab Biomat & Bioengn, Quebec City, PQ G1K 7P4, Canada.
   Univ Laval, Quebec Univ Hosp, Res Ctr, Quebec City, PQ G1K 7P4, Canada.
RP Mantovani, D (reprint author), Univ Laval, Quebec Univ Hosp, Dept Mat Engn, Lab Biomat & Bioengn, Pavillon Pouliot 1745-E, Quebec City, PQ G1K 7P4, Canada.
EM diego.mantovani@gmn.ulaval.ca
OI Mantovani, Diego/0000-0001-9672-895X
CR *AM HEART ASS, 2005, INT CARD DIS STAT
   *AM HEART ASS, 2005, HEART DIS STROK STAT
   Bailon J.-P., 2000, DES MATERIAUX
   COUET F, 2007, UNPUB REV SCI INSTRU
   COUET F, 2007, KEY ENG MATER, V335, P1169
   Couet F, 2007, MACROMOL BIOSCI, V7, P701, DOI 10.1002/mabi.200700002
   Kannan RY, 2005, J BIOMED MATER RES B, V74B, P570, DOI 10.1002/jbm.b.30247
   Lehoux S, 2003, J BIOMECH, V36, P631, DOI 10.1016/S0021-9290(02)00441-4
   Lehoux S, 2006, CARDIOVASC RES, V71, P269, DOI 10.1016/j.cardiores.2006.05.008
   MEGERMAN J, 1983, VASCULAR GRAFTING, P344
   Pries AR, 2005, AM J PHYSIOL-HEART C, V288, pH1010, DOI 10.1152/ajpheart.00752.2004
   ROSATELLA G, 2003, ENG MED BIOL SOC, V4, P17
   Tranquillo RT, 1996, BIOMATERIALS, V17, P349, DOI 10.1016/0142-9612(96)85573-6
   WEINBERG CB, 1986, SCIENCE, V231, P397, DOI 10.1126/science.2934816
NR 14
TC 5
Z9 5
U1 0
U2 7
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUL
PY 2008
VL 19
IS 7
BP 2551
EP 2554
DI 10.1007/s10856-007-3242-z
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 301EL
UT WOS:000255879100004
PM 17914629
DA 2018-10-19
ER

PT J
AU Lin, CJ
   Han, HJ
   Zhang, F
   Li, AM
AF Lin, Changjian
   Han, Huijuan
   Zhang, Fang
   Li, Aimin
TI Electrophoretic deposition of HA/MWNTs composite coating for biomaterial
   applications
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 5th Asian-Australian Conference on Composite Materials (ACCM-5_
CY NOV 27-30, 2006
CL Hong Kong, PEOPLES R CHINA
ID HYDROXYAPATITE COATINGS; CARBON NANOTUBES; TITANIUM; FIBERS;
   BIOCERAMICS; PARTICLES; SURFACE; LAYER
AB A composite coating of hydroxyapatite (HA)/multi-walled carbon nanotubes (MWNTs) has been fabricated by electrophoretic deposition (EPD). The nano powders of HA and MWNTs were dispersed in ethanol with total concentration of 0.005 g/mL and MWNTs 20% and 30% contents (wt). And the pH value of suspension was adjusted in a range from 4 to 5. After stabilization the mixture was ultrasonically treated for 3 h to form a stable suspension. Prior to the electrophoretic deposition, the titanium substrate was hydrothermally treated at 140 in NaOH (10 mol/L) solution for 6 h. A titanium sheet and circinal net of stainless steel were used as a cathode and an anode respectively, and a constant deposition voltage of 30 V was applied for 50-60 s in the EPD process. The thickness of the coatings was controlled from 10 mu m to 20 mu m. The samples of composite coating were then sintered in a resistance tube furnace in flowing argon at 700 for 2 h. The structure of the as prepared coating was characterized by SEM and XRD, and the bonding force of the coating/substrate was measured by an interfacial shear strength test. It is shown that the bonding strengths between the coating and the titanium substrate is as high as 35 MPa. The cell culture experiments indicate that the prepared composite coating of HA/MWNTs possesses good biocompatibility.
C1 [Lin, Changjian; Han, Huijuan; Zhang, Fang; Li, Aimin] Xiamen Univ, Dept Chem, Coll Chem & Chem Engn, State Key Lab Phys Chem Solid Surface, Xiamen 361005, Peoples R China.
   [Li, Aimin] Shandong Univ, Coll Mat Sci & Engn, Jinan 250061, Peoples R China.
RP Li, AM (reprint author), Xiamen Univ, Dept Chem, Coll Chem & Chem Engn, State Key Lab Phys Chem Solid Surface, Xiamen 361005, Peoples R China.
EM cjlin@xmu.edu.cn
RI Lin, CJ/G-3392-2010
CR Bae JC, 2002, PHYSICA B, V323, P168, DOI 10.1016/S0921-4526(02)00890-6
   BRENDEL T, 1992, J MATER SCI-MATER M, V3, P175, DOI 10.1007/BF00713445
   Chen F, 2005, KEY ENG MAT, V288-289, P183, DOI 10.4028/www.scientific.net/KEM.288-289.183
   Chen F, 2002, MATER LETT, V57, P858, DOI 10.1016/S0167-577X(02)00885-6
   CHEN F, 2004, THESIS XIAMEN U
   Chen Hong, 2002, CARBON NANOTUBES SYN
   CHEN Y, 2005, J APPL PHYS LETT, V86, P51905
   der Biest O. O. V., 1999, ANNU REV MATER SCI, V29, P327
   DOREMUS RH, 1992, J MATER SCI, V27, P285, DOI 10.1007/BF00543915
   Du CS, 2002, J MATER SCI LETT, V21, P565, DOI 10.1023/A:1015417206987
   GAO B, 2001, ADV MATER, V13, P23
   Gomez-Vega JM, 2000, BIOMATERIALS, V21, P105, DOI 10.1016/S0142-9612(99)00131-3
   Gong HJ, 2005, ACTA POLYM SIN, P297
   Gross KA, 2002, J BIOMED MATER RES, V63, P106, DOI 10.1002/jbm.10090
   Haddon RC, 2002, ACCOUNTS CHEM RES, V35, P997, DOI 10.1021/ar020259h
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Huang HH, 2005, SCRIPTA MATER, V53, P1037, DOI 10.1016/j.scriptamat.2005.07.006
   IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0
   Kim HW, 2004, BIOMATERIALS, V25, P2533, DOI 10.1016/j.biomaterials.2003.09.041
   Ma J, 2003, BIOMATERIALS, V24, P3505, DOI 10.1016/S0142-9612(03)00203-5
   Nie X, 2000, SURF COAT TECH, V125, P407, DOI 10.1016/S0257-8972(99)00612-X
   NIEH TG, 1991, SCRIPTA METALL MATER, V25, P955, DOI 10.1016/0956-716X(91)90256-Z
   Poulin P, 2002, CARBON, V40, P1741, DOI 10.1016/S0008-6223(02)00042-8
   SHIRKHANZADEH M, 1991, J MATER SCI LETT, V10, P1415, DOI 10.1007/BF00735695
   Wang C, 2002, MATER LETT, V57, P99, DOI 10.1016/S0167-577X(02)00706-1
   Wei M, 2005, J MATER SCI-MATER M, V16, P319, DOI 10.1007/s10856-005-0630-0
   Wei M, 2001, J SOL-GEL SCI TECHN, V21, P39, DOI 10.1023/A:1011201414651
   Wei M, 1999, J MATER SCI-MATER M, V10, P401, DOI 10.1023/A:1008923029945
   Zhao B, 2005, CHEM MATER, V17, P3235, DOI 10.1021/cm0500399
   Zhao LP, 2004, CARBON, V42, P423, DOI 10.1016/j.carbon.2003.10.024
   Zhitomirsky I, 1998, J EUR CERAM SOC, V18, P849, DOI 10.1016/S0955-2219(97)00213-6
   Zhitomirsky I, 2000, MATER LETT, V42, P262, DOI 10.1016/S0167-577X(99)00197-4
NR 32
TC 37
Z9 40
U1 0
U2 25
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUL
PY 2008
VL 19
IS 7
BP 2569
EP 2574
DI 10.1007/s10856-007-3196-1
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 301EL
UT WOS:000255879100007
PM 17619960
DA 2018-10-19
ER

PT J
AU Kundu, J
   Dewan, M
   Ghoshal, S
   Kundu, SC
AF Kundu, Joydip
   Dewan, Moumita
   Ghoshal, Sarani
   Kundu, S. C.
TI Mulberry non-engineered silk gland protein vis-a-vis silk cocoon protein
   engineered by silkworms as biomaterial matrices
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 5th Asian-Australian Conference on Composite Materials (ACCM-5_
CY NOV 27-30, 2006
CL Hong Kong, PEOPLES R CHINA
ID BOMBYX-MORI; CONTROLLED-RELEASE; AQUEOUS-SOLUTIONS; FIBROIN FILMS;
   SPIDER SILK; SCAFFOLDS; POLYMER; GENE; FIBERS; REGENERATION
AB Silk fibroin from silk gland of Bombyx mori 5th instar larvae was utilized to fabricate films, which may find possible applications as two-dimensional matrices for tissue engineering. Bombyx mori cocoon fibroin is well characterized as potential biomaterial by virtue of its good mechanical strength, water stability, thermal properties, surface roughness and biocompatibility. The present study aims to characterize the biophysical, thermal, mechanical, rheological, swelling properties along with spectroscopic analysis, surface morphology and biocompatibility of the silk gland fibroin films compared with cocoon fibroin. Fibroin solutions showed increased turbidity and shear thinning at higher concentration. The films after methanol treatment swelled moderately and were less hydrophilic compared to the untreated. The spectroscopic analysis of the films illustrated the presence of various amide peaks and conformational transition from random coil to beta sheet on methanol treatment. X-ray diffraction studies also confirmed the secondary structure. Thermogravimetric analysis showed distinct weight loss of the films. The films were mechanically stronger and AFM studies showed surfaces were rougher on methanol treatment. The matrices were biocompatible and supported L929 mouse fibroblast cell growth and proliferation. The results substantiate the silk gland fibroin films as potential biomaterial matrices.
C1 [Kundu, Joydip; Dewan, Moumita; Ghoshal, Sarani; Kundu, S. C.] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
RP Kundu, SC (reprint author), Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
EM kundu@hijli.iitkgp.ernet.in
RI Kundu, Subhas/P-1989-2016
OI Kundu, Subhas/0000-0002-7170-2291
CR Agarwal N, 1997, J APPL POLYM SCI, V63, P401
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Arai T, 2004, J APPL POLYM SCI, V91, P2383, DOI 10.1002/app.13393
   ASTM, 1993, ANN BOOK ASTM STAND, P59
   Bayraktar O, 2005, EUR J PHARM BIOPHARM, V60, P373, DOI 10.1016/j.ejpb.2005.02.002
   Cai KY, 2002, BIOMATERIALS, V23, P1603, DOI 10.1016/S0142-9612(01)00287-3
   Chen X, 2001, POLYMER, V42, P9969, DOI 10.1016/S0032-3861(01)00541-9
   Feng XX, 2007, INT J BIOL MACROMOL, V40, P105, DOI 10.1016/j.ijbiomac.2006.06.011
   Fini M, 2005, BIOMATERIALS, V26, P3527, DOI 10.1016/j.biomaterials.2004.09.040
   GAMO T, 1982, BIOCHEM GENET, V20, P165, DOI 10.1007/BF00484944
   GIMENES ML, 2007, J MEMB SCI, V29, P71
   Gobin AS, 2005, J BIOMED MATER RES A, V74A, P465, DOI 10.1002/jbm.a.30382
   GRZELAK K, 1995, COMP BIOCHEM PHYS B, V110, P671, DOI 10.1016/0305-0491(94)00215-G
   Hino T, 2003, J COLLOID INTERF SCI, V266, P68, DOI 10.1016/S0021-9797(03)00584-8
   Hofmann S, 2006, J CONTROL RELEASE, V111, P219, DOI 10.1016/j.jconrel.205.12.009
   Hu K, 2006, J BIOACT COMPAT POL, V21, P23, DOI 10.1177/0883911506060455
   Hwang JS, 2001, BIOTECHNOL LETT, V23, P1321, DOI 10.1023/A:1010542011150
   Iliescu T, 2005, CHEM PHYS, V310, P189, DOI 10.1016/j.chemphys.2004.10.034
   Inoue S, 2000, J BIOL CHEM, V275, P40517, DOI 10.1074/jbc.M006897200
   Inoue SI, 2000, J POLYM SCI POL PHYS, V38, P1436, DOI 10.1002/(SICI)1099-0488(20000601)38:11<1436::AID-POLB30>3.0.CO;2-8
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   KAPLAN DL, 1992, MRS BULL, V17, P41
   KAPLAN DL, 1998, PROTEIN BASED MAT, P103
   Li MZ, 2001, J APPL POLYM SCI, V79, P2192, DOI 10.1002/1097-4628(20010321)79:12<2192::AID-APP1027>3.0.CO;2-0
   Malay O, 2007, INT J BIOL MACROMOL, V40, P387, DOI 10.1016/j.ijbiomac.2006.09.017
   MANDAL BB, IN PRESS BIOTECHNOL
   Mathur AB, 1997, BIOPOLYMERS, V42, P61, DOI 10.1002/(SICI)1097-0282(199707)42:1<61::AID-BIP6>3.0.CO;2-#
   MICHAILLE JJ, 1986, BIOCHIMIE, V68, P1165, DOI 10.1016/S0300-9084(86)80060-8
   MINIURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511
   Motta A, 2002, MACROMOL CHEM PHYSIC, V203, P1658, DOI 10.1002/1521-3935(200207)203:10/11<1658::AID-MACP1658>3.0.CO;2-3
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Park KE, 2006, INT J BIOL MACROMOL, V38, P165, DOI 10.1016/j.ijbiomac.2006.03.003
   Putthanarat S, 2002, POLYMER, V43, P3405, DOI 10.1016/S0032-3861(02)00161-1
   Rammensee S, 2006, APPL PHYS A-MATER, V82, P261, DOI 10.1007/s00339-005-3431-x
   Rousseau ME, 2004, BIOMACROMOLECULES, V5, P2247, DOI 10.1021/bm049717V
   SHIOZAKI H, 2003, ANGEW MAKROMOLEKULAR, V64, P1
   Sugihara A, 2000, P SOC EXP BIOL MED, V225, P58, DOI 10.1046/j.1525-1373.2000.22507.x
   Sun YY, 1997, J APPL POLYM SCI, V65, P959, DOI 10.1002/(SICI)1097-4628(19970801)65:5<959::AID-APP14>3.0.CO;2-N
   Tao W, 2007, INT J BIOL MACROMOL, V40, P472, DOI 10.1016/j.ijbiomac.2006.11.006
   TELLEZGARAY AM, 1999, THESIS TEXAS A M U C
   TSUKADA M, 1994, J POLYM SCI POL PHYS, V32, P961, DOI 10.1002/polb.1994.090320519
   Um IC, 2001, INT J BIOL MACROMOL, V29, P91, DOI 10.1016/S0141-8130(01)00159-3
   Valluzzi R, 1999, INT J BIOL MACROMOL, V24, P237, DOI 10.1016/S0141-8130(99)00002-1
   van Egmond JW, 1998, CURR OPIN COLLOID IN, V3, P385, DOI 10.1016/S1359-0294(98)80054-X
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang H, 2005, INT J BIOL MACROMOL, V36, P66, DOI 10.1016/j.ijbiomac.2005.03.011
   Wang WB, 2005, J BIOSCIENCES, V30, P605, DOI 10.1007/BF02703560
   Wang XY, 2007, J CONTROL RELEASE, V121, P190, DOI 10.1016/j.jconrel.2007.06.006
   Wang XY, 2005, LANGMUIR, V21, P11335, DOI 10.1021/la051862m
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   Yeo JH, 2003, EUR POLYM J, V39, P1195, DOI 10.1016/S0014-3057(02)00359-2
   Yoo MK, 2004, INT J BIOL MACROMOL, V34, P263, DOI 10.1016/j.ijbiomac.2004.06.002
   Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413
   Zhu JX, 2007, INT J BIOL MACROMOL, V41, P469, DOI 10.1016/j.ijbiomac.2007.06.006
NR 55
TC 28
Z9 28
U1 1
U2 22
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUL
PY 2008
VL 19
IS 7
BP 2679
EP 2689
DI 10.1007/s10856-008-3398-1
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 301EL
UT WOS:000255879100021
PM 18283532
DA 2018-10-19
ER

PT J
AU Biggs, MJP
   Richards, RG
   Wilkinson, CDW
   Dalby, MJ
AF Biggs, M. J. P.
   Richards, R. G.
   Wilkinson, C. D. W.
   Dalby, M. J.
TI Focal adhesion interactions with topographical structures: a novel
   method for immuno-SEM labelling of focal adhesions in S-phase cells
SO JOURNAL OF MICROSCOPY
LA English
DT Article
DE cell cycle; focal adhesions; immunocytochemistry; osteoblast; scanning
   electron microscopy; S-phase
ID SCANNING ELECTRON-MICROSCOPY; SUBSTRATUM ADHESION; CONTACT GUIDANCE;
   PROLIFERATION; ENHANCEMENT; BIOMATERIALS; UNDERSURFACE; FIBROBLASTS;
   MARKERS; GROWTH
AB Current understanding of the mechanisms involved in osseointegration following implantation of a biomaterial has led to adhesion quantification being implemented as an assay of cytocompatibility. Such measurement can be hindered by intra-sample variation owing to morphological changes associated with the cell cycle. Here we report on a new scanning electron microscopical method for the simultaneous immunogold labelling of cellular focal adhesions and S-phase nuclei identified by BrdU incorporation. Prior to labelling, cellular membranes are removed by tritonization and antigens of non-interest blocked by serum incubation. Adhesion plaque-associated vinculin and S-phase nuclei were both separately labelled with a 1.4 nm gold colloid and visualized by subsequent colloid enhancement via silver deposition. This study is specifically concerned with the effects microgroove topographies have on adhesion formation in S-phase osteoblasts. By combining backscattered electron (BSE) imaging with secondary electron (SE) imaging it was possible to visualize S-phase nuclei and the immunogold-labelled adhesion sites in one energy 'plane' and the underlying nanotopography in another. Osteoblast adhesion to these nanotopographies was ascertained by quantification of adhesion complex formation.
C1 [Biggs, M. J. P.; Wilkinson, C. D. W.; Dalby, M. J.] Univ Glasgow, Inst Biomed & Life Sci, Ctr Cell Engn, Glasgow G12 8QQ, Lanark, Scotland.
RP Biggs, MJP (reprint author), Univ Glasgow, Inst Biomed & Life Sci, Ctr Cell Engn, Joseph Black Bldg, Glasgow G12 8QQ, Lanark, Scotland.
EM m.biggs.1@research.gla.ac.uk
RI Messier, Claude/A-2322-2008; Dalby, Matthew/G-2426-2012; Richards,
   Robert/I-8235-2015
OI Messier, Claude/0000-0002-4791-1763; Richards,
   Robert/0000-0002-7778-2480; Dalby, Matthew/0000-0002-0528-3359; Biggs,
   Manus/0000-0003-4699-1025
FU Biotechnology and Biological Sciences Research Council
CR BEISKER W, 1987, CYTOMETRY, V8, P235, DOI 10.1002/cyto.990080218
   Bershadsky AD, 2006, EUR J CELL BIOL, V85, P165, DOI 10.1016/j.ejcb.2005.11.001
   Besser A, 2006, BIOPHYS J, V90, P3469, DOI 10.1529/biophysj.105.074377
   Biggs MJP, 2007, J MATER SCI-MATER M, V18, P399, DOI 10.1007/s10856-006-0705-6
   BIGGS MJ, 2006, J ORTHOP RES, V25, P273, DOI DOI 10.1002/JOR.20319
   CHRISTENSEN MM, 1992, HISTOCHEMISTRY, V97, P207, DOI 10.1007/BF00267629
   DAVIES PF, 1993, J CLIN INVEST, V91, P2640, DOI 10.1172/JCI116503
   EVERHART LP, 1974, J CELL BIOL, V60, P434, DOI 10.1083/jcb.60.2.434
   FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0
   Gadegaard N, 2003, MACROMOL MATER ENG, V288, P76, DOI 10.1002/mame.200290037
   GADEGAARD N, 2003, MICROELECTRON ENG, V67, P126
   HALL PA, 1990, CELL TISSUE KINET, V23, P505, DOI 10.1111/j.1365-2184.1990.tb01343.x
   HOWARD A, 1951, NATURE, V167, P599, DOI 10.1038/167599a0
   HUNTER A, 1995, BIOMATERIALS, V16, P287, DOI 10.1016/0142-9612(95)93256-D
   Ingber DE, 1995, J BIOMECH, V28, P1471, DOI 10.1016/0021-9290(95)00095-X
   Karuri NW, 2004, J CELL SCI, V117, P3153, DOI 10.1242/jcs.01146
   Laitinen OH, 2006, CELL MOL LIFE SCI, V63, P2992, DOI 10.1007/s00018-006-6288-z
   LORZ M, 1994, EUR ARCH OTO-RHINO-L, V251, P91
   LOTZ MM, 1989, J CELL BIOL, V109, P1795, DOI 10.1083/jcb.109.4.1795
   Matsuzaka K, 2000, CLIN ORAL IMPLAN RES, V11, P325, DOI 10.1034/j.1600-0501.2000.011004325.x
   Meredith DO, 2004, EXP CELL RES, V293, P58, DOI 10.1016/j.yexcr.2003.10.005
   Mokry J, 1995, Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove, V38, P107
   OHARA PT, 1979, EXP CELL RES, V121, P235, DOI 10.1016/0014-4827(79)90002-8
   Oleschuk RD, 2000, BIOMATERIALS, V21, P1701, DOI 10.1016/S0142-9612(00)00054-5
   Owen GR, 2002, J MICROSC-OXFORD, V207, P27, DOI 10.1046/j.1365-2818.2002.01035.x
   Owen GRH, 2001, CELL BIOL INT, V25, P1251, DOI 10.1006/cbir.2001.0846
   PELC SR, 1952, BRIT MED BULL, V8, P132
   RICHARDS RG, 1993, J MICROSC-OXFORD, V171, P205, DOI 10.1111/j.1365-2818.1993.tb03377.x
   RICHARDS RG, 1995, J MICROSC-OXFORD, V177, P43, DOI 10.1111/j.1365-2818.1995.tb03532.x
   Richards RG, 2001, CELL BIOL INT, V25, P1237, DOI 10.1006/cbir.2001.0807
   Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383
   Weipoltshammer K, 2000, HISTOCHEM CELL BIOL, V114, P489
   Yanai T, 1996, J COMP PATHOL, V114, P265, DOI 10.1016/S0021-9975(96)80048-X
   Zamir E, 2001, J CELL SCI, V114, P3583
   Zimerman B, 2004, CELL MOTIL CYTOSKEL, V58, P143, DOI 10.1002/cm.20005
NR 35
TC 22
Z9 22
U1 1
U2 9
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0022-2720
J9 J MICROSC-OXFORD
JI J. Microsc..
PD JUL
PY 2008
VL 231
IS 1
BP 28
EP 37
DI 10.1111/j.1365-2818.2008.02013.x
PG 10
WC Microscopy
SC Microscopy
GA 324CH
UT WOS:000257494800004
PM 18638187
OA Bronze
DA 2018-10-19
ER

PT J
AU Intini, G
   Andreana, S
   Buhite, RJ
   Bobek, LA
AF Intini, Giuseppe
   Andreana, Sebastiano
   Buhite, Robert J.
   Bobek, Libuse A.
TI A comparative analysis of bone formation induced by human demineralized
   freeze-dried bone and enamel matrix derivative in rat calvaria
   critical-size bone defects
SO JOURNAL OF PERIODONTOLOGY
LA English
DT Article
DE bone morphogenetic protein 2; bone regeneration; demineralized bone
ID PERIODONTAL DEFECTS; MORPHOGENETIC PROTEIN-2; IN-VIVO; REGENERATION;
   EMDOGAIN(R); ALLOGRAFTS; SITES; MODEL; BMP; OSTEOINDUCTION
AB Background: Human demineralized freeze-dried bone allograft (DFDBA) and enamel matrix derivative (EMD) have been used with varying success for the treatment of bone and periodontal defects. The purpose of this study was to compare qualitatively and quantitatively the bone formation induced by DFDBA and EMD to that of a positive control, recombinant human bone morphogenetic protein 2 (rhBMP-2), in the 8-mm rat calvaria critical-size bone defect.
   Methods: Five groups of five rats each were used. The two test groups were DFDBA and EMD. A negative control consisted of a defect without any biomaterial implanted, a positive control consisted of a defect filled with collagen carrying rhBMP-2, and a non-surgical control consisted of the intact rat calvaria. Eight weeks after implantation of the biomaterials, histologic analysis was used for qualitative assessments and microcomputed tomography was used for quantitative assessments of bone formation. Statistical evaluation was performed by analysis of variance followed by the Fisher's least significant difference multiple-comparison test.
   Results: In the negative control and EMD groups, the histologic analysis showed no bone formation within the center of the defect and limited bone repair at its margins. In the DFDBA group, granules of DFDBA were still present 8 weeks after implantation, and a limited degree of osteoinduction was seen at the center of the defect. The microcomputed tomography quantitative analysis showed a limited capacity of DFDBA and EMD to induce bone formation, and no statistically significant difference was detected among DFDBA, EMD, and the negative control. On the contrary, the positive control (rhBMP-2) consistently showed regeneration of bone throughout the critical-size defects.
   Conclusion: Unlike rhBMP-2, DFDBA and EMD had limited ability to induce bone formation in the rat calvaria critical-size bone defect; therefore, they may not be effective as bone-regenerative therapy for critical-size defects.
C1 [Intini, Giuseppe; Buhite, Robert J.] SUNY Buffalo, Dept Periodont & Endodont, Buffalo, NY 14260 USA.
   [Intini, Giuseppe; Bobek, Libuse A.] SUNY Buffalo, Dept Oral Biol, Buffalo, NY 14260 USA.
   [Andreana, Sebastiano] Loma Linda Univ, Dept Periodont, Loma Linda, CA 92350 USA.
   [Buhite, Robert J.] SUNY Buffalo, Dept Restorat Dent, Buffalo, NY 14260 USA.
   [Buhite, Robert J.] SUNY Buffalo, Dept Oral Maxillofacial Surg, Buffalo, NY 14260 USA.
RP Intini, G (reprint author), Harvard Univ, Sch Dent Med, Dept Dev Biol, 188 Longwood Ave,REB 513, Boston, MA 02115 USA.
EM giuseppe_intini@hsdm.harvard.edu
FU NIDCR NIH HHS [R01 DE 009820]
CR Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282
   *AM ASS TISS BANKS, 2006, STAND TISS BANK
   AN YH, 1999, ANIMAL MODELS ORTHOP, P241
   Becker W, 1998, J PERIODONTOL, V69, P414, DOI 10.1902/jop.1998.69.4.414
   BECKER W, 1995, J PERIODONTOL, V66, P822, DOI 10.1902/jop.1995.66.9.822
   Becker W, 1996, J PERIODONTOL, V67, P1025, DOI 10.1902/jop.1996.67.10.1025
   Bonadio J, 1999, NAT MED, V5, P753, DOI 10.1038/10473
   Bostrom MPG, 1999, ORTHOP CLIN N AM, V30, P647, DOI 10.1016/S0030-5898(05)70117-6
   Boyan BD, 2000, J PERIODONTOL, V71, P1278, DOI 10.1902/jop.2000.71.8.1278
   Cochran D, 2001, J PERIODONTOL, V72, P834, DOI 10.1902/jop.2001.72.6.834
   Cortellini P, 1995, Int J Periodontics Restorative Dent, V15, P128
   Donos N, 2006, CLIN ORAL IMPLAN RES, V17, P434, DOI 10.1111/j.1600-0501.2006.01260.x
   Edwards JT, 1998, CLIN ORTHOP RELAT R, P219
   Feighan JE, 1995, J ORTHOP RES, V13, P881, DOI 10.1002/jor.1100130612
   Giannobile William V, 2003, Ann Periodontol, V8, P193, DOI 10.1902/annals.2003.8.1.193
   Govender S, 2002, J BONE JOINT SURG AM, V84A, P2123, DOI 10.2106/00004623-200212000-00001
   Heden G, 1999, J CLIN PERIODONTOL, V26, P855
   Heden G, 2006, J PERIODONTOL, V77, P295, DOI 10.1902/jop.2006.050071
   Heijl L, 1997, J CLIN PERIODONTOL, V24, P705, DOI 10.1111/j.1600-051X.1997.tb00253.x
   Intini G, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-13
   Iwata T, 2002, J DENT RES, V81, P387, DOI 10.1177/154405910208100606
   Kawana F, 2001, ANAT REC, V264, P438, DOI 10.1002/ar.10016
   Kawase T, 2001, J PERIODONTAL RES, V36, P367, DOI 10.1034/j.1600-0765.2001.360604.x
   Laurell L, 1998, J PERIODONTOL, V69, P303, DOI 10.1902/jop.1998.69.3.303
   LIBIN BM, 1975, J PERIODONTOL, V46, P51, DOI 10.1902/jop.1975.46.1.51
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Machtei E E, 1995, Int J Periodontics Restorative Dent, V15, P146
   MARDEN LJ, 1994, J BIOMED MATER RES, V28, P1127, DOI 10.1002/jbm.820281003
   Oliver RC, 1998, J PERIODONTOL, V69, P269, DOI 10.1902/jop.1998.69.2.269
   Ozturk A, 2006, INT ORTHOP, V30, P147, DOI 10.1007/s00264-006-0079-x
   Pacaccio Douglas J, 2005, Clin Podiatr Med Surg, V22, P599, DOI 10.1016/j.cpm.2005.07.001
   PINHOLT EM, 1992, SCAND J DENT RES, V100, P361
   Reynolds Mark A, 2003, Ann Periodontol, V8, P227, DOI 10.1902/annals.2003.8.1.227
   Rosen P S, 1997, Int J Periodontics Restorative Dent, V17, P516
   Rosen V, 2006, ANN NY ACAD SCI, V1068, P19, DOI 10.1196/annals.1346.005
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, P299
   SCHMITZ JP, 1990, ACTA ANAT, V138, P185
   Schwartz Z, 1996, J PERIODONTOL, V67, P918, DOI 10.1902/jop.1996.67.9.918
   Stevenson S, 1998, CLIN ORTHOP RELAT R, pS239
   Suzuki S, 2005, J DENT RES, V84, P510, DOI 10.1177/154405910508400605
   Szpalski Marek, 2005, Acta Orthop Belg, V71, P133
   TAKAGI K, 1982, ANN SURG, V196, P100, DOI 10.1097/00000658-198207000-00020
   Termaat MF, 2005, J BONE JOINT SURG AM, V87A, P1367, DOI 10.2106/JBJS.D.02585
   Turonis James W, 2006, J Oral Implantol, V32, P55, DOI 10.1563/780.1
   WANG EA, 1990, P NATL ACAD SCI USA, V87, P2220, DOI 10.1073/pnas.87.6.2220
   Yoneda S, 2003, J PERIODONTAL RES, V38, P333, DOI 10.1034/j.1600-0765.2003.00667.x
   Zetterstrom O, 1997, J CLIN PERIODONTOL, V24, P697, DOI 10.1111/j.1600-051X.1997.tb00252.x
NR 48
TC 20
Z9 23
U1 0
U2 6
PU AMER ACAD PERIODONTOLOGY
PI CHICAGO
PA 737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA
SN 0022-3492
J9 J PERIODONTOL
JI J. Periodont.
PD JUL
PY 2008
VL 79
IS 7
BP 1217
EP 1224
DI 10.1902/jop.2008.070435
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 326FJ
UT WOS:000257643600014
PM 18597604
DA 2018-10-19
ER

PT J
AU Traini, T
   Degidi, M
   Sammons, R
   Stanley, P
   Piattelli, A
AF Traini, Tonino
   Degidi, Marco
   Sammons, Rachel
   Stanley, Paul
   Piattelli, Adriano
TI Histologic and elemental microanalytical study of anorganic bovine bone
   substitution following sinus floor augmentation in humans
SO JOURNAL OF PERIODONTOLOGY
LA English
DT Article
DE bio-oss; bone regeneration; electron microscopy; histology; sinus
ID PLATELET-RICH PLASMA; PROTEIN-KINASE-A; MAXILLARY SINUS; EXTRACELLULAR
   CALCIUM; BIO-OSS; SURFACE-ROUGHNESS; IMPLANT PLACEMENT; DENTAL IMPLANTS;
   2003 UPDATE; FLUID-FLOW
AB Background: Histologic data regarding the use of anorganic bovine bone (ABB) in humans are scarce. This study was a histologic evaluation and an examination of the elemental composition of ABB particles and adjacent bone in humans.
   Methods: Ten biopsies were retrieved 20 months after maxillary sinus augmentation in five patients. The investigation was carried out using light microscopy in brightfield, fluorescence, and circularly polarized light and scanning electron microscopy (SEM) with energy-dispersive x-ray spectroscopy.
   Results: The regenerated tissue consisted of 38% +/- 2.1% newly formed bone, 36% +/- 1.3% marrow spaces, and 29% +/- 1.8% residual ABB particles. Under polarized light, the newly formed bone was characterized by randomly oriented collagen fibers. Under fluorescence, the biomaterial showed close apposition to bone; under SEM, several projections of newly formed bone were seen penetrating the ABB particles. ABB and bone were distinguished by the lighter gray color of the biomaterial in back-scattered electron images; ABB particles were surrounded and linked by newly formed bone. Elemental analysis gave average calcium/phosphorus ratios (atomic %) similar to 1.9 for ABB and 1.4 for bone. Relatively high concentrations of calcium and phosphorus in the biomaterial decreased gradually toward the interface with bone.
   Conclusion: The persistence of ABB in the human tissue after 20 months might have been related to the relatively high calcium content of the biomaterial as well as the absence of proteins.
C1 [Traini, Tonino; Piattelli, Adriano] Univ G dAnnunzio, Sch Dent, Chieti, Italy.
   [Sammons, Rachel] Univ Birmingham, Sch Dent, Birmingham, W Midlands, England.
   [Stanley, Paul] Univ Birmingham, Electron Microscopy Unit, Birmingham B15 2TT, W Midlands, England.
RP Piattelli, A (reprint author), Via F Sciucchi 63, I-66100 Chieti, Italy.
EM apiattelli@unich.it
OI Traini, Tonino/0000-0002-0265-8709; Sammons, Rachel/0000-0002-4787-048X
CR Araujo MG, 2002, J CLIN PERIODONTOL, V29, P1122, DOI 10.1034/j.1600-051X.2002.291213.x
   Artzi Z, 2002, CLIN ORAL IMPLAN RES, V13, P420, DOI 10.1034/j.1600-0501.2002.130411.x
   Bigi A, 1997, J INORG BIOCHEM, V68, P45, DOI 10.1016/S0162-0134(97)00007-X
   Blomqvist JE, 1998, ORAL SURG ORAL MED O, V86, P268, DOI 10.1016/S1079-2104(98)90170-6
   Boyan BD, 1999, BIOMATERIALS, V20, P2305, DOI 10.1016/S0142-9612(99)00159-3
   Burr DB, 2002, BONE, V30, P2, DOI 10.1016/S8756-3282(01)00619-6
   DACULSI G, 1990, BIOMATERIALS, V11, P86
   DEGROOT K, 1981, BIOCOMPATIBILITY CLI, P199
   Friedmann A, 2002, CLIN ORAL IMPLAN RES, V13, P587, DOI 10.1034/j.1600-0501.2002.130603.x
   Frost HM, 2004, ANGLE ORTHOD, V74, P3
   Frost HM, 2003, ANAT REC PART A, V275A, P1081, DOI 10.1002/ar.a.10119
   Froum SJ, 1998, INT J PERIODONT REST, V18, P529
   GOMI K, 1993, BIOMATERIALS, V14, P91, DOI 10.1016/0142-9612(93)90216-O
   Haas R, 2002, INT J ORAL MAX IMPL, V17, P337
   HALL TJ, 1994, BIOCHEM BIOPH RES CO, V202, P456, DOI 10.1006/bbrc.1994.1950
   Hallman M, 2001, CLIN ORAL IMPLAN RES, V12, P135, DOI 10.1034/j.1600-0501.2001.012002135.x
   JENSEN OT, 1992, TISSUE INTEGRATION IN ORAL, ORTHOPEDIC, AND MAXILLOFACIAL RECONSTRUCTION, P321
   Landi L, 2000, INT J PERIODONT REST, V20, P575
   LANDIS WJ, 1995, BONE, V16, P533, DOI 10.1016/8756-3282(95)00076-P
   Lorget F, 2000, BIOCHEM BIOPH RES CO, V268, P899, DOI 10.1006/bbrc.2000.2229
   Maiorana C, 2003, INT J PERIODONT REST, V23, P227
   Martin RB, 2002, BONE, V30, P8, DOI 10.1016/S8756-3282(01)00620-2
   MCDOWELL H, 1977, J RES NBS A PHYS CH, V81, P273, DOI 10.6028/jres.081A.017
   Merkx MAW, 2003, INT J ORAL MAX SURG, V32, P1, DOI 10.1054/ijom.2002.0346
   Merkx MAW, 1999, BIOMATERIALS, V20, P2029, DOI 10.1016/S0142-9612(99)00105-2
   Misch C E, 1990, Int J Oral Implantol, V6, P23
   MIYAUCHI A, 1990, J CELL BIOL, V111, P2543, DOI 10.1083/jcb.111.6.2543
   Noble BS, 1997, BONE, V20, P273, DOI 10.1016/S8756-3282(96)00365-1
   Orsini G, 2005, J BIOMED MATER RES B, V74B, P448, DOI 10.1002/jbm.b.30196
   Ozaki W, 1998, PLAST RECONSTR SURG, V102, P291, DOI 10.1097/00006534-199808000-00001
   Parfitt AM, 2002, BONE, V30, P5, DOI 10.1016/S8756-3282(01)00642-1
   Piattelli A, 1997, BIOMATERIALS, V18, P577, DOI 10.1016/S0142-9612(96)00177-9
   Piattelli M, 1999, INT J ORAL MAX IMPL, V14, P835
   Ramaswamy Y, 2005, J MATER SCI-MATER M, V16, P1199, DOI 10.1007/s10856-005-4729-0
   Rodriguez A, 2003, J ORAL MAXIL SURG, V61, P157, DOI 10.1053/joms.2003.50041
   Schwartz Z, 2000, J PERIODONTOL, V71, P1258, DOI 10.1902/jop.2000.71.8.1258
   Schwartz Z, 2001, BIOMATERIALS, V22, P731, DOI 10.1016/S0142-9612(00)00241-6
   SHIMIZU H, 1989, BONE MINER, V6, P261, DOI 10.1016/0169-6009(89)90033-0
   Siebers MC, 2005, BIOMATERIALS, V26, P137, DOI 10.1016/j.biomaterials.2004.02.021
   Smit TH, 2002, J BONE MINER RES, V17, P2021, DOI 10.1359/jbmr.2002.17.11.2021
   Tadjoedin ES, 2003, J CLIN PERIODONTOL, V30, P261, DOI 10.1034/j.1600-051X.2003.01099.x
   Tami AE, 2002, J BONE MINER RES, V17, P2030, DOI 10.1359/jbmr.2002.17.11.2030
   Traini T, 2007, J PERIODONTOL, V78, P955, DOI 10.1902/jop.2007.060308
   Valentini P, 2003, INT J ORAL MAX IMPL, V18, P556
   Valentini P, 2000, INT J PERIODONT REST, V20, P245
   Valentini P, 1997, INT J PERIODONT REST, V17, P233
   Verborgt O, 2000, J BONE MINER RES, V15, P60, DOI 10.1359/jbmr.2000.15.1.60
   Wallace SS, 1996, INT J PERIODONT REST, V16, P47
   Wallace Stephen S, 2003, Ann Periodontol, V8, P328, DOI 10.1902/annals.2003.8.1.328
   WETZEL AC, 1995, CLIN ORAL IMPLAN RES, V6, P155, DOI 10.1034/j.1600-0501.1995.060304.x
   Wheeler SL, 1997, J ORAL MAXIL SURG, V55, P1287, DOI 10.1016/S0278-2391(97)90186-5
   You LD, 2004, ANAT REC PART A, V278A, P505, DOI 10.1002/ar.a.20050
NR 52
TC 35
Z9 39
U1 0
U2 4
PU AMER ACAD PERIODONTOLOGY
PI CHICAGO
PA 737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA
SN 0022-3492
EI 1943-3670
J9 J PERIODONTOL
JI J. Periodont.
PD JUL
PY 2008
VL 79
IS 7
BP 1232
EP 1240
DI 10.1902/jop.2008.070504
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 326FJ
UT WOS:000257643600016
PM 18597606
DA 2018-10-19
ER

PT J
AU Giannoni, P
   Mastrogiacomo, M
   Alini, M
   Pearce, SG
   Corsi, A
   Santolini, F
   Muraglia, A
   Bianco, P
   Cancedda, R
AF Giannoni, P.
   Mastrogiacomo, M.
   Alini, M.
   Pearce, S. G.
   Corsi, A.
   Santolini, F.
   Muraglia, A.
   Bianco, P.
   Cancedda, R.
TI Regeneration of large bone defects in sheep using bone marrow stromal
   cells
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE bone repair; bone tissue engineering; cell differentiation; ceramic
   scaffold; in vivo test; mesenchymal stem cells
ID MESENCHYMAL STEM-CELLS; GRAFT HARVEST; TISSUE-REPAIR; RABBIT MODEL;
   IN-VIVO; DIFFERENTIATION; HYDROXYAPATITE; RECONSTRUCTION;
   MICROTOMOGRAPHY; DISTRACTION
AB Bone repair was addressed in a critical-sized defect model in sheep, combining a ceramic biomaterial and mesenchymal progenitor cells. The defects in the tibial mid-diaphysis were treated with autologous bone or with a silicon-stabilized tricalcium phosphate biomaterial, implemented cor not by the addition of expanded bone marrow stromal cells. An internal locking compression plate and an external fixator were applied for stabilization. Radiographies were taken during the 8 months follow-up: the pixel grey levels of the lesion areas were determined to evaluate the repair process radiologically. Microradiography, histology and vascular density tests were performed. The autologous bone-treated group performed best, as assessed radiologically, within 20-24 weeks after surgery. Very limited healing was detected in the other experimental group: a partial bone deposition occurred at the periphery of the bony stumps only in the cell-seeded scaffolds. Interestingly, this effect ended within 20-24 weeks, as for the autologous bone, suggesting similar kinetics of the repair processes involved. Moreover, bone deposition was located where a significant reduction of the ceramic scaffold was detected. Faxitron microradiography and histology data confirmed these results. Vascular density analysis evidenced that cell-seeded scaffolds supported an increased vascular ingrowth. Thus, the interactions with the proper microenvironment and the oxygen and nutrient supply in the inner part of the constructs seem fundamental to initiate scaffold substitution and to improve cell performance in tissue-engineered approaches to bone repair. Copyright (C) 2008 John Wiley & Sons, Ltd.
C1 [Mastrogiacomo, M.; Cancedda, R.] Natl Inst Canc Res, Adv Biotechnol Ctr, Stem Cell Lab, I-16132 Genoa, Italy.
   [Giannoni, P.; Muraglia, A.] Biorigen SRL, I-16149 Genoa, Italy.
   [Mastrogiacomo, M.; Cancedda, R.] Univ Genoa, Dept Oncol Biol & Genet, I-16132 Genoa, Italy.
   [Alini, M.; Pearce, S. G.] AO Res Inst, CH-7270 Davos, Switzerland.
   [Corsi, A.; Bianco, P.] Univ Roma La Sapienza, Expt Med & Pathol Dept, I-00169 Rome, Italy.
   [Santolini, F.] Azienda Ospedaliera San Martino, I-16132 Genoa, Italy.
RP Giannoni, P (reprint author), Natl Inst Canc Res, Adv Biotechnol Ctr, Stem Cell Lab, Largo R Benzi 10, I-16132 Genoa, Italy.
EM paolo.giannoni@cba-biotecnologie.it
CR Bensaid W, 2005, TISSUE ENG, V11, P814, DOI 10.1089/ten.2005.11.814
   Brawley SC, 2006, ORTHOPEDICS, V29, P342
   Bruder SP, 1998, J BONE JOINT SURG AM, V80A, P985, DOI 10.2106/00004623-199807000-00007
   Chaudhary LR, 2004, BONE, V34, P402, DOI 10.1016/j.bone.2003.11.014
   Chen YC, 2006, HEAD NECK-J SCI SPEC, V28, P496, DOI 10.1002/hed.20452
   Choong PFM, 2003, CLIN ORTHOP RELAT R, pS19, DOI 10.1097/01.blo.0000093839.72468.da
   Chou LB, 2007, FOOT ANKLE INT, V28, P199, DOI 10.3113/FAI.2007.0199
   Delloye C, 2003, Chir Organi Mov, V88, P335
   Derubeis AR, 2004, ANN BIOMED ENG, V32, P160, DOI 10.1023/B:ABME.0000007800.89194.95
   El-Ghannam A, 2005, EXPERT REV MED DEVIC, V2, P87, DOI 10.1586/17434440.2.1-87
   Follmar KE, 2007, ANN PLAS SURG, V58, P561, DOI 10.1097/01.sap.0000245119.74126.09
   Gregory CA, 2005, EXP CELL RES, V306, P330, DOI 10.1016/j.yexcr.2005.03.018
   Hall N R, 1992, Surg Oncol, V1, P223, DOI 10.1016/0960-7404(92)90068-V
   HEIPLE KG, 1987, ORTHOP CLIN N AM, V18, P179
   HEISE U, 1990, INT ORTHOP, V14, P329
   Hu ZM, 2005, J CRANIOFAC SURG, V16, P1006, DOI 10.1097/01.scs.0000170449.72040.ee
   Jilka RL, 2007, J BONE MINER RES, V22, P1492, DOI 10.1359/JBMR.070518
   Khosla S, 2006, ANN NY ACAD SCI, V1068, P489, DOI 10.1196/annals.1346.022
   Komlev VS, 2006, TISSUE ENG, V12, P3449, DOI 10.1089/ten.2006.12.3449
   Kon E, 2000, J BIOMED MATER RES, V49, P328
   Lee SY, 2007, J CELL PHYSIOL, V210, P561, DOI 10.1002/jcp.20890
   Lisignoli G, 2006, J CELL PHYSIOL, V207, P364, DOI 10.1002/jcp.20572
   Logeart-Avramoglou D, 2005, J CELL MOL MED, V9, P72, DOI 10.1111/j.1582-4934.2005.tb00338.x
   Marcacci M, 1999, CALCIFIED TISSUE INT, V64, P83, DOI 10.1007/s002239900583
   Marie PJ, 2006, REGEN MED, V1, P539, DOI 10.2217/17460751.1.4.539
   Mastrogiacomo M, 2007, BIOMATERIALS, V28, P1376, DOI 10.1016/j.biomaterials.2006.10.001
   Mastrogiacomo M, 2004, TISSUE ENG, V10, P1767, DOI 10.1089/ten.2004.10.1767
   Matsushita T, 1998, ACTA ORTHOP SCAND, V69, P95, DOI 10.3109/17453679809002365
   MODDER UI, 2007, J CELL BIOCHEM, V103, P393
   Nakagami H, 2006, J ATHEROSCLER THROMB, V13, P77, DOI 10.5551/jat.13.77
   OONISHI H, 1991, BIOMATERIALS, V12, P171, DOI 10.1016/0142-9612(91)90196-H
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Potier E, 2007, TISSUE ENG, V13, P1325, DOI 10.1089/ten.2006.0325
   Richards M, 1998, CLIN ORTHOP RELAT R, pS191
   Ringe J, 2007, J CELL BIOCHEM, V101, P135, DOI 10.1002/jcb.21172
   SARTORIS D J, 1992, Journal of Foot Surgery, V31, P301
   Shao XX, 2006, TISSUE ENG, V12, P1539, DOI 10.1089/ten.2006.12.1539
   Soucacos PN, 2006, INJURY, V37, pS41, DOI 10.1016/j.injury.2006.02.040
   Tate MLK, 2007, J BONE JOINT SURG AM, V89A, P307, DOI 10.2106/JBJS.E.00512
   Weiss ML, 2006, STEM CELL REV, V2, P155, DOI 10.1007/s12015-006-0022-y
   Wheeler D L, 2001, Biomed Sci Instrum, V37, P251
   Wheeler DL, 2005, CLIN ORTHOP RELAT R, P36, DOI 10.1097/01.blo.0000165850.58583.50
   Zhang XP, 2005, J BONE MINER RES, V20, P2124, DOI 10.1359/JBMR.050806
NR 43
TC 57
Z9 61
U1 1
U2 7
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD JUL
PY 2008
VL 2
IS 5
BP 253
EP 262
DI 10.1002/term.90
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 328OG
UT WOS:000257807100002
PM 18537203
DA 2018-10-19
ER

PT J
AU Hunt, JA
   Callaghan, JT
AF Hunt, John A.
   Callaghan, Jill T.
TI Polymer-hydroxyapatite composite versus polymer interference screws in
   anterior cruciate ligament reconstruction in a large animal model
SO KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY
LA English
DT Article
DE anterior cruciate ligament; bioabsorbable implants;
   hydroxyapatite-tricalciumphosphate composite;
   hydroxyapatite-polylactide; medical device
ID ANKLE FRACTURES; INTRAARTICULAR MIGRATION; FIXATION DEVICES; IMPLANTS;
   GRAFT; POLYGLYCOLIDE
AB The aim of the study was to assess the hard tissue response of a composite hydroxyapatite/poly L-lactic acid (HA/PLLA) interference screw for anterior cruciate ligament (ACL) reconstruction compared to a standard PLLA screw. Twelve skeletally mature rams underwent unilateral ACL reconstruction using an autologous bone-patellar tendon graft. Each animal received either two test HA/PLLA interference screws or two control PLLA interference screws. Animals were sacrificed at 6 and 12 months post-implantation and the operated knees excised. Undecalcified sections of the screw and surrounding tissues were cut from resin embedded samples and stained; sections were approximately parallel to the longitudinal axis of the screws. A quantitative assessment of bone formation between each screw type (PLLA vs. HA/PLLA) and adjacent tissue in both the tibia and femur was undertaken using automated image analysis (KS400, Zeiss, UK). The inflammatory response of each screw type was assessed by histological evaluation. New bone formation along the perimeter of the screw threads was statistically significantly higher with the HA/PLLA than the PLLA alone. The inflammatory response as assessed semi-quantitatively by histologically determining the number of inflammatory cells present in the tissue adjacent to the implant, was higher for PLLA than HA/PLLA. Significantly increased new bone formation and decreased inflammatory cells were observed in vivo with the composite screw in comparison with the standard polymer. A novel HA/PLLA composite biomaterial in the form of an interference screw demonstrated an improved hard-tissue response compared to PLLA in a large animal ACL reconstruction. This study determined the differences in the tissue response between PLLA and a composite material of HA/PLLA. The improved tissue related outcomes observed in vivo, may be of benefit clinically in ACL reconstruction.
C1 [Hunt, John A.; Callaghan, Jill T.] Univ Liverpool, Sch Clin Sci, UK Ctr Tissue Engn, Liverpool L69 3GA, Merseyside, England.
RP Hunt, JA (reprint author), Univ Liverpool, Sch Clin Sci, UK Ctr Tissue Engn, Duncan Bldg,Daulby St, Liverpool L69 3GA, Merseyside, England.
EM huntja@liv.ac.uk
RI Hunt, John/G-6366-2012
OI Hunt, John/0000-0002-5168-4778; Callaghan, Jill T/0000-0002-5147-7218
FU Medical Research Council [MC_QA137917]
CR Agrawal CM, 1997, J BIOMED MATER RES, V38, P105, DOI 10.1002/(SICI)1097-4636(199722)38:2<105::AID-JBM4>3.0.CO;2-U
   Athanasiou KA, 1998, ARTHROSCOPY, V14, P726, DOI 10.1016/S0749-8063(98)70099-4
   Barber FA, 2006, ARTHROSCOPY, V22, P820, DOI 10.1016/j.arthro.2006.04.096
   Baums MH, 2006, KNEE SURG SPORT TR A, V14, P865, DOI 10.1007/s00167-006-0049-2
   BOSTMAN OM, 1992, CLIN ORTHOP RELAT R, P193
   Bostman OM, 2000, CLIN ORTHOP RELAT R, P216
   Brand J, 2000, AM J SPORT MED, V28, P761, DOI 10.1177/03635465000280052501
   Bush-Joseph C A, 1998, Am J Knee Surg, V11, P32
   Ciccone W J 2nd, 2001, J Am Acad Orthop Surg, V9, P280
   FROKJAER J, 1992, ACTA ORTHOP SCAND, V63, P434, DOI 10.3109/17453679209154762
   Gefen A, 2002, MED ENG PHYS, V24, P337, DOI 10.1016/S1350-4533(02)00027-9
   Goetzen N, 2005, J BIOMECH, V38, P595, DOI 10.1016/j.jbiomech.2004.01.023
   Han I, 2005, AM J SPORT MED, V33, P1742, DOI 10.1177/0363546505275150
   Hovis WD, 1997, FOOT ANKLE INT, V18, P128, DOI 10.1177/107110079701800303
   Krappel FA, 2006, ARCH ORTHOP TRAUM SU, V126, P615, DOI 10.1007/s00402-006-0101-1
   Macarini Luca, 2004, Radiol Med, V107, P47
   Marumo K, 2006, J ORTHOP SCI, V11, P154, DOI 10.1007/s00776-005-0989-2
   MATTHEWS L S, 1989, Arthroscopy, V5, P225, DOI 10.1016/0749-8063(89)90177-1
   Middleton JC, 1998, MED PLASTICS BIO MAR, P31
   Moonot P, 2006, KNEE SURG SPORT TR A, V14, P1004, DOI 10.1007/s00167-005-0010-9
   Park MC, 2006, ARTHROSCOPY, V22
   Pihlajamaki H, 1997, BIOMATERIALS, V18, P1311, DOI 10.1016/S0142-9612(97)00068-9
   Resinger C, 2005, ARTHROSCOPY, V21, P1398, DOI 10.1016/j.arthro.2005.08.0351398
   Sassmannshausen Greg, 2003, Arthroscopy, V19, pE133, DOI 10.1016/j.arthro.2003.09.017
   SHELLOCK FG, 1992, JMRI-J MAGN RESON IM, V2, P225, DOI 10.1002/jmri.1880020217
   Sidhu DS, 1997, AM J SPORT MED, V25, P268, DOI 10.1177/036354659702500223
   Weiler A, 2000, ARTHROSCOPY, V16, P305, DOI 10.1016/S0749-8063(00)90055-0
   Wilson TC, 2004, AM J SPORT MED, V32, P543, DOI 10.1177/0363546504263151
   Zantop T, 2006, ARTHROSCOPY, V22, P1204, DOI 10.1016/j.arthro.2006.06.015
NR 29
TC 19
Z9 19
U1 0
U2 12
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0942-2056
J9 KNEE SURG SPORT TR A
JI Knee Surg. Sports Traumatol. Arthrosc.
PD JUL
PY 2008
VL 16
IS 7
BP 655
EP 660
DI 10.1007/s00167-008-0528-8
PG 6
WC Orthopedics; Sport Sciences; Surgery
SC Orthopedics; Sport Sciences; Surgery
GA 320IV
UT WOS:000257227800006
PM 18418577
DA 2018-10-19
ER

PT J
AU Wettero, J
   Hellerstedt, T
   Nygren, P
   Broo, K
   Aili, D
   Liedberg, B
   Magnusson, KE
AF Wettero, Jonas
   Hellerstedt, Tobias
   Nygren, Patrik
   Broo, Klas
   Aili, Daniel
   Liedberg, Bo
   Magnusson, Karl-Eric
TI Immobilized chemoattractant peptides mediate adhesion and distinct
   calcium-dependent cell signaling in human neutrophils
SO LANGMUIR
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYERS; LEUKOCYTE CHEMOSENSORY MIGRATION; VASCULAR
   PROSTHETIC BIOMATERIAL; POLYMORPHONUCLEAR LEUKOCYTES; CHEMOTACTIC
   FACTORS; AMINO-ACIDS; RECEPTOR; BINDING; SPECTROSCOPY; COMPLEMENT
AB Chemotaxis is the stimulated directional migration of cells in response to chemotactic factors, manifested for instance during leukocyte interaction with chemoattractants in inflammation. The N-formyl-Met-Leu-Phe (fMLF) bacterial peptide family is particularly potent in attracting and activating neutrophilic granulocytes. To accomplish defined circumstances for recruitment and activation of cells, we fabricated semitransparent gold-coated glass coverslips functionalized with chemoattractant fMLF receptor peptide agonist analogues. Peptides based on a common leading four-amino-acid sequence Gly-Gly-Gly-Cys were thus coupled to two potent fMLF receptor agonists, N-formyl-Tyr-Nle-Phe-Leu-Nle-Gly-Gly-Gly-Cys and N-formyl-Met-Leu-Phe-Gly-Gly-Gly-Cys, and a formylated control peptide, N-formyl-Gly-Gly-Gly-Cys. They were anchored via the SH group of Cys either directly to the gold surface or a mixed self-assembled monolayer composed of maleimide- and hydroxyl-terminated oligo(ethylene glycol) alkyldisulfides. The overall peptide immobilization procedure was characterized with ellipsometry, contact angle measurement, and infrared spectroscopy. When exposed to granulocytes, the agonist surface rapidly recruited neutrophils and the cells responded with extensive spreading and intracellular calcium transients within minutes. The reference peptide generated no such activation, and the cells maintained a more spherical morphology, suggesting that we have been able to immobilize chemoattractant receptor agonist peptides with retained bioactivity. This is a crucial step in designing surfaces with specific effects on cellular behavior.
C1 [Wettero, Jonas] Linkoping Univ, Dept Clin & Expt Med, Rheumatol AIR, Linkoping, Sweden.
   [Hellerstedt, Tobias; Nygren, Patrik; Aili, Daniel; Liedberg, Bo] Linkoping Univ, Dept Phys Biol & Chem, Div Mol Phys, Linkoping, Sweden.
   [Broo, Klas] Univ Gothenburg, Sahlgrenska Univ Hosp, Gothenburg, Sweden.
RP Wettero, J (reprint author), Linkoping Univ, Dept Clin & Expt Med, Rheumatol AIR, Linkoping, Sweden.
EM jonwe@imk.liu.se
RI Liedberg, Bo/N-6093-2014; Nygren, Patrik/B-7319-2015; Aili,
   Daniel/L-2668-2013; Wettero, Jonas/C-9578-2009
OI Nygren, Patrik/0000-0002-9233-2859; Aili, Daniel/0000-0002-7001-9415;
   Wettero, Jonas/0000-0002-6916-5490; Magnusson,
   Karl-Eric/0000-0002-7809-8437
CR ANDERSON DC, 1986, J IMMUNOL, V137, P15
   Andersson J, 2005, BIOMATERIALS, V26, P1477, DOI 10.1016/j.biomaterials.2004.05.011
   BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453
   Boyum A, 1968, Scand J Clin Lab Invest Suppl, V97, P77
   Brock A, 2003, LANGMUIR, V19, P1611, DOI 10.1021/la026394k
   Chang CC, 2000, J MATER SCI-MATER M, V11, P337, DOI 10.1023/A:1008925722623
   Chang CC, 2000, BIOMATERIALS, V21, P2305, DOI 10.1016/S0142-9612(00)00157-5
   CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002
   Cohen M, 2004, CHEMBIOCHEM, V5, P1393, DOI 10.1002/cbic.200400162
   DAHLGREN C, 1984, J IMMUNOL METHODS, V75, P23, DOI 10.1016/0022-1759(84)90221-7
   Dahlgren C, 1999, J IMMUNOL METHODS, V232, P3, DOI 10.1016/S0022-1759(99)00146-5
   Ekeroth J, 2002, J COLLOID INTERF SCI, V254, P322, DOI 10.1006/cjis.2002.8576
   EKEROTH J, 2002, THESIS LINKOPING U L
   Entschladen F, 2005, EXP CELL RES, V307, P418, DOI 10.1016/j.yexcr.2005.03.029
   FERRANTE A, 1980, J IMMUNOL METHODS, V36, P109, DOI 10.1016/0022-1759(80)90036-8
   Frow Emma K, 2004, Med Res Rev, V24, P276, DOI 10.1002/med.10062
   Fu HM, 2008, J IMMUNOL METHODS, V331, P50, DOI 10.1016/j.jim.2007.11.005
   Fu HM, 2006, J LEUKOCYTE BIOL, V79, P247, DOI 10.1189/jlb.0905498
   GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Houseman BT, 2003, LANGMUIR, V19, P1522, DOI 10.1021/la0262304
   IHS A, 1990, J COLLOID INTERF SCI, V140, P192, DOI 10.1016/0021-9797(90)90335-L
   ISLAM LN, 1985, J IMMUNOL METHODS, V85, P137, DOI 10.1016/0022-1759(85)90282-0
   ISSEKUTZ A, 1983, J IMMUNOL METHODS, V59, P19, DOI 10.1016/0022-1759(83)90141-2
   JACKSON M, 1995, CRIT REV BIOCHEM MOL, V30, P95, DOI 10.3109/10409239509085140
   JOHANSSON B, 1993, J CELL BIOL, V121, P1281, DOI 10.1083/jcb.121.6.1281
   Johnson Z, 2005, CYTOKINE GROWTH F R, V16, P625, DOI 10.1016/j.cytogfr.2005.04.006
   KAISER E, 1970, ANAL BIOCHEM, V34, P595, DOI 10.1016/0003-2697(70)90146-6
   Kuschert GSV, 1999, BIOCHEMISTRY-US, V38, P12959, DOI 10.1021/bi990711d
   Lang K, 2003, SCAND J IMMUNOL, V57, P350, DOI 10.1046/j.1365-3083.2003.01247.x
   LEVITT M, 1978, BIOCHEMISTRY-US, V17, P4277, DOI 10.1021/bi00613a026
   Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156
   LIEDBERG B, 1986, J COLLOID INTERF SCI, V114, P386, DOI 10.1016/0021-9797(86)90424-8
   Loitto VM, 2001, J LEUKOCYTE BIOL, V69, P762
   McCrackin F. L., 1969, 479 NBS
   Middleton J, 1997, CELL, V91, P385, DOI 10.1016/S0092-8674(00)80422-5
   MOGHE PV, 1995, J IMMUNOL METHODS, V180, P193, DOI 10.1016/0022-1759(94)00314-M
   Mrksich M, 1996, P NATL ACAD SCI USA, V93, P10775, DOI 10.1073/pnas.93.20.10775
   NIEDEL J, 1979, J BIOL CHEM, V254, P700
   Panaro MA, 1999, IMMUNOPHARM IMMUNOT, V21, P397, DOI 10.3109/08923979909007117
   PARIKH AN, 1992, J CHEM PHYS, V96, P927, DOI 10.1063/1.462847
   REMES JJ, 1993, EXP CELL RES, V209, P26, DOI 10.1006/excr.1993.1280
   Selvatici R, 2006, EUR J PHARMACOL, V534, P1, DOI 10.1016/j.ejphar.2006.01.034
   SHOWELL HJ, 1976, J EXP MED, V143, P1154, DOI 10.1084/jem.143.5.1154
   Simon SI, 2005, ANNU REV BIOMED ENG, V7, P151, DOI 10.1146/annurev.biomed.7.060804.100423
   Sjoberg A, 2005, J BIOL CHEM, V280, P32301, DOI 10.1074/jbc.M504828200
   SOON L, 2007, J MICROSC RES TECH, V70, P252
   Stenfeldt AL, 2007, INFLAMMATION, V30, P224, DOI 10.1007/s10753-007-9040-4
   TSIEN RY, 1985, CELL CALCIUM, V6, P145, DOI 10.1016/0143-4160(85)90041-7
   UHING JR, 1999, INFLANUNATION BASIC, P607
   Valiokas R, 1999, LANGMUIR, V15, P3390, DOI 10.1021/la981647o
   Wettero J, 2003, J BIOMED MATER RES A, V66A, P162, DOI 10.1002/jbm.a.10591
   Wettero J, 2002, BIOMATERIALS, V23, P981, DOI 10.1016/S0142-9612(01)00203-4
   WITT DP, 1994, CURR BIOL, V4, P394, DOI 10.1016/S0960-9822(00)00088-9
   Zhao XJ, 2005, BIOMATERIALS, V26, P5048, DOI 10.1016/j.biomaterials.2004.12.003
   ZICHA D, 1991, J CELL SCI, V99, P769
   ZIGMOND SH, 1977, J CELL BIOL, V75, P606, DOI 10.1083/jcb.75.2.606
   ZIGMOND SH, 1973, J EXP MED, V137, P387, DOI 10.1084/jem.137.2.387
NR 58
TC 10
Z9 10
U1 0
U2 7
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD JUL 1
PY 2008
VL 24
IS 13
BP 6803
EP 6811
DI 10.1021/la703502y
PG 9
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 318OI
UT WOS:000257101100057
PM 18507416
DA 2018-10-19
ER

PT J
AU Wirth, C
   Grosgogeat, B
   Lagneau, C
   Jaffrezic-Renault, N
   Ponsonnet, L
AF Wirth, Carine
   Grosgogeat, Brigitte
   Lagneau, Christelle
   Jaffrezic-Renault, Nicole
   Ponsonnet, Laurence
TI Biomaterial surface properties modulate in vitro rat calvaria
   osteoblasts response: Roughness and or chemistry?
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT 5th Maghreb/Europe Meeting on Materials and Their Applications for
   Devices and Physical, Chemical and Biological Sensors (MADICA 2006)
CY OCT 30-NOV 01, 2006
CL Mahdia, TUNISIA
DE nickel-titanium; roughness; chemistry; wettability; osteoblast
ID NICKEL-TITANIUM ALLOY; SHAPE-MEMORY ALLOY; CELL RESPONSE;
   HISTOMORPHOMETRIC ANALYSIS; BONE; ADHESION; BEHAVIOR; BIOCOMPATIBILITY;
   NITINOL; MINERALIZATION
AB The aim of this study was a better understanding of the regulation mechanisms of in vitro osteoblast activity on biomaterials. Rat osteoblast behaviour on different surfaces was studied. Surfaces with different roughness (and a similar surface chemistry) or with different surface chemistry (and a similar roughness) were compared. Cellular morphology was observed by scanning electron microscopy and cell adhesion was quantified using an image analysis system. Osteoblast proliferation was quantified by a MTT test and total protein content and alkaline phosphatase (ALP) activity were evaluated by spectrophotometry. Data were compared by statistical analysis.
   Results showed that NiTi surface roughness did not influence osteoblasts morphology, adhesion, total protein content and ALP activity whereas it modulated cell proliferation. Roughness was shown to stimulate cell proliferation. For smooth surfaces exhibiting two different chemical compositions, adhesion rate was found to be higher on Thermanox (R) than on NiTi whereas proliferation was shown to be smaller. ALP activity was also modulated by surface chemistry. Thus, cell adhesion and ALP activity were found to be more governed by surface chemistry than by roughness whereas cell proliferation was shown to be modulated by roughness (this effect increasing during cell culture) and by chemistry (this effect remaining stable in time) together. Total protein content and cell morphology were found to be independent of both parameters (roughness and chemistry). Effects of surface chemistry were discussed in terms of wettability and electron acceptor/donor properties of the surfaces of interest. Immunofluorescence images of adhesion proteins could not demonstrate differences between the three surfaces. (c) 2007 Elsevier B.V. All rights reserved.
C1 [Ponsonnet, Laurence] Univ Rouen, Lab Polymeres Biopolymeres & Membranes, CNRS, UMR 6522, F-76821 Mont St Aignan, France.
   [Wirth, Carine; Grosgogeat, Brigitte; Lagneau, Christelle] Univ Lyon 1, Lab Etud Interfaces & Biofilms Odontol, F-69372 Lyon, France.
   [Grosgogeat, Brigitte] Univ Lyon 1, CNRS, UMR 5615, Lab Multimat & Interfaces, F-69622 Lyon, France.
   [Jaffrezic-Renault, Nicole] Univ Lyon 1, CNRS, UMR 5180, Sci Analyt Lab, F-69622 Lyon, France.
RP Ponsonnet, L (reprint author), Univ Rouen, Lab Polymeres Biopolymeres & Membranes, CNRS, UMR 6522, F-76821 Mont St Aignan, France.
EM laurence.ponsonnet@galilee.univ-paris13.fr
CR Ahmad M, 1999, J BIOMED MATER RES, V46, P121, DOI 10.1002/(SICI)1097-4636(199907)46:1<121::AID-JBM14>3.0.CO;2-P
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Anselme K, 2002, J BIOMED MATER RES, V60, P529, DOI 10.1002/jbm.10101
   Assad M, 1998, J BIOMED MATER RES, V41, P154, DOI 10.1002/(SICI)1097-4636(199807)41:1<154::AID-JBM18>3.3.CO;2-0
   Ayers RA, 1999, J BIOMED MATER RES, V45, P42
   Bierbaum S, 2003, J BIOMED MATER RES A, V67A, P431, DOI 10.1002/jbm.a.10084
   BOUVIER M, 1994, CELL MATER, V4, P135
   Boyan BD, 1998, J BIOMED MATER RES, V39, P77, DOI 10.1002/(SICI)1097-4636(199801)39:1<77::AID-JBM10>3.0.CO;2-L
   Boyan BD, 2002, CALCIFIED TISSUE INT, V71, P519, DOI 10.1002/s00223-001-1114-y
   BRAUN G, 1995, CLIN ORAL IMPLAN RES, V6, P1, DOI 10.1034/j.1600-0501.1995.060101.x
   BUEHLER WJ, 1963, J APPL PHYS, V34, P1475, DOI 10.1063/1.1729603
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   Castellani R, 1999, CLIN ORAL IMPLAN RES, V10, P369, DOI 10.1034/j.1600-0501.1999.100504.x
   CASTLEMAN LS, 1976, J BIOMED MATER RES, V10, P695, DOI 10.1002/jbm.820100505
   Chou LS, 1996, J BIOMED MATER RES, V31, P209
   Defilippi P, 1999, MICROSC RES TECHNIQ, V47, P67, DOI 10.1002/(SICI)1097-0029(19991001)47:1<67::AID-JEMT7>3.3.CO;2-G
   Dubois JC, 1999, BIOMATERIALS, V20, P1841, DOI 10.1016/S0142-9612(99)00082-4
   Feng B, 2003, BIOMATERIALS, V24, P4663, DOI 10.1016/S0142-9612(03)00366-1
   GROESSNERSCHREIBER B, 1992, J CELL SCI, V101, P209
   Hatano K, 1999, BONE, V25, P439, DOI 10.1016/S8756-3282(99)00192-1
   HEAD WC, 1995, CLIN ORTHOP RELAT R, V311, P85
   Kapanen A, 2001, BIOMATERIALS, V22, P2475, DOI 10.1016/S0142-9612(00)00435-X
   Kapanen A, 2002, BIOMATERIALS, V23, P645, DOI 10.1016/S0142-9612(01)00143-0
   Krause A, 2000, J BIOMED MATER RES, V52, P738, DOI 10.1002/1097-4636(20001215)52:4<738::AID-JBM19>3.0.CO;2-F
   Ku CH, 2002, BIOMATERIALS, V23, P4193, DOI 10.1016/S0142-9612(02)00161-8
   Kulkarni RP, 1999, BJU INT, V83, P755
   KUNETSOV MV, 1992, J ELECT SPECTROSC RE, V58, P169
   Liao HH, 2003, BIOMATERIALS, V24, P649, DOI 10.1016/S0142-9612(02)00379-4
   Linez-Bataillon P, 2002, BIOMOL ENG, V19, P133, DOI 10.1016/S1389-0344(02)00024-2
   LOWRY OH, 1954, J BIOL CHEM, V207, P19
   Mabboux F, 2004, COLLOID SURFACE B, V39, P199, DOI 10.1016/j.colsurfb.2004.08.002
   Mailhot JM, 1998, CLIN ORAL IMPLAN RES, V9, P43, DOI 10.1034/j.1600-0501.1998.090106.x
   Marks L S, 1999, Tech Urol, V5, P226
   Matsuzaka K, 2004, J BIOMED MATER RES A, V68A, P227, DOI 10.1002/jbm.a.10158
   Matsuzaka K, 2003, BIOMATERIALS, V24, P2711, DOI 10.1016/S0142-9612(03)00085-1
   Maxian SH, 1998, J BIOMED MATER RES, V40, P171, DOI 10.1002/(SICI)1097-4636(199805)40:2<171::AID-JBM1>3.0.CO;2-I
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Mueller L, 2003, J SURG RES, V114, P146, DOI 10.1016/S0022-4804(03)00252-X
   Mustafa K, 2000, CLIN ORAL IMPLAN RES, V11, P116, DOI 10.1034/j.1600-0501.2000.011002116.x
   Nattrass C, 1998, EUR J ORTHODONT, V20, P169, DOI 10.1093/ejo/20.2.169
   NEFUSSI JR, 1985, DIFFERENTIATION, V29, P160, DOI 10.1111/j.1432-0436.1985.tb00310.x
   Ponsonnet L, 2002, MAT SCI ENG C-BIO S, V21, P157, DOI 10.1016/S0928-4931(02)00097-8
   PONSONNET L, 2003, MAT SCI ENG C-BIO S, V23, P467
   PUTTERS JLM, 1992, EUR SURG RES, V24, P378, DOI 10.1159/000129231
   Rhalmi S, 1999, BIO-MED MATER ENG, V9, P151
   ROBEY PG, 1972, DISORDERS BONE MINER, P241
   Rosa AL, 2003, CLIN ORAL IMPLAN RES, V14, P43, DOI 10.1034/j.1600-0501.2003.140106.x
   Ryhanen J, 1999, J BIOMED MATER RES, V47, P472, DOI 10.1002/(SICI)1097-4636(19991215)47:4<472::AID-JBM3>3.0.CO;2-Z
   Ryhanen J, 1999, BIOMATERIALS, V20, P1309, DOI 10.1016/S0142-9612(99)00032-0
   Schneevoigt R, 1999, MED ENG PHYS, V21, P119, DOI 10.1016/S1350-4533(99)00034-X
   SIMON A, 2002, INTERET AFM BIOFONCT
   Skjodt H, 1994, CYTOKINES BONE METAB, P1
   Sun JS, 2004, BIOMATERIALS, V25, P607, DOI 10.1016/S0142-9612(03)00567-2
   Takeshita F, 1997, BIOMATERIALS, V18, P21, DOI 10.1016/S0142-9612(96)00051-8
   Thierry B, 2000, J BIOMED MATER RES, V51, P685, DOI 10.1002/1097-4636(20000915)51:4<685::AID-JBM17>3.0.CO;2-S
   Trepanier C, 1999, J BIOMED MATER RES, V48, P165, DOI 10.1002/(SICI)1097-4636(1999)48:2<165::AID-JBM11>3.0.CO;2-#
   Wever DJ, 1998, BIOMATERIALS, V19, P761, DOI 10.1016/S0142-9612(97)00210-X
   Wever DJ, 1997, BIOMATERIALS, V18, P1115, DOI 10.1016/S0142-9612(97)00041-0
   Wilke A, 1998, J BIOMED MATER RES, V40, P301, DOI 10.1002/(SICI)1097-4636(199805)40:2<301::AID-JBM15>3.0.CO;2-O
   Wirth C, 2005, MAT SCI ENG C-BIO S, V25, P51, DOI 10.1016/j.msec.2004.06.001
   Yang YZ, 2002, BIOMATERIALS, V23, P1383, DOI 10.1016/S0142-9612(01)00259-9
NR 61
TC 51
Z9 56
U1 0
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD JUL 1
PY 2008
VL 28
IS 5-6
SI SI
BP 990
EP 1001
DI 10.1016/j.msec.2007.10.085
PG 12
WC Materials Science, Multidisciplinary
SC Materials Science
GA 332IG
UT WOS:000258076100075
DA 2018-10-19
ER

PT J
AU Moscato, S
   Mattii, L
   D'Alessandro, D
   Cascone, MG
   Lazzeri, L
   Serino, LP
   Dolfi, A
   Bernardini, N
AF Moscato, Stefania
   Mattii, Letizia
   D'Alessandro, Delfo
   Cascone, Maria Grazia
   Lazzeri, Luigi
   Serino, Lorenzo Pio
   Dolfi, Arnelio
   Bernardini, Nunzia
TI Interaction of human gingival fibroblasts with PVA/gelatine
SO MICRON
LA English
DT Review
DE tissue engineering; biomimetic scaffolds; PVA; gelatine; human
   fibroblasts; extracellular matrix molecules; TGF-beta 1; RhoA;
   immunocytochemistry; ultrastructure
ID ACTIVATED PROTEIN-KINASE; CELL-CYCLE PROGRESSION; TRANSFORMING
   GROWTH-FACTOR-BETA-1; POLYMERIC SCAFFOLDS; STEM-CELLS; IN-VITRO;
   FIBRONECTIN; EXPRESSION; COLLAGENASE-3; ANGIOGENESIS
AB Tissue engineering scaffolds should be able to reproduce optimal microenvironments in order to support cell attachment, three-dimensional growth, migration and, regarding fibroblasts, must also promote extracellular matrix production. Various bioactive molecules are employed in the preparation of spongy scaffolds to obtain biomimetic matrices by either surface-coating or introducing them into the bulk composition of the biomaterial. The biomimetic properties of a spongy matrix composed of PVA combined with the natural component gelatine were evaluated by culturing human gingival fibroblasts on the scaffold. Cell adhesion, morphology and distribution within the scaffold were assessed by histology and electron microscopy; viability and metabolic activity as well as extracellular matrix production were analyzed by MTT assay, cytochemistry and immunocytochemistry. Fibroblasts interacted positively with PVA/gelatine. They adhered to the PVA/gelatine matrix in which they had good spreading activity and active metabolism; fibroblasts were also able to produce extracellular matrix molecules (type I collagen, fibronectin and laminin) compared to bi-dimensionally grown cells. The in situ creation of a biological matrix by human fibroblasts together with the ability to produce growth factor TGF-beta 1 and the intracellular signal transduction molecule RhoA, suggests that this kind of PVA/gelatine sponge may represent a suitable support for in vitro extracellular matrix production and connective tissue regeneration. (c) 2007 Elsevier Ltd. All rights reserved.
C1 [Moscato, Stefania; Mattii, Letizia; D'Alessandro, Delfo; Serino, Lorenzo Pio; Dolfi, Arnelio; Bernardini, Nunzia] Univ Pisa, Fac Med, Med Histol & Embriol Sect, Dept Human Morphol & Appl Biol, I-56126 Pisa, Italy.
   [Cascone, Maria Grazia; Lazzeri, Luigi] Univ Pisa, Dept Chem Engn, Fac Engn, I-56100 Pisa, Italy.
RP Bernardini, N (reprint author), Univ Pisa, Fac Med, Med Histol & Embriol Sect, Dept Human Morphol & Appl Biol, Via Roma 55, I-56126 Pisa, Italy.
EM n.bernardini@med.unipi.it
RI Moscato, Stefania/B-6151-2018; Mattii, Letizia/B-6123-2018
OI Moscato, Stefania/0000-0001-9283-6902; Mattii,
   Letizia/0000-0001-6835-7987
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.0.CO;2-J
   Alberts B., 2002, MOL BIOL CELL
   Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045
   Bernardini N, 1999, NEPHRON, V81, P289, DOI 10.1159/000045295
   Bourdoulous S, 1998, J CELL BIOL, V143, P267, DOI 10.1083/jcb.143.1.267
   Danen EHJ, 2000, J CELL BIOL, V151, P1413, DOI 10.1083/jcb.151.7.1413
   Fan HB, 2006, BIOMATERIALS, V27, P4573, DOI 10.1016/j.biomaterials.2006.04.013
   Fried K, 2005, EXP CELL RES, V307, P329, DOI 10.1016/j.yexcr.2005.04.009
   Konttinen YT, 2000, ARTHRITIS RES, V2, P348, DOI 10.1186/ar111
   Lavik E, 2004, APPL MICROBIOL BIOT, V65, P1, DOI 10.1007/s00253-004-1580-z
   Lee DY, 2005, ARCH DERMATOL RES, V296, P296, DOI 10.1007/s00403-004-0529-5
   Moscato S, 2006, J BIOMED MATER RES A, V76A, P214, DOI 10.1002/jbm.a.30538
   OVERALL CM, 1991, J BIOL CHEM, V266, P14064
   Patel N, 1998, FASEB J, V12, P1447
   Pierce RA, 1998, AM J RESP CELL MOL, V19, P237, DOI 10.1165/ajrcmb.19.2.3087
   Ravanti L, 1999, J BIOL CHEM, V274, P2446, DOI 10.1074/jbc.274.4.2446
   Reed MJ, 2003, MICROVASC RES, V65, P9, DOI 10.1016/S0026-2862(02)00026-2
   Reed MJ, 1998, AM J PATHOL, V152, P113
   REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208
   RIDLEY AJ, 1995, MOL CELL BIOL, V15, P1110
   Seliktar D, 2005, ANN NY ACAD SCI, V1047, P386, DOI 10.1196/annals.1341.034
   Shah M, 1999, AM J PATHOL, V154, P1115, DOI 10.1016/S0002-9440(10)65364-3
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Sottile J, 2002, MOL BIOL CELL, V13, P3546, DOI 10.1091/mbc.E02-01-0048
   Specchia N, 2001, J ORTHOPAED RES, V19, P294, DOI 10.1016/S0736-0266(00)00026-7
   Uria JA, 1998, J BIOL CHEM, V273, P9769, DOI 10.1074/jbc.273.16.9769
   Velling T, 2002, J BIOL CHEM, V277, P37377, DOI 10.1074/jbc.M206286200
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yoshinouchi T, 1999, EUR RESPIR J, V14, P579, DOI 10.1034/j.1399-3003.1999.14c16.x
   Zavan B, 2005, BIOMATERIALS, V26, P7038, DOI 10.1016/j.biomaterials.2005.04.067
NR 30
TC 36
Z9 41
U1 2
U2 17
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0968-4328
J9 MICRON
JI Micron
PD JUL
PY 2008
VL 39
IS 5
BP 569
EP 579
DI 10.1016/j.micron.2007.06.016
PG 11
WC Microscopy
SC Microscopy
GA 324QF
UT WOS:000257532400008
PM 17702585
DA 2018-10-19
ER

PT J
AU Noth, U
   Steinert, AF
   Tuan, RS
AF Noeth, Ulrich
   Steinert, Andre F.
   Tuan, Rocky S.
TI Technology Insight: adult mesenchymal stem cells for osteoarthritis
   therapy
SO NATURE CLINICAL PRACTICE RHEUMATOLOGY
LA English
DT Review
DE articular cartilage; biomaterial scaffold; gene delivery;
   osteoarthritis; mesenchymal stem cell
ID AUTOLOGOUS CHONDROCYTE IMPLANTATION; GENE-THERAPY; ARTICULAR-CARTILAGE;
   BONE-MARROW; CHONDROGENIC DIFFERENTIATION; OSTEOCHONDRAL DEFECTS; JOINT
   DISEASES; STROMAL CELLS; KNEE; REPAIR
AB Despite the high prevalence and morbidity of osteoarthritis (OA), an effective treatment for this disease is currently lacking. Restoration of the diseased articular cartilage in patients with OA is, therefore, a challenge of considerable appeal to researchers and clinicians. Techniques that cause multipotent adult mesenchymal stem cells (MSCs) to differentiate into cells of the chondrogenic lineage have led to a variety of experimental strategies to investigate whether MSCs instead of chondrocytes can be used for the regeneration and maintenance of articular cartilage. MSC-based strategies should provide practical advantages for the patient with OA. These strategies include use of MSCs as progenitor cells to engineer cartilage implants that can be used to repair chondral and osteochondral lesions, or as trophic producers of bioactive factors to initiate endogenous regenerative activities in the OA joint. Targeted gene therapy might further enhance these activities of MSCs. Delivery of MSCs might be attained by direct intra-articular injection or by graft of engineered constructs derived from cell-seeded scaffolds; this latter approach could provide a three dimensional construct with mechanical properties that are congruous with the weight-bearing function of the joint. Promising experimental and clinical data are beginning to emerge in support of the use of MSCs for regenerative applications.
C1 [Tuan, Rocky S.] NIAMSD, Cartilage Biol & Orthoped Branch, NIH, Bethesda, MD 20892 USA.
   [Noeth, Ulrich] Univ Wurzburg, Orthoped Ctr Musculoskeletal Res, Div Tissue Engn, Wurzburg, Germany.
RP Tuan, RS (reprint author), NIAMSD, Cartilage Biol & Orthoped Branch, NIH, Bldg 50,Room 1523,50 S Dr MSC 8022, Bethesda, MD 20892 USA.
EM tuanr@mail.nih.gov
RI Steinert, Prof. Dr., Andre/P-4559-2015
OI Steinert, Prof. Dr., Andre/0000-0002-4397-8434
FU Intramural NIH HHS
CR Aigner T, 2007, NAT CLIN PRACT RHEUM, V3, P391, DOI 10.1038/ncprheum0534
   Barry Frank P., 2003, Birth Defects Research, V69, P250, DOI 10.1002/bdrc.10021
   Bartlett W, 2005, J BONE JOINT SURG BR, V87B, P640, DOI 10.1302/0301-620X.87B5.15905
   Bentley G, 2003, J BONE JOINT SURG BR, V85B, P223, DOI 10.1302/0301-620X.85B2.13543
   Bert JM, 2002, ARTHROSCOPY, V18, P107, DOI 10.1053/jars.2002.36513
   Brooks PM, 2002, CURR OPIN RHEUMATOL, V14, P573, DOI 10.1097/01.BOR.0000025200.21474.83
   Buckwalter JA, 2006, BIORHEOLOGY, V43, P603
   Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886
   Chen FH, 2006, NAT CLIN PRACT RHEUM, V2, P373, DOI 10.1038/ncprheum0216
   Chen X, 2006, IMMUNOL CELL BIOL, V84, P413, DOI 10.1111/j.1440-1711.2006.01458.x
   De Bari C, 2007, CLIN SCI, V113, P339, DOI 10.1042/CS20070126
   Deschner J, 2003, CURR OPIN CLIN NUTR, V6, P289, DOI 10.1097/01.mco.0000068964.34812.2b
   Elders MJ, 2000, J RHEUMATOL, V27, P6
   Evans CH, 2005, P NATL ACAD SCI USA, V102, P8698, DOI 10.1073/pnas.0502854102
   Evans CH, 2004, GENE THER, V11, P379, DOI 10.1038/sj.gt.3302196
   Evans CH, 1996, HUM GENE THER, V7, P1261, DOI 10.1089/hum.1996.7.10-1261
   Evans CH, 2006, NAT CLIN PRACT RHEUM, V2, P344, DOI 10.1038/ncprheum0215
   Frisbie DD, 2002, GENE THER, V9, P12, DOI 10.1038/sj.gt.3301608
   Gelse K, 2003, ARTHRITIS RHEUM, V48, P430, DOI 10.1002/art.10759
   Gerwin N, 2006, ADV DRUG DELIVER REV, V58, P226, DOI 10.1016/j.addr.2006.01.018
   Gouze E, 2007, MOL THER, V15, P1114, DOI 10.1038/sj.mt.6300151
   Gunther JP, 2001, BEST PRACT RES CL RH, V15, P627, DOI 10.1053/berh.2001.0178
   Hangody L, 2003, J BONE JOINT SURG AM, V85A, P25, DOI 10.2106/00004623-200300002-00004
   Haupt JL, 2005, J ORTHOP RES, V23, P118, DOI 10.1016/j.orthres.2004.06.020
   Henderson I, 2005, KNEE, V12, P209, DOI 10.1016/j.knee.2004.07.002
   HOCHBERG MC, 1995, ARTHRITIS RHEUM, V38, P1541, DOI 10.1002/art.1780381104
   Hollander AP, 2006, TISSUE ENG, V12, P1787, DOI 10.1089/ten.2006.12.1787
   Im GI, 2006, TISSUE ENG, V12, P527, DOI 10.1089/ten.2006.12.527
   Kafienah W, 2007, ARTHRITIS RHEUM, V56, P177, DOI 10.1002/art.22285
   Kan I., 2007, V180, P219
   Knutsen G, 2004, J BONE JOINT SURG AM, V86A, P455, DOI 10.2106/00004623-200403000-00001
   Kolf CM, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2116
   Kuo CK, 2006, CURR OPIN RHEUMATOL, V18, P64, DOI 10.1097/01.bor.0000198005.88568.df
   Kuroda R, 2007, OSTEOARTHR CARTILAGE, V15, P226, DOI 10.1016/j.joca.2006.08.008
   Lee KBL, 2007, STEM CELLS, V25, P2964, DOI 10.1634/stemcells.2006-0311
   Leskela HV, 2003, BIOCHEM BIOPH RES CO, V311, P1008, DOI 10.1016/j.bbrc.2003.10.095
   Li WJ, 2006, TISSUE ENG, V12, P1775, DOI 10.1089/ten.2006.12.1775
   Li WJ, 2005, J BIOMED NANOTECHNOL, V1, P259, DOI 10.1166/jbn.2005.032
   Martin JA, 2004, CLIN ORTHOP RELAT R, pS96, DOI 10.1097/01.blo.0000143818.74887.b1
   Mi Z, 2003, ARTHRITIS RES THER, V5, pR132, DOI 10.1186/ar745
   Moseley JB, 2002, NEW ENGL J MED, V347, P81, DOI 10.1056/NEJMoa013259
   Mouw JK, 2005, OSTEOARTHR CARTILAGE, V13, P828, DOI 10.1016/j.joca.2005.04.020
   Murphy JM, 2003, ARTHRITIS RHEUM, V48, P3464, DOI 10.1002/art.11365
   Murphy JM, 2002, ARTHRITIS RHEUM, V46, P704, DOI 10.1002/art.10118
   Muschler GF, 2001, J ORTHOPAED RES, V19, P117, DOI 10.1016/S0736-0266(00)00010-3
   Nesic D, 2006, ADV DRUG DELIVER REV, V58, P300, DOI 10.1016/j.addr.2006.01.012
   Nixon AJ, 2005, GENE THER, V12, P177, DOI 10.1038/sj.gt.3302396
   Noth U, 2007, J BIOMED MATER RES A, V83A, P626, DOI 10.1002/jbm.a.31254
   Noth U, 2002, TISSUE ENG, V8, P131, DOI 10.1089/107632702753503126
   NOTH U, 2006, EUROPEAN MUSCULOSKEL, P62
   Peterson L, 2003, J BONE JOINT SURG AM, V85A, P17, DOI 10.2106/00004623-200300002-00003
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   QUARTO R, 1995, CALCIFIED TISSUE INT, V56, P123, DOI 10.1007/BF00296343
   Raghunath J, 2007, BIOTECHNOL APPL BIOC, V46, P73, DOI 10.1042/BA20060134
   Robbins PD, 2003, GENE THER, V10, P902, DOI 10.1038/sj.gt.3302040
   Scharstuhl A, 2007, STEM CELLS, V25, P3244, DOI 10.1634/stemcells.2007.0300
   Steinert AF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2195
   Terada S, 2005, J BIOMED MATER RES A, V75A, P907, DOI 10.1002/jbm.a.30505
   Trippel SB, 2004, GENE THER, V11, P351, DOI 10.1038/sj.gt.3302201
   Tuli R, 2003, ARTHRITIS RES THER, V5, P235, DOI 10.1186/ar991
   Uccelli A, 2007, TRENDS IMMUNOL, V28, P219, DOI 10.1016/j.it.2007.03.001
   Verbruggen G, 2006, RHEUMATOLOGY, V45, P129, DOI 10.1093/rheumatology/kei171
   Wakitani S, 2004, CELL TRANSPLANT, V13, P595, DOI 10.3727/000000004783983747
NR 63
TC 155
Z9 161
U1 5
U2 35
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1745-8382
J9 NAT CLIN PRACT RHEUM
JI Nat. Clin. Pract. Rheumatol.
PD JUL
PY 2008
VL 4
IS 7
BP 371
EP 380
DI 10.1038/ncprheum0816
PG 10
WC Rheumatology; Social Issues
SC Rheumatology; Social Issues
GA 320XP
UT WOS:000257268800013
PM 18477997
DA 2018-10-19
ER

PT J
AU Waese, EYL
   Kandel, RR
   Stanford, WL
AF Waese, Elaine Y. L.
   Kandel, Rita R.
   Stanford, William L.
TI Application of stem cells in bone repair
SO SKELETAL RADIOLOGY
LA English
DT Review
DE bone repair; osteoprogenitors; mesenchymal stromal cells; embryonic stem
   cells; pluripotent; scaffold
ID MARROW STROMAL CELLS; SEVERE OSTEOGENESIS IMPERFECTA; THERAPY POSITION
   STATEMENT; REGIONAL GENE-THERAPY; MESENCHYMAL STEM; IN-VITRO;
   INTERNATIONAL-SOCIETY; ARTICULAR-CARTILAGE; PROGENITOR CELLS; HUMAN FAT
AB Bone has the ability to repair minor injuries through remodeling. However, when the host source of osteoprogenitors is compromised at the defect site, one effective treatment may be cell-based therapy, as it replenishes the area of bone loss with cells possessing osteogenic potential. This review is a concise comparison of different types of stem cells that have the potential to be used in tissue-engineered scaffolds for bone repair. The clinical use of mesenchymal stem or stromal cells isolated from the bone marrow for treating various diseases has been well documented. However, the scarcity of these cells prompts the search for alternative sources of multipotential cells such as amniotic fluid stem cells and umbilical cord perivascular cells. Embryonic stem cells are another controversial source of cells with osteogenic potential. These cells have the ability to differentiate into all cell types of the adult body. Issues such as the use of human embryos and the risk of contamination from animal-derived culture components continue to prevent the therapeutic use of ESCs. As a result, abundant research has been carried out to design defined culture conditions for culturing ESCs, and alternative strategies such as the generation of induced pluripotent stem cells are being developed to eliminate the need for using embryos for cell derivation. In addition to the cell source, the ability to control stem cell differentiation into functional bone and the choice of biomaterial are also paramount objectives that are being examined in research and clinical trials.
C1 [Waese, Elaine Y. L.; Kandel, Rita R.; Stanford, William L.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada.
   [Kandel, Rita R.] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada.
   [Waese, Elaine Y. L.; Stanford, William L.] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3G9, Canada.
RP Stanford, WL (reprint author), Univ Toronto, Inst Biomat & Biomed Engn, 164 Coll St, Toronto, ON M5S 3G9, Canada.
EM william.stanford@utoronto.ca
RI Kandel, Rita/E-2149-2017
OI Kandel, Rita/0000-0003-4047-3913; Stanford, William/0000-0002-5813-8016
CR Ahmed N, 2007, SKELETAL RADIOL, V36, P909, DOI 10.1007/s00256-007-0333-3
   Ahn SE, 2006, BIOCHEM BIOPH RES CO, V340, P403, DOI 10.1016/j.bbrc.2005.12.020
   Baksh D, 2004, J CELL MOL MED, V8, P301, DOI 10.1111/j.1582-4934.2004.tb00320.x
   Bielby RC, 2004, TISSUE ENG, V10, P1518, DOI 10.1089/ten.2004.10.1518
   Boden SD, 2005, ORTHOP NURS, V24, P49
   Bonab MM, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-14
   Bonyadi M, 2003, P NATL ACAD SCI USA, V100, P5840, DOI 10.1073/pnas.1036475100
   Bruder SP, 1998, J ORTHOPAED RES, V16, P155, DOI 10.1002/jor.1100160202
   Bruder SP, 1999, CLIN ORTHOP RELAT R, pS68
   Bruder SP, 1998, J BONE JOINT SURG AM, V80A, P985, DOI 10.2106/00004623-199807000-00007
   Cao T, 2005, TISSUE CELL, V37, P325, DOI 10.1016/j.tice.2005.03.008
   Chiavegato A, 2007, J MOL CELL CARDIOL, V42, P746, DOI 10.1016/j.yjmcc.2006.12.008
   Chin ACP, 2007, J BIOTECHNOL, V130, P320, DOI 10.1016/j.jbiotec.2007.04.013
   D'Ippolito G, 1999, J BONE MINER RES, V14, P1115, DOI 10.1359/jbmr.1999.14.7.1115
   Dallari D, 2007, J BONE JOINT SURG AM, V89A, P2413, DOI 10.2106/JBJS.F.01026
   De Bari C, 2001, ARTHRITIS RHEUM, V44, P1928, DOI 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P
   De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274
   den Boer FC, 2003, J ORTHOPAED RES, V21, P521, DOI 10.1016/S0736-0266(02)00205-X
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Dragoo JL, 2003, J ORTHOP RES, V21, P622, DOI 10.1016/S0736-0266(02)00238-3
   Dragoo JL, 2005, PLAST RECONSTR SURG, V115, P1665, DOI 10.1097/01.PRS.0000161459.90856.AB
   Erices A, 2000, BRIT J HAEMATOL, V109, P235, DOI 10.1046/j.1365-2141.2000.01986.x
   Fehrer C, 2005, EXP GERONTOL, V40, P926, DOI 10.1016/j.exger.2005.07.006
   FRIEDENS.AJ, 1966, J EMBRYOL EXP MORPH, V16, P381
   Galotto M, 1999, EXP HEMATOL, V27, P1460, DOI 10.1016/S0301-472X(99)00076-4
   Gazit D, 1999, J GENE MED, V1, P121, DOI 10.1002/(SICI)1521-2254(199903/04)1:2<121::AID-JGM26>3.0.CO;2-J
   Gertow K, 2004, STEM CELLS DEV, V13, P421, DOI 10.1089/1547328041797499
   Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529
   Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234
   Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399
   Horwitz EM, 2001, BLOOD, V97, P1227, DOI 10.1182/blood.V97.5.1227
   Hyslop Louise A., 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405009804
   Jankowski RJ, 2002, GENE THER, V9, P642, DOI 10.1038/sj/gt/3301719
   Karp JM, 2006, STEM CELLS, V24, P835, DOI 10.1634/stemcells.2005-0383
   Kim K, 2007, SCIENCE, V315, P482, DOI 10.1126/science.1133542
   Kitoh H, 2004, BONE, V35, P892, DOI 10.1016/j.bone.2004.06.013
   Kneser U, 2006, J CELL MOL MED, V10, P7, DOI 10.1111/j.1582-4934.2006.tb00287.x
   Le Blanc K, 2005, TRANSPLANTATION, V79, P1607, DOI 10.1097/01.TP.0000159029.48678.93
   Lieberman JR, 1999, J BONE JOINT SURG AM, V81A, P905, DOI 10.2106/00004623-199907000-00002
   Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   Mano JF, 2007, J TISSUE ENG REGEN M, V1, P261, DOI 10.1002/term.37
   Marcacci M, 2007, TISSUE ENG, V13, P947, DOI 10.1089/ten.2006.0271
   Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181
   Muschler GF, 2003, CLIN ORTHOP RELAT R, P102, DOI 10.1097/01.blo.0000030504.43495.46
   NAKAHARA H, 1990, BONE, V11, P181, DOI 10.1016/8756-3282(90)90212-H
   O'Shea KS, 1999, ANAT REC, V257, P32, DOI 10.1002/(SICI)1097-0185(19990215)257:1<32::AID-AR6>3.0.CO;2-2
   OFLAHERTY E, 1995, BONE MARROW TRANSPL, V15, P207
   Oreffo ROC, 1998, SCAND J RHEUMATOL, V27, P415
   Perry CR, 1999, CLIN ORTHOP RELAT R, P71
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Prusa Andrea-Romana, 2002, Med Sci Monit, V8, pRA253
   Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516
   Redman S N, 2005, Eur Cell Mater, V9, P23
   Richards M, 2002, NAT BIOTECHNOL, V20, P933, DOI 10.1038/nbt726
   Rodriguez JP, 2000, J CELL BIOCHEM, V79, P557, DOI 10.1002/1097-4644(20001215)79:4<557::AID-JCB40>3.0.CO;2-H
   Rodriguez JP, 2004, J CELL BIOCHEM, V92, P745, DOI 10.1002/jcb.20119
   Sarugaser R, 2005, STEM CELLS, V23, P220, DOI 10.1634/stemcells.2004-0166
   Schnutgen F, 2006, METHOD ENZYMOL, V420, P100, DOI 10.1016/S0076-6879(06)20007-7
   SHAPIRO F, 1993, J BONE JOINT SURG AM, V75A, P532, DOI 10.2106/00004623-199304000-00009
   Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Takigami H, 2007, J ORTHOP RES, V25, P1333, DOI 10.1002/jor.20411
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Tu Q, 2007, TISSUE ENG, V13, P2431, DOI 10.1089/ten.2006.0406
   Tu QS, 2006, BIOCHEM BIOPH RES CO, V341, P1257, DOI 10.1016/j.bbrc.2006.01.092
   Wang JC, 2003, J BONE JOINT SURG AM, V85A, P905, DOI 10.2106/00004623-200305000-00020
   Wu L, 2007, MOL CELL BIOCHEM, V301, P83, DOI 10.1007/s11010-006-9399-9
   Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526
   Zhang X, 2006, CALCIFIED TISSUE INT, V79, P169, DOI 10.1007/s00223-006-0083-6
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 73
TC 38
Z9 43
U1 0
U2 18
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0364-2348
J9 SKELETAL RADIOL
JI Skeletal Radiol.
PD JUL
PY 2008
VL 37
IS 7
BP 601
EP 608
DI 10.1007/s00256-007-0438-8
PG 8
WC Orthopedics; Radiology, Nuclear Medicine & Medical Imaging
SC Orthopedics; Radiology, Nuclear Medicine & Medical Imaging
GA 304EF
UT WOS:000256092100002
PM 18193216
DA 2018-10-19
ER

PT J
AU Mok, JM
   Durrani, SK
   Piper, SL
   Hu, SS
   Deviren, V
   Berven, SH
   Burch, S
AF Mok, James M.
   Durrani, Salim K.
   Piper, Samantha L.
   Hu, Serena S.
   Deviren, Vedat
   Berven, Sigurd H.
   Burch, Shane
TI Extravasation of rhBMP-2 with use of postoperative drains after
   posterolateral spinal fusion
SO SPINE
LA English
DT Article
DE bone morphogenetic protein; rhBMP-2; BMP-2; leakage; extravasation;
   drains; posterolateral spinal fusion; collagen sponge
ID BONE MORPHOGENETIC PROTEIN-2; ANTERIOR INTERBODY FUSION; RAT ECTOPIC
   MODEL; NONHUMAN PRIMATE; BIOMATERIAL CARRIERS; GRAFT SUBSTITUTE;
   COLLAGEN SPONGES; IN-VIVO; ARTHRODESIS; SAFETY
AB Study Design. Prospective measurement of rhBMP-2 from drains in a cohort of patients undergoing posterolateral spinal fusion.
   Objective. To quantify the amount of rhBMP-2 that extravasates into drains after posterolateral fusion using its current commercially available form, rhBMP-2 within an absorbable collagen sponge.
   Summary of Background Data. Retention of rhBMP-2 at the fusion site is essential for clinical efficacy and avoidance of unintentional bony growth in other areas of the spine. In vitro studies have shown a large degree of rhBMP-2 release from the sponge within the first 48 hours. It is unknown what effect drainage may have on changing the local concentration of BMP at the posterolateral site.
   Methods. The entire contents of drains were collected for 48 hours after surgery from 9 patients who underwent instrumented posterolateral fusion with rhBMP-2. The total amount collected was calculated from the concentration of BMP-2 as measured by enzyme-linked immunosorbent assay.
   Results. A median 68 mu g of BMP-2 ( range, 13-498) was recovered from drains, representing a median 0.58% ( range, 0.21%-4.2%) of the amount implanted; adjusted for yield rate, a median 1.08% was recovered. No significant relationships were found between percentage of BMP-2 extravasation and amount implanted, number of levels, blood loss, and drainage output. A mean 54% of the total amount recovered was in the drain within the first 6 hours.
   Conclusion. The greater bleeding and muscular compression associated with posterolateral fusion did not result in a substantial amount of rhBMP-2 extravasation into postoperative drains. Based on the small rates of recovery, suction drains may be placed after even complex surgeries involving large blood loss without the loss of significant amounts of the implanted rhBMP-2 into the drain.
C1 [Mok, James M.; Durrani, Salim K.; Piper, Samantha L.; Hu, Serena S.; Deviren, Vedat; Berven, Sigurd H.; Burch, Shane] Univ Calif San Francisco, Dept Orthopaed Surg, San Francisco, CA 94143 USA.
RP Burch, S (reprint author), Univ Calif San Francisco, Dept Orthopaed Surg, 500 Parnassus,MU320-W,Box 0728, San Francisco, CA 94143 USA.
EM burchs@orthosurg.ucsf.edu
CR Barnes B, 2005, SPINE, V30, P1127, DOI 10.1097/01.brs.0000162623.48058.8c
   Boden SD, 1999, SPINE, V24, P1179, DOI 10.1097/00007632-199906150-00002
   Boden SD, 1998, J SPINAL DISORD, V11, P95
   Boden SD, 2002, SPINE, V27, P2662, DOI 10.1097/00007632-200212010-00005
   Bouxsein ML, 2001, J BONE JOINT SURG AM, V83A, P1219, DOI 10.2106/00004623-200108000-00012
   COOK SD, 1994, SPINE, V19, P1655, DOI 10.1097/00007632-199408000-00002
   Dimar J, 2006, SPINE, V31, P2540
   Dimar JR, 2006, SPINE, V31, P2534, DOI 10.1097/01.brs.0000240715.78657.81
   Friess W, 1999, INT J PHARM, V187, P91, DOI 10.1016/S0378-5173(99)00174-X
   Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010
   GLASSMAN SD, 2007, SPINE J, V8, P443
   Glassman SD, 2007, SPINE J, V7, P44, DOI 10.1016/j.spinee.2006.06.381
   Haid Jr RW, 2004, SPINE J, V4, P38
   Haid Regis W Jr, 2004, Spine J, V4, P527, DOI 10.1016/j.spinee.2004.03.025
   Hecht BP, 1999, SPINE, V24, P629, DOI 10.1097/00007632-199904010-00004
   Kwon Brian, 2005, Spine J, V5, p224S, DOI 10.1016/j.spinee.2005.02.007
   Li G, 1998, ACTA ORTHOP SCAND, V69, P420, DOI 10.3109/17453679808999060
   Li RH, 2001, TRENDS BIOTECHNOL, V19, P255, DOI 10.1016/S0167-7799(01)01665-1
   Martin GJ, 1999, J SPINAL DISORD, V12, P179, DOI 10.1097/00002517-199906000-00001
   Meyer RA, 1999, SPINE, V24, P747, DOI 10.1097/00007632-199904150-00004
   MUSCHLER GF, 1994, CLIN ORTHOP RELAT R, P229
   Patel Vikas V, 2006, Spine J, V6, P397, DOI 10.1016/j.spinee.2005.11.006
   Patel VV, 2006, SPINE, V31, P1201, DOI 10.1097/01.brs.0000217650.90861.99
   Poynton AR, 2002, SPINE, V27, pS40, DOI 10.1097/01.BRS.0000020734.34957.6A
   Sandhu HS, 2002, SPINE, V27, P567, DOI 10.1097/00007632-200203150-00003
   Sandhu HS, 1995, SPINE, V20, P2669, DOI 10.1097/00007632-199512150-00008
   SCHIMANDLE JH, 1995, SPINE, V20, P1326, DOI 10.1097/00007632-199506000-00002
   Sciadini MF, 2000, J ORTHOPAED RES, V18, P289, DOI 10.1002/jor.1100180218
   Seeherman H, 2005, CYTOKINE GROWTH F R, V16, P329, DOI 10.1016/j.cytogfr.2005.05.001
   Singh K, 2006, J SPINAL DISORD TECH, V19, P416, DOI 10.1097/00024720-200608000-00008
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 2001, J BONE JOINT SURG AM, V83A, pS128
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Winn SR, 1999, CLIN ORTHOP RELAT R, pS95
   Yoon ST, 2004, SPINE, V29, P2603, DOI 10.1097/01.brs.0000146103.94600.85
NR 36
TC 7
Z9 7
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0362-2436
J9 SPINE
JI SPINE
PD JUL 1
PY 2008
VL 33
IS 15
BP 1668
EP 1674
DI 10.1097/BRS.0b013e31817b6229
PG 7
WC Clinical Neurology; Orthopedics
SC Neurosciences & Neurology; Orthopedics
GA 322RS
UT WOS:000257393600009
PM 18594460
DA 2018-10-19
ER

PT J
AU Nettles, DL
   Kitaoka, K
   Hanson, NA
   Flahiff, CM
   Mata, BA
   Hsu, EW
   Chilkoti, A
   Setton, LA
AF Nettles, Dana L.
   Kitaoka, Kenichi
   Hanson, Neil A.
   Flahiff, Charlene M.
   Mata, Brian A.
   Hsu, Edward W.
   Chilkoti, Ashutosh
   Setton, Lori A.
TI In situ crosslinking elastin-like polypeptide gels for application to
   articular cartilage repair in a goat osteochondral defect model
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID AUTOLOGOUS CHONDROCYTE TRANSPLANTATION; TISSUE-ENGINEERED CARTILAGE;
   FULL-THICKNESS DEFECTS; PROTEIN-BASED POLYMERS; CULTURED CHONDROCYTES;
   HYDROGELS; MATRIX; SCAFFOLD; VITRO
AB The objective of this study was to evaluate an injectable, in situ crosslinkable elastin-like polypeptide (ELP) gel for application to cartilage matrix repair in critically sized defects in goat knees. One cylindrical, osteochondral defect in each of seven animals was filled with an aqueous solution of ELP and a biocompatible, chemical crosslinker, while the contralateral defect remained unfilled and served as an internal control. Joints were sacrificed at 3 (n=3) or 6 (n=4) months for MRI, histological, and gross evaluation of features of biomaterial performance, including integration, cellular infiltration, surrounding matrix quality, and new matrix in the defect. At 3 months, ELP-filled defects scored significantly higher for integration by histological and gross grading compared to unfilled defects. ELP did not impede cell infiltration but appeared to be partly degraded. At 6 months, new matrix in unfilled defects outpaced that in ELP-filled defects and scored significantly better for MRI evidence of adverse changes, as well as integration and proteoglycan-containing matrix via gross and histological grading. The ELP-crosslinker solution was easily delivered and formed stable, well-integrated gels that supported cell infiltration and matrix synthesis; however, rapid degradation suggests that ELP formulation modifications should be optimized for longer-term benefits in cartilage repair applications.
C1 [Nettles, Dana L.; Flahiff, Charlene M.; Chilkoti, Ashutosh; Setton, Lori A.] Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA.
   [Kitaoka, Kenichi] Kochi Med Sch, Dept Orthopaed Surg, Kochi, Japan.
   [Hanson, Neil A.] Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27708 USA.
   [Mata, Brian A.; Setton, Lori A.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27708 USA.
   [Hsu, Edward W.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.
RP Setton, LA (reprint author), Duke Univ, Dept Biomed Engn, 136 Hudson Hall,Box 90281,Sci Dr, Durham, NC 27708 USA.
EM setton@duke.edu
FU NIBIB NIH HHS [R01 EB002263-08, EB002263, R01 EB002263]
CR Betre H, 2006, BIOMATERIALS, V27, P91, DOI 10.1016/j.biomaterials.2005.05.071
   Betre H, 2002, BIOMACROMOLECULES, V3, P910, DOI 10.1021/bm0255037
   Brittberg M, 1996, CLIN ORTHOP RELAT R, P270
   Brittberg M, 2003, J BONE JOINT SURG AM, V85A, P109, DOI 10.2106/00004623-200300003-00017
   Bryant SJ, 2004, BIOTECHNOL BIOENG, V86, P747, DOI 10.1002/bit.20160
   Buckwalter JA, 1997, J BONE JOINT SURG AM, V79A, P612, DOI 10.2106/00004623-199704000-00022
   Buckwalter JA, 2002, CLIN ORTHOP RELAT R, P21, DOI 10.1097/01.blo.0000026073.30435.dc
   Buckwalter JA, 1997, J BONE JOINT SURG AM, V79A, P600, DOI 10.2106/00004623-199704000-00021
   BUCKWALTER JA, 1983, INSTR COURSE LECT, V32, P349
   Elisseeff J, 1999, PLAST RECONSTR SURG, V104, P1014, DOI 10.1097/00006534-199909040-00017
   GRANDE DA, 1989, J ORTHOP RES, V7, P208, DOI 10.1002/jor.1100070208
   HANSON NA, 2006, T ORTHOP RES SOC, V31
   Henderson IJP, 2003, J BONE JOINT SURG BR, V85B, P1060, DOI 10.1302/0301-620X.85B7.13782
   Hoemann CD, 2005, OSTEOARTHR CARTILAGE, V13, P318, DOI 10.1016/j.joca.2004.12.001
   Huber M, 2000, INVEST RADIOL, V35, P573, DOI 10.1097/00004424-200010000-00003
   Hunziker EB, 1999, OSTEOARTHR CARTILAGE, V7, P15, DOI 10.1053/joca.1998.0159
   Jackson DW, 2001, J BONE JOINT SURG AM, V83A, P53, DOI 10.2106/00004623-200101000-00008
   Lee J, 2001, BIOMACROMOLECULES, V2, P170, DOI 10.1021/bm0000900
   Lim DW, 2007, BIOMACROMOLECULES, V8, P1463, DOI 10.1021/bm061059m
   Mainil-Varlet P, 2003, J BONE JOINT SURG AM, V85A, P45, DOI 10.2106/00004623-200300002-00007
   Marlovits S, 2006, EUR J RADIOL, V57, P24, DOI 10.1016/j.ejrad.2005.08.009
   Marlovits S, 2004, EUR J RADIOL, V52, P310, DOI 10.1016/j.ejrad.2004.03.014
   McHale MK, 2005, TISSUE ENG, V11, P1768, DOI 10.1089/ten.2005.11.1768
   Meyer DE, 2002, BIOMACROMOLECULES, V3, P357, DOI 10.1021/bm015630n
   Meyer DE, 1999, NAT BIOTECHNOL, V17, P1112, DOI 10.1038/15100
   MUIR H, 1995, BIOESSAYS, V17, P1039, DOI 10.1002/bies.950171208
   Nagapudi K, 2002, MACROMOLECULES, V35, P1730, DOI 10.1021/ma011429t
   Nettles DL, 2004, ANN BIOMED ENG, V32, P391, DOI 10.1023/B:ABME.0000017552.65260.94
   Nowatzki PJ, 2004, BIOMATERIALS, V25, P1261, DOI 10.1016/S0142-9612(03)000365-5
   ODRISCOLL SW, 1988, J BONE JOINT SURG AM, V70A, P595, DOI 10.2106/00004623-198870040-00017
   Ong SR, 2006, BIOMATERIALS, V27, P1930, DOI 10.1016/j.biomaterials.2005.10.018
   Passaretti D, 2001, TISSUE ENG, V7, P805, DOI 10.1089/107632701753337744
   Recht M, 2003, SKELETAL RADIOL, V32, P185, DOI 10.1007/s00256-003-0631-3
   Saim AB, 2000, LARYNGOSCOPE, V110, P1694, DOI 10.1097/00005537-200010000-00023
   SANDBERG LB, 1981, NEW ENGL J MED, V304, P566, DOI 10.1056/NEJM198103053041004
   Silverman RP, 1999, PLAST RECONSTR SURG, V103, P1809, DOI 10.1097/00006534-199906000-00001
   Sims CD, 1996, PLAST RECONSTR SURG, V98, P843, DOI 10.1097/00006534-199610000-00015
   Stile RA, 1999, MACROMOLECULES, V32, P7370, DOI 10.1021/ma990130w
   Trabbic-Carlson K, 2003, BIOMACROMOLECULES, V4, P572, DOI 10.1021/bm025671z
   URRY DW, 1991, J BIOACT COMPAT POL, V6, P263, DOI 10.1177/088391159100600306
   URRY DW, 1992, PROG BIOPHYS MOL BIO, V57, P23, DOI 10.1016/0079-6107(92)90003-O
   Urry DW, 1998, J BIOMAT SCI-POLYM E, V9, P1015, DOI 10.1163/156856298X00316
   Verstraete KL, 2004, CLIN RADIOL, V59, P674, DOI 10.1016/j.crad.2004.01.012
NR 43
TC 58
Z9 58
U1 2
U2 19
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD JUL
PY 2008
VL 14
IS 7
BP 1133
EP 1140
DI 10.1089/ten.tea.2007.0245
PG 8
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 327WR
UT WOS:000257759700002
PM 18433311
OA Green Accepted
DA 2018-10-19
ER

EF